#Release Date: 2020-2-12
Geneid	Keywords
100009667	ENDOMETRIAL CARCINOMA#0.9166
10000	PROTEIN KINASE B#1.0047;BREAST CANCER#1.0021;PROTEIN KINASE#0.9926;TUMOR SUPPRESSOR#0.9906;CELL PROLIFERATION#0.9890;CELL GROWTH#0.9872;OVARIAN CANCER#0.9869;PROSTATE CANCER#0.9868;APOPTOSIS#0.9858;CANCER CELL#0.9808;SIGNALING PATHWAY#0.9799;CELL CYCLE#0.9797;BREAST CANCER CELL#0.9787;GROWTH FACTOR#0.9783;AUTOPHAGY#0.9743;GENE EXPRESSION#0.9716;OVARIAN#0.9715;AKT SIGNALING#0.9690;THYROID CANCER#0.9681;KINASE ACTIVITY#0.9666;SKELETAL MUSCLE#0.9651;APOPTOTIC#0.9584;ONCOGENIC#0.9542;TUMOR CELLS#0.9527;MICROCEPHALY#0.9454;CELL MIGRATION#0.9454;QUANTITATIVE REAL TIME#0.9451;ENDOTHELIAL CELL#0.9444;CELL DEATH#0.9412;T CELL#0.9402;LUNG CANCER#0.9396;POLYMERASE CHAIN REACTION#0.9338;RAPAMYCIN#0.9338;KINASE INHIBITOR#0.9279;TARGET OF RAPAMYCIN#0.9270;SIGNALING CASCADE#0.9236;GLYCOGEN SYNTHASE KINASE#0.9153;STEM CELL#0.9148;ANGIOGENESIS#0.9057;REVERSE TRANSCRIPTION#0.8998;ADIPOCYTE#0.8975;MITOGEN ACTIVATED PROTEIN#0.8909;HEPATOCELLULAR CARCINOMA#0.8838;PROTEIN SYNTHESIS#0.8746;MACROPHAGE#0.8650;M PHASE#0.8552;NERVOUS SYSTEM#0.8515;POTASSIUM CHANNEL#0.8452;SQUAMOUS CELL CARCINOMA#0.8426;CELL MOTILITY#0.8316;INSULIN-LIKE GROWTH FACTOR#0.8267;EPIDERMAL GROWTH FACTOR#0.8257;ADENOCARCINOMA#0.8239;TRANSCRIPTION FACTOR#0.8235;CELL CYCLE ARREST#0.8186;GLUCOSE UPTAKE#0.8172;GROWTH FACTOR RECEPTOR#0.8163;SIGNAL TRANSDUCTION#0.8010;PLASMA MEMBRANE#0.8009;RIBOSOMAL PROTEIN#0.7980;MUSCLE CELL#0.7955;2-DEOXYGLUCOSE#0.7944;ESTROGEN RECEPTOR#0.7938;SPINAL CORD#0.7936;EPILEPSY#0.7933;DUAL LUCIFERASE REPORTER#0.7892;MAPK SIGNALING#0.7881;INSULIN RECEPTOR#0.7814;RNA INTERFERENCE#0.7808;COLORECTAL CANCER#0.7802;B CELL#0.7739;GLIOBLASTOMA MULTIFORME#0.7655;BRAIN DEVELOPMENT#0.7637;CISPLATIN#0.7610;COLORECTAL#0.7545;HAIR CELL#0.7500;CARDIOMYOCYTE#0.7490;PROGENITOR CELL#0.7393;ENDOTHELIAL GROWTH FACTOR#0.7385;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7385;EPITHELIAL CELL#0.7323;LYMPH NODE#0.7148;INTELLECTUAL DISABILITY#0.7069;TAMOXIFEN#0.7042;DNA REPAIR#0.6858;SENESCENCE#0.6798;ANCHORAGE INDEPENDENT GROWTH#0.6785;MAP KINASE#0.6767;SIGNALLING PATHWAY#0.6755;GLUCOSE HOMEOSTASIS#0.6746;ATHEROSCLEROSIS#0.6670;HUMAN BREAST CANCER#0.6591;INSULIN RECEPTOR SUBSTRATE#0.6528;TUMOR TISSUES#0.6491;BREAST CANCER PATIENTS#0.6484;TYPE 2 DIABETES#0.6442;TOXICITY#0.6430;FOCAL ADHESION#0.6310;EXTRACELLULAR MATRIX#0.6269;DEVELOPMENTAL DELAY#0.6193;PROTEIN KINASE C#0.6165;SMOOTH MUSCLE CELL#0.6164;SMOOTH MUSCLE#0.6148;DRUG RESISTANCE#0.6022;AXON REGENERATION#0.6015;IMMUNE CELL#0.6002
10002	ENHANCED S-CONE SYNDROME#1.0764;PHOTORECEPTOR DEVELOPMENT#1.0406;RETINAL DEGENERATION#1.0346;PHOTORECEPTOR CELL#1.0224;RETINITIS PIGMENTOSA#1.0211;NUCLEAR HORMONE RECEPTOR#1.0201;RETINITIS#1.0149;INDUCED PLURIPOTENT STEM CELL#1.0068;TRANSCRIPTION FACTOR#1.0015;RETINAL DISEASE#0.9975;CARDIOMYOCYTE#0.9965;PLURIPOTENT STEM CELL#0.9909;LIGAND BINDING DOMAIN#0.9901;PROGENITOR CELL#0.9890;GENE EXPRESSION#0.9870;DNA BINDING#0.9864;STEM CELL#0.9736;OPSIN#0.9699;HUMAN EMBRYONIC STEM#0.9670;EMBRYONIC STEM CELL#0.9662;SIGNALING PATHWAY#0.9536;CELL CYCLE#0.9433;NEURAL RETINA#0.9337;POLYMERASE CHAIN REACTION#0.9298;CANCER CELL#0.9249;GROWTH FACTOR#0.9156;OPTICAL COHERENCE TOMOGRAPHY#0.8948;NUCLEAR LAYER#0.8930;CELL DIFFERENTIATION#0.8864;STROMAL CELL#0.8859;MOUSE EMBRYONIC STEM#0.8826;BLINDNESS#0.8741;NEURAL RETINA LEUCINE#0.8703;CELL PROLIFERATION#0.8703;OUTER NUCLEAR LAYER#0.8658;NIGHT BLINDNESS#0.8584;RETINAL DEVELOPMENT#0.8564;MESENCHYMAL STEM CELL#0.8540;CELL SURFACE#0.8494;RETINAL PIGMENT EPITHELIUM#0.8484;ENDOTHELIAL CELL#0.8429;HYPOXIA#0.8415;PHOTOTRANSDUCTION#0.8344;NEURAL STEM CELL#0.8338;HISTONE MODIFICATION#0.8293;TERATOMA#0.8135;BONE MARROW#0.8114;DECIDUALIZATION#0.8101;EXTRACELLULAR MATRIX#0.8094;LEUCINE#0.8024;BREAST CANCER#0.7820;APOPTOSIS#0.7736;REVERSE TRANSCRIPTION#0.7466;EPITHELIAL CELL#0.7449;CELL DEATH#0.7334;NERVOUS SYSTEM#0.7232;REGENERATION#0.7086;RETINOIC ACID#0.7027;STEM CELL DIFFERENTIATION#0.7015;MACROPHAGE#0.6979;ESTROGEN RECEPTOR#0.6860;CELL FATE DETERMINATION#0.6845;DNA METHYLATION#0.6801;PRECURSOR CELL#0.6790;EMBRYOID BODY#0.6747;INNER CELL MASS#0.6715;EPIBLAST#0.6666;FIBROBLAST GROWTH FACTOR#0.6596;NEURAL PROGENITOR CELL#0.6565;GERM CELL#0.6553;BETA CELL#0.6548;NEURAL CELL#0.6518;LYSINE#0.6298;HEMATOPOIETIC CELL#0.6293;NEURONAL CELLS#0.6263;HEPATOCYTE DIFFERENTIATION#0.6164;PARKINSON'S DISEASE#0.6148;GOOD MANUFACTURING PRACTICE#0.6143;TOXICITY#0.6075
100033819	LIVER CANCER#0.9746;STEM CELL#0.9622;CANCER STEM CELL#0.8215;EPITHELIAL BARRIER FUNCTION#0.6391;MESENCHYMAL STEM CELL#0.6170;CANCER CELL#0.6081
100048905	IFN-GAMMA#0.9004
100048912	ANTISENSE RNA#1.0771;CANCER CELL#1.0489;SIGNALING PATHWAY#1.0457;CYCLIN DEPENDENT KINASE INHIBITOR#1.0451;HEPATOCELLULAR CARCINOMA#1.0434;LUNG CANCER#1.0430;CYCLIN DEPENDENT KINASE#1.0405;KINASE INHIBITOR#1.0390;CELL PROLIFERATION#1.0380;POLYMERASE CHAIN REACTION#1.0359;CELL GROWTH#1.0353;PERIODONTITIS#1.0321;CORONARY ARTERY DISEASE#1.0261;APOPTOSIS#1.0254;ARTERY DISEASE#1.0234;QUANTITATIVE REAL TIME#1.0212;CORONARY ARTERY#1.0190;SQUAMOUS CELL CARCINOMA#1.0165;MYOCARDIAL INFARCTION#1.0135;CELL CYCLE#1.0131;OPEN ANGLE GLAUCOMA#1.0123;ATHEROSCLEROSIS#1.0115;ARTERY#1.0099;PRIMARY OPEN ANGLE GLAUCOMA#1.0084;TYPE 2 DIABETES#1.0016;GENE EXPRESSION#1.0009;PERIPHERAL BLOOD#1.0004;ONCOGENIC#0.9952;DNA METHYLATION#0.9927;TRANSCRIPTION FACTOR#0.9926;TUMOR SUPPRESSOR#0.9906;INTRACRANIAL ANEURYSM#0.9709;LUNG ADENOCARCINOMA#0.9692;LYMPH NODE#0.9656;SMOOTH MUSCLE#0.9608;INFLAMMATORY RESPONSE#0.9594;SENESCENCE#0.9550;HEART DISEASE#0.9548;ATHEROSCLEROTIC#0.9498;CORONARY HEART DISEASE#0.9464;COLORECTAL CANCER#0.9459;DUAL LUCIFERASE REPORTER#0.9433;TUMOR TISSUES#0.9288;REVERSE TRANSCRIPTION#0.9218;EPITHELIAL CELL#0.9218;LYMPH NODE METASTASIS#0.9200;CELL CYCLE ARREST#0.9197;ADENOCARCINOMA#0.9183;DIABETES MELLITUS#0.9151;SMOOTH MUSCLE CELL#0.9101;MUSCLE CELL#0.9093;BREAST CANCER#0.9013;HYPOXIA#0.8989;CELL MIGRATION#0.8968;GROWTH FACTOR#0.8959;ADJACENT NORMAL TISSUE#0.8951;CERVICAL CANCER#0.8845;ENDOTHELIAL CELL#0.8842;CEREBRAL INFARCTION#0.8840;OVARIAN CANCER#0.8806;CISPLATIN#0.8797;LIVER CANCER#0.8583;ENDOMETRIOSIS#0.8515;ACUTE MYELOID LEUKEMIA#0.8442;MYELOID LEUKEMIA#0.8424;POLYCOMB REPRESSIVE COMPLEX#0.8396;HYPERTENSION#0.8296;COLORECTAL#0.8208;VASCULAR SMOOTH MUSCLE CELL#0.8045;PROSTATE CANCER#0.7866;NORMAL TENSION GLAUCOMA#0.7688;SQUAMOUS CELL CANCER#0.7672;OVARIAN#0.7616;RETINOBLASTOMA#0.7615;WNT SIGNALING PATHWAY#0.7562;DIABETIC RETINOPATHY#0.7523;HYPOXIA INDUCIBLE FACTOR#0.7485;GLUCOSE METABOLISM#0.7476;ULCERATIVE COLITIS#0.7439;ACUTE MYOCARDIAL INFARCTION#0.7434;CERVICAL#0.7317;URIC ACID#0.7281;G1 PHASE#0.7270;APOPTOTIC#0.7191;AGGRESSIVE PERIODONTITIS#0.7162;TYPE 2 DIABETES MELLITUS#0.7100;2 DIABETES MELLITUS#0.7100;PROTEIN CODING GENE#0.7065;LOW DENSITY LIPOPROTEIN#0.6877;VASCULAR DISEASE#0.6843;OPTIC NERVE#0.6834;C REACTIVE PROTEIN#0.6719;PRO-INFLAMMATORY#0.6674;TUMOR NECROSIS FACTOR#0.6519;T CELL#0.6501;POLYCOMB REPRESSIVE COMPLEX 1#0.6313;STEM CELL#0.6283;PACLITAXEL#0.6280;CELL ADHESION#0.6278;LIPID METABOLISM#0.6263;ANGIOGENESIS#0.6261;NEPHROPATHY#0.6244;GROWTH REGULATOR#0.6206;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6108;CAROTID ARTERY STENOSIS#0.6101;THYROID CANCER#0.6091;CAROTID ARTERY#0.6083;VSMC PROLIFERATION#0.6044
100049160	INTENTION TO TREAT#0.6962
100049579	CARNITINE#1.0813;CARNITINE TRANSPORTER#1.0250;CARNITINE TRANSPORT#0.8986;L-CARNITINE#0.8253;MAMMARY GLAND#0.7898;ORGANIC CATION TRANSPORTER#0.7572;PEROXISOMAL MEMBRANE#0.6108
100049587	MYELOID CELL#0.9825;LECTIN#0.9397;INFLAMMATORY RESPONSE#0.8850;SIALIC ACID BINDING#0.8713;IMMUNE RESPONSE#0.7966;MONOCYTE#0.7778;GENE CONVERSION#0.7340;NEUTROPHIL#0.6462;PRO-INFLAMMATORY#0.6379
100049615	EPITHELIAL CELL#1.1799
10004	MUTAGENESIS#0.7419
10005	PALMITOYL-COA HYDROLASE ACTIVITY#1.1367;THIOESTERASE II#1.1340;COA HYDROLASE ACTIVITY#1.1117;ACYL COA THIOESTERASE#1.1044;PALMITOYL COA HYDROLASE#1.0966;COA HYDROLASE#1.0867;HYDROLASE ACTIVITY#1.0728;PALMITOYL#1.0723;PEROXISOMAL#1.0614;CARNITINE#1.0137;PEROXISOME#0.9897;COENZYME A#0.9722;L-CARNITINE#0.9239;ENZYME ACTIVITY#0.9124;MAMMARY GLAND#0.9032;ACYL COA HYDROLASE#0.8908;FATTY ACID SYNTHASE#0.8193;MITOCHONDRIA#0.8141;OLEIC ACID#0.8090;CLOFIBRATE#0.7876;COASH#0.7590;BLOOD PLATELETS#0.7002;GLUCOSE 6 PHOSPHATASE#0.6972;NUCLEOSOME#0.6965;ADIPOSE TISSUE#0.6856;PALMITIC ACID#0.6789;MICROSOME#0.6778;ACYLTRANSFERASE ACTIVITY#0.6749;URATE OXIDASE#0.6569;4'-PHOSPHOPANTETHEINE#0.6509;SYNTHETASE ACTIVITY#0.6500;LIPID METABOLISM#0.6416;FATTY ACID OXIDATION#0.6354;DICARBOXYLIC ACID#0.6316;NUCLEOSOME ASSEMBLY#0.6287;HISTONE CHAPERONE#0.6254;INTRACELLULAR LOCALIZATION#0.6077
10006	WAVE COMPLEX#1.0559;ABA SIGNALING#1.0549;ACTIN CYTOSKELETON#1.0207;CANCER CELL#1.0176;SIGNAL TRANSDUCTION#1.0100;COMPLEX I#1.0041;NUCLEOTIDE EXCHANGE FACTOR#1.0038;ACTIN POLYMERIZATION#1.0005;GROWTH FACTOR#0.9994;CELL MIGRATION#0.9987;STOMATAL CLOSURE#0.9685;COLORECTAL CARCINOMA#0.9601;PROTEIN KINASE#0.9592;OVARIAN CANCER#0.9538;SIGNALING PATHWAY#0.9484;CELL ADHESION#0.9349;GUANINE#0.9316;BREAST CANCER#0.9208;ANION CHANNEL#0.9160;GENE EXPRESSION#0.9105;ABA SIGNAL TRANSDUCTION#0.8889;EPIDERMAL GROWTH FACTOR#0.8816;WISKOTT ALDRICH SYNDROME#0.8629;COLORECTAL#0.8557;GERMINATION#0.8515;ACTIN CYTOSKELETON REMODELING#0.8480;DENDRITIC SPINE#0.8281;KINASE ACTIVITY#0.8023;COLORECTAL CANCER#0.8002;PLASMA MEMBRANE#0.7996;OVARIAN#0.7982;SIGNALLING PATHWAY#0.7945;TRANSCRIPTION FACTOR#0.7710;CELL PROLIFERATION#0.7631;BINDING PROTEIN 1#0.7561;GROWTH FACTOR RECEPTOR#0.7529;MORPHOGENESIS#0.7401;RNA INTERFERENCE#0.7277;REGULATION OF MACROPINOCYTOSIS#0.7261;EXTRACELLULAR MATRIX#0.7117;MACROPINOCYTOSIS#0.7037;ONCOGENIC#0.6928;NERVOUS SYSTEM#0.6914;SEED DORMANCY#0.6812;BREAST CANCER CELL#0.6747;RUFFLE#0.6697;RECEPTOR TYROSINE KINASE#0.6675;ENDOCYTOSIS#0.6576;SEED GERMINATION#0.6495;CAMKII#0.6398;PROTEIN COMPLEX#0.6335;TUMOR SUPPRESSOR#0.6287;KINASE INHIBITOR#0.6237;ACTIN FILAMENT#0.6120;DRUG RESISTANCE#0.6110;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.6106;B CELL#0.6065;Y CHROMOSOME#0.6012
100073347	OUTER MEMBRANE#1.0411;TOM COMPLEX#1.0281;TRANSCRIPTION FACTOR#0.9982;DNA BINDING#0.9429;GENE EXPRESSION#0.8753;MITOCHONDRIAL OUTER MEMBRANE#0.8748;CELL CYCLE#0.8597;TRANSACTIVATION#0.8327;MITOCHONDRIA#0.8244;PROMYELOCYTE#0.8143;APOPTOSIS#0.8079;GRANULOCYTE#0.7337;MITOCHONDRIAL MEMBRANE#0.7025;TOB COMPLEX#0.6861;CANCER CELL#0.6852;COMPLEX I#0.6754;SAM COMPLEX#0.6743;T CELL#0.6691;NEUTROPHIL#0.6686;ENHANCER BINDING PROTEIN#0.6452;ENHANCER BINDING#0.6447;ABT-263#0.6423;POLYMORPHONUCLEAR LEUKOCYTES#0.6155;HEMATOPOIETIC CELL#0.6128
10007	GLUCOSAMINE 6-PHOSPHATE#1.0851;GLUCOSAMINE#1.0670;FRUCTOSE -6-PHOSPHATE#1.0427;GLCNAC#1.0135;FRUCTOSE#1.0130;CATABOLISM#0.8588;GLUCOSE-6-PHOSPHATE#0.7863;FERTILIZATION#0.7353;CELL WALL#0.7251;GLYCOSYLATION#0.6709;GLUTAMINE#0.6647;2-DEOXY-D-GLUCOSE#0.6486;SPERMATOZOA#0.6445;PLASMA MEMBRANE#0.6400;OOCYTE#0.6371;ACROSOME REACTION#0.6210;DEAMINASE ACTIVITY#0.6157;N ACETYLGLUCOSAMINE KINASE#0.6124
10008	POTASSIUM CHANNEL#1.0219;PARALYSIS#0.9960;ION CHANNEL#0.9544;ACTION POTENTIAL#0.9001;ARRHYTHMIA#0.8922;SKELETAL MUSCLE#0.8687;EPITHELIAL CELL#0.8635;CHANNEL ACTIVITY#0.8484;OOCYTE#0.8476;ATRIAL FIBRILLATION#0.8178;CYSTIC FIBROSIS#0.7941;INNER EAR#0.7319;LONG QT SYNDROME#0.6967;SMALL INTESTINE#0.6895;BRUGADA SYNDROME#0.6230;LIPID RAFT#0.6067
100093630	CELL PROLIFERATION#0.9502;APOPTOSIS#0.9389;CELL CYCLE#0.8700;CANCER CELL#0.7317;SMALL NUCLEOLAR RNA#0.7166;DUAL LUCIFERASE REPORTER#0.6698;FASTING BLOOD GLUCOSE#0.6683;CELL COUNTING KIT#0.6669;PANCREATIC ADENOCARCINOMA#0.6114;ENDOMETRIAL CARCINOMA#0.6105;CEREBRAL ISCHEMIA#0.6027
10009	LUNG CANCER#1.0825;CANCER CELL#1.0617;ZINC FINGER PROTEIN#1.0590;TRANSCRIPTION FACTOR#1.0521;DNA BINDING#1.0369;BREAST CANCER#1.0363;GENE EXPRESSION#1.0361;CELL CYCLE#1.0265;CELL PROLIFERATION#1.0183;DNA METHYLATION#1.0084;METHYL CPG BINDING#0.9843;ENDOTHELIAL CELL#0.9667;LYMPH NODE#0.9584;BREAST CANCER CELL#0.9311;SIGNALING PATHWAY#0.9218;APOPTOSIS#0.8836;PROSTATE CANCER#0.8554;COLON CANCER#0.8527;CYTOPLASM#0.8370;CELL ADHESION#0.8226;NUCLEAR EXPORT#0.8215;EPITHELIAL CELL#0.7804;NUCLEAR IMPORT#0.7643;LYMPH NODE METASTASES#0.7606;EPITHELIAL MESENCHYMAL TRANSITION#0.7421;HUMAN CORNEAL ENDOTHELIAL#0.7175;CELL MIGRATION#0.7005;5-AZA-2'-DEOXYCYTIDINE#0.6940;2'-DEOXYCYTIDINE#0.6934;ELECTROPHORETIC MOBILITY SHIFT#0.6876;APOPTOTIC#0.6795;TUMOR SUPPRESSOR#0.6695;TRANSCRIPTION REPRESSOR#0.6358;INTESTINAL CANCER#0.6319;P53 BINDING#0.6188;SECRETORY CELL#0.6174;CELL DIFFERENTIATION#0.6158;INVASIVE BREAST CANCER#0.6126;INTESTINAL EPITHELIAL CELL#0.6086;CHRONIC MYELOID LEUKEMIA#0.6053
1000	ADH-1#1.0864;VSMC APOPTOSIS#1.0593;CADHERIN BINDING#1.0572;ZONULA OCCLUDENS 1#1.0518;ZONULA OCCLUDENS#1.0446;OSTEOBLAST DIFFERENTIATION#1.0295;INTERCALATED DISK#1.0260;INTERCALATED DISC#1.0175;CONNEXIN#1.0162;MYOBLAST#1.0160;SCHWANN CELL#1.0158;MYOGENESIS#1.0154;CATENIN COMPLEX#1.0151;NEURONAL MIGRATION#1.0150;OSTEOBLAST#1.0148;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0147;AXON GROWTH#1.0143;SMOOTH MUSCLE ACTIN#1.0134;DENDRITIC SPINE#1.0132;CHONDROGENESIS#1.0127;PERICYTE#1.0110;ENDOCYTOSIS#1.0109;NEURAL CELL#1.0081;MYOBLAST FUSION#1.0073;NEURITE OUTGROWTH#1.0068;CELL AGGREGATION#1.0067;SOMITE#1.0063;GROWTH CONE#1.0060;E BOX BINDING#1.0058;NEURAL RETINA#1.0052;GRANULOSA CELL#1.0049;NEURITE#1.0046;ASTROCYTE#1.0042;CORNEAL ENDOTHELIUM#1.0027;MAP KINASE#1.0023;SMOOTH MUSCLE#1.0022;CELL-CELL ADHESION MOLECULE#1.0018;BONE FORMATION#1.0014;SMOOTH MUSCLE CELL#1.0012;SCIATIC NERVE#1.0009;NEURAL CREST CELL#1.0000;TIGHT JUNCTION PROTEIN#0.9999;NEURAL CREST#0.9996;CARDIOMYOCYTE#0.9987;MUSCLE CELL#0.9980;NEURAL TUBE#0.9980;SYNAPTOGENESIS#0.9979;VASCULAR SMOOTH MUSCLE CELL#0.9976;CELL CELL JUNCTION#0.9975;STEM CELL MARKER#0.9969;CELL MEMBRANE#0.9956;CONTACT SITE#0.9955;ENDOMETRIUM#0.9953;HEMATOPOIETIC STEM CELL#0.9944;GLIAL CELL#0.9944;SERTOLI CELL#0.9941;TROPHOBLAST CELL#0.9933;ACTIN FILAMENT#0.9929;CELL JUNCTION#0.9921;MYOFIBRIL#0.9920;PROTEIN TYROSINE PHOSPHATASE#0.9919;MELANOCYTE#0.9919;ENDOTHELIUM#0.9913;CELL POLARITY#0.9909;RETINAL GANGLION CELL#0.9908;MESENCHYME#0.9906;MESENCHYMAL CELL#0.9899;KERATINOCYTE#0.9892;ENDOTHELIAL GROWTH FACTOR#0.9891;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9891;MESENCHYMAL TO EPITHELIAL TRANSITION#0.9889;SKELETAL MUSCLE#0.9887;ADHERENS JUNCTION#0.9882;BREAST CARCINOMA#0.9878;GAP JUNCTION#0.9878;MYOCYTES#0.9871;CONTACT INHIBITION#0.9870;MYOFIBROBLAST#0.9866;PROTEIN KINASE B#0.9866;FIBROBLAST GROWTH FACTOR#0.9864;SPINAL CORD#0.9857;PLASMA MEMBRANE#0.9856;PROTEIN KINASE C#0.9850;BLOOD TESTIS BARRIER#0.9842;CELL ADHESION MOLECULE#0.9841;CELL SURFACE#0.9840;CLEAVED CASPASE 3#0.9839;CELL MATRIX ADHESION#0.9839;B CELL#0.9833;INTERCELLULAR JUNCTION#0.9832;HEPATOCYTE GROWTH FACTOR#0.9831;DESMOSOME#0.9831;VSMC PROLIFERATION#0.9830;FOCAL ADHESION KINASE#0.9828;GROWTH FACTOR RECEPTOR#0.9828;MESOTHELIAL CELL#0.9825;LUNG ADENOCARCINOMA#0.9821;CELL CELL ADHESION#0.9821;EXCITATORY SYNAPSE#0.9818;STRESS FIBER#0.9813;TIGHT JUNCTION#0.9813;CYCLIN DEPENDENT KINASE#0.9813;GERM CELL#0.9813;BONE MORPHOGENETIC PROTEIN#0.9810;CELL MOTILITY#0.9809;LIPID RAFT#0.9803;MELANOMA CELL LINES#0.9802;NEURAL STEM CELL#0.9797;COLLAGEN TYPE I#0.9789;MESENCHYMAL EPITHELIAL TRANSITION#0.9788;EMBRYONIC STEM CELL#0.9779;FOCAL ADHESION#0.9777;NEURITE GROWTH#0.9774;ANDROGEN RECEPTOR#0.9767;CELL ADHESION#0.9760;HYPOXIA#0.9756;CELL DIVISION#0.9754;BASEMENT MEMBRANE#0.9753;CERVICAL#0.9749;CYTOPLASM#0.9748;CERVICAL CANCER#0.9748;NEURAL PLATE#0.9747;NEURONAL CELLS#0.9746;MICROTUBULE#0.9746;ESTROGEN RECEPTOR#0.9743;TROPHOBLAST#0.9742;MAPK SIGNALING#0.9741;ENDOMETRIAL CARCINOMA#0.9735;NEURITE EXTENSION#0.9734;ACTIN CYTOSKELETON#0.9733;CORNEAL ENDOTHELIAL CELL#0.9732;HYPOXIA INDUCIBLE FACTOR#0.9729;SIGNALING MOLECULE#0.9729;ENDOTHELIAL CELL#0.9724;CELL DIFFERENTIATION#0.9721;MORPHOGENESIS#0.9718;STROMA#0.9715;RECURRENCE FREE SURVIVAL#0.9714;BREAST CANCER PATIENTS#0.9713;HYPOXIC#0.9710;REVERSE TRANSCRIPTION#0.9709;MYOCARDIUM#0.9709;RNA INTERFERENCE#0.9707;PROGENITOR CELL#0.9700;GANGLION CELLS#0.9698;BLOOD VESSEL#0.9696;ENDOPLASMIC RETICULUM#0.9695;CHOLANGIOCARCINOMA#0.9693;SIGNAL TRANSDUCTION#0.9693;TUMOR TISSUES#0.9692;GASTRULATION#0.9688;T CELL#0.9688;QUANTITATIVE REVERSE TRANSCRIPTION#0.9686;RENAL CELL CARCINOMA#0.9684;ORAL SQUAMOUS CELL CARCINOMA#0.9682;SIGNALLING PATHWAY#0.9679;KINASE ACTIVITY#0.9678;LYMPH NODE METASTASES#0.9675;OVARIAN#0.9673;MULTIPLE MYELOMA#0.9672;BONE MARROW#0.9670;MACROPHAGE#0.9669;CEREBRAL CORTEX#0.9667;CENTRAL NERVOUS SYSTEM#0.9666;SIGNALING CASCADE#0.9666;OVARIAN CARCINOMA#0.9662;CARDIOMYOPATHY#0.9661;G1 PHASE#0.9660;TUBE FORMATION#0.9658;PANCREATIC CANCER#0.9653;KINASE INHIBITOR#0.9651;ADJACENT NORMAL TISSUE#0.9650;CISPLATIN#0.9649;AKT SIGNALING#0.9648;COLON CANCER#0.9645;LUNG CARCINOMA#0.9645;STROMAL CELL#0.9641;PROSTATE CANCER#0.9641;RECEPTOR TYROSINE KINASE#0.9637;FOLLICLE STIMULATING HORMONE#0.9636;MESENCHYMAL STEM CELL#0.9632;ALZHEIMER'S DISEASE#0.9629;ANGIOGENESIS#0.9629;OVARIAN CANCER#0.9628;EPIDERMAL GROWTH FACTOR#0.9628;TRANSCRIPTION FACTOR#0.9626;ADENOCARCINOMA#0.9626;S PHASE#0.9623;MITOGEN ACTIVATED PROTEIN#0.9622;APOPTOTIC#0.9620;GENE SILENCING#0.9619;CONNECTIVE TISSUE#0.9618;REGENERATION#0.9615;NERVOUS SYSTEM#0.9612;HUMAN BREAST CANCER#0.9612;B CELL LYMPHOMA#0.9610;CELL MOVEMENT#0.9609;POLYMERASE CHAIN REACTION#0.9609;CELL DEATH#0.9608;SIGNAL TRANSDUCER#0.9607;TRANSFORMING GROWTH FACTOR BETA#0.9602;GENE EXPRESSION#0.9601;CHONDROCYTE#0.9600;PROTEIN KINASE#0.9600;EPITHELIAL CELL#0.9595;WNT SIGNALING PATHWAY#0.9594;NUCLEUS PULPOSUS#0.9594;MAMMARY EPITHELIAL CELL#0.9593;TUMOR NECROSIS FACTOR#0.9593;EXTRACELLULAR MATRIX#0.9590;HEART DEVELOPMENT#0.9589;EPITHELIAL TO MESENCHYMAL#0.9589;MYOTUBE#0.9589;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9589;SPERMATOGENESIS#0.9586;HEPATOCELLULAR CARCINOMA CELL#0.9585;TUMOR CELLS#0.9583;BREAST CANCER CELL#0.9581;COMPLEX I#0.9579;GLYCOGEN SYNTHASE KINASE#0.9577;COLONY FORMATION ASSAY#0.9575;REACTIVE OXYGEN SPECIES#0.9573;GROWTH FACTOR#0.9572;LYMPH NODE METASTASIS#0.9572;AMYLOID PRECURSOR PROTEIN#0.9572;GLYCOSYLATION#0.9570;CANCER STEM CELL#0.9568;LIVER CANCER#0.9565;AUTOPHAGY#0.9565;STEM CELL#0.9564;SQUAMOUS CELL CARCINOMA#0.9563;DRUG RESISTANCE#0.9558;LUNG METASTASIS#0.9557;TRANSFORMING GROWTH FACTOR#0.9552;LYMPH NODE#0.9552;CELL MIGRATION#0.9552;EPITHELIAL MESENCHYMAL TRANSFORMATION#0.9549;QUANTITATIVE REAL TIME#0.9549;BREAST CANCER#0.9547;DUAL LUCIFERASE REPORTER#0.9546;EPITHELIAL MESENCHYMAL TRANSITION#0.9545;CELL GROWTH#0.9534;CELL COUNTING KIT#0.9534;DISEASE FREE SURVIVAL#0.9530;CELL CYCLE ARREST#0.9529;HISTOGENESIS#0.9523;ONCOGENIC#0.9521;ENDOMETRIAL CANCER#0.9516;TOXICITY#0.9508;PROTEOGLYCAN#0.9507;PERIPHERAL NERVE#0.9505;OSTEOGENESIS#0.9500;LUNG CANCER#0.9500;BLADDER CARCINOMA#0.9493;PLURIPOTENT STEM CELL#0.9492;HUMAN PANCREATIC CANCER#0.9492;PROTEIN COMPLEX#0.9491;CELL CYCLE#0.9487;COLORECTAL#0.9487;EPITHELIAL OVARIAN CANCER#0.9485;SYNAPTIC JUNCTION#0.9480;ALKALINE PHOSPHATASE#0.9477;TUMOR SUPPRESSOR#0.9477;COLORECTAL CANCER#0.9476;CANCER RELATED DEATH#0.9474;CANCER CELL#0.9473;APOPTOSIS#0.9472;INSULIN-LIKE GROWTH FACTOR#0.9470;HEPATOCELLULAR CARCINOMA#0.9461;SIGNALING PATHWAY#0.9459;NERVE FIBER#0.9446;PERIPHERAL NERVOUS SYSTEM#0.9444;CELL PROLIFERATION#0.9440;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9437;TRANSCRIPTASE#0.9436;WOUND HEALING#0.9428;RETINAL PIGMENT EPITHELIAL#0.9419;NMDA RECEPTOR#0.9412;RETINOIC ACID#0.9411;NEURULATION#0.9407;TESTOSTERONE#0.9403;PANCREATIC DUCTAL ADENOCARCINOMA#0.9402;ENDOMETRIOSIS#0.9399;LYSINE#0.9394;MOUSE EMBRYONIC STEM#0.9393;AMPA RECEPTOR#0.9382;CYTOTOXICITY#0.9373;NEURAL PROGENITOR CELL#0.9371;NEUROGENESIS#0.9367;TISSUE MORPHOGENESIS#0.9361;HISTONE DEACETYLASE#0.9352;TYROSINE KINASE INHIBITOR#0.9344;RAPAMYCIN#0.9333;ESTRADIOL#0.9330;PULMONARY FIBROSIS#0.9322;TRANSMISSION ELECTRON MICROSCOPY#0.9314;STEM CELL LIKE#0.9310;NEUROBLASTOMA#0.9303;FOREBRAIN#0.9302;ESOPHAGEAL CANCER#0.9297;AGGRESSIVE BEHAVIOR#0.9294;TUBULAR EPITHELIAL CELL#0.9294;GALECTIN#0.9290;PROGESTERONE#0.9290;THYROID CARCINOMA#0.9288;OOCYTE#0.9264;CHEMOKINE RECEPTOR#0.9259;BRAIN DEVELOPMENT#0.9256;PRECURSOR CELL#0.9254;FORMALIN#0.9232;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9220;THYROID CANCER#0.9211;MECHANISM OF ACTION#0.9211;CIRCULATING TUMOR CELL#0.9210;M PHASE#0.9199;OLIGODENDROCYTE#0.9195;CARDIAC MUSCLE#0.9194;TARGET OF RAPAMYCIN#0.9185;ACTIN BINDING#0.9179;NERVE GROWTH FACTOR#0.9169;LONG TERM POTENTIATION#0.9158;MICROVASCULAR ENDOTHELIAL CELL#0.9148;YOLK SAC#0.9145;EXHERIN#0.9143;REPORTER GENE ASSAY#0.9139;CALCIUM CHANNEL#0.9126;CILIARY GANGLION#0.9110;METFORMIN#0.9089;UBIQUITIN#0.9087;DNA BINDING#0.9079;ARRHYTHMIA#0.9071;INDUCED PLURIPOTENT STEM CELL#0.9067;MYELINATION#0.9066;ACTIN-N#0.9065;DILATED CARDIOMYOPATHY#0.9060;BASAL CELL#0.9048;LUCIFERASE ACTIVITY#0.9041;PLATELET-DERIVED GROWTH FACTOR#0.9040;INTERSTITIAL CELL#0.9012;METASTATIC MELANOMA#0.9009;GLUTAMATE RECEPTOR#0.9009;DEDIFFERENTIATION#0.9007;LEYDIG CELL#0.9002;L-LYSINE#0.8999;LUMINAL#0.8997;LOCALISATION#0.8996;MALIGNANT MESOTHELIOMA#0.8995;UMBILICAL CORD#0.8994;BASAL ES#0.8982;ANCHORAGE INDEPENDENT GROWTH#0.8979;MICROFILAMENT#0.8969;PROSTATE CARCINOMA#0.8969;PROTEIN SYNTHESIS#0.8965;GLUTAMATERGIC SYNAPSE#0.8965;SYNAPTIC CLEFT#0.8962;LEUKOCYTE#0.8956;TONGUE SQUAMOUS CELL CARCINOMA#0.8953;INTERMEDIATE FILAMENT#0.8922;IMMUNE RESPONSE#0.8921;RETINAL DEVELOPMENT#0.8913;CELL COMMUNICATION#0.8909;DOMINANT NEGATIVE MUTANT#0.8909;ISCHEMIA#0.8899;MESENCHYMAL STROMAL CELL#0.8884;MEMBRANE RUFFLE#0.8860;METASTATIC BREAST CANCER#0.8851;PERIPHERAL BLOOD#0.8839;SURFACE EPITHELIUM#0.8822;OPTIC NERVE#0.8819;INVASIVE BREAST CANCER#0.8798;CANCER ASSOCIATED FIBROBLASTS#0.8785;GESTATION#0.8771;ARTERY#0.8748;FLOW CYTOMETRY ANALYSIS#0.8740;LECTIN#0.8714;GASTROINTESTINAL STROMAL TUMOR#0.8693;NOTCH SIGNALING PATHWAY#0.8681;PROSTATE SPECIFIC ANTIGEN#0.8677;HEAD AND NECK CANCER#0.8675;NECK CANCER#0.8675;SCANNING ELECTRON MICROSCOPY#0.8674;ANOIKIS#0.8669;EPHRIN#0.8655;NEUROBLAST#0.8651;TRANSACTIVATION#0.8648;HOST CELL#0.8640;TRADITIONAL CHINESE MEDICINE#0.8638;NEUROLIGIN#0.8622;OVARIAN SURFACE EPITHELIAL#0.8619;BLOOD BRAIN BARRIER#0.8612;T CELL FACTOR#0.8609;NEUROEPITHELIAL CELL#0.8606;LENS DEVELOPMENT#0.8597;SYNAPTIC VESICLE#0.8583;HIGH MOBILITY GROUP#0.8574;EPENDYMAL CELL#0.8566;EPITHELIAL STEM CELL#0.8554;ORGANOGENESIS#0.8552;NEUROFILAMENT#0.8549;EPIBLAST#0.8541;MESODERM CELL#0.8532;PIGMENT EPITHELIAL CELL#0.8517;INHIBITION OF CELL MIGRATION#0.8516;PACLITAXEL#0.8507;GLIOBLASTOMA MULTIFORME#0.8500;SPERMATOCYTES#0.8495;N GLYCAN#0.8493;INVASIVE CARCINOMA#0.8488;TO TUMOR PROGRESSION#0.8487;COLORECTAL CARCINOMA#0.8482;GROWTH PATTERN#0.8480;UMBILICAL VEIN#0.8472;EPIBLAST CELL#0.8464;BONE MARROW STROMAL#0.8457;ENDOMETRIAL EPITHELIAL CELLS#0.8449;TRANSDIFFERENTIATION#0.8448;DORSAL ROOT GANGLION#0.8447;CELLULAR LOCALIZATION#0.8440;NUCLEUS PULPOSUS CELL#0.8435;MYOCARDIAL INFARCTION#0.8430;HEMATOPOIESIS#0.8424;RETINAL PIGMENT EPITHELIAL CELLS#0.8406;ACTOMYOSIN#0.8385;LEUKEMIC STEM CELL#0.8384;AXON GUIDANCE#0.8384;HUMAN MESENCHYMAL STEM#0.8371;HUMAN CORNEAL ENDOTHELIAL#0.8369;LOCOMOTION#0.8363;PHOTORECEPTOR CELL#0.8361;HUMAN UMBILICAL VEIN#0.8357;INDUCTION OF APOPTOSIS#0.8355;NUCLEOTIDE EXCHANGE FACTOR#0.8354;TERMINAL DIFFERENTIATION#0.8341;DERMAL FIBROBLAST#0.8338;MARROW STROMAL CELLS#0.8335;BONE MARROW STROMAL CELL#0.8335;NEURON MIGRATION#0.8334;OVARIES#0.8333;CELL ADHESION COMPLEX#0.8327;YEAR SURVIVAL RATE#0.8317;ASTROCYTOMA#0.8316;PLANAR CELL POLARITY#0.8305;MITOCHONDRIA#0.8294;MUTAGENESIS#0.8293;TECTUM#0.8274;ANCHORING#0.8272;AQUAPORIN#0.8270;TERATOMA#0.8259;HISTONE DEACETYLASE INHIBITOR#0.8258;STEM CELL DIFFERENTIATION#0.8256;MYOGENIC CELL#0.8252;RETINOBLASTOMA#0.8239;PHOSPHATASE AND TENSIN HOMOLOG#0.8239;ACTION POTENTIAL#0.8238;OVARIAN SURFACE EPITHELIUM#0.8235;KINESIN#0.8233;ADHERENS JUNCTION FORMATION#0.8229;SODIUM CHANNEL#0.8199;ACTIN POLYMERIZATION#0.8195;UROKINASE#0.8191;DNA METHYLATION#0.8173;EOSIN#0.8171;LEUCINE#0.8164;CORNEAL EPITHELIAL CELL#0.8162;EMBRYONIC HEART#0.8148;EYE DEVELOPMENT#0.8148;PURKINJE CELL#0.8142;GEMCITABINE#0.8123;COLLAGEN TYPE IV#0.8120;COLON CARCINOMA#0.8118;DOXORUBICIN#0.8091;QUIESCENCE#0.8064;RADIAL GLIAL CELL#0.8050;PAPILLARY THYROID CARCINOMA#0.8032;MAMMARY GLAND#0.8017;TUMOR NODE METASTASIS#0.8016;CHONDROCYTE DIFFERENTIATION#0.8012;METASTATIC PROSTATE CANCER#0.8011;KIDNEY DISEASE#0.8005;JUXTAMEMBRANE#0.7993;CELL BODY#0.7990;TISSUE HOMEOSTASIS#0.7986;OVERALL SURVIVAL RATE#0.7980;CELL PERIPHERY#0.7970;OLFACTORY EPITHELIUM#0.7951;PHOSPHATASE ACTIVITY#0.7944;POLY ADP RIBOSE#0.7939;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7938;ENDOCRINE CELL#0.7929;HYALURONAN#0.7918;SPHINGOSINE#0.7910;SKIN CANCER#0.7906;PRO-INFLAMMATORY#0.7903;CELL ELONGATION#0.7895;EPITHELIAL OVARIAN CARCINOMA#0.7890;PROXIMAL TUBULAR EPITHELIAL#0.7867;CARDIAC DEVELOPMENT#0.7861;CELL DEVELOPMENT#0.7851;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY#0.7851;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7843;VASCULAR ENDOTHELIAL CADHERIN#0.7837;LARYNGEAL CARCINOMA#0.7836;HOMOPHILIC CELL ADHESION#0.7833;INFLAMMATORY RESPONSE#0.7830;HEAT SHOCK PROTEIN#0.7828;NON-SMALL CELL LUNG CARCINOMA#0.7828;5-AZA-2'-DEOXYCYTIDINE#0.7825;TOLL LIKE RECEPTOR#0.7825;2'-DEOXYCYTIDINE#0.7821;EMBRYO IMPLANTATION#0.7808;DEPHOSPHORYLATION#0.7801;CANCER STEM-LIKE CELL#0.7794;PANCREATIC CARCINOMA#0.7783;SOMITOGENESIS#0.7778;CORD BLOOD#0.7771;PROGRAMMED CELL DEATH#0.7769;OSTEOARTHRITIS#0.7753;LIVER METASTASIS#0.7750;IMMUNE CELL#0.7742;TISSUE REGENERATION#0.7741;ACTIN BINDING PROTEIN#0.7728;RELAPSE FREE SURVIVAL#0.7726;AXON EXTENSION#0.7720;LEUCINE RICH REPEAT#0.7711;APICAL ES#0.7706;HEPATIC STELLATE CELL#0.7705;QUERCETIN#0.7697;CYTOSKELETON ORGANIZATION#0.7695;INTEGRIN LINKED KINASE#0.7691;SYNAPTIC TRANSMISSION#0.7689;NEURAL FOLD#0.7684;FACTOR I#0.7683;PROTEIN PROTEIN INTERACTION#0.7667;INFLAMMATORY CELL#0.7656;SPERMATOZOA#0.7651;EXOSOME#0.7647;CELL FUSION#0.7639;GUANINE#0.7629;ADENOMATOUS POLYPOSIS COLI#0.7619;BETA CATENIN BINDING#0.7618;FILAMENTOUS ACTIN#0.7608;OLFACTORY BULB#0.7605;EXTRACELLULAR REGION#0.7600;COLLAGEN TYPE II#0.7598;SRC FAMILY KINASE#0.7594;EPITHELIAL TISSUES#0.7584;RESVERATROL#0.7578;EMBRYO DEVELOPMENT#0.7566;HEPATOMA CELLS#0.7558;SPHINGOSINE 1 PHOSPHATE#0.7556;HYALURONIC ACID#0.7546;SENESCENCE#0.7540;NEURAL TUBE CLOSURE#0.7533;TUBE CLOSURE#0.7532;EXTRACELLULAR MATRIX COMPONENT#0.7531;CARDIOMYOCYTE DIFFERENTIATION#0.7527;MALIGNANT GLIOMA#0.7524;HUMAN EMBRYONIC STEM#0.7524;VASCULAR CELL#0.7519;CRANIAL NEURAL CREST#0.7509;72-HOURS#0.7502;PROTEIN TYROSINE KINASE#0.7499;NOTOCHORD#0.7497;ROS GENERATION#0.7495;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7484;HUMAN MAMMARY EPITHELIAL#0.7479;NITRIC OXIDE#0.7461;CANCER SPECIFIC SURVIVAL#0.7455;ANTISENSE RNA#0.7453;TEMOZOLOMIDE#0.7450;METASTATIC LYMPH NODE#0.7441;HUMAN BRONCHIAL EPITHELIAL#0.7439;NEUROENDOCRINE CARCINOMA#0.7431;DELAMINATION#0.7428;LIMB DEVELOPMENT#0.7428;MONOCYTE#0.7427;CELL CYCLE REGULATOR#0.7424;BRONCHIAL EPITHELIAL CELLS#0.7423;BETA CELL#0.7421;UMBILICAL CORD BLOOD#0.7421;GASTRIC MUCOSA#0.7411;CERVICAL SQUAMOUS CELL CARCINOMA#0.7406;CHOROID PLEXUS#0.7403;CELLULAR PROCESS#0.7402;5 FLUOROURACIL#0.7399;LUNG DISEASE#0.7396;GLUTATHIONE#0.7392;POSTSYNAPTIC DENSITY#0.7382;NEURAL CREST CELL MIGRATION#0.7382;PROTEIN KINASE A#0.7371;YES ASSOCIATED PROTEIN#0.7363;ADULT RAT CARDIOMYOCYTES#0.7363;MUSCLE FIBER#0.7362;RELATED PROTEIN 1#0.7360;GOBLET CELL#0.7342;MYOSIN HEAVY CHAIN#0.7337;ENHANCER BINDING#0.7337;MURAL CELL#0.7331;CAMKII#0.7330;PRIMITIVE STREAK#0.7303;SPECIFIC PROTEIN 1#0.7297;ETHANOL#0.7289;CNS DEVELOPMENT#0.7288;CENTROSOME#0.7281;POSTSYNAPTIC MEMBRANE#0.7277;APOPTOTIC CELL DEATH#0.7268;PHOSPHOLIPASE C#0.7267;RUFFLE#0.7265;MEMBRANE TYPE 1#0.7261;LENS MORPHOGENESIS#0.7253;PRESYNAPTIC TERMINAL#0.7241;ENDOSOME#0.7228;AIRWAY EPITHELIUM#0.7226;LUNG EPITHELIAL CELL#0.7217;17β-ESTRADIOL#0.7216;TO THE PROGRESSION#0.7214;RETINAL PIGMENT EPITHELIUM#0.7209;TYROSINE KINASE RECEPTOR#0.7205;HAIR CELL#0.7201;FLUOROURACIL#0.7194;CARCINOMA IN SITU#0.7193;ADENOSINE#0.7192;TOXICANT#0.7145;IDIOPATHIC PULMONARY FIBROSIS#0.7141;MAST CELL#0.7127;RECEPTOR ANTAGONIST#0.7118;HEART MUSCLE#0.7108;DUCTAL EPITHELIAL CELLS#0.7105;TAMOXIFEN#0.7100;NEPHRON#0.7095;RIBOSE#0.7089;ION CHANNEL#0.7084;ALKALINE PHOSPHATASE ACTIVITY#0.7068;HOMOTYPIC CELL-CELL ADHESION#0.7065;ZONULA ADHERENS#0.7057;CYTOSKELETAL ELEMENT#0.7057;BILE DUCT#0.7051;BIOTIN#0.7051;SYNAPTIC MEMBRANE#0.7051;MICROTUBULE ASSOCIATED PROTEIN#0.7046;BRAIN ENDOTHELIAL CELL#0.7045;MYOBLAST DIFFERENTIATION#0.7035;SYNAPSE DEVELOPMENT#0.7035;OSTEOSARCOMA CELL LINES#0.7033;COLUMNAR#0.7032;CYTOPLASMIC REGION#0.7019;VASCULAR MORPHOGENESIS#0.7012;GEFITINIB#0.7008;CORNEAL EPITHELIUM#0.7002;PAPILLARY THYROID CANCER#0.7002;EMBRYONAL CARCINOMA#0.7000;INVASIVE DUCTAL CARCINOMA#0.6996;ONCOGENESIS#0.6993;LENS VESICLE#0.6989;CLEAR CELL RENAL CELL CARCINOMA#0.6988;BASAL LAMINA#0.6988;PYRAMIDAL CELL#0.6982;MACROPINOSOME#0.6970;METHYLATION SPECIFIC PCR#0.6969;INTERNEURON#0.6967;GONAD#0.6951;ELECTROPHORETIC MOBILITY SHIFT#0.6927;SYSTEM DEVELOPMENT#0.6924;ASCITES#0.6918;LASER SCANNING MICROSCOPY#0.6915;RENAL FIBROSIS#0.6888;GASTRIC EPITHELIAL CELLS#0.6867;NEGATIVE CONTROL GROUP#0.6865;TROPHECTODERM#0.6863;EDEMA#0.6863;TISSUE DEVELOPMENT#0.6859;PROTEASOME#0.6842;ERLOTINIB#0.6839;RNA BINDING#0.6838;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.6824;CELL MORPHOGENESIS#0.6822;ZINC FINGER PROTEIN#0.6821;AXON TERMINAL#0.6819;MOUSE EMBRYONIC FIBROBLAST#0.6817;MESOTHELIOMA CELL#0.6814;ANTISENSE MORPHOLINO OLIGONUCLEOTIDE#0.6808;ENDMT#0.6797;HEMATOPOIETIC CELL#0.6780;ADVANCED GASTRIC CANCER#0.6778;ICI 182,780#0.6775;ESOPHAGEAL CARCINOMA#0.6775;JUNCTIONAL ADHESION MOLECULE#0.6770;EMBRYONIC BRAIN#0.6769;CYTOCHROME C#0.6760;TESTICULAR DEVELOPMENT#0.6756;ARGININE#0.6748;INSULIN SECRETION#0.6736;NEURAL ECTODERM#0.6722;MAMMARY EPITHELIUM#0.6722;PITUITARY ADENOMA#0.6713;ADHESION BELT#0.6712;TISSUE REMODELING#0.6705;IFN-GAMMA#0.6699;N-ACETYLCYSTEINE#0.6689;ADIPOCYTE#0.6686;DIGESTION#0.6686;BUDDING#0.6679;BONE GROWTH#0.6676;ORAL MUCOSA#0.6674;CIGARETTE SMOKE EXTRACT#0.6666;LYSOSOME#0.6644;MYELOID LEUKEMIA#0.6643;ORAL EPITHELIAL CELLS#0.6635;ADULT STEM CELL#0.6634;MONONUCLEAR CELLS#0.6624;ALVEOLAR EPITHELIAL CELL#0.6615;TRYPTOPHAN#0.6589;CHONDROITIN SULFATE PROTEOGLYCAN#0.6582;SURFACE ECTODERM#0.6582;P38 MAPK SIGNALING#0.6572;OVARIAN SURFACE EPITHELIAL CELL#0.6564;INHIBITION OF LOCOMOTION#0.6552;DISCOIDIN DOMAIN RECEPTOR#0.6538;INVASIVE GROWTH#0.6536;IMMUNE SYSTEM#0.6531;VASCULAR ENDOTHELIUM#0.6524;PEROXISOME#0.6511;VASCULAR ENDOTHELIAL CELL#0.6507;GALLBLADDER#0.6505;INHIBITORY SYNAPSE#0.6502;ORGANELLE#0.6482;CELLULAR ADHESION MOLECULE#0.6479;NEUROPROTECTION#0.6475;PATTERN FORMATION#0.6473;DEXAMETHASONE#0.6453;FLOW CYTOMETRY ASSAY#0.6447;SKELETON#0.6447;OVARIAN FOLLICLE#0.6435;ACTIVATING TRANSCRIPTION FACTOR#0.6434;SALIVARY GLAND#0.6431;INTERVERTEBRAL DISC#0.6431;TISSUE GROWTH FACTOR#0.6426;2'-DEOXYURIDINE#0.6418;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6415;INFLAMMATORY BOWEL DISEASE#0.6414;LITHIUM#0.6401;ACETYLCHOLINE RECEPTOR#0.6392;MODE OF ACTION#0.6392;HIPPOCAMPAL MOSSY FIBER#0.6387;TRANSIENT RECEPTOR POTENTIAL#0.6387;EPITHELIAL PROGENITOR CELL#0.6383;ARACHIDONIC ACID#0.6367;COLLAGENASE#0.6354;METASTASIS FREE SURVIVAL#0.6351;HEART DISEASE#0.6351;INFERTILITY#0.6348;FASCIA ADHERENS#0.6335;RETINAL LAMINATION#0.6331;ACETYLCHOLINE#0.6325;GENE EXPRESSION OMNIBUS#0.6318;BASAL ECTOPLASMIC SPECIALIZATION#0.6318;ATHEROSCLEROSIS#0.6313;AIRWAY EPITHELIAL CELL#0.6301;SORAFENIB#0.6298;PROSTATE EPITHELIAL CELL#0.6282;GENISTEIN#0.6278;BONE MARROW MICROENVIRONMENT#0.6276;ENDOMETRIAL ADENOCARCINOMA#0.6273;HUMAN LIMBAL EPITHELIAL#0.6271;OUTFLOW TRACT#0.6268;MECHANISMS OF ACTION#0.6265;CARDIAC TRABECULATION#0.6254;PANCREATIC ADENOCARCINOMA#0.6253;PLANAR CELL POLARITY PATHWAY#0.6251;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6246;INTRACELLULAR SIGNALING PATHWAY#0.6240;ADIPOSE TISSUE#0.6237;STATUS EPILEPTICUS#0.6229;CYCLIN DEPENDENT KINASE INHIBITOR#0.6226;DNA METHYLTRANSFERASE#0.6218;THYROID TRANSCRIPTION FACTOR#0.6217;EARLY TIME POINT#0.6217;DENTATE GYRUS#0.6209;HEMATOPOIETIC PROGENITOR CELL#0.6201;ADENINE#0.6197;HEMORRHAGE#0.6183;FIBROBLAST ACTIVATION#0.6182;EPITHELIAL CARCINOMA#0.6179;INVASIVE BREAST CARCINOMA#0.6177;APICAL CONSTRICTION#0.6166;DIABETES MELLITUS#0.6162;HATCHING#0.6161;POST-TRANSLATIONAL MODIFICATION#0.6159;TUMOR INITIATING CELL#0.6155;ADENOID CYSTIC CARCINOMA#0.6140;AXON PATHFINDING#0.6140;NORMAL BREAST TISSUE#0.6123;PITUITARY GLAND#0.6100;EXTRACELLULAR SPACE#0.6092;LIMBAL EPITHELIAL CELL#0.6080;SARCOMERE#0.6069;AXONAL GROWTH CONE#0.6065;OSELTAMIVIR PHOSPHATE#0.6054;SMOOTH MUSCLE CELL APOPTOSIS#0.6041;CONSTRICTION#0.6039;DIHYDROTESTOSTERONE#0.6039;HEART FORMATION#0.6037;MUSCLE CELL APOPTOSIS#0.6017;BIOLOGICAL PROCESS#0.6004;ATHEROSCLEROTIC#0.6003;SKIN MELANOMA#0.6001
10010	TANK BINDING KINASE#1.0717;NF-KAPPAB ACTIVATION#1.0535;B CELL#1.0191;SIGNALING PATHWAY#1.0066;TOLL LIKE RECEPTOR#0.9965;INTERFERON REGULATORY FACTOR#0.9958;TUMOR NECROSIS FACTOR#0.9954;UBIQUITIN#0.9698;TRANSCRIPTION FACTOR#0.9587;IMMUNE RESPONSE#0.9207;GENE EXPRESSION#0.9055;APOPTOSIS#0.9011;PROTEIN KINASE#0.8804;SIGNAL TRANSDUCTION#0.8226;INNATE IMMUNITY#0.8105;ANTIVIRAL RESPONSE#0.8059;TYPE I IFN PRODUCTION#0.8055;MACROPHAGE#0.7803;INFLAMMATORY RESPONSE#0.7763;VIRAL INFECTION#0.7724;TRAF SIGNALING#0.7604;INNATE IMMUNE RESPONSE#0.7603;CELL PROLIFERATION#0.7322;SIGNALING CASCADE#0.7317;IFN REGULATORY FACTOR#0.6976;LIPID RAFT#0.6916;APOPTOTIC#0.6761;IKK COMPLEX#0.6750;IKAPPAB KINASE#0.6686;EPSTEIN BARR VIRUS#0.6416;B LYMPHOCYTE#0.6408;BONE MARROW#0.6362;CELL DEATH#0.6360;KINASE ACTIVITY#0.6282;ACTIVATION OF NF-KAPPAB#0.6121;IMMUNE SYSTEM#0.6047
100113403	PRO-INFLAMMATORY#0.9008;INFLAMMATORY RESPONSE#0.8993;MACROPHAGE#0.6424
100113407	BREAST CANCER#1.1796
10011	STEROID RECEPTOR COACTIVATOR#1.0573;RNA BINDING#1.0324;SRA BINDING#1.0303;ESTROGEN RECEPTOR ALPHA#1.0225;BREAST CANCER#1.0193;BREAST CANCER CELL#1.0107;THYROID HORMONE RECEPTOR#1.0070;ANDROGEN RECEPTOR#1.0063;PROGESTERONE#1.0044;TRANSCRIPTION FACTOR#1.0015;CANCER CELL#1.0001;ESTROGEN RECEPTOR#0.9995;GENE EXPRESSION#0.9910;SIGNALING PATHWAY#0.9868;TRANSACTIVATION#0.9787;PROTEIN KINASE#0.9700;OVARIAN#0.9648;MAMMARY GLAND#0.9600;PROSTATE CANCER#0.9499;GLUCOCORTICOID RECEPTOR#0.9482;CELL CYCLE#0.9377;CREB BINDING#0.9364;GROWTH FACTOR#0.9195;CELL PROLIFERATION#0.9151;APOPTOSIS#0.9045;NUCLEAR HORMONE RECEPTOR#0.8971;ESTRADIOL#0.8821;POLYMERASE CHAIN REACTION#0.8753;STEROID HORMONE RECEPTOR#0.8719;TAMOXIFEN#0.8635;RNA HELICASE#0.8626;LIGAND BINDING DOMAIN#0.8625;VITAMIN D RECEPTOR#0.8605;CELL MIGRATION#0.8596;DNA BINDING#0.8572;HISTONE ACETYLTRANSFERASE#0.8233;RECEPTOR INTERACTING PROTEIN#0.7980;REVERSE TRANSCRIPTION#0.7859;MITOGEN ACTIVATED PROTEIN#0.7629;ADIPOCYTE#0.7597;ONCOGENIC#0.7447;UBIQUITIN#0.7445;CELL GROWTH#0.7278;STEM CELL#0.7262;PEROXISOME#0.7177;PSEUDOURIDINE SYNTHASE#0.7146;BREAST CANCER PATIENTS#0.7120;TUMOR SUPPRESSOR#0.7044;RNA INTERFERENCE#0.7015;POLYCYSTIC OVARY SYNDROME#0.6792;INSULIN-LIKE GROWTH FACTOR#0.6791;STEROIDOGENESIS#0.6643;PSEUDOURIDYLATION#0.6639;UTERUS#0.6632;RETINOIC ACID#0.6526;OVARIAN CANCER#0.6522;PROTEASOME#0.6375;ENDOMETRIOSIS#0.6336;ADIPOGENESIS#0.6311;TUMOR TISSUES#0.6297;RECEPTOR ACTIVITY#0.6276;QUANTITATIVE REAL TIME#0.6276;CYCLIN DEPENDENT KINASE#0.6234;CYTOPLASM#0.6222;KERATINOCYTE#0.6151;STROMAL CELL#0.6067;ATHEROSCLEROSIS#0.6066;TRIGLYCERIDE LIPASE#0.6031
100124696	SERUM RESPONSE FACTOR#0.6467;RECEPTOR TYROSINE KINASE#0.6290
100124700	OVARIAN CANCER#1.0683;OVARIAN#1.0631;COLON CANCER#1.0627;RNA INTERFERENCE#1.0625;EPITHELIAL MESENCHYMAL TRANSITION#1.0602;RENAL CELL CARCINOMA#1.0593;BREAST CANCER PATIENTS#1.0573;ANTISENSE RNA#1.0551;LYMPH NODE METASTASIS#1.0504;LUNG CANCER#1.0498;CERVICAL CANCER#1.0495;POLYCOMB REPRESSIVE COMPLEX#1.0481;PROSTATE CANCER#1.0463;CERVICAL#1.0461;CELL MIGRATION#1.0461;HEPATOCELLULAR CARCINOMA#1.0458;QUANTITATIVE REAL TIME#1.0455;AUTOPHAGY#1.0453;TUMOR TISSUES#1.0452;LYMPH NODE#1.0452;CISPLATIN#1.0448;COLORECTAL CANCER#1.0448;CANCER STEM CELL#1.0439;COLORECTAL#1.0435;BREAST CANCER CELL#1.0433;LUNG ADENOCARCINOMA#1.0421;PANCREATIC CANCER#1.0392;EPITHELIAL TO MESENCHYMAL TRANSITION#1.0391;EPITHELIAL TO MESENCHYMAL#1.0389;STEM CELL#1.0363;ONCOGENIC#1.0359;ADENOCARCINOMA#1.0344;SQUAMOUS CELL CARCINOMA#1.0337;DRUG RESISTANCE#1.0330;REVERSE TRANSCRIPTION#1.0324;BREAST CANCER#1.0318;CELL GROWTH#1.0317;POLYMERASE CHAIN REACTION#1.0271;CANCER CELL#1.0258;GENE SILENCING#1.0242;GROWTH FACTOR#1.0237;CELL PROLIFERATION#1.0232;APOPTOSIS#1.0221;SIGNALING PATHWAY#1.0218;EXOSOME#1.0217;LIVER CANCER#1.0189;DUAL LUCIFERASE REPORTER#1.0172;CELL CYCLE#1.0137;DNA METHYLATION#1.0133;DISEASE FREE SURVIVAL#1.0122;RNA BINDING#1.0032;LYSINE#0.9959;TUMOR SUPPRESSOR#0.9943;EPITHELIAL CELL#0.9842;GENE EXPRESSION#0.9821;CELL CYCLE ARREST#0.9799;EXTRACELLULAR MATRIX#0.9778;EPITHELIAL OVARIAN CANCER#0.9728;ENDOMETRIAL CANCER#0.9716;ENDOMETRIAL CARCINOMA#0.9672;CHONDROCYTE#0.9657;TRANSCRIPTION FACTOR#0.9656;QUANTITATIVE REVERSE TRANSCRIPTION#0.9651;MYELOID LEUKEMIA#0.9634;G1 PHASE#0.9611;ADJACENT NORMAL TISSUE#0.9540;CARDIOMYOCYTE#0.9524;ENDOTHELIAL CELL#0.9479;COLONY FORMATION ASSAY#0.9466;PERIPHERAL BLOOD#0.9439;NUCLEUS PULPOSUS#0.9296;TUMOR CELLS#0.9243;GASTRIC ADENOCARCINOMA#0.9230;WOUND HEALING#0.9165;CELL COUNTING KIT#0.9139;RHEUMATOID ARTHRITIS#0.9130;ACUTE MYELOID LEUKEMIA#0.9119;GASTROINTESTINAL STROMAL TUMOR#0.9079;WNT SIGNALING PATHWAY#0.9064;THYROID CARCINOMA#0.9052;ESTROGEN RECEPTOR#0.9039;SIGNALLING PATHWAY#0.9007;APOPTOTIC#0.8981;PROTEIN CODING GENE#0.8906;AKT SIGNALING#0.8903;HUMAN BREAST CANCER#0.8896;REPORTER GENE ASSAY#0.8877;RNA BINDING PROTEIN#0.8872;ORAL SQUAMOUS CELL CARCINOMA#0.8831;PARKINSON'S DISEASE#0.8816;HYPOXIA#0.8795;CHROMATIN ORGANIZATION#0.8736;ANGIOGENESIS#0.8649;TUMOR NECROSIS FACTOR#0.8605;HEPATOCELLULAR CARCINOMA CELL#0.8554;TROPHOBLAST#0.8502;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.8494;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8485;TUMOR NODE METASTASIS#0.8436;CELL MOTILITY#0.8407;THYROID CANCER#0.8400;BONE MARROW#0.8392;ESOPHAGEAL CANCER#0.8381;INFLAMMATORY RESPONSE#0.8321;LUCIFERASE ACTIVITY#0.8263;ENDOTHELIAL GROWTH FACTOR#0.8177;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8177;LUNG METASTASIS#0.8085;PROTEIN KINASE#0.8048;DEMETHYLATION#0.8024;PRC2 COMPLEX#0.7989;OSTEOARTHRITIS#0.7893;CHROMATIN REMODELING#0.7887;MACROPHAGE#0.7838;B CELL#0.7770;ESTRADIOL#0.7700;HISTONE MODIFICATION#0.7656;GROWTH FACTOR RECEPTOR#0.7634;OESOPHAGEAL SQUAMOUS CELL#0.7616;SENESCENCE#0.7543;DOXORUBICIN#0.7527;T CELL#0.7526;CONGENITAL HEART DISEASE#0.7524;MYOCARDIAL INFARCTION#0.7398;REGULATION OF GENE EXPRESSION#0.7397;CELL DEATH#0.7364;HEART DISEASE#0.7360;RAPAMYCIN#0.7336;INSULIN-LIKE GROWTH FACTOR#0.7329;PROPOFOL#0.7226;TARGET OF RAPAMYCIN#0.7213;GENISTEIN#0.7074;MECHANISM OF ACTION#0.7033;CARDIOMYOPATHY#0.7031;ATHEROSCLEROSIS#0.6986;HISTONE METHYLTRANSFERASE#0.6951;B CELL LYMPHOMA#0.6863;CHROMATIN MODIFICATION#0.6854;NUCLEUS PULPOSUS CELL#0.6853;CIGARETTE SMOKE EXTRACT#0.6820;CANCER STEM-LIKE CELL#0.6800;RENAL CARCINOMA#0.6766;OVARIAN CARCINOMA#0.6743;PRIMARY BREAST CANCER#0.6729;SIGNAL TRANSDUCER#0.6464;GASTRIC TISSUE#0.6324;HUMAN BRONCHIAL EPITHELIAL#0.6290;RETINOBLASTOMA#0.6235;MESENCHYMAL STEM CELL#0.6216;ANDROGEN RECEPTOR#0.6173;SQUAMOUS CELL CANCER#0.6147;LIVER METASTASIS#0.6093;RENAL INTERSTITIAL FIBROSIS#0.6053
100125288	GERM CELL#1.0173;GERM CELL DEVELOPMENT#0.8049;ZINC FINGER PROTEIN#0.7940;CELL DEVELOPMENT#0.7881;GONAD#0.6637
100126270	NEURAL PRECURSOR CELL#0.9168;PRECURSOR CELL#0.9020;GENE EXPRESSION#0.6597;FRAGILE X SYNDROME#0.6295
100126299	TUMOR SUPPRESSOR#1.0378;PROTEIN KINASE#0.9772;CANCER CELL#0.9269;CELL PROLIFERATION#0.8787;DNA METHYLATION#0.8740;PROTEIN KINASE R#0.8024;PROSTATE CANCER#0.7949;APOPTOSIS#0.7281;GENE EXPRESSION#0.7067;CELL DEATH#0.7059;T CELL#0.7038;MAJOR VAULT PROTEIN#0.6653;DIFFERENTIALLY METHYLATED REGION#0.6610;DRUG RESISTANCE#0.6229
100126302	BONE FORMATION#0.6774;CELL DIFFERENTIATION#0.6743
100126306	VENOUS BLOOD#0.7630
100126308	CELL PROLIFERATION#0.6570;VSMC PROLIFERATION#0.6148;NEURITE OUTGROWTH#0.6018;LUNG CARCINOMA#0.6002
100126310	APOPTOSIS#0.7275;ENDOTHELIAL CELL APOPTOSIS#0.6846;BREAST CANCER CELL#0.6605;TUMOR SUPPRESSOR#0.6586;CELL GROWTH#0.6574;ENDOTHELIAL CELL#0.6555;BREAST CANCER#0.6553;CANCER CELL#0.6537
100126311	CELL PROLIFERATION#1.0110;COLORECTAL CANCER#0.6651;LYMPH NODE#0.6469;CELL CYCLE#0.6456;LUNG CANCER#0.6317
100126313	CELL PROLIFERATION#0.9759;SIGNALING PATHWAY#0.9682;CANCER CELL#0.9598;CELL GROWTH#0.8278;HEPATOCELLULAR CARCINOMA#0.7738;POLYMERASE CHAIN REACTION#0.7639;GENE EXPRESSION#0.7558;APOPTOSIS#0.7063;REVERSE TRANSCRIPTION#0.6716;ONCOGENIC#0.6559;TUMOR SUPPRESSOR#0.6291;PANCREATIC CANCER#0.6233;CELL MIGRATION#0.6198;EPITHELIAL CELL#0.6161;STEM CELL#0.6156;CELL CYCLE#0.6082
100126314	CELL PROLIFERATION#0.9236;HEPATOCELLULAR CARCINOMA#0.7461;CERVICAL CANCER#0.6169;CANCER CELL#0.6036
100126315	SIGNALING PATHWAY#1.0670;CELL PROLIFERATION#1.0059;APOPTOSIS#0.9973;CELL GROWTH#0.8333;GASTRIC ADENOCARCINOMA#0.8107;STEM CELL#0.7606;REVERSE TRANSCRIPTION#0.7195;ADENOCARCINOMA#0.6636;QUANTITATIVE REVERSE TRANSCRIPTION#0.6408;EPITHELIAL MESENCHYMAL TRANSITION#0.6388;AKT SIGNALING#0.6323;GROWTH FACTOR#0.6205
100126316	CANCER CELL#1.0746;BREAST CANCER#1.0039;BREAST CANCER CELL#0.9495;TUMOR SUPPRESSOR#0.9171;CELL PROLIFERATION#0.8969;APOPTOSIS#0.8118;CARDIOMYOCYTE#0.7577;DUAL LUCIFERASE REPORTER#0.6857;TAMOXIFEN#0.6644;COLORECTAL CANCER#0.6359;CERVICAL CANCER#0.6335;GROWTH FACTOR#0.6310;DRUG RESISTANCE#0.6229;T CELL#0.6219;LUNG CANCER#0.6194
100126317	CELL PROLIFERATION#0.9937;SIGNALING PATHWAY#0.8812;APOPTOSIS#0.8331;DUAL LUCIFERASE REPORTER#0.7251;CANCER CELL#0.6887
100126318	CANCER CELL#1.0112;PROSTATE CANCER#0.9205;CELL PROLIFERATION#0.8902;HYPOXIA#0.7466;APOPTOSIS#0.7336;TUMOR SUPPRESSOR#0.6600;AUTOPHAGY#0.6125
100126319	CELL PROLIFERATION#1.0911;TUMOR SUPPRESSOR#1.0508;CANCER CELL#1.0486;APOPTOSIS#1.0432;DUAL LUCIFERASE REPORTER#1.0375;AUTOPHAGY#1.0324;COLORECTAL CANCER#0.9069;SIGNALING PATHWAY#0.9036;CELL GROWTH#0.8463;ADJACENT NORMAL TISSUE#0.8387;COLORECTAL#0.7973;CELL CYCLE#0.7674;CISPLATIN#0.7460;PANCREATIC CANCER#0.7338;REVERSE TRANSCRIPTION#0.6935;LUNG CANCER#0.6758;POLYMERASE CHAIN REACTION#0.6666;LYMPH NODE#0.6448;PROTEIN KINASE#0.6429;GENE EXPRESSION#0.6304;DRUG RESISTANCE#0.6296;HEPATOCELLULAR CARCINOMA#0.6272;BREAST CANCER#0.6244;LUCIFERASE ACTIVITY#0.6185
100126324	CANCER CELL#0.7176;PROTEIN DEGRADATION#0.6827;BREAST CARCINOMA#0.6789;OVARIAN CANCER#0.6756;CELL GROWTH#0.6711;CELL PROLIFERATION#0.6681
100126325	CELL PROLIFERATION#1.1117;CANCER CELL#0.9925;LUNG CANCER#0.8523;SIGNET RING CELL#0.6397;DUAL LUCIFERASE REPORTER#0.6274;LIVER CANCER#0.6231
100126328	CELL PROLIFERATION#1.0545;CANCER CELL#1.0215;APOPTOSIS#1.0105;POLYMERASE CHAIN REACTION#0.8802;BREAST CANCER#0.8733;HEPATOCELLULAR CARCINOMA#0.7994;CELL CYCLE#0.7965;SIGNALING PATHWAY#0.7818;LYMPH NODE METASTASIS#0.7778;LYMPH NODE#0.7731;QUANTITATIVE REAL TIME#0.7691;EPITHELIAL MESENCHYMAL TRANSITION#0.7067;CERVICAL CANCER#0.7059;LUNG CANCER#0.6540;PANCREATIC CANCER#0.6245;INFLAMMATORY RESPONSE#0.6191;SQUAMOUS CELL CARCINOMA#0.6146;CERVICAL#0.6103;CELL GROWTH#0.6102
100126331	APOPTOSIS#0.8022;CANCER CELL#0.7346;SQUAMOUS CELL CARCINOMA#0.7258;DUAL LUCIFERASE REPORTER#0.6588;COLORECTAL CANCER#0.6474
100126333	LAYER BY LAYER#0.7780;COLORECTAL CARCINOMA#0.7575
100126334	VITAMIN D RECEPTOR#0.6343;CELL DIFFERENTIATION#0.6260;CELL PROLIFERATION#0.6198
100126335	CELL PROLIFERATION#1.0733;CANCER CELL#0.9804;APOPTOSIS#0.9773;COLORECTAL CANCER#0.9438;CELL CYCLE#0.8579;COLORECTAL#0.7993;SIGNALING PATHWAY#0.7867;TUMOR SUPPRESSOR#0.7828;EPITHELIAL MESENCHYMAL TRANSITION#0.7721;LUNG CANCER#0.7667;ENDOMETRIUM#0.6530;DUAL LUCIFERASE REPORTER#0.6370;ESOPHAGEAL CANCER#0.6284;PROSTATE CANCER#0.6125;ENDOMETRIOSIS#0.6066
100126336	MYOCARDIAL INFARCTION#1.0056;SKELETAL MUSCLE#0.9962;MYOSIN HEAVY CHAIN#0.9610;GENE EXPRESSION#0.9287;ACUTE MYOCARDIAL INFARCTION#0.9234;MUSCLE FIBER#0.8243;TRANSCRIPTION FACTOR#0.7579;POLYMERASE CHAIN REACTION#0.7178;MUSCLE CELL#0.6944;CARDIOMYOCYTE#0.6378;QUANTITATIVE REAL TIME#0.6378;REVERSE TRANSCRIPTION#0.6361;LEFT VENTRICULAR REMODELING#0.6347;CELL CYCLE#0.6083
100126338	CANCER CELL#0.9418;DUAL LUCIFERASE REPORTER#0.8858;PERIPHERAL BLOOD#0.8680;BREAST CANCER#0.8676;CELL PROLIFERATION#0.8284;BREAST CANCER CELL#0.6892;LUNG CANCER#0.6872;KAWASAKI DISEASE#0.6553;COLON CANCER#0.6348;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6331;CORONARY ARTERY#0.6320;MONONUCLEAR CELLS#0.6311
100126340	CANCER CELL#1.0586;CELL PROLIFERATION#0.9915;CELL MIGRATION#0.9615;CERVICAL CANCER#0.9404;COLORECTAL CANCER#0.8877;BREAST CANCER#0.8481;CERVICAL#0.7708;APOPTOSIS#0.7681;LUNG CANCER#0.7309;COLORECTAL#0.7221;CELL GROWTH#0.7174;EPITHELIAL MESENCHYMAL TRANSITION#0.6439;POLYMERASE CHAIN REACTION#0.6416;BREAST CANCER CELL#0.6401;CERVICAL CANCER CELL LINES#0.6004
100126343	TUMOR SUPPRESSOR#1.0599;CELL PROLIFERATION#1.0450;APOPTOSIS#0.9996;COLORECTAL CANCER#0.8339;CANCER CELL#0.8296;SIGNALING PATHWAY#0.8169;INFLAMMATORY RESPONSE#0.7847;BREAST CANCER#0.7663;REVERSE TRANSCRIPTION#0.7487;POLYMERASE CHAIN REACTION#0.7462;COLORECTAL#0.6814;DUAL LUCIFERASE REPORTER#0.6391;ADJACENT NORMAL TISSUE#0.6322;SQUAMOUS CELL CARCINOMA#0.6211;LUNG CANCER#0.6138;CELL GROWTH#0.6134;CELL CYCLE#0.6120;GROWTH FACTOR#0.6094
100126345	GRANULOMA FORMATION#0.6378;CERVICAL CANCER#0.6214;LUNG CANCER#0.6124;SIGNALING PATHWAY#0.6086
100126346	BREAST CANCER#1.0083;GENE EXPRESSION#0.7441;CELL PROLIFERATION#0.6654;APOPTOSIS#0.6435;SIGNALING PATHWAY#0.6260;SKELETAL MUSCLE WASTING#0.6097
100126348	CANCER CELL#1.0304;CELL PROLIFERATION#0.9996;COLORECTAL CANCER#0.9945;COLORECTAL#0.9221;BREAST CANCER#0.9129;APOPTOSIS#0.8273;LUNG CANCER#0.7771;BREAST CANCER CELL#0.7245;CELL CYCLE#0.7054;QUANTITATIVE REAL TIME#0.6807;EPITHELIAL MESENCHYMAL TRANSITION#0.6342;OVARIAN CANCER#0.6314;POLYMERASE CHAIN REACTION#0.6146;SENESCENCE#0.6121;CAMP SIGNALLING#0.6028
100126351	CELL PROLIFERATION#0.8995;CANCER CELL#0.8278;APOPTOSIS#0.8230;GENE EXPRESSION#0.7602;OVARIAN CANCER#0.6362;CELL DEATH#0.6311
100126355	LUNG ADENOCARCINOMA#0.6265;LUNG CANCER#0.6176
100126572	GAP JUNCTION#0.9422;CONNEXIN#0.8425;GAP JUNCTION CHANNEL#0.7576
100126791	EOSINOPHIL#0.9685;EOSINOPHIL DEVELOPMENT#0.7805;TUMOR SUPPRESSOR#0.7104;CELL PROLIFERATION#0.7070;BREAST CANCER PATIENTS#0.6640;BREAST CANCER#0.6553
100126794	COLORECTAL#0.9920;ESOPHAGEAL CANCER#0.9200;ADENOCARCINOMA#0.8713;COLORECTAL CANCER#0.8532;SQUAMOUS CELL CARCINOMA#0.8531;COLORECTAL ADENOCARCINOMA#0.7995;CELL PROLIFERATION#0.7814;COLORECTAL CARCINOMA#0.7191;COLON CANCER#0.7138;CANCER CELL#0.6537;GENE EXPRESSION#0.6525;POLYMERASE CHAIN REACTION#0.6090
100127888	COLORECTAL CANCER#1.0453;COLORECTAL#0.8420;CELL PROLIFERATION#0.7788
100128098	BREAST CANCER#0.7599
100128191	CELL PROLIFERATION#0.6980;CELL CYCLE#0.6826;CERVICAL CANCER#0.6559
100128252	CANCER CELL#1.0145;CERVICAL CANCER#0.9225;SQUAMOUS CELL CARCINOMA#0.7224;NORMAL CERVICAL TISSUE#0.7103;CERVICAL#0.6989;ESOPHAGEAL CANCER#0.6858;SPINAL CORD INJURY#0.6831;SPINAL CORD#0.6737;CELL CYCLE#0.6692
100128262	LUNG CANCER#0.8997;CELL PROLIFERATION#0.8960;ANGIOGENESIS#0.6451
100128338	CELL PROLIFERATION#1.0756;CANCER CELL#0.9164;SIGNALING PATHWAY#0.8747;OVARIAN CANCER#0.8435;NOTCH SIGNALING PATHWAY#0.6800;ADJACENT NORMAL TISSUE#0.6753;CELL GROWTH#0.6624;OVARIAN#0.6403;NUCLEUS PULPOSUS#0.6228;COLORECTAL CARCINOMA#0.6113;CERVICAL CANCER#0.6091;CELL MIGRATION#0.6022;HEPATOCELLULAR CARCINOMA#0.6021
100128537	DNA METHYLATION#0.8748;HEMATOPOIETIC STEM CELL#0.6644;STEM CELL#0.6550
100128553	CUTANEOUS T CELL LYMPHOMA#1.2018;T CELL#1.1769
100128590	SIGNALING PATHWAY#1.1785
100128731	GLYCOSYLATION#0.7132
100128750	COPY NUMBER ALTERATION#1.2051
100128881	PROSTATE CANCER#0.7024;CANCER CELL#0.6975;CELL PROLIFERATION#0.6818;CELL CYCLE#0.6444
100128927	SKELETAL MUSCLE#0.8522
100128977	BREAST CANCER#0.8978;METASTATIC LYMPH NODE#0.7363;BREAST CANCER PATIENTS#0.7187;BREAST CANCER CELL#0.7152;LYMPH NODE#0.7122;CELL GROWTH#0.7121;CANCER CELL#0.7084
100129075	CELL PROLIFERATION#0.8960;APOPTOSIS#0.6411
100129080	CHLOROPLAST RIBOSOME#0.7251
100129123	ANGIOTENSIN CONVERTING ENZYME#0.8381;MUSCLE CELL#0.7124;LACTOSE METABOLISM#0.6844;CHORION#0.6437;TRANSCRIPTION FACTOR#0.6298
100129193	MAJOR URINARY PROTEIN#1.0326;URINARY PROTEIN#1.0263;GENE EXPRESSION#0.9165;TESTOSTERONE#0.8829;EXCRETION#0.7877;GROWTH HORMONE#0.7222;ALLERGEN#0.7159;GENE CONVERSION#0.7133;THYMIDINE KINASE#0.7085;PHEROMONE BINDING#0.6962;ODORANT BINDING#0.6783;ISOTHERMAL TITRATION CALORIMETRY#0.6261;MAMMARY GLAND#0.6190;PAROTID GLAND#0.6102
100129339	T LYMPHOCYTE#0.9193;BONE MARROW#0.7715
100129405	HUMAN BRONCHIAL EPITHELIAL#0.8164;BRONCHIAL EPITHELIAL CELLS#0.8147;LUNG CANCER#0.7994;EPITHELIAL CELL#0.7969;CELL PROLIFERATION#0.7958
100129460	CRYPTOCOCCAL MENINGITIS#1.2297;MENINGITIS#0.8585
100129528	HUMAN AIRWAY EPITHELIAL#1.1238;AIRWAY EPITHELIAL CELL#1.1167;POLYMERASE CHAIN REACTION#1.0490;SIGNALING PATHWAY#1.0433;EPITHELIAL CELL#1.0427;GENE EXPRESSION#1.0296;HUMAN NASAL EPITHELIAL#0.9964;REVERSE TRANSCRIPTION#0.8817;PROTEIN KINASE#0.8212;TRANSCRIPTASE#0.8159;CILIATED CELL#0.7880;NASAL EPITHELIUM#0.7732;TOLL LIKE RECEPTOR#0.7579;GROWTH FACTOR#0.7286;MITOGEN ACTIVATED PROTEIN#0.6964;MIDDLE EAR#0.6663;P38 MAPK SIGNALING#0.6431;MAPK SIGNALING#0.6349
100129575	CELL SURFACE#0.7806
100129583	PARKINSON'S DISEASE#0.6896
100129662	BREAST CANCER CELL#1.1848;BREAST CANCER#1.1796;CANCER CELL#1.1780;GLYCOLYSIS#0.8539
100129669	MALE INFERTILITY#0.7640
100129696	VACUOLAR ACIDIFICATION#0.6943
100129827	SIGNALING PATHWAY#1.1785;PACLITAXEL#0.8542
100129973	APOPTOSIS#0.7665;VASCULAR ENDOTHELIAL CELL#0.7612;ENDOTHELIAL CELL#0.7524
100129983	QUANTITATIVE REAL TIME#0.6748;HEPATOCELLULAR CARCINOMA#0.6738;POLYMERASE CHAIN REACTION#0.6707
100130015	URIC ACID#0.8173;URATE OXIDASE#0.7383
100130097	KINESIN#1.1084;MICROTUBULE#0.9450;INTRAFLAGELLAR TRANSPORT#0.8246;MICROTUBULE DYNAMICS#0.6731;KINETOCHORE#0.6412;MITOSIS#0.6122
100130155	ASTROCYTE ACTIVATION#0.9289;AUTOPHAGY#0.6475;ASTROCYTE#0.6472
100130275	CELL CYCLE#0.8971;BREAST CANCER#0.8969;APOPTOSIS#0.6411
100130302	TRANSCRIPTION FACTOR#0.7285
100130535	METALLO BETA LACTAMASE#1.0344;IMIPENEM#0.9989;MEROPENEM#0.9960;CEFTAZIDIME#0.9704;POLYMERASE CHAIN REACTION#0.9580;MINIMUM INHIBITORY CONCENTRATION#0.9573;MYELOID CELL#0.9385;BONE MARROW#0.8834;INTENSIVE CARE UNIT#0.8825;COLISTIN#0.8563;SELECTIN#0.8477;GLCNAC#0.8247;LEUKOCYTE#0.8201;CELL SURFACE#0.8123;AZTREONAM#0.7956;EFFLUX PUMP#0.7898;BLAST CELL#0.7730;OUTER MEMBRANE#0.7635;DRUG RESISTANCE#0.7515;CEFEPIME#0.7362;DIPICOLINIC ACID#0.7226;CHONDROCYTE#0.7181;CONJUGATION#0.6945;PIPERACILLIN#0.6643;GRANULOCYTE#0.6448;ANTIMICROBIAL SUSCEPTIBILITY TESTING#0.6383;ACUTE LEUKEMIA#0.6356;TAZOBACTAM#0.6154;AMIKACIN#0.6119
100130613	CERAMIDE KINASE#0.9564;LEUCINE RICH REPEAT#0.9142;LEUCINE#0.6483
100130733	LEUCINE RICH REPEAT#1.1969;LEUCINE#0.8511
100130776	CELL PROLIFERATION#1.0569;CANCER CELL#0.9348;APOPTOSIS#0.8571;ONCOGENIC#0.8467;LUNG CANCER#0.8199;BREAST CANCER#0.8112;HISTAMINE#0.7891;BREAST CANCER CELL#0.7688;SIGNALING PATHWAY#0.6018
100130889	PSORIASIS#0.8158
100131096	THYROID CANCER#1.0007;SIGNALLING PATHWAY#0.9952;APOPTOSIS#0.9055;PAPILLARY THYROID CANCER#0.7688;ANTISENSE RNA#0.7661;AUTOPHAGY#0.7579
100131137	SEMINAL PLASMA#0.9837;SEMINAL VESICLE#0.9129;SPERM CAPACITATION#0.8419;SPERMATOZOA#0.7435;SEMEN#0.7168;ACROSOME REACTION#0.6974;FERTILIZATION#0.6655;HEPARIN#0.6473;EPIDIDYMIS#0.6290
100131176	HYPOXIA#0.8487
100131187	GLUTATHIONE#0.7109;THIOSULFATE SULFURTRANSFERASE#0.7062;MAJOR DEPRESSIVE EPISODE#0.6710;SPINAL CORD#0.6321
100131439	CELL SURFACE#0.6637
100131726	CELL PROLIFERATION#0.8232;ANTISENSE RNA#0.7326;LUNG ADENOCARCINOMA#0.7216;CELL MIGRATION#0.7148
100131796	COLON CANCER#1.0496;DNA METHYLATION#0.8293;CANCER CELL#0.8214
100131801	CYTOCHROME C OXIDASE#0.9641;CYTOCHROME C#0.9567;CYTOCHROME C OXIDASE ACTIVITY#0.6411
100131827	ZINC FINGER PROTEIN#0.7687
100131897	CELL PROLIFERATION#1.1443;LUNG ADENOCARCINOMA#0.9086;AKT SIGNALING#0.9079;TUMOR TISSUES#0.9069;S PHASE#0.9044;CELL CYCLE#0.8971;SIGNALING PATHWAY#0.8958;ADENOCARCINOMA#0.6456;APOPTOSIS#0.6411
100132074	TRANSCRIPTION FACTOR#1.0268;CANCER CELL#1.0157;CELL PROLIFERATION#0.9964;APOPTOSIS#0.9536;GROWTH FACTOR#0.9092;GLUCOSE METABOLISM#0.8288;CELL CYCLE#0.8219;BREAST CANCER#0.7603;HYPERGLYCEMIA#0.7058;REACTIVE OXYGEN SPECIES#0.6746;BREAST CANCER CELL#0.6269;LYMPH NODE METASTASIS#0.6124;LUNG CANCER#0.6080;LYMPH NODE#0.6076;GLUCONEOGENESIS#0.6033
100132116	LUNG ADENOCARCINOMA#0.7890
100132159	CERVICAL CANCER#0.9086;CELL PROLIFERATION#0.9035;APOPTOSIS#0.6741;CERVICAL#0.6472
100132285	T CELL#0.9966;NATURAL KILLER CELL#0.9934;LEUKOCYTE#0.9672;HUMAN LEUKOCYTE ANTIGEN#0.9465;POLYMERASE CHAIN REACTION#0.9322;SEQUENCE SPECIFIC PRIMER#0.9265;PERIPHERAL BLOOD#0.9044;CELL ACTIVATION#0.8928;CYTOTOXICITY#0.8866;CELL SURFACE#0.8799;STEM CELL#0.8594;NK CELL ACTIVATION#0.8229;IFN-GAMMA#0.8088;STEM CELL TRANSPLANTATION#0.8059;IMMUNE RESPONSE#0.7984;HEMATOPOIETIC STEM CELL#0.7693;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7569;RHEUMATOID ARTHRITIS#0.7549;RECEPTOR LIGAND#0.7306;COLORECTAL CANCER#0.7293;CD4+ T CELL#0.7261;VASCULITIS#0.7221;HEMATOPOIETIC CELL TRANSPLANTATION#0.7004;TYPE 1 DIABETES#0.6981;HEMATOPOIETIC CELL#0.6892;LYSIS#0.6736;HEPATITIS C#0.6559;VIRAL INFECTION#0.6226;HEPATITIS C VIRUS#0.6048;MYELOID LEUKEMIA#0.6038
100132464	CELL PROLIFERATION#1.1787
100132510	GLUTATHIONE#0.9192
100132891	CELL PROLIFERATION#1.0410
100133307	CYTOCHROME P450#0.7967
100133311	CELL CYCLE#0.8208;CELL PROLIFERATION#0.7549;NON-SMALL CELL LUNG CARCINOMA#0.6418;LUNG CARCINOMA#0.6328;DRUG RESISTANCE#0.6284;SIGNALING PATHWAY#0.6195
100133790	CELL DEATH#0.7333;TRANSCRIPTION FACTOR#0.6852
100133941	EPITHELIAL SPECIFIC ANTIGEN#1.0856;TRANSITIONAL B CELL#1.0674;SELECTIN#1.0441;INVASIVE DUCTAL CARCINOMA#1.0307;LYMPH NODE METASTASIS#1.0255;MULTIPLE SCLEROSIS#1.0241;CELL ADHESION MOLECULE#1.0240;DISEASE FREE SURVIVAL#1.0217;GRANULOCYTE#1.0208;CELL SURFACE ANTIGEN#1.0195;BOWMAN'S CAPSULE#1.0166;TUMOR TISSUES#1.0151;TUMOR STEM CELL#1.0144;OVARIAN#1.0110;CELL ASSOCIATED#1.0103;PRIMARY BREAST CANCER#1.0102;FLOW CYTOMETRY ANALYSIS#1.0097;EXOSOME#1.0094;LIPID RAFT#1.0089;REGULATORY B CELL#1.0086;B CELL#1.0075;QUANTITATIVE REAL TIME#1.0074;OVARIAN CANCER#1.0069;PROSTATE CANCER#1.0068;NEUTROPHIL#1.0064;MAMMARY EPITHELIAL CELL#1.0058;CELL ADHESION#1.0052;LUNG CANCER#1.0045;BREAST CARCINOMA#1.0027;CELL SURFACE#1.0020;STEM CELL MARKER#1.0019;PANCREATIC CANCER#1.0017;AUTOIMMUNE DISEASE#1.0014;SQUAMOUS CELL CARCINOMA#0.9995;CANCER INITIATING CELLS#0.9991;CANCER STEM-LIKE CELL#0.9978;LUMINAL#0.9977;COLORECTAL#0.9975;MONOCYTE#0.9972;CERVICAL CANCER#0.9968;COLON CANCER#0.9967;CERVICAL#0.9962;STEM CELL LIKE#0.9958;MAMMARY GLAND#0.9955;PANCREATIC ADENOCARCINOMA#0.9954;TUMOR INITIATING CELL#0.9953;HEPATOCELLULAR CARCINOMA#0.9943;MEMORY B CELL#0.9934;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9934;LUPUS ERYTHEMATOSUS#0.9931;NEURAL CELL#0.9931;MESENCHYMAL STEM CELL#0.9917;B LYMPHOCYTE#0.9906;BREAST CANCER PATIENTS#0.9906;COLORECTAL CANCER#0.9904;LUMINAL PROGENITOR#0.9902;LYMPH NODE#0.9893;PROGESTERONE#0.9893;T LYMPHOCYTE#0.9891;BREAST CANCER#0.9888;CELL MIGRATION#0.9888;GROWTH FACTOR RECEPTOR#0.9885;HYPOXIA#0.9882;ADENOCARCINOMA#0.9882;BREAST CANCER CELL#0.9875;ESTROGEN RECEPTOR#0.9857;CELL DIFFERENTIATION#0.9856;CELL DEATH#0.9853;EPITHELIAL CELL#0.9851;DOXORUBICIN#0.9850;CELL GROWTH#0.9849;PROGENITOR CELL#0.9847;EPIDERMAL GROWTH FACTOR#0.9846;CELL PROLIFERATION#0.9843;OVARIAN CARCINOMA#0.9838;HUMAN BREAST CANCER#0.9830;MONONUCLEAR CELLS#0.9825;PLASMA CELL#0.9821;CELL DEVELOPMENT#0.9819;CISPLATIN#0.9814;LEUKOCYTE#0.9813;CENTRAL NERVOUS SYSTEM#0.9813;HEMATOPOIETIC CELL#0.9810;EMBRYONIC STEM CELL#0.9810;NERVOUS SYSTEM#0.9809;POLYMERASE CHAIN REACTION#0.9808;DENDRITIC CELL#0.9807;STEM CELL#0.9795;TRANSFORMING GROWTH FACTOR#0.9793;CANCER CELL#0.9790;PERIPHERAL BLOOD#0.9789;NUCLEUS PULPOSUS#0.9788;INVASIVE BREAST CARCINOMA#0.9785;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9781;TUMOR CELLS#0.9779;EPITHELIAL TO MESENCHYMAL#0.9777;GEMCITABINE#0.9775;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9774;ORAL SQUAMOUS CELL CARCINOMA#0.9762;APOPTOSIS#0.9760;EPITHELIAL MESENCHYMAL TRANSITION#0.9755;PROTEIN KINASE#0.9751;CANCER STEM CELL#0.9749;STROMAL CELL#0.9744;SMOOTH MUSCLE#0.9741;B CELL DEVELOPMENT#0.9737;CD4+ T CELL#0.9735;T CELL#0.9732;ENDOTHELIAL CELL#0.9730;MACROPHAGE#0.9725;GROWTH FACTOR#0.9722;APOPTOTIC#0.9716;THYMOCYTE#0.9708;SIGNALING PATHWAY#0.9708;CELL CYCLE#0.9705;ANGIOGENESIS#0.9703;IMMUNE RESPONSE#0.9701;DRUG RESISTANCE#0.9700;PANCREATIC DUCTAL ADENOCARCINOMA#0.9697;TRANSCRIPTION FACTOR#0.9695;CELL ACTIVATION#0.9691;CD8+ T CELL#0.9684;B CELL DIFFERENTIATION#0.9683;ANDROGEN RECEPTOR#0.9675;BONE MARROW#0.9674;CYTOPLASM#0.9673;BASAL CELL#0.9673;REGENERATION#0.9672;EPITHELIAL STEM CELL#0.9647;GENE EXPRESSION#0.9645;IMMUNE CELL#0.9617;MESENCHYMAL CELL#0.9608;ADIPOCYTE#0.9608;CYTOTOXICITY#0.9602;NEURAL STEM CELL#0.9601;FAT PAD#0.9601;HUMAN EMBRYONIC STEM#0.9599;TUMOR NECROSIS FACTOR#0.9555;NEUROBLASTOMA#0.9541;ONCOGENIC#0.9539;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9522;INVASIVE BREAST CANCER#0.9513;PLURIPOTENT STEM CELL#0.9505;SIGNAL TRANSDUCER#0.9501;EXTRACELLULAR MATRIX#0.9494;CELL MATURATION#0.9492;TUMOR SUPPRESSOR#0.9484;TIGHT JUNCTION#0.9481;PACLITAXEL#0.9479;CHOLANGIOCARCINOMA#0.9473;CELL MOTILITY#0.9448;STROMA#0.9441;SIGNAL TRANSDUCTION#0.9427;IMMUNE SYSTEM#0.9417;REACTIVE OXYGEN SPECIES#0.9394;LIVER CANCER#0.9384;METASTASIS FREE SURVIVAL#0.9329;SALIVARY GLAND#0.9302;ALKALINE PHOSPHATASE#0.9271;HEMATOPOIETIC STEM CELL#0.9267;PRECURSOR CELL#0.9251;SMOOTH MUSCLE ACTIN#0.9225;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.9209;CELL MEMBRANE#0.9200;REVERSE TRANSCRIPTION#0.9158;RENAL CELL CARCINOMA#0.9150;LUMINAL CELL#0.9140;INFLAMMATORY RESPONSE#0.9139;ENCEPHALOMYELITIS#0.9131;PLASMA MEMBRANE#0.9127;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9108;RETINOIC ACID#0.9089;ANCHORAGE INDEPENDENT GROWTH#0.9052;LYMPH NODE METASTASES#0.9038;GASTRIC ADENOCARCINOMA#0.9033;KINASE ACTIVITY#0.9028;MITOGEN ACTIVATED PROTEIN#0.9016;GLYCOSYLATION#0.9010;METASTATIC BREAST CANCER#0.9009;HUMAN PANCREATIC CANCER#0.8933;NORMAL BREAST TISSUE#0.8920;LUNG ADENOCARCINOMA#0.8893;MYELOID CELL#0.8887;LYMPHOID CELL#0.8875;5 FLUOROURACIL#0.8875;LYMPH NODE INVOLVEMENT#0.8822;HEDGEHOG SIGNALING PATHWAY#0.8814;GALLBLADDER CARCINOMA#0.8809;ATP BINDING CASSETTE#0.8780;HUMAN MAMMARY EPITHELIAL#0.8777;ATP BINDING#0.8763;INSULIN-LIKE GROWTH FACTOR#0.8754;COLONY FORMATION ASSAY#0.8746;LUNG CARCINOMA#0.8729;TRANSCRIPTASE#0.8728;CIRCULATING TUMOR CELL#0.8724;INFLAMMATORY BOWEL DISEASE#0.8711;SMALL INTESTINE#0.8706;BONE MARROW CELLS#0.8696;RNA INTERFERENCE#0.8689;EPSTEIN BARR VIRUS#0.8684;CLEAR CELL RENAL CELL CARCINOMA#0.8677;ENDOMETRIAL CARCINOMA#0.8657;CARCINOMA IN SITU#0.8648;LECTIN#0.8625;MAMMARY FAT PAD#0.8608;CORD BLOOD#0.8599;HEMOGLOBINURIA#0.8586;DUCTAL CARCINOMA IN SITU#0.8580;TRANSFORMING GROWTH FACTOR BETA#0.8554;AUTOPHAGY#0.8549;NUCLEUS PULPOSUS CELL#0.8500;PRO-INFLAMMATORY#0.8467;ASCITES#0.8465;CHEMOKINE RECEPTOR#0.8453;MYELOID LEUKEMIA#0.8438;DNA METHYLATION#0.8438;ADIPOSE TISSUE#0.8424;WOUND HEALING#0.8369;HYPOXIC#0.8366;ERYTHROCYTE#0.8345;NEURITE OUTGROWTH#0.8323;INVASIVE CARCINOMA#0.8286;INTERVERTEBRAL DISC#0.8259;HEPATOCELLULAR CARCINOMA CELL#0.8241;KINASE INHIBITOR#0.8240;MULTIPLE MYELOMA#0.8229;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8220;REGULATORY T CELL#0.8216;T CELL PROLIFERATION#0.8204;PODOCYTE#0.8191;FLUOROURACIL#0.8169;ANTIGEN PRESENTING CELLS#0.8137;SENESCENCE#0.8104;IFN-GAMMA#0.8097;DOCETAXEL#0.8097;FORMALIN#0.8074;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8070;GALLBLADDER#0.8070;OVAL CELL#0.8058;RHEUMATOID ARTHRITIS#0.8053;CHONDROCYTE#0.8045;CELL CYCLE ARREST#0.8033;IL-10 PRODUCTION#0.8020;LYMPH NODE INVASION#0.8017;CELL FRACTION#0.7976;PLASMABLAST#0.7958;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7942;AUTOIMMUNITY#0.7923;COLORECTAL CARCINOMA#0.7909;INTRAHEPATIC CHOLANGIOCARCINOMA#0.7906;TAMOXIFEN#0.7886;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7848;ENDOTHELIAL GROWTH FACTOR#0.7847;COLORECTAL ADENOCARCINOMA#0.7840;RITUXIMAB#0.7814;TOLL LIKE RECEPTOR#0.7785;NOTOCHORD#0.7764;HEAT SHOCK PROTEIN#0.7757;T CELL ACTIVATION#0.7739;MAMMARY EPITHELIUM#0.7733;GESTATION#0.7716;NAIVE B CELL#0.7709;CYTOKINE PRODUCTION#0.7694;LEUCINE#0.7693;PERIPHERAL BLOOD LEUKOCYTE#0.7693;TOXICITY#0.7680;ORAL EPITHELIAL CELLS#0.7665;CELL EXPANSION#0.7659;CANCER RELATED DEATH#0.7630;WHITE BLOOD CELL#0.7623;LASER CAPTURE MICRODISSECTION#0.7623;COLON CARCINOMA#0.7609;EPITHELIAL OVARIAN CANCER#0.7598;T CELL DIFFERENTIATION#0.7593;OVERALL SURVIVAL TIME#0.7592;TRASTUZUMAB#0.7588;IMMUNOTOXIN#0.7586;ASTROCYTE#0.7573;MITOCHONDRIAL MEMBRANE#0.7565;CERVICAL SQUAMOUS CELL CARCINOMA#0.7541;DUCTAL BREAST CANCER#0.7538;SIGNALING MOLECULE#0.7529;NEPHRON#0.7500;FETAL KIDNEY#0.7497;METFORMIN#0.7496;EPENDYMAL CELL#0.7493;B CELL RECEPTOR#0.7446;UMBILICAL CORD#0.7439;PROSTATE CARCINOMA#0.7424;S PHASE#0.7407;NON-SMALL CELL LUNG CARCINOMA#0.7403;ULCERATIVE COLITIS#0.7373;CROHN'S DISEASE#0.7368;LYMPHOCYTIC LEUKEMIA#0.7360;PERIODONTAL DISEASE#0.7350;SPINAL CORD#0.7321;TRANSIT AMPLIFYING CELL#0.7281;INTESTINAL STEM CELL#0.7259;LIVER METASTASIS#0.7257;KERATINOCYTE#0.7232;INDUCED PLURIPOTENT STEM CELL#0.7229;ENDOMETRIAL CANCER#0.7197;COLONY-STIMULATING FACTOR#0.7183;SORAFENIB#0.7162;ESOPHAGEAL CANCER#0.7159;HOST CELL#0.7144;ACTIVATED T CELL#0.7139;NORMAL STEM CELLS#0.7137;MESENCHYME#0.7132;DEDIFFERENTIATION#0.7131;MUSCLE FIBER#0.7131;ADIPOGENESIS#0.7128;RED BLOOD CELL#0.7121;BILIARY TRACT#0.7064;TUMOR ASSOCIATED ANTIGEN#0.7030;ABC TRANSPORTER#0.7017;HODGKIN'S LYMPHOMA#0.6990;LYMPHOID TISSUE#0.6982;PHOSPHOLIPASE C#0.6967;STEM CELL ANTIGEN#0.6960;HEPATITIS B#0.6954;DNA REPAIR#0.6943;PANETH CELL#0.6941;PATHOLOGIC COMPLETE RESPONSE#0.6936;METANEPHRIC MESENCHYME#0.6931;ACTIVATED T-CELLS#0.6909;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6892;B CELL ACTIVATION#0.6871;Y CHROMOSOME#0.6859;MICROVESICLE#0.6855;AMNIOTIC FLUID#0.6837;NEURAL CREST#0.6826;NEURITE#0.6822;BILE DUCT#0.6816;MARGINAL ZONE B CELL#0.6779;LUNG METASTASIS#0.6778;MARGINAL ZONE B#0.6775;CROSS PRESENTATION#0.6773;AGGRESSIVE BEHAVIOR#0.6757;MINIMAL RESIDUAL DISEASE#0.6754;GERMINAL CENTER#0.6733;GASTROINTESTINAL TRACT#0.6701;CELLULAR SENESCENCE#0.6695;PERIODONTITIS#0.6665;NEUROGENESIS#0.6641;TIGHT JUNCTION PROTEIN#0.6640;LYSIS#0.6631;MYOEPITHELIAL CELL#0.6626;TRAUMATIC BRAIN INJURY#0.6611;ENDOTHELIUM#0.6607;ALANINE#0.6606;RETINOBLASTOMA#0.6600;BREAST CELL LINES#0.6586;NECK CANCER#0.6572;IMMATURE TRANSITIONAL B CELL#0.6555;GM-CSF#0.6533;FLOW CYTOMETRY ASSAY#0.6502;METAPLASTIC CARCINOMA#0.6466;WHITE ADIPOSE TISSUE#0.6440;ONCOGENESIS#0.6434;FOCAL ADHESION#0.6426;ENDOMETRIUM#0.6421;ACUTE MYELOID LEUKEMIA#0.6416;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6412;BLOOD VESSEL#0.6401;METAPLASIA#0.6308;PRE-B-LYMPHOCYTE#0.6308;RICIN#0.6290;HEMATOPOIESIS#0.6288;RETICULOCYTE#0.6283;TUMOR NODE METASTASIS#0.6257;PANCREATITIS#0.6257;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.6252;M PHASE#0.6247;HYPOXIA INDUCIBLE FACTOR#0.6237;GROWTH FACTOR BINDING#0.6229;SIGNALLING PATHWAY#0.6226;ANTIGEN PRESENTATION#0.6226;FIBROBLAST GROWTH FACTOR#0.6216;MEDULLOBLASTOMA#0.6207;INVASIVE MICROPAPILLARY CARCINOMA#0.6204;QUIESCENCE#0.6196;SIGNALING CASCADE#0.6194;RECURRENCE FREE SURVIVAL#0.6167;UMBILICAL CORD BLOOD#0.6165;YEAR SURVIVAL RATE#0.6153;GRAFT VERSUS HOST#0.6144;PERIPHERAL BLOOD LYMPHOCYTES#0.6138;AQUAPORIN#0.6123;ANEMIA#0.6116;OXALIPLATIN#0.6106;CANINE MAMMARY TUMORS#0.6097;NATURAL KILLER CELL#0.6093;FLUORESCEIN#0.6057;MORPHOGENESIS#0.6054;CYCLOPHOSPHAMIDE#0.6052;BLADDER CARCINOMA#0.6034;DIFFERENTIAL GENE EXPRESSION#0.6015
100133957	COLORECTAL CANCER#1.1841;CELL PROLIFERATION#1.1787;COLORECTAL#0.8485;APOPTOSIS#0.8439
100134229	RESPONSE TO NUTRIENT#0.8306;PANCREATIC CANCER#0.8300;CANCER CELL#0.7951
100134444	PARALYSIS#1.0599;POTASSIUM CHANNEL#1.0305;THYROTOXIC#0.9982;SKELETAL MUSCLE#0.8958;HYPOKALEMIC PERIODIC PARALYSIS#0.8479
100134934	CST COMPLEX#1.0958;TELOMERE#1.0570;TELOMERE MAINTENANCE#1.0074;CDC13-STN1-TEN1 COMPLEX#1.0052;BUDDING#0.9965;COMPLEX I#0.9965;TELOMERE CAPPING#0.9865;DNA BINDING#0.9545;DNA REPLICATION#0.9189;REPLICATION PROTEIN A#0.8840;PROTEIN COMPLEX#0.8809;SSDNA BINDING#0.7317;SUMOYLATION#0.7060;REPLICATION RESTART#0.6838;SINGLE-STRANDED DNA BINDING#0.6531;CELL CYCLE#0.6471;S PHASE#0.6302;TELOMERE BINDING#0.6233;CANCER CELL#0.6163;DNA DAMAGE RESPONSE#0.6155;ENZYME ACTIVITY#0.6030
100135756	PLASMA MEMBRANE#0.6002
100137047	ARGININE#0.6865;HISTONE DEMETHYLASE#0.6023
100137049	PHOSPHOLIPASE A2#0.7875
10013	TUBULIN DEACETYLASE ACTIVITY#1.1211;TUBULIN DEACETYLATION#1.0888;TUBULIN DEACETYLASE#1.0734;UBIQUITIN BINDING#1.0604;AGGRESOME#1.0513;AXONAL TRANSPORT#1.0506;DEACETYLASE ACTIVITY#1.0427;DYNEIN#1.0408;SQUAMOUS CELL CARCINOMA#1.0382;CELL MOTILITY#1.0374;ACUTE KIDNEY INJURY#1.0339;AUTOPHAGOSOME#1.0297;PRO-INFLAMMATORY#1.0294;MICROTUBULE DYNAMICS#1.0258;CISPLATIN#1.0200;CELL MIGRATION#1.0197;AUTOPHAGOSOME-LYSOSOME FUSION#1.0152;MACROPHAGE#1.0134;B CELL#1.0130;CYTOPLASM#1.0119;CATALYTIC ACTIVITY#1.0106;MICROTUBULE#1.0105;GLUCOCORTICOID RECEPTOR#1.0101;STEM CELL#1.0083;MULTIPLE MYELOMA#1.0080;PROTEIN DEGRADATION#1.0080;AUTOPHAGY#1.0076;ZINC BINDING#1.0075;ENDOTHELIAL CELL#1.0061;UBIQUITIN PROTEASOME SYSTEM#1.0060;UBIQUITIN#1.0056;HEAT SHOCK PROTEIN#1.0044;PROSTATE CANCER#1.0043;BORTEZOMIB#1.0037;ONCOGENIC#1.0035;MITOCHONDRIA#1.0032;STRUCTURE ACTIVITY RELATIONSHIP#1.0028;ZINC BINDING GROUP#1.0024;MITOCHONDRIAL TRANSPORT#1.0022;BREAST CANCER#1.0017;LUNG CANCER#1.0009;BREAST CANCER CELL#0.9996;HISTONE DEACETYLASE#0.9995;LYSOSOME#0.9994;EPITHELIAL CELL#0.9984;GROWTH FACTOR#0.9976;GROWTH FACTOR RECEPTOR#0.9972;NEURODEGENERATIVE DISEASE#0.9970;VORINOSTAT#0.9961;HYPOXIA#0.9949;PROTEASOME#0.9949;TUMOR CELLS#0.9942;TUMOR SUPPRESSOR#0.9942;OVARIAN CANCER#0.9924;CELL PROLIFERATION#0.9916;LYSINE#0.9915;SIGNALING PATHWAY#0.9911;T CELL#0.9882;ALZHEIMER'S DISEASE#0.9875;HISTONE ACETYLATION#0.9874;SUBEROYLANILIDE HYDROXAMIC ACID#0.9863;CYTOTOXICITY#0.9857;INFLAMMATORY RESPONSE#0.9850;CELL CYCLE ARREST#0.9839;ENDOPLASMIC RETICULUM#0.9837;CELL DEATH#0.9835;REACTIVE OXYGEN SPECIES#0.9833;CELL GROWTH#0.9830;HUMAN BREAST CANCER#0.9819;PROTEIN KINASE#0.9817;CANCER CELL#0.9811;APOPTOSIS#0.9799;HEPATOCELLULAR CARCINOMA#0.9797;ESTROGEN RECEPTOR#0.9792;CELL CYCLE#0.9789;IMMUNE RESPONSE#0.9777;TRANSCRIPTION FACTOR#0.9777;DNA BINDING#0.9766;CELL ACTIVATION#0.9758;PROTEIN ACETYLATION#0.9754;APOPTOTIC#0.9725;PANCREATIC CANCER#0.9719;PACLITAXEL#0.9717;OVARIAN#0.9695;TOXICITY#0.9695;NERVOUS SYSTEM#0.9688;GENE EXPRESSION#0.9687;BONE MARROW#0.9681;POST-TRANSLATIONAL MODIFICATION#0.9678;B CELL LYMPHOMA#0.9643;HISTONE DEACETYLASE INHIBITOR#0.9609;AMYOTROPHIC LATERAL SCLEROSIS#0.9580;LATERAL SCLEROSIS#0.9580;POLYMERASE CHAIN REACTION#0.9572;ANGIOGENESIS#0.9571;EPIDERMAL GROWTH FACTOR#0.9568;KIDNEY DISEASE#0.9558;PARKINSON'S DISEASE#0.9551;DEXAMETHASONE#0.9539;MICROTUBULE ASSOCIATED PROTEIN#0.9538;QUANTITATIVE REAL TIME#0.9463;ANDROGEN RECEPTOR#0.9435;ORGANELLE#0.9407;DRUG RESISTANCE#0.9380;NEUROPATHY#0.9376;VIRAL INFECTION#0.9322;CILIUM#0.9311;COLON CANCER#0.9235;MICROTUBULE BINDING#0.9220;HYPERTENSION#0.9124;CHAPERONE ACTIVITY#0.9072;SMOOTH MUSCLE#0.9025;OOCYTE#0.9023;NEUROBLASTOMA#0.9008;SKELETAL MUSCLE#0.8982;POSTTRANSLATIONAL MODIFICATION#0.8937;KINASE ACTIVITY#0.8930;CENTROSOME#0.8923;HOST CELL#0.8899;PRIMARY CILIUM#0.8858;HISTONE MODIFICATION#0.8849;T CELL ACTIVATION#0.8848;HISTONE ACETYLTRANSFERASE#0.8795;BREAST CANCER PATIENTS#0.8764;ROS GENERATION#0.8764;DISEASE FREE SURVIVAL#0.8733;INFLUENZA A VIRUS#0.8732;DIFFUSE LARGE B-CELL LYMPHOMA#0.8727;EPITHELIAL MESENCHYMAL TRANSITION#0.8717;DNA REPAIR#0.8688;POLYCYSTIC KIDNEY DISEASE#0.8687;MYELOID LEUKEMIA#0.8680;G1 PHASE#0.8623;CHARCOT-MARIE-TOOTH DISEASE#0.8614;TOOTH DISEASE#0.8613;CHARCOT MARIE TOOTH#0.8594;NEUROPROTECTION#0.8496;COLORECTAL#0.8469;MITOGEN ACTIVATED PROTEIN#0.8451;LIGHT CHAIN 3#0.8426;REGENERATION#0.8421;PROTEIN COMPLEX#0.8412;SIGNALING CASCADE#0.8349;ACUTE MYELOID LEUKEMIA#0.8348;RNA INTERFERENCE#0.8344;INCLUSION BODY#0.8336;MECHANISM OF ACTION#0.8330;HISTONE DEACETYLATION#0.8329;PLASMA MEMBRANE#0.8325;COLORECTAL CANCER#0.8322;CELL ADHESION#0.8316;MICROTUBULE STABILIZATION#0.8295;NADPH OXIDASE#0.8294;CILIOGENESIS#0.8287;DNA METHYLATION#0.8283;ENZYME ACTIVITY#0.8208;TIGHT JUNCTION#0.8184;EMBRYONIC STEM CELL#0.8172;POLYUBIQUITIN#0.8163;HUNTINGTON'S DISEASE#0.8149;ENDOPLASMIC RETICULUM STRESS#0.8125;PLURIPOTENT STEM CELL#0.8118;GLYCOGEN SYNTHASE KINASE#0.8102;PERIPHERAL BLOOD#0.8099;CYTOCHROME C#0.8079;TRANSACTIVATION#0.7997;DOUBLE STRAND BREAK#0.7964;OSTEOBLAST#0.7955;VALPROIC ACID#0.7950;BINDING PROTEIN 1#0.7949;MESENCHYMAL STEM CELL#0.7938;OOCYTE MATURATION#0.7932;MODE OF ACTION#0.7922;CERVICAL CANCER#0.7919;DENDRITIC CELL#0.7911;TUBULAR EPITHELIAL CELL#0.7907;MUSCLE CELL#0.7903;REVERSE TRANSCRIPTION#0.7902;PLATELET ACTIVATION#0.7871;TAMOXIFEN#0.7865;EPITHELIAL TO MESENCHYMAL#0.7832;SELECTIVE AUTOPHAGY#0.7821;CYSTIC FIBROSIS#0.7806;CENTRAL NERVOUS SYSTEM#0.7788;MOUSE EMBRYONIC FIBROBLAST#0.7780;ACTIN CYTOSKELETON#0.7773;ADIPOCYTE#0.7766;NOCODAZOLE#0.7748;RNA BINDING#0.7741;CD8+ T CELL#0.7728;OXYGEN GLUCOSE DEPRIVATION#0.7714;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7681;STRESS GRANULE#0.7679;MICROTUBULE DISASSEMBLY#0.7675;MITOSIS#0.7666;PERIPHERAL NERVE#0.7662;ISCHEMIA#0.7661;FOCAL ADHESION#0.7606;ESTROGEN RECEPTOR ALPHA#0.7596;HEMORRHAGIC#0.7592;NEUROTOXICITY#0.7585;IMMUNE CELL#0.7573;OSTEOCLAST#0.7564;RETINOIC ACID#0.7561;NUCLEAR EXPORT#0.7560;STROMAL CELL#0.7555;BLOOD VESSEL#0.7555;CERVICAL#0.7552;LYMPH NODE#0.7532;DEUBIQUITINATING ENZYME#0.7524;RAPAMYCIN#0.7508;CYTOPLASMIC INCLUSION#0.7507;SIGNAL TRANSDUCTION#0.7500;SIGNALLING PATHWAY#0.7488;NON HODGKIN LYMPHOMA#0.7444;MICROTUBULE DEPOLYMERIZATION#0.7436;CARDIOMYOCYTE#0.7433;CELL FUSION#0.7433;DNA DAMAGE RESPONSE#0.7429;CELL MOVEMENT#0.7420;MANTLE CELL LYMPHOMA#0.7405;MUSCLE WASTING#0.7398;TEMOZOLOMIDE#0.7397;CLEAVED CASPASE 3#0.7396;PROTEASOME PATHWAY#0.7386;ORAL SQUAMOUS CELL CARCINOMA#0.7377;T LYMPHOCYTE#0.7366;REGULATORY T CELL#0.7362;FLOWERING#0.7345;TRANSFORMING GROWTH FACTOR#0.7332;EXTRACELLULAR MATRIX#0.7331;CELL SURFACE#0.7323;HYPOXIC#0.7299;PROTEIN DEACETYLASE#0.7298;INDUCED PLURIPOTENT STEM CELL#0.7253;CHEMOTAXIS#0.7253;ACUTE LUNG INJURY#0.7250;LIPID DROPLET#0.7249;ASTROCYTE#0.7245;NEUTROPHIL#0.7237;HISTONE H3 ACETYLATION#0.7232;ALPHA-TUBULIN ACETYLATION#0.7223;KINESIN#0.7218;SENESCENCE#0.7203;AUTOIMMUNE DISEASE#0.7199;RESPONSE TO STRESS#0.7199;CELL DIFFERENTIATION#0.7194;GENE SILENCING#0.7186;TUMOR NECROSIS FACTOR#0.7176;ADENOCARCINOMA#0.7171;LIVER CANCER#0.7160;CYTOKINE PRODUCTION#0.7132;SMOOTH MUSCLE CELL#0.7122;CHROMATIN REMODELING#0.7122;MECHANISMS OF ACTION#0.7094;MULTIPLE MYELOMA CELLS#0.7083;BASAL BODY#0.7061;EMBRYONIC KIDNEY#0.7019;REGULATION OF MICROTUBULE DYNAMICS#0.7013;DOXORUBICIN#0.6984;TOLL LIKE RECEPTOR#0.6982;OLIGODENDROCYTE#0.6967;GLIAL CYTOPLASMIC INCLUSION#0.6942;RNA BINDING PROTEIN#0.6936;CELL POLARIZATION#0.6928;DEMENTIA#0.6922;ATP BINDING#0.6918;INNATE IMMUNE RESPONSE#0.6820;ENDOTHELIAL GROWTH FACTOR#0.6801;AUTOPHAGOSOME FORMATION#0.6767;INVASIVE DUCTAL CARCINOMA#0.6747;SPERM MOTILITY#0.6743;M PHASE#0.6728;NUCLEAR MATRIX#0.6718;PROTEIN PROTEIN INTERACTION#0.6717;ACUTE LIVER FAILURE#0.6716;CELL CYCLE REGULATION#0.6709;DEFENSE RESPONSE#0.6701;MELANOMA CELL LINES#0.6674;PLATELET-DERIVED GROWTH FACTOR#0.6657;NEURITE#0.6650;KINASE INHIBITOR#0.6589;MICROTUBULE ORGANIZING CENTER#0.6584;WOUND HEALING#0.6526;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6524;ENDOSOME#0.6465;NEUROLOGICAL DISORDER#0.6458;RHEUMATOID ARTHRITIS#0.6456;TARGET OF RAPAMYCIN#0.6435;VASCULAR SMOOTH MUSCLE CELL#0.6421;SUPEROXIDE DISMUTASE#0.6401;ADIPOSE TISSUE#0.6396;MACROAUTOPHAGY#0.6394;DNA METHYLTRANSFERASE#0.6277;MONOCYTE#0.6264;MISMATCH REPAIR#0.6250;MITOCHONDRIAL MEMBRANE#0.6246;MITOPHAGY#0.6245;ESTRADIOL#0.6240;THYROID CANCER#0.6240;HUMAN EMBRYONIC KIDNEY#0.6223;RENAL CELL CARCINOMA#0.6220;TUMOR GROWTH INHIBITION#0.6219;TAXOL#0.6217;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6186;LUPUS ERYTHEMATOSUS#0.6184;BONE MARROW STROMAL#0.6183;AUTOPHAGOSOME MATURATION#0.6161;APOPTOTIC CELL DEATH#0.6145;17-DMAG#0.6145;CD4+ T CELL#0.6114;20S PROTEASOME#0.6106;MONONUCLEAR CELLS#0.6078;SKELETAL MUSCLE WASTING#0.6062;COLITIS#0.6061;LUNG ENDOTHELIAL CELLS#0.6053;RELAPSE FREE SURVIVAL#0.6051;ACUTE LUNG INFLAMMATION#0.6050;AXON INITIAL SEGMENT#0.6042;LUPUS NEPHRITIS#0.6040;MUSCLE ATROPHY#0.6034;CARFILZOMIB#0.6015;PULMONARY FIBROSIS#0.6004
100144434	NOTOCHORD#0.6311
100144632	PHOSPHATE BINDING PROTEIN#1.1505;PHOSPHATE BINDING#1.1447
100144748	BREAST CANCER#1.0349;CELL CYCLE#0.9946;TUMOR SUPPRESSOR#0.9741;APOPTOSIS#0.9661;S PHASE#0.9339;DNA BINDING#0.8921;THYROID CANCER#0.8564;BREAST CARCINOMA#0.8536;DNA REPLICATION#0.7916;CANCER CELL#0.7255;TRANSCRIPTION FACTOR#0.7123;DUAL LUCIFERASE REPORTER#0.6471;DNA SYNTHESIS#0.6392;ANDROGEN RECEPTOR#0.6308;BREAST CANCER CELL#0.6287;PERICENTRIC HETEROCHROMATIN#0.6152;FOLLICULAR THYROID CANCER#0.6076
10014	PROTEIN KINASE D#1.0556;NUCLEAR EXPORT#1.0547;CANCER CELL#1.0247;MYOCYTE ENHANCER FACTOR#1.0229;HISTONE DEACETYLASE#1.0171;AXON REGENERATION#1.0161;PROTEIN KINASE#1.0089;TRANSCRIPTION FACTOR#0.9984;ENDOTHELIAL CELL#0.9982;SKELETAL MUSCLE#0.9978;APOPTOSIS#0.9965;CAMKII#0.9880;BREAST CANCER#0.9874;GENE EXPRESSION#0.9859;HISTONE ACETYLATION#0.9841;SIGNALING PATHWAY#0.9824;NUCLEAR IMPORT#0.9781;T CELL#0.9770;GROWTH FACTOR#0.9691;MYOCYTES#0.9652;CARDIOMYOCYTE#0.9571;CYTOPLASM#0.9488;CELL PROLIFERATION#0.9480;LYSINE#0.9208;MUSCLE CELL#0.9162;SMOOTH MUSCLE#0.8855;CELL GROWTH#0.8619;REGENERATION#0.8589;PROTEIN KINASE C#0.8416;ANGIOGENESIS#0.8372;CAMP RESPONSE ELEMENT#0.8234;SMOOTH MUSCLE CELL#0.8166;HISTONE MODIFICATION#0.8122;CAMP RESPONSE ELEMENT BINDING#0.8101;CD4+ T CELL#0.7935;VASCULAR SMOOTH MUSCLE CELL#0.7899;PRO-INFLAMMATORY#0.7884;KINASE ACTIVITY#0.7808;DEPHOSPHORYLATION#0.7789;STEM CELL#0.7761;HYPOXIA#0.7747;HISTONE DEACETYLASE INHIBITOR#0.7687;POLYMERASE CHAIN REACTION#0.7605;HISTONE ACETYLTRANSFERASE#0.7582;HYPOXIA INDUCIBLE FACTOR#0.7506;CELL DIFFERENTIATION#0.7502;CELL CYCLE#0.7358;PROTEIN KINASE A#0.7312;MITOGEN ACTIVATED PROTEIN#0.7273;MYOCARDIAL INFARCTION#0.7264;INFLAMMATORY RESPONSE#0.7263;MYOBLAST#0.7256;RNA INTERFERENCE#0.7233;OSTEOBLAST#0.7222;TUMOR CELLS#0.7193;ISCHEMIA#0.7180;MYOTUBE#0.7100;EPITHELIAL CELL#0.7024;ADRENERGIC RECEPTOR#0.7019;TRANSACTIVATION#0.6905;GLUCOSE UPTAKE#0.6850;COLORECTAL CANCER#0.6806;B CELL#0.6785;CELL DEATH#0.6781;PROGENITOR CELL#0.6777;HIGH FAT DIET#0.6760;C TERMINAL DOMAIN#0.6740;BREAST CANCER CELL#0.6739;HEPATOCELLULAR CARCINOMA#0.6735;TUMOR SUPPRESSOR#0.6608;TUBULIN DEACETYLATION#0.6537;HUMAN BREAST CANCER#0.6514;QUANTITATIVE REAL TIME#0.6508;OSTEOBLAST DIFFERENTIATION#0.6367;TUBULIN DEACETYLASE#0.6366;ISOPROTERENOL#0.6364;OSTEOCYTE#0.6330;HISTONE H3 ACETYLATION#0.6320;OBESE#0.6275;BONE FORMATION#0.6220;REVERSE TRANSCRIPTION#0.6193;DNA METHYLATION#0.6180;DNA BINDING#0.6159;STRIATUM#0.6148;HEART VALVE FORMATION#0.6142;MYOSIN HEAVY CHAIN#0.6036;PHENYLEPHRINE#0.6020
100151683	SPLICEOSOME#1.0658;SMALL NUCLEAR RNA#0.9432;U6ATAC SNRNP#0.9300;MICROCEPHALY#0.7203;BASE PAIRING#0.7201;U5 SNRNP#0.6622
100151684	SPLICEOSOME#1.0768;U6ATAC SNRNP#1.0478;BASE PAIRING#0.7957;U5 SNRNP#0.6699
10015	ABSCISSION#1.0599;VIRUS BUDDING#1.0506;PROGRAMMED CELL DEATH#1.0454;MIDBODY#1.0402;LATE ENDOSOME#1.0396;CELL DEATH#1.0302;EXOSOME#1.0295;VIRAL BUDDING#1.0270;MULTIVESICULAR BODY#1.0263;BUDDING#1.0179;CYTOKINESIS#1.0174;APOPTOSIS#1.0164;ENDOSOME#1.0124;VIRION#1.0081;UBIQUITIN#1.0050;CYTOKINETIC ABSCISSION#1.0045;GROWTH FACTOR#1.0035;VIRUS LIKE PARTICLE#1.0013;EXOSOME BIOGENESIS#0.9982;EXTRACELLULAR VESICLE#0.9819;PLASMA MEMBRANE#0.9806;HUMAN IMMUNODEFICIENCY VIRUS#0.9781;STEM CELL#0.9720;TRANSMISSION ELECTRON MICROSCOPY#0.9704;HOST CELL#0.9547;NUCLEOCAPSID#0.9540;CELL ADHESION#0.9523;MULTIVESICULAR ENDOSOME#0.9514;ENDOCYTOSIS#0.9470;CELL SURFACE#0.9410;LYSOSOME#0.9356;ACTIN CYTOSKELETON#0.9328;CANCER CELL#0.9118;ESCRT III COMPLEX#0.9079;CELL PROLIFERATION#0.9039;EQUINE INFECTIOUS ANEMIA#0.8958;VESICLE FORMATION#0.8851;ENDOTHELIAL CELL#0.8811;EPIDERMAL GROWTH FACTOR#0.8723;VACUOLAR PROTEIN SORTING#0.8707;RNA INTERFERENCE#0.8687;CELL MEMBRANE#0.8672;EPITHELIAL CELL#0.8623;SIGNALING PATHWAY#0.8588;CYTOPLASM#0.8563;MICROVESICLE#0.8535;MEMBRANE FISSION#0.8523;BREAST CANCER#0.8505;ENDOSOMAL MEMBRANE#0.8435;CELL DIVISION#0.8425;ACTIN FILAMENT#0.8416;T CELL#0.8349;GROWTH FACTOR RECEPTOR#0.8324;ANGIOGENESIS#0.8285;AUTOPHAGY#0.8207;CELL MIGRATION#0.8198;APOPTOTIC#0.8094;CELL CYCLE#0.8014;PROTEIN COMPLEX#0.7874;GLUTATHIONE#0.7833;HEAT SHOCK PROTEIN#0.7791;VACUOLE#0.7611;GALECTIN#0.7559;CELL COMMUNICATION#0.7490;ANEMIA#0.7359;VIRAL REPLICATION#0.7308;PROTEIN TYROSINE PHOSPHATASE#0.7270;ACTIN POLYMERIZATION#0.7142;LIPID RAFT#0.6949;SIGNAL TRANSDUCTION#0.6921;MESENCHYMAL STEM CELL#0.6771;CELLULAR MEMBRANE#0.6677;PROTEIN PROTEIN INTERACTION#0.6625;IMMUNE RESPONSE#0.6573;ASTROCYTE#0.6571;INTERCELLULAR BRIDGE#0.6547;CENTROSOME#0.6399;SIMIAN IMMUNODEFICIENCY VIRUS#0.6381;PROGENITOR CELL#0.6295;MUSCLE CELL#0.6261;SKELETAL MUSCLE#0.6260;ORGANELLE#0.6242;EARLY ENDOSOME#0.6234;MIDBODY RING#0.6232;CONTRACTILE RING#0.6163;TUMOR CELLS#0.6130;GERMLINE STEM CELL#0.6126;ESCRT I COMPLEX#0.6125;MVB BIOGENESIS#0.6102;ESCRT COMPLEX#0.6071;M PHASE#0.6066;EPITHELIAL BARRIER FUNCTION#0.6045
100169750	TETRAHYDROPYRAN#1.0656;ACETAL#0.9790;DNA SYNTHESIS#0.7074;SKELETON#0.6947;DODECANE#0.6148;CANCER CELL#0.6132
10016	PROGRAMMED CELL DEATH#1.0573;APOPTOTIC#1.0448;CELL DEATH#1.0436;APOPTOSIS#1.0425;CANCER CELL#1.0165;ENDOPLASMIC RETICULUM#1.0147;OVARIAN CANCER#0.9920;T CELL#0.9888;CELL PROLIFERATION#0.8972;CYTOPLASM#0.8887;LUNG CANCER#0.8884;ER TO GOLGI TRANSPORT#0.8839;OVARIAN#0.8304;ENDOPLASMIC RETICULUM EXIT SITE#0.8241;ER EXIT SITE#0.8137;ER EXIT#0.8073;COPII VESICLE#0.7980;PLASMA MEMBRANE#0.7946;ENDOSOME#0.7872;SIGNAL TRANSDUCTION#0.7766;CELL CYCLE#0.7720;SIGNALING PATHWAY#0.7476;POLYMERASE CHAIN REACTION#0.7323;BUDDING#0.7205;GLUTATHIONE#0.6952;COPII VESICLE BUDDING#0.6839;MULTIVESICULAR BODY#0.6569;BIOTIN#0.6448;CERVICAL#0.6427;SURFACE PLASMON RESONANCE#0.6391;MICROTUBULE#0.6209;GENE EXPRESSION#0.6192;CELL GROWTH#0.6120;PROTEIN COMPLEX#0.6086;EPITHELIAL OVARIAN CANCER#0.6082;CEREBRAL ISCHEMIA#0.6036;RNA BINDING#0.6027
10017	APOPTOTIC#1.0360;CELL DEATH#1.0350;APOPTOSIS#1.0248;CANCER CELL#0.9507;OOCYTE#0.9276;B CELL#0.8651;OOCYTE MATURATION#0.8163;AUTOPHAGY#0.7740;CELL CYCLE#0.7599;GENE EXPRESSION#0.7464;BONE MARROW#0.7200;MITOCHONDRIA#0.7170;B CELL LYMPHOMA#0.7136;PLASMA CELL#0.6911;RNA INTERFERENCE#0.6887;OVARIAN#0.6625;OVARIES#0.6129;MYELODYSPLASTIC SYNDROME#0.6067;MYELOID LEUKEMIA#0.6024
100187716	APOPTOSIS#0.7532;GENE EXPRESSION#0.7434;CELL PROLIFERATION#0.6315;SIGNALING PATHWAY#0.6313;HIPPO SIGNALING PATHWAY#0.6087;HIPPO SIGNALING#0.6031
100187907	TRIIODOTHYRONINE#0.8505;THYROID HORMONE RECEPTOR#0.7752;RETINOID X RECEPTOR#0.7032;QUADRUPOLE ION TRAP#0.6416;LINEAR ION TRAP#0.6316;ALIZARIN RED S#0.6150
100188011	PNEUMONIA#0.7798;INTERSTITIAL LUNG DISEASE#0.7749;LUNG DISEASE#0.7688;LANGERHANS CELL#0.6524
100188278	BREAST CANCER#0.6913
100188754	PNEUMONIA#0.6685
100188771	CELL SURFACE#0.7485;CELL WALL#0.7401
100188776	TRANSCRIPTION FACTOR#0.9248;SIGNALING PATHWAY#0.6102;ENDOTHELIAL CELL#0.6013
100188785	CHROMATIN REMODELING#0.6821
100188789	T CELL#0.6838;PROSTATE CANCER#0.6292
100188795	GROWTH FACTOR#1.0102;NERVE GROWTH FACTOR#0.9860;ALZHEIMER'S DISEASE#0.9427;CANCER CELL#0.7987;GENE EXPRESSION#0.7727;T CELL#0.7666;TROPISM#0.6946
100188812	RESTLESS LEGS SYNDROME#0.7222
100188813	AGE AT ONSET#0.7278;RESTLESS LEGS SYNDROME#0.6051
100188821	EGG LAYING#0.9286;SIGNALING PATHWAY#0.7837;HETEROTRIMERIC G-PROTEIN#0.7807;COMPLEX I#0.7028;SPINDLE POSITIONING#0.6781;DIACYLGLYCEROL KINASE#0.6484;LOCOMOTION#0.6394;SYNAPTIC TRANSMISSION#0.6276;PROTEIN KINASE#0.6082
100188830	CELL SURFACE#1.0478;DNA METHYLATION#1.0457;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0370;TUMOR CELLS#1.0356;VIRAL GENOME#1.0350;DNA REPLICATION#1.0279;ONCOGENIC#1.0269;VIRION#1.0196;DNA BINDING#1.0024;DNA INTEGRATION#1.0023;GENE EXPRESSION#1.0013;TUMOR ANTIGEN#1.0001;T LYMPHOCYTE#0.9842;HOST CELL#0.9768;DNA SYNTHESIS#0.9736;CYTOTOXIC T-LYMPHOCYTE#0.9708;VIRAL DNA REPLICATION#0.9688;VIRAL REPLICATION#0.9265;LYSIS#0.8805;S PHASE#0.8547;METAPHASE#0.8006;ONCOGENESIS#0.7863;TRANSCRIPTION FACTOR#0.7854;CELL CYCLE#0.7853;CYTOPLASM#0.7792;CARRIE#0.7703;PROTEIN KINASE#0.7401;IFN-GAMMA#0.7213;VIRAL INFECTION#0.6802;RETINOBLASTOMA#0.6768;TRANSACTIVATION#0.6727;T CELL#0.6695;PROTEIN SYNTHESIS#0.6620;HUMAN EMBRYONIC KIDNEY#0.6555;EMBRYONIC KIDNEY#0.6550;CYTOSINE ARABINOSIDE#0.6387;CYTOTOXICITY#0.6325;C-TERMINAL BINDING#0.6285;MHC PROTEIN#0.6203;SMALL NUCLEAR RNA#0.6042;DNA DEGRADATION#0.6033
100188832	AUTISTIC#0.6075
100188839	RESTLESS LEGS SYNDROME#0.7856;RESTLESS#0.6024
100188845	OPTIC DISC#1.0711;OPTIC PIT#0.9942;OPTIC NERVE#0.9235;OPTICAL COHERENCE TOMOGRAPHY#0.6615
100188846	ABBREVIATED INJURY SCALE#0.9240;INSOMNIA#0.8311;INJURY SEVERITY SCORE#0.8017;TRAUMATIC BRAIN INJURY#0.6779
100188848	MESIAL TEMPORAL LOBE#1.1435;TEMPORAL LOBE EPILEPSY#1.1321;TEMPORAL LOBE#1.1279;EPILEPSY#1.0427
100188857	DYNEIN#1.0323;MICROTUBULE#0.7333;ATP HYDROLYSIS#0.6912;MICROTUBULE BINDING#0.6904;NUCLEOTIDE BINDING#0.6826
100188863	XYLANASE#0.9370;CELL SURFACE#0.6943;CELL WALL#0.6746;GLUCOSE HOMEOSTASIS#0.6238
100188864	MEDULLARY SPONGE KIDNEY#1.1186;ANIRIDIA#1.0698;GIGANTISM#1.0676;NEVUS#1.0433;SCOLIOSIS#1.0410;MACROCEPHALY#1.0408;BECKWITH-WIEDEMANN SYNDROME#1.0269;KLIPPEL-TRENAUNAY SYNDROME#1.0258;PROTEUS SYNDROME#1.0254;MENTAL RETARDATION#1.0145;EPIDERMAL NEVUS#0.9915;HEMANGIOMA#0.9729;HYPOGLYCEMIA#0.9692;LIPOMATOSIS#0.9500;HEPATOBLASTOMA#0.9490;OMPHALOCELE#0.9362;VARICOSE VEINS#0.9058;ADRENOCORTICAL CARCINOMA#0.9001;HAMARTOMA#0.8967;DEVELOPMENTAL DELAY#0.8620;CONNECTIVE TISSUE#0.8387;LIPOMA#0.8379;PHEOCHROMOCYTOMA#0.8252;NEPHROBLASTOMA#0.7566;UMBILICAL HERNIA#0.7564;CENTRAL NERVOUS SYSTEM#0.7553;NERVOUS SYSTEM#0.7543;NODULAR#0.7502;RENAL CELL CARCINOMA#0.7427;CRYPTORCHIDISM#0.7122;RHABDOMYOSARCOMA#0.6969;CONGENITAL HEART DISEASE#0.6965;CONGENITAL HEART DEFECTS#0.6872;HEART DISEASE#0.6859;PORT-WINE STAIN#0.6634;CONGENITAL DISORDER#0.6587;MAGNETIC RESONANCE IMAGING#0.6355;ADRENAL CARCINOMA#0.6339;CONGENITAL HIP DISLOCATION#0.6250;POLYDACTYLY#0.6241;SWELLING#0.6214;CLEAR CELL ADENOCARCINOMA#0.6183;DENYS-DRASH SYNDROME#0.6157;PLEXIFORM NEUROFIBROMA#0.6089;NEUROFIBROMA#0.6003
100188881	T CELL#0.9845;POLYMERASE CHAIN REACTION#0.9801;AMPICILLIN#0.8168;TOXICITY#0.7995;CYTOTOXICITY#0.7976;TETRACYCLINE#0.7746;CANCER CELL#0.7663;CEFTAZIDIME#0.7282;APOPTOSIS#0.6968;MINIMUM INHIBITORY CONCENTRATION#0.6882;DYNAMIC LIGHT SCATTERING#0.6833;IMIPENEM#0.6759;CEFOTAXIME#0.6578;BETA-LACTAMASE ACTIVITY#0.6336;CELL WALL#0.6232;MITOCHONDRIA#0.6204;DRUG RESISTANCE#0.6048
100188893	GIP COMPLEX#1.0568;TOM COMPLEX#1.0513;OUTER MEMBRANE#1.0131;MITOCHONDRIA#0.8926;MITOCHONDRIAL OUTER MEMBRANE#0.8380;OUTER MITOCHONDRIAL MEMBRANE#0.6806;MITOCHONDRIAL MEMBRANE#0.6719;PROTEIN IMPORT#0.6091
10018	ANOIKIS#1.0394;HEPATOCYTE APOPTOSIS#1.0297;DYNEIN#1.0281;GEFITINIB#1.0278;CLEAVED CASPASE 3#1.0274;ERLOTINIB#1.0232;ER STRESS-INDUCED APOPTOSIS#1.0206;ACTIVATED T CELL#1.0197;SORAFENIB#1.0196;THYMOCYTE#1.0195;INTRINSIC APOPTOTIC PATHWAY#1.0176;OSTEOCLAST#1.0174;APOPTOSIS INDUCING FACTOR#1.0165;ACTIVATED T-CELLS#1.0145;LYMPHOID CELL#1.0128;PACLITAXEL#1.0122;BETA CELL#1.0090;ABT-263#1.0087;DEPHOSPHORYLATION#1.0076;IMATINIB#1.0070;CD8+ T CELL#1.0069;B LYMPHOCYTE#1.0044;MITOCHONDRIAL TRANSLOCATION#1.0043;PROTEIN KINASE C#1.0042;RNA INTERFERENCE#1.0027;BORTEZOMIB#1.0004;AUTOPHAGY#1.0003;DEXAMETHASONE#0.9994;LUNG ADENOCARCINOMA#0.9993;MEMORY T CELL#0.9988;VORINOSTAT#0.9985;AUTOIMMUNITY#0.9982;CELL KILLING#0.9980;APOPTOTIC#0.9970;INTRINSIC APOPTOSIS#0.9969;T CELL APOPTOSIS#0.9966;MOUSE EMBRYONIC FIBROBLAST#0.9963;CISPLATIN#0.9960;MAP KINASE#0.9960;CYTOCHROME C RELEASE#0.9958;EPSTEIN BARR VIRUS#0.9951;HEMATOPOIETIC CELL#0.9947;DEATH RECEPTOR#0.9946;MICROTUBULE#0.9941;PROTEASOME#0.9939;POLY ADP RIBOSE#0.9938;CD4+ T CELL#0.9931;POLYMERASE CHAIN REACTION#0.9929;SIGNALLING PATHWAY#0.9920;MACROPHAGE#0.9918;MITOCHONDRIAL OUTER MEMBRANE#0.9906;CYCLIN DEPENDENT KINASE#0.9899;B CELL LYMPHOMA#0.9896;MAST CELL#0.9891;PANCREATIC CANCER#0.9889;THYMOCYTE APOPTOSIS#0.9886;OUTER MEMBRANE#0.9885;ISCHEMIA#0.9881;RIBOSE#0.9880;DOXORUBICIN#0.9878;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9873;T CELL#0.9861;B CELL#0.9860;LUNG CANCER#0.9860;HYPOXIA#0.9854;OVARIAN CANCER#0.9853;TYROSINE KINASE INHIBITOR#0.9848;CYTOCHROME C#0.9845;LYMPHOCYTIC LEUKEMIA#0.9842;APOPTOSIS#0.9842;OVARIAN#0.9841;ACTIVATED CASPASE 3#0.9840;CASPASE ACTIVATION#0.9840;DNA FRAGMENTATION#0.9832;ENDOTHELIAL CELL#0.9831;DYNEIN LIGHT CHAIN#0.9827;MYELOID CELL#0.9825;HISTONE DEACETYLASE INHIBITOR#0.9823;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9821;CASPASE-3 ACTIVITY#0.9819;CELL DEATH#0.9813;MITOCHONDRIA#0.9810;SENSITIZATION#0.9810;T LYMPHOCYTE#0.9802;BREAST CANCER CELL#0.9802;PERIPHERAL BLOOD#0.9801;UBIQUITIN#0.9793;CELL DEVELOPMENT#0.9789;SIGNALING CASCADE#0.9789;INDUCTION OF APOPTOSIS#0.9785;MITOCHONDRIAL MEMBRANE#0.9784;CHRONIC MYELOID LEUKEMIA#0.9775;HUMAN BREAST CANCER#0.9772;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9765;EPIDERMAL GROWTH FACTOR#0.9764;KINASE INHIBITOR#0.9762;CELL ACTIVATION#0.9761;DRUG RESISTANCE#0.9761;ADENOCARCINOMA#0.9761;ETOPOSIDE#0.9758;MITOGEN ACTIVATED PROTEIN#0.9751;PROGRAMMED CELL DEATH#0.9748;ONCOGENIC#0.9748;CARDIOMYOCYTE#0.9747;MITOSIS#0.9747;CYTOPLASM#0.9746;TUMOR SUPPRESSOR#0.9745;GROWTH FACTOR RECEPTOR#0.9741;REGULATION OF APOPTOSIS#0.9739;APOPTOTIC CELL DEATH#0.9738;MULTIPLE MYELOMA#0.9736;ENDOPLASMIC RETICULUM STRESS#0.9733;NEURONAL CELLS#0.9728;GRANULOSA CELL#0.9727;HISTONE DEACETYLASE#0.9723;EPITHELIAL CELL#0.9722;AKT SIGNALING#0.9720;RAPAMYCIN#0.9718;BONE MARROW#0.9718;SIGNAL TRANSDUCTION#0.9717;PROGENITOR CELL#0.9717;T CELL ACTIVATION#0.9710;TRANSCRIPTION FACTOR#0.9710;NEUTROPHIL#0.9708;COLORECTAL CANCER#0.9706;COLON CANCER#0.9704;TUMOR NECROSIS FACTOR#0.9704;REVERSE TRANSCRIPTION#0.9703;PROTEIN KINASE#0.9701;BREAST CANCER#0.9701;COLORECTAL#0.9700;MYELOID LEUKEMIA#0.9695;PROSTATE CANCER#0.9693;MITOCHONDRIAL DEPOLARIZATION#0.9691;RESVERATROL#0.9691;ENDOPLASMIC RETICULUM#0.9689;IMMUNE RESPONSE#0.9689;NEURONAL CELL DEATH#0.9688;SQUAMOUS CELL CARCINOMA#0.9666;TARGET OF RAPAMYCIN#0.9665;STEM CELL#0.9661;APOPTOSIS SIGNALING#0.9661;MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION#0.9661;PROTEIN KINASE B#0.9661;ACTIVE CASPASE 3#0.9658;TUMOR CELLS#0.9655;REACTIVE OXYGEN SPECIES#0.9651;RECEPTOR TYROSINE KINASE#0.9650;CYTOTOXICITY#0.9650;OSTEOBLAST#0.9650;PROTEIN PROTEIN INTERACTION#0.9647;TRANSFORMING GROWTH FACTOR#0.9646;TOXICITY#0.9639;GROWTH FACTOR#0.9639;HEPATOCELLULAR CARCINOMA#0.9637;NEURON DEATH#0.9634;GENE EXPRESSION#0.9633;SIGNALING PATHWAY#0.9631;CELL CYCLE ARREST#0.9625;MULTIPLE MYELOMA CELLS#0.9620;M PHASE#0.9615;IMMUNE SYSTEM#0.9615;ACUTE MYELOID LEUKEMIA#0.9614;CANCER CELL#0.9602;MECHANISM OF ACTION#0.9594;CELL CYCLE#0.9586;DNA BINDING#0.9586;CASPASE INHIBITOR#0.9571;LYSINE#0.9565;CELL PROLIFERATION#0.9557;NEUROBLASTOMA#0.9555;CELL GROWTH#0.9547;INHIBITION OF APOPTOSIS#0.9540;MYELOID CELL LEUKEMIA#0.9535;G1 PHASE#0.9535;QUANTITATIVE REAL TIME#0.9491;LYMPH NODE#0.9488;ANGIOGENESIS#0.9464;VIRAL INFECTION#0.9464;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9449;STROMAL CELL#0.9448;HOST CELL#0.9444;REGULATORY T CELL#0.9437;AUTOIMMUNE DISEASE#0.9426;B CELL RECEPTOR#0.9419;NITRIC OXIDE#0.9398;OUTER MITOCHONDRIAL MEMBRANE#0.9398;SIGNAL TRANSDUCER#0.9378;APOPTOTIC PROGRAM#0.9372;LYMPHOCYTE APOPTOSIS#0.9346;CELL DIFFERENTIATION#0.9340;CELL SURFACE#0.9338;DNA METHYLATION#0.9338;COMPLEX I#0.9325;UNFOLDED PROTEIN RESPONSE#0.9323;PHOSPHATASE 2A#0.9307;T CELL HOMEOSTASIS#0.9301;NEUROPROTECTION#0.9296;CDK INHIBITOR#0.9290;DENDRITIC CELL#0.9280;MELANOMA CELL LINES#0.9269;EXTRACELLULAR MATRIX#0.9264;MELPHALAN#0.9258;PROTEIN SYNTHESIS#0.9247;CERVICAL CANCER#0.9229;CELL MIGRATION#0.9226;ESTROGEN RECEPTOR#0.9212;DEATH RECEPTOR 5#0.9200;KINASE ACTIVITY#0.9196;IMMUNE CELL#0.9182;ISCHEMIA REPERFUSION INJURY#0.9170;INSULIN-LIKE GROWTH FACTOR#0.9154;NERVOUS SYSTEM#0.9127;TUMOR TISSUES#0.9115;TRANSACTIVATION#0.9105;MAPK SIGNALING#0.9081;MANTLE CELL LYMPHOMA#0.9071;TOLL LIKE RECEPTOR#0.9046;EFFECTOR T CELL#0.9045;PROPIDIUM#0.9028;MOLECULAR DYNAMICS SIMULATION#0.8996;TRANSFORMING GROWTH FACTOR BETA#0.8984;COLONY-STIMULATING FACTOR#0.8977;CYCLIN DEPENDENT KINASE INHIBITOR#0.8976;PROTEIN KINASE A#0.8967;MAMMARY GLAND#0.8953;LYMPHOMA CELL LINES#0.8937;RECEPTOR AGONIST#0.8923;ROS GENERATION#0.8910;SEQUESTERING#0.8909;PROTEIN PHOSPHATASE 2A#0.8891;CEREBELLAR GRANULE NEURON#0.8881;PROTEASOME PATHWAY#0.8878;GLYCOGEN SYNTHASE KINASE#0.8866;NERVE GROWTH FACTOR#0.8855;MAMMARY EPITHELIAL CELL#0.8849;GLUCOCORTICOID RECEPTOR#0.8842;LUMINAL#0.8840;ALZHEIMER'S DISEASE#0.8805;S PHASE#0.8805;MAPK ACTIVATION#0.8777;SUPEROXIDE DISMUTASE#0.8733;ANTI APOPTOSIS#0.8730;EXTRINSIC APOPTOSIS#0.8720;PHOSPHATASE AND TENSIN HOMOLOG#0.8719;PRO-INFLAMMATORY#0.8703;GENE SILENCING#0.8674;ACTIVATION-INDUCED CELL DEATH#0.8672;MUTAGENESIS#0.8671;HYPOXIC#0.8665;T CELL DEVELOPMENT#0.8660;BURKITT LYMPHOMA#0.8647;DIFFUSE LARGE B-CELL LYMPHOMA#0.8642;CERVICAL#0.8605;PARKINSON'S DISEASE#0.8589;HEAT SHOCK PROTEIN#0.8558;NITRIC OXIDE SYNTHASE#0.8543;APOPTOTIC PROCESS#0.8538;ADENOSINE#0.8537;MITOCHONDRIAL DAMAGE#0.8533;B CELL DEVELOPMENT#0.8517;OVARIAN CARCINOMA#0.8475;DISEASE CONTROL RATE#0.8462;INFLAMMATORY RESPONSE#0.8461;OBJECTIVE RESPONSE RATE#0.8428;CELL ADHESION#0.8422;PLASMA CELL#0.8419;HISTONE ACETYLATION#0.8359;HYPOXIA INDUCIBLE FACTOR#0.8314;SIGNALING MOLECULE#0.8310;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.8300;NON HODGKIN LYMPHOMA#0.8286;JNK SIGNALING PATHWAY#0.8279;LYSOSOME#0.8278;ARTERY#0.8219;ENHANCER BINDING#0.8209;MITOCHONDRION#0.8208;RECEPTOR ANTAGONIST#0.8203;PROTEIN DEGRADATION#0.8201;HEPATOCELLULAR CARCINOMA CELL#0.8195;MELANOCYTE#0.8187;GLUTATHIONE#0.8184;GERM CELL#0.8178;N-ACETYLCYSTEINE#0.8147;OXYGEN GLUCOSE DEPRIVATION#0.8130;MAST CELL APOPTOSIS#0.8129;RENAL CARCINOMA#0.8112;ARSENIC TRIOXIDE#0.8104;MITOCHONDRIAL MEMBRANE PERMEABILITY#0.8062;DNA REPAIR#0.8045;LEUKOCYTE#0.7990;LAPATINIB#0.7957;EXTRINSIC APOPTOTIC PATHWAY#0.7936;ENDOTHELIAL GROWTH FACTOR#0.7924;CEREBRAL ISCHEMIA#0.7919;ALANINE#0.7901;VINCRISTINE#0.7886;GRANULOCYTE#0.7882;MELATONIN#0.7841;DOCETAXEL#0.7825;NECROPTOSIS#0.7815;DNA DAMAGE RESPONSE#0.7811;HEPATOMA CELLS#0.7805;DASATINIB#0.7790;CYTARABINE#0.7788;OVARIES#0.7786;MITOCHONDRIAL MEMBRANE DEPOLARIZATION#0.7778;ENHANCER BINDING PROTEIN#0.7762;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7755;FOLLICULAR LYMPHOMA#0.7753;SUBEROYLANILIDE HYDROXAMIC ACID#0.7734;LYMPHOCYTIC CHORIOMENINGITIS#0.7729;OOCYTE#0.7728;MECHANISMS OF ACTION#0.7726;APOPTOTIC SIGNALING PATHWAY#0.7726;GM-CSF#0.7698;TYPE 1 DIABETES#0.7697;BELINOSTAT#0.7694;MEMBRANE DEPOLARIZATION#0.7674;TREG CELL#0.7644;RESONANCE ENERGY TRANSFER#0.7637;L-PAM#0.7629;ADRENERGIC RECEPTOR#0.7618;BRAIN ISCHEMIA#0.7616;T CELL PROLIFERATION#0.7615;CELL DIVISION#0.7604;RENAL CELL CARCINOMA#0.7596;CENTRAL NERVOUS SYSTEM#0.7574;VIRAL REPLICATION#0.7572;LIGHT CHAIN 1#0.7571;GRANULOSA CELL APOPTOSIS#0.7559;KIDNEY DISEASE#0.7539;HEMATOPOIESIS#0.7536;5 FLUOROURACIL#0.7515;MONONUCLEAR CELLS#0.7470;PLASMA MEMBRANE#0.7465;FRAGMENT LENGTH POLYMORPHISM#0.7464;OPTIC NERVE#0.7461;MORPHOGENESIS#0.7428;BREAST CARCINOMA#0.7412;EPITHELIAL MESENCHYMAL TRANSITION#0.7412;RETINAL GANGLION CELL#0.7409;BETA ADRENERGIC RECEPTOR#0.7406;LIGHT CHAIN 3#0.7405;MRNA SPLICING#0.7390;LIVER DISEASE#0.7390;COLONY FORMATION ASSAY#0.7379;TRANSCRIPTIONAL CONTROL#0.7369;CYCLIC AMP#0.7363;TYPE 2 DIABETES#0.7360;ADENOSINE MONOPHOSPHATE#0.7358;MEMORY B CELL#0.7355;STATUS EPILEPTICUS#0.7354;ANISOMYCIN#0.7348;GERMINAL CENTER#0.7322;MESOTHELIOMA CELL#0.7315;MONOCYTE#0.7305;METFORMIN#0.7291;GASTRIC EPITHELIAL CELLS#0.7275;GLYCOLYSIS#0.7268;BREAST CANCER PATIENTS#0.7258;CASPASE ACTIVITY#0.7258;NEUROTOXICITY#0.7247;5-AZA-2'-DEOXYCYTIDINE#0.7238;TISSUE HOMEOSTASIS#0.7234;2'-DEOXYCYTIDINE#0.7233;LIPID OXIDATION#0.7232;COLORECTAL ADENOMA#0.7214;COLORECTAL CARCINOMA#0.7207;MICROTUBULE ASSOCIATED PROTEIN#0.7198;TAMOXIFEN#0.7182;INSULIN RECEPTOR#0.7181;CALCINEURIN#0.7179;SEVOFLURANE#0.7146;ACETYLCYSTEINE#0.7144;PI3K SIGNALING#0.7127;PROTEIN BINDING#0.7124;STAUROSPORINE#0.7119;JUN PHOSPHORYLATION#0.7112;NEUTROPHIL APOPTOSIS#0.7085;RHEUMATOID ARTHRITIS#0.7084;LIVER CANCER#0.7077;DAUNORUBICIN#0.7075;PANCREATIC BETA CELL APOPTOSIS#0.7071;POST-TRANSLATIONAL MODIFICATION#0.7066;SENESCENCE#0.7065;PALMITATE#0.7047;FACTOR I#0.7041;LYMPHOCYTE HOMEOSTASIS#0.7030;HISTONE MODIFICATION#0.7012;INHIBITION OF CELL PROLIFERATION#0.7002;GANGLION CELLS#0.6993;REPORTER GENE ASSAY#0.6989;CYTOTOXIC T CELL#0.6973;MIDDLE CEREBRAL ARTERY#0.6965;CEREBRAL ARTERY#0.6963;SENSITIZER#0.6941;NEURODEGENERATIVE DISEASE#0.6936;WOUND HEALING#0.6936;DUAL LUCIFERASE REPORTER#0.6926;MITOCHONDRIAL LOCALIZATION#0.6920;MUSCLE CELL#0.6918;LYMPHOCYTE DEVELOPMENT#0.6904;AUTOPHAGOSOME#0.6901;RECEPTOR LIGAND#0.6897;FLOW CYTOMETRY ANALYSIS#0.6887;OXALIPLATIN#0.6861;MITOTIC SPINDLE#0.6854;HEMATOPOIETIC STEM CELL#0.6799;COLITIS#0.6797;B CELL DIFFERENTIATION#0.6776;MALIGNANT GLIOMA#0.6757;TH1 CELL#0.6743;CEREBRAL ARTERY OCCLUSION#0.6713;NF-KAPPAB ACTIVATION#0.6703;BONE MARROW CELLS#0.6695;CELL CYCLE REGULATOR#0.6685;RETINOBLASTOMA#0.6640;VACCINIA#0.6609;HEAD AND NECK CANCER#0.6600;TUMOR GROWTH INHIBITION#0.6599;NECK CANCER#0.6599;CELL COUNTING KIT#0.6562;HEPATOCYTE GROWTH FACTOR#0.6537;NADPH OXIDASE#0.6531;GENOTOXIC#0.6527;DOPAMINERGIC NEURON#0.6523;HEPATITIS C#0.6513;ENDOTHELIAL CELL APOPTOSIS#0.6511;HEART DISEASE#0.6505;ACTIVATED B CELL#0.6504;ASTROCYTE#0.6490;PHOSPHATIDYLSERINE#0.6469;NAIVE T CELL#0.6464;FLUOROURACIL#0.6458;GLUCOSE REGULATED PROTEIN#0.6456;PRECURSOR CELL#0.6454;ADENYLATE CYCLASE#0.6450;HUNTINGTON'S DISEASE#0.6447;VIRULENCE#0.6444;ANCHORAGE INDEPENDENT GROWTH#0.6438;RESPONSE TO TREATMENT#0.6425;CORD BLOOD#0.6410;CYTOKINE PRODUCTION#0.6386;MEDIATED DRUG RESISTANCE#0.6374;SPINAL CORD#0.6369;LENALIDOMIDE#0.6323;CAMKII#0.6294;SPINDLE ASSEMBLY#0.6289;ACTIVATING TRANSCRIPTION FACTOR#0.6275;SIMVASTATIN#0.6269;BONE MARROW STROMAL CELL#0.6254;BONE MARROW STROMAL#0.6250;ALVEOLAR EPITHELIAL CELL#0.6246;ERYTHROID CELL#0.6237;EARLY GROWTH RESPONSE#0.6231;DOUBLE STRAND BREAK#0.6230;PHAGOCYTOSIS#0.6230;GRAFT VERSUS HOST#0.6230;BERBERINE#0.6225;GLUCOSE METABOLISM#0.6220;HIGH FAT DIET#0.6214;MYOCARDIAL INFARCTION#0.6198;ESTRADIOL#0.6189;T-CELL LEUKEMIA#0.6148;ACTINOMYCIN D#0.6134;HUMAN PANCREATIC CANCER#0.6133;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6133;EPITHELIAL TO MESENCHYMAL#0.6131;B CELL APOPTOSIS#0.6101;IFN-GAMMA#0.6072;ERYTHROPOIESIS#0.6064;FORSKOLIN#0.6039;LYSOSOMAL MEMBRANE#0.6032;LEUCINE#0.6021;UBIQUITIN PROTEASOME PATHWAY#0.6018;RESPONSE TO ER STRESS#0.6012;PHOTORECEPTOR CELL#0.6011;B CELL HOMEOSTASIS#0.6010;RHABDOMYOSARCOMA#0.6005
100190939	CELL PROLIFERATION#0.7283;AKT SIGNALING#0.7209
100192378	HIPPO SIGNALING PATHWAY#1.2153;HIPPO SIGNALING#1.2097;BREAST CANCER#1.1796;SIGNALING PATHWAY#1.1785
10019	ENDOTHELIAL CELL#1.0605;HEMATOPOIETIC CELL#1.0467;CELL PROLIFERATION#1.0396;SIGNALING PATHWAY#1.0361;B CELL#1.0347;T CELL#1.0293;MYELOPROLIFERATIVE NEOPLASM#1.0261;STEM CELL#1.0230;HEMATOPOIETIC STEM CELL#1.0201;BONE MARROW#1.0195;TYPE 1 DIABETES#1.0171;GROWTH FACTOR#1.0092;CYTOKINE RECEPTOR#1.0032;HEMATOPOIESIS#0.9901;PROGENITOR CELL#0.9856;STEM CELL FACTOR#0.9798;AUTOIMMUNE DISEASE#0.9792;CELL GROWTH#0.9762;GENE EXPRESSION#0.9638;APOPTOSIS#0.9610;CELL ADHESION#0.9481;SIGNAL TRANSDUCTION#0.9458;CELIAC DISEASE#0.9372;HYPERTENSION#0.9350;PROTEIN KINASE#0.9170;ESSENTIAL THROMBOCYTHEMIA#0.8591;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8506;INSULIN RECEPTOR#0.8493;MYELOID LEUKEMIA#0.8210;POLYCYTHEMIA VERA#0.8100;TUMOR NECROSIS FACTOR#0.8049;MITOGEN ACTIVATED PROTEIN#0.8027;ANGIOGENESIS#0.7966;MYOCARDIAL INFARCTION#0.7857;IMMUNE RESPONSE#0.7802;MYELOFIBROSIS#0.7651;MAST CELL#0.7521;INSULIN-LIKE GROWTH FACTOR#0.7508;SIGNAL TRANSDUCER#0.7488;VASCULAR CELL#0.7480;TRANSCRIPTION FACTOR#0.7428;CANCER CELL#0.7424;MEGAKARYOCYTE#0.7330;CELL ACTIVATION#0.7275;ONCOGENIC#0.7244;ARTERY#0.7114;PLASMA MEMBRANE#0.7073;POLYCYTHEMIA#0.7064;COLORECTAL#0.6937;T LYMPHOCYTE#0.6912;LEUKOCYTE#0.6806;CORONARY ARTERY#0.6801;CELL DEVELOPMENT#0.6554;ARTERY DISEASE#0.6524;COLORECTAL CANCER#0.6320;CORONARY ARTERY DISEASE#0.6206;PERIPHERAL BLOOD#0.6205;HEMATOPOIETIC PROGENITOR CELL#0.6162;CHRONIC MYELOID LEUKEMIA#0.6148
1001	HYPOTRICHOSIS#1.0887;CELL ADHESION#1.0063;BREAST CANCER#0.9389;CANCER CELL#0.8823;CELL ADHESION MOLECULE#0.8694;BREAST CARCINOMA#0.8170;BREAST CANCER CELL#0.8153;HAIR FOLLICLE#0.7002;EPITHELIAL CELL#0.6986;GENE EXPRESSION#0.6909;ECTODERMAL DYSPLASIA#0.6611;RETINAL PIGMENT EPITHELIUM#0.6456
10020	INCLUSION BODY MYOPATHY#1.0460;GLCNAC#1.0425;MYOPATHY#1.0386;INCLUSION BODY#1.0372;SKELETAL MUSCLE#1.0300;SIALYLATION#1.0286;VACUOLE#1.0192;MUSCLE WEAKNESS#1.0074;QUADRICEPS#1.0057;MUSCLE ATROPHY#0.9290;GLUCOSAMINE#0.9148;CELL SURFACE#0.9143;ENZYME ACTIVITY#0.9033;CELL ADHESION#0.8806;MUSCLE CELL#0.8400;KINASE ACTIVITY#0.8200;GLYCOSYLATION#0.8176;STEM CELL#0.8003;EMBRYONIC STEM CELL#0.7955;URIDINE#0.7758;MYOBLAST#0.7640;LECTIN#0.7571;GLCNAC 2-EPIMERASE ACTIVITY#0.7492;GENE EXPRESSION#0.7240;MUSCLE FIBER#0.6982;APOPTOSIS#0.6912;MUSCULAR DYSTROPHY#0.6859;INCLUSION BODY MYOSITIS#0.6305;DIPHOSPHATE#0.6205;NEURAL CELL#0.6116;CELL ADHESION MOLECULE#0.6089
100216344	DYSTONIA#0.7788
10021	POTASSIUM CHANNEL#1.0475;BRADYCARDIA#1.0288;SICK SINUS SYNDROME#1.0231;CONNEXIN#1.0215;CATION CHANNEL#1.0173;TRANSCRIPTION FACTOR#1.0113;SINOATRIAL NODE CELL#1.0096;CARDIAC CONDUCTION#1.0023;CYCLIC NUCLEOTIDE GATED#0.9970;MYOCYTES#0.9949;STEM CELL#0.9917;ATRIAL FIBRILLATION#0.9913;POLYMERASE CHAIN REACTION#0.9888;GENE EXPRESSION#0.9885;CARDIOMYOCYTE#0.9878;MYOCARDIUM#0.9869;OOCYTE#0.9857;ION CHANNEL#0.9847;ARRHYTHMIA#0.9824;ACTION POTENTIAL#0.9797;SINUS NODE DYSFUNCTION#0.9696;TACHYCARDIA#0.9596;EMBRYONIC STEM CELL#0.9567;CELL MEMBRANE#0.9531;NERVOUS SYSTEM#0.9491;REVERSE TRANSCRIPTION#0.9445;CYCLIC NUCLEOTIDE BINDING#0.9373;PROTEIN KINASE#0.9349;CELL SURFACE#0.9258;CAMP BINDING#0.9234;NUCLEOTIDE BINDING#0.9142;NUCLEOTIDE BINDING DOMAIN#0.9030;ADRENERGIC RECEPTOR#0.9000;GAP JUNCTION#0.8784;HUMAN EMBRYONIC KIDNEY#0.8730;EMBRYONIC KIDNEY#0.8725;MESENCHYMAL STEM CELL#0.8717;BIPOLAR CELL#0.8645;EMBRYONIC HEART#0.8631;EPILEPSY#0.8597;MOUSE EMBRYONIC STEM#0.8496;LEFT VENTRICULAR NONCOMPACTION#0.8489;THALAMUS#0.8267;CARDIOMYOPATHY#0.8239;HEART DISEASE#0.8149;ATRIAL CELL#0.8127;ISOPROTERENOL#0.8093;GROWTH FACTOR#0.7926;CHANNEL ACTIVITY#0.7926;PULMONARY VEIN#0.7846;OUTFLOW TRACT#0.7683;RIGHT ATRIUM#0.7622;PLURIPOTENT STEM CELL#0.7617;GANGLION CELLS#0.7579;SPINAL CORD#0.7550;LIPID RAFT#0.7512;MYOCARDIAL INFARCTION#0.7478;HEART RATE VARIABILITY#0.7385;SMOOTH MUSCLE#0.7174;ISCHEMIA#0.7153;INDUCED PLURIPOTENT STEM CELL#0.7074;CORONARY ARTERY#0.7020;PROGENITOR CELL#0.7019;SODIUM CHANNEL#0.7015;HEART DEVELOPMENT#0.6978;VENA CAVA#0.6977;CAMP BINDING DOMAIN#0.6964;SINUS VENOSUS#0.6904;CALCIUM CHANNEL#0.6904;CELL DIFFERENTIATION#0.6877;CENTRAL NERVOUS SYSTEM#0.6863;DORSAL ROOT GANGLION#0.6811;REDUCED HEART RATE#0.6805;ACTION POTENTIAL DURATION#0.6569;ARTERY#0.6446;BONE MARROW#0.6261;CAVEOLAE#0.6188;BETA ADRENERGIC RECEPTOR#0.6116;RYANODINE RECEPTOR#0.6107;SEPTUM#0.6068;ATRIOVENTRICULAR BLOCK#0.6050
10022	ENTEROENDOCRINE CELL#0.9687;PEPTIDE HORMONE#0.8891;RECEPTOR BINDING#0.8681;COLORECTAL#0.7527;GLUCOSE HOMEOSTASIS#0.7514;INSULIN SECRETION#0.6970;LEUCINE RICH REPEAT#0.6197;SIGNALLING PATHWAY#0.6079
100233209	MACROPHAGE APOPTOSIS#0.9337;APOPTOSIS#0.8714;TUBERCULOSIS#0.6491;AUTOPHAGY#0.6475;MONOCYTE#0.6444;MACROPHAGE#0.6424
100233226	ASPARTIC ACID#0.6710
10023	T CELL#1.0718;SIGNALING PATHWAY#1.0534;CANCER CELL#0.9690;WNT SIGNALING PATHWAY#0.9536;GLYCOGEN SYNTHASE KINASE#0.9129;LUNG CANCER#0.8151;ADENOCARCINOMA#0.7034;APOPTOSIS#0.6679;KINASE ACTIVITY#0.6305;ESOPHAGEAL CANCER#0.6284;CELL GROWTH#0.6109;CELL PROLIFERATION#0.6069
100240731	MALE INFERTILITY#0.9308;INFERTILITY#0.7314
10024	CELL ADHESION#1.0511;EMBRYO IMPLANTATION#0.9662;EPITHELIAL CELL#0.9299;CELL PROLIFERATION#0.8423;HEPATOCELLULAR CARCINOMA#0.8346;CELL CYCLE#0.8226;ENDOMETRIAL EPITHELIAL CELLS#0.8181;CELL ADHESION MOLECULE#0.8129;SPINDLE ASSEMBLY#0.7972;MICROTUBULE#0.7376;TROPHOBLAST#0.6482;POLYMERASE CHAIN REACTION#0.6312
10025	MEDIATOR COMPLEX#1.0515;GENE EXPRESSION#0.9647;IRON HOMEOSTASIS#0.7274
10026	ANCHORING#0.9397;ENDOPLASMIC RETICULUM#0.8987;CELL SURFACE#0.7181;PROTEIN COMPLEX#0.6446;DOPA OXIDASE#0.6194
100270639	HYPERTROPHIC PYLORIC STENOSIS#1.2471;PYLORIC STENOSIS#1.2341
100270680	CANCER CELL#1.1397;CELL PROLIFERATION#1.0806;LUNG CANCER#0.8612;HEPATOCELLULAR CARCINOMA#0.8223;OVARIAN SQUAMOUS CELL CARCINOMA#0.7933;CELL MIGRATION#0.7275;APOPTOSIS#0.7255;SIGNALING PATHWAY#0.7226;COLORECTAL CANCER#0.6703;ADJACENT NORMAL TISSUE#0.6600;DUAL LUCIFERASE REPORTER#0.6598;TUMOR TISSUES#0.6535;EPITHELIAL MESENCHYMAL TRANSITION#0.6535;CELL CYCLE PATHWAY#0.6199;ESOPHAGEAL CARCINOMA#0.6050
100271694	RNA BINDING#0.7579;HEART RATE VARIABILITY#0.7256;VIRUS LIKE PARTICLE#0.6116
100271696	SEX CHROMOSOME#0.6632;X CHROMOSOME#0.6488
100271849	B CELL LYMPHOMA#1.0645;B CELL#1.0521;MYOCYTE ENHANCER FACTOR#1.0467;GERMINAL CENTER#1.0376;TRANSCRIPTION FACTOR#1.0185;DIFFUSE LARGE B-CELL LYMPHOMA#1.0117;DNA BINDING#0.9853;GENE EXPRESSION#0.9380;MANTLE CELL LYMPHOMA#0.8306;SKELETAL MUSCLE#0.8011;SMOOTH MUSCLE#0.7688;CELL GROWTH#0.7520;MUSCLE CELL#0.7234;ENHANCER BINDING#0.6767;NON HODGKIN LYMPHOMA#0.6558;SMOOTH MUSCLE CELL#0.6402;GROWTH FACTOR#0.6307;LYMPHOID TISSUE#0.6237;T CELL#0.6235;TUMOR CELLS#0.6090
100271873	DNA METHYLATION#0.8713;PI3K SIGNALING#0.6203
100287082	TUMOR TISSUES#0.6790;PANCREATIC CANCER#0.6781;POLYMERASE CHAIN REACTION#0.6455;REVERSE TRANSCRIPTION#0.6189
100287226	ZINC FINGER PROTEIN#1.1975
100287301	NODULATION#1.0079;CATALYTIC ACTIVITY#0.7411
100287559	CELL PROLIFERATION#1.0123;APOPTOSIS#0.7665;DUAL LUCIFERASE REPORTER#0.7277;REPORTER GENE ASSAY#0.7268
100287616	CELL PROLIFERATION#1.1250;PROSTATE CANCER#0.8798;CANCER CELL#0.8743;BREAST CANCER#0.8367;APOPTOSIS#0.8311;CELL CYCLE#0.7379;BREAST CANCER CELL#0.6649;ONCOGENIC#0.6418;ATP BINDING CASSETTE TRANSPORTER#0.6236;ATP BINDING CASSETTE#0.6135;ENDOMETRIAL CANCER#0.6132;CELL MIGRATION#0.6092;ATP BINDING#0.6070;PANCREATIC CANCER#0.6064
100287932	TIM23 COMPLEX#1.0853;TIM22 COMPLEX#1.0840;TOM COMPLEX#1.0609;COMPLEX I#1.0482;INNER MITOCHONDRIAL MEMBRANE#1.0407;MITOCHONDRIAL PROTEIN IMPORT#1.0376;MITOCHONDRIAL INNER MEMBRANE#1.0317;MITOCHONDRIAL MATRIX#1.0245;MITOCHONDRIAL MEMBRANE#1.0176;PROTEIN IMPORT#1.0167;MEMBRANE OF MITOCHONDRIA#1.0165;OUTER MEMBRANE#1.0151;MITOCHONDRIA#0.9953;RESPIRATORY CHAIN#0.9517;HEAT SHOCK PROTEIN#0.9209;OUTER MITOCHONDRIAL MEMBRANE#0.8818;MITOCHONDRIAL INTERMEMBRANE SPACE#0.8794;PROTEIN TRANSPORT#0.8703;MITOPHAGY#0.8600;C TERMINAL DOMAIN#0.8558;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8487;MITOCHONDRIAL OUTER MEMBRANE#0.7984;TRANSCRIPTION FACTOR#0.7851;CYTOCHROME C#0.7750;ORGANELLE#0.7668;ATP SYNTHASE#0.7627;CARDIOLIPIN#0.7335;APOPTOSIS#0.7327;CELL DEATH#0.7096;MITOCHONDRIAL DNA#0.6851;PROTEIN COMPLEX#0.6574;AUTOPHAGY#0.6491;GENE EXPRESSION#0.6304;PERIPHERAL MEMBRANE PROTEIN#0.6294;OXIDATIVE PHOSPHORYLATION#0.6249;CHANNEL ACTIVITY#0.6160;CYTOCHROME C OXIDASE#0.6078;CONTACT SITE#0.6038
100288077	AUTOPHAGY#0.6475;ANGIOGENESIS#0.6451
100288139	INFLAMMATORY CELL#0.6045
100288428	ASPIRIN#0.6519
100288687	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY#1.0832;TRANSCRIPTION FACTOR#1.0739;MUSCULAR DYSTROPHY#1.0683;MYOBLAST#0.9289;MUSCLE CELL#0.8567;GENE EXPRESSION#0.7959;EWING SARCOMA#0.7941;SKELETAL MUSCLE#0.6845;MYOTUBE#0.6800;MESENCHYMAL CHONDROSARCOMA#0.6335;DNA BINDING#0.6306;OLFACTORY NEUROBLASTOMA#0.6277;MYOEPITHELIAL CARCINOMA#0.6167;DESMOPLASTIC SMALL ROUND CELL TUMOR#0.6165;NONSENSE MEDIATED DECAY#0.6017;MURINE EMBRYONIC STEM#0.6002
100288711	MYOBLAST#0.9448;MYOTUBE#0.6983;MUSCULAR DYSTROPHY#0.6959;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY#0.6782;REGENERATION#0.6037
100289017	OLFACTION#0.8210
100289019	COLORECTAL CANCER#0.9014;CANCER CELL#0.8953;COLORECTAL#0.6458
100289178	BREAST CANCER#0.7966
100289419	CILIARY NEUROTROPHIC FACTOR#0.9900;LEUKEMIA INHIBITORY FACTOR#0.8470
100289683	CENTRAL NERVOUS SYSTEM#0.6473;NERVOUS SYSTEM#0.6463
1002	CELL ADHESION#0.9928;CELL CELL ADHESION#0.9887;CELL ADHESION MOLECULE#0.9829;RETINAL GANGLION CELL#0.9257;OPTIC NERVE#0.9001;FOREBRAIN#0.8865;MORPHOGENESIS#0.8443;GANGLION CELLS#0.8378;NERVOUS SYSTEM#0.8378;SIGNALING PATHWAY#0.8161;SKELETAL MUSCLE#0.8113;EPITHELIAL CELL#0.8091;CANCER CELL#0.7649;NEURITE#0.7572;SPINAL CORD#0.7534;NEUROBLAST#0.7499;CELL MIGRATION#0.7496;TUMOR SUPPRESSOR#0.7340;STEM CELL#0.6930;SMOOTH MUSCLE#0.6794;CELL PROLIFERATION#0.6775;TRANSCRIPTION FACTOR#0.6527;POLYMERASE CHAIN REACTION#0.6512;ADHERENS JUNCTION#0.6449;CELL-CELL ADHESION MOLECULE#0.6434;CELL SURFACE#0.6338;BREAST CANCER#0.6289;TELENCEPHALON#0.6269;CENTRAL NERVOUS SYSTEM#0.6209;CELL AGGREGATION#0.6154;SYSTEM DEVELOPMENT#0.6154;STRIATED MUSCLE#0.6095;CELL MOTILITY#0.6027
100301525	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA#0.6032
100302112	CANCER CELL#1.0665;CELL PROLIFERATION#0.8633;APOPTOSIS#0.8360;OVARIAN CANCER#0.6723;LUNG CANCER#0.6567;OVERALL SURVIVAL RATE#0.6236;CERVICAL CANCER#0.6169;TUMOR TISSUES#0.6152;SIGNALLING PATHWAY#0.6129;BREAST CANCER CELL#0.6104;COLORECTAL CANCER#0.6096;BREAST CANCER#0.6051;GENE EXPRESSION#0.6024
100302123	CELL PROLIFERATION#0.9003;LUNG CANCER#0.7862;APOPTOSIS#0.7050;CANCER CELL#0.6998;POLYMERASE CHAIN REACTION#0.6957;HEPATOCELLULAR CARCINOMA#0.6818;DUAL LUCIFERASE REPORTER#0.6398;GENE EXPRESSION#0.6169;QUANTITATIVE REAL TIME#0.6135
100302133	HEPATOCELLULAR CARCINOMA#0.6196;COLORECTAL CANCER#0.6193
100302138	BONE FORMATION#0.7184;STEM CELL#0.7096
100302145	CANCER CELL#1.0339;PANCREATIC CANCER#0.8948;TUMOR SUPPRESSOR#0.8486;CELL PROLIFERATION#0.7902;DNA METHYLATION#0.6998;APOPTOSIS#0.6834;LUNG CANCER#0.6483;TRANSCRIPTION FACTOR#0.6300;ECTOPIC PREGNANCY#0.6082
100302150	CELL PROLIFERATION#0.8613;BREAST CANCER#0.7406;CANCER CELL#0.7121;APOPTOSIS#0.6888;BREAST CANCER CELL#0.6679;CELL CYCLE#0.6638;ADJACENT NORMAL TISSUE#0.6191;FATTY LIVER DISEASE#0.6139;FATTY LIVER#0.6119;LIVER DISEASE#0.6068;PROSTATE CANCER#0.6055
100302172	BREAST CANCER#0.9008;CANCER CELL#0.8996;OVARIAN CANCER#0.8733;CELL CYCLE#0.8675;CELL PROLIFERATION#0.8578;APOPTOSIS#0.8154;LUNG CANCER#0.7328;OVARIAN#0.6835;METHYLATION SPECIFIC PCR#0.6666;CELL GROWTH#0.6548;LYMPH NODE#0.6548;LIVER CANCER#0.6015
100302174	OVARIAN CANCER#1.0081;CANCER CELL#0.9500;OVARIAN#0.8981;CELL PROLIFERATION#0.7367;APOPTOSIS#0.6862;BREAST CANCER#0.6493;TERMINAL LOOP#0.6412;FOOT AND MOUTH DISEASE#0.6276;MOUTH DISEASE#0.6270;EPITHELIAL OVARIAN CANCER#0.6147;PROSTATE CANCER#0.6018
100302177	ECTOPIC PREGNANCY#0.7234
100302179	CANCER CELL#0.9063;CELL PROLIFERATION#0.8483;SIGNALING PATHWAY#0.6778;CISPLATIN#0.6349;OSTEOSARCOMA CELL LINES#0.6160;WNT SIGNALING PATHWAY#0.6031
100302181	CELL PROLIFERATION#0.9502;TUMOR SUPPRESSOR#0.8439;ADJACENT NORMAL TISSUE#0.6783;LYMPH NODE METASTASIS#0.6709;SQUAMOUS CELL CARCINOMA#0.6550;LYMPH NODE#0.6535;EPITHELIAL MESENCHYMAL TRANSITION#0.6110
100302187	CELL PROLIFERATION#1.0771;APOPTOSIS#0.9825;CANCER CELL#0.9052;TUMOR SUPPRESSOR#0.8960;SIGNALING PATHWAY#0.8458;CELL GROWTH#0.8425;AKT SIGNALING#0.8152;GERM CELL#0.7815;SQUAMOUS CELL CARCINOMA#0.6856;ADENOCARCINOMA#0.6722;HEPATOCELLULAR CARCINOMA CELL#0.6486;CELL CYCLE#0.6349;HEPATOCELLULAR CARCINOMA#0.6301;HUMAN CERVICAL CARCINOMA#0.6018
100302197	GRANULOSA CELL#0.8095;SIGNALING PATHWAY#0.7955
100302201	CANCER CELL#0.9468;CELL PROLIFERATION#0.8020;APOPTOSIS#0.7314;BREAST CANCER#0.6575;BREAST CANCER CELL#0.6573;CELL GROWTH#0.6442;HEPATOMA CELLS#0.6024
100302202	CELL PROLIFERATION#0.8862;PANCREATIC CANCER#0.6781;PSORIASIS#0.6575;PAPILLARY THYROID CARCINOMA#0.6286;THYROID CARCINOMA#0.6216
100302213	OVARIAN CANCER#0.9035;OVARIAN#0.6451
100302217	WNT SIGNALING PATHWAY#0.9146;SIGNALING PATHWAY#0.8958
100302221	CELL PROLIFERATION#0.9963;CANCER CELL#0.7736;PANCREATIC CANCER#0.6545;CELL CYCLE#0.6473;CELL CYCLE TRANSITION#0.6133;SMALL NUCLEOLAR RNA#0.6129
100302232	CELL DEATH#0.6868
100302235	CANCER CELL#0.8524;BREAST CANCER#0.8301;SIGNALING PATHWAY#0.6545;CELL CYCLE#0.6449;FAMILIAL BREAST CANCER#0.6236;NOTCH SIGNALING PATHWAY#0.6148;LUNG CANCER#0.6045
100302246	CELL PROLIFERATION#0.9719;CELL MIGRATION#0.7324;APOPTOSIS#0.6807;PROSTATE CANCER#0.6545;DISEASE SPECIFIC SURVIVAL#0.6080
100302255	CANCER CELL#0.6257
100302256	SIGNALING PATHWAY#0.9046;CANCER CELL#0.9043;APOPTOSIS#0.8557;CELL PROLIFERATION#0.8555;OVARIAN CANCER#0.8400;HEPATOCELLULAR CARCINOMA#0.7504;GLYCOLYSIS#0.6443;OVARIAN#0.6377;WNT SIGNALING PATHWAY#0.6117;DUAL LUCIFERASE REPORTER#0.6117;PANCREATIC CANCER#0.6031
100302263	CELL PROLIFERATION#0.8888;ADIPOCYTE#0.6044;NF KAPPAB BINDING#0.6007
100302270	STEM CELL#0.9534;MAINTENANCE OF PLURIPOTENCY#0.7144;CELL PROLIFERATION#0.7012;PLURIPOTENT STEM CELL#0.6679;AKT SIGNALING#0.6663;CELL CYCLE#0.6555
100302279	LUNG CANCER#0.7353
100302280	CANCER CELL#0.8953
100302510	CORNEAL DYSTROPHY#0.6768
100302512	CLINICAL GLOBAL IMPRESSION#1.0461;RESTLESS LEGS SYNDROME#1.0261;RESTLESS#0.9824;ROTIGOTINE#0.8290
100302513	HEARING IMPAIRMENT#1.2052
100302650	CELL PROLIFERATION#0.7788;CANCER CELL#0.7782;PROSTATE CARCINOMA#0.7633;CELL GROWTH#0.7457
100302692	X CHROMOSOME#0.9011;X CHROMOSOME INACTIVATION#0.7115;CHROMOSOME INACTIVATION#0.7112;AKT SIGNALING#0.6668;SIGNALING PATHWAY#0.6570
100302739	ANTISENSE RNA#0.7978;COLORECTAL CANCER#0.7480;CANCER CELL#0.7420
100302740	APOPTOSIS#0.8297;CELL DEATH#0.6891;APOPTOTIC#0.6009
100302746	COLORECTAL CANCER#0.8011
100303453	ENDOMETRIAL CARCINOMA#0.7632
100303491	CANCER CELL#1.1144;CELL PROLIFERATION#1.0806;APOPTOSIS#1.0222;ANTISENSE RNA#0.9951;E BOX BINDING#0.9104;COLON CANCER#0.8251;EPITHELIAL MESENCHYMAL TRANSITION#0.7208;NATURAL ANTISENSE TRANSCRIPT#0.6941;COLORECTAL CANCER#0.6490;SQUAMOUS CELL CARCINOMA#0.6489;LUNG CANCER#0.6476;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6077
100303728	SIGNALLING PATHWAY#0.9046;CELL PROLIFERATION#0.8960;APOPTOSIS#0.6411
100303755	MITOCHONDRIAL DISEASE#0.7397;CYTOCHROME C OXIDASE#0.6304;CYTOCHROME C#0.6248
100306940	FOLLICULAR LYMPHOMA#0.8346
100307118	METASTATIC GASTRIC CANCER#0.6487
100307119	BASAL CELL CARCINOMA#0.8163;BASAL CELL#0.8123
100310785	ACUTE LEUKEMIA#1.0712;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0540;ACUTE MYELOID LEUKEMIA#0.9565;MYELOID LEUKEMIA#0.9552;MIXED LINEAGE LEUKEMIA#0.9494;TRANSCRIPTION FACTOR#0.8797;IRON HOMEOSTASIS#0.7949;MINIMAL RESIDUAL DISEASE#0.7076;TOPOISOMERASE II#0.7028;BONE MARROW#0.6769;TOPOISOMERASE#0.6563;GENE EXPRESSION#0.6444
100312954	GENE EXPRESSION#0.8942
100313780	TUMOR SUPPRESSOR#0.7133;CELL PROLIFERATION#0.7091
100313824	CELL PROLIFERATION#1.0125;CANCER CELL#0.9346;APOPTOSIS#0.8374;DUAL LUCIFERASE REPORTER#0.6566
100313923	CELL PROLIFERATION#0.7431;CANCER CELL#0.6537;DNA METHYLATION#0.6133;CELL GROWTH#0.6073
100316868	CELL CYCLE#1.0826;APOPTOSIS#1.0802;COLORECTAL CANCER#1.0755;PANCREATIC CANCER#1.0715;CELL PROLIFERATION#1.0711;CANCER CELL#1.0697;LYMPH NODE METASTASIS#1.0530;LYMPH NODE#1.0485;CELL GROWTH#1.0405;LUNG CANCER#1.0367;ONCOGENIC#1.0219;POLYMERASE CHAIN REACTION#1.0178;COLORECTAL#1.0080;EPITHELIAL MESENCHYMAL TRANSITION#1.0027;HEPATOCELLULAR CARCINOMA#0.9906;CELL MIGRATION#0.9865;SIGNALING PATHWAY#0.9801;GENE EXPRESSION#0.9619;QUANTITATIVE REAL TIME#0.9612;PROSTATE CANCER#0.9492;ANTISENSE RNA#0.9191;DUAL LUCIFERASE REPORTER#0.9137;RNA INTERFERENCE#0.9093;SQUAMOUS CELL CARCINOMA#0.8807;ADJACENT NORMAL TISSUE#0.8465;LUNG ADENOCARCINOMA#0.8236;OVARIAN CANCER#0.8139;ENDOTHELIAL CELL#0.8081;BREAST CANCER#0.8079;ADENOCARCINOMA#0.8014;LIVER CANCER#0.7893;HEPATIC STELLATE CELL#0.7766;G1 PHASE#0.7751;STEM CELL#0.7376;RENAL CELL CARCINOMA#0.7245;REVERSE TRANSCRIPTION#0.7171;CELL CYCLE ARREST#0.6859;CELL COUNTING KIT#0.6444;EXOSOME#0.6436;CISPLATIN#0.6383;OVARIAN#0.6368;REPORTER GENE ASSAY#0.6253;TONGUE SQUAMOUS CELL CARCINOMA#0.6204;HUMAN PANCREATIC CANCER#0.6170;GLUTAMATE RECEPTOR#0.6082;TUMOR SUPPRESSOR#0.6081;DISEASE FREE SURVIVAL#0.6076;BREAST CANCER CELL#0.6041;ACUTE MYELOID LEUKEMIA#0.6029;MYELOID LEUKEMIA#0.6014
100322879	PARAPLEGIA#0.7005
100329167	AORTIC ANEURYSM#1.0358;DYNEIN#1.0331;ARTERY#0.9776;OPEN AAA REPAIR#0.9665;ATP HYDROLYSIS#0.8668;ILIAC ARTERY#0.8534;MICROTUBULE#0.8338;ATP BINDING#0.7170;CORONARY ARTERY#0.6856;MICROTUBULE BINDING#0.6079
100329168	CHLAMYDIA#0.9174
100359393	CEREBELLAR ATAXIA#0.6988
100359403	PARKINSON'S DISEASE#1.0515
10036	FACTOR I#1.0894;HISTONE CHAPERONE#1.0749;CHROMATIN ASSEMBLY#1.0670;NUCLEOSOME ASSEMBLY#1.0467;NUCLEOSOME#1.0431;DNA REPLICATION#1.0353;S PHASE#1.0191;CELL PROLIFERATION#1.0169;CANCER CELL#0.9436;CAF-1 COMPLEX#0.9278;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9082;DNA REPAIR#0.8880;HETEROCHROMATIN#0.8775;GENE SILENCING#0.8710;CELL CYCLE#0.8253;DNA SYNTHESIS#0.8146;PROTEIN COMPLEX#0.7873;REPLICATION FORK#0.7831;STEM CELL#0.7171;APOPTOSIS#0.6887;CHROMATIN ASSEMBLY COMPLEX#0.6161;EPITHELIAL CELL#0.6138;TRANSCRIPTION FACTOR#0.6128;GENE EXPRESSION#0.6097;LUNG CANCER#0.6011
100379142	CENTRAL NERVOUS SYSTEM#1.1823;NERVOUS SYSTEM#1.1805
100379174	COLORECTAL#0.6458
100379198	EPILEPSY#0.9715;ABSENCE EPILEPSY#0.6252;AGGRESSIVE BEHAVIOR#0.6034
100379199	TYROSINASE ACTIVITY#0.6243;MELANIN SYNTHESIS#0.6077;MELANOCYTE#0.6071
100379249	NATURAL ANTISENSE TRANSCRIPT#0.9568;APOPTOTIC#0.6435;APOPTOSIS#0.6411
100379251	CARDIOMYOCYTE#0.6485
100379571	ALZHEIMER'S DISEASE#0.9435;AMYLOID PRECURSOR PROTEIN#0.7254;PERIPHERAL BLOOD#0.6002
100380873	DNA REPAIR#0.6928;ICL REPAIR#0.6876;FANCONI ANEMIA#0.6486;FOCAL CORTICAL DYSPLASIA#0.6192
100380876	LIPID DROPLET#0.8443;CONTACT SITE#0.6842;METHIONINE SYNTHASE#0.6328;NUCLEAR ENVELOPE#0.6198
100381207	HEARING LOSS#0.7582
100381270	TRANSCRIPTION FACTOR#1.1212;SKELETAL MUSCLE#1.0205;GENE EXPRESSION#0.8545;BETA CELL#0.8337;MYOBLAST#0.8177;CELL PROLIFERATION#0.8001;CELL CYCLE#0.6511;NEURAL CREST STEM CELL#0.6350;NEURAL CREST STEM#0.6343;CELL AGGREGATION#0.6139;CELL JUNCTION#0.6066;NEURAL CREST#0.6001
10038	BASE EXCISION REPAIR#1.0355;SINGLE STRAND BREAK#1.0322;T CELL#1.0288;DNA BINDING#1.0125;DNA DAMAGE RESPONSE#1.0073;DOUBLE STRAND BREAK#1.0048;CELL CYCLE#0.9987;POLY ADP RIBOSE#0.9972;RIBOSE#0.9956;DNA REPAIR#0.9953;HOMOLOGOUS RECOMBINATION#0.9905;CATALYTIC ACTIVITY#0.9892;BREAST CANCER#0.9874;APOPTOSIS#0.9860;CANCER CELL#0.9846;OVARIAN CANCER#0.9811;CELL DEATH#0.9810;OVARIAN#0.9788;GENE EXPRESSION#0.9681;REPLICATION FORK#0.9539;SIGNALING PATHWAY#0.9502;GENOTOXIC#0.9200;APOPTOTIC#0.9055;POSTTRANSLATIONAL MODIFICATION#0.9006;TELOMERE#0.8877;BONE MARROW#0.8615;SINGLE STRAND BREAK REPAIR#0.8580;POST-TRANSLATIONAL MODIFICATION#0.8438;CELL DIFFERENTIATION#0.8410;S PHASE#0.8318;PROSTATE CANCER#0.8302;RNASE P#0.8226;TEMOZOLOMIDE#0.8123;TUMOR CELLS#0.8105;TRANSCRIPTION FACTOR#0.8020;CEREBRAL ISCHEMIA#0.7941;TOXICITY#0.7920;IMMUNE RESPONSE#0.7849;CYTOTOXICITY#0.7577;SKELETAL MUSCLE#0.7529;LUNG CANCER#0.7485;DNA REPLICATION#0.7405;DOUBLE-STRAND BREAK REPAIR#0.7318;TOPOISOMERASE#0.7294;ISCHEMIA#0.7172;PANCREATIC CANCER#0.7103;DNA REPAIR ENZYME#0.7090;SPERMATOGENESIS#0.6945;MUTAGENESIS#0.6908;PROTEIN PROTEIN INTERACTION#0.6761;LIPID METABOLISM#0.6751;CELL DEVELOPMENT#0.6727;ADENINE#0.6724;CISPLATIN#0.6716;BREAST CANCER CELL#0.6615;MOUSE EMBRYONIC FIBROBLAST#0.6564;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6535;NICOTINAMIDE#0.6514;HYDROXYUREA#0.6433;PROTEIN KINASE#0.6280;THYMOCYTE#0.6279;LYSINE#0.6279;RECURRENT OVARIAN CANCER#0.6165;REPLICATION PROTEIN A#0.6076
10039	DOUBLE STRAND BREAK#1.0633;RIBOSE#1.0333;POLY ADP RIBOSE#1.0297;BREAST CANCER#1.0217;DNA REPAIR#1.0063;CANCER CELL#0.9949;SINGLE STRAND BREAK#0.9946;BREAST CANCER CELL#0.9680;DOUBLE-STRAND BREAK REPAIR#0.9231;GENE EXPRESSION#0.8843;CELL CYCLE#0.8296;CELL DEATH#0.8171;BASE EXCISION REPAIR#0.7337;DNA LIGASE#0.7057;OVARIAN CANCER#0.7038;HOMOLOGOUS RECOMBINATION#0.6482;POST-TRANSLATIONAL MODIFICATION#0.6479;DNA BINDING#0.6334;DNA DAMAGE RESPONSE#0.6331;APOPTOSIS#0.6198;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6156;EPITHELIAL TO MESENCHYMAL#0.6153;OVARIAN#0.6144;TELOMERE#0.6129;CATALYTIC ACTIVITY#0.6067
1003	SOLUBLE VASCULAR ENDOTHELIAL#1.0773;CADHERIN BINDING#1.0567;JUNCTIONAL ADHESION MOLECULE#1.0540;ZONULA OCCLUDENS 1#1.0529;CATENIN COMPLEX#1.0510;ENDOTHELIAL CELL-CELL ADHESION#1.0487;ZONULA OCCLUDENS#1.0415;VASCULAR ENDOTHELIAL CADHERIN#1.0405;ENDOCYTOSIS#1.0353;TIGHT JUNCTION PROTEIN#1.0230;ENDMT#1.0228;CELL PERIPHERY#1.0205;ACTIN FILAMENT#1.0173;SMOOTH MUSCLE ACTIN#1.0160;CELL MEMBRANE#1.0139;FETAL LIVER#1.0114;PROTEIN TYROSINE PHOSPHATASE#1.0100;SELECTIN#1.0071;ADHERENS JUNCTION#1.0071;INTERCELLULAR JUNCTION#1.0067;HYPOXIA INDUCIBLE FACTOR#1.0057;LECTIN#1.0053;ENDOTHELIAL NITRIC OXIDE#1.0050;GROWTH FACTOR RECEPTOR#1.0047;CELL CELL JUNCTION#1.0042;STRESS FIBRE#1.0039;CELL ADHESION MOLECULE#1.0030;TIGHT JUNCTION#1.0022;ACTIN CYTOSKELETON#0.9998;CELL JUNCTION#0.9986;VASCULAR MORPHOGENESIS#0.9986;DEPHOSPHORYLATION#0.9983;NITRIC OXIDE SYNTHASE#0.9982;MATURE ENDOTHELIAL CELL#0.9974;STRESS FIBER#0.9970;CELL SURFACE#0.9963;PLATELET-DERIVED GROWTH FACTOR#0.9951;ENDOTHELIAL CELL MIGRATION#0.9937;CELL CELL ADHESION#0.9934;PLASMA MEMBRANE#0.9925;T CELL#0.9919;HEMATOPOIETIC CELL#0.9910;PERICYTE#0.9910;KINASE INSERT DOMAIN#0.9895;FOCAL ADHESION#0.9892;REVERSE TRANSCRIPTION#0.9889;CELL ADHESION#0.9887;QUANTITATIVE REAL TIME#0.9886;BREAST CANCER CELL#0.9884;YOLK SAC#0.9880;POLYMERASE CHAIN REACTION#0.9877;ENDOTHELIAL MICROPARTICLE#0.9872;LYMPHATIC VESSEL#0.9868;LOW DENSITY LIPOPROTEIN#0.9862;LYMPHATIC ENDOTHELIAL CELL#0.9857;RETINAL ENDOTHELIAL CELLS#0.9854;HISTAMINE#0.9853;TRANSENDOTHELIAL ELECTRICAL RESISTANCE#0.9852;BREAST CANCER#0.9849;SPHINGOSINE 1 PHOSPHATE#0.9849;SMOOTH MUSCLE#0.9839;EPIDERMAL GROWTH FACTOR#0.9839;PROTEIN KINASE C#0.9837;NITRIC OXIDE#0.9835;TRANSFORMING GROWTH FACTOR#0.9826;HYPOXIA#0.9822;MICROPARTICLE#0.9817;MONOCYTE#0.9811;FLUID SHEAR STRESS#0.9808;COMPLEX I#0.9803;BASEMENT MEMBRANE#0.9791;VASCULAR CELL#0.9789;CIRCULATING ENDOTHELIAL CELL#0.9788;NEUTROPHIL#0.9788;FOCAL ADHESION KINASE#0.9784;ADHERENS JUNCTION FORMATION#0.9782;CELL GROWTH#0.9781;MESENCHYMAL CELL#0.9771;VASCULAR ENDOTHELIUM#0.9771;OVARIAN#0.9770;CONTACT INHIBITION#0.9769;LEUKOCYTE#0.9764;TUBE FORMATION#0.9761;MACROPHAGE#0.9758;SPHINGOSINE#0.9742;MORPHOGENESIS#0.9736;TUMOR NECROSIS FACTOR#0.9735;TRANSCRIPTION FACTOR#0.9734;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9731;ENDOMT#0.9729;ENDOTHELIAL GROWTH FACTOR#0.9729;CELL MIGRATION#0.9729;EPITHELIAL CELL#0.9728;HEMATOPOIESIS#0.9728;ATHEROSCLEROTIC#0.9723;BETA CATENIN BINDING#0.9717;VASCULAR ENDOTHELIAL CELL#0.9714;MYOCARDIUM#0.9706;VASCULOGENESIS#0.9701;ENDOTHELIAL CELL#0.9701;PRO-INFLAMMATORY#0.9697;GENE EXPRESSION#0.9696;APOPTOSIS#0.9694;OVARIAN CANCER#0.9694;MONONUCLEAR CELLS#0.9693;DIABETIC RETINOPATHY#0.9690;TUMOR CELLS#0.9686;EPITHELIAL MESENCHYMAL TRANSITION#0.9684;CANCER CELL#0.9681;STROMAL CELL#0.9680;FIBROBLAST GROWTH FACTOR#0.9680;SIMVASTATIN#0.9680;PROTEIN KINASE#0.9675;FETAL LIVER KINASE#0.9675;REACTIVE OXYGEN SPECIES#0.9673;HEMATOPOIETIC STEM CELL#0.9672;MUSCLE CELL#0.9663;SMOOTH MUSCLE CELL#0.9661;GROWTH FACTOR#0.9661;UMBILICAL CORD#0.9649;CELL PROLIFERATION#0.9639;SIGNALING PATHWAY#0.9639;MICROTUBULE#0.9635;FLUORESCEIN#0.9635;FLOW CYTOMETRY ANALYSIS#0.9627;CORONARY ARTERY#0.9626;PULMONARY ARTERY#0.9623;CELL MOTILITY#0.9622;ENDOTHELIUM#0.9620;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9616;BRAIN ENDOTHELIAL CELL#0.9614;CELL DIFFERENTIATION#0.9613;PERIPHERAL BLOOD#0.9609;PLURIPOTENT STEM CELL#0.9608;MICROVASCULAR ENDOTHELIAL CELL#0.9607;ANGIOGENESIS#0.9603;KINASE INHIBITOR#0.9603;UMBILICAL VEIN#0.9596;HUMAN UMBILICAL VEIN#0.9595;HYPOXIC#0.9594;EXTRACELLULAR MATRIX#0.9590;EMBRYONIC STEM CELL#0.9589;MYOCARDIAL INFARCTION#0.9582;ENDOTHELIAL CELL PROLIFERATION#0.9582;BLOOD BRAIN BARRIER#0.9580;MESENCHYMAL STEM CELL#0.9579;HEMORRHAGE#0.9577;EDEMA#0.9575;ACUTE LUNG INJURY#0.9572;VASCULAR DISEASE#0.9572;BLOOD VESSEL#0.9571;ACTOMYOSIN#0.9568;SPECIFIC PROTEIN 1#0.9561;MITOGEN ACTIVATED PROTEIN#0.9560;VENULE#0.9559;LUNG CANCER#0.9559;CORD BLOOD#0.9558;APOPTOTIC#0.9554;ARTERY DISEASE#0.9549;CELL DEATH#0.9545;ATHEROSCLEROSIS#0.9544;ENDOTHELIAL PROGENITOR CELL#0.9543;BONE MARROW#0.9541;TROPHOBLAST#0.9539;ISCHEMIA#0.9537;SIGNAL TRANSDUCTION#0.9536;HEMORRHAGIC#0.9534;DIABETES MELLITUS#0.9531;PROGENITOR CELL#0.9530;PERIAPICAL GRANULOMA#0.9525;CORONARY ARTERY DISEASE#0.9519;ARTERY#0.9519;HYPERTENSION#0.9513;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9510;UMBILICAL CORD BLOOD#0.9508;DIAPEDESIS#0.9506;WOUND HEALING#0.9505;INFLAMMATORY RESPONSE#0.9502;STEM CELL#0.9487;CELL POLARITY#0.9484;CELL-CELL ADHESION MOLECULE#0.9484;TRANSFORMING GROWTH FACTOR BETA#0.9482;INFLAMMATORY CELL#0.9481;REGENERATION#0.9480;LYMPH NODE#0.9480;CELL CYCLE#0.9478;LUNG MICROVASCULAR ENDOTHELIAL#0.9471;INDUCED PLURIPOTENT STEM CELL#0.9453;NERVOUS SYSTEM#0.9440;NADPH OXIDASE#0.9427;COLORECTAL CANCER#0.9427;VEGF SIGNALING#0.9427;SIGNALING MOLECULE#0.9420;BLOOD RETINAL BARRIER#0.9385;STEM CELL MARKER#0.9380;MOUSE EMBRYONIC STEM#0.9368;TOXICITY#0.9336;HUMAN EMBRYONIC STEM#0.9335;ENDOTHELIAL CELL DIFFERENTIATION#0.9327;KINASE ACTIVITY#0.9324;HEPATOCELLULAR CARCINOMA#0.9290;ADIPOSE TISSUE#0.9290;CELL ACTIVATION#0.9285;CENTRAL NERVOUS SYSTEM#0.9268;SPROUTING ANGIOGENESIS#0.9255;ACTIN POLYMERIZATION#0.9247;CONNEXIN#0.9239;CYTOTOXICITY#0.9227;LAMINAR SHEAR STRESS#0.9209;CIRCULATING ENDOTHELIAL PROGENITOR#0.9206;PULMONARY EDEMA#0.9192;IMMUNE CELL#0.9190;COLONY-STIMULATING FACTOR#0.9150;EXOSOME#0.9122;FACTOR VIII#0.9113;LUNG ENDOTHELIAL CELLS#0.9109;TRANSCRIPTASE#0.9101;CELL ELONGATION#0.9080;INTERMEDIATE FILAMENT#0.9078;COLORECTAL#0.9068;VASCULAR SMOOTH MUSCLE CELL#0.9058;TRANSDIFFERENTIATION#0.9042;HEPATOCYTE GROWTH FACTOR#0.9031;HINDLIMB#0.8999;BONE MORPHOGENETIC PROTEIN#0.8998;ACUTE MYOCARDIAL INFARCTION#0.8997;RNA INTERFERENCE#0.8991;LUMINAL#0.8983;PROTEIN COMPLEX#0.8981;IFN-GAMMA#0.8970;HEPARIN#0.8954;AKT SIGNALING#0.8929;SIGNALING CASCADE#0.8867;ENDOTHELIAL CELL ACTIVATION#0.8859;MAP KINASE#0.8858;ISCHEMIA REPERFUSION INJURY#0.8844;RESPIRATORY DISTRESS#0.8842;ANGIOGENIC GROWTH FACTORS#0.8810;NUCLEOTIDE EXCHANGE FACTOR#0.8807;ADIPOCYTE#0.8796;HIGH MOBILITY GROUP#0.8777;ENDOTHELIAL CELL APOPTOSIS#0.8774;GAP JUNCTION#0.8771;BONE MARROW CELLS#0.8765;ACETYLCHOLINE#0.8762;CANCER STEM CELL#0.8744;STREPTOZOTOCIN#0.8736;TROPHOBLAST CELL#0.8732;CORPUS LUTEUM#0.8730;ERYTHROCYTE#0.8730;SUPEROXIDE DISMUTASE#0.8716;SIGNALLING PATHWAY#0.8691;CYTOPLASM#0.8686;TRANSMISSION ELECTRON MICROSCOPY#0.8683;COAGULATION#0.8654;PANCREATIC CANCER#0.8650;SKELETAL MUSCLE#0.8642;HYPERGLYCEMIA#0.8641;LOCALISATION#0.8635;MURAL CELL#0.8632;GRANULOCYTE#0.8620;PROTEIN KINASE A#0.8607;P21 ACTIVATED KINASE#0.8589;MYOFIBROBLAST#0.8588;MYOSIN HEAVY CHAIN#0.8581;INSULIN-LIKE GROWTH FACTOR#0.8577;GENE SILENCING#0.8566;RETINOIC ACID#0.8560;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8542;INSOLUBLE FRACTION#0.8531;CHEMOTAXIS#0.8528;HUMAN MESENCHYMAL STEM#0.8512;PRECURSOR CELL#0.8509;ASTROCYTE#0.8505;INHIBITION OF ANGIOGENESIS#0.8478;OSTEOBLAST#0.8472;ADVANCED GLYCATION END#0.8466;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8449;MAST CELL#0.8427;DEFINITIVE HEMATOPOIESIS#0.8406;CARDIOMYOCYTE#0.8401;CELL FRACTION#0.8388;ADENOSINE#0.8386;AUTOPHAGY#0.8384;CHEMOKINE RECEPTOR#0.8382;RESVERATROL#0.8359;FILAMENTOUS ACTIN#0.8354;SURFACE PLASMON RESONANCE#0.8342;GESTATION#0.8328;VASCULAR TISSUE ENGINEERING#0.8284;ARTERIOLE#0.8277;ANGIOBLASTS#0.8255;TUMOR ENDOTHELIAL CELL#0.8243;TUMOUR NECROSIS FACTOR#0.8232;FOCAL ADHESION FORMATION#0.8228;ADENOCARCINOMA#0.8227;DORSAL AORTA#0.8218;TUBULOGENESIS#0.8215;HUMAN BREAST CANCER#0.8199;ATORVASTATIN#0.8190;FIBRINOGEN#0.8188;HUMAN PULMONARY ARTERY#0.8183;STEM CELL DIFFERENTIATION#0.8178;RECEPTOR TYROSINE KINASE#0.8170;DENDRITIC CELL#0.8147;INTEGRIN ACTIVATION#0.8141;C REACTIVE PROTEIN#0.8137;THROMBOSIS#0.8119;LYMPHANGIOGENESIS#0.8108;DEXAMETHASONE#0.8082;HEMATOPOIETIC PROGENITOR CELL#0.8075;ENDOSOME#0.8065;CARDIOVASCULAR SYSTEM#0.8058;GUANINE#0.8041;TUMOR TISSUES#0.8029;CELL PENETRATING PEPTIDE#0.8014;FACTOR I#0.8014;LEUKOCYTE ADHESION#0.8007;PROTEASE ACTIVATED RECEPTOR#0.8002;PLATELET ACTIVATING FACTOR#0.7995;IMMUNE RESPONSE#0.7993;SENESCENCE#0.7968;VASCULAR PROGENITOR CELL#0.7963;ADIPOSE-DERIVED STEM CELL#0.7962;IMATINIB#0.7960;FORSKOLIN#0.7939;TOLL LIKE RECEPTOR#0.7936;METASTATIC MELANOMA#0.7932;METASTATIC BREAST CANCER#0.7930;EPHRIN#0.7918;PULMONARY HYPERTENSION#0.7897;ROS GENERATION#0.7889;INHIBITION OF CELL GROWTH#0.7874;SRC FAMILY KINASE#0.7847;GOLGI APPARATUS#0.7833;RECEPTOR COMPLEX#0.7788;CONTACT SITE#0.7787;MECHANISM OF ACTION#0.7769;PROSTACYCLIN#0.7754;SERUM ALBUMIN#0.7753;REGULATION OF VASCULAR PERMEABILITY#0.7739;CYTOTROPHOBLAST#0.7719;EOSIN#0.7712;COLONY-FORMING CELL#0.7685;ALKALINE PHOSPHATASE#0.7665;CELL MATRIX ADHESION#0.7664;DNA BINDING#0.7663;TYPE 2 DIABETES#0.7660;SCANNING ELECTRON MICROSCOPY#0.7630;TRANSIENT RECEPTOR POTENTIAL#0.7627;EPITHELIOID SARCOMA#0.7626;CEREBRAL ARTERY#0.7618;ZONULA ADHERENS#0.7614;CELL AGGREGATION#0.7582;MICROVESICLE#0.7580;CEREBRAL ISCHEMIA#0.7569;MESENCHYMAL STROMAL CELL#0.7555;INTIMA MEDIA THICKNESS#0.7536;OVARIAN HYPERSTIMULATION SYNDROME#0.7517;HEART DISEASE#0.7515;TYROSINE KINASE INHIBITOR#0.7491;MYOSIN LIGHT-CHAIN KINASE#0.7462;RETINAL VASCULAR PERMEABILITY#0.7456;CEREBRAL ARTERY OCCLUSION#0.7431;HUMAN CORD BLOOD#0.7426;COLLAGENASE#0.7421;MIDDLE CEREBRAL ARTERY#0.7418;PLASMA PROTEIN#0.7405;CONNECTIVE TISSUE#0.7395;TYROSINE KINASE RECEPTOR#0.7373;PROSTATE CANCER#0.7372;SQUAMOUS CELL CARCINOMA#0.7372;RESPONSE TO TNF#0.7369;HEMANGIOBLAST#0.7364;DIGESTION#0.7326;CORONARY ARTERY ENDOTHELIAL CELLS#0.7325;GLUTATHIONE#0.7286;STROMA#0.7283;L-ARGININE#0.7282;MESONEPHROS#0.7255;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7215;EPITHELIAL TO MESENCHYMAL#0.7213;NEURAL STEM CELL#0.7210;CARDIOVASCULAR RISK FACTOR#0.7198;ENDOTHELIAL CELL DYSFUNCTION#0.7179;CYCLIC AMP#0.7176;OXYGEN INDUCED RETINOPATHY#0.7175;CELL ASSOCIATED#0.7167;CHOROID PLEXUS#0.7159;GM-CSF#0.7158;MELATONIN#0.7101;UROKINASE#0.7080;BRAIN WATER CONTENT#0.7058;EARLY ENDOSOME#0.7018;STRESS FIBRE FORMATION#0.6990;DOXYCYCLINE#0.6979;ENDOTHELIAL CELL DENSITY#0.6938;ANGIOTENSIN CONVERTING ENZYME#0.6932;KIDNEY DISEASE#0.6931;PROTEIN SYNTHESIS#0.6922;LUNG METASTASIS#0.6904;UTERUS#0.6902;ENDOTHELIAL GROWTH MEDIUM#0.6899;TAMOXIFEN#0.6888;PKC ACTIVATION#0.6848;GLIOBLASTOMA MULTIFORME#0.6821;LUNG CARCINOMA#0.6813;PARENCHYMA#0.6809;BREAST CARCINOMA#0.6802;GRANULOCYTE COLONY STIMULATING FACTOR#0.6802;PROTEIN PROTEIN INTERACTION#0.6798;TYPE 2 DIABETES MELLITUS#0.6795;2 DIABETES MELLITUS#0.6795;COLON CANCER#0.6788;TYPE 1 DIABETES#0.6779;QUIESCENCE#0.6733;CAVEOLAE#0.6732;ACTIN BINDING#0.6719;PLATELET ACTIVATION#0.6702;RESPONSE TO LPS#0.6694;RELATED PROTEIN 1#0.6689;VASODILATION#0.6684;LYMPH NODE METASTASIS#0.6679;MEMBRANE FRACTION#0.6662;MRNA TRANSCRIPTION#0.6659;RECEPTOR ANTAGONIST#0.6647;NEUTROPHIL EXTRAVASATION#0.6646;EXTRACELLULAR VESICLE#0.6644;CELL COMMUNICATION#0.6641;ARGININE#0.6638;ENDOTHELIAL PRECURSOR CELL#0.6636;ADULT BONE MARROW#0.6634;GLYCOSYLATION#0.6608;EVANS BLUE EXTRAVASATION#0.6601;CELL MOVEMENT#0.6599;CAROTID ARTERY#0.6594;LUNG DISEASE#0.6593;BRAIN EDEMA#0.6589;METASTATIC MELANOMA CELLS#0.6576;ARACHIDONIC ACID#0.6520;THROMBIN RECEPTOR#0.6476;PHOSPHATIDYLSERINE#0.6455;PROTEIN PHOSPHORYLATION#0.6433;CATION CHANNEL#0.6430;CYTOCHROME P450#0.6421;VASCULAR ENDOTHELIAL DYSFUNCTION#0.6416;POST-TRANSLATIONAL MODIFICATION#0.6401;MAGNETIC RESONANCE IMAGING#0.6380;SPINAL CORD#0.6374;LIMB ISCHEMIA#0.6366;JUXTAMEMBRANE#0.6342;UREMIC TOXIN#0.6318;PULMONARY FIBROSIS#0.6310;ANCHORING#0.6306;GONAD#0.6301;TISSUE DAMAGE#0.6290;AMIODARONE#0.6269;RENAL FIBROSIS#0.6265;SIGNALLING CASCADE#0.6252;FOCAL CEREBRAL ISCHEMIA#0.6246;CELL FUSION#0.6244;TRADITIONAL CHINESE MEDICINE#0.6239;BLOOD COAGULATION#0.6212;UVEAL MELANOMA#0.6202;KERATINOCYTE#0.6197;HEMORRHAGIC FEVER WITH RENAL SYNDROME#0.6193;ACETYLCHOLINE RECEPTOR#0.6193;STEM CELL LIKE#0.6180;OXYGEN GLUCOSE DEPRIVATION#0.6170;LDL RECEPTOR#0.6127;SYSTOLIC BLOOD PRESSURE#0.6102;GINKGOLIDE-B#0.6100;INDUCIBLE NITRIC OXIDE#0.6100;GLYCOGEN SYNTHASE KINASE#0.6093;CELL DEVELOPMENT#0.6078;PHOSPHOLIPASE C#0.6077;HISTONE DEACETYLASE#0.6071;SIGNAL TRANSDUCER#0.6070;CHRONIC KIDNEY DISEASE#0.6070;BRADYKININ RECEPTOR#0.6062;PHOSPHODIESTERASE#0.6031;ALLANTOIS#0.6028;TRYPTOPHAN#0.6025;BLOOD CIRCULATION#0.6018;GREEN TEA CATECHIN#0.6011
10040	SIGNALING MOLECULE#0.9029;KERATINOCYTE#0.8807;GROWTH FACTOR#0.8368;DNA SYNTHESIS#0.8198;BREAST CANCER#0.8116;KERATINOCYTE DIFFERENTIATION#0.8090;SRC FAMILY KINASE#0.7344;ENDOSOME#0.6819;CLATHRIN HEAVY CHAIN#0.6721;MVB FORMATION#0.6676
100420505	GERM CELL#0.9589;ENDOPLASMIC RETICULUM#0.7556
100422496	PRE-MRNA SPLICING#1.0586;MRNA SPLICING#1.0554;SPLICEOSOME#1.0352;NINETEEN COMPLEX#0.8815;LIPID DROPLET#0.8496;COMPLEX I#0.7408;PROTEIN COMPLEX#0.6835
100422824	CELL PROLIFERATION#1.1787
100422833	CELL PROLIFERATION#0.9021;SIGNALING PATHWAY#0.7598;CANCER CELL#0.7573;BREAST CANCER#0.6850;APOPTOSIS#0.6395;TYPE 2 DIABETES#0.6308
100422861	SIGNALING PATHWAY#0.7737;MONOCYTE DERIVED MACROPHAGE#0.6861;CORONARY ARTERY#0.6745
100422876	ERBB SIGNALING PATHWAY#0.8055;ERBB SIGNALING#0.7839;LUCIFERASE ACTIVITY#0.7595;SIGNALING PATHWAY#0.7424
100422896	CELL GROWTH#0.9059
100422908	DUAL LUCIFERASE REPORTER#0.9146
100422943	CELL PROLIFERATION#0.7515;CANCER CELL#0.7084
100422945	TUMOR SUPPRESSOR#0.9002;LUNG CANCER#0.8997;CELL PROLIFERATION#0.8960;CANCER CELL#0.8953
100422948	POLYMERASE CHAIN REACTION#0.6032
100422957	BREAST CANCER#0.7099
100422974	BREAST CANCER#0.8019;CANCER CELL#0.7613;BREAST CANCER CELL#0.6596;G1 PHASE#0.6015
100422979	EPITHELIAL TO MESENCHYMAL TRANSITION#0.6589;EPITHELIAL TO MESENCHYMAL#0.6586
100422981	OVARIAN#0.6451
100422982	APOPTOSIS#0.8319;CELL PROLIFERATION#0.8153;ESOPHAGEAL CARCINOMA#0.6361
100422983	OVARIAN#0.8479
100422991	CANCER CELL#0.8573;CELL PROLIFERATION#0.7953;GENISTEIN#0.6357;SIGNALING PATHWAY#0.6352;RENAL CANCER CELLS#0.6211;VSMC PROLIFERATION#0.6074
100422992	APOPTOSIS#0.8229;ACUTE MYELOID LEUKEMIA#0.7265;MYELOID LEUKEMIA#0.7253;CELL PROLIFERATION#0.7181;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6826;LYMPHOCYTIC LEUKEMIA#0.6813;AKT SIGNALING#0.6799;DNA METHYLATION#0.6772;TUMOR SUPPRESSOR#0.6723
100422995	TUMOR SUPPRESSOR#0.6586;SIGNALING PATHWAY#0.6542
100423001	INFLUENZA A VIRUSES#1.2182;VIRAL REPLICATION#1.1914
100423014	BREAST CANCER#0.6637;CELL PROLIFERATION#0.6487;BREAST CANCER CELL#0.6026;TUMOR SUPPRESSOR#0.6007
100423036	BEVACIZUMAB#0.8570
100423038	EXOSOME#0.6544
100423062	B CELL#1.0111;POLYMERASE CHAIN REACTION#0.8203;T CELL#0.8114;IMMUNE RESPONSE#0.7664;B LYMPHOCYTE#0.7488;B CELL DEVELOPMENT#0.7467;CELL DEVELOPMENT#0.7409;PLASMA CELL#0.7238;B CELL RECEPTOR#0.6648;BONE MARROW#0.6385;ANTIGEN BINDING#0.6268
10042	HIGH MOBILITY GROUP#0.7928;SMOOTH MUSCLE#0.6571
100431172	LECTIN#0.9751;KERATINOCYTE#0.9634;CYTOTOXICITY#0.6499
10043	UBIQUITIN#1.0486;ENDOSOME#1.0071;GENE EXPRESSION#0.8711;CLATHRIN BINDING#0.8185;EARLY ENDOSOME#0.8156;SYNAPTIC VESICLE#0.8106;TRANSCRIPTION FACTOR#0.8070;PROTEIN DEGRADATION#0.8067;SIGNALING PATHWAY#0.7945;AUTOPHAGY#0.7627;CELL CYCLE#0.7556;AUTOPHAGOSOME MATURATION#0.7222;PLASMA MEMBRANE#0.7148;C TERMINAL DOMAIN#0.6911;UBIQUITIN BINDING#0.6859;B CELL#0.6569;RNA REPLICATION#0.6506;SYNAPTIC TRANSMISSION#0.6405;AUTOPHAGOSOME#0.6118;M PHASE#0.6068;GROWTH FACTOR#0.6040;S PHASE#0.6034;RIBOSOMAL PROTEIN#0.6033
10044	POLY-A BINDING#1.0481;RNA BINDING#1.0395;CHIKUNGUNYA#1.0136;EQUINE ENCEPHALITIS#1.0100;VENEZUELAN EQUINE ENCEPHALITIS#1.0046;SEVERE ACUTE RESPIRATORY SYNDROME#1.0006;VIRAL REPLICATION#0.9989;RNA SYNTHESIS#0.9939;RNA REPLICATION#0.9894;HOST CELL#0.9861;GROUP A ROTAVIRUS#0.9825;RIBOSE#0.9800;PROTEIN SYNTHESIS#0.9721;VIRULENCE#0.9691;STRESS GRANULE#0.9490;TRANSLATION INITIATION#0.9470;POLYMERASE CHAIN REACTION#0.9462;GASTROENTERITIS#0.9461;EIF4G BINDING#0.9451;DIARRHEA#0.9432;C TERMINAL DOMAIN#0.9220;REVERSE TRANSCRIPTION#0.9214;RNA BINDING PROTEIN#0.9051;IMMUNE RESPONSE#0.9043;SIGNALING PATHWAY#0.8934;VIRAL INFECTION#0.8700;TRANSLATION INITIATION FACTOR#0.8656;T CELL#0.8556;ENDOPLASMIC RETICULUM#0.8534;ARGININE#0.8436;NUCLEOCAPSID#0.8384;SH3 DOMAIN BINDING#0.8105;CYTOPLASM#0.8102;VIRION#0.8004;NEURONAL CELLS#0.7868;VIRAL GENOME#0.7846;MARGINAL ZONE B#0.7658;MUTAGENESIS#0.7634;TRANSCRIPTASE#0.7507;RNA HELICASE#0.7357;B CELL#0.7197;PROTEIN KINASE#0.7134;EPITHELIAL CELL#0.7000;GENE EXPRESSION#0.6911;PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME#0.6881;OUTER CAPSID#0.6875;BREAST CANCER#0.6827;UBIQUITIN#0.6690;INNATE IMMUNE RESPONSE#0.6677;INTERNEURON#0.6599;CELL MIGRATION#0.6523;SIGNAL TRANSDUCER#0.6487;STRESS GRANULE ASSEMBLY#0.6452;NUCLEIC ACID#0.6317;PROTEASOME#0.6307;HEMATOPOIETIC CELL#0.6257;CELL ADHESION#0.6254;KINASE ACTIVITY#0.6232;VACCINIA#0.6169;CYTOPLASMIC FOCI#0.6167;VIRAL PROTEIN SYNTHESIS#0.6161;NUCLEOTIDE EXCHANGE FACTOR#0.6099;DOUBLE-STRANDED RNA BINDING#0.6072;MARGINAL ZONE B CELL#0.6051;INFECTIOUS BRONCHITIS VIRUS#0.6021;HYDROLASE ACTIVITY#0.6015
10045	PROTEASOME#1.0345;NUCLEAR PORE#1.0310;PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME#1.0218;GENE EXPRESSION#1.0212;SEVERE ACUTE RESPIRATORY SYNDROME#1.0206;METHYLTRANSFERASE ACTIVITY#1.0185;TRANSCRIPTION FACTOR#1.0162;VIRAL REPLICATION#1.0145;RNA REPLICATION#1.0112;VIRULENCE#1.0109;RNA SYNTHESIS#1.0073;PROTEIN SYNTHESIS#1.0060;SIGNALING PATHWAY#1.0002;CHIKUNGUNYA#0.9984;NODULATION#0.9960;IMMUNE RESPONSE#0.9956;MRNA DEGRADATION#0.9947;NUCLEAR PORE COMPLEX#0.9891;PORE COMPLEX#0.9882;MUTAGENESIS#0.9882;GASTROENTERITIS#0.9775;GROUP A ROTAVIRUS#0.9770;HOST CELL#0.9754;EQUINE ENCEPHALITIS#0.9710;UBIQUITIN#0.9666;CYTOPLASM#0.9655;DIARRHEA#0.9591;IFN REGULATORY FACTOR#0.9578;INNATE IMMUNE RESPONSE#0.9576;PLASMA MEMBRANE#0.9485;VENEZUELAN EQUINE ENCEPHALITIS#0.9353;VIRAL GENOME#0.9090;NUCLEAR ENVELOPE#0.9050;NUCLEAR EXPORT#0.8972;ANTIVIRAL RESPONSE#0.8710;INTERFERON REGULATORY FACTOR#0.8651;RNA BINDING#0.8540;MRNA SYNTHESIS#0.8517;IMMUNE EVASION#0.8490;CREB BINDING#0.8474;T CELL#0.8374;MRNA CAPPING#0.8326;SYMBIOSIS#0.8299;OUTER CAPSID#0.8124;RNA CAPPING#0.8063;RIBOSOME#0.8022;PROTEIN PROCESSING#0.7996;VIRAL INFECTION#0.7991;INNATE IMMUNITY#0.7840;VIRION#0.7775;PROTEASE ACTIVITY#0.7765;POLYMERASE CHAIN REACTION#0.7763;ALANINE#0.7715;METHIONINE#0.7713;S-ADENOSYLMETHIONINE#0.7492;NUCLEOCAPSID#0.7410;RNA METHYLTRANSFERASE#0.7146;NODULE FORMATION#0.7140;RIBOSOMAL SUBUNIT#0.7127;40S RIBOSOMAL SUBUNIT#0.7075;GUANINE#0.7073;NUCLEAR PORE COMPLEXES#0.7044;HEPATITIS C#0.6869;INTERFERON PRODUCTION#0.6828;PROTEIN TRANSLATION#0.6815;VACCINIA#0.6706;NUCLEAR TRANSPORT#0.6585;C TERMINAL DOMAIN#0.6299;CULLIN-RING LIGASE#0.6254;APOPTOSIS#0.6244;CYTOPLASMIC TRANSPORT#0.6190;CYSTEINE PROTEASE ACTIVITY#0.6172;DENDRITIC CELL#0.6166;VIRAL GENE EXPRESSION#0.6158;NUCLEAR PERIPHERY#0.6042
100462725	OBESE#0.8494
100463488	RABIES#0.8692
100463489	ERLOTINIB#0.8586;GEFITINIB#0.8581
100463498	SQUAMOUS CELL CARCINOMA#0.9702;CANCER CELL#0.9543;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9398;CELL CYCLE#0.9314;KERATINOCYTE#0.8966;APOPTOSIS#0.8892;ORAL CANCER CELL#0.8058;SIGNALING PATHWAY#0.7834;CISPLATIN#0.7385;HEAD AND NECK CANCER#0.6906;NECK CANCER#0.6906;CYTOTOXIN#0.6740;GROWTH FACTOR#0.6499;DOCETAXEL#0.6270;CYTOTOXICITY#0.6115;LYMPH NODE#0.6114;CELL DEATH#0.6008
100463500	CANCER CELL#0.6415;SQUAMOUS CELL CARCINOMA#0.6161;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6155;MITOCHONDRIAL MEMBRANE#0.6129
10046	HYPOSPADIAS#1.0870;TESTOSTERONE#1.0086;LEYDIG CELL#0.9305;TUMOR CELLS#0.8776;TRANSCRIPTION FACTOR#0.7672;DNA BINDING#0.7498;STEROIDOGENIC FACTOR 1#0.7323;GONADAL DYSGENESIS#0.7278;TRANSACTIVATION#0.6852;FUNCTIONAL LUTEOLYSIS#0.6223
10047	CYSTATIN#1.0998;EPIDIDYMIS#1.0685;SPERMATOZOA#0.9868;GERM CELL#0.9271;PITUITARY GLAND#0.8042;CAPUT#0.7820;ACROSOME#0.7748;ACROSOME REACTION#0.7247;FERTILIZATION#0.6804;LUMINAL#0.6176;EFFERENT DUCT#0.6019;INITIAL SEGMENT#0.6008
10048	RAN-BINDING PROTEIN#1.0955;MICROTUBULE#1.0642;MICROTUBULE ORGANIZING CENTER#1.0599;SIGNALING PATHWAY#1.0458;CANCER CELL#1.0121;GERM CELL#0.9793;UBIQUITIN#0.9416;CELL MIGRATION#0.9348;CELL CYCLE#0.9144;GENE EXPRESSION#0.8910;CYTOPLASM#0.8877;ALZHEIMER'S DISEASE#0.8408;APOPTOSIS#0.8362;PROTEIN COMPLEX#0.8201;TUMOR SUPPRESSOR#0.8125;STEM CELL#0.8109;SIGNAL TRANSDUCTION#0.8091;MICROTUBULE NUCLEATION#0.8053;NERVOUS SYSTEM#0.8032;CELL PROLIFERATION#0.7956;TRANSCRIPTION FACTOR#0.7943;CELL SURFACE#0.7829;TRANSACTIVATION#0.7760;TYROSINE KINASE DOMAIN#0.7756;LUNG CANCER#0.7644;SPERMATOGENESIS#0.7592;CELL ADHESION#0.7559;ANDROGEN RECEPTOR#0.7062;NEUROTROPHIN RECEPTOR#0.7013;CELL DEVELOPMENT#0.6935;AMYLOID PRECURSOR PROTEIN#0.6902;GLUTATHIONE#0.6445;SPERMATOCYTES#0.6379;PROTEIN KINASE#0.6350;CENTROSOME#0.6322;GERM CELL DEVELOPMENT#0.6198;THYROID HORMONE RECEPTOR#0.6179;CELL DEATH#0.6158;M PHASE#0.6108;GLUCOCORTICOID RECEPTOR#0.6048;CELL DIFFERENTIATION#0.6013;NEURITE#0.6012
10049	LIMB-GIRDLE MUSCULAR DYSTROPHY#1.0616;MUSCULAR DYSTROPHY#1.0569;ATP HYDROLYSIS#1.0431;ATPASE ACTIVITY#1.0302;MYOPATHY#1.0189;HEAT SHOCK PROTEIN#1.0131;CHAPERONE ACTIVITY#1.0057;PROTEIN FOLDING#0.9998;GERM CELL#0.9954;NUCLEOTIDE EXCHANGE FACTOR#0.9882;CELL CYCLE#0.9858;RIBOSOME#0.9447;ENDOPLASMIC RETICULUM#0.9359;DNA REPLICATION#0.9289;PEPTIDE BINDING#0.9282;TRANSCRIPTION FACTOR#0.9137;TOXICITY#0.9108;GENE EXPRESSION#0.8966;NEURODEGENERATIVE DISEASE#0.8854;PROTEASOME#0.8633;CHLOROPLAST#0.8568;PARKINSON'S DISEASE#0.8535;CANCER CELL#0.8526;DNA BINDING#0.8452;BREAST CANCER#0.8312;CYTOPLASM#0.8214;PROTEIN DISULFIDE ISOMERASE#0.8163;PROTEIN QUALITY CONTROL#0.8126;SPERMATOZOA#0.8061;TUMOR SUPPRESSOR#0.8017;UBIQUITIN#0.7986;HUNTINGTON'S DISEASE#0.7682;RENATURATION#0.7643;SKELETAL MUSCLE#0.7598;PLACENTAL DEVELOPMENT#0.7593;PROTEIN PROTEIN INTERACTION#0.7443;ACROSOME#0.7411;SPINAL CORD#0.7410;NUCLEAR IMPORT#0.7343;CHAPERONIN#0.7337;LUCIFERASE ACTIVITY#0.7299;CELL DIVISION#0.7252;PROTEIN SYNTHESIS#0.7204;NUCLEOTIDE BINDING#0.7180;APOPTOSIS#0.7126;RNA BINDING#0.7101;SUBSTRATE BINDING DOMAIN#0.7067;MITOCHONDRIA#0.6862;MYOFIBRILLAR MYOPATHY#0.6777;SIGNALING PATHWAY#0.6678;STEM CELL#0.6629;CELL GROWTH#0.6520;POLYMERASE CHAIN REACTION#0.6456;FIBRIL#0.6369;AUTOPHAGY#0.6123;Z DISC#0.6109;AMYLOID FIBRIL FORMATION#0.6108;STRESS GRANULE#0.6018
1004	RENAL CELL CARCINOMA#1.0318;CELL ADHESION MOLECULE#1.0041;CELL ADHESION#1.0031;GENE EXPRESSION#0.9806;CANCER CELL#0.9605;CELL CELL ADHESION#0.9392;NEURAL CREST#0.9369;NERVOUS SYSTEM#0.8966;TUMOR CELLS#0.8751;NEURAL CREST CELL#0.8716;EPITHELIAL CELL#0.8499;OVARIAN#0.8415;POLYMERASE CHAIN REACTION#0.8214;LYMPH NODE#0.8075;TRANSCRIPTION FACTOR#0.8024;GROWTH FACTOR#0.7895;RENAL CELL CANCER#0.7822;LYMPH NODE METASTASIS#0.7634;STROMAL CELL#0.7393;MESENCHYME#0.7027;KIDNEY DEVELOPMENT#0.6962;PERIPHERAL BLOOD#0.6961;CEREBRAL CORTEX#0.6886;FOREBRAIN#0.6592;URETERIC BUD#0.6577;PERIPHERAL NERVOUS SYSTEM#0.6209;RETINAL DEVELOPMENT#0.6207;OVARIAN CANCER#0.6152;KIDNEY CANCER#0.6119;AMACRINE CELL#0.6107;NEURAL TUBE#0.6090;OVARIAN CARCINOMA#0.6070;HINDBRAIN#0.6029
100500809	CELL GROWTH#0.6766;CELL PROLIFERATION#0.6610
100500812	GASTRIC ANTRAL VASCULAR ECTASIA#0.6594;CELL PROLIFERATION#0.6544
100500827	BREAST CANCER CELL#1.1848;BREAST CANCER#1.1796;CELL PROLIFERATION#1.1787;CANCER CELL#1.1780
100500833	EPITHELIAL MESENCHYMAL TRANSITION#0.6653;COLON CANCER#0.6627;CANCER CELL#0.6537
100500840	GEMCITABINE#0.6544
100500843	LYMPHOPROLIFERATIVE DISEASE#1.2052
100500844	LIVER CANCER#1.1930;CANCER CELL#1.1780
100500857	DIABETIC RETINOPATHY#1.1947
100500858	CANCER CELL#0.7084
100500878	OSTEOBLAST#0.8509
100500880	ACUTE MYELOID LEUKEMIA#0.7596;MYELOID LEUKEMIA#0.7579;QUANTITATIVE TRAIT LOCUS#0.7357;HEPATOCELLULAR CARCINOMA#0.7147;LUNG CANCER#0.7127
100500914	HYPOPITUITARISM#0.6629
100500918	SQUAMOUS CELL CANCER#0.6726
100505385	ANTISENSE RNA#0.6668;SURFACE PLASMON RESONANCE#0.6592
100505390	ATP HYDROLYSIS#0.7070;DYNEIN#0.6896;CORPUS STRIATUM#0.6822;NUCLEOTIDE BINDING#0.6106;ATPASE ACTIVITY#0.6083
100505475	CARDIOMYOCYTE#0.8513
100505495	CELL PROLIFERATION#0.9518;PROSTATE CANCER#0.6422;LUNG CANCER#0.6240
100505592	GASTRIC ADENOCARCINOMA#1.0636;CELL MIGRATION#1.0406;CELL PROLIFERATION#0.9801;ADENOCARCINOMA#0.9374;CELL CYCLE#0.8273;COLORECTAL CANCER#0.7341;CANCER CELL#0.7295;LUNG CANCER#0.6553
100505641	CANCER CELL#0.8948;CELL PROLIFERATION#0.8498;COLORECTAL CANCER#0.7114
100505648	DNA REPAIR#0.7850;EPITHELIAL OVARIAN CANCER#0.7609;OVARIAN CANCER#0.7501;CELL CYCLE#0.7437
100505666	CELL PROLIFERATION#0.7427
100505705	PROGENITOR CELL#1.1842;CELL DEATH#1.1799
100505741	BREAST CANCER#0.8730;STORAGE PROTEIN#0.7920;CANCER CELL#0.7538;HUMAN BREAST CANCER#0.7232;BREAST CANCER CELL#0.6882
100505746	BREAST CANCER CELL#0.7152;BREAST CANCER#0.7099;CELL PROLIFERATION#0.7091;CANCER CELL#0.7084
100505806	SMALL NUCLEOLAR RNA#1.2156;MULTIPLE MYELOMA#0.8071;HEPATOCELLULAR CARCINOMA#0.8014;TUMOR SUPPRESSOR#0.7999
100505832	PAPILLARY THYROID CARCINOMA#0.7054;THYROID CANCER#0.6996;THYROID CARCINOMA#0.6983;CANCER CELL#0.6849
100505854	CELL PROLIFERATION#0.7037;PORTAL HYPERTENSION#0.6910;HEPATIC STELLATE CELL#0.6854;PORTAL VEIN#0.6848
100505881	BREAST CANCER#0.9757;CELL PROLIFERATION#0.8681;CANCER CELL#0.8501;BREAST CANCER CELL#0.8325;CELL GROWTH#0.8014;APOPTOSIS#0.7314;ANTISENSE RNA#0.6687;POLYMERASE CHAIN REACTION#0.6546;NON-SMALL CELL LUNG CARCINOMA#0.6092;LUNG CARCINOMA#0.6002
100505994	CELL PROLIFERATION#1.0991;LUNG CANCER#1.0947;CELL CYCLE#1.0580;CANCER CELL#1.0390;APOPTOSIS#1.0271;BREAST CANCER#0.8777;CERVICAL CANCER#0.8001;POLYMERASE CHAIN REACTION#0.7872;SIGNALING PATHWAY#0.7545;DRUG RESISTANCE#0.6376;CELL CYCLE ARREST#0.6360;HEPATOCELLULAR CARCINOMA#0.6192;SQUAMOUS CELL CARCINOMA#0.6189;CELL MIGRATION#0.6150;CARDIOMYOCYTE#0.6070;CERVICAL#0.6055;PRC2 COMPLEX#0.6042
100506013	STEM CELL#1.0215;SIGNALING PATHWAY#1.0211;APOPTOSIS#0.9765;PEPTIDE HORMONE#0.9743;CARDIOVASCULAR SYSTEM#0.9517;EMBRYONIC STEM CELL#0.8819;HYPERTENSION#0.8773;CANCER CELL#0.8621;HEART DEVELOPMENT#0.8328;CARDIAC DEVELOPMENT#0.7888;HUMAN EMBRYONIC STEM#0.7832;PRE-ECLAMPSIA#0.7745;ANGIOGENESIS#0.7650;CELL CYCLE#0.7599;TROPHOBLAST#0.7525;CYTOTOXICITY#0.7461;CARDIOVASCULAR SYSTEM DEVELOPMENT#0.6872;CERVICAL#0.6621;GROWTH FACTOR#0.6394;SYSTEM DEVELOPMENT#0.6216;ECLAMPSIA#0.6190;ARGININE VASOPRESSIN#0.6133;CERVICAL CANCER#0.6130;BLOOD VESSEL#0.6086;CELL GROWTH#0.6052
100506020	DIABETIC NEPHROPATHY#0.9084;NEPHROPATHY#0.6485
100506046	ORAL SUBMUCOUS FIBROSIS#0.7572;LUNG CANCER#0.7127
100506164	INTIMA MEDIA THICKNESS#0.6804;TYPE 1 DIABETES#0.6619;LEFT VENTRICULAR MASS#0.6273;DNA BINDING#0.6092
100506211	COLORECTAL ADENOCARCINOMA#0.6579;INVASIVE BREAST CANCER#0.6540;COLON CANCER#0.6425;HEPATOCELLULAR CARCINOMA#0.6398;BREAST CANCER#0.6350
100506237	LUNG CARCINOMA#0.7557;CELL MIGRATION#0.7484
100506311	CELL PROLIFERATION#1.0513;APOPTOSIS#1.0424;ANTISENSE RNA#0.9387;GENE EXPRESSION#0.8839;ACUTE MYELOID LEUKEMIA#0.8788;MYELOID LEUKEMIA#0.8771;LUNG CANCER#0.8750;CELL CYCLE#0.7890;MYELOID CELL#0.7840;CELL DIFFERENTIATION#0.7063;ACUTE PROMYELOCYTIC LEUKEMIA#0.6416;DRUG RESISTANCE#0.6219
100506365	CLEAR CELL RENAL CELL CARCINOMA#0.7654;RENAL CELL CARCINOMA#0.7534;SIGNALING PATHWAY#0.7424
100506392	LUNG CANCER#1.1823
100506394	CANCER CELL#0.7278;BREAST CANCER#0.7099;SIGNALING PATHWAY#0.7088;APOPTOSIS#0.6905
100506428	CELL PROLIFERATION#1.1195;PROSTATE CANCER#1.0639;APOPTOSIS#1.0392;EPITHELIAL MESENCHYMAL TRANSITION#0.8763;ANDROGEN RECEPTOR#0.8748;CANCER CELL#0.8573;COLORECTAL CANCER#0.7341;CELL CYCLE#0.7308;NORMAL PROSTATE EPITHELIAL#0.6906;PROSTATE EPITHELIAL CELL#0.6742;LYMPH NODE METASTASIS#0.6604;HEPATOCELLULAR CARCINOMA#0.6569;LYMPH NODE#0.6548;EPITHELIAL CELL#0.6429;ACUTE KIDNEY INJURY#0.6027
100506492	BREAST CANCER#1.0654;CELL PROLIFERATION#0.9597;CANCER CELL#0.9445;POLYMERASE CHAIN REACTION#0.7438;TUMOR TISSUES#0.7420;BREAST CANCER CELL#0.6649;QUANTITATIVE REAL TIME#0.6625;COLORECTAL#0.6384;APOPTOSIS#0.6348;COLORECTAL ADENOCARCINOMA#0.6168;INVASIVE DUCTAL CARCINOMA#0.6161;BREAST CANCER PATIENTS#0.6027;OVARIAN CANCER#0.6006
100506495	LEUKEMIA INHIBITORY FACTOR#0.8075;ANTISENSE RNA#0.7181;CELL PROLIFERATION#0.7181;BREAST CANCER CELL#0.6742;CANCER CELL#0.6674
100506658	VASCULAR ENDOTHELIAL CADHERIN#1.0563;SCAVENGER RECEPTOR#1.0455;DEPHOSPHORYLATION#1.0440;INSOLUBLE FRACTION#1.0430;JUNCTIONAL ADHESION MOLECULE#1.0405;ZONULA OCCLUDENS 1#1.0343;ZONULA OCCLUDENS#1.0290;CONNEXIN#1.0283;LIPID RAFT#1.0283;ENDOCYTIC RECYCLING#1.0210;SOLUBLE FRACTION#1.0199;TIGHT JUNCTION ASSEMBLY#1.0196;RETINAL ENDOTHELIAL CELLS#1.0125;C TERMINAL DOMAIN#1.0098;SMOOTH MUSCLE ACTIN#1.0081;TIGHT JUNCTION FORMATION#1.0077;LOCALISATION#1.0073;FOCAL ADHESION KINASE#1.0063;IFN-GAMMA#1.0060;EVANS BLUE EXTRAVASATION#1.0046;MAP KINASE#1.0044;B CELL#1.0033;CELL CELL JUNCTION#1.0012;SQUAMOUS CELL CARCINOMA#1.0007;ENDOCYTOSIS#1.0004;CELL MEMBRANE#1.0003;TIGHT JUNCTION PROTEIN#1.0001;SERTOLI CELL#0.9993;AQUAPORIN#0.9993;INULIN#0.9987;FOCAL ADHESION#0.9971;DIAMINE OXIDASE#0.9953;JEJUNUM#0.9952;CYTOPLASM#0.9948;SMOOTH MUSCLE#0.9943;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9943;GAP JUNCTION#0.9934;MYOSIN LIGHT-CHAIN KINASE#0.9929;B CELL LYMPHOMA#0.9924;PERICYTE#0.9922;DUODENUM#0.9922;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9916;TIGHT JUNCTION#0.9913;PROTEIN COMPLEX#0.9911;ACTIN FILAMENT#0.9905;ETHANOL#0.9903;STRESS FIBER#0.9899;QUANTITATIVE REAL TIME#0.9897;CELL SURFACE#0.9896;LOW DENSITY LIPOPROTEIN#0.9895;REVERSE TRANSCRIPTION#0.9892;INTERCELLULAR SPACE#0.9886;CORNEAL EPITHELIAL CELL#0.9880;ACTIN CYTOSKELETON#0.9867;HEPATITIS C#0.9864;GOBLET CELL#0.9862;LYMPH NODE#0.9862;DESMOSOME#0.9858;KERATINOCYTE#0.9857;CONTACT SITE#0.9855;HYPOXIA#0.9855;BRAIN WATER CONTENT#0.9855;PLASMA MEMBRANE#0.9851;CELL JUNCTION#0.9850;HEPATITIS C VIRUS#0.9846;BILE DUCT#0.9833;SIGNALING MOLECULE#0.9832;VASCULAR ENDOTHELIAL CELL#0.9832;LASER SCANNING MICROSCOPY#0.9828;CEREBRAL CORTEX#0.9828;INTERCELLULAR JUNCTION#0.9827;ESTRADIOL#0.9826;GLIAL CELL#0.9818;NADPH OXIDASE#0.9815;CORNEAL EPITHELIUM#0.9815;BLOOD VESSEL#0.9813;ADHERENS JUNCTION#0.9806;BLOOD TESTIS BARRIER#0.9804;CELL CELL ADHESION#0.9804;EPIDERMAL GROWTH FACTOR#0.9799;SPINAL CORD#0.9799;FOCAL CEREBRAL ISCHEMIA#0.9798;RETINAL PIGMENT EPITHELIAL#0.9797;GROWTH FACTOR RECEPTOR#0.9797;POLYMERASE CHAIN REACTION#0.9796;MANNITOL#0.9795;BRAIN ENDOTHELIAL CELL#0.9794;CELL ADHESION MOLECULE#0.9793;BASEMENT MEMBRANE#0.9792;NEUTROPHIL#0.9788;BREAST CANCER#0.9784;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9779;ENDOTHELIAL GROWTH FACTOR#0.9776;HYPOXIC#0.9775;BASAL LAMINA#0.9771;INTESTINAL MUCOSAL BARRIER#0.9770;SUCROSE#0.9768;NITRIC OXIDE SYNTHASE#0.9763;PROTEIN KINASE C#0.9761;MAST CELL#0.9760;BLOOD RETINAL BARRIER#0.9757;ALVEOLAR EPITHELIAL CELL#0.9756;TOLL LIKE RECEPTOR#0.9755;CERVICAL#0.9753;COLONIC EPITHELIAL CELLS#0.9751;MONOCYTE#0.9741;TRANSFORMING GROWTH FACTOR#0.9740;HOST CELL#0.9738;INDUCIBLE NITRIC OXIDE#0.9737;TRANSENDOTHELIAL ELECTRICAL RESISTANCE#0.9733;AIRWAY EPITHELIAL CELL#0.9732;GERM CELL#0.9727;DEXAMETHASONE#0.9724;CELL MIGRATION#0.9719;T CELL#0.9716;CELL POLARITY#0.9715;HUMAN INTESTINAL EPITHELIAL#0.9715;ENTEROCYTE#0.9714;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9712;UMBILICAL VEIN#0.9711;HUMAN UMBILICAL VEIN#0.9708;GLUTATHIONE PEROXIDASE#0.9703;ADENOCARCINOMA#0.9700;ACUTE PANCREATITIS#0.9699;INTESTINAL MUCOSA#0.9698;EXTRACELLULAR MATRIX#0.9696;SMALL INTESTINE#0.9694;SIGNAL TRANSDUCTION#0.9692;TRANSCRIPTION FACTOR#0.9692;GENE EXPRESSION#0.9690;APOPTOTIC#0.9689;HEAT SHOCK PROTEIN#0.9688;ANGIOGENESIS#0.9686;TRANSCRIPTASE#0.9686;BRAIN EDEMA#0.9685;KINASE INHIBITOR#0.9685;MICROTUBULE#0.9674;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9674;MITOGEN ACTIVATED PROTEIN#0.9673;EPITHELIAL TO MESENCHYMAL#0.9673;LACTULOSE#0.9670;WOUND HEALING#0.9668;ALKALINE PHOSPHATASE#0.9667;BILE DUCT LIGATION#0.9666;CELL ADHESION#0.9661;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.9659;NITRIC OXIDE#0.9656;LARGE INTESTINE#0.9656;CANCER CELL#0.9652;ASTROCYTE#0.9652;CELL PROLIFERATION#0.9652;OXYGEN GLUCOSE DEPRIVATION#0.9652;BIOTIN#0.9651;LACTIC ACID#0.9650;CYTOTOXICITY#0.9650;ENDOTHELIUM#0.9650;COLITIS#0.9647;PROTEIN KINASE#0.9647;GLUTATHIONE#0.9643;INTESTINAL EPITHELIAL CELL#0.9641;VASCULAR CELL#0.9640;APICAL JUNCTION#0.9638;LUMINAL#0.9638;CAVEOLAE#0.9636;CEREBRAL ISCHEMIA#0.9635;CELL PERIPHERY#0.9634;LEUKOCYTE#0.9626;TARGET OF RAPAMYCIN#0.9626;ENDOTHELIAL CELL#0.9625;TRANSMISSION ELECTRON MICROSCOPY#0.9624;MICROVASCULAR ENDOTHELIAL CELL#0.9624;PRO-INFLAMMATORY#0.9623;ISCHEMIA#0.9620;GROWTH FACTOR#0.9620;CELL DIFFERENTIATION#0.9618;MACROPHAGE#0.9615;PIGMENT EPITHELIAL CELL#0.9615;DIABETIC RETINOPATHY#0.9615;REACTIVE OXYGEN SPECIES#0.9611;SUPEROXIDE DISMUTASE#0.9608;EPITHELIAL BARRIER FUNCTION#0.9607;APOPTOSIS#0.9607;HIGH FAT DIET#0.9607;EPITHELIAL MESENCHYMAL TRANSITION#0.9606;CROHN'S DISEASE#0.9604;SALIVARY GLAND#0.9604;MEMBRANE FRACTION#0.9603;ISCHEMIA REPERFUSION INJURY#0.9599;MAPK SIGNALING#0.9597;D-LACTIC ACID#0.9596;DEXTRAN SULFATE SODIUM#0.9592;DIARRHEA#0.9591;COLORECTAL#0.9591;IRRITABLE BOWEL SYNDROME#0.9590;ULCERATIVE COLITIS#0.9590;RAPAMYCIN#0.9589;WEIGHT LOSS#0.9585;INFLAMMATORY CELL#0.9582;STREPTOZOTOCIN#0.9580;BREAST CANCER CELL#0.9578;MULTIPLE SCLEROSIS#0.9573;FLUORESCEIN#0.9572;CEREBRAL ARTERY OCCLUSION#0.9571;TUMOR NECROSIS FACTOR#0.9569;WEIGHT GAIN#0.9568;STEM CELL#0.9566;CELL CYCLE#0.9560;BASAL CELL#0.9559;CELL DEATH#0.9556;SPERMATOGENESIS#0.9553;LIVER DISEASE#0.9552;EPITHELIAL CELL#0.9549;MESENTERIC LYMPH NODE#0.9548;EDEMA#0.9548;MIDDLE CEREBRAL ARTERY#0.9548;CEREBRAL ARTERY#0.9547;ADVANCED GLYCATION END#0.9544;KINASE ACTIVITY#0.9544;ALZHEIMER'S DISEASE#0.9543;TRAUMATIC BRAIN INJURY#0.9537;MEMBRANE MICRODOMAIN#0.9534;PARENCHYMA#0.9534;HEMORRHAGE#0.9534;GASTROINTESTINAL TRACT#0.9523;TUMOUR NECROSIS FACTOR#0.9517;TOXICITY#0.9510;SIGNALING PATHWAY#0.9505;TESTOSTERONE#0.9501;DEXTRAN SODIUM SULFATE#0.9499;GLUTAMINE#0.9492;HYPOXIA INDUCIBLE FACTOR#0.9491;IMMUNE CELL#0.9485;ALLERGEN#0.9484;BLOOD BRAIN BARRIER#0.9480;EOSIN#0.9479;INFLAMMATORY BOWEL DISEASE#0.9476;GLUCOCORTICOID RECEPTOR#0.9476;ARTERY#0.9470;RETINAL PIGMENT EPITHELIUM#0.9468;CENTRAL NERVOUS SYSTEM#0.9464;IMMUNE SYSTEM#0.9461;INFLAMMATORY RESPONSE#0.9456;PROTEIN KINASE A#0.9456;IMMUNE RESPONSE#0.9456;PROTEIN LOCALIZATION#0.9455;MICROVILLI#0.9455;AUTOPHAGY#0.9453;CELL GROWTH#0.9450;NERVOUS SYSTEM#0.9448;DISEASE ACTIVITY INDEX#0.9444;PANCREATITIS#0.9441;ALANINE#0.9439;RECEPTOR ANTAGONIST#0.9414;BRAIN DAMAGE#0.9413;LUNG CANCER#0.9410;MELATONIN#0.9396;RETINOIC ACID#0.9388;ENDOSOME#0.9383;RETINAL PIGMENT EPITHELIAL CELLS#0.9376;FATTY LIVER#0.9369;IMMUNOGLOBULIN G#0.9365;SIGNALLING PATHWAY#0.9365;ACUTE LUNG INJURY#0.9362;OVARIAN#0.9361;HEMORRHAGIC#0.9359;SPERMATOCYTES#0.9346;MECHANISM OF ACTION#0.9344;ENDOPLASMIC RETICULUM#0.9342;HEPATOCELLULAR CARCINOMA#0.9335;ESTROGEN RECEPTOR#0.9320;AIRWAY EPITHELIUM#0.9317;CLEAVED CASPASE 3#0.9313;PROTEIN DEGRADATION#0.9309;TUMOR CELLS#0.9305;ARGININE#0.9304;CHOROID PLEXUS#0.9303;CELLULAR LOCALIZATION#0.9300;FATTY LIVER DISEASE#0.9255;COLORECTAL CANCER#0.9238;AVERAGE DAILY GAIN#0.9227;PERIPHERAL BLOOD#0.9226;HUMAN NASAL EPITHELIAL#0.9221;MYELOPEROXIDASE ACTIVITY#0.9213;INSULIN-LIKE GROWTH FACTOR#0.9210;PROGESTERONE#0.9205;BRONCHIAL EPITHELIAL CELLS#0.9205;FACTOR I#0.9203;HUMAN AIRWAY EPITHELIAL#0.9198;ADENOSINE#0.9196;DENDRITIC CELL#0.9178;EPIDIDYMIS#0.9177;WATER CHANNEL#0.9172;ACID PHOSPHATASE#0.9163;HYPERGLYCEMIA#0.9149;GENISTEIN#0.9134;TRANSEPITHELIAL ELECTRIC RESISTANCE#0.9134;VASCULAR ENDOTHELIUM#0.9131;HUMAN CORNEAL EPITHELIAL#0.9113;HISTONE DEACETYLASE#0.9110;HUMAN BRONCHIAL EPITHELIAL#0.9101;REGENERATION#0.9100;NEUROPROTECTION#0.9081;INTESTINAL DAMAGE#0.9067;ASPARTATE#0.9036;ATPASE ACTIVITY#0.9032;PULMONARY EDEMA#0.8985;VIRULENCE#0.8967;72-HOURS#0.8936;DIABETES MELLITUS#0.8925;BASAL ECTOPLASMIC SPECIALIZATION#0.8921;L-ARGININE#0.8909;UBIQUITIN#0.8908;17β-ESTRADIOL#0.8907;SERUM ALBUMIN#0.8905;CELIAC DISEASE#0.8890;MAPK ACTIVATION#0.8879;ZONULA ADHERENS#0.8873;RNA INTERFERENCE#0.8868;QUANTITATIVE REVERSE TRANSCRIPTION#0.8864;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8862;BONE MARROW#0.8850;RESVERATROL#0.8826;SPINAL CORD INJURY#0.8804;TUMOR SUPPRESSOR#0.8791;TUBE FORMATION#0.8771;LIVER DAMAGE#0.8765;MECHANISMS OF ACTION#0.8752;FILAMENTOUS ACTIN#0.8739;MITOCHONDRIA#0.8738;SWELLING#0.8737;BRAIN ISCHEMIA#0.8729;INFERTILITY#0.8713;PROTEIN PHOSPHATASE 2A#0.8703;PHOSPHATASE 2A#0.8700;HYPERSENSITIVITY#0.8697;NORMAL CONTROL GROUP#0.8688;FATTY ACID BINDING#0.8674;TRANSFORMING GROWTH FACTOR BETA#0.8671;HUMAN BREAST CANCER#0.8646;SIGNAL TRANSDUCER#0.8639;CHOLESTASIS#0.8637;OXYGENASE#0.8635;TRYPTOPHAN#0.8626;OBESE#0.8625;BODY WEIGHT GAIN#0.8599;PROTEASOME#0.8593;MORPHOGENESIS#0.8583;MAMMARY EPITHELIAL CELL#0.8559;INTESTINAL TRACT#0.8558;TRADITIONAL CHINESE MEDICINE#0.8551;HISTAMINE#0.8549;ANCHORING#0.8536;PKC ACTIVITY#0.8525;SIGNALING CASCADE#0.8524;RETINAL VASCULAR PERMEABILITY#0.8513;TRANSFERRIN RECEPTOR#0.8512;MESENCHYMAL STEM CELL#0.8507;ROS GENERATION#0.8504;STRIATUM#0.8498;HEPATOCYTE GROWTH FACTOR#0.8497;APICAL JUNCTIONAL COMPLEX#0.8488;BODY WEIGHT LOSS#0.8487;GASTRIC MUCOSA#0.8482;ADIPOSE TISSUE#0.8475;BERBERINE#0.8471;DIGESTION#0.8467;ALCOHOLIC FATTY LIVER#0.8459;TRANSMISSION ELECTRON MICROSCOPE#0.8455;AKT SIGNALING#0.8455;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8446;INTESTINAL DISEASE#0.8426;SCIATIC NERVE#0.8412;COLON CANCER#0.8404;HEPATOMA CELLS#0.8393;SUBMANDIBULAR GLAND#0.8392;DAILY FEED INTAKE#0.8391;NASAL MUCOSA#0.8390;PSORIASIS#0.8362;FOLLICLE STIMULATING HORMONE#0.8355;GRANULOSA CELL#0.8343;PERIPHERAL NERVE#0.8336;HIGH MOBILITY GROUP#0.8319;HEME OXYGENASE 1#0.8313;STROMAL CELL#0.8306;PKC ACTIVATION#0.8301;FRUCTOSE#0.8300;HYPERTENSION#0.8273;BICELLULAR TIGHT JUNCTION#0.8254;GM6001#0.8234;ACINAR CELL#0.8229;CELL ACTIVATION#0.8208;PHOSPHATASE ACTIVITY#0.8201;ATOPIC DERMATITIS#0.8197;EPITHELIAL CELL APOPTOSIS#0.8188;ACETIC ACID#0.8184;QUERCETIN#0.8176;MAMMARY GLAND#0.8172;RECEPTOR AGONIST#0.8154;MAGNETIC RESONANCE IMAGING#0.8149;SEVERE ACUTE PANCREATITIS#0.8120;TIGHT JUNCTION DISASSEMBLY#0.8116;CELL MOTILITY#0.8110;ENCEPHALOMYELITIS#0.8083;ION TRANSPORT#0.8071;PROTEIN KINASE B#0.8061;INTESTINAL DEVELOPMENT#0.8045;SCANNING ELECTRON MICROSCOPY#0.8037;CEREBRAL INFARCTION#0.8006;PROGENITOR CELL#0.8004;MRNA TRANSCRIPTION#0.8000;LUBIPROSTONE#0.8000;TYPE 2 DIABETES#0.7998;NECROTIZING#0.7997;INFLAMMATORY CELL INFILTRATION#0.7993;VITAMIN D RECEPTOR#0.7965;BRAIN GLIOMA#0.7954;ENDOTHELIAL NITRIC OXIDE#0.7953;DIAMINE OXIDASE ACTIVITY#0.7951;CHLORIDE CHANNEL#0.7941;EPITHELIAL TISSUES#0.7930;EARLY ENDOSOME#0.7923;PROTEIN SYNTHESIS#0.7920;APICAL ES#0.7919;CELLULAR MEMBRANE#0.7908;DERMATITIS#0.7904;SPHINGOSINE 1 PHOSPHATE#0.7898;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7885;CYTOCHROME C#0.7873;L-ARG#0.7866;LIPID METABOLISM#0.7865;POST-TRANSLATIONAL MODIFICATION#0.7861;CYTOKINE PRODUCTION#0.7860;GESTATION#0.7849;PERIPHERAL MEMBRANE PROTEIN#0.7840;EXCRETION#0.7838;HYPERPHOSPHORYLATION#0.7827;NEURONAL CELL DEATH#0.7817;METALLOPROTEINASE INHIBITOR#0.7793;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7790;LATERAL PLASMA MEMBRANE#0.7784;MITOCHONDRIAL MEMBRANE#0.7763;SKIN DISEASE#0.7739;MALE INFERTILITY#0.7736;FEED CONVERSION RATIO#0.7735;MESENCHYMAL EPITHELIAL TRANSITION#0.7732;NEUROLOGICAL DISORDER#0.7726;STEM CELL MARKER#0.7720;T LYMPHOCYTE#0.7720;ISOFLURANE#0.7712;CYSTIC FIBROSIS#0.7711;NASAL EPITHELIUM#0.7703;TOPICAL#0.7699;HYDROCORTISONE#0.7691;UTERUS#0.7678;METFORMIN#0.7655;CORTISOL#0.7648;COLON CARCINOMA#0.7618;OUABAIN#0.7585;COMPLEX I#0.7581;TROPHECTODERM#0.7578;PANCREATIC CANCER#0.7574;GLYCOGEN SYNTHASE KINASE#0.7542;MESENCHYMAL CELL#0.7541;LUNG EPITHELIAL CELL#0.7537;LUNG DISEASE#0.7531;TIGHT JUNCTION ORGANIZATION#0.7530;BLASTOCYST FORMATION#0.7526;LATE ENDOSOME#0.7522;OBSTRUCTIVE JAUNDICE#0.7511;SKELETAL MUSCLE#0.7502;DEMENTIA#0.7497;EARLY BRAIN INJURY#0.7486;LUNG CARCINOMA#0.7454;L-CYSTEINE#0.7433;MACULAR DEGENERATION#0.7426;TH17 CELL#0.7420;ENDOPLASMIC RETICULUM STRESS#0.7417;INHIBIN#0.7415;PROTEIN TYROSINE PHOSPHATASE#0.7405;CATENIN COMPLEX#0.7396;CELL DIVISION#0.7396;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7390;PROTEIN PROTEIN INTERACTION#0.7384;BASAL ES#0.7383;PEROXISOME#0.7381;ORAL MUCOSA#0.7380;KIDNEY DISEASE#0.7378;LACTATION#0.7374;FIBROBLAST GROWTH FACTOR#0.7373;INTRACELLULAR LOCALIZATION#0.7366;GASTRIC TISSUE#0.7358;ASPARTIC ACID#0.7344;CLOSTRIDIUM PERFRINGENS ENTEROTOXIN#0.7321;EXOSOME#0.7314;SPHINGOSINE#0.7303;HIGH DENSITY LIPOPROTEIN#0.7279;CLATHRIN-MEDIATED ENDOCYTOSIS#0.7263;KERATINOCYTE DIFFERENTIATION#0.7263;CELL POLARIZATION#0.7262;ENDOCYTIC VESICLE#0.7253;ENZYME ACTIVITY#0.7247;ACUTE ISCHEMIC STROKE#0.7232;ACTOMYOSIN#0.7226;SPERMATOGENIC CELLS#0.7218;AGE RELATED MACULAR DEGENERATION#0.7211;NEUROTOXIC#0.7207;N-ACETYLCYSTEINE#0.7198;ASPIRIN#0.7197;CHRONIC HEPATITIS C#0.7188;BASAL GANGLIA#0.7188;TISSUE DAMAGE#0.7182;HUMAN IMMUNODEFICIENCY VIRUS#0.7162;OF DIABETIC RATS#0.7160;TYROSINE KINASE INHIBITOR#0.7157;VITAMIN C#0.7135;METHIONINE#0.7123;MYELOID CELL#0.7121;TOXICANT#0.7105;STROMA#0.7095;EOSINOPHIL#0.7093;LYSOZYME ACTIVITY#0.7087;FIBRINOGEN#0.7086;PARKINSON'S DISEASE#0.7073;VIRION#0.7072;BRAIN CORTEX#0.7065;APICAL ECTOPLASMIC SPECIALIZATION#0.7049;PLATELET-DERIVED GROWTH FACTOR#0.7038;SIMVASTATIN#0.7027;COLLAGENASE#0.7024;EICOSAPENTAENOIC ACID#0.6995;NONALCOHOLIC FATTY LIVER DISEASE#0.6977;LEUCINE#0.6965;IRINOTECAN#0.6957;MUTAGENESIS#0.6952;ATHEROSCLEROSIS#0.6951;BRAIN DEVELOPMENT#0.6951;LUNG ADENOCARCINOMA#0.6943;PHOSPHATASE INHIBITOR#0.6927;ANDROGEN RECEPTOR#0.6918;OOCYTE#0.6917;DOXYCYCLINE#0.6916;TROPISM#0.6904;DNA BINDING#0.6895;SENESCENCE#0.6881;BINDING PROTEIN 1#0.6878;CAROTID ARTERY#0.6853;LEPTOTENE#0.6838;WATER CHANNEL PROTEIN#0.6823;PORTAL VEIN#0.6818;ESOPHAGUS#0.6807;TRANSIENT RECEPTOR POTENTIAL#0.6804;LYSINE#0.6801;TUMOR TISSUES#0.6788;MAGUK#0.6778;MONONUCLEAR CELLS#0.6754;ACUTE LIVER FAILURE#0.6748;OVARIAN CANCER#0.6743;EPITHELIAL CELL PROLIFERATION#0.6741;CENTROSOME#0.6732;SKIN BARRIER FUNCTION#0.6724;CEREBROVASCULAR DISEASE#0.6722;MUCOSITIS#0.6717;NEUROEPITHELIAL CELL#0.6713;GENE SILENCING#0.6698;RESPIRATORY DISTRESS#0.6696;REPRODUCTIVE TOXICITY#0.6688;VIRAL INFECTION#0.6665;LYMPH NODE METASTASIS#0.6662;CORPUS LUTEUM#0.6657;ANCHORING JUNCTION#0.6618;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6599;VASCULAR DISEASE#0.6577;SELECTIN#0.6572;ADENINE#0.6572;DEATH RECEPTOR#0.6566;STRESS FIBRE#0.6552;ACTIN POLYMERIZATION#0.6550;VOCAL FOLD#0.6544;ADENOSINE MONOPHOSPHATE#0.6531;NEUTROPHIL MIGRATION#0.6523;VASCULAR DEMENTIA#0.6521;DUCTAL CELL#0.6494;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6488;INNER EAR#0.6476;VACUOLE#0.6447;RESPONSE TO CORTISOL#0.6441;LECTIN#0.6426;RELATED PROTEIN 1#0.6425;RESONANCE ENERGY TRANSFER#0.6420;DUAL LUCIFERASE REPORTER#0.6419;PROTEIN PHOSPHORYLATION#0.6419;DIABETIC MACULAR EDEMA#0.6411;ENTRY INTO HOST CELL#0.6408;ENTRY INTO HOST#0.6401;NEUROTOXICITY#0.6388;APICAL JUNCTION COMPLEX#0.6386;SENSITIZATION#0.6382;INNATE IMMUNITY#0.6379;FERMENTATION#0.6371;DRUG RESISTANCE#0.6369;EMODIN#0.6355;GLYCINE#0.6344;C REACTIVE PROTEIN#0.6341;BODY SURFACE AREA#0.6329;IMMUNOFLUORESCENCE CONFOCAL MICROSCOPY#0.6319;PHOSPHATE BUFFERED SALINE#0.6304;L-GLUTAMINE#0.6297;LIVER CIRRHOSIS#0.6288;GI TRACT#0.6273;INTESTINAL ABSORPTION#0.6270;EYE DISEASE#0.6270;ENDOTHELIAL CELL PROLIFERATION#0.6262;PROTEOGLYCAN#0.6261;TAUROCHOLATE#0.6258;ANDROGEN BINDING#0.6254;RESPONSE TO LPS#0.6248;DOMINANT NEGATIVE MUTANT#0.6245;EPITHELIAL SPECIFIC ANTIGEN#0.6231;GASTROENTERITIS#0.6215;COLON MUCOSA#0.6211;BREAST CARCINOMA#0.6189;PROPOFOL#0.6185;GASTRIC EPITHELIAL CELLS#0.6181;L-TRYPTOPHAN#0.6181;NEPHRON#0.6178;SURFACE EPITHELIUM#0.6175;INDOMETHACIN#0.6164;MEMBRANE ASSEMBLY#0.6152;MESOTHELIAL CELL#0.6122;RIBOSOMAL PROTEIN#0.6106;GLUCOSE TRANSPORT#0.6100;PROTEASE ACTIVITY#0.6098;MYELOID CELL LEUKEMIA#0.6096;MICROFILAMENT#0.6075;MACROPINOCYTOSIS#0.6070;EMBRYONIC STEM CELL#0.6060;CHRONIC KIDNEY DISEASE#0.6056;HUMAN CORNEAL EPITHELIUM#0.6056;CONTROLLED CORTICAL IMPACT#0.6052;ACETYLCYSTEINE#0.6047;ARTERIOLE#0.6046;FIBRIL#0.6038;NECROTIC#0.6027;P38 MAPK SIGNALING#0.6021
100506660	SISTER CHROMATID COHESION#0.7345;DNA REPLICATION#0.6648
100506668	INTERFERON STIMULATED GENE#0.9237;ANTIVIRAL RESPONSE#0.9207
100506696	CANCER CELL#1.0732;LUNG CANCER#1.0264;CELL PROLIFERATION#0.9650;CELL GROWTH#0.9005;PROSTATE CANCER#0.8695;APOPTOSIS#0.8235;ONCOGENIC#0.7514;ADJACENT NORMAL TISSUE#0.7424;LYMPH NODE METASTASIS#0.7355;LYMPH NODE#0.7304;QUANTITATIVE REAL TIME#0.6755;POLYMERASE CHAIN REACTION#0.6713;WOUND HEALING#0.6567;INTRAHEPATIC CHOLANGIOCARCINOMA#0.6154
100506742	ENHANCER BINDING PROTEIN#1.0358;ENHANCER BINDING#1.0356;TUDCA#1.0353;EUKARYOTIC INITIATION FACTOR#1.0318;CLEAVED CASPASE 3#1.0203;GLUCOSE REGULATED PROTEIN#1.0154;ACTIVATING TRANSCRIPTION FACTOR#1.0148;REVERSE TRANSCRIPTION#1.0129;CASPASE-3 ACTIVITY#1.0121;TRANSLATION INITIATION FACTOR#1.0119;BINDING PROTEIN 1#1.0109;TRANSLATION INITIATION#1.0084;B CELL#1.0058;B CELL LYMPHOMA#1.0034;ER STRESS RESPONSE#0.9999;ER STRESS-INDUCED APOPTOSIS#0.9995;POLYMERASE CHAIN REACTION#0.9964;TRANSCRIPTION FACTOR#0.9962;POLY ADP RIBOSE#0.9946;CYTOCHROME C RELEASE#0.9943;SUPEROXIDE DISMUTASE#0.9912;DNA FRAGMENTATION#0.9902;TUMOR NECROSIS FACTOR#0.9894;SPINAL CORD#0.9883;HEPATOCYTE APOPTOSIS#0.9866;ASPARTATE#0.9863;PROTEIN KINASE#0.9843;CARDIOMYOCYTE#0.9840;APOPTOSIS#0.9840;MYOCARDIUM#0.9839;CEREBRAL ISCHEMIA#0.9831;CYTOCHROME C#0.9816;GENE EXPRESSION#0.9794;CASPASE INHIBITOR#0.9771;AUTOPHAGY#0.9771;DEATH RECEPTOR#0.9769;RIBOSE#0.9769;APOPTOTIC#0.9757;PROTEIN STRUCTURE PREDICTION#0.9753;HYPOXIA#0.9751;INFLAMMATORY RESPONSE#0.9748;APOPTOSIS INDUCING FACTOR#0.9742;GLUTATHIONE#0.9740;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9722;APOPTOTIC CELL DEATH#0.9721;UNFOLDED PROTEIN RESPONSE#0.9721;EPITHELIAL CELL#0.9720;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9717;ENDOTHELIAL CELL#0.9701;ISCHEMIA REPERFUSION INJURY#0.9697;INDUCTION OF APOPTOSIS#0.9693;MITOCHONDRIAL MEMBRANE#0.9687;TAUROURSODEOXYCHOLIC ACID#0.9674;CELL PROLIFERATION#0.9674;SIGNALING PATHWAY#0.9669;CYTOTOXICITY#0.9666;MITOCHONDRIA#0.9659;ENDOPLASMIC RETICULUM#0.9655;NEUROTOXICITY#0.9650;TOXICITY#0.9648;CELL DEATH#0.9638;NEURONAL CELLS#0.9637;CANCER CELL#0.9622;CISPLATIN#0.9613;REACTIVE OXYGEN SPECIES#0.9595;ENDOPLASMIC RETICULUM STRESS#0.9587;CALPAIN ACTIVITY#0.9587;ARTERY#0.9586;ISCHEMIA#0.9579;GROWTH FACTOR#0.9569;MITOGEN ACTIVATED PROTEIN#0.9557;ALZHEIMER'S DISEASE#0.9551;CELL CYCLE#0.9524;NITRIC OXIDE#0.9506;QUANTITATIVE REAL TIME#0.9494;MIDDLE CEREBRAL ARTERY#0.9486;ACTIVE CASPASE 3#0.9485;CEREBRAL ARTERY#0.9484;NEURODEGENERATIVE DISEASE#0.9483;NEURONAL CELL DEATH#0.9463;TRANSMISSION ELECTRON MICROSCOPY#0.9461;CYTOPLASM#0.9453;PRO-INFLAMMATORY#0.9442;MYOCARDIAL INFARCTION#0.9430;SPINAL CORD INJURY#0.9424;RNA INTERFERENCE#0.9423;ASTROCYTE#0.9405;CASPASE ACTIVATION#0.9395;NEUROPROTECTION#0.9375;EOSIN#0.9360;IMMUNE RESPONSE#0.9324;CEREBRAL ARTERY OCCLUSION#0.9315;MACROPHAGE#0.9279;OLIGODENDROCYTE#0.9262;T CELL#0.9240;NERVOUS SYSTEM#0.9234;PROTEASOME#0.9228;HEAT SHOCK PROTEIN#0.9191;ROS GENERATION#0.9176;ETHANOL#0.9156;BETA CELL#0.9130;BREAST CANCER#0.9108;NEUROBLASTOMA#0.9089;PODOCYTE APOPTOSIS#0.9087;SIGNALING MOLECULE#0.9085;PARKINSON'S DISEASE#0.9084;STREPTOZOTOCIN#0.9061;UBIQUITIN#0.8961;BREAST CANCER CELL#0.8941;APOPTOSIS SIGNALING#0.8924;PROGRAMMED CELL DEATH#0.8806;MORRIS WATER MAZE#0.8799;CELL CYCLE ARREST#0.8752;PROTEIN SYNTHESIS#0.8697;PODOCYTE#0.8696;CARDIOMYOPATHY#0.8625;TUMOR CELLS#0.8608;N-ACETYLCYSTEINE#0.8608;BLOOD UREA NITROGEN#0.8550;ADENOSINE#0.8544;NORMAL CONTROL GROUP#0.8535;DIABETES MELLITUS#0.8534;CELL GROWTH#0.8529;NITRIC OXIDE SYNTHASE#0.8505;HEPATOCELLULAR CARCINOMA#0.8491;NADPH OXIDASE#0.8480;DOXORUBICIN#0.8432;CENTRAL NERVOUS SYSTEM#0.8426;ACTIVATED CASPASE 3#0.8421;NEURON APOPTOSIS#0.8412;MELATONIN#0.8394;OXYGEN GLUCOSE DEPRIVATION#0.8390;SHAM OPERATION GROUP#0.8389;LIVER DISEASE#0.8383;PROTEIN FOLDING#0.8380;CHONDROCYTE#0.8374;ER MEMBRANE#0.8294;OOCYTE#0.8236;ORGANELLE#0.8215;PROTEIN KINASE R#0.8214;CEREBRAL CORTEX#0.8211;MUSCLE CELL#0.8154;SMOOTH MUSCLE#0.8144;MYOCYTES#0.8086;GLUTATHIONE PEROXIDASE#0.8081;MYOBLAST#0.8072;OF DIABETIC RATS#0.8022;PROTEIN DISULFIDE ISOMERASE#0.8018;STEM CELL#0.8012;MITOCHONDRIAL DAMAGE#0.7971;AGEING#0.7897;ENZYME ACTIVITY#0.7877;SKELETAL MUSCLE#0.7871;RETINAL DEGENERATION#0.7867;PROPIDIUM#0.7862;SMOOTH MUSCLE CELL#0.7852;NEUROTOXIC#0.7794;SARCOPLASMIC RETICULUM#0.7793;LUNG CANCER#0.7789;ACETYLCYSTEINE#0.7769;GERM CELL#0.7762;CAMKII#0.7747;SIGNALLING PATHWAY#0.7718;RETINAL PIGMENT EPITHELIAL#0.7697;AKT SIGNALING#0.7541;RAPAMYCIN#0.7473;TRADITIONAL CHINESE MEDICINE#0.7394;APOPTOTIC PROCESS#0.7393;CORONARY ARTERY#0.7338;RESVERATROL#0.7337;CERVICAL CANCER#0.7310;SIGNAL TRANSDUCTION#0.7286;MITOCHONDRIAL PERMEABILITY TRANSITION#0.7284;TRAUMATIC BRAIN INJURY#0.7246;PULMONARY ARTERY#0.7233;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7220;HUMAN UMBILICAL VEIN#0.7216;SIGNALING CASCADE#0.7214;UMBILICAL VEIN#0.7213;LEFT ANTERIOR DESCENDING#0.7181;BONE MARROW#0.7151;AMYOTROPHIC LATERAL SCLEROSIS#0.7135;LATERAL SCLEROSIS#0.7134;HEART DISEASE#0.7118;DOPAMINERGIC NEURON#0.7107;TYPE 2 DIABETES#0.7105;PLASMA MEMBRANE#0.7053;CASPASE ACTIVITY#0.7046;ANTI APOPTOSIS#0.7046;OLIGODENDROCYTE APOPTOSIS#0.7044;FOCAL CEREBRAL ISCHEMIA#0.7039;ALANINE#0.6996;MALARIA#0.6988;HIGH FAT DIET#0.6974;QUANTITATIVE REVERSE TRANSCRIPTION#0.6936;NEURAL CELL#0.6934;NEUROLOGICAL DEFICIT SCORE#0.6918;DEPHOSPHORYLATION#0.6910;CASPASE-8 ACTIVITY#0.6878;MECHANISM OF ACTION#0.6870;HEME OXYGENASE 1#0.6850;EPITHELIAL CELL APOPTOSIS#0.6839;LYSOSOME#0.6822;PERMEABILITY TRANSITION PORE#0.6793;PRION DISEASE#0.6789;IFN-GAMMA#0.6772;L-CYSTEINE#0.6754;NEPHROTOXICITY#0.6729;CREATINE KINASE#0.6728;FATTY LIVER#0.6722;INDUCIBLE NITRIC OXIDE#0.6713;KIDNEY DISEASE#0.6700;ENDOTHELIAL GROWTH FACTOR#0.6680;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6680;CASPASE-9 ACTIVITY#0.6679;ACUTE KIDNEY INJURY#0.6640;FLOW CYTOMETRY ASSAY#0.6637;HYPOXIC#0.6636;OVARIAN#0.6621;HYPERTENSION#0.6606;MEMORY IMPAIRMENT#0.6596;CERVICAL#0.6560;ESTROGEN RECEPTOR#0.6533;PROTEIN KINASE C#0.6532;STEROL REGULATORY ELEMENT#0.6473;MAPK SIGNALING#0.6454;LIVER DAMAGE#0.6447;NEUROLOGICAL DISORDER#0.6443;ER LUMEN#0.6443;INNATE IMMUNE RESPONSE#0.6441;HYPERGLYCEMIA#0.6425;NEONATAL RAT CARDIOMYOCYTES#0.6406;ADIPOCYTE#0.6405;COLORECTAL CANCER#0.6399;APOPTOTIC SIGNALING PATHWAY#0.6367;RETINAL PIGMENT EPITHELIAL CELLS#0.6338;PIGMENT EPITHELIAL CELL#0.6328;ALVEOLAR EPITHELIAL CELL#0.6310;NEPHROPATHY#0.6298;ATORVASTATIN#0.6293;CEREBRAL INFARCTION#0.6289;DIABETIC NEPHROPATHY#0.6263;BIOTIN#0.6248;OXYGENASE#0.6239;TRANSFORMING GROWTH FACTOR#0.6219;TRANSMISSION ELECTRON MICROSCOPE#0.6187;SWELLING#0.6148;GLIAL CELL#0.6099;TRANSCRIPTASE#0.6045;REGENERATION#0.6038;ENDOTHELIAL CELL APOPTOSIS#0.6026;TUBULAR EPITHELIAL CELL#0.6023;BACTERIAL SEPSIS#0.6018
100506776	CELL PROLIFERATION#0.8960
100506779	INFLUENZA A VIRUS#0.6906
100506783	CELL CYCLE#0.7437
100506834	BREAST CANCER#1.1796
100506866	CELL PROLIFERATION#1.0147;LUNG ADENOCARCINOMA#0.9924;EPITHELIAL MESENCHYMAL TRANSITION#0.8726;COLORECTAL CANCER#0.8414;ADENOCARCINOMA#0.7911;APOPTOSIS#0.7855;CELL MIGRATION#0.7415;CANCER CELL#0.7366;POLYMERASE CHAIN REACTION#0.6783;DUAL LUCIFERASE REPORTER#0.6750;ANTISENSE RNA#0.6744;CERVICAL CANCER#0.6701;SQUAMOUS CELL CARCINOMA#0.6642;BREAST CANCER#0.6606;COLORECTAL#0.6410;DRUG RESISTANCE#0.6051;OVARIAN CANCER#0.6039;PROSTATE CANCER#0.6018
100506881	HEPATOCELLULAR CARCINOMA#1.1843
100506897	CHOLESTEROL METABOLISM#0.9158;INFLAMMATORY RESPONSE#0.8993;MACROPHAGE#0.6424
100506898	DNA METHYLATION#1.1878
100507027	SKELETAL MUSCLE#0.9410;LYMPH NODE#0.7230;CELL DIFFERENTIATION#0.6466;SIGNALING PATHWAY#0.6413;SARCOPLASMIC RETICULUM#0.6341;MUSCLE CELL DIFFERENTIATION#0.6101;GENE EXPRESSION#0.6035
100507043	NEURAL CELL#0.6711;SODIUM CHANNEL#0.6597;BLASTOMERE#0.6076
100507056	ADJACENT NORMAL TISSUE#1.0877;HEPATOCELLULAR CARCINOMA#1.0818;ONCOGENIC#1.0709;COLON CANCER#1.0685;CANCER CELL#1.0658;CELL PROLIFERATION#1.0637;APOPTOSIS#1.0527;LYMPH NODE#1.0483;CELL CYCLE#1.0364;COLORECTAL CANCER#1.0298;COLORECTAL#1.0229;CERVICAL CANCER#1.0171;POLYMERASE CHAIN REACTION#0.9933;QUANTITATIVE REAL TIME#0.9757;LYMPH NODE METASTASIS#0.9678;SIGNALING PATHWAY#0.9401;REVERSE TRANSCRIPTION#0.9337;OVARIAN CANCER#0.9238;BREAST CANCER#0.9182;CELL MIGRATION#0.8954;SQUAMOUS CELL CARCINOMA#0.8794;CELL GROWTH#0.8780;ADENOCARCINOMA#0.8720;CERVICAL#0.8659;ACUTE MYELOID LEUKEMIA#0.8550;MYELOID LEUKEMIA#0.8534;ENDOMETRIAL CARCINOMA#0.8240;LUNG CANCER#0.8160;PROSTATE CANCER#0.8102;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7729;EPITHELIAL TO MESENCHYMAL#0.7725;OVARIAN#0.7644;CELL COUNTING KIT#0.7614;AKT SIGNALING#0.7578;PROTEIN KINASE#0.7508;STEM CELL#0.7486;TRANSCRIPTION FACTOR#0.7315;EPITHELIAL MESENCHYMAL TRANSITION#0.7199;TUMOR TISSUES#0.7049;ORAL SQUAMOUS CELL CARCINOMA#0.6939;HEPATOCELLULAR CARCINOMA CELL#0.6922;QUANTITATIVE REVERSE TRANSCRIPTION#0.6647;WOUND HEALING#0.6613;G1 PHASE#0.6396;EPITHELIAL CELL#0.6335;TUMOR SUPPRESSOR#0.6294;CIGARETTE SMOKE EXTRACT#0.6233;TUMOR NODE METASTASIS#0.6188;5 FLUOROURACIL#0.6084;ZINC FINGER PROTEIN#0.6077;LUNG ADENOCARCINOMA#0.6077;COLONY FORMATION ASSAY#0.6067;CYCLIN DEPENDENT KINASE#0.6051;GENE EXPRESSION#0.6040
100507057	COLORECTAL CANCER#0.7558;DUAL LUCIFERASE REPORTER#0.7277;EXTRACELLULAR MATRIX#0.7130;INFLAMMATORY RESPONSE#0.7124;CELL PROLIFERATION#0.7091
100507086	CERVICAL CANCER#0.8083;CANCER CELL#0.7951
100507098	CANCER CELL#0.9308;CELL PROLIFERATION#0.8853;DUAL LUCIFERASE REPORTER#0.7293;APOPTOSIS#0.6655;ANTISENSE RNA#0.6567;TUMOR SUPPRESSOR#0.6397;BREAST CANCER#0.6370
100507246	CANCER CELL#1.1019;SMALL NUCLEOLAR RNA#1.0969;DUAL LUCIFERASE REPORTER#1.0836;CELL PROLIFERATION#1.0739;APOPTOSIS#1.0642;HEPATOCELLULAR CARCINOMA#1.0489;CELL CYCLE#1.0068;QUANTITATIVE REAL TIME#1.0047;ONCOGENIC#0.9860;POLYMERASE CHAIN REACTION#0.9229;TUMOR TISSUES#0.9222;CELL GROWTH#0.9106;COLORECTAL CANCER#0.9078;CELL MIGRATION#0.9051;SIGNALING PATHWAY#0.9032;LUNG CANCER#0.8662;REPORTER GENE ASSAY#0.8333;COLORECTAL#0.8166;LYMPH NODE#0.8034;NEUROBLASTOMA#0.7886;PANCREATIC CANCER#0.7807;EPITHELIAL MESENCHYMAL TRANSITION#0.7715;DISEASE FREE SURVIVAL#0.7665;CERVICAL CANCER#0.7557;LYMPH NODE METASTASIS#0.7457;CELL COUNTING KIT#0.6744;WOUND HEALING#0.6453;LIPID METABOLISM#0.6150;BREAST CANCER#0.6090;SQUAMOUS CELL CARCINOMA#0.6074;SORAFENIB#0.6028
100507249	PROSTATE CANCER#0.7558;BLAST CELL#0.7314;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7210;MONONUCLEAR CELLS#0.7137;BONE MARROW#0.7108;PERIPHERAL BLOOD#0.7103;BREAST CANCER#0.7099;CANCER CELL#0.7084
100507308	DEMETHYLATION#0.7641
100507316	CELL PROLIFERATION#1.0915;HEPATOCELLULAR CARCINOMA#1.0031;CELL CYCLE#0.8549;LUNG CANCER#0.7533;GALLBLADDER CANCER#0.7011;APOPTOSIS#0.6917;CELL CYCLE ARREST#0.6217
100507347	EPITHELIAL MESENCHYMAL TRANSITION#0.7603;ANTISENSE RNA#0.7326;COLORECTAL CANCER#0.7145;GENE EXPRESSION#0.7072;WOUND HEALING#0.6271
100507392	SMOOTH MUSCLE#0.9932;ENDOTHELIAL CELL#0.9902;SMOOTH MUSCLE CELL#0.9203;MUSCLE CELL#0.9195;CORONARY ARTERY#0.6888;CELL MIGRATION#0.6746;VASCULAR CELL#0.6209;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6201;HUMAN UMBILICAL VEIN#0.6192;UMBILICAL VEIN#0.6189;REVERSE TRANSCRIPTION#0.6131
100507410	HEPATOCELLULAR CARCINOMA#1.1501;SIGNALING PATHWAY#1.1440;DUAL LUCIFERASE REPORTER#0.9146;REPORTER GENE ASSAY#0.9137;CELL PROLIFERATION#0.8960;APOPTOSIS#0.6741
100507436	ANTIGEN PROCESSING MACHINERY#1.0458;ANKYLOSING SPONDYLITIS#1.0389;CERVICAL CANCER#1.0369;ANTIGEN PROCESSING#1.0298;ANTIGEN PRESENTATION#1.0298;HEPATITIS C#1.0224;CERVICAL#1.0220;EPITHELIAL CELL#1.0213;ENDOTHELIAL CELL#1.0195;MONOCYTE#1.0189;HEPATOCELLULAR CARCINOMA#1.0160;SQUAMOUS CELL CARCINOMA#1.0141;CHRONIC HEPATITIS C#1.0098;TRANSCRIPTION FACTOR#1.0042;BETA-2#1.0019;HEPATITIS B#1.0009;OVARIAN#1.0008;POLYMERASE CHAIN REACTION#1.0000;CELL ACTIVATION#0.9997;LUNG CANCER#0.9968;HEPATITIS C VIRUS#0.9964;IFN-GAMMA#0.9959;NK CELL MEDIATED CYTOTOXICITY#0.9956;CELL SURFACE#0.9925;CELIAC DISEASE#0.9911;IMMUNE EVASION#0.9911;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9891;CYTOTOXIC T CELL#0.9879;CYTOTOXIC T-LYMPHOCYTE#0.9867;MONONUCLEAR CELLS#0.9852;CYTOLYSIS#0.9844;T LYMPHOCYTE#0.9842;CYTOTOXICITY#0.9841;TUMOR CELLS#0.9831;CD8+ T CELL#0.9827;GROWTH FACTOR#0.9820;HISTONE DEACETYLASE#0.9820;CANCER CELL#0.9817;T CELL#0.9812;B CELL#0.9811;DENDRITIC CELL#0.9805;IMMUNE CELL#0.9799;MELANOMA CELL LINES#0.9783;LYSIS#0.9782;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9776;SEQUENCE SPECIFIC PRIMER#0.9774;CELL RECOGNITION#0.9762;NATURAL KILLER CELL#0.9756;RECEPTOR LIGAND#0.9748;PERIPHERAL BLOOD#0.9743;AUTOIMMUNE DISEASE#0.9742;BREAST CANCER#0.9740;HUMAN LEUKOCYTE ANTIGEN#0.9716;SPONDYLITIS#0.9714;TUMOR ANTIGEN#0.9684;IMMUNE SYSTEM#0.9676;LEUKOCYTE#0.9650;GENE EXPRESSION#0.9624;IMMUNE RESPONSE#0.9622;CELL KILLING#0.9609;LYMPH NODE#0.9601;NK CELL ACTIVATION#0.9600;VIRAL INFECTION#0.9596;RENAL CELL CARCINOMA#0.9569;BONE MARROW#0.9552;CD4+ T CELL#0.9551;APOPTOSIS#0.9549;TUMOR NECROSIS FACTOR#0.9527;OVARIAN CANCER#0.9514;UVEAL MELANOMA#0.9512;HEPATITIS B VIRUS#0.9510;STEM CELL#0.9447;TYPE 1 DIABETES#0.9403;SEQUENCE BASED TYPING#0.9343;ADDISON'S DISEASE#0.9275;MULTIPLE MYELOMA#0.9260;KIDNEY TRANSPLANT RECIPIENTS#0.9231;SIGNALING PATHWAY#0.9223;PSORIASIS#0.9199;TRANSFORMING GROWTH FACTOR#0.9103;PLASMA MEMBRANE#0.9071;KERATINOCYTE#0.9032;COLORECTAL#0.8986;INNATE IMMUNITY#0.8974;HEAT SHOCK PROTEIN#0.8971;CYTOKINE PRODUCTION#0.8961;ENDOPLASMIC RETICULUM#0.8959;DIABETES MELLITUS#0.8940;PLASMA CELL#0.8931;CELL PROLIFERATION#0.8922;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8919;LUPUS ERYTHEMATOSUS#0.8916;GAMMA DELTA T CELL#0.8885;MYELOID LEUKEMIA#0.8874;ANTIGEN PROCESSING AND PRESENTATION#0.8868;RETINOIC ACID#0.8849;HISTONE DEACETYLASE INHIBITOR#0.8746;DISEASE FREE SURVIVAL#0.8725;MACROPHAGE#0.8705;CHRONIC HEPATITIS B#0.8666;INNATE IMMUNE RESPONSE#0.8626;SEQUENCING BASED TYPING#0.8611;EXOSOME#0.8576;TUMOR ASSOCIATED ANTIGEN#0.8549;PROTEIN KINASE#0.8544;ACTIVATED T-CELLS#0.8499;ACTIVATED T CELL#0.8496;RHEUMATOID ARTHRITIS#0.8479;COLORECTAL CANCER#0.8466;OVARIAN CARCINOMA#0.8434;STATIONARY PHASE#0.8416;INNATE IMMUNE SYSTEM#0.8412;PSORIATIC ARTHRITIS#0.8405;ACUTE MYELOID LEUKEMIA#0.8381;PROSTATE CANCER#0.8379;CELL CYCLE#0.8328;EPSTEIN BARR VIRUS#0.8308;VALPROIC ACID#0.8263;HUMAN LEUCOCYTE ANTIGEN#0.8263;ADENOCARCINOMA#0.8261;T CELL ACTIVATION#0.8224;DONOR SPECIFIC ANTIBODIES#0.8184;OUTER MEMBRANE#0.8123;CELL DEATH#0.8108;NEUTROPHIL#0.8094;FORMALIN#0.8070;LECTIN#0.8062;STROMAL CELL#0.8058;IMMUNE SUPPRESSION#0.8049;ULCERATIVE COLITIS#0.7982;LEPROSY#0.7982;ANTIBODY MEDIATED REJECTION#0.7976;BREAST CARCINOMA#0.7966;PANCREATIC CANCER#0.7952;AUTOIMMUNITY#0.7947;T CELL PROLIFERATION#0.7929;GRAFT VERSUS HOST#0.7840;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7825;SIGNAL TRANSDUCTION#0.7735;CELL MEMBRANE#0.7724;SHORT TANDEM REPEAT#0.7668;HYPOXIA#0.7657;HEMATOPOIETIC STEM CELL#0.7648;MULTIPLE MYELOMA CELLS#0.7643;CELL SURFACE ANTIGEN#0.7634;INFLAMMATORY BOWEL DISEASE#0.7609;BREAST CANCER CELL#0.7559;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7539;TAKAYASU'S ARTERITIS#0.7532;HEAT SHOCK FACTOR#0.7513;COLITIS#0.7449;ORAL SQUAMOUS CELL CARCINOMA#0.7428;FLOW CYTOMETRY ANALYSIS#0.7411;SENSITIZATION#0.7376;METASTATIC MELANOMA#0.7364;ADAPTIVE IMMUNE RESPONSE#0.7356;CELL GROWTH#0.7293;STEM CELL TRANSPLANTATION#0.7234;PRO-INFLAMMATORY#0.7070;PERIPHERAL BLOOD LYMPHOCYTES#0.7018;BETA CELL#0.7015;CROHN'S DISEASE#0.7000;PROTEIN KINASE C#0.6988;COLON CANCER#0.6986;HEPATOCELLULAR CARCINOMA CELL#0.6970;PROTEASOME#0.6956;LYMPH NODE METASTASIS#0.6923;UVEITIS#0.6911;LIVER DISEASE#0.6905;TROPHOBLAST#0.6864;HEPATOMA CELLS#0.6859;APOPTOTIC#0.6720;REGULATORY T CELL#0.6720;ENDOTHELIAL GROWTH FACTOR#0.6645;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6645;ONCOGENIC#0.6607;HEAD AND NECK CANCER#0.6532;NECK CANCER#0.6531;BREAST CANCER PATIENTS#0.6487;LIVER CANCER#0.6457;TOLL LIKE RECEPTOR#0.6427;EPIDERMAL GROWTH FACTOR#0.6410;GROWTH FACTOR RECEPTOR#0.6410;NKT CELL#0.6315;GEMCITABINE#0.6299;CHRONIC CERVICITIS#0.6297;CYTOPLASM#0.6282;MAXILLARY SINUS SQUAMOUS CELL CARCINOMA#0.6195;LUNG CARCINOMA#0.6164;RNA INTERFERENCE#0.6143;CERVICAL CANCER CELL LINES#0.6137;NATURAL CYTOTOXICITY RECEPTOR#0.6123;GENOTOXIC#0.6096;GRANULOCYTE#0.6048;BINDING PROTEIN 1#0.6014;LYMPHOCYTE ANTIGEN#0.6002
100507488	BREAST CANCER#1.1796
100507500	CELL PROLIFERATION#0.8312;SQUAMOUS CELL CARCINOMA#0.6831;CELL CYCLE#0.6797;PLACENTA TISSUES#0.6787;LUNG CANCER#0.6234;CANCER CELL#0.6191
100507533	CELL PROLIFERATION#0.9416;ANTISENSE RNA#0.7844;APOPTOSIS#0.7635;CERVICAL CANCER#0.7008;CERVICAL#0.6723;WNT SIGNALING PATHWAY#0.6528;HEPATOCELLULAR CARCINOMA#0.6398;SIGNALING PATHWAY#0.6339
100507567	BREAST CANCER CELL#0.8018;BREAST CANCER#0.7966;CANCER CELL#0.7951;APOPTOSIS#0.6131
10051	CONDENSIN COMPLEX#1.0512;CHROMOSOME CONDENSATION#0.9805;CELL CYCLE#0.9788;MITOTIC CHROMOSOME#0.9594;CHROMATID#0.9353;MITOSIS#0.9326;SISTER CHROMATID COHESION#0.9156;GENE EXPRESSION#0.8224;DNA REPAIR#0.7972;COLORECTAL CANCER#0.7679;CHROMOSOME SEGREGATION#0.7579;HEPATOCELLULAR CARCINOMA#0.6904;INTERPHASE#0.6175
100526737	PARASPECKLES#0.6883;ALANINE#0.6459
100526790	T CELL#0.9005;TUBERCULIN SKIN TEST#0.8676;TUBERCULOSIS#0.8507
100526820	COLORECTAL#0.8485
100526823	T CELL#0.8823;TUBERCULIN SKIN TEST#0.7404
100527960	GTPASE ACTIVITY#1.2026;APOPTOSIS#0.8439
100527963	TRANSCRIPTION FACTOR#0.7694
100528023	EPILEPSY#0.7578;FOCAL EPILEPSY#0.6486
100528024	MENTAL RETARDATION#1.0960;WAGR SYNDROME#1.0820;ANIRIDIA#1.0703;FRASER SYNDROME#0.6694
100529141	CELL SURFACE#0.7533
10052	BIPOLAR CELL#1.0183;POLYMERASE CHAIN REACTION#1.0140;SMOOTH MUSCLE#1.0128;MYOCYTES#1.0081;CONNEXIN#1.0073;CARDIOMYOCYTE#1.0072;SMOOTH MUSCLE CELL#1.0028;REVERSE TRANSCRIPTION#0.9984;MUSCLE CELL#0.9966;GAP JUNCTION CHANNEL#0.9958;GAP JUNCTION#0.9924;GENE EXPRESSION#0.9922;ENDOTHELIAL CELL#0.9915;MYOCARDIUM#0.9910;ELECTRICAL SYNAPSE#0.9845;ACTION POTENTIAL#0.9809;STEM CELL#0.9791;CELL COMMUNICATION#0.9766;GROWTH FACTOR#0.9665;ARRHYTHMIA#0.9644;ENDOTHELIUM#0.9619;OOCYTE#0.9499;CONNEXON#0.9428;OLIGODENDROCYTE#0.9423;BLOOD VESSEL#0.9319;EMBRYONIC STEM CELL#0.9231;CARDIAC CONDUCTION#0.9163;ARTERY#0.9122;VASCULAR SMOOTH MUSCLE CELL#0.9116;AMACRINE CELL#0.9099;BLADDER SMOOTH MUSCLE#0.8966;TRANSCRIPTION FACTOR#0.8883;ARTERIOLE#0.8880;PROTEIN KINASE#0.8796;PLASMA MEMBRANE#0.8729;INTERCELLULAR CHANNEL#0.8670;OSTEOBLAST#0.8649;ASTROCYTE#0.8538;PROGENITOR CELL#0.8529;TRANSCRIPTASE#0.8506;INTERCALATED DISC#0.8304;HYPERTENSION#0.8298;ZONULA OCCLUDENS#0.8236;GAP JUNCTION COMMUNICATION#0.8189;MESENCHYMAL STEM CELL#0.8187;CARDIOVASCULAR SYSTEM#0.8178;ZONULA OCCLUDENS 1#0.8171;EMBRYONIC HEART#0.8137;GAP JUNCTION PLAQUE#0.8113;QUANTITATIVE REAL TIME#0.8004;SKELETAL MUSCLE#0.7936;ATRIAL FIBRILLATION#0.7911;CELL SURFACE#0.7820;EPITHELIAL CELL#0.7584;CYCLIC NUCLEOTIDE GATED#0.7553;HEART DISEASE#0.7484;NERVOUS SYSTEM#0.7452;CELL DIFFERENTIATION#0.7450;HEART DEVELOPMENT#0.7369;CELL PROLIFERATION#0.7327;ION CHANNEL#0.7277;CELL MEMBRANE#0.7130;TRANSFORMING GROWTH FACTOR#0.7037;ALKALINE PHOSPHATASE#0.7011;DETRUSOR SMOOTH MUSCLE#0.6970;NEONATAL RAT CARDIOMYOCYTES#0.6921;MESENCHYMAL CELL#0.6916;RIGHT ATRIUM#0.6608;MYOCARDIAL INFARCTION#0.6593;STROMAL CELL#0.6531;POTASSIUM CHANNEL#0.6498;MYOFIBROBLAST#0.6493;APOPTOSIS#0.6473;INTERCALATED DISK#0.6403;GRANULOSA CELL#0.6310;TIGHT JUNCTION#0.6301;FIBROBLAST GROWTH FACTOR#0.6264;BONE MARROW#0.6256;GLIAL CELL#0.6157;ACETYLCHOLINE#0.6100;PDZ BINDING MOTIF#0.6072;GANGLION CELLS#0.6005;BASILAR ARTERY#0.6002
100533619	CERVICAL CANCER#0.9827;CANCER CELL#0.8214;GENE EXPRESSION#0.7939;CERVICAL#0.7546
10053	EPITHELIAL CELL#1.0363;TRANS GOLGI NETWORK#0.8429;PLASMA MEMBRANE#0.8158;CLATHRIN ADAPTOR#0.7467;CYTOKINESIS#0.6689;ADAPTIN#0.6364
10054	SUMO ACTIVATING ENZYME#1.0879;SUMOYLATION#1.0283;CONJUGATION#1.0208;UBIQUITIN#1.0126;CANCER CELL#1.0009;UBIQUITIN ACTIVATING ENZYME#0.9206;CELL CYCLE#0.8747;COLORECTAL CANCER#0.8550;APOPTOSIS#0.7941;GENE EXPRESSION#0.7938;CELL PROLIFERATION#0.7866;IMPORTIN#0.7851;POST-TRANSLATIONAL MODIFICATION#0.7721;NUCLEAR IMPORT#0.7629;LUNG CANCER#0.7587;SIGNALING PATHWAY#0.7347;PROTEIN SUMOYLATION#0.7252;DNA REPAIR#0.6986;CELL DEATH#0.6972;TRANSCRIPTION FACTOR#0.6951;COLORECTAL#0.6885;LYSINE#0.6795;POLYMERASE CHAIN REACTION#0.6561;XERODERMA PIGMENTOSUM#0.6164;RNA BINDING PROTEIN#0.6073;RNA BINDING#0.6012
10055	SUMOYLATION#1.0418;SUMO ACTIVATING ENZYME#1.0127;UBIQUITIN#1.0054;CONJUGATION#0.9708;CELL CYCLE#0.7617;CANCER CELL#0.7531;PROTEIN SUMOYLATION#0.6380;GENE EXPRESSION#0.6255
10056	INTERSTITIAL LUNG DISEASE#0.6741;LUNG DISEASE#0.6663
10057	GEMCITABINE#1.0217;MULTIDRUG RESISTANCE PROTEIN#1.0100;BREAST CANCER#1.0082;ABC TRANSPORTER#1.0048;ATP BINDING CASSETTE TRANSPORTER#1.0009;ATP BINDING CASSETTE#0.9927;ORGANIC ANION TRANSPORTER#0.9924;CANCER CELL#0.9922;ENDOTHELIAL CELL#0.9919;ATP BINDING#0.9912;POLYMERASE CHAIN REACTION#0.9910;GENE EXPRESSION#0.9885;DRUG RESISTANCE#0.9855;GLUTATHIONE#0.9750;LUNG CANCER#0.9736;5 FLUOROURACIL#0.9600;TUMOR CELLS#0.9589;CISPLATIN#0.9574;CYTOTOXICITY#0.9527;PANCREATIC CANCER#0.9496;EFFLUX PUMP#0.9254;BLOOD BRAIN BARRIER#0.9186;STEM CELL#0.9079;DOXORUBICIN#0.9062;METHOTREXATE#0.8861;PLASMA MEMBRANE#0.8860;MUSCLE CELL#0.8813;TOXICITY#0.8773;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8694;EPITHELIAL CELL#0.8652;PHOSPHODIESTERASE#0.8643;FLUOROURACIL#0.8638;APOPTOSIS#0.8616;BREAST CANCER CELL#0.8564;PROBENECID#0.8483;FOLATE#0.8386;CELL PROLIFERATION#0.8249;QUANTITATIVE REAL TIME#0.8173;ERYTHROCYTE#0.8161;ARA-C#0.8123;COLORECTAL#0.8065;MULTI DRUG RESISTANCE#0.8033;ASTROCYTE#0.8028;PANCREATIC CARCINOMA#0.7995;COLORECTAL CANCER#0.7973;MYELOID LEUKEMIA#0.7887;PERIPHERAL BLOOD#0.7866;SMOOTH MUSCLE#0.7857;IRINOTECAN#0.7839;ACUTE MYELOID LEUKEMIA#0.7740;HUMAN EMBRYONIC KIDNEY#0.7538;EMBRYONIC KIDNEY#0.7533;EPILEPSY#0.7509;GUANOSINE#0.7470;SMOOTH MUSCLE CELL#0.7459;CELL MEMBRANE#0.7442;T CELL#0.7394;TRANSCRIPTASE#0.7262;HYALURONAN#0.7184;ADENOSINE#0.7156;RESPONSE TO GEMCITABINE#0.7141;MERCAPTOPURINE#0.7042;CGMP TRANSPORT#0.6999;GS-X PUMP#0.6735;ADENOSINE TRIPHOSPHATE#0.6673;TRANSCRIPTION FACTOR#0.6469;SILDENAFIL#0.6426;ADENINE#0.6388;TROPHOBLAST#0.6296;DRUG TRANSPORT#0.6294;PRIMARY ANGLE-CLOSURE GLAUCOMA#0.6281;DETOXIFICATION#0.6274;PRIMARY ANGLE CLOSURE#0.6260;ADENOCARCINOMA#0.6244;CYSTIC FIBROSIS#0.6234;OVARIAN CANCER#0.6214;ANGLE-CLOSURE GLAUCOMA#0.6208;GROWTH FACTOR#0.6159;REVERSE TRANSCRIPTION#0.6159
10058	MAJOR FACILITATOR SUPERFAMILY#1.0522;ACTIVE TRANSPORTER#1.0270;PEROXISOMAL MEMBRANE#1.0268;PEROXISOMAL#1.0221;MDR PROTEIN#1.0181;SULFONYLUREA RECEPTOR#1.0108;LIPID TRANSPORTER#1.0105;LIPID TRANSPORT#1.0101;MALTOSE#1.0100;DIGESTION#1.0076;MULTI DRUG RESISTANCE#1.0072;ION CHANNEL#1.0071;CYTOCHROME P450#1.0069;TRANSMEMBRANE TRANSPORTER#1.0060;PEPTIDE TRANSPORTER#1.0047;SPINAL CORD#1.0045;ABC TRANSPORTER#1.0019;EFFLUX PUMP#0.9980;CYSTIC FIBROSIS#0.9972;CYTOPLASMIC MEMBRANE#0.9960;ATP BINDING CASSETTE#0.9935;ATP BINDING#0.9933;BREAST CANCER#0.9930;DETOXIFICATION#0.9922;PROTEOGLYCAN#0.9921;ACUTE MYELOID LEUKEMIA#0.9910;MYELOID LEUKEMIA#0.9907;CELL MEMBRANE#0.9902;MULTIDRUG RESISTANCE PROTEIN#0.9896;MEMBRANE TRANSPORT#0.9891;ANTIGEN PROCESSING#0.9889;OVARIAN CANCER#0.9889;DNA REPAIR#0.9888;OUTER MEMBRANE#0.9888;SPINAL CORD INJURY#0.9876;CHOLESTEROL EFFLUX#0.9876;NUCLEOTIDE BINDING DOMAIN#0.9859;HEPATOCELLULAR CARCINOMA#0.9857;CHOLESTEROL TRANSPORTER#0.9854;TRANSPORTER ACTIVITY#0.9850;CHOLESTEROL TRANSPORT#0.9848;ADENOSINE#0.9845;REVERSE CHOLESTEROL TRANSPORT#0.9844;DRUG TRANSPORT#0.9841;BLOOD BRAIN BARRIER#0.9837;HUMAN BREAST CANCER#0.9832;MITOCHONDRIA#0.9830;CELLULAR MEMBRANE#0.9828;ATP HYDROLYSIS#0.9826;SCAVENGER RECEPTOR#0.9823;NUCLEOTIDE BINDING#0.9817;MITOXANTRONE#0.9815;ATP BINDING CASSETTE TRANSPORTER#0.9810;TUBERCULOSIS#0.9805;BREAST CANCER CELL#0.9795;PEROXISOME#0.9782;DRUG BINDING#0.9778;CELLULAR DETOXIFICATION#0.9770;GLYCINE#0.9767;EXCRETION#0.9764;CANCER STEM CELL#0.9763;TUMOR CELLS#0.9760;VIRULENCE#0.9759;QUANTITATIVE REAL TIME#0.9755;SIGNALING PATHWAY#0.9748;MACROPHAGE#0.9743;ENDOTHELIAL CELL#0.9743;DRUG RESISTANCE#0.9741;TRANSMEMBRANE TRANSPORT#0.9726;REVERSE TRANSCRIPTION#0.9716;VERAPAMIL#0.9715;GLUTATHIONE#0.9713;KINASE INHIBITOR#0.9711;CHOLESTEROL HOMEOSTASIS#0.9696;VACUOLE#0.9694;OVARIAN#0.9691;CANCER CELL#0.9689;LIVER X RECEPTOR#0.9689;POTASSIUM CHANNEL#0.9688;REGENERATION#0.9686;EPITHELIAL CELL#0.9681;CENTRAL NERVOUS SYSTEM#0.9668;STEM CELL#0.9665;ATHEROSCLEROSIS#0.9663;BONE MARROW#0.9659;CYTOPLASM#0.9658;ENDOPLASMIC RETICULUM#0.9654;CELL WALL#0.9649;PLASMA MEMBRANE#0.9648;GROWTH FACTOR#0.9647;NERVOUS SYSTEM#0.9643;TRANSCRIPTION FACTOR#0.9640;CELL CYCLE#0.9631;POLYMERASE CHAIN REACTION#0.9629;DOXORUBICIN#0.9625;HIGH DENSITY LIPOPROTEIN#0.9619;LUNG CANCER#0.9616;C TERMINAL DOMAIN#0.9611;GENE EXPRESSION#0.9610;CELL SURFACE#0.9609;CELL GROWTH#0.9600;ATPASE ACTIVITY#0.9596;PACLITAXEL#0.9592;PROTEIN KINASE#0.9583;TOXICITY#0.9582;TYROSINE KINASE INHIBITOR#0.9582;APOPTOSIS#0.9579;MECHANISM OF ACTION#0.9570;CISPLATIN#0.9568;SIGNAL TRANSDUCTION#0.9564;LIPID METABOLISM#0.9557;MUTAGENESIS#0.9555;SITOSTEROLEMIA#0.9548;CHONDROITIN SULFATE PROTEOGLYCAN#0.9529;CYTOTOXICITY#0.9526;GLIBENCLAMIDE#0.9508;ADENOSINE TRIPHOSPHATE#0.9502;PREGNANE X RECEPTOR#0.9499;REACTIVE OXYGEN SPECIES#0.9496;COLORECTAL#0.9484;MITOCHONDRIAL MEMBRANE#0.9483;COLORECTAL CANCER#0.9471;CELL PROLIFERATION#0.9467;ERYTHROCYTE#0.9465;LOW DENSITY LIPOPROTEIN#0.9462;RIBOSOME#0.9449;ADENYLATE KINASE#0.9438;DYSCHROMATOSIS UNIVERSALIS HEREDITARIA#0.9424;SMALL INTESTINE#0.9423;SIGNALING MOLECULE#0.9408;GLYCOSYLATION#0.9398;HISTIDINE#0.9394;FLUCONAZOLE#0.9391;APOPTOTIC#0.9357;CHANNEL ACTIVITY#0.9335;IVERMECTIN#0.9334;LYSOSOME#0.9331;CHLORIDE CHANNEL#0.9325;CELL DEATH#0.9316;ORGANELLE#0.9312;TOPOTECAN#0.9307;MEMBRANE FUSION#0.9283;DNA BINDING#0.9282;ATHEROSCLEROTIC#0.9281;DAUNORUBICIN#0.9276;MEDIATED DRUG RESISTANCE#0.9270;HYPOXIA#0.9253;GENETIC DISEASE#0.9239;ORGANIC ANION TRANSPORTER#0.9232;RED BLOOD CELL#0.9225;PROGENITOR CELL#0.9202;VINBLASTINE#0.9189;CHOLESTEROL METABOLISM#0.9163;IRINOTECAN#0.9161;RNA INTERFERENCE#0.9157;VINCRISTINE#0.9137;ANION CHANNEL#0.9130;AUXIN TRANSPORT#0.9127;IRON HOMEOSTASIS#0.9100;DRUG METABOLISM#0.9099;KINASE ACTIVITY#0.9086;STRUCTURE ACTIVITY RELATIONSHIP#0.9075;SIDEROPHORE#0.9056;OTHER ORGANISM#0.9041;METHOTREXATE#0.9041;ALZHEIMER'S DISEASE#0.9026;TIGHT JUNCTION#0.9020;LIPID HOMEOSTASIS#0.9007;T CELL#0.8996;MONOCYTE#0.8972;GROWTH FACTOR RECEPTOR#0.8955;LUMINAL#0.8945;SIGNAL PEPTIDE#0.8942;EXTRACELLULAR MATRIX#0.8917;CELL DIVISION#0.8917;PROTEIN SYNTHESIS#0.8893;LYSINE#0.8858;NUTRIENT UPTAKE#0.8849;ADENYLATE#0.8843;COMPLEX I#0.8829;CYCLOSPORIN A#0.8813;CELLULAR LOCALIZATION#0.8780;IMATINIB#0.8768;ADENINE#0.8758;IMMUNE RESPONSE#0.8756;STEROL REGULATORY ELEMENT#0.8743;MALARIA#0.8736;TRANSCRIPTASE#0.8732;EPIDERMAL GROWTH FACTOR#0.8725;ESTROGEN RECEPTOR#0.8723;SUPEROXIDE DISMUTASE#0.8718;MODE OF ACTION#0.8685;SUCROSE#0.8666;MALTOSE BINDING#0.8662;HOST CELL#0.8653;CATABOLISM#0.8645;NEURODEGENERATIVE DISEASE#0.8638;STEROL TRANSPORTER#0.8633;TRANSLATION INITIATION#0.8582;PROTEIN PROTEIN INTERACTION#0.8567;MALTOSE TRANSPORT#0.8550;SIDE-POPULATION CELL#0.8541;ASTROCYTE#0.8537;STARGARDT DISEASE#0.8505;RHODAMINE 6G#0.8464;ENDOCYTOSIS#0.8403;HYALURONIDASE#0.8369;VACUOLAR MEMBRANE#0.8361;PORPHYRIN SYNTHESIS#0.8354;PROBENECID#0.8352;PERIPLASM#0.8351;CHOLESTASIS#0.8336;PERIPHERAL BLOOD#0.8326;HEME ACQUISITION#0.8324;HEAT SHOCK PROTEIN#0.8316;GLIAL CELL#0.8310;GEFITINIB#0.8297;LIVER DISEASE#0.8295;METAL BINDING#0.8241;PROTEIN COMPLEX#0.8210;HEME BIOSYNTHESIS#0.8176;ENTEROCYTE#0.8115;CHOROID PLEXUS#0.8113;MECHANISMS OF ACTION#0.8111;EXTRACELLULAR SPACE#0.8101;LIPID RAFT#0.8095;ESTRADIOL#0.8086;ARGININE#0.8080;CYCLOSPORIN#0.8018;NODULATION#0.7980;RIBOSE#0.7967;ANGIOGENESIS#0.7961;ADENYLATE KINASE ACTIVITY#0.7952;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7949;ADENOCARCINOMA#0.7938;ENDOSOME#0.7924;SUGAR BINDING#0.7914;B CELL#0.7905;CYCLOSPORINE#0.7890;QUANTITATIVE REVERSE TRANSCRIPTION#0.7884;RIBOSOMAL PROTEIN#0.7880;5 FLUOROURACIL#0.7878;TANGIER DISEASE#0.7864;BLOOD GROUP ANTIGEN#0.7841;FATTY ACID METABOLISM#0.7832;HYALURONAN#0.7825;HUMAN EMBRYONIC KIDNEY#0.7819;EMBRYONIC KIDNEY#0.7815;ALANINE#0.7776;ARSENITE#0.7773;HEPARIN#0.7756;IRON ACQUISITION#0.7745;GLUTAMINE#0.7737;ATRIAL FIBRILLATION#0.7735;COLON CANCER#0.7705;NEUROBLASTOMA#0.7705;METHIONINE#0.7703;PROTEASOME#0.7702;ETHANOL#0.7696;ADENOSINE 5'-TRIPHOSPHATE#0.7693;IMMUNE SYSTEM#0.7685;ASPARTATE#0.7679;TRYPTOPHAN#0.7643;DIPHOSPHATE#0.7642;HEME SYNTHESIS#0.7621;INSULIN SECRETION#0.7600;SUGAR TRANSPORT#0.7577;PRIMARY ACTIVE TRANSPORTER#0.7574;CARCINOGEN#0.7567;RELATED PROTEIN 1#0.7565;TOXICANT#0.7553;PUMP ACTIVITY#0.7539;OOCYTE#0.7511;CELL DIFFERENTIATION#0.7505;TRANSMISSION ELECTRON MICROSCOPY#0.7501;ANEMIA#0.7480;CHOLESTEROL SYNTHESIS#0.7457;ERYTHROID PRECURSOR#0.7453;TOPOISOMERASE#0.7453;CAMPTOTHECIN#0.7452;ADRIAMYCIN#0.7442;OUTER MITOCHONDRIAL MEMBRANE#0.7436;AXON REGENERATION#0.7436;GOLGI APPARATUS#0.7431;ORGANIC CATION TRANSPORTER#0.7427;MULTIDRUG RESISTANT PROTEIN#0.7393;ETOPOSIDE#0.7389;FOAM CELL FORMATION#0.7363;MONONUCLEAR CELLS#0.7363;CHOLINE#0.7321;PORPHYRIN BIOSYNTHESIS#0.7309;ELECTROPHORETIC MOBILITY SHIFT#0.7292;PSEUDOXANTHOMA ELASTICUM#0.7289;HEME BINDING#0.7288;VESICULAR TRANSPORT#0.7270;PROTOPORPHYRIN IX#0.7255;INTESTINAL ABSORPTION#0.7249;NITRIC OXIDE#0.7236;GESTATION#0.7220;IRON SULFUR CLUSTER#0.7218;IRON TRANSPORT#0.7214;ARYL HYDROCARBON RECEPTOR#0.7209;HEMATOPOIETIC STEM CELL#0.7181;ENDOTHELIUM#0.7178;CHONDROITIN SULPHATE PROTEOGLYCAN#0.7174;HEME BINDING PROTEIN#0.7171;CYTOCHROME C#0.7158;MITOCHONDRIAL INNER MEMBRANE#0.7144;LACTIC ACID#0.7134;IMMUNE CELL#0.7134;CARRIE#0.7125;ERWINIA CHRYSANTHEMI#0.7121;PROTEIN PHOSPHORYLATION#0.7111;GERMINATION#0.7105;LECTIN#0.7100;COENZYME A#0.7059;RAPAMYCIN#0.7049;SIGNALLING PATHWAY#0.7039;DIABETES MELLITUS#0.7014;PHOSPHATE BINDING#0.6999;EPILEPSY#0.6982;MAMMARY GLAND#0.6953;GASTROINTESTINAL TRACT#0.6945;EMBRYONIC STEM CELL#0.6942;CALCIUM CHANNEL#0.6940;PROSTATE CANCER#0.6916;COLCHICINE#0.6903;SIDEROBLASTIC ANEMIA#0.6881;ARTERY#0.6879;FLUOROURACIL#0.6878;SENSITIZATION#0.6865;LEUCINE#0.6856;ELACRIDAR#0.6856;CELLULAR HOMEOSTASIS#0.6842;MULTIPLE SEQUENCE ALIGNMENT#0.6798;CATALYTIC ACTIVITY#0.6796;BINDING PROTEIN 1#0.6781;CELL ADHESION#0.6764;FLIPPASE#0.6755;NILOTINIB#0.6731;PHASE II METABOLISM#0.6731;VITAMIN B12#0.6730;INTRACELLULAR LOCALIZATION#0.6729;DIFFERENTIAL GENE EXPRESSION#0.6727;URIC ACID#0.6689;TRANSPORTER COMPLEX#0.6666;TUMOR SUPPRESSOR#0.6656;HYPOXIC#0.6652;NEUROLOGICAL DISORDER#0.6649;ALKALINE PHOSPHATASE#0.6647;TYPE 2 DIABETES#0.6646;TETRACYCLINE#0.6646;UBIQUITIN#0.6642;RESVERATROL#0.6637;ITRACONAZOLE#0.6606;MOLECULAR DYNAMICS SIMULATION#0.6596;DNA METHYLATION#0.6594;PROTEIN SECRETION#0.6563;ENZYME ACTIVITY#0.6554;ADRENAL GLAND#0.6536;HORIZONTAL GENE TRANSFER#0.6522;CELL MIGRATION#0.6492;BIOTIN#0.6478;BERBERINE#0.6475;SEQUESTERING#0.6450;SORAFENIB#0.6433;TONOPLAST#0.6429;INDOLE#0.6421;HYALURONIC ACID#0.6419;GENETIC DISORDER#0.6409;VASCULAR ENDOTHELIAL CELL#0.6404;PEPTIDOGLYCAN#0.6404;PEPTIDE TRANSPORT#0.6403;OLFACTORY ENSHEATHING GLIA#0.6395;PANCREATIC CANCER#0.6393;TARGET OF RAPAMYCIN#0.6392;PERIPHERAL NERVE#0.6392;GENISTEIN#0.6387;CARNITINE#0.6385;BETA CELL#0.6384;CELL ENVELOPE#0.6373;BLOOD TESTIS BARRIER#0.6364;RIFAMPICIN#0.6330;INTRAHEPATIC CHOLESTASIS#0.6316;MACULAR DEGENERATION#0.6308;LOCALISATION#0.6298;AMINOLEVULINIC ACID#0.6297;INTRACELLULAR MEMBRANE#0.6292;DIGOXIN#0.6279;HEME TRANSPORTER#0.6269;GLYBURIDE#0.6260;COLON ADENOCARCINOMA#0.6251;CHRONIC MYELOID LEUKEMIA#0.6246;COLICIN#0.6244;POLYCYCLIC AROMATIC HYDROCARBON#0.6232;ISCHEMIA#0.6231;FRUCTOSE#0.6218;PRAZOSIN#0.6207;FACTOR I#0.6199;MITOGEN ACTIVATED PROTEIN#0.6184;INFLAMMATORY RESPONSE#0.6177;ER MEMBRANE#0.6175;STEROL TRANSPORT#0.6172;SCHWANN CELL#0.6168;PROTEIN TRANSPORTER#0.6159;INTESTINAL EPITHELIAL CELL#0.6121;MELANOCYTE#0.6121;LEISHMANIASIS#0.6115;RECEPTOR TYROSINE KINASE#0.6091;GENE SILENCING#0.6080;GERM CELL#0.6070;SIGNALING CASCADE#0.6067;BLOOD VESSEL#0.6052;TOLL LIKE RECEPTOR#0.6049;SMOOTH MUSCLE#0.6029;BACITRACIN#0.6016;CHOLESTEROL UPTAKE#0.6015
10059	MEMBRANE FISSION#1.0684;MITOCHONDRIAL TRANSLOCATION#1.0610;GTPASE ACTIVITY#1.0568;DEPHOSPHORYLATION#1.0553;GTP HYDROLYSIS#1.0545;CALCINEURIN#1.0518;DOMINANT NEGATIVE MUTANT#1.0442;SUMOYLATION#1.0436;RELATED PROTEIN 1#1.0380;OPTIC ATROPHY#1.0336;MITOCHONDRIAL DIVISION#1.0324;CONSTRICTION#1.0321;MITOCHONDRIAL OUTER MEMBRANE#1.0263;BREAST CANCER CELL#1.0251;ENDOCYTOSIS#1.0231;PEROXISOMAL#1.0228;GTP BINDING#1.0225;MITOCHONDRIAL FISSION#1.0220;CAMKII#1.0218;BREAST CANCER#1.0198;NECROPTOSIS#1.0192;REGULATION OF MITOCHONDRIAL FISSION#1.0192;CYCLIN DEPENDENT KINASE#1.0157;MITOCHONDRIAL DEPOLARIZATION#1.0151;OUTER MEMBRANE#1.0137;PEROXISOME#1.0101;LUNG CANCER#1.0085;CARDIAC ARREST#1.0078;CYTOPLASM#1.0068;OUTER MITOCHONDRIAL MEMBRANE#1.0062;CYTOCHROME C RELEASE#1.0058;VACUOLE#1.0056;MITOCHONDRIAL LOCALIZATION#1.0043;NEURONAL CELL DEATH#1.0043;CEREBRAL ISCHEMIA#1.0032;GENE EXPRESSION#1.0021;POST-TRANSLATIONAL MODIFICATION#1.0012;MITOCHONDRIAL FUSION#1.0007;MICROTUBULE#0.9999;MELATONIN#0.9996;PROTEIN KINASE A#0.9995;ENDOSOME#0.9995;CARDIOMYOPATHY#0.9980;MEMBRANE FUSION#0.9974;NEURONAL CELLS#0.9964;MITOPHAGY#0.9953;UBIQUITIN#0.9946;DILATED CARDIOMYOPATHY#0.9946;MITOCHONDRIAL PERMEABILITY TRANSITION#0.9938;MICROTUBULE ASSOCIATED PROTEIN#0.9932;STEM CELL#0.9925;CARDIOMYOCYTE#0.9919;NLRP3 INFLAMMASOME ACTIVATION#0.9919;PERMEABILITY TRANSITION PORE#0.9918;CISPLATIN#0.9908;CELL CYCLE#0.9904;GLYCOLYSIS#0.9903;CRISTAE#0.9902;CANCER CELL#0.9901;ISCHEMIA REPERFUSION INJURY#0.9892;ENDOPLASMIC RETICULUM#0.9885;T CELL#0.9884;HYPERGLYCEMIA#0.9880;ACTIN FILAMENT#0.9876;HYPOXIA#0.9867;APOPTOTIC CELL DEATH#0.9866;ROS GENERATION#0.9854;PROTEIN KINASE#0.9852;TRANSCRIPTION FACTOR#0.9850;ENDOTHELIAL CELL#0.9850;CYTOCHROME C#0.9846;HUNTINGTON'S DISEASE#0.9842;ISCHEMIA#0.9839;SIGNALING PATHWAY#0.9835;AUTOPHAGY#0.9831;ELECTRON TRANSPORT#0.9824;COMPLEX I#0.9821;RESPIRATION#0.9819;CELL PROLIFERATION#0.9818;ACTIN POLYMERIZATION#0.9810;MITOCHONDRIA#0.9807;ELECTRON TRANSPORT CHAIN#0.9796;LIGHT CHAIN 3#0.9796;OXIDATIVE PHOSPHORYLATION#0.9789;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9785;APOPTOSIS#0.9782;PLASMA MEMBRANE#0.9782;MITOCHONDRIAL MEMBRANE#0.9780;MTDNA#0.9780;CARDIOLIPIN#0.9774;SUPEROXIDE DISMUTASE#0.9767;EPITHELIAL CELL#0.9765;MUSCLE CELL#0.9761;CELL DEATH#0.9759;NITRIC OXIDE#0.9748;OXYGEN GLUCOSE DEPRIVATION#0.9747;ALZHEIMER'S DISEASE#0.9745;AUTOPHAGOSOME#0.9745;SKELETAL MUSCLE#0.9741;TOXICITY#0.9735;SMOOTH MUSCLE#0.9730;MITOCHONDRIAL DAMAGE#0.9720;PARKINSON'S DISEASE#0.9706;RESPIRATORY CHAIN#0.9702;MITOCHONDRIAL DNA#0.9702;APOPTOTIC#0.9692;MITOCHONDRIAL DISTRIBUTION#0.9677;RNA INTERFERENCE#0.9675;ARTERY#0.9656;NEURODEGENERATIVE DISEASE#0.9647;PODOCYTE#0.9638;HYPOXIC#0.9635;NERVOUS SYSTEM#0.9626;MYOCYTES#0.9625;SENESCENCE#0.9622;PEROXISOME DIVISION#0.9621;TRANSMISSION ELECTRON MICROSCOPY#0.9620;REACTIVE OXYGEN SPECIES#0.9618;MITOCHONDRIAL TRANSCRIPTION#0.9616;CELL MIGRATION#0.9615;B CELL#0.9613;ADENOSINE TRIPHOSPHATE#0.9607;CYTOCHROME C OXIDASE#0.9592;GROWTH FACTOR#0.9589;ORGANELLE#0.9588;PROGRAMMED CELL DEATH#0.9558;NEUROTOXICITY#0.9538;STATUS EPILEPTICUS#0.9520;DISTRIBUTION OF MITOCHONDRIA#0.9494;SMOOTH MUSCLE CELL#0.9493;BETA CELL#0.9488;INFLAMMATORY RESPONSE#0.9480;MOUSE EMBRYONIC FIBROBLAST#0.9480;MORPHOGENESIS#0.9450;LYSOSOME#0.9429;PALMITATE#0.9428;ADENOSINE#0.9415;NEUROPROTECTION#0.9393;LATE GOLGI#0.9387;HEPATOTOXICITY#0.9379;PROTEASOME#0.9340;HIGH FAT DIET#0.9334;MITOCHONDRION#0.9314;INSULIN SECRETION#0.9300;SWELLING#0.9271;GUANOSINE#0.9262;PRO-INFLAMMATORY#0.9246;HYPERTENSION#0.9191;NEUROBLASTOMA#0.9186;OVARIAN CANCER#0.9185;TYPE 2 DIABETES#0.9160;TUMOR NECROSIS FACTOR#0.9144;CYTOTOXICITY#0.9120;MIDDLE CEREBRAL ARTERY#0.9103;CEREBRAL ARTERY#0.9100;RECEPTOR INTERACTING PROTEIN#0.9099;NUCLEAR RESPIRATORY FACTOR#0.9092;POSTTRANSLATIONAL MODIFICATION#0.9075;CASPASE ACTIVATION#0.9058;INNER MITOCHONDRIAL MEMBRANE#0.9032;MYOCARDIAL INFARCTION#0.8999;DOPAMINERGIC NEURON#0.8985;MITOSIS#0.8982;OBESE#0.8956;SPINAL CORD#0.8940;CLEAVED CASPASE 3#0.8903;MACROPHAGE#0.8871;ATP SYNTHESIS#0.8869;VACUOLAR PROTEIN SORTING#0.8863;STAUROSPORINE#0.8840;CEREBRAL ARTERY OCCLUSION#0.8824;TUMOR CELLS#0.8819;BRAIN DAMAGE#0.8819;ENDOCYTIC VESICLE#0.8739;RETINAL GANGLION CELL#0.8726;CENTRAL NERVOUS SYSTEM#0.8719;ASTROCYTE#0.8693;TARGET OF RAPAMYCIN#0.8678;MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION#0.8666;INTRINSIC APOPTOSIS#0.8618;NEURITE#0.8618;MIXED LINEAGE KINASE#0.8611;HEART DISEASE#0.8610;PEROXISOMAL MEMBRANE#0.8606;DNA FRAGMENTATION#0.8586;ENDOTHELIUM#0.8568;RAPAMYCIN#0.8506;MITOCHONDRIAL INNER MEMBRANE#0.8466;B CELL LYMPHOMA#0.8459;NITRIC OXIDE SYNTHASE#0.8433;MITOCHONDRIAL MATRIX#0.8415;MYOCARDIUM#0.8368;DOXORUBICIN#0.8328;ACTIN BINDING#0.8320;ATP SYNTHASE#0.8301;EMBRYONIC STEM CELL#0.8273;CELLULAR HOMEOSTASIS#0.8270;MITOCHONDRIAL TRANSPORT#0.8261;VASCULAR SMOOTH MUSCLE CELL#0.8259;OVARIAN#0.8257;PROTEIN DISULFIDE ISOMERASE#0.8253;LATERAL SCLEROSIS#0.8229;ENDOPLASMIC RETICULUM STRESS#0.8227;SIGNALLING PATHWAY#0.8218;AXONAL TRANSPORT#0.8162;MEMBRANE SCISSION#0.8150;GLUTATHIONE#0.8099;AMYOTROPHIC LATERAL SCLEROSIS#0.8082;BLOOD BRAIN BARRIER#0.8079;NEUROLOGICAL DISORDER#0.8074;S PHASE#0.8072;POLYMERASE CHAIN REACTION#0.8027;STREPTOZOTOCIN#0.8023;UNFOLDED PROTEIN RESPONSE#0.8018;NECROTIC#0.8006;NEPHROPATHY#0.7985;MYOBLAST#0.7960;MITOCHONDRIAL CRISTAE#0.7957;ADENOCARCINOMA#0.7954;PYRUVATE#0.7942;GLUCOSE METABOLISM#0.7930;GLYCOGEN SYNTHASE KINASE#0.7917;ACTIN CYTOSKELETON#0.7904;LUNG ADENOCARCINOMA#0.7903;MYOTUBE#0.7899;CELL GROWTH#0.7876;NEUROPATHY#0.7865;SUCCINATE#0.7857;ACUTE KIDNEY INJURY#0.7842;MYOCARDIAL INFARCT SIZE#0.7838;PRIMARY CORTICAL NEURON#0.7834;SUBSTANTIA NIGRA#0.7825;HEPATOCELLULAR CARCINOMA#0.7787;DOPAMINE#0.7782;DENDRITIC SPINE#0.7776;DESUMOYLATION#0.7743;PHOSPHOGLYCERATE MUTASE#0.7743;PROTEIN KINASE C#0.7695;MITOGEN ACTIVATED PROTEIN#0.7689;FATTY ACID OXIDATION#0.7663;BRAIN EDEMA#0.7662;DOMINANT OPTIC ATROPHY#0.7631;ANION CHANNEL#0.7626;CYTOKINESIS#0.7612;CELL DIFFERENTIATION#0.7595;PODOCYTE APOPTOSIS#0.7553;KINASE ACTIVITY#0.7541;APOPTOSIS INDUCING FACTOR#0.7502;ADIPOSE TISSUE#0.7471;ANCHORING#0.7461;EPILEPSY#0.7431;SYNAPTIC TRANSMISSION#0.7417;ADIPOCYTE#0.7413;QUANTITATIVE REAL TIME#0.7409;MECHANISM OF ACTION#0.7407;PROGRAMMED NECROSIS#0.7406;DEVELOPMENTAL DELAY#0.7401;L-CYSTEINE#0.7396;LEUCINE RICH REPEAT#0.7353;CORONARY ARTERY#0.7328;PROGENITOR CELL#0.7328;ATHEROSCLEROSIS#0.7327;IMMUNE RESPONSE#0.7301;METFORMIN#0.7277;AUTOPHAGOSOME FORMATION#0.7230;BUDDING#0.7204;HEPATOMA CELLS#0.7196;DRUG RESISTANCE#0.7195;HUMAN BREAST CANCER#0.7192;HEAT SHOCK PROTEIN#0.7187;TUBULAR EPITHELIAL CELL#0.7182;CASPASE-3 ACTIVITY#0.7162;GENE SILENCING#0.7151;PULMONARY ARTERIAL HYPERTENSION#0.7136;INDUCTION OF APOPTOSIS#0.7135;ACTIVATION OF APOPTOSIS#0.7102;COLON CANCER#0.7089;DIABETIC NEPHROPATHY#0.7089;PEROXISOME MEMBRANE#0.7078;CONTACT SITE#0.7051;TRANS GOLGI NETWORK#0.7049;CHARCOT MARIE TOOTH#0.7041;SKIN FIBROBLASTS#0.7035;N-ACETYLCYSTEINE#0.7002;COATED VESICLE#0.7000;NUCLEOID#0.6992;ONCOGENIC#0.6989;PLURIPOTENT STEM CELL#0.6982;NEUROGENESIS#0.6970;SIGNALING CASCADE#0.6964;CELL PLATE#0.6959;LIVER DISEASE#0.6951;COLORECTAL CANCER#0.6944;MEMBRANE CURVATURE#0.6881;HOST CELL#0.6873;SYNAPTIC VESICLE#0.6840;NEURITE OUTGROWTH#0.6828;CELL DIVISION#0.6823;ACTIVATED CASPASE 3#0.6804;PANCREATIC CANCER#0.6797;LIPID METABOLISM#0.6790;UBIQUITIN PROTEASOME SYSTEM#0.6763;TRANSIENT RECEPTOR POTENTIAL#0.6749;OPTIC NERVE#0.6739;TRAUMATIC BRAIN INJURY#0.6732;LATE ENDOSOME#0.6731;PHOSPHATASE 2A#0.6717;EDEMA#0.6712;CELL CYCLE ARREST#0.6691;BRAIN DEVELOPMENT#0.6687;NEURAL CELL#0.6679;LEUCINE#0.6677;MITOCHONDRIAL ELECTRON TRANSPORT CHAIN#0.6670;MITOCHONDRIAL MEMBRANE FUSION#0.6663;MITOCHONDRIAL ELECTRON TRANSPORT#0.6647;CELL ACTIVATION#0.6614;SIGNALING MOLECULE#0.6602;ANGIOGENESIS#0.6548;RESPIRATORY CHAIN COMPLEX#0.6544;INTRINSIC APOPTOTIC PATHWAY#0.6535;UBIQUITIN PROTEIN LIGASE#0.6529;RENAL ISCHEMIA REPERFUSION#0.6521;REACTIVE OXYGEN SPECIES GENERATION#0.6508;NULL CELL#0.6489;NEUROTOXIC#0.6483;COLORECTAL#0.6483;INTERPHASE#0.6479;ISOPROTERENOL#0.6464;PULMONARY HYPERTENSION#0.6454;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6450;LYSINE#0.6437;FOREBRAIN#0.6419;MULTIPLE SCLEROSIS#0.6417;ENZYME ACTIVITY#0.6400;PROSTATE CANCER#0.6398;REGULATION OF APOPTOSIS#0.6367;DNA COPY NUMBER#0.6329;NEUROTOXIN#0.6326;PROXIMAL TUBULAR CELL#0.6314;KIDNEY DISEASE#0.6290;RESVERATROL#0.6287;SELECTIVE AUTOPHAGY#0.6272;PULMONARY ARTERY#0.6265;PEROXISOME PROLIFERATION#0.6261;IRON OVERLOAD#0.6223;CLATHRIN-MEDIATED ENDOCYTOSIS#0.6221;CARNITINE#0.6179;SQUAMOUS CELL CARCINOMA#0.6171;MITOCHONDRIAL RESPIRATORY CHAIN#0.6167;NEURAL STEM CELL#0.6156;MUSCLE ATROPHY#0.6147;LEFT ANTERIOR DESCENDING#0.6140;POLY ADP RIBOSE#0.6133;GANGLION CELLS#0.6117;KINESIN#0.6099;REVERSE TRANSCRIPTION#0.6094;LACTIC ACIDOSIS#0.6091;CONJUGATION#0.6075;HEMORRHAGE#0.6057;STRIATUM#0.6045;OOCYTE#0.6038;MORRIS WATER MAZE#0.6005
1005	NEURAL CREST CELL#1.0169;NEURAL CREST#1.0121;CELL ADHESION#0.9729;CELL MIGRATION#0.8976;CELL CELL ADHESION#0.7820;NERVOUS SYSTEM#0.7631;SPINAL CORD#0.7524;NEURAL TUBE#0.7317;BASAL PLATE#0.6548;CENTRAL NERVOUS SYSTEM#0.6278
10060	SULFONYLUREA RECEPTOR#1.0342;SMOOTH MUSCLE#1.0182;ABC TRANSPORTER#1.0113;GLIBENCLAMIDE#1.0065;POTASSIUM CHANNEL#1.0047;ATP BINDING CASSETTE#1.0000;DIAZOXIDE#0.9993;ATP BINDING#0.9982;SKELETAL MUSCLE#0.9926;POLYMERASE CHAIN REACTION#0.9909;NUCLEOTIDE BINDING#0.9514;ARTERY#0.9447;GENE EXPRESSION#0.9401;CHANNEL ACTIVITY#0.9396;REVERSE TRANSCRIPTION#0.9362;ADENOSINE TRIPHOSPHATE#0.9312;BETA CELL#0.9145;MITOCHONDRIA#0.9040;HYPERTRICHOSIS#0.8951;CORONARY ARTERY#0.8789;ADENOSINE#0.8773;ALZHEIMER'S DISEASE#0.8673;CARDIOMYOCYTE#0.8634;SMOOTH MUSCLE CELL#0.8333;MUSCLE CELL#0.8326;PLASMA MEMBRANE#0.8289;NUCLEOTIDE BINDING DOMAIN#0.8110;CELL PROLIFERATION#0.8093;MYOCYTES#0.8051;MYOCARDIAL INFARCTION#0.7698;DILATED CARDIOMYOPATHY#0.7693;ISCHEMIA#0.7684;TOLBUTAMIDE#0.7670;ION CHANNEL#0.7552;HYPERTENSION#0.7534;ASTROCYTE#0.7242;HYPOXIA#0.7108;CARDIOMYOPATHY#0.7101;INSULIN SECRETION#0.7087;EPITHELIAL CELL#0.6739;CORONARY ARTERY VASOSPASM#0.6585;AUXIN HOMEOSTASIS#0.6424;VASODILATION#0.6420;CALCIUM CHANNEL#0.6356;ARRHYTHMIA#0.6275;SPINAL CORD#0.6227;MYOCARDIUM#0.6173;CYSTIC FIBROSIS#0.6118;MESENTERIC ARTERY#0.6045;OXIDATIVE METABOLISM#0.6024
100616115	BREAST CANCER#1.1452
100616119	PARKINSON'S DISEASE#0.9644
100616142	CELL PROLIFERATION#0.9257;LUNG CANCER#0.8713;CANCER CELL#0.8678;BREAST CANCER#0.7472;COLON CANCER#0.6767;CELL GROWTH#0.6596;APOPTOSIS#0.6285;BREAST CANCER CELL#0.6149
100616170	NOT OTHERWISE SPECIFIED#0.6740;PERIPHERAL T-CELL LYMPHOMA#0.6726;ANAPLASTIC LARGE CELL LYMPHOMA#0.6665;BONE MORPHOGENETIC PROTEIN#0.6538;T CELL#0.6416
100616200	CANCER CELL#1.1780
100616224	APOPTOSIS#0.6411
100616258	KERATINOCYTE#0.6131;APOPTOSIS#0.6058
100616312	SOLUBLE LEPTIN RECEPTOR#0.7329;CELL PROLIFERATION#0.6856
100616327	BREAST CANCER#0.6707
100616353	INSULIN SECRETION#0.6440
100616364	OVARIAN#0.6451
100616379	HEMATURIA#0.6593
100616388	PROSTATE CANCER#1.1840;CANCER CELL#1.1780
100616407	BREAST CANCER#0.8653;CANCER CELL#0.7053;T CELL#0.6648;LIVER METASTASIS#0.6247;CD4+ T CELL#0.6099
100616448	EPITHELIAL MESENCHYMAL TRANSITION#0.7535
100616454	TUMOR TISSUES#0.7200
100616467	APOPTOSIS#0.9055;VASCULAR ENDOTHELIAL CELL#0.6468;ENDOTHELIAL CELL#0.6406
100616469	EPITHELIAL MESENCHYMAL TRANSITION#0.6653;POLYMERASE CHAIN REACTION#0.6546
100616481	AIRWAY EPITHELIUM#1.2019;LUNG CANCER#1.1823;EPITHELIAL CELL#1.1799
100616489	CELL PROLIFERATION#0.6434
100616496	VIRION#1.0128;PROVIRUS#1.0123;TRANSCRIPTASE#0.9988;VIRAL GENOME#0.9870;HUMAN IMMUNODEFICIENCY VIRUS#0.9868;GENE EXPRESSION#0.9833;T CELL#0.9820;PERIPHERAL BLOOD#0.9683;T-CELL LEUKEMIA#0.9472;AVIAN LEUKOSIS#0.9393;CANCER CELL#0.9382;MULTIPLE SCLEROSIS#0.9009;MONONUCLEAR CELLS#0.8901;REVERSE TRANSCRIPTION#0.8732;ONCOGENIC#0.8708;NUCLEIC ACID#0.8631;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8532;VIRUS LIKE PARTICLE#0.8512;REVERSE TRANSCRIPTASE ACTIVITY#0.8225;MILLION YEARS AGO#0.7795;HOST CELL#0.7689;BUDDING#0.7685;RNA INTERFERENCE#0.7580;TRANSCRIPTION FACTOR#0.7566;KIDNEY TRANSPLANT RECIPIENTS#0.7560;TRANSPOSITION#0.7502;HERPES SIMPLEX VIRUS#0.7456;HERPES SIMPLEX#0.7449;GENE SILENCING#0.7290;NUCLEOCAPSID#0.6846;MUTAGENESIS#0.6744;NERVOUS SYSTEM#0.6722;IFN-GAMMA#0.6683;DNA METHYLATION#0.6587;QUANTITATIVE REAL TIME#0.6462;ADULT T-CELL LEUKEMIA#0.6100
100616497	PEPTIDE TRANSPORTER#0.9982;PEPTIDE TRANSPORT#0.9172;OLIGOPEPTIDE TRANSPORTER#0.8855;DNA BINDING#0.8381;UBIQUITIN#0.7305
100616498	LUNG ADENOCARCINOMA#0.7552
10061	ABC TRANSPORTER#0.9989;ATP BINDING CASSETTE#0.9370;ATP BINDING#0.9354;CLEAR CELL ADENOCARCINOMA#0.9133;BREAST CANCER#0.8461;ADENOCARCINOMA#0.8317;OVARIAN#0.8228;CANCER CELL#0.7697;OVARIAN CANCER#0.7624;GENE EXPRESSION#0.7287;HOST CELL#0.6399;ENDOMETRIAL CANCER#0.6389;EPITHELIAL CELL#0.6263;STEM CELL#0.6258;TUMOR CELLS#0.6202;PROGESTERONE#0.6160
100628315	CELL PROLIFERATION#0.6547;PULMONARY FIBROSIS#0.6060;DNA DAMAGE RESPONSE#0.6040;TUMOR TISSUES#0.6009
10062	FARNESOID X RECEPTOR#1.0401;LIVER X RECEPTOR#1.0398;RETINOID X RECEPTOR#1.0310;NUCLEAR HORMONE RECEPTOR#1.0288;FATTY ACID SYNTHASE#1.0219;SCAVENGER RECEPTOR#1.0209;CHOLESTEROL HOMEOSTASIS#1.0095;PEROXISOME#1.0076;TRANSCRIPTION FACTOR#1.0055;STEROL REGULATORY ELEMENT#1.0045;ATP BINDING CASSETTE TRANSPORTER#1.0033;NUCLEAR RECEPTOR SUPERFAMILY#0.9997;CHOLESTEROL EFFLUX#0.9982;PREGNANE X RECEPTOR#0.9958;ATP BINDING CASSETTE#0.9953;ATP BINDING#0.9943;MACROPHAGE#0.9940;LIPOGENESIS#0.9899;LIPID METABOLISM#0.9886;ADIPOSE TISSUE#0.9859;LOW DENSITY LIPOPROTEIN#0.9835;POLYMERASE CHAIN REACTION#0.9828;CHOLESTEROL METABOLISM#0.9826;SIGNALING PATHWAY#0.9823;LIPID HOMEOSTASIS#0.9814;REVERSE CHOLESTEROL TRANSPORT#0.9777;CHOLESTEROL TRANSPORT#0.9777;ADIPOCYTE#0.9734;GENE EXPRESSION#0.9709;HIGH DENSITY LIPOPROTEIN#0.9700;ATHEROSCLEROSIS#0.9669;PROTEIN KINASE#0.9586;COENZYME A#0.9559;EXCRETION#0.9522;MULTIPLE SCLEROSIS#0.9501;ATHEROSCLEROTIC#0.9447;HIGH FAT DIET#0.9399;TRANSACTIVATION#0.9343;FATTY LIVER#0.9331;STEAROYL COA DESATURASE#0.9272;LIVER DISEASE#0.9253;MONOCYTE#0.9238;FATTY ACID SYNTHESIS#0.9150;BINDING PROTEIN 1#0.9126;ADENOSINE TRIPHOSPHATE#0.9096;BILE ACID SYNTHESIS#0.9055;FOAM CELL FORMATION#0.9020;GLUCOSE METABOLISM#0.9018;ADENOSINE#0.8932;INFLAMMATORY RESPONSE#0.8919;TYPE 2 DIABETES#0.8845;ACETYL COA CARBOXYLASE#0.8810;MONONUCLEAR CELLS#0.8717;FATTY LIVER DISEASE#0.8673;TUMOR NECROSIS FACTOR#0.8614;REVERSE TRANSCRIPTION#0.8609;LDL RECEPTOR#0.8558;CHOLESTEROL UPTAKE#0.8551;HIGH CHOLESTEROL DIET#0.8530;FATTY ACID METABOLISM#0.8468;CHOLESTEROL TRANSPORTER#0.8464;FATTY ACID OXIDATION#0.8432;CONSTITUTIVE ANDROSTANE RECEPTOR#0.8402;ENHANCER BINDING PROTEIN#0.8314;ENHANCER BINDING#0.8309;REGULATION OF LIPID METABOLISM#0.8284;CELL PROLIFERATION#0.8271;OBESE#0.8260;DNA BINDING#0.8102;PERIPHERAL BLOOD#0.8100;ADIPOGENESIS#0.8087;DNA METHYLATION#0.8079;RETINOIC ACID#0.7979;GROWTH FACTOR#0.7918;FATTY ACID BINDING#0.7648;SMALL HETERODIMER PARTNER#0.7600;LIPID DROPLET#0.7527;KUPFFER CELL#0.7503;HYPERCHOLESTEROLEMIA#0.7460;CYTOCHROME P450#0.7407;ABC TRANSPORTER#0.7403;ATORVASTATIN#0.7402;GLUCOSE HOMEOSTASIS#0.7297;EPITHELIAL CELL#0.7226;APOPTOSIS#0.7225;GLUCOCORTICOID RECEPTOR#0.7208;CHOLESTEROL SYNTHESIS#0.7196;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7184;SKELETAL MUSCLE#0.7171;RECEPTOR AGONIST#0.7125;NONALCOHOLIC FATTY LIVER DISEASE#0.7096;ADIPOCYTE DIFFERENTIATION#0.7076;CATABOLISM#0.7074;VITAMIN D RECEPTOR#0.6996;DE NOVO LIPOGENESIS#0.6851;CHOLESTEROL BIOSYNTHESIS#0.6837;CANCER CELL#0.6828;LIGAND BINDING DOMAIN#0.6703;BILE ACID METABOLISM#0.6614;SMALL INTESTINE#0.6606;ESTROGEN RECEPTOR#0.6467;PRO-INFLAMMATORY#0.6447;INNATE IMMUNITY#0.6307;CARBOHYDRATE RESPONSE ELEMENT BINDING#0.6299;HEPATOMA CELLS#0.6180;T CELL#0.6095
10063	COPPER CHAPERONE#1.0814;CYTOCHROME C OXIDASE#1.0434;CYTOCHROME C#1.0380;COPPER BINDING#1.0167;MITOCHONDRIA#1.0055;SUPEROXIDE DISMUTASE#0.9501;METAL BINDING#0.8982;MITOCHONDRIAL INTERMEMBRANE SPACE#0.8758;CISPLATIN#0.8313;MRNA DECAY#0.8269;GENE EXPRESSION#0.8239;COPPER HOMEOSTASIS#0.7677;MICOS COMPLEX#0.7519;RESPIRATORY CHAIN#0.7460;MITOCHONDRION#0.7098;CYTOPLASM#0.6771;RESPIRATION#0.6472;REACTIVE OXYGEN SPECIES#0.6412;MITOCHONDRIAL INNER MEMBRANE#0.6332;GLUTATHIONE#0.6229;FETAL LIVER#0.6147
100642175	EPITHELIAL MESENCHYMAL TRANSITION#1.1006;CANCER CELL#1.0928;CELL PROLIFERATION#1.0896;BREAST CANCER#1.0798;APOPTOSIS#1.0635;CELL GROWTH#1.0427;SQUAMOUS CELL CARCINOMA#0.9396;CELL MIGRATION#0.9378;HEPATOCELLULAR CARCINOMA#0.9377;QUANTITATIVE REAL TIME#0.9375;BREAST CANCER CELL#0.9200;LYMPH NODE METASTASIS#0.8993;LYMPH NODE#0.8950;LUNG CANCER#0.8809;OVARIAN CANCER#0.8624;ONCOGENIC#0.8586;COLORECTAL CANCER#0.8210;CELL CYCLE#0.8014;POLYMERASE CHAIN REACTION#0.7948;COLORECTAL#0.7465;EPITHELIAL CELL#0.7130;OVARIAN#0.6995;TUMOR TISSUES#0.6988;TRANSCRIPTION FACTOR#0.6873;TUMOR NODE METASTASIS#0.6786;COLONY FORMATION ASSAY#0.6516;ADJACENT NORMAL TISSUE#0.6510;RNA BINDING PROTEIN#0.6290;RNA BINDING#0.6276;DISEASE FREE SURVIVAL#0.6269;SIGNALING PATHWAY#0.6202;TROPHOBLAST CELL#0.6171;BREAST CANCER PATIENTS#0.6096
100652748	TRANSCRIPTION FACTOR#1.1783
100652772	LUNG CANCER#1.0624;CELL PROLIFERATION#1.0615;CANCER CELL#1.0093;NICOTINAMIDE#0.9066;CELL CYCLE#0.8606;BREAST CANCER#0.8301;SIGNALING PATHWAY#0.8289;APOPTOSIS#0.7975;ANTISENSE RNA#0.7565;TUMOR TISSUES#0.6628;POLYMERASE CHAIN REACTION#0.6563;CERVICAL CANCER#0.6026;EPITHELIAL MESENCHYMAL TRANSITION#0.6009
100653366	CHOLANGITIS#0.9271;SCLEROSING CHOLANGITIS#0.8733;CHOLANGIOCARCINOMA#0.7955;BILE DUCT#0.6292
100653377	Y CHROMOSOME#1.0130;SERTOLI CELL#1.0000;AZOOSPERMIA#0.9958;SERTOLI CELL-ONLY SYNDROME#0.9935;GERM CELL#0.9836;INFERTILE#0.9831;MALE INFERTILITY#0.9813;SEMEN#0.9789;INFERTILITY#0.9748;SPERMATOGENESIS#0.9738;SPERMATOZOA#0.9633;SEX CHROMOSOME#0.9623;POLYMERASE CHAIN REACTION#0.9585;GENE EXPRESSION#0.9321;MEIOSIS#0.9315;X CHROMOSOME#0.9146;STEM CELL#0.9066;TESTOSTERONE#0.9036;SPERMATOCYTES#0.8633;COPY NUMBER VARIATION#0.8109;AUTOSOME#0.8090;LEYDIG CELL#0.7918;FOLLICLE STIMULATING HORMONE#0.7833;ANDROGEN RECEPTOR#0.7750;GERM CELL DEVELOPMENT#0.7743;CELL DEVELOPMENT#0.7632;PACHYTENE#0.7610;STERILITY#0.7601;HOMOLOGOUS RECOMBINATION#0.7546;CRYPTORCHIDISM#0.7460;OLIGOSPERMIA#0.6667;PERIPHERAL BLOOD#0.6655;SPERMATOGONIAL STEM CELL#0.6623;INHIBIN#0.6434;SPERM MOTILITY#0.6406;APOPTOSIS#0.6374;SEMINAL PLASMA#0.6303;FERTILIZATION#0.6072
100653382	CHRONIC LYMPHOCYTIC LEUKEMIA#0.8395;LYMPHOCYTIC LEUKEMIA#0.8388;LYMPH NODE#0.7347;B CELL#0.6663
100653385	3P- SYNDROME#1.1608
10066	CELL SURFACE#1.0092;EXOCYTOSIS#0.9745;PLASMA MEMBRANE#0.9522;DENSE CORE VESICLE#0.7571;DENSE CORE VESICLE EXOCYTOSIS#0.6988;VESICLE EXOCYTOSIS#0.6624;RECYCLING ENDOSOME#0.6551;SECRETORY VESICLE#0.6517;TRANSPORTER ACTIVITY#0.6068
10067	ENDOSOME#0.8271;MULTIVESICULAR ENDOSOME#0.6337;FEED FORWARD LOOP#0.6164;RECEPTOR DEGRADATION#0.6138
10068	INTERLEUKIN 18 BINDING#1.0851;IL-1RA#1.0653;IL-18 BINDING#1.0466;IFN-GAMMA#1.0304;RHEUMATOID ARTHRITIS#1.0105;PRO-INFLAMMATORY#1.0062;T CELL#1.0033;MACROPHAGE#1.0011;PERIPHERAL BLOOD#1.0005;POLYMERASE CHAIN REACTION#0.9872;ISCHEMIA#0.9843;IMMUNE RESPONSE#0.9794;TUMOR NECROSIS FACTOR#0.9782;GENE EXPRESSION#0.9708;MONONUCLEAR CELLS#0.9597;GROWTH FACTOR#0.9413;AUTOIMMUNE DISEASE#0.9317;RECEPTOR ANTAGONIST#0.9302;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9280;EPITHELIAL CELL#0.9072;SPINAL CORD#0.8950;MONOCYTE#0.8604;CELL SURFACE#0.8603;INFLAMMATORY RESPONSE#0.8539;NEUTROPHIL#0.8350;INFLAMMATORY BOWEL DISEASE#0.8231;COLITIS#0.8098;APOPTOSIS#0.7985;LIVER DISEASE#0.7897;TRANSFORMING GROWTH FACTOR#0.7870;ACUTE KIDNEY INJURY#0.7804;CANCER CELL#0.7694;QUANTITATIVE REAL TIME#0.7657;INTERFERON REGULATORY FACTOR#0.7586;KERATINOCYTE#0.7554;IL-18 PRODUCTION#0.7523;MAST CELL#0.7323;PROSTATE CANCER#0.7296;STEM CELL#0.7259;SIGNAL TRANSDUCTION#0.7229;ATHEROSCLEROTIC#0.7122;PURPURA#0.6926;RENAL FIBROSIS#0.6879;ARTERY#0.6776;OVARIAN#0.6681;LUPUS ERYTHEMATOSUS#0.6664;NATURAL KILLER CELL#0.6554;INFLAMMATORY CELL#0.6530;MUTAGENESIS#0.6501;ADULT-ONSET STILL'S DISEASE#0.6456;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6362;BONE MARROW#0.6316;FERTILIZATION#0.6302;EOSINOPHIL#0.6295;OXIDATIVE STRESS INDEX#0.6294;TRANSFORMING GROWTH FACTOR BETA#0.6290;C REACTIVE PROTEIN#0.6212;MOLLUSCUM CONTAGIOSUM#0.6203;VACCINIA#0.6058;ISCHEMIA REPERFUSION INJURY#0.6035;TOLL LIKE RECEPTOR#0.6012;LYMPHOCYTE ACTIVATION#0.6012
1006	CELL ADHESION#0.9276;CELL ADHESION MOLECULE#0.7578;SUPERIOR COLLICULUS#0.7135;AUTISM SPECTRUM DISORDER#0.7039;STRIATUM#0.6569;NERVOUS SYSTEM#0.6481
10071	COLORECTAL CANCER#0.7585;REVERSE TRANSCRIPTION#0.7345;COLORECTAL#0.7117;GENE EXPRESSION#0.7113;POLYMERASE CHAIN REACTION#0.6437;EPITHELIAL CELL#0.6031
10072	DIPEPTIDYL PEPTIDASE#1.0582;ZINC BINDING#1.0005;ENZYME ACTIVITY#0.9510;FARNESOL#0.8972;CARBOXYPEPTIDASE A#0.8369;ERYTHROCYTE#0.8087;ANGIOTENSIN CONVERTING ENZYME#0.7174;TRANSCRIPTION FACTOR#0.6872;LEUCINE#0.6624;MUTAGENESIS#0.6224;OVARIAN#0.6207
10073	NUCLEAR IMPORT#1.0620;IMPORTIN#0.9730;U1 SNRNP#0.8623;NUCLEAR EXPORT#0.8537
100750225	PROSTATE CANCER#1.0833;CELL PROLIFERATION#1.0825;CANCER CELL#1.0713;APOPTOSIS#1.0681;SIGNALING PATHWAY#1.0035;ONCOGENIC#0.9997;QUANTITATIVE REAL TIME#0.9888;POLYMERASE CHAIN REACTION#0.9866;CELL GROWTH#0.9859;OVARIAN CANCER#0.9757;HEPATOCELLULAR CARCINOMA#0.9429;COLORECTAL CANCER#0.9283;CELL CYCLE#0.9241;TUMOR TISSUES#0.8793;LYMPH NODE#0.8666;SQUAMOUS CELL CARCINOMA#0.8324;LUNG CANCER#0.8215;OVARIAN#0.8166;REVERSE TRANSCRIPTION#0.8048;ENDOMETRIAL CARCINOMA#0.7926;COLORECTAL#0.7856;CELL MIGRATION#0.7798;LYMPH NODE METASTASIS#0.7669;STEM CELL#0.7599;CISPLATIN#0.7435;WOUND HEALING#0.6272;DUAL LUCIFERASE REPORTER#0.6242;HOMOLOGOUS RECOMBINATION#0.6196;DRUG RESISTANCE#0.6161;SIGNALLING PATHWAY#0.6161;TUMOR SUPPRESSOR#0.6059;BREAST CANCER#0.6051
100750246	ANTISENSE RNA#0.9770;APOPTOSIS#0.9590;VASCULAR SMOOTH MUSCLE CELL#0.7533;HYPOXIA INDUCIBLE FACTOR#0.7503;SMOOTH MUSCLE CELL#0.7503;MUSCLE CELL#0.7496;SMOOTH MUSCLE#0.7484;AORTIC ANEURYSM#0.6879;ENDOTHELIAL CELL#0.6471;CELL PROLIFERATION#0.6463;INTRACRANIAL ANEURYSM#0.6281;VSMC PROLIFERATION#0.6207;COLORECTAL CARCINOMA#0.6079;VASCULAR ENDOTHELIAL CELL#0.6051
100750247	CELL PROLIFERATION#1.0729;ANTISENSE RNA#1.0287;HYPOXIA INDUCIBLE FACTOR#1.0197;HYPOXIA#0.9906;CELL MIGRATION#0.9189;APOPTOSIS#0.6838;BREAST CANCER#0.6614;CELL CYCLE#0.6580;CANCER CELL#0.6458;ADIPOSE-DERIVED STEM CELL#0.6174;AKT SIGNALING#0.6049
100750329	HEARING LOSS#0.6225
10075	UBIQUITIN PROTEIN LIGASE#1.0667;INTELLECTUAL DISABILITY#1.0523;UBIQUITIN#1.0417;BREAST CANCER#1.0395;CANCER CELL#1.0385;TUMOR SUPPRESSOR#1.0169;APOPTOSIS#1.0118;PROTEASOME#1.0067;DNA DAMAGE RESPONSE#1.0046;CELL PROLIFERATION#0.9795;SIGNALING PATHWAY#0.9703;STEM CELL#0.9698;DNA REPAIR#0.9474;CELL CYCLE#0.9395;B CELL#0.9385;APOPTOTIC#0.9311;BREAST CANCER CELL#0.9229;LUNG CANCER#0.9211;GENE EXPRESSION#0.8670;UBIQUITIN PROTEASOME SYSTEM#0.8492;COPY NUMBER GAIN#0.8276;CELL DEATH#0.8242;OXYGEN GLUCOSE DEPRIVATION#0.8185;BASE EXCISION REPAIR#0.8054;LYSINE#0.7707;UBIQUITIN PROTEASOME PATHWAY#0.7602;PROTEASOME PATHWAY#0.7583;COLORECTAL CANCER#0.7525;EPITHELIAL CELL#0.7273;DNA REPLICATION#0.7066;RNA INTERFERENCE#0.7060;BINDING PROTEIN 1#0.7003;PROSTATE CANCER#0.6956;COLORECTAL#0.6870;TRANSCRIPTION FACTOR#0.6796;HECT E3#0.6674;SPERMATOGENESIS#0.6601;MITOPHAGY#0.6416;DEUBIQUITINATING ENZYME#0.6385;GENOTOXIC#0.6354;CELLULAR DNA DAMAGE RESPONSE#0.6353;B LYMPHOCYTE HOMEOSTASIS#0.6254;NEUROGENESIS#0.6218;OXIDATIVE STRESS RESPONSE#0.6086;CELL DEVELOPMENT#0.6001
10076	PROTEIN TYROSINE PHOSPHATASE#1.0523;SECRETORY VESICLE#0.9419;STEM CELL#0.9170;T CELL#0.9145;SIGNALING PATHWAY#0.9106;TUMOR SUPPRESSOR#0.8364;GENE EXPRESSION#0.7441;PROTEIN KINASE#0.7256;CANCER CELL#0.7069;PERIPHERAL BLOOD#0.6939;MONONUCLEAR CELLS#0.6931;CELL ADHESION#0.6923;PROTEIN TYROSINE KINASE#0.6839;DRG DEVELOPMENT#0.6709;OSTEOCLAST#0.6570;EXTRACELLULAR REGION#0.6382;VESICLE FUSION#0.6350;JUXTAMEMBRANE#0.6275;B CELL#0.6234;SECRETORY VESICLE MEMBRANE#0.6208;FOCAL ADHESION#0.6190;MAST CELL#0.6165;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6148;BONE MARROW#0.6107;MITOGEN ACTIVATED PROTEIN#0.6080
100775105	BREAST CANCER#1.0351;SIGNAL PEPTIDE#1.0256;CANCER CELL#1.0178;VACCINIA#1.0074;MODIFIED VACCINIA ANKARA#1.0049;IFN-GAMMA#0.9945;CELL SURFACE#0.9928;VIRUS LIKE PARTICLE#0.9901;CIRCULATING RECOMBINANT FORM#0.9890;TROPISM#0.9886;MULTIPLE SCLEROSIS#0.9881;VIRAL GENOME#0.9877;POLYMERASE CHAIN REACTION#0.9873;LYMPH NODE#0.9867;SIMIAN IMMUNODEFICIENCY VIRUS#0.9853;VIRION#0.9851;PROVIRUS#0.9848;AVIAN LEUKOSIS#0.9846;REVERSE TRANSCRIPTION#0.9829;VIRAL ENVELOPE#0.9827;CD8+ T CELL#0.9822;GLYCOSYLATION#0.9805;HUMAN BREAST CANCER#0.9798;B CELL#0.9768;ADULT T-CELL LEUKEMIA#0.9743;HOST CELL#0.9730;TRANSCRIPTASE#0.9728;MONONUCLEAR CELLS#0.9725;DRUG RESISTANCE#0.9722;EPSTEIN BARR VIRUS#0.9721;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9717;GENE EXPRESSION#0.9715;T-CELL LEUKEMIA#0.9713;VIRAL REPLICATION#0.9707;CD4+ T CELL#0.9704;CYTOTOXIC T-LYMPHOCYTE#0.9700;HUMORAL IMMUNE RESPONSE#0.9687;VISNA#0.9658;MONOCYTE#0.9656;PERIPHERAL BLOOD#0.9655;T CELL#0.9652;MACROPHAGE#0.9641;NUCLEIC ACID#0.9635;T LYMPHOCYTE#0.9631;CELLULAR IMMUNE RESPONSE#0.9631;HUMAN IMMUNODEFICIENCY VIRUS#0.9620;IMMUNE RESPONSE#0.9569;NERVOUS SYSTEM#0.9552;CENTRAL NERVOUS SYSTEM#0.9491;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9485;IMMUNE SYSTEM#0.9479;CYTOPLASM#0.9478;VIRAL INFECTION#0.9394;PERIPHERAL BLOOD LYMPHOCYTES#0.9348;DENDRITIC CELL#0.9280;INTRACELLULAR CYTOKINE STAINING#0.9259;REVERSE TRANSCRIPTASE ACTIVITY#0.9251;ONCOGENIC#0.9221;VESICULAR STOMATITIS VIRUS#0.9141;APOPTOSIS#0.9124;BUDDING#0.9049;HERPES SIMPLEX#0.9025;NORMAL BREAST TISSUE#0.9021;TROPICAL SPASTIC PARAPARESIS#0.8927;CYTOTOXIC T CELL#0.8908;ANEMIA#0.8897;LEUKOCYTE#0.8877;PLASMA MEMBRANE#0.8825;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.8801;TRANSACTIVATION#0.8793;TYPE 1 DIABETES#0.8757;BONE MARROW#0.8755;CELL-MEDIATED IMMUNE RESPONSE#0.8741;TUMOR CELLS#0.8722;CELL PROLIFERATION#0.8711;HOMOLOGOUS RECOMBINATION#0.8706;ENDOPLASMIC RETICULUM#0.8659;HERPES SIMPLEX VIRUS#0.8647;EQUINE INFECTIOUS ANEMIA#0.8585;MUTAGENESIS#0.8562;LYMPHOID CELL#0.8526;BREAST CANCER CELL#0.8461;CELL MEMBRANE#0.8447;CELL FUSION#0.8415;NUCLEAR EXPORT#0.8402;CYTOTOXICITY#0.8389;LYMPHOID TISSUE#0.8367;B LYMPHOCYTE#0.8344;STOMATITIS#0.8335;PROTEIN SYNTHESIS#0.8302;REVERSE TRANSCRIPTASE INHIBITOR#0.8279;SYNCYTIUM FORMATION#0.8222;VIRAL GLYCOPROTEIN#0.8197;TRANSCRIPTION FACTOR#0.8131;ZIDOVUDINE#0.8084;LYSIS#0.8062;MILLION YEARS AGO#0.7985;ENFUVIRTIDE#0.7984;CELL ASSOCIATED#0.7947;NUCLEOCAPSID#0.7840;ANTISENSE RNA#0.7832;GERM CELL#0.7804;DIGESTION#0.7787;ENDOTHELIAL CELL#0.7751;AUTOIMMUNE DISEASE#0.7662;BREAST CANCER PATIENTS#0.7614;METHIONINE#0.7582;FRAGMENT LENGTH POLYMORPHISM#0.7546;RECEPTOR BINDING#0.7524;TROPHOBLAST#0.7520;VIRAL TRANSCRIPTION#0.7485;SYNCYTIOTROPHOBLAST#0.7482;RHEUMATOID ARTHRITIS#0.7444;DNA SYNTHESIS#0.7291;QUANTITATIVE REAL TIME#0.7127;CELL ACTIVATION#0.7046;APOPTOTIC#0.7031;SALIVARY GLAND#0.6970;INNATE IMMUNE RESPONSE#0.6958;PROTEIN KINASE#0.6906;MAMMARY GLAND#0.6823;CARRIE#0.6822;NEOMYCIN#0.6762;ERYTHROPOIETIN RECEPTOR#0.6744;CELL-MEDIATED IMMUNITY#0.6736;AUTOIMMUNITY#0.6711;FOWLPOX#0.6703;ANTIGEN PRESENTING CELLS#0.6701;TUMOR TISSUES#0.6696;LUNG CANCER#0.6673;PARALYSIS#0.6671;SIGNALING PATHWAY#0.6636;VIRAL ASSEMBLY#0.6627;COLON CANCER#0.6613;MEMORY T CELL#0.6567;VIRAL GENE EXPRESSION#0.6499;PLASMA VIRAL LOAD#0.6409;VIRULENCE#0.6284;AIDS RELATED COMPLEX#0.6276;ACUTE LEUKEMIA#0.6265;ANTIGEN PRESENTATION#0.6257;CUTANEOUS T CELL LYMPHOMA#0.6149;THYMOCYTE#0.6139;PLACENTATION#0.6134;RNA BINDING#0.6091;DNA METHYLATION#0.6079;EPITHELIAL CELL#0.6039
100775107	CANCER STEM-LIKE CELL#0.9250;COLON CANCER#0.9044
10077	T CELL#1.0412;HEMATOPOIETIC CELL#0.7283;SKELETAL MUSCLE#0.7232;IMMUNE RESPONSE#0.7213;COLON CARCINOMA#0.6544;MULTIPLE SCLEROSIS#0.6486;APOPTOSIS#0.6182
1007	CELL ADHESION#0.7451
10081	COLICIN#0.8068;OUTER MEMBRANE#0.7531;CELL DEATH#0.6261
100820829	INTERCALATED DISC#0.7841;SERUM RESPONSE FACTOR#0.7644;ZONULA OCCLUDENS 1#0.6850;ZONULA OCCLUDENS#0.6829;CARDIOMYOPATHY#0.6363
10082	PROTEOGLYCAN#0.9508;CELL SURFACE#0.8978;GROWTH FACTOR#0.8483;CANCER CELL#0.6972;OVARIAN CANCER#0.6551;FIBROBLAST GROWTH FACTOR#0.6524;GENE EXPRESSION#0.6376
10083	HAIR CELL#1.0359;USHER SYNDROME#1.0238;INNER EAR#1.0159;HEARING LOSS#0.9946;USHER SYNDROME TYPE 1#0.9877;RETINITIS PIGMENTOSA#0.9845;RETINITIS#0.9584;BLINDNESS#0.9451;HEARING IMPAIRMENT#0.9144;RETINAL DEGENERATION#0.9128;PHOTORECEPTOR CELL#0.8838;PDZ BINDING MOTIF#0.8269;BRUSH BORDER#0.7752;COLON CANCER#0.7575;SENSORINEURAL HEARING LOSS#0.7210;MICROVILLI#0.7062;PTC124#0.6886;EPITHELIAL CELL#0.6868;OUTER HAIR CELL#0.6707;ACTIN BUNDLING#0.6515;PROTEIN COMPLEX#0.6315;CYTOPLASMIC REGION#0.6122;PROTEIN PROTEIN INTERACTION#0.6080
100847001	DIPEPTIDYL PEPTIDASE 4#1.1984;DIPEPTIDYL PEPTIDASE#1.1936;VASCULAR ENDOTHELIAL CELL#1.1907;ENDOTHELIAL CELL#1.1798;PROTEIN KINASE#1.1787;AUTOPHAGY#0.8503;APOPTOSIS#0.8439
100847081	CANCER CELL#0.7566;OVARIAN#0.6451
10084	RENPENNING SYNDROME#1.1508;BINDING PROTEIN 1#1.0843;INTELLECTUAL DISABILITY#1.0640;MENTAL RETARDATION#1.0578;MRNA SPLICING#1.0308;PRE-MRNA SPLICING#0.9993;X CHROMOSOME#0.9910;MICROCEPHALY#0.9874;C TERMINAL DOMAIN#0.9425;GENE EXPRESSION#0.9012;STEM CELL#0.8587;CELL DEATH#0.8010;INTRINSICALLY DISORDERED PROTEIN#0.7802;NEURAL STEM PROGENITOR#0.7698;NEURODEGENERATIVE DISEASE#0.7603;TRANSCRIPTION FACTOR#0.7595;PROGENITOR CELL#0.7445;NEURONAL RNA GRANULE#0.6644;RNA GRANULE#0.6451
100859927	DYNEIN#0.8704;MICROTUBULE BINDING#0.7814;MICROTUBULE#0.7436;ATP HYDROLYSIS#0.6836;NUCLEOTIDE BINDING#0.6795
100859930	CELL PROLIFERATION#1.0437;HEPATOCELLULAR CARCINOMA#0.8939;APOPTOSIS#0.7920;CANCER CELL#0.6783;HEPATOCELLULAR CARCINOMA CELL#0.6377;ENDOMETRIAL CANCER#0.6365;HEPATOMA CELLS#0.6350;MAPK SIGNALING#0.6335;TUMOR TISSUES#0.6307;LUNG CANCER#0.6234;QUANTITATIVE REAL TIME#0.6229;BREAST CANCER#0.6206;SIGNALING PATHWAY#0.6195
10085	LEUKOCYTE#1.0662;KNEE JOINT#1.0604;EPIDERMAL GROWTH FACTOR#1.0578;GROWTH FACTOR#1.0568;ENDOTHELIAL CELL#1.0558;BREAST CANCER#1.0495;EXTRACELLULAR MATRIX#1.0479;ANGIOGENESIS#1.0466;LEUKOCYTE ADHESION#1.0065;CANCER CELL#0.9985;NEUTROPHIL#0.9949;APOPTOSIS#0.9705;TUMOR CELLS#0.9595;MACROPHAGE#0.9222;GENE EXPRESSION#0.9160;PERIODONTITIS#0.8981;BONE MARROW#0.8935;BLOOD VESSEL#0.8918;STEM CELL#0.8871;TRANSCRIPTION FACTOR#0.8686;CHONDROCYTE#0.8580;INFLAMMATORY CELL#0.8484;BREAST CANCER CELL#0.8467;WOUND HEALING#0.8301;OSTEOARTHRITIS#0.8200;ENDOTHELIAL GROWTH FACTOR#0.8051;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8051;ENDOTHELIUM#0.7941;MESENCHYMAL STEM CELL#0.7923;INTEGRIN BINDING#0.7656;CELL PROLIFERATION#0.7624;INTERMITTENT CLAUDICATION#0.7586;SALIVARY GLAND#0.7581;CELL CYCLE#0.7487;PERIPHERAL ARTERIAL DISEASE#0.7477;SIGNALING PATHWAY#0.7435;CELL MIGRATION#0.7319;ANOIKIS#0.7296;ISCHEMIA#0.7129;FIBROBLAST GROWTH FACTOR#0.7125;EXTRACELLULAR VESICLE#0.6865;LUNG CARCINOMA#0.6790;EPITHELIAL MESENCHYMAL TRANSITION#0.6774;HYPOXIA#0.6607;APOPTOTIC#0.6588;INFLAMMATORY RESPONSE#0.6520;VASCULAR MORPHOGENESIS#0.6370;INTEGRIN LIGAND#0.6287;SMOOTH MUSCLE#0.6271;CHONDROGENESIS#0.6248;PROTEOGLYCAN#0.6165;EARLY BREAST CANCER#0.6067;MORPHOGENESIS#0.6021
100861412	FIBRINOGEN#0.6803
100861440	HEARING IMPAIRMENT#1.2052
100861514	MACROPHAGE#0.8452
100861540	ACETAMINOPHEN#0.6570
100861550	URINARY TRACT OBSTRUCTION#0.7890;LOWER URINARY TRACT#0.7686
100862684	GERM CELL TUMORS#0.6005
10086	TERATOCARCINOMA#0.9046
100873790	PHOTOTOXICITY#0.6383
100874009	PHENYLALANINE AMMONIA LYASE#0.8548;GENE EXPRESSION#0.7470;TRANSCRIPTION FACTOR#0.6697
100874011	COLON CANCER#1.1871
100874028	BREAST CANCER#0.8969
100874041	CELL PROLIFERATION#0.7515;PANCREATIC CARCINOMA#0.7317;CELL GROWTH#0.7305;RNA BINDING PROTEIN#0.7230;RNA BINDING#0.7205;HEPATOCELLULAR CARCINOMA#0.7147;CANCER CELL#0.7084
100874054	CELL PROLIFERATION#1.1262;CANCER CELL#1.0820;CELL CYCLE#1.0751;ONCOGENIC#1.0459;SQUAMOUS CELL CARCINOMA#0.8894;QUANTITATIVE REAL TIME#0.8540;AKT SIGNALING#0.8515;ESOPHAGEAL CANCER#0.8152;ENDOTHELIAL CELL#0.7981;APOPTOSIS#0.7975;SIGNALING PATHWAY#0.7967;POLYMERASE CHAIN REACTION#0.7220;DUAL LUCIFERASE REPORTER#0.6443;TUMOR TISSUES#0.6381;RNA HELICASE#0.6380;EXOSOME#0.6209
100874074	LYMPH NODE METASTASIS#1.1886;COLORECTAL CANCER#1.1841;LYMPH NODE#1.1818;COLORECTAL#0.8485
100874075	CERVICAL CANCER#0.8083;CELL MIGRATION#0.8014;SIGNALING PATHWAY#0.7955
100874207	AKT SIGNALING#0.9079;COLORECTAL CANCER#0.9014;SIALYLATION#0.6621;COLORECTAL#0.6458
100874323	LUNG ADENOCARCINOMA#0.7216;STEM CELL#0.7096
100874345	PARATHYROID HORMONE#1.1854;OSTEOGENESIS#0.8559;OSTEOPOROSIS#0.8524;PARATHYROID#0.8500
100874366	CELL PROLIFERATION#0.9518;ANTISENSE RNA#0.7430;BREAST CANCER CELL#0.7152;BREAST CANCER#0.7099;CANCER CELL#0.7084;HEPATOCELLULAR CARCINOMA#0.6254
100874433	CELL CYCLE#1.1798
10087	GOLGI APPARATUS#1.0405;ENDOPLASMIC RETICULUM#1.0375;GOLGI MEMBRANE#0.9814;OXYSTEROL BINDING#0.9746;CONTACT SITE#0.9553;CERAMIDE TRANSPORT#0.9265;PROTEIN KINASE D#0.9224;GOLGI COMPLEX#0.9127;PROTEIN KINASE#0.9067;CHLAMYDIA#0.8022;PLASMA MEMBRANE#0.7967;ANTIGEN BINDING#0.7874;VESICULAR TRANSPORT#0.7800;HOST CELL#0.7783;TRANS GOLGI NETWORK#0.7684;BREAST CANCER#0.7435;SPHINGOSINE#0.7267;SPHINGOMYELIN SYNTHESIS#0.7055;CANCER CELL#0.7027;SPHINGOLIPID METABOLISM#0.6934;PHOSPHOINOSITIDE BINDING#0.6435;LIPID METABOLISM#0.6361;CELL DEATH#0.6323;APOPTOTIC#0.6252;T- PA#0.6186;GOLGI DISASSEMBLY#0.6183;CERAMIDE BINDING#0.6093
100885775	CELL PROLIFERATION#1.0817;CANCER CELL#1.0774;APOPTOSIS#1.0719;SIGNALING PATHWAY#1.0645;LYMPH NODE METASTASIS#1.0164;LYMPH NODE#1.0116;CELL MIGRATION#0.9924;POLYMERASE CHAIN REACTION#0.9561;COLORECTAL CANCER#0.9525;TUMOR TISSUES#0.9500;LUNG CANCER#0.9491;THYROID CANCER#0.9482;EPITHELIAL CELL#0.9389;ADJACENT NORMAL TISSUE#0.9254;CELL GROWTH#0.9057;THYROID CARCINOMA#0.8533;CELL CYCLE#0.8353;MAPK SIGNALING#0.8341;COLORECTAL#0.8272;SQUAMOUS CELL CARCINOMA#0.8264;REVERSE TRANSCRIPTION#0.7932;DIABETIC RETINOPATHY#0.7918;HEPATOCELLULAR CARCINOMA#0.7712;EPITHELIAL MESENCHYMAL TRANSITION#0.7155;PIGMENT EPITHELIAL CELL#0.7128;RETINAL PIGMENT EPITHELIAL#0.7108;ONCOGENIC#0.7108;PAPILLARY THYROID CARCINOMA#0.7029;TUMOR SUPPRESSOR#0.6694;RETINAL PIGMENT EPITHELIAL CELLS#0.6339;CELL CYCLE ARREST#0.6290;RETINOBLASTOMA#0.6214;BREAST CANCER#0.6129
100885779	CANCER CELL#1.0906;CELL PROLIFERATION#1.0775;STEM CELL#1.0757;BREAST CANCER#1.0621;APOPTOSIS#1.0469;PANCREATIC CANCER#1.0221;LYMPH NODE#1.0087;SIGNALING PATHWAY#1.0081;EPITHELIAL MESENCHYMAL TRANSITION#0.9886;POLYMERASE CHAIN REACTION#0.9828;SQUAMOUS CELL CARCINOMA#0.9583;TUMOR TISSUES#0.9422;CANCER STEM CELL#0.9422;LYMPH NODE METASTASIS#0.9258;LUNG CANCER#0.9136;BREAST CANCER CELL#0.9042;QUANTITATIVE REAL TIME#0.9032;EMBRYONIC STEM CELL#0.8974;EPITHELIAL TO MESENCHYMAL#0.8717;HYPOXIA#0.8645;PLURIPOTENT STEM CELL#0.8470;DUAL LUCIFERASE REPORTER#0.8279;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8268;TRANSCRIPTION FACTOR#0.8250;COLORECTAL CANCER#0.8175;INDUCED PLURIPOTENT STEM CELL#0.8083;COLON CANCER#0.7737;OVARIAN CANCER#0.7728;TUMOR CELLS#0.7229;ADJACENT NORMAL TISSUE#0.7143;HEPATOCELLULAR CARCINOMA#0.7067;REVERSE TRANSCRIPTION#0.7051;GENE EXPRESSION#0.6996;OVARIAN#0.6947;CELL MIGRATION#0.6645;COLORECTAL#0.6496;EXOSOME#0.6476;NEGATIVE CONTROL GROUP#0.6262;DISEASE FREE SURVIVAL#0.6246;EXTRACELLULAR VESICLE#0.6163;RNA INTERFERENCE#0.6116;DNA REPAIR#0.6103
100885789	T CELL#1.0743;TH1 CELL#0.7859;TRANSCRIPTION FACTOR#0.6752;IMMUNE RESPONSE#0.6139
100886964	THYROID CARCINOMA#1.0987;PAPILLARY THYROID CARCINOMA#1.0886;CANCER CELL#1.0512;CELL PROLIFERATION#1.0452;THYROID CANCER#1.0278;TUMOR SUPPRESSOR#0.8589;TUMOR TISSUES#0.8348;CELL CYCLE#0.7291;STEM CELL#0.6406;CERVICAL#0.6333;PERIODONTAL LIGAMENT STEM CELL#0.6274;APOPTOSIS#0.6266;ANAPLASTIC THYROID CANCER#0.6230;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6145;PERIODONTAL LIGAMENT#0.6056
100887755	CELL MIGRATION#0.7773;EPITHELIAL MESENCHYMAL TRANSITION#0.7069;HEPATOMA CELLS#0.6586;COLORECTAL CANCER#0.6487
10089	POTASSIUM CHANNEL#0.8996;ION CHANNEL#0.8088;SPINAL CORD#0.7927;ANESTHETIC#0.7901;GENE EXPRESSION#0.6698;EPITHELIAL CELL#0.6646;PROTEIN KINASE#0.6447
1008	CELL ADHESION#0.8013;NERVOUS SYSTEM#0.7375;PROSTATE CANCER#0.6336
10090	SULFATION#0.8121;CELL MIGRATION#0.6676;ACETYLGALACTOSAMINE-4-SULFATE#0.6114
10092	ACTIN RELATED PROTEIN#1.0468;ACTIN CYTOSKELETON#0.6221
10093	ACTIN RELATED PROTEIN#1.0460;ACTIN CYTOSKELETON#0.8373;ACTIN FILAMENT#0.7528;CELL MIGRATION#0.7162;CANCER CELL#0.7129
10094	ACTIN RELATED PROTEIN#0.9774;ACTIN NUCLEATION#0.7756;ACTIN FILAMENT#0.7057;ACTIN CYTOSKELETON#0.7023;PROTEIN COMPLEX#0.6771;COMPLEX I#0.6594;ACTIN POLYMERIZATION#0.6082
10095	ACTIN RELATED PROTEIN#0.9234;T CELL#0.8201;ACTIN FILAMENT#0.7409;ACTIN POLYMERIZATION#0.6939;CD8+ T CELL#0.6286
10096	ACTIN FILAMENT NUCLEATION#1.0654;WAVE COMPLEX#1.0454;F-ACTIN BINDING#1.0399;LAMELLIPODIUM#1.0291;PROTEIN COMPLEX#1.0256;ACTIN NUCLEATION#1.0252;ACTIN RELATED PROTEIN#1.0240;WISKOTT ALDRICH SYNDROME#1.0214;COMPLEX I#1.0210;ACTIN POLYMERIZATION#1.0064;ACTIN FILAMENT#1.0049;ACTIN FILAMENT BUNDLE#0.9981;SIGNALING PATHWAY#0.9981;SCAR COMPLEX#0.9980;WAVE REGULATORY COMPLEX#0.9971;ACTIN BINDING PROTEIN#0.9941;MORPHOGENESIS#0.9923;ACTIN BINDING#0.9922;ENDOCYTOSIS#0.9912;PODOSOME#0.9885;MICROTUBULE#0.9875;CYTOKINESIS#0.9866;FILAMENTOUS ACTIN#0.9864;OOCYTE#0.9856;HOST CELL#0.9856;CELL MOTILITY#0.9847;PHAGOCYTOSIS#0.9821;CANCER CELL#0.9816;GROWTH FACTOR#0.9815;PLASMA MEMBRANE#0.9808;CELL MIGRATION#0.9790;ACTIN CYTOSKELETON#0.9775;FOCAL ADHESION#0.9773;ACTIN FILAMENT BRANCHING#0.9759;T CELL#0.9740;CELL MORPHOGENESIS#0.9687;CELL ADHESION#0.9670;CELL POLARITY#0.9655;DENDRITIC SPINE#0.9639;CELL SURFACE#0.9637;CYTOPLASM#0.9637;ATP BINDING#0.9622;EPITHELIAL CELL#0.9604;ENDOTHELIAL CELL#0.9569;SMOOTH MUSCLE#0.9511;EXTRACELLULAR MATRIX#0.9498;EPIDERMAL GROWTH FACTOR#0.9477;GROWTH CONE#0.9414;NUCLEOTIDE BINDING#0.9413;PROTEIN KINASE#0.9303;RUFFLE#0.9220;GENE EXPRESSION#0.9206;ACTIN PATCH#0.9199;FILOPODIA FORMATION#0.9158;MACROPHAGE#0.9103;RNA INTERFERENCE#0.9060;ENDOSOME#0.9048;CELL PERIPHERY#0.9002;CELL MOVEMENT#0.8988;CELL MEMBRANE#0.8970;ACTIN DEPOLYMERIZING FACTOR#0.8940;CLATHRIN-MEDIATED ENDOCYTOSIS#0.8917;CELL DIVISION#0.8912;GROWTH FACTOR RECEPTOR#0.8851;GOLGI MEMBRANE#0.8756;ATP HYDROLYSIS#0.8737;MYOBLAST FUSION#0.8720;MICROFILAMENT#0.8715;CELL CORTEX#0.8699;STRESS FIBER#0.8684;MEMBRANE RUFFLING#0.8671;CELL CYCLE#0.8650;ACTOMYOSIN#0.8616;WASP INTERACTING PROTEIN#0.8583;MEMBRANE RUFFLE#0.8536;ORGANELLE#0.8532;VACCINIA#0.8504;CELL JUNCTION#0.8502;LAMELLIPODIUM FORMATION#0.8497;BREAST CANCER#0.8490;SIGNAL TRANSDUCTION#0.8488;STEM CELL#0.8452;TOTAL INTERNAL REFLECTION#0.8375;CHEMOTAXIS#0.8365;AXON DEVELOPMENT#0.8347;LOCOMOTION#0.8299;MYOBLAST#0.8219;CELL ACTIVATION#0.8215;CELL LEADING EDGE#0.8200;NEUTROPHIL#0.8187;CELL GROWTH#0.8081;NERVOUS SYSTEM#0.8058;SIGNALING CASCADE#0.8018;VASODILATOR#0.8014;SERTOLI CELL#0.7992;ENDOCYTIC VESICLE#0.7977;ACTIN BUNDLING#0.7931;BUDDING#0.7920;APICAL ES#0.7871;ADHERENS JUNCTION#0.7841;INVADOPODIUM FORMATION#0.7832;CELL LOCOMOTION#0.7796;VESICLE TRAFFICKING#0.7726;ACTIN CABLE#0.7673;PHAGOCYTIC CUP#0.7646;MUSCLE CELL#0.7635;ACTIN CAP#0.7598;INVADOPODIUM#0.7587;SIGNALLING PATHWAY#0.7549;WASH COMPLEX#0.7548;ACTIN MONOMER BINDING#0.7526;ACTIN FILAMENT BINDING#0.7485;PHAGOSOME#0.7454;C TERMINAL DOMAIN#0.7425;FILOPODIUM FORMATION#0.7377;MEIOSIS#0.7278;DOMINANT NEGATIVE MUTANT#0.7219;CELL CELL ADHESION#0.7157;P21 ACTIVATED KINASE#0.7116;MOLECULAR DYNAMICS SIMULATION#0.7060;SRC FAMILY KINASE#0.7060;FOCAL ADHESION KINASE#0.7047;MITOSIS#0.7042;RESONANCE ENERGY TRANSFER#0.7035;NEURONAL CELLS#0.7025;CORTICAL ACTIN CYTOSKELETON#0.6970;FILOPODIUM#0.6796;NEURITE#0.6777;TIGHT JUNCTION#0.6750;CELL EXPANSION#0.6746;BLOOD TESTIS BARRIER#0.6732;MICROTUBULE CYTOSKELETON#0.6713;OOCYTE MATURATION#0.6637;T CELL ACTIVATION#0.6635;MICROSPIKE FORMATION#0.6581;WOUND HEALING#0.6568;CELL BODY#0.6518;PROTEIN KINASE C#0.6480;SIGNALING MOLECULE#0.6458;KINASE ACTIVITY#0.6431;TUMOR CELLS#0.6407;IMMUNOLOGICAL SYNAPSE#0.6393;MICROVILLI#0.6363;EARLY ENDOSOME#0.6339;GUANINE#0.6329;BRUSH BORDER ASSEMBLY#0.6324;NUCLEOTIDE EXCHANGE FACTOR#0.6314;G ACTIN BINDING#0.6272;ZONULA ADHERENS#0.6211;OSTEOCLAST#0.6184;ASTROCYTE#0.6160;BASAL ES#0.6147;ACTIN CYTOSKELETON REMODELING#0.6146;ENDOPLASMIC RETICULUM#0.6135;CELL CELL JUNCTION#0.6115;NUCLEAR MIGRATION#0.6102;HOMOLOGY-DIRECTED REPAIR#0.6099;LYMPH NODE#0.6092;PSEUDOPOD#0.6084;REGULATION OF ACTIN POLYMERIZATION#0.6076;INTRACELLULAR TRANSPORT#0.6015
10097	ACTIN FILAMENT NUCLEATION#1.0661;ACTIN FILAMENT BRANCHING#1.0595;F-ACTIN BINDING#1.0436;WAVE COMPLEX#1.0422;LAMELLIPODIUM#1.0351;COMPLEX I#1.0322;PROTEIN COMPLEX#1.0321;ACTIN NUCLEATION#1.0267;PODOSOME#1.0262;ACTIN RELATED PROTEIN#1.0224;SCAR COMPLEX#1.0211;WISKOTT ALDRICH SYNDROME#1.0204;OOCYTE#1.0154;ACTIN POLYMERIZATION#1.0080;ACTIN FILAMENT#1.0056;FILOPODIA FORMATION#1.0020;SIGNALING PATHWAY#0.9977;MORPHOGENESIS#0.9976;ENDOCYTOSIS#0.9975;FILAMENTOUS ACTIN#0.9972;FOCAL ADHESION#0.9961;ACTIN BINDING#0.9925;ACTIN PATCH#0.9921;GROWTH CONE#0.9914;ACTIN BINDING PROTEIN#0.9914;MICROTUBULE#0.9912;CANCER CELL#0.9901;T CELL#0.9891;GROWTH FACTOR#0.9885;HOST CELL#0.9838;CELL MOTILITY#0.9807;CYTOKINESIS#0.9807;CELL MORPHOGENESIS#0.9790;PLASMA MEMBRANE#0.9784;CELL MIGRATION#0.9784;CELL ADHESION#0.9773;RUFFLE#0.9765;DENDRITIC SPINE#0.9764;STRESS FIBER#0.9727;ACTIN CYTOSKELETON#0.9704;ENDOTHELIAL CELL#0.9693;CELL SURFACE#0.9690;CYTOPLASM#0.9675;PHAGOCYTOSIS#0.9631;EPITHELIAL CELL#0.9625;EXTRACELLULAR MATRIX#0.9611;VACCINIA#0.9554;EPIDERMAL GROWTH FACTOR#0.9545;CLATHRIN-MEDIATED ENDOCYTOSIS#0.9539;CELL POLARITY#0.9523;RNA INTERFERENCE#0.9509;ATP HYDROLYSIS#0.9474;ATP BINDING#0.9469;ACTOMYOSIN#0.9444;MACROPHAGE#0.9398;MEMBRANE RUFFLE#0.9371;MEMBRANE RUFFLING#0.9339;LOCOMOTION#0.9326;CELL DIVISION#0.9310;ACTIN CABLE#0.9271;TOTAL INTERNAL REFLECTION#0.9240;SMOOTH MUSCLE#0.9236;ACTIN FILAMENT BUNDLE#0.9136;CELL LOCOMOTION#0.9132;ADHERENS JUNCTION#0.9126;CELL CORTEX#0.9122;ENDOSOME#0.9119;LAMELLIPODIUM FORMATION#0.9098;CELL PERIPHERY#0.9074;CELL MEMBRANE#0.9040;ORGANELLE#0.9015;WAVE REGULATORY COMPLEX#0.8999;ACTIN DEPOLYMERIZING FACTOR#0.8932;VESICLE TRAFFICKING#0.8925;SIGNAL TRANSDUCTION#0.8860;CELL MOVEMENT#0.8803;MUSCLE CELL#0.8792;CELL JUNCTION#0.8749;WASH COMPLEX#0.8714;ACTIN CYTOSKELETON REMODELING#0.8713;MYOBLAST FUSION#0.8712;GENE EXPRESSION#0.8662;BUDDING#0.8639;SIGNALLING PATHWAY#0.8598;STEM CELL#0.8555;MICROFILAMENT#0.8545;CORTICAL ACTIN CYTOSKELETON#0.8506;ACTIN MONOMER BINDING#0.8500;MYOBLAST#0.8412;NEUTROPHIL#0.8367;AXON DEVELOPMENT#0.8335;SIGNALING CASCADE#0.8259;NUCLEOTIDE BINDING#0.8212;C TERMINAL DOMAIN#0.8207;GROWTH FACTOR RECEPTOR#0.8195;MITOSIS#0.8191;NUCLEAR MIGRATION#0.8182;CENTROSOME#0.8125;BREAST CANCER#0.8098;ENDOCYTIC VESICLE#0.8084;ACTIVIN RECEPTOR#0.8026;ACTIN CAP#0.8014;BRISTLE DEVELOPMENT#0.7967;CHEMOTAXIS#0.7966;NERVOUS SYSTEM#0.7963;OOCYTE MATURATION#0.7902;CONTRACTILE RING#0.7846;INVADOPODIUM FORMATION#0.7824;COATED PIT#0.7767;CELL LEADING EDGE#0.7732;CLATHRIN-COATED PIT#0.7645;CELL CYCLE#0.7611;PROTEIN KINASE#0.7589;INVADOPODIUM#0.7580;KINASE ACTIVITY#0.7571;MOLECULAR DYNAMICS SIMULATION#0.7547;WASP INTERACTING PROTEIN#0.7542;GOLGI MEMBRANE#0.7533;HEALTHY CONTROL GROUP#0.7484;MEIOSIS#0.7440;REGULATION OF ACTIN POLYMERIZATION#0.7428;VASODILATOR#0.7344;WOUND HEALING#0.7326;SPINE HEAD#0.7292;FILOPODIUM#0.7279;CELL CELL ADHESION#0.7278;CELL GROWTH#0.7275;MEMBRANE INVAGINATION#0.7129;OSTEOCLAST#0.7000;ZONULA ADHERENS#0.6996;ACTIN BUNDLING#0.6986;T LYMPHOCYTE#0.6957;CELL EXPANSION#0.6890;P21 ACTIVATED KINASE#0.6863;G ACTIN BINDING#0.6797;TUMOR CELLS#0.6785;ACTIN FILAMENT BINDING#0.6751;VIRULENCE#0.6710;PHAGOCYTIC CUP#0.6696;AUTOPHAGY#0.6656;AUTOPHAGOSOME#0.6652;CD4+ T CELL#0.6645;CELL CELL JUNCTION#0.6612;MICROTUBULE CYTOSKELETON#0.6592;FOCAL ADHESION KINASE#0.6535;APOPTOSIS#0.6535;LYMPH NODE#0.6535;CELL BODY#0.6511;DOMINANT NEGATIVE MUTANT#0.6497;RESONANCE ENERGY TRANSFER#0.6489;SIGNALING MOLECULE#0.6451;RECEPTOR TYROSINE KINASE#0.6435;ENDOPLASMIC RETICULUM#0.6426;SMOOTH MUSCLE CELL#0.6417;INTRACELLULAR TRANSPORT#0.6338;EARLY ENDOSOME#0.6332;CELL FUSION#0.6327;NEURITE#0.6324;AXON GUIDANCE#0.6316;BRUSH BORDER ASSEMBLY#0.6311;MUTAGENESIS#0.6306;EMBRYO DEVELOPMENT#0.6300;IMMUNOLOGICAL SYNAPSE#0.6277;NEURONAL CELLS#0.6249;MICROVILLI#0.6248;APICAL ES#0.6228;FILOPODIUM FORMATION#0.6217;NUCLEOTIDE EXCHANGE FACTOR#0.6158;PLATELET-DERIVED GROWTH FACTOR#0.6122;HOMOLOGY-DIRECTED REPAIR#0.6089;CELL PROLIFERATION#0.6070
10098	ENDOPLASMIC RETICULUM#0.6835;TROPHOBLAST#0.6220;OSTEOCLAST#0.6194
100996301	ANTISENSE RNA#0.6974;CELL PROLIFERATION#0.6831;LUNG EPITHELIAL CELL#0.6544;THYROID CANCER#0.6481;BREAST CANCER CELL#0.6403;EPITHELIAL CELL#0.6353;SIGNALING PATHWAY#0.6339
100996348	COLORECTAL CANCER#0.9014;COLORECTAL#0.6458;APOPTOSIS#0.6411
100996569	T CELL#0.7409
100996949	PYRUVATE#1.0433;PYRUVATE DEHYDROGENASE COMPLEX#1.0029;DEHYDROGENASE COMPLEX#0.9995;DNA BINDING#0.7734;VIRULENCE#0.6599;ANTHER DEVELOPMENT#0.6165
10099	FIBRONECTIN BINDING#0.6175
1009	NEURAL CREST#1.0658;MYOFIBROBLAST#1.0497;STROMAL CELL#1.0406;NEURAL CREST CELL#1.0388;SMOOTH MUSCLE#1.0362;PROSTATE CANCER#1.0357;FIBROBLAST LIKE SYNOVIOCYTES#1.0353;OSTEOBLAST#1.0326;MESENCHYMAL CELL#1.0322;AORTIC VALVE#1.0197;BREAST CANCER CELL#1.0195;TUMOR SUPPRESSOR#1.0165;SYNOVIUM#1.0161;CELL CELL ADHESION#1.0144;CELL MIGRATION#1.0115;POLYMERASE CHAIN REACTION#1.0112;BREAST CANCER#1.0107;RHEUMATOID ARTHRITIS#1.0096;SMOOTH MUSCLE ACTIN#1.0094;EPITHELIAL CELL#1.0093;CELL ADHESION MOLECULE#1.0083;CELL SURFACE#1.0070;CANCER CELL#1.0062;EPITHELIAL TO MESENCHYMAL#1.0059;MACROPHAGE#1.0039;GROWTH FACTOR#1.0006;CELL ADHESION#0.9998;TRANSFORMING GROWTH FACTOR#0.9932;STEM CELL#0.9924;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9907;EXTRACELLULAR MATRIX#0.9859;TRANSCRIPTION FACTOR#0.9843;ADHERENS JUNCTION#0.9805;CELL PROLIFERATION#0.9791;GENE EXPRESSION#0.9789;MESENCHYMAL STEM CELL#0.9630;BONE MARROW#0.9521;CELL DIFFERENTIATION#0.9498;REVERSE TRANSCRIPTION#0.9413;MUSCLE CELL#0.9365;TROPHOBLAST#0.9301;CRANIAL NEURAL CREST#0.9279;CELL-CELL ADHESION MOLECULE#0.9264;TUMOR NECROSIS FACTOR#0.9218;SMOOTH MUSCLE CELL#0.9203;MESENCHYME#0.9195;FOCAL ADHESION#0.9188;STROMA#0.9162;EPITHELIAL MESENCHYMAL TRANSITION#0.9127;AORTIC VALVE DISEASE#0.9068;MORPHOGENESIS#0.9008;SIGNALING PATHWAY#0.8974;LYMPH NODE#0.8939;ENDOMETRIUM#0.8894;CELL MOTILITY#0.8876;MENSTRUAL CYCLE#0.8853;DETRUSOR SMOOTH MUSCLE#0.8771;OSTEOBLAST DIFFERENTIATION#0.8704;GROWTH FACTOR RECEPTOR#0.8656;ALKALINE PHOSPHATASE#0.8638;PULMONARY FIBROSIS#0.8476;ESTRADIOL#0.8440;PROGENITOR CELL#0.8422;PERIPHERAL BLOOD#0.8418;RETINOBLASTOMA#0.8366;BONE FORMATION#0.8365;OSTEOARTHRITIS#0.8335;CELL JUNCTION#0.8253;INTERSTITIAL CELL#0.8230;ENDOTHELIAL CELL#0.8197;TUMOR CELLS#0.8126;CYTOTROPHOBLAST#0.8016;TROPHOBLAST CELL#0.7982;HUMAN BREAST CANCER#0.7883;PROGESTERONE#0.7812;CELL CELL JUNCTION#0.7790;ONCOGENIC#0.7777;CONNEXIN#0.7610;SYNOVITIS#0.7606;SPINAL CORD#0.7564;PLASMA MEMBRANE#0.7473;QUANTITATIVE REAL TIME#0.7471;TERMINAL DIFFERENTIATION#0.7452;APOPTOSIS#0.7380;DNA METHYLATION#0.7290;OSTEOGENESIS#0.7246;NODULE FORMATION#0.7219;CELL AGGREGATION#0.7216;PLATELET-DERIVED GROWTH FACTOR#0.7092;CELL GROWTH#0.7010;INVASIVE BREAST CANCER#0.6803;ACTIN CYTOSKELETON#0.6760;RNA INTERFERENCE#0.6743;NERVOUS SYSTEM#0.6741;CHONDROCYTE#0.6723;CANCER STEM CELL#0.6721;EMBRYONIC STEM CELL#0.6629;WOUND HEALING#0.6615;TRANSFORMING GROWTH FACTOR BETA#0.6600;PROTEIN KINASE#0.6573;TRANSCRIPTASE#0.6557;BLOOD VESSEL#0.6544;VASCULAR CELL#0.6511;ADENOCARCINOMA#0.6463;REGENERATION#0.6393;CONNECTIVE TISSUE#0.6319;SIGNALLING PATHWAY#0.6291;MYOBLAST#0.6278;CELL MEMBRANE#0.6243;ANGIOGENESIS#0.6225;FIBROBLAST GROWTH FACTOR#0.6191;KERATINOCYTE#0.6124;OVARIAN#0.6101;AKT SIGNALING#0.6076;SYSTEM DEVELOPMENT#0.6073;DERMAL FIBROBLAST#0.6040;ALKALINE PHOSPHATASE ACTIVITY#0.6030;IL-11#0.6017;PHOSPHATASE ACTIVITY#0.6004
100	ADENOSINE AMINOHYDROLASE#1.0911;ADENOSINE DEAMINASE#1.0703;ADENOSINE#1.0452;ERYTHROCYTE#1.0257;HISTONE ACETYLTRANSFERASE#1.0064;ADENINE#0.9855;DEOXYADENOSINE#0.9430;TUBERCULOSIS#0.9236;ACETYLTRANSFERASE COMPLEX#0.9212;SAGA COMPLEX#0.9110;SEVERE COMBINED IMMUNODEFICIENCY#0.8976;T CELL#0.8733;COMPLEX I#0.8282;DIABETES MELLITUS#0.8169;PLEURISY#0.8155;INTESTINAL MUCOSA#0.8088;DEOXYCOFORMYCIN#0.8029;HISTONE ACETYLTRANSFERASE COMPLEX#0.7467;LYMPHOBLAST#0.7465;TOXICITY#0.7342;INOSINE#0.7270;PULMONARY TUBERCULOSIS#0.7089;HISTONE ACETYLATION#0.7067;LYSINE#0.6901;ADENOSINE DEAMINASE DEFICIENCY#0.6824;GLUCOCORTICOID RECEPTOR#0.6743;TYPE 2 DIABETES#0.6621;PLASMA PROTEIN#0.6535;B CELL#0.6305;PYRIMIDINE METABOLISM#0.6249;IMMUNE RESPONSE#0.6149;SPUTUM#0.6039
10100	GENE EXPRESSION#0.9114;CELL MOTILITY#0.6327;MIGRAINE#0.6305;LUNG CANCER#0.6244;SMOOTH MUSCLE#0.6237;LARGE EXTRACELLULAR LOOP#0.6116
10101	NUCLEOTIDE BINDING#1.0726;NEUROBLASTOMA#1.0684;IRON SULFUR CLUSTER#0.8948;PROTEASOME#0.8737;CELL DEATH#0.7086;IRON-SULFUR CLUSTER ASSEMBLY#0.6960;VITAMIN E#0.6747;SUCCINATE#0.6130;APOPTOSIS#0.6117;CYCLIC AMP#0.6103
10102	NUCLEOTIDE EXCHANGE FACTOR#1.0643;GUANINE#1.0518;TRANSLATION ELONGATION FACTOR#1.0467;TRANSLATION ELONGATION#1.0433;RIBOSOMAL PROTEIN#1.0346;PROTEIN SYNTHESIS#1.0159;RIBOSOME#0.9994;PROTEIN SYNTHESIS ELONGATION#0.9975;MITOCHONDRIAL TRANSLATION#0.9897;MITOCHONDRIAL TRANSLATION ELONGATION#0.9528;GTP HYDROLYSIS#0.9312;NUCLEOTIDE BINDING#0.8960;GTPASE ACTIVITY#0.8706;COMPLEX I#0.8492;GUANOSINE#0.7720;TRANSLATIONAL ELONGATION#0.7361;PROTEIN BIOSYNTHESIS#0.7226;RNA REPLICATION#0.6987;MITOCHONDRIA#0.6561;CHLOROPLAST#0.6470;TRNA BINDING#0.6219;RENATURATION#0.6068;RIBOSOMAL SUBUNIT#0.6040
10103	CANCER CELL#1.0533;CELL SURFACE#1.0178;CELL MIGRATION#0.9906;GENE EXPRESSION#0.9198;CELL CYCLE#0.9041;PANCREATIC CANCER#0.8992;CELL PROLIFERATION#0.8940;CELL MOTILITY#0.8180;APOPTOSIS#0.8030;PLASMA MEMBRANE#0.7831;EPITHELIAL CELL#0.7830;PULMONARY FIBROSIS#0.7495;POLYMERASE CHAIN REACTION#0.7304;SQUAMOUS CELL CARCINOMA#0.7029;REVERSE TRANSCRIPTION#0.6851;ADENOCARCINOMA#0.6781;CELL ADHESION#0.6723;T CELL#0.6689;SIGNAL TRANSDUCTION#0.6602;LYMPH NODE#0.6601;WOUND HEALING#0.6437;COLON CANCER#0.6198;PROSTATE CANCER#0.6178;HUMAN PANCREATIC CANCER#0.6175;ALVEOLAR EPITHELIAL CELL#0.6170;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6123;EPITHELIAL TO MESENCHYMAL#0.6121;LEUKOCYTE#0.6060;HEPATOCELLULAR CARCINOMA#0.6042
101054525	CONN'S SYNDROME#0.6095
10105	ADENINE NUCLEOTIDE TRANSLOCASE#1.0618;ANION CHANNEL#1.0541;CYCLOPHILIN#1.0471;CYCLOSPORINE#1.0388;ADENINE#1.0376;MITOCHONDRIAL MATRIX#1.0376;CYCLOSPORIN A#1.0182;CYCLOSPORIN#1.0172;ATP SYNTHASE#1.0166;SKELETAL MUSCLE#1.0133;CANCER CELL#1.0113;CYTOCHROME C#1.0055;MITOCHONDRIAL MEMBRANE POTENTIAL#1.0026;CELL DEATH#1.0015;MITOCHONDRIAL PERMEABILITY TRANSITION#0.9984;PERMEABILITY TRANSITION PORE#0.9976;ISCHEMIA#0.9969;APOPTOTIC#0.9949;APOPTOSIS#0.9948;MITOCHONDRIAL MEMBRANE#0.9945;REACTIVE OXYGEN SPECIES#0.9851;MITOCHONDRIA#0.9843;SWELLING#0.9840;ISCHEMIA REPERFUSION INJURY#0.9816;INNER MITOCHONDRIAL MEMBRANE#0.9780;ISOMERASE ACTIVITY#0.9728;CARDIOMYOCYTE#0.9702;NECROTIC#0.9664;NECROPTOSIS#0.9567;ALZHEIMER'S DISEASE#0.9468;NECROTIC CELL DEATH#0.9383;PHOSPHATE CARRIER#0.9326;GENE EXPRESSION#0.9161;CYTOCHROME C RELEASE#0.9093;PROGRAMMED NECROSIS#0.8819;MITOCHONDRIAL INNER MEMBRANE#0.8787;MITOCHONDRIAL DEPOLARIZATION#0.8735;CYTOTOXICITY#0.8718;PANCREATIC CANCER#0.8452;SIGNALING PATHWAY#0.8401;OUTER MEMBRANE#0.8397;CIS-TRANS ISOMERASE ACTIVITY#0.8333;RESPIRATION#0.8273;GLUTATHIONE#0.8140;PROTEIN KINASE#0.8101;COMPLEX I#0.8072;MITOCHONDRIAL MEMBRANE PERMEABILITY#0.7902;TOXICITY#0.7635;PPIASE ACTIVITY#0.7634;T CELL#0.7530;CALCINEURIN#0.7297;LUNG CANCER#0.7251;APOPTOTIC CELL DEATH#0.7249;OXYGEN GLUCOSE DEPRIVATION#0.7232;SUPEROXIDE DISMUTASE#0.7142;AUTOPHAGY#0.7097;GLYCOGEN SYNTHASE KINASE#0.7089;PROGRAMMED CELL DEATH#0.7070;MITOCHONDRIAL DAMAGE#0.6989;ARTERY#0.6887;HIGH FAT DIET#0.6760;CEREBRAL ISCHEMIA#0.6744;MYOCYTES#0.6734;MITOCHONDRIAL MEMBRANE PERMEABILITY TRANSITION#0.6691;REGULATED NECROSIS#0.6633;MEMBRANE PERMEABILITY TRANSITION#0.6620;OXIDATIVE PHOSPHORYLATION#0.6537;SIGNAL TRANSDUCTION#0.6492;MYOCARDIAL INFARCTION#0.6487;TRANSCRIPTION FACTOR#0.6469;MYOCARDIAL INFARCT SIZE#0.6447;MYOCARDIUM#0.6384;ROS GENERATION#0.6359;MUSCULAR DYSTROPHY#0.6336;COMPOUND 19#0.6282;ETHANOL#0.6248;NEUROTOXICITY#0.6159;MITOCHONDRION#0.6120;KREBS CYCLE#0.6085;MITOCHONDRIAL TRANSCRIPTION#0.6027
101060264	TUMOR TISSUES#0.6790;HEPATOCELLULAR CARCINOMA#0.6737;ANTISENSE RNA#0.6105;APOPTOSIS#0.6095;QUANTITATIVE REAL TIME#0.6012
10106	STEROL CARRIER PROTEIN#1.0606;C TERMINAL DOMAIN#0.7881;CELL CYCLE#0.6750;GENE EXPRESSION#0.6466;PLASMA MEMBRANE#0.6459;PHOSPHATASE ACTIVITY#0.6328
10107	TRANSCRIPTION FACTOR#0.9327;GENE EXPRESSION#0.8272;ERYTHROID CELL#0.6267;TERMINAL DIFFERENTIATION#0.6172
10109	ACTIN RELATED PROTEIN#1.0797;BREAST CANCER#0.9231;CANCER CELL#0.9045;CELL MIGRATION#0.8079;ACTIN FILAMENT#0.7638;CELL GROWTH#0.7535;ACTIN NUCLEATION#0.7248;ACTIN CYTOSKELETON#0.7027;ACTIN POLYMERIZATION#0.6887;COMPLEX I#0.6579;ACTIN BINDING#0.6551;REGULATORY LIGHT CHAIN#0.6415;MUSCLE CELL#0.6288;SMOOTH MUSCLE#0.6277;WISKOTT ALDRICH SYNDROME#0.6236;SMOOTH MUSCLE CELL#0.6126
1010	CELL ADHESION#0.7994;COLORECTAL CANCER#0.7692;NERVOUS SYSTEM#0.6894;CENTRAL NERVOUS SYSTEM#0.6609;CANCER CELL#0.6593;COLORECTAL#0.6579;ADENOID CYSTIC CARCINOMA#0.6497;TUBE FORMATION#0.6397;COLORECTAL CARCINOMA#0.6389
101101692	TROPHOBLAST#0.8549
10110	OOCYTE#0.9039;PROTEIN KINASE#0.8623;PROTEIN KINASE B#0.8288
10111	RAD50 COMPLEX#1.0972;DNA REPAIR COMPLEX#1.0881;MRX COMPLEX#1.0693;PROTEIN COMPLEX#1.0442;ATP BINDING#1.0384;MRE11 COMPLEX#1.0365;MRN COMPLEX#1.0351;DNA LIGASE#1.0285;ATP HYDROLYSIS#1.0252;RECOMBINATIONAL REPAIR#1.0221;TELOMERE MAINTENANCE#1.0207;DNA REPAIR PROTEIN#1.0127;COMPLEX I#1.0105;S-PHASE CHECKPOINT#1.0046;TELOMERE#1.0041;DOUBLE-STRAND BREAK REPAIR#1.0028;REPLICATION PROTEIN A#1.0026;DNA DAMAGE CHECKPOINT#0.9992;NUCLEASE ACTIVITY#0.9982;MISMATCH REPAIR#0.9963;ATAXIA TELANGIECTASIA MUTATED#0.9960;HOMOLOGOUS RECOMBINATION REPAIR#0.9959;DNA BINDING#0.9946;NIJMEGEN BREAKAGE SYNDROME#0.9931;REPLICATION FORK#0.9921;CELL CYCLE CHECKPOINT#0.9920;BREAST CANCER#0.9904;MEIOSIS#0.9897;OVARIAN CANCER#0.9865;BUDDING#0.9850;DNA REPAIR#0.9848;S PHASE#0.9845;TOPOISOMERASE#0.9841;PROTEIN KINASE#0.9836;EXONUCLEASE ACTIVITY#0.9827;ATAXIA TELANGIECTASIA#0.9826;CELL CYCLE ARREST#0.9818;COLORECTAL#0.9814;DOUBLE STRAND BREAK#0.9810;CELLULAR DNA DAMAGE RESPONSE#0.9807;CHROMATID#0.9806;COLORECTAL CANCER#0.9805;DNA DAMAGE RESPONSE#0.9787;HOMOLOGOUS RECOMBINATION#0.9783;TUMOR SUPPRESSOR#0.9779;KINASE ACTIVITY#0.9766;DNA REPLICATION#0.9722;OVARIAN#0.9717;CELL CYCLE#0.9716;CANCER CELL#0.9704;APOPTOSIS#0.9703;MITOTIC RECOMBINATION#0.9690;GENE EXPRESSION#0.9688;SIGNALING PATHWAY#0.9674;ATPASE ACTIVITY#0.9650;GENE CONVERSION#0.9621;CELL DEATH#0.9593;TRANSCRIPTION FACTOR#0.9587;DNA SYNTHESIS#0.9545;GENOTOXIC#0.9520;HYPERSENSITIVITY#0.9486;ENDONUCLEASE ACTIVITY#0.9481;CISPLATIN#0.9460;POLY ADP RIBOSE#0.9388;DNA HELICASE#0.9346;CELL CYCLE CONTROL#0.9298;RESPONSE TO IONIZING RADIATION#0.9257;VIRAL REPLICATION#0.9253;ADENYLATE KINASE#0.9251;VIRAL DNA REPLICATION#0.9177;TUMOR CELLS#0.9163;FANCONI ANEMIA#0.9137;MITOSIS#0.9120;ATP BINDING CASSETTE#0.9110;NUCLEOTIDE EXCISION REPAIR#0.9089;V-D-J RECOMBINATION#0.9067;CYTOTOXICITY#0.9023;TELOMERASE ACTIVITY#0.9004;RIBOSE#0.8998;HEREDITARY BREAST CANCER#0.8980;T CELL#0.8979;C TERMINAL DOMAIN#0.8971;G2 PHASE#0.8950;CELL PROLIFERATION#0.8911;PERIPHERAL BLOOD#0.8825;PROPHASE#0.8825;SENESCENCE#0.8783;BASE EXCISION REPAIR#0.8753;CHROMATIN REMODELING#0.8748;CAMPTOTHECIN#0.8655;SYNAPTONEMAL COMPLEX#0.8645;POLYMERASE CHAIN REACTION#0.8640;APOPTOTIC#0.8633;GENETIC DISORDER#0.8606;STEM CELL#0.8589;VIRAL GENOME#0.8537;BREAST CANCER PATIENTS#0.8482;LUNG CANCER#0.8482;UBIQUITIN#0.8461;GERM CELL#0.8404;SINGLE STRAND ANNEALING#0.8375;CYTOPLASM#0.8365;DNA RECOMBINATION#0.8363;SYNAPSIS#0.8322;B CELL#0.8301;CELL DIVISION#0.8291;DNA UNWINDING#0.8277;PROSTATE CANCER#0.8248;CYCLIN DEPENDENT KINASE#0.8239;ANEMIA#0.8217;CELL GROWTH#0.8111;NUCLEOTIDE BINDING#0.8086;BREAST CANCER CELL#0.8075;DNA METHYLATION#0.8060;ADENYLATE#0.8024;MUTAGENESIS#0.8017;MEIOTIC CHROMOSOME#0.7952;ADENYLATE KINASE ACTIVITY#0.7947;TH2 CELL#0.7943;TELOMERE CAPPING#0.7922;ONCOGENIC#0.7894;SPORULATION#0.7840;PROTEIN PROTEIN INTERACTION#0.7826;HOMOLOGY-DIRECTED REPAIR#0.7774;FAMILIAL BREAST CANCER#0.7742;POST-TRANSLATIONAL MODIFICATION#0.7652;CHROMOSOME SEGREGATION#0.7587;ABC TRANSPORTER#0.7586;CELL CYCLE REGULATION#0.7571;DNASE I#0.7457;MICROCEPHALY#0.7430;ARGININE#0.7412;BONE MARROW#0.7392;M PHASE#0.7336;NUCLEOTIDE BINDING DOMAIN#0.7232;HISTONE DEACETYLASE#0.7217;TUMOR TISSUES#0.7176;EPITHELIAL CELL#0.7168;REACTIVE OXYGEN SPECIES#0.7102;SIGNAL TRANSDUCTION#0.7057;ATPASE COMPLEX#0.7041;DNA TOPOISOMERASE#0.7039;MITOMYCIN C#0.7037;GROWTH FACTOR#0.7022;RNA INTERFERENCE#0.6973;CLASS SWITCH RECOMBINATION#0.6937;BREAST CARCINOMA#0.6921;HYDROXYUREA#0.6881;DNASE#0.6872;CELL KILLING#0.6861;DNA METABOLISM#0.6854;SISTER CHROMATID COHESION#0.6847;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6845;TOXICITY#0.6823;HEMATOPOIETIC CELL#0.6821;PROTEASOME#0.6817;SINGLE-STRANDED DNA BINDING#0.6814;LYSINE#0.6809;HOMOLOGOUS RECOMBINATIONAL REPAIR#0.6759;MAINTENANCE OF GENOME INTEGRITY#0.6742;NUCLEOSOME#0.6726;CYSTIC FIBROSIS#0.6724;ETOPOSIDE#0.6721;SSDNA BINDING#0.6710;KINASE INHIBITOR#0.6690;SINGLE STRAND BREAK#0.6652;TELOMERE BINDING#0.6621;HEAD AND NECK CANCER#0.6578;AXIAL ELEMENT#0.6577;NECK CANCER#0.6577;IMMUNE RESPONSE#0.6569;IONIZING RADIATION-INDUCED FOCI#0.6540;BINDING PROTEIN 1#0.6455;CHROMOSOME BREAKAGE#0.6454;DNA METABOLIC#0.6437;ENDOTHELIAL CELL#0.6426;5'-EXONUCLEASE ACTIVITY#0.6348;SYNAPTONEMAL COMPLEX FORMATION#0.6287;SIGNALING CASCADE#0.6255;DNA FRAGMENTATION#0.6247;DNA REPAIR ENZYME#0.6223;DISEASE FREE SURVIVAL#0.6220;SUMOYLATION#0.6219;DNA END BINDING#0.6141;ENDOPLASMIC RETICULUM#0.6112;DNA INTEGRATION#0.6062
10112	CENTRAL SPINDLE#1.1054;PANCREATIC CANCER#1.0825;KINESIN#1.0645;CANCER CELL#1.0614;CYTOKINESIS#1.0547;CELL PROLIFERATION#1.0240;MICROTUBULE#1.0146;CELL CYCLE#1.0124;ANAPHASE#0.9659;GENE EXPRESSION#0.9500;CELL DIVISION#0.9415;MITOSIS#0.9411;APOPTOSIS#0.8967;BREAST CANCER#0.8820;T CELL#0.8630;HEPATOCELLULAR CARCINOMA#0.8465;ADVANCED PANCREATIC CANCER#0.8257;SIGNALING PATHWAY#0.8225;SPINDLE MIDZONE#0.8173;MITOTIC SPINDLE#0.8148;SPINDLE ORGANIZATION#0.8088;FURROW#0.7776;CENTROMERE#0.7414;EPITHELIAL CELL#0.7173;PROTEIN PROTEIN INTERACTION#0.7166;SPINDLE ASSEMBLY#0.7137;OVARIAN#0.7017;CERVICAL CANCER#0.6919;LYMPH NODE METASTASIS#0.6900;CLEAVAGE FURROW#0.6897;METAPHASE#0.6866;LUNG CANCER#0.6856;LYMPH NODE#0.6852;MIDBODY#0.6818;GROWTH FACTOR#0.6799;GENE EXPRESSION OMNIBUS#0.6663;SPINDLE FORMATION#0.6519;GENISTEIN#0.6450;OOCYTE#0.6394;PERIPHERAL BLOOD#0.6338;CHROMOSOMAL PASSENGER COMPLEX#0.6251;CELL CORTEX#0.6201;DISEASE FREE SURVIVAL#0.6200;OVARIAN CANCER#0.6178;OOCYTE MATURATION#0.6151;RECURRENCE FREE SURVIVAL#0.6081;PROGENITOR CELL#0.6023;SQUAMOUS CELL CARCINOMA#0.6022
10113	NUCLEOTIDE EXCHANGE FACTOR#1.0433;GUANINE#1.0218;ER EXIT#1.0143;ENDOPLASMIC RETICULUM#1.0066;ER EXIT SITE#0.9764;TRANSPORT VESICLE#0.9548;BUDDING#0.9476;TRANSCRIPTION FACTOR#0.9181;VESICLE BUDDING#0.9119;ER MEMBRANE#0.8883;GOLGI APPARATUS#0.8818;PROTEIN TRANSPORT#0.8718;COPII VESICLE#0.8589;GENE EXPRESSION#0.8541;VESICLE FORMATION#0.8463;RESPONSE TO GLUCOSE#0.7925;GTP BINDING#0.7857;ADRENAL GLAND#0.7824;ADIPOSE TISSUE#0.7736;SECRETORY PATHWAY#0.7507;ER TO GOLGI TRANSPORT#0.6914;ADENOSINE 5'-MONOPHOSPHATE#0.6365;PROTEIN COMPLEX#0.6343;TRANSITIONAL ER#0.6284;BETA CELL#0.6143;PLASMA MEMBRANE#0.6124
10114	PROTEIN KINASE#1.0387;CELL CYCLE#0.9490;APOPTOSIS#0.9443;CELL PROLIFERATION#0.9240;TRANSCRIPTION FACTOR#0.9239;SIGNALING PATHWAY#0.9176;KINASE ACTIVITY#0.9017;GENE EXPRESSION#0.8847;LUNG CANCER#0.8567;CELL GROWTH#0.8254;CANCER CELL#0.8213;JUN PHOSPHORYLATION#0.7988;PROTEIN KINASE A#0.7783;INSULIN SECRETION#0.7689;EPITHELIAL CELL#0.6080;POLYMERASE CHAIN REACTION#0.6075;CELL DEATH#0.6066;AMILORIDE#0.6060;TYPE 2 DIABETES#0.6026;QUANTITATIVE REAL TIME#0.6010
101154753	CELL PROLIFERATION#1.0431;APOPTOSIS#1.0360;COLORECTAL CANCER#1.0252;CANCER CELL#0.9724;CELL CYCLE#0.9425;TRANSCRIPTION FACTOR#0.9363;COLORECTAL#0.9220;POLYMERASE CHAIN REACTION#0.9130;SIROLIMUS ELUTING STENT#0.9114;LYMPH NODE#0.8662;RIBOSOMAL PROTEIN#0.8440;BREAST CANCER#0.8377;SERTRALINE#0.8300;GENE REGULATORY NETWORK#0.8293;QUANTITATIVE REAL TIME#0.8167;PERIPHERAL BLOOD#0.8112;LYMPH NODE METASTASIS#0.8026;GENE EXPRESSION#0.7788;CELL GROWTH#0.7709;SENESCENCE#0.7684;ONCOGENIC#0.7584;EPITHELIAL MESENCHYMAL TRANSITION#0.7438;SIROLIMUS#0.7435;HEPATOCELLULAR CARCINOMA#0.7399;RANDOMISED CONTROLLED TRIAL#0.6803;ADJACENT NORMAL TISSUE#0.6793;TUMOR SUPPRESSOR#0.6732;PROTEIN KINASE C#0.6495;PROTEIN KINASE#0.6461;RENAL CELL CARCINOMA#0.6286;LUNG CANCER#0.6244;MYOCARDIAL INFARCTION#0.6207;DEPRESSIVE SYMPTOMS#0.6140;TUMOR TISSUES#0.6091;SIGNALING PATHWAY#0.6007
10116	APOPTOSIS#0.9939;SEX DETERMINATION#0.9493;CANCER CELL#0.8863;INSULIN SECRETION#0.8093;COLON CANCER#0.8078;APOPTOTIC#0.8071;UBIQUITIN#0.7062;GENE EXPRESSION#0.6385
10117	AMELOGENESIS IMPERFECTA#1.0256;AUTOIMMUNE HEPATITIS#1.0223;AMELOGENESIS#1.0116;ENAMEL FORMATION#1.0112;TOOTH DEVELOPMENT#1.0032;MINERALIZATION#0.9915;EXTRACELLULAR MATRIX#0.9893;SMOOTH MUSCLE#0.9884;MOLAR#0.9870;HEPATITIS C#0.9748;GENE EXPRESSION#0.9727;ENAMEL ORGAN#0.9613;ENAMEL DEVELOPMENT#0.9504;INCISORS#0.9387;POLYMERASE CHAIN REACTION#0.9265;LIVER DISEASE#0.9114;ENAMEL MINERALIZATION#0.8927;T CELL#0.8863;CHRONIC HEPATITIS C#0.8755;CYTOCHROME P450#0.8701;EPITHELIAL CELL#0.8551;DENTAL CARIES#0.8455;TRANSCRIPTION FACTOR#0.8394;BIOMINERALIZATION#0.8285;IMMUNE RESPONSE#0.7873;SCANNING ELECTRON MICROSCOPY#0.7562;TRANSLATION INITIATION#0.7478;ODONTOGENESIS#0.7425;HEPATITIS C VIRUS#0.7251;CD8+ T CELL#0.7251;SCLEROSING CHOLANGITIS#0.7183;MANDIBLE#0.6939;DYNAMIC LIGHT SCATTERING#0.6841;CELL PROLIFERATION#0.6789;MICROSOME#0.6706;MORPHOGENESIS#0.6512;ALKALINE PHOSPHATASE#0.6324;DENTIN MATRIX PROTEIN#0.6076;HUMAN LEUKOCYTE ANTIGEN#0.6043
101180900	SCHWANN CELL#0.9012;MYELINATION#0.6076
101180976	CHRONIC HEPATITIS C#1.0314;RIBAVIRIN#1.0287;HEPATITIS C#1.0200;HEPATITIS C VIRUS#1.0090;GENE EXPRESSION#1.0041;INTERFERON STIMULATED GENE#0.9583;HEPATITIS B#0.9549;SUSTAINED VIROLOGICAL RESPONSE#0.9480;LIVER DISEASE#0.8669;SUSTAINED VIROLOGIC RESPONSE#0.8587;HEPATITIS B VIRUS#0.7632;IMMUNE RESPONSE#0.7208;T CELL#0.6963;PERIPHERAL BLOOD#0.6690;CHRONIC HEPATITIS B#0.6362;INNATE IMMUNITY#0.6061
10121	ACTIN RELATED PROTEIN#1.0851;DYNACTIN COMPLEX#1.0716;DYNEIN#1.0439;MICROTUBULE#1.0161;SPECTRIN#0.8925;CENTROSOME#0.8914;NUCLEAR MIGRATION#0.7004;MICROTUBULE BASED#0.6829;CHAPERONIN#0.6579;MITOTIC SPINDLE#0.6545;COMPLEX I#0.6383;ORGANELLE#0.6062;MICROTUBULE END#0.6007
101234261	CELL PROLIFERATION#1.0097;OVARIAN CANCER#0.9609;CANCER CELL#0.8641;ONCOGENIC#0.8339;SIGNALING PATHWAY#0.7995;OVARIAN#0.7892;CELL MIGRATION#0.6645;BREAST CANCER#0.6493;APOPTOSIS#0.6368;ENDOMETRIAL CARCINOMA#0.6170;DIFFERENTIAL GENE EXPRESSION#0.6165;LUNG CANCER#0.6001
10123	CANCER CELL#0.9400;LUNG CANCER#0.8840;CHOLESTEROL EFFLUX#0.8406;GROWTH FACTOR#0.8012;GTP BINDING#0.7811;COLORECTAL CANCER#0.7106;FILOPODIUM FORMATION#0.6895;COLORECTAL#0.6567;VESICULAR TRANSPORT#0.6479;PLASMA MEMBRANE#0.6375;OVARIAN CANCER#0.6314;GENE EXPRESSION#0.6035
101241892	CELL PROLIFERATION#0.8672;CANCER CELL#0.8056;APOPTOSIS#0.7622;HYPOXIA#0.6909;HEPATOCELLULAR CARCINOMA#0.6645;HISTONE ACETYLATION#0.6149
101241897	TUBERCULOSIS#0.8374
101241900	MUSCULAR ATROPHY#0.7415;AMYOTROPHIC LATERAL SCLEROSIS#0.6449;LATERAL SCLEROSIS#0.6448;SPINAL MUSCULAR ATROPHY#0.6344
10125	THYMOCYTE#1.0467;B CELL#1.0453;NUCLEOTIDE EXCHANGE FACTOR#1.0408;GUANINE#1.0395;PLASMA MEMBRANE#1.0379;CELL DEVELOPMENT#1.0303;T CELL#1.0258;PROTEIN KINASE C#1.0245;PROTEIN KINASE#1.0210;PHOSPHOLIPASE C#0.9970;T CELL DEVELOPMENT#0.9949;SIGNALING PATHWAY#0.9856;GENE EXPRESSION#0.9815;CD4+ T CELL#0.9457;SIGNAL TRANSDUCTION#0.9442;KERATINOCYTE#0.9413;DIACYLGLYCEROL BINDING#0.9312;T LYMPHOCYTE#0.9211;MITOGEN ACTIVATED PROTEIN#0.9166;AUTOIMMUNITY#0.8896;CELL PROLIFERATION#0.8843;CELL ACTIVATION#0.8816;T CELL ACTIVATION#0.8731;MAP KINASE#0.8687;DIACYLGLYCEROL KINASE#0.8499;CD8+ T CELL#0.8494;GUANINE EXCHANGE FACTOR#0.8470;GROWTH FACTOR#0.8356;APOPTOSIS#0.8326;B CELL RECEPTOR#0.8025;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7812;LUPUS ERYTHEMATOSUS#0.7810;GERMINAL CENTER#0.7643;ONCOGENIC#0.7579;BONE MARROW#0.7462;IMMUNE RESPONSE#0.7061;MAST CELL#0.6971;GOLGI APPARATUS#0.6932;STRIATUM#0.6891;NEUTROPHIL#0.6272;B CELL PROLIFERATION#0.6101;LEUKOCYTE#0.6096;TYPE 2 DIABETES#0.6092;CYTOKINE RECEPTOR#0.6042;CELL DIFFERENTIATION#0.6033
10126	SPERM MOTILITY#0.7082
10127	TRANSCRIPTION FACTOR#0.9027
10128	LEUCINE#1.0724;PROSTATE CANCER#1.0557;CYTOCHROME C OXIDASE#1.0467;RNA BINDING#1.0434;MITOCHONDRIA#1.0413;CYTOCHROME C#1.0408;MITOCHONDRIAL TRANSCRIPTION#1.0027;GENE EXPRESSION#0.9887;AUTOPHAGY#0.9825;RNA BINDING PROTEIN#0.9385;SKELETAL MUSCLE#0.9040;APOPTOSIS#0.9017;MTDNA#0.8570;CANCER CELL#0.8558;MITOCHONDRIAL GENE EXPRESSION#0.8343;MITOCHONDRIAL DNA#0.8307;OXIDATIVE PHOSPHORYLATION#0.8300;MITOCHONDRIAL TRANSLATION#0.8192;MITOCHONDRION#0.8054;MITOCHONDRIAL DISEASE#0.7763;MITOPHAGY#0.7737;ATP SYNTHASE#0.7535;LUNG ADENOCARCINOMA#0.7446;ADENOCARCINOMA#0.7427;TRANSCRIPTION FACTOR#0.7287;FATTY ACID OXIDATION#0.7090;COMPLEX I#0.7032;MICROTUBULE#0.7002;STEM CELL#0.6982;DNA BINDING#0.6595;VACCINIA#0.6437;CELL CYCLE#0.6336;RIBONUCLEOPROTEIN COMPLEX#0.6280;IL-11#0.6192;PARKINSON'S DISEASE#0.6089;CANCER STEM CELL#0.6082
10129	MITOTIC SPINDLE#0.7885;TUBULIN DEACETYLASE ACTIVITY#0.7790;TUBULIN DEACETYLASE#0.7523;POLO BOX DOMAIN#0.7093;SPINDLE POLE#0.6815;MITOTIC CHROMOSOME#0.6768;DEACETYLASE ACTIVITY#0.6742
1012	ADIPONECTIN BINDING#1.1237;SMOOTH MUSCLE CELL#1.0626;MUSCLE CELL#1.0620;CELL SURFACE#1.0613;SMOOTH MUSCLE#1.0606;LYMPH NODE#1.0423;ENDOTHELIAL CELL#1.0382;CELL PROLIFERATION#1.0376;ANGIOGENESIS#1.0320;VASCULAR CELL#1.0298;METHYLATION SPECIFIC POLYMERASE#1.0250;COLORECTAL CANCER#1.0250;GROWTH FACTOR#1.0249;CELL ADHESION MOLECULE#1.0230;METHYLATION SPECIFIC PCR#1.0227;BREAST CANCER#1.0213;LIPOPROTEIN BINDING#1.0203;CELL ADHESION#1.0171;POLYMERASE CHAIN REACTION#1.0166;SQUAMOUS CELL CARCINOMA#1.0164;APOPTOSIS#1.0159;CANCER CELL#1.0127;CERVICAL CANCER#1.0125;CERVICAL#1.0117;SIGNALING PATHWAY#1.0076;LUNG CANCER#1.0043;CELL CYCLE#1.0026;LOW DENSITY LIPOPROTEIN#0.9984;TUMOR SUPPRESSOR#0.9966;COLORECTAL#0.9942;TRANSITIONAL CELL CARCINOMA#0.9891;2'-DEOXYCYTIDINE#0.9882;GENE EXPRESSION#0.9817;CELL GROWTH#0.9802;DNA METHYLATION#0.9777;5-AZA-2'-DEOXYCYTIDINE#0.9760;KERATINOCYTE#0.9754;ATHEROSCLEROSIS#0.9731;CELL MIGRATION#0.9728;BASAL CELL#0.9718;ADIPOSE TISSUE#0.9638;CARDIOVASCULAR SYSTEM#0.9635;LDL BINDING#0.9627;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9623;PROSTATE CANCER#0.9564;VASCULAR SMOOTH MUSCLE CELL#0.9547;CYCLIN DEPENDENT KINASE#0.9509;ADENOCARCINOMA#0.9456;SIGNAL TRANSDUCTION#0.9428;HEPATOCELLULAR CARCINOMA#0.9421;CELL CELL ADHESION#0.9379;CELL MEMBRANE#0.9367;OVARIAN#0.9366;ATHEROSCLEROTIC#0.9336;TRANSCRIPTION FACTOR#0.9320;KINASE INHIBITOR#0.9314;BLOOD VESSEL#0.9300;PROTEIN KINASE#0.9216;HYPERACTIVITY#0.9185;ADIPOCYTE#0.9158;PLASMA MEMBRANE#0.9125;EPIDERMAL GROWTH FACTOR#0.9096;CORONARY ARTERY#0.9006;REVERSE TRANSCRIPTION#0.8955;ARTERY#0.8950;EPITHELIAL CELL#0.8904;INSULIN-LIKE GROWTH FACTOR#0.8885;NEURITE#0.8873;TUMOR TISSUES#0.8838;DNA METHYLTRANSFERASE#0.8779;TUMOR CELLS#0.8727;VASCULAR ENDOTHELIAL CELL#0.8697;MYELOID LEUKEMIA#0.8615;CYCLIN DEPENDENT KINASE INHIBITOR#0.8562;LUNG CARCINOMA#0.8561;CORONARY ARTERY DISEASE#0.8533;ARTERY DISEASE#0.8531;OVARIAN CANCER#0.8523;EXTRACELLULAR MATRIX#0.8496;HUMAN UMBILICAL VEIN#0.8463;UMBILICAL VEIN#0.8461;LIPID RAFT#0.8286;ESTROGEN RECEPTOR#0.8252;LYMPH NODE METASTASIS#0.8235;DISEASE FREE SURVIVAL#0.8162;ENDOMETRIAL CANCER#0.8135;COLON CANCER#0.8077;NEURITE OUTGROWTH#0.8067;DNA HYPERMETHYLATION#0.8063;ENDOTHELIUM#0.8007;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8000;M PHASE#0.7998;NERVE GROWTH FACTOR#0.7975;SKELETAL MUSCLE#0.7931;CHRONIC MYELOID LEUKEMIA#0.7895;STROMAL CELL#0.7861;TYPE 2 DIABETES#0.7839;ADENOMATOUS POLYPOSIS COLI#0.7797;RETINOIC ACID RECEPTOR#0.7750;RETINOIC ACID#0.7689;GALLBLADDER CANCER#0.7659;PERIPHERAL BLOOD#0.7579;HYPERTENSION#0.7539;BONE MARROW#0.7511;CELL RECOGNITION#0.7505;ESOPHAGEAL CANCER#0.7501;BREAST CARCINOMA#0.7473;NERVOUS SYSTEM#0.7447;S PHASE#0.7435;PHOSPHOLIPASE C#0.7238;ALZHEIMER'S DISEASE#0.7205;TRANSCRIPTASE#0.7194;OBESE#0.7147;AORTIC SMOOTH MUSCLE CELLS#0.7119;HUMAN BREAST CANCER#0.7071;TRANSFORMING GROWTH FACTOR#0.7006;APOPTOTIC#0.6992;STEM CELL#0.6990;QUANTITATIVE REAL TIME#0.6958;GROWTH FACTOR RECEPTOR#0.6936;EPITHELIAL TISSUES#0.6787;GENE SILENCING#0.6782;ADJACENT NORMAL TISSUE#0.6781;VASCULAR ENDOTHELIUM#0.6760;CELL MOTILITY#0.6751;DILATED CARDIOMYOPATHY#0.6738;BETA-2#0.6720;SPINAL CORD#0.6642;ENDOMETRIAL CARCINOMA#0.6607;BREAST CANCER PATIENTS#0.6594;LUNG ADENOCARCINOMA#0.6489;3-OST-2#0.6470;GROWTH REGULATOR#0.6369;PROGESTERONE#0.6319;VASCULAR DISEASE#0.6293;FOCAL ADHESION#0.6292;CPG ISLAND METHYLATION#0.6281;HIGH DENSITY LIPOPROTEIN#0.6276;B CELL#0.6229;RETINOBLASTOMA#0.6146;BINDING PROTEIN 3#0.6096;MACROPHAGE#0.6071;NEURAL CELL#0.6056;MAMMARY GLAND#0.6048;ACTIN CYTOSKELETON#0.6047;CONTACT INHIBITION#0.6031;WEIGHT LOSS#0.6024
10130	PROTEIN DISULFIDE ISOMERASE#1.0585;ENDOPLASMIC RETICULUM#1.0216;CELL SURFACE#0.9174;CANCER CELL#0.8523;PROTEIN FOLDING#0.8338;UNFOLDED PROTEIN RESPONSE#0.7839;SIGNALING PATHWAY#0.7522;APOPTOSIS#0.7430;THROMBOSIS#0.6853;ENDOTHELIAL CELL#0.6414;GENE EXPRESSION#0.6247;BREAST CANCER#0.6169;ER STRESS RESPONSE#0.6139;LYMPH NODE#0.6047
10131	COLORECTAL CARCINOMA#1.0815;COLORECTAL#1.0629;TUMOR NECROSIS FACTOR#1.0562;ENDOPLASMIC RETICULUM#1.0454;COLORECTAL CANCER#1.0297;MITOCHONDRIA#1.0271;CANCER CELL#1.0254;APOPTOSIS#1.0231;DRUG RESISTANCE#1.0205;TUMOR CELLS#1.0202;CELL DEATH#1.0200;HEAT SHOCK PROTEIN#1.0193;LYMPH NODE#1.0112;MITOCHONDRIAL MEMBRANE POTENTIAL#1.0017;MITOCHONDRIAL MEMBRANE#0.9979;REACTIVE OXYGEN SPECIES#0.9899;CELL CYCLE#0.9844;OVARIAN CANCER#0.9814;CELL PROLIFERATION#0.9721;GENE EXPRESSION#0.9636;APOPTOTIC#0.9555;CARDIOMYOCYTE#0.9472;PROSTATE CANCER#0.9438;OVARIAN#0.9047;MITOCHONDRIAL PERMEABILITY TRANSITION#0.9046;PERMEABILITY TRANSITION PORE#0.9009;SUCCINATE DEHYDROGENASE#0.8974;LYMPH NODE METASTASIS#0.8928;EPITHELIAL CELL#0.8830;TRANSCRIPTION FACTOR#0.8818;SIGNALING PATHWAY#0.8800;CELL MOTILITY#0.8608;PROTEIN SYNTHESIS#0.8472;ATPASE ACTIVITY#0.8464;STEM CELL#0.8399;ATP HYDROLYSIS#0.8394;LUNG CANCER#0.8346;MITOCHONDRIAL MATRIX#0.8245;5 FLUOROURACIL#0.8084;BREAST CARCINOMA#0.8063;SUCCINATE#0.8061;CYTOCHROME C#0.8033;VACTERL ASSOCIATION#0.8023;CELL MIGRATION#0.7779;OXIDATIVE PHOSPHORYLATION#0.7744;HYPOXIC#0.7725;HYPOXIA#0.7678;AUTOPHAGY#0.7638;BREAST CANCER#0.7570;PROTEIN FOLDING#0.7551;UNFOLDED PROTEIN RESPONSE#0.7405;MITOCHONDRIAL LOCALIZATION#0.7310;CYTOPLASM#0.7257;GLUCOSE REGULATED PROTEIN#0.7054;POLYMERASE CHAIN REACTION#0.7000;ONCOGENIC#0.6947;CISPLATIN#0.6858;PARKINSON'S DISEASE#0.6664;COMPLEX I#0.6626;RESPIRATION#0.6599;ADENOCARCINOMA#0.6537;CELL GROWTH#0.6533;PROTEIN KINASE#0.6516;ORGANELLE#0.6512;PROTEIN QUALITY CONTROL#0.6451;ISCHEMIA#0.6383;FLUOROURACIL#0.6348;TUMOUR NECROSIS FACTOR#0.6327;SPORE DIFFERENTIATION#0.6310;TUMOR SUPPRESSOR#0.6295;ATP BINDING#0.6275;GLYCOLYSIS#0.6210;PROTEASOME#0.6191;MITOCHONDRIAL FUSION#0.6147;CELL MEMBRANE#0.6106;METASTATIC PROSTATE CANCER#0.6100;OXIDATIVE METABOLISM#0.6055;CYCLOPHILIN#0.6028;TOXICITY#0.6022;TUBULAR EPITHELIAL CELL#0.6005;EPITHELIAL OVARIAN CANCER#0.6004
10133	UBIQUITIN BINDING#1.0619;SELECTIVE AUTOPHAGY#1.0589;NORMAL TENSION GLAUCOMA#1.0568;TANK BINDING KINASE#1.0490;AUTOPHAGOSOME FORMATION#1.0489;MITOPHAGY#1.0431;TUMOR NECROSIS FACTOR#1.0417;AUTOPHAGY#1.0384;APOPTOSIS#1.0335;TRANSFERRIN RECEPTOR#1.0315;VESICLE TRAFFICKING#1.0307;CELL DEATH#1.0301;RETINAL GANGLION CELL#1.0297;MITOCHONDRIA#1.0286;AUTOPHAGOSOME#1.0280;PRIMARY OPEN ANGLE GLAUCOMA#1.0235;GOLGI APPARATUS#1.0232;UBIQUITIN#1.0210;GANGLION CELLS#1.0208;OPEN ANGLE GLAUCOMA#1.0204;PAGET'S DISEASE OF BONE#1.0195;TRANSCRIPTION FACTOR#1.0128;NEURODEGENERATIVE DISEASE#1.0086;AMYOTROPHIC LATERAL SCLEROSIS#1.0080;LATERAL SCLEROSIS#1.0080;LIGHT CHAIN 3#1.0066;LYSOSOME#1.0009;GENE EXPRESSION#1.0007;PLASMA MEMBRANE#1.0007;MICROTUBULE ASSOCIATED PROTEIN#1.0006;MICROTUBULE#0.9993;POLYMERASE CHAIN REACTION#0.9938;CYTOPLASM#0.9863;EPITHELIAL CELL#0.9598;SPINAL CORD#0.9555;GOLGI COMPLEX#0.9487;PROTEIN KINASE#0.9456;DEMENTIA#0.9408;FRONTOTEMPORAL DEMENTIA#0.9275;OPTIC NERVE#0.9253;DNA BINDING#0.9224;NEURONAL CELLS#0.9165;BLINDNESS#0.8978;MACROPHAGE#0.8740;SIGNAL TRANSDUCTION#0.8738;NF-KAPPAB ACTIVATION#0.8695;MITOCHONDRIAL MEMBRANE#0.8681;PARKINSON'S DISEASE#0.8642;RAPAMYCIN#0.8574;REACTIVE OXYGEN SPECIES#0.8380;ENDOSOME#0.8313;ENDOPLASMIC RETICULUM#0.8260;IMMUNE RESPONSE#0.8258;SIGNALING PATHWAY#0.8253;INCLUSION BODY#0.8251;POLYUBIQUITIN#0.8137;BONE MARROW#0.8085;COMPLEX I#0.8044;TOLL LIKE RECEPTOR#0.7985;OSTEOCLAST#0.7983;APOPTOTIC#0.7976;ALZHEIMER'S DISEASE#0.7968;NEUROPATHY#0.7941;SUPEROXIDE DISMUTASE#0.7939;CYTOPLASMIC INCLUSION#0.7937;HUNTINGTON'S DISEASE#0.7932;STEM CELL#0.7922;CELLULAR MORPHOGENESIS#0.7763;PROTEASOME#0.7755;MOTOR NEURON DISEASE#0.7716;CELL SURFACE#0.7675;PHAGOPHORE#0.7636;RNA INTERFERENCE#0.7581;OSTEOCLAST DIFFERENTIATION#0.7533;CELL CYCLE#0.7521;LEUCINE#0.7500;GROWTH FACTOR#0.7496;HUMAN TRABECULAR MESHWORK#0.7486;CANCER CELL#0.7376;PHOTORECEPTOR CELL#0.7324;XENOPHAGY#0.7225;RECYCLING ENDOSOME#0.7099;NEURONAL INTRANUCLEAR INCLUSIONS#0.7074;T CELL#0.7008;INNATE IMMUNITY#0.6989;CYTOCHROME P450#0.6970;MITOCHONDRIAL DAMAGE#0.6967;RECEPTOR DEGRADATION#0.6906;IMMUNE CELL#0.6871;SECRETORY VESICLE#0.6807;ORGANELLE#0.6707;EXOCYTOSIS#0.6604;NEURITE#0.6585;MORPHOGENESIS#0.6581;NERVOUS SYSTEM#0.6577;POLYUBIQUITIN BINDING#0.6505;ENDOCYTOSIS#0.6486;INTERFERON REGULATORY FACTOR#0.6355;OUTER MITOCHONDRIAL MEMBRANE#0.6355;INNATE IMMUNE RESPONSE#0.6323;REGULATION OF AUTOPHAGY#0.6323;UBIQUITIN PROTEIN LIGASE#0.6310;LOW TENSION GLAUCOMA#0.6305;BONE DISEASE#0.6246;ENDOCYTIC RECYCLING#0.6245;PROTEIN DEGRADATION#0.6230;ASTROCYTE#0.6213;CELL DIVISION#0.6061
10134	B CELL RECEPTOR#1.0976;B CELL#1.0653;ER MEMBRANE#1.0650;MITOCHONDRIA#1.0357;APOPTOSIS#1.0281;ENDOPLASMIC RETICULUM#1.0226;CELL SURFACE#1.0205;APOPTOTIC#1.0171;CYTOCHROME C#1.0129;CELL DEATH#0.9992;ENDOPLASMIC RETICULUM STRESS#0.8470;CANCER CELL#0.8375;ENDOPLASMIC RETICULUM MEMBRANE#0.8353;EPITHELIAL CELL#0.8332;CYTOCHROME C RELEASE#0.8178;CELL ASSOCIATED#0.8031;DYSTONIA#0.7680;STEM CELL#0.7663;GOLGI APPARATUS#0.7657;CERVICAL CANCER#0.7436;SECRETORY PATHWAY#0.7420;PLASMA MEMBRANE#0.7150;EMBRYONIC STEM CELL#0.7034;MITOCHONDRIAL FISSION#0.6978;ER STRESS RESPONSE#0.6964;C TERMINAL DOMAIN#0.6879;CASPASE ACTIVATION#0.6655;T CELL#0.6614;UBIQUITIN#0.6613;ER-GOLGI INTERMEDIATE COMPARTMENT#0.6474;CREATINE TRANSPORTER#0.6443;UNFOLDED PROTEIN RESPONSE#0.6423;EXTRINSIC APOPTOSIS#0.6296;CELL ADHESION#0.6007;COMPLEX I#0.6003
10135	GINGIVAL CREVICULAR FLUID#1.0805;NAD BIOSYNTHETIC#1.0797;NAD SALVAGE PATHWAY#1.0706;CORD BLOOD#1.0640;CEREBRAL ISCHEMIA#1.0609;NAD SALVAGE#1.0608;DIABETIC NEPHROPATHY#1.0563;NAD SYNTHESIS#1.0562;BREAST CANCER CELL#1.0554;FATTY ACID BINDING#1.0492;NAD METABOLISM#1.0489;RETINOL BINDING#1.0483;SOLUBLE LEPTIN RECEPTOR#1.0474;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0467;RETINOL#1.0466;ACUTE LUNG INJURY#1.0445;NEPHROPATHY#1.0445;NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE#1.0436;PERIODONTITIS#1.0434;UMBILICAL VEIN#1.0434;ENDOTHELIAL GROWTH FACTOR#1.0428;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0428;NAD BIOSYNTHESIS#1.0385;ISCHEMIA#1.0369;CHONDROCYTE#1.0368;METFORMIN#1.0358;INSULIN RESISTANCE INDEX#1.0358;BREAST CANCER#1.0353;B CELL#1.0348;PSORIASIS#1.0340;FASTING BLOOD GLUCOSE#1.0336;NICOTINAMIDE#1.0330;AKT SIGNALING#1.0327;COLORECTAL#1.0322;NEUTROPHIL#1.0321;NICOTINAMIDE MONONUCLEOTIDE#1.0318;COLORECTAL CANCER#1.0317;HUMAN BREAST CANCER#1.0314;TUMOUR NECROSIS FACTOR#1.0311;EPITHELIAL CELL#1.0307;ENDOMETRIAL CANCER#1.0285;MYOCARDIAL INFARCTION#1.0275;FASTING PLASMA GLUCOSE#1.0273;ENDOTHELIAL CELL#1.0269;GESTATIONAL DIABETES#1.0267;SENESCENCE#1.0267;VISCERAL ADIPOSE TISSUE#1.0259;CORONARY ARTERY DISEASE#1.0253;ARTERY DISEASE#1.0251;LYMPH NODE#1.0245;CARDIOMYOCYTE#1.0241;HYPOXIA#1.0241;GESTATIONAL DIABETES MELLITUS#1.0237;UMBILICAL VEIN ENDOTHELIAL CELLS#1.0233;MONOCYTE#1.0231;HUMAN UMBILICAL VEIN#1.0228;SUBCUTANEOUS ADIPOSE TISSUE#1.0224;FIBROBLAST GROWTH FACTOR#1.0217;CORONARY ARTERY#1.0211;C REACTIVE PROTEIN#1.0209;APOPTOTIC#1.0205;MULTIPLE REGRESSION ANALYSIS#1.0201;FACTOR I#1.0199;PERIODONTAL DISEASE#1.0194;GLUCOSE HOMEOSTASIS#1.0192;TUMOR NECROSIS FACTOR#1.0190;NICOTINIC ACID#1.0190;CELL PROLIFERATION#1.0187;ANGIOGENESIS#1.0181;INSULIN RECEPTOR#1.0168;ROSIGLITAZONE#1.0165;QUANTITATIVE REAL TIME#1.0165;BONE MINERAL DENSITY#1.0162;ATHEROSCLEROTIC#1.0162;RESVERATROL#1.0159;SYNOVIAL FLUID#1.0158;LINEAR REGRESSION ANALYSIS#1.0157;GLUCOSE UPTAKE#1.0156;LEUKOCYTE#1.0151;RHEUMATOID ARTHRITIS#1.0142;MACROPHAGE#1.0138;AUTOPHAGY#1.0138;WAIST HIP RATIO#1.0137;WEIGHT LOSS#1.0130;POLYCYSTIC OVARY SYNDROME#1.0118;CELL GROWTH#1.0116;INSULIN SECRETION#1.0116;CANCER CELL#1.0114;PRE-ECLAMPSIA#1.0110;OVARIAN#1.0108;REVERSE TRANSCRIPTION#1.0108;BETA CELL#1.0106;ALCOHOLIC FATTY LIVER#1.0105;SKELETAL MUSCLE#1.0101;KIDNEY DISEASE#1.0100;CELL DEATH#1.0090;TYPE 2 DIABETIC#1.0090;TESTOSTERONE#1.0089;NONALCOHOLIC FATTY LIVER DISEASE#1.0081;HYPOXIA INDUCIBLE FACTOR#1.0078;BONE MARROW#1.0074;CHRONIC KIDNEY DISEASE#1.0071;CARDIOVASCULAR RISK FACTOR#1.0068;GROWTH FACTOR#1.0068;SIGNALING PATHWAY#1.0063;POLYMERASE CHAIN REACTION#1.0056;SIGNALLING PATHWAY#1.0054;MUSCLE CELL#1.0042;FATTY LIVER DISEASE#1.0039;NITRIC OXIDE#1.0030;TYPE 2 DIABETES MELLITUS#1.0019;2 DIABETES MELLITUS#1.0019;GLUCOSE METABOLISM#1.0017;ARTERY#1.0014;PROTEIN KINASE#1.0012;PRO-INFLAMMATORY#1.0008;PANCREATIC CANCER#1.0002;TUBE FORMATION#1.0001;LIPID METABOLISM#0.9999;LIVER DISEASE#0.9999;PEROXISOME#0.9999;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9989;APOPTOSIS#0.9989;MITOGEN ACTIVATED PROTEIN#0.9988;OSTEOARTHRITIS#0.9983;FATTY LIVER#0.9982;SMOOTH MUSCLE#0.9980;PROTEIN DEACETYLASE#0.9977;LOW DENSITY LIPOPROTEIN#0.9975;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9973;STEM CELL#0.9970;T CELL#0.9968;TRANSCRIPTION FACTOR#0.9966;CELLULAR METABOLISM#0.9966;AND BODY COMPOSITION#0.9962;ADENINE#0.9960;GESTATION#0.9955;PERIPHERAL BLOOD#0.9949;GLUCOSE TOLERANCE TEST#0.9944;ADIPOCYTE#0.9938;HIGH DENSITY LIPOPROTEIN#0.9936;GLYCOLYSIS#0.9934;PALMITATE#0.9931;ATHEROSCLEROSIS#0.9919;PROGENITOR CELL#0.9919;OBESE#0.9917;GENE EXPRESSION#0.9913;INFLAMMATORY RESPONSE#0.9912;MONONUCLEAR CELLS#0.9908;ORAL GLUCOSE TOLERANCE#0.9899;REACTIVE OXYGEN SPECIES#0.9895;HIGH FAT DIET#0.9894;DIABETES MELLITUS#0.9893;CELL CYCLE#0.9886;POLY ADP RIBOSE#0.9884;PREADIPOCYTE#0.9870;PROGESTERONE#0.9867;HEPATITIS C#0.9864;ADIPOCYTE DIFFERENTIATION#0.9854;STEROIDOGENESIS#0.9850;ENDOTHELIUM#0.9849;TYPE 2 DIABETES#0.9842;EXTRACELLULAR MATRIX#0.9831;HYPERTENSION#0.9809;ADIPOSE TISSUE#0.9800;TUMOR CELLS#0.9796;CYTOTOXICITY#0.9789;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9783;CELL ADHESION#0.9779;INFLAMMATORY CELL#0.9768;RIBOSE#0.9766;HYPERTHYROIDISM#0.9763;SMOOTH MUSCLE CELL#0.9759;VENOUS BLOOD#0.9756;SYSTOLIC BLOOD PRESSURE#0.9740;GLUCOSE INTOLERANCE#0.9734;LUNG CANCER#0.9728;WEIGHT GAIN#0.9709;HYPERGLYCEMIA#0.9678;VASCULAR CELL#0.9675;WHITE ADIPOSE TISSUE#0.9675;G-CSF#0.9674;BODY FAT MASS#0.9665;IMMUNE RESPONSE#0.9645;ENDOTHELIAL PROGENITOR CELL#0.9637;TYPE 1 DIABETES#0.9605;ACUTE PANCREATITIS#0.9598;MULTIPLE LINEAR REGRESSION#0.9594;SUPEROXIDE DISMUTASE#0.9587;OVARIAN CANCER#0.9582;SELECTIN#0.9542;INFLAMMATORY BOWEL DISEASE#0.9534;ENERGY HOMEOSTASIS#0.9518;CHRONIC HEPATITIS C#0.9505;PIOGLITAZONE#0.9499;SKELETAL MUSCLE CELLS#0.9498;TRAUMATIC BRAIN INJURY#0.9497;MITOCHONDRIA#0.9492;CELL ADHESION MOLECULE#0.9492;HISTONE DEACETYLASE#0.9482;CYTOKINE PRODUCTION#0.9472;TOXICITY#0.9453;PROTEIN KINASE B#0.9436;OSTEOBLAST#0.9429;IMMUNE CELL#0.9408;ADENOCARCINOMA#0.9407;IMPAIRED GLUCOSE TOLERANCE#0.9406;IMMUNE SYSTEM#0.9405;ENZYME ACTIVITY#0.9385;WHITE BLOOD CELL#0.9340;GROWTH HORMONE#0.9337;VASCULAR DISEASE#0.9318;INSULIN-LIKE GROWTH FACTOR#0.9315;GLUCOSE TRANSPORT#0.9309;RESPIRATORY DISTRESS#0.9291;MECHANISM OF ACTION#0.9275;CIRCADIAN RHYTHM#0.9270;NICOTINATE PHOSPHORIBOSYLTRANSFERASE#0.9267;HEART DISEASE#0.9260;ACUTE CORONARY SYNDROME#0.9248;NEUTROPHIL APOPTOSIS#0.9237;STROMAL CELL#0.9228;NORMAL GLUCOSE TOLERANCE#0.9223;NEUROPROTECTION#0.9209;MARKERS OF INFLAMMATION#0.9207;ECLAMPSIA#0.9198;NITRIC OXIDE SYNTHASE#0.9184;SERUM ADIPONECTIN LEVELS#0.9183;VASCULAR ENDOTHELIAL CELL#0.9157;AND VISCERAL FAT#0.9133;FAT CELL#0.9121;DNA REPAIR#0.9064;CELLULAR SENESCENCE#0.9062;GLOMERULAR FILTRATION RATE#0.9040;GLOMERULAR FILTRATION#0.9037;FIBRINOGEN#0.9011;RHEUMATIC DISEASE#0.9007;OMENTAL ADIPOSE TISSUE#0.9003;ESTRADIOL#0.8995;DIET INDUCED OBESITY#0.8991;PANCREATIC DUCTAL ADENOCARCINOMA#0.8967;ASYMMETRIC DIMETHYLARGININE#0.8941;MELATONIN#0.8941;ANOREXIA#0.8938;SIMVASTATIN#0.8938;VASCULAR SMOOTH MUSCLE CELL#0.8934;CELL MIGRATION#0.8911;SIGNAL TRANSDUCTION#0.8904;REGENERATION#0.8880;EPIDERMAL GROWTH FACTOR#0.8877;ADENOSINE#0.8861;URIC ACID#0.8856;BLOOD GLUCOSE LEVEL#0.8852;PROSTATE CANCER#0.8842;ONCOGENIC#0.8834;HEPATOCELLULAR CARCINOMA#0.8828;FLOW MEDIATED DILATATION#0.8822;MONOCYTE CHEMOTACTIC PROTEIN#0.8764;ENDOPLASMIC RETICULUM#0.8735;GLUTATHIONE#0.8718;MICROVASCULAR ENDOTHELIAL CELL#0.8716;NADPH OXIDASE#0.8715;COLORECTAL CARCINOMA#0.8712;EUGLYCEMIC HYPERINSULINEMIC CLAMP#0.8698;GRANULOSA CELL#0.8695;VISCERAL FAT MASS#0.8672;CORTISOL#0.8668;OSTEOPOROSIS#0.8654;HYPOXIC#0.8652;INTIMA MEDIA THICKNESS#0.8626;FATTY ACID SYNTHASE#0.8617;LIPOGENESIS#0.8613;DEACETYLASE ACTIVITY#0.8609;LYMPH NODE METASTASIS#0.8588;HEPATIC STELLATE CELL#0.8581;CORONARY HEART DISEASE#0.8576;DEXAMETHASONE#0.8561;LIVER CIRRHOSIS#0.8559;MESENCHYMAL STEM CELL#0.8556;ADIPOGENESIS#0.8525;UMBILICAL CORD#0.8515;PANCREATITIS#0.8502;AUTOIMMUNE DISEASE#0.8493;CISPLATIN#0.8479;HYPERANDROGENISM#0.8471;BRAIN NATRIURETIC PEPTIDE#0.8466;TOLL LIKE RECEPTOR#0.8429;COLORECTAL ADENOMA#0.8419;ALKALINE PHOSPHATASE#0.8418;SERUM LEPTIN LEVEL#0.8327;CHOLESTEROL METABOLISM#0.8321;BLOOD VESSEL#0.8319;PROTEIN SECRETION#0.8317;LEYDIG CELL#0.8298;MESANGIAL CELL#0.8290;ALANINE#0.8289;ULCERATIVE COLITIS#0.8277;STRUCTURE ACTIVITY RELATIONSHIP#0.8266;OXYGEN GLUCOSE DEPRIVATION#0.8265;COLITIS#0.8253;ANOREXIA NERVOSA#0.8222;ASTROCYTE#0.8201;DRUG RESISTANCE#0.8198;DEDIFFERENTIATION#0.8170;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8165;ACROMEGALY#0.8156;SIGNALING MOLECULE#0.8122;PROTEIN SYNTHESIS#0.8115;MULTIPLE LOGISTIC REGRESSION#0.8106;RECEPTOR ANTAGONIST#0.8105;ALZHEIMER'S DISEASE#0.8090;IL-6 PRODUCTION#0.8084;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8072;LUPUS ERYTHEMATOSUS#0.8070;SIGNAL TRANSDUCER#0.8068;HYPOTHYROIDISM#0.8050;C-LEVEL#0.8050;DNA BINDING#0.8018;ALDOSTERONE#0.8016;VITAMIN B3#0.8005;FATTY ACID OXIDATION#0.8005;ESTROGEN RECEPTOR#0.8001;GLYCERALDEHYDE-3-PHOSPHATE#0.7990;RUPTURE OF MEMBRANES#0.7985;MAMMARY EPITHELIAL CELL#0.7979;PRIMARY HUMAN HEPATOCYTES#0.7979;VASCULAR ENDOTHELIAL FUNCTION#0.7978;ASPARTATE#0.7963;ATP BINDING CASSETTE#0.7955;CEREBROVASCULAR DISEASE#0.7947;ATP BINDING#0.7936;KERATINOCYTE#0.7926;AMNION#0.7925;AMNIOTIC FLUID#0.7921;POLYCYSTIC OVARIAN SYNDROME#0.7909;MULTIPLE MYELOMA#0.7886;REPLICATIVE SENESCENCE#0.7881;FAT FREE MASS#0.7881;SILENT INFORMATION REGULATOR#0.7875;AREA UNDER CURVE#0.7856;OOCYTE#0.7855;SQUAMOUS CELL CARCINOMA#0.7834;MYOCYTES#0.7833;SLEEP APNEA#0.7825;SERUM ALBUMIN#0.7823;CYTOKINE SECRETION#0.7809;OSTEOBLAST DIFFERENTIATION#0.7787;DILATED CARDIOMYOPATHY#0.7787;HYALURONIC ACID#0.7777;EPITHELIAL MESENCHYMAL TRANSITION#0.7775;INNATE IMMUNITY#0.7774;HEPATITIS B#0.7768;MORBID OBESITY#0.7750;CELL DIFFERENTIATION#0.7714;PYRUVATE#0.7690;SERUM AMYLOID A#0.7673;TYPE 1 DIABETES MELLITUS#0.7672;72-HOURS#0.7651;STREPTOZOTOCIN#0.7644;5-PHOSPHORIBOSYL 1-PYROPHOSPHATE#0.7605;CAROTID ARTERY#0.7585;MENISCUS#0.7581;VISCERAL FAT ACCUMULATION#0.7581;CARDIOVASCULAR SYSTEM#0.7578;T LYMPHOCYTE#0.7575;RESPIRATION#0.7570;REGULATION OF GLUCOSE HOMEOSTASIS#0.7554;COLLAGEN INDUCED ARTHRITIS#0.7547;TRANSCRIPTASE#0.7538;MITOCHONDRIAL MEMBRANE#0.7517;TRANSFORMING GROWTH FACTOR#0.7489;WATER TRANSPORT#0.7467;BREAST CANCER PATIENTS#0.7466;KAWASAKI DISEASE#0.7465;OVARIES#0.7454;LYMPHOCYTIC LEUKEMIA#0.7453;MACROPHAGE POLARIZATION#0.7450;PNEUMONIA#0.7423;PI3K SIGNALING#0.7413;ATP BINDING CASSETTE TRANSPORTER#0.7409;EZETIMIBE#0.7402;L-CARNITINE#0.7401;MIDDLE CEREBRAL ARTERY#0.7400;CEREBRAL ARTERY#0.7397;RESPIRATORY BURST#0.7390;LIPOPROTEIN LIPASE#0.7366;LIPID RAFT#0.7350;ANKYLOSING SPONDYLITIS#0.7346;DISEASE FREE SURVIVAL#0.7346;AEROBIC EXERCISE TRAINING#0.7339;UMBILICAL CORD BLOOD#0.7338;NEGATIVE ENERGY BALANCE#0.7338;CAROTID STENOSIS#0.7336;DNA METHYLATION#0.7330;EXCRETION#0.7320;CYTOCHROME C#0.7320;NF-KAPPAB ACTIVATION#0.7306;KINASE INHIBITOR#0.7304;MAP KINASE#0.7275;MYOTUBE#0.7272;LOW BIRTH WEIGHT#0.7263;TYPE 1 DIABETIC#0.7226;FOAM CELL FORMATION#0.7221;CARDIOMYOPATHY#0.7214;FAT SPECIFIC PROTEIN#0.7209;BONE FORMATION#0.7187;DIABETIC RETINOPATHY#0.7185;ADVANCED GLYCATION END#0.7181;HEPATITIS C VIRUS#0.7177;CHOLESTEROL EFFLUX#0.7176;COLON CANCER#0.7168;INSULIN RECEPTOR SUBSTRATE#0.7166;MYELOID LEUKEMIA#0.7165;SYNOVIUM#0.7163;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7149;SCAVENGER RECEPTOR#0.7144;ORAL SQUAMOUS CELL CARCINOMA#0.7136;INDUCTION OF APOPTOSIS#0.7123;GENOTOXIC#0.7116;COAGULATION#0.7115;HEPARIN#0.7109;TUMOR SUPPRESSOR#0.7107;LYSINE#0.7107;TRANSACTIVATION#0.7087;NORMAL GLUCOSE TOLERANT#0.7064;STEROL REGULATORY ELEMENT#0.7034;OLEIC ACID#0.7026;COLLAGEN TYPE I#0.7025;CEREBRAL ARTERY OCCLUSION#0.7015;LUNG DISEASE#0.6993;HEMORRHAGE#0.6982;ACUTE MYOCARDIAL INFARCTION#0.6971;FASTING SERUM INSULIN#0.6966;LUNG ENDOTHELIUM#0.6963;FREE ANDROGEN INDEX#0.6951;IFN-GAMMA#0.6940;CROHN'S DISEASE#0.6905;INDUCES CANCER#0.6846;IMPAIRED FASTING GLUCOSE#0.6839;RAPAMYCIN#0.6810;CONTROLLED OVARIAN STIMULATION#0.6807;SALIVARY GLAND#0.6806;PROTEIN BINDING#0.6799;CYTOPLASM#0.6788;GRANULOCYTE#0.6785;ACUTE MYELOID LEUKEMIA#0.6783;DE NOVO LIPOGENESIS#0.6777;TCA CYCLE#0.6776;JNK SIGNALING PATHWAY#0.6752;DEHYDROEPIANDROSTERONE SULFATE#0.6728;ENDOTHELIAL NITRIC OXIDE#0.6726;TYROSINE KINASE 1#0.6711;ALVEOLAR EPITHELIAL CELL#0.6704;IL-8 SECRETION#0.6704;MECHANISMS OF ACTION#0.6699;NF-KAPPAB INHIBITOR#0.6699;WOUND HEALING#0.6699;TELOMERASE ACTIVITY#0.6688;RECURRENCE FREE SURVIVAL#0.6687;ACTIVATED T LYMPHOCYTES#0.6686;RECEPTOR ACTIVATOR#0.6675;METASTATIC MELANOMA#0.6669;PANCREATIC ISLET#0.6665;DIURNAL#0.6665;CARNITINE#0.6665;LEFT VENTRICULAR MASS#0.6664;ELECTROPHORETIC MOBILITY SHIFT#0.6659;NERVOUS SYSTEM#0.6650;AUTOIMMUNITY#0.6628;CELL SURFACE#0.6600;HEAT SHOCK PROTEIN#0.6542;CELL CYCLE ARREST#0.6521;VIRAL HEPATITIS#0.6521;HUMAN ADIPOSE TISSUE#0.6500;P21 ACTIVATED KINASE#0.6499;INSULIN SIGNALING PATHWAY#0.6493;ADENOSINE MONOPHOSPHATE#0.6482;FAT PAD#0.6478;BODY WEIGHT LOSS#0.6476;OBSTRUCTIVE SLEEP APNEA#0.6475;ATORVASTATIN#0.6469;SATURATED FATTY ACID#0.6468;CATABOLISM#0.6462;GLIAL CELL#0.6447;CELL MATURATION#0.6446;INHIBITION OF NEUTROPHIL APOPTOSIS#0.6407;ISCHEMIA REPERFUSION INJURY#0.6404;PHAGOCYTOSIS#0.6401;INDUCIBLE NITRIC OXIDE#0.6396;S PHASE#0.6387;FASTING BLOOD SUGAR#0.6343;HUMAN PULMONARY ARTERY#0.6328;REGULATION OF METABOLISM#0.6328;LIPOLYSIS#0.6313;DISEASE ACTIVITY SCORE#0.6295;SENSITIZATION#0.6268;ENHANCER BINDING PROTEIN#0.6265;M2 MACROPHAGE#0.6263;ENHANCER BINDING#0.6261;OXIDATIVE PHOSPHORYLATION#0.6260;PROTEINURIA#0.6239;HEALTHY CONTROL GROUP#0.6236;FEEDING BEHAVIOR#0.6233;TOTAL BODY FAT#0.6231;OSTEOCLAST#0.6230;PERIODONTAL LIGAMENT#0.6222;NEURODEGENERATIVE DISEASE#0.6219;ROS GENERATION#0.6214;MAPK SIGNALING#0.6211;CAMKII#0.6197;KIDNEY TRANSPLANT RECIPIENTS#0.6191;DEATH RECEPTOR#0.6189;HIGH MOBILITY GROUP#0.6186;PULMONARY ARTERY#0.6184;RESPONSE TO TREATMENT#0.6184;ESSENTIAL HYPERTENSION#0.6184;HORMONE BINDING#0.6179;LOSARTAN#0.6167;HEPARIN BINDING#0.6150;ENDOPLASMIC RETICULUM STRESS#0.6140;COLONY-STIMULATING FACTOR#0.6134;NEUROPATHY#0.6130;ABNORMAL GLUCOSE METABOLISM#0.6120;GROWTH FACTOR RECEPTOR#0.6119;RNA INTERFERENCE#0.6110;COMPLEX I#0.6109;EPICARDIAL ADIPOSE TISSUE#0.6093;PARTURITION#0.6089;PLASMA MEMBRANE#0.6080;VEGF PRODUCTION#0.6064;MYOBLAST#0.6061;MULTIVARIATE LINEAR REGRESSION#0.6061;SPERMATOGENESIS#0.6058;NLRP3 INFLAMMASOME ACTIVATION#0.6048;DOXORUBICIN#0.6040;PSORIATIC ARTHRITIS#0.6030;ERYTHROCYTE#0.6026;ETHANOL#0.6026
10137	CELL WALL#0.6325;G-CSF#0.6304;MAGNETIC RESONANCE IMAGING#0.6280
10138	APOPTOSIS#0.6715;DNA BINDING#0.6569;STEM CELL#0.6428;TRANSCRIPTION FACTOR#0.6423;P38 MAPK SIGNALING#0.6093
10139	RELATED PROTEIN 1#1.1125;PLASMA MEMBRANE#0.9985;GOLGI MEMBRANE#0.8946;TRANS GOLGI NETWORK#0.8208;ACTIN RELATED PROTEIN#0.8047;ADIPOCYTE#0.7816;EPITHELIAL CELL#0.7639;LIPID DROPLET#0.7597;ENDOSOME#0.7463;LIPOLYSIS#0.7216;CHYLOMICRON#0.7154;GTP BINDING#0.6780;DYNACTIN COMPLEX#0.6587;DYNEIN#0.6418;ADIPOSE TISSUE#0.6298;COATOMER#0.6269;CELL SURFACE#0.6106
1013	CELL ADHESION#0.9420;SKELETAL MUSCLE#0.8557;GENE EXPRESSION#0.7544;FATTY ACID OXIDATION#0.6423;CELL CELL ADHESION#0.6298;MYOBLAST#0.6198
101409257	TRANSFORMING GROWTH FACTOR#0.7996;BREAST CANCER#0.7966;GROWTH FACTOR#0.7931;APOPTOSIS#0.7926;CANCER CELL#0.6701
101409265	DRUG DELIVERY SYSTEM#1.1995
10140	CANCER CELL#1.0549;T CELL#1.0544;TUMOR SUPPRESSOR#1.0518;CELL PROLIFERATION#1.0366;CELL CYCLE#1.0293;BREAST CANCER#1.0156;SIGNALING PATHWAY#1.0148;APOPTOSIS#0.9888;CELL GROWTH#0.9792;GENE EXPRESSION#0.9765;LUNG CANCER#0.9567;TRANSCRIPTION FACTOR#0.9491;B CELL#0.9184;MRNA DEADENYLATION#0.9159;TH17 CELL#0.9036;S PHASE#0.8884;POLY-A BINDING#0.8776;BREAST CANCER CELL#0.8655;BONE FORMATION#0.8600;GROWTH FACTOR#0.8591;UBIQUITIN#0.8391;NUCLEAR EXPORT#0.8192;RNA BINDING PROTEIN#0.8145;RNA BINDING#0.8019;CCR4 NOT COMPLEX#0.7911;PROTEASOME#0.7865;CELL CYCLE REGULATOR#0.7725;CD4+ T CELL#0.7675;NUCLEAR LOCALIZATION SIGNAL#0.7611;CENTRAL NERVOUS SYSTEM#0.7544;STEM CELL#0.7536;NERVOUS SYSTEM#0.7532;CYCLIN DEPENDENT KINASE#0.7350;BONE MORPHOGENETIC PROTEIN#0.7171;FOG 3#0.7143;QUIESCENCE#0.7097;TH1 CELL#0.7065;NUCLEAR EXPORT SIGNAL#0.6992;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6879;POLYMERASE CHAIN REACTION#0.6830;BONE MARROW#0.6812;LYMPH NODE#0.6807;OSTEOBLAST#0.6674;CELL DIFFERENTIATION#0.6582;CELL CYCLE ARREST#0.6395;MRNA DECAY#0.6255;ONCOGENIC#0.6213;GERM CELL#0.6171;CELL MIGRATION#0.6138;SKELETAL MUSCLE#0.6129;HUMAN BRONCHIAL EPITHELIAL#0.6063
10142	T CELL#1.0598;MICROTUBULE NUCLEATION#1.0585;CENTROSOME#1.0510;GOLGI APPARATUS#1.0505;ANCHORING#1.0498;MICROTUBULE#1.0359;PROTEIN KINASE A#1.0228;PROTEIN KINASE#1.0186;NMDA RECEPTOR#0.9871;CELL CYCLE#0.9679;TREATMENT PLANNING SYSTEM#0.9608;POTASSIUM CHANNEL#0.9417;MICROTUBULE DYNAMICS#0.9347;PROTEIN PHOSPHATASE 1#0.9132;LONG QT SYNDROME#0.9078;CELL MIGRATION#0.9077;COLORECTAL CANCER#0.9066;EPITHELIAL CELL#0.8598;CELL PROLIFERATION#0.7979;COLORECTAL#0.7596;MICROTUBULE CYTOSKELETON#0.7500;MACROMOLECULAR COMPLEX#0.7466;INTERPHASE#0.7175;ARRHYTHMIA#0.7071;ION CHANNEL#0.7035;CENTROSOME DUPLICATION#0.7002;ORGANELLE#0.6562;DIGESTION#0.6382;ACTION POTENTIAL#0.6372;LYMPH NODE#0.6304;VOLATILE ORGANIC COMPOUND#0.6141
10143	LECTIN#1.0108;EXTRACELLULAR MATRIX#0.7027;INVASIVE DUCTAL CANCER#0.6968;SEPTIC ARTHRITIS#0.6600;PLASMINOGEN ACTIVATION#0.6465;AKT SIGNALING#0.6316;QUANTITATIVE REAL TIME#0.6271;CELL SURFACE#0.6220;CELL PROLIFERATION#0.6198
101448070	GLUCOSE-6-PHOSPHATE#0.7419
10144	LUNG CANCER#1.0579;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#1.0255;LUNG DISEASE#1.0209;PULMONARY FIBROSIS#0.9630;HEDGEHOG INTERACTING PROTEIN#0.9568;GENE EXPRESSION#0.8932;EPITHELIAL CELL#0.8720;ADIPOSE TISSUE#0.7286;ADIPOCYTE#0.7009;CANCER CELL#0.6080
10146	GTPASE ACTIVATING PROTEIN BINDING#1.1207;SG ASSEMBLY#1.0807;SH3 DOMAIN BINDING#1.0785;STRESS GRANULE ASSEMBLY#1.0778;BINDING PROTEIN 1#1.0662;PROTEIN BINDING#1.0651;CANCER CELL#1.0348;STRESS GRANULE#1.0332;SIGNALING PATHWAY#1.0298;VIRAL REPLICATION#1.0267;BREAST CANCER#1.0240;RNA BINDING#1.0234;RNA BINDING PROTEIN#1.0217;T CELL#1.0173;GALECTIN#1.0058;APOPTOSIS#0.9981;TRANSLATION INITIATION#0.9932;BREAST CANCER CELL#0.9844;RNA GRANULE#0.9781;CAPRIN#0.9720;PROTEIN KINASE#0.9678;VIRAL INFECTION#0.9642;GENE EXPRESSION#0.9498;GROWTH FACTOR#0.9496;LUNG CANCER#0.9384;ARSENITE#0.9297;MRNA BINDING#0.9153;TRANSLATION INITIATION FACTOR#0.9070;HOST CELL#0.8995;POLY-A BINDING#0.8983;CHIKUNGUNYA#0.8921;CELL PROLIFERATION#0.8914;ANTIVIRAL RESPONSE#0.8904;RNA METABOLISM#0.8808;TRANSCRIPTION FACTOR#0.8761;CYTOPLASM#0.8636;PROTEIN SYNTHESIS#0.8379;NUCLEAR TRANSPORT#0.8301;CELL GROWTH#0.8256;PROTEIN KINASE R#0.8056;IMMUNE RESPONSE#0.7996;EUKARYOTIC INITIATION FACTOR#0.7969;CELL CYCLE#0.7886;RNA REPLICATION#0.7806;CYTOPLASMIC STRESS GRANULE#0.7668;ARGININE#0.7650;CELL DEATH#0.7636;NEURODEGENERATIVE DISEASE#0.7631;CYTOPLASMIC FOCI#0.7603;LYMPH NODE#0.7588;HEPATITIS C#0.7520;LYMPH NODE METASTASIS#0.7515;UBIQUITIN#0.7398;RIBOSOMAL SUBUNIT#0.7373;INNATE IMMUNE RESPONSE#0.7270;MOUSE EMBRYONIC FIBROBLAST#0.7156;RIBOSOME#0.7133;CELL ADHESION#0.6912;INNATE IMMUNITY#0.6830;DNA BINDING#0.6762;RESPONSE TO STRESS#0.6760;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6543;LUPUS ERYTHEMATOSUS#0.6541;EPITHELIAL CELL#0.6488;MICROTUBULE#0.6389;MACROPHAGE#0.6329;ESOPHAGEAL SQUAMOUS CARCINOMA#0.6304;FOOT AND MOUTH DISEASE#0.6236;MOUTH DISEASE#0.6232;HUMAN BREAST CANCER#0.6107;S PHASE#0.6087;DNA HELICASE#0.6078
10148	EPSTEIN BARR VIRUS#1.0567;TREG CELL#1.0351;B CELL#1.0226;PERIPHERAL BLOOD MONONUCLEAR CELLS#1.0193;MONONUCLEAR CELLS#1.0147;MACROPHAGE#1.0121;PERIPHERAL BLOOD#1.0113;CD4+ T CELL#1.0080;GENE EXPRESSION#0.9947;REGULATORY T CELL#0.9922;DENDRITIC CELL#0.9900;POLYMERASE CHAIN REACTION#0.9885;LYMPH NODE#0.9879;T CELL#0.9863;IMMUNE RESPONSE#0.9840;SIGNALING PATHWAY#0.9778;TH17 CELL#0.9764;TRANSCRIPTION FACTOR#0.9758;AUTOIMMUNE DISEASE#0.9672;IFN-GAMMA#0.9383;INFLAMMATORY BOWEL DISEASE#0.9035;CELL PROLIFERATION#0.9018;INFLAMMATORY RESPONSE#0.8960;EPITHELIAL CELL#0.8898;CD8+ T CELL#0.8818;PRO-INFLAMMATORY#0.8678;COLITIS#0.8549;ALLERGIC RHINITIS#0.8538;IMMUNE CELL#0.8512;EFFECTOR T CELL#0.8442;TROPHOBLAST#0.8381;IMMUNE SYSTEM#0.8373;CELL DIFFERENTIATION#0.8340;CYTOKINE PRODUCTION#0.8317;MONOCYTE#0.8189;T LYMPHOCYTE#0.8184;TH1 CELL#0.7767;ULCERATIVE COLITIS#0.7744;CELL ACTIVATION#0.7701;PLASMA CELL#0.7655;TUBERCULOSIS#0.7555;QUANTITATIVE REAL TIME#0.7471;IL-27 PRODUCTION#0.7457;TUMOR NECROSIS FACTOR#0.7436;CROHN'S DISEASE#0.7357;ANTIGEN PRESENTING CELLS#0.7339;B CELL LYMPHOMA#0.7337;T CELL PROLIFERATION#0.7211;CELL DEVELOPMENT#0.7150;B LYMPHOCYTE#0.7109;CYTOKINE RECEPTOR#0.7078;APOPTOSIS#0.7072;RHINITIS#0.7014;GROWTH FACTOR#0.6962;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6902;IL-10 PRODUCTION#0.6862;NORMAL CONTROL GROUP#0.6827;CYTOTOXIC T-LYMPHOCYTE#0.6614;T CELL ACTIVATION#0.6549;INFLAMMATORY CELL#0.6539;ENCEPHALOMYELITIS#0.6430;SYNCYTIOTROPHOBLAST#0.6395;EOSINOPHIL#0.6391;TOLL LIKE RECEPTOR#0.6344;REVERSE TRANSCRIPTION#0.6273;DELAYED-TYPE HYPERSENSITIVITY#0.6169;NEUTROPHIL#0.6140;LEUKOCYTE#0.6127;CHAGAS DISEASE#0.6022
10149	EPIDIDYMIS#0.8600;INFERTILITY#0.8310;MALE INFERTILITY#0.7553;SIGNAL TRANSDUCTION#0.6394;CELL ADHESION#0.6253;CYSTIC FIBROSIS#0.6232
1014	EPITHELIAL CELL#1.0335;RENAL CELL CARCINOMA#1.0101;TUBULAR EPITHELIAL CELL#0.9684;NEPHRON#0.9592;CELL ADHESION#0.9366;TRANSCRIPTION FACTOR#0.9082;CHROMOPHOBE RENAL CELL CARCINOMA#0.8699;GENE EXPRESSION#0.7606;CELL ADHESION MOLECULE#0.7233;TUMOR CELLS#0.7019;RENAL ONCOCYTOMA#0.7010;PAPILLARY RENAL CELL CARCINOMA#0.6946;COLLECTING DUCT CARCINOMA#0.6613;URETERIC BUD#0.6279;THYROID CARCINOMA#0.6146
10150	RNA BINDING#0.9667;RNA BINDING PROTEIN#0.9269;GENE EXPRESSION#0.8672;MYOTONIC DYSTROPHY TYPE 1#0.8458;MYOBLAST#0.7860;SKELETAL MUSCLE#0.7221;RNA PROCESSING#0.6244;NERVOUS SYSTEM#0.6141
10151	MULTIPLE ENDOCRINE NEOPLASIA#0.9166
10152	ABA SIGNALING#1.0434;SIGNAL TRANSDUCTION#1.0127;PHOSPHATASE ACTIVITY#0.9976;SIGNALING PATHWAY#0.9878;PROTEIN KINASE#0.9824;GERMINATION#0.9761;ABA SIGNAL TRANSDUCTION#0.9668;SEED GERMINATION#0.9516;TRANSCRIPTION FACTOR#0.9253;GENE EXPRESSION#0.9247;WAVE COMPLEX#0.9038;STOMATAL CLOSURE#0.8917;CELL MIGRATION#0.8663;SIGNALLING PATHWAY#0.8462;PLASMA MEMBRANE#0.7763;ANION CHANNEL#0.7288;ACTIN CYTOSKELETON#0.7094;SEED DORMANCY#0.6308;TUMOR SUPPRESSOR#0.6125;NITRATE TRANSPORT#0.6039
10153	FREEZING TOLERANCE#1.0406;COLD ACCLIMATION#1.0184;TRANSCRIPTION FACTOR#1.0114;DNA BINDING#0.9990;GENE EXPRESSION#0.9863;SIGNALING PATHWAY#0.8453;DEHYDRATION#0.8452;DEHYDRATION RESPONSIVE ELEMENT#0.8406;LEAF SENESCENCE#0.8363;ELECTROPHORETIC MOBILITY SHIFT#0.8243;RESPONSE TO COLD#0.8216;SIGNAL TRANSDUCTION#0.8015;ENHANCER BINDING PROTEIN#0.7598;ENHANCER BINDING#0.7593;CENTROMERE BINDING#0.7388;SENESCENCE#0.7158;TRANSACTIVATION#0.6784;CENTROMERE#0.6630;CELL SURFACE#0.6079
10154	SEMAPHORIN RECEPTOR#1.0562;GROWTH CONE#1.0233;CELL MIGRATION#1.0182;AXON GUIDANCE#1.0138;NERVOUS SYSTEM#1.0061;CELL SURFACE#1.0052;ACTIN CYTOSKELETON#0.9982;SIGNAL TRANSDUCTION#0.9971;CELL ADHESION#0.9890;CYTOPLASMIC REGION#0.9767;ENDOTHELIAL CELL#0.9763;ANGIOGENESIS#0.9739;T CELL#0.9737;GAP ACTIVITY#0.9704;GROWTH CONE COLLAPSE#0.9696;TRANSMEMBRANE RECEPTOR#0.9647;IMMUNE SYSTEM#0.9567;IMMUNE RESPONSE#0.9523;DENDRITIC CELL#0.9471;GROWTH FACTOR#0.9465;SIGNALING PATHWAY#0.9300;TUMOR SUPPRESSOR#0.9201;MELANOCYTE#0.9176;GTPASE BINDING#0.9168;MORPHOGENESIS#0.8903;CELL MOTILITY#0.8751;PROTEIN KINASE#0.8744;RECEPTOR COMPLEX#0.8617;NEURITE#0.8566;TRANSCRIPTION FACTOR#0.8564;CANCER CELL#0.8400;NUCLEOTIDE EXCHANGE FACTOR#0.8120;IMMUNE CELL#0.7827;COMPLEX I#0.7767;RECEPTOR TYROSINE KINASE#0.7678;RHO GTPASE BINDING#0.7608;CELL PROLIFERATION#0.7487;AXON PRUNING#0.7383;SIGNALLING PATHWAY#0.7320;SPINAL CORD#0.7298;EPITHELIAL CELL#0.7274;RHOGEF#0.7264;GUANINE#0.7256;EXTRACELLULAR REGION#0.7202;ACTIN FILAMENT#0.7161;TYROSINE KINASE RECEPTOR#0.7151;NEURITE OUTGROWTH#0.7107;CENTRAL NERVOUS SYSTEM#0.7047;APOPTOSIS#0.6948;ENDOTHELIAL GROWTH FACTOR#0.6905;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6905;NEUTROPHIL#0.6818;RAS GAP ACTIVITY#0.6816;BLOOD VESSEL#0.6807;INFLAMMATORY RESPONSE#0.6695;AXON GUIDANCE RECEPTOR#0.6648;GENE EXPRESSION#0.6463;AXON COLLATERAL#0.6256;CELL ADHESION MOLECULE#0.6080;MIDLINE#0.6054;BREAST CANCER#0.6033
10155	HETEROCHROMATIN PROTEIN 1#1.0645;SUMOYLATION#1.0584;HETEROCHROMATIN#1.0398;GENE SILENCING#1.0372;DNA METHYLATION#1.0364;CELL PROLIFERATION#1.0322;CANCER CELL#1.0293;HISTONE DEACETYLASE#1.0290;ZINC FINGER PROTEIN#1.0268;DNA DAMAGE RESPONSE#1.0201;DNA REPAIR#1.0125;LUNG CANCER#1.0125;EMBRYONIC STEM CELL#1.0120;CHROMATIN REMODELING#1.0076;CELL CYCLE#1.0065;BREAST CANCER#1.0050;STEM CELL#1.0033;TRANSCRIPTION FACTOR#0.9990;DNA BINDING#0.9987;LYSINE#0.9941;DOUBLE STRAND BREAK#0.9925;GENE EXPRESSION#0.9909;T CELL#0.9883;TUMOR SUPPRESSOR#0.9857;APOPTOSIS#0.9843;CELL DIFFERENTIATION#0.9766;HISTONE METHYLTRANSFERASE#0.9751;ATAXIA TELANGIECTASIA#0.9748;ATAXIA TELANGIECTASIA MUTATED#0.9726;UBIQUITIN#0.9617;SIGNALING PATHWAY#0.9615;BREAST CANCER CELL#0.9573;HISTONE MODIFICATION#0.9451;HETEROCHROMATIN FORMATION#0.9320;DNA METHYLTRANSFERASE#0.9269;MOUSE EMBRYONIC STEM#0.9159;POST-TRANSLATIONAL MODIFICATION#0.9114;HEPATOCELLULAR CARCINOMA#0.8801;PROGENITOR CELL#0.8800;B CELL#0.8774;PROTEIN PROTEIN INTERACTION#0.8553;NEURAL PROGENITOR CELL#0.8533;OOCYTE#0.8470;COLORECTAL CANCER#0.8450;CENTROMERIC HETEROCHROMATIN#0.8365;GERM CELL#0.8322;PROTEIN KINASE#0.8085;KAPOSI'S SARCOMA#0.7886;NUCLEOSOME#0.7836;OVARIAN#0.7811;POSTTRANSLATIONAL MODIFICATION#0.7633;TUMOR CELLS#0.7538;TRANSACTIVATION#0.7536;HOMOLOGOUS RECOMBINATION#0.7529;PLURIPOTENT STEM CELL#0.7511;CELL GROWTH#0.7405;OVARIAN CANCER#0.7384;DNA REPLICATION#0.7300;ARGININE#0.7293;CERVICAL CANCER#0.7264;COLORECTAL#0.7021;VIRAL GENOME#0.6976;G1 PHASE#0.6762;SIGNAL TRANSDUCTION#0.6714;CELL MIGRATION#0.6670;AUTOPHAGY#0.6571;PROTEIN COMPLEX#0.6515;RETINOIC ACID#0.6491;NURD COMPLEX#0.6484;EUCHROMATIN#0.6470;DE NOVO DNA METHYLATION#0.6351;ERYTHROPOIESIS#0.6276;CELL DEVELOPMENT#0.6273;GLOBIN#0.6266;TRANSCRIPTION REPRESSOR#0.6239;MDM2 BINDING#0.6219;METHYLTRANSFERASE ACTIVITY#0.6172;DEMETHYLATION#0.6169;CHROMATIN MODIFICATION#0.6104;VIRAL LATENCY#0.6076;COMPLEX I#0.6062;REGULATORY T CELL#0.6049
10156	PLASMA MEMBRANE#1.0071;PROTEIN PROTEIN INTERACTION#0.9769;INFLAMMATORY BOWEL DISEASE#0.9767;PROTEIN COMPLEX#0.8815;PROTEIN-PROTEIN COMPLEX#0.8343;METASTATIC COLORECTAL CANCER#0.7521;COLORECTAL CANCER#0.7414;T CELL#0.7407;IMMUNE RESPONSE#0.7273;ROOT MEAN SQUARE#0.7177;INFERTILITY#0.6632
10157	LYSINE CATABOLISM#1.0991;LYSINE#1.0692;CATABOLISM#1.0450;LYSINE DEGRADATION#0.9961;HYPERLYSINEMIA#0.7035;LYSINE METABOLISM#0.6471
10158	TUMOR CELLS#1.0323;EPITHELIAL CELL#0.9573;PROXIMAL TUBULAR EPITHELIAL#0.8485;REACTIVE OXYGEN SPECIES#0.8470;TUBULAR EPITHELIAL CELL#0.8387;BRUSH BORDER#0.8042;BORTEZOMIB#0.7569;STEM CELL#0.7163;CELL PROLIFERATION#0.7099;CANCER CELL#0.7095;PROTEASOME#0.6520;HEMATOPOIETIC CELL#0.6215;BREAST CANCER#0.6132
10159	HANDLE REGION PEPTIDE#1.0454;END ORGAN DAMAGE#1.0423;PODOCYTE#1.0336;SIGNAL TRANSDUCTION#1.0282;SIGNALING PATHWAY#1.0262;MESANGIAL CELL#1.0230;ALISKIREN#1.0228;DUCT CELL#1.0220;NEPHRON#1.0159;MITOGEN ACTIVATED PROTEIN#1.0146;AUTOPHAGY#1.0136;PROTEIN KINASE#1.0099;NEPHROPATHY#1.0070;ANGIOTENSIN CONVERTING ENZYME#1.0067;SMOOTH MUSCLE#1.0063;CELL PROLIFERATION#1.0051;DIABETIC NEPHROPATHY#1.0031;SMOOTH MUSCLE CELL#1.0023;ALDOSTERONE#1.0019;ENDOTHELIAL CELL#1.0018;MUSCLE CELL#1.0017;APOPTOSIS#0.9993;RENIN ACTIVITY#0.9924;GENE EXPRESSION#0.9923;KIDNEY DISEASE#0.9915;HYPERTENSION#0.9897;DIABETES MELLITUS#0.9891;DIABETIC RETINOPATHY#0.9870;GROWTH FACTOR#0.9832;EXCRETION#0.9822;TRANSFORMING GROWTH FACTOR#0.9802;NERVOUS SYSTEM#0.9791;STEM CELL#0.9710;ATPASE ACTIVITY#0.9680;ADIPOSE TISSUE#0.9676;DIRECT RENIN INHIBITOR#0.9616;ENZYME INHIBITOR#0.9520;PROTON PUMP#0.9486;COLLECTING DUCTS#0.9485;RECEPTOR ANTAGONIST#0.9430;CENTRAL NERVOUS SYSTEM#0.9418;ACIDIFICATION#0.9405;VASCULAR SMOOTH MUSCLE CELL#0.9389;ENDOTHELIAL GROWTH FACTOR#0.9355;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9355;POLYMERASE CHAIN REACTION#0.9285;LOSARTAN#0.9265;CHRONIC KIDNEY DISEASE#0.9212;CELL SURFACE#0.9169;SIGNALLING PATHWAY#0.9119;REACTIVE OXYGEN SPECIES#0.9100;STREPTOZOTOCIN#0.8925;ANGIOTENSIN RECEPTOR#0.8899;PROTEINURIA#0.8897;WNT RECEPTOR#0.8844;GLOMERULAR FILTRATION#0.8834;RENAL FIBROSIS#0.8822;ENDOTHELIUM#0.8775;NADPH OXIDASE#0.8762;LOW DENSITY LIPOPROTEIN#0.8722;VASOPRESSIN#0.8667;V-ATPASE ASSEMBLY#0.8657;INTRACELLULAR SIGNALING PATHWAY#0.8616;GESTATIONAL DIABETES#0.8592;OBSTRUCTIVE SLEEP APNEA#0.8564;SLEEP APNEA#0.8548;VALSARTAN#0.8471;KIDNEY DEVELOPMENT#0.8467;CARDIOMYOPATHY#0.8434;CATALYTIC ACTIVITY#0.8404;BRAIN RENIN-ANGIOTENSIN SYSTEM#0.8338;INFLAMMATORY RESPONSE#0.8297;CANCER CELL#0.8271;SYSTOLIC BLOOD PRESSURE#0.8259;NITRIC OXIDE#0.8245;CELL DEATH#0.8234;TRANSCRIPTION FACTOR#0.8139;RETINAL DEVELOPMENT#0.8110;ZINC FINGER PROTEIN#0.8061;ALCOHOLIC CARDIOMYOPATHY#0.8033;EPITHELIAL CELL#0.7993;SITE 1 PROTEASE#0.7931;CELL POLARITY#0.7913;URINARY PROTEIN#0.7911;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7881;HUMAN UMBILICAL VEIN#0.7874;UMBILICAL VEIN#0.7871;SKELETAL MUSCLE#0.7818;RECEPTOR COMPLEX#0.7816;EXTRACELLULAR MATRIX#0.7816;GESTATIONAL DIABETES MELLITUS#0.7791;MONOCYTE#0.7785;HIGH FAT DIET#0.7644;TISSUE DAMAGE#0.7632;PLASMA MEMBRANE#0.7611;MACROPHAGE#0.7601;EPITHELIAL SODIUM CHANNEL#0.7597;ACE INHIBITOR#0.7509;MENTAL RETARDATION#0.7485;EMBRYONIC STEM CELL#0.7463;TUMOR NECROSIS FACTOR#0.7436;PANCREATIC CANCER#0.7407;PLANAR CELL POLARITY#0.7402;BLOOD PRESSURE REGULATION#0.7353;WNT RECEPTOR COMPLEX#0.7267;SODIUM CHANNEL#0.7247;ENDOPLASMIC RETICULUM#0.7240;CELL MEMBRANE#0.7203;URETERIC BUD#0.7194;OF DIABETIC RATS#0.7138;T CELL#0.7131;CAPTOPRIL#0.7099;STROMAL CELL#0.7044;SLEEP APNEA SYNDROME#0.7037;CARDIOMYOCYTE#0.7026;MAP KINASE#0.7024;SMOOTH MUSCLE ACTIN#0.6970;AORTIC SMOOTH MUSCLE CELLS#0.6952;EXTRACELLULAR SPACE#0.6929;DIABETIC KIDNEY DISEASE#0.6905;MORPHOGENESIS#0.6895;GLOMERULAR FILTRATION RATE#0.6860;PROLIFERATIVE DIABETIC RETINOPATHY#0.6853;ARTERY#0.6839;ISCHEMIA#0.6837;RECEPTOR BINDING#0.6762;MAPK ACTIVATION#0.6726;GESTATION#0.6677;ATPASE COMPLEX#0.6675;C REACTIVE PROTEIN#0.6669;BAFILOMYCIN A1#0.6574;REVERSE TRANSCRIPTION#0.6572;TYPE 2 DIABETES#0.6556;ADENOCARCINOMA#0.6528;BRAIN DEVELOPMENT#0.6512;CARDIOVASCULAR SYSTEM#0.6506;HYPOXIA#0.6443;APOPTOTIC#0.6292;PANCREATIC DUCTAL ADENOCARCINOMA#0.6284;NEUROGENESIS#0.6225;CELL DIFFERENTIATION#0.6213;GLOMERULAR FILTRATION BARRIER#0.6201;BRANCHING MORPHOGENESIS#0.6152;INTELLECTUAL DISABILITY#0.6074;ANGIOGENESIS#0.6073;REGULATION OF BLOOD PRESSURE#0.6070;MALIGNANT HYPERTENSION#0.6066;ADULT HIPPOCAMPAL NEUROGENESIS#0.6020
1015	PEPTIDE TRANSPORTER#1.0699;HEPATOCELLULAR CARCINOMA#1.0417;CANCER CELL#1.0347;COLORECTAL#1.0313;ADENOCARCINOMA#1.0249;LYMPH NODE#1.0197;CELL PROLIFERATION#1.0155;COLORECTAL ADENOCARCINOMA#1.0055;COLORECTAL CANCER#1.0035;GENE EXPRESSION#0.9983;CELL ADHESION#0.9929;APOPTOSIS#0.9888;LYMPH NODE METASTASIS#0.9873;COLON CANCER#0.9818;SIGNALING PATHWAY#0.9508;TRANSCRIPTION FACTOR#0.9345;RNA INTERFERENCE#0.9030;CELL CYCLE#0.8802;EPITHELIAL CELL#0.8726;INTEGRIN ACTIVATION#0.8706;GROWTH FACTOR#0.8703;METASTATIC COLORECTAL ADENOCARCINOMA#0.8672;GASTRIC ADENOCARCINOMA#0.8321;PANCREATIC CANCER#0.8154;METAPLASIA#0.8153;TOCOPHEROL#0.8106;TIGHT JUNCTION#0.7583;NEOPLASTIC TISSUES#0.7529;GASTROINTESTINAL TRACT#0.7528;CELL ADHESION MOLECULE#0.7512;CELL CYCLE ARREST#0.7494;ONCOGENIC#0.7352;POLYMERASE CHAIN REACTION#0.7248;SMALL INTESTINE#0.7071;CLEAVED CASPASE 3#0.6846;COLORECTAL CARCINOMA#0.6844;HYPOXANTHINE#0.6815;TUMOR TISSUES#0.6590;LYMPH NODE MICROMETASTASIS#0.6520;APOPTOTIC#0.6510;LIVER METASTASIS#0.6455;METANEPHRIC ADENOMA#0.6413;GUANINE#0.6405;TUMOR SUPPRESSOR#0.6311;EPIDERMAL GROWTH FACTOR#0.6307;ORGANIC CATION TRANSPORTER#0.6148;ORGANIC ANION TRANSPORTER#0.6134;PROTEIN KINASE#0.6089;HISTIDINE#0.6051;REVERSE TRANSCRIPTION#0.6035;CELL SURFACE#0.6024
10160	NUCLEOTIDE EXCHANGE FACTOR#0.6835;CHONDROCYTE#0.6295;ADVANCED GASTRIC CANCER#0.6036;OVERALL SURVIVAL TIME#0.6033
10161	AUTOSOMAL RECESSIVE HYPOTRICHOSIS#1.1080;HYPOTRICHOSIS#1.0891;HAIR GROWTH#0.9783;HAIR FOLLICLE#0.9445;CANCER CELL#0.8658;ENDOTHELIAL CELL#0.8403;HAIR LOSS#0.8130;CELL PROLIFERATION#0.8100;SIGNALING PATHWAY#0.7908;GENE EXPRESSION#0.7506;SCALP#0.6708;GROWTH FACTOR#0.6376;HEPATOCELLULAR CARCINOMA#0.6373;QUANTITATIVE REAL TIME#0.6322;HAIR FOLLICLE DEVELOPMENT#0.6245;BREAST CANCER#0.6144
10162	ARACHIDONIC ACID#0.9243;MACROPHAGE#0.8452;LIPID METABOLISM#0.7646;SMALL INTESTINE#0.7562;ATHEROSCLEROSIS#0.7384;ENTEROCYTE#0.7379;CHOLESTEROL BIOSYNTHESIS#0.7094;PHOSPHOLIPID HOMEOSTASIS#0.6588;LIVER X RECEPTOR#0.6171;CELL DEATH#0.6118;T CELL#0.6047
10163	T CELL#1.0589;ACTIN RELATED PROTEIN#1.0360;WISKOTT ALDRICH SYNDROME#1.0331;CELL MIGRATION#1.0247;ACTIN POLYMERIZATION#1.0231;CANCER CELL#1.0127;CELL MOTILITY#1.0041;GROWTH FACTOR#1.0011;SIGNALING PATHWAY#1.0010;ACTIN FILAMENT#0.9990;ACTIN CYTOSKELETON#0.9987;ACTIN NUCLEATION#0.9904;WAVE COMPLEX#0.9662;MICROTUBULE#0.9624;BREAST CANCER#0.9612;RUFFLE#0.9470;RNA INTERFERENCE#0.9306;COMPLEX I#0.9041;MACROPHAGE#0.8881;MEMBRANE RUFFLING#0.8819;INSULIN RECEPTOR#0.8633;LAMELLIPODIUM FORMATION#0.8571;CELL MOVEMENT#0.8452;CELL ADHESION#0.8420;CELL PERIPHERY#0.8359;T CELL ACTIVATION#0.8318;LYMPH NODE#0.8297;CELL ACTIVATION#0.8295;MEMBRANE TRANSPORT#0.8212;EPITHELIAL CELL#0.7881;LYMPH NODE METASTASIS#0.7676;OOCYTE#0.7615;INSULIN RECEPTOR SUBSTRATE#0.7614;PANCREATIC CANCER#0.7588;HEPATOCYTE GROWTH FACTOR#0.7580;PLASMA MEMBRANE#0.7547;LAMELLIPODIUM#0.7541;PROTEIN KINASE#0.7309;BINDING PROTEIN 1#0.7011;PROTEIN COMPLEX#0.6836;FILOPODIUM FORMATION#0.6819;CD4+ T CELL#0.6766;KINESIN COMPLEX#0.6741;BREAST CANCER CELL#0.6674;EXTRACELLULAR MATRIX#0.6663;ASYMMETRIC CYTOKINESIS#0.6630;ACTIN BINDING#0.6620;CELL MEMBRANE#0.6557;MEMBRANE RUFFLE#0.6555;IMMUNOLOGICAL SYNAPSE#0.6526;KINESIN#0.6405;ZONULA ADHERENS#0.6390;ENDOTHELIAL CELL#0.6326;MORPHOGENESIS#0.6323;SH3 DOMAIN BINDING#0.6287;NUCLEAR MIGRATION#0.6281;CELL POLARITY#0.6106;REVERSE TRANSCRIPTION#0.6101;WAVE REGULATORY COMPLEX#0.6074;HUMAN BREAST CANCER#0.6060
10164	SELECTIN#1.0421;LYMPHOCYTE HOMING#1.0418;LYMPH NODE#1.0384;GLCNAC#1.0223;SULFATION#1.0095;VENULE#0.9632;ENDOTHELIAL CELL#0.9554;PERIPHERAL LYMPH NODES#0.8677;MUCINOUS ADENOCARCINOMA#0.8516;O GLYCAN#0.8367;ADENOCARCINOMA#0.7540;EPITHELIAL CELL#0.6962;LEUKOCYTE#0.6616;T CELL#0.6473;PAPILLARY SEROUS ADENOCARCINOMA#0.6400;HUMAN UMBILICAL VEIN#0.6206;UMBILICAL VEIN#0.6203;COLITIS#0.6090;B CELL#0.6085;CANCER CELL#0.6067
10165	CITRULLINEMIA#1.0753;INTRAHEPATIC CHOLESTASIS#1.0418;ASPARTATE#1.0414;UREA CYCLE#1.0366;CHOLESTASIS#1.0365;HEPATOCELLULAR CARCINOMA#1.0177;ARGININOSUCCINATE#1.0071;CITRULLINE#1.0068;LIVER DISEASE#0.9724;MALATE ASPARTATE SHUTTLE#0.9607;FATTY LIVER#0.9135;HEPATIC ENCEPHALOPATHY#0.8983;PERIPHERAL BLOOD#0.8799;ARGININE#0.8799;GLYCOLYSIS#0.8536;PYRUVATE#0.8216;MITOCHONDRIA#0.8197;PERIPHERAL BLOOD LYMPHOCYTES#0.8128;AUTOSOMAL RECESSIVE DISEASE#0.8042;BRAIN EDEMA#0.7907;EDEMA#0.7869;METHIONINE#0.7447;FATTY LIVER DISEASE#0.6870;PANCREATITIS#0.6570;BILIARY ATRESIA#0.6528;LACTOSE#0.6153
101669762	CELL PROLIFERATION#1.0901;CANCER CELL#1.0787;LYMPH NODE METASTASIS#0.9702;LYMPH NODE#0.9649;LUNG CANCER#0.9011;ONCOGENIC#0.8845;SIGNALING PATHWAY#0.8822;CERVICAL CANCER#0.8426;COLORECTAL CANCER#0.8372;POLYMERASE CHAIN REACTION#0.8076;ADJACENT NORMAL TISSUE#0.7376;SQUAMOUS CELL CARCINOMA#0.7168;CELL CYCLE#0.7151;COLORECTAL#0.6723;CERVICAL#0.6651;REVERSE TRANSCRIPTION#0.6619;EPITHELIAL MESENCHYMAL TRANSITION#0.6428;APOPTOSIS#0.6407;BREAST CANCER#0.6347;PRC2 COMPLEX#0.6197;NORMAL ADJACENT TISSUE#0.6036
101669763	HISTONE H4 ACETYLATION#1.2243
101669767	PROSTATE CANCER#1.0867;SWI-SNF COMPLEX#0.8776
10166	ORNITHINE#1.0756;UREA CYCLE#1.0480;MITOCHONDRIAL MEMBRANE#0.8438;ARGININE#0.8021;INNER MITOCHONDRIAL MEMBRANE#0.7817;ORNITHINE TRANSPORT#0.7381;UREA CYCLE DISORDER#0.6834;CITRULLINE#0.6007
10167	CYSTIC FIBROSIS#0.8240
10170	3-ALPHA-HSD ACTIVITY#1.1001;RETINOL DEHYDROGENASE#1.0588;RETINOL#1.0426;BETA-HYDROXYSTEROID DEHYDROGENASE#1.0421;ALDO KETO REDUCTASE#1.0184;ANTI INFLAMMATORY DRUGS#1.0148;CHLORDECONE REDUCTASE#1.0127;5.ALPHA.-DIHYDROTESTOSTERONE#1.0072;5ALPHA DIHYDROTESTOSTERONE#0.9995;DIHYDROTESTOSTERONE#0.9986;INDOMETHACIN#0.9909;TESTOSTERONE#0.9855;PROGESTERONE#0.9846;ENZYME ACTIVITY#0.9809;RETINOIC ACID#0.9748;ANDROGEN METABOLISM#0.9407;BILE ACID BINDING#0.9386;EPITHELIAL CELL#0.9273;ANDROGEN RECEPTOR#0.9262;MICROSOME#0.9253;GENE EXPRESSION#0.9202;ASTROCYTE#0.9136;STEROID BINDING#0.8882;ESTRADIOL#0.8828;ALDEHYDE REDUCTASE#0.8741;ANDROSTENEDIONE#0.8674;LEYDIG CELL#0.8601;SUBMANDIBULAR GLAND#0.8479;CHENODEOXYCHOLIC ACID#0.8409;GLIAL CELL#0.8356;OVARIAN#0.8184;CHOLIC ACID#0.8172;MUTAGENESIS#0.8138;ADIPOSE TISSUE#0.8071;NICOTINAMIDE#0.7955;GLYCINE#0.7880;CANCER CELL#0.7832;ESTROGENS#0.7827;PROGESTIN#0.7785;PROSTAGLANDIN F SYNTHASE#0.7655;STEROID METABOLISM#0.7641;PROSTATE CANCER#0.7641;20ALPHA-HYDROXYSTEROID DEHYDROGENASE#0.7602;COFACTOR BINDING#0.7594;TRANSCRIPTION FACTOR#0.7217;MEDROXYPROGESTERONE ACETATE#0.7131;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7077;NERVOUS SYSTEM#0.6997;OLIGODENDROCYTE#0.6927;ADENINE#0.6812;CENTRAL NERVOUS SYSTEM#0.6747;STROMAL CELL#0.6722;DIHYDRODIOL DEHYDROGENASE ACTIVITY#0.6717;STEROID DEHYDROGENASE#0.6705;3BETA-HYDROXYSTEROID DEHYDROGENASE#0.6639;STEROID 5ALPHA-REDUCTASE#0.6611;GRANULOSA CELL#0.6577;DODECYL SULFATE#0.6382;GLUCOSE-6-PHOSPHATE#0.6296;MACROPHAGE#0.6265;VITAMIN A#0.6243;STROMA#0.6232;OMENTAL ADIPOSE TISSUE#0.6166;OLFACTORY BULB#0.6100;PROGESTERONE METABOLISM#0.6100;GLUTATHIONE#0.6090;SODIUM DODECYL SULFATE#0.6051;POLYCYCLIC AROMATIC HYDROCARBON#0.6040
10171	RRNA PROCESSING#0.7718;SMALL NUCLEOLAR RNA#0.6536;RIBOSOMAL SUBUNIT#0.6363;RIBOSOME#0.6075
10172	TRANSCRIPTIONAL REPRESSOR ACTIVITY#0.8602;CELL PROLIFERATION#0.7958
10174	FOCAL ADHESION#1.0728;CELL ADHESION#1.0501;GROWTH FACTOR#0.9552;GENE EXPRESSION#0.9530;EPIDERMAL GROWTH FACTOR#0.8654;SIGNAL TRANSDUCTION#0.8649;PROTEIN KINASE#0.8647;CELL MIGRATION#0.8448;VINCULIN BINDING#0.8073;DNA METHYLATION#0.6977;CELL GROWTH#0.6902;EXTRACELLULAR MATRIX#0.6359;CAM BINDING#0.6283;CYTOKINETIC ABSCISSION#0.6259;ACTIN CYTOSKELETON#0.6174;GERM CELL#0.6162;ESTROGEN RECEPTOR#0.6073;SKELETAL MUSCLE#0.6061;TUMOR SUPPRESSOR#0.6060;SMOOTH MUSCLE#0.6050
10175	T CELL ACTIVATION#0.6440;CELL ACTIVATION#0.6406;T CELL#0.6324
10178	BREAST CANCER#0.8062;HUMAN BREAST CANCER#0.7161;NOTTINGHAM PROGNOSTIC INDEX#0.6766;LYMPH NODE#0.6694
10179	RNA BINDING#1.0487;EXOSOME#0.9626;RNA SPLICING#0.6247
1017	CYCLIN A1-CDK2 COMPLEX#1.0698;CYCLIN E KINASE ACTIVITY#1.0530;CENTROSOME DUPLICATION#1.0347;OLOMOUCINE#1.0330;FLAVOPIRIDOL#1.0310;PURVALANOL A#1.0310;CYCLIN BINDING#1.0211;DNA POLYMERASE ALPHA#1.0208;CENTROSOME#1.0178;CATALYTIC ACTIVITY#1.0164;S-PHASE CHECKPOINT#1.0099;CENTRIOLE#1.0090;HYPOXIA#1.0073;KINASE INHIBITOR P27#1.0071;THYMOCYTE#1.0060;ATP BINDING#1.0049;MEIOSIS#1.0044;CDC2 KINASE ACTIVITY#1.0033;DOMINANT NEGATIVE MUTANT#1.0030;PROTEIN COMPLEX#1.0025;KINASE ACTIVITY#1.0006;CLEAVED CASPASE 3#0.9993;STAUROSPORINE#0.9984;PROTEIN PHOSPHORYLATION#0.9983;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9978;CYCLIN DEPENDENT KINASE#0.9976;HYPERPHOSPHORYLATION#0.9973;DNA DAMAGE CHECKPOINT#0.9970;IFN-GAMMA#0.9970;DEPHOSPHORYLATION#0.9970;MOLECULAR DYNAMICS SIMULATION#0.9965;CELL DIVISION CYCLE#0.9940;ATAXIA TELANGIECTASIA#0.9927;COMPLEX I#0.9924;OOCYTE#0.9923;INTERPHASE#0.9923;CELL CYCLE TRANSITION#0.9909;CELLULAR SENESCENCE#0.9904;THYMOCYTE APOPTOSIS#0.9903;ENTRY INTO MITOSIS#0.9896;MITOTIC CELL CYCLE#0.9891;HEPATOMA CELLS#0.9874;MAP KINASE#0.9873;LOVASTATIN#0.9873;B CELL LYMPHOMA#0.9864;PROTEIN KINASE ACTIVITY#0.9864;GERM CELL#0.9857;NUCLEAR EXPORT#0.9855;ANAPHASE#0.9849;DEGRADATION OF CYCLIN#0.9848;G2 PHASE#0.9846;MESANGIAL CELL#0.9840;TELOMERE#0.9831;REGULATION OF CELL CYCLE#0.9831;PROGESTERONE#0.9824;MAMMARY EPITHELIAL CELL#0.9818;RETINOBLASTOMA#0.9817;GLYCOGEN SYNTHASE KINASE#0.9817;PROTEIN KINASE B#0.9811;TRANSACTIVATION#0.9810;GENISTEIN#0.9810;CELL CYCLE REGULATOR#0.9802;S PHASE#0.9800;MYOBLAST#0.9799;SENESCENCE#0.9798;ANDROGEN RECEPTOR#0.9789;CELL CYCLE PHASE#0.9787;VSMC PROLIFERATION#0.9786;LIVER CANCER#0.9783;GENOTOXIC#0.9781;CYCLIN D1-CDK4 COMPLEX#0.9781;STRUCTURE ACTIVITY RELATIONSHIP#0.9779;DOUBLE STRAND BREAK#0.9776;FACTOR XA#0.9774;QUIESCENCE#0.9773;C TERMINAL DOMAIN#0.9773;LIVER REGENERATION#0.9771;MOUSE EMBRYONIC FIBROBLAST#0.9768;CYCLIN-DEPENDENT KINASE ACTIVITY#0.9768;DNA REPLICATION#0.9763;DNA DAMAGE RESPONSE#0.9762;PROPHASE#0.9761;CDK INHIBITOR#0.9759;CELL DIFFERENTIATION#0.9757;GRANULOSA CELL#0.9755;SIGNALLING PATHWAY#0.9753;ESTRADIOL#0.9751;ENDOTHELIAL GROWTH FACTOR#0.9743;INHIBITION OF CELL PROLIFERATION#0.9743;PROTEIN KINASE INHIBITOR#0.9740;RAPAMYCIN#0.9740;LYMPH NODE#0.9739;KERATINOCYTE#0.9737;OVARIAN CARCINOMA#0.9737;CISPLATIN#0.9730;TOPOISOMERASE#0.9730;CERVICAL CANCER#0.9730;REVERSE TRANSCRIPTION#0.9729;TUMOR TISSUES#0.9728;ENZYME ACTIVITY#0.9722;LUNG CARCINOMA#0.9722;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9719;PROGENITOR CELL#0.9718;DNA REPAIR#0.9714;CELL CYCLE CHECKPOINT#0.9713;CELL DIVISION#0.9713;QUANTITATIVE REAL TIME#0.9713;CELL ADHESION#0.9712;CENTRIOLE DUPLICATION#0.9708;PYRAZOLE#0.9707;MACROPHAGE#0.9706;PROTEIN KINASE C#0.9705;G1 PHASE#0.9702;MITOSIS#0.9700;VIRAL REPLICATION#0.9699;TAMOXIFEN#0.9699;RNA INTERFERENCE#0.9696;HEPATOCYTE PROLIFERATION#0.9696;HEMATOPOIETIC CELL#0.9694;PURVALANOL#0.9694;TERMINAL DIFFERENTIATION#0.9694;CELL CYCLE#0.9693;ALANINE#0.9692;INSULIN-LIKE GROWTH FACTOR#0.9692;FIBROBLAST GROWTH FACTOR#0.9692;NEUROBLASTOMA#0.9687;OVARIAN CANCER#0.9685;T CELL#0.9685;PANCREATIC CANCER#0.9683;EPITHELIAL MESENCHYMAL TRANSITION#0.9681;CASPASE-3 ACTIVITY#0.9678;B CELL#0.9677;OVARIAN#0.9677;CELL CYCLE CONTROL#0.9676;CARDIOMYOCYTE#0.9673;CYTOPLASM#0.9671;PROTEASOME#0.9671;PACLITAXEL#0.9670;CDK ACTIVITY#0.9670;MAPK SIGNALING#0.9669;GROWTH FACTOR RECEPTOR#0.9669;FACTOR I#0.9669;GLUTATHIONE#0.9668;DNA SYNTHESIS#0.9665;PROTEIN PROTEIN INTERACTION#0.9665;CYCLIN DEPENDENT KINASE INHIBITOR#0.9663;RETINOIC ACID#0.9662;LYMPH NODE METASTASIS#0.9661;UBIQUITIN#0.9659;ESTROGEN RECEPTOR#0.9656;EMBRYONIC STEM CELL#0.9654;BONE MARROW#0.9653;TARGET OF RAPAMYCIN#0.9651;CERVICAL#0.9651;CELL CYCLE ARREST#0.9650;SMOOTH MUSCLE CELL PROLIFERATION#0.9650;TRANSFORMING GROWTH FACTOR BETA#0.9649;PROTEIN KINASE#0.9649;AUTOPHAGY#0.9648;DOXORUBICIN#0.9647;COLORECTAL CANCER#0.9647;MUSCLE CELL PROLIFERATION#0.9647;ANCHORAGE INDEPENDENT GROWTH#0.9645;AKT SIGNALING#0.9643;PLATELET-DERIVED GROWTH FACTOR#0.9642;POLYMERASE CHAIN REACTION#0.9639;OLIGODENDROCYTE#0.9638;INHIBITION OF CELL GROWTH#0.9637;FLOW CYTOMETRY ANALYSIS#0.9632;REGENERATION#0.9632;EPIDERMAL GROWTH FACTOR#0.9632;BREAST CARCINOMA#0.9630;ADENOSINE#0.9630;ORIGIN RECOGNITION COMPLEX#0.9630;CELL CYCLE PATHWAY#0.9629;PROTEIN SYNTHESIS#0.9628;MICROTUBULE#0.9625;T LYMPHOCYTE#0.9623;COLORECTAL#0.9623;ANAPHASE PROMOTING COMPLEX#0.9619;APOPTOTIC CELL DEATH#0.9613;RENAL CELL CARCINOMA#0.9610;ENDOTHELIAL CELL#0.9610;RESVERATROL#0.9608;SIGNALING CASCADE#0.9608;SQUAMOUS CELL CARCINOMA#0.9607;COLON CARCINOMA#0.9602;M PHASE#0.9602;HEPATOCELLULAR CARCINOMA CELL#0.9601;CELL CYCLE REGULATION#0.9600;EPITHELIAL CELL#0.9600;KINASE INHIBITOR#0.9600;DNA BINDING#0.9599;CYTOCHROME C#0.9597;TRANSFORMING GROWTH FACTOR#0.9596;TUMOR NECROSIS FACTOR#0.9593;ENDOMETRIAL CARCINOMA#0.9588;PROTEASOME PATHWAY#0.9587;HOST CELL#0.9586;MOUSE EMBRYO FIBROBLASTS#0.9585;MUTAGENESIS#0.9585;CELL MIGRATION#0.9585;MITOTIC SPINDLE#0.9583;THYMIDINE#0.9583;POLY ADP RIBOSE#0.9581;MECHANISM OF ACTION#0.9579;RIBOSE#0.9576;BREAST CANCER CELL#0.9575;BREAST CANCER#0.9575;SPERMATOCYTES#0.9574;SIGNAL TRANSDUCTION#0.9573;TRANSCRIPTASE#0.9573;CASPASE ACTIVATION#0.9573;MITOGEN ACTIVATED PROTEIN#0.9572;SIGNALING MOLECULE#0.9572;MOUSE EMBRYONIC STEM#0.9568;COLON CANCER#0.9564;TUMOR CELLS#0.9559;ONCOGENIC#0.9559;MYELOID LEUKEMIA#0.9558;ATAXIA TELANGIECTASIA MUTATED#0.9557;CELL SURFACE#0.9556;HUMAN BREAST CANCER#0.9556;RECEPTOR TYROSINE KINASE#0.9551;MECHANISMS OF ACTION#0.9544;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9542;TUMOR SUPPRESSOR#0.9537;EXTRACELLULAR MATRIX#0.9537;COLONY FORMATION ASSAY#0.9537;STEM CELL#0.9535;MITOTIC ENTRY#0.9534;LUNG CANCER#0.9531;HISTONE DEACETYLASE#0.9529;ADENOCARCINOMA#0.9526;REPLICATION FORK#0.9525;SMOOTH MUSCLE#0.9523;PROSTATE CANCER#0.9523;LUNG ADENOCARCINOMA#0.9522;ANGIOGENESIS#0.9521;PROSTATE CARCINOMA#0.9521;VASCULAR SMOOTH MUSCLE CELL#0.9521;TRANSCRIPTION FACTOR#0.9520;SKELETAL MUSCLE#0.9520;DNA FRAGMENTATION#0.9519;NERVOUS SYSTEM#0.9519;GROWTH FACTOR#0.9519;MITOCHONDRIAL MEMBRANE#0.9517;ARTERY#0.9517;CYTOCHROME C RELEASE#0.9512;ACUTE MYELOID LEUKEMIA#0.9512;PROPIDIUM#0.9512;HEPATOCELLULAR CARCINOMA#0.9511;COLORECTAL CARCINOMA#0.9510;LYSINE#0.9510;MUSCLE CELL#0.9508;ASTROCYTE#0.9508;GENE EXPRESSION#0.9507;SMOOTH MUSCLE CELL#0.9506;CELL DEATH#0.9506;MITOCHONDRIA#0.9504;PROTEIN KINASE A#0.9503;ENDOPLASMIC RETICULUM#0.9503;APOPTOSIS#0.9501;INTESTINAL EPITHELIAL CELL#0.9500;INDUCTION OF APOPTOSIS#0.9496;HEAT SHOCK PROTEIN#0.9496;REACTIVE OXYGEN SPECIES#0.9491;APOPTOTIC#0.9490;TOXICITY#0.9487;CANCER CELL#0.9484;CELL GROWTH#0.9480;CYTOTOXICITY#0.9478;WOUND HEALING#0.9476;CELL PROLIFERATION#0.9476;CELL COUNTING KIT#0.9474;MELANOCYTE#0.9467;ROS GENERATION#0.9466;PREADIPOCYTE#0.9463;PERIPHERAL BLOOD#0.9457;SIGNALING PATHWAY#0.9457;FOCAL ADHESION#0.9454;ATHEROSCLEROSIS#0.9452;METAPHASE#0.9446;OOCYTE MATURATION#0.9443;CONTACT INHIBITION#0.9436;PROGRAMMED CELL DEATH#0.9427;ETOPOSIDE#0.9425;DNA LIGASE#0.9412;SIMVASTATIN#0.9409;ENHANCER BINDING PROTEIN#0.9404;RIBOSOMAL PROTEIN#0.9403;TRADITIONAL CHINESE MEDICINE#0.9403;ENHANCER BINDING#0.9400;TOPOISOMERASE II#0.9394;ONCOGENESIS#0.9393;TYROSINE KINASE INHIBITOR#0.9391;MULTIPLE MYELOMA#0.9390;NITRIC OXIDE#0.9368;CELL DEVELOPMENT#0.9361;PEROXISOME#0.9357;LEIOMYOMA#0.9351;ALL TRANS RETINOIC ACID#0.9340;CASPASE INHIBITOR#0.9339;FOCAL ADHESION KINASE#0.9322;DEXAMETHASONE#0.9309;CHROMATIN REMODELING#0.9305;SIGNAL TRANSDUCER#0.9299;CYCLIC AMP#0.9271;NUCLEAR LOCALIZATION SIGNAL#0.9258;IMMUNE RESPONSE#0.9250;MODE OF ACTION#0.9243;HOMOLOGOUS RECOMBINATION#0.9242;MYOTUBE#0.9241;REPLICATIVE SENESCENCE#0.9240;PHOSPHATASE ACTIVITY#0.9234;SEQUESTERING#0.9214;HUMAN PANCREATIC CANCER#0.9203;CENTRAL NERVOUS SYSTEM#0.9200;NUCLEAR IMPORT#0.9200;BREAST CANCER PATIENTS#0.9188;MYELOID CELL#0.9160;EPSTEIN BARR VIRUS#0.9147;DRUG RESISTANCE#0.9135;HYPOXIC#0.9129;FERTILIZATION#0.9125;ARGININE#0.9095;NULL CELL#0.9086;HUMAN MAMMARY EPITHELIAL#0.9054;HYDROXYUREA#0.9040;ALZHEIMER'S DISEASE#0.9031;NUCLEAR ENVELOPE#0.9024;HELICASE ACTIVITY#0.9024;TELOMERASE ACTIVITY#0.9016;INDOLE#0.9016;HEAD AND NECK CANCER#0.9003;NECK CANCER#0.9002;LYMPHOCYTIC LEUKEMIA#0.8992;ADIPOGENESIS#0.8985;PHOSPHOLIPASE C#0.8971;DIHYDROFOLATE REDUCTASE#0.8964;TRASTUZUMAB#0.8956;DEATH RECEPTOR#0.8954;5 FLUOROURACIL#0.8941;PROTEIN BINDING#0.8938;DUAL SPECIFICITY PHOSPHATASE#0.8930;ORAL SQUAMOUS CELL CARCINOMA#0.8910;MAMMARY GLAND#0.8909;FLOW CYTOMETRY ASSAY#0.8906;LEUCINE#0.8897;HUMAN UMBILICAL VEIN#0.8881;CYTOKINESIS#0.8880;UMBILICAL VEIN#0.8879;HUMAN IMMUNODEFICIENCY VIRUS#0.8877;CELL ACTIVATION#0.8862;REPLICATION PROTEIN A#0.8858;ACTINOMYCIN D#0.8849;INSULIN RECEPTOR#0.8825;BUDDING#0.8804;HISTONE DEACETYLASE INHIBITOR#0.8803;UBIQUITIN PROTEASOME PATHWAY#0.8802;ADIPOCYTE#0.8797;PLASMA MEMBRANE#0.8785;HEPATITIS B#0.8781;ADJACENT NORMAL TISSUE#0.8778;MELANOMA CELL LINES#0.8775;NEURODEGENERATIVE DISEASE#0.8771;CELL MEMBRANE#0.8765;PROGESTIN#0.8764;CARCINOGEN#0.8762;G0 PHASE#0.8761;GENE SILENCING#0.8751;72-HOURS#0.8749;MESENCHYMAL STEM CELL#0.8747;ETHANOL#0.8742;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8724;AORTIC SMOOTH MUSCLE CELLS#0.8711;VASCULAR ENDOTHELIAL CELL#0.8710;MONONUCLEAR CELLS#0.8706;CELLULAR GROWTH#0.8697;DUAL LUCIFERASE REPORTER#0.8692;ENDOMETRIAL CANCER#0.8680;2'-DEOXYURIDINE#0.8650;B LYMPHOCYTE#0.8649;CANCER RELATED DEATH#0.8647;CAROTID ARTERY#0.8647;PROTEIN TYROSINE KINASE#0.8599;CD4+ T CELL#0.8594;BINDING PROTEIN 1#0.8590;HEPATOCYTE GROWTH FACTOR#0.8588;TETRACYCLINE#0.8585;CAFFEINE#0.8582;UBIQUITIN LIGASE COMPLEX#0.8581;THYROID CARCINOMA#0.8569;STROMAL CELL#0.8557;PROTEIN DATA BANK#0.8550;LINES OF EVIDENCE#0.8548;PROTEIN TYROSINE PHOSPHATASE#0.8541;ARYL HYDROCARBON RECEPTOR#0.8537;DNA REPLICATION INITIATION#0.8518;SCHWANN CELL#0.8499;MIMOSINE#0.8476;SKIN CANCER#0.8441;P53 SIGNALING PATHWAY#0.8435;TUBE FORMATION#0.8428;MAPK ACTIVATION#0.8393;CANCER STEM CELL#0.8365;LUNG FIBROBLASTS#0.8353;HEPATITIS B VIRUS#0.8350;POST-TRANSLATIONAL MODIFICATION#0.8349;GLOMERULONEPHRITIS#0.8333;MISMATCH REPAIR#0.8322;PROTEASOME DEGRADATION#0.8321;SMOOTH MUSCLE ACTIN#0.8311;OSTEOBLAST#0.8302;EPITHELIAL CELL PROLIFERATION#0.8301;HERPES SIMPLEX VIRUS#0.8299;GUANINE#0.8296;HERPES SIMPLEX#0.8296;SPINDLE ASSEMBLY#0.8295;ELECTROPHORETIC MOBILITY SHIFT#0.8291;NEURAL STEM CELL#0.8283;FLUOROURACIL#0.8271;NEUTROPHIL#0.8267;ADRIAMYCIN#0.8258;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8257;TUBULAR EPITHELIAL CELL#0.8248;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8239;REGULATION OF CELL PROLIFERATION#0.8238;RNA BINDING#0.8229;MONOCYTE#0.8222;GASTRIC MUCOSA#0.8217;PHOSPHATASE INHIBITOR#0.8207;ENDOTHELIAL CELL PROLIFERATION#0.8206;ARA-C#0.8189;CAMPTOTHECIN#0.8177;LYMPHOMA CELL LINES#0.8171;NERVE GROWTH FACTOR#0.8141;CHROMOSOME SEGREGATION#0.8128;BERBERINE#0.8115;T CELL PROLIFERATION#0.8087;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8082;CHRONIC MYELOID LEUKEMIA#0.8049;ADIPOCYTE DIFFERENTIATION#0.8045;FIBROBLAST PROLIFERATION#0.8031;HYPOXIA INDUCIBLE FACTOR#0.8029;MYOCYTES#0.8021;MITOTIC CATASTROPHE#0.8020;PLURIPOTENT STEM CELL#0.8012;HEMATOPOIESIS#0.8012;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7998;LUMINAL#0.7992;NON-SMALL CELL LUNG CARCINOMA#0.7991;IMMUNE SYSTEM#0.7985;POSTTRANSLATIONAL MODIFICATION#0.7960;TROPHOBLAST#0.7958;MCM COMPLEX#0.7951;PROTEIN DEGRADATION#0.7950;GEMCITABINE#0.7933;DNA METHYLATION#0.7903;PROTEIN PHOSPHATASE 2A#0.7896;PHOSPHATASE 2A#0.7893;RECEPTOR ANTAGONIST#0.7891;LUCIFERASE ACTIVITY#0.7874;CELL ADHESION MOLECULE#0.7856;SENSITIZATION#0.7847;NOCODAZOLE#0.7841;ANTI HER2#0.7829;MITOTIC EXIT#0.7829;HISTONE KINASE#0.7823;CASEIN KINASE 2#0.7821;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7821;ADENINE#0.7818;SRC FAMILY KINASE#0.7817;LIGASE ACTIVITY#0.7814;QUERCETIN#0.7810;MEIOSIS I#0.7805;GLIOBLASTOMA MULTIFORME#0.7803;T-CELL LEUKEMIA#0.7803;RETINOIC ACID RECEPTOR#0.7800;RHEUMATOID ARTHRITIS#0.7789;MITOTIC CLONAL EXPANSION#0.7762;HEMATOPOIETIC STEM CELL#0.7759;T CELL ACTIVATION#0.7740;APOPTOSIS INDUCING FACTOR#0.7737;ESTROGENS#0.7729;SUPEROXIDE DISMUTASE#0.7721;ISCHEMIA#0.7715;VITAMIN D3#0.7710;OLIGODENDROCYTE PROGENITOR CELL#0.7704;VIRAL DNA REPLICATION#0.7703;ENDOMETRIUM#0.7701;BONE MORPHOGENETIC PROTEIN#0.7692;PRECURSOR CELL#0.7674;INHIBITION OF GROWTH#0.7663;KERATINOCYTE DIFFERENTIATION#0.7632;EPIGALLOCATECHIN#0.7630;GRANULOCYTE#0.7614;POLY T#0.7610;HYPERTENSION#0.7608;HISTONE KINASE ACTIVITY#0.7595;RNA BINDING PROTEIN#0.7592;SMC PROLIFERATION#0.7587;MEIOTIC PROPHASE I#0.7586;ACTIVATED T CELL#0.7582;THYROID CANCER#0.7581;MICROTUBULE ASSOCIATED PROTEIN#0.7577;APOPTOTIC PROCESS#0.7575;PHOSPHATASE I#0.7573;PROTEIN PHOSPHATASE 1#0.7545;N-ACETYLCYSTEINE#0.7537;CELECOXIB#0.7516;DIFFUSE LARGE B-CELL LYMPHOMA#0.7504;REGULATION OF CENTROSOME DUPLICATION#0.7475;PACHYTENE#0.7474;VITAMIN D RECEPTOR#0.7465;DNA HELICASE#0.7461;ACTIVATED CASPASE 3#0.7446;CHROMATIN BINDING#0.7429;STEROID RECEPTOR COACTIVATOR#0.7418;QUANTITATIVE REVERSE TRANSCRIPTION#0.7391;LYMPHOID CELL#0.7385;DISEASE FREE SURVIVAL#0.7380;PI3K SIGNALING#0.7375;GLIAL CELL#0.7373;GENE EXPRESSION OMNIBUS#0.7361;COLONY-STIMULATING FACTOR#0.7357;ADIPOSE TISSUE#0.7354;7-HYDROXYSTAUROSPORINE#0.7330;SPERMATOGENESIS#0.7330;INFERTILITY#0.7324;BETA GALACTOSIDASE#0.7323;REGULATION OF CELLULAR#0.7321;VASCULAR DISEASE#0.7309;GLIDE#0.7298;TESTOSTERONE#0.7294;ESOPHAGEAL CARCINOMA#0.7246;PODOCYTE#0.7233;VAN DER WAALS#0.7230;PCNA COMPLEX#0.7228;BLADDER CARCINOMA#0.7225;CASPASE ACTIVITY#0.7221;KAPOSI'S SARCOMA#0.7215;PHOSPHATASE AND TENSIN HOMOLOG#0.7209;ENDOSOME#0.7179;HEPARIN#0.7179;CYCLOSOME#0.7177;GLUCOCORTICOID RECEPTOR#0.7162;INHIBITION OF DNA REPLICATION#0.7146;INTERFERON REGULATORY FACTOR#0.7132;PAPILLOMA#0.7131;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7129;TYPE 2 DIABETES#0.7128;GLYCINE#0.7126;PROTEIN INTERACTION NETWORK#0.7110;EMBRYONIC LUNG#0.7091;CENTROSOME CYCLE#0.7077;HUMAN EMBRYONIC STEM#0.7073;THYMIDYLATE SYNTHASE#0.7071;GERM CELL DEVELOPMENT#0.7068;EPITHELIAL OVARIAN CANCER#0.7066;ALKALINE PHOSPHATASE#0.7050;CAJAL BODY#0.7035;CORONARY ARTERY#0.6999;DNA REPAIR PROTEIN#0.6998;HISTONE ACETYLTRANSFERASE#0.6967;HISTONE ACETYLATION#0.6960;THYMIDINE KINASE#0.6959;CELL KILLING#0.6959;ADENOSINE TRIPHOSPHATE#0.6939;NEURAL CELL#0.6934;CORD BLOOD#0.6925;BETA-ESTRADIOL#0.6904;MALIGNANT GLIOMA#0.6873;SPINDLE ASSEMBLY CHECKPOINT#0.6871;CPT-11#0.6870;TRANSCRIPTIONAL CONTROL#0.6860;SUMOYLATION#0.6839;MEIOSIS II#0.6838;TUBEROUS SCLEROSIS#0.6837;INHIBITION OF APOPTOSIS#0.6832;CAK COMPLEX#0.6831;OLOMOUCINE II#0.6826;VIRAL INFECTION#0.6824;GEFITINIB#0.6818;PARKINSON'S DISEASE#0.6812;BLOOD VESSEL#0.6811;INHIBITION OF PHOSPHORYLATION#0.6811;ESOPHAGEAL CANCER#0.6809;METASTATIC MELANOMA#0.6802;CELL MOTILITY#0.6788;NEURONAL CELLS#0.6781;TAXOL#0.6750;RHABDOMYOSARCOMA#0.6746;CHOLANGIOCARCINOMA#0.6740;PREGNANE X RECEPTOR#0.6731;ASPIRIN#0.6725;UBIQUITIN LIGASE ACTIVITY#0.6720;SKELETAL MUSCLE CELLS#0.6714;LUNG EPITHELIAL CELL#0.6704;TROPHOBLAST CELL#0.6703;MEIOTIC CELL CYCLE#0.6698;NEURITE OUTGROWTH#0.6692;ENDOPLASMIC RETICULUM STRESS#0.6677;NEURITE#0.6672;LYMPH NODE METASTASES#0.6639;TRANSFORMING GROWTH FACTOR ALPHA#0.6601;L-CYSTEINE#0.6593;ACETYLCYSTEINE#0.6590;ASTROCYTOMA#0.6587;PREREPLICATION COMPLEX#0.6571;COENZYME A#0.6565;PREINITIATION COMPLEX#0.6562;ENDOMETRIAL EPITHELIAL CELLS#0.6560;ANTI APOPTOSIS#0.6560;ARSENIC TRIOXIDE#0.6544;PRE-MRNA SPLICING#0.6543;ORNITHINE DECARBOXYLASE#0.6539;TROGLITAZONE#0.6534;LOW DENSITY LIPOPROTEIN#0.6518;MRNA SPLICING#0.6517;RESPONSE TO IONIZING RADIATION#0.6517;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.6507;HYPERACTIVE#0.6506;ACTIVATED T-CELLS#0.6505;BASAL CELL#0.6491;BETA CELL#0.6490;FORMALIN#0.6481;NEURAL PROGENITOR CELL#0.6480;ICI 182,780#0.6463;DOUBLE-STRAND BREAK REPAIR#0.6448;GASTRIC ULCER#0.6430;VALPROIC ACID#0.6426;INTRACELLULAR LOCALIZATION#0.6425;PANCREATIC ISLET#0.6424;MELATONIN#0.6422;THYMIDYLATE#0.6414;REPORTER GENE ASSAY#0.6401;MALE MEIOSIS#0.6394;CENTRIOLE AMPLIFICATION#0.6386;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.6370;GRANULOSA CELL PROLIFERATION#0.6368;NUCLEIC ACID#0.6366;DERMAL PAPILLA CELL#0.6354;G-CSF#0.6354;HERCEPTIN#0.6348;PROTEIN KINASE COMPLEX#0.6344;NITRIC OXIDE SYNTHASE#0.6337;TUMOR GROWTH INHIBITION#0.6327;SV40 T-ANTIGEN#0.6318;DNA REPLICATION CHECKPOINT#0.6313;CHROMOSOME CONDENSATION#0.6312;DIHYDROTESTOSTERONE#0.6281;P53 BINDING#0.6279;NUCLEOSOME#0.6276;UMBILICAL CORD#0.6274;REGULATION OF DNA REPLICATION#0.6274;CYCLE INHIBITOR P21#0.6272;HISTONE METHYLTRANSFERASE#0.6260;HEPATITIS C VIRUS#0.6253;HEPATITIS C#0.6245;RETINOID X RECEPTOR#0.6242;T CELL DEVELOPMENT#0.6242;GERMLINE STEM CELL#0.6235;MEMBRANE DEPOLARIZATION#0.6232;GLYCOGEN PHOSPHORYLASE#0.6215;SALICYLIC ACID#0.6214;PHOSPHATIDYLSERINE#0.6205;PEMETREXED#0.6204;ACTIN CYTOSKELETON#0.6200;NEUROGENESIS#0.6191;EVEROLIMUS#0.6185;NUCLEAR DIVISION#0.6183;LEYDIG CELL#0.6181;RAD001#0.6149;CELL CYCLE DYSREGULATION#0.6148;EMODIN#0.6132;1α,25-DIHYDROXYVITAMIN D3#0.6126;CENTRIOLAR SATELLITE#0.6125;PARATHYROID#0.6114;BIOTIN#0.6112;ENDOTHELIUM#0.6107;TISSUE HOMEOSTASIS#0.6093;SULFONAMIDE#0.6083;CYTARABINE#0.6079;REGULATION OF GENE EXPRESSION#0.6078;EMBRYONIC KIDNEY#0.6074;MEVASTATIN#0.6074;PROSTATE SPECIFIC ANTIGEN#0.6072;ENDOMETRIOID ENDOMETRIAL CARCINOMA#0.6054;MEGAKARYOCYTE#0.6045;LUPUS ERYTHEMATOSUS#0.6044;CAM BINDING#0.6035;GROWTH OF CELL#0.6034;PHOSPHATE BINDING#0.6032;PARATHYROID HORMONE#0.6027;CEREBELLAR GRANULE NEURON#0.6018;STEM CELL PROLIFERATION#0.6013;CHONDROCYTE#0.6011;MYOBLAST PROLIFERATION#0.6010
101805488	BREAST CANCER#1.0934;SIGNALING PATHWAY#1.0919;CELL PROLIFERATION#1.0868;COLON CANCER#1.0788;CANCER CELL#1.0697;LYMPH NODE#1.0659;LUNG CANCER#1.0642;APOPTOSIS#1.0549;TUMOR TISSUES#1.0458;COLORECTAL CANCER#1.0340;LYMPH NODE METASTASIS#1.0259;ONCOGENIC#1.0231;QUANTITATIVE REAL TIME#1.0182;SQUAMOUS CELL CARCINOMA#1.0045;POLYMERASE CHAIN REACTION#0.9744;COLORECTAL#0.9695;HEPATOCELLULAR CARCINOMA#0.9364;WNT SIGNALING PATHWAY#0.9161;LUNG ADENOCARCINOMA#0.9112;OVARIAN CANCER#0.8974;CELL CYCLE#0.8660;ADENOCARCINOMA#0.8484;ADJACENT NORMAL TISSUE#0.8297;EPITHELIAL MESENCHYMAL TRANSITION#0.8244;CELL GROWTH#0.8180;OVARIAN#0.8137;EPITHELIAL OVARIAN CARCINOMA#0.8020;ORAL SQUAMOUS CELL CARCINOMA#0.7837;OVARIAN CARCINOMA#0.7829;OVERALL SURVIVAL TIME#0.7770;BREAST CANCER CELL#0.7660;CELL MIGRATION#0.7608;G1 PHASE#0.7109;REVERSE TRANSCRIPTION#0.7064;TRANSCRIPTION FACTOR#0.7034;EXOSOME#0.6729;CERVICAL#0.6424;SQUAMOUS CELL CANCER#0.6298;EPITHELIAL CELL#0.6202;ESOPHAGEAL CANCER#0.6141;CERVICAL CANCER#0.6107
101805492	CELL PROLIFERATION#1.0785;CELL GROWTH#1.0391;CANCER CELL#1.0334;SQUAMOUS CELL CARCINOMA#1.0330;APOPTOSIS#1.0285;CELL MIGRATION#0.9293;BREAST CANCER#0.8919;LYMPH NODE#0.8445;LYMPH NODE METASTASIS#0.7907;ESOPHAGEAL CANCER#0.7887;POLYMERASE CHAIN REACTION#0.7266;CELL CYCLE#0.7146;ONCOGENIC#0.7121;GENE EXPRESSION#0.6513;RNA BINDING PROTEIN#0.6464;AKT SIGNALING#0.6447;RNA BINDING#0.6444;BREAST CANCER CELL#0.6401;TRANSCRIPTION FACTOR#0.6348
10180	RNA BINDING#1.0353;TUMOR SUPPRESSOR#0.9316;LUNG CANCER#0.9312;RNA BINDING PROTEIN#0.7581;SPLICING SPECKLE#0.6652;CANCER CELL#0.6382
10181	TUMOR SUPPRESSOR#1.0823;CANCER CELL#1.0818;CELL CYCLE#1.0778;LUNG CANCER#1.0732;RNA BINDING#1.0728;APOPTOSIS#1.0678;RNA BINDING PROTEIN#1.0579;CELL PROLIFERATION#1.0508;CELL GROWTH#1.0437;APOPTOTIC#1.0219;ADENOCARCINOMA#1.0117;LUNG ADENOCARCINOMA#0.9991;POLYMERASE CHAIN REACTION#0.9352;PROSTATE CANCER#0.9123;T CELL#0.8782;TUMOR TISSUES#0.8695;RNA RECOGNITION MOTIF#0.8474;CELL CYCLE ARREST#0.8311;MRNA SPLICING#0.8302;GENE EXPRESSION#0.8225;MYOBLAST DIFFERENTIATION#0.7952;GROWTH FACTOR#0.7807;PRE-MRNA SPLICING#0.7746;PANCREATIC CANCER#0.7724;REVERSE TRANSCRIPTION#0.7374;BREAST CANCER#0.7010;CELL DEATH#0.6601;QUANTITATIVE REVERSE TRANSCRIPTION#0.6442;EPIDERMAL GROWTH FACTOR#0.6186
101867536	PROSTATE CANCER#1.1037;CANCER CELL#0.9267;ANDROGEN RECEPTOR#0.9077;COLORECTAL CANCER#0.7895;COLORECTAL#0.7233;CELL CYCLE#0.6383;APOPTOSIS#0.6300;CELL PROLIFERATION#0.6016
10186	LIPOMA#0.8215
10188	RECEPTOR TYROSINE KINASE#1.0655;KINASE ACTIVITY#1.0524;EPIDERMAL GROWTH FACTOR#1.0421;PROSTATE CANCER#1.0366;CANCER CELL#1.0300;GROWTH FACTOR#1.0275;BREAST CANCER#1.0201;ANDROGEN RECEPTOR#1.0064;GROWTH FACTOR RECEPTOR#0.9898;PROTEIN KINASE#0.9861;SIGNALING PATHWAY#0.9587;ONCOGENIC#0.9435;UBIQUITIN#0.9360;APOPTOSIS#0.8970;TUMOR SUPPRESSOR#0.8901;CELL MIGRATION#0.8869;CELL PROLIFERATION#0.8790;GENE EXPRESSION#0.8549;DASATINIB#0.8512;DORSAL CLOSURE#0.8047;HEPATOCELLULAR CARCINOMA#0.7998;AKT SIGNALING#0.7958;CELL GROWTH#0.7826;KINASE INHIBITOR#0.7735;PROTEIN TYROSINE KINASE#0.7685;ENDOCYTOSIS#0.7568;BREAST CANCER CELL#0.7507;CELL DIVISION#0.7479;1 REPETITION MAXIMUM#0.7406;LUNG CANCER#0.7310;WISKOTT ALDRICH SYNDROME#0.7248;CELL CYCLE#0.7227;SRC FAMILY KINASE#0.7190;MAP KINASE#0.6803;RNA INTERFERENCE#0.6797;CELL ADHESION#0.6778;FOCAL ADHESION#0.6566;TYROSINE KINASE 1#0.6433;GTP BINDING#0.6401;SIGNAL TRANSDUCTION#0.6396;NUCLEOTIDE EXCHANGE FACTOR#0.6080
10189	TREX COMPLEX#1.0904;THO COMPLEX#1.0717;RNA BINDING#1.0282;NUCLEAR EXPORT#1.0282;CYTOPLASM#0.9844;EXON JUNCTION COMPLEX#0.9821;RNA BINDING PROTEIN#0.9752;GENE EXPRESSION#0.9749;MRNA SPLICING#0.9706;PRE-MRNA SPLICING#0.9512;MRNA PROCESSING#0.9496;HERPES SIMPLEX VIRUS#0.9263;HERPES SIMPLEX#0.9259;T CELL#0.8613;RNA HELICASE#0.8471;DNA BINDING#0.7782;NUCLEAR SPECKLE#0.7767;NUCLEAR PORE#0.7748;RNA EXPORT FACTOR#0.7681;ARGININE#0.7530;SPLICEOSOME#0.7408;EXON-EXON JUNCTION COMPLEX#0.7262;CELL PROLIFERATION#0.7108;TRANSCRIPTION FACTOR#0.6916;COMPLEX I#0.6853;PI3K SIGNALING#0.6100
1018	BREAST CANCER#1.0500;CYCLIN DEPENDENT KINASE#1.0384;CANCER CELL#1.0208;CELL CYCLE#1.0154;CELL PROLIFERATION#0.9821;BREAST CANCER CELL#0.9649;S PHASE#0.9046;KINASE ACTIVITY#0.8752;APOPTOSIS#0.8513;CELL GROWTH#0.8287;KINASE INHIBITOR#0.8181;TAMOXIFEN#0.8181;CYCLIN DEPENDENT KINASE INHIBITOR#0.8106;CDK INHIBITOR#0.8057;G1 PHASE#0.7765;GENE EXPRESSION#0.7601;TRANSCRIPTION FACTOR#0.7600;PROTEIN KINASE#0.7390;TUMOR SUPPRESSOR#0.7353;CELL DIVISION#0.6946;EPITHELIAL CELL#0.6683;CELL CYCLE REGULATOR#0.6415;CELL CYCLE TRANSITION#0.6181;M PHASE#0.6067;CELL CYCLE ARREST#0.6041
10190	TUBULIN FOLDING#0.6467;BREAST CANCER#0.6458;GERMINAL VESICLE#0.6003
101926885	OCULOCUTANEOUS ALBINISM#0.6249
101927003	SPINAL NERVE LIGATION#1.2165
101927034	CELL MIGRATION#1.0787;COLORECTAL CANCER#1.0439;OVERALL SURVIVAL TIME#0.9239;EPITHELIAL MESENCHYMAL TRANSITION#0.9067;SIGNALING PATHWAY#0.8952;COLORECTAL#0.8387;CELL GROWTH#0.7837;POLYMERASE CHAIN REACTION#0.6955;LUNG ADENOCARCINOMA#0.6670;CANCER CELL#0.6537
101927152	HEPATOCELLULAR CARCINOMA#0.6398
101927174	ENDOMETRIOSIS#0.8576;ENDOMETRIUM#0.8544;OVARIAN#0.8479
101927193	CELL PROLIFERATION#0.8960;ENDOMETRIOSIS#0.6857;OVARIAN#0.6774
101927423	DNA DEMETHYLATION#0.7711;HISTONE MODIFICATION#0.7603;TUMOR SUPPRESSOR#0.7468
101927525	HYPERTROPHIC SCAR FIBROBLASTS#0.8748
101927597	CANCER CELL#1.0378;CERVICAL CANCER#0.9767;CELL PROLIFERATION#0.9015;CERVICAL#0.7831;CELL CYCLE#0.7079;OVARIAN CANCER#0.6619;CELL MIGRATION#0.6601;PROSTATE CANCER#0.6597
101927703	LYMPH NODE#0.6931;CELL PROLIFERATION#0.6831;GASTRIC ADENOCARCINOMA#0.6556;LYMPH NODE METASTASIS#0.6440;PROSTATE CANCER#0.6395
101927813	ANTISENSE RNA#0.7978;EPITHELIAL OVARIAN CANCER#0.7609;LUNG ADENOCARCINOMA#0.7552;OVARIAN CANCER#0.7501;BREAST CANCER CELL#0.7487;BREAST CANCER#0.7435;CANCER CELL#0.7420
101927953	CANCER CELL#0.9840;SQUAMOUS CELL CARCINOMA#0.7776;CERVICAL CANCER#0.7008;GASTRIC CARDIA ADENOCARCINOMA#0.6997;NULL CELL#0.6562;ESOPHAGEAL CANCER#0.6519
101928099	CELL PROLIFERATION#0.7520;PROSTATE CANCER#0.6430
101928243	CANCER CELL#0.9511;THYROID CANCER#0.7230;APOPTOTIC CELL DEATH#0.7204;TUMOR TISSUES#0.7200;OVARIAN CANCER#0.7166;CELL DEATH#0.7103;CELL PROLIFERATION#0.6213
101928337	THYROID CANCER#0.7464
101928353	ADENOCARCINOMA#0.8483
101928483	T CELL#0.8022;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7167;NOTCH SIGNALING PATHWAY#0.6792;GOBLET CELL#0.6723;SIGNALING PATHWAY#0.6542
101928601	TRANSCRIPTION FACTOR#1.0876;MEIOSIS#1.0279;DOUBLE STRAND BREAK#0.9439;MEIOSIS I#0.8559;PROPHASE#0.7848;SPORULATION#0.7404;DNA REPLICATION#0.7247;NUCLEAR MOVEMENT#0.6672;MEIOTIC CHROMOSOME#0.6611;DNA SYNTHESIS#0.6573;DNA BINDING#0.6205
101928607	APOPTOSIS#0.9092;CELL PROLIFERATION#0.8284;LUNG CANCER#0.7628;PROSTATE CANCER#0.6736;HEPATOCELLULAR CARCINOMA#0.6320
101928931	CANCER CELL#0.9856;GASTRIC CARDIA ADENOCARCINOMA#0.8320;TUMOR SUPPRESSOR#0.7822;HEPATOCELLULAR CARCINOMA CELL#0.7606;ESOPHAGEAL CANCER#0.7604;HEPATOCELLULAR CARCINOMA#0.7483
101928941	X CHROMOSOME#1.1934;PROGENITOR CELL#1.1842;TROPHECTODERM#0.8665
101929110	NEURAL CELL#0.9098
101929222	MAJOR PSYCHIATRIC DISORDERS#0.7964;PROTEIN TRANSLATION#0.7697;OXIDOREDUCTASE ACTIVITY#0.7465;MITOCHONDRIA#0.6947
101929328	EPITHELIAL OVARIAN CANCER#1.1970;OVARIAN CANCER#1.1862;CANCER CELL#1.1780;OVARIAN#0.8479;APOPTOSIS#0.8439
101929639	COLON CANCER#0.7510
101929665	APOPTOSIS#0.6411
10193	RECEPTOR DEGRADATION#1.1112;UBIQUITIN#1.0735;APOPTOSIS#1.0640;BREAST CANCER#0.9749;CELL GROWTH#0.9668;GROWTH FACTOR#0.9601;CANCER CELL#0.9424;CYTOKINE RECEPTOR#0.9411;GROWTH FACTOR RECEPTOR#0.9089;EPIDERMAL GROWTH FACTOR#0.8930;PROTEASOME#0.8823;RECEPTOR TYROSINE KINASE#0.8743;MITOPHAGY#0.8284;CARDIOMYOCYTE#0.7797;DEUBIQUITINATING ENZYME#0.7783;CELL SURFACE#0.7747;COLORECTAL CANCER#0.7605;CELL CYCLE#0.7119;CELL PROLIFERATION#0.7044;HEPATOCELLULAR CARCINOMA#0.6938;PARKINSON'S DISEASE#0.6918;EPITHELIAL CELL#0.6871;TRANSCRIPTION FACTOR#0.6324;CELL POLARITY#0.6151;HEMATOPOIETIC STEM CELL#0.6139;RNA INTERFERENCE#0.6133;RETINOIC ACID#0.6125;HEART DISEASE#0.6114;CELL MIGRATION#0.6056;PROGENITOR CELL#0.6054;T CELL#0.6044;STEM CELL#0.6020;COLORECTAL#0.6014
10194	TRANSCRIPTION FACTOR#0.8818;SPINAL CORD#0.8118;GLUTAMINE#0.7707;MIDDLE EAR#0.6313
10195	N GLYCAN#1.0284;GLYCOSYLATION#1.0255;ENDOPLASMIC RETICULUM#0.9180;GLCNAC#0.9105;CONGENITAL DISORDER#0.9018;APOPTOSIS#0.8831;ALZHEIMER'S DISEASE#0.8727;CONGENITAL DISORDER OF GLYCOSYLATION#0.8398;ASPARAGINE#0.6451
10196	RIBOSOMAL PROTEIN#1.0486;ARGININE#1.0470;N METHYLTRANSFERASE#1.0318;RIBOSOMAL SUBUNIT#0.8486;PANCREATIC CANCER#0.7828;RIBOSOME#0.7709;L-METHIONINE#0.7518;GENE EXPRESSION#0.7212;METHYLTRANSFERASE ACTIVITY#0.7126;S-ADENOSYL-L-METHIONINE#0.7087;CANCER CELL#0.6930;METHIONINE#0.6751;ASYMMETRIC DIMETHYLARGININE#0.6645;POLY-A BINDING#0.6445;RRNA PROCESSING#0.6385;GLYCINE#0.6315;FATTY LIVER#0.6195;TUMOR SUPPRESSOR#0.6064
101978785	PROSTATE CANCER#0.9967;HEPATOCELLULAR CARCINOMA#0.6600;CELL CYCLE#0.6555
10197	20S PROTEASOME#1.0601;PROTEASOME#1.0538;CELL CYCLE#1.0502;UBIQUITIN#1.0108;HCV CORE PROTEIN#0.9992;CANCER CELL#0.9973;HEPATITIS C VIRUS#0.8731;HEPATITIS C#0.8721;BREAST CANCER#0.8529;APOPTOSIS#0.8457;CELL GROWTH#0.8201;CELL PROLIFERATION#0.8085;T CELL#0.7773;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7607;LUPUS ERYTHEMATOSUS#0.7604;PROTEIN DEGRADATION#0.7494;STEROID RECEPTOR COACTIVATOR#0.7032;IFN-GAMMA#0.6952;GENE EXPRESSION#0.6594;TUMOR SUPPRESSOR#0.6391;CYCLIN DEPENDENT KINASE INHIBITOR#0.6271;CYTOPLASM#0.6246;RNA INTERFERENCE#0.6229;CYCLIN DEPENDENT KINASE#0.6229;KINASE INHIBITOR#0.6202;M PHASE#0.6130;PANCREATIC CANCER#0.6109;LUNG CANCER#0.6057;S PHASE#0.6049
10198	TYPE 2 DIABETES#0.8049;M PHASE#0.7214;MULTIPLE SCLEROSIS#0.6462;GROWTH FACTOR#0.6375;MOTHER CENTRIOLE#0.6197
10199	SMALL NUCLEOLAR RIBONUCLEOPROTEIN#1.1468;SSU PROCESSOME#1.0948;SNORNP#1.0797;RRNA PROCESSING#1.0278;RIBOSOME#0.9548;RIBOSOME BIOGENESIS#0.9062;M PHASE#0.7846;SMALL NUCLEOLAR RNA#0.7456;NUCLEOLUS#0.7251;RIBOSOMAL PROTEIN#0.6609;SMALL SUBUNIT PROCESSOME#0.6148;RIBONUCLEOPROTEIN COMPLEX#0.6008
1019	CYCLIN D1-CDK4 COMPLEX#1.0846;MURINE DOUBLE MINUTE#1.0615;BETA CELL#1.0355;FLAVOPIRIDOL#1.0268;TELOMERASE REVERSE TRANSCRIPTASE#1.0223;FAMILIAL MELANOMA#1.0195;ANTI HER2#1.0181;ATYPICAL LIPOMATOUS TUMOR#1.0165;LUNG FIBROBLASTS#1.0137;COMPLEX I#1.0123;CELL DIVISION CYCLE#1.0111;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#1.0087;CELL CYCLE PATHWAY#1.0084;MULTIPLE PRIMARY MELANOMA#1.0062;CYCLIN DEPENDENT KINASE#1.0051;PROTEIN PHOSPHORYLATION#1.0049;CARDIOMYOCYTE#1.0027;ADVANCED BREAST CANCER#1.0027;FULVESTRANT#1.0010;CELL CYCLE TRANSITION#1.0005;MYOTUBE#0.9998;MELANOMA CELL LINES#0.9986;LETROZOLE#0.9984;CLEAVED CASPASE 3#0.9973;METASTATIC BREAST CANCER#0.9964;DEPHOSPHORYLATION#0.9962;SMOOTH MUSCLE ACTIN#0.9961;EVEROLIMUS#0.9956;KINASE INHIBITOR P27#0.9952;LIPOSARCOMA#0.9947;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9939;MYOBLAST#0.9932;HYPERPHOSPHORYLATION#0.9923;MALIGNANT GLIOMA#0.9915;KINASE ACTIVITY#0.9915;B CELL LYMPHOMA#0.9900;METASTATIC MELANOMA#0.9891;HYPOXIA#0.9890;QUIESCENCE#0.9887;LUMINAL#0.9882;LIPOMA#0.9874;CELL CYCLE PHASE#0.9870;COPY NUMBER VARIATION#0.9866;NUCLEAR IMPORT#0.9866;ENDOMETRIAL CANCER#0.9864;RETINOBLASTOMA#0.9861;SENESCENCE#0.9861;MAMMARY EPITHELIAL CELL#0.9860;TELOMERASE ACTIVITY#0.9860;GRANULOSA CELL#0.9860;TRANSCRIPTASE#0.9858;NEUROBLASTOMA#0.9857;CATALYTIC ACTIVITY#0.9857;ASTROCYTOMA#0.9854;MESANGIAL CELL#0.9847;G2 PHASE#0.9841;CELLULAR SENESCENCE#0.9834;RAPAMYCIN#0.9833;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9828;BREAST CANCER PATIENTS#0.9824;MULTIPLE MYELOMA#0.9821;PROTEIN KINASE B#0.9821;OVARIAN CARCINOMA#0.9817;REGULATION OF CELL CYCLE#0.9807;INSULIN-LIKE GROWTH FACTOR#0.9805;MOUSE EMBRYONIC FIBROBLAST#0.9802;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9802;ATP BINDING#0.9801;CELL CYCLE REGULATOR#0.9801;DNA REPAIR#0.9798;STANDARD OF CARE#0.9798;CDK INHIBITOR#0.9797;TARGET OF RAPAMYCIN#0.9793;ORAL SQUAMOUS CELL CARCINOMA#0.9792;TERMINAL DIFFERENTIATION#0.9792;MELANOCYTE#0.9790;LUNG CARCINOMA#0.9783;CELL DIVISION#0.9782;BREAST CARCINOMA#0.9773;HEMATOPOIETIC CELL#0.9767;KERATINOCYTE#0.9767;PROTEIN KINASE C#0.9765;STRUCTURE ACTIVITY RELATIONSHIP#0.9760;REVERSE TRANSCRIPTION#0.9758;GROWTH FACTOR RECEPTOR#0.9754;BREAST CANCER#0.9754;ESOPHAGEAL CANCER#0.9753;PANCREATIC CANCER#0.9751;PACLITAXEL#0.9751;CERVICAL CANCER#0.9751;REPLICATIVE SENESCENCE#0.9749;HEPATOCYTE GROWTH FACTOR#0.9749;STROMAL CELL#0.9749;MAPK SIGNALING#0.9749;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9749;MANTLE CELL LYMPHOMA#0.9747;ENDOTHELIAL GROWTH FACTOR#0.9746;EPITHELIAL MESENCHYMAL TRANSITION#0.9744;INHIBITION OF CELL PROLIFERATION#0.9743;ARGININE#0.9740;B CELL#0.9739;MAP KINASE#0.9739;CELL CYCLE CONTROL#0.9737;CELL CYCLE#0.9737;G1 PHASE#0.9737;RHABDOMYOSARCOMA#0.9737;CYCLIN DEPENDENT KINASE INHIBITOR#0.9736;CHROMOSOMAL REGION#0.9735;GLYCOGEN SYNTHASE KINASE#0.9735;RECEPTOR TYROSINE KINASE#0.9734;MITOSIS#0.9733;COPY NUMBER ALTERATION#0.9732;FIBROBLAST GROWTH FACTOR#0.9731;OVARIAN CANCER#0.9730;CHONDROSARCOMA#0.9730;GLIOBLASTOMA MULTIFORME#0.9727;EMBRYONIC LUNG#0.9726;PROTEASOME#0.9726;SIGNALING CASCADE#0.9726;DOXORUBICIN#0.9725;ESTROGEN RECEPTOR#0.9725;CYTOPLASM#0.9725;RIBOSOMAL PROTEIN#0.9719;PLATELET-DERIVED GROWTH FACTOR#0.9717;VSMC PROLIFERATION#0.9715;AUTOPHAGY#0.9714;CDK ACTIVITY#0.9714;CELL CYCLE CHECKPOINT#0.9713;CERVICAL#0.9710;QUANTITATIVE REVERSE TRANSCRIPTION#0.9709;COMPARATIVE GENOMIC HYBRIDIZATION#0.9708;TRANSFORMING GROWTH FACTOR BETA#0.9708;PROGESTERONE#0.9705;DRUG RESISTANCE#0.9702;ESTRADIOL#0.9696;RNA INTERFERENCE#0.9695;PROTEIN PROTEIN INTERACTION#0.9693;QUANTITATIVE REAL TIME#0.9693;LUNG ADENOCARCINOMA#0.9691;EPIDERMAL GROWTH FACTOR#0.9687;SOFT TISSUE SARCOMA#0.9687;SIGNALING MOLECULE#0.9686;MYXOID LIPOSARCOMA#0.9682;ASTROCYTE#0.9682;PROGENITOR CELL#0.9681;UBIQUITIN#0.9681;BONE MARROW#0.9674;LIVER CANCER#0.9672;POLYMERASE CHAIN REACTION#0.9672;TRANSACTIVATION#0.9672;PERIPHERAL BLOOD#0.9670;MACROPHAGE#0.9668;HEPATOCYTE PROLIFERATION#0.9668;S PHASE#0.9663;KINASE INHIBITOR#0.9660;OVARIAN#0.9659;CELL CYCLE ARREST#0.9659;T CELL#0.9659;PROTEIN SYNTHESIS#0.9658;MECHANISM OF ACTION#0.9657;SQUAMOUS CELL CARCINOMA#0.9656;LYMPH NODE#0.9654;SKIN CANCER#0.9653;CENTRAL NERVOUS SYSTEM#0.9650;ENDOTHELIAL CELL#0.9650;MYELOID LEUKEMIA#0.9649;FLOW CYTOMETRY ANALYSIS#0.9647;T LYMPHOCYTE#0.9644;DNA BINDING#0.9644;TYROSINE KINASE INHIBITOR#0.9644;ACUTE MYELOID LEUKEMIA#0.9643;PROTEIN COMPLEX#0.9639;AKT SIGNALING#0.9636;M PHASE#0.9635;ONCOGENIC#0.9633;TUMOR SUPPRESSOR#0.9632;POLY ADP RIBOSE#0.9632;ONCOGENESIS#0.9632;ADIPOSE TISSUE#0.9632;COLORECTAL CANCER#0.9631;RIBOSE#0.9630;CELL CYCLE REGULATION#0.9629;NEUTROPENIA#0.9629;DOMINANT NEGATIVE MUTANT#0.9628;CELL DIFFERENTIATION#0.9624;TRANSFORMING GROWTH FACTOR#0.9624;COLORECTAL CARCINOMA#0.9623;TUMOR TISSUES#0.9620;DNA REPLICATION#0.9620;CELLULAR GROWTH#0.9620;NERVOUS SYSTEM#0.9618;PANCREATIC ISLET#0.9617;ISCHEMIA#0.9614;ANCHORAGE INDEPENDENT GROWTH#0.9614;HEAT SHOCK PROTEIN#0.9613;CISPLATIN#0.9611;COLONY FORMATION ASSAY#0.9609;CYTOCHROME C#0.9605;COLON CANCER#0.9603;SIGNALLING PATHWAY#0.9602;RETINOIC ACID#0.9599;STEM CELL#0.9598;EPITHELIAL CELL#0.9598;COLORECTAL#0.9598;STAUROSPORINE#0.9593;SKELETAL MUSCLE#0.9593;HEPATOCELLULAR CARCINOMA CELL#0.9592;REGENERATION#0.9591;PROTEIN KINASE#0.9590;APOPTOTIC CELL DEATH#0.9588;NUCLEAR EXPORT#0.9587;BREAST CANCER CELL#0.9586;CYCLIC AMP#0.9580;LYMPH NODE METASTASIS#0.9578;DNA SYNTHESIS#0.9577;UVEAL MELANOMA#0.9577;THYMIDINE#0.9577;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9577;HISTONE DEACETYLASE#0.9570;MAMMARY GLAND#0.9564;TUMOR CELLS#0.9562;GROWTH FACTOR#0.9561;WOUND HEALING#0.9560;PROPIDIUM#0.9558;CARCINOGEN#0.9557;MECHANISMS OF ACTION#0.9556;LUNG CANCER#0.9553;MITOCHONDRIAL MEMBRANE#0.9552;CANCER STEM CELL#0.9552;DNA FRAGMENTATION#0.9550;MITOCHONDRIA#0.9549;ANDROGEN RECEPTOR#0.9546;RESVERATROL#0.9543;SIGNAL TRANSDUCER#0.9542;HUMAN BREAST CANCER#0.9537;TUMOR NECROSIS FACTOR#0.9537;MITOGEN ACTIVATED PROTEIN#0.9532;CELL MIGRATION#0.9532;TOXICITY#0.9528;TRANSCRIPTION FACTOR#0.9528;ADIPOCYTE#0.9528;INHIBITION OF CELL GROWTH#0.9527;HISTONE DEACETYLASE INHIBITOR#0.9525;ANGIOGENESIS#0.9524;GENE EXPRESSION#0.9524;SIGNAL TRANSDUCTION#0.9521;ADENOCARCINOMA#0.9521;CELL GROWTH#0.9511;REACTIVE OXYGEN SPECIES#0.9510;SMOOTH MUSCLE#0.9509;PROSTATE CANCER#0.9509;INDUCTION OF APOPTOSIS#0.9507;DNA DAMAGE RESPONSE#0.9505;ADENOSINE#0.9504;CYTOTOXICITY#0.9503;CELL PROLIFERATION#0.9502;TAMOXIFEN#0.9502;VASCULAR SMOOTH MUSCLE CELL#0.9501;INTESTINAL EPITHELIAL CELL#0.9499;LOVASTATIN#0.9492;APOPTOTIC#0.9491;HEPATOCELLULAR CARCINOMA#0.9490;BETA CELL MASS#0.9488;PROSTATE CARCINOMA#0.9484;MESENCHYMAL STEM CELL#0.9483;CONTACT INHIBITION#0.9482;SIGNALING PATHWAY#0.9482;CANCER CELL#0.9477;SMOOTH MUSCLE CELL#0.9472;APOPTOSIS#0.9472;MUSCLE CELL#0.9468;CELL DEATH#0.9468;EXTRACELLULAR MATRIX#0.9468;TELOMERE#0.9465;DISEASE FREE SURVIVAL#0.9464;PEROXISOME#0.9463;LIVER REGENERATION#0.9459;ARTERY#0.9457;COLON CARCINOMA#0.9455;RENAL CELL CARCINOMA#0.9454;ALZHEIMER'S DISEASE#0.9451;FACTOR I#0.9450;2'-DEOXYURIDINE#0.9445;ROS GENERATION#0.9444;PROTEIN DEGRADATION#0.9434;LYMPHOCYTIC LEUKEMIA#0.9427;OOCYTE#0.9421;CELL ACTIVATION#0.9416;BINDING PROTEIN 1#0.9403;MYELOID CELL#0.9399;DUAL LUCIFERASE REPORTER#0.9399;GENE SILENCING#0.9397;CASPASE-3 ACTIVITY#0.9382;CHONDROCYTE#0.9377;EMBRYONIC STEM CELL#0.9372;DNA METHYLATION#0.9364;DEDIFFERENTIATION#0.9361;CELL ADHESION#0.9341;MONONUCLEAR CELLS#0.9341;NON-SMALL CELL LUNG CARCINOMA#0.9336;PROGRAMMED CELL DEATH#0.9333;GERM CELL#0.9330;T-CELL LEUKEMIA#0.9328;METFORMIN#0.9321;ENZYME ACTIVITY#0.9314;PITUITARY ADENOMA#0.9308;GENOTOXIC#0.9306;5 FLUOROURACIL#0.9305;UMBILICAL VEIN#0.9289;NITRIC OXIDE#0.9287;TYPE 2 DIABETES#0.9287;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9287;KERATINOCYTE PROLIFERATION#0.9277;GLUTATHIONE#0.9267;MUTAGENESIS#0.9259;HUMAN UMBILICAL VEIN#0.9258;SEQUESTERING#0.9248;MUSCLE CELL PROLIFERATION#0.9247;ATHEROSCLEROSIS#0.9246;ALL TRANS RETINOIC ACID#0.9246;THYROID CANCER#0.9200;INTERPHASE#0.9199;PLEOMORPHIC LIPOSARCOMA#0.9191;ENDOMETRIAL CARCINOMA#0.9190;CASPASE INHIBITOR#0.9182;MOLECULAR DYNAMICS SIMULATION#0.9181;IMMUNE RESPONSE#0.9171;B LYMPHOCYTE#0.9167;DEXAMETHASONE#0.9164;HUMAN BRONCHIAL EPITHELIAL#0.9152;TRADITIONAL CHINESE MEDICINE#0.9139;OSTEOBLAST#0.9130;SMOOTH MUSCLE CELL PROLIFERATION#0.9130;CYTOCHROME C RELEASE#0.9128;CANCER RELATED DEATH#0.9108;HYPOXIC#0.9100;HYPOXIA INDUCIBLE FACTOR#0.9097;PHOSPHATASE AND TENSIN HOMOLOG#0.9095;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9054;CELL COUNTING KIT#0.9052;BLOOD BRAIN BARRIER#0.9050;LEIOMYOSARCOMA#0.9043;ENDOPLASMIC RETICULUM#0.9016;CELL SURFACE#0.9011;GELDANAMYCIN#0.9005;ALANINE#0.9002;DIARRHEA#0.8995;HEPATOMA CELLS#0.8993;HUMAN MAMMARY EPITHELIAL#0.8993;MOUSE EMBRYONIC STEM#0.8975;G0 PHASE#0.8975;ADJACENT NORMAL TISSUE#0.8971;ANTI APOPTOSIS#0.8963;PANCREATIC DUCTAL ADENOCARCINOMA#0.8952;IMMUNE SYSTEM#0.8930;FLUOROURACIL#0.8927;MYOGENESIS#0.8921;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8915;EARLY BREAST CANCER#0.8909;PRECURSOR CELL#0.8894;GLUCOSE METABOLISM#0.8893;OLIGODENDROGLIOMA#0.8887;IMATINIB#0.8883;RECURRENCE FREE SURVIVAL#0.8866;TRASTUZUMAB#0.8864;SORAFENIB#0.8848;MUCOSAL MELANOMA#0.8846;ACTIVATED T-CELLS#0.8822;ACTIVATED T CELL#0.8819;BLOOD VESSEL#0.8801;GEMCITABINE#0.8784;MYOGENIC CELL#0.8775;CELL EXPANSION#0.8766;CELL MEMBRANE#0.8764;ESOPHAGEAL CARCINOMA#0.8746;FOCAL ADHESION#0.8744;MEDULLOBLASTOMA#0.8744;FIBROUS HISTIOCYTOMA#0.8740;ETHANOL#0.8739;GENISTEIN#0.8737;CEREBRAL ISCHEMIA#0.8726;HODGKIN'S LYMPHOMA#0.8697;NEURONAL CELL DEATH#0.8695;BERBERINE#0.8691;LUNG EPITHELIAL CELL#0.8681;CASPASE ACTIVATION#0.8680;NEURAL STEM CELL#0.8670;TRANSCRIPTIONAL CONTROL#0.8669;MODE OF ACTION#0.8667;FORMALIN#0.8656;IMMUNE CELL#0.8649;STROMA#0.8630;BREAST CANCER MODEL#0.8630;EPSTEIN BARR VIRUS#0.8618;NITRIC OXIDE SYNTHASE#0.8614;EPITHELIAL CELL PROLIFERATION#0.8586;ENHANCER BINDING#0.8573;REPORTER GENE ASSAY#0.8561;CALCINEURIN#0.8548;CELL CYCLE DYSREGULATION#0.8543;SIMVASTATIN#0.8540;TUBE FORMATION#0.8532;CARDIOMYOCYTE PROLIFERATION#0.8525;NULL CELL#0.8505;DEGRADATION OF CYCLIN#0.8504;MELATONIN#0.8504;ACTIVE CASPASE 3#0.8479;ADULT T-CELL LEUKEMIA#0.8475;ENDOTHELIAL CELL PROLIFERATION#0.8459;HEMATOPOIETIC STEM CELL#0.8449;OLOMOUCINE#0.8446;INSULIN SECRETION#0.8445;ACUTE LEUKEMIA#0.8445;LYSINE#0.8444;PAPILLOMA#0.8421;EPIGALLOCATECHIN#0.8405;ANEMIA#0.8401;LYMPHOMA CELL LINES#0.8399;SUPEROXIDE DISMUTASE#0.8393;ACTIVATOR PROTEIN 1#0.8392;DEATH RECEPTOR#0.8378;HAIR FOLLICLE#0.8368;PROTEASOME PATHWAY#0.8368;PROTEIN KINASE A#0.8353;MITOTIC CELL CYCLE#0.8335;LINES OF EVIDENCE#0.8334;BORTEZOMIB#0.8329;BRONCHIAL EPITHELIAL CELLS#0.8327;RANDOMIZED CONTROLLED TRIAL#0.8324;G-CSF#0.8322;CYCLIN D2-CDK4 COMPLEX#0.8308;DOUBLE STRAND BREAK#0.8288;MULTIPLE MYELOMA CELLS#0.8282;OBJECTIVE RESPONSE RATE#0.8282;CHONDROCYTE PROLIFERATION#0.8280;TOPOISOMERASE#0.8266;ENHANCER BINDING PROTEIN#0.8257;TARGET OF RAPAMYCIN COMPLEX#0.8246;ARYL HYDROCARBON RECEPTOR#0.8246;CHROMOSOME REGION#0.8241;ALTERNATIVE READING FRAME#0.8235;PERIPHERAL NERVE#0.8234;PHOSPHOLIPASE C#0.8226;APOPTOTIC PROCESS#0.8217;HUMAN PANCREATIC CANCER#0.8215;DIFFUSE LARGE B-CELL LYMPHOMA#0.8210;URINARY BLADDER#0.8208;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8194;TUMOR ANTIGEN#0.8186;DIABETES MELLITUS#0.8186;RECEPTOR ANTAGONIST#0.8184;CYCLIN-DEPENDENT KINASE ACTIVITY#0.8174;PHOSPHATASE ACTIVITY#0.8171;IFN-GAMMA#0.8166;HYPERTENSION#0.8165;FLOW CYTOMETRY ASSAY#0.8165;ANASTROZOLE#0.8156;CEREBELLAR GRANULE NEURON#0.8138;GLIAL CELL#0.8138;IB-MECA#0.8110;WHOLE TISSUE SECTIONS#0.8106;VASCULAR ENDOTHELIAL CELL#0.8085;PRIMARY BREAST CANCER#0.8079;SMALL INTESTINE#0.8078;THYROID CARCINOMA#0.8077;AORTIC SMOOTH MUSCLE CELLS#0.8076;ESTROGENS#0.8069;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.8069;CHOLANGIOCARCINOMA#0.8058;C TERMINAL DOMAIN#0.8039;MOUSE EMBRYO FIBROBLASTS#0.8036;CYCLIN BINDING#0.8034;HEAD AND NECK CANCER#0.8033;NECK CANCER#0.8033;RANDOMIZED CLINICAL TRIAL#0.8029;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8027;EPITHELIAL TO MESENCHYMAL#0.8025;OOCYTE MATURATION#0.8008;TUMOR GROWTH INHIBITION#0.8002;PI3K SIGNALING#0.8000;LEYDIG CELL#0.7977;COLONY-STIMULATING FACTOR#0.7976;ISOQUINOLINE#0.7975;MALIGNANT MESOTHELIOMA#0.7973;COPY NUMBER CHANGE#0.7968;INFLAMMATORY RESPONSE#0.7960;GRANULOCYTE#0.7947;CELL MOTILITY#0.7945;SRC FAMILY KINASE#0.7941;MAXIMUM TOLERATED DOSE#0.7925;HEPATITIS B#0.7922;METAPHASE#0.7918;GENE COPY NUMBER#0.7906;HEPATIC STELLATE CELL#0.7905;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.7884;HOMOLOGOUS RECOMBINATION#0.7880;CHRONIC MYELOID LEUKEMIA#0.7872;ARA-C#0.7859;BASAL CELL#0.7859;ALVEOLAR RHABDOMYOSARCOMA#0.7856;INSULIN RECEPTOR#0.7854;ACTIVATED CASPASE 3#0.7826;CORNEAL ENDOTHELIAL CELL#0.7796;INDOLE#0.7794;UBIQUITIN PROTEASOME PATHWAY#0.7787;ANAPLASTIC OLIGODENDROGLIOMA#0.7775;PLASMA CELL#0.7768;RNA BINDING#0.7766;VITAMIN C#0.7758;SPINDLE CELL LIPOMA#0.7749;INHIBITION OF GROWTH#0.7747;PLASMA MEMBRANE#0.7725;ESOPHAGUS#0.7719;CARCINOMA IN SITU#0.7709;LEUCINE#0.7705;HISTIOCYTOMA#0.7704;CERVICAL CANCER CELL LINES#0.7699;CELL DEVELOPMENT#0.7698;INFERTILITY#0.7695;NERVE GROWTH FACTOR#0.7656;ADIPOGENESIS#0.7635;CLINICAL BENEFIT RATE#0.7619;ORAL CAVITY#0.7604;LYMPHOID CELL#0.7592;HEPATITIS B VIRUS#0.7588;SALIVARY GLAND#0.7588;VASCULAR DISEASE#0.7587;PROTEIN BINDING#0.7583;HOST CELL#0.7573;REGULATION OF CELL PROLIFERATION#0.7553;NEUROENDOCRINE TUMOR#0.7545;YEAR SURVIVAL RATE#0.7535;EWING SARCOMA#0.7498;MYOBLAST DIFFERENTIATION#0.7489;HERPES SIMPLEX#0.7484;SKIN FIBROBLASTS#0.7477;ORAL LICHEN PLANUS#0.7454;PROGESTIN#0.7444;HISTONE ACETYLATION#0.7421;TETRACYCLINE#0.7417;LEUKOCYTE#0.7416;MEDIAN OVERALL SURVIVAL#0.7416;EPITHELIAL OVARIAN CANCER#0.7412;STEM CELL MARKER#0.7408;FOCAL ADHESION KINASE#0.7408;ELECTROPHORETIC MOBILITY SHIFT#0.7389;NEUTROPHIL#0.7386;LICHEN PLANUS#0.7386;POST-TRANSLATIONAL MODIFICATION#0.7379;PROTEIN KINASE ACTIVITY#0.7366;INDUCIBLE NITRIC OXIDE#0.7366;LIVER DISEASE#0.7348;DOSE LIMITING TOXICITIES#0.7338;PROTEIN KINASE INHIBITOR#0.7315;NODULAR#0.7312;OVERALL SURVIVAL RATE#0.7304;CELL KILLING#0.7298;LUCIFERASE ACTIVITY#0.7291;WORLD HEALTH ORGANIZATION#0.7288;ENDOPLASMIC RETICULUM STRESS#0.7280;PULMONARY ARTERY#0.7279;MONOCYTE#0.7278;HERPES SIMPLEX VIRUS#0.7275;COPY NUMBER GAIN#0.7272;BONE MARROW CELLS#0.7269;ADRENOCORTICAL CARCINOMA#0.7267;T CELL PROLIFERATION#0.7266;SYNOVIAL SARCOMA#0.7252;MEGAKARYOCYTE#0.7234;PODOCYTE#0.7232;THYMOCYTE#0.7206;ERYTHROCYTE#0.7201;ADIPOCYTE DIFFERENTIATION#0.7195;HIGH MOBILITY GROUP#0.7173;VITAMIN D RECEPTOR#0.7171;PROTEIN INTERACTION NETWORK#0.7170;GLUCOSE HOMEOSTASIS#0.7167;HYPERGLYCEMIA#0.7163;MICROTUBULE#0.7162;PANCREATIC BETA CELL PROLIFERATION#0.7150;CELL NUCLEUS#0.7149;RHEUMATOID ARTHRITIS#0.7137;METHYLATION SPECIFIC PCR#0.7123;CHROMATIN REMODELING#0.7105;TO TUMOR PROGRESSION#0.7104;LEIOMYOMA#0.7099;OLIGODENDROCYTE#0.7090;INHIBITION OF PHOSPHORYLATION#0.7070;ATAXIA TELANGIECTASIA#0.7066;VALPROIC ACID#0.7066;NEVUS#0.7051;GLUTAMINE#0.7032;THROMBOCYTOPENIA#0.7003;OVARIES#0.6997;QUERCETIN#0.6994;REACTIVE OXYGEN SPECIES GENERATION#0.6991;APOPTOSIS INDUCING FACTOR#0.6989;TESTOSTERONE#0.6979;INSULINOMA#0.6977;SPINAL CORD#0.6969;CENTROSOME#0.6962;KINASE INHIBITOR PROTEIN#0.6962;CELLULAR METABOLISM#0.6961;72-HOURS#0.6943;PROTEIN TYROSINE KINASE#0.6941;RNA BINDING PROTEIN#0.6936;DNA METHYLTRANSFERASE#0.6932;INFLAMMATORY CELL#0.6896;DOCETAXEL#0.6874;REPLICATION COMPARTMENT#0.6866;STEM CELL PROLIFERATION#0.6865;AGE AT DIAGNOSIS#0.6864;BIOTIN#0.6858;N-ACETYLCYSTEINE#0.6857;BETA GALACTOSIDASE#0.6848;BLADDER CARCINOMA#0.6842;TRANSDIFFERENTIATION#0.6839;REGULATION OF CELLULAR#0.6832;CAMPTOTHECIN#0.6813;AUTOIMMUNE DISEASE#0.6810;MELANOCYTE DIFFERENTIATION#0.6807;PREADIPOCYTE#0.6806;SERTOLI CELL#0.6799;EXEMESTANE#0.6797;PARATHYROID#0.6785;NEUROECTODERMAL TUMOR#0.6773;DNA DAMAGE CHECKPOINT#0.6762;SENSITIZATION#0.6760;DNA AMPLIFICATION#0.6758;ANTHRACENE#0.6756;NEOPLASTIC TISSUES#0.6754;CORD BLOOD#0.6751;MALIGNANT BRAIN TUMOR#0.6745;CORONARY ARTERY#0.6744;26S PROTEASOME#0.6727;EMBRYONAL CARCINOMA#0.6721;LUNG METASTASIS#0.6702;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6702;NUCLEAR LOCALIZATION SIGNAL#0.6702;MYOSIN HEAVY CHAIN#0.6682;PROSTATE SPECIFIC ANTIGEN#0.6680;RESPONSE TO TREATMENT#0.6674;DIPHOSPHATE#0.6667;GASTROINTESTINAL TRACT#0.6656;EOSIN#0.6645;GROWTH HORMONE#0.6639;RB-E2F COMPLEX#0.6638;NEPHROPATHY#0.6630;CERVIX#0.6622;SOLITARY FIBROUS TUMOR#0.6617;FACTOR VIII#0.6595;MAPK ACTIVATION#0.6592;NEURON DEATH#0.6577;ETOPOSIDE#0.6577;COENZYME A#0.6564;ATAXIA TELANGIECTASIA MUTATED#0.6554;TRANSITIONAL CELL CARCINOMA#0.6544;ANTISENSE RNA#0.6543;NEURODEGENERATIVE DISEASE#0.6542;HEMATOPOIESIS#0.6532;FIBROSARCOMA#0.6521;ERLOTINIB#0.6502;MESOTHELIOMA CELL#0.6497;ORAL CANCER CELL#0.6492;UMBILICAL CORD#0.6490;MYOCYTES#0.6482;BLAST CELL#0.6478;CD8+ T CELL#0.6471;FORSKOLIN#0.6469;BONE FORMATION#0.6462;VEMURAFENIB#0.6460;GERM CELL TUMORS#0.6458;DNA COPY NUMBER#0.6447;SCHWANN CELL#0.6435;RETINOID X RECEPTOR#0.6423;TEMOZOLOMIDE#0.6418;CDC2 KINASE ACTIVITY#0.6415;EUKARYOTIC INITIATION FACTOR#0.6412;PERIPHERAL BLOOD LEUKOCYTE#0.6412;GROWTH PATTERN#0.6408;L-CYSTEINE#0.6401;GM-CSF#0.6398;HIGH RISK PATIENTS#0.6396;MISMATCH REPAIR#0.6388;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6365;FIBROUS DYSPLASIA#0.6364;GALACTOSIDASE ACTIVITY#0.6338;OVARIAN SURFACE EPITHELIUM#0.6335;COLON ADENOCARCINOMA#0.6319;NERVE SHEATH TUMORS#0.6316;GENE EXPRESSION OMNIBUS#0.6312;GASTROINTESTINAL STROMAL TUMOR#0.6304;EMBRYONAL RHABDOMYOSARCOMA#0.6295;HSP90 BINDING#0.6284;CASEIN KINASE 1#0.6284;DIABETIC NEPHROPATHY#0.6264;SURFACE EPITHELIUM#0.6262;PROTEIN PHOSPHATASE 2A#0.6244;PHOSPHATASE 2A#0.6241;INVASIVE BREAST CANCER#0.6238;WNT SIGNALING PATHWAY#0.6232;TRAMETINIB#0.6222;UMBILICAL CORD BLOOD#0.6217;NEURITE OUTGROWTH#0.6211;SV40 T-ANTIGEN#0.6211;PIPERAZIN#0.6209;DEMETHYLATION#0.6203;VIRAL REPLICATION#0.6201;VASCULAR CELL#0.6198;PLEOMORPHIC ADENOMA#0.6193;ERYTHROLEUKEMIA#0.6191;UTERUS#0.6188;T CELL ACTIVATION#0.6186;LEUKOPENIA#0.6185;ENDOMETRIOSIS#0.6164;HUMAN PAPILLOMA VIRUS#0.6163;MAMMARY EPITHELIUM#0.6147;ICI 182,780#0.6129;OXIDATIVE METABOLISM#0.6122;GRANULOSA CELL PROLIFERATION#0.6122;ORNITHINE DECARBOXYLASE#0.6119;GESTATION#0.6114;CUGBP1-EIF2 COMPLEX#0.6110;GLYCOLYSIS#0.6109;CASPASE ACTIVITY#0.6109;VON HIPPEL LINDAU#0.6107;OESOPHAGEAL SQUAMOUS CELL#0.6105;LYMPH NODE INVOLVEMENT#0.6103;CYCLOSPORIN A#0.6101;MULTIPLE ENDOCRINE NEOPLASIA#0.6095;NEURAL CELL#0.6090;L-OHP#0.6086;HISTIDINE#0.6075;GLUCOCORTICOID RECEPTOR#0.6074;TRANSLATION INITIATION#0.6066;CORE NEEDLE BIOPSIES#0.6060;VORINOSTAT#0.6060;ATPASE ACTIVITY#0.6059;NEURONAL CELLS#0.6054;ENDOMETRIOID ENDOMETRIAL CARCINOMA#0.6052;CYTOTOXIC T-LYMPHOCYTE#0.6047;CETUXIMAB#0.6045;ENTEROCYTE#0.6043;HYPERGLYCEMIC#0.6041;PRIMARY CUTANEOUS MELANOMA#0.6039;CELL ADHESION MOLECULE#0.6033;SERUM ALBUMIN#0.6009;17-DMAG#0.6003
101	LEUKOCYTE DIFFERENTIATION#1.0804;PANCREATIC CANCER#1.0612;LEUKOCYTE#1.0404;CANCER CELL#1.0224;MACROPHAGE#1.0091;GROWTH FACTOR#1.0076;LUNG CANCER#1.0064;HEPATOCELLULAR CARCINOMA#0.9833;CELL ADHESION#0.9745;GENE EXPRESSION#0.9732;ENDOTHELIAL CELL#0.9700;B CELL#0.9597;EXTRACELLULAR MATRIX#0.9570;MYOCARDIAL INFARCTION#0.9516;POLYMERASE CHAIN REACTION#0.9481;BREAST CANCER#0.9471;CELL SURFACE#0.9469;T CELL#0.9444;OSTEOCLAST#0.9220;NEUTROPHIL#0.9206;PERIPHERAL BLOOD#0.9152;CELL MIGRATION#0.8936;INFLAMMATORY CELL#0.8837;EOSINOPHIL#0.8790;EPITHELIAL CELL#0.8697;EPIDERMAL GROWTH FACTOR#0.8608;MONOCYTE#0.8518;EOSINOPHILIC PNEUMONIA#0.8453;TUMOR NECROSIS FACTOR#0.8426;ALLERGEN#0.8269;APOPTOSIS#0.8209;CELL GROWTH#0.8191;MONONUCLEAR CELLS#0.8023;SIGNALING PATHWAY#0.7975;BREAST CANCER CELL#0.7944;BONE MARROW#0.7651;PERIODONTAL DISEASE#0.7642;BLOOD VESSEL#0.7630;AMNIOTIC FLUID#0.7621;SPINAL CORD#0.7500;SKELETAL MUSCLE#0.7488;SELECTIN#0.7434;ADENOCARCINOMA#0.7400;STEM CELL#0.7293;REVERSE TRANSCRIPTION#0.7242;CELL FUSION#0.7187;DENDRITIC CELL#0.7117;T LYMPHOCYTE#0.7108;PROTEIN KINASE#0.7084;TUMOR CELLS#0.7072;ANGIOGENESIS#0.7071;INFLAMMATORY RESPONSE#0.7061;SQUAMOUS CELL CARCINOMA#0.6930;PERIODONTITIS#0.6915;SMOOTH MUSCLE#0.6913;BATIMASTAT#0.6901;BLOOD CIRCULATION#0.6875;IMMUNE CELL#0.6779;CHONDROCYTE#0.6642;CATALYTIC ACTIVITY#0.6556;RHEUMATOID ARTHRITIS#0.6530;CELL PROLIFERATION#0.6503;HYPOXIA#0.6372;GROWTH FACTOR RECEPTOR#0.6316;PNEUMONIA#0.6310;ATHEROSCLEROTIC#0.6286;TOXICITY#0.6261;GINGIVAL CREVICULAR FLUID#0.6229;CCL22 PRODUCTION#0.6178;ALLERGIC AIRWAY INFLAMMATION#0.6089;CELL DEATH#0.6054
10200	M PHASE#0.8897;NERVE FIBER#0.6143;RNA BINDING#0.6116
10201	NUCLEOSIDE DIPHOSPHATE KINASE#0.6630;STEM CELL#0.6094
10202	CHOLINE BINDING#1.1024;HISTIDINE#1.0609;OUTER MEMBRANE#1.0310;GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE#1.0229;CHOLINE#1.0194;ACUTE OTITIS MEDIA#1.0073;PNEUMOCOCCAL CONJUGATE VACCINE#1.0062;DIPHTHERIA#0.9996;OTITIS MEDIA#0.9964;INVASIVE PNEUMOCOCCAL DISEASE#0.9956;VIRULENCE#0.9948;SURFACTANT PROTEIN D#0.9906;IMMUNE RESPONSE#0.9708;PNEUMONIA#0.9551;RESPIRATORY TRACT#0.9514;GENE EXPRESSION#0.9430;MIDDLE EAR#0.9256;HEPATITIS B#0.8947;SERIOUS ADVERSE EVENT#0.8938;PERTUSSIS#0.8884;POLYAMINE TRANSPORT#0.8839;RANDOMIZED CONTROLLED TRIAL#0.8783;PHOSPHODIESTERASE#0.8613;RESPIRATORY TRACT INFECTION#0.8543;HEPATOCELLULAR CARCINOMA#0.8379;T CELL#0.8213;CELL CYCLE#0.8040;LUNG DISEASE#0.8008;MACROPHAGE#0.7822;SODIUM DODECYL SULFATE#0.7815;DODECYL SULFATE#0.7814;CHLAMYDIA#0.7785;RANDOMISED CONTROLLED TRIAL#0.7698;HEPATITIS A#0.7590;APOPTOSIS#0.7581;SICKLE CELL DISEASE#0.7576;EPIDIDYMIS#0.7569;B CELL#0.7456;PROTEIN COMPLEX#0.7257;RESPIRATORY-BURST OXIDASE#0.7189;DICARBOXYLIC ACID TRANSPORT#0.7169;RESPIRATORY BURST#0.7128;EPITHELIAL CELL#0.7106;MONOCYTE#0.7051;HOST CELL#0.7039;CANCER CELL#0.7015;PROTEIN SYNTHESIS#0.6964;CLARA CELL#0.6840;RIBOSOME#0.6797;DNA SYNTHESIS#0.6733;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6630;POLYMERASE CHAIN REACTION#0.6569;YERSINIA OUTER PROTEIN#0.6476;PARACETAMOL#0.6356;MEMBRANE PROTEIN COMPLEX#0.6321;IMMUNE SYSTEM#0.6288;CAPUT#0.6265;IGD BINDING#0.6247;CAUDA#0.6237;BREAST CANCER#0.6235;PROTEIN KINASE#0.6196;ASPARTATE#0.6163;CELL SURFACE#0.6162;LYSIS#0.6139;LECTIN#0.6113;HEPATOCELLULAR CARCINOMA CELL#0.6107;DICARBOXYLIC ACID#0.6041
10203	CALCITONIN RECEPTOR#1.0467;RECEPTOR ACTIVITY#1.0353;AM BINDING#1.0346;ADRENOMEDULLIN RECEPTOR#1.0300;POLYMERASE CHAIN REACTION#1.0244;CGRP RECEPTOR#1.0167;RECEPTOR COMPLEX#1.0149;GENE EXPRESSION#1.0127;ENDOTHELIAL CELL#1.0103;MUSCLE CELL#1.0061;SMOOTH MUSCLE CELL#1.0052;REVERSE TRANSCRIPTION#1.0049;CELL SURFACE#1.0018;PLASMA MEMBRANE#1.0015;SMOOTH MUSCLE#1.0001;VASCULAR SMOOTH MUSCLE CELL#0.9894;GLYCOSYLATION#0.9889;VASODILATOR#0.9761;ARTERY#0.9697;RECEPTOR ANTAGONIST#0.9641;ANGIOGENESIS#0.9637;GROWTH FACTOR#0.9564;SIGNALING PATHWAY#0.9462;ADRENOMEDULLIN BINDING#0.9443;ENDOTHELIUM#0.9428;MIGRAINE#0.9409;TRANSCRIPTASE#0.9376;HYPERTENSION#0.9312;PROTEIN KINASE#0.9287;BLOOD VESSEL#0.9285;NERVOUS SYSTEM#0.9111;NITRIC OXIDE#0.9057;APOPTOSIS#0.9033;EPITHELIAL CELL#0.9015;SIGNAL TRANSDUCTION#0.8925;HYPOTENSIVE#0.8841;CELL PROLIFERATION#0.8809;SPINAL CORD#0.8523;HYPOXIA#0.8500;MACROPHAGE#0.8433;PEPTIDE HORMONE#0.8309;UTERUS#0.8303;ADIPOSE TISSUE#0.8274;CARDIOMYOCYTE#0.8244;VASODILATION#0.8197;CELLULAR LOCALIZATION#0.8173;CELL MEMBRANE#0.7999;CANCER CELL#0.7944;ACUTE MYELOID LEUKEMIA#0.7932;MYELOID LEUKEMIA#0.7913;MYOCARDIUM#0.7867;PHEOCHROMOCYTOMA#0.7766;ADENYLATE CYCLASE#0.7709;PROTEIN KINASE A#0.7705;AMYLIN RECEPTOR#0.7676;CLASS B GPCR#0.7553;TROPHOBLAST#0.7531;GESTATION#0.7351;CENTRAL NERVOUS SYSTEM#0.7346;HYPOXIC#0.7321;MAST CELL#0.7275;COMPLEX I#0.7231;SUBSTANCE P#0.7201;HYDROPS FETALIS#0.6969;RECEPTOR INTERNALIZATION#0.6962;MUTAGENESIS#0.6897;ALANINE#0.6888;QUANTITATIVE REAL TIME#0.6871;ISCHEMIA#0.6848;APOPTOTIC#0.6835;PEPTIDE BINDING#0.6834;STEM CELL#0.6823;ADRENAL MEDULLA#0.6814;TROPHOBLAST CELL#0.6793;OSTEOBLAST#0.6778;ADRENAL GLAND#0.6758;PANCREATIC CANCER#0.6733;CONGESTIVE HEART FAILURE#0.6726;NERVE FIBER#0.6625;RECEPTOR BINDING#0.6612;ADENYLATE#0.6596;BONE MARROW#0.6570;HUMAN EMBRYONIC KIDNEY#0.6533;EMBRYONIC KIDNEY#0.6529;MYOCYTES#0.6517;NEUROPEPTIDE RECEPTOR#0.6510;OSTEOCLAST#0.6488;ENDOTHELIAL GROWTH FACTOR#0.6339;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6339;COTRANSLATIONAL MODIFICATION#0.6289;ANGLE-CLOSURE GLAUCOMA#0.6169;REPRODUCTIVE SYSTEM#0.6053;BASILAR ARTERY#0.6041;ADENOSINE#0.6014;PULMONARY HYPERTENSION#0.6009
10204	IMPORTIN#1.0457;NUCLEAR TRANSPORT#1.0439;NUCLEAR IMPORT#1.0392;PROTEIN IMPORT#1.0380;PORE COMPLEX#1.0058;NUCLEAR PORE COMPLEX#1.0043;NUCLEAR PORE#1.0034;MOLECULAR DYNAMICS SIMULATION#1.0025;NUCLEAR EXPORT#0.9900;NUCLEAR ENVELOPE#0.9856;CYTOPLASM#0.9731;MOLAR#0.9151;INSULIN RECEPTOR#0.8996;ADIPOCYTE#0.8996;NUCLEAR PORE COMPLEXES#0.8875;KARYOPHERIN#0.8610;LITHIUM#0.8253;NUCLEOCYTOPLASMIC TRANSPORT#0.8115;RECEPTOR TYROSINE KINASE#0.8107;NUCLEAR LOCALIZATION SIGNAL#0.7954;CELL CYCLE#0.7658;RNA BINDING#0.7641;ETHANOL#0.7403;SIGNAL TRANSDUCTION#0.7253;PROTEIN TRANSPORT#0.7203;SIGNAL TRANSMISSION#0.6857;CATALYTIC ACTIVITY#0.6825;NUCLEOTIDE EXCHANGE FACTOR#0.6793;GLUCOSE TRANSPORT#0.6767;TRANSPORTIN#0.6757;LIMITS OF DETECTION#0.6314;GUANINE#0.6228
10205	MYELIN PROTEIN ZERO#1.0075;EPITHELIAL CELL#0.9940;T CELL#0.9838;CELL ADHESION#0.9290;GENE EXPRESSION#0.7968;THYMOCYTE#0.7917;B LYMPHOCYTE#0.7898;CELL ADHESION MOLECULE#0.7016;ANTI-VLA4#0.6653;T LYMPHOCYTE#0.6534;CANCER CELL#0.6505;CHOROID PLEXUS#0.6327;INNER EAR#0.6311
102060282	TUMOR SUPPRESSOR#0.7133
10206	DIHYDROMORPHINE#1.0648;SUBSTANCE P#1.0309;ETORPHINE#1.0269;RECEPTOR AGONIST#1.0212;MU OPIOID RECEPTOR#1.0119;DELTA OPIOID RECEPTOR#1.0090;LEUCINE#1.0085;RECEPTOR BINDING#1.0050;UBIQUITIN#1.0024;OPIOID PEPTIDE#0.9932;DOPAMINE#0.9901;KAPPA OPIOID RECEPTOR#0.9834;OPIOID RECEPTOR#0.9828;NALOXONE#0.9772;SPINAL CORD#0.9768;ADENYLATE CYCLASE#0.9435;RECEPTOR ANTAGONIST#0.9405;NEUROBLASTOMA#0.9246;TUMOR SUPPRESSOR#0.9175;T CELL#0.9138;PLASMA MEMBRANE#0.9132;STRIATUM#0.9034;CYCLASE ACTIVITY#0.8976;METHIONINE#0.8908;FENTANYL#0.8889;ADENYLATE#0.8739;PERTUSSIS#0.8625;DIPRENORPHINE#0.8532;B CELL#0.8473;NALTREXONE#0.8428;PEPTIDASE INHIBITOR#0.8380;OPIOID RECEPTOR BINDING#0.8221;ADENYLATE CYCLASE ACTIVITY#0.8221;NORADRENALINE#0.8127;MORPHINE SULFATE#0.8118;NERVOUS SYSTEM#0.8065;ADRENAL MEDULLA#0.8047;CAPTOPRIL#0.7829;NITRIC OXIDE SYNTHASE#0.7803;NITRIC OXIDE#0.7783;MEMBRANE FRACTION#0.7714;CELL DEATH#0.7642;LIGASE ACTIVITY#0.7481;SUBSTANTIA NIGRA#0.7472;THIORPHAN#0.7339;BETA-ENDORPHIN BINDING#0.7304;RECEPTOR LIGAND#0.7280;STRUCTURE ACTIVITY RELATIONSHIP#0.7271;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7221;LYMPHOCYTIC LEUKEMIA#0.7214;NERVE TERMINAL#0.7053;AXON TERMINAL#0.6992;ENDOPEPTIDASE 24.11#0.6950;ACETYLCHOLINE#0.6851;BLOOD BRAIN BARRIER#0.6759;SMOOTH MUSCLE#0.6561;ANGIOTENSIN CONVERTING ENZYME#0.6524;LEUCINE BIOSYNTHESIS#0.6476;GUANINE#0.6468;BESTATIN#0.6459;THALAMUS#0.6459;ENDOPLASMIC RETICULUM#0.6455;FORSKOLIN#0.6344;ISCHEMIA#0.6315;CEREBRAL CORTEX#0.6297;CYCLIC AMP#0.6295;VASOPRESSIN#0.6195;SUFENTANIL#0.6176;LEVORPHANOL#0.6132;NERVOUS TISSUE#0.6119;AMIDE BINDING#0.6119;CENTRAL NERVOUS SYSTEM#0.6115;ALANINE#0.6076;PYRAMIDAL CELL#0.6071;CHROMAFFIN CELL#0.6041;UBIQUITIN LIGASE ACTIVITY#0.6020;N-ETHYLMALEIMIDE#0.6013
10207	TIGHT JUNCTION PROTEIN#1.0653;TIGHT JUNCTION#1.0484;EPITHELIAL CELL#1.0065;PROTEIN KINASE C#1.0061;PROTEIN KINASE#1.0052;CELL POLARITY#1.0043;PLASMA MEMBRANE#0.9556;PDZ BINDING MOTIF#0.9168;PROTEIN COMPLEX#0.8956;ADHERENS JUNCTION#0.8806;GLUTAMATE RECEPTOR#0.8776;MORPHOGENESIS#0.7903;SIGNALING PATHWAY#0.7809;PDZ DOMAIN BINDING#0.7667;ION CHANNEL#0.7225;SYNAPSE ASSOCIATED PROTEIN#0.7106;CELL SURFACE#0.6927;SIGNAL TRANSDUCTION#0.6814;NERVOUS SYSTEM#0.6810;INSULIN RECEPTOR#0.6794;CELL JUNCTION#0.6753;PHOTORECEPTOR CELL#0.6746;ZONULA OCCLUDENS#0.6658;PROTEIN PROTEIN INTERACTION#0.6553;USHER SYNDROME#0.6428;POSTSYNAPTIC DENSITY#0.6416;COMPLEX I#0.6381;RECEPTOR TYROSINE KINASE#0.6272;GROWTH FACTOR#0.6049
10208	SNRNA TRANSCRIPTION#0.6730;CAJAL BODY#0.6660;CYTOCHROME C#0.6568
10209	CYTOCHROME C#1.0831;PREINITIATION COMPLEX#1.0479;40S RIBOSOMAL SUBUNIT#1.0339;TRANSLATION INITIATION FACTOR#1.0339;EUKARYOTIC INITIATION FACTOR#1.0228;RIBOSOMAL SUBUNIT#1.0153;TRANSLATION INITIATION#1.0152;RIBOSOME#1.0091;PROTEIN SYNTHESIS#1.0040;OVARIAN CARCINOMA#0.9826;OVARIAN#0.9761;GTP HYDROLYSIS#0.9668;BASE PAIRING#0.9490;C TERMINAL DOMAIN#0.9045;RIBOSOMAL PROTEIN#0.8436;MRNA BINDING#0.8299;RETICULOCYTE#0.8240;TRANSLATION INITIATION COMPLEX#0.8132;GENE EXPRESSION#0.7960;SMALL RIBOSOMAL SUBUNIT#0.7952;GROWTH FACTOR#0.7692;INTERNODE#0.7496;HEPATOCELLULAR CARCINOMA#0.7434;80S RIBOSOME#0.7323;CANCER CELL#0.7239;RIBOSOME BINDING#0.7131;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7065;ENDOTHELIAL GROWTH FACTOR#0.7064;COMPLEX I#0.6833;PROTEIN SYNTHESIS INITIATION#0.6550;CELL GROWTH#0.6003
1020	TAU PROTEIN KINASE#1.0834;OLOMOUCINE#1.0533;CAMKII#1.0481;BETA CELL#1.0459;PROSTATE CANCER#1.0390;INSULIN SECRETION#1.0378;SYNAPTIC TRANSMISSION#1.0363;MAP KINASE#1.0330;HYPERACTIVITY#1.0302;ISCHEMIA#1.0297;MYOCYTE ENHANCER FACTOR#1.0294;MITOCHONDRIAL FISSION#1.0274;NEURONAL MIGRATION#1.0259;PODOCYTE#1.0256;CYCLIN DEPENDENT KINASE#1.0254;CELL MIGRATION#1.0238;MITOGEN ACTIVATED PROTEIN#1.0232;BRAIN DEVELOPMENT#1.0220;ATP BINDING#1.0209;CALCINEURIN#1.0207;GLYCOGEN SYNTHASE KINASE#1.0202;KINASE ACTIVITY#1.0197;HYPOXIA#1.0196;NEUROFILAMENT#1.0196;DENDRITIC SPINE#1.0187;NMDA RECEPTOR#1.0182;NEURITE OUTGROWTH#1.0176;NEUROTRANSMISSION#1.0174;CYTOPLASM#1.0170;CEREBRAL ISCHEMIA#1.0169;ENDOTHELIAL CELL#1.0161;SYNAPTIC VESICLE#1.0155;NEUROGENESIS#1.0154;PROTEIN PHOSPHATASE 2A#1.0152;NEUROTOXIC#1.0146;LUNG CANCER#1.0144;NEURONAL CELL DEATH#1.0144;PHOSPHATASE 2A#1.0136;EXOCYTOSIS#1.0129;AUTOPHAGY#1.0129;NEUROTOXICITY#1.0128;NEURONAL CELLS#1.0127;CELL DIFFERENTIATION#1.0127;CELL CYCLE REGULATION#1.0119;EPITHELIAL CELL#1.0116;PURKINJE CELL#1.0114;ACTIN CYTOSKELETON#1.0107;OLIGODENDROCYTE#1.0104;AXONAL TRANSPORT#1.0102;NERVOUS SYSTEM DEVELOPMENT#1.0088;NEUROTRANSMITTER RELEASE#1.0082;AMYOTROPHIC LATERAL SCLEROSIS#1.0081;ENDOCYTOSIS#1.0077;PROTEIN KINASE A#1.0075;GROWTH CONE#1.0075;CENTRAL NERVOUS SYSTEM#1.0073;SYSTEM DEVELOPMENT#1.0064;LATERAL SCLEROSIS#1.0059;SPINAL CORD#1.0047;HYPERPHOSPHORYLATION#1.0046;NITRIC OXIDE#1.0045;CELL ADHESION#1.0044;CANCER CELL#1.0038;BREAST CANCER CELL#1.0035;NEUROLOGICAL DISORDER#1.0031;PROTEIN KINASE C#1.0029;CALPAIN ACTIVITY#1.0027;NERVOUS SYSTEM#1.0020;PROTEIN KINASE#1.0016;MORPHOGENESIS#1.0015;PRIMARY CORTICAL NEURON#1.0011;NEURITE#1.0006;PROTEASOME#1.0003;BREAST CANCER#0.9998;CELL GROWTH#0.9992;DEPHOSPHORYLATION#0.9991;T CELL#0.9982;NEUROPROTECTION#0.9980;SIGNALING CASCADE#0.9980;UBIQUITIN#0.9976;GLUTAMATE RECEPTOR#0.9974;DOPAMINE#0.9965;GROWTH CONE COLLAPSE#0.9965;CELL DEATH#0.9964;PARKINSON'S DISEASE#0.9961;APOPTOSIS#0.9946;TRANSCRIPTION FACTOR#0.9942;PANCREATIC CANCER#0.9940;CELL MOTILITY#0.9936;S PHASE#0.9927;PROTEIN PHOSPHATASE 1#0.9926;NERVE TERMINAL#0.9926;STRIATUM#0.9926;CDK INHIBITOR#0.9921;TOXICITY#0.9915;SENSITIZATION#0.9914;CEREBRAL CORTEX#0.9914;SIGNALING PATHWAY#0.9911;APOPTOTIC#0.9907;ASTROCYTE#0.9901;MOLECULAR DYNAMICS SIMULATION#0.9900;DOPAMINERGIC NEURON#0.9894;AMYLOID PRECURSOR PROTEIN#0.9888;CELL CYCLE#0.9882;CYCLIC AMP#0.9879;PROTEIN PHOSPHORYLATION#0.9872;POSTSYNAPTIC DENSITY#0.9869;NEURODEGENERATIVE DISEASE#0.9868;STEM CELL#0.9867;FOREBRAIN#0.9863;NEUROBLASTOMA#0.9858;CELL DIVISION#0.9857;TUMOR SUPPRESSOR#0.9845;ASPARTATE#0.9843;GROWTH FACTOR#0.9830;CELL CYCLE ARREST#0.9829;TYPE 2 DIABETES#0.9824;RETINOIC ACID#0.9817;COMPLEX I#0.9816;MICROTUBULE#0.9814;GENE EXPRESSION#0.9807;CNS DEVELOPMENT#0.9806;ANGIOGENESIS#0.9805;SIGNAL TRANSDUCTION#0.9802;CELL PROLIFERATION#0.9791;NEUROFIBRILLARY TANGLE#0.9790;MICROTUBULE ASSOCIATED PROTEIN#0.9738;PROTEIN PROTEIN INTERACTION#0.9732;DENTATE GYRUS#0.9729;KINASE INHIBITOR#0.9723;MORRIS WATER MAZE#0.9722;LYMPH NODE#0.9709;TAUOPATHY#0.9703;MEMORY IMPAIRMENT#0.9698;ALZHEIMER'S DISEASE#0.9694;LONG TERM POTENTIATION#0.9687;REACTIVE OXYGEN SPECIES#0.9685;DYNEIN#0.9678;ENDOPLASMIC RETICULUM#0.9675;FOCAL ADHESION#0.9659;MITOCHONDRIA#0.9655;PEROXISOME#0.9653;DOPAMINE RECEPTOR#0.9648;NEUROMUSCULAR JUNCTION#0.9644;LITHIUM#0.9632;SPATIAL LEARNING#0.9617;DEMENTIA#0.9613;STRUCTURE ACTIVITY RELATIONSHIP#0.9595;EPITHELIAL MESENCHYMAL TRANSITION#0.9594;SYNAPSE DEVELOPMENT#0.9587;LYMPH NODE METASTASIS#0.9581;OPIOID RECEPTOR#0.9567;POLYMERASE CHAIN REACTION#0.9567;CASEIN KINASE 1#0.9557;SYNAPTOGENESIS#0.9555;SRC FAMILY KINASE#0.9549;DIABETES MELLITUS#0.9525;TUMOR CELLS#0.9518;REGENERATION#0.9508;MICROTUBULE BINDING#0.9492;NITRIC OXIDE SYNTHASE#0.9491;SIGNALLING PATHWAY#0.9488;GLUCOSE UPTAKE#0.9480;AMPA RECEPTOR#0.9473;DENDRITIC SPINE DENSITY#0.9461;CELL CYCLE REGULATOR#0.9445;HUNTINGTON'S DISEASE#0.9432;SENESCENCE#0.9420;SUBSTANTIA NIGRA#0.9409;STRESS FIBER#0.9396;DENDRITE DEVELOPMENT#0.9393;RETINOBLASTOMA#0.9388;HISTONE DEACETYLASE#0.9384;NEURAL CELL#0.9375;ALANINE#0.9363;CYCLIN DEPENDENT KINASE INHIBITOR#0.9350;PLASMA MEMBRANE#0.9319;INFLAMMATORY RESPONSE#0.9313;ACTIN BINDING#0.9309;ADIPOSE TISSUE#0.9308;COGNITION#0.9292;NERVE GROWTH FACTOR#0.9282;CALCIUM CHANNEL#0.9272;CEREBELLAR GRANULE NEURON#0.9248;SCIATIC NERVE#0.9231;ACTIN POLYMERIZATION#0.9212;SKELETAL MUSCLE#0.9208;CLEAVED CASPASE 3#0.9190;GANGLION CELLS#0.9187;CORNEAL EPITHELIAL CELL#0.9185;MIDDLE CEREBRAL ARTERY#0.9182;DNA BINDING#0.9182;CEREBRAL ARTERY#0.9179;MYOGENESIS#0.9174;TUMOR NECROSIS FACTOR#0.9159;POST-TRANSLATIONAL MODIFICATION#0.9142;EPILEPSY#0.9110;ADIPOCYTE#0.9110;GLUCOCORTICOID RECEPTOR#0.9108;INTERMEDIATE FILAMENT#0.9102;AXON GUIDANCE#0.9099;NEURITE GROWTH#0.9080;AMYGDALA#0.9063;GINSENOSIDE RB1#0.9061;AKT SIGNALING#0.9056;CATALYTIC ACTIVITY#0.9046;ACTIN FILAMENT#0.9038;ACETYLCHOLINE RECEPTOR#0.9023;GLIAL CELL#0.9004;TRANSIENT RECEPTOR POTENTIAL#0.8998;INTERNEURON#0.8957;CERVICAL CANCER#0.8949;RETINAL GANGLION CELL#0.8920;CELL BODY#0.8912;HEPATOCELLULAR CARCINOMA#0.8909;WOUND HEALING#0.8907;DORSAL ROOT GANGLION#0.8899;ACETYLCHOLINE#0.8896;GLUTATHIONE#0.8873;SIGNAL TRANSDUCER#0.8862;CELL CYCLE CONTROL#0.8813;FRONTAL#0.8793;ETHANOL#0.8790;TPK II#0.8767;RNA INTERFERENCE#0.8758;RELATED PROTEIN 1#0.8748;MEMBRANE FRACTION#0.8736;CEREBRAL ARTERY OCCLUSION#0.8723;ARTERY#0.8706;PHOSPHATASE ACTIVITY#0.8679;RECEPTOR TYROSINE KINASE#0.8664;EPHRIN#0.8662;NEURAL STEM CELL#0.8657;ACTIN BINDING PROTEIN#0.8656;FRONTOTEMPORAL DEMENTIA#0.8656;PHOSPHATASE INHIBITOR#0.8627;CAMP RESPONSE ELEMENT#0.8625;NERVOUS TISSUE#0.8614;PIOGLITAZONE#0.8605;PROGENITOR CELL#0.8590;TYPE 2 DIABETES MELLITUS#0.8582;2 DIABETES MELLITUS#0.8581;APOPTOTIC CELL DEATH#0.8576;DNA REPAIR#0.8571;MYOTUBE#0.8565;CAMP RESPONSE ELEMENT BINDING#0.8530;CYTOSKELETAL ELEMENT#0.8502;PRECURSOR CELL#0.8495;HYPOXIC#0.8480;MOTOR LEARNING#0.8472;BLOOD BRAIN BARRIER#0.8470;MITOSIS#0.8463;NEURON DEVELOPMENT#0.8461;MUTAGENESIS#0.8456;SYNAPTIC VESICLE ENDOCYTOSIS#0.8454;SPECTRIN#0.8449;ORGANELLE#0.8433;VESICLE ENDOCYTOSIS#0.8427;SPINAL DORSAL HORN#0.8417;ADENOCARCINOMA#0.8404;CYTOTOXICITY#0.8373;DNA DAMAGE RESPONSE#0.8345;TRANSFORMING GROWTH FACTOR#0.8330;SUPEROXIDE DISMUTASE#0.8329;G1 PHASE#0.8327;DNA METHYLATION#0.8317;EMBRYONIC BRAIN#0.8315;MICROTUBULE DYNAMICS#0.8312;FIBRIL#0.8307;ENDOPLASMIC RETICULUM STRESS#0.8285;PODOCYTE APOPTOSIS#0.8273;ION CHANNEL#0.8217;KINESIN#0.8210;AMYLOID PROTEIN#0.8193;SIGNALING MOLECULE#0.8184;AXON GROWTH#0.8178;MACROPHAGE#0.8164;NEURON APOPTOSIS#0.8139;M PHASE#0.8137;OOCYTE#0.8135;LISSENCEPHALY#0.8103;MOTOR NEURON DISEASE#0.8077;MYOBLAST#0.8077;CHANNEL ACTIVITY#0.8072;GAP ACTIVITY#0.8059;NEUROTOXIN#0.8050;PRO-INFLAMMATORY#0.8039;QUANTITATIVE REAL TIME#0.8022;PROTEIN PROCESSING#0.8018;PROTEASOME PATHWAY#0.8016;CONDITIONED PLACE PREFERENCE#0.7979;METABOTROPIC GLUTAMATE RECEPTORS#0.7963;DOMINANT NEGATIVE MUTANT#0.7952;CENTRAL NERVOUS SYSTEM DEVELOPMENT#0.7944;EXTRACELLULAR MATRIX#0.7934;HISTONE ACETYLATION#0.7929;MYELINATION#0.7928;PROTEIN KINASE B#0.7924;NEURON SURVIVAL#0.7919;RECEPTOR ANTAGONIST#0.7916;PROTEIN SYNTHESIS#0.7898;MELATONIN#0.7897;LYMPHATIC VESSEL#0.7895;PROGRAMMED CELL DEATH#0.7882;COLCHICINE#0.7878;ANDROGEN RECEPTOR#0.7864;PROTEIN KINASE INHIBITOR#0.7862;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7803;LIPID RAFT#0.7783;ACTION POTENTIAL#0.7782;LEYDIG CELL#0.7776;SERTOLI CELL#0.7768;MECHANISM OF ACTION#0.7768;HYPERACTIVE#0.7767;NUCLEAR EXPORT#0.7760;MOTOR NEURON DEGENERATION#0.7752;DNA REPLICATION#0.7737;ADENYLATE CYCLASE#0.7734;CERVICAL#0.7733;INNATE IMMUNITY#0.7726;STEERED MOLECULAR DYNAMICS#0.7719;ADENOSINE#0.7693;CALCINEURIN SIGNALING#0.7681;INSULIN-LIKE GROWTH FACTOR#0.7679;CELLULAR SENESCENCE#0.7675;OLIGODENDROCYTE LINEAGE CELLS#0.7658;NEURON DEATH#0.7656;SYNAPTOSOME#0.7648;NOCICEPTION#0.7638;DENDRITIC SPINE DEVELOPMENT#0.7633;SPERM TAIL#0.7632;TAXOL#0.7621;ENDOSOME#0.7599;GENOTOXIC#0.7573;EPIDERMAL GROWTH FACTOR#0.7553;POSTTRANSLATIONAL MODIFICATION#0.7543;NEURITE EXTENSION#0.7518;MUSCLE CELL#0.7513;HERPES SIMPLEX VIRUS#0.7494;HERPES SIMPLEX#0.7490;CENTROSOME#0.7476;DOPAMINE D1 RECEPTOR#0.7473;INDUCTION OF APOPTOSIS#0.7468;CORTICOGENESIS#0.7462;ENDOTHELIAL CELL MIGRATION#0.7437;LOCOMOTION#0.7385;HAIR CELL#0.7358;CELL MATURATION#0.7357;C TERMINAL DOMAIN#0.7357;MICROCEPHALY#0.7350;PITUITARY ADENOMA#0.7341;CASEIN KINASE 2#0.7317;ONCOGENIC#0.7317;ENZYME ACTIVITY#0.7309;STAUROSPORINE#0.7280;GUANINE#0.7252;REGULATION OF PHOSPHORYLATION#0.7243;NUCLEOTIDE EXCHANGE FACTOR#0.7231;HISTONE MODIFICATION#0.7225;DENDRITIC CELL#0.7217;MENTAL RETARDATION#0.7214;L-DOPA#0.7206;GABAERGIC NEURON#0.7199;NEURON MIGRATION#0.7196;DIABETIC NEPHROPATHY#0.7192;POLY ADP RIBOSE#0.7186;FOCAL ADHESION KINASE#0.7178;CELLULAR LOCALIZATION#0.7177;SEVOFLURANE#0.7161;REVERSE TRANSCRIPTION#0.7159;PHOSPHODIESTERASE#0.7123;IMMATURE NEURON#0.7116;AXONAL GROWTH CONE#0.7109;NEUROPATHY#0.7107;LYSINE#0.7106;CELL SURFACE#0.7077;MAP KINASE KINASE#0.7076;CISPLATIN#0.7076;MICROTUBULE ASSEMBLY#0.7069;PODOCYTE DIFFERENTIATION#0.7003;REGULATION OF CELL CYCLE#0.6996;RIBOSOMAL PROTEIN#0.6981;ATAXIA TELANGIECTASIA MUTATED#0.6959;ATAXIA TELANGIECTASIA#0.6937;DOUBLE TRANSGENIC MICE#0.6934;IN UTERO ELECTROPORATION#0.6894;CELL DIVISION CYCLE#0.6891;NEUROBLAST#0.6887;OLIGODENDROCYTE DEVELOPMENT#0.6872;SIGNALLING CASCADE#0.6867;PROTEIN KINASE ACTIVITY#0.6867;ENDOTHELIAL CELL PROLIFERATION#0.6859;LIGAND BINDING DOMAIN#0.6852;MAPK SIGNALING#0.6812;TRANSACTIVATION#0.6801;PROTEIN PHOSPHATASE INHIBITOR#0.6798;MEMORY LOSS#0.6792;OLIGODENDROCYTE PRECURSOR CELL#0.6792;MYOBLAST DIFFERENTIATION#0.6779;COGNITIVE DISORDER#0.6778;ACTIN BUNDLING#0.6760;LEWY BODY#0.6740;TAMOXIFEN#0.6724;PACLITAXEL#0.6723;CASPASE-3 ACTIVITY#0.6717;PERIPHERAL NERVE#0.6705;PROTEIN COMPLEX#0.6703;TARGET OF RAPAMYCIN#0.6690;ADENO ASSOCIATED VIRUS#0.6685;UBIQUITIN PROTEASOME PATHWAY#0.6675;CHROMAFFIN CELL#0.6658;ISCHEMIA REPERFUSION INJURY#0.6651;TPK I#0.6636;APOPTOSIS OF NEURONS#0.6612;SYNAPTIC SIGNALING#0.6593;SILDENAFIL#0.6571;CAMP SIGNALING#0.6543;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6541;MEDIUM SPINY NEURONS#0.6520;OPTIC NERVE#0.6491;GTPASE ACTIVITY#0.6487;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.6476;NUCLEAR IMPORT#0.6465;TUMOR TISSUES#0.6457;HUMAN EMBRYONIC KIDNEY#0.6448;EMBRYONIC KIDNEY#0.6444;PERIPHERAL NERVOUS SYSTEM#0.6430;FLAVOPIRIDOL#0.6428;ACTIVATION OF GSK#0.6418;DNA SYNTHESIS#0.6395;RAPAMYCIN#0.6364;ENDOTHELIUM#0.6346;METHAMPHETAMINE#0.6343;PRIMARY MICROCEPHALY#0.6326;NEURONAL CELL BODIES#0.6323;INCLUSION BODY#0.6291;VESICLE FUSION#0.6284;INHIBITION OF GSK#0.6271;ROSIGLITAZONE#0.6264;BASAL GANGLIA#0.6264;ASPARTIC ACID#0.6263;BRAIN DAMAGE#0.6253;OVARIAN#0.6246;ADENYLATE#0.6245;CDK ACTIVITY#0.6228;PUROMYCIN#0.6218;PROTEIN DEGRADATION#0.6216;CELL POLARITY#0.6210;SUNITINIB#0.6205;SUMOYLATION#0.6203;MULTIPLE MYELOMA#0.6195;NEUTROPHIL#0.6195;THYROID CANCER#0.6180;NOVEL OBJECT RECOGNITION#0.6176;COLORECTAL CANCER#0.6158;SQUAMOUS CELL CARCINOMA#0.6157;TEMPORAL LOBE#0.6154;OUTER DENSE FIBER#0.6152;TRAUMATIC BRAIN INJURY#0.6142;ANTEROGRADE AXONAL TRANSPORT#0.6131;LUNG ADENOCARCINOMA#0.6127;INCLUSION BODY MYOSITIS#0.6119;NEURONAL CELL APOPTOSIS#0.6116;LINES OF EVIDENCE#0.6108;HEAT SHOCK PROTEIN#0.6068;TOPOISOMERASE#0.6058;RIBOSE#0.6050;HYPERSENSITIVITY#0.6048;NEPHROPATHY#0.6040;MEDIAL PREFRONTAL CORTEX#0.6024;PHOSPHATASE 2B#0.6014
10210	UBIQUITIN#1.0543;TOPOISOMERASE#1.0373;TUMOR SUPPRESSOR#0.9979;RETINITIS PIGMENTOSA#0.9879;SUMOYLATION#0.9427;RETINITIS#0.8711;LIGASE ACTIVITY#0.7879;SUMO LIGASE#0.7397;GENE EXPRESSION#0.7328;P53 BINDING#0.7319;DNA TOPOISOMERASE#0.7152;BREAST CANCER#0.6549;SUMO LIGASE ACTIVITY#0.6418;CELL GROWTH#0.6326;PERICENTRIC HETEROCHROMATIN#0.6002
10211	MEMBRANE RAFT#1.0351;CELL PROLIFERATION#1.0304;MEMBRANE MICRODOMAIN#1.0295;LIPID RAFT#1.0287;EXOSOME#1.0252;ENDOCYTOSIS#1.0164;CAVEOLAE#1.0098;CANCER CELL#1.0074;GROWTH FACTOR#1.0047;SUCROSE#1.0004;T CELL#0.9954;DETERGENT RESISTANT MEMBRANE#0.9941;PLASMA MEMBRANE#0.9904;SIGNAL TRANSDUCTION#0.9791;BREAST CANCER#0.9787;SIGNALING PATHWAY#0.9607;EPITHELIAL CELL#0.9602;CELL MEMBRANE#0.9594;LYMPH NODE#0.9563;CELL ADHESION#0.9473;MACROPHAGE#0.9410;ENDOSOME#0.9398;PROTEIN KINASE#0.9351;ENDOPLASMIC RETICULUM#0.9252;UROPOD#0.9192;LYMPH NODE METASTASIS#0.9177;CELL GROWTH#0.9023;CELL SURFACE#0.9005;ALZHEIMER'S DISEASE#0.9004;GENE EXPRESSION#0.8976;BREAST CANCER CELL#0.8971;NEUTROPHIL#0.8876;LYSOSOME#0.8861;GROWTH FACTOR RECEPTOR#0.8857;SERTOLI CELL#0.8786;CELL MIGRATION#0.8650;ENDOTHELIAL CELL#0.8640;MEMBRANE FRACTION#0.8613;TRANSMISSION ELECTRON MICROSCOPY#0.8447;ACTIN CYTOSKELETON#0.8244;PERIPHERAL BLOOD#0.8137;LUNG CANCER#0.8118;APOPTOSIS#0.8024;RECEPTOR TYROSINE KINASE#0.7892;MITOGEN ACTIVATED PROTEIN#0.7862;CLATHRIN HEAVY CHAIN#0.7800;PHAGOSOME#0.7742;HOST CELL#0.7716;CELL CYCLE#0.7687;REGENERATION#0.7667;EXTRACELLULAR VESICLE#0.7589;MUSCLE CELL#0.7563;OVERALL SURVIVAL TIME#0.7552;PHAGOCYTOSIS#0.7548;ORGANELLE#0.7531;CLEAR CELL RENAL CELL CARCINOMA#0.7516;ASTROCYTE#0.7508;RENAL CELL CARCINOMA#0.7487;EPIDERMAL GROWTH FACTOR#0.7485;HEPATOCELLULAR CARCINOMA#0.7472;PROTEIN KINASE C#0.7276;TOTAL INTERNAL REFLECTION#0.7130;AKT SIGNALING#0.7115;SKELETAL MUSCLE#0.7067;LATE ENDOSOME#0.6871;INSULIN RECEPTOR#0.6716;POLYMERASE CHAIN REACTION#0.6702;ERYTHROCYTE#0.6668;ADIPOCYTE#0.6582;EPITHELIAL MESENCHYMAL TRANSITION#0.6516;RNA INTERFERENCE#0.6515;DOPAMINE#0.6505;PLASMA MEMBRANE RAFT#0.6444;HUMAN BREAST CANCER#0.6332;TRANSFERRIN RECEPTOR#0.6246;UROPOD FORMATION#0.6239;SEEDLING DEVELOPMENT#0.6212;CYTOPLASM#0.6207;CELL ACTIVATION#0.6202;AMYLOID PRECURSOR PROTEIN#0.6192
10212	RNA HELICASE#1.0998;NUCLEOCYTOPLASMIC SHUTTLING#0.8459;NUCLEAR EXPORT#0.8151;CANCER CELL#0.7831;RNA BINDING#0.7111;TREX COMPLEX#0.6817;DISEASE FREE SURVIVAL#0.6268;PROTEIN SYNTHESIS#0.6235
10213	DEUBIQUITINASE#1.0778;DEUBIQUITINATING ENZYME#1.0675;DEUBIQUITINATION#1.0469;PROTEASOME#1.0407;26S PROTEASOME#1.0371;UBIQUITIN#1.0051;CELL CYCLE#1.0036;GENE EXPRESSION#0.9311;COP9 SIGNALOSOME#0.9306;PROTEASOME ASSEMBLY#0.9094;20S PROTEASOME#0.9029;CANCER CELL#0.8902;SIGNALOSOME#0.8861;APOPTOSIS#0.8121;PROTEIN DEGRADATION#0.7967;TRANSCRIPTION FACTOR#0.7937;POLYUBIQUITIN#0.7885;CELL PROLIFERATION#0.7862;BREAST CANCER#0.7320;SIGNALING PATHWAY#0.7144;CELL GROWTH#0.6979;19S REGULATORY PARTICLE#0.6902;C TERMINAL DOMAIN#0.6900;ISOPEPTIDASE ACTIVITY#0.6684;DEUBIQUITINASE ACTIVITY#0.6507;SUPEROXIDE DISMUTASE#0.6334;MITOCHONDRIAL FISSION#0.6167;HEPATOCELLULAR CARCINOMA#0.6151;ESOPHAGEAL CANCER#0.6098
10214	SYNOVIAL SARCOMA#0.6777
102157401	CANCER CELL#1.0541;CELL MIGRATION#0.9014;CELL GROWTH#0.7837;CELL PROLIFERATION#0.7775;HEPATOCELLULAR CARCINOMA#0.6936;TONGUE SQUAMOUS CELL CARCINOMA#0.6892;PROSTATE CARCINOMA#0.6751;CERVICAL CANCER#0.6670;TUMOR TISSUES#0.6653;SQUAMOUS CELL CARCINOMA#0.6596;LUNG CANCER#0.6580
102157402	ADENYLATE KINASE#0.8973;ADENYLATE#0.7261;CDK INHIBITOR#0.7201;CYCLIN DEPENDENT KINASE#0.6576;ADRENAL GLAND#0.6354;TRANSCRIPTION FACTOR#0.6236
10215	TRANSCRIPTION FACTOR#1.0209;OLIGODENDROCYTE DEVELOPMENT#1.0168;OLIGODENDROCYTE DIFFERENTIATION#1.0153;TUMOR CELLS#1.0147;GROWTH FACTOR RECEPTOR#1.0147;OLIGODENDROGLIOMA#1.0143;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0106;OLIGODENDROCYTE#1.0090;ASTROCYTOMA#1.0089;PLATELET-DERIVED GROWTH FACTOR#1.0085;OLIGODENDROCYTE LINEAGE CELLS#1.0045;INTERNEURON#1.0043;NEURAL CELL#1.0025;OLIGODENDROCYTE PRECURSOR CELL#1.0012;CEREBRAL CORTEX#1.0003;NEURAL TUBE#0.9994;CELL CYCLE#0.9980;NEURAL PROGENITOR CELL#0.9978;OLIGODENDROCYTE PROGENITOR CELL#0.9940;FOREBRAIN#0.9929;NEUROFILAMENT#0.9927;PRECURSOR CELL#0.9906;ASTROCYTE#0.9901;EPIDERMAL GROWTH FACTOR#0.9887;MYELINATION#0.9878;EMBRYONIC STEM CELL#0.9871;NEUROEPITHELIAL CELL#0.9869;SPINAL CORD#0.9849;T CELL#0.9843;MALIGNANT GLIOMA#0.9833;PROGENITOR CELL#0.9833;CELL PROLIFERATION#0.9791;GENE EXPRESSION#0.9790;NEUROGENESIS#0.9789;GROWTH FACTOR#0.9780;NEURAL STEM CELL#0.9763;GLIAL CELL#0.9760;RETINOIC ACID#0.9743;HUMAN EMBRYONIC STEM#0.9677;CELL DEATH#0.9671;FIBROBLAST GROWTH FACTOR#0.9665;STEM CELL#0.9661;SPINAL CORD INJURY#0.9650;TELENCEPHALON#0.9643;APOPTOSIS#0.9632;PLURIPOTENT STEM CELL#0.9627;MULTIPLE SCLEROSIS#0.9619;GLIOGENESIS#0.9586;STEM CELL MARKER#0.9584;CENTRAL NERVOUS SYSTEM#0.9576;SIGNALING PATHWAY#0.9575;NERVOUS SYSTEM#0.9549;DEMYELINATING DISEASE#0.9537;PHOSPHODIESTERASE#0.9536;POLYMERASE CHAIN REACTION#0.9530;HINDBRAIN#0.9529;DOWN SYNDROME#0.9512;CELL DIFFERENTIATION#0.9479;PILOCYTIC ASTROCYTOMA#0.9471;NEURAL PRECURSOR CELL#0.9422;MYELIN SHEATH#0.9378;MOUSE EMBRYONIC STEM#0.9321;MICROTUBULE ASSOCIATED PROTEIN#0.9310;NEURAL STEM PROGENITOR#0.9264;REGENERATION#0.9257;BRAIN DEVELOPMENT#0.9247;ASTROCYTE DIFFERENTIATION#0.9239;MAGNETIC RESONANCE IMAGING#0.9213;GABAERGIC NEURON#0.9198;CELL ADHESION#0.9121;REVERSE TRANSCRIPTION#0.9105;DNA METHYLATION#0.9092;WHITE MATTER INJURY#0.9056;NEURODEGENERATIVE DISEASE#0.9029;OLIGODENDROGLIAL CELLS#0.8959;BONE MORPHOGENETIC PROTEIN#0.8907;LATERAL VENTRICLE#0.8902;INDUCED PLURIPOTENT STEM CELL#0.8874;TERMINAL DIFFERENTIATION#0.8860;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8860;CYTOPLASM#0.8847;ANAPLASTIC OLIGODENDROGLIOMA#0.8835;GLIOBLASTOMA MULTIFORME#0.8799;TEMPORAL LOBE#0.8769;PURKINJE CELL#0.8720;NEURON DIFFERENTIATION#0.8715;DNA BINDING#0.8701;OLFACTORY BULB#0.8695;MESENCHYMAL STEM CELL#0.8661;NEURONAL CELLS#0.8605;MICROTUBULE#0.8390;FRONTAL#0.8338;CANCER STEM CELL#0.8322;ASTROCYTE DEVELOPMENT#0.8322;CELL ADHESION MOLECULE#0.8242;PROTEOGLYCAN#0.8207;PARENCHYMA#0.8153;APOPTOTIC#0.8146;STROMAL CELL#0.8144;CNS DEVELOPMENT#0.8144;ENCEPHALOMYELITIS#0.8121;BONE MARROW#0.8114;NEUROBLAST#0.8093;FETAL BRAIN#0.8082;ONCOGENIC#0.8040;RETINAL PROGENITOR CELL#0.8037;MICROGLIAL CELL#0.8003;ISCHEMIA#0.7994;OBSESSIVE COMPULSIVE DISORDER#0.7959;TAMOXIFEN#0.7943;EPILEPSY#0.7941;PROTEIN KINASE#0.7896;DIFFUSE ASTROCYTOMA#0.7890;CELL FATE DETERMINATION#0.7864;2'-DEOXYURIDINE#0.7836;MACROPHAGE#0.7788;PROGESTERONE#0.7749;TUMOR SUPPRESSOR#0.7718;IMMATURE NEURON#0.7714;TUMOR INITIATING CELL#0.7710;HYPOXIA#0.7625;LOW GRADE GLIOMAS#0.7475;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.7468;DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR#0.7387;STRIATUM#0.7370;CENTRAL NEUROCYTOMA#0.7368;NEURON DEVELOPMENT#0.7357;GESTATION#0.7276;OPTIC NERVE#0.7269;MEDULLOBLASTOMA#0.7204;OLIGODENDROGLIAL PROGENITOR CELLS#0.7174;CELL GROWTH#0.7126;ARTERY#0.7033;TEMOZOLOMIDE#0.7022;MYELIN FORMATION#0.7008;EXTRACELLULAR MATRIX#0.6966;FACTOR I#0.6919;HYPOXIC#0.6911;POST-TRANSLATIONAL MODIFICATION#0.6853;STEM CELL DIFFERENTIATION#0.6809;GENE REGULATORY NETWORK#0.6793;TOXICITY#0.6767;DENTATE GYRUS#0.6747;CELL DIVISION#0.6735;MEDIAL GANGLIONIC EMINENCE#0.6678;WORLD HEALTH ORGANIZATION#0.6662;SYSTEM DEVELOPMENT#0.6641;PERIPHERAL NERVOUS SYSTEM#0.6590;ADENOMATOUS POLYPOSIS COLI#0.6530;ANGIOGENESIS#0.6523;TRANSIT AMPLIFYING CELL#0.6477;EMBRYONIC BRAIN#0.6380;NERVOUS SYSTEM DEVELOPMENT#0.6354;THALAMUS#0.6346;MIDBRAIN#0.6344;ACTION POTENTIAL#0.6340;NEURITE#0.6325;DAYS POST INJURY#0.6300;SCHWANN CELL#0.6297;DOPAMINERGIC NEURON#0.6290;INTERMEDIATE FILAMENT#0.6285;ENDOTHELIAL GROWTH FACTOR#0.6238;MORRIS WATER MAZE#0.6154;QUANTITATIVE REAL TIME#0.6141;CELL MIGRATION#0.6100;CHOLINERGIC NEURON#0.6047;MIDLINE#0.6039;NEUROECTODERMAL TUMOR#0.6035;TRAUMATIC BRAIN INJURY#0.6026
10216	SUPERFICIAL ZONE PROTEIN#1.0928;COEFFICIENT OF FRICTION#1.0509;HYALURONAN#1.0466;PROTEOGLYCAN#1.0443;HYALURONIC ACID#1.0436;COLLAGEN TYPE I#1.0375;ANTERIOR CRUCIATE LIGAMENT#1.0356;SYNOVIAL FLUID#1.0298;CRUCIATE LIGAMENT#1.0274;COLLAGEN TYPE II#1.0234;TRANSFORMING GROWTH FACTOR#1.0160;CHONDROCYTE#1.0150;POLYMERASE CHAIN REACTION#1.0146;GENE EXPRESSION#1.0123;KNEE JOINT#1.0079;GROWTH FACTOR#1.0075;PROGENITOR CELL#1.0074;EXTRACELLULAR MATRIX#1.0035;ARTHROPATHY#0.9993;TRANSFORMING GROWTH FACTOR BETA#0.9957;BONE MORPHOGENETIC PROTEIN#0.9952;PERICARDITIS#0.9938;OSTEOARTHRITIS#0.9898;STEM CELL#0.9889;MESENCHYMAL STEM CELL#0.9833;MENISCUS#0.9817;RHEUMATOID ARTHRITIS#0.9761;MEGAKARYOCYTE#0.9715;SYNOVIUM#0.9658;PARATHYROID HORMONE#0.9343;BONE MARROW#0.9338;PHOSPHATE BUFFERED SALINE#0.9268;GLYCOSYLATION#0.9242;TUMOR NECROSIS FACTOR#0.9205;APOPTOSIS#0.9140;INTERVERTEBRAL DISC#0.9131;STROMAL CELL#0.9069;TRANSCRIPTION FACTOR#0.8886;ENDOTHELIAL CELL#0.8859;SMOOTH MUSCLE#0.8812;CHONDROGENESIS#0.8756;REGENERATION#0.8749;SIGNALING PATHWAY#0.8747;REVERSE TRANSCRIPTION#0.8650;DIGESTION#0.8600;NUCLEUS PULPOSUS#0.8499;CARTILAGE HOMEOSTASIS#0.8496;SMOOTH MUSCLE ACTIN#0.8475;CARTILAGE FORMATION#0.8462;SYNOVIOCYTE PROLIFERATION#0.8436;CELL ADHESION#0.8325;CELL PROLIFERATION#0.8251;MACROPHAGE#0.8160;FIBROBLAST GROWTH FACTOR#0.8125;PARATHYROID#0.7913;TOLL LIKE RECEPTOR#0.7907;FLEXOR DIGITORUM PROFUNDUS#0.7872;BREAST CANCER#0.7855;MATRIX METALLOPROTEINASE 13#0.7723;INFLAMMATORY RESPONSE#0.7677;EYELID#0.7673;NADPH OXIDASE#0.7594;QUANTITATIVE REAL TIME#0.7416;HYALURONAN SYNTHASE#0.7219;CONNECTIVE TISSUE#0.7211;CARTILAGE DEVELOPMENT#0.7198;OSTEOARTHRITIC CARTILAGE#0.7086;ADIPOSE TISSUE#0.7051;BONE FORMATION#0.7051;HYPOXIA#0.6879;AUTOLOGOUS CHONDROCYTE IMPLANTATION#0.6878;INSULIN-LIKE GROWTH FACTOR#0.6712;HYALURONATE#0.6708;TISSUE HOMEOSTASIS#0.6353;CHONDROITIN SULPHATE PROTEOGLYCAN#0.6296;SODIUM HYALURONATE#0.6230;MEDIAL COLLATERAL LIGAMENT#0.6187;O GLYCAN#0.6168;TISSUE CULTURE POLYSTYRENE#0.6164;DRY EYE DISEASE#0.6089
10217	TUMOR SUPPRESSOR#1.0613;CELL CYCLE#0.9952;CELL GROWTH#0.8790;LUNG CANCER#0.8571;CERVICAL#0.8088;DEPHOSPHORYLATION#0.7829;C TERMINAL DOMAIN#0.7757;TRANSCRIPTION FACTOR#0.7701;GENE EXPRESSION#0.7552;PHOSPHATIDYLSERINE#0.7090;CANCER CELL#0.6955;SQUAMOUS CELL CARCINOMA#0.6884;SIGNALING PATHWAY#0.6816;APOPTOSIS#0.6509;CERVICAL CANCER#0.6457;PLASMA MEMBRANE#0.6297
10218	EXTRACELLULAR MATRIX#0.9124;GENE EXPRESSION#0.8029;HUMAN TRABECULAR MESHWORK#0.7969;GROWTH FACTOR#0.7642;PROGENITOR CELL#0.7597;ANGIOGENESIS#0.7438;CELL PROLIFERATION#0.7143;STEM CELL#0.7098;DEXAMETHASONE#0.6577;SIGNALING PATHWAY#0.6119
102191832	ANGIOGENESIS#0.7469;NEURAL TUBE#0.6805;CAROTID ARTERY DISEASE#0.6574;AUTOPHAGY#0.6491;CAROTID ARTERY#0.6171;ARTERY DISEASE#0.6129;ENDOTHELIAL CELL#0.6054
10219	MAST CELL#1.0772;LECTIN#1.0512;CELL SURFACE#1.0368;EFFECTOR T CELL#1.0226;SENESCENCE#1.0197;T CELL#1.0192;CD8+ T CELL#1.0181;CD4+ T CELL#1.0086;MEMORY T CELL#1.0062;VIRAL INFECTION#1.0042;PERIPHERAL BLOOD#1.0027;T LYMPHOCYTE#0.9989;NATURAL KILLER CELL#0.9982;T CELL DIFFERENTIATION#0.9973;TRANSCRIPTION FACTOR#0.9951;CELL DIFFERENTIATION#0.9910;IMMUNE RESPONSE#0.9838;EFFECTOR MEMORY T CELL#0.9814;CYTOKINE PRODUCTION#0.9773;GENE EXPRESSION#0.9769;CYTOTOXICITY#0.9637;TERMINAL DIFFERENTIATION#0.9550;TREG CELL#0.9434;IMMUNE SYSTEM#0.9273;BONE MARROW#0.9245;CELL ACTIVATION#0.9105;TUBERCULOSIS#0.9084;REGULATORY T CELL#0.8912;IFN-GAMMA#0.8874;CELL PROLIFERATION#0.8847;DENDRITIC CELL#0.8671;CELL MATURATION#0.8501;IMMUNE CELL#0.8451;LYMPH NODE#0.8407;APOPTOSIS#0.8397;CELL DEATH#0.8321;CYTOKINE SECRETION#0.8234;LYMPHOCYTIC CHORIOMENINGITIS#0.8141;HEPATITIS B#0.8136;TELOMERE#0.8079;CHEMOKINE RECEPTOR#0.8008;CELL EXPANSION#0.7514;CHRONIC HEPATITIS B#0.7479;CELL CYCLE#0.7433;CADHERIN BINDING#0.7243;REPLICATIVE SENESCENCE#0.7208;SIGNALING PATHWAY#0.7188;TNF PRODUCTION#0.7001;PRECURSOR CELL#0.6942;T CELL ACTIVATION#0.6924;PROGRAMMED CELL DEATH#0.6848;CELL ADHESION#0.6781;HEPATITIS C VIRUS#0.6776;HEPATITIS C#0.6765;PRO-INFLAMMATORY#0.6619;LYMPHOID CELL#0.6527;CYTOTOXIC T-LYMPHOCYTE#0.6516;CELL DEVELOPMENT#0.6350;CELL DIVISION#0.6327;MONONUCLEAR CELLS#0.6314;B CELL#0.6300;STEM CELL#0.6144;TH1 CELL#0.6125;ACTIVATED CD8+ T CELL#0.6057;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.6045;T CELL PROLIFERATION#0.6024;EPSTEIN BARR VIRUS#0.6022;TRANSMEMBRANE RECEPTOR#0.6003
1021	ANTI HER2#1.0286;MEDULLOBLASTOMA#1.0082;FULVESTRANT#1.0061;CELL CYCLE TRANSITION#1.0049;LETROZOLE#1.0038;CELL CYCLE PATHWAY#1.0026;TARGET OF RAPAMYCIN#1.0025;ADVANCED BREAST CANCER#1.0015;LUMINAL#1.0014;CYCLIN DEPENDENT KINASE#0.9995;KINASE ACTIVITY#0.9986;RAPAMYCIN#0.9978;SENESCENCE#0.9948;METASTATIC BREAST CANCER#0.9947;OVARIAN CANCER#0.9946;CLEAVED CASPASE 3#0.9942;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.9942;CELL CYCLE REGULATOR#0.9932;KAPOSI'S SARCOMA#0.9928;CELLULAR SENESCENCE#0.9913;PANCREATIC CANCER#0.9890;COLON CANCER#0.9890;RETINOBLASTOMA#0.9879;CELL CYCLE CONTROL#0.9867;T CELL#0.9862;CDK INHIBITOR#0.9859;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9850;CELL DIVISION#0.9846;T LYMPHOCYTE#0.9843;PROTEIN PHOSPHORYLATION#0.9843;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9835;NEUROBLASTOMA#0.9833;OVARIAN#0.9828;B CELL LYMPHOMA#0.9827;DRUG RESISTANCE#0.9825;BREAST CANCER#0.9818;GROWTH FACTOR RECEPTOR#0.9813;SQUAMOUS CELL CARCINOMA#0.9803;TRANSFORMING GROWTH FACTOR#0.9802;BREAST CANCER PATIENTS#0.9801;MAPK SIGNALING#0.9799;G1 PHASE#0.9795;CHONDROCYTE#0.9790;CYCLIN DEPENDENT KINASE INHIBITOR#0.9790;CELL CYCLE#0.9785;S PHASE#0.9784;B CELL#0.9783;PROGENITOR CELL#0.9780;ONCOGENIC#0.9778;QUANTITATIVE REAL TIME#0.9778;ESTROGEN RECEPTOR#0.9775;REVERSE TRANSCRIPTION#0.9768;EPIDERMAL GROWTH FACTOR#0.9768;TUMOR TISSUES#0.9754;CELL CYCLE ARREST#0.9741;MECHANISM OF ACTION#0.9740;MYELOID LEUKEMIA#0.9738;BONE MARROW#0.9726;STEM CELL#0.9725;PROTEIN KINASE#0.9725;COLORECTAL#0.9724;COLORECTAL CANCER#0.9720;POLYMERASE CHAIN REACTION#0.9716;DNA SYNTHESIS#0.9713;CELL CYCLE REGULATION#0.9711;CISPLATIN#0.9705;KINASE INHIBITOR#0.9705;TUMOR CELLS#0.9698;BREAST CANCER CELL#0.9696;ACUTE MYELOID LEUKEMIA#0.9696;HEPATOCELLULAR CARCINOMA#0.9685;CERVICAL#0.9682;G2 PHASE#0.9673;GROWTH FACTOR#0.9673;TOXICITY#0.9670;REGULATION OF CELL CYCLE#0.9664;CELL DIFFERENTIATION#0.9658;TYROSINE KINASE INHIBITOR#0.9653;PROSTATE CANCER#0.9650;TUMOR SUPPRESSOR#0.9647;POLY ADP RIBOSE#0.9645;HUMAN BREAST CANCER#0.9644;LUNG CANCER#0.9641;CELL GROWTH#0.9636;INDUCTION OF APOPTOSIS#0.9635;EVEROLIMUS#0.9632;M PHASE#0.9631;SIGNAL TRANSDUCTION#0.9622;CYTOTOXICITY#0.9621;MULTIPLE MYELOMA#0.9615;FLOW CYTOMETRY ANALYSIS#0.9612;CDK ACTIVITY#0.9610;TRANSCRIPTION FACTOR#0.9608;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9605;CYTOPLASM#0.9605;CELL MIGRATION#0.9603;SIGNALING PATHWAY#0.9602;CELL ACTIVATION#0.9601;MITOSIS#0.9599;RIBOSE#0.9599;HISTONE DEACETYLASE#0.9597;EPITHELIAL CELL#0.9596;RNA INTERFERENCE#0.9590;GENE EXPRESSION#0.9572;MITOGEN ACTIVATED PROTEIN#0.9569;ADENOCARCINOMA#0.9568;CELL PROLIFERATION#0.9566;DNA REPAIR#0.9562;CELL DEATH#0.9545;ANGIOGENESIS#0.9544;APOPTOTIC#0.9541;CANCER CELL#0.9540;KERATINOCYTE#0.9538;EPITHELIAL MESENCHYMAL TRANSITION#0.9533;APOPTOSIS#0.9532;REACTIVE OXYGEN SPECIES#0.9532;NEUTROPENIA#0.9526;CELL DIVISION CYCLE#0.9508;STANDARD OF CARE#0.9494;ORAL SQUAMOUS CELL CARCINOMA#0.9481;SMOOTH MUSCLE#0.9480;CERVICAL CANCER#0.9479;MUSCLE CELL#0.9467;COLONY FORMATION ASSAY#0.9461;DNA METHYLATION#0.9419;CYTOCHROME C#0.9412;AKT SIGNALING#0.9403;NERVOUS SYSTEM#0.9402;WOUND HEALING#0.9389;LYMPH NODE#0.9386;SMOOTH MUSCLE CELL#0.9381;COMPLEX I#0.9375;PACLITAXEL#0.9350;UBIQUITIN#0.9350;APOPTOTIC CELL DEATH#0.9332;DEPHOSPHORYLATION#0.9299;TRANSFORMING GROWTH FACTOR BETA#0.9293;DNA BINDING#0.9249;ANDROGEN RECEPTOR#0.9244;DUAL LUCIFERASE REPORTER#0.9232;CENTRAL NERVOUS SYSTEM#0.9225;GLIOBLASTOMA MULTIFORME#0.9218;DNA REPLICATION#0.9182;ESOPHAGEAL CANCER#0.9173;HYPOXIA#0.9154;ENDOTHELIAL GROWTH FACTOR#0.9150;AUTOPHAGY#0.9145;MITOCHONDRIAL MEMBRANE#0.9134;PROTEASOME#0.9123;MECHANISMS OF ACTION#0.9113;PROTEIN KINASE C#0.9106;HEMATOPOIETIC CELL#0.9094;QUIESCENCE#0.9074;COMPARATIVE GENOMIC HYBRIDIZATION#0.9071;TUMOR NECROSIS FACTOR#0.9016;MACROPHAGE#0.9009;CELL CYCLE CHECKPOINT#0.8996;CATALYTIC ACTIVITY#0.8989;PERIPHERAL BLOOD#0.8976;TAMOXIFEN#0.8953;LUNG CARCINOMA#0.8950;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8942;INHIBITION OF CELL PROLIFERATION#0.8912;DOXORUBICIN#0.8906;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8893;OSTEOBLAST#0.8888;DNA FRAGMENTATION#0.8876;INDOLE#0.8861;ENDOTHELIAL CELL#0.8771;EXTRACELLULAR MATRIX#0.8761;STROMAL CELL#0.8647;VASCULAR SMOOTH MUSCLE CELL#0.8644;MANTLE CELL LYMPHOMA#0.8632;CELL COUNTING KIT#0.8630;CELLULAR GROWTH#0.8612;MAMMARY EPITHELIAL CELL#0.8607;SIGNALLING PATHWAY#0.8582;MITOCHONDRIA#0.8569;HEMATOPOIETIC STEM CELL#0.8557;BETA CELL#0.8521;ANCHORAGE INDEPENDENT GROWTH#0.8512;DNA DAMAGE RESPONSE#0.8489;RENAL CELL CARCINOMA#0.8463;REPLICATIVE SENESCENCE#0.8448;FLAVOPIRIDOL#0.8418;MELANOMA CELL LINES#0.8390;THYMIDINE#0.8379;TERMINAL DIFFERENTIATION#0.8374;RHEUMATOID ARTHRITIS#0.8366;CANCER RELATED DEATH#0.8365;CELL CYCLE PHASE#0.8348;IMMUNE RESPONSE#0.8292;MYELOID CELL#0.8267;EARLY BREAST CANCER#0.8254;QUANTITATIVE REVERSE TRANSCRIPTION#0.8233;CELL DEVELOPMENT#0.8188;SIGNALING CASCADE#0.8181;CELL ADHESION#0.8180;RECEPTOR TYROSINE KINASE#0.8175;HEPATOCELLULAR CARCINOMA CELL#0.8160;INSULIN-LIKE GROWTH FACTOR#0.8153;HYPERPHOSPHORYLATION#0.8138;CANCER STEM CELL#0.8133;RETINOIC ACID#0.8102;LYMPHOBLAST#0.8083;COPY NUMBER ALTERATION#0.8048;ACTIVATED T-CELLS#0.8047;ACTIVATED T CELL#0.8044;PLATELET-DERIVED GROWTH FACTOR#0.8036;SIGNAL TRANSDUCER#0.8034;FIBROBLAST GROWTH FACTOR#0.8011;T-CELL LEUKEMIA#0.8005;LYMPHOID CELL#0.7979;PROTEIN PROTEIN INTERACTION#0.7962;LUNG ADENOCARCINOMA#0.7962;METASTATIC MELANOMA#0.7947;5-AZA-2'-DEOXYCYTIDINE#0.7936;2'-DEOXYCYTIDINE#0.7932;THYROID CANCER#0.7926;TRASTUZUMAB#0.7921;BLOOD BRAIN BARRIER#0.7912;LYMPHOID LEUKEMIA#0.7905;ENDOPLASMIC RETICULUM#0.7876;REGENERATION#0.7859;THYMOCYTE#0.7830;B LYMPHOCYTE#0.7794;PANCREATIC DUCTAL ADENOCARCINOMA#0.7742;NEUROGENESIS#0.7736;GLYCOGEN SYNTHASE KINASE#0.7721;IMMUNE SYSTEM#0.7698;KINASE INHIBITOR P27#0.7684;HISTONE DEACETYLASE INHIBITOR#0.7652;BREAST CANCER MODEL#0.7638;DIARRHEA#0.7614;MAP KINASE#0.7608;SIGNALING MOLECULE#0.7607;HEAT SHOCK PROTEIN#0.7598;ANEMIA#0.7564;ATP BINDING#0.7543;LIVER CANCER#0.7527;TOPOISOMERASE II#0.7518;INHIBITION OF CELL GROWTH#0.7497;REGULATION OF CELL PROLIFERATION#0.7494;HEPATOCYTE GROWTH FACTOR#0.7480;MOLECULAR DYNAMICS SIMULATION#0.7452;TOPOISOMERASE#0.7443;DISEASE FREE SURVIVAL#0.7415;CELLULAR METABOLISM#0.7392;LUCIFERASE ACTIVITY#0.7374;CASPASE INHIBITOR#0.7371;ASTROCYTE#0.7361;EPSTEIN BARR VIRUS#0.7343;MALIGNANT GLIOMA#0.7342;PROTEIN KINASE B#0.7310;FOCAL ADHESION#0.7301;GERM CELL#0.7295;HUMAN MAMMARY EPITHELIAL#0.7292;APOPTOTIC PROCESS#0.7265;CHONDROCYTE DIFFERENTIATION#0.7258;B CELL PROLIFERATION#0.7226;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7222;EPITHELIAL TO MESENCHYMAL#0.7220;NEURAL STEM CELL#0.7207;CELL CYCLE DYSREGULATION#0.7200;MODE OF ACTION#0.7191;DEXAMETHASONE#0.7163;NEUTROPHIL#0.7033;MONONUCLEAR CELLS#0.7030;PROPIDIUM#0.7019;PRIMARY BREAST CANCER#0.6998;RESVERATROL#0.6983;TRANSCRIPTASE#0.6976;ONCOGENESIS#0.6953;FACTOR I#0.6937;GEMCITABINE#0.6935;HUMAN PANCREATIC CANCER#0.6920;SEQUESTERING#0.6882;CENTROSOME#0.6859;OSTEOCLAST DIFFERENTIATION#0.6844;ERYTHROID CELL#0.6841;ENDOMETRIAL CANCER#0.6840;PLASMA CELL#0.6817;COLORECTAL CARCINOMA#0.6808;MESENCHYMAL STEM CELL#0.6795;CYCLIN BINDING#0.6794;MONOCYTE#0.6788;LYMPHOMA CELL LINES#0.6776;P53 SIGNALING PATHWAY#0.6771;CELL EXPANSION#0.6730;CHOLANGIOCARCINOMA#0.6716;ANASTROZOLE#0.6714;ROS GENERATION#0.6708;ESTRADIOL#0.6706;PROTEIN KINASE ACTIVITY#0.6703;BREAST CARCINOMA#0.6691;HOST CELL#0.6684;LIPOSARCOMA#0.6674;SORAFENIB#0.6672;TRANSACTIVATION#0.6671;INTERPHASE#0.6659;ADULT T-CELL LEUKEMIA#0.6659;T CELL ACTIVATION#0.6637;SKIN CANCER#0.6626;ADENOSINE#0.6565;CELL SURFACE#0.6548;LYMPHOCYTIC LEUKEMIA#0.6543;GENE SILENCING#0.6542;IMMUNE CELL#0.6508;OSTEOBLAST DIFFERENTIATION#0.6495;OOCYTE#0.6482;PROSTATE SPECIFIC ANTIGEN#0.6480;MAXIMUM TOLERATED DOSE#0.6465;COPY NUMBER VARIATION#0.6452;MOUSE EMBRYONIC FIBROBLAST#0.6450;ADIPOCYTE#0.6408;EMBRYONIC STEM CELL#0.6399;EXEMESTANE#0.6383;PRIMARY EFFUSION LYMPHOMA#0.6359;PROGESTERONE#0.6343;VSMC PROLIFERATION#0.6315;MYOBLAST#0.6294;EWING SARCOMA#0.6292;PROGRAMMED CELL DEATH#0.6291;NON-SMALL CELL LUNG CARCINOMA#0.6286;OBJECTIVE RESPONSE RATE#0.6283;CHROMOSOMAL REGION#0.6269;GRANULOCYTE#0.6259;RANDOMIZED CLINICAL TRIAL#0.6258;1α,25-DIHYDROXYVITAMIN D3#0.6245;5 FLUOROURACIL#0.6240;T CELL PROLIFERATION#0.6235;MAMMARY GLAND#0.6222;CLINICAL BENEFIT RATE#0.6220;PROTEIN DEGRADATION#0.6210;INFLAMMATORY RESPONSE#0.6188;TUMOR GROWTH INHIBITION#0.6152;EPITHELIAL OVARIAN CANCER#0.6152;CHRONIC MYELOID LEUKEMIA#0.6111;CASPASE ACTIVATION#0.6110;OLOMOUCINE#0.6097;TEMOZOLOMIDE#0.6084;CETUXIMAB#0.6083;LYMPH NODE METASTASIS#0.6077;IMATINIB#0.6072;METFORMIN#0.6064;MALIGNANT BRAIN TUMOR#0.6044;OSTEOCLAST#0.6044;FAMILIAL MELANOMA#0.6017;TRAMETINIB#0.6009;PROSTATE CARCINOMA#0.6009;HYPERTENSION#0.6004
10220	GROWTH DIFFERENTIATION FACTOR#1.0561;TRANSFORMING GROWTH FACTOR BETA#1.0537;NEUROGENESIS#1.0523;TRANSFORMING GROWTH FACTOR#1.0405;PROGENITOR CELL#1.0393;BONE MORPHOGENETIC PROTEIN#1.0282;GROWTH FACTOR#1.0278;SIGNALING PATHWAY#1.0276;SKELETAL MUSCLE#1.0231;STEM CELL#1.0224;REGENERATION#1.0220;TAIL BUD#1.0077;CARDIOMYOCYTE#0.9860;GENE EXPRESSION#0.9852;ENDOTHELIAL CELL#0.9847;CELL PROLIFERATION#0.9828;BONE FORMATION#0.9750;SKELETON#0.9712;AXIAL SKELETON#0.9697;APOPTOSIS#0.9683;ISCHEMIA#0.9620;ACTIVIN RECEPTOR#0.9497;SKELETAL MUSCLE MASS#0.9339;VERTEBRAE#0.9145;NERVOUS SYSTEM#0.9140;AGEING#0.9075;SPINAL CORD#0.8940;BONE MARROW#0.8856;ANGIOGENESIS#0.8851;CANCER CELL#0.8772;NEURAL STEM CELL#0.8562;POLYMERASE CHAIN REACTION#0.8525;CELL CYCLE#0.8517;HYPOXIA#0.8285;ERYTHROPOIESIS#0.8199;RETINOIC ACID#0.8083;ANEMIA#0.8053;CACHEXIA#0.8035;REACTIVE OXYGEN SPECIES#0.8026;MUSCLE WASTING#0.7814;MYELODYSPLASTIC SYNDROME#0.7807;MYOCARDIAL INFARCTION#0.7743;MUSCLE ATROPHY#0.7739;CENTRAL NERVOUS SYSTEM#0.7727;HINDLIMB#0.7670;LIVER REGENERATION#0.7608;CEREBRAL ISCHEMIA#0.7538;DENTAL PULP#0.7537;ISCHEMIA REPERFUSION INJURY#0.7516;ENDOTHELIAL PROGENITOR CELL#0.7510;CELL DIFFERENTIATION#0.7498;TRANSCRIPTION FACTOR#0.7483;INSULIN-LIKE GROWTH FACTOR#0.7448;REVERSE TRANSCRIPTION#0.7441;ADIPOCYTE#0.7433;MYOTUBE#0.7407;TUMOR SUPPRESSOR#0.7405;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7335;EPITHELIAL TO MESENCHYMAL#0.7332;EMBRYONIC STEM CELL#0.7325;MUSCLE CELL#0.7290;MESENCHYME#0.7193;MYOBLAST#0.7137;SKELETAL MUSCLE REGENERATION#0.7109;URETERIC BUD#0.6973;PRO-INFLAMMATORY#0.6904;CARDIAC MUSCLE#0.6798;HEART DISEASE#0.6766;CELL MIGRATION#0.6758;COLORECTAL CANCER#0.6707;AUTOPHAGY#0.6691;DIABETES MELLITUS#0.6559;MESENCHYMAL STEM CELL#0.6529;URETERIC BUD FORMATION#0.6380;SMOOTH MUSCLE#0.6289;PERIPHERAL BLOOD#0.6280;PRIMITIVE STREAK#0.6260;CELL GROWTH#0.6254;PANCREAS DEVELOPMENT#0.6178;ADENO ASSOCIATED VIRUS#0.6143;ARTERY#0.6124;SMOOTH MUSCLE CELL#0.6060;ADIPOSE TISSUE#0.6060;TYPE 2 DIABETES#0.6052;HYPERTROPHIC CARDIOMYOPATHY#0.6036;ZINC FINGER PROTEIN#0.6002;OSTEOPOROSIS#0.6001
10221	LIPID METABOLISM#1.0519;MACROPHAGE#1.0349;ACUTE MYELOID LEUKEMIA#1.0115;MYELOID LEUKEMIA#1.0088;TRANSCRIPTION FACTOR#1.0020;GENE EXPRESSION#0.9944;CORONARY ARTERY DISEASE#0.9904;ARTERY DISEASE#0.9903;CORONARY ARTERY#0.9895;LOW DENSITY LIPOPROTEIN#0.9802;HEART DISEASE#0.9378;SIGNALING PATHWAY#0.9327;BONE MARROW#0.9321;ARTERY#0.9191;POLYMERASE CHAIN REACTION#0.9115;ENHANCER BINDING PROTEIN#0.8910;ENHANCER BINDING#0.8905;CELL PROLIFERATION#0.8880;APOPTOSIS#0.8778;LIVER DISEASE#0.8752;FATTY LIVER DISEASE#0.8585;FATTY LIVER#0.8573;CORONARY HEART DISEASE#0.8455;CELL CYCLE#0.8339;LIPOGENESIS#0.8082;ADIPOSE TISSUE#0.8060;HIGH DENSITY LIPOPROTEIN#0.8011;PROSTATE CANCER#0.7965;T CELL#0.7871;CANCER CELL#0.7866;LIPOPROTEIN METABOLISM#0.7699;ANTIBODY MEDIATED REJECTION#0.7695;PROTEIN KINASE#0.7645;MYOCARDIAL INFARCTION#0.7492;UBIQUITIN#0.7473;MYELOID CELL#0.7182;MITOGEN ACTIVATED PROTEIN#0.7032;ALCOHOLIC FATTY LIVER#0.6868;RETINOIC ACID#0.6781;STEM CELL#0.6641;M2 MACROPHAGE#0.6406;BONE MARROW CELLS#0.6352;MAP KINASE#0.6135;FOAM CELL FORMATION#0.6114;LIGASE ACTIVITY#0.6107;TUMOR SUPPRESSOR#0.6096;DOWN SYNDROME#0.6073
10223	COLORECTAL CANCER#1.0750;COLORECTAL#1.0497;COLON CANCER#1.0423;VACCINIA#1.0017;EPITHELIAL CELL#0.9666;VIRION#0.9606;CANCER CELL#0.9318;CELL SURFACE#0.9126;INTESTINAL EPITHELIAL CELL#0.8425;EXOSOME#0.7370;COLORECTAL CARCINOMA#0.7175;TUMOR CELLS#0.6478;T CELL#0.6453;TRANSCRIPTION FACTOR#0.6414;VIRION MEMBRANE#0.6338
10224	ZINC FINGER PROTEIN#0.9219
10225	T CELL#1.0584;STEM CELL#1.0319;ACUTE MYELOID LEUKEMIA#0.9966;MYELOID LEUKEMIA#0.9954;CELL SURFACE#0.9650;BONE MARROW#0.9567;CELL ADHESION#0.9194;NATURAL KILLER CELL#0.9034;LEUKEMIA STEM CELL#0.8611;IMMUNE RESPONSE#0.8562;CELL ACTIVATION#0.8422;GENE EXPRESSION#0.7889;T CELL ACTIVATION#0.7780;ACUTE LEUKEMIA#0.7557;MYELODYSPLASTIC SYNDROME#0.7537;HEMATOPOIETIC STEM CELL#0.7388;LEUKEMIC STEM CELL#0.7356;MONONUCLEAR CELLS#0.6705;IMMUNE CELL#0.6122
10226	LIPID DROPLET PROTEIN#1.0535;ENDOSOME#1.0378;LIPID DROPLET#1.0115;SKELETAL MUSCLE#1.0038;ADIPOCYTE#1.0009;ADIPOCYTE DIFFERENTIATION#0.9912;LIPID METABOLISM#0.9855;TRANS GOLGI NETWORK#0.9814;MACROPHAGE#0.9767;LIPID STORAGE#0.9740;LIPOLYSIS#0.9651;LATE ENDOSOME#0.9515;ADIPOSE TISSUE#0.9498;ENDOPLASMIC RETICULUM#0.9160;CARGO SELECTION#0.9135;RECEPTOR BINDING#0.8774;LIPID DROPLET FORMATION#0.8549;CELL DEATH#0.8402;MITOCHONDRIA#0.8254;OLEIC ACID#0.8237;CYTOPLASM#0.8224;ORGANELLE#0.8198;TRIGLYCERIDE LIPASE#0.8003;HEPATITIS C#0.7944;LIVER DISEASE#0.7754;GENE EXPRESSION#0.7601;MITOCHONDRIAL MEMBRANE#0.7554;BINDING PROTEIN 1#0.7337;CERVICAL#0.7254;FATTY LIVER#0.7119;COATOMER#0.7090;EPITHELIAL CELL#0.7061;HEPATITIS C VIRUS#0.7054;HORMONE SENSITIVE LIPASE#0.6468;FATTY LIVER DISEASE#0.6399;MAMMARY GLAND#0.6393;APOPTOSIS#0.6366;PALMITATE#0.6362;LOW DENSITY LIPOPROTEIN#0.6192;CERVICAL CANCER#0.6143;VIRION#0.6060
10227	EOSINOPHIL#0.6421
10228	TRANS GOLGI NETWORK#1.0353;ENDOSOME#1.0214;PLASMA MEMBRANE#1.0090;SNARE COMPLEX#1.0051;CELL SURFACE#0.9955;N-ETHYLMALEIMIDE#0.9895;EARLY ENDOSOME#0.9771;EXOCYTOSIS#0.9407;RECYCLING ENDOSOME#0.9314;MEMBRANE FUSION#0.9023;SECRETORY GRANULE#0.8954;VESICLE TRAFFICKING#0.8913;SECRETORY PATHWAY#0.8632;INTRACELLULAR MEMBRANE#0.8251;CELL MIGRATION#0.8153;GOLGI APPARATUS#0.7933;LYSOSOME#0.7530;MICROTUBULE#0.7464;LATE ENDOSOME#0.7459;COATED VESICLE#0.7318;ORGANELLE#0.7244;CLATHRIN COATED VESICLE#0.7182;ENDOPLASMIC RETICULUM#0.7117;GOLGI MEMBRANE#0.6964;ENDOCYTOSIS#0.6892;GROWTH FACTOR#0.6787;COG COMPLEX#0.6767;TRANSFERRIN RECEPTOR#0.6632;TRANSPORT VESICLE#0.6541;PROGRESSIVE SUPRANUCLEAR PALSY#0.6510;VESICULAR TRANSPORT#0.6509;GOLGI COMPLEX#0.6383;ADIPOCYTE#0.6333;CLATHRIN ADAPTOR#0.6195;MACROPHAGE#0.6114;ENDOTHELIAL CELL#0.6112
10229	UBIQUINONE BIOSYNTHESIS#1.1087;MITOCHONDRIA#1.0165;RESPIRATION#1.0114;RESPIRATORY CHAIN#0.9686;COENZYME Q BIOSYNTHESIS#0.9258;ELECTRON TRANSPORT#0.8501;COMPLEX I#0.8310;PLASMA MEMBRANE#0.7994;MITOCHONDRIAL RESPIRATORY CHAIN#0.7489;RHYTHMIC BEHAVIOR#0.7411;DEFECATION#0.7215;MITOCHONDRIAL DNA#0.7072;GLYCOLYSIS#0.6420;REACTIVE OXYGEN SPECIES#0.6400;INHIBITION OF GLYCOLYSIS#0.6340;ELECTRON CARRIER#0.6306;ELECTRON TRANSPORT CHAIN#0.6214
1022	CAK COMPLEX#1.0878;BUDDING#1.0270;C TERMINAL DOMAIN#1.0140;KINASE ACTIVITY#1.0104;PROTEIN KINASE#1.0102;BREAST CANCER#1.0099;CELL CYCLE CONTROL#1.0033;CELL DEATH#1.0032;CTD KINASE ACTIVITY#0.9999;TRANSCRIPTION FACTOR#0.9978;CELL PROLIFERATION#0.9948;DNA REPAIR#0.9944;CYCLIN DEPENDENT KINASE#0.9941;CELL CYCLE ARREST#0.9934;M PHASE#0.9914;CELL CYCLE REGULATION#0.9902;CELL CYCLE#0.9900;CDK INHIBITOR#0.9871;CELL DIVISION#0.9871;CANCER CELL#0.9828;NECROPTOSIS#0.9809;CELL GROWTH#0.9791;APOPTOSIS#0.9779;TRANSACTIVATION#0.9761;GENE EXPRESSION#0.9725;KINASE INHIBITOR#0.9702;SIGNALING PATHWAY#0.9658;NUCLEOTIDE EXCISION REPAIR#0.9613;ONCOGENIC#0.9588;OOCYTE#0.9586;SQUAMOUS CELL CARCINOMA#0.9575;APOPTOTIC#0.9557;GROWTH FACTOR#0.9541;PROSTATE CANCER#0.9539;S PHASE#0.9539;LUNG CANCER#0.9499;CYCLIN DEPENDENT KINASE INHIBITOR#0.9433;FLAVOPIRIDOL#0.9260;BREAST CANCER CELL#0.9259;TUMOR CELLS#0.9218;COMPLEX I#0.9090;MITOSIS#0.8908;T CELL#0.8854;OVARIAN CANCER#0.8816;ESTROGEN RECEPTOR#0.8716;XERODERMA PIGMENTOSUM#0.8624;PREINITIATION COMPLEX#0.8605;TUMOR NECROSIS FACTOR#0.8602;CYCLIN BINDING#0.8550;MIXED LINEAGE KINASE#0.8547;HEPATOCELLULAR CARCINOMA#0.8393;GROWTH FACTOR RECEPTOR#0.8355;RNA SYNTHESIS#0.8325;G1 PHASE#0.8265;MITOGEN ACTIVATED PROTEIN#0.8160;MEIOSIS#0.8140;RETINOBLASTOMA#0.8131;OVARIAN#0.8057;DEPHOSPHORYLATION#0.7933;STEM CELL#0.7930;CISPLATIN#0.7860;MECHANISM OF ACTION#0.7848;CYTOTOXICITY#0.7828;APOPTOTIC CELL DEATH#0.7622;HUMAN GASTRIC CARCINOMA#0.7621;TRANSCRIPTIONAL CONTROL#0.7596;DNA BINDING#0.7547;RETINOIC ACID#0.7468;MAP KINASE#0.7408;ENDOTHELIAL CELL#0.7396;NEUROBLASTOMA#0.7395;HUMAN IMMUNODEFICIENCY VIRUS#0.7390;SIGNAL TRANSDUCTION#0.7328;RETINOIC ACID RECEPTOR#0.7299;HYPERPHOSPHORYLATION#0.7278;PROTEIN KINASE ACTIVITY#0.7261;GLUTATHIONE#0.7149;TRANSCRIPTION INITIATION FACTOR#0.7138;CDK ACTIVITY#0.7125;POLYMERASE CHAIN REACTION#0.7077;ANDROGEN RECEPTOR#0.7048;CATALYTIC ACTIVITY#0.7021;B CELL#0.6977;CELL MIGRATION#0.6933;ATP BINDING#0.6877;SIGNALLING PATHWAY#0.6848;MRNA SYNTHESIS#0.6827;COLORECTAL CANCER#0.6756;CDK-ACTIVATING KINASE COMPLEX#0.6574;MYELOID LEUKEMIA#0.6569;HISTIDINE#0.6470;COLON CANCER#0.6468;COLORECTAL#0.6463;TUMOR SUPPRESSOR#0.6445;SPORE WALL#0.6436;MEDIATOR COMPLEX#0.6435;DRUG RESISTANCE#0.6285;CELL DIVISION CYCLE#0.6268;CYTOPLASM#0.6170;FACTOR I#0.6166;PROTEIN KINASE C#0.6122;EPITHELIAL CELL#0.6099;OOCYTE MATURATION#0.6088;ISCHEMIA#0.6069;INDUCTION OF APOPTOSIS#0.6021
10230	CANCER CELL#1.0856;BREAST CANCER#0.8696;BREAST CANCER CELL#0.8043;COLORECTAL CANCER#0.8036;OVARIAN CANCER#0.6934;ADENOSINE MONOPHOSPHATE#0.6422;PROTEIN KINASE#0.6389;CELL PROLIFERATION#0.6228;COLORECTAL#0.6122;OVARIAN#0.6116
10231	CALCINEURIN#1.0583;STATIONARY PHASE#1.0081;THYROID HORMONE RECEPTOR#0.9947;TRANSCRIPTION FACTOR#0.9807;GENE EXPRESSION#0.9771;TRIIODOTHYRONINE#0.9696;GROWTH HORMONE#0.9651;RETINOIC ACID#0.9550;POLYMERASE CHAIN REACTION#0.9366;MALIC ENZYME#0.9267;DNA BINDING#0.8923;CEREBRAL CORTEX#0.8861;RETINOID X RECEPTOR#0.8744;SKELETAL MUSCLE#0.8547;NERVOUS SYSTEM#0.8533;FATTY ACID SYNTHASE#0.8423;ADIPOSE TISSUE#0.8122;BRAIN DEVELOPMENT#0.8010;GROWTH FACTOR#0.7962;DOWN SYNDROME#0.7960;3,5,3'-TRIIODOTHYRONINE#0.7879;HYPOTHYROIDISM#0.7848;MYOSIN HEAVY CHAIN#0.7688;COMPETENCE STIMULATING PEPTIDE#0.7596;LIPOGENESIS#0.7547;STEROL REGULATORY ELEMENT#0.7501;RETINOIC ACID RECEPTOR#0.7476;METAMORPHOSIS#0.7471;HORMONE BINDING#0.7418;REVERSE TRANSCRIPTION#0.7417;CENTRAL NERVOUS SYSTEM#0.7020;ELECTROPHORETIC MOBILITY SHIFT#0.6809;SKIN FIBROBLASTS#0.6806;DIET INDUCED OBESITY#0.6775;T CELL#0.6755;9-CIS-RETINOIC ACID#0.6709;THYROID HORMONE BINDING#0.6518;SIGNALING PATHWAY#0.6446;STEAROYL COA DESATURASE#0.6369;APOPTOSIS#0.6316;PROTEIN KINASE#0.6276;RECEPTOR BINDING#0.6176;ACTIVATED T-CELLS#0.6078;ACTIVATED T CELL#0.6074;INSULIN-LIKE GROWTH FACTOR#0.6030;MAMMARY GLAND#0.6011;NEURONAL CELLS#0.6010
10232	MEGAKARYOCYTE POTENTIATING FACTOR#1.1125;MEGAKARYOCYTE#1.0700;LUNG ADENOCARCINOMA#1.0532;TUMOR ASSOCIATED ANTIGEN#1.0529;IMMUNOTOXIN#1.0481;CELL ADHESION#1.0451;OOCYTE#1.0433;PLEURAL DISEASE#1.0396;MESOTHELIAL CELL#1.0382;PANCREATIC ADENOCARCINOMA#1.0351;PANCREATIC CANCER#1.0327;MESOTHELIOMA CELL#1.0324;CELL SURFACE#1.0312;PROSTATE STEM CELL#1.0302;T CELL#1.0282;LYMPH NODE#1.0258;BREAST CANCER#1.0256;EPITHELIAL OVARIAN CANCER#1.0248;STEM CELL ANTIGEN#1.0243;OVARIAN CARCINOMA#1.0236;OVARIAN#1.0231;CD8+ T CELL#1.0224;LUNG CANCER#1.0213;GROWTH FACTOR#1.0209;OVARIAN CANCER#1.0201;TUMOR CELLS#1.0183;CANCER CELL#1.0183;TUMOR ANTIGEN#1.0168;CHIMERIC ANTIGEN RECEPTOR#1.0152;MALIGNANT MESOTHELIOMA#1.0123;CELL PROLIFERATION#1.0097;ADENOCARCINOMA#1.0091;PLEURA#1.0065;MALIGNANT PLEURAL MESOTHELIOMA#1.0044;PANCREATIC DUCTAL ADENOCARCINOMA#1.0040;STEM CELL#1.0039;CYTOTOXICITY#1.0034;IMMUNE RESPONSE#0.9992;APOPTOSIS#0.9988;EPITHELIAL CELL#0.9955;PERIPHERAL BLOOD#0.9944;SQUAMOUS CELL CARCINOMA#0.9917;GENE EXPRESSION#0.9835;T LYMPHOCYTE#0.9818;BILE DUCT#0.9809;COLORECTAL#0.9809;ENDOTHELIAL GROWTH FACTOR#0.9796;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9796;PERITONEUM#0.9788;PROTEIN KINASE#0.9784;PANCREATIC CARCINOMA#0.9734;LUMINAL#0.9602;EPIDERMAL GROWTH FACTOR#0.9577;DENDRITIC CELL#0.9544;SIGNALING PATHWAY#0.9539;TRANSCRIPTION FACTOR#0.9521;TOXICITY#0.9513;GROWTH FACTOR RECEPTOR#0.9439;COLORECTAL CANCER#0.9257;CELL CYCLE#0.9235;MESOTHELIUM#0.9221;HUMAN PANCREATIC CANCER#0.9213;ASCITES#0.9146;BREAST CANCER CELL#0.9079;PERITONEAL MESOTHELIOMA#0.9043;BREAST CARCINOMA#0.9030;B CELL#0.8948;MACROPHAGE#0.8947;FINE NEEDLE ASPIRATION#0.8914;THYROID TRANSCRIPTION FACTOR#0.8845;POLYMERASE CHAIN REACTION#0.8769;FOLATE RECEPTOR ALPHA#0.8722;REVERSE TRANSCRIPTION#0.8694;THYMIC CARCINOMA#0.8661;DISEASE FREE SURVIVAL#0.8640;CELL ADHESION MOLECULE#0.8639;FOLATE#0.8632;CELL SURFACE ANTIGEN#0.8602;PANCREATITIS#0.8566;INSULIN-LIKE GROWTH FACTOR#0.8554;CHOLANGIOCARCINOMA#0.8473;NEGATIVE PREDICTIVE VALUE#0.8471;GASTRIC ADENOCARCINOMA#0.8461;EPIDIDYMIS#0.8461;CYTOTOXIC T-LYMPHOCYTE#0.8440;POSITRON EMISSION TOMOGRAPHY#0.8415;WILMS TUMOR 1#0.8274;ESTROGEN RECEPTOR#0.8181;FORMALIN#0.8119;EPITHELIAL OVARIAN CARCINOMA#0.8028;M PHASE#0.8004;LYMPH NODE METASTASIS#0.8004;GALECTIN#0.7982;ASBESTOSIS#0.7972;RESPONSE TO TREATMENT#0.7966;POSITIVE PREDICTIVE VALUE#0.7828;CELL MEMBRANE#0.7749;CISPLATIN#0.7658;METASTATIC PANCREATIC ADENOCARCINOMA#0.7658;CERVICAL CANCER#0.7648;PACLITAXEL#0.7613;PROTEIN SYNTHESIS#0.7585;GLOMERULAR FILTRATION RATE#0.7585;MUCINOUS NEOPLASM#0.7581;GLOMERULAR FILTRATION#0.7581;RENAL CARCINOMA#0.7519;PEMETREXED#0.7396;LIVER CANCER#0.7384;PERICARDIUM#0.7360;RENAL CELL CARCINOMA#0.7352;RECEIVER OPERATOR CHARACTERISTIC#0.7352;CERVICAL#0.7310;CYTOKINE SECRETION#0.7211;CELL DEATH#0.7200;IFN-GAMMA#0.7171;COLONY-STIMULATING FACTOR#0.7160;PROGESTERONE#0.7156;CELL GROWTH#0.7142;MECHANISM OF ACTION#0.7024;MITOGEN ACTIVATED PROTEIN#0.6986;TUMOR TISSUES#0.6954;MAXIMUM TOLERATED DOSE#0.6923;GROWTH FACTOR BINDING#0.6892;PLATELET-DERIVED GROWTH FACTOR#0.6858;CYTOPLASM#0.6844;IMMUNE SYSTEM#0.6837;CLEAR CELL CARCINOMA#0.6816;COLORECTAL ADENOCARCINOMA#0.6749;TRANSITIONAL CELL CARCINOMA#0.6748;DOXORUBICIN#0.6742;SIGNAL TRANSDUCTION#0.6715;GEMCITABINE#0.6709;MITOSIS#0.6683;HEAT SHOCK PROTEIN#0.6678;TUMOR SUPPRESSOR#0.6672;PERIPHERAL BLOOD LYMPHOCYTES#0.6672;TUMOR NECROSIS FACTOR#0.6654;COLON CANCER#0.6631;PERITONEAL CAVITY#0.6521;GM-CSF#0.6465;REGULATORY T CELL#0.6464;CD4+ T CELL#0.6445;MONONUCLEAR CELLS#0.6426;MALIGNANT PLEURAL EFFUSION#0.6412;CELL KILLING#0.6327;MULTIPLE LINEAR REGRESSION#0.6262;MAP KINASE#0.6255;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6199;BILE DUCT CANCER#0.6096;OVARIAN SEROUS CARCINOMA#0.6086;HUMORAL IMMUNE RESPONSE#0.6052
10234	LEUCINE RICH REPEAT#0.9204;LEUCINE#0.7391;OSTEOCLAST DIFFERENTIATION#0.6747
10235	NUCLEOTIDE EXCHANGE FACTOR#1.0764;GUANINE#1.0653;ENDOTHELIAL CELL#0.9994;FACTOR I#0.9861;PROTEIN KINASE#0.9252;INTEGRIN ACTIVATION#0.8952;PLATELET AGGREGATION#0.7940;VASCULAR ENDOTHELIAL CELL#0.7044;PROTEIN KINASE C#0.7036;NEUTROPHIL#0.6917;SIGNALING PATHWAY#0.6488;APOPTOSIS#0.6425;PROTEIN KINASE A#0.6221;LEUKOCYTE#0.6078
10236	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#1.1242;RNA BINDING#0.7150;RNA BINDING PROTEIN#0.6883;SPINAL MUSCULAR ATROPHY#0.6798;MUSCULAR ATROPHY#0.6778
10237	UDP GALACTOSE#0.7109;ER MEMBRANE#0.6588
10238	CRANIOFACIAL DEVELOPMENT#0.9687;PROTEIN KINASE#0.9024;TRANSCRIPTION FACTOR#0.7840;ANTHOCYANIN SYNTHESIS#0.6577;ANTHOCYANIN BIOSYNTHESIS#0.6100;CYTOPLASM#0.6090
10239	TYPE 2 DIABETES#0.7121
10240	T CELL#0.8218
10241	NUCLEAR DOT#1.0864;SELECTIVE AUTOPHAGY#1.0539;AUTOPHAGY#1.0474;UBIQUITIN#1.0462;UBIQUITIN BINDING#1.0264;AUTOPHAGOSOME#1.0166;GALECTIN#1.0058;MITOPHAGY#1.0020;MITOCHONDRIA#0.9813;XENOPHAGY#0.9718;AUTOPHAGOSOME MATURATION#0.8434;TOLL LIKE RECEPTOR#0.8128;INNATE IMMUNITY#0.7839;LIGHT CHAIN 3#0.7823;MICROTUBULE ASSOCIATED PROTEIN#0.7759;MICROTUBULE#0.7699;LYSOSOME#0.7659;PHAGOPHORE#0.7393;IMMUNE RESPONSE#0.7359;VACUOLE#0.7016;TRANSCRIPTION FACTOR#0.6854;TANK BINDING KINASE#0.6187;ULK1 COMPLEX#0.6064;TARGET OF RAPAMYCIN#0.6019
10243	MOCO BIOSYNTHESIS#1.0674;RECEPTOR CLUSTERING#1.0656;PERIPHERAL MEMBRANE PROTEIN#1.0618;TUBULIN BINDING#1.0576;MOLYBDENUM COFACTOR#1.0569;POSTSYNAPTIC MEMBRANE#1.0531;ANCHORING#1.0421;GLYCINE RECEPTOR#1.0377;GABA A RECEPTOR#1.0322;GLYCINE#1.0304;NEUROLIGIN#1.0276;POSTSYNAPTIC DENSITY#1.0262;MICROTUBULE#1.0213;INHIBITORY SYNAPSE#1.0210;NUCLEOTIDE EXCHANGE FACTOR#1.0194;NEUROTRANSMITTER RECEPTOR#1.0161;CELL SURFACE#1.0160;PLASMA MEMBRANE#1.0146;COFACTOR BIOSYNTHESIS#1.0056;PRESYNAPTIC TERMINAL#1.0027;GLYCINERGIC SYNAPSE#0.9993;BOUTON#0.9978;SPINAL CORD#0.9972;NEUROTRANSMISSION#0.9900;EXCITATORY SYNAPSE#0.9881;CENTRAL NERVOUS SYSTEM#0.9855;INTERNEURON#0.9853;GLUTAMIC ACID#0.9847;NERVOUS SYSTEM#0.9834;SYNAPTIC TRANSMISSION#0.9814;SYNAPTOGENESIS#0.9768;GUANINE#0.9711;EPILEPSY#0.9698;PYRAMIDAL CELL#0.9692;MOLYBDENUM COFACTOR DEFICIENCY#0.9653;INHIBITORY SYNAPSE FORMATION#0.9604;GLUTAMATE RECEPTOR#0.9603;AMYGDALA#0.9598;DENTATE GYRUS#0.9589;PROTEIN KINASE#0.9578;POSTSYNAPSE#0.9547;GLUTAMATERGIC SYNAPSE#0.9462;C TERMINAL DOMAIN#0.9450;AMPA RECEPTOR#0.9319;ION CHANNEL#0.9296;RECEPTOR BINDING#0.9269;SINGLE PARTICLE TRACKING#0.9256;OLFACTORY BULB#0.9187;INNERVATION#0.9173;GENE EXPRESSION#0.9122;TEMPORAL LOBE EPILEPSY#0.8974;TEMPORAL LOBE#0.8933;NMDA RECEPTOR#0.8855;SYNAPSE DEVELOPMENT#0.8737;SYNAPTIC VESICLE#0.8713;RECEPTOR COMPLEX#0.8707;HYPEREKPLEXIA#0.8429;GANGLION CELLS#0.8324;CELL ADHESION#0.8314;BIPOLAR CELL#0.8254;AXON TERMINAL#0.8193;PROTEIN KINASE C#0.8180;AMACRINE CELL#0.8121;DENDRITIC SPINE#0.8093;POST SYNAPTIC DENSITY#0.7937;CYCLIN DEPENDENT KINASE#0.7916;LASER SCANNING MICROSCOPY#0.7914;ERGIC#0.7874;SIGNALING PATHWAY#0.7759;POSTSYNAPTIC SPECIALIZATION#0.7703;CEREBRAL CORTEX#0.7629;SIGNALING MOLECULE#0.7610;PROXIMAL DENDRITE#0.7584;CELL ADHESION MOLECULE#0.7577;INITIAL SEGMENT#0.7568;AUTISM SPECTRUM DISORDER#0.7541;PURKINJE CELL#0.7534;NEURONAL CELLS#0.7436;NITRIC OXIDE#0.7417;SULFITE OXIDASE#0.7375;BETA-2#0.7369;CYTOPLASM#0.7328;INTELLECTUAL DISABILITY#0.7313;THALAMUS#0.7230;ASPARTATE#0.7224;LONG TERM POTENTIATION#0.7176;SIGNAL TRANSDUCTION#0.7170;MENTAL RETARDATION#0.7163;FOREBRAIN#0.7155;NITRIC OXIDE SYNTHASE#0.7038;ALZHEIMER'S DISEASE#0.6997;POST-TRANSLATIONAL MODIFICATION#0.6894;CHOLINE#0.6758;CELL MEMBRANE#0.6753;COFACTOR SYNTHESIS#0.6726;PRESYNAPTIC BOUTON#0.6722;AXON INITIAL SEGMENT#0.6669;PROTEIN COMPLEX#0.6555;CAMKII#0.6548;POSTTRANSLATIONAL MODIFICATION#0.6517;GLYCOGEN SYNTHASE KINASE#0.6506;MICROTUBULE ASSOCIATED PROTEIN#0.6500;XANTHINE#0.6466;DYNEIN#0.6400;GABAERGIC NEURON#0.6374;CHLORIDE CHANNEL#0.6354;MUTAGENESIS#0.6319;MICROFILAMENT#0.6297;ACTIN CYTOSKELETON#0.6293;NERVE TERMINAL#0.6184;MEDIAL PREFRONTAL CORTEX#0.6121;XANTHINE DEHYDROGENASE#0.6079;DISTAL DENDRITE#0.6075
10244	IFN-GAMMA#1.0310;T CELL#1.0152;MACROPHAGE#0.9762;CD8+ T CELL#0.9290;IMMUNE RESPONSE#0.9281;CD4+ T CELL#0.8951;LYMPH NODE#0.8727;DENDRITIC CELL#0.8591;LYSOSOMAL MEMBRANE#0.7937;GENE EXPRESSION#0.7096;LATE ENDOSOME#0.7054;ENDOSOME#0.6317;DRAINING LYMPH NODE#0.6223;MONONUCLEAR CELLS#0.6120;DNA BINDING#0.6043
10245	INNER MITOCHONDRIAL MEMBRANE#0.8005;MITOCHONDRIAL MEMBRANE#0.7880;HOST MITOCHONDRIA#0.7578;MITOCHONDRIAL MATRIX#0.6800;HOST CELL#0.6639
102465513	FERROPTOSIS#0.6715
102465753	TRANSCRIPTION FACTOR#1.1783;GLUTATHIONE#0.8473
102465858	MALARIA#0.6515
102466081	ENDOTHELIAL CELL#1.1798
102466519	UMBILICAL VEIN ENDOTHELIAL CELLS#0.7653;HUMAN UMBILICAL VEIN#0.7647;UMBILICAL VEIN#0.7644;ENDOTHELIAL CELL#0.7579;APOPTOSIS#0.6411
102466854	BLADDER UROTHELIAL CARCINOMA#1.2270
102467146	T CELL DIFFERENTIATION#0.8164;CELL DIFFERENTIATION#0.8019;T CELL#0.7940
10247	PROTEIN SYNTHESIS#1.0276;PYRIDOXAL 5-PHOSPHATE#0.9992;RNASE P#0.9374;PYRIDOXAL#0.9224;C REACTIVE PROTEIN#0.9016;CELL PROLIFERATION#0.8618;RETICULOCYTE#0.8360;CANCER CELL#0.8056;TUMOR ANTIGEN#0.7598;POST-TRANSLATIONAL MODIFICATION#0.7107;MACROPHAGE#0.7100;REGULATION OF CELLULAR#0.7094;DEAMINASE ACTIVITY#0.6999;MITOCHONDRIA#0.6658;OTHER ORGANISM#0.6454;PYRUVATE#0.6448;CELLULAR GROWTH#0.6234;ENDOPLASMIC RETICULUM#0.6139;INFLAMMATORY RESPONSE#0.6127
10248	RNASE P#1.1148;RNASE MRP#1.1100;RIBONUCLEASE P#0.6767;RNA BINDING#0.6361
10249	GLYCINE N ACYLTRANSFERASE#1.1240;N ACYLTRANSFERASE#1.1000;ASPARTIC ACID#1.0758;N-ACYLTRANSFERASE ACTIVITY#1.0673;N ACETYLTRANSFERASE#1.0565;GLYCINE#1.0504;GENTAMICIN#1.0324;ACYLTRANSFERASE ACTIVITY#1.0134;AMIKACIN#1.0030;POLYMERASE CHAIN REACTION#0.9792;CIPROFLOXACIN#0.9786;CONJUGATION#0.9776;COENZYME A#0.9449;STREPTOMYCIN#0.9117;TETRACYCLINE#0.9063;TOBRAMYCIN#0.9045;MITOCHONDRIA#0.8997;KANAMYCIN#0.8896;ALANINE#0.8634;NALIDIXIC ACID#0.8563;DETOXIFICATION#0.8485;IMMUNE RESPONSE#0.8375;ENZYME ACTIVITY#0.7882;NETILMICIN#0.7455;GLUTAMIC ACID#0.7292;DNA BINDING#0.7290;TRIMETHOPRIM#0.7210;AMPICILLIN#0.7062;ADIPOSE TISSUE#0.6497;THYMIDINE#0.6496;ASPARAGINE#0.6189;BENZOIC ACID#0.6186;VIRULENCE#0.6063;CHLORAMPHENICOL#0.6033;TUMOR CELLS#0.6028
1024	CDK8 KINASE MODULE#1.1593;COLON CANCER#1.0531;KINASE ACTIVITY#1.0521;BREAST CANCER#1.0460;COLORECTAL CANCER#1.0406;CYCLIN DEPENDENT KINASE#1.0391;MEDIATOR COMPLEX#1.0296;COLORECTAL#1.0238;CANCER CELL#1.0194;PROTEIN KINASE#1.0162;CELL CYCLE#1.0038;SIGNALING PATHWAY#1.0002;TRANSCRIPTION FACTOR#0.9969;GENE EXPRESSION#0.9924;CELL PROLIFERATION#0.9872;COMPLEX I#0.9506;APOPTOSIS#0.9416;ONCOGENIC#0.9254;CELL GROWTH#0.8961;DNA BINDING#0.8791;GROWTH FACTOR#0.8646;PROSTATE CANCER#0.8578;BREAST CANCER CELL#0.8420;PROTEIN COMPLEX#0.8181;KINASE INHIBITOR#0.8153;UBIQUITIN#0.8145;C TERMINAL DOMAIN#0.8027;TUMOR SUPPRESSOR#0.7829;G1 PHASE#0.7714;STEM CELL#0.7647;PANCREATIC CANCER#0.7501;T CELL#0.7468;RNA INTERFERENCE#0.7465;CELL DIFFERENTIATION#0.7295;TRANSACTIVATION#0.7286;POLYMERASE CHAIN REACTION#0.7132;LIPOGENESIS#0.6869;TRANSCRIPTIONAL CONTROL#0.6830;CELL DEATH#0.6762;LYMPH NODE#0.6733;CTD KINASE ACTIVITY#0.6701;TUMOR TISSUES#0.6532;LIPID METABOLISM#0.6516;LEIOMYOMA#0.6424;ADJACENT NORMAL TISSUE#0.6385;CELL CYCLE ARREST#0.6335;EMBRYONIC STEM CELL#0.6333;GLYCOLYSIS#0.6285;CELL CYCLE CONTROL#0.6283;MITOSIS#0.6248;TUMOR CELLS#0.6243;S PHASE#0.6227;APOPTOTIC#0.6206;DEVELOPMENTAL TIMING#0.6160;DE NOVO LIPOGENESIS#0.6099;CDK INHIBITOR#0.6071;LUNG CANCER#0.6055
10250	NUCLEAR MATRIX#1.0975;EXON JUNCTION COMPLEX#0.9288;GENE EXPRESSION#0.8113;MRNA PROCESSING#0.7968;PRE-MRNA SPLICING#0.7661;MRNA SPLICING#0.7635;SPLICEOSOME#0.7449;ARGININE#0.7331;NUCLEIC ACID BINDING#0.6715;NUCLEIC ACID#0.6590;NUCLEAR SPECKLE#0.6579;RNA BINDING#0.6421
10251	X CHROMOSOME#0.7556;GROWTH FACTOR#0.6313
10252	CELL PROLIFERATION#1.0230;GROWTH FACTOR#1.0085;CANCER CELL#0.9969;RECEPTOR TYROSINE KINASE#0.9934;SIGNALING PATHWAY#0.9923;BREAST CANCER#0.9822;EPITHELIAL CELL#0.9658;STEM CELL#0.9564;T CELL#0.9421;APOPTOSIS#0.9419;ENDOTHELIAL CELL#0.9400;URETERIC BUD#0.9223;GENE EXPRESSION#0.9200;OVARIAN CANCER#0.9197;FIBROBLAST GROWTH FACTOR#0.9106;MAP KINASE#0.8951;TUMOR SUPPRESSOR#0.8858;CELL DEATH#0.8735;TRANSCRIPTION FACTOR#0.8698;MORPHOGENESIS#0.8516;QUIESCENCE#0.8280;CELL CYCLE#0.8220;AKT SIGNALING#0.8184;OTIC PLACODE#0.8096;INFLAMMATORY RESPONSE#0.8039;PROGENITOR CELL#0.7926;ANGIOGENESIS#0.7858;OVARIAN#0.7822;MAPK SIGNALING#0.7723;BRANCHING MORPHOGENESIS#0.7722;RHEUMATOID ARTHRITIS#0.7583;KIDNEY DEVELOPMENT#0.7517;HYPOXIA#0.7407;SIGNALLING PATHWAY#0.6870;MITOGEN ACTIVATED PROTEIN#0.6811;SENESCENCE#0.6602;MUSCLE STEM CELL#0.6579;LENS VESICLE#0.6496;ARSENITE#0.6462;ATRIAL FIBRILLATION#0.6436;ADIPOCYTE#0.6331;PROTEIN KINASE#0.6244;PHOSPHATASE AND TENSIN HOMOLOG#0.6233;ENDOTHELIAL CELL DEVELOPMENT#0.6187;ADIPOSE TISSUE#0.6130;TISSUE REMODELING#0.6094;EPITHELIAL OVARIAN CANCER#0.6039;CELL DEVELOPMENT#0.6030;S PHASE#0.6004
10253	COLON CANCER#1.0632;CANCER CELL#1.0370;TUMOR SUPPRESSOR#1.0338;PROTEIN KINASE#1.0291;EPIDERMAL GROWTH FACTOR#1.0242;MITOGEN ACTIVATED PROTEIN#1.0207;EPITHELIAL CELL#1.0167;CELL PROLIFERATION#1.0120;GROWTH FACTOR RECEPTOR#1.0110;RECEPTOR TYROSINE KINASE#1.0095;CELL MIGRATION#1.0071;FIBROBLAST GROWTH FACTOR#1.0022;SIGNALING PATHWAY#0.9984;GROWTH FACTOR#0.9964;GENE EXPRESSION#0.9830;MAP KINASE#0.9822;HYPOXIA#0.9803;TRANSCRIPTION FACTOR#0.9697;APOPTOSIS#0.9664;MAPK SIGNALING#0.9549;CELL DEATH#0.9284;PROSTATE CANCER#0.9222;KINASE ACTIVITY#0.9197;UBIQUITIN#0.9182;OVARIAN CANCER#0.8860;ANGIOGENESIS#0.8828;B CELL#0.8655;WOUND HEALING#0.8620;T CELL#0.8614;HEPATOCELLULAR CARCINOMA#0.8605;CELL GROWTH#0.8587;OVARIAN#0.8527;CELL CYCLE#0.8411;MORPHOGENESIS#0.8383;OSTEOBLAST#0.8335;ENDOTHELIAL CELL#0.8132;SIGNALLING PATHWAY#0.8066;ONCOGENIC#0.8062;REGENERATION#0.8014;OTIC PLACODE#0.7996;PHOSPHATASE AND TENSIN HOMOLOG#0.7974;POLYMERASE CHAIN REACTION#0.7879;LUNG DEVELOPMENT#0.7429;CLEFT PALATE#0.7409;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7367;EPITHELIAL TO MESENCHYMAL#0.7364;MAMMARY GLAND#0.7346;EPITHELIAL MESENCHYMAL TRANSITION#0.7266;BRANCHING MORPHOGENESIS#0.7222;STEM CELL#0.7032;GINGIVAL EPITHELIAL CELLS#0.6997;C TERMINAL DOMAIN#0.6965;MESENCHYME#0.6791;GLUCOSE UPTAKE#0.6770;TYPE 2 DIABETES#0.6755;NEURITE#0.6628;GRANULOSA CELL#0.6625;APOPTOTIC#0.6513;TISSUE REGENERATION#0.6396;NEURITE OUTGROWTH#0.6328;INHIBITION OF CELL MIGRATION#0.6284;TUMOR TISSUES#0.6251;ENDOCYTOSIS#0.6171;CLEFT LIP#0.6122;AXON GROWTH#0.6083;AXON REGENERATION#0.6054;INTRACELLULAR LOCALIZATION#0.6021
10254	GROWTH FACTOR#1.0503;ENDOSOME#0.9800;GROWTH FACTOR RECEPTOR#0.9767;EARLY ENDOSOME#0.9708;UBIQUITIN#0.9221;EPIDERMAL GROWTH FACTOR#0.8406;HEPATOCYTE GROWTH FACTOR#0.8013;NERVOUS SYSTEM#0.7617;DEUBIQUITINATING ENZYME#0.6750;EXOCYTOSIS#0.6649;GALACTOSIDASE ACTIVITY#0.6450;UBIQUITIN BINDING#0.6382;INTERSTITIAL CELL#0.6376;SECRETORY GRANULE#0.6376;MAST CELL#0.6298;ENDOSOME MEMBRANE#0.6163
10255	MAJOR HISTOCOMPATIBILITY COMPLEX#0.8792;BIPOLAR DISORDER#0.7228;HUMAN LEUKOCYTE ANTIGEN#0.6653
10256	CELL PROLIFERATION#0.9881;PROTEIN KINASE#0.9850;SIGNALING PATHWAY#0.9684;MITOGEN ACTIVATED PROTEIN#0.9217;CANCER CELL#0.9022;PLASMA MEMBRANE#0.8855;ONCOGENIC#0.8422;GROWTH FACTOR#0.8196;STERILE ALPHA MOTIF#0.7362;ERK CASCADE#0.7102;NUCLEOTIDE EXCHANGE FACTOR#0.7061;RECEPTOR TYROSINE KINASE#0.6955;CELL MIGRATION#0.6948;SIGNAL TRANSMISSION#0.6521;MAP KINASE CASCADE#0.6379;SIGNAL TRANSDUCTION#0.6377;MAP KINASE#0.6295;BREAST CANCER#0.6234;GENE EXPRESSION#0.6216;MAPK CASCADE#0.6184
102578074	PROSTATE CANCER#0.9014
10257	CGMP TRANSPORT#1.0540;MULTI DRUG RESISTANCE#1.0400;ADEFOVIR#1.0337;ORGANIC ANION TRANSPORTER#1.0300;URIC ACID#1.0293;6-MERCAPTOPURINE#1.0250;CISPLATIN#1.0228;EFFLUX PUMP#1.0218;MERCAPTOPURINE#1.0217;TENOFOVIR#1.0179;MULTIDRUG RESISTANCE PROTEIN#1.0167;ORGANIC CATION TRANSPORTER#1.0150;ATP BINDING CASSETTE TRANSPORTER#1.0120;METHOTREXATE#1.0102;CIPROFLOXACIN#1.0086;HUMAN EMBRYONIC KIDNEY#1.0085;EMBRYONIC KIDNEY#1.0080;PROSTATE CANCER#1.0079;CELL PROLIFERATION#1.0049;LUNG CANCER#1.0045;DRUG RESISTANCE#1.0017;PLATELET AGGREGATION#1.0016;BREAST CANCER#0.9990;ABC TRANSPORTER#0.9988;PLASMA MEMBRANE#0.9987;URATE#0.9984;POLYMERASE CHAIN REACTION#0.9971;EXCRETION#0.9945;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9943;ADENOSINE#0.9937;ATP BINDING CASSETTE#0.9928;ASPIRIN#0.9928;ATP BINDING#0.9919;PROSTAGLANDIN E2#0.9918;CANCER CELL#0.9912;ADENINE#0.9904;CHOLESTASIS#0.9890;ENDOTHELIAL CELL#0.9883;CYTOTOXICITY#0.9881;EPITHELIAL CELL#0.9873;ADENOSINE TRIPHOSPHATE#0.9870;PROBENECID#0.9870;RNA INTERFERENCE#0.9869;BLOOD BRAIN BARRIER#0.9850;TAUROCHOLATE#0.9836;GENE EXPRESSION#0.9791;GLUTATHIONE#0.9791;TOXICITY#0.9776;DETOXIFICATION#0.9736;BILE DUCT#0.9690;LUMINAL#0.9670;ADEFOVIR DIPIVOXIL#0.9643;CYTOCHROME P450#0.9636;REVERSE TRANSCRIPTION#0.9636;TUMOR CELLS#0.9635;IRINOTECAN#0.9581;ERYTHROCYTE#0.9579;COLORECTAL#0.9579;ESTRADIOL#0.9565;CELL MEMBRANE#0.9520;SIGNALING PATHWAY#0.9517;PHOSPHODIESTERASE#0.9468;DRUG TRANSPORT#0.9419;REGULATION OF FIBROBLAST MIGRATION#0.9412;PROXIMAL TUBULE CELL#0.9403;APOPTOSIS#0.9354;TRANSCRIPTION FACTOR#0.9324;HEPATOTOXICITY#0.9274;MULTIDRUG RESISTANT PROTEIN#0.9271;CPT-11#0.9271;CYSTIC FIBROSIS#0.9269;ADENOSINE MONOPHOSPHATE#0.9235;DUBIN-JOHNSON SYNDROME#0.9232;GLOMERULAR FILTRATION#0.9173;VESICULAR TRANSPORT#0.9172;SMOOTH MUSCLE#0.9156;CELL CYCLE#0.9147;BILE DUCT LIGATION#0.9134;CHOROID PLEXUS#0.9119;PLATELET ACTIVATION#0.9117;BILE ACID SYNTHESIS#0.9108;SMOOTH MUSCLE CELL#0.9093;MUSCLE CELL#0.9085;TIGHT JUNCTION#0.9068;LIVER DISEASE#0.9049;SIGNALING MOLECULE#0.9034;QUANTITATIVE REAL TIME#0.9031;STEM CELL#0.8999;EMBRYO IMPLANTATION#0.8968;COLORECTAL CANCER#0.8966;ENDOMETRIUM#0.8959;PREGNANE X RECEPTOR#0.8923;PROTEIN KINASE#0.8917;CYCLIC ADENOSINE MONOPHOSPHATE#0.8917;KUPFFER CELL#0.8882;HEPATITIS B#0.8857;T CELL#0.8843;FARNESOID X RECEPTOR#0.8833;CELECOXIB#0.8794;CELL GROWTH#0.8778;CELL MIGRATION#0.8770;NEUROBLASTOMA#0.8747;ASTROCYTE#0.8746;MEMBRANE TRANSPORT#0.8693;ACETAMINOPHEN#0.8668;MACROPHAGE#0.8667;URATE TRANSPORT#0.8615;HUMAN IMMUNODEFICIENCY VIRUS#0.8614;DOXORUBICIN#0.8577;CELL SURFACE#0.8564;ANTI INFLAMMATORY DRUGS#0.8556;6-THIOGUANINE#0.8512;GLOMERULAR FILTRATION RATE#0.8487;ORGANIC SOLUTE TRANSPORTER#0.8449;DIPYRIDAMOLE#0.8415;INDOMETHACIN#0.8411;PANCREATIC CANCER#0.8399;OVARIAN#0.8331;B CELL#0.8251;DICLOFENAC#0.8147;FIBROBLAST MIGRATION#0.8131;BRUSH BORDER#0.8125;PACLITAXEL#0.8083;CYCLIC AMP#0.8079;TRANSCRIPTASE#0.8072;CAMPTOTHECIN#0.8038;BONE MARROW#0.8032;ADENOCARCINOMA#0.8024;5 FLUOROURACIL#0.7987;TOPOTECAN#0.7979;CENTRAL NERVOUS SYSTEM#0.7973;NERVOUS SYSTEM#0.7963;CONSTITUTIVE ANDROSTANE RECEPTOR#0.7956;THIOGUANINE#0.7939;PROGENITOR CELL#0.7939;VINCRISTINE#0.7927;VERAPAMIL#0.7916;PULMONARY HYPERTENSION#0.7908;PERIPHERAL BLOOD#0.7869;IMMUNE RESPONSE#0.7853;VASCULAR ENDOTHELIAL CELL#0.7829;RITONAVIR#0.7821;ANION TRANSPORT#0.7789;ETOPOSIDE#0.7704;MEGAKARYOCYTE#0.7695;GUANOSINE#0.7694;AZIDOTHYMIDINE#0.7678;ORGANIC ANION TRANSPORT#0.7674;INTESTINAL ABSORPTION#0.7661;INTRAHEPATIC CHOLESTASIS#0.7656;MYELOID LEUKEMIA#0.7634;RECEPTOR ANTAGONIST#0.7572;CYCLOPHOSPHAMIDE#0.7532;BREAST CANCER CELL#0.7491;MEMBRANE FRACTION#0.7485;ESTROUS CYCLE#0.7459;BRUSH BORDER MEMBRANE#0.7458;ACUTE MYELOID LEUKEMIA#0.7448;FOLATE#0.7402;ATPASE ACTIVITY#0.7401;CYCLOSPORINE#0.7393;ALANINE#0.7361;NEUTROPENIA#0.7336;OOCYTE#0.7311;ARYL HYDROCARBON RECEPTOR#0.7267;JEJUNUM#0.7248;THIOPURINE S METHYLTRANSFERASE#0.7233;ESTRADIOL-17BETA#0.7217;TIGHT JUNCTION PROTEIN#0.7216;S METHYLTRANSFERASE#0.7204;CELL DIFFERENTIATION#0.7200;RIBOSOMAL PROTEIN#0.7180;KIDNEY DISEASE#0.7137;ARTERY#0.7128;FUROSEMIDE#0.7126;SMALL INTESTINE#0.7103;SERUM URIC ACID#0.7076;CELL DEATH#0.7056;DRUG METABOLISM#0.7039;ISOPROTERENOL#0.7025;FLUORESCEIN#0.7013;CORONARY ARTERY#0.6971;REACTIVE OXYGEN SPECIES#0.6959;TESTOSTERONE#0.6952;PROTEIN KINASE A#0.6936;KIDNEY PROXIMAL TUBULE#0.6931;DOCETAXEL#0.6896;LEYDIG CELL#0.6877;SERTOLI CELL#0.6871;FORSKOLIN#0.6868;UREMIC TOXIN#0.6838;PEROXISOME#0.6825;PDZ BINDING MOTIF#0.6812;ENDOMETRIOSIS#0.6802;GUT GRANULE#0.6795;HYPERTENSION#0.6751;BILE ACID TRANSPORT#0.6746;BLOOD VESSEL#0.6715;SPHINGOSINE 1 PHOSPHATE#0.6684;FLUOROURACIL#0.6678;CHRONIC HEPATITIS B#0.6671;TRANSMEMBRANE TRANSPORT#0.6632;LEUKOPENIA#0.6597;ANTIOXIDANT RESPONSE ELEMENT#0.6545;ZIDOVUDINE#0.6531;REVERSE TRANSCRIPTASE INHIBITOR#0.6525;CYCLIC GUANOSINE MONOPHOSPHATE#0.6522;VITAMIN D RECEPTOR#0.6476;MICROVASCULAR ENDOTHELIAL CELL#0.6469;MYOCYTES#0.6446;OVARIAN CANCER#0.6437;ACTIVE TRANSPORTER#0.6376;CHOLIC ACID#0.6373;PRAVASTATIN#0.6365;COLITIS#0.6315;NAPROXEN#0.6307;CYTOPLASM#0.6293;HYPERURICEMIA#0.6284;NEUTROPHIL#0.6280;SIGNAL TRANSDUCTION#0.6235;SPHINGOSINE#0.6219;URSODEOXYCHOLIC ACID#0.6209;GROWTH FACTOR#0.6201;GLUCURONATE#0.6182;NUCLEOTIDE BINDING#0.6173;GLYCOSYLATION#0.6168;HEPATITIS B VIRUS#0.6166;CELLULAR DETOXIFICATION#0.6155;BREAST CANCER PATIENTS#0.6151;GLIAL CELL#0.6148;LIVER DAMAGE#0.6143;GAMMA-GLUTAMYLCYSTEINE#0.6127;DUODENUM#0.6098;TOPOISOMERASE#0.6096;CEFAZOLIN#0.6041;COLORECTAL CARCINOMA#0.6015;ADVERSE DRUG REACTION#0.6015
1025	P-TEFB COMPLEX#1.0470;FLAVOPIRIDOL#1.0374;COMPLEX I#1.0257;CD4+ T CELL#1.0177;KINASE ACTIVITY#1.0160;CYCLIN DEPENDENT KINASE#1.0061;TRANSACTIVATION#1.0041;C TERMINAL DOMAIN#1.0026;PROTEIN KINASE#0.9979;T CELL#0.9964;BREAST CANCER#0.9955;VIRAL TRANSCRIPTION#0.9953;MACROPHAGE#0.9948;CANCER CELL#0.9940;B CELL#0.9932;MONOCYTE#0.9931;CELL GROWTH#0.9881;CELL PROLIFERATION#0.9868;HUMAN IMMUNODEFICIENCY VIRUS#0.9857;APOPTOTIC#0.9847;CDK INHIBITOR#0.9828;KINASE INHIBITOR#0.9817;APOPTOSIS#0.9815;DEPHOSPHORYLATION#0.9800;MYELOID LEUKEMIA#0.9782;PROTEIN PHOSPHATASE 1#0.9770;RNA INTERFERENCE#0.9767;TRANSCRIPTION FACTOR#0.9753;GENE EXPRESSION#0.9753;CELL CYCLE#0.9736;CELL DEATH#0.9727;CYCLIN DEPENDENT KINASE INHIBITOR#0.9712;RNA SYNTHESIS#0.9711;T LYMPHOCYTE#0.9676;VIRAL REPLICATION#0.9667;ACUTE MYELOID LEUKEMIA#0.9650;INDUCTION OF APOPTOSIS#0.9646;SMALL NUCLEAR RNA#0.9644;MECHANISM OF ACTION#0.9628;NUCLEAR SPECKLE#0.9601;HOST CELL#0.9586;VIRAL GENE EXPRESSION#0.9586;PERIPHERAL BLOOD#0.9578;CELL CYCLE ARREST#0.9563;SIGNALING PATHWAY#0.9561;TUMOR SUPPRESSOR#0.9524;UBIQUITIN#0.9524;CTD KINASE ACTIVITY#0.9468;CARDIOMYOCYTE#0.9463;RETINOBLASTOMA#0.9431;B CELL LYMPHOMA#0.9417;MRNA PROCESSING#0.9413;CELL DIVISION#0.9400;CELLULAR TRANSCRIPTION#0.9376;CELL DIFFERENTIATION#0.9365;PERIPHERAL BLOOD LYMPHOCYTES#0.9365;HISTONE ACETYLTRANSFERASE#0.9353;STEM CELL#0.9345;MUSCLE CELL#0.9257;LYSINE#0.9254;LUNG CANCER#0.9235;MULTIPLE MYELOMA#0.9115;PROVIRUS#0.9092;CELL ACTIVATION#0.9091;ATP BINDING#0.9075;ONCOGENIC#0.9071;T CELL ACTIVATION#0.9052;CHROMATIN REMODELING#0.9007;PROSTATE CANCER#0.8960;M PHASE#0.8921;TOXICITY#0.8909;INDIRUBIN-3'-MONOXIME#0.8906;RNA BINDING#0.8830;MRNA SYNTHESIS#0.8809;CYTOTOXICITY#0.8797;HERPES SIMPLEX VIRUS#0.8759;HERPES SIMPLEX#0.8756;HISTONE MODIFICATION#0.8660;DIFFUSE LARGE B-CELL LYMPHOMA#0.8630;DNA REPAIR#0.8595;DNA BINDING#0.8580;TUMOR NECROSIS FACTOR#0.8475;OOCYTE#0.8467;MRNA 3' END PROCESSING#0.8423;HISTONE DEACETYLASE#0.8363;HYPERPHOSPHORYLATION#0.8359;S PHASE#0.8354;PROTEASOME#0.8343;PREINITIATION COMPLEX#0.8253;CYTOPLASM#0.8241;EPITHELIAL CELL#0.8208;ADENOCARCINOMA#0.8202;PROTEIN KINASE ACTIVITY#0.8171;DNA REPLICATION#0.8116;GROWTH FACTOR#0.8015;PROTEIN CODING GENE#0.7989;ALVOCIDIB#0.7988;REVERSE TRANSCRIPTION#0.7980;CELL CYCLE REGULATION#0.7958;LYMPHOCYTIC LEUKEMIA#0.7940;IMMUNE RESPONSE#0.7901;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7770;HEPATOCELLULAR CARCINOMA#0.7769;PROTEIN COMPLEX#0.7767;TUMOR CELLS#0.7736;INFLAMMATORY RESPONSE#0.7730;NEUROBLASTOMA#0.7730;SIGNAL TRANSDUCTION#0.7712;CELL DIVISION CYCLE#0.7669;BREAST CANCER CELL#0.7627;RNA PROCESSING#0.7614;PAF1 COMPLEX#0.7570;EMBRYONIC STEM CELL#0.7555;PROTEIN SYNTHESIS#0.7550;LYMPHOID TISSUE#0.7547;OVARIAN CANCER#0.7468;PROTEIN PROTEIN INTERACTION#0.7456;DOMINANT NEGATIVE MUTANT#0.7431;TRANSCRIPTIONAL CONTROL#0.7426;TRANSCRIPTION ELONGATION COMPLEX#0.7412;RNA BINDING PROTEIN#0.7409;MEDIATOR COMPLEX#0.7322;ADIPOSE TISSUE#0.7306;CELL CYCLE REGULATOR#0.7284;STRUCTURE ACTIVITY RELATIONSHIP#0.7243;HOST CELL FACTOR#0.7241;HEMATOPOIETIC CELL#0.7234;CATALYTIC ACTIVITY#0.7194;NUCLEOSOME#0.7188;HISTONE METHYLATION#0.7136;CHROMATIN MODIFICATION#0.7113;MITOSIS#0.7037;FACTOR I#0.6981;VIRAL LIFE CYCLE#0.6972;MACROPHAGE DIFFERENTIATION#0.6832;BONE MARROW#0.6808;VIRAL GENOME#0.6793;CTD PHOSPHATASE#0.6779;CERVICAL#0.6778;OVARIAN#0.6762;DNA DAMAGE RESPONSE#0.6753;ACTINOMYCIN D#0.6720;SPECKLE DOMAIN#0.6664;5 FLUOROURACIL#0.6647;ARGININE#0.6636;CERVICAL CANCER#0.6517;PEROXISOME#0.6516;MECHANISMS OF ACTION#0.6461;CHROMATIN BINDING#0.6384;NUT MIDLINE CARCINOMA#0.6333;CELL CYCLE CONTROL#0.6316;MYOBLAST#0.6313;OLOMOUCINE#0.6305;COLON CANCER#0.6262;MYOGENESIS#0.6239;MRNA TRANSCRIPTION#0.6238;PANCREATIC CANCER#0.6237;POSTTRANSLATIONAL MODIFICATION#0.6191;EMBRYONIC GENOME ACTIVATION#0.6189;MONONUCLEAR CELLS#0.6127;GERMINAL VESICLE#0.6107;ASTROCYTE#0.6072;NEUTROPHIL#0.6043;GERMINAL CENTER#0.6032
10260	PROMOTER BINDING#1.1288;BINDING PROTEIN 1#1.1056;TRANSCRIPTION FACTOR#0.6840;HUMAN CERVICAL CARCINOMA#0.6642
10261	PROTEIN KINASE#0.8917;PROTEIN KINASE C#0.8232;INFLAMMATORY BOWEL DISEASE#0.6406
10262	RNA BINDING#1.0214;U2 SNRNP#1.0162;SPLICEOSOME#0.9992;MRNA SPLICING#0.9981;ACROFACIAL DYSOSTOSIS#0.9893;PRE-MRNA SPLICING#0.9432;DYSOSTOSIS#0.8700;HEPATOCELLULAR CARCINOMA#0.8602;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.8257;CELL CYCLE#0.8256;RNA RECOGNITION MOTIF#0.7699;GENE EXPRESSION#0.7496;RNA SPLICING#0.7245;PROTEIN COMPLEX#0.6883;RNA BINDING PROTEIN#0.6646
10263	TUMOR SUPPRESSOR#0.8284;GENE EXPRESSION#0.6301
102659353	TUMOR NECROSIS FACTOR#0.6482
10265	TRANSCRIPTION FACTOR#0.8411;POTASSIUM CHANNEL#0.6535
10266	ADRENOMEDULLIN RECEPTOR#1.0316;AM BINDING#1.0304;POLYMERASE CHAIN REACTION#1.0227;CGRP RECEPTOR#1.0124;CALCITONIN RECEPTOR#1.0116;GENE EXPRESSION#1.0106;RECEPTOR ACTIVITY#1.0105;ENDOTHELIAL CELL#1.0100;CELL SURFACE#1.0038;SMOOTH MUSCLE#1.0023;VASCULAR SMOOTH MUSCLE CELL#0.9993;SMOOTH MUSCLE CELL#0.9918;MUSCLE CELL#0.9912;ANGIOGENESIS#0.9584;REVERSE TRANSCRIPTION#0.9481;RECEPTOR ANTAGONIST#0.9383;CARDIOMYOCYTE#0.9371;VASODILATOR#0.9365;HYPERTENSION#0.9322;PLASMA MEMBRANE#0.8859;MYOCARDIUM#0.8816;RECEPTOR COMPLEX#0.8723;AMYLIN RECEPTOR#0.8626;CALCITONIN LIKE RECEPTOR#0.8571;SIGNALING PATHWAY#0.8543;EPITHELIAL CELL#0.8535;ARTERY#0.8431;CELL PROLIFERATION#0.8422;TRANSCRIPTASE#0.8374;HYPOXIA#0.8285;HYPOXIC#0.8244;GROWTH FACTOR#0.8179;GLUCAGON RECEPTOR#0.8120;NITRIC OXIDE#0.8120;CANCER CELL#0.8071;CELL DEATH#0.8030;PHEOCHROMOCYTOMA#0.7659;VASCULAR ENDOTHELIAL CELL#0.7635;HYPOTENSIVE#0.7568;UTERUS#0.7563;ADRENOMEDULLIN RECEPTOR ACTIVITY#0.7426;BLOOD VESSEL#0.7263;PEPTIDE HORMONE#0.7224;ISCHEMIA#0.7180;PROTEIN KINASE#0.7023;ADRENOMEDULLIN BINDING#0.6975;ADRENAL GLAND#0.6962;DILATED CARDIOMYOPATHY#0.6800;GESTATION#0.6744;MACROPHAGE#0.6655;ADIPOSE TISSUE#0.6565;COMPLEX I#0.6524;APOPTOSIS#0.6457;SYSTOLIC BLOOD PRESSURE#0.6293;NERVOUS SYSTEM#0.6279;APOPTOTIC#0.6107;CARDIOVASCULAR SYSTEM#0.6047;VENTRICULAR CARDIOMYOCYTE#0.6042;ADRENAL MEDULLA#0.6019
10267	CALCITONIN LIKE RECEPTOR#1.1068;AMYLIN RECEPTOR#1.0467;POLYMERASE CHAIN REACTION#1.0275;ADRENOMEDULLIN RECEPTOR#1.0273;ENDOTHELIAL CELL#1.0273;CGRP RECEPTOR#1.0254;SMOOTH MUSCLE CELL#1.0243;SMOOTH MUSCLE#1.0237;MUSCLE CELL#1.0236;CELL SURFACE#1.0207;RECEPTOR ACTIVITY#1.0198;CALCITONIN RECEPTOR#1.0177;GENE EXPRESSION#1.0160;PLASMA MEMBRANE#1.0080;NERVOUS SYSTEM#0.9957;MIGRAINE#0.9913;RECEPTOR ANTAGONIST#0.9788;RECEPTOR COMPLEX#0.9626;VASCULAR SMOOTH MUSCLE CELL#0.9597;GROWTH FACTOR#0.9536;HYPERTENSION#0.9525;VASODILATOR#0.9271;ARTERY#0.9164;BONE MARROW#0.8969;NITRIC OXIDE#0.8941;MACROPHAGE#0.8912;REVERSE TRANSCRIPTION#0.8908;STEM CELL#0.8884;IMMUNE CELL#0.8862;VASODILATION#0.8811;AMYLIN BINDING#0.8707;CARDIOMYOCYTE#0.8655;PEPTIDE BINDING#0.8369;MAST CELL#0.8354;MUTAGENESIS#0.8340;PROTEIN KINASE#0.8269;LYMPHATIC VESSEL#0.8072;T CELL#0.8040;PURKINJE CELL#0.8034;MESENCHYMAL STEM CELL#0.8001;ALANINE#0.7991;BLOOD VESSEL#0.7975;GROWTH FACTOR RECEPTOR#0.7909;AM BINDING#0.7909;MYOCARDIAL INFARCTION#0.7888;NERVE FIBER#0.7742;ENDOTHELIUM#0.7720;SIGNALING PATHWAY#0.7665;TRANSCRIPTASE#0.7658;SUBSTANCE P#0.7631;ENDOTHELIAL GROWTH FACTOR#0.7559;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7559;PLATELET-DERIVED GROWTH FACTOR#0.7473;PROSTATE CANCER#0.7423;CELLULAR LOCALIZATION#0.7296;OSTEOBLAST#0.7242;SPINAL CORD#0.7208;LYMPHANGIOGENESIS#0.7183;CELL PROLIFERATION#0.7176;ANGIOGENESIS#0.7168;CANCER CELL#0.7161;HYPOXIA#0.7078;SIGNAL TRANSDUCTION#0.7024;CENTRAL NERVOUS SYSTEM#0.6879;ENDOSOME#0.6819;C TERMINAL DOMAIN#0.6782;GLIAL CELL#0.6752;CYTOKINE PRODUCTION#0.6742;TRANSCRIPTION FACTOR#0.6741;HYPOXIC#0.6524;CELL MEMBRANE#0.6491;PRO-INFLAMMATORY#0.6479;VENTRICULAR CARDIOMYOCYTE#0.6399;GLYCOSYLATION#0.6376;NITRIC OXIDE SYNTHASE#0.6305;EPITHELIAL CELL#0.6255;ADENYLATE CYCLASE#0.6189;EXTRACELLULAR REGION#0.6175;TUMOR NECROSIS FACTOR#0.6172;RECEPTOR AGONIST#0.6166;TRYPTOPHAN#0.6145;BRAIN NATRIURETIC PEPTIDE#0.6119;SYSTOLIC BLOOD PRESSURE#0.6077;ALDOSTERONE#0.6072;WOUND HEALING#0.6050
10268	ADRENOMEDULLIN RECEPTOR#1.0364;AMYLIN RECEPTOR#1.0179;CGRP RECEPTOR#1.0128;POLYMERASE CHAIN REACTION#1.0124;CALCITONIN RECEPTOR#1.0115;GENE EXPRESSION#1.0115;RECEPTOR ACTIVITY#1.0046;AM BINDING#0.9890;CELL SURFACE#0.9862;ENDOTHELIAL CELL#0.9319;REVERSE TRANSCRIPTION#0.9317;SMOOTH MUSCLE#0.8966;CARDIOMYOCYTE#0.8872;HYPERTENSION#0.8634;EPITHELIAL CELL#0.8598;PLASMA MEMBRANE#0.8445;RECEPTOR ANTAGONIST#0.8366;SMOOTH MUSCLE CELL#0.8200;MUSCLE CELL#0.8193;ANGIOGENESIS#0.8095;VASODILATOR#0.8039;SIGNALING PATHWAY#0.7507;NITRIC OXIDE#0.7168;GROWTH FACTOR#0.7144;ESTROGEN RECEPTOR#0.7128;ADRENAL GLAND#0.6994;RECEPTOR COMPLEX#0.6984;VASCULAR SMOOTH MUSCLE CELL#0.6841;UTERUS#0.6781;ADENYLATE CYCLASE#0.6571;CANCER CELL#0.6556;MYOCARDIUM#0.6553;GLYCOSYLATION#0.6417;COTRANSLATIONAL MODIFICATION#0.6412;SYSTOLIC BLOOD PRESSURE#0.6321;PROTEIN KINASE#0.6321;TRANSCRIPTASE#0.6171;APOPTOSIS#0.6036;BLOOD VESSEL#0.6028;HYPOTENSIVE#0.6020;GESTATION#0.6011
10269	SENESCENCE#1.0250;PROGERIA#1.0215;ANGIOTENSIN CONVERTING ENZYME#1.0121;NUCLEAR LAMINA#1.0111;NUCLEAR ENVELOPE#1.0062;LIPODYSTROPHY#1.0007;METALLOPROTEINASE INHIBITOR#0.9978;FARNESYL#0.9373;MOUSE EMBRYONIC FIBROBLAST#0.9268;ENDOPLASMIC RETICULUM#0.9153;GROWTH FACTOR#0.8977;STEM CELL#0.8888;CELL PROLIFERATION#0.8634;CELL SURFACE#0.8541;CELLULAR SENESCENCE#0.8106;DNA REPAIR#0.8033;ADIPOSE TISSUE#0.8021;HEMORRHAGIC#0.7871;SMOOTH MUSCLE#0.7851;HIV PROTEASE INHIBITOR#0.7792;AGEING#0.7723;GENE EXPRESSION#0.7659;NUCLEAR MORPHOLOGY#0.7645;PLASMA PROTEIN#0.7616;TOXICITY#0.7487;WOUND HEALING#0.7456;SMOOTH MUSCLE CELL#0.7276;MUSCLE CELL#0.7269;POST-TRANSLATIONAL MODIFICATION#0.7249;DNA DAMAGE RESPONSE#0.7131;BONE MARROW#0.7051;MUTAGENESIS#0.7015;VASCULAR SMOOTH MUSCLE CELL#0.6916;ER MEMBRANE#0.6868;MUSCLE WEAKNESS#0.6825;PROTEIN KINASE#0.6702;NUCLEAR MEMBRANE#0.6589;FRUITING BODY DEVELOPMENT#0.6499;TRANSCRIPTION FACTOR#0.6464;AMYLOID PRECURSOR PROTEIN#0.6344;CLAVICLE#0.6305;TUMOUR NECROSIS FACTOR#0.6273;PARTIAL LIPODYSTROPHY#0.6226;ENDOPLASMIC RETICULUM MEMBRANE#0.6212;GENETIC DISORDER#0.6211;INSULIN-LIKE GROWTH FACTOR#0.6198;EXTRACELLULAR MATRIX#0.6153;ZINC BINDING#0.6133;PRENYLATION#0.6093;ABNORMAL NUCLEAR MORPHOLOGY#0.6092;L-PROLINE#0.6089;BASEMENT MEMBRANE#0.6070;PROGENITOR CELL#0.6037
1026	KINASE INHIBITOR PROTEIN#1.0518;CYCLE INHIBITOR P21#1.0468;SULINDAC#1.0383;MELATONIN#1.0336;CYCLIN BINDING#1.0333;P21 ACTIVATED KINASE#1.0311;CYCLIN-DEPENDENT KINASE ACTIVITY#1.0309;CYTOSINE ARABINOSIDE#1.0303;MRNA STABILIZATION#1.0303;HCV CORE PROTEIN#1.0296;LOVASTATIN#1.0271;HISTONE H3 ACETYLATION#1.0260;PKCDELTA#1.0243;CDC2 KINASE ACTIVITY#1.0212;PCNA COMPLEX#1.0206;INVERTED PAPILLOMA#1.0199;RESPONSE TO UV#1.0186;CELECOXIB#1.0173;METFORMIN#1.0158;FLAVOPIRIDOL#1.0151;OOCYTE MATURATION#1.0146;HYDROXYUREA#1.0145;CYCLIN DEPENDENT KINASE INHIBITOR#1.0145;CDK INHIBITOR#1.0134;CENTROSOME DUPLICATION#1.0124;ARSENITE#1.0120;DEGRADATION OF CYCLIN#1.0120;BERBERINE#1.0113;GASTRIC ADENOCARCINOMA#1.0108;GTPASE ACTIVITY#1.0106;PODOCYTE#1.0104;SALIVARY GLAND#1.0100;KINASE INHIBITOR P27#1.0096;SIMVASTATIN#1.0090;IFN-GAMMA#1.0088;S-PHASE CHECKPOINT#1.0082;PROTEIN KINASE INHIBITOR#1.0079;THYMIDINE KINASE#1.0073;LEIOMYOMA#1.0070;QUERCETIN#1.0068;ARA-C#1.0067;BETA CELL#1.0049;CYCLIN D1-CDK4 COMPLEX#1.0042;BETA-GALACTOSIDASE ACTIVITY#1.0041;KINASE INHIBITOR#1.0040;CONTACT INHIBITION#1.0038;GM-CSF#1.0036;CDK ACTIVITY#1.0035;TROGLITAZONE#1.0028;CYCLIN DEPENDENT KINASE#1.0023;GTP HYDROLYSIS#1.0016;UBIQUITIN LIGASE COMPLEX#1.0015;ENDOMETRIAL CARCINOMA#1.0013;THYMIDYLATE SYNTHASE#1.0012;G0 PHASE#1.0011;LARYNGEAL SQUAMOUS CELL CARCINOMA#1.0005;EMODIN#1.0005;KERATINOCYTE DIFFERENTIATION#0.9999;MOUSE EMBRYO FIBROBLASTS#0.9991;GENISTEIN#0.9989;ACTIVE CASPASE 3#0.9988;RESPONSE TO RADIATION#0.9987;VORINOSTAT#0.9986;BILE DUCT#0.9976;NUCLEOTIDE BINDING#0.9973;DENTATE GYRUS#0.9972;THYMIDYLATE#0.9968;CLEAVED CASPASE 3#0.9967;PITUITARY ADENOMA#0.9965;GTP BINDING#0.9964;OOCYTE#0.9957;RESPONSE TO IONIZING RADIATION#0.9957;TRANSITIONAL CELL CARCINOMA#0.9956;ASTROCYTOMA#0.9950;MITOTIC EXIT#0.9946;ESOPHAGUS#0.9944;HAIR FOLLICLE#0.9941;PROTEIN PHOSPHORYLATION#0.9940;GALACTOSIDASE ACTIVITY#0.9939;SENESCENCE#0.9937;SCHWANN CELL#0.9936;CELL CYCLE TRANSITION#0.9936;LUCIFERASE ACTIVITY#0.9934;NULL CELL#0.9932;INTESTINAL CRYPT#0.9931;HEPATOCYTE PROLIFERATION#0.9930;FATTY ACID SYNTHASE#0.9928;NUCLEOTIDE EXCISION REPAIR#0.9928;GRANULOSA CELL#0.9925;CHONDROCYTE#0.9925;MITOMYCIN#0.9923;MITOMYCIN C#0.9921;P53 BINDING#0.9920;HEME OXYGENASE 1#0.9920;PHOSPHATASE AND TENSIN HOMOLOG#0.9914;CENTROSOME#0.9913;MURINE DOUBLE MINUTE#0.9913;ADRIAMYCIN#0.9910;ACTIVATED CASPASE 3#0.9910;BINDING PROTEIN 3#0.9906;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9906;ENHANCER BINDING PROTEIN#0.9896;MESOTHELIOMA CELL#0.9895;ONCOGENE INDUCED SENESCENCE#0.9893;KERATINOCYTE PROLIFERATION#0.9891;RESVERATROL#0.9887;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9886;HETEROCHROMATIN#0.9883;LYMPH NODE METASTASES#0.9883;CELL CYCLE DYSREGULATION#0.9882;CELL CYCLE REGULATOR#0.9882;ENHANCER BINDING#0.9879;EXTRACELLULAR REGULATED KINASE#0.9879;CELL DIVISION CYCLE#0.9879;ZINC FINGER PROTEIN#0.9878;BIOTIN#0.9877;RETINOIC ACID RECEPTOR#0.9876;MITOTIC CATASTROPHE#0.9873;BLADDER CARCINOMA#0.9872;C TERMINAL DOMAIN#0.9872;PANCREATIC ADENOCARCINOMA#0.9871;ENDOMETRIAL CANCER#0.9869;DNA DAMAGE CHECKPOINT#0.9868;MESANGIAL CELL#0.9867;GUANOSINE#0.9863;PREADIPOCYTE#0.9861;MYOCYTES#0.9861;CYTOCHROME P450#0.9860;PROTEIN BINDING#0.9859;COLORECTAL ADENOCARCINOMA#0.9857;ALVEOLAR EPITHELIAL CELL#0.9857;BORTEZOMIB#0.9855;BETA GALACTOSIDASE#0.9854;MYOSIN HEAVY CHAIN#0.9853;NEURITE OUTGROWTH#0.9853;TRANSCRIPTIONAL CONTROL#0.9851;ESOPHAGEAL CARCINOMA#0.9851;PROTEIN STABILIZATION#0.9850;ACINAR CELL#0.9850;MAST CELL#0.9846;STRESS-INDUCED PREMATURE SENESCENCE#0.9845;FORMALIN#0.9843;STEM CELL PROLIFERATION#0.9842;DEPHOSPHORYLATION#0.9841;UBIQUITIN PROTEASOME PATHWAY#0.9841;OXYGENASE#0.9840;INDUCIBLE NITRIC OXIDE#0.9840;RECURRENCE FREE SURVIVAL#0.9839;DNA LIGASE#0.9839;BLEOMYCIN#0.9838;ESOPHAGEAL CANCER#0.9838;TAXOL#0.9835;VITAMIN D3#0.9835;HYPERPHOSPHORYLATION#0.9834;ACTINOMYCIN D#0.9833;STAUROSPORINE#0.9830;HUMAN PAPILLOMA VIRUS#0.9830;CREB BINDING#0.9829;GASTRIC MUCOSA#0.9829;TUBULAR EPITHELIAL CELL#0.9829;ARSENIC TRIOXIDE#0.9828;MALIGNANT PLEURAL MESOTHELIOMA#0.9827;EPITHELIAL OVARIAN CANCER#0.9827;ACTIVATION OF APOPTOSIS#0.9826;NUCLEAR LOCALIZATION SIGNAL#0.9824;GROWTH FACTOR BINDING#0.9823;HUMAN IMMUNODEFICIENCY VIRUS#0.9822;TETRACYCLINE#0.9822;ATAXIA TELANGIECTASIA MUTATED#0.9821;METHYLATION SPECIFIC PCR#0.9821;PROTEASOME PATHWAY#0.9819;YEAR SURVIVAL RATE#0.9819;PANCREATIC CARCINOMA#0.9818;VSMC PROLIFERATION#0.9818;FARNESYL#0.9818;ANTI APOPTOSIS#0.9817;GROWTH REGULATOR#0.9816;MAPK ACTIVATION#0.9816;DISEASE SPECIFIC SURVIVAL#0.9816;NON-SMALL CELL LUNG CARCINOMA#0.9815;VITAMIN D RECEPTOR#0.9814;PARATHYROID#0.9814;PULMONARY ARTERY#0.9813;HODGKIN'S LYMPHOMA#0.9813;APOPTOSIS INDUCING FACTOR#0.9813;FRAGMENT LENGTH POLYMORPHISM#0.9813;DNA TOPOISOMERASE#0.9812;PROSTATE SPECIFIC ANTIGEN#0.9811;CD4+ T CELL#0.9811;HISTONE ACETYLATION#0.9811;MYELOID CELL#0.9810;PAPILLOMA#0.9807;ENTEROCYTE#0.9806;MYOBLAST#0.9804;ACTIVIN RECEPTOR#0.9802;CARDIOMYOCYTE#0.9801;REPORTER GENE ASSAY#0.9801;HOMOLOGOUS RECOMBINATION#0.9800;B CELL LYMPHOMA#0.9799;HEPATOCYTE GROWTH FACTOR#0.9799;SMALL INTESTINE#0.9797;ORAL CANCER CELL#0.9796;ISCHEMIA REPERFUSION INJURY#0.9795;RETINOBLASTOMA#0.9794;TOPOISOMERASE II#0.9794;EPITHELIAL CELL PROLIFERATION#0.9793;INTESTINAL EPITHELIAL CELL#0.9792;HEPATITIS C#0.9792;REGULATION OF APOPTOSIS#0.9790;ROSIGLITAZONE#0.9790;QUANTITATIVE REVERSE TRANSCRIPTION#0.9788;RESPONSE TO GENOTOXIC STRESS#0.9788;RESPONSE TO TREATMENT#0.9787;TRANSACTIVATION#0.9787;T CELL PROLIFERATION#0.9786;HUMAN MAMMARY EPITHELIAL#0.9786;COLONY-STIMULATING FACTOR#0.9786;CAFFEINE#0.9786;PROTEIN DEGRADATION#0.9784;DEMETHYLATION#0.9784;QUIESCENCE#0.9783;AORTIC SMOOTH MUSCLE CELLS#0.9781;CYCLIC AMP#0.9781;LUNG FIBROBLASTS#0.9781;DIABETIC NEPHROPATHY#0.9780;SMOOTH MUSCLE ACTIN#0.9779;HYPOXIA INDUCIBLE FACTOR#0.9778;NUCLEOTIDE EXCHANGE FACTOR#0.9778;DNA SYNTHESIS#0.9778;ANTIGEN BINDING#0.9778;MEGAKARYOCYTE#0.9778;BONE MARROW CELLS#0.9777;1α,25-DIHYDROXYVITAMIN D3#0.9777;ETOPOSIDE#0.9777;COLORECTAL CARCINOMA#0.9776;MIMOSINE#0.9776;MISMATCH REPAIR#0.9775;COLON CARCINOMA#0.9775;TELOMERE#0.9774;APOPTOTIC PROCESS#0.9774;BASAL CELL#0.9774;ELLAGIC ACID#0.9773;CELLULAR LOCALIZATION#0.9773;INTERFERON REGULATORY FACTOR#0.9773;NEURITE#0.9773;METAPLASIA#0.9771;HEPATITIS C VIRUS#0.9770;GALECTIN#0.9768;INTRACELLULAR LOCALIZATION#0.9768;MAP KINASE CASCADE#0.9766;MYOBLAST DIFFERENTIATION#0.9764;HEPATOMA CELLS#0.9763;ESTROGEN RECEPTOR ALPHA#0.9763;VASCULAR CELL#0.9763;ENDOMETRIUM#0.9762;HYPOXIA#0.9762;MOUSE EMBRYONIC FIBROBLAST#0.9762;PROGESTERONE#0.9761;LIVER REGENERATION#0.9761;PROTEIN KINASE B#0.9760;DOMINANT NEGATIVE MUTANT#0.9760;INTRINSIC APOPTOSIS#0.9758;RESPONSE TO STRESS#0.9756;CELL CYCLE CHECKPOINT#0.9754;OXALIPLATIN#0.9754;DECITABINE#0.9753;REGULATION OF CELL CYCLE#0.9751;INTERSTITIAL CELL#0.9751;INHIBITION OF APOPTOSIS#0.9751;BRONCHIAL EPITHELIAL CELLS#0.9751;RHABDOMYOSARCOMA#0.9750;GUANINE#0.9750;ANDROGEN RECEPTOR#0.9750;TERMINAL DIFFERENTIATION#0.9750;TELOMERASE ACTIVITY#0.9749;DOCETAXEL#0.9749;HISTONE ACETYLTRANSFERASE#0.9747;CELL CYCLE#0.9745;PULMONARY HYPERTENSION#0.9745;CAMPTOTHECIN#0.9744;MAP KINASE#0.9744;GEMCITABINE#0.9744;RNA BINDING#0.9743;NF-KAPPAB ACTIVATION#0.9743;INHIBITION OF DNA REPLICATION#0.9742;G2 PHASE#0.9741;NEURAL CELL#0.9741;DEXAMETHASONE#0.9741;CELL ADHESION MOLECULE#0.9741;GLYCINE#0.9740;POSTTRANSLATIONAL MODIFICATION#0.9739;CARCINOMA IN SITU#0.9739;HYPERSENSITIVITY#0.9739;NEUROGENESIS#0.9738;MYOTUBE#0.9737;OVARIAN CARCINOMA#0.9737;INVASIVE CARCINOMA#0.9736;REPLICATIVE SENESCENCE#0.9735;BINDING PROTEIN 1#0.9735;KAPOSI'S SARCOMA#0.9735;CPT-11#0.9735;OSTEOBLAST#0.9733;P53 SIGNALING PATHWAY#0.9733;RNA BINDING PROTEIN#0.9732;NEPHROPATHY#0.9732;GLUCOCORTICOID RECEPTOR#0.9732;OSTEOCLAST#0.9731;NOCODAZOLE#0.9731;PROTEIN COMPLEX#0.9731;CELL CYCLE PATHWAY#0.9730;CELL CYCLE PHASE#0.9728;MELANOCYTE#0.9727;COLON ADENOCARCINOMA#0.9726;SMC PROLIFERATION#0.9726;MYOGENESIS#0.9725;ARGININE#0.9725;REPLICATION FORK#0.9725;ATAXIA TELANGIECTASIA#0.9723;COMPLEX I#0.9723;TELOMERASE REVERSE TRANSCRIPTASE#0.9722;PROXIMAL TUBULAR CELL#0.9722;NEURAL STEM CELL#0.9722;INTRINSIC APOPTOTIC PATHWAY#0.9720;SORAFENIB#0.9720;DNA REPLICATION#0.9719;FOCAL ADHESION KINASE#0.9719;LIGHT CHAIN 3#0.9719;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9719;CELL ACTIVATION#0.9718;NUCLEAR EXPORT#0.9718;HISTONE DEACETYLATION#0.9718;LOCALISATION#0.9718;LYMPH NODE METASTASIS#0.9718;HUMAN BRONCHIAL EPITHELIAL#0.9718;HUMAN CERVICAL CARCINOMA#0.9717;B CELL#0.9716;HISTONE MODIFICATION#0.9716;CELL QUIESCENCE#0.9716;OSTEOBLAST DIFFERENTIATION#0.9715;MESENCHYMAL CELL#0.9715;DISEASE FREE SURVIVAL#0.9714;LINES OF EVIDENCE#0.9714;ORAL SQUAMOUS CELL CARCINOMA#0.9713;METHIONINE#0.9713;INHIBITION OF CELL PROLIFERATION#0.9713;MAPK SIGNALLING#0.9712;DUAL LUCIFERASE REPORTER#0.9711;ASTROCYTE#0.9710;INHIBITION OF GROWTH#0.9710;HEMATOPOIETIC PROGENITOR CELL#0.9709;TOPOISOMERASE#0.9708;ULCERATIVE COLITIS#0.9708;GASTROINTESTINAL TRACT#0.9708;CERVIX#0.9706;MICROTUBULE ASSOCIATED PROTEIN#0.9706;THYROID CANCER#0.9705;SMOOTH MUSCLE CELL PROLIFERATION#0.9703;GERM CELL#0.9703;LEUKOCYTE#0.9702;MYOFIBROBLAST#0.9701;CELL CYCLE ARREST#0.9700;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9700;HEPATITIS B VIRUS#0.9699;CELL NUCLEUS#0.9699;KINASE ACTIVITY#0.9698;COLITIS#0.9697;ANAPLASTIC THYROID CARCINOMA#0.9696;MUSCLE CELL PROLIFERATION#0.9696;ENDOTHELIAL GROWTH FACTOR#0.9696;CELLULAR GROWTH#0.9695;DNA REPAIR PROTEIN#0.9695;REGULATION OF CELLULAR#0.9695;GLYCOGEN SYNTHASE KINASE#0.9695;INHIBITION OF CELL GROWTH#0.9694;CATALYTIC ACTIVITY#0.9694;PROTEIN KINASE C#0.9693;GERMINAL CENTER#0.9692;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9692;ETHANOL#0.9692;BASE EXCISION REPAIR#0.9690;METASTATIC MELANOMA#0.9690;ALKALINE PHOSPHATASE#0.9689;CASPASE-3 ACTIVITY#0.9689;CELLULAR SENESCENCE#0.9689;72-HOURS#0.9688;MONOCYTE#0.9688;KERATINOCYTE#0.9687;MUTAGENESIS#0.9687;HYPOXIC#0.9686;EARLY GROWTH RESPONSE#0.9686;PROTEIN KINASE A#0.9685;LYMPHOCYTIC LEUKEMIA#0.9685;THYROID CARCINOMA#0.9685;NADPH OXIDASE#0.9684;FIBROSARCOMA#0.9684;HEAD AND NECK CANCER#0.9683;NECK CANCER#0.9683;DEACETYLASE ACTIVITY#0.9683;GASTRITIS#0.9683;HEMATOPOIETIC CELL#0.9682;MAMMARY GLAND#0.9682;ADIPOCYTE#0.9682;CELL MOTILITY#0.9681;PLURIPOTENT STEM CELL#0.9681;G1 PHASE#0.9680;CELL KILLING#0.9680;DIGESTION#0.9680;PHOSPHOLIPASE C#0.9679;TESTOSTERONE#0.9678;HEAT SHOCK PROTEIN#0.9677;VASCULAR ENDOTHELIAL CELL#0.9677;5-AZA-2'-DEOXYCYTIDINE#0.9675;TAMOXIFEN#0.9675;RIBOSOMAL PROTEIN#0.9674;NITRIC OXIDE SYNTHASE#0.9674;DNA DAMAGE RESPONSE#0.9674;CELL CYCLE CONTROL#0.9673;HEPATITIS B#0.9673;TUBE FORMATION#0.9671;MALIGNANT GLIOMA#0.9670;PRECURSOR CELL#0.9670;ENDOTHELIAL CELL PROLIFERATION#0.9670;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9670;CASPASE ACTIVATION#0.9670;DEATH RECEPTOR#0.9668;2'-DEOXYCYTIDINE#0.9668;REVERSE TRANSCRIPTION#0.9668;CYTOKINESIS#0.9667;STRESS FIBER#0.9666;ADJACENT NORMAL TISSUE#0.9666;L-CYSTEINE#0.9665;HIGH MOBILITY GROUP#0.9665;OXIDATIVE DNA DAMAGE#0.9663;S PHASE#0.9662;MAMMARY EPITHELIAL CELL#0.9661;EPSTEIN BARR VIRUS#0.9661;VITAMIN C#0.9661;BREAST CANCER PATIENTS#0.9661;PROTEIN SYNTHESIS#0.9660;PKC ACTIVITY#0.9659;PACLITAXEL#0.9658;TRANSCRIPTASE#0.9658;PROTEASOME#0.9658;PROTEIN PROTEIN INTERACTION#0.9657;NERVE GROWTH FACTOR#0.9657;NEUTROPHIL#0.9656;ISCHEMIA#0.9656;BUDDING#0.9655;GLUTATHIONE PEROXIDASE#0.9655;PROSTATE EPITHELIAL CELL#0.9655;CELLULAR QUIESCENCE#0.9654;MITOTIC SPINDLE#0.9653;ACTIN POLYMERIZATION#0.9653;SUMOYLATION#0.9653;THYMOCYTE#0.9652;MRNA DECAY#0.9652;ADVANCED BREAST CANCER#0.9652;REGULATION OF CELL PROLIFERATION#0.9651;VIRAL REPLICATION#0.9650;COLORECTAL ADENOMA#0.9650;INDUCED PLURIPOTENT STEM CELL#0.9649;HUMAN MESENCHYMAL STEM#0.9649;LYMPH NODE#0.9649;ALZHEIMER'S DISEASE#0.9648;PLASMA MEMBRANE#0.9648;LUNG ADENOCARCINOMA#0.9648;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9647;STEM CELL MARKER#0.9647;LUNG CARCINOMA#0.9647;GEFITINIB#0.9646;GRANULOCYTE#0.9646;AGEING#0.9645;HEPATIC STELLATE CELL#0.9644;BREAST CARCINOMA#0.9643;UBIQUITIN#0.9642;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9642;DNA METHYLTRANSFERASE#0.9641;GROWTH FACTOR RECEPTOR#0.9641;EPIGALLOCATECHIN#0.9640;PROSTATE CARCINOMA#0.9640;CERVICAL CANCER CELL LINES#0.9639;ADENOSINE MONOPHOSPHATE#0.9639;LYSINE#0.9639;M PHASE#0.9639;BLOOD VESSEL#0.9639;RAPAMYCIN#0.9639;SEQUENCE SPECIFIC DNA BINDING#0.9639;ADENOSINE#0.9639;MITOTIC ENTRY#0.9639;DOXORUBICIN#0.9638;TUMOR TISSUES#0.9638;APOPTOSIS SIGNALING#0.9638;CASPASE ACTIVITY#0.9637;EPIDERMAL GROWTH FACTOR#0.9637;OVARIAN CANCER#0.9636;GLIAL CELL#0.9635;ADIPOCYTE DIFFERENTIATION#0.9634;SUBEROYLANILIDE HYDROXAMIC ACID#0.9634;FOCAL ADHESION#0.9634;SPINDLE CHECKPOINT#0.9634;BONE MORPHOGENETIC PROTEIN#0.9633;REACTIVE OXYGEN SPECIES GENERATION#0.9632;FIBROBLAST GROWTH FACTOR#0.9632;CISPLATIN#0.9630;EMBRYONAL CARCINOMA#0.9629;ELECTROPHORETIC MOBILITY SHIFT#0.9629;T CELL#0.9628;VINCRISTINE#0.9627;RNA INTERFERENCE#0.9626;T-CELL LEUKEMIA#0.9626;TROPHOBLAST#0.9625;EPITHELIAL TO MESENCHYMAL#0.9624;MELANOMA CELL LINES#0.9624;MEDULLOBLASTOMA#0.9624;TRANSFORMING GROWTH FACTOR BETA#0.9623;CORD BLOOD#0.9623;TRANSFORMING GROWTH FACTOR ALPHA#0.9623;PANCREATIC DUCTAL ADENOCARCINOMA#0.9623;CELL DEVELOPMENT#0.9622;OVARIAN#0.9622;ACTIN CYTOSKELETON#0.9622;RHEUMATOID ARTHRITIS#0.9622;LUNG EPITHELIAL CELL#0.9621;GESTATION#0.9621;SIGNAL TRANSDUCER#0.9620;HEMATOPOIETIC STEM CELL#0.9618;SENSITIZATION#0.9618;CHRONIC MYELOID LEUKEMIA#0.9617;ANAPHASE#0.9616;DNA REPAIR#0.9616;REGULATION OF CELL GROWTH#0.9616;MYELODYSPLASTIC SYNDROME#0.9615;LIVER DISEASE#0.9615;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9614;GENE SILENCING#0.9614;ENDOMETRIAL ADENOCARCINOMA#0.9614;POST-TRANSLATIONAL MODIFICATION#0.9613;RENAL CELL CARCINOMA#0.9612;SERTOLI CELL#0.9612;ALANINE#0.9611;CERVICAL#0.9611;PHOSPHATASE ACTIVITY#0.9611;SUPEROXIDE DISMUTASE#0.9611;PROGESTIN#0.9610;POLYMERASE CHAIN REACTION#0.9610;DERMAL FIBROBLAST#0.9610;HUMAN DERMAL FIBROBLAST#0.9609;SIGNALLING PATHWAY#0.9609;CELL DIVISION#0.9609;MACROPHAGE#0.9608;LEUCINE#0.9608;EPITHELIAL CELL DIFFERENTIATION#0.9608;SKIN FIBROBLASTS#0.9607;ADIPOSE TISSUE#0.9606;VALPROIC ACID#0.9605;MICROTUBULE#0.9605;DOUBLE STRAND BREAK#0.9604;SIGNALING CASCADE#0.9604;PROGRAMMED CELL DEATH#0.9603;BETA-2#0.9603;DNA METHYLATION#0.9603;FLOW CYTOMETRY ASSAY#0.9603;HISTONE METHYLTRANSFERASE#0.9603;MESENCHYMAL STROMAL CELL#0.9602;GINSENOSIDE RG1#0.9602;CELL CYCLE REGULATION#0.9602;CONNECTIVE TISSUE#0.9602;REGULATION OF GENE EXPRESSION#0.9602;AUTOPHAGY#0.9602;CHROMATIN REMODELING#0.9602;TO TUMOR PROGRESSION#0.9601;MITOCHONDRIAL DNA#0.9601;PLASMA CELL#0.9601;T LYMPHOCYTE#0.9600;RETINOID X RECEPTOR#0.9600;QUANTITATIVE REAL TIME#0.9600;PANCREATIC CANCER#0.9599;INVASIVE DUCTAL CARCINOMA#0.9599;CELL MEMBRANE#0.9599;MAPK SIGNALING#0.9598;ENDOPLASMIC RETICULUM STRESS#0.9597;PROTEIN KINASE ACTIVITY#0.9597;ENZYME ACTIVITY#0.9595;URINARY BLADDER#0.9594;IMATINIB#0.9594;MODE OF ACTION#0.9594;2'-DEOXYURIDINE#0.9593;NEURONAL CELLS#0.9593;CERVICAL CANCER#0.9593;PLATELET-DERIVED GROWTH FACTOR#0.9593;NITRIC OXIDE#0.9592;NOTCH SIGNALING PATHWAY#0.9592;CELL ADHESION#0.9591;VASCULAR DISEASE#0.9591;HYPERGLYCEMIA#0.9590;N-ACETYLCYSTEINE#0.9590;TARGET OF RAPAMYCIN#0.9589;PROTEIN KINASE#0.9589;ACTIN FILAMENT#0.9588;ESTRADIOL#0.9587;COLON CANCER#0.9586;GENOTOXIC#0.9586;SIGNALING MOLECULE#0.9585;IMMUNE CELL#0.9585;CELL DIFFERENTIATION#0.9584;ACETYLCYSTEINE#0.9584;ACUTE PROMYELOCYTIC LEUKEMIA#0.9584;MUTAGENIC#0.9583;POLY ADP RIBOSE#0.9583;PRIMARY BREAST CANCER#0.9583;NEUROBLASTOMA#0.9583;COLORECTAL#0.9582;RETINOIC ACID#0.9581;CYTOCHROME C RELEASE#0.9581;PULMONARY FIBROSIS#0.9581;MYOBLAST PROLIFERATION#0.9580;ALL TRANS RETINOIC ACID#0.9580;HYPERTENSION#0.9579;PROTEIN TYROSINE KINASE#0.9579;THYMIDINE#0.9579;ADENOCARCINOMA#0.9579;EPITHELIAL MESENCHYMAL TRANSITION#0.9578;ENDOPLASMIC RETICULUM#0.9577;INSULIN-LIKE GROWTH FACTOR#0.9577;MORPHOGENESIS#0.9577;MANTLE CELL LYMPHOMA#0.9577;STROMAL CELL#0.9576;MONONUCLEAR CELLS#0.9576;SKELETAL MUSCLE#0.9575;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9575;INVASIVE BREAST CANCER#0.9575;SQUAMOUS CELL CANCER#0.9574;STROMA#0.9574;HEMATOPOIESIS#0.9574;RECEPTOR TYROSINE KINASE#0.9573;INTERPHASE#0.9573;MYOGENIC REGULATORY FACTOR#0.9572;SQUAMOUS CELL CARCINOMA#0.9571;TUMOR SUPPRESSOR#0.9570;VIRAL INFECTION#0.9570;EMBRYONIC KIDNEY#0.9568;LUMINAL#0.9568;CANCER STEM CELL#0.9567;RIBOSE#0.9567;ANCHORAGE INDEPENDENT GROWTH#0.9566;MITOSIS#0.9566;DIFFUSE LARGE B-CELL LYMPHOMA#0.9566;GENOTOXICITY#0.9565;APOPTOSIS#0.9565;PRO-INFLAMMATORY#0.9565;METHOTREXATE#0.9565;MITOGEN ACTIVATED PROTEIN#0.9564;NUCLEOSOME#0.9563;CANCER SPECIFIC SURVIVAL#0.9563;GLIOBLASTOMA MULTIFORME#0.9563;INFLAMMATORY RESPONSE#0.9561;ENDOMETRIOSIS#0.9561;TUMOR NECROSIS FACTOR#0.9561;PERIPHERAL BLOOD#0.9560;CYTOPLASM#0.9560;ATHEROSCLEROTIC#0.9560;HOST CELL#0.9559;TRANSFORMING GROWTH FACTOR#0.9559;ACUTE LEUKEMIA#0.9558;INSULIN RECEPTOR#0.9557;FIBROBLAST PROLIFERATION#0.9557;PEROXISOME#0.9557;ENDOTHELIAL NITRIC OXIDE#0.9556;DOXYCYCLINE#0.9556;REGENERATION#0.9556;FACTOR I#0.9556;LIVER CIRRHOSIS#0.9555;MOLAR#0.9554;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9554;ACTIVATING TRANSCRIPTION FACTOR#0.9554;COLORECTAL CANCER#0.9552;SMOOTH MUSCLE#0.9552;TUMOUR NECROSIS FACTOR#0.9552;PI3K SIGNALING#0.9551;ROS GENERATION#0.9551;BONE FORMATION#0.9551;LIVER CANCER#0.9550;ADVANCED GLYCATION END#0.9550;CELL COUNTING KIT#0.9550;PROGENITOR CELL#0.9549;HISTONE METHYLATION#0.9549;AKT SIGNALING#0.9549;ESTROGEN RECEPTOR#0.9548;DEDIFFERENTIATION#0.9548;CELL POLARITY#0.9548;HUMAN UMBILICAL VEIN#0.9548;INDOLE#0.9547;NECROTIC#0.9547;UMBILICAL CORD#0.9545;CYTOCHROME C#0.9545;OXIDATIVE STRESS RESPONSE#0.9544;UMBILICAL VEIN#0.9544;HUMAN EMBRYONIC STEM#0.9544;ACUTE MYELOID LEUKEMIA#0.9543;SKIN CANCER#0.9542;OSTEOSARCOMA CELL LINES#0.9541;TONGUE CANCER#0.9540;CARCINOGEN#0.9540;GLUTATHIONE#0.9540;ABERRANT CRYPT FOCI#0.9540;GAP JUNCTION#0.9540;ENDOTHELIAL CELL#0.9540;ONCOGENIC#0.9539;DNA BINDING#0.9538;ONCOGENESIS#0.9538;HEPATOCELLULAR CARCINOMA CELL#0.9537;TYROSINE KINASE INHIBITOR#0.9537;26S PROTEASOME#0.9536;ARTERY#0.9536;WNT SIGNALING PATHWAY#0.9535;PROSTATE CANCER#0.9535;THYMINE#0.9534;B LYMPHOCYTE#0.9534;CHOLANGIOCARCINOMA#0.9533;VASCULAR SMOOTH MUSCLE CELL#0.9533;SIGNAL TRANSDUCTION#0.9531;EMBRYONIC STEM CELL#0.9530;5 FLUOROURACIL#0.9530;SMOOTH MUSCLE CELL#0.9529;HUMAN PANCREATIC CANCER#0.9529;COLONY FORMATION ASSAY#0.9528;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.9528;MUSCLE CELL#0.9527;FLUOROURACIL#0.9526;KIDNEY DISEASE#0.9525;APOPTOTIC#0.9523;ANAPLASTIC THYROID CANCER#0.9522;MYELOID LEUKEMIA#0.9521;CELL MATURATION#0.9521;CHROMOSOME SEGREGATION#0.9521;HUMAN GASTRIC CARCINOMA#0.9520;APOPTOTIC SIGNALING PATHWAY#0.9520;CERVICAL ADENOCARCINOMA#0.9517;ADIPOGENESIS#0.9516;GROWTH HORMONE#0.9515;MITOCHONDRIAL DAMAGE#0.9514;CELL PROLIFERATION#0.9513;DIABETES MELLITUS#0.9512;TOPICAL#0.9511;SPINAL CORD#0.9510;APOPTOTIC CELL DEATH#0.9509;ENDOTHELIUM#0.9508;GENE EXPRESSION#0.9508;RESPONSE TO OXIDATIVE STRESS#0.9508;BREAST CANCER#0.9508;DENDRITIC CELL#0.9508;MULTIPLE MYELOMA#0.9507;KIDNEY CANCER#0.9507;STREPTOZOTOCIN#0.9505;CREATINE KINASE#0.9505;GLYCOLYSIS#0.9505;BREAST CANCER CELL#0.9504;GROWTH FACTOR#0.9504;IMMUNE SYSTEM#0.9503;CELL MIGRATION#0.9503;BONE MARROW#0.9502;FLOW CYTOMETRY ANALYSIS#0.9501;AIRWAY EPITHELIAL CELL#0.9501;TRADITIONAL CHINESE MEDICINE#0.9500;NUCLEIC ACID#0.9499;HIGH FAT DIET#0.9499;CANCER RELATED DEATH#0.9498;RECEPTOR ANTAGONIST#0.9498;CENTRAL NERVOUS SYSTEM#0.9497;LUNG CANCER#0.9497;HISTONE DEACETYLASE INHIBITOR#0.9497;CELL GROWTH#0.9496;PHOSPHATIDYLSERINE#0.9496;LUNG DISEASE#0.9496;ACETYLTRANSFERASE ACTIVITY#0.9495;EPITHELIAL CELL#0.9494;NUCLEOLUS#0.9494;IMMUNE RESPONSE#0.9492;LYMPHOID CELL#0.9492;GALLBLADDER CANCER#0.9491;ANAPHASE PROMOTING COMPLEX#0.9491;CASPASE INHIBITOR#0.9489;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9489;DRUG RESISTANCE#0.9488;COMPARATIVE GENOMIC HYBRIDIZATION#0.9488;BREAST ADENOCARCINOMA#0.9487;BONE MARROW STROMAL#0.9487;ADULT T-CELL LEUKEMIA#0.9485;MESENCHYMAL STEM CELL#0.9485;TRANSMISSION ELECTRON MICROSCOPY#0.9484;NEURAL CREST#0.9483;HISTONE DEACETYLASE#0.9483;TUMOR CELLS#0.9482;GDP DISSOCIATION INHIBITOR#0.9482;HUMAN BREAST CANCER#0.9481;ADVANCED PROSTATE CANCER#0.9480;ASPARTATE#0.9480;T CELL ACTIVATION#0.9479;TUMOR GROWTH INHIBITION#0.9479;HUMAN HEPATOMA CELL LINES#0.9478;PROTEOGLYCAN#0.9477;ORAL CAVITY#0.9477;CPG ISLAND METHYLATION#0.9476;INDUCTION OF APOPTOSIS#0.9474;MYOGENIC CELL#0.9474;SOFT TISSUE SARCOMA#0.9474;OBESE#0.9473;MITOCHONDRIAL MEMBRANE#0.9472;PROTEIN TYROSINE PHOSPHATASE#0.9472;EOSIN#0.9471;CELL EXPANSION#0.9471;ANGIOGENESIS#0.9470;MRNA SYNTHESIS#0.9470;CELL SURFACE#0.9469;SKELETAL MUSCLE CELLS#0.9469;INTRACELLULAR SIGNALING PATHWAY#0.9467;CHRONIC LIVER DISEASE#0.9467;MITOCHONDRIA#0.9465;TRANSCRIPTION FACTOR#0.9464;ATHEROSCLEROSIS#0.9463;SIGNALING PATHWAY#0.9463;LIPID METABOLISM#0.9462;MAPK CASCADE#0.9460;CANCER CELL#0.9457;DNA FRAGMENTATION#0.9456;REACTIVE OXYGEN SPECIES#0.9456;PROPIDIUM#0.9456;XERODERMA PIGMENTOSUM#0.9455;CELL DEATH#0.9454;HERPES SIMPLEX#0.9454;STEM CELL#0.9451;TYPE 2 DIABETES#0.9450;HEPATOCELLULAR CARCINOMA#0.9449;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9449;BASEMENT MEMBRANE#0.9447;ANEMIA#0.9446;TUMOR ANTIGEN#0.9445;SIGNALLING CASCADE#0.9443;DNASE#0.9443;ANTISENSE RNA#0.9442;DNA DEMETHYLATION#0.9441;NICOTINAMIDE#0.9440;ARYL HYDROCARBON RECEPTOR#0.9439;WOUND HEALING#0.9439;RENAL FIBROSIS#0.9438;MOUSE EMBRYONIC STEM#0.9438;CYTOTOXICITY#0.9436;LYMPH NODE INVOLVEMENT#0.9436;EXTRACELLULAR MATRIX#0.9436;HIGH GRADE DYSPLASIA#0.9433;NERVOUS SYSTEM#0.9432;RNA SYNTHESIS#0.9432;PHEOCHROMOCYTOMA#0.9432;LIGASE ACTIVITY#0.9431;NUCLEUS PULPOSUS#0.9428;METAPHASE#0.9426;MECHANISM OF ACTION#0.9426;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9424;NEURODEGENERATIVE DISEASE#0.9423;SPINDLE ASSEMBLY#0.9420;GALLBLADDER#0.9420;MULTIPLE MYELOMA CELLS#0.9419;BONE MARROW STROMAL CELL#0.9419;FLUORESCEIN#0.9418;MEMBRANE DEPOLARIZATION#0.9417;STRUCTURE ACTIVITY RELATIONSHIP#0.9417;HERPES SIMPLEX VIRUS#0.9415;ANTIOXIDANT ACTIVITY#0.9414;SEQUESTERING#0.9414;STOMACH CANCER#0.9411;MECHANISMS OF ACTION#0.9409;GLUTAMINE#0.9407;OLIGODENDROCYTE#0.9406;SPHINGOSINE#0.9403;ORNITHINE DECARBOXYLASE#0.9401;PHOSPHATASE 2A#0.9399;FLUDARABINE#0.9398;MARROW STROMAL CELLS#0.9395;ESTROGENS#0.9394;GROWTH OF CELL#0.9392;RENAL CARCINOMA#0.9391;CANCER STEM-LIKE CELL#0.9390;MICROVASCULAR ENDOTHELIAL CELL#0.9388;TOXICITY#0.9386;PERIPHERAL BLOOD LYMPHOCYTES#0.9386;OLIGODENDROGLIOMA#0.9384;APOPTOTIC PROGRAM#0.9383;CHEMOKINE RECEPTOR#0.9383;CYCLIN E KINASE ACTIVITY#0.9382;20S PROTEASOME#0.9381;PRIMARY OPEN ANGLE GLAUCOMA#0.9381;STEM CELL LIKE#0.9381;UNFOLDED PROTEIN RESPONSE#0.9380;HEPARIN#0.9373;GLYCERALDEHYDE-3-PHOSPHATE#0.9371;LYMPHOCYTE PROLIFERATION#0.9370;CAMKII#0.9370;PROTEIN PHOSPHATASE 2A#0.9368;SINGLE STRAND BREAK#0.9368;CARDIOMYOCYTE PROLIFERATION#0.9368;CORONARY ARTERY#0.9367;PLEOMORPHIC ADENOMA#0.9367;ACT D#0.9367;OPEN ANGLE GLAUCOMA#0.9365;UBIQUITIN PROTEASOME SYSTEM#0.9362;AZACYTIDINE#0.9360;TEMOZOLOMIDE#0.9360;IRINOTECAN#0.9359;CALCITRIOL#0.9358;UROKINASE#0.9357;TO THE PROGRESSION#0.9357;INFLAMMATORY CELL#0.9357;SV40 T-ANTIGEN#0.9355;REGULATION OF GROWTH#0.9354;GINSENG#0.9354;HAIR CELL#0.9352;CAROTID ARTERY#0.9351;LARYNGEAL CARCINOMA#0.9350;ARECOLINE#0.9350;CALCIUM CHANNEL#0.9349;ANTHRACENE#0.9346;ENTRY INTO MITOSIS#0.9344;CHLORAMPHENICOL#0.9344;PROSTATE ADENOCARCINOMA#0.9341;KINASE BINDING#0.9338;LARYNX#0.9335;SMOOTH MUSCLE TUMOR#0.9335;PARATHYROID HORMONE#0.9334;MYOCARDIUM#0.9332;LEIOMYOSARCOMA#0.9331;AUTOIMMUNE DISEASE#0.9330;NUCLEAR MATRIX#0.9328;TISSUE REGENERATION#0.9325;MICROTUBULE DYNAMICS#0.9325;LYMPHOMA CELL LINES#0.9325;METHYLATION SPECIFIC POLYMERASE#0.9324;NON HODGKIN LYMPHOMA#0.9321;ADENINE#0.9318;LOW DENSITY LIPOPROTEIN#0.9317;TISSUE HOMEOSTASIS#0.9315;NUCLEAR MORPHOLOGY#0.9314;ANTI INFLAMMATORY DRUGS#0.9314;DIPHOSPHATE#0.9310;OVERALL SURVIVAL RATE#0.9309;POLYCYCLIC AROMATIC HYDROCARBON#0.9305;ACTIVATION OF NF-KAPPAB#0.9305;CELL FUSION#0.9304;P38 MAPK SIGNALING#0.9302;LUPUS ERYTHEMATOSUS#0.9300;PHAGOCYTOSIS#0.9297;HUMAN EPIDERMAL KERATINOCYTES#0.9295;ACTIVATOR PROTEIN 1#0.9293;COENZYME A#0.9293;ERYTHROLEUKEMIA#0.9293;ORAL MUCOSA#0.9290;CARRIE#0.9287;PAPILLARY THYROID CARCINOMA#0.9286;BURKITT LYMPHOMA#0.9286;VINBLASTINE#0.9281;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.9276;PAPILLARY THYROID CANCER#0.9273;MITOTIC CHECKPOINT#0.9271;VACUOLE#0.9270;RESPONSE TO HYPOXIA#0.9268;METASTATIC BREAST CANCER#0.9268;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9266;HISTONE DEMETHYLASE#0.9263;FOLATE#0.9262;MACROPHAGE DIFFERENTIATION#0.9261;DIFFERENTIAL GENE EXPRESSION#0.9260;RECEPTOR AGONIST#0.9257;DNA REPLICATION FACTOR#0.9253;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9253;OSTEOARTHRITIS#0.9253;SPERMATOGENESIS#0.9250;MAP KINASE KINASE#0.9248;CARBOPLATIN#0.9244;IDIOPATHIC PULMONARY FIBROSIS#0.9242;ERYTHROID CELL#0.9237;CHONDROSARCOMA#0.9236;SURFACE PLASMON RESONANCE#0.9232;ADENOMATOUS POLYPOSIS COLI#0.9232;SLIDING CLAMP#0.9231;MICRONUCLEUS#0.9231;ADULT STEM CELL#0.9220;FOREBRAIN#0.9217;DOPAMINERGIC NEURON#0.9216;NEUROBLAST#0.9216;CD8+ T CELL#0.9216;HISTONE DEACETYLASE ACTIVITY#0.9215;DIHYDROFOLATE REDUCTASE#0.9215;NUCLEAR IMPORT#0.9215;OVARIES#0.9212;CORNEAL ENDOTHELIAL CELL#0.9212;SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCI#0.9207;EUKARYOTIC INITIATION FACTOR#0.9205;POLYCYSTIC KIDNEY DISEASE#0.9204;PKC ACTIVATION#0.9201;17β-ESTRADIOL#0.9195;FACTOR S#0.9195;DNA REPAIR ENZYME#0.9188;ATP BINDING#0.9185;ORNITHINE#0.9182;GUANYLATE CYCLASE#0.9180;ASPIRIN#0.9179;HUMAN EMBRYONIC KIDNEY#0.9178;LUNG METASTASIS#0.9178;NORMAL BREAST TISSUE#0.9177;UTERUS#0.9175;LUNG DEVELOPMENT#0.9175;NEUROTOXICITY#0.9172;MALIGNANT MESOTHELIOMA#0.9170;CELL AGING#0.9165;CELLULAR HOMEOSTASIS#0.9164;AUTOPHAGIC CELL DEATH#0.9163;ALDOSTERONE#0.9160;FIBROSARCOMA CELLS#0.9158;AGGRESSIVE BEHAVIOR#0.9157;MRNA TRANSCRIPTION#0.9153;CANCER SPECIFIC MORTALITY#0.9151;CYCLOSPORINE#0.9149;DETOXIFICATION#0.9143;GASTRIC EPITHELIAL CELLS#0.9142;ENDOTHELIAL PROGENITOR CELL#0.9142;FRONTAL#0.9130;ACTIVATED B CELL#0.9128;TRANSLATION INITIATION#0.9122;LI-FRAUMENI SYNDROME#0.9116;GTPASE BINDING#0.9114;MEDROXYPROGESTERONE ACETATE#0.9112;FATTY LIVER#0.9110;MOLECULAR FUNCTION#0.9110;ACTIVATED T CELL#0.9109;INSULIN SECRETION#0.9108;GENE COPY NUMBER#0.9106;DENDRITIC SPINE#0.9106;CHRONIC KIDNEY DISEASE#0.9103;HEXANE#0.9099;WISKOTT ALDRICH SYNDROME#0.9092;MITOTIC CELL CYCLE#0.9090;NUCLEUS PULPOSUS CELL#0.9087;PARKINSON'S DISEASE#0.9086;SPINDLE ASSEMBLY CHECKPOINT#0.9085;MEMBRANE FRACTION#0.9083;TOLL LIKE RECEPTOR#0.9079;MATRIX METALLOPROTEINASE 1#0.9077;MYOCARDIAL INFARCTION#0.9076;ACUTE KIDNEY INJURY#0.9075;MINERALIZATION#0.9072;G-CSF#0.9069;ACTIVATED T-CELLS#0.9063;CHLOROQUINE#0.9062;CREATINE#0.9054;PROSTAGLANDIN E2#0.9052;PROTEIN TRANSLATION#0.9046;NEUROENDOCRINE TUMOR#0.9032;POLYCOMB REPRESSIVE COMPLEX#0.9026;JUN KINASE#0.9025;TELOMERE MAINTENANCE#0.9025;MURINE EMBRYONIC FIBROBLASTS#0.9017;FORSKOLIN#0.9014;NOTCH RECEPTOR#0.9012;MYOEPITHELIAL CELL#0.9012;CEREBRAL CORTEX#0.8995;ADRENERGIC RECEPTOR#0.8989;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8987;GENE EXPRESSION OMNIBUS#0.8984;EXTRINSIC APOPTOTIC PATHWAY#0.8984;CLEAR CELL RENAL CELL CARCINOMA#0.8983;OSTEOCLAST DIFFERENTIATION#0.8982;PARENCHYMA#0.8974;TRYPTOPHAN#0.8973;RIBOSOME#0.8970;GLOMERULONEPHRITIS#0.8969;INTERVERTEBRAL DISC#0.8969;SENSITIZER#0.8969;AUTOPHAGOSOME#0.8967;ADENO ASSOCIATED VIRUS#0.8964;PARATHYROID GLAND#0.8956;RENAL ISCHEMIA REPERFUSION#0.8954;MAP KINASE ACTIVITY#0.8954;BRAIN DEVELOPMENT#0.8953;RETINAL PIGMENT EPITHELIAL#0.8948;ENDOCYTOSIS#0.8942;DNA DAMAGE FOCI#0.8940;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8937;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.8937;VON HIPPEL LINDAU#0.8936;CYTARABINE#0.8934;COLLAGENASE#0.8934;GLUCOSE UPTAKE#0.8934;TRANSCRIPTION FACTOR ACTIVITY#0.8934;CELL CYCLE MODULATION#0.8930;AU RICH ELEMENT#0.8927;MUSCULAR DYSTROPHY#0.8925;MITOCHONDRIAL MEMBRANE DEPOLARIZATION#0.8925;RECEPTOR BINDING#0.8918;HUMAN PROXIMAL TUBULAR#0.8909;ICI 182,780#0.8909;HISTONE H4 ACETYLATION#0.8903;CHROMATID#0.8901;IGF BINDING#0.8900;CIGARETTE SMOKE EXTRACT#0.8897;VP-16#0.8891;MALIGNANT BRAIN TUMOR#0.8890;MESENCHYME#0.8889;INGENUITY PATHWAY ANALYSIS#0.8888;PANCREATITIS#0.8883;HEPATOCYTE APOPTOSIS#0.8870;EARLY TIME POINT#0.8862;POST NATAL DAY#0.8860;FORESKIN#0.8859;CIS-DIAMMINEDICHLOROPLATINUM#0.8859;OSTEOPOROSIS#0.8856;TH1 CELL#0.8851;DUCTAL CARCINOMA IN SITU#0.8849;HEPATOTOXICITY#0.8849;LYMPHOBLAST#0.8847;LECTIN#0.8847;EMBRYONIC LUNG#0.8839;VITAMIN E#0.8839;HISTIDINE#0.8838;PRIMARY EFFUSION LYMPHOMA#0.8837;ERYTHROPOIESIS#0.8835;SERUM ALBUMIN#0.8833;DEATH RECEPTOR 5#0.8828;NEUROPROTECTION#0.8827;MAMMARY GLAND DEVELOPMENT#0.8824;BARRETT'S ESOPHAGUS#0.8824;PIGMENT EPITHELIAL CELL#0.8821;ACTIVATION OF MAP KINASE#0.8814;WORLD HEALTH ORGANIZATION#0.8813;PROTEIN KINASE ACTIVATION#0.8812;ASCITES#0.8811;WEIGHT LOSS#0.8811;SEVERE COMBINED IMMUNODEFICIENCY#0.8810;GLAND DEVELOPMENT#0.8808;CAMP RESPONSE ELEMENT#0.8808;ASPARTIC ACID#0.8804;INTERMEDIATE FILAMENT#0.8804;VIRULENCE#0.8802;NODULAR#0.8800;CHROMATIN MODIFICATION#0.8797;TISSUE REMODELING#0.8792;DUAL SPECIFICITY PHOSPHATASE#0.8790;PHOSPHOLIPASE A2#0.8788;VELCADE#0.8787;FANCONI ANEMIA#0.8786;COLONIC EPITHELIAL CELLS#0.8784;PHOSPHATASE INHIBITOR#0.8782;DNA TOPOISOMERASE II#0.8779;IFN-BETA#0.8779;PIOGLITAZONE#0.8778;LYSOSOME#0.8777;ORGANELLE#0.8774;DOUBLE-STRAND BREAK REPAIR#0.8774;VALINE#0.8769;ERYTHROID PROGENITOR#0.8766;MITHRAMYCIN#0.8763;MYOSIN LIGHT-CHAIN KINASE#0.8760;OLOMOUCINE#0.8760;LENALIDOMIDE#0.8754;CONNEXIN#0.8751;LITHIUM#0.8747;TRANSLATION INITIATION FACTOR#0.8745;ARACHIDONIC ACID#0.8742;3-METHYLADENINE#0.8736;TISSUE GROWTH FACTOR#0.8729;GROWTH PATTERN#0.8728;PROMOTER BINDING#0.8727;CALCINEURIN#0.8727;HEART DISEASE#0.8725;SRC FAMILY KINASE#0.8719;KERATOSIS#0.8717;INTRACELLULAR SIGNAL TRANSDUCTION#0.8714;MYELOID PROGENITOR CELL#0.8712;BRONCHOPULMONARY DYSPLASIA#0.8705;TISSUE DAMAGE#0.8702;PANCREATIC ISLET#0.8699;HISTONE ACETYLTRANSFERASE ACTIVITY#0.8699;PROTEIN INTERACTION NETWORK#0.8694;PROXIMAL TUBULAR EPITHELIAL#0.8691;ADENYLATE CYCLASE#0.8688;VIRAL GENOME#0.8687;GLUTAMATE RECEPTOR#0.8685;DODECYL SULFATE#0.8683;CHEMOTAXIS#0.8682;ADENYLATE#0.8680;BREAST CELL LINES#0.8666;REGIONAL LYMPH NODE#0.8664;VIRAL HEPATITIS#0.8659;EXOSOME#0.8657;CAMP RESPONSE ELEMENT BINDING#0.8641;ERK CASCADE#0.8637;CYCLOSPORIN A#0.8633;GLUCOSE METABOLISM#0.8630;INHIBITION OF ANGIOGENESIS#0.8630;PARATHYROID ADENOMA#0.8624;INDOMETHACIN#0.8614;MUSCLE CELL DIFFERENTIATION#0.8609;NEDD8 ACTIVATING ENZYME#0.8602;HYPERTHERMIA#0.8599;PERIPHERAL NERVE#0.8594;RAD001#0.8594;REGULATION OF CELLULAR SENESCENCE#0.8592;NORMAL PROSTATE EPITHELIAL#0.8592;CAROTENOID#0.8586;SURFACE EPITHELIUM#0.8581;DERMIS#0.8576;THYMIDINE KINASE 1#0.8576;STEROID HORMONE RECEPTOR#0.8563;STEM CELL DIFFERENTIATION#0.8559;MAMMARY EPITHELIUM#0.8558;ROS FORMATION#0.8557;TRANSCRIPTION FACTOR BINDING#0.8554;LACTATION#0.8548;PROTEIN KINASE CASCADE#0.8546;TRANSFERASE INHIBITOR#0.8543;HIGH RISK PATIENTS#0.8538;ERLOTINIB#0.8536;LEYDIG CELL#0.8533;L-ARGININE#0.8529;CHORIOCARCINOMA#0.8520;RESPONSE TO CISPLATIN#0.8518;CELL CELL ADHESION#0.8513;PCNA INTERACTING PROTEIN#0.8511;MEIOSIS#0.8508;ALKALINE PHOSPHATASE ACTIVITY#0.8508;SPHINGOSINE 1 PHOSPHATE#0.8508;X CHROMOSOME#0.8502;GREEN TEA POLYPHENOL#0.8502;CEREBRAL ISCHEMIA#0.8502;ADRENAL GLAND#0.8500;SYNOVIAL SARCOMA#0.8500;7-HYDROXYSTAUROSPORINE#0.8497;DENTAL PULP#0.8490;MITOCHONDRION#0.8483;MTDNA#0.8476;WHITE BLOOD CELL#0.8473;UMBILICAL CORD BLOOD#0.8472;GROWTH DIFFERENTIATION FACTOR#0.8471;8-HYDROXY-2'-DEOXYGUANOSINE#0.8468;NEGATIVE CONTROL GROUP#0.8467;TRANSCRIPTION ACTIVATOR#0.8464;SCHWANN CELL PROLIFERATION#0.8464;CHROMOSOMAL REGION#0.8457;CELL FRACTION#0.8448;MENTAL RETARDATION#0.8447;SKIN DISEASE#0.8442;DAUNORUBICIN#0.8442;RESPONSE TO GROWTH FACTOR#0.8441;CYCLOPHOSPHAMIDE#0.8438;COLCHICINE#0.8438;PRIMARY BILIARY CIRRHOSIS#0.8437;AGE AT DIAGNOSIS#0.8433;CRYSTAL VIOLET#0.8420;STEM CELL TRANSPLANTATION#0.8420;COLLAGEN TYPE I#0.8420;INFERTILITY#0.8411;EXTRINSIC APOPTOSIS#0.8408;LEUCINE RICH REPEAT#0.8402;FERMENTATION#0.8400;PERTUSSIS#0.8399;CYTOKINE PRODUCTION#0.8397;EPITHELIAL OVARIAN CARCINOMA#0.8396;FIBROBLAST LIKE SYNOVIOCYTES#0.8393;MDM2 BINDING#0.8388;PROTEASOME DEGRADATION#0.8385;GERM CELL TUMORS#0.8382;AUTOIMMUNITY#0.8382;RETINAL PIGMENT EPITHELIUM#0.8380;ANAPLASTIC LARGE CELL LYMPHOMA#0.8380;SODIUM DODECYL SULFATE#0.8370;NUCLEOPLASM#0.8366;TRANSCRIPTIONAL TRANSACTIVATION#0.8365;CHOLINE#0.8364;TRANSDIFFERENTIATION#0.8350;CYTOKINE RECEPTOR#0.8350;REGULATION OF MRNA#0.8347;URETERAL OBSTRUCTION#0.8344;RESPONSE TO DOXORUBICIN#0.8344;PML NB#0.8340;LOW DOSE RATE#0.8336;VDR BINDING#0.8335;CLEAR CELL CARCINOMA#0.8330;TYPE 2 DIABETIC#0.8326;NATIONAL CANCER INSTITUTE#0.8315;MEMBRANE RUFFLING#0.8313;SINONASAL INVERTED PAPILLOMA#0.8312;TUMOR REGRESSION GRADE#0.8311;POTASSIUM CHANNEL#0.8309;HETEROTRIMERIC G-PROTEIN#0.8307;SPINDLE FORMATION#0.8299;DEOXYADENOSINE#0.8296;CHONDROGENESIS#0.8294;MITOCHONDRIAL DEPOLARIZATION#0.8292;GENOTOXINS#0.8286;SOMATOSTATIN RECEPTOR#0.8285;FERTILIZATION#0.8285;NEURONAL CELL DEATH#0.8285;GAP ACTIVITY#0.8279;FETAL LIVER#0.8278;HEPATOBLASTOMA#0.8275;INVASIVE BREAST CARCINOMA#0.8275;ENZYME INHIBITOR#0.8274;CELL FATE DETERMINATION#0.8273;LOW DOSE RADIATION#0.8263;EPITHELIAL TISSUES#0.8259;RECEPTOR LIGAND#0.8255;ARABINOFURANOSYLCYTOSINE#0.8251;SPECIFICITY PROTEIN 1#0.8248;EPITHELIAL CARCINOMA#0.8244;BIOLUMINESCENCE#0.8243;SYSTEM DEVELOPMENT#0.8242;ACETYL COA CARBOXYLASE#0.8238;NEURAL PRECURSOR CELL#0.8235;MITOTIC CLONAL EXPANSION#0.8235;MTOR COMPLEX#0.8235;INTESTINAL EPITHELIAL CELL DIFFERENTIATION#0.8231;TUMOR GROWTH DELAY#0.8230;SPERMATOCYTES#0.8229;NUCLEAR TRANSPORT#0.8226;MRNA SPLICING#0.8219;CORNEAL EPITHELIAL CELL#0.8218;LIPID DROPLET#0.8217;CIRCADIAN RHYTHM#0.8208;IFN REGULATORY FACTOR#0.8205;MEAN TELOMERE LENGTH#0.8203;PAPILLARY CARCINOMA#0.8200;FILAMENTOUS ACTIN#0.8200;CELL COMMUNICATION#0.8199;RNA HELICASE#0.8197;BREAST CARCINOMA CELL LINES#0.8195;PERIPHERAL NERVOUS SYSTEM#0.8194;HIGH POWER FIELD#0.8190;LUNG CARCINOMA CELL LINES#0.8189;LEUKEMIA INHIBITORY FACTOR#0.8177;DNASE I#0.8176;RECTUM#0.8173;MEDROXYPROGESTERONE#0.8171;PURKINJE CELL#0.8171;MUSCLE CONTRACTION#0.8165;PKCALPHA#0.8164;MELPHALAN#0.8161;MITOTIC CELL DEATH#0.8157;UBIQUITIN LIGASE ACTIVITY#0.8156;STEM CELL MAINTENANCE#0.8154;HEPARIN BINDING#0.8153;VITAMIN A#0.8152;DNA HYPERMETHYLATION#0.8145;IONOPHORE#0.8141;ACETYLCHOLINE#0.8140;T CELL ANERGY#0.8138;DEFEROXAMINE#0.8135;CHRONIC HEPATITIS C#0.8128;TUMOR NODE METASTASIS#0.8127;LYMPHOBLASTOID CELLS#0.8127;MEMBRANE BLEBBING#0.8127;STATUS EPILEPTICUS#0.8126;RETINAL PIGMENT EPITHELIAL CELLS#0.8124;INTESTINAL STEM CELL#0.8117;CELL CYCLE PROCESS#0.8116;SQUAMOUS INTRAEPITHELIAL LESION#0.8114;CHONDROCYTE PROLIFERATION#0.8114;AMLODIPINE#0.8107;DECIDUALIZATION#0.8103;HYPERCALCEMIA#0.8099;HISTONE ACETYL TRANSFERASE#0.8088;CARDIAC DEVELOPMENT#0.8085;OSSIFICATION#0.8084;CHROMATIN REMODELING COMPLEX#0.8084;SKIN PAPILLOMA#0.8083;HYPERACTIVE#0.8082;STEROIDOGENESIS#0.8078;MRNA DEGRADATION#0.8077;PROXIMAL TUBULE CELL#0.8073;PYRUVATE#0.8072;ADRENAL CORTEX#0.8070;SMOOTH MUSCLE CONTRACTION#0.8069;CARCINOGENICITY#0.8063;UBIQUITIN PROTEIN LIGASE#0.8061;TIGHT JUNCTION#0.8052;HEPATOCYTE NUCLEAR FACTOR#0.8050;LIVER METASTASIS#0.8042;T CELL DEVELOPMENT#0.8040;ALPHA-DIFLUOROMETHYLORNITHINE#0.8040;MUSCLE STEM CELL#0.8037;PUROMYCIN#0.8036;PROTEIN PHOSPHATASE 1#0.8035;RED BLOOD CELL#0.8033;MEMBRANE RUFFLE#0.8030;URACIL#0.8029;CATABOLISM#0.8027;TERATOMA#0.8026;BILE DUCT CARCINOMA#0.8021;DIHYDROTESTOSTERONE#0.8018;RECEPTOR ACTIVATOR#0.8012;CYTOKINE SECRETION#0.8011;NEURAL STEM PROGENITOR#0.8011;INTERVERTEBRAL DISC DEGENERATION#0.8009;ENDOCHONDRAL OSSIFICATION#0.8002;LIVER DAMAGE#0.8000;AUTOPHAGIC VACUOLE#0.7998;INVASIVE GROWTH#0.7996;GASTROINTESTINAL STROMAL TUMOR#0.7987;JNK SIGNALING PATHWAY#0.7982;INFLAMMATORY BOWEL DISEASE#0.7982;BONE MARROW FAILURE#0.7979;MOLECULAR DYNAMICS SIMULATION#0.7973;GLUTAMIC ACID#0.7973;SINGLE CELL GEL#0.7968;MITOGENIC ACTIVITY#0.7965;MESOTHELIAL CELL#0.7955;ACETAMINOPHEN#0.7953;AIRWAY SMOOTH MUSCLE#0.7949;LUMINAL CELL#0.7948;MONOCYTIC LEUKEMIA#0.7944;RENAL CANCER CELLS#0.7943;CHONDROCYTE DIFFERENTIATION#0.7942;CARDIOMYOPATHY#0.7937;ADENOID CYSTIC CARCINOMA#0.7932;MUTAGEN#0.7930;RELAPSE FREE SURVIVAL#0.7929;STEM CELL FACTOR#0.7922;RUFFLE#0.7921;9-CIS-RETINOIC ACID#0.7919;HYPERPARATHYROIDISM#0.7915;FAILURE FREE SURVIVAL#0.7905;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.7900;EXIT FROM MITOSIS#0.7896;GDP BINDING#0.7895;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.7892;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.7891;ACUTE MYELOID LEUKAEMIA#0.7879;CYCLOSPORIN#0.7878;COLORECTUM#0.7878;MITOCHONDRIAL TRANSLOCATION#0.7862;NEPHRITIS#0.7862;PULMONARY ARTERIAL HYPERTENSION#0.7857;PHOSPHODIESTERASE#0.7855;SKELETAL MUSCLE REGENERATION#0.7855;GANGLION CELLS#0.7854;TROPHOBLAST CELL#0.7851;CHROMATIN REMODELLING#0.7843;FLUVASTATIN#0.7842;SECONDARY HYPERPARATHYROIDISM#0.7841;GANCICLOVIR#0.7838;VIRION#0.7835;FOLLICULAR LYMPHOMA#0.7832;BRAIN CANCER#0.7830;GASTROESOPHAGEAL REFLUX DISEASE#0.7826;RESPIRATION#0.7824;DIPEPTIDYL PEPTIDASE#0.7823;BETA CELL MASS#0.7823;ORGANOGENESIS#0.7820;FEMALE BREAST CANCER#0.7819;TELOMERASE INHIBITOR#0.7819;HETEROCHROMATIN PROTEIN 1#0.7817;ORAL SQUAMOUS CARCINOMA#0.7817;ERYTHROBLAST#0.7816;CENTRIOLE#0.7813;MONOCYTE DIFFERENTIATION#0.7810;SEBACEOUS GLAND#0.7803;METASTATIC MELANOMA CELLS#0.7799;PSORIASIS#0.7798;DIAMMINEDICHLOROPLATINUM#0.7797;WEIGHT GAIN#0.7796;MOTHERS AGAINST DECAPENTAPLEGIC#0.7792;ISOTHERMAL TITRATION CALORIMETRY#0.7792;RU486#0.7790;PROTEIN MODIFICATION#0.7789;MYELOID CELL LEUKEMIA#0.7780;INSULIN GROWTH FACTOR#0.7779;DIMETHYL SULFOXIDE#0.7778;2-METHOXYESTRADIOL#0.7777;OVARIAN SURFACE EPITHELIAL#0.7776;BASAL CELL CARCINOMA#0.7776;CELLULAR COMPONENT#0.7770;SWISS ALBINO MICE#0.7768;MELATONIN RECEPTOR#0.7764;TYROSINE KINASE RECEPTOR#0.7762;ANCHORING#0.7757;OUABAIN#0.7754;ERYTHROCYTE#0.7753;GENETIC DISORDER#0.7749;ADENOSINE TRIPHOSPHATE#0.7746;CONSTITUTIVELY ACTIVE MUTANT#0.7741;TRANSFERRIN RECEPTOR#0.7740;FATTY LIVER DISEASE#0.7739;DNA REPLICATION LICENSING#0.7738;LYSIS#0.7737;BAFILOMYCIN A1#0.7732;SIGNAL PEPTIDE#0.7724;MALIGNANT LYMPHOMA#0.7721;SERUM RESPONSE FACTOR#0.7716;HUMAN PROSTATE EPITHELIAL#0.7715;CHOLESTEROL SYNTHESIS#0.7708;ENDOTHELIAL CELL MIGRATION#0.7708;RELATED PROTEIN 1#0.7706;LASER CAPTURE MICRODISSECTION#0.7704;OSTEOGENESIS#0.7702;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.7701;GOBLET CELL#0.7693;LYSINE SPECIFIC DEMETHYLASE#0.7683;SCIATIC NERVE#0.7682;FATTY ACID METABOLISM#0.7680;EDEMA#0.7671;ETHYL ACETATE EXTRACT#0.7671;GASTRIC EPITHELIUM#0.7669;NORMAL LIVER TISSUES#0.7667;GLOBIN#0.7661;CARDIAC MUSCLE#0.7659;ACTINIC KERATOSIS#0.7651;PALMITATE#0.7644;PRENYLATION#0.7644;PATHOLOGIC COMPLETE RESPONSE#0.7643;FIBRILLAR COLLAGEN#0.7639;ACETYLCHOLINE RECEPTOR#0.7638;NEPHROTOXICITY#0.7634;IN SITU CARCINOMA#0.7634;UVEAL MELANOMA#0.7632;OVERALL SURVIVAL TIME#0.7630;NATURAL KILLER CELL#0.7627;EPITHELIAL CELL APOPTOSIS#0.7623;BIOLOGICAL PROCESS#0.7619;ANAL CARCINOMA#0.7617;ATORVASTATIN#0.7615;UROKINASE PLASMINOGEN ACTIVATOR#0.7604;LARGE INTESTINE#0.7600;MUSCLE ATROPHY#0.7594;KINETOCHORE#0.7593;ADENINE DINUCLEOTIDE PHOSPHATE#0.7590;PALMITIC ACID#0.7585;B CELL DEVELOPMENT#0.7585;GASTRIC LYMPHOMA#0.7578;NEURAL TUBE#0.7578;RIBOSOMAL S6 KINASE#0.7576;JUN PHOSPHORYLATION#0.7575;LEUKEMIA STEM CELL#0.7572;DECIDUAL CELL#0.7571;OXIDATIVE PHOSPHORYLATION#0.7569;METASTASIS FREE SURVIVAL#0.7565;SCANNING ELECTRON MICROSCOPY#0.7562;DENSITY FUNCTIONAL THEORY#0.7547;INTRACELLULAR SIGNALING CASCADE#0.7547;TRAUMATIC BRAIN INJURY#0.7545;OXYGEN INDUCED RETINOPATHY#0.7545;INNATE IMMUNE RESPONSE#0.7544;CYTOSKELETON ORGANIZATION#0.7543;INO80 COMPLEX#0.7541;NUCLEAR EXPORT SIGNAL#0.7539;PITUITARY GLAND#0.7539;CAMP-RESPONSIVE ELEMENT BINDING#0.7538;OPIOID GROWTH FACTOR#0.7534;BONE RESORPTION#0.7534;REGULATORY T CELL#0.7534;GLUCOSE REGULATED PROTEIN#0.7531;NEURAL PROGENITOR CELL#0.7529;NEUROENDOCRINE CARCINOMA#0.7526;THYROID HORMONE RECEPTOR#0.7523;FOLLICULAR ADENOMA#0.7522;T CELL FACTOR#0.7521;LEWIS LUNG CARCINOMA#0.7521;TOXICANT#0.7520;HEART DEVELOPMENT#0.7518;SMAD BINDING#0.7511;GRANULOSA CELL PROLIFERATION#0.7508;SIGNET RING CELL#0.7505;BODY WEIGHT RATIO#0.7504;AGE RELATED MACULAR DEGENERATION#0.7503;SWELLING#0.7502;NEUROECTODERMAL TUMOR#0.7500;MACULAR DEGENERATION#0.7499;SUCROSE#0.7498;STRESS FIBRE#0.7496;MICROTUBULE POLYMERIZATION#0.7489;PRINCIPAL COMPONENT ANALYSIS#0.7487;TRANSCRIPTION REPRESSOR#0.7482;QUINACRINE#0.7481;EVEROLIMUS#0.7480;PROTEINASE INHIBITOR#0.7479;AMNIOTIC FLUID#0.7477;DNA HYPOMETHYLATION#0.7453;TESTICULAR CANCER#0.7450;O CELL#0.7440;ENTEROCYTE DIFFERENTIATION#0.7439;B CELL ACTIVATION#0.7437;TOTAL ANTIOXIDANT CAPACITY#0.7437;MELANOMA DIFFERENTIATION ASSOCIATED#0.7435;ADVANCED OVARIAN CANCER#0.7434;ANOIKIS#0.7432;LARGE CELL CARCINOMA#0.7429;CELL POLARIZATION#0.7429;NERVOUS SYSTEM DEVELOPMENT#0.7423;LAMINAR SHEAR STRESS#0.7422;METASTATIC PROSTATE CANCER#0.7418;ADIPOSE-DERIVED STEM CELL#0.7413;MYELOID-DERIVED SUPPRESSOR CELL#0.7413;CAMP SIGNALING#0.7408;CASPASE-INDEPENDENT APOPTOSIS#0.7399;ADVANCED GASTRIC CANCER#0.7393;SALICYLATE#0.7391;CELLULAR METABOLISM#0.7390;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.7380;TRASTUZUMAB#0.7379;RISK OF DEATH#0.7377;EPITHELIAL STEM CELL#0.7374;BLEBBING#0.7372;PHENOBARBITAL#0.7369;PROSTATE EPITHELIUM#0.7367;INTESTINAL MUCOSA#0.7365;AIRWAY EPITHELIUM#0.7363;MUSCLE SATELLITE CELL#0.7355;NORMAL ORAL MUCOSA#0.7350;VIRAL DNA REPLICATION#0.7347;MITOTIC SPINDLE CHECKPOINT#0.7345;OUTER MEMBRANE#0.7345;BONE REGENERATION#0.7344;CELLULAR TRANSCRIPTION#0.7343;ALPHA CELL#0.7342;KERATOACANTHOMA#0.7338;SEBACEOUS CARCINOMA#0.7333;GRANULOCYTE COLONY STIMULATING FACTOR#0.7332;SKELETON#0.7332;CELLULAR RESPONSE TO STRESS#0.7331;E BOX BINDING#0.7329;EPHRIN#0.7327;TRANSCRIPTION REGULATOR#0.7326;SPERMINE#0.7326;SKIN CARCINOMA#0.7326;TIME TO PROGRESSION#0.7321;TRANSMEMBRANE RECEPTOR#0.7315;RELATIVE TELOMERE LENGTH#0.7303;ENDOTHELIAL CELL APOPTOSIS#0.7299;ADJUSTED ODDS RATIO#0.7295;RESPIRATORY CHAIN#0.7294;HYALURONIC ACID#0.7293;FRUCTOSE#0.7292;TOPOTECAN#0.7283;HYPERACTIVITY#0.7278;RNA PROCESSING#0.7277;OVARIAN SURFACE EPITHELIUM#0.7271;NUCLEAR ENVELOPE#0.7266;SAHF FORMATION#0.7264;STEROL REGULATORY ELEMENT#0.7263;AMYOTROPHIC LATERAL SCLEROSIS#0.7261;DRUG METABOLISM#0.7261;ION CHANNEL#0.7261;LATERAL SCLEROSIS#0.7260;CYTOCHROME C OXIDASE#0.7252;DNA METABOLISM#0.7244;LIVER DEVELOPMENT#0.7242;POLYAMINE BIOSYNTHESIS#0.7235;ENDOCRINE DISRUPTING CHEMICAL#0.7234;UBIQUITIN SPECIFIC PROTEASE#0.7234;CELL WALL#0.7229;THYROID GLAND#0.7226;LASER DESORPTION IONIZATION#0.7224;YES ASSOCIATED PROTEIN#0.7219;CENTROMERE#0.7216;NEURITE EXTENSION#0.7215;CEREBELLAR GRANULE NEURON#0.7213;CELL PERIPHERY#0.7212;INHIBITION OF PHOSPHORYLATION#0.7205;SUCCINATE#0.7202;CONJUGATION#0.7191;CUTANEOUS T CELL LYMPHOMA#0.7187;CYTIDINE#0.7185;GRAPE SEED EXTRACT#0.7183;PROPHASE#0.7177;NEUROTROPHIN RECEPTOR#0.7176;B CELL RECEPTOR#0.7163;SUNITINIB#0.7161;CYCLIC ADENOSINE MONOPHOSPHATE#0.7160;MAGNETIC RESONANCE SPECTROSCOPY#0.7159;CASPASE-9 ACTIVITY#0.7157;METHYL THIAZOLYL TETRAZOLIUM#0.7153;INHIBITION OF DNA REPAIR#0.7151;CHOLESTEATOMA#0.7147;PHOSPHATE BUFFERED SALINE#0.7147;STEARIC ACID#0.7144;MUSCLE FIBER#0.7142;VACCINIA#0.7141;ACTIN DEPOLYMERIZATION#0.7141;GLUCOSE HOMEOSTASIS#0.7139;NF-KAPPAB INHIBITOR#0.7134;ALVEOLAR MACROPHAGE#0.7131;FAMILIAL ADENOMATOUS POLYPOSIS#0.7123;BENZIMIDAZOLE#0.7107;INHIBITION OF TELOMERASE ACTIVITY#0.7103;ALTERNATIVE READING FRAME#0.7097;REPLICATION PROTEIN A#0.7097;GLYCOSYLASE#0.7093;PROTEIN KINASE C SIGNALING#0.7091;BILE DUCT LIGATION#0.7090;NEURONAL PROGENITOR CELL#0.7082;DASATINIB#0.7080;GERMINAL CENTER B CELL#0.7077;GERMINAL CENTER B#0.7075;MYOMETRIUM#0.7075;BILIARY TRACT#0.7072;ARA-A#0.7070;PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY#0.7068;CARDIOVASCULAR SYSTEM#0.7064;RIBOSOMAL RNA#0.7036;HYALURONAN#0.7035;HUMAN CORNEAL ENDOTHELIAL#0.7034;AORTIC ANEURYSM#0.7034;TYPE 2 DIABETES MELLITUS#0.7033;2 DIABETES MELLITUS#0.7033;TO TUMOR RECURRENCE#0.7031;PROTEASE ACTIVITY#0.7026;DEMETHYLASE ACTIVITY#0.7025;HDAC COMPLEX#0.7023;NALIDIXIC ACID#0.7020;ENDOMETRIAL EPITHELIAL CELLS#0.7019;SILENT INFORMATION REGULATOR#0.7014;CYCLOSOME#0.7012;FILAMENTOUS GROWTH#0.7005;VERRUCOUS CARCINOMA#0.7003;MYCOPHENOLIC ACID#0.6988;DNA DEGRADATION#0.6987;BREAST CANCER MODEL#0.6982;TOOTH DEVELOPMENT#0.6981;ANGIOTENSIN CONVERTING ENZYME#0.6976;ALA-PDT#0.6975;RESPONSE TO TPA#0.6969;THROMBIN RECEPTOR#0.6969;NECROTIC CELL DEATH#0.6967;DIARRHEA#0.6967;CELLULAR DNA DAMAGE RESPONSE#0.6965;SEMINAL VESICLE#0.6964;CHROMOSOME REGION#0.6964;LYMPH NODE DISSECTION#0.6955;RETICULOCYTE#0.6954;FAT PAD#0.6941;ENCAPSULATED THYMOMA#0.6936;PERIODONTAL LIGAMENT#0.6935;URINARY BLADDER CANCER#0.6935;MULTIPLE ENDOCRINE NEOPLASIA#0.6933;ESOPHAGEAL EPITHELIAL CELLS#0.6931;ADHERENS JUNCTION#0.6929;MACROPHAGE MIGRATION#0.6928;GROWTH CONE#0.6927;RESPONSE TO CURCUMIN#0.6926;INNER EAR#0.6925;PUTRESCINE#0.6915;OLFACTORY BULB#0.6904;GELDANAMYCIN#0.6903;MEMORY T CELL#0.6902;FOLLICLE STEM CELL#0.6897;TUMOR INITIATING CELL#0.6895;ASCORBIC ACID#0.6894;MEVASTATIN#0.6893;GALLBLADDER ADENOCARCINOMA#0.6891;TARGET OF RAPAMYCIN COMPLEX#0.6884;CYCLIC GUANOSINE MONOPHOSPHATE#0.6883;RIBOSOME BIOGENESIS#0.6872;L-OHP#0.6872;ARTERY DISEASE#0.6871;AMELOBLASTOMA#0.6862;IMATINIB MESYLATE#0.6861;FALSE DISCOVERY RATE#0.6853;CELLULAR RESPONSE TO UV#0.6851;ESOPHAGEAL SQUAMOUS CARCINOMA#0.6851;HESPERETIN#0.6846;POLYCYSTIN#0.6838;EPIRUBICIN#0.6820;CELL PROLIFERATION INDEX#0.6820;METHYLTRANSFERASE ACTIVITY#0.6819;AUTOPHAGOSOME FORMATION#0.6817;IKAPPAB KINASE#0.6812;CELL MORPHOGENESIS#0.6805;GLYCOSYLATION#0.6804;NB1011#0.6803;PROTEIN KINASE B SIGNALING#0.6802;PROTEASOMAL PATHWAY#0.6802;PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING#0.6800;NEOMYCIN#0.6795;APOPTOTIC BODY#0.6795;FATTY ACID SYNTHESIS#0.6792;ORAL EPITHELIAL DYSPLASIA#0.6791;OVARIAN SURFACE EPITHELIAL CELL#0.6791;ORAL EPITHELIAL CELLS#0.6790;LASER SCANNING MICROSCOPY#0.6789;PROTEIN CODING GENE#0.6787;CALMODULIN BINDING#0.6785;PHOSPHOLIPASE A#0.6784;DNA DAMAGE BINDING#0.6782;MULTIPLE SCLEROSIS#0.6781;CROSS SECTIONAL AREA#0.6780;PILOCYTIC ASTROCYTOMA#0.6776;INSULIN RECEPTOR SUBSTRATE#0.6769;PLASMACYTOMA#0.6766;NASAL MUCOSA#0.6766;ELECTRON TRANSPORT#0.6765;FATTY ACID BINDING#0.6764;RESONANCE ENERGY TRANSFER#0.6764;COPY NUMBER VARIATION#0.6762;NEUROTOXIC#0.6752;RESPONSE TO DRUG#0.6749;PRIMARY BREAST TUMORS#0.6745;PROTEIN FOLDING#0.6739;ANDRO#0.6738;MITOCHONDRIAL LOCALIZATION#0.6730;MICROTUBULE ASSEMBLY#0.6725;MIDDLE CEREBRAL ARTERY#0.6720;ESTROGEN RESPONSE ELEMENT#0.6718;CEREBRAL ARTERY#0.6717;MITOCHONDRIAL FISSION#0.6716;SPERMIDINE#0.6711;NEVUS#0.6709;GENE REGULATORY NETWORK#0.6706;RENAL CELL CANCER#0.6706;CORTICAL CELL#0.6702;INDUCES CANCER#0.6699;TOCOPHEROL#0.6690;TYPE II PNEUMOCYTE#0.6684;CYTOTROPHOBLAST#0.6684;DOWN SYNDROME#0.6683;SYNCYTIOTROPHOBLAST#0.6678;MALE INFERTILITY#0.6672;DUCHENNE MUSCULAR DYSTROPHY#0.6670;LICHEN PLANUS#0.6668;COLUMNAR#0.6662;CELL SURFACE ANTIGEN#0.6661;LUMINAL EPITHELIAL CELL#0.6646;PORTAL VEIN#0.6644;COLON ADENOMA#0.6639;HEARING LOSS#0.6638;TYPE 1 DIABETES#0.6618;FILOPODIA FORMATION#0.6617;INNATE IMMUNITY#0.6617;ZEBULARINE#0.6616;K-252A#0.6613;GASTRULATION#0.6613;SCF COMPLEX#0.6605;REGULATION OF TELOMERASE ACTIVITY#0.6594;CELL DEDIFFERENTIATION#0.6587;RESPONSE TO PACLITAXEL#0.6583;VIRAL TRANSCRIPTION#0.6583;PRE-MRNA SPLICING#0.6582;TIME TO RECURRENCE#0.6576;PTERYGIUM#0.6576;RETINOL#0.6575;REPRODUCTIVE SYSTEM#0.6575;S-ADENOSYLMETHIONINE#0.6575;PROLIFERATIVE GLOMERULONEPHRITIS#0.6572;MAXIMUM TOLERATED DOSE#0.6570;BELINOSTAT#0.6568;ACID PHOSPHATASE#0.6567;HYPERGLYCEMIC#0.6559;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.6552;ACE INHIBITOR#0.6547;MRNA BINDING#0.6547;NOTCH LIGAND#0.6545;COAGULATION#0.6545;VASCULAR ENDOTHELIUM#0.6542;DNA FRAGMENTATION FACTOR#0.6540;CORNEAL EPITHELIUM#0.6536;DOPAMINE#0.6534;NURD COMPLEX#0.6530;B CELL PROLIFERATION#0.6530;RESPONSE TO PLATINUM#0.6523;TUMOR ASSOCIATED ANTIGEN#0.6512;LINEAR ENERGY TRANSFER#0.6509;MAGNETIC RESONANCE IMAGING#0.6507;CELLULAR MEMBRANE#0.6506;EXCRETION#0.6503;ZD1694#0.6498;ACTOMYOSIN#0.6495;GENETIC DISEASE#0.6493;APOPTOTIC DNA FRAGMENTATION#0.6493;CASPASE-8 ACTIVITY#0.6491;MUSCULAR ATROPHY#0.6487;CELL ASSOCIATED#0.6485;TERATOCARCINOMA#0.6480;HIGH RISK NEUROBLASTOMA#0.6476;CASPASE-INDEPENDENT CELL DEATH#0.6476;LIPOGENESIS#0.6475;IMMUNOGLOBULIN G#0.6473;INHIBITION OF CELL MIGRATION#0.6473;ATP BINDING CASSETTE#0.6469;MYELOID CELL LINES#0.6468;CERVICAL SQUAMOUS CELL CARCINOMA#0.6466;FTASE ACTIVITY#0.6466;R115777#0.6464;NUCLEOCYTOPLASMIC SHUTTLING#0.6455;4-HYDROXYTAMOXIFEN#0.6448;STEROID RECEPTOR COACTIVATOR#0.6446;CANCER TESTIS ANTIGEN#0.6443;INTEGRIN LINKED KINASE#0.6440;NEOPLASTIC TISSUES#0.6435;ISOQUINOLINE#0.6433;PERIPHERAL T-CELL LYMPHOMA#0.6433;XENOBIOTIC METABOLISM#0.6431;ORAL PREMALIGNANT LESIONS#0.6430;COLLAGEN TYPE IV#0.6429;CELL PENETRATING PEPTIDE#0.6428;PRIMORDIAL GERM CELL#0.6426;DESFERRIOXAMINE#0.6423;AMPK ACTIVITY#0.6421;DNA POLYMERASE BETA#0.6418;GASTRIC TISSUE#0.6417;ANDROGEN DEPRIVATION THERAPY#0.6412;DNA COPY NUMBER#0.6410;CORTISOL#0.6408;OTHER ORGANISM#0.6406;CYCLOPHILIN#0.6405;BONE DEVELOPMENT#0.6404;CLEFT PALATE#0.6402;DUCT CELL#0.6401;CELL MOVEMENT#0.6401;DORSAL ROOT GANGLION#0.6398;WHITE ADIPOSE TISSUE#0.6398;TREG CELL#0.6396;FORESKIN KERATINOCYTES#0.6395;LYMPHATIC VESSEL#0.6391;INOSINE#0.6390;NUCLEAR MEMBRANE#0.6387;PROTEINURIA#0.6383;CALCIUM SIGNALING#0.6377;EMBRYO DEVELOPMENT#0.6376;MONOCYTE CHEMOTACTIC PROTEIN#0.6375;TRADITIONAL CHINESE MEDICINAL#0.6371;FOLIC ACID#0.6369;UROTHELIAL CELL CARCINOMA#0.6362;LDL RECEPTOR#0.6355;TERATOGEN#0.6353;RECEPTOR COMPLEX#0.6351;REGULATION OF PHOSPHORYLATION#0.6344;POSITRON EMISSION TOMOGRAPHY#0.6336;TRANSCRIPTION COFACTOR#0.6331;URIDINE#0.6330;NMDA RECEPTOR#0.6330;FURAN#0.6321;NEUROFILAMENT#0.6320;ZOLEDRONIC ACID#0.6319;PRIMARY EPITHELIAL CELLS#0.6312;HUMAN LENS EPITHELIAL#0.6302;BMP SIGNALING PATHWAY#0.6299;CETRORELIX#0.6299;BIRTH DEFECT#0.6296;ETHANE#0.6294;BENIGN PROSTATE HYPERPLASIA#0.6290;MULTIPOTENT STEM CELL#0.6284;NEURITE FORMATION#0.6281;GROWTH ARREST SPECIFIC#0.6276;THYMIC CARCINOMA#0.6273;LOW GRADE GLIOMAS#0.6273;PULMONARY VASCULAR REMODELING#0.6273;VIRAL LIFE CYCLE#0.6268;BETA-ESTRADIOL#0.6268;INTERNATIONAL PROGNOSTIC INDEX#0.6265;PROTEIN DEPHOSPHORYLATION#0.6264;ANAPLASTIC CARCINOMA#0.6260;HYPOXANTHINE#0.6259;ADRENOCORTICAL CARCINOMA#0.6259;NEUROPATHY#0.6256;DAUNOMYCIN#0.6256;HUMAN INTESTINAL EPITHELIAL#0.6256;DNA AMPLIFICATION#0.6255;DEUBIQUITINATING ENZYME#0.6249;MUCOEPIDERMOID CARCINOMA#0.6245;DOUBLE TRANSGENIC MICE#0.6239;PROTEIN LOCALIZATION#0.6235;ATP SYNTHESIS#0.6232;OPIOID RECEPTOR#0.6229;COLONY-FORMING CELL#0.6228;BONE GROWTH#0.6223;COMBINED TREATMENT GROUP#0.6220;MGI-114#0.6219;MITOXANTRONE#0.6219;PITAVASTATIN#0.6211;DEXTRAN SULFATE SODIUM#0.6209;C-TERMINAL BINDING#0.6208;MONOCYTE DERIVED MACROPHAGE#0.6200;VINORELBINE#0.6197;NUCLEOCAPSID#0.6195;IL-6 PRODUCTION#0.6192;GLCNAC#0.6191;ACTIN BINDING#0.6188;HUMAN PULMONARY ARTERY#0.6187;EXTRAHEPATIC BILE DUCT CARCINOMA#0.6186;GREEN TEA CATECHIN#0.6185;SEPTUM#0.6175;NITRO-L-ARGININE#0.6170;WERNER SYNDROME#0.6163;PHENOXODIOL#0.6162;CEREBRAL ARTERY OCCLUSION#0.6160;PROTEIN ACETYLATION#0.6159;MENSTRUAL CYCLE#0.6157;OSTEOBLAST PROLIFERATION#0.6154;SPERMATOGENIC CELLS#0.6150;SWI-SNF COMPLEX#0.6149;IN STENT RESTENOSIS#0.6135;DNA POLYMERASE ALPHA#0.6135;IMIPRAMINE#0.6132;CALYCULIN A#0.6130;GERMINAL VESICLE#0.6129;ANESTHETIC#0.6126;VEGF PRODUCTION#0.6126;DENTAL PULP CELL#0.6126;ABC TRANSPORTER#0.6125;CARNITINE#0.6124;TERBINAFINE#0.6111;DIFFUSE ALVEOLAR DAMAGE#0.6106;MULTIPLE ENDOCRINE NEOPLASIA TYPE 1#0.6102;HISTONE LYSINE METHYLATION#0.6102;MYOCYTE PROLIFERATION#0.6098;CANCER ASSOCIATED FIBROBLASTS#0.6097;TRANSMISSION ELECTRON MICROSCOPE#0.6089;CELL BODY#0.6088;MYELOBLAST#0.6086;SUBSTANCE P#0.6080;RB-E2F COMPLEX#0.6077;MULTIDRUG RESISTANCE PROTEIN#0.6075;MUSCLE WASTING#0.6071;YOLK SAC#0.6064;PHOSPHOLIPASE D#0.6062;C-LEVEL#0.6048;MITOCHONDRIA MEMBRANE POTENTIAL#0.6047;GLUCOSE INTOLERANCE#0.6045;DNA DEMETHYLASE ACTIVITY#0.6044;BONE DISEASE#0.6044;MEDIAN OVERALL SURVIVAL#0.6044;RECEPTOR ACTIVITY#0.6041;APC ACTIVATION#0.6033;EXTRAMEDULLARY PLASMACYTOMA#0.6032;PEUTZ-JEGHERS SYNDROME#0.6028;DECIDUA#0.6024;ATPASE ACTIVITY#0.6022;UBIQUITIN-DEPENDENT PROTEOLYSIS#0.6019;PODOCYTE APOPTOSIS#0.6016;MSC PROLIFERATION#0.6014;CHOLESTEROL BIOSYNTHETIC#0.6005;FOLLICULAR THYROID CANCER#0.6004;CORONARY ARTERY DISEASE#0.6001
10270	ANCHORING#1.0632;PROTEIN KINASE#1.0276;PROTEIN KINASE A#1.0186;NUCLEAR MATRIX#1.0056;CELL CYCLE#0.9970;MITOSIS#0.9740;LUNG CANCER#0.9093;INTERPHASE#0.8677;CHROMOSOME CONDENSATION#0.7869;BREAST CANCER#0.7750;LYMPH NODE METASTASIS#0.7529;LYMPH NODE#0.7486;METAPHASE#0.7375;CONDENSIN COMPLEX#0.6722;PKA BINDING#0.6648;ESOPHAGEAL CANCER#0.6188;DNA REPLICATION#0.6136
102723099	CANCER CELL#1.1145;CELL PROLIFERATION#1.1141;CELL CYCLE#1.0071;EPITHELIAL MESENCHYMAL TRANSITION#0.9700;APOPTOSIS#0.9471;LYMPH NODE#0.9445;SIGNALING PATHWAY#0.8821;LYMPH NODE METASTASIS#0.8674;CERVICAL CANCER#0.8147;BREAST CANCER#0.8026;G1 PHASE#0.7321;CELL CYCLE ARREST#0.7297;ADJACENT NORMAL TISSUE#0.7262;POLYMERASE CHAIN REACTION#0.6400;BREAST CANCER CELL#0.6379;HEPATOCELLULAR CARCINOMA#0.6375;COLORECTAL CANCER#0.6373;CELL GROWTH#0.6354;ONCOGENIC#0.6317;CERVICAL#0.6166
102723100	OTOSCLEROSIS#0.6880
102723356	ANTISENSE RNA#0.7972;RENAL CELL CANCER#0.6826;APOPTOSIS#0.6815;GASTRIC TISSUE#0.6808;TUMOR TISSUES#0.6653;CANCER CELL#0.6537
102723508	INTERNAL SPHINCTER#1.0746;SPHINCTER OF ODDI#1.0517;METHYLERGOMETRINE#1.0490;DOBUTAMINE STRESS ECHOCARDIOGRAPHY#1.0486;ERGOMETRINE#1.0395;PRINZMETAL ANGINA#1.0393;SUCCINYLCHOLINE#1.0370;MASSETER#1.0364;CERVICAL DYSTONIA#1.0352;TRIGEMINAL NEURALGIA#1.0346;BELL'S PALSY#1.0337;ACOUSTIC NEUROMA#1.0324;NEURALGIA#1.0315;MODIFIED ASHWORTH SCALE#1.0315;SUXAMETHONIUM#1.0312;MITRAL VALVE PROLAPSE#1.0285;ARACHNOID CYST#1.0277;BLEPHAROSPASM#1.0268;VERTIGO#1.0257;ACHALASIA#1.0234;CORONARY THROMBOSIS#1.0230;BTX-A#1.0215;ERGOTAMINE#1.0206;HEPATIC ARTERY#1.0205;DOBUTAMINE#1.0199;MYOCARDIAL STUNNING#1.0194;FOCAL DYSTONIA#1.0192;TINNITUS#1.0187;FACIAL PARALYSIS#1.0180;SCLERODERMA#1.0180;NIMODIPINE#1.0166;HYPERHIDROSIS#1.0152;HAMSTRING#1.0150;ERGONOVINE#1.0144;THYROTOXICOSIS#1.0135;IMPLANTABLE CARDIOVERTER DEFIBRILLATOR#1.0131;RENAL ARTERY#1.0125;BONT/A#1.0111;CONVULSION#1.0092;NICARDIPINE#1.0090;MITRAL VALVE#1.0089;NITROGLYCERINE#1.0080;OPHTHALMIC ARTERY#1.0074;EMBOLISM#1.0073;OESOPHAGUS#1.0069;BILE DUCT#1.0068;ALLERGIC REACTION#1.0063;HYPERACTIVE#1.0054;RAYNAUD’S#1.0048;BOTOX#1.0046;BOTULINUM TOXIN A#1.0037;AORTIC VALVE#1.0030;PULMONARY EDEMA#1.0028;FACIAL NUCLEUS#1.0026;DYSTONIA#1.0025;MALIGNANT HYPERTHERMIA#1.0008;CORONARY ARTERY#0.9997;KINASE INHIBITOR#0.9997;DYSKINESIA#0.9995;LOW BACK PAIN#0.9993;ESOPHAGUS#0.9991;IRRITATION#0.9989;PAPAVERINE#0.9984;TUBEROUS SCLEROSIS#0.9983;EYELID#0.9983;PLATELET ACTIVATION#0.9981;ARTERIOVENOUS MALFORMATION#0.9980;MAGNETIC RESONANCE ANGIOGRAPHY#0.9979;DOXORUBICIN#0.9977;DIAZEPAM#0.9976;BOTULINUM TOXIN TYPE A#0.9975;BASILAR ARTERY#0.9975;THROMBOSIS#0.9975;MYOCARDITIS#0.9974;ENDOTHELIAL NITRIC OXIDE#0.9972;DIZZINESS#0.9971;ESOTROPIA#0.9969;HYPERACTIVITY#0.9968;CONSTIPATION#0.9967;AORTIC VALVE REPLACEMENT#0.9966;HYDROCEPHALUS#0.9965;PERISTALSIS#0.9965;CORONARY FLOW RESERVE#0.9964;HISTAMINE#0.9964;ARTERIOLE#0.9959;CARDIAC ARREST#0.9954;MAST CELL#0.9953;ADRENOCORTICOTROPIC HORMONE#0.9952;ESOPHAGITIS#0.9952;SYNCOPE#0.9948;NEUROPATHY#0.9947;HYPOXIA#0.9946;VERTEBRAL ARTERY#0.9937;ANAPHYLAXIS#0.9937;LOSS OF CONSCIOUSNESS#0.9937;METHYLERGONOVINE#0.9935;RANGE OF MOTION#0.9934;DIARRHEA#0.9929;CEREBRAL PALSY#0.9929;VIGABATRIN#0.9927;CORONARY STENOSIS#0.9926;SKELETAL MUSCLE#0.9924;CHRONIC PELVIC PAIN#0.9922;INDOMETHACIN#0.9921;POLIOMYELITIS#0.9920;OPTICAL COHERENCE TOMOGRAPHY#0.9917;GLYCERYL TRINITRATE#0.9917;ARTERY#0.9915;GASTROESOPHAGEAL REFLUX DISEASE#0.9914;VOMITING#0.9912;ATRIOVENTRICULAR BLOCK#0.9898;NEUROMA#0.9896;NUMBNESS#0.9895;ISOSORBIDE DINITRATE#0.9893;ANAPHYLACTIC#0.9892;HYOSCINE#0.9887;NITRIC OXIDE SYNTHASE#0.9882;BACLOFEN#0.9881;DIAGNOSTIC CORONARY ANGIOGRAPHY#0.9881;HYPERTHERMIA#0.9878;SWELLING#0.9877;FLUOROURACIL#0.9876;5 FLUOROURACIL#0.9875;MUSCLE WEAKNESS#0.9875;NARCOTIC#0.9874;INTERNAL CAROTID ARTERY#0.9872;CORONARY MICROVASCULAR DYSFUNCTION#0.9869;CORONARY ARTERY STENOSIS#0.9869;SUBSTANCE P#0.9868;VISUAL ANALOGUE SCALE#0.9863;EDEMA#0.9862;SEVERE PAIN#0.9862;BRADYCARDIA#0.9857;PARALYSIS#0.9856;WEST SYNDROME#0.9855;LEVATOR ANI#0.9854;ACETYLCHOLINE#0.9852;HYPERTROPHIC CARDIOMYOPATHY#0.9851;ISCHEMIC HEART DISEASE#0.9843;INTRACRANIAL ANEURYSM#0.9843;GALLBLADDER#0.9842;SUDDEN CARDIAC DEATH#0.9841;SCOLIOSIS#0.9840;CONNECTIVE TISSUE#0.9838;SUBARACHNOID SPACE#0.9835;TRANSPOSITION#0.9834;PLATELET AGGREGATION#0.9831;NIFEDIPINE#0.9828;PANCREATITIS#0.9828;NITROGLYCERIN#0.9826;PARKINSON'S DISEASE#0.9820;SMOOTH MUSCLE CONTRACTION#0.9819;ATRIAL FIBRILLATION#0.9819;COAGULATION#0.9818;SODIUM NITROPRUSSIDE#0.9816;ARRHYTHMIA#0.9816;FENTANYL#0.9815;BILIARY TRACT#0.9814;CORONARY ARTERY VASOSPASM#0.9812;MUSCLE CONTRACTION#0.9811;CERVICAL#0.9808;CEREBRAL INFARCTION#0.9807;EPINEPHRINE#0.9806;ANGINAL#0.9804;TRACHEA#0.9804;VASOMOTION#0.9803;ATHEROSCLEROSIS#0.9797;MIGRAINE#0.9796;MULTIPLE SCLEROSIS#0.9794;TOPICAL#0.9792;DYSPNEA#0.9791;ADRENERGIC RECEPTOR#0.9791;PROSTACYCLIN#0.9791;LARYNX#0.9783;VASODILATION#0.9783;DILTIAZEM#0.9783;PEDICLE#0.9782;BLOOD VESSEL#0.9782;AGE AT ONSET#0.9781;CEREBRAL ARTERY#0.9780;HEARING LOSS#0.9780;GASTRO#0.9777;DANTROLENE#0.9775;ATHEROSCLEROTIC#0.9775;DIPLOPIA#0.9774;PARESTHESIA#0.9772;MIDDLE CEREBRAL ARTERY#0.9770;CEREBRAL ISCHEMIA#0.9769;CORONARY ARTERY BYPASS#0.9768;PROPRANOLOL#0.9767;LEFT ANTERIOR DESCENDING#0.9766;METHACHOLINE#0.9766;CONSTRICTION#0.9766;VISUAL ANALOG SCALE#0.9762;CORONARY HEART DISEASE#0.9762;PROPOFOL#0.9761;VASODILATATION#0.9760;BLOOD CLOT#0.9757;NEUROLOGICAL DISORDER#0.9756;HALOTHANE#0.9755;LIDOCAINE#0.9754;STIFF PERSON SYNDROME#0.9754;EPILEPSY#0.9753;VASOPRESSIN#0.9752;MENTAL RETARDATION#0.9752;VASCULITIS#0.9748;VERAPAMIL#0.9745;SEDATION#0.9744;CAROTID ARTERY#0.9743;RECEPTOR ANTAGONIST#0.9738;VASCULAR SMOOTH MUSCLE CELL#0.9736;NITROPRUSSIDE#0.9735;INTRACRANIAL HYPERTENSION#0.9734;HYPERTHYROIDISM#0.9734;HYPOTENSION#0.9733;BLOOD BRAIN BARRIER#0.9732;HEART RATE VARIABILITY#0.9732;ISCHEMIA#0.9731;ASPIRIN#0.9731;CARDIOMYOPATHY#0.9728;BUPIVACAINE#0.9726;VASCULAR DISEASE#0.9726;ACUTE MYOCARDIAL INFARCTION#0.9724;PTOSIS#0.9722;TACHYCARDIA#0.9721;LUMINAL#0.9721;ADENOSINE#0.9720;ABDOMINAL PAIN#0.9719;HYPERSENSITIVITY#0.9718;NORADRENALINE#0.9713;SMOOTH MUSCLE#0.9710;NEUROTOXIN#0.9709;FOREARM#0.9709;HEART DISEASE#0.9703;VASODILATOR#0.9702;ACUTE CORONARY SYNDROME#0.9700;CONGESTIVE HEART FAILURE#0.9698;ANAESTHETIC#0.9695;MYOCARDIAL INFARCTION#0.9694;SPINAL CORD INJURY#0.9694;ATROPINE#0.9694;DIABETES MELLITUS#0.9694;ARACHIDONIC ACID#0.9694;NITRIC OXIDE#0.9693;CAROTID SINUS#0.9692;DIPYRIDAMOLE#0.9686;VASOCONSTRICTOR#0.9686;BLOOD CIRCULATION#0.9684;HEPARIN#0.9683;RESPIRATION#0.9682;FRONTAL#0.9681;CARBAMAZEPINE#0.9678;HYPERTENSION#0.9678;HYPOTENSIVE#0.9678;HEMORRHAGE#0.9676;VASOCONSTRICTION#0.9670;CALCIUM CHANNEL#0.9670;PREDNISOLONE#0.9670;NERVE FIBER#0.9668;INCONTINENCE#0.9665;ISOPROTERENOL#0.9663;ENDOTHELIAL CELL#0.9660;ACTION POTENTIAL#0.9659;MECHANISM OF ACTION#0.9658;PHENTOLAMINE#0.9653;INNERVATION#0.9648;MESENTERIC ARTERY#0.9646;ADVENTITIA#0.9643;MYOCARDIUM#0.9642;SPINAL CORD#0.9638;POTASSIUM CHLORIDE#0.9637;NERVOUS SYSTEM#0.9635;MOTOR ACTIVITY#0.9632;ANESTHETIC#0.9631;POLYMORPHIC VENTRICULAR TACHYCARDIA#0.9629;INFLAMMATORY RESPONSE#0.9626;PERCUTANEOUS CORONARY INTERVENTION#0.9625;SMOOTH MUSCLE CELL#0.9622;TOXICITY#0.9622;ESOPHAGEAL DISEASE#0.9621;MUSCLE CELL#0.9620;SUDDEN CARDIAC ARREST#0.9619;CORONARY ARTERY DISEASE#0.9614;DRUG ELUTING STENT#0.9614;MYOFASCIAL PAIN SYNDROME#0.9613;ENDOTHELIUM#0.9611;EMISSION COMPUTED TOMOGRAPHY#0.9606;ARTERY DISEASE#0.9606;PERIPHERAL NERVE#0.9603;UTERUS#0.9602;RANDOMIZED CONTROLLED TRIAL#0.9599;ASPHYXIA#0.9597;DOPAMINE#0.9596;VASCULAR ENDOTHELIUM#0.9593;PARALYTIC#0.9592;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9592;ARTERIOSCLEROSIS#0.9591;PHENOXYBENZAMINE#0.9590;PERIPHERAL VASCULAR DISEASE#0.9586;RESPIRATORY FAILURE#0.9586;HEMORRHAGIC#0.9584;COMPARTMENT SYNDROME#0.9576;CENTRAL NERVOUS SYSTEM#0.9569;COMMUNICATING ARTERY#0.9569;PNEUMONIA#0.9567;PROTEIN KINASE#0.9564;CREATINE#0.9561;RHEUMATOID ARTHRITIS#0.9556;STRUCTURAL HEART DISEASE#0.9548;IRRITABLE BOWEL SYNDROME#0.9545;C REACTIVE PROTEIN#0.9541;ERYTHROCYTE#0.9540;INTENSIVE CARE UNIT#0.9537;L-ARGININE#0.9530;MOTOR EVOKED POTENTIAL#0.9529;REGENERATION#0.9527;NOREPINEPHRINE#0.9525;PHENYLEPHRINE#0.9524;MAGNETIC RESONANCE IMAGING#0.9522;ANTI INFLAMMATORY DRUGS#0.9521;BASAL GANGLIA#0.9519;HEARING IMPAIRMENT#0.9519;ETHANOL#0.9518;CREATINE KINASE#0.9517;RESPONSE TO TREATMENT#0.9508;HYPOXIC#0.9507;SCALP#0.9497;MULTIPLE LOGISTIC REGRESSION#0.9492;AMINOPHYLLINE#0.9475;ALOPECIA#0.9473;SYSTOLIC BLOOD PRESSURE#0.9471;CARDIOVASCULAR SYSTEM#0.9468;LEUKOCYTE#0.9465;LARGE ARTERIES#0.9464;ARGININE#0.9464;GASTROINTESTINAL TRACT#0.9461;URINARY TRACT INFECTION#0.9459;RECEPTOR AGONIST#0.9457;SENSORINEURAL HEARING LOSS#0.9443;URETER#0.9438;URETHRA#0.9430;POSITRON EMISSION TOMOGRAPHY#0.9421;METHYSERGIDE#0.9420;STATUS EPILEPTICUS#0.9420;ADRENALINE#0.9418;ESSENTIAL HYPERTENSION#0.9417;72-HOURS#0.9415;NALOXONE#0.9414;TOPIRAMATE#0.9409;LIPOMA#0.9398;PENTAGASTRIN#0.9392;BRAIN DAMAGE#0.9385;HEMIPLEGIA#0.9361;POTASSIUM CHANNEL#0.9359;VENULE#0.9357;RED BLOOD CELL#0.9343;DUODENUM#0.9338;SALBUTAMOL#0.9337;CLONAZEPAM#0.9337;MEDULLA OBLONGATA#0.9335;MYOCARDIAL PERFUSION SCINTIGRAPHY#0.9334;TRANSCRANIAL MAGNETIC STIMULATION#0.9333;ANAL CANAL#0.9332;NERVE DAMAGE#0.9315;INFLAMMATORY CELL#0.9308;CARDIOVASCULAR RISK FACTOR#0.9306;PROTEIN KINASE C#0.9296;MIDDLE EAR#0.9293;HEMOSTASIS#0.9291;PROTON PUMP#0.9284;CELL MEMBRANE#0.9269;CAFFEINE#0.9268;PULMONARY HYPERTENSION#0.9255;CROSS SECTIONAL AREA#0.9253;SCIATIC NERVE#0.9250;INFERIOR MYOCARDIAL INFARCTION#0.9249;ACUTE PANCREATITIS#0.9231;MECHANISMS OF ACTION#0.9229;ESSENTIAL TREMOR#0.9227;PARAPLEGIA#0.9224;CORONARY ARTERY LESIONS#0.9224;SIGNALING PATHWAY#0.9224;BRUGADA SYNDROME#0.9223;RESPONSE TO ACETYLCHOLINE#0.9221;CARISOPRODOL#0.9220;LIMB ISCHEMIA#0.9206;APOPTOSIS#0.9198;COMMON CAROTID ARTERY#0.9197;DURA MATER#0.9197;SMALL INTESTINE#0.9194;PROTON PUMP INHIBITOR#0.9191;NECROTIC#0.9187;BRUXISM#0.9177;FIBROMYALGIA#0.9176;SENSITIZATION#0.9174;TRAPEZIUS#0.9173;URINARY BLADDER#0.9157;TETRAETHYLAMMONIUM#0.9157;ADENOSINE TRIPHOSPHATE#0.9153;HEMATURIA#0.9153;FACTOR I#0.9152;TEMPORAL BONE#0.9151;HIGH RISK PATIENTS#0.9150;LOW DENSITY LIPOPROTEIN#0.9148;PULMONARY ARTERY#0.9137;AIRWAY SMOOTH MUSCLE#0.9124;HYPERCHOLESTEROLEMIA#0.9123;MENINGITIS#0.9116;PERIPHERAL BLOOD#0.9113;WHITE BLOOD CELL#0.9109;QUANTITATIVE CORONARY ANGIOGRAPHY#0.9106;PARENTERAL#0.9103;GABAPENTIN#0.9080;COCAINE ABUSE#0.9062;DIAPHRAGM#0.9055;PALPITATION#0.9047;RANDOMIZED CLINICAL TRIAL#0.9038;TUBEROUS SCLEROSIS COMPLEX#0.9035;NEUROMUSCULAR JUNCTION#0.9021;CYSTIC DUCT#0.9012;VOCAL FOLD#0.9005;RANDOMISED CONTROLLED TRIAL#0.9004;STABLE ANGINA PECTORIS#0.9002;BLINDNESS#0.9002;DROWSINESS#0.8998;COUGHING#0.8998;PHOSPHODIESTERASE#0.8998;BLURRED VISION#0.8995;PHEOCHROMOCYTOMA#0.8989;ENDOTHELIUM-DERIVED RELAXING FACTOR#0.8987;MUCOUS#0.8976;LYSIS#0.8974;RESPIRATORY TRACT#0.8966;JOINT PAIN#0.8964;SUBCLAVIAN ARTERY#0.8947;MIDAZOLAM#0.8939;IN STENT RESTENOSIS#0.8927;RECURRENT LARYNGEAL NERVE#0.8918;AMLODIPINE#0.8915;PROSTAGLANDIN E2#0.8904;LENNOX-GASTAUT SYNDROME#0.8900;SLEEP APNEA#0.8893;ECLAMPSIA#0.8878;DELAYED CEREBRAL ISCHEMIA#0.8868;POLYMERASE CHAIN REACTION#0.8867;EXCRETION#0.8859;RESPONSE TO EXERCISE#0.8851;ILIAC ARTERY#0.8839;TIZANIDINE#0.8836;PHARYNX#0.8833;WEIGHT LOSS#0.8826;SEPTUM#0.8822;THEOPHYLLINE#0.8816;GROWTH FACTOR#0.8816;HYPERKINETIC#0.8816;RESPIRATORY DISTRESS#0.8815;FLUSHING#0.8809;CLONIDINE#0.8801;PROSTAGLANDIN E1#0.8799;MAGNESIUM SULFATE#0.8798;FIBROMUSCULAR DYSPLASIA#0.8755;DILATED CARDIOMYOPATHY#0.8738;MODE OF ACTION#0.8727;ANGIOTENSIN CONVERTING ENZYME#0.8725;ARTERIAL SYSTEM#0.8721;BRONCHITIS#0.8711;PULMONARY EMBOLISM#0.8707;WOUND HEALING#0.8698;NEUTROPHIL#0.8694;PYLORIC STENOSIS#0.8681;SALIVATION#0.8679;CLOTTING#0.8675;DEVELOPMENTAL DELAY#0.8662;STREPTOKINASE#0.8654;DUCTUS ARTERIOSUS#0.8648;SEVOFLURANE#0.8647;MUSCLE FIBER#0.8646;CEREBRAL CORTEX#0.8645;INSOMNIA#0.8641;OPTIC NERVE#0.8634;BOTULINUM TOXIN TYPE B#0.8632;CARDIAC MAGNETIC RESONANCE#0.8616;EDROPHONIUM#0.8615;SERIOUS ADVERSE EVENT#0.8595;ISOFLURANE#0.8584;CARRIE#0.8577;ANEMIA#0.8561;POSITIVE PREDICTIVE VALUE#0.8560;LUNG CANCER#0.8558;PLATELET ACTIVATING FACTOR#0.8554;OXYBUTYNIN#0.8553;BLOOD LOSS#0.8549;PREDNISONE#0.8530;CORONARY FLOW VELOCITY#0.8529;TISSUE DAMAGE#0.8526;SHORTNESS OF BREATH#0.8521;DEFECATION#0.8521;COLORECTAL#0.8520;HIGH DENSITY LIPOPROTEIN#0.8516;METABOLIC ACIDOSIS#0.8515;CERVIX#0.8509;APHASIA#0.8506;GLASGOW COMA SCALE#0.8500;COLITIS#0.8475;NEGATIVE PREDICTIVE VALUE#0.8470;BASAL CISTERN#0.8468;CHAGAS DISEASE#0.8468;MAGNESIUM DEFICIENCY#0.8457;BRACHIAL PLEXUS#0.8451;PNEUMOTHORAX#0.8450;OSTEOARTHRITIS#0.8447;STRIATED MUSCLE#0.8446;INTRACTABLE EPILEPSY#0.8432;ACUTE MYOCARDITIS#0.8430;VENOUS BLOOD#0.8426;NERVE TRUNK#0.8424;NEOSTIGMINE#0.8421;LEVETIRACETAM#0.8416;IRRITABILITY#0.8416;DANTROLENE SODIUM#0.8410;MASTICATION#0.8410;PARACETAMOL#0.8402;TRANSIENT ISCHEMIC ATTACK#0.8394;REMIFENTANIL#0.8382;CYCLIC AMP#0.8375;PERIPHERAL ARTERIAL DISEASE#0.8369;GLOMERULAR FILTRATION#0.8365;CARDIOMYOCYTE#0.8363;ASTIGMATISM#0.8360;HERPES ZOSTER#0.8357;ASPIRATION PNEUMONIA#0.8346;CONNECTIVE TISSUE DISEASE#0.8339;CEREBROVASCULAR DISEASE#0.8310;VITAMIN E#0.8298;MIDLINE#0.8277;INTERVERTEBRAL DISC#0.8264;ISOPRENALINE#0.8262;MILRINONE#0.8260;CARDIAC TAMPONADE#0.8252;SEXUAL DYSFUNCTION#0.8241;BETA ADRENOCEPTOR#0.8240;DIHYDROERGOTAMINE#0.8239;SPINAL CORD INJURED#0.8237;ORPHENADRINE#0.8234;MACROPHAGE#0.8217;ALLERGEN#0.8209;CARBACHOL#0.8204;METAIODOBENZYLGUANIDINE#0.8200;ADVERSE DRUG REACTION#0.8200;GASTRIC ULCER#0.8192;CARDIAC SYNDROME X#0.8171;MOYAMOYA DISEASE#0.8153;ALPHA ADRENOCEPTOR#0.8149;QUADRICEPS#0.8143;SPASTIC CEREBRAL PALSY#0.8142;TENSION TYPE HEADACHE#0.8124;BETA-2#0.8114;URTICARIA#0.8109;FIBRINOLYSIS#0.8108;RADICULOPATHY#0.8107;MUSCLE HYPERTROPHY#0.8096;ILOPROST#0.8095;CRAMPING#0.8083;PILOCARPINE#0.8083;NEUROMUSCULAR DISEASE#0.8074;DYSPEPSIA#0.8071;GLUTAMIC ACID#0.8070;PARENCHYMA#0.8053;HYPOKALEMIA#0.8051;TRADITIONAL CHINESE MEDICINE#0.8036;MYASTHENIA GRAVIS#0.8033;AUDITORY BRAINSTEM RESPONSE#0.8031;GASTRIC EMPTYING#0.8028;GESTATION#0.8020;NEUROMYELITIS OPTICA#0.8015;IPRATROPIUM BROMIDE#0.8013;UPPER MOTOR NEURON#0.8012;CHOLESTEATOMA#0.8011;LOWER URINARY TRACT#0.8005;AICARDI SYNDROME#0.8004;LYMPH NODE#0.7995;ERYTHROCYTE SEDIMENTATION RATE#0.7991;CIMETIDINE#0.7991;OSTEOPOROSIS#0.7987;PROCAINE#0.7970;SEROTONIN RECEPTOR#0.7967;TETRODOTOXIN#0.7959;DICLOFENAC#0.7947;EOSINOPHIL#0.7944;CAPECITABINE#0.7935;MAGNESIUM SULPHATE#0.7923;HEART MUSCLE#0.7923;KAWASAKI DISEASE#0.7915;PRAZOSIN#0.7912;ERYTHEMA#0.7902;COMPUTED TOMOGRAPHY ANGIOGRAPHY#0.7902;WHEEZING#0.7901;CEREBRAL BLOOD VOLUME#0.7889;LIGNOCAINE#0.7888;THALAMUS#0.7877;FLUORESCEIN#0.7865;VARICOSE VEINS#0.7856;MANDIBLE#0.7852;GINKGO BILOBA#0.7841;BARE METAL STENT#0.7840;MEDIAN NERVE#0.7815;PELVIS#0.7815;PULMONARY VEIN#0.7805;PAROXYSMAL ATRIAL FIBRILLATION#0.7803;OUTFLOW TRACT#0.7775;BRAIN EDEMA#0.7773;NERVE TERMINAL#0.7765;SCANNING ELECTRON MICROSCOPY#0.7759;VECURONIUM#0.7755;BARRETT'S ESOPHAGUS#0.7752;CORONARY ENDOTHELIAL DYSFUNCTION#0.7726;KETAMINE#0.7718;MYOCYTES#0.7698;CHEWING#0.7680;JOINT DISORDER#0.7677;HYDROCORTISONE#0.7669;CORTICOTROPIN#0.7667;HEALTHY CONTROL SUBJECTS#0.7665;LUPUS ERYTHEMATOSUS#0.7665;EOSINOPHILIC ESOPHAGITIS#0.7655;DEXAMETHASONE#0.7641;TEAR SECRETION#0.7638;FALLOPIAN TUBES#0.7630;INTESTINAL OBSTRUCTION#0.7627;DUODENAL ULCER#0.7623;HEMOLYSIS#0.7614;INTENTION TO TREAT#0.7614;VITAMIN D DEFICIENCY#0.7575;VALPROIC ACID#0.7568;LENGTH OF STAY#0.7546;NERVE ENDING#0.7542;EPIGASTRIC ARTERY#0.7521;VERTEBRA#0.7501;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7496;OTITIS MEDIA#0.7496;OBESE#0.7490;BILIARY DYSKINESIA#0.7486;RESPONSE TO NITROGLYCERIN#0.7479;INCREASED INTRACRANIAL PRESSURE#0.7478;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7478;KIDNEY DISEASE#0.7459;TIMI FRAME COUNT#0.7450;METHYLPREDNISOLONE#0.7449;ADIPOSE TISSUE#0.7449;HEMANGIOMA#0.7447;TUBERCULOSIS#0.7445;FLOW MEDIATED DILATION#0.7421;LUMBAR DISC HERNIATION#0.7417;MEATUS#0.7416;MYOPATHY#0.7403;MUSCLE ATROPHY#0.7394;FIBRINOGEN#0.7391;MYOCARDIAL PERFUSION IMAGING#0.7386;TRAUMATIC BRAIN INJURY#0.7381;CURARE#0.7379;CYSTITIS#0.7377;MIDBRAIN#0.7375;SLEEP DISORDER#0.7375;SPONDYLOLISTHESIS#0.7365;ENZYME INHIBITOR#0.7362;TRADITIONAL RISK FACTORS#0.7357;PURE TONE AUDIOMETRY#0.7355;OPTIMAL MEDICAL THERAPY#0.7343;PENICILLIN#0.7340;DEHYDRATION#0.7328;PERICARDITIS#0.7326;PLASMA MEMBRANE#0.7320;ESOPHAGEAL CANCER#0.7314;DUODENAL PAPILLA#0.7309;VENOUS SYSTEM#0.7309;MULTIPLE REGRESSION ANALYSIS#0.7308;KETOROLAC#0.7305;CHLORPROMAZINE#0.7303;SPINAL CORD INJURIES#0.7296;AS MYOCARDIAL INFARCTION#0.7291;AORTIC ANEURYSM#0.7282;CISPLATIN#0.7281;PHOSPHOLIPASE C#0.7277;LATERAL WALL#0.7275;ASPARTATE#0.7269;BRAIN INFARCTION#0.7267;METHOXAMINE#0.7255;MUSCULAR DYSTROPHY#0.7244;INTERNEURON#0.7207;IPRATROPIUM#0.7206;MUCUS SECRETION#0.7206;RECTUM#0.7205;PANIC DISORDER#0.7205;TEMPOROMANDIBULAR JOINT DISORDER#0.7204;LOWER LEG#0.7199;ALVERINE CITRATE#0.7198;RESERPINE#0.7194;SOMNOLENCE#0.7193;GLIBENCLAMIDE#0.7192;JEJUNUM#0.7185;GUANYLATE CYCLASE#0.7184;MEPERIDINE#0.7175;FENOTEROL#0.7174;MICROCEPHALY#0.7174;UROKINASE#0.7171;THIOPENTAL#0.7168;GENE EXPRESSION#0.7166;INFERTILITY#0.7165;PORTAL VEIN#0.7159;CILIARY BODY#0.7157;MYOSITIS#0.7151;ULCERATIVE COLITIS#0.7151;VITAMIN C#0.7146;MUSCLE DAMAGE#0.7139;THROMBOCYTOPENIA#0.7126;PROSTAGLANDIN SYNTHESIS#0.7124;SELECTIN#0.7116;PECTORALIS MAJOR#0.7115;INCOORDINATION#0.7102;PATENT DUCTUS ARTERIOSUS#0.7100;ASTROCYTOMA#0.7091;OVARIAN#0.7086;TUBOCURARINE#0.7085;SARCOPLASMIC RETICULUM#0.7085;CELL PROLIFERATION#0.7081;VERTEBRAE#0.7080;SULCUS#0.7079;MONOCYTE#0.7073;GLASGOW OUTCOME SCALE#0.7052;TEMPORAL LOBE#0.7038;AGITATION#0.7035;SINUSITIS#0.7032;COLORECTAL CANCER#0.7026;RETINAL DETACHMENT#0.7009;BECK DEPRESSION INVENTORY#0.7002;PROSTATITIS#0.7000;ILEUS#0.6985;LEVOSIMENDAN#0.6981;HIP JOINT#0.6971;RHINITIS#0.6968;PAROTID GLAND#0.6966;HYPOTHYROIDISM#0.6956;CRANIAL NERVE PALSY#0.6953;CEREBRAL HEMORRHAGE#0.6952;ULNAR NERVE#0.6935;AMNESIA#0.6932;ALDOSTERONE#0.6930;FUNCTIONAL INDEPENDENCE MEASURE#0.6929;DEMENTIA#0.6927;PERIPHERAL NERVOUS SYSTEM#0.6915;RESTLESS#0.6896;CONTROLLED CLINICAL TRIALS#0.6888;CAROTID ARTERY STENTING#0.6884;COGNITION#0.6884;APRAXIA#0.6880;APPENDICITIS#0.6866;GASTRITIS#0.6865;FEMORAL VEIN#0.6863;LETHARGY#0.6858;HEAD AND NECK CANCER#0.6856;BRIEF PAIN INVENTORY#0.6856;NECK CANCER#0.6855;TORSADE DE POINTES#0.6852;EPHEDRINE#0.6851;TUMOR NECROSIS FACTOR#0.6847;MITOCHONDRIA#0.6845;ACETIC ACID#0.6844;L-THYROXINE#0.6842;ACUTE HEART FAILURE#0.6842;CARDIAC MUSCLE#0.6838;VASCULAR SMOOTH MUSCLE CONTRACTION#0.6836;ANURIA#0.6824;NITRO-L-ARGININE#0.6822;PRE-ECLAMPSIA#0.6807;BETA ADRENERGIC RECEPTOR#0.6802;ANXIETY DISORDER#0.6789;CELIAC DISEASE#0.6780;MEPYRAMINE#0.6775;METRIZAMIDE#0.6766;CACL2#0.6753;GINKGO BILOBA EXTRACT#0.6752;VIRAL INFECTION#0.6742;PHOTOSENSITIVE EPILEPSY#0.6717;SUMATRIPTAN#0.6714;DEPRESSANT#0.6707;TENDINITIS#0.6699;OXALIPLATIN#0.6696;PHOSPHODIESTERASE INHIBITOR#0.6695;PHENYTOIN#0.6694;ENDOMETRIOSIS#0.6681;T LYMPHOCYTE#0.6680;MARFAN SYNDROME#0.6677;MAST CELL DEGRANULATION#0.6671;COMPLEX REGIONAL PAIN SYNDROME#0.6668;CLEFT LIP#0.6667;ANOREXIA#0.6661;ADENOSINE MONOPHOSPHATE#0.6653;GASTRIC MUCOSA#0.6652;UMBILICAL CORD#0.6645;NEPHROPATHY#0.6619;METHERGINE#0.6598;ANAEMIA#0.6587;CELL DEATH#0.6583;LEVODOPA#0.6579;METHERGIN#0.6577;RIGHT ATRIUM#0.6573;T CELL#0.6568;ACE INHIBITOR#0.6552;4-AMINOPYRIDINE#0.6546;LIPOPROTEIN METABOLISM#0.6530;BICEPS#0.6530;NEUROTRANSMITTER RELEASE#0.6520;DEPRESSIVE SYMPTOMS#0.6518;GRAVES' DISEASE#0.6511;STANDARD OF CARE#0.6504;IBUPROFEN#0.6502;ALLERGAN#0.6497;RESPONSE TO COLD#0.6497;SODIUM CHANNEL#0.6495;BROMOCRIPTINE#0.6490;BREAST CANCER#0.6484;HEART ATTACK#0.6481;LUNG DISEASE#0.6480;L-TYPE CALCIUM CHANNEL#0.6477;WEIGHT GAIN#0.6465;AMAUROSIS#0.6459;SODIUM BICARBONATE#0.6454;RHEUMATIC DISEASE#0.6454;CELL ACTIVATION#0.6447;IODOPHENYL#0.6446;ACETYLSALICYLIC ACID#0.6422;OBSTRUCTIVE SLEEP APNEA#0.6417;IMMUNE RESPONSE#0.6417;EVERY OTHER DAY#0.6412;HEROIN#0.6410;SMOOTH MUSCLE CELL PROLIFERATION#0.6406;RESPONSE TO SEROTONIN#0.6405;MUSCLE CELL PROLIFERATION#0.6404;JUGULAR VEIN#0.6402;HYOSCYAMINE#0.6397;NEURITIS#0.6396;DRY MOUTH#0.6374;VALPROATE#0.6350;SPINAL CORD ISCHEMIA#0.6344;UMBILICAL VEIN#0.6343;URIC ACID#0.6341;TERBUTALINE#0.6336;LACRIMATION#0.6331;INSTITUTIONAL REVIEW BOARD#0.6325;EPILEPSIA PARTIALIS CONTINUA#0.6296;NECROTIZING#0.6273;NEUROGENIC BLADDER#0.6266;LEFT ATRIUM#0.6266;CRUCIATE LIGAMENT#0.6265;RIGHT UPPER QUADRANT#0.6257;TRANSMISSION ELECTRON MICROSCOPY#0.6240;IRRITANT#0.6233;VENA CAVA#0.6230;KNEE JOINT#0.6223;DEHISCENCE#0.6213;CAUDATE NUCLEUS#0.6199;FATALITY#0.6193;SPONDYLOSIS#0.6193;BONE MARROW#0.6190;NAPROXEN#0.6179;HIRSCHSPRUNG'S DISEASE#0.6174;PRESSURE PAIN THRESHOLD#0.6174;EOSINOPHILIA-MYALGIA SYNDROME#0.6170;OBSESSIVE COMPULSIVE DISORDER#0.6163;TIMOLOL#0.6150;QUADRATUS LUMBORUM#0.6143;CONDUCTIVE HEARING LOSS#0.6143;INFERTILE#0.6142;PERIPHERAL ARTERY DISEASE#0.6129;BRAIN ISCHEMIA#0.6123;PERITONITIS#0.6120;MENIERE'S DISEASE#0.6117;DISSEMINATED INTRAVASCULAR COAGULATION#0.6109;ERECTOR SPINAE#0.6094;ALLERGIC RHINITIS#0.6093;BODY SURFACE AREA#0.6083;ZONISAMIDE#0.6080;PAIN DISORDER#0.6079;CHRONIC HEART FAILURE#0.6066;CYCLIC ADENOSINE MONOPHOSPHATE#0.6060;INTELLECTUAL DISABILITY#0.6059;PITRESSIN#0.6057;CORONARY ATHEROSCLEROTIC PLAQUE#0.6051;CARCINOID SYNDROME#0.6048;ENURESIS#0.6045;CORONAL#0.6045;NOXIOUS#0.6029;SARCOGLYCAN COMPLEX#0.6024;CALCIUM CHLORIDE#0.6017;BUSCOPAN#0.6016;DIABETIC KETOACIDOSIS#0.6015;CHOLECYSTITIS#0.6013;AMIODARONE#0.6012;PHENOBARBITAL#0.6011;HYPEREKPLEXIA#0.6003
102723547	TAXOL#1.0743;CANCER TESTIS ANTIGEN#1.0402;T CELL#0.9351;BREAST CANCER#0.9317;IMMUNE RESPONSE#0.8474;CANCER CELL#0.7921;PACLITAXEL#0.7323;OVARIAN CARCINOMA#0.7314;NON-SMALL CELL LUNG CARCINOMA#0.6594;LUNG CARCINOMA#0.6521;CYTOTOXIC T-LYMPHOCYTE#0.6504;DENDRITIC CELL#0.6456;IFN-GAMMA#0.6451;T LYMPHOCYTE#0.6446;OVARIAN#0.6268
102724047	OVARIAN#0.6451
102724362	SQUAMOUS CELL CARCINOMA#0.9013;CANCER CELL#0.8953;LAPATINIB#0.6604
10272	ACTIVIN BINDING#1.0930;BONE MORPHOGENETIC PROTEIN#1.0180;GROWTH FACTOR#1.0103;SKELETAL MUSCLE#0.9950;TRANSFORMING GROWTH FACTOR#0.9938;GENE EXPRESSION#0.9785;CELL PROLIFERATION#0.9610;TRANSFORMING GROWTH FACTOR BETA#0.9357;ACTIVIN RECEPTOR#0.9331;GESTATIONAL DIABETES#0.9245;RELATED PROTEIN 1#0.9082;INHIBIN#0.9048;TROPHOBLAST#0.8923;ENDOMETRIUM#0.8918;STROMAL CELL#0.8639;RHEUMATOID ARTHRITIS#0.8463;OBESE#0.8268;GESTATIONAL DIABETES MELLITUS#0.8211;POLYMERASE CHAIN REACTION#0.8165;DIABETES MELLITUS#0.8165;PRE-ECLAMPSIA#0.8101;OVARIAN#0.7928;CELL SURFACE#0.7923;B CELL#0.7899;GESTATION#0.7716;GLUCOSE HOMEOSTASIS#0.7707;TUMOR NECROSIS FACTOR#0.7280;GROWTH DIFFERENTIATION FACTOR#0.7241;HEMATOPOIESIS#0.7225;INSULIN-LIKE GROWTH FACTOR#0.7121;DECIDUA#0.6989;HEPARIN BINDING#0.6893;EXTRACELLULAR MATRIX#0.6831;BONE FORMATION#0.6800;EPITHELIAL CELL#0.6776;SIGNALING PATHWAY#0.6644;BREAST CANCER#0.6527;ECLAMPSIA#0.6504;SMAD BINDING ELEMENT#0.6249;SMAD BINDING#0.6202;GROWTH FACTOR BINDING#0.6185;HORMONE BINDING#0.6172;HEMATOPOIETIC CELL#0.6150;HEART DEVELOPMENT#0.6135;HEPARIN#0.6034;GLUCOCORTICOID RECEPTOR#0.6004
10273	UBIQUITIN LIGASE ACTIVITY#1.0783;HSC70 INTERACTING PROTEIN#1.0728;HSP70 INTERACTING PROTEIN#1.0687;LIGASE ACTIVITY#1.0621;PROTEIN QUALITY CONTROL#1.0255;UBIQUITIN#1.0183;HEMATOPOIESIS#1.0076;NEURODEGENERATIVE DISEASE#1.0037;PROTEIN DEGRADATION#1.0023;HISTONE MODIFICATION#1.0000;DNA BINDING#0.9950;UBIQUITIN PROTEASOME SYSTEM#0.9943;PROTEASOME#0.9937;CELL DEATH#0.9929;HEAT SHOCK PROTEIN#0.9925;PROTEASOME PATHWAY#0.9895;PROSTATE CANCER#0.9894;T CELL#0.9889;AUTOPHAGY#0.9879;LYSINE#0.9868;TRANSCRIPTION FACTOR BINDING#0.9866;CELL GROWTH#0.9853;TUMOR SUPPRESSOR#0.9811;ONCOGENIC#0.9811;BREAST CANCER CELL#0.9795;UBIQUITIN PROTEASOME PATHWAY#0.9785;ENDOPLASMIC RETICULUM#0.9782;BREAST CANCER#0.9781;CELL CYCLE#0.9734;LUNG CANCER#0.9722;EPITHELIAL CELL#0.9717;PROTEIN KINASE#0.9691;TRANSACTIVATION#0.9691;APOPTOSIS#0.9683;STEM CELL#0.9669;CANCER CELL#0.9665;PROTEIN FOLDING#0.9655;GENE EXPRESSION#0.9654;COLORECTAL CANCER#0.9641;TRANSCRIPTION FACTOR#0.9618;HYPOXIA#0.9612;COLON CANCER#0.9604;MACROPHAGE#0.9595;ALZHEIMER'S DISEASE#0.9588;GROWTH FACTOR#0.9588;SIGNALING PATHWAY#0.9588;CELL PROLIFERATION#0.9581;OSTEOBLAST DIFFERENTIATION#0.9554;ESTROGEN RECEPTOR#0.9547;DNA METHYLATION#0.9540;CYTOPLASM#0.9511;B CELL#0.9480;ENDOTHELIAL CELL#0.9478;CELL DIFFERENTIATION#0.9471;SENESCENCE#0.9441;COLORECTAL#0.9440;IMMUNE RESPONSE#0.9431;PARKINSON'S DISEASE#0.9417;ANDROGEN RECEPTOR#0.9415;HISTONE DEACETYLASE#0.9413;APOPTOTIC#0.9411;GELDANAMYCIN#0.9357;MYOCARDIAL INFARCTION#0.9348;NITRIC OXIDE#0.9325;CELL MIGRATION#0.9311;CARDIOMYOCYTE#0.9280;CELL SURFACE#0.9250;TOXICITY#0.9248;PROTEIN UBIQUITINATION#0.9225;PERIPHERAL BLOOD#0.9198;ANGIOGENESIS#0.9195;NUCLEOSOME#0.9179;MUTAGENESIS#0.9130;OSTEOBLAST#0.9106;AKT SIGNALING#0.9097;NITRIC OXIDE SYNTHASE#0.9064;NERVOUS SYSTEM#0.9059;EXOSOME#0.9047;EMBRYONIC STEM CELL#0.9042;RNA INTERFERENCE#0.8966;TRANSFORMING GROWTH FACTOR#0.8936;MOUSE EMBRYONIC FIBROBLAST#0.8919;CHAPERONE ACTIVITY#0.8902;HUMAN BREAST CANCER#0.8891;PROTEASOME DEGRADATION#0.8870;CYTOCHROME P450#0.8797;TUMOR CELLS#0.8785;OVARIAN#0.8759;PROTEIN PROTEIN INTERACTION#0.8697;MYELOID LEUKEMIA#0.8667;REPORTER GENE ASSAY#0.8635;CYSTIC FIBROSIS#0.8633;TF BINDING#0.8590;TRANSCRIPTIONAL CONTROL#0.8540;POST-TRANSLATIONAL MODIFICATION#0.8531;OVARIAN CANCER#0.8488;LUCIFERASE ACTIVITY#0.8418;TOLL LIKE RECEPTOR#0.8347;DNASE#0.8340;BONE MARROW#0.8326;CEREBELLAR ATAXIA#0.8323;ENDOCYTOSIS#0.8318;HISTONE ACETYLATION#0.8293;INSULIN RECEPTOR#0.8286;CHAPERONE BINDING#0.8270;PROGENITOR CELL#0.8251;DNA REPAIR#0.8178;EPITHELIAL MESENCHYMAL TRANSITION#0.8149;HYPOXIC#0.8117;REGULATORY T CELL#0.8094;SIGNAL TRANSDUCTION#0.8064;FACTOR I#0.8055;UNFOLDED PROTEIN RESPONSE#0.8030;SMOOTH MUSCLE#0.8029;26S PROTEASOME#0.8021;MONOCYTE#0.7968;OXYGEN GLUCOSE DEPRIVATION#0.7953;QUALITY CONTROL SYSTEM#0.7907;MUSCLE CELL#0.7877;UBIQUITIN PROTEIN LIGASE#0.7851;MITOCHONDRIA#0.7847;CANCER STEM CELL#0.7843;HEAT SHOCK FACTOR#0.7828;TREG CELL#0.7814;DUAL LUCIFERASE REPORTER#0.7787;HYPOXIA INDUCIBLE FACTOR#0.7761;HYPOGONADISM#0.7743;HYPOXIA RESPONSE ELEMENT#0.7721;CHROMATIN REMODELING#0.7677;ISCHEMIA#0.7655;HEMATOPOIETIC STEM CELL#0.7646;LYSOSOME#0.7614;ACUTE MYELOID LEUKEMIA#0.7571;HEPATOCELLULAR CARCINOMA#0.7548;POLYMERASE CHAIN REACTION#0.7520;REACTIVE OXYGEN SPECIES#0.7500;PANCREATIC CANCER#0.7435;POLYUBIQUITIN#0.7416;LYMPH NODE#0.7366;MICROTUBULE#0.7308;SMOOTH MUSCLE CELL#0.7301;OSTEOCLAST#0.7299;ARGININE#0.7248;GENE EXPRESSION OMNIBUS#0.7246;MECHANISM OF ACTION#0.7202;ADENOCARCINOMA#0.7180;TUMOR NECROSIS FACTOR#0.7154;ZINC FINGER PROTEIN#0.7139;DRUG RESISTANCE#0.7132;NECROPTOSIS#0.7093;NEURONAL CELL DEATH#0.7062;ERYTHROID CELL#0.6975;ESTRADIOL#0.6844;DNA REPLICATION#0.6839;COMPLEX I#0.6833;KINASE INHIBITOR#0.6810;ENHANCER BINDING PROTEIN#0.6756;ENHANCER BINDING#0.6752;COLON CARCINOMA#0.6751;PROTEIN BINDING#0.6732;S PHASE#0.6710;CENTRAL NERVOUS SYSTEM#0.6704;SURFACE PLASMON RESONANCE#0.6701;DENDRITIC CELL#0.6692;CYTOTOXICITY#0.6625;MOUSE EMBRYONIC STEM#0.6610;CELL CYCLE ARREST#0.6607;CELL ADHESION#0.6592;PROTEIN COMPLEX#0.6571;RNA BINDING#0.6567;QUANTITATIVE REAL TIME#0.6545;TELOMERE#0.6544;KINASE ACTIVITY#0.6543;DEUBIQUITINATING ENZYME#0.6538;LEUCINE#0.6531;ADIPOCYTE#0.6512;HOST CELL#0.6480;CD4+ T CELL#0.6456;AMYLOID PRECURSOR PROTEIN#0.6438;BONE MORPHOGENETIC PROTEIN#0.6430;AR BINDING#0.6380;SELECTIVE AUTOPHAGY#0.6288;INFLAMMATORY RESPONSE#0.6285;RESPONSE TO STRESS#0.6277;INNATE IMMUNITY#0.6260;MITOSIS#0.6259;CELLULAR SENESCENCE#0.6242;AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA#0.6234;MESENCHYMAL STEM CELL#0.6233;PRO-INFLAMMATORY#0.6229;HEART DISEASE#0.6226;GROWTH FACTOR RECEPTOR#0.6223;LYMPH NODE METASTASIS#0.6219;CORONARY ARTERY#0.6161;C TERMINAL DOMAIN#0.6158;CEREBRAL CORTEX#0.6142;CYCLIN DEPENDENT KINASE#0.6138;GRANULOSA CELL#0.6127;ARTERY#0.6126;GERM CELL#0.6112;BREAST CANCER PATIENTS#0.6107;RECEPTOR TYROSINE KINASE#0.6105;SIGNALLING PATHWAY#0.6102;IMMUNE SYSTEM#0.6081;INTESTINAL TRACT#0.6074;ATHEROSCLEROSIS#0.6048;HUMAN EMBRYONIC STEM#0.6046;VALOSIN CONTAINING PROTEIN#0.6020;HEAD AND NECK CANCER#0.6013;NECK CANCER#0.6013;BINDING PROTEIN 1#0.6003
10274	TELOMERE#1.0212;COHESIN COMPLEX#1.0168;SISTER CHROMATID COHESION#0.9991;CHROMATID#0.9975;FIBROSARCOMA#0.9417;TUMOR CELLS#0.9067;GENE EXPRESSION#0.9054;CANCER CELL#0.8422;CISPLATIN#0.8407;T CELL#0.8255;MITOSIS#0.8248;CENTROMERE#0.8139;CYSTATIN#0.8101;DNA REPAIR#0.8077;CELL DIVISION#0.7561;CHROMOSOME SEGREGATION#0.7507;CYTOTOXICITY#0.7293;BLEOMYCIN#0.7002;TUMOR GROWTH DELAY#0.7002;PROTEIN COMPLEX#0.6864;DNA REPLICATION#0.6854;MEIOSIS#0.6309;OVARIAN#0.6276;COMPLEX I#0.6047
10276	NUCLEOTIDE EXCHANGE FACTOR#1.0751;CANCER CELL#1.0698;GUANINE#1.0692;BREAST CANCER#1.0641;CELL MOTILITY#1.0378;SQUAMOUS CELL CARCINOMA#1.0075;SKIN SQUAMOUS CELL CARCINOMA#0.9710;BREAST CANCER CELL#0.9708;NEUROEPITHELIAL CELL#0.9669;HEPATOCELLULAR CARCINOMA#0.9565;FOCAL ADHESION#0.9531;STRESS FIBER#0.9485;CELL PROLIFERATION#0.9435;SIGNALING PATHWAY#0.9396;GENE EXPRESSION#0.8993;RHOGEF#0.8935;CELL MIGRATION#0.8808;GROWTH FACTOR#0.8503;ONCOGENIC#0.8159;PLASMA MEMBRANE#0.8062;MAMMARY GLAND#0.7828;EPITHELIAL CELL#0.7594;EXTRACELLULAR MATRIX#0.7236;PROTEASOME#0.7012;HUMAN BREAST CANCER#0.6960;TUMOR SUPPRESSOR#0.6915;POLYMERASE CHAIN REACTION#0.6887;APOPTOSIS#0.6714;TRANSFORMING GROWTH FACTOR#0.6427;ADENOCARCINOMA#0.6292;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.6190;BREAST CANCER PATIENTS#0.6158;CATALYTIC ACTIVITY#0.6111;CELL ADHESION#0.6068;CELL DEATH#0.6043
10277	UBIQUITIN#1.0453;NICOTINAMIDE MONONUCLEOTIDE#1.0215;APOPTOSIS#0.9813;PROTEASOME#0.9413;NICOTINAMIDE#0.9265;NEUROBLASTOMA#0.9186;TUMOR SUPPRESSOR#0.8611;CELL PROLIFERATION#0.8120;PROTEIN DEGRADATION#0.7887;NEURODEGENERATIVE DISEASE#0.7651;EPIDERMAL GROWTH FACTOR#0.7408;GROWTH FACTOR RECEPTOR#0.7408;GROWTH FACTOR#0.7382;CELL CYCLE#0.7202;GENE EXPRESSION#0.7150;CISPLATIN#0.6959;ENDOPLASMIC RETICULUM#0.6692;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6689;PROTEASOME PATHWAY#0.6419;PROTEIN QUALITY CONTROL#0.6195;CELL MIGRATION#0.6062;CELL GROWTH#0.6040;BREAST CANCER#0.6022;MUSCLE CELL#0.6010
10278	SIGNAL TRANSDUCTION#1.0410;CRISPR-CAS SYSTEM#1.0151;APOPTOSIS#1.0050;GROWTH FACTOR#1.0042;PROTEIN KINASE#1.0035;DNA DEGRADATION#1.0000;T CELL#0.9866;TRANSCRIPTION FACTOR#0.9829;GENE EXPRESSION#0.9710;IMMUNE SYSTEM#0.9573;GLUTAMINE#0.9160;CHEMOTAXIS#0.9066;T LYMPHOCYTE#0.8985;CELL CYCLE#0.8965;APOPTOTIC#0.8952;SIGNALING PATHWAY#0.8853;PHOSPHATASE ACTIVITY#0.8796;CANCER CELL#0.8704;NITROGEN FIXATION#0.8418;DNA BINDING#0.8247;NUCLEIC ACID#0.8205;ARGININE#0.8154;ADAPTIVE IMMUNE SYSTEM#0.8122;PROTEIN KINASE C#0.8118;PROTEIN PROTEIN INTERACTION#0.7813;CELL PROLIFERATION#0.7733;NUCLEASE ACTIVITY#0.7630;MITOGEN ACTIVATED PROTEIN#0.7605;HISTIDINE#0.7496;LYMPH NODE#0.7391;TUMOR NECROSIS FACTOR#0.7380;STEM CELL#0.7330;POLYMERASE CHAIN REACTION#0.7223;REACTIVE OXYGEN SPECIES#0.7172;INTRACELLULAR SIGNAL TRANSDUCTION#0.7148;AMP BINDING#0.7034;KINASE ACTIVITY#0.7023;TOXICITY#0.6874;REVERSE TRANSCRIPTION#0.6745;GTP BINDING#0.6732;DOCKING PROTEIN#0.6650;RIBONUCLEOPROTEIN COMPLEX#0.6644;NUCLEOTIDE BINDING#0.6634;EPITHELIAL CELL#0.6568;CELL ADHESION#0.6468;BASE PAIRING#0.6417;BIOFILM FORMATION#0.6378;N-ACETYL-L-GLUTAMATE#0.6354;VIRULENCE#0.6289;CELL GROWTH#0.6274;FOCAL ADHESION#0.6170;CATALYTIC ACTIVITY#0.6043;CELL MIGRATION#0.6017
10279	T CELL#1.0773;CD4+ T CELL#1.0702;EPITHELIAL CELL#0.9993;THYMIC EPITHELIAL CELLS#0.9448;T CELL DEVELOPMENT#0.8955;CELL DEVELOPMENT#0.8886;THYMOCYTE#0.7397;TYPE 1 DIABETES#0.6243
1027	MULTIPLE ENDOCRINE NEOPLASIA TYPE 4#1.0674;NUCLEAR EXPORT#1.0376;SERTOLI CELL#1.0319;BINDING PROTEIN 1#1.0242;PAPILLARY THYROID CARCINOMA#1.0206;MESANGIAL CELL#1.0160;CYCLIN DEPENDENT KINASE INHIBITOR#1.0117;CDK INHIBITOR#1.0093;CDK ACTIVITY#1.0068;KINASE INHIBITOR#1.0057;PITUITARY ADENOMA#1.0049;LYMPH NODE METASTASES#1.0045;CONTACT INHIBITION#1.0039;DISEASE FREE SURVIVAL#1.0035;COLORECTAL CARCINOMA#1.0033;SENESCENCE#1.0028;QUIESCENCE#1.0024;ANDROGEN RECEPTOR#1.0020;MULTIPLE ENDOCRINE NEOPLASIA TYPE 1#1.0019;ORAL SQUAMOUS CELL CARCINOMA#1.0014;MULTIPLE ENDOCRINE NEOPLASIA#1.0012;THYROID CARCINOMA#1.0012;HODGKIN'S LYMPHOMA#1.0011;CYCLIN DEPENDENT KINASE#0.9992;RAPAMYCIN#0.9978;OVARIAN CANCER#0.9975;PROGESTERONE#0.9971;NEUROBLASTOMA#0.9963;KINASE INHIBITOR P27#0.9951;RETINOIC ACID#0.9945;INHIBITION OF CELL PROLIFERATION#0.9934;REGULATION OF CELL CYCLE#0.9929;TRANSFORMING GROWTH FACTOR BETA#0.9928;BASAL CELL#0.9923;BREAST CARCINOMA#0.9921;TELOMERASE ACTIVITY#0.9920;UBIQUITIN#0.9909;BREAST CANCER PATIENTS#0.9908;DEPHOSPHORYLATION#0.9907;CELL ADHESION#0.9903;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9901;T LYMPHOCYTE#0.9899;CERVICAL#0.9899;B CELL LYMPHOMA#0.9889;LYMPH NODE METASTASIS#0.9888;COLORECTAL CANCER#0.9886;CORNEAL ENDOTHELIAL CELL#0.9879;SQUAMOUS CELL CARCINOMA#0.9876;COLON CANCER#0.9875;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9868;RNA INTERFERENCE#0.9864;RENAL CELL CARCINOMA#0.9864;HEPATOCELLULAR CARCINOMA#0.9862;PROTEASOME#0.9861;PROSTATE CARCINOMA#0.9857;M PHASE#0.9855;COLORECTAL#0.9855;CYCLIC AMP#0.9850;AUTOPHAGY#0.9842;PARATHYROID#0.9841;ENDOTHELIAL CELL#0.9838;T CELL#0.9837;CELL CYCLE REGULATOR#0.9836;NEUROENDOCRINE TUMOR#0.9832;B CELL#0.9825;MYELOID LEUKEMIA#0.9824;DNA REPLICATION#0.9824;OVARIAN#0.9815;PROSTATE CANCER#0.9815;HYPERPARATHYROIDISM#0.9806;VASCULAR SMOOTH MUSCLE CELL#0.9804;CYTOPLASM#0.9802;PRECURSOR CELL#0.9800;PROGENITOR CELL#0.9800;LYMPH NODE#0.9800;CELL CYCLE TRANSITION#0.9798;TRANSFORMING GROWTH FACTOR#0.9797;PROTEIN KINASE B#0.9797;SMOOTH MUSCLE#0.9792;ASTROCYTOMA#0.9791;PROTEASOME PATHWAY#0.9791;BREAST CANCER#0.9790;ACUTE MYELOID LEUKEMIA#0.9787;SMOOTH MUSCLE ACTIN#0.9786;CELL CYCLE#0.9785;CELL CYCLE CONTROL#0.9784;IFN-GAMMA#0.9784;PROTEIN SYNTHESIS#0.9780;TUMOR SUPPRESSOR#0.9778;KINASE ACTIVITY#0.9777;RETINOBLASTOMA#0.9774;CELL MIGRATION#0.9773;MAMMARY EPITHELIAL CELL#0.9769;NEUROGENESIS#0.9767;S PHASE#0.9763;SMOOTH MUSCLE CELL#0.9761;CELL CYCLE ARREST#0.9760;CELL DIFFERENTIATION#0.9754;CELL CYCLE REGULATION#0.9752;MUSCLE CELL#0.9749;CELL DIVISION#0.9744;BREAST CANCER CELL#0.9743;MAP KINASE#0.9743;MEDULLOBLASTOMA#0.9743;G1 PHASE#0.9742;ENDOTHELIAL GROWTH FACTOR#0.9742;ADENOCARCINOMA#0.9738;PLATELET-DERIVED GROWTH FACTOR#0.9737;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9737;REVERSE TRANSCRIPTION#0.9734;LUNG CANCER#0.9732;MITOGEN ACTIVATED PROTEIN#0.9725;KERATINOCYTE#0.9725;POLYMERASE CHAIN REACTION#0.9724;HUMAN BREAST CANCER#0.9723;ESTROGEN RECEPTOR#0.9721;CYTOCHROME C#0.9720;ONCOGENIC#0.9716;OVARIAN CARCINOMA#0.9714;INDUCTION OF APOPTOSIS#0.9710;EPIDERMAL GROWTH FACTOR#0.9708;UBIQUITIN PROTEASOME PATHWAY#0.9707;GROWTH FACTOR RECEPTOR#0.9706;PANCREATIC CANCER#0.9702;TUMOR CELLS#0.9700;INHIBITION OF CELL GROWTH#0.9699;NERVOUS SYSTEM#0.9691;PROTEIN DEGRADATION#0.9688;AKT SIGNALING#0.9688;THYROID CANCER#0.9685;DNA SYNTHESIS#0.9684;HYPOXIA#0.9674;MULTIPLE MYELOMA#0.9672;APOPTOTIC CELL DEATH#0.9667;REGENERATION#0.9664;VSMC PROLIFERATION#0.9663;SPINAL CORD#0.9663;STEM CELL#0.9661;HEPATOCELLULAR CARCINOMA CELL#0.9655;EPITHELIAL CELL#0.9653;APOPTOTIC#0.9646;MACROPHAGE#0.9644;CELL PROLIFERATION#0.9640;CANCER CELL#0.9638;MUSCLE CELL PROLIFERATION#0.9638;DNA FRAGMENTATION#0.9637;APOPTOSIS#0.9637;PROTEIN KINASE#0.9637;HISTONE DEACETYLASE#0.9634;THYMIDINE#0.9624;BONE MARROW#0.9620;CENTRAL NERVOUS SYSTEM#0.9614;ANCHORAGE INDEPENDENT GROWTH#0.9599;GROWTH FACTOR#0.9596;POLY ADP RIBOSE#0.9594;CYTOTOXICITY#0.9590;CELL GROWTH#0.9587;OLIGODENDROCYTE#0.9581;TRANSCRIPTION FACTOR#0.9577;GENE EXPRESSION#0.9575;DNA REPAIR#0.9574;CISPLATIN#0.9571;SIGNALING PATHWAY#0.9564;TUMOR TISSUES#0.9553;EXTRACELLULAR MATRIX#0.9551;CELL DEATH#0.9545;PRIMARY HYPERPARATHYROIDISM#0.9545;DEXAMETHASONE#0.9542;SMOOTH MUSCLE CELL PROLIFERATION#0.9541;TARGET OF RAPAMYCIN#0.9538;SIGNAL TRANSDUCTION#0.9532;CHOLANGIOCARCINOMA#0.9521;TERMINAL DIFFERENTIATION#0.9517;PERIPHERAL BLOOD#0.9514;HYPERPHOSPHORYLATION#0.9502;CELL DIVISION CYCLE#0.9502;REACTIVE OXYGEN SPECIES#0.9500;CARNEY COMPLEX#0.9496;MITOSIS#0.9494;GRANULOSA CELL#0.9488;INSULIN-LIKE GROWTH FACTOR#0.9472;BORTEZOMIB#0.9468;CELL SURFACE#0.9462;ANGIOGENESIS#0.9461;DNA BINDING#0.9440;FORMALIN#0.9439;STROMAL CELL#0.9434;DRUG RESISTANCE#0.9406;RIBOSE#0.9402;TRASTUZUMAB#0.9354;RECEPTOR TYROSINE KINASE#0.9352;CD4+ T CELL#0.9347;MECHANISM OF ACTION#0.9342;CERVICAL CANCER#0.9311;SKELETAL MUSCLE#0.9288;RESVERATROL#0.9266;DIFFUSE LARGE B-CELL LYMPHOMA#0.9245;PROTEIN KINASE C#0.9241;SCIATIC NERVE#0.9227;CELLULAR SENESCENCE#0.9226;1α,25-DIHYDROXYVITAMIN D3#0.9223;CELL DEVELOPMENT#0.9221;T CELL PROLIFERATION#0.9217;DNA METHYLATION#0.9208;VITAMIN D3#0.9195;GERM CELL#0.9189;ASTROCYTE#0.9183;B LYMPHOCYTE#0.9159;ATHEROSCLEROSIS#0.9136;PAPILLARY CARCINOMA#0.9117;ONCOGENESIS#0.9108;ESTRADIOL#0.9104;INVASIVE CARCINOMA#0.9100;ARYL HYDROCARBON RECEPTOR#0.9099;ENDOTHELIAL CELL PROLIFERATION#0.9097;MITOCHONDRIAL MEMBRANE#0.9072;OOCYTE#0.9056;TYROSINE KINASE INHIBITOR#0.9056;CELL CYCLE CHECKPOINT#0.9054;TOXICITY#0.9034;COLON CARCINOMA#0.9023;RNA BINDING#0.8995;CELL MOTILITY#0.8981;LUNG CARCINOMA#0.8942;PARATHYROID ADENOMA#0.8928;PHEOCHROMOCYTOMA#0.8902;TUMOR NECROSIS FACTOR#0.8884;MOUSE EMBRYONIC FIBROBLAST#0.8883;LYMPHOCYTIC LEUKEMIA#0.8867;CELL CYCLE PATHWAY#0.8865;GLYCOGEN SYNTHASE KINASE#0.8863;EPSTEIN BARR VIRUS#0.8857;CELL CYCLE PHASE#0.8855;EPITHELIAL CELL PROLIFERATION#0.8854;HEMATOPOIETIC CELL#0.8852;HISTONE DEACETYLASE INHIBITOR#0.8850;MITOCHONDRIA#0.8842;QUANTITATIVE REAL TIME#0.8834;ARTERY#0.8827;LYMPHOID TISSUE#0.8817;MECHANISMS OF ACTION#0.8816;SIGNAL TRANSDUCER#0.8810;PROSTATE SPECIFIC ANTIGEN#0.8784;5 FLUOROURACIL#0.8781;SIGNALLING PATHWAY#0.8778;UBIQUITIN LIGASE COMPLEX#0.8773;TAMOXIFEN#0.8771;FIBROBLAST GROWTH FACTOR#0.8767;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8766;MALIGNANT GLIOMA#0.8753;TRANSCRIPTASE#0.8736;LUMINAL#0.8732;PRIMARY BREAST CANCER#0.8700;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.8699;PAPILLOMA#0.8694;LUNG ADENOCARCINOMA#0.8684;PROTEIN KINASE A#0.8659;GENISTEIN#0.8652;TRANSACTIVATION#0.8640;HAIR CELL#0.8618;HEMATOPOIETIC STEM CELL#0.8601;FLOW CYTOMETRY ANALYSIS#0.8564;DENDRITIC CELL#0.8515;HYPOXIC#0.8470;MAMMARY GLAND#0.8464;CARCINOGEN#0.8458;SIGNALING MOLECULE#0.8457;GLIAL CELL#0.8454;FLUOROURACIL#0.8452;G2 PHASE#0.8449;MALIGNANT LYMPHOMA#0.8427;DIABETES MELLITUS#0.8427;CARDIOMYOCYTE#0.8418;RECEPTOR INTERACTING PROTEIN#0.8386;CANCER SPECIFIC SURVIVAL#0.8376;MELANOCYTE#0.8370;LYMPHOID CELL#0.8356;GM-CSF#0.8329;CYCLIN-DEPENDENT KINASE ACTIVITY#0.8320;MICROTUBULE#0.8287;MANTLE CELL LYMPHOMA#0.8275;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8274;RNA BINDING PROTEIN#0.8263;CARCINOMA IN SITU#0.8247;NEURAL PROGENITOR CELL#0.8247;DOXORUBICIN#0.8243;PHOSPHATASE AND TENSIN HOMOLOG#0.8240;GEFITINIB#0.8232;HEPATOMA CELLS#0.8229;MAPK ACTIVATION#0.8217;CELL ACTIVATION#0.8181;OVARIES#0.8149;CASPASE INHIBITOR#0.8142;VASCULAR CELL#0.8135;CYTOCHROME C RELEASE#0.8133;ENDOMETRIUM#0.8125;IMMUNE RESPONSE#0.8122;BETA CELL#0.8121;CELL EXPANSION#0.8105;KINASE INHIBITOR PROTEIN#0.8103;LIVER CANCER#0.8080;GENE SILENCING#0.8070;ALL TRANS RETINOIC ACID#0.8058;TOPOISOMERASE#0.8054;FOCAL ADHESION#0.8033;FIBROBLAST PROLIFERATION#0.7996;OSTEOBLAST#0.7992;WOUND HEALING#0.7989;PITUITARY GLAND#0.7978;PANCREATIC ADENOCARCINOMA#0.7977;ACTIVATED T CELL#0.7966;CHROMOSOMAL REGION#0.7952;ANAPLASTIC LARGE CELL LYMPHOMA#0.7944;OXIDATIVE DNA DAMAGE#0.7941;HYPERTENSION#0.7933;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7932;ENDOMETRIAL CANCER#0.7927;CLEAVED CASPASE 3#0.7924;RECURRENCE FREE SURVIVAL#0.7915;PANCREATIC ISLET#0.7914;POST-TRANSLATIONAL MODIFICATION#0.7913;HUMAN UMBILICAL VEIN#0.7897;UMBILICAL VEIN#0.7895;SIGNALING CASCADE#0.7888;PROSTATE ADENOCARCINOMA#0.7884;SEQUESTERING#0.7882;MYOCARDIAL INFARCTION#0.7880;ENDOPLASMIC RETICULUM#0.7875;COLONY-STIMULATING FACTOR#0.7873;SERTOLI CELL PROLIFERATION#0.7853;NITRIC OXIDE#0.7849;PACLITAXEL#0.7848;DOMINANT NEGATIVE MUTANT#0.7829;CELL MATURATION#0.7821;MITOTIC SPINDLE#0.7819;LEYDIG CELL#0.7802;URINARY BLADDER#0.7799;LYMPH NODE INVOLVEMENT#0.7789;SPINAL CORD INJURY#0.7788;DENTATE GYRUS#0.7772;HUMAN PANCREATIC CANCER#0.7753;G0 PHASE#0.7726;PROGRAMMED CELL DEATH#0.7721;FAMILIAL ISOLATED HYPERPARATHYROIDISM#0.7715;DIABETIC NEPHROPATHY#0.7702;CD8+ T CELL#0.7700;PROTEIN PROTEIN INTERACTION#0.7689;LYSINE#0.7688;ACTIVE CASPASE 3#0.7687;MOUSE EMBRYO FIBROBLASTS#0.7677;EPITHELIAL OVARIAN CANCER#0.7653;UBIQUITIN PROTEASOME SYSTEM#0.7652;INNER EAR#0.7649;TRANSCRIPTIONAL CONTROL#0.7637;COPY NUMBER CHANGE#0.7635;LEUCINE#0.7625;ADENOSINE#0.7611;LOCALIZED PROSTATE CANCER#0.7609;TOPOISOMERASE II#0.7603;FACTOR I#0.7586;REGULATION OF CELL PROLIFERATION#0.7582;EPITHELIAL MESENCHYMAL TRANSITION#0.7536;PROPIDIUM#0.7520;ACTIVATED T-CELLS#0.7510;GROWTH HORMONE#0.7509;NORMAL ORAL MUCOSA#0.7506;MYELOID CELL#0.7504;TASTE BUD#0.7496;COP9 SIGNALOSOME#0.7492;LOVASTATIN#0.7491;ORGAN OF CORTI#0.7488;COPY NUMBER ALTERATION#0.7487;COMPARATIVE GENOMIC HYBRIDIZATION#0.7454;METHYLATION SPECIFIC PCR#0.7452;NEPHROPATHY#0.7440;YEAR SURVIVAL RATE#0.7432;COMPLEX I#0.7392;ACROMEGALY#0.7385;HEAT SHOCK PROTEIN#0.7381;BIOTIN#0.7350;CYCLIN E KINASE ACTIVITY#0.7341;PLASMA CELL#0.7338;T CELL ANERGY#0.7330;METFORMIN#0.7315;DEGRADATION OF CYCLIN#0.7309;MONOCYTE#0.7292;PROSTATE EPITHELIAL CELL#0.7273;ESOPHAGEAL CARCINOMA#0.7270;VASCULAR DISEASE#0.7269;THYMOCYTE#0.7266;ADVANCED PROSTATE CANCER#0.7260;ANTI HER2#0.7257;PROTEASOME DEGRADATION#0.7257;METASTATIC MELANOMA#0.7213;CASPASE ACTIVATION#0.7213;MYELODYSPLASTIC SYNDROME#0.7210;ORAL MUCOSA#0.7210;FATTY ACID SYNTHASE#0.7208;RIBOSOMAL PROTEIN#0.7197;GASTRIC MUCOSA#0.7195;CELL QUIESCENCE#0.7178;CEREBRAL CORTEX#0.7162;ESOPHAGEAL CANCER#0.7151;PODOCYTE#0.7146;NULL CELL#0.7115;CATALYTIC ACTIVITY#0.7111;CELLULAR GROWTH#0.7102;CONNEXIN#0.7101;CYCLIN D1-CDK4 COMPLEX#0.7078;IMMUNE SYSTEM#0.7072;DNA DAMAGE RESPONSE#0.7072;ENDOTHELIUM#0.7057;PANCREATIC CARCINOMA#0.7041;MESENCHYMAL STEM CELL#0.7041;TO TUMOR PROGRESSION#0.7033;PARATHYROID HORMONE#0.7033;26S PROTEASOME#0.7031;TRANSITIONAL CELL CARCINOMA#0.7025;VON HIPPEL LINDAU#0.7017;ACTIVATED CASPASE 3#0.7008;EVEROLIMUS#0.7006;TESTOSTERONE#0.6993;UBIQUITIN PROTEIN LIGASE#0.6985;PULMONARY HYPERTENSION#0.6977;NODULAR#0.6974;ENHANCER BINDING#0.6969;MAPK SIGNALING#0.6963;VASCULAR ENDOTHELIAL CELL#0.6955;CYCLIN BINDING#0.6954;PROTEIN STABILIZATION#0.6944;MYOBLAST#0.6914;LYMPHOCYTE PROLIFERATION#0.6912;LINES OF EVIDENCE#0.6903;REPLICATIVE SENESCENCE#0.6900;CANCER RELATED DEATH#0.6899;SIGNALOSOME#0.6893;EMBRYONIC STEM CELL#0.6855;RETINAL PROGENITOR CELL#0.6846;PROTEIN PHOSPHORYLATION#0.6830;OLIGODENDROCYTE DIFFERENTIATION#0.6823;CORNEAL ENDOTHELIUM#0.6822;ACUTE PROMYELOCYTIC LEUKEMIA#0.6806;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6803;SMALL INTESTINE#0.6796;GLUTATHIONE#0.6781;LYMPHOMA CELL LINES#0.6768;PLASMA MEMBRANE#0.6763;LIVER REGENERATION#0.6752;POSTTRANSLATIONAL MODIFICATION#0.6734;BERBERINE#0.6709;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6704;BETA GALACTOSIDASE#0.6702;PARAGANGLIOMA#0.6701;CELL ADHESION MOLECULE#0.6666;ZD1839#0.6664;PERIPHERAL NERVE#0.6645;FAMILIAL HYPOCALCIURIC HYPERCALCEMIA#0.6631;MCCUNE ALBRIGHT SYNDROME#0.6598;GRANULOSA CELL PROLIFERATION#0.6596;DIFFERENTIAL GENE EXPRESSION#0.6571;MELANOMA CELL LINES#0.6555;GERMINAL CENTER#0.6554;QUANTITATIVE REVERSE TRANSCRIPTION#0.6540;HYPERCALCEMIA#0.6536;CAROTID ARTERY#0.6533;PRIMARY EFFUSION LYMPHOMA#0.6532;NUCLEAR IMPORT#0.6509;SMC PROLIFERATION#0.6502;INFLAMMATORY RESPONSE#0.6483;HEAD AND NECK CANCER#0.6478;NOTCH SIGNALING PATHWAY#0.6478;NECK CANCER#0.6477;INVASIVE DUCTAL CARCINOMA#0.6468;ATHEROSCLEROTIC#0.6459;RELAPSE FREE SURVIVAL#0.6458;COLON ADENOCARCINOMA#0.6457;B CELL RECEPTOR#0.6454;COLONY FORMATION ASSAY#0.6438;CELLULAR LOCALIZATION#0.6430;STAUROSPORINE#0.6423;ALANINE#0.6418;HEMATOPOIESIS#0.6409;FLAVOPIRIDOL#0.6400;PEROXISOME#0.6384;T CELL DEVELOPMENT#0.6330;ORAL CANCER CELL#0.6316;HEPATOCYTE PROLIFERATION#0.6307;CERVIX#0.6302;BLADDER CARCINOMA#0.6280;PROXIMAL TUBULAR CELL#0.6280;CENTROSOME#0.6277;ENDOMETRIAL CARCINOMA#0.6271;ADIPOCYTE#0.6260;GRANULOCYTE#0.6252;LOCALISATION#0.6248;CHROMOSOME REGION#0.6240;CANCER STEM CELL#0.6231;DNA TOPOISOMERASE#0.6226;GLOMERULONEPHRITIS#0.6225;PANCREATIC DUCTAL ADENOCARCINOMA#0.6223;INTERNATIONAL PROGNOSTIC INDEX#0.6221;T CELL ACTIVATION#0.6215;HEPATITIS B#0.6214;MONONUCLEAR CELLS#0.6188;HAIR FOLLICLE#0.6187;ARGININE#0.6180;NON-SMALL CELL LUNG CARCINOMA#0.6165;ORAL SQUAMOUS CARCINOMA#0.6159;ENTEROCYTE DIFFERENTIATION#0.6158;T CELL DIFFERENTIATION#0.6157;MORPHOGENESIS#0.6154;SIMVASTATIN#0.6154;TYROSINE KINASE RECEPTOR#0.6143;FOCAL ADHESION KINASE#0.6132;ACTINOMYCIN D#0.6131;INTESTINAL EPITHELIAL CELL#0.6126;CELL CYCLE DYSREGULATION#0.6126;COPY NUMBER VARIATION#0.6125;NUCLEAR LOCALIZATION SIGNAL#0.6120;SOMATOSTATIN RECEPTOR#0.6114;ADVANCED OVARIAN CANCER#0.6080;HOST CELL#0.6067;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6049;CORONARY ARTERY#0.6048;PROTEINURIA#0.6035;PERIPHERAL NERVE INJURY#0.6033;IN VIVO ELECTROPORATION#0.6033;PARATHYROID GLAND#0.6000
102800310	AUTOPHAGY#1.0678;APOPTOSIS#0.9911;SIGNALING PATHWAY#0.6739;LYMPHOMA CELL LINES#0.6407;MANTLE CELL LYMPHOMA#0.6370;LUNG CARCINOMA#0.6270;DISEASE FREE SURVIVAL#0.6244;OVARIAN CANCER#0.6214;HEPATOCELLULAR CARCINOMA#0.6196
102800311	CANCER CELL#1.0680;CELL PROLIFERATION#1.0653;APOPTOSIS#1.0581;SIGNALING PATHWAY#1.0189;SMOOTH MUSCLE#1.0167;SMOOTH MUSCLE CELL#1.0023;MUSCLE CELL#1.0015;CELL CYCLE#0.9852;HEPATOCELLULAR CARCINOMA#0.9473;VASCULAR SMOOTH MUSCLE CELL#0.9079;COLORECTAL CANCER#0.8912;TUMOR SUPPRESSOR#0.8552;POLYMERASE CHAIN REACTION#0.8521;GENE EXPRESSION#0.8451;PROSTATE CANCER#0.8105;LIVER CANCER#0.7848;ENDOTHELIAL CELL#0.7449;COLORECTAL#0.7305;AORTIC ANEURYSM#0.7034;HEPATIC STELLATE CELL#0.7015;CORONARY ARTERY#0.6957;CELL GROWTH#0.6906;DNA DAMAGE RESPONSE#0.6487;HYPOXIC#0.6480;GLYCOLYSIS#0.6477;REVERSE TRANSCRIPTION#0.6429;ARTERY#0.6413;GINKGO BILOBA EXTRACT#0.6411;GINKGO BILOBA#0.6339;HYPOXIA#0.6295;CELL MIGRATION#0.6248;VASCULAR ENDOTHELIAL CELL#0.6177;EPITHELIAL MESENCHYMAL TRANSITION#0.6168;HEPATITIS B#0.6159;COLON CANCER#0.6148;GLUTAMINE CATABOLISM#0.6093
10280	LATERAL SCLEROSIS#1.0448;AMYOTROPHIC LATERAL SCLEROSIS#1.0406;PENTAZOCINE#1.0292;ENDOPLASMIC RETICULUM#1.0236;ION CHANNEL#1.0034;MITOCHONDRIA#0.9930;NEUROPROTECTION#0.9900;CELL DEATH#0.9879;SPINAL CORD#0.9846;NEURODEGENERATIVE DISEASE#0.9660;NEUROPATHY#0.9528;FLUVOXAMINE#0.9506;ER MEMBRANE#0.9363;ALZHEIMER'S DISEASE#0.9149;HEREDITARY MOTOR NEUROPATHY#0.8998;PROTEIN KINASE#0.8960;APOPTOSIS#0.8768;GANGLION CELLS#0.8736;NMDA RECEPTOR#0.8690;PLASMA MEMBRANE#0.8530;NEURITE#0.8064;RETINAL GANGLION CELL#0.8041;DOPAMINE#0.7964;GENE EXPRESSION#0.7879;NERVOUS SYSTEM#0.7847;ETHANOL#0.7662;NEURITE OUTGROWTH#0.7648;PARKINSON'S DISEASE#0.7363;SIGNALING PATHWAY#0.7311;ASTROCYTE#0.7184;HALOPERIDOL#0.7158;NUCLEAR ENVELOPE#0.7053;CENTRAL NERVOUS SYSTEM#0.7036;METHAMPHETAMINE#0.6995;ER STRESS RESPONSE#0.6971;AUTOPHAGY#0.6954;HUNTINGTON'S DISEASE#0.6910;CARDIOMYOCYTE#0.6877;CANCER CELL#0.6768;MOTOR NEURON DISEASE#0.6731;OPIOID RECEPTOR#0.6665;CAMKIV#0.6611;PROTEASOME#0.6554;TOXICITY#0.6539;RECEPTOR ANTAGONIST#0.6531;RECEPTOR AGONIST#0.6382;ASPARTATE#0.6382;ENDOPLASMIC RETICULUM STRESS#0.6315;CHRONIC NEUROPATHIC PAIN#0.6258;UBIQUITIN PROTEASOME PATHWAY#0.6120;PROTEASOME PATHWAY#0.6100;RECEPTOR LIGAND#0.6083;MAJOR DEPRESSIVE DISORDER#0.6077;OPTIC NERVE#0.6054;DEMENTIA#0.6041;DENDRITIC SPINE#0.6034;PROTEIN KINASE B#0.6030;CYTOPLASM#0.6019;PROTEIN PROTEIN INTERACTION#0.6002
10281	DOWN SYNDROME#0.9127;PERIPHERAL BLOOD CELLS#0.6416;PERIPHERAL BLOOD#0.6210
10282	PHOSPHORAMIDON#0.9452;ENDOPLASMIC RETICULUM#0.9407;SNARE COMPLEX#0.9368;CARDIAC ARREST#0.8320;TRANEXAMIC ACID#0.7830;GOLGI COMPLEX#0.7649;GOLGI APPARATUS#0.7615;CELL WALL#0.7608;ER TO GOLGI TRANSPORT#0.7578;VESICULAR TRANSPORT#0.7454;PULMONARY EMBOLISM#0.7054;TOPICAL#0.6262;TRANSPORT VESICLE#0.6224
10283	RETINAL DEGENERATION#0.7141;SPLICEOSOME#0.6143
10284	HISTONE DEACETYLASE#1.0231;HDAC COMPLEX#0.9575;HISTONE DEACETYLASE COMPLEX#0.9286;TRANSCRIPTION FACTOR#0.8424;UBIQUITIN#0.7613;GENE EXPRESSION#0.7098;TRANSCRIPTIONAL REPRESSOR COMPLEX#0.6250
10285	SKIN CANCER#0.7810;SPLICEOSOME#0.7296;SURVIVAL MOTOR NEURON#0.7267;TOPICAL#0.7243;PHOTOPROTECTION#0.6922
10286	DASH COMPLEX#1.1406;DAM1 COMPLEX#1.1232;COMPLEX I#1.0712;KINETOCHORE#1.0578;BREAST CANCER#1.0465;MICROTUBULE#1.0410;CANCER CELL#1.0325;KINETOCHORE MICROTUBULE#1.0308;MICROTUBULE BINDING#1.0220;CHROMOSOME SEGREGATION#1.0215;BUDDING#1.0199;MITOSIS#0.9795;BREAST CANCER CELL#0.9623;SPINDLE MICROTUBULE#0.9560;MRNA SPLICING#0.9514;MICROTUBULE DEPOLYMERIZATION#0.9402;CELL CYCLE#0.9188;PRE-MRNA SPLICING#0.9151;NDC80 COMPLEX#0.9084;CENTROMERE#0.8775;KINETOCHORE-MICROTUBULE ATTACHMENT#0.8760;MITOTIC SPINDLE#0.8748;PROTEIN COMPLEX#0.8120;ESTROGEN RECEPTOR#0.8109;SPINDLE POLE#0.8108;METAPHASE#0.8069;ANAPHASE#0.7984;MICROTUBULE PLUS END#0.7753;BREAST CARCINOMA#0.7736;MICROTUBULE END#0.7443;APOPTOSIS#0.7382;SPINDLE ASSEMBLY#0.6979;CHROMATID#0.6937;CENTROMERE CLUSTERING#0.6889;PROTEIN PROTEIN INTERACTION#0.6871;SPINDLE ASSEMBLY CHECKPOINT#0.6730;MICROTUBULE DYNAMICS#0.6718;BIPOLAR ATTACHMENT#0.6457;KINETOCHORE LOCALIZATION#0.6447;SPLICEOSOME#0.6441;PROTEIN KINASE#0.6382
10287	GROWTH FACTOR#0.9783;GTPASE ACTIVITY#0.9703;CELL PROLIFERATION#0.9676;OPIOID RECEPTOR#0.9634;SIGNALING PATHWAY#0.9600;PROTEIN KINASE#0.9382;GAP ACTIVITY#0.9239;HETEROTRIMERIC G-PROTEIN#0.9230;GTP HYDROLYSIS#0.9129;CANCER CELL#0.9094;CLATHRIN COATED VESICLE#0.8829;COATED VESICLE#0.8783;RECEPTOR TYROSINE KINASE#0.8654;AUTOPHAGY#0.7787;COLON CANCER#0.7612;EPITHELIAL CELL#0.7591;PROTEIN KINASE C#0.7404;PLASMA MEMBRANE#0.7136;TRANS GOLGI NETWORK#0.6968;WNT RECEPTOR#0.6621;CELL MEMBRANE#0.6610;SIGNAL TRANSDUCTION#0.6596;MITOGEN ACTIVATED PROTEIN#0.6407;PDZ BINDING MOTIF#0.6365;MACROAUTOPHAGY#0.6196;OVARIAN CANCER#0.6182;CELL CYCLE#0.6140;DORSAL ROOT GANGLION#0.6070
10288	ENDOTHELIAL CELL#1.0404;MONOCYTE#1.0270;CELL SURFACE#1.0139;LEUKOCYTE#1.0133;DENDRITIC CELL#1.0119;HUMAN LEUKOCYTE ANTIGEN#1.0077;CANCER CELL#1.0046;ANTIGEN PRESENTING CELLS#1.0032;MACROPHAGE#0.9943;T CELL#0.9931;IMMUNE CELL#0.9882;GENE EXPRESSION#0.9875;IMMUNE RESPONSE#0.9854;PERIPHERAL BLOOD#0.9732;LUNG CANCER#0.9646;CELL PROLIFERATION#0.9384;SIGNALING PATHWAY#0.9343;POLYMERASE CHAIN REACTION#0.8962;TOLEROGENIC DENDRITIC CELLS#0.8951;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8909;STEM CELL#0.8856;LYMPH NODE#0.8690;IMMUNE SYSTEM#0.8618;CD8+ T CELL#0.8448;REGULATORY T CELL#0.8258;GROWTH FACTOR#0.8223;B CELL#0.8176;TUMOR CELLS#0.8175;CELL ACTIVATION#0.8080;TUMOR TISSUES#0.7936;CYTOKINE PRODUCTION#0.7841;CD4+ T CELL#0.7622;APOPTOSIS#0.7563;MYELOID CELL#0.7545;STROMAL CELL#0.7443;SMOOTH MUSCLE#0.7409;IFN-GAMMA#0.7303;HEPATOCELLULAR CARCINOMA#0.7266;CYTOTOXICITY#0.7103;T CELL PROLIFERATION#0.7102;PERIPHERAL BLOOD MONOCYTES#0.6927;IL-10 PRODUCTION#0.6863;AUTOIMMUNE DISEASE#0.6814;MONONUCLEAR CELLS#0.6638;TROPHOBLAST#0.6423;TRYPTOPHAN#0.6303;BREAST CANCER#0.6290;CELL DIFFERENTIATION#0.6231;CYTOKINE SECRETION#0.6136;TROPHOBLAST CELL#0.6084;MYELOID DENDRITIC CELL#0.6047;DUAL LUCIFERASE REPORTER#0.6017
1028	IMAGE SYNDROME#1.1366;VILLOUS CYTOTROPHOBLAST#1.0547;CYTOTROPHOBLAST#1.0508;LOSS OF METHYLATION#1.0380;STROMAL CELL#1.0353;PANCREATIC CANCER#1.0332;CDK INHIBITOR#1.0322;CYCLIN DEPENDENT KINASE INHIBITOR#1.0272;PODOCYTE#1.0267;IMPRINTING CONTROL REGION#1.0223;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0215;KINASE INHIBITOR#1.0205;HEPATOCELLULAR CARCINOMA#1.0196;CYCLIN DEPENDENT KINASE#1.0166;MOLAR#1.0162;BECKWITH-WIEDEMANN SYNDROME#1.0142;PARTIAL HYDATIDIFORM MOLE#1.0139;INSULIN-LIKE GROWTH FACTOR#1.0103;PROTEIN KINASE#1.0088;TROPHOBLAST#1.0076;TUMOR SUPPRESSOR#1.0069;POLYMERASE CHAIN REACTION#1.0033;CELL CYCLE REGULATOR#1.0027;TRANSFORMING GROWTH FACTOR#1.0016;SKELETAL MUSCLE#1.0008;HISTONE DEACETYLASE#1.0004;CELL DIFFERENTIATION#0.9999;CELL CYCLE CONTROL#0.9986;TUMOR CELLS#0.9974;REVERSE TRANSCRIPTION#0.9972;DNA METHYLATION#0.9968;CELL CYCLE ARREST#0.9954;BREAST CANCER#0.9948;CELL CYCLE#0.9947;LYMPH NODE#0.9944;CELL CYCLE REGULATION#0.9922;G1 PHASE#0.9911;CELL GROWTH#0.9907;SENESCENCE#0.9891;S PHASE#0.9882;MUSCLE CELL#0.9875;APOPTOTIC#0.9867;CANCER CELL#0.9862;QUIESCENCE#0.9855;PROGENITOR CELL#0.9849;GROWTH FACTOR#0.9835;RETINOBLASTOMA#0.9829;OVARIAN#0.9827;CELL DEATH#0.9819;APOPTOSIS#0.9786;SIGNALING PATHWAY#0.9773;T CELL#0.9772;CHONDROCYTE#0.9766;EPITHELIAL CELL#0.9764;KINASE ACTIVITY#0.9745;STEM CELL#0.9740;5-AZA-2'-DEOXYCYTIDINE#0.9736;BONE MARROW#0.9736;2'-DEOXYCYTIDINE#0.9732;GESTATION#0.9730;CELL PROLIFERATION#0.9722;ONCOGENIC#0.9721;HISTONE DEACETYLASE INHIBITOR#0.9711;PLACENTAL DEVELOPMENT#0.9708;LUNG CANCER#0.9690;TRANSCRIPTION FACTOR#0.9673;CELL MIGRATION#0.9661;B CELL#0.9656;GENE EXPRESSION#0.9656;SMOOTH MUSCLE#0.9644;MYOBLAST#0.9636;DIFFERENTIALLY METHYLATED REGION#0.9632;UBIQUITIN#0.9595;SHORT TANDEM REPEAT#0.9589;TUMOR TISSUES#0.9587;PROTEASOME#0.9558;BREAST CANCER CELL#0.9476;HUMAN PANCREATIC CANCER#0.9469;COLORECTAL#0.9459;PRECURSOR CELL#0.9428;SCHWANN CELL#0.9412;NEUROGENESIS#0.9398;OVARIAN CANCER#0.9383;VILLOUS STROMAL CELL#0.9382;NERVOUS SYSTEM#0.9355;HEMATOPOIETIC STEM CELL#0.9347;DEXAMETHASONE#0.9338;CELL DIVISION#0.9299;BETA CELL#0.9280;SQUAMOUS CELL CARCINOMA#0.9276;CYTOPLASM#0.9265;SMOOTH MUSCLE CELL#0.9197;TRANSFORMING GROWTH FACTOR BETA#0.9178;TERMINAL DIFFERENTIATION#0.9176;SILVER RUSSELL SYNDROME#0.9151;DNA REPLICATION#0.9110;QUANTITATIVE REAL TIME#0.9110;KERATINOCYTE#0.9051;EMBRYONIC STEM CELL#0.9033;ENDOTHELIAL CELL#0.8976;DECIDUA#0.8956;PROSTATE CANCER#0.8943;NEURAL STEM CELL#0.8941;PROTEASOME PATHWAY#0.8930;DEMETHYLATION#0.8914;REGENERATION#0.8878;HYPOXIA#0.8870;OLIGODENDROCYTE#0.8844;HISTONE MODIFICATION#0.8822;METAPHYSEAL DYSPLASIA#0.8799;INDUCTION OF APOPTOSIS#0.8795;ACTIN CYTOSKELETON#0.8723;LYMPH NODE METASTASIS#0.8696;RNA INTERFERENCE#0.8693;B CELL LYMPHOMA#0.8605;CHORIOCARCINOMA#0.8599;GREEN TEA POLYPHENOL#0.8522;DNA SYNTHESIS#0.8497;VASCULAR SMOOTH MUSCLE CELL#0.8488;OVARIAN CARCINOMA#0.8429;CARDIOMYOCYTE#0.8391;SIGNAL TRANSDUCTION#0.8388;CENTRAL NERVOUS SYSTEM#0.8387;MYELOID LEUKEMIA#0.8342;CLEFT PALATE#0.8313;CHROMOSOMAL REGION#0.8296;ADENOCARCINOMA#0.8255;QUANTITATIVE REVERSE TRANSCRIPTION#0.8241;OSTEOBLAST#0.8220;DECIDUALIZATION#0.8219;PERIPHERAL BLOOD#0.8198;CELL ADHESION#0.8140;RETINAL PROGENITOR CELL#0.8132;UBIQUITIN PROTEASOME PATHWAY#0.8126;M PHASE#0.8115;FORMALIN#0.8098;DNA BINDING#0.8072;HYPOXIC#0.8062;DIFFUSE LARGE B-CELL LYMPHOMA#0.8018;MYELODYSPLASTIC SYNDROME#0.7993;ADRENAL CORTEX#0.7976;COLORECTAL CARCINOMA#0.7943;HYPERTENSION#0.7929;LIPID RAFT#0.7910;SPINAL CORD#0.7909;REGULATION OF CELL CYCLE#0.7872;MITOSIS#0.7849;TRANSCRIPTASE#0.7831;INHIBITION OF CELL PROLIFERATION#0.7830;HUMAN BREAST CANCER#0.7818;APOPTOTIC CELL DEATH#0.7813;CYCLIN BINDING#0.7726;FIBROBLAST GROWTH FACTOR#0.7689;TRANSACTIVATION#0.7670;GENE SILENCING#0.7574;MAMMARY EPITHELIAL CELL#0.7477;HISTONE DEACETYLATION#0.7466;TROPHOBLAST GIANT CELLS#0.7458;MOUSE EMBRYONIC STEM#0.7448;METHYLATION SPECIFIC PCR#0.7428;TROPHOBLAST CELL#0.7428;FACTOR I#0.7423;ADRENOCORTICAL CARCINOMA#0.7422;PATERNALLY EXPRESSED GENE#0.7417;EPITHELIAL CELL PROLIFERATION#0.7405;TYPE 2 DIABETES#0.7404;C TERMINAL DOMAIN#0.7401;DNA METHYLTRANSFERASE#0.7399;COLORECTAL CANCER#0.7382;MORPHOGENESIS#0.7378;DISEASE FREE SURVIVAL#0.7375;RHABDOMYOSARCOMA#0.7352;BLADDER CARCINOMA#0.7253;ANGIOGENESIS#0.7246;ONCOGENESIS#0.7234;CEREBRAL CORTEX#0.7213;LEYDIG CELL#0.7190;CORTICOGENESIS#0.7176;POLYPYRIMIDINE TRACT BINDING#0.7161;ACUTE MYELOID LEUKEMIA#0.7153;CDK ACTIVITY#0.7141;OOCYTE#0.7122;FETAL GROWTH RESTRICTION#0.7113;PROTEIN KINASE INHIBITOR#0.7058;DOPAMINERGIC NEURON#0.7036;THYROID CARCINOMA#0.7028;DNA DAMAGE RESPONSE#0.7015;MESENCHYME#0.7000;ACUTE LYMPHOCYTIC LEUKEMIA#0.6955;DIABETES MELLITUS#0.6948;SYNCYTIOTROPHOBLAST#0.6909;MACROPHAGE#0.6883;CELL MOTILITY#0.6848;LYMPHOCYTIC LEUKEMIA#0.6841;NEUROBLASTOMA#0.6826;ENDOTHELIAL GROWTH FACTOR#0.6778;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6778;INTERNEURON#0.6770;ALLELE SPECIFIC EXPRESSION#0.6737;LENS DEVELOPMENT#0.6733;PROTEIN SYNTHESIS#0.6701;MONONUCLEAR CELLS#0.6691;NEURAL CELL#0.6688;DNASE#0.6636;LYSINE#0.6605;CELL ADHESION MOLECULE#0.6591;DOPAMINE#0.6572;PRE-ECLAMPSIA#0.6497;GLUCOCORTICOID RECEPTOR#0.6491;WOUND HEALING#0.6473;BONE MORPHOGENETIC PROTEIN#0.6443;PROTEIN PROTEIN INTERACTION#0.6442;DNA REPAIR#0.6428;HYPERINSULINISM#0.6405;CHONDROCYTE DIFFERENTIATION#0.6368;REPLICATIVE SENESCENCE#0.6360;PODOCYTE DIFFERENTIATION#0.6341;ASTROCYTOMA#0.6314;GROWTH FACTOR RECEPTOR#0.6287;BRAIN DEVELOPMENT#0.6285;PAPILLARY THYROID CARCINOMA#0.6283;MESENCHYMAL CELL#0.6280;DNASE I#0.6274;HEMATOPOIESIS#0.6258;COLONY FORMATION ASSAY#0.6247;TO THE PROGRESSION#0.6246;METHYLATION SPECIFIC POLYMERASE#0.6239;KINASE INHIBITOR PROTEIN#0.6205;ADIPOSE TISSUE#0.6193;MOUSE EMBRYONIC FIBROBLAST#0.6151;FETAL KIDNEY#0.6145;CLEAVED CASPASE 3#0.6136;SOMATIC TISSUE#0.6121;CELL QUIESCENCE#0.6103;OMPHALOCELE#0.6035;HUMAN MAMMARY EPITHELIAL#0.6032
10290	STRIATED MUSCLE#1.0762;PROTEIN KINASE#1.0282;SMOOTH MUSCLE#0.9983;DILATED CARDIOMYOPATHY#0.9938;CARDIOMYOPATHY#0.9637;MUSCLE CELL#0.8709;SMOOTH MUSCLE CELL#0.8610;CARDIOMYOCYTE#0.8001;SKELETAL MUSCLE#0.7836;CENTRONUCLEAR MYOPATHY#0.7561;MYOPATHY#0.6953;TRANSVERSE TUBULE#0.6685;VASCULAR SMOOTH MUSCLE CELL#0.6214
10291	U2 SNRNP#1.0827;SPLICEOSOME#0.8982;GENE EXPRESSION#0.8040;MRNA SPLICING#0.7820;PRE-MRNA SPLICING#0.6478;17S U2 SNRNP#0.6365;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.6168;SPLICEOSOME ASSEMBLY#0.6038
10293	UBIQUITIN#1.0383;DNA DAMAGE RESPONSE#0.9614;TUMOR NECROSIS FACTOR#0.9006;CELL CYCLE#0.8431;MITOSIS#0.7729;DNA REPLICATION#0.7612;REPLICATION FORK#0.7486;CELL PROLIFERATION#0.7173;TRAF SIGNALING#0.7158;LIGASE ACTIVITY#0.6881;REPLISOME#0.6786;SECKEL SYNDROME#0.6254
10294	HEAT SHOCK PROTEIN#1.0239;ATPASE ACTIVITY#1.0195;PROTEIN FOLDING#1.0075;ATP HYDROLYSIS#0.9948;CHAPERONE ACTIVITY#0.9299;ENDOPLASMIC RETICULUM#0.8376;NUCLEOTIDE EXCHANGE FACTOR#0.8135;CYCLOPHILIN#0.7887;SUBSTRATE BINDING DOMAIN#0.7336;C TERMINAL DOMAIN#0.7204;MITOCHONDRIAL PROTEIN IMPORT#0.7121;GENE EXPRESSION#0.7064;PROTEIN IMPORT#0.6986;IMMUNE RESPONSE#0.6817;TUMOR SUPPRESSOR#0.6798;CELL CYCLE#0.6352;T CELL#0.6318;TRANSCRIPTION FACTOR#0.6234;ISOMERASE ACTIVITY#0.6206
10295	ALPHA KETOACID DEHYDROGENASE#1.1161;DEHYDROGENASE COMPLEX#1.0636;CATABOLISM#1.0237;KINASE ACTIVITY#0.9583;PROTEIN KINASE#0.9108;PYRUVATE DEHYDROGENASE KINASE#0.8915;PYRUVATE#0.8332;SKELETAL MUSCLE#0.8231;INTELLECTUAL DISABILITY#0.7049;COMPLEX I#0.6711;LEUCINE#0.6399;MITOCHONDRIA#0.6254
10296	ERYTHROBLAST#1.0698;MACROPHAGE#1.0519;TETRAHYDROCANNABINOL#1.0125;CELL WALL#1.0082;ETHANOL#1.0063;BONE MARROW#0.9821;ERYTHROID CELL#0.9558;MULTIPLE SCLEROSIS#0.9007;DELTA-9-TETRAHYDROCANNABINOL#0.8926;GENE EXPRESSION#0.8441;ANTIOXIDANT ACTIVITY#0.8354;SECONDARY CELL WALL#0.8304;FERMENTATION#0.8242;YOLK SAC#0.8182;TOXICITY#0.7998;LUNG DISEASE#0.7987;GERMINATION#0.7904;FETAL LIVER#0.7894;SCANNING ELECTRON MICROSCOPY#0.7871;SOY PROTEIN ISOLATE#0.7720;SUCCINIC ACID#0.7708;FLOWERING#0.7673;ERYTHROPOIESIS#0.7514;APOPTOSIS#0.7384;DIGESTION#0.7331;LUNG CANCER#0.7007;GROWTH REGULATOR#0.7000;HEMATOPOIESIS#0.6872;FRAGMENT LENGTH POLYMORPHISM#0.6858;SEX CHROMOSOME#0.6837;ERYTHROCYTE#0.6830;DIABETES MELLITUS#0.6818;TYPE 2 DIABETES MELLITUS#0.6700;2 DIABETES MELLITUS#0.6700;CELL MOTILITY#0.6679;TYPE 2 DIABETES#0.6663;FORCED EXPIRATORY VOLUME#0.6540;NERVOUS SYSTEM#0.6530;DRONABINOL#0.6522;DELTA-9-THC#0.6519;CANNABINOID RECEPTOR#0.6501;HISTAMINE#0.6499;INTERNAL TRANSCRIBED SPACER#0.6442;CHRONIC RESPIRATORY DISEASE#0.6430;SWELLING#0.6296;CELL MIGRATION#0.6231;ENUCLEATION#0.6214;RAPAMYCIN#0.6189;PERIPHERAL BLOOD#0.6127
10297	ADENOMATOUS POLYPOSIS COLI#1.0535;MICROTUBULE#1.0385;TUMOR SUPPRESSOR#1.0340;SIGNALING PATHWAY#1.0115;CANCER CELL#0.9935;5 AZC#0.9533;NERVOUS SYSTEM#0.9393;ADENOMATOSIS POLYPOSIS COLI#0.9261;WNT SIGNALING PATHWAY#0.9205;CELL PROLIFERATION#0.8901;COLORECTAL CANCER#0.8320;COLORECTAL#0.7797;OVARIAN CANCER#0.7516;OVARIAN#0.7278;COLON CANCER#0.7229;CENTRAL NERVOUS SYSTEM#0.6916;BREAST CANCER#0.6895;DENDRITE BRANCH#0.6664;STEM CELL#0.6453;CENTROSOME#0.6419;CELL CYCLE#0.6351;GENE EXPRESSION#0.6335;MITOTIC SPINDLE#0.6250;LUNG CANCER#0.6115
10298	BREAST CANCER#1.0718;BREAST CANCER CELL#1.0643;KINASE ACTIVITY#1.0498;CELL MIGRATION#1.0375;CANCER CELL#1.0344;ONCOGENIC#1.0334;P21 ACTIVATED KINASE#1.0325;CELL CYCLE#1.0320;EPITHELIAL CELL#1.0316;CELL PROLIFERATION#1.0302;PANCREATIC CANCER#1.0301;LUNG CANCER#1.0265;SIGNALING PATHWAY#1.0192;PROTEIN KINASE#1.0178;APOPTOSIS#1.0177;CELL GROWTH#1.0148;CELL MOTILITY#0.9934;GROWTH FACTOR#0.9928;CELL ADHESION#0.9911;PROSTATE CANCER#0.9849;ANCHORAGE INDEPENDENT GROWTH#0.9834;ACTIN CYTOSKELETON#0.9611;GENE EXPRESSION#0.9581;FOCAL ADHESION#0.9517;HUMAN BREAST CANCER#0.9215;KINASE INHIBITOR#0.9015;CELL DEATH#0.8750;SIGNALING CASCADE#0.8706;MAMMARY EPITHELIAL CELL#0.8590;TRANSCRIPTION FACTOR#0.8562;TUMOR NECROSIS FACTOR#0.8520;SIGNALLING PATHWAY#0.8513;COLON CANCER#0.8511;APICAL JUNCTION#0.8445;COLORECTAL CANCER#0.8394;TUMOR SUPPRESSOR#0.8296;ENDOMETRIUM#0.8296;ADENOCARCINOMA#0.8288;MITOGEN ACTIVATED PROTEIN#0.8261;LYMPH NODE#0.8254;ENDOTHELIAL CELL#0.8193;AKT SIGNALING#0.8111;EPITHELIAL MESENCHYMAL TRANSITION#0.8015;ACINAR CELL#0.8007;CISPLATIN#0.7988;CYTOPLASM#0.7728;PANCREATIC DUCTAL ADENOCARCINOMA#0.7576;MORPHOGENESIS#0.7554;STRESS FIBER#0.7519;ENDOMETRIAL CANCER#0.7501;CELL CYCLE ARREST#0.7494;STEM CELL#0.7443;COLORECTAL#0.7330;RNA INTERFERENCE#0.7281;SENESCENCE#0.7115;NERVOUS SYSTEM#0.7076;MICROTUBULE#0.7073;ENDOTHELIAL MICROPARTICLE#0.7014;MOLECULAR DYNAMICS SIMULATION#0.6969;CELL JUNCTION#0.6928;TOXICITY#0.6878;PROTEIN KINASE A#0.6798;FOCAL ADHESION KINASE#0.6791;MAMMARY GLAND#0.6764;HEPATOCELLULAR CARCINOMA#0.6756;INFLAMMATORY RESPONSE#0.6744;CYCLIN DEPENDENT KINASE#0.6741;OVARIAN#0.6729;CELL CELL JUNCTION#0.6717;NICOTINAMIDE#0.6641;OVARIAN CANCER#0.6583;G1 PHASE#0.6543;GROWTH FACTOR RECEPTOR#0.6497;NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE#0.6460;PODOSOME RING#0.6439;ACTIN POLYMERIZATION#0.6391;SPINDLE POSITIONING#0.6293;GUANINE EXCHANGE FACTOR#0.6226;METASTATIC GASTRIC CANCER#0.6215;STRESS FIBRE#0.6185;DISEASE FREE SURVIVAL#0.6104;S PHASE#0.6092;RHOGEF#0.6083;CLEAR CELL RENAL CELL CARCINOMA#0.6037
102997063	INTELLECTUAL DISABILITY#1.1965
10299	UBIQUITIN#1.0592;ER MEMBRANE#1.0225;ENDOPLASMIC RETICULUM#1.0110;PROTEASOME#0.9517;PROTEIN DEGRADATION#0.9275;CHOLESTEROL SYNTHESIS#0.9111;PROTEIN QUALITY CONTROL#0.8361;NUCLEAR ENVELOPE#0.8273;TRANSCRIPTION FACTOR#0.8215;ERAD PATHWAY#0.8077;INNER NUCLEAR MEMBRANE#0.7862;NUCLEAR MEMBRANE#0.7770;COENZYME A#0.7320;CHOLESTEROL BIOSYNTHESIS#0.6598;ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION#0.6320;GENE EXPRESSION#0.6101
1029	ARF BINDING#1.0803;OROPHARYNX CANCER#1.0609;ALTERNATIVE READING FRAME#1.0516;VAGINAL CANCER#1.0495;ORAL EPITHELIAL DYSPLASIA#1.0475;HYBRID CAPTURE 2#1.0456;MURINE DOUBLE MINUTE#1.0419;INTRAEPITHELIAL NEOPLASM#1.0391;ANAL INTRAEPITHELIAL NEOPLASIA#1.0378;ACTINIC KERATOSIS#1.0373;PHOSPHATASE AND TENSIN HOMOLOG#1.0348;NORMAL CERVICAL TISSUE#1.0346;PERITONEAL MESOTHELIOMA#1.0345;EMBRYONAL CARCINOMA#1.0317;ADENOMATOUS POLYPOSIS COLI#1.0314;SUMOYLATION#1.0304;SPUTUM#1.0298;ASCUS#1.0278;MULTIPLE PRIMARY MELANOMA#1.0262;NUCLEOPLASM#1.0256;FAMILIAL MELANOMA#1.0248;NULL CELL#1.0247;GALLBLADDER CARCINOMA#1.0244;PLEOMORPHIC ADENOMA#1.0241;RIBOSOME BIOGENESIS#1.0232;NUCLEOLUS#1.0227;HIGH GRADE LESION#1.0219;BETA-GALACTOSIDASE ACTIVITY#1.0218;INVERTED PAPILLOMA#1.0217;LIQUID BASED CYTOLOGY#1.0214;PENILE CANCER#1.0214;EYE DEVELOPMENT#1.0212;NUCLEOTIDE EXCHANGE FACTOR#1.0201;ANAPLASTIC OLIGODENDROGLIOMA#1.0201;SMOOTH MUSCLE TUMOR#1.0191;P53 SIGNALING PATHWAY#1.0178;CDK ACTIVITY#1.0163;RETINOIC ACID RECEPTOR#1.0153;LARYNGEAL SQUAMOUS CELL CARCINOMA#1.0152;ATYPICAL SQUAMOUS CELLS#1.0146;NEUROFIBROMA#1.0145;MDM2 BINDING#1.0141;NEURAL CELL#1.0139;COLON CARCINOMA#1.0136;ENDOMETRIAL ADENOCARCINOMA#1.0136;LEIOMYOMA#1.0129;CYCLIN DEPENDENT KINASE INHIBITOR#1.0129;CERVICAL ADENOCARCINOMA#1.0128;BETA-2#1.0127;MOUSE EMBRYO FIBROBLASTS#1.0120;ENDOCERVICAL ADENOCARCINOMA#1.0118;QUANTITATIVE METHYLATION SPECIFIC#1.0114;LARYNGEAL CARCINOMA#1.0113;MALT LYMPHOMA#1.0112;CDK INHIBITOR#1.0109;KERATOSIS#1.0108;FOLLICULAR ADENOMA#1.0106;LICHEN PLANUS#1.0100;GASTRIC TISSUE#1.0094;METHYLATION SPECIFIC POLYMERASE#1.0093;HISTIDINE#1.0090;ESOPHAGEAL CARCINOMA#1.0087;METASTATIC LYMPH NODE#1.0084;ACUTE LYMPHOCYTIC LEUKEMIA#1.0082;TONGUE CANCER#1.0078;COLORECTAL ADENOCARCINOMA#1.0076;INTERPHASE#1.0074;CERVICAL CANCER SCREENING#1.0073;LYNCH SYNDROME#1.0072;UVEAL MELANOMA#1.0072;LIVER CIRRHOSIS#1.0072;NON-SMALL CELL LUNG CARCINOMA#1.0071;BIOTIN#1.0068;LYMPHOCYTIC CHORIOMENINGITIS#1.0067;RETINOIC ACID#1.0065;MESOTHELIOMA CELL#1.0063;CLEAVED CASPASE 3#1.0062;HUMAN MAMMARY EPITHELIAL#1.0059;BLADDER CARCINOMA#1.0058;HODGKIN'S LYMPHOMA#1.0056;FAMILIAL PANCREATIC CANCER#1.0056;EWING SARCOMA#1.0055;GASTRIC ADENOCARCINOMA#1.0055;COLORECTAL ADENOMA#1.0055;LIGASE ACTIVITY#1.0053;PROSTATE CARCINOMA#1.0051;CHROMOSOME REGION#1.0049;STRESS-INDUCED PREMATURE SENESCENCE#1.0048;LEIOMYOSARCOMA#1.0047;GALECTIN#1.0042;CANCER SPECIFIC SURVIVAL#1.0042;HUMAN PANCREATIC CANCER#1.0041;LIPOSARCOMA#1.0040;GALLBLADDER#1.0035;CERVICAL SQUAMOUS CELL CARCINOMA#1.0033;KINASE INHIBITOR#1.0033;EVENT FREE SURVIVAL#1.0028;MYCOSIS FUNGOIDES#1.0024;SCALP#1.0021;GALACTOSIDASE ACTIVITY#1.0020;SENESCENCE#1.0020;CYCLIN D1-CDK4 COMPLEX#1.0019;ALL TRANS RETINOIC ACID#1.0017;VON HIPPEL LINDAU#1.0016;PITUITARY ADENOMA#1.0015;SMOOTH MUSCLE ACTIN#1.0011;PILOCYTIC ASTROCYTOMA#1.0011;CYCLIN DEPENDENT KINASE#1.0009;MEDULLOBLASTOMA#1.0009;GTP BINDING#1.0007;POSITIVE PREDICTIVE VALUE#1.0006;MELANOMA CELL LINES#1.0006;VERRUCOUS CARCINOMA#1.0005;INVASIVE CERVICAL CANCER#1.0004;ESOPHAGEAL CANCER#1.0003;DEMETHYLATION#1.0003;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0002;RIBOSOME#1.0000;ONCOGENE INDUCED SENESCENCE#0.9998;NORMAL BREAST TISSUE#0.9998;GENE COPY NUMBER#0.9995;ESTROGEN RECEPTOR#0.9992;LI-FRAUMENI SYNDROME#0.9991;CONTACT INHIBITION#0.9991;THYMOCYTE#0.9990;PROGESTERONE#0.9988;TOPOISOMERASE#0.9987;DEPHOSPHORYLATION#0.9987;CHONDROSARCOMA#0.9986;PANCREATIC CARCINOMA#0.9983;AMELOBLASTOMA#0.9982;CERVICITIS#0.9979;ARSENIC TRIOXIDE#0.9976;BILE DUCT#0.9975;COPY NUMBER GAIN#0.9975;MYOCYTES#0.9974;GENETICALLY ENGINEERED MOUSE#0.9974;OVARIAN CARCINOMA#0.9973;CELL CYCLE DYSREGULATION#0.9972;QUANTITATIVE REVERSE TRANSCRIPTION#0.9972;ANDROGEN RECEPTOR#0.9972;SMALL CELL CARCINOMA#0.9971;HYPOXIA INDUCIBLE FACTOR#0.9970;IMATINIB#0.9970;RNA BINDING PROTEIN#0.9969;ASTROCYTE#0.9969;ADJACENT NORMAL TISSUE#0.9969;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9968;METHYLATION SPECIFIC PCR#0.9967;BARRETT'S ESOPHAGUS#0.9964;ORAL MUCOSA#0.9963;MALIGNANT LYMPHOMA#0.9961;MALIGNANT GLIOMA#0.9957;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.9956;RELAPSE FREE SURVIVAL#0.9956;SQUAMOUS INTRAEPITHELIAL LESION#0.9955;TO TUMOR PROGRESSION#0.9953;COLORECTAL CARCINOMA#0.9953;BASAL CELL CARCINOMA#0.9953;GUANINE#0.9953;AZACYTIDINE#0.9952;CELL CYCLE TRANSITION#0.9950;GASTROINTESTINAL STROMAL TUMOR#0.9947;COLITIS#0.9945;CERVICAL LYMPH NODE#0.9945;ULCERATIVE COLITIS#0.9945;VIRION#0.9945;CD8+ T CELL#0.9945;NEUROBLASTOMA#0.9945;HYPERMETHYLATION OF CPG ISLAND#0.9945;LUNG CARCINOMA#0.9941;MALIGNANT PLEURAL MESOTHELIOMA#0.9941;TO THE PROGRESSION#0.9939;BETA GALACTOSIDASE#0.9938;NERVE SHEATH TUMORS#0.9937;TOPOISOMERASE II#0.9936;INHIBITION OF CELL GROWTH#0.9935;LIVER METASTASIS#0.9935;MAMMARY EPITHELIAL CELL#0.9933;CELL DIVISION CYCLE#0.9932;DIFFUSE ASTROCYTOMA#0.9931;CELL CYCLE PATHWAY#0.9931;NEURAL STEM CELL#0.9931;TUMOR SUPPRESSOR#0.9930;HISTONE METHYLATION#0.9930;ANAL CANAL#0.9930;FOLLICULAR LYMPHOMA#0.9929;RHABDOMYOSARCOMA#0.9928;REGULATION OF CELL CYCLE#0.9924;NEGATIVE PREDICTIVE VALUE#0.9923;MEDIAN NERVE#0.9923;MOUSE EMBRYONIC FIBROBLAST#0.9923;DYSPLASTIC NEVUS#0.9922;LARGE CELL CARCINOMA#0.9922;DUCTAL CARCINOMA IN SITU#0.9922;MULTIPLE MYELOMA#0.9921;RETINOBLASTOMA#0.9921;CARDIOMYOCYTE#0.9920;FOLATE#0.9919;IFN-GAMMA#0.9919;BRONCHIAL EPITHELIAL CELLS#0.9919;CHONDROCYTE#0.9918;ADENOCARCINOMA IN SITU#0.9918;PLASMA CELL#0.9918;MAMMARY GLAND#0.9917;TELOMERASE ACTIVITY#0.9913;RIBOSOMAL RNA#0.9913;RIBOSOMAL PROTEIN#0.9912;MESOTHELIAL CELL#0.9909;LYMPHOCYTIC LEUKEMIA#0.9908;FOCAL ADHESION#0.9906;RNA BINDING#0.9905;LINES OF EVIDENCE#0.9905;URINARY BLADDER#0.9904;BETA CELL#0.9904;BREAST CARCINOMA#0.9903;5-AZA-2'-DEOXYCYTIDINE#0.9903;PANCREATIC ADENOCARCINOMA#0.9903;CELL AGING#0.9901;AUTOPHAGY#0.9899;2'-DEOXYCYTIDINE#0.9899;CENTROSOME#0.9897;MAP KINASE#0.9897;OVERALL SURVIVAL RATE#0.9896;TETRACYCLINE#0.9896;ENDOMETRIAL CARCINOMA#0.9895;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.9894;EOSIN#0.9892;ORAL SQUAMOUS CELL CARCINOMA#0.9892;CERVICAL#0.9892;CELL CYCLE PHASE#0.9892;URINARY BLADDER CANCER#0.9891;ANOIKIS#0.9890;GASTRIC MUCOSA#0.9889;OLIGODENDROGLIOMA#0.9886;CYTOCHROME C#0.9886;PRIMARY BREAST CANCER#0.9885;CELL CYCLE REGULATOR#0.9885;THYROID CARCINOMA#0.9883;ADENOID CYSTIC CARCINOMA#0.9882;CHOLANGIOCARCINOMA#0.9882;BONE MARROW CELLS#0.9881;MYOGENESIS#0.9881;REPLICATIVE SENESCENCE#0.9878;THYROID CANCER#0.9878;HEPATITIS B VIRUS#0.9875;SALIVARY GLAND#0.9874;CPG ISLAND METHYLATION#0.9873;GERM CELL#0.9873;LYMPH NODE INVOLVEMENT#0.9870;TELOMERE MAINTENANCE#0.9870;DNA METHYLTRANSFERASE#0.9868;HEPATITIS C VIRUS#0.9867;NUCLEAR EXPORT#0.9866;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9864;CERVICAL CANCER CELL LINES#0.9863;HIGH GRADE DYSPLASIA#0.9862;NEVUS#0.9861;TRANSACTIVATION#0.9861;MALIGNANT MESOTHELIOMA#0.9858;SQUAMOUS CELL CANCER#0.9857;ENDOMETRIAL CANCER#0.9857;SCHWANN CELL#0.9856;PLATELET-DERIVED GROWTH FACTOR#0.9855;NEUROENDOCRINE TUMOR#0.9854;LARYNX#0.9852;GLUTATHIONE#0.9851;HEPATOCELLULAR CARCINOMA CELL#0.9850;QUIESCENCE#0.9850;MELANOCYTE#0.9850;MISMATCH REPAIR#0.9845;INSULIN-LIKE GROWTH FACTOR#0.9845;INVASIVE CARCINOMA#0.9844;CARDIAC MUSCLE#0.9844;CELL CYCLE CHECKPOINT#0.9844;NEUROENDOCRINE CARCINOMA#0.9843;ASTROCYTOMA#0.9842;MONONUCLEAR CELLS#0.9842;VESICLE TRAFFICKING#0.9841;MAPK SIGNALING#0.9838;PAPILLARY CARCINOMA#0.9836;ATAXIA TELANGIECTASIA MUTATED#0.9834;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9832;HIGH FAT DIET#0.9831;CORONARY ARTERY DISEASE#0.9830;LUNG CANCER#0.9830;ADULT T-CELL LEUKEMIA#0.9829;ARTERY DISEASE#0.9828;ESOPHAGUS#0.9828;TIME TO PROGRESSION#0.9828;EPIDERMAL GROWTH FACTOR#0.9827;CENTROMERE#0.9827;DOUBLE STRAND BREAK#0.9826;VULVA#0.9825;MUCINOUS ADENOCARCINOMA#0.9824;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9824;CERVICAL CANCER#0.9823;LYMPH NODE METASTASES#0.9822;PARATHYROID ADENOMA#0.9822;NORMAL ORAL MUCOSA#0.9820;INHIBITION OF CELL PROLIFERATION#0.9820;HEMATOPOIETIC CELL#0.9819;POLYCOMB REPRESSIVE COMPLEX#0.9819;BILIARY TRACT#0.9818;RISK OF DEATH#0.9818;PANCREATIC CANCER#0.9817;SOFT TISSUE SARCOMA#0.9816;PERIPHERAL NERVE#0.9815;CETUXIMAB#0.9813;HEPATITIS C#0.9813;ANAPLASTIC MENINGIOMA#0.9811;LYMPH NODE METASTASIS#0.9810;HOST CELL#0.9809;HETEROCHROMATIN#0.9809;DNA HYPERMETHYLATION#0.9809;METASTATIC MELANOMA#0.9807;PROTEIN PROTEIN INTERACTION#0.9807;CHRONIC MYELOID LEUKEMIA#0.9806;WHITE BLOOD CELL#0.9806;UBIQUITIN#0.9806;PROTEASOME#0.9806;TELOMERASE REVERSE TRANSCRIPTASE#0.9805;POLYMERASE CHAIN REACTION#0.9805;ACUTE LEUKEMIA#0.9804;BASAL CELL#0.9803;ARGININE#0.9802;TELOMERE#0.9800;SIGNALLING PATHWAY#0.9800;GROWTH FACTOR RECEPTOR#0.9799;AGE AT DIAGNOSIS#0.9798;OVARIAN CANCER#0.9797;MALIGNANT PLEURAL EFFUSION#0.9797;CELL CYCLE CONTROL#0.9796;NEURONAL CELLS#0.9795;ATAXIA TELANGIECTASIA#0.9794;TERMINAL DIFFERENTIATION#0.9793;AGEING#0.9792;HEPATITIS B#0.9791;LEUKOCYTE#0.9790;CERVIX#0.9789;HEPATOCYTE GROWTH FACTOR#0.9788;PROTEIN SYNTHESIS#0.9787;DIFFUSE LARGE B-CELL LYMPHOMA#0.9787;PROTEIN COMPLEX#0.9787;DISEASE SPECIFIC SURVIVAL#0.9786;OVARIAN#0.9785;CELLULAR SENESCENCE#0.9785;RECURRENCE FREE SURVIVAL#0.9784;RNA INTERFERENCE#0.9784;TRANSITIONAL CELL CARCINOMA#0.9784;ANCHORAGE INDEPENDENT GROWTH#0.9784;QUANTITATIVE REAL TIME#0.9783;MYELODYSPLASTIC SYNDROME#0.9782;VSMC PROLIFERATION#0.9781;CHROMOSOMAL REGION#0.9780;ADIPOSE TISSUE#0.9780;INVASIVE BREAST CANCER#0.9780;DNA FRAGMENTATION#0.9779;TUMOR TISSUES#0.9779;HEAT SHOCK PROTEIN#0.9779;CORONARY ARTERY#0.9779;INVASIVE DUCTAL CARCINOMA#0.9779;EPITHELIAL OVARIAN CANCER#0.9779;PANCREATITIS#0.9779;MANTLE CELL LYMPHOMA#0.9778;PHOSPHOLIPASE D#0.9776;STEM CELL MARKER#0.9774;AGGRESSIVE BEHAVIOR#0.9774;GALLBLADDER CANCER#0.9773;COPY NUMBER CHANGE#0.9773;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9772;AKT SIGNALING#0.9771;TRANSCRIPTASE#0.9770;DNA HYPOMETHYLATION#0.9770;OSTEOBLAST#0.9769;KERATINOCYTE#0.9769;HUMAN PAPILLOMA VIRUS#0.9769;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9769;CELL CYCLE#0.9768;THYMIC CARCINOMA#0.9768;ACUTE MYELOID LEUKEMIA#0.9767;ENDOTHELIAL GROWTH FACTOR#0.9766;HISTONE MODIFICATION#0.9764;NITRIC OXIDE SYNTHASE#0.9764;BURKITT LYMPHOMA#0.9764;ADIPOCYTE#0.9764;ORAL CAVITY#0.9763;NUCLEIC ACID#0.9763;HUMAN BREAST CANCER#0.9763;TONSIL#0.9760;NODULAR#0.9760;HYPERPHOSPHORYLATION#0.9760;GENE SILENCING#0.9759;HYPOXIA#0.9757;NEUROGENESIS#0.9756;POLYCOMB REPRESSIVE COMPLEX 1#0.9756;LUNG ADENOCARCINOMA#0.9756;METHIONINE#0.9755;T-CELL LEUKEMIA#0.9755;REVERSE TRANSCRIPTION#0.9754;ONCOGENESIS#0.9754;DERMAL FIBROBLAST#0.9753;FIBROBLAST GROWTH FACTOR#0.9753;MESANGIAL CELL#0.9753;ATHEROSCLEROSIS#0.9752;BREAST CANCER PATIENTS#0.9749;PROTEIN KINASE C#0.9749;PROTEIN PHOSPHORYLATION#0.9748;COLORECTAL#0.9748;G2 PHASE#0.9747;LUMINAL#0.9746;HEAD AND NECK CARCINOMA#0.9745;G1 PHASE#0.9745;CELL ADHESION MOLECULE#0.9745;DNA SYNTHESIS#0.9744;ENDOMETRIUM#0.9744;TRANSFORMING GROWTH FACTOR BETA#0.9744;YEAR SURVIVAL RATE#0.9744;LYSINE#0.9743;CELL CYCLE ARREST#0.9742;MICROTUBULE#0.9742;ALZHEIMER'S DISEASE#0.9741;SUPEROXIDE DISMUTASE#0.9741;DNA DAMAGE RESPONSE#0.9741;CELL DEVELOPMENT#0.9740;TONGUE SQUAMOUS CELL CARCINOMA#0.9739;TRANSCRIPTIONAL CONTROL#0.9738;SKELETAL MUSCLE#0.9737;COLORECTAL CANCER#0.9736;MYELOID LEUKEMIA#0.9735;ORAL LICHEN PLANUS#0.9734;KINASE ACTIVITY#0.9734;HISTONE ACETYLATION#0.9731;CANCER STEM CELL#0.9730;IMMUNE CELL#0.9729;TYPE 2 DIABETES MELLITUS#0.9729;2 DIABETES MELLITUS#0.9729;TYPE 2 DIABETES#0.9729;PAPILLOMA#0.9729;CELL ADHESION#0.9727;DENDRITIC CELL#0.9725;B LYMPHOCYTE#0.9723;FINE NEEDLE ASPIRATION#0.9722;CELL CYCLE REGULATION#0.9722;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9722;PROSTATE CANCER#0.9720;ATHEROSCLEROTIC#0.9720;LYMPHOMA CELL LINES#0.9720;EPITHELIAL TO MESENCHYMAL#0.9719;CARCINOMA IN SITU#0.9719;SEQUESTERING#0.9718;MUTAGENESIS#0.9717;B CELL LYMPHOMA#0.9716;COLON CANCER#0.9715;METASTATIC SQUAMOUS CELL CARCINOMA#0.9715;RAPAMYCIN#0.9715;MITOCHONDRIA#0.9714;HYPOXIC#0.9713;SMOOTH MUSCLE#0.9713;METAPLASIA#0.9711;EPSTEIN BARR VIRUS#0.9710;COPY NUMBER VARIATION#0.9710;HUMAN BRONCHIAL EPITHELIAL#0.9710;DIGESTION#0.9710;MUCINOUS NEOPLASM#0.9709;HIGH RISK PATIENTS#0.9709;BREAST CANCER#0.9709;INFLUENZA A VIRUS#0.9708;PANCREATIC DUCTAL ADENOCARCINOMA#0.9708;BREAST CANCER CELL#0.9707;CELL MIGRATION#0.9706;SPINAL CORD#0.9706;T CELL#0.9705;5 FLUOROURACIL#0.9701;PROTEIN KINASE B#0.9701;FORMALIN#0.9701;MRNA BINDING#0.9701;RISK OF RELAPSE#0.9700;NITRIC OXIDE#0.9698;ARTERY#0.9698;EMBRYONIC STEM CELL#0.9697;BINDING PROTEIN 3#0.9695;ISCHEMIA#0.9694;THYROID TRANSCRIPTION FACTOR#0.9693;REGULATION OF CELLULAR#0.9693;VASCULAR SMOOTH MUSCLE CELL#0.9693;TRANSFORMING GROWTH FACTOR#0.9692;REGENERATION#0.9692;DNA COPY NUMBER#0.9692;T LYMPHOCYTE#0.9690;PROTEIN KINASE#0.9690;PLURIPOTENT STEM CELL#0.9690;COMPLEX I#0.9690;LIVER DISEASE#0.9690;PRO-INFLAMMATORY#0.9689;SKIN CANCER#0.9689;PLASMA MEMBRANE#0.9689;RESPONSE TO TREATMENT#0.9688;CHROMATIN REMODELING#0.9688;LOW GRADE GLIOMAS#0.9688;MACROPHAGE#0.9687;PHARYNX#0.9686;POLYCOMB REPRESSIVE COMPLEXES#0.9685;COLUMNAR#0.9685;DISEASE FREE SURVIVAL#0.9685;GASTRITIS#0.9685;LIVER CANCER#0.9684;HISTONE DEACETYLASE INHIBITOR#0.9683;MITOCHONDRIAL MEMBRANE#0.9682;GLIAL CELL#0.9682;NASOPHARYNX#0.9681;ENDOMETRIOSIS#0.9681;ONCOGENIC#0.9680;S PHASE#0.9680;APOPTOTIC CELL DEATH#0.9676;EPITHELIAL MESENCHYMAL TRANSITION#0.9676;DOXORUBICIN#0.9675;SEBACEOUS CARCINOMA#0.9673;B CELL#0.9671;M PHASE#0.9671;TUMOR NECROSIS FACTOR#0.9670;DNA BINDING#0.9669;CELL MEMBRANE#0.9669;DNA METHYLATION#0.9668;HISTONE DEACETYLASE#0.9668;ADENOCARCINOMA#0.9668;XERODERMA PIGMENTOSUM#0.9668;LYMPH NODE#0.9666;DRUG RESISTANCE#0.9665;MYOCARDIAL INFARCTION#0.9664;COPY NUMBER ALTERATION#0.9664;GLIOBLASTOMA MULTIFORME#0.9664;CYTOPLASM#0.9664;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9664;GENOTOXIC#0.9663;POLY ADP RIBOSE#0.9662;PERIPHERAL BLOOD#0.9661;MONOCYTE#0.9660;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9655;CELL GROWTH#0.9653;FLUOROURACIL#0.9653;LIPOMA#0.9653;INDUCTION OF APOPTOSIS#0.9652;PROGENITOR CELL#0.9652;PSORIASIS#0.9651;SMOOTH MUSCLE CELL#0.9651;HEAD AND NECK CANCER#0.9651;LEUCINE#0.9651;GROWTH FACTOR#0.9651;HEPATOCELLULAR CARCINOMA#0.9650;DENTATE GYRUS#0.9650;DNA REPAIR#0.9648;HEMATOPOIETIC STEM CELL#0.9648;DNA DEMETHYLATION#0.9648;NECK CANCER#0.9648;FRONTAL#0.9648;ACTIN CYTOSKELETON#0.9647;GROWTH PATTERN#0.9646;UBIQUITIN LIGASE ACTIVITY#0.9646;PACLITAXEL#0.9646;CELL DIVISION#0.9645;SQUAMOUS CELL CARCINOMA#0.9645;FACTOR I#0.9644;TUMOR CELLS#0.9642;DNA REPLICATION#0.9642;VIRAL INFECTION#0.9642;SIGNALING CASCADE#0.9642;RECEPTOR TYROSINE KINASE#0.9641;KERATINIZING SQUAMOUS CELL CARCINOMA#0.9641;RENAL CELL CARCINOMA#0.9641;TARGET OF RAPAMYCIN#0.9638;CD4+ T CELL#0.9638;BONE MORPHOGENETIC PROTEIN#0.9637;PRECURSOR CELL#0.9635;INFLAMMATORY RESPONSE#0.9632;SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCI#0.9632;CELL PROLIFERATION#0.9632;RENAL CARCINOMA#0.9631;CYTOTOXICITY#0.9631;CLEAR CELL CARCINOMA#0.9631;CELL DIFFERENTIATION#0.9631;EPITHELIAL CELL#0.9630;DIABETES MELLITUS#0.9629;HEMATOPOIESIS#0.9629;MITOGEN ACTIVATED PROTEIN#0.9628;POSITRON EMISSION TOMOGRAPHY#0.9627;SKIN CARCINOMA#0.9627;THYMIDINE#0.9626;PERIPHERAL BLOOD LYMPHOCYTES#0.9624;MESENCHYMAL STEM CELL#0.9623;STROMAL CELL#0.9622;CISPLATIN#0.9621;MUSCLE CELL#0.9620;CANCER CELL#0.9620;APOPTOSIS#0.9618;THYMIDYLATE SYNTHASE#0.9618;CELL SURFACE#0.9614;FLAVOPIRIDOL#0.9613;ENDOTHELIAL CELL#0.9612;PEUTZ-JEGHERS SYNDROME#0.9611;HAIR FOLLICLE#0.9610;HEPATOMA CELLS#0.9609;MYELOID CELL#0.9609;PRIMARY CUTANEOUS MELANOMA#0.9609;PROGRAMMED CELL DEATH#0.9608;SIGNAL TRANSDUCTION#0.9608;ORAL CAVITY CANCER#0.9607;ANGIOGENESIS#0.9605;FIBROSARCOMA#0.9604;OVARIAN SEROUS CARCINOMA#0.9602;LYMPHOID TISSUE#0.9602;BONE MARROW#0.9602;APOPTOTIC#0.9600;ENDOPLASMIC RETICULUM#0.9600;SIGNET RING CELL#0.9599;ADULT STEM CELL#0.9599;HOMOLOGOUS RECOMBINATION#0.9598;STEM CELL TRANSPLANTATION#0.9598;WORLD HEALTH ORGANIZATION#0.9597;OXYGEN INDUCED RETINOPATHY#0.9596;STROMA#0.9596;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9596;TYROSINE KINASE INHIBITOR#0.9596;HIGH MOBILITY GROUP#0.9595;RIBOSE#0.9595;ACRAL LENTIGINOUS MELANOMA#0.9594;OXIDATIVE DNA DAMAGE#0.9594;WOUND HEALING#0.9594;SIGNAL TRANSDUCER#0.9591;REACTIVE OXYGEN SPECIES#0.9591;SPORADIC BREAST CANCER#0.9591;FRAGMENT LENGTH POLYMORPHISM#0.9591;DOMINANT NEGATIVE MUTANT#0.9590;CARCINOGEN#0.9586;REGIONAL LYMPH NODE#0.9585;COMPARATIVE GENOMIC HYBRIDIZATION#0.9584;ADENINE#0.9582;PARATHYROID#0.9580;IMMUNE SYSTEM#0.9579;STEM CELL#0.9576;MULTIPLE SCLEROSIS#0.9576;CANCER RELATED DEATH#0.9576;NUCLEUS PULPOSUS#0.9575;IMMUNE RESPONSE#0.9574;CARRIE#0.9574;P53 BINDING#0.9573;UNCERTAIN MALIGNANT POTENTIAL#0.9571;CORD BLOOD#0.9571;ENHANCER BINDING#0.9569;MITOSIS#0.9568;MEDIAN OVERALL SURVIVAL#0.9568;MECHANISM OF ACTION#0.9564;DIMETHYL SULFOXIDE#0.9561;SIGNALING PATHWAY#0.9561;HISTONE METHYLTRANSFERASE#0.9561;SPITZ NEVUS#0.9559;GASTROINTESTINAL TRACT#0.9559;TRANSCRIPTION FACTOR#0.9558;MUCOEPIDERMOID CARCINOMA#0.9557;GENE EXPRESSION#0.9556;ANAL SQUAMOUS CELL CARCINOMA#0.9554;FOCAL ADHESION KINASE#0.9554;SYNOVIAL SARCOMA#0.9554;CELL DEATH#0.9553;EXTRACELLULAR MATRIX#0.9550;GERM CELL TUMORS#0.9543;WHOLE GENOME SEQUENCING#0.9543;CELLULAR GROWTH#0.9542;HISTONE DEMETHYLASE#0.9542;HUMAN IMMUNODEFICIENCY VIRUS#0.9540;BINDING PROTEIN 1#0.9539;CELL MOTILITY#0.9537;TUMOR ASSOCIATED ANTIGEN#0.9532;CALCIUM CHANNEL#0.9523;UMBILICAL VEIN#0.9521;RESPONSE TO UV#0.9520;SIGNALING MOLECULE#0.9516;ANEMIA#0.9516;LASER CAPTURE MICRODISSECTION#0.9511;TERATOCARCINOMA#0.9509;CEREBRAL CORTEX#0.9508;MAGNETIC RESONANCE IMAGING#0.9508;DECITABINE#0.9507;GESTATION#0.9507;OVARIES#0.9506;HUMAN UMBILICAL VEIN#0.9506;CENTRAL NERVOUS SYSTEM#0.9503;NERVOUS SYSTEM#0.9499;NEOPLASTIC TISSUES#0.9493;INDUCED PLURIPOTENT STEM CELL#0.9479;ADJUSTED ODDS RATIO#0.9478;INVASIVE UROTHELIAL CARCINOMA#0.9478;ADENO ASSOCIATED VIRUS#0.9477;DOXYCYCLINE#0.9475;MYOFIBROBLAST#0.9473;METHYL CPG BINDING#0.9473;ENDOSOME#0.9472;POST-TRANSLATIONAL MODIFICATION#0.9470;ENHANCER BINDING PROTEIN#0.9465;ADENOSINE#0.9455;RESVERATROL#0.9450;TOXICITY#0.9450;MYOBLAST#0.9449;STANDARD OF CARE#0.9448;VIRAL REPLICATION#0.9443;NMDA RECEPTOR#0.9443;DEDIFFERENTIATION#0.9442;INCREASED COPY NUMBER#0.9439;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9435;INTERNATIONAL PROGNOSTIC INDEX#0.9434;INTERVERTEBRAL DISC#0.9433;MOUSE EMBRYONIC STEM#0.9432;ATP BINDING#0.9431;CHEWING#0.9428;HUMAN MESENCHYMAL STEM#0.9428;ELECTROPHORETIC MOBILITY SHIFT#0.9424;UMBILICAL CORD#0.9423;INFLAMMATORY CELL#0.9422;ACUTE MYELOID LEUKAEMIA#0.9421;PEROXISOME#0.9421;VASCULAR ENDOTHELIAL CELL#0.9420;OPTIC NERVE#0.9420;QUERCETIN#0.9418;NECROTIC#0.9418;COLONY FORMATION ASSAY#0.9418;DNA TOPOISOMERASE#0.9416;OESOPHAGUS#0.9414;PAPILLARY THYROID CARCINOMA#0.9399;MESENCHYMAL CELL#0.9399;NADPH OXIDASE#0.9398;GINSENOSIDE RG1#0.9398;CELL EXPANSION#0.9388;ALKALINE PHOSPHATASE#0.9386;GLUCOSE HOMEOSTASIS#0.9381;NATIONAL CANCER INSTITUTE#0.9372;CYTOCHROME C RELEASE#0.9370;LOCALISATION#0.9369;IN SITU CARCINOMA#0.9365;MINIMAL RESIDUAL DISEASE#0.9358;NEUROECTODERMAL TUMOR#0.9355;PLEOMORPHIC XANTHOASTROCYTOMA#0.9349;ROS GENERATION#0.9347;GEMCITABINE#0.9347;NEURITE#0.9347;ENDOTHELIUM#0.9346;UTERUS#0.9345;HYPERTENSION#0.9344;HUMAN DERMAL FIBROBLAST#0.9339;GLYCOGEN SYNTHASE KINASE#0.9336;LANGERHANS CELL#0.9332;N-ACETYLCYSTEINE#0.9331;ETOPOSIDE#0.9329;NEURAL CREST#0.9327;HISTONE DEACETYLATION#0.9325;CUNEATE NUCLEUS#0.9322;BASALOID SQUAMOUS CELL CARCINOMA#0.9321;HIGH RESOLUTION MELTING#0.9320;FLOW CYTOMETRY ANALYSIS#0.9312;NEPHROPATHY#0.9311;FIBROUS HISTIOCYTOMA#0.9307;CATALYTIC ACTIVITY#0.9307;ANION EXCHANGER 1#0.9306;MRNA TRANSCRIPTION#0.9299;ADJUSTED HAZARD RATIO#0.9299;ANAL CARCINOMA#0.9296;RETINOID X RECEPTOR#0.9291;PLASMACYTOMA#0.9290;CARCINOSARCOMA#0.9288;GERMINAL CENTER#0.9287;RIBOZYME#0.9286;TYROSINE KINASE RECEPTOR#0.9284;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9282;UROTHELIAL CELL CARCINOMA#0.9275;CUTANEOUS T CELL LYMPHOMA#0.9265;GALLBLADDER ADENOCARCINOMA#0.9261;REGULATION OF GENE EXPRESSION#0.9260;DNA DAMAGE CHECKPOINT#0.9258;HEART DISEASE#0.9258;PROSTATE EPITHELIAL CELL#0.9257;COLON MUCOSA#0.9244;PROSTATE SPECIFIC ANTIGEN#0.9244;MYOMETRIUM#0.9244;DOCETAXEL#0.9240;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9237;LARGE CELL NEUROENDOCRINE CARCINOMA#0.9235;REGULATION OF CELL PROLIFERATION#0.9233;MORPHOGENESIS#0.9229;METAPHASE#0.9228;ANGIOSARCOMA#0.9226;LYMPHOBLASTIC LYMPHOMA#0.9226;CENTRAL NERVOUS SYSTEM LYMPHOMA#0.9222;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9217;LYMPHOID CELL#0.9210;PATHOLOGIC COMPLETE RESPONSE#0.9209;DESMOPLASTIC MELANOMA#0.9203;LUNG DISEASE#0.9203;GESTATIONAL DIABETES#0.9200;THYMIDINE KINASE#0.9196;CELL ACTIVATION#0.9194;ANAPLASTIC LARGE CELL LYMPHOMA#0.9194;TONSIL CANCER#0.9191;HEPATOCYTE NUCLEAR FACTOR#0.9190;NON HODGKIN LYMPHOMA#0.9189;INTERVERTEBRAL DISC DEGENERATION#0.9189;X CHROMOSOME#0.9176;PAROTID GLAND#0.9172;REGULATION OF CELLULAR SENESCENCE#0.9172;C TERMINAL DOMAIN#0.9172;MERKEL CELL#0.9168;ORGANELLE#0.9167;CARCINOMA OF UNKNOWN PRIMARY#0.9162;BILE DUCT CARCINOMA#0.9155;ESTROGEN RECEPTOR ALPHA#0.9148;ALANINE#0.9147;GEFITINIB#0.9140;ADENOSQUAMOUS CARCINOMA#0.9139;STEM CELL LIKE#0.9139;TOLL LIKE RECEPTOR#0.9138;MUCOSAL MELANOMA#0.9135;NORMAL LIVER TISSUES#0.9133;CAUSE SPECIFIC SURVIVAL#0.9130;SMALL INTESTINE#0.9127;SKIN MELANOMA#0.9126;CELLULAR LOCALIZATION#0.9125;PERIPHERAL BLOOD LEUKOCYTE#0.9120;BILE DUCT CANCER#0.9107;NEUTROPHIL#0.9106;GENISTEIN#0.9106;INDUCIBLE NITRIC OXIDE#0.9105;PURKINJE CELL#0.9101;BUDDING#0.9089;LECTIN#0.9086;AMERICAN CANCER SOCIETY#0.9084;POSITIVE FAMILY HISTORY#0.9083;GRANULOCYTE#0.9083;GUANOSINE#0.9070;GROWTH OF CELL#0.9061;TUMOR ANTIGEN#0.9057;SORAFENIB#0.9057;MUTAGENIC#0.9056;LUNG EPITHELIAL CELL#0.9054;HISTONE ACETYLTRANSFERASE#0.9054;CAROTID ARTERY#0.9050;ZINC FINGER PROTEIN#0.9047;BLOOD VESSEL#0.9046;SERPIN#0.9039;TAMOXIFEN#0.9037;ACTINOMYCIN D#0.9028;FLUORESCEIN#0.9025;GROWTH FACTOR BINDING#0.9024;HYPERSENSITIVITY#0.9024;METASTASIS FREE SURVIVAL#0.9021;TUMOR NODE METASTASIS#0.9020;CARBOPLATIN#0.9019;CHROMATIN MODIFICATION#0.9019;TERATOMA#0.9012;HAIR CELL#0.9009;RHEUMATOID ARTHRITIS#0.9000;GOBLET CELL#0.8984;HIGH POWER FIELD#0.8977;KIDNEY CANCER#0.8970;MAPK SIGNALLING#0.8968;CYTOKINESIS#0.8968;ASPARTATE#0.8968;SENSITIZATION#0.8952;BILIARY TRACT CANCER#0.8950;PHEOCHROMOCYTOMA#0.8950;CARCINOGENICITY#0.8943;SURFACE EPITHELIUM#0.8939;ATYPICAL MENINGIOMA#0.8934;CARDIOMYOCYTE DIFFERENTIATION#0.8925;FINE NEEDLE ASPIRATE#0.8925;OSTEOSARCOMA CELL LINES#0.8922;DIGESTIVE TRACT#0.8916;HERPES SIMPLEX#0.8908;DIED OF DISEASE#0.8906;CAMPTOTHECIN#0.8906;MESENCHYMAL STROMAL CELL#0.8903;HEMATOPOIETIC PROGENITOR CELL#0.8896;RETINOIC ACID BINDING#0.8895;PLEURA#0.8894;CONJUGATION#0.8892;VASCULAR CELL#0.8887;BONE MARROW STROMAL#0.8884;NEURODEGENERATIVE DISEASE#0.8881;CHRONIC CERVICITIS#0.8873;PROTEIN BINDING#0.8867;COOH-TERMINAL BINDING#0.8866;GROWTH HORMONE#0.8864;THYMIDYLATE#0.8864;TRANS GOLGI NETWORK#0.8862;CONNECTIVE TISSUE#0.8859;ENDOCYTOSIS#0.8856;PANCREATIC NEUROENDOCRINE TUMOR#0.8855;BONE FORMATION#0.8854;RNA SYNTHESIS#0.8849;CHANGES IN DNA METHYLATION#0.8847;ACETYLCYSTEINE#0.8841;FOLIC ACID#0.8838;LUNG FIBROBLASTS#0.8834;LUNG SQUAMOUS CELL CARCINOMA#0.8833;PRIMARY BILIARY CIRRHOSIS#0.8821;ENDOTHELIAL PROGENITOR CELL#0.8820;C-TERMINAL BINDING#0.8817;LOW DENSITY LIPOPROTEIN#0.8814;DERMIS#0.8811;UTERINE SEROUS CARCINOMA#0.8808;MYOSIN HEAVY CHAIN#0.8807;PROTEIN TYROSINE PHOSPHATASE#0.8807;DNA AMPLIFICATION#0.8798;UBIQUITIN PROTEIN LIGASE#0.8787;ETHANOL#0.8787;INSULIN SECRETION#0.8784;DODECYL SULFATE#0.8782;ACTION POTENTIAL#0.8782;NEURITE OUTGROWTH#0.8778;INHIBITION OF GROWTH#0.8776;PROTEIN KINASE INHIBITOR#0.8767;TISSUE HOMEOSTASIS#0.8756;ESTRADIOL#0.8740;BRAIN DEVELOPMENT#0.8732;DNA REPAIR CAPACITY#0.8724;VIRAL GENOME#0.8723;CHRONIC LIVER DISEASE#0.8720;PITUITARY GLAND#0.8717;TRANSDIFFERENTIATION#0.8715;GRANULOSA CELL#0.8714;PRIMARY SCLEROSING CHOLANGITIS#0.8713;PROTEIN DEGRADATION#0.8711;NUCLEOSOME#0.8706;SCLEROSING CHOLANGITIS#0.8701;OBESE#0.8700;MODE OF ACTION#0.8700;MALIGNANT BRAIN TUMOR#0.8697;SODIUM DODECYL SULFATE#0.8695;VASCULAR DISEASE#0.8694;SIRNA BINDING#0.8692;CORONARY HEART DISEASE#0.8690;RECEPTOR ANTAGONIST#0.8688;NOT OTHERWISE SPECIFIED#0.8686;RETINOPATHY OF PREMATURITY#0.8683;NUCLEUS PULPOSUS CELL#0.8679;CHOLANGITIS#0.8675;VACUOLE#0.8674;MEDIAN SURVIVAL TIME#0.8671;PERIPHERAL BLOOD CELLS#0.8670;OLFACTORY BULB#0.8662;IFN-BETA#0.8661;DIHYDROFOLATE REDUCTASE#0.8657;HEARING LOSS#0.8648;LUCIFERASE ACTIVITY#0.8646;TUBULAR EPITHELIAL CELL#0.8642;MARROW STROMAL CELLS#0.8637;BONE MARROW STROMAL CELL#0.8637;AGE AT ONSET#0.8635;ULNAR-MAMMARY SYNDROME#0.8629;PRIMARY BREAST TUMORS#0.8628;POSTTRANSLATIONAL MODIFICATION#0.8625;ARSENITE#0.8624;NORMAL SQUAMOUS EPITHELIUM#0.8622;GERMINAL CENTER B CELL#0.8618;BASEMENT MEMBRANE#0.8616;GERMINAL CENTER B#0.8615;DYSPLASTIC NEVUS SYNDROME#0.8614;EPIGALLOCATECHIN#0.8612;ENZYME ACTIVITY#0.8612;HUMAN GASTRIC CARCINOMA#0.8608;MICROTUBULE ASSOCIATED PROTEIN#0.8608;NEURAL PROGENITOR CELL#0.8608;PARENCHYMA#0.8600;ASCITES#0.8599;COENZYME A#0.8595;TYPE 1 DIABETES#0.8592;TISSUE REGENERATION#0.8586;CELL COUNTING KIT#0.8580;UTERINE CERVICAL CANCER#0.8571;DNA INTEGRATION#0.8567;LARYNX CANCER#0.8560;GASTRINOMA#0.8557;OLIGODENDROCYTE#0.8557;CELL CELL ADHESION#0.8552;UROKINASE#0.8551;CELL KILLING#0.8549;METHOTREXATE#0.8547;GLYCINE#0.8544;SKIN FIBROBLASTS#0.8544;LUNG METASTASIS#0.8543;METASTATIC CARCINOMA#0.8542;TUBE FORMATION#0.8538;THALAMUS#0.8532;CHOLANGIOLOCELLULAR CARCINOMA#0.8532;HEPATIC STELLATE CELL#0.8526;ACINAR CELL#0.8525;HERPES SIMPLEX VIRUS#0.8523;T CELL PROLIFERATION#0.8518;TYPE 2 DIABETIC#0.8513;CORNEAL ENDOTHELIAL CELL#0.8511;CHROMATIN REMODELLING#0.8503;LYMPHOID LEUKEMIA#0.8501;WEIGHT LOSS#0.8499;PANCREATIC ISLET#0.8497;MIDLINE#0.8497;EYELID#0.8497;THYMINE#0.8496;INVASIVE GROWTH#0.8494;HISTIOCYTOMA#0.8494;GLUTAMATE RECEPTOR#0.8490;ACTIVATED B CELL#0.8489;TRADITIONAL CHINESE MEDICINE#0.8486;DUCTAL CELL#0.8483;ADRIAMYCIN#0.8473;INVASIVE BREAST CARCINOMA#0.8470;SINONASAL INVERTED PAPILLOMA#0.8463;OESOPHAGEAL SQUAMOUS CELL#0.8461;EPITHELIAL TISSUES#0.8459;ENDOMETRIAL STROMAL SARCOMA#0.8458;PHOTORECEPTOR CELL#0.8455;HUMAN PROSTATE EPITHELIAL#0.8454;ORAL PREMALIGNANT LESIONS#0.8450;STROMAL SARCOMA#0.8445;HISTOGENESIS#0.8442;CELL FUSION#0.8439;ABERRANT CRYPT FOCI#0.8438;TEMOZOLOMIDE#0.8438;SALIVARY GLAND CARCINOMA#0.8435;MRNA DECAY#0.8433;FETAL LIVER#0.8430;G0 PHASE#0.8430;2'-DEOXYURIDINE#0.8425;UMBILICAL CORD BLOOD#0.8422;STREPTOZOTOCIN#0.8421;GOLGI APPARATUS#0.8407;AUTOIMMUNE DISEASE#0.8402;TAXOL#0.8394;DASATINIB#0.8391;MITOTIC CHECKPOINT#0.8386;PANCREATIC DUCTAL CARCINOMA#0.8371;KERATOACANTHOMA#0.8371;SINGLE NUCLEOTIDE VARIANTS#0.8369;METHYLTRANSFERASE ACTIVITY#0.8367;FOLATE METABOLISM#0.8365;GESTATIONAL DIABETES MELLITUS#0.8354;ENDOMETRIOID ENDOMETRIAL CARCINOMA#0.8352;KIDNEY DISEASE#0.8351;GOLGI COMPLEX#0.8342;TROPICAL SPASTIC PARAPARESIS#0.8334;COLORECTUM#0.8330;GLYCOLYSIS#0.8329;TIME TO RECURRENCE#0.8317;NUCLEOTIDE EXCISION REPAIR#0.8314;SKIN DISEASE#0.8309;MITOTIC CATASTROPHE#0.8308;ATYPICAL NEUROFIBROMA#0.8308;CASPASE ACTIVATION#0.8307;YOLK SAC#0.8306;COLONY-STIMULATING FACTOR#0.8294;BETA CELL MASS#0.8291;DIPHOSPHATE#0.8290;ANTI EGFR#0.8287;PROPIDIUM#0.8284;EXTRAHEPATIC BILE DUCT CARCINOMA#0.8283;CYSTADENOMA#0.8279;MURINE EMBRYONIC FIBROBLASTS#0.8277;ENDOTHELIAL NITRIC OXIDE#0.8276;HEALTHY CONTROL GROUP#0.8276;HUMAN UROTHELIAL CELLS#0.8274;ISCHEMIA REPERFUSION INJURY#0.8269;SESSILE SERRATED ADENOMA#0.8264;INSULINOMA#0.8264;CYCLIN-DEPENDENT KINASE ACTIVITY#0.8256;TRANSMISSION ELECTRON MICROSCOPY#0.8254;MAST CELL#0.8253;PROTEASOME PATHWAY#0.8253;RESPONSE TO RADIATION#0.8249;OXIDATIVE STRESS RESPONSE#0.8241;PREMATURITY#0.8240;LYMPHOBLAST#0.8238;PRIMARY BRAIN TUMORS#0.8226;OSTEOCLAST#0.8220;FALSE DISCOVERY RATE#0.8210;B CELL DEVELOPMENT#0.8205;SENTINEL LYMPH NODE#0.8204;QUANTITATIVE TRAIT LOCI#0.8203;MITOMYCIN C#0.8193;RECTUM#0.8191;SMOOTH MUSCLE CELL PROLIFERATION#0.8185;MUSCLE CELL PROLIFERATION#0.8182;MESENCHYME#0.8180;DIABETIC NEPHROPATHY#0.8180;MERKEL CELL CARCINOMA#0.8177;RETINAL GANGLION CELL#0.8177;KINASE INHIBITOR PROTEIN#0.8177;FAILURE FREE SURVIVAL#0.8176;PULMONARY FIBROSIS#0.8170;POSTNATAL DAY 7#0.8164;GANGLION CELLS#0.8163;MULTIPLE LOGISTIC REGRESSION#0.8160;CROHN'S DISEASE#0.8158;ACUTE PROMYELOCYTIC LEUKEMIA#0.8158;WNT SIGNALING PATHWAY#0.8157;KERATINIZATION#0.8143;BARRETT'S ADENOCARCINOMA#0.8143;PROTEIN KINASE A#0.8142;STANDARDIZED UPTAKE VALUE#0.8140;DEATH RECEPTOR#0.8136;ESOPHAGITIS#0.8134;NUCLEOTIDE BINDING#0.8125;DEXAMETHASONE#0.8125;SWI-SNF COMPLEX#0.8121;MARGINAL ZONE B CELL#0.8119;MECHANISMS OF ACTION#0.8117;MARGINAL ZONE B#0.8116;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.8116;CLEAR CELL RENAL CELL CARCINOMA#0.8115;CELLULAR HOMEOSTASIS#0.8107;MICROPHTHALMIA#0.8105;PLEXIFORM NEUROFIBROMA#0.8101;FOREBRAIN#0.8100;PERICYTE#0.8099;RETINAL DEGENERATION#0.8094;VILLOUS ADENOMA#0.8092;ZEBULARINE#0.8090;INFLAMMATORY BOWEL DISEASE#0.8086;MYOEPITHELIAL CELL#0.8085;GENE EXPRESSION SIGNATURES#0.8084;STAUROSPORINE#0.8083;LASER DESORPTION IONIZATION#0.8083;OXYGENASE#0.8079;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8077;IMATINIB MESYLATE#0.8070;ORAL SQUAMOUS CARCINOMA#0.8064;ADVANCED GASTRIC CANCER#0.8053;ENDOTHELIAL CELL PROLIFERATION#0.8052;CHOLINE#0.8048;GLUTATHIONE PEROXIDASE#0.8034;LYSOSOME#0.8026;MULTIPLE LINEAR REGRESSION#0.8026;HUMORAL IMMUNE RESPONSE#0.8025;GENETIC DISEASE#0.8022;PULMONARY ARTERY#0.8013;MAPK ACTIVATION#0.8011;MUCINOUS CYSTIC NEOPLASM#0.8002;RANDOMIZED CONTROLLED TRIAL#0.7995;INNATE IMMUNITY#0.7994;INNATE IMMUNE RESPONSE#0.7993;POST NATAL DAY#0.7991;TRANSLATION INITIATION#0.7989;ATP BINDING CASSETTE#0.7983;VESICLE FORMATION#0.7979;CYCLIC AMP#0.7979;OSTEOARTHRITIS#0.7973;BENIGN MENINGIOMA#0.7969;CLASSICAL HODGKIN LYMPHOMA#0.7968;STEM CELL DIFFERENTIATION#0.7967;NUCLEAR LAYER#0.7963;MORTAL#0.7963;IRINOTECAN#0.7962;LYSIS#0.7952;MAMMARY EPITHELIUM#0.7947;CELLULAR COMPONENT#0.7943;ERLOTINIB#0.7942;STEROID HORMONE RECEPTOR#0.7940;CHORIOCARCINOMA#0.7935;ORAL CANCER CELL#0.7932;VEMURAFENIB#0.7927;RNA HELICASE#0.7921;PROTEIN TRANSLATION#0.7911;ANTISENSE RNA#0.7906;ANTI APOPTOSIS#0.7903;GROWTH CONE#0.7902;CELL FRACTION#0.7896;MITOMYCIN#0.7896;RECEIVER OPERATOR CHARACTERISTIC#0.7895;DNA DAMAGE FOCI#0.7894;TRANSCRIPTION FACTOR BINDING#0.7894;T CELL ACTIVATION#0.7889;SAHF FORMATION#0.7887;LIPID METABOLISM#0.7881;RESPONSE TO STRESS#0.7880;PI3K SIGNALING#0.7878;VITAMIN A#0.7873;CHRONIC HEPATITIS B#0.7871;SERTOLI CELL#0.7870;MATRIX METALLOPROTEINASE 1#0.7868;CYCLOPHOSPHAMIDE#0.7867;PROTEIN CODING GENE#0.7860;SOLITARY FIBROUS TUMOR#0.7855;OVAL CELL#0.7849;GROWTH REGULATOR#0.7838;OSTEOPOROSIS#0.7838;HUMAN EPIDERMAL KERATINOCYTES#0.7834;MITOTIC SPINDLE#0.7833;FORESKIN#0.7817;RRNA PROCESSING#0.7814;NEOPLASTIC DISEASE#0.7805;LANGERHANS CELL HISTIOCYTOSIS#0.7800;AZACITIDINE#0.7799;MARGINAL ZONE LYMPHOMA#0.7794;B CELL DIFFERENTIATION#0.7791;IDIOPATHIC PULMONARY FIBROSIS#0.7789;NUCLEAR TRANSPORT#0.7771;OOCYTE#0.7770;NICOTINAMIDE#0.7766;METFORMIN#0.7764;CELL AGGREGATION#0.7763;BLAST CELL#0.7758;CYTIDINE#0.7757;UBIQUITIN SPECIFIC PROTEASE#0.7754;MARGINAL ZONE B-CELL LYMPHOMA#0.7748;TUMOR INITIATING CELL#0.7741;METASTATIC PROSTATE CANCER#0.7741;TIGHT JUNCTION#0.7739;VIRAL HEPATITIS#0.7729;NATURAL KILLER CELL#0.7728;VINCRISTINE#0.7722;RELATIVE TELOMERE LENGTH#0.7720;CELLULAR MEMBRANE#0.7714;NEUTROPENIA#0.7713;ACTIVATOR PROTEIN 1#0.7701;SECRETORY PATHWAY#0.7700;COLON ADENOMA#0.7699;GAP ACTIVITY#0.7697;ORGANOGENESIS#0.7692;GLUCOSE UPTAKE#0.7686;HETEROCHROMATIN PROTEIN 1#0.7684;RELATED PROTEIN 1#0.7683;INTERSTITIAL CELL#0.7673;CAMP RESPONSE ELEMENT#0.7661;RECEPTOR BINDING#0.7660;STEM CELL MAINTENANCE#0.7658;ANTHRACENE#0.7656;GENES OF INTEREST#0.7654;ACETIC ACID#0.7651;BRACHIAL PLEXUS#0.7648;GLUCOSE TOLERANCE TEST#0.7645;MALIGNANT PERITONEAL MESOTHELIOMA#0.7644;ANAPLASTIC EPENDYMOMA#0.7642;MOLECULAR DYNAMICS SIMULATION#0.7640;GASTRIC EPITHELIAL CELLS#0.7632;MUCOSITIS#0.7632;ERYTHROCYTE#0.7626;TOPICAL#0.7622;EPITHELIAL CELL PROLIFERATION#0.7617;KAPOSI'S SARCOMA#0.7604;RNA SILENCING SUPPRESSOR#0.7600;ORAL SUBMUCOUS FIBROSIS#0.7598;OCULAR MELANOMA#0.7598;SEBORRHEIC KERATOSIS#0.7595;CELL POLARITY#0.7592;HEDGEHOG SIGNALING PATHWAY#0.7583;CHROMATIN REMODELING COMPLEX#0.7580;GOLGI MEMBRANE#0.7577;GENETIC DISORDER#0.7566;PKCALPHA#0.7561;HYDROXYUREA#0.7558;INHIBITION OF DNA METHYLATION#0.7553;LYMPHANGIOGENESIS#0.7543;3-OST-2#0.7536;EPITHELIAL OVARIAN CARCINOMA#0.7531;RNA PROCESSING#0.7531;MOLECULAR FUNCTION#0.7531;RESPONSE TO OXIDATIVE STRESS#0.7529;TISSUE REMODELING#0.7520;LINEAR REGRESSION ANALYSIS#0.7518;ADVANCED COLORECTAL CANCER#0.7511;RRNA TRANSCRIPTION#0.7505;DENTAL PULP#0.7498;INHIBITION OF APOPTOSIS#0.7498;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.7497;TESTICULAR CANCER#0.7492;UROTHELIAL BLADDER CANCER#0.7491;TISSUE INVASION#0.7486;IMPORTIN#0.7485;DERMAL PAPILLA CELL#0.7484;CASPASE INHIBITOR#0.7473;STEM CELL FACTOR#0.7471;MAMMARY GLAND DEVELOPMENT#0.7470;REGULATORY T CELL#0.7461;PROTEIN STABILIZATION#0.7457;DETOXIFICATION#0.7454;CYTOSINE METHYLATION#0.7451;GLAND DEVELOPMENT#0.7450;CANCER SPECIFIC MORTALITY#0.7444;MURAL CELL#0.7444;ADVANCED OVARIAN CANCER#0.7442;RRNA SYNTHESIS#0.7441;SUCROSE#0.7441;DSRNA BINDING#0.7437;FAMILIAL ADENOMATOUS POLYPOSIS#0.7428;8-HYDROXY-2'-DEOXYGUANOSINE#0.7428;ATYPICAL LIPOMATOUS TUMOR#0.7426;GLUTAMINE#0.7425;GLYCOSYLATION#0.7422;CORNEAL ENDOTHELIUM#0.7410;COLON ADENOCARCINOMA#0.7407;VALINE#0.7397;MYOTUBE#0.7392;HIERARCHICAL CLUSTERING ANALYSIS#0.7388;DIABETIC RETINOPATHY#0.7376;MYOGENIC CELL#0.7372;INTERMEDIATE FILAMENT#0.7369;OVERALL SURVIVAL TIME#0.7361;CASPASE-3 ACTIVITY#0.7360;VITAMIN D RECEPTOR#0.7359;PRIMARY EFFUSION LYMPHOMA#0.7357;P38 MAPK SIGNALING#0.7354;MITOCHONDRIAL DNA#0.7353;CYTOTOXIC T-LYMPHOCYTE#0.7349;IRON OVERLOAD#0.7345;DUCT CELL#0.7337;SOFT PALATE#0.7333;ESOPHAGEAL SQUAMOUS CARCINOMA#0.7327;PARATHYROID HORMONE#0.7327;Y CHROMOSOME#0.7321;STEM CELL PROLIFERATION#0.7320;PARKINSON'S DISEASE#0.7319;CYTOKINE PRODUCTION#0.7319;NUCLEAR LOCALIZATION SIGNAL#0.7318;SEMINOMA#0.7312;AMELANOTIC MELANOMA#0.7309;OSTEOGENESIS#0.7304;LASER CAPTURE MICRODISSECTED#0.7299;NF-KAPPAB ACTIVATION#0.7285;MYOCARDIUM#0.7279;POLYCYCLIC AROMATIC HYDROCARBON#0.7277;CELLULAR METABOLISM#0.7275;SARCOMATOID MESOTHELIOMA#0.7267;BLOOD BRAIN BARRIER#0.7264;LEUKEMIA STEM CELL#0.7262;AFRICAN SWINE FEVER#0.7258;GM-CSF#0.7257;ORAL GLUCOSE TOLERANCE#0.7250;72-HOURS#0.7250;INTESTINAL EPITHELIAL CELL#0.7247;SOMATIC TISSUE#0.7238;UNCONDITIONAL LOGISTIC REGRESSION#0.7235;WILCOXON RANK SUM#0.7235;METASTATIC MELANOMA CELLS#0.7231;ORGAN OF CORTI#0.7225;C REACTIVE PROTEIN#0.7222;ION CHANNEL#0.7222;CPT-11#0.7221;LEUKEMIA INITIATING CELLS#0.7219;RESPONSE TO GENOTOXIC STRESS#0.7212;ARF GAP ACTIVITY#0.7198;CYCLE INHIBITOR P21#0.7186;SEVERE COMBINED IMMUNODEFICIENCY#0.7183;ADENINE DINUCLEOTIDE PHOSPHATE#0.7177;INTRACELLULAR SIGNALING PATHWAY#0.7161;TIRAPAZAMINE#0.7157;CIRCULATING CELL FREE#0.7156;VACCINIA#0.7148;CHOLECYSTITIS#0.7145;BENIGN NEOPLASM#0.7144;SIGNAL PEPTIDE#0.7134;UNDIFFERENTIATED PLEOMORPHIC SARCOMA#0.7133;MAPK CASCADE#0.7132;JOHNS HOPKINS HOSPITAL#0.7130;ENDOTHELIN RECEPTOR#0.7127;SPERMATOGENESIS#0.7127;PAPILLARY RENAL CELL CARCINOMA#0.7122;INTRACRANIAL ANEURYSM#0.7122;MINERALIZATION#0.7121;EMBRYO DEVELOPMENT#0.7100;ATROPHIC GASTRITIS#0.7095;APOPTOSIS SIGNALING#0.7094;SUNITINIB#0.7093;PERIPHERAL T-CELL LYMPHOMA#0.7092;ASPARTIC ACID#0.7079;OUTER MEMBRANE#0.7076;OSTEOCYTE#0.7066;RITUXIMAB#0.7048;INFERTILITY#0.7038;LOW BIRTH WEIGHT#0.7036;GLIOSARCOMA#0.7035;SKELETAL MUSCLE CELLS#0.7029;SKELETON#0.7028;PNEUMONIA#0.7027;ARYL HYDROCARBON RECEPTOR#0.7024;REPLICATION FORK#0.7019;METASTATIC BREAST CANCER#0.7015;CELL AGEING#0.7010;RICHTER'S SYNDROME#0.7009;SWEAT GLAND#0.7002;MIXED LINEAGE LEUKEMIA#0.6996;MELANOCYTIC NEVUS#0.6992;PELVIS#0.6991;TROPHOBLAST#0.6970;ADVANCED PROSTATE CANCER#0.6967;CHROMOSOME INACTIVATION#0.6967;AUXIN EFFLUX#0.6962;TO TUMOR RECURRENCE#0.6957;NUCLEOCYTOPLASMIC SHUTTLING#0.6957;THYROID HORMONE RECEPTOR#0.6957;DOUBLE-STRAND BREAK REPAIR#0.6953;HYPERACTIVITY#0.6947;NEUROFILAMENT#0.6946;MAP KINASE CASCADE#0.6944;RETINITIS PIGMENTOSA#0.6936;REPORTER GENE ASSAY#0.6924;GANGLIOGLIOMA#0.6920;CYTOTOXIC T CELL#0.6911;ADVANCED GLYCATION END#0.6904;CENTROSOME DUPLICATION#0.6904;AREA UNDER CURVE#0.6902;HUMAN LEUKOCYTE ANTIGEN#0.6900;BEVACIZUMAB#0.6895;EYE DISEASE#0.6893;DUODENUM#0.6889;KINASE INHIBITOR P27#0.6883;LACTATION#0.6881;WEIGHT GAIN#0.6872;TUMOUR NECROSIS FACTOR#0.6871;ANGIOTENSIN CONVERTING ENZYME#0.6867;FOLLICULAR THYROID CARCINOMA#0.6865;DE NOVO DNA METHYLATION#0.6860;GRANULAR COMPONENT#0.6856;CAMP RESPONSE ELEMENT BINDING#0.6855;COPY NUMBER VARIANTS#0.6855;VESICLE TRANSPORT#0.6852;LIPID DROPLET#0.6847;OUTER NUCLEAR LAYER#0.6844;TRANSCRIPTION TERMINATION FACTOR#0.6837;HUMAN CORNEAL ENDOTHELIAL#0.6836;HEPATOBLASTOMA#0.6834;CANCER ASSOCIATED FIBROBLASTS#0.6832;COMPARATIVE GENOMIC HYBRIDISATION#0.6820;GLUCOCORTICOID RECEPTOR#0.6813;VIRULENCE#0.6812;INSULIN RECEPTOR#0.6809;LYMPHOBLASTOID CELLS#0.6804;TISSUE DAMAGE#0.6804;LEUKOCYTE TELOMERE LENGTH#0.6804;PANCREATIC LESIONS#0.6801;RETINAL PIGMENT EPITHELIAL#0.6798;OBJECTIVE RESPONSE RATE#0.6796;INTERNEURON#0.6792;ADVANCED BREAST CANCER#0.6791;ONE CARBON METABOLISM#0.6790;DIFFERENTIAL GENE EXPRESSION#0.6788;IN UTERO EXPOSURE#0.6786;BLADDER UROTHELIAL CARCINOMA#0.6784;METASTATIC ADENOCARCINOMA#0.6782;RECEPTOR INTERACTING PROTEIN#0.6780;RESPIRATION#0.6773;OPIOID GROWTH FACTOR#0.6772;LYMPHOEPITHELIOMA-LIKE CARCINOMA#0.6771;MUSCLE STEM CELL#0.6766;ARTIFICIAL NEURAL NETWORK#0.6761;ANAPLASTIC OLIGOASTROCYTOMA#0.6758;SYNAPTIC TRANSMISSION#0.6758;NEGATIVE LIKELIHOOD RATIO#0.6755;ADRENERGIC RECEPTOR#0.6748;KINASE BINDING#0.6743;GASTRO#0.6725;CYCLIN BINDING#0.6724;CYTOCHROME P450#0.6721;RECEPTOR AGONIST#0.6720;CELL FATE DETERMINATION#0.6717;HISTONE H3 ACETYLATION#0.6715;X CHROMOSOME INACTIVATION#0.6705;AORTIC SMOOTH MUSCLE CELLS#0.6699;THYROID ADENOMA#0.6696;TYPE 1 DIABETIC#0.6694;LIGHT CHAIN 3#0.6686;CIRCULATING TUMOR CELL#0.6685;MYOFIBROBLAST DIFFERENTIATION#0.6684;MULTIPLE ENDOCRINE NEOPLASIA#0.6674;T CELL DIFFERENTIATION#0.6674;FIBROSARCOMA CELLS#0.6672;SEROUS BORDERLINE TUMORS#0.6669;DUAL LUCIFERASE REPORTER#0.6664;ACTIN POLYMERIZATION#0.6660;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6651;SKIN SQUAMOUS CELL CARCINOMA#0.6644;GASTRIC LYMPHOMA#0.6644;ACTIN FILAMENT#0.6644;LIVER FLUKE-RELATED CHOLANGIOCARCINOMA#0.6636;HETEROTRIMERIC G-PROTEIN#0.6636;ARA-C#0.6634;PROSTAGLANDIN E2#0.6633;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6629;LUPUS ERYTHEMATOSUS#0.6627;BRAIN CANCER#0.6626;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6619;PERITONEUM#0.6618;DNASE I#0.6611;HYPERGLYCEMIA#0.6608;BORTEZOMIB#0.6607;HEMORRHAGE#0.6606;CYTOCHROME C OXIDASE#0.6603;LUNG ADENOMA#0.6598;EPITHELIAL CARCINOMA#0.6595;MELANOCYTE DIFFERENTIATION#0.6588;EPITHELIAL STEM CELL#0.6574;NUCLEAR EXPORT SIGNAL#0.6567;PANCREATIC DUCTAL CELL#0.6567;V-D-J RECOMBINATION#0.6561;ACETYLCHOLINE#0.6552;OLOMOUCINE#0.6547;PROTEIN INTERACTION NETWORK#0.6544;HEPARIN#0.6540;COLONY-FORMING CELL#0.6537;SWELLING#0.6534;REGULATION OF APOPTOSIS#0.6526;MALIGNANT EYELID TUMOR#0.6526;TUBEROUS SCLEROSIS#0.6525;SIGNALLING CASCADE#0.6524;CHRONIC KIDNEY DISEASE#0.6521;NERVE GROWTH FACTOR#0.6519;HISTIOCYTOSIS#0.6517;FIBROBLAST PROLIFERATION#0.6513;HUMAN EMBRYONIC STEM#0.6508;NORMAL HUMAN UROTHELIAL#0.6505;5'-DEOXY-5'-METHYLTHIOADENOSINE#0.6505;MRNA SPLICING#0.6504;TISSUE MICROARRAY ANALYSIS#0.6500;ADENOMATOID TUMOR#0.6496;NORMAL ADJACENT TISSUE#0.6493;EMBRYONIC KIDNEY#0.6490;THYMIC EPITHELIAL CELLS#0.6486;RESPIRATORY TRACT#0.6482;TRASTUZUMAB#0.6473;EMBRYOID BODY#0.6471;OPEN ANGLE GLAUCOMA#0.6466;SYNCYTIUM FORMATION#0.6462;NEURAL STEM PROGENITOR#0.6460;POTASSIUM CHANNEL#0.6458;INNERVATION#0.6438;IMIQUIMOD#0.6436;HYDRALAZINE#0.6435;CELL PENETRATING PEPTIDE#0.6434;BIZARRE LEIOMYOMA#0.6434;TRANSCRIPTION ACTIVATOR#0.6433;HAEMATOPOIETIC STEM CELL#0.6423;MEMORY IMPAIRMENT#0.6415;DNA REPAIR PROTEIN#0.6413;SPINDLE ASSEMBLY#0.6408;PROLACTINOMA#0.6403;DERMATITIS#0.6402;MELANOCYTE PROLIFERATION#0.6401;APOPTOTIC PROCESS#0.6400;ACTIVE CASPASE 3#0.6398;NEUROENDOCRINE CELL#0.6394;INTRACELLULAR LOCALIZATION#0.6390;T CELL DEVELOPMENT#0.6390;AUTOIMMUNITY#0.6390;MICRONUCLEUS#0.6390;ATPASE ACTIVITY#0.6385;MTDNA#0.6384;ADIPOCYTE DIFFERENTIATION#0.6382;REGULATION OF RIBOSOME BIOGENESIS#0.6382;CHROMOSOME SEGREGATION#0.6380;PORTAL VEIN#0.6371;ATYPICAL DUCTAL HYPERPLASIA#0.6365;MEMORY T CELL#0.6363;TH17 CELL#0.6357;PELVIC LYMPH NODE#0.6356;CELL WALL#0.6349;SPINDLE CELL CARCINOMA#0.6341;POLYCOMB REPRESSOR COMPLEX#0.6341;DIDEOXYCYTIDINE#0.6338;APPARENT DIFFUSION COEFFICIENT#0.6336;CELL QUIESCENCE#0.6332;GLUCOSE METABOLISM#0.6331;GINSENG#0.6324;HEPATOCELLULAR ADENOMA#0.6317;GRANULOSA CELL TUMOR#0.6308;DIGITAL IMAGE ANALYSIS#0.6299;MITOTIC ENTRY#0.6291;CYSTITIS#0.6286;GENE EXPRESSION OMNIBUS#0.6282;PRINCIPAL COMPONENT ANALYSIS#0.6278;B CELL RECEPTOR#0.6274;URETHANE#0.6273;GIANT CELL GLIOBLASTOMA#0.6272;LUMINAL CELL#0.6272;NEOMYCIN#0.6269;RETINAL ISCHEMIA#0.6269;PRIMARY EPITHELIAL CELLS#0.6263;ERYTHROLEUKEMIA#0.6262;DNA METHYLTRANSFERASE ACTIVITY#0.6261;BILE DUCT ADENOMA#0.6257;OMENTUM#0.6256;PTERYGIUM#0.6238;ACTIVATION OF MAP KINASE#0.6236;STANDARD UPTAKE VALUE#0.6236;LITHIUM#0.6232;MIDBRAIN#0.6230;COPY NUMBER INCREASE#0.6230;EPHRIN#0.6228;EARLY BREAST CANCER#0.6226;MOLAR#0.6221;PROTEIN KINASE ACTIVITY#0.6220;PRIMARY OPEN ANGLE GLAUCOMA#0.6215;RENAL CELL CANCER#0.6213;SPERMATOCYTES#0.6211;DIFFERENTIATED THYROID CARCINOMA#0.6211;RANDOMISED CONTROLLED TRIAL#0.6208;RESPIRATORY FAILURE#0.6206;ALVEOLAR EPITHELIAL CELL#0.6198;L-CYSTEINE#0.6197;SIMVASTATIN#0.6194;DOPAMINE#0.6192;HUMAN EMBRYONIC KIDNEY#0.6191;MEGAKARYOCYTE#0.6191;FIBROMA#0.6190;TESTOSTERONE#0.6188;HEALTHY CONTROL SUBJECTS#0.6184;BILE TRACT#0.6180;DNA METABOLISM#0.6173;MATURE CYSTIC TERATOMA#0.6170;FATTY LIVER#0.6165;PEDIATRIC OSTEOSARCOMA#0.6165;CHEMOKINE RECEPTOR#0.6159;TENOFOVIR#0.6157;AUTOPHAGIC CELL DEATH#0.6150;DEACETYLASE ACTIVITY#0.6150;CARDIOVASCULAR RISK FACTOR#0.6145;EDEMA#0.6145;SPINDLE ASSEMBLY CHECKPOINT#0.6142;FATTY ACID BINDING#0.6140;BONE RESORPTION#0.6138;RECURSIVE PARTITIONING ANALYSIS#0.6136;CYSTIC TERATOMA#0.6132;ATP BINDING CASSETTE TRANSPORTER#0.6129;CORNEAL EPITHELIAL CELL#0.6125;GRADIENT GEL ELECTROPHORESIS#0.6119;INSULIN RECEPTOR SUBSTRATE#0.6118;KERATINOCYTE DIFFERENTIATION#0.6104;RESPONSE TO HYPOXIA#0.6103;GLOBIN#0.6086;HYPERTHERMIA#0.6081;MICROGLIAL CELL#0.6074;TRYPTOPHAN#0.6070;PARAGANGLIOMA#0.6063;SOLID CARCINOMA#0.6062;T-TYPE CALCIUM CHANNEL#0.6059;ACTIVATION OF NF-KAPPAB#0.6055;INHIBITION OF TELOMERASE ACTIVITY#0.6052;PYRAMIDAL CELL#0.6051;ECTODERM DEVELOPMENT#0.6046;PHOSPHOLIPASE C#0.6043;EXTRAMEDULLARY PLASMACYTOMA#0.6042;ACUTE KIDNEY INJURY#0.6040;SEROUS CYSTADENOMA#0.6030;APOPTOTIC SIGNALLING PATHWAY#0.6022;BLEOMYCIN#0.6013;MOUSE LUNG EPITHELIAL#0.6008
102	RNA INTERFERENCE#1.0446;SQUAMOUS CELL CARCINOMA#1.0411;HEPATOCELLULAR CARCINOMA#1.0394;RETINOIC ACID#1.0338;B CELL#1.0320;GERM CELL#1.0305;BREAST CANCER#1.0283;NOTCH RECEPTOR#1.0280;BREAST CANCER CELL#1.0277;METALLOPROTEINASE INHIBITOR#1.0223;EXOSOME#1.0203;LYMPH NODE#1.0130;CELL GROWTH#1.0126;MEPRIN#1.0122;POLYMERASE CHAIN REACTION#1.0079;TUMOR CELLS#1.0066;CELL MEMBRANE#1.0058;CELL CELL ADHESION#1.0043;APOPTOSIS#1.0030;CELL MIGRATION#1.0015;PLASMA MEMBRANE#0.9999;ENDOPLASMIC RETICULUM#0.9997;NEUROBLASTOMA#0.9993;CELL PROLIFERATION#0.9982;EPITHELIAL CELL#0.9975;CANCER CELL#0.9949;LEUKOCYTE#0.9937;ENDOTHELIAL CELL#0.9935;T CELL#0.9917;AMYLOID PROTEIN#0.9899;MONOCYTE#0.9894;GENE EXPRESSION#0.9887;TUMOR NECROSIS FACTOR#0.9885;PROGENITOR CELL#0.9881;CELL ADHESION MOLECULE#0.9875;CELL SURFACE#0.9874;MACROPHAGE#0.9873;EPHRIN#0.9865;NERVOUS SYSTEM#0.9858;PERIPHERAL BLOOD#0.9847;SIGNALING PATHWAY#0.9841;TRANSCRIPTION FACTOR#0.9838;CELL ADHESION#0.9831;APP METABOLISM#0.9815;EPIDERMAL GROWTH FACTOR#0.9814;PROTEIN KINASE C#0.9800;CELL DEATH#0.9785;STEM CELL#0.9779;AMYLOID PRECURSOR PROTEIN#0.9776;GROWTH FACTOR RECEPTOR#0.9767;PROTEIN KINASE#0.9762;EXTRACELLULAR MATRIX#0.9756;GROWTH FACTOR#0.9732;NEURODEGENERATIVE DISEASE#0.9689;ANGIOGENESIS#0.9681;SYNAPSE ASSOCIATED PROTEIN#0.9679;ALZHEIMER'S DISEASE#0.9640;CENTRAL NERVOUS SYSTEM#0.9636;IMMUNE RESPONSE#0.9611;ENZYME ACTIVITY#0.9578;REVERSE TRANSCRIPTION#0.9578;NOTCH SIGNALING PATHWAY#0.9578;METALLOPROTEASE INHIBITOR#0.9563;ECTODOMAIN CLEAVAGE#0.9559;REGULATED INTRAMEMBRANE PROTEOLYSIS#0.9553;NEUTROPHIL#0.9517;PROTEIN PROCESSING#0.9503;ASTROCYTE#0.9498;DEMENTIA#0.9481;NEURONAL CELLS#0.9474;GENE SILENCING#0.9471;PRO-INFLAMMATORY#0.9467;ACITRETIN#0.9460;MITOGEN ACTIVATED PROTEIN#0.9459;PRION DISEASE#0.9418;SMOOTH MUSCLE#0.9414;TUMOR SUPPRESSOR#0.9412;CYTOTOXICITY#0.9342;ORAL SQUAMOUS CELL CARCINOMA#0.9300;NEUROGENESIS#0.9266;RECEPTOR TYROSINE KINASE#0.9259;TUMOUR NECROSIS FACTOR#0.9219;ENDOCYTOSIS#0.9194;INFLAMMATORY RESPONSE#0.9179;CATALYTIC ACTIVITY#0.9165;ATHEROSCLEROSIS#0.9157;TOXICITY#0.9157;MURINE EMBRYONIC FIBROBLASTS#0.9137;ATHEROSCLEROTIC#0.9113;CELL DEVELOPMENT#0.9094;HEPARIN BINDING#0.9077;TRANSFORMING GROWTH FACTOR#0.9073;LIPID RAFT#0.9071;CELL DIFFERENTIATION#0.9054;APOPTOTIC#0.9051;T LYMPHOCYTE#0.9038;NEUROTOXIC#0.9032;ENDOTHELIUM#0.8976;BONE MARROW#0.8923;HEPARIN#0.8922;ADVANCED GLYCATION END#0.8916;TRASTUZUMAB#0.8898;METALLOPROTEASE ACTIVITY#0.8892;NEURITE#0.8889;REGENERATION#0.8859;RHEUMATOID ARTHRITIS#0.8859;MUSCLE CELL#0.8850;KERATINOCYTE#0.8828;GM6001#0.8820;COLORECTAL CANCER#0.8798;MYELOID CELL#0.8784;LONG TERM POTENTIATION#0.8758;TRANSACTIVATION#0.8756;SMOOTH MUSCLE CELL#0.8681;ADHERENS JUNCTION#0.8681;ZINC BINDING#0.8670;EXTRACELLULAR REGION#0.8634;SYNAPTIC MEMBRANE#0.8612;ESTROGEN RECEPTOR#0.8611;RETINOIC ACID RECEPTOR#0.8602;SIGNALING MOLECULE#0.8591;CELL JUNCTION#0.8590;MYELINATION#0.8585;EXCITATORY SYNAPSE#0.8568;HYPOXIA#0.8541;CHONDROCYTE#0.8537;TUMOR TISSUES#0.8530;PANCREATIC CANCER#0.8477;DENDRITIC SPINE#0.8461;MORRIS WATER MAZE#0.8458;CELL MOTILITY#0.8392;IMMUNE SYSTEM#0.8392;REACTIVE OXYGEN SPECIES#0.8372;CELL ACTIVATION#0.8334;GANGLION CELLS#0.8324;NEUROPROTECTION#0.8292;IMMUNE CELL#0.8275;NMDA RECEPTOR#0.8230;KIDNEY DISEASE#0.8157;MAST CELL#0.8139;NOTCH INTRACELLULAR DOMAIN#0.8126;CD8+ T CELL#0.8124;DOUBLE TRANSGENIC MICE#0.8105;PROSTATE CANCER#0.8074;CELL CYCLE#0.8050;DENTATE GYRUS#0.7991;INTESTINAL STEM CELL#0.7988;SECRETORY PATHWAY#0.7985;COLON CANCER#0.7976;NEURITE OUTGROWTH#0.7976;INSULIN DEGRADING ENZYME#0.7939;SIGNALLING PATHWAY#0.7933;SYNAPTOGENESIS#0.7928;PODOCYTE#0.7910;COLORECTAL#0.7901;QUANTITATIVE REAL TIME#0.7895;SIGNAL TRANSDUCTION#0.7876;STROMAL CELL#0.7870;B CELL DEVELOPMENT#0.7865;GROWTH CONE#0.7856;AKT SIGNALING#0.7826;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7814;CALCIUM CHANNEL#0.7814;EPITHELIAL TO MESENCHYMAL#0.7812;HOST CELL#0.7777;DENDRITIC CELL#0.7773;BRAIN DEVELOPMENT#0.7770;NOTCH LIGAND#0.7769;LUNG CANCER#0.7742;ONCOGENIC#0.7737;CYTOPLASM#0.7726;MORPHOGENESIS#0.7692;OVARIAN#0.7664;TISSUE HOMEOSTASIS#0.7663;PROTEASE ACTIVITY#0.7624;INSULIN-LIKE GROWTH FACTOR#0.7622;CARDIOMYOCYTE#0.7599;MICROVASCULAR ENDOTHELIAL CELL#0.7589;GLIAL CELL#0.7572;VIRULENCE#0.7537;MONONUCLEAR CELLS#0.7526;MULTIPLE MYELOMA#0.7479;STATUS EPILEPTICUS#0.7466;EPILEPSY#0.7454;TOLL LIKE RECEPTOR#0.7423;KINASE INHIBITOR#0.7413;LOW DENSITY LIPOPROTEIN#0.7403;PITUITARY ADENOMA#0.7399;5ALPHA DIHYDROTESTOSTERONE#0.7397;SYNAPTIC VESICLE#0.7393;BRUSH BORDER#0.7373;EPITHELIAL MESENCHYMAL TRANSITION#0.7373;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7348;HEMATOPOIETIC CELL#0.7323;AUTOPHAGY#0.7298;FACTOR I#0.7292;NEURAL PROGENITOR CELL#0.7291;TRANSMEMBRANE RECEPTOR#0.7280;DUAL LUCIFERASE REPORTER#0.7267;RESONANCE ENERGY TRANSFER#0.7257;RECEPTOR LIGAND#0.7240;TRANSFORMING GROWTH FACTOR ALPHA#0.7209;MEMBRANE FRACTION#0.7208;DOXORUBICIN#0.7200;CORONARY ARTERY#0.7197;ENDOTHELIAL GROWTH FACTOR#0.7188;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7188;SPINAL CORD#0.7185;PRIMARY CORTICAL NEURON#0.7086;JUXTAMEMBRANE#0.7048;ARTERY#0.7012;BREAST CANCER PATIENTS#0.7009;MUTAGENESIS#0.7008;TIGHT JUNCTION#0.7006;NEURAL CELL#0.7002;OVARIAN CANCER#0.6995;BASEMENT MEMBRANE#0.6994;OSTEOBLAST#0.6950;SENESCENCE#0.6936;DRUG RESISTANCE#0.6913;NEUROFIBRILLARY TANGLE#0.6875;CELL FATE SPECIFICATION#0.6843;MAP KINASE#0.6840;INTERLEUKIN 6 RECEPTOR#0.6830;WOUND HEALING#0.6828;VASCULAR ENDOTHELIAL CADHERIN#0.6820;CELL FUSION#0.6814;L-TYPE CALCIUM CHANNEL#0.6779;BATIMASTAT#0.6778;MARGINAL ZONE B CELL#0.6777;IGE RECEPTOR#0.6775;MARGINAL ZONE B#0.6772;MELATONIN#0.6771;CELL FATE DETERMINATION#0.6751;BRAIN ENDOTHELIAL CELL#0.6740;GOLGI APPARATUS#0.6712;CARDIOMYOPATHY#0.6711;GERMINAL CENTER#0.6710;RECEPTOR SHEDDING#0.6698;BASAL CELL#0.6692;PERIPHERAL NERVE#0.6626;SPERMATOGENESIS#0.6625;ARGININE#0.6625;GASTROINTESTINAL TRACT#0.6613;VASCULAR SMOOTH MUSCLE CELL#0.6561;BLOOD BRAIN BARRIER#0.6559;CELLULAR LOCALIZATION#0.6523;NEURAL CREST#0.6520;SCRAPIE#0.6500;HEPATOCYTE GROWTH FACTOR#0.6457;GLUTAMATE RECEPTOR#0.6448;CEREBRAL CORTEX#0.6443;NEUROTOXICITY#0.6437;NITRIC OXIDE#0.6436;RECEPTOR AGONIST#0.6426;SIGNAL PEPTIDE PEPTIDASE#0.6386;MEMBRANE TYPE 1#0.6346;GAMMA SECRETASE COMPLEX#0.6343;HUPERZINE A#0.6334;MILD COGNITIVE IMPAIRMENT#0.6305;GLYCOSYLATION#0.6303;OSTEOCLAST#0.6297;EMBRYONIC KIDNEY#0.6290;VITAMIN A#0.6267;EPITHELIAL CELL-CELL ADHESION#0.6259;CELL CELL JUNCTION#0.6245;TYPE 1 DIABETES#0.6228;RENAL CELL CARCINOMA#0.6227;ETOPOSIDE#0.6196;CELL ASSOCIATED#0.6179;RENAL CANCER CELLS#0.6177;EXTRACELLULAR VESICLE#0.6175;CHEMOTAXIS#0.6174;CELL COMMUNICATION#0.6172;SIGNAL PEPTIDE#0.6169;GOLGI OUTPOST#0.6112;BRAIN CORTEX#0.6106;MELATONIN RECEPTOR#0.6106;TRANSITIONAL B CELL#0.6093;POSTSYNAPTIC DENSITY#0.6063;1α,25-DIHYDROXYVITAMIN D3#0.6053;GRANULOCYTE#0.6053;APOPTOTIC VESICLE#0.6011;MESENCHYMAL CELL#0.6000
10300	KATANIN COMPLEX#1.1598;MICROTUBULE SEVERING ACTIVITY#1.0949;MEIOTIC SPINDLE#1.0887;MICROTUBULE SEVERING#1.0613;SPINDLE POLE#1.0523;CORTICAL MICROTUBULE#1.0499;MICROTUBULE#1.0356;MEIOSIS#1.0262;MITOSIS#1.0252;MITOTIC SPINDLE#1.0136;CENTROSOME#1.0126;MICROTUBULE DYNAMICS#1.0039;CELL DIVISION#0.9924;MICROTUBULE MINUS END#0.9911;MICROTUBULE DISASSEMBLY#0.9850;CELL WALL#0.9643;MICROTUBULE BINDING#0.9544;CELL CYCLE#0.9366;MICROTUBULE ASSOCIATED PROTEIN#0.9364;CELL ELONGATION#0.9129;BASAL BODY#0.9087;BREAST CANCER#0.9082;CYTOKINESIS#0.9064;LYMPH NODE#0.8737;INTERPHASE#0.8687;ATPASE ACTIVITY#0.8559;ATP HYDROLYSIS#0.8381;KINESIN#0.8367;MORPHOGENESIS#0.8366;TUBULIN COMPLEX#0.8351;SPINDLE FORMATION#0.8202;LYMPH NODE METASTASIS#0.8037;SPINDLE ASSEMBLY#0.7966;C TERMINAL DOMAIN#0.7799;M PHASE#0.7578;UBIQUITIN#0.7565;OOCYTE#0.7539;TRANSITION FIBER#0.7370;COMPLEX I#0.7117;HEREDITARY SPASTIC PARAPLEGIA#0.6957;SPERMATOGENESIS#0.6907;PHRAGMOPLAST#0.6888;CELL PROLIFERATION#0.6816;SPINDLE MICROTUBULE#0.6693;CANCER CELL#0.6690;GERM CELL#0.6559;GENE EXPRESSION#0.6547;MICROTUBULE CYTOSKELETON#0.6505;MICROCEPHALY#0.6381;PARAPLEGIA#0.6342;CELL EXPANSION#0.6309;SPERM HEAD#0.6277;DYNEIN#0.6242;CELL MIGRATION#0.6239;CENTRAL SPINDLE#0.6222;PROTEASOME#0.6176;CENTRIOLE#0.6157;PROSTATE CANCER#0.6084;MEIOTIC SPINDLE ASSEMBLY#0.6051
10301	CELL PROLIFERATION#1.0560;SMALL INTESTINE#1.0258;LEUCINE#1.0230;T CELL#1.0179;LYMPHOCYTIC LEUKEMIA#1.0122;CHRONIC LYMPHOCYTIC LEUKEMIA#1.0082;B CELL#1.0034;APOPTOSIS#0.9956;TUMOR SUPPRESSOR#0.9937;T LYMPHOCYTE#0.9930;B LYMPHOCYTE#0.9875;PERIPHERAL BLOOD#0.9722;BONE MARROW#0.9713;T-CELL LEUKEMIA#0.9267;CELL DIFFERENTIATION#0.9250;LYMPHOID CELL#0.9044;CELL SURFACE#0.9038;GENE EXPRESSION#0.8740;B CELL LYMPHOMA#0.8738;MULTIPLE SCLEROSIS#0.8705;B CELL DIFFERENTIATION#0.8412;THYMOCYTE#0.8398;MONONUCLEAR CELLS#0.8296;EPITHELIAL CELL#0.8282;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8268;LYMPH NODE#0.8219;PLASMA CELL#0.8034;ERYTHROCYTE#0.7964;ONCOGENIC#0.7739;ADULT T-CELL LEUKEMIA#0.7625;RENAL CELL CARCINOMA#0.7529;MUTAGEN#0.7203;LYMPHOBLASTIC LYMPHOMA#0.6926;TUMOR CELLS#0.6898;DUAL LUCIFERASE REPORTER#0.6816;REPORTER GENE ASSAY#0.6809;POLYMERASE CHAIN REACTION#0.6771;LUNG CANCER#0.6751;CANCER CELL#0.6721;MUTAGENESIS#0.6475;LEUCINE BIOSYNTHESIS#0.6432;HODGKIN'S LYMPHOMA#0.6384;HAIRY CELL LEUKEMIA#0.6356;SUPPRESSOR T CELL#0.6352;STEM CELL#0.6307;O CELL#0.6204;PANCREATIC DUCTAL ADENOCARCINOMA#0.6006
103021165	COLORECTAL CANCER#0.8458;NON-SMALL CELL LUNG CARCINOMA#0.6764;LUNG CARCINOMA#0.6674;COLORECTAL#0.6608
103021294	TYPE 2 DIABETIC#0.6012
10306	CELL ENVELOPE#0.6299
10307	AMYLOID PRECURSOR PROTEIN#1.0370;HUMAN LENS EPITHELIAL#0.8976;EPITHELIAL CELL#0.7883;ALZHEIMER'S DISEASE#0.6392;MAPK SIGNALLING#0.6134
10308	ZINC FINGER PROTEIN#1.1210;TRANSCRIPTION FACTOR#0.7916;GENE EXPRESSION#0.7904;LIVER DISEASE#0.7235;HEPATOCELLULAR CARCINOMA#0.7227
10309	KINASE ACTIVITY#0.8217;MOTILE CILIA#0.7813;APOPTOSIS#0.7236;LYMPHOID CELL#0.6537;CENTRIOLE#0.6453;CELL CYCLE#0.6269
1030	ANTISENSE RNA#1.0439;DEMETHYLATION#1.0273;METHYLATION SPECIFIC POLYMERASE#1.0200;DECITABINE#1.0196;CYCLIN DEPENDENT KINASE INHIBITOR#1.0185;MULTIPLE MYELOMA#1.0156;CDK INHIBITOR#1.0156;KINASE INHIBITOR#1.0115;METHYLATION SPECIFIC PCR#1.0092;CYCLIN DEPENDENT KINASE#1.0078;ACUTE LEUKEMIA#1.0058;MYELODYSPLASTIC SYNDROME#1.0053;SENESCENCE#1.0043;PANCREATIC CANCER#1.0033;5-AZA-2'-DEOXYCYTIDINE#1.0007;DNA METHYLTRANSFERASE#1.0003;ESTROGEN RECEPTOR#1.0003;2'-DEOXYCYTIDINE#0.9996;ACUTE MYELOID LEUKEMIA#0.9978;MYELOID LEUKEMIA#0.9961;PERIPHERAL BLOOD#0.9957;PROSTATE CANCER#0.9946;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.9942;CHROMOSOMAL REGION#0.9937;TUMOR SUPPRESSOR#0.9926;LYMPHOCYTIC LEUKEMIA#0.9925;ASTROCYTOMA#0.9920;CPG ISLAND METHYLATION#0.9919;RETINOBLASTOMA#0.9912;B CELL LYMPHOMA#0.9909;DISEASE FREE SURVIVAL#0.9908;ATHEROSCLEROSIS#0.9907;SMOOTH MUSCLE#0.9906;CELL CYCLE REGULATOR#0.9902;LUNG ADENOCARCINOMA#0.9893;OVARIAN#0.9887;T CELL#0.9874;MUSCLE CELL#0.9870;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9868;BONE MARROW#0.9867;SMOOTH MUSCLE CELL#0.9858;TYPE 2 DIABETES#0.9853;COLORECTAL CANCER#0.9847;OVARIAN CANCER#0.9846;PROGENITOR CELL#0.9846;CELL CYCLE CONTROL#0.9844;PROTEIN KINASE#0.9842;POLYMERASE CHAIN REACTION#0.9841;CELL CYCLE REGULATION#0.9839;LUNG CANCER#0.9828;CELL CYCLE ARREST#0.9826;TRANSFORMING GROWTH FACTOR BETA#0.9823;REVERSE TRANSCRIPTION#0.9821;CORONARY ARTERY DISEASE#0.9816;COPY NUMBER ALTERATION#0.9812;ARTERY DISEASE#0.9809;CELL CYCLE#0.9806;S PHASE#0.9803;ACUTE LYMPHOCYTIC LEUKEMIA#0.9784;SQUAMOUS CELL CARCINOMA#0.9781;APOPTOTIC#0.9779;MYOCARDIAL INFARCTION#0.9779;COLORECTAL#0.9772;TRANSCRIPTASE#0.9771;CORONARY ARTERY#0.9770;MYELOID CELL#0.9769;G1 PHASE#0.9769;CELLULAR SENESCENCE#0.9765;ONCOGENIC#0.9757;BREAST CANCER#0.9757;HEPATOCELLULAR CARCINOMA#0.9754;TRANSCRIPTION FACTOR#0.9749;EPITHELIAL CELL#0.9749;TRANSFORMING GROWTH FACTOR#0.9747;DNA METHYLATION#0.9744;ARTERY#0.9742;CELL DIFFERENTIATION#0.9741;TUMOR CELLS#0.9733;OPEN ANGLE GLAUCOMA#0.9730;BREAST CANCER CELL#0.9730;ADENOCARCINOMA#0.9725;SIGNALING PATHWAY#0.9718;KINASE ACTIVITY#0.9715;COMPARATIVE GENOMIC HYBRIDIZATION#0.9707;B CELL#0.9703;CANCER CELL#0.9693;CELL GROWTH#0.9686;GROWTH FACTOR RECEPTOR#0.9685;PRIMARY OPEN ANGLE GLAUCOMA#0.9682;GROWTH FACTOR#0.9668;CELL PROLIFERATION#0.9666;REPLICATIVE SENESCENCE#0.9646;APOPTOSIS#0.9643;STEM CELL#0.9637;MALIGNANT MESOTHELIOMA#0.9633;EVENT FREE SURVIVAL#0.9624;GENE EXPRESSION#0.9621;DIABETES MELLITUS#0.9618;REGULATION OF CELL CYCLE#0.9604;BETA CELL#0.9583;GENE SILENCING#0.9564;MITOGEN ACTIVATED PROTEIN#0.9552;CHRONIC MYELOID LEUKEMIA#0.9552;CELL DEATH#0.9550;CERVICAL#0.9534;DIFFUSE LARGE B-CELL LYMPHOMA#0.9529;DNA REPAIR#0.9498;LYMPH NODE#0.9480;COLON CANCER#0.9451;NERVOUS SYSTEM#0.9443;ESOPHAGEAL CANCER#0.9440;COPY NUMBER CHANGE#0.9439;HODGKIN'S LYMPHOMA#0.9424;TELOMERASE ACTIVITY#0.9410;KERATINOCYTE#0.9400;HISTONE DEACETYLASE#0.9399;DNA HYPERMETHYLATION#0.9397;EPIDERMAL GROWTH FACTOR#0.9386;DNA SYNTHESIS#0.9346;PLASMA CELL#0.9343;CELL DIVISION#0.9319;T-CELL LEUKEMIA#0.9314;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9273;CELL CYCLE PATHWAY#0.9257;TYPE 2 DIABETES MELLITUS#0.9210;2 DIABETES MELLITUS#0.9209;TUMOR TISSUES#0.9199;MELANOMA CELL LINES#0.9165;ATHEROSCLEROTIC#0.9113;COMMON MYELOID PROGENITOR#0.9109;ENDOTHELIAL CELL#0.9088;COPY NUMBER VARIATION#0.9086;HEMATOPOIETIC CELL#0.9083;CENTRAL NERVOUS SYSTEM#0.9080;PARATHYROID ADENOMA#0.9064;QUANTITATIVE REAL TIME#0.9056;INSULIN SECRETION#0.8996;MONONUCLEAR CELLS#0.8994;RETINOIC ACID#0.8987;ORAL SQUAMOUS CELL CARCINOMA#0.8960;MALIGNANT GLIOMA#0.8958;M PHASE#0.8941;ADULT T-CELL LEUKEMIA#0.8911;CERVICAL CANCER#0.8890;HUMAN BREAST CANCER#0.8871;EXTRACELLULAR MATRIX#0.8791;BREAST CARCINOMA#0.8781;BONE MARROW CELLS#0.8756;NEUROBLASTOMA#0.8752;FOLLICULAR LYMPHOMA#0.8739;PARATHYROID#0.8721;GLIOBLASTOMA MULTIFORME#0.8718;HYPOXIA#0.8715;UBIQUITIN#0.8705;MONOCYTE#0.8683;HEART DISEASE#0.8668;LYSINE#0.8650;LEUKOCYTE#0.8649;DNA COPY NUMBER#0.8632;CELL ADHESION#0.8533;ACUTE PROMYELOCYTIC LEUKEMIA#0.8528;FORMALIN#0.8508;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8491;ONCOGENESIS#0.8481;CORONARY HEART DISEASE#0.8477;MYCOSIS FUNGOIDES#0.8464;SIGNAL TRANSDUCTION#0.8459;VON HIPPEL LINDAU#0.8448;OLIGODENDROGLIOMA#0.8424;LYMPHOBLASTIC LYMPHOMA#0.8412;GESTATIONAL DIABETES#0.8392;MACROPHAGE#0.8359;VASCULAR SMOOTH MUSCLE CELL#0.8349;ARSENIC TRIOXIDE#0.8348;QUANTITATIVE REVERSE TRANSCRIPTION#0.8346;DRUG RESISTANCE#0.8342;PERIPHERAL NERVE#0.8337;GRANULOCYTE#0.8312;FAMILIAL MELANOMA#0.8298;DNA BINDING#0.8293;CYTOPLASM#0.8279;INDUCTION OF APOPTOSIS#0.8264;HISTONE METHYLATION#0.8249;CELL MIGRATION#0.8231;GERM CELL#0.8217;HYPERMETHYLATION OF CPG ISLAND#0.8206;LYMPH NODE METASTASIS#0.8185;CELL CYCLE CHECKPOINT#0.8133;CARCINOGEN#0.8112;PROTEASOME#0.8093;REGENERATION#0.8027;CELL DIVISION CYCLE#0.8001;ADENOMATOUS POLYPOSIS COLI#0.7995;SOFT TISSUE SARCOMA#0.7991;GENE COPY NUMBER#0.7982;PROTEIN KINASE INHIBITOR#0.7972;ACUTE MYELOID LEUKAEMIA#0.7967;HEMATOPOIETIC STEM CELL#0.7966;CUTANEOUS T CELL LYMPHOMA#0.7962;PANCREATIC CARCINOMA#0.7959;ALTERNATIVE READING FRAME#0.7953;DNA REPLICATION#0.7911;TYROSINE KINASE INHIBITOR#0.7874;HEMATOPOIESIS#0.7867;POLYCOMB REPRESSIVE COMPLEX#0.7843;PLEOMORPHIC XANTHOASTROCYTOMA#0.7843;ADIPOSE TISSUE#0.7835;MANTLE CELL LYMPHOMA#0.7826;RENAL CELL CARCINOMA#0.7802;WHITE BLOOD CELL#0.7791;PITUITARY ADENOMA#0.7789;CDK ACTIVITY#0.7711;ANAPLASTIC MENINGIOMA#0.7696;HUMAN PANCREATIC CANCER#0.7693;PROSTATE CARCINOMA#0.7685;ESOPHAGEAL CARCINOMA#0.7673;RELAPSE FREE SURVIVAL#0.7635;THYROID CANCER#0.7624;TYPE 1 DIABETES#0.7621;LUNG CARCINOMA#0.7618;GLUTATHIONE#0.7604;MINIMAL RESIDUAL DISEASE#0.7569;HISTONE DEACETYLASE INHIBITOR#0.7549;RNA INTERFERENCE#0.7541;ORAL GLUCOSE TOLERANCE#0.7537;WOUND HEALING#0.7534;GLUCOSE TOLERANCE TEST#0.7527;AZACYTIDINE#0.7434;BASAL CELL#0.7434;QUIESCENCE#0.7405;MAPK SIGNALING#0.7400;HISTONE MODIFICATION#0.7380;STROMAL CELL#0.7282;PROGESTERONE#0.7274;TRANSITIONAL CELL CARCINOMA#0.7271;NERVE SHEATH TUMORS#0.7263;HYPERTENSION#0.7259;PERIPHERAL BLOOD CELLS#0.7252;LUNG EPITHELIAL CELL#0.7250;HISTONE ACETYLATION#0.7231;METASTATIC MELANOMA#0.7225;OVARIAN CARCINOMA#0.7210;STRIATUM#0.7205;HEMATOPOIETIC PROGENITOR CELL#0.7195;PROTEIN PHOSPHORYLATION#0.7158;ONCOGENE INDUCED SENESCENCE#0.7141;INHIBITION OF CELL PROLIFERATION#0.7125;OPTIC NERVE#0.7098;TERMINAL DIFFERENTIATION#0.7097;MISMATCH REPAIR#0.7093;MITOSIS#0.7075;VSMC PROLIFERATION#0.7063;MOUSE EMBRYO FIBROBLASTS#0.7062;CHONDROSARCOMA#0.7062;AORTIC ANEURYSM#0.7038;DNA HYPOMETHYLATION#0.7014;ANGIOGENESIS#0.7003;CELL ADHESION MOLECULE#0.6940;INFLAMMATORY RESPONSE#0.6913;RNA BINDING#0.6897;GESTATIONAL DIABETES MELLITUS#0.6893;AGEING#0.6846;ADJACENT NORMAL TISSUE#0.6837;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6819;TELOMERE#0.6818;COPY NUMBER GAIN#0.6816;CHOLANGIOCARCINOMA#0.6807;HISTONE DEMETHYLASE#0.6792;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.6780;RNASE P#0.6779;LIVER FLUKE-RELATED CHOLANGIOCARCINOMA#0.6777;CARCINOMA IN SITU#0.6741;COLORECTAL CARCINOMA#0.6740;EPITHELIAL OVARIAN CANCER#0.6736;INTERPHASE#0.6727;THYROID CARCINOMA#0.6727;PHOSPHATASE AND TENSIN HOMOLOG#0.6709;ASTROCYTE#0.6691;MECHANISM OF ACTION#0.6676;PILOCYTIC ASTROCYTOMA#0.6668;WORLD HEALTH ORGANIZATION#0.6623;RECURRENCE FREE SURVIVAL#0.6578;MUTAGENESIS#0.6577;EPSTEIN BARR VIRUS#0.6542;CELL CYCLE TRANSITION#0.6539;MALIGNANT LYMPHOMA#0.6531;DENTATE GYRUS#0.6528;GASTRIC ADENOCARCINOMA#0.6522;INSULIN-LIKE GROWTH FACTOR#0.6508;HYPOXIC#0.6491;BLAST CELL#0.6479;PROTEIN CODING GENE#0.6472;CAROTID ARTERY#0.6469;HEAD AND NECK CANCER#0.6448;ENDOMETRIAL CANCER#0.6448;NECK CANCER#0.6447;DIDEOXYCYTIDINE#0.6430;SYPHILIS#0.6360;3-OST-2#0.6321;EPITHELIAL CELL PROLIFERATION#0.6306;DEPHOSPHORYLATION#0.6278;MOUSE EMBRYONIC FIBROBLAST#0.6271;GASTRIC MUCOSA#0.6245;STEM CELL TRANSPLANTATION#0.6238;CELL DEVELOPMENT#0.6237;MESENCHYMAL STEM CELL#0.6219;DNA DEMETHYLATION#0.6214;PROTEIN SYNTHESIS#0.6210;GENOTOXIC#0.6185;MELANOCYTE#0.6181;ANAPLASTIC OLIGODENDROGLIOMA#0.6180;ATYPICAL MENINGIOMA#0.6178;T LYMPHOCYTE#0.6177;BASAL CELL CARCINOMA#0.6174;MICROTUBULE#0.6169;WNT SIGNALING PATHWAY#0.6160;DOUBLE STRAND BREAK#0.6125;FIBROBLAST GROWTH FACTOR#0.6065;CISPLATIN#0.6042;IMMUNE RESPONSE#0.6036
10311	DOWN SYNDROME#0.8430
10312	PROTON PUMP#1.0672;AUTOSOMAL RECESSIVE OSTEOPETROSIS#1.0638;T CELL#1.0632;IMMUNE RESPONSE#1.0559;OSTEOPETROSIS#1.0320;OSTEOCLAST#1.0201;BONE RESORPTION#0.9960;ACIDIFICATION#0.9852;BONE MARROW#0.9802;CELL ACTIVATION#0.9773;STEM CELL#0.9683;CHLORIDE CHANNEL#0.9648;GENE EXPRESSION#0.9517;T CELL ACTIVATION#0.9405;PERIPHERAL BLOOD#0.8958;HEMATOPOIETIC STEM CELL#0.8698;STEM CELL TRANSPLANTATION#0.8515;OSTEOCLAST DIFFERENTIATION#0.8215;B CELL#0.8118;BONE DISEASE#0.8107;VACUOLE#0.7930;CELL PROLIFERATION#0.7777;T CELL PROLIFERATION#0.7549;ACTIVATED T CELL#0.7410;ATPASE COMPLEX#0.7248;ACID PHOSPHATASE#0.7151;T LYMPHOCYTE#0.7129;MONOCYTE#0.6850;VACUOLAR ACIDIFICATION#0.6744;MACROPHAGE#0.6634;THROMBOCYTOPENIA#0.6467;ACTIVATED T-CELLS#0.6317;OSTEOCLAST PRECURSOR CELL#0.6313;POLYMERASE CHAIN REACTION#0.6304;OPTIC NERVE#0.6133;COLLAGEN INDUCED ARTHRITIS#0.6117;LYMPHOCYTE ACTIVATION#0.6045;INDUCED PLURIPOTENT STEM CELL#0.6028;PLURIPOTENT STEM CELL#0.6010;PRECURSOR CELL#0.6002
10313	APOPTOSIS#1.0524;ENDOPLASMIC RETICULUM#1.0477;NEURITE#0.9950;ALZHEIMER'S DISEASE#0.9739;APOPTOTIC#0.9270;AMYLOID PRECURSOR PROTEIN#0.8952;VIRAL REPLICATION#0.8251;AUTOPHAGY#0.8191;CEREBRAL CORTEX#0.8137;ER MEMBRANE#0.7783;CYTOCHROME C#0.7612;CELL DEATH#0.7045;AXONAL TRANSPORT#0.7029;MITOCHONDRIA#0.6981;PLASMA MEMBRANE#0.6883;CENTRAL NERVOUS SYSTEM#0.6639;NERVOUS SYSTEM#0.6629;NEURODEGENERATIVE DISEASE#0.6429;REGENERATION#0.6274
10314	NADPH OXIDASE#0.9623;ERYTHROCYTE#0.9110;GLUTATHIONE#0.7967;PROTEIN TYROSINE KINASE#0.7058;MAURER'S CLEFT#0.6466
103164619	MACROPHAGE#0.8847;IFN-GAMMA#0.8083;PRINCIPAL COMPONENT ANALYSIS#0.7808;PURKINJE CELL#0.7752;ATPASE ACTIVITY#0.7374;VIRULENCE#0.7007;GENE EXPRESSION#0.6936;PARATHYROID HORMONE#0.6151
10316	NEUROMEDIN U RECEPTOR#1.0572;NERVOUS SYSTEM#0.9770;CENTRAL NERVOUS SYSTEM#0.9441;POLYMERASE CHAIN REACTION#0.8127;GASTROINTESTINAL TRACT#0.7203;REVERSE TRANSCRIPTION#0.7048;PITUITARY GLAND#0.6692;STRUCTURE ACTIVITY RELATIONSHIP#0.6677;GROWTH HORMONE#0.6644;INSULIN SECRETION#0.6431;MAST CELL#0.6425;GENE EXPRESSION#0.6414;ENERGY HOMEOSTASIS#0.6216;ANORECTIC#0.6081
10317	PANCREATIC CANCER#0.7304;COLON CANCER#0.7292;TRANSCRIPTION FACTOR#0.6734;N GLYCAN#0.6619
10318	VAN DER WOUDE SYNDROME#1.1183;VAN DER WAALS#1.0829;UBIQUITIN BINDING#1.0504;PSORIASIS#1.0299;UBIQUITIN#1.0286;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0176;LUPUS ERYTHEMATOSUS#1.0174;T CELL#1.0064;APOPTOSIS#1.0042;TUMOR NECROSIS FACTOR#0.9892;GENE EXPRESSION#0.9889;SIGNALING PATHWAY#0.9808;PROTEIN KINASE#0.9753;KERATINOCYTE#0.9733;AUTOIMMUNE DISEASE#0.9705;NF-KAPPAB ACTIVATION#0.9700;TRANSCRIPTION FACTOR#0.9419;IMMUNE RESPONSE#0.9388;PERIPHERAL BLOOD#0.9120;HUMAN IMMUNODEFICIENCY VIRUS#0.9011;GROWTH FACTOR#0.8954;RETINOIC ACID#0.8845;EOSIN#0.8798;EPITHELIAL CELL#0.8725;KINASE ACTIVITY#0.8544;RETINOIC ACID RECEPTOR#0.8455;B CELL#0.8391;CELL DEATH#0.8376;NEPHRITIS#0.8328;TOLL LIKE RECEPTOR#0.8284;MITOGEN ACTIVATED PROTEIN#0.8269;CLEFT LIP#0.8255;POLYMERASE CHAIN REACTION#0.8248;PLANAR CELL POLARITY#0.8160;CELL POLARITY#0.8076;CANCER CELL#0.7943;APOPTOTIC#0.7855;IMMUNE CELL#0.7846;IMMUNE SYSTEM#0.7808;CELL PROLIFERATION#0.7780;PSORIATIC ARTHRITIS#0.7777;CLEFT PALATE#0.7707;INNATE IMMUNE RESPONSE#0.7670;LUPUS NEPHRITIS#0.7532;CELL SURFACE#0.7527;INFLAMMATORY RESPONSE#0.7391;CELL GROWTH#0.7390;AUTOIMMUNITY#0.7367;RHEUMATOID ARTHRITIS#0.7360;POPLITEAL PTERYGIUM SYNDROME#0.7344;NEURAL TUBE#0.7253;SPINA BIFIDA#0.7215;SIGNAL TRANSDUCTION#0.7005;REVERSE TRANSCRIPTION#0.6944;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6891;MACROPHAGE#0.6827;ENHANCER BINDING PROTEIN#0.6780;ENHANCER BINDING#0.6774;TUMOUR NECROSIS FACTOR#0.6732;DNA BINDING#0.6704;DENDRITIC CELL#0.6697;LEUKOCYTE#0.6635;INTERFERON REGULATORY FACTOR#0.6542;VIRION#0.6537;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6526;MONONUCLEAR CELLS#0.6514;PROTEIN KINASE C#0.6473;POLYUBIQUITIN#0.6229;MYASTHENIA GRAVIS#0.6124;CARCINOMA IN SITU#0.6027
10319	BASEMENT MEMBRANE#0.8342;APICAL ES#0.6805;ANTISENSE MORPHOLINO OLIGONUCLEOTIDE#0.6058
1031	BREAST CANCER#1.0378;CDK INHIBITOR#1.0271;B CELL#1.0260;CYCLIN DEPENDENT KINASE INHIBITOR#1.0174;KINASE INHIBITOR#1.0109;CELL CYCLE ARREST#1.0102;CELL CYCLE REGULATOR#1.0068;TUMOR SUPPRESSOR#1.0063;CELL GROWTH#1.0051;CYCLIN DEPENDENT KINASE#1.0043;T CELL#0.9978;CANCER CELL#0.9976;CELL CYCLE#0.9945;STEM CELL#0.9943;CELL PROLIFERATION#0.9930;TUMOR CELLS#0.9920;G1 PHASE#0.9893;POLYMERASE CHAIN REACTION#0.9886;RETINOBLASTOMA#0.9859;MULTIPLE MYELOMA#0.9843;APOPTOSIS#0.9816;APOPTOTIC#0.9783;GENE EXPRESSION#0.9780;TRANSCRIPTION FACTOR#0.9750;CELL DIVISION#0.9696;CELL DIFFERENTIATION#0.9614;CELL CYCLE REGULATION#0.9596;BONE MARROW#0.9592;CELL CYCLE CONTROL#0.9591;BREAST CANCER CELL#0.9584;PITUITARY ADENOMA#0.9523;MULTIPLE ENDOCRINE NEOPLASIA#0.9518;CELL DEATH#0.9436;PLASMA CELL#0.9380;HEMATOPOIETIC STEM CELL#0.9366;PROGENITOR CELL#0.9281;S PHASE#0.9210;PARATHYROID ADENOMA#0.9207;PROTEIN KINASE#0.9205;SIGNALING PATHWAY#0.9107;PARATHYROID#0.9089;OLIGODENDROGLIOMA#0.8876;LUNG CANCER#0.8839;CELL DIVISION CYCLE#0.8788;KINASE ACTIVITY#0.8787;CISPLATIN#0.8595;PROSTATE CANCER#0.8517;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8474;B LYMPHOCYTE#0.8406;REVERSE TRANSCRIPTION#0.8386;THYROID CARCINOMA#0.8381;MULTIPLE ENDOCRINE NEOPLASIA TYPE 1#0.8320;GROWTH FACTOR#0.8286;LUMINAL PROGENITOR CELL#0.8142;SENESCENCE#0.8112;LUMINAL PROGENITOR#0.7947;PANCREATIC ISLET#0.7825;MEDULLOBLASTOMA#0.7705;NEUROBLASTOMA#0.7652;CELL EXPANSION#0.7639;LEYDIG CELL#0.7450;SPERMATOGENESIS#0.7343;LUMINAL#0.7270;BETA CELL#0.7083;EPITHELIAL CELL#0.6994;HEPATOCELLULAR CARCINOMA#0.6876;HUMAN BREAST CANCER#0.6813;CELL CYCLE PATHWAY#0.6789;SQUAMOUS CELL CARCINOMA#0.6754;MANTLE CELL LYMPHOMA#0.6574;COMPARATIVE GENOMIC HYBRIDIZATION#0.6534;ONCOGENIC#0.6437;TERMINAL DIFFERENTIATION#0.6332;DNA REPLICATION#0.6319;HYPOXIA#0.6292;QUIESCENCE#0.6191;OVARIAN CANCER#0.6191;OVARIAN#0.6189;INDUCTION OF APOPTOSIS#0.6167;B CELL LYMPHOMA#0.6046
10320	ZINC FINGER PROTEIN#1.0594;LYMPHOCYTE DEVELOPMENT#1.0537;CHROMATIN REMODELING#1.0470;LYMPHOCYTE DIFFERENTIATION#1.0446;HETEROCHROMATIN#1.0403;T CELL DEVELOPMENT#1.0333;T CELL DIFFERENTIATION#1.0332;DNA BINDING#1.0308;THYMOCYTE#1.0304;LENALIDOMIDE#1.0298;HISTONE DEACETYLASE#1.0284;HEMATOPOIETIC CELL#1.0283;TUMOR SUPPRESSOR#1.0272;CD4+ T CELL#1.0268;POMALIDOMIDE#1.0250;EVENT FREE SURVIVAL#1.0239;HEMATOPOIESIS#1.0224;LYMPHOID CELL#1.0220;TRANSCRIPTION FACTOR#1.0190;B CELL DIFFERENTIATION#1.0185;B CELL DEVELOPMENT#1.0178;CELL DIFFERENTIATION#1.0122;CELL DEVELOPMENT#1.0115;CELL CYCLE#1.0099;T LYMPHOCYTE#1.0098;UBIQUITIN#1.0088;MINIMAL RESIDUAL DISEASE#1.0074;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0071;LUPUS ERYTHEMATOSUS#1.0069;T CELL#1.0039;ONCOGENIC#1.0031;ACUTE MYELOID LEUKEMIA#1.0029;B CELL RECEPTOR#1.0026;COPY NUMBER ALTERATION#1.0012;CYTOKINE RECEPTOR#1.0012;HEMATOPOIETIC STEM CELL#1.0010;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0005;SIGNALING PATHWAY#0.9979;MYELOID LEUKEMIA#0.9973;B CELL#0.9961;B LYMPHOCYTE#0.9953;MULTIPLE MYELOMA#0.9951;POLYMERASE CHAIN REACTION#0.9945;GENE EXPRESSION#0.9910;IMMUNE SYSTEM#0.9909;STEM CELL#0.9900;CELL PROLIFERATION#0.9898;PROGENITOR CELL#0.9896;APOPTOSIS#0.9866;THALIDOMIDE#0.9847;KINASE INHIBITOR#0.9810;BONE MARROW#0.9797;NURD COMPLEX#0.9779;PERIPHERAL BLOOD#0.9740;MACROPHAGE#0.9714;DENDRITIC CELL#0.9692;THYMOCYTE DIFFERENTIATION#0.9691;MYELOID CELL#0.9678;T-CELL LEUKEMIA#0.9674;REVERSE TRANSCRIPTION#0.9670;PROTEIN PHOSPHATASE 1#0.9667;TYROSINE KINASE INHIBITOR#0.9647;ACUTE LEUKEMIA#0.9644;WHITE BLOOD CELL#0.9626;CELL ACTIVATION#0.9622;FACTOR I#0.9606;CASEIN KINASE 2#0.9582;UBIQUITIN LIGASE COMPLEX#0.9552;IMMUNE RESPONSE#0.9516;AUTOIMMUNITY#0.9440;PROTEASOME#0.9404;ERYTHROID CELL#0.9379;PROTEIN KINASE#0.9271;CELL SURFACE#0.9182;DISEASE FREE SURVIVAL#0.9153;DEXAMETHASONE#0.9133;CANCER CELL#0.9117;CELL GROWTH#0.9096;MULTIPLE MYELOMA CELLS#0.9081;MYELODYSPLASTIC SYNDROME#0.9011;PLASMA CELL#0.8986;STEM CELL TRANSPLANTATION#0.8977;REGULATORY T CELL#0.8940;PRE-B CELL DIFFERENTIATION#0.8933;CD8+ T CELL#0.8931;GROWTH FACTOR#0.8904;AUTOIMMUNE DISEASE#0.8874;SIGNAL TRANSDUCTION#0.8868;GLOBIN#0.8841;CELL DEATH#0.8767;RISK OF RELAPSE#0.8706;CELL ADHESION#0.8697;CHRONIC MYELOID LEUKEMIA#0.8641;MYELOPROLIFERATIVE NEOPLASM#0.8588;MECHANISM OF ACTION#0.8496;HISTONE ACETYLATION#0.8484;DRUG RESISTANCE#0.8482;COLORECTAL CANCER#0.8472;LYMPHOID LEUKEMIA#0.8455;MONONUCLEAR CELLS#0.8452;IFN-GAMMA#0.8450;IMATINIB#0.8397;ELECTROPHORETIC MOBILITY SHIFT#0.8379;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8312;C-TERMINAL BINDING#0.8299;TRANSCRIPTION FACTOR BINDING#0.8285;CELL MATURATION#0.8283;COLORECTAL#0.8233;RELAPSE FREE SURVIVAL#0.8224;T CELL ACTIVATION#0.8185;CELL CYCLE ARREST#0.8145;LYMPHOBLAST#0.8130;HISTONE DEACETYLATION#0.8072;NUCLEOSOME#0.8052;DNA METHYLATION#0.7991;CASEIN KINASE 1#0.7982;IMMUNE CELL#0.7900;STROMAL CELL#0.7880;PANCREATIC CANCER#0.7857;MONOCYTE#0.7857;B CELL LYMPHOMA#0.7840;ACTIVATED T CELL#0.7830;MUTAGENESIS#0.7820;COMPARATIVE GENOMIC HYBRIDIZATION#0.7792;PLASMA MEMBRANE#0.7776;SEQUENCE SPECIFIC DNA BINDING#0.7691;LYMPHOID TISSUE#0.7591;T CELL HOMEOSTASIS#0.7575;POLYCOMB REPRESSIVE COMPLEX#0.7543;TRANSCRIPTION REPRESSOR#0.7538;TRANSCRIPTION REGULATOR#0.7503;MOLECULAR FUNCTION#0.7494;CYTOPLASM#0.7449;POTASSIUM CHANNEL#0.7449;LEUCINE#0.7448;INTERFERON REGULATORY FACTOR#0.7438;CYTOTOXICITY#0.7420;PRECURSOR CELL#0.7393;CORD BLOOD#0.7389;T HELPER CELL#0.7376;INFLAMMATORY RESPONSE#0.7347;S PHASE#0.7312;FETAL LIVER#0.7275;LYMPHOCYTIC LEUKEMIA#0.7249;CYCLIN DEPENDENT KINASE#0.7182;LYSINE#0.7154;PROTEIN DEGRADATION#0.7128;B CELL ACTIVATION#0.7092;QUANTITATIVE REAL TIME#0.7089;STEM CELL DIFFERENTIATION#0.7085;TH2 CELL#0.7064;GERMINAL CENTER#0.7030;TRANSCRIPTIONAL CONTROL#0.7029;HISTIDINE#0.6959;NATURAL KILLER CELL#0.6938;LEUKEMIA FREE SURVIVAL#0.6935;GROWTH FACTOR RECEPTOR#0.6894;ACTIVATED T-CELLS#0.6849;PROTEIN PROTEIN INTERACTION#0.6849;ALKALINE PHOSPHATASE#0.6800;CHANNEL ACTIVITY#0.6796;CHROMATIN MODIFICATION#0.6790;SYSTEM DEVELOPMENT#0.6767;PLASMACYTOID DENDRITIC CELL#0.6765;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6756;REGULATION OF GENE EXPRESSION#0.6726;ONCOGENESIS#0.6693;NERVOUS SYSTEM#0.6686;DIFFUSE LARGE B-CELL LYMPHOMA#0.6489;ERYTHROPOIESIS#0.6470;PROTEIN KINASE A#0.6444;GENE REGULATORY NETWORK#0.6361;BONE MARROW STROMAL#0.6311;SUMOYLATION#0.6251;C TERMINAL DOMAIN#0.6217;DNA COPY NUMBER#0.6204;CENTROMERIC HETEROCHROMATIN#0.6167;HIGH RISK PATIENTS#0.6155;SIGNAL TRANSDUCER#0.6152;NK CELL DIFFERENTIATION#0.6151;ADENOCARCINOMA#0.6136;EPITHELIAL CELL#0.6075;HYPOXIA#0.6049;V-D-J RECOMBINATION#0.6039;CYCLIN DEPENDENT KINASE INHIBITOR#0.6039;AGE AT DIAGNOSIS#0.6035;NATIONAL CANCER INSTITUTE#0.6013;ACTIVATED CD8+ T CELL#0.6006
10321	SPECIFIC GRANULE#1.1115;SEMINAL PLASMA#1.0730;PROSTATE CANCER#1.0614;SALIVARY GLAND#1.0529;NEUTROPHIL#1.0123;GENE EXPRESSION#0.9338;SEMEN#0.8917;PLASMA PROTEIN#0.8912;CANCER CELL#0.8907;B CELL#0.8554;EPIDIDYMIS#0.7884;GRANULOCYTE#0.7482;EPITHELIAL CELL#0.7381;EOSINOPHIL#0.7155;PERIPHERAL BLOOD#0.7152;ACINAR CELL#0.7106;ACIDIC EPIDIDYMAL GLYCOPROTEIN#0.7034;REVERSE TRANSCRIPTION#0.6602;ANDROGEN RECEPTOR#0.6395;ENDOMETRIAL EPITHELIAL CELLS#0.6281;POLYMERASE CHAIN REACTION#0.6062
10322	HETEROCHROMATIN#0.6398
10324	SKELETAL MUSCLE#0.9817;CELL CYCLE#0.9217;CYCLIN DEPENDENT KINASE#0.8961;MYOFIBRIL#0.8507;CYCLIN DEPENDENT KINASE INHIBITOR#0.8397;KINASE INHIBITOR#0.8317;NEMALINE MYOPATHY#0.7433;MYOPATHY#0.6587
10325	GTP BINDING#0.9878;TARGET OF RAPAMYCIN#0.9480;TARGET OF RAPAMYCIN COMPLEX#0.9206;RAPAMYCIN#0.8811;GAP ACTIVITY#0.8565;CELL GROWTH#0.8112;LYSOSOME#0.7682;LYSOSOME LOCALIZATION#0.7135;LEUCINE#0.6599;MTOR COMPLEX#0.6367
10326	CELL PROLIFERATION#0.6599;MYELOID CELL#0.6569;QUANTITATIVE TRAIT LOCUS#0.6231;COLONY FORMATION ASSAY#0.6163;PROSTATE CANCER#0.6018
10327	ALDO KETO REDUCTASE#1.0342;DAUNORUBICIN#0.6461
10329	LECTIN#1.0119;ENDOPLASMIC RETICULUM#0.9938;GLYCOSYLATION#0.9899;APOPTOSIS#0.9785;CELL SURFACE#0.9777;T CELL#0.9692;GOLGI APPARATUS#0.9605;TUMOR NECROSIS FACTOR#0.9472;PLASMA MEMBRANE#0.9361;LOW DENSITY LIPOPROTEIN#0.9016;VIRION#0.8506;B CELL#0.8410;CELL WALL#0.8363;SIGNAL PEPTIDE#0.8042;HERPES SIMPLEX VIRUS#0.8038;HERPES SIMPLEX#0.8035;POLYMERASE CHAIN REACTION#0.7409;GLCNAC#0.7402;ACTIVATED T-CELLS#0.7334;ACTIVATED T CELL#0.7331;ENDOTHELIAL CELL#0.7274;DENDRITIC CELL#0.7227;ENZYME ACTIVITY#0.7167;LUMINAL#0.7150;NEUTRAL ENDOPEPTIDASE 24.11#0.6993;ENDOPEPTIDASE 24.11#0.6946;CYTOPLASMIC REGION#0.6891;N GLYCAN#0.6870;TRANSFERRIN RECEPTOR#0.6845;TUMOUR NECROSIS FACTOR#0.6778;PSEUDORABIES#0.6770;GLUCAN SYNTHESIS#0.6653;MACROPHAGE#0.6518;CELL DEATH#0.6491;PROSTATE-SPECIFIC MEMBRANE ANTIGEN#0.6332;O GLYCAN#0.6295;T LYMPHOCYTE#0.6169;ENDOCYTOSIS#0.6164
1032	KINASE INHIBITOR#1.0382;CYCLIN DEPENDENT KINASE#1.0340;CELL CYCLE#1.0338;CYCLIN DEPENDENT KINASE INHIBITOR#1.0313;CDK INHIBITOR#0.9962;GENE EXPRESSION#0.9402;APOPTOSIS#0.9365;CELL PROLIFERATION#0.9228;TUMOR SUPPRESSOR#0.9102;GERM CELL#0.7916;CANCER CELL#0.7805;HEARING LOSS#0.7784;POLYMERASE CHAIN REACTION#0.7543;LUNG CANCER#0.7440;CELL GROWTH#0.7400;OVARIAN#0.7365;SIGNALING PATHWAY#0.7167;CELL CYCLE CONTROL#0.7142;OVARIAN CANCER#0.6346;OVARIAN CARCINOMA#0.6149;RETINOIC ACID#0.6046
10330	GROWTH FACTOR#0.8985;CELL PROLIFERATION#0.8900;ENDOPLASMIC RETICULUM#0.8864;NEURITE OUTGROWTH#0.7239;ANGIOGENESIS#0.7207;APOPTOSIS#0.7171;REGULATORY LIGHT CHAIN#0.6644;SAPOSIN#0.6450;CELL GROWTH#0.6441;SIGNALING PATHWAY#0.6420;POLYMERASE CHAIN REACTION#0.6408;CELL MIGRATION#0.6387;PROSTATE CANCER#0.6383;SMOOTH MUSCLE#0.6362;GENE EXPRESSION#0.6325
10331	LEUCINE#0.6422;LYMPH NODE METASTASIS#0.6258;LYMPH NODE#0.6142
10332	ENDOTHELIAL CELL#1.0581;LYMPH NODE#1.0570;LECTIN#1.0422;HEPATITIS C VIRUS#1.0371;HEPATITIS C#1.0362;CARBOHYDRATE RECOGNITION DOMAIN#1.0323;DENDRITIC CELL#1.0211;HUMAN IMMUNODEFICIENCY VIRUS#1.0199;CELL SURFACE#1.0046;T CELL#0.9571;SEVERE ACUTE RESPIRATORY SYNDROME#0.9250;MACROPHAGE#0.9069;PERIPHERAL BLOOD#0.8974;CELL ADHESION#0.8608;VIRAL INFECTION#0.8514;IMMUNE RESPONSE#0.8508;IMMUNE SYSTEM#0.8483;VIRION#0.8371;GLYCOSYLATION#0.8325;TUBERCULOSIS#0.7953;HOST CELL#0.7896;GLCNAC#0.7896;ENDOTHELIUM#0.7788;LIVER METASTASIS#0.7715;MICROVASCULAR ENDOTHELIAL CELL#0.7663;CARBOHYDRATE BINDING#0.7640;CD4+ T CELL#0.7357;PATHOGEN RECOGNITION RECEPTOR#0.7354;T LYMPHOCYTE#0.7313;ENDOCYTOSIS#0.7282;VIRAL ENVELOPE#0.7250;N GLYCAN#0.6898;COLON CANCER#0.6801;MANNOSE BINDING#0.6677;INNATE IMMUNE SYSTEM#0.6615;ANGIOTENSIN CONVERTING ENZYME#0.6580;VIRAL GLYCOPROTEIN#0.6549;MANNOSE RECEPTOR#0.6268;HUMAN DENDRITIC CELL#0.6148;SIMIAN IMMUNODEFICIENCY VIRUS#0.6052
10333	CELL SURFACE#1.0043;MONONUCLEAR CELLS#0.9962;CYTOKINE PRODUCTION#0.9949;MACROPHAGE#0.9931;TUMOR NECROSIS FACTOR#0.9901;BONE MARROW#0.9879;MONOCYTE#0.9874;PRO-INFLAMMATORY#0.9873;PEPTIDOGLYCAN#0.9867;TOLL LIKE RECEPTOR#0.9848;TUBERCULOSIS#0.9841;EPITHELIAL CELL#0.9822;SIGNALING PATHWAY#0.9801;T CELL#0.9797;PERIPHERAL BLOOD#0.9781;INFLAMMATORY RESPONSE#0.9774;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9753;GENE EXPRESSION#0.9745;PATTERN RECOGNITION RECEPTOR#0.9730;INNATE IMMUNE RESPONSE#0.9725;DENDRITIC CELL#0.9721;INNATE IMMUNE SYSTEM#0.9714;IMMUNE SYSTEM#0.9698;B CELL#0.9695;APOPTOSIS#0.9690;IMMUNE RESPONSE#0.9599;IMMUNE CELL#0.9590;INNATE IMMUNITY#0.9581;HUMAN EMBRYONIC KIDNEY#0.9579;EMBRYONIC KIDNEY#0.9574;NEUTROPHIL#0.9564;POLYMERASE CHAIN REACTION#0.9522;NF-KAPPAB ACTIVATION#0.9327;CELL WALL#0.9265;TLR2:TLR6 HETERODIMER#0.9215;GRANULOCYTE#0.9191;PROTEIN KINASE#0.9094;MITOGEN ACTIVATED PROTEIN#0.9057;CELL ACTIVATION#0.8991;TRANSCRIPTION FACTOR#0.8884;CYTOKINE SECRETION#0.8844;ALVEOLAR MACROPHAGE#0.8830;SIGNALING MOLECULE#0.8770;GROWTH FACTOR#0.8703;NITRIC OXIDE#0.8648;PHAGOCYTOSIS#0.8540;CANCER CELL#0.8485;ENDOTHELIAL CELL#0.8478;IFN-GAMMA#0.8439;KERATINOCYTE#0.8316;NUCLEOTIDE BINDING#0.7982;LEUCINE RICH REPEAT#0.7823;BREAST CANCER#0.7802;SIGNALING CASCADE#0.7791;CELL PROLIFERATION#0.7725;LYMPH NODE#0.7653;ADAPTIVE IMMUNE RESPONSE#0.7643;MALARIA#0.7636;LEUKOCYTE#0.7497;CELL DEATH#0.7437;LIPID RAFT#0.7437;QUANTITATIVE REAL TIME#0.7407;STEM CELL#0.7216;INTERLEUKIN 1 RECEPTOR#0.7178;TNF PRODUCTION#0.7138;SIGNALLING PATHWAY#0.7132;DNA METHYLATION#0.7061;MYELOID CELL#0.7037;HOST CELL#0.7028;PLASMA MEMBRANE#0.7027;REGULATORY T CELL#0.7024;LEUCINE#0.6940;COLITIS#0.6891;T LYMPHOCYTE#0.6852;RESPONSE TO PHENOL#0.6809;ACTIVATION OF NF-KAPPAB#0.6784;CORD BLOOD#0.6778;ANTIGEN PRESENTING CELLS#0.6773;SIGNAL TRANSDUCTION#0.6733;MAST CELL#0.6719;PALMITOYL#0.6710;COLORECTAL CANCER#0.6691;ATOPIC DERMATITIS#0.6636;MAP KINASE#0.6607;LYMPHOID TISSUE#0.6563;APOPTOTIC#0.6528;RECEPTOR COMPLEX#0.6509;COLONY-STIMULATING FACTOR#0.6454;TNF-ALPHA PRODUCTION#0.6350;GM-CSF#0.6299;B LYMPHOCYTE#0.6190;BOVINE TUBERCULOSIS#0.6159;ALLERGEN#0.6126;RESPIRATORY TRACT#0.6059;CONNECTIVE TISSUE#0.6025
103344718	TUMOR SUPPRESSOR#1.1829
103344929	BETA GLUCOSIDASE#0.8851;GLOBIN#0.6970
10335	SMOOTH MUSCLE#0.9988;PROTEIN KINASE#0.8451;PLATELET AGGREGATION#0.8408;NITRIC OXIDE#0.8239;SMOOTH MUSCLE CELL#0.7882;MUSCLE CELL#0.7874
1033	KINASE INHIBITOR PROTEIN#1.0776;KINASE INHIBITOR P27#1.0540;FLAVOPIRIDOL#1.0448;CYCLIN DEPENDENT KINASE INHIBITOR#1.0281;CYCLIN DEPENDENT KINASE#1.0262;KINASE INHIBITOR#1.0247;CDK INHIBITOR#1.0135;CHRONIC LYMPHOCYTIC LEUKEMIA#1.0007;OLOMOUCINE#0.9975;HISTONE DEACETYLASE#0.9952;LYMPHOCYTIC LEUKEMIA#0.9945;SENESCENCE#0.9932;HISTONE DEACETYLASE INHIBITOR#0.9881;CELL CYCLE CHECKPOINT#0.9879;OVARIAN CANCER#0.9862;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9849;MULTIPLE MYELOMA#0.9848;DNA REPLICATION#0.9837;OVARIAN#0.9820;PROSTATE CANCER#0.9820;TERMINAL DIFFERENTIATION#0.9817;CERVICAL CANCER#0.9808;CDK ACTIVITY#0.9800;TUMOR SUPPRESSOR#0.9797;CELLULAR SENESCENCE#0.9796;CELL CYCLE REGULATOR#0.9793;RETINOIC ACID#0.9789;CERVICAL#0.9783;QUIESCENCE#0.9773;PROTEASOME#0.9771;UBIQUITIN#0.9770;KERATINOCYTE#0.9764;RETINOBLASTOMA#0.9761;VASCULAR SMOOTH MUSCLE CELL#0.9757;COLORECTAL#0.9756;TRANSFORMING GROWTH FACTOR BETA#0.9755;T CELL#0.9755;GROWTH FACTOR RECEPTOR#0.9752;B CELL#0.9749;G1 PHASE#0.9742;EPIDERMAL GROWTH FACTOR#0.9742;DNA REPAIR#0.9734;COLORECTAL CANCER#0.9728;CELL DIVISION#0.9728;CELL CYCLE REGULATION#0.9724;BREAST CANCER CELL#0.9723;HEPATOCELLULAR CARCINOMA#0.9720;DEPHOSPHORYLATION#0.9720;MITOSIS#0.9717;CISPLATIN#0.9715;STEM CELL#0.9710;TRANSFORMING GROWTH FACTOR#0.9710;LUNG CANCER#0.9705;SMOOTH MUSCLE CELL#0.9702;SMOOTH MUSCLE#0.9700;S PHASE#0.9698;CELL CYCLE ARREST#0.9697;SQUAMOUS CELL CARCINOMA#0.9689;HUMAN BREAST CANCER#0.9683;ENDOTHELIAL CELL#0.9683;MYELOID LEUKEMIA#0.9681;BREAST CANCER#0.9678;DNA SYNTHESIS#0.9676;COLON CANCER#0.9674;INDUCTION OF APOPTOSIS#0.9671;CELL CYCLE#0.9666;MUSCLE CELL#0.9665;CELL CYCLE CONTROL#0.9660;CELL DIFFERENTIATION#0.9659;M PHASE#0.9657;MECHANISM OF ACTION#0.9650;PROGENITOR CELL#0.9646;B CELL LYMPHOMA#0.9645;CYTOTOXICITY#0.9638;ADENOCARCINOMA#0.9636;HYPOXIA#0.9633;REVERSE TRANSCRIPTION#0.9632;ESTROGEN RECEPTOR#0.9631;APOPTOTIC CELL DEATH#0.9621;PANCREATIC CANCER#0.9614;CELL MIGRATION#0.9613;BREAST CARCINOMA#0.9612;ONCOGENIC#0.9612;POLYMERASE CHAIN REACTION#0.9604;TUMOR CELLS#0.9601;APOPTOSIS#0.9601;PROTEIN KINASE C#0.9601;MITOGEN ACTIVATED PROTEIN#0.9600;KINASE ACTIVITY#0.9598;EPITHELIAL CELL#0.9591;INSULIN-LIKE GROWTH FACTOR#0.9583;MAP KINASE#0.9577;NERVOUS SYSTEM#0.9575;OVARIAN CARCINOMA#0.9574;G2 PHASE#0.9571;CANCER CELL#0.9566;PROTEIN KINASE#0.9566;CELL GROWTH#0.9563;SIGNALING PATHWAY#0.9559;CYTOPLASM#0.9558;DNA METHYLATION#0.9556;SIGNAL TRANSDUCTION#0.9555;MACROPHAGE#0.9553;GROWTH FACTOR#0.9551;BONE MARROW#0.9551;DNA BINDING#0.9549;CELL PROLIFERATION#0.9537;TOXICITY#0.9532;APOPTOTIC#0.9529;DRUG RESISTANCE#0.9524;GENE EXPRESSION#0.9524;POLY ADP RIBOSE#0.9522;TRANSCRIPTION FACTOR#0.9507;CELL DEATH#0.9476;LYMPH NODE#0.9475;TRANSACTIVATION#0.9441;CELL ADHESION#0.9424;PERIPHERAL BLOOD#0.9414;RAPAMYCIN#0.9410;MULTIPLE ENDOCRINE NEOPLASIA#0.9361;PROTEASOME PATHWAY#0.9348;LUNG ADENOCARCINOMA#0.9347;THYMIDINE#0.9324;DOXORUBICIN#0.9321;ANGIOGENESIS#0.9317;RIBOSE#0.9304;COLON CARCINOMA#0.9299;NEUTROPHIL APOPTOSIS#0.9293;DNA DAMAGE RESPONSE#0.9290;CYTOCHROME C#0.9288;VSMC PROLIFERATION#0.9283;MYOBLAST#0.9279;LUNG CARCINOMA#0.9275;SKELETAL MUSCLE#0.9267;DNA FRAGMENTATION#0.9252;MYELOID CELL#0.9233;CELLULAR GROWTH#0.9227;CENTRAL NERVOUS SYSTEM#0.9225;REACTIVE OXYGEN SPECIES#0.9212;TUMOR NECROSIS FACTOR#0.9187;PROTEIN PROTEIN INTERACTION#0.9171;NEUROBLASTOMA#0.9169;CASPASE INHIBITOR#0.9168;PROTEIN PHOSPHORYLATION#0.9165;SIGNAL TRANSDUCER#0.9155;BECKWITH-WIEDEMANN SYNDROME#0.9154;UBIQUITIN PROTEASOME PATHWAY#0.9149;PROGRAMMED CELL DEATH#0.9135;RNA INTERFERENCE#0.9127;ACUTE MYELOID LEUKEMIA#0.9121;PROTEIN SYNTHESIS#0.9056;MOUSE EMBRYONIC FIBROBLAST#0.9040;REPLICATIVE SENESCENCE#0.9037;FAMILIAL MELANOMA#0.8987;EXTRACELLULAR MATRIX#0.8975;MAMMARY EPITHELIAL CELL#0.8960;NITRIC OXIDE#0.8953;CELL DIVISION CYCLE#0.8943;TARGET OF RAPAMYCIN#0.8929;ISCHEMIA#0.8925;REGENERATION#0.8919;PACLITAXEL#0.8917;HEAT SHOCK PROTEIN#0.8912;CELL CYCLE TRANSITION#0.8888;UBIQUITIN LIGASE COMPLEX#0.8874;NEUTROPHIL#0.8858;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8854;INHIBITION OF CELL PROLIFERATION#0.8852;THYROID CANCER#0.8850;HEMATOPOIETIC CELL#0.8849;BETA GALACTOSIDASE#0.8839;CASPASE-3 ACTIVITY#0.8795;MAXIMUM TOLERATED DOSE#0.8761;TRANSCRIPTASE#0.8703;PLATELET-DERIVED GROWTH FACTOR#0.8680;MUSCLE CELL PROLIFERATION#0.8676;NEUROGENESIS#0.8667;CELL SURFACE#0.8638;HEAD AND NECK CANCER#0.8612;NECK CANCER#0.8612;REGULATION OF CELL CYCLE#0.8602;ESTRADIOL#0.8588;SMOOTH MUSCLE CELL PROLIFERATION#0.8573;BINDING PROTEIN 1#0.8572;AKT SIGNALING#0.8571;DISEASE FREE SURVIVAL#0.8544;HEMATOPOIETIC STEM CELL#0.8541;CHROMOSOMAL REGION#0.8512;ARTERY#0.8508;DUAL SPECIFICITY PHOSPHATASE#0.8486;MITOCHONDRIAL MEMBRANE#0.8476;CELL CYCLE PHASE#0.8472;PROGESTERONE#0.8460;GRANULOCYTE#0.8460;TYROSINE KINASE INHIBITOR#0.8457;ANAPHASE#0.8450;T LYMPHOCYTE#0.8450;PARATHYROID#0.8434;GENOTOXIC#0.8434;ORAL SQUAMOUS CELL CARCINOMA#0.8415;MITOCHONDRIA#0.8386;PRECURSOR CELL#0.8382;COLORECTAL CARCINOMA#0.8367;PROTEIN DEGRADATION#0.8366;BUDDING#0.8363;ANDROGEN RECEPTOR#0.8329;DOSE LIMITING TOXICITIES#0.8328;HUMAN IMMUNODEFICIENCY VIRUS#0.8322;PROSTATE CARCINOMA#0.8313;MELANOMA CELL LINES#0.8309;CASPASE ACTIVATION#0.8279;C TERMINAL DOMAIN#0.8270;GENE SILENCING#0.8260;TELOMERASE ACTIVITY#0.8257;QUANTITATIVE REAL TIME#0.8240;OOCYTE#0.8232;IMMUNE RESPONSE#0.8203;LYMPH NODE METASTASIS#0.8185;ASTROCYTE#0.8180;ANAPHASE PROMOTING COMPLEX#0.8162;ALZHEIMER'S DISEASE#0.8159;TUMOR TISSUES#0.8102;STROMAL CELL#0.8093;ATHEROSCLEROSIS#0.8088;DNA METHYLTRANSFERASE#0.8086;LIVER CANCER#0.8084;PURVALANOL#0.8054;MONOCYTE#0.8051;COLONY-STIMULATING FACTOR#0.8038;LYSINE#0.8033;LYSIS#0.8031;METHYLATION SPECIFIC PCR#0.8014;TETRACYCLINE#0.8004;SKIN CANCER#0.8002;DIFFUSE LARGE B-CELL LYMPHOMA#0.7997;ALL TRANS RETINOIC ACID#0.7991;MANTLE CELL LYMPHOMA#0.7972;RETINOIC ACID RECEPTOR#0.7943;HYPERPHOSPHORYLATION#0.7923;CELL QUIESCENCE#0.7917;TOPOISOMERASE#0.7917;DOUBLE STRAND BREAK#0.7882;FIBROBLAST GROWTH FACTOR#0.7880;ONCOGENESIS#0.7866;CARDIOMYOCYTE#0.7841;PROPIDIUM#0.7833;ARA-C#0.7831;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7817;DIARRHEA#0.7815;PURVALANOL A#0.7809;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7798;SIGNALLING PATHWAY#0.7781;INHIBITION OF CELL GROWTH#0.7780;DEXAMETHASONE#0.7780;METASTATIC MELANOMA#0.7775;APOPTOTIC PROCESS#0.7767;MONONUCLEAR CELLS#0.7763;PHOSPHATASE AND TENSIN HOMOLOG#0.7762;CYTOCHROME C RELEASE#0.7758;NEURAL STEM CELL#0.7757;PHOSPHATASE ACTIVITY#0.7757;THYROID CARCINOMA#0.7753;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.7750;PLASMA MEMBRANE#0.7740;MICROTUBULE#0.7732;TELOMERE#0.7725;TAMOXIFEN#0.7720;GENISTEIN#0.7666;NEUTROPENIA#0.7657;ENDOMETRIAL CARCINOMA#0.7655;MULTIPLE ENDOCRINE NEOPLASIA TYPE 1#0.7645;1α,25-DIHYDROXYVITAMIN D3#0.7620;UBIQUITIN PROTEASOME SYSTEM#0.7597;FACTOR I#0.7596;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7571;ENDOTHELIAL GROWTH FACTOR#0.7570;PROTEIN KINASE B#0.7556;2'-DEOXYURIDINE#0.7554;ACUTE LEUKEMIA#0.7536;HODGKIN'S LYMPHOMA#0.7529;CONTACT INHIBITION#0.7520;RENAL CELL CARCINOMA#0.7504;RECEPTOR TYROSINE KINASE#0.7496;PAPILLOMA#0.7457;VITAMIN D3#0.7453;PEROXISOME#0.7440;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7438;TUMOR LYSIS SYNDROME#0.7414;INDIRUBIN-3'-MONOXIME#0.7412;AUTOPHAGY#0.7407;EMBRYONIC STEM CELL#0.7405;ATP BINDING#0.7405;GALACTOSIDASE ACTIVITY#0.7381;INFLAMMATORY RESPONSE#0.7365;HOST CELL#0.7327;ADIPOCYTE#0.7321;RNA BINDING#0.7295;BREAST CANCER PATIENTS#0.7285;HYPOXIC#0.7281;PARATHYROID ADENOMA#0.7268;ENDOPLASMIC RETICULUM#0.7261;GLUTATHIONE#0.7253;MALIGNANT GLIOMA#0.7239;PROSTATE ADENOCARCINOMA#0.7229;HUMAN MAMMARY EPITHELIAL#0.7216;EPSTEIN BARR VIRUS#0.7199;CENTROSOME#0.7183;ESOPHAGEAL CANCER#0.7156;ADENOSINE#0.7148;CALCIUM CHANNEL#0.7120;NON-SMALL CELL LUNG CARCINOMA#0.7119;DEGRADATION OF CYCLIN#0.7081;MELANOCYTE#0.7078;FLUOROURACIL#0.7077;RNA BINDING PROTEIN#0.7076;GERM CELL#0.7059;RENAL ISCHEMIA REPERFUSION#0.7052;PROTEIN KINASE INHIBITOR#0.7004;NUCLEAR EXPORT#0.6995;CELL EXPANSION#0.6988;HERPES SIMPLEX#0.6986;T-CELL LEUKEMIA#0.6986;HEPATOCELLULAR CARCINOMA CELL#0.6984;NEPHROPATHY#0.6984;NF-KAPPAB ACTIVATION#0.6964;PLASMA CELL#0.6960;MECHANISMS OF ACTION#0.6954;MITOTIC CELL CYCLE#0.6953;ETOPOSIDE#0.6948;CYCLIN-DEPENDENT KINASE ACTIVITY#0.6925;SPINAL CORD#0.6917;HUMAN PAPILLOMA VIRUS#0.6892;CATALYTIC ACTIVITY#0.6883;5 FLUOROURACIL#0.6871;HUMAN PANCREATIC CANCER#0.6864;MYOTUBE#0.6820;HOMOLOGOUS RECOMBINATION#0.6816;EPITHELIAL MESENCHYMAL TRANSITION#0.6805;FORMALIN#0.6799;HERPES SIMPLEX VIRUS#0.6797;BETA-GALACTOSIDASE ACTIVITY#0.6797;IFN-GAMMA#0.6771;MYOGENESIS#0.6769;EPITHELIAL CELL PROLIFERATION#0.6759;MEIOSIS#0.6751;MULTIPLE MYELOMA CELLS#0.6748;ISCHEMIA REPERFUSION INJURY#0.6688;EPITHELIAL OVARIAN CANCER#0.6682;TYROSINE KINASE RECEPTOR#0.6681;SERTOLI CELL#0.6669;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6666;PRO-INFLAMMATORY#0.6653;NULL CELL#0.6643;COLONY FORMATION ASSAY#0.6633;ALTERNATIVE READING FRAME#0.6630;DOMINANT NEGATIVE MUTANT#0.6624;HYPERTENSION#0.6587;TUBULAR EPITHELIAL CELL#0.6567;CELL MOTILITY#0.6543;DNA DAMAGE CHECKPOINT#0.6542;ASTROCYTOMA#0.6525;CELL ADHESION MOLECULE#0.6513;CELL ACTIVATION#0.6504;ADIPOCYTE DIFFERENTIATION#0.6495;OLIGODENDROCYTE#0.6485;P53 BINDING#0.6481;CELL CYCLE DYSREGULATION#0.6461;RNA SYNTHESIS#0.6460;5-AZA-2'-DEOXYCYTIDINE#0.6451;2'-DEOXYCYTIDINE#0.6447;ANCHORAGE INDEPENDENT GROWTH#0.6439;METASTATIC BREAST CANCER#0.6429;ENDOMETRIAL CANCER#0.6427;ACTINOMYCIN D#0.6422;T CELL PROLIFERATION#0.6414;MAMMARY GLAND#0.6405;VASCULAR ENDOTHELIAL CELL#0.6403;GM-CSF#0.6398;BONE MORPHOGENETIC PROTEIN#0.6395;NITRIC OXIDE SYNTHASE#0.6368;LEUKOCYTE#0.6367;CERVIX#0.6306;26S PROTEASOME#0.6296;PROTEIN BINDING#0.6296;INHIBITION OF APOPTOSIS#0.6283;MESENCHYMAL STEM CELL#0.6275;NUCLEAR IMPORT#0.6251;HEPATOMA CELLS#0.6247;DOXYCYCLINE#0.6213;RHEUMATOID ARTHRITIS#0.6201;CD8+ T CELL#0.6154;GENE EXPRESSION OMNIBUS#0.6135;PROTEIN TYROSINE PHOSPHATASE#0.6126;CDC2 KINASE ACTIVITY#0.6116;7-HYDROXYSTAUROSPORINE#0.6106;ROS GENERATION#0.6095;BLOOD VESSEL#0.6088;INTRINSICALLY DISORDERED PROTEIN#0.6086;FOCAL ADHESION#0.6083;SIGNALING MOLECULE#0.6073;B LYMPHOCYTE#0.6073;ALVOCIDIB#0.6071;EXIT FROM MITOSIS#0.6062;IMATINIB#0.6057;CORONARY ARTERY#0.6052;ADIPOSE TISSUE#0.6052;MITOTIC EXIT#0.6018;MITOCHONDRIAL DAMAGE#0.6016;SMC PROLIFERATION#0.6007
10342	ENDOPLASMIC RETICULUM#1.0244;NEUROPATHY#1.0059;TROPOMYOSIN RECEPTOR KINASE#0.9682;ONCOGENIC#0.8876;EXTRASKELETAL MYXOID CHONDROSARCOMA#0.8530;MYXOID CHONDROSARCOMA#0.8512;PROTEIN SECRETION#0.8345;HEREDITARY SPASTIC PARAPLEGIA#0.8056;ANAPLASTIC LARGE CELL LYMPHOMA#0.7892;PARAPLEGIA#0.7860;CHONDROSARCOMA#0.7789;ENDOPLASMIC RETICULUM EXIT SITE#0.7559;CHARCOT MARIE TOOTH#0.7205;ER EXIT#0.7137;THYROID CARCINOMA#0.7133;ERGIC#0.7122;POLYMERASE CHAIN REACTION#0.7118;ER EXIT SITE#0.6949;DNA BINDING#0.6421;TRANSCRIPTION FACTOR#0.6389;CHARCOT-MARIE-TOOTH DISEASE#0.6373;TOOTH DISEASE#0.6372;TRANSITIONAL ER#0.6365;ONCOGENESIS#0.6341;MOTOR NEURON DEGENERATION#0.6314;TYROSINE KINASE DOMAIN#0.6160;UBIQUITIN#0.6057;CANCER CELL#0.6015
10343	POLYCYSTIN#0.7303;SPERM COMPETITION#0.6946;ACROSOME REACTION#0.6309;POLYCYSTIC KIDNEY DISEASE#0.6276;KIDNEY DISEASE#0.6197
10344	IFN-GAMMA#1.0461;DERMAL FIBROBLAST#1.0409;BRONCHIAL EPITHELIAL CELLS#1.0336;CC CHEMOKINE RECEPTOR#1.0303;AIRWAY EPITHELIAL CELL#1.0229;MAST CELL#1.0218;ALVEOLAR EPITHELIAL CELL#1.0207;MONOCYTE#1.0167;EPITHELIAL CELL#1.0164;CHEMOKINE RECEPTOR#1.0153;TUMOR NECROSIS FACTOR#1.0149;MACROPHAGE#1.0097;POLYMERASE CHAIN REACTION#1.0096;EOSINOPHIL#1.0087;GROWTH FACTOR#1.0050;CHEMOTAXIS#0.9973;EOSINOPHILIC ESOPHAGITIS#0.9957;GENE EXPRESSION#0.9942;ENDOTHELIAL CELL#0.9897;ESOPHAGITIS#0.9890;TRANSFORMING GROWTH FACTOR#0.9853;T CELL#0.9817;ATOPIC DERMATITIS#0.9752;PROTON PUMP INHIBITOR#0.9729;PROTON PUMP#0.9727;SIGNAL TRANSDUCER#0.9720;MACROPHAGE INFLAMMATORY PROTEIN#0.9664;ALLERGEN#0.9639;PRO-INFLAMMATORY#0.9629;IMMUNE RESPONSE#0.9545;KERATINOCYTE#0.9534;DERMATITIS#0.9530;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9468;CANCER CELL#0.9378;MONOCYTE CHEMOTACTIC PROTEIN#0.9327;PERIPHERAL BLOOD#0.9228;INFLAMMATORY RESPONSE#0.9133;LEUKOCYTE#0.9021;ALLERGIC ASTHMA#0.9010;BASOPHIL#0.8899;LUNG EPITHELIAL CELL#0.8811;OMEPRAZOLE#0.8638;CC CHEMOKINE LIGAND#0.8538;ALLERGIC RHINITIS#0.8528;SIGNALING PATHWAY#0.8517;PROTEIN SECRETION#0.8460;DENDRITIC CELL#0.8399;GASTROESOPHAGEAL REFLUX DISEASE#0.8391;CHURG STRAUSS SYNDROME#0.8270;TOPICAL#0.8138;ESOPHAGEAL EPITHELIAL CELLS#0.8133;ESOPHAGUS#0.8112;CELL SURFACE#0.7987;HUMAN BRONCHIAL EPITHELIAL#0.7877;SELECTIN#0.7848;RHEUMATOID ARTHRITIS#0.7839;REVERSE TRANSCRIPTION#0.7823;APOPTOSIS#0.7682;RHINITIS#0.7675;NEUTROPHIL#0.7627;SMOOTH MUSCLE#0.7608;EOSINOPHIL MIGRATION#0.7438;SKIN DISEASE#0.7328;TH2 CELL#0.7326;HIGH POWER FIELD#0.7288;SPUTUM#0.7265;TSC1 TSC2 COMPLEX#0.7162;ANGIOGENESIS#0.7057;INFLAMMATORY CELL#0.7041;INTERLEUKIN 4 RECEPTOR#0.6957;COLITIS#0.6912;TUMOUR NECROSIS FACTOR#0.6902;TRANSFORMING GROWTH FACTOR BETA#0.6889;HUMAN DERMAL FIBROBLAST#0.6850;ULCERATIVE COLITIS#0.6842;TRANSCRIPTION FACTOR#0.6832;NEUROTOXIN#0.6768;TARGET OF RAPAMYCIN#0.6749;TRANSCRIPTASE#0.6707;CELL CYCLE#0.6634;AIRWAY EPITHELIUM#0.6583;EOSINOPHIL CHEMOTAXIS#0.6518;VASCULAR ENDOTHELIAL CELL#0.6513;MUSCLE CELL#0.6480;COLONY-STIMULATING FACTOR#0.6480;QUANTITATIVE REAL TIME#0.6480;LUNG FIBROBLASTS#0.6371;CD8+ T CELL#0.6298;ALLERGIC REACTION#0.6264;GM-CSF#0.6209;GRANULOCYTE#0.6205;HEPATOCELLULAR CARCINOMA#0.6189;EXTRACELLULAR MATRIX#0.6179;T LYMPHOCYTE#0.6142;GRANULOMATOSIS WITH POLYANGIITIS#0.6070
10345	LUMINAL#1.0462;RYANODINE RECEPTOR#1.0285;MYOTUBE#1.0257;SKELETAL MUSCLE#1.0128;T TUBULE#1.0120;SARCOPLASMIC RETICULUM#1.0055;CARDIAC MUSCLE#1.0043;MUSCLE CELL#0.9982;ARRHYTHMIA#0.9937;SARCOPLASMIC RETICULUM MEMBRANE#0.9753;HISTIDINE#0.9733;MYOCYTES#0.9401;CARDIOMYOCYTE#0.9161;POLYMORPHIC VENTRICULAR TACHYCARDIA#0.9103;PROTEIN KINASE#0.9059;CAFFEINE#0.9053;MUSCLE FIBER#0.9037;STRIATED MUSCLE#0.8901;TACHYCARDIA#0.8823;CALCIUM RELEASE CHANNEL#0.8656;CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA#0.8379;ENDOPLASMIC RETICULUM#0.8322;PROTEIN PROTEIN INTERACTION#0.8125;ANCHORING#0.7891;CHANNEL ACTIVITY#0.7745;SKELETAL MUSCLE CELLS#0.7644;CARDIAC ARREST#0.7642;MUSCLE CONTRACTION#0.7387;CALCIUM CHANNEL#0.7354;TRIAD JUNCTION#0.7013;RYANODINE RECEPTOR COMPLEX#0.6955;GLUTATHIONE#0.6606;COMPLEX I#0.6562;MYOCARDIUM#0.6466;MYOBLAST#0.6406;RECEPTOR COMPLEX#0.6356;PROTEIN COMPLEX#0.6338;TRANSVERSE TUBULE#0.6245;RECEPTOR ACTIVITY#0.6173;SUDDEN CARDIAC DEATH#0.6118;GLYCOSYLATION#0.6026
10346	T CELL#1.0084;HEPATITIS B#0.9370;HEPATITIS C#0.9360;SIGNALING PATHWAY#0.9354;UBIQUITIN#0.9283;HUMAN IMMUNODEFICIENCY VIRUS#0.9042;UBIQUITIN LIGASE ACTIVITY#0.8843;LIGASE ACTIVITY#0.8787;MONONUCLEAR CELLS#0.8727;GENE EXPRESSION#0.8577;CELL CYCLE#0.8381;PERIPHERAL BLOOD#0.8272;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8161;CHRONIC HEPATITIS C#0.8130;VIRAL REPLICATION#0.8079;LUNG CANCER#0.8041;MACROPHAGE#0.7903;HEPATITIS B VIRUS#0.7791;HEPATITIS C VIRUS#0.7659;IMMUNE RESPONSE#0.7548;INNATE IMMUNE RESPONSE#0.6915;T LYMPHOCYTE#0.6900;CANCER CELL#0.6408;TUMOR NECROSIS FACTOR#0.6374;CD4+ T CELL#0.6338;CELL PROLIFERATION#0.6307;TRANSCRIPTION FACTOR#0.6305;NUCLEAR LOCALIZATION SIGNAL#0.6193
10347	ATP BINDING CASSETTE TRANSPORTER#1.0403;ATP BINDING CASSETTE#1.0317;ATP BINDING#1.0304;ABC TRANSPORTER#1.0289;MACROPHAGE#1.0238;CHOLESTEROL EFFLUX#1.0192;ALZHEIMER'S DISEASE#1.0041;HIGH DENSITY LIPOPROTEIN#0.9658;PHAGOCYTOSIS#0.9521;GENE EXPRESSION#0.8785;DEMENTIA#0.8657;LIPID METABOLISM#0.8555;NEURODEGENERATIVE DISEASE#0.8512;AMYLOID PRECURSOR PROTEIN#0.7901;CELL SURFACE#0.7506;CHOLESTEROL HOMEOSTASIS#0.7226;LIPID TRANSPORT#0.7173;PREMATURE TERMINATION CODON#0.7111;BONE MARROW#0.6783;TRANSCRIPTION FACTOR#0.6524;PHOSPHOLIPID EFFLUX#0.6515;DNA METHYLATION#0.6388;MINOR ALLELE FREQUENCY#0.6381;LIPID HOMEOSTASIS#0.6357;MINI MENTAL STATE#0.6348;IMMUNE RESPONSE#0.6324;LOW DENSITY LIPOPROTEIN#0.6244;MINOR HISTOCOMPATIBILITY ANTIGEN#0.6232;COMPLEMENT RECEPTOR#0.6219;ENDOCYTOSIS#0.6208;ADENOSINE TRIPHOSPHATE#0.6181;MAMMARY GLAND#0.6155;PERIPHERAL BLOOD#0.6082;WHITE ADIPOSE TISSUE#0.6046;AGE AT ONSET#0.6020
10349	ABC TRANSPORTER#0.7845
10350	ABC TRANSPORTER#0.8059;ATP BINDING CASSETTE#0.8047;ATP BINDING#0.8032;GENE EXPRESSION#0.7913;MONOCYTE DIFFERENTIATION#0.6288
10351	ATP BINDING#1.0586;ATP BINDING CASSETTE#1.0345;ABC TRANSPORTER#0.9847;ATP BINDING CASSETTE TRANSPORTER#0.8210;GENE EXPRESSION#0.7793;CHOROID PLEXUS#0.6491;CHOLESTEROL EFFLUX#0.6486;OVARIAN CANCER#0.6454;OLIGODENDROCYTE#0.6081;ALDEHYDE REDUCTASE#0.6070
10352	INTELLECTUAL DISABILITY#0.7469;LACTIC ACIDOSIS#0.6551
10360	CHROMATIN REMODELING#0.6840;HISTONE CHAPERONE#0.6742;RRNA SYNTHESIS#0.6196
103611090	CANCER CELL#1.0629;APOPTOSIS#1.0367;CELL PROLIFERATION#1.0067;SIGNALING PATHWAY#0.9669;LUNG CANCER#0.9467;HEPATOCELLULAR CARCINOMA#0.9088;SQUAMOUS CELL CARCINOMA#0.9085;BREAST CANCER#0.9050;LYMPH NODE#0.8820;STEM CELL#0.8587;RELATED PROTEIN 1#0.8552;CISPLATIN#0.8505;CELL MIGRATION#0.7773;TUMOR TISSUES#0.7676;COLORECTAL CANCER#0.7635;TUMOR SUPPRESSOR#0.7626;OVARIAN CANCER#0.7522;GENE EXPRESSION#0.7414;ALZHEIMER'S DISEASE#0.7280;PERIODONTAL LIGAMENT STEM CELL#0.6439;POLYMERASE CHAIN REACTION#0.6413;QUANTITATIVE REVERSE TRANSCRIPTION#0.6306;LYMPH NODE METASTASIS#0.6280;PERIODONTAL LIGAMENT#0.6262;REVERSE TRANSCRIPTION#0.6246;ADJACENT NORMAL TISSUE#0.6244;INSULIN SECRETION#0.6171;MYOCARDIAL INFARCTION#0.6139;COLORECTAL#0.6038
103611155	GLYCOSIDE HYDROLASE FAMILY#0.9506
103611157	AUTOPHAGY#0.6918;HUMAN EMBRYONIC STEM#0.6628;EMBRYONIC STEM CELL#0.6540;STEM CELL#0.6439;VASCULAR ENDOTHELIAL CELL#0.6383;ENDOTHELIAL CELL#0.6324
10361	OOCYTE#1.0603;CHROMATIN REMODELING#0.8670;GENE EXPRESSION#0.6751;HISTONE CHAPERONE#0.6747;FERTILIZATION#0.6647
10362	HIGH MOBILITY GROUP#0.9551;DNA BINDING#0.9528;HISTONE DEACETYLASE#0.6529;PROSTATE CANCER#0.6490;KINESIN#0.6467;CELL DIVISION#0.6427
10363	TYPE 2 DIABETES#0.9115;TRANSCRIPTION FACTOR#0.6636;HIGH MOBILITY GROUP#0.6543
10365	SIMVASTATIN#1.0773;ENDOTHELIAL NITRIC OXIDE#1.0448;NITRIC OXIDE SYNTHASE#1.0423;CANCER CELL#1.0271;NITRIC OXIDE#1.0247;TRANSCRIPTION FACTOR#1.0216;PRO-INFLAMMATORY#1.0200;T CELL#1.0182;QUIESCENCE#1.0087;PROTEIN KINASE#1.0026;B CELL#1.0020;CELL ACTIVATION#1.0011;ENDOTHELIUM#1.0007;SIGNALING PATHWAY#1.0007;SMOOTH MUSCLE#1.0003;GROWTH FACTOR#1.0003;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9996;UMBILICAL VEIN#0.9981;CELL ADHESION#0.9979;ANGIOGENESIS#0.9975;MUSCLE CELL#0.9975;CELL PROLIFERATION#0.9970;MONOCYTE#0.9952;HUMAN UMBILICAL VEIN#0.9943;ENDOTHELIAL CELL#0.9937;APOPTOSIS#0.9932;MACROPHAGE#0.9903;STEM CELL#0.9893;BLOOD VESSEL#0.9882;TUMOR SUPPRESSOR#0.9833;GENE EXPRESSION#0.9819;NAIVE T CELL#0.9792;INFLAMMATORY RESPONSE#0.9785;ATHEROSCLEROSIS#0.9763;SMOOTH MUSCLE CELL#0.9754;CELL MIGRATION#0.9702;POLYMERASE CHAIN REACTION#0.9685;LUNG DEVELOPMENT#0.9685;CELL CYCLE#0.9681;CHEMOKINE RECEPTOR#0.9616;ATHEROSCLEROTIC#0.9608;ARTERY#0.9594;CD8+ T CELL#0.9581;TUMOR NECROSIS FACTOR#0.9556;EMBRYONIC STEM CELL#0.9550;VASCULAR ENDOTHELIUM#0.9510;BONE MARROW#0.9461;ENDOTHELIAL GROWTH FACTOR#0.9397;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9397;ADIPOCYTE DIFFERENTIATION#0.9364;CELL ADHESION MOLECULE#0.9325;SELECTIN#0.9306;ADIPOGENESIS#0.9306;ENHANCER BINDING PROTEIN#0.9214;ENHANCER BINDING#0.9209;PLURIPOTENT STEM CELL#0.9177;SPHINGOSINE 1 PHOSPHATE#0.9167;CELL DIFFERENTIATION#0.9149;ADIPOCYTE#0.9140;IMMUNE RESPONSE#0.9113;LYMPHOID ORGANS#0.9050;LUNG CANCER#0.8974;FLUID SHEAR STRESS#0.8972;LAMINAR SHEAR STRESS#0.8967;LOW DENSITY LIPOPROTEIN#0.8903;LYMPH NODE#0.8848;VASCULAR CELL#0.8769;DNA BINDING#0.8752;CELL GROWTH#0.8739;VASCULAR ENDOTHELIAL CELL#0.8696;THYMOCYTE#0.8655;PERIPHERAL BLOOD#0.8624;CD4+ T CELL#0.8606;INDUCED PLURIPOTENT STEM CELL#0.8573;EPITHELIAL CELL#0.8509;HEME OXYGENASE 1#0.8489;QUANTITATIVE REAL TIME#0.8424;MYELOID CELL#0.8423;FACTOR I#0.8340;MARGINAL ZONE LYMPHOMA#0.8310;ISCHEMIA#0.8305;T CELL ACTIVATION#0.8242;MEMORY T CELL#0.8203;OXYGENASE#0.8147;ONCOGENIC#0.8133;T LYMPHOCYTE#0.8127;HEPATOCELLULAR CARCINOMA#0.8118;SPLENIC MARGINAL ZONE LYMPHOMA#0.8096;LEUKOCYTE#0.8084;CELL QUIESCENCE#0.8062;ACTIVATED T CELL#0.8058;INTRACRANIAL ANEURYSM#0.8054;ELECTROPHORETIC MOBILITY SHIFT#0.8006;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7969;SPHINGOSINE#0.7962;ALZHEIMER'S DISEASE#0.7939;GLOBIN#0.7939;TRANSACTIVATION#0.7919;HISTONE DEACETYLASE#0.7871;MOUSE EMBRYONIC STEM#0.7840;SKELETAL MUSCLE#0.7835;ERYTHROID CELL#0.7770;MITOGEN ACTIVATED PROTEIN#0.7769;LUCIFERASE ACTIVITY#0.7751;THROMBOSIS#0.7721;HYPOXIA#0.7721;IMMUNE SYSTEM#0.7671;BASILAR ARTERY#0.7654;VASCULAR DISEASE#0.7647;AUTOPHAGY#0.7629;ACTIVATED T-CELLS#0.7593;MORPHOGENESIS#0.7512;ADIPOSE TISSUE#0.7472;CYCLIN DEPENDENT KINASE#0.7426;PREADIPOCYTE#0.7419;LYSINE#0.7350;PEROXISOME#0.7318;CELL SURFACE#0.7168;EXTRACELLULAR MATRIX#0.7116;REACTIVE OXYGEN SPECIES#0.7112;TUBE FORMATION#0.7088;RAPAMYCIN#0.7012;TRANSFORMING GROWTH FACTOR#0.7004;B CELL LYMPHOMA#0.6980;T CELL DIFFERENTIATION#0.6959;HYPERTENSION#0.6949;REVERSE TRANSCRIPTION#0.6947;LYSINE SPECIFIC DEMETHYLASE#0.6932;CELL DEATH#0.6754;CEREBRAL CAVERNOUS MALFORMATION#0.6679;CAROTID ARTERY#0.6630;PORTAL HYPERTENSION#0.6629;CELL DEVELOPMENT#0.6623;MYOCYTE ENHANCER FACTOR#0.6623;CYTOKINE PRODUCTION#0.6533;PROGENITOR CELL#0.6473;TYPE I PNEUMOCYTE#0.6392;CORONARY ARTERY#0.6289;DENDRITIC CELL#0.6221;EPIBLAST#0.6212;TOLL LIKE RECEPTOR#0.6181;COLORECTAL CANCER#0.6174;LYMPH NODE METASTASIS#0.6161;LEUKOCYTE ADHESION#0.6106;SMOOTH MUSCLE CELL MIGRATION#0.6086;MUSCLE CELL MIGRATION#0.6082;ACTIVATED CD8+ T CELL#0.6075;VASCULOGENESIS#0.6040;PANCREATIC CANCER#0.6039;STROMAL CELL#0.6021;CARDIOVASCULAR SYSTEM#0.6019;MYOCARDIAL INFARCTION#0.6013
10367	MITOCHONDRIAL CALCIUM UPTAKE#1.0991;MITOCHONDRIAL MEMBRANE#1.0036;MITOCHONDRIA#1.0003;CELL DEATH#0.9068;APOPTOSIS#0.8970;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8459;INNER MITOCHONDRIAL MEMBRANE#0.8068;CANCER CELL#0.8022;MITOCHONDRIAL MATRIX#0.7609;OXIDATIVE METABOLISM#0.7035;CELL CYCLE#0.7016;MUSCLE WEAKNESS#0.6965;CYTOCHROME C#0.6882;CRISTAE JUNCTION#0.6347;ORGANELLE#0.6244;SKELETAL MUSCLE#0.6190;NEUROLOGICAL DISORDER#0.6130;REACTIVE OXYGEN SPECIES#0.6091
103689915	OVARIAN CANCER#1.1862;OVARIAN#0.8479
10369	CALCIUM CHANNEL#1.0590;AMPA RECEPTOR#1.0373;POSTSYNAPTIC DENSITY#1.0138;PLASMA MEMBRANE#1.0125;GLUTAMATE RECEPTOR#0.9998;SYNAPTIC TRANSMISSION#0.9893;ABSENCE EPILEPSY#0.9656;EPILEPSY#0.9586;ION CHANNEL#0.9466;POSTSYNAPTIC MEMBRANE#0.9090;PROTEIN KINASE#0.8848;NMDA RECEPTOR#0.8789;OOCYTE#0.8781;CELL SURFACE#0.8779;BIPOLAR DISORDER#0.8495;EXCITATORY SYNAPSE#0.8387;CEREBELLAR ATAXIA#0.8344;NERVOUS SYSTEM#0.7928;CAMKII#0.7909;ENDOPLASMIC RETICULUM#0.7494;RECEPTOR ACTIVITY#0.7422;PDZ BINDING MOTIF#0.7305;SKELETAL MUSCLE#0.7299;DEPHOSPHORYLATION#0.7185;ANCHORING#0.7013;CENTRAL NERVOUS SYSTEM#0.6943;PROTEIN KINASE A#0.6853;AMPA RECEPTOR ACTIVITY#0.6582;PURKINJE CELL#0.6439;LONG TERM POTENTIATION#0.6428;IONOTROPIC GLUTAMATE RECEPTOR#0.6199;LIGAND BINDING DOMAIN#0.6126;GLUTAMATERGIC SYNAPSE#0.6085;RECEPTOR COMPLEX#0.6001
1036	CYSTEINE DIOXYGENASE#1.1032;DNA METHYLATION#1.0570;BREAST CANCER#0.9938;METHYLATION SPECIFIC PCR#0.9754;GENE EXPRESSION#0.9613;CANCER CELL#0.8919;COLORECTAL CANCER#0.8686;QUANTITATIVE METHYLATION SPECIFIC#0.8675;TUMOR SUPPRESSOR#0.8437;POLYMERASE CHAIN REACTION#0.7781;TUMOR TISSUES#0.7708;COLORECTAL#0.7360;PRIMARY BREAST CANCER#0.7029;TAURINE BIOSYNTHESIS#0.6835;DNA HYPERMETHYLATION#0.6387;TAURINE SYNTHESIS#0.6271;ENDOMETRIAL CANCER#0.6211;BONE MARROW#0.6088
10370	CONGENITAL HEART DISEASE#1.0606;STEM CELL#1.0564;CANCER CELL#1.0557;NEURAL TUBE#1.0472;HEART DISEASE#1.0428;BREAST CANCER#1.0386;HYPOXIA#1.0313;HYPOXIA INDUCIBLE FACTOR#1.0282;TRANSCRIPTION FACTOR#1.0277;GROWTH FACTOR#1.0231;TRANSACTIVATION#1.0174;EMBRYONIC STEM CELL#1.0161;CREB BINDING#1.0102;APOPTOSIS#1.0098;HEMATOPOIETIC STEM CELL#1.0048;GENE EXPRESSION#1.0009;CARDIAC DEVELOPMENT#0.9874;BREAST CANCER CELL#0.9767;FETAL LIVER#0.9631;CELL PROLIFERATION#0.9557;HYPOXIC#0.9473;GLUTAMIC ACID#0.9456;VENTRICULAR SEPTAL DEFECT#0.9321;CELL CYCLE#0.9300;ASPARTIC ACID#0.9179;QUIESCENCE#0.9028;CONGENITAL HEART DEFECTS#0.8702;NEURAL CREST#0.8533;TRANSFORMING GROWTH FACTOR#0.8445;CHONDROCYTE#0.8411;MOUSE EMBRYONIC STEM#0.8292;ENDOTHELIAL GROWTH FACTOR#0.8176;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8176;SIGNALING PATHWAY#0.8141;CARDIOMYOCYTE#0.8008;BONE MARROW#0.7920;HEART DEVELOPMENT#0.7892;PEROXISOME#0.7697;TROPHOBLAST#0.7635;ENDOTHELIAL CELL#0.7597;MACROPHAGE#0.7524;ADRENAL GLAND#0.7380;ANGIOGENESIS#0.7293;PROGENITOR CELL#0.7256;MELANOCYTE#0.7195;MYELOID LEUKEMIA#0.7144;CELL GROWTH#0.7112;HISTONE ACETYLTRANSFERASE#0.7042;TUMOR SUPPRESSOR#0.7016;EMBRYONIC HEART#0.6994;POLYMERASE CHAIN REACTION#0.6993;OUTFLOW TRACT#0.6959;GONAD#0.6925;IL-11#0.6903;ADRENAL CORTEX#0.6850;FOLIC ACID#0.6846;ACUTE MYELOID LEUKEMIA#0.6821;HUMAN BREAST CANCER#0.6821;HEMATOPOIESIS#0.6582;CELL MIGRATION#0.6534;MOUSE EMBRYONIC FIBROBLAST#0.6370;SEPTUM#0.6349;PROTEIN BINDING#0.6337;AKT SIGNALING#0.6333;PRO-INFLAMMATORY#0.6331;MORPHOGENESIS#0.6322;CISPLATIN#0.6312;NEURAL TUBE CLOSURE#0.6311;TUBE CLOSURE#0.6309;CYTOCHROME C#0.6307;TETRALOGY OF FALLOT#0.6111;CELL ADHESION#0.6095;TROPHOBLAST CELL#0.6050;SEX DETERMINATION#0.6048;INDUCED PLURIPOTENT STEM CELL#0.6017
10371	GROWTH CONE COLLAPSE#1.0525;RECEPTOR COMPLEX#1.0474;NERVE FIBER#1.0335;T CELL#1.0302;GROWTH CONE#1.0278;AXON GROWTH#1.0258;DORSAL ROOT GANGLION#1.0253;ACUTE KIDNEY INJURY#1.0245;APOPTOSIS#1.0235;OLFACTORY BULB#1.0226;TUMOR CELLS#1.0212;ALKALINE PHOSPHATASE#1.0212;PERIPHERAL NERVE#1.0199;NERVE GROWTH FACTOR#1.0192;BONE FORMATION#1.0190;OSTEOBLAST#1.0189;EPITHELIAL CELL#1.0176;POLYMERASE CHAIN REACTION#1.0175;NEURITE OUTGROWTH#1.0174;CELL PROLIFERATION#1.0165;PODOCYTE#1.0115;PROTEIN SYNTHESIS#1.0104;PROTEIN KINASE#1.0095;INNERVATION#1.0093;CHEMOREPULSION#1.0092;REGENERATION#1.0090;NEURITE#1.0089;IMMUNE RESPONSE#1.0086;ENDOTHELIAL CELL#1.0084;STEM CELL#1.0065;CELL SURFACE#1.0050;ENDOTHELIAL GROWTH FACTOR#1.0044;SPINAL CORD#1.0044;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0044;B CELL#1.0042;AXONAL TRANSPORT#1.0042;MUSCLE FIBER#1.0039;CANCER CELL#1.0033;SIGNALING PATHWAY#1.0025;AXON GUIDANCE#1.0003;MACROPHAGE#0.9996;CELL MIGRATION#0.9989;GROWTH FACTOR#0.9988;ANGIOGENESIS#0.9985;NEURAL CREST#0.9939;AXONAL GROWTH CONE#0.9934;BONE MARROW#0.9931;MESENCHYMAL STEM CELL#0.9923;KERATINOCYTE#0.9902;GENE EXPRESSION#0.9876;BLOOD VESSEL#0.9854;OSTEOBLAST DIFFERENTIATION#0.9853;MORPHOGENESIS#0.9823;CELL ADHESION#0.9818;REVERSE TRANSCRIPTION#0.9809;MULTIPLE SCLEROSIS#0.9785;CELL DEATH#0.9777;ISCHEMIA#0.9776;EXTRACELLULAR MATRIX#0.9770;NERVOUS SYSTEM#0.9732;FOCAL ADHESION#0.9732;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9723;LUPUS ERYTHEMATOSUS#0.9720;PURKINJE CELL#0.9700;ENDOCYTOSIS#0.9700;INTERNEURON#0.9692;TRANSCRIPTION FACTOR#0.9688;RETINAL GANGLION CELL#0.9670;NEURAL CREST CELL#0.9631;CENTRAL NERVOUS SYSTEM#0.9619;CELL ADHESION MOLECULE#0.9601;BONE RESORPTION#0.9576;QUANTITATIVE REAL TIME#0.9555;SIGNAL TRANSDUCTION#0.9554;NEURONAL MIGRATION#0.9486;MESENCHYME#0.9477;CEREBRAL CORTEX#0.9466;HEPATOCYTE GROWTH FACTOR#0.9406;KALLMANN SYNDROME#0.9395;OXYGEN GLUCOSE DEPRIVATION#0.9376;OSTEOCLAST#0.9374;TUMOR SUPPRESSOR#0.9346;MICROTUBULE#0.9333;GANGLION CELLS#0.9321;CHONDROCYTE#0.9321;OPTIC NERVE#0.9310;AUTOIMMUNE DISEASE#0.9295;BRANCHING MORPHOGENESIS#0.9271;BONE REMODELING#0.9269;GLYCOGEN SYNTHASE KINASE#0.9264;SYSTEM DEVELOPMENT#0.9259;CORNEAL EPITHELIAL CELL#0.9241;BONE REGENERATION#0.9239;BREAST CANCER#0.9210;FOCAL ADHESION KINASE#0.9175;HYPOXIA#0.9163;RHEUMATOID ARTHRITIS#0.9156;PROGENITOR CELL#0.9146;CARDIOMYOCYTE#0.9103;DENDRITIC CELL#0.9086;DENTAL PULP#0.9064;TRANSFORMING GROWTH FACTOR#0.9047;CYCLIN DEPENDENT KINASE#0.9033;ATOPIC DERMATITIS#0.9014;APICAL DENDRITE#0.9001;ACTIN CYTOSKELETON#0.8996;NERVOUS SYSTEM DEVELOPMENT#0.8991;OSTEOGENESIS#0.8934;SIGNALLING PATHWAY#0.8921;OLIGODENDROCYTE#0.8912;SCHWANN CELL#0.8904;PROTEOGLYCAN#0.8839;CELL BODY#0.8822;SEMAPHORIN RECEPTOR#0.8814;MYOCARDIAL INFARCTION#0.8781;CD4+ T CELL#0.8706;ARRHYTHMIA#0.8682;TRAUMATIC BRAIN INJURY#0.8679;ASTROCYTE#0.8679;SMOOTH MUSCLE#0.8675;SPINAL CORD INJURY#0.8647;SIGNALING CASCADE#0.8645;IMMUNE SYSTEM#0.8632;MIDDLE CEREBRAL ARTERY#0.8611;CEREBRAL ARTERY#0.8608;IMMUNE CELL#0.8592;GLOMERULAR FILTRATION BARRIER#0.8548;DERMATITIS#0.8523;ARTERY#0.8497;ADIPOSE-DERIVED STEM CELL#0.8468;CORNEAL EPITHELIUM#0.8438;MONOCYTE#0.8425;GLOMERULAR FILTRATION#0.8406;EPHRIN#0.8390;SIGNALING MOLECULE#0.8370;NEURITE EXTENSION#0.8357;SCIATIC NERVE#0.8339;PROSTATE CANCER#0.8280;MITOGEN ACTIVATED PROTEIN#0.8277;TUBE FORMATION#0.8233;DISTAL AXON#0.8223;RETROGRADE AXONAL TRANSPORT#0.8221;VASCULAR ENDOTHELIAL CELL#0.8208;NEURONAL CELLS#0.8183;OSTEOPOROSIS#0.8087;FIBROBLAST GROWTH FACTOR#0.8079;STRIATUM#0.8067;CEREBRAL ISCHEMIA#0.8064;TOLL LIKE RECEPTOR#0.8062;C FIBER#0.8061;AXON PATHFINDING#0.8054;PERIPHERAL NERVOUS SYSTEM#0.8048;PERINEURONAL NET#0.8035;GLIAL CELL#0.7970;WOUND HEALING#0.7954;INFLAMMATORY RESPONSE#0.7933;TREG CELL#0.7925;MYOBLAST#0.7917;LYMPHATIC VESSEL#0.7884;AXOPLASMIC TRANSPORT#0.7868;CEREBRAL ARTERY OCCLUSION#0.7862;PANCREATIC CANCER#0.7834;MUSCLE CELL#0.7815;DIABETES MELLITUS#0.7785;AXON COLLATERAL#0.7764;CLIMBING FIBER#0.7760;PLASMA MEMBRANE#0.7748;SYNAPSE ELIMINATION#0.7680;CHONDROITIN SULFATE PROTEOGLYCAN#0.7672;AMYOTROPHIC LATERAL SCLEROSIS#0.7594;LATERAL SCLEROSIS#0.7594;BONE DISEASE#0.7576;FACTOR I#0.7561;DENTATE GYRUS#0.7545;BASAL DENDRITE#0.7534;BONE CELLS#0.7503;HUMAN EPIDERMAL KERATINOCYTES#0.7490;RAPAMYCIN#0.7461;OSTEOCLAST DIFFERENTIATION#0.7447;MOLAR#0.7438;OSTEOCYTE#0.7426;NEUROGENESIS#0.7400;PRO-INFLAMMATORY#0.7397;AXON GROWTH CONE#0.7353;APOPTOTIC#0.7351;TYPE 2 DIABETES MELLITUS#0.7334;2 DIABETES MELLITUS#0.7334;MOTOR NEURON DISEASE#0.7307;TYPE 2 DIABETES#0.7295;OVARIAN#0.7223;BONE MINERAL DENSITY#0.7201;ACTIN FILAMENT#0.7197;NEURAL CELL#0.7192;RNA INTERFERENCE#0.7189;NEURAL TUBE#0.7150;PERIPHERAL BLOOD#0.7140;OVARIAN CANCER#0.7136;SOMITE#0.7113;SMOOTH MUSCLE CELL#0.7086;URETERIC BUD BRANCHING#0.7075;DIABETIC RETINOPATHY#0.7070;EXOSOME#0.7050;CELL CYCLE#0.6973;SKELETAL MUSCLE#0.6966;PERIPHERAL NERVE INJURY#0.6940;NEURAL PROGENITOR CELL#0.6922;CELL ACTIVATION#0.6917;KINASE INHIBITOR#0.6908;URETERIC BUD#0.6868;NEURITE GROWTH#0.6844;MYOCARDIUM#0.6841;MESENCHYMAL CELL#0.6761;PRECURSOR CELL#0.6751;ALLERGIC RHINITIS#0.6746;AMPA RECEPTOR#0.6739;KINASE ACTIVITY#0.6721;CELL DIFFERENTIATION#0.6717;COLLAGEN INDUCED ARTHRITIS#0.6717;ADIPOCYTE#0.6708;GUANYLATE CYCLASE#0.6703;GROWTH FACTOR RECEPTOR#0.6702;HINDBRAIN#0.6687;PROTEINURIA#0.6678;OXYGEN INDUCED RETINOPATHY#0.6665;BASAL CELL#0.6661;CELL GROWTH#0.6653;ALZHEIMER'S DISEASE#0.6545;LUNG CANCER#0.6543;TUMOR ASSOCIATED MACROPHAGE#0.6520;REPULSIVE GUIDANCE MOLECULE#0.6480;TIBIA#0.6479;CELL MOTILITY#0.6467;FILOPODIA FORMATION#0.6440;NEPHROPATHY#0.6438;BREAST CANCER CELL#0.6437;CERVICAL#0.6427;CHEMOTAXIS#0.6423;ALIZARIN RED S#0.6400;AXON EXTENSION#0.6376;SUDDEN CARDIAC DEATH#0.6345;DENDRITIC SPINE#0.6301;EOSINOPHIL#0.6272;AXON REGENERATION#0.6270;NEURAL CREST CELL MIGRATION#0.6265;HYPOGONADOTROPIC HYPOGONADISM#0.6260;OCULAR DOMINANCE PLASTICITY#0.6252;MICROTUBULE ASSOCIATED PROTEIN#0.6227;THYMOCYTE#0.6199;BONE REMODELLING#0.6147;AXON BRANCHING#0.6145;GALECTIN#0.6126;STROMAL CELL#0.6112;TOPICAL#0.6101;SENSITIZATION#0.6092;HISTAMINE#0.6083;HYPOXIC#0.6076;PERIODONTAL LIGAMENT#0.6064;KERATINOCYTE MIGRATION#0.6061;COLLAGEN TYPE I#0.6055;PHOSPHATE BUFFERED SALINE#0.6054;NERVE TERMINAL#0.6043;OLFACTORY EPITHELIUM#0.6038;MUSCLE SATELLITE CELL#0.6023;BRUGADA SYNDROME#0.6014
103752554	TUMOR TISSUES#0.7535;BREAST CANCER CELL#0.7487;BREAST CANCER#0.7435;CANCER CELL#0.7420
103752587	DOXORUBICIN#0.8545;ERYTHROID CELL#0.6463;SMOOTH MUSCLE CELL#0.6319;PROSTATE CANCER#0.6318;MUSCLE CELL#0.6308;SMOOTH MUSCLE#0.6291;BREAST CANCER#0.6273;TRANSCRIPTION FACTOR#0.6260;CANCER CELL#0.6257
103752588	AUTOPHAGY#0.8125;HOPS COMPLEX#0.7970;AUTOPHAGOSOME MATURATION#0.7873;LIPID METABOLISM#0.6084
103753528	LOCALISATION#0.6539
10376	MICROTUBULE#1.0141;GENE EXPRESSION#0.9607;NERVOUS SYSTEM#0.8461;HEAT SHOCK PROTEIN#0.7914;TUBULIN TYROSINE LIGASE#0.7813;POST-TRANSLATIONAL MODIFICATION#0.7660;EPITHELIAL CELL#0.7483;TRANSCRIPTION FACTOR#0.7446;CENTRAL NERVOUS SYSTEM#0.7092;GLYCERALDEHYDE-3-PHOSPHATE#0.7024;LUNG TRANSPLANT RECIPIENTS#0.7016;GROWTH FACTOR#0.6981;CYTOPLASM#0.6941;CELL CYCLE#0.6915;POSTTRANSLATIONAL MODIFICATION#0.6601;BETA-2#0.6558;CANCER CELL#0.6510;RIBOSOMAL PROTEIN#0.6349;IMMUNE RESPONSE#0.6330;TUBULIN BINDING#0.6160
10379	ISGF3 COMPLEX#1.0884;TRANSCRIPTION FACTOR COMPLEX#1.0786;INTERFERON STIMULATED GENE#1.0320;IFN REGULATORY FACTOR#1.0299;INTERFERON REGULATORY FACTOR#1.0254;IFN-BETA#1.0199;DNA BINDING#1.0174;IFN STIMULATED GENES#1.0060;IFN-GAMMA#1.0033;TRANSCRIPTION FACTOR#1.0026;SIGNAL TRANSDUCER#1.0011;ANTIVIRAL RESPONSE#1.0011;T CELL#0.9994;MACROPHAGE#0.9884;PROTEIN KINASE#0.9874;VIRAL INFECTION#0.9817;SIGNALING PATHWAY#0.9802;SIGNAL TRANSDUCTION#0.9789;CYTOPLASM#0.9784;INNATE IMMUNE RESPONSE#0.9764;GENE EXPRESSION#0.9741;IMMUNE RESPONSE#0.9738;RETINOIC ACID#0.9728;TRANSACTIVATION#0.9649;ELECTROPHORETIC MOBILITY SHIFT#0.9644;MONOCYTE#0.9627;APOPTOSIS#0.9624;CANCER CELL#0.9570;CELL SURFACE#0.9556;PROTEIN SYNTHESIS#0.9450;VIRAL REPLICATION#0.9379;INNATE IMMUNITY#0.9365;HEPATOMA CELLS#0.9204;CELL GROWTH#0.9174;HEPATITIS C#0.9101;IMMUNE SYSTEM#0.9052;INTERFERON RECEPTOR#0.9000;SIGNALING MOLECULE#0.8860;EPITHELIAL CELL#0.8804;PERIPHERAL BLOOD#0.8793;GROWTH FACTOR#0.8783;HEPATITIS C VIRUS#0.8758;TUMOR CELLS#0.8621;B CELL#0.8618;TUMOR NECROSIS FACTOR#0.8601;POLYMERASE CHAIN REACTION#0.8469;HEPATITIS B#0.8424;DAMAGED DNA BINDING#0.8300;TUMOR SUPPRESSOR#0.8258;NUCLEAR LOCALIZATION SIGNAL#0.8015;PROTEIN PROTEIN INTERACTION#0.7995;DENDRITIC CELL#0.7965;SIGNALING CASCADE#0.7874;INFLAMMATORY RESPONSE#0.7836;COMPLEX I#0.7806;SIGNALLING PATHWAY#0.7803;ACINAR CELL#0.7752;PROTEIN COMPLEX#0.7635;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7483;IMMUNE CELL#0.7470;CELL CYCLE#0.7442;CELL DEATH#0.7436;ENDOTHELIAL CELL#0.7436;TOLL LIKE RECEPTOR#0.7350;MONONUCLEAR CELLS#0.7340;CELL PROLIFERATION#0.7216;MYELOID LEUKEMIA#0.7049;HEPATITIS B VIRUS#0.7037;HOST CELL#0.7024;PROTEIN KINASE C#0.7013;GENISTEIN#0.6903;GLIAL CELL#0.6866;REVERSE TRANSCRIPTION#0.6838;CELL DIFFERENTIATION#0.6743;VESICULAR STOMATITIS VIRUS#0.6671;PROTEIN KINASE R#0.6628;JAK-STAT SIGNAL TRANSDUCTION#0.6601;PERIPHERAL BLOOD MONOCYTES#0.6597;NUCLEAR IMPORT#0.6550;BINDING PROTEIN 1#0.6493;HISTONE DEACETYLASE#0.6474;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6452;PRO-INFLAMMATORY#0.6443;BREAST CANCER#0.6423;LYMPHOCYTIC CHORIOMENINGITIS#0.6351;PROTEIN TYROSINE KINASE#0.6324;FACTOR I#0.6286;KINASE INHIBITOR#0.6272;NERVOUS SYSTEM#0.6256;MUSCLE CELL#0.6236;ENHANCER BINDING PROTEIN#0.6223;ENHANCER BINDING#0.6219;STOMATITIS#0.6149;HEPATOCELLULAR CARCINOMA#0.6128;PROTEASOME#0.6095
10380	PLASMA MEMBRANE#0.8353;PHOSPHOLIPASE C#0.7729;LITHIUM#0.6539
10381	NEUROFILAMENT#1.0379;ADVANCED GASTRIC CANCER#1.0343;OVARIAN CANCER#1.0341;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0300;BETA-2#1.0294;CONGENITAL FIBROSIS OF THE EXTRAOCULAR MUSCLES#1.0281;OVARIAN#1.0269;THYMIDYLATE SYNTHASE#1.0261;MICROTUBULE ASSOCIATED PROTEIN#1.0259;PACLITAXEL#1.0239;DOCETAXEL#1.0239;BREAST CANCER#1.0179;ADENOCARCINOMA#1.0173;COMPLEMENTATION GROUP 1#1.0160;CISPLATIN#1.0146;AXON GUIDANCE#1.0119;LUNG CANCER#1.0094;THYMIDYLATE#1.0086;DRUG RESISTANCE#1.0031;MICROTUBULE#1.0023;CANCER CELL#0.9989;POLYMERASE CHAIN REACTION#0.9986;NEURITE OUTGROWTH#0.9974;TUMOR CELLS#0.9927;CELL PROLIFERATION#0.9862;SQUAMOUS CELL CARCINOMA#0.9862;GENE EXPRESSION#0.9851;APOPTOSIS#0.9849;RETINOIC ACID#0.9847;NERVOUS SYSTEM#0.9847;REVERSE TRANSCRIPTION#0.9841;TRANSCRIPTION FACTOR#0.9833;COLORECTAL#0.9832;GROWTH FACTOR#0.9819;NEURITE#0.9795;ASTROCYTE#0.9767;PROGENITOR CELL#0.9761;VINORELBINE#0.9748;SKELETAL MUSCLE#0.9744;CENTRAL NERVOUS SYSTEM#0.9737;NEUROGENESIS#0.9672;SPINAL CORD#0.9660;STEM CELL#0.9654;SIGNALING PATHWAY#0.9645;NEURAL STEM CELL#0.9611;EPIDERMAL GROWTH FACTOR#0.9606;CELL CYCLE#0.9583;MICROTUBULE DYNAMICS#0.9578;NEURONAL CELLS#0.9564;GROWTH FACTOR RECEPTOR#0.9564;EPITHELIAL CELL#0.9542;REGENERATION#0.9493;CELL ADHESION#0.9480;TAXOL#0.9406;NEURAL CELL#0.9330;OLIGODENDROCYTE#0.9303;COLORECTAL CANCER#0.9257;HYPOXIA#0.9202;CELL DIFFERENTIATION#0.9115;PROTEIN KINASE#0.9109;NEURAL CREST#0.9107;EMBRYONIC STEM CELL#0.9087;CELL DEATH#0.9073;SEQUESTERING#0.9070;GLIAL CELL#0.9064;EMBRYONAL CARCINOMA#0.9036;NEURONAL MIGRATION#0.9024;MEDULLOBLASTOMA#0.9009;LYMPH NODE#0.8996;LUNG CARCINOMA#0.8984;SCHWANN CELL#0.8980;GEMCITABINE#0.8980;CELL MIGRATION#0.8885;TUBULIN BINDING#0.8808;GROWTH CONE#0.8793;BREAST CANCER PATIENTS#0.8749;MELANOCYTE#0.8729;BREAST CANCER CELL#0.8725;CELL ADHESION MOLECULE#0.8709;HEPATIC STELLATE CELL#0.8696;QUANTITATIVE REAL TIME#0.8635;NERVE FIBER#0.8573;NEUROBLASTOMA#0.8532;MESENCHYMAL STEM CELL#0.8484;OLFACTORY BULB#0.8448;POSTTRANSLATIONAL MODIFICATION#0.8377;NEUROBLAST#0.8336;PERIPHERAL NERVE#0.8287;TOPOISOMERASE II#0.8170;CALCIUM CHANNEL#0.8141;PRECURSOR CELL#0.8110;DISEASE FREE SURVIVAL#0.8101;GANGLION CELLS#0.8042;5 FLUOROURACIL#0.7996;BASEMENT MEMBRANE#0.7942;HAIR CELL#0.7916;NEURAL TUBE#0.7857;AKT SIGNALING#0.7849;PTOSIS#0.7837;KINESIN#0.7829;PLURIPOTENT STEM CELL#0.7693;DORSAL ROOT GANGLION#0.7673;RETINAL PIGMENT EPITHELIAL#0.7619;OPTIC NERVE#0.7601;BRAIN DEVELOPMENT#0.7594;TOXICITY#0.7583;BONE MARROW#0.7556;LYMPH NODE METASTASIS#0.7538;CELL GROWTH#0.7455;OPHTHALMOPLEGIA#0.7420;FLUOROURACIL#0.7414;TUMOR TISSUES#0.7407;CEREBRAL CORTEX#0.7354;MAGNETIC RESONANCE IMAGING#0.7244;PERIPHERAL NERVOUS SYSTEM#0.7216;PLASMA MEMBRANE#0.7216;PROSTATE CANCER#0.7215;CYTOPLASM#0.7204;BLOOD VESSEL#0.7084;ENDOTHELIAL CELL#0.7073;FORMALIN#0.6987;INNER EAR#0.6914;DOXORUBICIN#0.6885;PATUPILONE#0.6818;NEOPLASTIC TISSUES#0.6795;MEDIAN OVERALL SURVIVAL#0.6791;ACTIN BINDING#0.6790;STEM CELL MARKER#0.6789;TOPOISOMERASE#0.6743;WOUND HEALING#0.6738;DNA REPAIR#0.6736;NEUROLOGICAL DISORDER#0.6729;FIBROBLAST GROWTH FACTOR#0.6729;CAPECITABINE#0.6718;EXTRACELLULAR MATRIX#0.6715;PANCREATIC CANCER#0.6698;NEUROPATHY#0.6680;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6658;APOPTOTIC#0.6634;MITOTIC SPINDLE#0.6632;RESPONSE TO DOCETAXEL#0.6548;DESMOPLASTIC MEDULLOBLASTOMA#0.6482;CYTOTOXICITY#0.6474;ENDOTHELIAL GROWTH FACTOR#0.6436;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6436;MITOSIS#0.6337;NETRIN RECEPTOR#0.6319;NEUROBLASTIC TUMOR#0.6317;TUMOR SUPPRESSOR#0.6254;CARBOPLATIN#0.6254;B CELL#0.6228;NEURAL PROGENITOR CELL#0.6197;COLON CANCER#0.6162;SUBSTANCE P#0.6162;LAMININ RECEPTOR#0.6156;CAROTID BODY#0.6146;GLOMUS CELL#0.6133;RESPONSE TO PACLITAXEL#0.6118;THYMIC CARCINOMA#0.6111;PROTEASOME#0.6093;OOCYTE#0.6079;IMMATURE NEURON#0.6067;KALLMANN SYNDROME#0.6047;QUANTITATIVE REVERSE TRANSCRIPTION#0.6046;SCIATIC NERVE#0.6035;ADRENAL GLAND#0.6031;DENTATE GYRUS#0.6027;LUNG ADENOCARCINOMA#0.6021
10382	DYSTONIA#1.0723;BASAL GANGLIA#1.0598;BETA-2#1.0202;MICROTUBULE#1.0037;HYPOMYELINATING LEUKODYSTROPHY#0.9557;LEUKODYSTROPHY#0.8965;GENERALIZED DYSTONIA#0.8112;GENE EXPRESSION#0.7770;PARAPLEGIA#0.7338;MITOCHONDRIAL TRANSPORT#0.6362;MICROTUBULE ASSEMBLY#0.6177;HEREDITARY SPASTIC PARAPLEGIA#0.6174
10383	BETA2 ADRENOCEPTOR#1.1056;EOSINOPHIL#1.0484;BETA-2#1.0434;AXONEME#1.0304;SALBUTAMOL#1.0126;NEUTROPHIL#1.0049;MAST CELL#1.0003;MICROTUBULE#1.0001;FIBRIL#0.9775;GENE EXPRESSION#0.9392;CELL SURFACE#0.9376;MAST CELL DEGRANULATION#0.9355;SPERMATOGENESIS#0.9210;MITOTIC SPINDLE#0.8975;SALMETEROL#0.8738;EOSINOPHIL DEGRANULATION#0.8561;LEUKOCYTE#0.8519;CELL CYCLE#0.8419;GM-CSF#0.8277;MACROPHAGE#0.8095;SIGNALING PATHWAY#0.8020;CANCER CELL#0.7981;PROTEIN KINASE#0.7942;PLATELET ACTIVATING FACTOR#0.7772;BETA ADRENOCEPTOR#0.7762;SELECTIN#0.7716;NEUTROPHIL DEGRANULATION#0.7527;FENOTEROL#0.7488;TRYPTOPHAN#0.7438;GRANULOCYTE#0.7435;SIGNAL TRANSDUCTION#0.7429;AMYLOIDOSIS#0.7386;ADRENERGIC RECEPTOR#0.7330;PROPRANOLOL#0.7173;CELL ADHESION#0.7151;CYTOPLASMIC MICROTUBULE#0.7089;PLASMA MEMBRANE#0.7075;HEAT SHOCK PROTEIN#0.7070;MICROTUBULE ASSEMBLY#0.6894;TAXOL#0.6767;T LYMPHOCYTE#0.6732;NEUTROPHIL ACTIVATION#0.6718;GROWTH FACTOR#0.6697;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6521;COLONY-STIMULATING FACTOR#0.6509;GUANIDINE#0.6355;GERM CELL#0.6329;MITOSIS#0.6308;MICROTUBULE ASSOCIATED PROTEIN#0.6249;ISOPROTERENOL#0.6182;PROTEIN KINASE C#0.6170;ALBUTEROL#0.6122;CELL ACTIVATION#0.6054
10384	T CELL#0.9614
10385	T CELL#1.0684;T LYMPHOCYTE#0.6893
10388	SYNAPTONEMAL COMPLEX#1.0695;MEIOSIS#0.9379;AXIAL ELEMENT#0.8850;PROPHASE#0.7854;MEIOTIC CHROMOSOME#0.7718;SYNAPSIS#0.7574;LATERAL ELEMENT#0.7112;CHROMOSOMAL SYNAPSIS#0.6855;SPERMATOCYTES#0.6793;OOCYTE#0.6776;CENTROMERE#0.6636;BREAST CANCER#0.6211;METAPHASE#0.6016
10389	POLYCOMB REPRESSIVE COMPLEX 1#0.7929;POLYCOMB REPRESSIVE COMPLEX#0.7811;SPERMATOGENESIS#0.7789;GENE EXPRESSION#0.7679;SEX CHROMOSOME#0.7634;MEIOSIS#0.7583;HETEROCHROMATIN ORGANIZATION#0.6523;XY BODY#0.6459;DNA BINDING#0.6441;MALE MEIOSIS#0.6226
1038	ABC TRANSPORTER#1.0433;EFFLUX PUMP#1.0311;RHODAMINE 6G#1.0241;ATP BINDING CASSETTE#1.0138;CLINICAL DEMENTIA RATING#1.0127;ATP BINDING#1.0106;MILD COGNITIVE IMPAIRMENT#1.0083;DEMENTIA#1.0074;ANTIGEN BINDING#1.0055;ATP BINDING CASSETTE TRANSPORTER#1.0026;FLUCONAZOLE#1.0000;DRUG RESISTANCE#0.9980;TRANSCRIPTION FACTOR#0.9976;PROTEIN KINASE#0.9974;ERGOSTEROL#0.9962;GENE EXPRESSION#0.9953;POLYMERASE CHAIN REACTION#0.9929;REVERSE TRANSCRIPTION#0.9871;RELATED PROTEIN 1#0.9849;T CELL#0.9779;ALZHEIMER'S DISEASE#0.9663;B CELL#0.9563;ITRACONAZOLE#0.9510;ERGOSTEROL BIOSYNTHESIS#0.9481;CANDIDIASIS#0.9345;AMPHOTERICIN B#0.9291;CELL CYCLE#0.9089;PLASMA MEMBRANE#0.9043;MUTAGENESIS#0.9043;AMPHOTERICIN#0.8809;PUMP ACTIVITY#0.8717;MINI MENTAL STATE#0.8620;VIRULENCE#0.8613;KETOCONAZOLE#0.8345;VERY MILD DEMENTIA#0.8334;QUANTITATIVE REAL TIME#0.8317;MITOTIC ENTRY#0.8287;MITOSIS#0.8236;FLUPHENAZINE#0.8187;EPITHELIAL CELL#0.8090;CANCER CELL#0.8078;BIOFILM FORMATION#0.8075;DISEASE RESISTANCE#0.8070;ALANINE#0.7941;NUCLEOTIDE BINDING#0.7852;VORICONAZOLE#0.7827;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7686;LUPUS ERYTHEMATOSUS#0.7684;IMMUNE RESPONSE#0.7634;MAJOR FACILITATOR SUPERFAMILY#0.7554;PURKINJE CELL#0.7480;NUCLEOTIDE BINDING DOMAIN#0.7304;CELL WALL#0.7277;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7257;DEMENTIA RATING SCALE#0.7245;TERBINAFINE#0.6852;ASPARTIC ACID#0.6757;PERIPHERAL BLOOD#0.6610;OROPHARYNGEAL CANDIDIASIS#0.6606;MINIMUM INHIBITORY CONCENTRATION#0.6555;LANOSTEROL#0.6463;ASPARAGINE#0.6357;HUMAN IMMUNODEFICIENCY VIRUS#0.6343;AUTOIMMUNE DISEASE#0.6338;INTERNATIONAL WORKING GROUP#0.6265;HYPERACTIVE#0.6258;CELL GROWTH#0.6142;CALYCULIN A#0.6042;CELL ACTIVATION#0.6004
10390	CHOLINE#1.0532;ETHANOLAMINE#0.9257
103910	REGULATORY LIGHT CHAIN#1.0708;MYOSIN LIGHT-CHAIN KINASE#1.0401;MUSCLE CONTRACTION#1.0227;MYOSIN PHOSPHATASE#1.0203;SMOOTH MUSCLE CONTRACTION#1.0195;SMOOTH MUSCLE#1.0155;MUSCLE CELL#1.0130;SMOOTH MUSCLE CELL#1.0100;ATPASE ACTIVITY#1.0013;PROTEIN KINASE#0.9994;DEPHOSPHORYLATION#0.9762;PROTEIN KINASE C#0.9640;ARTERY#0.9321;SENSITIZATION#0.8694;PHOSPHATASE ACTIVITY#0.8393;SIGNALING PATHWAY#0.8307;KINASE INHIBITOR#0.8058;MYOSIN HEAVY CHAIN#0.7973;MYOSIN ATPASE ACTIVITY#0.7946;VASCULAR SMOOTH MUSCLE CELL#0.7702;KINASE ACTIVITY#0.7582;ACTOMYOSIN#0.7565;AIRWAY SMOOTH MUSCLE#0.7454;ACTIN FILAMENT#0.7239;CARBACHOL#0.7105;GENE EXPRESSION#0.6938;BLADDER SMOOTH MUSCLE#0.6606;BETA-ESCIN#0.6304;PHENYLEPHRINE#0.6268;TIGHT JUNCTION#0.6188;MESENTERIC ARTERY#0.6133;AORTIC SMOOTH MUSCLE CELLS#0.6132;ACTIN POLYMERIZATION#0.6055;PORTAL VEIN#0.6042
10391	ACTIN CYTOSKELETON#0.9644;FOOT PROCESS EFFACEMENT#0.7519;PODOCYTE#0.7392
10392	ADIPOCYTE#1.0457;RECEPTOR INTERACTING PROTEIN#1.0415;NUCLEOTIDE OLIGOMERIZATION DOMAIN#1.0372;NF-KAPPAB ACTIVATION#1.0326;INTESTINAL EPITHELIAL CELL#1.0299;ENDOTHELIAL CELL#1.0270;NEUTROPHIL#1.0238;POLYMERASE CHAIN REACTION#1.0205;PEPTIDOGLYCAN#1.0192;AUTOPHAGY#1.0183;GASTRIC EPITHELIAL CELLS#1.0158;T CELL#1.0122;PROTEIN KINASE#1.0115;DENDRITIC CELL#1.0094;EPITHELIAL CELL#1.0092;CELL WALL#1.0090;CYTOKINE PRODUCTION#1.0088;NUCLEOTIDE BINDING#1.0080;MONOCYTE#1.0066;LEUCINE RICH REPEAT#1.0040;MACROPHAGE#1.0039;MITOGEN ACTIVATED PROTEIN#1.0035;SIGNALLING PATHWAY#1.0030;COLITIS#1.0027;INFLAMMATORY BOWEL DISEASE#1.0026;TUMOR NECROSIS FACTOR#1.0012;GRAM NEGATIVE BACTERIAL#1.0008;SIGNALING PATHWAY#1.0000;PRO-INFLAMMATORY#0.9985;HOST CELL#0.9982;PATTERN RECOGNITION RECEPTOR#0.9967;LEUCINE#0.9963;INNATE IMMUNE RESPONSE#0.9957;TROPHOBLAST CELL#0.9952;TROPHOBLAST#0.9946;INNATE IMMUNITY#0.9941;APOPTOSIS#0.9907;INFLAMMATORY RESPONSE#0.9899;NUCLEOTIDE BINDING DOMAIN#0.9893;IMMUNE CELL#0.9888;GENE EXPRESSION#0.9876;TOLL LIKE RECEPTOR#0.9873;INNATE IMMUNE SYSTEM#0.9870;RNA INTERFERENCE#0.9863;TRANSCRIPTION FACTOR#0.9856;BONE MARROW#0.9820;IMMUNE RESPONSE#0.9816;PERIPHERAL BLOOD#0.9811;CROHN'S DISEASE#0.9802;IMMUNE SYSTEM#0.9796;ULCERATIVE COLITIS#0.9709;ALLERGIC RHINITIS#0.9626;MONONUCLEAR CELLS#0.9601;CELL ACTIVATION#0.9581;CYTOKINE SECRETION#0.9520;REVERSE TRANSCRIPTION#0.9511;CANCER CELL#0.9510;SIGNALING MOLECULE#0.9489;IFN-GAMMA#0.9453;SIGNAL TRANSDUCTION#0.9450;FRAGMENT LENGTH POLYMORPHISM#0.9443;GLUCOSE UPTAKE#0.9436;ADAPTIVE IMMUNE RESPONSE#0.9379;CASPASE ACTIVATION#0.9366;OUTER MEMBRANE#0.9273;QUANTITATIVE REAL TIME#0.9112;IL-8 SECRETION#0.9042;GASTRITIS#0.9022;MAMMARY GLAND#0.9008;CELL SURFACE#0.8957;CELL DEATH#0.8939;CHLAMYDIA#0.8932;PLASMA MEMBRANE#0.8905;DISEASE RESISTANCE#0.8904;AIRWAY EPITHELIAL CELL#0.8888;VIRULENCE#0.8862;SIGNALING CASCADE#0.8849;B CELL#0.8811;MYELOID CELL#0.8790;ACTIVATION OF NF-KAPPAB#0.8780;CELL PROLIFERATION#0.8694;RECEPTOR LIGAND#0.8584;PATHOGEN RECOGNITION RECEPTOR#0.8571;UBIQUITIN#0.8545;IL-8 PRODUCTION#0.8485;CARDIOMYOCYTE#0.8408;MAPK SIGNALING#0.8350;MAST CELL#0.8320;BREAST CANCER#0.8296;PATTERN RECOGNITION MOLECULES#0.8259;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8230;NOD2 SIGNALING PATHWAY#0.8156;RHINITIS#0.8142;APOPTOTIC#0.8114;HUMAN BETA DEFENSIN#0.8109;HOST CYTOSOL#0.8095;GROWTH FACTOR#0.8060;EARLY ENDOSOME#0.8008;LEUKOCYTE#0.8000;VIRAL INFECTION#0.7990;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7960;ENDOPLASMIC RETICULUM#0.7951;CHEMOKINE PRODUCTION#0.7903;PHAGOCYTOSIS#0.7893;MAPK ACTIVATION#0.7862;REACTIVE OXYGEN SPECIES#0.7822;RECEPTOR AGONIST#0.7804;ADIPOSE TISSUE#0.7745;HUMAN EMBRYONIC KIDNEY#0.7720;EMBRYONIC KIDNEY#0.7716;CYTOPLASM#0.7687;ISCHEMIA#0.7684;TUMOUR NECROSIS FACTOR#0.7672;ORAL EPITHELIAL CELLS#0.7619;BLAU SYNDROME#0.7616;ALLERGEN#0.7606;PANCREATITIS#0.7550;HUMAN DENDRITIC CELL#0.7492;BEHCET'S DISEASE#0.7453;ISCHEMIA REPERFUSION INJURY#0.7429;LYMPH NODE#0.7429;MONOCYTE DERIVED MACROPHAGE#0.7429;TUBULAR EPITHELIAL CELL#0.7418;ANTIGEN PRESENTING CELLS#0.7413;TYPE 2 DIABETES#0.7372;CIGARETTE SMOKE EXTRACT#0.7367;EOSINOPHIL#0.7299;INFLAMMATORY CELL#0.7244;STROMAL CELL#0.7230;LIPOLYSIS#0.7149;HEPATOCELLULAR CARCINOMA#0.7142;ATHEROSCLEROSIS#0.6978;NEUTROPHIL MIGRATION#0.6967;STRUCTURE ACTIVITY RELATIONSHIP#0.6961;ENDOSOME#0.6895;MAP KINASE#0.6869;PERIODONTITIS#0.6846;DAP I#0.6845;ALLERGIC ASTHMA#0.6837;HEART DISEASE#0.6835;NOD SIGNALING PATHWAY#0.6752;SIGNAL TRANSDUCER#0.6750;MESOTHELIAL CELL#0.6746;LUNG EPITHELIAL CELL#0.6726;CELL CYCLE#0.6724;BONE RESORPTION#0.6707;HEAT SHOCK PROTEIN#0.6692;SQUAMOUS CELL CARCINOMA#0.6668;SARCOIDOSIS#0.6617;IL-6 PRODUCTION#0.6570;T CELL ACTIVATION#0.6518;IFN-BETA#0.6511;TH17 CELL#0.6491;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6471;PROTEASOME#0.6453;ALVEOLAR MACROPHAGE#0.6286;MOLECULAR DYNAMICS SIMULATION#0.6247;NITRIC OXIDE#0.6245;METAPLASIA#0.6243;ISOPROTERENOL#0.6232;GASTRIC EPITHELIUM#0.6178;ABSENT IN MELANOMA#0.6156;IL-1 SECRETION#0.6147;CHAPERONE COMPLEX#0.6108;DEFENSE RESPONSE#0.6027
10393	ANAPHASE PROMOTING COMPLEX#1.0480;ANAPHASE#1.0258;CELL CYCLE#0.9693;UBIQUITIN#0.9386;CYCLOSOME#0.8963;MITOSIS#0.7634;BUDDING#0.6117
10394	EOSINOPHIL#0.8750
10395	FOCAL ADHESION KINASE#1.0643;CELL GROWTH#1.0625;BREAST CANCER#1.0608;FOCAL ADHESION#1.0586;LIVER CANCER#1.0540;TUMOR SUPPRESSOR#1.0495;HEPATOCELLULAR CARCINOMA#1.0488;CELL MIGRATION#1.0417;APOPTOSIS#1.0410;CANCER CELL#1.0373;GENE EXPRESSION#1.0321;CELL PROLIFERATION#1.0305;BREAST CANCER CELL#1.0250;CELL CYCLE#1.0155;PROSTATE CANCER#1.0111;COLON CANCER#1.0084;CELL MOTILITY#1.0062;SIGNALING PATHWAY#0.9872;GAP ACTIVITY#0.9691;GROWTH FACTOR#0.9680;POLYMERASE CHAIN REACTION#0.9633;ENDOTHELIAL CELL#0.9628;REVERSE TRANSCRIPTION#0.9581;ACTIN CYTOSKELETON#0.9489;PROTEIN KINASE#0.9469;HEPATOCELLULAR CARCINOMA CELL#0.9463;NON-SMALL CELL LUNG CARCINOMA#0.9426;LUNG CARCINOMA#0.9343;LUNG CANCER#0.9316;EPITHELIAL CELL#0.8937;PROSTATE CARCINOMA#0.8764;DNA METHYLATION#0.8763;HISTONE DEACETYLASE#0.8590;STRESS FIBER#0.8555;MULTIPLE MYELOMA#0.8543;5-AZA-2'-DEOXYCYTIDINE#0.8525;2'-DEOXYCYTIDINE#0.8520;SQUAMOUS CELL CARCINOMA#0.8491;ONCOGENIC#0.8465;DYNEIN LIGHT CHAIN#0.8386;OVARIAN#0.8065;COLORECTAL#0.7884;SUBEROYLANILIDE HYDROXAMIC ACID#0.7829;CONTACT INHIBITION#0.7800;ANGIOGENESIS#0.7702;METHYLATION SPECIFIC PCR#0.7577;COLORECTAL CANCER#0.7523;TRANSCRIPTION FACTOR#0.7501;LYMPH NODE#0.7475;CYTOPLASM#0.7419;PANCREATIC CANCER#0.7374;PHOSPHOTYROSINE BINDING#0.7340;INHIBITION OF CELL PROLIFERATION#0.7053;STERILE ALPHA MOTIF#0.7027;BREAST CARCINOMA#0.6987;ANCHORAGE INDEPENDENT GROWTH#0.6872;DYNEIN#0.6726;LYMPH NODE METASTASIS#0.6572;OVARIAN CANCER#0.6558;TUMOR CELLS#0.6535;METHYLATION SPECIFIC POLYMERASE#0.6490;SIGNALING MOLECULE#0.6335;HISTONE DEACETYLASE INHIBITOR#0.6187;G1 PHASE#0.6151;PLASMA MEMBRANE#0.6093;PEPTIDE BINDING#0.6073;ADHERENS JUNCTION#0.6067;CELL POLARITY#0.6060;PROTEIN DEGRADATION#0.6024
10396	SCRAMBLASE#1.0539;FLIPPASE#1.0416;ERYTHROCYTE#1.0236;PLASMA MEMBRANE#1.0174;PHOSPHATIDYLETHANOLAMINE#1.0069;PHOSPHATIDYLSERINE#1.0013;PHOSPHOLIPID SCRAMBLASE#0.9961;APOPTOSIS#0.9862;N-ETHYLMALEIMIDE#0.9827;RED BLOOD CELL#0.9796;MEMBRANE LEAFLET#0.9547;CELL MEMBRANE#0.9086;CELL SURFACE#0.8985;ATPASE ACTIVITY#0.8887;APOPTOTIC#0.8468;CHROMAFFIN GRANULE#0.7961;ADENOSINE#0.7912;EXTERNALIZATION OF PHOSPHATIDYLSERINE#0.7562;MACROPHAGE#0.7305;DNA DEPENDENT ATPASE#0.7025;ADENOSINE TRIPHOSPHATE#0.6851;IONOPHORE#0.6789;ENDOTHELIAL CELL#0.6772;OUTER MEMBRANE#0.6570;FLIPPASE ACTIVITY#0.6447;PHOSPHOLIPID TRANSLOCATION#0.6153
10397	CHARCOT-MARIE-TOOTH DISEASE TYPE 4D#1.1039;PANCREATIC CANCER#1.0625;COLON CANCER#1.0582;CELL DIFFERENTIATION#1.0514;CELL MIGRATION#1.0471;COLORECTAL CANCER#1.0437;HYPOXIA#1.0338;LUNG CANCER#1.0310;COLORECTAL#1.0309;HEPATOCELLULAR CARCINOMA#1.0306;EPITHELIAL MESENCHYMAL TRANSITION#1.0279;EPITHELIAL CELL#1.0277;TOOTH DISEASE#1.0276;CHARCOT-MARIE-TOOTH DISEASE#1.0276;LYMPH NODE#1.0269;TUMOR SUPPRESSOR#1.0250;BREAST CANCER CELL#1.0248;HYPOXIC#1.0237;PROSTATE CANCER#1.0206;NEUROPATHY#1.0203;TUMOR CELLS#1.0180;BREAST CANCER#1.0176;GROWTH FACTOR#1.0174;CELL GROWTH#1.0160;ANGIOGENESIS#1.0154;LYMPH NODE METASTASIS#1.0144;CHARCOT MARIE TOOTH#1.0133;CANCER CELL#1.0126;APOPTOSIS#1.0125;SIGNALING PATHWAY#1.0110;HYPOXIA INDUCIBLE FACTOR#1.0106;SCHWANN CELL#1.0091;PROTEIN KINASE#1.0070;CELL PROLIFERATION#1.0061;ADENOCARCINOMA#1.0030;ONCOGENIC#1.0022;TRANSCRIPTION FACTOR#0.9999;CELL CYCLE#0.9994;SQUAMOUS CELL CARCINOMA#0.9947;POLYMERASE CHAIN REACTION#0.9927;HUMAN BREAST CANCER#0.9887;CELL DEATH#0.9882;CYTOPLASM#0.9871;GENE EXPRESSION#0.9860;CELL CYCLE ARREST#0.9775;MAST CELL#0.9774;PERIPHERAL NERVE#0.9718;APOPTOTIC#0.9678;TROPHOBLAST#0.9585;DISEASE RESISTANCE#0.9579;NERVOUS SYSTEM#0.9571;EPIDERMAL GROWTH FACTOR#0.9524;RETINOIC ACID#0.9444;MACROPHAGE#0.9404;DISEASE FREE SURVIVAL#0.9294;ENDOTHELIAL CELL#0.9293;ENDOTHELIAL GROWTH FACTOR#0.9179;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9179;DNA METHYLATION#0.9163;RNA INTERFERENCE#0.9095;PLASMA MEMBRANE#0.9091;NEUROBLASTOMA#0.8998;CERVICAL#0.8979;GROWTH FACTOR RECEPTOR#0.8922;BINDING PROTEIN 1#0.8904;REVERSE TRANSCRIPTION#0.8899;CPT-11#0.8867;AUTOPHAGY#0.8865;ESOPHAGEAL CANCER#0.8839;DRUG RESISTANCE#0.8791;BREAST CANCER PATIENTS#0.8668;POLYNEUROPATHY#0.8591;T CELL#0.8543;ACTIVATING TRANSCRIPTION FACTOR#0.8529;CELL MEMBRANE#0.8489;LIPID DROPLET#0.8449;HISTONE DEACETYLASE#0.8344;PROTEIN KINASE C#0.8316;CENTRAL NERVOUS SYSTEM#0.8252;ER STRESS RESPONSE#0.8099;UBIQUITIN#0.8097;TRANSFORMING GROWTH FACTOR#0.8094;TUMOR TISSUES#0.8088;LIPID METABOLISM#0.8070;CENTROSOME#0.7981;HEAT SHOCK PROTEIN#0.7969;DOXORUBICIN#0.7963;STEM CELL#0.7759;ENDOPLASMIC RETICULUM#0.7759;CENTROSOME DUPLICATION#0.7741;CERVICAL ADENOCARCINOMA#0.7728;LUNG ADENOCARCINOMA#0.7722;OVARIAN#0.7693;MECHANISM OF ACTION#0.7673;GENE SILENCING#0.7624;PROTEASOME#0.7622;KINASE INHIBITOR#0.7594;PANCREATIC DUCTAL ADENOCARCINOMA#0.7585;CELL ADHESION#0.7575;STROMAL CELL#0.7542;PROSTATE CARCINOMA#0.7528;OLIGODENDROCYTE#0.7523;SYSTEMIC ACQUIRED RESISTANCE#0.7513;DEATH RECEPTOR#0.7468;HUMAN PANCREATIC CANCER#0.7466;KINASE ACTIVITY#0.7444;METASTASIS SUPPRESSOR GENES#0.7422;MYELINATION#0.7406;CERVICAL CANCER#0.7396;IMMUNE RESPONSE#0.7366;ANDROGEN RECEPTOR#0.7366;EARLY GROWTH RESPONSE#0.7313;DNA METHYLTRANSFERASE#0.7254;COLORECTAL CARCINOMA#0.7245;MICROTUBULE#0.7235;QUANTITATIVE REAL TIME#0.7186;CISPLATIN#0.7163;TARGET OF RAPAMYCIN#0.7137;RAPAMYCIN#0.7136;SALICYLIC ACID#0.7093;S PHASE#0.7017;IRINOTECAN#0.6957;RESPONSE TO HYPOXIA#0.6956;DEFENSE RESPONSE#0.6877;MYELIN SHEATH#0.6779;SIGNALING CASCADE#0.6767;REACTIVE OXYGEN SPECIES#0.6729;MAMMARY EPITHELIAL CELL#0.6720;MITOGEN ACTIVATED PROTEIN#0.6694;B CELL#0.6677;ISCHEMIA#0.6667;PERIPHERAL NERVOUS SYSTEM#0.6519;MIMOSINE#0.6518;AKT SIGNALING#0.6487;TRANSACTIVATION#0.6479;PROTEIN PROTEIN INTERACTION#0.6473;CYTOTOXICITY#0.6442;TUMOR NECROSIS FACTOR#0.6425;COLON CARCINOMA#0.6311;G1 PHASE#0.6284;RIBOSOMAL PROTEIN#0.6260;OVARIAN CANCER#0.6258;ENDOMETRIUM#0.6233;HEPATOCELLULAR CARCINOMA CELL#0.6231;BREAST CARCINOMA#0.6193;NEUTROPHIL#0.6170;SIGNALLING PATHWAY#0.6145;NORMAL PROSTATE EPITHELIAL#0.6131;BONE MARROW#0.6110;CELLULAR LOCALIZATION#0.6077;GLYCOGEN SYNTHASE KINASE#0.6068;METAL BINDING#0.6038;FLAVOPIRIDOL#0.6008
10398	REGULATORY LIGHT CHAIN#1.0256;MYOSIN PHOSPHATASE#1.0200;SMOOTH MUSCLE CONTRACTION#1.0126;MUSCLE CONTRACTION#1.0094;MYOSIN LIGHT-CHAIN KINASE#1.0061;DEPHOSPHORYLATION#1.0027;MUSCLE CELL#0.9990;SMOOTH MUSCLE#0.9982;SMOOTH MUSCLE CELL#0.9968;PROTEIN KINASE C#0.9966;ACTOMYOSIN#0.9892;PROTEIN KINASE#0.9876;ATPASE ACTIVITY#0.9844;ARTERY#0.9818;TRANSCRIPTION FACTOR#0.9552;KINASE INHIBITOR#0.9500;SKELETAL MUSCLE#0.9380;AIRWAY SMOOTH MUSCLE#0.9321;PHOSPHATASE ACTIVITY#0.9264;CANCER CELL#0.9233;VASCULAR SMOOTH MUSCLE CELL#0.9209;SIGNALING PATHWAY#0.9181;GENE EXPRESSION#0.9167;MYOSIN HEAVY CHAIN#0.9077;TOXICITY#0.9023;SENSITIZATION#0.8786;CELL MIGRATION#0.8683;PHENYLEPHRINE#0.8669;STRESS FIBER#0.8640;VASCULAR SMOOTH MUSCLE CONTRACTION#0.8547;KINASE ACTIVITY#0.8545;PHOSPHATASE INHIBITOR#0.8248;BREAST CANCER#0.8184;BREAST CANCER CELL#0.8099;COLON CANCER#0.8006;T CELL#0.7989;BETA-ESCIN#0.7791;ENDOTHELIAL CELL#0.7609;ACTIN FILAMENT#0.7547;NOREPINEPHRINE#0.7446;MUSCLE FIBER#0.7262;MESENTERIC ARTERY#0.6981;GROWTH FACTOR#0.6731;SUPEROXIDE DISMUTASE#0.6476;HYPOXIA#0.6444;VASOCONSTRICTION#0.6399;CARDIOMYOPATHY#0.6386;ARTERIOLE#0.6374;ZIPPER INTERACTING PROTEIN#0.6373;HYPERTROPHIC CARDIOMYOPATHY#0.6294;APOPTOSIS#0.6256;DIGESTION#0.6239;PROTEIN PHOSPHORYLATION#0.6215;CARBACHOL#0.6184;RECEPTOR AGONIST#0.6169;CATION BINDING#0.6164;MAP KINASE#0.6080;PROTEIN PHOSPHATASE 1#0.6078;SIGNAL TRANSDUCTION#0.6029;CONSTRICTION#0.6013
10399	AUTOPHAGY#1.0561;PKC BINDING#1.0546;ACTIVATED PROTEIN C#1.0511;ANCHORING#1.0489;CELL MIGRATION#1.0466;PKC ACTIVATION#1.0423;FOCAL ADHESION#1.0394;LYMPH NODE#1.0381;RIBOSOMAL PROTEIN#1.0377;BREAST CANCER#1.0319;RIBOSOMAL SUBUNIT#1.0319;RIBOSOME#1.0310;CELL CYCLE#1.0277;CYTOKINE PRODUCTION#1.0276;PLASMA MEMBRANE#1.0244;CELL PROLIFERATION#1.0232;SMOOTH MUSCLE#1.0231;CELL ADHESION#1.0212;EPITHELIAL CELL#1.0210;KINASE ACTIVITY#1.0210;MITOGEN ACTIVATED PROTEIN#1.0202;CELL GROWTH#1.0197;CANCER CELL#1.0193;PROTEIN KINASE C#1.0158;BREAST CANCER CELL#1.0154;SIGNALING PATHWAY#1.0136;HETEROTRIMERIC G-PROTEIN#1.0129;T CELL#1.0128;SQUAMOUS CELL CARCINOMA#1.0128;SIGNALING MOLECULE#1.0118;APOPTOSIS#1.0118;PROTEIN KINASE#1.0114;PKCEPSILON#1.0098;GROWTH FACTOR#1.0071;INSULIN-LIKE GROWTH FACTOR#1.0061;SIGNAL TRANSDUCTION#1.0059;LYMPH NODE METASTASIS#1.0038;PROTEIN SYNTHESIS#1.0022;UBIQUITIN#1.0017;SIGNALING CASCADE#0.9997;NUCLEOTIDE BINDING#0.9988;APOPTOTIC#0.9938;ONCOGENIC#0.9868;COLON CANCER#0.9862;HEPATOCELLULAR CARCINOMA#0.9858;PHOSPHODIESTERASE#0.9839;ISCHEMIA#0.9828;TRANSCRIPTION FACTOR#0.9822;GENE EXPRESSION#0.9820;ETHANOL#0.9703;RNA INTERFERENCE#0.9640;SMOOTH MUSCLE CELL#0.9603;MUSCLE CELL#0.9598;40S RIBOSOMAL SUBUNIT#0.9597;CYTOPLASM#0.9579;MACROPHAGE#0.9574;HYPOXIA#0.9553;CORTISOL#0.9461;PKCDELTA#0.9454;PROTEASOME#0.9445;POLYMERASE CHAIN REACTION#0.9435;CELL SURFACE#0.9406;TRANSLATION INITIATION#0.9339;SIGNALLING PATHWAY#0.9316;PKCALPHA#0.9296;LEUKOCYTE#0.9257;GUANINE#0.9251;PROSTATE CANCER#0.9216;CELL DEATH#0.9203;LUNG CANCER#0.9146;PROTEIN PROTEIN INTERACTION#0.9141;ISCHEMIA REPERFUSION INJURY#0.9123;PKC ACTIVITY#0.9064;PROTEIN TRANSLATION#0.9032;ALVEOLAR MACROPHAGE#0.9027;NERVOUS SYSTEM#0.9026;ADENOCARCINOMA#0.8974;MAPK CASCADE#0.8912;TUMOR CELLS#0.8890;EUKARYOTIC INITIATION FACTOR#0.8887;IMMUNE RESPONSE#0.8863;BREAST CARCINOMA#0.8845;ENDOTHELIAL CELL#0.8790;BETA-2#0.8775;SMALL RIBOSOMAL SUBUNIT#0.8762;PHOSPHOLIPASE C#0.8734;FACTOR I#0.8678;ANGIOGENESIS#0.8661;HYPOXIA INDUCIBLE FACTOR#0.8631;AKT SIGNALING#0.8617;ASPARTATE#0.8605;FARNESYL#0.8583;CELLULAR LOCALIZATION#0.8536;ORAL SQUAMOUS CELL CARCINOMA#0.8535;CELL MEMBRANE#0.8531;TRANSFORMING GROWTH FACTOR#0.8520;RIBOSOME BINDING#0.8490;ENDOPLASMIC RETICULUM#0.8382;EPITHELIAL MESENCHYMAL TRANSITION#0.8372;TRYPTOPHAN#0.8224;PROTEIN PHOSPHATASE 2A#0.8177;PHOSPHATASE 2A#0.8174;FOCAL ADHESION KINASE#0.8144;DEHYDROEPIANDROSTERONE#0.8136;CELL DIFFERENTIATION#0.8114;S PHASE#0.8107;NMDA RECEPTOR#0.8074;CELL CELL ADHESION#0.8070;DRUG RESISTANCE#0.8055;ANCHORAGE INDEPENDENT GROWTH#0.7976;PANCREATIC DUCTAL ADENOCARCINOMA#0.7968;CARDIOMYOCYTE#0.7934;REACTIVE OXYGEN SPECIES#0.7934;TUMOR SUPPRESSOR#0.7909;RNA BINDING#0.7824;TUMOUR NECROSIS FACTOR#0.7810;PROTEIN DEGRADATION#0.7800;CHANNEL ACTIVITY#0.7733;PROTEIN TYROSINE KINASE#0.7709;ANDROGEN RECEPTOR#0.7673;PROTEASOME DEGRADATION#0.7655;CAMP SIGNALING#0.7644;IMMUNE CELL#0.7615;ADENOSINE#0.7591;POLYSOME#0.7581;INFLUENZA A VIRUS#0.7514;GLUTATHIONE#0.7458;TUMOR NECROSIS FACTOR#0.7424;RETINOIC ACID#0.7409;CD4+ T CELL#0.7391;CELL MOTILITY#0.7386;REVERSE TRANSCRIPTION#0.7373;CENTRAL NERVOUS SYSTEM#0.7369;VIRULENCE#0.7339;INSULIN RECEPTOR#0.7250;CERVICAL CANCER#0.7245;MICROTUBULE#0.7190;BETA CELL#0.7180;CENTROSOME#0.7176;CELL ACTIVATION#0.7150;EXTRACELLULAR MATRIX#0.7069;DEPHOSPHORYLATION#0.7063;RNA BINDING PROTEIN#0.7049;80S RIBOSOME#0.7028;MELANOCYTE#0.6997;RECEPTOR COMPLEX#0.6984;STRESS GRANULE#0.6983;HYPOXIC#0.6956;RECEPTOR TYROSINE KINASE#0.6949;HEAT SHOCK PROTEIN#0.6937;GROWTH CONE#0.6931;TYROSINE KINASE 2#0.6872;MIRNA BIOGENESIS#0.6843;RECYCLING ENDOSOME#0.6842;MUTAGENESIS#0.6836;SPECTRIN#0.6833;PROTEIN KINASE A#0.6785;FRONTAL#0.6785;CALCINEURIN#0.6771;GABA A RECEPTOR#0.6740;GLYCOGEN SYNTHASE KINASE#0.6735;NEURONAL CELLS#0.6719;ADENYLATE CYCLASE#0.6715;GLUCOCORTICOID RECEPTOR#0.6714;INNATE IMMUNITY#0.6713;WOUND HEALING#0.6698;CEREBRAL ISCHEMIA#0.6670;REGENERATION#0.6661;TANDEM AFFINITY PURIFICATION#0.6638;CELL WALL#0.6605;ION CHANNEL#0.6592;GERMINATION#0.6522;TRANSACTIVATION#0.6500;VIRAL REPLICATION#0.6487;ACTIN CYTOSKELETON#0.6474;DOPAMINE#0.6459;CERVICAL#0.6443;ALZHEIMER'S DISEASE#0.6440;RAPAMYCIN#0.6310;CYTOKINESIS#0.6252;MONONUCLEAR CELLS#0.6224;VASCULAR SMOOTH MUSCLE CELL#0.6222;RIBOSOME ASSEMBLY#0.6221;GLIAL CELL#0.6218;ENDOSOME#0.6215;MEMBRANE FRACTION#0.6204;ASTRAL MICROTUBULE#0.6173;PKC SIGNAL TRANSDUCTION#0.6166;HEPATITIS C#0.6165;UBIQUITIN LIGASE COMPLEX#0.6153;KINASE INHIBITOR#0.6146;BRAIN CORTEX#0.6133;BUDDING#0.6131;ORAL SQUAMOUS CARCINOMA#0.6129;NEURITE#0.6104;ENDOCYTOSIS#0.6099;ALANINE#0.6078;AIRWAY EPITHELIAL CELL#0.6078;OVARIAN#0.6074;MEMORY IMPAIRMENT#0.6062;TH2 CELL#0.6051;GENE SILENCING#0.6028;OOCYTE#0.6017;PANCREATIC CANCER#0.6009;CYTOCHROME C#0.6009;RNA REPLICATION#0.6004;RESPONSE TO STRESS#0.6004
1039	ABC TRANSPORTER#1.0544;EFFLUX PUMP#1.0399;ANTIGEN BINDING#1.0248;ATP BINDING#1.0189;ATP BINDING CASSETTE#1.0168;CLINICAL DEMENTIA RATING#1.0098;DEMENTIA#1.0093;FLUCONAZOLE#1.0064;GENE EXPRESSION#0.9962;DRUG RESISTANCE#0.9915;TRANSCRIPTION FACTOR#0.9887;T CELL#0.9866;OVARIAN#0.9827;MITOTIC ENTRY#0.9668;B CELL#0.9611;OVARIAN CANCER#0.9569;MUTAGENESIS#0.9476;CELL CYCLE#0.9470;ALZHEIMER'S DISEASE#0.9401;IMMUNE RESPONSE#0.9390;MULTIPLE SCLEROSIS#0.9341;RHODAMINE 6G#0.9311;POLYMERASE CHAIN REACTION#0.9249;PROTEIN KINASE#0.8859;MITOSIS#0.8844;ATP BINDING CASSETTE TRANSPORTER#0.8742;REVERSE TRANSCRIPTION#0.8544;TUMOR CELLS#0.8497;ERGOSTEROL#0.8413;CANDIDIASIS#0.8383;MILD COGNITIVE IMPAIRMENT#0.8338;CELL GROWTH#0.8244;PLASMA MEMBRANE#0.8243;KINASE ACTIVITY#0.8230;ENCEPHALOMYELITIS#0.7935;DEMENTIA RATING SCALE#0.7728;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7657;REGULATORY T CELL#0.7571;ITRACONAZOLE#0.7565;CD8+ T CELL#0.7479;RENAL CELL CARCINOMA#0.7444;CELL TIP#0.7435;HUMAN IMMUNODEFICIENCY VIRUS#0.7373;CYTOKINESIS#0.7281;PURKINJE CELL#0.7256;MINI MENTAL STATE#0.7256;CELL SURFACE#0.7237;AMPHOTERICIN B#0.7135;TUMOR ANTIGEN#0.7101;PUMP ACTIVITY#0.7058;AUTOIMMUNE DISEASE#0.7026;PERIPHERAL BLOOD#0.6991;VORICONAZOLE#0.6980;DNA BINDING#0.6952;ARGININE#0.6869;MICAFUNGIN#0.6601;T LYMPHOCYTE#0.6584;GENE CONVERSION#0.6567;FLUPHENAZINE#0.6558;AMPHOTERICIN#0.6321;CELL DIVISION#0.6315;CELL POLARITY#0.6306;LYSINE#0.6301;CANCER CELL#0.6258;QUANTITATIVE REAL TIME#0.6237;BREAST CANCER#0.6232;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6163;PROLYL 4-HYDROXYLASE#0.6089;CYTOKINETIC RING#0.6027
103	DOUBLE-STRANDED RNA BINDING#1.0440;T CELL#1.0408;STEM CELL#1.0394;CELL DEATH#1.0379;MRNA EDITING#1.0351;DNA BINDING#1.0319;APOPTOSIS#1.0225;ADENOSINE DEAMINASE#1.0197;DEAMINASE ACTIVITY#1.0165;INTERFERON STIMULATED GENE#1.0162;CANCER CELL#1.0140;RNA EDITING#1.0135;RNA BINDING#1.0127;ADENOSINE#1.0127;PROTEIN KINASE#1.0120;IMMUNE RESPONSE#1.0112;VIRAL INFECTION#1.0104;DSRNA BINDING#1.0101;INNATE IMMUNE RESPONSE#1.0090;CELL PROLIFERATION#1.0054;RNA BINDING PROTEIN#1.0048;GLUTAMATE RECEPTOR#1.0044;POLYMERASE CHAIN REACTION#1.0010;INOSINE#0.9999;BREAST CANCER#0.9997;MACROPHAGE#0.9992;ADENOSINE TO INOSINE EDITING#0.9969;GENE EXPRESSION#0.9955;RNA INTERFERENCE#0.9833;CYTOPLASM#0.9789;NERVOUS SYSTEM#0.9768;INNATE IMMUNITY#0.9766;VIRAL REPLICATION#0.9755;NUCLEIC ACID#0.9682;GUANOSINE#0.9637;STRESS GRANULE#0.9543;CELL CYCLE#0.9464;MIRNA PROCESSING#0.9411;RNA MODIFICATION#0.9387;SIGNALING PATHWAY#0.9366;NALIDIXIC ACID#0.9294;PERIPHERAL BLOOD#0.9184;NUCLEAR LOCALIZATION SIGNAL#0.8990;MYELOID LEUKEMIA#0.8965;T LYMPHOCYTE#0.8937;PROTEIN SYNTHESIS#0.8931;BASE PAIRING#0.8928;ONCOGENIC#0.8839;TRANSCRIPTION FACTOR#0.8810;ION CHANNEL#0.8738;CENTRAL NERVOUS SYSTEM#0.8698;NUCLEAR EXPORT#0.8685;GENE SILENCING#0.8627;ANTIVIRAL RESPONSE#0.8561;AUTOIMMUNE DISEASE#0.8525;ALVEOLAR MACROPHAGE#0.8348;IMMUNE SYSTEM#0.8341;SQUAMOUS CELL CARCINOMA#0.8311;PROTEIN TRANSLATION#0.8278;MEASLES#0.8258;CYTIDINE DEAMINASE#0.8181;CYTIDINE#0.8046;DYSTONIA#0.8035;LEUKEMIA STEM CELL#0.8012;HEPATITIS B#0.7974;LUPUS ERYTHEMATOSUS#0.7959;LUNG ADENOCARCINOMA#0.7892;APOBEC#0.7891;CIPROFLOXACIN#0.7826;REVERSE TRANSCRIPTION#0.7815;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7787;HOST CELL#0.7781;HEPATOCELLULAR CARCINOMA#0.7780;NUCLEAR EXPORT SIGNAL#0.7667;APOPTOTIC#0.7652;INTERFERON PRODUCTION#0.7642;MUTAGENESIS#0.7598;CHRONIC MYELOID LEUKEMIA#0.7571;MOUSE EMBRYO FIBROBLASTS#0.7571;SALMONELLOSIS#0.7553;VESICULAR STOMATITIS VIRUS#0.7496;METASTATIC MELANOMA#0.7448;MICRORNA PROCESSING#0.7431;HUMAN IMMUNODEFICIENCY VIRUS#0.7379;PROGENITOR CELL#0.7371;CELL DEVELOPMENT#0.7350;B CELL#0.7346;REGULATION OF GENE EXPRESSION#0.7276;ADENOCARCINOMA#0.7232;EMBRYONIC STEM CELL#0.7198;TUMOR CELLS#0.7183;IFN-GAMMA#0.7160;ADENOSINE DEAMINASE ACTIVITY#0.7116;HEPATITIS C#0.7101;RNA PROCESSING#0.7062;ASTROCYTE#0.7047;CHEMICAL SHIFT PERTURBATION#0.7040;AUTOIMMUNITY#0.6999;HYPOXIA#0.6965;NERVOUS TISSUE#0.6941;SEROTONIN RECEPTOR#0.6921;SIGNAL TRANSDUCTION#0.6903;MRNA SPLICING#0.6902;NUCLEOLUS#0.6839;ERYTHROPOIESIS#0.6761;ARGININE#0.6746;ADENINE#0.6734;GASTROENTERITIS#0.6715;DISEASE FREE SURVIVAL#0.6688;LIVER DAMAGE#0.6666;RNA REPLICATION#0.6575;HEMATOPOIESIS#0.6502;BONE MARROW#0.6398;NEUROTRANSMITTER RECEPTOR#0.6367;PROTEIN KINASE R#0.6363;VIRION#0.6302;NEUROLOGICAL DISORDER#0.6296;NUCLEAR IMPORT#0.6278;TYPE I IFN PRODUCTION#0.6209;SKIN DISEASE#0.6197;RNA DEGRADATION#0.6154;REGENERATION#0.6151;STEM CELL MAINTENANCE#0.6145;ENZYME ACTIVITY#0.6137;BINDING PROTEIN 1#0.6029;VIRAL GENOME#0.6000
10400	N-METHYLTRANSFERASE ACTIVITY#1.0836;PHOSPHATIDYLETHANOLAMINE N METHYLTRANSFERASE#1.0652;HEPATOMA CELLS#1.0612;CDP CHOLINE PATHWAY#1.0512;N METHYLTRANSFERASE#1.0505;METHYLTRANSFERASE ACTIVITY#1.0505;PHOSPHATIDYLETHANOLAMINE#1.0463;HIGH FAT DIET#1.0253;ADIPOCYTE#1.0235;FATTY LIVER#1.0215;LOW DENSITY LIPOPROTEIN#1.0189;S-ADENOSYLMETHIONINE#1.0179;CHOLINE#1.0158;PHENYLETHANOLAMINE N METHYLTRANSFERASE#1.0145;PHOSPHOCHOLINE#1.0139;LIVER DISEASE#1.0138;FATTY LIVER DISEASE#1.0056;CHOLINE METABOLISM#1.0007;CELL DIVISION#1.0002;METHIONINE#0.9960;PLASMA MEMBRANE#0.9933;VERY-LOW-DENSITY LIPOPROTEIN#0.9904;DIET INDUCED OBESITY#0.9897;LIVER DAMAGE#0.9867;PHOSPHATIDYLCHOLINE SYNTHESIS#0.9826;ENDOPLASMIC RETICULUM#0.9822;NONALCOHOLIC FATTY LIVER DISEASE#0.9692;GENE EXPRESSION#0.9659;PHOSPHATIDYLCHOLINE BIOSYNTHESIS#0.9647;ETHANOLAMINE#0.9527;ADOMET#0.9524;MITOCHONDRIA#0.9461;PROTEIN KINASE#0.9406;L-METHIONINE#0.9207;WEIGHT GAIN#0.9187;FOLATE#0.9120;APOPTOSIS#0.9112;CHOLINE DEHYDROGENASE#0.9094;CHOLINE DEFICIENT DIET#0.9091;ISOPROTERENOL#0.9067;MICROSOME#0.9020;S-ADENOSYL-L-METHIONINE#0.9011;CELL PROLIFERATION#0.8886;BREAST CANCER#0.8846;SKELETAL MUSCLE#0.8820;CHOLINE KINASE#0.8730;CYCLIC AMP#0.8612;MITOCHONDRIA-ASSOCIATED MEMBRANE#0.8499;EPINEPHRINE#0.8488;ADIPOSE TISSUE#0.8376;PHOSPHATIDYLSERINE#0.8349;ENZYME ACTIVITY#0.8278;ATHEROSCLEROSIS#0.8197;FETAL BRAIN#0.8116;LIPOLYSIS#0.8011;ETHANOL#0.7938;CELL DEATH#0.7865;OBESE#0.7759;PHOSPHATIDYLSERINE DECARBOXYLASE#0.7739;LIPID METABOLISM#0.7721;PHOSPHOLIPID METABOLISM#0.7665;BRUSH BORDER MEMBRANE#0.7585;BRUSH BORDER#0.7546;PHOSPHOLIPASE A2#0.7519;CELL MEMBRANE#0.7510;ADENYLATE CYCLASE#0.7504;HIGH DENSITY LIPOPROTEIN#0.7473;LIVER CANCER#0.7464;METHIONINE SYNTHASE#0.7372;GLYCINE#0.7354;CYTIDYLYLTRANSFERASE ACTIVITY#0.7277;ALZHEIMER'S DISEASE#0.7274;CELL GROWTH#0.7268;KENNEDY PATHWAY#0.7080;DNA METHYLATION#0.6918;HEPATOCYTE PROLIFERATION#0.6860;METHIONINE ADENOSYLTRANSFERASE#0.6707;SIGNALING PATHWAY#0.6648;S-ADENOSYL-L-HOMOCYSTEINE#0.6510;PROTEIN KINASE C#0.6295;HEPATOCELLULAR CARCINOMA#0.6294;NOREPINEPHRINE#0.6238;CATABOLISM#0.6162;BRAIN DEVELOPMENT#0.6109;FOLIC ACID#0.6056
10401	LUNG CANCER#1.0459;SUMOYLATION#1.0455;CANCER CELL#1.0356;DNA BINDING#1.0328;CELL GROWTH#1.0182;SIGNAL TRANSDUCER#1.0148;SUMO LIGASE#1.0127;GENE EXPRESSION#1.0073;SIGNALING PATHWAY#1.0013;UBIQUITIN#0.9985;TRANSCRIPTION FACTOR#0.9917;PROSTATE CANCER#0.9875;BREAST CANCER#0.9871;MAST CELL#0.9715;APOPTOSIS#0.9599;CELL PROLIFERATION#0.9387;T CELL#0.9210;GROWTH FACTOR#0.8670;CONJUGATION#0.8303;LIGASE ACTIVITY#0.8293;BREAST CANCER CELL#0.8108;TRANSACTIVATION#0.8100;EPITHELIAL CELL#0.8049;LYSINE#0.7930;CELL MIGRATION#0.7923;CELL CYCLE#0.7910;RESVERATROL#0.7696;MELANOCYTE#0.7608;OSTEOCLAST#0.7395;ONCOGENIC#0.7099;PERIPHERAL BLOOD#0.7062;MICROPHTHALMIA#0.7045;TH17 CELL#0.7013;SIGNAL TRANSDUCTION#0.6816;ANDROGEN RECEPTOR#0.6680;IMMUNE RESPONSE#0.6332;B CELL#0.6320;POST-TRANSLATIONAL MODIFICATION#0.6240;APOPTOTIC#0.6155;TUMOR TISSUES#0.6132;MALIGNANT MESOTHELIOMA#0.6108;OSTEOCLAST DIFFERENTIATION#0.6061
10402	SIALYLATION#0.9249;GLYCOSYLATION#0.7782;CELL PROLIFERATION#0.7067;SELECTIN#0.6841;ADJACENT NORMAL TISSUE#0.6429;HEPATOCELLULAR CARCINOMA#0.6321
10403	MIS12 COMPLEX#1.0992;NDC80 COMPLEX#1.0707;MICROTUBULE BINDING#1.0428;KINETOCHORE MICROTUBULE INTERACTION#1.0418;ENDOMETRIAL ADENOCARCINOMA#1.0393;KINETOCHORE#1.0365;KINETOCHORE-MICROTUBULE ATTACHMENT#1.0338;MICROTUBULE PLUS END#1.0320;COMPLEX I#1.0318;SPINDLE CHECKPOINT#1.0297;KINETOCHORE LOCALIZATION#1.0249;M PHASE#1.0238;KINETOCHORE MICROTUBULE#1.0235;ADENOCARCINOMA#1.0224;MICROTUBULE#1.0178;CELL DEATH#1.0168;CANCER CELL#1.0093;MITOTIC CHECKPOINT#1.0082;CENTROMERE#1.0078;CELL PROLIFERATION#1.0077;METAPHASE#1.0017;SPINDLE ASSEMBLY CHECKPOINT#1.0002;SPINDLE MICROTUBULE#0.9990;SPINDLE ASSEMBLY#0.9974;DAM1 COMPLEX#0.9945;SPINDLE POLE#0.9940;CELL CYCLE#0.9922;KINETOCHORE ASSEMBLY#0.9907;APOPTOSIS#0.9903;CELL DIVISION#0.9903;ENDOMETRIAL CANCER#0.9879;ANAPHASE#0.9878;CHROMOSOME CONGRESSION#0.9877;CHROMOSOME SEGREGATION#0.9871;BUDDING#0.9864;MITOSIS#0.9851;MITOTIC SPINDLE#0.9799;GENE EXPRESSION#0.9795;CHROMOSOME MOVEMENT#0.9704;NUCLEAR DIVISION#0.9661;BREAST CANCER#0.9565;MICROTUBULE DYNAMICS#0.9549;CELL GROWTH#0.9517;MEIOSIS#0.9509;RNA INTERFERENCE#0.9457;PROTEIN PROTEIN INTERACTION#0.9326;CHROMATID#0.9240;TRANSCRIPTION FACTOR#0.9224;PROTEIN COMPLEX#0.9167;DYNEIN#0.9057;OOCYTE#0.9016;CENTROSOME#0.8938;HEPATOCELLULAR CARCINOMA#0.8769;ENDOMETRIAL CARCINOMA#0.8657;EPITHELIAL CELL#0.8500;LUNG CANCER#0.8371;MICROTUBULE END#0.8220;CELL CYCLE ARREST#0.8168;MIND COMPLEX#0.8165;MICROTUBULE ASSOCIATED PROTEIN#0.8034;STEM CELL#0.7977;PROPHASE#0.7973;KINESIN#0.7921;POLYMERASE CHAIN REACTION#0.7790;MEIOSIS I#0.7764;SPINDLE POLE BODY#0.7657;GROWTH FACTOR#0.7637;CYCLIN DEPENDENT KINASE#0.7629;PROTEIN KINASE#0.7553;MITOTIC CHROMOSOME#0.7520;OVARIAN#0.7503;OVARIAN CANCER#0.7475;BREAST CANCER CELL#0.7275;PROTEASOME#0.7238;MICROTUBULE DEPOLYMERIZATION#0.7236;METAPHASE CHROMOSOME#0.7124;TUMOR TISSUES#0.7099;ANAPHASE PROMOTING COMPLEX#0.7026;DEPHOSPHORYLATION#0.6807;MITOTIC EXIT#0.6645;STROMAL CELL#0.6547;LEUCINE#0.6494;TUMOR CELLS#0.6455;SIGNALING PATHWAY#0.6442;INTERPHASE#0.6407;ENDOMETRIUM#0.6373;SPINDLE ORGANIZATION#0.6319;PLASMA MEMBRANE#0.6263;SPINDLE FORMATION#0.6107;NUCLEOSOME#0.6075
10404	BLOOD PLASMA#0.7894;DIPEPTIDASE ACTIVITY#0.6766;QUERCETIN#0.6640
10406	ENDOMETRIOSIS#1.0577;ENDOMETRIAL CANCER#1.0454;EPIDIDYMIS#1.0453;CANCER CELL#1.0348;OVARIAN CARCINOMA#1.0301;POSITIVE PREDICTIVE VALUE#1.0299;NEGATIVE PREDICTIVE VALUE#1.0260;OVARIAN#1.0255;EPITHELIAL OVARIAN CANCER#1.0226;OVARIAN CANCER#1.0201;BORDERLINE OVARIAN TUMOR#1.0176;ADENOCARCINOMA#1.0144;ENDOMETRIAL CARCINOMA#1.0068;LYMPH NODE#1.0055;STATISTICALLY SIGNIFICANT DIFFERENCE#1.0029;GENE EXPRESSION#0.9979;OVARIAN CYST#0.9761;RECEIVER OPERATOR CHARACTERISTIC#0.9397;GROWTH FACTOR#0.9270;ASCITES#0.9265;LYMPH NODE METASTASIS#0.9151;CELL PROLIFERATION#0.9123;LUNG CANCER#0.9067;OVARIAN DISEASE#0.9028;POSITIVE LIKELIHOOD RATIO#0.8848;MAGNETIC RESONANCE IMAGING#0.8545;EPITHELIAL CELL#0.8542;DISEASE FREE SURVIVAL#0.8413;APOPTOSIS#0.8370;PERITONEAL CARCINOMA#0.8337;ENDOMETRIOID ENDOMETRIAL CANCER#0.8243;CERVICAL#0.8184;UTERUS#0.8060;GLOMERULAR FILTRATION#0.7984;MENSTRUAL CYCLE#0.7942;LUNG ADENOCARCINOMA#0.7919;AREA UNDER CURVE#0.7724;EPITHELIAL OVARIAN CARCINOMA#0.7578;OVARIES#0.7536;TUMOR CELLS#0.7531;BREAST CANCER#0.7399;RECURRENT OVARIAN CANCER#0.7289;NEGATIVE LIKELIHOOD RATIO#0.7189;HIGH RISK PATIENTS#0.7103;GLOMERULAR FILTRATION RATE#0.7083;SIGNALING PATHWAY#0.7020;ADVANCED OVARIAN CANCER#0.6964;MICROPARTICLE#0.6957;UTERINE CANCER#0.6947;CLEAR CELL CARCINOMA#0.6862;CELL ADHESION#0.6861;CELL CYCLE#0.6834;RESPIRATORY TRACT#0.6730;SALIVARY GLAND#0.6721;OVARIAN CANCER SCREENING#0.6380;PELVIC INFLAMMATORY DISEASE#0.6185
10407	EPIDIDYMIS#1.0905;CAPUT#0.8488;POLYMERASE CHAIN REACTION#0.8158;VARICOCELE#0.6877;HUMAN BETA DEFENSIN#0.6801;SPERMATOZOA#0.6665;MRNA SPLICING#0.6420;GENE EXPRESSION#0.6398
10408	DNA BINDING#1.0938;NEUROBLASTOMA#0.9776;GENE EXPRESSION#0.9048;SEQUENCE SPECIFIC DNA BINDING#0.7337;TRANSCRIPTION FACTOR#0.6168
10409	CALMODULIN BINDING#1.0752;SYNAPTIC VESICLE#1.0383;PROTEIN KINASE C#1.0203;PROTEIN KINASE#1.0166;PLASMA MEMBRANE#0.9818;MEMBRANE MICRODOMAIN#0.9241;TUMOR SUPPRESSOR#0.9153;NEURITE OUTGROWTH#0.9040;AMYLOID PROTEIN#0.8998;GENE EXPRESSION#0.8914;APOPTOSIS#0.8824;NERVE TERMINAL#0.8173;CANCER CELL#0.8166;NEURITE#0.8144;LIPID RAFT#0.7887;REGENERATION#0.7864;INSOLUBLE FRACTION#0.7731;ACTIN CYTOSKELETON#0.7729;PHOSPHATASE ACTIVITY#0.7670;GROWTH CONE#0.7429;NERVOUS SYSTEM#0.7346;CELL CYCLE#0.6967;CELL MEMBRANE#0.6593;TRANSCRIPTION FACTOR#0.6554;CORTICAL CYTOSKELETON#0.6438;PRESYNAPTIC MEMBRANE#0.6389;PROTEIN SYNTHESIS#0.6151;MEMBRANE FRACTION#0.6116;ION CHANNEL#0.6038;CHROMATOID BODY#0.6011;PHOSPHATIDYLSERINE#0.6001
1040	PHOSPHATIDATE CYTIDYLYLTRANSFERASE#1.1631;PHOSPHOLIPASE C#0.8735;ENDOPLASMIC RETICULUM#0.8729;CARDIOLIPIN#0.7801;GENE EXPRESSION#0.7633;CYTIDYLYLTRANSFERASE ACTIVITY#0.7505;PROTEIN KINASE#0.6893;MITOCHONDRIA#0.6300;ER MEMBRANE#0.6291;PHOTOTRANSDUCTION#0.6281;PROTEIN KINASE C#0.6138;PHOSPHOLIPID BIOSYNTHESIS#0.6013
10410	GERM CELL#1.0634;ENDOSOME#1.0445;INFLUENZA A VIRUS#1.0366;INTERFERON STIMULATED GENE#1.0334;HEPATOCELLULAR CARCINOMA#1.0178;VIRAL INFECTION#1.0136;T CELL#1.0095;PLASMA MEMBRANE#0.9869;GENE EXPRESSION#0.9817;LATE ENDOSOME#0.9703;IMMUNE RESPONSE#0.9525;CELL PROLIFERATION#0.9492;CANCER CELL#0.9297;CELL SURFACE#0.9269;MEMBRANE FUSION#0.9155;EPITHELIAL CELL#0.9143;CELL GROWTH#0.9085;SQUAMOUS CELL CARCINOMA#0.9070;ANTIVIRAL RESPONSE#0.9061;VESICULAR STOMATITIS VIRUS#0.8915;HOST CELL#0.8824;IMMUNE SYSTEM#0.8797;VIRION#0.8792;MACROPHAGE#0.8778;VIRAL REPLICATION#0.8724;PRIMORDIAL GERM CELL#0.8639;ASTROCYTE#0.8500;AVIAN INFLUENZA#0.8465;ENDOCYTOSIS#0.8454;CELL CYCLE#0.8405;SIGNALING PATHWAY#0.8334;LYSOSOME#0.8257;INFLUENZA A VIRUSES#0.8122;WEST NILE VIRUS#0.8077;STEM CELL#0.7965;CELL ADHESION#0.7869;LYMPH NODE#0.7737;CYTOPLASM#0.7664;AMPHOTERICIN B#0.7649;STOMATITIS#0.7629;POLYMERASE CHAIN REACTION#0.7618;CELL DEATH#0.7580;COLON CANCER#0.7515;APOPTOSIS#0.7357;INNATE IMMUNE SYSTEM#0.7295;EARLY ENDOSOME#0.7190;HEPATITIS C#0.7100;COLITIS#0.7095;PERIPHERAL BLOOD#0.7042;AVIAN INFLUENZA VIRUS#0.6973;ENDOTHELIAL CELL#0.6893;ULCERATIVE COLITIS#0.6826;BONE MARROW#0.6743;CD8+ T CELL#0.6731;IFN STIMULATED GENES#0.6681;TOLL LIKE RECEPTOR#0.6532;CELL DEVELOPMENT#0.6370;INNATE IMMUNE RESPONSE#0.6368;HEPATITIS C VIRUS#0.6360;DENDRITIC CELL#0.6335;GROWTH FACTOR#0.6296;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6234;MONONUCLEAR CELLS#0.6223;CELL FUSION#0.6181;AMPHOTERICIN#0.6116
10411	CAMP BINDING DOMAIN#1.0746;CANCER CELL#1.0605;CAMKII#1.0569;CARDIOMYOCYTE#1.0473;CAMP BINDING#1.0393;SIGNALING CASCADE#1.0299;MACROPHAGE#1.0292;PLASMA MEMBRANE#1.0282;CELL MIGRATION#1.0280;NUCLEOTIDE EXCHANGE FACTOR#1.0277;RESONANCE ENERGY TRANSFER#1.0276;GUANINE#1.0225;CELL ADHESION#1.0189;FORSKOLIN#1.0184;INSULIN SECRETION#1.0181;PHOSPHOLIPASE C#1.0174;SIGNAL TRANSDUCTION#1.0136;SMOOTH MUSCLE#1.0115;ENDOTHELIAL CELL#1.0114;CYCLIC ADENOSINE MONOPHOSPHATE#1.0114;ADENOSINE MONOPHOSPHATE#1.0108;EXOCYTOSIS#1.0091;SMOOTH MUSCLE CELL#1.0073;MUSCLE CELL#1.0067;CAMP SIGNALING#1.0040;ISOPROTERENOL#1.0032;CYCLIC AMP#1.0009;CELL PROLIFERATION#1.0006;GROWTH FACTOR#0.9998;MYOCYTES#0.9988;SIGNALING PATHWAY#0.9987;APOPTOSIS#0.9984;GENE EXPRESSION#0.9980;PROTEIN KINASE A#0.9975;ADENOSINE#0.9958;CAMP SIGNALLING#0.9956;ADRENERGIC RECEPTOR#0.9939;PROTEIN KINASE#0.9929;PROSTAGLANDIN E2#0.9862;TRANSCRIPTION FACTOR#0.9822;PHOSPHODIESTERASE#0.9816;SIGNALLING PATHWAY#0.9738;LUNG CANCER#0.9738;ION CHANNEL#0.9712;RETINAL ENDOTHELIAL CELLS#0.9621;CAMP RESPONSE ELEMENT#0.9618;ACTIN CYTOSKELETON#0.9594;VASCULAR ENDOTHELIAL CELL#0.9580;SKELETAL MUSCLE#0.9567;RYANODINE RECEPTOR#0.9554;CELL JUNCTION#0.9541;CAMP RESPONSE ELEMENT BINDING#0.9427;MICROTUBULE#0.9382;HUMAN UMBILICAL VEIN#0.9335;PROTEIN KINASE C#0.9335;UMBILICAL VEIN#0.9333;STEM CELL#0.9328;HISTONE DEACETYLASE#0.9309;T CELL#0.9306;BETA CELL#0.9265;CELL CYCLE#0.9256;NUCLEOTIDE BINDING#0.9237;NUCLEAR EXPORT#0.9234;ADENYLATE CYCLASE#0.9217;SPINAL CORD#0.9107;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9088;CYCLIC NUCLEOTIDE BINDING#0.8901;SARCOPLASMIC RETICULUM#0.8885;ISCHEMIA#0.8878;TRANSFORMING GROWTH FACTOR#0.8793;RECEPTOR AGONIST#0.8752;CELL DEATH#0.8744;AIRWAY SMOOTH MUSCLE#0.8709;VASCULAR SMOOTH MUSCLE CELL#0.8676;ADENYLATE#0.8585;BONE MARROW#0.8520;NUCLEAR PORE#0.8518;ANGIOGENESIS#0.8509;RESPONSE TO CAMP#0.8470;HYPOXIA#0.8432;ARRHYTHMIA#0.8418;NUCLEOTIDE BINDING DOMAIN#0.8364;GUANINE EXCHANGE FACTOR#0.8355;RNA INTERFERENCE#0.8345;PROTEIN KINASE B#0.8319;CELL CELL JUNCTION#0.8251;SENSITIZATION#0.8200;EPITHELIAL CELL#0.8155;EXTRACELLULAR MATRIX#0.8121;ENDOTHELIAL GROWTH FACTOR#0.8101;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8101;MITOGEN ACTIVATED PROTEIN#0.8092;SIGNALING MOLECULE#0.8048;CHEMOTAXIS#0.8047;PRO-INFLAMMATORY#0.7972;ENHANCER BINDING PROTEIN#0.7934;ENHANCER BINDING#0.7928;PROSTATE CANCER#0.7882;MONOCYTE#0.7825;KINASE ACTIVITY#0.7801;CELL SURFACE#0.7748;FOCAL ADHESION#0.7669;SMOOTH MUSCLE CELL MIGRATION#0.7634;MUSCLE CELL MIGRATION#0.7631;ADIPOCYTE#0.7624;ENDOTHELIUM#0.7563;ACROSOME REACTION#0.7509;SECRETORY GRANULE#0.7473;NUCLEAR ENVELOPE#0.7455;MESENCHYMAL STEM CELL#0.7433;ADIPOSE TISSUE#0.7415;PHAGOCYTOSIS#0.7399;RECEPTOR ANTAGONIST#0.7388;INFLAMMATORY RESPONSE#0.7387;CILOSTAZOL#0.7364;ANCHORING#0.7281;NEURITE#0.7249;NEURITE OUTGROWTH#0.7232;TOLBUTAMIDE#0.7175;CYCLIC NUCLEOTIDE GATED#0.7146;HIGH FAT DIET#0.7065;ENDOPLASMIC RETICULUM#0.6945;5'-ADENOSINE MONOPHOSPHATE#0.6884;PROGENITOR CELL#0.6850;PHOSPHODIESTERASE INHIBITOR#0.6843;BREAST CANCER#0.6820;CELL FUSION#0.6763;BLOOD VESSEL#0.6756;ACROSOME#0.6734;HEPATIC STELLATE CELL#0.6732;ARTERY#0.6725;MITOCHONDRIA#0.6676;NEUTROPHIL#0.6667;ACTION POTENTIAL#0.6620;DORSAL ROOT GANGLION#0.6583;ADHERENS JUNCTION#0.6546;ROFLUMILAST#0.6496;TRANSENDOTHELIAL ELECTRICAL RESISTANCE#0.6456;NITRIC OXIDE#0.6448;TUMOR NECROSIS FACTOR#0.6444;RELATED PROTEIN 1#0.6304;PROTEIN SYNTHESIS#0.6257;LATE PHAGOSOME#0.6256;LEUKOCYTE#0.6207;UBIQUITIN#0.6198;ALZHEIMER'S DISEASE#0.6161;MECHANISM OF ACTION#0.6141;JUN PHOSPHORYLATION#0.6086;OXYGEN INDUCED RETINOPATHY#0.6073;MICROTUBULE ASSOCIATED PROTEIN#0.6067;CYCLIC NUCLEOTIDE PHOSPHODIESTERASE#0.6052;PLATELET-DERIVED GROWTH FACTOR#0.6034;MUSCLE HYPERTROPHY#0.6026;VASCULAR ENDOTHELIAL CADHERIN#0.6016
10412	MESANGIAL CELL#0.8426;DIABETIC NEPHROPATHY#0.8389;CELL PROLIFERATION#0.7891;CELL CYCLE#0.7308;RIBOSOMAL SUBUNIT#0.6687;RIBOSOME BIOGENESIS#0.6610;NEPHROPATHY#0.6368
10413	SWH PATHWAY#1.0779;TRANSCRIPTION REGULATOR#1.0691;HIPPO SIGNALING CASCADE#1.0661;CARDIOMYOCYTE PROLIFERATION#1.0657;TRANSCRIPTION COACTIVATOR#1.0655;LOCALISATION#1.0543;VERTEPORFIN#1.0531;PDZ BINDING MOTIF#1.0507;NUCLEAR EXPORT#1.0504;PODOCYTE#1.0487;KERATINOCYTE#1.0474;THYROID CANCER#1.0432;TRANSCRIPTION COFACTOR#1.0410;RESPONSE TO OXIDATIVE STRESS#1.0380;DEPHOSPHORYLATION#1.0374;LIVER REGENERATION#1.0374;YES ASSOCIATED PROTEIN#1.0357;AKT SIGNALING#1.0351;TISSUE GROWTH FACTOR#1.0331;CARDIOMYOCYTE#1.0327;COLON CANCER#1.0314;TRANSACTIVATION#1.0301;ACTOMYOSIN#1.0260;OVARIAN CANCER#1.0257;PANCREATIC CANCER#1.0236;MYOBLAST#1.0217;CONNECTIVE TISSUE#1.0212;ACTIN CYTOSKELETON#1.0210;ORGAN GROWTH#1.0207;LUNG ADENOCARCINOMA#1.0201;MYOFIBROBLAST#1.0199;LIVER CANCER#1.0194;HEPATOCELLULAR CARCINOMA CELL#1.0192;STROMAL CELL#1.0187;GLYCOLYSIS#1.0186;DNA BINDING#1.0184;STRESS FIBER#1.0184;DASATINIB#1.0167;OXIDATIVE STRESS RESPONSE#1.0160;CYTOPLASM#1.0159;HYPOXIA#1.0158;S PHASE#1.0155;SENESCENCE#1.0154;OVARIAN#1.0153;PROSTATE CANCER#1.0153;ANCHORAGE INDEPENDENT GROWTH#1.0150;GRANULOSA CELL#1.0148;CELL MOTILITY#1.0144;CONTACT INHIBITION#1.0141;AUTOPHAGY#1.0137;MITOGEN ACTIVATED PROTEIN#1.0128;DISEASE FREE SURVIVAL#1.0127;SKELETAL MUSCLE#1.0125;RNA INTERFERENCE#1.0124;CISPLATIN#1.0120;ORAL SQUAMOUS CELL CARCINOMA#1.0120;DUAL LUCIFERASE REPORTER#1.0116;SMOOTH MUSCLE CELL#1.0108;CHOLANGIOCARCINOMA#1.0094;CERVICAL CANCER#1.0090;FOCAL ADHESION#1.0089;CHONDROCYTE#1.0088;SQUAMOUS CELL CARCINOMA#1.0088;UVEAL MELANOMA#1.0086;NEURAL CREST#1.0078;TRANSCRIPTION ACTIVATOR#1.0077;RECEPTOR TYROSINE KINASE#1.0069;EPITHELIAL TO MESENCHYMAL TRANSITION#1.0068;HEPATIC STELLATE CELL#1.0063;LUNG CANCER#1.0060;FIBROBLAST ACTIVATION#1.0057;EPITHELIAL TO MESENCHYMAL#1.0057;ONCOGENIC#1.0053;TRANSCRIPTION FACTOR#1.0052;MACROPHAGE#1.0050;OSTEOGENESIS#1.0047;BREAST CANCER CELL#1.0046;ENDOTHELIAL CELL#1.0044;MUSCLE CELL#1.0043;ACTIN POLYMERIZATION#1.0043;ADHERENS JUNCTION#1.0042;PANCREATIC DUCTAL ADENOCARCINOMA#1.0036;MORPHOGENESIS#1.0034;KINASE ACTIVITY#1.0032;PROGENITOR CELL#1.0027;MAMMARY EPITHELIAL CELL#1.0024;DRUG RESISTANCE#1.0019;OSTEOBLAST#1.0010;SIGNALING MOLECULE#1.0006;RENAL CELL CARCINOMA#1.0006;EPITHELIAL MESENCHYMAL TRANSITION#1.0006;ANGIOGENESIS#1.0004;STEM CELL PROLIFERATION#1.0003;HIPPO SIGNALING#0.9998;UBIQUITIN#0.9998;CELLULAR LOCALIZATION#0.9996;HIPPO SIGNALING PATHWAY#0.9995;TUMOR TISSUES#0.9994;T CELL#0.9991;TISSUE REGENERATION#0.9989;ESOPHAGEAL CANCER#0.9988;POLYMERASE CHAIN REACTION#0.9981;COLORECTAL#0.9981;COLORECTAL CANCER#0.9980;QUANTITATIVE REAL TIME#0.9980;ADENOCARCINOMA#0.9977;CELL CYCLE ARREST#0.9975;TRANSFORMING GROWTH FACTOR#0.9973;SMOOTH MUSCLE#0.9973;SIGNALING CASCADE#0.9971;CELL DIFFERENTIATION#0.9965;HEPATOCELLULAR CARCINOMA#0.9963;BREAST CANCER#0.9958;CELL JUNCTION#0.9956;PROTEIN PROTEIN INTERACTION#0.9955;CANCER CELL#0.9951;EPITHELIAL CELL#0.9949;REVERSE TRANSCRIPTION#0.9946;REGENERATION#0.9945;HUMAN BREAST CANCER#0.9942;CANCER STEM CELL#0.9938;TIGHT JUNCTION#0.9933;EPIDERMAL GROWTH FACTOR#0.9931;APOPTOTIC#0.9927;TISSUE DEVELOPMENT#0.9927;CELL EXPANSION#0.9925;SIGNALLING PATHWAY#0.9919;CELL GROWTH#0.9918;KERATINOCYTE PROLIFERATION#0.9916;CELL POLARITY#0.9915;BREAST CANCER PATIENTS#0.9915;CELL MIGRATION#0.9915;HYPOXIC#0.9913;CELL ACTIVATION#0.9911;GROWTH FACTOR RECEPTOR#0.9906;CELL ADHESION#0.9897;MESENCHYMAL STEM CELL#0.9892;G1 PHASE#0.9890;GROWTH FACTOR#0.9890;CERVICAL#0.9888;TUMOR SUPPRESSOR#0.9887;SIGNALING PATHWAY#0.9884;GLUTATHIONE#0.9879;KINASE INHIBITOR#0.9878;CELL PROLIFERATION#0.9878;CLEAR CELL RENAL CELL CARCINOMA#0.9866;TISSUE HOMEOSTASIS#0.9860;TUMOR CELLS#0.9857;PLURIPOTENT STEM CELL#0.9857;APOPTOSIS#0.9855;PROTEIN KINASE#0.9849;SUPEROXIDE DISMUTASE#0.9849;PRO-INFLAMMATORY#0.9845;GENE EXPRESSION#0.9838;CELL CYCLE#0.9837;EMBRYONIC STEM CELL#0.9837;LYMPH NODE METASTASIS#0.9832;TYROSINE KINASE INHIBITOR#0.9832;STEM CELL#0.9830;CELL DEATH#0.9828;MAPK SIGNALING#0.9827;SCHWANN CELL#0.9825;LYMPH NODE#0.9823;ONCOGENESIS#0.9820;QUIESCENCE#0.9800;TRANSCRIPTIONAL CONTROL#0.9800;LIVER DEVELOPMENT#0.9796;CELL DIVISION#0.9789;CELL CYCLE REGULATOR#0.9781;B CELL#0.9772;MYOCARDIAL INFARCTION#0.9772;WOUND HEALING#0.9772;INTESTINAL STEM CELL#0.9765;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9763;EXTRACELLULAR MATRIX#0.9754;MITOCHONDRIAL FISSION#0.9741;PROTEASOME#0.9732;TOXICITY#0.9730;SIGNAL TRANSDUCTION#0.9722;THYROID CARCINOMA#0.9712;SRC FAMILY KINASE#0.9708;NUCLEAR IMPORT#0.9707;REACTIVE OXYGEN SPECIES#0.9692;TARGET OF RAPAMYCIN#0.9688;MUTAGENESIS#0.9680;BLOOD VESSEL#0.9676;LIVER DISEASE#0.9673;RAPAMYCIN#0.9668;CANCER STEM-LIKE CELL#0.9665;GASTRIC ADENOCARCINOMA#0.9650;GLUCOSE METABOLISM#0.9638;C TERMINAL DOMAIN#0.9636;MEDULLOBLASTOMA#0.9609;PODOCYTE APOPTOSIS#0.9607;NEURAL STEM CELL#0.9600;BASAL CELL#0.9599;CELL SURFACE#0.9586;STEM CELL MAINTENANCE#0.9568;RHABDOMYOSARCOMA#0.9545;MESOTHELIAL CELL#0.9540;NERVOUS SYSTEM#0.9536;EPIDERMAL STEM CELL#0.9532;IMMUNE RESPONSE#0.9530;SMOOTH MUSCLE ACTIN#0.9529;COMPLEX I#0.9505;METFORMIN#0.9499;SIGNALLING CASCADE#0.9481;GEMCITABINE#0.9479;MAMMARY GLAND#0.9471;REGULATION OF CELL PROLIFERATION#0.9463;STEM CELL LIKE#0.9461;INSULIN-LIKE GROWTH FACTOR#0.9455;LEUCINE#0.9443;PLASMA MEMBRANE#0.9436;HEPATOCYTE PROLIFERATION#0.9427;BUDDING#0.9420;ESTROGEN RECEPTOR#0.9417;ADIPOGENESIS#0.9409;STROMA#0.9406;DETOXIFICATION#0.9401;LYSINE#0.9400;BONE MARROW#0.9396;HYPOXIA INDUCIBLE FACTOR#0.9373;SPHINGOSINE 1 PHOSPHATE#0.9372;TRANSDIFFERENTIATION#0.9369;VASCULAR SMOOTH MUSCLE CELL#0.9356;OSTEOBLAST DIFFERENTIATION#0.9352;MAP KINASE#0.9320;STEM CELL MARKER#0.9290;WNT SIGNALING PATHWAY#0.9289;REPORTER GENE ASSAY#0.9288;EMBRYONAL RHABDOMYOSARCOMA#0.9269;PERIODONTAL LIGAMENT#0.9264;CYTOTOXICITY#0.9263;PROTEIN DEGRADATION#0.9253;INDUCTION OF APOPTOSIS#0.9234;ATHEROSCLEROSIS#0.9199;DEDIFFERENTIATION#0.9161;ORGAN DEVELOPMENT#0.9160;GENE SILENCING#0.9155;ERLOTINIB#0.9148;BRAIN DEVELOPMENT#0.9145;CYTOCHROME C#0.9140;DNA REPLICATION#0.9138;SIMVASTATIN#0.9137;INTESTINAL EPITHELIAL CELL#0.9133;GLUTATHIONE PEROXIDASE#0.9127;ISCHEMIA#0.9125;LUMINAL#0.9115;TROPHECTODERM#0.9109;PROTEASE ACTIVATED RECEPTOR#0.9098;TISSUE DAMAGE#0.9096;MALIGNANT MESOTHELIOMA#0.9088;HEART GROWTH#0.9080;PULMONARY FIBROSIS#0.9060;MESENCHYMAL CELL#0.9050;BONE FORMATION#0.9040;FACTOR I#0.9029;INNER CELL MASS#0.9022;CELLULAR SENESCENCE#0.9022;NUCLEOCYTOPLASMIC SHUTTLING#0.9018;SIGNAL TRANSDUCER#0.9007;CHROMATIN REMODELING#0.9004;OVARIAN FOLLICLE#0.8991;SPINAL CORD#0.8989;BILE DUCT#0.8981;SOFT TISSUE SARCOMA#0.8981;ADJACENT NORMAL TISSUE#0.8968;ENDOMETRIAL CANCER#0.8930;CELL COUNTING KIT#0.8923;COLONY FORMATION ASSAY#0.8900;MITOCHONDRIA#0.8897;ENDOTHELIAL GROWTH FACTOR#0.8897;NEURAL PROGENITOR CELL#0.8894;TERMINAL DIFFERENTIATION#0.8888;CENTRAL NERVOUS SYSTEM#0.8887;KIDNEY DISEASE#0.8848;OOCYTE#0.8839;HEPATOBLASTOMA#0.8836;DUCTAL CELL#0.8832;STEM CELL DIFFERENTIATION#0.8826;GLUTAMINE#0.8810;NEUROGENESIS#0.8789;PANCREATITIS#0.8789;SKIN CANCER#0.8783;PRECURSOR CELL#0.8759;MUSCLE FIBER#0.8759;LUNG FIBROBLASTS#0.8758;EPITHELIAL TISSUES#0.8741;MITOCHONDRIAL MEMBRANE#0.8737;DNA REPAIR#0.8736;VASCULAR CELL#0.8732;IMMUNE CELL#0.8730;NEUROBLASTOMA#0.8721;CHONDROCYTE DIFFERENTIATION#0.8717;SPHINGOSINE#0.8706;MITOSIS#0.8687;MAJOR FACILITATOR SUPERFAMILY#0.8686;ANOIKIS#0.8672;TO TUMOR PROGRESSION#0.8669;SERUM RESPONSE FACTOR#0.8660;ORGANOGENESIS#0.8660;PROTEIN KINASE A#0.8657;ANTI APOPTOSIS#0.8638;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8613;TUBE FORMATION#0.8603;NEURAL TUBE#0.8598;ETHANOL#0.8585;INDUCED PLURIPOTENT STEM CELL#0.8580;LUNG DEVELOPMENT#0.8570;PERIPHERAL NERVE#0.8565;DNA METHYLATION#0.8562;HYPERTENSION#0.8554;RNA BINDING#0.8550;ISCHEMIA REPERFUSION INJURY#0.8549;HISTONE DEACETYLASE#0.8542;CELL CELL JUNCTION#0.8538;HEPATOCYTE DIFFERENTIATION#0.8531;INFLAMMATORY RESPONSE#0.8525;O CELL#0.8525;VIRULENCE#0.8523;CYTOKINESIS#0.8522;DERMAL FIBROBLAST#0.8468;EPITHELIAL CELL PROLIFERATION#0.8442;GLUCOSE UPTAKE#0.8435;CANCER ASSOCIATED FIBROBLASTS#0.8410;OVERALL SURVIVAL RATE#0.8358;KINASE ACTIVATOR#0.8357;EPITHELIAL OVARIAN CANCER#0.8352;ACTIN BINDING#0.8347;MENADIONE#0.8345;DNA DAMAGE RESPONSE#0.8342;OSTEOARTHRITIS#0.8339;FOCAL ADHESION KINASE#0.8338;MALIGNANT PLEURAL MESOTHELIOMA#0.8314;PROTEIN SYNTHESIS#0.8313;MESOTHELIOMA CELL#0.8275;MYOFIBROBLAST DIFFERENTIATION#0.8268;HYPERSENSITIVITY#0.8265;BLASTOCYST FORMATION#0.8263;CELLULAR METABOLISM#0.8255;PRIMORDIAL FOLLICLE ACTIVATION#0.8224;PROTEIN KINASE C#0.8224;REGULATION OF HIPPO SIGNALING#0.8221;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8195;POST-TRANSLATIONAL MODIFICATION#0.8184;VSMC APOPTOSIS#0.8176;FERMENTATION#0.8167;TROPHOBLAST CELL#0.8158;CILIOGENESIS#0.8142;DEUBIQUITINASE#0.8139;PLATELET-DERIVED GROWTH FACTOR#0.8120;TUMOR NECROSIS FACTOR#0.8117;BONE DEVELOPMENT#0.8115;NOTCH SIGNALING PATHWAY#0.8107;SPROUTING ANGIOGENESIS#0.8106;OSTEOCLAST#0.8081;CELL CYCLE CONTROL#0.8066;BREAST CARCINOMA#0.8057;BASAL CELL CARCINOMA#0.8043;CYCLIC AMP#0.8029;CHONDROCYTE PROLIFERATION#0.8020;ADIPOCYTE#0.8006;BLOOD BRAIN BARRIER#0.8004;CELL NUCLEUS#0.8000;ARTERY#0.7999;NORMAL ORAL MUCOSA#0.7995;GRANULOSA CELL PROLIFERATION#0.7993;GLUTAMINE METABOLISM#0.7991;EYE DEVELOPMENT#0.7990;HYPERACTIVE#0.7982;INTERVERTEBRAL DISC DEGENERATION#0.7974;HUMAN MESENCHYMAL STEM#0.7952;CELLULAR GROWTH#0.7946;HYALURONIC ACID#0.7945;KIDNEY DEVELOPMENT#0.7941;OVARIAN SEROUS CYSTADENOCARCINOMA#0.7938;EFFLUX PUMP#0.7935;PROTEIN TYROSINE PHOSPHATASE#0.7928;PULMONARY HYPERTENSION#0.7918;PROTEIN COMPLEX#0.7917;LINES OF EVIDENCE#0.7915;GLIAL CELL#0.7897;TRANSFORMING GROWTH FACTOR BETA#0.7878;INTERVERTEBRAL DISC#0.7877;VEGF SIGNALING#0.7873;ORAL MUCOSA#0.7871;ENDOPLASMIC RETICULUM#0.7864;MYELINATION#0.7864;GAMMA-GLUTAMYLCYSTEINE#0.7864;INTRAHEPATIC CHOLANGIOCARCINOMA#0.7855;ADVANCED GASTRIC CANCER#0.7842;ASTROCYTE#0.7826;LIVER METASTASIS#0.7826;MYOGENESIS#0.7819;GASTRIC MUCOSA#0.7788;DOXORUBICIN#0.7784;MICROVASCULAR ENDOTHELIAL CELL#0.7784;SEQUESTERING#0.7783;PANCREATIC STELLATE CELL#0.7781;OVARIES#0.7780;ACTIN FILAMENT#0.7780;FIN REGENERATION#0.7777;HUMAN EMBRYONIC STEM#0.7771;INHIBITION OF CELL PROLIFERATION#0.7755;RECURRENCE FREE SURVIVAL#0.7741;VASCULAR ENDOTHELIAL CELL#0.7741;MINERALIZATION#0.7732;LUCIFERASE ACTIVITY#0.7729;RNA BINDING PROTEIN#0.7711;M PHASE#0.7704;OSSIFICATION#0.7686;SEROUS CYSTADENOCARCINOMA#0.7685;ANDROGEN RECEPTOR#0.7683;TOOTH MORPHOGENESIS#0.7679;MONOCYTE#0.7670;AGGRESSIVE BEHAVIOR#0.7669;MELANOCYTE#0.7647;HUMAN PERIODONTAL LIGAMENT#0.7620;GEFITINIB#0.7614;EMBRYO DEVELOPMENT#0.7612;CELL WALL#0.7602;EPITHELIAL PROGENITOR CELL#0.7588;BRANCHING MORPHOGENESIS#0.7580;TRANSLATION INITIATION#0.7577;CANCER RELATED DEATH#0.7576;POLYCYSTIC OVARY SYNDROME#0.7569;MYOCARDIUM#0.7569;TROPHOBLAST#0.7539;BONE RESORPTION#0.7512;BONE REMODELING#0.7504;ADENOSINE MONOPHOSPHATE#0.7489;ENDOMETRIOSIS#0.7466;CETUXIMAB#0.7456;ENDOTHELIUM#0.7455;NOTCH LIGAND#0.7447;INHIBITION OF GROWTH#0.7436;UBIQUITIN PROTEIN LIGASE#0.7432;MACROPHAGE POLARIZATION#0.7428;STATIONARY PHASE#0.7423;ENDOMETRIUM#0.7410;LUNG DISEASE#0.7402;PLANAR CELL POLARITY#0.7400;ALANINE#0.7396;LATRUNCULIN B#0.7393;MOUSE EMBRYONIC STEM#0.7389;MECHANISM OF ACTION#0.7386;PAPILLARY CARCINOMA#0.7385;BONE REGENERATION#0.7381;CELL MEMBRANE#0.7377;TIGHT JUNCTION PROTEIN#0.7376;LONGISSIMUS DORSI MUSCLE#0.7371;LIVER PROGENITOR CELL#0.7367;NUCLEOTIDE BIOSYNTHESIS#0.7365;LUNG GROWTH#0.7329;OSTEOCLAST DIFFERENTIATION#0.7328;NUCLEIC ACID#0.7328;HIGH FAT DIET#0.7319;RETINOIC ACID#0.7314;SWI-SNF COMPLEX#0.7310;MITOCHONDRIAL FUSION#0.7276;MICROTUBULE#0.7268;SKELETAL DEVELOPMENT#0.7266;COLITIS#0.7251;IMMUNE SYSTEM#0.7251;ADENOSINE#0.7247;NUCLEAR PORE#0.7246;CELLULAR HOMEOSTASIS#0.7241;REGULATION OF CELLULAR#0.7236;LIPOSARCOMA#0.7226;CELL FATE DETERMINATION#0.7213;NEPHROPATHY#0.7212;FILAMENTOUS ACTIN#0.7206;RENAL FIBROSIS#0.7202;NULL CELL#0.7196;NADPH OXIDASE#0.7184;PACLITAXEL#0.7174;CERIVASTATIN#0.7159;FEED FORWARD LOOP#0.7155;HEART DISEASE#0.7153;METAPLASIA#0.7145;MACULAR DEGENERATION#0.7142;HEPATOMA CELLS#0.7135;ADIPOSE TISSUE#0.7130;B CELL LYMPHOMA#0.7124;CELL ADHESION MOLECULE#0.7094;CD8+ T CELL#0.7086;5 FLUOROURACIL#0.7065;NUCLEAR EXPORT SIGNAL#0.7064;MECHANISMS OF ACTION#0.7054;BASEMENT MEMBRANE#0.7051;PEROXISOME#0.7046;IMMUNE EVASION#0.7025;NEPHRON#0.7014;COLUMNAR#0.7009;INTRACELLULAR LOCALIZATION#0.6998;MELANOMA CELL LINES#0.6989;HEPATIC STELLATE CELL ACTIVATION#0.6977;TRABECULAR MESHWORK CELLS#0.6970;FATTY LIVER DISEASE#0.6962;RESVERATROL#0.6957;FATTY LIVER#0.6951;MUSCULAR DYSTROPHY#0.6948;CARDIOMYOPATHY#0.6945;GERM CELL#0.6945;MIRNA BIOGENESIS#0.6931;GLOMERULAR FILTRATION#0.6929;GLUTATHIONE BIOSYNTHESIS#0.6911;ATP BINDING CASSETTE#0.6890;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6882;COLOBOMA#0.6881;RESPIRATION#0.6880;ATP BINDING#0.6875;ORGAN REGENERATION#0.6874;CHONDROGENESIS#0.6863;BODY WEIGHT RATIO#0.6858;M2 MACROPHAGE#0.6841;YOLK SAC#0.6839;PERIODONTAL LIGAMENT STEM CELL#0.6833;MYOTUBE#0.6827;PRIMARY BREAST CANCER#0.6827;CYCLIC ADENOSINE MONOPHOSPHATE#0.6820;ACINAR CELL#0.6811;FORSKOLIN#0.6806;CELL DEVELOPMENT#0.6802;LIVER CIRRHOSIS#0.6791;RIBOSOMAL PROTEIN#0.6787;NUCLEUS PULPOSUS CELL#0.6785;PROGESTERONE#0.6777;DIABETIC NEPHROPATHY#0.6777;EMBRYONIC HEART#0.6776;CELL MATRIX ADHESION#0.6763;MIDGUT#0.6759;NUCLEUS PULPOSUS#0.6717;REGULATION OF GENE EXPRESSION#0.6712;MYELOID-DERIVED SUPPRESSOR CELL#0.6701;ACTIN BINDING PROTEIN#0.6693;ATP BINDING CASSETTE TRANSPORTER#0.6681;SUMOYLATION#0.6680;TAXOL#0.6679;COLLAGEN TYPE I#0.6671;ADRIAMYCIN#0.6660;ABC TRANSPORTER#0.6659;PROTEIN FOLDING#0.6651;ALKALINE PHOSPHATASE#0.6649;IMATINIB#0.6644;MITOCHONDRIAL DAMAGE#0.6639;TRAMETINIB#0.6612;INSULIN RECEPTOR#0.6604;DILATED CARDIOMYOPATHY#0.6602;ATHEROSCLEROTIC#0.6597;NEURITE OUTGROWTH#0.6575;UBIQUITIN LIGASE COMPLEX#0.6562;QUANTITATIVE REVERSE TRANSCRIPTION#0.6538;ANGIOSARCOMA#0.6523;LEUKEMIA INHIBITORY FACTOR#0.6498;FIBROBLAST GROWTH FACTOR#0.6498;PAPILLARY THYROID CARCINOMA#0.6493;INVASIVE BREAST CANCER#0.6493;DOBUTAMINE#0.6486;POSTTRANSLATIONAL MODIFICATION#0.6472;TRANSCRIPTASE#0.6468;IDIOPATHIC PULMONARY FIBROSIS#0.6448;HUMAN BRONCHIAL EPITHELIAL#0.6440;STEM CELL FACTOR#0.6433;BRONCHIAL EPITHELIAL CELLS#0.6430;PALMITATE#0.6425;OVARIAN FOLLICLE DEVELOPMENT#0.6423;COLORECTAL CARCINOMA#0.6421;PREADIPOCYTE#0.6408;BONE MORPHOGENETIC PROTEIN#0.6397;TUMOR-PROPAGATING CELL#0.6396;ENTEROCYTE#0.6390;HEPATOBLAST#0.6346;MUSCLE STEM CELL#0.6345;LEUKOCYTE#0.6338;ANKYRIN REPEAT DOMAIN#0.6332;OVAL CELL#0.6323;SPECTRIN#0.6299;SALIVARY GLAND CELL DEATH#0.6297;ADULT STEM CELL#0.6292;AXIS ELONGATION#0.6282;GENE EXPRESSION OMNIBUS#0.6276;CYCLIN DEPENDENT KINASE#0.6274;TISSUE REMODELING#0.6262;GERMLINE STEM CELL#0.6261;TUMOR ASSOCIATED MACROPHAGE#0.6249;EWING SARCOMA#0.6243;STEAROYL COA DESATURASE#0.6239;HEART DEVELOPMENT#0.6239;MESENCHYMAL STROMAL CELL#0.6237;PHOTORECEPTOR CELL#0.6237;PHOSPHATASE ACTIVITY#0.6226;GENETICALLY ENGINEERED MOUSE#0.6221;DISEASE SPECIFIC SURVIVAL#0.6219;EPITHELIAL STEM CELL#0.6217;FLUOROURACIL#0.6216;TUMOR INITIATING CELL#0.6213;GROWTH REGULATOR#0.6212;HEPATOCYTE NUCLEAR FACTOR#0.6212;INHIBITION OF APOPTOSIS#0.6210;ENDOTHELIAL CELL PROLIFERATION#0.6207;EMBRYONIC KIDNEY#0.6206;REGULATION OF CELL GROWTH#0.6204;HYDROCEPHALUS#0.6203;FERROPTOSIS#0.6189;OSTEOCYTE#0.6178;TARGET OF RAPAMYCIN COMPLEX#0.6176;NURD COMPLEX#0.6164;LIPOGENESIS#0.6149;GALECTIN#0.6146;MOUSE EMBRYONIC FIBROBLAST#0.6141;DRG DEVELOPMENT#0.6139;OVULATION#0.6127;LIVER DAMAGE#0.6123;MITOCHONDRIAL DNA#0.6116;NEURITE#0.6110;GLOMERULAR FILTRATION BARRIER#0.6103;PROTEIN STABILIZATION#0.6102;ERBB SIGNALING PATHWAY#0.6091;INTRINSICALLY DISORDERED PROTEIN#0.6088;MYELOID LEUKEMIA#0.6086;AUTOPHAGOSOME#0.6064;ENDOSOME#0.6046;UNDIFFERENTIATED PLEOMORPHIC SARCOMA#0.6042;SYNOVIAL SARCOMA#0.6037;AIRWAY SMOOTH MUSCLE#0.6010;FATTY ACID METABOLISM#0.6006;CARDINAL VEIN#0.6003
10415	MODE OF ACTION#0.8089;HUMAN BREAST CANCER#0.8058;BREAST CANCER CELL#0.8018;BREAST CANCER#0.7966;CANCER CELL#0.7951
10417	EXTRACELLULAR MATRIX#1.0655;IMMUNE RESPONSE#1.0250;PROSTATE CANCER#1.0071;MACROPHAGE#0.9765;DIABETIC NEPHROPATHY#0.9487;INNATE IMMUNE RESPONSE#0.8715;OVARIAN CANCER#0.8648;GENE EXPRESSION#0.8582;ANGIOGENESIS#0.8543;AKT SIGNALING#0.8230;HEPATOCELLULAR CARCINOMA#0.8064;FOAM CELL FORMATION#0.7911;REVERSE TRANSCRIPTION#0.7866;INTEGRIN LIGAND#0.7825;QUANTITATIVE REVERSE TRANSCRIPTION#0.7805;NEPHROPATHY#0.7777;POLYMERASE CHAIN REACTION#0.7715;APOPTOSIS#0.7695;INFLAMMATORY CELL#0.7606;CELL MIGRATION#0.7579;GROWTH FACTOR#0.7347;COLORECTAL#0.7020;PROSTATE SPECIFIC ANTIGEN#0.6945;OVARIAN#0.6943;COLON CANCER#0.6939;LYMPH NODE#0.6873;COLORECTAL CANCER#0.6710;ALLERGIC AIRWAYS DISEASE#0.6420;IMMUNE SYSTEM#0.6207;CELL PROLIFERATION#0.6179;CYTOKINE PRODUCTION#0.6097;T LYMPHOCYTE#0.6067;SMOOTH MUSCLE#0.6059;TUMOR CELLS#0.6055;ENDOTHELIAL CELL#0.6006
10418	FLOOR PLATE#1.0728;EXTRACELLULAR MATRIX#1.0305;GENE EXPRESSION#0.9561;SMOOTH MUSCLE#0.9360;NEURITE#0.9165;CELL MIGRATION#0.9058;NERVOUS SYSTEM#0.9055;OVARIAN#0.8792;VASCULAR SMOOTH MUSCLE CELL#0.8662;SMOOTH MUSCLE CELL#0.8631;MUSCLE CELL#0.8622;BASEMENT MEMBRANE#0.8622;AMYLOID PRECURSOR PROTEIN#0.8190;CELL GROWTH#0.8118;CELL ADHESION#0.7734;GROWTH FACTOR#0.7704;PERIODONTAL LIGAMENT#0.7309;SPINAL CORD#0.7209;CELL DEATH#0.6995;OVARIAN CARCINOMA#0.6945;RETINOIC ACID#0.6896;OVARIAN CANCER#0.6891;STEM CELL#0.6824;T CELL#0.6783;APOPTOSIS#0.6627;RETINOIC ACID BINDING#0.6284;NEURITE OUTGROWTH#0.6232;IL-6 PRODUCTION#0.6137;PERIPHERAL NERVE#0.6091;AKT SIGNALING#0.6085
10419	METHYLOSOME#1.1009;B CELL#1.0632;LUNG CANCER#1.0622;METHYLTRANSFERASE ACTIVITY#1.0573;BINDING PROTEIN 1#1.0558;BREAST CANCER#1.0543;HISTONE ARGININE METHYLATION#1.0500;GERM CELL#1.0446;CELL GROWTH#1.0362;CYTOPLASM#1.0359;ARGININE#1.0280;PROTEIN METHYLTRANSFERASE#1.0271;CANCER CELL#1.0270;CELL PROLIFERATION#1.0244;TUMOR SUPPRESSOR#1.0231;PROSTATE CANCER#1.0204;STEM CELL#1.0196;APOPTOSIS#1.0148;SIGNALING PATHWAY#1.0110;CELL CYCLE#1.0091;HEPATOCELLULAR CARCINOMA#1.0069;T CELL#1.0053;DNA BINDING#1.0020;GENE EXPRESSION#1.0013;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.9977;TRANSCRIPTION FACTOR#0.9968;CELL DEATH#0.9940;CHROMATIN REMODELING#0.9907;S-ADENOSYLMETHIONINE#0.9833;PROGENITOR CELL#0.9825;ONCOGENIC#0.9814;LYSINE#0.9763;POST-TRANSLATIONAL MODIFICATION#0.9670;MRNA SPLICING#0.9518;N METHYLTRANSFERASE#0.9432;PROTEIN KINASE#0.9345;EPITHELIAL CELL#0.9339;GROWTH FACTOR#0.9274;HISTONE METHYLATION#0.9194;CELL DEVELOPMENT#0.9174;CELL CYCLE ARREST#0.9031;MANTLE CELL LYMPHOMA#0.9015;HISTONE MODIFICATION#0.8992;HISTONE DEACETYLASE#0.8964;DNA METHYLATION#0.8935;RNA PROCESSING#0.8922;CELL DIFFERENTIATION#0.8892;METHIONINE#0.8832;PRE-MRNA SPLICING#0.8766;DNA REPAIR#0.8749;KINASE BINDING#0.8743;POSTTRANSLATIONAL MODIFICATION#0.8712;UBIQUITIN#0.8649;THYMIDINE#0.8628;ANDROGEN RECEPTOR#0.8543;SIGNAL TRANSDUCTION#0.8527;RNA BINDING#0.8441;PANCREATIC CANCER#0.8409;ACUTE MYELOID LEUKEMIA#0.8401;MYELOID LEUKEMIA#0.8385;SQUAMOUS CELL CARCINOMA#0.8365;MYOGENESIS#0.8356;COMPLEX I#0.8351;GLOBIN#0.8349;SMN COMPLEX#0.8308;GERM CELL DEVELOPMENT#0.8305;OLIGODENDROCYTE DIFFERENTIATION#0.8177;PRIMORDIAL GERM CELL#0.8135;L-METHIONINE#0.8085;RNA SPLICING#0.8056;HISTONE METHYLTRANSFERASE#0.8051;B CELL LYMPHOMA#0.8044;SURVIVAL MOTOR NEURON#0.8002;DNA METHYLTRANSFERASE#0.7998;SKELETAL MUSCLE#0.7967;RNA INTERFERENCE#0.7966;PROTEIN METHYLTRANSFERASE ACTIVITY#0.7959;COLORECTAL CANCER#0.7954;B LYMPHOCYTE#0.7933;PROTEIN METHYLATION#0.7882;FLOWERING#0.7738;COLORECTAL#0.7718;CATALYTIC ACTIVITY#0.7623;CANCER STEM CELL#0.7594;BREAST CANCER CELL#0.7549;ENZYME ACTIVITY#0.7546;HYPOXIA#0.7487;CYCLIN DEPENDENT KINASE#0.7471;DEMETHYLATION#0.7433;LUNG ADENOCARCINOMA#0.7411;VIRAL GENE EXPRESSION#0.7387;APOPTOTIC#0.7327;REGULATION OF GENE EXPRESSION#0.7315;EPITHELIAL MESENCHYMAL TRANSITION#0.7283;GENE SILENCING#0.7255;MYELINATION#0.7214;CELL SURFACE#0.7201;S-ADENOSYL-L-METHIONINE#0.7109;EPSTEIN BARR VIRUS#0.7090;THYMINE#0.6952;LYMPHOMA CELL LINES#0.6853;SENESCENCE#0.6844;KERATINOCYTE DIFFERENTIATION#0.6825;IMMUNE RESPONSE#0.6824;ENDOTHELIAL CELL#0.6754;SIGNALING CASCADE#0.6737;BONE MARROW#0.6688;GLUTATHIONE#0.6672;EMBRYONIC STEM CELL#0.6619;SPLICEOSOME#0.6602;CHROMATIN MODIFICATION#0.6596;MITOSIS#0.6577;MITOGEN ACTIVATED PROTEIN#0.6573;ERYTHROID PROGENITOR#0.6565;TUMOR CELLS#0.6502;METHYLASE#0.6483;HISTONE BINDING#0.6393;CIRCADIAN RHYTHM#0.6320;OLIGODENDROCYTE#0.6249;KERATINOCYTE#0.6219;GROWTH FACTOR RECEPTOR#0.6212;PRMT ACTIVITY#0.6186;RETINOBLASTOMA#0.6148;GLYCINE#0.6124;ADJACENT NORMAL TISSUE#0.6108;OOCYTE#0.6104;ZINC FINGER PROTEIN#0.6097;ADENOCARCINOMA#0.6094;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6076;EPITHELIAL TO MESENCHYMAL#0.6074;HOMOLOGOUS RECOMBINATION#0.6059;QUANTITATIVE REAL TIME#0.6037;COLON CANCER#0.6029;RESPONSE TO TNF#0.6028;LYMPH NODE#0.6011
1041	PEELING#1.0703;HAIR FOLLICLE#1.0523;SKIN DISEASE#1.0520;PSORIASIS#1.0507;DESMOSOME#1.0174;KERATINOCYTE#1.0108;HYPOTRICHOSIS#0.9845;PEELING SKIN SYNDROME#0.9818;SCALP#0.9514;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8745;ATOPIC DERMATITIS#0.8682;LAYER BY LAYER#0.8283;DERMATITIS#0.7975;ROOT SHEATH#0.7948;CELL ADHESION#0.7148;HUMAN LEUKOCYTE ANTIGEN#0.7100;GENE EXPRESSION#0.7061;CELL CELL ADHESION#0.7054;GLYCINE#0.7006;CORNIFIED ENVELOPE#0.6454;CORNIFICATION#0.6382;TIGHT JUNCTION#0.6301;GROWTH FACTOR#0.6271;LEUKOCYTE#0.6014;PROTEIN PROTEIN INTERACTION#0.6001
10420	PROTEIN KINASE#0.9095;SERTOLI CELL#0.6840;KINASE ACTIVITY#0.6751
10421	TRANSCRIPTION FACTOR#1.0743;SIGNALING PATHWAY#1.0212;MAP KINASE#0.9940;T CELL#0.9633;U5 SNRNP#0.8672;PRECURSOR CELL#0.8176;RECEPTOR TYROSINE KINASE#0.7679;SIGNAL TRANSDUCTION#0.7212;CARCINOMA IN SITU#0.6978;VULVA#0.6865;VULVAL DEVELOPMENT#0.6836;DENDRITIC CELL#0.6038;SUMOYLATION#0.6020
10422	CEFTAZIDIME#1.0237;COLISTIN#1.0021;WHOLE GENOME SEQUENCING#0.9984;CLAVULANIC ACID#0.9982;IMIPENEM#0.9938;TIGECYCLINE#0.9925;MEROPENEM#0.9864;ERTAPENEM#0.9807;VIRULENCE#0.9704;POLYMERASE CHAIN REACTION#0.9647;METALLO BETA LACTAMASE#0.9633;CONJUGATION#0.9603;INTENSIVE CARE UNIT#0.9559;GENTAMICIN#0.9456;MINIMUM INHIBITORY CONCENTRATION#0.9403;DRUG RESISTANCE#0.9383;PNEUMONIA#0.9259;AMIKACIN#0.9162;AZTREONAM#0.9107;WASTEWATER TREATMENT PLANT#0.9089;FOSFOMYCIN#0.9017;CEFOTAXIME#0.9010;ANTIMICROBIAL SUSCEPTIBILITY TESTING#0.8947;TAZOBACTAM#0.8815;UBIQUITIN#0.8400;CLAVULANATE#0.8348;CEFEPIME#0.7928;METHYLASE#0.7671;OUTER MEMBRANE#0.7640;CYSTIC FIBROSIS#0.7227;CIPROFLOXACIN#0.7217;PENICILLIN#0.7204;AMPICILLIN#0.7168;URINARY TRACT INFECTION#0.7099;MOLECULAR DYNAMICS SIMULATION#0.6913;GENE EXPRESSION#0.6664;MINIMAL INHIBITORY CONCENTRATION#0.6300;RRNA METHYLTRANSFERASE#0.6265;CEFTRIAXONE#0.6219;CYTOPLASM#0.6189;PHENYL BORONIC ACID#0.6188;PIPERACILLIN#0.6178;RESPIRATORY TRACT#0.6003
10423	MYO-INOSITOL#1.0448;PHOSPHOLIPID BIOSYNTHETIC#1.0268;ENDOPLASMIC RETICULUM#1.0232;PHOSPHATIDYLSERINE#1.0170;PLASMA MEMBRANE#1.0015;ALPHA 1-ANTITRYPSIN#0.9855;PHOSPHOLIPASE C#0.9442;GENE EXPRESSION#0.9266;PHOSPHATIDYLINOSITOL SYNTHESIS#0.9255;CYTIDINE#0.8746;ALPHA 1-ANTITRYPSIN DEFICIENCY#0.8741;PHOSPHOLIPID SYNTHESIS#0.8684;CHOLINE#0.8409;PHOSPHATIDYLETHANOLAMINE#0.8285;CELL MEMBRANE#0.8224;PHOSPHOLIPID BIOSYNTHESIS#0.7866;AUTOPHAGOSOME FORMATION#0.7733;EPITHELIAL CELL#0.7729;ERYTHROCYTE#0.7700;MICROSOME#0.7576;LIVER DISEASE#0.7430;MEMBRANE FRACTION#0.7193;TRANSCRIPTION FACTOR#0.6905;L-SERINE#0.6683;SIGNAL TRANSDUCTION#0.6648;AUXIN TRANSPORT INHIBITOR#0.6537;AUTOPHAGY-INITIATION COMPLEX#0.6447;CARBACHOL#0.6422;POLAR AUXIN TRANSPORT#0.6366;CELL GROWTH#0.6340;ULK COMPLEX#0.6237;AUXIN TRANSPORT#0.6230;RETINAL PIGMENT EPITHELIAL#0.6067
10424	PROGESTERONE#1.0570;CELL CYCLE#1.0278;PROGESTIN#0.9870;ESTROUS CYCLE#0.9615;GRANULOSA CELL#0.9069;OVARIAN#0.8618;GENE EXPRESSION#0.8568;MRNA BINDING#0.7846;OOCYTE#0.7840;BINDING PROTEIN 1#0.7741;ENDOMETRIUM#0.7566;CYTOCHROME P450#0.6765;APOPTOSIS#0.6651;CELL PROLIFERATION#0.6649;OVIDUCT#0.6596;OOCYTE MATURATION#0.6596;STEROID BINDING#0.6584;ENDOMETRIOSIS#0.6555;CANCER CELL#0.6458;MITOTIC SPINDLE#0.6259;MITOSIS#0.6174;MEMBRANE PROGESTIN RECEPTOR#0.6163;OVARIAN CANCER#0.6100
10425	UBIQUITIN#1.0501;MYELOID CELL#0.8802;MYELOID PROGENITOR CELL#0.8543;LIGASE ACTIVITY#0.8461;PROGENITOR CELL#0.8178;BONE MARROW#0.8147;APOPTOSIS#0.6469;MYO-INOSITOL#0.6361;ELECTRON TRANSFER#0.6167;STEM CELL#0.6156;CANCER CELL#0.6146;PROTEASOME#0.6120
10426	GAMMA TUBULIN COMPLEX#1.0986;TUBULIN COMPLEX#1.0858;SPINDLE POLE BODY#1.0743;SPINDLE POLE#1.0640;MICROTUBULE#1.0258;MICROTUBULE NUCLEATION#1.0245;CENTROSOME#0.9228;CELL CYCLE#0.8608;MICROTUBULE ORGANIZING CENTER#0.8092;MITOTIC SPINDLE#0.7791;COMPLEX I#0.7062
10427	COPII VESICLE#1.0844;ENDOPLASMIC RETICULUM#0.9981;PROTEIN COMPLEX#0.9959;COMPLEX II#0.9815;NEURAL TUBE#0.9469;COATED VESICLE#0.8350;COPII-COATED VESICLE#0.7933;ER EXIT#0.7840;PROTEIN TRANSPORT#0.7801;CARGO SELECTION#0.7501;SECRETORY PATHWAY#0.7263;NEURAL TUBE CLOSURE#0.7190;TUBE CLOSURE#0.7188;VESICLE FORMATION#0.6833;TRANSPORT VESICLE#0.6824;PLASMA MEMBRANE#0.6629;BUDDING#0.6550;GOLGI APPARATUS#0.6532;ER TO GOLGI TRANSPORT#0.6399;CELL SURFACE#0.6124
10428	CRANIOFACIAL DEVELOPMENT#1.0055;CHROMATIN ORGANIZATION#0.7251;GENE EXPRESSION#0.7109;CORONARY ARTERY DISEASE#0.6378;ARTERY DISEASE#0.6376;CORONARY ARTERY#0.6356
10430	ENDOPLASMIC RETICULUM#0.7230;PLASMA MEMBRANE#0.6532;CELL PROLIFERATION#0.6294;COLON CANCER#0.6251
104326057	CELL GROWTH#0.7121
104326192	INFLAMMATORY CELL#0.9041;HEMORRHAGE#0.6492
10432	RNA BINDING#1.0445;RNA BINDING PROTEIN#1.0046;CELL DIFFERENTIATION#0.9101;STEM CELL#0.8188;TRANSCRIPTION FACTOR#0.7352;RNA SPLICING#0.7180;PARASPECKLES#0.6202;GENE EXPRESSION#0.6172;CELL PROLIFERATION#0.6125;MESODERM DEVELOPMENT#0.6037
10434	ACYL PROTEIN THIOESTERASE#1.1024;SYNAPTIC FACILITATION#1.0578;SENSITIZATION#1.0282;PALMITOYL#0.9067;TRANSCRIPTION FACTOR#0.8497;LYSOPHOSPHOLIPASE ACTIVITY#0.8375;SERINE HYDROLASE#0.7951;PALMITATE#0.6949;PLASMA MEMBRANE#0.6835;PROTEIN KINASE#0.6813;NITRIC OXIDE#0.6802;PROTEIN PALMITOYLATION#0.6680;ENZYME ACTIVITY#0.6304;DENDRITIC SPINE#0.6137;CHOLINERGIC NEURON#0.6135;OPIOID PEPTIDE#0.6135;LIPID DROPLET#0.6065
104355217	APOPTOSIS#0.6411
104355290	LUNG CANCER#0.8997
10435	MYOBLAST DIFFERENTIATION#0.6866
10436	RIBOSOME BIOGENESIS#1.0600;RIBOSOME#1.0435;CELL DEATH#1.0002;RIBOSOME ASSEMBLY#0.7895;VIRULENCE#0.7804;TRANSCRIPTION FACTOR#0.7682;GENE EXPRESSION#0.7318;RIBOSOMAL SUBUNIT#0.7316;RIBOSOMAL PROTEIN#0.7176;IMMUNE RESPONSE#0.7029;40S RIBOSOMAL SUBUNIT#0.6672;STOMATAL CLOSURE#0.6469;PROTEIN KINASE#0.6174;MITOGEN ACTIVATED PROTEIN#0.6030
10437	ANTIGEN PROCESSING#1.0594;T CELL#1.0439;IMMUNE RESPONSE#1.0165;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0047;ANTIGEN PRESENTING CELLS#0.9507;B CELL#0.9287;ANTIGEN PRESENTATION#0.9192;CD4+ T CELL#0.8980;MACROPHAGE#0.8737;IFN-GAMMA#0.8733;LYSOSOME#0.8275;GENE EXPRESSION#0.8202;GLYCOSYLATION#0.8068;INNATE IMMUNE RESPONSE#0.7899;MELANOCYTE#0.7728;ANTIGEN PROCESSING AND PRESENTATION#0.7560;APOPTOSIS#0.7490;IMMUNE SYSTEM#0.7330;CELL PROLIFERATION#0.6996;SIGNAL PEPTIDE#0.6994;AUTOPHAGY#0.6935;METASTATIC MELANOMA#0.6933;SUPEROXIDE DISMUTASE#0.6604;CROSS PRESENTATION#0.6532;PHAGOSOME#0.6521;MELANOCYTE DIFFERENTIATION#0.6378;CELL RECOGNITION#0.6303;DISEASE FREE SURVIVAL#0.6084;NADPH OXIDASE#0.6049;SIGNAL TRANSDUCER#0.6035;MECHANISM OF ACTION#0.6014
10438	HIGH MOBILITY GROUP#1.0801;EXOSOME#1.0630;DNA BINDING#1.0613;RNA PROCESSING#0.9442;TRANSCRIPTION FACTOR#0.8338;POLY ADP RIBOSE#0.8296;GENE EXPRESSION#0.7876;DNA REPAIR#0.7584;INFLAMMATORY RESPONSE#0.7512;NUCLEAR MATRIX#0.6965;RIBOSE#0.6877;MACROPHAGE#0.6643;PROTEIN KINASE#0.6551;DOUBLE STRAND BREAK#0.6434;RRNA PROCESSING#0.6243;RNA BINDING#0.6186;RNA SURVEILLANCE#0.6057
10439	NEURAL CREST#1.0280;EPITHELIAL CELL#0.9565;NEURAL CREST CELL#0.8401;CELL DEATH#0.8338;NEURAL TUBE#0.8243;OPTIC NERVE#0.8219;CEREBRAL CORTEX#0.8186;NERVOUS SYSTEM#0.7800;NEUROBLASTOMA#0.7484;SIGNALING PATHWAY#0.7458;AMPA RECEPTOR#0.7066;RETINAL GANGLION CELL#0.7058;OLFACTORY BULB#0.7056;EMBRYO IMPLANTATION#0.6408;MEMBRANE FRACTION#0.6227
1043	CAMPATH#1.0499;ALEMTUZUMAB#1.0452;MONOCYTE#1.0450;CELL SURFACE#1.0371;B LYMPHOCYTE#1.0326;EPIDIDYMIS#1.0247;SPERMATOZOA#1.0235;IMMUNE CELL#1.0230;CD4+ T CELL#1.0221;T LYMPHOCYTE#1.0160;SEMINAL PLASMA#1.0127;LEUKOCYTE#1.0063;EOSINOPHIL#1.0061;RITUXIMAB#0.9997;GRAFT VERSUS HOST#0.9978;PLASMA CELL#0.9970;T CELL#0.9968;LYMPHOCYTIC LEUKEMIA#0.9964;B CELL#0.9963;MULTIPLE SCLEROSIS#0.9960;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9960;CYTOTOXICITY#0.9939;DENDRITIC CELL#0.9917;CELL ACTIVATION#0.9892;BONE MARROW#0.9877;STEM CELL#0.9876;FLUDARABINE#0.9873;STEM CELL TRANSPLANTATION#0.9838;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.9797;PERIPHERAL BLOOD#0.9790;T CELL ACTIVATION#0.9735;CELL SURFACE ANTIGEN#0.9717;IMMUNE SYSTEM#0.9716;RHEUMATOID ARTHRITIS#0.9661;MACROPHAGE#0.9649;GENE EXPRESSION#0.9640;AUTOIMMUNE DISEASE#0.9627;PROLYMPHOCYTIC LEUKEMIA#0.9593;NEUTROPHIL#0.9592;LYSIS#0.9587;HODGKIN'S LYMPHOMA#0.9585;TUMOR CELLS#0.9583;CD8+ T CELL#0.9563;MONONUCLEAR CELLS#0.9537;HEMATOPOIETIC STEM CELL#0.9498;CYCLOPHOSPHAMIDE#0.9348;APOPTOSIS#0.9296;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9247;TOXICITY#0.9218;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9208;LYMPHOCYTE ANTIGEN#0.9185;B CELL LYMPHOMA#0.9146;PERIPHERAL T-CELL LYMPHOMA#0.9133;EPITHELIAL CELL#0.9052;MULTIPLE MYELOMA#0.9037;IMMUNE RESPONSE#0.8901;CELL DEATH#0.8889;GLYCOSYLATION#0.8829;MECHANISM OF ACTION#0.8752;LECTIN#0.8733;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8729;INFERTILITY#0.8708;LYMPHOPENIA#0.8670;MINIMAL RESIDUAL DISEASE#0.8643;POLYMERASE CHAIN REACTION#0.8605;CAUDA#0.8552;COMPLEMENT DEPENDENT CYTOTOXICITY#0.8543;PROGENITOR CELL#0.8237;GRANULOCYTE#0.8198;LYMPH NODE#0.8159;STEM CELL TRANSPLANT#0.8128;GROWTH FACTOR#0.8043;CYTOTOXIC T-LYMPHOCYTE#0.8032;O GLYCAN#0.7985;LARGE GRANULAR LYMPHOCYTE#0.7979;T-CELL LEUKEMIA#0.7919;AGGLUTINATION#0.7846;INFERTILE#0.7836;NON HODGKIN LYMPHOMA#0.7769;REGULATORY T CELL#0.7683;AUTOIMMUNITY#0.7640;N GLYCAN#0.7634;PHOSPHOLIPASE C#0.7612;NATALIZUMAB#0.7551;MYELOID LEUKEMIA#0.7474;NERVOUS SYSTEM#0.7446;CUTANEOUS T CELL LYMPHOMA#0.7439;LYMPHOID CELL#0.7434;ANTITHYMOCYTE GLOBULIN#0.7405;LYMPHOPROLIFERATIVE DISEASE#0.7368;TUMOR NECROSIS FACTOR#0.7368;CELL PROLIFERATION#0.7361;SEMEN#0.7348;ANEMIA#0.7303;ANTIGEN BINDING#0.7301;CENTRAL NERVOUS SYSTEM#0.7235;CELL MEMBRANE#0.7204;MACROGLOBULINEMIA#0.7167;EPRATUZUMAB#0.7140;LYMPHOPLASMACYTIC LYMPHOMA#0.7128;MYELOID CELL#0.7073;DACLIZUMAB#0.7052;INTERLEUKIN 2 RECEPTOR#0.7017;NATURAL KILLER CELL#0.6973;LANGERHANS CELL#0.6928;INTERFERON BETA-1A#0.6833;T CELL PROLIFERATION#0.6735;CLADRIBINE#0.6734;ANTI-CD33#0.6726;THROMBOCYTOPENIA#0.6665;MANTLE CELL LYMPHOMA#0.6664;HEMATOPOIETIC CELL#0.6609;ANAPLASTIC LARGE CELL LYMPHOMA#0.6551;ACTIVATED T-CELLS#0.6490;ACTIVATED T CELL#0.6487;ACUTE MYELOID LEUKEMIA#0.6485;MECHANISMS OF ACTION#0.6476;SIGNAL TRANSDUCTION#0.6439;GROWTH FACTOR RECEPTOR#0.6437;ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA#0.6436;LEUCOCYTE DIFFERENTIATION#0.6421;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.6420;NEUTROPENIA#0.6406;HAIRY CELL LEUKEMIA#0.6404;MATURE B-CELL NEOPLASM#0.6321;NOT OTHERWISE SPECIFIED#0.6300;TUMOUR NECROSIS FACTOR#0.6298;ERYTHROCYTE#0.6088;ADULT T-CELL LEUKEMIA#0.6044;METHOTREXATE#0.6039;FOLLICULAR LYMPHOMA#0.6029
10440	OUTER MITOCHONDRIAL MEMBRANE#1.0628;MITOCHONDRIAL OUTER MEMBRANE#1.0482;TOM COMPLEX#1.0435;MITOCHONDRIAL INNER MEMBRANE#1.0410;MITOCHONDRIAL MEMBRANE#1.0336;OUTER MEMBRANE#1.0268;INNER MITOCHONDRIAL MEMBRANE#1.0242;COMPLEX I#1.0089;MITOCHONDRIA#0.9984;PROTEIN IMPORT#0.9982;MITOCHONDRIAL PROTEIN IMPORT#0.9817;TIM23 COMPLEX#0.9785;BREAST CANCER#0.9530;BREAST CANCER CELL#0.9024;MEMBRANE OF MITOCHONDRIA#0.8986;CANCER CELL#0.8955;HEAT SHOCK PROTEIN#0.8373;PROTEIN TRANSPORT#0.6968;ATPASE ACTIVITY#0.6267;MITOCHONDRIAL DNA#0.6179;ORGANELLE#0.6055;HUMAN BREAST CANCER#0.6013
104457406	SMOOTH MUSCLE CELL#0.7409;MUSCLE CELL#0.7401;SMOOTH MUSCLE#0.7390;PULMONARY ARTERIAL HYPERTENSION#0.7303;CELL PROLIFERATION#0.6213
10445	CELL PROLIFERATION#1.0943;CELL CYCLE#1.0738;LUNG CANCER#0.9499;CANCER CELL#0.9406;ONCOGENIC#0.8545;NUCLEOLUS#0.8324;TELOMERASE ACTIVITY#0.7762;APOPTOSIS#0.7681;CELL CYCLE ARREST#0.7678;RRNA TRANSCRIPTION#0.7280;GENE EXPRESSION#0.7196;NSL COMPLEX#0.7078;COLORECTAL#0.7018;COLORECTAL CANCER#0.6960;S PHASE#0.6716;SPINDLE ASSEMBLY#0.6572;SIGNALING PATHWAY#0.6431;TRANSCRIPTION FACTOR#0.6238;EPITHELIAL MESENCHYMAL TRANSITION#0.6207;RENAL CELL CARCINOMA#0.6205;CYCLIN DEPENDENT KINASE#0.6194;HEPATOCELLULAR CARCINOMA#0.6164;PROTEIN KINASE#0.6118;CENTRIOLAR SATELLITE#0.6097
10446	LEUCINE RICH REPEAT#0.7128
104472713	PROSTATE CANCER#0.8544;TUMOR SUPPRESSOR#0.7040;SIGNALING PATHWAY#0.6542
104472715	CELL PROLIFERATION#1.1077;SMALL NUCLEOLAR RNA#1.0629;APOPTOSIS#1.0582;CANCER CELL#1.0462;POLYMERASE CHAIN REACTION#1.0100;COLORECTAL CANCER#0.9523;OVARIAN CANCER#0.9415;CELL CYCLE#0.8351;BREAST CANCER#0.8349;QUANTITATIVE REAL TIME#0.8176;COLORECTAL#0.8066;CERVICAL CANCER#0.8024;CELL MIGRATION#0.7597;OVARIAN#0.7538;DUAL LUCIFERASE REPORTER#0.7290;PANCREATIC CANCER#0.7103;LUNG CANCER#0.7055;ADENOCARCINOMA#0.6549;LUNG ADENOCARCINOMA#0.6335;TRASTUZUMAB#0.6140;CERVICAL#0.6073
104472848	BREAST CANCER#0.9407;TUMOR SUPPRESSOR#0.7215;ACUTE MYELOID LEUKEMIA#0.7064;MYELOID LEUKEMIA#0.7050;CELL PROLIFERATION#0.7037;MULTIPLE MYELOMA#0.6795;PANCREATIC CANCER#0.6781;BREAST CANCER CELL#0.6742;CANCER CELL#0.6674
10447	EPITHELIAL TO MESENCHYMAL TRANSITION#1.0255;EPITHELIAL TO MESENCHYMAL#1.0253;EPITHELIAL MESENCHYMAL TRANSITION#1.0066;BREAST CANCER#0.9680;CANCER CELL#0.9314;GROWTH FACTOR#0.7825;GENE EXPRESSION#0.7696;HUMAN BREAST CANCER#0.7631;LIPID METABOLISM#0.7616;SQUAMOUS CELL CARCINOMA#0.7590;BONE MINERAL DENSITY#0.7156;MELANOMA CELL LINES#0.7124;SIGNALING PATHWAY#0.6969;EPITHELIAL CELL#0.6959;TRANSFORMING GROWTH FACTOR#0.6723;GLUCONEOGENESIS#0.6628;PROTEIN KINASE#0.6281;CELL MIGRATION#0.6157;OBESE#0.6104
10449	COENZYME A#1.0718;FATTY ACID OXIDATION#0.9048;BETA-KETOTHIOLASE DEFICIENCY#0.7801;LIPID METABOLISM#0.7668;GENE EXPRESSION#0.7666;APOPTOSIS#0.6679
1044	INTESTINAL EPITHELIAL CELL#1.0638;INTESTINAL DEVELOPMENT#1.0597;COLON CANCER#1.0483;COLORECTAL#1.0396;CANCER CELL#1.0348;COLORECTAL CANCER#1.0322;TRANSCRIPTION FACTOR#1.0203;METAPLASIA#1.0197;COLORECTAL CARCINOMA#1.0168;EPITHELIAL CELL#1.0125;CELL PROLIFERATION#1.0116;GENE EXPRESSION#0.9975;STEM CELL#0.9959;RETINOIC ACID#0.9876;SMALL INTESTINE#0.9869;ADENOCARCINOMA#0.9791;SIGNALING PATHWAY#0.9784;POLYMERASE CHAIN REACTION#0.9718;CELL DIFFERENTIATION#0.9608;TUMOR SUPPRESSOR#0.9596;CELL GROWTH#0.9590;ENTEROCYTE#0.9461;PRIMITIVE STREAK#0.9257;DNA METHYLATION#0.9122;ELECTROPHORETIC MOBILITY SHIFT#0.8995;ESOPHAGUS#0.8967;ONCOGENIC#0.8713;APOPTOSIS#0.8508;BARRETT'S ESOPHAGUS#0.8481;CELL CYCLE#0.8220;GOBLET CELL#0.8130;GASTRIC MUCOSA#0.7932;CANCER STEM CELL#0.7739;GASTRULATION#0.7738;CELL ADHESION#0.7689;HYPOXIA#0.7553;REVERSE TRANSCRIPTION#0.7451;GUT DEVELOPMENT#0.7397;MORPHOGENESIS#0.7377;ENTEROCYTE DIFFERENTIATION#0.7290;GASTROINTESTINAL TRACT#0.7144;DNA BINDING#0.7079;HINDGUT#0.7002;ALKALINE PHOSPHATASE#0.6920;EMBRYONIC STEM CELL#0.6668;URORECTAL SEPTUM#0.6663;SOMITE#0.6554;CERVICAL#0.6373;GESTATION#0.6352;HEPATOCYTE NUCLEAR FACTOR#0.6318;TRANSACTIVATION#0.6260;SIGNALLING PATHWAY#0.6243;T CELL FACTOR#0.6216;TRANSCRIPTASE#0.6158;CELL CELL ADHESION#0.6156;MESENCHYME#0.6050;GASTRIC EPITHELIAL CELLS#0.6041;T CELL#0.6023;INTESTINAL TRACT#0.6017
10450	CYCLOPHILIN#1.0288;RNA BINDING#0.8174
10451	PROSTATE CANCER#1.0650;NUCLEOTIDE EXCHANGE FACTOR#1.0354;CANCER CELL#1.0326;GUANINE#1.0318;ANDROGEN RECEPTOR#1.0111;CELL PROLIFERATION#1.0100;SIGNALING PATHWAY#1.0074;T CELL#0.9999;BREAST CANCER#0.9923;B CELL#0.9895;GROWTH FACTOR#0.9850;CELL GROWTH#0.9818;GENE EXPRESSION#0.9638;APOPTOSIS#0.9584;OSTEOCLAST#0.9425;SIGNAL TRANSDUCTION#0.8800;CELL MIGRATION#0.8706;BREAST CANCER CELL#0.8701;BONE RESORPTION#0.8519;OVARIAN CANCER#0.8502;ACTIN CYTOSKELETON#0.8378;NEUTROPHIL#0.8237;AKT SIGNALING#0.8100;MACROPHAGE#0.8017;GUANOSINE#0.7597;CELL CYCLE#0.7503;FACTOR I#0.7496;PHAGOCYTOSIS#0.7161;HYPERTENSION#0.7143;PROTEIN KINASE#0.7056;CELL ACTIVATION#0.7036;SIGNALING MOLECULE#0.6973;IMMUNE RESPONSE#0.6916;OPEN ANGLE GLAUCOMA#0.6914;OVARIAN#0.6826;HEMATOPOIETIC CELL#0.6820;EPIDERMAL GROWTH FACTOR#0.6777;STEM CELL#0.6763;B CELL RECEPTOR#0.6628;HYPOXIA#0.6293;GROWTH FACTOR RECEPTOR#0.6292;ANGIOGENESIS#0.6250;MEMBRANE RUFFLE#0.6201;TARGET ORGAN DAMAGE#0.6168;PROTEIN TYROSINE KINASE#0.6160;MAPK SIGNALING#0.6153;PHOSPHOLIPASE C#0.6143;PRIMARY OPEN ANGLE GLAUCOMA#0.6131;DRUG RESISTANCE#0.6119;POLYMERASE CHAIN REACTION#0.6001
10452	GIP COMPLEX#1.1100;SAM COMPLEX#1.1079;POLY T#1.0881;TOM COMPLEX#1.0343;MITOCHONDRIAL OUTER MEMBRANE#1.0328;OUTER MEMBRANE#1.0283;ANION CHANNEL#1.0228;OUTER MITOCHONDRIAL MEMBRANE#1.0182;COMPLEX I#1.0128;GENE EXPRESSION#1.0099;PROTEIN IMPORT#1.0082;MITOCHONDRIAL MEMBRANE#1.0016;ALZHEIMER'S DISEASE#0.9988;MITOCHONDRIAL FUSION#0.9866;MITOCHONDRIA#0.9854;AGE AT ONSET#0.9854;MITOCHONDRIAL PROTEIN IMPORT#0.9777;ORGANELLE#0.9660;APOPTOSIS#0.9633;TOB COMPLEX#0.9536;DEMENTIA#0.9463;MITOCHONDRIAL FISSION#0.9353;MITOPHAGY#0.9277;CYTOCHROME C#0.9169;MITOCHONDRIAL INTERMEMBRANE SPACE#0.9149;AUTOPHAGY#0.9087;MITOCHONDRIAL DNA#0.8884;ENDOPLASMIC RETICULUM#0.8644;CELL DEATH#0.8587;MTDNA#0.8548;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8164;LOW DENSITY LIPOPROTEIN#0.8088;INNER MITOCHONDRIAL MEMBRANE#0.8082;MILD COGNITIVE IMPAIRMENT#0.8070;NEURODEGENERATIVE DISEASE#0.7953;APOPTOTIC#0.7818;PROTEIN COMPLEX#0.7712;MEDIAL TEMPORAL LOBE#0.7638;PARKINSON'S DISEASE#0.7619;MEMBRANE OF MITOCHONDRIA#0.7575;TEMPORAL LOBE#0.7506;UBIQUITIN#0.7476;MAGNETIC RESONANCE IMAGING#0.7420;CONTACT SITE#0.7379;MITOCHONDRIAL INNER MEMBRANE#0.7377;NERVOUS SYSTEM#0.7337;COGNITION#0.7222;AGEING#0.7215;LIPID METABOLISM#0.7065;CHANNEL ACTIVITY#0.7017;HIDDEN MARKOV MODEL#0.6992;TRANSCRIPTION FACTOR#0.6980;BENZODIAZEPINE RECEPTOR#0.6839;FALSE DISCOVERY RATE#0.6810;REACTIVE OXYGEN SPECIES#0.6737;PROTEIN TRANSPORT#0.6704;CHARCOT MARIE TOOTH#0.6571;DNA METHYLATION#0.6543;OXIDATIVE PHOSPHORYLATION#0.6529;AUTOPHAGOSOME#0.6392;CYTOPLASM#0.6333;PROTEIN PROTEIN INTERACTION#0.6312;MITOCHONDRION#0.6296;PROTEIN DEGRADATION#0.6224;CENTRAL NERVOUS SYSTEM#0.6129;AGE RELATED MACULAR DEGENERATION#0.6087;MACULAR DEGENERATION#0.6081;INCLUSION BODY MYOSITIS#0.6048
10454	BINDING PROTEIN 1#1.0675;TRANSFORMING GROWTH FACTOR BETA#1.0147;KINASE ACTIVITY#1.0070;TRANSFORMING GROWTH FACTOR#1.0046;GROWTH FACTOR#1.0000;PROTEIN KINASE#0.9997;MITOGEN ACTIVATED PROTEIN#0.9966;SIGNALING PATHWAY#0.9894;APOPTOSIS#0.9813;T CELL#0.9757;TUMOR NECROSIS FACTOR#0.9693;TOLL LIKE RECEPTOR#0.9645;GENE EXPRESSION#0.9585;PRO-INFLAMMATORY#0.9577;IMMUNE RESPONSE#0.9522;NF-KAPPAB ACTIVATION#0.9522;MAP KINASE#0.9512;CELL DEATH#0.9438;SIGNAL TRANSDUCTION#0.9340;MACROPHAGE#0.9334;INFLAMMATORY RESPONSE#0.9225;CANCER CELL#0.9100;TRANSCRIPTION FACTOR#0.9096;UBIQUITIN#0.8989;INNATE IMMUNITY#0.8852;MAPK SIGNALING#0.8563;STEM CELL#0.8313;ISCHEMIA#0.8153;BREAST CANCER#0.8033;BONE MARROW#0.8025;CELL PROLIFERATION#0.8005;CELL ADHESION#0.7986;IKAPPAB KINASE#0.7853;APOPTOTIC#0.7823;SIGNALING CASCADE#0.7792;MAPK ACTIVATION#0.7743;EPITHELIAL CELL#0.7585;NITRIC OXIDE#0.7301;INNATE IMMUNE RESPONSE#0.6958;APOPTOSIS SIGNALING#0.6919;MOUSE EMBRYONIC FIBROBLAST#0.6846;GLCNAC#0.6825;BREAST CANCER CELL#0.6529;BONE MORPHOGENETIC PROTEIN#0.6371;SIGNALLING PATHWAY#0.6252;P38 MAPK SIGNALING#0.6098;DNA BINDING#0.6012
10455	PEROXISOMAL#0.9179;PROSTATE CANCER#0.8085;PEROXISOME#0.7046;RELATED PROTEIN 1#0.6504
104564224	CELL PROLIFERATION#0.7181;TUBE FORMATION#0.6839
104564225	APOPTOSIS#0.8607;MYOSIN HEAVY CHAIN#0.8126;CARDIOMYOCYTE#0.8001;HYPERTENSION#0.7571;CARDIO VASCULAR DISEASE#0.6830;VASCULAR DISEASE#0.6374
10456	BREAST CANCER#1.0739;MITOCHONDRIA#1.0706;APOPTOTIC#1.0537;CANCER CELL#1.0522;SEVERE CONGENITAL NEUTROPENIA#1.0418;CELL DEATH#1.0388;APOPTOSIS#1.0358;NEUTROPENIA#1.0313;CELL MIGRATION#1.0175;MITOCHONDRIAL MEMBRANE#1.0151;REGULATION OF APOPTOSIS#1.0118;NEUTROPHIL#1.0010;CELL PROLIFERATION#0.9955;ENDOPLASMIC RETICULUM#0.9484;STEM CELL#0.9449;BONE MARROW#0.9443;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9397;CELL MOTILITY#0.9393;B CELL#0.9378;SARCOPLASMIC RETICULUM#0.9152;G-CSF#0.9114;CARDIOMYOCYTE#0.9003;SPECIFIC PROTEIN 1#0.8985;HEMATOPOIETIC CELL#0.8941;ISCHEMIA#0.8910;CEREBRAL ISCHEMIA#0.8837;GRANULOCYTE COLONY STIMULATING FACTOR#0.8777;COLONY-STIMULATING FACTOR#0.8751;SIGNAL TRANSDUCTION#0.8622;BREAST CANCER CELL#0.8589;GRANULOCYTE#0.8487;SQUAMOUS CELL CARCINOMA#0.8461;CYTOPLASM#0.8242;ACTIN CYTOSKELETON#0.8072;LYMPH NODE#0.8032;EPITHELIAL CELL#0.7922;POLYMERASE CHAIN REACTION#0.7871;NERVOUS SYSTEM#0.7694;PERIPHERAL BLOOD#0.7521;CENTRAL NERVOUS SYSTEM#0.7516;PROGENITOR CELL#0.7513;C TERMINAL DOMAIN#0.7512;LYMPH NODE METASTASIS#0.7487;INFLUENZA A VIRUS#0.7441;NUCLEAR EXPORT#0.7412;INDUCED PLURIPOTENT STEM CELL#0.7386;PLURIPOTENT STEM CELL#0.7364;ISCHEMIA REPERFUSION INJURY#0.7344;FOCAL ADHESION#0.6987;TUMOR TISSUES#0.6833;HEAT SHOCK PROTEIN#0.6762;GENE EXPRESSION#0.6742;PROGRAMMED CELL DEATH#0.6568;CISPLATIN#0.6535;PROTEIN KINASE#0.6505;INNER MITOCHONDRIAL MEMBRANE#0.6415;MYELOID LEUKEMIA#0.6369;P BODY#0.6303;REVERSE TRANSCRIPTION#0.6293;CASPASE ACTIVATION#0.6171;RNA INTERFERENCE#0.6128;INDUCTION OF APOPTOSIS#0.6125;NEGATIVE CONTROL GROUP#0.6114;FOCAL CEREBRAL ISCHEMIA#0.6069;MRNA PROCESSING#0.6061;B CELL DEVELOPMENT#0.6029
10457	IRIS DISEASE#1.0812;METASTATIC MELANOMA#1.0558;CELL ADHESION MOLECULE#1.0539;EPITHELIAL CELL#1.0466;CELL ADHESION#1.0402;OSTEOBLAST DIFFERENTIATION#1.0368;OSTEOBLAST#1.0341;BREAST CANCER CELL#1.0301;MACROPHAGE#1.0216;GROWTH FACTOR#1.0166;BREAST CANCER#1.0159;EPIDERMAL GROWTH FACTOR#1.0139;CANCER CELL#1.0078;TRANSCRIPTION FACTOR#1.0068;SIGNALING PATHWAY#0.9989;STEM CELL#0.9988;CELL SURFACE#0.9946;CELL PROLIFERATION#0.9932;TUMOR CELLS#0.9920;ENDOTHELIAL CELL#0.9783;GENE EXPRESSION#0.9751;MELANOSOME#0.9750;T CELL#0.9721;GROWTH FACTOR RECEPTOR#0.9706;DENDRITIC CELL#0.9654;PROSTATE CANCER#0.9653;ANGIOGENESIS#0.9630;EXTRACELLULAR MATRIX#0.9617;HEMATOPOIETIC CELL#0.9601;OSTEOCLAST DIFFERENTIATION#0.9556;INFLAMMATORY RESPONSE#0.9541;OSTEOCLAST#0.9515;BONE MARROW#0.9504;MELANOCYTE#0.9462;REGENERATION#0.9444;APOPTOSIS#0.9415;PARKINSON'S DISEASE#0.9357;SKELETAL MUSCLE#0.9313;KINASE ACTIVITY#0.9219;BONE FORMATION#0.9206;MONOCYTE#0.9175;IMMUNE RESPONSE#0.9171;HUMAN BREAST CANCER#0.9038;AMYOTROPHIC LATERAL SCLEROSIS#0.8980;LATERAL SCLEROSIS#0.8980;CELL GROWTH#0.8979;CELL MIGRATION#0.8838;OSTEOGENESIS#0.8679;LYMPH NODE#0.8642;ADENOCARCINOMA#0.8608;PROTEIN KINASE#0.8604;PERIPHERAL BLOOD#0.8394;SIGNAL TRANSDUCTION#0.8278;MESENCHYMAL STEM CELL#0.8164;MINERALIZATION#0.8091;NERVOUS SYSTEM#0.8066;PANCREATIC CANCER#0.8052;COLORECTAL#0.7990;CELL ACTIVATION#0.7986;CELL DIFFERENTIATION#0.7956;CELL CELL ADHESION#0.7914;POLYMERASE CHAIN REACTION#0.7777;KIDNEY INJURY MOLECULE#0.7719;ALZHEIMER'S DISEASE#0.7689;MELANOMA CELL LINES#0.7686;SQUAMOUS CELL CARCINOMA#0.7644;CELL CYCLE#0.7618;TUMOR SUPPRESSOR#0.7611;APOPTOTIC#0.7580;ALKALINE PHOSPHATASE#0.7577;M2 MACROPHAGE#0.7570;ASTROCYTE#0.7494;CELL MEMBRANE#0.7488;SUBSTANCE P#0.7452;KINASE INHIBITOR#0.7452;GLYCOSYLATION#0.7433;ADIPOSE TISSUE#0.7414;MITOGEN ACTIVATED PROTEIN#0.7409;BONE REGENERATION#0.7350;METASTATIC BREAST CANCER#0.7317;NEURODEGENERATIVE DISEASE#0.7280;KIDNEY DISEASE#0.7270;COLORECTAL CANCER#0.7265;SUBSTANTIA NIGRA#0.7254;REVERSE TRANSCRIPTION#0.7254;TOXICITY#0.7250;CANCER STEM CELL#0.7237;RENAL CELL CARCINOMA#0.7092;PRO-INFLAMMATORY#0.7053;STROMAL CELL#0.7030;CELL DEATH#0.7030;BLOOD VESSEL#0.7030;IMMUNE CELL#0.6967;ENDOTHELIAL GROWTH FACTOR#0.6953;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6953;MELANIN SYNTHESIS#0.6889;LECTIN#0.6771;NEUTROPHIL#0.6681;BONE RESORPTION#0.6627;PLASMA MEMBRANE#0.6590;CENTRAL NERVOUS SYSTEM#0.6574;LUNG CANCER#0.6519;KERATINOCYTE#0.6509;HEPATOCELLULAR CARCINOMA#0.6481;PROGENITOR CELL#0.6481;B CELL#0.6448;TUMOR ASSOCIATED ANTIGEN#0.6270;INSULIN RECEPTOR#0.6260;SMOOTH MUSCLE#0.6250;TRANSFORMING GROWTH FACTOR#0.6222;MICROPHTHALMIA#0.6211;UVEAL MELANOMA#0.6171;RECEPTOR TYROSINE KINASE#0.6165;DENTAL PULP#0.6127;ISCHEMIA#0.6101;BLOOD COAGULATION#0.6100;HUMAN DENTAL PULP#0.6037;INSULIN-LIKE GROWTH FACTOR#0.6034;ACUTE LIVER INJURY#0.6019
10458	FILOPODIA FORMATION#1.0823;FILOPODIUM FORMATION#1.0789;INSULIN RECEPTOR SUBSTRATE#1.0786;INSULIN RECEPTOR#1.0648;RECEPTOR TYROSINE KINASE#1.0489;ACTIN FILAMENT#1.0280;FILOPODIUM#1.0250;PLASMA MEMBRANE#1.0179;ACTIN CYTOSKELETON#1.0126;ACTIN BUNDLING#0.9897;POSTSYNAPTIC DENSITY#0.9619;LEUCINE#0.9476;CELL MIGRATION#0.9435;DENDRITIC SPINE#0.9323;NMDA RECEPTOR#0.9303;NEURITE#0.8881;WISKOTT ALDRICH SYNDROME#0.8862;ACTIN POLYMERIZATION#0.8832;MISSING IN METASTASIS#0.8785;GROWTH FACTOR#0.8744;SIGNALING PATHWAY#0.8693;ANGIOGENESIS#0.8421;EPITHELIAL CELL#0.8064;GENE EXPRESSION#0.7900;TRANSCRIPTION FACTOR#0.7874;CANCER CELL#0.7872;HOST CELL#0.7818;CELL ADHESION#0.7727;MEMBRANE RUFFLING#0.7172;NEURITE OUTGROWTH#0.7095;MEMBRANE CURVATURE#0.7050;LEADING EDGE OF CELL#0.6510;LOCALISATION#0.6369;CELL MOTILITY#0.6305;RESPONSE TO INSULIN#0.6103;LONG TERM POTENTIATION#0.6047;ACTIN BINDING#0.6012
10459	MITOTIC ARREST DEFICIENT#1.1234;CELL CYCLE#1.0378;DNA REPAIR#1.0327;DNA SYNTHESIS#1.0321;MITOTIC CHECKPOINT#1.0258;DOUBLE STRAND BREAK#1.0249;TRANSLESION SYNTHESIS#1.0206;MUTAGENESIS#1.0158;CELL CYCLE CONTROL#0.9849;ANAPHASE#0.9786;ANAPHASE PROMOTING COMPLEX#0.9694;CANCER CELL#0.9486;HOMOLOGOUS RECOMBINATION#0.9454;SPINDLE ASSEMBLY#0.9285;S PHASE#0.9146;DNA DAMAGE TOLERANCE#0.9132;SPINDLE ASSEMBLY CHECKPOINT#0.9073;MITOTIC SPINDLE#0.9019;CELL CYCLE REGULATION#0.9004;CELL PROLIFERATION#0.8968;DNA REPLICATION#0.8959;C TERMINAL DOMAIN#0.8952;GENE EXPRESSION#0.8448;GERM CELL#0.8257;CISPLATIN#0.8112;MUTAGENIC#0.8057;OVARIAN#0.7986;SPINDLE CHECKPOINT#0.7976;APOPTOSIS#0.7952;TRANSCRIPTION FACTOR#0.7841;DOUBLE-STRAND BREAK REPAIR#0.7786;RENAL CELL CARCINOMA#0.7526;EPITHELIAL CELL#0.7514;DNA DAMAGE RESPONSE#0.7183;OVARIAN CANCER#0.7143;CLASS SWITCH RECOMBINATION#0.7133;REPLICATION FORK#0.7041;BREAST CANCER#0.7027;PRIMORDIAL GERM CELL#0.6984;APC INHIBITOR#0.6739;M PHASE#0.6604;DNA DAMAGE CHECKPOINT#0.6500;PROTEIN PROTEIN INTERACTION#0.6404;CELL CYCLE ARREST#0.6383;CELL DEATH#0.6246;EPITHELIAL OVARIAN CANCER#0.6209;COLORECTAL CANCER#0.6131;SIGNAL TRANSDUCTION#0.6121;HISTONE METHYLTRANSFERASE#0.6121;LASER SCANNING MICROSCOPY#0.6102;COLORECTAL#0.6026
1045	GASTRIC INTESTINAL METAPLASIA#1.0534;INTESTINAL DEVELOPMENT#1.0533;THYROID TRANSCRIPTION FACTOR#1.0462;HEPATOCYTE NUCLEAR FACTOR#1.0385;SMOOTH MUSCLE ACTIN#1.0360;ESTROGEN RECEPTOR#1.0277;SMOOTH MUSCLE#1.0240;PROGESTERONE#1.0238;HINDGUT#1.0232;PROSTATE SPECIFIC ANTIGEN#1.0226;OVARIAN CARCINOMA#1.0218;MYELOID LEUKEMIA#1.0206;TUMOR SUPPRESSOR#1.0200;MIDGUT#1.0190;TROPHOBLAST STEM CELL#1.0180;ACUTE MYELOID LEUKEMIA#1.0173;PROSTATE CANCER#1.0159;REVERSE TRANSCRIPTION#1.0157;INTESTINAL EPITHELIAL CELL#1.0137;ENTEROCYTE#1.0125;ATROPHIC GASTRITIS#1.0111;GASTRIC MUCOSA#1.0110;GOBLET CELL#1.0099;COLON CARCINOMA#1.0097;GASTRITIS#1.0092;YOLK SAC#1.0091;CELL MIGRATION#1.0086;MISMATCH REPAIR#1.0083;BARRETT'S ESOPHAGUS#1.0081;POLYMERASE CHAIN REACTION#1.0075;METAPLASIA#1.0069;COLORECTAL ADENOCARCINOMA#1.0067;TRANSCRIPTION FACTOR#1.0064;LACTASE-PHLORIZIN HYDROLASE#1.0061;TROPHOBLAST#1.0058;NEUROENDOCRINE TUMOR#1.0048;TUMOR CELLS#1.0043;COLON CANCER#1.0043;CANCER CELL#1.0038;GROWTH FACTOR RECEPTOR#1.0038;LYMPH NODE METASTASIS#1.0028;TROPHECTODERM#1.0025;METASTATIC ADENOCARCINOMA#1.0023;BLASTOCYST FORMATION#1.0023;DNA BINDING#1.0019;ELECTROPHORETIC MOBILITY SHIFT#1.0005;BLASTOMERE#1.0002;EPIDERMAL GROWTH FACTOR#0.9992;MORPHOGENESIS#0.9989;COLORECTAL CARCINOMA#0.9978;QUANTITATIVE REAL TIME#0.9977;RECTUM#0.9975;ALKALINE PHOSPHATASE#0.9965;PANCREATIC ADENOCARCINOMA#0.9963;CELL PROLIFERATION#0.9963;ESOPHAGUS#0.9962;LUNG ADENOCARCINOMA#0.9961;RNA INTERFERENCE#0.9956;GASTROINTESTINAL TRACT#0.9940;CELL POLARITY#0.9936;SMALL INTESTINE#0.9936;GASTRIC ADENOCARCINOMA#0.9927;DNA REPAIR#0.9926;BREAST CANCER#0.9922;COLORECTAL CANCER#0.9918;CELL CYCLE#0.9915;GASTRIC EPITHELIAL CELLS#0.9913;SQUAMOUS CELL CARCINOMA#0.9908;GALLBLADDER#0.9905;COLORECTAL#0.9903;PYLORIC GLAND#0.9899;SIGNET RING CELL#0.9897;EPITHELIAL CELL#0.9893;CELL ADHESION#0.9881;ESOPHAGEAL EPITHELIAL CELLS#0.9881;CELL DIFFERENTIATION#0.9880;OVARIAN#0.9877;DNA METHYLATION#0.9875;TIGHT JUNCTION#0.9872;FORMALIN#0.9867;MUCINOUS ADENOCARCINOMA#0.9865;APOPTOSIS#0.9862;VITAMIN D RECEPTOR#0.9858;OVARIAN CANCER#0.9854;DISEASE FREE SURVIVAL#0.9844;URINARY BLADDER#0.9831;INNER CELL MASS#0.9822;TRANSCRIPTASE#0.9814;HIGH GRADE DYSPLASIA#0.9814;METASTATIC COLORECTAL ADENOCARCINOMA#0.9808;APOPTOTIC#0.9807;COLUMNAR#0.9799;GROWTH FACTOR#0.9789;EPIBLAST#0.9787;GERM CELL#0.9785;TROPHOBLAST CELL#0.9784;CERVICAL#0.9776;TERATOMA#0.9776;MUCINOUS NEOPLASM#0.9773;OOCYTE#0.9772;LUNG CANCER#0.9771;CERVICAL ADENOCARCINOMA#0.9770;DUODENUM#0.9770;ANDROGEN RECEPTOR#0.9766;BILE DUCT#0.9763;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9761;GENE EXPRESSION#0.9759;ADENOCARCINOMA#0.9754;SIGNALING PATHWAY#0.9749;BONE MINERAL DENSITY#0.9744;TRANSACTIVATION#0.9743;CHOLANGIOCARCINOMA#0.9736;PLURIPOTENT STEM CELL#0.9735;CELL GROWTH#0.9718;MOUSE EMBRYONIC STEM#0.9711;LYMPH NODE#0.9683;EMBRYO DEVELOPMENT#0.9682;METASTATIC CARCINOMA#0.9678;QUANTITATIVE REVERSE TRANSCRIPTION#0.9674;LIVER METASTASIS#0.9654;TROPHECTODERM CELL#0.9652;PROTEIN KINASE#0.9650;FACTOR I#0.9635;PROGENITOR CELL#0.9634;STEM CELL#0.9629;INTESTINAL MUCOSA#0.9627;BLASTOCYST DEVELOPMENT#0.9604;EMBRYONIC STEM CELL#0.9601;CYTOPLASM#0.9570;EPITHELIAL CELL DIFFERENTIATION#0.9567;ONCOGENIC#0.9525;INTESTINAL CRYPT#0.9520;BONE MARROW#0.9515;GROWTH PATTERN#0.9512;INTESTINAL EPITHELIAL CELL DIFFERENTIATION#0.9486;T CELL#0.9484;BREAST CARCINOMA#0.9481;GI TRACT#0.9454;PANCREATIC DUCTAL ADENOCARCINOMA#0.9454;OESOPHAGUS#0.9452;INTESTINAL STEM CELL#0.9451;COLORECTAL ADENOMA#0.9447;STEM CELL MARKER#0.9431;GASTRIC EPITHELIUM#0.9409;HEPATOCELLULAR CARCINOMA#0.9399;METASTATIC COLORECTAL CARCINOMA#0.9394;FERTILIZATION#0.9379;HUMAN INTESTINAL EPITHELIAL#0.9379;FIBROBLAST GROWTH FACTOR#0.9374;SMALL CELL CARCINOMA#0.9351;NEUROENDOCRINE CARCINOMA#0.9340;BLADDER ADENOCARCINOMA#0.9307;FOREGUT#0.9302;GUT DEVELOPMENT#0.9287;SIGNALLING PATHWAY#0.9281;CELL CELL ADHESION#0.9278;PANCREATIC CANCER#0.9270;ALPHA CELL#0.9264;EOSIN#0.9250;COLON ADENOCARCINOMA#0.9234;LARGE INTESTINE#0.9213;GASTRIC TISSUE#0.9207;INTESTINAL TRACT#0.9192;RETINOIC ACID#0.9183;HISTONE MODIFICATION#0.9152;INVASIVE CARCINOMA#0.9138;STROMA#0.9138;DEOXYCHOLIC ACID#0.9138;CELL DEATH#0.9107;HIPPO SIGNALING#0.9078;ADVANCED GASTRIC CANCER#0.9058;HUMAN EMBRYONIC STEM#0.8992;METASTATIC COLORECTAL CANCER#0.8962;BONE MORPHOGENETIC PROTEIN#0.8943;GERM CELL TUMORS#0.8927;ENTEROCYTE DIFFERENTIATION#0.8921;MITOGEN ACTIVATED PROTEIN#0.8910;PSEUDOMYXOMA PERITONEI#0.8910;ENDOCRINE CELL#0.8910;LYMPH NODE METASTASES#0.8901;LUNG CARCINOMA#0.8868;GASTRO#0.8840;HISTONE ACETYLATION#0.8814;JEJUNUM#0.8799;WNT SIGNALING PATHWAY#0.8795;NEURAL TUBE#0.8789;BETA CELL#0.8777;DEMETHYLATION#0.8776;CERVIX#0.8758;KERATINOCYTE#0.8758;TRANSCRIPTION FACTOR BINDING#0.8748;TUMOR TISSUES#0.8746;COLORECTUM#0.8732;COLITIS#0.8722;ESOPHAGITIS#0.8672;CYCLIN DEPENDENT KINASE#0.8668;ACID PHOSPHATASE#0.8667;OSTEOPOROSIS#0.8627;ABDOMINAL PAIN#0.8576;TRANSDIFFERENTIATION#0.8575;KINASE INHIBITOR#0.8555;UTERUS#0.8548;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8544;FINE NEEDLE ASPIRATION#0.8542;HATCHING#0.8536;CELL DIVISION#0.8533;LYSINE#0.8532;CHROMATIN REMODELING#0.8522;CANCER STEM CELL#0.8490;PANCREATIC ISLET#0.8478;NEOPLASTIC TISSUES#0.8444;HISTONE DEACETYLASE#0.8443;PLACENTAL DEVELOPMENT#0.8416;COENZYME A#0.8372;THYROID CARCINOMA#0.8339;S PHASE#0.8313;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8312;GASTROESOPHAGEAL REFLUX DISEASE#0.8311;ENDOTHELIAL GROWTH FACTOR#0.8311;BRUSH BORDER#0.8307;LUCIFERASE ACTIVITY#0.8301;TUBERCULOSIS#0.8277;TWO-CELL STAGE#0.8276;OVARIES#0.8271;INFLAMMATORY BOWEL DISEASE#0.8268;TUBULAR ADENOCARCINOMA#0.8250;FARNESOID X RECEPTOR#0.8240;WORLD HEALTH ORGANIZATION#0.8229;POSITIVE PREDICTIVE VALUE#0.8226;TUMOR NECROSIS FACTOR#0.8218;PROTEASOME#0.8215;BASAL CELL#0.8212;POSITRON EMISSION TOMOGRAPHY#0.8209;FRAGMENT LENGTH POLYMORPHISM#0.8190;QUANTITATIVE REVERSE TRANSCRIPTASE#0.8113;METHYLATION SPECIFIC PCR#0.8111;ASCITES#0.8078;EARLY GASTRIC CANCER#0.8075;ENTEROENDOCRINE CELL#0.8068;GASTRIC GLAND#0.8059;ENDOMETRIUM#0.8025;HYPOXIA#0.7990;GALLBLADDER CARCINOMA#0.7980;5-AZA-2'-DEOXYCYTIDINE#0.7947;2'-DEOXYCYTIDINE#0.7942;INDUCED PLURIPOTENT STEM CELL#0.7933;GESTATION#0.7928;DNA METHYLTRANSFERASE#0.7907;IMMUNE RESPONSE#0.7864;ADENOSQUAMOUS CARCINOMA#0.7860;PULMONARY TUBERCULOSIS#0.7824;HAMARTOMA#0.7818;ESOPHAGEAL CANCER#0.7795;CAMP RESPONSE ELEMENT BINDING#0.7790;CAMP RESPONSE ELEMENT#0.7775;CELL MEMBRANE#0.7769;HUMAN GASTRIC CARCINOMA#0.7748;NITRIC OXIDE#0.7719;INVASIVE DUCTAL CARCINOMA#0.7703;ADENOMATOUS POLYPOSIS COLI#0.7699;BREAST CANCER CELL#0.7691;FATTY ACID BINDING#0.7651;MESENCHYME#0.7594;SIGNET RING CELL ADENOCARCINOMA#0.7583;EPITHELIAL MESENCHYMAL TRANSITION#0.7552;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7543;IN VITRO FERTILIZED#0.7516;ACUTE LEUKEMIA#0.7515;SIGNAL TRANSDUCTION#0.7512;CISPLATIN#0.7495;CELL FATE SPECIFICATION#0.7489;DIGESTIVE TRACT#0.7480;ENDOMETRIAL ADENOCARCINOMA#0.7459;YEAR SURVIVAL RATE#0.7448;CYSTIC TERATOMA#0.7430;PROSTATE ADENOCARCINOMA#0.7428;TROPHOBLAST GIANT CELLS#0.7416;MEDULLARY CARCINOMA#0.7414;ENDOMETRIAL CARCINOMA#0.7403;DIGESTION#0.7361;INGUINAL LYMPH NODE#0.7353;HEPATOID ADENOCARCINOMA#0.7334;DIED OF DISEASE#0.7330;PANETH CELL#0.7327;GALLBLADDER CANCER#0.7325;LUMINAL#0.7250;MATURE CYSTIC TERATOMA#0.7216;PAPILLARY THYROID CARCINOMA#0.7179;RESPONSE TO BILE ACID#0.7169;ENDODERM CELL#0.7143;MUCOUS#0.7120;AXIS ELONGATION#0.7096;GASTRULATION#0.7064;CYSTADENOMA#0.7047;GOBLET CELL METAPLASIA#0.7037;PANCREATIC CARCINOMA#0.7036;EXTRACELLULAR MATRIX#0.7007;RNA BINDING#0.6987;MACROPHAGE#0.6950;OVARIAN MUCINOUS ADENOCARCINOMA#0.6949;HISTOGENESIS#0.6945;PERITONEUM#0.6937;NORMAL ESOPHAGEAL MUCOSA#0.6928;TYPE 2 DIABETES#0.6926;SESSILE SERRATED ADENOMA#0.6922;INFLAMMATORY RESPONSE#0.6915;PERIPHERAL BLOOD#0.6904;METHYLATION SPECIFIC POLYMERASE#0.6902;NOTCH SIGNALING PATHWAY#0.6883;CELL ADHESION MOLECULE#0.6879;STOMACH CANCER#0.6850;COLON EPITHELIUM#0.6846;B CELL#0.6844;PERIAMPULLARY ADENOCARCINOMA#0.6830;NEURAL TUBE CLOSURE#0.6829;TUBE CLOSURE#0.6828;EPITHELIAL CELL MIGRATION#0.6825;CELL POLARIZATION#0.6818;CARCINOMA OF UNKNOWN PRIMARY#0.6814;RNA BINDING PROTEIN#0.6810;CROHN'S DISEASE#0.6804;PROTEIN BINDING#0.6800;SURFACE EPITHELIUM#0.6782;CELL SURFACE#0.6770;INTESTINAL TYPE CARCINOMA#0.6748;ULCERATIVE COLITIS#0.6711;NEGATIVE PREDICTIVE VALUE#0.6678;ANTISENSE RNA#0.6669;INTESTINAL CANCER#0.6660;TAIL BUD#0.6643;LYMPH NODE INVOLVEMENT#0.6583;EMBRYONAL CARCINOMA#0.6538;GENE SILENCING#0.6530;EPITHELIAL CELL PROLIFERATION#0.6493;MESOTHELIAL CELL#0.6483;PELVIS#0.6463;REGENERATION#0.6462;URORECTAL SEPTUM#0.6461;TELOMERASE REVERSE TRANSCRIPTASE#0.6454;HOMOLOGOUS RECOMBINATION#0.6415;PHOSPHATASE ACTIVITY#0.6411;ASCENDING COLON#0.6400;MUTAGENESIS#0.6357;GENE REGULATORY NETWORK#0.6324;BILIARY TRACT#0.6312;EPIBLAST CELL#0.6292;WEIGHT LOSS#0.6288;MAGNETIC RESONANCE IMAGING#0.6285;BIOTIN#0.6282;5 FLUOROURACIL#0.6246;COLON MUCOSA#0.6240;ACINAR CELL#0.6236;FLUOROURACIL#0.6231;NOT OTHERWISE SPECIFIED#0.6227;IN VITRO PRODUCED#0.6224;EXTRAMAMMARY PAGET'S DISEASE#0.6218;HUMAN BREAST CANCER#0.6189;URETHRA#0.6183;RELAPSE FREE SURVIVAL#0.6175;EPITHELIUM DEVELOPMENT#0.6147;PRC2 COMPLEX#0.6108;CELL CYCLE ARREST#0.6103;INSULIN-LIKE GROWTH FACTOR#0.6090;MAINTENANCE OF PLURIPOTENCY#0.6089;RENAL CELL CARCINOMA#0.6088;BASEMENT MEMBRANE#0.6087;CHRONIC CHOLANGITIS#0.6082;BUDDING#0.6074;CYSTITIS#0.6069;T CELL FACTOR#0.6066;CARCINOGEN#0.6052;MEDIAN SURVIVAL TIME#0.6028;DISEASE SPECIFIC SURVIVAL#0.6026
10460	CELL DEATH#1.0557;SPINDLE ASSEMBLY#1.0500;CENTROSOME#1.0490;CANCER CELL#1.0454;MITOTIC SPINDLE#1.0439;MICROTUBULE#1.0368;ONCOGENIC#1.0255;CELL CYCLE#1.0167;SIGNALING PATHWAY#1.0028;MITOTIC SPINDLE ASSEMBLY#1.0000;MITOSIS#0.9966;CELL PROLIFERATION#0.9941;SPINDLE POLE#0.9903;KINETOCHORE#0.9898;LUNG CANCER#0.9517;GROWTH FACTOR#0.9271;MICROTUBULE DYNAMICS#0.9223;GENE EXPRESSION#0.9144;CELL ADHESION MOLECULE#0.9137;CELL ADHESION#0.9116;NEURAL CELL#0.9100;FIBROBLAST GROWTH FACTOR#0.9072;APOPTOSIS#0.9008;BREAST CANCER#0.8993;GROWTH FACTOR RECEPTOR#0.8976;EPITHELIAL MESENCHYMAL TRANSITION#0.8932;CERVICAL CANCER#0.8929;SQUAMOUS CELL CARCINOMA#0.8630;CLATHRIN COMPLEX#0.8426;STEM CELL#0.8394;CELL GROWTH#0.8392;CERVICAL#0.8389;CELL DIVISION#0.8242;MICROTUBULE PLUS END#0.8221;KINASE ACTIVITY#0.8203;CHROMOSOME SEGREGATION#0.8164;PACLITAXEL#0.8051;KINASE INHIBITOR#0.8041;CLATHRIN HEAVY CHAIN#0.7996;MICROTUBULE ASSEMBLY#0.7925;LUNG ADENOCARCINOMA#0.7820;SPINDLE MICROTUBULE#0.7714;DISEASE FREE SURVIVAL#0.7665;TRANSCRIPTION FACTOR#0.7633;OVARIAN#0.7550;OVARIAN CANCER#0.7526;KINETOCHORE MICROTUBULE#0.7309;ADENOCARCINOMA#0.7248;OOCYTE#0.7245;SPINDLE FORMATION#0.7177;MICROTUBULE NUCLEATION#0.7059;EPITHELIAL CELL#0.7002;POLYMERASE CHAIN REACTION#0.6996;PROGENITOR CELL#0.6857;NUCLEAR ENVELOPE#0.6855;AKT SIGNALING#0.6796;METAPHASE#0.6676;MULTIPLE MYELOMA#0.6636;MITOTIC SPINDLE ORGANIZATION#0.6441;URINARY BLADDER#0.6414;SPINDLE ORGANIZATION#0.6386;CELL CYCLE ARREST#0.6354;RNA INTERFERENCE#0.6321;MICROTUBULE ASSOCIATED PROTEIN#0.6287;SOFT TISSUE SARCOMA#0.6032;MESENCHYMAL CELL#0.6008;DNA DAMAGE RESPONSE#0.6005
10461	TYROSINE KINASE RECEPTOR#1.0586;APOPTOTIC CELL CLEARANCE#1.0493;EFFEROCYTOSIS#1.0447;PROTEIN TYROSINE KINASE#1.0361;B CELL#1.0349;RECEPTOR TYROSINE KINASE#1.0319;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0295;TYROSINE KINASE INHIBITOR#1.0284;MER A#1.0282;PROTEIN KINASE#1.0227;RETINITIS PIGMENTOSA#1.0222;PHAGOCYTOSIS#1.0206;RETINITIS#1.0201;GROWTH ARREST SPECIFIC#1.0177;PHOTORECEPTOR OUTER SEGMENT#1.0147;ONCOGENIC#1.0143;INNATE IMMUNE RESPONSE#1.0142;RETINAL PIGMENT EPITHELIUM#1.0136;RETINAL DEGENERATION#1.0130;CANCER CELL#1.0127;KINASE INHIBITOR#1.0121;MONOCYTE#1.0120;APOPTOTIC#1.0108;MACROPHAGE#1.0100;RETINAL PIGMENT EPITHELIAL#1.0094;PHOSPHATIDYLSERINE#1.0081;BONE MARROW#1.0060;IMMUNE RESPONSE#1.0052;CELL PROLIFERATION#1.0025;EPITHELIAL CELL#1.0022;INFLAMMATORY RESPONSE#1.0003;PHOTORECEPTOR CELL#1.0003;T CELL#0.9991;GROWTH FACTOR#0.9990;VITAMIN K#0.9988;SIGNALING PATHWAY#0.9959;DENDRITIC CELL#0.9953;IMMUNE CELL#0.9946;APOPTOSIS#0.9934;STEM CELL#0.9931;CELL DEATH#0.9923;GENE EXPRESSION#0.9906;ATHEROSCLEROSIS#0.9903;TUMOR CELLS#0.9869;CELL ADHESION#0.9862;SIGNAL TRANSDUCTION#0.9804;LUNG CANCER#0.9791;NEUTROPHIL#0.9790;SERTOLI CELL#0.9777;PLATELET AGGREGATION#0.9680;CELL SURFACE#0.9650;ACUTE LUNG INJURY#0.9637;ENDOTHELIAL CELL#0.9623;AUTOIMMUNITY#0.9606;CONE DYSTROPHY#0.9596;CELL ACTIVATION#0.9556;PIGMENT EPITHELIAL CELL#0.9538;RETINAL PIGMENT EPITHELIAL CELLS#0.9508;TRANSCRIPTION FACTOR#0.9493;CYTOKINE PRODUCTION#0.9483;GLIOBLASTOMA MULTIFORME#0.9471;FOCAL ADHESION#0.9464;NERVOUS SYSTEM#0.9448;TOLL LIKE RECEPTOR#0.9439;BREAST CANCER#0.9422;THYMOCYTE#0.9415;ANGIOGENESIS#0.9405;PRO-INFLAMMATORY#0.9372;KINASE ACTIVITY#0.9354;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9342;MITOGEN ACTIVATED PROTEIN#0.9340;LUPUS ERYTHEMATOSUS#0.9340;NECROTIC#0.9309;FOCAL ADHESION KINASE#0.9274;AUTOIMMUNE DISEASE#0.9267;MULTIPLE SCLEROSIS#0.9244;LIVER DISEASE#0.9216;PLATELET ACTIVATION#0.9164;GROWTH FACTOR RECEPTOR#0.9081;CELL ADHESION MOLECULE#0.9022;THROMBOSIS#0.9019;CELL GROWTH#0.8983;TUMOR NECROSIS FACTOR#0.8891;CENTRAL NERVOUS SYSTEM#0.8798;MAP KINASE#0.8770;INNATE IMMUNITY#0.8766;ALVEOLAR MACROPHAGE#0.8763;PROTEIN KINASE C#0.8760;RETINAL DISEASE#0.8741;ATHEROSCLEROTIC#0.8671;EPIDERMAL GROWTH FACTOR#0.8623;ACUTE MYELOID LEUKEMIA#0.8570;MYELOID LEUKEMIA#0.8556;ENGULFMENT OF APOPTOTIC CELL#0.8555;FATTY LIVER DISEASE#0.8370;FATTY LIVER#0.8355;MONOCYTE DERIVED MACROPHAGE#0.8341;IMMUNE SYSTEM#0.8291;PROSTATE CANCER#0.8254;POLYMERASE CHAIN REACTION#0.8204;PERIPHERAL BLOOD#0.8090;ADENO ASSOCIATED VIRUS#0.8068;GERMINAL CENTER#0.8066;HEPATITIS C#0.8061;PLASMA MEMBRANE#0.8002;MYELOID CELL#0.7960;T CELL ACTIVATION#0.7956;LIVER X RECEPTOR#0.7930;MACULAR DEGENERATION#0.7862;WOUND HEALING#0.7810;SIGNALING MOLECULE#0.7804;TRANSFORMING GROWTH FACTOR#0.7743;GERM CELL#0.7701;AGE RELATED MACULAR DEGENERATION#0.7689;CELL MIGRATION#0.7617;RECEPTOR LIGAND#0.7498;INFLAMMATORY CELL#0.7468;TISSUE HOMEOSTASIS#0.7454;CELL CYCLE#0.7430;LEBER CONGENITAL AMAUROSIS#0.7424;ATP BINDING#0.7413;AUTOPHAGY#0.7322;SCAVENGER RECEPTOR#0.7299;SIGNALING CASCADE#0.7257;MACROPHAGE ACTIVATION#0.7235;MYOCARDIAL INFARCTION#0.7230;REVERSE TRANSCRIPTION#0.7220;RHEUMATOID ARTHRITIS#0.7171;MAMMARY GLAND#0.7071;CD8+ T CELL#0.7033;CYTOKINE SECRETION#0.6988;PHAGOSOME#0.6958;VIRAL INFECTION#0.6958;CELL MEMBRANE#0.6941;DEXAMETHASONE#0.6939;LEUKOCYTE#0.6935;PLURIPOTENT STEM CELL#0.6889;ASTROCYTE#0.6842;ANTI APOPTOSIS#0.6761;INDUCED PLURIPOTENT STEM CELL#0.6754;HEMATOPOIETIC CELL#0.6722;COAGULATION#0.6719;AMAUROSIS#0.6686;PROTEIN KINASE B#0.6686;ISCHEMIA#0.6667;EXTRACELLULAR REGION#0.6563;NEPHRITIS#0.6525;BLINDNESS#0.6500;OLIGODENDROCYTE#0.6442;MACROPHAGE POLARIZATION#0.6373;PATTERN RECOGNITION RECEPTOR#0.6320;FACTOR I#0.6271;HEPATITIS C VIRUS#0.6264;REACTIVE OXYGEN SPECIES#0.6258;NEURAL CELL#0.6252;DRUG RESISTANCE#0.6138;TUMOR ASSOCIATED MACROPHAGE#0.6101;B CELL ACTIVATION#0.6087;RNA INTERFERENCE#0.6027;M2 MACROPHAGE#0.6026;MARGINAL ZONE B CELL#0.6022;LIPID METABOLISM#0.6005
10462	LECTIN#1.0585;MACROPHAGE#1.0388;BREAST CANCER#1.0062;T CELL#1.0027;DENDRITIC CELL#0.9665;STEM CELL#0.9222;PERIPHERAL BLOOD#0.9068;TRANSCRIPTION FACTOR#0.8901;IMMUNE RESPONSE#0.8774;PROVIRUS#0.8454;GENE EXPRESSION#0.8100;BREAST CANCER PATIENTS#0.8010;M2 MACROPHAGE#0.7817;GERM CELL#0.7791;CANCER CELL#0.7414;MONOCYTE#0.7321;MONONUCLEAR CELLS#0.7141;ADIPOSE TISSUE#0.7123;CYTOKINE SECRETION#0.6911;TRANSCRIPTASE#0.6669;GLYCOSYLATION#0.6452;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6393;CYTOKINE PRODUCTION#0.6294;MANNOSE RECEPTOR#0.6286;PROSTATE CANCER#0.6140;TRANSCRIPTION FACTOR BINDING#0.6062;MYELOID CELL#0.6004
10463	ZINC HOMEOSTASIS#0.7404;CANCER CELL#0.6408;DNA BINDING#0.6370
10464	PROGESTERONE#1.0594;CYTOKINE PRODUCTION#1.0480;PERIPHERAL BLOOD#1.0359;TROPHOBLAST#1.0026;GESTATION#0.9898;MIFEPRISTONE#0.9714;SPONTANEOUS ABORTION#0.9708;IMMUNE RESPONSE#0.9578;T CELL#0.9226;IMMUNE SYSTEM#0.8785;DYDROGESTERONE#0.8673;IL-10 PRODUCTION#0.8371;CANCER CELL#0.7822;PRO-INFLAMMATORY#0.7717;B CELL#0.7697;FOLLICULAR PHASE#0.7557;MONONUCLEAR CELLS#0.7213;T LYMPHOCYTE#0.7207;NATURAL KILLER CELL#0.7188;JOUBERT SYNDROME#0.7153;DECIDUA#0.7105;BREAST CANCER#0.7003;CELL CYCLE REGULATION#0.6967;RECEPTOR ANTAGONIST#0.6886;CELL CYCLE#0.6857;CYTOTOXICITY#0.6832;CENTRIOLAR SATELLITE#0.6589;CHORIOCARCINOMA#0.6518;LEUKOCYTE#0.6374;IFN-GAMMA#0.6373;EXTRACELLULAR VESICLE#0.6292;SPINDLE POLE#0.6158;AKT SIGNALING#0.6098;CYTOTROPHOBLAST#0.6086;LUTEAL PHASE#0.6079;PERIPHERAL BLOOD LYMPHOCYTES#0.6063;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6014
10465	CYCLOPHILIN#1.0277;CYCLOSPORIN A#0.8244;PRE-MRNA SPLICING#0.7602;MRNA SPLICING#0.7571;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.6810;CYCLOSPORIN#0.6669;SPLICEOSOME#0.6062
10466	COG COMPLEX#0.9841;CONSERVED OLIGOMERIC GOLGI#0.9396;GOLGI COMPLEX#0.9070;GLYCOSYLATION#0.8478;CONGENITAL DISORDER#0.7499;COMPLEX I#0.6961;CONSERVED OLIGOMERIC GOLGI COMPLEX#0.6768
10467	CELL PROLIFERATION#0.9096;LGR5+ STEM CELL#0.7379;STEM CELL MAINTENANCE#0.7004;CELL CYCLE#0.7001;STEM CELL#0.6686
10468	INHIBIN BETA-A#1.0668;HEPATOCYTE GROWTH FACTOR#1.0591;FSH-BETA#1.0546;ACTIVIN BINDING#1.0540;LIVER REGENERATION#1.0443;POLYCYSTIC OVARY SYNDROME#1.0348;HEPARIN BINDING#1.0329;COLONY-STIMULATING FACTOR#1.0323;ALPHA-2 MACROGLOBULIN#1.0323;AMNIOTIC FLUID#1.0276;ENDOMETRIUM#1.0236;INHIBIN#1.0232;EPIDERMAL GROWTH FACTOR#1.0223;HEPARIN#1.0221;MUSCLE HYPERTROPHY#1.0208;MYOBLAST#1.0207;PLATELET-DERIVED GROWTH FACTOR#1.0204;OOCYTE MATURATION#1.0203;FSH SECRETION#1.0191;GRANULOCYTE COLONY STIMULATING FACTOR#1.0190;FIBROBLAST GROWTH FACTOR#1.0172;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0170;INSULIN-LIKE GROWTH FACTOR#1.0169;MENSTRUAL CYCLE#1.0163;ENDOTHELIAL GROWTH FACTOR#1.0154;GROWTH DIFFERENTIATION FACTOR#1.0133;PROSTATE CANCER#1.0119;ACTIVIN RECEPTOR#1.0104;WOUND HEALING#1.0100;STROMAL CELL#1.0087;ESTROUS CYCLE#1.0086;OOCYTE#1.0074;GRANULOSA CELL#1.0066;DNA SYNTHESIS#1.0059;OBESE#1.0057;PRE-ECLAMPSIA#1.0056;SERTOLI CELL#1.0049;BONE MARROW#1.0033;REVERSE TRANSCRIPTION#1.0030;GONAD#1.0024;GESTATION#1.0024;ESTRADIOL#1.0016;GONADOTROPIN RELEASING HORMONE#1.0013;TESTOSTERONE#1.0006;ADIPOSE TISSUE#1.0003;MUSCLE WASTING#1.0002;G-CSF#0.9989;CELL SURFACE#0.9983;GERM CELL#0.9981;LUTEAL PHASE#0.9975;PROGENITOR CELL#0.9974;ANDROSTENEDIONE#0.9971;PROGESTERONE#0.9966;OVARIES#0.9963;REGENERATION#0.9962;ENDOTHELIAL CELL#0.9960;POLYMERASE CHAIN REACTION#0.9955;EPITHELIAL CELL#0.9951;FOLLICLE STIMULATING HORMONE#0.9951;MUSCLE CELL#0.9945;OVARIAN FOLLICLE#0.9942;TRANSCRIPTASE#0.9935;OVARIAN#0.9885;BONE MORPHOGENETIC PROTEIN#0.9871;SKELETAL MUSCLE MASS#0.9870;LIVER DISEASE#0.9860;CANCER CELL#0.9859;ANGIOGENESIS#0.9851;CELL GROWTH#0.9841;BREAST CANCER#0.9841;FORSKOLIN#0.9839;GENE EXPRESSION#0.9832;EXTRACELLULAR MATRIX#0.9828;MORPHOGENESIS#0.9815;MUSCLE ATROPHY#0.9815;SKELETAL MUSCLE#0.9810;MYOGENESIS#0.9807;TUMOR NECROSIS FACTOR#0.9806;CELL DIFFERENTIATION#0.9802;GROWTH FACTOR#0.9801;PROTEIN KINASE#0.9794;PROTEIN KINASE C#0.9791;TRANSFORMING GROWTH FACTOR BETA#0.9788;APOPTOSIS#0.9788;SOMITE#0.9785;INFLAMMATORY RESPONSE#0.9776;MUSCULAR DYSTROPHY#0.9774;PITUITARY GLAND#0.9774;TRANSCRIPTION FACTOR#0.9750;CELL PROLIFERATION#0.9749;CUMULUS OOCYTE COMPLEXES#0.9746;GRANULOCYTE#0.9745;SMOOTH MUSCLE#0.9740;PROTEIN KINASE A#0.9736;STEM CELL#0.9732;TRANSFORMING GROWTH FACTOR#0.9731;OVARIAN CANCER#0.9730;DECIDUA#0.9728;CELL CYCLE#0.9727;SIGNALING PATHWAY#0.9701;STEROIDOGENESIS#0.9700;TYPE 2 DIABETES#0.9689;NERVOUS SYSTEM#0.9685;QUANTITATIVE REAL TIME#0.9674;ENDOMETRIOSIS#0.9666;INHIBIN BETA-B#0.9637;GROWTH HORMONE#0.9636;CELL ADHESION#0.9630;OSTEOBLAST#0.9629;SIGNAL TRANSDUCTION#0.9627;PROTEIN SYNTHESIS#0.9616;OVULATION#0.9608;FERTILIZATION#0.9604;PROTEOGLYCAN#0.9567;ADIPOCYTE#0.9566;CORPUS LUTEUM#0.9563;FOLLICULAR PHASE#0.9539;GASTRULATION#0.9521;MYOTUBE#0.9512;ADENYLATE CYCLASE#0.9486;HORMONE SECRETION#0.9465;RETINOIC ACID#0.9431;HAIR FOLLICLE#0.9429;ESTRUS#0.9417;SPERMATOGENESIS#0.9398;UTERUS#0.9396;OESTRADIOL#0.9348;EPIDIDYMIS#0.9346;RECEPTOR BINDING#0.9340;SURFACE PLASMON RESONANCE#0.9339;CELL ADHESION MOLECULE#0.9336;MESANGIAL CELL#0.9304;HEPATITIS C#0.9243;GROWTH FACTOR BINDING#0.9237;SKELETAL MUSCLE HYPERTROPHY#0.9236;IN VITRO MATURATION#0.9227;C REACTIVE PROTEIN#0.9223;ANDROGEN RECEPTOR#0.9222;TUMOR SUPPRESSOR#0.9220;TUMOR CELLS#0.9186;PERIPHERAL BLOOD#0.9169;HEPATOCELLULAR CARCINOMA#0.9162;ECLAMPSIA#0.9137;DECIDUALIZATION#0.9135;GLYCOSYLATION#0.9102;MUSCLE FIBER#0.9100;CYTOPLASM#0.9079;MAMMARY GLAND#0.9076;PRIMITIVE STREAK#0.9073;LEYDIG CELL#0.9068;B CELL#0.9066;SEMINAL PLASMA#0.9061;TUMOUR NECROSIS FACTOR#0.9054;MACROPHAGE#0.9053;SIGNALLING PATHWAY#0.9032;ISCHEMIA#0.9030;HYPOXIA#0.8988;CACHEXIA#0.8986;CENTRAL NERVOUS SYSTEM#0.8974;POLYCYSTIC OVARIAN SYNDROME#0.8973;FACTOR I#0.8972;OVARIAN DEVELOPMENT#0.8943;CHONDROCYTE#0.8928;IMMUNE RESPONSE#0.8893;GONADOTROPIN SECRETION#0.8875;PROGESTERONE SECRETION#0.8834;HINDBRAIN#0.8824;TROPHOBLAST#0.8818;KERATINOCYTE#0.8817;LUNG CANCER#0.8817;PROESTRUS#0.8813;IGF BINDING#0.8812;WHITE ADIPOSE TISSUE#0.8811;REPRODUCTIVE SYSTEM#0.8770;NOTOCHORD#0.8760;ADENO ASSOCIATED VIRUS#0.8729;MONOCYTE#0.8722;ADENYLATE#0.8721;CELL DEATH#0.8706;PLACENTAL GROWTH FACTOR#0.8699;STROMA#0.8695;EMBRYO DEVELOPMENT#0.8613;ADENOCARCINOMA#0.8599;IMMUNE CELL#0.8559;PORTAL VEIN#0.8547;APOPTOTIC#0.8546;SIGNALING CASCADE#0.8486;SMOOTH MUSCLE CELL#0.8435;MESODERM FORMATION#0.8427;PITUITARY ADENOMA#0.8419;DIESTRUS#0.8419;NITRIC OXIDE#0.8415;BONE FORMATION#0.8400;CROSS SECTIONAL AREA#0.8391;MESENCHYMAL STEM CELL#0.8338;BONE MORPHOGENIC PROTEIN#0.8336;THYMIDINE#0.8262;MESENCHYMAL CELL#0.8253;THECAL CELL#0.8234;PUBERTY#0.8223;BREAST CANCER CELL#0.8222;DECIDUAL CELL#0.8205;NEURAL PLATE#0.8200;OVARIAN FOLLICLE DEVELOPMENT#0.8126;PEROXISOME#0.8080;QUADRICEPS#0.8071;BRANCHING MORPHOGENESIS#0.8060;EMBRYONIC MUSCLE#0.8044;OVARIAN CYST#0.8041;MESENCHYME#0.8029;GLUCOSE HOMEOSTASIS#0.8028;NEUROGENESIS#0.8000;SMOOTH MUSCLE ACTIN#0.7985;KIDNEY DISEASE#0.7983;SIGNALING MOLECULE#0.7979;PROTEIN BINDING#0.7964;SPINAL CORD#0.7956;FATTY LIVER#0.7947;HEMATOPOIETIC CELL#0.7942;PLASMA PROTEIN#0.7924;GERMINAL VESICLE#0.7900;PROSTAGLANDIN E2#0.7892;ENDOCRINE CELL#0.7834;LEUKOCYTE#0.7833;INTESTINAL EPITHELIAL CELL#0.7778;PRO-INFLAMMATORY#0.7718;ARTERY#0.7695;INFERTILITY#0.7683;AMNION#0.7669;RAPAMYCIN#0.7655;AMELOBLAST DIFFERENTIATION#0.7643;PANCREATIC ISLET#0.7635;HEPARAN SULFATE BINDING#0.7634;PREMATURE OVARIAN FAILURE#0.7632;MINERALIZATION#0.7616;OSTEOGENESIS#0.7590;SULFATE BINDING#0.7571;ORGANOGENESIS#0.7569;MOLAR#0.7562;CILIARY GANGLION#0.7545;TOOTH DEVELOPMENT#0.7520;HIGH FAT DIET#0.7477;DEXAMETHASONE#0.7461;INHIBIN BINDING#0.7431;COLITIS#0.7425;GONADOTROPHIN SECRETION#0.7410;KINASE INHIBITOR#0.7395;OVARIAN CARCINOMA#0.7394;UMBILICAL VEIN#0.7391;BETA CELL#0.7389;MYOBLAST PROLIFERATION#0.7376;HEMATOPOIESIS#0.7375;INCLUSION BODY MYOSITIS#0.7368;HISTONE DEACETYLASE#0.7349;MECHANISM OF ACTION#0.7336;CONNECTIVE TISSUE#0.7306;CORTISOL#0.7304;INCLUSION BODY#0.7296;ZONA PELLUCIDA#0.7275;HEART MUSCLE#0.7271;HEPATOCYTE APOPTOSIS#0.7262;TERMINAL DIFFERENTIATION#0.7240;ENDOTHELIUM#0.7239;ACUTE LIVER FAILURE#0.7237;FATTY LIVER DISEASE#0.7215;AROMATASE ACTIVITY#0.7209;OVIDUCT#0.7180;MYOCARDIAL INFARCTION#0.7180;DIABETES MELLITUS#0.7179;RECEPTOR ANTAGONIST#0.7167;ISCHEMIA REPERFUSION INJURY#0.7162;TARGET OF RAPAMYCIN#0.7154;PARTURITION#0.7151;LUTEINIZATION#0.7141;INSULIN SECRETION#0.7133;DUCHENNE MUSCULAR DYSTROPHY#0.7121;CELL ACTIVATION#0.7114;ALKALINE PHOSPHATASE#0.7052;HATCHING#0.7033;ANDROGEN SECRETION#0.7029;PULMONARY FIBROSIS#0.7007;LUNG DISEASE#0.7006;LATE PREGNANCY#0.6977;VASCULAR ENDOTHELIAL CELL#0.6974;SODIUM DODECYL SULFATE#0.6972;DODECYL SULFATE#0.6971;WEIGHT LOSS#0.6964;TUBULOGENESIS#0.6959;ADENOSINE#0.6944;IMMUNE SYSTEM#0.6939;OSTEOCLAST#0.6918;T CELL#0.6908;GRANULOSA CELL PROLIFERATION#0.6891;ATHEROSCLEROSIS#0.6890;BLOOD VESSEL#0.6862;BMP SIGNALING PATHWAY#0.6860;TESTICULAR DEVELOPMENT#0.6819;ECTOPIC PREGNANCY#0.6817;CERVICAL#0.6811;MYOBLAST FUSION#0.6805;MITOGEN ACTIVATED PROTEIN#0.6794;STREPTOZOTOCIN#0.6767;DNA BINDING#0.6763;BMP BINDING#0.6757;FOLLICLE STIMULATING HORMONE SECRETION#0.6757;EPIBLAST#0.6748;CILIARY BODY#0.6724;NONALCOHOLIC FATTY LIVER DISEASE#0.6702;GLIAL CELL#0.6698;QUANTITATIVE REVERSE TRANSCRIPTION#0.6681;72-HOURS#0.6677;GLAND MORPHOGENESIS#0.6662;INSULIN RECEPTOR#0.6658;HYPERGLYCEMIA#0.6642;CHRONIC HEPATITIS C#0.6615;HYPOXIC#0.6614;EMBRYONIC STEM CELL#0.6606;MYOGENIC REGULATORY FACTOR#0.6563;ROOT SHEATH#0.6535;MYOSITIS#0.6527;NEUROMUSCULAR DISEASE#0.6526;HEPATOCYTE PROLIFERATION#0.6519;TERATOCARCINOMA#0.6508;VENOUS BLOOD#0.6491;TISSUE GROWTH FACTOR#0.6475;PROTEIN SECRETION#0.6474;INCREASED MUSCLE MASS#0.6450;MYOFIBROBLAST#0.6437;ADRENAL GLAND#0.6433;MECHANISMS OF ACTION#0.6430;BINDING PROTEIN 1#0.6428;LYMPH NODE#0.6423;IN VITRO MATURED#0.6412;RHOMBOMERE#0.6394;ESTROGEN RECEPTOR#0.6385;SMAD BINDING ELEMENT#0.6345;ANTI MULLERIAN HORMONE#0.6344;SPERMATOGENIC CELLS#0.6340;SEX DETERMINATION#0.6322;SMAD BINDING#0.6308;CYTOTROPHOBLAST#0.6277;LUCIFERASE ACTIVITY#0.6276;DIHYDROTESTOSTERONE#0.6260;SPERMATOCYTES#0.6258;BROWN ADIPOSE TISSUE#0.6253;CELL DEVELOPMENT#0.6249;HEPATIC STELLATE CELL#0.6247;MYOSIN HEAVY CHAIN#0.6239;PATTERN FORMATION#0.6238;ADIPOCYTE DIFFERENTIATION#0.6222;TROPHECTODERM CELL#0.6219;S PHASE#0.6217;SQUAMOUS CELL CARCINOMA#0.6216;BREAST CARCINOMA#0.6206;CHRONIC KIDNEY DISEASE#0.6200;NEURAL TUBE#0.6167;NERVE GROWTH FACTOR#0.6166;GRANULOSA CELL DIFFERENTIATION#0.6143;VASCULAR SMOOTH MUSCLE CELL#0.6125;ERYTHROPOIESIS#0.6073;FLOOR PLATE#0.6060;LEAN BODY MASS#0.6043;RELATED PROTEIN 1#0.6032;GESTATIONAL DIABETES#0.6028;MYOGENIC CELL#0.6006
10469	INNER MITOCHONDRIAL MEMBRANE#1.0716;MITOCHONDRIAL MEMBRANE#1.0466;PROTEIN IMPORT#1.0383;MITOCHONDRIAL INNER MEMBRANE#1.0267;HEAT SHOCK PROTEIN#1.0170;TIM23 COMPLEX#1.0052;MITOCHONDRIA#1.0034;MITOCHONDRIAL PROTEIN IMPORT#0.9863;MITOCHONDRIAL MATRIX#0.9823;C TERMINAL DOMAIN#0.9745;PEPTIDE BINDING#0.9680;PERIPHERAL MEMBRANE PROTEIN#0.8933;NUCLEOTIDE EXCHANGE FACTOR#0.8515;GENE EXPRESSION#0.7107;OUTER MEMBRANE#0.7092;ATP HYDROLYSIS#0.6437;COMPLEX I#0.6381;MITOCHONDRIAL FUSION#0.6316;CELL PROLIFERATION#0.6198
1046	STEM CELL#1.0200;GENE EXPRESSION#1.0192;TRANSCRIPTION FACTOR#1.0153;SPINAL CORD#0.9934;HEMATOPOIESIS#0.9528;PROGENITOR CELL#0.9275;MYELOID LEUKEMIA#0.9191;RETINOIC ACID#0.8742;ACUTE MYELOID LEUKEMIA#0.8574;EMBRYONIC STEM CELL#0.8328;MYELOID PROGENITOR CELL#0.8306;HINDBRAIN#0.8267;HEMATOPOIETIC STEM CELL#0.8233;BONE MARROW#0.7437;HINDGUT#0.7179;SIGNALING PATHWAY#0.7113;URORECTAL SEPTUM#0.6861;PRIMITIVE HEMATOPOIESIS#0.6456;NEURAL TUBE#0.6226;MORPHOGENESIS#0.6008
10471	LIGASE INHIBITOR#0.6808;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6533
10472	CEREBRAL CORTEX#1.0468;TRANSCRIPTION FACTOR#1.0083;ZINC FINGER PROTEIN#0.9230;PROGENITOR CELL#0.9071;TELOMERE BINDING#0.8911;TRANSACTIVATION#0.8854;CELL CYCLE#0.8655;CREB BINDING#0.8575;GENE EXPRESSION#0.8413;TELOMERE#0.8343;DNA BINDING#0.8340;NEURONAL MIGRATION#0.8316;MICROCEPHALY#0.8058;ZINC BINDING#0.7908;INTELLECTUAL DISABILITY#0.7274;BRAIN DEVELOPMENT#0.6724;HETEROCHROMATIN#0.6559;TUMOR SUPPRESSOR#0.6361;GABAERGIC NEURON#0.6265;HYPOXIC#0.6150
10473	NUCLEOSOME BINDING#0.6567;HEART MUSCLE#0.6292;KINASE ACTIVITY#0.6113;DNA BINDING#0.6092
10474	HISTONE ACETYLTRANSFERASE#1.0554;CELL CYCLE#1.0098;TRANSACTIVATION#0.9911;CANCER CELL#0.9760;CELL PROLIFERATION#0.9477;TRANSCRIPTION FACTOR#0.9201;BREAST CANCER#0.9182;HISTONE ACETYLATION#0.8530;MAMMARY EPITHELIAL CELL#0.8253;SAGA COMPLEX#0.8123;EPITHELIAL CELL#0.8112;BREAST CANCER CELL#0.8050;GLUCOSE REPRESSION#0.8041;GENE EXPRESSION#0.7792;LYSINE#0.7623;APOPTOSIS#0.7461;ESTROGEN RECEPTOR#0.7236;DNA REPAIR#0.7063;HUMAN MAMMARY EPITHELIAL#0.7042;MOUSE EMBRYONIC FIBROBLAST#0.6964;CERVICAL CANCER#0.6922;CERVICAL#0.6414;RETINOIC ACID#0.6216;BREAST CANCER PATIENTS#0.6097
10475	INFLAMMATORY RESPONSE#0.7449;VIRAL INFECTION#0.6603;SIGNALING PATHWAY#0.6419;IFN REGULATORY FACTOR#0.6152;VESICULAR STOMATITIS VIRUS#0.6103;OSTEOBLAST DIFFERENTIATION#0.6053
10476	ATP SYNTHASE#0.9837;OXIDATIVE PHOSPHORYLATION#0.7229;APOPTOSIS#0.6468
10477	UBIQUITIN PROTEIN LIGASE#1.0855;UBIQUITIN#1.0699;TRANSCRIPTION FACTOR#0.8632;CELL PROLIFERATION#0.6168
10478	PEROXISOMAL MEMBRANE#1.0580;PEROXISOMAL#1.0523;ATP BINDING#1.0495;ATP BINDING CASSETTE#1.0438;PROTEIN IMPORT#1.0208;PEROXISOMAL MATRIX#1.0121;PEROXISOME#0.9975;ORGANELLE#0.9664;ZELLWEGER SYNDROME#0.9521;ENDOPLASMIC RETICULUM#0.9411;PEROXISOME PROLIFERATION#0.9366;ATP BINDING CASSETTE TRANSPORTER#0.9189;PEROXISOME MEMBRANE#0.8611;MITOCHONDRIA#0.8115;ACYL COA OXIDASE#0.8051;PTS1 RECEPTOR#0.7401;FATTY ACID OXIDATION#0.7375;PEXOPHAGY#0.7280;GENE EXPRESSION#0.7144;ABC TRANSPORTER#0.7128;SUPEROXIDE DISMUTASE#0.7081;NERVOUS SYSTEM#0.6908;CYTOPLASM#0.6617;MEMBRANE BIOGENESIS#0.6545;LIPID METABOLISM#0.6529;PROTEIN TARGETING#0.6472;UBIQUITIN#0.6250;COENZYME A#0.6127
104797537	CELL PROLIFERATION#1.0895;CANCER CELL#0.9506;BREAST CANCER#0.8791;APOPTOSIS#0.6827;COLORECTAL CANCER#0.6673;LUNG CANCER#0.6659;CELL GROWTH#0.6654;SIGNALING PATHWAY#0.6511;COLONY FORMATION ASSAY#0.6200;ADJACENT NORMAL TISSUE#0.6191
10479	CHRISTIANSON SYNDROME#1.1419;ENDOSOME#1.0596;PLASMA MEMBRANE#1.0250;RECYCLING ENDOSOME#1.0229;INTELLECTUAL DISABILITY#0.9947;ANGELMAN SYNDROME#0.9551;MICROCEPHALY#0.9480;EPILEPSY#0.9113;MENTAL RETARDATION#0.8706;SODIUM:HYDROGEN EXCHANGER#0.8497;TRANS GOLGI NETWORK#0.7810;STATUS EPILEPTICUS#0.7655;LUMINAL#0.7542;ACIDIFICATION#0.6989;ORGANELLE#0.6321;EARLY ENDOSOME#0.6274;CELL POLARITY#0.6243
1047	ENDOPLASMIC RETICULUM#0.9939;ZONA PELLUCIDA#0.9306;SPERMATOGENESIS#0.8714;GERM CELL#0.8706;OVIDUCT#0.7967;LECTIN#0.6502;ANGIOTENSIN CONVERTING ENZYME#0.6423;ACROSOME#0.6174
10480	TRANSLATION INITIATION#0.8706;TRANSLATION INITIATION FACTOR#0.8283;EUKARYOTIC INITIATION FACTOR#0.7755;CANCER CELL#0.7113;DENDRITIC CELL#0.6293;PROTEIN SYNTHESIS#0.6192
10481	TAMOXIFEN#1.0438;BREAST CANCER#1.0379;PROSTATE CANCER#1.0267;CANCER CELL#1.0263;ANDROGEN RECEPTOR#1.0244;TRANSCRIPTION FACTOR#1.0238;CELL PROLIFERATION#1.0232;CELL GROWTH#1.0219;GENE EXPRESSION#0.9972;BREAST CANCER PATIENTS#0.9858;PROSTATE SPECIFIC ANTIGEN#0.9494;TUMOR SUPPRESSOR#0.9491;LYMPH NODE#0.9483;ESTROGEN RECEPTOR#0.9431;EPITHELIAL CELL#0.9414;POLYMERASE CHAIN REACTION#0.9258;PROSTATE DEVELOPMENT#0.9153;COLORECTAL CANCER#0.8912;WOUND HEALING#0.8870;OVARIAN CANCER#0.8866;COLORECTAL#0.8422;ADENOCARCINOMA#0.8387;SPINAL CORD#0.8185;ANGIOGENESIS#0.8165;METASTATIC PROSTATE CANCER#0.8165;COLON CANCER#0.7967;REVERSE TRANSCRIPTION#0.7670;DISEASE FREE SURVIVAL#0.7503;OVARIAN#0.7436;DNA BINDING#0.7278;BREAST CANCER CELL#0.6941;CELL CYCLE#0.6907;PROSTATE EPITHELIAL CELL#0.6656;APOPTOSIS#0.6523;TUMOR TISSUES#0.6325;QUANTITATIVE REAL TIME#0.6304;LUMINAL#0.6187;TOXICITY#0.6145;RECURRENCE FREE SURVIVAL#0.6038;ENDOMETRIAL CANCER#0.6019
10482	RNA EXPORT FACTOR#1.0712;NUCLEAR PORE COMPLEX#1.0345;PORE COMPLEX#1.0338;RNA HELICASE#1.0313;NUCLEAR PORE#1.0240;TREX COMPLEX#1.0227;NUCLEAR EXPORT#1.0196;RNA BINDING#1.0179;NUCLEAR TRANSPORT#1.0046;CYTOPLASM#0.9860;RIBOSOMAL SUBUNIT#0.9809;NUCLEAR PORE COMPLEXES#0.9779;RNA BINDING PROTEIN#0.9748;GENE EXPRESSION#0.9721;HERPES SIMPLEX VIRUS#0.9698;HERPES SIMPLEX#0.9695;MRNA PROCESSING#0.9637;EXON JUNCTION COMPLEX#0.9405;ARGININE#0.9379;T CELL#0.9271;UBIQUITIN#0.9212;MRNA TRANSPORT#0.9169;NUCLEOCYTOPLASMIC TRANSPORT#0.9154;NUCLEAR ENVELOPE#0.9040;NUCLEOCYTOPLASMIC SHUTTLING#0.9027;RIBOSOME#0.8910;NUCLEAR EXPORT SIGNAL#0.8795;TRANSCRIPTION FACTOR#0.8612;VIRAL REPLICATION#0.8574;LEUCINE#0.8550;COMPLEX I#0.8454;NUCLEAR SPECKLE#0.8352;RNA HELICASE A#0.8238;PROTEIN SYNTHESIS#0.8209;OOCYTE#0.8136;LEUCINE RICH REPEAT#0.8071;C TERMINAL DOMAIN#0.8062;THO COMPLEX#0.8037;IFN-GAMMA#0.8008;IMMUNE RESPONSE#0.7975;NUCLEAR IMPORT#0.7936;MRNA METABOLISM#0.7893;INFLUENZA A VIRUS#0.7762;RNA TRANSPORT#0.7743;IMPORTIN#0.7603;PROTEIN KINASE#0.7598;RNA PROCESSING#0.7581;MRNA SPLICING#0.7565;TAP BINDING#0.7458;HUMAN IMMUNODEFICIENCY VIRUS#0.7286;HOST CELL#0.7164;MRNA BINDING#0.7104;NUCLEOPLASM#0.7074;KARYOPHERIN#0.6956;ANTIGEN PROCESSING#0.6823;NUP84 COMPLEX#0.6795;NEURONAL CELLS#0.6729;PRE-MRNA SPLICING#0.6704;RNA RECOGNITION MOTIF#0.6636;RNA INTERFERENCE#0.6326;EPITHELIAL CELL#0.6284;RESONANCE ENERGY TRANSFER#0.6255;POLYSOME#0.6228;PROTEASOME#0.6225;PROTEIN PROTEIN INTERACTION#0.6180;ANTIGEN PRESENTATION#0.6027;CELL SURFACE#0.6018;EPSTEIN BARR VIRUS#0.6010;GERM CELL#0.6004
10483	CONGENITAL DYSERYTHROPOIETIC ANEMIA#1.0568;ANEMIA#1.0361;ERYTHROCYTE#1.0344;ANAEMIA#0.9677;BONE MARROW#0.9640;ENDOPLASMIC RETICULUM#0.9332;ERYTHROBLAST#0.9192;PROTEIN COMPLEX#0.8817;ERYTHROPOIESIS#0.8427;COMPLEX II#0.8212;GLYCOSYLATION#0.7945;IRON OVERLOAD#0.7692;APOPTOSIS#0.7313;GOLGI APPARATUS#0.6678;RED BLOOD CELL#0.6634;CELL MEMBRANE#0.6622;RETINOIC ACID#0.6065
10484	ENDOPLASMIC RETICULUM#1.0161;PROTEIN COMPLEX#0.8818;COMPLEX II#0.7979;TRANSCRIPTION FACTOR#0.6688;CELL PROLIFERATION#0.6511;COPII VESICLE#0.6361;COLLAGEN SYNTHESIS#0.6312;EXTRACELLULAR MATRIX#0.6184
10485	HEPATOCELLULAR CARCINOMA#0.7116
10486	ACTIN CYTOSKELETON#0.8282;HEPATOCELLULAR CARCINOMA#0.8130;YEAR SURVIVAL RATE#0.8006;SKELETAL MUSCLE#0.7760;ADENYLATE CYCLASE#0.7216;WOUND HEALING#0.6253;BREAST CANCER#0.6195
10487	BREAST CANCER#1.0841;C TERMINAL DOMAIN#1.0732;ADENYLATE CYCLASE#1.0708;ADENYLATE#1.0688;CANCER CELL#1.0593;ACTIN FILAMENT#1.0569;ACTIN BINDING#1.0481;ACTIN CYTOSKELETON#1.0218;CELL ADHESION#1.0161;BREAST CANCER CELL#1.0025;CAMP SIGNALING#0.9646;SIGNALING PATHWAY#0.9463;ACTIN MONOMER BINDING#0.9178;GENE EXPRESSION#0.9044;CELL MOTILITY#0.9021;PANCREATIC CANCER#0.8900;SIGNAL TRANSDUCTION#0.8900;CYCLASE ACTIVITY#0.8900;LUNG CANCER#0.8880;CELL PROLIFERATION#0.8715;ACTIN BINDING PROTEIN#0.8564;ACTIN POLYMERIZATION#0.8500;CYCLIC AMP#0.8495;ADENYLYL CYCLASE ACTIVITY#0.8368;STRESS FIBER#0.8141;POLYMERASE CHAIN REACTION#0.8070;EPITHELIAL CELL#0.7927;MORPHOGENESIS#0.7718;PROTEIN KINASE#0.7451;PERIPHERAL BLOOD#0.7267;CELL GROWTH#0.7250;ENDOCYTOSIS#0.7120;CELL POLARITY#0.7033;CELL MIGRATION#0.6951;SEQUESTERING#0.6847;ACTIN FILAMENT DEPOLYMERIZATION#0.6705;VIRULENCE#0.6570;CAMP SYNTHESIS#0.6325;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6311;MONONUCLEAR CELLS#0.6299;SH3 DOMAIN BINDING#0.6275;FILAMENTOUS GROWTH#0.6269;GERM TUBE#0.6242;CELL CORTEX#0.6131;ACTIN DEPOLYMERIZATION#0.6123;TOLL LIKE RECEPTOR#0.6116;PLASMA MEMBRANE#0.6088;BONE DISEASE#0.6041;TRAUMATIC BRAIN INJURY#0.6023
10488	LEUCINE#1.0530;UNFOLDED PROTEIN RESPONSE#1.0325;CELL MIGRATION#1.0287;TRANSCRIPTION FACTOR#1.0242;ENDOPLASMIC RETICULUM#1.0214;DNA BINDING#1.0000;GENE EXPRESSION#0.9923;TRANSACTIVATION#0.9860;CANCER CELL#0.9767;HERPES SIMPLEX VIRUS#0.9562;HERPES SIMPLEX#0.9558;BREAST CANCER#0.9511;CELL PROLIFERATION#0.9259;T CELL#0.9207;CYTOPLASM#0.9006;HOST CELL#0.8936;HOST CELL FACTOR#0.8886;APOPTOSIS#0.8748;CAMP RESPONSE ELEMENT#0.8604;GLUCOCORTICOID RECEPTOR#0.8549;CELL CYCLE#0.8513;ENDOPLASMIC RETICULUM STRESS#0.8489;CAMP RESPONSE ELEMENT BINDING#0.8400;ACTIVATING TRANSCRIPTION FACTOR#0.8305;REGULATED INTRAMEMBRANE PROTEOLYSIS#0.8082;BREAST CANCER CELL#0.8041;CELLULAR TRANSCRIPTION#0.7959;ER STRESS RESPONSE#0.7935;T-CELL LEUKEMIA#0.7760;CERVICAL CANCER#0.7621;ENHANCER BINDING PROTEIN#0.7611;ENHANCER BINDING#0.7606;BINDING PROTEIN 3#0.7569;GRANULOSA CELL#0.7388;ER MEMBRANE#0.7385;ELECTROPHORETIC MOBILITY SHIFT#0.7083;CAMP-RESPONSIVE ELEMENT BINDING#0.6963;AXON GROWTH#0.6940;VIRAL TRANSCRIPTION#0.6725;DECIDUAL CELL#0.6157;CC CHEMOKINE RECEPTOR#0.6133;CELL BODY#0.6083;JUN DIMERIZATION PROTEIN#0.6044
10489	LEUCINE RICH REPEAT#0.9705;LEUCINE#0.7323;UBIQUITIN#0.6960
1048	FACTOR VIII#1.0465;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0455;BETA-2#1.0451;PROSTATE SPECIFIC ANTIGEN#1.0342;GLASSY CARBON ELECTRODE#1.0330;ENDOMETRIAL ADENOCARCINOMA#1.0291;LOW DETECTION LIMIT#1.0286;ENDOCERVICAL ADENOCARCINOMA#1.0272;THYROID TRANSCRIPTION FACTOR#1.0271;C REACTIVE PROTEIN#1.0249;OVARIAN CYST#1.0231;ALPHA 1-ANTITRYPSIN#1.0200;BREAST DISEASE#1.0178;MALIGNANT PLEURAL EFFUSION#1.0165;CELL ADHESION MOLECULE#1.0153;SMOOTH MUSCLE ACTIN#1.0150;PERICARDIAL EFFUSION#1.0147;ESTROGEN RECEPTOR#1.0145;MUCINOUS CYSTADENOCARCINOMA#1.0141;LIMIT OF DETECTION#1.0138;ALKALINE PHOSPHATASE#1.0126;COLON CARCINOMA#1.0117;COLORECTAL ADENOCARCINOMA#1.0101;CERVICAL ADENOCARCINOMA#1.0088;PROGESTERONE#1.0084;IFN-GAMMA#1.0081;CYSTADENOCARCINOMA#1.0069;SWEAT GLAND#1.0061;MECONIUM#1.0055;OVARIAN CARCINOMA#1.0049;GM-CSF#1.0046;LUMINAL#1.0042;SMOOTH MUSCLE#1.0041;NEUROFILAMENT#1.0039;METASTATIC ADENOCARCINOMA#1.0037;CELL ADHESION#1.0036;LEUKOCYTE#1.0031;TRANSCRIPTION FACTOR#1.0031;TUMOR ANTIGEN#1.0027;MEDULLARY CARCINOMA#1.0022;ADVANCED BREAST CANCER#1.0021;LUNG DISEASE#1.0016;TUMOR ASSOCIATED ANTIGEN#1.0015;COLORECTAL CARCINOMA#1.0014;CERVICAL CANCER#1.0006;DENDRITIC CELL#0.9992;LIVER DISEASE#0.9990;CELL SURFACE#0.9983;METASTATIC CARCINOMA#0.9975;SIGNET RING CELL#0.9971;PANCREATIC LESIONS#0.9964;TUMOR TISSUES#0.9962;METASTATIC BREAST CANCER#0.9957;EPIDERMAL GROWTH FACTOR#0.9954;MESOTHELIAL CELL#0.9953;GASTRIC ADENOCARCINOMA#0.9948;LUNG ADENOCARCINOMA#0.9944;BILIARY TRACT#0.9929;PRIMARY BREAST CANCER#0.9929;ESOPHAGEAL CANCER#0.9929;COLORECTAL CANCER#0.9924;SQUAMOUS CELL CARCINOMA#0.9916;ENDOTHELIAL GROWTH FACTOR#0.9911;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9911;SMALL CELL CARCINOMA#0.9903;BIOTIN#0.9900;SERUM ALBUMIN#0.9899;PANCREATIC CARCINOMA#0.9895;BREAST CANCER PATIENTS#0.9895;T LYMPHOCYTE#0.9889;LECTIN#0.9888;PSEUDOMYXOMA PERITONEI#0.9884;TRANSCRIPTASE#0.9882;METAPLASIA#0.9881;CELL MEMBRANE#0.9880;MICROPARTICLE#0.9877;PANCREATIC CANCER#0.9872;LUNG CARCINOMA#0.9872;HEPATOCELLULAR CARCINOMA#0.9864;MYOEPITHELIAL CELL#0.9864;BREAST CANCER#0.9862;GROWTH FACTOR RECEPTOR#0.9861;MUCINOUS CYSTIC NEOPLASM#0.9860;ASCITES#0.9855;MUCINOUS ADENOCARCINOMA#0.9851;INTERMEDIATE FILAMENT#0.9850;LUNG CANCER#0.9850;TRANSITIONAL CELL CARCINOMA#0.9848;BONE MARROW#0.9846;CELL DIFFERENTIATION#0.9843;ADVANCED GASTRIC CANCER#0.9843;GALLBLADDER#0.9843;MUCINOUS NEOPLASM#0.9834;REVERSE TRANSCRIPTION#0.9834;LIVER METASTASIS#0.9832;LYMPH NODE INVOLVEMENT#0.9831;PERIPHERAL BLOOD#0.9827;COLORECTAL#0.9825;COLON CANCER#0.9822;BREAST CARCINOMA#0.9818;BLOOD GROUP ANTIGEN#0.9818;OVARIAN#0.9813;MALIGNANT MESOTHELIOMA#0.9812;CHOLANGIOCARCINOMA#0.9811;PANCREATIC ADENOCARCINOMA#0.9811;OVARIAN CANCER#0.9810;SURFACE PLASMON RESONANCE#0.9805;CERVIX#0.9805;FORMALIN#0.9804;CIRCULATING TUMOR CELL#0.9803;RECURRENCE FREE SURVIVAL#0.9801;EOSIN#0.9793;THYROID CARCINOMA#0.9792;WEIGHT LOSS#0.9788;NEUTROPHIL#0.9787;LYMPH NODE METASTASES#0.9787;PELVIS#0.9786;EPITHELIAL CELL#0.9786;CERVICAL#0.9784;STOMACH CANCER#0.9782;TUMOR CELLS#0.9780;GROWTH FACTOR#0.9779;CYSTADENOMA#0.9774;LYMPH NODE METASTASIS#0.9773;COLORECTAL LIVER METASTASES#0.9771;LARGE CELL CARCINOMA#0.9764;T CELL#0.9761;GASTROINTESTINAL TRACT#0.9761;MEDIAN SURVIVAL TIME#0.9752;EXTRAMAMMARY PAGET'S DISEASE#0.9747;BILE DUCT#0.9745;POSITIVE PREDICTIVE VALUE#0.9741;NEGATIVE PREDICTIVE VALUE#0.9737;ACID PHOSPHATASE#0.9734;ADENOSQUAMOUS CARCINOMA#0.9725;FINE NEEDLE ASPIRATE#0.9723;IMMUNE RESPONSE#0.9719;GERM CELL#0.9718;GENE EXPRESSION#0.9717;SALIVARY GLAND#0.9717;COLUMNAR#0.9713;AREA UNDER CURVE#0.9713;MACROPHAGE#0.9709;POLYMERASE CHAIN REACTION#0.9707;GRANULOCYTE#0.9703;ENDOMETRIAL CARCINOMA#0.9702;ADENOCARCINOMA#0.9699;COLON ADENOCARCINOMA#0.9694;DISEASE FREE SURVIVAL#0.9692;MUCINOUS CYSTADENOMA#0.9687;THYROID CANCER#0.9681;GALLBLADDER CANCER#0.9677;LYMPH NODE#0.9669;CANCER CELL#0.9666;SEROUS CYSTADENOMA#0.9655;BASAL CELL#0.9655;LYMPH NODE DISSECTION#0.9652;QUANTITATIVE REAL TIME#0.9646;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9645;YEAR SURVIVAL RATE#0.9644;LUMINAL CELL#0.9632;CYTOTOXIC T-LYMPHOCYTE#0.9632;PANCREATIC DUCTAL ADENOCARCINOMA#0.9632;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9630;FINE NEEDLE ASPIRATION#0.9629;GROWTH PATTERN#0.9628;STEM CELL#0.9624;CYTOPLASM#0.9624;RECTUM#0.9622;URINARY BLADDER#0.9621;INVASIVE CARCINOMA#0.9618;BREAST CANCER CELL#0.9612;COLONY-STIMULATING FACTOR#0.9606;POSITRON EMISSION TOMOGRAPHY#0.9605;CELL PROLIFERATION#0.9601;ELECTRON TRANSFER#0.9590;LIMITS OF DETECTION#0.9588;PLEURA#0.9588;ENDOTHELIAL CELL#0.9574;CPT-11#0.9573;ABDOMINAL PAIN#0.9572;GOBLET CELL#0.9565;METASTATIC LYMPH NODE#0.9563;CLEAR CELL CARCINOMA#0.9561;NEUROENDOCRINE TUMOR#0.9561;MAGNETIC RESONANCE IMAGING#0.9557;DIFFERENTIAL PULSE VOLTAMMETRY#0.9554;STROMA#0.9549;CYTOTOXICITY#0.9546;CISPLATIN#0.9545;TOXICITY#0.9521;FALSE POSITIVE RATE#0.9520;REGIONAL LYMPH NODE#0.9519;HISTOGENESIS#0.9518;LIVER CANCER#0.9498;ADENOID CYSTIC CARCINOMA#0.9495;RENAL CELL CARCINOMA#0.9471;ANOIKIS#0.9456;GEMCITABINE#0.9453;5 FLUOROURACIL#0.9450;GLYCOSYLATION#0.9435;RESPONSE TO TREATMENT#0.9428;MEDIAN OVERALL SURVIVAL#0.9426;EARLY GASTRIC CANCER#0.9413;STROMAL CELL#0.9408;MONONUCLEAR CELLS#0.9403;PROSTATE CANCER#0.9397;POINT OF CARE#0.9381;TUMOR SUPPRESSOR#0.9342;PANCREATITIS#0.9334;FLUOROURACIL#0.9333;CD8+ T CELL#0.9302;ENDOMETRIUM#0.9288;G-CSF#0.9286;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9284;PACLITAXEL#0.9283;SEROUS CYSTADENOCARCINOMA#0.9283;CARCINOMA IN SITU#0.9281;MALIGNANT PLEURAL MESOTHELIOMA#0.9278;DOCETAXEL#0.9259;ESOPHAGUS#0.9253;SWELLING#0.9246;ADENOCARCINOMA IN SITU#0.9242;OVERALL SURVIVAL RATE#0.9240;APOPTOSIS#0.9236;OXALIPLATIN#0.9235;MEDIASTINAL LYMPH NODE#0.9229;PERITONEUM#0.9215;EARLY BREAST CANCER#0.9209;HEALTHY CONTROL GROUP#0.9208;KINASE INHIBITOR#0.9186;UTERUS#0.9182;B CELL#0.9163;TUMOR NECROSIS FACTOR#0.9156;ADVANCED PANCREATIC CANCER#0.9133;TUBULAR ADENOCARCINOMA#0.9129;PULMONARY ALVEOLAR PROTEINOSIS#0.9115;BETA GLUCURONIDASE#0.9098;TUBERCULOSIS#0.9096;PAPILLARY ADENOCARCINOMA#0.9049;PAPILLOMA#0.9042;NODULAR#0.9034;INHIBIN#0.9027;APOCRINE GLAND#0.9003;GEFITINIB#0.8975;ESOPHAGEAL CARCINOMA#0.8972;ARTERY#0.8971;GERM CELL TUMORS#0.8968;PATHOLOGIC COMPLETE RESPONSE#0.8960;TRASTUZUMAB#0.8938;PERITONEAL CAVITY#0.8920;DUCT CELL#0.8916;WHITE BLOOD CELL#0.8907;MICROVILLI#0.8904;IRINOTECAN#0.8896;PORTAL VEIN#0.8855;LIVER CIRRHOSIS#0.8854;CELL CYCLE#0.8852;CAPECITABINE#0.8834;WIDE DYNAMIC RANGE#0.8832;DERMIS#0.8821;TYROSINE KINASE INHIBITOR#0.8816;ERLOTINIB#0.8815;MUCOUS#0.8806;GASTRITIS#0.8781;ANEMIA#0.8779;ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY#0.8744;BASAL CELL CARCINOMA#0.8717;TOTAL MESORECTAL EXCISION#0.8713;CYST WALL#0.8706;DIGESTIVE TRACT#0.8705;THYMIDINE KINASE#0.8694;GASTROINTESTINAL CARCINOMA#0.8683;PERICARDITIS#0.8673;MEDULLARY THYROID CANCER#0.8659;RISK OF DEATH#0.8644;SPUTUM#0.8620;GALLBLADDER CARCINOMA#0.8617;BORDERLINE OVARIAN TUMOR#0.8612;HIGH RISK PATIENTS#0.8593;AGE AT DIAGNOSIS#0.8588;PLEOMORPHIC ADENOMA#0.8574;DISEASE CONTROL RATE#0.8571;HEPATITIS B#0.8550;APOPTOTIC#0.8536;CONNECTIVE TISSUE#0.8518;THYROID GLAND#0.8501;TERATOMA#0.8494;PAPILLARY CARCINOMA#0.8487;OVARIES#0.8481;ATROPHIC GASTRITIS#0.8455;EXTRACELLULAR MATRIX#0.8445;FIBRINOGEN#0.8438;PATHOLOGICAL COMPLETE RESPONSE#0.8436;THYMIC CARCINOMA#0.8428;HMN-14#0.8419;ANTI HER2#0.8415;BILIARY TRACT CANCER#0.8397;CELL AGGREGATION#0.8391;DIABETES MELLITUS#0.8386;PNEUMONIA#0.8382;RESONANCE ENERGY TRANSFER#0.8376;NEUROENDOCRINE CARCINOMA#0.8373;BLADDER CARCINOMA#0.8371;BLOOD PLASMA#0.8358;NEURAL CELL#0.8358;THYMIDINE#0.8328;GASTRIC MUCOSA#0.8320;AMNIOTIC FLUID#0.8294;CARCINOSARCOMA#0.8259;DIARRHEA#0.8246;EXOSOME#0.8234;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8233;BLOOD VESSEL#0.8218;ANDROGEN RECEPTOR#0.8216;TUMOR REGRESSION GRADE#0.8208;QUANTITATIVE REVERSE TRANSCRIPTION#0.8205;SPECIFIC SURFACE AREA#0.8177;HEPATOCYTE GROWTH FACTOR#0.8173;KERATINOCYTE#0.8169;TIME TO PROGRESSION#0.8156;ANGIOGENESIS#0.8147;ADENOSINE#0.8123;NEOPLASTIC DISEASE#0.8094;PERITONEAL MESOTHELIOMA#0.8071;IMMUNE SYSTEM#0.8062;OBSTRUCTIVE JAUNDICE#0.8055;LYMPH NODE RATIO#0.8051;PERITONITIS#0.8049;MELANOSOME#0.8044;EPITHELIAL OVARIAN CANCER#0.7983;MUCOEPIDERMOID CARCINOMA#0.7981;SENTINEL LYMPH NODE#0.7975;STANDARDIZED UPTAKE VALUE#0.7946;NON-SMALL CELL LUNG CARCINOMA#0.7914;SWEAT GLAND CARCINOMA#0.7857;BASEMENT MEMBRANE#0.7852;CELL GROWTH#0.7838;NERVOUS SYSTEM#0.7831;SQUAMOUS CELL CANCER#0.7830;EPITHELIAL OVARIAN CARCINOMA#0.7812;VOMITING#0.7811;NEUTROPENIA#0.7802;PLEURISY#0.7792;DERMOID CYST#0.7782;TRANSMISSION ELECTRON MICROSCOPY#0.7781;RECEIVER OPERATOR CHARACTERISTIC#0.7774;CELLULAR IMMUNE RESPONSE#0.7774;ENHANCED COMPUTED TOMOGRAPHY#0.7741;ENDOMETRIAL CANCER#0.7741;DOXORUBICIN#0.7728;BEVACIZUMAB#0.7680;TUBERCULOUS PERITONITIS#0.7676;DIGESTION#0.7676;PARENCHYMA#0.7671;MITOMYCIN C#0.7646;RELAPSE FREE SURVIVAL#0.7644;TYPE 2 DIABETES#0.7629;GALL BLADDER#0.7605;CARBOPLATIN#0.7602;SQUARE WAVE VOLTAMMETRY#0.7588;HUMAN PANCREATIC CANCER#0.7582;MODAL#0.7572;INDIUM TIN OXIDE#0.7551;CHONDROSARCOMA#0.7551;WORLD HEALTH ORGANIZATION#0.7550;SCANNING ELECTRON MICROSCOPY#0.7539;CERVICAL SQUAMOUS CELL CARCINOMA#0.7522;IMMUNOGLOBULIN G#0.7517;HEPATIC ARTERY#0.7484;SYNOVIAL SARCOMA#0.7481;NECK CANCER#0.7475;LEUCOVORIN#0.7449;LOCALISATION#0.7442;HYALURONIC ACID#0.7418;HUMAN PAPILLOMA VIRUS#0.7405;VENOUS BLOOD#0.7397;MONOCYTE#0.7397;SMALL INTESTINE#0.7380;CELL MIGRATION#0.7357;ORAL SQUAMOUS CELL CARCINOMA#0.7345;HUMAN LEUKOCYTE ANTIGEN#0.7331;HEMORRHAGE#0.7322;ANAPLASTIC CARCINOMA#0.7308;S PHASE#0.7301;VULVA#0.7293;SIGMOID COLON CANCER#0.7264;METHOTREXATE#0.7238;CONJUGATION#0.7235;RECEIVER OPERATING CURVE#0.7232;AGGRESSIVE BEHAVIOR#0.7228;PULMONARY TUBERCULOSIS#0.7221;CELL DEATH#0.7220;RELATIVE STANDARD DEVIATION#0.7195;ADENOSINE DEAMINASE#0.7169;LARGE INTESTINE#0.7164;BILE DUCT CARCINOMA#0.7144;METASTATIC COLORECTAL CARCINOMA#0.7133;PARAGANGLIOMA#0.7131;CREATINE KINASE#0.7124;ERYTHROCYTE#0.7118;PAROTID GLAND#0.7116;ALANINE#0.7114;TRANSVERSE COLON#0.7110;INVASIVE DUCTAL CARCINOMA#0.7104;TRICOM#0.7089;ONCOGENIC#0.7078;DUCTAL CELL#0.7070;LAYER BY LAYER#0.7059;DYSPNEA#0.7054;DESMOSOME#0.7042;DUODENUM#0.7031;VACUOLE#0.7024;NEGATIVE LIKELIHOOD RATIO#0.7008;HEMATURIA#0.7007;PLEURAL DISEASE#0.6994;YOLK SAC#0.6983;BILE DUCT CANCER#0.6983;INGUINAL LYMPH NODE#0.6974;HYPOXIA#0.6945;CATALYTIC ACTIVITY#0.6924;INFLAMMATORY CELL#0.6918;WILMS TUMOR 1#0.6918;NUCLEOSOME#0.6915;ANAL CANAL#0.6904;LUNG SQUAMOUS CELL CARCINOMA#0.6901;MEDIASTINUM#0.6898;TRANSFORMING GROWTH FACTOR#0.6886;CENTRAL NERVOUS SYSTEM#0.6885;SECRETORY GRANULE#0.6879;OVERALL SURVIVAL TIME#0.6873;CIRCULATING TUMOUR CELLS#0.6866;PROTEIN KINASE#0.6865;MITOMYCIN#0.6862;HEAT SHOCK PROTEIN#0.6840;MYOBLAST#0.6811;METASTATIC COLORECTAL CANCER#0.6810;PELVIC LYMPH NODE#0.6808;LUNG LESIONS#0.6800;ENDOCRINE CELL#0.6800;GALECTIN#0.6796;BRUSH BORDER#0.6796;HEAD AND NECK CANCER#0.6790;PRIMARY BRAIN TUMORS#0.6765;ENDOPLASMIC RETICULUM#0.6755;SYRINGOMA#0.6755;BILIARY TRACT DISEASE#0.6754;ASCENDING COLON#0.6724;MELANOCYTE#0.6717;COLLAGEN TYPE IV#0.6715;ORAL CAVITY#0.6705;CANCER SPECIFIC SURVIVAL#0.6700;PERITONEAL CARCINOMA#0.6683;HIGH GRADE DYSPLASIA#0.6674;HEPATOCYTE NUCLEAR FACTOR#0.6672;GRANULOCYTE COLONY STIMULATING FACTOR#0.6665;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6650;CELL MATURATION#0.6644;BLADDER ADENOCARCINOMA#0.6639;MALIGNANT LYMPHOMA#0.6629;FOLATE#0.6618;SIGNALING PATHWAY#0.6611;EDEMA#0.6597;OVARIAN MUCINOUS CYSTADENOCARCINOMA#0.6570;CHOLANGITIS#0.6555;ETOPOSIDE#0.6553;SECRETORY CELL#0.6514;EPSTEIN BARR VIRUS#0.6513;UMBILICAL CORD#0.6504;FOWLPOX#0.6475;CHONDROID CHORDOMA#0.6435;ERYTHEMA#0.6427;LUNG METASTASIS#0.6424;CREATINE#0.6419;DETECTION OF TUMOR CELL#0.6403;ADRENAL GLAND#0.6394;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6393;ERYTHROCYTE SEDIMENTATION RATE#0.6390;MESOTHELIUM#0.6384;PLATELET-DERIVED GROWTH FACTOR#0.6382;CHOLECYSTITIS#0.6370;LYSIS#0.6347;HYPERTENSION#0.6346;DISEASE SPECIFIC SURVIVAL#0.6271;OVERALL RESPONSE RATE#0.6248;BOWEL OBSTRUCTION#0.6244;ASCORBIC ACID#0.6226;INTESTINAL EPITHELIAL CELL#0.6225;OVARIAN SEROUS TUMOR#0.6222;GLUTATHIONE#0.6205;HOST CELL#0.6197;REGULATORY T CELL#0.6196;HIDRADENOMA#0.6190;MUTAGENESIS#0.6181;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.6171;ALVEOLAR MACROPHAGE#0.6151;CYSTIC TERATOMA#0.6148;TUMOR NODE METASTASIS#0.6136;CELL SURFACE ANTIGEN#0.6134;PHOSPHOLIPASE C#0.6131;INVASIVE BREAST CANCER#0.6104;RESPIRATORY FAILURE#0.6103;INSULIN-LIKE GROWTH FACTOR#0.6097;METASTATIC GASTRIC CANCER#0.6062;DIED OF DISEASE#0.6056;SIGNAL TRANSDUCTION#0.6049;UROTHELIAL CELL CARCINOMA#0.6044;FLUORESCEIN#0.6035
10490	SYNAPTIC VESICLE#1.0212;SNARE COMPLEX#1.0193;LATE ENDOSOME#1.0109;SECRETORY VESICLE#1.0105;ENDOSOME#1.0078;TRANSPORT VESICLE#1.0026;EXOCYTOSIS#0.9973;VACUOLE#0.9946;LYSOSOME#0.9883;N-ETHYLMALEIMIDE#0.9881;VESICLE FUSION#0.9871;MEMBRANE FUSION#0.9858;PLASMA MEMBRANE#0.9852;ENDOPLASMIC RETICULUM#0.9790;SNARE BINDING#0.9732;CELL SURFACE#0.9653;TRANS GOLGI NETWORK#0.9639;COPII VESICLE#0.9403;PROTEIN COMPLEX#0.9376;VESICLE TRANSPORT#0.9350;EARLY ENDOSOME#0.9271;VESICLE DOCKING#0.9230;SNAP RECEPTOR#0.9128;ORGANELLE#0.9127;NEUROTRANSMITTER RELEASE#0.9107;ENDOCYTOSIS#0.9082;RECYCLING ENDOSOME#0.9007;COATED VESICLE#0.8597;COMPLEX I#0.8500;SECRETORY PATHWAY#0.8420;ADIPOCYTE#0.8418;GOLGI APPARATUS#0.8415;INTRACELLULAR MEMBRANE#0.7991;GOLGI MEMBRANE#0.7834;VESICULAR TRANSPORT#0.7763;NEUROTOXIN#0.7707;AUTOPHAGY#0.7680;GENE EXPRESSION#0.7661;BUDDING#0.7584;VESICLE EXOCYTOSIS#0.7411;CONSTITUTIVE EXOCYTOSIS#0.7403;MICROTUBULE#0.7267;TOTAL INTERNAL REFLECTION#0.7185;MACROPHAGE#0.7152;LATE GOLGI#0.7109;AUTOPHAGOSOME#0.7105;RNA INTERFERENCE#0.7077;VACUOLE FUSION#0.7070;CLATHRIN COATED VESICLE#0.6763;VESICLE FORMATION#0.6762;PHAGOCYTOSIS#0.6749;NERVE TERMINAL#0.6670;CELL WALL#0.6645;SYNAPTIC VESICLE FUSION#0.6560;EPITHELIAL CELL#0.6475;DENSE CORE VESICLE#0.6466;GOLGI STACK#0.6406;SNARE COMPLEX ASSEMBLY#0.6396;EXOCYST#0.6314;PHAGOSOME#0.6305;NEUROTRANSMISSION#0.6147
10491	CYCLOPHILIN#1.0445;OSTEOGENESIS IMPERFECTA#1.0265;OSTEOGENESIS#1.0175;ENDOPLASMIC RETICULUM#0.9832;COLLAGEN TYPE I#0.8285;POST-TRANSLATIONAL MODIFICATION#0.8014;CONNECTIVE TISSUE#0.7069;EXTRACELLULAR MATRIX#0.6651;OSTEOPOROSIS#0.6518;COLE-CARPENTER SYNDROME#0.6447;COMPLEX I#0.6381
10492	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#1.1056;RNA BINDING#1.0547;RNA BINDING PROTEIN#1.0545;GAIT COMPLEX#0.9911;RIBOSOMAL PROTEIN#0.8993;GLYCERALDEHYDE-3-PHOSPHATE#0.8410;GENE EXPRESSION#0.7804;STEM CELL#0.7415;MRNA BINDING#0.7263;RNA EDITING#0.7052;INSULIN RECEPTOR#0.6925;RNA RECOGNITION MOTIF#0.6798;APOBEC#0.6615;MRNA TRANSPORT#0.6318;T CELL#0.6305;RNA REPLICATION#0.6297;NEUROMUSCULAR JUNCTION#0.6194;SPINAL MUSCULAR ATROPHY#0.6171;MUSCULAR ATROPHY#0.6149
10493	SYNAPTIC VESICLE#1.0894;VESICLE MEMBRANE#0.9705;SYNAPTIC VESICLE MEMBRANE#0.8928;CANCER CELL#0.8592;ATPASE ACTIVITY#0.6572;PLASMA MEMBRANE#0.6494;CELL PROLIFERATION#0.6369
10494	PROTEIN KINASE#1.0443;HIGH FAT DIET#0.9949;CELL DEATH#0.9760;GERMINAL CENTER#0.9204;LIPID DROPLET#0.9148;SIGNALING PATHWAY#0.8890;GENE EXPRESSION#0.8783;APOPTOSIS#0.8753;SKELETAL MUSCLE#0.8608;CELL PROLIFERATION#0.8448;LIPID METABOLISM#0.8223;CELL MIGRATION#0.8195;CANCER CELL#0.8166;MYOBLAST#0.7842;TYPE 2 DIABETES#0.7650;KINASE ACTIVITY#0.7155;TUMOR SUPPRESSOR#0.7074;LIPID OXIDATION#0.7049;GLUCOSE UPTAKE#0.6961;SIGNAL TRANSDUCTION#0.6648;GOLGI APPARATUS#0.6544;CEREBRAL CAVERNOUS MALFORMATION#0.6497;LIPID STORAGE#0.6367;APOPTOTIC CELL DEATH#0.6153;PANCREAS DISEASE#0.6136
10495	PHENOXODIOL#1.0776;CELL SURFACE#1.0623;PLASMA MEMBRANE#1.0536;CANCER CELL#1.0497;APOPTOSIS#0.9835;CELL GROWTH#0.8980;GREEN TEA CATECHIN#0.8463;ELECTRON TRANSPORT#0.8228;CELL PROLIFERATION#0.8208;EPIGALLOCATECHIN#0.7325;HUMAN CERVICAL CARCINOMA#0.6451;ADENINE#0.6388;MALIGNANT MESOTHELIOMA#0.6321;CERVICAL#0.6086;PROTEIN KINASE#0.6060
10497	SYNAPTIC VESICLE PRIMING#1.0890;VESICLE EXOCYTOSIS#1.0575;SNARE COMPLEX ASSEMBLY#1.0539;SNARE COMPLEX#1.0389;CAM BINDING#1.0293;EXOCYTOSIS#1.0230;NEUROTRANSMITTER RELEASE#1.0226;SYNAPTIC TRANSMISSION#1.0201;SYNAPTIC VESICLE#1.0177;VESICLE FUSION#1.0168;SYNAPTIC VESICLE EXOCYTOSIS#1.0152;PROTEIN KINASE C#1.0131;PROTEIN KINASE#1.0129;MAST CELL#1.0042;MEMBRANE FUSION#1.0036;PLASMA MEMBRANE#0.9905;PRESYNAPTIC ACTIVE ZONE#0.9794;DENSE CORE VESICLE#0.9724;NERVOUS SYSTEM#0.9700;VESICLE DOCKING#0.9696;NEUROMUSCULAR JUNCTION#0.9637;NERVE TERMINAL#0.9400;SECRETORY GRANULE#0.9329;N-ETHYLMALEIMIDE#0.9327;SYNAPTIC VESICLE FUSION#0.8460;RIBBON SYNAPSE#0.8401;SNARE BINDING#0.8341;NEUROENDOCRINE CELL#0.8293;PHOTORECEPTOR RIBBON SYNAPSE#0.7919;MAST CELL DEGRANULATION#0.7703;PRESYNAPTIC TERMINAL#0.7419;ACETYLCHOLINE#0.7403;LYSOSOME#0.7372;REGULATED EXOCYTOSIS#0.7334;HYPERGLYCEMIA#0.7327;NEUROTRANSMISSION#0.7309;CALCIUM CHANNEL#0.6958;CHROMAFFIN CELL#0.6937;SECRETORY CELL#0.6878;ETHANOL#0.6854;GOBLET CELL#0.6654;CALMODULIN BINDING#0.6633;READILY RELEASABLE POOL#0.6608;SYNAPTOGENESIS#0.6605;FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS#0.6549;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS#0.6448;SYNAPTIC VESICLE PROTEIN#0.6445;SECRETORY PATHWAY#0.6351;SIGNALING PATHWAY#0.6305;SYNAPTIC VESICLE CYCLE#0.6281;ACTION POTENTIAL#0.6260;PARALLEL FIBER#0.6129;GLUTAMATERGIC SYNAPSE#0.6048;PURKINJE CELL#0.6002
10498	METHYLTRANSFERASE ACTIVITY#1.0700;STEM CELL#1.0429;BREAST CANCER#1.0370;ARGININE#1.0303;CANCER CELL#1.0276;TRANSCRIPTION FACTOR#1.0191;AUTOPHAGY#1.0180;CELL CYCLE#1.0176;HISTONE METHYLATION#1.0167;ESTROGEN RECEPTOR#1.0138;GENE EXPRESSION#1.0082;CHROMATIN REMODELING#1.0042;CELL PROLIFERATION#0.9975;PROTEIN METHYLTRANSFERASE#0.9973;STEROID RECEPTOR COACTIVATOR#0.9962;SIGNALING PATHWAY#0.9923;APOPTOSIS#0.9884;BREAST CANCER CELL#0.9830;HISTONE METHYLTRANSFERASE#0.9822;EPITHELIAL CELL#0.9557;LYSINE#0.9517;HISTONE ACETYLTRANSFERASE#0.9507;SKELETAL MUSCLE#0.9492;OVARIAN CANCER#0.9491;CREB BINDING#0.9457;TRANSACTIVATION#0.9437;CELL PENETRATING PEPTIDE#0.9434;EMBRYONIC STEM CELL#0.9311;ONCOGENIC#0.9288;GLUCOCORTICOID RECEPTOR#0.9276;COLORECTAL CANCER#0.9201;POST-TRANSLATIONAL MODIFICATION#0.9013;HISTONE MODIFICATION#0.8779;LUNG CANCER#0.8700;RNA BINDING#0.8585;RECEPTOR INTERACTING PROTEIN#0.8485;ANDROGEN RECEPTOR#0.8467;LIPID METABOLISM#0.8407;PROTEIN KINASE#0.8286;POSTTRANSLATIONAL MODIFICATION#0.8282;NUCLEAR HORMONE RECEPTOR#0.8265;T CELL#0.8135;TUMOR SUPPRESSOR#0.8027;CELL GROWTH#0.8020;PROTEIN METHYLTRANSFERASE ACTIVITY#0.8010;OVARIAN#0.7978;ADIPOCYTE DIFFERENTIATION#0.7976;COLORECTAL#0.7950;LIVER CANCER#0.7940;N METHYLTRANSFERASE#0.7937;GLUCOSE METABOLISM#0.7906;ESTROGEN RECEPTOR ALPHA#0.7905;CELL DIFFERENTIATION#0.7870;CAMP RESPONSE ELEMENT BINDING#0.7802;CAMP RESPONSE ELEMENT#0.7791;PROTEIN PROTEIN INTERACTION#0.7708;UBIQUITIN#0.7695;MUSCULAR ATROPHY#0.7694;C TERMINAL DOMAIN#0.7641;PROSTATE CANCER#0.7588;HEMATOPOIESIS#0.7377;CYTOPLASM#0.7376;SENESCENCE#0.7354;DNA BINDING#0.7294;HISTONE ARGININE METHYLATION#0.7261;POLYMERASE CHAIN REACTION#0.7195;BLASTOMERE#0.7076;SPINAL MUSCULAR ATROPHY#0.7027;PRE-MRNA SPLICING#0.7022;MRNA SPLICING#0.6991;RNA BINDING PROTEIN#0.6950;INNER CELL MASS#0.6919;MYOGENESIS#0.6914;ADENOSINE#0.6907;HUMAN EMBRYONIC STEM#0.6849;HUMAN BREAST CANCER#0.6782;PROTEIN METHYLATION#0.6772;REGULATION OF GENE EXPRESSION#0.6686;GROWTH FACTOR#0.6584;L-METHIONINE#0.6426;ADIPOCYTE#0.6361;ADIPOGENESIS#0.6322;MAINTENANCE OF PLURIPOTENCY#0.6316;PROTEIN BINDING#0.6304;S-ADENOSYLMETHIONINE#0.6301;PEROXISOME#0.6236;S PHASE#0.6227;ACETYLTRANSFERASE ACTIVITY#0.6172;MUSCLE STEM CELL#0.6151;MYOCYTE ENHANCER FACTOR#0.6112
10499	MESENCHYMAL CHONDROSARCOMA#1.0758;RECEPTOR INTERACTING PROTEIN#1.0551;STEROID RECEPTOR COACTIVATOR#1.0269;GLUCOCORTICOID RECEPTOR#1.0208;HISTONE ACETYLTRANSFERASE#1.0203;CREB BINDING#1.0194;CHONDROSARCOMA#1.0142;ACUTE MYELOID LEUKEMIA#1.0130;MYELOID LEUKEMIA#1.0118;PROTEIN PROTEIN INTERACTION#1.0118;MAMMARY GLAND#1.0118;RETINOIC ACID#1.0060;PROTEIN KINASE#1.0025;THYROID HORMONE RECEPTOR#1.0020;BREAST CANCER#1.0008;ESTROGEN RECEPTOR ALPHA#0.9994;TRANSACTIVATION#0.9973;NUCLEAR HORMONE RECEPTOR#0.9948;PROSTATE CANCER#0.9920;BREAST CANCER CELL#0.9887;CELL PROLIFERATION#0.9870;DNA BINDING#0.9866;ANDROGEN RECEPTOR#0.9864;PROGESTERONE#0.9853;ARGININE#0.9842;VITAMIN D RECEPTOR#0.9841;LIGAND BINDING DOMAIN#0.9841;STROMAL CELL#0.9815;CANCER CELL#0.9815;CELL CYCLE#0.9800;HORMONE BINDING#0.9796;RETINOID X RECEPTOR#0.9794;ENDOMETRIUM#0.9772;ESTROGEN RECEPTOR#0.9766;CAMP RESPONSE ELEMENT BINDING#0.9766;POLYMERASE CHAIN REACTION#0.9765;ESTRADIOL#0.9763;CAMP RESPONSE ELEMENT#0.9754;GROWTH FACTOR#0.9752;UTERUS#0.9728;GENE EXPRESSION#0.9672;TRANSCRIPTION FACTOR#0.9670;SIGNALING PATHWAY#0.9667;PROTEIN BINDING#0.9634;SERTOLI CELL#0.9627;SKELETAL MUSCLE#0.9594;STEROID HORMONE RECEPTOR#0.9545;GLUTATHIONE#0.9504;TUMOR NECROSIS FACTOR#0.9326;RETINOIC ACID RECEPTOR#0.9237;PEROXISOME#0.9233;EPITHELIAL CELL#0.9224;ESTROGEN RESPONSE ELEMENT#0.9105;HISTONE ACETYLATION#0.9092;RECEPTOR BINDING#0.9086;APOPTOSIS#0.9046;REVERSE TRANSCRIPTION#0.9038;TAMOXIFEN#0.8986;LIVER CANCER#0.8790;CONSTITUTIVE ANDROSTANE RECEPTOR#0.8746;DECIDUALIZATION#0.8724;STEM CELL#0.8693;MACROPHAGE#0.8632;MUTAGENESIS#0.8577;RHABDOMYOSARCOMA#0.8557;DEXAMETHASONE#0.8539;NUCLEAR RECEPTOR SUPERFAMILY#0.8537;NUCLEAR RECEPTOR BINDING#0.8518;CELL GROWTH#0.8461;DIHYDROTESTOSTERONE#0.8445;BICALUTAMIDE#0.8425;TUMOR SUPPRESSOR#0.8385;CYTOPLASM#0.8355;SMOOTH MUSCLE#0.8277;SIGNAL TRANSDUCTION#0.8211;OVARIAN#0.8192;RECEPTOR LIGAND#0.8192;C TERMINAL DOMAIN#0.8120;RECEPTOR ACTIVITY#0.7975;ADIPOSE TISSUE#0.7961;HYPOXIA#0.7907;COLORECTAL#0.7905;EPIDERMAL GROWTH FACTOR#0.7903;RU486#0.7857;ZINC FINGER PROTEIN#0.7822;BONE MARROW#0.7785;CHROMATIN REMODELING#0.7708;METHYLTRANSFERASE ACTIVITY#0.7704;MITOGEN ACTIVATED PROTEIN#0.7644;ADIPOCYTE#0.7577;HISTONE DEACETYLASE#0.7567;MONOCYTIC LEUKEMIA#0.7518;ESTROGENS#0.7483;KUPFFER CELL#0.7468;ACTIVATOR PROTEIN 1#0.7449;PROTEIN KINASE A#0.7405;REPORTER GENE ASSAY#0.7396;4-HYDROXYTAMOXIFEN#0.7385;HEPATOCYTE NUCLEAR FACTOR#0.7318;EMBRYO IMPLANTATION#0.7309;ONCOGENIC#0.7287;RESONANCE ENERGY TRANSFER#0.7247;COMPLEX I#0.7202;MUSCLE CELL#0.7173;UBIQUITIN#0.7162;PROTEASOME#0.7145;ICI 182,780#0.7127;SUMOYLATION#0.7081;ACETYLTRANSFERASE ACTIVITY#0.7079;LIVER X RECEPTOR#0.7079;HISTONE MODIFICATION#0.7068;PROSTATE SPECIFIC ANTIGEN#0.7042;SMOOTH MUSCLE CELL#0.6993;LEUCINE#0.6976;SIGNALING CASCADE#0.6952;PEPTIDE BINDING#0.6925;HISTONE ACETYL TRANSFERASE#0.6921;TUMOR CELLS#0.6906;ACUTE LEUKEMIA#0.6899;ARYL HYDROCARBON RECEPTOR#0.6886;LIPID METABOLISM#0.6858;MECHANISM OF ACTION#0.6851;LYSINE#0.6839;HISTONE ACETYLTRANSFERASE ACTIVITY#0.6654;GROWTH FACTOR RECEPTOR#0.6435;ANDROGEN INSENSITIVITY SYNDROME#0.6429;MYOBLAST#0.6337;SPINDLE CELL RHABDOMYOSARCOMA#0.6321;RECEPTOR TRANSACTIVATION#0.6282;GERM CELL#0.6260;TRANSFORMING GROWTH FACTOR#0.6253;PREGNANE X RECEPTOR#0.6214;ENERGY HOMEOSTASIS#0.6205;INFERTILITY#0.6202;MORPHOGENESIS#0.6153;ACUTE MYELOID LEUKAEMIA#0.6107;TRANSCRIPTASE#0.6087;APOPTOTIC#0.6061;EMBRYONAL RHABDOMYOSARCOMA#0.6038;17β-ESTRADIOL#0.6015
104	AXIAL ELEMENT#1.0608;MEIOSIS#1.0244;AMPA RECEPTOR#1.0226;GLUTAMATE RECEPTOR#1.0133;RNA BINDING#1.0108;RNA EDITING#1.0103;ADENOSINE DEAMINASE#1.0011;ADENOSINE#0.9974;AMYOTROPHIC LATERAL SCLEROSIS#0.9960;LATERAL SCLEROSIS#0.9959;MRNA EDITING#0.9937;INOSINE#0.9855;SYNAPTONEMAL COMPLEX#0.9830;MEIOTIC CHROMOSOME#0.9798;GENE EXPRESSION#0.9790;DOUBLE-STRANDED RNA BINDING#0.9750;ARGININE#0.9716;DOUBLE STRAND BREAK#0.9497;GLUTAMINE#0.9228;DEAMINASE ACTIVITY#0.9163;SYNAPSIS#0.9066;DSRNA BINDING#0.9048;ASTROCYTE#0.8834;NERVOUS SYSTEM#0.8827;BUDDING#0.8817;PACHYTENE#0.8510;CHROMATID#0.8362;PROPHASE#0.8268;DNA BINDING#0.8147;LATERAL ELEMENT#0.8104;MEIOSIS I#0.7955;DNA DAMAGE CHECKPOINT#0.7846;SPINAL CORD#0.7791;PROTEIN KINASE#0.7784;ASTROCYTOMA#0.7633;TUMOR SUPPRESSOR#0.7602;TRANSCRIPTION FACTOR#0.7593;NEUROTRANSMITTER RECEPTOR#0.7550;ION CHANNEL#0.7449;SPORULATION#0.7321;NUCLEOLUS#0.7262;CELL CYCLE#0.7245;RNA INTERFERENCE#0.7160;KINASE ACTIVITY#0.7053;RNA BINDING PROTEIN#0.6930;IMMUNE RESPONSE#0.6841;MEIOTIC RECOMBINATION CHECKPOINT#0.6838;CANCER CELL#0.6735;CYTOPLASM#0.6657;FLUOXETINE#0.6657;CHROMOSOME SEGREGATION#0.6628;EXOSOME#0.6564;SEROTONIN RECEPTOR#0.6559;GENE SILENCING#0.6511;CATALYTIC ACTIVITY#0.6509;GUANOSINE#0.6506;CELL DEATH#0.6466;MUTAGENESIS#0.6447;ADENOSINE TO INOSINE EDITING#0.6387;FOREBRAIN#0.6364;BIPOLAR DISORDER#0.6356;INNATE IMMUNE RESPONSE#0.6329;EPILEPSY#0.6231;POLYMERASE CHAIN REACTION#0.6128;ZINC FINGER PROTEIN#0.6125;DNA REPAIR#0.6057;CYTOPLASMIC INCLUSION#0.6048
10500	GROWTH CONE#0.8275;PRIMORDIAL FOLLICLE ACTIVATION#0.6790;SKELETAL MUSCLE#0.6698;RETINAL DEVELOPMENT#0.6362;CELL JUNCTION#0.6263
10501	AXON GUIDANCE#0.8953;BREAST CANCER#0.8291;GENE EXPRESSION#0.7794;RETINOIC ACID#0.7752;CANCER CELL#0.7104;FENOFIBRATE#0.6287
105031671	SYNCOPE#1.0516;LOSS OF CONSCIOUSNESS#1.0478;BRADYCARDIA#1.0393;TACHYCARDIA#1.0297;HYPOTENSION#1.0170;METOPROLOL#0.9909;CAROTID SINUS#0.9602;NITROGLYCERIN#0.9523;SYSTOLIC BLOOD PRESSURE#0.9245;HEART RATE VARIABILITY#0.9169;NERVOUS SYSTEM#0.9150;RANDOMIZED CONTROLLED TRIAL#0.8752;VASOCONSTRICTION#0.8597;NOREPINEPHRINE#0.7828;ADENOSINE#0.7563;NITRIC OXIDE#0.7468;MIDODRINE#0.7443;MIDODRINE HYDROCHLORIDE#0.7388;HEART DISEASE#0.7019;EPINEPHRINE#0.6997;VENOUS BLOOD#0.6794;HYPERSENSITIVITY#0.6632;FLUOXETINE#0.6388;ARGININE VASOPRESSIN#0.6371;STRUCTURAL HEART DISEASE#0.6354;PROPRANOLOL#0.6345;ADRENERGIC RECEPTOR#0.6325;ABDOMINAL PAIN#0.6000
10505	PROSTATE CANCER#0.6672;CANCER CELL#0.6508;POST SYNAPTIC DENSITY#0.6446;BREAST CANCER#0.6010
10507	GROWTH CONE COLLAPSE#1.0705;GROWTH CONE#1.0598;OLIGODENDROCYTE#1.0589;ENDOTHELIAL CELL#1.0485;ANGIOGENESIS#1.0443;DENDRITIC CELL#1.0422;PERIPHERAL BLOOD#1.0399;GROWTH FACTOR#1.0398;B CELL#1.0382;T CELL#1.0377;T LYMPHOCYTE#1.0366;CELL PROLIFERATION#1.0358;OSTEOCLAST#1.0354;MACROPHAGE#1.0345;BONE FORMATION#1.0344;OSTEOBLAST#1.0318;IMMUNE SYSTEM#1.0278;CANCER CELL#1.0268;CELL ACTIVATION#1.0243;CELL SURFACE#1.0238;SQUAMOUS CELL CARCINOMA#1.0224;BREAST CANCER#1.0223;IMMUNE RESPONSE#1.0199;AXON GUIDANCE#1.0148;SIGNALING PATHWAY#1.0124;GAP ACTIVITY#1.0083;CELL MIGRATION#1.0083;MONOCYTE#1.0022;NERVOUS SYSTEM#1.0018;APOPTOSIS#0.9961;IMMUNE CELL#0.9863;TUMOR CELLS#0.9849;RAS GAP ACTIVITY#0.9754;OVARIAN CANCER#0.9610;B LYMPHOCYTE#0.9467;INHIBITORY SYNAPSE#0.9458;INFLAMMATORY RESPONSE#0.9353;OVARIAN#0.9337;LYMPH NODE#0.9277;NEURITE#0.9274;HYPOXIA#0.9225;SPINAL CORD#0.9199;EPITHELIAL CELL#0.9129;HEPATITIS C#0.9103;MULTIPLE SCLEROSIS#0.9073;BONE RESORPTION#0.9029;KERATINOCYTE#0.8810;RHOGEF#0.8809;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8774;ENDOTHELIAL GROWTH FACTOR#0.8773;HEPATITIS C VIRUS#0.8753;T CELL ACTIVATION#0.8714;INVASIVE GROWTH#0.8679;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8617;TUMOR ASSOCIATED MACROPHAGE#0.8573;ENDOTHELIAL CELL MIGRATION#0.8547;NEURITE OUTGROWTH#0.8545;PROTEIN TYROSINE PHOSPHATASE#0.8541;LYMPH NODE METASTASIS#0.8530;BONE MARROW#0.8527;LEUKOCYTE#0.8515;PLATELET ACTIVATION#0.8500;MIDDLE CEREBRAL ARTERY#0.8494;CEREBRAL ARTERY#0.8490;OSTEOBLAST DIFFERENTIATION#0.8483;COLORECTAL#0.8462;GENE EXPRESSION#0.8449;CD8+ T CELL#0.8433;CELL ADHESION#0.8422;AXONAL GROWTH CONE#0.8359;HYPOXIA INDUCIBLE FACTOR#0.8182;SYNAPSE DEVELOPMENT#0.8166;BONE REMODELING#0.8090;T CELL PROLIFERATION#0.8051;CEREBRAL ARTERY OCCLUSION#0.8047;COLORECTAL CARCINOMA#0.8037;PROSTATE CANCER#0.8000;STEM CELL#0.7992;COLON CANCER#0.7978;CENTRAL NERVOUS SYSTEM#0.7970;SIGNALING MOLECULE#0.7911;REGENERATION#0.7884;COLORECTAL CANCER#0.7865;PROGENITOR CELL#0.7865;SIGNAL TRANSDUCTION#0.7698;ATHEROSCLEROSIS#0.7532;OSTEOPOROSIS#0.7514;WOUND HEALING#0.7485;BONE MINERAL DENSITY#0.7450;BREAST CANCER PATIENTS#0.7308;ANTIGEN PRESENTING CELLS#0.7286;RHEUMATOID ARTHRITIS#0.7282;PERICYTE#0.7174;SPINAL CORD INJURY#0.7152;NUCLEOTIDE EXCHANGE FACTOR#0.7114;BREAST CANCER CELL#0.7094;RECEPTOR TYROSINE KINASE#0.7069;EPITHELIAL OVARIAN CANCER#0.6986;LYMPHOID TISSUE#0.6954;CEREBRAL ISCHEMIA#0.6949;BLOOD BRAIN BARRIER#0.6928;OLIGODENDROCYTE PROGENITOR CELL#0.6925;KINASE ACTIVITY#0.6911;LUNG CANCER#0.6889;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6823;BONE DISEASE#0.6817;ATHEROSCLEROTIC#0.6806;RECEPTOR ACTIVATOR#0.6803;ARTERY#0.6801;EPITHELIAL MESENCHYMAL TRANSITION#0.6786;HEMATOPOIETIC CELL#0.6779;DEPHOSPHORYLATION#0.6767;NEURAL CELL#0.6763;MORPHOGENESIS#0.6745;DISEASE FREE SURVIVAL#0.6737;GROWTH FACTOR RECEPTOR#0.6488;SERINE KINASE ACTIVITY#0.6486;EXTRACELLULAR REGION#0.6385;ISCHEMIA#0.6340;TUBE FORMATION#0.6323;APOPTOTIC#0.6304;CELL DIFFERENTIATION#0.6304;PRESYNAPTIC BOUTON#0.6267;AXON REGENERATION#0.6214;GUANINE#0.6146;DENTAL PULP STEM CELL#0.6109;BRANCHING MORPHOGENESIS#0.6082;CELL AGGREGATION#0.6079;CD4+ T CELL#0.6066;CELL DEATH#0.6039;SOFT TISSUE SARCOMA#0.6026;CELL CYCLE#0.6023;DENTAL PULP#0.6018
10509	LUNG CANCER#1.0111;BONE MARROW#0.7705;SIGNALING PATHWAY#0.7098
1050	GRANULOCYTE DIFFERENTIATION#1.0600;FETAL LIVER#1.0318;CAAT ENHANCER BINDING#1.0285;LIVER DEVELOPMENT#1.0252;INTERNAL TANDEM DUPLICATION#1.0246;STEROL REGULATORY ELEMENT#1.0245;LIPOPROTEIN LIPASE#1.0230;FATTY ACID SYNTHASE#1.0209;BINDING PROTEIN 1#1.0206;FATTY ACID BINDING#1.0188;G-CSF#1.0185;HEPATOCYTE NUCLEAR FACTOR#1.0163;CELL CYCLE ARREST#1.0162;HEPATOCYTE PROLIFERATION#1.0162;PROTEIN PROTEIN INTERACTION#1.0150;PEROXISOME#1.0146;ENHANCER BINDING PROTEIN#1.0138;ENHANCER BINDING#1.0135;GRANULOCYTE COLONY STIMULATING FACTOR#1.0132;S PHASE#1.0103;TRANSCRIPTION FACTOR BINDING#1.0097;WHITE BLOOD CELL#1.0076;TUMOR SUPPRESSOR#1.0072;HYPOXIA#1.0072;KERATINOCYTE#1.0069;ACUTE MYELOID LEUKAEMIA#1.0049;GRANULOCYTE#1.0048;CAMP RESPONSE ELEMENT#1.0042;LUNG CANCER#1.0039;GLUCOCORTICOID RECEPTOR#1.0039;ELECTROPHORETIC MOBILITY SHIFT#1.0026;B CELL#1.0015;FACTOR I#1.0013;TRANSACTIVATION#1.0004;HEPATOMA CELLS#1.0003;LUNG DEVELOPMENT#0.9993;MITOTIC CLONAL EXPANSION#0.9991;LIPOGENESIS#0.9989;PROSTATE CANCER#0.9977;HEMATOPOIETIC CELL#0.9971;COLONY-STIMULATING FACTOR#0.9968;CANCER CELL#0.9967;ACETYL COA CARBOXYLASE#0.9951;TERMINAL DIFFERENTIATION#0.9949;NEUTROPHIL#0.9948;ACUTE PHASE RESPONSE#0.9943;LEUCINE#0.9942;HISTONE ACETYLATION#0.9942;EVENT FREE SURVIVAL#0.9940;MYELOID CELL#0.9940;LIVER REGENERATION#0.9937;DNA BINDING#0.9929;REVERSE TRANSCRIPTION#0.9926;STEAROYL COA DESATURASE#0.9916;FAT CELL#0.9913;BRM COMPLEX#0.9910;CORE BINDING FACTOR#0.9909;TRANSCRIPTION FACTOR#0.9906;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.9906;ADIPOCYTE#0.9894;CELL CYCLE#0.9891;DISEASE FREE SURVIVAL#0.9891;HEPATOCELLULAR CARCINOMA#0.9890;ACUTE LEUKEMIA#0.9883;BREAST CANCER#0.9878;MYELODYSPLASTIC SYNDROME#0.9875;MUTAGENESIS#0.9872;CYTOCHROME P450#0.9870;DNA METHYLATION#0.9869;RETINOIC ACID#0.9861;MACROPHAGE#0.9860;CLARA CELL#0.9860;POLYMERASE CHAIN REACTION#0.9847;CAMP RESPONSE ELEMENT BINDING#0.9844;HEMATOPOIESIS#0.9838;ONCOGENIC#0.9837;HYPOXIA INDUCIBLE FACTOR#0.9834;LIPID DROPLET#0.9829;T CELL#0.9822;INSULIN-LIKE GROWTH FACTOR#0.9820;REPORTER GENE ASSAY#0.9817;CELL GROWTH#0.9815;MONOCYTE#0.9815;ADIPOCYTE DIFFERENTIATION#0.9797;ADIPOGENESIS#0.9796;EPITHELIAL CELL#0.9795;REGENERATION#0.9793;ALL TRANS RETINOIC ACID#0.9786;DNA SYNTHESIS#0.9785;HISTONE DEACETYLASE#0.9785;GLUCOSE UPTAKE#0.9785;ACUTE MYELOID LEUKEMIA#0.9782;MYELOID LEUKEMIA#0.9781;CYCLIN DEPENDENT KINASE#0.9780;CELL DIFFERENTIATION#0.9779;HEPATIC NUCLEAR FACTOR#0.9773;PREADIPOCYTE#0.9770;CREB BINDING#0.9767;TUMOR NECROSIS FACTOR#0.9757;QUANTITATIVE REAL TIME#0.9756;PROGENITOR CELL#0.9751;CELL PROLIFERATION#0.9735;DEXAMETHASONE#0.9732;SIGNAL TRANSDUCER#0.9731;TRANSDIFFERENTIATION#0.9731;BROWN ADIPOSE TISSUE#0.9725;PHOSPHOENOLPYRUVATE#0.9722;HEMATOPOIETIC STEM CELL#0.9718;HORMONE SENSITIVE LIPASE#0.9716;OSTEOBLAST#0.9715;DNASE I#0.9713;SMOOTH MUSCLE#0.9710;LIPID METABOLISM#0.9705;WHITE ADIPOSE TISSUE#0.9701;STROMAL CELL#0.9697;GROWTH FACTOR#0.9685;RETINOID X RECEPTOR#0.9678;CELL DEVELOPMENT#0.9655;GROWTH HORMONE#0.9655;KINASE INHIBITOR#0.9654;STEM CELL TRANSPLANTATION#0.9646;ACTIVATOR PROTEIN 1#0.9643;OBESE#0.9642;GENE EXPRESSION#0.9640;GLUCONEOGENESIS#0.9637;ESTROGEN RECEPTOR#0.9630;PROTEIN BINDING#0.9623;SUBCUTANEOUS ADIPOSE TISSUE#0.9621;PRECURSOR CELL#0.9619;HIGH FAT DIET#0.9619;DEPHOSPHORYLATION#0.9606;ACUTE PROMYELOCYTIC LEUKEMIA#0.9605;APOPTOSIS#0.9604;PROTEIN KINASE#0.9604;BONE MARROW#0.9600;MITOGEN ACTIVATED PROTEIN#0.9598;ADIPOSE TISSUE#0.9598;PERIPHERAL BLOOD#0.9585;SIGNALING PATHWAY#0.9582;PROTEASOME#0.9579;SIGNAL TRANSDUCTION#0.9574;LIPOLYSIS#0.9567;MESENCHYMAL STEM CELL#0.9563;HEMATOPOIETIC PROGENITOR CELL#0.9560;MUSCLE CELL#0.9555;APOPTOTIC#0.9541;STEM CELL#0.9541;CELL DEATH#0.9517;GLUCOSE TRANSPORT#0.9509;INFLAMMATORY RESPONSE#0.9495;INSULIN RECEPTOR#0.9480;BREAST CANCER CELL#0.9474;CYCLIC AMP#0.9473;DNASE#0.9464;ESTRADIOL#0.9463;TYPE 2 DIABETES#0.9461;CHLORAMPHENICOL#0.9457;GLUCOSE METABOLISM#0.9455;REGULATION OF ADIPOGENESIS#0.9442;ALKALINE PHOSPHATASE#0.9426;WORLD HEALTH ORGANIZATION#0.9422;FOR ADIPOCYTE DIFFERENTIATION#0.9420;PROTEIN COMPLEX#0.9399;HEPATOCYTE DIFFERENTIATION#0.9395;CYTOPLASM#0.9392;TRANSFORMING GROWTH FACTOR#0.9386;RETINOBLASTOMA#0.9382;RELAPSE FREE SURVIVAL#0.9358;EXTRACELLULAR MATRIX#0.9333;GESTATION#0.9315;ENERGY HOMEOSTASIS#0.9296;TROGLITAZONE#0.9277;WEIGHT GAIN#0.9249;LUCIFERASE ACTIVITY#0.9248;LIPID BINDING PROTEIN#0.9218;TUMOR CELLS#0.9210;SQUAMOUS CELL CARCINOMA#0.9207;CHRONIC MYELOID LEUKEMIA#0.9197;TRANSCRIPTASE#0.9180;EPIDERMAL GROWTH FACTOR#0.9174;LIPID BINDING#0.9149;INHIBITION OF ADIPOGENESIS#0.9130;RETINOIC ACID RECEPTOR#0.9082;SUMOYLATION#0.9070;COENZYME A#0.9069;ALANINE#0.9068;ENDOTHELIAL CELL#0.9064;GM-CSF#0.9051;MAMMARY GLAND#0.9020;NEUTROPHIL DIFFERENTIATION#0.9014;SKELETAL MUSCLE#0.9005;MYELOBLAST#0.8999;MYELOID PROGENITOR CELL#0.8987;PROTEIN SYNTHESIS#0.8981;MOUSE EMBRYONIC FIBROBLAST#0.8980;TRANSCRIPTIONAL CONTROL#0.8964;CHROMATIN REMODELING#0.8961;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8949;UBIQUITIN#0.8942;TRANSFORMING GROWTH FACTOR BETA#0.8913;MALIC ENZYME#0.8905;MAST CELL#0.8901;SMOOTH MUSCLE CELL#0.8894;TRANSLATION INITIATION#0.8890;PRO-INFLAMMATORY#0.8890;VASCULAR CELL#0.8867;OVARIAN#0.8866;ENDOPLASMIC RETICULUM#0.8866;DNA REPLICATION#0.8866;LIVER DISEASE#0.8837;TISSUE DEVELOPMENT#0.8777;FATTY LIVER#0.8768;LIVER X RECEPTOR#0.8756;GLUTATHIONE#0.8744;ROSIGLITAZONE#0.8711;BONE MARROW CELLS#0.8677;REACTIVE OXYGEN SPECIES#0.8648;MARROW STROMAL CELLS#0.8620;BONE MARROW STROMAL CELL#0.8620;BONE MARROW STROMAL#0.8616;CELLULAR TRANSCRIPTION#0.8596;GLUCOSE HOMEOSTASIS#0.8583;RNA INTERFERENCE#0.8573;A-GEL#0.8567;CELL NUCLEUS#0.8565;ADIPOSE TISSUE DEVELOPMENT#0.8562;ANDROGEN RECEPTOR#0.8515;LIGAND BINDING DOMAIN#0.8487;DEMETHYLATION#0.8483;SERUM ALBUMIN#0.8476;HETEROCHROMATIN#0.8471;LIPID HOMEOSTASIS#0.8448;FACTOR S#0.8423;LOW DENSITY LIPOPROTEIN#0.8396;SEBACEOUS GLAND#0.8396;RESONANCE ENERGY TRANSFER#0.8387;HISTONE DEACETYLASE INHIBITOR#0.8385;MAMMARY EPITHELIAL CELL#0.8376;LIVER CANCER#0.8375;KINASE ACTIVITY#0.8369;MYELOID NEOPLASM#0.8362;THYMIDINE#0.8354;MESENCHYMAL CELL#0.8336;MYOBLAST#0.8333;EPIDIDYMAL ADIPOSE TISSUE#0.8332;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8324;IMMUNE RESPONSE#0.8323;MYELOPROLIFERATIVE NEOPLASM#0.8317;DENDRITIC CELL#0.8308;MECHANISM OF ACTION#0.8296;DIET INDUCED OBESITY#0.8293;GLUCOSE 6 PHOSPHATASE#0.8275;PROTEIN KINASE A#0.8262;BONE MORPHOGENETIC PROTEIN#0.8259;BASOPHIL#0.8257;ETHANOL#0.8254;MINIMAL RESIDUAL DISEASE#0.8240;CELL CYCLE CONTROL#0.8233;INSULIN RECEPTOR SUBSTRATE#0.8221;FATTY ACID OXIDATION#0.8216;CENTROMERIC HETEROCHROMATIN#0.8189;KAPOSI'S SARCOMA#0.8185;FAT PAD#0.8183;MORPHOGENESIS#0.8162;OSTEOBLAST DIFFERENTIATION#0.8160;GLYCOGEN SYNTHASE KINASE#0.8140;LEUKOCYTE#0.8123;OSTEOGENESIS#0.8117;GRANULOCYTE-MONOCYTE PROGENITOR#0.8045;BLAST CELL#0.8029;KERATINOCYTE DIFFERENTIATION#0.8029;ADENOSINE#0.8006;DIABETES MELLITUS#0.8001;HEPATOBLAST#0.7999;TYROSINE KINASE DOMAIN#0.7994;VITAMIN D RECEPTOR#0.7987;UNFOLDED PROTEIN RESPONSE#0.7986;3-ISOBUTYL-1-METHYLXANTHINE#0.7980;FATTY ACID SYNTHESIS#0.7940;TOXICITY#0.7927;REGULATION OF ADIPOCYTE DIFFERENTIATION#0.7921;STROMAL VASCULAR CELLS#0.7921;SIGNALING MOLECULE#0.7901;RNA BINDING PROTEIN#0.7893;REGULATION OF GENE EXPRESSION#0.7886;ADIPOGENIC DIFFERENTIATION MEDIUM#0.7880;RNA BINDING#0.7879;DNA HYPERMETHYLATION#0.7866;CELL SURFACE#0.7831;HAIR FOLLICLE#0.7820;HEPATOCYTE GROWTH FACTOR#0.7808;RAPAMYCIN#0.7802;SIGNALING CASCADE#0.7793;HUMAN ADIPOSE TISSUE#0.7783;LYSINE#0.7778;MONONUCLEAR CELLS#0.7766;MYELOID CELL DEVELOPMENT#0.7748;COMPLEX I#0.7692;GENE SILENCING#0.7623;POST-TRANSLATIONAL MODIFICATION#0.7619;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7615;HYPOGLYCEMIA#0.7603;METHYLATION SPECIFIC POLYMERASE#0.7583;2'-DEOXYCYTIDINE#0.7581;LUNG EPITHELIAL CELL#0.7578;BODY WEIGHT GAIN#0.7577;QUANTITATIVE REVERSE TRANSCRIPTION#0.7562;CARNITINE#0.7535;MONOCYTE DIFFERENTIATION#0.7529;MAP KINASE#0.7518;NEUTROPENIA#0.7517;MITOCHONDRIA#0.7505;TYROSINE KINASE INHIBITOR#0.7497;ANEMIA#0.7491;FIBROBLAST GROWTH FACTOR#0.7484;VISCERAL ADIPOSE TISSUE#0.7449;HISTONE MODIFICATION#0.7446;BONE MARROW FAILURE#0.7434;5-AZA-2'-DEOXYCYTIDINE#0.7397;GRANULOSA CELL#0.7392;LYMPHOID CELL#0.7388;ALKALINE PHOSPHATASE ACTIVITY#0.7377;PHOSPHATASE ACTIVITY#0.7348;MYELOID CELL DIFFERENTIATION#0.7330;LIPID STORAGE#0.7282;PLASMA MEMBRANE#0.7257;MIXED LINEAGE LEUKEMIA#0.7243;PROMOTER BINDING#0.7240;OLEIC ACID#0.7228;DOMINANT NEGATIVE MUTANT#0.7228;ADIPOSE TISSUE MASS#0.7227;HEPATIC STELLATE CELL#0.7224;GROWTH FACTOR BINDING#0.7217;COMMON MYELOID PROGENITOR#0.7194;EOSINOPHIL#0.7170;CELL CYCLE REGULATOR#0.7167;BETA-2#0.7163;HUMAN MESENCHYMAL STEM#0.7161;MICROGLIAL CELL#0.7134;ATP BINDING#0.7118;HYPOXIC#0.7108;ERYTHROID PROGENITOR#0.7052;GROWTH FACTOR RECEPTOR#0.7023;NITRIC OXIDE#0.7015;NICOTINAMIDE#0.7014;ACTIVATING TRANSCRIPTION FACTOR#0.7003;SEVERE CONGENITAL NEUTROPENIA#0.6981;DNA METHYLTRANSFERASE#0.6970;PEROXISOME PROLIFERATION#0.6938;TYROSINE KINASE RECEPTOR#0.6927;IFN-GAMMA#0.6913;HEMATOPOIETIC CELL TRANSPLANTATION#0.6905;CELL DIVISION#0.6883;THYMIDINE KINASE#0.6853;CYCLIN DEPENDENT KINASE INHIBITOR#0.6836;TROPHOBLAST#0.6829;EPSTEIN BARR VIRUS#0.6787;PROGESTERONE#0.6772;TOLL LIKE RECEPTOR#0.6761;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6744;DEDIFFERENTIATION#0.6723;MULTIPLE MYELOMA#0.6712;LEUKEMIA INITIATING CELLS#0.6710;HEPATITIS B VIRUS#0.6698;ADENOCARCINOMA#0.6698;DNA DEMETHYLATION#0.6695;HEPATITIS B#0.6684;SMALL INTESTINE#0.6684;STANDARD OF CARE#0.6679;SUPEROXIDE DISMUTASE#0.6650;NORMAL CONTROL GROUP#0.6623;OSTEOPOROSIS#0.6617;ORNITHINE CYCLE#0.6610;LACTATION#0.6604;HODGKIN'S LYMPHOMA#0.6595;ADENOSINE MONOPHOSPHATE#0.6551;TRANSCRIPTION REGULATOR#0.6518;TETRACYCLINE#0.6517;CHONDROCYTE#0.6513;CHROMATIN REMODELING COMPLEX#0.6511;TRANSCRIPTION ACTIVATOR#0.6503;ORNITHINE#0.6501;HEPATOCELLULAR CARCINOMA CELL#0.6435;CELL CYCLE REGULATION#0.6428;RECEPTOR LIGAND#0.6423;ATP BINDING CASSETTE#0.6423;MYOTUBE#0.6393;TUMOUR NECROSIS FACTOR#0.6393;PROTEIN KINASE C#0.6382;DYSKERATOSIS CONGENITA#0.6339;BROWN ADIPOCYTE DIFFERENTIATION#0.6333;UREA CYCLE#0.6312;MINERALIZATION#0.6296;AIRWAY SMOOTH MUSCLE#0.6285;NUCLEAR MATRIX#0.6279;PKCDELTA#0.6270;MYOGENESIS#0.6256;LIPODYSTROPHY#0.6236;EARLY GROWTH RESPONSE#0.6235;PYRUVATE#0.6213;BERBERINE#0.6212;IMMUNE CELL#0.6204;INHIBITION OF CELL PROLIFERATION#0.6169;INSULIN SIGNALING PATHWAY#0.6160;THYROID HORMONE RECEPTOR#0.6133;PROSTATE EPITHELIUM#0.6123;RESPONSE TO TREATMENT#0.6099;ERYTHROPOIESIS#0.6068;MLL1 COMPLEX#0.6066;CALCINEURIN#0.6052;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.6028;ASTROCYTE#0.6025;CRE BINDING#0.6023;REGULATION OF 'MALIC' ENZYME#0.6019;CORTISOL#0.6019;COMMON LYMPHOID PROGENITOR#0.6017;PROTEIN PHOSPHATASE 2A#0.6015;PHOSPHATASE 2A#0.6012;ENAMEL FORMATION#0.6003
10512	BREAST CANCER#1.0216;CANCER CELL#1.0183;ENDOTHELIAL CELL#1.0123;GENE EXPRESSION#0.9885;ANGIOGENESIS#0.9707;NEURAL CREST#0.9600;CELL PROLIFERATION#0.9565;PROSTATE CANCER#0.9560;GROWTH CONE#0.9264;OUTFLOW TRACT#0.9173;SIGNALING PATHWAY#0.8735;BREAST CANCER CELL#0.8500;EPITHELIAL CELL#0.8321;AXON GUIDANCE#0.8239;GROWTH FACTOR#0.8044;MORPHOGENESIS#0.7779;NERVOUS SYSTEM#0.7769;CELL MIGRATION#0.7728;SIGNAL TRANSDUCTION#0.7172;EXTRACELLULAR MATRIX#0.7141;CARDIAC NEURAL CREST#0.7114;NEURAL CREST CELL#0.6958;POLYMERASE CHAIN REACTION#0.6837;TRANSCRIPTION FACTOR#0.6834;INNERVATION#0.6560;ADENOCARCINOMA#0.6429;APOPTOSIS#0.6257;GROWTH CONE COLLAPSE#0.6238;WOUND HEALING#0.6020
10513	CELL SURFACE#0.9669;AMYLOID PRECURSOR PROTEIN#0.8779;KINESIN LIGHT CHAIN#0.8341;KINESIN#0.6367;CELL DEATH#0.6348;PRIMARY CORTICAL NEURON#0.6051
10514	STEROID RECEPTOR COACTIVATOR#1.0513;TRANSCRIPTION FACTOR#1.0118;TUMOR SUPPRESSOR#0.9959;GENE EXPRESSION#0.9949;CREB BINDING#0.9751;CELL CYCLE#0.9537;ANTHOCYANIN BIOSYNTHESIS#0.9342;NUCLEOLUS#0.9335;BREAST CANCER#0.9300;GLUCOCORTICOID RECEPTOR#0.9169;HISTONE ACETYLTRANSFERASE#0.9150;TRANSACTIVATION#0.8567;CANCER CELL#0.8493;HISTONE DEACETYLASE#0.8251;NUCLEOPLASM#0.8133;CAMP RESPONSE ELEMENT BINDING#0.7970;CAMP RESPONSE ELEMENT#0.7959;PROTEIN BINDING#0.7756;LEUCINE#0.7440;APOPTOSIS#0.7258;PROTEIN METHYLTRANSFERASE#0.7209;BREAST CANCER CELL#0.7187;LIGAND BINDING DOMAIN#0.7046;ANDROGEN RECEPTOR#0.6999;THYROID HORMONE RECEPTOR#0.6784;DNA BINDING#0.6698;RETINOIC ACID#0.6601;ESTROGEN RECEPTOR#0.6589;GROWTH FACTOR#0.6542;SIGNALING PATHWAY#0.6366;CELL CYCLE ARREST#0.6161;ACETYLTRANSFERASE ACTIVITY#0.6155;PROTEIN INTERACTION NETWORK#0.6114;RIBOSOME BIOGENESIS#0.6091;MITOSIS#0.6078
10516	ELASTIC FIBRE#1.0744;ELASTIC FIBER ASSEMBLY#1.0705;CUTIS LAXA#1.0643;FIBRILLIN#1.0528;CEREBRAL PALSY#1.0522;ENDOTHELIAL CELL#1.0479;PARKINSON'S DISEASE#1.0474;PELVIC ORGAN PROLAPSE#1.0397;CELL PROLIFERATION#1.0372;ELASTIC FIBER#1.0304;ANGIOGENESIS#1.0285;MICROFIBRIL#1.0274;RANGE OF MOTION#1.0232;CANCER CELL#1.0166;DEMENTIA#1.0159;SMOOTH MUSCLE CELL#1.0141;MUSCLE CELL#1.0135;AGE RELATED MACULAR DEGENERATION#1.0129;MACULAR DEGENERATION#1.0124;GROWTH FACTOR#1.0099;SMOOTH MUSCLE#1.0063;EPIDERMAL GROWTH FACTOR#1.0039;RANDOMIZED CONTROLLED TRIAL#1.0015;INTEGRIN BINDING#0.9997;EXTRACELLULAR MATRIX#0.9992;TRANSFORMING GROWTH FACTOR#0.9916;CELL ADHESION#0.9897;GENE EXPRESSION#0.9892;BREAST CANCER#0.9806;COGNITION#0.9801;VASCULAR SMOOTH MUSCLE CELL#0.9797;CELL MIGRATION#0.9683;CONNECTIVE TISSUE#0.9526;RANDOMISED CONTROLLED TRIAL#0.9458;QUANTITATIVE REAL TIME#0.9378;POLYMERASE CHAIN REACTION#0.9237;WOUND HEALING#0.9120;ARTERY#0.9065;DERMAL FIBROBLAST#0.8980;ELASTIC FIBRE ASSEMBLY#0.8939;NEURAL CREST#0.8885;PEOPLE WITH DEMENTIA#0.8829;DERMIS#0.8716;HUNTINGTON'S DISEASE#0.8709;AUTISM SPECTRUM DISORDER#0.8383;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.8293;EPITHELIAL CELL#0.8255;LUNG FIBROBLASTS#0.8121;CELL SURFACE#0.8074;BASEMENT MEMBRANE#0.7979;DOWN SYNDROME#0.7966;OBESE#0.7948;ENDOTHELIAL GROWTH FACTOR#0.7918;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7918;TRANSFORMING GROWTH FACTOR BETA#0.7914;TRANSCRIPTION FACTOR#0.7911;AORTIC ANEURYSM#0.7858;LUNG CANCER#0.7811;PROTEOGLYCAN#0.7808;APOPTOSIS#0.7708;CELL MOTILITY#0.7697;ELASTIN FIBER#0.7547;TUMOR SUPPRESSOR#0.7496;LEUCINE RICH REPEAT#0.7443;PERIODONTAL LIGAMENT#0.7421;MILD COGNITIVE IMPAIRMENT#0.7415;BONE RESORPTION#0.7368;OVARIAN CANCER#0.7333;BREAST CANCER CELL#0.7319;FIBROMYALGIA#0.7271;VASCULAR CELL#0.7206;HEPATOCELLULAR CARCINOMA#0.7121;AGEING#0.7030;PHYSICAL ACTIVITY LEVEL#0.7010;TERIPARATIDE#0.6931;CELL GROWTH#0.6898;LONG TERM CARE#0.6875;CERVICAL#0.6821;ECSTASY#0.6803;CHARCOT MARIE TOOTH#0.6781;THORACIC AORTA#0.6765;RETINAL PIGMENT EPITHELIAL#0.6721;RHEUMATOID ARTHRITIS#0.6658;STROMAL CELL#0.6609;ABDOMINAL AORTIC ANEURYSM#0.6587;HUMAN DERMAL FIBROBLAST#0.6535;PLASMA MEMBRANE#0.6466;BLOOD VESSEL#0.6431;ALZHEIMER'S DISEASE#0.6204;CAROTID ARTERY#0.6176;HEPARIN#0.6165;NEUTROPHIL#0.6136;HUMAN PERIODONTAL LIGAMENT#0.6126;MOTOR LEARNING#0.6095;HYPERTENSION#0.6055;PROTEASE ACTIVITY#0.6046;AEROBIC EXERCISE TRAINING#0.6008
10518	INTEGRIN BINDING#1.0936;HAIR CELL#1.0760;HEARING LOSS#1.0612;USHER SYNDROME#1.0554;NONSYNDROMIC DEAFNESS#0.8135;SKELETAL MUSCLE#0.7087
10519	BINDING PROTEIN 1#1.0737;CDK INHIBITOR#1.0671;INTEGRIN BINDING#1.0671;CYCLIN DEPENDENT KINASE INHIBITOR#1.0400;CYCLIN DEPENDENT KINASE#1.0273;KINASE INHIBITOR#1.0268;CALCINEURIN#1.0253;CELL MIGRATION#1.0057;CELL CYCLE#1.0056;CELL DEATH#1.0019;PROTEIN KINASE#0.9990;CELL PROLIFERATION#0.9886;APOPTOSIS#0.9784;CANCER CELL#0.9768;SIGNALING PATHWAY#0.9752;DNA BINDING#0.9608;BREAST CANCER#0.9207;G1 PHASE#0.9184;ENDOTHELIAL CELL#0.9004;GENE EXPRESSION#0.8939;CELL CYCLE REGULATOR#0.8868;KINASE ACTIVITY#0.8798;FIBRINOGEN#0.8757;ANGIOGENESIS#0.8749;S PHASE#0.8711;CELL CYCLE ARREST#0.8677;APOPTOTIC#0.8534;MEGAKARYOCYTE#0.8407;PROTEIN PROTEIN INTERACTION#0.8363;ALZHEIMER'S DISEASE#0.8269;CELL CYCLE REGULATION#0.8245;PLASMA MEMBRANE#0.8167;TRANSCRIPTION FACTOR#0.8156;C TERMINAL DOMAIN#0.7990;PLATELET AGGREGATION#0.7919;GROWTH FACTOR#0.7871;CELL GROWTH#0.7653;BREAST CANCER CELL#0.7616;SPINAL CORD#0.7491;FOCAL ADHESION#0.7472;CELL ADHESION#0.7427;P21 ACTIVATED KINASE#0.7256;FILOPODIA FORMATION#0.7001;STEM CELL#0.6810;RESPONSE TO BLUE LIGHT#0.6574;PROTEIN COMPLEX#0.6559;ONCOGENIC#0.6558;RNA INTERFERENCE#0.6542;CELL DIVISION#0.6534;TUMOR SUPPRESSOR#0.6521;CYTOPLASM#0.6470;HEMOSTASIS#0.6429;DNA DAMAGE RESPONSE#0.6376;TELOMERE#0.6331;SENESCENCE#0.6182;MACROPINOCYTOSIS#0.6147;CALCIUM SIGNALING#0.6036
1051	IL-6 BINDING#1.0841;BETA-NF#1.0459;MITOTIC CLONAL EXPANSION#1.0408;ALKALINE PHOSPHATASE#1.0339;ACTIVATION OF NF-KAPPAB#1.0304;CAAT ENHANCER BINDING#1.0289;CAMP RESPONSE ELEMENT BINDING#1.0258;CREB BINDING#1.0243;NF KAPPAB BINDING#1.0225;G-CSF#1.0214;ACTIVATING TRANSCRIPTION FACTOR#1.0213;ACTIVATOR PROTEIN 1#1.0200;MAMMARY GLAND#1.0198;HYPOXIA#1.0197;DOMINANT NEGATIVE MUTANT#1.0188;GRANULOSA CELL#1.0176;MAMMARY EPITHELIAL CELL#1.0139;S PHASE#1.0133;LEUCINE#1.0130;IFN-GAMMA#1.0124;HEPATOCYTE NUCLEAR FACTOR#1.0119;BINDING PROTEIN 1#1.0113;GLUCOCORTICOID RECEPTOR#1.0104;ASTROCYTE#1.0092;CAMP RESPONSE ELEMENT#1.0085;CRE BINDING#1.0085;STROMAL CELL#1.0069;ENHANCER BINDING#1.0065;ENHANCER BINDING PROTEIN#1.0064;TRANSACTIVATION#1.0059;TRANSCRIPTION FACTOR BINDING#1.0052;PROTEIN PROTEIN INTERACTION#1.0045;LIVER REGENERATION#1.0040;CYCLIC AMP#1.0017;CHONDROCYTE#1.0015;TRANSLATION INITIATION#1.0013;OSTEOBLAST#1.0012;FACTOR I#1.0007;MAP KINASE#1.0004;CAMP-RESPONSIVE ELEMENT BINDING#1.0001;KERATINOCYTE#0.9994;SIGNAL TRANSDUCER#0.9990;PROTEIN KINASE A#0.9985;ACUTE PHASE RESPONSE#0.9984;B CELL#0.9981;GLUTATHIONE#0.9974;LUCIFERASE ACTIVITY#0.9973;NF-KAPPAB ACTIVATION#0.9969;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.9968;DNA BINDING#0.9967;IL-6 PRODUCTION#0.9963;MYELOID CELL#0.9949;BREAST CANCER#0.9947;TERMINAL DIFFERENTIATION#0.9938;PEROXISOME#0.9938;ESTROGEN RECEPTOR#0.9917;ELECTROPHORETIC MOBILITY SHIFT#0.9910;TRANSCRIPTION FACTOR#0.9907;ADIPOGENESIS#0.9906;RETINOIC ACID#0.9899;PREADIPOCYTE#0.9898;PROTEIN COMPLEX#0.9892;MUTAGENESIS#0.9891;ADIPOCYTE DIFFERENTIATION#0.9888;REGENERATION#0.9888;RNA INTERFERENCE#0.9880;MUSCLE CELL#0.9879;SKELETAL MUSCLE#0.9878;OVARIAN#0.9876;T CELL#0.9869;MACROPHAGE#0.9866;SMOOTH MUSCLE#0.9861;INSULIN-LIKE GROWTH FACTOR#0.9859;PROTEIN BINDING#0.9855;COLONY-STIMULATING FACTOR#0.9853;BREAST CANCER CELL#0.9853;SMOOTH MUSCLE CELL#0.9850;ENDOTHELIAL CELL#0.9850;ONCOGENIC#0.9844;TUMOR SUPPRESSOR#0.9838;ADIPOCYTE#0.9835;CELL PROLIFERATION#0.9833;DEXAMETHASONE#0.9831;CELL DEATH#0.9821;MOUSE EMBRYONIC FIBROBLAST#0.9818;SENESCENCE#0.9816;TUMOR CELLS#0.9815;PRO-INFLAMMATORY#0.9809;SIGNAL TRANSDUCTION#0.9803;C REACTIVE PROTEIN#0.9803;GRANULOCYTE#0.9802;GROWTH HORMONE#0.9802;BETA CELL#0.9801;ALANINE#0.9793;ENDOPLASMIC RETICULUM#0.9792;CELL CYCLE#0.9791;NITRIC OXIDE SYNTHASE#0.9791;MONOCYTE#0.9791;BONE MARROW#0.9783;HEPATOMA CELLS#0.9780;NITRIC OXIDE#0.9778;CANCER CELL#0.9777;PROTEIN KINASE C#0.9776;LIVER DEVELOPMENT#0.9775;PROTEIN SYNTHESIS#0.9767;DNASE I#0.9765;CHLORAMPHENICOL#0.9765;EPITHELIAL CELL#0.9764;CELL DIFFERENTIATION#0.9758;INDUCIBLE NITRIC OXIDE#0.9753;PERIPHERAL BLOOD#0.9747;DNASE#0.9746;OSTEOBLAST DIFFERENTIATION#0.9744;PROGESTERONE#0.9735;APOPTOSIS#0.9725;STEROL REGULATORY ELEMENT#0.9724;PROGENITOR CELL#0.9723;INFLAMMATORY RESPONSE#0.9720;STEM CELL#0.9720;PHOSPHOENOLPYRUVATE#0.9718;FATTY ACID BINDING#0.9711;MITOGEN ACTIVATED PROTEIN#0.9703;APOPTOTIC#0.9696;NEUTROPHIL#0.9695;KINASE INHIBITOR#0.9690;CELL GROWTH#0.9687;SIGNALING PATHWAY#0.9687;GLYCOGEN SYNTHASE KINASE#0.9684;PROTEIN KINASE#0.9682;PROTEASOME#0.9680;GLIAL CELL#0.9677;ADIPOSE TISSUE#0.9661;SALICYLATE#0.9658;GENE EXPRESSION#0.9656;TUMOR NECROSIS FACTOR#0.9654;BETA-2#0.9649;RNA BINDING#0.9648;RESPONSE TO LPS#0.9640;POLYMERASE CHAIN REACTION#0.9637;IMMUNE RESPONSE#0.9631;IFN-BETA#0.9630;TRANSFORMING GROWTH FACTOR#0.9627;ADENOSINE#0.9627;EXTRACELLULAR MATRIX#0.9610;ALL TRANS RETINOIC ACID#0.9602;TUBERCULOSIS#0.9599;REPORTER GENE ASSAY#0.9597;VIRAL REPLICATION#0.9592;PROSTATE CANCER#0.9592;REVERSE TRANSCRIPTION#0.9589;GROWTH FACTOR#0.9578;MESENCHYMAL STEM CELL#0.9569;FORSKOLIN#0.9566;GRANULOCYTE COLONY STIMULATING FACTOR#0.9559;TRANSCRIPTIONAL CONTROL#0.9555;CYTOPLASM#0.9554;ENZYME ACTIVITY#0.9533;POST-TRANSLATIONAL MODIFICATION#0.9515;DEPHOSPHORYLATION#0.9514;SIGNALLING PATHWAY#0.9480;LIPOPROTEIN LIPASE#0.9474;AUTOPHAGY#0.9471;AIRWAY EPITHELIAL CELL#0.9470;PROMOTER BINDING#0.9463;MICROGLIAL CELL#0.9454;MAMMARY GLAND DEVELOPMENT#0.9451;HEPATOCYTE PROLIFERATION#0.9448;GLAND DEVELOPMENT#0.9432;RETINOIC ACID RECEPTOR#0.9423;ENDOPLASMIC RETICULUM STRESS#0.9412;LIPID DROPLET#0.9383;WHITE ADIPOSE TISSUE#0.9381;EPIDERMAL GROWTH FACTOR#0.9373;HUMAN IMMUNODEFICIENCY VIRUS#0.9367;CELL ACTIVATION#0.9364;REACTIVE OXYGEN SPECIES#0.9358;INSULIN RECEPTOR#0.9354;TOLL LIKE RECEPTOR#0.9326;PROSTAGLANDIN E2#0.9309;VIRAL INFECTION#0.9303;VITAMIN D RECEPTOR#0.9283;FATTY ACID SYNTHASE#0.9279;RNA BINDING PROTEIN#0.9258;HISTONE ACETYLATION#0.9233;DNA-PROTEIN COMPLEX#0.9231;EARLY GROWTH RESPONSE#0.9212;LUNG EPITHELIAL CELL#0.9187;ALVEOLAR MACROPHAGE#0.9177;HISTONE DEACETYLASE#0.9172;RHEUMATOID ARTHRITIS#0.9161;TRANSFORMING GROWTH FACTOR BETA#0.9158;OSTEOCLAST#0.9157;CELL CYCLE ARREST#0.9143;ADENOCARCINOMA#0.9140;HEPATOCELLULAR CARCINOMA#0.9133;RAPAMYCIN#0.9131;HYPOXIA INDUCIBLE FACTOR#0.9122;LIPID METABOLISM#0.9112;CYTOKINE PRODUCTION#0.9098;INTESTINAL EPITHELIAL CELL#0.9096;VASCULAR SMOOTH MUSCLE CELL#0.9085;LYSINE#0.9060;CYTOCHROME P450#0.9049;HEPATIC STELLATE CELL#0.9048;MYELOID LEUKEMIA#0.9042;T LYMPHOCYTE#0.9033;LEUKOCYTE#0.9017;LIVER DISEASE#0.8991;QUANTITATIVE REAL TIME#0.8986;RETINOID X RECEPTOR#0.8984;ESTRADIOL#0.8967;CYCLIN DEPENDENT KINASE#0.8940;SIGNALING CASCADE#0.8925;SIGNALING MOLECULE#0.8923;FAT CELL#0.8914;TYPE 2 DIABETES#0.8913;KINASE ACTIVITY#0.8909;HEMATOPOIESIS#0.8881;RESPONSE TO TNF#0.8876;IL-8 PRODUCTION#0.8865;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8861;DECIDUALIZATION#0.8860;IMMUNE CELL#0.8852;NUCLEAR MATRIX#0.8850;GM-CSF#0.8848;FIBROBLAST GROWTH FACTOR#0.8832;FETAL LIVER#0.8802;ADENOSINE MONOPHOSPHATE#0.8797;HEPATOCYTE GROWTH FACTOR#0.8786;RIBOSOMAL S6 KINASE#0.8778;DNA SYNTHESIS#0.8764;ISCHEMIA#0.8759;HUMAN BREAST CANCER#0.8754;FOR ADIPOCYTE DIFFERENTIATION#0.8729;BROWN ADIPOSE TISSUE#0.8709;TRANSCRIPTASE#0.8703;STEROIDOGENIC FACTOR 1#0.8694;CELL SURFACE#0.8692;GLUCONEOGENESIS#0.8641;PLASMA MEMBRANE#0.8637;UNFOLDED PROTEIN RESPONSE#0.8628;CYCLIC ADENOSINE MONOPHOSPHATE#0.8626;GROWTH FACTOR RECEPTOR#0.8624;STEAROYL COA DESATURASE#0.8577;MYOTUBE#0.8576;PLASMA PROTEIN#0.8574;TARGET OF RAPAMYCIN#0.8550;TETRACYCLINE#0.8539;ANGIOGENESIS#0.8538;ONCOGENE INDUCED SENESCENCE#0.8537;COLORECTAL CANCER#0.8524;CELL ADHESION#0.8520;REGULATION OF GENE EXPRESSION#0.8503;MAPK ACTIVATION#0.8495;BILE DUCT#0.8472;HYPOXIC#0.8471;B LYMPHOCYTE#0.8470;MAPK SIGNALING#0.8461;COMPLEX I#0.8435;COLORECTAL#0.8416;MECHANISM OF ACTION#0.8416;HUMAN BRONCHIAL EPITHELIAL#0.8375;BRONCHIAL EPITHELIAL CELLS#0.8365;MONONUCLEAR CELLS#0.8354;IMMUNE SYSTEM#0.8342;MORPHOGENESIS#0.8331;UBIQUITIN#0.8327;OBESE#0.8322;COLON CANCER#0.8317;IL-6 SECRETION#0.8297;LIVER DAMAGE#0.8282;EOSINOPHIL#0.8267;HIGH FAT DIET#0.8234;INTERFERON REGULATORY FACTOR#0.8233;DENDRITIC CELL#0.8228;MYOBLAST#0.8225;CYTOTOXICITY#0.8176;FACTOR S#0.8153;CHROMATIN REMODELING#0.8150;GLUCOSE 6 PHOSPHATASE#0.8130;PRECURSOR CELL#0.8128;AMINO ACID RESPONSE#0.8107;RECEPTOR TYROSINE KINASE#0.8095;GLUCOSE HOMEOSTASIS#0.8083;HEMATOPOIETIC CELL#0.8067;MACROPHAGE INFLAMMATORY PROTEIN#0.8067;NERVOUS SYSTEM#0.8066;BONE MORPHOGENETIC PROTEIN#0.8063;DNA REPLICATION#0.8063;HEPATITIS B#0.8059;METHIONINE#0.8054;INNATE IMMUNITY#0.8036;SUPEROXIDE DISMUTASE#0.8025;LUNG CANCER#0.8023;MOUSE EMBRYO FIBROBLASTS#0.8018;MACROPHAGE DIFFERENTIATION#0.8012;RETINOBLASTOMA#0.7996;KERATINOCYTE DIFFERENTIATION#0.7976;ANAPLASTIC LARGE CELL LYMPHOMA#0.7952;TROPHOBLAST#0.7940;OSTEOCLAST DIFFERENTIATION#0.7931;NUCLEAR EXPORT#0.7923;MACROPHAGE ACTIVATION#0.7913;DNA METHYLATION#0.7896;SERUM RESPONSE FACTOR#0.7887;ARGININE#0.7879;CARCINOGEN#0.7870;SERUM AMYLOID A#0.7847;CYCLIN DEPENDENT KINASE INHIBITOR#0.7826;LIPOGENESIS#0.7815;TOXICITY#0.7802;ETHANOL#0.7800;HEAT SHOCK PROTEIN#0.7775;MITOCHONDRIA#0.7764;ACETYL COA CARBOXYLASE#0.7761;GESTATION#0.7760;MESENCHYMAL CELL#0.7751;FATTY LIVER#0.7749;OSTEOARTHRITIS#0.7732;HUMAN AIRWAY EPITHELIAL#0.7728;UTERUS#0.7726;SUBCUTANEOUS ADIPOSE TISSUE#0.7671;BONE FORMATION#0.7665;HYPERGLYCEMIA#0.7640;1α,25-DIHYDROXYVITAMIN D3#0.7621;THYMIDINE#0.7601;IL-8 SECRETION#0.7599;ACUTE PROMYELOCYTIC LEUKEMIA#0.7596;TRANSLATION INITIATION FACTOR#0.7590;GROWTH FACTOR BINDING#0.7550;ENDOMETRIUM#0.7538;LUMINAL#0.7524;ACUTE MYELOID LEUKEMIA#0.7501;C TERMINAL DOMAIN#0.7486;HEAT SHOCK FACTOR#0.7479;SUMOYLATION#0.7475;PULMONARY TUBERCULOSIS#0.7444;INNATE IMMUNE RESPONSE#0.7417;HYPERTENSION#0.7416;ACETYLTRANSFERASE ACTIVITY#0.7402;LYMPHOID CELL#0.7386;ANDROGEN RECEPTOR#0.7362;ACID PHOSPHATASE#0.7346;HEPATITIS B VIRUS#0.7346;ATHEROSCLEROSIS#0.7316;LEYDIG CELL#0.7309;STEROIDOGENESIS#0.7302;TYROSINE KINASE INHIBITOR#0.7284;CEREBRAL ISCHEMIA#0.7278;SQUAMOUS CELL CARCINOMA#0.7263;LOW DENSITY LIPOPROTEIN#0.7251;ENDOCHONDRAL OSSIFICATION#0.7224;YOLK SAC#0.7216;BONE RESORPTION#0.7195;CELL DEVELOPMENT#0.7122;TROGLITAZONE#0.7078;MAMMARY EPITHELIUM#0.7073;PHOSPHODIESTERASE#0.7069;TUMOUR NECROSIS FACTOR#0.7055;AIRWAY EPITHELIUM#0.7015;MESANGIAL CELL#0.6984;CIRCADIAN RHYTHM#0.6980;ACTINOMYCIN D#0.6979;CERVICAL#0.6976;CALCIUM CHANNEL#0.6974;EXCRETION#0.6965;SWI-SNF COMPLEX#0.6963;MAST CELL#0.6958;NUCLEAR LOCALIZATION SIGNAL#0.6938;STROMA#0.6920;REGULATION OF ADIPOGENESIS#0.6915;LEUKEMIA INHIBITORY FACTOR#0.6910;RESPONSE TO CAMP#0.6874;CELL ADHESION MOLECULE#0.6869;FUNCTIONAL DIFFERENTIATION#0.6834;HERPES SIMPLEX VIRUS#0.6823;HERPES SIMPLEX#0.6820;XANTHINE#0.6818;VASCULAR CELL#0.6813;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6809;EPITHELIAL TO MESENCHYMAL#0.6807;TRANSCRIPTION REGULATOR#0.6796;PROSTAGLANDIN ENDOPEROXIDE SYNTHASE#0.6795;TRANSDIFFERENTIATION#0.6784;RECEPTOR ANTAGONIST#0.6768;MATRIX METALLOPROTEINASE 13#0.6766;EPITHELIAL CELL PROLIFERATION#0.6763;MARROW STROMAL CELLS#0.6757;BONE MARROW STROMAL CELL#0.6757;BONE MARROW STROMAL#0.6753;IFN REGULATORY FACTOR#0.6740;HUMAN MESENCHYMAL STEM#0.6740;THYMIDINE KINASE#0.6734;LIGAND BINDING DOMAIN#0.6727;SEBACEOUS GLAND#0.6709;ENDOMETRIOSIS#0.6708;PHOSPHOLIPASE A2#0.6704;GALECTIN#0.6702;UMBILICAL VEIN#0.6702;BREAST CARCINOMA#0.6687;INSULIN RECEPTOR SUBSTRATE#0.6667;DIABETES MELLITUS#0.6666;PALMITATE#0.6663;CHLORAMPHENICOL ACETYLTRANSFERASE ACTIVITY#0.6661;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.6660;CD4+ T CELL#0.6659;PANCREATIC ISLET#0.6655;EPITHELIAL CELL DIFFERENTIATION#0.6646;INHIBITION OF ADIPOGENESIS#0.6621;CHOLINE#0.6620;CARDIOMYOCYTE#0.6609;HUMAN INTESTINAL EPITHELIAL#0.6568;CACHEXIA#0.6551;TRANSLATIONAL INITIATION#0.6541;OXYGENASE#0.6493;CELL MIGRATION#0.6479;ARTERY#0.6471;NUCLEAR HORMONE RECEPTOR#0.6464;HISTONE ACETYLTRANSFERASE#0.6462;ACTIVATED T-CELLS#0.6459;ACTIVATED T CELL#0.6456;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6450;EUKARYOTIC INITIATION FACTOR#0.6446;HUMAN UMBILICAL VEIN#0.6445;CUGBP1-EIF2 COMPLEX#0.6417;QUANTITATIVE REVERSE TRANSCRIPTION#0.6415;ASPARTATE#0.6413;G1 PHASE#0.6411;SMOOTH MUSCLE ACTIN#0.6408;HEPATIC NUCLEAR FACTOR#0.6394;LECTIN#0.6390;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6377;ALZHEIMER'S DISEASE#0.6363;GROWTH ARREST SPECIFIC#0.6332;MYOCYTES#0.6326;ER STRESS RESPONSE#0.6311;GENISTEIN#0.6305;CAMP SIGNALING#0.6299;LUNG DISEASE#0.6298;FOCAL ADHESION#0.6294;NUTRIENT SENSING#0.6290;OVARIES#0.6285;LYMPHOBLAST#0.6279;GLUTAMINE#0.6260;CENTRAL NERVOUS SYSTEM#0.6253;ORNITHINE#0.6244;GAMMA GLUTAMYLTRANSFERASE#0.6238;LUNG CARCINOMA#0.6237;COLLAGEN SYNTHESIS#0.6236;AMNION#0.6225;ESTROGENS#0.6223;MULTIPLE MYELOMA#0.6213;BLOOD VESSEL#0.6207;CELL MEMBRANE#0.6204;LYMPHOID TISSUE#0.6202;PROLACTIN RECEPTOR#0.6198;BINDING PROTEIN 3#0.6196;PLASMA CELL#0.6193;LYMPH NODE#0.6185;OVULATION#0.6179;FAT PAD#0.6171;NF-KAPPAB INHIBITOR#0.6163;ESTROGEN RECEPTOR ALPHA#0.6146;METFORMIN#0.6144;BLOOD BRAIN BARRIER#0.6103;OVARIAN CANCER#0.6091;MAMMARY GLAND INVOLUTION#0.6091;PLATELET-DERIVED GROWTH FACTOR#0.6076;INFLAMMATORY CELL#0.6065;CALCINEURIN#0.6061;ACTIVATED MONOCYTES#0.6054;LACTATION#0.6049;ASPIRIN#0.6047;THYMOCYTE#0.6042;HYPERSENSITIVITY#0.6040;MONOCYTE DIFFERENTIATION#0.6035;FIBRINOGEN#0.6033;VILLOUS CYTOTROPHOBLAST#0.6014;RESPONSE TO IL-6#0.6007
10521	RNA HELICASE#1.0702;GENE EXPRESSION#1.0100;ESTROGEN RECEPTOR#1.0076;TRANSCRIPTION FACTOR#0.9251;MIRNA BIOGENESIS#0.8796;RNA BINDING#0.8456;CELL PROLIFERATION#0.8022;BREAST CANCER#0.7697;CANCER CELL#0.7074;HISTONE DEACETYLASE#0.7062;MIRNA PROCESSING#0.7052;ATPASE ACTIVITY#0.6918;RNA METABOLISM#0.6746;REGULATION OF MIRNA BIOGENESIS#0.6343;SIGNALING PATHWAY#0.6151;TRANSACTIVATION#0.6113;COLON CANCER#0.6077;ESTROGEN RECEPTOR ALPHA#0.6076;APOPTOSIS#0.6046;CELL DIFFERENTIATION#0.6017
105221694	PAPILLARY CARCINOMA#0.7669;HEPATITIS E VIRUS#0.7473;HEPATITIS E#0.7455
10522	TRANSCRIPTION FACTOR#1.0537;INTELLECTUAL DISABILITY#1.0513;DNA BINDING#1.0350;LYMPH NODE#0.9773;GENE EXPRESSION#0.9608;PANCREATIC LYMPH NODE#0.8973;TYPE 1 DIABETES#0.8951;CELL PROLIFERATION#0.8949;IMMUNE RESPONSE#0.7696;CELL CYCLE#0.7196;STROMAL CELL#0.6907;POLYMERASE CHAIN REACTION#0.6657;NUCLEOSOME#0.6471;PROTEIN PROTEIN INTERACTION#0.6463;NUCLEAR EXPORT SIGNAL#0.6260;RETINOIC ACID#0.6207;THYMIDINE KINASE#0.6166;NUCLEAR EXPORT#0.6164;MAMMARY EPITHELIAL CELL#0.6144;INNATE IMMUNE RESPONSE#0.6100;EPITHELIAL CELL#0.6018;DNA-PK COMPLEX#0.6006
10523	ENDOPLASMIC RETICULUM#1.1111;CELL PROLIFERATION#0.7431;ER MEMBRANE#0.6289;CELLULAR GROWTH#0.6239;ACTIVATED T-CELLS#0.6169;ACTIVATED T CELL#0.6164;T LYMPHOCYTE#0.6080;CELL SURFACE#0.6065;T CELL#0.6025
10524	HISTONE ACETYL TRANSFERASE#1.0795;HISTONE ACETYLTRANSFERASE ACTIVITY#1.0572;ACETYLTRANSFERASE COMPLEX#1.0467;ACETYLTRANSFERASE ACTIVITY#1.0464;HISTONE ACETYLTRANSFERASE COMPLEX#1.0446;PHOSPHOLIPASE A2#1.0322;TRANSACTIVATION#1.0256;TUMOR SUPPRESSOR#1.0230;HISTONE ACETYLTRANSFERASE#1.0213;CHROMATIN REMODELING#1.0179;PROSTATE CANCER#1.0178;BREAST CANCER#1.0146;TIP60 HISTONE ACETYLTRANSFERASE COMPLEX#1.0129;ATAXIA TELANGIECTASIA#1.0122;APOPTOSIS#1.0069;COMPLEX I#1.0068;DNA DAMAGE RESPONSE#1.0068;LYSINE#1.0052;T CELL#1.0047;SIGNALING PATHWAY#1.0037;APOPTOTIC#1.0031;CELL CYCLE#1.0019;AMYLOID PRECURSOR PROTEIN#1.0012;DNA REPAIR#0.9964;ATAXIA TELANGIECTASIA MUTATED#0.9959;HISTONE DEACETYLASE#0.9958;KINASE ACTIVITY#0.9924;CELL CYCLE ARREST#0.9920;CELL PROLIFERATION#0.9919;HISTONE ACETYLATION#0.9917;APP INTRACELLULAR DOMAIN#0.9917;PROTEIN KINASE#0.9913;UBIQUITIN#0.9913;CANCER CELL#0.9912;DOUBLE STRAND BREAK#0.9898;GENE EXPRESSION#0.9891;CELL GROWTH#0.9879;CELL DEATH#0.9871;NUCLEOSOME#0.9869;HOMOLOGOUS RECOMBINATION#0.9867;DNA BINDING#0.9828;TRANSCRIPTION FACTOR#0.9805;ANDROGEN RECEPTOR#0.9785;STEM CELL#0.9758;AUTOPHAGY#0.9731;HISTONE H4 ACETYLATION#0.9703;ALZHEIMER'S DISEASE#0.9653;CHROMATIN REMODELING COMPLEX#0.9579;PROTEASOME#0.9560;POST-TRANSLATIONAL MODIFICATION#0.9489;HISTONE MODIFICATION#0.9431;CELL MIGRATION#0.9414;GENOTOXIC#0.9281;POSTTRANSLATIONAL MODIFICATION#0.9273;CISPLATIN#0.9211;GROWTH FACTOR#0.9108;EMBRYONIC STEM CELL#0.9004;CHROMATIN MODIFICATION#0.8943;DNA REPLICATION#0.8850;ONCOGENIC#0.8833;RNA INTERFERENCE#0.8753;CATALYTIC ACTIVITY#0.8750;COLORECTAL CANCER#0.8668;MITOSIS#0.8563;HETEROCHROMATIN#0.8556;S PHASE#0.8545;COLORECTAL#0.8457;LUNG CANCER#0.8323;CHROMOSOME SEGREGATION#0.8282;NERVOUS SYSTEM#0.8258;ZINC FINGER PROTEIN#0.8181;NUCLEAR HORMONE RECEPTOR#0.8161;EPITHELIAL CELL#0.8088;HUMAN IMMUNODEFICIENCY VIRUS#0.7963;G1 PHASE#0.7912;CYTOPLASM#0.7891;SIGNAL TRANSDUCTION#0.7830;ESTROGEN RECEPTOR#0.7820;SENESCENCE#0.7790;MRN COMPLEX#0.7782;POLYMERASE CHAIN REACTION#0.7719;PROTEIN PROTEIN INTERACTION#0.7680;DNA METHYLATION#0.7668;HISTONE EXCHANGE#0.7631;MYOBLAST DIFFERENTIATION#0.7621;MESANGIAL CELL#0.7453;DNA METHYLTRANSFERASE#0.7435;COENZYME A#0.7422;REGULATORY T CELL#0.7404;SUMOYLATION#0.7361;CYCLIN DEPENDENT KINASE#0.7252;THYROID CARCINOMA#0.7230;SET3 COMPLEX#0.7211;AKT SIGNALING#0.7203;ARACHIDONIC ACID#0.7190;MONOCYTIC LEUKEMIA#0.7152;MACROPHAGE#0.6968;RESPONSE TO UV#0.6902;DOUBLE-STRAND BREAK REPAIR#0.6835;FANCONI ANEMIA#0.6824;B CELL#0.6807;THYROID CANCER#0.6778;SIGNALING CASCADE#0.6757;HYPOXIA#0.6751;GLYCOGEN SYNTHASE KINASE#0.6739;ADIPOCYTE#0.6732;MITOGEN ACTIVATED PROTEIN#0.6727;ADIPOCYTE DIFFERENTIATION#0.6722;GERM CELL#0.6717;BREAST CANCER CELL#0.6691;ADIPOSE TISSUE#0.6676;HISTONE METHYLTRANSFERASE#0.6667;ATP-DEPENDENT CHROMATIN REMODELING#0.6658;CELL CYCLE CONTROL#0.6579;TUMOR CELLS#0.6554;MUTAGENESIS#0.6527;ENDOPLASMIC RETICULUM#0.6495;ACUTE MYELOID LEUKEMIA#0.6477;EPITHELIAL MESENCHYMAL TRANSITION#0.6470;MYELOID LEUKEMIA#0.6465;BUDDING#0.6452;QUANTITATIVE REAL TIME#0.6450;XPF-ERCC1 COMPLEX#0.6394;HISTONE METHYLATION#0.6379;HISTONE DEMETHYLASE#0.6337;ACETYLASE ACTIVITY#0.6329;ACETYL-COA BINDING#0.6313;CERVICAL CANCER#0.6279;POLY ADP RIBOSE#0.6272;PEROXISOMAL#0.6253;MOLECULAR FUNCTION#0.6242;PERICENTRIC HETEROCHROMATIN#0.6190;PROGRAMMED CELL DEATH#0.6182;SIGNALLING PATHWAY#0.6170;MOUSE EMBRYONIC STEM#0.6076;HISTONE BINDING#0.6059;M PHASE#0.6045
105259599	LOSS OF METHYLATION#1.0575;IMPRINTING CONTROL REGION#1.0554;DNA METHYLATION#1.0388;SILVER RUSSELL SYNDROME#1.0200;BECKWITH-WIEDEMANN SYNDROME#1.0063;DIFFERENTIALLY METHYLATED REGION#0.9826;GROWTH FACTOR#0.8458;GENE EXPRESSION#0.8318;DEMETHYLATION#0.7824;INSULIN-LIKE GROWTH FACTOR#0.7364;MACROCEPHALY#0.6735;ZINC FINGER PROTEIN#0.6359;DNA HYPOMETHYLATION#0.6311;MALE INFERTILITY#0.6248;GROWTH PATTERN#0.6235;HISTONE MODIFICATION#0.6049
105259600	GIGANTISM#0.7096;PITUITARY ADENOMA#0.6068
10525	NUCLEOTIDE EXCHANGE FACTOR#1.0854;GLUCOSE REGULATED PROTEIN#1.0619;HYPOXIA#1.0460;HEAT SHOCK PROTEIN#1.0337;CELL DEATH#1.0277;CANCER CELL#1.0155;ISCHEMIA#1.0120;ENDOPLASMIC RETICULUM#1.0074;APOPTOSIS#1.0021;ENDOPLASMIC RETICULUM STRESS#1.0006;T CELL#0.9835;HYPOXIC#0.9823;IMMUNE RESPONSE#0.9783;APOPTOTIC#0.9712;GROWTH FACTOR#0.9640;BREAST CANCER#0.9640;TRANSCRIPTION FACTOR#0.9551;ENDOTHELIAL CELL#0.9488;ENDOTHELIAL GROWTH FACTOR#0.9299;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9299;GENE EXPRESSION#0.9212;PROTEIN DISULFIDE ISOMERASE#0.9151;DENDRITIC CELL#0.9111;PROSTATE CANCER#0.8910;BETA CELL#0.8714;EPITHELIAL CELL#0.8678;UNFOLDED PROTEIN RESPONSE#0.8580;CROSS PRESENTATION#0.8570;ANGIOGENESIS#0.8466;TUMOR CELLS#0.8364;MACROPHAGE#0.8361;CHAPERONE COMPLEX#0.8314;PROTEIN FOLDING#0.8312;CD8+ T CELL#0.8217;INSULIN SECRETION#0.8038;ASTROCYTE#0.7879;THYROID CANCER#0.7594;PROTEASOME#0.7390;ANTIGEN PRESENTING CELLS#0.7318;APOPTOTIC CELL DEATH#0.7162;PROTEIN TRANSPORT#0.6937;SCAVENGER RECEPTOR#0.6865;TYPE 2 DIABETES#0.6843;ISCHEMIA REPERFUSION INJURY#0.6826;HIGH FAT DIET#0.6811;PRO-INFLAMMATORY#0.6773;LYMPH NODE#0.6768;POLYMERASE CHAIN REACTION#0.6747;ATHEROSCLEROTIC#0.6547;2-DEOXYGLUCOSE#0.6207;PEPTIDE BINDING#0.6186;TOXICITY#0.6149;CALPAIN ACTIVITY#0.6141;MIDDLE CEREBRAL ARTERY#0.6140;CEREBRAL ARTERY#0.6137;PROLIFERATIVE DIABETIC RETINOPATHY#0.6120;ER STRESS RESPONSE#0.6045;INVASIVE BREAST CANCER#0.6043;BRAIN ISCHEMIA#0.6035;NEURONAL CELL DEATH#0.6030;DIABETIC RETINOPATHY#0.6012
10526	IMPORTIN#1.0989;GENE EXPRESSION#1.0121;NUCLEAR IMPORT#0.9367;OSTEOBLAST DIFFERENTIATION#0.6307;GENE SILENCING#0.6265;REVERSE TRANSCRIPTION#0.6233;OSTEOBLAST#0.6012
105274375	MOOD DISORDER#0.8455
10527	IMPORTIN#1.0693;NUCLEAR IMPORT#1.0511;NUCLEAR LOCALIZATION SIGNAL#0.9213;NUCLEAR PORE#0.9014;NUCLEAR TRANSPORT#0.8896;TRANSPORTIN#0.8862;TRANSCRIPTION FACTOR#0.8852;RIBOSOMAL PROTEIN#0.8540;CYTOPLASM#0.8502;GENE EXPRESSION#0.8271;METALLO BETA LACTAMASE#0.7622;PROTEIN KINASE#0.7514;CANCER CELL#0.7015;SIGNALING PATHWAY#0.6742;GROWTH FACTOR#0.6542;CELL CYCLE#0.6240;APOPTOSIS#0.6222;HUMAN IMMUNODEFICIENCY VIRUS#0.6188;SIMIAN IMMUNODEFICIENCY VIRUS#0.6178;MITOGEN ACTIVATED PROTEIN#0.6082
10528	SNORNP#1.0715;RIBOSOMAL RNA#0.8898;SMALL NUCLEOLAR RNA#0.8873;RRNA METHYLATION#0.8798;RIBOSOME BIOGENESIS#0.8599;CEREBELLAR ATAXIA#0.8317;RIBOSOME#0.8183;SMALL NUCLEOLAR RIBONUCLEOPROTEIN#0.7248;AMYOTROPHIC LATERAL SCLEROSIS#0.7169;LATERAL SCLEROSIS#0.7169;RNA PROCESSING#0.7049;RNA BINDING#0.6491
10529	Z LINE#1.1238;FOCAL ADHESION#1.0769;ACTIN BINDING#1.0631;ACTIN BINDING PROTEIN#1.0255;CARDIAC MUSCLE#0.9245;DILATED CARDIOMYOPATHY#0.9176;CANCER CELL#0.9071;ACTIN FILAMENT#0.9030;Z DISC#0.8967;STRIATED MUSCLE#0.8916;Z DISK#0.8661;MYOFIBRIL#0.8613;SARCOMERE#0.8472;COLORECTAL CANCER#0.8269;SKELETAL MUSCLE#0.8201;CARDIOMYOPATHY#0.8020;CARDIOMYOCYTE#0.7614;POLYMERASE CHAIN REACTION#0.7247;GENE EXPRESSION#0.7087;CELL MIGRATION#0.6969;SIGNALING PATHWAY#0.6924;ENDOCARDIAL FIBROELASTOSIS#0.6703;CARDIAC MYOFIBRIL#0.6669;COLORECTAL#0.6492;LYMPH NODE METASTASIS#0.6205;LYMPH NODE#0.6096
1052	MAMMARY EPITHELIAL CELL#1.0672;TUMOR SUPPRESSOR#1.0629;BREAST CANCER#1.0257;ACUTE PHASE RESPONSE#1.0204;EPITHELIAL CELL#1.0190;MAMMARY GLAND#1.0184;ASTROCYTE#1.0167;CANCER CELL#1.0164;OSTEOBLAST#1.0136;APOPTOSIS#1.0116;ADIPOCYTE DIFFERENTIATION#1.0101;ENHANCER BINDING#1.0082;ENHANCER BINDING PROTEIN#1.0079;FACTOR I#1.0059;GROWTH FACTOR#1.0055;CELL CYCLE#1.0046;DNA BINDING#1.0040;ELECTROPHORETIC MOBILITY SHIFT#1.0034;LEUCINE#1.0029;PEROXISOME#1.0026;MACROPHAGE#0.9987;ADIPOCYTE#0.9985;CELL GROWTH#0.9974;CELL PROLIFERATION#0.9973;ADIPOGENESIS#0.9960;PREADIPOCYTE#0.9933;TRANSACTIVATION#0.9933;SIGNALING PATHWAY#0.9905;INFLAMMATORY RESPONSE#0.9904;DEXAMETHASONE#0.9887;PROTEIN KINASE#0.9877;TRANSCRIPTION FACTOR#0.9874;TUMOR NECROSIS FACTOR#0.9776;GENE EXPRESSION#0.9772;ADIPOSE TISSUE#0.9753;SIGNAL TRANSDUCTION#0.9594;INSULIN-LIKE GROWTH FACTOR#0.9554;SMOOTH MUSCLE#0.9511;CAAT ENHANCER BINDING#0.9396;PROSTATE CANCER#0.9296;BREAST CANCER CELL#0.9278;ALZHEIMER'S DISEASE#0.9044;MUSCLE CELL#0.9009;CAMP RESPONSE ELEMENT#0.8993;HUMAN BREAST CANCER#0.8978;CELL DIFFERENTIATION#0.8919;SIGNAL TRANSDUCER#0.8853;SMOOTH MUSCLE CELL#0.8848;VASCULAR SMOOTH MUSCLE CELL#0.8781;CELL DEATH#0.8729;STEROL REGULATORY ELEMENT#0.8704;BONE MARROW#0.8605;CYCLIC AMP#0.8411;POLYMERASE CHAIN REACTION#0.8356;MAMMARY GLAND INVOLUTION#0.8338;PROTEIN COMPLEX#0.8296;PLATELET-DERIVED GROWTH FACTOR#0.8284;PRO-INFLAMMATORY#0.8275;STEM CELL#0.8249;APOPTOTIC#0.8218;INTESTINAL EPITHELIAL CELL#0.8195;ACTIVATOR PROTEIN 1#0.8192;TERMINAL DIFFERENTIATION#0.8192;PROTEIN BINDING#0.8158;ESTROGEN RECEPTOR#0.8106;TRANSFORMING GROWTH FACTOR#0.8093;FAT CELL#0.8082;MITOTIC CLONAL EXPANSION#0.8069;STROMAL CELL#0.8003;MYELOID LEUKEMIA#0.7957;IMMUNE RESPONSE#0.7945;PROTEIN SYNTHESIS#0.7944;MITOGEN ACTIVATED PROTEIN#0.7671;CAMP RESPONSE ELEMENT BINDING#0.7666;HUMAN MAMMARY EPITHELIAL#0.7619;HEPATOCELLULAR CARCINOMA#0.7544;MAP KINASE#0.7541;PROSTAGLANDIN E2#0.7481;PROTEIN KINASE A#0.7436;PROGENITOR CELL#0.7401;SKELETAL MUSCLE#0.7398;MUTAGENESIS#0.7358;T CELL#0.7318;KERATINOCYTE#0.7249;MYELOID CELL#0.7221;ACUTE MYELOID LEUKEMIA#0.7211;SUPEROXIDE DISMUTASE#0.7175;CELL ADHESION#0.7119;KINASE INHIBITOR#0.7008;GLIAL CELL#0.6881;UBIQUITIN#0.6881;EXTRACELLULAR MATRIX#0.6861;NITRIC OXIDE#0.6731;CERVICAL CANCER#0.6703;RNA BINDING#0.6694;DNA-PROTEIN COMPLEX#0.6661;LIPID DROPLET#0.6650;NERVOUS SYSTEM#0.6571;FOR ADIPOCYTE DIFFERENTIATION#0.6558;LUCIFERASE ACTIVITY#0.6527;HEPATOMA CELLS#0.6526;MONOCYTE#0.6494;IFN-GAMMA#0.6454;INTESTINAL CRYPT#0.6427;SUMOYLATION#0.6409;FATTY ACID BINDING#0.6345;PROLACTINOMA#0.6342;MOUSE EMBRYONIC FIBROBLAST#0.6337;HISTONE DEACETYLASE#0.6287;B CELL#0.6268;ENDOTHELIAL CELL#0.6264;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6177;PROTEIN PROTEIN INTERACTION#0.6161;MESANGIAL CELL#0.6077;GLUCOCORTICOID RECEPTOR#0.6042;TOLL LIKE RECEPTOR#0.6031;RETINOIC ACID#0.6026;AU RICH ELEMENT#0.6015;WHITE ADIPOSE TISSUE#0.6015
10531	GROWTH FACTOR#1.0165;MITOCHONDRIA#0.9450;TRANSFORMING GROWTH FACTOR#0.9285;EXTRACELLULAR MATRIX#0.8620;TUMOR NECROSIS FACTOR#0.8449;TUBERCULOSIS#0.7897;ALZHEIMER'S DISEASE#0.7693;MACROPHAGE#0.7555;GENE EXPRESSION#0.7444;TRANSFORMING GROWTH FACTOR BETA#0.7333;MITOCHONDRIAL MATRIX#0.7331;POLYMERASE CHAIN REACTION#0.7291;ENDOTHELIAL GROWTH FACTOR#0.7000;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7000;CHLOROPLAST#0.6648;APOPTOSIS#0.6190
10533	CONJUGATION#1.0269;BAFILOMYCIN A1#1.0162;AUTOPHAGY#1.0103;CHLOROQUINE#1.0086;SENESCENCE#1.0059;3-METHYLADENINE#1.0049;POLYMERASE CHAIN REACTION#1.0028;BETA CELL#1.0012;CLEAVED CASPASE 3#1.0002;RNA INTERFERENCE#0.9997;MACROPHAGE#0.9993;T CELL#0.9981;LIGHT CHAIN 3#0.9979;CISPLATIN#0.9971;MICROTUBULE ASSOCIATED PROTEIN#0.9969;MOUSE EMBRYONIC FIBROBLAST#0.9960;GERM CELL#0.9932;MICROTUBULE#0.9926;AUTOPHAGOSOME FORMATION#0.9908;AUTOLYSOSOME#0.9901;ADIPOSE TISSUE#0.9899;MITOPHAGY#0.9891;AUTOPHAGIC CELL DEATH#0.9872;UBIQUITIN#0.9864;KERATINOCYTE#0.9853;AUTOPHAGIC VACUOLE#0.9834;ENDOTHELIAL CELL#0.9818;CELL PROLIFERATION#0.9806;EPITHELIAL CELL#0.9805;OVARIAN#0.9803;LUNG CANCER#0.9801;BREAST CANCER#0.9795;REGULATION OF AUTOPHAGY#0.9793;BREAST CANCER CELL#0.9792;MACROAUTOPHAGY#0.9789;CYTOTOXICITY#0.9788;APOPTOTIC CELL DEATH#0.9786;GENE EXPRESSION#0.9778;BONE MARROW#0.9778;SKELETAL MUSCLE#0.9776;CARDIOMYOCYTE#0.9773;AUTOPHAGOSOME#0.9772;HYPOXIA#0.9766;CELL DEATH#0.9764;VACUOLE#0.9764;TARGET OF RAPAMYCIN#0.9752;RAPAMYCIN#0.9740;PROTEIN DEGRADATION#0.9733;CYTOPLASM#0.9721;CELL CYCLE#0.9719;APOPTOTIC#0.9716;TRANSCRIPTION FACTOR#0.9701;TOXICITY#0.9684;B CELL#0.9683;TRANSMISSION ELECTRON MICROSCOPY#0.9680;STEM CELL#0.9678;PROTEASOME#0.9673;TUMOR NECROSIS FACTOR#0.9670;CELLULAR HOMEOSTASIS#0.9653;APOPTOSIS#0.9652;PRO-INFLAMMATORY#0.9645;MITOCHONDRIA#0.9642;HEPATOCELLULAR CARCINOMA#0.9642;PROTEIN KINASE#0.9642;ENDOPLASMIC RETICULUM#0.9641;GROWTH FACTOR#0.9636;INFLAMMATORY RESPONSE#0.9633;CELL GROWTH#0.9628;REACTIVE OXYGEN SPECIES#0.9627;ISCHEMIA#0.9620;LYSOSOME#0.9610;CANCER CELL#0.9595;PHOSPHATIDYLETHANOLAMINE#0.9593;CELL CYCLE ARREST#0.9586;SIGNALING PATHWAY#0.9567;IMMUNE RESPONSE#0.9551;TUMOR CELLS#0.9544;CYTOCHROME C#0.9516;ORGANELLE#0.9506;QUANTITATIVE REAL TIME#0.9503;ADIPOCYTE#0.9498;DNA FRAGMENTATION#0.9421;HIGH FAT DIET#0.9418;MYELOID LEUKEMIA#0.9395;TUMOR SUPPRESSOR#0.9392;FATTY LIVER#0.9385;DRUG RESISTANCE#0.9383;MYELOID CELL#0.9367;CATABOLIC PROCESS#0.9356;OVARIAN CANCER#0.9321;MITOCHONDRIAL MEMBRANE#0.9318;PROGRAMMED CELL DEATH#0.9315;PEROXISOME#0.9285;CASPASE INHIBITOR#0.9275;LIPID DROPLET#0.9269;COLORECTAL CANCER#0.9257;NEURODEGENERATIVE DISEASE#0.9229;ENDOPLASMIC RETICULUM STRESS#0.9224;MUSCLE ATROPHY#0.9218;SMOOTH MUSCLE#0.9207;ONCOGENIC#0.9205;TYPE 2 DIABETES#0.9124;OBESE#0.9091;HYPOXIC#0.9086;COLORECTAL#0.9082;KINASE INHIBITOR#0.9068;PROSTATE CANCER#0.9046;NERVOUS SYSTEM#0.9045;CHONDROCYTE#0.8983;SUPEROXIDE DISMUTASE#0.8917;ANGIOGENESIS#0.8899;DUAL LUCIFERASE REPORTER#0.8893;LIPID METABOLISM#0.8889;SELECTIVE AUTOPHAGY#0.8878;OSTEOCLAST#0.8875;MITOGEN ACTIVATED PROTEIN#0.8870;ROS GENERATION#0.8842;CENTRAL NERVOUS SYSTEM#0.8837;COLON CANCER#0.8834;LIVER DISEASE#0.8825;T LYMPHOCYTE#0.8805;REVERSE TRANSCRIPTION#0.8770;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8767;PROGENITOR CELL#0.8681;MUSCLE CELL#0.8640;HISTONE DEACETYLASE#0.8605;CELLULAR COMPONENT#0.8561;PERIPHERAL BLOOD#0.8556;EXTRACELLULAR MATRIX#0.8496;TRANSFORMING GROWTH FACTOR#0.8495;ACUTE MYELOID LEUKEMIA#0.8478;INSULIN SECRETION#0.8465;UBIQUITIN ACTIVATING ENZYME#0.8387;STROMAL CELL#0.8358;INDUCTION OF APOPTOSIS#0.8340;CYTOKINE PRODUCTION#0.8328;HYPERGLYCEMIA#0.8301;S PHASE#0.8268;OSTEOBLAST#0.8265;PROTEIN SYNTHESIS#0.8254;CELL DIFFERENTIATION#0.8246;MYOCARDIAL INFARCTION#0.8245;CANCER STEM CELL#0.8198;CELLULAR PROCESS#0.8173;TUBE FORMATION#0.8126;BINDING PROTEIN 1#0.8090;DENDRITIC CELL#0.8059;UNFOLDED PROTEIN RESPONSE#0.8022;HEPATIC STELLATE CELL#0.7990;C TERMINAL DOMAIN#0.7978;CELL MIGRATION#0.7965;N-ACETYLCYSTEINE#0.7953;NITRIC OXIDE#0.7944;PANCREATIC CANCER#0.7930;DOPAMINE#0.7919;VIRAL INFECTION#0.7898;ETHANOL#0.7866;DOPAMINERGIC NEURON#0.7818;SMOOTH MUSCLE CELL#0.7796;ENDOSOME#0.7785;PLASMA MEMBRANE#0.7784;CD4+ T CELL#0.7764;PHAGOCYTOSIS#0.7738;AUTOPHAGIC DEATH#0.7720;PARKINSON'S DISEASE#0.7708;PHAGOPHORE#0.7702;FATTY ACID OXIDATION#0.7670;LYSOSOMAL MEMBRANE#0.7661;HOST CELL#0.7635;NEUROPROTECTION#0.7599;EPITHELIAL MESENCHYMAL TRANSITION#0.7595;PALMITATE#0.7593;HEMATOPOIETIC STEM CELL#0.7590;TYROSINE KINASE INHIBITOR#0.7558;SIGNALLING PATHWAY#0.7521;KINASE ACTIVITY#0.7513;MONOCYTE#0.7493;CASPASE ACTIVATION#0.7471;ADENINE#0.7460;ADENOCARCINOMA#0.7450;ISCHEMIA REPERFUSION INJURY#0.7444;INNATE IMMUNITY#0.7441;PURKINJE CELL#0.7420;MITOCHONDRIAL DEPOLARIZATION#0.7409;HEPATOCELLULAR CARCINOMA CELL#0.7359;NEURON DEATH#0.7324;SIGNALING CASCADE#0.7318;REGENERATION#0.7292;SQUAMOUS CELL CARCINOMA#0.7291;RESPIRATION#0.7282;GLUTATHIONE#0.7279;INTESTINAL EPITHELIAL CELL#0.7237;ARTERY#0.7231;ACETYLCYSTEINE#0.7231;HYDROXYCHLOROQUINE#0.7219;CD8+ T CELL#0.7191;DIGESTION#0.7187;RIBOSOMAL PROTEIN#0.7164;ATHEROSCLEROSIS#0.7144;UBIQUITIN PROTEASOME SYSTEM#0.7142;RESVERATROL#0.7141;RED FLUORESCENT PROTEIN#0.7118;MECHANISM OF ACTION#0.7116;FATTY LIVER DISEASE#0.7103;PROTEIN KINASE B#0.7103;HYPERTENSION#0.7102;OOCYTE#0.7098;MESENCHYMAL STEM CELL#0.7074;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7068;MIDBRAIN#0.7065;HUMAN UMBILICAL VEIN#0.7063;ESTROGEN RECEPTOR#0.7062;UMBILICAL VEIN#0.7061;CELL SURFACE#0.7042;MICROVASCULAR ENDOTHELIAL CELL#0.7034;ATHEROSCLEROTIC#0.7031;CELL KILLING#0.7016;WHITE ADIPOSE TISSUE#0.7007;PRECURSOR CELL#0.6995;GENE SILENCING#0.6986;RENAL CELL CARCINOMA#0.6984;INHIBITION OF CELL PROLIFERATION#0.6975;MELANIN DEGRADATION#0.6952;IMMUNE SYSTEM#0.6948;MONONUCLEAR CELLS#0.6948;ADENOSINE#0.6928;ACINAR CELL#0.6856;ALZHEIMER'S DISEASE#0.6853;DIABETES MELLITUS#0.6853;GROWTH FACTOR RECEPTOR#0.6851;SIGNALING MOLECULE#0.6828;PODOCYTE#0.6812;PANETH CELL#0.6811;MITOCHONDRIAL DAMAGE#0.6777;GLYCOLYSIS#0.6759;DNA DAMAGE RESPONSE#0.6733;MITOCHONDRIAL DNA#0.6729;RELATED PROTEIN 1#0.6724;TOLL LIKE RECEPTOR#0.6693;PHAGOSOME#0.6679;HUMAN BREAST CANCER#0.6666;DOXORUBICIN#0.6643;TRANSMISSION ELECTRON MICROSCOPE#0.6639;MYOBLAST#0.6631;AUTOPHAGOSOME-LYSOSOME FUSION#0.6613;SENSITIZATION#0.6610;VASCULAR SMOOTH MUSCLE CELL#0.6610;ASTROCYTE#0.6594;NUCLEUS PULPOSUS#0.6575;GLUCOSE HOMEOSTASIS#0.6571;NEURONAL CELLS#0.6563;BETA CELL MASS#0.6533;SWELLING#0.6506;PROTEIN COMPLEX#0.6488;G1 PHASE#0.6483;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6478;TUBULAR EPITHELIAL CELL#0.6477;LUPUS ERYTHEMATOSUS#0.6475;CELL ACTIVATION#0.6452;HEAT SHOCK PROTEIN#0.6416;RETINOIC ACID#0.6411;SIGNAL TRANSDUCTION#0.6389;NEUROBLASTOMA#0.6383;ACUTE KIDNEY INJURY#0.6337;ANTIGEN PRESENTATION#0.6336;AKT SIGNALING#0.6319;MYOFIBROBLAST DIFFERENTIATION#0.6312;MYOFIBROBLAST#0.6310;INTRACELLULAR MEMBRANE#0.6308;PALMITIC ACID#0.6297;EPIDERMAL GROWTH FACTOR#0.6279;AUTOPHAGOLYSOSOME#0.6274;INNATE IMMUNE RESPONSE#0.6255;GLUCOSE METABOLISM#0.6249;SCHWANN CELL#0.6244;OVARIAN CARCINOMA#0.6243;NECROTIC#0.6193;MTDNA#0.6185;IMPAIRED GLUCOSE TOLERANCE#0.6182;NEURONAL CELL DEATH#0.6178;NEUROTOXICITY#0.6161;DIET INDUCED OBESITY#0.6144;LYSINE#0.6141;BORTEZOMIB#0.6120;NADPH OXIDASE#0.6110;BRAIN ENDOTHELIAL CELL#0.6075;MELANOCYTE#0.6073;LYSOSOMAL MEMBRANE PERMEABILIZATION#0.6034;PHOSPHATE BUFFERED SALINE#0.6024;RETICULOCYTE#0.6023;TRADITIONAL CHINESE MEDICINE#0.6012;ATPASE INHIBITOR#0.6011;ENERGY HOMEOSTASIS#0.6009
10534	CENTROMERE#0.6738;CYCLIN DEPENDENT KINASE#0.6601;GASTROINTESTINAL STROMAL TUMOR#0.6076;TRADITIONAL CHINESE MEDICINE#0.6038
10535	RNASE H ACTIVITY#1.0441;DNA POLYMERASE I#1.0368;EXONUCLEASE ACTIVITY#1.0279;DNA POLYMERASE ACTIVITY#1.0268;DIGESTION#1.0206;RIBONUCLEASE H#1.0144;DNA LIGASE#1.0076;REVERSE TRANSCRIPTASE INHIBITOR#1.0071;VIRAL GENOME#1.0058;RNA DEGRADATION#1.0053;HEPATITIS B VIRUS#1.0052;HEPATITIS B#1.0029;DRUG RESISTANCE#1.0026;TOPOISOMERASE#1.0004;TRANSCRIPTASE#0.9988;RNA BINDING#0.9955;VIRION#0.9950;MECHANISM OF ACTION#0.9934;DNASE#0.9928;VIRAL REPLICATION#0.9925;RIBOZYME#0.9905;DNA REPLICATION#0.9904;CATALYTIC ACTIVITY#0.9903;MUTAGENESIS#0.9881;DNA SYNTHESIS#0.9869;NUCLEASE ACTIVITY#0.9867;DNA BINDING#0.9864;C TERMINAL DOMAIN#0.9856;HUMAN IMMUNODEFICIENCY VIRUS#0.9840;REVERSE TRANSCRIPTASE ACTIVITY#0.9836;NUCLEOCAPSID#0.9817;BASE PAIRING#0.9817;PROTEIN SYNTHESIS#0.9787;NUCLEIC ACID#0.9765;MRNA CLEAVAGE#0.9753;LOCKED NUCLEIC ACID#0.9751;REVERSE TRANSCRIPTION#0.9746;POLYMERASE CHAIN REACTION#0.9719;RIBOSOME#0.9671;GENE EXPRESSION#0.9601;OOCYTE#0.9597;GLOBIN#0.9570;DNASE I#0.9561;DNA REPAIR#0.9551;SURFACE PLASMON RESONANCE#0.9547;ENDONUCLEASE ACTIVITY#0.9537;SPLICEOSOME#0.9518;NUCLEIC ACID BINDING#0.9510;ENZYME ACTIVITY#0.9495;RNA INTERFERENCE#0.9455;PROTEIN BINDING#0.9442;RETICULOCYTE#0.9433;THYMIDINE#0.9415;NEVIRAPINE#0.9374;DNA POLYMERASE ALPHA#0.9358;TRANSLATION INITIATION#0.9313;GENE SILENCING#0.9283;RIBOSOMAL SUBUNIT#0.9271;STRUCTURE ACTIVITY RELATIONSHIP#0.9255;HOST CELL#0.9232;MRNA SPLICING#0.9229;HISTIDINE#0.9207;RESONANCE ENERGY TRANSFER#0.9169;MRNA DEGRADATION#0.9164;SMALL NUCLEAR RNA#0.9139;N-ETHYLMALEIMIDE#0.9129;STRAND DISPLACEMENT#0.9118;STRAND TRANSFER REACTION#0.9103;FLAP ENDONUCLEASE#0.9086;T CELL#0.9071;RIBOSOMAL RNA#0.9057;PRE-MRNA SPLICING#0.9054;CANCER CELL#0.9003;RNA SYNTHESIS#0.8993;TRANSPOSITION#0.8972;MODE OF ACTION#0.8971;ALANINE#0.8891;HEPATITIS C VIRUS#0.8880;HEPATITIS C#0.8872;CELL PROLIFERATION#0.8840;EFAVIRENZ#0.8797;CELL GROWTH#0.8742;RNASE T1#0.8712;CYTOPLASM#0.8668;METAL BINDING#0.8658;PEPTIDE NUCLEIC ACID#0.8618;SINGLE-STRANDED DNA BINDING#0.8593;U2 SNRNP#0.8565;TOXICITY#0.8516;5'-EXONUCLEASE ACTIVITY#0.8503;ANTISENSE RNA#0.8427;REPLICATION FORK#0.8407;CYTOTOXICITY#0.8375;SUCROSE#0.8361;DNA PRIMASE#0.8310;ACTINOMYCIN D#0.8297;MITOCHONDRIA#0.8288;DNA TOPOISOMERASE#0.8243;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.8238;MOLECULAR DYNAMICS SIMULATION#0.8212;APOPTOSIS#0.8187;DEOXYTHYMIDINE#0.8106;ASPARTIC ACID#0.8091;TRANSCRIPTION FACTOR#0.8067;RNA BINDING PROTEIN#0.7978;COMPLEX I#0.7965;RIBOSE#0.7932;CARRIE#0.7882;ADENOSINE#0.7865;RNA PROCESSING#0.7767;NUCLEOTIDE BINDING#0.7758;HOMOLOGOUS RECOMBINATION#0.7753;CELL CYCLE#0.7752;TUMOR CELLS#0.7663;DOUBLE STRAND BREAK#0.7628;CYTIDINE#0.7620;RIBONUCLEASE ACTIVITY#0.7568;SODIUM DODECYL SULFATE#0.7422;DODECYL SULFATE#0.7421;DSRNA BINDING#0.7377;SUBSTRATE BINDING DOMAIN#0.7328;GUANIDINIUM CHLORIDE#0.7327;U1 SNRNP#0.7245;VIRAL INFECTION#0.7199;TELOMERE#0.7198;PERIPHERAL BLOOD#0.7155;PROVIRUS#0.7152;ROLLING CIRCLE AMPLIFICATION#0.7061;URACIL#0.7048;DNA HELICASE#0.7045;LYSINE#0.7010;HERPES SIMPLEX VIRUS#0.6974;HERPES SIMPLEX#0.6971;U12 SNRNP#0.6934;RETROTRANSPOSITION#0.6874;SPLICEOSOME ASSEMBLY#0.6871;RNA-INDUCED SILENCING COMPLEX#0.6846;GUANINE#0.6679;30S RIBOSOMAL SUBUNIT#0.6677;IMMUNE RESPONSE#0.6646;DOUBLE-STRANDED RNA BINDING#0.6579;3'-5' EXONUCLEASE ACTIVITY#0.6497;MUTAGENIC#0.6490;CHLORAMPHENICOL#0.6490;ENZYME COMPLEX#0.6485;HEPARIN#0.6472;THYMINE#0.6436;RISC COMPLEX#0.6418;RNASE ACTIVITY#0.6409;ZIDOVUDINE#0.6373;DNA DEPENDENT ATPASE#0.6371;EQUINE INFECTIOUS ANEMIA#0.6339;MITOCHONDRIAL DNA#0.6311;CONJUGATION#0.6300;FURAN#0.6287;ASPARTATE#0.6241;GROWTH FACTOR#0.6232;PHOSPHODIESTERASE#0.6222;METHIONINE#0.6216;ENDOTHELIAL CELL#0.6184;MRNA DECAY#0.6151;POSTREPLICATION REPAIR#0.6136;DNA POLYMERASE III#0.6109;DNASE ACTIVITY#0.6012
10536	COLD SHOCK PROTEIN#1.0910;FIBRONECTIN BINDING#1.0898;METASTATIC MELANOMA#1.0886;HEAT SHOCK PROTEIN#1.0478;OUTER MEMBRANE#1.0339;RIBOSOME#1.0250;PROGESTERONE#1.0237;ESTRADIOL-17BETA#1.0214;AMYOTROPHIC LATERAL SCLEROSIS#1.0197;LATERAL SCLEROSIS#1.0197;GROWTH FACTOR#1.0157;POLYMERASE CHAIN REACTION#0.9995;VIRULENCE#0.9886;HOST CELL#0.9761;IMMUNE RESPONSE#0.9633;NERVE GROWTH FACTOR#0.9617;ENDOPLASMIC RETICULUM#0.9575;B CELL#0.9454;DNA BINDING#0.9445;GESTATION#0.9435;GENE EXPRESSION#0.9421;ESTRADIOL#0.9368;MACROPHAGE#0.9311;SIGNALING PATHWAY#0.9287;CELL WALL#0.9258;INSEMINATION#0.9212;SPHINGOLIPID ACTIVATOR PROTEIN#0.9186;CELL SURFACE#0.9135;TUBERCULOSIS#0.9073;PROSTAGLANDIN E2#0.9015;IRON ACQUISITION#0.8877;SPOTTED FEVER#0.8815;T CELL#0.8809;TRANSCRIPTION FACTOR#0.8774;RIBOSOMAL PROTEIN#0.8740;BIOFILM FORMATION#0.8625;MOTOR NEURON DISEASE#0.8576;BREAST CANCER#0.8566;PROTEIN KINASE#0.8561;HIGH MOBILITY GROUP#0.8513;DODECYL SULFATE#0.8509;SODIUM DODECYL SULFATE#0.8509;LYME DISEASE#0.8506;CELL PROLIFERATION#0.8486;DENTAL CARIES#0.8416;EPITHELIAL CELL#0.8393;LUNG CANCER#0.8302;PROTEIN SYNTHESIS#0.8246;PERIPHERAL BLOOD#0.8208;CANCER CELL#0.8203;ELECTRON TRANSFER#0.8143;CENTROMERE BINDING#0.8048;CENTROMERE#0.8043;FIBRINOGEN#0.8023;MICROTUBULE#0.8014;ESTRUS#0.7916;RENAL CELL CARCINOMA#0.7879;COLICIN#0.7876;APOPTOSIS#0.7873;PLASMA PROTEIN#0.7849;ESTROUS CYCLE#0.7814;RESPIRATORY DISTRESS#0.7691;TUBERCULOUS MENINGITIS#0.7638;REVERSE TRANSCRIPTION#0.7632;STEM CELL#0.7613;GLYCINE#0.7601;MUTAGENESIS#0.7446;MENINGITIS#0.7341;CELL DIVISION#0.7175;LYSINE#0.7124;CYTOPLASM#0.7090;CELL DEATH#0.7066;INTERFERON STIMULATED GENE#0.7042;UNFOLDED PROTEIN RESPONSE#0.7038;CHLAMYDIA#0.6903;IMMUNOGLOBULIN G#0.6880;TF BINDING#0.6867;METACHROMATIC LEUKODYSTROPHY#0.6864;QUANTITATIVE REAL TIME#0.6844;LEUKOCYTE#0.6812;DUODENAL ULCER#0.6787;C TERMINAL DOMAIN#0.6756;PROTEIN PROTEIN INTERACTION#0.6739;PEPTIDOGLYCAN#0.6544;HISTIDINE#0.6530;TYPHUS#0.6491;DIGESTION#0.6485;NUCLEIC ACID#0.6452;ENDOMETRIUM#0.6442;RIBONUCLEOPROTEIN COMPLEX#0.6370;AUTOPHAGY#0.6299;FIBRINOGEN BINDING#0.6292;ENHANCER BINDING PROTEIN#0.6250;ENHANCER BINDING#0.6245;SIGNAL TRANSDUCTION#0.6244;CELLULOSE BINDING#0.6187;PENICILLIN BINDING#0.6174;SURFACE PLASMON RESONANCE#0.6157;SAPOSIN#0.6112;Q FEVER#0.6062;ALPHA GALACTOSIDASE#0.6017;MICROTUBULE ASSOCIATED PROTEIN#0.6016;QUALITY CONTROL SYSTEM#0.6007
105371906	ORAL SQUAMOUS CELL CARCINOMA#0.9119;SQUAMOUS CELL CARCINOMA#0.9013
105373853	VSMC DIFFERENTIATION#0.7277;SERUM RESPONSE FACTOR#0.6950;TRANSFORMING GROWTH FACTOR#0.6719;GROWTH FACTOR#0.6655
105375355	MESOTHELIOMA CELL#0.6238;MESOTHELIAL CELL#0.6129
105377108	COLORECTAL CANCER#1.1841;SIGNALING PATHWAY#1.1785;COLORECTAL#0.8485
105377363	DNA METHYLATION#0.8293;STEM CELL#0.7963
10537	HEPATOCELLULAR CARCINOMA#1.0500;APOPTOSIS#1.0409;PROTEASOME#1.0233;UBIQUITIN#1.0220;26S PROTEASOME#1.0172;CONJUGATION#1.0144;UBIQUITIN BINDING#1.0058;CELL CYCLE#1.0028;POLYUBIQUITIN#0.9969;GENE EXPRESSION#0.9924;CANCER CELL#0.9850;DEUBIQUITINATING ENZYME#0.9662;DEUBIQUITINASE#0.9612;LYSINE#0.9588;TUMOR NECROSIS FACTOR#0.9426;SIGNALING PATHWAY#0.9358;CELL PROLIFERATION#0.9154;PROTEIN DEGRADATION#0.9104;IMMUNE RESPONSE#0.9031;DENDRITIC CELL#0.8986;PRO-INFLAMMATORY#0.8934;POST-TRANSLATIONAL MODIFICATION#0.8877;UBIQUITIN ACTIVATING ENZYME#0.8732;IFN-GAMMA#0.8666;CELL DEATH#0.8458;COLON CANCER#0.8456;EPITHELIAL CELL#0.8347;T CELL#0.8309;ANTIGEN PRESENTATION#0.8130;BREAST CANCER#0.7918;TUMOR SUPPRESSOR#0.7880;COLON CARCINOMA#0.7568;MITOSIS#0.7313;HUMAN LEUKOCYTE ANTIGEN#0.7311;LEUKOCYTE#0.7236;AUTOPHAGY#0.7069;DNA DAMAGE RESPONSE#0.6953;LYMPH NODE#0.6891;ONCOGENIC#0.6835;B CELL#0.6773;CELL SURFACE#0.6600;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6593;DNA REPAIR#0.6507;CYTOPLASM#0.6501;ENDOPLASMIC RETICULUM#0.6324;QUANTITATIVE REAL TIME#0.6278;PROTEIN QUALITY CONTROL#0.6223;POLYMERASE CHAIN REACTION#0.6186;MUTAGENESIS#0.6133;VIRAL INFECTION#0.6086;SPINDLE ASSEMBLY#0.6038
10538	ACTIVATING TRANSCRIPTION FACTOR#1.0870;LEUCINE#1.0771;TH17 CELL#1.0558;TRANSCRIPTION FACTOR#1.0534;B CELL#1.0519;GENE EXPRESSION#1.0373;CD4+ T CELL#1.0351;T CELL#1.0301;ACTIVATOR PROTEIN 1#1.0273;CELL DIFFERENTIATION#1.0159;CELL DEVELOPMENT#1.0110;DNA BINDING#0.9809;TH9 CELL#0.9456;CD8+ T CELL#0.9231;GM-CSF#0.8887;RETINOIC ACID#0.8779;TH2 CELL#0.8665;IMMUNE RESPONSE#0.8318;INTERFERON REGULATORY FACTOR#0.8237;ALLERGIC ASTHMA#0.7974;HEPATITIS B#0.7730;T HELPER CELL#0.7695;CELL PROLIFERATION#0.7588;NKT CELL#0.7577;EFFECTOR T CELL#0.7312;RELATED ORPHAN RECEPTOR#0.7271;IL-9 PRODUCTION#0.6584;AUTOIMMUNE DISEASE#0.6499;T FOLLICULAR HELPER#0.6481;QUANTITATIVE REAL TIME#0.6407;DENDRITIC CELL#0.6393;EPSTEIN BARR VIRUS#0.6369;SIGNAL TRANSDUCER#0.6357;T CELL DIFFERENTIATION#0.6217;CLASS SWITCH RECOMBINATION#0.6194;CELLULAR GROWTH#0.6183;HISTONE ACETYLATION#0.6174;PERIPHERAL BLOOD#0.6173;HEPATITIS B VIRUS#0.6124;T CELL PROLIFERATION#0.6123;COLITIS#0.6122;CELL ACTIVATION#0.6113;MYELOID LEUKEMIA#0.6089;MACROPHAGE#0.6061
10539	IRON SULFUR CLUSTER#1.0228;GLUTATHIONE#1.0057;IRON HOMEOSTASIS#0.9970;PROTEIN KINASE#0.9947;CANCER CELL#0.9701;PROTEIN KINASE C#0.9604;T CELL#0.9193;SIGNALING PATHWAY#0.9113;TRANSCRIPTION FACTOR#0.9048;CELL GROWTH#0.8888;REACTIVE OXYGEN SPECIES#0.8697;OXIDATIVE STRESS RESPONSE#0.8067;ACTIN CYTOSKELETON#0.7607;RESPONSE TO IRON#0.7532;GENE EXPRESSION#0.7513;L-CYSTEINE#0.7416;CELL CYCLE#0.7313;LUNG CANCER#0.7292;CARDIOMYOCYTE#0.7185;IRON REGULATORY PROTEIN#0.7005;MITOCHONDRIA#0.6942;COLON CANCER#0.6826;BREAST CANCER#0.6726;CHAPERONE COMPLEX#0.6197;PROTEIN PROTEIN INTERACTION#0.6137;T LYMPHOCYTE#0.6094;PKC ACTIVITY#0.6043;HISTIDINE#0.6043
1053	G-CSF#1.0561;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0453;ENHANCER BINDING PROTEIN#1.0361;MYELOID CELL#1.0360;ENHANCER BINDING#1.0359;NEUTROPHIL#1.0283;DNA BINDING#1.0270;GENE EXPRESSION#1.0244;TRANSCRIPTION FACTOR#1.0208;GRANULOCYTE#1.0178;SPECIFIC GRANULE#1.0147;RETINOIC ACID#1.0117;MACROPHAGE#1.0050;BONE MARROW#0.9927;SECONDARY GRANULE#0.9868;MYELOID LEUKEMIA#0.9507;COLONY-STIMULATING FACTOR#0.9366;B CELL#0.9321;CELL CYCLE#0.9225;T CELL#0.9206;MONOCYTE#0.9168;EOSINOPHIL#0.9148;ACUTE MYELOID LEUKEMIA#0.8969;TERMINAL DIFFERENTIATION#0.8932;PERIPHERAL BLOOD#0.8470;ALL TRANS RETINOIC ACID#0.8298;APOPTOSIS#0.8276;GRANULOCYTE COLONY STIMULATING FACTOR#0.8268;HEMATOPOIETIC CELL#0.8146;PROMYELOCYTE#0.8144;TRANSACTIVATION#0.8123;LEUCINE#0.8031;NEUTROPHIL DIFFERENTIATION#0.7992;STEM CELL#0.7932;ACUTE PROMYELOCYTIC LEUKEMIA#0.7727;HEMATOPOIETIC STEM CELL#0.7608;RETINOIC ACID RECEPTOR#0.7131;PROGENITOR CELL#0.7114;GRANULOCYTE DIFFERENTIATION#0.6951;CELL CYCLE ARREST#0.6867;BONE MARROW CELLS#0.6859;POLYMERASE CHAIN REACTION#0.6787;KINASE INHIBITOR#0.6372;CELL DIFFERENTIATION#0.6280;PROTEIN PROTEIN INTERACTION#0.6095;ELECTROPHORETIC MOBILITY SHIFT#0.6002
10540	DYNACTIN COMPLEX#1.0721;DYNEIN#1.0548;MICROTUBULE#0.9993;KINETOCHORE#0.8377;KINESIN#0.8250;CELL SURFACE#0.8177;ENDOPLASMIC RETICULUM#0.8099;CELL PERIPHERY#0.7686;NOCODAZOLE#0.7643;MICROTUBULE MOTOR#0.7574;CENTROSOME#0.7275;MITOTIC SPINDLE#0.7032;DYNEIN COMPLEX#0.6953;ORGANELLE#0.6836;ACTIN RELATED PROTEIN#0.6811;ENDOSOME#0.6428;MACROPHAGE#0.6354;PLASMA MEMBRANE#0.6265;BASAL CORTEX#0.6259;MICROTUBULE BASED#0.6246;GROWTH CONE#0.6177
105416157	BREAST CANCER#1.0850;APOPTOSIS#1.0497;SIGNALING PATHWAY#1.0084;CANCER CELL#0.9565;CELL PROLIFERATION#0.9525;EPITHELIAL MESENCHYMAL TRANSITION#0.9323;CELL DEATH#0.8408;LUNG CANCER#0.7694;TUMOR SUPPRESSOR#0.7107;INFLAMMATORY RESPONSE#0.7100;SQUAMOUS CELL CARCINOMA#0.6584;TUMOR TISSUES#0.6372;SIGNALLING PATHWAY#0.6354;AUTOPHAGY#0.6125
10541	STEM CELL#0.9891;BONE MARROW#0.9814;STEM CELL TRANSPLANTATION#0.9811;PERIPHERAL BLOOD#0.9742;HUMAN LEUKOCYTE ANTIGEN#0.9685;T CELL#0.9651;GRAFT VERSUS HOST#0.9566;LEUKOCYTE#0.9557;LEUCINE#0.9521;HEMATOPOIETIC STEM CELL#0.9449;MYELOID LEUKEMIA#0.9438;CYCLOPHOSPHAMIDE#0.9234;ANEMIA#0.8779;CORD BLOOD#0.8760;ACUTE MYELOID LEUKEMIA#0.8665;CYCLOSPORINE#0.8566;APLASTIC ANEMIA#0.8367;APOPTOSIS#0.8216;MYELODYSPLASTIC SYNDROME#0.8184;HISTONE CHAPERONE#0.8049;DISEASE FREE SURVIVAL#0.7880;MATCHED SIBLING DONOR#0.7855;CHRONIC MYELOID LEUKEMIA#0.7666;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7502;UVEITIS#0.7469;ACUTE LEUKEMIA#0.7462;BUSULFAN#0.7357;STEM CELL TRANSPLANT#0.7294;UMBILICAL CORD#0.7293;METHOTREXATE#0.7082;T LYMPHOCYTE#0.6853;B CELL#0.6725;UMBILICAL CORD BLOOD#0.6653;ETOPOSIDE#0.6466;ANTERIOR UVEITIS#0.6309;APOPTOTIC#0.6276;IMMUNE RESPONSE#0.6244;GENE EXPRESSION#0.6243;DIABETES MELLITUS#0.6125;INFLUENZA A VIRUS#0.6113;POLYMERASE CHAIN REACTION#0.6107;FLUDARABINE#0.6102
10542	BREAST CANCER CELL#1.0932;BREAST CANCER#1.0862;CANCER CELL#1.0774;HEPATITIS B#1.0596;CELL PROLIFERATION#1.0592;HEPATITIS B VIRUS#1.0512;TRANSCRIPTION FACTOR#1.0466;LYMPH NODE#1.0209;LYMPH NODE METASTASIS#0.9706;APOPTOSIS#0.9456;CELL MIGRATION#0.9355;HEPATOMA CELLS#0.9163;HUMAN BREAST CANCER#0.9080;BREAST CANCER PATIENTS#0.8635;HEPATOCELLULAR CARCINOMA#0.8502;SIGNALING PATHWAY#0.8248;AKT SIGNALING#0.8241;QUANTITATIVE REAL TIME#0.8200;ONCOGENIC#0.8005;CELL GROWTH#0.7883;GLUCOSE METABOLISM#0.7765;TUMOR SUPPRESSOR#0.7751;OVARIAN CANCER#0.7736;REPORTER GENE ASSAY#0.7732;SQUAMOUS CELL CARCINOMA#0.7713;CELL CYCLE#0.7562;LIVER CANCER#0.7131;ACTIVATING TRANSCRIPTION FACTOR#0.7012;BREAST CARCINOMA#0.6935;GENE EXPRESSION#0.6887;CENTROSOME REPLICATION#0.6516;REVERSE TRANSCRIPTION#0.6406;SPINDLE FORMATION#0.6305
10544	RECEPTOR SHEDDING#1.0939;APC BINDING#1.0934;CEREBRAL MALARIA#1.0446;MALARIA#1.0434;HEMATOPOIETIC STEM CELL#1.0327;PROTEASE ACTIVATED RECEPTOR#1.0320;NEUTROPHIL#1.0241;CANCER CELL#1.0233;TUMOR NECROSIS FACTOR#1.0233;STEM CELL#1.0229;BREAST CANCER#1.0204;SELECTIN#1.0202;ENDOTHELIAL CELL#1.0174;MAP KINASE#1.0150;CELL SURFACE#1.0137;ENDOTHELIUM#1.0135;HUMAN UMBILICAL VEIN#1.0130;UMBILICAL VEIN ENDOTHELIAL CELLS#1.0118;ERYTHROCYTE#1.0105;UMBILICAL VEIN#1.0102;VASCULAR ENDOTHELIAL CELL#1.0065;POLYMERASE CHAIN REACTION#1.0024;ACTIVATED PROTEIN C#1.0016;SIGNALING PATHWAY#0.9979;FACTOR V LEIDEN#0.9962;GROWTH FACTOR#0.9960;ANTICOAGULANT ACTIVITY#0.9960;INFLAMMATORY RESPONSE#0.9954;LEUKOCYTE#0.9877;APOPTOSIS#0.9869;BLOOD VESSEL#0.9869;THROMBOSIS#0.9867;GENE EXPRESSION#0.9860;BLOOD COAGULATION#0.9857;ANTICOAGULANT PROTEIN C#0.9845;COAGULATION#0.9835;BONE MARROW#0.9810;LIPID RAFT#0.9763;T CELL#0.9756;CELL ADHESION#0.9742;BRAIN ENDOTHELIAL CELL#0.9732;THROMBIN RECEPTOR#0.9688;PROGENITOR CELL#0.9672;MACROPHAGE#0.9665;APOPTOTIC#0.9651;NITRIC OXIDE#0.9569;MONOCYTE#0.9559;HEMOSTASIS#0.9541;MYOCARDIAL INFARCTION#0.9457;CELL PROLIFERATION#0.9435;CLOTTING#0.9419;C-LEVEL#0.9397;MICROPARTICLE#0.9258;FIBRINOGEN#0.9200;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9200;PROTEIN KINASE#0.9163;LUPUS ERYTHEMATOSUS#0.9115;REVERSE TRANSCRIPTION#0.9095;SMOOTH MUSCLE#0.9066;TUMOR CELLS#0.9065;CELL CYCLE#0.9057;EPITHELIAL CELL#0.9057;FIBRINOLYSIS#0.9033;FACTOR XA#0.9018;SMOOTH MUSCLE CELL#0.9015;MUSCLE CELL#0.9008;CELL ADHESION MOLECULE#0.9005;MITOGEN ACTIVATED PROTEIN#0.8985;LUNG CANCER#0.8982;VITAMIN K#0.8960;ECTODOMAIN CLEAVAGE#0.8955;IMMUNE CELL#0.8947;MICROVASCULAR ENDOTHELIAL CELL#0.8922;ARTERY#0.8903;BREAST CANCER CELL#0.8867;THROMBOPHILIA#0.8827;TROPHOBLAST#0.8770;HEMOPHILIA#0.8762;IMMUNE RESPONSE#0.8686;CELL MIGRATION#0.8628;KERATINOCYTE#0.8588;SURFACE PLASMON RESONANCE#0.8545;ANGIOGENESIS#0.8520;PLASMA PROTEIN#0.8519;STEM CELL MARKER#0.8504;SPHINGOSINE 1 PHOSPHATE#0.8436;VASCULAR ENDOTHELIUM#0.8417;OVARIAN CANCER#0.8415;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8330;PLATELET ACTIVATION#0.8275;CANCER STEM CELL#0.8231;PRO-INFLAMMATORY#0.8155;TRANSCRIPTION FACTOR#0.8127;VASCULAR CELL#0.8114;FACTOR VIII#0.8092;NITRIC OXIDE SYNTHASE#0.8086;PLASMA MEMBRANE#0.8078;HEMATOPOIETIC CELL#0.7988;DISSEMINATED INTRAVASCULAR COAGULATION#0.7983;PERIPHERAL BLOOD#0.7968;CELL GROWTH#0.7961;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7908;ENDOTHELIAL GROWTH FACTOR#0.7907;OVARIAN#0.7852;SPHINGOSINE#0.7818;ATHEROSCLEROSIS#0.7817;CHEMOTAXIS#0.7736;BREAST CANCER PATIENTS#0.7686;NEPHRITIS#0.7563;EXTRACELLULAR REGULATED KINASE#0.7477;WOUND HEALING#0.7461;C REACTIVE PROTEIN#0.7431;HEART DISEASE#0.7427;ENDOTHELIAL MICROPARTICLE#0.7421;VASCULAR SMOOTH MUSCLE CELL#0.7420;DENDRITIC CELL#0.7415;ISCHEMIA#0.7323;INTENSIVE CARE UNIT#0.7269;TRANSCRIPTASE#0.7265;HEPARIN#0.7137;ACTIVATION OF COAGULATION#0.7130;HEMATOPOIESIS#0.7011;GROWTH FACTOR RECEPTOR#0.7006;LEUKOCYTE ADHESION#0.6923;CIRCULATING ENDOTHELIAL CELL#0.6905;ACUTE LUNG INJURY#0.6899;RECEPTOR COMPLEX#0.6894;EPIDERMAL GROWTH FACTOR#0.6814;ENDOCYTOSIS#0.6778;ANTIPHOSPHOLIPID SYNDROME#0.6775;RHEUMATOID ARTHRITIS#0.6756;HIGH MOBILITY GROUP#0.6737;LUPUS NEPHRITIS#0.6737;CORONARY ARTERY#0.6728;TROPHOBLAST CELL#0.6726;MAMMARY GLAND#0.6723;CORONARY HEART DISEASE#0.6708;HEME OXYGENASE 1#0.6675;LUNG CARCINOMA#0.6672;INNATE IMMUNE RESPONSE#0.6528;PURPURA FULMINANS#0.6485;SIGNAL TRANSDUCTION#0.6483;ENDOTHELIAL NITRIC OXIDE#0.6475;PNEUMONIA#0.6472;CELL DEATH#0.6466;EXTRACELLULAR MATRIX#0.6439;RESPONSE TO ENDOTOXIN#0.6325;TIGHT JUNCTION#0.6273;CELL ACTIVATION#0.6269;IMMUNE SYSTEM#0.6259;MONONUCLEAR CELLS#0.6259;RESPIRATORY DISTRESS#0.6257;RECEPTOR BINDING#0.6221;DIABETES MELLITUS#0.6220;ANGIOTENSIN CONVERTING ENZYME#0.6216;INNATE IMMUNITY#0.6178;METALLOPROTEINASE INHIBITOR#0.6146;HEMORRHAGE#0.6104;PNEUMOCOCCAL PNEUMONIA#0.6091;EPIDERMAL STEM CELL#0.6088;PROTEIN C DEFICIENCY#0.6074;T- PA#0.6071;TUBE FORMATION#0.6047;72-HOURS#0.6044;PHOSPHOLIPASE A2#0.6034;INFLAMMATORY BOWEL DISEASE#0.6012
105463123	X CHROMOSOME#0.9328
105463127	PROGRESSIVE FAMILIAL HEART BLOCK#1.0887
10547	PSORIASIS#1.0272;EPIDERMAL DIFFERENTIATION COMPLEX#0.9513;LATE CORNIFIED ENVELOPE#0.6055
10548	AUTOPHAGY#0.8725;ENDOPLASMIC RETICULUM#0.8575;AUTOPHAGOSOME FORMATION#0.7569;AUTOPHAGOSOME#0.7178;IMMUNE RESPONSE#0.6518;INNATE IMMUNE RESPONSE#0.6184
10549	THIOREDOXIN PEROXIDASE ACTIVITY#1.1517;OXIDATIVE PROTEIN FOLDING#1.0780;THIOREDOXIN PEROXIDASE#1.0593;PROTEIN FOLDING#1.0446;SUPEROXIDE DISMUTASE#1.0410;GLUTATHIONE PEROXIDASE#1.0311;PEROXIDASE ACTIVITY#1.0185;GLUTATHIONE#1.0138;ENDOPLASMIC RETICULUM#1.0078;APOPTOSIS#1.0040;PROTEIN DISULFIDE ISOMERASE#0.9915;CELL DEATH#0.9763;HEAT SHOCK PROTEIN#0.9725;SIGNAL TRANSDUCTION#0.9723;REACTIVE OXYGEN SPECIES#0.9692;GENE EXPRESSION#0.9566;MITOCHONDRIA#0.9435;ANTIOXIDANT ACTIVITY#0.9432;IMMUNE RESPONSE#0.9394;TRANSCRIPTION FACTOR#0.9294;CANCER CELL#0.9162;INFLAMMATORY RESPONSE#0.9045;DETOXIFICATION#0.8907;SIGNALING PATHWAY#0.8833;MACROPHAGE#0.8761;LUNG CANCER#0.8752;GLYCERALDEHYDE-3-PHOSPHATE#0.8732;GROWTH FACTOR#0.8394;SIGNAL PEPTIDE#0.8391;POLYMERASE CHAIN REACTION#0.8388;ATP SYNTHASE#0.8365;QUANTITATIVE REAL TIME#0.8340;UBIQUITIN#0.8328;CELL PROLIFERATION#0.8253;LASER DESORPTION IONIZATION#0.8177;TYPE 2 DIABETES#0.8062;TOXICITY#0.8028;GALECTIN#0.8018;EPITHELIAL CELL#0.8010;DIABETES MELLITUS#0.7939;CELL GROWTH#0.7934;ADENOCARCINOMA#0.7931;SQUAMOUS CELL CARCINOMA#0.7859;OXYGENASE#0.7791;OXIDATIVE STRESS RESPONSE#0.7708;COLORECTAL CANCER#0.7640;THIOREDOXIN REDUCTASE 1#0.7635;ENDOTHELIAL CELL#0.7453;MYELOID LEUKEMIA#0.7444;RNA INTERFERENCE#0.7429;ASCORBATE#0.7121;PROTEIN KINASE#0.7099;PROSTATE CANCER#0.7052;HYPOXIA#0.7020;COLORECTAL#0.6993;PANCREATIC ISLET#0.6915;HEPATOCELLULAR CARCINOMA#0.6785;PROTEASOME#0.6765;LUNG ADENOCARCINOMA#0.6758;AKT SIGNALING#0.6753;ACUTE MYELOID LEUKEMIA#0.6740;CELL CYCLE#0.6731;BREAST CANCER#0.6731;STREPTOZOTOCIN#0.6343;HUMAN CARDIAC FIBROBLASTS#0.6273;LIVER DISEASE#0.6270;APOPTOTIC#0.6255;ALLOGRAFT INFLAMMATORY FACTOR#0.6231;LYMPH NODE#0.6213;FRUCTOSE#0.6148;GLUCOSE REGULATED PROTEIN#0.6135;NITRIC OXIDE#0.6125;SPERMATOGENIC CELLS#0.6053;ATHEROSCLEROSIS#0.6029
1054	ENHANCER BINDING PROTEIN#1.0625;ENHANCER BINDING#1.0621;TRANSCRIPTION FACTOR#1.0106;B CELL#0.9505;DNA BINDING#0.9381;LEUCINE#0.8897;GENE EXPRESSION#0.8041;BRONCHIAL EPITHELIAL CELLS#0.7808;DNA REPAIR#0.7729;EPITHELIAL CELL#0.7684;GLOBIN#0.6555;ELECTROPHORETIC MOBILITY SHIFT#0.6440;FETAL LIVER#0.6366;HUMAN BRONCHIAL EPITHELIAL#0.6293;LUNG CANCER#0.6271;IFN-GAMMA#0.6105
10550	APOPTOSIS#1.0727;CELL MIGRATION#1.0554;CANCER CELL#1.0342;SIGNALING PATHWAY#0.9875;ENDOPLASMIC RETICULUM#0.9858;PLASMA MEMBRANE#0.9621;SQUAMOUS CELL CARCINOMA#0.9435;TRANSCRIPTION FACTOR#0.8976;MAPK SIGNALING#0.8713;RETINOIC ACID#0.8704;GLUTATHIONE#0.8546;HEAT SHOCK PROTEIN#0.8203;HUMAN BRONCHIAL EPITHELIAL#0.7874;PROTEIN KINASE#0.7724;POLYMERASE CHAIN REACTION#0.7373;ANGIOGENESIS#0.7354;BASE EXCISION REPAIR#0.7034;TUBE FORMATION#0.6975;CELL DIFFERENTIATION#0.6935;DNA REPAIR#0.6913;EPITHELIAL CELL#0.6863;CELL PROLIFERATION#0.6619;MICROTUBULE#0.6496;CISPLATIN#0.6430;ER EXIT#0.6421;CELL SURFACE#0.6395;SINGLE STRAND BREAK#0.6277;MICROTUBULE ASSOCIATED PROTEIN#0.6270;MAPK CASCADE#0.6259;MITOGEN ACTIVATED PROTEIN#0.6217;ACTIN CYTOSKELETON#0.6149;BREAST CARCINOMA#0.6137;BREAST CANCER#0.6056
10551	PROTEIN DISULFIDE ISOMERASE#1.0778;GOBLET CELL#1.0660;PANCREATIC CANCER#1.0526;ENDOPLASMIC RETICULUM#1.0524;PROSTATE CANCER#1.0522;CELL PROLIFERATION#1.0418;BREAST CANCER CELL#1.0399;ESTROGEN RECEPTOR#1.0375;ONCOGENIC#1.0326;CANCER CELL#1.0268;ADENOCARCINOMA#1.0252;BREAST CANCER#1.0213;EPITHELIAL CELL#1.0132;COLORECTAL CANCER#1.0115;TAMOXIFEN#1.0106;OVARIAN CANCER#1.0091;TUMOR CELLS#1.0007;LUNG CANCER#0.9928;LUNG ADENOCARCINOMA#0.9907;STEM CELL#0.9829;CELL CYCLE#0.9828;TRANSCRIPTION FACTOR#0.9816;GENE EXPRESSION#0.9784;LYMPH NODE#0.9718;OVARIAN#0.9712;DRUG RESISTANCE#0.9660;COLORECTAL#0.9642;SQUAMOUS CELL CARCINOMA#0.9585;GROWTH FACTOR#0.9545;REGENERATION#0.9528;BREAST CANCER PATIENTS#0.9516;APOPTOSIS#0.9406;CELL SURFACE#0.9251;SIGNALING PATHWAY#0.9179;PANCREATIC DUCTAL ADENOCARCINOMA#0.9089;INFLAMMATORY BOWEL DISEASE#0.9072;CELL MIGRATION#0.8889;CIRCULATING TUMOR CELL#0.8696;PROTEIN FOLDING#0.8685;CELL GROWTH#0.8680;ANGIOGENESIS#0.8634;EPITHELIAL MESENCHYMAL TRANSITION#0.8578;CELL DEATH#0.8350;QUANTITATIVE REAL TIME#0.8269;POLYMERASE CHAIN REACTION#0.8145;IMMUNE RESPONSE#0.7993;BILIARY TRACT CANCER#0.7827;T CELL#0.7769;BILIARY TRACT#0.7673;ANDROGEN RECEPTOR#0.7613;COLON CANCER#0.7607;MAMMARY EPITHELIAL CELL#0.7569;METASTATIC PROSTATE CANCER#0.7554;HYPOXIA#0.7519;UNFOLDED PROTEIN RESPONSE#0.7510;SIGNALLING PATHWAY#0.7490;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7489;HUMAN BREAST CANCER#0.7468;ESOPHAGUS#0.7440;LYMPH NODE METASTASIS#0.7090;BREAST CARCINOMA#0.6932;TUMOR SUPPRESSOR#0.6781;STROMAL CELL#0.6761;MAMMARY GLAND#0.6753;MECHANISM OF ACTION#0.6508;REVERSE TRANSCRIPTION#0.6493;GROWTH FACTOR RECEPTOR#0.6488;BEVACIZUMAB#0.6313;PANCREATITIS#0.6296;KINASE INHIBITOR#0.6295;DISEASE FREE SURVIVAL#0.6291;ADJUVANT HORMONAL THERAPY#0.6268;PEPTIDE BINDING#0.6152;TUMOR TISSUES#0.6098;RNA INTERFERENCE#0.6088;TYROSINE KINASE INHIBITOR#0.6075
10553	HEPATOCELLULAR CARCINOMA#1.0767;TUMOR SUPPRESSOR#1.0631;APOPTOSIS#1.0414;CANCER CELL#1.0401;TUMOR CELLS#1.0205;GENE EXPRESSION#0.9645;CELL PROLIFERATION#0.9611;TUMOR TISSUES#0.9439;BREAST CANCER#0.9276;LYMPH NODE#0.9059;GROWTH FACTOR#0.8958;CELL DEATH#0.8944;SORAFENIB#0.8784;TRANSCRIPTION FACTOR#0.8379;LIPID METABOLISM#0.8157;SQUAMOUS CELL CARCINOMA#0.8139;LUNG CANCER#0.8127;APOPTOTIC#0.8118;HISTONE ACETYLTRANSFERASE#0.8082;ANGIOGENESIS#0.8038;ADENOCARCINOMA#0.7782;GENE SILENCING#0.7734;LUNG ADENOCARCINOMA#0.7730;BREAST CARCINOMA#0.7712;CELL GROWTH#0.7705;SIGNALING PATHWAY#0.7683;IMPORTIN#0.7485;PROTEIN COMPLEX#0.7468;LYMPH NODE METASTASIS#0.7212;COLORECTAL#0.7208;NUCLEAR IMPORT#0.7131;ESTROGEN RECEPTOR#0.7030;CELL CYCLE#0.7004;EARLY ENDOSOME#0.6984;HYPOXIA INDUCIBLE FACTOR#0.6924;PANCREATIC CANCER#0.6920;MAMMARY GLAND#0.6904;COLORECTAL CANCER#0.6888;HUMAN IMMUNODEFICIENCY VIRUS#0.6630;DNA METHYLATION#0.6448;NUCLEOCYTOPLASMIC TRANSPORT#0.6370;CLEAVED CASPASE 3#0.6245;EXTRACELLULAR MATRIX#0.6176;OVERALL SURVIVAL RATE#0.6158;ADJACENT NORMAL TISSUE#0.6155;HEPATOCELLULAR CARCINOMA CELL#0.6147;HEPATOMA CELLS#0.6125;EPITHELIAL MESENCHYMAL TRANSITION#0.6122;DISEASE FREE SURVIVAL#0.6086;KINASE ACTIVITY#0.6016;PROSTATE CANCER#0.6004
10554	ACYLTRANSFERASE ACTIVITY#1.0687;PHOSPHOLIPASE A2#0.9222;O ACYLTRANSFERASE#0.8995;PHOSPHATIDYLETHANOLAMINE#0.7882;LIPID METABOLISM#0.7859;LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE#0.7788;ARACHIDONIC ACID#0.7445;ACYL COA HYDROLASE#0.7399;ENDOPLASMIC RETICULUM#0.7285;COA HYDROLASE#0.7247;HORMONE SENSITIVE LIPASE#0.7047;GOLGI COMPLEX#0.7045;PHOSPHOLIPASE A#0.6546;PHOSPHOLIPASE A1#0.6444;TRIGLYCERIDE LIPASE#0.6266;SKELETAL MUSCLE#0.6022
10555	LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE#1.1121;O ACYLTRANSFERASE#1.0876;CONGENITAL GENERALIZED LIPODYSTROPHY#1.0534;LIPODYSTROPHY#1.0333;ADIPOCYTE#1.0201;ADIPOSE TISSUE#1.0030;APOPTOSIS#0.9575;LIPID DROPLET#0.9336;PARTIAL LIPODYSTROPHY#0.9194;ADIPOGENESIS#0.9066;DIABETES MELLITUS#0.8690;OVARIAN CANCER#0.8585;TRIGLYCERIDE SYNTHESIS#0.8090;PEROXISOME#0.8025;CANCER CELL#0.7986;LIPID METABOLISM#0.7926;GENE EXPRESSION#0.7889;OVARIAN#0.7684;BROWN ADIPOSE TISSUE#0.7675;CELL DEATH#0.7672;PREADIPOCYTE#0.7603;ADIPOCYTE DIFFERENTIATION#0.7480;FAMILIAL PARTIAL LIPODYSTROPHY#0.6959;ACANTHOSIS NIGRICANS#0.6935;TRIGLYCERIDE BIOSYNTHESIS#0.6529;PHOSPHOLIPID SYNTHESIS#0.6313
10556	RNASE P#1.0767;RIBONUCLEASE P#0.9587;TUMOR CELLS#0.7016;RNASE MRP#0.6189;TRNA PROCESSING#0.6135
10557	RNASE P#1.0843;RNASE MRP#0.9329;RNASE MRP COMPLEX#0.7645;RIBONUCLEASE P#0.7604;TRNA PROCESSING#0.6265
10558	HEREDITARY SENSORY NEUROPATHY#1.0971;HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1#1.0859;AUTONOMIC NEUROPATHY#1.0511;NEUROPATHY#1.0509;SPHINGOLIPID SYNTHESIS#1.0412;SERINE PALMITOYLTRANSFERASE#1.0389;SPHINGOLIPID BIOSYNTHESIS#1.0137;L-SERINE#1.0022;PALMITOYLTRANSFERASE ACTIVITY#0.9758;B CELL#0.9424;CERAMIDE SYNTHESIS#0.9365;PALMITOYL#0.9184;ENDOPLASMIC RETICULUM#0.9082;SPHINGOLIPID METABOLISM#0.8700;INHERITED NEUROPATHY#0.8447;SERINE PALMITOYL TRANSFERASE#0.7473;NEUROTOXIC#0.7185;LYMPHOBLAST#0.7069;CELL DEATH#0.6927;GENE EXPRESSION#0.6910;LIPID METABOLISM#0.6888;NERVOUS SYSTEM#0.6815;ALANINE#0.6497;CHARCOT MARIE TOOTH#0.6462;DEMENTIA#0.6421;SPHINGOSINE#0.6214;HEARING LOSS#0.6170;DIABETIC NEUROPATHY#0.6077;FOCAL ADHESION#0.6006
10559	UDP GALACTOSE#0.8644;GLYCOSYLATION#0.7394;NUCLEOTIDE SUGAR TRANSPORTER#0.6994;SUGAR TRANSPORTER#0.6823;UDP-GAL#0.6686;SIALYLATION#0.6564;CST COMPLEX#0.6526;TELOMERE#0.6185;GOLGI MEMBRANE#0.6016
10560	THIAMINE#1.0590;MEGALOBLASTIC ANEMIA#1.0571;ANEMIA#1.0363;ACINAR CELL#1.0267;T CELL#1.0252;THIAMINE TRANSPORT#1.0209;FOLATE#1.0176;DIABETES MELLITUS#1.0081;ANAEMIA#0.9902;REDUCED FOLATE CARRIER#0.9809;IFN-GAMMA#0.9790;CD8+ T CELL#0.9742;T LYMPHOCYTE#0.9301;HEARING LOSS#0.9149;VITAMIN B1#0.8854;GENE EXPRESSION#0.8546;PLASMA MEMBRANE#0.8289;EPITHELIAL CELL#0.7524;TH1 CELL#0.7177;BREAST CANCER#0.7105;TRANSCRIPTION FACTOR#0.6996;GLYCOSYLATION#0.6987;CELL DEATH#0.6918;IMMUNE RESPONSE#0.6900;TYPE 2 DIABETES#0.6853;TUMOR CELLS#0.6774;CELL SURFACE#0.6768;SENSORINEURAL HEARING LOSS#0.6759;NEONATAL DIABETES MELLITUS#0.6591;BONE MARROW#0.6525;TH17 CELL#0.6162;DOWN SYNDROME#0.6018
10561	MAP KINASE#1.0722;MITOGEN ACTIVATED PROTEIN#1.0613;PROTEIN KINASE#1.0536;SIGNALING PATHWAY#0.9993;IFN-GAMMA#0.9938;GENE EXPRESSION#0.9840;IMMUNE RESPONSE#0.9390;PERIPHERAL BLOOD#0.9154;MICROTUBULE#0.8861;HEPATITIS C#0.8771;GROWTH FACTOR#0.8579;MACROPHAGE#0.8492;TRANSCRIPTION FACTOR#0.8052;IFN STIMULATED GENES#0.7862;T CELL#0.7831;PROTEIN KINASE C#0.7821;MICROTUBULE ASSOCIATED PROTEIN#0.7756;INTERFERON STIMULATED GENE#0.7644;KINASE INHIBITOR#0.7514;POLYMERASE CHAIN REACTION#0.7488;MONONUCLEAR CELLS#0.7459;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7236;CELL CYCLE#0.7206;HEPATITIS C VIRUS#0.7145;APOPTOSIS#0.7114;SIGNAL TRANSDUCER#0.6849;PHOSPHOLIPASE C#0.6845;VIRAL INFECTION#0.6715;EPITHELIAL CELL#0.6368;MONOCYTE#0.6349;TUMOR NECROSIS FACTOR#0.6217;INNATE IMMUNE RESPONSE#0.6108
10562	NEUTROPHIL#1.0642;STEM CELL MARKER#1.0434;INTESTINAL STEM CELL#1.0389;CANCER CELL#1.0385;STEM CELL#1.0267;APOPTOSIS#1.0190;COLORECTAL CANCER#1.0158;COLORECTAL#1.0065;ADENOCARCINOMA#0.9954;PROSTATE CANCER#0.9936;GENE EXPRESSION#0.9874;BREAST CANCER#0.9731;EPITHELIAL CELL#0.9469;CELL PROLIFERATION#0.9469;PANCREATIC CANCER#0.9440;SMALL INTESTINE#0.9394;CELL ADHESION#0.9207;PERIPHERAL BLOOD#0.9183;LYMPH NODE#0.9112;SIGNALING PATHWAY#0.8960;G-CSF#0.8906;TRANSCRIPTION FACTOR#0.8785;LUNG CANCER#0.8713;INTESTINAL CRYPT#0.8620;GROWTH FACTOR#0.8586;CELL GROWTH#0.8288;TUMOR SUPPRESSOR#0.8071;BONE MARROW#0.8032;POLYMERASE CHAIN REACTION#0.8021;EPITHELIAL MESENCHYMAL TRANSITION#0.7969;ESTROGEN RECEPTOR#0.7929;IMMUNE RESPONSE#0.7849;CELL CYCLE#0.7647;INFLAMMATORY BOWEL DISEASE#0.7582;LYMPH NODE METASTASIS#0.7549;GASTRIC MUCOSA#0.7353;PROGENITOR CELL#0.7328;APOPTOTIC#0.7104;INNATE IMMUNITY#0.6836;BREAST CANCER PATIENTS#0.6786;GROWTH FACTOR RECEPTOR#0.6786;TUMOR CELLS#0.6586;GOBLET CELL#0.6424;GASTROINTESTINAL TRACT#0.6380;LGR5+ STEM CELL#0.6372;RETINOIC ACID#0.6363;CATHEPSIN C ACTIVITY#0.6334;SPECIFIC GRANULE#0.6208;GRANULOCYTE COLONY STIMULATING FACTOR#0.6143;COLONY-STIMULATING FACTOR#0.6113;EPIDERMAL GROWTH FACTOR#0.6087;INTESTINAL EPITHELIAL CELL#0.6078;5-AZA-2'-DEOXYCYTIDINE#0.6074;PANCREATIC ADENOCARCINOMA#0.6072;TUMOR TISSUES#0.6071;2'-DEOXYCYTIDINE#0.6068;COLON CANCER#0.6056;CASPASE-3 ACTIVITY#0.6019;CERVICAL CANCER#0.6001
10563	CXCL13 PRODUCTION#1.1290;B1 CELL#1.0397;LUPUS NEPHRITIS#1.0385;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0256;B LYMPHOCYTE#1.0219;FOLLICULAR HELPER T CELL#1.0201;LUPUS ERYTHEMATOSUS#1.0191;CANCER CELL#1.0177;CC CHEMOKINE LIGAND#1.0173;ENDOTHELIAL CELL#1.0143;CHEMOTAXIS#1.0135;MACROPHAGE INFLAMMATORY PROTEIN#1.0117;PROSTATE CANCER#1.0114;NEPHRITIS#1.0098;ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA#1.0062;TUMOR CELLS#1.0053;STROMAL CELL#1.0049;BREAST CANCER#1.0045;MONOCYTE#1.0041;B CELL#1.0038;PRO-INFLAMMATORY#1.0023;CELL MIGRATION#1.0023;CELL ADHESION#1.0019;SALIVARY GLAND#1.0016;TUMOR NECROSIS FACTOR#0.9976;FOLLICULAR DENDRITIC CELL#0.9964;LYMPHOID TISSUE#0.9956;B CELL ACTIVATION#0.9954;TOLL LIKE RECEPTOR#0.9935;SECONDARY LYMPHOID ORGANS#0.9930;GROWTH FACTOR#0.9917;SIGNALING PATHWAY#0.9914;EPITHELIAL CELL#0.9910;MACROPHAGE#0.9908;SPINAL CORD#0.9899;T LYMPHOCYTE#0.9893;LYMPHOID ORGANS#0.9884;CD8+ T CELL#0.9884;GERMINAL CENTER#0.9880;POLYMERASE CHAIN REACTION#0.9878;CHEMOKINE RECEPTOR#0.9874;G-CSF#0.9859;GERMINAL CENTER FORMATION#0.9859;B CELL LYMPHOMA#0.9857;MEMORY B CELL#0.9856;CELL ACTIVATION#0.9837;CENTRAL NERVOUS SYSTEM#0.9836;VENULE#0.9836;NEUROFILAMENT#0.9834;MENINGITIS#0.9832;AUTOIMMUNE DISEASE#0.9830;RHEUMATOID ARTHRITIS#0.9810;DENDRITIC CELL#0.9810;NERVOUS SYSTEM#0.9808;APOPTOSIS#0.9800;MULTIPLE SCLEROSIS#0.9798;LEUKOCYTE#0.9794;CELL PROLIFERATION#0.9794;T FOLLICULAR HELPER#0.9792;LYMPH NODE#0.9792;ANTIBODY PRODUCTION#0.9790;CD4+ T CELL#0.9786;TRANSCRIPTION FACTOR#0.9776;STEM CELL#0.9775;PERIPHERAL T-CELL LYMPHOMA#0.9775;REVERSE TRANSCRIPTION#0.9775;T HELPER CELL#0.9766;BONE MARROW#0.9765;T CELL#0.9761;PLASMA CELL#0.9758;PERIPHERAL BLOOD#0.9739;CLINICALLY ISOLATED SYNDROME#0.9733;INFLAMMATORY RESPONSE#0.9722;NEUTROPHIL#0.9721;IMMUNE CELL#0.9689;GENE EXPRESSION#0.9682;LYMPHOCYTIC LEUKEMIA#0.9616;IMMUNE RESPONSE#0.9609;ORGANOGENESIS#0.9605;CELL ADHESION MOLECULE#0.9598;IMMUNE SYSTEM#0.9588;SYNOVIUM#0.9584;MONONUCLEAR CELLS#0.9540;RITUXIMAB#0.9528;MESENCHYMAL STEM CELL#0.9469;CELL DIFFERENTIATION#0.9460;IFN-GAMMA#0.9450;GM-CSF#0.9402;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9395;TRANSFORMING GROWTH FACTOR#0.9370;TONSIL#0.9369;INFLAMMATORY CELL#0.9324;LYMPHOID TISSUE INDUCER#0.9294;ENCEPHALOMYELITIS#0.9293;QUANTITATIVE REAL TIME#0.9259;C REACTIVE PROTEIN#0.9234;SELECTIN#0.9233;MYASTHENIA GRAVIS#0.9219;SPHINGOSINE 1 PHOSPHATE#0.9173;NOT OTHERWISE SPECIFIED#0.9149;LYMPH NODE METASTASIS#0.9147;EPSTEIN BARR VIRUS#0.9110;NEOPTERIN#0.9033;DRAINING LYMPH NODE#0.9021;HUMORAL IMMUNE RESPONSE#0.8998;HEPATITIS B#0.8975;DISEASE ACTIVITY INDEX#0.8943;COLONY-STIMULATING FACTOR#0.8908;EXTRACELLULAR MATRIX#0.8858;ACTIVATED T-CELLS#0.8829;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8828;ACTIVATED T CELL#0.8826;EPIDERMAL GROWTH FACTOR#0.8813;TUMOUR NECROSIS FACTOR#0.8811;LUNG CANCER#0.8804;DISEASE ACTIVITY SCORE#0.8793;AUTOIMMUNITY#0.8786;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8774;PROTEIN KINASE#0.8753;GROWTH FACTOR RECEPTOR#0.8731;OSTEOBLAST#0.8671;CELL SURFACE#0.8570;PERITONEAL CAVITY#0.8532;TREG CELL#0.8525;SYNOVIAL FLUID#0.8523;COLORECTAL CANCER#0.8469;LYMPHOID CELL#0.8437;CELL DEVELOPMENT#0.8429;EOSINOPHIL#0.8428;OSTEOARTHRITIS#0.8427;CELL DEATH#0.8372;SQUAMOUS CELL CARCINOMA#0.8339;RECEPTOR LIGAND#0.8310;REGULATORY T CELL#0.8288;STROMA#0.8283;SPHINGOSINE#0.8272;CYTOKINE PRODUCTION#0.8262;BREAST CANCER PATIENTS#0.8237;LYMPHOCYTE HOMING#0.8233;ATTRACTANT#0.8223;MAGNETIC RESONANCE IMAGING#0.8205;MALT LYMPHOMA#0.8181;TRANSCRIPTASE#0.8162;MARGINAL ZONE B CELL#0.8113;MARGINAL ZONE B#0.8110;TUBERCULOSIS#0.8065;FOLLICULAR LYMPHOMA#0.8060;C CHEMOKINE RECEPTOR#0.8051;CELL CYCLE#0.8045;ASEPTIC MENINGITIS#0.8031;TH17 CELL#0.8015;VIRULENCE#0.8007;SYPHILIS#0.8001;LYMPHOTOXIN BETA RECEPTOR#0.7987;SYNOVITIS#0.7980;PLASMABLAST#0.7965;RETINOIC ACID#0.7955;VASCULAR CELL#0.7947;GRANULOCYTE#0.7916;B CELL PROLIFERATION#0.7910;B CELL RECEPTOR#0.7884;GASTRIC MUCOSA#0.7837;ACTIVATED B CELL#0.7824;TICK-BORNE ENCEPHALITIS#0.7815;HEPATOCELLULAR CARCINOMA#0.7798;B CELL DEPLETION#0.7744;HEMATOPOIETIC CELL#0.7737;ASTROCYTE#0.7735;SMOOTH MUSCLE#0.7723;COLORECTAL#0.7716;SYSTEMIC AUTOIMMUNE DISEASE#0.7680;SMALL INTESTINE#0.7649;MAST CELL#0.7635;CELL ASSOCIATED#0.7594;ATHEROSCLEROSIS#0.7584;GERMINAL CENTER B#0.7535;BREAST CANCER CELL#0.7533;B CELL DEVELOPMENT#0.7509;ORGAN DEVELOPMENT#0.7481;COLON CANCER#0.7455;CD3+ T CELL#0.7444;NODULAR#0.7433;HYPERTENSION#0.7402;B CELL DIFFERENTIATION#0.7393;CORD BLOOD#0.7391;WHITE BLOOD CELL#0.7376;ANTIGEN PRESENTATION#0.7352;RESPONSE TO TREATMENT#0.7349;NEUROMYELITIS OPTICA#0.7316;DISABILITY STATUS SCALE#0.7314;CELL CHEMOTAXIS#0.7297;NKT CELL#0.7267;NEUROLOGICAL DISORDER#0.7245;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.7191;GERMINAL CENTER B CELL#0.7187;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7174;INNATE IMMUNITY#0.7155;SJOGREN'S SYNDROME#0.7124;CENTRAL NERVOUS SYSTEM LYMPHOMA#0.7110;BLOOD VESSEL#0.7077;CHEMOKINE PRODUCTION#0.7060;COLLAGEN INDUCED ARTHRITIS#0.7059;HUMAN MESENCHYMAL STEM#0.7053;CUTANEOUS T CELL LYMPHOMA#0.7052;KINASE INHIBITOR#0.6951;DISEASE FREE SURVIVAL#0.6921;NON HODGKIN LYMPHOMA#0.6890;PLASMACYTOID DENDRITIC CELL#0.6889;NAIVE B CELL#0.6872;ORAL SQUAMOUS CELL CARCINOMA#0.6857;GASTRITIS#0.6829;COLITIS#0.6825;ERYTHROCYTE#0.6822;MYCOSIS FUNGOIDES#0.6807;TISSUE DEVELOPMENT#0.6807;CYTOTOXICITY#0.6795;FOLLICULAR T CELL#0.6788;METHOTREXATE#0.6770;ADAPTIVE IMMUNE RESPONSE#0.6744;BETA-2#0.6737;FOLLICULAR B CELL#0.6734;LYME DISEASE#0.6732;ALKALINE PHOSPHATASE#0.6715;GLIAL CELL#0.6715;IL-1RA#0.6711;EARLY BREAST CANCER#0.6707;SIGNAL TRANSDUCTION#0.6687;LUNG FIBROBLASTS#0.6686;ENDOTHELIUM#0.6630;ANAPLASTIC LARGE CELL LYMPHOMA#0.6628;SPINAL NERVE LIGATION#0.6588;HEPATITIS B VIRUS#0.6572;LYMPHOCYTE MIGRATION#0.6559;T CELL ACTIVATION#0.6558;CYTOPLASM#0.6514;APOPTOTIC#0.6500;ADJACENT NORMAL TISSUE#0.6478;ERYTHROCYTE SEDIMENTATION RATE#0.6465;POSITIVE PREDICTIVE VALUE#0.6461;MEMORY T CELL#0.6461;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6444;BLOOD BRAIN BARRIER#0.6438;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6431;MECHANISM OF ACTION#0.6412;B CELL CHEMOTAXIS#0.6411;FORMALIN#0.6400;MENINGES#0.6371;THYMIC EPITHELIAL CELLS#0.6344;CELL LOCALIZATION#0.6324;LUMINAL#0.6302;EMETIC#0.6298;CYTOKINE RECEPTOR#0.6296;DIFFUSE LARGE B-CELL LYMPHOMA#0.6292;PULMONARY FIBROSIS#0.6287;CHRONIC HEPATITIS B#0.6283;LYMPH NODE DEVELOPMENT#0.6282;HODGKIN'S LYMPHOMA#0.6275;TUMOR TISSUES#0.6261;NEUROBLAST#0.6253;B CELL ADHESION#0.6251;FIBROBLASTIC RETICULAR CELLS#0.6239;HYPOXIA#0.6238;PROGENITOR CELL#0.6232;HUMAN BREAST CANCER#0.6220;ESTROGEN RECEPTOR#0.6194;MESENCHYMAL CELL#0.6165;LUNG DISEASE#0.6156;EARLY RHEUMATOID ARTHRITIS#0.6138;VIRAL INFECTION#0.6108;COMPARATIVE GENOMIC HYBRIDISATION#0.6100;LACRIMAL GLAND#0.6093;ADULT-ONSET STILL'S DISEASE#0.6090;TNF-R2#0.6056;IMMUNOGLOBULIN PRODUCTION#0.6042;MARROW STROMAL CELLS#0.6028;BONE MARROW STROMAL CELL#0.6028;BONE MARROW STROMAL#0.6024;EFFECTOR T CELL#0.6022;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6006;EPITHELIAL TO MESENCHYMAL#0.6004
10564	RECYCLING ENDOSOME#1.0652;TRANS GOLGI NETWORK#1.0615;NUCLEOTIDE EXCHANGE FACTOR#1.0564;GUANINE#1.0512;ENDOSOME#1.0456;GUANINE EXCHANGE FACTOR#0.9722;VESICLE TRAFFICKING#0.9559;MICROCEPHALY#0.9397;NEURONAL MIGRATION#0.9319;PERIVENTRICULAR NODULAR HETEROTOPIA#0.9106;GOLGI MEMBRANE#0.8999;ANCHORING#0.8295;PROTEIN KINASE#0.8015;PROTEIN KINASE A#0.7800;MEMBRANE TUBULATION#0.7420;NODULAR#0.7408;ENDOMEMBRANE ORGANIZATION#0.6982;ENDOTHELIAL CELL#0.6901;CELL MIGRATION#0.6900;CELL SURFACE#0.6878;ACTIN BINDING#0.6721;CELL ADHESION#0.6646;PLASMA MEMBRANE#0.6641;CLATHRIN ADAPTOR#0.6612;LATERAL VENTRICLE#0.6380;ENDOSOMAL MEMBRANE#0.6264;CEREBRAL CORTEX#0.6252;GOLGI APPARATUS#0.6102;SIGNALING PATHWAY#0.6008
10565	GUANINE#1.0480;NUCLEOTIDE EXCHANGE FACTOR#1.0463;GOLGI MEMBRANE#1.0321;TRANS GOLGI NETWORK#1.0053;RECYCLING ENDOSOME#0.9488;ENDOSOME#0.9137;GOLGI COMPLEX#0.8573;CLATHRIN ADAPTOR#0.8455;SCHWANN CELL#0.7800;PROTEIN KINASE#0.7405;MICROTUBULE#0.7370;CELL SURFACE#0.7223;PLASMA MEMBRANE#0.7169;CELL WALL#0.7109;VESICLE TRAFFICKING#0.7047;ENDOMEMBRANE ORGANIZATION#0.6964;CELL MIGRATION#0.6883;TUMOR SUPPRESSOR#0.6871;PROTEIN KINASE A#0.6741;ANCHORING#0.6323;SIGNALING PATHWAY#0.6171;EXOSOME PRODUCTION#0.6079
105664404	COLORECTAL CANCER#0.8193;STEM CELL#0.7086;EPITHELIAL CELL#0.6709;COLORECTAL#0.6479;COLONIC EPITHELIAL CELLS#0.6375;REPORTER GENE ASSAY#0.6265;HEPATOCELLULAR CARCINOMA#0.6159
10566	ANCHORING#1.0615;PROTEIN KINASE#0.9877;PROTEIN KINASE A#0.9644;SPERMATOZOA#0.9298;SPERM TAIL#0.9146;SPERM MOTILITY#0.9033;SPERM CAPACITATION#0.8533;OVARIAN CANCER#0.7874;FLAGELLUM#0.7745;GENE EXPRESSION#0.7695;SPERM FLAGELLUM#0.7144;PKA BINDING#0.6844;SPERMATOGENESIS#0.6491;POLYMERASE CHAIN REACTION#0.6461;T CELL ACTIVATION#0.6235;CELL ACTIVATION#0.6208;T CELL#0.6141
10567	GOLGI COMPLEX#0.9481;VESICLE TRAFFICKING#0.7980;PLASMA MEMBRANE#0.7962;ENDOPLASMIC RETICULUM#0.7923;CELL WALL#0.7594;T CELL#0.7343;GOLGI APPARATUS#0.7109;CELL SURFACE#0.7084;ZINC BINDING#0.7025;IMMUNE EVASION#0.6993;VIRULENCE#0.6795;BIOFILM FORMATION#0.6137;EPSTEIN BARR VIRUS#0.6048;CELL MIGRATION#0.6045
105682749	CELL PROLIFERATION#1.0959;CANCER CELL#1.0889;CERVICAL#1.0224;CERVICAL CANCER#0.9191;METASTATIC PANCREATIC ADENOCARCINOMA#0.6663;ADENOCARCINOMA#0.6437;COLON ADENOCARCINOMA#0.6236;PANCREATIC ADENOCARCINOMA#0.6215
10568	PULMONARY ALVEOLAR MICROLITHIASIS#1.0673;SMALL INTESTINE#1.0539;LUNG CANCER#1.0121;GENE EXPRESSION#1.0114;PHOSPHATE TRANSPORT#1.0066;DUODENUM#0.9952;OOCYTE#0.9909;EPITHELIAL CELL#0.9770;JEJUNUM#0.9702;BRUSH BORDER#0.9528;CANCER CELL#0.9426;BRUSH BORDER MEMBRANE#0.9133;SIGNALING PATHWAY#0.9118;BREAST CANCER#0.9116;STEM CELL#0.8860;STEM CELL LIKE#0.8605;GROWTH FACTOR#0.8555;CELL PROLIFERATION#0.8254;LUNG ADENOCARCINOMA#0.8222;POLYMERASE CHAIN REACTION#0.8191;EXCRETION#0.8123;ADENOCARCINOMA#0.8047;PLASMA MEMBRANE#0.7721;INTESTINAL ABSORPTION#0.7600;ALVEOLAR EPITHELIAL CELL#0.7453;VITAMIN D RECEPTOR#0.7404;CANCER STEM CELL#0.7164;AKT SIGNALING#0.6817;REVERSE TRANSCRIPTION#0.6551;PARATHYROID HORMONE#0.6543;CELL GROWTH#0.6538;APOPTOSIS#0.6512;KINASE INHIBITOR#0.6365;PARATHYROID#0.6292;OVARIAN#0.6176;ED-71#0.6117;COLORECTAL CANCER#0.6111;HYPERPHOSPHATEMIA#0.6005
10569	SPLICEOSOME#1.0309;PRE-MRNA SPLICING#1.0206;MRNA SPLICING#1.0179
1056	CHOLESTEROL ESTERASE ACTIVITY#1.0711;MAMMARY GLAND#1.0579;TRIGLYCERIDE LIPASE#1.0456;PHOSPHOLIPASE A2#1.0424;GLYCOSYLATION#1.0400;ESTERASE ACTIVITY#1.0395;LIPOPROTEIN LIPASE#1.0372;PANCREATITIS#1.0346;ESTERASE A#1.0345;ACINAR CELL#1.0345;MATURITY-ONSET DIABETES OF THE YOUNG#1.0245;HORMONE SENSITIVE LIPASE#1.0149;INTESTINAL MUCOSA#1.0138;PROTEIN KINASE#1.0106;MACROPHAGE#1.0081;LIPASE ACTIVITY#1.0067;GENE EXPRESSION#1.0057;ADIPOSE TISSUE#1.0049;DIGESTION#1.0025;TAUROCHOLATE#0.9996;PANCREATIC CANCER#0.9987;MONOCYTE#0.9952;ATHEROSCLEROSIS#0.9936;HEPARIN#0.9917;CYCLIC AMP#0.9902;LOW DENSITY LIPOPROTEIN#0.9885;OLEIC ACID#0.9880;URETHANE#0.9870;SMALL INTESTINE#0.9819;ENZYME ACTIVITY#0.9815;T CELL#0.9808;MICROSOME#0.9744;LIPID METABOLISM#0.9721;HIGH DENSITY LIPOPROTEIN#0.9709;ACID PHOSPHATASE#0.9615;ATHEROSCLEROTIC#0.9579;LIPOLYSIS#0.9545;ADENOCARCINOMA#0.9535;HIGH CHOLESTEROL DIET#0.9528;CATALYTIC ACTIVITY#0.9463;ENTEROCYTE#0.9421;ADRENAL GLAND#0.9289;ETHANOL#0.9271;DUODENUM#0.9209;CHOLESTEROL METABOLISM#0.9186;MONOCYTE DERIVED MACROPHAGE#0.9170;COENZYME A#0.9156;PHOSPHOLIPASE A#0.9149;ENDOPLASMIC RETICULUM#0.9050;REVERSE TRANSCRIPTION#0.9046;2,3-DIMERCAPTOPROPANOL#0.9020;INTESTINAL ABSORPTION#0.9019;EPITHELIAL CELL#0.8935;PANCREATIC ADENOCARCINOMA#0.8929;PERIPHERAL BLOOD#0.8924;VERY-LOW-DENSITY LIPOPROTEIN#0.8903;MOLAR#0.8860;LIPID DIGESTION#0.8790;SERINE HYDROLASE#0.8785;PLASMA MEMBRANE#0.8762;CHYLOMICRON#0.8754;CELL SURFACE#0.8660;LACTATION#0.8628;APOPTOSIS#0.8619;GESTATION#0.8583;POLYMERASE CHAIN REACTION#0.8543;PANCREATIC DUCTAL ADENOCARCINOMA#0.8539;HUMAN IMMUNODEFICIENCY VIRUS#0.8514;ACUTE PANCREATITIS#0.8444;O GLYCAN#0.8441;ESTRADIOL#0.8439;ENDOTHELIAL CELL#0.8420;ALVEOLAR MACROPHAGE#0.8401;SCANNING ELECTRON MICROSCOPY#0.8378;KINASE ACTIVITY#0.8376;MILK PROTEIN#0.8363;ADIPOCYTE#0.8270;SMOOTH MUSCLE#0.8200;ACAT ACTIVITY#0.8191;CHOLESTEROL UPTAKE#0.8099;HEART DISEASE#0.8087;GASTROINTESTINAL TRACT#0.8079;INTRACELLULAR MEMBRANE#0.8030;LIPID DROPLET#0.8029;ADRENAL CORTEX#0.7998;BETA-HYDROXYSTEROID DEHYDROGENASE#0.7983;CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.7930;STEROIDOGENESIS#0.7908;ACYLTRANSFERASE ACTIVITY#0.7885;BRUSH BORDER#0.7858;CHOLESTEROL TRANSPORT#0.7802;MUSCLE CELL#0.7751;LYSOSOME#0.7748;LDL PARTICLE#0.7724;LYSINE#0.7717;INFLAMMATORY RESPONSE#0.7700;CHEMOKINE RECEPTOR#0.7654;BRUSH BORDER MEMBRANE#0.7599;SMOOTH MUSCLE CELL#0.7578;GROWTH FACTOR#0.7578;DODECYL SULFATE#0.7571;SODIUM DODECYL SULFATE#0.7571;TUMOR CELLS#0.7558;TESTOSTERONE#0.7553;MONONUCLEAR CELLS#0.7550;HYDROLASE ACTIVITY#0.7544;HYPERTENSION#0.7452;CELL MEMBRANE#0.7427;CALCIUM MOBILIZATION#0.7400;DIMERCAPTOSUCCINIC ACID#0.7400;SIGNALING PATHWAY#0.7389;LIPID RAFT#0.7377;PALMITATE#0.7317;DIABETES MELLITUS#0.7298;PHOSPHATASE ACTIVITY#0.7232;DENDRITIC CELL#0.7205;SERUM ALBUMIN#0.7188;BETA CELL#0.7156;LECTIN#0.7100;CHOLESTEROL O ACYLTRANSFERASE#0.7099;CANCER CELL#0.7096;PROTEIN SYNTHESIS#0.7078;TRANSCRIPTION FACTOR#0.7042;WEIGHT GAIN#0.7014;OVARIAN#0.7001;ACID PHOSPHATASE ACTIVITY#0.6974;ARACHIDONIC ACID#0.6924;LIPOPROTEIN METABOLISM#0.6878;ACYL-COA:CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.6839;O ACYLTRANSFERASE#0.6819;TOXICITY#0.6796;CORONARY HEART DISEASE#0.6753;BETA-ESTRADIOL#0.6741;MUTAGENESIS#0.6724;C TERMINAL DOMAIN#0.6687;EXCRETION#0.6683;CHOLINE#0.6661;HISTIDINE#0.6660;CAROTENOID#0.6587;EPIDIDYMAL ADIPOSE TISSUE#0.6586;NEUTROPHIL#0.6479;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6427;LEUKOCYTE#0.6369;FOAM CELL FORMATION#0.6340;SCAVENGER RECEPTOR#0.6289;VITAMIN E#0.6283;IMMUNE RESPONSE#0.6277;LYMPHOID CELL#0.6246;T LYMPHOCYTE#0.6229;B CELL#0.6219;PHOSPHATE BUFFER SOLUTION#0.6203;PROTEIN KINASE C#0.6200;ENDOCYTOSIS#0.6167;ENZYME INHIBITOR#0.6122;COLLAGENASE#0.6090;N GLYCAN#0.6049;PHOSPHOLIPASE ACTIVITY#0.6016;HOMOLOGOUS RECOMBINATION#0.6012;SIGNAL PEPTIDE#0.6006
10570	NEURITE#0.7043;NERVOUS SYSTEM#0.6804;APOPTOSIS#0.6609;NEURITE OUTGROWTH#0.6493;CEREBRAL ISCHEMIA#0.6413;GENE EXPRESSION#0.6291;MORPHOGENESIS#0.6229;ISCHEMIA#0.6128
10572	APOPTOSIS#1.0548;APOPTOTIC#1.0539;T CELL#1.0291;CANCER CELL#1.0274;CELL DEATH#0.9551;SIGNALING PATHWAY#0.9076;GENE EXPRESSION#0.8681;BREAST CANCER#0.8613;TUMOR NECROSIS FACTOR#0.8149;UBIQUITIN#0.7959;CELL CYCLE#0.7632;TRANSCRIPTION FACTOR#0.7617;CELL PROLIFERATION#0.7425;CISPLATIN#0.7314;INDUCTION OF APOPTOSIS#0.7294;TUMOR SUPPRESSOR#0.7256;CYTOCHROME C#0.7093;LUNG CANCER#0.7068;BREAST CANCER CELL#0.6909;PROTEIN KINASE#0.6388;LYMPHOID CELL#0.6164;WOUND HEALING#0.6123;CELL MIGRATION#0.6056;SKELETAL MUSCLE#0.6047;T LYMPHOCYTE#0.6042
10573	CYCLIN DEPENDENT KINASE#1.0270;CELL CYCLE#1.0139;TUMOR SUPPRESSOR#1.0131;T CELL#0.9877;CYCLIN DEPENDENT KINASE INHIBITOR#0.9806;KINASE INHIBITOR#0.9735;T LYMPHOCYTE#0.9357;CELL CYCLE ARREST#0.8749;RETINOBLASTOMA#0.8270;PERIPHERAL BLOOD#0.8055;APOPTOSIS#0.8043;POLYMERASE CHAIN REACTION#0.8023;IMMUNE RESPONSE#0.7934;MELANOCYTE#0.7894;BONE MARROW#0.7788;CDK INHIBITOR#0.7770;CYTOTOXIC T-LYMPHOCYTE#0.7604;CELL SURFACE#0.7494;B CELL#0.7096;MELANOMA CELL LINES#0.6767;SENESCENCE#0.6622;VIRION#0.6244;CELL SURFACE ANTIGEN#0.6126;BREAST CANCER#0.6102;PERIPHERAL BLOOD LYMPHOCYTES#0.6098;RIBOSOMAL PROTEIN#0.6052;APOPTOTIC#0.6048
10574	CHAPERONIN-CONTAINING T-COMPLEX#0.9954;CHAPERONIN#0.9449;WOUND HEALING#0.7124;SOLUBLE GUANYLYL CYCLASE#0.6500;SMOOTH MUSCLE ACTIN#0.6408;SMOOTH MUSCLE#0.6358
10575	CHAPERONIN#1.0482;CHAPERONIN-CONTAINING T-COMPLEX#0.9456;CELL CYCLE#0.6060
105761008	REGULATION OF MACROPHAGE ACTIVATION#0.8786;EXTRACELLULAR VESICLE#0.8186;MACROPHAGE ACTIVATION#0.8132
10576	CHAPERONIN#1.0243;CELL CYCLE#0.8670;BREAST CANCER#0.8080;CANCER CELL#0.7894;GENE EXPRESSION#0.6904;LEBER CONGENITAL AMAUROSIS#0.6392;BREAST CANCER CELL#0.6088;CELL DEATH#0.6053
10577	CHOLESTEROL BINDING#1.0522;LYSOSOMAL STORAGE DISORDER#1.0371;CHOLESTEROL TRANSPORT#1.0319;LATE ENDOSOME#1.0241;NIEMANN-PICK DISEASE#1.0217;LIPID STORAGE#1.0138;CHOLESTEROL HOMEOSTASIS#1.0136;ENDOSOME#1.0111;STEROL BINDING#1.0106;LYSOSOME#1.0077;LYSOSOMAL STORAGE DISEASE#0.9948;EPIDIDYMIS#0.9925;LOW DENSITY LIPOPROTEIN#0.9908;CHOLESTEROL STORAGE#0.9877;CHOLESTEROL EFFLUX#0.9815;PLASMA MEMBRANE#0.9801;LIPID TRANSPORT#0.9771;NEURODEGENERATIVE DISEASE#0.9692;MACROPHAGE#0.9632;CHOLESTEROL METABOLISM#0.9553;GENE EXPRESSION#0.9549;ENDOPLASMIC RETICULUM#0.9432;ORGANELLE#0.9153;STEROL TRANSPORT#0.8995;INTRACELLULAR CHOLESTEROL TRANSPORT#0.8860;BONE MARROW#0.8630;MIGLUSTAT#0.8604;LYSOSOMAL MEMBRANE#0.8533;ASTROCYTE#0.8468;PURKINJE CELL#0.8408;LIPID METABOLISM#0.8313;CELL DEATH#0.8305;LIPID STORAGE DISEASE#0.8256;CHOLESTEROL EXPORT#0.8173;DEMENTIA#0.8075;SKIN FIBROBLASTS#0.7937;BREAST CANCER#0.7880;GALLSTONE FORMATION#0.7777;ODORANT BINDING PROTEIN#0.7645;ODORANT BINDING#0.7641;LUMINAL#0.7603;ADIPOSE TISSUE#0.7566;INTESTINAL CHOLESTEROL ABSORPTION#0.7539;SEMINAL PLASMA#0.7515;LIVER CANCER#0.7510;GROWTH FACTOR#0.7387;AUTOPHAGY#0.7175;ALLERGEN#0.7131;ADIPOCYTE#0.7098;AUTOSOMAL RECESSIVE DISEASE#0.7085;SAPOSIN#0.7048;CHOLESTEROL ESTERIFICATION#0.7026;SPERMATOZOA#0.6962;RESPIRATORY DISTRESS#0.6948;PROTEIN KINASE#0.6940;CANCER CELL#0.6838;ENDOCYTOSIS#0.6718;ALZHEIMER'S DISEASE#0.6657;LUNG DISEASE#0.6521;NIEMANN-PICK DISEASE TYPE C1#0.6469;NERVOUS SYSTEM#0.6456;INTRACELLULAR LIPID TRANSPORT#0.6396;CHOLESTEROL UPTAKE#0.6357;ACID SPHINGOMYELINASE#0.6329;HEPATOCELLULAR CARCINOMA#0.6298;LIPID BINDING#0.6291;ENZYME ACTIVITY#0.6280;STEM CELL#0.6279;CHOLESTEROL TRANSPORTER#0.6266;GLYCOSYLATION#0.6143;GARP COMPLEX#0.6071;DYSTONIA#0.6038
10578	CYTOLYTIC GRANULE#1.0814;GRANULYSIN PRODUCTION#1.0761;NOTCH RECEPTOR#1.0361;NATURAL KILLER CELL#1.0341;CD8+ T CELL#1.0327;CD4+ T CELL#1.0313;CYTOTOXIC T CELL#1.0293;CELL DEATH#1.0235;APOPTOSIS#1.0180;CYTOTOXICITY#1.0157;CYTOTOXIC T-LYMPHOCYTE#1.0149;TUBERCULOSIS#1.0143;PERIPHERAL BLOOD#1.0102;T CELL#1.0094;T LYMPHOCYTE#1.0075;TUMOR CELLS#1.0034;STEVENS-JOHNSON SYNDROME#0.9932;GENE EXPRESSION#0.9899;MACROPHAGE#0.9889;KERATINOCYTE#0.9875;TOXIC EPIDERMAL NECROLYSIS#0.9854;EXOCYTOSIS#0.9832;LYSIS#0.9816;IMMUNE RESPONSE#0.9773;IFN-GAMMA#0.9757;DENDRITIC CELL#0.9739;APOPTOTIC#0.9736;MONONUCLEAR CELLS#0.9708;POLYMERASE CHAIN REACTION#0.9692;IMMUNE SYSTEM#0.9643;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9598;IMMUNE CELL#0.9555;MONOCYTE#0.9548;TUMOR NECROSIS FACTOR#0.9414;LEUKOCYTE#0.9346;NOTCH LIGAND#0.9314;PERIPHERAL BLOOD LYMPHOCYTES#0.9290;CELL SURFACE#0.9278;SIGNALING PATHWAY#0.9264;TRANSCRIPTION FACTOR#0.9155;CELL ACTIVATION#0.8988;ADRENALINE#0.8943;PRECURSOR CELL#0.8922;REGULATORY T CELL#0.8763;NKT CELL#0.8733;B CELL#0.8620;CYTOCHROME C#0.8561;STEM CELL#0.8492;CELL-MEDIATED IMMUNITY#0.8395;LYSOSOME#0.8368;GROWTH FACTOR#0.8325;PRO-INFLAMMATORY#0.8289;HOST CELL#0.8113;ACTIVATED T LYMPHOCYTES#0.8088;ENDOTHELIAL CELL#0.8059;ANTIGEN PRESENTING CELLS#0.7996;ACTIVATOR PROTEIN 1#0.7987;CELL PROLIFERATION#0.7975;PSORIASIS#0.7948;ENDOMETRIUM#0.7938;LIPID RAFT#0.7894;T CELL ACTIVATION#0.7873;MITOCHONDRIA#0.7860;HUMAN LEUKOCYTE ANTIGEN#0.7608;ARGININE#0.7465;CELL MEMBRANE#0.7400;RED BLOOD CELL#0.7257;SAPOSIN#0.7219;CANCER CELL#0.7196;TROPHOBLAST#0.7103;MEMORY T CELL#0.7079;REACTIVE OXYGEN SPECIES#0.7019;ACTIVATED T CELL#0.6979;APOPTOTIC CELL DEATH#0.6884;SIGNAL TRANSDUCTION#0.6849;ADVERSE DRUG REACTION#0.6839;LYMPHOCYTE ACTIVATION#0.6779;INNATE IMMUNITY#0.6769;ACTIVATED T-CELLS#0.6739;B CELL LYMPHOMA#0.6669;GM-CSF#0.6662;DECIDUA#0.6612;ALLOPURINOL#0.6573;NERVOUS SYSTEM#0.6560;HEPATITIS B#0.6484;EPIDERMAL GROWTH FACTOR#0.6438;CORD BLOOD#0.6284;HYPERSENSITIVITY#0.6280;MYOCARDIAL INFARCTION#0.6269;GONAD#0.6264;LEPROSY#0.6199;LYSINE#0.6194;KERATINOCYTE APOPTOSIS#0.6179;APOPTOSIS INDUCING FACTOR#0.6118;TRANSCRIPTASE#0.6101;CASPASE INHIBITOR#0.6073;OXYPURINOL#0.6025
10579	BREAST CANCER#1.0019;TUMOR SUPPRESSOR#0.9153;CENTROSOME#0.8877;CELL CYCLE#0.8031;MICROTUBULE#0.7940;CANCER CELL#0.7721;EPITHELIAL CELL#0.6588;BREAST CANCER CELL#0.6296;CELL PROLIFERATION#0.6246;GENE EXPRESSION#0.6031
10580	PROSTATE CANCER#1.0605;INSULIN RECEPTOR#1.0574;GLUCOSE UPTAKE#1.0211;SKELETAL MUSCLE#1.0104;ADIPOCYTE#1.0098;LIPID RAFT#1.0082;ADIPOSE TISSUE#1.0072;GLUCOSE TRANSPORT#1.0054;FOCAL ADHESION#1.0008;SIGNALING PATHWAY#0.9798;ANDROGEN RECEPTOR#0.9767;PLASMA MEMBRANE#0.9479;GENE EXPRESSION#0.9464;EPITHELIAL CELL#0.9456;SIGNALING CASCADE#0.9249;CANCER CELL#0.8979;GROWTH FACTOR#0.8947;APOPTOSIS#0.8926;MUSCLE CELL#0.8915;STRESS FIBER#0.8599;CELL PROLIFERATION#0.8571;CELL ADHESION#0.8332;STROMAL CELL#0.8289;SIGNAL TRANSDUCTION#0.8188;PROTEIN KINASE#0.8177;HIGH FAT DIET#0.8079;AGE AT ONSET#0.7660;TRANSCRIPTION FACTOR#0.7652;INSULIN SIGNALING PATHWAY#0.7383;EXTRACELLULAR MATRIX#0.7021;POLYMERASE CHAIN REACTION#0.7000;TYPE 2 DIABETES#0.6921;DNA BINDING#0.6857;PEROXISOME#0.6847;COSTAMERE#0.6648;SIGNALLING PATHWAY#0.6558;MACROPHAGE#0.6511;VINCULIN BINDING#0.6435;METASTATIC PROSTATE CANCER#0.6419;BONE MARROW#0.6280;CELL CYCLE#0.6276;SH3 DOMAIN BINDING#0.6274;HIGH FAT FEEDING#0.6155
10581	GENE EXPRESSION#0.8634;MEMBRANE FUSION#0.7596;INTERFERON STIMULATED GENE#0.6814;ENDOSOME#0.6657;T CELL#0.6653;VIRAL INFECTION#0.6520;DENDRITIC CELL#0.6272;IMMUNE RESPONSE#0.6188
10584	LECTIN#1.0414;MANNAN BINDING LECTIN#0.9619;MANNAN BINDING#0.9602;PATTERN RECOGNITION MOLECULES#0.9022;MANNOSE BINDING LECTIN#0.8344;MANNOSE BINDING#0.8329
10585	WALKER-WARBURG SYNDROME#1.0381;LIMB-GIRDLE MUSCULAR DYSTROPHY#1.0275;MENTAL RETARDATION#1.0274;MANNOSYLATION#1.0252;GLYCOSYLATION#1.0247;CONGENITAL MUSCULAR DYSTROPHY#1.0071;CONGENITAL MUSCULAR DYSTROPHIES#1.0059;MANNOSYLTRANSFERASE ACTIVITY#1.0053;MUSCULAR DYSTROPHY#1.0038;BRAIN DISEASE#0.9752;PROTEIN O-MANNOSYLTRANSFERASE ACTIVITY#0.9175;EXTRACELLULAR MATRIX#0.8868;NEURONAL MIGRATION#0.8477;LISSENCEPHALY#0.8134;ENDOPLASMIC RETICULUM#0.7977;LAMININ BINDING#0.7936;ENZYME ACTIVITY#0.7714;BASEMENT MEMBRANE#0.7439;NERVOUS SYSTEM#0.7238;CENTRAL NERVOUS SYSTEM#0.6992;SKELETAL MUSCLE#0.6884;MICROCEPHALY#0.6551;MUSCLE WEAKNESS#0.6535;POLYMERASE CHAIN REACTION#0.6283;FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY#0.6021
10586	CELL PROLIFERATION#0.8017;EYE DEVELOPMENT#0.7638;OPTIC CUP#0.7480;COLOBOMA#0.7436;MORPHOGENESIS#0.6960;CHOROID FISSURE#0.6691;MICROPHTHALMIA#0.6424;TECTUM#0.6357;NEURAL TUBE#0.6087
10587	BETA-2#1.0584;THYROID CARCINOMA#1.0262;FOLLICULAR THYROID CARCINOMA#1.0249;GLUTATHIONE PEROXIDASE#1.0204;LIGAND BINDING DOMAIN#1.0149;THYROID CANCER#1.0149;MITOCHONDRIA#1.0137;TRANSACTIVATION#1.0096;POLYMERASE CHAIN REACTION#1.0051;METAMORPHOSIS#1.0017;HORMONE BINDING#1.0003;GLUTATHIONE#0.9999;RETINOID X RECEPTOR#0.9973;DNA BINDING#0.9949;THIOREDOXIN REDUCTASE 1#0.9922;THYROID HORMONE RECEPTOR#0.9902;APOPTOSIS#0.9877;REACTIVE OXYGEN SPECIES#0.9876;SIGNALING PATHWAY#0.9842;STEROID RECEPTOR COACTIVATOR#0.9827;SELENOCYSTEINE#0.9821;HYPOTHYROIDISM#0.9809;RETINOIC ACID#0.9805;NUCLEAR HORMONE RECEPTOR#0.9804;CELL PROLIFERATION#0.9800;GENE EXPRESSION#0.9789;TRANSCRIPTION FACTOR#0.9781;TRIIODOTHYRONINE#0.9758;CELL DEATH#0.9606;ESTROGEN RECEPTOR#0.9559;SKELETAL MUSCLE#0.9487;CANCER CELL#0.9443;HAIR CELL#0.9353;GROWTH FACTOR#0.9337;3,5,3'-TRIIODOTHYRONINE#0.9336;GLUCOCORTICOID RECEPTOR#0.9321;GC-24#0.9287;TACHYCARDIA#0.9262;MALIC ENZYME#0.9237;RETINOIC ACID RECEPTOR#0.9175;SUPEROXIDE DISMUTASE#0.9152;BREAST CANCER#0.9106;GOITER#0.9040;ELECTROPHORETIC MOBILITY SHIFT#0.8942;THYROTROPIN RELEASING HORMONE#0.8770;MYOSIN HEAVY CHAIN#0.8757;ONCOGENIC#0.8722;NERVOUS SYSTEM#0.8720;HYPERTHYROIDISM#0.8691;THYROID HORMONE RESISTANCE SYNDROME#0.8688;CARDIOMYOCYTE#0.8678;METHIONINE#0.8592;ENDOTHELIAL CELL#0.8591;AURANOFIN#0.8556;PITUITARY GLAND#0.8456;3,5,3'-TRIIODO-L-THYRONINE#0.8349;GROWTH HORMONE#0.8296;LIPID METABOLISM#0.8255;TSH SECRETION#0.8214;DILATED CARDIOMYOPATHY#0.8056;EPITHELIAL CELL#0.8045;PROTEIN PROTEIN INTERACTION#0.7964;TUMOR SUPPRESSOR#0.7946;THYROTOXICOSIS#0.7943;THYROID GLAND#0.7890;INNER EAR#0.7890;PEROXISOME#0.7885;CHOLESTEROL METABOLISM#0.7879;APOPTOTIC#0.7824;TOXICITY#0.7794;BRAIN DEVELOPMENT#0.7783;CELL GROWTH#0.7750;OPSIN#0.7703;PROSTATE CANCER#0.7648;HYPERCHOLESTEROLEMIA#0.7648;ARGININE#0.7608;QUANTITATIVE REAL TIME#0.7586;HYPERACTIVITY#0.7580;GENETIC DISEASE#0.7440;CENTRAL NERVOUS SYSTEM#0.7436;THYROID HORMONE BINDING#0.7421;FOLLICULAR THYROID CANCER#0.7380;TUMOR TISSUES#0.7379;CELL DIFFERENTIATION#0.7375;SKELETAL DEVELOPMENT#0.7347;LEUCINE#0.7322;ALANINE#0.7308;PROTEIN KINASE#0.7295;COCHLEA#0.7212;REVERSE TRANSCRIPTION#0.7212;CHONDROCYTE#0.7151;RESPONSE TO THYROID HORMONE#0.7100;HYPOXIA#0.7096;ADIPOSE TISSUE#0.7092;FAMILIAL GLUCOCORTICOID DEFICIENCY#0.7028;RECEPTOR LIGAND#0.7025;ISCHEMIA#0.7022;PROTEIN SYNTHESIS#0.7015;CARDIOMYOPATHY#0.7015;OSTEOBLAST#0.6990;STEM CELL#0.6955;STRUCTURE ACTIVITY RELATIONSHIP#0.6954;INSULIN-LIKE GROWTH FACTOR#0.6837;CYTOPLASM#0.6821;LIVER X RECEPTOR#0.6773;PURKINJE CELL#0.6743;CHROMATIN REMODELING#0.6737;3,3',5-TRIIODO-L-THYRONINE#0.6729;TUMOR CELLS#0.6701;ANDROGEN RECEPTOR#0.6695;HATCHING#0.6608;NUCLEAR RECEPTOR SUPERFAMILY#0.6547;DOMINANT NEGATIVE MUTANT#0.6509;CEREBRAL CORTEX#0.6465;MYOCARDIUM#0.6450;CELL CYCLE#0.6405;CYTOCHROME C#0.6232;DIABETES MELLITUS#0.6210;ESTROGEN RECEPTOR ALPHA#0.6207;THYMIDINE#0.6181;PROTEASOME#0.6179;HYPOXIA INDUCIBLE FACTOR#0.6169;ALTERNATIVE SPLICING VARIANT#0.6159;OUTER HAIR CELL#0.6127;OLIGODENDROCYTE#0.6109;GUANINE#0.6098;ADIPOCYTE#0.6083;SERTOLI CELL#0.6038
10588	FOLATE#1.0394;SYNTHETASE ACTIVITY#0.7819;ONE CARBON METABOLISM#0.7520;NEUROBLASTOMA#0.7083;TETRAHYDROFOLATE#0.6676;FOLATE METABOLISM#0.6647;FOLINIC ACID#0.6343
1058	CENP-A LOADING#1.1348;MIS18 COMPLEX#1.1104;CENP-A DEPOSITION#1.0963;INNER KINETOCHORE PLATE#1.0846;CENTROMERE SPECIFIC NUCLEOSOME#1.0726;CENTROMERE ASSEMBLY#1.0533;NUCLEOSOME ASSEMBLY#1.0515;CENTROMERIC NUCLEOSOME#1.0486;KINETOCHORE FORMATION#1.0464;CHROMATIN ASSEMBLY#1.0420;CENTROMERE LOCALIZATION#1.0418;HISTONE CHAPERONE#1.0398;NUCLEOSOME#1.0320;CENTROMERE#1.0270;KINETOCHORE ASSEMBLY#1.0268;INTERPHASE#1.0110;KINETOCHORE#1.0081;BUDDING#1.0059;DNA REPLICATION#1.0053;HETEROCHROMATIN#1.0034;S PHASE#1.0027;MITOTIC CHROMOSOME#1.0022;DNA BINDING#0.9992;POSTTRANSLATIONAL MODIFICATION#0.9966;CELL CYCLE#0.9960;RNA INTERFERENCE#0.9942;CHROMOSOMAL REGION#0.9937;HISTONE MODIFICATION#0.9929;G1 PHASE#0.9901;SPINDLE MICROTUBULE#0.9897;CHROMOSOME SEGREGATION#0.9887;MEIOSIS#0.9883;MITOTIC SPINDLE#0.9877;METAPHASE#0.9870;PROPHASE#0.9856;ANAPHASE#0.9845;COMPLEX I#0.9831;MITOTIC EXIT#0.9830;LYSINE#0.9805;MICROTUBULE#0.9788;CELL DIVISION#0.9773;CONSTRICTION#0.9765;KINETOCHORE MICROTUBULE#0.9761;MITOSIS#0.9754;GENE EXPRESSION#0.9709;CHROMATID#0.9709;CENTROMERIC HETEROCHROMATIN#0.9704;CHROMATIN ORGANIZATION#0.9552;TRANSCRIPTION FACTOR#0.9451;CANCER CELL#0.9446;MITOTIC CHECKPOINT#0.9427;HUMAN ARTIFICIAL CHROMOSOME#0.9409;APOPTOSIS#0.9398;UBIQUITIN#0.9302;BREAST CANCER#0.9265;TOPOISOMERASE#0.9209;CYTOKINESIS#0.9195;KINETOCHORE LOCALIZATION#0.9194;MICROTUBULE BINDING#0.9168;CELL DEATH#0.9132;EUCHROMATIN#0.9123;TELOPHASE#0.9070;OOCYTE#0.9009;PROTEIN COMPLEX#0.9007;PERICENTRIC HETEROCHROMATIN#0.8855;CENTROMERE BINDING#0.8842;SPINDLE ASSEMBLY#0.8815;CELL PROLIFERATION#0.8809;CELL CYCLE ARREST#0.8798;SISTER CHROMATID COHESION#0.8745;MEIOTIC CHROMOSOME#0.8738;METAPHASE CHROMOSOME#0.8677;HISTONE DEACETYLASE#0.8609;ARGININE#0.8591;POST-TRANSLATIONAL MODIFICATION#0.8408;NDC80 COMPLEX#0.8395;LUNG ADENOCARCINOMA#0.8327;NUCLEAR DIVISION#0.8272;TOPOISOMERASE II#0.8248;CELL CYCLE REGULATION#0.8236;HEPATOCELLULAR CARCINOMA#0.8229;MEIOSIS I#0.8228;CHROMATIN REMODELING#0.8122;DNA REPAIR#0.8071;CHROMATIN MODIFICATION#0.8061;PROTEIN PROTEIN INTERACTION#0.8013;TELOMERE#0.7999;SCLERODERMA#0.7908;STEM CELL#0.7906;MEIOTIC CHROMOSOME SEGREGATION#0.7756;G2 PHASE#0.7729;CHROMOSOME CONGRESSION#0.7680;HISTONE ACETYLATION#0.7669;C TERMINAL DOMAIN#0.7590;SPINDLE ASSEMBLY CHECKPOINT#0.7562;POLYMERASE CHAIN REACTION#0.7515;CELL DIVISION CYCLE#0.7481;LIGASE ACTIVITY#0.7444;CELL GROWTH#0.7417;COLORECTAL CANCER#0.7367;MITOTIC CELL CYCLE#0.7365;SPINDLE CHECKPOINT#0.7352;CHROMOSOME CONDENSATION#0.7304;NUCLEOSOME POSITIONING#0.7262;DNA METHYLATION#0.7236;CHROMOSOME MOVEMENT#0.7211;CYCLIN DEPENDENT KINASE#0.7164;KINETOCHORE-MICROTUBULE ATTACHMENT#0.7147;SPINDLE POLE#0.7089;CHROMOSOME TRANSMISSION#0.7061;PROTEASOME#0.7037;TUMOR CELLS#0.6977;COLORECTAL#0.6828;ADENOCARCINOMA#0.6826;HETEROCHROMATIN DOMAIN#0.6773;RSF COMPLEX#0.6749;M PHASE#0.6749;HETEROCHROMATIN FORMATION#0.6687;CHROMOSOMAL PASSENGER COMPLEX#0.6497;LINES OF EVIDENCE#0.6483;AUTOIMMUNE DISEASE#0.6428;NUCLEAR PERIPHERY#0.6416;GERM CELL#0.6161;HISTONE ACETYLTRANSFERASE#0.6059;SENESCENCE#0.6013;RHEUMATIC DISEASE#0.6009
10590	INSULIN SECRETION#0.9520;INTERNEURON#0.8936;NEUROENDOCRINE TUMOR#0.7088;NEUROENDOCRINE CELL#0.6591;STRIATUM#0.6553;VOMERONASAL ORGAN#0.6542
10591	ANCHORAGE INDEPENDENT GROWTH#0.6603;CANCER CELL#0.6349;NUCLEOTIDE METABOLISM#0.6135
10592	CONDENSIN COMPLEX#1.0704;CHROMOSOME CONDENSATION#0.9948;MITOTIC CHROMOSOME#0.9802;CHROMATID#0.9469;SISTER CHROMATID COHESION#0.9417;MITOSIS#0.9194;CELL CYCLE#0.8837;TUBERCULOSIS#0.8534;CHROMOSOME SEGREGATION#0.8405;DNA REPAIR#0.7845;COMPLEX I#0.7649;HEALTH CARE PROVIDER#0.7644;INTERPHASE#0.7221;SEXUALLY TRANSMITTED INFECTION#0.7125;CELL DIVISION#0.7072;TOPOISOMERASE#0.6936;BREAST CANCER#0.6713;CENTROMERE#0.6352;TOPOISOMERASE II#0.6278;DNA LIGASE#0.6069
10594	INTEIN#1.1073;U5 SNRNP#1.0716;SPLICEOSOME ASSEMBLY#1.0354;RETINITIS PIGMENTOSA#1.0270;RETINITIS#1.0261;MRNA PROCESSING#1.0256;SPLICEOSOME#1.0206;SMALL NUCLEAR RIBONUCLEOPROTEIN#1.0157;PRE-MRNA SPLICING#1.0048;MRNA SPLICING#1.0020;RNA HELICASE#0.9998;SMALL NUCLEAR RNA#0.9882;RNA SPLICING#0.9770;PROTEIN SPLICING#0.9595;PROTEIN SYNTHESIS#0.9247;CELL CYCLE#0.9195;GENE EXPRESSION#0.8998;PROTEIN COMPLEX#0.8984;TRANSCRIPTASE#0.8657;SPLICE SITE SELECTION#0.8308;T CELL#0.7959;C TERMINAL DOMAIN#0.7791;RNA PROCESSING#0.7784;RNA BINDING#0.7329;CANCER CELL#0.7260;COMPLEX I#0.7253;MUTAGENESIS#0.7235;PROTEIN PROTEIN INTERACTION#0.7176;CAP BINDING COMPLEX#0.7097;DNA DAMAGE RESPONSE#0.6776;HOST CELL#0.6531;APOPTOSIS#0.6491;PROTEIN KINASE#0.6476;BREAST CANCER#0.6280;NINETEEN COMPLEX#0.6150;RETINAL DEGENERATION#0.6073;U2 SNRNP#0.6039
10595	ENDOPLASMIC RETICULUM#0.9919;TRANSCRIPTION FACTOR#0.9061;UNFOLDED PROTEIN RESPONSE#0.8966;PROTEIN KINASE#0.8152;SIGNALING PATHWAY#0.8151;AUTOPHAGY#0.7483;RNASE ACTIVITY#0.6525;NODULE DEVELOPMENT#0.6181;MESODERM FORMATION#0.6018
10598	ATPASE ACTIVITY#1.0781;HEAT SHOCK PROTEIN#0.8304;ATPASE ACTIVATOR#0.7165;CANCER CELL#0.7033;CYSTIC FIBROSIS#0.6269
10599	REPAGLINIDE#1.0540;GEMFIBROZIL#1.0524;FLUVASTATIN#1.0497;PITAVASTATIN#1.0417;HUMAN EMBRYONIC KIDNEY#1.0398;EMBRYONIC KIDNEY#1.0396;IRINOTECAN#1.0372;DIGOXIN#1.0342;ESTRADIOL-17BETA#1.0329;PRAVASTATIN#1.0319;OOCYTE#1.0300;ROSUVASTATIN#1.0275;SIMVASTATIN#1.0269;ATORVASTATIN#1.0261;MYOPATHY#1.0260;RIFAMPIN#1.0256;PRIMARY HUMAN HEPATOCYTES#1.0204;ESTRONE#1.0201;MULTIDRUG RESISTANCE PROTEIN#1.0200;ORGANIC ANION TRANSPORTER#1.0151;ESTRADIOL#1.0146;CYCLOSPORINE#1.0135;RIFAMPICIN#1.0115;METHOTREXATE#1.0109;RITONAVIR#1.0101;ORGANIC CATION TRANSPORTER#1.0098;LOPINAVIR#1.0084;TAUROCHOLATE#1.0037;CYCLOSPORIN A#1.0026;BREAST CANCER#0.9953;PLASMA MEMBRANE#0.9946;FRAGMENT LENGTH POLYMORPHISM#0.9932;POLYMERASE CHAIN REACTION#0.9914;URSODEOXYCHOLIC ACID#0.9904;PREGNANE X RECEPTOR#0.9904;CYCLOSPORIN#0.9898;DRUG TRANSPORT#0.9894;ATP BINDING CASSETTE#0.9884;ATP BINDING#0.9870;CYTOCHROME P450#0.9867;ORGANIC ANION TRANSPORT#0.9815;TOXICITY#0.9794;CHOLESTASIS#0.9787;GENE EXPRESSION#0.9783;HEPATOTOXICITY#0.9781;DRUG METABOLISM#0.9766;RIFAMYCIN#0.9765;ANION TRANSPORT#0.9749;LOW DENSITY LIPOPROTEIN#0.9743;NATEGLINIDE#0.9727;PACLITAXEL#0.9693;TAUROCHOLIC ACID#0.9691;DOCETAXEL#0.9677;EXCRETION#0.9673;OLMESARTAN#0.9666;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9639;ADVERSE DRUG REACTION#0.9634;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9626;TUBERCULOSIS#0.9570;NEUTROPENIA#0.9554;BLOOD BRAIN BARRIER#0.9540;LIVER DISEASE#0.9530;CANCER CELL#0.9528;BOSENTAN#0.9524;REVERSE TRANSCRIPTION#0.9521;VALSARTAN#0.9511;CYTOTOXICITY#0.9461;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9400;KINASE INHIBITOR#0.9400;FLUORESCEIN#0.9363;SULFATE TRANSPORT#0.9359;CHOLESTEROL SYNTHESIS#0.9344;TRANSPORTER ACTIVITY#0.9340;RESPONSE TO STATIN#0.9335;UREMIC TOXIN#0.9268;HEPATOCELLULAR CARCINOMA#0.9227;RECEPTOR ANTAGONIST#0.9224;MIDAZOLAM#0.9203;COLORECTAL CANCER#0.9176;ABC TRANSPORTER#0.9153;METFORMIN#0.9149;FEXOFENADINE#0.9139;CHOROID PLEXUS#0.9138;COENZYME A#0.9114;HYPERCHOLESTEROLEMIA#0.9107;ESTRONE SULFATE#0.9035;TYROSINE KINASE INHIBITOR#0.9026;HEPATOCYTE NUCLEAR FACTOR#0.9021;CLOPIDOGREL#0.9013;MICROSOME#0.9006;HEPATITIS C#0.8967;EFFLUX PUMP#0.8956;TELMISARTAN#0.8949;LOVASTATIN#0.8947;QUERCETIN#0.8941;CERIVASTATIN#0.8882;BILE ACID SYNTHESIS#0.8876;CHOLIC ACID#0.8837;PHENOBARBITAL#0.8822;TRANSCRIPTION FACTOR#0.8818;GLUCOSE-6-PHOSPHATE#0.8787;TACROLIMUS#0.8748;URIDINE#0.8687;COPROPORPHYRIN I#0.8676;EFAVIRENZ#0.8666;CLARITHROMYCIN#0.8639;PROBENECID#0.8614;COLORECTAL#0.8570;DEHYDROEPIANDROSTERONE SULFATE#0.8557;WARFARIN#0.8540;TYPE 2 DIABETES#0.8504;DEOXYCHOLIC ACID#0.8490;EZETIMIBE#0.8488;FARNESOID X RECEPTOR#0.8488;PIOGLITAZONE#0.8434;ALANINE#0.8356;DETOXIFICATION#0.8348;EPITHELIAL CELL#0.8320;SORAFENIB#0.8186;GLUCURONIDE TRANSPORT#0.8156;QUINIDINE#0.8055;HYPERTENSION#0.8043;KETOCONAZOLE#0.8039;ROSIGLITAZONE#0.8034;ATAZANAVIR#0.8022;METASTATIC COLORECTAL CANCER#0.8013;RENAL TRANSPLANT RECIPIENTS#0.7990;TRANSMEMBRANE TRANSPORT#0.7977;SIROLIMUS#0.7951;RESPONSE TO SIMVASTATIN#0.7937;DEHYDROEPIANDROSTERONE#0.7919;RECEPTOR AGONIST#0.7889;MYCOPHENOLIC ACID#0.7887;ENDOTHELIAL CELL#0.7885;TAMOXIFEN#0.7874;VERAPAMIL#0.7845;INTESTINAL ABSORPTION#0.7811;REGORAFENIB#0.7730;CELL MEMBRANE#0.7711;CHENODEOXYCHOLIC ACID#0.7697;SAQUINAVIR#0.7631;BILE ACID TRANSPORT#0.7598;SMALL INTESTINE#0.7552;INTRAHEPATIC CHOLESTASIS#0.7551;GEOMETRIC MEAN RATIO#0.7544;GLUTATHIONE#0.7448;CORONARY ARTERY DISEASE#0.7426;ARTERY DISEASE#0.7425;CORONARY ARTERY#0.7407;DEXAMETHASONE#0.7402;GLIBENCLAMIDE#0.7396;RECEPTOR LIGAND#0.7353;GLYCINE#0.7306;HARDY WEINBERG EQUILIBRIUM#0.7278;ASPIRIN#0.7259;HEPATOMA CELLS#0.7249;CREATINE#0.7209;SKELETAL MUSCLE#0.7194;APOPTOSIS#0.7140;PAZOPANIB#0.7129;PROTEIN KINASE#0.7091;GD-EOB-DTPA#0.7060;GLIMEPIRIDE#0.7024;ARTERY#0.7008;CREATINE KINASE#0.6991;ENTEROCYTE#0.6936;DIPHOSPHATE#0.6928;MEMBRANE TRANSPORT#0.6917;DRUG RESISTANCE#0.6908;EPIGALLOCATECHIN#0.6897;CPT-11#0.6866;LIVER DAMAGE#0.6841;ENALAPRIL#0.6816;TRANSCRIPTASE#0.6809;FUROSEMIDE#0.6712;DIABETES MELLITUS#0.6685;PERIPHERAL BLOOD#0.6669;BILE DUCT#0.6636;ERYTHROMYCIN METABOLISM#0.6624;DIARRHEA#0.6622;ITRACONAZOLE#0.6618;TORASEMIDE#0.6616;ERYTHROMYCIN#0.6594;TROGLITAZONE#0.6550;ENZYME ACTIVITY#0.6534;ENDOTHELIN RECEPTOR#0.6501;ROCURONIUM#0.6501;DOXORUBICIN#0.6426;MAGNETIC RESONANCE IMAGING#0.6416;GLICLAZIDE#0.6402;MERCAPTOPURINE#0.6398;THERAPEUTIC DRUG MONITORING#0.6373;POPULATION PHARMACOKINETIC MODEL#0.6345;ISONIAZID#0.6336;TICAGRELOR#0.6312;CICLOSPORIN#0.6311;IRBESARTAN#0.6304;ATP BINDING CASSETTE TRANSPORTER#0.6303;HIV PROTEASE INHIBITOR#0.6294;DASATINIB#0.6274;ACETIC ACID#0.6247;NAFCILLIN#0.6245;HUMAN IMMUNODEFICIENCY VIRUS#0.6243;CELL SURFACE#0.6213;MYELOID LEUKEMIA#0.6204;ENZYME INHIBITOR#0.6195;MYOCARDIAL INFARCTION#0.6191;GROWTH FACTOR#0.6188;NEONATAL JAUNDICE#0.6169;IBUPROFEN#0.6141;TESTOSTERONE#0.6090;GADOXETATE DISODIUM#0.6059;LIVER X RECEPTOR#0.6049
1059	DNA BINDING#1.0392;CENTROMERE#1.0324;CENTROMERIC HETEROCHROMATIN#1.0277;HETEROCHROMATIN#1.0199;NUCLEOSOME#1.0087;KINETOCHORE#1.0064;CENTROMERE BINDING#1.0055;SCLERODERMA#1.0002;CELL CYCLE#0.9877;TOPOISOMERASE#0.9812;HUMAN ARTIFICIAL CHROMOSOME#0.9798;MITOSIS#0.9539;METAPHASE#0.9309;CENTROMERE ASSEMBLY#0.9217;CHROMOSOME SEGREGATION#0.9184;AUTOIMMUNE DISEASE#0.9140;CONNECTIVE TISSUE DISEASE#0.8989;CONNECTIVE TISSUE#0.8901;INTERPHASE#0.8894;RAYNAUD’S#0.8871;MITOTIC CHROMOSOME#0.8609;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8347;LUPUS ERYTHEMATOSUS#0.8344;RHEUMATIC DISEASE#0.8319;KINETOCHORE ASSEMBLY#0.8272;GROWTH FACTOR#0.8002;MICROTUBULE#0.7829;PRIMARY BILIARY CIRRHOSIS#0.7818;CONSTRICTION#0.7710;HETEROCHROMATIN FORMATION#0.7651;Y CHROMOSOME#0.7535;GENE EXPRESSION#0.7506;PROTEIN BINDING#0.7484;SMOOTH MUSCLE CELL#0.7457;MUSCLE CELL#0.7445;SMOOTH MUSCLE#0.7428;CELL PROLIFERATION#0.6961;AUTOIMMUNE HEPATITIS#0.6948;CELL DIVISION#0.6932;MEIOSIS#0.6856;S PHASE#0.6839;RHEUMATOID ARTHRITIS#0.6632;CENTROMERE LOCALIZATION#0.6605;ANAPHASE#0.6512;CHROMATIN ASSEMBLY#0.6493;METAPHASE CHROMOSOME#0.6466;TELOMERE#0.6400;DIGESTION#0.6153;COMPLEX I#0.6090;CENTROMERE SPECIFIC NUCLEOSOME#0.6072;CHROMATID#0.6053;SPINDLE CHECKPOINT#0.6041
105	ADENOSINE DEAMINASE#1.0379;RNA EDITING#1.0334;ADENOSINE#0.9909;RNA BINDING#0.8627;GENE EXPRESSION#0.8217;GLUTAMATE RECEPTOR#0.6433
10600	CELL CYCLE#0.9679;UBIQUITIN#0.9370;DEUBIQUITINASE#0.9351;DEUBIQUITINATION#0.8422;GENE EXPRESSION#0.8106;STEM CELL#0.7304;NUCLEAR EXPORT#0.6679;KINETOCHORE LOCALIZATION#0.6479;MITOSIS#0.6385;MITOTIC CHROMOSOME#0.6235;DNA DAMAGE RESPONSE#0.6012
10602	CENTROMERE#0.8751;KINETOCHORE#0.7972;DNA BINDING#0.7038;CANCER ASSOCIATED FIBROBLASTS#0.6407
10603	INSULIN RECEPTOR#1.0746;ADIPOCYTE#1.0023;GROWTH FACTOR#0.9381;PLASMA MEMBRANE#0.8749;SIGNALING PATHWAY#0.8422;PROTEIN KINASE#0.7984;GLUCOSE TRANSPORT#0.7972;ACTIN CYTOSKELETON#0.7126;B CELL#0.6912;ACTIN CYTOSKELETON ORGANISATION#0.6725;INSULIN RECEPTOR SUBSTRATE#0.6721;HIGH FAT FEEDING#0.6316;CYTOSKELETON ORGANISATION#0.6311;SKELETAL MUSCLE#0.6221;CELL PROLIFERATION#0.6193;GLUCOSE UPTAKE#0.6083;ADIPOSE TISSUE#0.6044
10605	POLY-A BINDING#1.0248;TRANSLATION INITIATION#0.8741;CELL CYCLE#0.8324;SIGNALING PATHWAY#0.7049;TRANSLATION INITIATION FACTOR#0.6692
10606	ADENINE#1.0192;GENE CONVERSION#0.9941;MITOTIC RECOMBINATION#0.9778;MUTAGENESIS#0.9598;MITOTIC GENE CONVERSION#0.9417;GENE EXPRESSION#0.9332;HOMOLOGOUS RECOMBINATION#0.9222;MUTAGENIC#0.8781;TRANSCRIPTION FACTOR#0.8629;MUTAGEN#0.8223;BREAST CANCER#0.8197;VACUOLE#0.8194;CANCER CELL#0.8186;CELL PROLIFERATION#0.7959;CENTROMERE#0.7853;LUNG ADENOCARCINOMA#0.7522;ADENOSINE#0.7378;PROSTATE CANCER#0.7087;CELL CYCLE#0.6759;NUCLEOTIDE SYNTHESIS#0.6694;PURINE NUCLEOTIDE SYNTHESIS#0.6605;CARRIE#0.6577;MEIOSIS#0.6091
10607	L-RHAMNOSE#0.6493
10608	TRANSCRIPTION FACTOR#0.9600;CELL CYCLE#0.8161;REPLICATIVE SENESCENCE#0.8023;GENE EXPRESSION#0.7415;PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY#0.7290;B CELL#0.6906;CELL PROLIFERATION#0.6300;T CELL#0.6210;LEUKOENCEPHALOPATHY#0.6167;CELL DEATH#0.6055
106099130	CD8+ T CELL#0.7491;T CELL#0.7409
10609	SYNAPTONEMAL COMPLEX#1.0184;ENDOPLASMIC RETICULUM#0.8560;GRANULAR COMPONENT#0.6345
1060	CENTROMERE LOCALIZATION#1.0895;MIS12 COMPLEX#1.0825;INNER KINETOCHORE PLATE#1.0666;DNA BINDING#1.0397;KINETOCHORE ASSEMBLY#1.0385;KINETOCHORE#1.0277;CENTROMERE#1.0260;NUCLEOSOME#1.0238;INTERPHASE#1.0236;METAPHASE#0.9979;CELL CYCLE#0.9940;MITOSIS#0.9929;NDC80 COMPLEX#0.9889;CHROMOSOME SEGREGATION#0.9872;ANAPHASE#0.9864;MICROTUBULE#0.9793;CELL DIVISION#0.9695;MEIOSIS#0.9571;HETEROCHROMATIN#0.9386;SPINDLE MICROTUBULE#0.9100;CENTROMERIC NUCLEOSOME#0.9099;KINETOCHORE FORMATION#0.8973;MITOTIC SPINDLE#0.8964;MITOTIC CHROMOSOME#0.8946;CENTROMERE ASSEMBLY#0.8820;CHROMATID#0.8639;BUDDING#0.8502;KINETOCHORE MICROTUBULE#0.8487;SPINDLE CHECKPOINT#0.8322;SCLERODERMA#0.8178;MICROTUBULE BINDING#0.8135;CHROMATIN ASSEMBLY#0.7869;MITOTIC CHECKPOINT#0.7796;MEIOSIS I#0.7793;CONSTRICTION#0.7481;KINETOCHORE LOCALIZATION#0.7385;MIS18 COMPLEX#0.7264;UBIQUITIN#0.7173;PROTEIN COMPLEX#0.6831;C TERMINAL DOMAIN#0.6764;PROPHASE#0.6697;SPINDLE ASSEMBLY#0.6422;PROTEASOME#0.6378;APOPTOSIS#0.6338;METAPHASE CHROMOSOME#0.6138;C-LEVEL#0.6119;G1 PHASE#0.6099;NUCLEAR IMPORT#0.6027;HUMAN ARTIFICIAL CHROMOSOME#0.6021
10610	BREAST CANCER#0.9702;CANCER CELL#0.8799;SIGNALING PATHWAY#0.8435;CELL SURFACE#0.7451;AKT SIGNALING#0.7199;GLYCOSYLATION#0.6987;SIALYLATION#0.6145;FOLLICULAR THYROID CANCER#0.6076;LEUKOCYTE#0.6027
10611	BIPOLAR DISORDER#1.0869;PROTEIN KINASE#1.0084;GENE EXPRESSION#0.9781;Z LINE#0.9714;PROTEIN KINASE C#0.9598;TRANSCRIPTION FACTOR#0.9381;DILATED CARDIOMYOPATHY#0.8282;HEPATITIS B VIRUS#0.8227;HEPATITIS B#0.8210;CELL PROLIFERATION#0.8118;SKELETAL MUSCLE#0.7881;CARDIOMYOCYTE#0.7801;PROSTATE CANCER#0.7720;MAJOR DEPRESSIVE DISORDER#0.7571;STRIATED MUSCLE#0.7352;HEART DEVELOPMENT#0.7067;LEUKOCYTE#0.7055;MUSCLE CELL#0.7053;POSTSYNAPTIC DENSITY#0.7022;SMOOTH MUSCLE CELL#0.6881;SMOOTH MUSCLE#0.6860;CARDIOMYOPATHY#0.6430;CANCER CELL#0.6411;PKCEPSILON#0.6114;PULMONARY HYPERTENSION#0.6105;CELL MIGRATION#0.6080
10612	CELL PROLIFERATION#1.0352;TUMOR SUPPRESSOR#0.9533;CANCER CELL#0.9459;STEM CELL#0.8814;UBIQUITIN#0.8305;CERVICAL CANCER#0.8050;CELL CYCLE#0.7212;APOPTOSIS#0.6525;NEURITE OUTGROWTH#0.6372;HEPATOCELLULAR CARCINOMA#0.6299;CERVICAL#0.6092
10613	COMPLEX I#0.9056;ER MEMBRANE#0.8589;ENDOPLASMIC RETICULUM#0.7843;PHOSPHATIDYLINOSITOL 3-PHOSPHATE BINDING#0.6879;PHOSPHATE BINDING#0.6065
106144538	BREAST CANCER PATIENTS#0.7148;BREAST CANCER#0.7077;CANCER CELL#0.6892;PANCREATIC CANCER#0.6644
10614	SMALL NUCLEAR RNA#1.0513;P-TEFB COMPLEX#1.0503;RNA BINDING#1.0488;ACETAMIDE#1.0466;BREAST CANCER#1.0260;KINASE ACTIVITY#1.0247;TRANSCRIPTION FACTOR#1.0188;GENE EXPRESSION#1.0080;GROWTH FACTOR#0.9747;CYCLIN DEPENDENT KINASE#0.9429;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.9367;ENDOTHELIAL GROWTH FACTOR#0.9266;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9266;TUMOR SUPPRESSOR#0.8985;HUMAN IMMUNODEFICIENCY VIRUS#0.8970;CANCER CELL#0.8805;RIBONUCLEOPROTEIN COMPLEX#0.8723;HYPOXIA#0.8606;C TERMINAL DOMAIN#0.8557;T CELL#0.8511;CARDIOMYOCYTE#0.8437;CELL PROLIFERATION#0.8410;SKELETAL MUSCLE#0.8048;TRANSACTIVATION#0.8011;PROSTATE CANCER#0.7993;CELL GROWTH#0.7699;ANGIOGENESIS#0.7645;KINASE INHIBITOR#0.7507;GLUCOCORTICOID RECEPTOR#0.7386;CELL DIFFERENTIATION#0.6984;RNA BINDING PROTEIN#0.6853;HYPOXIA INDUCIBLE FACTOR#0.6828;ACUTE MYELOID LEUKEMIA#0.6597;MYELOID LEUKEMIA#0.6586;CELL CYCLE#0.6542;CYTOPLASM#0.6541;SPECKLE DOMAIN#0.6477;ARGININE#0.6195;CELL PENETRATING PEPTIDE#0.6184;MUSCLE CELL#0.6122;NUCLEAR LOCALIZATION SIGNAL#0.6099;STEM CELL#0.6097;METASTATIC BREAST CANCER#0.6056;APOPTOSIS#0.6006
10615	MITOTIC SPINDLE#1.0854;MICROTUBULE#1.0679;KINETOCHORE#1.0587;BREAST CANCER#1.0351;CELL CYCLE#1.0316;MICROTUBULE ASSOCIATED PROTEIN#1.0078;HEPATOCELLULAR CARCINOMA#0.9976;SPINDLE POLE#0.9825;CANCER CELL#0.9778;APOPTOSIS#0.9761;CELL PROLIFERATION#0.9628;MITOSIS#0.9380;LYMPH NODE#0.9149;CHROMOSOME SEGREGATION#0.9065;CERVICAL CANCER#0.9050;CELL DEATH#0.9041;SERTOLI CELL#0.8980;CENTROSOME#0.8480;AMNIOTIC FLUID#0.8232;SIGNALING PATHWAY#0.8150;GENE EXPRESSION#0.8092;SPINDLE MICROTUBULE#0.7804;CELL DIVISION#0.7750;AKT SIGNALING#0.7476;CERVICAL#0.7416;SPINDLE ASSEMBLY#0.7331;SPERM TAIL#0.7297;ONCOGENIC#0.7238;DISEASE FREE SURVIVAL#0.7212;LYMPH NODE METASTASIS#0.7208;BLADDER UROTHELIAL CARCINOMA#0.7172;LUNG CANCER#0.7170;CHROMATID#0.7039;T CELL#0.6790;MICROTUBULE BINDING#0.6733;CELL GROWTH#0.6597;MICROTUBULE PLUS END#0.6410;QUANTITATIVE REAL TIME#0.6386;SPINDLE ASSEMBLY CHECKPOINT#0.6335;METAPHASE#0.6293;DYNEIN#0.6169;LUNG ADENOCARCINOMA#0.6097;OVARIAN CANCER#0.6056;APOPTOTIC#0.6051;ENDOPLASMIC RETICULUM#0.6037
10616	PROTEIN KINASE#1.0581;UBIQUITIN#1.0540;PROTEIN KINASE C#0.9383;SIGNALING PATHWAY#0.8704;ESTROGEN RECEPTOR#0.8677;DNA BINDING#0.8257;TRANSCRIPTION FACTOR#0.8141;BREAST CANCER#0.8092;CELL DEATH#0.7829;POLYUBIQUITIN#0.7821;MYOPATHY#0.7658;IRON REGULATORY PROTEIN#0.7079;CANCER CELL#0.7055;PROTEIN KINASE C BINDING#0.6926;TUMOR NECROSIS FACTOR#0.6346;PKCBETA#0.6238;NUCLEAR EXPORT#0.6168;BREAST CANCER CELL#0.6076;T CELL#0.6020
10617	DEUBIQUITINATING ENZYME#1.0870;ENDOSOME#1.0457;UBIQUITIN#1.0406;DEUBIQUITINATION#1.0368;CELL SURFACE#0.9956;GROWTH FACTOR#0.9437;POLYUBIQUITIN#0.9093;MICROCEPHALY#0.8581;GROWTH FACTOR RECEPTOR#0.8479;EARLY ENDOSOME#0.8274;EPIDERMAL GROWTH FACTOR#0.8199;DEUBIQUITINASE#0.7921;LYSOSOME#0.7620;SIGNAL TRANSDUCTION#0.7486;LATE ENDOSOME#0.7416;ENDOCYTOSIS#0.7350;ESCRT III COMPLEX#0.6771;SIGNALING PATHWAY#0.6470;INTRACELLULAR SIGNAL TRANSDUCTION#0.6315
106182249	LUNG CANCER#0.7463;CELL CYCLE#0.7437
10618	TRANS GOLGI NETWORK#1.0282;RECYCLING ENDOSOME#1.0226;EARLY ENDOSOME#1.0197;LATE ENDOSOME#1.0155;ENDOSOME#1.0135;CELL SURFACE#1.0092;GOLGI APPARATUS#1.0072;GOLGI COMPLEX#1.0070;TRANSFERRIN RECEPTOR#1.0029;PLASMA MEMBRANE#1.0003;ENDOPLASMIC RETICULUM#0.9876;SECRETORY PATHWAY#0.9752;ORGANELLE#0.9687;LYSOSOME#0.9402;CYTOPLASM#0.9285;GOLGI STACK#0.9101;MICROTUBULE#0.9031;EXOCYTIC VESICLE#0.8410;ENDOCYTOSIS#0.8326;BUDDING#0.8191;NOCODAZOLE#0.8173;EPITHELIAL CELL#0.8169;GOLGI MEMBRANE#0.8128;PROTEIN TRANSPORT#0.7651;ENDOCYTIC RECYCLING#0.7446;ADAPTIN#0.7433;GOLGI CISTERNAE#0.7379;ALPHA-MANNOSIDASE II#0.7302;INTRACELLULAR MEMBRANE#0.7288;SECRETORY GRANULE#0.7250;CLATHRIN ADAPTOR#0.7205;CELL BODY#0.7181;ALPHA MANNOSIDASE#0.7110;COATED VESICLE#0.7085;TRANSPORT VESICLE#0.7076;VESICULAR STOMATITIS VIRUS#0.7020;LUMINAL#0.6936;INTRACELLULAR VESICLE#0.6908;GTP BINDING#0.6834;PROTEIN COMPLEX#0.6683;VIRION#0.6640;MEMBRANE TRANSPORT#0.6615;NEUROENDOCRINE CELL#0.6279;CELL DIVISION#0.6112;CELL JUNCTION#0.6053
10620	OVARIAN CANCER#1.0561;CANCER CELL#1.0104;OVARIAN#0.9161;TRANSCRIPTION FACTOR#0.9139;BREAST CANCER CELL#0.7983;BREAST CANCER#0.7637;DNA BINDING#0.7554;GENE EXPRESSION#0.7472;NEUROBLASTOMA#0.6640;APOPTOSIS#0.6617;B CELL#0.6598;STEM CELL#0.6581;MOUSE EMBRYONIC FIBROBLAST#0.6400;CELL DEATH#0.6263
10622	PLURIPOTENT STEM CELL#0.9812;STEM CELL#0.9729
10623	DNA UNWINDING#0.6391
10625	PLASMACYTOMA#0.9920;B CELL#0.9907;CELL SURFACE#0.9686;INFLUENZA A VIRUS#0.9678;LYMPH NODE#0.9669;PERIPHERAL BLOOD#0.9628;T CELL#0.9351;CELL FUSION#0.9169;GROWTH FACTOR#0.8949;TUMOR CELLS#0.8923;NEURITE OUTGROWTH#0.8848;GENE EXPRESSION#0.8694;T LYMPHOCYTE#0.8630;CYTOTOXICITY#0.8432;DNA REPLICATION#0.8420;NERVOUS SYSTEM#0.8416;B LYMPHOCYTE#0.8289;MACROPHAGE#0.8249;ASCITES#0.8232;BONE MARROW#0.8169;NEURITE#0.7954;APOPTOSIS#0.7936;SERUM ALBUMIN#0.7593;POLYMERASE CHAIN REACTION#0.7593;CANCER CELL#0.7588;CELL GROWTH#0.7446;IGM ANTIBODY#0.7404;PERIPHERAL BLOOD LYMPHOCYTES#0.7310;CELL SURFACE ANTIGEN#0.7253;MYELOMAS#0.7128;SQUAMOUS CELL CARCINOMA#0.7062;MONOCYTE#0.7021;IMMUNE RESPONSE#0.7002;B CELL LYMPHOMA#0.6905;MRNA SPLICING#0.6812;DODECYL SULFATE#0.6793;SODIUM DODECYL SULFATE#0.6793;LOW DENSITY LIPOPROTEIN#0.6648;CELL PROLIFERATION#0.6502;EPSTEIN BARR VIRUS#0.6333;ADENOCARCINOMA#0.6330;VIRAL GENOME#0.6327;RETINOIC ACID#0.6290;NERVE GROWTH FACTOR#0.6260;VIRAL DNA REPLICATION#0.6218;PLASMA MEMBRANE#0.6178;CYTOPLASM#0.6098;RNA BINDING#0.6064;HOST CELL#0.6050;S PHASE#0.6044;LYMPHOID CELL#0.6009
10626	CANCER CELL#1.0773;CELL MIGRATION#0.9523;AUTOPHAGY#0.9424;NEUROBLASTOMA#0.9144;CELL GROWTH#0.8522;BREAST CANCER#0.8196;GENE EXPRESSION#0.7840;SQUAMOUS CELL CARCINOMA#0.7766;BREAST CANCER CELL#0.7613;KERATINOCYTE#0.7526;CELL CYCLE#0.7158;DNA BINDING#0.7022;UBIQUITIN#0.6837;CELL PROLIFERATION#0.6717;SIGNALING PATHWAY#0.6534;LUNG CANCER#0.6504;CASPASE-2 ACTIVITY#0.6387;EPITHELIAL MESENCHYMAL TRANSITION#0.6359;VEMURAFENIB#0.6203;LYMPH NODE METASTASIS#0.6199;GALECTIN#0.6178;LYMPH NODE#0.6151
10627	REGULATORY LIGHT CHAIN#0.9426;T CELL#0.6449
10628	THIOREDOXIN ACTIVITY#1.0941;CARBOHYDRATE RESPONSE ELEMENT BINDING#1.0820;VITAMIN D3#1.0625;MESANGIAL CELL#1.0535;BETA CELL#1.0445;GLUCOSE UPTAKE#1.0426;NADPH OXIDASE#1.0387;VERAPAMIL#1.0340;TUMOR SUPPRESSOR#1.0338;NLRP3 INFLAMMASOME ACTIVATION#1.0325;DIABETIC RETINOPATHY#1.0301;GLUCOSE METABOLISM#1.0281;AUTOPHAGY#1.0259;CARDIOMYOCYTE#1.0243;ENDOPLASMIC RETICULUM STRESS#1.0237;BREAST CANCER#1.0214;DIABETIC NEPHROPATHY#1.0201;HEPATOCELLULAR CARCINOMA#1.0196;MACROPHAGE#1.0193;CELL GROWTH#1.0167;INSULIN SECRETION#1.0156;HYPOXIA#1.0155;ENDOTHELIAL CELL#1.0140;PODOCYTE#1.0139;NEPHROPATHY#1.0136;PALMITATE#1.0130;ISCHEMIA#1.0121;LIPID METABOLISM#1.0120;PROTEIN KINASE#1.0110;CELL PROLIFERATION#1.0106;HYPERGLYCEMIA#1.0094;GLYCOLYSIS#1.0094;SKELETAL MUSCLE#1.0093;CELLULAR OXIDATIVE STRESS#1.0082;ANGIOGENESIS#1.0078;CELL CYCLE#1.0068;CANCER CELL#1.0054;ENDOPLASMIC RETICULUM#1.0024;STREPTOZOTOCIN#1.0022;APOPTOSIS#1.0017;POLYMERASE CHAIN REACTION#1.0015;APOPTOTIC#1.0011;MITOGEN ACTIVATED PROTEIN#1.0005;GLUCOSE HOMEOSTASIS#1.0003;REVERSE TRANSCRIPTION#0.9997;EPITHELIAL CELL#0.9980;INFLAMMATORY RESPONSE#0.9977;FRUCTOSE#0.9977;GROWTH FACTOR#0.9970;CELL DEATH#0.9957;RESVERATROL#0.9951;HISTONE DEACETYLASE#0.9951;HUMAN UMBILICAL VEIN#0.9949;UMBILICAL VEIN#0.9947;ROS GENERATION#0.9943;SENESCENCE#0.9938;SIGNALING PATHWAY#0.9934;ISCHEMIA REPERFUSION INJURY#0.9932;NITRIC OXIDE#0.9924;PRO-INFLAMMATORY#0.9924;HIGH FAT DIET#0.9924;DIABETES MELLITUS#0.9906;CELL CYCLE ARREST#0.9905;MITOCHONDRIA#0.9901;TRANSCRIPTION FACTOR#0.9899;TYPE 1 DIABETES#0.9894;ADIPOSE TISSUE#0.9892;REACTIVE OXYGEN SPECIES#0.9887;GLUTATHIONE#0.9873;SUPEROXIDE DISMUTASE#0.9863;TYPE 2 DIABETES#0.9842;GENE EXPRESSION#0.9826;UBIQUITIN#0.9826;T CELL#0.9771;TUMOR NECROSIS FACTOR#0.9700;IL-1 SECRETION#0.9692;PROTEASOME#0.9661;DNA METHYLATION#0.9632;QUANTITATIVE REAL TIME#0.9531;BREAST CANCER CELL#0.9521;ARTERY#0.9499;LIVER DISEASE#0.9483;IL-1 PRODUCTION#0.9475;METFORMIN#0.9465;CLEAVED CASPASE 3#0.9460;NUCLEOTIDE BINDING#0.9458;STEM CELL#0.9456;PERIPHERAL BLOOD#0.9451;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9408;ENDOTHELIAL GROWTH FACTOR#0.9407;HYPOXIA INDUCIBLE FACTOR#0.9403;RNA INTERFERENCE#0.9383;N-ACETYLCYSTEINE#0.9382;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9351;PANCREATIC CANCER#0.9308;TYPE 2 DIABETES MELLITUS#0.9290;2 DIABETES MELLITUS#0.9290;PLASMA MEMBRANE#0.9257;CALCIUM CHANNEL#0.9211;RESPONSE TO GLUCOSE#0.9186;HEPATOCELLULAR CARCINOMA CELL#0.9153;PEROXISOME#0.9153;PROTEIN SYNTHESIS#0.9134;NEURODEGENERATIVE DISEASE#0.9082;NEURONAL CELLS#0.9068;PANCREATIC ISLET#0.9010;B CELL#0.8954;BETA CELL MASS#0.8951;IMMUNE RESPONSE#0.8895;LUNG CANCER#0.8885;TOXICITY#0.8855;QUERCETIN#0.8854;GENE SILENCING#0.8826;FATTY LIVER#0.8823;CASPASE-1 ACTIVITY#0.8753;HIGH GLUCOSE LEVEL#0.8739;MAPK SIGNALING#0.8733;CELL ADHESION#0.8705;MYOCARDIAL INFARCTION#0.8696;CYTOPLASM#0.8694;CYTOTOXICITY#0.8666;PYROPTOSIS#0.8661;ATHEROSCLEROSIS#0.8652;HEME OXYGENASE 1#0.8647;SIGNALING MOLECULE#0.8638;TRANSFORMING GROWTH FACTOR#0.8584;HYPERGLYCEMIC#0.8584;SIGNAL TRANSDUCTION#0.8577;ACETYLCYSTEINE#0.8554;ADIPOCYTE#0.8517;PROSTATE CANCER#0.8505;MAP KINASE#0.8499;IMPAIRED GLUCOSE TOLERANCE#0.8481;ADENOCARCINOMA#0.8452;CEREBRAL ARTERY OCCLUSION#0.8424;FATTY LIVER DISEASE#0.8419;HISTONE DEACETYLASE INHIBITOR#0.8416;MIDDLE CEREBRAL ARTERY#0.8410;TYPE 2 DIABETIC#0.8408;CEREBRAL ARTERY#0.8407;KIDNEY DISEASE#0.8372;MUSCLE CELL#0.8339;TARGET OF RAPAMYCIN#0.8309;CELL MIGRATION#0.8238;DNA BINDING#0.8234;ALZHEIMER'S DISEASE#0.8228;NERVOUS SYSTEM#0.8209;BONE MARROW#0.8208;GLUCOCORTICOID RECEPTOR#0.8201;RAPAMYCIN#0.8106;CARDIOMYOPATHY#0.8093;PYRUVATE#0.8075;REGULATION OF AMPK#0.8073;KINASE INHIBITOR#0.8069;EXTRACELLULAR MATRIX#0.8052;ADENOSINE#0.8037;PROTEASOME PATHWAY#0.8024;MITOPHAGY#0.8019;NEUROTOXICITY#0.8002;MYOCARDIUM#0.7986;GLUTAMINE#0.7972;POLY ADP RIBOSE#0.7964;PROTEIN COMPLEX#0.7951;HEAT SHOCK PROTEIN#0.7949;MONONUCLEAR CELLS#0.7922;TUMOR CELLS#0.7907;GANGLION CELLS#0.7871;ENERGY HOMEOSTASIS#0.7817;CASPASE-3 ACTIVITY#0.7811;AMPK ACTIVITY#0.7798;IMMUNE CELL#0.7796;ADVANCED GLYCATION END#0.7779;MITOCHONDRIAL MEMBRANE#0.7742;SMOOTH MUSCLE#0.7742;GLUCOSE SENSING#0.7691;PROTEIN DEFICIENCY#0.7683;ACUTE LUNG INJURY#0.7654;CORONARY ARTERY#0.7593;GLUTATHIONE PEROXIDASE#0.7583;PROTEASOME DEGRADATION#0.7534;OBESE#0.7524;OXYGENASE#0.7466;LIVER REGENERATION#0.7455;LEUKOCYTE#0.7426;ASCORBIC ACID#0.7410;HUMAN BREAST CANCER#0.7403;UNFOLDED PROTEIN RESPONSE#0.7380;TOLL LIKE RECEPTOR#0.7371;ADENINE#0.7331;CYTOCHROME C#0.7329;HISTONE ACETYLATION#0.7285;2-DEOXYGLUCOSE#0.7277;OOCYTE#0.7253;FATTY ACID SYNTHASE#0.7238;CELL ADHESION MOLECULE#0.7220;NITRIC OXIDE SYNTHASE#0.7211;CELL DIFFERENTIATION#0.7208;MICROVASCULAR ENDOTHELIAL CELL#0.7201;HEMATOPOIETIC CELL#0.7168;SMOOTH MUSCLE CELL#0.7145;ESTRADIOL#0.7116;MONOCYTE#0.7099;L-CYSTEINE#0.7082;TUBE FORMATION#0.7069;THIOREDOXIN REDUCTASE 1#0.7065;CEREBRAL ISCHEMIA#0.7048;DIABETIC KIDNEY DISEASE#0.7045;NEUROBLASTOMA#0.7045;RIBOSE#0.7041;ATHEROSCLEROTIC#0.7036;HEMATOPOIETIC STEM CELL#0.7031;MOUSE MESANGIAL CELLS#0.7010;GLUCOSE-6-PHOSPHATE#0.7001;ALLOPURINOL#0.6964;AKT SIGNALING#0.6948;PROTEIN PROTEIN INTERACTION#0.6941;EARLY BRAIN INJURY#0.6922;ONCOGENIC#0.6913;LIPOGENESIS#0.6908;CELLULAR SENESCENCE#0.6901;NEUTROPHIL#0.6889;TELMISARTAN#0.6862;VASCULAR CELL#0.6853;OXIDATIVE STRESS RESPONSE#0.6836;ALANINE#0.6835;CYTOKINE PRODUCTION#0.6822;OXIDATIVE PHOSPHORYLATION#0.6799;REACTIVE OXYGEN SPECIES GENERATION#0.6783;LACTIC ACIDOSIS#0.6781;LYSOSOME#0.6753;CELLULAR METABOLISM#0.6752;NUCLEAR EXPORT#0.6748;FATTY ACID OXIDATION#0.6733;GESTATIONAL DIABETES#0.6720;RENAL CELL CARCINOMA#0.6689;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6675;NEUROPATHY#0.6674;BREAST CANCER PATIENTS#0.6626;ENDOTHELIUM#0.6614;NUCLEIC ACID#0.6510;ALCOHOLIC FATTY LIVER#0.6505;BLOOD GLUCOSE LEVEL#0.6470;VASCULAR DISEASE#0.6470;BINDING PROTEIN 1#0.6465;TUMOR TISSUES#0.6451;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6451;SIGNALING CASCADE#0.6447;CYCLIN DEPENDENT KINASE#0.6442;ESTROGEN RECEPTOR#0.6422;QUIESCENCE#0.6359;FAMILIAL COMBINED HYPERLIPIDEMIA#0.6340;HYPOXIC#0.6304;LYSINE#0.6296;DIET INDUCED OBESITY#0.6296;FENOFIBRATE#0.6282;STEROL REGULATORY ELEMENT#0.6261;HEART DISEASE#0.6257;RESPONSE TO OXIDATIVE STRESS#0.6241;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6240;EPITHELIAL TO MESENCHYMAL#0.6238;GLIAL CELL#0.6236;CORONARY ARTERY DISEASE#0.6235;ARTERY DISEASE#0.6233;OF DIABETIC RATS#0.6224;MELATONIN#0.6209;COMPLEX I#0.6202;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6195;KINASE ACTIVITY#0.6190;OSTEOCLAST#0.6182;HYPERTENSION#0.6173;NUTRIENT SENSING#0.6150;GLUCONEOGENESIS#0.6127;REDOX ACTIVITY#0.6071;PYRUVATE KINASE#0.6063;1α,25-DIHYDROXYVITAMIN D3#0.6060;SCIATIC NERVE#0.6022;VASCULAR ENDOTHELIAL CADHERIN#0.6012;REGULATION OF CELLULAR#0.6008
1062	MICROTUBULE CAPTURE#1.1091;CHROMOSOME CONGRESSION#1.0634;KINESIN#1.0559;DYNEIN#1.0472;KINETOCHORE#1.0415;CENTROMERE#1.0402;KINETOCHORE MICROTUBULE#1.0394;MITOTIC CHECKPOINT#1.0223;SPINDLE CHECKPOINT#1.0152;METAPHASE#1.0133;SPINDLE MICROTUBULE#1.0122;MICROTUBULE MOTOR#1.0095;KINETOCHORE LOCALIZATION#1.0064;MICROTUBULE#1.0059;CELL CYCLE#1.0044;ANAPHASE#0.9996;SPINDLE ASSEMBLY#0.9960;CHROMOSOME MOVEMENT#0.9960;MITOSIS#0.9915;KINETOCHORE-MICROTUBULE ATTACHMENT#0.9899;CHROMOSOME SEGREGATION#0.9895;MICROTUBULE PLUS END#0.9854;MITOTIC SPINDLE#0.9812;SPINDLE EQUATOR#0.9788;CANCER CELL#0.9722;CELL DIVISION#0.9664;SPINDLE POLE#0.9628;SPINDLE ASSEMBLY CHECKPOINT#0.9609;SPINDLE MIDZONE#0.9510;MICROTUBULE END#0.9266;MICROTUBULE BINDING#0.9266;GENE EXPRESSION#0.9145;KINASE ACTIVITY#0.8908;KINETOCHORE BINDING#0.8807;PROTEIN KINASE#0.8646;CHROMATID#0.8630;MITOTIC CHROMOSOME#0.8447;CYTOKINESIS#0.8321;KINETOCHORE ASSEMBLY#0.8284;CENTRAL SPINDLE#0.8271;MOTOR ACTIVITY#0.8186;METAPHASE PLATE#0.8148;RNA INTERFERENCE#0.8101;MEIOSIS#0.8095;METAPHASE CHROMOSOME#0.7987;INTERPHASE#0.7961;OOCYTE#0.7894;KINETOCHORE MICROTUBULE INTERACTION#0.7478;BREAST CANCER#0.7474;MEIOSIS I#0.7462;CENTROSOME#0.7420;MICROTUBULE DYNAMICS#0.7417;APOPTOSIS#0.7415;SPINDLE FORMATION#0.7388;TELOPHASE#0.7269;LUNG CANCER#0.7095;TRANSFERASE INHIBITOR#0.6967;PROPHASE#0.6923;CELL CYCLE ARREST#0.6783;SPINDLE ELONGATION#0.6426;FARNESYL#0.6383;MEIOSIS II#0.6327;MIDBODY#0.6320;ADENOCARCINOMA#0.6250;TUMOR SUPPRESSOR#0.6217;PROTEIN PROTEIN INTERACTION#0.6083;MRNA SPLICING#0.6013
10630	FIBROBLASTIC RETICULAR CELLS#1.0649;GERM CELL#1.0522;PROLYL 4-HYDROXYLASE#1.0506;GERM CELL TUMORS#1.0503;HYALURONAN#1.0444;PODOCYTE#1.0425;O GLYCAN#1.0413;BASAL CELL#1.0406;PLATELET AGGREGATION#1.0400;CELL MOTILITY#1.0378;KERATINOCYTE#1.0334;ORAL SQUAMOUS CELL CARCINOMA#1.0331;PLATELET ACTIVATION#1.0320;SMOOTH MUSCLE ACTIN#1.0297;MYOEPITHELIAL CELL#1.0294;BREAST CARCINOMA#1.0277;CANCER ASSOCIATED FIBROBLASTS#1.0271;SALIVARY GLAND#1.0271;AMELOBLASTOMA#1.0261;CELL MIGRATION#1.0246;LUNG ADENOCARCINOMA#1.0238;LUNG SQUAMOUS CELL CARCINOMA#1.0227;EPIDERMAL GROWTH FACTOR#1.0215;STEM CELL MARKER#1.0212;MESOTHELIAL CELL#1.0189;LECTIN#1.0186;CELL SURFACE#1.0179;GROWTH FACTOR RECEPTOR#1.0170;FACTOR VIII#1.0169;OSTEOCYTE#1.0168;LYMPHATIC ENDOTHELIAL CELL#1.0159;FOLLICULAR DENDRITIC CELL#1.0146;PLASMA MEMBRANE#1.0146;ENDOTHELIUM#1.0133;ORAL CAVITY#1.0132;VASCULAR ENDOTHELIAL CELL#1.0112;LYMPHATIC VESSEL DENSITY#1.0111;SMOOTH MUSCLE#1.0100;EPITHELIAL MESENCHYMAL TRANSITION#1.0067;GLYCOSYLATION#1.0064;LYMPH NODE METASTASES#1.0062;EXTRACELLULAR MATRIX#1.0051;CARDINAL VEIN#1.0051;STROMAL CELL#1.0035;LYMPHATIC VESSEL#1.0030;CELL ADHESION#1.0029;CELL MEMBRANE#1.0029;EPITHELIAL CELL#1.0022;SQUAMOUS CELL CARCINOMA#1.0022;ALVEOLAR TYPE I#1.0005;OVARIAN#1.0002;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9999;ENDOTHELIAL CELL#0.9999;CANCER CELL#0.9982;ENDOTHELIAL GROWTH FACTOR#0.9979;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9979;STROMA#0.9976;BREAST CANCER#0.9972;TRANSCRIPTION FACTOR#0.9965;CELL PROLIFERATION#0.9960;MALIGNANT MESOTHELIOMA#0.9958;OSTEOBLAST#0.9951;MACROPHAGE#0.9942;DENDRITIC CELL#0.9939;SEMINOMA#0.9938;CERVICAL#0.9937;ADENOCARCINOMA#0.9934;TUMOR CELLS#0.9932;MESENCHYMAL CELL#0.9927;NERVOUS SYSTEM#0.9924;COLORECTAL#0.9920;LYMPHATIC SYSTEM#0.9913;LYMPHOID ORGANS#0.9913;CANCER STEM CELL#0.9896;HUMAN IMMUNODEFICIENCY VIRUS#0.9893;GROWTH FACTOR#0.9887;POLYMERASE CHAIN REACTION#0.9877;THYROID TRANSCRIPTION FACTOR#0.9872;SIGNALING PATHWAY#0.9868;STEM CELL#0.9866;DISEASE FREE SURVIVAL#0.9863;TUMOR TISSUES#0.9856;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9851;VASCULAR ENDOTHELIUM#0.9846;LYMPHATIC MICROVESSEL DENSITY#0.9832;CHOROID PLEXUS#0.9826;BLOOD VESSEL#0.9824;THROMBOSIS#0.9819;TRANSFORMING GROWTH FACTOR#0.9818;T CELL#0.9813;WOUND HEALING#0.9804;LYMPH NODE METASTASIS#0.9798;MYOFIBROBLAST#0.9797;PROGENITOR CELL#0.9791;REGIONAL LYMPH NODE#0.9790;APOPTOSIS#0.9762;GENE EXPRESSION#0.9759;LYMPHANGIOGENESIS#0.9752;TUMOR ASSOCIATED MACROPHAGE#0.9747;RENAL CELL CARCINOMA#0.9738;LUNG CANCER#0.9734;ANGIOGENESIS#0.9727;COLORECTAL CANCER#0.9725;B CELL#0.9717;CELL GROWTH#0.9699;LYMPHANGIOMA#0.9697;LYMPH NODE#0.9691;IMMUNE CELL#0.9674;TUBE FORMATION#0.9650;LUNG METASTASIS#0.9650;CELL DIFFERENTIATION#0.9631;BONE MARROW#0.9605;QUANTITATIVE REAL TIME#0.9599;AGGRESSIVE BEHAVIOR#0.9580;CYTOPLASM#0.9573;CONNECTIVE TISSUE#0.9569;CELL ADHESION MOLECULE#0.9552;IMMUNE RESPONSE#0.9547;ALVEOLAR EPITHELIAL CELL#0.9538;EOSIN#0.9524;VIRION#0.9490;ANGIOSARCOMA#0.9482;PLATELET-DERIVED GROWTH FACTOR#0.9477;ESTROGEN RECEPTOR#0.9464;FORMALIN#0.9455;LYMPHEDEMA#0.9443;DISEASE SPECIFIC SURVIVAL#0.9431;FIBROBLAST GROWTH FACTOR#0.9385;CENTRAL NERVOUS SYSTEM#0.9376;RHEUMATOID ARTHRITIS#0.9301;HEMANGIOMA#0.9299;TH17 CELL#0.9283;OVARIAN CARCINOMA#0.9282;CYTOTOXICITY#0.9257;GLOMERULAR EPITHELIAL CELL#0.9247;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9227;REVERSE TRANSCRIPTION#0.9223;CERVICAL CANCER#0.9193;LUNG CARCINOMA#0.9166;FIBROBLAST ACTIVATION#0.9149;MONOCYTE#0.9133;KAPOSI'S SARCOMA#0.9095;INFLAMMATORY CELL#0.9095;RENAL GLOMERULUS#0.9083;LUMINAL#0.9060;CLEAR CELL RENAL CELL CARCINOMA#0.9056;PARENCHYMA#0.9032;PERICYTE#0.9010;COMPLEMENT DEPENDENT CYTOTOXICITY#0.8995;DERMIS#0.8991;LEUKOCYTE#0.8989;LYMPHOID TISSUE#0.8971;SURFACE PLASMON RESONANCE#0.8917;MUSCLE CELL#0.8906;LUNG DEVELOPMENT#0.8865;CHEMOKINE RECEPTOR#0.8864;RECURRENCE FREE SURVIVAL#0.8839;SMOOTH MUSCLE CELL#0.8835;MICROVASCULAR ENDOTHELIAL CELL#0.8826;MALIGNANT PLEURAL MESOTHELIOMA#0.8803;LYMPH NODE INVOLVEMENT#0.8789;CILIARY BODY#0.8789;LYMPH NODE DISSECTION#0.8772;BASAL CELL CARCINOMA#0.8740;PROTEINURIA#0.8736;INVASIVE BREAST CANCER#0.8730;ALKALINE PHOSPHATASE#0.8723;PROTEIN KINASE#0.8717;INVASIVE CARCINOMA#0.8714;MYOCARDIUM#0.8714;OVARIAN CANCER#0.8706;PERIPHERAL NERVE#0.8635;GLOMERULUS#0.8634;PROGESTERONE#0.8613;EPITHELIAL TO MESENCHYMAL#0.8611;GESTATION#0.8585;ADENOCARCINOMA IN SITU#0.8559;PANCREATIC CANCER#0.8543;TUMOR NECROSIS FACTOR#0.8525;CARCINOMA IN SITU#0.8513;SYNOVIUM#0.8495;HEAD AND NECK CANCER#0.8478;NECK CANCER#0.8477;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.8461;TUMOR NODE METASTASIS#0.8446;PLEURA#0.8413;PERITONEUM#0.8381;BLOOD VESSEL INVASION#0.8369;EMBRYONAL CARCINOMA#0.8368;CANCER SPECIFIC SURVIVAL#0.8314;PERIPHERAL BLOOD#0.8313;OVERALL SURVIVAL RATE#0.8312;HYPOXIA#0.8309;BASEMENT MEMBRANE#0.8278;LARYNGEAL CARCINOMA#0.8270;NEUROFIBROMA#0.8265;METASTATIC CARCINOMA#0.8207;NODULAR#0.8206;IL-17 SECRETION#0.8194;EDEMA#0.8169;POSITRON EMISSION TOMOGRAPHY#0.8148;CELL SURFACE ANTIGEN#0.8105;AQUAPORIN#0.8102;BREAST CANCER CELL#0.8059;HEMATOPOIETIC CELL#0.8056;FOLATE#0.8024;TONGUE CANCER#0.8013;INSULIN-LIKE GROWTH FACTOR#0.8011;ESOPHAGEAL CANCER#0.7983;SENTINEL LYMPH NODE#0.7906;TRANSMEMBRANE RECEPTOR#0.7833;TRANSMISSION ELECTRON MICROSCOPY#0.7821;ALVEOLAR MACROPHAGE#0.7775;INFLAMMATORY RESPONSE#0.7773;GROWTH PATTERN#0.7765;BREAST CANCER PATIENTS#0.7757;YEAR SURVIVAL RATE#0.7749;METASTATIC LYMPH NODE#0.7728;SUBLINGUAL GLAND#0.7667;METASTATIC ADENOCARCINOMA#0.7656;RESPIRATORY FAILURE#0.7612;MONONUCLEAR CELLS#0.7596;MYELOID CELL#0.7590;ORAL MUCOSA#0.7562;MALIGNANT GLIOMA#0.7546;MESOTHELIOMA CELL#0.7537;SKIN CANCER#0.7535;SEBACEOUS GLAND#0.7504;BLOOD VESSEL ENDOTHELIUM#0.7476;BACTERIAL ARTIFICIAL CHROMOSOME#0.7468;FETAL LIVER#0.7466;TRANSFORMING GROWTH FACTOR BETA#0.7465;HEMOSTASIS#0.7459;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7453;VIRAL ENVELOPE#0.7444;ATHEROSCLEROTIC#0.7438;SARCOMATOID MESOTHELIOMA#0.7416;COLORECTAL CARCINOMA#0.7381;BUDDING#0.7379;URINARY BLADDER#0.7366;CELL CYCLE#0.7365;FIBROBLAST ACTIVATION PROTEIN#0.7345;LYMPH VESSEL DENSITY#0.7338;DENTATE GYRUS#0.7321;THYROID CANCER#0.7314;WILMS TUMOR 1#0.7311;SYNOVIAL SARCOMA#0.7308;BLOOD VESSEL DENSITY#0.7303;IMMUNE SYSTEM#0.7279;GALECTIN#0.7267;EFFECTOR T CELL#0.7236;LUNG EPITHELIAL CELL#0.7216;REGENERATION#0.7192;CD4+ T CELL#0.7178;HEPATITIS B#0.7153;HUMAN BREAST CANCER#0.7134;METASTASIS TO LYMPH NODE#0.7099;NEUTROPHIL#0.7098;ERYTHROCYTE#0.7081;UMBILICAL VEIN#0.7076;SINUS VENOSUS#0.6995;PULMONARY VEIN#0.6963;VENULE#0.6951;ASTROCYTE#0.6951;OPTIC NERVE#0.6938;TUMOR SUPPRESSOR#0.6930;CHONDROCYTE#0.6929;CERVICAL LYMPH NODE#0.6884;EPITHELIOID SARCOMA#0.6862;FOLATE BINDING#0.6851;FLOW CYTOMETRY ANALYSIS#0.6840;MEDIASTINAL LYMPH NODE#0.6814;SECONDARY LYMPHOID ORGANS#0.6798;APICAL PLASMA MEMBRANE#0.6788;DERMAL FIBROBLAST#0.6768;MRNA BINDING#0.6767;GLUTATHIONE#0.6763;ADENOID CYSTIC CARCINOMA#0.6762;MEGAKARYOCYTE#0.6756;EPENDYMAL CELL#0.6736;INVASIVE DUCTAL CARCINOMA#0.6732;REGULATORY T CELL#0.6719;B LYMPHOCYTE#0.6701;HOST CELL#0.6700;HYALURONIC ACID#0.6696;PRO-INFLAMMATORY#0.6676;DIGESTION#0.6673;T LYMPHOCYTE#0.6671;ACTIN CYTOSKELETON#0.6670;CERVIX#0.6669;KNEE JOINT#0.6666;HEPATOCELLULAR CARCINOMA#0.6608;ATYPICAL NEUROFIBROMA#0.6602;PAROTID GLAND#0.6559;HUMAN UMBILICAL VEIN#0.6545;CIRCULATING TUMOR CELL#0.6544;PROTEOGLYCAN#0.6494;COAGULATION#0.6494;CRIMEAN-CONGO HEMORRHAGIC FEVER#0.6484;DRAINING LYMPH NODE#0.6456;BINDING PROTEIN 1#0.6427;PNEUMONIA#0.6421;LIP CANCER#0.6396;CHRONIC MAXILLARY SINUSITIS#0.6396;SIGNAL TRANSDUCTION#0.6372;CHONDROSARCOMA#0.6356;TRANSDIFFERENTIATION#0.6341;MYCOSIS FUNGOIDES#0.6326;FIBROSARCOMA#0.6309;TUMOR INITIATING CELL#0.6295;MUCOUS#0.6289;ADENOMATOID TUMOR#0.6269;HEPATOCYTE GROWTH FACTOR#0.6255;MORPHOGENESIS#0.6228;FACTOR I#0.6227;METASTASIS FREE SURVIVAL#0.6227;HAIR FOLLICLE#0.6215;ENCAPSULATING PERITONEAL SCLEROSIS#0.6203;SCHWANN CELL#0.6201;MESOTHELIUM#0.6195;TOXICITY#0.6190;SEPTUM#0.6181;HEMORRHAGE#0.6175;INTERSTITIAL CELL#0.6170;GENE SILENCING#0.6141;ORAL EPITHELIAL DYSPLASIA#0.6124;MATRIX PROTEIN 1#0.6118;NEVOID BASAL CELL CARCINOMA SYNDROME#0.6107;CHOLANGIOCARCINOMA#0.6103;PIA MATER#0.6102;TOOTH DEVELOPMENT#0.6097;MESENCHYME#0.6087;CELL ACTIVATION#0.6075;ADIPOSE TISSUE#0.6071;STANDARDIZED UPTAKE VALUE#0.6056;ADIPOCYTE#0.6045;EXTRACELLULAR VESICLE#0.6033
10631	PROSTATE CANCER#1.0573;PERIOSTEUM#1.0533;COLORECTAL CANCER#1.0510;DERMAL FIBROBLAST#1.0454;LUNG CANCER#1.0454;AIRWAY EPITHELIAL CELL#1.0442;EXHALED NITRIC OXIDE#1.0393;LUNG FIBROBLASTS#1.0390;MYOFIBROBLAST DIFFERENTIATION#1.0388;CANCER ASSOCIATED FIBROBLASTS#1.0370;OVARIAN CANCER#1.0352;COLON CANCER#1.0337;BONE TURNOVER MARKER#1.0336;OSTEOBLAST DIFFERENTIATION#1.0317;CELL ADHESION MOLECULE#1.0312;LYMPH NODE METASTASIS#1.0311;KERATINOCYTE#1.0311;TISSUE REMODELING#1.0306;TISSUE GROWTH FACTOR#1.0294;COLLAGEN TYPE I#1.0276;CANCER STEM CELL#1.0264;OVARIAN#1.0262;ENDOTHELIAL GROWTH FACTOR#1.0251;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0251;LYMPH NODE#1.0249;CELL MIGRATION#1.0243;NITRIC OXIDE#1.0239;FOCAL ADHESION#1.0238;PULMONARY FIBROSIS#1.0238;WOUND HEALING#1.0237;BASEMENT MEMBRANE#1.0232;STROMA#1.0231;FOCAL ADHESION KINASE#1.0230;SMOOTH MUSCLE ACTIN#1.0227;SPUTUM#1.0227;KIDNEY DISEASE#1.0223;COLORECTAL#1.0219;MESENCHYMAL CELL#1.0215;OSTEOBLAST#1.0213;QUANTITATIVE REAL TIME#1.0211;MYOFIBROBLAST#1.0203;MACROPHAGE#1.0197;EOSINOPHIL#1.0196;TUMOR NECROSIS FACTOR#1.0190;HYPOXIA#1.0184;PANCREATIC CANCER#1.0183;EPITHELIAL MESENCHYMAL TRANSITION#1.0172;CONNECTIVE TISSUE#1.0163;SMOOTH MUSCLE CELL#1.0158;BREAST CANCER#1.0157;MUSCLE CELL#1.0146;ATOPIC DERMATITIS#1.0145;EPITHELIAL CELL#1.0140;PERIPHERAL BLOOD#1.0136;ANGIOGENESIS#1.0125;MESENCHYMAL STEM CELL#1.0118;CELL ADHESION#1.0116;IDIOPATHIC PULMONARY FIBROSIS#1.0116;OSTEOGENESIS#1.0112;PERIODONTITIS#1.0108;TRANSFORMING GROWTH FACTOR BETA#1.0108;MYOCARDIAL INFARCTION#1.0097;SMOOTH MUSCLE#1.0094;TUMOR CELLS#1.0078;TRANSFORMING GROWTH FACTOR#1.0075;SQUAMOUS CELL CARCINOMA#1.0074;CANCER CELL#1.0071;PERIODONTAL LIGAMENT#1.0069;REVERSE TRANSCRIPTION#1.0069;CHOLANGIOCARCINOMA#1.0067;CELL SURFACE#1.0066;DERMATITIS#1.0064;HEPATOCELLULAR CARCINOMA#1.0062;MESENCHYME#1.0061;HUMAN PERIODONTAL LIGAMENT#1.0061;HYPOXIC#1.0053;BLEOMYCIN#1.0053;CELL GROWTH#1.0040;APOPTOSIS#1.0039;PERIODONTAL DISEASE#1.0038;STROMAL CELL#1.0032;CARDIOMYOCYTE#1.0026;FATTY LIVER#1.0025;TRANSCRIPTION FACTOR#1.0019;ENDOTHELIAL CELL#1.0017;CELL CYCLE#1.0013;MINERALIZATION#1.0013;INFLAMMATORY CELL#1.0011;SIGNALING PATHWAY#1.0011;BONE MORPHOGENETIC PROTEIN#1.0010;POLYMERASE CHAIN REACTION#0.9995;BONE FORMATION#0.9993;T CELL#0.9985;GROWTH FACTOR#0.9983;EXTRACELLULAR MATRIX#0.9973;EXTRACELLULAR MATRIX COMPONENT#0.9971;ALKALINE PHOSPHATASE#0.9969;MYOCARDIUM#0.9968;CELL PROLIFERATION#0.9943;EXHALED BREATH CONDENSATE#0.9926;HEPATIC STELLATE CELL#0.9924;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9923;EPITHELIAL TO MESENCHYMAL#0.9920;CHONDROCYTE#0.9911;NEUTROPHIL#0.9900;REGENERATION#0.9899;ADENOCARCINOMA#0.9897;BRONCHIAL EPITHELIAL CELLS#0.9892;BONE MARROW#0.9882;STEM CELL#0.9880;LIVER DISEASE#0.9875;OMALIZUMAB#0.9874;GINGIVAL CREVICULAR FLUID#0.9871;IMMUNE RESPONSE#0.9864;TISSUE REGENERATION#0.9853;AKT SIGNALING#0.9848;ACUTE MYOCARDIAL INFARCTION#0.9838;CARDIAC DEVELOPMENT#0.9836;INFLAMMATORY RESPONSE#0.9835;PROTEIN KINASE#0.9817;BREAST CANCER CELL#0.9800;ADIPOSE TISSUE#0.9797;TUBE FORMATION#0.9779;VASCULAR SMOOTH MUSCLE CELL#0.9769;PROGENITOR CELL#0.9766;BLOOD VESSEL#0.9757;ALLERGIC RHINITIS#0.9738;GROWTH FACTOR RECEPTOR#0.9720;GENE EXPRESSION#0.9714;SKELETAL MUSCLE#0.9705;BONE REMODELING#0.9704;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9688;MAST CELL#0.9675;TUMOR ASSOCIATED MACROPHAGE#0.9671;SYNOVIAL FLUID#0.9648;DERMIS#0.9617;MONOCYTE#0.9616;CHRONIC KIDNEY DISEASE#0.9599;FORCED EXPIRATORY VOLUME#0.9571;AORTIC VALVE#0.9544;BONE MINERAL DENSITY#0.9532;C REACTIVE PROTEIN#0.9530;CELL DIFFERENTIATION#0.9525;OSTEOARTHRITIS#0.9523;THYROID CARCINOMA#0.9513;EOSINOPHILIC ESOPHAGITIS#0.9512;ARTERY#0.9509;DIABETIC RETINOPATHY#0.9493;GALECTIN#0.9489;OSTEOPOROSIS#0.9488;MORPHOGENESIS#0.9467;ISCHEMIA#0.9467;M2 MACROPHAGE#0.9467;BONE REGENERATION#0.9465;SIGNALLING PATHWAY#0.9460;DENTAL PULP#0.9452;RHINITIS#0.9449;OSTEOCYTE#0.9422;INTERSTITIAL CELL#0.9410;ALLERGEN#0.9353;OSTEOCLAST#0.9339;TYPE 2 DIABETES#0.9316;FIBRIL#0.9287;PROTEOGLYCAN#0.9276;LUNG ADENOCARCINOMA#0.9273;RENAL FIBROSIS#0.9255;PARATHYROID HORMONE#0.9213;ACID PHOSPHATASE#0.9193;MESENCHYMAL STROMAL CELL#0.9174;ANCHORAGE INDEPENDENT GROWTH#0.9152;SCLERODERMA#0.9136;MATRIX GLA PROTEIN#0.9134;VITAMIN K#0.9117;APOPTOTIC#0.9076;ALLERGIC ASTHMA#0.9073;PANCREATIC DUCTAL ADENOCARCINOMA#0.9058;NEPHROPATHY#0.9039;CARDIOMYOPATHY#0.9035;DRUG RESISTANCE#0.9006;PRO-INFLAMMATORY#0.9001;ORTHODONTIC TOOTH MOVEMENT#0.8972;DISEASE FREE SURVIVAL#0.8940;ADIPOCYTE#0.8931;TUMOR TISSUES#0.8927;FATTY LIVER DISEASE#0.8912;COLLAGEN SYNTHESIS#0.8896;GOBLET CELL#0.8830;EPIDERMAL GROWTH FACTOR#0.8819;SCHWANN CELL#0.8813;HEAD AND NECK CANCER#0.8775;NECK CANCER#0.8775;ESOPHAGITIS#0.8760;RNA INTERFERENCE#0.8716;B CELL#0.8709;BREAST CARCINOMA#0.8708;TISSUE DEVELOPMENT#0.8706;ASPIRIN#0.8691;SKIN DISEASE#0.8687;SPINAL CORD#0.8686;ESTROGEN RECEPTOR#0.8684;MYOCYTES#0.8676;FIBROBLAST GROWTH FACTOR#0.8666;CISPLATIN#0.8646;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8617;RENAL CELL CARCINOMA#0.8592;BONE DEVELOPMENT#0.8559;TUMOR SUPPRESSOR#0.8552;MYOSIN HEAVY CHAIN#0.8551;DENTIN MATRIX PROTEIN#0.8539;HEMORRHAGE#0.8519;VASCULAR CELL#0.8514;HEART DISEASE#0.8493;HUMAN UMBILICAL VEIN#0.8465;MATRIX PROTEIN 1#0.8463;UMBILICAL VEIN#0.8463;SPHINGOSINE 1 PHOSPHATE#0.8457;SENSITIZATION#0.8441;MOLAR#0.8425;TIBIA#0.8421;ENDOMETRIOSIS#0.8417;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8387;PNEUMONIA#0.8369;SIGNAL TRANSDUCER#0.8342;BILE DUCT#0.8339;CORONARY ARTERY#0.8339;LIVER CANCER#0.8305;BASOPHIL#0.8295;CELL DEATH#0.8292;OUTFLOW TRACT#0.8291;HYPOXIA INDUCIBLE FACTOR#0.8282;QUANTITATIVE REVERSE TRANSCRIPTION#0.8230;FEMUR#0.8200;C TERMINAL DOMAIN#0.8182;PARATHYROID#0.8161;CELL MOTILITY#0.8159;HYPERTENSION#0.8129;DIFFERENTIAL GENE EXPRESSION#0.8113;DIPEPTIDYL PEPTIDASE#0.8084;DIABETES MELLITUS#0.8052;REACTIVE OXYGEN SPECIES#0.8050;IMMUNE CELL#0.8037;ATHEROSCLEROTIC#0.8030;COLITIS#0.8027;MITOGEN ACTIVATED PROTEIN#0.8027;ZOLEDRONIC ACID#0.8011;LIVER METASTASIS#0.8010;TYPE 2 IMMUNE RESPONSE#0.7993;NASAL MUCOSA#0.7992;DIPEPTIDYL PEPTIDASE 4#0.7968;PLATELET-DERIVED GROWTH FACTOR#0.7945;GM-CSF#0.7919;TARGET OF RAPAMYCIN#0.7896;PROLIFERATIVE DIABETIC RETINOPATHY#0.7895;PANCREATIC STELLATE CELL#0.7894;SKIN FIBROBLASTS#0.7836;PAPILLARY THYROID CARCINOMA#0.7829;NEURAL CREST#0.7810;ANNULUS#0.7805;GENE SILENCING#0.7793;TRANSCRIPTASE#0.7789;DIGESTION#0.7787;OBESE#0.7777;COLONY-STIMULATING FACTOR#0.7767;GINGIVA#0.7734;RECEPTOR ACTIVATOR#0.7672;CEREBRAL ISCHEMIA#0.7656;CORE BINDING FACTOR#0.7652;MUCUS PRODUCTION#0.7641;INTEGRIN LINKED KINASE#0.7634;LEUKOCYTE#0.7624;AGGRESSIVE PERIODONTITIS#0.7593;SIGNALING MOLECULE#0.7588;SKELETON#0.7579;DISCOIDIN DOMAIN RECEPTOR#0.7578;ENDOMETRIAL EPITHELIAL CELLS#0.7568;ESOPHAGEAL CANCER#0.7543;ENDOPLASMIC RETICULUM#0.7538;INSULIN-LIKE GROWTH FACTOR#0.7519;ENDOMETRIUM#0.7516;SIGNAL TRANSDUCTION#0.7509;DIABETIC NEPHROPATHY#0.7507;HUMAN BREAST CANCER#0.7492;BILE DUCT CARCINOMA#0.7468;BONE RESORPTION#0.7435;EPITHELIAL OVARIAN CANCER#0.7425;NORMAL BREAST TISSUE#0.7411;CYTOPLASM#0.7405;TRANSVERSE AORTIC CONSTRICTION#0.7339;CREATINE KINASE#0.7334;KERATINOCYTE PROLIFERATION#0.7318;ASTROCYTE#0.7305;HUMAN ADIPOSE TISSUE#0.7302;INTEGRIN BINDING#0.7271;ATHEROSCLEROSIS#0.7228;GROWTH DIFFERENTIATION FACTOR#0.7228;LUNG DISEASE#0.7224;INTERVERTEBRAL DISC#0.7223;POLYCYSTIC KIDNEY DISEASE#0.7210;NEURITE#0.7190;ISOPROTERENOL#0.7138;RAPAMYCIN#0.7028;ALKALINE PHOSPHATASE ACTIVITY#0.7014;PERIODONTAL LIGAMENT STEM CELL#0.7002;PHOSPHATASE ACTIVITY#0.6987;FACTOR I#0.6982;SPHINGOSINE#0.6972;HEART DEVELOPMENT#0.6918;CANCER SPECIFIC SURVIVAL#0.6908;BREAST CANCER PATIENTS#0.6906;EARLY BRAIN INJURY#0.6886;CHLORIDE CHANNEL#0.6872;TOOTH ERUPTION#0.6869;ADJACENT NORMAL TISSUE#0.6865;TOOTH DEVELOPMENT#0.6859;ALLERGIC CONJUNCTIVITIS#0.6854;PSORIASIS#0.6853;LINEAR REGRESSION ANALYSIS#0.6850;FIBROUS DYSPLASIA#0.6849;DEXAMETHASONE#0.6817;FIBROBLAST ACTIVATION#0.6816;BLOOD VESSEL DENSITY#0.6816;DNA SYNTHESIS#0.6798;HEAT SHOCK PROTEIN#0.6787;CONSTRICTION#0.6772;OSSIFICATION#0.6771;MACROPHAGE POLARIZATION#0.6755;TH2 CELL#0.6745;NIFEDIPINE#0.6744;HUMAN BRONCHIAL EPITHELIAL#0.6726;ALCOHOLIC FATTY LIVER#0.6708;HEPATOCELLULAR CARCINOMA CELL#0.6704;NEUROTOXIN#0.6679;CELL DEVELOPMENT#0.6659;BONE MARROW STROMAL#0.6651;TYPE 2 DIABETES MELLITUS#0.6645;2 DIABETES MELLITUS#0.6645;CELL ACTIVATION#0.6644;INGENUITY PATHWAY ANALYSIS#0.6640;NEURITE OUTGROWTH#0.6625;TRANSMISSION ELECTRON MICROSCOPY#0.6604;SUBSTANCE P#0.6578;VASCULAR ENDOTHELIAL CELL#0.6486;PROGESTERONE#0.6478;CORONARY ARTERY DISEASE#0.6467;ARTERY DISEASE#0.6465;HYDROXYPROLINE#0.6462;YEAR SURVIVAL RATE#0.6454;T HELPER CELL#0.6453;ENDOSCOPIC SINUS SURGERY#0.6446;GLYCOGEN SYNTHASE KINASE#0.6442;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6412;HIGH FAT DIET#0.6411;GLOMERULAR FILTRATION#0.6410;NERVOUS SYSTEM#0.6386;KINASE INHIBITOR#0.6386;PIRFENIDONE#0.6384;GRANULOCYTE#0.6367;BONE MARROW STROMAL CELL#0.6354;LYMPHANGIOGENESIS#0.6345;FIBRILLIN#0.6341;MANDIBLE#0.6319;GEMCITABINE#0.6284;CONJUNCTIVITIS#0.6281;PHENYTOIN#0.6264;DISEASE SPECIFIC SURVIVAL#0.6258;SINUSITIS#0.6251;NONALCOHOLIC FATTY LIVER DISEASE#0.6230;HYPERTROPHIC SCAR FIBROBLASTS#0.6217;AIRWAY EPITHELIUM#0.6204;LIPID METABOLISM#0.6198;URETER DEVELOPMENT#0.6172;TUMOUR NECROSIS FACTOR#0.6131;CELL MEMBRANE#0.6115;LOSARTAN#0.6100;SMOOTH MUSCLE CELL DIFFERENTIATION#0.6098;EOSINOPHILIC PNEUMONIA#0.6090;CYSTATIN#0.6087;ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS#0.6082;TOPICAL#0.6075;HUMAN DERMAL FIBROBLAST#0.6063;STEM CELL LIKE#0.6055;LUMINAL#0.6053;ADIPOSE-DERIVED STEM CELL#0.6052;SKIN DEVELOPMENT#0.6051;INTRAMEMBRANOUS OSSIFICATION#0.6050;BODY SURFACE AREA#0.6040;ENDOTHELIUM#0.6036;EXCRETION#0.6031;HAIR FOLLICLE#0.6025;ADJUSTED ODDS RATIO#0.6022;LYMPH NODE METASTASES#0.6020
10633	TUMOR SUPPRESSOR#0.9535;HISTONE MODIFICATION#0.7267
10634	GROWTH ARREST SPECIFIC#0.7553;MICROTUBULE#0.7044;CELL DIFFERENTIATION#0.6201
10635	HOMOLOGOUS RECOMBINATION#1.0740;DNA REPAIR#1.0235;DNA BINDING#0.9486;CANCER CELL#0.8834;DOUBLE STRAND BREAK#0.7756;STRUCTURE SPECIFIC DNA BINDING#0.6855;CELL CYCLE#0.6748;LUNG CANCER#0.6263
10636	SIGNALING PATHWAY#1.0508;PLASMA MEMBRANE#0.9614;GUANINE#0.9551;GTPASE ACTIVITY#0.9528;HETEROTRIMERIC G-PROTEIN#0.9526;SIGNALLING PATHWAY#0.8795;GAP ACTIVITY#0.8624;RESONANCE ENERGY TRANSFER#0.8087;PROTEIN KINASE#0.7983;CENTROSOME#0.7469;MITOGEN ACTIVATED PROTEIN#0.7211;NEPHROLITHIASIS#0.7134;MITOTIC SPINDLE#0.7002;MAP KINASE#0.6924;PROTEIN BINDING#0.6383;CELL DIVISION#0.6371;NERVOUS SYSTEM#0.6325;NUCLEOTIDE BINDING#0.6269;MICROTUBULE ASSOCIATED PROTEIN#0.6149;BIOLUMINESCENCE#0.6126
10637	NODAL SIGNALING#1.0465;MIDLINE#1.0369;LATERAL PLATE MESODERM#1.0362;STEM CELL#1.0063;GROWTH FACTOR#0.9936;GENE EXPRESSION#0.9779;EMBRYONIC STEM CELL#0.9736;TRANSCRIPTION FACTOR#0.9551;TRANSFORMING GROWTH FACTOR#0.9315;SIGNALING PATHWAY#0.8861;PRIMITIVE STREAK#0.8541;MOUSE EMBRYONIC STEM#0.8497;FLOOR PLATE#0.8013;EPIBLAST#0.7755;TRANSFORMING GROWTH FACTOR BETA#0.7542;ENDODERM CELL#0.7268;NOTOCHORD#0.7074;PLURIPOTENT STEM CELL#0.7029;HEART LOOPING#0.7027;ACTIVIN RECEPTOR#0.6969;HUMAN EMBRYONIC STEM#0.6935;VISCERAL ENDODERM CELL#0.6591;TERATOCARCINOMA#0.6200;ANTERIOR VISCERAL ENDODERM#0.6026
10638	S PHASE#1.1420;DNA SYNTHESIS#0.7901
10639	HEPATOCELLULAR CARCINOMA#0.9916
1063	CENTROMERE#1.0658;KINETOCHORE#1.0572;PROSTATE CANCER#1.0567;CELL CYCLE#1.0085;MICROTUBULE#0.9782;MITOSIS#0.9741;GENE EXPRESSION#0.9531;CHROMOSOME SEGREGATION#0.9435;CANCER CELL#0.9420;CELL PROLIFERATION#0.9278;M PHASE#0.9166;BREAST CANCER#0.9166;HEPATOCELLULAR CARCINOMA#0.8657;MITOTIC CHECKPOINT#0.8511;ASTROCYTOMA#0.8468;TOPOISOMERASE#0.8431;SQUAMOUS CELL CARCINOMA#0.8140;CELL DIVISION#0.8106;DNA TOPOISOMERASE#0.8074;DNA TOPOISOMERASE II#0.7805;TOPOISOMERASE II#0.7713;PROTEIN PROTEIN INTERACTION#0.7697;DISEASE FREE SURVIVAL#0.7534;METAPHASE#0.7503;ANAPHASE#0.7361;DYNEIN#0.7286;TRANSCRIPTION FACTOR#0.7260;SPINDLE CHECKPOINT#0.7158;DIFFUSE ASTROCYTOMA#0.7106;CELL MIGRATION#0.6985;SPINDLE POLE#0.6770;APOPTOSIS#0.6597;ONCOGENIC#0.6595;REVERSE TRANSCRIPTION#0.6569;GENE EXPRESSION OMNIBUS#0.6522;RECURRENCE FREE SURVIVAL#0.6222;LEUCINE#0.6218;POLYMERASE CHAIN REACTION#0.6028
10640	EXOCYST#1.0872;EXOCYST COMPLEX#1.0837;PLASMA MEMBRANE#0.9993;CILIOGENESIS#0.8370;EXOCYTOSIS#0.8355;PROTEIN COMPLEX#0.7611;SECRETORY VESICLE#0.7571;COMPLEX I#0.6519;EPITHELIAL CELL#0.6478;SPIRAL GANGLION NEURONS#0.6434;RETINAL DEVELOPMENT#0.6378;EYE DEVELOPMENT#0.6362;HAIR CELL#0.6270;URETER#0.6119
10641	TUMOR SUPPRESSOR#1.0820;CANCER CELL#1.0623;LUNG CANCER#1.0482;APOPTOSIS#1.0176;CELL CYCLE#1.0084;AUTOPHAGY#1.0063;TARGET OF RAPAMYCIN#0.9951;RESPONSE TO AMINO ACID#0.9684;GATOR1 COMPLEX#0.9660;RAPAMYCIN#0.9504;FOCAL EPILEPSY#0.9441;EPILEPSY#0.9307;GAP ACTIVITY#0.8846;GENE EXPRESSION#0.8721;CELL GROWTH#0.8714;TARGET OF RAPAMYCIN COMPLEX#0.8706;COLORECTAL CANCER#0.8622;CELL PROLIFERATION#0.8510;L-OHP#0.8309;PROSTATE CANCER#0.8204;CISPLATIN#0.8182;DNA DAMAGE CHECKPOINT#0.7957;SIGNALING PATHWAY#0.7878;PROTEIN COMPLEX#0.7649;COLON CANCER#0.7636;MTOR COMPLEX#0.7252;COLORECTAL#0.7089;GTP HYDROLYSIS#0.7088;DRUG RESISTANCE#0.6937;FOCAL CORTICAL DYSPLASIA#0.6661;G1 PHASE#0.6463;RENAL CANCER CELLS#0.6402;REGULATION OF AUTOPHAGY#0.6395;TCA CYCLE#0.6275;SQUAMOUS CELL CARCINOMA#0.6234;BREAST CANCER#0.6206;5 FLUOROURACIL#0.6173;DNA REPAIR#0.6130;MITOPHAGY#0.6048;ADENOCARCINOMA#0.6019
10642	BINDING PROTEIN 1#1.0598;MRNA BINDING#1.0483;INSULIN-LIKE GROWTH FACTOR#1.0470;GROWTH FACTOR#1.0436;OVARIAN CANCER#1.0387;RNA BINDING PROTEIN#1.0287;RNA BINDING#1.0285;CANCER CELL#1.0278;BREAST CANCER#1.0267;ONCOGENIC#1.0220;CELL PROLIFERATION#1.0132;GROWTH CONE#1.0105;CELL MIGRATION#1.0088;OVARIAN#1.0034;BREAST CANCER CELL#1.0010;TRANSCRIPTION FACTOR#0.9965;APOPTOSIS#0.9947;STEM CELL#0.9910;CELL GROWTH#0.9893;HEPATOCELLULAR CARCINOMA#0.9831;GENE EXPRESSION#0.9810;PROTEIN SYNTHESIS#0.9523;COLORECTAL CANCER#0.9461;COLORECTAL#0.9429;TUMOR SUPPRESSOR#0.9317;SIGNALING PATHWAY#0.9257;CELL CYCLE#0.9178;MACROPHAGE#0.9007;LUNG CANCER#0.8988;TUMOR CELLS#0.8923;MRNA TRANSPORT#0.8879;CELL ADHESION#0.8834;CELL DEATH#0.8749;CELL MOTILITY#0.8748;ADENOCARCINOMA#0.8653;RIBOSOME#0.8608;LUNG ADENOCARCINOMA#0.8448;RNA LOCALIZATION#0.8214;CYTOPLASM#0.8077;METASTATIC MELANOMA#0.8062;BREAST CARCINOMA#0.8050;PRO-INFLAMMATORY#0.7956;EPITHELIAL CELL#0.7836;METALLO BETA LACTAMASE#0.7576;COLON CANCER#0.7496;SQUAMOUS CELL CARCINOMA#0.7474;RNA RECOGNITION MOTIF#0.7149;MICROPHTHALMIA#0.7147;BONE MARROW#0.7047;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6952;DNA METHYLATION#0.6916;QUANTITATIVE REAL TIME#0.6765;CORD BLOOD#0.6756;PROTEIN KINASE#0.6718;POLYMERASE CHAIN REACTION#0.6486;NEURONAL CELLS#0.6309;MICROTUBULE#0.6238;CELL POLARITY#0.6149;INTESTINAL EPITHELIAL CELL#0.6122;COPY NUMBER GAIN#0.6118;AKT SIGNALING#0.6102;MRNA STABILIZATION#0.6068;MRNA DEGRADATION#0.6019
10643	HIGH GRADE DYSPLASIA#1.0812;RENAL CELL CARCINOMA#1.0592;BREAST CANCER#1.0569;BINDING PROTEIN 3#1.0514;MRNA BINDING#1.0488;LYMPH NODE#1.0446;LYMPH NODE METASTASIS#1.0433;LUNG CANCER#1.0420;CELL PROLIFERATION#1.0420;CANCER CELL#1.0418;ADENOCARCINOMA#1.0406;TUMOR CELLS#1.0405;INSULIN-LIKE GROWTH FACTOR#1.0401;GROWTH FACTOR#1.0364;SQUAMOUS CELL CARCINOMA#1.0363;RNA BINDING#1.0360;RNA BINDING PROTEIN#1.0346;DISEASE FREE SURVIVAL#1.0266;LUNG ADENOCARCINOMA#1.0213;BREAST CANCER CELL#1.0140;COLORECTAL CANCER#1.0109;PANCREATIC CANCER#1.0073;PANCREATIC DUCTAL ADENOCARCINOMA#1.0065;COLORECTAL#1.0056;OVARIAN#1.0020;MALIGNANT MESOTHELIOMA#0.9980;CLEAR CELL CARCINOMA#0.9913;GENE EXPRESSION#0.9889;HEPATOCELLULAR CARCINOMA#0.9881;CELL MIGRATION#0.9861;ENDOMETRIAL CARCINOMA#0.9705;STEM CELL#0.9673;MESOTHELIAL CELL#0.9578;CELL CYCLE#0.9500;BILE DUCT#0.9415;PROSTATE CANCER#0.9376;GASTRIC ADENOCARCINOMA#0.9340;OVERALL SURVIVAL RATE#0.9265;BREAST CARCINOMA#0.9242;CERVICAL#0.9233;POLYMERASE CHAIN REACTION#0.9132;ONCOGENIC#0.9082;VON HIPPEL LINDAU#0.8972;FINE NEEDLE ASPIRATION#0.8962;DISEASE SPECIFIC SURVIVAL#0.8957;NEUROENDOCRINE TUMOR#0.8917;IMMUNE RESPONSE#0.8850;INVASIVE UROTHELIAL CARCINOMA#0.8815;SIGNALING PATHWAY#0.8736;ANGIOGENESIS#0.8599;T CELL#0.8595;METASTATIC MELANOMA#0.8511;CELL GROWTH#0.8460;PROTEIN KINASE#0.8440;DRUG RESISTANCE#0.8247;GROWTH FACTOR RECEPTOR#0.8243;CANCER TESTIS ANTIGEN#0.8178;EPITHELIAL MESENCHYMAL TRANSITION#0.8089;ESOPHAGUS#0.8056;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.8028;EPITHELIAL CELL#0.8021;PERIPHERAL BLOOD#0.7981;CORE NEEDLE BIOPSIES#0.7980;AGGRESSIVE BEHAVIOR#0.7957;ESOPHAGEAL CANCER#0.7955;RNA INTERFERENCE#0.7882;OVARIAN CANCER#0.7876;ORAL SQUAMOUS CELL CARCINOMA#0.7868;B CELL#0.7830;CANCER SPECIFIC MORTALITY#0.7827;TUMOR SUPPRESSOR#0.7799;APOPTOSIS#0.7777;METASTASIS FREE SURVIVAL#0.7740;EXTRACELLULAR MATRIX#0.7662;OVARIAN CARCINOMA#0.7648;CELL CYCLE ARREST#0.7598;RECURRENCE FREE SURVIVAL#0.7557;SALIVARY GLAND#0.7527;THYROID CARCINOMA#0.7513;ENDOTHELIAL GROWTH FACTOR#0.7451;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7451;EPIDERMAL GROWTH FACTOR#0.7425;OOCYTE#0.7424;NEUROENDOCRINE CARCINOMA#0.7412;CERVICAL CANCER#0.7326;CELL ADHESION#0.7240;PANCREATIC LESIONS#0.6999;METASTATIC ADENOCARCINOMA#0.6925;INTRAHEPATIC CHOLANGIOCARCINOMA#0.6922;HYPOXIA#0.6780;CYTOTOXIC T-LYMPHOCYTE#0.6774;T LYMPHOCYTE#0.6733;SMALL INTESTINE#0.6727;PROGESTERONE#0.6716;TUMOR TISSUES#0.6527;ESTROGEN RECEPTOR#0.6498;CANCER SPECIFIC SURVIVAL#0.6375;ENDOMETRIAL CANCER#0.6366;BILE DUCT CARCINOMA#0.6346;LYMPH NODE METASTASES#0.6325;TUMOR ASSOCIATED ANTIGEN#0.6293;CANCER STEM CELL#0.6246;LYMPHOCYTE ANTIGEN#0.6171;SMALL CELL CARCINOMA#0.6169;LARGE CELL NEUROENDOCRINE CARCINOMA#0.6168;PANCREATITIS#0.6168;CARCINOMA IN SITU#0.6144;COLON CANCER#0.6066;CHOLANGIOCARCINOMA#0.6046;CLEAR CELL RENAL CELL CARCINOMA#0.6019;DIFFERENTIATED THYROID CARCINOMA#0.6019;TUMOR NODE METASTASIS#0.6006
10644	MRNA BINDING#1.0625;INSULIN-LIKE GROWTH FACTOR#1.0483;GROWTH FACTOR#1.0433;RNA BINDING#1.0389;RNA BINDING PROTEIN#1.0344;TYPE 2 DIABETES MELLITUS#1.0051;2 DIABETES MELLITUS#1.0051;TYPE 2 DIABETES#1.0042;BREAST CANCER#1.0016;DIABETES MELLITUS#0.9977;CELL PROLIFERATION#0.9927;INSULIN SECRETION#0.9884;GENE EXPRESSION#0.9823;HEPATOCELLULAR CARCINOMA#0.9796;CANCER CELL#0.9732;SIGNALING PATHWAY#0.9353;BETA CELL#0.9262;PANCREATIC CANCER#0.8996;STEM CELL#0.8647;CELL MIGRATION#0.8383;TRANSCRIPTION FACTOR#0.7975;ONCOGENIC#0.7948;OVARIAN#0.7777;ORAL GLUCOSE TOLERANCE#0.7587;COLON CANCER#0.7530;SKELETAL MUSCLE#0.7492;GLUCOSE TOLERANCE TEST#0.7357;GESTATIONAL DIABETES#0.7164;ADENOCARCINOMA#0.6910;COLORECTAL CANCER#0.6781;GESTATIONAL DIABETES MELLITUS#0.6756;TUMOR SUPPRESSOR#0.6527;POLYMERASE CHAIN REACTION#0.6496;COLORECTAL#0.6346;CYCLIN DEPENDENT KINASE#0.6312;CANCER STEM CELL#0.6131;TYPE 1 DIABETES#0.6127;PANCREATIC DUCTAL ADENOCARCINOMA#0.6026;FATTY ACID OXIDATION#0.6013
10645	CAMKIV#1.0811;PROSTATE CANCER#1.0453;SIGNALING CASCADE#1.0273;PROTEIN KINASE#1.0213;GLUCOSE UPTAKE#1.0198;SKELETAL MUSCLE#1.0153;SIGNALING PATHWAY#1.0030;CELL GROWTH#1.0004;ADENOSINE MONOPHOSPHATE#1.0002;CANCER CELL#0.9921;ENDOTHELIAL CELL#0.9862;ADENOSINE#0.9803;CAMKII#0.9789;TARGET OF RAPAMYCIN#0.9695;AMPK ACTIVITY#0.9681;CELL CYCLE#0.9442;MUSCLE CELL#0.9436;AUTOPHAGY#0.9371;5'-AMP#0.9369;INFLAMMATORY RESPONSE#0.9346;CELL PROLIFERATION#0.9292;GENE EXPRESSION#0.9237;APOPTOSIS#0.9128;RAPAMYCIN#0.9027;ACETYL COA CARBOXYLASE#0.8953;TRANSCRIPTION FACTOR#0.8835;GROWTH FACTOR#0.8822;MACROPHAGE#0.8762;KINASE INHIBITOR#0.8562;CAMKKBETA#0.8537;SKELETAL MUSCLE CELLS#0.8465;T CELL#0.8432;CELL DEATH#0.8403;HIGH FAT DIET#0.8313;PLASMA MEMBRANE#0.8168;GLUCOSE INTOLERANCE#0.8069;SIGNAL TRANSDUCTION#0.7829;REACTIVE OXYGEN SPECIES#0.7789;HYPOXIA#0.7757;CAM BINDING#0.7665;ENERGY HOMEOSTASIS#0.7664;CALCIUM SIGNALING#0.7602;CYTOPLASM#0.7523;RNA INTERFERENCE#0.7467;BETA CELL#0.7443;TUMOR SUPPRESSOR#0.7284;TYPE 2 DIABETES#0.7156;NITRIC OXIDE#0.7143;BLOOD BRAIN BARRIER#0.7092;NERVOUS SYSTEM#0.7070;GLUCOSE HOMEOSTASIS#0.7042;NMDA RECEPTOR#0.7027;KINASE ACTIVITY#0.7002;CAMP RESPONSE ELEMENT BINDING#0.6824;GROWTH CONE#0.6822;NEURITE OUTGROWTH#0.6817;CAMP RESPONSE ELEMENT#0.6813;LUNG CANCER#0.6811;PROTEIN KINASE A#0.6782;CENTRAL NERVOUS SYSTEM#0.6739;ANDROGEN RECEPTOR#0.6648;NEURITE#0.6621;CELL CYCLE ARREST#0.6579;CARBACHOL#0.6551;REGULATION OF AMPK#0.6471;FATTY ACID OXIDATION#0.6384;ADIPOCYTE#0.6363;INSULIN SECRETION#0.6291;OOCYTE#0.6269;CEREBRAL CORTEX#0.6097;IMMUNE CELL#0.6074;PRO-INFLAMMATORY#0.6051;BINDING PROTEIN 1#0.6035;COENZYME A#0.6030
106478911	CYSTATIN#0.6107
106478956	CELL PROLIFERATION#1.0410;CANCER CELL#1.0403;TUMOR SUPPRESSOR#0.7999
106478973	AUTISTIC#0.6291
106479023	APOPTOSIS#0.8439;CYTOPLASMIC NUCLEOSOME#0.6015
106479059	ASPIRIN#0.8547
10647	CANCER CELL#0.6249;PANCREATIC CANCER#0.6188
106480318	CELL PROLIFERATION#0.8960;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7789;SQUAMOUS CELL CARCINOMA#0.7609;APOPTOSIS#0.6411
106480735	CANCER CELL#1.1436;COLON CANCER#0.9044;CELL CYCLE#0.8971;APOPTOSIS#0.6741
10648	OVARIAN CARCINOMA#0.6194
10651	METAXIN#0.9371;TOXICITY#0.8245;MITOCHONDRIA#0.6744;EPIBOLY#0.6399;METHOTREXATE#0.6270;CEREBRAL CORTEX#0.6261;APOPTOSIS#0.6177
10652	VACUOLE FUSION#1.0363;SNARE COMPLEX#1.0332;VACUOLE#1.0289;ENDOSOME#1.0240;AUTOPHAGOSOME#0.9998;N-ETHYLMALEIMIDE#0.9983;PLASMA MEMBRANE#0.9953;LYSOSOME#0.9943;MEMBRANE FUSION#0.9937;ENDOPLASMIC RETICULUM#0.9648;AUTOPHAGOSOME-LYSOSOME FUSION#0.9310;SECRETORY PATHWAY#0.9250;ORGANELLE#0.9243;LATE ENDOSOME#0.9089;EXOCYTOSIS#0.8833;RECYCLING ENDOSOME#0.7837;GOLGI APPARATUS#0.7824;INTRACELLULAR MEMBRANE#0.7688;SNARE COMPLEX ASSEMBLY#0.7654;COMPLEX I#0.7598;ARGININE#0.7222;VESICLE FUSION#0.7110;AUTOPHAGY#0.6885;VESICLE TRAFFICKING#0.6695;TRANS GOLGI NETWORK#0.6675;PROTEIN PALMITOYLATION#0.6643;SYNAPTIC VESICLE#0.6444;PRENYLATION#0.6089;EXOSOME#0.6001
10653	TUMOR SUPPRESSOR#1.0686;EPITHELIAL CELL#1.0481;CANCER CELL#1.0470;BREAST CANCER#1.0453;HEPATOCYTE GROWTH FACTOR#1.0439;GROWTH FACTOR#1.0374;CELL SURFACE#1.0294;CELL MOTILITY#1.0098;PROSTATE CANCER#0.9819;BREAST CANCER CELL#0.9654;DIARRHEA#0.9568;PEPTIDASE INHIBITOR#0.9538;GENE EXPRESSION#0.9489;METHYLATION SPECIFIC PCR#0.8974;ZYMOGEN ACTIVATION#0.8866;RENAL CELL CARCINOMA#0.8846;PROTEINASE INHIBITOR#0.8542;POLYMERASE CHAIN REACTION#0.8200;CELL PROLIFERATION#0.8126;PLASMA MEMBRANE#0.8095;SQUAMOUS CELL CARCINOMA#0.8020;APOPTOSIS#0.7735;CERVICAL CANCER#0.7685;5-AZA-2'-DEOXYCYTIDINE#0.7629;2'-DEOXYCYTIDINE#0.7625;MAMMARY EPITHELIAL CELL#0.7604;HEPATOCELLULAR CARCINOMA#0.7387;SIGNALING PATHWAY#0.7046;INVASIVE GROWTH#0.7033;CELL MIGRATION#0.6858;STROMAL CELL#0.6667;DNA METHYLATION#0.6612;PLACENTAL DEVELOPMENT#0.6299;OVARIAN CANCER#0.6166;NEURAL TUBE#0.6108;PANCREATIC CANCER#0.6006
10654	PHOSPHOMEVALONATE KINASE#1.0971;MEVALONATE KINASE#1.0883;DIPHOSPHATE#1.0600;DIPHOSPHOMEVALONATE DECARBOXYLASE#1.0269;PEROXISOMAL#0.9420;CHOLESTEROL BIOSYNTHESIS#0.8962;PEROXISOME#0.7964;ISOPENTENYL PYROPHOSPHATE#0.7874;ISOPRENOID BIOSYNTHESIS#0.7390;POROKERATOSIS#0.7221;FARNESYL DIPHOSPHATE#0.6920;FARNESYL#0.6576
10655	TRANSCRIPTION FACTOR#0.9278;SEX DETERMINATION#0.8793;SOMITE#0.8399;GONAD#0.7193;DERMOMYOTOME#0.6884;DNA BINDING#0.6854;GERM CELL#0.6214;SKELETAL MUSCLE#0.6169
10656	RNA BINDING#1.0542;RNA BINDING PROTEIN#1.0349;TELOMERASE ACTIVITY#0.8316;CALCINEURIN#0.7549;GENE EXPRESSION#0.7495;PLASMA MEMBRANE#0.7184;CANCER CELL#0.7038;SIGNAL TRANSDUCTION#0.6644
10657	STRESS GRANULE#1.0429;GERM CELL#1.0429;MITOSIS#1.0422;BREAST CANCER#1.0421;RNA METABOLISM#1.0401;RNA BINDING PROTEIN#1.0390;INSULIN RECEPTOR#1.0372;RNA BINDING#1.0350;CELL PROLIFERATION#1.0246;BREAST CANCER CELL#1.0203;T CELL#1.0194;CELL CYCLE#1.0166;EPITHELIAL CELL#1.0165;NUCLEAR EXPORT#1.0164;CYTOPLASM#1.0112;CANCER CELL#1.0106;PROTEIN KINASE#1.0059;APOPTOSIS#1.0056;GENE EXPRESSION#1.0055;SRC FAMILY KINASE#1.0036;SIGNALING PATHWAY#1.0034;SIGNAL TRANSDUCTION#1.0024;ARGININE#0.9951;PROSTATE CANCER#0.9926;EPIDERMAL GROWTH FACTOR#0.9922;GROWTH FACTOR#0.9919;KINASE ACTIVITY#0.9875;B CELL#0.9836;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.9780;RNA PROCESSING#0.9737;PROTEIN TYROSINE KINASE#0.9715;APOPTOTIC#0.9704;SIGNALING MOLECULE#0.9640;SPERMATOGENESIS#0.9598;MRNA SPLICING#0.9597;RNA HELICASE#0.9546;CELL GROWTH#0.9533;TRANSCRIPTION FACTOR#0.9508;ONCOGENIC#0.9494;DOCKING PROTEIN#0.9459;MITOGEN ACTIVATED PROTEIN#0.9447;PLASMA MEMBRANE#0.9444;NUCLEIC ACID#0.9363;LYMPH NODE METASTASIS#0.9355;CELL DEATH#0.9346;PHOSPHOLIPASE C#0.9310;LYMPH NODE#0.9284;NERVOUS SYSTEM#0.9198;MRNA PROCESSING#0.9184;ADIPOCYTE#0.9160;HUMAN IMMUNODEFICIENCY VIRUS#0.9118;NUCLEAR LOCALIZATION SIGNAL#0.9100;PROTEIN PROTEIN INTERACTION#0.9092;SH3 DOMAIN BINDING#0.8984;GROWTH FACTOR RECEPTOR#0.8922;AUTOPHAGY#0.8921;REVERSE TRANSCRIPTION#0.8845;KINASE INHIBITOR#0.8817;ADIPOGENESIS#0.8774;STEM CELL#0.8741;RNA SPLICING#0.8728;RECEPTOR TYROSINE KINASE#0.8724;PRE-MRNA SPLICING#0.8722;SIGNALING ADAPTOR#0.8698;SIGNALLING PATHWAY#0.8415;MAP KINASE#0.8408;DOMINANT NEGATIVE MUTANT#0.8401;TRANSACTIVATION#0.8391;CELL CYCLE REGULATION#0.8390;ADIPOSE TISSUE#0.8357;BONE MARROW#0.8249;S PHASE#0.8224;CERVICAL CANCER#0.8105;POLYMERASE CHAIN REACTION#0.8077;MACROPHAGE#0.8040;PREADIPOCYTE#0.7997;CELL MIGRATION#0.7986;GENE SILENCING#0.7948;PROTEIN SYNTHESIS#0.7941;UBIQUITIN#0.7876;CELL ACTIVATION#0.7850;LUNG CANCER#0.7831;COLORECTAL CANCER#0.7801;SQUAMOUS CELL CARCINOMA#0.7800;T LYMPHOCYTE#0.7797;PROTEIN KINASE C#0.7793;PRIMARY OVARIAN INSUFFICIENCY#0.7792;PERIPHERAL BLOOD#0.7782;PELVIC LYMPH NODE#0.7697;MRNA METABOLISM#0.7616;KERATINOCYTE DIFFERENTIATION#0.7608;CELL DIFFERENTIATION#0.7606;GENOTOXIC#0.7578;COLORECTAL#0.7522;RECURRENCE FREE SURVIVAL#0.7511;M PHASE#0.7463;CELL ADHESION#0.7459;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7446;MONONUCLEAR CELLS#0.7433;EPITHELIAL MESENCHYMAL TRANSITION#0.7428;KERATINOCYTE#0.7418;CYCLIN DEPENDENT KINASE#0.7418;PROTEIN KINASE ACTIVITY#0.7347;ENDOPLASMIC RETICULUM#0.7345;ADENOCARCINOMA#0.7327;CERVICAL#0.7304;T CELL ACTIVATION#0.7274;OVARIAN#0.7265;MEIOSIS#0.7258;TUMOR SUPPRESSOR#0.7238;SPLICE SITE SELECTION#0.7186;MAST CELL#0.7061;DEPHOSPHORYLATION#0.7048;RESPONSE TO INSULIN#0.7048;NUCLEIC ACID BINDING#0.7026;NUCLEAR BODY#0.6992;RNA INTERFERENCE#0.6967;CENTRAL NERVOUS SYSTEM#0.6935;VIRAL REPLICATION#0.6897;ANDROGEN RECEPTOR#0.6873;FOCAL ADHESION#0.6780;HUMAN BREAST CANCER#0.6728;TUMOR CELLS#0.6727;NUCLEAR STRESS GRANULE#0.6721;MUTAGENESIS#0.6686;HEAT SHOCK PROTEIN#0.6652;RHEUMATOID ARTHRITIS#0.6646;B LYMPHOCYTE#0.6540;INSULIN RECEPTOR SUBSTRATE#0.6525;FOCAL ADHESION KINASE#0.6523;DNA REPAIR#0.6467;PROGENITOR CELL#0.6465;NUCLEOPLASM#0.6404;SPERMATOCYTES#0.6395;SPINAL MUSCULAR ATROPHY#0.6378;MUSCULAR ATROPHY#0.6362;RNA GRANULE#0.6294;MYELOID CELL#0.6289;REGULATION OF GENE EXPRESSION#0.6283;DNA BINDING#0.6278;TUMOR TISSUES#0.6247;HEPATOCELLULAR CARCINOMA#0.6216;PROTEIN BINDING#0.6205;ASTROCYTE#0.6201;OVERALL SURVIVAL TIME#0.6152;TUMOR NECROSIS FACTOR#0.6144;GLYCINE#0.6115;RIBONUCLEOPROTEIN COMPLEX#0.6077;UNFERTILIZED EGG#0.6065;QUANTITATIVE REAL TIME#0.6029;FIBROBLAST LIKE SYNOVIOCYTES#0.6010;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.6002
10658	CUGBP1-EIF2 COMPLEX#1.1943;MRNA DECAY#1.0920;BINDING PROTEIN 1#1.0672;CANCER CELL#1.0550;RNA BINDING#1.0340;RNA BINDING PROTEIN#1.0329;APOPTOSIS#1.0237;MYOBLAST#1.0197;RNA PROCESSING#1.0147;MYOTONIC DYSTROPHY TYPE 1#1.0095;SKELETAL MUSCLE#1.0092;CELL CYCLE#0.9986;GENE EXPRESSION#0.9864;EPITHELIAL CELL#0.9853;PROTEIN KINASE#0.9803;CELL GROWTH#0.9753;CELL PROLIFERATION#0.9667;LUNG CANCER#0.9601;TRANSCRIPTION FACTOR#0.9343;T CELL#0.9151;RNA RECOGNITION MOTIF#0.9122;TOXICITY#0.9007;ALZHEIMER'S DISEASE#0.8955;MYOGENESIS#0.8724;MUSCLE CELL#0.8613;ENHANCER BINDING PROTEIN#0.8218;ENHANCER BINDING#0.8214;STRESS GRANULE#0.8206;NERVOUS SYSTEM#0.8146;RNA METABOLISM#0.8127;CARDIOMYOCYTE#0.8087;CARDIOMYOPATHY#0.7859;RNA SPLICING#0.7831;CYTOPLASM#0.7806;INSULIN RECEPTOR#0.7749;HEART MUSCLE#0.7733;MRNA DEGRADATION#0.7579;PRE-MRNA SPLICING#0.7560;MRNA SPLICING#0.7533;T CELL ACTIVATION#0.7518;CELL ACTIVATION#0.7483;AU RICH ELEMENT#0.7480;MUSCLE WASTING#0.7396;PROTEIN TRANSLATION#0.7365;BLOOD VESSEL#0.7270;SIGNALING PATHWAY#0.7202;MRNA DEADENYLATION#0.7161;INTESTINAL EPITHELIAL CELL#0.7134;MUSCULAR DYSTROPHY#0.7098;GROWTH FACTOR#0.7051;NEUROMUSCULAR DISEASE#0.7039;MYOTUBE#0.6840;LIVER CANCER#0.6825;OOCYTE#0.6743;BREAST CANCER#0.6731;TUMOR SUPPRESSOR#0.6705;HYPERPHOSPHORYLATION#0.6570;APOPTOTIC#0.6513;SPERMIOGENESIS#0.6446;SOMITE#0.6384;EMBRYONIC HEART#0.6255;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.6210;FERTILIZATION#0.6180;TRANSLATION INITIATION#0.6133;ORAL CANCER CELL#0.6124;MYOBLAST DIFFERENTIATION#0.6118;DILATED CARDIOMYOPATHY#0.6068
10659	RNA BINDING PROTEIN#1.0548;T CELL#1.0525;RNA BINDING#1.0523;APOPTOSIS#1.0417;CANCER CELL#1.0167;MITOTIC CATASTROPHE#0.9644;RNA RECOGNITION MOTIF#0.9440;NERVOUS SYSTEM#0.9276;COLON CANCER#0.9118;RNA PROCESSING#0.8483;GENE EXPRESSION#0.8269;TUMOR SUPPRESSOR#0.8175;BREAST CANCER#0.8076;CELL DEATH#0.7824;PANCREATIC CANCER#0.7435;MYOTONIC DYSTROPHY TYPE 1#0.7334;BINDING PROTEIN 3#0.6936;HINDBRAIN#0.6491;NEUROBLASTOMA#0.6469;MRNA EDITING#0.6285;RNA EDITING#0.6207;T CELL DEVELOPMENT#0.6153;CELL CYCLE#0.6143;APOBEC#0.6083;CELL DEVELOPMENT#0.6082;BREAST CANCER CELL#0.6038;ALZHEIMER'S DISEASE#0.6021
10660	ADOLESCENT IDIOPATHIC SCOLIOSIS#1.0710;IDIOPATHIC SCOLIOSIS#1.0667;SPINAL CORD#1.0634;SCOLIOSIS#1.0466;TRANSCRIPTION FACTOR#1.0408;MUSCLE PRECURSOR CELL#1.0193;PRECURSOR CELL#1.0085;SOMITE#0.9621;SKELETAL MUSCLE#0.9613;INTERNEURON#0.9321;MYOBLAST#0.9034;NEURAL TUBE#0.8800;HINDBRAIN#0.8205;MUSCLE CELL#0.8139;DERMOMYOTOME#0.8006;MYOGENESIS#0.7447;GENE EXPRESSION#0.7369;FORELIMB#0.7312;NEURAL CREST#0.7298;CARDIAC NEURAL CREST#0.7249;CELL PROLIFERATION#0.6826;MYOGENIC PRECURSOR CELL#0.6618;PROGENITOR CELL#0.6438;CELL MIGRATION#0.6393;MYOBLAST MIGRATION#0.6030
10661	DEFINITIVE ERYTHROPOIESIS#1.0811;CONGENITAL DYSERYTHROPOIETIC ANEMIA#1.0582;FETAL LIVER#1.0346;CELL CYCLE#1.0268;GLOBIN#1.0248;DNA BINDING#1.0237;TRANSACTIVATION#1.0233;ERYTHROID PROGENITOR#1.0231;TRANSCRIPTION FACTOR#1.0213;ANEMIA#1.0129;THALASSEMIA#1.0116;ERYTHROID CELL#1.0105;ERYTHROPOIESIS#1.0073;GENE EXPRESSION#0.9995;ERYTHROBLAST#0.9991;PROGENITOR CELL#0.9982;RED BLOOD CELL#0.9979;MEGAKARYOCYTE#0.9903;BONE MARROW#0.9881;STEM CELL#0.9876;TERMINAL DIFFERENTIATION#0.9770;ERYTHROCYTE#0.9715;POLYMERASE CHAIN REACTION#0.9700;YOLK SAC#0.9698;SICKLE CELL DISEASE#0.9680;PRIMITIVE ERYTHROPOIESIS#0.9649;ERYTHROLEUKEMIA#0.9615;HEMATOPOIESIS#0.9581;BETA THALASSEMIA#0.9536;CHROMATIN REMODELING#0.9502;PLURIPOTENT STEM CELL#0.9263;ZINC FINGER PROTEIN#0.9164;ERYTHROID PRECURSOR#0.9045;HEMOLYTIC ANEMIA#0.9004;HEMATOPOIETIC STEM CELL#0.8979;SIGNALING PATHWAY#0.8951;CELL DIFFERENTIATION#0.8848;HYDROPS FETALIS#0.8750;CORD BLOOD#0.8711;MEGAKARYOCYTE-ERYTHROID PROGENITOR#0.8613;MACROPHAGE#0.8541;HEMATOPOIETIC CELL#0.8499;PRIMITIVE ERYTHROID CELL#0.8461;INDUCED PLURIPOTENT STEM CELL#0.8301;BINDING PROTEIN 1#0.8286;PERIPHERAL BLOOD#0.8242;ERYTHROPOIETIN RECEPTOR#0.8164;T CELL#0.8073;EMBRYONIC STEM CELL#0.7905;DNASE I#0.7887;DNA METHYLATION#0.7865;DNASE#0.7693;CELL DIVISION#0.7637;FACTOR I#0.7620;CELL DEVELOPMENT#0.7456;HISTONE DEACETYLASE#0.7447;TRANSCRIPTIONAL CONTROL#0.7267;CELL MEMBRANE#0.7234;BLOOD GROUP ANTIGEN#0.7209;HEMOGLOBINOPATHY#0.7158;APOPTOSIS#0.7105;RETICULOCYTE#0.7000;CELL PROLIFERATION#0.6998;HYDROXYUREA#0.6925;CHROMATIN REMODELING COMPLEX#0.6902;NUCLEAR IMPORT#0.6838;ANEMIC#0.6804;PROTEIN PROTEIN INTERACTION#0.6793;RESPONSE TO ERYTHROPOIETIN#0.6788;GROWTH FACTOR#0.6723;ENDOTHELIAL CELL#0.6692;APOPTOTIC#0.6679;MYELOID LEUKEMIA#0.6554;HEMOLYSIS#0.6545;LYSINE#0.6511;MEGAKARYOCYTE DIFFERENTIATION#0.6499;HEMATOPOIETIC PROGENITOR CELL#0.6372;MYELOID CELL#0.6334;ACUTE MYELOID LEUKEMIA#0.6305;PROTEIN KINASE#0.6263;ENUCLEATION#0.6252;HEMOGLOBIN METABOLISM#0.6241;ANAEMIA#0.6008
10663	CXCR6+ T CELL#1.1699;CC CHEMOKINE RECEPTOR#1.0779;C CHEMOKINE RECEPTOR#1.0671;NKT CELL#1.0619;PROSTATE CANCER#1.0502;CD8+ T CELL#1.0311;CHEMOKINE RECEPTOR#1.0238;NATURAL KILLER T#1.0219;CANCER CELL#1.0170;LYMPHOID TISSUE#1.0160;REVERSE TRANSCRIPTION#1.0125;T LYMPHOCYTE#1.0110;POLYMERASE CHAIN REACTION#1.0088;CD4+ T CELL#1.0077;T CELL#1.0042;CELL ACTIVATION#1.0027;CHEMOTAXIS#0.9989;MEMORY T CELL#0.9966;MONOCYTE#0.9961;LYMPH NODE#0.9957;STEM CELL#0.9916;BONE MARROW#0.9912;PERIPHERAL BLOOD#0.9909;MACROPHAGE#0.9901;CELL SURFACE#0.9901;DENDRITIC CELL#0.9895;EPITHELIAL CELL#0.9893;SIMIAN IMMUNODEFICIENCY VIRUS#0.9855;BREAST CANCER#0.9848;ENDOTHELIAL CELL#0.9840;SIGNALING PATHWAY#0.9838;IMMUNE CELL#0.9825;CELL MIGRATION#0.9821;STROMAL CELL#0.9789;IMMUNE RESPONSE#0.9777;B CELL#0.9766;TH17 CELL#0.9752;HUMAN IMMUNODEFICIENCY VIRUS#0.9739;LEUKOCYTE#0.9697;MONONUCLEAR CELLS#0.9651;CELL PROLIFERATION#0.9562;RHEUMATOID ARTHRITIS#0.9491;NEUTROPHIL#0.9489;HEPATOCELLULAR CARCINOMA#0.9476;CYTOKINE PRODUCTION#0.9383;LUNG CANCER#0.9355;ATHEROSCLEROSIS#0.9348;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9296;GENE EXPRESSION#0.9251;CELL ADHESION#0.9158;SCAVENGER RECEPTOR#0.9131;TUMOR NECROSIS FACTOR#0.9050;TROPHOBLAST#0.9042;TROPHOBLAST CELL#0.8937;TUMOR CELLS#0.8926;ACTIVATED T CELL#0.8893;LIVER DISEASE#0.8839;ACTIVATED T-CELLS#0.8803;NATURAL KILLER T CELL#0.8752;SMOOTH MUSCLE#0.8741;OVARIAN#0.8736;TROPISM#0.8724;INFLAMMATORY RESPONSE#0.8617;T CELL ACTIVATION#0.8473;GROWTH FACTOR#0.8470;LYMPH NODE METASTASIS#0.8404;BREAST CANCER CELL#0.8376;TH1 CELL#0.8330;APOPTOSIS#0.8293;PRO-INFLAMMATORY#0.8251;CC CHEMOKINE LIGAND#0.8226;ANGIOGENESIS#0.8219;LYMPHOID CELL#0.8186;IFN-GAMMA#0.8182;TRANSCRIPTION FACTOR#0.8156;EFFECTOR T CELL#0.7929;NATURAL KILLER CELL#0.7835;CELL DEATH#0.7794;LOW DENSITY LIPOPROTEIN#0.7788;MESENCHYMAL STEM CELL#0.7689;ATHEROSCLEROTIC#0.7576;OVARIAN CARCINOMA#0.7493;FLOW CYTOMETRY ANALYSIS#0.7472;SMOOTH MUSCLE CELL#0.7451;MUSCLE CELL#0.7444;T CELL MIGRATION#0.7275;COLORECTAL CANCER#0.7190;ENDOTHELIUM#0.7190;SIGNAL TRANSDUCTION#0.7181;COLITIS#0.7042;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7018;PERIPHERAL BLOOD LYMPHOCYTES#0.6917;MULTIPLE SCLEROSIS#0.6774;CANCER STEM CELL#0.6760;CELL GROWTH#0.6743;RENAL CELL CARCINOMA#0.6695;COLORECTAL#0.6684;CHRONIC LIVER DISEASE#0.6595;VIRAL REPLICATION#0.6516;STROMA#0.6344;REGULATORY T CELL#0.6311;KERATINOCYTE#0.6307;B CELL LYMPHOMA#0.6292;CENTRAL NERVOUS SYSTEM#0.6282;NERVOUS SYSTEM#0.6272;SELECTIN#0.6222;TUMOUR NECROSIS FACTOR#0.6201;NKT CELL ACTIVATION#0.6186;INFLAMMATORY CELL#0.6155;PRECURSOR CELL#0.6059;MALT LYMPHOMA#0.6059;TUBERCULOSIS#0.6056;FATTY LIVER#0.6055;JUVENILE IDIOPATHIC ARTHRITIS#0.6022;SPINAL CORD#0.6015;ALVEOLAR MACROPHAGE#0.6009
10664	CORNEAL EPITHELIAL CELL#1.0848;COHESIN COMPLEX#1.0628;ZINC FINGER PROTEIN#1.0509;CHROMATIN LOOPING#1.0413;FACTOR I#1.0296;TUMOR SUPPRESSOR#1.0237;BREAST CANCER CELL#1.0224;DNA BINDING#1.0214;X CHROMOSOME#1.0201;X CHROMOSOME INACTIVATION#1.0198;CHROMOSOME INACTIVATION#1.0196;GLOBIN#1.0194;GERM CELL#1.0185;ERYTHROID CELL#1.0182;CELL PROLIFERATION#1.0171;CHROMATIN ORGANIZATION#1.0153;IMPRINTING CONTROL REGION#1.0149;ELECTROPHORETIC MOBILITY SHIFT#1.0145;VIRAL GENOME#1.0131;DEMETHYLATION#1.0110;NUCLEOSOME POSITIONING#1.0082;BREAST CANCER#1.0081;CELL GROWTH#1.0060;EPITHELIAL CELL#1.0054;NUCLEOSOME#1.0052;POLYCOMB REPRESSIVE COMPLEX#1.0028;PROSTATE CANCER#1.0012;CELL CYCLE#1.0009;B CELL#1.0002;APOPTOTIC#1.0001;HISTONE MODIFICATION#0.9998;DNASE I#0.9994;CHROMATIN REMODELING#0.9992;DIFFERENTIALLY METHYLATED REGION#0.9989;CELL DIFFERENTIATION#0.9988;HETEROCHROMATIN#0.9984;CANCER CELL#0.9969;DNASE#0.9968;NUCLEOLUS#0.9966;LYSINE#0.9945;APOPTOSIS#0.9936;T CELL#0.9932;TRANSCRIPTION FACTOR#0.9921;INTELLECTUAL DISABILITY#0.9914;DNA METHYLATION#0.9909;MITOSIS#0.9908;INSULIN-LIKE GROWTH FACTOR#0.9906;GROWTH FACTOR#0.9900;GENE SILENCING#0.9892;LUNG CANCER#0.9886;HISTONE DEACETYLASE#0.9879;NUCLEAR ORGANIZATION#0.9879;EMBRYONIC STEM CELL#0.9871;PROTEIN BINDING#0.9862;V-D-J RECOMBINATION#0.9831;OVARIAN#0.9819;TRANSCRIPTION REGULATOR#0.9808;STEM CELL#0.9774;ESTROGEN RECEPTOR#0.9771;TRANSCRIPTION FACTOR BINDING#0.9765;MOUSE EMBRYONIC STEM#0.9744;GENE EXPRESSION#0.9728;HOST CELL#0.9701;NUCLEAR MATRIX#0.9694;ENDOMETRIAL CANCER#0.9653;EPSTEIN BARR VIRUS#0.9649;CHROMATIN BINDING#0.9617;KAPOSI'S SARCOMA#0.9582;HISTONE ACETYLATION#0.9573;ONCOGENIC#0.9561;TRANSCRIPTIONAL CONTROL#0.9553;BECKWITH-WIEDEMANN SYNDROME#0.9550;DNA REPLICATION#0.9542;CHROMATIN MODIFICATION#0.9513;DNA METHYLTRANSFERASE#0.9510;PROTEIN COMPLEX#0.9491;HUMAN CORNEAL EPITHELIAL#0.9427;HYPERSENSITIVITY#0.9421;SPERMATOGENESIS#0.9413;COHESIN LOADING#0.9393;PROGENITOR CELL#0.9385;SIGNALING PATHWAY#0.9360;CELL DEVELOPMENT#0.9347;INTERPHASE#0.9336;TF BINDING#0.9335;POLY ADP RIBOSE#0.9335;REGULATION OF GENE EXPRESSION#0.9330;OVARIAN CANCER#0.9302;CELL DEATH#0.9287;CANCER TESTIS ANTIGEN#0.9012;DNA HYPOMETHYLATION#0.8989;POST-TRANSLATIONAL MODIFICATION#0.8981;RNA BINDING#0.8962;HEPATOCELLULAR CARCINOMA#0.8941;DOUBLE STRAND BREAK#0.8920;FERTILIZATION#0.8918;DNA DEMETHYLATION#0.8887;DNA REPAIR#0.8866;LOSS OF METHYLATION#0.8864;TELOMERE#0.8849;SISTER CHROMATID COHESION#0.8771;RIBOSE#0.8710;HISTONE METHYLATION#0.8705;CHROMATID#0.8658;HERPES SIMPLEX#0.8585;RNA INTERFERENCE#0.8505;POSTTRANSLATIONAL MODIFICATION#0.8494;MONOCYTE#0.8488;HOMOLOGOUS RECOMBINATION#0.8408;CARDIOMYOCYTE#0.8368;VIRAL TRANSCRIPTION#0.8336;SIGNALLING PATHWAY#0.8303;HUMAN EMBRYONIC STEM#0.8294;POLYMERASE CHAIN REACTION#0.8292;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8286;CD4+ T CELL#0.8257;EUCHROMATIN#0.8146;PROTEIN CODING GENE#0.8130;LIVER CANCER#0.8050;CHROMOSOME SEGREGATION#0.8044;COLORECTAL#0.8039;OOCYTE#0.8038;HETEROCHROMATIN FORMATION#0.8035;HERPES SIMPLEX VIRUS#0.7977;CHROMOSOME ORGANIZATION#0.7976;IMMUNE RESPONSE#0.7943;MYELOID CELL#0.7919;MYELOID LEUKEMIA#0.7894;EPITHELIAL OVARIAN CANCER#0.7848;HUMAN BREAST CANCER#0.7807;SQUAMOUS CELL CARCINOMA#0.7770;CYSTIC FIBROSIS#0.7769;NERVOUS SYSTEM#0.7727;MACROPHAGE#0.7697;SEQUENCE SPECIFIC DNA BINDING#0.7676;PLURIPOTENT STEM CELL#0.7652;TRANSFORMING GROWTH FACTOR#0.7606;EPIDERMAL GROWTH FACTOR#0.7598;PROTEIN KINASE#0.7581;SUMOYLATION#0.7574;RETINOIC ACID#0.7563;EPISOME#0.7520;DNA DAMAGE RESPONSE#0.7492;AMYLOID PRECURSOR PROTEIN#0.7391;5-AZA-2'-DEOXYCYTIDINE#0.7384;2'-DEOXYCYTIDINE#0.7380;TUMOR CELLS#0.7324;TUMOR NECROSIS FACTOR#0.7311;COLORECTAL CANCER#0.7298;ALLELE SPECIFIC EXPRESSION#0.7269;THYMOCYTE#0.7215;SILVER RUSSELL SYNDROME#0.7206;CELL MOTILITY#0.7204;PANCREATIC ISLET#0.7201;GAMETOGENESIS#0.7191;PLASMA CELL#0.7163;NUCLEAR LAMINA#0.7161;TOPOISOMERASE#0.7108;NUCLEAR PERIPHERY#0.7078;SUBTELOMERE#0.7056;DNA HYPERMETHYLATION#0.7027;ANGIOGENESIS#0.7000;PRECURSOR CELL#0.6990;CELL DIVISION#0.6979;VIRAL GENE EXPRESSION#0.6943;ACUTE MYELOID LEUKEMIA#0.6916;ANTISENSE RNA#0.6907;HEPATOCYTE NUCLEAR FACTOR#0.6899;CHROMATIN REMODELLING#0.6882;CO BINDING#0.6874;HETEROCHROMATIN PROTEIN 1#0.6827;CLASS SWITCH RECOMBINATION#0.6816;MITOTIC CHROMOSOME#0.6808;DEACETYLASE ACTIVITY#0.6804;B CELL DEVELOPMENT#0.6784;HEMATOPOIESIS#0.6749;MUTAGENESIS#0.6698;VDR BINDING#0.6689;REVERSE TRANSCRIPTION#0.6639;VITAMIN D RECEPTOR#0.6581;B LYMPHOCYTE#0.6556;S PHASE#0.6549;EARLY GROWTH RESPONSE#0.6509;CELL NUCLEUS#0.6508;CORNELIA DE LANGE SYNDROME#0.6472;ENHANCER BINDING#0.6470;CHROMOSOMAL REGION#0.6470;BINDING PROTEIN 1#0.6443;CERVICAL#0.6435;COMPLEX I#0.6433;BREAST CELL LINES#0.6415;BONE MARROW#0.6384;SOMATIC TISSUE#0.6373;NUCLEAR CHROMATIN#0.6338;SPERMATOZOA#0.6331;CYTOSINE METHYLATION#0.6281;SENESCENCE#0.6257;B CELL LYMPHOMA#0.6255;KERATINOCYTE#0.6255;HEMATOPOIETIC STEM CELL#0.6254;BREAST CARCINOMA#0.6223;MOLECULAR FUNCTION#0.6203;THYROID HORMONE RECEPTOR#0.6201;ENDOTHELIAL CELL#0.6161;PROTEIN PROTEIN INTERACTION#0.6141;CELL CYCLE ARREST#0.6127;NEURONAL CELLS#0.6118;RNA SPLICING#0.6075;NORMAL BREAST TISSUE#0.6065;RESPONSE TO ESTROGEN#0.6022;OVARIAN CARCINOMA#0.6000
10666	LEUKOCYTE ADHESION#1.0636;NATURAL CYTOTOXICITY RECEPTOR#1.0486;CD8+ T CELL#1.0365;ENDOTHELIAL CELL#1.0333;LEUKOCYTE#1.0331;CELL ADHESION#1.0313;TYPE 1 DIABETES#1.0283;CELL DIFFERENTIATION#1.0283;T CELL DIFFERENTIATION#1.0242;T CELL ACTIVATION#1.0240;AUTOIMMUNE DISEASE#1.0181;T LYMPHOCYTE#1.0165;NK CELL ACTIVATION#1.0165;RHEUMATOID ARTHRITIS#1.0152;T CELL#1.0108;DENDRITIC CELL#1.0107;CELL ACTIVATION#1.0094;LYSIS#1.0074;CYTOTOXIC T-LYMPHOCYTE#1.0063;RECEPTOR LIGAND#1.0041;CELL SURFACE#1.0025;CD4+ T CELL#1.0013;MULTIPLE MYELOMA#1.0012;CELL CELL ADHESION#1.0012;MONOCYTE#1.0007;CYTOTOXICITY#1.0001;CELL RECOGNITION#1.0000;MULTIPLE SCLEROSIS#0.9942;PERIPHERAL BLOOD#0.9933;TUMOR CELLS#0.9906;NATURAL KILLER CELL#0.9880;NKT CELL#0.9855;MONONUCLEAR CELLS#0.9844;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9832;LUPUS ERYTHEMATOSUS#0.9829;CANCER CELL#0.9818;IMMUNE RESPONSE#0.9816;CELL ADHESION MOLECULE#0.9800;IMMUNE CELL#0.9729;PLATELET ACTIVATION#0.9718;TRANSCRIPTION FACTOR#0.9715;B CELL#0.9704;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9678;STEM CELL#0.9667;CYTOKINE PRODUCTION#0.9654;GENE EXPRESSION#0.9606;IMMUNE SYSTEM#0.9574;BONE MARROW#0.9485;NK CELL MEDIATED CYTOTOXICITY#0.9409;GRAFT VERSUS HOST#0.9372;REGULATORY T CELL#0.9366;EPITHELIAL CELL#0.9290;MYELOID LEUKEMIA#0.9284;ACUTE MYELOID LEUKEMIA#0.9243;CELL PROLIFERATION#0.9146;NEUTROPHIL#0.9052;EXTRACELLULAR REGION#0.8916;APOPTOSIS#0.8798;LYMPH NODE#0.8703;CELL KILLING#0.8684;DNA DAMAGE RESPONSE#0.8681;VIRAL INFECTION#0.8635;PROTEIN KINASE#0.8604;ACTIVATED T CELL#0.8573;TUMOR NECROSIS FACTOR#0.8470;OVARIAN#0.8459;LIPID RAFT#0.8451;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8397;MACROPHAGE#0.8386;GLYCOPROTEIN COMPLEX#0.8368;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8356;HUMAN UMBILICAL VEIN#0.8350;UMBILICAL VEIN#0.8347;AUTOIMMUNITY#0.8327;PROTEIN KINASE C#0.8197;ACTIVATED T-CELLS#0.8144;NAIVE T CELL#0.7958;IMMUNOLOGICAL SYNAPSE#0.7849;ENDOTHELIUM#0.7833;BREAST CANCER#0.7822;CD3+ T CELL#0.7786;INNATE IMMUNITY#0.7777;NEUROBLASTOMA#0.7707;CELL MATURATION#0.7700;INFLAMMATORY MONOCYTE#0.7651;EXTRACELLULAR MATRIX#0.7566;OVARIAN CARCINOMA#0.7457;MELANOMA CELL LINES#0.7439;CHEMOKINE RECEPTOR#0.7417;NERVOUS SYSTEM#0.7369;SIGNALING PATHWAY#0.7312;ANTIGEN PRESENTING CELLS#0.7277;HEMATOPOIETIC STEM CELL#0.7268;GROWTH FACTOR#0.7193;IMMUNE EVASION#0.7191;POLYMERASE CHAIN REACTION#0.7141;NK CELL DEGRANULATION#0.7054;CYTOKINE SECRETION#0.7050;STEM CELL TRANSPLANTATION#0.7032;CYTOLYSIS#0.6947;MULTIPLE MYELOMA CELLS#0.6870;IFN-GAMMA#0.6849;OVARIAN CANCER#0.6775;THYMOCYTE#0.6774;MYELOID CELL#0.6771;CELL DEATH#0.6737;TH17 CELL#0.6705;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6508;HEPATOCELLULAR CARCINOMA#0.6446;NATURAL KILLER T#0.6347;EFFECTOR T CELL#0.6334;PLASMA CELL#0.6310;PROGENITOR CELL#0.6263;MAST CELL#0.6262;MEGAKARYOCYTE#0.6257;ARTERY#0.6164;T CELL PROLIFERATION#0.6159;CENTRAL NERVOUS SYSTEM#0.6150;TH1 CELL#0.6068;MEMORY T CELL#0.6064;PLATELET AGGREGATION#0.6038;IL-17 PRODUCTION#0.6006
10667	PARAPLEGIA#0.7244;TRNA CHARGING#0.6729;TRNA BINDING#0.6404;ADENYLATE#0.6251;PROTEIN SYNTHESIS#0.6224
10668	NORMAL BREAST TISSUE#0.6591;ENDOMETRIAL CANCER#0.6509;BREAST CANCER#0.6350
10669	CELL GROWTH#0.7683;CELL ADHESION#0.6389
1066	CHOLESTERYL ESTER HYDROLASE ACTIVITY#1.0887;CHOLESTEROL O ACYLTRANSFERASE#1.0834;CHOLESTEROL ACYLTRANSFERASE ACTIVITY#1.0615;O ACYLTRANSFERASE#1.0601;OSELTAMIVIR#1.0538;ACYLTRANSFERASE ACTIVITY#1.0507;BETA GLUCURONIDASE#1.0496;CLOPIDOGREL#1.0452;ACAT ACTIVITY#1.0356;COENZYME A#1.0340;ADIPOCYTE#1.0328;HYDROLASE ACTIVITY#1.0327;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0326;B CELL#1.0314;TRIGLYCERIDE LIPASE#1.0297;CPT-11#1.0296;HORMONE SENSITIVE LIPASE#1.0270;METHYLPHENIDATE#1.0200;BILE ACID SYNTHESIS#1.0147;DRUG METABOLISM#1.0125;IRINOTECAN#1.0118;HMG-COA REDUCTASE ACTIVITY#1.0111;LIPOLYSIS#1.0099;SMALL INTESTINE#1.0098;CHOLESTEROL EFFLUX#1.0095;ETHANOL#1.0070;CHOLESTEROL ESTERIFICATION#1.0053;SERINE HYDROLASE#1.0051;ENDOPLASMIC RETICULUM#1.0038;RETINOL#1.0023;CYTOCHROME P450#1.0016;ADIPOSE TISSUE#1.0010;STRUCTURE ACTIVITY RELATIONSHIP#1.0002;FOAM CELL FORMATION#0.9993;LDL RECEPTOR#0.9978;MACROPHAGE#0.9973;HYPERCHOLESTEROLEMIA#0.9967;LIPOPROTEIN LIPASE#0.9966;VITAMIN A#0.9956;MICROSOME#0.9951;OLEIC ACID#0.9945;ESTERASE ACTIVITY#0.9935;LIPID DROPLET#0.9920;CHOLESTEROL TRANSPORT#0.9915;ANGIOTENSIN CONVERTING ENZYME#0.9913;LIPASE ACTIVITY#0.9909;SCAVENGER RECEPTOR#0.9904;MONOCYTE#0.9902;CHOLESTEROL HOMEOSTASIS#0.9896;CATALYTIC ACTIVITY#0.9881;PROTEIN KINASE#0.9877;PLASMA MEMBRANE#0.9875;VERY-LOW-DENSITY LIPOPROTEIN#0.9870;CHOLESTEROL SYNTHESIS#0.9867;SMOOTH MUSCLE#0.9850;CELL DEATH#0.9850;CYTOTOXICITY#0.9848;PALMITATE#0.9836;GENE EXPRESSION#0.9821;ENZYME ACTIVITY#0.9818;CHOLESTEROL METABOLISM#0.9814;ATHEROSCLEROTIC#0.9809;SMOOTH MUSCLE CELL#0.9802;LIVER DISEASE#0.9801;MUSCLE CELL#0.9796;ATP BINDING CASSETTE#0.9795;LIPID METABOLISM#0.9782;MAMMARY GLAND#0.9782;ATP BINDING#0.9779;ATHEROSCLEROSIS#0.9778;APOPTOSIS#0.9763;HIGH DENSITY LIPOPROTEIN#0.9734;ENZYME INHIBITOR#0.9727;HIGH CHOLESTEROL DIET#0.9726;TRANSCRIPTION FACTOR#0.9710;DABIGATRAN#0.9702;TOXICITY#0.9681;LOW DENSITY LIPOPROTEIN#0.9675;CHYLOMICRON#0.9602;LYSOSOME#0.9585;CANCER CELL#0.9539;HEROIN#0.9532;CELL SURFACE#0.9495;ENALAPRIL#0.9486;PROGESTERONE#0.9457;MONOCYTE DERIVED MACROPHAGE#0.9430;REVERSE CHOLESTEROL TRANSPORT#0.9414;STEROIDOGENESIS#0.9350;POLYMERASE CHAIN REACTION#0.9338;RETINOL BINDING#0.9320;HIGH FAT DIET#0.9308;CYCLIC AMP#0.9265;HEPATOMA CELLS#0.9208;ADRENAL GLAND#0.9154;CATABOLISM#0.9153;MONONUCLEAR CELLS#0.9151;COA HYDROLASE#0.9135;DABIGATRAN ETEXILATE#0.9133;FATTY LIVER#0.9102;CHOLESTEROL BIOSYNTHESIS#0.9037;INTESTINAL CHOLESTEROL ABSORPTION#0.8979;INTESTINAL ABSORPTION#0.8950;HEPARIN#0.8888;ACYL COA HYDROLASE#0.8877;RETINOIC ACID#0.8874;RETINAL PIGMENT EPITHELIUM#0.8873;SIGNALING PATHWAY#0.8860;TUMOR CELLS#0.8826;SIMVASTATIN#0.8807;IFN-GAMMA#0.8797;CORONARY HEART DISEASE#0.8787;CHOLESTEROL UPTAKE#0.8768;HEART DISEASE#0.8763;CELL PROLIFERATION#0.8745;ARTERY#0.8738;EXCRETION#0.8720;HYDROLASE INHIBITOR#0.8707;DETOXIFICATION#0.8687;VLDL ASSEMBLY#0.8687;CHOLESTYRAMINE#0.8656;INTESTINAL MUCOSA#0.8653;T CELL#0.8636;LIPOGENESIS#0.8634;FATTY LIVER DISEASE#0.8627;ESTRADIOL#0.8578;PROTEIN KINASE C#0.8565;ATP BINDING CASSETTE TRANSPORTER#0.8564;PERIPHERAL BLOOD#0.8538;OBESE#0.8519;VITAMIN A METABOLISM#0.8509;ACE INHIBITOR#0.8474;CELL GROWTH#0.8461;BRUSH BORDER#0.8436;LIPID SYNTHESIS#0.8428;CARBOXYLESTERASE ACTIVITY#0.8404;PLATELET AGGREGATION#0.8382;PEROXISOME#0.8366;ASPIRIN#0.8357;ACID PHOSPHATASE#0.8356;VITAMIN E#0.8307;TAUROCHOLATE#0.8300;CELL DIVISION#0.8277;EPITHELIAL CELL#0.8237;COLORECTAL#0.8142;LIPOPROTEIN METABOLISM#0.8137;CHOLESTEROL ESTERASE ACTIVITY#0.8125;ACUTE CORONARY SYNDROME#0.8121;CELL CYCLE#0.8076;CLOFIBRATE#0.8067;PROGRAMMED CELL DEATH#0.8059;LOVASTATIN#0.8027;BREAST CANCER#0.8017;MITOCHONDRIA#0.7970;COLORECTAL CANCER#0.7964;REVERSE TRANSCRIPTION#0.7899;GLUTATHIONE#0.7895;CELL MEMBRANE#0.7883;CONGESTIVE HEART FAILURE#0.7877;ENTEROCYTE#0.7876;TESTOSTERONE#0.7820;PROBUCOL#0.7817;B LYMPHOCYTE#0.7793;TRANDOLAPRIL#0.7784;STEROL REGULATORY ELEMENT#0.7783;PROTEIN KINASE A#0.7762;GROWTH FACTOR#0.7751;HEPATOCELLULAR CARCINOMA#0.7732;CHOLESTEROL STORAGE#0.7674;OVARIAN#0.7645;TOPOISOMERASE#0.7617;HYDROXYLASE ACTIVITY#0.7611;IRINOTECAN, CPT-11#0.7608;PRASUGREL#0.7584;BRUSH BORDER MEMBRANE#0.7584;CHYLOMICRON REMNANT#0.7579;5 FLUOROURACIL#0.7566;ELECTROPHORETIC MOBILITY SHIFT#0.7563;HYPERTENSION#0.7493;ENDOTHELIAL CELL#0.7455;ATORVASTATIN#0.7453;LEYDIG CELL#0.7443;MUTAGENESIS#0.7420;MYOCARDIAL INFARCTION#0.7418;CORONARY ARTERY#0.7416;CELL POLARITY#0.7403;CAPECITABINE#0.7383;JEJUNUM#0.7343;HEPATIC LIPASE#0.7305;LIPID BINDING#0.7247;CORPUS LUTEUM#0.7245;HEPATOCYTE NUCLEAR FACTOR#0.7226;OOCYTE#0.7223;ARACHIDONIC ACID#0.7212;FATTY ACID OXIDATION#0.7206;SIGNAL TRANSDUCTION#0.7178;PRIMARY HUMAN HEPATOCYTES#0.7135;BEZAFIBRATE#0.7114;FARNESOID X RECEPTOR#0.7071;ACYL-COA:CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.7070;HISTIDINE#0.7045;CELL DIFFERENTIATION#0.7040;BONE MARROW#0.7015;RECEPTOR ACTIVITY#0.7011;WHITE ADIPOSE TISSUE#0.7008;QUANTITATIVE REAL TIME#0.6958;FATTY ACID BINDING#0.6949;PHOSPHOLIPASE A2#0.6933;ADENOSINE#0.6929;GLYCOSYLATION#0.6903;AORTIC SMOOTH MUSCLE CELLS#0.6895;LIPID HOMEOSTASIS#0.6887;SUPEROXIDE DISMUTASE#0.6875;HDL RECEPTOR#0.6866;HEPATITIS C#0.6822;LIPID STORAGE#0.6810;ASYMMETRIC CELL DIVISION#0.6801;RETINOID METABOLISM#0.6775;HISTONE DEACETYLASE#0.6713;CORONARY ARTERY DISEASE#0.6707;ARTERY DISEASE#0.6705;T LYMPHOCYTE#0.6697;MECHANISM OF ACTION#0.6695;ALKALINE PHOSPHATASE#0.6688;ALZHEIMER'S DISEASE#0.6679;DEXAMETHASONE#0.6634;DIPHOSPHATE#0.6629;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.6615;HEPATITIS C VIRUS#0.6552;CHLOROQUINE#0.6546;FLUOROURACIL#0.6516;STEROL SYNTHESIS#0.6408;MYELOID LEUKEMIA#0.6407;KINASE INHIBITOR#0.6395;TEMOCAPRIL#0.6376;PREGNENOLONE#0.6355;NARCOTIC#0.6309;KUPFFER CELL#0.6293;BENZOIC ACID#0.6273;UBIQUITIN#0.6261;KERATINOCYTE#0.6239;FATTY ACID SYNTHASE#0.6223;SERUM ALBUMIN#0.6215;DIACYLGLYCEROL O ACYLTRANSFERASE#0.6199;FAMILIAL HYPERCHOLESTEROLEMIA#0.6193;VERAPAMIL#0.6192;HUMAN INTESTINAL MICROSOMES#0.6186;DIGESTION#0.6171;ABC TRANSPORTER#0.6165;INDOMETHACIN#0.6159;BREAST CANCER CELL#0.6156;SULFONAMIDE#0.6139;LOPERAMIDE#0.6011
10670	TARGET OF RAPAMYCIN#1.0019;GAP ACTIVITY#0.9955;LYSOSOME#0.9822;RAPAMYCIN#0.9814;GTP BINDING#0.9749;TARGET OF RAPAMYCIN COMPLEX#0.9509;RAGULATOR COMPLEX#0.9248;CELL GROWTH#0.8754;GROWTH FACTOR#0.7768;LYSOSOMAL MEMBRANE#0.7745;MTOR COMPLEX#0.7572;STEM CELL#0.7450;NUTRIENT SENSING#0.7412;AUTOPHAGY#0.7041;LYSOSOME LOCALIZATION#0.7015;PROTEIN COMPLEX#0.6707;SKELETAL MUSCLE#0.6479;AUTOSOMAL DOMINANT CATARACT#0.6184;TRANSCRIPTION FACTOR#0.6026
10671	KINASE INHIBITOR P27#1.0640;CDK INHIBITOR#1.0383;CELL CYCLE REGULATOR#1.0376;CYCLIN DEPENDENT KINASE INHIBITOR#1.0363;SENESCENCE#1.0216;CYCLIN DEPENDENT KINASE#1.0211;KINASE INHIBITOR#1.0204;RETINOBLASTOMA#1.0121;CELLULAR SENESCENCE#1.0100;UBIQUITIN#1.0067;KINASE ACTIVITY#1.0061;RAPAMYCIN#1.0060;PROTEASOME#1.0038;DNA SYNTHESIS#0.9971;G1 PHASE#0.9970;S PHASE#0.9965;CYTOPLASM#0.9943;CELL CYCLE#0.9937;M PHASE#0.9924;CELL CYCLE REGULATION#0.9922;CELL CYCLE ARREST#0.9921;CELL CYCLE CONTROL#0.9915;T CELL#0.9900;TUMOR SUPPRESSOR#0.9881;POLY ADP RIBOSE#0.9870;ENDOTHELIAL GROWTH FACTOR#0.9843;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9843;OVARIAN#0.9841;AKT SIGNALING#0.9839;INDUCTION OF APOPTOSIS#0.9830;ENDOTHELIAL CELL#0.9816;SQUAMOUS CELL CARCINOMA#0.9810;PROTEIN KINASE#0.9808;SMOOTH MUSCLE#0.9806;HUMAN BREAST CANCER#0.9805;CELL MIGRATION#0.9805;TUMOR CELLS#0.9776;OVARIAN CANCER#0.9769;GROWTH FACTOR RECEPTOR#0.9769;COLORECTAL CANCER#0.9758;SMOOTH MUSCLE CELL#0.9753;PROSTATE CANCER#0.9751;CELL DIVISION#0.9748;ANGIOGENESIS#0.9744;ONCOGENIC#0.9744;MUSCLE CELL#0.9739;ADENOCARCINOMA#0.9739;BREAST CANCER#0.9735;APOPTOTIC#0.9725;RIBOSE#0.9723;BREAST CANCER CELL#0.9721;LUNG CANCER#0.9716;VASCULAR SMOOTH MUSCLE CELL#0.9716;STEM CELL#0.9706;PANCREATIC CANCER#0.9695;MITOGEN ACTIVATED PROTEIN#0.9695;EPITHELIAL CELL#0.9694;HEPATOCELLULAR CARCINOMA#0.9682;GENE EXPRESSION#0.9680;APOPTOSIS#0.9676;COLON CANCER#0.9673;DEPHOSPHORYLATION#0.9664;CELL PROLIFERATION#0.9663;TRANSCRIPTION FACTOR#0.9662;GROWTH FACTOR#0.9662;TARGET OF RAPAMYCIN#0.9655;COLORECTAL#0.9652;CELL ADHESION#0.9651;EPIDERMAL GROWTH FACTOR#0.9649;B CELL#0.9645;CELL GROWTH#0.9644;SIGNALING PATHWAY#0.9625;CYTOCHROME C#0.9615;HISTONE DEACETYLASE#0.9613;CYTOTOXICITY#0.9608;CELL DEATH#0.9601;CANCER CELL#0.9584;REVERSE TRANSCRIPTION#0.9541;ORAL SQUAMOUS CELL CARCINOMA#0.9535;RNA INTERFERENCE#0.9532;POLYMERASE CHAIN REACTION#0.9523;CENTROSOME#0.9480;CLEAVED CASPASE 3#0.9473;INHIBITION OF CELL PROLIFERATION#0.9457;MULTIPLE ENDOCRINE NEOPLASIA#0.9432;LYMPH NODE#0.9422;THYROID CARCINOMA#0.9400;ESTROGEN RECEPTOR#0.9375;VSMC PROLIFERATION#0.9350;SIGNAL TRANSDUCTION#0.9323;TUMOR TISSUES#0.9322;DNA BINDING#0.9316;DRUG RESISTANCE#0.9296;CERVICAL CANCER#0.9262;REACTIVE OXYGEN SPECIES#0.9247;CISPLATIN#0.9222;CELL MOTILITY#0.9213;PROTEIN KINASE B#0.9204;TRANSFORMING GROWTH FACTOR#0.9187;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9167;CELL DIFFERENTIATION#0.9135;MITOCHONDRIAL MEMBRANE#0.9133;TOXICITY#0.9091;BONE MARROW#0.9057;BREAST CARCINOMA#0.9047;AUTOPHAGY#0.9006;CERVICAL#0.9004;QUIESCENCE#0.8948;MECHANISM OF ACTION#0.8888;MACROPHAGE#0.8868;MOUSE EMBRYONIC FIBROBLAST#0.8859;LUNG ADENOCARCINOMA#0.8820;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8815;PLATELET-DERIVED GROWTH FACTOR#0.8793;ANDROGEN RECEPTOR#0.8786;APOPTOTIC CELL DEATH#0.8774;HISTONE DEACETYLASE INHIBITOR#0.8753;MICROTUBULE#0.8743;FOCAL ADHESION#0.8727;MITOSIS#0.8712;ANCHORAGE INDEPENDENT GROWTH#0.8691;COLONY FORMATION ASSAY#0.8620;B CELL LYMPHOMA#0.8612;MITOCHONDRIA#0.8605;SIGNAL TRANSDUCER#0.8575;MYELOID LEUKEMIA#0.8506;DISEASE FREE SURVIVAL#0.8487;SIMIAN IMMUNODEFICIENCY VIRUS#0.8485;REGULATION OF CELL CYCLE#0.8482;PROGENITOR CELL#0.8457;SMOOTH MUSCLE CELL PROLIFERATION#0.8452;MUSCLE CELL PROLIFERATION#0.8449;UBIQUITIN LIGASE COMPLEX#0.8418;NERVOUS SYSTEM#0.8355;SIGNALING CASCADE#0.8351;NUCLEAR EXPORT#0.8344;TYROSINE KINASE INHIBITOR#0.8342;GENE SILENCING#0.8339;TERMINAL DIFFERENTIATION#0.8325;EXTRACELLULAR MATRIX#0.8316;TETRACYCLINE#0.8295;MULTIPLE MYELOMA#0.8287;CELL SURFACE#0.8247;DNA REPLICATION#0.8245;HYPOXIA#0.8225;PROTEIN KINASE C#0.8219;PROTEIN DEGRADATION#0.8200;BINDING PROTEIN 1#0.8191;PROTEASOME PATHWAY#0.8136;RETINOIC ACID#0.8133;CELL CYCLE CHECKPOINT#0.8131;RNA BINDING#0.8074;QUANTITATIVE REAL TIME#0.8052;LUNG CARCINOMA#0.7999;DOXORUBICIN#0.7998;TRANSACTIVATION#0.7967;HEPATOCELLULAR CARCINOMA CELL#0.7948;HEAT SHOCK PROTEIN#0.7920;CELL CYCLE TRANSITION#0.7895;CELLULAR GROWTH#0.7878;TUMOR NECROSIS FACTOR#0.7857;FOCAL ADHESION KINASE#0.7820;SIGNALLING PATHWAY#0.7754;ARTERY#0.7661;UBIQUITIN PROTEASOME PATHWAY#0.7656;PROPIDIUM#0.7620;ENDOTHELIAL CELL PROLIFERATION#0.7578;DNA DAMAGE RESPONSE#0.7556;RECEPTOR TYROSINE KINASE#0.7531;MALIGNANT GLIOMA#0.7530;INTRINSIC APOPTOTIC PATHWAY#0.7485;QUANTITATIVE REVERSE TRANSCRIPTION#0.7432;INVASIVE CARCINOMA#0.7399;TRANSFORMING GROWTH FACTOR BETA#0.7354;MAPK SIGNALING#0.7342;TRANSITIONAL CELL CARCINOMA#0.7281;TELOMERASE ACTIVITY#0.7272;NUCLEAR LOCALIZATION SIGNAL#0.7207;PEROXISOME#0.7193;CENTROSOME DUPLICATION#0.7179;MELATONIN#0.7085;ENHANCER BINDING PROTEIN#0.7050;ENHANCER BINDING#0.7045;CELL QUIESCENCE#0.7041;CASPASE INHIBITOR#0.7020;CELL DIVISION CYCLE#0.7010;PITUITARY ADENOMA#0.6956;IMMUNE RESPONSE#0.6925;SIGNALING MOLECULE#0.6915;DYNEIN#0.6904;EPITHELIAL MESENCHYMAL TRANSITION#0.6893;CDK ACTIVITY#0.6876;THYROID CANCER#0.6856;PROSTATE EPITHELIAL CELL#0.6843;PROGESTERONE#0.6818;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6797;NEUROBLASTOMA#0.6791;LIVER CANCER#0.6739;RNA BINDING PROTEIN#0.6738;ONCOGENESIS#0.6723;CD4+ T CELL#0.6713;COLON CARCINOMA#0.6706;THYMIDINE#0.6693;MYELOID CELL#0.6681;HUMAN PANCREATIC CANCER#0.6675;CANCER RELATED DEATH#0.6662;RENAL CELL CARCINOMA#0.6619;ACUTE MYELOID LEUKEMIA#0.6616;WOUND HEALING#0.6606;CARDIOMYOCYTE#0.6591;STROMAL CELL#0.6543;MESANGIAL CELL#0.6517;HYPOXIC#0.6516;ACTIVATED CASPASE 3#0.6500;TRANSCRIPTASE#0.6463;PROTEIN PHOSPHORYLATION#0.6461;CELLULAR LOCALIZATION#0.6458;ATHEROSCLEROSIS#0.6452;VIRAL REPLICATION#0.6452;DYNACTIN COMPLEX#0.6444;PERIPHERAL BLOOD#0.6381;HYPERPHOSPHORYLATION#0.6337;5 FLUOROURACIL#0.6331;MECHANISMS OF ACTION#0.6321;SIMVASTATIN#0.6311;FLOW CYTOMETRY ANALYSIS#0.6288;C TERMINAL DOMAIN#0.6235;CENTRAL NERVOUS SYSTEM#0.6204;KINASE INHIBITOR PROTEIN#0.6201;PROTEIN KINASE A#0.6144;MAP KINASE#0.6140;MESOTHELIOMA CELL#0.6130;TRASTUZUMAB#0.6093;ENDOPLASMIC RETICULUM#0.6082;ASTROCYTE#0.6056;IMATINIB#0.6011;NEUROGENESIS#0.6005;JUN PHOSPHORYLATION#0.6003
10672	HETEROTRIMERIC G-PROTEIN#1.0375;CANCER CELL#1.0094;SIGNALING PATHWAY#1.0047;B CELL#0.9916;GUANINE#0.9851;RHOGEF#0.9482;NUCLEOTIDE EXCHANGE FACTOR#0.9469;GENE EXPRESSION#0.9360;NUCLEOTIDE BINDING#0.9214;CELL MIGRATION#0.9124;B CELL LYMPHOMA#0.8932;CELL PROLIFERATION#0.8785;PROTEIN KINASE#0.8683;SIGNAL TRANSDUCTION#0.8578;DIFFUSE LARGE B-CELL LYMPHOMA#0.8578;COLORECTAL CANCER#0.8462;PROSTATE CANCER#0.8433;THROMBIN RECEPTOR#0.8338;APOPTOSIS#0.8302;STRESS FIBER#0.8099;CELL CYCLE#0.8047;PERTUSSIS#0.8019;BREAST CANCER#0.8010;BREAST CANCER CELL#0.7959;CELL GROWTH#0.7734;TRANSCRIPTION FACTOR#0.7650;COLORECTAL#0.7449;GERMINAL CENTER#0.7401;KINASE INHIBITOR#0.7320;GTP BINDING#0.7252;PHOSPHOLIPASE C#0.7224;SMOOTH MUSCLE#0.7114;ONCOGENIC#0.7015;GROWTH FACTOR#0.6617;PLASMA MEMBRANE#0.6516;GUANOSINE#0.6436;TUMOR SUPPRESSOR#0.6239;PHOSPHOLIPASE D#0.6065;ACTIN CYTOSKELETON#0.6060;BURKITT LYMPHOMA#0.6049;METASTATIC BREAST CANCER#0.6014
10673	BELIMUMAB#1.0481;FACTOR I#1.0456;CLASS SWITCHING#1.0352;TUMOUR NECROSIS FACTOR#1.0332;IMMUNOGLOBULIN SECRETION#1.0325;B CELL HOMEOSTASIS#1.0285;TRANSFORMING GROWTH FACTOR#1.0281;HEPATITIS C#1.0260;SJOGREN'S SYNDROME#1.0256;IMMUNOGLOBULIN PRODUCTION#1.0256;B CELL#1.0202;B LYMPHOCYTE#1.0187;TUMOR NECROSIS FACTOR#1.0178;REGULATORY B CELL#1.0175;CELL MATURATION#1.0156;CYCLOPHILIN#1.0152;MYELOID CELL#1.0149;FREE LIGHT CHAIN#1.0144;TRANSITIONAL B CELL#1.0134;HEPATITIS C VIRUS#1.0132;B CELL DIFFERENTIATION#1.0123;B CELL PROLIFERATION#1.0109;B CELL DEVELOPMENT#1.0105;CELL EXPANSION#1.0104;COLLAGEN INDUCED ARTHRITIS#1.0093;LYMPHOCYTIC LEUKEMIA#1.0091;CHRONIC LYMPHOCYTIC LEUKEMIA#1.0090;MULTIPLE MYELOMA#1.0088;EPITHELIAL CELL#1.0084;CELL GROWTH#1.0068;B CELL SELECTION#1.0068;MONOCYTE#1.0053;NAIVE B CELL#1.0050;FOLLICULAR B CELL#1.0046;CELL DEVELOPMENT#1.0045;ANTIBODY PRODUCTION#1.0020;GROWTH FACTOR#1.0014;MYASTHENIA GRAVIS#1.0014;CELL SURFACE#1.0013;HUMORAL IMMUNE RESPONSE#1.0012;MULTIPLE MYELOMA CELLS#1.0002;CELL CYCLE#0.9997;B CELL RECEPTOR#0.9997;SALIVARY GLAND#0.9996;B CELL ACTIVATION#0.9991;B LYMPHOCYTE PROLIFERATION#0.9985;T CELL ACTIVATION#0.9984;NEUTROPHIL#0.9984;PLASMABLAST#0.9973;GM-CSF#0.9970;IL-10 PRODUCTION#0.9969;STROMAL CELL#0.9967;SIGNALING PATHWAY#0.9962;CELL DIFFERENTIATION#0.9960;CLASS SWITCH RECOMBINATION#0.9957;B CELL LYMPHOMA#0.9952;ACTIVATED B CELL#0.9952;MARGINAL ZONE B#0.9951;NON HODGKIN LYMPHOMA#0.9949;LUPUS NEPHRITIS#0.9948;B CELL DEPLETION#0.9945;APOPTOSIS#0.9931;GRAFT VERSUS HOST#0.9930;MARGINAL ZONE B CELL#0.9927;TOLL LIKE RECEPTOR#0.9925;SYSTEMIC AUTOIMMUNE DISEASE#0.9924;MACROPHAGE#0.9918;CELL DEATH#0.9914;TH17 CELL#0.9912;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9904;CELL PROLIFERATION#0.9903;DISEASE ACTIVITY INDEX#0.9901;POLYMERASE CHAIN REACTION#0.9899;PROTEIN KINASE#0.9899;APOPTOTIC#0.9888;RITUXIMAB#0.9887;MONONUCLEAR CELLS#0.9886;ANTIBODY MEDIATED REJECTION#0.9883;LYMPHOCYTE PROLIFERATION#0.9881;CELL ACTIVATION#0.9869;LYMPHOID CELL#0.9866;REVERSE TRANSCRIPTION#0.9864;IFN-GAMMA#0.9859;T LYMPHOCYTE#0.9856;VASCULITIS#0.9853;MEMORY B CELL#0.9846;DENDRITIC CELL#0.9844;MULTIPLE SCLEROSIS#0.9839;RHEUMATOID ARTHRITIS#0.9839;AUTOIMMUNITY#0.9832;STEM CELL#0.9831;AUTOIMMUNE DISEASE#0.9819;NEPHRITIS#0.9819;LYMPH NODE#0.9819;CENTRAL NERVOUS SYSTEM#0.9810;RHEUMATIC DISEASE#0.9807;CD4+ T CELL#0.9804;LEUKOCYTE#0.9799;LUPUS ERYTHEMATOSUS#0.9799;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9799;GERMINAL CENTER#0.9798;NERVOUS SYSTEM#0.9795;IMMUNE CELL#0.9785;TREG CELL#0.9783;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9767;STEM CELL TRANSPLANTATION#0.9764;PLASMA CELL#0.9764;PERIPHERAL BLOOD#0.9760;LYMPHOCYTE ACTIVATION#0.9757;GENE EXPRESSION#0.9748;CD8+ T CELL#0.9740;T CELL#0.9739;PRO-INFLAMMATORY#0.9737;C REACTIVE PROTEIN#0.9733;LYMPHOID TISSUE#0.9732;CANCER CELL#0.9731;TRANSCRIPTION FACTOR#0.9724;INNATE IMMUNITY#0.9719;COMMON VARIABLE IMMUNODEFICIENCY#0.9717;IMMUNE SYSTEM#0.9712;MECHANISM OF ACTION#0.9698;BONE MARROW#0.9697;DONOR SPECIFIC ANTIBODIES#0.9695;PURPURA#0.9683;IMMUNE RESPONSE#0.9675;HODGKIN'S LYMPHOMA#0.9675;INFLAMMATORY RESPONSE#0.9667;PROTEINURIA#0.9664;REGULATORY T CELL#0.9663;THROMBOCYTOPENIA#0.9583;DIFFUSE LARGE B-CELL LYMPHOMA#0.9580;GERMINAL CENTER B#0.9562;ANTIGEN PRESENTING CELLS#0.9552;ADAPTIVE IMMUNE RESPONSE#0.9542;GERMINAL CENTER B CELL#0.9533;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9515;BORTEZOMIB#0.9485;LYMPHOID ORGANS#0.9481;ADIPOSE TISSUE#0.9480;CYTIDINE DEAMINASE#0.9425;RECEPTOR LIGAND#0.9399;IMMUNOGLOBULIN G#0.9394;STANDARD OF CARE#0.9384;GRAVES' DISEASE#0.9318;GRANULOCYTE#0.9313;SYNOVIAL FLUID#0.9306;CELL ADHESION#0.9305;RECEPTOR BINDING#0.9294;ADIPOCYTE#0.9294;ENCEPHALOMYELITIS#0.9287;MITOGEN ACTIVATED PROTEIN#0.9281;BREAST CANCER#0.9265;SIGNAL TRANSDUCTION#0.9180;ISOTYPE SWITCHING#0.9144;NEPHROPATHY#0.9139;DEXAMETHASONE#0.9083;CHRONIC HEPATITIS C#0.9074;CYTOKINE PRODUCTION#0.9049;PLASMACYTOID DENDRITIC CELL#0.9017;MANTLE CELL LYMPHOMA#0.9009;RESPONSE TO TREATMENT#0.9003;EOSINOPHIL#0.8991;DERMATOMYOSITIS#0.8959;RECEPTOR ACTIVATOR#0.8950;CHEMOKINE RECEPTOR#0.8939;HEMATOPOIETIC STEM CELL#0.8934;LUNG DISEASE#0.8934;LYMPHOCYTE HOMEOSTASIS#0.8924;ATHEROSCLEROSIS#0.8922;T HELPER CELL#0.8909;B CELL APOPTOSIS#0.8905;CYCLIC CITRULLINATED PEPTIDE#0.8903;BREAST CANCER CELL#0.8897;NF-KAPPAB ACTIVATION#0.8877;EPSTEIN BARR VIRUS#0.8874;VIRAL INFECTION#0.8863;HEPATITIS B#0.8861;HEMATOPOIETIC CELL#0.8860;CYTIDINE#0.8841;FOLLICULAR DENDRITIC CELL#0.8815;ENDOTHELIAL GROWTH FACTOR#0.8801;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8801;SIGNALLING PATHWAY#0.8747;HYPERGAMMAGLOBULINEMIA#0.8733;SPINAL CORD#0.8712;GLOMERULONEPHRITIS#0.8676;B LYMPHOCYTE HOMEOSTASIS#0.8674;IMMUNOSUPPRESSANT#0.8671;CONNECTIVE TISSUE#0.8667;NITRIC OXIDE#0.8621;ENDOTHELIAL CELL#0.8615;DNA BINDING#0.8589;HYPERACTIVITY#0.8584;FIBROBLAST LIKE SYNOVIOCYTES#0.8570;LIVER DISEASE#0.8567;INTERSTITIAL LUNG DISEASE#0.8565;LYMPHOCYTE DEVELOPMENT#0.8563;NEUROMYELITIS OPTICA#0.8545;TUMOR CELLS#0.8543;CYCLOPHOSPHAMIDE#0.8516;CYTOTOXICITY#0.8514;BULLOUS PEMPHIGOID#0.8491;SYNOVIUM#0.8484;CORD BLOOD#0.8452;MALARIA#0.8438;MARROW STROMAL CELLS#0.8413;BONE MARROW STROMAL CELL#0.8413;BONE MARROW STROMAL#0.8408;IFN-BETA#0.8349;REACTIVE OXYGEN SPECIES#0.8327;POLYMYOSITIS#0.8322;RETINOIC ACID#0.8314;INTRAVENOUS IMMUNOGLOBULIN#0.8288;PLASMA MEMBRANE#0.8285;OSTEOARTHRITIS#0.8262;PEMPHIGUS#0.8258;MEMORY T CELL#0.8254;ACETYLCHOLINE RECEPTOR#0.8234;CELL ASSOCIATED#0.8225;HUMAN IMMUNODEFICIENCY VIRUS#0.8176;AUTOIMMUNE HEPATITIS#0.8171;TRANSCRIPTASE#0.8163;KIDNEY TRANSPLANT RECIPIENTS#0.8158;GERMINAL CENTER FORMATION#0.8100;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8094;IL-11#0.8048;TONSIL#0.8039;G-CSF#0.8034;COLONY-STIMULATING FACTOR#0.8027;CELL MEMBRANE#0.8020;CONNECTIVE TISSUE DISEASE#0.7998;SKIN DISEASE#0.7957;B LYMPHOCYTE ACTIVATION#0.7945;METHOTREXATE#0.7945;TYPE 1 DIABETES#0.7930;CYTOKINE RECEPTOR#0.7924;T CELL PROLIFERATION#0.7923;HIGH FAT DIET#0.7918;MYOSITIS#0.7893;TRANSFORMING GROWTH FACTOR BETA#0.7889;MESENTERIC LYMPH NODE#0.7861;DISEASE ACTIVITY SCORE#0.7808;CYTOKINE SECRETION#0.7779;INFLAMMATORY BOWEL DISEASE#0.7740;ALLERGEN#0.7705;MACROGLOBULINEMIA#0.7686;ASTROCYTE#0.7681;FACTOR S#0.7663;INNATE IMMUNE SYSTEM#0.7642;ACTIVATION OF NF-KAPPAB#0.7578;PERIPHERAL BLOOD LYMPHOCYTES#0.7568;HEPATITIS B VIRUS#0.7561;MESENCHYMAL STEM CELL#0.7558;SWITCHED MEMORY B CELL#0.7527;IL-1RA#0.7518;LYMPHOPENIA#0.7505;PROTEASOME#0.7505;PERIODONTITIS#0.7499;TOXICITY#0.7490;ANEMIA#0.7414;PRIMARY BILIARY CIRRHOSIS#0.7381;RAPAMYCIN#0.7380;MAP KINASE#0.7379;PROTEOGLYCAN#0.7346;OSTEOCLAST#0.7337;ANTIGEN PRESENTATION#0.7326;INSULIN-LIKE GROWTH FACTOR#0.7309;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7298;QUANTITATIVE REAL TIME#0.7284;ANTIPHOSPHOLIPID SYNDROME#0.7283;JUVENILE IDIOPATHIC ARTHRITIS#0.7282;BASOPHIL#0.7262;ACETYLCHOLINE#0.7255;SERIOUS ADVERSE EVENT#0.7247;T1 B CELL#0.7187;STEM CELL FACTOR#0.7186;INFLAMMATORY CELL#0.7181;OBESE#0.7157;SIGNAL TRANSDUCER#0.7123;PEMPHIGUS VULGARIS#0.7116;PLASMA CELL DIFFERENTIATION#0.7111;PROTEIN KINASE C#0.7100;HUMAN LEUKOCYTE ANTIGEN#0.7092;ALEMTUZUMAB#0.7092;ENDOMETRIOSIS#0.7074;ADAPTIVE IMMUNE SYSTEM#0.7027;ERYTHROCYTE SEDIMENTATION RATE#0.6977;BETA-2#0.6971;EPRATUZUMAB#0.6970;CELL ADHESION MOLECULE#0.6944;CHRONIC HEPATITIS B#0.6930;RESPONSE TO TNF#0.6915;MONOCYTE DERIVED DENDRITIC CELL#0.6879;IGG ANTIBODY#0.6872;CD3+ T CELL#0.6871;IMMUNE THROMBOCYTOPENIC PURPURA#0.6862;IL-6 PRODUCTION#0.6839;RHEUMATISM#0.6838;CRYOGLOBULINEMIA#0.6832;RANDOMIZED CONTROLLED TRIAL#0.6817;T FOLLICULAR HELPER#0.6816;GLYCOSYLATION#0.6815;OLIGODENDROCYTE#0.6812;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6807;SECONDARY LYMPHOID ORGANS#0.6789;ERYTHROCYTE#0.6781;NITRIC OXIDE SYNTHASE#0.6760;HEPATOCELLULAR CARCINOMA#0.6755;HYPERSENSITIVITY#0.6709;GELONIN#0.6708;GINGIVAL CREVICULAR FLUID#0.6702;PROTEIN SYNTHESIS#0.6691;COMPLEMENT ACTIVATION#0.6678;HYDROXYCHLOROQUINE#0.6638;BONE MARROW MICROENVIRONMENT#0.6582;FOLLICULAR HELPER T CELL#0.6571;SIALADENITIS#0.6569;ALANINE#0.6569;INNATE IMMUNE RESPONSE#0.6540;TERMINAL DIFFERENTIATION#0.6434;HIGH MOBILITY GROUP#0.6426;AUTOIMMUNE BULLOUS DISEASES#0.6402;B1 CELL#0.6402;CELL CYCLE ARREST#0.6401;FRAGMENT LENGTH POLYMORPHISM#0.6398;STROMA#0.6396;TUMOR NECROSIS FACTOR RECEPTOR 2#0.6388;IL-35 PRODUCTION#0.6375;MEAN FLUORESCENCE INTENSITY#0.6329;MYELOID DENDRITIC CELL#0.6314;ETANERCEPT#0.6304;METHYLPREDNISOLONE#0.6286;ABATACEPT#0.6284;FOLLICULAR LYMPHOMA#0.6281;SENSITIZATION#0.6279;INTERLEUKIN 6 RECEPTOR#0.6276;HEALTHY CONTROL SUBJECTS#0.6259;ATOPIC DERMATITIS#0.6248;NATURAL KILLER CELL#0.6237;MUTAGENESIS#0.6213;AIRWAY EPITHELIAL CELL#0.6209;POLYNEUROPATHY#0.6198;PANCREATITIS#0.6198;SPUTUM#0.6178;TO FIRST TREATMENT#0.6146;QUANTITATIVE REVERSE TRANSCRIPTION#0.6137;UBIQUITIN#0.6122;AUTOIMMUNE PANCREATITIS#0.6120;ARTERY#0.6102;HYPOXIA#0.6093;SURFACTANT PROTEIN D#0.6082;GERMINAL CENTRE B#0.6046;MYCOPHENOLATE MOFETIL#0.6025;ANGIOGENESIS#0.6018;CYTOPLASM#0.6015
10675	CHONDROITIN SULFATE PROTEOGLYCAN#1.1140;PROTEOGLYCAN#1.1016;GROWTH FACTOR#1.0042;EPIDERMAL GROWTH FACTOR#0.9308;NERVOUS SYSTEM#0.9165;CENTRAL NERVOUS SYSTEM#0.8762;RETINAL DEGENERATION#0.8115;CELL SURFACE#0.7197;NEURITE OUTGROWTH#0.7165;NEURITE#0.7042;LEUCINE#0.6624;PROTEIN TYROSINE PHOSPHATASE#0.6422;NEURONAL MIGRATION#0.6405;RETINAL PIGMENT EPITHELIUM#0.6398;GENE EXPRESSION#0.6333;GLYCOSYLATION#0.6178;SOTOS SYNDROME#0.6102
10677	IBUPROFEN#0.9020;ACTIN BINDING#0.8832;ACTIN BINDING PROTEIN#0.7617;DORSAL ROOT GANGLION#0.6905
106783499	DOMINANT OPTIC ATROPHY#0.7687;OPTIC ATROPHY#0.7564
10678	O GLYCAN#1.0910;GLCNAC#1.0525;N GLYCAN#1.0494;GROWTH FACTOR#1.0243;TRANSFORMING GROWTH FACTOR#1.0095;GLYCOSYLATION#1.0048;BETA-2#0.9782;CELL SURFACE#0.9757;BETA GALACTOSIDASE#0.9408;CANCER CELL#0.9253;UDP-GAL#0.9240;LECTIN#0.9189;ASPARAGINE#0.9171;EPITHELIAL CELL#0.8871;CELL ADHESION#0.8315;UDP GALACTOSE#0.8162;ERYTHROCYTE#0.7909;DIGESTION#0.7843;MICROSOME#0.7828;TRANSFERASE ACTIVITY#0.7639;GLUCOSAMINE#0.7484;GLCNAC TRANSFERASE ACTIVITY#0.7456;SIALYLATION#0.7240;LEUKOCYTE#0.7072;EXTRACELLULAR MATRIX#0.7069;CELL GROWTH#0.7007;SMALL INTESTINE#0.6966;POLYMERASE CHAIN REACTION#0.6904;CHONDROCYTE#0.6413;WALKER-WARBURG SYNDROME#0.6306;CELL MIGRATION#0.6295;GENE EXPRESSION#0.6161;COLON CANCER#0.6106;TUMOR CELLS#0.6002
10681	BIPOLAR CELL#1.0192;PLASMA MEMBRANE#0.9769;HETEROTRIMERIC G-PROTEIN#0.8688;SIGNALING PATHWAY#0.8538;GTPASE ACTIVITY#0.8084;NUCLEOTIDE BINDING#0.8073;SIGNAL TRANSDUCTION#0.7584;NERVOUS SYSTEM#0.7428;GUANINE#0.7064;OPIOID RECEPTOR#0.6505;PROTEIN PROTEIN INTERACTION#0.6374;AKT SIGNALING#0.6259;SPINAL CORD#0.6093
10682	CHONDRODYSPLASIA PUNCTATA#1.0552;CHOLESTEROL BIOSYNTHESIS#1.0441;GLUCOSE REGULATED PROTEIN#1.0371;DOMINANT NEGATIVE MUTANT#1.0223;STEROL REGULATORY ELEMENT#1.0188;ENHANCER BINDING#1.0156;ACTIVATING TRANSCRIPTION FACTOR#1.0156;ENHANCER BINDING PROTEIN#1.0155;DNA BINDING#1.0069;TRANSCRIPTION FACTOR#0.9997;PROTEIN DISULFIDE ISOMERASE#0.9994;EPITHELIAL CELL#0.9988;ADIPOGENESIS#0.9977;TRANSACTIVATION#0.9966;ELECTROPHORETIC MOBILITY SHIFT#0.9956;ADIPOCYTE#0.9909;UNFOLDED PROTEIN RESPONSE#0.9851;SIGNALING PATHWAY#0.9841;MACROPHAGE#0.9837;LEUCINE#0.9835;ADIPOCYTE DIFFERENTIATION#0.9827;PROTEIN KINASE#0.9827;GENE EXPRESSION#0.9808;BINDING PROTEIN 1#0.9805;ADIPOSE TISSUE#0.9801;ENDOPLASMIC RETICULUM#0.9800;APOPTOSIS#0.9800;ENDOPLASMIC RETICULUM STRESS#0.9692;PROTEIN BINDING#0.9609;GROWTH FACTOR#0.9593;PEROXISOME#0.9514;PREADIPOCYTE#0.9506;CAAT ENHANCER BINDING#0.9357;APOPTOTIC#0.9344;CAMP RESPONSE ELEMENT#0.9331;TUMOR NECROSIS FACTOR#0.9296;TERMINAL DIFFERENTIATION#0.9293;CELL CYCLE#0.9251;EUKARYOTIC INITIATION FACTOR#0.9225;HEPATOMA CELLS#0.9224;INTESTINAL EPITHELIAL CELL#0.9181;CELL DEATH#0.9160;ACUTE PHASE RESPONSE#0.9158;CHOLINE#0.9142;SIGNAL TRANSDUCTION#0.9044;DEXAMETHASONE#0.9032;GLUCOCORTICOID RECEPTOR#0.8889;CELL PROLIFERATION#0.8887;POLYMERASE CHAIN REACTION#0.8809;MONOCYTE#0.8806;MUTAGENESIS#0.8684;SKELETAL MUSCLE#0.8639;CANCER CELL#0.8635;MUSCLE CELL#0.8556;MITOGEN ACTIVATED PROTEIN#0.8523;CELL GROWTH#0.8432;PHOSPHATIDYLCHOLINE SYNTHESIS#0.8088;ICHTHYOSIS#0.8081;PHOSPHATIDYLETHANOLAMINE#0.7979;REACTIVE OXYGEN SPECIES#0.7919;CYCLIC AMP#0.7833;FATTY LIVER#0.7698;FATTY ACID SYNTHASE#0.7669;FACTOR I#0.7573;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.7557;SMOOTH MUSCLE#0.7523;FATTY ACID BINDING#0.7461;PROTEIN FOLDING#0.7316;PHOSPHOLIPID BIOSYNTHETIC#0.7213;T CELL#0.7205;ALOPECIA#0.7205;SIGNAL TRANSDUCER#0.7203;MITOTIC CLONAL EXPANSION#0.7186;SUPEROXIDE DISMUTASE#0.7168;REGENERATION#0.7123;LIVER DISEASE#0.7123;HEPATOCYTE NUCLEAR FACTOR#0.7119;N METHYLTRANSFERASE#0.7046;ASTROCYTE#0.6992;CAMP RESPONSE ELEMENT BINDING#0.6929;LIPID METABOLISM#0.6928;WHITE ADIPOSE TISSUE#0.6921;CRE BINDING#0.6872;CELL DIFFERENTIATION#0.6866;RESPONSE TO LPS#0.6864;NITRIC OXIDE#0.6843;PROTEIN KINASE A#0.6774;MAP KINASE#0.6770;PHOSPHOLIPID BIOSYNTHESIS#0.6668;CAMP-RESPONSIVE ELEMENT BINDING#0.6600;ENDOTHELIAL CELL#0.6543;MYELOID CELL#0.6499;FATTY LIVER DISEASE#0.6493;PLASMA MEMBRANE#0.6455;PHOSPHOENOLPYRUVATE#0.6390;MYOTUBE#0.6337;IL-6 PRODUCTION#0.6330;X CHROMOSOME#0.6328;TAMOXIFEN#0.6321;GLUTATHIONE#0.6319;OUTER MEMBRANE#0.6299;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6297;HUMAN IMMUNODEFICIENCY VIRUS#0.6265;REVERSE TRANSCRIPTION#0.6160;PROTEIN SYNTHESIS#0.6136;MITOTIC SPINDLE#0.6097;LUNG EPITHELIAL CELL#0.6097;ER STRESS RESPONSE#0.6063;LIVER DEVELOPMENT#0.6052;ACTIVATOR PROTEIN 1#0.6016;ISOMERASE ACTIVITY#0.6013;SMOOTH MUSCLE CELL#0.6010
10683	SPONDYLOCOSTAL DYSOSTOSIS#1.0705;NOTCH LIGAND#1.0471;DYSOSTOSIS#1.0220;NOTCH RECEPTOR#1.0155;LUNG CANCER#1.0105;GAMMA DELTA T CELL#1.0090;NOTCH SIGNALING PATHWAY#1.0059;ENOYL COA HYDRATASE#0.9961;T CELL#0.9930;SIGNALING PATHWAY#0.9909;POLYMERASE CHAIN REACTION#0.9908;SOMITOGENESIS#0.9904;BREAST CANCER#0.9902;PERIPHERAL BLOOD#0.9849;GENE EXPRESSION#0.9773;TUMOR CELLS#0.9724;STEM CELL#0.9579;TRANSCRIPTION FACTOR#0.9514;ISOMERASE ACTIVITY#0.9372;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9360;SOMITE#0.9284;PEROXISOMAL#0.9222;CANCER CELL#0.9177;B CELL#0.9106;GROWTH FACTOR#0.9081;NERVOUS SYSTEM#0.8892;NEUROENDOCRINE TUMOR#0.8857;PHOSPHOLIPASE C#0.8628;CELL SURFACE#0.8370;PULMONARY NEUROENDOCRINE TUMOR#0.8324;APOPTOSIS#0.8236;ESTROGEN RECEPTOR#0.8125;BONE MARROW#0.7996;NEUROENDOCRINE CARCINOMA#0.7922;1,8-CINEOLE#0.7895;EPITHELIAL CELL#0.7824;PROTEIN KINASE#0.7818;BETA-HYDROXYSTEROID DEHYDROGENASE#0.7787;CELL DIFFERENTIATION#0.7666;PROGENITOR CELL#0.7662;CELL DEVELOPMENT#0.7659;NOTCH SIGNALLING PATHWAY#0.7638;SIGNALLING PATHWAY#0.7614;HEPATOCELLULAR CARCINOMA#0.7336;OVARIAN#0.7325;ELECTRON TRANSFER#0.7294;SCOLIOSIS#0.7265;DNA BINDING#0.7236;MULTIPLE SCLEROSIS#0.7189;PEROXISOME#0.7129;NEUROGENESIS#0.7018;EPIDERMAL GROWTH FACTOR#0.6989;VERTEBRAE#0.6968;MINIMAL RESIDUAL DISEASE#0.6940;GROWTH HORMONE#0.6769;REVERSE TRANSCRIPTION#0.6733;CELL PROLIFERATION#0.6732;T CELL DEVELOPMENT#0.6647;BREAST CANCER CELL#0.6636;PROSTATE CANCER#0.6630;T LYMPHOCYTE#0.6569;SKELETAL MUSCLE#0.6499;LYMPH NODE#0.6491;CELL CYCLE#0.6424;CINEOLE#0.6424;OCTAHYDROINDOLE-2-CARBOXYLIC ACID#0.6410;NEUROENDOCRINE CELL#0.6352;TRIFUNCTIONAL ENZYME#0.6349;PROGESTERONE#0.6181;HEAT SHOCK PROTEIN#0.6171;AXIAL SKELETON#0.6167
10686	TIGHT JUNCTION PROTEIN#1.0624;NEPHROCALCINOSIS#1.0489;TIGHT JUNCTION#1.0311;EPITHELIAL CELL#1.0138;EXCRETION#0.9459;GENE EXPRESSION#0.9195;LOOP OF HENLE#0.9136;BREAST CANCER#0.8956;MAGNESIUM TRANSPORT#0.8801;TRANSIENT RECEPTOR POTENTIAL#0.8782;PROTEIN KINASE#0.8714;NEPHROLITHIASIS#0.8640;NEPHRON#0.8617;PLASMA MEMBRANE#0.8534;PROTEIN KINASE A#0.8114;LYSOSOME#0.8084;CANCER CELL#0.7933;KIDNEY DISEASE#0.7776;AUTOSOMAL RECESSIVE DISEASE#0.7160;HUMAN BREAST CANCER#0.6809;ENDOCYTOSIS#0.6587;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.6456;ION TRANSPORT#0.6453;CALCIUM TRANSPORT#0.6173;PRE-MRNA SPLICING#0.6109;CELL SURFACE#0.6095;POLYURIA#0.6080;MRNA SPLICING#0.6072
10687	POTASSIUM CHANNEL#0.9099;NMDA RECEPTOR#0.8657;ASPARTATE#0.8197;PARANEOPLASTIC NEUROLOGICAL SYNDROME#0.8157;CEREBRAL CORTEX#0.8091;BREAST CANCER#0.7766;GERM CELL#0.7689;CELL MEMBRANE#0.7506;SPINAL CORD#0.6563;NEURONAL CELL BODIES#0.6263;T CELL#0.6184;GANGLION CELLS#0.6177;CREUTZFELDT JAKOB DISEASE#0.6047;CELL SURFACE ANTIGEN#0.6026
1068	BASAL BODY#1.0225;CENTROSOME#0.9341;CENTROMERE#0.9254;GENE EXPRESSION#0.6405;CANCER TESTIS ANTIGEN#0.6369;PANCREATIC CANCER#0.6178;CELL DIVISION#0.6096
10690	NEURITE OUTGROWTH#0.8286;CELL SURFACE#0.8202;FUCOSYLATION#0.8189;COLORECTAL CANCER#0.7874;STEM CELL#0.7518;GLYCOSYLATION#0.7426;NEURITE#0.6635;LEUKOCYTE#0.6189;CANCER CELL#0.6112
10691	BINDING PROTEIN 1#1.0620;GLUCOCORTICOID RECEPTOR#1.0524;APOPTOSIS#0.8669;TRANSACTIVATION#0.8152;DNA BINDING#0.6437;M LINE#0.6340;T CELL APOPTOSIS#0.6137;ZINC BINDING#0.6099
10692	OPSIN#1.0958;RETINAL PIGMENT EPITHELIUM#0.9812;RETINITIS PIGMENTOSA#0.8475;RETINITIS#0.6809;RETINAL VEIN OCCLUSION#0.6621
10694	CHAPERONIN#1.0326;CHAPERONIN-CONTAINING T-COMPLEX#0.6657;CELL PROLIFERATION#0.6158
10695	CELL SURFACE#1.1086;TOLL LIKE RECEPTOR#0.9559;ENDOPLASMIC RETICULUM#0.8515;IMMUNE RESPONSE#0.8204;CLASSICAL MONOCYTE#0.6262;PANETH CELL#0.6127
10699	HYPERTENSION#1.0549;CARDIOMYOCYTE#0.9617;ZYMOGEN ACTIVATION#0.9601;CELL SURFACE#0.9259;HEART DISEASE#0.9237;DILATED CARDIOMYOPATHY#0.8906;SYSTOLIC BLOOD PRESSURE#0.8141;ARTERY#0.8073;CARDIOMYOPATHY#0.7725;TOTAL HIP ARTHROPLASTY#0.7084;GENE EXPRESSION#0.7041;FLOOR PLATE#0.6776;DALLAS HEART STUDY#0.6503;MIDBRAIN#0.6273;PRE-ECLAMPSIA#0.6267;CORONARY ARTERY#0.6159;SIGNALING PATHWAY#0.6120;NEPHROTIC SYNDROME#0.6099;TRANSCRIPTION FACTOR#0.6045;CORONARY ARTERY DISEASE#0.6043;ARTERY DISEASE#0.6041
1069	CENTROMERE#1.0374;NUCLEOTIDE EXCISION REPAIR#1.0305;CENTROSOME#1.0300;XERODERMA PIGMENTOSUM GROUP C#1.0240;XERODERMA PIGMENTOSUM#1.0211;CENTRIOLE#0.9979;BASAL BODY#0.9440;C TERMINAL DOMAIN#0.9017;CENTROSOME DUPLICATION#0.8963;SPINDLE POLE#0.8810;GENE EXPRESSION#0.8739;DNA REPAIR#0.8625;CONNECTING CILIUM#0.7971;CELL CYCLE#0.7952;CILIOGENESIS#0.7667;MICROTUBULE#0.7627;CELL DIVISION#0.7552;CILIUM#0.7454;CENTRIOLE ASSEMBLY#0.7316;CENTRIOLE DUPLICATION#0.7173;EPITHELIAL CELL#0.6374;METAL BINDING#0.6143;PROTEIN COMPLEX#0.6013
106	HETEROCHROMATIN FORMATION#0.7827
1070	SPINDLE POLE BODY#1.0149;SPINDLE POLE#1.0061;CENTROMERE#1.0002;TREX-2 COMPLEX#0.9771;CENTROSOME#0.8775;NUCLEAR PORE#0.8509;NUCLEAR EXPORT#0.8116;BASAL BODY#0.7942;MICROTUBULE#0.7721;SPINDLE POLE BODY DUPLICATION#0.7643;GENE EXPRESSION#0.7593;CONNECTING CILIUM#0.7310;MICROTUBULE ORGANIZING CENTER#0.6807;MITOSIS#0.6733;CELL CYCLE#0.6417;CELL DIVISION#0.6360;CENTRIOLE#0.6245
107126360	ACYL COA OXIDASE#0.6292
10712	HEPATOCELLULAR CARCINOMA#0.7369
10713	CELL CYCLE#1.0938;CANCER CELL#1.0859;UBIQUITIN#1.0759;CELL PROLIFERATION#1.0648;APOPTOSIS#1.0244;M PHASE#1.0062;MRNA SPLICING#0.9908;UBIQUITIN SPECIFIC PROTEASE#0.9495;RNA INTERFERENCE#0.9182;HEPATOCELLULAR CARCINOMA#0.9153;CELL GROWTH#0.9093;CELL CYCLE ARREST#0.8970;ONCOGENIC#0.8362;PRE-MRNA SPLICING#0.8358;COLORECTAL CANCER#0.8303;BREAST CANCER#0.8253;SIGNALING PATHWAY#0.7929;OVARIAN CANCER#0.7874;BREAST CANCER CELL#0.7700;SPINDLE CHECKPOINT#0.7194;SPLICEOSOME#0.7026;PROTEIN KINASE#0.6954;COLORECTAL#0.6519;MRNA PROCESSING#0.6431;DEUBIQUITINASE#0.6234
10714	TRANSCRIPTASE#1.0196;DNA REPLICATION#1.0100;DNA SYNTHESIS#0.9986;HUMAN IMMUNODEFICIENCY VIRUS#0.9934;TELOMERE#0.9291;RNASE H ACTIVITY#0.9190;CELL CYCLE#0.9057;DNA REPAIR#0.8760;DNA DAMAGE RESPONSE#0.8704;VIRION#0.8653;MUTAGENESIS#0.8078;S PHASE#0.8069;TRANSLESION SYNTHESIS#0.7746;CANCER CELL#0.7541;RIBONUCLEASE H#0.7501;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7490;HOMOLOGOUS RECOMBINATION#0.7395;REPLICATION FORK#0.6903;DNA BINDING#0.6813;PYRIMIDINE METABOLISM#0.6344;DNA POLYMERASE ACTIVITY#0.6204
10715	CERAMIDE SYNTHESIS#1.0044;CELL DEATH#1.0037;ENDOPLASMIC RETICULUM#0.9736;APOPTOSIS#0.9181;CERAMIDE SYNTHASE ACTIVITY#0.8749;SKELETAL MUSCLE#0.8352;SPHINGOSINE#0.7974;CANCER CELL#0.7568;GENE EXPRESSION#0.7222;APOPTOTIC#0.6996;ENZYME ACTIVITY#0.6377;SPHINGOLIPID BIOSYNTHESIS#0.6331;SPHINGOLIPID METABOLISM#0.6291;MITOCHONDRIA#0.6234;PROTEIN KINASE#0.6148;CELL GROWTH#0.6129
10716	TRANSCRIPTION FACTOR#1.0295;AUTISM SPECTRUM DISORDER#1.0256;CEREBRAL CORTEX#1.0033;PROGENITOR CELL#0.9932;NEUROGENESIS#0.9764;INTELLECTUAL DISABILITY#0.9730;GLUTAMATERGIC NEURON#0.9722;TELENCEPHALON#0.9712;OLFACTORY BULB#0.9690;GENE EXPRESSION#0.9671;STEM CELL#0.9609;FOREBRAIN#0.9563;INTERNEURON#0.9423;BRAIN DEVELOPMENT#0.9355;INTERMEDIATE PROGENITOR CELL#0.9059;AMYGDALA#0.9043;CAJAL-RETZIUS CELL#0.8611;CORTICOGENESIS#0.8408;NEURONAL MIGRATION#0.8294;NMDA RECEPTOR#0.8138;GROWTH FACTOR#0.8054;PLURIPOTENT STEM CELL#0.7274;NERVOUS SYSTEM#0.7215;AUTISTIC#0.7200;INDUCED PLURIPOTENT STEM CELL#0.7038;NEURAL STEM CELL#0.6980;ASTROCYTE#0.6929;PROTEIN KINASE#0.6749;FOREBRAIN DEVELOPMENT#0.6466;POLYMERASE CHAIN REACTION#0.6214;CELL ADHESION#0.6197;GUANYLATE KINASE#0.6100;CENTRAL NERVOUS SYSTEM#0.6067
10717	INTELLECTUAL DISABILITY#0.9230;PARAPLEGIA#0.9229;PROTEIN COMPLEX#0.8838;HEREDITARY SPASTIC PARAPLEGIA#0.8809;HEMIDESMOSOME#0.7303;GROWTH FACTOR#0.6988;SIGNAL TRANSDUCTION#0.6214
10718	GROWTH FACTOR#1.0089;MAMMARY GLAND#0.9374;EPIDERMAL GROWTH FACTOR#0.8973;NERVOUS SYSTEM#0.8804;BIPOLAR DISORDER#0.8647;BREAST CANCER#0.8274;CENTRAL NERVOUS SYSTEM#0.8007;RECEPTOR TYROSINE KINASE#0.7849;SIGNALING PATHWAY#0.7796;MAMMARY GLAND DEVELOPMENT#0.7386;GLAND DEVELOPMENT#0.7367;GENE EXPRESSION#0.7124;INTERNEURON#0.7106;MORPHOGENESIS#0.6508;CANCER CELL#0.6151
1071	PROTEIN DEFICIENCY#1.0569;PROBUCOL#1.0391;HDL REMODELING#1.0366;PLASMA PROTEIN#1.0305;HEPATIC LIPASE#1.0303;PRAVASTATIN#1.0302;MOLECULAR DYNAMICS SIMULATION#1.0261;OLEIC ACID#1.0258;FRAGMENT LENGTH POLYMORPHISM#1.0208;LIPID BINDING#1.0184;LIPOPOLYSACCHARIDE BINDING#1.0177;ALZHEIMER'S DISEASE#1.0171;TYPE 2 DIABETIC#1.0160;LCAT ACTIVITY#1.0157;PHOSPHOLIPASE A2#1.0146;ATP BINDING CASSETTE TRANSPORTER#1.0113;INTIMA MEDIA THICKNESS#1.0108;PEROXISOME#1.0106;TYPE 1 DIABETIC#1.0098;NIACIN#1.0091;LIPOPROTEIN LIPASE#1.0090;ADIPOCYTE#1.0082;CHOLESTEROL METABOLISM#1.0081;LIVER X RECEPTOR#1.0077;ALDOSTERONE#1.0070;C REACTIVE PROTEIN#1.0043;PALMITIC ACID#1.0042;SIMVASTATIN#1.0041;VASCULAR DISEASE#1.0038;HIGH CHOLESTEROL DIET#1.0037;ADIPOSE TISSUE#1.0034;HIGH FAT DIET#1.0034;ATP BINDING CASSETTE#1.0032;OBESE#1.0027;CHOLESTEROL ESTERIFICATION#1.0026;FAMILIAL HYPERCHOLESTEROLEMIA#1.0016;ATP BINDING#1.0005;ATORVASTATIN#1.0002;EZETIMIBE#0.9999;NICOTINIC ACID#0.9997;SCAVENGER RECEPTOR#0.9995;TYPE 2 DIABETES MELLITUS#0.9991;2 DIABETES MELLITUS#0.9991;TRIGLYCERIDE LIPASE#0.9989;COENZYME A#0.9985;LDL RECEPTOR#0.9978;POLYMERASE CHAIN REACTION#0.9977;CHOLESTEROL HOMEOSTASIS#0.9977;LIPASE ACTIVITY#0.9969;ACUTE CORONARY SYNDROME#0.9959;LIPOPROTEIN PARTICLE#0.9952;RECEPTOR AGONIST#0.9949;CATABOLISM#0.9946;C-LEVEL#0.9942;HDL PARTICLE#0.9921;LDL PARTICLE#0.9921;REVERSE CHOLESTEROL TRANSPORT#0.9907;HIGH CARDIOVASCULAR RISK#0.9901;HYPERCHOLESTEROLEMIA#0.9899;CHOLESTEROL TRANSPORT#0.9897;FENOFIBRATE#0.9896;MULTIPLE REGRESSION ANALYSIS#0.9894;MULTIPLE LINEAR REGRESSION#0.9875;STRUCTURE ACTIVITY RELATIONSHIP#0.9875;CHOLESTEROL EFFLUX#0.9872;LINEAR REGRESSION ANALYSIS#0.9871;CORONARY ARTERY DISEASE#0.9871;ARTERY DISEASE#0.9868;LIPOPROTEIN METABOLISM#0.9863;FIBRINOGEN#0.9859;NITRIC OXIDE#0.9855;WEIGHT LOSS#0.9840;CORONARY ARTERY#0.9835;DIABETES MELLITUS#0.9834;RESPONSE TO STATIN#0.9833;TYPE 2 DIABETES#0.9825;VERY-LOW-DENSITY LIPOPROTEIN#0.9823;GENE EXPRESSION#0.9816;B CELL#0.9812;MYOCARDIAL INFARCTION#0.9808;LIPID METABOLISM#0.9807;CHYLOMICRON#0.9803;ATHEROSCLEROSIS#0.9800;HYPERTENSION#0.9795;ARTERY#0.9794;MACROPHAGE#0.9777;ATHEROSCLEROTIC#0.9774;WESTERN TYPE DIET#0.9769;HIGH DENSITY LIPOPROTEIN#0.9767;CORONARY HEART DISEASE#0.9767;HEART DISEASE#0.9749;GRADIENT GEL ELECTROPHORESIS#0.9738;CARDIOVASCULAR RISK FACTOR#0.9729;EXCRETION#0.9725;FATTY LIVER#0.9711;LOW DENSITY LIPOPROTEIN#0.9694;PLASMA GLYCOPROTEIN#0.9689;LIPOLYSIS#0.9670;ENDOTHELIAL NITRIC OXIDE#0.9665;LIPID TRANSPORT#0.9651;TRANSCRIPTION FACTOR#0.9636;GLUCOSE METABOLISM#0.9634;AGE RELATED MACULAR DEGENERATION#0.9615;MACULAR DEGENERATION#0.9610;ISCHEMIC HEART DISEASE#0.9589;TOXICITY#0.9585;DOUBLE TRANSGENIC MICE#0.9511;TRANS FATTY ACID#0.9511;ENDOTHELIAL CELL#0.9504;NEPHROTIC SYNDROME#0.9497;PARTICLE SIZE DISTRIBUTION#0.9460;HEPARIN#0.9451;HIGH-DENSITY LIPOPROTEIN PARTICLE#0.9391;KUPFFER CELL#0.9373;LOW-DENSITY LIPOPROTEIN PARTICLE#0.9336;NITRIC OXIDE SYNTHASE#0.9320;CHOLESTEROL SYNTHESIS#0.9296;LPS BINDING#0.9295;ANGIOTENSIN CONVERTING ENZYME#0.9278;INCREASE BLOOD PRESSURE#0.9192;MUTAGENESIS#0.9183;LIPOPROTEIN LIPASE ACTIVITY#0.9149;FARNESOID X RECEPTOR#0.9144;HYPOTHYROIDISM#0.9142;SYSTOLIC BLOOD PRESSURE#0.9121;MECHANISM OF ACTION#0.9113;DEMENTIA#0.9101;ALPHA-TOCOPHEROL#0.9053;CAROTID ARTERY#0.9051;LIPID DROPLET#0.9028;ACYLTRANSFERASE ACTIVITY#0.9003;HEAT SHOCK PROTEIN#0.8997;LECITHIN:CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.8995;VLDL PARTICLE#0.8990;VITAMIN E#0.8990;PHOSPHOLIPASE A#0.8971;CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.8962;MONOCYTE#0.8934;SERUM AMYLOID A#0.8911;IMMUNE RESPONSE#0.8872;PARAOXONASE ACTIVITY#0.8869;WEIGHT GAIN#0.8862;STEROL REGULATORY ELEMENT#0.8822;LIPID LOWERING AGENT#0.8785;SERUM ALBUMIN#0.8770;ATRIAL FIBRILLATION#0.8702;GEMFIBROZIL#0.8663;DIGESTION#0.8662;SATURATED FATTY ACID#0.8614;HIGH RISK PATIENTS#0.8595;GROWTH HORMONE#0.8532;LIPID LOWERING THERAPY#0.8479;DISCOIDAL HDL#0.8473;INSULIN SECRETION#0.8427;C TERMINAL DOMAIN#0.8425;SMOOTH MUSCLE#0.8424;TUMOR NECROSIS FACTOR#0.8417;RESPONSE TO CHOLESTEROL#0.8412;ENZYME ACTIVITY#0.8411;TOCOPHEROL#0.8406;MAGNETIC RESONANCE SPECTROSCOPY#0.8395;TYPE 1 DIABETES#0.8366;INCREASED BLOOD PRESSURE#0.8359;CELL ADHESION#0.8312;LOW FAT DIET#0.8293;RANDOMIZED CLINICAL TRIAL#0.8245;BEZAFIBRATE#0.8216;GLYCOSYLATION#0.8208;MECHANISMS OF ACTION#0.8184;SMOOTH MUSCLE CELL#0.8182;MUSCLE CELL#0.8176;T CELL#0.8169;LIPID MODIFICATION#0.8118;THROMBOSIS#0.8083;RANDOMIZED CONTROLLED TRIAL#0.8066;SMALL INTESTINE#0.8060;CELL ADHESION MOLECULE#0.8050;BONE MARROW#0.8044;ETHANOL#0.8002;SIGNALING PATHWAY#0.7995;CEREBROVASCULAR DISEASE#0.7980;GROWTH FACTOR#0.7955;LIPOPROTEIN BINDING#0.7943;MICROSOMAL TRANSFER PROTEIN#0.7930;IMPAIRED GLUCOSE TOLERANCE#0.7922;ROSUVASTATIN#0.7882;VASCULAR CELL#0.7881;LEUKOCYTE#0.7879;CHYLOMICRON REMNANT#0.7877;LEUCINE#0.7870;HUMAN ADIPOSE TISSUE#0.7863;VALINE#0.7853;CHOLESTEROL BIOSYNTHESIS#0.7806;AORTIC ATHEROSCLEROSIS#0.7792;MOLAR#0.7781;SIGNAL PEPTIDE#0.7773;ISCHEMIA#0.7697;RETINOIC ACID#0.7694;CHOLESTYRAMINE#0.7689;CHOLESTERYL LINOLEATE#0.7671;CYCLOSPORINE#0.7667;HARDY WEINBERG EQUILIBRIUM#0.7667;MONOUNSATURATED FATTY ACIDS#0.7653;GLUCOSE HOMEOSTASIS#0.7631;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7601;KIDNEY DISEASE#0.7579;MENOPAUSE#0.7572;ADENOSINE TRIPHOSPHATE#0.7550;TRIGLYCERIDE METABOLISM#0.7490;ENDOPLASMIC RETICULUM#0.7487;CAROTENOID#0.7473;REACTIVE OXYGEN SPECIES#0.7464;RECEPTOR ACTIVITY#0.7411;CHANGE FROM BASELINE#0.7399;ADJUSTED HAZARD RATIO#0.7397;BINDING PROTEIN 1#0.7388;STEARIC ACID#0.7295;LIVER DISEASE#0.7271;HDL RECEPTOR#0.7240;BREAST CANCER#0.7195;LIPID HOMEOSTASIS#0.7191;FASTING BLOOD GLUCOSE#0.7152;EXTENDED RELEASE NIACIN#0.7152;CORONARY STENOSIS#0.7128;SPHERICAL HDL#0.7113;HEPATITIS C#0.7112;COAGULATION#0.7069;ADENOSINE#0.6963;ACUTE MYOCARDIAL INFARCTION#0.6957;GESTATION#0.6935;LIPOPROTEIN OXIDATION#0.6921;SELECTIN#0.6903;PROTEINURIA#0.6898;FAMILIAL COMBINED HYPERLIPIDEMIA#0.6853;TESTOSTERONE#0.6781;TOTAL BODY FAT#0.6764;CELL MEMBRANE#0.6760;ADVERSE CLINICAL OUTCOME#0.6747;SIZE EXCLUSION CHROMATOGRAPHY#0.6739;APOPTOSIS#0.6703;AMPHOTERICIN B#0.6691;CYTOCHROME P450#0.6668;INFLAMMATORY RESPONSE#0.6661;URIC ACID#0.6654;PLASMA LIPOPROTEIN PARTICLE#0.6650;REMNANT LIKE PARTICLE#0.6620;MIPOMERSEN#0.6609;MONONUCLEAR CELLS#0.6605;SQUALENE SYNTHASE#0.6555;FATTY LIVER DISEASE#0.6543;CELL PROLIFERATION#0.6472;NASCENT HDL#0.6469;GLUCOSE UPTAKE#0.6459;TANGIER DISEASE#0.6397;INSULIN-LIKE GROWTH FACTOR#0.6361;POLYPOIDAL CHOROIDAL VASCULOPATHY#0.6300;APOBEC#0.6298;LIPOPROTEIN FORMATION#0.6292;ALCOHOLIC FATTY LIVER#0.6266;CHOLESTEROL UPTAKE#0.6245;FLUVASTATIN#0.6245;SODIUM DODECYL SULFATE#0.6230;DODECYL SULFATE#0.6229;FASTING PLASMA GLUCOSE#0.6221;ATHEROSCLEROTIC HEART DISEASE#0.6219;ESSENTIAL HYPERTENSION#0.6206;MULTIPLE LOGISTIC REGRESSION#0.6203;ENDOTHELIUM#0.6191;FATTY ACID BINDING#0.6187;RESPONSE TO SIMVASTATIN#0.6187;NEPHROPATHY#0.6168;ADULT TREATMENT PANEL#0.6161;ASPARAGINE#0.6158;TOLL LIKE RECEPTOR#0.6128;CORONARY ARTERY CALCIUM#0.6118;ESTRADIOL#0.6111;RED BLOOD CELL#0.6100;ANTIOXIDANT ACTIVITY#0.6096;PROTEIN SYNTHESIS#0.6085;PRO-INFLAMMATORY#0.6049;GENETIC ASSOCIATION STUDIES#0.6048;PROTHROMBINASE ACTIVITY#0.6047;BILE ACID SYNTHESIS#0.6001
10721	DOUBLE STRAND BREAK#1.0522;DNA REPAIR#0.9676;BREAST CANCER#0.9545;TRANSLESION SYNTHESIS#0.9162;DNA REPLICATION#0.8665;HOMOLOGOUS RECOMBINATION#0.8649;DNA SYNTHESIS#0.8625;REPLICATION FORK#0.8136;DOUBLE-STRAND BREAK REPAIR#0.7222;BREAST CANCER PATIENTS#0.6117;CANCER CELL#0.6036
10723	PROTEIN KINASE#0.9015;SWELLING#0.8729;ADRENOCORTICAL CARCINOMA#0.8428;OOCYTE#0.8422;POTASSIUM CHLORIDE#0.8282;CHOROID PLEXUS#0.8228;NERVOUS SYSTEM#0.7203;RENAL TUBULAR ACIDOSIS#0.7143;EPITHELIAL CELL#0.6877;POLYMERASE CHAIN REACTION#0.6328
10724	BETA-N-ACETYLGLUCOSAMINIDASE ACTIVITY#1.0820;BETA-HEXOSAMINIDASE ACTIVITY#1.0725;BETA MANNOSIDASE#1.0545;ALPHA L FUCOSIDASE#1.0535;HEXOSAMINIDASE ACTIVITY#1.0516;KIDNEY INJURY MOLECULE#1.0511;BETA N ACETYLHEXOSAMINIDASE#1.0497;GAMMA GLUTAMYLTRANSFERASE#1.0426;ALPHA GALACTOSIDASE#1.0393;SUCCINATE DEHYDROGENASE#1.0373;SOMATIC CELL COUNT#1.0372;HEXOSAMINIDASE A#1.0370;BETA N ACETYLGLUCOSAMINIDASE#1.0369;RETINOL BINDING#1.0351;RETINOL#1.0328;BETA GLUCOSIDASE#1.0314;ALPHA MANNOSIDASE#1.0312;CYSTATIN#1.0298;ALPHA GLUCOSIDASE#1.0293;IMMUNOGLOBULIN G#1.0266;BETA GLUCURONIDASE#1.0266;O-GLCNAC TRANSFERASE#1.0260;ALPHA N ACETYLGALACTOSAMINIDASE#1.0256;BETA GALACTOSIDASE#1.0233;HYALURONIDASE#1.0224;LEUCINE#1.0218;SANDHOFF DISEASE#1.0206;ALANINE#1.0202;AMNIOTIC FLUID#1.0195;ACID PHOSPHATASE#1.0193;SEMINAL PLASMA#1.0177;BETA-2#1.0175;PERIPHERAL BLOOD LYMPHOCYTES#1.0160;TAY-SACHS DISEASE#1.0158;MALATE DEHYDROGENASE#1.0147;URIC ACID#1.0147;ALKALINE PHOSPHATASE#1.0101;ASPARTATE#1.0093;BRUSH BORDER#1.0081;GLCNAC#1.0076;LIVER DISEASE#1.0068;HISTAMINE#1.0059;CYTOCHROME C#1.0059;SECRETORY GRANULE#1.0058;GANGLIOSIDOSIS#1.0046;BLOOD UREA NITROGEN#1.0042;LYSOSOMAL STORAGE DISORDER#1.0025;SKIN FIBROBLASTS#1.0019;URINARY TRACT INFECTION#0.9999;SUCCINATE#0.9995;STREPTOZOTOCIN#0.9977;EXCRETION#0.9977;NAG ACTIVITY#0.9969;LYSOSOMAL STORAGE DISEASE#0.9963;TUMOR NECROSIS FACTOR#0.9961;IONOPHORE#0.9957;MASTITIS#0.9956;PERIPHERAL BLOOD#0.9950;NEPHROTIC SYNDROME#0.9945;GLUCOSE 6 PHOSPHATASE#0.9930;CHLOROQUINE#0.9928;GENTAMICIN#0.9927;SPERMATOZOA#0.9926;RHEUMATOID ARTHRITIS#0.9918;N GLYCAN#0.9916;ETHANOL#0.9913;EXOCYTOSIS#0.9909;HYALURONIC ACID#0.9900;CISPLATIN#0.9899;URINARY PROTEIN#0.9891;SERUM ALBUMIN#0.9884;EPIDIDYMIS#0.9883;FRUCTOSE#0.9882;ALVEOLAR MACROPHAGE#0.9882;NEUTROPHIL#0.9876;BETA-N-ACETYLHEXOSAMINIDASE ACTIVITY#0.9872;ESSENTIAL HYPERTENSION#0.9862;CELL WALL#0.9856;PROXIMAL TUBULAR CELL#0.9853;PYELONEPHRITIS#0.9848;ADENOSINE#0.9844;ANGIOTENSIN CONVERTING ENZYME#0.9840;MYOCARDIAL INFARCTION#0.9835;TYPE 2 DIABETIC#0.9835;LYSOSOMAL MEMBRANE#0.9833;MAST CELL DEGRANULATION#0.9830;ACUTE KIDNEY INJURY#0.9828;GLUTAMINE#0.9827;PHOSPHODIESTERASE#0.9827;IGE RECEPTOR#0.9827;DIGESTION#0.9823;MAST CELL#0.9819;GLOMERULONEPHRITIS#0.9818;TYPE 1 DIABETES#0.9812;DIABETES MELLITUS#0.9810;GLUTATHIONE#0.9807;ACID PHOSPHATASE ACTIVITY#0.9802;NEURODEGENERATIVE DISEASE#0.9797;AMIKACIN#0.9792;GLYCOSIDASE ACTIVITY#0.9789;MONOCYTE#0.9788;MITOCHONDRIA#0.9782;CARBACHOL#0.9779;PROTEIN KINASE#0.9778;ARACHIDONIC ACID#0.9769;GALACTOSIDASE ACTIVITY#0.9768;ENDOCYTOSIS#0.9768;SOLUBLE FRACTION#0.9765;TYPE 2 DIABETES MELLITUS#0.9765;2 DIABETES MELLITUS#0.9765;SKELETAL MUSCLE#0.9762;HYPERTENSION#0.9760;SUPEROXIDE DISMUTASE#0.9760;TYPE 2 DIABETES#0.9759;GLUCOSIDASE ACTIVITY#0.9758;LEUKOCYTE#0.9757;GLUTATHIONE PEROXIDASE#0.9756;SYSTOLIC BLOOD PRESSURE#0.9753;N-ACETYLHEXOSAMINIDASE ACTIVITY#0.9746;T CELL#0.9745;LACRIMAL GLAND#0.9742;ALZHEIMER'S DISEASE#0.9737;N-ACETYL-D-GLUCOSAMINE#0.9737;PROTEIN MODIFICATION#0.9734;GLOMERULAR FILTRATION RATE#0.9732;MACROPHAGE#0.9724;PLASMA MEMBRANE#0.9720;APOPTOSIS#0.9719;PHOSPHATASE ACTIVITY#0.9719;GLUCOSAMINE#0.9718;ENDOTHELIAL CELL#0.9718;NERVOUS SYSTEM#0.9715;LECTIN#0.9714;BREAST CANCER#0.9711;CANCER CELL#0.9709;ENDOPLASMIC RETICULUM#0.9704;BONE MARROW#0.9704;PROTEINURIA#0.9702;GLOMERULAR FILTRATION#0.9699;ERYTHROCYTE#0.9699;POSTTRANSLATIONAL MODIFICATION#0.9696;KIDNEY DAMAGE#0.9693;KIDNEY DISEASE#0.9692;NITRIC OXIDE#0.9689;SMOOTH MUSCLE#0.9688;SUCROSE#0.9688;GENE EXPRESSION#0.9687;GROWTH FACTOR#0.9683;ORGANELLE#0.9681;LYSOSOME#0.9679;PYRUVATE KINASE#0.9675;SPINAL CORD#0.9674;CELL DEATH#0.9671;HEXOSAMINE BIOSYNTHETIC PATHWAY#0.9666;DIABETIC NEPHROPATHY#0.9662;GLYCOSYLATION#0.9658;CENTRAL NERVOUS SYSTEM#0.9657;REACTIVE OXYGEN SPECIES#0.9657;DIABETIC RETINOPATHY#0.9657;INULIN#0.9655;STEM CELL#0.9654;CONNECTIVE TISSUE#0.9651;CATABOLISM#0.9644;PROSTAGLANDIN E2#0.9638;ISCHEMIA#0.9635;L IDURONIDASE#0.9631;TISSUE DAMAGE#0.9629;LIVER CIRRHOSIS#0.9628;CYCLOSPORIN A#0.9627;GRANULOCYTE#0.9624;LITHIUM#0.9622;BRUSH BORDER MEMBRANE#0.9620;HISTONE ACETYLTRANSFERASE#0.9619;NEPHROTOXICITY#0.9618;SIGNALING PATHWAY#0.9618;ACINAR CELL#0.9612;PROTEIN KINASE C#0.9606;GLUTAMATE DEHYDROGENASE#0.9605;CELL MEMBRANE#0.9600;PEROXISOME#0.9599;CELL SURFACE#0.9596;CYTOPLASM#0.9594;OVARIAN#0.9588;POLYMERASE CHAIN REACTION#0.9587;TRANSCRIPTION FACTOR#0.9584;HYPOXIA#0.9584;POST-TRANSLATIONAL MODIFICATION#0.9580;MEMBRANE FRACTION#0.9577;CATALYTIC ACTIVITY#0.9573;NEPHROTOXIC#0.9569;EXTRACELLULAR MATRIX#0.9567;ARTERY#0.9567;ENZYME ACTIVITY#0.9562;ARGININE#0.9562;CELL CYCLE#0.9558;EPITHELIAL CELL#0.9554;INFLAMMATORY RESPONSE#0.9551;NEPHROPATHY#0.9550;CELL ACTIVATION#0.9548;SUBSTANCE P#0.9545;POLYMORPHONUCLEAR LEUKOCYTES#0.9540;TYPE 1 DIABETIC#0.9538;PHAGOCYTOSIS#0.9525;PARATHYROID HORMONE#0.9524;SUBMANDIBULAR GLAND#0.9519;CYCLOSPORIN#0.9512;ADENOCARCINOMA#0.9511;SIGNAL TRANSDUCTION#0.9506;TOXICITY#0.9501;B CELL#0.9500;PROTEIN SYNTHESIS#0.9490;TYPE 1 DIABETES MELLITUS#0.9488;DIURESIS#0.9483;SYNOVIAL FLUID#0.9477;BASEMENT MEMBRANE#0.9469;NEPHRITIS#0.9451;HYPERGLYCEMIA#0.9444;CELL PROLIFERATION#0.9436;DODECYL SULFATE#0.9434;SODIUM DODECYL SULFATE#0.9434;LUNG CANCER#0.9421;LACTATION#0.9420;MAST CELL ACTIVATION#0.9420;TUBULAR EPITHELIAL CELL#0.9408;CYSTIC FIBROSIS#0.9397;GLUCOSE-6-PHOSPHATE#0.9391;RENIN ACTIVITY#0.9389;RED BLOOD CELL#0.9385;MUSCLE CELL#0.9385;TRANSFORMING GROWTH FACTOR#0.9385;BETA CELL#0.9381;VACUOLE#0.9380;BASOPHIL#0.9379;ALPHA N ACETYLGLUCOSAMINIDASE#0.9362;CYTOCHROME C OXIDASE#0.9336;CREATINE#0.9333;BETA-GLUCOCEREBROSIDASE#0.9332;BETA-GALACTOSIDASE ACTIVITY#0.9331;LACTOSE#0.9331;CYCLOSPORINE#0.9323;L-ALANINE#0.9318;PHOSPHOLIPASE C#0.9313;CELL BOUND#0.9307;PERTUSSIS#0.9288;ACUTE PYELONEPHRITIS#0.9278;NEPHRON#0.9275;PHOSPHOLIPASE A2#0.9270;MULTIPLE REGRESSION ANALYSIS#0.9268;VALINE#0.9266;INTRACELLULAR LOCALIZATION#0.9265;ALBUMIN CREATININE RATIO#0.9258;DIPEPTIDYL-AMINOPEPTIDASE IV#0.9249;ASPARAGINE#0.9247;TOBRAMYCIN#0.9238;INTRACELLULAR TRANSPORT#0.9216;ANAPHYLAXIS#0.9188;EOSINOPHIL#0.9187;GOLGI APPARATUS#0.9186;SMOOTH MUSCLE CELL#0.9178;PYRUVATE#0.9169;ALLERGIC REACTION#0.9149;C REACTIVE PROTEIN#0.9136;LUMINAL#0.9128;PEROXIDASE ACTIVITY#0.9121;GLUCURONIDASE ACTIVITY#0.9101;CHRONIC KIDNEY DISEASE#0.9098;ALLERGEN#0.9083;BETA-GLUCOSIDASE ACTIVITY#0.9081;RECEPTOR ANTAGONIST#0.9072;FATTY ACID BINDING#0.9062;PHOSPHODIESTERASE I#0.9051;CYTOTOXICITY#0.9046;ACUTE MYOCARDIAL INFARCTION#0.9046;FERTILIZATION#0.9028;OBESE#0.8999;MUTAGENESIS#0.8996;CYCLIC AMP#0.8980;ENZYME INHIBITOR#0.8975;BETA-GLUCURONIDASE ACTIVITY#0.8972;SEVOFLURANE#0.8968;PARATHYROID#0.8968;HEPARIN#0.8956;FRUCTOSE -6-PHOSPHATE#0.8952;TUMOR CELLS#0.8940;ENDOTHELIUM#0.8940;P-NITROPHENOL#0.8934;AUTOPHAGY#0.8916;INTENSIVE CARE UNIT#0.8912;RNA INTERFERENCE#0.8908;DEXAMETHASONE#0.8897;CREATININE CLEARANCE RATE#0.8889;GLUTATHIONE TRANSFERASE#0.8878;CORONARY ARTERY#0.8873;TESTOSTERONE#0.8870;PROTEIN GLYCOSYLATION#0.8860;PLATELET ACTIVATING FACTOR#0.8855;MANNOSIDASE ACTIVITY#0.8851;CELL GROWTH#0.8849;MAMMARY GLAND#0.8838;ACROSOME#0.8838;CREATINE KINASE#0.8830;NITRIC OXIDE SYNTHASE#0.8817;CEREBRAL CORTEX#0.8815;IMMUNE RESPONSE#0.8814;MICROTUBULE#0.8810;ADENOSINE DEAMINASE#0.8802;T LYMPHOCYTE#0.8780;BLOOD PLASMA#0.8774;PROTEIN PHOSPHORYLATION#0.8772;SECRETION OF LYSOSOMAL ENZYMES#0.8752;INDUCED RENAL INJURY#0.8747;PROXIMAL TUBULE CELL#0.8746;CHRONIC LIVER DISEASE#0.8739;IOHEXOL#0.8728;D-GLCNAC#0.8722;MONONUCLEAR CELLS#0.8704;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8702;PROTEIN DEGRADATION#0.8701;ENDOSOME#0.8674;IGE ANTIBODY#0.8659;ATPASE ACTIVITY#0.8650;INDOMETHACIN#0.8628;ADIPOCYTE#0.8626;SWELLING#0.8619;SECONDARY LYSOSOME#0.8604;EPIDERMAL GROWTH FACTOR#0.8595;GLUCOSE METABOLISM#0.8580;HYDROXYPROLINE#0.8580;GESTATION#0.8572;LYSINE#0.8570;CHITIN DEGRADATION#0.8564;ASCORBIC ACID#0.8554;SENSITIZATION#0.8552;PRO-INFLAMMATORY#0.8550;METHIONINE#0.8549;ALDOSTERONE#0.8548;INSULIN SECRETION#0.8546;HYDROLASE ACTIVITY#0.8501;VESICOURETERAL REFLUX#0.8496;RENAL TRANSPLANT RECIPIENTS#0.8489;RENAL ARTERY#0.8464;BONE RESORPTION#0.8461;CARDIOMYOCYTE#0.8430;PANCREATITIS#0.8410;HEMATURIA#0.8399;MOLAR#0.8390;MUCOPOLYSACCHARIDOSIS#0.8371;PHOSPHOLIPASE D#0.8348;GLYCOLYSIS#0.8341;MECHANISM OF ACTION#0.8339;CELL ADHESION#0.8327;LYSIS#0.8299;RECEPTOR MEDIATED ENDOCYTOSIS#0.8298;KIDNEY PROXIMAL TUBULE#0.8286;COLORECTAL CANCER#0.8279;MITOGEN ACTIVATED PROTEIN#0.8254;SIGNAL PEPTIDE#0.8253;COLORECTAL#0.8231;MANNITOL#0.8223;LYMPHOID CELL#0.8184;CHEMOTAXIS#0.8182;TRANSFERASE ACTIVITY#0.8166;DIPHOSPHATE#0.8147;TUMOUR NECROSIS FACTOR#0.8145;CYTOKINE PRODUCTION#0.8136;FLUORESCEIN#0.8131;MYOCARDIUM#0.8128;CELL DIFFERENTIATION#0.8125;OOCYTE#0.8074;MAST CELL GRANULE#0.8072;CELL ASSOCIATED#0.8068;MICROSOME#0.8068;ACUTE PANCREATITIS#0.8067;CHOLESTASIS#0.8050;LOW DENSITY LIPOPROTEIN#0.8047;PLATELET AGGREGATION#0.8046;SECRETORY PATHWAY#0.8045;ESTRADIOL#0.8044;ALKALINE PHOSPHATASE ACTIVITY#0.8044;OVARIAN CANCER#0.8011;ATHEROSCLEROSIS#0.7996;IFOSFAMIDE#0.7983;REVERSE TRANSCRIPTION#0.7974;IFN-GAMMA#0.7966;COLLAGENASE#0.7965;DIMERCAPTOSUCCINIC ACID#0.7963;METHOTREXATE#0.7961;EMBRYONIC STEM CELL#0.7935;APOPTOTIC#0.7934;BILE DUCT#0.7906;SMALL INTESTINE#0.7871;PROTEOGLYCAN#0.7867;SEMEN#0.7864;GROWTH HORMONE#0.7855;SECRETORY VESICLE#0.7845;VANCOMYCIN#0.7832;HEAT SHOCK PROTEIN#0.7828;HEART DISEASE#0.7827;SEMINAL VESICLE#0.7789;ALPHA-MANNOSIDASE ACTIVITY#0.7789;QUERCETIN#0.7781;GLUTATHIONE PEROXIDASE ACTIVITY#0.7764;PROSTAGLANDIN I2#0.7754;FASTING BLOOD GLUCOSE#0.7748;KUPFFER CELL#0.7745;REGENERATION#0.7743;CAUDA#0.7715;DIATRIZOATE#0.7713;HUMAN SERUM ALBUMIN#0.7703;RETINAL BINDING#0.7685;ADENINE#0.7683;TRANSFORMING GROWTH FACTOR BETA#0.7683;FOSFOMYCIN#0.7674;PROGESTERONE#0.7669;GOLGI COMPLEX#0.7652;HYALURONATE#0.7622;EDEMA#0.7614;CIS-DIAMMINEDICHLOROPLATINUM#0.7610;LARYNX#0.7595;AMPHOTERICIN B#0.7593;ISCHEMIA REPERFUSION INJURY#0.7590;PROXIMAL TUBULAR EPITHELIAL#0.7576;MULTIPLE MYELOMA#0.7562;UTERUS#0.7558;COLITIS#0.7548;BONE MARROW CELLS#0.7544;PARTURITION#0.7518;TRANSMISSION ELECTRON MICROSCOPY#0.7483;HOST CELL#0.7471;SODIUM DODECYL SULPHATE#0.7465;LOWER URINARY TRACT#0.7413;CLARA CELL#0.7411;ESTERASE ACTIVITY#0.7399;RENOVASCULAR HYPERTENSION#0.7397;MICROVILLI#0.7396;STRUCTURE ACTIVITY RELATIONSHIP#0.7384;RESPIRATORY BURST#0.7369;DNA SYNTHESIS#0.7368;CELL FRACTION#0.7366;MYELOPEROXIDASE ACTIVITY#0.7355;IRON OVERLOAD#0.7355;PROTEINASE INHIBITOR#0.7347;ALPHA 1-ANTITRYPSIN#0.7321;CHONDROCYTE#0.7312;ANAPHYLACTIC#0.7296;PINOCYTOSIS#0.7292;THYMIDINE#0.7259;FIBRINOGEN#0.7239;VIRAL HEPATITIS#0.7206;NEPHROTOXIN#0.7205;ANEMIA#0.7202;MUSCLE ATROPHY#0.7202;LOCALISATION#0.7201;HEXOSAMINE BIOSYNTHESIS PATHWAY#0.7195;HYPERGLYCEMIC#0.7188;ADRIAMYCIN#0.7187;LUPUS NEPHRITIS#0.7171;WHITE BLOOD CELL#0.7158;C TERMINAL DOMAIN#0.7153;RECEPTOR BINDING#0.7152;MYOCYTES#0.7151;COAGULATION#0.7131;LOSARTAN#0.7130;GASTRIC MUCOSA#0.7115;XANTHINE#0.7113;GLUCOSE UPTAKE#0.7099;HYDRONEPHROSIS#0.7089;POLYURIA#0.7084;LYSOZYME ACTIVITY#0.7079;URIDINE#0.7074;GUANOSINE#0.7073;SPINAL CORD INJURY#0.7070;CORONARY ARTERY BYPASS#0.7051;VITAMIN E#0.7051;ACROSOME REACTION#0.7048;CARBAMAZEPINE#0.7047;ADENYLATE#0.7047;NUTRIENT SENSING#0.7047;LIPID DROPLET#0.7041;ADENYLATE CYCLASE#0.7038;AUTOPHAGIC VACUOLE#0.7030;CHITINASE ACTIVITY#0.7027;KINASE INHIBITOR#0.7001;PERIPHERAL BLOOD MONOCYTES#0.6998;ISOPROTERENOL#0.6985;MOUSE EMBRYONIC FIBROBLAST#0.6985;HYALURONAN#0.6980;ACUTE LEUKEMIA#0.6976;MOLECULAR DYNAMICS SIMULATION#0.6960;MACROPHAGE ACTIVATION#0.6955;PANCREATIC ISLET#0.6940;PLASMA CELL#0.6933;NETILMICIN#0.6931;TYPE III PROCOLLAGEN#0.6920;INFLAMMATORY CELL#0.6913;CYCLOPHOSPHAMIDE#0.6909;GLOMERULUS#0.6909;ADIPOSE TISSUE#0.6903;HYALURONIDASE ACTIVITY#0.6900;CARDIAC MUSCLE#0.6892;MANNOSE RECEPTOR#0.6871;OUTER MEMBRANE#0.6870;NADPH OXIDASE#0.6861;DEAMINASE BINDING#0.6851;ROUGH ENDOPLASMIC RETICULUM#0.6846;METHYLPREDNISOLONE#0.6818;XANTHINE OXIDASE#0.6815;CORTICAL GRANULE#0.6805;HEALTHY CONTROL SUBJECTS#0.6804;IMMUNE SYSTEM#0.6804;VASCULAR DISEASE#0.6786;RESPIRATORY DISTRESS#0.6777;OVARIAN CARCINOMA#0.6772;GLUCURONIC ACID#0.6756;LACTATE DEHYDROGENASE ACTIVITY#0.6743;ACIDIFICATION#0.6732;INFERTILE#0.6713;8-HYDROXY-2'-DEOXYGUANOSINE#0.6706;ALPHA-TOCOPHEROL#0.6705;UBIQUITIN#0.6682;RESPIRATION#0.6657;HYPERTHYROIDISM#0.6635;ISOFLURANE#0.6629;ALPHA-GLUCOSIDASE ACTIVITY#0.6618;OUABAIN#0.6612;DIPEPTIDYL PEPTIDASE#0.6611;NEUROPATHY#0.6593;GLYCINE#0.6587;NECROTIC#0.6575;INITIAL SEGMENT#0.6514;ZONA PELLUCIDA#0.6506;INFLAMMATORY BOWEL DISEASE#0.6500;CAPUT#0.6492;GANGLIOSIDE DEGRADATION#0.6467;IGE BINDING#0.6454;MICROGLIAL CELL#0.6454;NEPHROSIS#0.6453;DIAMMINEDICHLOROPLATINUM#0.6435;PHOSPHOLIPASE A#0.6421;GERMINATION#0.6416;ATHEROSCLEROTIC#0.6413;AMINOHIPPURIC ACID#0.6410;STEM CELL FACTOR#0.6403;MUSCLE FIBER#0.6399;ROS GENERATION#0.6398;STROMAL CELL#0.6394;AMINOHIPPURATE#0.6393;RIBOSE#0.6377;LUPUS ERYTHEMATOSUS#0.6376;CHOLINE#0.6372;GLIAL CELL#0.6370;SILICOSIS#0.6366;KINASE ACTIVITY#0.6359;VASOCONSTRICTION#0.6353;RENAL ISCHEMIA REPERFUSION#0.6347;ENDOTHELIAL GROWTH FACTOR#0.6342;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6342;AMPHOTERICIN#0.6326;RESPONSE TO NUTRIENT#0.6324;PENICILLAMINE#0.6319;EFFERENT DUCT#0.6298;AMINOPEPTIDASE A#0.6292;PARENCHYMA#0.6269;L-ARGININE#0.6257;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.6245;SELECTIN#0.6240;CERVICAL#0.6227;SARCOPLASMIC RETICULUM#0.6227;ADENOSINE TRIPHOSPHATE#0.6225;MYOTUBE#0.6223;ANTI INFLAMMATORY DRUGS#0.6218;ACUTE RENAL INJURY#0.6214;C-LEVEL#0.6212;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6211;CELL DIVISION#0.6196;COLON CANCER#0.6186;OSTEOBLAST#0.6177;LYMPH NODE#0.6158;AZUROPHIL GRANULE#0.6150;VIRULENCE#0.6134;SERUM URIC ACID#0.6127;PROTEASOME#0.6127;DEVELOPMENTAL DELAY#0.6122;NEPHROLITHIASIS#0.6108;ORAL GLUCOSE TOLERANCE#0.6106;CELLULAR MEMBRANE#0.6101;INTESTINAL MUCOSA#0.6084;HIGH DENSITY LIPOPROTEIN#0.6083;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6080;ACTINOMYCIN D#0.6078;BLOOD GLUCOSE LEVEL#0.6074;ANTIOXIDANT ACTIVITY#0.6070;PHOSPHOLIPID METABOLISM#0.6055;PROTEIN PROTEIN INTERACTION#0.6050;PEROXISOMAL#0.6043;ASPIRIN#0.6023;HISTIDINE#0.6010
10725	OSMOTIC RESPONSE#1.0924;RESPONSE TO HYPERTONICITY#1.0654;NUCLEUS PULPOSUS#1.0603;ENHANCER BINDING PROTEIN#1.0583;ENHANCER BINDING#1.0579;TRANSACTIVATION#1.0574;NUCLEUS PULPOSUS CELL#1.0483;MACROPHAGE#1.0460;DNA BINDING#1.0425;ACTIVATED T-CELLS#1.0423;MUSCLE CELL#1.0396;SMOOTH MUSCLE#1.0395;ACTIVATED T CELL#1.0391;T CELL#1.0338;SMOOTH MUSCLE CELL#1.0325;TRANSCRIPTION FACTOR#1.0322;RNA INTERFERENCE#1.0229;MYO-INOSITOL#1.0221;HEAT SHOCK PROTEIN#1.0219;SIGNALING PATHWAY#1.0206;PRO-INFLAMMATORY#1.0186;EPITHELIAL CELL#1.0125;GROWTH FACTOR#1.0116;REACTIVE OXYGEN SPECIES#1.0100;AQUAPORIN#1.0095;CALCINEURIN#1.0056;NITRIC OXIDE#1.0032;APOPTOSIS#1.0026;PROTEIN KINASE#1.0022;HYPOXIA#0.9989;GENE EXPRESSION#0.9948;CARDIOMYOCYTE#0.9938;CELL DEATH#0.9922;MEDULLARY CELL#0.9920;INTERVERTEBRAL DISC#0.9780;SKELETAL MUSCLE#0.9763;T LYMPHOCYTE#0.9645;ENDOTHELIAL CELL#0.9627;ENDOTHELIAL GROWTH FACTOR#0.9601;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9601;MITOGEN ACTIVATED PROTEIN#0.9561;ISCHEMIA#0.9558;NUCLEAR EXPORT#0.9549;CYTOPLASM#0.9526;MONOCYTE#0.9492;IMMUNE CELL#0.9458;VASCULAR SMOOTH MUSCLE CELL#0.9450;CELL PROLIFERATION#0.9440;CELL MIGRATION#0.9419;DUCT CELL#0.9315;VASOPRESSIN#0.9279;CELL CYCLE#0.9269;TOLL LIKE RECEPTOR#0.9269;OSMOREGULATION#0.9253;HYPERTENSION#0.9153;OSMOTIC STRESS RESPONSE#0.9138;DEHYDRATION#0.9085;ELECTROPHORETIC MOBILITY SHIFT#0.8961;WATER CHANNEL#0.8832;IMMUNE RESPONSE#0.8811;TUMOR NECROSIS FACTOR#0.8809;ANGIOGENESIS#0.8753;RESPONSE TO OSMOTIC STRESS#0.8752;NITRIC OXIDE SYNTHASE#0.8519;BREAST CANCER#0.8475;LYMPHANGIOGENESIS#0.8397;APOPTOTIC#0.8393;PROTEASOME#0.8383;WATER HOMEOSTASIS#0.8306;AUTOPHAGY#0.8198;COLLECTING DUCTS#0.8138;CCL2 SECRETION#0.8039;CELL DIFFERENTIATION#0.8008;CANCER CELL#0.7918;AUTOIMMUNE DISEASE#0.7872;LUCIFERASE ACTIVITY#0.7776;SIGNAL TRANSDUCTION#0.7774;CHONDROCYTE#0.7761;BONE MARROW#0.7676;ARGININE#0.7650;RHEUMATOID ARTHRITIS#0.7418;PHOSPHOLIPASE C#0.7414;HYPOXIA INDUCIBLE FACTOR#0.7409;ATHEROSCLEROSIS#0.7379;DIABETIC RETINOPATHY#0.7327;RETINAL PIGMENT EPITHELIAL#0.7290;EXTRACELLULAR MATRIX#0.7188;LUNG CANCER#0.7181;MOUSE EMBRYONIC FIBROBLAST#0.7112;ARGININE VASOPRESSIN#0.7081;HYPERGLYCEMIA#0.7053;HYPOXIC#0.7046;INDUCIBLE NITRIC OXIDE#0.6989;CELLULAR HOMEOSTASIS#0.6978;PROTEIN KINASE C#0.6965;CELL DEVELOPMENT#0.6910;ASTROCYTE#0.6899;STEM CELL#0.6853;RNA HELICASE#0.6836;MACROPHAGE ACTIVATION#0.6800;NERVOUS SYSTEM#0.6768;CELL GROWTH#0.6706;TROPHOBLAST#0.6605;DIABETIC NEPHROPATHY#0.6574;FUROSEMIDE#0.6570;NUCLEAR IMPORT#0.6568;CYCLOSPORIN A#0.6533;CELL ACTIVATION#0.6488;IMMUNE SYSTEM#0.6477;INFLAMMATORY RESPONSE#0.6471;POLYMERASE CHAIN REACTION#0.6454;MYOBLAST MIGRATION#0.6431;MANNITOL#0.6415;MYOBLAST#0.6373;ENHANCEOSOME#0.6370;RETINAL PIGMENT EPITHELIAL CELLS#0.6300;PIGMENT EPITHELIAL CELL#0.6289;ADIPOSE TISSUE#0.6270;SIGNALING MOLECULE#0.6259;ADIPOCYTE#0.6228;GLYCINE#0.6185;NULL CELL#0.6130;DNA DAMAGE RESPONSE#0.6088;APOPTOTIC CELL DEATH#0.6072;CENTRAL NERVOUS SYSTEM#0.6008
10726	NUCLEAR MIGRATION#1.0935;DYNEIN#1.0543;MEGAKARYOCYTE#1.0393;MICROTUBULE#0.9623;MITOSIS#0.9570;CELL PROLIFERATION#0.9436;NUCLEAR MOVEMENT#0.9163;CELL CYCLE#0.9143;CELL DIVISION#0.8878;NEURONAL MIGRATION#0.8502;DYNEIN COMPLEX#0.8349;CYTOKINESIS#0.8327;BONE MARROW#0.8300;CANCER CELL#0.8159;PROSTATE CANCER#0.7044;CELL GROWTH#0.7028;MICROTUBULE MOTOR#0.6780;MIDBODY#0.6725;CHROMOSOME CONGRESSION#0.6588;LISSENCEPHALY#0.6492;CHAPERONE ACTIVITY#0.6462;CELL SURFACE#0.6302;CELL WALL#0.6286;SPINDLE POLE#0.6037
10728	PROSTAGLANDIN E SYNTHASE#1.0542;STEROID BINDING#1.0322;IMMUNOPHILIN#1.0296;CHAPERONE COMPLEX#1.0180;HSP90 BINDING#1.0136;ATP BINDING#1.0130;CELL DEATH#1.0095;CHAPERONE ACTIVITY#1.0056;ARYL HYDROCARBON RECEPTOR#1.0032;GLUCOCORTICOID RECEPTOR#1.0013;PROSTAGLANDIN E2#1.0000;CANCER CELL#0.9934;GELDANAMYCIN#0.9912;ESTROGEN RECEPTOR#0.9911;ATPASE ACTIVITY#0.9903;PROGESTERONE#0.9881;FK506 BINDING#0.9857;HEAT SHOCK PROTEIN#0.9839;PROTEIN KINASE#0.9833;BREAST CANCER#0.9804;APOPTOSIS#0.9761;SIGNAL TRANSDUCTION#0.9696;TRANSCRIPTION FACTOR#0.9653;FK506 BINDING PROTEIN#0.9632;GENE EXPRESSION#0.9607;R2TP COMPLEX#0.9540;RETICULOCYTE#0.9501;COMPLEX I#0.9300;CYTOPLASM#0.9274;STEROID HORMONE RECEPTOR#0.9254;PROTEIN FOLDING#0.9205;HORMONE BINDING#0.9128;ARACHIDONIC ACID#0.9101;DNA BINDING#0.8948;CYCLOPHILIN#0.8944;TELOMERE#0.8836;ATP HYDROLYSIS#0.8815;PROTEIN COMPLEX#0.8799;TELOMERASE ACTIVITY#0.8721;CELL PROLIFERATION#0.8596;GLUTATHIONE#0.8505;EPITHELIAL CELL#0.8381;PROTEASOME#0.8332;SIGNALING PATHWAY#0.8156;PROTEIN PHOSPHATASE 5#0.8090;UBIQUITIN#0.8043;APOPTOTIC#0.7983;PROSTATE CANCER#0.7858;BREAST CANCER PATIENTS#0.7850;CELL CYCLE#0.7839;MACROPHAGE#0.7723;C TERMINAL DOMAIN#0.7654;NEURODEGENERATIVE DISEASE#0.7626;LIGAND BINDING DOMAIN#0.7545;DRUG RESISTANCE#0.7423;ANSAMYCIN#0.7299;RADICICOL#0.7279;TRANSCRIPTASE#0.7245;NUCLEOTIDE BINDING#0.7170;PROTEIN DEGRADATION#0.6920;POLYMERASE CHAIN REACTION#0.6726;BREAST CANCER CELL#0.6716;HSP90 ORGANIZING PROTEIN#0.6697;NUCLEAR IMPORT#0.6625;ANDROGEN RECEPTOR#0.6613;PRO-INFLAMMATORY#0.6575;RECEPTOR COMPLEX#0.6522;AHR COMPLEX#0.6436;GROWTH FACTOR#0.6431;CELL GROWTH#0.6278;NOVOBIOCIN#0.6261;HEPATITIS B VIRUS#0.6215;HEPATITIS B#0.6200;ATPASE ACTIVATOR#0.6173;PROTEIN PROTEIN INTERACTION#0.6165;BUDDING#0.6152;TELOMERASE REVERSE TRANSCRIPTASE#0.6034;DYNEIN#0.6027
1072	ACTIN ROD FORMATION#1.1536;ACTIN DEPOLYMERIZATION FACTOR#1.1141;COFILIN-ACTIN ROD#1.1119;ACTIN ROD#1.0888;MITOCHONDRIAL TRANSLOCATION#1.0848;ACTIN FILAMENT SEVERING#1.0717;F-ACTIN SEVERING#1.0692;ACTIN DEPOLYMERIZING FACTOR#1.0420;ACTIN RELATED PROTEIN#1.0378;DEPHOSPHORYLATION#1.0378;DNASE I#1.0340;ACTIN DEPOLYMERIZATION#1.0331;F-ACTIN BINDING#1.0313;CYTOCHROME C#1.0313;GROWTH CONE#1.0270;PHOSPHATASE ACTIVITY#1.0262;DNASE#1.0253;PHAGOCYTOSIS#1.0226;FOCAL ADHESION KINASE#1.0202;ACTIN CYTOSKELETON REORGANIZATION#1.0179;LAMELLIPODIUM#1.0170;GALECTIN#1.0137;PROSTATE CANCER#1.0128;ACTIN BINDING PROTEIN#1.0118;CALCINEURIN#1.0111;MITOCHONDRIA#1.0108;SKELETAL MUSCLE#1.0090;HEAT SHOCK PROTEIN#1.0088;NEUTROPHIL#1.0085;LUNG CANCER#1.0081;ACTIN BINDING#1.0069;ACTIN FILAMENT#1.0057;CHEMOTAXIS#1.0037;CELL ACTIVATION#1.0032;MICROFILAMENT#1.0019;FILAMENTOUS ACTIN#1.0017;P21 ACTIVATED KINASE#1.0010;NEURITE OUTGROWTH#1.0007;CONTRACTILE RING#1.0005;STRESS FIBER#0.9982;ACTIN POLYMERIZATION#0.9981;FOCAL ADHESION#0.9943;NEURITE#0.9943;T CELL ACTIVATION#0.9936;TIGHT JUNCTION#0.9936;CYTOKINESIS#0.9935;OOCYTE#0.9929;APOPTOTIC#0.9926;HOST CELL#0.9926;T CELL#0.9914;T LYMPHOCYTE#0.9912;AMPA RECEPTOR#0.9912;SUPEROXIDE DISMUTASE#0.9898;SIGNALING CASCADE#0.9898;CYCLOPHILIN#0.9894;RNA INTERFERENCE#0.9892;DENDRITIC SPINE#0.9890;CELL MOVEMENT#0.9882;SEQUESTERING#0.9882;MUSCLE CELL#0.9880;CELL MOTILITY#0.9880;MORPHOGENESIS#0.9878;WISKOTT ALDRICH SYNDROME#0.9877;OVARIAN CANCER#0.9875;SIGNALLING PATHWAY#0.9874;KINASE INHIBITOR#0.9869;TUMOR CELLS#0.9857;EPIDERMAL GROWTH FACTOR#0.9856;HYPOXIA#0.9854;ACTOMYOSIN#0.9852;MACROPHAGE#0.9847;MUTAGENESIS#0.9846;COMPLEX I#0.9842;EPITHELIAL MESENCHYMAL TRANSITION#0.9840;SMOOTH MUSCLE CELL#0.9833;CELL MIGRATION#0.9833;BREAST CANCER CELL#0.9827;ACTIN NUCLEATION#0.9827;GLUTATHIONE#0.9825;CYTOPLASM#0.9822;MICROTUBULE#0.9820;ACTIN FILAMENT BINDING#0.9815;SMOOTH MUSCLE#0.9814;LONG TERM POTENTIATION#0.9807;G ACTIN BINDING#0.9803;SIGNALING PATHWAY#0.9793;PLASMA MEMBRANE#0.9788;NEURODEGENERATIVE DISEASE#0.9787;ALZHEIMER'S DISEASE#0.9780;CELL ADHESION#0.9773;APOPTOSIS#0.9767;EPITHELIAL CELL#0.9767;CELL DEATH#0.9764;GROWTH FACTOR RECEPTOR#0.9764;BREAST CANCER#0.9763;LYMPH NODE#0.9762;ACTIN CYTOSKELETON#0.9759;SIGNAL TRANSDUCTION#0.9753;PROTEIN KINASE C#0.9751;CELL CYCLE#0.9750;CD4+ T CELL#0.9749;KINASE ACTIVITY#0.9744;PROTEIN KINASE#0.9740;ADENOCARCINOMA#0.9729;ENDOTHELIAL CELL#0.9725;CELL MEMBRANE#0.9724;REACTIVE OXYGEN SPECIES#0.9723;CELL PROLIFERATION#0.9722;CELL DIVISION#0.9722;GLUTAMATE RECEPTOR#0.9721;CANCER CELL#0.9720;GENE EXPRESSION#0.9719;ENDOCYTOSIS#0.9718;ISCHEMIA#0.9713;ACTIN CYTOSKELETON REMODELING#0.9708;GROWTH FACTOR#0.9693;TRANSCRIPTION FACTOR#0.9678;STEM CELL#0.9677;NUCLEAR TRANSPORT#0.9671;MITOGEN ACTIVATED PROTEIN#0.9667;NEURITE EXTENSION#0.9667;CELL GROWTH#0.9664;LATRUNCULIN A#0.9660;CELL POLARITY#0.9659;STROMAL CELL#0.9657;NERVOUS SYSTEM#0.9653;POLYMERASE CHAIN REACTION#0.9640;OVARIAN#0.9634;ESTRADIOL#0.9626;EXTRACELLULAR MATRIX#0.9612;PHOSPHOLIPASE C#0.9606;PODOCYTE#0.9606;SIGNALING MOLECULE#0.9597;EXCITATORY SYNAPSE#0.9589;CENTRAL NERVOUS SYSTEM#0.9584;COLON CANCER#0.9583;CYTOSKELETON ORGANIZATION#0.9582;TRANSFORMING GROWTH FACTOR#0.9577;MITOCHONDRIAL FISSION#0.9571;MOLAR#0.9568;CELL SURFACE#0.9562;HUMAN BREAST CANCER#0.9559;REGULATORY LIGHT CHAIN#0.9557;OOCYTE MATURATION#0.9545;WOUND HEALING#0.9535;SQUAMOUS CELL CARCINOMA#0.9525;IMMUNE RESPONSE#0.9498;KERATINOCYTE#0.9471;ACTIN FILAMENT DEPOLYMERIZATION#0.9458;AXON GROWTH#0.9455;REGENERATION#0.9448;ACTIN MONOMER BINDING#0.9422;DRUG RESISTANCE#0.9405;TUMOR SUPPRESSOR#0.9395;COLORECTAL CANCER#0.9395;CELL PERIPHERY#0.9395;UBIQUITIN#0.9380;SPINAL CORD#0.9365;PROTEASOME#0.9360;MITOSIS#0.9341;ARTERY#0.9333;NUCLEAR IMPORT#0.9312;PERIPHERAL BLOOD#0.9300;LASER DESORPTION IONIZATION#0.9291;MICROTUBULE ASSOCIATED PROTEIN#0.9281;ADHERENS JUNCTION#0.9274;ANGIOGENESIS#0.9271;LEUKOCYTE#0.9241;NEURONAL CELLS#0.9236;MYOSIN PHOSPHATASE#0.9231;LAMELLIPODIUM FORMATION#0.9220;BONE MARROW#0.9198;MONOCYTE#0.9136;TRANS GOLGI NETWORK#0.9132;STRESS FIBRE#0.9128;ACTIN BUNDLING#0.9128;LYMPH NODE METASTASIS#0.9117;LOCOMOTION#0.9108;ACTIN DEPOLYMERIZING ACTIVITY#0.9104;PLATELET-DERIVED GROWTH FACTOR#0.9101;MICROVASCULAR ENDOTHELIAL CELL#0.9090;MYOBLAST#0.9078;LONG TERM DEPRESSION#0.9071;NMDA RECEPTOR#0.9016;SMOOTH MUSCLE ACTIN#0.9006;FATTY ACID BINDING#0.8993;B CELL#0.8990;NEUROBLASTOMA#0.8990;PHOSPHOGLYCERATE KINASE#0.8988;PROTEIN SYNTHESIS#0.8986;PROTEIN PHOSPHORYLATION#0.8965;NEURAL TUBE#0.8956;NADPH OXIDASE#0.8942;PLASTIN#0.8919;CELL ADHESION MOLECULE#0.8918;CELL CHEMOTAXIS#0.8908;ACTIN CABLE#0.8895;MYOFIBRIL#0.8884;NEURONAL MIGRATION#0.8877;OSTEOBLAST#0.8871;COLORECTAL#0.8865;CYCLIN DEPENDENT KINASE#0.8856;GUANINE#0.8854;PROTEIN DISULFIDE ISOMERASE#0.8845;INTESTINAL EPITHELIAL CELL#0.8838;ATPASE ACTIVITY#0.8827;TOTAL INTERNAL REFLECTION#0.8791;LATRUNCULIN B#0.8784;RESONANCE ENERGY TRANSFER#0.8777;PANCREATIC CANCER#0.8760;NUCLEOSIDE DIPHOSPHATE KINASE#0.8741;CYTOCHROME C RELEASE#0.8711;ENDOMETRIUM#0.8678;BODY WALL MUSCLE#0.8660;ADENOSINE#0.8658;NITRIC OXIDE#0.8620;EXOCYTOSIS#0.8593;INVADOPODIUM#0.8563;MITOCHONDRIAL MEMBRANE#0.8548;CAMKII#0.8544;MICROTUBULE DYNAMICS#0.8543;STRIATED MUSCLE#0.8538;PI3K SIGNALING#0.8530;HYPERTENSION#0.8517;MYOSIN LIGHT-CHAIN KINASE#0.8512;NUCLEOTIDE EXCHANGE FACTOR#0.8511;PULMONARY ARTERY#0.8491;AXONAL GROWTH CONE#0.8485;DIPHOSPHATE#0.8475;NEURAL TUBE CLOSURE#0.8467;TUBE CLOSURE#0.8465;MYOTUBE#0.8448;ATP SYNTHASE#0.8446;DIMETHYL SULFOXIDE#0.8446;GDP DISSOCIATION INHIBITOR#0.8438;ESTROGEN RECEPTOR#0.8422;MECHANISM OF ACTION#0.8421;TOXICITY#0.8412;PHAGOCYTIC CUP#0.8409;PROTEIN KINASE D#0.8373;MEMBRANE RUFFLING#0.8368;ACTIN CYTOSKELETON ORGANIZATION#0.8364;NUCLEOTIDE BINDING#0.8355;CLEAVAGE FURROW#0.8355;INDUCTION OF APOPTOSIS#0.8349;MOLECULAR DYNAMICS SIMULATION#0.8342;ASTROCYTE#0.8338;PYRUVATE KINASE#0.8308;GLYCERALDEHYDE-3-PHOSPHATE#0.8305;ENDOTHELIAL GROWTH FACTOR#0.8305;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8305;DOMINANT NEGATIVE MUTANT#0.8304;QUANTITATIVE REAL TIME#0.8304;ONCOGENIC#0.8290;DENDRITIC CELL#0.8289;LUNG ADENOCARCINOMA#0.8246;GERM CELL#0.8234;CYTOTOXICITY#0.8232;ENDOMETRIOSIS#0.8223;RUFFLE#0.8215;TRIOSE PHOSPHATE ISOMERASE#0.8199;POSTSYNAPTIC DENSITY#0.8196;AMYLOID PRECURSOR PROTEIN#0.8194;MEMBRANE REGION#0.8152;VASODILATOR#0.8112;IMMUNOLOGICAL SYNAPSE#0.8081;NEURAL CREST#0.8061;AXON REGENERATION#0.8047;PYRIDOXAL 5-PHOSPHATE#0.8039;HEPATOCELLULAR CARCINOMA#0.8037;FACTOR I#0.8030;SKELETAL MUSCLE CELLS#0.7995;AXON GUIDANCE#0.7978;SYNAPTIC TRANSMISSION#0.7975;CARDIOMYOCYTE#0.7970;DNA REPAIR#0.7966;VASCULAR SMOOTH MUSCLE CELL#0.7950;BUDDING#0.7947;CELL DIFFERENTIATION#0.7929;PODOSOME#0.7923;BLOOD BRAIN BARRIER#0.7904;CELL CYCLE ARREST#0.7893;SERUM RESPONSE FACTOR#0.7889;CELL CORTEX#0.7878;PROTEIN PROTEIN INTERACTION#0.7877;RECEPTOR ANTAGONIST#0.7869;MEMBRANE RUFFLE#0.7864;FURROW#0.7850;HAIR CELL#0.7843;PIP2 BINDING#0.7836;ASPARTATE#0.7834;PROTEIN KINASE A#0.7801;GUANOSINE#0.7793;EPITHELIAL OVARIAN CANCER#0.7783;GTP BINDING#0.7782;GROWTH CONE COLLAPSE#0.7772;PLASMA MEMBRANE REGION#0.7770;ENDOPLASMIC RETICULUM#0.7769;CHEMOKINE RECEPTOR#0.7735;NEUROTOXICITY#0.7728;INTERMEDIATE FILAMENT#0.7725;ACTIN FILAMENT NUCLEATION#0.7723;PHOSPHOINOSITIDE BINDING#0.7722;FLUID SHEAR STRESS#0.7716;ENDOSOME#0.7671;ATP HYDROLYSIS#0.7662;MEMBRANE EXTENSION#0.7634;HYPERPHOSPHORYLATION#0.7631;CELL WALL#0.7629;SPINE HEAD#0.7616;PROTEIN PHOSPHATASE 1#0.7607;NUCLEAR LOCALIZATION SIGNAL#0.7581;REVERSE TRANSCRIPTION#0.7579;PYRUVATE#0.7567;NEMALINE MYOPATHY#0.7549;RNA BINDING PROTEIN#0.7544;PYRIDOXAL#0.7541;ALKALINE PHOSPHATASE#0.7536;MESENCHYMAL STEM CELL#0.7532;RNA BINDING#0.7530;LYMPHOCYTE ACTIVATION#0.7521;DNA REPAIR CAPACITY#0.7513;RETINOIC ACID#0.7511;REGULATION OF ACTIN POLYMERIZATION#0.7506;RIBOSOMAL PROTEIN#0.7489;PRO-INFLAMMATORY#0.7478;INFLAMMATORY RESPONSE#0.7470;ACTIN MONOMER SEQUESTERING#0.7467;MUSCLE CONTRACTION#0.7448;VASCULAR ENDOTHELIAL CELL#0.7419;ADIPOCYTE#0.7410;SARCOMERE#0.7409;EPITHELIAL TO MESENCHYMAL#0.7405;COLON ADENOCARCINOMA#0.7402;AKT SIGNALING#0.7385;MEIOSIS#0.7372;ASSOCIATIVE LEARNING#0.7349;PROGRAMMED CELL DEATH#0.7344;RNA SYNTHESIS#0.7343;TUBULAR EPITHELIAL CELL#0.7332;BRAIN DEVELOPMENT#0.7298;HUMAN UMBILICAL VEIN#0.7296;NEURITE GROWTH#0.7294;UMBILICAL VEIN#0.7294;AXONAL TRANSPORT#0.7255;BRANCHING MORPHOGENESIS#0.7250;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.7250;MYOGENIC CELL#0.7237;MOUSE EMBRYONIC FIBROBLAST#0.7232;CISPLATIN#0.7228;INTEGRIN ACTIVATION#0.7228;SCIATIC NERVE#0.7203;VIRION#0.7200;RELATED PROTEIN 1#0.7200;NERVE GROWTH FACTOR#0.7184;CARDIAC MUSCLE#0.7182;TRANSFORMING GROWTH FACTOR BETA#0.7174;TRANSLATION INITIATION#0.7166;SYNAPTIC VESICLE#0.7155;CELL LOCOMOTION#0.7150;GENE SILENCING#0.7135;ASTROCYTOMA#0.7126;SENESCENCE#0.7119;LIVER CANCER#0.7116;MYOFIBROBLAST#0.7114;MYOPATHY#0.7099;DORSAL ROOT GANGLION#0.7096;ANTIGEN PRESENTING CELLS#0.7070;G1 PHASE#0.7069;ZONULA OCCLUDENS#0.7069;ACTIN PATCH#0.7053;M PHASE#0.7051;DOPAMINE#0.7043;PHOSPHOLIPASE D#0.7019;TRANSLATION INITIATION FACTOR#0.7007;C TERMINAL DOMAIN#0.6990;NEUROFIBRILLARY TANGLE#0.6984;NEUROLOGICAL DISORDER#0.6980;GLUCOSE UPTAKE#0.6971;ATP BINDING#0.6958;T CELL MIGRATION#0.6932;VIRULENCE#0.6926;FIBRINOGEN#0.6919;CONSTRICTION#0.6908;CELL POLARIZATION#0.6899;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6892;NEURAL CREST CELL#0.6861;SPECTRIN#0.6860;EPHRIN#0.6828;OSTEOCLAST#0.6815;IONOPHORE#0.6811;MAP KINASE#0.6807;RAPAMYCIN#0.6806;EARLY ENDOSOME#0.6786;ENDOTHELIUM#0.6783;BETA-2#0.6772;LOW DENSITY LIPOPROTEIN#0.6769;PROGESTERONE#0.6763;MEDIAL PREFRONTAL CORTEX#0.6762;PHOSPHATASE INHIBITOR#0.6752;PULMONARY HYPERTENSION#0.6742;FOREBRAIN#0.6736;NECROTIC#0.6719;INTEGRIN LINKED KINASE#0.6717;BONE RESORPTION#0.6713;PHOSPHATASE AND TENSIN HOMOLOG#0.6706;AORTIC SMOOTH MUSCLE CELLS#0.6705;LUMINAL#0.6702;POST-TRANSLATIONAL MODIFICATION#0.6700;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6696;INTRACELLULAR LOCALIZATION#0.6692;AUTOPHAGY#0.6690;NEURONAL CELL DEATH#0.6688;ADENYLATE#0.6633;CEREBRAL CORTEX#0.6590;HUMAN IMMUNODEFICIENCY VIRUS#0.6579;CELL CELL ADHESION#0.6557;DENTATE GYRUS#0.6544;MICROTUBULE ASSEMBLY#0.6519;FLUORESCEIN#0.6511;T CELL CHEMOTAXIS#0.6507;ADIPOCYTE DIFFERENTIATION#0.6502;KIDNEY DISEASE#0.6493;SERTOLI CELL#0.6485;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6482;GLUCOSE REGULATED PROTEIN#0.6466;COGNITION#0.6464;CASPASE ACTIVATION#0.6443;DIGESTION#0.6439;OUABAIN#0.6432;PROTEINURIA#0.6424;TRYPTOPHAN#0.6424;PLATELET AGGREGATION#0.6422;METHIONINE#0.6421;NEURAL CELL#0.6417;TUMOR TISSUES#0.6413;ETHANOL#0.6413;EMBRYONIC STEM CELL#0.6412;TARGET OF RAPAMYCIN#0.6408;CREATINE KINASE#0.6408;FRUCTOSE BISPHOSPHATE ALDOLASE#0.6404;BONE MORPHOGENETIC PROTEIN#0.6401;PARKINSON'S DISEASE#0.6385;PROGENITOR CELL#0.6383;TELOPHASE#0.6364;ACTIN BUNDLING ACTIVITY#0.6354;PHOSPHOGLYCERATE MUTASE#0.6345;DEOXYRIBONUCLEASE I#0.6291;MEIOTIC SPINDLE#0.6288;STATUS EPILEPTICUS#0.6288;LYSOSOME#0.6283;MACROPINOCYTOSIS#0.6273;AORTIC ANEURYSM#0.6266;CELL CYCLE REGULATION#0.6261;UBIQUINONE-1#0.6244;POLYSACCHARIDE SYNTHESIS#0.6243;ANION CHANNEL#0.6241;TAUOPATHY#0.6240;RECEPTOR TYROSINE KINASE#0.6222;NEPHROPATHY#0.6218;ORGANELLE#0.6213;LUNG CARCINOMA#0.6203;VIRAL REPLICATION#0.6201;CELL DEVELOPMENT#0.6193;ACTIN FILAMENT POLYMERIZATION#0.6172;INFLAMMATORY CELL#0.6171;ADIPOSE TISSUE#0.6155;TISSUE MICROARRAY ANALYSIS#0.6148;SWELLING#0.6140;ATHEROSCLEROSIS#0.6138;ARGININE#0.6137;FILOPODIUM#0.6129;CYCLIC AMP#0.6109;ACTIN FILAMENT BUNDLE#0.6081;GLIAL CELL#0.6076;NEUTROPHIL CHEMOTAXIS#0.6067;T LYMPHOCYTE ACTIVATION#0.6060;CEREBELLAR GRANULE NEURON#0.6059;KERATINOCYTE MIGRATION#0.6057;FORSKOLIN#0.6047;DEXAMETHASONE#0.6035;EDEMA#0.6029;GLUTAMATE DEHYDROGENASE#0.6022;ACETYLCHOLINE#0.6019;ENDOTHELIAL CELL PROLIFERATION#0.6007;ALVEOLAR EPITHELIAL CELL#0.6006
10730	THYLAKOID MEMBRANE#1.0806;THYLAKOID#1.0760;CHLOROPLAST#1.0443;PHOTOSYSTEM II#1.0369;PHOTOSYSTEM#1.0294;PROTEASE ACTIVITY#1.0269;MITOCHONDRIA#1.0218;PROTEIN QUALITY CONTROL#0.9805;CELL DIVISION#0.9481;MITOCHONDRIAL FUSION#0.9419;CYTOPLASMIC MEMBRANE#0.9293;ATP HYDROLYSIS#0.8972;MITOCHONDRIAL INNER MEMBRANE#0.8881;PROTEASE COMPLEX#0.8769;RESPIRATORY CHAIN#0.8555;TRANSCRIPTION FACTOR#0.8491;MITOCHONDRIAL MEMBRANE#0.8277;REACTION CENTER#0.8101;PROTEIN DEGRADATION#0.7928;SPORULATION#0.7774;PHOTOSYNTHESIS#0.7659;CELL GROWTH#0.7623;OPTIC ATROPHY#0.7617;PLASTID#0.7472;CRISTAE#0.7226;PHOTOINHIBITION#0.7068;ATP BINDING#0.7061;MEMBRANE FRACTION#0.6869;MITOCHONDRIAL FISSION#0.6660;ATPASE ACTIVITY#0.6587;COMPLEX I#0.6568;LIPOPOLYSACCHARIDE BIOSYNTHESIS#0.6554;ZINC BINDING#0.6422;CYTOPLASM#0.6388;TUBERCULOSIS#0.6327;FLAVODOXIN#0.6082
10732	TRANSCRIPTION FACTOR#1.0517;STATIONARY PHASE#0.6565
10733	CENTRIOLE AMPLIFICATION#1.0821;PROCENTRIOLE#1.0816;CENTRIOLE ASSEMBLY#1.0618;KINASE ACTIVITY#1.0588;CENTRIOLE DUPLICATION#1.0490;CENTRIOLE#1.0487;CENTROSOME DUPLICATION#1.0481;CELL PROLIFERATION#1.0448;PROTEIN KINASE#1.0355;DAUGHTER CENTRIOLE#1.0324;MOTHER CENTRIOLE#1.0214;CENTROSOME#1.0166;CANCER CELL#1.0055;MITOSIS#0.9972;CELL CYCLE#0.9920;MICROTUBULE#0.9839;CELL DIVISION#0.9739;APOPTOSIS#0.9579;BREAST CANCER#0.9524;GENE EXPRESSION#0.9507;SPINDLE ASSEMBLY#0.9500;SPINDLE FORMATION#0.9364;CYTOKINESIS#0.9289;UBIQUITIN#0.9249;MITOTIC SPINDLE#0.8932;HEPATOCELLULAR CARCINOMA#0.8898;MURINE EMBRYONIC FIBROBLASTS#0.8771;PERICENTRIOLAR MATERIAL#0.8758;CHROMOSOME SEGREGATION#0.8576;CENTRIOLE REPLICATION#0.8554;COLORECTAL CANCER#0.8451;M PHASE#0.8436;OOCYTE#0.8376;S PHASE#0.8350;CENTRIOLAR SATELLITE#0.8193;EMBRYO DEVELOPMENT#0.8115;SIGNALING PATHWAY#0.8018;MEIOSIS#0.8013;LUNG CANCER#0.7915;EPITHELIAL CELL#0.7669;INTERPHASE#0.7662;TUMOR SUPPRESSOR#0.7657;MICROCEPHALY#0.7541;POLO BOX DOMAIN#0.7527;CELL GROWTH#0.7492;CELL CYCLE REGULATION#0.7469;STEM CELL#0.7455;TRANSCRIPTION FACTOR#0.7049;CLEAVAGE FURROW#0.7014;MICROTUBULE ORGANIZING CENTER#0.6966;GERM CELL#0.6808;COLORECTAL#0.6806;RNA INTERFERENCE#0.6546;HUMAN BREAST CANCER#0.6544;SECKEL SYNDROME#0.6530;POLYMERASE CHAIN REACTION#0.6249;QUANTITATIVE REAL TIME#0.6096;GERMINAL VESICLE#0.6095;BREAST CANCER CELL#0.6011
10734	MEIOSIS#1.0697;MALE INFERTILITY#1.0453;SYNAPTONEMAL COMPLEX#1.0103;OVARIAN#1.0032;COHESIN COMPLEX#0.9884;CHROMATID#0.9781;INFERTILITY#0.9665;PROPHASE#0.9617;SISTER CHROMATID COHESION#0.9436;OOCYTE#0.8959;PRIMARY OVARIAN INSUFFICIENCY#0.8624;SYNAPSIS#0.8362;LATERAL ELEMENT#0.7113;MEIOTIC CHROMOSOME#0.6913;CENTROMERE#0.6864;GERM CELL#0.6766;MEIOSIS I#0.6711;PREMATURE OVARIAN FAILURE#0.6474;AZOOSPERMIA#0.6466;OVARIAN CANCER#0.6230;SPERMATOCYTES#0.6195
10735	BONE MARROW STROMAL#1.0798;COHESIN COMPLEX#1.0655;BONE MARROW#1.0571;CANCER CELL#1.0273;SISTER CHROMATID COHESION#1.0209;CHROMATID#1.0176;TUMOR SUPPRESSOR#0.9999;DNA REPAIR#0.9780;MITOSIS#0.9696;GENE EXPRESSION#0.9533;EWING SARCOMA#0.9475;CENTROMERE#0.9344;CELL PROLIFERATION#0.9251;LARYNGOTRACHEITIS#0.8983;CYSTATIN#0.8693;TUMOR CELLS#0.8640;ACUTE MYELOID LEUKEMIA#0.8629;MYELOID LEUKEMIA#0.8617;DNA REPLICATION#0.8604;VIRION#0.8510;TELOMERE#0.8368;CELL DIVISION#0.8335;CHROMOSOME SEGREGATION#0.8303;CELL CYCLE#0.8274;STEM CELL#0.8160;HUMAN IMMUNODEFICIENCY VIRUS#0.8062;PROTEIN COMPLEX#0.7944;ANAPHASE#0.7677;PROPHASE#0.7635;CELL SURFACE#0.7502;MYELODYSPLASTIC SYNDROME#0.7493;BREAST CANCER#0.7470;DEVELOPMENTAL DELAY#0.7391;PLASMA MEMBRANE#0.7289;MEIOSIS#0.7161;DNA METHYLATION#0.7022;COMPLEX I#0.7022;DENDRITIC CELL#0.6910;BUDDING#0.6870;INTELLECTUAL DISABILITY#0.6829;GROWTH FACTOR#0.6754;TUMOR NECROSIS FACTOR#0.6681;T CELL#0.6479;RNA SPLICING#0.6386;X CHROMOSOME#0.6327;DOUBLE STRAND BREAK#0.6313
10736	METANEPHRIC MESENCHYME#1.0559;TRANSCRIPTION FACTOR#1.0392;NEPHROGENESIS#1.0382;MESENCHYME#1.0343;NEPHRON#1.0312;PROGENITOR CELL#1.0299;APOPTOSIS#1.0289;KIDNEY DEVELOPMENT#1.0234;STEM CELL#1.0227;MESENCHYMAL CELL#1.0088;BREAST CANCER#0.9865;URETERIC BUD#0.9823;GENE EXPRESSION#0.9701;CELL PROLIFERATION#0.9533;POLYMERASE CHAIN REACTION#0.8699;NEURAL CREST#0.8668;EMBRYONIC KIDNEY#0.8527;CANCER CELL#0.8423;RENAL HYPOPLASIA#0.8381;SIGNALING PATHWAY#0.8380;FETAL KIDNEY#0.8363;EPITHELIAL CELL#0.8027;HEPATOCELLULAR CARCINOMA#0.8019;DNA BINDING#0.7718;MORPHOGENESIS#0.7499;PLURIPOTENT STEM CELL#0.7474;BONE MORPHOGENETIC PROTEIN#0.7139;KIDNEY DISEASE#0.7097;ORGANOGENESIS#0.7068;GROWTH FACTOR#0.6900;STROMA#0.6814;BREAST CANCER CELL#0.6760;PODOCYTE#0.6549;PYLORIC SPHINCTER#0.6348;BRANCHIAL ARCH#0.6188
10738	LUNG CANCER#1.0561;CANCER CELL#0.9393;TELOMERASE ACTIVITY#0.7336;SIGNALING PATHWAY#0.7179;PROMOTER BINDING#0.7000;HUMAN IMMUNODEFICIENCY VIRUS#0.6761
1073	SKELETAL MUSCLE#0.9940;MYOPATHY#0.9589;NEMALINE MYOPATHY#0.9355;ACTIN FILAMENT#0.9354;ACTIN BINDING#0.9236;SMOOTH MUSCLE#0.9044;ACTIN BINDING PROTEIN#0.8430;CANCER CELL#0.7852;ACTIN CYTOSKELETON#0.7620;SARCOMERE#0.7449;CONGENITAL MYOPATHY#0.7205;REGENERATION#0.7073;HEAT SHOCK PROTEIN#0.6898;MUSCLE CELL#0.6882;GENE EXPRESSION#0.6579;CARDIAC MUSCLE#0.6476;ACTIN DEPOLYMERIZATION#0.6439;STRIATED MUSCLE#0.6323;ACTIN DEPOLYMERIZING FACTOR#0.6236;CELL PROLIFERATION#0.6177;CELL CYCLE#0.6048;BREAST CANCER#0.6046
10741	SERINE HYDROLASE#1.0883;RETINOBLASTOMA#0.9099;HYDROLASE ACTIVITY#0.6674
10742	RETINOIC ACID#1.1043;BREAST CANCER#0.7556;NANCE-HORAN SYNDROME#0.7369;AKT SIGNALING#0.6885;BREAST CANCER CELL#0.6259;COLORECTAL CANCER#0.6251;CANCER CELL#0.6191
10743	RETINOIC ACID#1.0789;SMITH-MAGENIS SYNDROME#1.0574;INTELLECTUAL DISABILITY#0.9417;MENTAL RETARDATION#0.9377;GENE EXPRESSION#0.8963;CIRCADIAN RHYTHM#0.8776;TRANSCRIPTION FACTOR#0.8580;DEVELOPMENTAL DELAY#0.8540;COMPARATIVE GENOMIC HYBRIDIZATION#0.8251;TRANSCRIPTION FACTOR ACTIVITY#0.7988;AUTISM SPECTRUM DISORDER#0.7837;GENETIC DISORDER#0.7816;HEARING LOSS#0.7426;AUTISTIC#0.6480;NUCLEOSOME BINDING#0.6429;SOCIAL BEHAVIOR#0.6299;AGE AT ONSET#0.6270;QUANTITATIVE REAL TIME#0.6061
10744	CELL ADHESION#0.6311
10745	ENDOPLASMIC RETICULUM#0.8954;TYPE 1 DIABETES#0.6688;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6259;CELL PROLIFERATION#0.6140;GENE EXPRESSION#0.6121
10746	MAP KINASE#1.0351;MITOGEN ACTIVATED PROTEIN#1.0209;T CELL#1.0209;PROTEIN KINASE#1.0187;GENE EXPRESSION#1.0061;CELL PROLIFERATION#1.0054;GROWTH FACTOR#0.9924;APOPTOSIS#0.9888;CANCER CELL#0.9872;SIGNALING PATHWAY#0.9569;UBIQUITIN#0.9282;MAST CELL#0.9226;BREAST CANCER#0.9101;MAP KINASE KINASE#0.9028;SIGNALING CASCADE#0.8907;CYTOKINE PRODUCTION#0.8509;PROTEIN KINASE C#0.8351;EPIDERMAL GROWTH FACTOR#0.8254;KINASE ACTIVITY#0.8253;NF-KAPPAB ACTIVATION#0.7742;FOCAL ADHESION#0.7663;SIGNALING MOLECULE#0.7176;LUNG CANCER#0.7169;TRANSCRIPTION FACTOR#0.6947;BREAST CANCER CELL#0.6832;B CELL#0.6779;MAPK ERK KINASE#0.6773;LYSINE#0.6607;OSTEOBLAST#0.6366;MAPK SIGNALING#0.6332;SIGNAL TRANSDUCTION#0.6234;HEPATITIS B#0.6172;MAPKK#0.6142;TRANSFORMING GROWTH FACTOR#0.6134;HEPATOMA CELLS#0.6078;BONE FORMATION#0.6030
10747	C1-INH#1.0471;MANNAN BINDING LECTIN#1.0299;MANNAN BINDING#1.0289;LECTIN COMPLEMENT PATHWAY#1.0206;MANNOSE BINDING LECTIN#1.0121;LECTIN#1.0112;MANNOSE BINDING#1.0109;COMPLEMENT ACTIVATION#0.9985;PATTERN RECOGNITION MOLECULES#0.9952;IMMUNE SYSTEM#0.9799;INNATE IMMUNITY#0.9658;COMPLEMENT CASCADE#0.9615;INNATE IMMUNE SYSTEM#0.9587;IMMUNE RESPONSE#0.9142;COLORECTAL CANCER#0.8850;GROWTH FACTOR#0.8710;FIBRINOGEN#0.8535;GENE EXPRESSION#0.8486;PLASMA PROTEIN#0.8384;ISCHEMIA#0.8327;FACTOR D#0.8290;EPIDERMAL GROWTH FACTOR#0.8226;TUBERCULOSIS#0.8211;COAGULATION#0.8182;INFLAMMATORY RESPONSE#0.8138;HEPATITIS C#0.7901;SERPIN#0.7591;RHEUMATIC FEVER#0.7533;ISCHEMIA REPERFUSION INJURY#0.7522;COLORECTAL#0.7497;GLYCINE#0.7383;SURFACE PLASMON RESONANCE#0.7086;ALANINE#0.7075;AUTOIMMUNE DISEASE#0.6980;INNATE IMMUNE RESPONSE#0.6692;C REACTIVE PROTEIN#0.6595;RHEUMATOID ARTHRITIS#0.6545;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6500;LUPUS ERYTHEMATOSUS#0.6498;CARBOHYDRATE BINDING#0.6422;LUNG DISEASE#0.6323;PNEUMOCOCCAL MENINGITIS#0.6201;GLCNAC#0.6187;POLYMERASE CHAIN REACTION#0.6163;RHEUMATIC HEART DISEASE#0.6157;HEART DISEASE#0.6039
10748	LECTIN#1.0420;NKT CELL#1.0337;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0235;GENE EXPRESSION#1.0227;BONE MARROW#1.0138;CELL SURFACE#1.0071;T CELL#1.0048;CELL DEVELOPMENT#1.0047;NATURAL KILLER CELL#1.0043;CYTOTOXICITY#0.9869;CELL ACTIVATION#0.9807;IMMUNE RESPONSE#0.9614;TUMOR CELLS#0.9488;CD8+ T CELL#0.9421;IMMUNE SYSTEM#0.9372;LYSIS#0.9206;NK CELL ACTIVATION#0.9034;CYTOKINE PRODUCTION#0.8395;STEM CELL#0.7995;IFN-GAMMA#0.7897;T LYMPHOCYTE#0.7858;LEUKOCYTE#0.7821;SELF RECOGNITION#0.7707;RECEPTOR LIGAND#0.7691;DENDRITIC CELL#0.7657;VIRAL INFECTION#0.7194;CELL RECOGNITION#0.6621;B CELL#0.6501;IMMUNE CELL#0.6320;INNATE IMMUNE SYSTEM#0.6052
10749	KINESIN#1.0937;MICROTUBULE#1.0516;GOLGI APPARATUS#0.8348;PODOSOME#0.8105;ENDOPLASMIC RETICULUM#0.7758;VESICLE TRANSPORT#0.7533;MACROPHAGE#0.7450;HEREDITARY SPASTIC PARAPLEGIA#0.7411;SPASTIC ATAXIA#0.7120;PARAPLEGIA#0.6882;GOLGI MEMBRANE#0.6467;CELL PERIPHERY#0.6454
10750	T CELL#0.9008;B CELL#0.7248;NONSYNDROMIC DEAFNESS#0.6319
10752	NEURAL CELL#1.0309;CELL ADHESION MOLECULE#1.0293;CELL ADHESION#1.0284;CELL RECOGNITION#1.0177;LUNG CANCER#1.0145;MICROTUBULE ASSOCIATED PROTEIN#1.0138;LONG TERM POTENTIATION#1.0132;NEUROBLAST#1.0125;NEUROFILAMENT#1.0109;AXON GUIDANCE#1.0095;PROTEOGLYCAN#1.0094;NEURONAL MIGRATION#1.0091;GROWTH FACTOR RECEPTOR#1.0064;NERVE GROWTH FACTOR#1.0064;LUNG CARCINOMA#1.0047;IMMATURE NEURON#1.0026;TASTE BUD#0.9997;HYDROCEPHALUS#0.9997;SYNAPTOGENESIS#0.9974;GROWTH CONE#0.9961;MUSCLE FIBER#0.9953;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9950;FIBROBLAST GROWTH FACTOR#0.9948;MUSCLE CELL#0.9930;CANCER CELL#0.9926;NERVOUS SYSTEM DEVELOPMENT#0.9924;OLIGODENDROCYTE#0.9922;NEURITE OUTGROWTH#0.9911;INTERNEURON#0.9909;BRAIN DEVELOPMENT#0.9906;SYSTEM DEVELOPMENT#0.9905;NEUROMUSCULAR JUNCTION#0.9901;INNERVATION#0.9897;SCHWANN CELL#0.9895;MICROTUBULE#0.9895;GLIAL CELL#0.9894;STRIATUM#0.9884;SKELETAL MUSCLE#0.9871;PRECURSOR CELL#0.9863;CELL CELL ADHESION#0.9859;MORPHOGENESIS#0.9858;EXTRACELLULAR MATRIX#0.9855;SMOOTH MUSCLE#0.9842;ROSTRAL MIGRATORY STREAM#0.9837;NEURITE#0.9832;SPATIAL LEARNING#0.9829;CELL MIGRATION#0.9828;ASTROCYTE#0.9826;NERVE FIBER#0.9826;REGENERATION#0.9821;T CELL#0.9821;FOREBRAIN#0.9810;GROWTH FACTOR#0.9810;PROGENITOR CELL#0.9807;CEREBRAL CORTEX#0.9806;AXON GROWTH#0.9799;MYELINATION#0.9799;NEUROBLASTOMA#0.9798;DENTATE GYRUS#0.9794;NEURAL STEM CELL#0.9790;MENTAL RETARDATION#0.9790;CENTRAL NERVOUS SYSTEM#0.9789;TUMOR SUPPRESSOR#0.9788;SIALYLATION#0.9786;SIGNALING PATHWAY#0.9776;OLFACTORY BULB#0.9774;SPINAL CORD#0.9773;STEM CELL#0.9763;PROTEIN KINASE#0.9763;MULTIPLE MYELOMA#0.9760;OPTIC NERVE#0.9759;NMDA RECEPTOR#0.9754;NERVOUS SYSTEM#0.9752;TUMOR CELLS#0.9747;MYOTUBE#0.9746;TRANSCRIPTION FACTOR#0.9745;CELL PROLIFERATION#0.9743;CELL SURFACE#0.9742;PLASMA MEMBRANE#0.9741;SIGNAL TRANSDUCTION#0.9733;SPINAL CORD INJURY#0.9722;PERIPHERAL NERVOUS SYSTEM#0.9711;EPIDERMAL GROWTH FACTOR#0.9707;SQUAMOUS CELL CARCINOMA#0.9695;POSTTRANSLATIONAL MODIFICATION#0.9690;EPITHELIAL CELL#0.9684;NEUROGENESIS#0.9680;MYOBLAST#0.9670;GENE EXPRESSION#0.9664;POLYMERASE CHAIN REACTION#0.9661;NEURONAL CELLS#0.9659;PERIPHERAL NERVE#0.9648;SYNAPTIC TRANSMISSION#0.9621;NEURONAL CELL ADHESION#0.9598;AMYGDALA#0.9582;RETINOIC ACID#0.9547;ENDOTHELIAL CELL#0.9535;DENDRITIC SPINE#0.9533;CELL GROWTH#0.9527;CELL DEATH#0.9520;BONE MARROW#0.9520;CELL MEMBRANE#0.9515;APICAL DENDRITE#0.9503;MITOGEN ACTIVATED PROTEIN#0.9502;RETINAL GANGLION CELL#0.9497;ADENOID CYSTIC CARCINOMA#0.9481;GLYCOSYLATION#0.9473;TRANSFORMING GROWTH FACTOR#0.9456;NEUROTROPHIN RECEPTOR#0.9418;EXTRACELLULAR REGION#0.9406;NATURAL KILLER CELL#0.9395;N GLYCAN#0.9378;HEPARIN#0.9377;ALZHEIMER'S DISEASE#0.9358;SCIATIC NERVE#0.9335;APOPTOSIS#0.9331;ADENOCARCINOMA#0.9326;CELL DIFFERENTIATION#0.9274;PYRAMIDAL CELL#0.9230;LEUKOCYTE#0.9216;DOPAMINE#0.9179;FACTOR I#0.9175;CHONDROITIN SULFATE PROTEOGLYCAN#0.9163;ACETYLCHOLINE RECEPTOR#0.9151;BASAL LAMINA#0.9149;SMOOTH MUSCLE ACTIN#0.9137;B CELL#0.9114;MORRIS WATER MAZE#0.9104;PROTEIN KINASE C#0.9073;NITRIC OXIDE#0.9062;MYOGENESIS#0.9056;LATERAL VENTRICLE#0.9029;POST-TRANSLATIONAL MODIFICATION#0.9026;ASPARTATE#0.9014;INSULIN-LIKE GROWTH FACTOR#0.9012;OLFACTORY EPITHELIUM#0.8981;SYNAPTIC VESICLE#0.8967;NEURAL CREST#0.8953;RECEPTOR ANTAGONIST#0.8908;SODIUM CHANNEL#0.8905;ACETYLCHOLINE#0.8895;CEREBELLAR GRANULE NEURON#0.8889;CYTOPLASM#0.8879;RHABDOMYOSARCOMA#0.8856;LONG TERM MEMORY#0.8855;PURKINJE CELL#0.8843;CELL SURFACE ANTIGEN#0.8841;ENDOTHELIAL GROWTH FACTOR#0.8838;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8838;HEPARIN BINDING#0.8805;GONADOTROPIN RELEASING HORMONE#0.8780;MEDIAL PREFRONTAL CORTEX#0.8774;NEUROENDOCRINE CARCINOMA#0.8768;HISTOGENESIS#0.8737;SPECTRIN#0.8712;OVARIAN#0.8702;EMBRYONIC STEM CELL#0.8696;BETA-2#0.8686;TELENCEPHALON#0.8681;SMALL CELL CARCINOMA#0.8681;LYMPH NODE#0.8678;RECEPTOR TYROSINE KINASE#0.8653;MYOBLAST FUSION#0.8647;EPILEPSY#0.8633;CNS DEVELOPMENT#0.8633;GANGLION CELLS#0.8614;NEURAL TUBE#0.8595;TRANSFORMING GROWTH FACTOR BETA#0.8575;ALKALINE PHOSPHATASE#0.8536;BONE MORPHOGENETIC PROTEIN#0.8536;ENDOCRINE CELL#0.8534;ETHANOL#0.8530;HYPOXIA#0.8513;DOPAMINERGIC NEURON#0.8510;MULTIPLE SCLEROSIS#0.8506;BREAST CANCER#0.8472;BETA CELL#0.8459;MAGNETIC RESONANCE IMAGING#0.8458;BASEMENT MEMBRANE#0.8447;GESTATION#0.8446;MESENCHYME#0.8444;BLOOD VESSEL#0.8380;2'-DEOXYURIDINE#0.8377;PLASMA CELL#0.8375;BASAL CELL#0.8366;EMBRYONIC BRAIN#0.8312;NEURITE EXTENSION#0.8295;NEURAL PROGENITOR CELL#0.8286;MASA SYNDROME#0.8267;AMYLOID PRECURSOR PROTEIN#0.8231;GLUTAMATE RECEPTOR#0.8218;PERIPHERAL BLOOD#0.8212;NEURODEGENERATIVE DISEASE#0.8188;STROMAL CELL#0.8174;COLORECTAL#0.8122;RENAL CELL CARCINOMA#0.8119;ENDOCYTOSIS#0.8103;REVERSE TRANSCRIPTION#0.8091;CELL AGGREGATION#0.8078;ISCHEMIA#0.8071;RECEPTOR AGONIST#0.8025;GROWTH PATTERN#0.8020;COLORECTAL CANCER#0.8015;NERVOUS TISSUE#0.7998;STROMA#0.7976;OPTIC NERVE HEAD#0.7966;MYOSIN HEAVY CHAIN#0.7947;MEMBRANE FRACTION#0.7943;BILE DUCT#0.7937;TECTUM#0.7892;TEMPORAL LOBE#0.7844;APOPTOTIC#0.7811;LIPID RAFT#0.7798;CONTEXTUAL FEAR CONDITIONING#0.7791;MACROPHAGE#0.7753;LECTIN#0.7753;PHOSPHOLIPASE C#0.7741;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7721;T LYMPHOCYTE#0.7713;CHRONIC RESTRAINT STRESS#0.7703;GROWTH CONE COLLAPSE#0.7702;PARAPLEGIA#0.7690;NEUROENDOCRINE TUMOR#0.7661;TUMOR NECROSIS FACTOR#0.7659;SIGNALING CASCADE#0.7619;NEUROECTODERMAL TUMOR#0.7611;DORSAL ROOT GANGLION#0.7548;COGNITION#0.7546;MYELOID LEUKEMIA#0.7517;IMMUNE SYSTEM#0.7484;LARGE CELL CARCINOMA#0.7480;PERIPHERAL T-CELL LYMPHOMA#0.7475;NERVE TERMINAL#0.7443;OLFACTORY PLACODE#0.7414;PARKINSON'S DISEASE#0.7400;CELL ACTIVATION#0.7395;AMPA RECEPTOR#0.7390;CHRONIC MILD STRESS#0.7357;ACUTE MYELOID LEUKEMIA#0.7339;INTERMEDIATE FILAMENT#0.7325;NITRIC OXIDE SYNTHASE#0.7317;GLUTAMIC ACID#0.7316;HEPATIC PROGENITOR CELL#0.7296;FETAL BRAIN#0.7270;TRANSCRIPTASE#0.7240;HEPATIC STELLATE CELL#0.7237;MUSCLE FIBRE#0.7199;COMPARATIVE GENOMIC HYBRIDIZATION#0.7179;CELL CYCLE#0.7145;MONOCYTE#0.7143;MESENCHYMAL CELL#0.7139;AXON TERMINAL#0.7133;MIDLINE#0.7077;ASTROCYTOMA#0.7061;NEUROTOXIN#0.7039;MYOPATHY#0.7027;NEUROENDOCRINE CELL#0.7024;LASER SCANNING MICROSCOPY#0.7016;MYOGENIC CELL#0.6997;THYROID CARCINOMA#0.6997;NEUROLOGICAL DISORDER#0.6982;ADRENAL GLAND#0.6977;LARGE CELL NEUROENDOCRINE CARCINOMA#0.6968;SIGNALLING PATHWAY#0.6947;HIPPOCAMPAL MOSSY FIBER#0.6905;3P- SYNDROME#0.6888;CILIARY GANGLION#0.6877;FETAL ALCOHOL SPECTRUM DISORDER#0.6871;FETAL ALCOHOL SPECTRUM#0.6870;HEPATOCELLULAR CARCINOMA#0.6867;PARENCHYMA#0.6858;IMMUNOTOXIN#0.6857;HAIR FOLLICLE#0.6855;LOW DENSITY LIPOPROTEIN#0.6852;FRONTAL#0.6846;ENDOPLASMIC RETICULUM#0.6844;NEUROEPITHELIAL CELL#0.6829;CELL DIVISION#0.6815;KINASE ACTIVITY#0.6798;CERVICAL#0.6788;ORGANOGENESIS#0.6780;TOXICITY#0.6770;INTELLECTUAL DISABILITY#0.6763;CELLULAR LOCALIZATION#0.6752;CAM BINDING#0.6711;CHROMOSOMAL REGION#0.6699;PLATELET-DERIVED GROWTH FACTOR#0.6696;SIGNALING MOLECULE#0.6695;NEUROTOXICITY#0.6684;BOUTON#0.6676;PANCREATIC ISLET#0.6668;NEUROTRANSMISSION#0.6644;NEURONAL PROGENITOR CELL#0.6589;DIGESTION#0.6586;MOLAR#0.6579;INTERSTITIAL CELL#0.6579;ESTRADIOL#0.6576;CYTOTOXICITY#0.6568;MUSCULAR DYSTROPHY#0.6549;SYNAPTIC MEMBRANE#0.6538;OLFACTORY PIT#0.6509;ENDOTHELIUM#0.6499;LIVER DISEASE#0.6496;THALAMUS#0.6482;NON-SMALL CELL LUNG CARCINOMA#0.6481;CREATINE KINASE#0.6472;CELL BODY#0.6459;BASAL SYNAPTIC TRANSMISSION#0.6427;PERINEURONAL NET#0.6355;HIPPOCAMPAL DENTATE GYRUS#0.6345;NEURITE GROWTH#0.6334;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.6332;EXCITATORY SYNAPSE#0.6318;MERKEL CELL#0.6314;MIDBRAIN#0.6306;GLUTAMATE DECARBOXYLASE#0.6301;VALPROIC ACID#0.6299;CELL COMMUNICATION#0.6297;CAMP RESPONSE ELEMENT BINDING#0.6265;CAMP RESPONSE ELEMENT#0.6255;HAIR CELL#0.6246;CELL MATRIX ADHESION#0.6243;PROTEIN KINASE A#0.6238;GLUCOCORTICOID RECEPTOR#0.6237;CHROMAFFIN CELL#0.6234;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6232;OLFACTORY RECEPTOR#0.6230;INFLAMMATORY CELL#0.6222;NEURONAL CELL BODIES#0.6216;MONONUCLEAR CELLS#0.6205;NEUROPATHY#0.6171;RICIN#0.6167;POSTSYNAPTIC SPECIALIZATION#0.6143;SCOPOLAMINE#0.6136;MEMORY IMPAIRMENT#0.6127;BIPOLAR DISORDER#0.6125;PANCREATIC CANCER#0.6117;AMYOTROPHIC LATERAL SCLEROSIS#0.6117;LATERAL SCLEROSIS#0.6117;COMPLEX I#0.6112;PREPULSE INHIBITION#0.6079;DENDRITIC SPINE DENSITY#0.6045;UBIQUITIN#0.6033;GDNF FAMILY RECEPTOR#0.6028;NEURAL CREST CELL#0.6026;AXONAL FASCICULATION#0.6019;DOWN SYNDROME#0.6010;ARTERY#0.6006;ADOLESCENT IDIOPATHIC SCOLIOSIS#0.6003
10753	DIGESTIVE TRACT#0.9453;GASTROINTESTINAL TRACT#0.7309;APOPTOSIS#0.6606;NOTTINGHAM PROGNOSTIC INDEX#0.6164
10755	ENDOTHELIAL CELL#1.0522;PDZ BINDING MOTIF#1.0521;PANCREATIC CANCER#1.0441;BREAST CANCER#1.0434;CANCER CELL#1.0406;GROWTH FACTOR#1.0246;CELL SURFACE#1.0050;PLASMA MEMBRANE#1.0043;CELL PROLIFERATION#0.9877;ENDOSOME#0.9266;AQUAPORIN#0.9187;OVARIAN#0.8780;BREAST CANCER CELL#0.8518;CELL MIGRATION#0.8514;ANGIOGENESIS#0.8498;OVARIAN CANCER#0.8465;INSULIN-LIKE GROWTH FACTOR#0.8398;WNT RECEPTOR#0.8321;MORPHOGENESIS#0.8266;SIGNALING PATHWAY#0.8135;DOPAMINE D2 RECEPTOR#0.8116;TRANSFORMING GROWTH FACTOR#0.8053;DOPAMINE#0.7973;EARLY ENDOSOME#0.7877;SIGNAL TRANSDUCTION#0.7829;RECEPTOR TYROSINE KINASE#0.7774;ENDOTHELIAL GROWTH FACTOR#0.7729;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7729;ENDOCYTOSIS#0.7631;TONOPLAST#0.7610;NERVOUS SYSTEM#0.7562;TYPE 2 DIABETES#0.7530;STEM CELL#0.7289;GENE EXPRESSION#0.7280;PROTEIN PROTEIN INTERACTION#0.7100;CELL MEMBRANE#0.7025;SMOOTH MUSCLE#0.6762;T CELL#0.6731;ARTERY#0.6579;DIABETES MELLITUS#0.6526;GROWTH FACTOR RECEPTOR#0.6524;PROTEIN KINASE#0.6495;PTB DOMAIN BINDING#0.6350;COLORECTAL#0.6266;RNA INTERFERENCE#0.6256;CELL ADHESION#0.6232;CELL GROWTH#0.6223;RECEPTOR INTERACTING PROTEIN#0.6205;PROTEIN COMPLEX#0.6135;BRANCHING MORPHOGENESIS#0.6120;BREAST CANCER PATIENTS#0.6110;ENDOTHELIAL CELL MIGRATION#0.6092;PROSTATE CANCER#0.6082;MOUSE EMBRYONIC STEM#0.6038;PANCREATIC ADENOCARCINOMA#0.6011
10758	B CELL#1.0658;PSORIASIS#1.0248;SIGNALING PATHWAY#1.0175;ENDOTHELIAL CELL#1.0141;UBIQUITIN#1.0131;TUMOR NECROSIS FACTOR#1.0107;EPITHELIAL CELL#1.0079;T CELL#0.9908;TRANSCRIPTION FACTOR#0.9825;IMMUNE RESPONSE#0.9819;GENE EXPRESSION#0.9802;PSORIATIC ARTHRITIS#0.9693;INFLAMMATORY RESPONSE#0.9682;AUTOIMMUNE DISEASE#0.9645;TH17 CELL#0.9434;POLYMERASE CHAIN REACTION#0.9430;PRO-INFLAMMATORY#0.9153;KERATINOCYTE#0.9135;APOPTOSIS#0.9036;AUTOIMMUNITY#0.8977;CARDIOMYOCYTE#0.8772;CANCER CELL#0.8719;PROTEIN KINASE#0.8703;QUANTITATIVE REAL TIME#0.8566;CELL DEATH#0.8492;CANDIDIASIS#0.8473;GLYCERALDEHYDE-3-PHOSPHATE#0.8413;SMOOTH MUSCLE#0.8351;BETA GLUCURONIDASE#0.8331;SIGNAL TRANSDUCTION#0.8251;RIBOSOMAL PROTEIN#0.8172;REVERSE TRANSCRIPTION#0.8130;INTERNAL TRANSCRIBED SPACER#0.8122;CELL PROLIFERATION#0.7963;ASTROCYTE#0.7915;NEUTROPHIL#0.7909;TRANSITIONAL B CELL#0.7832;SMOOTH MUSCLE CELL#0.7819;MUSCLE CELL#0.7810;RIBOSOMAL RNA#0.7775;MRNA STABILIZATION#0.7751;GROWTH FACTOR#0.7548;VIRULENCE#0.7351;CELL CYCLE#0.7338;CELL MIGRATION#0.7255;SKIN DISEASE#0.7188;TRANSLATION INITIATION#0.7113;NF-KAPPAB ACTIVATION#0.7110;STATIONARY PHASE#0.7099;MORPHOGENESIS#0.7090;HEART DISEASE#0.7036;ACTIN BINDING#0.7027;CELL SURFACE#0.6999;MRNA DECAY#0.6969;VASCULAR DISEASE#0.6907;PROTOPLAST#0.6902;INTERLEUKIN 17 RECEPTOR#0.6799;WOUND HEALING#0.6799;COLITIS#0.6772;RHEUMATOID ARTHRITIS#0.6758;SIGNALING MOLECULE#0.6739;STANDARD OF CARE#0.6534;CELL WALL#0.6517;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6516;INNATE IMMUNE RESPONSE#0.6499;CHLOROPLAST#0.6358;ENCEPHALOMYELITIS#0.6313;PERIPHERAL BLOOD#0.6259;TRANSLATION ELONGATION FACTOR#0.6204;FLUCONAZOLE#0.6203;TRANSLATION ELONGATION#0.6188;DNA BINDING#0.6176;SMOOTH MUSCLE CELL MIGRATION#0.6092;RECEPTOR COMPLEX#0.6090;MUSCLE CELL MIGRATION#0.6088
1075	CATHEPSIN C ACTIVITY#1.1398;NEUTROPHIL SERINE PROTEASE#1.0583;BETA GLUCURONIDASE#1.0509;MAST CELL#1.0499;DIPEPTIDYL PEPTIDASE#1.0490;CYSTATIN#1.0338;T CELL#1.0283;NEUTROPHIL#1.0282;BETA GALACTOSIDASE#1.0203;IMMUNE CELL#1.0067;AGGRESSIVE PERIODONTITIS#1.0057;LYSOSOME#1.0024;PERIODONTITIS#0.9981;BONE MARROW#0.9961;ENZYME ACTIVITY#0.9914;ACID PHOSPHATASE#0.9867;LEUKOCYTE#0.9635;IMMUNE RESPONSE#0.9583;LEUCINE#0.9491;MACROPHAGE#0.9476;GRANZYME B ACTIVITY#0.9441;L-PHENYLALANINE#0.9409;CD8+ T CELL#0.9405;INFLAMMATORY RESPONSE#0.9360;GENE EXPRESSION#0.9349;T LYMPHOCYTE#0.9334;PERIODONTAL DISEASE#0.9177;EPITHELIAL CELL#0.9147;POLYMERASE CHAIN REACTION#0.9044;PERIPHERAL BLOOD#0.8956;APOPTOSIS#0.8947;DIGESTION#0.8939;PROTEINASE INHIBITOR#0.8892;TRIPEPTIDYL PEPTIDASE#0.8654;INFLAMMATORY CELL#0.8653;CELL DEATH#0.8584;ALPHA MANNOSIDASE#0.8561;ENDOPLASMIC RETICULUM#0.8395;CYTOTOXICITY#0.8377;SKELETAL MUSCLE#0.8251;ARGININE#0.8189;L-LEUCINE#0.8096;ALPHA GLUCOSIDASE#0.8064;CYTOTOXIC T-LYMPHOCYTE#0.7958;COLLAGEN INDUCED ARTHRITIS#0.7921;DIPEPTIDYL PEPTIDASE IV#0.7855;GLYCOSYLATION#0.7850;CANCER CELL#0.7784;ERGIC#0.7757;PROTEASE ACTIVITY#0.7666;ORGANELLE#0.7649;SIGNALING PATHWAY#0.7633;CELL PROLIFERATION#0.7585;OXIDATIVE BURST#0.7555;PALMOPLANTAR KERATOSIS#0.7452;MYELOID CELL#0.7422;ALKALINE PHOSPHATASE#0.7401;KERATOSIS#0.7166;GRANULOCYTE#0.7136;CYTOTOXIC T CELL#0.7093;MONOCYTE#0.7032;B CELL#0.7006;PRO-INFLAMMATORY#0.6933;SIGNAL PEPTIDE#0.6903;COLLAGENASE#0.6881;IMMUNE SYSTEM#0.6830;AORTIC ANEURYSM#0.6783;ABDOMINAL AORTIC ANEURYSM#0.6764;GASTRIC MUCOSA#0.6752;ENDOTHELIAL CELL#0.6736;TOXICITY#0.6714;SERINE PROTEASE ACTIVITY#0.6660;AUTOSOMAL RECESSIVE DISEASE#0.6565;ADAPTIVE IMMUNE RESPONSE#0.6509;APOPTOTIC#0.6505;ENDOCYTOSIS#0.6434;GROWTH FACTOR#0.6413;BETA N ACETYLGLUCOSAMINIDASE#0.6386;NEUTROPHIL ACTIVATION#0.6356;TRANSFERASE ACTIVITY#0.6319;MUCOUS CELL METAPLASIA#0.6306;LYSIS#0.6302;HEPARIN#0.6286;MUSCULAR DYSTROPHY#0.6285;RHEUMATOID ARTHRITIS#0.6277;GENERALIZED AGGRESSIVE PERIODONTITIS#0.6173;GINGIVAL CREVICULAR FLUID#0.6137;ESTERASE ACTIVITY#0.6130;SKIN FIBROBLASTS#0.6003
10761	BREAST CANCER#1.1028;TROPHOBLAST#1.0862;CANCER CELL#1.0832;SPECIFIC PROTEIN 1#1.0246;PLACENTAL DEVELOPMENT#1.0098;CANCER TESTIS ANTIGEN#0.9674;SYNCYTIOTROPHOBLAST#0.8813;GESTATION#0.8714;GENE EXPRESSION#0.8617;TROPHOBLAST CELL#0.8359;BREAST CANCER CELL#0.8216;GROWTH FACTOR#0.8033;X CHROMOSOME#0.7836;CELL PROLIFERATION#0.7630;PRE-ECLAMPSIA#0.7627;OVARIAN#0.7213;PROSTATE CANCER#0.7091;T CELL#0.7044;PLASMA PROTEIN#0.6962;ADENOCARCINOMA#0.6640;QUANTITATIVE REAL TIME#0.6442;TUMOR CELLS#0.6412;STEM CELL#0.6402;POLYMERASE CHAIN REACTION#0.6400;ESTROGEN RECEPTOR#0.6243;GLIAL CELLS MISSING#0.6077
10762	IMPORTIN#1.0508;NUCLEAR PORE#1.0492;NUCLEAR IMPORT#1.0063;PORE COMPLEX#0.9838;NUCLEAR PORE COMPLEX#0.9480;PROTEIN IMPORT#0.8652;GERM CELL#0.8461;NUCLEAR PORE COMPLEXES#0.7611;NUCLEAR ENVELOPE#0.7453;CELL DIFFERENTIATION#0.6304
10763	NESTIN POSITIVE CELLS#1.0514;PODOCYTE#1.0386;STEM CELL FACTOR#1.0317;NEURONAL STEM CELL#1.0317;FOLLICLE STEM CELL#1.0288;INTERMEDIATE FILAMENT#1.0243;HAIR FOLLICLE#1.0207;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0207;MYOCARDIAL INFARCTION#1.0201;EPENDYMAL CELL#1.0200;NEURONAL PROGENITOR CELL#1.0197;SMOOTH MUSCLE ACTIN#1.0193;STEM CELL MARKER#1.0191;VASCULAR ENDOTHELIAL CELL#1.0174;SQUAMOUS CELL CARCINOMA#1.0162;BASAL CELL#1.0147;HEAT SHOCK PROTEIN#1.0133;MELATONIN#1.0122;LUNG CANCER#1.0100;ENDOCRINE CELL#1.0095;PROGENITOR STEM CELL#1.0091;VASCULAR SMOOTH MUSCLE CELL#1.0091;MICROTUBULE ASSOCIATED PROTEIN#1.0089;ROOT SHEATH#1.0078;LYMPH NODE#1.0073;BREAST CANCER#1.0072;PERICYTE#1.0071;NEUROFILAMENT#1.0071;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0064;IMMATURE NEURON#1.0063;PANCREATIC STEM CELL#1.0053;NEUROEPITHELIAL CELL#1.0050;RADIAL GLIAL CELL#1.0044;ENDOTHELIAL PROGENITOR CELL#1.0037;CONNECTIVE TISSUE#1.0029;CELL ADHESION MOLECULE#1.0028;ENDOTHELIUM#1.0027;MESENCHYME#1.0024;ATP BINDING CASSETTE#1.0024;MICROTUBULE#1.0018;NEURONAL PRECURSOR CELLS#1.0009;ATP BINDING#1.0008;CELL ASSOCIATED#1.0001;PANCREATIC CANCER#0.9999;SMOOTH MUSCLE#0.9993;HAIR CELL#0.9976;INTERSTITIAL CELL#0.9976;TUMOR STEM CELL#0.9970;NEURAL CREST STEM CELL#0.9967;BETA CELL#0.9950;NEURAL CREST STEM#0.9950;OPTIC NERVE#0.9941;QUANTITATIVE REVERSE TRANSCRIPTION#0.9939;BLOOD VESSEL#0.9939;KERATINOCYTE#0.9937;MEDULLOBLASTOMA#0.9935;ASTROCYTOMA#0.9931;FETAL PANCREAS#0.9924;HIPPOCAMPAL DENTATE GYRUS#0.9920;MELANOCYTE#0.9919;MYOBLAST#0.9919;OVARIAN CANCER#0.9918;LEYDIG CELL#0.9916;SMOOTH MUSCLE CELL#0.9913;ADENOCARCINOMA#0.9910;SKELETAL MUSCLE#0.9907;GLUTAMINE#0.9901;CONNEXIN#0.9900;TAMOXIFEN#0.9892;MULTIPOTENT STEM CELL#0.9892;NEURAL PRECURSOR CELL#0.9889;OVARIAN#0.9880;ENDOTHELIAL CELL#0.9875;NEURAL STEM PROGENITOR#0.9874;B CELL#0.9873;2'-DEOXYURIDINE#0.9872;MUSCLE CELL#0.9871;NEUROBLAST#0.9871;CYCLIN DEPENDENT KINASE#0.9870;PANCREATIC ISLET#0.9868;PROSTATE CANCER#0.9868;FOCAL CEREBRAL ISCHEMIA#0.9867;NEURAL CREST#0.9859;STROMA#0.9856;CELL ADHESION#0.9853;NEURAL TUBE#0.9851;RED FLUORESCENT PROTEIN#0.9851;CYTOPLASM#0.9850;ADULT HIPPOCAMPAL NEUROGENESIS#0.9848;LIPID BINDING PROTEIN#0.9844;NEURAL CREST CELL#0.9842;MESENCHYMAL CELL#0.9835;ALKALINE PHOSPHATASE#0.9833;RETINAL PROGENITOR CELL#0.9833;CARDIOMYOCYTE#0.9829;ROSTRAL MIGRATORY STREAM#0.9826;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9826;CNS DEVELOPMENT#0.9822;NERVOUS SYSTEM DEVELOPMENT#0.9821;DEDIFFERENTIATION#0.9814;QUANTITATIVE REAL TIME#0.9814;EPILEPSY#0.9812;ENDOTHELIAL GROWTH FACTOR#0.9812;SYSTEM DEVELOPMENT#0.9811;NERVE GROWTH FACTOR#0.9811;PROTEOGLYCAN#0.9810;GROWTH FACTOR RECEPTOR#0.9809;PRECURSOR CELL#0.9806;HEMATOPOIETIC STEM CELL#0.9802;HYPOXIA#0.9801;SCHWANN CELL#0.9800;MIDBRAIN#0.9800;TUMOR CELLS#0.9794;ASTROCYTE#0.9794;PLATELET-DERIVED GROWTH FACTOR#0.9792;LYMPH NODE METASTASIS#0.9790;NEURAL PROGENITOR CELL#0.9789;CELL BODY#0.9781;FETAL BRAIN#0.9781;EPITHELIAL CELL#0.9781;MESENCHYMAL STROMAL CELL#0.9779;LIPID BINDING#0.9776;PARENCHYMA#0.9776;REVERSE TRANSCRIPTION#0.9773;MALIGNANT GLIOMA#0.9772;FOREBRAIN#0.9769;MYOFIBROBLAST#0.9760;MYOTUBE#0.9759;MACROPHAGE#0.9758;GLIOGENESIS#0.9754;ANGIOGENESIS#0.9752;TRANSCRIPTASE#0.9750;CEREBRAL ISCHEMIA#0.9746;NEUROTROPHIN RECEPTOR#0.9744;CORTICAL CELL#0.9744;PROGENITOR CELL#0.9743;PERIPHERAL NERVE#0.9742;RECEPTOR ANTAGONIST#0.9739;BONE MORPHOGENETIC PROTEIN#0.9738;TRANSFORMING GROWTH FACTOR#0.9737;ISCHEMIA#0.9737;DENTATE GYRUS#0.9736;MICROGLIAL CELL#0.9736;OLFACTORY BULB#0.9734;OSTEOBLAST#0.9733;NEURAL STEM CELL#0.9730;NERVE FIBER#0.9728;CANCER STEM-LIKE CELL#0.9726;CELL SURFACE#0.9724;NORMAL CONTROL GROUP#0.9722;CHOLINE#0.9721;EMBRYOID BODY#0.9719;POLYMERASE CHAIN REACTION#0.9719;STEM CELL LIKE#0.9717;TISSUE REGENERATION#0.9714;OLIGODENDROCYTE#0.9711;NEUROBLASTOMA#0.9711;INSULIN-LIKE GROWTH FACTOR#0.9707;CORD BLOOD#0.9704;CANCER CELL#0.9702;BONE MARROW STROMAL#0.9698;CELL DIVISION#0.9698;DENTAL PULP#0.9691;DOPAMINERGIC NEURON#0.9689;BONE MARROW STROMAL CELL#0.9689;NEURAL CELL#0.9685;DENTAL PULP STEM CELL#0.9682;STRIATUM#0.9681;STEM CELL#0.9680;CELL GROWTH#0.9679;GLIAL CELL#0.9677;HYPOXIC#0.9676;MOLAR#0.9676;DOPAMINE#0.9676;SPINAL CORD#0.9671;MARROW STROMAL CELLS#0.9668;GANGLION CELLS#0.9663;LATERAL VENTRICLE#0.9663;WOUND HEALING#0.9661;CELL MOTILITY#0.9658;STEM CELL DIFFERENTIATION#0.9658;CELL MIGRATION#0.9657;GESTATION#0.9655;TERMINAL DIFFERENTIATION#0.9653;MITOSIS#0.9653;PANCREATIC DUCTAL ADENOCARCINOMA#0.9653;CEREBRAL CORTEX#0.9653;MYOCARDIUM#0.9651;TRANSMISSION ELECTRON MICROSCOPY#0.9650;CANCER STEM CELL#0.9649;STEM CELL PROLIFERATION#0.9647;NEURONAL CELLS#0.9646;CELL CYCLE#0.9643;TRANSCRIPTION FACTOR#0.9643;TRAUMATIC BRAIN INJURY#0.9641;CELL DEVELOPMENT#0.9640;CHONDROCYTE#0.9640;APOPTOTIC#0.9639;UMBILICAL CORD BLOOD#0.9632;TRANSDIFFERENTIATION#0.9630;CELL REPLACEMENT THERAPY#0.9630;PROTEIN KINASE#0.9629;GLIOBLASTOMA MULTIFORME#0.9628;BRAIN DEVELOPMENT#0.9628;UMBILICAL CORD#0.9626;ALL TRANS RETINOIC ACID#0.9621;TEMPORAL LOBE#0.9618;MOUSE EMBRYONIC STEM#0.9615;STROMAL CELL#0.9614;EMBRYONIC BRAIN#0.9613;NEURONAL MIGRATION#0.9611;CEREBRAL ARTERY OCCLUSION#0.9611;GENE EXPRESSION#0.9610;RETINOIC ACID#0.9607;TERATOMA#0.9607;SCIATIC NERVE#0.9606;DNA SYNTHESIS#0.9603;FLOW CYTOMETRY ANALYSIS#0.9603;PERIPHERAL BLOOD#0.9602;HUMAN DENTAL PULP#0.9600;DERMIS#0.9599;NEURITE OUTGROWTH#0.9593;TUMOR TISSUES#0.9592;MYOGENESIS#0.9589;GASTROINTESTINAL STROMAL TUMOR#0.9588;NEURITE#0.9583;INDUCED PLURIPOTENT STEM CELL#0.9582;MIDDLE CEREBRAL ARTERY#0.9582;PLURIPOTENT STEM CELL#0.9580;ADIPOSE TISSUE#0.9580;CEREBRAL ARTERY#0.9579;ADIPOCYTE#0.9572;SPINAL CORD INJURY#0.9571;ADIPOSE-DERIVED STEM CELL#0.9570;CELL DIFFERENTIATION#0.9570;THYMIDINE#0.9568;METASTATIC MELANOMA#0.9567;CELL PROLIFERATION#0.9565;PARKINSON'S DISEASE#0.9563;ADULT STEM CELL#0.9562;TELENCEPHALON#0.9560;CERVICAL#0.9559;CELL DEATH#0.9557;INNER EAR#0.9557;PITUITARY ADENOMA#0.9556;APOPTOSIS#0.9552;HUMAN EMBRYONIC STEM#0.9552;EMBRYONAL CARCINOMA#0.9551;NEUROLOGICAL DISORDER#0.9548;NEUROGENESIS#0.9542;MESENCHYMAL STEM CELL#0.9536;REGENERATION#0.9535;EXTRACELLULAR MATRIX#0.9533;CENTRAL NERVOUS SYSTEM#0.9532;RETINAL GANGLION CELL#0.9532;EPIDERMAL GROWTH FACTOR#0.9531;NITRIC OXIDE#0.9529;GROWTH FACTOR#0.9529;CHOROID PLEXUS#0.9526;TUMOR INITIATING CELL#0.9524;BRAIN DAMAGE#0.9518;NERVOUS SYSTEM#0.9517;ARTERY#0.9516;SEPTUM#0.9516;EPITHELIAL MESENCHYMAL TRANSITION#0.9516;BONE MARROW#0.9515;CHOLINERGIC NEURON#0.9514;SIGNALING MOLECULE#0.9511;FIBROBLAST GROWTH FACTOR#0.9511;DRUG RESISTANCE#0.9510;EOSIN#0.9509;NEUROMUSCULAR JUNCTION#0.9508;NERVOUS TISSUE#0.9506;ISCHEMIA REPERFUSION INJURY#0.9504;CLEAVED CASPASE 3#0.9501;ALZHEIMER'S DISEASE#0.9498;TUMOR SUPPRESSOR#0.9492;TOXICITY#0.9490;LEUKEMIA INHIBITORY FACTOR#0.9489;HUMAN MESENCHYMAL STEM#0.9489;MATRIX PROTEIN 1#0.9488;HYPOXIA INDUCIBLE FACTOR#0.9486;EMBRYONIC STEM CELL#0.9485;PERIPHERAL NERVOUS SYSTEM#0.9484;CHONDROITIN SULFATE PROTEOGLYCAN#0.9479;THYMIDINE KINASE#0.9473;ACINAR CELL#0.9473;MORPHOGENESIS#0.9471;MITOGEN ACTIVATED PROTEIN#0.9470;CELL CYCLE ARREST#0.9466;SIGNALING PATHWAY#0.9457;TUMOR NECROSIS FACTOR#0.9455;NEURODEGENERATIVE DISEASE#0.9445;S PHASE#0.9445;TRANSFORMING GROWTH FACTOR BETA#0.9440;DERMATOFIBROSARCOMA PROTUBERANS#0.9433;AMNIOTIC FLUID#0.9430;RAT BONE MARROW#0.9428;DNA METHYLATION#0.9426;ASPARTATE#0.9422;NEUROPROTECTION#0.9413;MAGNETIC RESONANCE IMAGING#0.9411;MONOCYTE#0.9407;MORRIS WATER MAZE#0.9406;INTERNEURON#0.9394;AQUAPORIN#0.9386;LYSINE#0.9385;BRAIN ISCHEMIA#0.9372;ONCOGENIC#0.9368;T CELL#0.9366;FRONTAL#0.9366;REACTIVE OXYGEN SPECIES#0.9364;RHABDOMYOSARCOMA#0.9352;MONONUCLEAR CELLS#0.9333;INFLAMMATORY RESPONSE#0.9332;GERM CELL#0.9331;MULTIPLE SCLEROSIS#0.9329;TEMOZOLOMIDE#0.9325;PURKINJE CELL#0.9321;CILIARY BODY#0.9312;MIDLINE#0.9311;RETINAL DEGENERATION#0.9301;STEM CELL TRANSPLANTATION#0.9300;SEBACEOUS GLAND#0.9295;FORMALIN#0.9288;SENESCENCE#0.9274;COLLAGEN TYPE I#0.9266;KINASE INHIBITOR#0.9265;ABC TRANSPORTER#0.9261;BLOOD BRAIN BARRIER#0.9254;SUBSTANTIA NIGRA#0.9243;NEURAL RETINA#0.9233;CARDIAC MUSCLE#0.9225;BRAIN CANCER#0.9222;CHEMOKINE RECEPTOR#0.9215;NEUROECTODERMAL TUMOR#0.9206;OLIGODENDROCYTE PRECURSOR CELL#0.9196;MUSCLE FIBER#0.9190;PHOSPHODIESTERASE#0.9188;EPITHELIAL STEM CELL#0.9186;COCHLEA#0.9175;OSTEOCYTE#0.9171;ACTION POTENTIAL#0.9165;SIGNAL TRANSDUCER#0.9160;CAROTID ARTERY#0.9144;PERIODONTAL LIGAMENT#0.9142;CENTRAL NERVOUS SYSTEM DEVELOPMENT#0.9141;DERMAL FIBROBLAST#0.9128;BONE MARROW CELLS#0.9112;STEM CELL MEDIUM#0.9097;ANAGEN#0.9084;DAYS POST INJURY#0.9071;SCANNING ELECTRON MICROSCOPY#0.9068;OLFACTORY EPITHELIUM#0.9063;ADULT BONE MARROW#0.9049;ASTROCYTE DIFFERENTIATION#0.9043;GLUTAMATE RECEPTOR#0.9043;CEREBRAL INFARCTION#0.9037;TEMPORAL LOBE EPILEPSY#0.9024;NEPHROPATHY#0.9016;ORGAN OF CORTI#0.8989;DUCT CELL#0.8986;FACTOR VIII#0.8979;HUMAN NEURAL PROGENITOR#0.8974;INSULIN SECRETION#0.8973;G-CSF#0.8967;NOTCH SIGNALING PATHWAY#0.8965;HYPERTENSION#0.8960;CISPLATIN#0.8955;PROTEIN SYNTHESIS#0.8954;CELL SURFACE ANTIGEN#0.8952;SIGNAL TRANSDUCTION#0.8951;PROTEIN KINASE C#0.8950;RETINAL DEVELOPMENT#0.8941;AMYOTROPHIC LATERAL SCLEROSIS#0.8919;LATERAL SCLEROSIS#0.8919;GLUTAMIC ACID#0.8916;HUMAN PANCREATIC CANCER#0.8912;STREPTOZOTOCIN#0.8899;SIGNALLING PATHWAY#0.8898;MYELINATION#0.8887;CYTOTOXICITY#0.8870;ACETYLCHOLINE#0.8864;NITRIC OXIDE SYNTHASE#0.8863;ODONTOBLAST DIFFERENTIATION#0.8862;BONE MORPHOGENIC PROTEIN#0.8854;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8846;NUCLEAR LAYER#0.8838;COLORECTAL CANCER#0.8837;NECROTIC#0.8834;GREEN FLUORESCENCE PROTEIN#0.8830;GASTROINTESTINAL TRACT#0.8830;L-LYSINE#0.8825;SHAM OPERATION GROUP#0.8819;PRO-INFLAMMATORY#0.8818;MELANOMA CELL LINES#0.8817;DENTIN MATRIX PROTEIN#0.8808;ACTIN CYTOSKELETON#0.8797;IMMUNE RESPONSE#0.8796;LOCALISATION#0.8795;CREUTZFELDT JAKOB DISEASE#0.8793;MALIGNANT BRAIN TUMOR#0.8787;GAP JUNCTION#0.8787;DIGESTION#0.8785;MINERALIZATION#0.8777;SWEAT GLAND#0.8767;HYDROCEPHALUS#0.8749;HISTONE DEACETYLASE#0.8741;CILIARY NEUROTROPHIC FACTOR#0.8735;SCALP#0.8721;NODULAR#0.8719;OVAL CELL#0.8719;STEM CELL ANTIGEN#0.8706;ESTROGEN RECEPTOR#0.8704;PROTEINURIA#0.8703;CELL REPLACEMENT THERAPIES#0.8673;MAMMARY GLAND#0.8673;ADRENAL GLAND#0.8652;FACTOR I#0.8643;RNA INTERFERENCE#0.8642;GABAERGIC NEURON#0.8633;CANCER SPECIFIC SURVIVAL#0.8628;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8628;BREAST CANCER CELL#0.8627;G1 PHASE#0.8626;GLYCOGEN SYNTHASE KINASE#0.8606;BASAL CELL CARCINOMA#0.8601;OLIGODENDROGLIOMA#0.8598;DEXAMETHASONE#0.8588;VALPROIC ACID#0.8586;BETA GALACTOSIDASE#0.8566;PITUITARY GLAND#0.8559;MYOTENDINOUS JUNCTION#0.8557;MARROW STEM CELLS#0.8555;TOOTH DEVELOPMENT#0.8550;BONE MARROW STEM CELL#0.8547;NMDA RECEPTOR#0.8547;HERPES SIMPLEX#0.8544;DIABETES MELLITUS#0.8531;INNERVATION#0.8526;VOMERONASAL ORGAN#0.8516;HEMORRHAGE#0.8511;SIDE-POPULATION CELL#0.8506;HEPATOCELLULAR CARCINOMA#0.8504;PHOTORECEPTOR CELL#0.8499;RAPAMYCIN#0.8485;HEPATIC STELLATE CELL#0.8455;NEUROTOXICITY#0.8450;MITOCHONDRIA#0.8442;BASEMENT MEMBRANE#0.8441;HERPES SIMPLEX VIRUS#0.8432;INDUCTION OF APOPTOSIS#0.8413;RECEPTOR TYROSINE KINASE#0.8404;DAYS OF DIFFERENTIATION#0.8403;STROMAL STEM CELL#0.8388;UBIQUITIN#0.8381;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8375;COLLAGENASE#0.8374;OLIGODENDROCYTE PROGENITOR CELL#0.8367;TELOMERASE ACTIVITY#0.8335;RETINAL PIGMENT EPITHELIUM#0.8333;OPSIN#0.8327;ORGANOGENESIS#0.8326;COLONY-STIMULATING FACTOR#0.8326;SPINAL CORD INJURIES#0.8322;FORSKOLIN#0.8309;HISTOGENESIS#0.8301;BONE FORMATION#0.8283;GROWTH PATTERN#0.8281;GROWTH CONE#0.8275;OVARIAN CARCINOMA#0.8275;MAP KINASE#0.8213;BASAL GANGLIA#0.8210;ENDOPLASMIC RETICULUM#0.8196;GENE SILENCING#0.8187;M PHASE#0.8185;ATP BINDING CASSETTE TRANSPORTER#0.8167;ENTERIC NERVOUS SYSTEM#0.8163;RNA BINDING#0.8161;TRANSIT AMPLIFYING CELL#0.8159;RETINALDEHYDE BINDING#0.8136;BULGE STEM CELL#0.8130;CELL EXPANSION#0.8130;YELLOW FLUORESCENT PROTEIN#0.8116;HEPATOCYTE GROWTH FACTOR#0.8105;NEUTROPHIL#0.8097;AUTOPHAGY#0.8053;MUSCULAR DYSTROPHY#0.8049;HAIR CYCLE#0.8044;COLORECTAL#0.8039;RNA BINDING PROTEIN#0.8035;NASAL MUCOSA#0.8034;HOST CELL#0.8032;UMBILICAL VEIN#0.8030;AMYGDALA#0.8020;EDEMA#0.8012;PANCREATIC PROGENITOR CELL#0.8004;B CELL LYMPHOMA#0.8003;CELL FRACTION#0.7995;CARDIAC STEM CELLS#0.7995;LEUKOCYTE#0.7986;CELLULAR COMPONENT#0.7986;ORAL SQUAMOUS CELL CARCINOMA#0.7984;PERIPHERAL NERVE INJURY#0.7969;SYNAPTIC VESICLE#0.7968;ACTIVE CASPASE 3#0.7959;NOTCH LIGAND#0.7946;AKT SIGNALING#0.7945;VENTRICULAR CARDIOMYOCYTE#0.7930;CELL MEMBRANE#0.7917;DENTAL PULP CELL#0.7895;HIPPOCAMPAL PROGENITOR CELLS#0.7890;WORLD HEALTH ORGANIZATION#0.7880;TARGET OF RAPAMYCIN#0.7874;ARTERIOLE#0.7859;EWING SARCOMA#0.7843;SMALL INTESTINE#0.7841;NEUROTOXIC#0.7838;GASTRIC ADENOCARCINOMA#0.7838;EPITHELIAL TO MESENCHYMAL#0.7794;MELATONIN RECEPTOR#0.7791;HEMATOPOIETIC CELL#0.7774;SIGNALING CASCADE#0.7770;ION CHANNEL#0.7769;PULMONARY HYPERTENSION#0.7766;HINDLIMB#0.7762;BIPOLAR CELL#0.7758;ETHANOL#0.7758;VASCULAR CELL#0.7722;THALAMUS#0.7721;ENCEPHALOMYELITIS#0.7716;GLYCINE#0.7713;FOCAL ADHESION#0.7711;MYOSIN HEAVY CHAIN#0.7706;CYCLIC AMP#0.7698;SUBSTANCE P#0.7691;MYOCYTES#0.7690;MULTIPLE MYELOMA#0.7682;PEROXISOME#0.7680;OSTEOGENESIS#0.7676;PACLITAXEL#0.7648;MENINGES#0.7641;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7610;RETINAL STEM CELLS#0.7602;ACETYLCHOLINE RECEPTOR#0.7597;MITOCHONDRIAL MEMBRANE#0.7573;MULTIPOTENT PROGENITOR CELL#0.7570;TELOMERASE REVERSE TRANSCRIPTASE#0.7566;SOMATIC STEM CELL#0.7559;DNA BINDING#0.7552;LUNG ADENOCARCINOMA#0.7546;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7538;FETAL LIVER#0.7537;HUMAN UMBILICAL VEIN#0.7532;NEUROREGENERATION#0.7526;INFLAMMATORY CELL#0.7518;MURINE EMBRYONIC STEM#0.7513;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.7485;DOXORUBICIN#0.7481;NEUROTRANSMITTER RECEPTOR#0.7476;SERTOLI CELL#0.7466;LIVER CANCER#0.7455;T LYMPHOCYTE#0.7451;STATUS EPILEPTICUS#0.7448;CONTROLLED CORTICAL IMPACT#0.7441;CELL COUNTING KIT#0.7427;PHOSPHATE BUFFERED SALINE#0.7426;DUCTAL CELL#0.7421;DENTINOGENESIS#0.7397;MYOBLAST DIFFERENTIATION#0.7393;ISLETS OF LANGERHANS#0.7393;ESOPHAGEAL CARCINOMA#0.7385;MESANGIAL CELL#0.7375;ANDROGEN RECEPTOR#0.7373;OXYGEN GLUCOSE DEPRIVATION#0.7373;D-LYSINE#0.7365;RETINAL DISEASE#0.7349;BREAST CANCER PATIENTS#0.7336;DEMENTIA#0.7335;ADENOSINE#0.7330;NEURON DIFFERENTIATION#0.7320;BETA-MERCAPTOETHANOL#0.7300;LECTIN#0.7298;PROGESTERONE#0.7297;NEURULATION#0.7278;PANCREATITIS#0.7262;METAPLASIA#0.7245;PLASMA MEMBRANE#0.7231;GLUCOCORTICOID RECEPTOR#0.7231;OLFACTORY ENSHEATHING CELL#0.7218;HUNTINGTON'S DISEASE#0.7211;HINDBRAIN#0.7205;EPITHELIAL OVARIAN CANCER#0.7191;CEREBRUM#0.7169;HUMAN ADIPOSE TISSUE#0.7164;POSTNATAL DAY 7#0.7153;LASER SCANNING MICROSCOPY#0.7151;MYELOID CELL#0.7149;IMMUNE CELL#0.7148;BREAST CARCINOMA#0.7144;QUANTITATIVE REVERSE TRANSCRIPTASE#0.7144;OUTER NUCLEAR LAYER#0.7141;HUMAN BREAST CANCER#0.7139;MYELOID LEUKEMIA#0.7126;FATTY ACID BINDING#0.7125;PTERYGIUM#0.7124;CERVICAL CANCER#0.7110;NICOTINAMIDE#0.7109;GLOMERULUS#0.7106;HEARING LOSS#0.7106;BASAL LAMINA#0.7104;INTRACTABLE EPILEPSY#0.7086;PYRAMIDAL CELL#0.7073;MESENCHYMAL PROGENITOR CELL#0.7068;TUBE FORMATION#0.7063;APOPTOTIC CELL DEATH#0.7039;HEPATIC STEM CELL#0.7017;SKELETAL MUSCLE CELLS#0.7014;CORONARY ARTERY#0.7008;RESVERATROL#0.6999;FOCAL CORTICAL DYSPLASIA#0.6999;GRANULOCYTE#0.6983;YEAR SURVIVAL RATE#0.6977;OLIGODENDROCYTE DIFFERENTIATION#0.6969;LUMINAL#0.6963;NEUROLOGICAL SEVERITY SCORE#0.6949;PROTEIN KINASE B#0.6937;ACUTE MYELOID LEUKEMIA#0.6936;KIDNEY DISEASE#0.6912;COLUMNAR#0.6911;GROWTH HORMONE#0.6905;QUIESCENCE#0.6904;SPATIAL LEARNING#0.6885;OLFACTORY RECEPTOR#0.6880;MOUSE EMBRYONIC FIBROBLAST#0.6875;FACTOR XIIIA#0.6875;HUMAN CORD BLOOD#0.6862;DNA METHYLTRANSFERASE#0.6858;PODOCYTE APOPTOSIS#0.6836;FLUORO JADE B#0.6826;CAMP RESPONSE ELEMENT BINDING#0.6821;LYMPHATIC VESSEL#0.6818;CAMP RESPONSE ELEMENT#0.6811;PILOCARPINE#0.6806;SUPEROXIDE DISMUTASE#0.6802;LOW GRADE GLIOMAS#0.6797;ADENYLATE CYCLASE#0.6787;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6784;CELL ACTIVATION#0.6758;OUTER LAYER#0.6727;PINEAL GLAND#0.6725;TESTOSTERONE#0.6722;AGGRESSIVE BEHAVIOR#0.6718;GEMCITABINE#0.6711;INDOMETHACIN#0.6709;MYOEPITHELIAL CELL#0.6707;AMD3100#0.6697;ASCORBIC ACID#0.6686;TYPE 1 DIABETES#0.6666;POTASSIUM CHANNEL#0.6661;NEURITE GROWTH#0.6659;ARGININE#0.6648;DESMOPLASTIC MELANOMA#0.6646;NEURAL TUBE DEFECT#0.6645;VASCULAR ENDOTHELIUM#0.6640;CORPUS STRIATUM#0.6640;HEPARIN#0.6635;FEMUR#0.6630;PROPIDIUM#0.6626;GLUTATHIONE#0.6623;ASTROCYTE ACTIVATION#0.6620;VIBRISSA#0.6597;HUMAN AMNIOTIC EPITHELIAL#0.6595;ACTIVATED CASPASE 3#0.6568;GANGLIOGLIOMA#0.6559;HEMATOPOIESIS#0.6501;ISOPROTERENOL#0.6491;MYOGENIC CELL#0.6478;INNER NUCLEAR LAYER#0.6461;FORESKIN#0.6459;HEART DISEASE#0.6459;AMNION#0.6456;BRAIN EDEMA#0.6450;LEUCINE#0.6443;ADRENAL MEDULLA#0.6441;SALIVARY GLAND#0.6435;VINCRISTINE#0.6435;AXON GUIDANCE#0.6435;HEPATOCYTE NUCLEAR FACTOR#0.6433;SYNAPTOGENESIS#0.6433;MULLER CELL#0.6427;L-ARGININE#0.6411;GRANULOCYTE COLONY STIMULATING FACTOR#0.6375;ADRENERGIC RECEPTOR#0.6374;NERVOUS SYSTEM DISEASE#0.6369;VIRAL INFECTION#0.6369;RECEPTOR AGONIST#0.6356;KINASE ACTIVITY#0.6355;CORNEAL ENDOTHELIUM#0.6336;NEURAL CELL DIFFERENTIATION#0.6331;POST NATAL DAY#0.6329;RETINAL PIGMENT EPITHELIAL#0.6320;WNT SIGNALING PATHWAY#0.6304;TRADITIONAL CHINESE MEDICINE#0.6295;EYE DEVELOPMENT#0.6294;NOTCH RECEPTOR#0.6291;CORTICOGENESIS#0.6287;MAPK SIGNALING#0.6280;HAIR FOLLICLE CELL#0.6260;CORONAL#0.6253;DNA REPAIR#0.6251;PANCREATIC ADENOCARCINOMA#0.6244;RECEPTOR ACTIVITY#0.6234;MYELOPROLIFERATIVE NEOPLASM#0.6233;HISTONE ACETYLATION#0.6228;HYALURONAN#0.6225;ORAL MUCOSA#0.6224;MENTAL RETARDATION#0.6218;PERIODONTAL LIGAMENT STEM CELL#0.6217;ALOPECIA#0.6216;PROGRAMMED CELL DEATH#0.6201;C CHEMOKINE RECEPTOR#0.6184;LACRIMAL GLAND#0.6182;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6180;CORNEAL ENDOTHELIAL CELL#0.6168;PLASMA CELL#0.6163;ACUTE PANCREATITIS#0.6159;PANCREASE#0.6148;CHROMAFFIN CELL#0.6147;PERIVENTRICULAR LEUKOMALACIA#0.6146;5-AZA-2'-DEOXYCYTIDINE#0.6143;2'-DEOXYCYTIDINE#0.6139;TALPHA1#0.6137;OPTIC STALK#0.6125;ENDOMETRIUM#0.6122;TUBEROUS SCLEROSIS#0.6116;NEVUS#0.6110;TRANSFORMING GROWTH FACTOR ALPHA#0.6101;ANAPLASTIC MENINGIOMA#0.6100;HISTONE MODIFICATION#0.6090;HYALURONIC ACID#0.6086;VASCULOGENESIS#0.6080;ACTIN FILAMENT#0.6075;TETRACYCLINE#0.6058;LITHIUM#0.6043;DEMETHYLATION#0.6043;STEM CELL MAINTENANCE#0.6040;TOLL LIKE RECEPTOR#0.6035;DUCTAL EPITHELIAL CELLS#0.6030;RETINOBLASTOMA#0.6030;DENDRITIC CELL#0.6027;INNER CELL MASS#0.6025;DNA DEMETHYLATION#0.6016;OLIGODENDROCYTE LINEAGE CELLS#0.6014
10765	BREAST CANCER CELL#1.0474;BREAST CANCER#1.0436;HISTONE DEMETHYLASE#1.0426;SQUAMOUS CELL CARCINOMA#1.0374;STEM CELL#1.0335;CELL PROLIFERATION#1.0318;TUMOR SUPPRESSOR#1.0289;CANCER CELL#1.0213;CELL CYCLE#1.0207;LYSINE#1.0201;DEMETHYLATION#1.0111;GENE EXPRESSION#0.9999;TRANSCRIPTION FACTOR#0.9992;DEMETHYLASE ACTIVITY#0.9932;APOPTOSIS#0.9900;SIGNALING PATHWAY#0.9791;CELL GROWTH#0.9772;DNA BINDING#0.9650;MAMMARY GLAND#0.9547;HISTONE METHYLATION#0.9446;HISTONE DEACETYLASE#0.9443;STEM CELL LIKE#0.9398;CELL DIFFERENTIATION#0.9378;HISTONE MODIFICATION#0.9354;LUNG CANCER#0.9319;CANCER STEM CELL#0.8852;HEPATOCELLULAR CARCINOMA#0.8847;LYSINE SPECIFIC DEMETHYLASE#0.8842;ONCOGENIC#0.8832;EPITHELIAL CELL#0.8634;HYPOXIA#0.8606;RETINOBLASTOMA#0.8544;DRUG RESISTANCE#0.8516;EPITHELIAL MESENCHYMAL TRANSITION#0.8443;T CELL#0.8336;PROSTATE CANCER#0.8330;CHROMATIN BINDING#0.8223;EMBRYONIC STEM CELL#0.8056;CELLULAR SENESCENCE#0.7995;CHROMATIN REMODELING#0.7910;DNA REPAIR#0.7837;DNA METHYLATION#0.7829;SENESCENCE#0.7706;ARGININE#0.7522;POLYMERASE CHAIN REACTION#0.7423;ENDOTHELIAL CELL#0.7384;METASTATIC MELANOMA#0.7372;INTELLECTUAL DISABILITY#0.6998;MAMMARY EPITHELIAL CELL#0.6843;EMBRYO DEVELOPMENT#0.6829;LYMPH NODE#0.6746;ANDROGEN RECEPTOR#0.6540;CELL MIGRATION#0.6521;BREAST CANCER PATIENTS#0.6339;ESTROGEN RECEPTOR#0.6277;NURD COMPLEX#0.6240;STEM CELL MARKER#0.6151;PROLINE DEHYDROGENASE#0.6128;BONE MARROW#0.6055
10766	CELL CYCLE#0.8112;UBIQUITIN#0.6953;ADIPOGENESIS#0.6131
10767	RIBOSOME#1.0290;GLOBIN#1.0238;THALASSEMIA#0.9971;TRANSCRIPTION FACTOR#0.9773;QUANTITATIVE TRAIT LOCI#0.9736;SICKLE CELL DISEASE#0.9680;DOM34-HBS1 COMPLEX#0.9124;TRANSLATION TERMINATION#0.8892;GENE EXPRESSION#0.8809;PROTEIN SYNTHESIS#0.8644;GTP BINDING#0.8536;SICKLE CELL ANEMIA#0.8503;SKI COMPLEX#0.8277;ANEMIA#0.8065;BETA THALASSEMIA#0.7667;POLYMERASE CHAIN REACTION#0.7659;TRANSLATION ELONGATION#0.7641;EXOSOME#0.7621;QUANTITATIVE TRAIT LOCUS#0.7471;80S RIBOSOME#0.7434;ERYTHROCYTE#0.7312;MRNA DECAY#0.6927;MYELOPROLIFERATIVE NEOPLASM#0.6893;TRANSLATION ELONGATION FACTOR#0.6709;QUALITY CONTROL SYSTEM#0.6504;ACTIN CROSSLINKING#0.6410;TRANSLATION TERMINATION FACTOR#0.6248;ERYTHROID CELL#0.6196;GLYCERALDEHYDE-3-PHOSPHATE#0.6189;ANAEMIA#0.6062
10768	RECEPTOR BINDING#1.0614;IP3 BINDING#0.9649;PROTEIN PHOSPHATASE 1#0.7138;EPITHELIAL CELL#0.7116;SIGNALING PATHWAY#0.6934;CAMP SIGNALING#0.6338;ION CHANNEL#0.6156;INSP3 RECEPTOR#0.6041
10769	CENTRIOLE DUPLICATION#1.1005;TUMOR SUPPRESSOR#1.0491;APOPTOSIS#1.0154;CELL PROLIFERATION#1.0114;DENDRITIC SPINE#1.0099;PROTEIN KINASE#1.0061;CENTRIOLE#1.0048;CELL CYCLE#1.0013;GENE EXPRESSION#0.9920;POLO BOX DOMAIN#0.9872;S PHASE#0.9821;KINASE ACTIVITY#0.9805;CANCER CELL#0.9787;CENTROSOME#0.9715;CELL DEATH#0.9635;SIGNALING PATHWAY#0.9548;PARKINSON'S DISEASE#0.9453;EARLY GROWTH RESPONSE#0.9329;MITOSIS#0.9003;CELL DIVISION#0.8815;UBIQUITIN#0.8613;TUMOR CELLS#0.8480;PACLITAXEL#0.8216;TRANSCRIPTION FACTOR#0.8125;B CELL#0.7998;DNA METHYLATION#0.7921;DNA DAMAGE RESPONSE#0.7880;INTEGRIN BINDING#0.7648;GLYCOGEN SYNTHASE KINASE#0.7497;COLORECTAL CANCER#0.7489;CELL CYCLE REGULATION#0.7367;COLORECTAL#0.7341;POLYMERASE CHAIN REACTION#0.7277;CELL CYCLE ARREST#0.7255;GROWTH FACTOR#0.7195;MEIOSIS#0.7068;NERVOUS SYSTEM#0.7062;KINASE INHIBITOR#0.7062;G1 PHASE#0.6960;CELL GROWTH#0.6908;RNA INTERFERENCE#0.6787;ANGIOGENESIS#0.6511;OVARIAN CANCER#0.6332;APOPTOTIC#0.6220;GENOTOXIC#0.6203;BREAST CANCER#0.6202;MITOTIC SPINDLE#0.6170;CASEIN KINASE 2#0.6135;CENTRAL NERVOUS SYSTEM#0.6060;ACUTE MYELOID LEUKEMIA#0.6032;MYELOID LEUKEMIA#0.6021;REVERSE TRANSCRIPTION#0.6002
10771	TUMOR SUPPRESSOR#1.0163;NF-KAPPAB ACTIVATION#0.9972;EPSTEIN BARR VIRUS#0.8525;INTELLECTUAL DISABILITY#0.8326;CELL GROWTH#0.8106;TRANSACTIVATION#0.7996;TRANSCRIPTION FACTOR#0.7903;SIGNALING PATHWAY#0.7221;GENE EXPRESSION#0.6923;TUMOR NECROSIS FACTOR#0.6425;RNA SPLICING#0.6299;MYELOID LEUKEMIA#0.6275;BREAST CANCER#0.6232;CELLULAR SENESCENCE#0.6188;CYTOKINE PRODUCTION#0.6159;BONE MORPHOGENETIC PROTEIN#0.6126;B CELL#0.6065
10772	ARGININE#0.9519;MRNA SPLICING#0.9117;RESPONSE TO HEAT SHOCK#0.9099;DEPHOSPHORYLATION#0.8950;RESPONSE TO HEAT#0.8916;PRE-MRNA SPLICING#0.8645;RNA BINDING#0.7543;CELL CYCLE#0.7468;GENE EXPRESSION#0.7079;RNA BINDING PROTEIN#0.6062;APOPTOSIS#0.6056;FOR ADIPOCYTE DIFFERENTIATION#0.6010
10773	ZINC FINGER PROTEIN#0.6594
10775	RNASE P#1.0879;RIBONUCLEASE P#0.9723;RNASE MRP#0.9192;TRNA PROCESSING#0.7344;NUCLEOLUS#0.6340;PROTEIN COMPLEX#0.6339
10776	MITOSIS#0.9740;PROTEIN KINASE#0.9610;PROTEIN PHOSPHATASE 2A#0.8860;PHOSPHATASE 2A#0.8857;DOPAMINE#0.8737;DEPHOSPHORYLATION#0.8668;CELL CYCLE#0.8383;OOCYTE#0.8243;MITOTIC ENTRY#0.8177;M PHASE#0.7696;CELL PROLIFERATION#0.7297;PROTEIN KINASE A#0.6749;SIGNAL TRANSDUCTION#0.6405;MEDIUM SPINY NEURONS#0.6327;BASAL GANGLIA#0.6279;CAUDATE NUCLEUS#0.6263
10777	DOPAMINE#1.0544;CYCLIC AMP#1.0308;STRIATUM#0.8713;BASAL GANGLIA#0.8176;PROTEIN KINASE#0.8039;BIOFILM FORMATION#0.7050;SUBSTANTIA NIGRA#0.6986;CAUDATE NUCLEUS#0.6147
10781	ZINC FINGER PROTEIN#1.1740;TRANSCRIPTION FACTOR#0.8050;CELL PROLIFERATION#0.6856
10782	ZINC FINGER PROTEIN#0.9186;TRANSCRIPTION FACTOR#0.6526;TRANSCRIPTION REPRESSOR#0.6180;DNA BINDING#0.6024
10783	CANCER CELL#1.0742;PROTEIN KINASE#1.0498;MITOSIS#1.0354;CELL CYCLE#1.0238;MICROTUBULE#1.0107;MITOTIC SPINDLE#1.0033;CORTICAL MICROTUBULE#0.9816;CELL PROLIFERATION#0.9011;M PHASE#0.8988;CENTROSOME#0.8775;HEPATOCELLULAR CARCINOMA#0.8535;APOPTOSIS#0.8533;SENESCENCE#0.8449;CELL CYCLE ARREST#0.8272;KINASE ACTIVITY#0.8084;SPINDLE FORMATION#0.8010;KINESIN#0.7951;MORPHOGENESIS#0.7768;SIGNAL TRANSDUCTION#0.7595;SIGNALING PATHWAY#0.7312;CELL GROWTH#0.7146;CELL EXPANSION#0.6922;CYTOKINESIS#0.6739;GENE EXPRESSION#0.6536;CORTICAL MICROTUBULE ORGANIZATION#0.6518;CENTROSOME SEPARATION#0.6506;SPINDLE ASSEMBLY#0.6397;MITOTIC CELL CYCLE#0.6366;CHROMOSOME CONGRESSION#0.6293;SPINDLE POLE#0.6186;MICROTUBULE CATASTROPHE#0.6037;METAPHASE#0.6016
10785	ESSENTIAL THROMBOCYTHEMIA#0.6072;METHYLTRANSFERASE ACTIVITY#0.6070;MESENCHYMAL STROMAL CELL#0.6007
10786	URIC ACID#1.0232;URATE#0.9705;SERUM URIC ACID#0.8122;ORGANIC ANION TRANSPORTER#0.7255;OOCYTE#0.6270;HYPERURICEMIA#0.6063
10787	WAVE COMPLEX#1.0651;ACTIN POLYMERIZATION#0.8703;COMPLEX I#0.8650;ACTIN CYTOSKELETON#0.7741;PROTEIN COMPLEX#0.7184;CELL MIGRATION#0.7035;ACTIN NUCLEATION#0.6990;MORPHOGENESIS#0.6429;NEURAL TUBE#0.6272;CELL CYCLE#0.6257;HEPATOCELLULAR CARCINOMA#0.6174
10788	HEPATOCELLULAR CARCINOMA#1.0620;TUMOR SUPPRESSOR#0.9727;SIGNALING PATHWAY#0.9372;CANCER CELL#0.7630;CELL ADHESION#0.7204;ACTIN CYTOSKELETON#0.7094;RHO GTPASE BINDING#0.6439;MEMBRANE RUFFLE#0.6297;GENE EXPRESSION#0.6124;PROSTATE CANCER#0.6070
10791	PLASMA MEMBRANE#0.9481;SKELETAL MUSCLE#0.6842;TOTAL COLONIC AGANGLIONOSIS#0.6682;MUSCLE CONTRACTION#0.6073;CARDIAC MUSCLE#0.6072
10795	ZINC FINGER PROTEIN#1.0797;CERVICAL CANCER#0.6566;TRANSCRIPTION FACTOR#0.6519;IKK COMPLEX#0.6164;LIVER DEVELOPMENT#0.6139;CAMP-RESPONSIVE ELEMENT BINDING#0.6106;ACTIVATING TRANSCRIPTION FACTOR#0.6007
10797	METHYLENETETRAHYDROFOLATE DEHYDROGENASE#1.1109;CANCER CELL#1.0626;FOLATE#1.0485;CELL PROLIFERATION#1.0323;BREAST CANCER#1.0200;ONE CARBON METABOLISM#0.9648;CELL CYCLE#0.9293;BREAST CANCER CELL#0.9041;GENE EXPRESSION#0.8805;FOLATE METABOLISM#0.8757;METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE#0.8716;CELL GROWTH#0.8545;MITOCHONDRIA#0.8332;RENAL CELL CARCINOMA#0.7811;APOPTOSIS#0.7773;GLYCINE#0.7253;COLORECTAL CANCER#0.6956;POLYMERASE CHAIN REACTION#0.6887;TETRAHYDROFOLATE#0.6640;GLYCINE SYNTHESIS#0.6345;LUNG CANCER#0.6234;HEPATOCELLULAR CARCINOMA#0.6075;TUMOR SUPPRESSOR#0.6065;REVERSE TRANSCRIPTION#0.6052;COLORECTAL#0.6030
107987522	TRANSFER RNA#0.6017
10798	TRANSCRIPTION FACTOR#0.8050;NERVOUS SYSTEM#0.6874
10799	TRNA PROCESSING#1.0578;RIBONUCLEASE P#1.0535;TRANSFER RNA#1.0440;RIBONUCLEOPROTEIN COMPLEX#1.0375;RNASE P#1.0260;RIBOZYME#1.0114;RNA PROCESSING#1.0019;RNASE MRP#0.9780;GENE EXPRESSION#0.9746;CATALYTIC ACTIVITY#0.9508;TRNA MATURATION#0.9452;NUCLEIC ACID#0.8876;RIBOSOMAL RNA#0.8628;MITOCHONDRIA#0.8394;RNA BINDING#0.8148;RIBOSOME#0.8019;ORGANELLE#0.8007;TYROSINE TRNA#0.7439;RIBOSOMAL PROTEIN#0.7314;CHLOROPLAST#0.7247;MITOCHONDRIAL RNA PROCESSING#0.6669;RIBONUCLEASE E#0.6518;TRNA BINDING#0.6204;METAL BINDING#0.6077;RNA BINDING PROTEIN#0.6016
107	ADENYL CYCLASE ACTIVITY#1.0524;FAT CELL#1.0397;CYCLASE ACTIVITY#1.0351;5'-ADENOSINE MONOPHOSPHATE#1.0318;CHOLERA#1.0290;CELL MEMBRANE#1.0269;PHOSPHOLIPASE C#1.0228;FORSKOLIN#1.0210;PROSTAGLANDIN E1#1.0209;VASOPRESSIN#1.0198;HISTAMINE#1.0182;ADIPOSE TISSUE#1.0166;PHOSPHODIESTERASE INHIBITOR#1.0160;EPINEPHRINE#1.0155;PHOSPHODIESTERASE#1.0143;PLASMA MEMBRANE#1.0116;PARATHYROID HORMONE#1.0103;PARATHYROID#1.0064;ISOPROTERENOL#1.0045;CAMP SIGNALING#1.0043;PROSTAGLANDIN E2#1.0040;SENSITIZATION#1.0040;CYCLIC NUCLEOTIDE PHOSPHODIESTERASE#1.0036;BETA ADRENERGIC RECEPTOR#1.0036;DOPAMINE#1.0028;ETHANOL#1.0012;CYCLIC ADENOSINE MONOPHOSPHATE#1.0005;ADENOSINE MONOPHOSPHATE#1.0004;THYROID GLAND#1.0003;PERTUSSIS#0.9998;PROTEIN KINASE C#0.9998;LIPOLYSIS#0.9997;PROTEIN KINASE A#0.9987;LEUKOCYTE#0.9967;CYCLIC AMP#0.9958;SMOOTH MUSCLE#0.9939;ADRENERGIC RECEPTOR#0.9935;5'-AMP#0.9932;SKELETAL MUSCLE#0.9929;ADENYLATE#0.9925;ADENYLATE CYCLASE#0.9925;PHOSPHODIESTERASE ACTIVITY#0.9924;NOREPINEPHRINE#0.9914;SIGNAL TRANSDUCTION#0.9903;THEOPHYLLINE#0.9892;ADENOSINE#0.9892;PROTEIN KINASE#0.9878;ISOPRENALINE#0.9860;PROPRANOLOL#0.9857;ERYTHROCYTE#0.9849;LONG TERM POTENTIATION#0.9848;SIGNALING PATHWAY#0.9847;EPITHELIAL CELL#0.9821;MAMMARY GLAND#0.9782;NERVOUS SYSTEM#0.9775;ADENOSINE TRIPHOSPHATE#0.9771;ADRENALINE#0.9766;PLATELET AGGREGATION#0.9707;NORADRENALINE#0.9702;OVARIAN#0.9701;GENE EXPRESSION#0.9701;BETA ADRENOCEPTOR#0.9695;LITHIUM#0.9679;MEMBRANE FRACTION#0.9673;MUSCLE CELL#0.9671;ADIPOCYTE#0.9660;PROTEIN SYNTHESIS#0.9596;ADENYLYL CYCLASE ACTIVITY#0.9546;NUCLEOTIDE BINDING#0.9544;CENTRAL NERVOUS SYSTEM#0.9521;PINEAL GLAND#0.9490;DOPAMINE RECEPTOR#0.9444;GUANINE#0.9363;ENZYME ACTIVITY#0.9309;BETA-2#0.9305;MECHANISM OF ACTION#0.9276;MACROPHAGE#0.9259;RECEPTOR ANTAGONIST#0.9206;CEREBRAL CORTEX#0.9206;MODE OF ACTION#0.9190;ANTERIOR CINGULATE CORTEX#0.9137;CELL SURFACE#0.9136;CIRCADIAN RHYTHM#0.9128;SMOOTH MUSCLE CELL#0.9110;GROWTH FACTOR#0.9078;CAMP RESPONSE ELEMENT#0.9047;ALKALINE PHOSPHATASE#0.9031;MYOCARDIUM#0.8894;NMDA RECEPTOR#0.8876;SPINAL CORD#0.8754;MITOGEN ACTIVATED PROTEIN#0.8751;ADENYLATE CYCLASE ACTIVITY#0.8727;GASTRIC MUCOSA#0.8722;PROGESTERONE#0.8693;CAMP SYNTHESIS#0.8654;ENDOTHELIAL CELL#0.8634;SYNAPTIC TRANSMISSION#0.8623;3-ISOBUTYL-1-METHYLXANTHINE#0.8619;STEROIDOGENESIS#0.8616;GRAVES' DISEASE#0.8606;CAMP RESPONSE ELEMENT BINDING#0.8547;ARTERY#0.8533;ADENINE#0.8518;STRIATUM#0.8470;AMP FORMATION#0.8405;SIGNALING CASCADE#0.8339;DNA SYNTHESIS#0.8330;OUABAIN#0.8325;ACID SECRETION#0.8324;CAMP FORMATION#0.8318;THALAMUS#0.8274;CORPUS LUTEUM#0.8264;FOREBRAIN#0.8172;PROSTACYCLIN#0.8156;PROSTAGLANDIN RECEPTOR#0.8126;CATABOLITE REPRESSION#0.8075;PHENTOLAMINE#0.7971;EXCRETION#0.7969;GRANULOSA CELL#0.7962;PANCREATIC ISLET#0.7960;ACETYLCHOLINE#0.7912;DENTATE GYRUS#0.7842;CELL PROLIFERATION#0.7840;HYPERTHYROIDISM#0.7786;SMALL INTESTINE#0.7786;PULMONARY ARTERY#0.7781;ASPARTATE#0.7775;ADRENAL GLAND#0.7774;PSORIASIS#0.7733;EDEMA#0.7732;URINARY BLADDER#0.7681;HYPOXIA#0.7675;PERIPHERAL BLOOD#0.7671;DNA REPLICATION#0.7636;RECEPTOR AGONIST#0.7618;GROWTH HORMONE#0.7607;SIGNALLING PATHWAY#0.7516;CELL DIFFERENTIATION#0.7504;RETINAL GANGLION CELL#0.7438;PYRUVATE#0.7433;RECEPTOR BINDING#0.7424;ISCHEMIA#0.7421;INSULIN SECRETION#0.7393;TUMOR NECROSIS FACTOR#0.7387;ARACHIDONIC ACID#0.7312;POLYMERASE CHAIN REACTION#0.7303;3',5'-CYCLIC AMP#0.7299;AMPA RECEPTOR#0.7253;BROWN ADIPOSE TISSUE#0.7247;TRANSIENT RECEPTOR POTENTIAL#0.7228;3'-5'-CYCLIC ADENOSINE MONOPHOSPHATE#0.7174;SPERMATOZOA#0.7167;ARGININE#0.7163;ESTRADIOL#0.7162;UTERUS#0.7154;CANCER CELL#0.7143;RED BLOOD CELL#0.7132;CALCIUM CHANNEL#0.7086;TRANSCRIPTION FACTOR#0.7074;CAFFEINE#0.7043;ADRENAL CORTEX#0.7029;GANGLION CELLS#0.7024;T CELL#0.7016;HYPERSENSITIVITY#0.7016;CHOLINE#0.7012;PHOSPHATASE ACTIVITY#0.7009;ATPASE ACTIVITY#0.6984;ION CHANNEL#0.6972;NITRIC OXIDE#0.6930;ADRENOCORTICOTROPIC HORMONE#0.6928;TUMOR CELLS#0.6860;PAPAVERINE#0.6818;EXCITATORY SYNAPSE#0.6758;GUANOSINE#0.6702;ANTIDIURETIC HORMONE#0.6700;NEPHRON#0.6680;IONOPHORE#0.6658;OOCYTE#0.6631;CORTISOL#0.6631;PSEUDOHYPOPARATHYROIDISM#0.6593;BLOOD PLATELETS#0.6591;NEUTROPHIL#0.6572;HEART DISEASE#0.6530;CARBACHOL#0.6502;TYPE 2 DIABETES#0.6495;CARDIAC MUSCLE#0.6454;HYPERTENSION#0.6432;CATALYTIC ACTIVITY#0.6430;CELL DEATH#0.6414;LYSINE#0.6370;XANTHINE#0.6322;TRIIODOTHYRONINE#0.6311;AMINOPHYLLINE#0.6306;TESTOSTERONE#0.6282;LONG TERM MEMORY#0.6260;KINASE ACTIVITY#0.6228;CYCLIC AMP METABOLISM#0.6223;GTP BINDING#0.6211;B CELL#0.6201;CELL CYCLE#0.6197;AMP METABOLISM#0.6197;TOXICITY#0.6193;VASODILATION#0.6172;BRUSH BORDER#0.6170;GENE SILENCING#0.6144;PROTEIN KINASE G#0.6095;METHIONINE#0.6049;DIGESTION#0.6049;DEXAMETHASONE#0.6043;ALANINE#0.6028;CYTOPLASM#0.6026;PHOTORECEPTOR CELL#0.6025;SPECIFIC SURFACE AREA#0.6015;SPERM CAPACITATION#0.6004
10800	ZAFIRLUKAST#1.0799;PRANLUKAST#1.0748;MONTELUKAST#1.0454;CYSTEINYL LEUKOTRIENE RECEPTOR#1.0451;CYSLT RECEPTOR#1.0369;ALLERGIC RHINITIS#1.0354;LEUKOTRIENE RECEPTOR#1.0302;CEREBRAL ISCHEMIA#1.0251;POLYMERASE CHAIN REACTION#1.0221;RHINITIS#1.0213;PERIPHERAL BLOOD#1.0169;RECEPTOR ANTAGONIST#1.0146;MONOCYTE#1.0136;GENE EXPRESSION#1.0097;MAST CELL#1.0072;APOPTOSIS#1.0045;ENDOTHELIAL CELL#1.0045;EOSINOPHIL#1.0043;SMOOTH MUSCLE#1.0031;ISCHEMIA#0.9982;MACROPHAGE#0.9975;MUSCLE CELL#0.9959;NEUTROPHIL#0.9924;ASPIRIN#0.9920;SMOOTH MUSCLE CELL#0.9883;CALCIUM MOBILIZATION#0.9868;PROTEIN KINASE#0.9827;INFLAMMATORY CELL#0.9812;ARACHIDONIC ACID#0.9776;LEUKOCYTE#0.9765;T CELL#0.9681;LEUKOTRIENE C4 SYNTHASE#0.9651;AIRWAY SMOOTH MUSCLE#0.9645;REVERSE TRANSCRIPTION#0.9587;EPITHELIAL CELL#0.9549;CANCER CELL#0.9504;PRO-INFLAMMATORY#0.9410;ALLERGEN#0.9402;ZILEUTON#0.9343;COLON CANCER#0.9247;INFLAMMATORY RESPONSE#0.9177;CELL PROLIFERATION#0.9168;BONE MARROW#0.9118;PROTEIN KINASE C#0.9072;PERTUSSIS#0.9050;LEUKOTRIENE SYNTHESIS#0.8998;TUMOR NECROSIS FACTOR#0.8975;CHEMOTAXIS#0.8915;INDOMETHACIN#0.8876;SIGNAL TRANSDUCTION#0.8816;PLASMA MEMBRANE#0.8815;SIGNALING PATHWAY#0.8714;RECEPTOR BINDING#0.8678;GLUTATHIONE#0.8659;IFN-GAMMA#0.8641;FOCAL CEREBRAL ISCHEMIA#0.8626;ASPIRIN INTOLERANT ASTHMA#0.8596;PHOSPHOLIPASE C#0.8543;ARTERY#0.8533;RECEPTOR AGONIST#0.8519;PROGENITOR CELL#0.8438;NASAL MUCOSA#0.8420;HISTAMINE#0.8370;MUSCLE CONTRACTION#0.8343;B CELL#0.8300;ADENOID HYPERTROPHY#0.8241;SMOOTH MUSCLE CONTRACTION#0.8241;GROWTH FACTOR#0.8231;T LYMPHOCYTE#0.8124;ASTROCYTE#0.7993;ALZHEIMER'S DISEASE#0.7761;SENSITIZATION#0.7754;GLOBAL CEREBRAL ISCHEMIA#0.7679;CELL GROWTH#0.7670;MONONUCLEAR CELLS#0.7584;RECEPTOR INTERNALIZATION#0.7583;MESANGIAL CELL#0.7579;OXYGEN GLUCOSE DEPRIVATION#0.7503;PLATELET ACTIVATING FACTOR#0.7469;COLORECTAL CANCER#0.7443;P2Y RECEPTOR#0.7399;HYPERSENSITIVITY#0.7354;PROSTATE CANCER#0.7353;MICROGLIAL CELL#0.7311;MUCUS SECRETION#0.7269;TRACHEA#0.7198;TONSIL#0.7136;FORCED EXPIRATORY VOLUME#0.7100;TUMOR CELLS#0.7004;REACTIVE OXYGEN SPECIES#0.7001;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6957;HEMATOPOIETIC PROGENITOR CELL#0.6944;CEREBRAL ARTERY OCCLUSION#0.6923;NEUROTOXICITY#0.6913;QUANTITATIVE REVERSE TRANSCRIPTION#0.6912;PHAGOCYTOSIS#0.6910;MIDDLE CEREBRAL ARTERY#0.6910;CEREBRAL ARTERY#0.6908;LIPOXYGENASE PATHWAY#0.6899;BLOOD BRAIN BARRIER#0.6872;RHEUMATOID ARTHRITIS#0.6853;IMMUNE RESPONSE#0.6842;CALCIUM SIGNALING#0.6806;BETA-2#0.6798;PROSTAGLANDIN E2#0.6781;VASCULAR ENDOTHELIAL CELL#0.6744;EXTRACELLULAR MATRIX#0.6742;CHEMOKINE RECEPTOR#0.6736;G-CSF#0.6736;B LYMPHOCYTE#0.6679;BLT RECEPTOR#0.6644;GRANULOCYTE#0.6568;CELL SURFACE#0.6555;ALLERGIC ASTHMA#0.6548;STRUCTURE ACTIVITY RELATIONSHIP#0.6495;COLORECTAL#0.6481;MITOGEN ACTIVATED PROTEIN#0.6466;ISCHEMIA REPERFUSION INJURY#0.6315;TOLL LIKE RECEPTOR#0.6263;CELL MIGRATION#0.6257;TH2 CELL#0.6232;CELL DEATH#0.6149;TRANSACTIVATION#0.6129
10801	BREAST CANCER#1.0393;PERIPHERAL BLOOD#1.0236;COLORECTAL#1.0212;COLORECTAL CANCER#1.0183;DNA METHYLATION#1.0105;MYELOID LEUKEMIA#0.9806;OVARIAN#0.9787;CYTOKINESIS#0.9682;MICROTUBULE#0.9664;CANCER CELL#0.9659;GTP BINDING#0.9630;ACUTE MYELOID LEUKEMIA#0.9613;POLYMERASE CHAIN REACTION#0.9368;CELL MIGRATION#0.9368;EPITHELIAL CELL#0.8940;T CELL#0.8753;APOPTOSIS#0.8550;BREAST CANCER CELL#0.8181;ACTIN FILAMENT#0.8119;CIRCULATING CELL FREE#0.7989;ABSCISSION#0.7961;NEUROPATHY#0.7942;CELL PROLIFERATION#0.7596;MAMMARY EPITHELIAL CELL#0.7545;SIGNALING PATHWAY#0.7476;COLORECTAL ADENOMA#0.7422;QUANTITATIVE METHYLATION SPECIFIC#0.7418;BRACHIAL PLEXUS#0.7368;EPITHELIAL OVARIAN CANCER#0.7346;CELL DIVISION#0.7313;OVARIAN CANCER#0.7290;CELL CYCLE#0.7263;METHYLATION SPECIFIC PCR#0.7073;SQUAMOUS CELL CARCINOMA#0.7046;TUMOR SUPPRESSOR#0.6617;PLASMA MEMBRANE#0.6549;GROWTH FACTOR#0.6463;KINESIN#0.6327;LUNG CANCER#0.6286;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6270;INTENTION TO TREAT#0.6251;PROLYMPHOCYTIC LEUKEMIA#0.6198;TYROSINE KINASE INHIBITOR#0.6085;HUMAN MAMMARY EPITHELIAL#0.6068;KINASE INHIBITOR#0.6059;ACTIN CYTOSKELETON#0.6026;HUMAN BREAST CANCER#0.6014
10802	ENDOPLASMIC RETICULUM#0.8486;COPII VESICLE#0.7106;COMPLEX II#0.6738;PROTEIN COMPLEX#0.6423
10803	CC CHEMOKINE RECEPTOR#1.0908;CANCER CELL#1.0823;THYMOCYTE#1.0645;CHEMOKINE RECEPTOR#1.0579;SMALL INTESTINE#1.0502;T LYMPHOCYTE#1.0457;CD8+ T CELL#1.0453;B CELL#1.0393;CHEMOTAXIS#1.0379;MESENTERIC LYMPH NODE#1.0301;T CELL#1.0273;CD4+ T CELL#1.0200;LYMPH NODE#1.0200;DENDRITIC CELL#1.0184;RETINOIC ACID#1.0150;CELL MIGRATION#1.0145;COLITIS#1.0109;CROHN'S DISEASE#1.0011;MONOCYTE#0.9950;T CELL DEVELOPMENT#0.9935;PERIPHERAL BLOOD#0.9899;CELL DEVELOPMENT#0.9876;APOPTOSIS#0.9849;EPITHELIAL CELL#0.9842;INTESTINAL MUCOSA#0.9832;IMMUNE RESPONSE#0.9758;IMMUNE CELL#0.9740;LYMPHOID TISSUE#0.9710;INFLAMMATORY BOWEL DISEASE#0.9635;LEUKOCYTE#0.9579;MACROPHAGE#0.9364;CELL ADHESION#0.9330;POLYMERASE CHAIN REACTION#0.9265;SIGNALING PATHWAY#0.9195;ULCERATIVE COLITIS#0.9114;BONE MARROW#0.9061;BREAST CANCER CELL#0.9002;BREAST CANCER#0.8754;IFN-GAMMA#0.8748;CELL ADHESION MOLECULE#0.8557;LUNG CANCER#0.8486;C CHEMOKINE RECEPTOR#0.8241;REVERSE TRANSCRIPTION#0.8201;REGULATORY T CELL#0.8136;PRO-INFLAMMATORY#0.8115;DRUG RESISTANCE#0.8063;OVARIAN CANCER#0.8052;STROMAL CELL#0.8045;TH17 CELL#0.7716;NAIVE T CELL#0.7644;LYMPHOID ORGANS#0.7639;LARGE INTESTINE#0.7457;OVARIAN#0.7123;MEMORY T CELL#0.7106;PLASMACYTOID DENDRITIC CELL#0.7077;IMMUNE SYSTEM#0.6947;ENDOMETRIOSIS#0.6932;QUANTITATIVE REVERSE TRANSCRIPTION#0.6874;TOLL LIKE RECEPTOR#0.6844;PANCREATIC CANCER#0.6803;GASTROINTESTINAL TRACT#0.6588;ADENOCARCINOMA#0.6524;CC CHEMOKINE LIGAND#0.6423;ILEITIS#0.6401;TUMOR NECROSIS FACTOR#0.6347;VITAMIN A#0.6323;CELL ACTIVATION#0.6321;TROPISM#0.6233;T CELL MIGRATION#0.6181;LYMPHOID CELL#0.6162;T CELL ACTIVATION#0.6146;LYMPHOCYTE HOMING#0.6126;GRAFT VERSUS HOST#0.6104;DEXTRAN SULFATE SODIUM#0.6064;NKT CELL#0.6041;PERIPHERAL BLOOD LYMPHOCYTES#0.6025
10804	CLOUSTON SYNDROME#1.1368;ECTODERMAL DYSPLASIA#1.0595;MITOCHONDRIAL DNA#1.0337;POLYMERASE CHAIN REACTION#1.0322;ASTROCYTE#1.0212;OLIGODENDROCYTE#1.0198;MACROPHAGE#1.0184;GAP JUNCTION PLAQUE#1.0155;LATERAL WALL#1.0127;CONNEXIN#1.0126;COCHLEA#1.0123;NONSYNDROMIC DEAFNESS#1.0121;HEARING IMPAIRMENT#1.0067;GAP JUNCTION CHANNEL#1.0039;INNER EAR#1.0028;HAIR CELL#0.9993;GAP JUNCTION#0.9944;HEARING LOSS#0.9925;SENSORINEURAL HEARING LOSS#0.9875;PLASMA MEMBRANE#0.9737;KERATINOCYTE#0.9708;ORGAN OF CORTI#0.9610;SKIN DISEASE#0.9589;EPITHELIAL CELL#0.9550;CONNEXON#0.9452;GLIAL CELL#0.9434;NERVOUS SYSTEM#0.9368;GENE EXPRESSION#0.9133;CENTRAL NERVOUS SYSTEM#0.9131;FIBROCYTE#0.9126;KERATITIS ICHTHYOSIS DEAFNESS#0.8999;MAMMARY GLAND#0.8966;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8770;BETA-2#0.8759;SPINAL CORD#0.8507;BLOOD VESSEL#0.8504;INTERCELLULAR CHANNEL#0.8487;COCHLEAR LATERAL WALL#0.8420;KERATITIS#0.8370;ICHTHYOSIS#0.8255;CELL DEATH#0.7932;MTDNA#0.7792;CELL PROLIFERATION#0.7751;APOPTOSIS#0.7654;WOUND HEALING#0.7634;BASAL CELL#0.7626;GROWTH FACTOR#0.7569;REVERSE TRANSCRIPTION#0.7567;CALCIUM SIGNALING#0.7441;ENDOTHELIAL CELL#0.7364;OUTER HAIR CELL#0.7236;NEWBORN HEARING SCREENING#0.7133;CEREBRAL CORTEX#0.7034;OTOCYST#0.6943;HATCHING#0.6834;PERIPHERAL BLOOD#0.6832;CYTOPLASM#0.6726;STEM CELL#0.6709;TEMPORAL BONE#0.6605;ENLARGED VESTIBULAR AQUEDUCT#0.6585;ALOPECIA#0.6491;SMOOTH MUSCLE#0.6428;CELL COMMUNICATION#0.6416;NEPHRON#0.6338;GAP JUNCTION COMMUNICATION#0.6335;STRIATUM#0.6311;OOCYTE#0.6287;CHANNEL ACTIVITY#0.6272;AUDITORY BRAINSTEM RESPONSE#0.6267;CELL SURFACE#0.6219;PRESSURE NATRIURESIS#0.6139;LUMINAL#0.6105;VOCAL FOLD#0.6084
10806	COLON CANCER#0.9901;CILIOPATHY#0.9368;BARDET BIEDL SYNDROME#0.9226;POLYDACTYLY#0.7999;NEPHRONOPHTHISIS#0.7521;RETINAL DEGENERATION#0.7506;CENTROSOME#0.6655;PERICENTRIOLAR MATERIAL#0.6059
10807	COLON CANCER#0.9996;REGULATION OF CYTOKINESIS#0.7215;DOMINANT NEGATIVE MUTANT#0.6615;PROTEIN TYROSINE PHOSPHATASE#0.6574;CELL SURFACE#0.6456
10808	HEAT SHOCK PROTEIN#1.0235;APOPTOSIS#0.9960;GENE EXPRESSION#0.9692;CELL DEATH#0.9605;COLORECTAL CANCER#0.9165;T CELL#0.8447;CYTOPLASM#0.8437;GERM CELL#0.8139;COLORECTAL#0.8084;CANCER CELL#0.7943;TUMOR CELLS#0.7169;ER MEMBRANE#0.6991;LYMPH NODE#0.6988;ADENOCARCINOMA#0.6914;APOPTOTIC#0.6859;ENDOPLASMIC RETICULUM#0.6590;NUCLEOTIDE EXCHANGE FACTOR#0.6473;TUMOR SUPPRESSOR#0.6151;PROTEIN KINASE#0.6117;CD8+ T CELL#0.6017;LYMPH NODE METASTASIS#0.6005
10809	BREAST CANCER#1.1265;BREAST CANCER CELL#0.8134;CANCER CELL#0.8083;LIPID BINDING#0.7271;PHOSPHATIDYLETHANOLAMINE#0.6771;BILE ACID METABOLISM#0.6378
1080	ADENYLATE KINASE ACTIVITY#1.1090;ADENYLATE KINASE#1.0730;LUBIPROSTONE#1.0696;CLATHRIN COATED VESICLE#1.0581;SPERM CAPACITATION#1.0542;COATED VESICLE#1.0532;BICARBONATE TRANSPORT#1.0495;ENDOCYTIC RECYCLING#1.0465;ANION EXCHANGER 2#1.0452;PDZ BINDING MOTIF#1.0445;SERTOLI CELL#1.0424;LIPID RAFT#1.0408;CHLORIDE CHANNEL ACTIVITY#1.0401;MACROMOLECULAR COMPLEX#1.0384;HYDRAZIDE#1.0371;SULFONYLUREA RECEPTOR#1.0351;DELTA F#1.0341;PROTEIN PROCESSING#1.0330;PLASMA MEMBRANE EXPRESSION#1.0311;RESPONSE TO CAMP#1.0295;BETA-2#1.0285;APICAL PLASMA MEMBRANE#1.0279;KINASE ACTIVITY#1.0270;Y CHROMOSOME#1.0265;IVACAFTOR#1.0259;ALVEOLAR EPITHELIAL CELL#1.0257;MULTIDRUG RESISTANCE PROTEIN#1.0246;CYSTEAMINE#1.0242;AUTOPHAGY#1.0232;PANCREATIC ADENOCARCINOMA#1.0231;GENISTEIN#1.0231;UTERUS#1.0228;ENDOSOME#1.0223;ANION CHANNEL ACTIVITY#1.0220;GUANYLIN#1.0219;SECRETORY DIARRHEA#1.0218;INTESTINAL OBSTRUCTION#1.0213;POLY T#1.0201;ION CHANNEL ACTIVITY#1.0201;SWEAT GLAND#1.0192;GUANYLATE CYCLASE#1.0189;ANION CHANNEL#1.0185;EPITHELIAL TISSUES#1.0183;LUNG DEVELOPMENT#1.0168;ADRENERGIC RECEPTOR#1.0155;INTESTINAL TRACT#1.0152;WATER CHANNEL#1.0152;CHLORIDE CHANNEL#1.0150;AQUAPORIN#1.0149;SECRETIN RECEPTOR#1.0148;ENDOCYTOSIS#1.0148;INTESTINAL DISEASE#1.0146;WATER TRANSPORT#1.0144;3-ISOBUTYL-1-METHYLXANTHINE#1.0144;CILIATED CELL#1.0141;SCLEROSING CHOLANGITIS#1.0140;ABC TRANSPORTER#1.0140;EXOCYTOSIS#1.0139;EPITHELIAL SODIUM CHANNEL#1.0136;CYSTIC FIBROSIS#1.0134;GLYCINE#1.0130;ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION#1.0126;HYPOXIA#1.0126;ACTIN CYTOSKELETON#1.0119;OOCYTE#1.0112;ALVEOLAR FLUID CLEARANCE#1.0110;NUCLEOTIDE BINDING DOMAIN#1.0107;CYCLIC ADENOSINE MONOPHOSPHATE#1.0106;POTASSIUM CHANNEL#1.0104;NASAL EPITHELIUM#1.0103;ANION TRANSPORT#1.0099;HUMAN NASAL EPITHELIAL#1.0096;ATP BINDING CASSETTE TRANSPORTER#1.0095;FLUID TRANSPORT#1.0094;ACUTE RECURRENT PANCREATITIS#1.0090;LYSOSOME#1.0082;ADENOSINE MONOPHOSPHATE#1.0082;CHLORIDE TRANSPORT#1.0080;CHANNEL INHIBITOR#1.0076;MYOCYTES#1.0074;ATP HYDROLYSIS#1.0074;NUCLEOTIDE BINDING#1.0073;ENDOMETRIUM#1.0069;AUTOSOMAL RECESSIVE DISEASE#1.0066;GLYCOSYLATION#1.0065;SECRETORY PATHWAY#1.0065;TRANSCRIPTASE#1.0061;BETA CELL#1.0059;BRUSH BORDER MEMBRANE#1.0056;CHANNEL ACTIVITY#1.0055;MONOGENIC DISEASE#1.0054;QUALITY CONTROL SYSTEM#1.0048;GLIBENCLAMIDE#1.0048;SODIUM CHANNEL#1.0046;HUMAN AIRWAY EPITHELIAL#1.0045;ADENYLATE#1.0042;SUBMANDIBULAR GLAND#1.0040;HEAT SHOCK PROTEIN#1.0036;RNA INTERFERENCE#1.0035;INSULIN SECRETION#1.0035;CYCLIC AMP#1.0031;ATP BINDING CASSETTE#1.0031;BRONCHITIS#1.0026;SPERMATOGENESIS#1.0025;CELL MIGRATION#1.0022;ALVEOLAR MACROPHAGE#1.0017;CELL SURFACE#1.0015;GAP JUNCTION#1.0015;ENDOMETRIAL EPITHELIAL CELLS#1.0012;ATPASE ACTIVITY#1.0011;NIFLUMIC ACID#1.0011;ADENO ASSOCIATED VIRUS#1.0010;CHOLERA#1.0008;ADENYLATE CYCLASE#1.0006;ENTEROCYTE#1.0005;DUCT CELL#1.0004;ATP BINDING#1.0001;AGGRESOME#0.9999;PHOSPHODIESTERASE#0.9998;LUNG CANCER#0.9994;BRUSH BORDER#0.9993;DUODENUM#0.9992;PLASMA MEMBRANE#0.9989;PANCREATITIS#0.9988;UNFOLDED PROTEIN RESPONSE#0.9987;EMBRYONIC KIDNEY#0.9985;PREMATURE TERMINATION CODON#0.9985;ION CHANNEL#0.9985;GALLBLADDER#0.9982;PROTEIN KINASE A#0.9980;GRADIENT GEL ELECTROPHORESIS#0.9980;KINASE INHIBITOR#0.9976;POLYCYSTIC KIDNEY DISEASE#0.9976;MACROPHAGE#0.9975;PROTEASOME#0.9975;JEJUNUM#0.9974;UBIQUITIN#0.9973;ADENOCARCINOMA#0.9972;ENDOTHELIAL CELL#0.9972;CAMP SIGNALING#0.9968;INFERTILE#0.9965;BETA GALACTOSIDASE#0.9963;WOUND HEALING#0.9963;PRIMARY SCLEROSING CHOLANGITIS#0.9961;REACTIVE OXYGEN SPECIES#0.9961;AIRWAY SURFACE LIQUID#0.9959;BRONCHIAL EPITHELIAL CELLS#0.9959;INTESTINAL EPITHELIAL CELL#0.9957;SWELLING#0.9952;ALANINE#0.9951;HUMAN AIRWAY EPITHELIUM#0.9950;ORGANELLE#0.9948;DUCTAL CELL#0.9947;EPIDIDYMIS#0.9947;CELL MEMBRANE#0.9947;OVARIAN#0.9946;ACINAR CELL#0.9943;PROTEIN PROTEIN INTERACTION#0.9939;HUMAN BRONCHIAL EPITHELIAL#0.9939;REGULATORY VOLUME DECREASE#0.9938;LUNG EPITHELIAL CELL#0.9938;AZOOSPERMIA#0.9938;ER MEMBRANE#0.9938;ACIDIFICATION#0.9935;AIRWAY EPITHELIAL CELL#0.9935;ADENOSINE TRIPHOSPHATE#0.9933;ENDOPLASMIC RETICULUM#0.9929;TYROSINE KINASE INHIBITOR#0.9929;TOPICAL#0.9928;GLUTATHIONE#0.9927;MALE INFERTILITY#0.9927;INNATE IMMUNITY#0.9927;ANION BINDING#0.9924;ILEUS#0.9924;HUMAN INTESTINAL EPITHELIAL#0.9923;GENTAMICIN#0.9921;MEMBRANE TRANSPORT#0.9916;PANCREATIC CANCER#0.9916;IL-8 SECRETION#0.9916;APOPTOSIS#0.9913;DRUG RESISTANCE#0.9912;MECONIUM#0.9912;NITRIC OXIDE#0.9912;ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS#0.9912;GASTROINTESTINAL TRACT#0.9912;GOBLET CELL#0.9911;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.9909;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.9908;SURFACE EPITHELIUM#0.9907;BILE DUCT#0.9905;TIGHT JUNCTION#0.9904;SIGNALLING PATHWAY#0.9903;TRACHEA#0.9903;GENETIC DISEASE#0.9901;CYTOPLASM#0.9899;MUSCLE CELL#0.9896;BRONCHIECTASIS#0.9896;PROTEIN KINASE#0.9895;HUMAN EMBRYONIC KIDNEY#0.9890;BENZOIC ACID#0.9889;K+ CONDUCTANCE#0.9889;MECHANISM OF ACTION#0.9888;PROTEIN KINASE C#0.9887;MITOCHONDRIA#0.9886;KIDNEY DISEASE#0.9884;DIARRHEA#0.9884;ADENOSINE#0.9884;PROTEIN COMPLEX#0.9879;SALIVARY GLAND#0.9878;SMALL INTESTINE#0.9878;ARGININE#0.9877;DEPHOSPHORYLATION#0.9873;GROWTH FACTOR RECEPTOR#0.9867;ARACHIDONIC ACID#0.9866;AIRWAY EPITHELIUM#0.9864;REVERSE TRANSCRIPTION#0.9861;TUMOR SUPPRESSOR#0.9858;EPITHELIAL CELL#0.9858;APOPTOTIC#0.9856;PERIPHERAL BLOOD#0.9856;INNATE IMMUNE RESPONSE#0.9856;LUMINAL#0.9852;CANCER CELL#0.9850;LUNG DAMAGE#0.9846;CONSTIPATION#0.9844;PROTEIN FOLDING#0.9836;RESPONSE TO FORSKOLIN#0.9836;MOLECULAR DYNAMICS SIMULATION#0.9836;AMILORIDE#0.9835;SMOOTH MUSCLE#0.9834;ERYTHROCYTE#0.9832;FORSKOLIN#0.9830;SMOOTH MUSCLE CELL#0.9827;CARBACHOL#0.9826;GENETIC DISORDER#0.9821;NEUTROPHIL#0.9817;ENDOTHELIUM#0.9811;BUMETANIDE#0.9809;PLURIPOTENT STEM CELL#0.9804;INFERTILITY#0.9804;LYSINE#0.9802;MONOCYTE#0.9801;PRO-INFLAMMATORY#0.9800;MUTAGENESIS#0.9799;RESPIRATORY TRACT#0.9796;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9792;MUCOUS#0.9790;CELIAC DISEASE#0.9790;ACUTE PANCREATITIS#0.9790;TUMOR NECROSIS FACTOR#0.9787;PHOSPHATASE INHIBITOR#0.9784;ANCHORING#0.9783;SKELETAL MUSCLE#0.9778;CELL DIFFERENTIATION#0.9777;BREAST CANCER#0.9777;SOLUBLE ADENYLYL CYCLASE#0.9770;MUCUS SECRETION#0.9768;INTESTINAL MUCOSA#0.9765;CHOLANGITIS#0.9761;COLONIC EPITHELIAL CELLS#0.9760;CELL PROLIFERATION#0.9760;T CELL#0.9757;PHAGOSOME#0.9756;RECEPTOR AGONIST#0.9754;LEUKOCYTE#0.9753;SIGNALING MOLECULE#0.9753;LIVER DISEASE#0.9752;SIGNAL TRANSDUCTION#0.9750;GROWTH FACTOR#0.9749;BASAL CELL#0.9749;DEHYDRATION#0.9748;ISOPROTERENOL#0.9746;SIGNALING PATHWAY#0.9745;STEM CELL#0.9738;ION TRANSPORT#0.9732;HUMAN BRONCHIAL EPITHELIA#0.9732;GENE EXPRESSION#0.9730;TOXICITY#0.9729;ALKALINE PHOSPHATASE#0.9726;NYSTATIN#0.9725;RED BLOOD CELL#0.9723;CELLULAR LOCALIZATION#0.9722;IMMUNE RESPONSE#0.9721;INFLAMMATORY RESPONSE#0.9719;GESTATION#0.9719;MECHANISMS OF ACTION#0.9716;SODIUM TRANSPORT#0.9707;DEXAMETHASONE#0.9706;AGE AT DIAGNOSIS#0.9704;NERVOUS SYSTEM#0.9702;CELL DEATH#0.9700;MITOGEN ACTIVATED PROTEIN#0.9696;THYMIDINE#0.9688;YELLOW FLUORESCENT PROTEIN#0.9687;MICROTUBULE#0.9685;MEMBRANE DEPOLARIZATION#0.9685;IMMUNE SYSTEM#0.9684;SIGNALING CASCADE#0.9684;LUNG DISEASE#0.9682;RESVERATROL#0.9680;POLYMERASE CHAIN REACTION#0.9678;CLARA CELL#0.9677;EXCRETION#0.9677;DIGESTION#0.9675;PROTEIN SYNTHESIS#0.9674;PROTEIN SECRETION#0.9664;MALNUTRITION#0.9659;EARLY ENDOSOME#0.9652;OBSTRUCTIVE LUNG DISEASE#0.9650;TRANSCRIPTION FACTOR#0.9635;UBIQUITIN PROTEASOME SYSTEM#0.9635;SPHINGOSINE 1 PHOSPHATE#0.9634;TRANSEPITHELIAL TRANSPORT#0.9631;SEMEN#0.9630;INTESTINAL CRYPT#0.9627;SPUTUM#0.9625;VIRULENCE#0.9624;SECRETORY CELL#0.9621;RECEPTOR ANTAGONIST#0.9619;ESTRADIOL#0.9614;FORCED EXPIRATORY VOLUME#0.9610;PULMONARY EDEMA#0.9605;TRANSFORMING GROWTH FACTOR#0.9604;PHOSPHODIESTERASE INHIBITOR#0.9600;ACUTE LUNG INJURY#0.9588;PNEUMONIA#0.9588;IMMUNE CELL#0.9586;SEMINAL VESICLE#0.9583;EDEMA#0.9580;ASPERGILLOSIS#0.9571;PHOSPHATASE ACTIVITY#0.9564;RESPIRATORY FAILURE#0.9561;HISTONE DEACETYLASE#0.9556;PROTEIN TYROSINE KINASE#0.9552;IL-8 PRODUCTION#0.9552;SPERMATOZOA#0.9552;AIRWAY SMOOTH MUSCLE#0.9542;IONOPHORE#0.9537;PREIMPLANTATION GENETIC DIAGNOSIS#0.9536;MRNA SPLICING#0.9535;AMPK ACTIVITY#0.9529;NASAL MUCOSA#0.9529;COMPLEX I#0.9528;INDUCED PLURIPOTENT STEM CELL#0.9523;PROGESTERONE#0.9520;HYPOXIC#0.9505;EPIDERMAL GROWTH FACTOR#0.9499;ACTIN FILAMENT#0.9496;GLYBENCLAMIDE#0.9490;ATP EFFLUX#0.9481;OSMOREGULATION#0.9478;HYPERTENSION#0.9473;CORNEAL ENDOTHELIUM#0.9473;EMBRYONIC STEM CELL#0.9466;BONE MARROW#0.9461;DIABETES MELLITUS#0.9457;TOLL LIKE RECEPTOR#0.9442;LEUCINE#0.9442;XANTHINE#0.9441;BONE DISEASE#0.9441;CORNEAL ENDOTHELIAL CELL#0.9438;OUABAIN#0.9432;CORNEAL EPITHELIAL CELL#0.9428;RESONANCE ENERGY TRANSFER#0.9412;NEPHRON#0.9412;PHOSPHOLIPASE C#0.9408;EPITHELIAL FLUID TRANSPORT#0.9398;PROTEIN PHOSPHORYLATION#0.9395;ISCHEMIA#0.9393;PROTEIN REPAIR#0.9386;ADENOSINE 5'-TRIPHOSPHATE#0.9384;INTRACELLULAR MEMBRANE#0.9374;LIPID METABOLISM#0.9362;CHANNEL REGULATOR#0.9355;RIBOSOME#0.9354;GERM CELL#0.9335;BETA2 ADRENERGIC RECEPTOR#0.9320;PHAGOCYTOSIS#0.9314;MONONUCLEAR CELLS#0.9306;CATALYTIC ACTIVITY#0.9304;PROSTAGLANDIN E2#0.9297;INTRACELLULAR RETENTION#0.9296;FERTILIZATION#0.9283;MDR PROTEIN#0.9283;WEIGHT GAIN#0.9280;VIRAL INFECTION#0.9276;VASOPRESSIN#0.9274;INTRACELLULAR VESICLE#0.9273;CALCIUM SIGNALING#0.9271;ETHANOL#0.9266;IFN-GAMMA#0.9265;ACUTE LUNG INFLAMMATION#0.9236;LOCALISATION#0.9235;QUANTITATIVE REAL TIME#0.9226;STRUCTURE ACTIVITY RELATIONSHIP#0.9223;DNASE#0.9220;BIOTIN#0.9214;INFLAMMATORY CELL#0.9208;PROTEASOME PATHWAY#0.9204;ALCOHOLIC PANCREATITIS#0.9186;CHOLESTASIS#0.9180;HISTIDINE#0.9180;POST-TRANSLATIONAL MODIFICATION#0.9170;SINUSITIS#0.9143;GOLGI APPARATUS#0.9142;COLON CARCINOMA#0.9136;FRAGMENT LENGTH POLYMORPHISM#0.9133;LECTIN#0.9129;CATION CHANNEL#0.9129;DRIED BLOOD SPOT#0.9123;PTC124#0.9122;HOMOLOGOUS RECOMBINATION#0.9120;RESPIRATORY SYSTEM#0.9119;CARDIOMYOCYTE#0.9099;HISTAMINE#0.9089;SUCROSE#0.9075;CELL CYCLE#0.9068;NADPH OXIDASE#0.9061;ANDROGEN RECEPTOR#0.9052;BONE FORMATION#0.9044;SPHINGOSINE#0.9043;CERVICAL#0.9040;RESPIRATORY TRACT INFECTION#0.9035;ASPARTATE#0.9029;CIGARETTE SMOKE EXPOSURE#0.9025;MAST CELL#0.9012;DNASE I#0.9011;ARTERY#0.9004;PROTON PUMP#0.9001;MICROSOME#0.8999;NITRIC OXIDE SYNTHASE#0.8996;CELL PHYSIOLOGY#0.8994;COLITIS#0.8988;GI TRACT#0.8986;TRANSLATION INITIATION#0.8971;TESTOSTERONE#0.8970;TRANSMISSION ELECTRON MICROSCOPY#0.8966;NUCLEIC ACID#0.8958;ATPASE INHIBITOR#0.8952;HOST CELL#0.8950;REPRODUCTIVE SYSTEM#0.8946;ACETYLCHOLINE#0.8941;BAFILOMYCIN A1#0.8940;DUODENAL ULCER#0.8939;CELL GROWTH#0.8930;MEMBRANE FRACTION#0.8927;KERATINOCYTE#0.8925;PROGENITOR CELL#0.8917;URIDINE#0.8916;EMBRYO DEVELOPMENT#0.8907;INSULIN-LIKE GROWTH FACTOR#0.8907;OUTER MEMBRANE#0.8907;UBIQUITIN PROTEASOME PATHWAY#0.8900;CIGARETTE SMOKE EXTRACT#0.8899;INFLAMMATORY BOWEL DISEASE#0.8898;SODIUM:HYDROGEN EXCHANGER#0.8893;PRIMARY CILIARY DYSKINESIA#0.8891;TISSUE DAMAGE#0.8890;RECYCLING ENDOSOME#0.8887;EXOCRINE PANCREATIC INSUFFICIENCY#0.8880;ACTIVE TRANSPORTER#0.8877;MUSCLE CONTRACTION#0.8869;EPOXIDE HYDROLASE#0.8866;TRANSIENT RECEPTOR POTENTIAL#0.8866;CYTOKINE PRODUCTION#0.8865;B CELL#0.8836;SILDENAFIL#0.8833;RECEPTOR MEDIATED ENDOCYTOSIS#0.8833;C TERMINAL DOMAIN#0.8829;ALPHA 1-ANTITRYPSIN#0.8823;PILOCARPINE#0.8823;BILIARY TRACT#0.8809;PROSTATE CANCER#0.8808;GTP BINDING#0.8788;MANNITOL#0.8785;POSITIVE PREDICTIVE VALUE#0.8781;CALYCULIN A#0.8780;SURFACE PLASMON RESONANCE#0.8755;URSODEOXYCHOLIC ACID#0.8733;GUANOSINE#0.8731;HIGH RESOLUTION MELTING#0.8724;SPINAL CORD#0.8714;DOXORUBICIN#0.8686;TARGET OF RAPAMYCIN#0.8678;GANGLION CELLS#0.8675;HETEROTRIMERIC G-PROTEIN#0.8674;C REACTIVE PROTEIN#0.8673;ABDOMINAL PAIN#0.8670;PROTEIN QUALITY CONTROL#0.8654;GRANULOSA CELL#0.8647;RENAL AGENESIS#0.8629;RAPAMYCIN#0.8617;EXTRACELLULAR MATRIX#0.8607;MILRINONE#0.8596;CENTRAL NERVOUS SYSTEM#0.8550;OSTEOBLAST#0.8549;SUMOYLATION#0.8546;PHOSPHOLIPASE A2#0.8543;CLOTRIMAZOLE#0.8538;BONE MINERAL DENSITY#0.8519;EFFERENT DUCT#0.8514;GLUTAMINE#0.8496;PROTEIN MATURATION#0.8488;PARATHYROID HORMONE#0.8483;PREMATURE STOP CODONS#0.8473;LARGE INTESTINE#0.8468;CHANGE FROM BASELINE#0.8461;CYTOTOXICITY#0.8457;AMNIOTIC FLUID#0.8451;ADENINE#0.8448;GOBLET CELL HYPERPLASIA#0.8413;PROXIMAL TUBULE CELL#0.8411;INTRACELLULAR ORGANELLE#0.8402;COLUMNAR#0.8397;DIPHOSPHATE#0.8372;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8369;ENDOCRINE CELL#0.8360;VERAPAMIL#0.8353;ADAPTIVE IMMUNE RESPONSE#0.8341;PKC ACTIVITY#0.8339;LUCIFERASE ACTIVITY#0.8329;INTRACELLULAR ACIDIFICATION#0.8327;STAUROSPORINE#0.8303;RESPIRATORY DISTRESS#0.8301;ENDOPLASMIC RETICULUM STRESS#0.8294;METHACHOLINE#0.8276;DNA METHYLATION#0.8273;SODIUM BICARBONATE#0.8267;HIGH THROUGHPUT SCREEN#0.8256;QUERCETIN#0.8239;SURAMIN#0.8238;COLLECTING DUCTS#0.8232;LUNG ADENOCARCINOMA#0.8231;PROTEIN KINASE INHIBITOR#0.8228;FORCED VITAL CAPACITY#0.8227;EPINEPHRINE#0.8224;WEIGHT LOSS#0.8198;INTRACELLULAR LOCALIZATION#0.8190;VESICLE TRAFFICKING#0.8189;N-ETHYLMALEIMIDE#0.8182;CARRIE#0.8181;RESPONSE TO ATP#0.8170;ACTION POTENTIAL#0.8147;PARENCHYMA#0.8137;FUROSEMIDE#0.8134;FOCAL ADHESION KINASE#0.8116;ALDOSTERONE#0.8111;ER DEGRADATION#0.8095;REGENERATION#0.8093;FOCAL ADHESION#0.8088;OLIGOSPERMIA#0.8074;RANDOMISED CONTROLLED TRIAL#0.8073;GAP JUNCTION CHANNEL#0.8067;CORTISOL#0.8059;LATE ENDOSOME#0.8052;LACRIMAL GLAND#0.8051;SPERM MOTILITY#0.8048;AUTOIMMUNE PANCREATITIS#0.8048;PROTEIN DEGRADATION#0.8042;CYTOKINE SECRETION#0.8041;NF-KAPPAB ACTIVATION#0.8035;ARGININE VASOPRESSIN#0.8033;TRANSEPITHELIAL CHLORIDE TRANSPORT#0.7995;CELL ADHESION#0.7987;COLORECTAL#0.7959;HEALTHY CONTROL SUBJECTS#0.7946;DICARBOXYLIC ACID#0.7941;DEUBIQUITINATING ENZYME#0.7939;ER EXIT#0.7936;GLOBIN#0.7915;QUANTITATIVE REVERSE TRANSCRIPTASE#0.7906;COLON CANCER#0.7890;FLUORESCEIN#0.7888;LINES OF EVIDENCE#0.7885;N-ACETYLCYSTEINE#0.7884;PERTUSSIS#0.7884;ISOPRENALINE#0.7881;EPITHELIAL CELL DIFFERENTIATION#0.7868;MINERALIZATION#0.7866;OVIDUCT#0.7844;SARCOIDOSIS#0.7841;CILIATED EPITHELIAL CELL#0.7839;MICROSOMAL MEMBRANE#0.7823;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7822;AKT SIGNALING#0.7813;METAPLASIA#0.7787;MIGLUSTAT#0.7777;ADENYLATE CYCLASE INHIBITOR#0.7763;ACID SECRETION#0.7739;PURINOCEPTOR#0.7734;RECTUM#0.7732;DYSKINESIA#0.7729;BRONCHIOLE#0.7724;CAMP RESPONSE ELEMENT#0.7718;MUCOUS CELLS#0.7711;PULMONARY ARTERY#0.7708;RESTING ENERGY EXPENDITURE#0.7707;TIGHT JUNCTION PROTEIN#0.7705;PROTEIN BINDING#0.7695;ASPARTIC ACID#0.7690;CALCIUM CHANNEL#0.7689;FLUFENAMIC ACID#0.7688;OVARIAN CANCER#0.7682;GLUTAMIC ACID#0.7668;MYOCARDIAL INFARCTION#0.7667;MUSCULAR DYSTROPHY#0.7666;MALTOSE BINDING#0.7666;CONNEXIN#0.7660;COLORECTAL CANCER#0.7655;T LYMPHOCYTE#0.7646;QUORUM SENSING#0.7643;LYMPH NODE#0.7642;PORTAL HYPERTENSION#0.7637;ENZYME ACTIVITY#0.7629;DNA BINDING#0.7625;PEPTIDE TRANSPORTER#0.7603;PULMONARY FIBROSIS#0.7595;NOCODAZOLE#0.7591;DIGESTIVE TRACT#0.7585;PAROTID GLAND#0.7579;TRANSFERRIN RECEPTOR#0.7577;ANTHRACENE#0.7575;POTASSIUM CHLORIDE#0.7570;HUMAN EMBRYONIC STEM#0.7568;CELL DEVELOPMENT#0.7564;LINACLOTIDE#0.7559;L-ARGININE#0.7551;CYTOCHROME P450#0.7547;DUCTAL EPITHELIAL CELLS#0.7532;MACROPHAGE INFLAMMATORY PROTEIN#0.7530;QUANTITATIVE REVERSE TRANSCRIPTION#0.7516;GLUCOCORTICOID RECEPTOR#0.7497;ASSISTED REPRODUCTIVE TECHNOLOGIES#0.7488;CHOROID PLEXUS#0.7479;SODIUM DODECYL SULFATE#0.7479;PROTEIN PHOSPHATASE 2A#0.7478;DODECYL SULFATE#0.7478;PHOSPHATASE 2A#0.7474;VACUOLE#0.7470;VITAMIN C#0.7455;ENDOTHELIAL GROWTH FACTOR#0.7433;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7433;GLUCOSE HOMEOSTASIS#0.7430;INDOMETHACIN#0.7421;ORGANOGENESIS#0.7416;TAMOXIFEN#0.7395;ROFLUMILAST#0.7389;TOBRAMYCIN#0.7386;DDAVP#0.7382;TOLBUTAMIDE#0.7353;PROSTATE EPITHELIAL CELL#0.7347;BETA ADRENERGIC RECEPTOR#0.7345;SUBSTANCE P#0.7340;MORPHOGENESIS#0.7334;COATED PIT#0.7334;AGE AT DEATH#0.7323;COPY NUMBER VARIATION#0.7305;PANCREATIC ISLET#0.7299;OPIOID RECEPTOR#0.7293;IBUPROFEN#0.7286;MITOCHONDRIAL MEMBRANE#0.7280;FACTOR I#0.7274;NUCLEOSIDE DIPHOSPHATE KINASE#0.7270;GLYCINE RECEPTOR#0.7260;POSTTRANSLATIONAL MODIFICATION#0.7247;ACUTE LEUKEMIA#0.7242;IRRITABLE BOWEL SYNDROME#0.7226;ATP TRANSPORT#0.7226;PARATHYROID#0.7205;MOLAR#0.7204;POLYCYSTIN#0.7201;BACTERIAL ARTIFICIAL CHROMOSOME#0.7188;RETINAL PIGMENT EPITHELIUM#0.7187;SINGLE PARTICLE TRACKING#0.7180;ASSISTED REPRODUCTION TREATMENT#0.7168;INNATE IMMUNE SYSTEM#0.7166;INCISORS#0.7155;STERILITY#0.7149;INTERMEDIATE FILAMENT#0.7147;FATTY ACID METABOLISM#0.7132;GROWTH HORMONE#0.7129;METHIONINE#0.7117;P2Y RECEPTOR#0.7111;EPIGALLOCATECHIN#0.7101;COLCHICINE#0.7085;ADIPOSE TISSUE#0.7043;ORAL GLUCOSE TOLERANCE#0.7042;ETHANE#0.7034;DEXTRAN SODIUM SULFATE#0.7031;GUANINE#0.7028;CERVICAL CANCER#0.7025;TUMOR CELLS#0.7024;MEMBRANE REGION#0.7019;LIGASE ACTIVITY#0.7011;CAUDA#0.7004;EPITHELIAL CELL PROLIFERATION#0.6990;MALE REPRODUCTIVE SYSTEM#0.6988;AZITHROMYCIN#0.6985;ALLERGIC RHINITIS#0.6955;MULTI DRUG RESISTANCE#0.6950;SULFATION#0.6948;CYCLASE ACTIVITY#0.6946;MICROVILLI#0.6942;PEROXISOME#0.6938;HEPATOBILIARY DISEASE#0.6937;PROTEIN LOCALIZATION#0.6929;BILE DUCT LIGATION#0.6926;MODE OF ACTION#0.6916;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6904;VASCULAR SMOOTH MUSCLE CELL#0.6901;INDUCIBLE NITRIC OXIDE#0.6898;MONOCYTE DERIVED MACROPHAGE#0.6891;SQUAMOUS CELL CARCINOMA#0.6884;PEPTIDE HORMONE#0.6876;FATTY ACID BINDING#0.6873;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.6858;REGULATION OF AQUAPORIN#0.6853;VESICULAR TRANSPORT#0.6838;TUBERCULOSIS#0.6833;EMBRYO IMPLANTATION#0.6832;ASSISTED REPRODUCTIVE TECHNOLOGY#0.6827;TRANSMEMBRANE TRANSPORT#0.6821;SMOOTH MUSCLE CONTRACTION#0.6820;CYTOPLASMIC MEMBRANE#0.6817;BREAST CANCER CELL#0.6812;NONSENSE MEDIATED DECAY#0.6810;PRE-MRNA SPLICING#0.6809;DETOXIFICATION#0.6808;HISTONE MODIFICATION#0.6777;ACTIN POLYMERIZATION#0.6776;NUCLEOTIDE EXCHANGE FACTOR#0.6769;ENAMEL MINERALIZATION#0.6756;ACID SPHINGOMYELINASE#0.6752;TYPE 2 DIABETES#0.6730;FRUCTOSE#0.6718;INTRACELLULAR TRANSPORT#0.6713;TRANS GOLGI NETWORK#0.6709;SNARE COMPLEX#0.6704;TRYPSINOGEN ACTIVATION#0.6701;THEOPHYLLINE#0.6699;CISPLATIN#0.6690;ACROSOME REACTION#0.6683;URIDINE 5'-TRIPHOSPHATE#0.6679;CYCLOSPORIN A#0.6671;CLATHRIN-COATED PIT#0.6668;MAPK SIGNALING#0.6660;CELLULAR MEMBRANE#0.6650;TISSUE HOMEOSTASIS#0.6648;MITOCHONDRION#0.6645;MESENCHYMAL STEM CELL#0.6643;SENSITIZATION#0.6630;FACTOR S#0.6630;METHYLATION SPECIFIC PCR#0.6628;MUCUS LAYER#0.6626;ALPHA CELL#0.6618;ACETYLCYSTEINE#0.6614;RETICULOCYTE#0.6612;LIPID HOMEOSTASIS#0.6596;VASOCONSTRICTION#0.6592;PROTEIN KINASE A ACTIVATION#0.6590;ERAD PATHWAY#0.6590;RESPONSE TO HYPOXIA#0.6585;SKELETAL MUSCLE CELLS#0.6584;BONE CELLS#0.6582;ACETAZOLAMIDE#0.6577;MYOCARDIUM#0.6576;FIBROBLAST GROWTH FACTOR#0.6570;SEROUS ACINAR CELL#0.6564;ER LUMEN#0.6557;GLUTATHIONE PEROXIDASE#0.6543;PEPTIDE BINDING#0.6538;GASTRO#0.6532;FACTOR VIII#0.6522;TAUROCHOLATE#0.6521;AUTOCRINE SIGNALING#0.6519;CROSS SECTIONAL AREA#0.6513;LIVER CIRRHOSIS#0.6505;GLUCOSE TOLERANCE TEST#0.6500;SURFACTANT PROTEIN C#0.6485;ACTIN FILAMENT ORGANIZATION#0.6471;SIZE EXCLUSION CHROMATOGRAPHY#0.6457;P2 RECEPTOR#0.6454;CALCINEURIN#0.6452;MALTOSE#0.6438;HEPATOCYTE NUCLEAR FACTOR#0.6417;FORMATE#0.6408;OXALATE SECRETION#0.6401;DIFFERENTIAL GENE EXPRESSION#0.6399;LASER DESORPTION IONIZATION#0.6389;CAFFEINE#0.6381;STROMAL CELL#0.6377;DYSPNEA#0.6374;TRANSLATIONAL READTHROUGH#0.6366;TYPHOID FEVER#0.6362;ASTROCYTE#0.6359;TUMOUR NECROSIS FACTOR#0.6358;GENE SILENCING#0.6358;INFLAMMATORY AIRWAY DISEASE#0.6353;EPITHELIAL MESENCHYMAL TRANSITION#0.6346;PLATELET-DERIVED GROWTH FACTOR#0.6342;FLUID-PHASE ENDOCYTOSIS#0.6325;SIALYLATION#0.6320;PROTEIN KINASE A ACTIVITY#0.6317;DENDRITIC CELL#0.6312;SULFONAMIDE#0.6305;PUMP ACTIVITY#0.6294;STEATORRHEA#0.6291;PHAGOSOMAL ACIDIFICATION#0.6286;CHLOROQUINE#0.6281;ENDOSOMAL RECYCLING COMPARTMENT#0.6273;PKG II#0.6272;GLYCOPROTEIN SECRETION#0.6263;BIOFILM FORMATION#0.6256;MIP-2 PRODUCTION#0.6245;ESTRUS#0.6239;LYSIS#0.6233;MEMBRANE FUSION#0.6232;LEVAMISOLE#0.6227;DEUBIQUITINATION#0.6217;OXIDATIVE PHOSPHORYLATION#0.6210;CLATHRIN-MEDIATED ENDOCYTOSIS#0.6204;TEAR SECRETION#0.6191;LACTIC ACID#0.6175;HYPERSENSITIVITY#0.6173;YOLK SAC#0.6169;MEMBRANE MICRODOMAIN#0.6163;PNEUMOTHORAX#0.6162;ESTROGEN RECEPTOR#0.6159;VITAMIN E#0.6154;GALL BLADDER#0.6153;ULCERATIVE COLITIS#0.6149;ZONULA OCCLUDENS#0.6144;MYELOID CELL#0.6138;RETINOIC ACID#0.6116;TISSUE REMODELING#0.6113;ENDOMETRIOSIS#0.6111;STANDARD OF CARE#0.6101;SALBUTAMOL#0.6095;BETA3 ADRENOCEPTOR#0.6066;SIGNAL TRANSDUCER#0.6061;NOSTRIL#0.6044;COLONY-STIMULATING FACTOR#0.6041;CELL DIVISION#0.6037;SURVIVAL MOTOR NEURON#0.6032;LATE GOLGI#0.6031;SUPEROXIDE DISMUTASE#0.6028;CASEIN KINASE 2#0.6025;INTESTINAL STEM CELL#0.6025;TRANSFORMING GROWTH FACTOR BETA#0.6023;UBIQUITIN LIGASE ACTIVITY#0.6014;SEVERE ACUTE PANCREATITIS#0.6004
10810	BREAST CANCER CELL#1.0836;BREAST CANCER#1.0806;CANCER CELL#1.0718;ACTIN CYTOSKELETON#1.0219;CELL MOTILITY#0.9948;WISKOTT ALDRICH SYNDROME#0.9916;PROSTATE CANCER#0.9392;ACTIN POLYMERIZATION#0.9230;CELL MIGRATION#0.8859;ACTIN CYTOSKELETON REMODELING#0.8073;TRANSCRIPTION FACTOR#0.7757;OVARIAN CANCER#0.7522;EPITHELIAL MESENCHYMAL TRANSITION#0.7325;APOPTOSIS#0.6863;CELL MOVEMENT#0.6794;SIGNALING PATHWAY#0.6646;PROTEIN KINASE#0.6090;CELL GROWTH#0.6066;CELL DEATH#0.6053;GROWTH FACTOR#0.6021
10811	NADPH OXIDASE#1.0198;REACTIVE OXYGEN SPECIES#0.9967;ROS GENERATION#0.9386;PROTEIN KINASE#0.9361;SMOOTH MUSCLE#0.9137;PLASMA MEMBRANE#0.8625;PROTEIN KINASE A#0.8108;GENE EXPRESSION#0.7931;CANCER CELL#0.7749;SMOOTH MUSCLE CELL#0.7638;MUSCLE CELL#0.7631;VASCULAR SMOOTH MUSCLE CELL#0.7471;PROTEIN KINASE C#0.7445;POLYMERASE CHAIN REACTION#0.7364;ENDOTHELIAL CELL#0.6684;EPITHELIAL CELL#0.6617;REVERSE TRANSCRIPTION#0.6023
10813	COLORECTAL CANCER#0.8544;APOPTOSIS#0.7028;COLORECTAL#0.6999;SSU PROCESSOME#0.6811;TUMOR CELLS#0.6541;LIGASE ACTIVITY#0.6120
10814	NEUROTRANSMITTER RELEASE#1.0223;SNARE COMPLEX#1.0125;EXOCYTOSIS#0.9871;HUNTINGTON'S DISEASE#0.9425;SYNAPTIC VESICLE#0.9246;GENE EXPRESSION#0.8718;N-ETHYLMALEIMIDE#0.8128;CEREBRAL CORTEX#0.8055;MAST CELL#0.8014;PLASMA MEMBRANE#0.7967;MEMBRANE FUSION#0.7857;SYNAPTIC TRANSMISSION#0.7418;VESICLE FUSION#0.6841;MEMORY IMPAIRMENT#0.6474;LONG TERM POTENTIATION#0.6415;SNARE BINDING#0.6345;EXCITATORY SYNAPSE#0.6283;PALMITOYL#0.6033
10815	SNARE COMPLEX#1.0506;NEUROTRANSMITTER RELEASE#1.0124;SYNAPTIC VESICLE#0.9966;EXOCYTOSIS#0.9937;PLASMA MEMBRANE#0.8787;VESICLE FUSION#0.7643;CEREBRAL CORTEX#0.7460;THALAMUS#0.7019;SYNAPTIC VESICLE FUSION#0.6985;N-ETHYLMALEIMIDE#0.6666;SYNAPTIC TRANSMISSION#0.6477;NERVOUS SYSTEM#0.6304;MEMORY IMPAIRMENT#0.6103
10817	FIBROBLAST GROWTH FACTOR#1.0603;GROWTH FACTOR#1.0472;GROWTH FACTOR RECEPTOR#1.0300;FACTOR RECEPTOR SUBSTRATE#0.9790;NEURITE OUTGROWTH#0.7780;DOCKING PROTEIN#0.7770;MAP KINASE#0.7145;RECEPTOR TYROSINE KINASE#0.7102;SIGNAL TRANSDUCTION#0.6493;PHOSPHOTYROSINE BINDING#0.6356;SIGNALING PATHWAY#0.6239
10818	FACTOR RECEPTOR SUBSTRATE#1.0939;DOCKING PROTEIN#1.0837;PHOSPHOTYROSINE BINDING#1.0674;MAP KINASE#1.0526;MITOGEN ACTIVATED PROTEIN#1.0152;SIGNALING PATHWAY#1.0119;SIGNALING CASCADE#1.0090;PROTEIN KINASE#1.0086;CELL PROLIFERATION#1.0078;GROWTH FACTOR RECEPTOR#1.0064;SIGNAL TRANSDUCTION#1.0032;FIBROBLAST GROWTH FACTOR#1.0025;GROWTH FACTOR#0.9936;NERVE GROWTH FACTOR#0.9936;RECEPTOR TYROSINE KINASE#0.9882;CELL CYCLE#0.9816;CANCER CELL#0.9782;NEURITE OUTGROWTH#0.9657;KINASE ACTIVITY#0.9649;SIGNALING MOLECULE#0.9530;PLASMA MEMBRANE#0.9421;EPITHELIAL CELL#0.9412;NEURITE#0.9273;ENDOTHELIAL CELL#0.9246;APOPTOSIS#0.9115;GENE EXPRESSION#0.9087;LIPOSARCOMA#0.9056;CELL GROWTH#0.9031;LIPID RAFT#0.8846;KINASE INHIBITOR#0.8803;MAPK SIGNALING#0.8726;PHOSPHOLIPASE C#0.8336;CELL DIFFERENTIATION#0.8040;JUXTAMEMBRANE#0.7925;MAPK ACTIVATION#0.7920;CELL MIGRATION#0.7911;CELL DEATH#0.7843;NEUROTROPHIN RECEPTOR#0.7720;BREAST CANCER#0.7699;SIGNALLING PATHWAY#0.7678;ONCOGENIC#0.7553;CEREBRAL CORTEX#0.7526;DNA SYNTHESIS#0.7320;ANGIOGENESIS#0.7298;LUNG CANCER#0.7293;STEM CELL#0.7274;MESODERM FORMATION#0.7176;INTRACELLULAR SIGNALING PATHWAY#0.7160;PROTEIN TYROSINE PHOSPHATASE#0.7053;ACTIVATION OF MAP KINASE#0.6914;SRC FAMILY KINASE#0.6887;PANCREATIC CANCER#0.6861;AKT SIGNALING#0.6836;SIGNALING ADAPTOR#0.6719;PROGENITOR CELL#0.6576;PROSTATE CANCER#0.6575;MORPHOGENESIS#0.6561;SMOOTH MUSCLE#0.6559;PRECURSOR CELL#0.6554;CELL MEMBRANE#0.6529;EPIDERMAL GROWTH FACTOR#0.6494;PTB DOMAIN BINDING#0.6260;INSULIN RECEPTOR#0.6109;BRANCHING MORPHOGENESIS#0.6101;PROSTATE EPITHELIAL CELL#0.6034;TYROSINE KINASE INHIBITOR#0.6023
1081	CG-BETA#1.0684;OESTRIOL#1.0578;ESTRIOL#1.0370;FSH-BETA#1.0354;HYPEREMESIS GRAVIDARUM#1.0281;EQUINE CHORIONIC GONADOTROPIN#1.0278;NEUROENDOCRINE CELL#1.0269;LUNG CANCER#1.0261;RU486#1.0249;PLASMA PROTEIN#1.0230;ADENYLYL CYCLASE ACTIVITY#1.0229;72-HOURS#1.0222;DECIDUALIZATION#1.0193;SECRETORY GRANULE#1.0189;LUTEINIZING GRANULOSA CELL#1.0186;ESTRADIOL-17BETA#1.0172;ISOPROTERENOL#1.0170;ENDOCRINE CELL#1.0170;ESTRADIOL BENZOATE#1.0166;MUSCLE CELL#1.0165;MELATONIN#1.0165;THECA INTERNA CELL#1.0160;SEMINOMA#1.0147;EARLY PREGNANCY LOSS#1.0139;ADENYLATE CYCLASE ACTIVITY#1.0136;CAMP FORMATION#1.0132;SMOOTH MUSCLE CELL#1.0129;TESTOSTERONE SECRETION#1.0129;OVARIAN CYST#1.0125;PROSTATE SPECIFIC ANTIGEN#1.0120;BUSERELIN#1.0119;CHOLERA#1.0115;THYROTOXICOSIS#1.0108;TROPHOBLASTIC NEOPLASM#1.0106;PRE-ECLAMPSIA#1.0105;PARATHYROID#1.0102;STEROID SYNTHESIS#1.0099;GESTATIONAL TROPHOBLASTIC NEOPLASIA#1.0099;TESTICULAR CANCER#1.0096;MAMMARY GLAND#1.0089;AMNIOTIC FLUID#1.0089;THECAL CELL#1.0089;RECEPTOR COMPLEX#1.0086;MOLAR#1.0085;HYPERTHYROIDISM#1.0081;CYCLASE ACTIVITY#1.0080;BREAST CANCER CELL#1.0075;GERM CELL TUMORS#1.0073;RESPONSE TO GNRH#1.0072;ECLAMPSIA#1.0069;DOWN SYNDROME#1.0067;LUTROPIN RECEPTOR#1.0065;CETRORELIX#1.0064;OVARIAN CANCER#1.0059;EXCRETION#1.0058;LECTIN#1.0057;ACTINOMYCIN D#1.0057;ADRENOCORTICOTROPIC HORMONE#1.0054;CYCLIC ADENOSINE MONOPHOSPHATE#1.0051;PRECOCIOUS PUBERTY#1.0045;BETA-2#1.0042;THYROID GLAND#1.0038;LEUPROLIDE ACETATE#1.0036;FORSKOLIN#1.0034;DECIDUAL CELL#1.0034;LEUPROLIDE#1.0033;MEMBRANE FRACTION#1.0028;AMINOGLUTETHIMIDE#1.0027;SMOOTH MUSCLE#1.0027;ADENYLATE CYCLASE#1.0026;DEHYDROEPIANDROSTERONE SULFATE#1.0025;BETA-ESTRADIOL#1.0022;ADENYLATE#1.0014;CHORIOCARCINOMA#1.0013;AROMATASE ACTIVITY#1.0011;EVERY OTHER DAY#1.0009;PROTEIN KINASE A#1.0008;ALKALINE PHOSPHATASE#1.0007;UMBILICAL CORD#1.0006;ASPARAGINE#1.0006;TAMOXIFEN#1.0006;PROGESTERONE SYNTHESIS#1.0000;DEXAMETHASONE#0.9996;ZONA PELLUCIDA#0.9990;CANCER CELL#0.9988;BREAST CANCER#0.9984;INHIBIN#0.9979;ARGININE#0.9979;PROSTATE CANCER#0.9978;OESTRUS#0.9977;ECTOPIC PREGNANCY#0.9975;MONONUCLEAR CELLS#0.9971;PROGESTERONE SECRETION#0.9970;PEPTIDE HORMONE#0.9967;GAP JUNCTION#0.9967;IN VITRO MATURED#0.9967;PLACENTATION#0.9966;CELL FUSION#0.9965;ADENOSINE MONOPHOSPHATE#0.9963;FALSE POSITIVE RATE#0.9961;OESTRADIOL#0.9959;LEYDIG CELL#0.9955;LUTEIN#0.9951;POOR OVARIAN RESPONSE#0.9951;NOREPINEPHRINE#0.9951;SYNCYTIOTROPHOBLAST#0.9948;3BETA-HYDROXYSTEROID DEHYDROGENASE#0.9947;PITUITARY ADENOMA#0.9944;CYTOTROPHOBLAST#0.9944;INTERSTITIAL CELL#0.9942;LATE PREGNANCY#0.9940;LETROZOLE#0.9939;OVARIAN DISEASE#0.9938;CAMP SYNTHESIS#0.9937;LH RECEPTOR#0.9935;INDOMETHACIN#0.9934;PLACENTAL DEVELOPMENT#0.9932;CELL MEMBRANE#0.9932;RECEPTOR BINDING#0.9930;4-ANDROSTENEDIONE#0.9928;T CELL#0.9925;TESTOSTERONE#0.9924;ANTRAL FOLLICLE COUNT#0.9924;INHIBIN SECRETION#0.9923;RANDOMISED CONTROLLED TRIAL#0.9923;YOLK SAC#0.9922;DODECYL SULFATE#0.9921;SODIUM DODECYL SULFATE#0.9921;GONAL F#0.9916;METHOTREXATE#0.9913;BROMOCRIPTINE#0.9912;ANDROGEN SECRETION#0.9912;THYROID CARCINOMA#0.9912;NEURAL TUBE DEFECT#0.9910;NEUROENDOCRINE TUMOR#0.9906;ADENOCARCINOMA#0.9905;THYMIDINE#0.9903;STROMAL CELL#0.9902;GLYCOSYLATION#0.9902;SEMINAL PLASMA#0.9901;RECEPTOR AGONIST#0.9900;TROPHOBLAST#0.9899;CYCLIC AMP#0.9897;MATERNAL SERUM MARKERS#0.9897;CRYPTORCHIDISM#0.9895;IN VITRO FERTILISATION#0.9894;COLLAGENASE#0.9894;ESTRADIOL SECRETION#0.9893;LUTEINIZATION#0.9889;VILLOUS CYTOTROPHOBLAST#0.9888;STEROID BIOSYNTHESIS#0.9888;TUMOR CELLS#0.9886;DNA SYNTHESIS#0.9885;NEURAL TUBE#0.9881;TROPHOBLAST CELL#0.9881;PROGESTIN#0.9880;CELL GROWTH#0.9878;MUTAGENESIS#0.9876;HYPOGONADOTROPIC HYPOGONADISM#0.9876;KINASE INHIBITOR#0.9874;ENZYME ACTIVITY#0.9873;LYASE ACTIVITY#0.9872;ESTRONE#0.9872;MYOMETRIUM#0.9870;UTERINE HORN#0.9869;KINASE ACTIVITY#0.9868;ADVERSE PREGNANCY OUTCOME#0.9867;TERATOMA#0.9866;OVIDUCT#0.9864;VOMITING#0.9864;PHOSPHODIESTERASE#0.9863;ESTRUS#0.9862;BETA-HYDROXYSTEROID DEHYDROGENASE#0.9860;EPITHELIAL CELL#0.9860;PROGESTERONE#0.9859;MENSTRUATION#0.9858;OVULATION#0.9858;BLOOD VESSEL#0.9857;METHIONINE#0.9855;PHOSPHODIESTERASE INHIBITOR#0.9855;PROTEIN KINASE C#0.9853;PROSTAGLANDIN E2#0.9850;FSH ACTIVITY#0.9850;MACROPHAGE#0.9849;OOCYTE MATURATION#0.9848;PERIPHERAL BLOOD#0.9847;DIGESTION#0.9846;VASOPRESSIN#0.9845;DEHYDROEPIANDROSTERONE#0.9844;CLOMIPHENE#0.9843;CELL SURFACE#0.9843;PREGNENOLONE#0.9843;PARATHYROID HORMONE#0.9843;DIETHYLSTILBESTROL#0.9842;VEGF PRODUCTION#0.9839;DNA BINDING#0.9836;LUTEOLYSIS#0.9835;PROLACTIN RECEPTOR#0.9834;ANDROSTENEDIONE#0.9833;RECEPTOR ANTAGONIST#0.9832;ANGIOGENESIS#0.9831;EPINEPHRINE#0.9830;OVARIAN CARCINOMA#0.9830;LIVE BIRTH RATE#0.9829;IMMUNE RESPONSE#0.9819;CUMULUS OOCYTE COMPLEXES#0.9817;ESTROUS CYCLE#0.9815;PROTEIN SYNTHESIS#0.9814;CELL ADHESION#0.9814;CORTISOL#0.9813;LUTEAL PHASE#0.9813;GRANULOSA CELL#0.9812;ESTRADIOL#0.9811;GERM CELL#0.9811;LOW DENSITY LIPOPROTEIN#0.9810;OOCYTE#0.9809;SEMINAL VESICLE#0.9808;SPONTANEOUS ABORTION#0.9808;RESPONSE TO GONADOTROPIN#0.9805;GERMINAL VESICLE#0.9803;SPERMATOGENESIS#0.9803;DECIDUA#0.9802;ARTERY#0.9802;ARACHIDONIC ACID#0.9802;APOPTOTIC#0.9801;SERUM ALBUMIN#0.9799;EMBRYO IMPLANTATION#0.9798;HYPERPROLACTINEMIA#0.9794;EPIDERMAL GROWTH FACTOR#0.9793;CLOMIPHENE CITRATE#0.9791;PLASMA MEMBRANE#0.9787;ADRENAL GLAND#0.9787;DIESTRUS#0.9786;PROTEIN KINASE#0.9786;TUMOR NECROSIS FACTOR#0.9786;DIHYDROTESTOSTERONE#0.9784;CONTROLLED OVARIAN STIMULATION#0.9782;MEIOSIS#0.9780;NITRIC OXIDE#0.9780;CELL CYCLE#0.9779;ABDOMINAL PAIN#0.9776;APOPTOSIS#0.9775;SINGLE EMBRYO TRANSFER#0.9772;ENDOPLASMIC RETICULUM#0.9769;OBESE#0.9769;ADENOSINE#0.9769;CELL DEATH#0.9768;VENOUS BLOOD#0.9767;INSEMINATION#0.9766;FSH SECRETION#0.9762;PROESTRUS#0.9761;CERVICAL#0.9759;CORPUS LUTEUM#0.9757;B CELL#0.9754;MALE INFERTILITY#0.9754;PHOSPHOLIPASE C#0.9751;THYROTROPIN RECEPTOR#0.9750;CELL PROLIFERATION#0.9750;LYMPH NODE#0.9746;ESTROGEN RECEPTOR#0.9744;WEIGHT GAIN#0.9744;OVARIES#0.9742;PUBERTY#0.9739;PLACENTAL SITE TROPHOBLASTIC TUMOR#0.9738;PITUITARY GLAND#0.9738;ANTI MULLERIAN HORMONE#0.9736;17BETA OESTRADIOL#0.9736;CUMULUS OOCYTE COMPLEX#0.9733;IN VITRO MATURATION#0.9732;TRANSFORMING GROWTH FACTOR BETA#0.9730;VARICOCELE#0.9728;ANOVULATION#0.9728;MECHANISM OF ACTION#0.9727;MENOPAUSE#0.9725;ENDOTHELIAL CELL#0.9723;ENDOMETRIUM#0.9722;TRIIODOTHYRONINE#0.9722;CYTOCHROME P450#0.9718;AZOOSPERMIA#0.9718;HYPOTHYROIDISM#0.9717;HORMONE BINDING#0.9717;SIGNAL TRANSDUCTION#0.9715;AMENORRHEA#0.9715;GESTATION#0.9714;GRAVES' DISEASE#0.9713;GROWTH HORMONE#0.9713;HYPOGONADISM#0.9711;17β-ESTRADIOL#0.9710;SIGNALING PATHWAY#0.9708;L-ARGININE#0.9705;ENDOTHELIAL GROWTH FACTOR#0.9704;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9704;ETHANE#0.9702;TRANSFORMING GROWTH FACTOR#0.9700;INSULIN-LIKE GROWTH FACTOR#0.9697;GROWTH FACTOR BINDING#0.9697;ENDOMETRIOSIS#0.9695;ASSISTED REPRODUCTIVE TECHNOLOGY#0.9694;ADRENERGIC RECEPTOR#0.9691;METAPHASE#0.9691;POSITIVE PREDICTIVE VALUE#0.9690;FOLLICULAR PHASE#0.9689;ANDROGEN RECEPTOR#0.9687;REVERSE TRANSCRIPTION#0.9686;ETHANOL#0.9683;COLONY-STIMULATING FACTOR#0.9681;ESTROGENS#0.9680;MENSTRUAL CYCLE#0.9680;POLYCYSTIC OVARIAN SYNDROME#0.9679;SERTOLI CELL#0.9677;EMBRYO DEVELOPMENT#0.9676;GROWTH FACTOR RECEPTOR#0.9676;GONADOTROPIN RELEASING HORMONE#0.9674;FOLLICLE STIMULATING HORMONE#0.9673;LYSOSOME#0.9672;OVARIAN HYPERSTIMULATION SYNDROME#0.9672;CYTOPLASM#0.9672;CERVIX#0.9671;CELL DIFFERENTIATION#0.9670;ASSISTED REPRODUCTIVE TECHNOLOGIES#0.9667;HORMONE SECRETION#0.9666;GONADOTROPIN SECRETION#0.9666;SPERMATOZOA#0.9666;CORTICOTROPIN#0.9663;PARTURITION#0.9659;STEROIDOGENESIS#0.9659;FIBROBLAST GROWTH FACTOR#0.9659;EXTRACELLULAR MATRIX#0.9657;MITOCHONDRIA#0.9656;OVARIAN FOLLICLE#0.9656;SEVERE PRE-ECLAMPSIA#0.9654;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9654;UTERUS#0.9652;GYNECOMASTIA#0.9652;PARTIAL HYDATIDIFORM MOLE#0.9650;RANDOMIZED CONTROLLED TRIAL#0.9647;LEUKOCYTE#0.9646;HORMONE SYNTHESIS#0.9644;TRANSCRIPTION FACTOR#0.9642;FACTOR I#0.9642;RANDOMIZED CLINICAL TRIAL#0.9642;CAMP RESPONSE ELEMENT#0.9641;STROMA#0.9639;GENE EXPRESSION#0.9638;GROWTH FACTOR#0.9633;LUTEINIZING HORMONE RECEPTOR#0.9628;DNA FRAGMENTATION#0.9627;SEMEN#0.9627;GONAD#0.9627;TRANSCRIPTASE#0.9625;PROGESTERONE BIOSYNTHESIS#0.9625;RECEPTOR SYNTHESIS#0.9624;CROWN RUMP LENGTH#0.9616;3-BETA-HSD ACTIVITY#0.9614;SPERM MOTILITY#0.9611;RNA SYNTHESIS#0.9610;ASSISTED REPRODUCTION TECHNIQUES#0.9609;DOPAMINE#0.9609;LACTATION#0.9603;REPRODUCTIVE SYSTEM#0.9603;OVARIAN#0.9602;STEM CELL#0.9602;IFN-GAMMA#0.9593;ANDROGEN BIOSYNTHESIS#0.9591;LEUCINE#0.9587;POLYMERASE CHAIN REACTION#0.9585;MEDROXYPROGESTERONE ACETATE#0.9583;5.ALPHA.-DIHYDROTESTOSTERONE#0.9581;MONOCYTE#0.9579;HYPERTENSION#0.9578;TOXICITY#0.9572;NERVOUS SYSTEM#0.9571;FALLOPIAN TUBES#0.9564;SQUAMOUS CELL CARCINOMA#0.9564;POLYCYSTIC OVARY SYNDROME#0.9562;ENDOMETRIAL EPITHELIAL CELLS#0.9561;ADRENAL HYPERPLASIA#0.9559;INFERTILE#0.9559;QUANTITATIVE REAL TIME#0.9558;DELAYED PUBERTY#0.9547;FERTILIZATION#0.9544;EMBRYONAL CARCINOMA#0.9533;WEIGHT LOSS#0.9528;BIOTIN#0.9527;RESPONSE TO TREATMENT#0.9517;ASSISTED REPRODUCTION TREATMENT#0.9517;FUNCTIONAL DIFFERENTIATION#0.9516;IMMUNOGLOBULIN G#0.9515;HYPOXIA#0.9511;MITOGEN ACTIVATED PROTEIN#0.9508;LDL RECEPTOR#0.9507;CELLULAR LOCALIZATION#0.9505;INFERTILITY#0.9497;N GLYCAN#0.9490;PSEUDOHERMAPHRODITISM#0.9486;OESTRONE#0.9481;ADRENAL CORTEX#0.9481;CUSHING'S SYNDROME#0.9475;ASCITES#0.9474;GONADOTROPHIN SECRETION#0.9463;CORD BLOOD#0.9445;ORNITHINE DECARBOXYLASE#0.9442;PERTUSSIS#0.9439;OVARIAN DEVELOPMENT#0.9435;HUMAN BREAST CANCER#0.9432;SPERMATOCYTES#0.9412;RECOMBINANT LUTEINIZING HORMONE#0.9411;NITRIC OXIDE SYNTHASE#0.9399;DIPHTHERIA#0.9397;TIMED ARTIFICIAL INSEMINATION#0.9390;RETINOIC ACID#0.9388;ALANINE#0.9382;TESTOSTERONE PROPIONATE#0.9382;NOS INHIBITOR#0.9380;TUMOUR NECROSIS FACTOR#0.9379;NEGATIVE PREDICTIVE VALUE#0.9373;LEUCINE RICH REPEAT#0.9370;GESTATIONAL CHORIOCARCINOMA#0.9361;STERILITY#0.9351;OVARIAN VEIN#0.9346;QUIESCENCE#0.9334;LIMIT OF DETECTION#0.9330;BLOOD PLASMA#0.9324;CONNECTIVE TISSUE#0.9324;ASCORBIC ACID#0.9321;LUMINAL#0.9312;BINDING PROTEIN 1#0.9310;BREAST CARCINOMA#0.9304;MAGNETIC RESONANCE IMAGING#0.9300;FACTOR S#0.9295;PROSTAGLANDIN SYNTHESIS#0.9287;ANDROGEN SYNTHESIS#0.9286;STEROID FORMATION#0.9283;STEROID METABOLISM#0.9274;IMMUNE CELL#0.9266;ENDOTHELIUM#0.9253;CISPLATIN#0.9244;HYPERANDROGENISM#0.9228;THYROID CANCER#0.9228;FIRST TRIMESTER SCREENING#0.9221;SIALYLATION#0.9220;IGF BINDING#0.9209;ADRENAL MEDULLA#0.9203;MIFEPRISTONE#0.9194;TESTICULAR DEVELOPMENT#0.9194;THYROID HORMONE RECEPTOR#0.9192;MEDROXYPROGESTERONE#0.9190;HYPOSPADIAS#0.9188;GUANINE#0.9186;BASEMENT MEMBRANE#0.9186;DIABETES MELLITUS#0.9185;TROPHECTODERM#0.9175;REGULATION OF STEROIDOGENESIS#0.9174;CELL DEVELOPMENT#0.9154;LYSINE#0.9153;PANCREATIC ISLET#0.9150;ACADEMIC MEDICAL CENTER#0.9150;CABERGOLINE#0.9136;WORLD HEALTH ORGANIZATION#0.9128;POINT OF CARE#0.9116;TRILOSTANE#0.9106;FLUTAMIDE#0.9100;LIPID DROPLET#0.9097;IMMUNE SYSTEM#0.9091;HYDROXYLASE ACTIVITY#0.9085;OESTRADIOL SECRETION#0.9074;SYNTHETIC LH-RH#0.9064;ADENYLATE CYCLASE ACTIVATION#0.9058;LEYDIG CELL TUMOR#0.9055;COLORECTAL#0.9051;HATCHING#0.9048;CELL MATURATION#0.9046;THYROTROPIN RELEASING HORMONE#0.9039;SUCROSE#0.9036;SURFACE EPITHELIUM#0.9034;FIRST POLAR BODY#0.9026;IONOPHORE#0.9014;DIMINISHED OVARIAN RESERVE#0.8995;CHORION#0.8994;T LYMPHOCYTE#0.8979;HIGH DENSITY LIPOPROTEIN#0.8977;TISSUE REMODELING#0.8974;O GLYCAN#0.8972;THYROIDITIS#0.8961;THYROXINE BINDING#0.8957;TRANSMISSION ELECTRON MICROSCOPY#0.8953;GLUCOSAMINE#0.8947;SIGNALLING PATHWAY#0.8937;OOCYTE DEVELOPMENT#0.8935;SECRETORY PATHWAY#0.8932;BLASTOCYST FORMATION#0.8932;SKELETAL MUSCLE#0.8928;PROLACTINOMA#0.8908;GLCNAC#0.8887;ASPIRIN#0.8881;ISOLATED HYPOGONADOTROPIC HYPOGONADISM#0.8877;ESTROGEN SECRETION#0.8872;KLINEFELTER'S SYNDROME#0.8865;ETOPOSIDE#0.8858;EPIDIDYMIS#0.8850;INHIBITION OF BINDING#0.8844;DIURNAL#0.8840;MULTIPLE REGRESSION ANALYSIS#0.8838;HIGH RISK PATIENTS#0.8829;MULTIPLES OF MEDIAN#0.8827;METFORMIN#0.8815;CARCINOGEN#0.8801;ROUGH ENDOPLASMIC RETICULUM#0.8796;COLLAGENASE ACTIVITY#0.8796;VERAPAMIL#0.8766;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM#0.8765;BETA ADRENERGIC RECEPTOR#0.8762;HEPARIN#0.8760;EDEMA#0.8749;BONE MARROW#0.8749;RICIN#0.8746;GERMINOMA#0.8746;CENTRAL NERVOUS SYSTEM#0.8730;ORGANELLE#0.8728;AT-17#0.8726;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8726;PLACENTAL GROWTH FACTOR#0.8710;MITOCHONDRIAL MEMBRANE#0.8707;MICROSOME#0.8683;BASAL BODY#0.8674;CHORIONIC VILLUS#0.8669;PROTEIN KINASE A SIGNALING#0.8666;ENDOCRINE SYSTEM#0.8659;PHEOCHROMOCYTOMA#0.8654;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8646;FETAL GROWTH RESTRICTION#0.8628;HISTAMINE#0.8613;S PHASE#0.8607;HYPOXIC#0.8606;BONE MORPHOGENETIC PROTEIN#0.8593;CONNEXIN#0.8591;OOCYTE GROWTH#0.8591;BLASTOCYST DEVELOPMENT#0.8586;TESTICLES#0.8566;REACTIVE OXYGEN SPECIES#0.8566;SELECTIN#0.8557;EMESIS#0.8556;MULTIPLE LOGISTIC REGRESSION#0.8553;OLIGOSPERMIA#0.8530;ISTHMUS#0.8512;CELL ADHESION MOLECULE#0.8505;CYTOCHROME P450SCC#0.8503;3-ISOBUTYL-1-METHYLXANTHINE#0.8496;AREA UNDER CURVE#0.8476;GLUTATHIONE#0.8463;ALDOSTERONE#0.8461;ANDROGEN BINDING#0.8448;PROTEIN KINASE ACTIVITY#0.8446;LINEAR REGRESSION ANALYSIS#0.8419;LUNG CARCINOMA#0.8407;TPA ACTIVITY#0.8407;ADIPOSE TISSUE#0.8403;GASTROINTESTINAL TRACT#0.8395;CORTISOL SECRETION#0.8355;BLASTOCYST IMPLANTATION#0.8351;GRANULOCYTE#0.8326;IL-1RA#0.8324;NALOXONE#0.8316;EOSIN#0.8308;TRANSACTIVATION#0.8304;SIGNALING MOLECULE#0.8286;IODINE DEFICIENCY#0.8284;ENDOCYTOSIS#0.8283;MRNA BINDING#0.8280;CAMP SIGNALING#0.8278;HORMONE BIOSYNTHESIS#0.8274;CATABOLISM#0.8273;SMALL INTESTINE#0.8272;SCROTUM#0.8252;COMPLEX I#0.8249;MAMMARY EPITHELIAL CELL#0.8248;HEMORRHAGE#0.8248;PROSTAGLANDIN E1#0.8238;ORNITHINE#0.8236;PRONUCLEUS#0.8234;SCANNING ELECTRON MICROSCOPY#0.8228;OPIOID PEPTIDE#0.8221;CYTOTOXICITY#0.8216;CHOLESTEROL TRANSPORT#0.8210;OVARIAN FOLLICLE DEVELOPMENT#0.8197;FOLLITROPIN BETA#0.8196;CELL FRACTION#0.8187;EMBRYONIC STEM CELL#0.8187;INFLAMMATORY RESPONSE#0.8165;NEUTROPHIL#0.8164;ADJUSTED ODDS RATIO#0.8163;MURAL CELL#0.8162;HUMAN EMBRYONIC KIDNEY#0.8160;BREAST CANCER PATIENTS#0.8157;EMBRYONIC KIDNEY#0.8156;EARLY EMBRYO DEVELOPMENT#0.8146;BLASTOMERE#0.8145;COAGULATION#0.8137;IN VITRO FERTILIZED#0.8131;Y CHROMOSOME#0.8120;SUPEROXIDE DISMUTASE#0.8118;MYOMETRIAL CONTRACTION#0.8113;AUTOIMMUNITY#0.8110;TUMOR SUPPRESSOR#0.8102;TWO-CELL STAGE#0.8095;PHOSPHOLIPASE A2#0.8082;HYPOPITUITARISM#0.8075;SECRETORY CELL#0.8058;PROTEIN BINDING#0.8018;UROKINASE#0.8016;RED BLOOD CELL#0.7992;ARGININE VASOPRESSIN#0.7990;AGGLUTINATION#0.7989;CONGENITAL ADRENAL HYPERPLASIA#0.7987;PROTEIN PROTEIN INTERACTION#0.7980;L-DOPA#0.7970;AGEING#0.7953;GESTATIONAL TROPHOBLASTIC NEOPLASM#0.7951;HDL BINDING#0.7942;HORMONE ACTIVITY#0.7941;INHIBITION OF APOPTOSIS#0.7938;KALLMANN SYNDROME#0.7918;INSULIN RECEPTOR#0.7908;BLOOD LOSS#0.7901;PROTEIN FOLDING#0.7895;ANDROGEN INSENSITIVITY SYNDROME#0.7888;PHOSPHATE BUFFERED SALINE#0.7888;CLOMID#0.7886;GRANULOSA CELL DIFFERENTIATION#0.7884;VITAMIN E#0.7877;NAFARELIN#0.7870;NUCLEOTIDE BINDING#0.7867;METOCLOPRAMIDE#0.7864;RECURRENT PREGNANCY LOSS#0.7864;WHITE BLOOD CELL#0.7856;STEROID DEHYDROGENASE#0.7855;G-CSF#0.7855;CALCIUM CHANNEL#0.7854;CORTICOTROPIN-RELEASING FACTOR#0.7848;RESPONSE TO HORMONE#0.7847;GUANOSINE#0.7846;FLUSHING#0.7843;SMOOTH MUSCLE ACTIN#0.7839;GRANULOSA CELL PROLIFERATION#0.7839;CHLORAMPHENICOL#0.7838;SPINAL CORD#0.7821;UTERINE ARTERY DOPPLER#0.7814;THEOPHYLLINE#0.7814;RECTUM#0.7797;DNASE#0.7771;MODE OF ACTION#0.7758;INNER MITOCHONDRIAL MEMBRANE#0.7750;ANASTROZOLE#0.7744;RESPONSE TO TRH#0.7740;GERM CELL CANCER#0.7720;SWELLING#0.7704;PROSTAGLANDIN ENDOPEROXIDE SYNTHASE#0.7704;RENIN ACTIVITY#0.7703;LEUKEMIA INHIBITORY FACTOR#0.7699;SIGNAL PEPTIDE#0.7698;REGENERATION#0.7691;ACID PHOSPHATASE#0.7682;SCAVENGER RECEPTOR#0.7681;GASTRINOMA#0.7678;COLCHICINE#0.7670;HUMAN EMBRYONIC STEM#0.7668;CYTOCHROME C#0.7667;ACT D#0.7638;KAPOSI'S SARCOMA#0.7623;TSH SECRETION#0.7610;PHOSPHODIESTERASE ACTIVITY#0.7603;CYCLOPHOSPHAMIDE#0.7599;HYPERPARATHYROIDISM#0.7594;FORMALIN#0.7586;CHOLESTEROL BIOSYNTHESIS#0.7585;QUANTITATIVE REVERSE TRANSCRIPTION#0.7575;NITRO-L-ARGININE#0.7574;CELL DIVISION#0.7554;PROPRANOLOL#0.7540;CLOMIFENE#0.7536;TESTOSTERONE ENANTHATE#0.7512;SIGNAL GENERATION#0.7508;GOLGI APPARATUS#0.7500;MEDIASTINUM#0.7467;STEROIDOGENIC FACTOR 1#0.7463;2'-DEOXYURIDINE#0.7460;COPULATION#0.7458;CELL MIGRATION#0.7458;FETAL KIDNEY#0.7450;PROPYLTHIOURACIL#0.7428;CYPROTERONE ACETATE#0.7416;LYMPH NODE METASTASES#0.7388;GENISTEIN#0.7388;NUCLEAR MEMBRANE#0.7385;EPITHELIAL OVARIAN CANCER#0.7358;PUROMYCIN#0.7351;ANTIGEN BINDING#0.7351;MICROVILLI#0.7351;PLATELET-DERIVED GROWTH FACTOR#0.7351;GTP BINDING#0.7347;MICROTUBULE#0.7344;VASOTOCIN#0.7334;RECEIVER OPERATOR CHARACTERISTIC#0.7328;DYDROGESTERONE#0.7323;MEIOTIC SPINDLE#0.7317;LOCALISATION#0.7317;ASPARTIC ACID#0.7315;GLIAL CELL#0.7302;CONJUGATION#0.7292;PRECURSOR CELL#0.7282;SIGNALING CASCADE#0.7279;MAP KINASE#0.7278;TURNER SYNDROME#0.7277;CACL2#0.7273;GNRH BINDING#0.7273;TUMOR TISSUES#0.7270;NIFEDIPINE#0.7268;ENDODERMAL SINUS TUMOR#0.7266;CIRCADIAN RHYTHM#0.7265;EGF BINDING#0.7263;GM-CSF#0.7259;PREIMPLANTATION EMBRYO DEVELOPMENT#0.7257;FREE ANDROGEN INDEX#0.7249;CONSTITUTIVELY ACTIVE MUTANT#0.7249;EXOCYTOSIS#0.7245;DENDRITIC CELL#0.7238;HORMONE RECEPTOR BINDING#0.7236;SEX CHROMOSOME#0.7234;COLORECTAL CANCER#0.7232;SPERMIOGENESIS#0.7231;VACUOLE#0.7228;HYPERSENSITIVITY#0.7222;XANTHINE#0.7218;AMNION#0.7208;GONADAL DYSGENESIS#0.7162;PAPILLARY CARCINOMA#0.7160;VINCRISTINE#0.7158;REPRODUCTIVE PROCESS#0.7149;ENDOMETRIAL CANCER#0.7149;SMOOTH ENDOPLASMIC RETICULUM#0.7142;PAPILLARY THYROID CANCER#0.7127;DUODENUM#0.7121;CHOLESTEROL METABOLISM#0.7114;PROTEIN SECRETION#0.7111;BETA CELL#0.7106;DANAZOL#0.7104;C REACTIVE PROTEIN#0.7091;ALZHEIMER'S DISEASE#0.7088;RECEPTOR DEGRADATION#0.7084;LEYDIG CELL DIFFERENTIATION#0.7068;HISTONE ACETYLATION#0.7061;PROLACTIN SECRETION#0.7055;CETRORELIX ACETATE#0.7052;TYROSINE KINASE INHIBITOR#0.7052;FINE NEEDLE ASPIRATION#0.7025;GLUTAMIC ACID#0.7021;GERMINAL EPITHELIUM#0.7002;STATISTICALLY SIGNIFICANTLY DIFFERENT#0.6978;PLACENTA ACCRETA#0.6965;CORTICAL GRANULE#0.6953;FOLIC ACID#0.6945;RESPONSE TO CAMP#0.6942;PROSTACYCLIN#0.6939;GLUTAMINE#0.6936;PERICYTE#0.6936;PEROXISOME#0.6929;VITELLOGENESIS#0.6923;TOPICAL#0.6922;GLUCOCORTICOID RECEPTOR#0.6904;STEROID HORMONE SECRETION#0.6897;ENDOTHELIAL CELL PROLIFERATION#0.6891;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.6888;CYPROTERONE#0.6886;EPITHELIOID TROPHOBLASTIC TUMOR#0.6882;SUBSTANCE P#0.6875;DYSGERMINOMA#0.6873;THYROXIN#0.6872;HYPOGLYCEMIA#0.6871;VASCULAR ENDOTHELIUM#0.6855;CRANIOPHARYNGIOMA#0.6853;GAMETOGENESIS#0.6845;HEMORRHAGIC#0.6841;VASOMOTION#0.6834;CYCLIN DEPENDENT KINASE#0.6821;PINEAL GLAND#0.6817;HYALURONAN#0.6813;MICROFILAMENT#0.6803;BLEOMYCIN#0.6787;HYPOPHYSIS#0.6786;HDL RECEPTOR#0.6778;ACETIC ACID#0.6776;ELECTROPHORETIC MOBILITY SHIFT#0.6764;GRANULOCYTE COLONY STIMULATING FACTOR#0.6755;FSH RECEPTOR BINDING#0.6736;CELL ACTIVATION#0.6732;THYROTOXIC#0.6731;OPIOID RECEPTOR#0.6724;THYROID NODULE#0.6719;GROWTH DIFFERENTIATION FACTOR#0.6712;EPITHELIAL OVARIAN CARCINOMA#0.6710;PANCREATIC CANCER#0.6707;SMALL CELL CARCINOMA#0.6707;END OF TREATMENT#0.6690;MATURE TERATOMA#0.6687;RECEPTOR ACTIVITY#0.6671;LUCIFERASE ACTIVITY#0.6667;ENHANCER BINDING PROTEIN#0.6667;MAPK SIGNALING#0.6666;TERMINAL DIFFERENTIATION#0.6663;ENHANCER BINDING#0.6662;MITOSIS#0.6652;FLUORESCEIN#0.6648;HYPOXIA INDUCIBLE FACTOR#0.6647;PREMATURE OVARIAN FAILURE#0.6647;PROTEIN KINASE INHIBITOR#0.6646;INDUCTION OF APOPTOSIS#0.6644;ADENOHYPOPHYSIS#0.6643;NEURITE#0.6641;HYDROXYUREA#0.6633;PARATHYROID GLAND#0.6618;SODIUM NITROPRUSSIDE#0.6618;PLASMINOGEN ACTIVATOR ACTIVITY#0.6609;OESTRADIOL R#0.6601;PENTOBARBITAL#0.6599;CETROTIDE#0.6579;ORNITHINE DECARBOXYLASE ACTIVITY#0.6577;RESPONSE TO FORSKOLIN#0.6570;OUABAIN#0.6569;ADENINE#0.6566;GLYCINE#0.6535;ESTRADIOL VALERATE#0.6531;DNA REPAIR#0.6529;LOW BIRTH WEIGHT#0.6525;CAMP RESPONSE ELEMENT BINDING#0.6516;GLASSY CARBON ELECTRODE#0.6515;NF-KAPPAB ACTIVATION#0.6510;PROSTATE ADENOCARCINOMA#0.6509;RESPONSE TO LUTEINIZING HORMONE#0.6500;HABITUAL ABORTION#0.6492;TERBUTALINE#0.6485;DECARBOXYLASE ACTIVITY#0.6483;UMBILICAL VEIN#0.6473;PARENCHYMA#0.6458;CELLULAR COMPONENT#0.6441;HISTONE MODIFICATION#0.6430;VITAMIN C#0.6429;PROPHASE#0.6423;FUNCTIONAL LUTEOLYSIS#0.6418;GESTATIONAL DIABETES#0.6415;ACROSOME#0.6415;GOITER#0.6411;DNASE I#0.6395;LEIOMYOMA#0.6385;PEAK SYSTOLIC VELOCITY#0.6379;PROGESTERONE FORMATION#0.6379;FETAL LIVER#0.6378;PHENYLEPHRINE#0.6366;MENOTROPINS#0.6366;TESTOLACTONE#0.6359;NATURAL KILLER CELL#0.6357;ARIMIDEX#0.6356;PROGRAMMED CELL DEATH#0.6354;FSH-B#0.6352;RECEPTOR LIGAND#0.6351;OVARIAN SURFACE EPITHELIUM#0.6322;SULPIRIDE#0.6315;ISLET CELL TUMOR#0.6308;ESTROGEN SYNTHESIS#0.6305;NODULAR#0.6301;JUGULAR VEIN#0.6300;IMPOTENCE#0.6300;RIBOSOME#0.6284;SKIN FIBROBLASTS#0.6271;ARGININE VASOTOCIN#0.6258;STEROID BINDING#0.6257;CONTACT SITE#0.6255;OVARIAN CORTEX#0.6248;ANCHORING#0.6247;MECHANISMS OF ACTION#0.6243;ADENOSQUAMOUS CARCINOMA#0.6243;DIABETES INSIPIDUS#0.6238;INSULINOMA#0.6232;CONTROL GROUP 1#0.6209;TRANSITIONAL CELL CARCINOMA#0.6203;ASPARTATE#0.6193;LOW DOSE ASPIRIN#0.6189;LASER SCANNING MICROSCOPY#0.6188;OOGENESIS#0.6185;ADRENAL ADENOMA#0.6169;PITUITARY DWARFISM#0.6168;RECEPTOR TYROSINE KINASE#0.6167;ANGIOTENSIN CONVERTING ENZYME#0.6165;FIBRINOGEN#0.6159;INNER CELL MASS#0.6156;CYTOCHROME P-450SCC#0.6154;HEPATITIS B#0.6148;PREMATURE MENOPAUSE#0.6144;SERUM LEPTIN LEVEL#0.6128;GOLGI COMPLEX#0.6127;ETHINYL ESTRADIOL#0.6127;PYRUVIC ACID#0.6109;GOSERELIN#0.6096;EDWARDS SYNDROME#0.6088;ADENYLATE CYCLASE ACTIVATOR#0.6078;HEPATOCYTE GROWTH FACTOR#0.6068;HISTOGENESIS#0.6059;HUMAN SERUM ALBUMIN#0.6058;NTPASE ACTIVITY#0.6055;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6051;COENZYME A#0.6039;HYPOXANTHINE#0.6033;GLUCOSE METABOLISM#0.6028;OVARIAN DYSFUNCTION#0.6027;PLASMIN ACTIVITY#0.6026;ALPHA MANNOSIDASE#0.6021;3'-5'-CYCLIC ADENOSINE MONOPHOSPHATE#0.6013;AUTOIMMUNE DISEASE#0.6012
10824	HYPOXIA#0.6459
10825	PLASMA MEMBRANE#1.0403;SIALIDASE ACTIVITY#1.0384;APOPTOSIS#1.0373;CANCER CELL#1.0303;COLON CANCER#1.0274;CELL SURFACE#1.0143;GROWTH FACTOR#0.9996;NEUROBLASTOMA#0.9909;CELL GROWTH#0.9721;EPIDERMAL GROWTH FACTOR#0.9720;GANGLIOSIDE DEGRADATION#0.9565;LYSOSOMAL MEMBRANE#0.9464;CELL DIFFERENTIATION#0.9372;SIGNALING PATHWAY#0.9286;GROWTH FACTOR RECEPTOR#0.9201;T CELL#0.9172;SKELETAL MUSCLE#0.9093;CELL PROLIFERATION#0.8895;CELL ADHESION#0.8737;GENE EXPRESSION#0.8696;MEMBRANE FRACTION#0.8143;SIALYLATION#0.7955;LYSOSOME#0.7722;ENZYME ACTIVITY#0.7676;ETHANOL#0.7644;CATABOLISM#0.7574;MUSCLE CELL#0.7518;PROSTATE CANCER#0.7301;MYOBLAST#0.7288;MONOCYTE#0.7140;CELL MIGRATION#0.7110;COLON MUCOSA#0.6994;ABERRANT CRYPT FOCI#0.6983;ERYTHROCYTE#0.6968;APOPTOTIC#0.6930;BETA GALACTOSIDASE#0.6843;CELL MOTILITY#0.6819;FOCAL ADHESION#0.6805;NEURITE#0.6395;POLYMERASE CHAIN REACTION#0.6333;CELL MEMBRANE#0.6258;PERIPHERAL MEMBRANE PROTEIN#0.6208;OVARIAN CANCER#0.6122;HEXOSAMINIDASE A#0.6103;ENDOCYTOSIS#0.6036;OVARIAN#0.6002
10827	DUAL LUCIFERASE REPORTER#0.8143;REPORTER GENE ASSAY#0.8134;SQUAMOUS CELL CARCINOMA#0.8010;CELL CYCLE#0.7968;CELL PROLIFERATION#0.7958
1082	CG-BETA#1.0942;FSH-BETA#1.0123;TROPHOBLAST#0.9851;TUMOR CELLS#0.9849;GENE EXPRESSION#0.9840;POLYMERASE CHAIN REACTION#0.9564;CHORIOCARCINOMA#0.9196;CYTOTROPHOBLAST#0.8631;TRANSCRIPTION FACTOR#0.8628;GLYCOSYLATION#0.8624;RECEPTOR BINDING#0.8414;CANCER CELL#0.8408;BETA-2#0.8094;LUTEINIZING HORMONE BETA SUBUNIT#0.7412;PITUITARY ADENOMA#0.7206;FOLLICLE STIMULATING HORMONE#0.7155;SYNCYTIOTROPHOBLAST#0.7107;FSH ACTIVITY#0.6850;BREAST CANCER#0.6608;LH RECEPTOR#0.6475;CYCLIC AMP#0.6404;TROPHOBLAST CELL#0.6356;INHIBIN#0.6120;CELL FUSION#0.6063;SIGNAL TRANSDUCTION#0.6046;PITUITARY GLAND#0.6012
10840	FDH I#1.0968;FORMYLTETRAHYDROFOLATE DEHYDROGENASE#1.0933;ASTROCYTE#1.0584;HYDROLASE ACTIVITY#1.0571;TETRAHYDROFOLATE#1.0467;FOLATE METABOLISM#1.0391;CANCER CELL#1.0353;FOLATE#1.0335;FORMATE#1.0193;APOPTOSIS#1.0138;ONE CARBON METABOLISM#0.9872;GENE EXPRESSION#0.9691;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9334;C TERMINAL DOMAIN#0.9066;TUMOR SUPPRESSOR#0.9054;NEURAL TUBE#0.8866;STEM CELL#0.8820;METHIONINE#0.8317;SPINAL CORD#0.8311;FOLATE BINDING#0.8255;NEURAL TUBE DEFECT#0.8156;CENTRAL NERVOUS SYSTEM#0.7947;NERVOUS SYSTEM#0.7936;CELL CYCLE#0.7780;ETHANOL#0.7752;FORMATE OXIDATION#0.7735;HEPATOCELLULAR CARCINOMA#0.7638;GLIAL CELL#0.7600;ALANINE#0.7397;ARGININE#0.6891;HISTIDINE#0.6824;S PHASE#0.6811;TOXICITY#0.6762;DNA METHYLATION#0.6702;GLYCINE#0.6676;S-ADENOSYLMETHIONINE#0.6477;GLUTATHIONE#0.6375
10841	FOLATE#0.9374;AUTOIMMUNE HEPATITIS#0.9298;FOLATE METABOLISM#0.8883;GOLGI COMPLEX#0.8469;HISTIDINE#0.8289;MICROTUBULE#0.8022;GOLGI MEMBRANE#0.6396;HEPATOCELLULAR CARCINOMA#0.6309;MICROTUBULE BINDING#0.6288
10842	PURKINJE CELL#1.1026;PROTEIN KINASE#1.0878;PHOSPHATASE INHIBITOR#1.0271;CYCLIC AMP#0.9286;PROTEIN PHOSPHATASE 1#0.8987;PROTEIN PHOSPHATASE INHIBITOR#0.8746;AMACRINE CELL#0.8266;GUANOSINE#0.6479;SIGNALING PATHWAY#0.6308
10844	GAMMA TUBULIN COMPLEX#1.1082;TUBULIN COMPLEX#1.0991;MICROTUBULE#1.0440;SPINDLE POLE#0.9976;SPINDLE POLE BODY#0.9490;MICROTUBULE NUCLEATION#0.9168;CENTROSOME#0.8702;MICROTUBULE ORGANIZING CENTER#0.7356;CELL CYCLE#0.7257
10845	ATP BINDING#1.0438;ATP HYDROLYSIS#1.0381;CLP PROTEASE#1.0289;ZINC BINDING#1.0241;VIRULENCE#1.0105;PROTEIN UNFOLDING#0.9912;PROTEIN DEGRADATION#0.9737;CELL DIVISION#0.9700;DNA REPLICATION#0.9549;GENE EXPRESSION#0.9488;ATPASE ACTIVITY#0.9354;HEAT SHOCK PROTEIN#0.9117;STATIONARY PHASE#0.8962;MITOCHONDRIA#0.8264;CELL WALL#0.8073;MUTAGENESIS#0.8018;CELL CYCLE#0.7993;C TERMINAL DOMAIN#0.7908;PEPTIDASE ACTIVITY#0.7898;TUBERCULOSIS#0.7794;MITOCHONDRIAL MATRIX#0.7758;PROTEASE COMPLEX#0.7689;PROTEASOME#0.7618;COMPLEX I#0.7472;SEPTUM#0.7159;DNA BINDING#0.7053;TRANSCRIPTION FACTOR#0.7026;PROTEIN PROTEIN INTERACTION#0.7025;NUCLEOTIDE BINDING#0.6803;TRANSPOSITION#0.6633;ATP-DEPENDENT CLP PROTEASE#0.6421;MITOCHONDRIAL UNFOLDED PROTEIN RESPONSE#0.6416;UNFOLDED PROTEIN RESPONSE#0.6381;BIOFILM FORMATION#0.6322;LYSIS#0.6284;CELL PHYSIOLOGY#0.6202
10846	PAPAVERINE#1.0655;MEDIUM SPINY NEURONS#1.0529;POSITRON EMISSION TOMOGRAPHY#1.0477;BASAL GANGLIA#1.0418;HUNTINGTON'S DISEASE#1.0408;DOPAMINE#1.0301;PHOSPHODIESTERASE#1.0301;STRIATUM#1.0292;PARKINSON'S DISEASE#1.0276;SIGNALING PATHWAY#1.0248;ADENOSINE MONOPHOSPHATE#1.0177;GENE EXPRESSION#1.0166;CYCLIC ADENOSINE MONOPHOSPHATE#1.0159;CYCLIC NUCLEOTIDE PHOSPHODIESTERASE#1.0114;CAMP SIGNALING#1.0091;NERVOUS SYSTEM#1.0005;ADENOSINE#0.9995;CENTRAL NERVOUS SYSTEM#0.9913;SUBSTANTIA NIGRA#0.9830;BENZIMIDAZOLE#0.9827;CYCLIC GUANOSINE MONOPHOSPHATE#0.9594;GUANOSINE#0.9332;HALOPERIDOL#0.9135;CELL PROLIFERATION#0.9133;APOPTOSIS#0.9110;STRUCTURE ACTIVITY RELATIONSHIP#0.9055;NEUROTRANSMISSION#0.8991;NEURODEGENERATIVE DISEASE#0.8991;MAGNETIC RESONANCE IMAGING#0.8572;RECEPTOR ANTAGONIST#0.8424;HYPERKINETIC#0.8331;SIGNALING CASCADE#0.8316;PROTEIN KINASE#0.8278;SIGNAL TRANSDUCTION#0.8237;DOPAMINE RECEPTOR#0.8207;CYCLIC AMP#0.7913;D-AMPHETAMINE#0.7605;AMYGDALA#0.7147;COGNITION#0.7113;RECEPTOR AGONIST#0.7093;HYPERACTIVITY#0.7014;CANCER CELL#0.6851;ADIPOSE TISSUE#0.6740;GLUCOSE METABOLISM#0.6726;PREPULSE INHIBITION#0.6642;RISPERIDONE#0.6630;PHENCYCLIDINE#0.6370;SPERMATOZOA#0.6310;DOPAMINE D2 RECEPTOR#0.6276;SIGNALLING CASCADE#0.6162;L-DOPA#0.6132
10847	SWR1 COMPLEX#1.1103;CHROMATIN REMODELLING#1.0837;CHROMATIN REMODELING COMPLEX#1.0790;CHROMATIN REMODELING#1.0457;HISTONE ACETYLTRANSFERASE#1.0400;ATP-DEPENDENT CHROMATIN REMODELING#1.0218;NUCLEOSOME#1.0217;GENE EXPRESSION#0.9921;HISTONE REPLACEMENT#0.9891;TRANSCRIPTION FACTOR#0.9795;CHROMATIN REMODELLING COMPLEX#0.9371;FLOWERING#0.9214;ACTIN RELATED PROTEIN#0.9109;DNA REPAIR#0.9040;ACETYLTRANSFERASE COMPLEX#0.8496;COMPLEX I#0.8232;HISTONE CHAPERONE#0.8091;DNA BINDING#0.8071;CREB BINDING#0.8037;BUDDING#0.7965;HISTONE ACETYLTRANSFERASE COMPLEX#0.7840;CELL CYCLE#0.7803;DOUBLE STRAND BREAK#0.7797;SIGNALING PATHWAY#0.7752;HISTONE MODIFICATION#0.7504;HISTONE EXCHANGE#0.7463;HISTONE ACETYLATION#0.7348;NUA4 HISTONE ACETYLTRANSFERASE COMPLEX#0.7247;CELLULAR TRANSCRIPTION#0.6188;DNA DEMETHYLATION#0.6143;NOTCH SIGNALING PATHWAY#0.6113;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.6092;TELOMERE#0.6066;LYSINE#0.6028;INO80 COMPLEX#0.6026;HETEROCHROMATIN#0.6018
10848	LUNG CANCER#1.0664;CANCER CELL#1.0460;CELL PROLIFERATION#1.0270;CELL CYCLE#1.0235;APOPTOSIS#1.0198;APOPTOTIC#1.0167;SQUAMOUS CELL CARCINOMA#0.9997;BREAST CANCER#0.9858;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9779;LYMPHOCYTIC LEUKEMIA#0.9774;CELL CYCLE ARREST#0.9730;B CELL#0.9722;CELL GROWTH#0.9656;DNA REPAIR#0.9602;COLORECTAL CANCER#0.9499;CELL DEATH#0.9321;TUMOR SUPPRESSOR#0.9150;COLORECTAL#0.9145;FLUDARABINE#0.8751;LYMPH NODE#0.8710;PERIPHERAL BLOOD#0.8576;GENE EXPRESSION#0.8558;POLYMERASE CHAIN REACTION#0.8548;CISPLATIN#0.8526;PROSTATE CANCER#0.8465;STEM CELL#0.8175;TRANSCRIPTION FACTOR#0.8173;CYTOPLASM#0.8127;HEPATOCELLULAR CARCINOMA#0.7943;G1 PHASE#0.7695;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7618;OVARIAN CANCER#0.7524;CYCLIN DEPENDENT KINASE#0.7492;PROTEIN PHOSPHATASE 1#0.7394;LYMPHOCYTE DOUBLING TIME#0.7369;BREAST CANCER CELL#0.7319;AUTOPHAGY#0.7211;TIME TO TREATMENT#0.7183;KERATINOCYTE#0.7122;RETINOIC ACID#0.7110;BONE MARROW#0.7055;ONCOGENIC#0.7007;CELL MIGRATION#0.6785;REVERSE TRANSCRIPTION#0.6769;DRUG RESISTANCE#0.6611;DESMOSOME#0.6419;SPINAL CHORDOMA#0.6327;CARDIOMYOCYTE#0.6305;SENESCENCE#0.6305;ADENOCARCINOMA#0.6266;LYMPH NODE METASTASIS#0.6122;BETA-2#0.6116;CYTOKINETIC ABSCISSION#0.6019;BASAL CELL CARCINOMA#0.6010
10849	LUNG CANCER#1.1077;DNA REPAIR#0.7499;FIBRILLAR CENTRE#0.6803;T CELL#0.6492;MULTIPLE MYELOMA#0.6394;NUCLEOLUS ORGANIZER REGION#0.6274
1084	COLON CARCINOMA#1.0582;NEUTROPHIL#1.0420;COLORECTAL CARCINOMA#1.0332;CELL SURFACE#1.0287;PHAGOCYTOSIS#1.0263;CELL ADHESION MOLECULE#1.0263;CELL ADHESION#1.0251;GRANULOCYTE#1.0246;LYMPH NODE#1.0173;ADENOCARCINOMA#1.0165;COLORECTAL#1.0152;KUPFFER CELL#1.0006;TUMOR CELLS#0.9998;CANCER CELL#0.9953;EPITHELIAL CELL#0.9949;LYMPH NODE METASTASIS#0.9911;CHOLANGIOCARCINOMA#0.9905;LUNG CANCER#0.9881;BREAST CANCER#0.9864;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9862;COLON CANCER#0.9824;HEPATOCELLULAR CARCINOMA#0.9774;SWEAT GLAND#0.9650;T CELL#0.9622;BILE DUCT#0.9564;IMMUNE RESPONSE#0.9564;POLYMERASE CHAIN REACTION#0.9400;ALKALINE PHOSPHATASE#0.9321;CYTOPLASM#0.9187;MECONIUM#0.9141;BREAST CARCINOMA#0.9063;TUMOR ASSOCIATED ANTIGEN#0.9026;IFN-GAMMA#0.9008;LUNG CARCINOMA#0.8935;MACROPHAGE#0.8644;PERIPHERAL BLOOD#0.8520;HOST CELL#0.8429;OVARIAN#0.8341;TUMOR TISSUES#0.8284;BACTERIAL BINDING#0.8256;SQUAMOUS CELL CARCINOMA#0.8132;CELL MEMBRANE#0.8120;MEDULLARY CARCINOMA#0.8103;B CELL#0.8034;ALVEOLAR MACROPHAGE#0.7969;COLORECTAL LIVER METASTASES#0.7960;FORMALIN#0.7641;LEUKOCYTE#0.7614;ENDOTHELIAL CELL#0.7561;BLOOD PLASMA#0.7490;LIVER DISEASE#0.7425;IMMUNE SYSTEM#0.7410;BILIARY TRACT#0.7379;PHOSPHOLIPASE C#0.7281;GASTROINTESTINAL TRACT#0.7279;BONE MARROW#0.7220;LIVER METASTASIS#0.7141;GROWTH FACTOR#0.7136;SODIUM DODECYL SULFATE#0.6985;DODECYL SULFATE#0.6984;COLON ADENOCARCINOMA#0.6970;BLADDER CARCINOMA#0.6829;LYMPH NODE DISSECTION#0.6792;TERMINAL DIFFERENTIATION#0.6726;GROWTH FACTOR RECEPTOR#0.6694;GENE EXPRESSION#0.6663;INFLAMMATORY RESPONSE#0.6503;COLORECTAL CANCER#0.6469;CHOLANGITIS#0.6351;LIVER CANCER#0.6326;LYMPHOID CELL#0.6302;CERVICAL#0.6293;PORTAL VEIN#0.6286;CYTOTOXICITY#0.6276;SIGNAL TRANSDUCTION#0.6276;COLORECTAL ADENOCARCINOMA#0.6270;PRIMARY SCLEROSING CHOLANGITIS#0.6266;SCLEROSING CHOLANGITIS#0.6256;CELL PROLIFERATION#0.6256;APOCRINE GLAND#0.6210;PANCREATIC CANCER#0.6195;BREAST CANCER PATIENTS#0.6193;MEMBRANE MICRODOMAIN#0.6157;ANTIGEN BINDING#0.6119;DIGESTIVE TRACT#0.6115;DIGESTION#0.6098;THYROID CARCINOMA#0.6052;HUMAN UMBILICAL VEIN#0.6051;UMBILICAL VEIN#0.6049;SEBACEOUS GLAND#0.6030;C REACTIVE PROTEIN#0.6007
10850	ASPARTATE#1.0475;ALANINE#1.0462;ALKALINE PHOSPHATASE#1.0388;KERATINOCYTE#1.0356;MINERALIZATION#1.0252;ACID PHOSPHATASE#1.0250;PSORIASIS#1.0249;ATOPIC DERMATITIS#1.0137;DERMATITIS#1.0119;CONTACT DERMATITIS#1.0113;COLLAGEN TYPE I#1.0112;T CELL#1.0106;CHEMOTAXIS#1.0103;TRANSCRIPTION FACTOR#1.0089;ALIZARIN RED STAINING#1.0058;BONE MORPHOGENETIC PROTEIN#1.0053;OSTEOBLAST DIFFERENTIATION#1.0045;CHEMOKINE RECEPTOR#1.0022;ALIZARIN RED S#0.9982;SKIN DISEASE#0.9967;OSTEOBLAST#0.9967;POLYMERASE CHAIN REACTION#0.9965;TUMOR NECROSIS FACTOR#0.9941;RECEPTOR ACTIVATOR#0.9916;OSTEOGENESIS#0.9903;GENE EXPRESSION#0.9901;PARATHYROID HORMONE#0.9887;GROWTH FACTOR#0.9882;MACROPHAGE#0.9844;CELL PROLIFERATION#0.9810;OSTEOCLAST#0.9806;STROMAL CELL#0.9801;IMMUNE RESPONSE#0.9792;MEMORY T CELL#0.9782;BONE FORMATION#0.9752;APOPTOSIS#0.9743;BONE MARROW#0.9742;BONE RESORPTION#0.9727;PROTEIN KINASE#0.9724;PRO-INFLAMMATORY#0.9723;BONE MINERAL DENSITY#0.9716;PERIPHERAL BLOOD#0.9710;INFLAMMATORY RESPONSE#0.9677;NODULE FORMATION#0.9671;MESENCHYMAL STEM CELL#0.9645;SIGNALING PATHWAY#0.9644;OSTEOPOROSIS#0.9620;STEM CELL#0.9610;REVERSE TRANSCRIPTION#0.9542;LYMPH NODE#0.9513;ALLERGIC CONTACT DERMATITIS#0.9482;BONE TURNOVER MARKER#0.9456;IFN-GAMMA#0.9449;EPITHELIAL CELL#0.9431;PERIODONTAL LIGAMENT#0.9374;PARATHYROID#0.9304;REGENERATION#0.9251;QUANTITATIVE REAL TIME#0.9236;LEUKOCYTE#0.9230;TRANSFORMING GROWTH FACTOR#0.9218;TOXICITY#0.9200;CD4+ T CELL#0.9197;ENDOTHELIAL CELL#0.9165;AKT SIGNALING#0.9074;BONE REMODELING#0.9052;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9051;ENDOTHELIAL GROWTH FACTOR#0.9050;G-CSF#0.8994;GM-CSF#0.8908;T LYMPHOCYTE#0.8872;MONOCYTE#0.8860;GLUTATHIONE#0.8824;MITOGEN ACTIVATED PROTEIN#0.8793;BONE REGENERATION#0.8745;FEMUR#0.8737;DENDRITIC CELL#0.8716;SUPEROXIDE DISMUTASE#0.8709;COLONY-STIMULATING FACTOR#0.8704;HUMAN PERIODONTAL LIGAMENT#0.8670;IMMUNE CELL#0.8615;HEPATOCYTE GROWTH FACTOR#0.8564;CELL MIGRATION#0.8507;TUMOUR NECROSIS FACTOR#0.8504;BONE MARROW STROMAL#0.8495;CANCER CELL#0.8454;ECZEMA#0.8442;INSULIN-LIKE GROWTH FACTOR#0.8356;EOSINOPHIL#0.8304;CELL SURFACE#0.8268;WOUND HEALING#0.8262;MIDGUT#0.8254;CELL DIFFERENTIATION#0.8253;SQUAMOUS CELL CARCINOMA#0.8241;OSTEOCLAST DIFFERENTIATION#0.8227;STEVENS-JOHNSON SYNDROME#0.8190;TOXIC EPIDERMAL NECROLYSIS#0.8172;IMMUNE SYSTEM#0.8143;CARNITINE#0.8137;CC CHEMOKINE LIGAND#0.8122;PROGENITOR CELL#0.8072;CC CHEMOKINE RECEPTOR#0.8069;VIRULENCE#0.8035;REACTIVE OXYGEN SPECIES#0.7987;TUMOR CELLS#0.7983;CELL GROWTH#0.7929;ANGIOGENESIS#0.7907;BONE MARROW STROMAL CELL#0.7906;EXTRACELLULAR MATRIX#0.7903;SMOOTH MUSCLE#0.7896;MAPK SIGNALING#0.7877;NEUTROPHIL#0.7869;RAT BONE MARROW#0.7866;BONE DISEASE#0.7824;SALMONELLA PATHOGENICITY ISLAND#0.7777;FIBROBLAST GROWTH FACTOR#0.7774;ADIPOCYTE#0.7767;MYCOSIS FUNGOIDES#0.7737;ALLERGEN#0.7731;BREAST CANCER#0.7611;HEALTHY CONTROL SUBJECTS#0.7575;LIVER DAMAGE#0.7495;TOLL LIKE RECEPTOR#0.7450;IL-1RA#0.7440;72-HOURS#0.7432;TIBIA#0.7272;SIGNALLING PATHWAY#0.7243;MACROPHAGE INFLAMMATORY PROTEIN#0.7219;RECEPTOR LIGAND#0.7201;TERBINAFINE HYDROCHLORIDE#0.7198;MARROW STROMAL CELLS#0.7168;CORE BINDING FACTOR#0.7162;CHEMOKINE PRODUCTION#0.7088;SELECTIN#0.7054;CELL COUNTING KIT#0.7050;CYTOTOXICITY#0.7016;ENZYME ACTIVITY#0.6992;MUSCLE CELL#0.6982;NITRIC OXIDE#0.6969;MIGRATION INHIBITORY FACTOR#0.6925;EPIDERMAL GROWTH FACTOR#0.6912;MONOCYTE CHEMOTACTIC PROTEIN#0.6910;INFLAMMATORY CELL#0.6907;OSTEOBLAST PROLIFERATION#0.6863;APOPTOTIC#0.6740;SMOOTH MUSCLE CELL#0.6723;CELL ADHESION#0.6719;CELL DEATH#0.6700;LOW DENSITY LIPOPROTEIN#0.6664;BONE CELLS#0.6649;CELL CHEMOTAXIS#0.6605;SMALL INTESTINE#0.6586;MAST CELL#0.6580;DENOSUMAB#0.6570;B CELL#0.6544;HYPOXIA#0.6526;ESTRADIOL#0.6484;PROSTAGLANDIN E2#0.6463;DEXAMETHASONE#0.6324;ACTIVATED T-CELLS#0.6297;ACTIVATED T CELL#0.6294;CYTOKINE PRODUCTION#0.6270;TOPICAL#0.6227;NORMAL CONTROL GROUP#0.6219;DENTAL PULP#0.6195;HEPATOTOXICITY#0.6191;HIGH DENSITY LIPOPROTEIN#0.6184;MULTIPLE MYELOMA#0.6142;VASCULAR SMOOTH MUSCLE CELL#0.6134;GAMMA GLUTAMYLTRANSFERASE#0.6113;IL-11#0.6111;SIGNAL TRANSDUCTION#0.6104;LARVAL DEVELOPMENT#0.6007
10855	PI-88#1.0821;CERVICAL CANCER#1.0816;EARLY GROWTH RESPONSE#1.0599;BETA GLUCURONIDASE#1.0590;FACTOR XA#1.0587;HEPARANASE ACTIVITY#1.0578;GENE SILENCING#1.0551;PANCREATIC CANCER#1.0541;CERVICAL#1.0516;SQUAMOUS CELL CARCINOMA#1.0503;DIABETIC NEPHROPATHY#1.0486;PROTEINURIA#1.0472;METASTATIC MELANOMA CELLS#1.0426;MULTIPLE MYELOMA#1.0411;METASTATIC MELANOMA#1.0405;ENDOMETRIUM#1.0400;MAST CELL#1.0393;LUNG CANCER#1.0389;NEPHROPATHY#1.0377;OVARIAN CANCER#1.0374;HEPARIN SULFATE#1.0324;LYMPH NODE METASTASIS#1.0314;GLYCOCALYX#1.0310;FIBRINOGEN#1.0298;HYPOXIA#1.0279;COLON CARCINOMA#1.0276;BONE MARROW#1.0268;T LYMPHOCYTE#1.0261;MACROPHAGE#1.0252;COAGULATION#1.0250;HEPATOCELLULAR CARCINOMA#1.0249;BREAST CARCINOMA#1.0243;NEUTROPHIL#1.0242;ESOPHAGEAL CANCER#1.0240;CELL MEMBRANE#1.0230;BREAST CANCER#1.0202;SELECTIN#1.0198;T CELL#1.0187;REVERSE TRANSCRIPTION#1.0181;SEQUENCE SPECIFIC PRIMER#1.0178;WOUND HEALING#1.0175;OVARIAN#1.0167;ANGIOGENESIS#1.0161;BREAST CANCER CELL#1.0157;CYTOPLASM#1.0151;ADENOCARCINOMA#1.0146;SULFATION#1.0137;CELL MIGRATION#1.0117;INFLAMMATORY RESPONSE#1.0116;PROSTATE CANCER#1.0107;CANCER CELL#1.0106;CELL ADHESION#1.0103;TUMOR TISSUES#1.0098;LYMPH NODE#1.0092;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0092;ENDOTHELIAL GROWTH FACTOR#1.0091;GENE EXPRESSION#1.0087;HEPARIN#1.0084;SURAMIN#1.0075;ENDOMETRIAL CANCER#1.0070;TUMOR CELLS#1.0066;BASEMENT MEMBRANE#1.0064;EPITHELIAL CELL#1.0061;HEPARIN BINDING#1.0059;PANCREATIC CARCINOMA#1.0053;ENZYME ACTIVITY#1.0044;DENDRITIC CELL#1.0040;TRANSCRIPTION FACTOR#1.0039;LOW MOLECULAR WEIGHT HEPARIN#1.0024;SIGNALING MOLECULE#1.0017;EXTRACELLULAR MATRIX#1.0006;TRANSCRIPTASE#1.0004;STROMAL CELL#0.9998;RNA INTERFERENCE#0.9997;ATHEROSCLEROSIS#0.9996;CELL PROLIFERATION#0.9990;THROMBOSIS#0.9989;CELL SURFACE#0.9987;SIGNALING PATHWAY#0.9980;CORONARY ARTERY#0.9979;BLOOD VESSEL#0.9979;FIBROBLAST GROWTH FACTOR#0.9977;POLYMERASE CHAIN REACTION#0.9971;PROTEIN KINASE#0.9967;HEPARANASE COMPLEX#0.9964;COLON CANCER#0.9962;MYOCARDIAL INFARCTION#0.9960;LEUKOCYTE#0.9959;PERIPHERAL BLOOD#0.9954;SMOOTH MUSCLE#0.9949;ANTICOAGULANT ACTIVITY#0.9948;DIGESTION#0.9947;PROTEOGLYCAN#0.9931;APOPTOSIS#0.9925;IMMUNE RESPONSE#0.9921;TUMOR NECROSIS FACTOR#0.9915;GROWTH FACTOR#0.9895;CELL GROWTH#0.9891;MONOCYTE#0.9873;SMOOTH MUSCLE CELL#0.9872;ENDOTHELIAL CELL#0.9869;MUSCLE CELL#0.9861;LYSOSOME#0.9840;IMMUNE CELL#0.9840;REACTIVE OXYGEN SPECIES#0.9838;ARTERY#0.9835;GLUCOSAMINE#0.9832;GROWTH FACTOR RECEPTOR#0.9829;QUANTITATIVE REAL TIME#0.9825;ALLOIMMUNIZATION#0.9821;ENDOTHELIUM#0.9800;CORONARY ARTERY DISEASE#0.9772;GLUCURONIC ACID#0.9770;ARTERY DISEASE#0.9770;COLON ADENOCARCINOMA#0.9764;STEM CELL#0.9757;COLORECTAL#0.9731;IMMUNE SYSTEM#0.9717;VASCULAR ENDOTHELIAL CELL#0.9699;EPITHELIAL MESENCHYMAL TRANSITION#0.9678;THROMBOCYTOPENIA#0.9673;B CELL#0.9667;COLORECTAL CANCER#0.9657;CELLULAR LOCALIZATION#0.9612;MICROVASCULAR ENDOTHELIAL CELL#0.9610;NERVE GROWTH FACTOR#0.9588;EPIDERMAL GROWTH FACTOR#0.9570;LOW DENSITY LIPOPROTEIN#0.9566;UMBILICAL VEIN#0.9566;TROPHOBLAST#0.9564;DNA METHYLATION#0.9558;MORPHOGENESIS#0.9548;CELL DIFFERENTIATION#0.9538;CARDIOMYOCYTE#0.9533;HUMAN GASTRIC CARCINOMA#0.9526;EXOSOME#0.9526;MAMMARY GLAND#0.9499;OVARIAN CARCINOMA#0.9493;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9482;BLOOD COAGULATION#0.9475;KERATINOCYTE#0.9470;PURPURA#0.9468;PODOCYTE#0.9449;HUMAN UMBILICAL VEIN#0.9436;ASTROCYTE#0.9390;NERVOUS SYSTEM#0.9370;ISCHEMIA#0.9356;INFLAMMATORY CELL#0.9318;NITRIC OXIDE#0.9306;HYPERGLYCEMIA#0.9304;MODE OF ACTION#0.9279;METASTATIC BREAST CANCER#0.9264;BREAST CANCER PATIENTS#0.9263;STROMA#0.9253;FACTOR V LEIDEN#0.9232;PRO-INFLAMMATORY#0.9223;LIPOPROTEIN LIPASE#0.9197;RETINAL VEIN OCCLUSION#0.9165;GALLBLADDER#0.9144;SMC PROLIFERATION#0.9135;BLOOD GLUCOSE LEVEL#0.9098;INVASIVE CERVICAL CANCER#0.9085;ANGIOGENIC GROWTH FACTORS#0.9070;EXTRACELLULAR MATRIX COMPONENT#0.9069;ADRIAMYCIN#0.9038;PLASMA MEMBRANE#0.9017;COLLAGENASE#0.9010;HYALURONIDASE#0.9000;HERPES SIMPLEX#0.8983;SULFATE BINDING#0.8927;HEPARAN SULFATE BINDING#0.8879;ENDOSOME#0.8873;CHORIOCARCINOMA#0.8869;ESOPHAGEAL CARCINOMA#0.8850;CENTRAL NERVOUS SYSTEM#0.8839;GALLBLADDER CARCINOMA#0.8819;ADVANCED GLYCATION END#0.8803;HUMAN BREAST CANCER#0.8794;PROSTATE CARCINOMA#0.8793;FRAGMENT LENGTH POLYMORPHISM#0.8776;CELL ADHESION MOLECULE#0.8755;LYMPHANGIOGENESIS#0.8746;ATHEROSCLEROTIC#0.8723;HERPES SIMPLEX VIRUS#0.8701;HOST CELL#0.8694;AUTOPHAGY#0.8675;GASTRIC TISSUE#0.8673;AUTOIMMUNITY#0.8657;CELL DEATH#0.8636;CELL CYCLE#0.8630;HYALURONIC ACID#0.8619;HEPATOCYTE GROWTH FACTOR#0.8617;VASCULAR ENDOTHELIUM#0.8549;MONONUCLEAR CELLS#0.8540;CATALYTIC ACTIVITY#0.8533;TYPE 2 DIABETES#0.8517;HYPERSENSITIVITY#0.8492;LECTIN#0.8479;CYTOTOXICITY#0.8472;ENDOMETRIOSIS#0.8454;DIABETES MELLITUS#0.8450;PANCREATIC ADENOCARCINOMA#0.8449;OSTEOBLAST#0.8428;ALZHEIMER'S DISEASE#0.8421;GRANULOCYTE#0.8393;LUNG CARCINOMA#0.8351;GESTATION#0.8350;MACROPHAGE MIGRATION#0.8336;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8328;MITOGEN ACTIVATED PROTEIN#0.8304;FONDAPARINUX#0.8283;HYPOXIA INDUCIBLE FACTOR#0.8271;CONNECTIVE TISSUE#0.8264;BETA CELL#0.8258;ESTROGEN RECEPTOR#0.8257;IFN-GAMMA#0.8184;TUMOR ASSOCIATED ANTIGEN#0.8130;LYMPHATIC VESSEL#0.8119;MELANOMA CELL LINES#0.8107;HEAD AND NECK CANCER#0.8087;NECK CANCER#0.8086;GLOMERULAR FILTRATION#0.8074;DIABETIC RETINOPATHY#0.8042;MAPK SIGNALING#0.8026;HEPATOCELLULAR CARCINOMA CELL#0.8001;MACROPHAGE ACTIVATION#0.7998;EMBRYO IMPLANTATION#0.7962;SIGNET RING CELL#0.7907;CD4+ T CELL#0.7907;ENDOPLASMIC RETICULUM#0.7904;RENAL CELL CARCINOMA#0.7888;HEAT SHOCK FACTOR#0.7878;CELL ACTIVATION#0.7868;ENDOTHELIAL CELL PROLIFERATION#0.7856;INTERVERTEBRAL DISC#0.7840;TOXICITY#0.7820;NEPHROTIC SYNDROME#0.7783;TRANSFORMING GROWTH FACTOR#0.7776;RHEUMATOID ARTHRITIS#0.7775;CELL MOTILITY#0.7768;YEAR SURVIVAL RATE#0.7756;SIGNALLING PATHWAY#0.7751;STREPTOZOTOCIN#0.7739;ACTIVATED T LYMPHOCYTES#0.7733;TUMOR SUPPRESSOR#0.7713;GEMCITABINE#0.7701;URINARY PROTEIN#0.7686;HEPATOMA CELLS#0.7654;TYPE 1 DIABETES#0.7635;VASCULAR SMOOTH MUSCLE CELL#0.7628;LUNG METASTASIS#0.7596;SULODEXIDE#0.7587;CHONDROCYTE#0.7552;INFLAMMATORY BOWEL DISEASE#0.7540;ORAL CANCER CELL#0.7527;SKELETAL MUSCLE#0.7503;BONE FORMATION#0.7486;ENDOTHELIAL CELL MIGRATION#0.7472;KIDNEY DISEASE#0.7463;GALLBLADDER CANCER#0.7461;GLOBIN#0.7450;TISSUE REMODELING#0.7447;HAIR GROWTH#0.7436;LYSIS#0.7431;DELAYED-TYPE HYPERSENSITIVITY#0.7428;TUBE FORMATION#0.7425;ENOXAPARIN#0.7418;OSTEOCLAST#0.7401;PROGESTERONE#0.7400;ORAL SQUAMOUS CELL CARCINOMA#0.7398;LIVER CANCER#0.7387;EUKARYOTIC INITIATION FACTOR#0.7364;CATABOLISM#0.7363;PROGENITOR CELL#0.7361;FOCAL ADHESION#0.7358;GASTRIC SIGNET RING CELL ADENOCARCINOMA#0.7345;ANGIOTENSIN CONVERTING ENZYME#0.7340;MECHANISM OF ACTION#0.7335;TOLL LIKE RECEPTOR#0.7334;GRANULOSA CELL#0.7329;MOLAR#0.7320;CROHN'S DISEASE#0.7319;SIGNAL TRANSDUCTION#0.7310;BONE RESORPTION#0.7300;METASTATIC LYMPH NODE#0.7299;PROLIFERATIVE DIABETIC RETINOPATHY#0.7269;DNASE I#0.7243;COLITIS#0.7223;ANTI INFLAMMATORY DRUGS#0.7220;OBESE#0.7198;DISEASE FREE SURVIVAL#0.7193;HEMORRHAGE#0.7184;SALIVARY GLAND#0.7180;TRANSMISSION ELECTRON MICROSCOPY#0.7165;HYPOXIC#0.7125;PHOTOSYNTHESIS#0.7121;UBIQUITIN#0.7080;TUMOR NODE METASTASIS#0.7066;EXOSOME BIOGENESIS#0.7044;OVARIES#0.7044;AGGRESSIVE BEHAVIOR#0.7036;GOLGI APPARATUS#0.7034;NEUROTROPHIN RECEPTOR#0.7031;COLON EPITHELIUM#0.7021;VIRAL RELEASE#0.7007;VIRULENCE#0.7005;GRAFT VERSUS HOST#0.6999;RESPONSE TO TREATMENT#0.6994;PLATELET ACTIVATION#0.6986;GLOMERULONEPHRITIS#0.6982;ENZYME INHIBITOR#0.6977;HEAT SHOCK PROTEIN#0.6946;NEOPLASTIC TISSUES#0.6927;VASCULAR CELL#0.6912;AKT SIGNALING#0.6911;STEM CELL TRANSPLANTATION#0.6910;CORTISOL#0.6886;HYALURONAN#0.6880;SECRETORY GRANULE#0.6851;LUMINAL#0.6846;ACUTE KIDNEY INJURY#0.6833;MALIGNANT MESOTHELIOMA#0.6821;PRIMARY BREAST TUMORS#0.6819;MYELOID CELL#0.6807;VACUOLAR MEMBRANE#0.6801;CYTOTOXIC T-LYMPHOCYTE#0.6801;MEDULLOBLASTOMA#0.6796;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6731;BRANCHING MORPHOGENESIS#0.6730;NON OBESE DIABETIC#0.6720;RENAL FIBROSIS#0.6717;ADVANCED GASTRIC CANCER#0.6716;GLUCOCORTICOID RECEPTOR#0.6707;MACROPHAGE POLARIZATION#0.6695;HAIR FOLLICLE#0.6693;HEPATITIS C#0.6693;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6691;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6684;CELL NUCLEUS#0.6677;ACTIVATED T-CELLS#0.6672;ACTIN CYTOSKELETON#0.6669;ACTIVATED T CELL#0.6668;PLASMA PROTEIN#0.6664;GASTROINTESTINAL TRACT#0.6662;AORTIC ANEURYSM#0.6653;SENESCENCE#0.6643;ACUTE MYELOID LEUKEMIA#0.6638;FASTING BLOOD GLUCOSE#0.6630;NITRIC OXIDE SYNTHASE#0.6628;MYELOID LEUKEMIA#0.6624;ACUTE MYOCARDIAL INFARCTION#0.6600;VASCULAR DISEASE#0.6554;FACTOR I#0.6530;UROKINASE#0.6511;MUTAGENESIS#0.6510;AMNIOTIC FLUID#0.6509;ACUTE LUNG INJURY#0.6499;SIGNAL PEPTIDE#0.6493;REGENERATION#0.6486;HEPARIN SULFATE PROTEOGLYCAN#0.6478;CELL ASSOCIATED#0.6458;DECIDUA#0.6455;HUMAN EMBRYONIC KIDNEY#0.6447;EMBRYONIC KIDNEY#0.6443;DIAPEDESIS#0.6438;EXCRETION#0.6427;SUPEROXIDE DISMUTASE#0.6425;RED BLOOD CELL#0.6417;BLOOD BRAIN BARRIER#0.6405;APOPTOTIC#0.6370;AMELOBLASTOMA#0.6336;HEAD AND NECK CARCINOMA#0.6328;DNASE#0.6318;GLYCOSYLATION#0.6285;ENCEPHALOMYELITIS#0.6262;PLATELET AGGREGATION#0.6253;GLYCERALDEHYDE-3-PHOSPHATE#0.6253;BASAL CELL#0.6250;LYMPH NODE METASTASES#0.6243;5-AZA-2'-DEOXYCYTIDINE#0.6237;GLYCINE#0.6237;2'-DEOXYCYTIDINE#0.6232;LIVER CIRRHOSIS#0.6227;OVERALL SURVIVAL RATE#0.6224;BINDING PROTEIN 1#0.6220;PORTAL VEIN#0.6208;VENULE#0.6200;ENDOTHELIAL NITRIC OXIDE#0.6183;LIVER METASTASIS#0.6181;ISCHEMIA REPERFUSION INJURY#0.6176;EXPERIMENTAL AUTOIMMUNE ENCEPHALITIS#0.6126;BIOTIN#0.6070;MUCOSAL MELANOMA#0.6064;SULFATASE ACTIVITY#0.6063;SOLVENT ACCESSIBLE SURFACE#0.6060;FAT PAD#0.6028;GASTRIC ADENOCARCINOMA#0.6023;PROTEASE ACTIVITY#0.6019;EPITHELIAL OVARIAN CANCER#0.6019;PERITONEAL CAVITY#0.6011;GLCNAC#0.6009
10856	R2TP COMPLEX#1.0968;DNA HELICASE#1.0538;CHROMATIN REMODELING#1.0400;HEPATOCELLULAR CARCINOMA#1.0354;SNORNP#1.0263;ATPASE ACTIVITY#1.0200;CANCER CELL#0.9795;TRANSCRIPTION FACTOR#0.9415;COMPLEX I#0.9350;GENE EXPRESSION#0.9309;CHROMATIN REMODELLING#0.9217;CELL GROWTH#0.9175;STEM CELL#0.9056;CELL CYCLE#0.9043;ATP BINDING#0.9019;CHROMATIN REMODELING COMPLEX#0.8864;APOPTOSIS#0.8842;PROTEIN PROTEIN INTERACTION#0.8841;SNORNP ASSEMBLY#0.8780;ONCOGENIC#0.8725;CELL PROLIFERATION#0.8556;DNA REPAIR#0.8192;NUCLEOTIDE BINDING#0.8017;ATP HYDROLYSIS#0.7615;INO80 CHROMATIN REMODELING COMPLEX#0.7521;DOUBLE STRAND BREAK#0.7374;HISTONE DEACETYLASE#0.7317;NUCLEOSOME#0.7186;PROTEIN KINASE#0.7164;EMBRYONIC STEM CELL#0.6980;CELL DEATH#0.6833;PROTEIN COMPLEX#0.6824;CYTOPLASM#0.6807;INO80 COMPLEX#0.6735;ATP-DEPENDENT CHROMATIN REMODELING#0.6579;DNA BINDING#0.6535;HISTONE ACETYLTRANSFERASE#0.6436;TELOMERASE REVERSE TRANSCRIPTASE#0.6431;CHROMATIN REMODELLING COMPLEX#0.6403;SENESCENCE#0.6387;SIGNALING PATHWAY#0.6326;TELOMERASE ACTIVITY#0.6320;HEAT SHOCK PROTEIN#0.6311;SMALL NUCLEOLAR RIBONUCLEOPROTEIN#0.6262;TELOMERE#0.6217;MITOSIS#0.6034
108570035	BREAST CANCER#1.0640;SIGNALING PATHWAY#1.0082;CANCER CELL#0.9930;TUMOR TISSUES#0.7514;POLYMERASE CHAIN REACTION#0.7508;APOPTOSIS#0.7431;CELL PROLIFERATION#0.7422;COLONY FORMATION ASSAY#0.6824;DISEASE FREE SURVIVAL#0.6747;BREAST CANCER CELL#0.6712;QUANTITATIVE REAL TIME#0.6693;DOUBLE STRAND BREAK#0.6628;P53 SIGNALING PATHWAY#0.6372;ADJACENT NORMAL TISSUE#0.6232;CERVICAL CANCER#0.6169;AKT SIGNALING#0.6161;GLUCOSE METABOLISM#0.6145;ACUTE MYELOID LEUKEMIA#0.6143;BREAST CANCER PATIENTS#0.6138;MYELOID LEUKEMIA#0.6122;OVARIAN CANCER#0.6117;PROSTATE CANCER#0.6096
10857	GRANULOSA CELL#1.0603;OVARIAN CANCER#1.0555;BREAST CANCER CELL#1.0518;ESTROUS CYCLE#1.0450;BREAST CANCER#1.0438;PROGESTIN#1.0426;PROGESTERONE#1.0371;CANCER CELL#1.0338;PLASMA MEMBRANE#1.0318;MRNA BINDING#1.0241;OOCYTE#1.0221;ESTROGEN RECEPTOR#1.0214;APOPTOSIS#1.0196;OVARIAN#1.0190;GROWTH FACTOR#1.0169;GENE EXPRESSION#1.0165;CYTOCHROME P450#1.0142;BINDING PROTEIN 1#1.0130;CELL PROLIFERATION#1.0122;APOPTOTIC#1.0019;CELL DEATH#0.9958;ESTRADIOL#0.9941;CYTOCHROME B5#0.9907;MEMBRANE PROGESTIN RECEPTOR#0.9840;RNA BINDING PROTEIN#0.9772;RNA BINDING#0.9754;CELL CYCLE#0.9733;ENDOMETRIUM#0.9671;OOCYTE MATURATION#0.9532;HEME BINDING#0.9524;EPITHELIAL CELL#0.9469;TRANSCRIPTION FACTOR#0.9357;OVARIES#0.9356;CORPUS LUTEUM#0.9350;CELL SURFACE#0.9347;CHOLESTEROL SYNTHESIS#0.9293;BREAST CANCER PATIENTS#0.9207;NERVOUS SYSTEM#0.9199;PREMATURE OVARIAN FAILURE#0.9015;CELL MEMBRANE#0.8991;MENSTRUAL CYCLE#0.8960;MYOMETRIUM#0.8731;OVIDUCT#0.8722;STEROID BINDING#0.8675;MITOSIS#0.8673;UTERUS#0.8666;PROTEIN COMPLEX#0.8643;CELLULAR LOCALIZATION#0.8624;EPIDERMAL GROWTH FACTOR#0.8568;GROWTH FACTOR RECEPTOR#0.8458;ENDOPLASMIC RETICULUM#0.8414;MEDROXYPROGESTERONE ACETATE#0.8253;LUTEAL PHASE#0.8253;HUMAN BREAST CANCER#0.8194;OVULATION#0.8177;CELL MIGRATION#0.8139;DRUG METABOLISM#0.8137;SIGNAL TRANSDUCTION#0.8123;PROTEIN KINASE#0.8100;AMNION#0.8099;T CELL#0.8089;RECEPTOR BINDING#0.8075;ALZHEIMER'S DISEASE#0.7993;DRUG RESISTANCE#0.7918;LUNG CANCER#0.7880;DOXORUBICIN#0.7860;POLYMERASE CHAIN REACTION#0.7797;CYTOPLASM#0.7772;SIGNALING PATHWAY#0.7760;ANDROGEN RECEPTOR#0.7746;CYTOCHROME B#0.7526;MITOTIC SPINDLE#0.7505;CHORION#0.7443;MEDROXYPROGESTERONE#0.7435;NORETHISTERONE#0.7392;NEUROPROTECTION#0.7385;METAPHASE#0.7339;RENAL CELL CARCINOMA#0.7270;ADENOCARCINOMA#0.7263;AUTOPHAGY#0.7120;ACROSOME REACTION#0.7110;STEM CELL#0.7049;OVARIAN FOLLICLE#0.6996;MEIOSIS#0.6905;CENTRAL NERVOUS SYSTEM#0.6886;HEME BINDING PROTEIN#0.6772;TRAUMATIC BRAIN INJURY#0.6662;CISPLATIN#0.6596;X CHROMOSOME#0.6544;LUMINAL#0.6536;ISTHMUS#0.6444;ENDOMETRIOSIS#0.6412;RU486#0.6235;ESTROGENS#0.6170;SQUALENE SYNTHASE#0.6134;HUMAN EMBRYONIC KIDNEY#0.6125;EMBRYONIC KIDNEY#0.6120;ENDOMETRIAL CANCER#0.6116;WATER HOMEOSTASIS#0.6111;SCHWANN CELL#0.6107;RNA INTERFERENCE#0.6079;MAP KINASE#0.6073;DRUG BINDING#0.6053;INFLAMMATORY RESPONSE#0.6028;RECEPTOR LIGAND#0.6025
10858	CHOLESTEROL 24 HYDROXYLASE#1.1006;CYTOCHROME P450#1.0405;CHOLESTEROL HOMEOSTASIS#1.0374;ALZHEIMER'S DISEASE#1.0279;EFAVIRENZ#1.0211;CHOLESTEROL METABOLISM#1.0083;TRANSCRIPTION FACTOR#1.0006;CENTRAL NERVOUS SYSTEM#0.9487;NERVOUS SYSTEM#0.9477;ATP BINDING CASSETTE#0.9350;ATP BINDING#0.9333;CHOLESTEROL SYNTHESIS#0.9177;GENE EXPRESSION#0.9132;BLOOD BRAIN BARRIER#0.9031;PRIMARY OPEN ANGLE GLAUCOMA#0.8642;OPEN ANGLE GLAUCOMA#0.8624;ATP BINDING CASSETTE TRANSPORTER#0.8411;ASTROCYTE#0.8411;VORICONAZOLE#0.8252;LIPID RAFT#0.8162;LIVER X RECEPTOR#0.8138;HUNTINGTON'S DISEASE#0.8051;CHOLESTEROL BIOSYNTHESIS#0.7663;HISTONE DEACETYLASE#0.7567;CHOLESTEROL DEGRADATION#0.7502;NEURODEGENERATIVE DISEASE#0.7456;NEURONAL CELLS#0.7378;MACROPHAGE#0.7308;MILD COGNITIVE IMPAIRMENT#0.7211;ADENO ASSOCIATED VIRUS#0.7044;COENZYME A#0.6842;GLIAL CELL#0.6643;RETINAL GANGLION CELL#0.6623;GANGLION CELLS#0.6609;MACULAR DEGENERATION#0.6431;DAYS POST INJURY#0.6216;AGE RELATED MACULAR DEGENERATION#0.6195;NEURAL RETINA#0.6105;CLOTRIMAZOLE#0.6011
10859	CELL GROWTH#1.0363;BREAST CANCER#1.0330;CELL MIGRATION#1.0325;TUMOR SUPPRESSOR#1.0303;BREAST CANCER CELL#1.0297;B CELL#1.0286;CD8+ T CELL#1.0253;CELL CYCLE#1.0233;LUNG CANCER#1.0225;LUCIFERASE ACTIVITY#1.0222;GROWTH FACTOR RECEPTOR#1.0199;EPIDERMAL GROWTH FACTOR#1.0190;REVERSE TRANSCRIPTION#1.0175;CELL CYCLE ARREST#1.0162;CELL DEATH#1.0147;CANCER CELL#1.0146;IFN-GAMMA#1.0133;SIGNALING PATHWAY#1.0112;MACROPHAGE#1.0109;QUANTITATIVE REAL TIME#1.0102;CD4+ T CELL#1.0095;CELL PROLIFERATION#1.0091;APOPTOSIS#1.0090;GROWTH FACTOR#1.0084;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0061;POLYMERASE CHAIN REACTION#1.0058;IMMUNE CELL#1.0054;LEUKOCYTE#1.0034;STEM CELL#1.0022;CELL SURFACE#0.9996;T CELL#0.9993;AUTOPHAGY#0.9970;DENDRITIC CELL#0.9958;ONCOGENIC#0.9957;CYTOTOXICITY#0.9956;T LYMPHOCYTE#0.9932;COLORECTAL CANCER#0.9920;PERIPHERAL BLOOD#0.9919;MONOCYTE#0.9912;TUMOR CELLS#0.9900;HEPATOCELLULAR CARCINOMA#0.9899;CELL ACTIVATION#0.9898;MONONUCLEAR CELLS#0.9883;CYTOKINE PRODUCTION#0.9839;HUMAN LEUKOCYTE ANTIGEN#0.9837;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9832;EPITHELIAL CELL#0.9818;NATURAL KILLER CELL#0.9809;IMMUNE RESPONSE#0.9705;MYELOID CELL#0.9671;IMMUNE SYSTEM#0.9627;GENE EXPRESSION#0.9624;RHEUMATOID ARTHRITIS#0.9624;PARKINSON'S DISEASE#0.9619;OVARIAN CANCER#0.9611;TRANSCRIPTION FACTOR#0.9579;LYMPH NODE#0.9569;TROPHOBLAST#0.9543;COLORECTAL#0.9525;SQUAMOUS CELL CARCINOMA#0.9513;PROSTATE CANCER#0.9497;ANTIGEN PRESENTING CELLS#0.9439;CELL DIFFERENTIATION#0.9431;B LYMPHOCYTE#0.9408;T CELL ACTIVATION#0.9357;BETA-2#0.9346;DUAL LUCIFERASE REPORTER#0.9303;PANCREATIC CANCER#0.9302;LYSIS#0.9301;ENDOTHELIAL CELL#0.9279;PROTEIN KINASE#0.9244;INFLAMMATORY RESPONSE#0.9196;ENDOCRINE CELL#0.9081;OVARIAN#0.8983;CYTOTOXIC T-LYMPHOCYTE#0.8912;AKT SIGNALING#0.8897;RENAL CELL CARCINOMA#0.8825;AUTOIMMUNE DISEASE#0.8707;BONE MARROW#0.8676;DNA METHYLATION#0.8642;CELL KILLING#0.8610;TROPHOBLAST CELL#0.8582;TUMOR TISSUES#0.8561;RECEPTOR COMPLEX#0.8536;QUANTITATIVE REVERSE TRANSCRIPTION#0.8457;MAPK SIGNALING#0.8452;HUMAN LEUCOCYTE ANTIGEN#0.8444;T CELL PROLIFERATION#0.8393;CERVICAL CANCER#0.8343;CANCER STEM CELL#0.8338;LYMPH NODE METASTASIS#0.8319;BREAST CANCER PATIENTS#0.8317;APOPTOTIC#0.8281;NERVOUS SYSTEM#0.8274;EXOSOME#0.8213;ADENOCARCINOMA#0.8172;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8134;LUPUS ERYTHEMATOSUS#0.8132;HUMAN BREAST CANCER#0.8110;MAST CELL#0.8087;INSULIN SECRETION#0.8001;LEUKOCYTE RECEPTOR COMPLEX#0.7978;LECTIN#0.7906;TOXICITY#0.7825;EFFECTOR T CELL#0.7808;PROGENITOR CELL#0.7805;CISPLATIN#0.7784;DRUG RESISTANCE#0.7784;BETA CELL#0.7681;DECIDUA#0.7527;PLASMA MEMBRANE#0.7493;NEUTROPHIL#0.7435;NEURAL STEM CELL#0.7385;INSULIN-LIKE GROWTH FACTOR#0.7381;MIRNA BINDING#0.7377;S PHASE#0.7337;TUMOR NECROSIS FACTOR#0.7304;ADJACENT NORMAL TISSUE#0.7257;DOPAMINERGIC NEURON#0.7202;EPITHELIAL MESENCHYMAL TRANSITION#0.7184;ISCHEMIA#0.7115;ANGIOGENESIS#0.7112;NUCLEIC ACID#0.7022;RNA INTERFERENCE#0.7014;SIGNALLING PATHWAY#0.6998;FOCAL ADHESION#0.6957;COLON CANCER#0.6839;SIGNAL TRANSDUCTION#0.6831;IMMATURE DENDRITIC CELL#0.6801;HUMAN DENDRITIC CELL#0.6790;INNATE IMMUNE SYSTEM#0.6769;CERVICAL#0.6751;CLEAR CELL RENAL CELL CARCINOMA#0.6738;TYPE 2 DIABETES#0.6738;FOCAL ADHESION KINASE#0.6737;TRANSFORMING GROWTH FACTOR#0.6712;INSULIN RECEPTOR#0.6704;STROMAL CELL#0.6620;VIRAL INFECTION#0.6584;EXTRACELLULAR REGION#0.6550;RELATED PROTEIN 1#0.6514;ONCOGENESIS#0.6510;INSULIN RECEPTOR SUBSTRATE#0.6499;EPSTEIN BARR VIRUS#0.6477;RECEPTOR LIGAND#0.6474;MITOGEN ACTIVATED PROTEIN#0.6438;CYTOLYSIS#0.6382;LYMPH GLAND#0.6303;CENTRAL NERVOUS SYSTEM#0.6248;GEFITINIB#0.6243;REACTIVE OXYGEN SPECIES#0.6232;LUNG ADENOCARCINOMA#0.6231;CYTOTOXIC T CELL#0.6196;PERIPHERAL BLOOD LYMPHOCYTES#0.6188;SUBSTANTIA NIGRA#0.6181;MYELOID LEUKEMIA#0.6157;REGULATORY T CELL#0.6129;AUTOIMMUNITY#0.6089;CELL MATURATION#0.6070;PULMONARY FIBROSIS#0.6041;IMMUNE EVASION#0.6008
10861	SULFATE TRANSPORT#0.9580;SULFATE HOMEOSTASIS#0.9475;OOCYTE#0.9333;OXALATE TRANSPORT#0.8647;OXALATE SECRETION#0.7762;KIDNEY PROXIMAL TUBULE#0.7197;ANION TRANSPORT#0.7187;EXCRETION#0.6962;DIASTROPHIC DYSPLASIA#0.6748;FORMATE#0.6613;NEPHROLITHIASIS#0.6196
10863	CELL PROLIFERATION#1.0766;APOPTOSIS#1.0758;GROWTH FACTOR#1.0159;LUNG CARCINOMA#1.0070;CANCER CELL#0.9966;GENE EXPRESSION#0.9904;BREAST CARCINOMA#0.9686;INSULIN-LIKE GROWTH FACTOR#0.9416;B CELL#0.9392;CELL ADHESION#0.9012;BINDING PROTEIN 3#0.8861;REVERSE TRANSCRIPTION#0.8717;LUNG CANCER#0.8701;STEM CELL#0.8680;CELL SURFACE#0.8558;COLORECTAL CANCER#0.8556;EPITHELIAL CELL#0.8522;NON-SMALL CELL LUNG CARCINOMA#0.8284;POLYMERASE CHAIN REACTION#0.8114;ALKALINE PHOSPHATASE#0.8024;LYMPH NODE#0.7985;GROWTH FACTOR BINDING#0.7801;DENTAL PULP STEM CELL#0.7664;HUMAN DENTAL PULP#0.7634;EPIDIDYMIS#0.7588;DENTAL PULP#0.7577;TISSUE GROWTH FACTOR#0.6975;COLORECTAL#0.6958;CATALYTIC ACTIVITY#0.6940;CONNECTIVE TISSUE#0.6898;T CELL#0.6812;LYMPH NODE METASTASIS#0.6418;LUNG ADENOCARCINOMA#0.6242;TOOTH DEVELOPMENT#0.6200;MESENCHYMAL CELL#0.6135;MALONATE#0.6129;EXTRACELLULAR MATRIX#0.6097;TUMOR TISSUES#0.6047;CELL DEATH#0.6028
10864	ORGANIC CATION TRANSPORTER#1.0557;ORGANIC ANION TRANSPORTER#1.0423;TAUROCHOLATE#0.9920;PRIMARY HUMAN HEPATOCYTES#0.9536;GENE EXPRESSION#0.9503;OOCYTE#0.8997;EXCRETION#0.8983;BREAST CANCER#0.8983;CLAVULANIC ACID#0.8239;KETOPROFEN#0.8170;CYTOCHROME P450#0.7901;MULTIDRUG RESISTANCE PROTEIN#0.7805;PROBENECID#0.7709;EMBRYONIC KIDNEY#0.7557;POLYMERASE CHAIN REACTION#0.7467;AMINOHIPPURATE#0.7297;ESTRONE#0.7138;HUMAN EMBRYONIC KIDNEY#0.7111;PLASMA MEMBRANE#0.6867;TOXICITY#0.6741;ESTRONE SULFATE#0.6549;DRUG TRANSPORT#0.6349;ATP BINDING CASSETTE#0.6259;ATP BINDING#0.6245;INDOMETHACIN#0.6214;OROTIC ACID#0.6210;KW-3902#0.6078;PROXIMAL TUBULE CELL#0.6061;FUROSEMIDE#0.6038
10865	RNA BINDING PROTEIN#1.0673;RNA BINDING#1.0656;T CELL#1.0191;GENE EXPRESSION#0.7963;AUTOIMMUNE DISEASE#0.7119;TRANSCRIPTION FACTOR#0.7076;RESPONSE TO LPS#0.6533;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6513;INFLAMMATORY RESPONSE#0.6452;CYTOKINE PRODUCTION#0.6411
10866	ABACAVIR#0.8806;HYPERSENSITIVITY#0.8578;HUMAN LEUKOCYTE ANTIGEN#0.6756;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6193;HEPATOCELLULAR CARCINOMA#0.6167;LEUKOCYTE#0.6077
10867	CANCER CELL#0.8389;LATE ENDOSOME#0.6233;EARLY ENDOSOME#0.6231;MEMBRANE FUSION#0.6202;5 FLUOROURACIL#0.6173
10868	UBIQUITIN SPECIFIC PROTEASE#1.0982;UBIQUITIN#1.0750;DEUBIQUITINATING ENZYME#0.9998;DEUBIQUITINATION#0.9644;DEUBIQUITINASE#0.9323;ADRENERGIC RECEPTOR#0.9037;TUMOR NECROSIS FACTOR#0.7171;CANCER CELL#0.7158;PROTEIN KINASE#0.7149;UBIQUITIN BINDING#0.6629;ANTIVIRAL RESPONSE#0.6535;PROTEIN KINASE A#0.6451;SIGNALING PATHWAY#0.6279;AUTOPHAGY#0.6011
10869	UBIQUITIN SPECIFIC PROTEASE#1.1236;DEUBIQUITINATING ENZYME#1.0905;UBIQUITIN#1.0838;SKELETAL MUSCLE#1.0545;MUSCLE ATROPHY#0.9698;ENDOPLASMIC RETICULUM#0.8191;MUSCLE WASTING#0.8016;DEUBIQUITINATION#0.7926;MUSCLE CELL#0.7646;PROTEASOME#0.7338;UNFOLDED PROTEIN RESPONSE#0.7156;DEUBIQUITINASE#0.6717;PROTEIN SYNTHESIS#0.6376;S PHASE#0.6301;CELL PROLIFERATION#0.6233;ESTROGEN RECEPTOR#0.6210
10870	CD8+ T CELL#1.0273;T CELL#1.0248;CYTOTOXICITY#1.0171;SIGNALING ADAPTOR#1.0145;SIGNALING PATHWAY#0.9929;CELL SURFACE#0.9877;NATURAL KILLER CELL#0.9732;CELL ACTIVATION#0.9472;RECEPTOR COMPLEX#0.9457;NK CELL ACTIVATION#0.8996;IMMUNE RESPONSE#0.8924;CYTOKINE PRODUCTION#0.8543;PERIPHERAL BLOOD#0.8379;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8001;TUMOR CELLS#0.7954;SIGNAL TRANSDUCTION#0.7720;MACROPHAGE#0.7645;IMMUNE SYSTEM#0.7583;IFN-GAMMA#0.7519;CANCER CELL#0.6808;CHIMERIC ANTIGEN RECEPTOR#0.6808;DENDRITIC CELL#0.6699;BONE MARROW#0.6567;SIGNALING MOLECULE#0.6374;GENE EXPRESSION#0.6358;PROTEIN TYROSINE KINASE#0.6341;LECTIN#0.6208;HEMATOPOIETIC CELL#0.6188;TRANSCRIPTION FACTOR#0.6109
10871	T CELL#0.9832;LEUKOCYTE#0.9745;MONOCYTE#0.9422;DENDRITIC CELL#0.9367;PERIPHERAL BLOOD#0.8419;CELL SURFACE#0.8364;MYELOID CELL#0.8159;MACROPHAGE#0.7725;T LYMPHOCYTE#0.7582;BASOPHIL#0.6630;B CELL#0.6540;CYTOKINE PRODUCTION#0.6519;PERIPHERAL BLOOD T-CELLS#0.6410;MAST CELL#0.6347;IMMUNOGLOBULIN RECEPTOR#0.6285;CD4+ T CELL#0.6223;IFN-GAMMA#0.6214
10873	MALIC ENZYME#1.0502;DNA HYPERMETHYLATION#0.6558;PANCREATIC CANCER#0.6364
10874	NEUROMEDIN U RECEPTOR#1.0991;INSULIN SECRETION#1.0887;ENERGY HOMEOSTASIS#1.0745;GASTROINTESTINAL TRACT#1.0647;ANORECTIC#1.0588;SPINAL CORD#1.0569;SMALL INTESTINE#1.0545;CENTRAL NERVOUS SYSTEM#1.0459;SMOOTH MUSCLE#1.0457;CANCER CELL#1.0326;NERVOUS SYSTEM#1.0295;FEEDING BEHAVIOR#1.0172;PARS TUBERALIS#1.0089;MUSCLE CONTRACTION#1.0071;SUBSTANCE P#1.0063;SIGNALING PATHWAY#1.0045;SMOOTH MUSCLE CONTRACTION#0.9974;OBESE#0.9963;GENE EXPRESSION#0.9913;UTERUS#0.9865;CIRCADIAN RHYTHM#0.9710;DOPAMINE#0.9310;BREAST CANCER#0.9172;PITUITARY GLAND#0.9003;POLYMERASE CHAIN REACTION#0.8953;PANCREATIC ISLET#0.8915;PROTEIN KINASE#0.8904;ADIPOSE TISSUE#0.8697;STRUCTURE ACTIVITY RELATIONSHIP#0.8637;RECEPTOR ANTAGONIST#0.8587;MAST CELL#0.8574;GASTRIC EMPTYING#0.8569;NOCICEPTION#0.8539;CORTICOTROPIN#0.8513;GLUCOSE HOMEOSTASIS#0.8462;ION TRANSPORT#0.8274;GI TRACT#0.8147;CORTICOTROPHIN#0.8119;RECEPTOR AGONIST#0.8032;MELATONIN#0.7785;GONADOTROPIN SECRETION#0.7696;REVERSE TRANSCRIPTION#0.7633;MEMORY IMPAIRMENT#0.7600;ARGININE#0.7499;GROWTH HORMONE#0.7484;GROWTH FACTOR#0.7358;HUMAN EMBRYONIC KIDNEY#0.7328;EMBRYONIC KIDNEY#0.7323;WEIGHT GAIN#0.7257;ACID SECRETION#0.7183;GROOMING BEHAVIOR#0.7053;LYMPHOID CELL#0.7043;GASTRIC ACID SECRETION#0.7020;URINARY BLADDER#0.6843;CELL MOTILITY#0.6819;HYPOTHALAMIC PITUITARY ADRENAL#0.6817;PROTEIN KINASE C#0.6762;T CELL#0.6709;ATROPINE#0.6595;VASOPRESSIN#0.6378;REGULATION OF FEEDING BEHAVIOR#0.6357;HIGH FAT DIET#0.6333;CORTICOTROPHIN RELEASING HORMONE#0.6247;HYPERTENSION#0.6232;TETRODOTOXIN#0.6217;REGULATION OF INSULIN SECRETION#0.6189;SOMATOSTATIN SECRETION#0.6172;BONE REMODELING#0.6148;ARGININE VASOPRESSIN#0.6120;BONE FORMATION#0.6088;GROWTH HORMONE SECRETAGOGUE#0.6045;ENTERIC NERVOUS SYSTEM#0.6012;PROLACTIN SECRETION#0.6011
10875	VIRAL HEPATITIS#1.0645;TREG CELL#1.0581;FIBRINOGEN#1.0548;DENDRITIC CELL#1.0460;IFN-GAMMA#1.0433;ENDOTHELIAL CELL#1.0421;REGULATORY T CELL#1.0419;MACROPHAGE#1.0369;APOPTOSIS#1.0321;B CELL#1.0314;T CELL#1.0294;HEPATITIS B#1.0269;PROTHROMBINASE ACTIVITY#1.0196;COAGULATION#1.0059;CELL PROLIFERATION#1.0045;PERIPHERAL BLOOD#0.9962;GENE EXPRESSION#0.9896;ACUTE PANCREATITIS#0.9872;CHRONIC HEPATITIS B#0.9830;MONONUCLEAR CELLS#0.9584;LIVER DISEASE#0.9301;VIRAL INFECTION#0.9288;SPONTANEOUS ABORTION#0.9083;TRANSCRIPTION FACTOR#0.8950;IMMUNE RESPONSE#0.8939;TUMOR NECROSIS FACTOR#0.8914;THROMBOSIS#0.8913;PANCREATITIS#0.8907;COLITIS#0.8889;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8716;MICROVASCULAR ENDOTHELIAL CELL#0.8632;HEPATOCELLULAR CARCINOMA#0.8622;T CELL PROLIFERATION#0.8609;ENDOTHELIUM#0.8219;ANGIOGENESIS#0.7995;EXPERIMENTAL AUTOIMMUNE MYOCARDITIS#0.7974;TROPHOBLAST#0.7943;PRO-INFLAMMATORY#0.7784;DECIDUA#0.7761;NUCLEOCAPSID#0.7752;CD8+ T CELL#0.7687;ISCHEMIA#0.7685;POLYMERASE CHAIN REACTION#0.7666;SIGNALING PATHWAY#0.7647;IMMUNE SUPPRESSION#0.7634;AUTOIMMUNE DISEASE#0.7540;T LYMPHOCYTE#0.7530;GENE SILENCING#0.7526;MACROPHAGE ACTIVATION#0.7224;INFLAMMATORY BOWEL DISEASE#0.7179;CYTOKINE PRODUCTION#0.7159;EPITHELIAL CELL#0.7118;MYOMETRIUM#0.6973;BONE MARROW#0.6934;HEPATITIS B VIRUS#0.6913;B CELL LYMPHOMA#0.6842;HEPATITIS C#0.6787;LEUKOCYTE#0.6753;LECTIN#0.6656;AUTOIMMUNE GLOMERULONEPHRITIS#0.6495;UTERUS#0.6406;PROTEASE ACTIVATED RECEPTOR#0.6403;CD4+ T CELL#0.6355;INFLAMMATORY CELL#0.6271;SEVERE ACUTE PANCREATITIS#0.6270;PROTEIN KINASE#0.6227;VASCULAR ENDOTHELIUM#0.6174;CD4+CD25+ REGULATORY T CELL#0.6137;BLOOD VESSEL#0.6120;TYPE 2 DIABETES#0.6101;M2 MACROPHAGE#0.6088;KUPFFER CELL#0.6018;CHRONIC SEVERE HEPATITIS#0.6004
10876	MAP KINASE ACTIVITY#0.6272;MAP KINASE#0.6032;KINASE ACTIVITY#0.6001
10877	COMPLEMENT FACTOR H#1.0333;COMPLEMENT ACTIVATION#0.9831;MACULAR DEGENERATION#0.6815;AGE RELATED MACULAR DEGENERATION#0.6499;ATYPICAL HEMOLYTIC-UREMIC SYNDROME#0.6246;HEPARIN#0.6190;HEMOLYTIC UREMIC SYNDROME#0.6185
10878	ATYPICAL HEMOLYTIC-UREMIC SYNDROME#1.0393;HEMOLYTIC UREMIC SYNDROME#1.0331;COMPLEMENT FACTOR H#1.0280;AGE RELATED MACULAR DEGENERATION#1.0074;MACULAR DEGENERATION#1.0068;COMPLEMENT ACTIVATION#0.9943;COPY NUMBER VARIATION#0.8496;ECULIZUMAB#0.7832;NEPHROPATHY#0.7563;B CELL#0.6870;PLASMA PROTEIN#0.6460;HEPARIN#0.6259;CELL ACTIVATION#0.6061;HEPATOCELLULAR CARCINOMA#0.6054
10879	CYSTATIN#0.6416;ORAL CAVITY#0.6400
1087	COLORECTAL#1.0511;COLORECTAL CANCER#1.0137;EPITHELIAL CELL#0.9192;CELL ADHESION#0.8612;POLYMERASE CHAIN REACTION#0.8575;CELL ADHESION MOLECULE#0.8496;ADENOCARCINOMA#0.7969;ENTEROCYTE#0.7688;COLORECTAL CARCINOMA#0.7192;COLORECTAL ADENOCARCINOMA#0.6468
10880	GERM CELL#0.8495
10881	SPERMATOZOA#0.7199
10882	CORTICOTROPIN-RELEASING FACTOR#1.0334;TUMOR NECROSIS FACTOR#0.9920;CORTICOTROPIN#0.9282;CLIMBING FIBER#0.6542;PURKINJE CELL#0.6391
10884	BREAST CANCER#1.0456;RIBOSOMAL PROTEIN#0.8986;ESTROGEN RECEPTOR#0.7885;APOPTOSIS#0.6262
10885	THYROID CANCER#0.8811;CANCER CELL#0.8660;CELL CYCLE#0.6706
108868751	TOWER OF LONDON#1.0898;BOSTON NAMING TEST#1.0700;SELECTIVE REMINDING TEST#1.0675;MINI MENTAL STATUS#1.0639;CONTINUOUS PERFORMANCE TEST#1.0540;CLOCK DRAWING TEST#1.0519;VERBAL FLUENCY TEST#1.0473;GERIATRIC DEPRESSION SCALE#1.0471;REGENERATION#1.0470;FRONTAL ASSESSMENT BATTERY#1.0373;TRAIL MAKING TEST#1.0329;VISUAL ANALOG SCALE#1.0260;SLEEPINESS#1.0241;BECK DEPRESSION INVENTORY#1.0184;MINI MENTAL STATE#1.0160;NEUROPSYCHOLOGICAL TEST BATTERY#1.0127;VISUAL ANALOGUE SCALE#1.0127;DISABILITY STATUS SCALE#1.0065;INFORMATION PROCESSING SPEED#1.0061;TESTOSTERONE#1.0054;LONG TERM MEMORY#1.0000;SHORT TERM MEMORY#0.9992;CHANGE FROM BASELINE#0.9887;DEPRESSION RATING SCALE#0.9850;MULTIPLE LINEAR REGRESSION#0.9849;SEDATION#0.9835;BRAIN DAMAGE#0.9819;SYSTOLIC BLOOD PRESSURE#0.9726;HUNTINGTON'S DISEASE#0.9722;DEPRESSIVE SYMPTOMS#0.9700;FRONTAL#0.9699;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9678;HYPERTENSION#0.9652;MAGNETIC RESONANCE IMAGING#0.9635;CLINICAL DEMENTIA RATING#0.9622;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9616;PARKINSON'S DISEASE#0.9613;DIFFUSION TENSOR IMAGING#0.9606;MEMORY IMPAIRMENT#0.9600;TEMPORAL LOBE#0.9599;ARTERY#0.9598;WORLD HEALTH ORGANIZATION#0.9597;TRAUMATIC BRAIN INJURY#0.9591;DISEASE ASSESSMENT SCALE#0.9586;EPILEPSY#0.9578;ALZHEIMER'S DISEASE#0.9564;MILD COGNITIVE IMPAIRMENT#0.9561;CORONARY ARTERY#0.9559;HYPERACTIVITY#0.9553;APHASIA#0.9550;MULTIPLE REGRESSION ANALYSIS#0.9537;COGNITION#0.9531;RANDOMIZED CONTROLLED TRIAL#0.9530;DEMENTIA#0.9529;MAJOR DEPRESSIVE DISORDER#0.9526;NERVOUS SYSTEM#0.9525;PHALANX#0.9514;MULTIPLE SCLEROSIS#0.9512;CENTRAL NERVOUS SYSTEM#0.9492;TYPE 2 DIABETES#0.9490;BIPOLAR DISORDER#0.9485;VISUAL PERCEPTION#0.9469;DIABETES MELLITUS#0.9465;SPATIAL WORKING MEMORY#0.9451;ATHEROSCLEROSIS#0.9430;IOWA GAMBLING TASK#0.9330;WHITE MATTER HYPERINTENSITIES#0.9279;HEALTHY CONTROL SUBJECTS#0.9189;GRAY MATTER VOLUME#0.9157;HEPATIC ENCEPHALOPATHY#0.9148;POLYDACTYLY#0.9142;CORTISOL#0.9136;DEMENTIA RATING SCALE#0.9133;DORSOLATERAL PREFRONTAL CORTEX#0.9002;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.8997;BASAL GANGLIA#0.8982;NEUROTOXIC#0.8878;MENTAL DISORDER#0.8875;MIDAZOLAM#0.8875;GENERALIZED ESTIMATING EQUATION#0.8859;OBESE#0.8854;ASSOCIATIVE LEARNING#0.8823;CLINICAL GLOBAL IMPRESSION#0.8818;CARDIOVASCULAR RISK FACTOR#0.8765;EPWORTH SLEEPINESS SCALE#0.8683;WHITE MATTER VOLUME#0.8682;DYSLEXIA#0.8671;INSOMNIA#0.8644;REGIONS OF INTEREST#0.8570;LINEAR REGRESSION ANALYSIS#0.8563;ESTRADIOL#0.8557;LINEAR MIXED EFFECTS#0.8429;WHITE MATTER LESIONS#0.8421;DIAZEPAM#0.8389;VOXEL BASED MORPHOMETRY#0.8388;SCHIZOAFFECTIVE DISORDER#0.8356;LINEAR MIXED MODEL#0.8333;TOTAL SLEEP TIME#0.8293;AUTISM SPECTRUM DISORDER#0.8239;NEURODEGENERATIVE DISEASE#0.8223;VASCULAR DISEASE#0.8186;SCHIZOPHRENIA SPECTRUM DISORDER#0.8186;HEARING LOSS#0.8128;MENOPAUSE#0.8120;AMNESIA#0.8097;SLEEP APNEA#0.8095;COGNITIVE DISORDER#0.8070;PROPOFOL#0.8038;CONFUSION ASSESSMENT METHOD#0.7989;C REACTIVE PROTEIN#0.7983;CARPAL TUNNEL SYNDROME#0.7972;HEALTHY CONTROL GROUP#0.7931;ARTERY DISEASE#0.7924;FIELD OF VIEW#0.7894;CLINICALLY ISOLATED SYNDROME#0.7858;RANDOMIZED CLINICAL TRIAL#0.7816;FOOD FREQUENCY QUESTIONNAIRE#0.7781;CORONARY ARTERY DISEASE#0.7758;THALAMUS#0.7722;INTRACLASS CORRELATION COEFFICIENT#0.7718;VASCULAR RISK FACTORS#0.7705;KIDNEY DISEASE#0.7697;METHYLPHENIDATE#0.7665;PRINCIPAL COMPONENT ANALYSIS#0.7654;BLASTEMA CELL#0.7606;BREAST CANCER#0.7604;END OF TREATMENT#0.7586;FOLATE#0.7572;CORONARY ARTERY BYPASS#0.7569;SELF REPORT QUESTIONNAIRE#0.7467;POSITRON EMISSION TOMOGRAPHY#0.7411;AGEING#0.7390;OBSTRUCTIVE SLEEP APNEA#0.7389;CARDIOVASCULAR HEALTH STUDY#0.7336;TYPE 2 DIABETES MELLITUS#0.7317;2 DIABETES MELLITUS#0.7317;CYSTATIN#0.7314;FOREARM#0.7312;SMALL VESSEL DISEASE#0.7311;DENTAL CARIES#0.7304;ANESTHETIC#0.7266;MYOCARDIAL INFARCTION#0.7255;MULTIPLE LOGISTIC REGRESSION#0.7228;ULNAR NERVE#0.7200;NEUROLOGICAL DISORDER#0.7200;HEART DISEASE#0.7152;CREATINE#0.7109;MOOD DISORDER#0.7109;INTENTION TO TREAT#0.7106;CHRONIC KIDNEY DISEASE#0.7093;GENERAL LINEAR MODEL#0.7054;DOPAMINE#0.7029;SPINAL CORD#0.7021;AND BODY COMPOSITION#0.7003;MELATONIN#0.6997;HINDLIMB#0.6978;GLOMERULAR FILTRATION#0.6932;WEIGHT LOSS#0.6923;FOLIC ACID#0.6918;GLASGOW COMA SCALE#0.6915;RANDOMISED CONTROLLED TRIAL#0.6897;HEARING IMPAIRMENT#0.6877;DROWSINESS#0.6854;ALPRAZOLAM#0.6805;CAROTID ARTERY#0.6805;WAKEFULNESS#0.6794;FIBROMYALGIA#0.6786;MULTIVARIATE LINEAR REGRESSION#0.6760;CONFIRMATORY FACTOR ANALYSIS#0.6738;MAGNETIC RESONANCE SPECTROSCOPY#0.6722;HYPERACTIVE#0.6679;GLOMERULAR FILTRATION RATE#0.6670;FUNCTIONAL INDEPENDENCE MEASURE#0.6656;SUBSTANCE ABUSE#0.6630;SERIOUS ADVERSE EVENT#0.6618;BRAIN LESIONS#0.6597;MEDIAN NERVE#0.6593;DEFAULT MODE NETWORK#0.6578;NATALIZUMAB#0.6559;DONEPEZIL#0.6521;LIMB DEVELOPMENT#0.6510;PATIENT REPORTED OUTCOME#0.6498;CHILDHOOD BRAIN TUMOR#0.6493;ANTERIOR CINGULATE CORTEX#0.6483;PERIPHERAL NERVE#0.6445;CEREBROVASCULAR DISEASE#0.6437;AGE AT ONSET#0.6426;METHADONE#0.6425;GROWTH FACTOR#0.6318;PATIENT HEALTH QUESTIONNAIRE#0.6297;LIVER CIRRHOSIS#0.6295;SOCIAL BEHAVIOUR#0.6274;CYTOCHROME P450#0.6261;POSTERIOR CINGULATE CORTEX#0.6261;STRUCTURAL EQUATION MODELING#0.6250;MODIFIED RANKIN SCALE#0.6244;PRINCIPAL COMPONENTS ANALYSIS#0.6208;ETHANOL#0.6110;HEPATITIS C#0.6055;EATING DISORDER#0.6037;MINIMAL HEPATIC ENCEPHALOPATHY#0.6005
10886	NERVOUS SYSTEM#0.8737;CENTRAL NERVOUS SYSTEM#0.7829;SPINAL CORD#0.7655;LIPOLYSIS#0.6513;RECEPTOR AGONIST#0.6480;ADIPOSE TISSUE#0.6357;FAT CELL#0.6238
10887	ENDOTHELIAL CELL#0.9974;GROWTH FACTOR#0.9931;ENDOTHELIAL GROWTH FACTOR#0.9928;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9925;PROGENITOR CELL#0.9722;ANGIOGENESIS#0.9704;SIGNALING PATHWAY#0.8947;EPITHELIAL CELL#0.8928;NERVOUS SYSTEM#0.8753;CARDIOMYOCYTE#0.8435;ENDOMETRIUM#0.8365;DECIDUA#0.8206;TROPHOBLAST#0.8024;SENSITIZATION#0.7900;MYOCARDIAL INFARCTION#0.7701;CELL PROLIFERATION#0.7694;MACROPHAGE#0.7651;SMOOTH MUSCLE#0.7230;CIRCADIAN RHYTHM#0.7190;ADIPOSE TISSUE#0.7010;NOCICEPTION#0.6745;GENE EXPRESSION#0.6537;NEURAL CREST#0.6466;HYPOXIA#0.6435;SPINAL CORD#0.6403;ADIPOCYTE#0.6377;NEUTROPHIL#0.6188
10888	T CELL#1.0141;REGULATORY T CELL#0.8084;CD4+ T CELL#0.7926;TREG CELL#0.7164;CELL DEVELOPMENT#0.6340;BASAL SIGNALING#0.6295
1088	SPECIFIC GRANULE#1.0402;EOSINOPHIL#1.0334;CELL ADHESION MOLECULE#1.0293;CELL ADHESION#1.0232;NEUTROPHIL#1.0205;MONOCYTE#1.0189;OXIDATIVE BURST#1.0175;CELL SURFACE#1.0108;GRANULOCYTE#1.0087;SECONDARY GRANULE#1.0038;NEUTROPHIL ACTIVATION#1.0026;SELECTIN#1.0004;MACROPHAGE#0.9972;PLASMA MEMBRANE#0.9931;T CELL#0.9894;ENDOTHELIAL CELL#0.9889;LEUKOCYTE#0.9853;PERIPHERAL BLOOD#0.9843;BONE MARROW#0.9794;IMMUNE CELL#0.9711;DENDRITIC CELL#0.9678;T LYMPHOCYTE#0.9647;REACTIVE OXYGEN SPECIES#0.9543;B CELL#0.9424;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.9370;PHAGOCYTOSIS#0.9348;INFLAMMATORY RESPONSE#0.9318;IMMUNE RESPONSE#0.9205;APOPTOSIS#0.9147;IMMUNE SYSTEM#0.9146;COLONY-STIMULATING FACTOR#0.9082;EPITHELIAL CELL#0.9026;MICROPARTICLE#0.9020;LEUKOCYTE ACTIVATION#0.9015;CELL ACTIVATION#0.8939;HEMOGLOBINURIA#0.8799;EXOCYTOSIS#0.8785;ERYTHROCYTE#0.8778;CD8+ T CELL#0.8769;INFLAMMATORY CELL#0.8634;POLYMORPHONUCLEAR LEUKOCYTES#0.8594;MYELOID CELL#0.8557;PRO-INFLAMMATORY#0.8443;POLYMORPHONUCLEAR NEUTROPHIL#0.8426;TUMOR CELLS#0.8270;ENDOTHELIUM#0.8262;RESPIRATORY BURST#0.8206;G-CSF#0.8180;SECRETORY VESICLE#0.8101;GENE EXPRESSION#0.7996;MYELOID-DERIVED SUPPRESSOR CELL#0.7961;NEUTROPHIL DEGRANULATION#0.7904;GM-CSF#0.7891;MONONUCLEAR CELLS#0.7803;COMPLEMENT RECEPTOR#0.7700;CELL PROLIFERATION#0.7655;SYNOVIAL FLUID#0.7514;TUMOR NECROSIS FACTOR#0.7464;STEM CELL#0.7380;HEMATOPOIETIC CELL#0.7292;B LYMPHOCYTE#0.7272;FLOW CYTOMETRY ANALYSIS#0.7258;AZUROPHIL GRANULE#0.7215;CHEMOTAXIS#0.7166;LYMPH NODE#0.7120;GRANULOCYTE COLONY STIMULATING FACTOR#0.6907;OBESE#0.6893;GROWTH FACTOR#0.6717;ADENOCARCINOMA#0.6572;CELL SURFACE ANTIGEN#0.6557;CORD BLOOD#0.6516;INNATE IMMUNE SYSTEM#0.6515;APOPTOTIC#0.6496;WHITE BLOOD CELL#0.6494;NEUTROPHIL GRANULOCYTES#0.6359;DISEASE FREE SURVIVAL#0.6322;CELL DIFFERENTIATION#0.6300;SQUAMOUS CELL CARCINOMA#0.6295;TYPE 2 DIABETES#0.6177;SIGNAL TRANSDUCTION#0.6139;LIPID RAFT#0.6100
10890	GTP BINDING#1.0609;ENDOSOME#1.0319;ENDOCYTIC RECYCLING#1.0314;PLASMA MEMBRANE#1.0149;ADIPOCYTE#1.0128;EXOCYTOSIS#0.9789;EARLY ENDOSOME#0.9714;RECYCLING ENDOSOME#0.9642;PARKINSON'S DISEASE#0.9618;CELL SURFACE#0.9543;EPITHELIAL CELL#0.9500;MEMBRANE TRANSPORT#0.9306;GUANINE#0.8890;ENDOCYTOSIS#0.8849;TRANS GOLGI NETWORK#0.8737;NUCLEOTIDE EXCHANGE FACTOR#0.8602;LEUCINE RICH REPEAT#0.8588;AXON DEVELOPMENT#0.8387;EXOCYST#0.8318;EXOCYST COMPLEX#0.8277;CELL PROLIFERATION#0.8239;NEURITE OUTGROWTH#0.8096;PROTEIN KINASE#0.8028;ENDOPLASMIC RETICULUM#0.8009;LEUCINE#0.7814;GAP ACTIVITY#0.7658;KINASE ACTIVITY#0.7555;PERIPHERAL BLOOD#0.7296;MUSCLE CELL#0.7173;TRANSPORT VESICLE#0.7139;CILIOGENESIS#0.7127;LYSOSOME#0.7057;ORGANELLE#0.6975;GLUCOSE UPTAKE#0.6903;SIGNAL TRANSDUCTION#0.6652;NEUTROPHIL#0.6546;VACUOLE#0.6447;NEURITE#0.6423;ALZHEIMER'S DISEASE#0.6293;APOPTOSIS#0.6253;SIGNALING PATHWAY#0.6177;GROWTH FACTOR#0.6165;SYNAPTIC VESICLE#0.6083;TUBULAR ENDOSOME#0.6071;CLATHRIN-MEDIATED ENDOCYTOSIS#0.6068;VESICLE TRAFFICKING#0.6052
10891	PPAR GAMMA COACTIVATOR#1.0593;ADAPTIVE THERMOGENESIS#1.0441;TRANSCRIPTION COACTIVATOR#1.0385;NUCLEAR RESPIRATORY FACTOR#1.0278;HEPATOCYTE NUCLEAR FACTOR#1.0273;MITOCHONDRIAL GENE EXPRESSION#1.0255;ADENOSINE MONOPHOSPHATE#1.0228;ESTROGEN RELATED RECEPTOR#1.0215;PALMITATE#1.0213;MUSCLE FIBER#1.0199;MITOCHONDRIAL TRANSCRIPTION#1.0196;ENDOTHELIAL CELL#1.0196;PEROXISOMAL#1.0190;PHOSPHOENOLPYRUVATE CARBOXYKINASE#1.0187;PEROXISOME#1.0187;CAMP RESPONSE ELEMENT#1.0185;NUCLEAR HORMONE RECEPTOR#1.0182;MUSCLE FIBRE#1.0173;PYRUVATE DEHYDROGENASE KINASE#1.0164;MYOCYTES#1.0157;CAMP RESPONSE ELEMENT BINDING#1.0152;GLUCOSE 6 PHOSPHATASE#1.0145;DNA METHYLATION#1.0127;TRANSACTIVATION#1.0096;TYPE 2 DIABETIC#1.0091;PHOSPHOENOLPYRUVATE#1.0089;TRANSCRIPTIONAL CONTROL#1.0086;DNA BINDING#1.0085;METFORMIN#1.0084;GLUCONEOGENESIS#1.0069;HISTONE DEACETYLASE#1.0064;MITOGEN ACTIVATED PROTEIN#1.0063;OXIDATIVE METABOLISM#1.0060;MYOBLAST#1.0054;CALCINEURIN#1.0051;ADRENERGIC RECEPTOR#1.0049;MTDNA#1.0045;CYTOCHROME C OXIDASE#1.0045;TYPE 2 DIABETES MELLITUS#1.0044;2 DIABETES MELLITUS#1.0044;HYPOXIA#1.0022;PYRUVATE#1.0017;SKELETAL MUSCLE CELLS#1.0017;CARNITINE#1.0016;HUNTINGTON'S DISEASE#1.0013;MYOTUBE#1.0008;ESTROGEN RECEPTOR#1.0002;INSULIN SECRETION#1.0002;ANGIOGENESIS#0.9994;SUPEROXIDE DISMUTASE#0.9993;LIGAND BINDING DOMAIN#0.9975;BETA CELL#0.9971;FATTY ACID OXIDATION#0.9968;ENERGY HOMEOSTASIS#0.9964;OXIDATIVE PHOSPHORYLATION#0.9961;MUSCLE CELL#0.9960;CYTOCHROME C#0.9960;TRANSCRIPTION FACTOR#0.9959;INSULIN RECEPTOR#0.9958;COENZYME A#0.9958;HYPERTENSION#0.9949;FATTY ACID METABOLISM#0.9946;RESPONSE TO EXERCISE#0.9943;ADENOSINE#0.9939;RETINOID X RECEPTOR#0.9932;PROTEIN KINASE B#0.9928;MYOCYTE ENHANCER FACTOR#0.9924;GLUCOSE UPTAKE#0.9922;AUTOPHAGY#0.9908;RESPIRATORY CHAIN#0.9904;DIABETES MELLITUS#0.9903;BROWN ADIPOSE TISSUE#0.9901;POLYMERASE CHAIN REACTION#0.9901;RESVERATROL#0.9896;RESPIRATION#0.9886;TUMOR NECROSIS FACTOR#0.9884;ADIPOCYTE#0.9873;GLUCOSE HOMEOSTASIS#0.9870;SUBCUTANEOUS ADIPOSE TISSUE#0.9869;SKELETAL MUSCLE#0.9856;MUSCLE ATROPHY#0.9849;GROWTH FACTOR#0.9847;MITOCHONDRIAL DNA#0.9843;GLUCOSE METABOLISM#0.9839;MUSCLE ADAPTATION#0.9823;LIPID METABOLISM#0.9822;PROTEIN KINASE#0.9822;CANCER CELL#0.9821;CELL PROLIFERATION#0.9809;STEROL REGULATORY ELEMENT#0.9804;NITRIC OXIDE#0.9801;CITRATE SYNTHASE ACTIVITY#0.9800;ACETYL COA CARBOXYLASE#0.9792;GENE EXPRESSION#0.9789;MITOCHONDRIAL FUSION#0.9786;APOPTOTIC#0.9774;ADIPOCYTE DIFFERENTIATION#0.9772;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9771;WHITE ADIPOSE TISSUE#0.9770;ADIPOSE TISSUE#0.9769;TYPE 2 DIABETES#0.9768;GLUTATHIONE#0.9763;SIGNALING PATHWAY#0.9763;APOPTOSIS#0.9761;NEURODEGENERATIVE DISEASE#0.9754;FATTY ACID SYNTHASE#0.9753;BREAST CANCER#0.9751;INSULIN-LIKE GROWTH FACTOR#0.9750;OBESE#0.9748;CELL DEATH#0.9748;GRANULOSA CELL#0.9743;ADIPOGENESIS#0.9743;CARDIOMYOCYTE#0.9741;FAT CELL#0.9740;FATTY LIVER#0.9724;MITOCHONDRIAL MEMBRANE#0.9723;ROSIGLITAZONE#0.9720;ENHANCER BINDING PROTEIN#0.9714;LIVER DISEASE#0.9712;ENHANCER BINDING#0.9709;LIPID OXIDATION#0.9707;DIET INDUCED OBESITY#0.9702;QUANTITATIVE REAL TIME#0.9692;FATTY LIVER DISEASE#0.9684;WEIGHT LOSS#0.9682;GLUCOSE TRANSPORT#0.9679;REACTIVE OXYGEN SPECIES#0.9675;PREADIPOCYTE#0.9650;LIPOPROTEIN LIPASE#0.9650;NERVOUS SYSTEM#0.9639;MITOCHONDRIA#0.9635;FRAGMENT LENGTH POLYMORPHISM#0.9625;PROTEIN SYNTHESIS#0.9623;HYPERGLYCEMIA#0.9623;HIGH FAT DIET#0.9616;VSMC PROLIFERATION#0.9613;MACROPHAGE#0.9606;PARKINSON'S DISEASE#0.9605;CELL CYCLE#0.9602;LIPID DROPLET#0.9583;CARDIOMYOPATHY#0.9556;ENZYME ACTIVITY#0.9545;AMPK ACTIVITY#0.9535;MYOCARDIUM#0.9532;NITRIC OXIDE SYNTHASE#0.9519;COMPLEX I#0.9507;THYROID HORMONE RECEPTOR#0.9498;DNA COPY NUMBER#0.9490;ISCHEMIA#0.9486;STEROID RECEPTOR COACTIVATOR#0.9476;ATP SYNTHASE#0.9473;STEM CELL#0.9456;ATP SYNTHESIS#0.9449;LOW DENSITY LIPOPROTEIN#0.9419;ACYL COA DEHYDROGENASE#0.9418;ELECTRON TRANSPORT#0.9411;FIBROBLAST GROWTH FACTOR#0.9411;BINDING PROTEIN 1#0.9410;ORGANELLE#0.9400;LIPID HOMEOSTASIS#0.9396;NONALCOHOLIC FATTY LIVER DISEASE#0.9385;FATTY ACID BETA-OXIDATION#0.9384;HEAT SHOCK PROTEIN#0.9381;LEUCINE#0.9362;TARGET OF RAPAMYCIN#0.9346;FRUCTOSE#0.9337;SIGNAL TRANSDUCTION#0.9324;5'-AMP#0.9299;SMOOTH MUSCLE#0.9258;TUMOR SUPPRESSOR#0.9257;WEIGHT GAIN#0.9257;CELLULAR METABOLISM#0.9252;LACTATION#0.9251;ROS GENERATION#0.9248;UBIQUITIN#0.9229;LIPOGENESIS#0.9217;GLUCOCORTICOID RECEPTOR#0.9199;SATURATED FATTY ACID#0.9189;INSULIN RECEPTOR SUBSTRATE#0.9186;GLUCOSE TOLERANCE TEST#0.9151;FARNESOID X RECEPTOR#0.9145;RAPAMYCIN#0.9126;BROWN FAT CELL#0.9092;GLUTATHIONE PEROXIDASE#0.9086;CELL GROWTH#0.9079;SKELETAL MUSCLE ADAPTATION#0.9079;LIPOLYSIS#0.9079;GLUCOSE INTOLERANCE#0.9063;GLYCOLYSIS#0.9049;REVERSE TRANSCRIPTION#0.9033;OVARIAN#0.9029;CYCLIC AMP#0.9029;PERIPHERAL BLOOD#0.9027;LIVER X RECEPTOR#0.9011;SMOOTH MUSCLE CELL#0.9004;HEPATOMA CELLS#0.8969;ALZHEIMER'S DISEASE#0.8966;PROSTATE CANCER#0.8957;MITOCHONDRIAL RESPIRATORY CHAIN#0.8938;SUCCINATE DEHYDROGENASE#0.8933;ENDOTHELIAL GROWTH FACTOR#0.8920;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8920;ATHEROSCLEROSIS#0.8915;FATTY ACID BINDING#0.8914;ARGININE#0.8914;ACTIVATING TRANSCRIPTION FACTOR#0.8909;DEXAMETHASONE#0.8903;CATABOLISM#0.8893;ARTERY#0.8892;PIOGLITAZONE#0.8883;BLOOD GLUCOSE LEVEL#0.8880;CARNITINE PALMITOYLTRANSFERASE I#0.8871;MELATONIN#0.8862;HEPATOCELLULAR CARCINOMA#0.8849;ETHANOL#0.8846;CHROMATIN REMODELING#0.8800;HYPOXIA INDUCIBLE FACTOR#0.8790;PROTEIN KINASE A#0.8773;INFLAMMATORY RESPONSE#0.8746;ADENOSINE TRIPHOSPHATE#0.8723;NF-KAPPAB ACTIVATION#0.8712;SIGNALLING PATHWAY#0.8708;MYOSIN HEAVY CHAIN#0.8707;ESTROGEN RECEPTOR ALPHA#0.8707;ELECTRON TRANSPORT CHAIN#0.8686;DETOXIFICATION#0.8653;BROWN ADIPOCYTE DIFFERENTIATION#0.8630;EPITHELIAL CELL#0.8622;SENESCENCE#0.8621;STRIATUM#0.8612;NICOTINAMIDE#0.8610;POST-TRANSLATIONAL MODIFICATION#0.8605;GLYCOGEN SYNTHASE KINASE#0.8590;PROTEASOME#0.8570;PROTEIN PROTEIN INTERACTION#0.8569;CENTRAL NERVOUS SYSTEM#0.8553;IMPAIRED GLUCOSE TOLERANCE#0.8522;SIGNALING CASCADE#0.8514;STREPTOZOTOCIN#0.8509;RELATED PROTEIN 1#0.8509;SUCCINATE#0.8504;TOXICITY#0.8503;T CELL#0.8501;CORONARY ARTERY#0.8471;REGULATION OF CELLULAR#0.8451;MITOPHAGY#0.8449;GESTATION#0.8447;BREAST CANCER CELL#0.8445;SMALL HETERODIMER PARTNER#0.8371;MITOCHONDRIAL PROLIFERATION#0.8356;PROTEIN KINASE C#0.8331;MITOCHONDRIAL GENOME#0.8330;TRICARBOXYLIC ACID CYCLE#0.8308;MUSCLE CONTRACTION#0.8307;PALMITOYL#0.8267;ENDOPLASMIC RETICULUM#0.8241;NEURONAL CELLS#0.8231;OXIDATIVE STRESS RESPONSE#0.8223;ELECTROPHORETIC MOBILITY SHIFT#0.8205;SILENT INFORMATION REGULATOR#0.8203;VASCULAR SMOOTH MUSCLE CELL#0.8190;RNA INTERFERENCE#0.8186;CREATINE#0.8179;PANCREATIC ISLET#0.8166;MITOCHONDRIAL FISSION#0.8165;HORMONE SENSITIVE LIPASE#0.8156;LONGISSIMUS DORSI MUSCLE#0.8136;ADENINE#0.8106;RETINOIC ACID#0.8103;KIDNEY DISEASE#0.8096;ORAL GLUCOSE TOLERANCE#0.8073;CARNITINE PALMITOYL TRANSFERASE#0.8069;CLENBUTEROL#0.8057;CARBOHYDRATE METABOLISM#0.8017;PRO-INFLAMMATORY#0.8016;OXYGENASE#0.7989;NADH DEHYDROGENASE#0.7973;SIGNALING MOLECULE#0.7971;POLYCYSTIC OVARY SYNDROME#0.7971;OLEIC ACID#0.7966;CARDIAC MUSCLE#0.7963;CELLULAR RESPIRATION#0.7961;RECEPTOR AGONIST#0.7957;OSTEOBLAST#0.7931;LYSINE#0.7918;CARDIAC DEVELOPMENT#0.7913;HEME OXYGENASE 1#0.7902;HIGH DENSITY LIPOPROTEIN#0.7853;TRIGLYCERIDE LIPASE#0.7819;MITOCHONDRIAL DAMAGE#0.7812;REGULATION OF METABOLIC#0.7787;MECHANISM OF ACTION#0.7786;CELL DIFFERENTIATION#0.7782;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7776;FAT PAD#0.7772;QUANTITATIVE TRAIT LOCI#0.7770;CAMKIV#0.7718;COMPLEX II#0.7703;GESTATIONAL DIABETES#0.7699;MICROTUBULE#0.7687;HYPOGLYCEMIA#0.7668;PROTEIN BINDING#0.7628;CREB BINDING#0.7616;OVARIAN CANCER#0.7586;FASTING BLOOD GLUCOSE#0.7583;GESTATIONAL DIABETES MELLITUS#0.7580;REGENERATION#0.7554;RNA PROCESSING#0.7551;HEPATIC NUCLEAR FACTOR#0.7535;TOLL LIKE RECEPTOR#0.7531;FASTING PLASMA GLUCOSE#0.7527;ESTRADIOL#0.7513;GLYCOGEN SYNTHESIS#0.7484;MAP KINASE#0.7483;ANTIOXIDANT DEFENSE SYSTEM#0.7471;CAFFEINE#0.7459;RESPONSE TO OXIDATIVE STRESS#0.7430;LIGHT CHAIN 3#0.7419;SIGNAL TRANSDUCER#0.7415;HYPOXIC#0.7411;FORSKOLIN#0.7404;NEUROPROTECTION#0.7365;QUADRICEPS#0.7363;ENDOTHELIAL NITRIC OXIDE#0.7359;LEYDIG CELL#0.7348;AGEING#0.7327;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7327;HIGH FAT FEEDING#0.7320;MONONUCLEAR CELLS#0.7315;BILE ACID SYNTHESIS#0.7311;CYTOCHROME C OXIDASE ACTIVITY#0.7303;GLUCAGON RECEPTOR#0.7292;PALMITIC ACID#0.7254;LEUKOCYTE#0.7251;NEUROMUSCULAR JUNCTION#0.7238;PROTEIN DEGRADATION#0.7227;RESPONSE TO COLD#0.7219;LIPOIC ACID#0.7212;LIVER CANCER#0.7210;MAMMARY GLAND#0.7209;CHRONIC KIDNEY DISEASE#0.7194;ARTERY DISEASE#0.7186;COMPLEX III#0.7181;HISTONE ACETYLATION#0.7175;FACTOR I#0.7167;MICROTUBULE ASSOCIATED PROTEIN#0.7167;ATP BINDING CASSETTE#0.7166;EPITHELIAL OVARIAN CANCER#0.7162;TRANSFORMING GROWTH FACTOR#0.7161;BODY WEIGHT GAIN#0.7156;ATP BINDING#0.7150;TRANSCRIPTASE#0.7119;PROTEIN DEACETYLASE#0.7099;B CELL#0.7080;CYTOPLASM#0.7068;RESPONSE TO INSULIN#0.7043;SKELETAL MUSCLE GENE#0.7032;ALCOHOLIC FATTY LIVER#0.7005;CALCINEURIN ACTIVATION#0.7004;DIABETIC RETINOPATHY#0.6999;HEALTHY CONTROL SUBJECTS#0.6996;MUTAGENESIS#0.6982;CREATINE KINASE#0.6970;SUBSTANTIA NIGRA#0.6968;CORONARY ARTERY DISEASE#0.6957;TRANSVERSE AORTIC CONSTRICTION#0.6945;MYOCARDIAL INFARCTION#0.6939;KINASE ACTIVITY#0.6939;NORMAL GLUCOSE TOLERANT#0.6925;MYOPATHY#0.6920;TRANSLATION INITIATION#0.6920;INSULIN SIGNALING PATHWAY#0.6902;CALCIUM SIGNALING#0.6858;GROWTH FACTOR RECEPTOR#0.6856;CYTOTOXICITY#0.6854;OSTEOBLAST DIFFERENTIATION#0.6842;AMYOTROPHIC LATERAL SCLEROSIS#0.6814;LATERAL SCLEROSIS#0.6814;CONSTITUTIVE ANDROSTANE RECEPTOR#0.6812;MYOGENESIS#0.6781;AGE AT ONSET#0.6769;VISCERAL ADIPOSE TISSUE#0.6762;LOW BIRTH WEIGHT#0.6724;NOREPINEPHRINE#0.6691;TRANSFORMING GROWTH FACTOR BETA#0.6682;ENDOMETRIAL CANCER#0.6676;RECEPTOR INTERACTING PROTEIN#0.6674;RIBOSOMAL PROTEIN#0.6671;NUTRIENT SENSING#0.6662;TUMOR CELLS#0.6653;TELOMERE#0.6649;LYSOSOME#0.6630;EPIDERMAL GROWTH FACTOR#0.6612;VITAMIN D RECEPTOR#0.6605;REGULATION OF GENE EXPRESSION#0.6572;COLORECTAL#0.6570;CIRCADIAN RHYTHM#0.6563;5'-ADENOSINE MONOPHOSPHATE#0.6557;ZUCKER DIABETIC FATTY#0.6557;TESTOSTERONE#0.6556;L-ARGININE#0.6534;MUSCLE HYPERTROPHY#0.6519;STEAROYL COA DESATURASE#0.6508;PREGNANE X RECEPTOR#0.6500;PLASMA MEMBRANE#0.6480;MUSCULAR DYSTROPHY#0.6473;RESPONSE TO HYPOXIA#0.6472;HYPERGLYCEMIC#0.6449;NEUROLOGICAL DISORDER#0.6438;CELL MIGRATION#0.6430;MAPK SIGNALING#0.6422;LUNG CANCER#0.6417;TRANSMISSION ELECTRON MICROSCOPY#0.6415;ESSENTIAL TREMOR#0.6353;OPTIC ATROPHY#0.6332;NORMAL GLUCOSE TOLERANCE#0.6311;STEROIDOGENESIS#0.6308;FATTY ACID SYNTHESIS#0.6296;HIBERNATION#0.6289;NEUROBLASTOMA#0.6281;AEROBIC EXERCISE TRAINING#0.6278;OVARIES#0.6249;BIPOLAR DISORDER#0.6242;ISCHEMIA REPERFUSION INJURY#0.6240;RIFAMPICIN#0.6217;COLORECTAL CANCER#0.6209;SUMOYLATION#0.6208;HEME BIOSYNTHESIS#0.6101;HINDLIMB#0.6079;CYTOCHROME P450#0.6074;CYTOCHROME OXIDASE ACTIVITY#0.6023;LIPID CATABOLISM#0.6016
10892	CARMA1-BCL10-MALT1 COMPLEX#1.1175;CBM COMPLEX#1.0755;PROTEASE ACTIVITY#1.0702;SIGNALOSOME#1.0581;IKK COMPLEX#1.0448;IKAPPAB KINASE#1.0407;LYMPHOCYTE ACTIVATION#1.0352;ACTIVATION OF NF-KAPPAB#1.0337;IMMUNE CELL#1.0329;NF-KAPPAB ACTIVATION#1.0306;MALT LYMPHOMA#1.0291;ACTIVATED B CELL#1.0286;T CELL ACTIVATION#1.0228;UBIQUITIN#1.0178;PROTEIN KINASE#1.0175;REVERSE TRANSCRIPTION#1.0165;MARGINAL ZONE B-CELL LYMPHOMA#1.0156;INTERPHASE#1.0148;CELL ACTIVATION#1.0119;T CELL#1.0117;COMPLEX I#1.0117;MARGINAL ZONE B CELL#1.0114;MARGINAL ZONE B#1.0112;POLYMERASE CHAIN REACTION#1.0106;AUTOIMMUNE DISEASE#1.0078;DIFFUSE LARGE B-CELL LYMPHOMA#1.0064;APOPTOSIS#1.0047;LYMPHOID TISSUE#1.0027;SIGNALING PATHWAY#1.0010;MARGINAL ZONE LYMPHOMA#1.0009;APOPTOTIC#1.0008;B CELL LYMPHOMA#1.0008;B CELL RECEPTOR#1.0005;GENE EXPRESSION#0.9983;B CELL#0.9964;CELL DEATH#0.9961;CELL PROLIFERATION#0.9938;TRANSCRIPTION FACTOR#0.9894;AUTOIMMUNITY#0.9893;IMMUNE RESPONSE#0.9884;CYTOKINE PRODUCTION#0.9775;MYELOID CELL#0.9751;REGULATORY T CELL#0.9748;CANCER CELL#0.9741;CATALYTIC ACTIVITY#0.9734;SIGNAL TRANSDUCTION#0.9731;PROTEIN KINASE C#0.9717;ONCOGENIC#0.9682;CD4+ T CELL#0.9622;GASTRIC MUCOSA#0.9545;GERMINAL CENTER#0.9532;MACROPHAGE#0.9512;ADAPTIVE IMMUNE RESPONSE#0.9441;GASTRIC LYMPHOMA#0.9432;FOLLICULAR LYMPHOMA#0.9383;LIPID RAFT#0.9290;SIGNALING CASCADE#0.9262;TRANSCRIPTASE#0.9199;MEMBRANE-ASSOCIATED GUANYLATE KINASE#0.9182;GUANYLATE KINASE#0.9156;INFLAMMATORY RESPONSE#0.9109;SIGNALLING PATHWAY#0.9058;PROTEIN COMPLEX#0.9049;ARGININE#0.8846;TUMOR CELLS#0.8824;IL-2 PRODUCTION#0.8783;TOLL LIKE RECEPTOR#0.8736;EPITHELIAL CELL#0.8706;T LYMPHOCYTE#0.8701;BONE MARROW#0.8692;TUMOR NECROSIS FACTOR#0.8580;SALIVARY GLAND#0.8557;IMMUNE SYSTEM#0.8547;KERATINOCYTE#0.8497;MANTLE CELL LYMPHOMA#0.8490;NON HODGKIN LYMPHOMA#0.8475;LYMPHOID CELL#0.8437;GERMINAL CENTER B CELL#0.8392;ENDOTHELIAL CELL#0.8391;GERMINAL CENTER B#0.8389;LYMPH NODE#0.8294;B LYMPHOCYTE#0.8285;CYTOPLASM#0.8266;PLASMA CELL#0.8204;TREG CELL#0.8063;LECTIN#0.8042;CELL SURFACE#0.7994;PRO-INFLAMMATORY#0.7958;DENDRITIC CELL#0.7921;REACTIVE OXYGEN SPECIES#0.7910;COLITIS#0.7908;PERIPHERAL BLOOD#0.7899;MULTIPLE SCLEROSIS#0.7855;RHEUMATOID ARTHRITIS#0.7825;ACTIVITY BASED PROBES#0.7760;PSORIASIS#0.7745;GROWTH FACTOR#0.7734;TUMOR SUPPRESSOR#0.7583;TH17 CELL#0.7555;ACTIVATED T-CELLS#0.7427;MAPK ACTIVATION#0.7426;ACTIVATED T CELL#0.7424;MAST CELL#0.7421;PHOSPHATIDYLSERINE#0.7401;GASTRITIS#0.7287;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7254;DNA FRAGMENTATION#0.7223;HEMATOPOIETIC STEM CELL#0.7056;MAGUK#0.7052;GASTROINTESTINAL TRACT#0.7024;STEM CELL#0.6995;EFFECTOR T CELL#0.6913;CELL DIFFERENTIATION#0.6855;LIGASE ACTIVITY#0.6815;INHIBITION OF APOPTOSIS#0.6786;LYMPHOCYTIC LEUKEMIA#0.6777;SMALL INTESTINE#0.6758;CENTRAL NERVOUS SYSTEM#0.6723;NERVOUS SYSTEM#0.6714;BREAST CANCER#0.6647;EPSTEIN BARR VIRUS#0.6607;PHENOTHIAZINE#0.6602;PROGRAMMED CELL DEATH#0.6587;ENCEPHALOMYELITIS#0.6526;CELL DEVELOPMENT#0.6488;CELL GROWTH#0.6485;MAP KINASE#0.6469;PATTERN RECOGNITION RECEPTOR#0.6339;THYROIDITIS#0.6305;RITUXIMAB#0.6301;SPLENIC MARGINAL ZONE LYMPHOMA#0.6293;MONOCYTE#0.6257;COLORECTAL#0.6224;FORMALIN#0.6201;IL-1 PRODUCTION#0.6114;PEANUT ALLERGY#0.6106;POST-TRANSLATIONAL MODIFICATION#0.6032;STEM CELL TRANSPLANTATION#0.6028;UBIQUITIN LIGASE ACTIVITY#0.6015
10893	NERVOUS SYSTEM#0.8773;EXTRACELLULAR MATRIX#0.8653;ALZHEIMER'S DISEASE#0.8235;EPITHELIAL CELL#0.8121;POLYMERASE CHAIN REACTION#0.7972;CELL SURFACE#0.6486;CENTRAL NERVOUS SYSTEM#0.6378;GROWTH CONE#0.6279
10894	HYALURONIC ACID#1.0524;HYALURONAN#1.0413;GROWTH FACTOR RECEPTOR#1.0155;LYMPHATIC VESSEL#1.0140;ENDOTHELIUM#1.0114;CELL SURFACE#1.0106;LYMPHATIC VESSEL DENSITY#1.0041;SMOOTH MUSCLE#1.0036;MACROPHAGE#1.0031;LUNG CANCER#1.0018;LYMPHATIC ENDOTHELIAL CELL#0.9985;BREAST CANCER#0.9984;DENDRITIC CELL#0.9960;LEUKOCYTE#0.9939;CELL ADHESION#0.9930;POLYMERASE CHAIN REACTION#0.9919;ENDOTHELIAL CELL#0.9889;BLOOD VESSEL#0.9877;T CELL#0.9847;ENDOTHELIAL GROWTH FACTOR#0.9835;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9835;LYMPH NODE METASTASIS#0.9816;VASCULAR ENDOTHELIAL CELL#0.9815;LYMPHATIC SYSTEM#0.9799;GROWTH FACTOR#0.9798;CILIARY BODY#0.9772;GENE EXPRESSION#0.9761;LYMPHANGIOGENESIS#0.9740;FIBROBLAST GROWTH FACTOR#0.9734;TUMOR CELLS#0.9725;BONE MARROW#0.9713;CANCER CELL#0.9712;REGIONAL LYMPH NODE#0.9712;LYMPH NODE#0.9704;TRANSCRIPTION FACTOR#0.9702;STEM CELL#0.9695;VASCULAR ENDOTHELIUM#0.9693;ANGIOGENESIS#0.9682;EXTRACELLULAR MATRIX#0.9678;IMMUNE CELL#0.9647;LYMPH VESSEL DENSITY#0.9616;IMMUNE RESPONSE#0.9504;CELL ADHESION MOLECULE#0.9469;MUSCLE CELL#0.9453;SMOOTH MUSCLE CELL#0.9420;SMOOTH MUSCLE ACTIN#0.9408;CELL PROLIFERATION#0.9376;SIGNALING PATHWAY#0.9371;STROMA#0.9330;FACTOR VIII#0.9306;SQUAMOUS CELL CARCINOMA#0.9255;TUMOR TISSUES#0.9173;WOUND HEALING#0.9104;LYMPHEDEMA#0.9089;EDEMA#0.9007;TUBE FORMATION#0.8966;LYMPH NODE METASTASES#0.8948;CONNECTIVE TISSUE#0.8920;COLORECTAL CANCER#0.8881;CORNEAL NEOVASCULARIZATION#0.8847;DERMIS#0.8846;BLOOD VESSEL DENSITY#0.8832;INFLAMMATORY CELL#0.8757;MONOCYTE#0.8741;CERVICAL#0.8738;HUMAN BREAST CANCER#0.8628;REVERSE TRANSCRIPTION#0.8586;APOPTOSIS#0.8569;BASEMENT MEMBRANE#0.8520;LYMPHATIC MICROVESSEL DENSITY#0.8489;TUMOR NECROSIS FACTOR#0.8481;CELL GROWTH#0.8476;BREAST CANCER CELL#0.8427;DRAINING LYMPH NODE#0.8421;MICROVASCULAR ENDOTHELIAL CELL#0.8412;QUANTITATIVE REAL TIME#0.8366;TRANSFORMING GROWTH FACTOR#0.8346;STROMAL CELL#0.8305;CELL MIGRATION#0.8286;PROGENITOR CELL#0.8284;COLORECTAL#0.8232;EPIDERMAL GROWTH FACTOR#0.8212;HEMANGIOMA#0.8142;ADIPOSE TISSUE#0.8140;HYALURONAN BINDING#0.7864;PLASMA MEMBRANE#0.7778;ENDOCYTOSIS#0.7754;FACTOR D#0.7743;HYPOXIA#0.7741;PLATELET-DERIVED GROWTH FACTOR#0.7684;ANTIGEN PRESENTING CELLS#0.7679;ARTERY#0.7672;VENULE#0.7611;LYMPHANGIOMA#0.7583;MESENTERY#0.7580;SENTINEL LYMPH NODE#0.7563;REGENERATION#0.7539;PANCREATIC CANCER#0.7399;SKELETAL MUSCLE#0.7375;OVARIAN#0.7370;B CELL#0.7308;EPITHELIAL CELL#0.7304;ADENOCARCINOMA#0.7274;CHEMOKINE RECEPTOR#0.7255;INFLAMMATORY RESPONSE#0.7217;INSULIN-LIKE GROWTH FACTOR#0.7176;LUMINAL#0.7175;EOSIN#0.7133;TRANSMISSION ELECTRON MICROSCOPY#0.7129;OVARIAN CANCER#0.7105;CERVICAL CANCER#0.7035;ANGIOSARCOMA#0.6930;PERICYTE#0.6899;PTERYGIUM#0.6865;INTERCELLULAR JUNCTION#0.6825;CELL CYCLE#0.6817;M2 MACROPHAGE#0.6812;YOLK SAC#0.6730;HYALURONIC ACID BINDING#0.6725;PROTEIN KINASE#0.6692;BINDING PROTEIN 1#0.6667;CYTOPLASM#0.6647;HYALURONATE#0.6612;KINASE INHIBITOR#0.6559;PRECURSOR CELL#0.6530;GROWTH FACTOR BINDING#0.6489;CARDINAL VEIN#0.6467;DURA MATER#0.6416;INHIBITION OF LYMPHANGIOGENESIS#0.6410;KAPOSI'S SARCOMA#0.6344;PROTEOGLYCAN#0.6320;TIGHT JUNCTION#0.6231;BREAST CARCINOMA#0.6174;EMBRYONIC STEM CELL#0.6137;GERM CELL TUMORS#0.6112;PROSTATE CANCER#0.6111;PRO-INFLAMMATORY#0.6108;PARENCHYMA#0.6103;RECEPTOR MEDIATED ENDOCYTOSIS#0.6098;GESTATION#0.6076;ENDOTHELIAL PROGENITOR CELL#0.6052;C-LEVEL#0.6024;UMBILICAL VEIN#0.6012;GERM CELL#0.6007
10896	PRIMARY OPEN ANGLE GLAUCOMA#0.7723;OPEN ANGLE GLAUCOMA#0.7707
10897	GOLGI APPARATUS#0.8564;ER TO GOLGI TRANSPORT#0.8360;ENDOPLASMIC RETICULUM#0.7385;ERGIC#0.6421
10898	CANCER CELL#1.0677;LUNG CANCER#1.0274;GENE EXPRESSION#1.0161;INFLUENZA A VIRUS#1.0060;MRNA PROCESSING#0.9054;RNA BINDING#0.9026;LUNG ADENOCARCINOMA#0.8666;INFLUENZA A VIRUSES#0.8610;VIRULENCE#0.7791;IMMUNE RESPONSE#0.7377;CELL GROWTH#0.7022;ADENOCARCINOMA#0.6928;SIGNALING PATHWAY#0.6914;MRNA POLYADENYLATION#0.6391;INNATE IMMUNE RESPONSE#0.6179;CPSF COMPLEX#0.6105;COLORECTAL CANCER#0.6016
10899	CENTROSOME#1.0154;CELL DEATH#1.0000;POLY ADP RIBOSE#0.9780;APOPTOSIS#0.9759;PROSTATE CANCER#0.9385;RIBOSE#0.9113;CELL CYCLE#0.8847;CELL DIVISION#0.8648;MICROTUBULE#0.8517;CANCER CELL#0.7964;CYTOKINESIS#0.7833;CELL GROWTH#0.7651;MITOCHONDRIA#0.7648;APOPTOSIS INDUCING FACTOR#0.7263;ANDROGEN RECEPTOR#0.7227;CELL POLARITY#0.7076;ACTOMYOSIN#0.6862;MITOTIC SPINDLE#0.6747;PARTHANATOS#0.6680;GENE EXPRESSION#0.6626;M PHASE#0.6527;PAR POLARITY COMPLEX#0.6342;TUMOR CELLS#0.6221
1089	GRANULOCYTE#1.0464;ADENOCARCINOMA#1.0447;CELL ADHESION#0.9235;COLON CARCINOMA#0.8766;COLORECTAL#0.8154;NEUTROPHIL#0.7802;COLORECTAL CARCINOMA#0.7799;OVARIAN#0.7681;TUMOR CELLS#0.7603;EPITHELIAL CELL#0.7597;BREAST CANCER#0.7590;CANCER CELL#0.7524;MYELOID CELL#0.7496;SQUAMOUS CELL CARCINOMA#0.7231;BONE MARROW#0.7208;PANCREATIC ADENOCARCINOMA#0.7015;PLASMA MEMBRANE#0.6891;CELL ADHESION MOLECULE#0.6344;KUPFFER CELL#0.6112;TUMOR ASSOCIATED ANTIGEN#0.6104;CELL SURFACE#0.6089;COLON CANCER#0.6087;FIMBRIAE#0.6074;BREAST CARCINOMA#0.6059;IMMUNE RESPONSE#0.6024
108	ADENYLATE CYCLASE#1.0648;ADENYLATE#1.0477;PROTEIN KINASE#0.9853;GENE EXPRESSION#0.9842;SMOOTH MUSCLE#0.9471;PROTEIN KINASE C#0.9312;FORSKOLIN#0.9302;SIGNALING PATHWAY#0.8677;CYCLIC AMP#0.8510;PHOSPHOLIPASE C#0.8231;GENE SILENCING#0.8105;CAMP SIGNALING#0.8012;AIRWAY SMOOTH MUSCLE#0.7865;POTASSIUM CHANNEL#0.7663;ADRENERGIC RECEPTOR#0.7362;PROTEIN KINASE A#0.6854;CYCLASE ACTIVITY#0.6682;DNA REPLICATION#0.6631;POLYMERASE CHAIN REACTION#0.6386;BETA ADRENERGIC RECEPTOR#0.6331;SPECIFIC SURFACE AREA#0.6227;ADENYLATE CYCLASE ACTIVITY#0.6218
10901	RETINOL DEHYDROGENASE#0.9522;RETINOL#0.8467;RC COMPLEX#0.6671;HIDDEN MARKOV MODEL#0.6156
10902	CANCER CELL#0.9423;T CELL#0.8810;MACROPHAGE#0.8690;GENE EXPRESSION#0.8163;PROTEIN KINASE#0.7896;COLORECTAL CANCER#0.7580;GROWTH FACTOR#0.7072;KINASE ACTIVITY#0.6994;PROTEIN KINASE ACTIVITY#0.6923;CELL CYCLE#0.6832;METHIONINE#0.6679;CELL ADHESION#0.6567;CELL SURFACE#0.6558;PROSTATE CANCER#0.6377;TRANSCRIPTION FACTOR#0.6204;ACTIVIN RECEPTOR#0.6171;ANDROGEN RECEPTOR#0.6158;TRANS GOLGI NETWORK#0.6076;EARLY ENDOSOME#0.6076;SMOOTH MUSCLE#0.6041;SIGNALING PATHWAY#0.6026
10903	CISPLATIN#1.0419
10904	CERVICAL CANCER#1.0415;TUMOR SUPPRESSOR#1.0386;CERVICAL#0.9555;APOPTOSIS#0.9129;RNA EDITING#0.8074;CELL GROWTH#0.7161;CELL PROLIFERATION#0.7142;CANCER CELL#0.7137;BLADDER CARCINOMA#0.6443;BREAST CANCER#0.6200
10905	N GLYCAN#1.0673;MANNOSIDASE I#1.0551;MANNOSIDASE ACTIVITY#1.0483;ENDOPLASMIC RETICULUM#1.0441;GLCNAC#0.8673;1-DEOXYMANNOJIRIMYCIN#0.8476;ALPHA MANNOSIDASE#0.8417;N-GLYCAN PROCESSING#0.7571;GLYCOSYLATION#0.7521;KEX2 PROTEASE#0.6319;MANNOSE TRIMMING#0.6262;KIFUNENSINE#0.6259
10906	TOLL LIKE RECEPTOR#0.7558;SIGNALING PATHWAY#0.6654;TUMOR NECROSIS FACTOR#0.6013
10907	MRNA SPLICING#0.9077;PRE-MRNA SPLICING#0.8689;U5 SNRNP#0.7620;C TERMINAL DOMAIN#0.7258;RENPENNING SYNDROME#0.6998;CELL CYCLE#0.6678;BINDING PROTEIN 1#0.6417;SPLICEOSOME#0.6352
10908	ESTERASE ACTIVITY#1.0503;SCIATIC NERVE#1.0491;NEUROPATHY#1.0450;NERVOUS TISSUE#1.0397;PERIPHERAL NERVE#1.0366;ENDOPLASMIC RETICULUM#1.0321;POLYNEUROPATHY#1.0298;NEUROBLASTOMA#1.0257;NEUROTOXIC#1.0248;SPINAL CORD#1.0235;HEREDITARY SPASTIC PARAPLEGIA#1.0234;PARAPLEGIA#1.0212;NERVOUS SYSTEM#1.0190;STEM CELL#1.0168;CHROMAFFIN CELL#1.0090;NEUROTOXICITY#1.0085;MOTOR NEURON DISEASE#1.0048;DIISOPROPYL PHOSPHOROFLUORIDATE#1.0009;TOXICITY#0.9984;SERINE HYDROLASE#0.9665;NEURITE#0.9637;EMBRYONIC STEM CELL#0.9610;CATALYTIC ACTIVITY#0.9504;NEURITE OUTGROWTH#0.9375;PARALYSIS#0.9349;SOLUBLE FRACTION#0.9271;PHOSPHOLIPASE A2#0.8810;AXONAL TRANSPORT#0.8711;NEURAL CELL#0.8584;RNA INTERFERENCE#0.8397;CELL PROLIFERATION#0.8359;PROTEIN KINASE#0.8358;NEURODEGENERATIVE DISEASE#0.8259;MOUSE EMBRYONIC STEM#0.8230;ADRENAL MEDULLA#0.8079;CENTRAL NERVOUS SYSTEM#0.8044;PHOSPHOLIPID HOMEOSTASIS#0.7940;CEREBELLAR ATAXIA#0.7829;MICROSOME#0.7658;ACETYLCHOLINE#0.7598;CHOLINE#0.7242;RETROGRADE AXONAL TRANSPORT#0.7137;ENZYME ACTIVITY#0.7054;HYPOGONADOTROPIC HYPOGONADISM#0.6867;PROTEASOME PATHWAY#0.6852;UBIQUITIN PROTEASOME PATHWAY#0.6830;PROTEASOME#0.6829;HYPOGONADISM#0.6781;ATROPINE#0.6753;PROTEIN KINASE A#0.6726;DIAPHRAGM#0.6422;GENE EXPRESSION#0.6273;MACROAUTOPHAGY#0.6248;UBIQUITIN#0.6234;RETINOIC ACID#0.6214;TOXICANT#0.6077;PHOSPHOLIPID METABOLISM#0.6052;TRANSCRIPTION FACTOR#0.6000
10910	KINETOCHORE ASSEMBLY#1.0962;KINETOCHORE#1.0744;DISEASE RESISTANCE#1.0505;UBIQUITIN#1.0273;CELL DEATH#1.0267;HEAT SHOCK PROTEIN#1.0122;VIRUS INDUCED GENE SILENCING#1.0083;GENE SILENCING#1.0032;LEUCINE RICH REPEAT#0.9920;INNATE IMMUNITY#0.9454;LEUCINE#0.9369;DEFENSE RESPONSE#0.9277;CELL CYCLE#0.9170;IMMUNE RESPONSE#0.9149;NUCLEOTIDE BINDING#0.9091;SIGNALING PATHWAY#0.8732;CHAPERONE COMPLEX#0.8401;UBIQUITIN LIGASE COMPLEX#0.7713;SIGNAL TRANSDUCTION#0.7574;SCF UBIQUITIN LIGASE COMPLEX#0.7319;MICROTUBULE#0.7316;TRANSCRIPTION FACTOR#0.7047;COMPLEX I#0.6847;MIS12 COMPLEX#0.6769;BUDDING#0.6662;MORPHOGENESIS#0.6393;IMMUNE SYSTEM#0.6290;INNATE IMMUNE RESPONSE#0.6193;MICROTUBULE BINDING#0.6184;PROTEIN KINASE#0.6119;CHAPERONE ACTIVITY#0.6108;PKA SIGNALING CASCADE#0.6080;SALICYLIC ACID#0.6074;CENP-A DEPOSITION#0.6069
10911	UMBILICAL VEIN#1.0745;COLLAGEN SYNTHESIS#1.0716;ESSENTIAL HYPERTENSION#1.0685;CHOLINERGIC NEURON#1.0631;VASCULAR SMOOTH MUSCLE CELL#1.0614;PORTAL HYPERTENSION#1.0565;CORONARY ARTERY DISEASE#1.0564;ARTERY DISEASE#1.0562;DIABETES MELLITUS#1.0545;TYPE 2 DIABETES#1.0542;CARDIOVASCULAR SYSTEM#1.0524;HUMAN UMBILICAL VEIN#1.0519;REACTIVE OXYGEN SPECIES#1.0497;CARDIOMYOCYTE#1.0485;MITOGEN ACTIVATED PROTEIN#1.0478;CELL PROLIFERATION#1.0453;GROWTH FACTOR RECEPTOR#1.0449;CENTRAL NERVOUS SYSTEM#1.0447;MACROPHAGE#1.0442;PULMONARY HYPERTENSION#1.0430;PEPTIDE HORMONE#1.0428;VASOCONSTRICTOR#1.0424;NERVOUS SYSTEM#1.0422;KINASE INHIBITOR#1.0417;HEART DISEASE#1.0410;VASOCONSTRICTION#1.0408;NADPH OXIDASE#1.0404;THORACIC AORTA#1.0399;CONGESTIVE HEART FAILURE#1.0387;KIDNEY DISEASE#1.0382;SMOOTH MUSCLE CELL#1.0382;ATHEROSCLEROSIS#1.0366;MUSCLE CELL#1.0362;ENDOTHELIAL CELL#1.0362;PROTEIN KINASE C#1.0361;SIGNALING PATHWAY#1.0359;ATHEROSCLEROTIC#1.0357;TRANSFORMING GROWTH FACTOR#1.0350;GROWTH FACTOR#1.0339;NITRIC OXIDE#1.0329;MYOCARDIAL INFARCTION#1.0328;PROTEIN KINASE#1.0327;SIGNAL TRANSDUCTION#1.0320;SPINAL CORD#1.0320;UMBILICAL VEIN ENDOTHELIAL CELLS#1.0295;UROTENSIN II RECEPTOR#1.0251;SMOOTH MUSCLE#1.0245;L-ARGININE#1.0234;HYPERTENSION#1.0230;VSMC PROLIFERATION#1.0227;SKELETAL MUSCLE#1.0226;MYOCARDIUM#1.0209;VASODILATOR#1.0208;ENDOTHELIUM#1.0200;POLYMERASE CHAIN REACTION#1.0200;HYPOXIA#1.0198;BLOOD VESSEL#1.0197;CORONARY ARTERY#1.0193;GENE EXPRESSION#1.0193;RECEPTOR ANTAGONIST#1.0193;ARGININE#1.0187;INSULIN SECRETION#1.0165;THYMIDINE#1.0164;LIVER DISEASE#1.0155;EPIDERMAL GROWTH FACTOR#1.0119;SMOOTH MUSCLE CELL PROLIFERATION#1.0116;MUSCLE CELL PROLIFERATION#1.0113;ARTERY#1.0084;NEPHROPATHY#1.0081;VASCULAR ENDOTHELIAL CELL#1.0080;VASODILATATION#1.0030;EXTRACELLULAR MATRIX#1.0023;APOPTOSIS#0.9981;STRUCTURE ACTIVITY RELATIONSHIP#0.9981;MONOCYTE#0.9967;DIABETIC NEPHROPATHY#0.9967;CHRONIC KIDNEY DISEASE#0.9939;LOW DENSITY LIPOPROTEIN#0.9916;EXCRETION#0.9909;NITRO-L-ARGININE#0.9871;DNA SYNTHESIS#0.9864;AIRWAY SMOOTH MUSCLE#0.9844;MOTOR ACTIVITY#0.9834;PHOSPHOLIPASE C#0.9830;ACUTE CORONARY SYNDROME#0.9767;PULMONARY ARTERY#0.9756;NITRIC OXIDE SYNTHASE#0.9728;PHEOCHROMOCYTOMA#0.9698;SYSTOLIC BLOOD PRESSURE#0.9657;PRE-ECLAMPSIA#0.9655;SOMATOSTATIN RECEPTOR#0.9653;TYPE 2 DIABETES MELLITUS#0.9647;2 DIABETES MELLITUS#0.9647;ROS GENERATION#0.9616;INDOMETHACIN#0.9584;ALDOSTERONE#0.9540;CORTICOTROPIN-RELEASING FACTOR#0.9518;RECEPTOR LIGAND#0.9502;ACUTE MYOCARDIAL INFARCTION#0.9438;CALCINEURIN#0.9402;FOAM CELL FORMATION#0.9354;REVERSE TRANSCRIPTION#0.9276;EPITHELIAL CELL#0.9260;CORTICOTROPIN#0.9258;ARGININE VASOTOCIN#0.9214;CHRONIC LIVER DISEASE#0.9200;PROTEIN SECRETION#0.9182;CALCIUM CHANNEL#0.9160;CALCIUM MOBILIZATION#0.9129;VASODILATION#0.9124;GLOMERULAR FILTRATION#0.9122;CORONARY HEART DISEASE#0.9029;ACETYLCHOLINE#0.8992;N-ACETYLCYSTEINE#0.8982;ECLAMPSIA#0.8941;LIVER CIRRHOSIS#0.8921;TACHYCARDIA#0.8913;GLOMERULAR FILTRATION RATE#0.8902;ASTROCYTE#0.8828;ADVENTITIA#0.8825;TYPE 2 DIABETIC#0.8806;FOREARM#0.8781;BETA CELL#0.8758;HEPATOCELLULAR CARCINOMA#0.8748;TRANSACTIVATION#0.8711;ISCHEMIA#0.8660;RECEPTOR BINDING#0.8548;SIGNALLING PATHWAY#0.8541;CHRONIC HEART FAILURE#0.8498;RENAL FIBROSIS#0.8464;HIGH FAT DIET#0.8426;NOREPINEPHRINE#0.8347;BRADYCARDIA#0.8344;VASOTOCIN#0.8309;TUMOR NECROSIS FACTOR#0.8270;NEONATAL RAT CARDIOMYOCYTES#0.8232;NORADRENALINE#0.8203;RECEPTOR AGONIST#0.8193;ADRENOCORTICAL CARCINOMA#0.8083;ENDOPLASMIC RETICULUM#0.8070;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8062;ENDOTHELIAL GROWTH FACTOR#0.8061;ION TRANSPORT#0.8032;INFLAMMATORY CELL#0.7996;MYOCYTES#0.7994;DIABETIC RETINOPATHY#0.7946;CANCER CELL#0.7935;RESPONSE TO HU#0.7918;AORTIC SMOOTH MUSCLE CELLS#0.7910;HYPOXIC#0.7880;ADIPOSE TISSUE#0.7775;ENDOTHELIAL NITRIC OXIDE#0.7704;ACETYLCYSTEINE#0.7689;FRAGMENT LENGTH POLYMORPHISM#0.7678;NICARDIPINE#0.7629;TUBULAR EPITHELIAL CELL#0.7599;PROTEIN KINASE A#0.7549;EPINEPHRINE#0.7507;APOPTOTIC#0.7494;RAPID EYE MOVEMENT#0.7487;NEUROMUSCULAR JUNCTION#0.7475;ACUTE LIVER FAILURE#0.7472;FIBROBLAST PROLIFERATION#0.7463;ATRIAL FIBRILLATION#0.7438;STRESS FIBER#0.7424;PROSTACYCLIN#0.7421;LUNG ADENOCARCINOMA#0.7411;PROPRANOLOL#0.7405;INFLAMMATORY RESPONSE#0.7366;TRANSCRIPTASE#0.7350;PROGENITOR CELL#0.7323;BREAST CANCER#0.7290;HYPOTENSIVE#0.7252;PLASMA MEMBRANE#0.7208;OSMOREGULATION#0.7207;MIGRAINE#0.7173;PERIPHERAL BLOOD#0.6991;CONSTRICTION#0.6967;COLLAGEN TYPE I#0.6908;ISCHEMIA REPERFUSION INJURY#0.6865;TYROSINE KINASE INHIBITOR#0.6853;ADRENAL GLAND#0.6803;ADRENAL MEDULLA#0.6783;BRAIN NATRIURETIC PEPTIDE#0.6750;HEALTHY CONTROL GROUP#0.6750;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6747;CONGENITAL HEART DISEASE#0.6746;PKC ACTIVITY#0.6743;HEME OXYGENASE 1#0.6726;LIPASE ACTIVITY#0.6723;MONOCYTE DERIVED MACROPHAGE#0.6723;ENDOTHELIAL PROGENITOR CELL#0.6711;SIGNALING CASCADE#0.6703;CELL CYCLE#0.6639;S PHASE#0.6636;TETRODOTOXIN#0.6597;CARBACHOL#0.6589;CORTISOL#0.6535;ANGIOGENESIS#0.6524;QUANTITATIVE REVERSE TRANSCRIPTION#0.6485;MECHANISM OF ACTION#0.6443;ADENOCARCINOMA#0.6429;CELL GROWTH#0.6420;PHENYLEPHRINE#0.6355;ARTERIOLE#0.6325;VERAPAMIL#0.6324;CARDIOMYOPATHY#0.6293;SMOOTH MUSCLE ACTIN#0.6263;CAROTID ARTERY#0.6239;DOXORUBICIN#0.6202;CELL ADHESION#0.6191;C REACTIVE PROTEIN#0.6182;AUTOPHAGY#0.6179;CELL DEATH#0.6170;DOPAMINE#0.6125;GABA A RECEPTOR#0.6086;CERVICAL#0.6081;TACHYCARDIC#0.6043;VASCULAR CELL#0.6037;LIVER LESIONS#0.6025;PROTEIN SYNTHESIS#0.6002
10912	CELL GROWTH#1.0245;APOPTOSIS#1.0178;CELL CYCLE#1.0118;GENE EXPRESSION#0.9925;CANCER CELL#0.9845;CELL PROLIFERATION#0.9675;SEX DETERMINATION#0.9653;TUMOR SUPPRESSOR#0.9562;DNA REPAIR#0.9486;CELL DEATH#0.9376;TRANSCRIPTION FACTOR#0.9204;T CELL#0.9155;SIGNALING PATHWAY#0.9055;HEPATOCELLULAR CARCINOMA#0.8911;APOPTOTIC#0.8766;GENOTOXIC#0.8571;CELL CYCLE ARREST#0.8402;TUMOR CELLS#0.7980;TH1 CELL#0.7708;PROSTATE CANCER#0.7558;TUMOR TISSUES#0.7544;GROWTH FACTOR#0.7471;CELLULAR SENESCENCE#0.7470;PITUITARY ADENOMA#0.7450;DNA BINDING#0.7325;KINASE ACTIVITY#0.7185;CELL DIFFERENTIATION#0.7180;POLYMERASE CHAIN REACTION#0.6831;SQUAMOUS CELL CARCINOMA#0.6797;SENESCENCE#0.6609;KINASE INHIBITOR#0.6572;MALE SEX DETERMINATION#0.6438;IMMUNE RESPONSE#0.6365;PRIMARY SEX DETERMINATION#0.6290;TESTIS DEVELOPMENT#0.6241;SEX DIFFERENTIATION#0.6227;CELL CYCLE CONTROL#0.6127;CELL CYCLE CHECKPOINT#0.6056;EPITHELIAL CELL#0.6048;STEM CELL#0.6034
109136579	BREAST CANCER CELL#0.8269;BREAST CANCER#0.8226;CANCER CELL#0.8214
10913	MACROPHAGE#1.0521;HYPOHIDROTIC ECTODERMAL DYSPLASIA#1.0395;TUMOR NECROSIS FACTOR#1.0340;SIGNALING PATHWAY#1.0284;HAIR FOLLICLE#1.0281;ECTODERMAL DYSPLASIA#1.0274;MORPHOGENESIS#1.0154;SWEAT GLAND#0.9947;TOOTH AGENESIS#0.9934;NF-KAPPAB ACTIVATION#0.9657;MONOCYTE#0.9632;SALIVARY GLAND#0.9609;T LYMPHOCYTE#0.9479;SIGNALLING PATHWAY#0.9435;TOOTH DEVELOPMENT#0.9434;TRANSCRIPTION FACTOR#0.9338;GROWTH FACTOR#0.9192;LYMPH NODE#0.8876;TUMOUR NECROSIS FACTOR#0.8800;DENDRITIC CELL#0.8773;APOPTOSIS#0.8741;T CELL#0.8416;HAIR FOLLICLE DEVELOPMENT#0.8252;CELL DEATH#0.7711;CONNECTIVE TISSUE#0.7623;B LYMPHOCYTE#0.7474;ORGAN DEVELOPMENT#0.7401;MAMMARY GLAND#0.7333;BRANCHING MORPHOGENESIS#0.7255;APPENDAGE DEVELOPMENT#0.7215;POLYMERASE CHAIN REACTION#0.7200;LYMPHOID ORGANS#0.7149;SIGNAL TRANSDUCTION#0.7045;TRANSFORMING GROWTH FACTOR#0.7045;SEBACEOUS GLAND#0.6978;MOLAR#0.6916;SMOOTH MUSCLE#0.6890;GENETIC DISORDER#0.6841;LYMPHOID TISSUE#0.6840;B CELL#0.6775;STEM CELL#0.6472;MESENCHYME#0.6435;SIGNALING MOLECULE#0.6240;ROOT SHEATH#0.6233;GLAND DEVELOPMENT#0.6108;OTITIS MEDIA#0.6067
10914	RNA BINDING#1.0158;CELL CYCLE#0.9984;OOCYTE#0.9949;GENE EXPRESSION#0.9825;APOPTOSIS#0.9366;DEPHOSPHORYLATION#0.9366;M PHASE#0.8999;MRNA POLYADENYLATION#0.8216;CYTOPLASM#0.8205;POLY ADP RIBOSE#0.7714;OOCYTE MATURATION#0.7470;CANCER CELL#0.7456;RIBOSE#0.7379;CPSF COMPLEX#0.7023;DNA FRAGMENTATION#0.6878;PAP COMPLEX#0.6645;U1 SNRNP#0.6623;FACTOR I#0.6350;RNA BINDING PROTEIN#0.6278
10915	TRANSCRIPTION FACTOR#1.0401;NUCLEAR SPECKLE#1.0307;MRNA PROCESSING#0.7980;GENE EXPRESSION#0.7450;HUNTINGTON'S DISEASE#0.7371;DNA BINDING#0.6291;SPLICEOSOME#0.6200;C TERMINAL DOMAIN#0.6138
10916	BREAST CANCER#1.0799;GENE EXPRESSION#0.8669;CELL CYCLE#0.8613;POLYHYDRAMNIOS#0.8256;APOPTOSIS#0.7776;ADENYLATE CYCLASE#0.7256;CALCINEURIN#0.6486;CANCER CELL#0.6420;COLONY MORPHOLOGY#0.6395;HEPATOCELLULAR CARCINOMA#0.6218;BREAST CANCER CELL#0.6124;TUMOR SUPPRESSOR#0.6114;TRANSCRIPTION FACTOR#0.6109
10917	T CELL#0.8924
10919	N METHYLTRANSFERASE#1.0733;AUTOPHAGY#1.0511;EUCHROMATIN#1.0455;LUNG CANCER#1.0415;DNA METHYLTRANSFERASE#1.0389;METHYLTRANSFERASE ACTIVITY#1.0348;HISTONE METHYLTRANSFERASE#1.0342;CELL DEATH#1.0336;CELL GROWTH#1.0310;HISTONE DEACETYLASE#1.0272;BREAST CANCER#1.0199;CELL PROLIFERATION#1.0187;GENE SILENCING#1.0184;CANCER CELL#1.0137;LYSINE#1.0118;SKELETAL MUSCLE#1.0114;TUMOR SUPPRESSOR#1.0094;HYPOXIA#1.0089;EMBRYONIC STEM CELL#1.0056;APOPTOSIS#1.0047;STRUCTURE ACTIVITY RELATIONSHIP#1.0021;HETEROCHROMATIN#1.0010;CELL DIFFERENTIATION#0.9972;HISTONE METHYLATION#0.9966;DNA METHYLATION#0.9937;T CELL#0.9924;BREAST CANCER CELL#0.9919;CATALYTIC ACTIVITY#0.9905;STEM CELL#0.9904;ZINC FINGER PROTEIN#0.9883;CELL CYCLE#0.9831;TRANSCRIPTION FACTOR#0.9825;HISTONE MODIFICATION#0.9806;SIGNALING PATHWAY#0.9804;HEPATOCELLULAR CARCINOMA#0.9769;GENE EXPRESSION#0.9761;HISTONE ACETYLATION#0.9633;HISTONE DEMETHYLASE#0.9633;DEMETHYLATION#0.9497;PROGENITOR CELL#0.9495;DNA BINDING#0.9491;CHROMATIN REMODELING#0.9452;BONE MARROW#0.9415;CELL MIGRATION#0.9341;ANKYRIN REPEAT DOMAIN#0.9259;HETEROCHROMATIN PROTEIN 1#0.9227;POLYMERASE CHAIN REACTION#0.9202;COLON CANCER#0.9184;POLYCOMB REPRESSIVE COMPLEX#0.9128;GROWTH FACTOR#0.9127;HYPOXIC#0.9069;CERVICAL CANCER#0.9053;ETHANOL#0.9003;PROTEIN KINASE#0.8995;PROTEIN COMPLEX#0.8989;OVARIAN CANCER#0.8977;CELL ADHESION#0.8955;UBIQUITIN#0.8888;METHYLTRANSFERASE COMPLEX#0.8883;ONCOGENIC#0.8797;MOUSE EMBRYONIC STEM#0.8791;TOXICITY#0.8771;DNA REPLICATION#0.8738;GERM CELL#0.8705;POST-TRANSLATIONAL MODIFICATION#0.8693;HISTONE DEACETYLATION#0.8664;NUCLEOSOME#0.8624;HETEROCHROMATIN FORMATION#0.8586;HISTONE METHYLTRANSFERASE ACTIVITY#0.8559;OOCYTE#0.8479;PANCREATIC CANCER#0.8439;CHROMATIN MODIFICATION#0.8384;MYOBLAST#0.8330;HISTONE ACETYLTRANSFERASE#0.8326;OVARIAN#0.8317;ARGININE#0.8242;DE NOVO DNA METHYLATION#0.8187;MUSCLE CELL#0.8106;CANCER STEM CELL#0.8090;APOPTOTIC#0.8000;METHIONINE#0.7976;DNA REPAIR#0.7973;RETINOIC ACID#0.7967;REACTIVE OXYGEN SPECIES#0.7954;MACROPHAGE#0.7934;TUMOR TISSUES#0.7908;CARDIOMYOCYTE#0.7887;HISTONE LYSINE METHYLATION#0.7871;SQUAMOUS CELL CARCINOMA#0.7826;RNA INTERFERENCE#0.7773;MYELOID LEUKEMIA#0.7757;COGNITION#0.7640;AUTOPHAGIC CELL DEATH#0.7609;CHOLESTEROL BIOSYNTHESIS#0.7540;GLOBIN#0.7521;CERVICAL#0.7520;PROTEIN METHYLTRANSFERASE#0.7465;CYTOTOXICITY#0.7448;GLUCOCORTICOID RECEPTOR#0.7434;NUCLEAR PERIPHERY#0.7432;SENESCENCE#0.7291;MESENCHYMAL STEM CELL#0.7242;PROSTATE CANCER#0.7224;POSTTRANSLATIONAL MODIFICATION#0.7207;METHYLASE#0.7183;CELL ADHESION MOLECULE#0.7172;TERMINAL DIFFERENTIATION#0.7068;REGULATION OF GENE EXPRESSION#0.7055;CELL DIVISION#0.7033;COLORECTAL CANCER#0.7024;NEUROBLASTOMA#0.7022;COLORECTAL#0.6985;EPITHELIAL CELL#0.6978;COMPLEX I#0.6953;EMBRYO DEVELOPMENT#0.6932;5-AZA-2'-DEOXYCYTIDINE#0.6820;2'-DEOXYCYTIDINE#0.6816;INHIBITION OF CELL PROLIFERATION#0.6789;PERIPHERAL NERVE INJURY#0.6772;ANGIOGENESIS#0.6745;CYTOPLASM#0.6742;NUCLEAR LOCALIZATION SIGNAL#0.6733;KINASE INHIBITOR#0.6729;PERIPHERAL NERVE#0.6727;LUNG ADENOCARCINOMA#0.6675;CENTROMERE CLUSTERING#0.6621;PROTEIN PROTEIN INTERACTION#0.6597;S PHASE#0.6587;CLEAVED CASPASE 3#0.6558;ADENOCARCINOMA#0.6521;B CELL#0.6476;PERIPHERAL BLOOD#0.6472;REVERSE TRANSCRIPTION#0.6446;LYMPH NODE#0.6426;TUMOR CELLS#0.6421;HISTONE DEACETYLASE INHIBITOR#0.6331;NERVOUS SYSTEM#0.6311;EPITHELIAL MESENCHYMAL TRANSITION#0.6297;ADOMET#0.6257;ACUTE MYELOID LEUKEMIA#0.6144;INFLAMMATORY RESPONSE#0.6143;ADIPOCYTE#0.6098;SAHF FORMATION#0.6096;NUCLEUS ACCUMBENS SHELL#0.6080;PEROXISOMAL MEMBRANE#0.6044;MENTAL RETARDATION#0.6041;ENZYME ACTIVITY#0.6005
10920	COP9 COMPLEX#1.1460;COP9 SIGNALOSOME#1.0496;SIGNALOSOME#1.0466;PHOTOMORPHOGENESIS#1.0425;PROTEIN COMPLEX#1.0411;TRANSLATION INITIATION#1.0365;26S PROTEASOME#1.0253;TRANSLATION INITIATION FACTOR#1.0244;COMPLEX I#1.0243;CULLIN-RING LIGASE#1.0238;LIGASE ACTIVITY#1.0148;BINDING PROTEIN 1#1.0147;PROTEIN DEGRADATION#1.0090;PROTEASOME#1.0087;UBIQUITIN PROTEASOME SYSTEM#1.0029;UBIQUITIN#0.9954;SIGNALING PATHWAY#0.9937;GENE EXPRESSION#0.9887;TRANSCRIPTION FACTOR#0.9877;PROTEIN KINASE#0.9815;PROTEASOME PATHWAY#0.9805;CELL PROLIFERATION#0.9794;CELL CYCLE#0.9752;APOPTOSIS#0.9674;DENEDDYLASE ACTIVITY#0.9591;SIGNAL TRANSDUCTION#0.9534;TUMOR SUPPRESSOR#0.9512;DNA REPAIR#0.9319;UBIQUITIN PROTEASOME PATHWAY#0.9269;CANCER CELL#0.9249;KINASE ACTIVITY#0.9241;ISOPEPTIDASE ACTIVITY#0.9196;PROTEIN UBIQUITINATION#0.8837;T CELL#0.8836;KINASE INHIBITOR#0.8651;CARDIOMYOCYTE#0.8435;UBIQUITIN LIGASE ACTIVITY#0.8425;CYTOPLASM#0.8379;GROWTH FACTOR#0.8234;CELL GROWTH#0.8171;UBIQUITIN LIGASE COMPLEX#0.8117;S PHASE#0.8116;STEM CELL#0.7961;CELL CYCLE ARREST#0.7872;NUCLEAR EXPORT#0.7836;DNA DAMAGE RESPONSE#0.7722;DNA REPLICATION#0.7702;CYCLIN DEPENDENT KINASE#0.7697;UBIQUITIN-DEPENDENT PROTEOLYSIS#0.7511;PROTEIN PROTEIN INTERACTION#0.7499;CELL CYCLE CONTROL#0.7428;CENP-A DEPOSITION#0.7382;MAP KINASE#0.7238;CELL CYCLE REGULATION#0.6814;SEEDLING DEVELOPMENT#0.6706;SECONDARY METABOLISM#0.6648;DNA BINDING#0.6588;CENTROMERE#0.6555;CYCLIN DEPENDENT KINASE INHIBITOR#0.6531;OVARIAN#0.6478;RNA INTERFERENCE#0.6477;MITOGEN ACTIVATED PROTEIN#0.6457;CONJUGATION#0.6373;CELL CYCLE REGULATOR#0.6358;DEUBIQUITINATION#0.6328;CELL DEATH#0.6326;G1 PHASE#0.6313;INTERFERON REGULATORY FACTOR#0.6307;BREAST CANCER#0.6264;AUTOPHAGOSOME MATURATION#0.6252;EMBRYONIC STEM CELL#0.6043
10921	PROTEIN SPLICING#1.0976;PROTEIN BINDING#1.0723;PROTEIN PHOSPHORYLATION#1.0464;NUCLEAR SPECKLE#1.0257;PROTEIN KINASE#1.0177;RNA SPLICING#1.0054;MRNA PROCESSING#1.0018;EXONIC SPLICING ENHANCER#0.9989;SPLICEOSOME#0.9980;EXON JUNCTION COMPLEX#0.9958;RNA RECOGNITION MOTIF#0.9956;RNA BINDING PROTEIN#0.9947;RNA BINDING#0.9922;DEPHOSPHORYLATION#0.9896;PRE-MRNA SPLICING#0.9893;MRNA SPLICING#0.9860;ARGININE#0.9736;SPLICE SITE SELECTION#0.9718;SARCOPLASMIC RETICULUM#0.9710;GENE EXPRESSION#0.9666;U1 SNRNP#0.9664;ATPASE ACTIVITY#0.9634;SPLICEOSOME ASSEMBLY#0.9522;RNA PROCESSING#0.9490;SKELETAL MUSCLE#0.9343;PROTEIN PROTEIN INTERACTION#0.9246;PROTEIN DEPHOSPHORYLATION#0.9221;APOPTOSIS#0.9181;CELL CYCLE#0.9146;ALTERNATIVE SPLICING FACTOR#0.9075;CYTOPLASM#0.8590;MRNA DECAY#0.8476;NONSENSE-MEDIATED MRNA DECAY#0.8390;PROTEIN COMPLEX#0.8176;TRANSCRIPTION FACTOR#0.7731;TOPOISOMERASE#0.7687;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.7620;C TERMINAL DOMAIN#0.7515;KINASE ACTIVITY#0.7484;EXON-EXON JUNCTION COMPLEX#0.7369;NUCLEOPLASM#0.7341;SIGNALING PATHWAY#0.7326;DNA TOPOISOMERASE#0.7289;NUCLEAR IMPORT#0.7153;RYANODINE RECEPTOR#0.7081;REGULATION OF SPLICING#0.7031;MYOCARDIUM#0.6701;ISCHEMIA#0.6532;POLYAMINE TRANSPORT#0.6272;CELL DEATH#0.6253;NUCLEAR EXPORT#0.6207;MRNA METABOLISM#0.6143;T CELL#0.6134;NONSENSE MEDIATED DECAY#0.6114;PROTEIN CODING GENE#0.6111;CARDIAC MUSCLE#0.6018
10922	APOPTOSIS#0.8785;COMPLEX I#0.8445;GENE EXPRESSION#0.7116;APOPTOTIC#0.6235;RNA GRANULE#0.6213
10923	CYCLIN DEPENDENT KINASE INHIBITOR#1.0619;SSDNA BINDING#1.0617;KINASE INHIBITOR#1.0486;CYCLIN DEPENDENT KINASE#1.0454;DNA BINDING#1.0210;DNA REPAIR#1.0076;CELL CYCLE#1.0044;CELL CYCLE ARREST#1.0006;TUMOR SUPPRESSOR#0.9957;CANCER CELL#0.9952;BREAST CANCER#0.9948;C TERMINAL DOMAIN#0.9907;GENE EXPRESSION#0.9904;APOPTOSIS#0.9868;TRANSCRIPTION FACTOR#0.9835;CELL PROLIFERATION#0.9829;TRANSFORMING GROWTH FACTOR BETA#0.9781;TRANSFORMING GROWTH FACTOR#0.9758;PREINITIATION COMPLEX#0.9738;GROWTH FACTOR#0.9718;SIGNALING PATHWAY#0.9470;DNA REPLICATION#0.9301;PROTEIN KINASE#0.9247;CDK INHIBITOR#0.9232;POLYMERASE CHAIN REACTION#0.9137;CHROMATIN ORGANIZATION#0.9110;MALARIA#0.9040;ONCOGENIC#0.9026;HISTONE DEACETYLASE#0.8958;EPITHELIAL CELL#0.8896;CELL GROWTH#0.8658;TRANSCRIPTION COACTIVATOR#0.8638;DNA METHYLATION#0.8516;S PHASE#0.8399;BONE MARROW#0.8360;T CELL#0.8275;ERYTHROCYTE#0.8233;NUCLEAR EXPORT#0.8194;MYELOID LEUKEMIA#0.8150;TRANSACTIVATION#0.8124;SENESCENCE#0.8112;TRANSCRIPTION COFACTOR#0.7985;ACUTE LEUKEMIA#0.7934;MUTAGENESIS#0.7890;CELL CYCLE REGULATOR#0.7847;PROSTATE CANCER#0.7667;G1 PHASE#0.7597;CPG ISLAND METHYLATION#0.7573;LUNG METASTASIS#0.7527;CELLULAR SENESCENCE#0.7512;ELECTRON TRANSPORT#0.7494;SINGLE-STRANDED DNA BINDING#0.7339;HOST CELL#0.7269;ACUTE MYELOID LEUKEMIA#0.7048;LYSINE#0.7023;PARASITOPHOROUS VACUOLE#0.6908;SIGNAL TRANSDUCTION#0.6856;GRANULOCYTE#0.6740;LUNG CANCER#0.6684;COLON CANCER#0.6588;ETHYLENE RESPONSE FACTOR#0.6566;COLORECTAL CANCER#0.6515;NUCLEIC ACID#0.6498;SUM FREQUENCY GENERATION#0.6452;B CELL#0.6448;HETEROCHROMATIN#0.6390;5-AZA-2'-DEOXYCYTIDINE#0.6367;2'-DEOXYCYTIDINE#0.6363;DNA METHYLTRANSFERASE#0.6331;TUBULIN FOLDING#0.6278;TRANSCRIPTIONAL CONTROL#0.6232;REPLICATION PROTEIN A#0.6178;GENE SILENCING#0.6172;QUANTITATIVE TRAIT LOCUS#0.6149;STEM CELL#0.6110;HETEROCHROMATIN FORMATION#0.6057;PANCREATIC CANCER#0.6033;MYELODYSPLASTIC SYNDROME#0.6007
109245082	CELL PROLIFERATION#0.8053;MULTIPLE MYELOMA#0.7416;LUNG CANCER#0.7353;CANCER CELL#0.6849;HEPATOCELLULAR CARCINOMA#0.6084
10924	SPHINGOMYELIN PHOSPHODIESTERASE#1.1091;PHOSPHODIESTERASE#1.0183;ACID SPHINGOMYELINASE#0.9851;LIVER X RECEPTOR#0.9113;PHOSPHODIESTERASE ACTIVITY#0.6996;DIPHOSPHATE#0.6122
10926	CDC7-DBF4 COMPLEX#1.0856;CYCLIN DEPENDENT KINASE#1.0376;PROTEIN KINASE#1.0356;KINASE ACTIVITY#1.0314;S PHASE#1.0182;S-PHASE CHECKPOINT#1.0175;DNA REPLICATION#1.0085;CELL CYCLE#1.0048;DNA SYNTHESIS#1.0015;REPLICATION FORK#1.0010;BUDDING#0.9893;MEIOSIS#0.9509;G1 PHASE#0.9132;MITOSIS#0.8893;MCM COMPLEX#0.8765;GENOTOXIC#0.8459;ORIGIN RECOGNITION COMPLEX#0.8459;CANCER CELL#0.8450;CELL DIVISION#0.8384;DNA REPAIR#0.8377;MEIOSIS I#0.8168;COMPLEX I#0.8071;DNA REPLICATION INITIATION#0.7800;HYDROXYUREA#0.7780;DNA HELICASE#0.7613;CELL DIVISION CYCLE#0.7603;CHROMATIN BINDING#0.7423;CHROMOSOME SEGREGATION#0.7404;DNA DAMAGE CHECKPOINT#0.7152;CELL CYCLE ARREST#0.6965;DOUBLE STRAND BREAK#0.6855;TRANSCRIPTION FACTOR#0.6324;PRE-REPLICATIVE COMPLEX#0.6298;KINASE INHIBITOR#0.6246;ANAPHASE#0.6240;GENE EXPRESSION#0.6048;UBIQUITIN#0.6047;ATAXIA TELANGIECTASIA MUTATED#0.6035;ATAXIA TELANGIECTASIA#0.6008;CELL PROLIFERATION#0.6001
10927	CELL CYCLE#1.0077;CANCER CELL#0.9855;OOCYTE#0.9565;OVARIAN#0.9447;OVARIAN CANCER#0.9430;CELL PROLIFERATION#0.8076;LYSINE#0.7932;OOCYTE MATURATION#0.7755;APOPTOSIS#0.7479;MEIOTIC SPINDLE#0.7334;MITOSIS#0.7144;GENE EXPRESSION#0.6963;Z CHROMOSOME#0.6645;METAPHASE#0.6605;DOCKING PROTEIN#0.6402;MRNA BINDING#0.6323;CELL CYCLE REGULATION#0.6229;INTERPHASE#0.6115;ARGININE#0.6039
10928	BINDING PROTEIN 1#1.0762;LUNG CANCER#1.0648;DRUG RESISTANCE#1.0590;ATPASE ACTIVITY#1.0530;ENDOCYTOSIS#1.0445;DOXORUBICIN#1.0386;GLUTATHIONE#1.0348;CANCER CELL#1.0185;ERYTHROCYTE#1.0172;RECEPTOR INTERACTING PROTEIN#1.0127;APOPTOSIS#1.0074;SIGNALING PATHWAY#1.0066;BREAST CANCER#0.9945;CELL CYCLE#0.9874;ATP BINDING#0.9612;ABC TRANSPORTER#0.9579;CELL PROLIFERATION#0.9575;DUAL LUCIFERASE REPORTER#0.9518;CELL DEATH#0.9476;GROWTH FACTOR#0.9463;CELL SURFACE#0.9374;KIDNEY CANCER#0.9308;PROSTATE CANCER#0.9080;CELL GROWTH#0.8978;CLATHRIN-DEPENDENT ENDOCYTOSIS#0.8890;CELL MIGRATION#0.8797;ATP HYDROLYSIS#0.8630;ENDOTHELIAL CELL#0.8606;APOPTOTIC#0.8558;PROTEIN KINASE#0.8419;EXOCYST#0.8417;GENE EXPRESSION#0.8265;NF-KAPPAB ACTIVATION#0.8236;ATP BINDING CASSETTE#0.8211;EPILEPSY#0.8208;MITOCHONDRIAL FISSION#0.8184;TUMOR CELLS#0.8154;ANGIOGENESIS#0.8149;TRANSCRIPTION FACTOR#0.8131;KINASE ACTIVITY#0.8096;RECEPTOR MEDIATED ENDOCYTOSIS#0.7999;PKCALPHA#0.7776;ACTIN CYTOSKELETON#0.7662;TOXICITY#0.7587;ONCOGENIC#0.7533;EXOCYST COMPLEX#0.7530;OVARIAN CANCER#0.7511;OVARIAN#0.7429;EPITHELIAL CELL#0.7288;TUMOR NECROSIS FACTOR#0.7288;SIGNALING MOLECULE#0.7039;RNA INTERFERENCE#0.7036;TANK BINDING KINASE#0.7026;DRUG TRANSPORT#0.6920;EPIDERMAL GROWTH FACTOR#0.6916;CYTOTOXICITY#0.6903;PLASMA MEMBRANE#0.6802;CELL CYCLE ARREST#0.6795;POST-TRANSLATIONAL MODIFICATION#0.6784;BLOOD BRAIN BARRIER#0.6763;BREAST CANCER PATIENTS#0.6763;SIGNAL TRANSDUCTION#0.6762;PRO-INFLAMMATORY#0.6726;VINORELBINE#0.6534;MITOSIS#0.6375;RENAL CELL CARCINOMA#0.6371;MOUSE EMBRYONIC FIBROBLAST#0.6361;REPORTER GENE ASSAY#0.6359;COLORECTAL CANCER#0.6343;AKT SIGNALING#0.6268;GUANINE#0.6166;CDC42 SIGNALING PATHWAY#0.6150;INVADOPODIUM FORMATION#0.6125;MULTI DRUG RESISTANCE#0.6119;ADENOSINE#0.6091;BREAST CANCER CELL#0.6084;NUCLEOTIDE EXCHANGE FACTOR#0.6076;GTPASE ACTIVITY#0.6069;GLIOBLASTOMA MULTIFORME#0.6023
10929	LACTIC ACID#0.7248
10930	MRNA EDITING#1.0670;CYTIDINE DEAMINASE#1.0307;APOBEC#1.0271;RNA EDITING#1.0209;CYTIDINE#0.9996;SKELETAL MUSCLE#0.9403;MYOBLAST#0.7868;MYOBLAST DIFFERENTIATION#0.7835;REGENERATION#0.7110;CARDIAC MUSCLE#0.7025;GENE EXPRESSION#0.6746;ACTIVATION INDUCED DEAMINASE#0.6653;TRANSCRIPTION FACTOR#0.6455;ZINC BINDING#0.6224;MUSCLE FIBER#0.6205;MYOPATHY#0.6003
10933	HISTONE DEACETYLASE#1.0425;HISTONE ACETYLTRANSFERASE#1.0284;DNA REPAIR#0.9461;TRANSCRIPTION FACTOR#0.9451;CELL PROLIFERATION#0.9401;CHROMATIN REMODELING#0.9078;HISTONE ACETYLATION#0.8721;GENE EXPRESSION#0.8546;ACETYLTRANSFERASE COMPLEX#0.8234;LYSINE#0.8007;SENESCENCE#0.7955;CELL CYCLE#0.7628;NUCLEOSOME#0.7247;MOUSE EMBRYONIC FIBROBLAST#0.7010;HISTONE DEACETYLASE COMPLEX#0.6914;HISTONE ACETYLTRANSFERASE COMPLEX#0.6659;INTERPHASE CHROMOSOME#0.6643;CELLULAR SENESCENCE#0.6521;POLYTENE CHROMOSOME#0.6378;CHROMATIN BINDING#0.6309;GERM CELL#0.6248;PRE-MRNA SPLICING#0.6229;MRNA SPLICING#0.6191;BREAST CANCER#0.6183;CELL DEATH#0.6008
10934	SENESCENCE#1.0538;RNA BINDING#1.0413;RNA BINDING PROTEIN#1.0370;GENE EXPRESSION#1.0166;VIRULENCE#0.8611;DNA REPAIR#0.8386;TRANSCRIPTION FACTOR#0.8316;BIOFILM FORMATION#0.8308;SEQUESTERING#0.7978;RNA PROCESSING#0.7961;RIBONUCLEOPROTEIN COMPLEX#0.7711;C TERMINAL DOMAIN#0.7703;CELLULAR SENESCENCE#0.7355;CELL CYCLE#0.7281;EXOSOME#0.7169;RNA HELICASE#0.7070;DNA HELICASE#0.6925;PROTEIN CODING GENE#0.6645;QUORUM SENSING#0.6525;NITROGEN FIXATION#0.6157;HISTONE ACETYLTRANSFERASE#0.6032
10935	SUPEROXIDE DISMUTASE#1.0286;MITOCHONDRIA#1.0045;APOPTOSIS#0.9891;GLUTATHIONE#0.9891;GLUTATHIONE PEROXIDASE#0.9757;EPITHELIAL CELL#0.9740;REACTIVE OXYGEN SPECIES#0.9731;CANCER CELL#0.9678;GENE EXPRESSION#0.9661;CELL PROLIFERATION#0.9487;OVARIAN#0.9482;CELL DEATH#0.9431;TRANSCRIPTION FACTOR#0.9371;APOPTOTIC#0.9368;HEPATOCELLULAR CARCINOMA#0.9305;CYTOCHROME C#0.9270;PEROXIDASE ACTIVITY#0.9169;PROSTATE CANCER#0.9061;MITOCHONDRIAL MEMBRANE#0.9038;HEAT SHOCK PROTEIN#0.8931;COPPER CHAPERONE#0.8920;OVARIAN CANCER#0.8733;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8704;HYPOXIA#0.8589;CERVICAL CANCER#0.8469;SIGNALING PATHWAY#0.8432;NITRIC OXIDE#0.8410;THIOREDOXIN PEROXIDASE#0.8329;CYTOTOXICITY#0.8223;POLYMERASE CHAIN REACTION#0.8133;ATP SYNTHASE#0.8106;BREAST CANCER#0.7982;OXIDATIVE STRESS RESPONSE#0.7589;CERVICAL#0.7563;ISCHEMIA#0.7503;TOXICITY#0.7476;NITRIC OXIDE SYNTHASE#0.7472;MITOCHONDRION#0.7433;CELL GROWTH#0.7417;ROS GENERATION#0.7325;MITOCHONDRIAL DNA#0.7321;ADIPOCYTE#0.7194;MACROPHAGE#0.7048;MTDNA#0.6950;PROTEIN KINASE#0.6864;ADRENAL CORTEX#0.6833;QUANTITATIVE REAL TIME#0.6788;REVERSE TRANSCRIPTION#0.6771;AURANOFIN#0.6713;COPPER HOMEOSTASIS#0.6686;RESPIRATORY CHAIN#0.6621;SKELETAL MUSCLE#0.6609;RESPONSE TO OXIDATIVE STRESS#0.6603;ANTIOXIDANT ACTIVITY#0.6538;IMMUNE RESPONSE#0.6519;ADIPOSE TISSUE#0.6498;THIOREDOXIN REDUCTASE 1#0.6476;CISPLATIN#0.6356;AUTOPHAGY#0.6246;MALIGNANT MESOTHELIOMA#0.6179;DETOXIFICATION#0.6163;CELL CYCLE#0.6140;STEM CELL#0.6137;LASER DESORPTION IONIZATION#0.6094
10936	CHEMOKINE RECEPTOR#0.6562;PROSTATE CANCER#0.6018
10938	RECYCLING ENDOSOME#1.0789;ENDOCYTIC RECYCLING COMPARTMENT#1.0746;EPS15 HOMOLOGY DOMAIN#1.0615;ENDOCYTIC RECYCLING#1.0606;FLOWERING#1.0520;ENDOSOME#1.0441;PLASMA MEMBRANE#1.0197;ENDOCYTOSIS#1.0176;LUNG CANCER#0.9714;CELL SURFACE#0.9615;GROWTH FACTOR#0.9312;RECEPTOR RECYCLING#0.9243;GENE EXPRESSION#0.9208;EARLY ENDOSOME#0.8842;TRANSCRIPTION FACTOR#0.8810;NEURITE OUTGROWTH#0.8796;CONSTAN#0.8384;FOCAL ADHESION#0.8001;SPINAL CORD INJURY#0.7615;CILIARY VESICLE#0.7540;SPINAL CORD#0.7519;MICROTUBULE#0.7289;RNA INTERFERENCE#0.7281;NEURITE#0.7278;MEMBRANE FISSION#0.7277;SIGNALING PATHWAY#0.7253;MYOBLAST FUSION#0.7008;ENDOSOMAL MEMBRANE#0.6959;INSULIN-LIKE GROWTH FACTOR#0.6943;GROWTH FACTOR RECEPTOR#0.6927;CANCER CELL#0.6902;CILIOGENESIS#0.6551;MYOBLAST#0.6355;SPERMATOGENESIS#0.6352;CILIUM#0.6340;APOPTOSIS#0.6320;PRIMARY CILIUM#0.6278;T TUBULE#0.6217;LYSINE#0.6160;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6123;SKELETAL MUSCLE#0.6086;CLATHRIN-MEDIATED ENDOCYTOSIS#0.6052;NEURAL TUBE#0.6034
10939	PURKINJE CELL#1.0266;MITOCHONDRIA#0.9601;PARAPLEGIA#0.9187;SPASTIC ATAXIA#0.9151;MITOCHONDRIAL MEMBRANE#0.9137;HEREDITARY SPASTIC PARAPLEGIA#0.9085;CEREBELLAR ATAXIA#0.8845;RESPIRATORY CHAIN#0.8843;NEURODEGENERATIVE DISEASE#0.8344;INNER MITOCHONDRIAL MEMBRANE#0.8262;MITOCHONDRIAL INNER MEMBRANE#0.8114;PROTEIN QUALITY CONTROL#0.7948;OPTIC ATROPHY#0.7940;MITOCHONDRIAL PROTEIN SYNTHESIS#0.7352;PROTEIN SYNTHESIS#0.7098;MITOCHONDRIAL FUSION#0.6894;AUTOSOMAL DOMINANT CEREBELLAR ATAXIA#0.6361;CELL DEATH#0.6030
10940	RNASE P#1.0776;RNASE MRP#1.0765;RNASE MRP COMPLEX#0.8359;TRANSCRIPTION FACTOR#0.7682;CELL DIVISION#0.6622;RNA PROCESSING#0.6313;PRECURSOR CELL#0.6265;ENDODERM DEVELOPMENT#0.6176
10941	NASAL EPITHELIUM#0.8754;POLYMERASE CHAIN REACTION#0.7380;REVERSE TRANSCRIPTION#0.7253;OLFACTORY BULB#0.7228;VITAMIN D BIOSYNTHESIS#0.6821;CARCINOGEN#0.6742;POLYCYCLIC AROMATIC HYDROCARBON#0.6524;NASAL MUCOSA#0.6488;DETOXIFICATION#0.6456;GENE EXPRESSION#0.6247
10942	GERM CELL#0.9443;TUMOR SUPPRESSOR#0.9088;TUMOR CELLS#0.8260;OVARIAN#0.8191;OVARIAN CANCER#0.7544;GENE EXPRESSION#0.7425;ACROSOME REACTION#0.7117;SPERMATOZOA#0.7078;CANCER CELL#0.7076;SPERMATOGENESIS#0.6744;CELL SURFACE#0.6483;LACRIMAL GLAND#0.6336;GERM CELL TUMORS#0.6243;GENE SILENCING#0.6207;EOSINOPHIL#0.6174;SIGNALING PATHWAY#0.6100
10943	DOSAGE COMPENSATION#1.0410;X CHROMOSOME#1.0291;MSL COMPLEX#1.0059;PLASTID#0.9189;DOSAGE COMPENSATION COMPLEX#0.8997;HISTONE ACETYLTRANSFERASE#0.8427;LYSINE#0.6982;COMPLEX I#0.6359
10944	ACYL CARRIER PROTEIN#0.9007;ACYL CARRIER#0.9005
10945	ENDOPLASMIC RETICULUM#1.0086;SECRETORY PATHWAY#0.9972;GOLGI APPARATUS#0.9944;LUMINAL#0.9587;SIGNAL PEPTIDE#0.9376;GLYCOSYLATION#0.8326;T CELL#0.7908;PROTEIN DISULFIDE ISOMERASE#0.7224;CELL SURFACE#0.7120;INTEGRATED STRESS RESPONSE#0.7094;PLASMA MEMBRANE#0.6961;COPI VESICLE#0.6577;ER LUMEN#0.6134;CELL WALL#0.6094;VACUOLE#0.6077
10946	U2 SNRNP#1.0963;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.8932;17S U2 SNRNP#0.8904;SPLICEOSOME#0.8849;MRNA SPLICING#0.8422;PROTEIN PROTEIN INTERACTION#0.7980;SPLICEOSOME ASSEMBLY#0.7522;PROTEIN COMPLEX#0.6376;PRESPLICEOSOME#0.6173;PRE-MRNA SPLICING#0.6173
10947	MACROPHAGE#0.7193
10948	LATE ENDOSOME#1.0841;ENDOSOME#1.0698;CHOLESTEROL TRANSPORT#1.0597;CHOLESTEROL BINDING#1.0497;METASTATIC LYMPH NODE#1.0342;BREAST CANCER#1.0312;MITOCHONDRIA#1.0215;LYMPH NODE#1.0178;STEROIDOGENESIS#0.9985;MITOCHONDRIAL MEMBRANE#0.9459;ENDOPLASMIC RETICULUM#0.9443;CANCER CELL#0.9399;PLASMA MEMBRANE#0.9271;LIPID BINDING#0.8837;GENE EXPRESSION#0.8803;BREAST CANCER CELL#0.8736;LUTEIN#0.8586;CHOLESTEROL TRANSPORTER#0.8451;TRANSCRIPTION FACTOR#0.8178;CONTACT SITE#0.8095;CAROTENOID#0.8072;LIPID TRANSPORT#0.8019;ENDOSOMAL MEMBRANE#0.7869;STEROL BINDING#0.7850;PROGESTERONE SYNTHESIS#0.7588;PROGESTERONE#0.7447;LYSOSOME#0.7341;INNER MITOCHONDRIAL MEMBRANE#0.7255;LIPID METABOLISM#0.7155;MACROPHAGE#0.7154;CHOLESTEROL HOMEOSTASIS#0.6674;BREAST CARCINOMA#0.6670;CHOLESTEROL EXPORT#0.6511;OXYSTEROL BINDING#0.6413;STEROID SYNTHESIS#0.6329;CYTOPLASM#0.6312;PREGNENOLONE#0.6265;LIVER DAMAGE#0.6060
10949	RNA BINDING#0.7441;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.7049;AU RICH ELEMENT#0.6740;MYELOID NEOPLASM#0.6130
10950	CANCER CELL#1.0519;TUMOR SUPPRESSOR#1.0427;B CELL#1.0420;APOPTOSIS#1.0122;CELL CYCLE#1.0120;CELL PROLIFERATION#1.0058;COLORECTAL CANCER#0.9955;RHEUMATOID ARTHRITIS#0.9665;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9643;LUPUS ERYTHEMATOSUS#0.9635;VASCULITIS#0.9559;LUNG CANCER#0.9550;NEPHRITIS#0.9497;LUPUS NEPHRITIS#0.9459;THROMBOCYTOPENIA#0.9346;ANEMIA#0.9312;T CELL#0.9306;CONNECTIVE TISSUE#0.9129;PROTEINURIA#0.9063;ALLERGEN#0.8999;SIGNALING PATHWAY#0.8959;CELL GROWTH#0.8881;CONNECTIVE TISSUE DISEASE#0.8811;GENE EXPRESSION#0.8796;COLORECTAL#0.8745;CARDIOLIPIN#0.8612;ERYTHROCYTE SEDIMENTATION RATE#0.8506;CENTROMERE#0.8490;CYCLOPHOSPHAMIDE#0.8454;NERVOUS SYSTEM#0.8399;PERIPHERAL BLOOD#0.8367;AUTOIMMUNE DISEASE#0.8344;GLOMERULONEPHRITIS#0.8232;PREDNISONE#0.8093;DISEASE ACTIVITY INDEX#0.8068;AUTOIMMUNE HEPATITIS#0.7985;CENTRAL NERVOUS SYSTEM#0.7981;OVARIAN#0.7944;RAYNAUD’S#0.7928;POLYMERASE CHAIN REACTION#0.7923;SALIVARY GLAND#0.7622;HISTONE MODIFICATION#0.7529;COMPLETE BLOOD COUNT#0.7524;DNA METHYLATION#0.7459;ERYTHEMA#0.7434;LUNG DISEASE#0.7404;TRANSCRIPTION FACTOR#0.7382;ERYTHROCYTE#0.7357;NEUTROPHIL#0.7048;HEPATITIS B#0.7045;BREAST CANCER#0.7030;NEPHROPATHY#0.6989;LIVER DISEASE#0.6885;OVERALL SURVIVAL TIME#0.6832;DEMETHYLATION#0.6822;HEPATITIS C#0.6777;HEPATOCELLULAR CARCINOMA#0.6716;SMOOTH MUSCLE#0.6703;RHEUMATIC DISEASE#0.6692;OVARIAN CANCER#0.6678;SCLERODERMA#0.6549;QUANTITATIVE REAL TIME#0.6483;EDEMA#0.6480;PREDNISOLONE#0.6478;DRY MOUTH#0.6472;HEMOLYTIC ANEMIA#0.6376;INTERSTITIAL LUNG DISEASE#0.6238;CELL DEATH#0.6208;C REACTIVE PROTEIN#0.6171;PROSTATE CANCER#0.6019
10951	CHLORIDE CHANNEL#1.0443;MALIC ENZYME#1.0389;HETEROCHROMATIN PROTEIN 1#1.0291;HETEROCHROMATIN#1.0248;LYSINE#0.9886;GENE EXPRESSION#0.9871;CELL CYCLE#0.9539;GENE SILENCING#0.9502;XY BODY#0.9402;CENTROMERE#0.9315;TRANSCRIPTION FACTOR#0.9267;SEROTONIN RECEPTOR#0.9242;UBIQUITIN#0.8816;INTERPHASE#0.8681;S PHASE#0.8510;POLYCOMB REPRESSIVE COMPLEX#0.8446;HETEROCHROMATIN FORMATION#0.8213;ENZYME ACTIVITY#0.8159;CELL PROLIFERATION#0.8153;POLYCOMB REPRESSIVE COMPLEX 1#0.8073;5-HT RECEPTOR#0.8046;EUCHROMATIN#0.7984;CHROMOCENTER#0.7982;CELL DIFFERENTIATION#0.7868;METAPHASE#0.7744;OOCYTE#0.7701;HETEROCHROMATIN DOMAIN#0.7696;BREAST CANCER#0.7657;MEIOSIS#0.7334;HEPATOCELLULAR CARCINOMA#0.7288;STEM CELL#0.7140;DOPAMINE#0.7123;DNA BINDING#0.7053;CENTROMERIC HETEROCHROMATIN#0.7042;SEX CHROMOSOME#0.6925;X CHROMOSOME#0.6883;PACHYTENE#0.6849;NUCLEAR ENVELOPE#0.6818;CANCER CELL#0.6762;ION CHANNEL#0.6535;MALE MEIOSIS#0.6463;NUCLEOSOME#0.6431;FATTY ACID BIOSYNTHESIS#0.6422;CHROMO SHADOW DOMAIN#0.6385;CHROMATIN REMODELING#0.6277;CHROMOSOME REGION#0.6201;HISTONE METHYLATION#0.6109;MITOSIS#0.6008
10952	ENDOPLASMIC RETICULUM#0.6535
10953	OUTER MITOCHONDRIAL MEMBRANE#1.1095;MITOCHONDRIAL MEMBRANE#1.0942;COLORECTAL CANCER#1.0408;COLORECTAL#1.0151;MITOCHONDRIA#0.9621;RECURRENT COLORECTAL CANCER#0.8809;PROTEIN IMPORT#0.8512;MITOCHONDRIAL PROTEIN IMPORT#0.8017;OUTER MEMBRANE#0.7857;TRANSCRIPTION FACTOR#0.7378;T LYMPHOCYTE#0.6759;MITOCHONDRIAL OUTER MEMBRANE#0.6442;ENDOTHELIAL GROWTH FACTOR#0.6346;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6346;GROWTH FACTOR RECEPTOR#0.6343;ATPASE ACTIVITY#0.6335;GROWTH FACTOR#0.6306;HEAT SHOCK PROTEIN#0.6214
10954	PROTEIN DISULFIDE ISOMERASE#1.0042
10955	T CELL#0.7268;ENDOPLASMIC RETICULUM#0.6256;PLASMA MEMBRANE#0.6191
10956	LECTIN#1.0797;N GLYCAN#1.0476;ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION#1.0114;ENDOPLASMIC RETICULUM#1.0057;HYPOXIA#0.9309;ER TO GOLGI TRANSPORT#0.8618;UBIQUITIN#0.8518;HYPOXIA INDUCIBLE FACTOR#0.8467;PROTEASOME#0.7849;UNFOLDED PROTEIN RESPONSE#0.7500;FRONTAL AFFINITY CHROMATOGRAPHY#0.7446;SECRETORY PATHWAY#0.7113;ERAD PATHWAY#0.6914;GLYCOPROTEIN ERAD#0.6817;TRANSCRIPTION FACTOR#0.6326;MEPRIN#0.6246;GLYCOSYLATION#0.6126;PROTEIN FOLDING#0.6011
10959	TRANSPORT VESICLE#1.0555;SECRETORY PATHWAY#1.0425;GOLGI APPARATUS#1.0399;ENDOPLASMIC RETICULUM#1.0189;T CELL#1.0058;COATED VESICLE#0.9832;GALACTOSIDASE ACTIVITY#0.9827;HUMAN IMMUNODEFICIENCY VIRUS#0.9746;SERUM ALBUMIN#0.9741;TRANSCRIPTASE#0.9421;COATOMER#0.9242;COPII VESICLE#0.9219;GOLGI COMPLEX#0.8957;CELL PROLIFERATION#0.8882;IMMUNE RESPONSE#0.8726;PROTEIN TRANSPORT#0.8369;GOLGI MEMBRANE#0.8302;PROTEIN COMPLEX#0.8264;PLASMA MEMBRANE#0.8092;CD4+ T CELL#0.8077;VESICLE FORMATION#0.7986;DENDRITIC CELL#0.7801;COPI COATED VESICLE#0.7669;COPI VESICLE#0.7368;VESICLE BUDDING#0.7081;ER EXIT#0.7043;VESICULAR TRANSPORT#0.6983;POLYMERASE CHAIN REACTION#0.6938;BUDDING#0.6778;VIRION#0.6632;ORGANELLE#0.6593;LUMINAL#0.6448;REVERSE TRANSCRIPTASE ACTIVITY#0.6359;MORPHOGENESIS#0.6343;L-LYSINE#0.6304;LYSINE#0.6103
10960	ERGIC#1.0861;LECTIN#1.0799;SECRETORY PATHWAY#1.0627;SUGAR BINDING#1.0359;ENDOPLASMIC RETICULUM#1.0354;GOLGI APPARATUS#0.9338;LUMINAL#0.9185;PLASMA MEMBRANE#0.8556;CARBOHYDRATE RECOGNITION DOMAIN#0.7849;FRONTAL AFFINITY CHROMATOGRAPHY#0.7563;CELL SURFACE#0.7496;MANNOSE BINDING#0.7312;EPITHELIAL CELL#0.6479;GOLGI COMPLEX#0.6220
10961	BREAST CANCER#1.0706;BREAST CANCER CELL#1.0699;CANCER CELL#1.0475;PROTEIN DISULFIDE ISOMERASE#1.0461;ENDOPLASMIC RETICULUM#1.0438;APOPTOSIS#1.0214;EPITHELIAL CELL#0.9944;CELL PROLIFERATION#0.9058;HEAT SHOCK PROTEIN#0.9051;ENDOPLASMIC RETICULUM STRESS#0.9008;CELL GROWTH#0.8852;MESENCHYMAL EPITHELIAL TRANSITION#0.8818;TUMOR SUPPRESSOR#0.8349;GENE EXPRESSION#0.8227;ER MEMBRANE#0.7937;GLUCOSE REGULATED PROTEIN#0.7925;PROTEIN FOLDING#0.7789;GEMCITABINE#0.7770;LUNG ADENOCARCINOMA#0.7683;ADENOCARCINOMA#0.7638;EPITHELIAL MESENCHYMAL TRANSITION#0.7612;COLORECTAL CANCER#0.7369;SUPEROXIDE DISMUTASE#0.7331;UNFOLDED PROTEIN RESPONSE#0.7143;PROTEIN UNFOLDING#0.7080;PROTEIN SYNTHESIS#0.7009;CHAPERONE ACTIVITY#0.6991;PLASMA MEMBRANE#0.6991;HEPATOMA CELLS#0.6925;NEURODEGENERATIVE DISEASE#0.6873;CYSTIC FIBROSIS#0.6860;CELL DEATH#0.6839;LASER DESORPTION IONIZATION#0.6627;SECRETORY PATHWAY#0.6426;C TERMINAL DOMAIN#0.6396;DOXORUBICIN#0.6391;APOPTOTIC#0.6312;TRANSCRIPTION FACTOR#0.6261;PROTEIN PROCESSING#0.6200;PEPTIDE BINDING#0.6131;GOLGI APPARATUS#0.6102;SPINAL CORD#0.6009
109623460	PROSTATE CANCER#0.7367;CANCER CELL#0.7318;CELL PROLIFERATION#0.7117;LUNG CANCER#0.6892
10962	BREAST CANCER#1.0739;CANCER CELL#1.0558;MYELOID LEUKEMIA#1.0160;ACUTE MYELOID LEUKEMIA#0.9999;BREAST CANCER CELL#0.9732;SIGNALING PATHWAY#0.9472;T CELL#0.9424;ONCOGENIC#0.8911;APOPTOSIS#0.8725;OVARIAN CANCER#0.7908;MYELODYSPLASTIC SYNDROME#0.7837;GENE EXPRESSION#0.7650;T CELL FACTOR#0.7191;MIXED LINEAGE LEUKEMIA#0.7146;TRANSCRIPTION FACTOR#0.7144;POLYMERASE CHAIN REACTION#0.6960;ACUTE LEUKEMIA#0.6308;HUMAN BREAST CANCER#0.6264;GROWTH FACTOR#0.6161;OVARIAN#0.6001
10963	HSP90 ORGANIZING PROTEIN#1.1007;OVARIAN CANCER#1.0692;CELL PROLIFERATION#1.0315;OVARIAN#1.0182;CANCER CELL#1.0082;PROTEIN KINASE#1.0075;SIGNALING PATHWAY#1.0070;ATPASE ACTIVITY#1.0040;HEAT SHOCK PROTEIN#1.0027;PROTEIN FOLDING#0.9985;CELL DEATH#0.9833;APOPTOSIS#0.9797;GLUCOCORTICOID RECEPTOR#0.9761;HSP90 BINDING#0.9558;GENE EXPRESSION#0.9316;CELL SURFACE#0.9157;PROTEIN DISULFIDE ISOMERASE#0.9008;NEUROPROTECTION#0.8986;RETICULOCYTE#0.8802;ASTROCYTE#0.8727;CHAPERONIN#0.8636;CELL GROWTH#0.8630;TRANSCRIPTION FACTOR#0.8618;CELL CYCLE#0.8606;GELDANAMYCIN#0.8584;CHAPERONE COMPLEX#0.8517;IMMUNOPHILIN#0.8487;APOPTOTIC#0.8406;PROTEIN COMPLEX#0.8375;PANCREATIC CANCER#0.8372;ATP HYDROLYSIS#0.8361;STEROID BINDING#0.8348;CYTOPLASM#0.8227;FK506 BINDING#0.8118;SIGNAL TRANSDUCTION#0.8025;UBIQUITIN#0.7978;ENDOPLASMIC RETICULUM#0.7862;PEPTIDE BINDING#0.7793;NERVOUS SYSTEM#0.7755;PROTEIN KINASE A#0.7717;POLYMERASE CHAIN REACTION#0.7650;KINASE ACTIVITY#0.7622;STEM CELL#0.7610;LYMPH NODE#0.7532;C TERMINAL DOMAIN#0.7497;ADJACENT NORMAL TISSUE#0.7462;QUANTITATIVE REAL TIME#0.7418;FK506 BINDING PROTEIN#0.7358;HSP70 INTERACTING PROTEIN#0.7275;PROTEIN SYNTHESIS#0.7258;CELL DIVISION#0.7217;GROWTH FACTOR#0.7211;COMPLEX I#0.7211;RIBOSOMAL PROTEIN#0.7078;ONCOGENIC#0.7062;ATP BINDING#0.7044;PROTEIN PROTEIN INTERACTION#0.7043;TOXICITY#0.6994;CHAPERONE ACTIVITY#0.6882;CYCLOPHILIN#0.6773;HSC70 INTERACTING PROTEIN#0.6766;BREAST CANCER#0.6755;T CELL#0.6739;TUMOR CELLS#0.6738;LYMPH NODE METASTASIS#0.6738;INTERMEDIATE FILAMENT#0.6725;HEPATOCELLULAR CARCINOMA#0.6708;PHOSPHOLIPASE C#0.6699;PROTEASOME#0.6698;ENDOTHELIAL CELL#0.6676;PROGESTERONE#0.6651;CELL DIVISION CYCLE#0.6587;CYTOTOXICITY#0.6551;MAP KINASE#0.6203;MITOGEN ACTIVATED PROTEIN#0.6174;PLASMA MEMBRANE#0.6169;EPITHELIAL CELL#0.6155;CELL WALL#0.6061
10964	GENE EXPRESSION#0.9965;PERIPHERAL BLOOD#0.9180;IMMUNE RESPONSE#0.9017;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8883;LUPUS ERYTHEMATOSUS#0.8881;INTERFERON STIMULATED GENE#0.8613;SIGNALING PATHWAY#0.7895;MONONUCLEAR CELLS#0.7881;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7696;DNA METHYLATION#0.7340;AUTOIMMUNE DISEASE#0.7074;INNATE IMMUNE RESPONSE#0.7004;MONOCYTE#0.6593;B CELL#0.6131;POLYMERASE CHAIN REACTION#0.6035
10965	ACYL COA THIOESTERASE#0.9625;MITOCHONDRIA#0.9247;SKELETAL MUSCLE#0.7406;LIPID METABOLISM#0.7077;GENE EXPRESSION#0.6741;PEROXISOME#0.6640;TELOMERE MAINTENANCE#0.6482;ADIPOCYTE#0.6091
10966	RETINOIC ACID#0.8766;CANCER CELL#0.8278;BREAST CANCER CELL#0.6351;RETINOIC ACID RECEPTOR#0.6348;BREAST CANCER#0.6234
10969	RIBOSOME BIOGENESIS#1.0393;RIBOSOME#1.0205;60S RIBOSOMAL SUBUNIT#1.0123;RIBOSOMAL SUBUNIT#0.9916;EPSTEIN BARR VIRUS#0.9163;MITOTIC CHROMOSOME#0.8828;RIBOSOMAL PROTEIN#0.8823;NUCLEOLUS#0.8785;ENHANCER BINDING#0.8418;RRNA PROCESSING#0.8088;CELL CYCLE#0.8001;TRANSCRIPTION FACTOR#0.7964;ENHANCER BINDING PROTEIN#0.7850;CELL GROWTH#0.7651;GENE EXPRESSION#0.7563;MITOSIS#0.7128;DNA BINDING#0.7089;CELL PROLIFERATION#0.6746;METAPHASE CHROMOSOME#0.6339;EPISOME#0.6019
109703458	FATTY ACID SYNTHESIS#0.9180
10970	BASAL CELL#1.0581;LUMINAL#1.0330;CANCER CELL#1.0275;ENDOPLASMIC RETICULUM#1.0265;STEM CELL#1.0237;EPITHELIAL CELL#1.0184;MICROTUBULE#1.0162;CELL PROLIFERATION#1.0052;PLASMA MEMBRANE#0.9744;PROGENITOR CELL#0.9659;LUMINAL CELL#0.9476;ROUGH ER#0.8866;GENE EXPRESSION#0.8690;ER MEMBRANE#0.8559;PROSTATE CANCER#0.8533;HEPATOCELLULAR CARCINOMA#0.8491;CELL SURFACE#0.8414;MICROTUBULE BINDING#0.8275;SECRETORY CELL#0.8269;ROUGH ENDOPLASMIC RETICULUM#0.8209;SQUAMOUS CELL CARCINOMA#0.8126;ANDROGEN RECEPTOR#0.7652;APOPTOSIS#0.7599;EPITHELIAL STEM CELL#0.7523;GOLGI APPARATUS#0.7231;CHOLANGIOCARCINOMA#0.7072;TYPE II PNEUMOCYTE#0.7020;TUMOR SUPPRESSOR#0.6961;PALMITOYL#0.6957;ADENOCARCINOMA#0.6768;LUNG CANCER#0.6763;TRANSCRIPTION FACTOR#0.6532;ERGIC#0.6446;ER-GOLGI INTERMEDIATE COMPARTMENT#0.6438;CELL CYCLE#0.6242;KERATINOCYTE#0.6205;STEM CELL MARKER#0.6200;DUCT CELL#0.6113;AIRWAY EPITHELIAL CELL#0.6074;BLADDER CARCINOMA#0.6069;ESOPHAGEAL CANCER#0.6067;CYTOPLASM#0.6022;GROWTH FACTOR#0.6003
10971	INTRINSICALLY DISORDERED PROTEIN#1.0593;MICROTUBULE BINDING#1.0501;MICROTUBULE#1.0191;HYPERPHOSPHORYLATION#1.0172;NEURODEGENERATIVE DISEASE#1.0078;NEUROFIBRILLARY TANGLE#1.0069;MICROTUBULE ASSOCIATED PROTEIN#0.9975;DEMENTIA#0.9961;ALZHEIMER'S DISEASE#0.9956;FRONTOTEMPORAL DEMENTIA#0.9876;TAUOPATHY#0.9661;PROTEIN KINASE#0.9642;GLYCOGEN SYNTHASE KINASE#0.9598;AMYLOID PRECURSOR PROTEIN#0.9568;PROGRESSIVE SUPRANUCLEAR PALSY#0.9281;NERVOUS SYSTEM#0.9275;FIBRIL#0.9272;APOPTOSIS#0.8918;AXONAL TRANSPORT#0.8752;CELL DEATH#0.8601;TOXICITY#0.8582;CENTRAL NERVOUS SYSTEM#0.8504;NEURITE#0.8355;UBIQUITIN#0.8059;GENE EXPRESSION#0.7834;PARKINSON'S DISEASE#0.7700;SPINAL CORD#0.7462;AMYLOID PROTEIN#0.7299;TRYPTOPHAN 5 MONOOXYGENASE#0.7178;TYROSINE 3 MONOOXYGENASE#0.7046;NEUROTOXICITY#0.7026;CYCLIN DEPENDENT KINASE#0.6787;MICROTUBULI#0.6713;AMYOTROPHIC LATERAL SCLEROSIS#0.6494;LATERAL SCLEROSIS#0.6494;NEUROFILAMENT#0.6483;CELL CYCLE#0.6277;ENDOTHELIAL CELL#0.6246;GINSENOSIDE RG1#0.6144;GROWTH FACTOR#0.6110;NEUROTOXIC#0.6065;MEMORY IMPAIRMENT#0.6036;NEUROLOGICAL DISORDER#0.6015
109729087	HEARING IMPAIRMENT#1.2052
109729094	HEARING IMPAIRMENT#1.2052
109729099	HEARING LOSS#1.1935
10972	SECRETORY PATHWAY#1.0173;ENDOPLASMIC RETICULUM#1.0163;GOLGI APPARATUS#1.0152;GOLGI COMPLEX#1.0110;PROTEIN TRANSPORT#0.9998;T CELL#0.9821;COPI COATED VESICLE#0.9479;COATED VESICLE#0.9451;COATOMER#0.9336;GENE EXPRESSION#0.8895;CIS GOLGI NETWORK#0.8740;ALZHEIMER'S DISEASE#0.8647;COPI VESICLE#0.8551;GOLGI MEMBRANE#0.8483;AMYLOID PRECURSOR PROTEIN#0.8419;PLASMA MEMBRANE#0.7938;CELL SURFACE#0.7853;HUMAN IMMUNODEFICIENCY VIRUS#0.7782;TRANSPORT VESICLE#0.7723;PROTEIN KINASE#0.7470;CD4+ T CELL#0.7356;AUTOPHAGY#0.7156;PERIPHERAL BLOOD#0.6821;CANCER CELL#0.6778;ER LOCALIZATION#0.6429;OPIOID RECEPTOR#0.6409;PROTEIN KINASE C#0.6130;UBIQUITIN PROTEASOME PATHWAY#0.6124;PROTEASOME PATHWAY#0.6104;UBIQUITIN#0.6033;BETA CELL#0.6004
10973	RNA HELICASE#1.0762;RNA METABOLISM#0.9166;RNA BINDING#0.8673;GENE EXPRESSION#0.8395;MRNA SPLICING#0.7916;ATPASE ACTIVITY#0.7819;IMMUNE RESPONSE#0.7153;PRE-MRNA SPLICING#0.6845;MELANOMA DIFFERENTIATION ASSOCIATED#0.6577;RIBOSOME BIOGENESIS#0.6557;RIBOSOME#0.6515
10974	ADIPOGENESIS#0.7263
10975	CYTOCHROME BC1 COMPLEX#0.7023;TH2 CELL#0.6708
10978	GTP BINDING#1.0736;KINASE ACTIVITY#0.9810;ATP BINDING#0.8144;TRANSFER RNA#0.7164;FACTOR I#0.6964;CELL CYCLE#0.6678;CYTOKINESIS#0.6344
10979	BREAST CANCER#1.0771;CANCER CELL#1.0579;CELL ADHESION#1.0443;INTEGRIN ACTIVATION#1.0429;FOCAL ADHESION#1.0402;ENDOTHELIAL CELL#1.0386;CELL PROLIFERATION#1.0361;INTEGRIN BINDING#0.9988;ACTIN CYTOSKELETON#0.9952;EXTRACELLULAR MATRIX#0.9867;SIGNALING PATHWAY#0.9668;CELL MATRIX ADHESION#0.9441;BREAST CANCER CELL#0.9415;INTEGRIN LINKED KINASE#0.9299;EPITHELIAL MESENCHYMAL TRANSITION#0.9262;ALZHEIMER'S DISEASE#0.9258;CELL MIGRATION#0.9209;EPITHELIAL CELL#0.9190;SMOOTH MUSCLE#0.9189;WOUND HEALING#0.9168;KERATINOCYTE#0.8832;GENE EXPRESSION#0.8798;PROSTATE CANCER#0.8784;KINDLER SYNDROME#0.8705;ANGIOGENESIS#0.8686;APOPTOSIS#0.8593;SQUAMOUS CELL CARCINOMA#0.8200;HEPATOCELLULAR CARCINOMA#0.8025;MUSCLE CELL#0.7927;TUMOR CELLS#0.7893;CARDIAC MUSCLE#0.7656;SMOOTH MUSCLE CELL#0.7642;LYMPH NODE METASTASIS#0.7373;ADENOCARCINOMA#0.7370;CELL SURFACE#0.7320;LYMPH NODE#0.7320;PODOCYTE#0.7316;GROWTH FACTOR#0.7295;LUNG CANCER#0.7291;INTERCALATED DISC#0.7026;PLASMA MEMBRANE#0.6943;PANCREATIC DUCTAL ADENOCARCINOMA#0.6858;PROLINE SYNTHESIS#0.6462;MACROPHAGE#0.6364;DISEASE FREE SURVIVAL#0.6338;OSTEOBLAST#0.6322;PHOSPHOINOSITIDE BINDING#0.6299;UNILATERAL URETERAL OBSTRUCTION#0.6136;URETERAL OBSTRUCTION#0.6121;CLEAR CELL RENAL CELL CARCINOMA#0.6090;RENAL FIBROSIS#0.6078;ADHERENS JUNCTION#0.6066;TUBULAR EPITHELIAL CELL#0.6054;TRANSMEMBRANE RECEPTOR#0.6024;UBIQUITIN#0.6020;MAMMARY GLAND#0.6006
10980	COP9 SIGNALOSOME#1.0494;SIGNALOSOME#1.0446;UBIQUITIN#1.0094;CANCER CELL#0.9479;CELL CYCLE#0.9219;PROTEASOME#0.9175;SIGNALING PATHWAY#0.9074;PHOTOMORPHOGENESIS#0.9033;CELL PROLIFERATION#0.8953;CELL GROWTH#0.8649;PROTEIN DEGRADATION#0.8537;APOPTOSIS#0.8444;CERVICAL CANCER#0.8323;26S PROTEASOME#0.6904;ISOPEPTIDASE ACTIVITY#0.6900;PROTEIN COMPLEX#0.6839;CERVICAL#0.6498;SIGNAL TRANSDUCTION#0.6386;BREAST CANCER#0.6243;LUNG ADENOCARCINOMA#0.6217
10981	MELANOSOME#1.0746;MELANOCYTE#1.0270;NUCLEOTIDE EXCHANGE FACTOR#0.9674;ORGANELLE#0.9483;MITOCHONDRIA#0.9217;LYSOSOME#0.8485;GUANINE#0.8461;MELANOSOME BIOGENESIS#0.8346;ENDOSOME#0.8239;AUTOPHAGY#0.7713;RELATED PROTEIN 1#0.7519;VACUOLE#0.7297;EARLY ENDOSOME#0.6598;APOPTOSIS#0.6488;LIPID STORAGE#0.6312;ANCHORING#0.6203;GTP BINDING#0.6156;COLON CANCER#0.6150;AUTOPHAGOSOME#0.6116
10982	MICROTUBULE END#1.0803;MICROTUBULE PLUS END#1.0616;TRANSCRIPTION FACTOR#1.0530;EPSTEIN BARR VIRUS#1.0434;MICROTUBULE#1.0373;MICROTUBULE DYNAMICS#1.0292;BINDING PROTEIN 1#1.0181;CANCER CELL#1.0122;T CELL#0.9623;MICROTUBULE BINDING#0.9145;B CELL#0.9119;DNA BINDING#0.8893;NEURITE OUTGROWTH#0.8543;MICROTUBULE ASSOCIATED PROTEIN#0.8432;PROTEIN KINASE#0.8293;CELL CYCLE#0.8048;CELL ADHESION#0.7984;MICROTUBULE POLYMERIZATION#0.7866;CELL MIGRATION#0.7774;MICROTUBULE PLUS-END BINDING#0.7679;LUNG CANCER#0.7620;BREAST CANCER CELL#0.7575;EPITHELIAL CELL#0.7547;BREAST CANCER#0.7295;CELL CORTEX#0.7230;APOPTOSIS#0.7225;FOCAL ADHESION#0.7204;NEURITE#0.6928;GENE EXPRESSION#0.6924;INTERPHASE#0.6843;PROTEIN KINASE C#0.6787;REACTIVE OXYGEN SPECIES#0.6616;CENTROSOME#0.6498;ADENOMATOUS POLYPOSIS COLI#0.6495;TUBULIN BINDING#0.6359;MITOSIS#0.6302;MICROTUBULE ASSEMBLY#0.6188;GROWING MICROTUBULE PLUS END#0.6139;CELL DEATH#0.6097;VIRAL GENOME#0.6052;PANCREATIC CANCER#0.6012
10983	CELL CYCLE#1.0641;CYCLIN DEPENDENT KINASE#0.9132;APOPTOSIS#0.8678;PODOCYTE#0.8415;EPITHELIAL OVARIAN CANCER#0.8117;OVARIAN CANCER#0.8006;ANGIOGENESIS#0.7950;CELL CYCLE REGULATION#0.7451;BREAST CANCER#0.7080;PODOCYTE APOPTOSIS#0.6637;CANCER CELL#0.6352;HUMAN BREAST CANCER#0.6263;CELL PROLIFERATION#0.6150
10984	LOSS OF METHYLATION#1.0692;IMPRINTING CONTROL REGION#1.0448;ANTISENSE RNA#1.0386;CELL PROLIFERATION#1.0363;APOPTOSIS#1.0321;DIFFERENTIALLY METHYLATED REGION#1.0248;CANCER CELL#1.0242;OOCYTE#1.0229;COLORECTAL CANCER#1.0159;NEMO LIKE KINASE#1.0137;DNA METHYLATION#1.0068;POLYMERASE CHAIN REACTION#1.0048;BECKWITH-WIEDEMANN SYNDROME#1.0009;GENE EXPRESSION#0.9835;STEM CELL#0.9742;GENE SILENCING#0.9627;SIGNALING PATHWAY#0.9618;GROWTH FACTOR#0.9585;HISTONE MODIFICATION#0.9520;QUANTITATIVE REAL TIME#0.9352;ASSISTED REPRODUCTIVE TECHNOLOGIES#0.9244;COLORECTAL#0.9093;ASSISTED REPRODUCTIVE TECHNOLOGY#0.8882;CYCLIN DEPENDENT KINASE#0.8781;TRANSCRIPTION FACTOR#0.8634;REVERSE TRANSCRIPTION#0.8532;DEMETHYLATION#0.8491;DUAL LUCIFERASE REPORTER#0.8440;KINASE INHIBITOR#0.8274;CYCLIN DEPENDENT KINASE INHIBITOR#0.8193;CORD BLOOD#0.8062;SILVER RUSSELL SYNDROME#0.8047;EPITHELIAL MESENCHYMAL TRANSITION#0.7985;FERTILIZATION#0.7978;LUNG CANCER#0.7971;OVARIAN CANCER#0.7954;MYOCARDIAL INFARCTION#0.7896;HEPATOCELLULAR CARCINOMA#0.7893;CELL DIVISION#0.7883;CELL CYCLE#0.7818;TUMOR SUPPRESSOR#0.7793;PYROPTOSIS#0.7741;MAP KINASE#0.7608;AUTOPHAGY#0.7569;PROTEIN KINASE#0.7539;HYPOXIA INDUCIBLE FACTOR#0.7432;SQUAMOUS CELL CARCINOMA#0.7386;ENDOTHELIAL CELL#0.7361;OVARIAN#0.7322;ADENOCARCINOMA#0.7015;INSULIN-LIKE GROWTH FACTOR#0.6895;IRON TRANSPORT#0.6870;NUCLEAR EXPORT#0.6790;ACUTE MYELOID LEUKEMIA#0.6769;MYELOID LEUKEMIA#0.6754;GERM CELL#0.6644;METHYLATION SPECIFIC PCR#0.6574;GESTATION#0.6539;CELL DEATH#0.6476;LYSINE#0.6476;MAXILLARY SINUS SQUAMOUS CELL CARCINOMA#0.6342;LUNG ADENOCARCINOMA#0.6333;CHROMATIN MODIFICATION#0.6323;LYMPH NODE METASTASIS#0.6316;MACROPHAGE#0.6286;RNA INTERFERENCE#0.6274;LYMPH NODE#0.6273;GERMINAL VESICLE#0.6193;SPERMATOGENESIS#0.6153;TONGUE CANCER#0.6150;INFERTILITY#0.6148;HYPOXIA#0.6123;KINASE ACTIVITY#0.6064;SIGNALLING PATHWAY#0.6061;MUSCLE CELL#0.6033;DNA METHYLTRANSFERASE#0.6031
10985	RIBOSOME#1.0148;TRANSLATION INITIATION#0.9745;TRANSLATION INITIATION FACTOR#0.9609;PROTEIN KINASE#0.8497;TRANSLATION ELONGATION#0.8043;KINASE ACTIVITY#0.8015;RIBOSOME BINDING#0.7937;POLYRIBOSOME#0.7744;TRANSLATION ELONGATION FACTOR#0.6907;PROTEIN SYNTHESIS#0.6849;RIBOSOMAL PROTEIN#0.6218
10986	COMMON VARIABLE IMMUNODEFICIENCY#0.7626
10987	ISOPEPTIDASE ACTIVITY#1.0958;NUCLEAR EXPORT#1.0656;BINDING PROTEIN 1#1.0533;PANCREATIC CANCER#1.0483;BREAST CANCER#1.0457;CYTOPLASM#1.0424;BREAST CANCER CELL#1.0423;BREAST CARCINOMA#1.0371;SQUAMOUS CELL CARCINOMA#1.0326;CANCER CELL#1.0312;CYCLIN DEPENDENT KINASE INHIBITOR#1.0289;LUNG CANCER#1.0286;TUMOR SUPPRESSOR#1.0273;DNA REPAIR#1.0247;CELL PROLIFERATION#1.0235;HEPATOCELLULAR CARCINOMA#1.0199;KINASE INHIBITOR#1.0185;APOPTOSIS#1.0176;SIGNALOSOME#1.0174;CYCLIN DEPENDENT KINASE#1.0164;COP9 SIGNALOSOME#1.0164;COLORECTAL CANCER#1.0133;TRANSCRIPTION FACTOR#1.0132;SIGNALING PATHWAY#1.0097;CELL GROWTH#1.0028;CELL CYCLE#1.0014;GENE EXPRESSION#0.9984;PROTEASOME#0.9969;CELL CYCLE ARREST#0.9957;ONCOGENIC#0.9957;26S PROTEASOME#0.9953;ACTIVATOR PROTEIN 1#0.9912;UBIQUITIN#0.9865;OVARIAN#0.9806;DNA BINDING#0.9766;PROTEIN COMPLEX#0.9756;MACROPHAGE#0.9715;BREAST CANCER PATIENTS#0.9703;KINASE INHIBITOR P27#0.9691;SIGNAL TRANSDUCTION#0.9650;MIGRATION INHIBITORY FACTOR#0.9612;S PHASE#0.9578;PROTEIN KINASE#0.9569;PROTEIN DEGRADATION#0.9556;MACROPHAGE MIGRATION#0.9550;GROWTH FACTOR#0.9481;COMPLEX I#0.9307;APOPTOTIC#0.9273;COLORECTAL#0.9273;PROTEIN PROTEIN INTERACTION#0.9214;STEM CELL#0.9209;CELL CYCLE REGULATOR#0.9136;HUMAN BREAST CANCER#0.9076;CELL CYCLE REGULATION#0.9026;CISPLATIN#0.9000;CELL DEATH#0.8875;CELL CYCLE CONTROL#0.8844;UBIQUITIN PROTEASOME SYSTEM#0.8741;T CELL#0.8621;ADENOCARCINOMA#0.8489;LYMPH NODE#0.8436;EPITHELIAL CELL#0.8372;CDK INHIBITOR#0.8357;ATHEROSCLEROTIC#0.8203;DEUBIQUITINATING ENZYME#0.8153;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.8130;PHOTOMORPHOGENESIS#0.8123;HYPOXIA#0.8108;TUMOR CELLS#0.8094;TUMOR TISSUES#0.8014;RNA INTERFERENCE#0.8004;ORAL SQUAMOUS CELL CARCINOMA#0.8002;LUNG ADENOCARCINOMA#0.7972;CELL SURFACE#0.7961;OOCYTE#0.7929;GALL BLADDER#0.7691;EPITHELIAL OVARIAN CARCINOMA#0.7691;G1 PHASE#0.7637;KINASE ACTIVITY#0.7610;MITOGEN ACTIVATED PROTEIN#0.7597;SENESCENCE#0.7580;DEUBIQUITINATION#0.7531;DNA DAMAGE RESPONSE#0.7529;DENEDDYLASE ACTIVITY#0.7488;PROGENITOR CELL#0.7433;AKT SIGNALING#0.7417;CELL DEVELOPMENT#0.7297;OVARIAN CARCINOMA#0.7279;ENDOTHELIAL CELL#0.7241;UBIQUITIN PROTEASOME PATHWAY#0.7235;PROTEASOME PATHWAY#0.7222;B CELL#0.7036;CELL ADHESION#0.7031;COP9 COMPLEX#0.6983;UNFOLDED PROTEIN RESPONSE#0.6945;ONCOGENESIS#0.6931;COLON CANCER#0.6888;PROSTATE CANCER#0.6868;DNA REPLICATION#0.6819;ADJACENT NORMAL TISSUE#0.6765;HYPOXIC#0.6720;THYROID CARCINOMA#0.6718;TRANSFORMING GROWTH FACTOR#0.6709;MIF BINDING#0.6673;CULLIN-RING LIGASE#0.6573;HEPATITIS B VIRUS#0.6511;HYPOXIA INDUCIBLE FACTOR#0.6510;HEPATITIS B#0.6496;UBIQUITIN LIGASE COMPLEX#0.6384;P GRANULE#0.6358;SPERMATOCYTES#0.6310;CHONDROCYTE#0.6250;LYMPH NODE METASTASIS#0.6208;DNA REPAIR PROTEIN#0.6163;ERBB2 SIGNALING PATHWAY#0.6070;LIMB DEVELOPMENT#0.6060;SIGNALING MOLECULE#0.6048;INVASIVE BREAST CARCINOMA#0.6032;ESTROGEN RECEPTOR#0.6023
10988	FUMAGILLIN#1.0720;EUKARYOTIC INITIATION FACTOR#1.0657;MICROTUBULE ASSOCIATED PROTEIN#1.0437;MICROTUBULE#1.0424;PROTEIN SYNTHESIS#1.0423;ENDOTHELIAL CELL#1.0357;METHIONINE#1.0300;CELL GROWTH#1.0283;CELL PROLIFERATION#1.0264;ANGIOGENESIS#1.0162;NADPH OXIDASE#1.0123;OVALICIN#0.9907;CELL MEMBRANE#0.9877;ENDOTHELIAL CELL PROLIFERATION#0.9847;CANCER CELL#0.9806;CELL CYCLE#0.9522;WEIGHT LOSS#0.9210;GROWTH FACTOR#0.9099;B CELL#0.9074;NEUTROPHIL#0.9071;APOPTOSIS#0.8987;PROTEIN KINASE#0.8869;UMBILICAL VEIN#0.8472;GENE EXPRESSION#0.8426;ENZYME ACTIVITY#0.8410;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8348;HUMAN UMBILICAL VEIN#0.8343;TRANSLATION INITIATION#0.8313;MECHANISM OF ACTION#0.8039;RETICULOCYTE#0.7926;GERMINAL CENTER B CELL#0.7714;GERMINAL CENTER B#0.7709;TELOMERASE ACTIVITY#0.7624;GERMINAL CENTER#0.7601;NEURITE#0.7426;TRANSLATION INITIATION FACTOR#0.7383;CATALYTIC ACTIVITY#0.7299;MYOBLAST#0.7253;OBESE#0.7214;REGULATION OF PROTEIN SYNTHESIS#0.7175;SULFONAMIDE#0.7058;LYSINE#0.6821;SKELETAL MUSCLE#0.6714;NITROXOLINE#0.6650;CELL CYCLE ARREST#0.6531;ISCHEMIA#0.6513;HEME REGULATED INHIBITOR#0.6465;ALANINE#0.6383;APOPTOTIC#0.6366;GLYCOSYLATION#0.6297;STEM CELL#0.6200;TRANSLATIONAL INITIATION#0.6161;MICROSPORIDIOSIS#0.6102;BODY WEIGHT LOSS#0.6057;ALPHA GLUCOSIDASE#0.6056
10989	MICOS COMPLEX#1.0505;CRISTA JUNCTION#1.0497;MITOCHONDRIAL INNER MEMBRANE#1.0419;MITOCHONDRIAL CRISTAE#1.0395;MICROTUBULE MOTOR#1.0362;ATP SYNTHASE#1.0307;CRISTAE#1.0248;OUTER HAIR CELL#1.0215;PROTEIN COMPLEX#1.0213;DYNEIN#1.0196;HAIR CELL#1.0158;MICROTUBULE BASED#1.0152;KINESIN#1.0100;ADENOSINE TRIPHOSPHATE#1.0098;MYOSIN HEAVY CHAIN#1.0016;PROTEIN TRANSPORT#1.0004;KINETOCHORE#0.9993;MICROTUBULE#0.9975;MITOCHONDRIAL MEMBRANE#0.9957;NON-MUSCLE MYOSIN#0.9949;INTRACELLULAR TRANSPORT#0.9943;AXONAL TRANSPORT#0.9935;OUTER MEMBRANE#0.9932;ADENOSINE#0.9927;ATP HYDROLYSIS#0.9926;VESICLE TRANSPORT#0.9924;CONTACT SITE#0.9922;KINESIN LIGHT CHAIN#0.9908;SPINDLE ASSEMBLY#0.9894;SKELETAL MUSCLE#0.9888;CENTROSOME#0.9887;INNER EAR#0.9883;CYTOKINESIS#0.9881;CELL CORTEX#0.9880;SPINDLE POLE#0.9862;MICROTUBULE ASSOCIATED PROTEIN#0.9858;MICROTUBULE MINUS END#0.9855;ACTIN FILAMENT#0.9855;OXIDATIVE PHOSPHORYLATION#0.9826;MITOTIC SPINDLE#0.9816;ACTIN CYTOSKELETON#0.9815;CHROMOSOME SEGREGATION#0.9805;SYNAPTIC VESICLE#0.9799;MITOSIS#0.9790;ORGANELLE#0.9775;MEIOSIS#0.9770;SIGNALING PATHWAY#0.9764;MUSCLE CONTRACTION#0.9763;COMPLEX I#0.9751;CELL DIVISION#0.9751;PROTEIN IMPORT#0.9739;ENDOCYTOSIS#0.9736;MICROTUBULE BINDING#0.9736;PLASMA MEMBRANE#0.9719;CELL MIGRATION#0.9713;MITOCHONDRIA#0.9694;CELL SURFACE#0.9694;ATPASE ACTIVITY#0.9681;PROTEIN KINASE#0.9681;MICROTUBULE DYNAMICS#0.9678;CELL CYCLE#0.9668;ANAPHASE#0.9656;RETROGRADE AXONAL TRANSPORT#0.9656;CELL DEATH#0.9643;CYTOCHROME C#0.9643;DYNACTIN COMPLEX#0.9637;ATP BINDING#0.9629;MUSCLE CELL#0.9626;DYNEIN LIGHT CHAIN#0.9620;MORPHOGENESIS#0.9619;ENDOPLASMIC RETICULUM#0.9609;CELL PROLIFERATION#0.9601;APOPTOSIS#0.9595;MOTOR ACTIVITY#0.9588;CANCER CELL#0.9572;ENDOSOME#0.9561;CYTOPLASM#0.9554;ACTOMYOSIN#0.9550;NUCLEOTIDE BINDING#0.9543;LIGHT CHAIN 1#0.9543;EPITHELIAL CELL#0.9537;TRANSCRIPTION FACTOR#0.9535;SPINDLE FORMATION#0.9524;TRANSPORT ALONG MICROTUBULE#0.9518;MITOCHONDRIAL DNA#0.9514;NERVOUS SYSTEM#0.9499;GROWTH FACTOR#0.9497;METAPHASE#0.9474;REACTIVE OXYGEN SPECIES#0.9472;CELL BODY#0.9468;CELL ADHESION#0.9461;ACTIN BINDING#0.9458;CENTROMERE#0.9453;ASTRAL MICROTUBULE#0.9439;OOCYTE#0.9434;BUDDING#0.9429;NEURODEGENERATIVE DISEASE#0.9423;RIBOSOME#0.9404;RESPIRATORY CHAIN#0.9386;GENE EXPRESSION#0.9352;INTRAFLAGELLAR TRANSPORT#0.9350;RNA INTERFERENCE#0.9322;VESICULAR TRANSPORT#0.9318;CELL MEMBRANE#0.9303;CHROMOSOME CONGRESSION#0.9261;C TERMINAL DOMAIN#0.9259;INTERPHASE#0.9248;CHROMOSOME MOVEMENT#0.9236;HOST CELL#0.9227;MUSCLE FIBER#0.9223;CYTOPLASMIC MEMBRANE#0.9218;HEARING LOSS#0.9209;LYSOSOME#0.9206;CELL MOTILITY#0.9203;INNER MITOCHONDRIAL MEMBRANE#0.9184;NEURITE#0.9177;ATP SYNTHESIS#0.9161;NOCODAZOLE#0.9110;NUCLEIC ACID#0.9103;ALZHEIMER'S DISEASE#0.9102;CALMODULIN BINDING#0.9102;MICROTUBULE ORGANIZING CENTER#0.9095;DYNACTIN MOTOR#0.9082;STEM CELL#0.9066;MTDNA#0.9047;NUCLEAR ENVELOPE#0.9006;T CELL#0.8957;VESICLE TRAFFICKING#0.8954;MICROTUBULE PLUS END#0.8941;SPINDLE MICROTUBULE#0.8935;CELL GROWTH#0.8905;DNA BINDING#0.8901;MELANOSOME#0.8894;RESPIRATION#0.8891;CELL POLARITY#0.8875;NEURONAL CELLS#0.8869;HEAT SHOCK PROTEIN#0.8840;COCHLEA#0.8816;OPTIC ATROPHY#0.8806;MEIOTIC SPINDLE#0.8770;SIGNAL TRANSDUCTION#0.8770;M PHASE#0.8759;NEUROPATHY#0.8731;GOLGI APPARATUS#0.8712;SPINDLE POSITIONING#0.8709;SMOOTH MUSCLE#0.8676;RESONANCE ENERGY TRANSFER#0.8633;ELECTRON TRANSPORT#0.8626;MICROFILAMENT#0.8610;CENTRAL NERVOUS SYSTEM#0.8564;MUTAGENESIS#0.8527;PROTEIN PROTEIN INTERACTION#0.8513;CELL PERIPHERY#0.8494;HOMOLOGOUS RECOMBINATION#0.8493;SPINAL CORD#0.8489;PROTEIN SYNTHESIS#0.8456;POLYMERASE CHAIN REACTION#0.8391;TOTAL INTERNAL REFLECTION#0.8389;AUTOPHAGY#0.8378;THICK FILAMENT#0.8362;MOVEMENT ALONG MICROTUBULE#0.8352;CHARCOT MARIE TOOTH#0.8341;MINOS COMPLEX#0.8328;MITOTIC CHROMOSOME#0.8325;HYPOXIA#0.8323;CARDIOMYOPATHY#0.8317;NUCLEAR MIGRATION#0.8274;BREAST CANCER#0.8274;LOCOMOTION#0.8256;MELANOSOME TRANSPORT#0.8254;MACROPHAGE#0.8222;HYPERTROPHIC CARDIOMYOPATHY#0.8147;APOPTOTIC#0.8109;PROTEIN BINDING#0.8087;EXOCYTOSIS#0.8074;MOLECULAR DYNAMICS SIMULATION#0.8066;SARCOMERE#0.8055;AMYLOID PRECURSOR PROTEIN#0.8055;MIB COMPLEX#0.8042;FLAGELLUM#0.8041;PEROXISOME#0.8031;MICROTUBULE CYTOSKELETON#0.8021;PROTEASOME#0.7970;KINETOCHORE MICROTUBULE#0.7960;REGULATORY LIGHT CHAIN#0.7934;ENDOTHELIAL CELL#0.7923;LEUCINE#0.7906;DYNEIN COMPLEX#0.7901;SPINDLE ELONGATION#0.7890;MELANOCYTE#0.7876;OUTER MITOCHONDRIAL MEMBRANE#0.7860;UBIQUITIN#0.7845;CENTROSOME SEPARATION#0.7824;MITOCHONDRIAL INTERMEMBRANE SPACE#0.7791;DENDRITIC TRANSPORT#0.7784;CYTOCHROME C OXIDASE#0.7778;TUMOR SUPPRESSOR#0.7771;GROWTH CONE#0.7766;CARDIAC MUSCLE#0.7753;HEREDITARY SPASTIC PARAPLEGIA#0.7734;MITOCHONDRIAL OUTER MEMBRANE#0.7708;MITOCHONDRIAL FISSION#0.7702;ELECTRON TRANSPORT CHAIN#0.7685;EXTRACELLULAR MATRIX#0.7674;MITOTIC CHECKPOINT#0.7661;OPTIC NERVE#0.7653;CRISTAE FORMATION#0.7645;RNA BINDING#0.7625;NUCLEAR MEMBRANE#0.7620;MIDBODY#0.7599;NUCLEOSOME#0.7575;LIGHT INTERMEDIATE CHAIN#0.7571;TOXICITY#0.7535;MEIOSIS I#0.7526;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7519;CARDIOLIPIN#0.7518;SYNAPTIC TRANSMISSION#0.7511;CRISTAE JUNCTION#0.7502;ANCHORING#0.7497;MONASTROL#0.7487;MITOCHONDRIAL LOCALIZATION#0.7474;PROTEIN SECRETION#0.7466;ACTIN POLYMERIZATION#0.7461;ANTEROGRADE AXONAL TRANSPORT#0.7459;INTRACELLULAR VESICLE#0.7454;INTERMEDIATE FILAMENT#0.7440;SALICYLATE#0.7434;MECHANISM OF ACTION#0.7398;PROTEIN KINASE C#0.7392;AUTOPHAGOSOME#0.7371;ADENINE#0.7339;NITRIC OXIDE#0.7299;MICROTUBULE SLIDING#0.7288;DNA REPAIR#0.7288;TOOTH DISEASE#0.7286;CHARCOT-MARIE-TOOTH DISEASE#0.7286;SWELLING#0.7276;PODOCYTE#0.7261;PARAPLEGIA#0.7257;CELL WALL#0.7216;RNA BINDING PROTEIN#0.7215;TELOPHASE#0.7199;SPINDLE ORIENTATION#0.7144;NEUROMUSCULAR JUNCTION#0.7115;CYTOSKELETAL ELEMENT#0.7081;AMYOTROPHIC LATERAL SCLEROSIS#0.7068;LATERAL SCLEROSIS#0.7068;ORGAN OF CORTI#0.7067;REGENERATION#0.7054;CELL DIFFERENTIATION#0.7048;RESPIRATORY CHAIN COMPLEX#0.7041;MEMBRANE BENDING#0.7037;AXONEME#0.7005;GTP HYDROLYSIS#0.6998;MAP KINASE#0.6963;BIPOLAR SPINDLE FORMATION#0.6960;MUSCLE WEAKNESS#0.6942;TAXOL#0.6941;DNA PACKAGING#0.6929;SIGNAL PEPTIDE#0.6919;ACTIN CABLE#0.6907;NUCLEAR TRANSPORT#0.6904;CYTOPLASMIC MICROTUBULE#0.6904;TRICHOME MORPHOGENESIS#0.6895;MITOTIC SPINDLE ASSEMBLY#0.6887;POST-TRANSLATIONAL MODIFICATION#0.6880;MYOPATHY#0.6832;KINASE ACTIVITY#0.6774;STRUCTURAL ORGANIZATION#0.6769;GOLGI COMPLEX#0.6769;MICROTUBULE BUNDLE#0.6754;SPERMATOGENESIS#0.6752;FILAMENTOUS ACTIN#0.6751;CENTRAL SPINDLE#0.6751;DENDRITIC SPINE#0.6747;STRESS FIBER#0.6742;SPINDLE POLE BODY#0.6722;GLUTAMATE RECEPTOR#0.6701;LIPID RAFT#0.6693;CELL CYCLE ARREST#0.6684;T LYMPHOCYTE#0.6677;MEMBRANE PROTEIN COMPLEX#0.6650;LOCALISATION#0.6625;SECRETORY VESICLE#0.6614;IMMUNOPHILIN#0.6608;CHEMOTAXIS#0.6605;AGGRESOME#0.6590;NEURONAL MIGRATION#0.6585;MITOCHONDRIAL FUSION#0.6529;S PHASE#0.6507;CLATHRIN-MEDIATED ENDOCYTOSIS#0.6502;NUCLEAR PORE#0.6491;MUSCLE FIBRE#0.6485;PROPHASE#0.6478;EARLY ENDOSOME#0.6470;INTRACELLULAR LOCALIZATION#0.6457;LIPID DROPLET#0.6452;ALANINE#0.6433;PROTEIN DEGRADATION#0.6428;NMDA RECEPTOR#0.6422;FOCAL ADHESION#0.6414;MEMBRANE ORGANIZATION#0.6407;NUCLEAR POSITIONING#0.6402;MULTIPLE SCLEROSIS#0.6392;CARDIOLIPIN BINDING#0.6390;LATERAL PLASMA MEMBRANE#0.6374;IMMUNE RESPONSE#0.6357;ASPARTATE#0.6356;CELL FUSION#0.6292;CELLULAR COMPONENT#0.6282;BREAST CANCER CELL#0.6276;LATERAL WALL#0.6269;CYTOCHROME C RELEASE#0.6258;VACUOLE#0.6237;CYCLIN DEPENDENT KINASE#0.6229;PROTEIN RECRUITMENT#0.6204;MUSCLE WASTING#0.6188;CELL NUCLEUS#0.6150;ACTIN BINDING PROTEIN#0.6143;SUCROSE#0.6129;MITOCHONDRIAL CRISTA#0.6109;WOLF-HIRSCHHORN SYNDROME#0.6092;CHROMATID#0.6090;DNA REPLICATION#0.6088;ION CHANNEL#0.6087;SPINDLE ASSEMBLY CHECKPOINT#0.6059;MYOFIBRIL#0.6035;MYOSIN BINDING#0.6023;MYOSIN LIGHT-CHAIN KINASE#0.6022;MICROTUBULE ASSEMBLY#0.6015
10990	PERIPHERAL MONOCYTE#0.6624;LEUKOCYTE#0.6034
10991	GLUTAMINE#1.0438;GLUTAMINE TRANSPORT#1.0409;ASTROCYTE#1.0371;METABOLIC ACIDOSIS#0.9818;OOCYTE#0.9441;PROTEIN KINASE#0.9387;PROTEIN KINASE C#0.8563;PLASMA MEMBRANE#0.8542;GLYCINE#0.8349;MALIGNANT GLIOMA#0.8180;HISTIDINE#0.7907;L-GLUTAMINE#0.7846;AMINO ACID TRANSPORT#0.7795;ALANINE#0.7427;CELL MEMBRANE#0.7116;ACID SECRETION#0.6638;GLIAL CELL#0.6590;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.6427;UBIQUITIN#0.6320;EPITHELIAL CELL#0.6248;CARDIAC DEVELOPMENT#0.6159
10992	U2 SNRNP#1.0091;SPLICEOSOME#0.9625;RNA BINDING#0.8798;RNA SPLICING#0.8475;MRNA SPLICING#0.6627;CELL CYCLE#0.6559;SPLICEOSOME ASSEMBLY#0.6478;PRE-MRNA SPLICING#0.6318
10993	L-THREONINE#1.0623;L-SERINE#1.0477;SUCCINATE DEHYDROGENASE#1.0466;PHOSPHOENOLPYRUVATE CARBOXYKINASE#1.0185;ALANINE#1.0113;PYRUVATE#1.0111;DEXAMETHASONE#1.0075;SUCCINATE#0.9962;GLUCONEOGENESIS#0.9947;PYRIDOXAL 5-PHOSPHATE#0.9929;PYRIDOXAL#0.9904;PHOSPHOENOLPYRUVATE#0.9841;GENE EXPRESSION#0.9835;CYCLIC AMP#0.9760;ORNITHINE#0.9759;GLUCOSE 6 PHOSPHATASE#0.9758;PYRIDOXAL PHOSPHATE#0.9751;ENZYME ACTIVITY#0.9749;GLYCINE#0.9749;PHOSPHOGLYCERATE DEHYDROGENASE#0.9706;GLUTAMINE#0.9648;ASPARTATE#0.9635;SERINE RACEMASE#0.9091;GLUTAMATE DEHYDROGENASE#0.9013;TRYPTOPHAN#0.9003;LEUCINE#0.8854;ADENYLATE#0.8644;DIGESTION#0.8429;MUSCLE FIBER#0.8395;CATABOLISM#0.8303;ADENOSINE#0.8272;LYSINE#0.7861;PROTEIN SYNTHESIS#0.7830;PYRUVATE KINASE#0.7694;METHIONINE#0.7675;CATALYTIC ACTIVITY#0.7511;ATPASE ACTIVITY#0.7108;COENZYME A#0.7102;L-METHIONINE#0.6832;GLUCOSE-6-PHOSPHATE#0.6788;AMINOTRANSFERASE ACTIVITY#0.6603;AMP DEAMINASE#0.6460;LYASE ACTIVITY#0.6439;ADENOSINE DEAMINASE#0.6371;OXYGENASE#0.6352;N-ETHYLMALEIMIDE#0.6213;GLYCINE CLEAVAGE SYSTEM#0.6184;D-SERINE#0.6107;ISOLEUCINE#0.6086;FRUCTOSE#0.6085;GLYCOLYSIS#0.6053;MITOCHONDRIA#0.6018
10998	COA LIGASE#1.1225;FATTY ACID TRANSPORT#1.0907;LIPID METABOLISM#0.8932;LIVER DISEASE#0.8473;N ACYLTRANSFERASE#0.8349;FATTY LIVER#0.8239;CONJUGATION#0.8093;FATTY LIVER DISEASE#0.7706;COENZYME A#0.7625;BILE ACID METABOLISM#0.7462;HIGH FAT DIET#0.7305;GENE EXPRESSION#0.7206;FATTY ACID TRANSPORTER#0.7125;MICROSOME#0.6302;ADENO ASSOCIATED VIRUS#0.6184;BILE ACID CONJUGATION#0.6120
10999	FATTY ACID TRANSPORTER#1.0606;FATTY ACID TRANSPORT#1.0451;ICHTHYOSIS#1.0281;PLASMA MEMBRANE#0.9797;FATTY ACID BINDING#0.9706;SKELETAL MUSCLE#0.9667;PREMATURITY#0.9479;HIGH FAT DIET#0.9125;LIPID METABOLISM#0.9048;GENE EXPRESSION#0.8992;ADIPOCYTE#0.8691;ADIPOSE TISSUE#0.8642;FATTY ACID TRANSLOCASE#0.8459;FATTY ACID OXIDATION#0.8330;KERATINOCYTE#0.8231;SMALL INTESTINE#0.8127;CANCER CELL#0.7299;ENTEROCYTE#0.7033;FATTY ACID SYNTHASE#0.6646;LIPOPROTEIN LIPASE#0.6622;CORD BLOOD#0.6422;PROTEIN KINASE#0.6307;ACYL-COA SYNTHETASE ACTIVITY#0.6054
109	ADENYLATE CYCLASE#1.0750;ADENYLATE#1.0732;MAIN OLFACTORY EPITHELIUM#1.0212;OLFACTORY EPITHELIUM#1.0037;SIGNALING PATHWAY#0.9531;OLFACTORY SENSORY NEURON#0.9498;GENE EXPRESSION#0.9489;PROTEIN KINASE#0.9389;FORSKOLIN#0.9291;CAMP SIGNALING#0.9052;SIGNAL TRANSDUCTION#0.9018;OLFACTORY RECEPTOR#0.8984;CYCLIC AMP#0.8889;CYCLIC NUCLEOTIDE GATED#0.8716;NERVOUS SYSTEM#0.8603;SMOOTH MUSCLE#0.8551;OBESE#0.7989;OLFACTORY BULB#0.7581;CENTRAL NERVOUS SYSTEM#0.7504;PROTEIN KINASE A#0.7327;CAMKII#0.6982;TYPE 2 DIABETES#0.6979;CILIUM#0.6907;ADIPOSE TISSUE#0.6896;PRIMARY CILIUM#0.6816;ADENOSINE#0.6520;LIRAGLUTIDE#0.6488;PLASMA MEMBRANE#0.6380;CYCLIC ADENOSINE MONOPHOSPHATE#0.6348;OLFACTION#0.6344;ADENOSINE MONOPHOSPHATE#0.6331;MUSCLE CELL#0.6273;CORPUS LUTEUM#0.6105
10	XANTHINE OXIDASE#1.0573;XANTHINE#1.0533;ARYLAMINE N ACETYLTRANSFERASE#1.0347;PROSTATE CANCER#1.0344;N ACETYLTRANSFERASE#1.0304;SULFAMETHAZINE#1.0303;EPOXIDE HYDROLASE#1.0298;ARYLAMINE#1.0255;CAFFEINE#1.0232;CYTOCHROME P450#1.0214;MUTAGENICITY#1.0210;PARKINSON'S DISEASE#1.0207;SQUAMOUS CELL CARCINOMA#1.0195;HEPATOTOXICITY#1.0192;LUNG CANCER#1.0191;N-ACETYLTRANSFERASE ACTIVITY#1.0180;MUTAGENESIS#1.0172;ISONIAZID#1.0164;BREAST CANCER#1.0157;URINARY BLADDER CANCER#1.0155;COLORECTAL#1.0153;FRAGMENT LENGTH POLYMORPHISM#1.0141;POLYMERASE CHAIN REACTION#1.0139;GLUTATHIONE#1.0135;HEPATOCELLULAR CARCINOMA#1.0129;ACETYLTRANSFERASE ACTIVITY#1.0103;COLON CANCER#1.0091;COLORECTAL CANCER#1.0077;URINARY BLADDER#1.0070;SULFASALAZINE#1.0059;ENZYME ACTIVITY#1.0045;PERIPHERAL BLOOD#1.0039;DNA REPAIR#1.0005;ENDOMETRIOSIS#0.9993;DAPSONE#0.9991;FOLATE#0.9980;TUBERCULOSIS#0.9980;XENOBIOTIC METABOLIZING ENZYME#0.9977;MUTAGEN#0.9976;DRUG METABOLISM#0.9971;DETOXIFICATION#0.9944;LUPUS ERYTHEMATOSUS#0.9928;TOXICITY#0.9907;DRUG-INDUCED HEPATITIS#0.9896;COLORECTAL ADENOMA#0.9895;POLYCYCLIC AROMATIC HYDROCARBON#0.9886;CARCINOGEN#0.9886;XENOBIOTIC METABOLISM#0.9885;RHEUMATOID ARTHRITIS#0.9855;DIABETES MELLITUS#0.9838;ADVERSE DRUG REACTION#0.9774;WHITE BLOOD CELL#0.9739;EXCRETION#0.9692;GENOTOXIC#0.9684;GENE EXPRESSION#0.9658;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9635;MUTAGENIC#0.9571;DEXTROMETHORPHAN#0.9554;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9511;CATALYTIC ACTIVITY#0.9482;NON HODGKIN LYMPHOMA#0.9442;EPITHELIAL CELL#0.9379;INFLAMMATORY BOWEL DISEASE#0.9363;PULMONARY TUBERCULOSIS#0.9362;ADENOCARCINOMA#0.9339;ADJUSTED ODDS RATIO#0.9244;GLUTATHIONE TRANSFERASE#0.9202;GENOTOXICITY#0.9138;HEAD AND NECK CANCER#0.9127;NECK CANCER#0.9126;PANCREATIC CANCER#0.9066;MALE INFERTILITY#0.9066;COENZYME A#0.8990;NUCLEOTIDE EXCISION REPAIR#0.8931;TYPE 2 DIABETES#0.8868;RIO DE JANEIRO#0.8867;EFAVIRENZ#0.8819;LEUKOCYTE#0.8812;LIVER DISEASE#0.8786;HYDRALAZINE#0.8736;ULCERATIVE COLITIS#0.8637;SMALL INTESTINE#0.8615;MOLAR#0.8556;ESOPHAGEAL CANCER#0.8376;GASTRIC ADENOCARCINOMA#0.8372;THYROID CANCER#0.8350;RIFAMPICIN#0.8350;NAT ACTIVITY#0.8269;TRANSITIONAL CELL CARCINOMA#0.8261;CONJUGATION#0.8201;BREAST CANCER PATIENTS#0.8063;HYPOXANTHINE#0.7920;DNA BINDING#0.7914;DERMATITIS#0.7913;HYPERSENSITIVITY#0.7809;COLITIS#0.7713;LIVER CIRRHOSIS#0.7660;NEURAL TUBE#0.7552;DIMETHYLXANTHINE#0.7504;CHROMATID#0.7491;OVARIAN CANCER#0.7484;OROFACIAL CLEFT#0.7470;INFERTILITY#0.7463;ALCOHOLIC LIVER CIRRHOSIS#0.7452;METHIONINE#0.7441;ATOPIC DERMATITIS#0.7378;COLORECTAL CARCINOMA#0.7346;CYSTIC FIBROSIS#0.7333;HEART DISEASE#0.7288;ALZHEIMER'S DISEASE#0.7266;MALIGNANT MESOTHELIOMA#0.7266;CROHN'S DISEASE#0.7226;O METHYLTRANSFERASE#0.7223;HUMAN IMMUNODEFICIENCY VIRUS#0.7207;PERIODONTAL DISEASE#0.7207;PHASE II METABOLISM#0.7154;ESTROGEN RECEPTOR#0.7127;UNCONDITIONAL LOGISTIC REGRESSION#0.7093;MIDAZOLAM#0.7077;CATECHOL O METHYLTRANSFERASE#0.7047;MELATONIN#0.7041;SULFONAMIDE#0.7006;PERIPHERAL BLOOD LYMPHOCYTES#0.6998;FOOD FREQUENCY QUESTIONNAIRE#0.6982;RIFAMPIN#0.6949;HEALTHY CONTROL SUBJECTS#0.6948;CLEFT LIP#0.6938;PYRAZINAMIDE#0.6928;AMINOSALICYLIC ACID#0.6898;CONTACT DERMATITIS#0.6854;CHLORZOXAZONE#0.6828;DEBRISOQUINE#0.6824;CYTOTOXICITY#0.6809;REACTIVE OXYGEN SPECIES#0.6799;FOLATE METABOLISM#0.6797;OVARIAN#0.6784;CLEFT PALATE#0.6766;SPONTANEOUS ABORTION#0.6725;ACUTE LEUKEMIA#0.6705;MONONUCLEAR CELLS#0.6688;CELL CYCLE#0.6671;MYELOID LEUKEMIA#0.6644;HYPERTENSION#0.6595;T CELL#0.6496;SUPEROXIDE DISMUTASE#0.6388;DIGESTION#0.6383;ALLERGIC CONTACT DERMATITIS#0.6374;PHENYTOIN#0.6265;LINEAR REGRESSION ANALYSIS#0.6221;PSORIASIS#0.6178;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6122;CONDITIONAL LOGISTIC REGRESSION#0.6071;MICROSOME#0.6064;SULFAMETHOXAZOLE#0.6027;XANTHINE OXIDASE ACTIVITY#0.6016;MENSTRUAL CYCLE#0.6004
11000	FATTY ACID TRANSPORT#0.7561;MALIGNANT GLIOMA#0.6574;LIPID METABOLISM#0.6536;QUANTITATIVE TRAIT LOCI#0.6481;LUNG CANCER#0.6445;STEM CELL#0.6420;STEM CELL MAINTENANCE#0.6061
11001	COA LIGASE#1.0929;FATTY ACID TRANSPORT#1.0690;FATTY ACID TRANSPORTER#1.0335;PEROXISOME#0.9664;GENE EXPRESSION#0.9473;PEROXISOMAL#0.9337;LIPID METABOLISM#0.9268;COENZYME A#0.9235;PLASMA MEMBRANE#0.8263;FATTY ACID SYNTHASE#0.7792;FATTY LIVER#0.7625;ADIPOSE TISSUE#0.7592;PALMITIC ACID#0.7322;CANCER CELL#0.7150;PROSTATE CANCER#0.6856;LOW DENSITY LIPOPROTEIN#0.6579;LIVER DISEASE#0.6575;TRANSCRIPTION FACTOR#0.6560;CARNITINE#0.6487;FATTY ACID METABOLISM#0.6483;HYPOXIA#0.6439;FATTY ACID TRANSLOCASE#0.6384;FATTY ACID BINDING#0.6355;FATTY LIVER DISEASE#0.6290;ACETATE FORMATION#0.6091;ARACHIDONIC ACID#0.6006
11004	MICROTUBULE END#1.0881;MICROTUBULE DEPOLYMERIZATION#1.0754;CENTROMERE#1.0624;KINESIN#1.0524;KINETOCHORE MICROTUBULE#1.0389;KINETOCHORE#1.0351;SPINDLE POLE#1.0328;SPINDLE ASSEMBLY#1.0309;MICROTUBULE#1.0299;MICROTUBULE DYNAMICS#1.0297;SPINDLE FORMATION#1.0293;CANCER CELL#1.0170;CELL CYCLE#1.0086;CHROMOSOME SEGREGATION#1.0074;MITOSIS#1.0064;CHROMOSOME CONGRESSION#1.0031;MITOTIC SPINDLE#0.9902;GENE EXPRESSION#0.9717;BREAST CANCER#0.9670;CHROMOSOME MOVEMENT#0.9639;SPINDLE MICROTUBULE#0.9618;ANAPHASE#0.9579;KINETOCHORE-MICROTUBULE ATTACHMENT#0.9566;CELL DIVISION#0.9450;OOCYTE#0.9374;CENTROSOME#0.9331;MICROTUBULE PLUS END#0.9271;COLORECTAL CANCER#0.9132;LYMPH NODE METASTASIS#0.8924;LYMPH NODE#0.8869;CHROMOSOMAL PASSENGER COMPLEX#0.8826;MICROTUBULE ASSEMBLY#0.8689;METAPHASE#0.8329;PACLITAXEL#0.8140;MEIOTIC SPINDLE ASSEMBLY#0.7959;MEIOSIS#0.7829;MEIOTIC SPINDLE#0.7719;INTERPHASE#0.7618;MICROTUBULE BINDING#0.7598;COLORECTAL#0.7576;ATPASE ACTIVITY#0.7511;TUMOR CELLS#0.7506;MEIOSIS I#0.7485;ATP HYDROLYSIS#0.7418;SIGNALING PATHWAY#0.7293;MICROTUBULE CYTOSKELETON#0.7199;PROPHASE#0.7197;CATALYTIC ACTIVITY#0.7165;DYNEIN#0.6892;C TERMINAL DOMAIN#0.6847;PROTEIN PROTEIN INTERACTION#0.6841;CYCLIN DEPENDENT KINASE#0.6777;PROTEIN KINASE#0.6751;T CELL#0.6742;ENDOTHELIAL CELL#0.6714;BREAST CANCER CELL#0.6604;RNA INTERFERENCE#0.6563;CELL PROLIFERATION#0.6504;SPINDLE ORGANIZATION#0.6386;KINASE ACTIVITY#0.6253;BIPOLAR SPINDLE FORMATION#0.6221;ATP BINDING#0.6127;DRUG RESISTANCE#0.6114;CANCER TESTIS ANTIGEN#0.6108;CYTOKINESIS#0.6070
11005	PROTEINASE INHIBITOR#1.0904;NETHERTON SYNDROME#1.0526;SKIN DISEASE#1.0264;KERATINOCYTE#1.0250;ATOPIC DERMATITIS#1.0199;DERMATITIS#1.0134;PROTEASE ACTIVITY#1.0100;ICHTHYOSIS#0.9971;PEPTIDASE INHIBITOR#0.9461;GENE EXPRESSION#0.9088;POLYMERASE CHAIN REACTION#0.9021;SERINE PROTEASE ACTIVITY#0.8947;SKIN BARRIER FUNCTION#0.8790;EPITHELIAL CELL#0.8232;PREMATURE TERMINATION CODON#0.8188;ECZEMA#0.7817;HUMAN EPIDERMAL KERATINOCYTES#0.7788;FOOD ALLERGY#0.7762;CONGENITAL ICHTHYOSIFORM ERYTHRODERMA#0.7475;PSORIASIS#0.6654;SQUAMOUS CELL CARCINOMA#0.6648;ALLERGEN#0.6584;HYPERACTIVITY#0.6556;NEUTROPHIL#0.6535;ZINC FINGER PROTEIN#0.6174;DESMOSOME#0.6092;TUMOR SUPPRESSOR#0.6074
11006	LEUKOCYTE#1.0337;ENDOTHELIAL CELL#1.0328;ANTIGEN PRESENTING CELLS#1.0145;MONOCYTE#1.0135;T CELL#1.0121;DENDRITIC CELL#1.0111;TOLEROGENIC DENDRITIC CELLS#1.0043;MACROPHAGE#1.0011;IMMUNE RESPONSE#0.9903;REGULATORY T CELL#0.9730;GENE EXPRESSION#0.9666;PERIPHERAL BLOOD#0.9626;B CELL#0.9542;CELL SURFACE#0.9542;CELL ACTIVATION#0.9248;LYMPH NODE#0.9059;CELL PROLIFERATION#0.9053;BONE MARROW#0.8987;T CELL PROLIFERATION#0.8814;IFN-GAMMA#0.8442;T CELL ACTIVATION#0.8395;CD4+ T CELL#0.8240;MONONUCLEAR CELLS#0.7666;INFLAMMATORY RESPONSE#0.7550;CD8+ T CELL#0.7518;POLYMERASE CHAIN REACTION#0.7484;MULTIPLE SCLEROSIS#0.7373;MAST CELL#0.7373;IMMUNE CELL#0.7362;AUTOIMMUNITY#0.7351;SIGNALING PATHWAY#0.7332;AUTOIMMUNE DISEASE#0.7233;HUMAN DENDRITIC CELL#0.7225;ACUTE MYELOID LEUKEMIA#0.7200;TRYPTOPHAN#0.7193;MYELOID LEUKEMIA#0.7187;IL-10 PRODUCTION#0.7071;NEUTROPHIL#0.6886;STEM CELL#0.6829;APOPTOSIS#0.6759;TREG CELL#0.6635;CYTOKINE PRODUCTION#0.6582;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6560;TOLERANCE INDUCTION#0.6380;SUPPRESSOR T CELL#0.6096;ARGININE METABOLIC#0.6011
11007	TRANSCRIPTION FACTOR#0.6840;LUNG CANCER#0.6301;CANCER CELL#0.6257
11009	HEPATOCELLULAR CARCINOMA CELL#1.0727;OVARIAN CANCER#1.0705;PANCREATIC CANCER#1.0675;CELL KILLING#1.0617;HEPATOCELLULAR CARCINOMA#1.0571;PROSTATE CANCER#1.0565;HUMAN BREAST CANCER#1.0556;ENDOPLASMIC RETICULUM#1.0526;MELANOMA DIFFERENTIATION ASSOCIATED#1.0513;BREAST CANCER CELL#1.0504;OVARIAN#1.0496;METASTATIC MELANOMA#1.0496;INDUCTION OF APOPTOSIS#1.0453;LUNG CANCER#1.0446;SQUAMOUS CELL CARCINOMA#1.0427;MONOCYTE#1.0418;MELANOCYTE#1.0410;BREAST CANCER#1.0409;PANCREATIC CARCINOMA#1.0393;TUMOR SUPPRESSOR#1.0374;TERMINAL DIFFERENTIATION#1.0371;REACTIVE OXYGEN SPECIES#1.0355;AUTOPHAGY#1.0349;MELANOMA CELL LINES#1.0340;ENDOPLASMIC RETICULUM STRESS#1.0319;COLON CANCER#1.0296;CELL GROWTH#1.0280;ANGIOGENESIS#1.0277;TOXICITY#1.0277;SIGNALING PATHWAY#1.0275;B CELL#1.0262;TUMOR CELLS#1.0261;APOPTOTIC#1.0258;CELL CYCLE ARREST#1.0257;CYTOTOXICITY#1.0255;SMOOTH MUSCLE#1.0254;CANCER CELL#1.0248;APOPTOSIS#1.0245;CELL DEATH#1.0231;MONONUCLEAR CELLS#1.0228;PROTEIN KINASE#1.0201;PERIPHERAL BLOOD#1.0198;CELL PROLIFERATION#1.0183;T CELL#1.0181;MITOGEN ACTIVATED PROTEIN#1.0149;CISPLATIN#1.0127;ENDOTHELIAL CELL#1.0106;EPITHELIAL CELL#1.0080;KERATINOCYTE#1.0078;CELL CYCLE#1.0074;CELL DIFFERENTIATION#1.0066;LIVER CANCER#1.0063;TUMOR NECROSIS FACTOR#1.0063;PERIPHERAL BLOOD MONONUCLEAR CELLS#1.0046;ENDOTHELIAL GROWTH FACTOR#1.0039;PSORIASIS#1.0021;M PHASE#1.0019;GROWTH FACTOR#1.0006;IFN-GAMMA#1.0005;POLYMERASE CHAIN REACTION#0.9978;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9974;TRANSCRIPTION FACTOR#0.9972;IFN-BETA#0.9940;COLORECTAL CANCER#0.9930;CERVICAL CANCER#0.9914;PRO-INFLAMMATORY#0.9913;GENE EXPRESSION#0.9911;IMMUNE RESPONSE#0.9903;CELL MIGRATION#0.9845;LUNG CARCINOMA#0.9830;MACROPHAGE#0.9826;IMMUNE CELL#0.9768;REVERSE TRANSCRIPTION#0.9718;STEM CELL#0.9707;IMMUNE SYSTEM#0.9696;WOUND HEALING#0.9675;LUNG ADENOCARCINOMA#0.9567;ADENOCARCINOMA#0.9556;RENAL CARCINOMA#0.9538;COLORECTAL#0.9531;INFLUENZA A VIRUS#0.9520;BONE MARROW#0.9516;VASCULAR SMOOTH MUSCLE CELL#0.9411;INFLAMMATORY RESPONSE#0.9407;MYELOID LEUKEMIA#0.9401;PACLITAXEL#0.9363;AUTOIMMUNE DISEASE#0.9359;SMOOTH MUSCLE CELL#0.9290;MUSCLE CELL#0.9281;SIGNAL TRANSDUCTION#0.9220;LYMPH NODE#0.9146;CD8+ T CELL#0.9124;TUMOR GROWTH INHIBITION#0.9073;RECEPTOR COMPLEX#0.9045;VIRAL REPLICATION#0.9010;TOLL LIKE RECEPTOR#0.8914;RHEUMATOID ARTHRITIS#0.8807;B CELL LYMPHOMA#0.8780;CERVICAL#0.8716;QUANTITATIVE REAL TIME#0.8713;GLIOBLASTOMA MULTIFORME#0.8703;VIRULENCE#0.8623;ER STRESS RESPONSE#0.8612;SKIN DISEASE#0.8566;TUMOR TISSUES#0.8566;MECHANISM OF ACTION#0.8528;DRUG RESISTANCE#0.8525;PROSTATE CARCINOMA#0.8525;SIGNAL PEPTIDE#0.8524;SIGNAL TRANSDUCER#0.8520;TH2 CELL#0.8476;NEUROBLASTOMA#0.8463;MESENCHYMAL STEM CELL#0.8427;PROGRAMMED CELL DEATH#0.8390;GLYCOSYLATION#0.8390;ASTROCYTE#0.8389;OVARIAN CARCINOMA#0.8369;INFLAMMATORY BOWEL DISEASE#0.8276;TRANSFORMING GROWTH FACTOR#0.8216;NEUTROPHIL#0.8198;PROTEIN KINASE R#0.8192;SENSITIZATION#0.8126;MYELOID CELL#0.8019;ARSENIC TRIOXIDE#0.8010;TEMOZOLOMIDE#0.7952;CELL SURFACE#0.7927;LEUKOCYTE#0.7840;POST-TRANSLATIONAL MODIFICATION#0.7827;CD4+ T CELL#0.7811;COLONY-STIMULATING FACTOR#0.7797;KINASE INHIBITOR#0.7740;CRYSTAL VIOLET#0.7698;GRANULOCYTE#0.7622;STROMAL CELL#0.7617;CYTOCHROME C#0.7573;IL-11#0.7476;ACUTE LEUKEMIA#0.7450;NF-KAPPAB ACTIVATION#0.7424;ADENO ASSOCIATED VIRUS#0.7407;BREAST CARCINOMA#0.7355;HISTONE DEACETYLASE#0.7355;CYTOKINE RECEPTOR#0.7295;ANTI APOPTOSIS#0.7288;HEPATOMA CELLS#0.7223;UBIQUITIN#0.7210;PROPIDIUM#0.7210;VANCOMYCIN#0.7204;RNA INTERFERENCE#0.7179;CELL ADHESION#0.7175;FLOW CYTOMETRY ASSAY#0.7148;INHIBITION OF ANGIOGENESIS#0.7132;CLEAVED CASPASE 3#0.7038;ACTIVATED MONOCYTES#0.6982;ONCOGENIC#0.6973;NON-SMALL CELL LUNG CARCINOMA#0.6935;TROPISM#0.6930;NITRIC OXIDE#0.6904;SYNOVIAL FLUID#0.6901;URTICARIA#0.6872;TUBERCULOSIS#0.6871;HUMAN UMBILICAL VEIN#0.6857;UMBILICAL VEIN#0.6855;CYTOKINE PRODUCTION#0.6853;LINEZOLID#0.6817;WHOLE GENOME SEQUENCING#0.6814;PROSTATE EPITHELIAL CELL#0.6805;26S PROTEASOME#0.6803;5 FLUOROURACIL#0.6722;MALIGNANT GLIOMA#0.6719;POLY ADP RIBOSE#0.6715;GROWTH FACTOR RECEPTOR#0.6715;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6709;ACUTE MYELOID LEUKEMIA#0.6707;MITOCHONDRIA#0.6660;RECEPTOR BINDING#0.6587;DENDRITIC CELL#0.6563;MUTAGENESIS#0.6521;FIBROBLAST INTERFERON#0.6454;FAS-FASL SIGNALING PATHWAY#0.6448;INDUCES CANCER#0.6439;FASL SIGNALING PATHWAY#0.6409;INTRINSIC APOPTOTIC PATHWAY#0.6342;ATOPIC DERMATITIS#0.6315;PROTEASOME#0.6296;DOXYCYCLINE#0.6267;EPIDERMAL GROWTH FACTOR#0.6252;AKT SIGNALING#0.6232;METASTATIC MELANOMA CELLS#0.6226;RECEPTOR AGONIST#0.6204;MYELOID CELL LEUKEMIA#0.6193;BLOOD VESSEL#0.6157;DERMATITIS#0.6104;NORMAL PROSTATE EPITHELIAL#0.6047;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6042;COLORECTAL CARCINOMA#0.6038;GM-CSF#0.6018
11010	PROSTATE CANCER#1.0981;TUMOR SUPPRESSOR#1.0738;CANCER CELL#1.0611;RELATED PROTEIN 1#1.0486;APOPTOSIS#0.9703;CELL PROLIFERATION#0.9412;CELL CYCLE#0.8840;MYELOID LEUKEMIA#0.8305;GENE EXPRESSION#0.8073;CELL MIGRATION#0.7852;MULTIPLE MYELOMA#0.7624;LUNG CANCER#0.7558;ACUTE MYELOID LEUKEMIA#0.7176;BONE MARROW#0.7136;MITOTIC CATASTROPHE#0.6443;APOPTOTIC#0.6373;REACTIVE OXYGEN SPECIES#0.6123
11011	CELL CYCLE#0.9436;BREAST CANCER#0.8803;PROTEIN KINASE#0.7109;DNA DAMAGE RESPONSE#0.6648;KINASE ACTIVITY#0.6420;DNA REPLICATION#0.6310
11012	OVARIAN CANCER#1.0596;SUBMANDIBULAR GLAND#1.0465;PROTEASE ACTIVITY#1.0430;PROSTATE CANCER#1.0426;OVARIAN#1.0355;CANCER CELL#1.0163;PROSTATE SPECIFIC ANTIGEN#0.9982;PROTEIN KINASE C#0.9929;PROTEIN KINASE#0.9876;PLASMA MEMBRANE#0.9821;BREAST CANCER#0.9593;PROTEASE S#0.9489;GENE EXPRESSION#0.9436;ARGININE#0.9435;LUNG CANCER#0.9308;HUMAN TISSUE KALLIKREIN#0.9249;L-LYSINE#0.9201;SALIVARY GLAND#0.9188;ENZYME ACTIVITY#0.8939;LYSINE#0.8873;BREAST CANCER CELL#0.8858;ALKALINE PHOSPHATASE#0.8832;APOPTOSIS#0.8751;SIGNALING PATHWAY#0.8635;VIRULENCE#0.8504;FERTILIZATION#0.8267;LYMPH NODE#0.8220;MAST CELL#0.8180;DIGESTION#0.7837;EPITHELIAL CELL#0.7794;GROWTH FACTOR#0.7788;APROTININ#0.7737;CELL BOUND#0.7727;ALLERGEN#0.7666;POLYMERASE CHAIN REACTION#0.7392;ALPHA-2 MACROGLOBULIN#0.7342;SODIUM DODECYL SULFATE#0.7308;DODECYL SULFATE#0.7307;L-ARGININE#0.7054;CLARA CELL#0.7041;EXTRACELLULAR VESICLE#0.6997;COLORECTAL#0.6898;COLORECTAL CANCER#0.6880;BIOFILM FORMATION#0.6861;SEMINAL PLASMA#0.6814;CHYMOSTATIN#0.6764;CELL SURFACE#0.6754;MUSCULAR DYSTROPHY#0.6731;IFN-GAMMA#0.6720;CELL PROLIFERATION#0.6698;REVERSE TRANSCRIPTION#0.6603;COLLAGENASE#0.6381;BENZAMIDINE#0.6379;ZONA PELLUCIDA#0.6164;OVARIAN CARCINOMA#0.6105;SQUAMOUS CELL CARCINOMA#0.6031;ATOPIC DERMATITIS#0.6028
11013	PROSTATE CANCER#0.8870;BREAST CANCER#0.6850;CANCER CELL#0.6026;GENE EXPRESSION#0.6019
11014	HYPERTHERMIA#0.7685;ENDOPLASMIC RETICULUM#0.6995
11016	ACTIVATING TRANSCRIPTION FACTOR#1.0655;TRANSCRIPTION FACTOR#1.0635;PROTEIN KINASE#0.9436;INNATE IMMUNITY#0.9244;GENE EXPRESSION#0.9089;CELL PROLIFERATION#0.8890;DNA BINDING#0.8684;MITOGEN ACTIVATED PROTEIN#0.8509;IMMUNE RESPONSE#0.8470;TELOMERE#0.7877;ADIPOSE TISSUE#0.7786;LEUCINE#0.7596;GROWTH FACTOR#0.6886;APOPTOSIS#0.6270;SIGNALING PATHWAY#0.6129;B CELL#0.6068;SUMOYLATION#0.6067
11018	MAST CELL#0.7830;CELL SURFACE#0.6372;CELL PROLIFERATION#0.6369
11019	LIPOIC ACID SYNTHASE#1.1118;LIPOATE#1.0990;LIPOIC ACID#1.0709;GENE EXPRESSION#0.7486;PYRUVATE#0.7228;MITOCHONDRIA#0.6862;BIOTIN#0.6846;GLYCINE#0.6809
1101	COLLAGEN TYPE II#1.0481;LEUCINE#1.0186;LEUCINE RICH REPEAT#1.0163;EXTRACELLULAR MATRIX#0.9631;CHONDROCYTE#0.9598;GENE EXPRESSION#0.9428;POLYMERASE CHAIN REACTION#0.8453;PROTEOGLYCAN#0.8253;INTERVERTEBRAL DISC#0.7652;HEPARIN BINDING#0.7607;REVERSE TRANSCRIPTION#0.6922;GROWTH FACTOR#0.6916;NUCLEUS PULPOSUS#0.6757;HEPARIN#0.6488;HYPOXIA INDUCIBLE FACTOR#0.6289;CELL ADHESION#0.6255;OSTEOARTHRITIS#0.6156
11020	INTRAFLAGELLAR TRANSPORT#1.0210;IFT COMPLEX#0.9965;IFT COMPLEX B#0.9634;BBSOME#0.8827;IFT B COMPLEX#0.7267;HAIR FOLLICLE MORPHOGENESIS#0.6797;HAIR FOLLICLE#0.6455;BARDET BIEDL SYNDROME#0.6415;RENAL AGENESIS#0.6117
11021	NEURITE OUTGROWTH#1.0972;ENDOSOME#1.0618;CELL MIGRATION#1.0592;ENDOCYTIC RECYCLING#1.0500;NEURITE#1.0377;CYTOKINESIS#1.0362;PLASMA MEMBRANE#1.0244;RECYCLING ENDOSOME#0.9743;GROWTH FACTOR#0.9589;NUCLEOTIDE EXCHANGE FACTOR#0.9587;CANCER CELL#0.9522;GUANINE#0.9069;PHAGOCYTOSIS#0.9048;PHAGOSOME#0.9007;CELL DIVISION#0.8373;ENDOCYTOSIS#0.8266;T CELL#0.7973;INTERCELLULAR BRIDGE#0.7920;GAP ACTIVITY#0.7908;PHAGOSOME MATURATION#0.7726;NERVE GROWTH FACTOR#0.7723;EARLY ENDOSOME#0.7502;PHAGOSOME FORMATION#0.7350;PHAGOCYTIC CUP#0.7201;APOPTOTIC CELL CLEARANCE#0.7171;CELL SURFACE#0.7119;RECEPTOR RECYCLING#0.7089;ONCOGENIC#0.6987;ACTIN CYTOSKELETON#0.6958;ACTIN FILAMENT#0.6647;EXOSOME#0.6640;APOPTOTIC#0.6576;OOCYTE#0.6380;PROTEIN KINASE#0.6367;ACTIN BUNDLING#0.6359;IRON ACQUISITION#0.6275;ABSCISSION#0.6273;VESICLE TRAFFICKING#0.6187;COATED PIT#0.6137;BREAST CANCER CELL#0.6021
11022	RNA BINDING PROTEIN#1.0670;RNA BINDING#1.0659;RNA RECOGNITION MOTIF#0.8778;GENE EXPRESSION#0.7227;ARGININE#0.7041;STEM CELL#0.6293
11023	TRANSCRIPTION FACTOR#1.0547;CLEFT LIP#1.0129;CLEFT PALATE#0.9925;FOREBRAIN#0.9098;OPTIC NERVE#0.8665;OROFACIAL CLEFT#0.8645;OPTIC STALK#0.7875;BIRTH DEFECT#0.6651;EYE DEVELOPMENT#0.6630;OPTIC VESICLE#0.6385;CORPUS CALLOSUM AGENESIS#0.6098;CHOROID FISSURE#0.6033
11024	LEUKOCYTE#0.7932
11025	LEUKOCYTE#0.8692;MAST CELL#0.8540;COPY NUMBER VARIATION#0.7417;CELL SURFACE#0.7325;CELL ACTIVATION#0.7188;MAST CELL ACTIVATION#0.6566
11026	LEUKOCYTE#1.0347;MULTIPLE SCLEROSIS#1.0170;MONOCYTE#0.9699;RHEUMATOID ARTHRITIS#0.9686;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7650;LUPUS ERYTHEMATOSUS#0.7647;T CELL#0.7194;IMMUNE RESPONSE#0.6716;TUMOR NECROSIS FACTOR#0.6197;B CELL#0.6111
11027	MACROPHAGE#0.8839;MONOCYTE#0.8387;MYELOID CELL#0.7952;T CELL#0.7808;LEUKOCYTE#0.7646;IMMUNE RESPONSE#0.6825;IMMUNE SYSTEM#0.6443;GM-CSF#0.6427;LYMPHOID CELL#0.6363
1102	CHROMOSOME CONDENSATION#0.9770;MULTIPLE MYELOMA#0.8623;PROSTATE CANCER#0.6623;SPINDLE CELL LIPOMA#0.6528;PERIPHERAL BLOOD LYMPHOCYTES#0.6037
11030	RNA BINDING PROTEIN#1.0663;RNA BINDING#1.0651;GANGLION CELLS#1.0144;RETINAL GANGLION CELL#1.0091;LYMPHOCYTE HOMING#0.9928;OPTIC NERVE#0.9860;TRANSPOSITION#0.9766;GERM PLASM#0.8275;T CELL#0.8239;OPTIC NERVE CRUSH#0.8053;AMACRINE CELL#0.7986;GENE EXPRESSION#0.7908;LYMPH NODE#0.7835;GLUTATHIONE#0.7778;CELL ADHESION#0.7776;VENULE#0.7279;RNA RECOGNITION MOTIF#0.7194;MODIFIED RANKIN SCALE#0.6770;GROWTH FACTOR#0.6480;EXTRACELLULAR MATRIX#0.6460;CELL DEATH#0.6262;SIGNALING PATHWAY#0.6231;OOCYTE#0.6120;RANDOMIZED CONTROLLED TRIAL#0.6067
11031	BREAST CANCER#1.0553;CELL PROLIFERATION#0.9607;TRANS GOLGI NETWORK#0.9590;CANCER CELL#0.9426;SIGNALING PATHWAY#0.9257;ENDOSOME#0.9192;BREAST CANCER CELL#0.8709;ESTROGEN RECEPTOR#0.8281;APOPTOSIS#0.8165;LATE ENDOSOME#0.7864;NUCLEOTIDE EXCHANGE FACTOR#0.7785;GENE EXPRESSION#0.7622;GROWTH FACTOR#0.7484;EPIDERMAL GROWTH FACTOR#0.7148;GROWTH FACTOR RECEPTOR#0.7148;EARLY ENDOSOME#0.7129;BREAST CANCER PATIENTS#0.7051;PHAGOSOME#0.6135;GUANINE#0.6119
11033	PLASMA MEMBRANE#1.0650;INOSITOL 1,3,4,5-TETRAKISPHOSPHATE#1.0399;GAP ACTIVITY#0.8530;GROWTH FACTOR#0.7699;PROTEIN KINASE#0.7320;KINESIN#0.7161;ARF GAP ACTIVITY#0.7048;ACTIN CYTOSKELETON#0.6856;INSP4 BINDING#0.6573;MITOGEN ACTIVATED PROTEIN#0.6212
11034	ACTIN DEPOLYMERIZING FACTOR#1.0711;ACTIN BINDING PROTEIN#1.0520;DEPHOSPHORYLATION#1.0456;ACTIN BINDING#1.0300;ACTIN FILAMENT#1.0265;FILAMENTOUS ACTIN#1.0092;ACTIN CYTOSKELETON#1.0046;ACTIN DEPOLYMERIZATION#0.9990;PROTEIN KINASE#0.9825;ACTIN POLYMERIZATION#0.9807;GROWTH CONE#0.9672;F-ACTIN BINDING#0.9592;GENE EXPRESSION#0.9562;EPITHELIAL CELL#0.9138;POLLEN TUBE#0.8659;CANCER CELL#0.8587;CELL MOTILITY#0.8439;SIGNALING PATHWAY#0.8371;ISCHEMIA#0.8275;CELL MIGRATION#0.8263;CORNEAL EPITHELIAL CELL#0.8209;STRESS FIBER#0.8167;COLON CANCER#0.7560;ACTIN FILAMENT SEVERING#0.7507;POLLEN TUBE GROWTH#0.7158;ACTIN DEPOLYMERIZING ACTIVITY#0.6889;MICROFILAMENT#0.6723;CYTOKINESIS#0.6632;CORNEAL DISEASE#0.6551;CELL ADHESION#0.6343;CYTOPLASM#0.6256;PROXIMAL TUBULE CELL#0.6236;ACTIN FILAMENT DEPOLYMERIZATION#0.6143;NEURITE EXTENSION#0.6141;PAROTID GLAND#0.6107
11035	NECROPTOSIS SIGNALING#1.0510;INDUCTION OF NECROPTOSIS#1.0506;NECROSOME#1.0492;ACTIVATION OF NECROPTOSIS#1.0470;TNF-INDUCED NECROPTOSIS#1.0380;CLEAVED CASPASE 3#1.0363;MIXED LINEAGE KINASE#1.0353;CISPLATIN#1.0271;RECEPTOR INTERACTING PROTEIN#1.0258;REGULATED NECROSIS#1.0207;NECROPTOSIS#1.0196;PROTEIN KINASE#1.0176;KINASE ACTIVITY#1.0167;NEUTROPHIL#1.0128;CARDIOMYOCYTE#1.0123;NECROTIC CELL DEATH#1.0111;PROGRAMMED NECROSIS#1.0095;HIGH MOBILITY GROUP#1.0080;SPINAL CORD#1.0052;PROGRAMMED NECROTIC CELL DEATH#1.0025;ISCHEMIA REPERFUSION INJURY#1.0018;MITOCHONDRIA#0.9998;TISSUE DAMAGE#0.9997;NECROTIC#0.9954;PRO-INFLAMMATORY#0.9948;BONE MARROW#0.9948;AUTOPHAGY#0.9945;T CELL#0.9941;MACROPHAGE#0.9933;PLASMA MEMBRANE#0.9929;COLON CANCER#0.9917;GENE EXPRESSION#0.9911;NLRP3 INFLAMMASOME ACTIVATION#0.9898;EPITHELIAL CELL#0.9896;ISCHEMIA#0.9887;DEATH RECEPTOR#0.9878;ENDOTHELIAL CELL#0.9870;CASPASE INHIBITOR#0.9862;SIGNALING PATHWAY#0.9860;CELL DEATH#0.9839;TOLL LIKE RECEPTOR#0.9837;TUMOUR NECROSIS FACTOR#0.9832;TUMOR NECROSIS FACTOR#0.9826;MYOCARDIAL INFARCTION#0.9820;CANCER CELL#0.9816;INFLAMMATORY RESPONSE#0.9813;CYTOKINE PRODUCTION#0.9801;REACTIVE OXYGEN SPECIES#0.9779;ROS GENERATION#0.9752;IMMUNE RESPONSE#0.9748;APOPTOSIS#0.9741;DENDRITIC CELL#0.9741;CASPASE-8 ACTIVITY#0.9737;PROGRAMMED CELL DEATH#0.9731;REGULATED CELL DEATH#0.9724;ACUTE KIDNEY INJURY#0.9721;INTESTINAL EPITHELIAL CELL#0.9719;SIGNAL TRANSDUCTION#0.9712;HYPOXIA#0.9699;POLY ADP RIBOSE#0.9697;LIVER DISEASE#0.9697;APOPTOTIC CELL DEATH#0.9695;KINASE INHIBITOR#0.9690;APOPTOTIC#0.9688;IMMUNE CELL#0.9668;TUMOR CELLS#0.9634;LUNG CANCER#0.9632;KERATINOCYTE#0.9628;MONOCYTE#0.9608;SIGNALING CASCADE#0.9591;UBIQUITIN#0.9562;COLITIS#0.9529;CYTOTOXICITY#0.9521;CELL CYCLE#0.9504;RIPOPTOSOME#0.9496;PYROPTOSIS#0.9485;INFLAMMATORY CELL#0.9483;PROPIDIUM#0.9477;INFLUENZA A VIRUS#0.9472;MYELOID CELL#0.9464;COMPLEX I#0.9460;CELL PROLIFERATION#0.9386;TUBULAR EPITHELIAL CELL#0.9383;SPINAL CORD INJURY#0.9337;SIGNALING MOLECULE#0.9333;POLYMERASE CHAIN REACTION#0.9324;B CELL#0.9303;CASPASE ACTIVATION#0.9296;RELATED PROTEIN 1#0.9291;TRANSCRIPTION FACTOR#0.9288;RESPONSE TO TNF#0.9263;INNATE IMMUNE RESPONSE#0.9236;NERVOUS SYSTEM#0.9235;IMMUNE SYSTEM#0.9229;MITOCHONDRIAL MEMBRANE#0.9224;CEREBRAL ISCHEMIA#0.9220;BREAST CANCER#0.9185;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9182;TOXICITY#0.9169;PROTEASOME#0.9157;OXYGEN GLUCOSE DEPRIVATION#0.9038;CENTRAL NERVOUS SYSTEM#0.8952;RIBOSE#0.8951;IL-1 SECRETION#0.8947;CELL MEMBRANE#0.8945;CAMKII#0.8942;CYTOPLASM#0.8921;DABRAFENIB#0.8919;PANCREATITIS#0.8864;GROWTH FACTOR#0.8819;MOUSE EMBRYONIC FIBROBLAST#0.8776;EXTRINSIC APOPTOSIS#0.8660;VIRAL INFECTION#0.8650;NEURODEGENERATIVE DISEASE#0.8640;QUANTITATIVE REAL TIME#0.8583;INFLAMMATORY BOWEL DISEASE#0.8548;TISSUE HOMEOSTASIS#0.8530;HIGH FAT DIET#0.8517;MELATONIN#0.8421;MYELOID LEUKEMIA#0.8386;COLORECTAL CANCER#0.8348;ACINAR CELL#0.8345;CASPASE ACTIVITY#0.8328;CERVICAL CANCER#0.8316;CD8+ T CELL#0.8305;INNATE IMMUNITY#0.8304;ACUTE PANCREATITIS#0.8290;MONONUCLEAR CELLS#0.8242;TRANSMISSION ELECTRON MICROSCOPY#0.8239;CASPASE-INDEPENDENT CELL DEATH#0.8171;HERPES SIMPLEX VIRUS#0.8133;HERPES SIMPLEX#0.8130;PHOTORECEPTOR CELL#0.8108;HOST CELL#0.8106;ENDOPLASMIC RETICULUM#0.8080;STEM CELL#0.8054;MITOGEN ACTIVATED PROTEIN#0.8046;MITOCHONDRIAL PERMEABILITY TRANSITION#0.7985;SUPEROXIDE DISMUTASE#0.7970;SYSTEMIC INFLAMMATORY RESPONSE#0.7955;WEIGHT LOSS#0.7947;COLORECTAL#0.7932;RETINAL GANGLION CELL#0.7858;HEMORRHAGE#0.7851;CELLULAR NECROSIS#0.7810;PANCREATIC CANCER#0.7806;GLUTATHIONE#0.7797;BINDING PROTEIN 1#0.7791;ARTERY#0.7775;PHOSPHOGLYCERATE MUTASE#0.7757;HYPOXIC#0.7753;APOPTOSIS INDUCING FACTOR#0.7729;FERROPTOSIS#0.7696;ACUTE MYELOID LEUKEMIA#0.7659;LYSIS#0.7624;LIVER DAMAGE#0.7611;ATHEROSCLEROSIS#0.7592;ADENOCARCINOMA#0.7589;DNA BINDING#0.7555;SIGNALLING PATHWAY#0.7537;PERIPHERAL BLOOD#0.7534;ACETAMINOPHEN#0.7530;NEPHRITIS#0.7529;MITOCHONDRIAL DAMAGE#0.7498;PANETH CELL#0.7495;MITOCHONDRIAL FISSION#0.7471;GANGLION CELLS#0.7403;CYCLOPHILIN#0.7360;FATTY LIVER DISEASE#0.7352;REGULATION OF NECROPTOSIS#0.7342;FATTY LIVER#0.7342;INDUCTION OF APOPTOSIS#0.7333;NITRIC OXIDE#0.7332;PONATINIB#0.7265;HEAT SHOCK PROTEIN#0.7212;HEPATOCELLULAR CARCINOMA#0.7203;ASTROCYTE#0.7195;SMOOTH MUSCLE#0.7118;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.7069;PERMEABILITY TRANSITION PORE#0.7067;HUMAN BREAST CANCER#0.7019;PROGENITOR CELL#0.6971;CELL ACTIVATION#0.6967;HEMATOPOIETIC CELL#0.6933;EOSIN#0.6920;LEUKOCYTE#0.6886;NF-KAPPAB ACTIVATION#0.6855;COMPLEX II#0.6846;CELL CYCLE ARREST#0.6833;CERVICAL#0.6832;EDEMA#0.6826;NUCLEOCYTOPLASMIC SHUTTLING#0.6813;CELL KILLING#0.6801;ETHANOL#0.6778;NEURONAL CELLS#0.6765;ACTIVATED CASPASE 3#0.6759;CYTOCHROME C#0.6713;EARLY BRAIN INJURY#0.6701;PROTEIN COMPLEX#0.6696;CELL SURFACE#0.6687;ALANINE#0.6682;TUMOR SUPPRESSOR#0.6649;IL-1 PRODUCTION#0.6645;TOXIC EPIDERMAL NECROLYSIS#0.6619;ONCOGENIC#0.6609;BRAIN DAMAGE#0.6589;GLOBAL CEREBRAL ISCHEMIA#0.6581;DEXTRAN SODIUM SULFATE#0.6539;LYSOSOME#0.6517;L-CYSTEINE#0.6491;BILE DUCT#0.6459;HEMATOPOIESIS#0.6455;AUTOPHAGOSOME#0.6434;RNA INTERFERENCE#0.6430;INTRINSIC APOPTOSIS#0.6378;PERIODONTITIS#0.6313;CHONDROCYTE#0.6283;PLASMA MEMBRANE INTEGRITY#0.6283;VIRAL REPLICATION#0.6278;OBESE#0.6253;BLOOD BRAIN BARRIER#0.6250;NEUROPROTECTION#0.6234;MITOCHONDRIA-ASSOCIATED MEMBRANE#0.6228;OVARIAN CANCER#0.6213;CD4+ T CELL#0.6201;CORONARY ARTERY#0.6170;NEURAL CELL#0.6170;ADIPOCYTE#0.6150;LEUKEMIA INITIATING CELLS#0.6149;REGULATION OF CELL DEATH#0.6109;REGENERATION#0.6094;SWELLING#0.6075;GLUTAMATE DEHYDROGENASE#0.6066;DEXTRAN SULFATE SODIUM#0.6065;RESPONSE TO LPS#0.6051;DEATH RECEPTOR LIGAND#0.6049;CELL EXPANSION#0.6035;SELECTIVE AUTOPHAGY#0.6013
11036	GERM CELL#1.0656;TRANSCRIPTION FACTOR#0.9633;GENE EXPRESSION#0.8619;DNA METHYLATION#0.6133
11037	CELL MOTILITY#0.6682
1103	ACETYLASE ACTIVITY#1.0929;CHOLINE O ACETYLTRANSFERASE#1.0729;PARABIGEMINAL NUCLEUS#1.0500;CHOLINE ACETYLTRANSFERASE ACTIVITY#1.0355;ACETYLTRANSFERASE ACTIVITY#1.0331;ADENINE DINUCLEOTIDE PHOSPHATE#1.0300;CHOLINE#1.0238;NICOTINAMIDE ADENINE DINUCLEOTIDE#1.0225;CARNITINE#1.0225;GLUTAMATE DECARBOXYLASE#1.0211;L-CARNITINE#1.0207;ORGAN OF CORTI#1.0187;T CELL#1.0174;HYPOGLOSSAL NUCLEUS#1.0164;NICOTINAMIDE#1.0157;PHENYLETHANOLAMINE N METHYLTRANSFERASE#1.0153;INTERPEDUNCULAR NUCLEUS#1.0145;AXONAL TRANSPORT#1.0144;PROXIMAL DENDRITE#1.0141;MEDULLA OBLONGATA#1.0140;ENDOTHELIAL CELL#1.0140;FACIAL NUCLEUS#1.0131;COCHLEAR NUCLEUS#1.0128;CONGENITAL MYASTHENIC SYNDROME#1.0127;COENZYME A#1.0125;GLUTAMATE DECARBOXYLASE ACTIVITY#1.0123;NERVOUS TISSUE#1.0120;COLCHICINE#1.0111;GLUTAMIC ACID#1.0103;N METHYLTRANSFERASE#1.0099;CHOLINE TRANSPORT#1.0094;CHOLINE KINASE#1.0092;AMACRINE CELL#1.0079;GLUTATHIONE PEROXIDASE#1.0074;CORPUS STRIATUM#1.0066;ACETYLCHOLINE METABOLISM#1.0065;ADENINE#1.0062;MICROTUBULE ASSOCIATED PROTEIN#1.0045;MUSCARINIC ACETYLCHOLINE RECEPTOR#1.0044;SALIVARY GLAND#1.0036;CILIARY GANGLION#1.0035;NEUROTROPHIN RECEPTOR#1.0025;TECTUM#1.0023;NITRIC OXIDE SYNTHASE#1.0018;GROWTH FACTOR RECEPTOR#1.0015;GLYCINE#1.0007;CAUDATE NUCLEUS#1.0006;GLUTAMINE#0.9996;ACETYLCHOLINESTERASE ACTIVITY#0.9994;CHOLINESTERASE ACTIVITY#0.9994;SCIATIC NERVE#0.9990;SUPERIOR COLLICULUS#0.9981;QUINOLINIC ACID#0.9978;CROSS SECTIONAL AREA#0.9968;LEUKEMIA INHIBITORY FACTOR#0.9966;NITRIC OXIDE#0.9963;SUBSTANCE P#0.9962;ACETYLCHOLINE SYNTHESIS#0.9961;SYNAPTOSOME#0.9952;NEUROFILAMENT#0.9950;AXON TERMINAL#0.9946;DECARBOXYLASE ACTIVITY#0.9946;PRESYNAPTIC TERMINAL#0.9934;NEURITE OUTGROWTH#0.9930;SWEAT GLAND#0.9930;ADRENAL GLAND#0.9926;DOPAMINE RECEPTOR#0.9922;ESTRADIOL#0.9919;RECEPTOR BINDING#0.9915;FRONTAL#0.9907;NERVE ENDING#0.9905;TYROSINE HYDROXYLASE ACTIVITY#0.9904;PROTEIN KINASE C#0.9901;CHOLINERGIC SYNAPSE#0.9898;LOCALISATION#0.9891;NEURAL CELL#0.9886;CYCLIC AMP#0.9885;BOUTON#0.9884;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9883;BRACHIAL PLEXUS#0.9881;TEMPORAL LOBE#0.9878;PLASMA MEMBRANE#0.9874;NEURAL STEM CELL#0.9874;ETHANOL#0.9873;ACETYL-L-CARNITINE#0.9872;CELL BODY#0.9872;BIOTIN#0.9872;FIMBRIA#0.9867;L-GLUTAMATE#0.9867;MICROTUBULE#0.9865;NEURONAL CELL BODIES#0.9865;SUPEROXIDE DISMUTASE#0.9855;ISCHEMIA#0.9854;HAIR CELL#0.9851;TEGMENTUM#0.9851;OLFACTORY BULB#0.9850;URINARY BLADDER#0.9843;PYRUVATE#0.9843;INNER NUCLEAR LAYER#0.9842;INTERNEURON#0.9842;REVERSE TRANSCRIPTION#0.9842;RETINOIC ACID#0.9840;CILIARY NEUROTROPHIC FACTOR#0.9840;TELENCEPHALON#0.9839;CYTOPLASM#0.9839;ACETYLCHOLINE#0.9833;COCHLEA#0.9831;EPITHELIAL CELL#0.9828;SEPTUM#0.9827;HYPOXIA#0.9823;DIENCEPHALON#0.9820;HYDROXYLASE ACTIVITY#0.9818;TRYPTOPHAN#0.9818;SYNAPTIC VESICLE#0.9818;ADENYLATE CYCLASE#0.9818;GLUTATHIONE#0.9809;RETICULAR FORMATION#0.9806;NUCLEAR LAYER#0.9805;SKELETAL MUSCLE#0.9804;NORADRENALINE#0.9800;ADENOSINE#0.9799;DENTATE GYRUS#0.9798;SPINAL CORD#0.9794;PERIPHERAL NERVOUS SYSTEM#0.9793;SMALL INTESTINE#0.9793;AMYGDALA#0.9790;PIRENZEPINE#0.9784;IMMUNOTOXIN#0.9784;NERVE FIBER#0.9784;IMMUNE CELL#0.9783;OPTIC NERVE#0.9782;NERVE TERMINAL#0.9781;MIDLINE#0.9779;NEURITE#0.9777;ACETYLCHOLINE RECEPTOR#0.9773;ADRENAL MEDULLA#0.9773;HALOPERIDOL#0.9772;GABAERGIC NEURON#0.9770;NICOTINIC ACETYLCHOLINE RECEPTOR#0.9770;PROTEIN KINASE#0.9768;MUSCLE CELL#0.9765;MIDBRAIN#0.9765;CERVICAL#0.9762;NOREPINEPHRINE#0.9760;CEREBRAL CORTEX#0.9760;FOREBRAIN#0.9759;ADENYLATE#0.9753;FIBROBLAST GROWTH FACTOR#0.9752;POLYMERASE CHAIN REACTION#0.9749;STRIATUM#0.9747;DOPAMINE#0.9747;PERIPHERAL NERVE#0.9745;DONEPEZIL#0.9740;NEUROBLASTOMA#0.9740;THALAMUS#0.9740;DUODENUM#0.9740;LATERAL VENTRICLE#0.9739;ESTROGEN RECEPTOR#0.9734;NEUROFIBRILLARY TANGLE#0.9733;CHROMAFFIN CELL#0.9730;CHOLINERGIC NEURON#0.9726;NERVE GROWTH FACTOR#0.9725;PROGENITOR CELL#0.9724;AMNESIA#0.9722;BASAL GANGLIA#0.9718;CELL SURFACE#0.9717;ENZYME ACTIVITY#0.9716;EPIDERMAL GROWTH FACTOR#0.9716;PYRAMIDAL CELL#0.9714;NEURAL CREST#0.9710;LOCUS COERULEUS#0.9709;CHOLERA#0.9704;GENE EXPRESSION#0.9702;ASPARTATE#0.9701;NEUROMUSCULAR JUNCTION#0.9699;MACROPHAGE#0.9698;BETA GALACTOSIDASE#0.9698;RADIAL ARM MAZE#0.9695;SCOPOLAMINE#0.9694;NEURONAL CELLS#0.9693;CYTOCHROME C#0.9693;SMOOTH MUSCLE#0.9686;GLUTAMATE RECEPTOR#0.9686;HUNTINGTON'S DISEASE#0.9684;STREPTOZOTOCIN#0.9683;ASTROCYTE#0.9683;GANGLION CELLS#0.9681;PHYSOSTIGMINE#0.9679;BLOOD VESSEL#0.9677;RETINAL GANGLION CELL#0.9675;GLUTAMATERGIC NEURON#0.9671;DOPAMINERGIC NEURON#0.9669;AMYLOID PRECURSOR PROTEIN#0.9669;HIPPOCAMPAL REGION#0.9667;PURKINJE CELL#0.9663;DENDRITIC SHAFT#0.9659;REGENERATION#0.9658;GESTATION#0.9657;RED NUCLEUS#0.9655;GROWTH FACTOR#0.9651;ENTERIC NERVOUS SYSTEM#0.9649;CEREBRAL ISCHEMIA#0.9649;TETRODOTOXIN#0.9645;BIPOLAR CELL#0.9643;TRANSCRIPTION FACTOR#0.9643;SUBSTANTIA NIGRA#0.9642;SYNAPTIC TRANSMISSION#0.9642;NMDA RECEPTOR#0.9634;INSULIN-LIKE GROWTH FACTOR#0.9632;ARTERY#0.9631;CATALYTIC ACTIVITY#0.9625;NEURON SURVIVAL#0.9623;STEM CELL#0.9621;CARBACHOL#0.9619;RAPHE NUCLEI#0.9614;NEUROPROTECTION#0.9613;DEMENTIA#0.9612;INNERVATION#0.9612;DEXAMETHASONE#0.9609;CELL MEMBRANE#0.9608;SPATIAL LEARNING#0.9606;B CELL#0.9605;LEWY BODY#0.9605;AMYOTROPHIC LATERAL SCLEROSIS#0.9604;LATERAL SCLEROSIS#0.9604;EDINGER-WESTPHAL NUCLEUS#0.9601;GLIAL CELL#0.9595;CORONAL#0.9593;AMYLOID PROTEIN#0.9593;PARKINSON'S DISEASE#0.9591;NEUROGENESIS#0.9590;MEMORY IMPAIRMENT#0.9585;NEUROTRANSMISSION#0.9582;NEUROTOXIN#0.9579;SYNAPTOGENESIS#0.9578;MITOCHONDRIA#0.9575;HYPOXIC#0.9575;ESOPHAGUS#0.9575;SYNAPTIC JUNCTION#0.9570;RECEPTOR AGONIST#0.9568;SIGNALING PATHWAY#0.9566;NEUROLOGICAL DISORDER#0.9564;ACTION POTENTIAL#0.9561;APOPTOSIS#0.9560;THYROTROPIN RELEASING HORMONE#0.9559;CENTRAL NERVOUS SYSTEM#0.9558;TESTOSTERONE#0.9557;NEUROTOXIC#0.9554;CELL GROWTH#0.9550;MORRIS WATER MAZE#0.9546;ERGIC#0.9546;LONG TERM POTENTIATION#0.9541;NEUROTOXICITY#0.9541;APOPTOTIC#0.9534;L-GLUTAMIC ACID#0.9531;COGNITION#0.9531;BRAIN DAMAGE#0.9531;TOXICITY#0.9528;MITOGEN ACTIVATED PROTEIN#0.9526;BLOOD BRAIN BARRIER#0.9526;MILD COGNITIVE IMPAIRMENT#0.9524;SPINAL CORD INJURY#0.9524;REACTIVE OXYGEN SPECIES#0.9522;NEURODEGENERATIVE DISEASE#0.9521;GASTROINTESTINAL TRACT#0.9520;PROTEIN SYNTHESIS#0.9517;NERVOUS SYSTEM#0.9517;TUMOR NECROSIS FACTOR#0.9511;CELL DEATH#0.9509;FACTOR I#0.9509;ATROPINE#0.9504;ALZHEIMER'S DISEASE#0.9501;PINEAL GLAND#0.9498;CORTICOTROPIN-RELEASING FACTOR#0.9495;BRAIN DEVELOPMENT#0.9491;CELL SOMA#0.9490;CELL ADHESION#0.9484;MUSCLE FIBER#0.9482;CHOLERA TOXIN B#0.9479;DORSAL ROOT GANGLION#0.9474;OUTER HAIR CELL#0.9451;HINDLIMB#0.9450;APOMORPHINE#0.9446;RAPID EYE MOVEMENT#0.9440;RECEPTOR ANTAGONIST#0.9438;SYMPATHETIC GANGLION#0.9403;BRAIN CORTEX#0.9400;MOTOR ENDPLATE#0.9399;OPIOID RECEPTOR#0.9383;CENTRAL GRAY#0.9379;ENDOPLASMIC RETICULUM#0.9378;SPATIAL WORKING MEMORY#0.9366;MIDDLE CEREBRAL ARTERY#0.9361;ARGININE#0.9361;CEREBRAL ARTERY#0.9359;OLIGODENDROCYTE#0.9341;TACHYKININ#0.9336;AGEING#0.9334;SIGNAL TRANSDUCTION#0.9333;CELL ADHESION MOLECULE#0.9330;MINI MENTAL STATE#0.9329;CARDIOMYOCYTE#0.9328;VASCULAR DEMENTIA#0.9308;QUISQUALATE#0.9301;FETAL BRAIN#0.9300;LARGE INTESTINE#0.9296;SENESCENCE#0.9287;MOTOR ACTIVITY#0.9276;NEUROTRANSMITTER SYNTHESIS#0.9268;PROTEIN KINASE A#0.9264;ASYMMETRIC SYNAPSE#0.9255;PHEOCHROMOCYTOMA#0.9247;GLYCINE RECEPTOR#0.9247;OVARIAN#0.9241;LASER SCANNING MICROSCOPY#0.9240;DENDRITIC SPINE#0.9230;INSULIN RECEPTOR#0.9218;POSITRON EMISSION TOMOGRAPHY#0.9210;PILOCARPINE#0.9207;NEURAL CREST CELL#0.9204;TRANSFORMING GROWTH FACTOR#0.9201;NEUROPATHY#0.9178;EMBRYONIC STEM CELL#0.9178;T LYMPHOCYTE#0.9173;SUCROSE#0.9168;CELL DIFFERENTIATION#0.9165;SYNAPTIC BOUTON#0.9164;LEUCINE#0.9162;MOTOR NEURON DISEASE#0.9162;CELL PROLIFERATION#0.9162;HYPERACTIVITY#0.9159;BRUSH CELL#0.9147;HISTAMINE#0.9140;L-ARGININE#0.9130;THYMIDINE#0.9129;ENUCLEATION#0.9127;LONG TERM MEMORY#0.9103;PRECURSOR CELL#0.9085;NEUROTRANSMITTER BIOSYNTHETIC#0.9078;HATCHING#0.9061;VASOPRESSIN#0.9041;ASPARTIC ACID#0.9030;FORSKOLIN#0.9018;HUPERZINE A#0.9017;TACRINE#0.9017;MECHANISM OF ACTION#0.9013;DIAPHRAGM#0.8984;OPEN FIELD TEST#0.8969;CEREBRAL ARTERY OCCLUSION#0.8962;INTERNAL CAPSULE#0.8961;PROGRESSIVE SUPRANUCLEAR PALSY#0.8958;SYMMETRIC SYNAPSE#0.8955;CALCIUM CHANNEL#0.8944;CAROTID ARTERY#0.8919;HINDBRAIN#0.8898;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8895;DIABETES MELLITUS#0.8865;LYSIS#0.8863;PAROTID GLAND#0.8862;LOCOMOTION#0.8844;CORTICOTROPIN#0.8842;FACTOR S#0.8842;PHOSPHOLIPASE C#0.8816;DIAPHORASE ACTIVITY#0.8805;MEMORY LOSS#0.8799;BETA-2#0.8798;NEURONAL CELL DEATH#0.8770;EPILEPSY#0.8764;MAST CELL#0.8758;MESENCHYMAL STEM CELL#0.8744;MEMBRANE FRACTION#0.8738;NEURITE EXTENSION#0.8728;WEIGHT GAIN#0.8726;ALANINE#0.8697;GROWTH HORMONE#0.8690;GINSENG#0.8686;SUBTHALAMIC NUCLEUS#0.8685;PHOSPHODIESTERASE#0.8684;LEUKOCYTE#0.8673;IMMUNE SYSTEM#0.8666;SHORT TERM MEMORY#0.8662;CAMP RESPONSE ELEMENT#0.8652;ORGANIC CATION TRANSPORTER#0.8645;ADRENERGIC RECEPTOR#0.8632;KINESIN#0.8631;INDUCIBLE NITRIC OXIDE#0.8630;NITRO-L-ARGININE#0.8625;IMMUNE RESPONSE#0.8613;PROGESTERONE#0.8613;BASAL LAMINA#0.8611;SIGNALING MOLECULE#0.8603;NEUROBLAST#0.8600;BONE MARROW#0.8598;CAT I#0.8593;CONSTRICTION#0.8592;INTERSTITIAL CELL#0.8572;DOWN SYNDROME#0.8561;RIGHT ATRIUM#0.8537;CELLULAR LOCALIZATION#0.8536;DIURNAL#0.8531;PERINEURONAL NET#0.8522;ENDOTHELIUM#0.8520;CYTOTOXICITY#0.8500;OOCYTE#0.8496;HISTIDINE#0.8491;SCHWANN CELL#0.8490;L-DOPA#0.8473;METHIONINE#0.8453;INNER EAR#0.8450;CORTICAL CELL#0.8439;SODIUM CHANNEL#0.8430;BACTERIAL ARTIFICIAL CHROMOSOME#0.8421;INFERIOR COLLICULUS#0.8417;MECAMYLAMINE#0.8407;DOPAMINE UPTAKE#0.8405;NASAL MUCOSA#0.8383;PRO-INFLAMMATORY#0.8383;ALPHA-2 MACROGLOBULIN#0.8366;CEREBRUM#0.8353;CHRONIC CEREBRAL HYPOPERFUSION#0.8321;SEROTONERGIC NEURON#0.8318;DODECYL SULFATE#0.8310;SODIUM DODECYL SULFATE#0.8310;ADRENALINE#0.8309;ESTERASE ACTIVITY#0.8306;INFLAMMATORY RESPONSE#0.8297;D-ASPARTIC ACID#0.8295;SUBSTANCE P RECEPTOR#0.8293;ESTROUS CYCLE#0.8286;BONE MORPHOGENETIC PROTEIN#0.8274;BETA-ALANINE#0.8274;GLUCOSE METABOLISM#0.8273;SYNAPTIC MEMBRANE#0.8261;LEFT ATRIUM#0.8249;EXTRACELLULAR MATRIX#0.8240;CONNECTIVE TISSUE#0.8213;NEURAL TUBE#0.8206;MELATONIN#0.8188;CAMP RESPONSE ELEMENT BINDING#0.8182;CREATINE KINASE#0.8169;SUBMANDIBULAR GLAND#0.8168;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8163;MYOCARDIUM#0.8162;ISLANDS OF CALLEJA#0.8156;MYOTUBE#0.8151;SYSTEM DEVELOPMENT#0.8146;WEIGHT LOSS#0.8128;CYCLASE ACTIVITY#0.8122;K-252A#0.8106;COLONIC TRANSIT#0.8105;TRANSCRIPTASE#0.8104;CUNEATE NUCLEUS#0.8079;ION CHANNEL#0.8072;GABA A RECEPTOR#0.8056;SPATIAL REFERENCE MEMORY#0.8055;LECTIN#0.8047;HYPERTENSION#0.8043;TRIIODOTHYRONINE#0.8042;SYNAPTIC CLEFT#0.8037;KINASE INHIBITOR#0.8027;ALL TRANS RETINOIC ACID#0.8021;PICK'S DISEASE#0.8012;HUPERZINE#0.7993;STRIATED MUSCLE#0.7984;NEURAL PROGENITOR CELL#0.7975;SMOOTH MUSCLE CELL#0.7969;FORMALIN#0.7968;GRANULOCYTE#0.7966;PARAFORMALDEHYDE#0.7950;SENESCENCE ACCELERATED MICE#0.7949;MYASTHENIA GRAVIS#0.7942;ESTROGENS#0.7939;CALYCULIN A#0.7935;CONSTIPATION#0.7935;BRONCHIAL EPITHELIAL CELLS#0.7933;MUSCLE FIBRE#0.7932;ORGANELLE#0.7929;SWELLING#0.7904;NICOTINE DEPENDENCE#0.7898;CEP-1347#0.7898;DISTAL DENDRITE#0.7888;PITUITARY GLAND#0.7884;AMPA RECEPTOR#0.7874;PERICELLULAR BASKET#0.7852;UBIQUITIN#0.7848;ENZYME INHIBITOR#0.7837;MUSCLE CONTRACTION#0.7793;SURFACE EPITHELIUM#0.7783;ESERINE#0.7782;LINES OF EVIDENCE#0.7781;RESERPINE#0.7761;HERPES SIMPLEX#0.7755;DORSAL MOTOR NUCLEUS OF VAGUS#0.7748;MEDIAL PREFRONTAL CORTEX#0.7735;CREATINE#0.7685;EXTRACELLULAR SPACE#0.7677;NOVEL OBJECT RECOGNITION#0.7671;BRAIN LESIONS#0.7668;NEUROTRANSMITTER RECEPTOR#0.7664;LATERAL PREOPTIC AREA#0.7650;MAGNETIC RESONANCE IMAGING#0.7646;HABENULAR NUCLEI#0.7634;LIMBIC SYSTEM#0.7605;CAROTID BODY#0.7600;GLYCOGEN SYNTHASE KINASE#0.7590;PRIMARY DENDRITE#0.7588;TRANSIENT RECEPTOR POTENTIAL#0.7587;COA METABOLISM#0.7584;AXON COLLATERAL#0.7580;VITAMIN E#0.7577;VARICOSITY#0.7562;ORNITHINE#0.7561;PENTOBARBITAL#0.7521;HISTONE DEACETYLASE#0.7514;TOXIN BINDING#0.7510;SUDDEN INFANT DEATH SYNDROME#0.7502;MEDIUM SPINY NEURONS#0.7492;GAP JUNCTION#0.7483;ACETYL-COA METABOLISM#0.7477;WAKEFULNESS#0.7472;NEURON DEATH#0.7470;PARALYSIS#0.7457;RETT SYNDROME#0.7447;PARABRACHIAL NUCLEI#0.7428;ISOFLURANE#0.7417;DOPAMINE D2 RECEPTOR#0.7405;MU OPIOID RECEPTOR#0.7397;CORNEAL EPITHELIUM#0.7394;DEHYDROGENASE COMPLEX#0.7385;NEOSTIGMINE#0.7383;HERPES SIMPLEX VIRUS#0.7377;COMPLEX I#0.7368;GASTRIC CORPUS#0.7347;CELL CYCLE#0.7314;SOCIAL DEFEAT STRESS#0.7314;TUBOCURARINE#0.7311;NERVE TRUNK#0.7308;VASCULAR ENDOTHELIAL CELL#0.7294;CATECHOLAMINE SYNTHESIS#0.7286;NO COGNITIVE IMPAIRMENT#0.7285;MUSCULAR ATROPHY#0.7284;COLLATERAL SPROUTING#0.7278;CLEAVED CASPASE 3#0.7277;INTESTINAL MOTILITY#0.7271;EMBRYONIC BRAIN#0.7258;CO-DERGOCRINE MESYLATE#0.7236;NERVOUS SYSTEM DEVELOPMENT#0.7232;CANCER CELL#0.7231;STRUCTURE ACTIVITY RELATIONSHIP#0.7221;DIGESTIVE TRACT#0.7210;OBJECT RECOGNITION TEST#0.7199;AIRWAY SMOOTH MUSCLE#0.7197;ORNITHINE DECARBOXYLASE#0.7180;AMYLOIDOSIS#0.7162;PULMONARY VEIN#0.7150;MONOCYTE#0.7146;SOLUBLE FRACTION#0.7132;STROMAL CELL#0.7127;SEMINAL VESICLE#0.7126;CELL DIVISION#0.7124;NEUROTRANSMITTER RELEASE#0.7121;ANTIGEN BINDING#0.7119;SERUM ALBUMIN#0.7118;D-TUBOCURARINE#0.7116;TRAUMATIC BRAIN INJURY#0.7096;ADENYLATE CYCLASE ACTIVITY#0.7093;DENDRITIC CELL#0.7090;HISTONE ACETYLATION#0.7082;NADPH DIAPHORASE ACTIVITY#0.7081;GROWTH CONE#0.7076;CELL ACTIVATION#0.7051;IMIPRAMINE#0.7037;POSTSYNAPTIC MEMBRANE#0.7028;SPINAL DORSAL HORN#0.7028;TYROSINE 3 MONOOXYGENASE#0.7023;MOTOR NEURON DEGENERATION#0.7020;CYTOSINE ARABINOSIDE#0.7004;MYO-INOSITOL#0.7000;TRACHEA#0.6999;SCRAPIE#0.6975;NITRIC OXIDE SYNTHASE ACTIVITY#0.6963;GASTRIC EMPTYING#0.6962;MUSCLE ATROPHY#0.6961;SENSITIZATION#0.6954;OLIVOPONTOCEREBELLAR ATROPHY#0.6954;PROTEOGLYCAN#0.6953;METHAMPHETAMINE#0.6952;ADENOSINE TRIPHOSPHATE#0.6934;TERMINAL BOUTON#0.6930;EXCITATORY POSTSYNAPTIC POTENTIAL#0.6925;TRANSMISSION ELECTRON MICROSCOPY#0.6921;GLUCOSE-6-PHOSPHATE#0.6909;PARENCHYMA#0.6906;PULMONARY ARTERY#0.6865;PERIPHERAL BLOOD#0.6855;GLUCOSE UPTAKE#0.6853;PRESYNAPTIC BOUTON#0.6838;ABDUCENS NUCLEUS#0.6826;PRENATAL NICOTINE EXPOSURE#0.6816;RECTUM#0.6810;DENDRITIC TREE#0.6805;ENDOCRINE CELL#0.6805;LUMINAL#0.6795;PICROTOXIN#0.6791;ARTERIOLE#0.6790;VASODILATION#0.6783;SIGNALING CASCADE#0.6765;MOTOR BEHAVIOR#0.6758;PREPULSE INHIBITION#0.6756;GI TRACT#0.6751;LIPOIC ACID#0.6749;ALKALINE PHOSPHATASE#0.6739;SOLITARY TRACT NUCLEUS#0.6732;HYPOXIA INDUCIBLE FACTOR#0.6728;PYRUVATE DEHYDROGENASE COMPLEX#0.6718;PSEUDORABIES#0.6712;MYOBLAST#0.6709;PHENOBARBITAL#0.6702;2'-DEOXYURIDINE#0.6698;ANTITHYMOCYTE GLOBULIN#0.6692;IFN-GAMMA#0.6686;HYPOGLYCEMIA#0.6668;MITOSIS#0.6665;OXYGENASE#0.6648;LYMPHOCYTIC CHORIOMENINGITIS#0.6645;HIGH FAT DIET#0.6643;NEURON DIFFERENTIATION#0.6642;MITOCHONDRIAL MEMBRANE#0.6640;SIGNALLING PATHWAY#0.6640;AXOPLASMIC TRANSPORT#0.6632;ADRENAL CORTEX#0.6629;APICAL DENDRITE#0.6628;ANTEROGRADE AXONAL TRANSPORT#0.6625;GASTRIC MOTILITY#0.6619;EVERY OTHER DAY#0.6612;RIVASTIGMINE#0.6595;T CELL ACTIVATION#0.6593;H-CORT#0.6578;LABYRINTH#0.6558;RETROGRADE AXONAL TRANSPORT#0.6543;SPINAL MUSCULAR ATROPHY#0.6542;ESTROGEN RECEPTOR ALPHA#0.6525;VITAMIN A#0.6523;TROCHLEAR NUCLEUS#0.6516;PTOSIS#0.6512;CHRONIC ALCOHOL CONSUMPTION#0.6506;PHOSPHOLIPASE A2#0.6506;HALLUCINATIONS#0.6504;DELTA OPIOID RECEPTOR#0.6502;SYNAPTIC VESICLE PROTEIN#0.6494;THIAMINE#0.6491;EOSIN#0.6481;JEJUNUM#0.6472;GUANETHIDINE#0.6453;BETAXOLOL#0.6444;HISTIDINE DECARBOXYLASE#0.6436;EXOCYTOSIS#0.6432;EOSINOPHIL#0.6429;CHOLINE METABOLISM#0.6428;ARRHYTHMIA#0.6428;CONVULSION#0.6425;MYOCYTES#0.6418;GUANYLATE CYCLASE#0.6417;OLFACTORY CORTEX#0.6403;ADENO ASSOCIATED VIRUS#0.6402;HEPARIN#0.6402;RECEPTOR ACTIVITY#0.6402;PHOSPHATE BUFFERED SALINE#0.6395;NGF BINDING#0.6390;CLONAZEPAM#0.6387;CARBAMYLCHOLINE#0.6386;KERATINOCYTE#0.6384;VAGUS NERVE STIMULATION#0.6382;ATPASE ACTIVITY#0.6381;VASODILATOR#0.6380;RECEPTOR LIGAND#0.6374;ISCHEMIA REPERFUSION INJURY#0.6370;DNA FRAGMENTATION#0.6362;POTASSIUM CHANNEL#0.6358;DESCENDING COLON#0.6347;MYOCARDIAL INFARCTION#0.6337;LUNG CANCER#0.6329;BRADYCARDIA#0.6303;CINGULUM#0.6295;EPIBATIDINE#0.6293;PEROXIDASE REACTION#0.6289;BENZODIAZEPINE RECEPTOR#0.6277;PENTAGASTRIN#0.6276;HEART RATE VARIABILITY#0.6269;MENTAL RETARDATION#0.6269;MECHANISMS OF ACTION#0.6255;ENCEPHALOMYELITIS#0.6254;SUPEROXIDE DISMUTASE ACTIVITY#0.6248;UTERUS#0.6241;TRANSDIFFERENTIATION#0.6235;LYSINE#0.6229;CATION CHANNEL#0.6225;DIHYDROTESTOSTERONE#0.6219;MUTAGENESIS#0.6208;TRANSFORMING GROWTH FACTOR ALPHA#0.6193;ARACHIDONIC ACID#0.6184;ULCERATIVE COLITIS#0.6183;MOLAR#0.6179;HABITUATION#0.6178;DNA SYNTHESIS#0.6177;HYPERSENSITIVITY#0.6176;MYELINATION#0.6166;POSTNATAL DAY 7#0.6153;NDPASE ACTIVITY#0.6146;RESPIRATION#0.6138;SEROTONIN RECEPTOR#0.6132;SKELETAL MUSCLE CELLS#0.6132;DUCTUS DEFERENS#0.6130;LITHIUM#0.6129;REPRESSOR ELEMENT 1#0.6118;OESTRADIOL#0.6113;DIGESTION#0.6113;SYNTHETASE ACTIVITY#0.6111;ROUGH ENDOPLASMIC RETICULUM#0.6106;HEME OXYGENASE 1#0.6084;SOMATOSTATIN RECEPTOR#0.6083;CYTOCHROME OXIDASE ACTIVITY#0.6074;IMMUNOGLOBULIN G#0.6060;RETINAL ISCHEMIA#0.6051;QUANTITATIVE REAL TIME#0.6051;OUABAIN#0.6048;COLONY-STIMULATING FACTOR#0.6045;NUCLEAR ORGANIZATION#0.6038;SELF INCOMPATIBILITY#0.6034;ACETYLCHOLINE TRANSPORT#0.6033;COMMON CAROTID ARTERIES#0.6025;CALCINEURIN#0.6023;POSITIVE CONTROL GROUP#0.6023;BLANK CONTROL GROUP#0.6010
11040	B CELL#1.0190;PROTEIN KINASE#1.0188;ONCOGENIC#1.0099;CANCER CELL#1.0085;BREAST CANCER#1.0056;MULTIPLE MYELOMA#1.0049;CELL PROLIFERATION#1.0047;TREG CELL#1.0035;T CELL#1.0005;KINASE ACTIVITY#0.9948;CELL DEATH#0.9930;APOPTOSIS#0.9923;CELL CYCLE#0.9910;INTENSIVE CARE UNIT#0.9897;BONE MARROW#0.9855;APOPTOTIC#0.9824;KINASE INHIBITOR#0.9816;MYELOID LEUKEMIA#0.9681;RAPAMYCIN#0.9624;GROWTH FACTOR#0.9577;SIGNALING PATHWAY#0.9548;GENE EXPRESSION#0.9506;CELL GROWTH#0.9421;STANDARDIZED MORTALITY RATIO#0.9409;ACUTE MYELOID LEUKEMIA#0.9249;PROSTATE CANCER#0.9219;ALPHA 1-ANTITRYPSIN#0.8854;TRANSCRIPTION FACTOR#0.8821;B CELL LYMPHOMA#0.8809;HEMATOPOIETIC CELL#0.8718;HEPATOCELLULAR CARCINOMA#0.8467;AUTOPHAGY#0.8026;TUMOR CELLS#0.7990;MYELOID CELL#0.7990;POLYMERASE CHAIN REACTION#0.7939;LYMPHOCYTIC LEUKEMIA#0.7770;LENGTH OF STAY#0.7688;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7635;STEM CELL#0.7568;LIVER CANCER#0.7523;BONE MARROW CELLS#0.7125;CELL CYCLE ARREST#0.6903;HUMAN BREAST CANCER#0.6767;SIGNAL TRANSDUCTION#0.6726;INTERNAL TANDEM DUPLICATION#0.6442;GLYCOLYSIS#0.6377;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6328;MITOGEN ACTIVATED PROTEIN#0.6246;DNA DAMAGE RESPONSE#0.6095;BREAST CANCER CELL#0.6043;STRUCTURE ACTIVITY RELATIONSHIP#0.6014;CELL DEVELOPMENT#0.6013
11041	GLCNAC#0.7727;WALKER-WARBURG SYNDROME#0.7528;GLYCOSYLATION#0.7342
11042	MAP KINASE#0.8974;BODY WALL MUSCLE#0.7560
11043	CELL WALL#1.0409;CELL WALL INTEGRITY#1.0134;CELL SURFACE#0.9824;PLASMA MEMBRANE#0.9561;SEPTIN RING#0.8596;PROTEIN KINASE#0.8544;UBIQUITIN#0.8029;OPITZ-GBBB SYNDROME#0.7777;MIDLINE#0.7722;MICROTUBULE#0.7709;MAP KINASE#0.7597;SIGNALING PATHWAY#0.6992;INTELLECTUAL DISABILITY#0.6965;PROTEIN KINASE C#0.6913;SIGNAL TRANSDUCTION#0.6735;FG SYNDROME#0.6688;TRANSCRIPTION FACTOR#0.6599;CYTOKINESIS#0.6552;SHMOO#0.6525;CELL DIVISION#0.6472;X CHROMOSOME#0.6260;GENE EXPRESSION#0.6247
11044	TRAMP COMPLEX#1.0554;EXOSOME#1.0400;SPORULATION#1.0102;GENE EXPRESSION#0.9927;STATIONARY PHASE#0.9894;FORESPORE#0.9781;TRANSCRIPTION FACTOR#0.9632;DNA BINDING#0.9506;CHLOROPLAST#0.8909;DNA REPLICATION#0.8877;FACTOR I#0.8765;SISTER CHROMATID COHESION#0.8322;PLASTID#0.8125;RNA BINDING#0.8028;MUTAGENESIS#0.7734;SPORE FORMATION#0.7689;CHROMATID#0.7654;BUDDING#0.7568;RNA SURVEILLANCE#0.7414;TOPOISOMERASE#0.7142;VIRULENCE#0.7026;RNA DEGRADATION#0.6455;SIGNAL TRANSDUCTION#0.6299;CELL CYCLE#0.6285;HISTIDINE#0.6147;DNA TOPOISOMERASE#0.6129;DNA POLYMERASE ACTIVITY#0.6095;CHROMOSOME CONDENSATION#0.6093;RNA PROCESSING#0.6061;RNA BINDING PROTEIN#0.6021;C TERMINAL DOMAIN#0.6016
11045	URINARY BLADDER#0.8089;URINARY TRACT INFECTION#0.8064;TRANSITIONAL CELL CARCINOMA#0.7827;GENE EXPRESSION#0.7650;CELL SURFACE#0.6745;TUMOR SUPPRESSOR#0.6143
11046	SUGAR TRANSPORTER#1.0013;NUCLEOTIDE SUGAR TRANSPORTER#0.9658;GOLGI APPARATUS#0.9164;UDP GALACTOSE#0.8367;GLCNAC#0.7640;GOLGI MEMBRANE#0.6387
11047	PROTEASOME#1.0539;CANCER CELL#1.0530;26S PROTEASOME#1.0463;UBIQUITIN#1.0447;OVARIAN CANCER#1.0117;19S REGULATORY PARTICLE#0.9903;DEUBIQUITINATING ENZYME#0.9398;GLYCOPROTEIN GP110#0.9254;OVARIAN#0.9167;PLASMA MEMBRANE#0.8966;UBIQUITIN BINDING#0.8846;RNA INTERFERENCE#0.8582;T CELL#0.8530;CELL ADHESION#0.8519;APOPTOSIS#0.8488;CELL PROLIFERATION#0.8429;INTRACELLULAR LOCALIZATION#0.8219;EPSTEIN BARR VIRUS#0.8204;CELL MIGRATION#0.7987;PROTEIN DEGRADATION#0.7640;POLYUBIQUITIN#0.7460;COLORECTAL CANCER#0.7364;MULTIPLE MYELOMA#0.6866;CELL SURFACE#0.6851;UBIQUITIN PROTEASOME SYSTEM#0.6783;ENDOPLASMIC RETICULUM#0.6587;CELL CYCLE#0.6323;DEUBIQUITINASE#0.6166;BREAST CANCER#0.6118;RNA BINDING#0.6053
1104	CHROMOSOME CONDENSATION#1.0611;NUCLEOTIDE EXCHANGE FACTOR#1.0534;CLATHRIN HEAVY CHAIN#1.0480;GUANINE#1.0443;CELL CYCLE#1.0284;NUCLEAR TRANSPORT#1.0100;NUCLEAR IMPORT#1.0097;GTP BINDING#1.0095;MITOSIS#1.0089;BREAST CANCER#1.0067;DNA REPLICATION#1.0032;IMPORTIN#0.9971;CYCLIN DEPENDENT KINASE#0.9971;MITOTIC SPINDLE#0.9960;CANCER CELL#0.9958;S PHASE#0.9952;SPINDLE ASSEMBLY#0.9938;ENDOCYTOSIS#0.9910;NUCLEAR ENVELOPE#0.9899;APOPTOSIS#0.9891;NUCLEOSOME#0.9879;INTERPHASE#0.9863;NUCLEOCYTOPLASMIC TRANSPORT#0.9858;CELL PROLIFERATION#0.9849;PROTEIN KINASE#0.9839;CYTOPLASM#0.9807;NUCLEAR PORE#0.9786;M PHASE#0.9737;DNA SYNTHESIS#0.9707;PROTEIN IMPORT#0.9680;GENE EXPRESSION#0.9676;CELL CYCLE ARREST#0.9628;G1 PHASE#0.9611;TUMOR SUPPRESSOR#0.9557;GTP HYDROLYSIS#0.9534;CELL GROWTH#0.9526;SIGNALING PATHWAY#0.9501;MICROTUBULE#0.9463;RETINOBLASTOMA#0.9460;MITOTIC SPINDLE ASSEMBLY#0.9416;TRANSCRIPTION FACTOR#0.9390;APOPTOTIC#0.9389;SPINDLE FORMATION#0.9315;RAN-BINDING PROTEIN#0.9301;CELL CYCLE REGULATION#0.9179;PLASMA MEMBRANE#0.9169;NUCLEAR EXPORT#0.9055;CELL DEATH#0.9006;GUANOSINE#0.8974;NUCLEAR LOCALIZATION SIGNAL#0.8898;KINASE INHIBITOR#0.8897;CELL CYCLE REGULATOR#0.8892;MITOTIC CHROMOSOME#0.8812;BREAST CANCER CELL#0.8744;DNA BINDING#0.8706;CHROMATIN BINDING#0.8670;INITIATION OF MITOSIS#0.8521;GROWTH FACTOR#0.8382;STEM CELL#0.8340;PORE COMPLEX#0.8300;B CELL#0.8292;UBIQUITIN#0.8228;RETINITIS PIGMENTOSA#0.8173;CELL CYCLE CONTROL#0.8158;NUCLEAR PORE COMPLEX#0.8154;CYCLIN DEPENDENT KINASE INHIBITOR#0.8151;T CELL#0.8037;MYELOID LEUKEMIA#0.7943;POLYMERASE CHAIN REACTION#0.7898;CELL DIVISION#0.7873;CENTROSOME#0.7841;KARYOPHERIN#0.7787;KINASE ACTIVITY#0.7758;THYMIDINE#0.7738;SMOOTH MUSCLE#0.7735;LYMPH NODE#0.7641;ENTRY INTO MITOSIS#0.7580;SIGNAL TRANSDUCTION#0.7547;KINETOCHORE#0.7474;CHROMOSOME SEGREGATION#0.7420;ACUTE MYELOID LEUKEMIA#0.7414;METAPHASE#0.7387;IFN-GAMMA#0.7331;GTPASE REGULATOR#0.7250;HYPOXIA#0.7188;PROSTATE CANCER#0.7171;SMOOTH MUSCLE CELL#0.7111;MUSCLE CELL#0.7105;VACUOLE#0.7082;RETINITIS#0.7002;BREAST CARCINOMA#0.6884;VACUOLAR PROTEIN SORTING#0.6879;HEPATITIS C#0.6862;TUMOR CELLS#0.6839;RENAL CELL CARCINOMA#0.6592;DNA REPAIR#0.6589;SPINDLE POLE#0.6577;TUMOR TISSUES#0.6539;HUMAN BREAST CANCER#0.6484;CELL SURFACE#0.6441;ADENOCARCINOMA#0.6408;MRNA METABOLISM#0.6357;BINDING PROTEIN 1#0.6315;GUANINE EXCHANGE FACTOR#0.6256;CATALYTIC ACTIVITY#0.6239;PROTEIN TRANSPORT#0.6235;CYTOPLASMIC TRANSPORT#0.6179;ESTROGEN RECEPTOR#0.6163;SENESCENCE#0.6119;NUCLEAR ORGANIZATION#0.6084;CHRONIC HEPATITIS C#0.6065;CHROMATIN REMODELING#0.6002
11051	CELL PROLIFERATION#0.9561;SIGNALING PATHWAY#0.8948;MIRNA-MEDIATED GENE SILENCING#0.8783;HEPATOCELLULAR CARCINOMA#0.8741;FACTOR I#0.8443;CANCER CELL#0.8135;GENE SILENCING#0.7997;LUNG FIBROBLASTS#0.7163;RNA BINDING#0.7043;GENE EXPRESSION#0.6825;MRNA CLEAVAGE#0.6789;TUMOR SUPPRESSOR#0.6756;PULMONARY FIBROSIS#0.6260
11052	FACTOR I#1.0528;NUCLEAR IMPORT#1.0241;VIRAL CAPSID#0.9615;MRNA CLEAVAGE#0.9009;REVERSE TRANSCRIPTION#0.8851;RNA PROCESSING#0.8735;HOST CELL#0.8206;NUCLEAR PORE#0.8025;CYCLOPHILIN#0.7619;MACROPHAGE#0.7466;MRNA PROCESSING#0.7110;CYTOPLASM#0.7049;GENE EXPRESSION#0.7007;MRNA 3' END PROCESSING#0.6366;GERM CELL#0.6145;ARGININE#0.6116
11054	OPIOID GROWTH FACTOR#1.1083;GROWTH FACTOR RECEPTOR#1.0800;GROWTH FACTOR#1.0754;CELL PROLIFERATION#1.0562;OPIOID RECEPTOR#1.0438;NALTREXONE#0.9933;CANCER CELL#0.9853;DNA SYNTHESIS#0.9765;SQUAMOUS CELL CARCINOMA#0.9239;OVARIAN CANCER#0.9152;IMIQUIMOD#0.8040;CELL GROWTH#0.7842;OPIOID PEPTIDE#0.7731;IMMUNE RESPONSE#0.7686;WOUND HEALING#0.7529;OVARIAN#0.7515;NUCLEAR ENVELOPE#0.7242;REGULATION OF CELL PROLIFERATION#0.7154;GENE EXPRESSION#0.6998;EPITHELIAL CELL#0.6978;PANCREATIC CANCER#0.6561;CORNEAL EPITHELIUM#0.6431;NUCLEAR PORE#0.6417;APOPTOSIS#0.6404;HUMAN PANCREATIC CANCER#0.6403;NUCLEAR LOCALIZATION SIGNAL#0.6391;TUMOR ANTIGEN#0.6283;RECEPTOR ANTAGONIST#0.6278;BASAL CELL#0.6188;PROSTATE CANCER#0.6183;LUNG CANCER#0.6169
11055	ZONA PELLUCIDA#1.1031;ACROSOME#0.9280;SPERMATOZOA#0.8297;SPERM HEAD#0.7326;FERTILIZATION#0.7174;BINDING PROTEIN 1#0.7117;OOCYTE#0.6960;PLASMA MEMBRANE#0.6557;ACROSOME REACTION#0.6349
11056	RNA HELICASE#1.0726;CELL CYCLE#0.8840;RRNA PROCESSING#0.7986;DUAL SPECIFICITY PHOSPHATASE#0.6584;SPERMATID DIFFERENTIATION#0.6362;PROTEIN KINASE#0.6261;RIBOSOME#0.6027
11057	SERINE HYDROLASE#0.7432;ACROSOME REACTION#0.6546;DNASE I#0.6468;B CELL#0.6199
11059	UBIQUITIN PROTEIN LIGASE#1.0961;BREAST CANCER#1.0754;BREAST CANCER CELL#1.0680;CANCER CELL#1.0619;UBIQUITIN#1.0524;APOPTOSIS#1.0158;CELL PROLIFERATION#1.0094;CELL MIGRATION#0.9627;TRANSCRIPTION FACTOR#0.9522;OSTEOBLAST#0.9371;CELL GROWTH#0.9335;SIGNALING PATHWAY#0.9281;PROTEASOME#0.9279;PROSTATE CANCER#0.8944;SKELETAL MUSCLE#0.8856;CELL CYCLE#0.8854;MUSCULAR DYSTROPHY#0.8579;LIGASE ACTIVITY#0.8501;OSTEOBLAST DIFFERENTIATION#0.8354;HECT E3#0.8219;TUMOR SUPPRESSOR#0.8077;PROTEASOME PATHWAY#0.8014;GROWTH FACTOR#0.7867;ONCOGENIC#0.7753;BUDDING#0.7679;T CELL#0.7355;GENE EXPRESSION#0.7214;UBIQUITIN LIGASE ACTIVITY#0.7194;EPITHELIAL CELL#0.7145;ESTROGEN RECEPTOR#0.6851;UBIQUITIN PROTEASOME PATHWAY#0.6711;GROWTH FACTOR RECEPTOR#0.6591;SQUAMOUS CELL CARCINOMA#0.6409;T-CELL LEUKEMIA#0.6253;COPY NUMBER GAIN#0.6185;BONE FORMATION#0.6122;AKT SIGNALING#0.6079
1105	BINDING PROTEIN 1#1.0781;DNA BINDING#1.0533;PROSTATE CANCER#1.0413;NUCLEOSOME#1.0372;CHROMATIN REMODELING#1.0343;CHROMATIN ASSEMBLY#1.0245;NUCLEOSOME SLIDING#1.0203;NUCLEOSOME SPACING#1.0093;CHROMATIN REMODELLING#1.0074;LYSINE#0.9958;GENE EXPRESSION#0.9841;ATP-DEPENDENT CHROMATIN REMODELING#0.9559;TUMOR SUPPRESSOR#0.9435;HISTONE MODIFICATION#0.9283;ANDROGEN RECEPTOR#0.9215;STEM CELL#0.8936;W CHROMOSOME#0.8749;Z CHROMOSOME#0.8426;POLYTENE CHROMOSOME#0.8308;NUCLEOSOME POSITIONING#0.8134;TRANSCRIPTION FACTOR#0.7980;PAF1 COMPLEX#0.7883;SEX CHROMOSOME#0.7811;EMBRYONIC STEM CELL#0.7802;CANCER CELL#0.7672;BREAST CANCER#0.7474;NUCLEOSOME ASSEMBLY#0.7218;BUDDING#0.7050;AR BINDING#0.7025;POLYMERASE CHAIN REACTION#0.6790;HISTONE EXCHANGE#0.6571;DNA REPLICATION#0.6365;CELL PROLIFERATION#0.6300;HISTONE CHAPERONE#0.6092;RNA SPLICING#0.6085;CHROMATIN ORGANIZATION#0.6070;DNA METHYLATION#0.6039;HISTONE REPLACEMENT#0.6017
11060	UBIQUITIN#1.0529;UBIQUITIN PROTEIN LIGASE#1.0414;CELL CYCLE#0.9887;STEM CELL#0.9824;TRANSCRIPTION FACTOR#0.9740;LIGASE ACTIVITY#0.9301;CANCER CELL#0.9088;LIVER CANCER#0.8977;T CELL#0.8911;APOPTOSIS#0.8771;CELL PROLIFERATION#0.8105;GENE EXPRESSION#0.7784;AKT SIGNALING#0.7769;SIGNALING PATHWAY#0.7529;EMBRYONIC STEM CELL#0.7369;TUMOR SUPPRESSOR#0.7100;PROTEASOME#0.7027;HECT E3#0.6744;CRANIOFACIAL DEVELOPMENT#0.6297;B CELL#0.6163;POST-TRANSLATIONAL MODIFICATION#0.6132;CHONDROGENESIS#0.6096;B CELL LYMPHOMA#0.6088;IMMUNE RESPONSE#0.6011
11061	ENDOTHELIAL CELL#1.0513;ANGIOGENESIS#1.0449;ENDOTHELIAL GROWTH FACTOR#1.0442;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0404;CHONDROCYTE#1.0349;GROWTH FACTOR#1.0258;T CELL#1.0209;APOPTOSIS#1.0138;VASCULAR ENDOTHELIAL CELL#1.0106;GENE EXPRESSION#1.0101;TUBE FORMATION#1.0002;BONE FORMATION#0.9813;STEM CELL#0.9687;CANCER CELL#0.9627;MESENCHYMAL STEM CELL#0.9481;EXTRACELLULAR MATRIX#0.9407;TUBE MORPHOGENESIS#0.9394;OSSIFICATION#0.9176;CHONDROSARCOMA#0.9110;CELL PROLIFERATION#0.8975;CARTILAGE DEVELOPMENT#0.8856;MORPHOGENESIS#0.8752;EWING SARCOMA#0.8713;BONE MARROW#0.8538;DNA SYNTHESIS#0.8528;ENDOCHONDRAL OSSIFICATION#0.8480;SIGNALING PATHWAY#0.8431;CHONDROGENESIS#0.8184;POLYMERASE CHAIN REACTION#0.8179;FIBROBLAST GROWTH FACTOR#0.8057;CELL CYCLE#0.8056;TUMOR CELLS#0.7788;INFECTIVE ENDOCARDITIS#0.7752;PROTEOGLYCAN#0.7621;INTERVERTEBRAL DISC#0.7488;OSTEOARTHRITIS#0.7305;DEMINERALIZED BONE MATRIX#0.7120;CONNECTIVE TISSUE#0.7081;CELL GROWTH#0.7044;COLLAGEN TYPE II#0.6977;CELL DEATH#0.6952;C TERMINAL DOMAIN#0.6884;TRANSFORMING GROWTH FACTOR#0.6844;HEART DISEASE#0.6842;HEPATOCELLULAR CARCINOMA#0.6791;BREAST CANCER#0.6755;BONE DEVELOPMENT#0.6687;HUMAN UMBILICAL VEIN#0.6665;UMBILICAL VEIN#0.6662;BLOOD VESSEL#0.6582;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6411;CELL SURFACE#0.6366;PROTEOGLYCAN SYNTHESIS#0.6311;CYTOCHROME C#0.6148;PLEOMORPHIC ADENOMA#0.6141;CASPASE INHIBITOR#0.6077;ENDOCARDITIS#0.6071;OSTEOBLAST#0.6050;MESENCHYME#0.6026;TRANSCRIPTION FACTOR#0.6023
11063	TRANSCRIPTION FACTOR#0.9731;LUNG CANCER#0.9545;CANCER CELL#0.8853;LUNG ADENOCARCINOMA#0.8531;GENE EXPRESSION#0.8206;CELL PROLIFERATION#0.7934;ADENOCARCINOMA#0.7611;SPERMIOGENESIS#0.7513;SPERMATOGENESIS#0.7233;TUMOR SUPPRESSOR#0.7123;GERM CELL#0.7104;MEIOSIS#0.6972;TESTIS DEVELOPMENT#0.6596;TUMOR TISSUES#0.6390;OVARIAN CANCER#0.6362
11064	CENTRIOLE#1.0650;CENTROSOME#0.9867;CELL CYCLE#0.8440;GROWTH FACTOR#0.8428;MICROTUBULE#0.7909;FIBROBLAST GROWTH FACTOR#0.7414;SPINDLE POLE#0.7262;CYTOKINESIS#0.7111;GROWTH FACTOR RECEPTOR#0.6922;MIDBODY#0.6859;MOTHER CENTRIOLE#0.6833;STEM CELL#0.6359;VESICLE TARGETING#0.6039;DAUGHTER CENTRIOLE#0.6038
11065	CANCER CELL#1.0439;UBIQUITIN#1.0407;RNA INTERFERENCE#1.0350;CELL GROWTH#1.0308;PROTEASOME#1.0271;CELL PROLIFERATION#1.0257;BREAST CANCER#1.0257;LUNG CANCER#1.0226;ANAPHASE PROMOTING COMPLEX#1.0216;ANAPHASE#1.0177;PROSTATE CANCER#1.0151;APOPTOSIS#1.0121;CELL CYCLE#1.0080;BREAST CANCER CELL#1.0040;CYCLOSOME#1.0016;SPINDLE ASSEMBLY#0.9976;SPINDLE ASSEMBLY CHECKPOINT#0.9864;GENE EXPRESSION#0.9832;ADENOCARCINOMA#0.9791;MITOSIS#0.9521;SIGNALING PATHWAY#0.9491;M PHASE#0.9425;COLORECTAL CANCER#0.9394;SQUAMOUS CELL CARCINOMA#0.9268;OVARIAN#0.9262;TRANSCRIPTION FACTOR#0.9192;COLORECTAL#0.9081;CERVICAL CANCER#0.8963;ANDROGEN RECEPTOR#0.8915;BREAST CARCINOMA#0.8908;CELL DIVISION#0.8855;GENE EXPRESSION OMNIBUS#0.8763;PROTEIN PROTEIN INTERACTION#0.8701;HEPATOCELLULAR CARCINOMA#0.8685;ADJACENT NORMAL TISSUE#0.8633;LYMPH NODE#0.8607;LYMPH NODE METASTASIS#0.8429;POLYMERASE CHAIN REACTION#0.8156;EPITHELIAL MESENCHYMAL TRANSITION#0.8131;DISEASE FREE SURVIVAL#0.8098;OVARIAN CARCINOMA#0.8087;COLORECTAL CARCINOMA#0.8084;OVARIAN CANCER#0.7960;PROTEASOME PATHWAY#0.7859;LUNG ADENOCARCINOMA#0.7801;CELL DIVISION CYCLE#0.7762;UBIQUITIN PROTEASOME PATHWAY#0.7750;EXIT FROM MITOSIS#0.7687;THYROID CARCINOMA#0.7672;CISPLATIN#0.7634;CELLULAR GROWTH#0.7603;CERVICAL#0.7562;G1 PHASE#0.7546;COLON CANCER#0.7536;DRUG RESISTANCE#0.7526;SPINDLE CHECKPOINT#0.7523;QUANTITATIVE REAL TIME#0.7483;ONCOGENIC#0.7260;MITOTIC SPINDLE#0.7220;TUMOR SUPPRESSOR#0.7070;S PHASE#0.7037;METAPHASE#0.6986;GROWTH FACTOR#0.6974;REVERSE TRANSCRIPTION#0.6770;LIGASE ACTIVITY#0.6643;OOCYTE#0.6630;TOPOISOMERASE#0.6594;CELL DEATH#0.6514;LYSINE#0.6401;TOPOISOMERASE II#0.6370;UBIQUITIN PROTEASOME SYSTEM#0.6323;CHROMATID#0.6243;AKT SIGNALING#0.6128;NEOPLASTIC DISEASE#0.6088;PANCREATIC DUCTAL ADENOCARCINOMA#0.6031
11066	CELL WALL#0.9329;OVARIAN CANCER#0.9112;CANCER CELL#0.9091;OVARIAN#0.8736;MEMBRANE FRACTION#0.8537;CORONARY ARTERY#0.7386;EMBRYONIC STEM CELL#0.6875;STEM CELL#0.6817;PROTEINASE ACTIVITY#0.6761;GLUCAN SYNTHESIS#0.6747;EMBRYONAL CARCINOMA#0.6470;VIRULENCE#0.6399;MUTAGENESIS#0.6361;PLASMA MEMBRANE#0.6352;IMMUNE RESPONSE#0.6334;ARGININE#0.6224
11067	PROGESTERONE#1.0047;ADIPOSE TISSUE#0.9716;GENE EXPRESSION#0.9490;TRANSCRIPTION FACTOR#0.9427;SKELETAL MUSCLE#0.8951;GROWTH FACTOR#0.8841;OBESE#0.8727;FATTY ACID OXIDATION#0.8408;AUTOPHAGY#0.8060;HYPOXIA#0.7977;PEROXISOME#0.7324;COLON CANCER#0.7296;CANCER CELL#0.7258;ENDOTHELIAL CELL#0.7233;APOPTOSIS#0.7099;MITOCHONDRIA#0.6735;CARNITINE#0.6601;ADIPOCYTE#0.6601;INSULIN-LIKE GROWTH FACTOR#0.6511;GROWTH HORMONE#0.6401;WEIGHT LOSS#0.6359;ENZYME ACTIVITY#0.6340
11069	CAMP BINDING#1.0388;EXOCYTOSIS#1.0333;NUCLEOTIDE EXCHANGE FACTOR#1.0327;GUANINE#1.0255;CAMP BINDING DOMAIN#1.0236;CAMP SIGNALING#1.0212;RESONANCE ENERGY TRANSFER#1.0212;BETA CELL#1.0190;INSULIN SECRETION#1.0176;PROTEIN KINASE A#1.0104;CYCLIC AMP#1.0067;PLASMA MEMBRANE#1.0054;PROTEIN KINASE#1.0031;FORSKOLIN#0.9961;SIGNALING PATHWAY#0.9943;GENE EXPRESSION#0.9940;ADENOSINE#0.9879;ADENOSINE MONOPHOSPHATE#0.9872;SIGNAL TRANSDUCTION#0.9809;CYCLIC ADENOSINE MONOPHOSPHATE#0.9806;ENDOTHELIAL CELL#0.9708;CELL MIGRATION#0.9601;PHOSPHOLIPASE C#0.9584;CELL PROLIFERATION#0.9575;GROWTH FACTOR#0.9502;ION CHANNEL#0.9417;ADRENERGIC RECEPTOR#0.9392;NUCLEOTIDE BINDING#0.9383;APOPTOSIS#0.9335;DENDRITIC SPINE#0.9310;CELL ADHESION#0.9305;SMOOTH MUSCLE#0.9295;CANCER CELL#0.9220;CYCLIC NUCLEOTIDE BINDING#0.9037;MYOCYTES#0.8941;NEURITE OUTGROWTH#0.8865;ARRHYTHMIA#0.8723;CARDIOMYOCYTE#0.8687;SIGNALING CASCADE#0.8679;TYPE 2 DIABETES#0.8672;CAMP SIGNALLING#0.8657;SULFONYLUREA RECEPTOR#0.8326;PHOSPHODIESTERASE#0.8160;SIGNALLING PATHWAY#0.8147;CAMKII#0.8141;EPITHELIAL CELL#0.7994;AMPA RECEPTOR#0.7950;SPINAL CORD#0.7891;GUANINE EXCHANGE FACTOR#0.7857;ADENYLATE CYCLASE#0.7821;PANCREATIC ISLET#0.7744;NUCLEOTIDE BINDING DOMAIN#0.7743;TRANSCRIPTION FACTOR#0.7668;NEURITE#0.7543;SIGNALING MOLECULE#0.7455;CELL DEATH#0.7448;MITOGEN ACTIVATED PROTEIN#0.7425;MICROTUBULE#0.7376;CAMP RESPONSE ELEMENT#0.7337;SMOOTH MUSCLE CELL#0.7277;DIABETES MELLITUS#0.7273;MUSCLE CELL#0.7271;SENSITIZATION#0.7208;RECEPTOR AGONIST#0.7157;CAMP RESPONSE ELEMENT BINDING#0.7107;ISLETS OF LANGERHANS#0.7024;PROSTAGLANDIN E2#0.7011;ISOPROTERENOL#0.6949;AIRWAY SMOOTH MUSCLE#0.6906;ADENYLATE#0.6777;POLYMERASE CHAIN REACTION#0.6705;CAMP MEDIATED SIGNALING#0.6517;REGULATED EXOCYTOSIS#0.6484;ISCHEMIA#0.6442;GTP BINDING#0.6368;HORMONE SECRETION#0.6341;LIPID RAFT#0.6322;ADIPOSE TISSUE#0.6250;TOLBUTAMIDE#0.6236;RESPONSE TO CAMP#0.6188;READILY RELEASABLE POOL#0.6179;STEM CELL#0.6172;SYNAPTIC TRANSMISSION#0.6096;DECIDUAL CELL#0.6066;ACTIN CYTOSKELETON#0.6016
1106	INTELLECTUAL DISABILITY#1.0986;DNA BINDING#1.0795;EPILEPSY#1.0642;CHROMATIN REMODELING#0.9749;GENE EXPRESSION#0.9385;PHOTOSENSITIVITY#0.8714;DNA DAMAGE RESPONSE#0.8333;AUTISM SPECTRUM DISORDER#0.8330;PHOTOSENSITIVE EPILEPSY#0.7292;DEVELOPMENTAL DELAY#0.6592;DNA REPAIR#0.6117
11070	GOLGI COMPLEX#0.6917;COG COMPLEX#0.6473
11072	DUAL SPECIFICITY PHOSPHATASE#1.0885;T CELL#1.0440;MAP KINASE#1.0093;SIGNALING PATHWAY#0.9982;PHOSPHATASE ACTIVITY#0.9216;MAP KINASE PHOSPHATASE#0.9176;PROTEIN KINASE#0.9129;T CELL ACTIVATION#0.8409;MITOGEN ACTIVATED PROTEIN#0.8404;CELL ACTIVATION#0.8379;IMMUNE RESPONSE#0.8148;INFLAMMATORY RESPONSE#0.6577;APOPTOSIS#0.6571;ROS GENERATION#0.6330
11073	DNA TOPOISOMERASE#1.0689;BINDING PROTEIN 1#1.0655;TOPOISOMERASE II#1.0649;TOPOISOMERASE#1.0611;DNA REPLICATION CHECKPOINT#1.0574;S PHASE#1.0335;DNA DAMAGE CHECKPOINT#1.0318;DNA REPLICATION#1.0222;ATAXIA TELANGIECTASIA#1.0178;REPLICATION FORK#1.0178;CANCER CELL#1.0141;BREAST CANCER#1.0137;APOPTOSIS#1.0104;DOUBLE STRAND BREAK#1.0072;DNA REPAIR#1.0014;DNA TOPOISOMERASE II#1.0014;DNA DAMAGE RESPONSE#1.0003;CELL CYCLE CHECKPOINT#0.9939;CELL CYCLE#0.9931;MRN COMPLEX#0.9914;KINASE ACTIVITY#0.9857;MITOSIS#0.9733;ATAXIA TELANGIECTASIA MUTATED#0.9726;HOMOLOGOUS RECOMBINATION#0.9617;TRANSCRIPTION FACTOR#0.9376;DNA SYNTHESIS#0.9352;LUNG CANCER#0.8876;CELL CYCLE ARREST#0.8722;CELL PROLIFERATION#0.8674;OVARIAN CANCER#0.8634;ATR-ATRIP COMPLEX#0.8631;VIRAL REPLICATION#0.8604;DNA BINDING#0.8458;PROTEIN KINASE#0.8193;GENOTOXIC#0.8066;SIGNALING PATHWAY#0.8045;GENE EXPRESSION#0.7805;CHROMATID#0.7785;POLY ADP RIBOSE#0.7784;BUDDING#0.7738;OVARIAN#0.7690;REPLICATION PROTEIN A#0.7662;UBIQUITIN#0.7659;CENTROSOME#0.7647;S-PHASE CHECKPOINT#0.7644;DNA REPLICATION INITIATION#0.7590;G1 PHASE#0.7489;VIRAL LIFE CYCLE#0.7475;CELL DIVISION#0.7333;MEIOTIC CHROMOSOME#0.6999;DNA POLYMERASE ALPHA#0.6930;RIBOSE#0.6768;HYDROXYUREA#0.6663;SIGNAL TRANSDUCTION#0.6616;GERM CELL#0.6606;CYCLIN DEPENDENT KINASE#0.6540;TUMOR SUPPRESSOR#0.6495;C TERMINAL DOMAIN#0.6371;BLOOM SYNDROME#0.6344;DOXORUBICIN#0.6296;DNA METABOLISM#0.6260;HOMOLOGOUS RECOMBINATION REPAIR#0.6255;COMPLEX I#0.6241;MEIOTIC RECOMBINATION CHECKPOINT#0.6111;MITOTIC ENTRY#0.6095;VIRAL DNA REPLICATION#0.6068;CELLULAR SENESCENCE#0.6012
11074	AKT SIGNALING#0.9593;SIGNALING PATHWAY#0.9237;CANCER CELL#0.9236;UBIQUITIN#0.8540;TUMOR SUPPRESSOR#0.8498;COLORECTAL CANCER#0.8086;UBIQUITIN LIGASE ACTIVITY#0.6596;LIGASE ACTIVITY#0.6542;PANCREATIC CANCER#0.6421;CELL PROLIFERATION#0.6407;TSC1 TSC2 COMPLEX#0.6400;HEPATOCELLULAR CARCINOMA#0.6301;IMPAIRED GLUCOSE METABOLISM#0.6043;GLUCOSE METABOLIC#0.6036
11075	GROWTH CONE#1.0676;MICROTUBULE DYNAMICS#1.0519;CERVICAL#1.0495;MICROTUBULE#1.0428;NEURITE OUTGROWTH#1.0354;REGENERATION#1.0270;NEURITE#1.0190;PROTEIN KINASE#1.0150;NERVE GROWTH FACTOR#1.0050;GROWTH FACTOR#1.0045;NERVOUS SYSTEM#1.0023;SCIATIC NERVE#0.9989;GENE EXPRESSION#0.9853;NEURONAL CELLS#0.9817;TRANSCRIPTION FACTOR#0.9369;CHROMAFFIN CELL#0.9359;SIGNAL TRANSDUCTION#0.8995;MICROTUBULE DISASSEMBLY#0.8926;REGULATION OF MICROTUBULE DYNAMICS#0.8647;AXON REGENERATION#0.8562;NEUROFILAMENT#0.8369;NEURAL CREST#0.7981;CEREBRAL CORTEX#0.7980;AXON EXTENSION#0.7960;STEM CELL#0.7891;SIGNALING PATHWAY#0.7891;GOLGI APPARATUS#0.7841;OLFACTORY EPITHELIUM#0.7740;SPINAL CORD#0.7538;CELL PROLIFERATION#0.7439;PROGENITOR CELL#0.7318;MICROTUBULE POLYMERIZATION#0.7300;DORSAL ROOT GANGLION#0.7163;BRAIN DEVELOPMENT#0.7076;GOLGI COMPLEX#0.7057;PRION DISEASE#0.6930;ALZHEIMER'S DISEASE#0.6808;NEUROGENESIS#0.6651;CENTRAL NERVOUS SYSTEM#0.6642;NEUROBLASTOMA#0.6638;PROTEIN KINASE C#0.6595;MICROTUBULE ASSOCIATED PROTEIN#0.6579;DENTATE GYRUS#0.6572;MICROTUBULE DESTABILIZATION#0.6330;PERIPHERAL NERVE#0.6233;OLFACTORY BULB#0.6019
11076	MULTIPLE SYSTEM ATROPHY#1.0570;OLIGODENDROCYTE#1.0569;MICROTUBULE#1.0407;PARKINSON'S DISEASE#1.0102;PROTEIN KINASE#1.0013;HUMAN IMMUNODEFICIENCY VIRUS#0.9708;CYTOPLASMIC INCLUSION#0.9471;MICROTUBULE ASSEMBLY#0.9457;NEURODEGENERATIVE DISEASE#0.9130;ALZHEIMER'S DISEASE#0.9052;GLYCOGEN SYNTHASE KINASE#0.8517;T CELL#0.8400;MYELIN SHEATH#0.8208;MICROTUBULE ASSOCIATED PROTEIN#0.8070;NERVOUS SYSTEM#0.8004;LEWY BODY#0.7871;HISTONE DEACETYLASE#0.7780;GLIAL CYTOPLASMIC INCLUSION#0.7542;CYCLIN DEPENDENT KINASE#0.7528;CENTRAL NERVOUS SYSTEM#0.7447;MICROTUBULE BUNDLING#0.7405;ASTRAL MICROTUBULE ORGANIZATION#0.7345;GENE EXPRESSION#0.7261;MICROTUBULE BINDING#0.7245;CELL PROLIFERATION#0.7048;MICROTUBULE DYNAMICS#0.6922;GLYCERALDEHYDE-3-PHOSPHATE#0.6859;MULTIPLE SCLEROSIS#0.6791;ENDOPLASMIC RETICULUM#0.6761;SECRETORY PATHWAY#0.6655;MONONUCLEAR CELLS#0.6510;CELL SURFACE#0.6506;PERIPHERAL BLOOD#0.6500;GOLGI OUTPOST#0.6310;GOLGI COMPLEX#0.6191;OLIGODENDROCYTE DIFFERENTIATION#0.6162;PROTEIN PROTEIN INTERACTION#0.6103;APOPTOSIS#0.6101;MYELINATION#0.6061;GTPASE ACTIVITY#0.6058;PLASMA MEMBRANE#0.6058;BONE MARROW#0.6045
11078	ACTIN BINDING#1.1098;ACTIN BINDING PROTEIN#1.0992;F-ACTIN BINDING#1.0876;HEARING LOSS#1.0216;ACTIN BUNDLING#0.9913;ACTIN FILAMENT#0.8412;INNER EAR#0.8128;HAIR CELL#0.7800;HEARING IMPAIRMENT#0.7355;CELL MOVEMENT#0.7208;CELL CYCLE#0.7185;CHROMOSOME SEGREGATION#0.6382;CELL MIGRATION#0.6362;CANCER CELL#0.6153
11079	ENDOPLASMIC RETICULUM#1.0550;GOLGI APPARATUS#0.7494;CELL SURFACE#0.7220;PLASMA MEMBRANE#0.7057;GD-BOPTA#0.6623;CEREBRAL CORTEX DEVELOPMENT#0.6237;SECRETORY PATHWAY#0.6034
1107	CHROMATIN REMODELING#1.0382;DNA BINDING#1.0344;POTENTIAL ENERGY SURFACE#1.0178;GENE EXPRESSION#0.9883;NUCLEOSOME#0.9802;NURD COMPLEX#0.9599;BINDING PROTEIN 3#0.9438;HISTONE DEACETYLASE#0.8113;LYSINE#0.7999;CHROMATIN REMODELLING#0.7878;INTELLECTUAL DISABILITY#0.7601;MACROCEPHALY#0.7560;TRANSCRIPTION FACTOR#0.7332;HETEROCHROMATIN#0.6477;ROOT DEVELOPMENT#0.6200
11080	TUMOR SUPPRESSOR#1.0870;LUNG CANCER#1.0681;CANCER CELL#1.0568;HEAT SHOCK PROTEIN#1.0490;LUNG ADENOCARCINOMA#0.8393;BREAST CANCER#0.8163;CELL PROLIFERATION#0.8156;TRANSCRIPTION FACTOR#0.7318;ADENOCARCINOMA#0.6815;MU OPIOID RECEPTOR#0.6352;ENHANCER BINDING PROTEIN#0.6310;ENHANCER BINDING#0.6303;OPIOID RECEPTOR#0.6274;BREAST CANCER CELL#0.6159
11081	CORNEA PLANA#1.1589;PROTEOGLYCAN#1.0328;SMOOTH MUSCLE ACTIN#1.0256;SMOOTH MUSCLE#1.0185;LEUCINE#1.0098;STROMA#1.0003;EXTRACELLULAR MATRIX#0.9977;POLYMERASE CHAIN REACTION#0.9924;FIBRIL#0.9791;GROWTH FACTOR#0.9784;GENE EXPRESSION#0.9696;STEM CELL#0.9684;LEUCINE RICH REPEAT#0.9356;COLLAGEN TYPE I#0.9184;STROMAL CELL#0.9174;WOUND HEALING#0.9100;MYOFIBROBLAST#0.8910;TRANSFORMING GROWTH FACTOR#0.8650;REVERSE TRANSCRIPTION#0.8064;CORNEAL EPITHELIUM#0.7962;FIBROBLAST GROWTH FACTOR#0.7569;CELL PROLIFERATION#0.7415;TRANSFORMING GROWTH FACTOR BETA#0.7222;KERATOCONUS#0.7140;QUANTITATIVE REAL TIME#0.6976;STROMAL STEM CELL#0.6896;MESENCHYMAL STEM CELL#0.6847;ANNULAR LIGAMENT#0.6695;INFLAMMATORY RESPONSE#0.6608;KERATITIS#0.6487;INSULIN-LIKE GROWTH FACTOR#0.6361;EPITHELIAL CELL#0.6199;AMNIOTIC MEMBRANE#0.6139
11082	CORONARY ARTERY#1.0783;PROTEOGLYCAN#1.0591;DIABETES MELLITUS#1.0590;TYPE 2 DIABETES MELLITUS#1.0521;2 DIABETES MELLITUS#1.0521;C REACTIVE PROTEIN#1.0485;HYPERTENSION#1.0477;TYPE 2 DIABETES#1.0455;INTIMA MEDIA THICKNESS#1.0435;ENDOTHELIAL GROWTH FACTOR#1.0412;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0412;ARTERY#1.0408;ENDOTHELIUM#1.0368;ENDOTHELIAL CELL#1.0357;CELL ADHESION#1.0351;ANGIOGENESIS#1.0294;CANCER CELL#1.0293;GROWTH FACTOR#1.0287;KIDNEY DISEASE#1.0281;CORONARY ARTERY DISEASE#1.0263;ARTERY DISEASE#1.0261;TUMOR NECROSIS FACTOR#1.0249;HEPATOCELLULAR CARCINOMA#1.0230;LUNG CANCER#1.0215;CELL ADHESION MOLECULE#1.0204;CHRONIC KIDNEY DISEASE#1.0199;ATHEROSCLEROSIS#1.0176;VASCULAR ENDOTHELIAL CELL#1.0176;LEUKOCYTE#1.0144;VASCULAR ENDOTHELIUM#1.0034;RESPIRATORY DISTRESS#1.0034;GENE EXPRESSION#0.9937;MYOCARDIAL INFARCTION#0.9929;PITUITARY ADENOMA#0.9889;INFLAMMATORY RESPONSE#0.9825;LINEAR REGRESSION ANALYSIS#0.9814;CELL PROLIFERATION#0.9702;APOPTOSIS#0.9694;HUMAN UMBILICAL VEIN#0.9579;UMBILICAL VEIN#0.9577;COLORECTAL CANCER#0.9575;PNEUMONIA#0.9468;CELL MIGRATION#0.9430;SIGNALING PATHWAY#0.9423;ACUTE LUNG INJURY#0.9402;HYPOXIA#0.9394;ENDOTHELIAL CELL ACTIVATION#0.9318;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9311;POLYMERASE CHAIN REACTION#0.9246;QUANTITATIVE REAL TIME#0.9175;CELL ACTIVATION#0.9155;PROSTATE CANCER#0.9051;PERIPHERAL BLOOD#0.8943;CELL CYCLE#0.8935;PSORIASIS#0.8827;INTENSIVE CARE UNIT#0.8820;VASCULAR CELL#0.8805;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8772;TUMOR CELLS#0.8643;LIVER CIRRHOSIS#0.8601;HYPOXIA INDUCIBLE FACTOR#0.8512;RESPIRATORY FAILURE#0.8470;GROWTH FACTOR RECEPTOR#0.8448;CORD BLOOD#0.8437;ACUTE CORONARY SYNDROME#0.8430;COLORECTAL#0.8313;BLOOD VESSEL#0.8306;HEPATOCYTE GROWTH FACTOR#0.8284;LOW GRADE GLIOMAS#0.8196;SLEEP APNEA#0.8146;MARKERS OF INFLAMMATION#0.8127;BLUNT CHEST TRAUMA#0.8077;LIVER DISEASE#0.8042;PRO-INFLAMMATORY#0.8009;ISCHEMIA#0.7976;NEPHROPATHY#0.7946;BONE MARROW#0.7946;DIABETIC NEPHROPATHY#0.7895;VASCULAR DISEASE#0.7885;MYELOID LEUKEMIA#0.7860;NEUTROPHIL#0.7797;SELECTIN#0.7778;GLOMERULAR FILTRATION RATE#0.7726;GLOMERULAR FILTRATION#0.7722;OBSTRUCTIVE SLEEP APNEA#0.7688;COMMUNITY ACQUIRED PNEUMONIA#0.7661;KIDNEY TRANSPLANT RECIPIENTS#0.7613;SENSORINEURAL HEARING LOSS#0.7612;TRANSCRIPTION FACTOR#0.7576;ENDOMETRIAL CANCER#0.7536;FASTING BLOOD GLUCOSE#0.7524;HEARING LOSS#0.7516;MAPK SIGNALING#0.7505;PRE-ECLAMPSIA#0.7505;SYSTOLIC BLOOD PRESSURE#0.7478;COLON CANCER#0.7449;ACUTE MYOCARDIAL INFARCTION#0.7273;STEM CELL#0.7243;OVARIAN CANCER#0.7228;HIGH DENSITY LIPOPROTEIN#0.7222;ADENOCARCINOMA#0.7219;TUBE FORMATION#0.7137;OBESE#0.7047;LYMPH NODE#0.7029;AREA UNDER CURVE#0.7014;BREAST CANCER#0.6946;ESSENTIAL HYPERTENSION#0.6938;ISCHEMIA MODIFIED ALBUMIN#0.6935;SYSTEMIC INFLAMMATORY RESPONSE#0.6836;HUMAN EMBRYONIC KIDNEY#0.6761;EMBRYONIC KIDNEY#0.6756;GENE SILENCING#0.6732;RENAL CELL CARCINOMA#0.6715;SERUM ALBUMIN#0.6711;EPIDERMAL GROWTH FACTOR#0.6660;MICROVASCULAR ENDOTHELIAL CELL#0.6545;FIBROBLAST GROWTH FACTOR#0.6497;REVERSE TRANSCRIPTION#0.6474;TRANSFORMING GROWTH FACTOR#0.6471;TUMOR TISSUES#0.6275;SQUAMOUS CELL CARCINOMA#0.6241;ADIPOCYTE#0.6239;PEAK SYSTOLIC VELOCITY#0.6222;OVARIAN#0.6213;ACUTE PYELONEPHRITIS#0.6176;CORONARY ARTERY BYPASS#0.6118;MONOCYTE#0.6103;STABLE ANGINA PECTORIS#0.6091;RUPTURE OF MEMBRANES#0.6068;RESPIRATORY SYSTEM#0.6043;ADIPOSE TISSUE#0.6031;PLACENTAL GROWTH FACTOR#0.6016;MITOGENIC ACTIVITY#0.6015
11083	APOPTOSIS#0.9529;TRANSCRIPTION FACTOR#0.9244;STEM CELL#0.8803;CELL DEATH#0.6532;EMBRYONIC STEM CELL#0.6401
11085	ALZHEIMER'S DISEASE#0.7559
11086	BREAST CANCER#0.8330;GENE EXPRESSION#0.8085;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7018;LYMPHOCYTIC LEUKEMIA#0.7011;CANCER CELL#0.6417
1108	NURD COMPLEX#1.0572;DNA BINDING#1.0527;HISTONE DEACETYLASE#1.0450;CHROMATIN REMODELLING#1.0412;DNA DAMAGE RESPONSE#1.0345;CHROMATIN REMODELING#1.0316;NUCLEOSOME#1.0303;GENE EXPRESSION#0.9957;STEM CELL#0.9956;POLY ADP RIBOSE#0.9910;CHROMATIN REMODELING COMPLEX#0.9882;COMPLEX I#0.9763;CELL CYCLE#0.9657;DNA REPAIR#0.9347;DOUBLE STRAND BREAK#0.9215;TRANSCRIPTION FACTOR#0.9201;RIBOSE#0.8791;CANCER CELL#0.8455;B CELL#0.8445;ENDOTHELIAL CELL#0.8439;TUMOR SUPPRESSOR#0.8378;CELL PROLIFERATION#0.8216;BREAST CANCER#0.8195;INTELLECTUAL DISABILITY#0.8036;COLORECTAL CANCER#0.7548;HISTONE DEACETYLATION#0.7488;EMBRYONIC STEM CELL#0.7395;ACUTE MYELOID LEUKEMIA#0.7391;MYELOID LEUKEMIA#0.7378;HISTONE BINDING#0.7330;MOUSE EMBRYONIC STEM#0.7073;ATAXIA TELANGIECTASIA#0.7065;CANCER STEM CELL#0.6844;COLORECTAL#0.6647;DNA METHYLATION#0.6591;PROTEIN COMPLEX#0.6417;UBIQUITIN#0.6393;HOMOLOGOUS RECOMBINATION#0.6314;PERIPHERAL NERVE#0.6175;CELLULAR SCHWANNOMA#0.6148;CELL DIFFERENTIATION#0.6133;B CELL DEVELOPMENT#0.6113;SIGNALING PATHWAY#0.6090;TH2 CELL#0.6067;LIVER CANCER#0.6050;CELL DEVELOPMENT#0.6027;SCHWANN CELL#0.6016
11091	METHYLTRANSFERASE COMPLEX#1.0762;MIXED LINEAGE LEUKEMIA#1.0429;METHYLTRANSFERASE ACTIVITY#1.0384;HISTONE METHYLTRANSFERASE#1.0383;PROTEIN PROTEIN INTERACTION#1.0281;CANCER CELL#1.0264;CELL PROLIFERATION#1.0257;OSTEOBLAST DIFFERENTIATION#1.0191;HISTONE METHYLTRANSFERASE COMPLEX#1.0139;LYSINE#1.0084;STEM CELL#0.9990;GENE EXPRESSION#0.9886;PROSTATE CANCER#0.9874;MLL1 COMPLEX#0.9862;CHROMATIN REMODELING#0.9848;SIGNALING PATHWAY#0.9768;OSTEOBLAST#0.9732;TRANSCRIPTION FACTOR#0.9683;CELL CYCLE#0.9591;HISTONE METHYLATION#0.9464;EMBRYONIC STEM CELL#0.9450;ARGININE#0.9434;COMPASS COMPLEX#0.9162;HISTONE MODIFICATION#0.9110;PROTEIN COMPLEX#0.9047;BREAST CANCER#0.8861;COMPLEX I#0.8700;LUNG CANCER#0.8692;CHONDROCYTE#0.8665;CHONDROCYTE DIFFERENTIATION#0.8606;HISTONE ACETYLTRANSFERASE#0.8426;ONCOGENIC#0.8405;CELL GROWTH#0.7856;CANONICAL WNT SIGNALING PATHWAY#0.7806;WNT SIGNALING PATHWAY#0.7616;BONE DEVELOPMENT#0.7438;APOPTOSIS#0.7403;ARGININE BINDING#0.7355;VIRAL REPLICATION#0.7354;HYPOXIA#0.7339;PROGENITOR CELL#0.7306;ACUTE LEUKEMIA#0.7303;CHROMATIN MODIFICATION#0.7185;DNA REPLICATION#0.7110;CATALYTIC ACTIVITY#0.7091;INDUCED PLURIPOTENT STEM CELL#0.6824;PLURIPOTENT STEM CELL#0.6809;EPITHELIAL MESENCHYMAL TRANSITION#0.6793;PROTEIN KINASE#0.6610;BONE MARROW#0.6554;POST-TRANSLATIONAL MODIFICATION#0.6371;RETINOBLASTOMA#0.6248;DNA BINDING#0.6222;RNA REPLICATION#0.6116;NSL COMPLEX#0.6071
11093	FLUID SHEAR STRESS#1.0605;C TERMINAL DOMAIN#1.0548;HEPATIC STELLATE CELL#1.0534;RESONANCE ENERGY TRANSFER#1.0458;LIVER CIRRHOSIS#1.0407;IMMUNOGLOBULIN G#1.0355;PROTEASE ACTIVITY#1.0315;COLLAGEN BINDING#1.0269;C REACTIVE PROTEIN#1.0233;FACTOR VIII#1.0226;ACUTE ISCHEMIC STROKE#1.0183;MYOCARDIAL INFARCTION#1.0180;B CELL#1.0176;ACUTE MYOCARDIAL INFARCTION#1.0150;ISCHEMIA REPERFUSION INJURY#1.0143;ENZYME ACTIVITY#1.0133;FIBRINOGEN#1.0098;NEUTROPHIL#1.0089;THERAPEUTIC PLASMA EXCHANGE#1.0056;HEART DISEASE#1.0001;HELLP SYNDROME#0.9994;VON WILLEBRAND DISEASE#0.9974;DISSEMINATED INTRAVASCULAR COAGULATION#0.9969;THROMBOTIC THROMBOCYTOPENIC PURPURA#0.9957;PLATELET AGGREGATION#0.9956;STEM CELL TRANSPLANTATION#0.9948;FACTOR I#0.9943;HUMAN UMBILICAL VEIN#0.9938;UMBILICAL VEIN#0.9936;PURPURA#0.9932;GENE EXPRESSION#0.9928;LIVER DISEASE#0.9927;SELECTIN#0.9921;ENDOTHELIAL CELL#0.9919;ARTERY#0.9904;PERIPHERAL BLOOD#0.9888;ENDOTHELIUM#0.9884;TUMOR NECROSIS FACTOR#0.9882;COMPLEMENT ACTIVATION#0.9878;ATYPICAL HEMOLYTIC-UREMIC SYNDROME#0.9876;HAEMOLYTIC URAEMIC SYNDROME#0.9869;ANGIOGENESIS#0.9859;POLYMERASE CHAIN REACTION#0.9851;THROMBOSIS#0.9851;STEM CELL#0.9847;MACROPHAGE#0.9846;COMPLEMENT FACTOR H#0.9845;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9838;HYPERACTIVE#0.9837;LEUKOCYTE#0.9824;LUPUS ERYTHEMATOSUS#0.9824;CORONARY ARTERY#0.9822;HEMOSTASIS#0.9821;RITUXIMAB#0.9812;AUTOIMMUNE DISEASE#0.9803;ECULIZUMAB#0.9803;T CELL#0.9799;COAGULATION#0.9790;ISCHEMIA#0.9789;BONE MARROW#0.9784;ANAEMIA#0.9750;PLATELET ACTIVATION#0.9749;HYPERTENSION#0.9748;HEMORRHAGE#0.9742;HEMOLYTIC UREMIC SYNDROME#0.9741;HEPARIN#0.9737;HEMOLYSIS#0.9700;VASCULAR ENDOTHELIAL CELL#0.9679;ANTIPHOSPHOLIPID SYNDROME#0.9674;MALARIA#0.9662;GROWTH FACTOR#0.9645;TICLOPIDINE#0.9643;ACUTE KIDNEY INJURY#0.9630;ATHEROSCLEROSIS#0.9624;HEMOLYTIC ANEMIA#0.9612;DIARRHEA#0.9611;THROMBOCYTOPENIA#0.9611;ATRIAL FIBRILLATION#0.9606;ANEMIA#0.9567;CELL SURFACE#0.9558;PORTAL HYPERTENSION#0.9554;SMOOTH MUSCLE#0.9536;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9513;NERVOUS SYSTEM#0.9501;CENTRAL NERVOUS SYSTEM#0.9455;TOXICITY#0.9418;CLOTTING#0.9400;HEMATOPOIETIC STEM CELL#0.9393;HEMORRHAGIC#0.9392;LUPUS NEPHRITIS#0.9387;T- PA#0.9386;NEPHROPATHY#0.9358;RED BLOOD CELL#0.9347;INFLAMMATORY RESPONSE#0.9318;HUMAN IMMUNODEFICIENCY VIRUS#0.9254;MALIGNANT HYPERTENSION#0.9251;CEREBRAL INFARCTION#0.9238;CONNECTIVE TISSUE#0.9190;DIABETES MELLITUS#0.9179;KIDNEY DISEASE#0.9125;IGG ANTIBODY#0.9118;ARTERIOLE#0.9083;VENTRICULAR ASSIST DEVICE#0.9070;ENDOTHELIAL GROWTH FACTOR#0.9067;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9067;GLYCOSYLATION#0.9051;MUTAGENESIS#0.9033;INTENSIVE CARE UNIT#0.9027;CYCLOSPORINE#0.9006;CYCLOPHOSPHAMIDE#0.9004;PROTEINURIA#0.9002;ERYTHROCYTE#0.8992;VINCRISTINE#0.8992;HEPATITIS C#0.8973;RISK OF RELAPSE#0.8967;NEPHRITIS#0.8912;BORTEZOMIB#0.8911;EXTRACELLULAR MATRIX#0.8908;BLOOD VESSEL#0.8884;CONNECTIVE TISSUE DISEASE#0.8872;PLASMA PROTEIN#0.8872;GLOMERULAR FILTRATION#0.8857;APOPTOSIS#0.8818;MICROVASCULAR ENDOTHELIAL CELL#0.8745;TUBE FORMATION#0.8743;OBESE#0.8738;DIGESTION#0.8732;ACUTE PANCREATITIS#0.8698;DENDRITIC CELL#0.8666;RESPONSE TO TREATMENT#0.8588;ARTERY DISEASE#0.8580;THROMBOPLASTIN#0.8500;CORONARY ARTERY DISEASE#0.8476;GLOMERULONEPHRITIS#0.8468;GLOMERULAR FILTRATION RATE#0.8447;HUMAN NEUTROPHIL PEPTIDE#0.8416;ACQUIRED VON WILLEBRAND SYNDROME#0.8376;DIABETIC NEPHROPATHY#0.8372;CEREBROVASCULAR DISEASE#0.8365;PANCREATITIS#0.8361;GESTATION#0.8297;CEREBRAL ISCHEMIA#0.8280;N-ACETYLCYSTEINE#0.8229;CEREBRAL ARTERY#0.8228;CD4+ T CELL#0.8212;LUNG CANCER#0.8169;IMMUNE RESPONSE#0.8134;ATHEROSCLEROTIC#0.8114;ACUTE ISCHAEMIC STROKE#0.8097;B CELL DEPLETION#0.8049;METALLOPROTEASE ACTIVITY#0.8028;METHYLPREDNISOLONE#0.7966;MONOCYTE#0.7941;FACTOR V LEIDEN#0.7938;CLOPIDOGREL#0.7916;VITAMIN B12#0.7858;AGGLUTINATION#0.7853;ACTIVATED PROTEIN C#0.7840;RNA BINDING PROTEIN#0.7779;CORONARY HEART DISEASE#0.7778;RNA BINDING#0.7764;HAEMOLYTIC UREMIC SYNDROME#0.7754;HEPARIN INDUCED THROMBOCYTOPENIA#0.7740;BASEMENT MEMBRANE#0.7740;CHRONIC KIDNEY DISEASE#0.7736;LECTIN#0.7722;B LYMPHOCYTE#0.7707;ALANINE#0.7700;VENULE#0.7698;ASPIRIN#0.7688;PULMONARY HYPERTENSION#0.7638;FIBRINOLYSIS#0.7637;SICKLE CELL DISEASE#0.7622;PREDNISOLONE#0.7607;PLASMIN ACTIVITY#0.7531;ALCOHOLIC HEPATITIS#0.7523;INFLAMMATORY BOWEL DISEASE#0.7474;MRNA DECAY#0.7439;CONGENITAL HEART DISEASE#0.7434;PREDNISONE#0.7409;CELL ACTIVATION#0.7393;ABDOMINAL PAIN#0.7371;INTRAVENOUS IMMUNOGLOBULIN#0.7345;HEPATITIS C VIRUS#0.7344;CARDIAC ARREST#0.7341;TYPE 2 DIABETIC#0.7301;STANDARD OF CARE#0.7238;ACUTE LIVER FAILURE#0.7221;SIGNALING PATHWAY#0.7215;ACETYLCYSTEINE#0.7206;PORTAL VEIN#0.7184;MULTIPLE SCLEROSIS#0.7172;HISTAMINE#0.7170;BLOOD COAGULATION#0.7160;HEPATOCELLULAR CARCINOMA#0.7152;NITRIC OXIDE#0.7144;METHIONINE#0.7121;PRO-INFLAMMATORY#0.7112;ENDOTHELIAL CELL ACTIVATION#0.7057;PRE-ECLAMPSIA#0.7032;VOMITING#0.7023;EPITHELIAL CELL#0.7011;IMMUNE SYSTEM#0.6942;END ORGAN DAMAGE#0.6935;SODIUM DODECYL SULFATE#0.6900;DODECYL SULFATE#0.6899;NEUTROPENIA#0.6852;ARE BINDING#0.6845;BLOOD CLOTTING#0.6796;END STAGE RENAL FAILURE#0.6772;SYSTEMIC INFLAMMATORY RESPONSE#0.6733;CARDIOVASCULAR RISK FACTOR#0.6727;MIDDLE CEREBRAL ARTERY#0.6712;MEGAKARYOCYTE#0.6711;PROTEIN SECRETION#0.6691;SURFACE PLASMON RESONANCE#0.6680;GEMCITABINE#0.6663;INTRACELLULAR RETENTION#0.6620;PROTEASOME#0.6619;ALLERGIC REACTION#0.6584;PLASMA GLYCOPROTEIN#0.6568;RETICULOCYTE#0.6548;SMOOTH MUSCLE CELL#0.6532;MUSCLE CELL#0.6523;ISCHEMIC HEART DISEASE#0.6504;COLORECTAL CANCER#0.6487;WEIGHT LOSS#0.6446;POSITIVE PREDICTIVE VALUE#0.6446;HEMATURIA#0.6431;VASCULAR DISEASE#0.6425;ENDOPLASMIC RETICULUM#0.6386;AUTOIMMUNITY#0.6376;CEREBRAL MALARIA#0.6326;PORTAL VEIN THROMBOSIS#0.6321;PODOCYTE#0.6283;AU RICH ELEMENT#0.6243;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6227;TRANSIENT ISCHEMIC ATTACK#0.6226;ECLAMPSIA#0.6225;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.6197;TYPE 1 DIABETES#0.6195;DISEASE ACTIVITY INDEX#0.6173;EDEMA#0.6160;GROWTH FACTOR RECEPTOR#0.6149;ACUTE CORONARY SYNDROME#0.6141;RESPIRATORY DISTRESS#0.6114;SOLID ORGAN TRANSPLANTATION#0.6023;N GLYCAN#0.6011;AORTIC SINUS#0.6009;LEUKOCYTE ADHESION#0.6004
11095	TUMOR SUPPRESSOR#0.9542;CANCER CELL#0.9353;POLYMERASE CHAIN REACTION#0.8502;EXTRACELLULAR MATRIX#0.8089;ANGIOGENESIS#0.7576;CELL PROLIFERATION#0.7266;REVERSE TRANSCRIPTION#0.6711;GENE EXPRESSION#0.6649;TUMOR TISSUES#0.6240;BREAST CANCER#0.6159
11096	MATRIX METALLOPROTEINASE 13#1.0519;COLLAGEN TYPE II#1.0175;REVERSE TRANSCRIPTION#1.0126;QUANTITATIVE REAL TIME#1.0102;INDUCIBLE NITRIC OXIDE#1.0058;NITRIC OXIDE SYNTHASE#1.0040;NITRIC OXIDE#0.9963;TRANSCRIPTION FACTOR#0.9923;POLYMERASE CHAIN REACTION#0.9904;CHONDROCYTE#0.9889;MATRIX METALLOPROTEINASE 1#0.9866;NUCLEUS PULPOSUS CELL#0.9847;TUMOR NECROSIS FACTOR#0.9844;SYNOVIAL FLUID#0.9828;GENE EXPRESSION#0.9823;NUCLEUS PULPOSUS#0.9816;INTERVERTEBRAL DISC DEGENERATION#0.9802;PRO-INFLAMMATORY#0.9802;PROTEOGLYCAN#0.9787;GROWTH FACTOR#0.9774;SYNOVIUM#0.9774;MENISCUS#0.9758;OSTEOARTHRITIC CARTILAGE#0.9752;TRANSFORMING GROWTH FACTOR#0.9741;CATABOLISM#0.9718;KNEE JOINT#0.9711;INTERVERTEBRAL DISC#0.9708;MITOGEN ACTIVATED PROTEIN#0.9704;SIGNALING PATHWAY#0.9698;PROTEIN KINASE#0.9697;EXTRACELLULAR MATRIX#0.9697;APOPTOSIS#0.9696;CELL PROLIFERATION#0.9660;PROSTAGLANDIN E2#0.9649;OSTEOARTHRITIS#0.9609;HUMAN NUCLEUS PULPOSUS#0.9533;INFLAMMATORY RESPONSE#0.9496;RETINOIC ACID#0.9414;HEPATOCELLULAR CARCINOMA#0.9361;ANGIOGENESIS#0.9360;ANTERIOR CRUCIATE LIGAMENT#0.9339;CRUCIATE LIGAMENT#0.9331;STEM CELL#0.9330;COLLAGEN TYPE I#0.9270;HUMAN ARTICULAR CHONDROCYTES#0.9265;ADIPOSE TISSUE#0.9249;COLLAGENASE#0.9246;CARTILAGE HOMEOSTASIS#0.9134;HYALURONAN#0.9055;RHEUMATOID ARTHRITIS#0.9045;MESENCHYMAL STEM CELL#0.8992;SMOOTH MUSCLE#0.8834;CHONDROCYTE PROLIFERATION#0.8793;ENDOTHELIAL GROWTH FACTOR#0.8685;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8685;LOW BACK PAIN#0.8531;T CELL#0.8442;SYNOVITIS#0.8311;MAPK SIGNALING#0.8290;PROTEOGLYCAN DEGRADATION#0.8285;CHONDROGENESIS#0.8280;MACROPHAGE#0.8265;HYPOXIA#0.8229;TRANSFORMING GROWTH FACTOR BETA#0.8226;FIBROBLAST GROWTH FACTOR#0.8218;AUTOPHAGY#0.8196;DIGESTION#0.8185;REGENERATION#0.8082;ENDOTHELIAL CELL#0.8073;CHONDROCYTE HYPERTROPHY#0.7950;AMNIOTIC FLUID#0.7856;RECEPTOR ANTAGONIST#0.7816;CELL ADHESION#0.7772;CARTILAGE DEVELOPMENT#0.7715;BONE MORPHOGENETIC PROTEIN#0.7668;REACTIVE OXYGEN SPECIES#0.7632;STROMAL CELL#0.7608;LOW DENSITY LIPOPROTEIN#0.7582;APOPTOTIC#0.7542;HYALURONIC ACID#0.7500;CELL SURFACE#0.7420;COLORECTAL CANCER#0.7376;BONE MARROW#0.7303;CLEAVED CASPASE 3#0.7269;DEGENERATIVE DISC DISEASE#0.7221;HISTONE DEACETYLASE#0.7176;TUMOUR NECROSIS FACTOR#0.7174;RNA INTERFERENCE#0.7171;MUTAGENESIS#0.7052;SENESCENCE#0.7044;HIGH FAT DIET#0.7006;SMOOTH MUSCLE CELL#0.6988;MUSCLE CELL#0.6981;TRANSCRIPTASE#0.6964;ENDOCYTOSIS#0.6868;FIBROBLAST LIKE SYNOVIOCYTES#0.6846;IL-1RA#0.6812;ANNULUS FIBROSUS#0.6794;AORTIC VALVE#0.6772;QUANTITATIVE REVERSE TRANSCRIPTION#0.6765;HYPOXIA INDUCIBLE FACTOR#0.6743;COLORECTAL#0.6734;CELL MIGRATION#0.6719;INSULIN-LIKE GROWTH FACTOR#0.6717;DIET INDUCED OBESITY#0.6701;CELL DEATH#0.6695;RELATED PROTEIN 1#0.6572;COLLAGEN DEGRADATION#0.6550;CELECOXIB#0.6369;MAGNETIC RESONANCE IMAGING#0.6330;METALLOPROTEINASE INHIBITOR#0.6273;SIGNALLING PATHWAY#0.6271;OSTEOCLAST#0.6262;ALKALINE PHOSPHATASE#0.6254;PROTEOGLYCAN SYNTHESIS#0.6249;ATHEROSCLEROSIS#0.6187;GENE SILENCING#0.6180;SIGNALING MOLECULE#0.6163;PROTEOGLYCANASE ACTIVITY#0.6130;JOINT DAMAGE#0.6053;72-HOURS#0.6032;SMOOTH MUSCLE ACTIN#0.6019;C TERMINAL DOMAIN#0.6017;GLUCOSAMINE#0.6011
11097	NUCLEAR ENVELOPE#0.7299;HYPOXIC#0.6680
11098	GENE EXPRESSION#0.8093;CANCER CELL#0.8049;CELL PROLIFERATION#0.6369
11099	PROTEIN TYROSINE PHOSPHATASE#1.0724;STEM CELL#0.8288;CANCER CELL#0.6619;GROWTH FACTOR#0.6372;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6312;EPIDERMAL GROWTH FACTOR#0.6253;ADHESION PLAQUE#0.6068
1109	3-ALPHA-HSD ACTIVITY#1.1513;CHLORDECONE REDUCTASE#1.0653;ALDO KETO REDUCTASE#1.0275;PROGESTERONE#0.9756;TESTOSTERONE#0.9601;DIHYDROTESTOSTERONE#0.9447;BETA-HYDROXYSTEROID DEHYDROGENASE#0.8945;ALDEHYDE REDUCTASE#0.8752;PROSTATE CANCER#0.7709;PROSTAGLANDIN F SYNTHASE#0.7428;BREAST CANCER#0.7397;POLYCYCLIC AROMATIC HYDROCARBON#0.7155;CYTOCHROME P450#0.7109;CANCER CELL#0.7045;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.6955;BILE ACID BINDING#0.6775;MUTAGENESIS#0.6520;NALTREXONE#0.6430;CONJUGATION#0.6340;NICOTINAMIDE#0.6204;GENE EXPRESSION#0.6162;HORMONE METABOLISM#0.6087;PHENOLPHTHALEIN#0.6053;HEPATOCYTE NUCLEAR FACTOR#0.6024;CORTISOL#0.6016
11100	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#1.0790;ARGININE#0.8773;RNA BINDING#0.7365;DNA DAMAGE RESPONSE#0.6779;MRNA PROCESSING#0.6605;RNA BINDING PROTEIN#0.6527
11101	PROTEIN ARGINYLATION#1.0884;ARGININE#0.9235;PROTEIN DEGRADATION#0.8358;UBIQUITIN#0.8243;CELL MIGRATION#0.8162;ANGIOGENESIS#0.7537;ACTIN CYTOSKELETON#0.7385;POST-TRANSLATIONAL MODIFICATION#0.7153;PROTEASOME#0.7100;SKELETAL MUSCLE#0.6893;MYOFIBRIL#0.6720;TRANSFERASE ACTIVITY#0.6215;BRAIN DEVELOPMENT#0.6139;ENDOPLASMIC RETICULUM#0.6101;TRANSCRIPTION FACTOR#0.6089;APOPTOSIS#0.6050
11102	RNASE P#1.0098;RIBONUCLEASE P#0.7113
11103	RIBOSOME#0.8225;NUCLEAR EXPORT SIGNAL#0.6559;RIBOSOMAL SUBUNIT#0.6537;RIBOSOME ASSEMBLY#0.6519;NUCLEAR EXPORT#0.6487;RRNA PROCESSING#0.6468;RIBOZYME#0.6305;BREAST CANCER#0.6299;GENE EXPRESSION#0.6161
11104	MICROTUBULE SEVERING#1.0120;MICROTUBULE#0.9748;MICROTUBULE SEVERING ACTIVITY#0.6896;OVARIAN CANCER#0.6076
11107	BRITTLE CORNEA SYNDROME#1.0787;TUMOR SUPPRESSOR#1.0520;APOPTOSIS#0.9170;BODY CONDITION SCORE#0.8815;DNA METHYLATION#0.8787;CANCER CELL#0.8562;EXTRACELLULAR MATRIX#0.8248;SPINAL CORD INJURY#0.7692;SPINAL CORD#0.7671;TRANSCRIPTION FACTOR#0.7579;CONNECTIVE TISSUE#0.7078;ACTIVE CASPASE 3#0.6265;CELL PROLIFERATION#0.6206;LUNG CANCER#0.6056;KERATOCONUS#0.6054;POLYMERASE CHAIN REACTION#0.6026
11108	ADIPOSE TISSUE#0.8349;TRANSCRIPTION FACTOR#0.7910;STEM CELL#0.7449;GENE EXPRESSION#0.6802;ZINC FINGER PROTEIN#0.6088
11112	VALINE#0.9066;SPERM MOTILITY#0.8484
11113	MIDBODY#1.0519;CYTOKINESIS#1.0486;CLEAVAGE FURROW#1.0448;MICROCEPHALY#0.9933;FURROW#0.9900;PRIMARY MICROCEPHALY#0.9874;CELL CYCLE#0.9717;CANCER CELL#0.9628;SIGNALING PATHWAY#0.9074;APOPTOSIS#0.9049;MIDBODY RING#0.8881;PROTEIN KINASE#0.8863;CELL PROLIFERATION#0.8828;CELL DIVISION#0.8721;ABSCISSION#0.8666;POLYMERASE CHAIN REACTION#0.8169;CONTRACTILE RING#0.7956;RNA INTERFERENCE#0.7791;P53 SIGNALING PATHWAY#0.7789;MITOSIS#0.7647;GENE EXPRESSION#0.7634;CENTRAL SPINDLE#0.7610;COLON CANCER#0.7536;GLUTAMATERGIC SYNAPSE#0.7499;REVERSE TRANSCRIPTION#0.7310;VIRION#0.7276;PROGENITOR CELL#0.6935;NMDA RECEPTOR#0.6826;NEUROGENESIS#0.6797;INTERCELLULAR BRIDGE#0.6637;KINASE ACTIVITY#0.6603;REGULATORY LIGHT CHAIN#0.6510;MICROTUBULE#0.6391;CEREBRAL CORTEX#0.6264;GLUTAMATERGIC NEURON#0.6147;SIGNALLING PATHWAY#0.6107;NEURITE OUTGROWTH#0.6001
11116	GROWTH FACTOR RECEPTOR#1.0612;FIBROBLAST GROWTH FACTOR#1.0557;GROWTH FACTOR#1.0470;CENTROSOME#0.9901;CELL CYCLE#0.9867;CENTRIOLAR SATELLITE#0.9012;STEM CELL#0.8554;CILIOGENESIS#0.8097;MICROTUBULE#0.7569;BASAL BODY#0.6553;CENTROSOME LOCALIZATION#0.6495;LUNG CANCER#0.6276
11117	PELVISES#1.0972;CENTRAL RETINAL VEIN#1.0580;MICROFIBRIL#1.0551;CENTRAL RETINAL VEIN OCCLUSION#1.0524;RETINAL VEIN OCCLUSION#1.0474;DESMOSOME#1.0464;L-DOPA#1.0331;FEMORAL NECK FRACTURE#1.0307;DIAPHRAGM#1.0285;MANDIBLE#1.0241;GAP JUNCTION#1.0230;PELVIS#1.0224;TOTAL HIP ARTHROPLASTY#1.0216;ACETAL#1.0210;SCROTUM#1.0191;HEPATIC VEIN#1.0188;REVERSE TRANSCRIPTION#1.0168;MAXILLA#1.0166;UTERUS#1.0156;POLYMERASE CHAIN REACTION#1.0146;ELASTIC FIBER#1.0081;DNA REPLICATION#1.0023;DYSKINESIA#1.0013;CONNEXIN#1.0008;CELL ADHESION#0.9992;PREMOLAR#0.9980;PROSTATE CANCER#0.9975;PARALYSIS#0.9971;AORTIC VALVE#0.9971;SPINAL CORD#0.9964;VERTEBRA#0.9963;LYMPH NODE DISSECTION#0.9954;EXTRACELLULAR MATRIX#0.9946;MIDLINE#0.9926;PLASMA MEMBRANE#0.9925;COLON CANCER#0.9922;STRIATUM#0.9917;HIP JOINT#0.9914;RENAL AGENESIS#0.9907;FEMUR#0.9893;OVARIAN#0.9888;PORTAL VEIN#0.9882;OOCYTE#0.9870;VENA CAVA#0.9865;LEVODOPA#0.9863;BONE MARROW#0.9852;CORONAL#0.9836;SCOLIOSIS#0.9828;CERVICAL#0.9819;HEPATOCELLULAR CARCINOMA#0.9812;GROWTH FACTOR#0.9806;TRANSFORMING GROWTH FACTOR#0.9795;HYPERTENSION#0.9794;RIGHT BUNDLE BRANCH BLOCK#0.9792;BASAL GANGLIA#0.9791;STEM CELL#0.9790;PEDICLE#0.9776;SUBSTANTIA NIGRA#0.9775;PERIPHERAL BLOOD#0.9772;ABDOMINAL PAIN#0.9767;SPINAL CORD INJURY#0.9765;DNA METHYLTRANSFERASE#0.9761;FRONTAL#0.9754;FIBRILLIN#0.9748;DOPAMINE#0.9743;RECEPTOR ANTAGONIST#0.9738;MEDIASTINUM#0.9738;LYMPH NODE#0.9719;SWELLING#0.9715;DNA METHYLATION#0.9714;MOLAR#0.9713;BLOOD LOSS#0.9702;HEMORRHAGE#0.9696;ARTERY#0.9677;BREAST CANCER#0.9674;REGENERATION#0.9673;ESSENTIAL HYPERTENSION#0.9657;VERTEBRAE#0.9640;GENE EXPRESSION#0.9622;RANGE OF MOTION#0.9613;MAGNETIC RESONANCE IMAGING#0.9611;NERVOUS SYSTEM#0.9608;COLORECTAL#0.9603;ENDOTHELIAL CELL#0.9597;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9584;ISCHEMIA#0.9583;OSTEOARTHRITIS#0.9583;TOXICITY#0.9576;CONNECTIVE TISSUE#0.9564;CANCER CELL#0.9553;SQUAMOUS CELL CARCINOMA#0.9551;THROMBOSIS#0.9543;BLOOD VESSEL#0.9537;PARKINSON'S DISEASE#0.9531;LUNG CANCER#0.9526;COLORECTAL CANCER#0.9524;DOPAMINERGIC NEURON#0.9517;EPIGASTRIC ARTERY#0.9514;LIVER DISEASE#0.9514;ADENOCARCINOMA#0.9508;CELL CYCLE#0.9490;HEMIPLEGIA#0.9466;CELL SURFACE#0.9441;TRANSPOSITION#0.9429;RESPIRATORY DISTRESS#0.9427;TRANSCRIPTASE#0.9407;TRANSCRIPTION FACTOR#0.9402;AORTIC VALVE REPLACEMENT#0.9392;EPILEPSY#0.9369;KNEE JOINT#0.9364;CORONARY ARTERY#0.9349;POSITRON EMISSION TOMOGRAPHY#0.9323;SUCCINATE#0.9316;MESENCHYMAL STEM CELL#0.9302;CENTRAL NERVOUS SYSTEM#0.9297;T CELL#0.9292;APOMORPHINE#0.9291;SMOOTH MUSCLE#0.9287;SCANNING ELECTRON MICROSCOPY#0.9263;CELL WALL#0.9246;DNA BINDING#0.9225;CELL DEATH#0.9223;OPTIC NERVE#0.9217;APOPTOSIS#0.9215;EPITHELIAL CELL#0.9211;ASCENDING COLON#0.9178;PULMONARY ARTERY#0.9169;BRACHIAL PLEXUS#0.9159;NEGATIVE PREDICTIVE VALUE#0.9133;SALICYLIC ACID#0.9106;MUSCLE CELL#0.9105;EDEMA#0.9103;IMMUNE RESPONSE#0.9099;BILE DUCT#0.9085;THYROID GLAND#0.9085;FOREARM#0.9012;FOREBRAIN#0.9005;SEPTUM#0.8975;BASEMENT MEMBRANE#0.8960;SMOOTH MUSCLE CELL#0.8937;INNERVATION#0.8915;CONVULSION#0.8897;DIGESTION#0.8895;RETINAL ARTERY OCCLUSION#0.8868;VOMITING#0.8864;APHASIA#0.8863;CAROTID ARTERY#0.8847;DYSTONIA#0.8825;PARENCHYMA#0.8823;LARYNX#0.8817;INTENSIVE CARE UNIT#0.8810;SUBTHALAMIC NUCLEUS#0.8799;CELL PROLIFERATION#0.8795;FINITE ELEMENT MODEL#0.8790;CORONARY ARTERY BYPASS#0.8780;CYTOPLASM#0.8777;REACTIVE OXYGEN SPECIES#0.8757;RHEUMATOID ARTHRITIS#0.8712;ASTROCYTE#0.8706;NODULAR#0.8690;CEREBRAL CORTEX#0.8672;BONE FORMATION#0.8655;THALAMUS#0.8651;OVARIES#0.8637;TRANSVERSE COLON#0.8637;POSITIVE PREDICTIVE VALUE#0.8630;THYROID NODULE#0.8622;NEUTROPHIL#0.8587;AORTIC ANEURYSM#0.8572;HEPATITIS B#0.8551;STROMA#0.8544;HEPATIC ARTERY#0.8530;STROMAL CELL#0.8515;WEIGHT LOSS#0.8514;STERNUM#0.8505;MITRAL VALVE#0.8497;B CELL#0.8495;PROTEIN KINASE#0.8473;ORAL CAVITY#0.8471;GANGLION CELLS#0.8459;RECTUM#0.8435;COAGULATION#0.8414;ALVEOLAR BONE LOSS#0.8409;MIDBRAIN#0.8397;LYMPHATIC VESSEL#0.8395;GOITER#0.8388;CONNEXON#0.8387;TIBIA#0.8378;LENGTH OF STAY#0.8359;SIGNALING PATHWAY#0.8355;RECEPTOR AGONIST#0.8346;SACRUM#0.8335;VOCAL FOLD#0.8331;BONE MINERAL DENSITY#0.8326;SMALL INTESTINE#0.8318;URETER#0.8312;EOSIN#0.8289;UTERINE HORN#0.8289;GESTATION#0.8288;CAUDATE LOBE#0.8284;LEYDIG CELL#0.8284;ABNORMAL INVOLUNTARY MOVEMENT#0.8283;RABIES#0.8259;AZYGOS VEIN#0.8254;CYTOTOXICITY#0.8247;THYROID CARCINOMA#0.8247;NITRIC OXIDE#0.8246;LYMPH NODE METASTASIS#0.8223;OPTICAL COHERENCE TOMOGRAPHY#0.8219;DYSPNEA#0.8217;MULTIPLE MYELOMA#0.8205;PITUITARY GLAND#0.8198;APOPTOTIC#0.8185;NERVE FIBER#0.8153;SKELETAL MUSCLE#0.8152;GAP JUNCTION CHANNEL#0.8141;GRANULOSA CELL#0.8126;NEUROPATHY#0.8125;MONONUCLEAR CELLS#0.8122;DEMETHYLATION#0.8093;ACUTE AORTIC DISSECTION#0.8075;DIABETES MELLITUS#0.8058;FORELIMB#0.8040;BONE RESORPTION#0.8030;RIGHT ATRIUM#0.8014;BOWEL OBSTRUCTION#0.8008;WOUND HEALING#0.7999;DOPAMINE RECEPTOR#0.7965;NECROTIC#0.7962;CEREBRAL ARTERY#0.7954;ANESTHETIC#0.7947;MACROPHAGE#0.7932;PNEUMONIA#0.7922;MISMATCH REPAIR#0.7908;VASCULAR CELL#0.7906;RECURRENT LARYNGEAL NERVE#0.7887;MONTE CARLO SIMULATION#0.7885;CHOLANGIOCARCINOMA#0.7872;ESOPHAGUS#0.7864;CELL MEMBRANE#0.7859;ASCITES#0.7842;FORMALIN#0.7826;ENDOPLASMIC RETICULUM#0.7816;ADENOSINE#0.7799;LECTIN#0.7781;MEMBRANE FUSION#0.7774;TUBERCULOSIS#0.7768;FACIAL PARALYSIS#0.7761;TESTOSTERONE#0.7754;MYOCARDIAL INFARCTION#0.7750;INFLAMMATORY RESPONSE#0.7731;HEPATITIS B VIRUS#0.7716;PROSTATE SPECIFIC ANTIGEN#0.7703;CENTRAL RETINAL ARTERY OCCLUSION#0.7703;LEUKOCYTE#0.7693;OSTEOPOROSIS#0.7688;APRAXIA#0.7681;GASTROINTESTINAL TRACT#0.7677;CELL DIVISION#0.7674;PERIPHERAL NERVE#0.7660;TRANSCRANIAL MAGNETIC STIMULATION#0.7649;PARESTHESIA#0.7618;ORGANELLE#0.7610;ADENINE#0.7585;OXALIC ACID#0.7549;TUMOR CELLS#0.7539;UBIQUITIN#0.7537;FINE NEEDLE ASPIRATION#0.7525;ACTION POTENTIAL#0.7525;PROGESTERONE#0.7519;LOCALIZED PROSTATE CANCER#0.7510;THYROID CANCER#0.7500;NMDA RECEPTOR#0.7499;HEMORRHAGIC#0.7469;FIBULA#0.7462;CAUDATE NUCLEUS#0.7459;LIVER METASTASIS#0.7437;OVULATION#0.7406;MUSCLE FIBER#0.7404;CROSS SECTIONAL AREA#0.7402;GLYCOGEN SYNTHESIS#0.7380;BICUSPID AORTIC VALVE#0.7371;CHRONIC LIVER DISEASE#0.7347;BONE REGENERATION#0.7320;EMBRYONIC STEM CELL#0.7313;BRAIN DAMAGE#0.7303;FERMENTATION#0.7297;DEEP BRAIN STIMULATION#0.7294;HEART DISEASE#0.7293;TRANSFORMING GROWTH FACTOR BETA#0.7286;RANDOMIZED CONTROLLED TRIAL#0.7272;MECHANISM OF ACTION#0.7250;JUGULAR VEIN#0.7235;INTESTINAL OBSTRUCTION#0.7221;ESTRADIOL#0.7216;LYMPH NODE METASTASES#0.7197;LOCOMOTION#0.7189;ATRIAL FIBRILLATION#0.7188;ACETIC ACID#0.7185;CHANNEL ACTIVITY#0.7184;INTERNEURON#0.7172;ADRENAL GLAND#0.7167;HYPOTHYROIDISM#0.7162;NUCLEIC ACID#0.7162;FINITE ELEMENT ANALYSIS#0.7160;HEPATITIS C#0.7160;EMISSION COMPUTED TOMOGRAPHY#0.7154;REPLICATION FORK#0.7149;KERATINOCYTE#0.7136;TRAUMATIC BRAIN INJURY#0.7120;MITOCHONDRIA#0.7118;SCALP#0.7111;OSTEOCLAST#0.7094;ETHANOL#0.7083;CHOLINE#0.7060;OSTEOBLAST#0.7052;PRIMARY MOTOR CORTEX#0.7039;GLIAL CELL#0.7030;ALKALINE PHOSPHATASE#0.7010;STATUS EPILEPTICUS#0.7005;CERVIX#0.7004;INCONTINENCE#0.6991;PHALANX#0.6990;CYTOSINE METHYLATION#0.6967;MINIMALLY INVASIVE SURGERY#0.6966;HEAD AND NECK CANCER#0.6963;NECK CANCER#0.6962;ANAESTHETIC#0.6938;AGEING#0.6929;CARRIE#0.6926;DEVELOPMENTAL DELAY#0.6903;EPIDERMAL GROWTH FACTOR#0.6884;FIBRIL#0.6874;FLUORESCEIN#0.6873;PLEURA#0.6862;DEFENSE RESPONSE#0.6851;MOTOR ACTIVITY#0.6840;TEMPORAL LOBE#0.6820;HIGH RISK PATIENTS#0.6817;ANAL CANAL#0.6806;BASAL CELL#0.6802;SUCROSE#0.6788;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.6779;LEUCINE#0.6763;HEPARIN#0.6760;IMMUNE SYSTEM#0.6751;LYMPHEDEMA#0.6726;URINARY TRACT INFECTION#0.6723;ANCHORING#0.6696;NUMBNESS#0.6695;SCIATIC NERVE#0.6685;ACID PHOSPHATASE#0.6670;SODIUM DODECYL SULFATE#0.6669;DODECYL SULFATE#0.6668;INCISORS#0.6665;EXTRACELLULAR SPACE#0.6662;METHIONINE#0.6658;ILIAC ARTERY#0.6637;HINDLIMB#0.6635;TYPE 2 DIABETES#0.6634;MUTAGENESIS#0.6633;TUMOR SUPPRESSOR#0.6628;ASCORBIC ACID#0.6619;ADHERENS JUNCTION#0.6596;PNEUMOTHORAX#0.6583;PAPILLARY CARCINOMA#0.6577;ANOSOGNOSIA#0.6574;MASTICATION#0.6569;DISEASE FREE SURVIVAL#0.6566;DEHISCENCE#0.6559;TRIGEMINAL NEURALGIA#0.6535;LYMPHATIC ENDOTHELIAL CELL#0.6528;CONGENITAL DIAPHRAGMATIC HERNIA#0.6523;FORCED VITAL CAPACITY#0.6521;DUODENUM#0.6513;SKELETON#0.6513;NEUROTOXIN#0.6458;VISUAL ANALOGUE SCALE#0.6446;NEUROTOXICITY#0.6433;BONE REMODELING#0.6415;HEARING LOSS#0.6407;YEAR SURVIVAL RATE#0.6405;PERICARDIUM#0.6383;INFLAMMATORY CELL#0.6363;ENUCLEATION#0.6356;TONGUE CANCER#0.6355;ILIAC BONE#0.6355;POST OPERATIVE DAY#0.6347;CELL GROWTH#0.6342;MASSETER#0.6338;DISEASE RESISTANCE#0.6338;KYPHOSIS#0.6329;CHONDROSARCOMA#0.6324;HEMOSTASIS#0.6288;CLEFT PALATE#0.6280;VACTERL ASSOCIATION#0.6269;AORTIC VALVE DISEASE#0.6259;REGIONAL LYMPH NODE#0.6259;PERIODONTAL LIGAMENT#0.6257;PROGENITOR CELL#0.6242;GASTROENTERITIS#0.6212;OSTEONECROSIS#0.6204;NEUROPROTECTION#0.6201;RECEPTOR BINDING#0.6198;MULTIPLE SCLEROSIS#0.6193;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6182;LIVER CANCER#0.6178;FLEXOR DIGITORUM PROFUNDUS#0.6177;HIGH DOSE RATE#0.6174;ALVEOLUS#0.6165;3,4-DIHYDROXYPHENYLALANINE#0.6160;MINERALIZATION#0.6156;VASCULAR SMOOTH MUSCLE CELL#0.6151;JOINT DISORDER#0.6149;ORAL MUCOSA#0.6147;OMENTUM#0.6131;ACETYLCHOLINE#0.6127;ENDOTHELIUM#0.6118;RECTUS ABDOMINIS#0.6115;THORACIC AORTA#0.6111;ENDOSCOPIC MUCOSAL RESECTION#0.6105;RANDOMISED CONTROLLED TRIAL#0.6105;MIDDLE CEREBRAL ARTERY#0.6102;ENDOMETRIAL CANCER#0.6088;SCHWANN CELL#0.6081;SCOTOMA#0.6081;HEPATITIS C VIRUS#0.6054;WEIGHT GAIN#0.6053;MOTOR EVOKED POTENTIAL#0.6043;COMPUTED TOMOGRAPHY ANGIOGRAPHY#0.6038;CANINE DISTEMPER#0.6031;MEMBRANE FISSION#0.6020;GLYCOSYLATION#0.6015;DEHYDROASCORBIC ACID#0.6012;DEMENTIA#0.6006;DIFFUSION WEIGHTED IMAGING#0.6005
11118	T CELL#0.9824;OVARIAN CANCER#0.6476;BREAST CANCER#0.6422;IMMUNE CELL#0.6373
11119	T CELL#1.0567;CELL ACTIVATION#0.9623;T CELL ACTIVATION#0.9358;T LYMPHOCYTE#0.8419;ISOPENTENYL PYROPHOSPHATE#0.7392;TUMOR CELLS#0.7101;DIPHOSPHATE#0.6157
1111	7-HYDROXYSTAUROSPORINE#1.0595;G2 DNA DAMAGE CHECKPOINT#1.0523;S M CHECKPOINT#1.0418;DNA REPLICATION CHECKPOINT#1.0259;SPINDLE CHECKPOINT#1.0239;GEMCITABINE#1.0216;RESPONSE TO UV#1.0193;RESPONSE TO GENOTOXIC STRESS#1.0190;CENTROSOME#1.0139;CELL DIVISION CYCLE#1.0127;PROTEIN KINASE C#1.0113;RESPONSE TO IONIZING RADIATION#1.0102;ATP BINDING#1.0088;ANAPHASE#1.0083;MITOTIC CATASTROPHE#1.0079;HYPOXIA#1.0072;HYDROXYUREA#1.0064;STRUCTURE ACTIVITY RELATIONSHIP#1.0062;MITOTIC EXIT#1.0054;SIGNALLING PATHWAY#1.0043;MITOTIC ENTRY#1.0043;SENSITIZATION#1.0041;CAFFEINE#1.0041;S-PHASE CHECKPOINT#1.0036;ENTRY INTO MITOSIS#1.0030;CELL CYCLE REGULATOR#1.0028;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0019;MITOGEN ACTIVATED PROTEIN#1.0016;PANCREATIC CANCER#1.0011;HOMOLOGOUS RECOMBINATION REPAIR#1.0011;KINASE ACTIVITY#1.0008;CAMPTOTHECIN#0.9995;REPLICATION PROTEIN A#0.9993;PROTEASOME#0.9993;CYTARABINE#0.9971;BINDING PROTEIN 1#0.9968;ETOPOSIDE#0.9967;SPINDLE ASSEMBLY#0.9954;HYPERPHOSPHORYLATION#0.9949;SPINDLE ASSEMBLY CHECKPOINT#0.9948;CELL CYCLE CONTROL#0.9947;CELL CYCLE CHECKPOINT#0.9946;AUTOPHAGY#0.9945;DNA DAMAGE CHECKPOINT#0.9945;CERVICAL CANCER#0.9945;PROTEIN KINASE#0.9944;CDK INHIBITOR#0.9943;DEPHOSPHORYLATION#0.9943;ACUTE MYELOID LEUKEMIA#0.9938;MITOTIC SPINDLE#0.9937;TELOMERE#0.9937;CELL KILLING#0.9928;5 FLUOROURACIL#0.9925;SENESCENCE#0.9925;B CELL#0.9923;COLON CARCINOMA#0.9922;ATAXIA TELANGIECTASIA#0.9921;MYELOID LEUKEMIA#0.9915;ATAXIA TELANGIECTASIA MUTATED#0.9914;CISPLATIN#0.9912;OVARIAN CANCER#0.9911;TOPOISOMERASE II#0.9909;MULTIPLE MYELOMA#0.9906;COLON CANCER#0.9903;METAPHASE#0.9901;T CELL#0.9896;UBIQUITIN PROTEASOME PATHWAY#0.9893;DOXORUBICIN#0.9887;SIGNALING CASCADE#0.9877;PROTEASOME PATHWAY#0.9875;BREAST CANCER CELL#0.9874;DNA REPAIR PROTEIN#0.9871;REPLICATION FORK#0.9871;G2 PHASE#0.9866;OVARIAN#0.9863;FANCONI ANEMIA#0.9863;CELL CYCLE REGULATION#0.9860;RNA INTERFERENCE#0.9851;UBIQUITIN#0.9851;CELL DIVISION#0.9845;TIMELESS-TIPIN COMPLEX#0.9837;TUMOR CELLS#0.9833;KINASE INHIBITOR#0.9833;SIGNAL TRANSDUCER#0.9831;TOPOISOMERASE#0.9829;M PHASE#0.9828;HEPATOCELLULAR CARCINOMA#0.9817;CYCLIN DEPENDENT KINASE#0.9814;COLORECTAL CANCER#0.9813;INDUCTION OF APOPTOSIS#0.9807;HISTIDINE#0.9806;LUNG CANCER#0.9801;OOCYTE#0.9797;G1 PHASE#0.9788;S PHASE#0.9788;CELL CYCLE ARREST#0.9787;BREAST CANCER#0.9787;COLORECTAL#0.9784;GENOTOXIC#0.9784;POLY ADP RIBOSE#0.9782;RIBOSE#0.9781;SIGNAL TRANSDUCTION#0.9778;CELL CYCLE#0.9771;DNA DAMAGE RESPONSE#0.9771;DNA SYNTHESIS#0.9766;SIGNALING PATHWAY#0.9765;TUMOR SUPPRESSOR#0.9761;DNA REPLICATION#0.9760;MITOSIS#0.9758;MISMATCH REPAIR#0.9757;SINGLE STRAND BREAK#0.9757;DRUG RESISTANCE#0.9755;GENE SILENCING#0.9745;C TERMINAL DOMAIN#0.9745;CYTOTOXICITY#0.9741;PROSTATE CANCER#0.9741;CATALYTIC ACTIVITY#0.9730;HOMOLOGOUS RECOMBINATION#0.9725;DNA BINDING#0.9723;ANEMIA#0.9723;ONCOGENIC#0.9721;GROWTH FACTOR#0.9721;NEUROBLASTOMA#0.9720;MICROTUBULE#0.9715;CYTOPLASM#0.9715;EPITHELIAL CELL#0.9713;HISTONE DEACETYLASE#0.9713;STEM CELL#0.9710;CANCER STEM CELL#0.9709;CDK ACTIVITY#0.9707;POLYMERASE CHAIN REACTION#0.9703;INHIBITION OF DNA REPLICATION#0.9700;CANCER CELL#0.9698;CERVICAL#0.9694;TOXICITY#0.9693;APOPTOSIS#0.9687;CELL GROWTH#0.9684;HUMAN BREAST CANCER#0.9681;ADENOCARCINOMA#0.9674;DOUBLE-STRAND BREAK REPAIR#0.9673;FLUOROURACIL#0.9672;MITOTIC CHECKPOINT#0.9671;DNA REPAIR#0.9659;SQUAMOUS CELL CARCINOMA#0.9656;TRANSCRIPTION FACTOR#0.9653;MRN COMPLEX#0.9649;CELL DEATH#0.9647;LUNG ADENOCARCINOMA#0.9642;CELL CYCLE PHASE#0.9639;APOPTOTIC#0.9634;APOPTOTIC CELL DEATH#0.9631;DOUBLE STRAND BREAK#0.9627;CELL PROLIFERATION#0.9620;MECHANISM OF ACTION#0.9610;REACTIVE OXYGEN SPECIES#0.9598;GENE EXPRESSION#0.9591;TEMOZOLOMIDE#0.9585;EWING SARCOMA#0.9584;CYTOKINESIS#0.9580;BUDDING#0.9573;VIRAL REPLICATION#0.9564;CELLULAR SENESCENCE#0.9563;ARA-C#0.9554;CYCLIN DEPENDENT KINASE INHIBITOR#0.9548;MAP KINASE#0.9528;HEAT SHOCK PROTEIN#0.9525;CHROMOSOME SEGREGATION#0.9516;VIRULENCE#0.9509;NUCLEOTIDE EXCISION REPAIR#0.9507;IRINOTECAN#0.9477;COMPLEX I#0.9468;CELLULAR DNA DAMAGE RESPONSE#0.9462;RETINOBLASTOMA#0.9458;HYPERSENSITIVITY#0.9458;DNA FRAGMENTATION#0.9457;INTERPHASE#0.9457;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9410;PROTEIN PHOSPHORYLATION#0.9409;CARCINOGEN#0.9398;BASE EXCISION REPAIR#0.9395;BREAST CARCINOMA#0.9343;NULL CELL#0.9339;KERATINOCYTE#0.9305;BONE MARROW#0.9269;GROWTH FACTOR RECEPTOR#0.9262;B CELL LYMPHOMA#0.9255;TUMOR TISSUES#0.9236;MITOMYCIN C#0.9224;CYTOCHROME C#0.9196;OXIDATIVE DNA DAMAGE#0.9186;ESTROGEN RECEPTOR#0.9181;RESPONSE TO HYDROXYUREA#0.9176;MITOCHONDRIAL MEMBRANE#0.9159;THYMIDINE#0.9159;PROGENITOR CELL#0.9151;DNA REPLICATION INHIBITOR#0.9149;MULTIPLE MYELOMA CELLS#0.9147;CELL CYCLE TRANSITION#0.9121;LYMPH NODE#0.9077;SIGNALLING CASCADE#0.9048;MELPHALAN#0.9036;NUCLEAR EXPORT#0.9031;MITOTIC SPINDLE CHECKPOINT#0.9001;AKT SIGNALING#0.8998;ALANINE#0.8986;REVERSE TRANSCRIPTION#0.8978;BREAST CANCER PATIENTS#0.8936;RESPONSE TO GEMCITABINE#0.8912;REPLISOME#0.8907;PEMETREXED#0.8905;P53 SIGNALING PATHWAY#0.8904;DNA METHYLTRANSFERASE#0.8875;PROTEIN COMPLEX#0.8862;KINETOCHORE#0.8860;REGULATION OF CELL CYCLE#0.8857;ENDOTHELIAL CELL#0.8850;PROGRAMMED CELL DEATH#0.8838;DNA DAMAGE FOCI#0.8814;DNA TOPOISOMERASE#0.8800;MOUSE EMBRYONIC FIBROBLAST#0.8795;HEAD AND NECK CANCER#0.8789;NECK CANCER#0.8788;LYSINE#0.8779;MITOMYCIN#0.8730;MELANOMA CELL LINES#0.8730;DNA REPLICATION INITIATION#0.8722;CHROMATIN REMODELING#0.8698;CHROMATID#0.8696;GERM CELL#0.8674;PROTEIN PROTEIN INTERACTION#0.8638;MUTAGENESIS#0.8636;REPLICATION FORK STALLING#0.8609;HOST CELL#0.8599;PROGESTERONE#0.8571;MITOCHONDRIA#0.8569;PERIPHERAL BLOOD#0.8554;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8544;MITOTIC CELL DEATH#0.8534;CARBOPLATIN#0.8530;NOCODAZOLE#0.8511;FLOW CYTOMETRY ANALYSIS#0.8462;EPIDERMAL GROWTH FACTOR#0.8423;NUCLEASE ACTIVITY#0.8401;POST-TRANSLATIONAL MODIFICATION#0.8391;HYPOXIC#0.8348;MECHANISMS OF ACTION#0.8313;OSTEOBLAST#0.8312;COLONY FORMATION ASSAY#0.8304;PROTEIN SYNTHESIS#0.8299;TOPOTECAN#0.8291;SKIN CANCER#0.8283;PANCREATIC DUCTAL ADENOCARCINOMA#0.8280;DDR SIGNALING PATHWAY#0.8274;ROS GENERATION#0.8263;SENSITIZER#0.8260;CELL WALL#0.8256;PROTEIN KINASE A#0.8246;STAUROSPORINE#0.8173;MAXIMUM TOLERATED DOSE#0.8162;PROPHASE#0.8110;STANDARD OF CARE#0.8096;PACLITAXEL#0.8088;DOMINANT NEGATIVE MUTANT#0.8070;HEPATOCELLULAR CARCINOMA CELL#0.8069;RECOMBINATIONAL REPAIR#0.8068;REPLICATION FORK STABILIZATION#0.8059;MAINTENANCE OF GENOME INTEGRITY#0.8055;EMBRYONIC STEM CELL#0.8030;HISTONE DEACETYLASE INHIBITOR#0.7996;P53 BINDING#0.7994;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7988;DNA HELICASE#0.7975;ENDOMETRIAL CANCER#0.7948;CASEIN KINASE 1#0.7943;PYRAZOLE#0.7920;IMMUNE RESPONSE#0.7904;GENOTOXICITY#0.7891;TAXOL#0.7868;ADRIAMYCIN#0.7833;GELDANAMYCIN#0.7829;OOCYTE MATURATION#0.7825;SECKEL SYNDROME#0.7771;QUANTITATIVE REAL TIME#0.7771;SMALL INTESTINE#0.7767;PROTEIN KINASE INHIBITOR#0.7760;IMATINIB#0.7749;TELOMERASE ACTIVITY#0.7745;EPITHELIAL MESENCHYMAL TRANSITION#0.7737;HEMATOPOIETIC CELL#0.7727;OVARIAN CARCINOMA#0.7722;SPINDLE FORMATION#0.7720;ANGIOGENESIS#0.7711;ANDROGEN RECEPTOR#0.7687;PROTEIN KINASE ACTIVITY#0.7670;CLEAVED CASPASE 3#0.7561;FDURD#0.7551;ESOPHAGEAL CARCINOMA#0.7534;PROTEIN KINASE B#0.7531;FAMILIAL BREAST CANCER#0.7530;LUNG CARCINOMA#0.7512;ESOPHAGEAL CANCER#0.7503;INHIBITION OF CELL PROLIFERATION#0.7460;MACROPHAGE#0.7448;L-CYSTEINE#0.7447;N-ACETYLCYSTEINE#0.7439;MANTLE CELL LYMPHOMA#0.7402;RECEPTOR TYROSINE KINASE#0.7393;TELOMERE MAINTENANCE#0.7385;CENTROMERE#0.7373;MEIOSIS#0.7362;PHOSPHATASE ACTIVITY#0.7334;NUCLEIC ACID#0.7333;ATR-ATRIP COMPLEX#0.7318;CASPASE ACTIVATION#0.7318;TRANSLESION SYNTHESIS#0.7317;BLEOMYCIN#0.7316;RESPONSE TO RADIATION#0.7314;CELL DIFFERENTIATION#0.7306;GLUTATHIONE#0.7249;HUMAN IMMUNODEFICIENCY VIRUS#0.7246;DNA METABOLISM#0.7228;HISTONE ACETYLATION#0.7223;ORAL SQUAMOUS CELL CARCINOMA#0.7210;PROTEIN DEGRADATION#0.7202;DOSE LIMITING TOXICITIES#0.7180;CHROMATIN BINDING#0.7175;DAUNORUBICIN#0.7164;ANAPHASE PROMOTING COMPLEX#0.7148;MONONUCLEAR CELLS#0.7147;NITRIC OXIDE#0.7133;DEBROMOHYMENIALDISINE#0.7101;PROPIDIUM#0.7086;TRANSFORMING GROWTH FACTOR#0.7072;LYMPHOMA CELL LINES#0.7067;GENOTOXINS#0.7049;TRANSCRIPTASE#0.7047;MUTAGENIC#0.7022;NUCLEAR IMPORT#0.7015;THYMIDYLATE SYNTHASE#0.7010;PHOSPHATASE 2A#0.7005;MEDULLOBLASTOMA#0.6999;ACUTE LEUKEMIA#0.6974;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6970;LYMPHOCYTIC LEUKEMIA#0.6963;HEMATOPOIESIS#0.6943;LEUCINE#0.6934;GENE EXPRESSION OMNIBUS#0.6913;DEGRADATION OF CYCLIN#0.6910;SSDNA BINDING#0.6872;6-THIOGUANINE#0.6852;SRC FAMILY KINASE#0.6840;DOCETAXEL#0.6836;DNA REPLICATION ELONGATION#0.6835;TRANSACTIVATION#0.6789;FOCAL ADHESION#0.6778;CELL DEVELOPMENT#0.6776;PROTEIN PHOSPHATASE 2A#0.6762;MITOTIC DNA DAMAGE CHECKPOINT#0.6753;CLEAR CELL CARCINOMA#0.6724;GLIOBLASTOMA MULTIFORME#0.6722;ANTI APOPTOSIS#0.6706;BORTEZOMIB#0.6677;SIGNALING MOLECULE#0.6676;MICROCEPHALY#0.6662;CHROMOSOME CONDENSATION#0.6644;CDC2 KINASE ACTIVITY#0.6635;REGULATION OF DNA REPLICATION#0.6622;MALE BREAST CANCER#0.6612;LYSOSOME#0.6581;CELL CYCLE PATHWAY#0.6569;CASPASE INHIBITOR#0.6557;GLYCOSYLASE#0.6550;LIVER CANCER#0.6542;MAPK SIGNALING#0.6539;CELLULAR LOCALIZATION#0.6532;ACTIVATION OF APOPTOSIS#0.6509;MCM COMPLEX#0.6484;MOLECULAR DYNAMICS SIMULATION#0.6462;MITOTIC ARREST DEFICIENT#0.6453;REPLICATION FORK RESTART#0.6444;HUMAN BRONCHIAL EPITHELIAL#0.6443;LYMPH NODE METASTASIS#0.6436;ACETYLCYSTEINE#0.6426;INDOLE#0.6425;ONCOGENESIS#0.6419;RESPONSE TO CISPLATIN#0.6371;DNA REPLICATION LICENSING#0.6369;ENDOTHELIAL GROWTH FACTOR#0.6365;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6365;REPLICATION FORK ARREST#0.6346;PHOSPHATASE I#0.6319;OXALIPLATIN#0.6318;XERODERMA PIGMENTOSUM#0.6294;TUMOR GROWTH INHIBITION#0.6285;RESPONSE TO OXIDATIVE STRESS#0.6265;KINETOCHORE LOCALIZATION#0.6234;DEUBIQUITINATING ENZYME#0.6204;RAPAMYCIN#0.6199;DNA TOPOISOMERASE II#0.6195;DNA REPAIR CAPACITY#0.6191;RESPONSE TO CPT#0.6151;HOMOLOGOUS RECOMBINATIONAL REPAIR#0.6138;HISTONE ACETYLTRANSFERASE#0.6125;NEUTROPENIA#0.6125;LOVASTATIN#0.6104;ADENOSINE#0.6104;ARGININE#0.6100;RNA BINDING#0.6078;SMOOTH MUSCLE#0.6060;CELL SURFACE#0.6057;OVARIAN CLEAR CELL CARCINOMA#0.6008
11120	MYOCARDIAL INFARCTION#1.0861;DIABETES MELLITUS#0.9499;TRANSCRIPTION FACTOR#0.8929;HYPERTENSION#0.8620;CHRONIC KIDNEY DISEASE#0.7270;KIDNEY DISEASE#0.7254
11122	PROTEIN TYROSINE PHOSPHATASE#1.0451;CELL ADHESION#1.0040;TRANSMEMBRANE RECEPTOR#1.0013;NERVOUS SYSTEM#0.9980;GROWTH FACTOR#0.9965;PHOSPHATASE ACTIVITY#0.9927;CANCER CELL#0.9926;CELL SURFACE#0.9899;CELL MIGRATION#0.9892;SIGNALING PATHWAY#0.9885;CELL ADHESION MOLECULE#0.9885;CENTRAL NERVOUS SYSTEM#0.9875;TUMOR SUPPRESSOR#0.9832;PROTEOGLYCAN#0.9711;DEPHOSPHORYLATION#0.9706;CHONDROITIN SULFATE PROTEOGLYCAN#0.9518;CATALYTIC ACTIVITY#0.9385;EXTRACELLULAR MATRIX#0.9275;REGENERATION#0.9205;ENDOTHELIAL CELL#0.9177;NEURITE OUTGROWTH#0.9145;MEPRIN#0.9134;NEURITE#0.9054;PROTEIN TYROSINE KINASE#0.8754;PROTEIN KINASE#0.8567;STEM CELL#0.8551;LEUKOCYTE#0.8541;CELL CELL ADHESION#0.8514;COLORECTAL CANCER#0.8471;ANAPLASTIC LYMPHOMA KINASE#0.8238;GENE EXPRESSION#0.8234;LUNG CANCER#0.8207;EPIDERMAL GROWTH FACTOR#0.8120;AXON GUIDANCE#0.8098;CELL GROWTH#0.7986;SYNTAXIN BINDING#0.7981;SIGNAL TRANSDUCTION#0.7879;PROSTATE CANCER#0.7872;RECEPTOR TYROSINE KINASE#0.7848;BREAST CANCER#0.7774;HEPARIN BINDING#0.7762;PHOSPHATASE I#0.7739;EXTRACELLULAR REGION#0.7614;FOCAL ADHESION#0.7535;HEPARIN#0.7506;ANGIOGENESIS#0.7488;NEURAL CELL#0.7332;SRC FAMILY KINASE#0.7303;PROTEIN KINASE C#0.7281;SPINAL CORD#0.7280;COLORECTAL#0.7206;SQUAMOUS CELL CARCINOMA#0.7130;GLIAL CELL#0.7059;AXON GROWTH#0.7014;POLYMERASE CHAIN REACTION#0.7010;ASTROCYTE#0.6885;CELL PROLIFERATION#0.6747;T CELL#0.6739;TUMOR CELLS#0.6656;ENDOTHELIAL CELL MIGRATION#0.6315;ADENOCARCINOMA#0.6310;COLON CANCER#0.6307;HEPATOCELLULAR CARCINOMA#0.6290;CHANNEL ACTIVITY#0.6115;GLYCOSYLATION#0.6055;KINASE ACTIVITY#0.6048
11123	DOWN SYNDROME#0.8298;CALCINEURIN#0.7936;T CELL#0.7626;GENE EXPRESSION#0.6822;BREAST CANCER#0.6579;SIGNALING PATHWAY#0.6357;TH17 CELL#0.6085
11124	CELL DEATH#1.0495;APOPTOSIS#1.0485;UBIQUITIN#1.0475;CANCER CELL#0.9926;DEATH-INDUCING SIGNALING COMPLEX#0.9843;APOPTOTIC#0.9780;FAS BINDING#0.9710;SIGNALING PATHWAY#0.9304;PROTEASOME#0.9288;PARKINSON'S DISEASE#0.8977;PROTEIN KINASE#0.8788;CELL CYCLE#0.8359;UBIQUITIN PROTEASOME PATHWAY#0.8307;PROTEASOME PATHWAY#0.8285;CELL PROLIFERATION#0.8212;HEAT SHOCK PROTEIN#0.8149;NF-KAPPAB ACTIVATION#0.8100;BREAST CANCER#0.7991;PROTEIN DEGRADATION#0.7785;VALOSIN CONTAINING PROTEIN#0.7260;TUMOR SUPPRESSOR#0.7179;ENDOPLASMIC RETICULUM#0.6424;OOCYTE#0.6407;TUMOR NECROSIS FACTOR#0.6296;HUMAN GASTRIC CARCINOMA#0.6263;IKAPPAB KINASE#0.6212;COMPLEX I#0.6208;RIBOSOMAL SUBUNIT#0.6193;BREAST CANCER CELL#0.6188;ANTIVIRAL RESPONSE#0.6175;REPLICATION FORK#0.6169;CELL CYCLE ARREST#0.6066;DNA REPLICATION#0.6041
11126	T LYMPHOCYTE#1.0332;IFN-GAMMA#1.0325;CD4+ T CELL#1.0302;CELL SURFACE#1.0299;CYTOTOXICITY#1.0270;CD8+ T CELL#1.0229;T CELL#1.0225;PERIPHERAL BLOOD#1.0210;CELL ACTIVATION#1.0180;CYTOKINE PRODUCTION#1.0145;BONE MARROW#1.0089;SUBSTANCE P#1.0074;NATURAL KILLER CELL#0.9939;IMMUNE RESPONSE#0.9874;CYTOTOXIC T-LYMPHOCYTE#0.9854;T CELL ACTIVATION#0.9601;B CELL#0.9540;CELL PROLIFERATION#0.9404;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9338;MONONUCLEAR CELLS#0.9045;CELL DIFFERENTIATION#0.8860;SIGNALING PATHWAY#0.8780;TUMOR NECROSIS FACTOR#0.8763;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8690;LYMPHOCYTIC LEUKEMIA#0.8682;TACHYKININ#0.8555;STEM CELL#0.8553;RECEPTOR ANTAGONIST#0.8378;TRANSCRIPTION FACTOR#0.8274;BETA CELL#0.8200;DELTA CELL#0.8156;IMMUNE SYSTEM#0.8073;CYTOTOXIC T CELL#0.8058;NKT CELL#0.8007;ENDOTHELIAL CELL#0.7989;GENE EXPRESSION#0.7987;LYMPHOCYTE ACTIVATION#0.7965;VIRAL INFECTION#0.7935;APOPTOSIS#0.7893;IL-4 PRODUCTION#0.7875;LYMPHOCYTE ANTIGEN#0.7856;THYMOCYTE#0.7823;MEMORY T CELL#0.7764;T CELL PROLIFERATION#0.7704;PERIPHERAL BLOOD LYMPHOCYTES#0.7666;CYTOKINE SECRETION#0.7359;IMMUNE CELL#0.7314;CELL DEATH#0.7218;HERPES SIMPLEX VIRUS#0.7059;HERPES SIMPLEX#0.7055;TACHYKININ RECEPTOR#0.6965;DENDRITIC CELL#0.6919;CELL DEVELOPMENT#0.6840;SIGNALING MOLECULE#0.6803;DECIDUA#0.6700;LYSIS#0.6615;PROGRAMMED CELL DEATH#0.6555;ANTIGEN PRESENTING CELLS#0.6262;LEUKOCYTE#0.6230
11127	KINESIN#1.0446;CILIOGENESIS#1.0401;INTRAFLAGELLAR TRANSPORT#1.0352;CILIUM#1.0135;MICROTUBULE#1.0116;PRIMARY CILIUM#1.0060;EPITHELIAL CELL#1.0010;ORGANELLE#0.9871;MICROTUBULE BASED#0.9787;CELL CYCLE#0.9752;BASAL BODY#0.9717;CELL PROLIFERATION#0.9434;DYNEIN#0.9359;KIDNEY DISEASE#0.9273;SPERMIOGENESIS#0.9220;PHOTORECEPTOR CELL#0.9064;SIGNALING PATHWAY#0.9025;INTRACELLULAR TRANSPORT#0.8995;TRANSCRIPTION FACTOR#0.8866;SPERMATOGENESIS#0.8845;AXONEME#0.8771;OSTEOBLAST#0.8347;GENE EXPRESSION#0.8329;NEURAL CREST#0.8243;POLYCYSTIC KIDNEY DISEASE#0.8178;CANCER CELL#0.8094;BONE FORMATION#0.7964;CELL MIGRATION#0.7910;BREAST CANCER#0.7860;NEURAL CREST CELL#0.7728;CELL DEATH#0.7674;MORPHOGENESIS#0.7482;COMPLEX I#0.7267;CILIATED CELL#0.7169;CRANIAL NEURAL CREST#0.7006;OPSIN#0.6947;PLASMA MEMBRANE#0.6915;CONNECTING CILIUM#0.6854;CELL DIVISION#0.6836;STEM CELL#0.6813;MICROTUBULE MOTOR#0.6720;AXONAL TRANSPORT#0.6625;GROWTH FACTOR#0.6603;RIBBON SYNAPSE#0.6572;MESENCHYME#0.6443;MOUSE EMBRYONIC FIBROBLAST#0.6360;ADIPOGENESIS#0.6333;CELL SURFACE#0.6325;RNA GRANULE#0.6286;SPERM TAIL#0.6240;PRESYNAPTIC RIBBON#0.6066;TONGUE DEVELOPMENT#0.6054;MOTOR ACTIVITY#0.6006
11128	HYPOMYELINATING LEUKODYSTROPHY#1.1073;LEUKODYSTROPHY#1.0887;HYPOGONADOTROPIC HYPOGONADISM#0.9538;SPASTIC ATAXIA#0.8746;HYPOGONADISM#0.8700;HEREDITARY SPASTIC PARAPLEGIA#0.7265;SCLERODERMA#0.6546
11129	CORTICAL MICROTUBULE#1.0441;MICROTUBULE#1.0427;MICROTUBULE ASSOCIATED PROTEIN#1.0073;MICROTUBULE DYNAMICS#1.0030;CELL DIVISION#0.9931;MICROTUBULE PLUS END#0.9543;CELL CORTEX#0.8951;KINETOCHORE#0.8759;MITOTIC SPINDLE#0.8437;MICROTUBULE BINDING#0.7998;KINESIN#0.7510;TUBULIN BINDING#0.7487;CELL EXPANSION#0.7061;CHROMOSOME SEGREGATION#0.7033;MICROTUBULE CATASTROPHE#0.7023;MITOSIS#0.6965;LOWER URINARY TRACT#0.6947;MICROTUBULE BUNDLE#0.6599;PLASMA MEMBRANE#0.6260;RANDOMISED CONTROLLED TRIAL#0.6220;MICROTUBULE RESCUE#0.6102;GROWTH CONE#0.6052
1112	TRANSCRIPTION FACTOR#1.0395;FASTING BLOOD GLUCOSE#1.0205;TUMOR SUPPRESSOR#0.9685;CELL CYCLE#0.9505;CANCER CELL#0.9373;BREAST CANCER#0.8954;GENE EXPRESSION#0.8620;CELL PROLIFERATION#0.7901;NEURAL CREST#0.7163;MYELOID LEUKEMIA#0.6158;DNA DAMAGE RESPONSE#0.6146;ARECA NUT EXTRACT#0.6141;BREAST CANCER CELL#0.6090
11130	KINETOCHORE#1.0861;KINETOCHORE LOCALIZATION#0.9459;GENE EXPRESSION#0.9170;HEPATOCELLULAR CARCINOMA#0.9088;CHROMOSOME SEGREGATION#0.9076;MITOTIC CHECKPOINT#0.9005;CELL CYCLE#0.8836;CENTROMERE#0.8745;SPINDLE CHECKPOINT#0.8550;SPINDLE ASSEMBLY#0.8158;LUNG CANCER#0.7765;CELL PROLIFERATION#0.7740;MICROTUBULE#0.7615;SPINDLE ASSEMBLY CHECKPOINT#0.7093;MITOSIS#0.6990;KINETOCHORE MICROTUBULE#0.6983;KINETOCHORE-MICROTUBULE ATTACHMENT#0.6384;TUMOR TISSUES#0.6298;ROBERTS SYNDROME#0.6296;KINETOCHORE ASSEMBLY#0.6121;CELL DIVISION#0.6098;SPINAL CORD#0.6092;PROTEIN PROTEIN INTERACTION#0.6008
11131	SKELETAL MUSCLE#0.6573
11132	SKELETAL MUSCLE#1.0737;POLYCYSTIC OVARY SYNDROME#1.0604;GESTATIONAL DIABETES#1.0592;GLUCOSE METABOLISM#1.0434;GESTATIONAL DIABETES MELLITUS#1.0432;INSULIN SECRETION#1.0263;POLYMERASE CHAIN REACTION#1.0246;TYPE 2 DIABETES#1.0239;TYPE 2 DIABETES MELLITUS#1.0225;2 DIABETES MELLITUS#1.0225;DIABETES MELLITUS#1.0190;BETA CELL#1.0147;APOPTOSIS#0.9977;CALPAIN ACTIVITY#0.9882;GENE EXPRESSION#0.9375;MITOCHONDRIA#0.8989;TRANSCRIPTION FACTOR#0.8747;GLUCOSE UPTAKE#0.8712;FRAGMENT LENGTH POLYMORPHISM#0.8703;CELL DEATH#0.8651;PEROXISOME#0.8493;GLUCOSE TOLERANCE TEST#0.8372;ORAL GLUCOSE TOLERANCE#0.8237;ADIPOCYTE#0.8151;IMPAIRED GLUCOSE TOLERANCE#0.8098;HYPERTENSION#0.8033;INSULIN RECEPTOR#0.8022;PANCREATIC ISLET#0.7948;TYPE 2 DIABETIC#0.7915;OBESE#0.7755;FAT CELL#0.7647;INSULIN RECEPTOR SUBSTRATE#0.7527;ATHEROSCLEROSIS#0.6898;MUSCLE CELL#0.6707;EXOCYTOSIS#0.6559;LIPOLYSIS#0.6322;BLOOD GLUCOSE LEVEL#0.6128;GLUCOSE HOMEOSTASIS#0.6121;HEPATIC LIPASE#0.6076;SKELETAL MUSCLE CELLS#0.6038;ENDOPLASMIC RETICULUM#0.6001
11133	MACROCEPHALY#0.9069;DEVELOPMENTAL DELAY#0.7273;HEARING LOSS#0.7239
11135	ENDOTHELIAL CELL#0.8222;FIBRINOGEN#0.6777;CELL MORPHOGENESIS#0.6229;NEURAL CREST CELL#0.6045
11136	CYSTINURIA#1.0519;RABIES#1.0382;AMINO ACID TRANSPORT#0.9816;GENE EXPRESSION#0.9521;SEVERE ACUTE RESPIRATORY SYNDROME#0.9278;EXCRETION#0.9084;SMALL INTESTINE#0.9070;LYSINE#0.8844;ARGININE#0.8799;MITOCHONDRIAL GENOME#0.8492;RECEPTOR BINDING#0.8456;ORNITHINE#0.8210;KIDNEY DISEASE#0.7980;RENAL REABSORPTION#0.7851;LEUCINE#0.7656;INFERIOR COLLICULUS#0.7604;CHRONIC KIDNEY DISEASE#0.7455;NEPHROLITHIASIS#0.7411;EPITHELIAL CELL#0.7258;MITOCHONDRIA#0.7038;GLOMERULAR FILTRATION#0.6999;LUMINAL#0.6897;VALINE#0.6880;GLOMERULAR FILTRATION RATE#0.6758;POLYMERASE CHAIN REACTION#0.6748;JEJUNUM#0.6637;REVERSE TRANSCRIPTION#0.6608;AUTOSOMAL RECESSIVE DISEASE#0.6605;ECHOLOCATION#0.6576;NUCLEOCAPSID#0.6462;FERMENTATION#0.6399;GLUTARYL-COA DEHYDROGENASE ACTIVITY#0.6235;INFLUENZA A VIRUSES#0.6091;HIBERNATION#0.6049;NUCLEIC ACID#0.6017;TUMOR NECROSIS FACTOR#0.6010;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6004
11137	CELL CYCLE#0.6708;GENE EXPRESSION#0.6561;CHAPERONE ACTIVITY#0.6373;RIBOSOMAL RNA#0.6288;CELL WALL#0.6215;SIGNAL TRANSDUCTION#0.6127
1113	ALPHA AMYLASE#1.0738;CATECHOLAMINE SECRETION#1.0345;HISTIDINE DECARBOXYLASE#1.0340;ESSENTIAL HYPERTENSION#1.0339;NULL CELL#1.0304;NEURAL CELL#1.0274;THYROID TRANSCRIPTION FACTOR#1.0263;ISLET CELL TUMOR#1.0262;SMOOTH MUSCLE ACTIN#1.0261;INHIBIN#1.0260;CHRONIC HEART FAILURE#1.0259;REGULATED SECRETORY PATHWAY#1.0259;NEUROFILAMENT#1.0237;CORTISOL#1.0233;HISTIDINE#1.0231;CELL ADHESION MOLECULE#1.0229;INSULIN-LIKE GROWTH FACTOR#1.0221;ESTROGEN RECEPTOR#1.0220;ALKALINE PHOSPHATASE#1.0201;DENSE CORE VESICLE#1.0191;SECRETORY VESICLE#1.0186;HISTAMINE#1.0182;PHOSPHOLIPASE C#1.0167;CHROMAFFIN GRANULE#1.0165;CELL ADHESION#1.0162;ACETIC ACID#1.0152;IRRITABLE BOWEL SYNDROME#1.0151;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0147;SUBSTANCE P#1.0137;SYNAPTIC VESICLE#1.0133;PARATHYROID GLAND#1.0130;PITUITARY ADENOMA#1.0113;ENTEROENDOCRINE CELL#1.0112;INFLAMMATORY BOWEL DISEASE#1.0108;C REACTIVE PROTEIN#1.0107;SECRETORY PATHWAY#1.0105;INSULIN SECRETION#1.0102;ANGIOGENESIS#1.0101;PROGESTERONE#1.0097;MEDULLARY CELL#1.0096;ENTEROCHROMAFFIN CELL#1.0096;NITRIC OXIDE#1.0079;PARATHYROID ADENOMA#1.0079;MECHANISM OF ACTION#1.0079;PARATHYROID HORMONE#1.0073;PROTON PUMP INHIBITOR#1.0070;PARATHYROID#1.0068;SMOOTH MUSCLE#1.0066;SECRETORY GRANULE#1.0064;TUMOR NECROSIS FACTOR#1.0062;CHROMAFFIN CELL#1.0054;GASTRINOMA#1.0054;PROTON PUMP#1.0049;PROSTATE ADENOCARCINOMA#1.0043;EXOCYTOSIS#1.0041;PROTEIN KINASE C#1.0041;DENSE CORE GRANULE#1.0038;NEURITE#1.0035;T CELL#1.0022;MALIGNANT PHEOCHROMOCYTOMA#1.0013;EPINEPHRINE#1.0004;TYPE 1 DIABETES#1.0003;MYOCARDIAL INFARCTION#1.0001;PEPTIDE HORMONE#1.0001;NEGATIVE PREDICTIVE VALUE#1.0000;ENDOTHELIAL CELL#0.9998;BIOTIN#0.9995;SALIVARY GLAND#0.9992;GASTRIC ADENOCARCINOMA#0.9989;LARGE CELL CARCINOMA#0.9989;NOREPINEPHRINE#0.9983;PROSTATE SPECIFIC ANTIGEN#0.9980;ENDOCRINE CELL#0.9979;ADRENAL MEDULLA#0.9974;MAST CELL#0.9969;ACID PHOSPHATASE#0.9962;ARGININE#0.9961;BETA CELL#0.9960;ALZHEIMER'S DISEASE#0.9948;RESPONSE TO GASTRIN#0.9947;CD4+ T CELL#0.9944;B CELL#0.9943;ANDROGEN RECEPTOR#0.9942;GROWTH HORMONE#0.9942;EXCRETION#0.9938;ADRENOCORTICOTROPIC HORMONE#0.9936;PANCREATIC ISLET#0.9935;VESICLE MEMBRANE#0.9929;PERTUSSIS#0.9926;NORADRENALINE#0.9921;ANDROGEN DEPRIVATION THERAPY#0.9919;HYPERTENSION#0.9913;PANCREATIC ENDOCRINE TUMORS#0.9913;INSULINOMA#0.9911;DOPAMINE#0.9906;ADENYLATE CYCLASE#0.9901;PANCREATIC NEUROENDOCRINE TUMOR#0.9897;NEUROBLASTOMA#0.9895;TRANSCRIPTION FACTOR#0.9893;ISCHEMIA#0.9893;MIDGUT#0.9888;DEXAMETHASONE#0.9888;EOSIN#0.9887;ACINAR CELL#0.9881;HORMONE SECRETION#0.9880;PHEOCHROMOCYTOMA#0.9879;TUMOR CELLS#0.9877;ATROPHIC GASTRITIS#0.9872;NEUROENDOCRINE CELL#0.9869;MERKEL CELL#0.9867;NERVE GROWTH FACTOR#0.9866;ACETYLCHOLINE#0.9860;HEPATOCELLULAR CARCINOMA#0.9858;PROTEIN KINASE#0.9858;SECRETORY CELL#0.9857;MACROPHAGE#0.9850;NERVE TERMINAL#0.9848;GOBLET CELL#0.9845;ACID SECRETION#0.9843;LIVER METASTASIS#0.9837;PROSTATE CANCER#0.9831;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9830;RECTUM#0.9829;ENDOTHELIAL GROWTH FACTOR#0.9829;SIGNAL TRANSDUCTION#0.9827;THYROID CARCINOMA#0.9825;COLORECTAL#0.9823;PROSTATE CARCINOMA#0.9822;GASTRIC MUCOSA#0.9821;COLITIS#0.9818;ORGANELLE#0.9812;OMEPRAZOLE#0.9812;ACETYLCHOLINE RECEPTOR#0.9808;PLASMA MEMBRANE#0.9807;SPINAL CORD#0.9806;GROWTH FACTOR RECEPTOR#0.9805;HEART DISEASE#0.9803;LARGE CELL NEUROENDOCRINE CARCINOMA#0.9802;GASTRITIS#0.9802;RECEPTOR ANTAGONIST#0.9800;TYPE 2 DIABETES#0.9798;FORMALIN#0.9795;APOPTOTIC#0.9794;COLORECTAL CARCINOMA#0.9793;LUNG CANCER#0.9790;GROWTH FACTOR#0.9787;DIABETES MELLITUS#0.9787;DIGESTION#0.9782;GI TRACT#0.9780;GANGLION CELLS#0.9778;NEURONAL CELLS#0.9776;RENAL CELL CARCINOMA#0.9776;TRANS GOLGI NETWORK#0.9775;METASTATIC PROSTATE CANCER#0.9772;SMALL INTESTINE#0.9771;GASTRO#0.9769;OBESE#0.9764;CELL GROWTH#0.9762;BREAST CANCER#0.9760;PRIMARY HYPERPARATHYROIDISM#0.9758;NERVOUS SYSTEM#0.9750;CARCINOID SYNDROME#0.9750;MERKEL CELL CARCINOMA#0.9749;COLORECTAL CANCER#0.9743;NERVE FIBER#0.9742;EPIDERMAL GROWTH FACTOR#0.9741;GENE EXPRESSION#0.9740;DUODENUM#0.9737;ADRENAL GLAND#0.9732;CENTRAL NERVOUS SYSTEM#0.9731;CANCER CELL#0.9731;APOPTOSIS#0.9731;ARTERY#0.9730;LUNG CARCINOMA#0.9727;LUMINAL#0.9723;OCTREOTIDE#0.9720;HYPERPARATHYROIDISM#0.9716;PITUITARY GLAND#0.9714;BASAL CELL#0.9713;SMALL CELL CARCINOMA#0.9710;MITOGEN ACTIVATED PROTEIN#0.9708;LYMPH NODE METASTASES#0.9704;PARAGANGLIOMA#0.9701;CYCLIC AMP#0.9699;NEUROENDOCRINE TUMOR#0.9698;POLYMERASE CHAIN REACTION#0.9695;SOMATOSTATIN RECEPTOR#0.9687;LYMPH NODE METASTASIS#0.9682;MULTIPLE ENDOCRINE NEOPLASIA TYPE 1#0.9676;BONE MARROW#0.9671;BREAST CARCINOMA#0.9668;MULTIPLE ENDOCRINE NEOPLASIA#0.9668;REVERSE TRANSCRIPTION#0.9667;BLOOD VESSEL#0.9659;SQUAMOUS CELL CARCINOMA#0.9658;CELL DIFFERENTIATION#0.9657;DIARRHEA#0.9652;LEUKOCYTE#0.9651;GASTROINTESTINAL TRACT#0.9645;CELL PROLIFERATION#0.9641;SIGNALING PATHWAY#0.9641;URINARY BLADDER#0.9640;EPITHELIAL CELL#0.9636;TRYPTOPHAN#0.9635;FIBROBLAST GROWTH FACTOR#0.9632;GALLBLADDER#0.9606;CUSHING'S SYNDROME#0.9604;LOCALISATION#0.9603;PROGENITOR CELL#0.9600;POSITRON EMISSION TOMOGRAPHY#0.9599;CELL CYCLE#0.9595;DUCTAL CELL#0.9595;ADENOCARCINOMA#0.9594;BILE DUCT#0.9586;GROWTH PATTERN#0.9585;ENDOPLASMIC RETICULUM#0.9585;NEUROENDOCRINE CARCINOMA#0.9582;ZOLLINGER-ELLISON SYNDROME#0.9581;CARDIOVASCULAR SYSTEM#0.9581;WORLD HEALTH ORGANIZATION#0.9579;FOLLICLE STIMULATING HORMONE#0.9578;FINE NEEDLE ASPIRATION#0.9571;OVARIAN#0.9569;ABDOMINAL PAIN#0.9569;MAGNETIC RESONANCE IMAGING#0.9569;YEAR SURVIVAL RATE#0.9563;NITRIC OXIDE SYNTHASE#0.9560;AUTOIMMUNE GASTRITIS#0.9555;LYMPH NODE DISSECTION#0.9554;WEIGHT LOSS#0.9544;NICOTINIC ACETYLCHOLINE RECEPTOR#0.9537;GASTRIC ACID SECRETION#0.9536;STEM CELL#0.9531;STROMA#0.9531;CISPLATIN#0.9525;THYROID GLAND#0.9523;SUBMANDIBULAR GLAND#0.9522;CYTOPLASM#0.9521;EVEROLIMUS#0.9506;MICROGLIAL CELL#0.9505;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9504;CERVICAL#0.9503;PARKINSON'S DISEASE#0.9499;ULCERATIVE COLITIS#0.9496;TOXICITY#0.9493;LYMPH NODE#0.9492;PANCREATIC CANCER#0.9484;POSITIVE PREDICTIVE VALUE#0.9482;HYPOGLYCEMIA#0.9469;CELL SURFACE#0.9467;ADENYLATE#0.9467;PARENCHYMA#0.9466;HISTOGENESIS#0.9458;CARBACHOL#0.9449;LARGE INTESTINE#0.9430;CAROTID BODY#0.9403;METHIONINE#0.9391;DEMENTIA#0.9380;MYOCARDIUM#0.9376;CARDIOMYOCYTE#0.9372;MONOCYTE#0.9369;VON HIPPEL LINDAU#0.9367;MEDULLARY CARCINOMA#0.9365;ENDOTHELIUM#0.9358;NEUROECTODERMAL TUMOR#0.9356;NODULAR#0.9356;INNATE IMMUNITY#0.9356;SIGNET RING CELL#0.9355;NEUTROPHIL#0.9351;ADRENALINE#0.9346;ACUTE CORONARY SYNDROME#0.9334;MICROTUBULE#0.9332;GASTRIN RECEPTOR#0.9331;GLUCOSE UPTAKE#0.9330;ADIPOCYTE#0.9326;TUMOR SUPPRESSOR#0.9324;ACUTE MYOCARDIAL INFARCTION#0.9317;TRANSCRIPTASE#0.9315;ESTRADIOL#0.9303;INTERMEDIATE FILAMENT#0.9285;ESOPHAGUS#0.9278;IMMUNE SYSTEM#0.9271;CERVIX#0.9269;CYSTATIN#0.9264;NON-SMALL CELL LUNG CARCINOMA#0.9257;METAPLASIA#0.9256;ENDOCRINE SYSTEM#0.9252;REGIONAL LYMPH NODE#0.9249;GLUCAGON SECRETION#0.9245;PERIPHERAL BLOOD#0.9245;GANGLIONEUROMA#0.9243;INFLAMMATORY RESPONSE#0.9241;BASEMENT MEMBRANE#0.9237;ALPHA 1-ANTITRYPSIN#0.9233;STROMAL CELL#0.9231;ANEMIA#0.9228;CELL MEMBRANE#0.9220;THYROID CANCER#0.9216;FORSKOLIN#0.9208;BRAIN NATRIURETIC PEPTIDE#0.9182;TRANSFORMING GROWTH FACTOR#0.9174;GLYCINE#0.9173;WOUND HEALING#0.9173;JEJUNUM#0.9169;COLUMNAR#0.9165;PROTEOGLYCAN#0.9159;TUMOR TISSUES#0.9159;PANETH CELL#0.9146;AMYLOID PRECURSOR PROTEIN#0.9136;CAMP RESPONSE ELEMENT#0.9135;ETOPOSIDE#0.9116;MEDIAN OVERALL SURVIVAL#0.9086;GASTRIC CORPUS#0.9075;PANCREATITIS#0.9067;LIVER DISEASE#0.9064;SIGNAL PEPTIDE#0.9055;ADVANCED PROSTATE CANCER#0.9050;MEDULLARY THYROID CANCER#0.9030;ADRENAL CORTEX#0.9028;CORONARY ARTERY#0.9014;AXONAL TRANSPORT#0.8984;MICROTUBULE ASSOCIATED PROTEIN#0.8976;HYPOXIA#0.8962;ENDOTHELIAL CELL PROLIFERATION#0.8958;NEURAL CREST#0.8950;ADENOSINE#0.8949;SYNAPTIC VESICLE PROTEIN#0.8935;PHENYLETHANOLAMINE N METHYLTRANSFERASE#0.8930;FLUSHING#0.8927;HEPATOMA CELLS#0.8923;INTESTINAL TRACT#0.8923;VOMITING#0.8920;SWELLING#0.8903;SECRETORY VESICLE MEMBRANE#0.8902;N METHYLTRANSFERASE#0.8881;SUCROSE#0.8877;SODIUM DODECYL SULFATE#0.8845;DODECYL SULFATE#0.8844;GESTATION#0.8840;NERVOUS TISSUE#0.8832;AGGRESSIVE BEHAVIOR#0.8829;PTH SECRETION#0.8828;ANAL CANAL#0.8828;ISLETS OF LANGERHANS#0.8821;L-ARGININE#0.8821;KINASE INHIBITOR#0.8820;MUSCLE CELL#0.8799;POST-TRANSLATIONAL MODIFICATION#0.8799;KINASE ACTIVITY#0.8765;ISLET AMYLOID POLYPEPTIDE#0.8763;PROTEIN SYNTHESIS#0.8762;RESPONSE TO TREATMENT#0.8757;GLUCOSE METABOLISM#0.8749;TESTOSTERONE#0.8744;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8725;HEART RATE VARIABILITY#0.8722;CIRCADIAN RHYTHM#0.8715;DISEASE FREE SURVIVAL#0.8713;ENTEROCYTE#0.8708;SUCCINATE DEHYDROGENASE#0.8699;GUANYLATE CYCLASE#0.8678;HIGH POWER FIELD#0.8671;AGE AT DIAGNOSIS#0.8661;SMOOTH MUSCLE CELL#0.8641;VISUAL ANALOG SCALE#0.8630;COLORECTAL ADENOCARCINOMA#0.8614;PRO-INFLAMMATORY#0.8604;HINDGUT#0.8602;INTESTINAL EPITHELIAL CELL#0.8590;HYPERGLYCEMIA#0.8539;SOMATOSTATIN SECRETION#0.8538;BETA-2#0.8522;TYPE 2 DIABETIC#0.8512;IMMUNE CELL#0.8510;ADIPOSE TISSUE#0.8452;CELL DEATH#0.8429;FACTOR I#0.8426;ALPHA CELL#0.8407;CYCLOPHOSPHAMIDE#0.8401;ISOPROTERENOL#0.8399;MITOCHONDRIAL DEPOLARISATION#0.8390;MITOCHONDRIA#0.8386;CD8+ T CELL#0.8373;SECRETORY GRANULE MEMBRANE#0.8343;LEUCINE#0.8340;AMYOTROPHIC LATERAL SCLEROSIS#0.8333;MAP KINASE#0.8333;LATERAL SCLEROSIS#0.8333;VASODILATOR#0.8331;RESERPINE#0.8314;RHEUMATOID ARTHRITIS#0.8310;ADRENERGIC RECEPTOR#0.8303;EXTRACELLULAR MATRIX#0.8275;PAPILLARY CARCINOMA#0.8263;PANCREATIC CARCINOMA#0.8248;ENHANCED COMPUTED TOMOGRAPHY#0.8239;CREATINE KINASE#0.8234;PP CELL#0.8223;GLYCOSYLATION#0.8217;MEDIAN SURVIVAL TIME#0.8217;QUANTITATIVE REAL TIME#0.8217;DECARBOXYLASE ACTIVITY#0.8207;PARATHYROID CARCINOMA#0.8202;ANTISENSE RNA#0.8195;NECROTIC#0.8179;KIDNEY DISEASE#0.8177;METAIODOBENZYLGUANIDINE#0.8169;MUCOUS#0.8139;NEOPLASTIC DISEASE#0.8127;DUCT CELL#0.8115;GLUCOSE HOMEOSTASIS#0.8112;CIRCULATING TUMOR CELL#0.8109;PERIODONTITIS#0.8109;OVARIAN CARCINOMA#0.8103;GOLGI COMPLEX#0.8096;ROUGH ENDOPLASMIC RETICULUM#0.8081;GOLGI APPARATUS#0.8077;PERIPHERAL NERVOUS SYSTEM#0.8069;PRECURSOR CELL#0.8050;COLON CANCER#0.8025;CRE BINDING#0.8020;SEROTONIN RELEASE#0.8005;CEREBRAL CORTEX#0.7989;PROLACTINOMA#0.7978;STEM CELL MARKER#0.7977;KERATINOCYTE#0.7970;ATHEROSCLEROSIS#0.7951;HEMATURIA#0.7951;BASAL CELL CARCINOMA#0.7947;HEPATIC ARTERY#0.7945;NERVE ENDING#0.7941;CHOLANGIOCARCINOMA#0.7936;CONNECTIVE TISSUE#0.7933;REGENERATION#0.7931;FOREGUT#0.7928;LEFT VENTRICULAR MASS#0.7924;CONSTIPATION#0.7919;FACTOR VIII#0.7910;ADENOSQUAMOUS CARCINOMA#0.7909;MESENCHYMAL CELL#0.7901;CONTROL OF BLOOD PRESSURE#0.7900;CORONARY ARTERY DISEASE#0.7873;ARTERY DISEASE#0.7871;IMMUNE RESPONSE#0.7866;WHITE MATTER LESIONS#0.7858;THYROID NODULE#0.7856;PELVIS#0.7847;HUMAN UMBILICAL VEIN#0.7846;UMBILICAL VEIN#0.7844;BAFILOMYCIN A1#0.7843;FUNCTIONING PITUITARY ADENOMA#0.7837;ACINAR CELL CARCINOMA#0.7832;HISTIDINE DECARBOXYLASE ACTIVITY#0.7821;PROSTATE-SPECIFIC MEMBRANE ANTIGEN#0.7820;MORPHOGENESIS#0.7818;CARCINOMA IN SITU#0.7818;NEUROTOXIC#0.7803;TUBULAR ADENOCARCINOMA#0.7791;DOCETAXEL#0.7790;CONSTITUTIVE SECRETORY PATHWAY#0.7784;PANCREATIC ADENOCARCINOMA#0.7781;HYPERCALCEMIA#0.7760;MOLAR#0.7753;PERNICIOUS ANEMIA#0.7752;CAROTID ARTERY#0.7742;PENTAGASTRIN#0.7738;C TERMINAL DOMAIN#0.7735;MITOSIS#0.7727;SUCCINATE#0.7723;DNA SYNTHESIS#0.7717;PROTEIN KINASE A#0.7707;FATTY LIVER DISEASE#0.7703;GLUTAMIC ACID#0.7689;FATTY LIVER#0.7687;GLOMUS CELL#0.7683;MYELOID RELATED PROTEIN#0.7666;DIGESTIVE TRACT#0.7653;POLY ADP RIBOSE#0.7589;GLIAL CELL#0.7577;STORAGE PROTEIN#0.7550;TIME TO PROGRESSION#0.7541;SIZE EXCLUSION CHROMATOGRAPHY#0.7498;ABIRATERONE#0.7455;DENDRITIC CELL#0.7451;ISCHEMIA REPERFUSION INJURY#0.7437;ACTH SECRETION#0.7433;DISEASE SPECIFIC SURVIVAL#0.7424;FRONTAL#0.7410;MEDIASTINUM#0.7409;L-DOPA#0.7396;CALCIUM CHANNEL#0.7395;CREATINE#0.7391;GTP BINDING#0.7380;GLOMERULAR FILTRATION#0.7302;HEAT SHOCK PROTEIN#0.7292;CYTOCHROME C#0.7284;LONG ACTING RELEASE#0.7283;PERIPHERAL NERVE#0.7280;INNERVATION#0.7279;DOXORUBICIN#0.7269;CILIATED CELL#0.7268;NEUROENDOCRINE CELL DIFFERENTIATION#0.7267;DEXTRAN SULFATE SODIUM#0.7242;CYTOCHROME B#0.7187;TUBE FORMATION#0.7177;LUNG DISEASE#0.7173;MAMMARY GLAND#0.7172;NEURONAL CELL ADHESION#0.7143;PULMONARY NEUROENDOCRINE TUMOR#0.7141;RETINOIC ACID#0.7129;BLOOD GLUCOSE LEVEL#0.7116;RETINOBLASTOMA#0.7113;METASTATIC LYMPH NODE#0.7104;LECTIN#0.7085;LIPID METABOLISM#0.7079;CELL CYCLE ARREST#0.7072;CAUSE SPECIFIC SURVIVAL#0.7067;CATECHOLAMINE SYNTHESIS#0.7062;CORTICOTROPIN#0.7053;STREPTOZOTOCIN#0.7047;TRANSMISSION ELECTRON MICROSCOPY#0.7043;CYTOCHROME B561#0.6997;HYPOTENSION#0.6988;LYSIS#0.6968;RENIN ACTIVITY#0.6922;INDOLE#0.6920;CELL ACTIVATION#0.6914;INTESTINAL STEM CELL#0.6901;T LYMPHOCYTE#0.6884;NEPHROPATHY#0.6884;TRANSITIONAL CELL CARCINOMA#0.6851;LYMPH NODE INVOLVEMENT#0.6843;VITAMIN B12#0.6834;TYROSINE KINASE INHIBITOR#0.6830;DOMINANT NEGATIVE MUTANT#0.6804;GASTRIC GLAND#0.6796;CARDIOMYOPATHY#0.6790;ASTROCYTE#0.6784;BENIGN PROSTATE HYPERPLASIA#0.6767;GLUTAMATE RECEPTOR#0.6751;LASER SCANNING MICROSCOPY#0.6744;AUTOIMMUNE DISEASE#0.6737;SEMINAL VESICLE#0.6732;RESPONSE TO STRESS#0.6708;CLEAVED CASPASE 3#0.6707;PANCREATIC DUCTAL ADENOCARCINOMA#0.6704;GLYCOGEN SYNTHESIS#0.6698;INTESTINAL MUCOSA#0.6697;PORTAL VEIN#0.6697;CALMODULIN BINDING#0.6693;ENUCLEATION#0.6691;5 FLUOROURACIL#0.6678;HYPERSENSITIVITY#0.6677;GESTATIONAL DIABETES#0.6666;PASIREOTIDE#0.6658;GLOMERULAR FILTRATION RATE#0.6656;LYSOSOME#0.6649;MIDDLE EAR#0.6649;RENOVASCULAR HYPERTENSION#0.6648;HYPOTENSIVE#0.6640;SCIATIC NERVE#0.6637;OLFACTORY BULB#0.6631;TERATOMA#0.6628;ENDOTHELIAL NITRIC OXIDE#0.6625;ELECTROPHORETIC MOBILITY SHIFT#0.6625;EPITHELIAL STEM CELL#0.6618;ASCITES#0.6613;ADRENOCORTICAL CARCINOMA#0.6612;MALIGNANT LYMPHOMA#0.6569;UMBILICAL CORD#0.6551;RISK OF DEATH#0.6550;RIBOSOMAL PROTEIN#0.6548;NEUROTOXICITY#0.6544;SOMATOSTATIN ANALOGUE THERAPY#0.6533;GASTRIN I#0.6511;RIBOSE#0.6489;LUMINAL CELL#0.6485;SUNITINIB#0.6485;INHIBITION OF ANGIOGENESIS#0.6478;CALCINEURIN#0.6472;HEMANGIOMA#0.6461;URETHRA#0.6442;INSULIN RECEPTOR#0.6417;COLON CARCINOMA#0.6411;OVARIAN CANCER#0.6400;CROHN'S DISEASE#0.6394;DIED OF DISEASE#0.6386;TYPE 2 DIABETES MELLITUS#0.6377;2 DIABETES MELLITUS#0.6377;HEMORRHAGE#0.6377;HIGH FAT DIET#0.6375;VASCULAR ENDOTHELIAL CELL#0.6373;CATECHOLAMINE BIOSYNTHESIS#0.6363;ADENOHYPOPHYSIS#0.6360;DYSPEPSIA#0.6350;OESOPHAGUS#0.6336;OVAL CELL#0.6326;COLLAGENOUS COLITIS#0.6305;METASTATIC CARCINOMA#0.6304;AMYLASE RELEASE#0.6288;HEARING LOSS#0.6287;CANCER STEM CELL#0.6277;DIURNAL#0.6276;THEOPHYLLINE#0.6272;ADVANCED GASTRIC CANCER#0.6263;BUDDING#0.6262;THYMIDINE#0.6253;ACUTE HEART FAILURE#0.6253;APPENDICITIS#0.6242;VON HIPPEL-LINDAU DISEASE#0.6230;URETER#0.6214;LOCALIZED PROSTATE CANCER#0.6210;TUMOUR NECROSIS FACTOR#0.6197;POSTTRANSLATIONAL MODIFICATION#0.6190;SOLID PSEUDOPAPILLARY NEOPLASM#0.6189;DYSPNEA#0.6187;ANAPLASTIC LYMPHOMA KINASE#0.6185;NUCLEAR CHROMATIN#0.6183;PANCREATIC POLYPEPTIDE CELL#0.6181;CARBOPLATIN#0.6180;ATPASE INHIBITOR#0.6179;INHIBITION OF SECRETION#0.6172;GANGLIOGLIOMA#0.6169;HYPOKALEMIA#0.6167;LASER CAPTURE MICRODISSECTION#0.6166;SEROTONIN SECRETION#0.6164;DNA METHYLATION#0.6144;IRINOTECAN#0.6142;DUCTAL CARCINOMA IN SITU#0.6129;SALIVARY FLOW RATE#0.6124;HEMORRHAGIC#0.6111;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6088;SYSTOLIC BLOOD PRESSURE#0.6083;SCHWANN CELL#0.6080;CORE NEEDLE BIOPSY#0.6075;MITOCHONDRIAL MEMBRANE#0.6074;TRANSDIFFERENTIATION#0.6070;TRANSFORMING GROWTH FACTOR BETA#0.6068;SCLEROSING HEMANGIOMA#0.6037;PLASMINOGEN ACTIVATION#0.6023;EPILEPSY#0.6021;ENDOCYTOSIS#0.6017;GASTRIC EPITHELIAL CELLS#0.6012;CATECHOLAMINE BIOSYNTHETIC#0.6010;ATRIAL CELL#0.6007
11140	HSP90-CDC37 CHAPERONE COMPLEX#1.1559;CHAPERONE COMPLEX#1.0734;CELL DIVISION CYCLE#1.0686;CELL DIVISION#1.0575;HSP90 BINDING#1.0270;CELL CYCLE#1.0229;PROTEIN KINASE#1.0174;SIGNALING PATHWAY#1.0146;CANCER CELL#1.0128;SIGNAL TRANSDUCTION#1.0100;CELL PROLIFERATION#1.0081;KINASE ACTIVITY#1.0054;HEAT SHOCK PROTEIN#1.0035;GELDANAMYCIN#0.9910;CYCLIN DEPENDENT KINASE#0.9862;APOPTOSIS#0.9780;TRANSCRIPTION FACTOR#0.9733;KINASE BINDING#0.9675;BREAST CANCER#0.9560;PROTEASOME#0.9545;ONCOGENIC#0.9527;PROSTATE CANCER#0.9385;ATPASE ACTIVITY#0.9360;PROTEIN PROTEIN INTERACTION#0.9354;GENE EXPRESSION#0.9272;CELL GROWTH#0.9200;COMPLEX I#0.8809;PROTEIN KINASE BINDING#0.8769;CELL CYCLE CONTROL#0.8722;ATP BINDING#0.8713;PROTEIN FOLDING#0.8617;HEPATOCELLULAR CARCINOMA#0.8565;GROWTH FACTOR#0.8447;CHAPERONE ACTIVITY#0.8423;MITOGEN ACTIVATED PROTEIN#0.8286;G1 PHASE#0.8218;CELL CYCLE ARREST#0.8027;GLUCOCORTICOID RECEPTOR#0.7770;KINASE INHIBITOR#0.7628;TUMOR CELLS#0.7589;APOPTOTIC#0.7581;BUDDING#0.7431;C TERMINAL DOMAIN#0.7332;MAP KINASE#0.7252;UBIQUITIN#0.7214;STEROID HORMONE RECEPTOR#0.7158;TOXICITY#0.7003;BREAST CANCER CELL#0.6996;IKK COMPLEX#0.6970;PROTEIN COMPLEX#0.6947;COLON CANCER#0.6724;EPITHELIAL CELL#0.6721;PROTEIN PHOSPHATASE 5#0.6503;CYTOPLASM#0.6488;CASEIN KINASE 2#0.6476;CELL DEATH#0.6472;POST-TRANSLATIONAL MODIFICATION#0.6359;PANCREATIC CANCER#0.6330;PROTEIN KINASE C#0.6325;RNA INTERFERENCE#0.6286;COLORECTAL#0.6244;ATPASE ACTIVATOR#0.6241;REGULATION OF CELLULAR#0.6170;T CELL#0.6137;MULTIPLE MYELOMA#0.6093;ANDROGEN RECEPTOR#0.6089
11141	INTELLECTUAL DISABILITY#1.0774;INTERLEUKIN 1 RECEPTOR#1.0761;MENTAL RETARDATION#1.0552;EXCITATORY SYNAPSE#1.0048;X CHROMOSOME#0.9652;GLYCEROL KINASE#0.9096;AUTISM SPECTRUM DISORDER#0.8999;DENDRITIC SPINE#0.8717;GENE EXPRESSION#0.7967;SIGNALING PATHWAY#0.7944;GLYCEROL KINASE DEFICIENCY#0.7435;T CELL#0.6989;NEURONAL CALCIUM SENSOR#0.6623;TRANS-SYNAPTIC ADHESION#0.6438;TOLL LIKE RECEPTOR#0.6015
11142	PROTEIN KINASE#1.0681;PROTEIN KINASE INHIBITOR#0.9977;KINASE INHIBITOR#0.9864;GENE EXPRESSION#0.7729;HUMAN MESENCHYMAL STEM#0.6547;OSTEOBLAST DIFFERENTIATION#0.6523;OSTEOBLAST#0.6466;MESENCHYMAL STEM CELL#0.6424;STEM CELL#0.6347
11143	HISTONE ACETYLTRANSFERASE BINDING#1.1300;HISTONE ACETYLTRANSFERASE#1.0628;DNA REPLICATION#1.0458;HISTONE ACETYLATION#1.0416;CELL PROLIFERATION#1.0308;LYSINE#1.0067;CANCER CELL#1.0058;CELL CYCLE#1.0005;DNA REPLICATION LICENSING#0.9758;STEM CELL#0.9572;GENE EXPRESSION#0.9557;HISTONE H4 ACETYLATION#0.9003;BREAST CANCER#0.8970;ACETYLTRANSFERASE ACTIVITY#0.8933;TUMOR SUPPRESSOR#0.8867;ORIGIN RECOGNITION COMPLEX#0.8615;TRANSCRIPTION FACTOR#0.8547;HISTONE ACETYL TRANSFERASE#0.8379;EPITHELIAL CELL#0.8206;ESTROGEN RECEPTOR#0.8017;MCM COMPLEX#0.7862;UBIQUITIN#0.7208;COMPLEX I#0.7047;S PHASE#0.6903;ANDROGEN RECEPTOR#0.6866;SIGNALING PATHWAY#0.6335;ONCOGENIC#0.6242;HISTONE ACETYLASE ACTIVITY#0.6188;NUCLEOTIDE EXCISION REPAIR#0.6153;CELL GROWTH#0.6073;EMBRYONIC STEM CELL#0.6030
11144	STRAND INVASION#1.0547;MEIOTIC CHROMOSOME#1.0234;SPERMATOCYTES#1.0188;BUDDING#1.0128;SYNAPTONEMAL COMPLEX#1.0102;MEIOSIS#1.0073;SYNAPSIS#1.0057;PROPHASE#1.0017;DNA BINDING#0.9995;DNA REPAIR#0.9984;GERM CELL#0.9984;DOUBLE-STRAND BREAK REPAIR#0.9893;DOUBLE STRAND BREAK#0.9875;HOMOLOGOUS RECOMBINATION#0.9866;MEIOSIS I#0.9859;PACHYTENE#0.9842;CHROMATID#0.9815;OOCYTE#0.9771;CHROMOSOME SEGREGATION#0.9695;CELL CYCLE#0.9540;RETINOIC ACID#0.9294;GENE EXPRESSION#0.9216;SPERMATOGENESIS#0.9150;ATP HYDROLYSIS#0.8948;ZYGOTENE#0.8893;OVARIAN#0.8857;LEPTOTENE#0.8800;ATP BINDING#0.8706;SPORULATION#0.8668;RECOMBINATIONAL REPAIR#0.8439;ATPASE ACTIVITY#0.8167;OVARIES#0.8098;TRANSCRIPTION FACTOR#0.8088;STERILITY#0.8026;MEIOTIC RECOMBINATION CHECKPOINT#0.7996;REPLICATION PROTEIN A#0.7944;SWI5-SFR1 COMPLEX#0.7722;GONAD#0.7711;INFERTILITY#0.7695;DNA SYNTHESIS#0.7677;MITOSIS#0.7607;APOPTOSIS#0.7495;GAMETOGENESIS#0.7487;RECOMBINASE ACTIVITY#0.7468;DNA TOPOISOMERASE II#0.7399;D-LOOP FORMATION#0.7367;TOPOISOMERASE II#0.7352;SEXUAL REPRODUCTION#0.7331;DNA TOPOISOMERASE#0.7324;PROTEIN COMPLEX#0.7243;TOPOISOMERASE#0.7213;AXIAL ELEMENT#0.7211;SSDNA BINDING#0.7163;STEM CELL#0.7115;CENTROMERE#0.7083;DNA RECOMBINATION#0.6928;SYNAPTONEMAL COMPLEX FORMATION#0.6911;DNA DAMAGE CHECKPOINT#0.6874;METAPHASE#0.6793;FEMALE MEIOSIS#0.6734;MEIOTIC PROPHASE I#0.6709;OOGENESIS#0.6449;OTHER ORGANISM#0.6403;S PHASE#0.6320;PROTEIN PROTEIN INTERACTION#0.6217;DNA REPLICATION#0.6056
11145	TUMOR SUPPRESSOR#1.0913;ADIPOSE TISSUE#1.0321;PHOSPHOLIPASE A#1.0238;PHOSPHOLIPASE A2#1.0063;SIGNALING PATHWAY#0.9376;ARACHIDONIC ACID#0.9115;LIPOLYSIS#0.9080;CANCER CELL#0.8951;CELL DEATH#0.8695;ADIPOCYTE#0.8469;OVARIAN CARCINOMA#0.8350;WHITE ADIPOSE TISSUE#0.7733;CELL MIGRATION#0.7536;APOPTOSIS#0.7526;GENE EXPRESSION#0.7196;PHOSPHOLIPID METABOLISM#0.7193;OVARIAN#0.6480;ANCHORAGE INDEPENDENT GROWTH#0.6274;METASTASIS FREE SURVIVAL#0.6272;LUNG CARCINOMA#0.6224;LIPID METABOLISM#0.6127;GROWTH FACTOR#0.6097
11146	CANCER CELL#0.9160;CANCER ASSOCIATED FIBROBLASTS#0.8994;STEM CELL#0.8933;COLORECTAL#0.8904;STROMA#0.8771;MACROPHAGE#0.8749;SMOOTH MUSCLE#0.8556;SMOOTH MUSCLE ACTIN#0.8297;T CELL#0.8284;FK506 BINDING#0.7984;GROWTH FACTOR#0.7935;APOPTOSIS#0.7808;REGENERATION#0.7737;ADIPOCYTE#0.7313;STROMAL CELL#0.7249;RAPAMYCIN#0.7202;COLORECTAL CANCER#0.7130;SKELETAL MUSCLE#0.7121;GENE EXPRESSION#0.7089;CELL SURFACE#0.6853;FK506 BINDING PROTEIN#0.6726;TUMOR CELLS#0.6552;EXTRACELLULAR MATRIX#0.6392;EPITHELIAL CELL#0.6378;CYTOPLASM#0.6333;BREAST CANCER#0.6046
11148	T CELL#1.0739;IMMUNE CELL#0.8822;PANCREATIC CANCER#0.8051;CD8+ T CELL#0.7956;PANCREATIC DUCTAL ADENOCARCINOMA#0.7207;ADENOCARCINOMA#0.7160;BLADDER UROTHELIAL CARCINOMA#0.6676;CLEAR CELL RENAL CELL CARCINOMA#0.6497;TUMOR TISSUES#0.6425;RENAL CELL CARCINOMA#0.6424;CYTOKINE PRODUCTION#0.6403;T CELL ACTIVATION#0.6355;CELL ACTIVATION#0.6251;T LYMPHOCYTE#0.6232;TUMOR CELLS#0.6221
11149	BLOOD VESSEL#1.1004;TIGHT JUNCTION#1.0644;CELL ADHESION#1.0249;SKELETAL MUSCLE#0.9863;CELL MIGRATION#0.9635;CANCER CELL#0.9357;EPITHELIAL CELL#0.9157;MUSCLE CELL#0.8505;SMOOTH MUSCLE#0.8494;CELL ADHESION MOLECULE#0.8347;BREAST CANCER CELL#0.7859;BREAST CANCER#0.7806;CARDIAC MUSCLE#0.7239;STRIATED MUSCLE#0.7067;CELL SURFACE#0.6999;CARDIOMYOCYTE#0.6726;COLITIS#0.6555;CELL MEMBRANE#0.6310;MUSCULAR DYSTROPHY#0.6190;RETINAL LAMINATION#0.6187;EPITHELIAL MESENCHYMAL TRANSITION#0.6178
1114	DENSE CORE VESICLE#1.0333;CHROMAFFIN GRANULE#1.0239;SECRETORY VESICLE#1.0135;SECRETORY PATHWAY#1.0132;SECRETORY GRANULE#1.0130;ENDOCRINE CELL#1.0124;ADRENAL MEDULLA#1.0091;NEUROENDOCRINE CELL#1.0085;PITUITARY GLAND#1.0058;CHROMAFFIN CELL#1.0053;PHEROMONE RESPONSE#1.0051;TRANS GOLGI NETWORK#0.9971;NEUROENDOCRINE TUMOR#0.9931;PANCREATIC ISLET#0.9902;PHEOCHROMOCYTOMA#0.9885;PITUITARY ADENOMA#0.9877;GROWTH FACTOR#0.9763;PARATHYROID#0.9698;GENE EXPRESSION#0.9679;DENTATE GYRUS#0.9470;ENDOPLASMIC RETICULUM#0.9458;NERVOUS SYSTEM#0.9432;PARATHYROID GLAND#0.9234;REGULATED SECRETORY PATHWAY#0.9206;FORSKOLIN#0.9195;PEPTIDE HORMONE#0.9077;PLASMA MEMBRANE#0.8920;NULL CELL#0.8906;EXOCYTOSIS#0.8770;DOPAMINE#0.8719;SYNAPTIC VESICLE#0.8691;NERVE GROWTH FACTOR#0.8659;NEUROBLASTOMA#0.8630;TRANSCRIPTION FACTOR#0.8601;ALPHA CELL#0.8586;PROTEIN KINASE#0.8499;ORGANELLE#0.8454;STORAGE PROTEIN#0.8415;CONSTITUTIVE SECRETORY PATHWAY#0.8343;CELL SURFACE#0.8308;CENTRAL NERVOUS SYSTEM#0.8267;VESICLE MEMBRANE#0.8179;AMYOTROPHIC LATERAL SCLEROSIS#0.8131;LATERAL SCLEROSIS#0.8131;BETA CELL#0.7983;TUMOR CELLS#0.7956;ALZHEIMER'S DISEASE#0.7792;GROWTH HORMONE#0.7597;SUBSTANCE P#0.7565;POLYMERASE CHAIN REACTION#0.7562;AXONAL TRANSPORT#0.7489;AGE AT ONSET#0.7458;NEURONAL CELLS#0.7446;SUPEROXIDE DISMUTASE#0.7437;NERVOUS TISSUE#0.7374;PROTEOGLYCAN#0.7371;PROTON PUMP INHIBITOR#0.7346;PROTON PUMP#0.7318;CYTOCHROME B#0.7244;SMALL INTESTINE#0.7238;PROLACTINOMA#0.7198;ADRENAL GLAND#0.7171;CALCIUM SIGNALING#0.7148;THYROID CARCINOMA#0.7097;DENSE CORE GRANULE#0.7084;NOREPINEPHRINE#0.7072;CALCIUM CHANNEL#0.7062;CATECHOLAMINE SECRETION#0.6930;MULTIPLE SCLEROSIS#0.6881;PARATHYROID ADENOMA#0.6829;BREAST CARCINOMA#0.6813;HISTAMINE#0.6809;ADENOCARCINOMA#0.6742;EPITHELIAL CELL#0.6729;HEAT SHOCK PROTEIN#0.6716;NEURITE#0.6639;PHEROMONE RECEPTOR#0.6589;INSULINOMA#0.6584;PROTEIN KINASE C#0.6525;SUBSTANTIA NIGRA#0.6503;HYPERTENSION#0.6494;CELL CYCLE#0.6450;SIGNALING PATHWAY#0.6431;LUMINAL#0.6345;NERVE FIBER#0.6334;GOLGI COMPLEX#0.6332;MALIGNANT PHEOCHROMOCYTOMA#0.6329;CYCLIC AMP#0.6311;SIGNAL TRANSDUCTION#0.6215;PANCREATIC NEUROENDOCRINE TUMOR#0.6023;LASER DESORPTION IONIZATION#0.6019
11151	PHAGOSOME#1.0694;ACTIN BINDING PROTEIN#1.0630;ACTIN BINDING#1.0580;T CELL#1.0543;MACROPHAGE#1.0469;PLASMA MEMBRANE#1.0353;PROTEIN KINASE#1.0178;TRYPTOPHAN#1.0137;ACTIN CYTOSKELETON#1.0030;LEUKOCYTE#0.9912;ASPARTATE#0.9893;B CELL#0.9847;LYSOSOME#0.9791;TUBERCULOSIS#0.9701;NAIVE T CELL#0.9622;PHAGOCYTOSIS#0.9608;NEUTROPHIL#0.9347;GENE EXPRESSION#0.9003;PHAGOSOME MATURATION#0.8813;T CELL HOMEOSTASIS#0.8698;APOPTOSIS#0.8494;SEVERE COMBINED IMMUNODEFICIENCY#0.8458;IMMUNE RESPONSE#0.8367;CD4+ T CELL#0.8344;IMMUNE CELL#0.8244;T LYMPHOCYTE#0.8225;SIGNALING PATHWAY#0.8184;FILAMENTOUS ACTIN#0.8084;ACTIN FILAMENT#0.7879;AXON GROWTH#0.7819;CALCINEURIN#0.7814;PROTEIN KINASE C#0.7562;LEUCINE#0.7427;ACTIN POLYMERIZATION#0.7408;CELL MOTILITY#0.6738;PHAGOSOME-LYSOSOME FUSION#0.6699;FILOPODIUM FORMATION#0.6589;INNATE IMMUNITY#0.6416;HEMATOPOIETIC CELL#0.6179;RETINOIC ACID#0.6162;KINASE ACTIVITY#0.6155;ASPARTIC ACID#0.6082;ANTIGEN PROCESSING#0.6073;C TERMINAL DOMAIN#0.6053;PROTEIN KINASE A#0.6036
11152	AUTOPHAGY#1.0550;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION#1.0494;DEVELOPMENTAL DELAY#1.0066;INTELLECTUAL DISABILITY#0.9011;BASAL GANGLIA#0.8994;SUBSTANTIA NIGRA#0.8092;GLOBAL DEVELOPMENTAL DELAY#0.7798;DYSTONIA#0.7596;AUTOPHAGOSOME#0.7304;MAGNETIC RESONANCE IMAGING#0.6944;PHAGOPHORE#0.6781;X CHROMOSOME#0.6719;DEMENTIA#0.6447;WEST SYNDROME#0.6443
11153	ENDOPLASMIC RETICULUM#0.7375;UNFOLDED PROTEIN RESPONSE#0.6958;POST-TRANSLATIONAL MODIFICATION#0.6374;HOST CELL#0.6360
11154	PARAPLEGIA#0.7932;PROTEIN COMPLEX#0.7635;DEVELOPMENTAL DELAY#0.6848
11155	DULOXETINE HYDROCHLORIDE#1.1047;CASPOFUNGIN ACETATE#1.0984;ESCITALOPRAM OXALATE#1.0982;PEGINTERFERON ALFA-2A#1.0890;ROSUVASTATIN CALCIUM#1.0888;Z BAND#1.0805;PEGINTERFERON ALFA-2B#1.0799;DARBEPOETIN ALFA#1.0734;Z LINE#1.0641;Z DISC#1.0628;IMATINIB MESYLATE#1.0608;ERLOTINIB HYDROCHLORIDE#1.0446;ATAZANAVIR SULFATE#1.0446;LIM DOMAIN BINDING#1.0417;PACLITAXEL ELUTING STENT#1.0411;POST MARKETING SURVEILLANCE#1.0410;ADALIMUMAB#1.0325;SIROLIMUS ELUTING STENT#1.0321;SIROLIMUS#1.0314;EVEROLIMUS#1.0306;DULOXETINE#1.0298;PIMECROLIMUS#1.0293;SOLIFENACIN SUCCINATE#1.0292;GEFITINIB#1.0276;PEMETREXED DISODIUM#1.0264;PACLITAXEL#1.0243;FUMARATE#1.0214;MYOFIBRILLAR MYOPATHY#1.0210;DILATED CARDIOMYOPATHY#1.0188;BORTEZOMIB#1.0155;STRIATED MUSCLE#1.0128;TENOFOVIR DISOPROXIL FUMARATE#1.0110;TENOFOVIR DISOPROXIL#1.0107;CICLESONIDE#1.0096;MYOPATHY#1.0077;TIOTROPIUM BROMIDE#1.0044;IMATINIB#1.0041;ADEFOVIR DIPIVOXIL#1.0015;BARE METAL STENT#1.0000;PREGABALIN#0.9999;VARDENAFIL HYDROCHLORIDE#0.9988;CARDIOMYOPATHY#0.9986;TEGASEROD MALEATE#0.9981;FONDAPARINUX SODIUM#0.9974;ESCITALOPRAM#0.9971;Z DISK#0.9963;SKELETAL MUSCLE#0.9949;BEVACIZUMAB#0.9948;HEART DISEASE#0.9945;ARIPIPRAZOLE#0.9944;ALEMTUZUMAB#0.9939;BOSENTAN#0.9929;ACUTE MYOCARDIAL INFARCTION#0.9928;CORONARY HEART DISEASE#0.9920;CASPOFUNGIN#0.9893;ROSUVASTATIN#0.9886;TARGET LESION REVASCULARIZATION#0.9882;CORONARY ARTERY DISEASE#0.9872;ARTERY DISEASE#0.9859;CORONARY ARTERY LESIONS#0.9856;IN STENT RESTENOSIS#0.9852;AMINOLEVULINIC ACID#0.9845;OLMESARTAN MEDOXOMIL#0.9839;EFALIZUMAB#0.9822;TARGET VESSEL REVASCULARIZATION#0.9805;CORONARY ARTERY#0.9799;ARTERY#0.9792;PERCUTANEOUS CORONARY INTERVENTION#0.9772;EZETIMIBE#0.9760;DRUG ELUTING STENT#0.9737;ANAKINRA#0.9655;NESIRITIDE#0.9644;PRASTERONE#0.9628;RAPAMYCIN#0.9628;MYOCARDIAL INFARCTION#0.9622;DIABETES MELLITUS#0.9609;THROMBOSIS#0.9605;CORONARY ARTERY BYPASS#0.9566;CERTOLIZUMAB PEGOL#0.9560;DROTRECOGIN ALFA#0.9555;LEFT ANTERIOR DESCENDING#0.9545;PARATHYROID HORMONE#0.9499;ALEFACEPT#0.9494;LUMINAL#0.9457;DUTASTERIDE#0.9443;RANDOMIZED CONTROLLED TRIAL#0.9432;CETUXIMAB#0.9430;MYCOPHENOLIC ACID#0.9404;TADALAFIL#0.9304;SUNITINIB MALATE#0.9296;CLOPIDOGREL#0.9286;OPTICAL COHERENCE TOMOGRAPHY#0.9267;LUMIRACOXIB#0.9244;SUCCINATE#0.9219;SORAFENIB#0.9210;TENOFOVIR#0.9181;BOTULINUM TOXIN TYPE B#0.9129;ENTECAVIR#0.9097;GENE EXPRESSION#0.9094;OMALIZUMAB#0.9088;BETAMETHASONE DIPROPIONATE#0.9082;PROTEIN KINASE#0.9081;TIOTROPIUM#0.9023;IXABEPILONE#0.8986;ERLOTINIB#0.8981;RUPTURE OF MEMBRANES#0.8909;ETORICOXIB#0.8898;ATAZANAVIR#0.8859;EMTRICITABINE#0.8854;ADEFOVIR#0.8852;SOLIFENACIN#0.8847;NATALIZUMAB#0.8838;DARIFENACIN#0.8827;PEMETREXED#0.8787;VARDENAFIL#0.8649;ATOMOXETINE#0.8625;BREAST CANCER#0.8545;FONDAPARINUX#0.8540;OLMESARTAN#0.8532;ESZOPICLONE#0.8519;ALISKIREN#0.8519;TEGASEROD#0.8461;MYOFIBRIL#0.8459;TIPIFARNIB#0.8378;ERYTHROMYCIN#0.8364;PARATHYROID#0.8360;DESLORATADINE#0.8358;VALDECOXIB#0.8317;PEXELIZUMAB#0.8272;SARCOMERE#0.8245;VORICONAZOLE#0.8234;PITAVASTATIN CALCIUM#0.8169;PRAMLINTIDE ACETATE#0.8169;ELETRIPTAN#0.8093;CORONARY STENT IMPLANTATION#0.8079;MUSCLE WEAKNESS#0.8041;ASPIRIN#0.8027;ESTRADIOL#0.7956;CALCIPOTRIOL#0.7908;APREPITANT#0.7856;SUNITINIB#0.7828;MUSCLE CELL#0.7798;DENOSUMAB#0.7786;PROTEIN KINASE C#0.7731;RIBAVIRIN#0.7702;ACUTE CORONARY SYNDROME#0.7669;DOXORUBICIN#0.7657;SITAXSENTAN#0.7643;MYOCARDIUM#0.7614;INFLAMMATORY RESPONSE#0.7607;CARDIAC MUSCLE#0.7600;BINDING PROTEIN 3#0.7566;BIMATOPROST#0.7556;ERTAPENEM#0.7492;SUPPORT VECTOR MACHINE#0.7487;QUINIDINE SULFATE#0.7466;CARDIOMYOCYTE#0.7449;PARECOXIB#0.7443;POSACONAZOLE#0.7442;PEGFILGRASTIM#0.7405;L-ARGININE HYDROCHLORIDE#0.7383;LEFT VENTRICULAR NONCOMPACTION#0.7353;BETAMETHASONE#0.7351;TREPROSTINIL#0.7335;LENALIDOMIDE#0.7320;AMLODIPINE BESYLATE#0.7309;RITONAVIR#0.7306;QUANTITATIVE CORONARY ANGIOGRAPHY#0.7301;LIDOCAINE#0.7300;LAPATINIB#0.7297;MUSCULAR DYSTROPHY#0.7238;ATORVASTATIN CALCIUM#0.7215;INSULIN DETEMIR#0.7196;CORONARY STENOSIS#0.7174;TERIPARATIDE#0.7142;IBRITUMOMAB#0.7133;ROTIGOTINE#0.7057;INSULIN GLARGINE#0.7026;EPRATUZUMAB#0.7007;MUSCLE FIBER#0.7005;CONIVAPTAN HYDROCHLORIDE#0.6960;TOCILIZUMAB#0.6959;RASAGILINE#0.6896;SIMVASTATIN#0.6886;ABATACEPT#0.6868;LOPINAVIR#0.6859;CINACALCET#0.6840;PRASUGREL#0.6836;L-ARGININE#0.6821;EXENATIDE#0.6815;HYDROCHLOROTHIAZIDE#0.6804;EVENT FREE SURVIVAL#0.6775;VALGANCICLOVIR#0.6757;RANDOMIZED CLINICAL TRIAL#0.6757;FALSE DISCOVERY RATE#0.6751;TELBIVUDINE#0.6702;CALCIUM CHANNEL#0.6672;ANECORTAVE ACETATE#0.6651;INDACATEROL#0.6575;EXTERNAL ELASTIC MEMBRANE#0.6525;TOSITUMOMAB#0.6459;MONTE CARLO SIMULATION#0.6430;PRILOCAINE#0.6424;TEMSIROLIMUS#0.6407;RASBURICASE#0.6393;DEFERASIROX#0.6366;INSULIN ASPART#0.6363;DROSPIRENONE#0.6355;PRAMLINTIDE#0.6343;ENFUVIRTIDE#0.6340;ROFLUMILAST#0.6323;FENRETINIDE#0.6322;PEGVISOMANT#0.6301;ICATIBANT#0.6293;ILIAC ARTERY#0.6283;EPLERENONE#0.6272;PITAVASTATIN#0.6271;RIMONABANT#0.6258;MYOTENDINOUS JUNCTION#0.6254;VORINOSTAT#0.6254;DECITABINE#0.6252;PANITUMUMAB#0.6238;FULVESTRANT#0.6237;AMLODIPINE#0.6224;HYPERTROPHIC CARDIOMYOPATHY#0.6214;MALARIA VACCINE#0.6172;ATORVASTATIN#0.6165;ATHEROSCLEROSIS#0.6139;ZOLEDRONIC ACID#0.6117;ARGININE#0.6095;SUDDEN CARDIAC DEATH#0.6062;ADENOSINE TRIPHOSPHATE#0.6025
11156	COLON CANCER#1.0781;LIVER METASTASIS#1.0703;COLORECTAL CANCER#1.0656;LYMPH NODE METASTASIS#1.0640;BREAST CANCER#1.0565;CELL MIGRATION#1.0559;COLORECTAL#1.0543;LYMPH NODE#1.0502;PROTEIN TYROSINE PHOSPHATASE#1.0470;CELL PROLIFERATION#1.0452;CANCER CELL#1.0391;COLORECTAL CARCINOMA#1.0381;SIGNALING PATHWAY#1.0381;LUNG CANCER#1.0375;PHOSPHATASE ACTIVITY#1.0354;ONCOGENIC#1.0335;TUMOR CELLS#1.0197;LYMPH NODE METASTASES#1.0131;GENE EXPRESSION#1.0030;PHOSPHATASE I#1.0005;GROWTH FACTOR#0.9997;RNA INTERFERENCE#0.9978;UVEAL MELANOMA#0.9964;APOPTOSIS#0.9915;AKT SIGNALING#0.9908;ENDOTHELIAL CELL#0.9881;OVARIAN CANCER#0.9684;CELL MOTILITY#0.9524;OVARIAN#0.9510;PLASMA MEMBRANE#0.9470;METASTATIC LYMPH NODE#0.9443;HEPATOCELLULAR CARCINOMA#0.9418;POLYMERASE CHAIN REACTION#0.9400;CELL ADHESION#0.9297;ANGIOGENESIS#0.9255;STROMAL CELL#0.9254;CELL CYCLE#0.8991;MYELOID LEUKEMIA#0.8984;FOCAL ADHESION#0.8923;DEPHOSPHORYLATION#0.8805;BREAST CANCER CELL#0.8717;3'-PHOSPHATASE ACTIVITY#0.8641;CELL GROWTH#0.8600;EPITHELIAL MESENCHYMAL TRANSITION#0.8432;ADENOCARCINOMA#0.8413;PRENYLATION#0.8309;EPITHELIAL CELL#0.8147;OVERALL SURVIVAL RATE#0.8115;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8075;EXTRACELLULAR MATRIX#0.8074;ENDOTHELIAL GROWTH FACTOR#0.8074;TRANSCRIPTION FACTOR#0.8044;SQUAMOUS CELL CARCINOMA#0.7888;PHOSPHATASE INHIBITOR#0.7850;ACUTE MYELOID LEUKEMIA#0.7775;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7542;PROTEIN SYNTHESIS#0.7282;TUMOR TISSUES#0.6965;BREAST CANCER PATIENTS#0.6956;LYMPH NODE INVOLVEMENT#0.6859;TUMOR SUPPRESSOR#0.6804;CELL MEMBRANE#0.6741;CATALYTIC ACTIVITY#0.6554;MULTIPLE MYELOMA#0.6363;DISEASE FREE SURVIVAL#0.6316;T CELL#0.6243;MACROPHAGE#0.6232;CYTOPLASM#0.6152;BREAST CARCINOMA#0.6123;ADVANCED GASTRIC CANCER#0.6101;COLORECTAL ADENOMA#0.6094;TUMOR ASSOCIATED MACROPHAGE#0.6060;DUAL SPECIFICITY PHOSPHATASE#0.6054;INVASIVE BREAST CANCER#0.6035;RECURRENCE FREE SURVIVAL#0.6028;COLON CARCINOMA#0.6003
11158	MALE INFERTILITY#0.6353
11160	ENDOPLASMIC RETICULUM#1.0452;LIPID RAFT#1.0260;BREAST CANCER#0.9952;BREAST CANCER CELL#0.9671;CANCER CELL#0.9619;HUMAN BREAST CANCER#0.9407;ER MEMBRANE#0.9390;PARAPLEGIA#0.9176;HEREDITARY SPASTIC PARAPLEGIA#0.9100;CELL GROWTH#0.7693;RNA INTERFERENCE#0.7339;PHOSPHATIDYLINOSITOL 3-PHOSPHATE BINDING#0.6536;CYTOSOLIC LIPID DROPLETS#0.6239;CELL PROLIFERATION#0.6173
11161	ERGOSTEROL#0.9049;ERGOSTEROL BIOSYNTHESIS#0.7219;STEROL SYNTHESIS#0.6688;POLAR AUXIN TRANSPORT#0.6433;AUXIN TRANSPORT#0.6265
11162	FIBROBLAST GROWTH FACTOR#1.0609;GROWTH FACTOR#1.0598;ANTISENSE RNA#0.9965;CELL CYCLE#0.9613;CELL PROLIFERATION#0.7691;ESOPHAGEAL CANCER#0.7169;S PHASE#0.6308
11164	RIBOSE#1.0704;BREAST CANCER#0.8857;BREAST CANCER CELL#0.8325;CANCER CELL#0.8269;DIPHOSPHATE#0.7739;GUANINE#0.6849;2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE#0.6591;RIBOSE-5-PHOSPHATE#0.6083
11166	STEM CELL#0.9484;TRANSCRIPTION FACTOR#0.9063;PROGENITOR CELL#0.8773;CELL DIFFERENTIATION#0.8330;NEUROGENESIS#0.7515;ANTISENSE RNA#0.7275;NERVOUS SYSTEM#0.7204;INNER EAR#0.7117;GENE EXPRESSION#0.6497;HAIR CELL#0.6325
11167	CANCER CELL#1.0550;ENDOTHELIAL CELL#1.0473;RHEUMATOID ARTHRITIS#1.0435;APOPTOSIS#1.0402;CELL PROLIFERATION#1.0335;SIGNALING PATHWAY#1.0284;GROWTH FACTOR#1.0268;MACROPHAGE#1.0245;PRO-INFLAMMATORY#1.0241;MUSCLE CELL#1.0222;EPITHELIAL CELL#1.0222;LUNG CANCER#1.0215;GENE EXPRESSION#1.0157;TRANSFORMING GROWTH FACTOR#1.0154;LUNG DEVELOPMENT#1.0150;PROTEIN KINASE#1.0129;SMOOTH MUSCLE#1.0098;MYOCARDIAL INFARCTION#1.0082;STEM CELL#1.0001;INFLAMMATORY RESPONSE#0.9996;BONE MORPHOGENETIC PROTEIN#0.9964;BREAST CANCER#0.9905;TOLL LIKE RECEPTOR#0.9876;CARDIOMYOCYTE#0.9811;SKELETAL MUSCLE#0.9811;MONOCYTE#0.9806;TUMOR NECROSIS FACTOR#0.9762;IMMUNE RESPONSE#0.9751;BONE MARROW#0.9712;MYOCYTES#0.9644;HYPOXIA#0.9586;SYNOVIAL FLUID#0.9559;CELL CYCLE#0.9414;MESENCHYMAL STEM CELL#0.9393;CYTOKINE PRODUCTION#0.9329;CELL MIGRATION#0.9325;TRANSCRIPTION FACTOR#0.9304;BREAST CANCER CELL#0.9197;CORONARY ARTERY#0.9157;SMOOTH MUSCLE CELL#0.9092;EXTRACELLULAR MATRIX#0.9090;ISCHEMIA REPERFUSION INJURY#0.9082;T CELL#0.8997;ARTERY#0.8956;ISCHEMIA#0.8804;INNATE IMMUNE RESPONSE#0.8803;ADIPOCYTE#0.8790;CHONDROCYTE#0.8789;TRANSFORMING GROWTH FACTOR BETA#0.8777;PERIPHERAL BLOOD#0.8741;COLLAGEN INDUCED ARTHRITIS#0.8648;MYOMETRIUM#0.8586;CELL GROWTH#0.8569;NEUTROPHIL#0.8427;SIGNALLING PATHWAY#0.8402;DENDRITIC CELL#0.8361;FIBROBLAST LIKE SYNOVIOCYTES#0.8170;TUMOR SUPPRESSOR#0.8134;POLYMERASE CHAIN REACTION#0.8106;LUNG FIBROBLASTS#0.8083;PULMONARY FIBROSIS#0.8073;ACUTE CORONARY SYNDROME#0.8063;AMNION#0.8055;WOUND HEALING#0.8044;OSTEOARTHRITIS#0.8025;SKELETAL MUSCLE CELLS#0.7995;ASTROCYTE#0.7990;CELL SURFACE#0.7987;MONONUCLEAR CELLS#0.7972;SQUAMOUS CELL CARCINOMA#0.7857;APOPTOTIC#0.7810;MITOGEN ACTIVATED PROTEIN#0.7802;NERVOUS SYSTEM#0.7649;CELL DEATH#0.7645;MYOFIBROBLAST#0.7574;KERATINOCYTE#0.7532;MAPK SIGNALING#0.7530;HEPATIC STELLATE CELL#0.7481;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7445;REVERSE TRANSCRIPTION#0.7431;ADIPOSE TISSUE#0.7291;STROMAL CELL#0.7284;LEUKOCYTE#0.7252;MYOCARDIUM#0.7245;PROSTATE CANCER#0.7230;CELL ACTIVATION#0.7091;RELATED PROTEIN 1#0.6990;CARDIOMYOCYTE PROLIFERATION#0.6977;URETER DEVELOPMENT#0.6916;IMMUNE CELL#0.6905;IL-1 PRODUCTION#0.6879;TUMOR CELLS#0.6874;ANOREXIA#0.6861;IMMUNE DYSFUNCTION#0.6841;CENTRAL NERVOUS SYSTEM#0.6803;CHRONIC HEART FAILURE#0.6798;AKT SIGNALING#0.6788;C REACTIVE PROTEIN#0.6729;VASCULAR SMOOTH MUSCLE CELL#0.6727;NITRIC OXIDE#0.6718;OVARIAN CANCER#0.6709;REGENERATION#0.6708;ANGIOGENESIS#0.6660;PHAGOCYTOSIS#0.6528;PREADIPOCYTE#0.6340;BLEOMYCIN#0.6335;ERYTHROCYTE SEDIMENTATION RATE#0.6311;PATTERN RECOGNITION RECEPTOR#0.6233;INNATE IMMUNITY#0.6194;HEPATIC STELLATE CELL ACTIVATION#0.6176;ALVEOLAR EPITHELIAL CELL#0.6157;KERATINOCYTE MIGRATION#0.6110;LEFT VENTRICULAR REMODELING#0.6103;TUMOR TISSUES#0.6093;JOINT DAMAGE#0.6079;FIBROBLAST ACTIVATION#0.6072;JUVENILE IDIOPATHIC ARTHRITIS#0.6063;SMOOTH MUSCLE CELL PROLIFERATION#0.6025;MUSCLE CELL PROLIFERATION#0.6020
11168	INTEGRASE BINDING DOMAIN#1.1091;NEUROTROPHIN RECEPTOR#1.0816;CHROMATIN BINDING#1.0740;DNA INTEGRATION#1.0570;NERVE GROWTH FACTOR#1.0446;PROSTATE CANCER#1.0418;GROWTH FACTOR RECEPTOR#1.0381;GROWTH FACTOR#1.0361;CELL DEATH#1.0335;RHEUMATIC DISEASE#1.0335;AUTOIMMUNE DISEASE#1.0234;PROTEIN PROTEIN INTERACTION#1.0225;EPITHELIAL CELL#1.0214;DNA BINDING#1.0196;CANCER CELL#1.0185;HEAT SHOCK PROTEIN#1.0155;HUMAN IMMUNODEFICIENCY VIRUS#1.0146;VIRAL REPLICATION#1.0091;APOPTOSIS#1.0071;STEM CELL#1.0068;T CELL#1.0041;TRANSCRIPTION FACTOR#1.0030;HOST CELL#0.9960;AUTOIMMUNE RHEUMATIC DISEASES#0.9951;GENE EXPRESSION#0.9895;NUCLEAR IMPORT#0.9863;REVERSE TRANSCRIPTION#0.9792;MECHANISM OF ACTION#0.9763;CATALYTIC ACTIVITY#0.9594;CELL CYCLE#0.9381;PRE-INTEGRATION COMPLEX#0.9150;RETINAL DEGENERATION#0.9127;SCHWANN CELL#0.9047;MYELOID LEUKEMIA#0.8998;NUCLEAR LOCALIZATION SIGNAL#0.8979;SYSTEMIC AUTOIMMUNE DISEASE#0.8940;RNA INTERFERENCE#0.8916;CYTOPLASM#0.8915;MOLECULAR DYNAMICS SIMULATION#0.8875;CONNECTIVE TISSUE#0.8822;MIXED LINEAGE LEUKEMIA#0.8806;CONNECTIVE TISSUE DISEASE#0.8760;PHOTORECEPTOR CELL#0.8724;TRANSACTIVATION#0.8695;APOPTOTIC#0.8568;POLYMERASE CHAIN REACTION#0.8468;LYSINE#0.8468;VIRUS MATURATION#0.8442;KERATINOCYTE#0.8400;NERVOUS SYSTEM#0.8369;FACTOR I#0.8327;PROTEIN KINASE#0.8279;B CELL#0.8218;AUTOIMMUNITY#0.8178;CD4+ T CELL#0.8125;STRUCTURE ACTIVITY RELATIONSHIP#0.8019;BASAL CELL#0.8002;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7991;TUMOR SUPPRESSOR#0.7971;C TERMINAL DOMAIN#0.7876;ATOPIC DERMATITIS#0.7873;HOST CHROMOSOME#0.7862;VIRION#0.7810;BREAST CANCER#0.7804;CELL PROLIFERATION#0.7728;ACUTE MYELOID LEUKEMIA#0.7705;CELL GROWTH#0.7659;PROGENITOR CELL#0.7623;TRANSCRIPTION COACTIVATOR#0.7620;SIGNALING PATHWAY#0.7565;OLFACTORY EPITHELIUM#0.7468;MRNA SPLICING#0.7441;RHEUMATOID ARTHRITIS#0.7412;PERIPHERAL BLOOD#0.7407;DNA REPAIR#0.7406;HOMOLOGOUS RECOMBINATION#0.7398;IBUPROFEN#0.7383;TRANSCRIPTASE#0.7304;ACETIC ACID#0.7253;MUTAGENESIS#0.7223;PROTEIN COMPLEX#0.7213;IMMUNE RESPONSE#0.7205;RALTEGRAVIR#0.7112;GLIAL CELL#0.6962;DRUG RESISTANCE#0.6927;NUCLEAR PERIPHERY#0.6918;REGENERATION#0.6882;HAIR FOLLICLE#0.6775;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6769;LUPUS ERYTHEMATOSUS#0.6767;NEURAL CREST#0.6756;SPINAL CORD#0.6698;ALKALINE PHOSPHATASE#0.6687;COMPLEX I#0.6531;DERMATITIS#0.6528;GAP JUNCTION ACTIVITY#0.6475;SUMOYLATION#0.6397;HAIR CELL#0.6288;B LYMPHOCYTE#0.6272;CENTRAL NERVOUS SYSTEM#0.6256;NUCLEOSOME#0.6233;CELL SURFACE#0.6146;IL-2 BINDING#0.6136;RNA SPLICING#0.6121;MORPHOGENESIS#0.6120;SWI-SNF COMPLEX#0.6085;RESONANCE ENERGY TRANSFER#0.6069;NEUROGENESIS#0.6056;GAP JUNCTION#0.6050
11169	REPLISOME#1.0819;SISTER CHROMATID COHESION#1.0702;CHROMATID#1.0557;DNA POLYMERASE ALPHA#1.0406;REPLICATION FORK#1.0348;DNA BINDING#1.0220;S PHASE#1.0186;DNA REPLICATION#1.0124;CELL CYCLE#0.9836;DNA SYNTHESIS#0.9023;TRANSCRIPTION FACTOR#0.8083;DNA HELICASE#0.8041;CANCER CELL#0.7807;MITOSIS#0.7758;BINDING PROTEIN 1#0.7756;CHROMOSOME TRANSMISSION#0.7745;CMG COMPLEX#0.7486;HOMOLOGOUS RECOMBINATION#0.7401;HELICASE ACTIVITY#0.7030;GINS COMPLEX#0.7014;DNA DAMAGE CHECKPOINT#0.6970;DOUBLE STRAND BREAK#0.6889;BUDDING#0.6728;CHROMOSOME SEGREGATION#0.6683;CENTROMERE#0.6438;DNA METABOLISM#0.6273;CELL DIVISION#0.6200;COHESIN COMPLEX#0.6191
1116	ENDOMETRIAL CANCER#1.0750;PANCREATIC CANCER#1.0747;COLONIC EPITHELIAL CELLS#1.0725;HYALURONIC ACID#1.0664;LYMPH NODE#1.0596;SLEEP APNEA#1.0548;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0541;PNEUMONIA#1.0529;ATRIAL FIBRILLATION#1.0491;OVARIAN CANCER#1.0482;SPUTUM#1.0471;NEUROFILAMENT#1.0467;CORONARY ARTERY DISEASE#1.0462;OBSTRUCTIVE SLEEP APNEA#1.0446;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0446;ARTERY DISEASE#1.0434;ENDOTHELIAL GROWTH FACTOR#1.0408;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0408;COLON CANCER#1.0405;DIABETES MELLITUS#1.0399;ENDOTHELIAL CELL#1.0395;OVARIAN#1.0384;ASTROCYTE#1.0379;LUNG CANCER#1.0368;COLORECTAL CANCER#1.0354;CANCER CELL#1.0354;TISSUE REMODELING#1.0354;MYOCARDIAL INFARCTION#1.0350;SYNOVIAL FLUID#1.0342;NEUTROPHIL#1.0342;LUNG DISEASE#1.0341;TYPE 2 DIABETES#1.0338;BREAST CANCER#1.0331;COLORECTAL#1.0327;ATHEROSCLEROSIS#1.0325;CONNECTIVE TISSUE#1.0309;C REACTIVE PROTEIN#1.0298;CHITIN BINDING#1.0293;PSORIASIS#1.0287;MACROPHAGE ACTIVATION#1.0284;CORONARY ARTERY#1.0283;HYPERTENSION#1.0269;CHONDROCYTE#1.0266;CELL PROLIFERATION#1.0265;CHITINASE ACTIVITY#1.0261;MUSCLE CELL#1.0255;HEART DISEASE#1.0253;TUMOR NECROSIS FACTOR#1.0246;ANGIOGENESIS#1.0245;EXTRACELLULAR MATRIX#1.0243;PRO-INFLAMMATORY#1.0239;COLITIS#1.0230;ARTERY#1.0230;MONOCYTE#1.0225;PROSTATE CANCER#1.0224;ATHEROSCLEROTIC#1.0213;EPITHELIAL CELL#1.0207;TYPE 2 DIABETIC#1.0206;SMOOTH MUSCLE CELL#1.0200;MACROPHAGE#1.0199;GROWTH FACTOR#1.0193;SMOOTH MUSCLE#1.0183;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#1.0177;TYPE 2 DIABETES MELLITUS#1.0162;2 DIABETES MELLITUS#1.0161;TUMOR CELLS#1.0153;T CELL#1.0138;POLYMERASE CHAIN REACTION#1.0136;PERIPHERAL BLOOD#1.0123;LIVER DISEASE#1.0119;ADIPOSE TISSUE#1.0114;TRANSFORMING GROWTH FACTOR#1.0096;HEPATITIS C#1.0081;RHEUMATOID ARTHRITIS#1.0080;SIGNALING PATHWAY#1.0072;DEMENTIA#1.0059;INFLAMMATORY BOWEL DISEASE#1.0052;MONONUCLEAR CELLS#1.0049;APOPTOSIS#1.0043;NITRIC OXIDE#1.0043;OBESE#1.0037;MULTIPLE SCLEROSIS#1.0023;INSULIN-LIKE GROWTH FACTOR#1.0016;OSTEOARTHRITIS#0.9976;STEM CELL#0.9937;MILD COGNITIVE IMPAIRMENT#0.9931;AMYLOID PRECURSOR PROTEIN#0.9923;IMMUNE RESPONSE#0.9898;ALZHEIMER'S DISEASE#0.9890;CERVICAL CANCER#0.9860;SQUAMOUS CELL CARCINOMA#0.9847;FIBROBLAST GROWTH FACTOR#0.9828;ASTROCYTOMA#0.9819;CLINICALLY ISOLATED SYNDROME#0.9805;INFLAMMATORY CELL#0.9793;INFLAMMATORY RESPONSE#0.9789;GENE EXPRESSION#0.9761;MARKERS OF INFLAMMATION#0.9739;QUANTITATIVE REAL TIME#0.9726;CENTRAL NERVOUS SYSTEM#0.9720;NERVOUS SYSTEM#0.9720;HEPATITIS C VIRUS#0.9712;PROTEIN KINASE#0.9699;TUMOUR NECROSIS FACTOR#0.9690;PULMONARY FIBROSIS#0.9667;HEPATOCELLULAR CARCINOMA#0.9656;NEURODEGENERATIVE DISEASE#0.9608;SLEEP APNEA SYNDROME#0.9577;LINEAR REGRESSION ANALYSIS#0.9574;OSTEOARTHRITIC CARTILAGE#0.9566;CROHN'S DISEASE#0.9541;ALKALINE PHOSPHATASE#0.9527;MULTIPLE MYELOMA#0.9513;DISEASE FREE SURVIVAL#0.9486;MITOGEN ACTIVATED PROTEIN#0.9485;MAGNETIC RESONANCE IMAGING#0.9474;CELL DEATH#0.9457;ASPARTATE#0.9441;ALLERGIC RHINITIS#0.9436;SYNOVIUM#0.9433;ISCHEMIC HEART DISEASE#0.9430;ULCERATIVE COLITIS#0.9417;GLIOBLASTOMA MULTIFORME#0.9404;VASCULAR SMOOTH MUSCLE CELL#0.9404;CYSTIC FIBROSIS#0.9382;TYPE 1 DIABETES#0.9365;SKELETAL MUSCLE#0.9363;IMMUNE CELL#0.9349;EOSINOPHIL#0.9316;ALLERGEN#0.9287;BREAST CARCINOMA#0.9285;INNATE IMMUNE RESPONSE#0.9284;INTERSTITIAL LUNG DISEASE#0.9279;CELL MIGRATION#0.9267;GROWTH FACTOR RECEPTOR#0.9233;WHITE BLOOD CELL#0.9212;LEUKOCYTE#0.9209;EPITHELIAL OVARIAN CANCER#0.9202;HEALTHY CONTROL SUBJECTS#0.9183;CHRONIC HEPATITIS C#0.9180;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9169;NEOPTERIN#0.9142;LIVER CIRRHOSIS#0.9137;LATERAL SCLEROSIS#0.9135;HEPARIN#0.9125;ERYTHROCYTE SEDIMENTATION RATE#0.9118;FRONTOTEMPORAL DEMENTIA#0.9114;LYMPH NODE METASTASIS#0.9084;CYTOKINE PRODUCTION#0.9046;M2 MACROPHAGE#0.9041;CELL DIFFERENTIATION#0.9037;KIDNEY INJURY MOLECULE#0.9032;AIRWAY EPITHELIAL CELL#0.9016;DENDRITIC CELL#0.9001;CERVICAL#0.8995;ACUTE MYOCARDIAL INFARCTION#0.8992;HEPATITIS B#0.8948;CELL ADHESION#0.8913;ERYTHROCYTE#0.8909;RETINOL BINDING#0.8883;DISEASE ACTIVITY SCORE#0.8882;KNEE JOINT#0.8863;ACUTE KIDNEY INJURY#0.8858;PSORIATIC ARTHRITIS#0.8840;SIGNALLING PATHWAY#0.8832;GESTATIONAL DIABETES#0.8829;ISCHEMIA#0.8824;LOW DENSITY LIPOPROTEIN#0.8823;HIGH DENSITY LIPOPROTEIN#0.8815;SERUM ALBUMIN#0.8802;AMYOTROPHIC LATERAL SCLEROSIS#0.8791;SYSTOLIC BLOOD PRESSURE#0.8786;BRONCHIAL EPITHELIAL CELLS#0.8779;RNA INTERFERENCE#0.8730;TYPE III PROCOLLAGEN#0.8726;SIGNALING CASCADE#0.8702;EARLY RHEUMATOID ARTHRITIS#0.8692;BREAST CANCER PATIENTS#0.8691;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8689;REVERSE TRANSCRIPTION#0.8682;CELL CYCLE#0.8663;ALBUMIN CREATININE RATIO#0.8609;CHRONIC LIVER DISEASE#0.8607;GLOMERULAR FILTRATION#0.8585;EPIDERMAL GROWTH FACTOR#0.8577;PARKINSON'S DISEASE#0.8543;FATTY LIVER#0.8522;MATRIX METALLOPROTEINASE 1#0.8494;GLOMERULAR FILTRATION RATE#0.8473;TUBE FORMATION#0.8446;COMMUNITY ACQUIRED PNEUMONIA#0.8430;BONE MARROW#0.8428;INTESTINAL EPITHELIAL CELL#0.8422;PRIMARY BREAST CANCER#0.8398;PERSISTENT ALLERGIC RHINITIS#0.8391;WEIGHT LOSS#0.8379;CYTOPLASM#0.8379;PROGENITOR CELL#0.8371;HUMAN BRONCHIAL EPITHELIAL#0.8365;IDIOPATHIC PULMONARY FIBROSIS#0.8365;ADJUSTED HAZARD RATIO#0.8362;TRANSFORMING GROWTH FACTOR BETA#0.8335;ESSENTIAL HYPERTENSION#0.8317;SARCOIDOSIS#0.8294;TRANSCRIPTION FACTOR#0.8290;CORONARY HEART DISEASE#0.8290;RHINITIS#0.8262;IMMUNE SYSTEM#0.8260;B CELL#0.8245;KIDNEY DISEASE#0.8220;OSTEOBLAST#0.8216;FIBRINOGEN#0.8195;VASCULAR DISEASE#0.8184;FORCED EXPIRATORY VOLUME#0.8152;BEVACIZUMAB#0.8126;ENDOTHELIUM#0.8102;METASTATIC BREAST CANCER#0.8093;SPECIFIC GRANULE#0.8088;INNATE IMMUNITY#0.8082;AKT SIGNALING#0.8073;ALANINE#0.8064;CELL GROWTH#0.8055;ADENOCARCINOMA#0.8053;COLLAGEN TYPE I#0.8019;IL-1RA#0.8016;HEPARIN BINDING#0.8012;TUMOR ASSOCIATED MACROPHAGE#0.8011;SYNOVITIS#0.8007;SELECTIN#0.8004;TUMOR TISSUES#0.7972;EXHALED NITRIC OXIDE#0.7955;CHRONIC HEPATITIS B#0.7952;BLOOD VESSEL#0.7946;CD4+ T CELL#0.7917;LUNG METASTASIS#0.7842;ANKYLOSING SPONDYLITIS#0.7839;NEPHROPATHY#0.7833;URIC ACID#0.7785;ESTROGEN RECEPTOR#0.7774;NORMAL GLUCOSE TOLERANCE#0.7745;PROTEOGLYCAN#0.7715;LECTIN#0.7709;MYOCARDIUM#0.7680;GROWTH FACTOR BINDING#0.7674;EPICARDIAL ADIPOSE TISSUE#0.7672;MURAL CELL#0.7639;CHRONIC KIDNEY DISEASE#0.7629;MONOCYTE DERIVED MACROPHAGE#0.7629;BREAST CANCER CELL#0.7613;APNEA HYPOPNEA INDEX#0.7557;STROMAL CELL#0.7557;PROTEIN KINASE B#0.7525;HEMATOPOIETIC CELL TRANSPLANTATION#0.7521;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7504;LUPUS ERYTHEMATOSUS#0.7502;PLATELET-DERIVED GROWTH FACTOR#0.7502;PERIPHERAL ARTERIAL DISEASE#0.7492;SPINAL CORD#0.7471;LUNG FIBROBLASTS#0.7452;RETINOL#0.7451;SERUM AMYLOID A#0.7448;COLLAGEN TYPE II#0.7430;GESTATIONAL DIABETES MELLITUS#0.7427;TISSUE DAMAGE#0.7419;DIABETIC RETINOPATHY#0.7419;PRION DISEASE#0.7409;TH1 CELL#0.7393;POLYCYSTIC OVARY SYNDROME#0.7392;CARDIOVASCULAR RISK FACTOR#0.7381;BETA-2#0.7369;CYSTATIN#0.7362;OVARIAN CARCINOMA#0.7348;MAPK SIGNALING#0.7338;HEMATOPOIETIC CELL#0.7331;BONE RESORPTION#0.7316;MALIGNANT GLIOMA#0.7269;APOPTOTIC#0.7268;MAMMARY GLAND#0.7233;ACUTE ISCHEMIC STROKE#0.7226;CEREBROVASCULAR DISEASE#0.7220;ADJUSTED ODDS RATIO#0.7214;AUTOIMMUNE DISEASE#0.7201;PLASMA PROTEIN#0.7179;CANCER STEM CELL#0.7166;ENDOMETRIOSIS#0.7111;MULTIVARIATE LINEAR REGRESSION#0.7088;SPONDYLITIS#0.7083;ANAL CARCINOMA#0.7081;DEHYDROASCORBIC ACID#0.7068;DISABILITY STATUS SCALE#0.7049;GALECTIN#0.7034;DIABETIC NEPHROPATHY#0.7022;PROGRESSIVE SUPRANUCLEAR PALSY#0.7020;TRANSCRIPTASE#0.7004;VASCULAR ENDOTHELIAL CELL#0.6996;PROGESTERONE#0.6996;VASCULAR CELL#0.6996;CELL ADHESION MOLECULE#0.6972;HEAT SHOCK PROTEIN#0.6966;STROMA#0.6910;FACTOR I#0.6902;PERIODONTITIS#0.6874;TRAUMATIC BRAIN INJURY#0.6850;NEUROLOGICAL DISORDER#0.6846;COGNITION#0.6837;GLIAL CELL#0.6831;PERCUTANEOUS CORONARY INTERVENTION#0.6790;HUMAN AIRWAY EPITHELIAL#0.6789;OSTEOCLAST#0.6781;IFN-GAMMA#0.6777;FORCED VITAL CAPACITY#0.6770;ALVEOLAR MACROPHAGE#0.6768;MACROPHAGE POLARIZATION#0.6764;CELL SURFACE#0.6763;HYALURONAN#0.6744;FATTY LIVER DISEASE#0.6737;GINGIVAL CREVICULAR FLUID#0.6736;BONE FORMATION#0.6736;MESENCHYMAL STEM CELL#0.6729;CHRONIC HEART FAILURE#0.6722;FATTY ACID BINDING#0.6710;LYMPH NODE METASTASES#0.6706;ONCOGENIC#0.6697;PHOSPHOLIPASE A2#0.6685;PROSTATE CARCINOMA#0.6682;C-LEVEL#0.6681;ADENOSINE DEAMINASE#0.6677;SIGNAL TRANSDUCER#0.6671;FASTING PLASMA GLUCOSE#0.6653;GM-CSF#0.6652;HUMAN ARTICULAR CHONDROCYTES#0.6636;OLIGODENDROGLIOMA#0.6531;EPITHELIAL MESENCHYMAL TRANSITION#0.6487;METHOTREXATE#0.6469;PREDNISOLONE#0.6465;GLUCOSE TOLERANCE TEST#0.6456;WOUND HEALING#0.6427;HEMORRHAGE#0.6421;TEMOZOLOMIDE#0.6358;INTERVERTEBRAL DISC#0.6297;INTIMA MEDIA THICKNESS#0.6293;DEXAMETHASONE#0.6293;AREA UNDER CURVE#0.6283;DERMATOMYOSITIS#0.6274;HEALTHY CONTROL GROUP#0.6264;GRANULOCYTE#0.6262;ACUTE CORONARY SYNDROME#0.6247;RECURRENCE FREE SURVIVAL#0.6238;PLASMA CELL#0.6233;VASCULAR DEMENTIA#0.6229;MULTIPLE LINEAR REGRESSION#0.6228;ANAPLASTIC OLIGODENDROGLIOMA#0.6212;RESVERATROL#0.6196;ADIPOCYTE#0.6178;MALARIA#0.6174;FRONTAL#0.6165;PROTEINURIA#0.6157;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6139;HYPOXIA#0.6136;EPITHELIAL OVARIAN CARCINOMA#0.6121;CELL ACTIVATION#0.6120;RECEPTOR ANTAGONIST#0.6104;ALCOHOLIC LIVER CIRRHOSIS#0.6086;COLITIS ASSOCIATED CANCER#0.6074;UTERINE CERVICAL CANCER#0.6068;SIMIAN IMMUNODEFICIENCY VIRUS#0.6055;ADVANCED BREAST CANCER#0.6036;ARGININE#0.6034;ASCORBIC ACID#0.6016;ATOPIC DERMATITIS#0.6003
11170	RENAL CELL CARCINOMA#1.0931;TUMOR SUPPRESSOR#1.0532;CANCER CELL#0.9507;GENE EXPRESSION#0.7955;LUNG CANCER#0.7537;CELL GROWTH#0.7310;NERVOUS SYSTEM#0.7302;SOCIAL BEHAVIOR#0.6253;ACTIN BINDING#0.6208;DNA METHYLATION#0.6148;LATERAL ROOT FORMATION#0.6014
11171	SMN COMPLEX#1.1231;TRANSFORMING GROWTH FACTOR#1.0086;GROWTH FACTOR#1.0040;TRANSFORMING GROWTH FACTOR BETA#0.9243;SURVIVAL MOTOR NEURON#0.9089;RECEPTOR INTERACTING PROTEIN#0.8894;CELL PROLIFERATION#0.8358;SPINAL MUSCULAR ATROPHY#0.7959;MUSCULAR ATROPHY#0.7941;SIGNALING PATHWAY#0.7795;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.7395;APOPTOSIS#0.7065;CELL CYCLE#0.6963;PROTEIN KINASE#0.6751;PROTEIN KINASE ACTIVATOR#0.6637;KINASE ACTIVATOR#0.6482;MITOGEN ACTIVATED PROTEIN#0.6117;CELL DEATH#0.6092
11172	GERM CELL#0.9202
11173	ATHEROSCLEROSIS#1.0576;CORONARY ARTERY DISEASE#1.0501;CORONARY ARTERY#1.0498;ARTERY DISEASE#1.0487;ARTERY#1.0382;SMOOTH MUSCLE CELL#1.0292;MUSCLE CELL#1.0284;SMOOTH MUSCLE#1.0230;VASCULAR SMOOTH MUSCLE CELL#0.9968;GRANULIN EPITHELIN PRECURSOR#0.9377;EXTRACELLULAR MATRIX#0.9155;MYOCARDIAL INFARCTION#0.9083;TUMOR NECROSIS FACTOR#0.8863;GROWTH FACTOR#0.8747;CHONDROCYTE#0.8611;OSTEOARTHRITIS#0.8527;ACUTE MYOCARDIAL INFARCTION#0.7825;CELL MIGRATION#0.7623;ALPHA-2 MACROGLOBULIN#0.7604;ATHEROSCLEROTIC#0.7455;CARDIOVASCULAR SYSTEM#0.6998;SMOOTH MUSCLE CELL MIGRATION#0.6431;MUSCLE CELL MIGRATION#0.6429;CHONDROCYTE DIFFERENTIATION#0.6328;CAROTID ARTERY#0.6286;COLLAGEN INDUCED ARTHRITIS#0.6252;ENDOTHELIAL CELL#0.6084
11176	CHROMATIN REMODELING#0.9596;CHROMATIN REMODELING COMPLEX#0.7821;HETEROCHROMATIN#0.7807;PROSTATE CANCER#0.7334;TRANSCRIPTION FACTOR#0.6944;NUCLEOLUS#0.6622;GENE EXPRESSION#0.6481;LYSINE#0.6333;TRANSCRIPTION TERMINATION FACTOR#0.6055;HETEROCHROMATIN FORMATION#0.6005
11177	CHROMATIN ASSEMBLY#1.0707;CHRAC#1.0703;CHROMATIN REMODELING#1.0582;ATP-DEPENDENT CHROMATIN REMODELING#1.0261;NUCLEOSOME#1.0175;GENE EXPRESSION#0.8567;HETEROCHROMATIN#0.7750;CHROMATIN REMODELING COMPLEX#0.7626;CHROMATIN ACCESSIBILITY COMPLEX#0.7612;DNA REPLICATION#0.7496;DOUBLE STRAND BREAK#0.7313;COMPLEX I#0.6754;NUCLEOSOME SLIDING#0.6500;TRANSCRIPTION FACTOR#0.6435;S PHASE#0.6254;CHROMATIN ORGANISATION#0.6247;CHROMATIN REMODELLING#0.6201
11178	TUMOR SUPPRESSOR#1.0700;BREAST CANCER#1.0518;CANCER CELL#1.0327;LEUCINE#1.0262;LUNG CANCER#0.9536;CELL GROWTH#0.9512;CELL PROLIFERATION#0.9103;CELL CYCLE#0.8480;LYMPH NODE#0.8308;PROSTATE CANCER#0.8196;MITOSIS#0.7939;BREAST CARCINOMA#0.7903;M PHASE#0.7745;UVEAL MELANOMA#0.7170;BREAST CANCER CELL#0.6492;OVARIAN#0.6480;NORMAL BREAST TISSUE#0.6354;CELL MOTILITY#0.6264;PRIMARY BREAST CANCER#0.6237;LYMPH NODE METASTASIS#0.6232;OVARIAN CANCER#0.6212
11179	ZINC FINGER PROTEIN#0.9192;COLON CANCER#0.6348
1117	CHONDROCYTE#0.9804;OSTEOARTHRITIS#0.9360;MACROPHAGE#0.9341;BREAST CANCER#0.9156;T CELL#0.9084;IMMUNE RESPONSE#0.8709;CELL PROLIFERATION#0.7952;LYMPHOCYTE PROLIFERATION#0.7863;OSTEOARTHRITIC CARTILAGE#0.7786;GROWTH FACTOR#0.7506;CHITINASE ACTIVITY#0.7329;GENE EXPRESSION#0.7170;MONOCYTE#0.7087;PERIPHERAL BLOOD#0.6348;SYNOVIAL FLUID#0.6322;M2 MACROPHAGE#0.6258;RHEUMATOID ARTHRITIS#0.6252
11180	CELL GROWTH#0.6170
11181	AMNIOTIC FLUID#1.0614;TREHALASE ACTIVITY#1.0563;MIDGUT#1.0520;GAMMA GLUTAMYLTRANSFERASE#1.0508;BETA GLUCOSIDASE#1.0360;CELL WALL#1.0332;ALPHA GLUCOSIDASE#1.0295;TREHALOSE-6-PHOSPHATE#1.0270;ALKALINE PHOSPHATASE#1.0262;STATIONARY PHASE#1.0206;FRUCTOSE#1.0155;ALPHA AMYLASE#1.0146;LEUCINE#1.0115;GERMINATION#1.0110;TREHALOSE METABOLISM#1.0077;TREHALOSE SYNTHESIS#1.0076;BRUSH BORDER MEMBRANE#1.0061;BETA-2#1.0054;PROTEIN KINASE#1.0045;CYCLIC AMP#1.0040;LACTASE ACTIVITY#1.0039;BRUSH BORDER#1.0014;GENE EXPRESSION#0.9997;SMALL INTESTINE#0.9992;PROTEIN SYNTHESIS#0.9990;PLASMA MEMBRANE#0.9970;BETA GALACTOSIDASE#0.9931;SUCRASE ACTIVITY#0.9897;GLUCOSE-6-PHOSPHATE#0.9888;SUCROSE#0.9875;ENZYME ACTIVITY#0.9867;GLYCOGEN PHOSPHORYLASE#0.9860;MALTOSE#0.9708;JEJUNUM#0.9664;VIRULENCE#0.9590;SIGNALLING PATHWAY#0.9517;ETHANOL#0.9467;CELL SURFACE#0.9462;DIAPAUSE#0.9389;CATABOLISM#0.9363;EPITHELIAL CELL#0.9347;DIGESTION#0.9343;GERM TUBE#0.9332;RNA INTERFERENCE#0.9285;AUTOPHAGY#0.9246;BETA-D-GLUCOSE#0.9168;MALTASE ACTIVITY#0.9168;FERMENTATION#0.9067;CARBOHYDRATE METABOLISM#0.9037;CYSTIC FIBROSIS#0.8980;TREHALOSE BIOSYNTHESIS#0.8979;THERMOTOLERANCE#0.8946;PROTEIN KINASE A#0.8926;CHITIN SYNTHESIS#0.8852;PHOSPHOLIPASE C#0.8812;INVERTASE ACTIVITY#0.8777;VACUOLE#0.8681;EXCRETION#0.8678;INTESTINAL MUCOSA#0.8660;DIABETES MELLITUS#0.8579;POLYMERASE CHAIN REACTION#0.8554;PYRUVATE KINASE#0.8531;PHOSPHATASE ACTIVITY#0.8506;LACTOSE#0.8496;1-DEOXYNOJIRIMYCIN#0.8464;SPORE GERMINATION#0.8441;SECRETORY PATHWAY#0.8407;PYRUVATE#0.8392;ENTEROCYTE#0.8384;DEPHOSPHORYLATION#0.8310;TOXICITY#0.8306;CELL CYCLE#0.8273;DORMANCY#0.8270;SIGNAL PEPTIDE#0.8263;SIGNALING PATHWAY#0.8171;MANNITOL#0.8155;HEAT SHOCK PROTEIN#0.8097;GESTATION#0.8071;KIDNEY DISEASE#0.8062;RIBOSOMAL PROTEIN#0.7956;APOPTOSIS#0.7913;CYTOPLASM#0.7884;NEPHROTIC SYNDROME#0.7871;GLUCOSE TRANSPORT#0.7846;ALKALINE PHOSPHATASE ACTIVITY#0.7821;HYDROCORTISONE#0.7781;SUPEROXIDE DISMUTASE#0.7743;CHITIN METABOLISM#0.7571;BETA GLUCURONIDASE#0.7483;SODIUM DODECYL SULFATE#0.7463;DODECYL SULFATE#0.7462;GLUTAMATE DEHYDROGENASE#0.7416;GLUTATHIONE#0.7354;MICROVILLUS#0.7270;GOBLET CELL#0.7237;TUBE FORMATION#0.7201;METAMORPHOSIS#0.7197;CELL MEMBRANE#0.7169;REACTIVE OXYGEN SPECIES#0.7127;GLYCOLYSIS#0.7120;SOLUBLE FRACTION#0.7066;CATALYTIC ACTIVITY#0.7009;ADENYLATE CYCLASE#0.7003;DUODENUM#0.6995;SPORULATION#0.6893;TRANSCRIPTION FACTOR#0.6796;GLUCOSE REPRESSION#0.6620;MITOCHONDRIA#0.6584;GLYCOSIDE HYDROLASE FAMILY#0.6502;MEMBRANE FRACTION#0.6483;ADENOSINE#0.6469;CAMP SIGNALLING#0.6465;ENDOPLASMIC RETICULUM#0.6413;GLYCOSYLATION#0.6406;SALT TOLERANCE#0.6382;ETHANOL FERMENTATION#0.6300;ALANINE#0.6273;MUTAGENESIS#0.6239;PUPAL DEVELOPMENT#0.6209;OVARIES#0.6197;PROTEIN PHOSPHORYLATION#0.6191;AMINOPEPTIDASE A#0.6184;CELL GROWTH#0.6118;ADENYLATE#0.6081;HORIZONTAL GENE TRANSFER#0.6024;2,4-DINITROPHENOL#0.6003
11182	GLUCOSE UPTAKE#0.7159;MYO-INOSITOL#0.6572;INFLAMMATORY RESPONSE#0.6389
11183	PROTEIN KINASE#1.0299;GERMINAL CENTER#1.0106;CANCER CELL#0.6042
11184	KINASE ACTIVITY#1.0741;B CELL#1.0680;HEMATOPOIETIC CELL#1.0654;T CELL#1.0591;SIGNALING PATHWAY#1.0481;PROTEIN KINASE#1.0351;GROWTH FACTOR#1.0282;MITOGEN ACTIVATED PROTEIN#0.9994;IMMUNE RESPONSE#0.9877;PANCREATIC CANCER#0.9821;CELL PROLIFERATION#0.9647;CELL ACTIVATION#0.9644;APOPTOSIS#0.9312;T CELL ACTIVATION#0.9155;TRANSCRIPTION FACTOR#0.8909;NF-KAPPAB ACTIVATION#0.8622;GERMINAL CENTER#0.8560;JNK SIGNALING PATHWAY#0.8532;CANCER CELL#0.8453;CELL DEATH#0.8276;SIGNALING CASCADE#0.8177;LEUKOCYTE#0.7747;CEREBRAL ISCHEMIA#0.7724;GROWTH FACTOR RECEPTOR#0.7704;IKAPPAB KINASE#0.7701;SIGNALING MOLECULE#0.7581;SIGNAL TRANSDUCTION#0.7542;CD4+ T CELL#0.7404;B CELL RECEPTOR#0.7310;CELL-MEDIATED IMMUNE RESPONSE#0.7306;DENDRITIC CELL#0.7211;MAP KINASE#0.6884;PROGENITOR CELL#0.6845;ACTIN BINDING#0.6678;T CELL PROLIFERATION#0.6650;KINASE ACTIVATION LOOP#0.6561;PROTEIN PHOSPHATASE 4#0.6553;IMMUNE CELL#0.6427;SPECIFIC PROTEIN 1#0.6406;ACTIVATED T CELL#0.6351;PROSTAGLANDIN E2#0.6216;B LYMPHOCYTE#0.6075;AUTOIMMUNE DISEASE#0.6011
11185	N METHYLTRANSFERASE#1.0939;S METHYLTRANSFERASE#1.0427;N-METHYLTRANSFERASE ACTIVITY#0.9678;METHYLTRANSFERASE ACTIVITY#0.9449;DIMETHYLTRYPTAMINE#0.8125;INDOLE#0.7869;ARYLAMINE#0.7252;METHIONINE#0.6960;NICOTINAMIDE N METHYLTRANSFERASE#0.6786
11186	RETINOIC ACID RECEPTOR#1.0595;ADENOMATOUS POLYPOSIS COLI#1.0562;RETINOIC ACID#1.0516;PRE-ECLAMPSIA#1.0467;CYCLIN DEPENDENT KINASE INHIBITOR#1.0440;CYCLIN DEPENDENT KINASE#1.0435;MICROTUBULE#1.0399;MITOSIS#1.0360;NEUROBLASTOMA#1.0345;KINASE INHIBITOR#1.0332;LUNG ADENOCARCINOMA#1.0301;CERVICAL#1.0299;THYROID CARCINOMA#1.0291;CELL CYCLE ARREST#1.0274;ADJACENT NORMAL TISSUE#1.0258;ESTROGEN RECEPTOR#1.0257;OVARIAN#1.0237;CERVICAL CANCER#1.0234;RENAL CELL CARCINOMA#1.0226;ENDOMETRIAL CANCER#1.0222;OVARIAN CANCER#1.0219;DEATH RECEPTOR#1.0189;SPUTUM#1.0188;THYROID CANCER#1.0185;QUANTITATIVE METHYLATION SPECIFIC#1.0185;METHYLATION SPECIFIC POLYMERASE#1.0172;PROTEIN KINASE#1.0149;UVEAL MELANOMA#1.0141;BREAST CANCER CELL#1.0138;5-AZA-2'-DEOXYCYTIDINE#1.0124;CISPLATIN#1.0121;BREAST CANCER PATIENTS#1.0121;QUANTITATIVE REAL TIME#1.0119;TUMOR TISSUES#1.0115;M PHASE#1.0113;DEMETHYLATION#1.0110;DISEASE FREE SURVIVAL#1.0108;2'-DEOXYCYTIDINE#1.0104;ADENOCARCINOMA#1.0095;APOPTOTIC#1.0089;LYMPH NODE METASTASIS#1.0081;PERIPHERAL BLOOD#1.0059;CELL DEATH#1.0056;PROSTATE CANCER#1.0052;EPITHELIAL CELL#1.0050;ONCOGENIC#1.0049;LUNG CARCINOMA#1.0042;TRANSCRIPTION FACTOR#1.0030;REVERSE TRANSCRIPTION#1.0025;CPG ISLAND METHYLATION#1.0018;CELL PROLIFERATION#1.0018;COLORECTAL#1.0016;METHYLATION SPECIFIC PCR#1.0010;BREAST CANCER#1.0009;DNA REPAIR#1.0001;DIGESTION#1.0001;LUNG CANCER#0.9997;CELL CYCLE#0.9996;APOPTOSIS#0.9986;SIGNALING PATHWAY#0.9985;POLYMERASE CHAIN REACTION#0.9984;HIGH RESOLUTION MELTING#0.9977;HEPATOCELLULAR CARCINOMA#0.9970;EPITHELIAL OVARIAN CANCER#0.9967;TUMOR SUPPRESSOR#0.9966;LYMPH NODE#0.9959;COLORECTAL CANCER#0.9955;NORMAL BREAST TISSUE#0.9953;DNA METHYLTRANSFERASE#0.9932;CELL GROWTH#0.9929;DNA HYPERMETHYLATION#0.9925;CANCER CELL#0.9924;ENDOMETRIAL CARCINOMA#0.9916;SQUAMOUS CELL CARCINOMA#0.9905;GENE SILENCING#0.9815;COLON CANCER#0.9814;GLUTATHIONE#0.9765;BREAST CARCINOMA#0.9744;GROWTH FACTOR#0.9721;GENE EXPRESSION#0.9703;TUMOR CELLS#0.9680;DNA METHYLATION#0.9679;RECURRENCE FREE SURVIVAL#0.9574;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9545;CELL ADHESION#0.9519;BETA-2#0.9485;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9469;CHOLANGIOCARCINOMA#0.9465;S PHASE#0.9460;HIPPO SIGNALING#0.9412;ECLAMPSIA#0.9375;MEDULLOBLASTOMA#0.9352;HISTONE MODIFICATION#0.9329;HISTONE DEACETYLASE#0.9306;PANCREATIC CANCER#0.9280;PRIMARY BREAST CANCER#0.9244;CELL CYCLE REGULATION#0.9224;LIVER CANCER#0.9212;PAPILLARY THYROID CARCINOMA#0.9204;NON-SMALL CELL LUNG CARCINOMA#0.9182;GASTRIC ADENOCARCINOMA#0.9173;RNA INTERFERENCE#0.9144;LYSINE#0.9119;GROWTH FACTOR RECEPTOR#0.9115;FORMALIN#0.9111;CARCINOMA IN SITU#0.9071;STEM CELL#0.9043;EPIDERMAL GROWTH FACTOR#0.8993;ANAPHASE PROMOTING COMPLEX#0.8965;MICROTUBULE ASSOCIATED PROTEIN#0.8948;GERM CELL#0.8898;B CELL#0.8891;CELL MIGRATION#0.8867;CLEAR CELL RENAL CELL CARCINOMA#0.8864;G1 PHASE#0.8853;MITOTIC SPINDLE#0.8802;ESOPHAGEAL CANCER#0.8726;UBIQUITIN#0.8683;INVASIVE CARCINOMA#0.8651;LYMPH NODE METASTASES#0.8650;MICROTUBULE DYNAMICS#0.8626;GEMCITABINE#0.8596;HEPATITIS C#0.8582;RETINOBLASTOMA#0.8527;HYPERMETHYLATION OF CPG ISLAND#0.8520;COLORECTAL CARCINOMA#0.8494;INVASIVE DUCTAL CARCINOMA#0.8418;PRIMARY BREAST TUMORS#0.8386;SOFT TISSUE SARCOMA#0.8373;CELL DIVISION#0.8359;PACLITAXEL#0.8351;DUCTAL CARCINOMA IN SITU#0.8323;HEPATITIS B#0.8234;DRUG RESISTANCE#0.8160;MELANOMA CELL LINES#0.8152;HISTONE DEACETYLASE INHIBITOR#0.8136;CELL CYCLE CONTROL#0.8123;DNA HYPOMETHYLATION#0.8108;HEPATITIS B VIRUS#0.8103;SIGNALLING PATHWAY#0.8081;ANAPHASE#0.8044;CHANGES IN DNA METHYLATION#0.8042;ONCOGENESIS#0.8023;TRANSCRIPTASE#0.7986;INVASIVE BREAST CANCER#0.7985;ASTROCYTOMA#0.7983;OVARIAN CARCINOMA#0.7958;DECITABINE#0.7955;NORMAL LIVER TISSUES#0.7937;HYPOXIA#0.7929;T CELL#0.7929;DNA DEMETHYLATION#0.7914;BONE MARROW#0.7898;CARDIOMYOCYTE#0.7838;SENESCENCE#0.7821;HUMAN BREAST CANCER#0.7819;CYTOKINESIS#0.7802;DE NOVO DNA METHYLATION#0.7796;MYELOID LEUKEMIA#0.7781;PROSTATE SPECIFIC ANTIGEN#0.7778;HISTIDINE#0.7751;INDUCTION OF APOPTOSIS#0.7728;PROGESTERONE#0.7721;CERVICAL SQUAMOUS CELL CARCINOMA#0.7664;KIDNEY CANCER#0.7654;FOLATE#0.7624;BLOOD PLASMA#0.7601;NEGATIVE PREDICTIVE VALUE#0.7597;HEPATOBLASTOMA#0.7550;QUANTITATIVE REVERSE TRANSCRIPTION#0.7454;PAPILLARY THYROID CANCER#0.7453;HEPATOCELLULAR CARCINOMA CELL#0.7423;SIGNAL TRANSDUCTION#0.7397;MAPK SIGNALING#0.7394;CARCINOGEN#0.7380;ENDOMETRIUM#0.7377;PROSTATE CARCINOMA#0.7374;COMPARATIVE GENOMIC HYBRIDIZATION#0.7366;CERVIX#0.7364;EPSTEIN BARR VIRUS#0.7326;CHROMOSOMAL REGION#0.7258;NEUROENDOCRINE TUMOR#0.7251;RECEIVER OPERATOR CHARACTERISTIC#0.7239;LIVER CIRRHOSIS#0.7237;NUCLEIC ACID#0.7215;BINDING PROTEIN 1#0.7190;GUANINE#0.7165;METHYL CPG BINDING#0.7103;HEAD AND NECK CANCER#0.7099;NECK CANCER#0.7098;BLADDER CARCINOMA#0.7090;SEMINOMA#0.7083;MESOTHELIAL CELL#0.7082;GESTATION#0.7079;COPY NUMBER ALTERATION#0.7078;FOLLICULAR THYROID CARCINOMA#0.6984;CELL CYCLE REGULATOR#0.6961;YEAR SURVIVAL RATE#0.6946;PARATHYROID#0.6939;HISTONE METHYLATION#0.6919;MICROTUBULE BINDING#0.6916;LIVER METASTASIS#0.6876;DOCETAXEL#0.6874;CENTROSOME#0.6861;ESTROGEN RECEPTOR ALPHA#0.6859;HIPPO SIGNALING PATHWAY#0.6856;BENIGN PROSTATE HYPERPLASIA#0.6839;CERVICAL CANCER CELL LINES#0.6821;HEPATITIS C VIRUS#0.6806;MITOMYCIN#0.6798;NEUROECTODERMAL TUMOR#0.6777;EWING SARCOMA#0.6773;GALECTIN#0.6772;BILIARY TRACT#0.6767;3-OST-2#0.6765;PLASMA CELL#0.6747;TRANSITIONAL CELL CARCINOMA#0.6744;FIBROBLAST PROLIFERATION#0.6700;NODULAR#0.6682;ALANINE#0.6620;ULCERATIVE COLITIS#0.6616;HEPATOCELLULAR ADENOMA#0.6597;FINE NEEDLE ASPIRATION#0.6596;CELL SURFACE#0.6594;NORMAL ADJACENT TISSUE#0.6586;MELTING CURVE ANALYSIS#0.6578;DNA DAMAGE RESPONSE#0.6572;BREAST DISEASE#0.6551;URINARY BLADDER#0.6518;METASTATIC BREAST CANCER#0.6504;ANGIOGENESIS#0.6485;WHITE BLOOD CELL#0.6479;PHEOCHROMOCYTOMA#0.6457;MAMMARY GLAND#0.6431;THYROID ADENOMA#0.6409;CELL ADHESION MOLECULE#0.6406;CERVICAL ADENOCARCINOMA#0.6403;LARGE CELL CARCINOMA#0.6360;LEUKOCYTE#0.6356;CANCER RELATED DEATH#0.6355;MALIGNANT MESOTHELIOMA#0.6332;ADENOID CYSTIC CARCINOMA#0.6325;CYSTADENOMA#0.6300;ARSENIC TRIOXIDE#0.6294;N METHYLTRANSFERASE#0.6292;ATAXIA TELANGIECTASIA MUTATED#0.6250;PROTEIN PROTEIN INTERACTION#0.6248;YES ASSOCIATED PROTEIN#0.6237;TELOMERASE REVERSE TRANSCRIPTASE#0.6235;ATAXIA TELANGIECTASIA#0.6228;TAXOL#0.6225;GASTRIC CARDIA ADENOCARCINOMA#0.6222;MULTIPLE MYELOMA#0.6218;CYTOTOXICITY#0.6214;VON HIPPEL LINDAU#0.6203;CELL MOTILITY#0.6200;FRAGMENT LENGTH POLYMORPHISM#0.6178;NERVOUS SYSTEM#0.6158;VIRAL INFECTION#0.6132;TUMOR NECROSIS FACTOR#0.6125;INTERPHASE#0.6098;SYNOVIAL SARCOMA#0.6080;TELOMERE#0.6078;SPINDLE POLE#0.6071;THYROID NODULE#0.6066;PARATHYROID ADENOMA#0.6064;FAMILIAL BREAST CANCER#0.6052;AUTOPHAGY#0.6052;PITUITARY ADENOMA#0.6004
11187	DESMOSOME#1.0660;CELL ADHESION#0.9685;CELL CELL ADHESION#0.9263;EPITHELIAL CELL#0.9123;CANCER CELL#0.8424;PEMPHIGUS VULGARIS#0.7844;DESMOSOME ASSEMBLY#0.7622;OVARIAN CANCER#0.7555;ADHERENS JUNCTION#0.7229;GENE EXPRESSION#0.7198;KERATINOCYTE#0.6542;TUMOR CELLS#0.6498;PEMPHIGUS#0.6389;STRESS GRANULE#0.6378;CIRCULATING TUMOR CELL#0.6307;TRANSCRIPTION FACTOR#0.6242;RNA BINDING PROTEIN#0.6170;RNA BINDING#0.6152;BREAST CANCER#0.6129;ADENOCARCINOMA#0.6079
11188	CANCER CELL#1.0913;BREAST CANCER#1.0905;CELL MIGRATION#1.0747;TUMOR SUPPRESSOR#1.0447;BREAST CANCER CELL#1.0419;OPIOID RECEPTOR#1.0287;AGMATINE#0.9379;LUNG CANCER#0.8879;INTEGRIN BINDING#0.8443;MORPHINE DEPENDENCE#0.8425;SIGNAL TRANSDUCTION#0.8356;CELL MOTILITY#0.8211;APOPTOSIS#0.7839;GENE EXPRESSION#0.7816;PROTEIN KINASE#0.7153;CELL GROWTH#0.7092;P21 ACTIVATED KINASE#0.7049;FOCAL ADHESION#0.6903;HUMAN BREAST CANCER#0.6889;SPINAL CORD#0.6855;CELL PROLIFERATION#0.6852;SIGNALING PATHWAY#0.6851;RECEPTOR AGONIST#0.6696;SECRETION OF EXOSOME#0.6625;APOPTOTIC#0.6449;MU OPIOID RECEPTOR#0.6289;PHOSPHOLIPASE C#0.6223;SPINAL CORD INJURY#0.6126;NEURITE OUTGROWTH#0.6123;EPSTEIN BARR VIRUS#0.6101;LYMPH NODE METASTASIS#0.6084;SIGNALING CASCADE#0.6042;RECEPTOR BINDING#0.6037;LYMPH NODE#0.6029;EPITHELIAL CELL#0.6014
11189	RNA BINDING PROTEIN#1.0438;RNA BINDING#1.0421;ABA SIGNALING#0.6067
1118	SARCOIDOSIS#1.0619;MACROPHAGE ACTIVATION#1.0539;ANGIOTENSIN CONVERTING ENZYME#1.0538;CHITIN BINDING#1.0420;INNATE IMMUNITY#1.0383;ACID PHOSPHATASE#1.0372;BETA THALASSEMIA#1.0309;ATHEROSCLEROSIS#1.0256;MACROPHAGE#1.0239;ENZYME ACTIVITY#1.0153;MONOCYTE#1.0124;GAUCHER'S DISEASE#1.0123;LUNG DISEASE#1.0083;CHITINASE ACTIVITY#1.0074;MULTIPLE SCLEROSIS#1.0038;BONE MARROW#1.0021;NIEMANN-PICK DISEASE#0.9999;LYSOSOMAL STORAGE DISORDER#0.9977;GENE EXPRESSION#0.9870;IMMUNE RESPONSE#0.9849;LEUKOCYTE#0.9846;ENZYME REPLACEMENT THERAPY#0.9837;LYSOSOMAL STORAGE DISEASE#0.9816;NEOPTERIN#0.9746;LATERAL SCLEROSIS#0.9688;ALZHEIMER'S DISEASE#0.9614;IMMUNE SYSTEM#0.9614;AMYOTROPHIC LATERAL SCLEROSIS#0.9448;THALASSEMIA#0.9435;LIVER DISEASE#0.9383;POLYMERASE CHAIN REACTION#0.9353;CELL WALL#0.9311;C REACTIVE PROTEIN#0.9272;TUMOR NECROSIS FACTOR#0.9264;MALARIA#0.9240;NEUTROPHIL#0.9078;INTERSTITIAL LUNG DISEASE#0.8983;PULMONARY TUBERCULOSIS#0.8967;MAGNETIC RESONANCE IMAGING#0.8898;OSTEOCLAST#0.8872;PULMONARY FIBROSIS#0.8830;ATHEROSCLEROTIC#0.8805;PERIPHERAL BLOOD#0.8794;BETA GLUCOSIDASE#0.8763;BONE MINERAL DENSITY#0.8741;NEUROFILAMENT#0.8694;GLUCOSIDASE ACTIVITY#0.8633;MIGLUSTAT#0.8527;SPUTUM#0.8481;INFLAMMATORY RESPONSE#0.8474;TUBERCULOSIS#0.8422;CORONARY ARTERY#0.8405;KUPFFER CELL#0.8402;CORONARY ARTERY DISEASE#0.8365;ARTERY DISEASE#0.8362;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8241;LECTIN#0.8221;T CELL#0.8206;PLASMODIUM FALCIPARUM MALARIA#0.8178;TYPE 2 DIABETES#0.8178;DRIED BLOOD SPOT#0.8113;QUANTITATIVE REAL TIME#0.8090;IRON OVERLOAD#0.8018;THROMBOCYTOPENIA#0.7997;LIPID STORAGE#0.7959;TISSUE REMODELING#0.7905;BETA-GLUCOCEREBROSIDASE#0.7857;BONE RESORPTION#0.7823;ALTERNATIVE MACROPHAGE ACTIVATION#0.7762;ALTERNATIVE MACROPHAGE#0.7716;ANEMIA#0.7705;PHOTOLYSIS#0.7618;ARTERY#0.7559;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7558;ACID SPHINGOMYELINASE#0.7525;GLYCOGEN STORAGE DISEASE#0.7510;DIGESTION#0.7487;LYSOSOME#0.7475;FATTY LIVER DISEASE#0.7451;TYPE 2 DIABETIC#0.7448;FATTY LIVER#0.7437;BLOOD PLASMA#0.7408;GROWTH FACTOR#0.7336;SUBSTRATE REDUCTION THERAPY#0.7304;SYNOVIAL FLUID#0.7246;SIGNAL PEPTIDE#0.7241;TALIGLUCERASE ALFA#0.7119;ATORVASTATIN#0.7081;DEMENTIA#0.7048;GLUCOCEREBROSIDASE ACTIVITY#0.7003;NERVOUS SYSTEM#0.6975;ALLERGIC ASTHMA#0.6926;MONOCYTE DERIVED MACROPHAGE#0.6775;MULTIPLE LINEAR REGRESSION#0.6754;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6730;CENTRAL NERVOUS SYSTEM#0.6719;PRO-INFLAMMATORY#0.6682;CARBOHYDRATE BINDING#0.6574;HIGH DENSITY LIPOPROTEIN#0.6563;ALLERGEN#0.6556;GLUCOSAMINE#0.6474;STEM CELL#0.6466;INFLAMMATORY CELL#0.6453;CARBOHYDRATE BINDING MODULE#0.6446;HEART DISEASE#0.6446;INTIMA MEDIA THICKNESS#0.6308;NEPHROPATHY#0.6191;CC CHEMOKINE LIGAND#0.6183;DIABETES MELLITUS#0.6144;N-ACETYL-D-GLUCOSAMINE#0.6112;OSTEOPOROSIS#0.6109;IDIOPATHIC PULMONARY FIBROSIS#0.6093;GASTROINTESTINAL TRACT#0.6018;GLCNAC#0.6015
11190	CENTRIOLE#1.0809;CENTROSOME#1.0599;CELL CYCLE#0.9784;MITOSIS#0.9664;INTERPHASE#0.9372;USHER SYNDROME#0.7952;MICROTUBULE#0.7911;CENTROSOME SEPARATION#0.7783;SPINDLE POLE#0.7449;MITOTIC SPINDLE#0.7199;CENTRIOLAR SATELLITE#0.6762;CONE ROD DYSTROPHY#0.6536;HEARING LOSS#0.6383;SPINDLE FORMATION#0.6339;MICROTUBULE ORGANIZING CENTER#0.6186;DAUGHTER CENTRIOLE#0.6149
11191	BREAST CANCER#1.0772;CELL PROLIFERATION#1.0749;CANCER CELL#1.0438;TUMOR SUPPRESSOR#0.9886;APOPTOSIS#0.9843;SIGNALING PATHWAY#0.8908;GENE EXPRESSION#0.8784;EXOSOME#0.8642;PHOSPHATASE AND TENSIN HOMOLOG#0.8237;HEPATOCELLULAR CARCINOMA#0.8206;BREAST CANCER CELL#0.8192;SQUAMOUS CELL CARCINOMA#0.8185;ORAL SQUAMOUS CELL CARCINOMA#0.7966;QUANTITATIVE REAL TIME#0.6506;ENDOMETRIAL CANCER#0.6296;SMC APOPTOSIS#0.6057
11192	DYSLEXIA#0.9334
11193	U2 SNRNP#0.6381;SPLICEOSOME#0.6231
11194	ATP BINDING CASSETTE#1.0264;ATP BINDING#1.0248;ABC TRANSPORTER#0.9529;MITOCHONDRIAL MEMBRANE#0.8165;MITOCHONDRIA#0.7598;DOXORUBICIN#0.6352
11196	ER EXIT SITE#1.0438;ENDOTHELIAL CELL#1.0354;ER EXIT#1.0344;ENDOPLASMIC RETICULUM#0.9723;PHOSPHOLIPASE A#0.7377;OVARIAN#0.6825
11197	WNT INHIBITORY FACTOR#1.0643;INHIBITORY FACTOR 1#1.0630;METHYLATION SPECIFIC PCR#1.0461;DEMETHYLATION#1.0331;REVERSE TRANSCRIPTION#1.0280;TUMOR SUPPRESSOR#1.0262;BREAST CANCER#1.0242;POLYMERASE CHAIN REACTION#1.0180;LUNG CANCER#1.0160;CANCER CELL#1.0072;TRANSCRIPTION FACTOR#1.0057;CELL GROWTH#1.0040;COLORECTAL#1.0030;WNT SIGNALING PATHWAY#1.0015;APOPTOSIS#0.9996;CELL PROLIFERATION#0.9996;METHYLATION SPECIFIC POLYMERASE#0.9970;COLORECTAL CANCER#0.9961;HEPATOCELLULAR CARCINOMA#0.9945;TUMOR TISSUES#0.9918;EPITHELIAL CELL#0.9918;DNA METHYLATION#0.9885;SIGNALING PATHWAY#0.9878;5-AZA-2'-DEOXYCYTIDINE#0.9857;2'-DEOXYCYTIDINE#0.9853;STEM CELL#0.9834;GENE EXPRESSION#0.9763;GROWTH FACTOR#0.9757;TUMOR CELLS#0.9639;COLON CANCER#0.9542;SALIVARY GLAND#0.9507;ADENOCARCINOMA#0.9343;SQUAMOUS CELL CARCINOMA#0.9304;SIGNALLING PATHWAY#0.9073;QUANTITATIVE REAL TIME#0.9066;MORPHOGENESIS#0.9035;OSTEOBLAST#0.8998;DNA METHYLTRANSFERASE#0.8915;CELL CYCLE#0.8900;CERVICAL CANCER#0.8857;RELATED PROTEIN 1#0.8752;PLEOMORPHIC ADENOMA#0.8642;ENDOTHELIAL CELL#0.8588;BONE MARROW#0.8376;MESENCHYME#0.8363;ANGIOGENESIS#0.8249;GALLBLADDER CANCER#0.8161;OSTEOSARCOMA CELL LINES#0.8146;KERATINOCYTE#0.8114;APOPTOTIC#0.8067;ASTROCYTOMA#0.8003;EXTRACELLULAR MATRIX#0.7984;T CELL#0.7959;ALKALINE PHOSPHATASE#0.7954;HUMAN BREAST CANCER#0.7951;CELL MIGRATION#0.7785;CERVICAL#0.7694;LUNG DEVELOPMENT#0.7662;RELAPSE FREE SURVIVAL#0.7566;ESTROGEN RECEPTOR#0.7461;FULVESTRANT#0.7422;ADJACENT NORMAL TISSUE#0.7347;MYELOID LEUKEMIA#0.7259;CHONDROCYTE#0.7197;PITUITARY ADENOMA#0.7135;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7126;EPITHELIAL TO MESENCHYMAL#0.7123;PROSTATIC BUD FORMATION#0.7123;QUANTITATIVE REVERSE TRANSCRIPTION#0.7088;CELL DEATH#0.7008;ENHANCER BINDING#0.6939;MELANOCYTE#0.6937;KINASE INHIBITOR#0.6866;HIGH RESOLUTION MELTING#0.6853;ADENOMATOUS POLYPOSIS COLI#0.6834;BONE MORPHOGENETIC PROTEIN#0.6790;TRANSFORMING GROWTH FACTOR#0.6592;PROSTATE CANCER#0.6532;OSTEOPOROSIS#0.6491;ONCOGENESIS#0.6397;CANCER STEM CELL#0.6336;FUNCTIONING PITUITARY ADENOMA#0.6312;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6311;GALLBLADDER#0.6304;SKELETAL DEVELOPMENT#0.6303;PANCREATIC CANCER#0.6261;CENTRAL NERVOUS SYSTEM#0.6258;NERVOUS SYSTEM#0.6247;TUMOR NECROSIS FACTOR#0.6243;HISTONE DEACETYLASE#0.6210;T CELL FACTOR#0.6167;PERIPHERAL BLOOD#0.6162;PROGENITOR CELL#0.6148;EXTRACELLULAR SPACE#0.6117;TUBE FORMATION#0.6100;CPG ISLAND METHYLATION#0.6086;BREAST CARCINOMA#0.6057;SPINAL CORD#0.6022
11198	FACT COMPLEX#1.0860;HISTONE CHAPERONE#1.0452;NUCLEOSOME#1.0267;DNA REPLICATION#0.9961;CHROMATIN REMODELING#0.9648;GENE EXPRESSION#0.9421;CELL CYCLE#0.9081;TRANSCRIPTION FACTOR#0.8486;COMPLEX I#0.8328;DNA POLYMERASE ALPHA#0.7862;FACILITATES CHROMATIN TRANSCRIPTION COMPLEX#0.7812;DNA REPAIR#0.7749;PROTEIN KINASE#0.7504;NUCLEOSOME ASSEMBLY#0.7036;NUCLEOSOME DISASSEMBLY#0.6879;PROTEIN COMPLEX#0.6632;DEVELOPMENTAL DELAY#0.6481;UBIQUITIN#0.6441;CHROMATIN REMODELING COMPLEX#0.6436;INTELLECTUAL DISABILITY#0.6429;HIGH MOBILITY GROUP#0.6412;C TERMINAL DOMAIN#0.6400
11199	COLORECTAL CARCINOMA#1.0063;CANCER CELL#1.0032;COLORECTAL#0.9953;SESSILE SERRATED ADENOMA#0.9818;TUMOR SUPPRESSOR#0.9438;ADENOCARCINOMA#0.8725;SPINAL CORD#0.8257;CELL GROWTH#0.8233;GENE EXPRESSION#0.8209;COLORECTAL CANCER#0.8138;EPITHELIAL CELL#0.7855;PHOSPHOLIPID BINDING#0.7090;GASTRIC MUCOSA#0.7054;HEPATOCELLULAR CARCINOMA#0.6985
1119	ETHANOLAMINE KINASE ACTIVITY#1.1266;ETHANOLAMINE KINASE#1.0780;CHOLINE KINASE ACTIVITY#1.0762;KINASE INHIBITOR#1.0564;KENNEDY PATHWAY#1.0509;CHOLINE KINASE#1.0487;ETHANOLAMINE#1.0475;KINASE ACTIVITY#1.0462;CDP CHOLINE PATHWAY#1.0449;CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE#1.0446;CHOLINE#1.0394;PROSTATE CANCER#1.0203;BREAST CANCER#1.0178;CHOLINE METABOLISM#1.0167;PHOSPHATIDYLCHOLINE BIOSYNTHESIS#1.0146;BREAST CANCER CELL#1.0143;PHOSPHOCHOLINE#1.0078;PHOSPHATIDYLCHOLINE SYNTHESIS#1.0061;PHOSPHOLIPASE C#1.0057;PHOSPHATIDYLETHANOLAMINE#1.0033;PHOSPHOLIPASE D#1.0024;PHOSPHOLIPID METABOLISM#1.0014;CHOLINE TRANSPORT#0.9981;CANCER CELL#0.9971;GROWTH FACTOR#0.9956;MAGNETIC RESONANCE SPECTROSCOPY#0.9850;PHOSPHOLIPID SYNTHESIS#0.9834;CELL PROLIFERATION#0.9772;LIPID METABOLISM#0.9756;GENE EXPRESSION#0.9737;MUSCULAR DYSTROPHY#0.9736;PROTEIN KINASE#0.9730;CELL GROWTH#0.9689;CYTIDINE#0.9608;CELL MEMBRANE#0.9560;CYTIDYLYLTRANSFERASE ACTIVITY#0.9537;ENZYME ACTIVITY#0.9322;HUMAN BREAST CANCER#0.9192;POLYCYCLIC AROMATIC HYDROCARBON#0.8894;PHOSPHATIDYLETHANOLAMINE SYNTHESIS#0.8876;EPITHELIAL CELL#0.8795;ACETYLCHOLINE#0.8763;DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE#0.8723;PHOSPHATIDYLCHOLINE METABOLISM#0.8649;HEPATOCELLULAR CARCINOMA#0.8596;APOPTOSIS#0.8590;CELL DEATH#0.8504;N METHYLTRANSFERASE#0.8480;TUMOR CELLS#0.8387;PHOSPHODIESTERASE#0.8347;DNA SYNTHESIS#0.8340;EPIDERMAL GROWTH FACTOR#0.8286;MECHANISM OF ACTION#0.8280;POSITRON EMISSION TOMOGRAPHY#0.8206;PHOSPHOLIPASE A2#0.8143;CHOLINE BINDING#0.7916;CHOLINE DEHYDROGENASE#0.7853;PROTEIN KINASE A#0.7845;CELL CYCLE#0.7818;PHOSPHATIDYLETHANOLAMINE N METHYLTRANSFERASE#0.7728;SIGNALING PATHWAY#0.7725;ONCOGENIC#0.7706;COLON CANCER#0.7684;ENDOPLASMIC RETICULUM#0.7599;OVARIAN CANCER#0.7475;POLYMERASE CHAIN REACTION#0.7405;CONGENITAL MUSCULAR DYSTROPHY#0.7306;ORNITHINE DECARBOXYLASE#0.7287;MITOCHONDRIA#0.7256;SYNAPTOSOME#0.7097;5 FLUOROURACIL#0.7088;TRANSCRIPTION FACTOR#0.7086;OVARIAN#0.7042;DRUG RESISTANCE#0.7036;SKELETAL MUSCLE#0.6998;PHOSPHOLIPID BIOSYNTHESIS#0.6962;LUNG CANCER#0.6934;PHOSPHATIDYLSERINE#0.6896;COLORECTAL#0.6841;NERVOUS SYSTEM#0.6822;PHOSPHATIDATE PHOSPHATASE#0.6821;NERVE ENDING#0.6811;HYPOXIA#0.6804;CHOLINE DEHYDROGENASE ACTIVITY#0.6642;RNA INTERFERENCE#0.6590;CARCINOGEN#0.6580;FATTY ACID SYNTHASE#0.6523;MAMMARY EPITHELIAL CELL#0.6518;PERIBACTEROID MEMBRANE#0.6278;CYTOPLASM#0.6277;GROWTH FACTOR RECEPTOR#0.6237;CERVICAL#0.6200;CATALYTIC ACTIVITY#0.6195;SIGNAL TRANSDUCTION#0.6124;TARGET OF RAPAMYCIN#0.6029;PHOSPHOLIPASE A#0.6028
111	ADENYLATE CYCLASE#1.0646;ADENYLATE#1.0623;STRIATUM#1.0551;DYSKINESIA#1.0513;DOPAMINE#1.0242;TYPE 2 DIABETES#1.0195;ADRENERGIC RECEPTOR#0.9728;GENE EXPRESSION#0.9628;CARDIOMYOPATHY#0.9572;FORSKOLIN#0.9570;PROTEIN KINASE#0.9556;SIGNALING PATHWAY#0.9489;DYSTONIA#0.9407;CYCLIC AMP#0.9295;DOPAMINE RECEPTOR#0.9254;BENIGN HEREDITARY CHOREA#0.9093;CAMP SIGNALING#0.9050;OPIOID RECEPTOR#0.8921;ISOPROTERENOL#0.8854;SMOOTH MUSCLE#0.8841;DNA METHYLATION#0.8710;INSULIN SECRETION#0.8625;ADENOSINE#0.8477;APOPTOSIS#0.8433;HYPERKINETIC#0.8274;PROTEIN KINASE A#0.8269;PHOSPHODIESTERASE#0.8059;ARA-A#0.8040;PROTEIN PROTEIN INTERACTION#0.7739;SENSITIZATION#0.7724;ETHANOL#0.7593;CARDIOMYOCYTE#0.7483;MYOCYTES#0.7395;RECEPTOR AGONIST#0.7332;CAMKII#0.7177;PERTUSSIS#0.7170;CYCLIC ADENOSINE MONOPHOSPHATE#0.7146;ADENOSINE MONOPHOSPHATE#0.7130;SIGNALING CASCADE#0.7126;CAMP SYNTHESIS#0.6834;MUSCLE CELL#0.6812;COMPLEX I#0.6800;RECEPTOR ANTAGONIST#0.6773;CAMP FORMATION#0.6747;CYCLASE ACTIVITY#0.6723;BETA ADRENERGIC RECEPTOR#0.6624;POLYMERASE CHAIN REACTION#0.6501;NITRIC OXIDE#0.6312;SIGNALOSOME ASSEMBLY#0.6255;MEDIUM SPINY NEURONS#0.6192;MU OPIOID RECEPTOR#0.6063
11200	LI-FRAUMENI SYNDROME#1.0345;DNA REPLICATION CHECKPOINT#1.0328;RESPONSE TO IONIZING RADIATION#1.0237;P53 SIGNALING PATHWAY#1.0202;CENTROSOME#1.0194;HYPERPHOSPHORYLATION#1.0190;S M CHECKPOINT#1.0176;HEREDITARY BREAST CANCER#1.0142;GENISTEIN#1.0135;BREAST CARCINOMA#1.0127;FAMILIAL BREAST CANCER#1.0113;CONTRALATERAL BREAST CANCER#1.0059;SIGNALLING PATHWAY#1.0045;DEPHOSPHORYLATION#1.0027;ATAXIA TELANGIECTASIA MUTATED#1.0016;CELL CYCLE CONTROL#1.0014;MITOTIC CATASTROPHE#1.0001;CELL DIVISION CYCLE#1.0001;MALE BREAST CANCER#0.9997;CAFFEINE#0.9977;SIGNALING CASCADE#0.9976;KINASE ACTIVITY#0.9973;TELOMERE#0.9970;ATAXIA TELANGIECTASIA#0.9969;S-PHASE CHECKPOINT#0.9962;RESPONSE TO GENOTOXIC STRESS#0.9961;CELL CYCLE REGULATOR#0.9958;MITOGEN ACTIVATED PROTEIN#0.9932;BREAST CANCER#0.9932;CELL CYCLE CHECKPOINT#0.9929;MITOTIC ENTRY#0.9927;ANAPHASE#0.9920;POLYMERASE CHAIN REACTION#0.9918;BREAST CANCER PATIENTS#0.9912;PROTEIN KINASE#0.9911;SIGNAL TRANSDUCER#0.9909;BILATERAL BREAST CANCER#0.9906;COLORECTAL CANCER#0.9899;G2 PHASE#0.9899;HYDROXYUREA#0.9897;DNA DAMAGE CHECKPOINT#0.9896;COLORECTAL#0.9886;HYPOXIA#0.9881;SENESCENCE#0.9880;TUMOR SUPPRESSOR#0.9873;COMPLEX I#0.9872;CELL CYCLE PHASE#0.9864;COLON CANCER#0.9863;DOXORUBICIN#0.9862;CELL CYCLE REGULATION#0.9862;MRN COMPLEX#0.9856;CAMPTOTHECIN#0.9851;OOCYTE#0.9850;CELL DIVISION#0.9849;M PHASE#0.9845;BUDDING#0.9843;CISPLATIN#0.9840;POLY ADP RIBOSE#0.9839;RNA INTERFERENCE#0.9834;PROSTATE CANCER#0.9827;ONCOGENIC#0.9819;B CELL#0.9816;REPLICATION FORK#0.9811;PANCREATIC CANCER#0.9808;T CELL#0.9805;CYCLIN DEPENDENT KINASE#0.9804;SIGNAL TRANSDUCTION#0.9803;SQUAMOUS CELL CARCINOMA#0.9799;MEIOSIS#0.9798;MISMATCH REPAIR#0.9794;ETOPOSIDE#0.9791;OVARIAN CANCER#0.9788;GEMCITABINE#0.9784;BASE EXCISION REPAIR#0.9782;DNA DAMAGE RESPONSE#0.9782;S PHASE#0.9777;LYNCH SYNDROME#0.9775;RIBOSE#0.9775;SIGNALING PATHWAY#0.9774;MITOTIC EXIT#0.9768;UBIQUITIN#0.9767;OVARIAN#0.9762;GENOTOXIC#0.9754;MITOTIC SPINDLE#0.9753;CELL CYCLE ARREST#0.9745;BREAST CANCER CELL#0.9744;TOPOISOMERASE#0.9744;ADENOCARCINOMA#0.9744;PROTEASOME#0.9743;KINASE INHIBITOR#0.9741;DNA SYNTHESIS#0.9738;G1 PHASE#0.9733;CELL CYCLE#0.9731;GERM CELL#0.9730;EPITHELIAL CELL#0.9728;INDUCTION OF APOPTOSIS#0.9721;LUNG CANCER#0.9721;DNA REPAIR#0.9717;DNA REPLICATION#0.9704;DOUBLE-STRAND BREAK REPAIR#0.9697;MITOSIS#0.9691;TUMOR CELLS#0.9678;DOUBLE STRAND BREAK#0.9673;MICROTUBULE#0.9668;TRANSCRIPTION FACTOR#0.9667;LUNG ADENOCARCINOMA#0.9662;APOPTOSIS#0.9654;APOPTOTIC#0.9651;HOMOLOGOUS RECOMBINATION#0.9639;STEM CELL#0.9633;HUMAN BREAST CANCER#0.9625;GROWTH FACTOR#0.9618;REACTIVE OXYGEN SPECIES#0.9613;GENE EXPRESSION#0.9608;HOMOLOGOUS RECOMBINATION REPAIR#0.9605;CELL GROWTH#0.9602;TOXICITY#0.9600;HISTONE DEACETYLASE#0.9600;PERIPHERAL BLOOD#0.9598;CYTOPLASM#0.9580;HEPATOCELLULAR CARCINOMA#0.9574;CELL PROLIFERATION#0.9574;CANCER CELL#0.9572;CELLULAR SENESCENCE#0.9562;CELL DEATH#0.9556;CYTOTOXICITY#0.9554;OVARIAN CARCINOMA#0.9547;APOPTOTIC CELL DEATH#0.9543;DNA REPAIR PROTEIN#0.9529;SPORADIC BREAST CANCER#0.9519;OXIDATIVE DNA DAMAGE#0.9512;MITOCHONDRIA#0.9511;DNA BINDING#0.9510;TOPOISOMERASE II#0.9505;MRE11 COMPLEX#0.9500;ENTRY INTO MITOSIS#0.9498;CELLULAR DNA DAMAGE RESPONSE#0.9479;LYMPH NODE#0.9461;THYROID CANCER#0.9452;BENZIMIDAZOLE#0.9442;PHOSPHOTHREONINE BINDING#0.9441;CDK INHIBITOR#0.9438;MUTAGENESIS#0.9436;P53 BINDING#0.9431;AGE AT DIAGNOSIS#0.9427;AUTOPHAGY#0.9427;MITOCHONDRIAL MEMBRANE#0.9412;CHROMOSOME SEGREGATION#0.9410;PROTEIN PHOSPHORYLATION#0.9407;BINDING PROTEIN 1#0.9391;CHROMATIN REMODELING#0.9377;SPINDLE ASSEMBLY#0.9360;CYCLIN DEPENDENT KINASE INHIBITOR#0.9334;DNA HELICASE#0.9323;ESTROGEN RECEPTOR#0.9317;HYPERSENSITIVITY#0.9316;CHROMATID#0.9314;NIJMEGEN BREAKAGE SYNDROME#0.9293;CYTOCHROME C#0.9272;ESOPHAGEAL CANCER#0.9266;DNA FRAGMENTATION#0.9259;DEATH RECEPTOR#0.9258;NUCLEOTIDE EXCISION REPAIR#0.9239;DRUG RESISTANCE#0.9234;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9216;CHROMATIN ASSEMBLY#0.9212;MAP KINASE#0.9200;MECHANISM OF ACTION#0.9193;MYELOID LEUKEMIA#0.9188;CERVICAL#0.9147;DEBROMOHYMENIALDISINE#0.9123;COPY NUMBER VARIATION#0.9118;CERVICAL CANCER#0.9116;VIRAL REPLICATION#0.9078;FEMALE BREAST CANCER#0.9077;METAPHASE#0.9065;RESPONSE TO UV#0.8994;NULL CELL#0.8989;ENDOMETRIAL CANCER#0.8972;SPINDLE CHECKPOINT#0.8959;COLON CARCINOMA#0.8954;SINGLE STRAND BREAK#0.8943;PROGENITOR CELL#0.8887;REPLICATION FORK STALLING#0.8872;REGULATION OF CELL CYCLE#0.8858;5 FLUOROURACIL#0.8852;REPLISOME#0.8845;LYSINE#0.8843;GLUTATHIONE#0.8773;CATALYTIC ACTIVITY#0.8772;SIGNALING MOLECULE#0.8767;PROTEIN COMPLEX#0.8686;B CELL LYMPHOMA#0.8681;ALANINE#0.8678;BONE MARROW#0.8661;RECOMBINATIONAL REPAIR#0.8641;MOUSE EMBRYONIC FIBROBLAST#0.8581;SENSITIZATION#0.8565;REPLICATION PROTEIN A#0.8496;REPLICATION FORK RESTART#0.8493;PRIMARY BREAST CANCER#0.8488;CELL KILLING#0.8472;POST-TRANSLATIONAL MODIFICATION#0.8472;ACUTE MYELOID LEUKEMIA#0.8451;INTERPHASE#0.8430;FANCONI ANEMIA#0.8404;RNA BINDING#0.8387;MELANOMA CELL LINES#0.8382;TRANSCRIPTASE#0.8376;ANGIOGENESIS#0.8358;CLEAVED CASPASE 3#0.8337;MITOTIC CHECKPOINT#0.8328;RESPONSE TO CISPLATIN#0.8319;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8319;HOST CELL#0.8304;LUMINAL#0.8300;KINETOCHORE#0.8274;AXIS SPECIFICATION#0.8259;TUMOR TISSUES#0.8256;GENE SILENCING#0.8250;COLONY FORMATION ASSAY#0.8234;EPSTEIN BARR VIRUS#0.8186;ANEMIA#0.8184;CARCINOGEN#0.8167;SPINDLE ASSEMBLY CHECKPOINT#0.8165;MITOCHONDRIAL DNA#0.8146;FLOW CYTOMETRY ANALYSIS#0.8139;REVERSE TRANSCRIPTION#0.8139;GROWTH FACTOR RECEPTOR#0.8139;PROTEIN PHOSPHATASE 2A#0.8121;PHOSPHATASE 2A#0.8117;KERATINOCYTE#0.8101;CASPASE ACTIVATION#0.8092;PROTEIN SYNTHESIS#0.8090;AKT SIGNALING#0.8065;ROS GENERATION#0.8064;NITRIC OXIDE#0.8000;ONCOGENESIS#0.7988;CENTROMERE#0.7956;RESPONSE TO OXIDATIVE STRESS#0.7950;THYROID CARCINOMA#0.7924;FLUOROURACIL#0.7918;TRANSACTIVATION#0.7904;ORIGIN RECOGNITION COMPLEX#0.7901;ADJUSTED HAZARD RATIO#0.7842;TELOMERASE ACTIVITY#0.7825;FILAMENTOUS GROWTH#0.7818;GENOTOXICITY#0.7797;OXALIPLATIN#0.7777;LYMPH NODE METASTASIS#0.7746;ATP BINDING#0.7742;G2 DNA DAMAGE CHECKPOINT#0.7731;RNA BINDING PROTEIN#0.7711;HISTONE CHAPERONE#0.7711;PML NB#0.7702;BLADDER CARCINOMA#0.7692;ENDOTHELIAL CELL#0.7679;TRANSLESION SYNTHESIS#0.7675;THYMOCYTE#0.7659;NOCODAZOLE#0.7658;N-ACETYLCYSTEINE#0.7636;RETINOBLASTOMA#0.7621;GENOTOXINS#0.7613;MECHANISMS OF ACTION#0.7612;EMBRYONIC STEM CELL#0.7610;CYTOKINESIS#0.7600;PROPHASE#0.7593;DNA DAMAGE FOCI#0.7590;ORAL SQUAMOUS CELL CARCINOMA#0.7589;MUTAGENIC#0.7561;DNA REPLICATION INITIATION#0.7553;REPLICATION FORK ARREST#0.7530;PROGRAMMED CELL DEATH#0.7501;POSITIVE FAMILY HISTORY#0.7481;PROTEIN PROTEIN INTERACTION#0.7407;RAPAMYCIN#0.7396;COLORECTAL CARCINOMA#0.7392;PAPILLARY THYROID CANCER#0.7370;SUPEROXIDE DISMUTASE#0.7363;IROFULVEN#0.7349;LUNG CARCINOMA#0.7345;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7320;CANCER STEM CELL#0.7299;CELL CYCLE PATHWAY#0.7292;TELOMERE MAINTENANCE#0.7285;DNA REPLICATION INHIBITOR#0.7258;DNA METHYLATION#0.7253;EPIDERMAL GROWTH FACTOR#0.7250;CYTOCHROME C RELEASE#0.7223;DNA DAMAGE TOLERANCE#0.7219;NUCLEAR IMPORT#0.7212;MYELODYSPLASTIC SYNDROME#0.7210;MULTIPLE MYELOMA#0.7193;RESPONSE TO RADIATION#0.7185;RESPONSE TO ETOPOSIDE#0.7146;STANDARD OF CARE#0.7138;NEUROBLASTOMA#0.7108;7-HYDROXYSTAUROSPORINE#0.7104;POSTREPLICATION REPAIR#0.7090;TEMOZOLOMIDE#0.7065;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7037;NON HODGKIN LYMPHOMA#0.7004;INVASIVE BREAST CANCER#0.6996;T-CELL LEUKEMIA#0.6994;OESOPHAGEAL SQUAMOUS CELL#0.6993;DIFFUSE LARGE B-CELL LYMPHOMA#0.6986;DNA REPAIR ENZYME#0.6963;TARGET OF RAPAMYCIN#0.6937;ANDROGEN RECEPTOR#0.6933;NUCLEAR EXPORT#0.6927;SPINDLE FORMATION#0.6913;DNA REPLICATION ELONGATION#0.6912;SYNAPSIS#0.6888;GLYCOSYLASE#0.6836;PACLITAXEL#0.6831;ADRIAMYCIN#0.6787;PHOSPHATASE ACTIVITY#0.6782;MORPHOGENESIS#0.6779;CELL MIGRATION#0.6775;DOMINANT NEGATIVE MUTANT#0.6723;EPITHELIAL OVARIAN CANCER#0.6722;HISTONE DEACETYLASE INHIBITOR#0.6719;STRUCTURE ACTIVITY RELATIONSHIP#0.6687;MAGNETIC RESONANCE IMAGING#0.6668;NUCLEAR PORE#0.6652;NUCLEASE ACTIVITY#0.6651;T LYMPHOCYTE#0.6648;MTDNA#0.6593;WHOLE GENOME SEQUENCING#0.6588;HETEROCHROMATIN#0.6550;PANCREATIC DUCTAL ADENOCARCINOMA#0.6546;ACETYLCYSTEINE#0.6536;ARSENIC TRIOXIDE#0.6520;BLEOMYCIN#0.6514;DNA REPAIR CAPACITY#0.6512;CHROMATIN BINDING#0.6507;QUANTITATIVE REAL TIME#0.6506;FDURD#0.6500;IRINOTECAN#0.6489;PROGESTERONE#0.6483;URINARY BLADDER#0.6482;NUCLEOSOME#0.6471;INTESTINAL EPITHELIAL CELL#0.6467;TOPOTECAN#0.6450;METHYLATION SPECIFIC PCR#0.6441;HISTONE ACETYLATION#0.6432;L-CYSTEINE#0.6430;REPLICATIVE SENESCENCE#0.6319;RESVERATROL#0.6301;COMPARATIVE GENOMIC HYBRIDIZATION#0.6265;CARCINOMA IN SITU#0.6265;ACUTE PROMYELOCYTIC LEUKEMIA#0.6236;ELECTROPHORETIC MOBILITY SHIFT#0.6230;MRNA SPLICING#0.6227;MRX COMPLEX#0.6216;ACTIVATION OF DNA REPAIR#0.6210;PHOSPHATASE I#0.6208;INSULIN-LIKE GROWTH FACTOR#0.6193;NERVOUS SYSTEM#0.6174;NUCLEAR LOCALIZATION SIGNAL#0.6155;MITOMYCIN#0.6122;MAINTENANCE OF GENOME INTEGRITY#0.6121;OOGENESIS#0.6117;DNA TOPOISOMERASE#0.6115;SUMOYLATION#0.6098;DNA METHYLTRANSFERASE#0.6095;HUMAN GASTRIC CARCINOMA#0.6064;MAPK SIGNALLING#0.6060;DDR SIGNALING PATHWAY#0.6058;CPT-11#0.6057;EPIRUBICIN#0.6043;MITOTIC CELL CYCLE#0.6037;MEIOTIC CELL CYCLE#0.6002;INTRINSIC APOPTOSIS#0.6000
11201	DNA SYNTHESIS#1.0048;BASE PAIRING#0.9359;TRANSLESION SYNTHESIS#0.8951;DNA REPLICATION#0.8297;MUTAGENIC#0.7641;GUANINE#0.7555;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7505;THYMINE#0.7431;CANCER CELL#0.7229;MUTAGENESIS#0.7148;CATALYTIC ACTIVITY#0.7058;BREAST CANCER#0.7038;DENSITY FUNCTIONAL THEORY#0.6881;XERODERMA PIGMENTOSUM#0.6866;ADENINE#0.6498;LUNG CANCER#0.6017
11202	OVARIAN CANCER#1.0296;OVARIAN#1.0140;KERATINOCYTE#0.9997;GENE EXPRESSION#0.9355;NERVOUS SYSTEM#0.8881;ALZHEIMER'S DISEASE#0.8876;CENTRAL NERVOUS SYSTEM#0.8254;CANCER CELL#0.7958;LUNG CANCER#0.7519;BREAST CANCER#0.7362;REVERSE TRANSCRIPTION#0.7320;PSORIASIS#0.7271;OVARIAN CARCINOMA#0.7077;SCHAFFER COLLATERAL#0.7059;POLYMERASE CHAIN REACTION#0.6987;SALIVARY GLAND#0.6977;HUMAN TISSUE KALLIKREIN#0.6637;ERBB SIGNALING#0.6322;EPITHELIAL CELL#0.6285;CELL PROLIFERATION#0.6279;SPINAL CORD#0.6172;DISEASE FREE SURVIVAL#0.6028;WOUND HEALING#0.6011
1120	CHOLINE KINASE#1.1216;CHOLINE#1.0956;MUSCULAR DYSTROPHY#1.0930;CONGENITAL MUSCULAR DYSTROPHY#1.0733;NARCOLEPSY#0.9133;MITOCHONDRIA#0.8312;KINASE ACTIVITY#0.7429;CHOLINE KINASE ACTIVITY#0.7009;PHOSPHOCHOLINE#0.6564;CREATINE KINASE#0.6527;BONE FORMATION#0.6329;RESPIRATORY CHAIN#0.6307
11211	SYNOVIAL SARCOMA#1.0314;WNT RECEPTOR#0.9746;SIGNALING PATHWAY#0.9696;CELL SURFACE#0.9618;CANCER CELL#0.9568;WNT SIGNALING PATHWAY#0.8373;BREAST CANCER#0.8174;GENE EXPRESSION#0.8080;STEM CELL#0.7629;COLORECTAL#0.6725;RETINOIC ACID#0.6486;NEURAL TUBE#0.6302;SMOOTH MUSCLE CELL#0.6103;MUSCLE CELL#0.6094;SMOOTH MUSCLE#0.6035
11212	EPILEPSY#0.8964;PYRIDOXAL#0.6900;PHOSPHATE BINDING#0.6837;VITAMIN B6#0.6686;PYRIDOXAL 5-PHOSPHATE#0.6646;CELL DIVISION#0.6034
11213	INTERLEUKIN 1 RECEPTOR#1.0332;MACROPHAGE#1.0230;MONOCYTE#1.0151;T CELL#1.0150;GENE EXPRESSION#1.0036;INNATE IMMUNITY#1.0024;EPITHELIAL CELL#0.9968;SIGNALING PATHWAY#0.9958;DENDRITIC CELL#0.9906;INFLAMMATORY RESPONSE#0.9879;TUMOR NECROSIS FACTOR#0.9840;BONE MARROW#0.9834;IMMUNE RESPONSE#0.9831;TOLL LIKE RECEPTOR#0.9824;PRO-INFLAMMATORY#0.9736;PERIPHERAL BLOOD#0.9734;CYTOKINE PRODUCTION#0.9728;POLYMERASE CHAIN REACTION#0.9432;PROTEIN KINASE#0.9156;TRANSCRIPTION FACTOR#0.9114;INNATE IMMUNE RESPONSE#0.9024;MONONUCLEAR CELLS#0.8982;PNEUMONIA#0.8921;NEUTROPHIL#0.8829;MITOGEN ACTIVATED PROTEIN#0.8784;TLR SIGNALING PATHWAY#0.8648;B CELL#0.8560;TUMOR CELLS#0.8481;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8471;IMMUNE SYSTEM#0.8361;CELL SURFACE#0.8179;PATTERN RECOGNITION RECEPTOR#0.8064;SIGNALING MOLECULE#0.8058;SIGNAL TRANSDUCTION#0.7845;TNF PRODUCTION#0.7791;IMMUNE CELL#0.7735;LEUKOCYTE#0.7600;MACROPHAGE ACTIVATION#0.7582;COLITIS#0.7532;APOPTOSIS#0.7485;ALVEOLAR MACROPHAGE#0.7458;REVERSE TRANSCRIPTION#0.7455;C TERMINAL DOMAIN#0.7331;GROWTH FACTOR#0.7196;SIGNALLING PATHWAY#0.7028;INNATE IMMUNE SYSTEM#0.6849;LUNG EPITHELIAL CELL#0.6838;KINASE ACTIVITY#0.6815;TRANSFORMING GROWTH FACTOR#0.6757;RESPONSE TO LPS#0.6724;TNF-ALPHA PRODUCTION#0.6665;TUBERCULOSIS#0.6562;ISCHEMIA#0.6381;CELL DEATH#0.6294;NITRIC OXIDE#0.6209;CANCER CELL#0.6195;PNEUMOCOCCAL PNEUMONIA#0.6147;ANTIGEN PRESENTING CELLS#0.6041
11214	RHOGEF#1.0792;CYTOCHROME B#1.0409;NUCLEOTIDE EXCHANGE FACTOR#1.0382;ANCHORING#1.0314;GUANINE#1.0312;PLASMA MEMBRANE#1.0247;NADPH OXIDASE#1.0167;NADPH OXIDASE COMPLEX#1.0126;BREAST CANCER#1.0121;PROTEIN KINASE A#1.0026;ARACHIDONIC ACID#0.9951;SIGNALING PATHWAY#0.9922;NEUTROPHIL#0.9917;CARDIOMYOCYTE#0.9869;GENE EXPRESSION#0.9838;PROTEIN KINASE#0.9823;CELL MEMBRANE#0.9763;REACTIVE OXYGEN SPECIES#0.9718;FLAVOCYTOCHROME B558#0.9689;ROS GENERATION#0.9613;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9455;ADENINE DINUCLEOTIDE PHOSPHATE#0.9428;ONCOGENIC#0.9141;STRESS FIBER#0.9124;MACROPHAGE#0.9050;PROTEIN KINASE C#0.9013;T CELL#0.8976;MITOGEN ACTIVATED PROTEIN#0.8930;APOPTOSIS#0.8857;NICOTINAMIDE#0.8783;ADENINE#0.8766;ESTROGEN RECEPTOR#0.8751;BONE MARROW#0.8730;EPITHELIAL CELL#0.8677;ADRENERGIC RECEPTOR#0.8675;PROTEIN PROTEIN INTERACTION#0.8580;PKA BINDING#0.8460;PROSTATE CANCER#0.8390;ENZYME ACTIVITY#0.8351;ENDOTHELIAL CELL#0.8309;TRANSCRIPTION FACTOR#0.8236;GROWTH FACTOR#0.8228;SIGNAL TRANSDUCTION#0.8110;MINOR HISTOCOMPATIBILITY ANTIGEN#0.7960;CANCER CELL#0.7927;CYCLIC AMP#0.7903;HETEROTRIMERIC G-PROTEIN#0.7893;RESPIRATORY BURST#0.7707;STEM CELL#0.7667;NF-KAPPAB ACTIVATION#0.7510;KINASE ACTIVITY#0.7477;CELL ADHESION#0.7418;SMOOTH MUSCLE#0.7260;COLORECTAL CANCER#0.7210;MONOCYTE#0.7188;FORSKOLIN#0.7075;MUSCLE CELL#0.7039;MEMBRANE FRACTION#0.7029;SERUM RESPONSE FACTOR#0.7024;PERIPHERAL BLOOD#0.7021;PROTEIN KINASE D#0.6922;RELAPSING FEVER#0.6900;PHAGOCYTOSIS#0.6898;SMOOTH MUSCLE CELL#0.6800;SIGNALING CASCADE#0.6797;GTP BINDING#0.6792;TUMOR NECROSIS FACTOR#0.6747;LEUKOCYTE#0.6686;ISOPROTERENOL#0.6537;LYMPH NODE#0.6527;MYELOID LEUKEMIA#0.6496;CELL GROWTH#0.6478;CELL SURFACE#0.6474;INFLAMMATORY RESPONSE#0.6464;NITRIC OXIDE#0.6347;CATALYTIC ACTIVITY#0.6313;CELL MIGRATION#0.6307;IMATINIB#0.6298;CELL PROLIFERATION#0.6277;MONONUCLEAR CELLS#0.6274;ELECTRON TRANSFER#0.6254;MUTAGENESIS#0.6215;EXTRACELLULAR MATRIX#0.6185;MYOCYTES#0.6153;KINASE INHIBITOR#0.6153;IMMUNE RESPONSE#0.6132;CHRONIC MYELOID LEUKEMIA#0.6114;FAMILIAL BREAST CANCER#0.6088;NUCLEAR HORMONE RECEPTOR#0.6003
11215	ANCHORING#1.0033;PROTEIN KINASE#0.9230;PROTEIN KINASE A#0.7382
11216	ANCHORING#1.0699;PKA BINDING#1.0151;PROTEIN KINASE#0.9841;PROTEIN KINASE A#0.9817;KINASE BINDING#0.9779;COLORECTAL CANCER#0.8821;COLORECTAL#0.7104;HEART RATE VARIABILITY#0.6344;CORD BLOOD#0.6240
11217	PROTEIN KINASE#0.9728;PROTEIN KINASE A#0.9044;ANCHORING#0.9015;CANCER CELL#0.8158
11218	RNA HELICASE#1.0811;SMN COMPLEX#1.0693;MIRNA PROCESSING#1.0113;SPINAL MUSCULAR ATROPHY#0.9862;MUSCULAR ATROPHY#0.9847;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.9694;SURVIVAL MOTOR NEURON#0.9439;APOPTOSIS#0.8247;CYTOPLASM#0.7850;BREAST CANCER#0.7533;PRE-MRNA SPLICING#0.7505;MRNA SPLICING#0.7479;GERM CELL#0.7081;GENE EXPRESSION#0.6979;NEURODEGENERATIVE DISEASE#0.6801;MICRORNA BIOGENESIS#0.6704;PROTEIN COMPLEX#0.6663;MICRORNA PROCESSING#0.6661;MIRNA BIOGENESIS#0.6490;COMPLEX I#0.6298;C TERMINAL DOMAIN#0.6121
11219	TREX-2 COMPLEX#1.1489;NUCLEAR PORE#1.0619;NUCLEAR EXPORT#1.0452;GENE EXPRESSION#1.0215;DNA BINDING#0.9550;DNA REPAIR#0.8541;COMPLEX I#0.8268;TRANSCRIPTION EXPORT COMPLEX#0.7837;DOUBLE STRAND BREAK#0.7706;KERATINOCYTE#0.7282;NUCLEAR PERIPHERY#0.6832;PROTEASOME#0.6486;MRNP GRANULE#0.6465;NUCLEAR PORE COMPLEXES#0.6304;26S PROTEASOME#0.6256;NULL CELL#0.6235;MUTAGENESIS#0.6127
1121	PRENYLATION#1.0477;PARKINSON'S DISEASE#1.0114;RETINAL PIGMENT EPITHELIUM#0.9979;RETINAL DEGENERATION#0.9953;PLASMID PARTITIONING#0.9363;X CHROMOSOME#0.9009;BLINDNESS#0.8923;AGE AT ONSET#0.8520;ADENO ASSOCIATED VIRUS#0.8240;CELL CYCLE#0.8207;TRANSCRIPTION FACTOR#0.8126;CANCER CELL#0.7904;GENE EXPRESSION#0.7478;DNA BINDING#0.7252;STORAGE PROTEIN#0.7208;POLYMERASE CHAIN REACTION#0.6966;CELL DIVISION#0.6934;RETINAL DISEASE#0.6278
11221	DUAL SPECIFICITY PHOSPHATASE#1.0529;MAP KINASE#1.0516;MAP KINASE PHOSPHATASE#1.0502;MITOGEN ACTIVATED PROTEIN#1.0193;PROTEIN KINASE#1.0138;CANCER CELL#0.9704;PROSTATE CANCER#0.9531;EPITHELIAL CELL#0.9320;MACROPHAGE#0.9222;SIGNALING PATHWAY#0.8983;IMMUNE RESPONSE#0.8879;SKELETAL MUSCLE#0.8546;TRANSCRIPTION FACTOR#0.8516;INFLAMMATORY RESPONSE#0.8496;GENE EXPRESSION#0.8403;MAPK ACTIVATION#0.8297;ADIPOSE TISSUE#0.8071;COLORECTAL CANCER#0.8070;CYTOKINE PRODUCTION#0.8059;T CELL#0.7943;MYOGENESIS#0.7842;APOPTOSIS#0.7605;COLORECTAL#0.7460;PROTEIN TYROSINE PHOSPHATASE#0.7164;CELL PROLIFERATION#0.7084;ADAPTIVE IMMUNE RESPONSE#0.6938;MAPK BINDING#0.6894;DEPHOSPHORYLATION#0.6818;ADIPOCYTE#0.6396;GLUCOSE INTOLERANCE#0.6162
11222	RIBOSOMAL PROTEIN#0.7690;PLANT GROWTH PROMOTING#0.6814
11223	SIGNALING PATHWAY#0.7088
11224	RIBOSOMAL PROTEIN#1.0826;RIBOSOMAL SUBUNIT#0.7844;60S RIBOSOMAL SUBUNIT#0.7755;RIBOSOME#0.6884;GENE EXPRESSION#0.6558;TRANSLATIONAL ELONGATION#0.6178
11226	POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE#1.1147;BREAST CANCER#1.0729;CANCER CELL#1.0694;GLYCOSYLATION#1.0255;BREAST CANCER CELL#0.9425;CELL ADHESION#0.8881;O GLYCAN#0.8446;ENDOMETRIAL CARCINOMA#0.8090;PANCREATIC CANCER#0.7982;ADENOCARCINOMA#0.6574;OVARIAN#0.6535;LUNG ADENOCARCINOMA#0.6323;COLON CANCER#0.6289;EPITHELIAL CELL#0.6230;SIGNALING PATHWAY#0.6219;OVARIAN CANCER#0.6210
11227	CANCER CELL#0.6749;CELL MIGRATION#0.6399
11228	TUMOR SUPPRESSOR#1.0201;CANCER CELL#0.8945;LYMPH NODE METASTASIS#0.8575;LUNG CANCER#0.8546;LYMPH NODE#0.8513;CELL GROWTH#0.7172;APOPTOSIS#0.6829;CELL PROLIFERATION#0.6671
1122	CELL CYCLE#0.9870;PLASMID PARTITIONING#0.9092;CELL DIVISION#0.8312;GENE EXPRESSION#0.8086;USHER SYNDROME#0.7972;S PHASE#0.7618;HOST CELL#0.6330
11230	CANCER CELL#0.6624;NEUROBLASTIC TUMOR#0.6576;NEUROBLASTOMA#0.6457;APOPTOSIS#0.6389;MALIGNANT GLIOMA#0.6196;SYNAPTIC VESICLE#0.6165;ENDOPLASMIC RETICULUM#0.6109;HEPATOCELLULAR CARCINOMA#0.6058;COLORECTAL CANCER#0.6055;CELL DEATH#0.6014
11231	POLYCYSTIC LIVER DISEASE#1.0667;LIVER DISEASE#1.0369;ER MEMBRANE#1.0179;SEC COMPLEX#1.0100;ENDOPLASMIC RETICULUM#0.9972;PROTEIN TRANSPORT#0.9209;POLYCYSTIC KIDNEY DISEASE#0.8747;KIDNEY DISEASE#0.8664;ER LUMEN#0.7921;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.7509;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.7509;PROTEIN KINASE#0.7172;NUCLEAR ENVELOPE#0.7014;COMPLEX I#0.6907;ENDOPLASMIC RETICULUM MEMBRANE#0.6859;SIGNAL PEPTIDE#0.6657;GENE EXPRESSION#0.6627;HEAT SHOCK PROTEIN#0.6616;SIGNAL RECOGNITION PARTICLE#0.6243;PROTEIN LOCALIZATION#0.6142
11232	MTDNA#1.0673;MITOCHONDRIAL DNA#1.0306;MTDNA REPLICATION#1.0148;DNA POLYMERASE GAMMA#0.9748;MITOCHONDRIAL DISEASE#0.9092;OPHTHALMOPLEGIA#0.9000;DNA REPLICATION#0.8484;OOCYTE#0.7827;MITOCHONDRIA#0.7685;DNA BINDING#0.7604;MITOCHONDRIAL DNA REPLICATION#0.6925;MITOCHONDRIAL GENOME#0.6719;APOPTOSIS#0.6710;TRANSCRIPTION FACTOR#0.6398
11234	HERMANSKY-PUDLAK SYNDROME#1.0392;ORGANELLE#0.8959;MELANOCYTE#0.8916;LYSOSOME#0.8305;MELANOSOME#0.8143;OCULOCUTANEOUS ALBINISM#0.7739;PLATELET DENSE GRANULE#0.6561;PULMONARY FIBROSIS#0.6492;COLITIS#0.6294;AUTOPHAGY#0.6117;MELANOCYTE DIFFERENTIATION#0.6030
11235	CEREBRAL CAVERNOUS MALFORMATION 3#1.1185;PROGRAMMED CELL DEATH#1.0701;CELL DEATH#1.0621;APOPTOSIS#1.0437;CEREBRAL CAVERNOUS MALFORMATION#1.0141;ANGIOGENESIS#1.0076;ENDOTHELIAL CELL#1.0025;CENTRAL NERVOUS SYSTEM#0.9717;NERVOUS SYSTEM#0.9710;HEMORRHAGE#0.9624;CELL PROLIFERATION#0.9584;CEREBRAL HEMORRHAGE#0.9380;BLOOD VESSEL#0.9139;SIGNALING PATHWAY#0.8945;HEMORRHAGIC#0.8941;GERMINAL CENTER#0.8790;MULTIPLE MENINGIOMAS#0.8738;KINASE ACTIVITY#0.8725;PROTEIN KINASE#0.8688;ENDOTHELIUM#0.8534;VASCULAR DISEASE#0.8205;CELL JUNCTION#0.7982;FOCAL ADHESION#0.7661;PROSTATE CANCER#0.7497;GROWTH FACTOR#0.7489;BRAIN DISEASE#0.7468;SIGNALLING PATHWAY#0.7338;BRAIN ENDOTHELIAL CELL#0.7262;PROTEIN COMPLEX#0.7055;APOPTOTIC#0.6908;STRESS FIBER#0.6838;TUMOR CELLS#0.6757;T CELL#0.6729;PROTEIN PROTEIN INTERACTION#0.6618;EXOCYTOSIS#0.6341;QUANTITATIVE REAL TIME#0.6340;BREAST CANCER#0.6299;MAGNETIC RESONANCE IMAGING#0.6208;ENDOCYTIC RECYCLING#0.6203;BLOOD BRAIN BARRIER#0.6109;STEM CELL#0.6049;NEURONAL MIGRATION#0.6035
11236	UBIQUITIN#1.0663;ENDOPLASMIC RETICULUM#0.9649;KIDNEY CANCER#0.8992;RENAL CARCINOMA#0.8546;LIGASE ACTIVITY#0.8477;ER MEMBRANE#0.7921;TUMOR SUPPRESSOR#0.7886;STEROL-SENSING DOMAIN#0.7597;UBIQUITIN LIGASE ACTIVITY#0.7245;HEME OXYGENASE 1#0.7107;CANCER CELL#0.7025;PROTEASOME#0.7022;TRANSCRIPTION FACTOR#0.6724;RENAL CELL CARCINOMA#0.6173;SREBP CLEAVAGE#0.6028
11237	OPTIC DISC#0.7785
112398	HIF PROLYL HYDROXYLASE#1.0571;OXYGEN SENSOR#1.0502;PROLYL 4-HYDROXYLASE#1.0307;PROLYL HYDROXYLASE DOMAIN#1.0298;BREAST CANCER#1.0066;HYPOXIA#1.0038;HYPOXIA INDUCIBLE FACTOR#0.9973;TRANSCRIPTION FACTOR#0.9969;GENE EXPRESSION#0.9845;LUNG CANCER#0.9802;FACTOR INHIBITING HIF#0.9789;HYPOXIC#0.9774;CANCER CELL#0.9724;APOPTOSIS#0.8995;CELL PROLIFERATION#0.8854;GROWTH FACTOR#0.8477;ANGIOGENESIS#0.8424;ISCHEMIA#0.8407;SIGNALING PATHWAY#0.8318;CELL CYCLE#0.8240;DNA METHYLATION#0.7942;VON HIPPEL LINDAU#0.7840;RESPONSE TO HYPOXIA#0.7835;EPITHELIAL CELL#0.7806;INDUCTION OF APOPTOSIS#0.7560;RNA INTERFERENCE#0.7499;TUMOR SUPPRESSOR#0.7416;CELL DEATH#0.7299;DNA BINDING#0.7253;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7182;ENDOTHELIAL GROWTH FACTOR#0.7181;ENDOTHELIAL CELL#0.7056;FILAMENTOUS GROWTH#0.7012;BONE MARROW#0.6763;PYRUVATE#0.6540;LYSINE#0.6494;UBIQUITIN#0.6491;PSEUDOHYPHAL GROWTH#0.6411;BLEOMYCIN#0.6382;ARTERY#0.6339;HYDROXYLASE ACTIVITY#0.6308;FEMORAL ARTERY LIGATION#0.6290;SKELETAL MUSCLE#0.6289;NICOTINE METABOLISM#0.6238;OXYGEN DEPENDENT DEGRADATION#0.6215;BREAST CARCINOMA#0.6133;RENAL CELL CARCINOMA#0.6125;LIGASE ACTIVITY#0.6089;COLORECTAL CANCER#0.6089;RESPONSE TO LEUCINE#0.6073;POLYCYTHEMIA#0.6024
112399	HYDROXYLASE ACTIVITY#1.0642;HIF PROLYL HYDROXYLASE#1.0563;OXYGEN SENSOR#1.0459;PROLYL HYDROXYLASE DOMAIN#1.0347;PROLYL 4-HYDROXYLASE#1.0330;CANCER CELL#1.0255;APOPTOSIS#1.0214;HYPOXIC#1.0045;HYPOXIA#0.9975;GROWTH FACTOR#0.9955;PROLYL HYDROXYLASE ACTIVITY#0.9948;SIGNALING PATHWAY#0.9926;GENE EXPRESSION#0.9883;HYPOXIA INDUCIBLE FACTOR#0.9869;BREAST CANCER#0.9849;ANGIOGENESIS#0.9820;SKELETAL MUSCLE#0.9786;MACROPHAGE#0.9747;TRANSCRIPTION FACTOR#0.9744;TUMOR SUPPRESSOR#0.9723;CELL PROLIFERATION#0.9663;VON HIPPEL LINDAU#0.9612;RENAL CELL CARCINOMA#0.9251;UBIQUITIN#0.9243;ENDOTHELIAL GROWTH FACTOR#0.9226;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9226;RESPONSE TO HYPOXIA#0.9134;LUNG CANCER#0.9072;ISCHEMIA#0.9031;PYRUVATE#0.8993;APOPTOTIC#0.8893;CELL CYCLE#0.8803;FACTOR INHIBITING HIF#0.8780;CELL DEATH#0.8665;CELL GROWTH#0.8420;MUSCLE CELL#0.8370;TUMOR CELLS#0.8303;ARTERY#0.8235;ENDOTHELIAL CELL#0.8159;PYRUVATE KINASE#0.8100;SMOOTH MUSCLE#0.8024;COLORECTAL CANCER#0.8005;GLUCOSE METABOLISM#0.7759;REVERSE TRANSCRIPTION#0.7588;HIND LIMB ISCHEMIA#0.7563;COLORECTAL#0.7525;LIMB ISCHEMIA#0.7457;PANCREATIC CANCER#0.7442;EPITHELIAL CELL#0.7425;DNA METHYLATION#0.7122;POLYMERASE CHAIN REACTION#0.7026;SMOOTH MUSCLE CELL#0.6998;MESANGIAL CELL#0.6831;COLITIS#0.6761;BREAST CANCER CELL#0.6758;CELL MIGRATION#0.6756;CELLULAR RESPONSE TO HYPOXIA#0.6723;MYOCARDIAL INFARCTION#0.6572;OXYGEN DEPENDENT DEGRADATION#0.6501;OXYGEN HOMEOSTASIS#0.6257;FEMORAL ARTERY LIGATION#0.6252;RNA INTERFERENCE#0.6238;PHEOCHROMOCYTOMA#0.6205;HYPOXIA RESPONSE ELEMENT#0.6081;LYMPH NODE#0.6044;B CELL#0.6036;ISCHEMIA REPERFUSION INJURY#0.6028;NUCLEUS PULPOSUS#0.6021
1123	DUANE RETRACTION SYNDROME#0.9861;UBIQUITIN#0.6521;GAP ACTIVITY#0.6466;RAC GAP ACTIVITY#0.6240;COMPARATIVE GENOMIC HYBRIDIZATION#0.6228
112401	APOPTOSIS#1.0080;APOPTOTIC#0.6496
11240	PEPTIDYL ARGININE DEIMINASE#1.0604;BREAST CANCER#1.0381;PROTEIN CITRULLINATION#1.0328;DEIMINATION#1.0323;CANCER CELL#1.0270;ASTROCYTE#1.0243;ARGININE#0.9950;FIBRINOGEN#0.9929;CITRULLINE#0.9904;RHEUMATOID ARTHRITIS#0.9809;BREAST CANCER CELL#0.9801;EPITHELIAL CELL#0.9692;MACROPHAGE#0.9591;GENE EXPRESSION#0.9591;MULTIPLE SCLEROSIS#0.9378;NERVOUS SYSTEM#0.9294;PROTEIN ARGININE DEIMINASE#0.9187;SIGNALING PATHWAY#0.9152;TUMOR CELLS#0.8829;NEUTROPHIL#0.8828;APOPTOSIS#0.8572;GLUTATHIONE#0.8566;SYNOVIAL FLUID#0.8532;POSTTRANSLATIONAL MODIFICATION#0.8491;POST-TRANSLATIONAL MODIFICATION#0.8468;ALZHEIMER'S DISEASE#0.8380;CELL PROLIFERATION#0.8094;PERIPHERAL BLOOD#0.8027;CENTRAL NERVOUS SYSTEM#0.7989;MAMMARY GLAND#0.7948;NEURODEGENERATIVE DISEASE#0.7844;PRION DISEASE#0.7582;AUTOIMMUNE DISEASE#0.7535;COLON CANCER#0.7515;SALICYLIC ACID#0.7415;T CELL#0.7271;CELL DEATH#0.7042;ENZYME ACTIVITY#0.7010;SYNOVIUM#0.7000;OPTIC NERVE#0.6995;POLYMERASE CHAIN REACTION#0.6978;MAMMARY EPITHELIUM#0.6949;PROTEIN DISULFIDE ISOMERASE#0.6912;MYELINATION#0.6903;IMMUNE RESPONSE#0.6779;TRANSCRIPTION FACTOR#0.6731;CELL SURFACE#0.6698;AUTOIMMUNITY#0.6639;ESTROGEN RECEPTOR#0.6520;SCRAPIE#0.6368;OSTEOARTHRITIS#0.6304;GAMMA-GLUTAMYLCYSTEINE#0.6127;DEFENSE RESPONSE#0.6120;COLORECTAL CANCER#0.6072;ESTROUS CYCLE#0.6022;NEUTROPHIL ACTIVATION#0.6017
11243	TRANSCRIPTION FACTOR#0.8722;SPERMIDINE#0.7859;SPERMINE#0.7855
11244	TRANSCRIPTION FACTOR#0.9912;CELL PROLIFERATION#0.8519;APOPTOSIS#0.7249;HEPATOCELLULAR CARCINOMA#0.7161;TRANSCRIPTION REPRESSOR#0.6631;GENE EXPRESSION#0.6387;CELL GROWTH#0.6354
112464	RED BLOOD CELL#1.0657;CAVEOLAE#1.0408;ERYTHROCYTE#1.0381;MACROPHAGE#1.0158;SERUM ALBUMIN#1.0086;HUMORAL IMMUNE RESPONSE#1.0081;HYPERSENSITIVITY#1.0073;TUMOR SUPPRESSOR#1.0063;DELAYED-TYPE HYPERSENSITIVITY#1.0014;T CELL#1.0007;ANTIBODY PRODUCTION#0.9999;IMMUNE RESPONSE#0.9948;B CELL#0.9937;LYMPH NODE#0.9697;PHAGOCYTOSIS#0.9594;IMMUNE SYSTEM#0.9496;PROTEIN KINASE#0.9326;SENSITIZATION#0.9183;CANCER CELL#0.9145;PROTEIN KINASE C#0.9062;CYCLOPHOSPHAMIDE#0.9010;T LYMPHOCYTE#0.8859;GENE EXPRESSION#0.8850;BONE MARROW#0.8718;B LYMPHOCYTE#0.8622;PERIPHERAL BLOOD#0.8459;IGM ANTIBODY#0.8289;IGG ANTIBODY#0.8244;CELL PROLIFERATION#0.7980;HEMOLYSIS#0.7945;LUNG CANCER#0.7880;TUMOR CELLS#0.7827;SUPPRESSOR T CELL#0.7813;HYPERSENSITIVITY RESPONSE#0.7770;THYMOCYTE#0.7564;IMMUNOTOXICITY#0.7515;PLASMA MEMBRANE#0.7492;CYTOTOXICITY#0.7254;APOPTOSIS#0.6868;CELL CYCLE#0.6862;CELL-MEDIATED IMMUNITY#0.6850;IMMUNOGLOBULIN G#0.6789;OVARIAN#0.6226;ANTIGEN BINDING#0.6157;GROWTH FACTOR#0.6124;CAVEOLAE-DEPENDENT ENDOCYTOSIS#0.6088;CD4+ T CELL#0.6044
112476	BENIGN FAMILIAL INFANTILE EPILEPSY#1.1227;CONVULSION#1.0557;MIGRAINE#1.0394;DYSKINESIA#1.0390;EPISODIC ATAXIA#1.0372;EPILEPSY#1.0279;NEUROLOGICAL DISORDER#1.0141;DYSTONIA#0.9935;SIGNALING PATHWAY#0.9632;PROTEIN KINASE#0.9570;NEUROTRANSMITTER RELEASE#0.9560;CARBAMAZEPINE#0.9380;SNARE COMPLEX#0.9010;INTELLECTUAL DISABILITY#0.8872;FAMILIAL HEMIPLEGIC MIGRAINE#0.8512;IFN-GAMMA#0.8441;ION CHANNEL#0.8346;PLASMA MEMBRANE#0.7856;INTRAHEPATIC CHOLANGIOCARCINOMA#0.7761;GLUTAMATE RECEPTOR#0.7668;NERVOUS SYSTEM#0.7629;GENE EXPRESSION#0.7608;CHOLANGIOCARCINOMA#0.7584;SIGNAL TRANSDUCTION#0.7503;SPINAL CORD#0.7473;BASAL GANGLIA#0.7353;STEM CELL#0.7263;SYNAPTIC TRANSMISSION#0.6801;AGE AT ONSET#0.6698;COPY NUMBER VARIATION#0.6593;CELL SURFACE#0.6494;MIGRAINE WITH AURA#0.6404;GASTROENTERITIS#0.6399;MENTAL RETARDATION#0.6358;PLURIPOTENT STEM CELL#0.6354;SYNAPTIC VESICLE#0.6330;SNARE COMPLEX ASSEMBLY#0.6329;APOPTOSIS#0.6192
11247	DIFFERENTIAL GROWTH#1.0043;GENE EXPRESSION#0.8739;AUXIN RESPONSE FACTOR#0.8403;NEOPTERIN#0.6555;PHOTOTROPISM#0.6332;HEPATOTOXICITY#0.6140;EDEMA#0.6093
112483	SPERMINE#1.0256;FOOT AND MOUTH DISEASE#1.0105;MOUTH DISEASE#1.0102;SPERMIDINE#0.9732;L-PROLINE TRANSPORT#0.6855;PX-12#0.6394;PROLINE TRANSPORT#0.6353
11248	INDUCED PLURIPOTENT STEM CELL#0.6594;PLURIPOTENT STEM CELL#0.6569;STEM CELL#0.6439
1124	DIABETIC RETINOPATHY#0.7704;PROTEINASE INHIBITOR#0.6513;TYPE 2 DIABETIC#0.6301;TYPE 2 DIABETES#0.6243
11251	ACETIC ACID#1.0646;BASOPHIL#1.0533;TH2 CELL#1.0460;INDOLE#1.0382;BETA CELL#1.0352;ALLERGIC RHINITIS#1.0348;RECEPTOR ANTAGONIST#1.0338;CHEMOTAXIS#1.0335;LEUKOCYTE#1.0327;PRO-INFLAMMATORY#1.0304;CHEMOKINE RECEPTOR#1.0286;RHINITIS#1.0283;EOSINOPHIL#1.0280;STRUCTURE ACTIVITY RELATIONSHIP#1.0240;CD4+ T CELL#1.0230;ATOPIC DERMATITIS#1.0184;T CELL#1.0158;EOSINOPHIL MIGRATION#1.0156;CYTOKINE PRODUCTION#1.0124;PERIPHERAL BLOOD#1.0058;INDOMETHACIN#1.0058;INFLAMMATORY CELL#1.0057;DERMATITIS#1.0046;MAST CELL#1.0045;APOPTOSIS#1.0037;CELL SURFACE#1.0016;INFLAMMATORY RESPONSE#1.0002;ALLERGEN#0.9973;EPITHELIAL CELL#0.9963;ALLERGIC ASTHMA#0.9956;SIGNALING PATHWAY#0.9735;IFN-GAMMA#0.9724;LYMPHOID CELL#0.9719;THROMBOXANE A2 RECEPTOR#0.9691;BONE MARROW#0.9679;GENE EXPRESSION#0.9664;DENDRITIC CELL#0.9649;IMMUNE RESPONSE#0.9594;TRANSCRIPTION FACTOR#0.9586;MACROPHAGE#0.9526;ARACHIDONIC ACID#0.9434;IMMUNE CELL#0.9385;T LYMPHOCYTE#0.9351;NEUTROPHIL#0.9307;CELL MIGRATION#0.9177;GM-CSF#0.8857;RECEPTOR AGONIST#0.8840;CD8+ T CELL#0.8818;T HELPER CELL#0.8799;EOSINOPHIL CHEMOTAXIS#0.8692;PROTEIN KINASE#0.8648;MONONUCLEAR CELLS#0.8644;B CELL#0.8583;PROSTAGLANDIN D SYNTHASE#0.8573;NASAL MUCOSA#0.8561;CALCIUM MOBILIZATION#0.8430;LYMPH NODE#0.8238;MONOCYTE#0.8196;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8193;SENSITIZATION#0.8069;ASPIRIN#0.7907;HYPERSENSITIVITY#0.7873;ANTI INFLAMMATORY DRUGS#0.7829;MEMORY T CELL#0.7706;COLITIS#0.7567;CENTRAL NERVOUS SYSTEM#0.7437;TREG CELL#0.7434;NERVOUS SYSTEM#0.7425;POLYMERASE CHAIN REACTION#0.7377;HAIR FOLLICLE#0.7324;ISOQUINOLINE#0.7316;PEROXISOME#0.7240;COLORECTAL CANCER#0.7227;HUMAN WHOLE BLOOD#0.7210;ALLERGIC AIRWAY INFLAMMATION#0.7152;CELL DEATH#0.6990;BETA CELL MASS#0.6876;HAIR GROWTH#0.6876;IMMUNE SYSTEM#0.6866;SMOOTH MUSCLE#0.6856;PEPTIDE BINDING#0.6811;BRONCHIAL EPITHELIAL CELLS#0.6799;TRANSMEMBRANE RECEPTOR#0.6768;MOLECULAR DYNAMICS SIMULATION#0.6718;OXYGENASE#0.6713;GROWTH FACTOR#0.6710;KINASE INHIBITOR#0.6700;DNA SYNTHESIS#0.6677;TH1 CELL#0.6538;SKIN DISEASE#0.6535;APOPTOTIC#0.6521;CHRONIC BERYLLIUM DISEASE#0.6509;KERATINOCYTE#0.6502;CANCER CELL#0.6485;NEUTROPHIL MIGRATION#0.6394;PROSTAGLANDIN RECEPTOR#0.6375;GLUTAMIC ACID#0.6307;MITOGEN ACTIVATED PROTEIN#0.6285;MONTELUKAST#0.6270;CELL PROLIFERATION#0.6261;REVERSE TRANSCRIPTION#0.6218;REGULATORY T CELL#0.6196;PROTEIN KINASE A#0.6168;CELL CYCLE#0.6152;ALLERGIC CONJUNCTIVITIS#0.6150;HISTAMINE#0.6114;FORCED EXPIRATORY VOLUME#0.6099;CROHN'S DISEASE#0.6059;DECIDUA#0.6028;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6003
11252	PLASMA MEMBRANE#1.0252;CAVEOLAE#0.9719;PROTEIN KINASE C#0.9442;PROTEIN KINASE#0.9439;ENDOCYTOSIS#0.9375;ACTIN CYTOSKELETON#0.8167;EPITHELIAL CELL#0.8102;CAVEOLAR BIOGENESIS#0.7862;TOXICITY#0.7683;ENDOSOME#0.7098;MEMBRANE TUBULATION#0.6703;MICROSPIKE FORMATION#0.6381;ACTIN FILAMENT#0.6204
11253	MANNOSIDASE I#1.0894;MANNOSIDASE ACTIVITY#1.0535;ENDOPLASMIC RETICULUM#1.0181;N GLYCAN#1.0081;ALPHA MANNOSIDASE#1.0021;GLYCOSYLATION#0.9942;GLCNAC#0.8729;CONGENITAL DISORDER#0.8288;INTELLECTUAL DISABILITY#0.7925;GOLGI COMPLEX#0.7488;1-DEOXYMANNOJIRIMYCIN#0.7473;ASPARAGINE#0.7426;ENZYME ACTIVITY#0.7210;CONGENITAL DISORDER OF GLYCOSYLATION#0.7188;LIVER DISEASE#0.6848;T CELL#0.6783;SECRETORY PATHWAY#0.6325;GOLGI MEMBRANE#0.6165;PROTEIN DEGRADATION#0.6059;HEPATOCELLULAR CARCINOMA#0.6034
11254	PLASMA MEMBRANE#0.8784;BREAST CANCER#0.8689;CANCER CELL#0.8534;CYSTIC FIBROSIS#0.8517;ARGININE#0.8321;EPITHELIAL CELL#0.8198;L-ARGININE#0.7843;MECONIUM#0.6664;ILEUS#0.6646;L-ARGININE TRANSPORT#0.6575;BETA-ALANINE#0.6437;ARGININE TRANSPORT#0.6401;GENE EXPRESSION#0.6304;PANCREATIC CANCER#0.6196;BREAST CANCER CELL#0.6109;L-ARGININE UPTAKE#0.6037;INFERTILITY#0.6004
11255	HISTAMINE#1.0259;COGNITIVE DISORDER#1.0235;HISTAMINE RECEPTOR#1.0198;ALZHEIMER'S DISEASE#1.0092;HISTIDINE DECARBOXYLASE#1.0075;NERVOUS SYSTEM#1.0049;CENTRAL NERVOUS SYSTEM#0.9883;DOPAMINE#0.9833;HISTIDINE#0.9788;RECEPTOR ANTAGONIST#0.9676;COGNITION#0.9382;NARCOLEPSY#0.9187;EPILEPSY#0.9175;STRIATUM#0.9049;ACETYLCHOLINE#0.8824;RECEPTOR AGONIST#0.8673;MAST CELL#0.8602;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.8386;DOPAMINE RECEPTOR#0.8237;GENE EXPRESSION#0.8044;VALPROIC ACID#0.8033;FORSKOLIN#0.7991;HYPERACTIVITY#0.7987;BLOOD BRAIN BARRIER#0.7877;NEUROTRANSMISSION#0.7785;MULTIPLE SCLEROSIS#0.7528;ENERGY HOMEOSTASIS#0.7501;STRUCTURE ACTIVITY RELATIONSHIP#0.7498;SIGNALING PATHWAY#0.7495;RECEPTOR LIGAND#0.7488;PYRILAMINE#0.7368;ETHANOL#0.7362;HISTAMINE BINDING#0.7354;BREAST CANCER#0.7226;PROTEIN KINASE#0.7147;CONVULSION#0.6934;NEURODEGENERATIVE DISEASE#0.6854;POLYMERASE CHAIN REACTION#0.6615;CELL PROLIFERATION#0.6548;WAKEFULNESS#0.6487;PIPERAZINE#0.6397;HISTAMINE N METHYLTRANSFERASE#0.6360;SLEEP DISORDER#0.6357;NOVEL OBJECT RECOGNITION#0.6355;CELL SURFACE#0.6300;CHLORPHENIRAMINE MALEATE#0.6246;N METHYLTRANSFERASE#0.6190;NASAL MUCOSA#0.6054;CAMP FORMATION#0.6050;DONEPEZIL#0.6039
112574	AUTOPHAGOSOME FORMATION#0.8883;RECYCLING ENDOSOME#0.8729;PLASMA MEMBRANE#0.8255;ENDOSOME#0.7962;AUTOPHAGOSOME#0.7910;ENDOCYTOSIS#0.7014
11257	CANCER CELL#0.6678;BREAST CANCER#0.6670;L-GLUTAMINE#0.6368;PANCREATIC DUCTAL ADENOCARCINOMA#0.6225;GLUCOSE METABOLISM#0.6145;CELL PROLIFERATION#0.6043
11258	IN VITRO MATURED#0.6476
112597	CELL CYCLE#1.0834;CANCER CELL#1.0822;CELL PROLIFERATION#1.0689;APOPTOSIS#1.0686;COLORECTAL CANCER#1.0603;LYMPH NODE METASTASIS#1.0539;LYMPH NODE#1.0494;SIGNALING PATHWAY#1.0483;ONCOGENIC#1.0425;BREAST CANCER#1.0120;SQUAMOUS CELL CARCINOMA#1.0113;HEPATOCELLULAR CARCINOMA#1.0030;CELL CYCLE ARREST#1.0014;ADJACENT NORMAL TISSUE#0.9984;COLORECTAL#0.9658;QUANTITATIVE REAL TIME#0.9583;POLYMERASE CHAIN REACTION#0.9388;OVARIAN CANCER#0.9266;GENE EXPRESSION#0.9254;CELL GROWTH#0.9102;CELL MIGRATION#0.8744;COLON CANCER#0.8664;LUNG CANCER#0.8630;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8355;EPITHELIAL TO MESENCHYMAL#0.8352;RENAL CELL CARCINOMA#0.8187;G1 PHASE#0.7763;OVARIAN#0.7667;BREAST CANCER CELL#0.7666;LUNG ADENOCARCINOMA#0.7658;TUMOR TISSUES#0.7646;REVERSE TRANSCRIPTION#0.6856;GENE EXPRESSION OMNIBUS#0.6787;GALLBLADDER CANCER#0.6544;ADENOCARCINOMA#0.6428;DISEASE FREE SURVIVAL#0.6410;DUAL LUCIFERASE REPORTER#0.6267;EPITHELIAL MESENCHYMAL TRANSITION#0.6222;CLEAR CELL RENAL CELL CARCINOMA#0.6188;EPITHELIAL OVARIAN CANCER#0.6151;PAPILLARY THYROID CARCINOMA#0.6108;CYTOPLASM#0.6077;THYROID CARCINOMA#0.6058
11259	A INTERACTING PROTEIN#1.1813;OVARIAN CANCER#1.1089;CANCER CELL#1.0462;OVARIAN#1.0396;DNA METHYLATION#0.8397;GENE EXPRESSION#0.8024;CELL PROLIFERATION#0.7644;EPITHELIAL CELL#0.6414
112609	MELANOCORTIN RECEPTOR#1.0803;ENERGY HOMEOSTASIS#1.0293;ADRENAL GLAND#0.8188;CELL SURFACE#0.7427;PLASMA MEMBRANE#0.6820
11260	IMPORTIN#1.0304;NUCLEAR EXPORT SIGNAL#1.0142;NUCLEAR EXPORT#1.0091;CYTOPLASM#0.9942;NUCLEAR PORE#0.9941;NUCLEAR IMPORT#0.9847;NUCLEAR TRANSPORT#0.9814;CHROMOSOME REGION#0.9809;TRANSCRIPTION FACTOR#0.9497;NUCLEAR PORE COMPLEX#0.9395;PORE COMPLEX#0.9387;NUCLEOCYTOPLASMIC TRANSPORT#0.9361;NUCLEOCYTOPLASMIC SHUTTLING#0.9090;KARYOPHERIN#0.9083;LEUCINE#0.8913;CELL CYCLE#0.8814;GENE EXPRESSION#0.8783;NUCLEAR LOCALIZATION SIGNAL#0.8391;NUCLEAR ENVELOPE#0.8174;PROTEIN KINASE#0.7975;NUCLEAR PORE COMPLEXES#0.7603;RNA BINDING#0.7508;CANCER CELL#0.7505;TRANSPORTIN#0.7044;MICROTUBULE#0.7013;TUMOR SUPPRESSOR#0.6926;MIRNA PROCESSING#0.6191;MITOSIS#0.6172;MOLECULAR DYNAMICS SIMULATION#0.6146;RNA BINDING PROTEIN#0.6064
112616	TUMOR SUPPRESSOR#0.9165;AKT SIGNALING#0.8857;CANCER CELL#0.8056;B CELL#0.8013;PLASMA CELL#0.6700;CELL DEVELOPMENT#0.6693;LUNG CANCER#0.6629;CELL GROWTH#0.6624;CELL CYCLE#0.6494;PLASMA CELL DIFFERENTIATION#0.6360;TERMINAL DIFFERENTIATION#0.6126;LIVER CANCER#0.6108;CELL DIFFERENTIATION#0.6027;PLASMA MEMBRANE#0.6002
11261	CALCINEURIN#1.0651;PROTEIN KINASE#1.0146;PLASMA MEMBRANE#1.0141;T CELL#1.0099;HOMOLOGOUS RECOMBINATION#0.9156;HUMAN IMMUNODEFICIENCY VIRUS#0.8770;VIRION#0.8511;NUCLEAR EXPORT#0.8095;DNA BINDING#0.7991;JUXTAMEMBRANE#0.7168;CELL SURFACE#0.7058;IMMUNE RESPONSE#0.7035;POLYMERASE CHAIN REACTION#0.7031;GENE EXPRESSION#0.7019;T-CELL LEUKEMIA#0.6909;METHIONINE#0.6860;PERIPHERAL BLOOD#0.6777;BORNA DISEASE#0.6775;HETEROCHROMATIN#0.6599;TRANSCRIPTASE#0.6590;APOPTOSIS#0.6556;NADPH OXIDASE#0.6549;LYSIS#0.6393;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6228;MONONUCLEAR CELLS#0.6217;CALCINEURIN ACTIVITY#0.6185;MICROTUBULE BINDING#0.6072
11262	NUCLEAR BODY#0.9556;MULTIPLE SCLEROSIS#0.7745;PML NB#0.7440;LEUKOCYTE#0.6900;PRIMARY BILIARY CIRRHOSIS#0.6707;PERIPHERAL BLOOD#0.6184
11264	PEROXISOMAL MEMBRANE#0.8006;PEROXISOMAL#0.7510;PEROXISOME MEMBRANE#0.6982;DNA METHYLATION#0.6355
11266	DUAL SPECIFICITY PHOSPHATASE#1.0759;MAP KINASE#1.0125;GENE EXPRESSION#1.0108;PROTEIN KINASE#0.9896;CANCER CELL#0.9873;APOPTOSIS#0.9544;MAPK SIGNALING#0.9117;MITOGEN ACTIVATED PROTEIN#0.8694;SIGNALING PATHWAY#0.8611;MAP KINASE PHOSPHATASE#0.8367;ZINC BINDING#0.8338;MACROPHAGE#0.8248;TYPE 2 DIABETES#0.8068;INFLAMMATORY RESPONSE#0.7951;PHOSPHATASE I#0.7781;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.7648;TUMOR NECROSIS FACTOR#0.7347;CELL DEATH#0.7231;CELL CYCLE#0.7230;RIBOSOME#0.7215;CELL PROLIFERATION#0.7039;CELL GROWTH#0.6962;SPORULATION#0.6952;DEPHOSPHORYLATION#0.6702;BONE MARROW#0.6629;PROTEIN TYROSINE PHOSPHATASE#0.6518;ANGIOGENESIS#0.6421;TUMOR CELLS#0.6396;PHOSPHATASE ACTIVITY#0.6389;PANCREATIC CANCER#0.6132;BREAST CANCER CELL#0.6101;GENE SILENCING#0.6101;BREAST CANCER#0.6058;SIGNAL TRANSDUCTION#0.6030;TRANSCRIPTION FACTOR#0.6007
11267	ESCRT II COMPLEX#1.0591;ENDOSOME#0.7438;GROWTH FACTOR#0.6771;MEIOTIC SPINDLE POLE#0.6722;MULTIVESICULAR BODY#0.6395
11269	RNA HELICASE#1.0873;ATPASE ACTIVITY#1.0817;NUCLEAR PORE COMPLEX#1.0322;NUCLEAR PORE#1.0322;PORE COMPLEX#1.0315;NUCLEAR EXPORT#1.0143;CYTOPLASM#0.9607;RNA BINDING#0.9423;TRANSLATION TERMINATION#0.8857;ATP HYDROLYSIS#0.8162;GENE EXPRESSION#0.7542;NUCLEAR PORE COMPLEXES#0.7378;RNA DEPENDENT ATPASE#0.6587;ATP BINDING#0.6518;NUCLEAR IMPORT#0.6256;RIBOSOMAL SUBUNIT#0.6199;RNA EXPORT FACTOR#0.6135
11270	NUCLEAR ENVELOPE#0.9069;NUCLEAR MEMBRANE#0.9010;INNER NUCLEAR MEMBRANE#0.7840
112724	RETINOL DEHYDROGENASE#1.0552;RETINOL#0.8958
11272	LACRIMAL GLAND#0.7595;ACINAR CELL#0.6770;GENE EXPRESSION#0.6614
11273	STRESS GRANULE#0.9468;C TERMINAL DOMAIN#0.6767;AKT SIGNALING#0.6120;EPIDERMAL GROWTH FACTOR#0.6038
112744	IL-17F PRODUCTION#1.1288;BRONCHIAL EPITHELIAL CELLS#1.0470;GM-CSF#1.0424;FRAGMENT LENGTH POLYMORPHISM#1.0221;CHRONIC MUCOCUTANEOUS CANDIDIASIS#1.0216;G-CSF#1.0199;RELATED ORPHAN RECEPTOR#1.0181;COLONY-STIMULATING FACTOR#1.0132;IFN-GAMMA#1.0131;CANDIDIASIS#1.0077;RETINOIC ACID#1.0062;ENDOTHELIAL CELL#1.0056;TUMOR NECROSIS FACTOR#1.0002;PERIODONTITIS#1.0001;B CELL#0.9995;SMOOTH MUSCLE#0.9950;CD4+ T CELL#0.9922;EPITHELIAL CELL#0.9922;GRANULOCYTE#0.9907;CHEMOKINE RECEPTOR#0.9906;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9903;TH17 CELL#0.9903;POLYMERASE CHAIN REACTION#0.9877;MONOCYTE#0.9869;PSORIASIS#0.9856;T LYMPHOCYTE#0.9853;SIGNALING PATHWAY#0.9834;RHEUMATOID ARTHRITIS#0.9830;MONONUCLEAR CELLS#0.9830;NEUTROPHIL#0.9829;T HELPER CELL#0.9828;COLITIS#0.9818;LYMPH NODE#0.9812;TRANSFORMING GROWTH FACTOR#0.9811;TRANSCRIPTION FACTOR#0.9809;GENE EXPRESSION#0.9801;PRO-INFLAMMATORY#0.9796;PERIPHERAL BLOOD#0.9785;PSORIATIC ARTHRITIS#0.9785;CELL DIFFERENTIATION#0.9777;GROWTH FACTOR#0.9776;T CELL#0.9776;TUMOUR NECROSIS FACTOR#0.9770;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9769;TH2 CELL#0.9757;PROTEIN KINASE#0.9752;MACROPHAGE#0.9750;OSTEOARTHRITIS#0.9747;IMMUNE CELL#0.9746;MAST CELL#0.9742;COLORECTAL CANCER#0.9725;INFLAMMATORY BOWEL DISEASE#0.9721;AUTOIMMUNITY#0.9713;INFLAMMATORY RESPONSE#0.9700;EOSINOPHIL#0.9698;REGULATORY T CELL#0.9698;IL-17 PRODUCTION#0.9697;DENDRITIC CELL#0.9694;CYTOKINE PRODUCTION#0.9693;KERATINOCYTE#0.9688;TUBERCULOSIS#0.9688;CROHN'S DISEASE#0.9684;BONE MARROW#0.9656;INFLAMMATORY CELL#0.9649;CELL PROLIFERATION#0.9631;ULCERATIVE COLITIS#0.9609;LEUKOCYTE#0.9604;CD8+ T CELL#0.9602;MULTIPLE SCLEROSIS#0.9601;ENCEPHALOMYELITIS#0.9599;TH1 CELL#0.9594;IMMUNE RESPONSE#0.9592;IMMUNE SYSTEM#0.9591;LYMPHOID CELL#0.9579;TREG CELL#0.9566;AUTOIMMUNE DISEASE#0.9562;MUSCLE CELL#0.9555;SMOOTH MUSCLE CELL#0.9543;LUNG CANCER#0.9534;MICROVASCULAR ENDOTHELIAL CELL#0.9525;KINASE INHIBITOR#0.9490;ALLERGEN#0.9437;REVERSE TRANSCRIPTION#0.9413;QUANTITATIVE REAL TIME#0.9392;C REACTIVE PROTEIN#0.9376;CANCER CELL#0.9354;NITRIC OXIDE#0.9339;CELL SURFACE#0.9333;IL-1RA#0.9325;SIGNAL TRANSDUCER#0.9312;DEXAMETHASONE#0.9308;CELL ACTIVATION#0.9294;ACTIVATED T CELL#0.9266;RETINOIC ACID RECEPTOR#0.9257;LEPROSY#0.9244;PROSTAGLANDIN E2#0.9221;SIGNAL TRANSDUCTION#0.9211;TRANSFORMING GROWTH FACTOR BETA#0.9188;COLORECTAL#0.9156;SKIN DISEASE#0.9117;ALLERGIC AIRWAY INFLAMMATION#0.9097;ANGIOGENESIS#0.9091;AIRWAY SMOOTH MUSCLE#0.9043;ACTIVATED T-CELLS#0.9042;APOPTOSIS#0.9035;MITOGEN ACTIVATED PROTEIN#0.8990;LUPUS ERYTHEMATOSUS#0.8975;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8789;TOLL LIKE RECEPTOR#0.8768;CERVICAL CANCER#0.8747;MEMORY T CELL#0.8744;CYTOKINE SECRETION#0.8720;UMBILICAL VEIN#0.8689;CYTOTOXICITY#0.8682;RECEPTOR ANTAGONIST#0.8655;SYNOVIAL FLUID#0.8638;IL-17A PRODUCTION#0.8604;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8590;STEM CELL#0.8567;EFFECTOR T CELL#0.8535;MACROPHAGE INFLAMMATORY PROTEIN#0.8507;TOPICAL#0.8474;PROTEIN KINASE C#0.8471;VASCULAR ENDOTHELIAL CELL#0.8396;HUMAN UMBILICAL VEIN#0.8347;BREAST CANCER#0.8319;ADAPTIVE IMMUNE RESPONSE#0.8313;IL-6 PRODUCTION#0.8256;T CELL ACTIVATION#0.8207;MESENTERIC LYMPH NODE#0.8205;IMIQUIMOD#0.8173;ALLERGIC ASTHMA#0.8151;RECEPTOR COMPLEX#0.8126;NAIVE CD4+ T CELL#0.8094;AUTOIMMUNE POLYENDOCRINE SYNDROME#0.8087;INNATE IMMUNITY#0.8065;CELL GROWTH#0.8053;LUNG MICROVASCULAR ENDOTHELIAL#0.8028;DERMATITIS#0.8008;COLON CANCER#0.8002;INNATE IMMUNE RESPONSE#0.7994;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.7982;CELL ASSOCIATED#0.7978;CENTRAL NERVOUS SYSTEM#0.7954;MAP KINASE#0.7948;B LYMPHOCYTE#0.7946;NERVOUS SYSTEM#0.7944;STROMAL CELL#0.7916;SIGNALLING PATHWAY#0.7893;CELL CYCLE#0.7890;TUBE FORMATION#0.7879;SQUAMOUS CELL CARCINOMA#0.7862;ALLERGIC RHINITIS#0.7825;UVEITIS#0.7808;CONNECTIVE TISSUE#0.7796;ARACHIDONIC ACID#0.7772;CYCLIC AMP#0.7591;IL-8 PRODUCTION#0.7586;GRANULOCYTE COLONY STIMULATING FACTOR#0.7573;CERVICAL#0.7540;CELL DEVELOPMENT#0.7539;IL-6 SECRETION#0.7483;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7460;IL-11#0.7426;BETA-2#0.7423;HEPATITIS B#0.7400;RESPONSE TO TREATMENT#0.7390;CD4+ T HELPER CELL#0.7357;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7330;ENDOTHELIAL GROWTH FACTOR#0.7329;PULMONARY TUBERCULOSIS#0.7284;ALVEOLAR MACROPHAGE#0.7243;NATURAL KILLER CELL#0.7219;LIVER DISEASE#0.7194;HEALTHY CONTROL SUBJECTS#0.7176;ORAL SQUAMOUS CELL CARCINOMA#0.7170;DEXTRAN SULFATE SODIUM#0.7053;CHEMOKINE PRODUCTION#0.7053;CELL DEATH#0.7039;COLLAGEN INDUCED ARTHRITIS#0.7036;DISEASE ACTIVITY INDEX#0.7032;GM-CSF PRODUCTION#0.7023;ATOPIC DERMATITIS#0.7007;MYOCARDIAL INFARCTION#0.6975;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6968;TH17 IMMUNE RESPONSE#0.6917;NAIVE T CELL#0.6892;RHINITIS#0.6881;MONOCYTE CHEMOTACTIC PROTEIN#0.6867;RESPIRATORY TRACT#0.6856;THROMBOCYTOPENIA#0.6848;TIGHT JUNCTION#0.6823;ARGININE#0.6822;L-ARGININE#0.6807;PERIODONTAL DISEASE#0.6764;CHEMOTAXIS#0.6739;MAGNETIC RESONANCE IMAGING#0.6725;INTERLEUKIN 17 RECEPTOR#0.6720;IFN-BETA#0.6713;SENSITIZATION#0.6694;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6685;USTEKINUMAB#0.6594;CYTOKINE RECEPTOR#0.6593;LUNG DISEASE#0.6567;HEPATITIS C#0.6525;DIABETES MELLITUS#0.6521;HISTAMINE#0.6505;ANKYLOSING SPONDYLITIS#0.6490;DOMINANT NEGATIVE MUTANT#0.6467;LIVER DAMAGE#0.6459;VIRAL INFECTION#0.6421;SILICOSIS#0.6330;OROPHARYNGEAL CANDIDIASIS#0.6301;AIRWAY EPITHELIAL CELL#0.6295;C CHEMOKINE RECEPTOR#0.6293;NITRIC OXIDE SYNTHASE#0.6288;G-CSF PRODUCTION#0.6269;GRAVES' DISEASE#0.6267;CHRONIC HEPATITIS B#0.6256;CHONDROCYTE#0.6254;OSTEOBLAST#0.6250;CONSERVED NONCODING SEQUENCE#0.6236;EXTRACELLULAR MATRIX#0.6218;PANCREATIC CANCER#0.6212;INFLIXIMAB#0.6208;GOBLET CELL#0.6178;IL-17A SECRETION#0.6174;T CELL DIFFERENTIATION#0.6156;THYMIDINE#0.6153;SUPEROXIDE DISMUTASE#0.6143;T CELL PROLIFERATION#0.6114;TISSUE DAMAGE#0.6112;ARTERY#0.6065;ASTROCYTE#0.6051;SYNOVIUM#0.6049
11274	UBIQUITIN SPECIFIC PROTEASE#1.0824;INTERFERON STIMULATED GENE#1.0408;UBIQUITIN#1.0407;APOPTOSIS#1.0287;INNATE IMMUNE RESPONSE#1.0219;SIGNALING PATHWAY#1.0136;MACROPHAGE#1.0111;IMMUNE RESPONSE#1.0044;HEPATITIS C#1.0023;IFN STIMULATED GENES#0.9974;HEPATITIS B#0.9947;GENE EXPRESSION#0.9942;T CELL#0.9833;PERIPHERAL BLOOD#0.9804;VIRAL INFECTION#0.9763;CANCER CELL#0.9695;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9656;MONONUCLEAR CELLS#0.9647;HEPATITIS C VIRUS#0.9646;INNATE IMMUNITY#0.9294;BONE MARROW#0.9221;CONJUGATION#0.9095;INTERFERON RECEPTOR#0.8794;CELL CYCLE#0.8711;VIRAL REPLICATION#0.8689;HEPATITIS B VIRUS#0.8356;HYPERSENSITIVITY#0.8352;SIGNAL TRANSDUCER#0.8214;IFN-BETA#0.8208;TUMOR NECROSIS FACTOR#0.8175;PROTEASE ACTIVITY#0.8143;ISOPEPTIDASE ACTIVITY#0.8041;LUNG CANCER#0.7918;INFLAMMATORY RESPONSE#0.7714;CELL PROLIFERATION#0.7647;DENDRITIC CELL#0.7641;CHRONIC HEPATITIS C#0.7605;HEMATOPOIETIC CELL#0.7596;GROWTH FACTOR#0.7469;ANTIVIRAL RESPONSE#0.7438;IMMUNE SYSTEM#0.7431;DEUBIQUITINASE#0.7311;TRANSCRIPTION FACTOR#0.7302;APOPTOTIC#0.7268;SIGNALLING PATHWAY#0.7164;AUTOIMMUNE DISEASE#0.6956;CHRONIC HEPATITIS B#0.6887;CD4+ T CELL#0.6808;S PHASE#0.6785;CELL DIFFERENTIATION#0.6768;EPIDERMAL GROWTH FACTOR#0.6748;POLYMERASE CHAIN REACTION#0.6525;LYMPHOCYTIC CHORIOMENINGITIS#0.6490;INTERFERON REGULATORY FACTOR#0.6442;MULTIPLE SCLEROSIS#0.6373;CELL GROWTH#0.6352;RNA INTERFERENCE#0.6333;CELL DEATH#0.6232;CD8+ T CELL#0.6113;BONE MARROW CELLS#0.6011
112752	RECEPTOR INTERACTING PROTEIN#1.0242;CELL DEATH#1.0097;PROGRAMMED CELL DEATH#1.0062;APOPTOSIS#0.9997;GERM CELL#0.9881;APOPTOTIC#0.9851;PROTEASE ACTIVITY#0.9755;APOPTOTIC CELL DEATH#0.9709;POLY ADP RIBOSE#0.9600;INDUCTION OF APOPTOSIS#0.9566;CELL KILLING#0.9477;CASPASE ACTIVATION#0.9151;PROTEIN KINASE#0.9133;DNA FRAGMENTATION#0.9127;CASPASE ACTIVITY#0.9037;RIBOSE#0.9031;MITOCHONDRIA#0.9025;GENE EXPRESSION#0.8658;ASPARTATE#0.8628;TRANSCRIPTION FACTOR#0.8616;IFT A COMPLEX#0.8398;CYTOCHROME C#0.8357;INTRAFLAGELLAR TRANSPORT#0.8224;APOPTOSOME#0.8211;SIGNALING PATHWAY#0.8175;SIGNAL TRANSDUCTION#0.8130;CASPASE INHIBITOR#0.8117;REGENERATION#0.7935;TUMOR NECROSIS FACTOR#0.7859;NERVOUS SYSTEM#0.7765;MITOCHONDRIAL MEMBRANE#0.7711;NEURONAL CELL DEATH#0.7500;SENSENBRENNER SYNDROME#0.7485;TUMOR SUPPRESSOR#0.7371;DNA DEGRADATION#0.7355;CELL CYCLE#0.7354;T CELL#0.7339;DEATH RECEPTOR#0.7329;PLASMA MEMBRANE#0.7198;GROWTH FACTOR#0.7149;NUCLEOTIDE BINDING#0.6939;TOXICITY#0.6936;REGULATION OF APOPTOSIS#0.6399;MITOGEN ACTIVATED PROTEIN#0.6278;STAUROSPORINE#0.6186;BASAL BODY#0.6059
112755	SYNAPTIC VESICLE#1.0070;PLASMA MEMBRANE#0.9963;EPILEPSY#0.9725;EXOCYTOSIS#0.9242;NEUROTRANSMITTER RELEASE#0.9074;NERVOUS SYSTEM#0.8874;PARKINSON'S DISEASE#0.8155;LONG TERM POTENTIATION#0.7684;DENTATE GYRUS#0.7463;VESICLE EXOCYTOSIS#0.7150;SYNAPTIC VESICLE EXOCYTOSIS#0.6949;CENTRAL NERVOUS SYSTEM#0.6605;GENE EXPRESSION#0.6442;SYNAPTIC TRANSMISSION#0.6242;PERIPHERAL NERVOUS SYSTEM#0.6132;NEUROMUSCULAR JUNCTION#0.6101;CALCIUM CHANNEL#0.6095;CHOLERA#0.6050
11275	ACTIN BINDING#0.9523;ACTIN BINDING PROTEIN#0.9175;OLIGODENDROCYTE#0.8172;UBIQUITIN#0.6908;OLIGODENDROCYTE LINEAGE CELLS#0.6327
11276	ADAPTIN#0.7831;ENDOTHELIAL CELL#0.6150
112770	LYSOSOMAL MEMBRANE#1.0647;LYSOSOME#0.8064;OVAL CELL#0.6543;KUPFFER CELL#0.6324;TRANSCRIPTION FACTOR#0.6136
11277	CHILBLAIN LUPUS#1.0968;AICARDI-GOUTIERES SYNDROME#1.0696;DNASE#1.0533;AUTOIMMUNE DISEASE#1.0454;LEUKODYSTROPHY#1.0410;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0167;LUPUS ERYTHEMATOSUS#1.0139;NUCLEIC ACID#1.0096;T CELL#0.9914;AUTOIMMUNITY#0.9869;IMMUNE RESPONSE#0.9833;EXONUCLEASE ACTIVITY#0.9482;STEM CELL#0.9197;CANCER CELL#0.9161;INNATE IMMUNE RESPONSE#0.9096;DNA REPAIR#0.9009;INNATE IMMUNITY#0.8854;MACROPHAGE#0.8762;DNA DEGRADATION#0.8623;IMMUNE SYSTEM#0.8510;LEUKOENCEPHALOPATHY#0.8399;DENDRITIC CELL#0.8397;TRANSCRIPTION FACTOR#0.8375;CELL DEATH#0.8298;ENDOPLASMIC RETICULUM#0.8288;SMALL VESSEL DISEASE#0.8224;DNA REPLICATION#0.8095;GENE EXPRESSION#0.7821;VIRAL INFECTION#0.7653;TUMOR CELLS#0.7469;GENOTOXIC#0.7275;INTERFERON STIMULATED GENE#0.7196;INTERFERON PRODUCTION#0.7142;ANTIVIRAL RESPONSE#0.7012;NERVOUS SYSTEM#0.6910;SIGNALING PATHWAY#0.6895;S PHASE#0.6803;DNA DAMAGE RESPONSE#0.6801;ENDOTHELIAL CELL#0.6752;CENTRAL NERVOUS SYSTEM#0.6641;REVERSE TRANSCRIPTION#0.6583;BASAL GANGLIA#0.6573;APOPTOSIS#0.6560;DIGESTION#0.6517;MYOCARDITIS#0.6389;DNASE ACTIVITY#0.6366;CYTOPLASM#0.6242;CUTANEOUS LUPUS ERYTHEMATOSUS#0.6132;OST COMPLEX#0.6042
11278	TRANSCRIPTION FACTOR#1.0327;CANCER CELL#0.9998;DECIDUALIZATION#0.9850;CELL PROLIFERATION#0.9124;TUMOR SUPPRESSOR#0.9120;STROMAL CELL#0.8771;RHEUMATOID ARTHRITIS#0.8672;APOPTOSIS#0.7213;ZINC FINGER PROTEIN#0.6554;GENE EXPRESSION#0.6520;CELL CYCLE#0.6499;NEURAL CREST#0.6259;TUMOR TISSUES#0.6221;ANOIKIS#0.6150;COLORECTAL CANCER#0.6119
11279	CELL CYCLE#1.0767;BREAST CANCER#1.0707;CANCER CELL#1.0602;CELL PROLIFERATION#1.0581;TRANSCRIPTION FACTOR#1.0528;APOPTOSIS#1.0291;ONCOGENIC#0.9548;GENE EXPRESSION#0.9428;SIGNALING PATHWAY#0.9393;HUMAN BREAST CANCER#0.9378;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9373;EPITHELIAL TO MESENCHYMAL#0.9371;BREAST CANCER CELL#0.9258;FOCAL ADHESION#0.9190;FOCAL ADHESION KINASE#0.9179;EPITHELIAL CELL#0.8609;CELL MIGRATION#0.8304;STEM CELL#0.8245;LUNG CANCER#0.8159;EPITHELIAL MESENCHYMAL TRANSITION#0.8003;QUANTITATIVE REAL TIME#0.7885;COLORECTAL CANCER#0.7702;HEPATOCELLULAR CARCINOMA#0.7587;LUNG ADENOCARCINOMA#0.7509;PANCREATIC CANCER#0.7501;OVARIAN#0.7470;CELL GROWTH#0.7381;ADENOCARCINOMA#0.7354;HYPOXIA#0.7242;POLYMERASE CHAIN REACTION#0.6610;SUMOYLATION#0.6539;RNA INTERFERENCE#0.6428;LUNG METASTASIS#0.6302;TUMOR TISSUES#0.6246;RENAL CARCINOMA#0.6237;LYMPH NODE#0.6198;AKT SIGNALING#0.6133;OVARIAN CANCER#0.6098
112802	ROOT SHEATH#0.9441;HAIR FOLLICLE#0.9051
11280	LITHIUM#1.0325;TETRODOTOXIN#1.0265;SODIUM CHANNEL#1.0162;DORSAL ROOT GANGLION#1.0040;PAIN DISORDER#0.9952;ACTION POTENTIAL#0.9886;MUTAGEN#0.9790;HYPERSENSITIVITY#0.9759;ION CHANNEL#0.9666;NEUROPATHY#0.9443;TRANSMISSION ELECTRON MICROSCOPY#0.9393;SCIATIC NERVE#0.9094;NERVOUS SYSTEM#0.9046;C FIBER#0.9029;NITRIC OXIDE#0.9016;PERIPHERAL NERVE#0.8974;DENSITY FUNCTIONAL THEORY#0.8942;NERVE FIBER#0.8915;GROWTH FACTOR#0.8699;FIELD EFFECT TRANSISTOR#0.8697;NOCICEPTION#0.8688;VAN DER WAALS#0.8629;GENE EXPRESSION#0.8491;MUTAGENICITY#0.8324;FLAKE#0.8319;CELL DEATH#0.8275;TOXICITY#0.8152;TRIGEMINAL NEURALGIA#0.8085;POLYMERASE CHAIN REACTION#0.8080;PROTEIN KINASE#0.8021;SPINAL CORD#0.7968;REVERSE TRANSCRIPTION#0.7932;CHANNEL ACTIVITY#0.7669;2,4-DINITROPHENOL#0.7607;NOXIOUS#0.7377;SENSITIZATION#0.7325;CONSTRICTION#0.7283;NERVE GROWTH FACTOR#0.7205;SUPEROXIDE DISMUTASE#0.7172;MUTAGENIC#0.7080;CATALYTIC ACTIVITY#0.7051;HYPOXIA#0.7012;NEUROMA#0.6973;CHRONIC CONSTRICTION INJURY#0.6927;L-ARGININE#0.6882;OUABAIN#0.6775;PLASMA MEMBRANE#0.6765;REACTIVE OXYGEN SPECIES#0.6736;SMOOTH MUSCLE#0.6623;CENTRAL NERVOUS SYSTEM#0.6577;CELL MEMBRANE#0.6465;NITRIC OXIDE SYNTHASE#0.6455;SMALL FIBER NEUROPATHY#0.6400;NEURALGIA#0.6383;ISCHEMIA#0.6326;LIGHT ABSORPTION#0.6251;MITOCHONDRIAL MEMBRANE#0.6238;SCANNING ELECTRON MICROSCOPY#0.6220;ARGININE#0.6146;NITRO-L-ARGININE#0.6072
112812	FERREDOXIN#1.0979;IRON SULFUR CLUSTER#0.8445;IRON-SULFUR CLUSTER ASSEMBLY#0.6203;MITOCHONDRIAL MYOPATHY#0.6099
112817	PRIMARY HYPEROXALURIA#1.0775
11281	TRANSCRIPTION FACTOR#0.8168;GANGLION CELLS#0.6473;WHOLE GENOME SEQUENCING#0.6029
11282	N GLYCAN#0.8929;SMALL INTESTINE#0.6652;PANCREATIC CANCER#0.6031
11283	SEMINAL VESICLE#1.1017;ARACHIDONIC ACID#0.8812;CYTOCHROME P450#0.6818;PROSTATE CANCER#0.6018
112849	L-PROLINE#0.9393
11284	RNA REPAIR#1.0802;MICROCEPHALY#1.0752;3'-PHOSPHATASE ACTIVITY#1.0726;DEVELOPMENTAL DELAY#1.0585;DNA LIGASE#1.0475;PHOSPHATASE ACTIVITY#1.0366;APRAXIA#1.0354;DNA REPAIR#1.0320;NUCLEIC ACID#1.0303;SINGLE STRAND BREAK#1.0284;DOUBLE STRAND BREAK#1.0081;KINASE ACTIVITY#0.9943;POLYNUCLEOTIDE KINASE ACTIVITY#0.9941;DNA REPAIR ENZYME#0.9900;SINGLE STRAND BREAK REPAIR#0.9748;BASE EXCISION REPAIR#0.9444;CANCER CELL#0.9185;PHOSPHODIESTERASE#0.8608;LOW DETECTION LIMIT#0.8356;DNA REPAIR PROTEIN#0.8331;LIGASE ACTIVITY#0.8201;POLYNEUROPATHY#0.7984;TOPOISOMERASE#0.7980;RIBOSE#0.7602;DNA DAMAGE RESPONSE#0.7590;ATAXIA OCULOMOTOR APRAXIA#0.7353;PROTEIN KINASE#0.7238;POLYNUCLEOTIDE LIGASE#0.7182;DOUBLE-STRAND BREAK REPAIR#0.6903;CHARCOT MARIE TOOTH#0.6901;POLY ADP RIBOSE#0.6828;PROSTATE CANCER#0.6760;PHOSPHATASE I#0.6688;NEUROPATHY#0.6659;ATAXIA TELANGIECTASIA#0.6622;DNA BINDING#0.6549;GLYCOSYLASE#0.6367;STRAND DISPLACEMENT#0.6248;DIGESTION#0.6186;APOPTOSIS#0.6140;CAMPTOTHECIN#0.6031;ADENOSINE#0.6017
112858	PROTEIN KINASE#1.1075;TELOMERE#0.6649;CELL GROWTH#0.6606;APOPTOSIS#0.6562;COLON CANCER#0.6321;KINASE ACTIVITY#0.6183
11285	GALACTOSYLTRANSFERASE I ACTIVITY#1.0799;EHLERS-DANLOS SYNDROME#1.0798;PROTEOGLYCAN#1.0345;UDP GALACTOSE#0.9268;CONNECTIVE TISSUE#0.8217;PROTEOGLYCAN BIOSYNTHESIS#0.7824;GLYCOSAMINOGLYCAN SYNTHESIS#0.6382;GLYCOSYLATION#0.6329;SKIN FIBROBLASTS#0.6177;GALACTOSYLTRANSFERASE ACTIVITY#0.6127
112869	SAGA COMPLEX#0.9790;HISTONE ACETYLTRANSFERASE#0.8739;HISTONE H3 ACETYLATION#0.7482
112885	STEM CELL LIKE#0.7336;CANCER STEM CELL#0.7219;DNA METHYLATION#0.7182;PROSTATE CANCER#0.7144;TUMOR SUPPRESSOR#0.7133;STEM CELL#0.7096;CANCER CELL#0.7084
1128	MUSCARINIC ACETYLCHOLINE RECEPTOR#1.0338;ACETYLCHOLINE RECEPTOR#1.0240;CARBACHOL#1.0238;ACETYLCHOLINE#1.0129;GENE EXPRESSION#0.9139;PIRENZEPINE#0.8975;T CELL#0.8870;SIGNAL TRANSDUCTION#0.8502;DAMP BINDING#0.7979;PROTEIN KINASE#0.7741;DOPAMINE#0.7589;NERVOUS SYSTEM#0.7551;PYRAMIDAL CELL#0.7461;PROSTATE CANCER#0.7363;CHOLINE#0.7146;SIGNALING PATHWAY#0.7079;RECEPTOR INTERNALIZATION#0.6966;PHOSPHOLIPASE C#0.6881;DORSOLATERAL PREFRONTAL CORTEX#0.6727;GROWTH FACTOR#0.6320;POLYMERASE CHAIN REACTION#0.6298;CHOLINERGIC NEURON#0.6218;POSITIVE ALLOSTERIC MODULATOR#0.6135;DENDRITIC SPINE#0.6091;TRANSCRIPTION FACTOR#0.6088;MOOD DISORDER#0.6063;ALANINE#0.6030
112936	RETROMER COMPLEX#0.9819;PLASMA MEMBRANE#0.9125
112937	RETINAL PIGMENT EPITHELIUM#0.8145
112939	OVARIAN CANCER#1.0962;CANCER CELL#1.0827;OVARIAN#1.0773;TRANSCRIPTION FACTOR#1.0460;STEM CELL#1.0133;OVARIAN SEROUS CARCINOMA#0.9905;CELL PROLIFERATION#0.9431;DRUG RESISTANCE#0.9375;GENE EXPRESSION#0.9113;APOPTOSIS#0.8881;EMBRYONIC STEM CELL#0.8722;PACLITAXEL#0.8674;CELL GROWTH#0.8669;TUMOR CELLS#0.8663;CELL MIGRATION#0.8605;OVARIAN CARCINOMA#0.8356;FATTY ACID SYNTHASE#0.8250;SENESCENCE#0.8159;CERVICAL#0.8116;LATERAL ROOT DEVELOPMENT#0.8093;ONCOGENIC#0.8045;SENSITIZATION#0.7883;ROOT DEVELOPMENT#0.7850;DNA BINDING#0.7725;PROTEASOME#0.7479;SQUAMOUS CELL CARCINOMA#0.7438;CISPLATIN#0.7355;BTB DOMAIN#0.7293;CELL CYCLE#0.7012;CERVICAL CANCER#0.6914;UBIQUITIN#0.6803;PROTEIN PROTEIN INTERACTION#0.6649;LATERAL ROOT FORMATION#0.6514;HISTONE DEACETYLASE#0.6413;AUTOPHAGY#0.6409;NUCLEAR BODY#0.6400;ADENOSQUAMOUS CARCINOMA#0.6302;ZINC FINGER PROTEIN#0.6274;PANCREATIC CARCINOMA#0.6195;ENDOMETRIAL CARCINOMA#0.6177;DENDRITIC SPINE#0.6169;CELLULAR SENESCENCE#0.6167;EPITHELIAL MESENCHYMAL TRANSITION#0.6099
112950	MEDIATOR COMPLEX#1.0654;TRANSCRIPTION FACTOR#0.9068;GENE EXPRESSION#0.6998;COMPLEX I#0.6806;TBP BINDING#0.6093
112970	TRNA MODIFICATION#0.7787;ATP HYDROLYSIS#0.6237
1129	ALCOHOL DEPENDENCE#1.0330;RECEPTOR ANTAGONIST#1.0288;MUSCARINIC ACETYLCHOLINE RECEPTOR#1.0246;ACETYLCHOLINE RECEPTOR#1.0189;SMOOTH MUSCLE#1.0060;PIRENZEPINE#1.0058;ACETYLCHOLINE#1.0039;GENE EXPRESSION#0.9925;RECEPTOR AGONIST#0.9864;CARBACHOL#0.9856;ATROPINE#0.9747;ADRENERGIC RECEPTOR#0.9377;RECEPTOR BINDING#0.9119;BETA ADRENOCEPTOR#0.9050;GALLAMINE#0.8830;PERTUSSIS#0.8636;BETA-2#0.8609;MAJOR DEPRESSIVE DISORDER#0.8513;NERVOUS SYSTEM#0.8425;PROTEIN KINASE#0.8389;ALZHEIMER'S DISEASE#0.8336;DRUG DEPENDENCE#0.8164;SIGNAL TRANSDUCTION#0.8156;ISOPRENALINE#0.8128;DILATED CARDIOMYOPATHY#0.8083;FRONTAL#0.8054;SIGNALING PATHWAY#0.7799;METHYLSCOPOLAMINE#0.7622;HETEROTRIMERIC G-PROTEIN#0.7606;ADENOSINE#0.7529;CELL SURFACE#0.7487;AIRWAY SMOOTH MUSCLE#0.7388;CENTRAL NERVOUS SYSTEM#0.7274;CARDIOMYOPATHY#0.7221;CHOLINE#0.7185;CYCLASE ACTIVITY#0.7062;PROTEIN KINASE C#0.7046;FORSKOLIN#0.6995;TRACHEA#0.6953;ADENYLYL CYCLASE ACTIVITY#0.6889;HISTAMINE#0.6818;PLASMA MEMBRANE#0.6775;GROWTH FACTOR#0.6579;ISOPROTERENOL#0.6568;DOPAMINE#0.6564;NITRIC OXIDE#0.6475;PILOCARPINE#0.6454;COGNITION#0.6389;METHACHOLINE#0.6228;TRANSMEMBRANE RECEPTOR#0.6118
112	ADENYLATE CYCLASE#1.0722;ADENYLATE#1.0652;LIPID RAFT#1.0397;PROTEIN KINASE#1.0023;FORSKOLIN#1.0003;ISOPROTERENOL#0.9980;ADRENERGIC RECEPTOR#0.9959;MYOCYTES#0.9957;SIGNALING PATHWAY#0.9943;ENDOTHELIAL CELL#0.9828;CAMP SIGNALING#0.9596;CYCLIC AMP#0.9509;CYCLASE ACTIVITY#0.9486;CAMP FORMATION#0.9328;PLASMA MEMBRANE#0.8834;SMOOTH MUSCLE#0.8752;GENE EXPRESSION#0.8595;ADENYLYL CYCLASE ACTIVITY#0.8544;ADENOSINE#0.8303;CAVEOLAE#0.8008;PROTEIN KINASE A#0.7934;SARCOPLASMIC RETICULUM#0.7815;VASOPRESSIN#0.7732;CAMP SYNTHESIS#0.7706;POLYMERASE CHAIN REACTION#0.7685;CALCIUM SIGNALING#0.7608;BETA-2#0.7397;CARDIOMYOCYTE#0.7342;APOPTOSIS#0.7120;PROTEIN KINASE C#0.7061;PHOSPHODIESTERASE#0.6994;COLLAGEN SYNTHESIS#0.6929;ADENOSINE MONOPHOSPHATE#0.6905;CYCLIC ADENOSINE MONOPHOSPHATE#0.6642;HUMAN EMBRYONIC KIDNEY#0.6635;EMBRYONIC KIDNEY#0.6631;LETHAL CONGENITAL CONTRACTURE SYNDROME#0.6479;PULMONARY ARTERY#0.6433;VASODILATOR#0.6387;MUSCLE CELL#0.6378;BETA ADRENERGIC RECEPTOR#0.6362;GROWTH FACTOR#0.6342;PERTUSSIS#0.6249;AIRWAY SMOOTH MUSCLE#0.6239;MEMBRANE FRACTION#0.6198;ARGININE VASOPRESSIN#0.6180;SMOOTH MUSCLE CELL#0.6054
113026	PHOSPHOLIPASE C#0.9593
113091	PARATHYROID HORMONE#0.9883;PARATHYROID#0.9550
11309	FEXOFENADINE#1.0455;OOCYTE#1.0443;HUMAN EMBRYONIC KIDNEY#1.0417;EMBRYONIC KIDNEY#1.0413;SMALL INTESTINE#1.0413;ROSUVASTATIN#1.0412;ATORVASTATIN#1.0403;ORGANIC CATION TRANSPORTER#1.0314;ESTRONE#1.0240;ORGANIC ANION TRANSPORTER#1.0229;INTESTINAL ABSORPTION#1.0195;TAUROCHOLATE#1.0193;PROSTATE CANCER#1.0151;PRAVASTATIN#1.0117;EPITHELIAL CELL#1.0115;BREAST CANCER#0.9961;GENE EXPRESSION#0.9951;MONTELUKAST#0.9792;INTESTINAL EPITHELIAL CELL#0.9740;PLASMA MEMBRANE#0.9590;POLYMERASE CHAIN REACTION#0.9581;MULTIDRUG RESISTANCE PROTEIN#0.9497;TOXICITY#0.9290;ATP BINDING CASSETTE#0.9250;ATP BINDING#0.9235;PRIMARY HUMAN HEPATOCYTES#0.9162;TIME TO PROGRESSION#0.8944;RIFAMPICIN#0.8918;QUERCETIN#0.8836;PROTEIN KINASE#0.8814;FLUVASTATIN#0.8784;EXCRETION#0.8769;DRUG TRANSPORT#0.8730;CYTOCHROME P450#0.8706;ANDROGEN DEPRIVATION THERAPY#0.8672;PITAVASTATIN#0.8533;SULFATE TRANSPORT#0.8444;GLIBENCLAMIDE#0.8384;DEHYDROEPIANDROSTERONE SULFATE#0.8252;ESTRADIOL#0.8180;ENTEROCYTE#0.8047;BLOOD BRAIN BARRIER#0.8016;ABC TRANSPORTER#0.7936;DEHYDROEPIANDROSTERONE#0.7864;PROTEIN KINASE C#0.7844;EFFLUX PUMP#0.7788;SKELETAL MUSCLE#0.7705;JEJUNUM#0.7561;CELL SURFACE#0.7404;B CELL#0.7181;ALISKIREN#0.6965;ESTRONE SULFATE#0.6957;ENDOTHELIAL CELL#0.6948;PEPTIDE TRANSPORTER#0.6887;PREGNANE X RECEPTOR#0.6871;CANCER CELL#0.6738;HUMAN INTESTINAL EPITHELIAL#0.6627;SYNCYTIOTROPHOBLAST#0.6445;RIFAMYCIN#0.6375;SIMVASTATIN#0.6332;ERLOTINIB#0.6320;TESTOSTERONE#0.6315;TRANSPORTER ACTIVITY#0.6285;PRO-INFLAMMATORY#0.6276;CELL PROLIFERATION#0.6268;CYCLOSPORINE#0.6251;RECEPTOR ANTAGONIST#0.6183;TAUROCHOLIC ACID#0.6096;PROGESTERONE#0.6050;CILIARY BODY#0.6049;MEMBRANE FRACTION#0.6027;LARGE INTESTINE#0.6002
1130	CHEDIAK-HIGASHI SYNDROME#1.0528;LYSOSOME#1.0273;OCULOCUTANEOUS ALBINISM#0.9152;ORGANELLE#0.8369;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS#0.7955;BONE MARROW#0.7882;VESICLE TRAFFICKING#0.7473;PURKINJE CELL#0.7472;T CELL#0.7343;EXOCYTOSIS#0.7195;T LYMPHOCYTE#0.7145;AUTOSOMAL RECESSIVE DISEASE#0.6979;CELL WALL#0.6631;CYTOTOXICITY#0.6523;EXFOLIATION SYNDROME#0.6501;ENDOSOME#0.6256;STEM CELL#0.6223;SECRETORY GRANULE#0.6064
113115	MITOCHONDRIAL FISSION#1.0340;BREAST CANCER CELL#0.7231;BREAST CANCER#0.7188;CANCER CELL#0.7176;GLUCOSE METABOLISM#0.6783
11311	ENDOSOME#0.9721;NEUTROPENIA#0.9315;SEVERE CONGENITAL NEUTROPENIA#0.9279;VACUOLAR PROTEIN SORTING#0.8751;EARLY ENDOSOME#0.8621;MYELOFIBROSIS#0.8363;VACUOLE#0.8321;MEMBRANE FUSION#0.7378;NEUTROPHIL#0.7087;SNARE COMPLEX#0.6954;PREVACUOLAR COMPARTMENT#0.6750;SNARE COMPLEX ASSEMBLY#0.6014;CILIARY MEMBRANE#0.6006
113130	CELL DIVISION CYCLE#1.0586;SISTER CHROMATID COHESION#1.0487;CHROMATID#1.0327;CELL DIVISION#1.0323;APOPTOSIS#1.0089;CELL CYCLE#1.0074;CELL PROLIFERATION#0.9784;GENE EXPRESSION#0.9655;CYCLIN DEPENDENT KINASE#0.9623;DNA REPLICATION#0.9512;COHESIN COMPLEX#0.9504;MITOSIS#0.9481;CHROMOSOME SEGREGATION#0.9295;CANCER CELL#0.9015;CELL CYCLE ARREST#0.8920;S PHASE#0.8893;HEPATOCELLULAR CARCINOMA#0.8613;BREAST CANCER#0.8492;G2 PHASE#0.7830;PROTEIN KINASE#0.7516;GROWTH FACTOR#0.7327;ANAPHASE#0.7138;CASPASE INHIBITOR#0.6931;PROPHASE#0.6726;M PHASE#0.6648;CENTROMERE#0.6530;G1 PHASE#0.6449;PRP19 COMPLEX#0.6306;CELL DEATH#0.6287;MEIOSIS#0.6233;APOPTOTIC#0.6216;INTERPHASE#0.6124;LIVER CANCER#0.6106;INDUCTION OF APOPTOSIS#0.6028
11313	ACYL PROTEIN THIOESTERASE#1.0344;LYSOPHOSPHOLIPASE ACTIVITY#0.6426
113146	UVEAL MELANOMA#0.6044
11314	T CELL#1.0330;MAST CELL#1.0286;PHOSPHATIDYLSERINE#0.9992;EOSINOPHIL#0.9971;CELL SURFACE#0.9562;CD4+ T CELL#0.9524;B CELL#0.9504;APOPTOTIC#0.9371;PERIPHERAL BLOOD#0.9356;LEUKOCYTE#0.9276;T LYMPHOCYTE#0.8853;MONOCYTE#0.8522;IMMUNE RESPONSE#0.8399;MACROPHAGE#0.8335;PERITONEAL CAVITY#0.8298;PHOSPHATIDYLETHANOLAMINE#0.8205;GM-CSF#0.8198;NEUTROPHIL#0.8193;CELL PROLIFERATION#0.8138;IMMUNE CELL#0.8044;TOLL LIKE RECEPTOR#0.7758;APOPTOSIS#0.7741;INFLAMMATORY RESPONSE#0.7735;CELL GROWTH#0.7675;MYELOID CELL#0.7396;SIGNALING PATHWAY#0.7023;GENE EXPRESSION#0.6879;BASOPHIL#0.6718;HYPOXIA#0.6393;DENDRITIC CELL#0.6338;ALLERGIC REACTION#0.6303;DIFFUSE LARGE B-CELL LYMPHOMA#0.6173;IFN-ALPHA SECRETION#0.6095;PRO-INFLAMMATORY#0.6074;B CELL LYMPHOMA#0.6069;IFN-GAMMA#0.6027;BONE MARROW#0.6008
113157	LUNG ADENOCARCINOMA#0.7206
11315	AUTOSOMAL RECESSIVE PARKINSONISM#1.0829;AKT SIGNALING#1.0616;EARLY-ONSET PARKINSON'S DISEASE#1.0590;EARLY ONSET PARKINSONISM#1.0556;PANCREATIC CANCER#1.0522;ANDROGEN RECEPTOR#1.0448;LEUCINE RICH REPEAT#1.0446;HYPOXIA#1.0434;OXIDATIVE STRESS RESPONSE#1.0407;SQUAMOUS CELL CARCINOMA#1.0382;NEURONAL CELLS#1.0380;LEUCINE#1.0365;ASTROCYTE#1.0336;BREAST CANCER#1.0327;PHOSPHATASE AND TENSIN HOMOLOG#1.0320;NEUROBLASTOMA#1.0318;NEUROPROTECTION#1.0271;RESPONSE TO OXIDATIVE STRESS#1.0271;MITOCHONDRIAL LOCALIZATION#1.0222;CELL PROLIFERATION#1.0218;CHAPERONE ACTIVITY#1.0191;HEAT SHOCK PROTEIN#1.0185;CYTOPLASM#1.0179;ENDOPLASMIC RETICULUM#1.0173;BREAST CANCER CELL#1.0168;SUPEROXIDE DISMUTASE#1.0160;NEUROTOXICITY#1.0160;ISCHEMIA#1.0155;NEURONAL CELL DEATH#1.0146;PROTEASOME#1.0135;MITOCHONDRIAL TRANSLOCATION#1.0114;STEM CELL#1.0093;AUTOPHAGY#1.0093;CANCER CELL#1.0089;COMPLEX I#1.0086;MITOCHONDRIAL MEMBRANE POTENTIAL#1.0079;SIGNALING PATHWAY#1.0076;TRANSCRIPTION FACTOR#1.0072;MITOCHONDRIA#1.0064;POLYMERASE CHAIN REACTION#1.0062;STRIATUM#1.0059;UBIQUITIN#1.0058;MITOCHONDRIAL MEMBRANE#1.0050;TOXICITY#1.0040;GLUTATHIONE#1.0030;HEPATOCELLULAR CARCINOMA#1.0023;PROTEIN KINASE#0.9999;APOPTOSIS#0.9993;MACROPHAGE#0.9990;APOPTOTIC#0.9986;CELL DEATH#0.9971;LYMPH NODE#0.9969;CELL MIGRATION#0.9941;DOPAMINE#0.9913;LUNG CANCER#0.9909;REACTIVE OXYGEN SPECIES#0.9892;GENE EXPRESSION#0.9887;PARKINSON'S DISEASE#0.9880;UBIQUITIN PROTEASOME SYSTEM#0.9880;PROTEASE ACTIVITY#0.9879;ROS GENERATION#0.9868;ALZHEIMER'S DISEASE#0.9860;DOPAMINERGIC NEURON#0.9850;NEURODEGENERATIVE DISEASE#0.9829;SPINAL CORD#0.9822;TUMOR SUPPRESSOR#0.9794;MUSCLE CELL#0.9788;GROWTH FACTOR#0.9777;CELL CYCLE#0.9774;SUBSTANTIA NIGRA#0.9754;NITRIC OXIDE#0.9741;HISTONE DEACETYLASE#0.9741;HYPOXIC#0.9691;PROSTATE CANCER#0.9680;TARGET OF RAPAMYCIN#0.9676;ADIPOSE TISSUE#0.9657;NEUROTOXIN#0.9644;SKELETAL MUSCLE#0.9637;MITOCHONDRIAL DAMAGE#0.9636;HEME OXYGENASE 1#0.9623;EPITHELIAL CELL#0.9618;GLUTATHIONE PEROXIDASE#0.9598;LEWY BODY#0.9596;SIGNAL TRANSDUCTION#0.9581;DEMENTIA#0.9578;MALE INFERTILITY#0.9577;INFERTILITY#0.9558;SUMOYLATION#0.9557;DETOXIFICATION#0.9552;ISCHEMIA REPERFUSION INJURY#0.9512;T CELL#0.9509;ONCOGENIC#0.9502;POST-TRANSLATIONAL MODIFICATION#0.9488;NERVOUS SYSTEM#0.9389;MITOCHONDRIAL MATRIX#0.9365;OXYGENASE#0.9362;MITOPHAGY#0.9323;HIGH FAT DIET#0.9316;SIGNALLING PATHWAY#0.9313;PROTEIN DEGRADATION#0.9309;MITOGEN ACTIVATED PROTEIN#0.9308;GLIAL CELL#0.9284;ENDOTHELIAL CELL#0.9223;RESPIRATION#0.9193;NEUROTOXIC#0.9189;MIDBRAIN#0.9187;PRO-INFLAMMATORY#0.9150;AMYOTROPHIC LATERAL SCLEROSIS#0.9101;LATERAL SCLEROSIS#0.9101;CELL GROWTH#0.9010;AGE AT ONSET#0.9010;BINDING PROTEIN 1#0.9003;RAPAMYCIN#0.8995;NUCLEOSIDE DIPHOSPHATE KINASE#0.8985;LARYNGEAL CARCINOMA#0.8984;FERTILIZATION#0.8954;OVARIAN CANCER#0.8926;QUANTITATIVE REAL TIME#0.8926;SMOOTH MUSCLE#0.8901;SEMINAL PLASMA#0.8874;CYTOTOXICITY#0.8868;CENTRAL NERVOUS SYSTEM#0.8867;LYMPH NODE METASTASIS#0.8843;NADPH OXIDASE#0.8792;LIPID RAFT#0.8790;UBIQUITIN C-TERMINAL HYDROLASE#0.8768;CARDIOMYOCYTE#0.8764;MICROTUBULE#0.8756;MAST CELL#0.8753;REVERSE TRANSCRIPTION#0.8679;CISPLATIN#0.8652;CEREBRAL ISCHEMIA#0.8628;ORGANELLE#0.8597;PROTEIN PROTEIN INTERACTION#0.8585;HYPOXIA INDUCIBLE FACTOR#0.8547;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.8545;OVARIAN#0.8537;TUMOR NECROSIS FACTOR#0.8537;RNA BINDING#0.8525;MITOCHONDRIAL DNA#0.8516;GLUTATHIONE SYNTHESIS#0.8506;RESVERATROL#0.8414;NULL CELL#0.8412;NEUROLOGICAL DISORDER#0.8397;GLYCOLYSIS#0.8386;COLORECTAL CANCER#0.8367;ENDOMETRIAL CANCER#0.8330;PROTEIN SYNTHESIS#0.8325;PANCREATIC ISLET#0.8303;SMOOTH MUSCLE CELL#0.8253;TUMOR CELLS#0.8234;MOUSE EMBRYONIC FIBROBLAST#0.8225;CELLULAR OXIDATIVE STRESS#0.8221;MITOCHONDRIAL FISSION#0.8195;GLUCOSE REGULATED PROTEIN#0.8151;RESPIRATORY CHAIN#0.8133;L-DOPA#0.8114;DYSTONIA#0.8110;NEURITE#0.8085;PHOSPHATASE ACTIVITY#0.8072;LEVODOPA#0.8070;MELATONIN#0.8067;MULTIPLE SCLEROSIS#0.8047;COPPER BINDING#0.8039;ENDOPLASMIC RETICULUM STRESS#0.7995;DOPAMINE SYNTHESIS#0.7989;PROTEIN FOLDING#0.7972;NEURAL CELL#0.7926;TOXICANT#0.7913;SIGNALING CASCADE#0.7900;ARTERY#0.7894;ATP SYNTHASE#0.7880;RENAL CELL CARCINOMA#0.7835;BREAST CANCER PATIENTS#0.7799;BETA CELL#0.7754;CYTOCHROME C#0.7744;TYPE 2 DIABETES#0.7739;PROTEIN DISULFIDE ISOMERASE#0.7730;RNA INTERFERENCE#0.7727;MECHANISM OF ACTION#0.7713;LYSINE#0.7695;FRONTAL#0.7682;COPPER CHAPERONE#0.7653;EMBRYONIC STEM CELL#0.7648;PROGENITOR CELL#0.7613;INFLAMMATORY RESPONSE#0.7592;ARGININE#0.7579;HUNTINGTON'S DISEASE#0.7578;TRANSLATION INITIATION#0.7577;DIABETES MELLITUS#0.7557;DNA FRAGMENTATION#0.7556;PERIPHERAL BLOOD#0.7540;SPERMATOZOA#0.7536;MICROTUBULE ASSOCIATED PROTEIN#0.7526;DIPHOSPHATE#0.7525;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.7487;PROXIMAL TUBULE CELL#0.7478;LASER DESORPTION IONIZATION#0.7477;MULTIPLE SYSTEM ATROPHY#0.7476;ADENOSINE#0.7476;OXIDATIVE PHOSPHORYLATION#0.7467;PYRUVATE#0.7462;DNA BINDING#0.7462;STREPTOZOTOCIN#0.7445;UVEAL MELANOMA#0.7444;MITOCHONDRIAL TOXIN#0.7431;TRANSLATION INITIATION FACTOR#0.7416;GLUTAMIC ACID#0.7393;MIGRATION INHIBITORY FACTOR#0.7388;MACROPHAGE MIGRATION#0.7378;GALECTIN#0.7364;GLUCOSE HOMEOSTASIS#0.7353;DRUG RESISTANCE#0.7352;MTDNA#0.7336;THYROID CANCER#0.7330;ENDOCYTOSIS#0.7329;VASCULAR SMOOTH MUSCLE CELL#0.7305;STATIONARY PHASE#0.7270;SYNAPTIC VESICLE#0.7220;RETINAL PIGMENT EPITHELIUM#0.7220;CHAPERONE MEDIATED AUTOPHAGY#0.7216;COLON CANCER#0.7194;BROWN ADIPOSE TISSUE#0.7192;GLUTAMINE#0.7145;COLORECTAL#0.7116;PROTEIN QUALITY CONTROL#0.7086;ERYTHROCYTE#0.7085;ADENOCARCINOMA#0.6994;HYPERTENSION#0.6940;BONE MARROW#0.6934;PTEN ACTIVITY#0.6922;MALATE DEHYDROGENASE#0.6879;EXOSOME#0.6879;METHIONINE#0.6833;TUMOR TISSUES#0.6822;MUTAGENESIS#0.6806;MESENCHYMAL STEM CELL#0.6798;MITOCHONDRIAL RESPIRATORY CHAIN#0.6794;SYNAPTIC MEMBRANE#0.6768;LOW DENSITY LIPOPROTEIN#0.6763;NADH DEHYDROGENASE#0.6763;CERVICAL#0.6757;20S PROTEASOME#0.6749;METAL BINDING#0.6744;DUAL LUCIFERASE REPORTER#0.6714;POSITRON EMISSION TOMOGRAPHY#0.6683;LIGASE ACTIVITY#0.6632;FIBRIL#0.6614;EPIDERMAL GROWTH FACTOR#0.6608;POLY ADP RIBOSE#0.6607;CYTOPLASMIC INCLUSION#0.6595;LEGUMAIN ACTIVITY#0.6576;PROTEASOME ACTIVATOR COMPLEX#0.6555;LYSOSOME#0.6509;COPY NUMBER VARIATION#0.6495;LOCUS COERULEUS#0.6483;GLYCERALDEHYDE-3-PHOSPHATE#0.6469;RIBOSOMAL PROTEIN#0.6455;LUNG CARCINOMA#0.6438;AMYLOID PRECURSOR PROTEIN#0.6432;ONCOGENESIS#0.6428;S PHASE#0.6411;NITRIC OXIDE SYNTHASE#0.6408;PLASMA MEMBRANE#0.6400;MYOBLAST#0.6290;ELECTRON TRANSPORT#0.6287;PROTEIN KINASE B#0.6270;APOPTOSIS INDUCING FACTOR#0.6266;PROTEIN PHOSPHATASE 2A#0.6246;PHOSPHATASE 2A#0.6243;KINASE ACTIVITY#0.6236;ADRIAMYCIN#0.6212;OXYGEN GLUCOSE DEPRIVATION#0.6206;ASTROCYTOMA#0.6200;NUCLEIC ACID#0.6187;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6186;BAT ACTIVITY#0.6177;DOPAMINE RECEPTOR#0.6166;ADENYLATE KINASE#0.6112;PHOSPHOGLYCERATE KINASE#0.6098;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.6087;3-METHYLADENINE#0.6069;EXTRACELLULAR REGULATED KINASE#0.6067;LEWY BODY DISEASE#0.6064;PERMEABILITY TRANSITION PORE#0.6059;ATHEROSCLEROSIS#0.6043;PICK'S DISEASE#0.6033;DISULFIDE OXIDOREDUCTASE#0.6027;MRNP GRANULE#0.6015
11316	COATOMER#1.0923;ENDOPLASMIC RETICULUM#0.7891;PROTEIN COMPLEX#0.7488;MEMBRANE TRANSPORT#0.6393;GOLGI APPARATUS#0.6333
113174	SYNOVIOCYTE PROLIFERATION#0.8882;COLLAGEN INDUCED ARTHRITIS#0.8394;CYCLIN DEPENDENT KINASE#0.8051;SERUM AMYLOID A#0.6822
113179	INTELLECTUAL DISABILITY#1.0464;INOSINE#0.8547;ADENOSINE DEAMINASE#0.7758;ADENOSINE#0.7562;BIRTH DEFECT#0.6083
11317	ACINAR CELL#1.0462;TRANSCRIPTION FACTOR#0.9913;CELL DEVELOPMENT#0.6640;RNA BINDING PROTEIN#0.6039;RNA BINDING#0.6015
113189	EHLERS-DANLOS SYNDROME#1.0883;CLUBFOOT#0.8614;CONNECTIVE TISSUE#0.8494;SULFATION#0.8177;NERVOUS SYSTEM#0.8059;EXTRACELLULAR MATRIX#0.7784;REGENERATION#0.7595;PROTEOGLYCAN#0.7371;DERMATAN SULFATE BIOSYNTHESIS#0.6971;HNK 1 SULFOTRANSFERASE#0.6912;SPINAL CORD#0.6321
11318	ADRENOMEDULLIN RECEPTOR#1.0768;RECEPTOR ANTAGONIST#1.0610;CGRP RECEPTOR#1.0319;RECEPTOR ACTIVITY#1.0297;CALCITONIN RECEPTOR#1.0281;GENE EXPRESSION#0.9751;SMOOTH MUSCLE#0.9351;POLYMERASE CHAIN REACTION#0.9248;MUSCLE CELL#0.9081;SMOOTH MUSCLE CELL#0.9030;ENDOTHELIAL CELL#0.8827;CELL SURFACE#0.8666;VASCULAR SMOOTH MUSCLE CELL#0.8614;PANCREATIC CANCER#0.8555;ARTERY#0.8322;SIGNAL TRANSDUCTION#0.8114;CANCER CELL#0.8056;HYPERTENSION#0.7864;PROTEIN KINASE#0.7846;NITRIC OXIDE#0.7568;ADRENOMEDULLIN BINDING#0.7408;GROWTH FACTOR#0.7192;PULMONARY HYPERTENSION#0.7182;RECEPTOR LIGAND#0.7042;REVERSE TRANSCRIPTION#0.6860;AM BINDING#0.6821;VASODILATOR#0.6776;CELL PROLIFERATION#0.6672;ENDOTHELIUM#0.6645;VASCULAR ENDOTHELIUM#0.6640;ADENYLATE CYCLASE#0.6429;PROTEIN KINASE A#0.6425;RECEPTOR BINDING#0.6416;PULMONARY ARTERY#0.6208;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6069;TRANSCRIPTASE#0.6054
11319	BREAST CANCER#1.0103;CELL CYCLE#1.0077;UBIQUITIN#0.9171;CANCER CELL#0.8420;TRASTUZUMAB#0.8219;TRANSCRIPTION FACTOR#0.8085;GENE EXPRESSION#0.7726;BREAST CANCER PATIENTS#0.7659;DNA BINDING#0.7630;DISEASE RESISTANCE#0.7609;CELL CYCLE ARREST#0.7288;IMMUNE RESPONSE#0.6932;XYLANASE INHIBITOR#0.6697;METASTATIC BREAST CANCER#0.6688;HEAT SHOCK PROTEIN#0.6411;CELL DEATH#0.6315;UBIQUITIN LIGASE COMPLEX#0.6283;R2TP COMPLEX#0.6210;MOUSE EMBRYONIC FIBROBLAST#0.6178;BREAST CARCINOMA#0.6119;PANCREATIC CANCER#0.6112;T CELL#0.6092
1131	PHOSPHOLIPASE C#1.0117;RECEPTOR ANTAGONIST#1.0106;PIRENZEPINE#0.9967;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.9909;PROTEIN KINASE#0.9870;CARBACHOL#0.9864;GENE EXPRESSION#0.9818;ATROPINE#0.9789;ACETYLCHOLINE RECEPTOR#0.9785;SMOOTH MUSCLE#0.9770;RECEPTOR AGONIST#0.9749;SIGNALING PATHWAY#0.9727;CANCER CELL#0.9722;ACETYLCHOLINE#0.9705;T CELL#0.9666;CELL PROLIFERATION#0.9638;IMMUNE RESPONSE#0.9542;GROWTH FACTOR#0.9518;EPITHELIAL CELL#0.9508;APOPTOSIS#0.9457;AIRWAY SMOOTH MUSCLE#0.9347;POLYMERASE CHAIN REACTION#0.9307;REGULATORY T CELL#0.9298;PROTEIN KINASE C#0.9294;MACROPHAGE#0.9275;URINARY BLADDER#0.9224;SCOPOLAMINE#0.9157;MUSCLE CELL#0.9149;METHACHOLINE#0.9096;SIGNAL TRANSDUCTION#0.8895;LYMPH NODE#0.8882;NEUTROPHIL#0.8818;APOPTOTIC#0.8817;PILOCARPINE#0.8779;SMOOTH MUSCLE CELL#0.8711;CHOLINE#0.8703;COLON CANCER#0.8701;IFN-GAMMA#0.8688;CYTOTOXICITY#0.8543;HISTAMINE#0.8497;ALLERGEN#0.8456;LUNG CANCER#0.8455;STEM CELL#0.8436;GOBLET CELL#0.8420;ARTERY#0.8364;NERVOUS SYSTEM#0.8191;MUSCLE CONTRACTION#0.8161;TOLL LIKE RECEPTOR#0.8154;PLASMA MEMBRANE#0.8132;NITRIC OXIDE#0.8128;ENDOTHELIAL CELL#0.8118;GALLAMINE#0.8086;BONE MARROW#0.8074;TOXICITY#0.8036;ADRENERGIC RECEPTOR#0.8031;PROSTATE CANCER#0.8016;NEUROBLASTOMA#0.7957;SIGNALLING PATHWAY#0.7922;TIOTROPIUM#0.7889;INFLAMMATORY CELL#0.7838;TUMOR CELLS#0.7806;TUMOR NECROSIS FACTOR#0.7800;METHYLSCOPOLAMINE#0.7655;CELL DEATH#0.7620;RECEPTOR LIGAND#0.7616;MITOGEN ACTIVATED PROTEIN#0.7567;DENDRITIC CELL#0.7531;PRO-INFLAMMATORY#0.7530;TRANSCRIPTION FACTOR#0.7502;MAST CELL#0.7454;MYOCARDIAL INFARCTION#0.7370;INFLAMMATORY RESPONSE#0.7351;TRACHEA#0.7343;DAMP BINDING#0.7250;CLOZAPINE#0.7247;INSULIN SECRETION#0.7234;KINASE ACTIVITY#0.7216;SMOOTH MUSCLE ACTIN#0.7179;PERTUSSIS#0.7095;GLUTATHIONE#0.7083;B CELL#0.7069;DARIFENACIN#0.7015;CD4+ T CELL#0.6986;SMOOTH MUSCLE CONTRACTION#0.6938;ADENOSINE#0.6909;MESENCHYMAL STEM CELL#0.6901;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6897;CONSTIPATION#0.6875;VIRAL INFECTION#0.6837;LACRIMAL GLAND#0.6776;EOSINOPHIL#0.6772;RECEPTOR BINDING#0.6738;CELL SURFACE#0.6599;CELL MEMBRANE#0.6562;CD8+ T CELL#0.6561;DOPAMINE#0.6533;SALIVARY GLAND#0.6480;LUNG CARCINOMA#0.6477;AKT SIGNALING#0.6457;RECEPTOR INTERNALIZATION#0.6355;MYOCYTES#0.6333;ALZHEIMER'S DISEASE#0.6307;MAPK SIGNALING#0.6268;CORONARY ARTERY#0.6253;ELECTRON TRANSFER#0.6249;SERUM ALBUMIN#0.6242;HYPERTENSION#0.6225;CELL CYCLE#0.6188;ENDOTHELIUM#0.6187;ANGIOGENESIS#0.6178;CYCLIC AMP#0.6127;PAROTID GLAND#0.6095;PERIPHERAL BLOOD#0.6084;STRIATUM#0.6077;MYASTHENIA GRAVIS#0.6070;IRRITABLE BOWEL SYNDROME#0.6032;BETA ADRENERGIC RECEPTOR#0.6004
11320	N GLYCAN#1.0805;GLYCOSYLATION#0.9295;BETA CELL#0.9236;CHORIOCARCINOMA#0.7743;GLUCOSE TRANSPORT#0.6426;TYPE 2 DIABETES#0.6398
11321	ATP BINDING#1.0498;ABC TRANSPORTER#1.0303;ATP BINDING CASSETTE#1.0152;CYTOPLASM#0.9433;GTP BINDING#0.9292;HEAT SHOCK PROTEIN#0.9184;NUCLEOTIDE BINDING#0.8740;NUCLEAR EXPORT#0.8511;CELL NUCLEUS#0.8148;ATP BINDING CASSETTE TRANSPORTER#0.8078;NUCLEAR IMPORT#0.8006;MUTAGENESIS#0.7822;CYTOPLASMIC MEMBRANE#0.7566;MALTOSE#0.7523;MICROTUBULE#0.7441;ATP HYDROLYSIS#0.7318;C TERMINAL DOMAIN#0.7281;RIBOSOMAL PROTEIN#0.7053;SUGAR BINDING#0.6967;ATPASE ACTIVITY#0.6959;GENE EXPRESSION#0.6931;VIRULENCE#0.6745;ENDOPLASMIC RETICULUM#0.6637;PROTEIN KINASE#0.6610;NUCLEOTIDE BINDING DOMAIN#0.6437;NUCLEOSIDE TRIPHOSPHATASE#0.6330;KINASE INHIBITOR#0.6273;T CELL#0.6270;QUORUM SENSING#0.6241;DNA BINDING#0.6222
113220	KINESIN#0.8577;CLEAVAGE FURROW#0.7647;MICROTUBULE MOTOR#0.6919;KIDNEY DISEASE#0.6539;ACTIN CYTOSKELETON#0.6087;BETA CELL#0.6063
11322	EPIDERMODYSPLASIA VERRUCIFORMIS#1.0567;SQUAMOUS CELL CARCINOMA#0.8499;KERATINOCYTE#0.8072;SKIN CANCER#0.7407;CERVICAL CANCER#0.6740;SKIN CARCINOMA#0.6723;CERVICAL#0.6518;T CELL#0.6462
113235	PEMETREXED#1.0617;REDUCED FOLATE CARRIER#1.0594;FOLATE#1.0504;SMALL INTESTINE#1.0498;CHOROID PLEXUS#1.0490;FOLATE TRANSPORT#1.0390;INTESTINAL ABSORPTION#1.0331;METHOTREXATE#1.0204;FOLIC ACID#1.0100;FOLATE RECEPTOR ALPHA#1.0000;PLASMA MEMBRANE#0.9883;GENE EXPRESSION#0.9863;BRUSH BORDER#0.9772;FOLATE BINDING#0.9733;TUMOR CELLS#0.9572;BRUSH BORDER MEMBRANE#0.9540;MYRICETIN#0.9306;CANCER CELL#0.9145;NERVOUS SYSTEM#0.8985;CENTRAL NERVOUS SYSTEM#0.8909;5-METHYLTETRAHYDROFOLATE#0.8893;OOCYTE#0.8635;5-AZA-2'-DEOXYCYTIDINE#0.8607;2'-DEOXYCYTIDINE#0.8600;HEME TRANSPORTER#0.8552;POLYMERASE CHAIN REACTION#0.8369;REACTIVE OXYGEN SPECIES#0.8276;PURINE NUCLEOTIDE BIOSYNTHESIS#0.8242;NUCLEOTIDE BIOSYNTHESIS#0.8145;LIPID RAFT#0.8039;DIVALENT METAL TRANSPORTER#0.7963;FOLATE SENSING#0.7931;GLYCINAMIDE RIBONUCLEOTIDE#0.7890;DUODENUM#0.7736;ANEMIA#0.7656;ENTEROCYTE#0.7348;THIAMINE#0.7275;METHIONINE SYNTHASE#0.7264;NEURAL TUBE DEFECT#0.7187;NEURAL TUBE#0.7140;MAJOR FACILITATOR SUPERFAMILY#0.7071;EPITHELIAL CELL#0.7054;REVERSE TRANSCRIPTION#0.6928;ENDOCYTOSIS#0.6909;MEMBRANE TRANSPORT#0.6647;RHEUMATOID ARTHRITIS#0.6542;HEME TRANSPORT#0.6517;FOLATE METABOLISM#0.6486;FOLINIC ACID#0.6410;METHIONINE#0.6403;CELL MEMBRANE#0.6301;MULTIDRUG RESISTANCE PROTEIN#0.6209;BIOTIN#0.6198;COLORECTAL CANCER#0.6087;PRE-ECLAMPSIA#0.6062;BIRTH DEFECT#0.6049;SCAVENGER RECEPTOR#0.6020;ETHANOL#0.6016
113246	EPITHELIAL CELL#1.0537;MACROPHAGE#0.9844;LUNG EPITHELIAL CELL#0.9698;MOUSE LUNG EPITHELIAL#0.9061;BONE MARROW#0.8924;GM-CSF#0.8215;T CELL#0.7549;GENE EXPRESSION#0.7403;PROTEIN KINASE#0.6938;INTELLECTUAL DISABILITY#0.6131;GROWTH FACTOR#0.6080;B LYMPHOCYTE#0.6074;TUMOR CELLS#0.6063;ENDOTHELIAL CELL#0.6054
113251	OVARIAN CANCER#0.8976;RNA BINDING#0.8726;OVARIAN#0.7026;RIBOSOMAL PROTEIN#0.6277;TUMOR NECROSIS FACTOR#0.6151;CELL PROLIFERATION#0.6140
11325	RNA HELICASE#1.1169;17S U2 SNRNP#0.7828;APOPTOSIS#0.7076;U2 SNRNP#0.6745
113263	GLUCOCORTICOID RECEPTOR#0.8779;GENE EXPRESSION#0.7897;RESPONSE TO GLUCOCORTICOID#0.7426;PODOCYTE#0.7164;CORTISOL#0.6575;GLOMERULAR DEVELOPMENT#0.6134
11326	COMPLEMENT RECEPTOR#1.0884;MACROPHAGE#1.0565;T CELL#1.0543;PHAGOCYTOSIS#1.0090;KUPFFER CELL#0.9932;COMPLEMENT ACTIVATION#0.9913;DENDRITIC CELL#0.9857;CELL ACTIVATION#0.9712;T CELL ACTIVATION#0.9708;GENE EXPRESSION#0.9112;IMMUNE RESPONSE#0.8967;T CELL PROLIFERATION#0.8884;CELL PROLIFERATION#0.8883;MONOCYTE#0.8274;CYTOKINE PRODUCTION#0.7578;CELL SURFACE#0.7174;RHEUMATOID ARTHRITIS#0.7041;BONE MARROW#0.6668;SYNOVIUM#0.6507;SIGNALING PATHWAY#0.6294;INNATE IMMUNITY#0.6226;TOLERANCE INDUCTION#0.6209;HIGH FAT DIET#0.6086;NITRIC OXIDE#0.6028
113277	TUMOR SUPPRESSOR#0.8998;APOPTOSIS#0.7275;CANCER CELL#0.7065;RENAL CANCER CELLS#0.6956;CELL PROLIFERATION#0.6544
113278	BROWN-VIALETTO-VAN LAERE SYNDROME#1.0973;SQUAMOUS CELL CARCINOMA#1.0715;INTESTINAL EPITHELIAL CELL#1.0111;EPITHELIAL CELL#1.0093;RIBOFLAVIN TRANSPORT#1.0005;SMALL INTESTINE#0.9045;CELL PROLIFERATION#0.8856;T CELL#0.8658;NEUROLOGICAL DISORDER#0.8004;VITAMIN B2#0.7977;ESOPHAGEAL CANCER#0.7702;CELL SURFACE#0.7021;INTESTINAL ABSORPTION#0.6970;LYMPH NODE METASTASIS#0.6895;T LYMPHOCYTE#0.6885;LYMPH NODE#0.6843;HEARING LOSS#0.6646;GASTRIC CARDIA ADENOCARCINOMA#0.6444;CERVICAL#0.6387;CERVICAL CANCER#0.6065;RHEUMATOID ARTHRITIS#0.6063
11328	FK506 BINDING PROTEIN#0.7727;FK506 BINDING#0.7724;ENDOPLASMIC RETICULUM#0.6494
11329	NUCLEAR DBF2 RELATED#1.1087;PROTEIN KINASE#1.0485;KINASE ACTIVITY#1.0408;CELL CYCLE#1.0364;APOPTOSIS#1.0247;MORPHOGENESIS#1.0071;SIGNALING PATHWAY#1.0067;TUMOR SUPPRESSOR#0.9867;CENTROSOME DUPLICATION#0.9722;CENTROSOME#0.9117;CELL PROLIFERATION#0.9085;CELL DIVISION#0.9064;AUTOPHAGY#0.8868;CYTOKINESIS#0.8695;T CELL#0.7958;MITOTIC EXIT#0.7886;MITOSIS#0.7875;HIPPO SIGNALING#0.7668;CELL DEATH#0.7352;CELL POLARITY#0.7270;PROTEIN KINASE A#0.7184;GENE EXPRESSION#0.7086;MITOTIC CHROMOSOME#0.7023;AUTOPHAGOSOME FORMATION#0.6970;CELL GROWTH#0.6852;LEUCINE ZIPPER KINASE#0.6463;REGULATION OF CELL DIVISION#0.6455;EPITHELIAL CELL#0.6362;CELL CYCLE ARREST#0.6093;ONCOGENIC#0.6057;CANCER CELL#0.6033;GROWTH FACTOR#0.6023
1132	ACETYLCHOLINE#0.9730;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.9668;ACETYLCHOLINE RECEPTOR#0.9631;ENDOPLASMIC RETICULUM#0.6975;GENE EXPRESSION#0.6826;DOPAMINE#0.6396
11330	TRYPSINOGEN ACTIVATION#1.0409;PANCREATITIS#1.0409;CYSTIC FIBROSIS#0.9885;ACUTE PANCREATITIS#0.9521;PROTEASE ACTIVITY#0.9202;PANCREATIC CANCER#0.8874;OSTEOCLAST#0.8324;RECEPTOR ACTIVATOR#0.7625;BONE RESORPTION#0.7593;AUTOLYSIS#0.7128;TRYPSIN ACTIVITY#0.7083;BONE MARROW#0.6821;OSTEOCLAST DIFFERENTIATION#0.6164;BONE MARROW CELLS#0.6104;ENDOPLASMIC RETICULUM#0.6091;ENZYME ACTIVITY#0.6047
11331	ESTROGEN RECEPTOR ACTIVITY#1.1086;RECEPTOR ACTIVITY#1.0803;HUMAN BREAST CANCER#1.0375;B CELL#1.0339;BREAST CANCER CELL#1.0309;BREAST CANCER#1.0249;CANCER CELL#1.0196;ESTROGEN RECEPTOR#1.0144;MITOCHONDRIAL INNER MEMBRANE#1.0130;ESTRADIOL#1.0129;DNA BINDING#1.0116;MITOPHAGY#1.0089;CELL PROLIFERATION#1.0077;MITOCHONDRIA#1.0067;TRANSCRIPTION FACTOR#1.0053;APOPTOTIC#1.0052;CELL CYCLE#1.0025;MITOCHONDRIAL MEMBRANE#1.0012;GENE EXPRESSION#0.9991;CELL DEATH#0.9977;SIGNALING PATHWAY#0.9935;EPITHELIAL CELL#0.9873;APOPTOSIS#0.9866;CELL ASSOCIATED#0.9829;REACTIVE OXYGEN SPECIES#0.9791;GROWTH FACTOR#0.9781;PROTEIN KINASE#0.9734;CELL GROWTH#0.9716;TUMOR CELLS#0.9692;NADPH OXIDASE#0.9692;CYTOTOXICITY#0.9462;BREAST CARCINOMA#0.9436;ARYL HYDROCARBON RECEPTOR#0.9421;POLYCYCLIC AROMATIC HYDROCARBON#0.9346;CELL MIGRATION#0.9292;CARCINOGEN#0.9207;S PHASE#0.9056;CYTOCHROME P450#0.9054;CELL CYCLE ARREST#0.8966;PROGESTERONE#0.8956;OVARIAN#0.8945;ESTROGEN RECEPTOR ALPHA#0.8880;LUNG CANCER#0.8860;INNER MITOCHONDRIAL MEMBRANE#0.8756;17β-ESTRADIOL#0.8643;PACLITAXEL#0.8550;MORPHOGENESIS#0.8498;STEM CELL#0.8488;TOXICITY#0.8476;TRANSACTIVATION#0.8468;PLASMA MEMBRANE#0.8377;T CELL#0.8377;ENDOTHELIAL CELL#0.8360;STROMAL CELL#0.8324;COMPLEX I#0.7978;ENZYME ACTIVITY#0.7977;PROSTATE CANCER#0.7974;SIGNAL TRANSDUCTION#0.7948;MITOCHONDRIAL FUSION#0.7927;TUMOR SUPPRESSOR#0.7920;CYTOCHROME C#0.7836;DNA SYNTHESIS#0.7819;TAMOXIFEN#0.7756;POLYMERASE CHAIN REACTION#0.7720;MUTAGENESIS#0.7709;CRISTAE#0.7613;APOPTOTIC CELL DEATH#0.7610;REVERSE TRANSCRIPTION#0.7587;PODOCYTE#0.7427;M PHASE#0.7276;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7269;PROTEIN COMPLEX#0.7209;G1 PHASE#0.7205;ENDOPLASMIC RETICULUM#0.7168;HISTONE DEACETYLASE#0.7060;RESPIRATION#0.7044;FLOW CYTOMETRY ANALYSIS#0.7000;HEPATOCELLULAR CARCINOMA#0.6938;DECIDUALIZATION#0.6915;MAMMARY GLAND#0.6885;SISTER CHROMATID COHESION#0.6883;MITOGEN ACTIVATED PROTEIN#0.6834;MACROPHAGE#0.6833;ANGIOGENESIS#0.6791;PROTEIN FOLDING#0.6760;QUANTITATIVE REAL TIME#0.6748;BETA-ESTRADIOL#0.6743;MECHANISM OF ACTION#0.6702;CELL DIFFERENTIATION#0.6698;MEMBRANE OF MITOCHONDRIA#0.6692;MITOCHONDRIAL PROHIBITIN COMPLEX#0.6578;PROTEIN KINASE C#0.6506;AUTOPHAGY#0.6482;HEPATITIS C VIRUS#0.6471;HEPATITIS C#0.6462;TESTOSTERONE#0.6453;PROTEIN SYNTHESIS#0.6449;SMOOTH MUSCLE#0.6442;CELL SURFACE#0.6427;REPRODUCTIVE SYSTEM#0.6344;MICROTUBULE#0.6319;HOST CELL#0.6294;VIRION#0.6242;GLUTATHIONE#0.6167;SUPEROXIDE DISMUTASE#0.6150;GENOTOXIC#0.6134;LIGHT CHAIN 3#0.6117;ATP SYNTHASE#0.6115;LYSIS#0.6113;COLORECTAL#0.6086;ESTROGENS#0.6036;SENESCENCE#0.6025;DRUG RESISTANCE#0.6019;SLIT DIAPHRAGM#0.6011;INSULIN-LIKE GROWTH FACTOR#0.6008
11332	ACYL COA HYDROLASE#1.1341;COA HYDROLASE#1.1238;ACYL COA THIOESTERASE#1.0824;COA HYDROLASE ACTIVITY#0.8537;FATTY ACID METABOLISM#0.8483;ACETYLCHOLINE#0.8379;HYDROLASE ACTIVITY#0.8211;LUNG CANCER#0.7511;PALMITOYL#0.7156;COENZYME A#0.7117;PALMITOYL-COA HYDROLASE ACTIVITY#0.7058;HIGH FAT DIET#0.6983;PALMITOYL COA HYDROLASE#0.6878;K+ CONDUCTANCE#0.6384;NERVOUS SYSTEM#0.6248
11333	TRANSCRIPTION FACTOR#0.6084
11334	LUNG CANCER#1.0806;CANCER CELL#1.0732;TUMOR SUPPRESSOR#1.0706;APOPTOSIS#1.0444;ALKALINE PHOSPHATASE#0.9039;GENE EXPRESSION#0.8922;CELL GROWTH#0.8687;APOPTOTIC#0.8476;BREAST CANCER#0.8158;THYROID CANCER#0.7835;CELL PROLIFERATION#0.7580;IMMUNE CELL#0.6957;SQUAMOUS CELL CARCINOMA#0.6948;GROWTH FACTOR#0.6893;CELL CYCLE#0.6640;ERLOTINIB#0.6545;T CELL#0.6388;LUNG METASTASIS#0.6328;ACID PHOSPHATASE#0.6278;OVARIAN CANCER#0.6133;EPIDERMAL GROWTH FACTOR#0.6101;GROWTH FACTOR RECEPTOR#0.6101
11335	HETEROCHROMATIN#1.0382;HETEROCHROMATIN PROTEIN 1#1.0359;CELL CYCLE#1.0150;GENE EXPRESSION#0.9992;CELL PROLIFERATION#0.9624;LYSINE#0.9588;STEM CELL#0.9551;S PHASE#0.9533;GENE SILENCING#0.8911;APOPTOSIS#0.8555;CHROMATIN REMODELING#0.8454;HISTONE MODIFICATION#0.8340;CANCER CELL#0.8093;DNA METHYLATION#0.7693;GERM CELL#0.7616;LUNG CANCER#0.7383;TRANSCRIPTION FACTOR#0.7099;SENESCENCE#0.6845;XY BODY#0.6567;CELL DIFFERENTIATION#0.6402;MITOTIC CHROMOSOME#0.6239;SQUAMOUS CELL CARCINOMA#0.6153;EUCHROMATIN#0.6146;EXTRAEMBRYONIC CELL#0.6022
11336	EXOCYST#1.0709;EXOCYST COMPLEX#1.0630;COMPLEX I#1.0428;EXOCYTIC VESICLE#1.0216;PLASMA MEMBRANE#1.0141;SECRETORY VESICLE#1.0137;EXOCYTOSIS#0.9964;EPITHELIAL CELL#0.9563;PROTEIN COMPLEX#0.9371;CELL CELL ADHESION#0.8634;CELL ADHESION#0.8593;CELL PLATE#0.8589;CELL WALL#0.8461;EXOCYST ASSEMBLY#0.7802;ACINAR CELL#0.7746;CYTOKINESIS#0.7251;CELL SURFACE#0.7121;CELL POLARITY#0.6953;VACUOLE#0.6848;MEMBRANE FUSION#0.6753;VESICLE FUSION#0.6741;VESICLE TETHERING#0.6522;SECRETORY PATHWAY#0.6473;MICROTUBULE#0.6465;CELL MIGRATION#0.6405;CELL GROWTH#0.6395;SNARE COMPLEX#0.6328;POLLEN TUBE#0.6245;NEURITE OUTGROWTH#0.6221;ACTIN CYTOSKELETON#0.6205;GOLGI APPARATUS#0.6137;GENE EXPRESSION#0.6112;INSULIN SECRETION#0.6054;CYTOPLASM#0.6053;C TERMINAL DOMAIN#0.6034;TIGHT JUNCTION#0.6031;TETHERING COMPLEX#0.6012;VESICLE TRAFFICKING#0.6009
11337	GABA A RECEPTOR#1.0640;LIGHT CHAIN 3#1.0520;MICROTUBULE#1.0413;MICROTUBULE ASSOCIATED PROTEIN#1.0371;AUTOPHAGOSOME FORMATION#1.0321;PLASMA MEMBRANE#1.0235;TUMOR CELLS#1.0207;UBIQUITIN#1.0185;AUTOPHAGOSOME#1.0170;CYTOTOXICITY#1.0135;AUTOPHAGY#1.0121;CELL SURFACE#1.0110;CELL DEATH#1.0066;CONJUGATION#0.9916;LYSOSOME#0.9728;ASCITES#0.9574;SELECTIVE AUTOPHAGY#0.9547;APOPTOSIS#0.9546;PHAGOPHORE#0.9379;MACROAUTOPHAGY#0.9313;CENTRIOLAR SATELLITE#0.9295;MACROPHAGE#0.9283;MITOPHAGY#0.9249;AUTOPHAGOSOME MEMBRANE#0.9175;ORGANELLE#0.8975;PHOSPHATIDYLETHANOLAMINE#0.8808;TUBULIN BINDING#0.8770;INHIBITORY SYNAPSE#0.8752;GENE EXPRESSION#0.8730;AUTOPHAGOSOME-LYSOSOME FUSION#0.8665;N-ETHYLMALEIMIDE#0.8656;NERVOUS SYSTEM#0.8642;MITOCHONDRIA#0.8620;PROTEASOME#0.8598;INTRACELLULAR MEMBRANE#0.8545;ENDOPLASMIC RETICULUM#0.8346;POLYMORPHONUCLEAR LEUKOCYTES#0.8115;CENTROSOME#0.8023;CENTRAL NERVOUS SYSTEM#0.7995;METHOTREXATE#0.7981;SERUM ALBUMIN#0.7828;FIBROSARCOMA#0.7727;APOPTOTIC#0.7700;GLYCINE#0.7673;PURKINJE CELL#0.7533;CYTOPLASM#0.7505;RECEPTOR CLUSTERING#0.7437;LYSIS#0.7353;PHOSPHOLIPASE C#0.7311;PROTEIN PROTEIN INTERACTION#0.7302;TUMOR NECROSIS FACTOR#0.7255;PROTEIN KINASE#0.7116;ANCHORING#0.7105;LEUKOCYTE#0.7090;SIGNALING PATHWAY#0.7037;IMMUNE RESPONSE#0.7011;TRANSCRIPTION FACTOR#0.7002;LYMPH NODE#0.6963;RAPAMYCIN#0.6909;CYTOLYSIS#0.6830;SYNAPTIC TRANSMISSION#0.6816;CELLULAR HOMEOSTASIS#0.6752;CELL GROWTH#0.6719;INTRACELLULAR TRANSPORT#0.6590;DIAZEPAM#0.6587;CANCER CELL#0.6580;MITOCHONDRIAL MEMBRANE#0.6504;RESPONSE TO STARVATION#0.6493;REACTIVE OXYGEN SPECIES#0.6482;GLYCINE RECEPTOR#0.6407;ENDOCYTOSIS#0.6336;PROTEIN SYNTHESIS#0.6290;TARGET OF RAPAMYCIN#0.6273;PERITONEAL CAVITY#0.6230;RNA INTERFERENCE#0.6217;TUMOR ASSOCIATED ANTIGEN#0.6148;MITOMYCIN C#0.6136;PHOSPHATE BUFFERED SALINE#0.6123;INITIAL SEGMENT#0.6109;GLUTAMIC ACID#0.6018
11338	SMALL NUCLEAR RIBONUCLEOPROTEIN#1.0580;U2 SNRNP#1.0449;SPLICEOSOME ASSEMBLY#1.0357;RNA RECOGNITION MOTIF#1.0265;SPLICEOSOME#1.0232;U1 SNRNP#1.0226;RNA BINDING#1.0063;RNA SPLICING#1.0002;PRE-MRNA SPLICING#0.9992;MRNA SPLICING#0.9960;ARGININE#0.9483;GENE EXPRESSION#0.9462;MRNA PROCESSING#0.9342;PROTEIN PROTEIN INTERACTION#0.9226;RNA BINDING PROTEIN#0.9101;POLYPYRIMIDINE TRACT BINDING#0.8380;TRANSCRIPTION FACTOR#0.8160;NUCLEAR EXPORT#0.8114;SMALL NUCLEAR RNA#0.8067;NUCLEAR SPECKLE#0.7920;FACTOR I#0.7902;T CELL#0.7567;PRP19 COMPLEX#0.7520;URIDINE#0.7241;CELL CYCLE#0.6903;APOPTOSIS#0.6697;RNA PROCESSING#0.6619;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.6351;PRESPLICEOSOME#0.6127
11339	CELL CYCLE#0.9772;CANCER CELL#0.9561;ANTISENSE RNA#0.8691;CELL GROWTH#0.7903;APOPTOSIS#0.7885;GENE EXPRESSION#0.7381;TUMOR TISSUES#0.6645;LUNG CANCER#0.6364;LIVER CANCER#0.6356;CERVICAL CANCER#0.6269
1133	MUSCARINIC ACETYLCHOLINE RECEPTOR#0.7331;ACETYLCHOLINE RECEPTOR#0.7251;ACETYLCHOLINE#0.6492
11340	EXOSOME#1.0764;EXOSOME COMPLEX#0.7534;RRNA PROCESSING#0.7479;PONTOCEREBELLAR HYPOPLASIA#0.6930
113419	NMDA RECEPTOR#0.8071;CELL DEATH#0.6851
11341	SCRAPIE#0.9895;TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES#0.8257;STEM CELL#0.7641;CCL22 PRODUCTION#0.7063;AUTOPHAGIC VACUOLE#0.6821;AUTOPHAGY#0.6401;CELL CELL ADHESION#0.6147;MESENCHYMAL STEM CELL#0.6087;NEURONAL CELLS#0.6054
11342	ZINC FINGER PROTEIN#1.1269;UBIQUITIN#1.0854;CELL PROLIFERATION#0.8449;LIGASE ACTIVITY#0.6733;ENDOSOME#0.6020;SKELETAL MUSCLE REGENERATION#0.6005
11343	LIPASE INHIBITOR#1.0532;HORMONE SENSITIVE LIPASE#1.0532;SERINE HYDROLASE#1.0410;PHOSPHOLIPASE D#1.0376;LIPOPROTEIN LIPASE#1.0310;LIPASE ACTIVITY#1.0176;TRIGLYCERIDE LIPASE#1.0164;CANCER CELL#1.0155;PHOSPHOLIPASE C#1.0096;POSITRON EMISSION TOMOGRAPHY#1.0094;SPINAL CORD#1.0047;ADIPOSE TISSUE#1.0031;ARACHIDONIC ACID#1.0021;LIPID METABOLISM#0.9967;PHOSPHATIDYLETHANOLAMINE#0.9954;NERVOUS SYSTEM#0.9933;RECEPTOR AGONIST#0.9906;LIPOLYSIS#0.9899;HYDROLASE ACTIVITY#0.9875;CANNABINOID RECEPTOR#0.9870;GENE EXPRESSION#0.9853;HYDROLASE INHIBITOR#0.9783;CENTRAL NERVOUS SYSTEM#0.9771;RECEPTOR ANTAGONIST#0.9771;ADIPOCYTE#0.9763;SIGNALING PATHWAY#0.9757;TETRAHYDROCANNABINOL#0.9656;RIMONABANT#0.9608;ASTROCYTE#0.9594;FATTY ACID BINDING#0.9512;HIGH FAT DIET#0.9500;PRO-INFLAMMATORY#0.9487;PHOSPHOLIPASE A2#0.9463;SYNAPTIC TRANSMISSION#0.9458;SMALL INTESTINE#0.9451;NEURODEGENERATIVE DISEASE#0.9429;STRUCTURE ACTIVITY RELATIONSHIP#0.9405;AXON TERMINAL#0.9354;PHOSPHOLIPASE A#0.9331;HEPATOCELLULAR CARCINOMA#0.9249;PIPERAZINE#0.9175;ENZYME INHIBITOR#0.9141;HEPARIN#0.9096;MECHANISM OF ACTION#0.9062;AMYGDALA#0.9029;PEROXISOME#0.9002;MACROPHAGE#0.8990;INFLAMMATORY RESPONSE#0.8990;PROTEIN KINASE#0.8849;ISCHEMIA#0.8820;PURKINJE CELL#0.8762;TUMOR TISSUES#0.8753;COLORECTAL CANCER#0.8701;RECEPTOR LIGAND#0.8634;POLYMERASE CHAIN REACTION#0.8561;TOXICITY#0.8499;CHRONIC CONSTRICTION INJURY#0.8495;TRANSIENT RECEPTOR POTENTIAL#0.8465;ETHANOLAMINE#0.8408;OBESE#0.8397;STRIATUM#0.8388;NEUROPROTECTION#0.8343;ALZHEIMER'S DISEASE#0.8342;NEUROLOGICAL DISORDER#0.8342;PALMITOYL#0.8271;CATABOLISM#0.8263;ETHANOL#0.8263;BREAST CANCER#0.8256;CELL DEATH#0.8192;SKELETAL MUSCLE#0.8135;APOPTOSIS#0.8110;GLUTAMATE RECEPTOR#0.8097;PROSTAGLANDIN SYNTHESIS#0.8088;DOPAMINE#0.8079;LIPID DROPLET#0.8052;MULTIPLE SCLEROSIS#0.8001;CELL PROLIFERATION#0.7911;COLORECTAL#0.7889;CELL CYCLE#0.7871;GROWTH FACTOR#0.7859;FATTY ACID SYNTHASE#0.7857;SIGNALING MOLECULE#0.7558;ENDOGENOUS CANNABINOID SYSTEM#0.7520;ENERGY HOMEOSTASIS#0.7495;CONSTRICTION#0.7487;PYRAMIDAL CELL#0.7463;FOREBRAIN#0.7449;PARALLEL FIBER#0.7427;PROSTAGLANDIN E2#0.7353;PLASMA MEMBRANE#0.7353;CELL GROWTH#0.7349;MICROSOME#0.7332;PIPERAZIN#0.7330;SCIATIC NERVE#0.7267;CANNABINOID RECEPTOR LIGAND#0.7257;SENSITIZATION#0.7194;NOCICEPTION#0.7167;PARKINSON'S DISEASE#0.7160;WOUND HEALING#0.7148;PALMITOYL COA HYDROLASE#0.7138;NEUROTRANSMISSION#0.7088;IMMUNE CELL#0.7013;PHOSPHOLIPASE A1#0.6973;COA HYDROLASE#0.6959;LONG TERM DEPRESSION#0.6947;CELL MEMBRANE#0.6924;MUTAGENESIS#0.6918;DIET INDUCED OBESITY#0.6902;PERIPHERAL BLOOD#0.6892;PROSTATE CANCER#0.6813;MORRIS WATER MAZE#0.6736;ENZYME ACTIVITY#0.6719;LIVER CANCER#0.6668;DIAZEPAM#0.6525;QUANTITATIVE REAL TIME#0.6493;LIVER DISEASE#0.6489;CELL MIGRATION#0.6483;FRONTAL#0.6481;CANNABIS DEPENDENCE#0.6464;GLIAL CELL#0.6458;FORMALIN#0.6420;MONONUCLEAR CELLS#0.6419;ADRENALINE#0.6373;NORADRENALINE#0.6340;LOCOMOTION#0.6322;ANTI INFLAMMATORY DRUGS#0.6304;MICROGLIAL CELL#0.6290;NERVE TERMINAL#0.6246;INSULIN SECRETION#0.6245;MIGRAINE#0.6137;NOVEL OBJECT RECOGNITION#0.6120;PRESYNAPTIC TERMINAL#0.6116;EPITHELIAL CELL#0.6116;INTERNEURON#0.6115;INDOMETHACIN#0.6090
113451	PUTRESCINE BIOSYNTHESIS#1.0775;PUTRESCINE SYNTHESIS#1.0728;ARGININE DECARBOXYLASE#1.0477;D-ARGININE#1.0409;DECARBOXYLASE ACTIVITY#1.0375;ARGININE#1.0370;AGMATINE#1.0307;SPERMIDINE SYNTHASE#1.0284;ADENOSYLMETHIONINE DECARBOXYLASE#1.0279;L-ARGININE#1.0266;POLYAMINE SYNTHESIS#1.0182;ORNITHINE DECARBOXYLASE#1.0181;S-ADENOSYLMETHIONINE#1.0178;POLYAMINE BIOSYNTHETIC#1.0169;LYSINE#1.0156;ORNITHINE#1.0155;NITRIC OXIDE SYNTHASE#1.0045;DIAMINE OXIDASE#1.0031;PUTRESCINE#1.0026;POLYAMINE BIOSYNTHESIS#0.9993;GENE EXPRESSION#0.9972;ENZYME ACTIVITY#0.9951;ALPHA-DIFLUOROMETHYLORNITHINE#0.9949;NITRIC OXIDE#0.9914;POLYAMINE METABOLISM#0.9885;SPERMIDINE#0.9850;SPERMINE#0.9801;POLYAMINE OXIDASE#0.9798;GLYCINE#0.9770;PYRIDOXAL#0.9752;CELL DIVISION#0.9702;ORNITHINE DECARBOXYLASE ACTIVITY#0.9701;CATABOLISM#0.9583;PYRIDOXAL 5-PHOSPHATE#0.9529;METHIONINE#0.9469;DROUGHT TOLERANCE#0.9467;FRUIT DEVELOPMENT#0.9325;POLYMERASE CHAIN REACTION#0.9320;L-ORNITHINE#0.9309;ARGININE METABOLISM#0.9120;REACTIVE OXYGEN SPECIES#0.9015;NERVOUS SYSTEM#0.8701;CELL PROLIFERATION#0.8690;S-ADENOSYL-L-METHIONINE#0.8669;L-METHIONINE#0.8618;POLYAMINE UPTAKE#0.8612;CENTRAL NERVOUS SYSTEM#0.8610;PYRIDOXAL PHOSPHATE#0.8518;CELL CYCLE#0.8265;CELL GROWTH#0.8223;DEHYDRATION#0.7921;TRANSCRIPTION FACTOR#0.7817;REVERSE TRANSCRIPTION#0.7780;ASPARTATE#0.7777;STEM CELL#0.7755;CITRULLINE#0.7738;VESICLE TRANSPORT#0.7659;SALT TOLERANCE#0.7605;ARGININE CATABOLISM#0.7574;CELL DEATH#0.7573;GLUTAMATE DECARBOXYLASE#0.7494;BETA GALACTOSIDASE#0.7472;SPINAL CORD#0.7435;HOST CELL#0.7416;SPERMINE SYNTHASE#0.7231;INTERNODE#0.7222;NMDA RECEPTOR#0.7208;CELL WALL#0.7057;GERMINAL CELLS#0.6969;POLYAMINE FORMATION#0.6930;GLUTAMINE#0.6884;ASTROCYTE#0.6875;ADRENAL GLAND#0.6749;CHLOROPLAST#0.6747;REGENERATION#0.6674;ENDOTHELIAL CELL#0.6600;PUTRESCINE CATABOLISM#0.6568;UBIQUITIN#0.6493;SENESCENCE#0.6472;ARGINASE ACTIVITY#0.6435;CARBOXY LYASE#0.6401;GERMINATION#0.6397;HYOSCYAMINE#0.6373;OVARIES#0.6341;ALANINE#0.6304;ALKALOID BIOSYNTHESIS#0.6300;PROTEASOME#0.6295;BIOFILM FORMATION#0.6128;SALICYLIC ACID#0.6044;L-LYSINE#0.6027
113452	DNA METHYLATION#0.6355
11345	ISOLATION MEMBRANE#1.0708;AUTOPHAGOSOME MEMBRANE#1.0616;LIGHT CHAIN 3#1.0502;PHOSPHATIDYLETHANOLAMINE#1.0454;PHAGOPHORE ASSEMBLY SITE#1.0370;PHAGOPHORE#1.0348;APICOPLAST#1.0343;CONJUGATION#1.0340;MICROTUBULE ASSOCIATED PROTEIN#1.0256;UBIQUITIN#1.0207;MITOPHAGY#1.0204;AUTOPHAGOSOME FORMATION#1.0189;PRE-AUTOPHAGOSOMAL STRUCTURE#1.0185;AUTOPHAGOSOME#1.0102;MICROTUBULE#1.0094;AUTOPHAGY#1.0032;SELECTIVE AUTOPHAGY#1.0015;MACROAUTOPHAGY#0.9857;MEMBRANE FUSION#0.9815;VACUOLE#0.9793;MITOCHONDRIA#0.9761;CYTOPLASM#0.9746;CELL DEATH#0.9742;PROTEIN PROTEIN INTERACTION#0.9708;LYSOSOME#0.9664;ENDOPLASMIC RETICULUM#0.9657;ATG12-ATG5-ATG16 COMPLEX#0.9619;ORGANELLE#0.9600;RAPAMYCIN#0.9592;GENE EXPRESSION#0.9397;APOPTOSIS#0.9359;CATABOLIC PROCESS#0.9317;COMPLEX I#0.9285;PROTEASOME#0.9284;INTRA-GOLGI TRANSPORT#0.9281;GLYCINE#0.9179;SENESCENCE#0.9131;CELLULAR HOMEOSTASIS#0.9126;ENDOSOME#0.9098;REACTIVE OXYGEN SPECIES#0.8979;PROTEIN KINASE#0.8951;MIDGUT#0.8949;REGULATION OF AUTOPHAGY#0.8922;AUTOPHAGOSOME MATURATION#0.8907;VESICLE FORMATION#0.8883;TRANSCRIPTION FACTOR#0.8769;PROTEIN DEGRADATION#0.8740;VACUOLAR MEMBRANE#0.8590;CYTOPLASM TO VACUOLE TARGETING#0.8545;PLASMA MEMBRANE#0.8541;MALARIA#0.8508;BUDDING#0.8444;NUCLEOTIDE EXCHANGE FACTOR#0.8435;NEURODEGENERATIVE DISEASE#0.8375;PROGRAMMED CELL DEATH#0.8334;CANCER CELL#0.8327;TRANSMISSION ELECTRON MICROSCOPY#0.8295;RNA INTERFERENCE#0.8133;TARGET OF RAPAMYCIN#0.8107;CONTRACTILE RING#0.8104;C TERMINAL DOMAIN#0.7995;VIRULENCE#0.7968;APOPTOTIC#0.7948;CELL CYCLE#0.7927;MACROPHAGE#0.7700;AUTOPHAGOSOME-LYSOSOME FUSION#0.7700;OUTER MEMBRANE#0.7699;3-METHYLADENINE#0.7557;GUANINE#0.7479;PEXOPHAGY#0.7466;LEAF SENESCENCE#0.7466;LIPID DROPLET#0.7449;MITOCHONDRIAL MEMBRANE#0.7403;PEROXISOMAL#0.7282;CELLULAR COMPONENT#0.7223;PEROXISOME#0.7120;PROTEIN COMPLEX#0.7030;HOST CELL#0.7017;TOXICITY#0.6952;GOLGI APPARATUS#0.6911;POLYMERASE CHAIN REACTION#0.6902;GABA A RECEPTOR#0.6823;RESPONSE TO STARVATION#0.6790;AUTOLYSOSOME#0.6581;CYTOKINESIS#0.6517;CENTRIOLAR SATELLITE#0.6426;PEROXISOMAL MEMBRANE#0.6424;IMMUNE RESPONSE#0.6416;SIGNALING PATHWAY#0.6411;POST-TRANSLATIONAL MODIFICATION#0.6363;26S PROTEASOME#0.6357;GIANT UNILAMELLAR VESICLES#0.6351;UBIQUITIN BINDING#0.6303;AUTOPHAGIC VACUOLE#0.6293;SIGNAL TRANSDUCTION#0.6225;PLASTID#0.6187;PARKINSON'S DISEASE#0.6130;CELL PROLIFERATION#0.6125;PHAGOSOME#0.6116;GAP ACTIVITY#0.6055
11346	ACTIN BINDING PROTEIN#1.0538;DENDRITIC SPINE#1.0527;ACTIN BINDING#1.0524;WILMS TUMOR 1#1.0489;SPINE NECK#1.0258;PODOCYTE#1.0215;SLIT DIAPHRAGM#1.0092;ACTIN CYTOSKELETON#1.0071;PODOCYTE FOOT#1.0043;SMOOTH MUSCLE#1.0024;FOOT PROCESS EFFACEMENT#0.9978;ORGANELLE#0.9951;DIAPHRAGM#0.9916;GROWTH FACTOR#0.9824;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.9812;APOPTOSIS#0.9812;PODOCYTE DIFFERENTIATION#0.9773;ACTIN FILAMENT#0.9756;NEPHROTIC SYNDROME#0.9749;SMOOTH MUSCLE ACTIN#0.9738;EPITHELIAL CELL#0.9729;PROTEINURIA#0.9728;GLOMERULAR FILTRATION#0.9696;DIABETIC NEPHROPATHY#0.9694;PODOCYTE FOOT PROCESS#0.9691;ENDOTHELIAL CELL#0.9677;POLYMERASE CHAIN REACTION#0.9672;KIDNEY DISEASE#0.9671;NEPHROPATHY#0.9670;GENE EXPRESSION#0.9634;EXCRETION#0.9634;GLOMERULAR FILTRATION BARRIER#0.9552;GLOMERULUS#0.9444;BASEMENT MEMBRANE#0.9425;CALCINEURIN#0.9225;MINIMAL CHANGE DISEASE#0.9225;GLOMERULONEPHRITIS#0.9213;STRESS FIBER#0.8990;LONG TERM POTENTIATION#0.8922;SIGNALING PATHWAY#0.8864;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8852;ENDOTHELIAL GROWTH FACTOR#0.8851;URINARY PROTEIN#0.8842;CELL MIGRATION#0.8740;NEPHRITIS#0.8736;GLOMERULAR EPITHELIAL CELL#0.8728;PUROMYCIN#0.8665;BOWMAN'S CAPSULE#0.8647;ACTIN BUNDLING#0.8646;DENTATE GYRUS#0.8560;PODOCYTE APOPTOSIS#0.8560;CHRONIC KIDNEY DISEASE#0.8414;CELL CYCLE#0.8400;ADRIAMYCIN#0.8391;TRANSCRIPTION FACTOR#0.8304;STRESS FIBRE#0.8231;GLOMERULAR FILTRATION RATE#0.8218;STEM CELL#0.8161;CELL PROLIFERATION#0.8116;HYPOXIA#0.7953;AXON INITIAL SEGMENT#0.7946;TRANSFORMING GROWTH FACTOR#0.7942;INITIAL SEGMENT#0.7898;STREPTOZOTOCIN#0.7876;DEDIFFERENTIATION#0.7791;MESANGIAL CELL#0.7666;PROTEIN KINASE#0.7656;CYCLIN DEPENDENT KINASE#0.7643;KINASE INHIBITOR#0.7617;ENDOPLASMIC RETICULUM#0.7486;ZONULA OCCLUDENS#0.7341;CYCLIN DEPENDENT KINASE INHIBITOR#0.7259;HIV-ASSOCIATED NEPHROPATHY#0.7253;CLEAVED CASPASE 3#0.7252;APOPTOTIC#0.7225;DIABETES MELLITUS#0.7173;REVERSE TRANSCRIPTION#0.7128;MICROTUBULE#0.6896;EXTRACELLULAR MATRIX#0.6650;MACROPHAGE#0.6630;T CELL#0.6563;CELL ADHESION#0.6479;CYTOPLASM#0.6431;HYPERTENSION#0.6415;BLOOD UREA NITROGEN#0.6354;ACTIN BUNDLING ACTIVITY#0.6319;ACTIN POLYMERIZATION#0.6256;QUANTITATIVE REAL TIME#0.6246;GALLOWAY-MOWAT SYNDROME#0.6151;RYANODINE RECEPTOR#0.6106;LUPUS NEPHRITIS#0.6104;WOUND HEALING#0.6038
1134	NICOTINIC ACETYLCHOLINE RECEPTOR#1.0518;ACETYLCHOLINE RECEPTOR#1.0456;ACETYLCHOLINE#1.0448;MYASTHENIA GRAVIS#1.0416;NEUROMUSCULAR JUNCTION#1.0172;SKELETAL MUSCLE#0.9975;CONGENITAL MYASTHENIC SYNDROME#0.9832;ION CHANNEL#0.9474;AUTOIMMUNE DISEASE#0.9083;D-TUBOCURARINE#0.7571;POLYMERASE CHAIN REACTION#0.7519;OOCYTE#0.7428;MUSCLE CELL#0.7189;EPITHELIAL CELL#0.7106;GENE EXPRESSION#0.7045;MUSCLE WEAKNESS#0.7009;TUBOCURARINE#0.6920;NERVOUS SYSTEM#0.6799;T CELL#0.6786;THYMIC EPITHELIAL CELLS#0.6256;CELL SURFACE#0.6230;LUNG CANCER#0.6085;ROCURONIUM#0.6046
113510	DNA HELICASE#1.0674;REPLICATION FORK#1.0358;DNA REPAIR#1.0238;DNA BINDING#0.9059;OVARIAN CANCER#0.7775;HOMOLOGOUS RECOMBINATION#0.7306;DNA REPLICATION#0.7252;ATP HYDROLYSIS#0.7170;OVARIAN#0.7103;CELLULAR RESPONSE TO CISPLATIN#0.6489;BREAST CANCER#0.6234
1135	FRONTAL LOBE EPILEPSY#1.0697;NICOTINIC ACETYLCHOLINE RECEPTOR#1.0510;AUTOSOMAL DOMINANT NOCTURNAL FRONTAL LOBE EPILEPSY#1.0487;ACETYLCHOLINE RECEPTOR#1.0484;ACETYLCHOLINE#1.0345;EPILEPSY#1.0322;FRONTAL#1.0011;NICOTINE DEPENDENCE#0.7383;MARTINOTTI CELL#0.6361
113612	CYTOCHROME P450#1.0334;PARAPLEGIA#0.9847;HEREDITARY SPASTIC PARAPLEGIA#0.9616;ARACHIDONIC ACID#0.8863
113675	POSITIVE PREDICTIVE VALUE#0.6424;CATALYTIC ACTIVITY#0.6371
1136	LUNG CANCER#1.0388;NICOTINE DEPENDENCE#1.0387;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#1.0281;NICOTINIC ACETYLCHOLINE RECEPTOR#1.0133;ACETYLCHOLINE RECEPTOR#1.0101;ACETYLCHOLINE#1.0076;CIGARETTES PER DAY#0.9279;GENE EXPRESSION#0.8424;ALCOHOL DEPENDENCE#0.8036;LUNG ADENOCARCINOMA#0.7946;HEDGEHOG INTERACTING PROTEIN#0.7909;GENETIC ASSOCIATION STUDIES#0.7078;ADENOCARCINOMA#0.7040;LUNG DISEASE#0.6677;COCAINE DEPENDENCE#0.6609;CANCER CELL#0.6540;FORCED EXPIRATORY VOLUME#0.6093;ION CHANNEL#0.6030
113730	BREAST CANCER#0.9566;BREAST CANCER CELL#0.7373;CANCER CELL#0.7112;SIGNALING PATHWAY#0.6854
113746	VIRULENCE#0.9287;SPERM TAIL#0.7685;CHLAMYDIA#0.7310
113791	PI3K SIGNALING#0.8664;T CELL#0.8290;APOPTOSIS#0.7635;GENE EXPRESSION#0.6485;SIGNALING PATHWAY#0.6395
1137	ABT-089#1.1251;GTS-21#1.0919;GALANTAMINE#1.0550;VARENICLINE#1.0506;AUTOSOMAL DOMINANT NOCTURNAL FRONTAL LOBE EPILEPSY#1.0486;FRONTAL LOBE EPILEPSY#1.0406;ETHANOL#1.0399;BETA-2#1.0333;ACETYLCHOLINE BINDING#1.0321;LIGAND BINDING DOMAIN#1.0321;POSITIVE ALLOSTERIC MODULATOR#1.0304;CHRONIC NICOTINE EXPOSURE#1.0268;MYASTHENIA GRAVIS#1.0248;NICOTINIC ACETYLCHOLINE RECEPTOR#1.0235;ANESTHETIC#1.0221;MECAMYLAMINE#1.0206;ACETYLCHOLINE RECEPTOR#1.0204;EPITHELIAL CELL#1.0189;CHROMAFFIN CELL#1.0179;NEUROMUSCULAR JUNCTION#1.0176;ACETYLCHOLINE#1.0161;NEUROPROTECTION#1.0140;SKELETAL MUSCLE#1.0134;MACROPHAGE#1.0128;MUSCARINIC ACETYLCHOLINE RECEPTOR#1.0124;EPILEPSY#1.0124;SIGNAL TRANSDUCTION#1.0116;NICOTINE DEPENDENCE#1.0113;D-TUBOCURARINE#1.0103;CELL PROLIFERATION#1.0101;GLYCINE RECEPTOR#1.0082;LUNG CANCER#1.0059;FRONTAL#1.0053;EPIBATIDINE#1.0051;HAIR CELL#1.0046;NMDA RECEPTOR#1.0045;TUBOCURARINE#1.0035;MUTAGENESIS#1.0035;OOCYTE#1.0028;CALCIUM CHANNEL#1.0020;CHOLINE#1.0008;STRUCTURE ACTIVITY RELATIONSHIP#1.0004;CEREBRAL CORTEX#1.0002;NERVE TERMINAL#0.9990;GLUTAMATE RECEPTOR#0.9983;ION CHANNEL#0.9982;CANCER CELL#0.9981;COGNITION#0.9970;POLYMERASE CHAIN REACTION#0.9960;SIGNALING PATHWAY#0.9959;ASTROCYTE#0.9956;CENTRAL NERVOUS SYSTEM#0.9953;NEUROTOXIN#0.9952;PARKINSON'S DISEASE#0.9940;T CELL#0.9935;INTERNEURON#0.9918;MUSCLE CELL#0.9915;ASPARTATE#0.9912;SYNAPTIC TRANSMISSION#0.9912;L-DOPA#0.9887;MYOTUBE#0.9887;PROTEIN KINASE#0.9881;DOPAMINE#0.9881;ALZHEIMER'S DISEASE#0.9878;CELL SURFACE#0.9878;NEUROTOXICITY#0.9875;MOLECULAR DYNAMICS SIMULATION#0.9873;INFLAMMATORY RESPONSE#0.9871;DOPAMINERGIC NEURON#0.9871;GENE EXPRESSION#0.9853;NEUROTRANSMITTER RECEPTOR#0.9846;POTASSIUM CHANNEL#0.9844;NERVOUS SYSTEM#0.9832;GLYCINE#0.9821;STRIATUM#0.9813;NEUROTRANSMISSION#0.9809;APOPTOSIS#0.9802;TOXICITY#0.9796;RECEPTOR BINDING#0.9756;RECEPTOR ANTAGONIST#0.9755;MECHANISM OF ACTION#0.9753;SPINAL CORD#0.9743;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9743;GROWTH FACTOR#0.9733;NOREPINEPHRINE#0.9700;NEUROTRANSMITTER RELEASE#0.9682;PRO-INFLAMMATORY#0.9681;THALAMUS#0.9674;CONVULSION#0.9667;PHENCYCLIDINE#0.9664;POSITRON EMISSION TOMOGRAPHY#0.9662;CARBAMYLCHOLINE#0.9661;HYPERACTIVITY#0.9649;ATROPINE#0.9583;PLASMA MEMBRANE#0.9567;RECEPTOR AGONIST#0.9566;CARBACHOL#0.9539;CHOLINERGIC NEURON#0.9533;TRANSCRIPTION FACTOR#0.9522;SYNAPTOSOME#0.9520;ENDOTHELIAL CELL#0.9459;MODE OF ACTION#0.9441;BREAST CANCER#0.9398;DONEPEZIL#0.9390;RESPONSE TO NICOTINE#0.9378;AUTOIMMUNE DISEASE#0.9359;MIDBRAIN#0.9353;REVERSE TRANSCRIPTION#0.9353;NITRIC OXIDE#0.9348;NEURONAL CELLS#0.9346;PROTEIN KINASE C#0.9331;BUPROPION#0.9330;NEUROLOGICAL DISORDER#0.9289;CELL DEATH#0.9263;FOREBRAIN#0.9240;APOPTOTIC#0.9182;KETAMINE#0.9179;SMOOTH MUSCLE#0.9170;CERVICAL#0.9169;LOBELINE#0.9132;RECEPTOR LIGAND#0.9111;B CELL#0.9103;IMMUNE RESPONSE#0.9103;ACTION POTENTIAL#0.9088;PRESYNAPTIC TERMINAL#0.9077;GANGLION CELLS#0.9074;NEUROTOXIC#0.9067;INNERVATION#0.9032;STEM CELL#0.9023;DEMENTIA#0.9014;BLOOD BRAIN BARRIER#0.9007;CELL GROWTH#0.8972;LEVAMISOLE#0.8966;AMYLOID PRECURSOR PROTEIN#0.8964;POSTSYNAPTIC MEMBRANE#0.8823;NEURODEGENERATIVE DISEASE#0.8754;GABA A RECEPTOR#0.8753;MUSCLE FIBER#0.8738;PHYSOSTIGMINE#0.8674;CELL MEMBRANE#0.8647;TETRODOTOXIN#0.8621;DOPAMINE RECEPTOR#0.8620;SCOPOLAMINE#0.8615;SODIUM CHANNEL#0.8595;PREPULSE INHIBITION#0.8592;ENDOPLASMIC RETICULUM#0.8558;TRYPTOPHAN#0.8539;SUBSTANTIA NIGRA#0.8523;SENSITIZATION#0.8504;JUVENILE MYOCLONIC EPILEPSY#0.8483;NEUROBLASTOMA#0.8455;FORCED SWIM TEST#0.8443;AXON TERMINAL#0.8442;IMMUNE CELL#0.8429;TUMOR NECROSIS FACTOR#0.8424;ANGIOGENESIS#0.8379;ALANINE#0.8377;CALCIUM SIGNALING#0.8362;CHANNEL ACTIVITY#0.8361;SPINOSAD#0.8358;SMOOTH MUSCLE CELL#0.8342;AIRWAY EPITHELIAL CELL#0.8313;CELL CYCLE#0.8295;AMPA RECEPTOR#0.8232;NITRIC OXIDE SYNTHASE#0.8189;PERIPHERAL BLOOD#0.8168;GLUTAMATERGIC NEURON#0.8145;NEUROPATHY#0.8129;CONGENITAL MYASTHENIC SYNDROME#0.8104;CHLORIDE CHANNEL#0.8093;CRAVING#0.8093;DENTATE GYRUS#0.8086;OUTER HAIR CELL#0.8076;LUNG CARCINOMA#0.8068;LINES OF EVIDENCE#0.8068;MITOGEN ACTIVATED PROTEIN#0.8039;CONDITIONED PLACE PREFERENCE#0.8008;SYNAPTOGENESIS#0.7996;ADENOSINE#0.7993;MEMANTINE#0.7962;RECEPTOR ACTIVITY#0.7950;MORRIS WATER MAZE#0.7947;FORMALIN#0.7944;MUSCLE CONTRACTION#0.7921;HUMAN EMBRYONIC KIDNEY#0.7918;EMBRYONIC KIDNEY#0.7914;LUNG FIBROBLASTS#0.7889;PROTEIN KINASE A#0.7884;CATECHOLAMINE SECRETION#0.7869;NOVEL OBJECT RECOGNITION#0.7841;INNER EAR#0.7829;DELTA-9-THC#0.7781;SEROTONIN RECEPTOR#0.7780;DIAPHRAGM#0.7776;RNA INTERFERENCE#0.7765;COGNITIVE DISORDER#0.7741;LONG TERM POTENTIATION#0.7738;QUANTITATIVE REAL TIME#0.7721;DYSKINESIA#0.7702;AMYGDALA#0.7591;EXTRACELLULAR REGION#0.7579;CATION CHANNEL#0.7573;LEUCINE#0.7562;DODECYL SULFATE#0.7535;SODIUM DODECYL SULFATE#0.7535;KERATINOCYTE#0.7519;CELL MIGRATION#0.7500;MEDIAL PREFRONTAL CORTEX#0.7487;IMMUNE SYSTEM#0.7481;C FIBER#0.7470;BREAST CANCER CELL#0.7442;MECHANISMS OF ACTION#0.7418;EXOCYTOSIS#0.7411;CLOZAPINE#0.7389;TECTUM#0.7388;HUPERZINE A#0.7387;HYPOXIA#0.7358;GLIAL CELL#0.7337;REACTIVE OXYGEN SPECIES#0.7261;IODOPHENYL#0.7244;GLYCOSYLATION#0.7208;STARTLE RESPONSE#0.7199;CHROMOSOMAL REGION#0.7196;NERVE ENDING#0.7192;MAGNETIC RESONANCE IMAGING#0.7190;NORADRENALINE#0.7183;HYDROGEN BOND DONOR#0.7182;RETINAL GANGLION CELL#0.7163;COCHLEA#0.7130;HYDROGEN BOND ACCEPTOR#0.7126;MEMBRANE DEPOLARIZATION#0.7123;PERIPHERAL NERVOUS SYSTEM#0.7097;MENTAL RETARDATION#0.7087;MAJOR DEPRESSIVE DISORDER#0.7037;CHONDROCYTE#0.7018;DORSAL ROOT GANGLION#0.6988;SIGNALING CASCADE#0.6978;CYCLIC AMP#0.6975;GABAERGIC NEURON#0.6966;AUTOIMMUNITY#0.6961;IDIOPATHIC GENERALIZED EPILEPSY#0.6939;HALOTHANE#0.6906;PRENATAL NICOTINE EXPOSURE#0.6863;RISPERIDONE#0.6847;ARTERY#0.6845;ACR-16#0.6819;PINEAL GLAND#0.6788;IONOTROPIC GLUTAMATE RECEPTOR#0.6786;OXALIPLATIN#0.6773;METHAMPHETAMINE#0.6753;MUSCLE FIBRE#0.6715;TRANSIENT RECEPTOR POTENTIAL#0.6714;ENZYME ACTIVITY#0.6668;CELL ADHESION#0.6663;GROWTH FACTOR RECEPTOR#0.6656;BONE MARROW#0.6646;GESTATION#0.6619;TRANSCRIPTASE#0.6610;MONOCYTE#0.6587;FORSKOLIN#0.6585;ARGININE#0.6566;TRAUMATIC BRAIN INJURY#0.6561;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6553;GLUTAMIC ACID#0.6548;SIGNAL TRANSMISSION#0.6515;DOPAMINE D2 RECEPTOR#0.6507;CARRIE#0.6464;SUCROSE#0.6456;HIGH MOBILITY GROUP#0.6439;SCIATIC NERVE#0.6437;NEOSTIGMINE#0.6416;ACOUSTIC STARTLE RESPONSE#0.6409;ADENYLATE CYCLASE#0.6407;REGENERATION#0.6404;SIGNALLING PATHWAY#0.6404;NERVE GROWTH FACTOR#0.6399;CYTOCHROME P450#0.6398;FRAGMENT LENGTH POLYMORPHISM#0.6397;LEUKOCYTE#0.6392;GABA B RECEPTOR#0.6330;QUINACRINE#0.6310;ISOFLURANE#0.6306;VECURONIUM#0.6263;SIGNALING MOLECULE#0.6229;MYOCARDITIS#0.6217;SEPTUM#0.6199;EPITHELIAL MESENCHYMAL TRANSITION#0.6193;PANCREATIC CANCER#0.6188;CONSTRICTION#0.6188;LOCUS COERULEUS#0.6172;MUSCLE WEAKNESS#0.6161;MELATONIN#0.6153;NEUROGENESIS#0.6149;THYMOCYTE#0.6141;ENDOCYTOSIS#0.6138;NEURAL CELL#0.6134;ANAESTHETIC#0.6126;FIBROBLAST GROWTH FACTOR#0.6095;POSITIVE ALLOSTERIC MODULATION#0.6086;INTERPEDUNCULAR NUCLEUS#0.6080;SHORT TERM MEMORY#0.6069;SYNAPSE ELIMINATION#0.6066;ISCHEMIA#0.6056;PKC ACTIVITY#0.6033;EXCITATORY POSTSYNAPTIC POTENTIAL#0.6008
113802	GERM CELL#0.9576;RNA METHYLTRANSFERASE#0.9332;RNA REPAIR#0.6420
113828	CELL PROLIFERATION#0.7803;SQUAMOUS CELL CARCINOMA#0.7770;REPORTER GENE ASSAY#0.7124;THYROID CANCER#0.6573;LUNG ADENOCARCINOMA#0.6559
113878	TOXICITY#0.9510;ION BINDING#0.6355
1138	LUNG CANCER#1.0333;NICOTINE DEPENDENCE#1.0278;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#1.0218;NICOTINIC ACETYLCHOLINE RECEPTOR#1.0104;ACETYLCHOLINE RECEPTOR#1.0084;ACETYLCHOLINE#1.0071;LUNG ADENOCARCINOMA#0.9586;CIGARETTES PER DAY#0.9561;GENE EXPRESSION#0.9551;ALCOHOL DEPENDENCE#0.9016;ADENOCARCINOMA#0.8534;COCAINE DEPENDENCE#0.8467;CANCER CELL#0.8316;HEDGEHOG INTERACTING PROTEIN#0.7896;NICOTINE REPLACEMENT THERAPY#0.7423;NICOTINE METABOLISM#0.7264;DOPAMINE#0.7208;SQUAMOUS CELL CARCINOMA#0.7069;ASPARTIC ACID#0.6978;GENETIC ASSOCIATION STUDIES#0.6643;FRONTAL#0.6622;INTERPEDUNCULAR NUCLEUS#0.6547;POLYMERASE CHAIN REACTION#0.6485;DNA METHYLATION#0.6328;RESPONSE TO NICOTINE#0.6293;PERIPHERAL BLOOD#0.6030
1139	ACETYLCHOLINE RECEPTOR#1.0431;NICOTINIC ACETYLCHOLINE RECEPTOR#1.0427;ACETYLCHOLINE#1.0388;BIPOLAR DISORDER#1.0050;ALZHEIMER'S DISEASE#0.9621;GENE EXPRESSION#0.9262;DNA METHYLATION#0.8173;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.7804;NICOTINE DEPENDENCE#0.7678;EPILEPSY#0.7636;HYPERACTIVITY#0.6676;INFLAMMATORY RESPONSE#0.6608;COPY NUMBER VARIANTS#0.6572;SMALL INTESTINE#0.6089
113	ADENYLATE CYCLASE#1.0588;ETHANOL#1.0303;ADENYLATE#0.9832;PROTEIN KINASE#0.8701;FORSKOLIN#0.7476;GENE EXPRESSION#0.7183;SIGNALING PATHWAY#0.7043;CAMP SIGNALING#0.6936;CYCLIC AMP#0.6557;PROTEIN KINASE A#0.6516;CAMP SYNTHESIS#0.6334;PLASMA MEMBRANE#0.6251;DOPAMINE#0.6127;PROTEIN KINASE C#0.6073
114026	GENE CONVERSION#0.7355
114034	TRANSCRIPTION FACTOR#0.8984;FLOWERING#0.7181
114041	LIVER METASTASIS#0.7296;ACUTE PANCREATITIS#0.7256;COLON CANCER#0.7174
114044	CELL PROLIFERATION#0.8751;ANTISENSE RNA#0.7753;CELL CYCLE#0.6797;ANGIOGENESIS#0.6587;CERVICAL SQUAMOUS CELL CARCINOMA#0.6552;APOPTOSIS#0.6543;PAPILLARY THYROID CANCER#0.6459;LYMPHATIC VESSEL#0.6413;METHYLATION SPECIFIC PCR#0.6398;DUAL LUCIFERASE REPORTER#0.6384;THYROID CANCER#0.6337;SQUAMOUS CELL CARCINOMA#0.6250;LUNG CANCER#0.6234;EPIDERMAL GROWTH FACTOR#0.6233;GROWTH FACTOR RECEPTOR#0.6233;GROWTH FACTOR#0.6171
114049	RIBOSOME#1.0060;COLORECTAL CANCER#0.9502;CANCER CELL#0.8873;METHYLTRANSFERASE ACTIVITY#0.8684;RIBOSOMAL SUBUNIT#0.8108;COLORECTAL#0.7632;40S RIBOSOMAL SUBUNIT#0.7437;RNA HELICASE#0.7284;RIBOSOME BIOGENESIS#0.7210;RRNA METHYLTRANSFERASE#0.6885;RRNA PROCESSING#0.6786;CELL GROWTH#0.6597;SSU PROCESSOME#0.6572;RNASE MRP#0.6326;OXALIPLATIN#0.6262;WILLIAMS BEUREN SYNDROME#0.6161
114086	T CELL#0.9750;BONE MARROW#0.9703;ETHANOL#0.7947;TUMOR CELLS#0.7509;GENE EXPRESSION#0.7266;IMMUNE RESPONSE#0.7041;MACROPHAGE#0.6987;CYTOCHROME P450#0.6850;TOXICITY#0.6536;DOPAMINE#0.6339;CELL DEATH#0.6293;BONE MARROW CELLS#0.6268;PROSTANOID SYNTHESIS#0.6254
114088	UBIQUITIN#0.9428;AXON BRANCHING#0.7558
1140	ACETYLCHOLINE RECEPTOR#0.9932;ACETYLCHOLINE#0.9010;NICOTINIC ACETYLCHOLINE RECEPTOR#0.7222;NICOTINE DEPENDENCE#0.6835;CONGENITAL MYASTHENIC SYNDROME#0.6467
114112	THIOREDOXIN GLUTATHIONE REDUCTASE#1.0912;GLUTATHIONE#1.0468;GLUTATHIONE PEROXIDASE#1.0385;SELENOCYSTEINE#1.0048;SCHISTOSOMIASIS#0.9885;AURANOFIN#0.9736;SUPEROXIDE DISMUTASE#0.9681;REACTIVE OXYGEN SPECIES#0.9324;THIOREDOXIN REDUCTASE 1#0.9254;GENE EXPRESSION#0.9191;PRAZIQUANTEL#0.7994;MITOCHONDRIA#0.7979;APOPTOSIS#0.7404;TOXICITY#0.7038
114131	BETA CELL#1.0671;GASTRIC EMPTYING#1.0383;AMYGDALA#0.9994;CORTICOTROPIN-RELEASING FACTOR#0.9953;CORTICOTROPIN#0.9925;INSULIN SECRETION#0.9808;RECEPTOR ANTAGONIST#0.9718;RECEPTOR AGONIST#0.9462;CORTICOTROPHIN#0.9373;NERVOUS SYSTEM#0.9324;GENE EXPRESSION#0.9307;HYPOTHALAMIC PITUITARY ADRENAL#0.9289;ENERGY HOMEOSTASIS#0.9008;TROPHOBLAST#0.8559;HIGH FAT DIET#0.8511;ETHANOL#0.8325;CENTRAL NERVOUS SYSTEM#0.8311;PEPTIDE HORMONE#0.8231;FORCED SWIMMING TEST#0.8175;TYPE 2 DIABETES#0.8107;NITRIC OXIDE#0.8090;NITRIC OXIDE SYNTHASE#0.7907;SUBSTANCE P#0.7895;VASOPRESSIN#0.7817;ADRENAL GLAND#0.7793;ELEVATED PLUS MAZE#0.7737;ANORECTIC#0.7477;CARDIOVASCULAR SYSTEM#0.7450;ADIPOSE TISSUE#0.7405;FEEDING BEHAVIOR#0.7404;SKELETAL MUSCLE#0.7397;CORTICOTROPHIN RELEASING HORMONE#0.7205;CRF BINDING#0.7061;ADENYLATE CYCLASE#0.7030;BLOOD GLUCOSE LEVEL#0.6968;NERVE FIBER#0.6815;CELL MATURATION#0.6804;SEPTUM#0.6779;PROTEIN KINASE#0.6600;HYPOXIA#0.6502;ANOREXIC#0.6385;TRANSCRIPTION FACTOR#0.6295;RESPONSE TO STRESS#0.6243;GROWTH FACTOR#0.6218;STEROL CARRIER PROTEIN#0.6204;POLYMERASE CHAIN REACTION#0.6185;ACTH SECRETION#0.6184;ANOREXIA#0.6179;SOMATOSTATIN SECRETION#0.6164;REGULATION OF ENERGY HOMEOSTASIS#0.6149;SIGNALING PATHWAY#0.6147
114132	GENE CONVERSION#0.9666;SIALIC ACID BINDING#0.8482;LECTIN#0.7431;MICROGLIAL CELL#0.6640;MACROPHAGE#0.6555;NEUROTOXICITY#0.6374;IMMUNE CELL#0.6056
114134	MYO-INOSITOL#1.1339
1141	AUTOSOMAL DOMINANT NOCTURNAL FRONTAL LOBE EPILEPSY#1.0821;FRONTAL LOBE EPILEPSY#1.0690;NICOTINE DEPENDENCE#1.0486;EPILEPSY#1.0424;FRONTAL#1.0409;NICOTINIC ACETYLCHOLINE RECEPTOR#1.0363;ACETYLCHOLINE RECEPTOR#1.0341;ACETYLCHOLINE#1.0317;BETA-2#0.8631;GENE EXPRESSION#0.7583;RESPONSE TO NICOTINE#0.6459;ION CHANNEL#0.6454;DENTATE GYRUS#0.6237;POTASSIUM CHANNEL#0.6220;ALZHEIMER'S DISEASE#0.6091
114294	TUMOR SUPPRESSOR#0.7924;BREAST CANCER#0.7899;PENICILLIN BINDING#0.7478;PENICILLIN#0.7375;LIPID METABOLISM#0.6513
1142	NICOTINE DEPENDENCE#1.0816;NICOTINIC ACETYLCHOLINE RECEPTOR#0.9913;ACETYLCHOLINE RECEPTOR#0.9891;ACETYLCHOLINE#0.9272;BIPOLAR DISORDER#0.7087;LUNG CANCER#0.6530;COCAINE DEPENDENCE#0.6463;ALCOHOL DEPENDENCE#0.6443;GENE EXPRESSION#0.6379
114327	JUVENILE MYOCLONIC EPILEPSY#1.0663;EPILEPSY#1.0534;IDIOPATHIC GENERALIZED EPILEPSY#1.0195;MITOTIC SPINDLE#0.9213;IDIOPATHIC GENERALIZED EPILEPSIES#0.8728;CHROMOSOMAL REGION#0.7783;MICROTUBULE#0.7724;CELL DIVISION#0.7677;ION CHANNEL#0.7247;CHOROID PLEXUS#0.7217;EPENDYMAL CELL#0.7131;CONVULSION#0.7055;INTRACTABLE EPILEPSY#0.6402;MOTILE CILIA#0.6364;ABSENCE EPILEPSY#0.6349;BRAIN DEVELOPMENT#0.6324;M PHASE#0.6199;APOPTOSIS#0.6004
114335	OVARIAN CANCER#0.8744;OVARIAN#0.6639;CANCER CELL#0.6257
114336	OVARIAN CANCER#0.8918;OVARIAN#0.6772
1143	NICOTINE DEPENDENCE#1.0580;LUNG CANCER#1.0503;NICOTINIC ACETYLCHOLINE RECEPTOR#1.0191;ACETYLCHOLINE RECEPTOR#1.0172;ACETYLCHOLINE#1.0149;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9004;GENE EXPRESSION#0.8224;GENETIC ASSOCIATION STUDIES#0.6999;CIGARETTES PER DAY#0.6766;ALCOHOL DEPENDENCE#0.6708;AGE AT ONSET#0.6481;DNA METHYLATION#0.6178
114475	CISPLATIN#0.6487
1144	ACETYLCHOLINE RECEPTOR#1.0249;ACETYLCHOLINE#0.9515;CONGENITAL MYASTHENIC SYNDROME#0.7679;MULTIPLE PTERYGIUM SYNDROME#0.7079;NEUROMUSCULAR JUNCTION#0.6889
114548	NALP3 INFLAMMASOME COMPLEX#1.1596;NLRP3 INFLAMMASOME COMPLEX#1.0737;EARLY BRAIN INJURY#1.0688;SCHNITZLER SYNDROME#1.0633;INTERLEUKIN-1 SECRETION#1.0610;NUCLEOTIDE OLIGOMERIZATION DOMAIN#1.0523;LUPUS NEPHRITIS#1.0516;CINCA SYNDROME#1.0511;MEVALONATE KINASE DEFICIENCY#1.0482;GENE SILENCING#1.0468;MELATONIN#1.0447;GLYBURIDE#1.0433;VASOPRESSIN#1.0402;MEVALONATE KINASE#1.0385;FAMILIAL COLD AUTOINFLAMMATORY SYNDROME#1.0384;PODOCYTE#1.0370;ALLERGIC AIRWAY INFLAMMATION#1.0369;NEPHRITIS#1.0361;IL-18 PRODUCTION#1.0356;MITOCHONDRIAL FISSION#1.0352;MTDNA#1.0342;NLRP3 INFLAMMASOME ACTIVATION#1.0334;AIRWAY EPITHELIUM#1.0332;COLLAGEN SYNTHESIS#1.0323;REACTIVE OXYGEN SPECIES GENERATION#1.0322;ABSENT IN MELANOMA#1.0302;MITOPHAGY#1.0302;GLIBENCLAMIDE#1.0295;FRUCTOSE#1.0290;BLAU SYNDROME#1.0280;IL-18 SECRETION#1.0277;INFLAMMASOME COMPLEX#1.0276;MESANGIAL CELL#1.0263;MUCKLE-WELLS SYNDROME#1.0257;ASC PYROPTOSOME#1.0255;PULMONARY FIBROSIS#1.0251;HEMORRHAGE#1.0241;RETINAL PIGMENT EPITHELIAL#1.0239;MAPK SIGNALING#1.0228;CARDIOMYOCYTE#1.0225;NUCLEOTIDE BINDING DOMAIN#1.0223;VASCULAR SMOOTH MUSCLE CELL#1.0221;FOAM CELL FORMATION#1.0211;HEREDITARY PERIODIC FEVER#1.0204;VASCULAR ENDOTHELIAL CELL#1.0203;COMPLEX I#1.0201;ALDOSTERONE#1.0200;JUVENILE IDIOPATHIC ARTHRITIS#1.0190;RESVERATROL#1.0178;LEUCINE RICH REPEAT#1.0172;METFORMIN#1.0169;ENDOPLASMIC RETICULUM STRESS#1.0169;ACUTE LIVER INJURY#1.0168;ISCHEMIA REPERFUSION INJURY#1.0167;MESOTHELIAL CELL#1.0166;TRAUMATIC BRAIN INJURY#1.0160;SQUAMOUS CELL CARCINOMA#1.0159;PANCREATITIS#1.0159;INTERLEUKIN-1 PRODUCTION#1.0152;INFLUENZA A VIRUS#1.0148;DIABETIC NEPHROPATHY#1.0146;PANCREATIC ISLET#1.0144;RESPONSE TO LPS#1.0141;PALMITATE#1.0140;EXOSOME#1.0137;LEUCINE#1.0136;ALVEOLAR MACROPHAGE#1.0131;PYODERMA GANGRENOSUM#1.0131;MITOCHONDRIAL DAMAGE#1.0130;NF-KAPPAB ACTIVATION#1.0126;MACROPHAGE POLARIZATION#1.0125;CLEAVED CASPASE 3#1.0124;MITOCHONDRIAL DNA#1.0119;COLITIS#1.0118;CANAKINUMAB#1.0115;NUCLEOTIDE BINDING#1.0114;IL-1 SECRETION#1.0114;ACUTE PANCREATITIS#1.0114;SMOOTH MUSCLE CELL#1.0112;KUPFFER CELL#1.0111;ACUTE MYOCARDIAL INFARCTION#1.0103;CEREBRAL ISCHEMIA#1.0102;FAMILIAL MEDITERRANEAN FEVER#1.0102;SENESCENCE#1.0102;CASPASE ACTIVATION#1.0102;LIVER DAMAGE#1.0097;SPINAL CORD INJURY#1.0093;RENAL FIBROSIS#1.0093;SIGNALLING PATHWAY#1.0092;BRAIN DAMAGE#1.0084;PALMITIC ACID#1.0080;ETHANOL#1.0079;ADVANCED GLYCATION END#1.0068;CORNEAL EPITHELIAL CELL#1.0068;M1 MACROPHAGE#1.0066;DOPAMINE#1.0066;CASPASE-1 ACTIVITY#1.0059;HUMAN CORNEAL EPITHELIAL#1.0056;PERIODONTAL DISEASE#1.0056;MUSCLE CELL#1.0055;ADENOSINE TRIPHOSPHATE#1.0055;MICROGLIAL CELL#1.0054;ION CHANNEL#1.0054;SATURATED FATTY ACID#1.0053;MICROVASCULAR ENDOTHELIAL CELL#1.0052;COLORECTAL CANCER#1.0050;CARDIOMYOPATHY#1.0050;WOUND HEALING#1.0048;NEUROINFLAMMATORY RESPONSE#1.0048;TUBULAR EPITHELIAL CELL#1.0047;HEPATIC STELLATE CELL#1.0044;ASTROCYTE#1.0043;MICROTUBULE#1.0042;KERATINOCYTE#1.0042;SPINAL CORD#1.0040;PROTEIN COMPLEX#1.0033;NEPHROPATHY#1.0032;LIPID METABOLISM#1.0031;HYPOXIC#1.0029;GLYCOLYSIS#1.0028;QUERCETIN#1.0027;PIGMENT EPITHELIAL CELL#1.0022;DEXMEDETOMIDINE#1.0021;DEXTRAN SULFATE SODIUM#1.0018;ACIDIFICATION#1.0018;PERIODONTITIS#1.0017;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#1.0015;OSTEOARTHRITIS#1.0015;MONOCYTE DERIVED MACROPHAGE#1.0010;NECROPTOSIS#1.0005;AUTOPHAGY#1.0001;DIABETIC RETINOPATHY#1.0001;ADIPOCYTE#0.9999;ENDOTHELIUM#0.9998;UBIQUITIN#0.9998;LUNG EPITHELIAL CELL#0.9994;PYROPTOSIS#0.9993;TH17 CELL#0.9993;RAPAMYCIN#0.9991;URTICARIA#0.9991;GLIAL CELL#0.9983;CROHN'S DISEASE#0.9981;TIGHT JUNCTION PROTEIN#0.9981;ACUTE KIDNEY INJURY#0.9980;CELL MIGRATION#0.9979;ENDOTHELIAL CELL#0.9978;LYSOSOME#0.9976;PERITONITIS#0.9976;ACUTE LUNG INJURY#0.9975;INTERLEUKIN 1 RECEPTOR#0.9974;MYELOID CELL#0.9972;NADPH OXIDASE#0.9970;OBESE#0.9969;MITOCHONDRIA#0.9968;URIC ACID#0.9968;IL-1 PRODUCTION#0.9967;REVERSE TRANSCRIPTION#0.9967;MYOCARDIAL INFARCTION#0.9965;PHAGOCYTOSIS#0.9957;SIGNALING MOLECULE#0.9954;ATP BINDING#0.9952;PSORIASIS#0.9949;TYPE 1 DIABETES#0.9949;DEXTRAN SODIUM SULFATE#0.9949;QUANTITATIVE REAL TIME#0.9949;ISCHEMIA#0.9948;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9948;TUMOUR NECROSIS FACTOR#0.9947;RHEUMATOID ARTHRITIS#0.9946;STEROL REGULATORY ELEMENT#0.9944;HYPOXIA#0.9943;HUMAN UMBILICAL VEIN#0.9942;UMBILICAL VEIN#0.9940;TIGHT JUNCTION#0.9939;LUNG CANCER#0.9934;ALLOPURINOL#0.9932;MAST CELL#0.9931;LYMPH NODE#0.9928;CANCER CELL#0.9927;INFLAMMATORY BOWEL DISEASE#0.9927;AGE RELATED MACULAR DEGENERATION#0.9926;ADENOSINE#0.9923;PARKINSON'S DISEASE#0.9919;SMOOTH MUSCLE#0.9918;HIGH MOBILITY GROUP#0.9917;N-ACETYLCYSTEINE#0.9917;IL-1RA#0.9917;ADIPOSE TISSUE#0.9917;SIGNALING CASCADE#0.9917;CEREBRAL CORTEX#0.9917;FIBROBLAST LIKE SYNOVIOCYTES#0.9916;MACULAR DEGENERATION#0.9915;AIRWAY EPITHELIAL CELL#0.9915;MULTIPLE SCLEROSIS#0.9910;CELL MEMBRANE#0.9910;TYPE 2 DIABETES MELLITUS#0.9908;2 DIABETES MELLITUS#0.9907;ALCOHOLIC FATTY LIVER#0.9907;TROPHOBLAST#0.9906;ENDOPLASMIC RETICULUM#0.9905;MACROPHAGE#0.9904;SIGNALING PATHWAY#0.9903;PNEUMONIA#0.9902;HEART DISEASE#0.9899;HYPERURICEMIA#0.9897;TRANSFORMING GROWTH FACTOR#0.9895;ATHEROSCLEROSIS#0.9894;ROS GENERATION#0.9894;COLORECTAL#0.9893;MITOCHONDRIAL MEMBRANE#0.9892;INTESTINAL EPITHELIAL CELL#0.9891;STEM CELL#0.9891;COLCHICINE#0.9890;APOPTOSIS#0.9889;NECROTIC#0.9888;CYTOPLASM#0.9888;URATE#0.9888;BRAIN EDEMA#0.9885;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9881;ULCERATIVE COLITIS#0.9876;MYOCARDIUM#0.9875;B CELL#0.9871;ENCEPHALOMYELITIS#0.9870;INDUCED RENAL INJURY#0.9870;VIRAL INFECTION#0.9866;LIGHT CHAIN 3#0.9864;MITOGEN ACTIVATED PROTEIN#0.9856;RECEPTOR AGONIST#0.9855;URETERAL OBSTRUCTION#0.9854;POLYMERASE CHAIN REACTION#0.9854;ATHEROSCLEROTIC#0.9853;RETINAL PIGMENT EPITHELIUM#0.9853;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9851;PYODERMA#0.9851;GM-CSF#0.9848;XANTHINE OXIDASE#0.9846;RNA INTERFERENCE#0.9846;RETINAL PIGMENT EPITHELIAL CELLS#0.9845;HIGH FAT DIET#0.9845;UNFOLDED PROTEIN RESPONSE#0.9844;HYPERTENSION#0.9841;MECHANISM OF ACTION#0.9839;ALZHEIMER'S DISEASE#0.9836;BONE MARROW#0.9836;PLASMA MEMBRANE#0.9833;HEARING LOSS#0.9833;SWELLING#0.9832;LUNG DISEASE#0.9832;EPITHELIAL CELL#0.9830;REACTIVE OXYGEN SPECIES#0.9829;DENTAL PULP#0.9829;LUPUS ERYTHEMATOSUS#0.9828;MONOCYTE#0.9824;HYPERGLYCEMIA#0.9823;ANTIGEN PRESENTING CELLS#0.9819;DENDRITIC CELL#0.9818;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9817;LEUKOCYTE#0.9816;LOW DENSITY LIPOPROTEIN#0.9816;PROTEASE ACTIVITY#0.9815;KIDNEY DISEASE#0.9814;CYTOKINE SECRETION#0.9809;GENE EXPRESSION#0.9808;PERIPHERAL BLOOD MONOCYTES#0.9807;FATTY LIVER DISEASE#0.9806;CELL ACTIVATION#0.9805;LYSOSOMAL MEMBRANE#0.9805;TOLL LIKE RECEPTOR#0.9804;TISSUE DAMAGE#0.9804;MESENCHYMAL STEM CELL#0.9802;FATTY LIVER#0.9801;ANAKINRA#0.9800;CHRONIC KIDNEY DISEASE#0.9798;CD4+ T CELL#0.9797;ADAPTIVE IMMUNE RESPONSE#0.9794;NEUROPROTECTION#0.9792;SIGNAL TRANSDUCTION#0.9792;TYPE 2 DIABETES#0.9792;PERIPHERAL BLOOD#0.9791;FIBRIL#0.9791;PROTEINURIA#0.9790;SERUM AMYLOID A#0.9786;MONONUCLEAR CELLS#0.9786;REGULATORY T CELL#0.9785;PATTERN RECOGNITION RECEPTOR#0.9782;TO THE PROGRESSION#0.9782;PROGRAMMED CELL DEATH#0.9781;EXTRACELLULAR MATRIX#0.9780;VIRULENCE#0.9779;PROTEIN KINASE#0.9778;M2 MACROPHAGE#0.9778;SIGNAL TRANSDUCER#0.9776;LECTIN#0.9776;MIDDLE CEREBRAL ARTERY#0.9773;NITRIC OXIDE SYNTHASE#0.9772;CEREBRAL ARTERY#0.9771;TUBERCULOSIS#0.9769;UNILATERAL URETERAL OBSTRUCTION#0.9766;TRANSCRIPTION FACTOR#0.9766;XANTHINE#0.9765;CEREBRAL ARTERY OCCLUSION#0.9764;NITRIC OXIDE#0.9761;DIABETES MELLITUS#0.9759;CYTOKINE PRODUCTION#0.9759;GROWTH FACTOR#0.9756;INDUCIBLE NITRIC OXIDE#0.9754;BLOOD BRAIN BARRIER#0.9750;BLEOMYCIN#0.9749;CORONARY ARTERY DISEASE#0.9748;ARTERY DISEASE#0.9748;MACROMOLECULAR COMPLEX#0.9748;AMYLOIDOSIS#0.9746;CORONARY ARTERY#0.9745;ASPARTATE#0.9740;ACETYLCYSTEINE#0.9740;APOPTOTIC#0.9736;CELL PROLIFERATION#0.9732;NEUTROPHIL#0.9725;HUMAN DENTAL PULP#0.9725;CELL DEATH#0.9724;STREPTOZOTOCIN#0.9722;MACROPHAGE ACTIVATION#0.9722;HYPERHOMOCYSTEINEMIA#0.9722;ROS FORMATION#0.9720;LIVER DISEASE#0.9718;TUMOR NECROSIS FACTOR#0.9715;EXCRETION#0.9713;OXYGEN GLUCOSE DEPRIVATION#0.9710;ACINAR CELL#0.9706;DOPAMINERGIC NEURON#0.9705;PRO-INFLAMMATORY#0.9704;INFLAMMATORY CELL INFILTRATION#0.9703;WEIGHT LOSS#0.9703;INNATE IMMUNE RESPONSE#0.9702;CELL SURFACE#0.9700;PORE FORMING TOXINS#0.9699;INNATE IMMUNITY#0.9697;MICROTUBULE ASSOCIATED PROTEIN#0.9696;AUTOPHAGOSOME#0.9690;L-CYSTEINE#0.9683;INFLAMMATORY RESPONSE#0.9681;ARTERY#0.9681;STROMAL CELL#0.9680;AUTOIMMUNE DISEASE#0.9679;TOXICITY#0.9678;EDEMA#0.9676;T CELL#0.9676;RECEPTOR ANTAGONIST#0.9676;NEURODEGENERATIVE DISEASE#0.9675;GRANULOCYTE#0.9675;PEROXISOME#0.9675;GLUTATHIONE#0.9673;AUTOIMMUNITY#0.9671;PROGENITOR CELL#0.9669;TRANSMISSION ELECTRON MICROSCOPY#0.9666;NONALCOHOLIC FATTY LIVER DISEASE#0.9662;T LYMPHOCYTE#0.9662;MALARIA#0.9660;NECROTIC CELL DEATH#0.9659;CYTOTOXICITY#0.9656;BETA CELL#0.9656;SENSITIZATION#0.9654;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9647;SENSORINEURAL HEARING LOSS#0.9647;EPITHELIAL MESENCHYMAL TRANSITION#0.9647;INFLAMMATORY CELL#0.9643;ACTIVATED B CELL#0.9641;RETINAL GANGLION CELL#0.9637;BRONCHIAL EPITHELIAL CELLS#0.9637;IMMUNE CELL#0.9633;RECEPTOR INTERACTING PROTEIN#0.9633;SUPEROXIDE DISMUTASE#0.9633;INNATE IMMUNE SYSTEM#0.9632;HEMORRHAGIC#0.9628;CD8+ T CELL#0.9625;ORGANELLE#0.9622;CENTRAL NERVOUS SYSTEM#0.9622;C REACTIVE PROTEIN#0.9615;CAROTID ARTERY#0.9615;VISCERAL ADIPOSE TISSUE#0.9614;ATPASE ACTIVITY#0.9609;RILONACEPT#0.9608;ADENOSINE MONOPHOSPHATE#0.9606;IMMUNE RESPONSE#0.9599;HOST CELL#0.9595;NERVOUS SYSTEM#0.9595;T CELL ACTIVATION#0.9594;AKT SIGNALING#0.9593;HEPATOTOXICITY#0.9592;PERIODONTAL LIGAMENT#0.9589;OSTEOBLAST#0.9588;NEUROLOGICAL DISORDER#0.9587;HYPERSENSITIVITY#0.9587;SKIN DISEASE#0.9577;ALLERGIC ASTHMA#0.9577;DEUBIQUITINATION#0.9574;MENINGITIS#0.9564;APHTHOUS STOMATITIS#0.9562;HEME OXYGENASE 1#0.9560;TRADITIONAL CHINESE MEDICINE#0.9559;DERMATITIS#0.9556;EOSIN#0.9553;IMMUNE SYSTEM#0.9548;PORE FORMATION#0.9537;LIPID DROPLET#0.9532;PROTEIN TYROSINE PHOSPHATASE#0.9529;BLOOD UREA NITROGEN#0.9526;NEUROTOXICITY#0.9517;ALVEOLAR EPITHELIAL CELL#0.9513;VASCULAR DISEASE#0.9509;TUMOR CELLS#0.9498;CISPLATIN#0.9498;PERITONEAL MESOTHELIAL CELLS#0.9488;HEPATITIS C#0.9486;ADULT-ONSET STILL'S DISEASE#0.9486;DIET INDUCED OBESITY#0.9485;CATHEPSIN B ACTIVITY#0.9472;SKELETAL MUSCLE#0.9465;HUMAN BRONCHIAL EPITHELIAL#0.9465;CHONDROCYTE#0.9439;GLUCOSE METABOLISM#0.9436;RENAL ISCHEMIA REPERFUSION#0.9431;LEISHMANIASIS#0.9431;OXYGENASE#0.9427;SYSTEMIC INFLAMMATORY RESPONSE#0.9427;PROTEIN SYNTHESIS#0.9425;HEMATOPOIETIC CELL#0.9424;TH2 CELL#0.9409;ALLERGEN#0.9399;CELL GROWTH#0.9390;MECHANISMS OF ACTION#0.9389;CELL WALL#0.9388;SILICOSIS#0.9382;ENDOTHELIAL GROWTH FACTOR#0.9382;STOMATITIS#0.9378;SCAVENGER RECEPTOR#0.9378;VIRAL REPLICATION#0.9368;NEUROTOXIC#0.9364;CHLAMYDIA#0.9354;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9351;SUCROSE#0.9350;TARGET OF RAPAMYCIN#0.9348;ANGIOGENESIS#0.9347;CARDIOLIPIN#0.9344;MACROPHAGE MIGRATION#0.9336;ARYL HYDROCARBON RECEPTOR#0.9331;CHRONIC MILD STRESS#0.9329;PHARYNGITIS#0.9329;MYELOID-DERIVED SUPPRESSOR CELL#0.9320;SMOOTH MUSCLE ACTIN#0.9315;RESPIRATORY DISTRESS#0.9315;PROPOFOL#0.9312;DOXORUBICIN#0.9310;GLUTATHIONE PEROXIDASE#0.9299;RETINOIC ACID#0.9285;MICROPARTICLE#0.9268;PROTEIN PROTEIN INTERACTION#0.9266;CHOLESTEROL EFFLUX#0.9262;KIDNEY DAMAGE#0.9260;MORRIS WATER MAZE#0.9256;SUBSTANTIA NIGRA#0.9255;CELIAC DISEASE#0.9245;BREAST CANCER#0.9240;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9238;AMPK ACTIVITY#0.9233;TNF PRODUCTION#0.9231;CELL DIFFERENTIATION#0.9228;COLONY-STIMULATING FACTOR#0.9228;PROSTAGLANDIN E2#0.9227;ANTIGEN PRESENTATION#0.9226;HYPOXIA INDUCIBLE FACTOR#0.9224;ESTROGEN RECEPTOR#0.9223;ENDOCYTOSIS#0.9222;RESPONSE TO LIPOPOLYSACCHARIDE#0.9221;KINASE ACTIVITY#0.9220;VASCULITIS#0.9219;ALLERGIC RHINITIS#0.9219;ASC PYROPTOSOME FORMATION#0.9212;ALANINE#0.9181;REGULATION OF AMPK#0.9181;NICOTINAMIDE#0.9180;3-METHYLADENINE#0.9174;HEAT SHOCK PROTEIN#0.9156;PEPTIDOGLYCAN#0.9151;EXTRACELLULAR VESICLE#0.9147;SMALL INTESTINE#0.9142;QUANTITATIVE REVERSE TRANSCRIPTION#0.9135;CONJUNCTIVITIS#0.9132;ADENINE#0.9126;APOPTOTIC CELL DEATH#0.9120;HISTONE DEACETYLASE#0.9119;MAJOR DEPRESSIVE DISORDER#0.9103;NUCLEIC ACID#0.9093;GLUTAMATE DEHYDROGENASE#0.9090;PROXIMAL TUBULAR CELL#0.9080;TNF SECRETION#0.9074;PROTEASOME#0.9073;WHITE ADIPOSE TISSUE#0.9070;BERBERINE#0.9066;GOBLET CELL#0.9064;RESPIRATORY TRACT#0.9054;MIGRATION INHIBITORY FACTOR#0.9053;TYPE 2 DIABETIC#0.9051;CHEMOTAXIS#0.9048;GRAFT VERSUS HOST#0.9044;DISEASE ACTIVITY INDEX#0.9042;BLADDER OUTLET OBSTRUCTION#0.9038;INFLAMMATORY MONOCYTE#0.9026;ANKYLOSING SPONDYLITIS#0.9009;CYTOCHROME C#0.8997;ADENOSINE 5'-TRIPHOSPHATE#0.8994;ACTIVATION OF NF-KAPPAB#0.8987;FLUOXETINE#0.8983;BRAIN WATER CONTENT#0.8974;THROMBOSIS#0.8969;ACUTE CORONARY SYNDROME#0.8968;CELL ADHESION#0.8949;ACUTE LIVER FAILURE#0.8947;FRAGMENT LENGTH POLYMORPHISM#0.8944;COMPLEMENT ACTIVATION#0.8938;ISOFLURANE#0.8933;HIGH DENSITY LIPOPROTEIN#0.8932;HEPATOCELLULAR CARCINOMA#0.8927;NEURONAL CELLS#0.8918;ENZYME ACTIVITY#0.8900;EYE DISEASE#0.8892;UVEITIS#0.8891;INSULIN SECRETION#0.8889;POST-TRANSLATIONAL MODIFICATION#0.8882;IL-6 PRODUCTION#0.8872;OF DIABETIC RATS#0.8861;VIROPORIN#0.8855;ADAPTIVE IMMUNE SYSTEM#0.8855;BILE DUCT#0.8849;ABDOMINAL PAIN#0.8837;ERYTHROCYTE#0.8832;MITOCHONDRIAL DNA SYNTHESIS#0.8823;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8823;MIDDLE EAR#0.8819;LYSIS#0.8817;HEPATITIS B#0.8770;ARGININE#0.8768;MINOCYCLINE#0.8768;RIBOSE#0.8765;NEUROGENESIS#0.8758;ATOPIC DERMATITIS#0.8750;ATP BINDING CASSETTE#0.8749;HEMATOPOIETIC STEM CELL#0.8743;SEVERE ACUTE PANCREATITIS#0.8736;NEPHROTIC SYNDROME#0.8733;AMYOTROPHIC LATERAL SCLEROSIS#0.8730;LATERAL SCLEROSIS#0.8729;HEPATITIS C VIRUS#0.8728;KAWASAKI DISEASE#0.8725;LUNG DAMAGE#0.8722;INDUCTION OF APOPTOSIS#0.8718;SKIN RASH#0.8707;OSTEOCLAST#0.8698;ACETAMINOPHEN#0.8691;MASTITIS#0.8685;BAFILOMYCIN A1#0.8654;PROTEIN KINASE A#0.8646;TRANSIENT RECEPTOR POTENTIAL#0.8643;DEXAMETHASONE#0.8623;NORMAL CONTROL GROUP#0.8621;CHOLINE#0.8618;OTITIS MEDIA#0.8616;STEM CELL TRANSPLANTATION#0.8613;ARTHROPATHY#0.8606;VX-765#0.8606;ANTI INFLAMMATORY DRUGS#0.8601;SERUM ALBUMIN#0.8601;REGENERATION#0.8582;RHEUMATIC DISEASE#0.8578;DUAL LUCIFERASE REPORTER#0.8573;PROPIDIUM#0.8573;METHOTREXATE#0.8559;MYOFIBROBLAST#0.8557;ISLET AMYLOID POLYPEPTIDE#0.8547;ROSUVASTATIN#0.8546;MODE OF ACTION#0.8537;CELL ADHESION MOLECULE#0.8528;CYSTIC FIBROSIS#0.8521;IDIOPATHIC PULMONARY FIBROSIS#0.8508;LYSOSOMAL MEMBRANE PERMEABILIZATION#0.8507;BRUTON TYROSINE KINASE#0.8496;PULMONARY EDEMA#0.8490;AORTIC ANEURYSM#0.8475;ANTIVIRAL RESPONSE#0.8467;CARDIAC ARREST#0.8466;EMODIN#0.8456;EOSINOPHIL#0.8451;MYELOPEROXIDASE ACTIVITY#0.8444;HUMAN PERIODONTAL LIGAMENT#0.8434;SPUTUM#0.8429;DNA METHYLATION#0.8426;OUTER MEMBRANE#0.8418;LIPOGENESIS#0.8402;ATORVASTATIN#0.8378;CHRONIC LIVER DISEASE#0.8369;CERVICAL#0.8349;PLATELET ACTIVATION#0.8347;CIGARETTE SMOKE EXTRACT#0.8344;DOPAMINE D1 RECEPTOR#0.8341;ACID SPHINGOMYELINASE#0.8337;CORONARY HEART DISEASE#0.8324;ADIPOSE TISSUE MACROPHAGE#0.8323;PROTEIN DEGRADATION#0.8316;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8314;FACTOR I#0.8304;PRIMARY RESPONSE GENE#0.8298;CELLULAR SENESCENCE#0.8292;MIXED LINEAGE KINASE#0.8291;VASCULAR CELL#0.8289;STRUCTURE ACTIVITY RELATIONSHIP#0.8287;CHEMOKINE RECEPTOR#0.8278;POTASSIUM CHANNEL#0.8275;CONNECTIVE TISSUE#0.8271;CASPASE INHIBITOR#0.8261;RESPONSE TO TREATMENT#0.8246;ABDOMINAL AORTIC ANEURYSM#0.8245;TREG CELL#0.8244;ANTIOXIDANT ACTIVITY#0.8230;SERTOLI CELL#0.8229;SERUM URIC ACID#0.8228;INTESTINAL DAMAGE#0.8220;PLATELET AGGREGATION#0.8202;MONOGENIC DISEASE#0.8199;DNA SYNTHESIS#0.8198;IMIQUIMOD#0.8176;GENETIC DISORDER#0.8172;ACETYLCHOLINE#0.8169;B LYMPHOCYTE#0.8166;LYSINE#0.8160;PROTEIN KINASE R#0.8152;MYOCARDITIS#0.8143;MAP KINASE#0.8141;DIARRHEA#0.8135;ADENOCARCINOMA#0.8135;TRANSCRIPTIONAL CONTROL#0.8132;BRILLIANT BLUE G#0.8131;ZONULA OCCLUDENS#0.8110;ASEPTIC MENINGITIS#0.8100;LIVER X RECEPTOR#0.8098;MOOD DISORDER#0.8095;TUMOR TISSUES#0.8093;LIRAGLUTIDE#0.8067;BLINDNESS#0.8059;PANCREATIC CANCER#0.8057;LINES OF EVIDENCE#0.8054;GANGLION CELLS#0.8051;SYNOVIUM#0.8050;MESENTERIC LYMPH NODE#0.8049;OSTEOMYELITIS#0.8044;RHINITIS#0.8018;COLLAGEN INDUCED ARTHRITIS#0.8013;PACLITAXEL#0.8012;PULMONARY HYPERTENSION#0.8012;MALIGNANT MESOTHELIOMA#0.8002;PROTEIN KINASE C#0.8002;OXIDATIVE METABOLISM#0.7999;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7997;TAIL SUSPENSION TEST#0.7970;FORCED SWIMMING TEST#0.7961;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7951;PROBENECID#0.7950;CELL CYCLE#0.7940;P38 MAPK SIGNALING#0.7940;DENTAL PULP CELL#0.7937;GLOMERULAR FILTRATION#0.7919;PROTEIN SECRETION#0.7917;AGEING#0.7911;CONNEXIN#0.7909;NASAL MUCOSA#0.7908;PHAGOSOME#0.7891;ADENINE DINUCLEOTIDE PHOSPHATE#0.7890;METHIONINE#0.7886;EXTRACELLULAR SPACE#0.7884;HISTONE ACETYLATION#0.7873;CYCLIC ADENOSINE MONOPHOSPHATE#0.7872;MICROVESICLE#0.7868;NEPHROTOXICITY#0.7865;RESPONSE TO ATP#0.7850;P2X RECEPTOR#0.7848;COMPLEMENT CASCADE#0.7847;PULMONARY ARTERY#0.7845;GRANULOMA FORMATION#0.7841;POLY ADP RIBOSE#0.7841;GAP JUNCTION#0.7839;RESPONSE TO INTERFERON BETA#0.7827;KNEE JOINT#0.7818;TRANSCRIPTASE#0.7817;HYPERACTIVITY#0.7797;ESTRADIOL#0.7793;GALECTIN#0.7792;NEUROPATHY#0.7788;GLUCOSE INTOLERANCE#0.7786;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7779;SPONDYLITIS#0.7771;LUNG FIBROBLASTS#0.7765;URINARY TRACT INFECTION#0.7757;ORAL SQUAMOUS CELL CARCINOMA#0.7755;IL-6 SECRETION#0.7754;GLOMERULAR FILTRATION RATE#0.7753;OPTIC NERVE#0.7739;MULTIPLE MYELOMA#0.7732;MAGNETIC RESONANCE IMAGING#0.7730;MITOQ#0.7729;KINASE INHIBITOR#0.7727;GLUCOCORTICOID RECEPTOR#0.7725;RNA BINDING#0.7721;CYSTITIS#0.7709;CYTOKINE RECEPTOR#0.7706;PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME#0.7701;COLON CANCER#0.7690;COGNITION#0.7688;MONOCYTIC LEUKEMIA#0.7682;MIDBRAIN#0.7682;CARDIOVASCULAR SYSTEM#0.7665;TUMOR SUPPRESSOR#0.7658;BODY WEIGHT RATIO#0.7642;PERIPHERAL BLOOD LEUKOCYTE#0.7635;MONOCYTE CHEMOTACTIC PROTEIN#0.7623;IL-10 PRODUCTION#0.7620;MUSCLE ATROPHY#0.7616;MEMORY IMPAIRMENT#0.7615;EPILEPSY#0.7609;ASPARTIC ACID#0.7608;PHAGOLYSOSOME#0.7593;LYMPHOID TISSUE#0.7589;SCIATIC NERVE#0.7585;MITOCHONDRIAL LOCALIZATION#0.7573;RED BLOOD CELL#0.7565;ENDOSOME#0.7557;CERVICAL ADENITIS#0.7547;BLOOD VESSEL#0.7542;U1 SNRNP#0.7538;INTERFERON REGULATORY FACTOR#0.7536;PERITONEAL CAVITY#0.7535;ETANERCEPT#0.7531;CATALYTIC ACTIVITY#0.7505;SUBCUTANEOUS ADIPOSE TISSUE#0.7495;OSTEOPOROSIS#0.7494;CHINESE HERBAL MEDICINE#0.7467;FATTY ACID SYNTHASE#0.7465;HYPERACTIVE#0.7461;CHRONIC HEPATITIS B#0.7461;MYOCARDIAL INFARCT SIZE#0.7453;LUNG ADENOCARCINOMA#0.7432;NUCLEUS PULPOSUS#0.7429;PRIMARY CORTICAL NEURON#0.7424;RESPONSE TO IL-1#0.7399;TRIOSE PHOSPHATE ISOMERASE#0.7394;GLUCOSE HOMEOSTASIS#0.7389;BINDING PROTEIN 1#0.7386;ADRENERGIC RECEPTOR#0.7382;LEFT VENTRICULAR REMODELING#0.7382;PRION DISEASE#0.7382;DIGESTION#0.7377;WEIGHT GAIN#0.7376;DEMENTIA#0.7373;PNEUMOCOCCAL MENINGITIS#0.7372;INTESTINAL MUCOSA#0.7371;PROSTATE EPITHELIAL CELL#0.7364;SIZE EXCLUSION CHROMATOGRAPHY#0.7350;TISSUE HOMEOSTASIS#0.7350;KERATITIS#0.7345;AMACRINE CELL#0.7340;CELL MATURATION#0.7339;REPORTER GENE ASSAY#0.7334;FASTING BLOOD GLUCOSE#0.7333;T HELPER CELL#0.7333;GLOMERULONEPHRITIS#0.7325;ATRIAL FIBRILLATION#0.7319;ADENYLATE CYCLASE#0.7300;RETINAL ENDOTHELIAL CELLS#0.7293;CHRONIC UNPREDICTABLE STRESS#0.7292;HYPERGLYCEMIC#0.7287;TAMOXIFEN#0.7271;TOPICAL#0.7266;INTRACELLULAR ACIDIFICATION#0.7265;CEREBRAL MALARIA#0.7264;GINGIVAL EPITHELIAL CELLS#0.7262;CONSTRICTION#0.7252;LIPOLYSIS#0.7227;EPITHELIAL BARRIER FUNCTION#0.7217;ELECTRON TRANSPORT CHAIN#0.7216;INTERVERTEBRAL DISC#0.7208;TISSUE REMODELING#0.7207;IMMUNE EVASION#0.7206;SIMVASTATIN#0.7204;GIARDIASIS#0.7191;MEMBRANE ATTACK COMPLEX#0.7190;ATP BINDING CASSETTE TRANSPORTER#0.7188;ELECTRON TRANSPORT#0.7185;ACUTE INFLAMMATORY RESPONSE#0.7178;RNA HELICASE#0.7175;HEMOLYSIS#0.7175;PRE-ECLAMPSIA#0.7169;PHOSPHOLIPASE A2#0.7152;OPEN FIELD TEST#0.7145;ENDOTHELIAL NITRIC OXIDE#0.7143;RECEPTOR COMPLEX#0.7126;LEFT ANTERIOR DESCENDING#0.7120;PHOSPHATE BUFFERED SALINE#0.7120;SERIOUS ADVERSE EVENT#0.7119;METHIONINE CHOLINE DEFICIENT#0.7117;ANTI-INFLAMMATORY RESPONSE#0.7116;HERPES SIMPLEX#0.7115;POSTTRANSLATIONAL MODIFICATION#0.7113;PYRUVATE#0.7098;LIVER REGENERATION#0.7097;PATHOGEN RECOGNITION RECEPTOR#0.7085;ANKLE JOINT#0.7079;ENDOMETRIAL CANCER#0.7075;MYOFIBROBLAST DIFFERENTIATION#0.7071;ION HOMEOSTASIS#0.7070;MARKERS OF INFLAMMATION#0.7069;FATTY ACID OXIDATION#0.7058;FLOW CYTOMETRY ANALYSIS#0.7057;KETAMINE#0.7054;OXIDATIVE PHOSPHORYLATION#0.7054;HEALTHY CONTROL SUBJECTS#0.7052;GUANINE#0.7047;COLONIC EPITHELIAL CELLS#0.7021;MONOCYTE DERIVED DENDRITIC CELL#0.7019;DEMYELINATING DISEASE#0.6988;DISEASE ACTIVITY SCORE#0.6982;ARRHYTHMIA#0.6976;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6973;17β-ESTRADIOL#0.6972;PIOGLITAZONE#0.6966;PANCREATIC DAMAGE#0.6964;RELATED PROTEIN 1#0.6963;ACTIN POLYMERIZATION#0.6962;VASCULAR ENDOTHELIUM#0.6959;OLEIC ACID#0.6958;P2 RECEPTOR#0.6957;MOLECULAR DYNAMICS SIMULATION#0.6952;ISCHEMIC HEART DISEASE#0.6952;TUBE FORMATION#0.6946;ACETYLCHOLINE RECEPTOR#0.6946;GLUCOSE UPTAKE#0.6927;GASTROINTESTINAL TRACT#0.6922;MITOCHONDRIAL PERMEABILITY TRANSITION#0.6918;AQUAPORIN#0.6916;PHOSPHOLIPASE C#0.6914;LYSOSOME MEMBRANE#0.6914;RELATIVE GENE EXPRESSION#0.6901;TRANSFORMING GROWTH FACTOR BETA#0.6894;ALKALINE PHOSPHATASE#0.6893;DNA BINDING#0.6891;POSITIVE CONTROL GROUP#0.6879;ZONULA OCCLUDENS 1#0.6867;CUTANEOUS LEISHMANIASIS#0.6864;GESTATION#0.6853;CANDIDIASIS#0.6834;MRNA TRANSCRIPTION#0.6829;LIPID METABOLISM DISORDER#0.6816;CHOLESTASIS#0.6815;IFN-GAMMA#0.6812;NEURONAL CELL DEATH#0.6812;JOINT SWELLING#0.6804;ERYTHROCYTE SEDIMENTATION RATE#0.6793;TELMISARTAN#0.6785;CYTOLYSIS#0.6780;STROMA#0.6774;BONE RESORPTION#0.6773;INSULIN RECEPTOR#0.6770;STRIATUM#0.6770;ASCORBIC ACID#0.6763;RETINAL DISEASE#0.6760;ARGININE VASOPRESSIN#0.6758;CHRONIC INFLAMMATORY RESPONSE#0.6756;RUTIN#0.6749;ADVANCED GLYCATION ENDPRODUCT#0.6740;SEVERE ACUTE RESPIRATORY SYNDROME#0.6733;NKT CELL#0.6733;IRRITANT#0.6730;CHAGAS DISEASE#0.6728;DIESEL EXHAUST PARTICLE#0.6725;HYPERCHOLESTEROLEMIA#0.6719;HEPATIC ISCHEMIA REPERFUSION#0.6717;MUCOSAL IMMUNE RESPONSE#0.6715;PROXIMAL TUBULAR EPITHELIAL#0.6710;CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS#0.6710;TRANSCRIPTION ACTIVATOR#0.6704;TROPHOBLAST CELL#0.6703;NOREPINEPHRINE#0.6690;FARNESOID X RECEPTOR#0.6687;GLYBENCLAMIDE#0.6685;PERIPHERAL NERVE#0.6680;MYELODYSPLASTIC SYNDROME#0.6680;PREADIPOCYTE#0.6677;PROTEIN KINASE B#0.6668;ARSENIC TRIOXIDE#0.6663;TRANS GOLGI NETWORK#0.6662;VESICULAR STOMATITIS VIRUS#0.6661;TYPE 1 DIABETES MELLITUS#0.6646;PHOTORECEPTOR CELL#0.6645;PURINOCEPTOR#0.6641;TH1 CELL#0.6641;ADENO ASSOCIATED VIRUS#0.6640;HYALURONAN#0.6625;NUCLEOTIDE EXCHANGE FACTOR#0.6621;BODY WEIGHT LOSS#0.6621;NATURAL KILLER CELL#0.6606;HEMATOPOIESIS#0.6600;MESENCHYMAL CELL#0.6599;CYCLIC AMP#0.6598;PKC ACTIVATION#0.6598;MEMORY LOSS#0.6593;CELL COUNTING KIT#0.6592;CARNITINE#0.6584;INTERFERON PRODUCTION#0.6581;G-CSF#0.6573;GLUCOSE TOLERANCE TEST#0.6570;VERAPAMIL#0.6563;SUCCINATE#0.6555;CELLULAR HOMEOSTASIS#0.6555;ASPIRIN#0.6544;MITOCHONDRION#0.6541;MUCUS PRODUCTION#0.6540;CHRONIC CONSTRICTION INJURY#0.6531;NEONATAL RAT CARDIOMYOCYTES#0.6521;SHAM OPERATION GROUP#0.6519;CASPASE-3 ACTIVITY#0.6516;TLR4 SIGNALING PATHWAY#0.6514;CREATINE KINASE#0.6505;IMMUNE CELL ACTIVATION#0.6494;PROGRAMMED NECROTIC CELL DEATH#0.6464;MONOCYTE ACTIVATION#0.6464;ORAL CAVITY#0.6454;CYTOTOXIN#0.6450;EPIGALLOCATECHIN#0.6446;LIPID HOMEOSTASIS#0.6443;MELIOIDOSIS#0.6431;LIVER CIRRHOSIS#0.6430;DIABETIC ENCEPHALOPATHY#0.6429;AMYLOID PROTEIN#0.6425;CHOLESTEROL METABOLISM#0.6422;CATION CHANNEL#0.6413;SUCROSE PREFERENCE TEST#0.6403;ENDOMETRIUM#0.6400;DEPHOSPHORYLATION#0.6396;MYELOID LEUKEMIA#0.6391;LUCIFERASE ACTIVITY#0.6390;MAMMARY EPITHELIAL CELL#0.6389;LOSARTAN#0.6388;BLOOD GLUCOSE LEVEL#0.6386;HERPES SIMPLEX VIRUS#0.6374;B CELL LYMPHOMA#0.6369;WHITE BLOOD CELL#0.6366;RECEPTOR TYROSINE KINASE#0.6365;NEBIVOLOL#0.6350;VACUOLE#0.6349;1,3-BUTANEDIOL#0.6338;PIRFENIDONE#0.6323;MITOCHONDRIAL ELECTRON TRANSPORT CHAIN#0.6289;PERIAPICAL PERIODONTITIS#0.6285;H POST INFECTION#0.6276;PROTEASOMAL PROCESSING#0.6274;MITOCHONDRIAL DEPOLARIZATION#0.6267;MITOCHONDRIAL ELECTRON TRANSPORT#0.6262;HEALTHY CONTROL GROUP#0.6258;IONOPHORE#0.6250;ATN-161#0.6242;FRONTAL#0.6242;C CHEMOKINE RECEPTOR#0.6223;RETINAL ISCHEMIA#0.6219;SELECTIVE AUTOPHAGY#0.6217;RETINAL DAMAGE#0.6215;VASODILATION#0.6209;OUTER MITOCHONDRIAL MEMBRANE#0.6209;RECEPTOR LIGAND#0.6206;SILENT INFORMATION REGULATOR#0.6205;LYMPHOID CELL#0.6204;RESPIRATION#0.6194;NERVOUS SYSTEM DISEASE#0.6189;CREATINE#0.6187;PERINUCLEAR SPACE#0.6180;VITAMIN D RECEPTOR#0.6167;BRAIN DISEASE#0.6167;MUCOSITIS#0.6165;URINARY PROTEIN#0.6162;OXONATE#0.6155;TRANSDIFFERENTIATION#0.6154;CHANNEL ACTIVITY#0.6150;HIGH TIDAL VOLUME#0.6145;CHLOROQUINE#0.6142;WATER CHANNEL#0.6132;CALCIUM SIGNALING#0.6128;T CELL DIFFERENTIATION#0.6128;AMITRIPTYLINE#0.6126;QS-21#0.6123;BREAST CANCER CELL#0.6113;CERAMIDE SYNTHESIS#0.6102;TELOMERE#0.6098;DNA REPAIR#0.6096;NECROTIZING#0.6094;1,8-CINEOLE#0.6093;5 FLUOROURACIL#0.6088;LIPID RAFT#0.6082;AMYLOID PRECURSOR PROTEIN#0.6082;LACTIC ACID#0.6081;NEUROFIBRILLARY TANGLE#0.6077;COAGULATION#0.6076;ALLERGIC AIRWAY DISEASE#0.6062;SPHINGOSINE#0.6041;EPIDERMAL GROWTH FACTOR#0.6036;HUMAN IMMUNODEFICIENCY VIRUS#0.6034;ACUTE LUNG INFLAMMATION#0.6034;HUMAN AIRWAY EPITHELIUM#0.6031;EXPERIMENTAL CEREBRAL MALARIA#0.6025;CYCLOPHOSPHAMIDE#0.6017;MULTIPLE ORGAN DYSFUNCTION#0.6014;OLIGODENDROCYTE#0.6012;HIPPOCAMPAL REGION#0.6012;DEUBIQUITINATING ENZYME#0.6010;INTERCELLULAR JUNCTION#0.6004
114569	MALTOSE#0.9651;TRANSCYTOSIS#0.9437;EPITHELIAL CELL#0.8609;BREAST CARCINOMA#0.6957;PLASMA MEMBRANE#0.6955;BREAST CANCER#0.6849;MALTOSE PERMEASE#0.6408;ENDOSOME#0.6309;GENE EXPRESSION#0.6256;KINETOCHORE#0.6114;FERMENTATION#0.6087
114571	ORGANIC ANION TRANSPORTER#1.0426;ESTRONE#1.0357;ESTRONE SULFATE#1.0135;PROXIMAL TUBULE CELL#0.9442;OOCYTE#0.9149;ORGANIC CATION TRANSPORTER#0.8130;BREAST CANCER#0.7582;URATE#0.7147;PROBENECID#0.6558;DEHYDROEPIANDROSTERONE SULFATE#0.6474;PLASMA MEMBRANE#0.6473;EMBRYONIC KIDNEY#0.6427;DEHYDROEPIANDROSTERONE#0.6420;GENE EXPRESSION#0.6329;URIC ACID#0.6294;AMINOHIPPURATE#0.6280;HUMAN EMBRYONIC KIDNEY#0.6118
1145	CONGENITAL MYASTHENIC SYNDROME#1.0302;ACETYLCHOLINE RECEPTOR#1.0017;ACETYLCHOLINE#0.9955;NEUROMUSCULAR JUNCTION#0.9539;GENE EXPRESSION#0.8259;MYASTHENIA GRAVIS#0.7514;NICOTINIC ACETYLCHOLINE RECEPTOR#0.7241;MUSCLE CELL#0.6910;MYOTUBE#0.6082
114609	IFN-BETA#1.0470;MALARIA#1.0338;TUBERCULOSIS#1.0295;SIGNALING ADAPTOR#1.0287;PLASMA MEMBRANE#1.0275;INTERLEUKIN 1 RECEPTOR#1.0238;PROTEIN KINASE#1.0224;NF-KAPPAB ACTIVATION#1.0170;TLR SIGNALING PATHWAY#1.0093;SIGNALLING PATHWAY#1.0089;SIGNAL TRANSDUCTION#0.9963;MACROPHAGE#0.9953;CYTOKINE PRODUCTION#0.9952;TUMOR NECROSIS FACTOR#0.9933;PRIMARY RESPONSE GENE#0.9913;INNATE IMMUNE RESPONSE#0.9910;GENE EXPRESSION#0.9906;SIGNALING PATHWAY#0.9898;TRANSCRIPTION FACTOR#0.9878;INFLAMMATORY RESPONSE#0.9818;PRO-INFLAMMATORY#0.9800;TOLL LIKE RECEPTOR#0.9740;IMMUNE RESPONSE#0.9714;INNATE IMMUNITY#0.9706;MITOGEN ACTIVATED PROTEIN#0.9684;IMMUNE SYSTEM#0.9570;POLYMERASE CHAIN REACTION#0.9524;B CELL#0.9460;DENDRITIC CELL#0.9456;PATTERN RECOGNITION RECEPTOR#0.9429;T CELL#0.9428;INNATE IMMUNE SYSTEM#0.9278;EPITHELIAL CELL#0.9184;APOPTOSIS#0.9158;CELL SURFACE#0.9095;INTERFERON REGULATORY FACTOR#0.9059;MONOCYTE#0.9039;SIGNALING MOLECULE#0.8933;PULMONARY TUBERCULOSIS#0.8911;SIGNALING CASCADE#0.8847;ENDOSOME#0.8552;RESPONSE TO LPS#0.8456;GROWTH FACTOR#0.8442;TLR4 SIGNALING PATHWAY#0.8293;PROTEIN PROTEIN INTERACTION#0.8282;ENDOTHELIAL CELL#0.8090;NEUTROPHIL#0.8006;BONE MARROW#0.7990;CELL DEATH#0.7987;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7867;LUPUS ERYTHEMATOSUS#0.7864;NITRIC OXIDE#0.7822;FRAGMENT LENGTH POLYMORPHISM#0.7778;APOPTOTIC#0.7606;LEUCINE#0.7340;SIGNAL TRANSDUCER#0.7191;RHEUMATOID ARTHRITIS#0.7170;IFN REGULATORY FACTOR#0.6970;PROTEIN KINASE C#0.6836;PERIPHERAL BLOOD#0.6828;TRANSFORMING GROWTH FACTOR#0.6828;ACTIVATION OF NF-KAPPAB#0.6805;RECEPTOR COMPLEX#0.6507;MAP KINASE#0.6479;LEUKOCYTE#0.6311;HEAT SHOCK PROTEIN#0.6278;MAPK ACTIVATION#0.6224;HUMAN EMBRYONIC KIDNEY#0.6217;EMBRYONIC KIDNEY#0.6213;ATOPIC DERMATITIS#0.6052;VIRAL INFECTION#0.6020
114610	BRASSINOSTEROID BIOSYNTHESIS#0.7517;SENSORY DENDRITE#0.7132
114614	B CELL#1.0296;T CELL#0.9331;BURKITT LYMPHOMA#0.8874;GENE EXPRESSION#0.8585;PRIMARY MICRORNA#0.7391;APOPTOSIS#0.7168;B CELL LYMPHOMA#0.6956;IMMUNE RESPONSE#0.6654;MACROPHAGE#0.6276;CELL PROLIFERATION#0.6224;B CELL RECEPTOR#0.6193;ONCOGENIC#0.6013
114625	ARA-C#0.9746;ERYTHROID CELL#0.8653;FETAL LIVER#0.8231;GENE EXPRESSION#0.6651;BONE MARROW#0.6365
1146	MULTIPLE PTERYGIUM SYNDROME#1.0968;ACETYLCHOLINE RECEPTOR#1.0658;ACETYLCHOLINE#1.0297;PTERYGIUM#0.9809;NEUROMUSCULAR JUNCTION#0.7094
114757	SMOOTH MUSCLE#1.0609;HEPATIC STELLATE CELL#1.0600;GLOBIN#1.0390;TUMOR SUPPRESSOR#1.0360;OXYGEN BINDING#1.0357;CELL ACTIVATION#1.0299;HYPOXIA#1.0266;CANCER CELL#1.0202;NITRIC OXIDE#1.0177;SMOOTH MUSCLE ACTIN#1.0110;HYPOXIC#1.0110;REACTIVE OXYGEN SPECIES#1.0078;GENE EXPRESSION#0.9987;CELL DEATH#0.9771;MYOFIBROBLAST#0.9728;HISTIDINE#0.9651;LUNG CANCER#0.9498;MUSCLE CELL#0.9034;BREAST CANCER#0.9017;PEROXIDASE ACTIVITY#0.8963;GROWTH FACTOR#0.8963;EXTRACELLULAR MATRIX#0.8817;CELL PROLIFERATION#0.8736;HYPOXIA INDUCIBLE FACTOR#0.8723;APOPTOSIS#0.8716;OXYGEN TRANSPORT#0.8461;SKELETAL MUSCLE#0.8378;QUANTITATIVE REAL TIME#0.8171;CYTOPLASM#0.8125;SMOOTH MUSCLE CELL#0.8006;BREAST CANCER CELL#0.8005;TRANSCRIPTION FACTOR#0.7989;LIVER DISEASE#0.7894;NERVOUS SYSTEM#0.7844;SIGNALING PATHWAY#0.7780;ISCHEMIA#0.7764;NITRIC OXIDE METABOLISM#0.7576;COLLAGEN SYNTHESIS#0.7526;OVARIAN CANCER#0.7479;CONNECTIVE TISSUE#0.7440;ASCORBATE#0.7397;HEPATOCELLULAR CARCINOMA#0.7281;REVERSE TRANSCRIPTION#0.7220;HEME BINDING#0.7141;WOUND HEALING#0.6921;ENDOTHELIAL CELL#0.6875;CO BINDING#0.6848;SUPEROXIDE DISMUTASE#0.6781;NITRITE REDUCTASE ACTIVITY#0.6537;DETOXIFICATION#0.6496;ELECTRON TRANSFER#0.6383;DIOXYGENASE ACTIVITY#0.6336;CEREBRAL CORTEX#0.6293;DNA HYPERMETHYLATION#0.6214;NUCLEAR LAYER#0.6173;OXIDATIVE DNA DAMAGE#0.6169;MITOCHONDRIA#0.6043;INNER NUCLEAR LAYER#0.6028;RESPONSE TO HYPOXIA#0.6024
114769	COP-1#1.1410;T CELL#1.0493;COPOLYMER-1#1.0110;GENE EXPRESSION#0.9924;UBIQUITIN#0.9632;PHOTOMORPHOGENESIS#0.9583;TRANSCRIPTION FACTOR#0.9511;MULTIPLE SCLEROSIS#0.9301;SEEDLING DEVELOPMENT#0.8109;APOPTOSIS#0.8070;ENCEPHALOMYELITIS#0.7509;GROWTH FACTOR#0.6945;PROTEASOME#0.6688;COP9 SIGNALOSOME#0.6603;COATED VESICLE#0.6476;ENDOPLASMIC RETICULUM#0.6288;SIGNALING PATHWAY#0.6259;ANTIGEN PRESENTING CELLS#0.6192;CELL DEATH#0.6121;IFN-BETA#0.6112;STIGMA#0.6049
114770	L-ALANINE#1.0656;AMIDASE ACTIVITY#1.0575;ALANINE#1.0570;PEPTIDOGLYCAN#1.0117;CELL WALL#0.9995;IMMUNE RESPONSE#0.9819;EPITHELIAL CELL#0.9370;LYSIS#0.9131;INNATE IMMUNE RESPONSE#0.9065;INNATE IMMUNITY#0.8798;SIGNAL PEPTIDE#0.8121;AUTOLYSIS#0.7534;GENE EXPRESSION#0.7507;PATTERN RECOGNITION RECEPTOR#0.7285;ENZYME ACTIVITY#0.6950;KERATINOCYTE#0.6906;VIRULENCE#0.6888;DIGESTION#0.6787;CHOLINE#0.6651
114771	PEPTIDOGLYCAN#1.0375;EPITHELIAL CELL#0.8708;EPIDERMAL DIFFERENTIATION COMPLEX#0.8624;INNATE IMMUNITY#0.7232;ESOPHAGUS#0.6879;CELL WALL#0.6816;COLITIS#0.6725;INFLAMMATORY RESPONSE#0.6273;GENE EXPRESSION#0.6214;MACROPHAGE#0.6086;IMMUNE RESPONSE#0.6077;PNEUMOCOCCAL PNEUMONIA#0.6019
114780	POLYCYSTIN#0.6651
114781	RESTLESS LEGS SYNDROME#1.0396;RESTLESS#1.0369;PERIODIC LIMB MOVEMENTS#0.9462;DOPAMINE#0.7436;RESTLESSNESS#0.6798;NEUROLOGICAL DISORDER#0.6063
114783	BREAST CANCER#1.1025;CANCER CELL#0.9999;ESTROGEN RECEPTOR#0.9435;BREAST CANCER CELL#0.8293;COLORECTAL CANCER#0.7791;LUNG CANCER#0.7669;ESTROGEN RECEPTOR ALPHA#0.7187;CELL GROWTH#0.7096;COLORECTAL#0.6879;BREAST CANCER PATIENTS#0.6420;CHROMATIN REMODELING#0.6394;PROTEIN KINASE#0.6347;ATP BINDING#0.6267;COLON CANCER#0.6251;RECEPTOR TYROSINE KINASE#0.6200
114784	DENDRITIC SPINE DENSITY#0.8744;DENDRITIC SPINE#0.8559;MAGUK#0.6718;PANCREATIC CANCER#0.6064
114785	METHYL CPG BINDING#0.7828;SKELETAL MUSCLE#0.6008
114787	NEURITE OUTGROWTH#1.1349;NEURITE#1.0901;NEURITE EXTENSION#0.6940;GROWTH CONE#0.6870;LIPID RAFT#0.6265;NEURONAL CELLS#0.6211
114788	DENDRITE DEVELOPMENT#0.6185
114789	SKELETAL MUSCLE#0.7947;INNER MITOCHONDRIAL MEMBRANE#0.6753;MITOCHONDRIAL MEMBRANE#0.6645
114791	TUBULIN COMPLEX#0.7827;GAMMA TUBULIN COMPLEX#0.6838;GAMMA-TUBULIN RING COMPLEX#0.6645;ANGELMAN SYNDROME#0.6461;DEVELOPMENTAL DELAY#0.6422;PRIMARY MICROCEPHALY#0.6125;MICROCEPHALY#0.6083;MICROTUBULE#0.6018
114793	COLORECTAL CANCER#1.0805;COLORECTAL#1.0636;CELL MOTILITY#0.9778;CANCER CELL#0.9716;CELL PROLIFERATION#0.8786;ACTIN FILAMENT#0.8549;COLORECTAL CARCINOMA#0.8380;POLYMERASE CHAIN REACTION#0.7496;EPITHELIAL CELL#0.7125;CELL MIGRATION#0.6990;ACTIN POLYMERIZATION#0.6387;EPITHELIAL MESENCHYMAL TRANSITION#0.6337;TRANSCRIPTION FACTOR#0.6263;TUMOR SUPPRESSOR#0.6124
114794	TOLL LIKE RECEPTOR#0.6610
114798	GILLES DE LA TOURETTE SYNDROME#0.9814;NEURITE OUTGROWTH#0.8802;OBSESSIVE COMPULSIVE DISORDER#0.8694;NEURITE#0.7227;TRICHOTILLOMANIA#0.6031
114799	S PHASE#1.0427;SISTER CHROMATID COHESION#1.0378;DNA REPLICATION#1.0318;CHROMATID#1.0288;COHESIN COMPLEX#1.0141;CHROMOSOME SEGREGATION#0.9909;BUDDING#0.9531;REPLICATION FORK#0.9514;CELL CYCLE#0.9417;LYSINE#0.9134;DNA REPAIR#0.8626;MITOSIS#0.8624;ACETYLTRANSFERASE ACTIVITY#0.8098;ROBERTS SYNDROME#0.7611;MEIOSIS#0.7521;ANAPHASE#0.7321;CENTROMERE#0.7237;SPINDLE ASSEMBLY#0.7159;DOUBLE STRAND BREAK#0.7146;TRANSCRIPTION FACTOR#0.6584;CHLORAMPHENICOL#0.6131
1147	LUCIFERASE ACTIVITY#1.0532;IKAPPAB PHOSPHORYLATION#1.0481;IKAPPAB KINASE COMPLEX#1.0323;KERATINOCYTE#1.0275;MOUSE EMBRYONIC FIBROBLAST#1.0236;DOMINANT NEGATIVE MUTANT#1.0205;IKK COMPLEX#1.0180;IKAPPAB KINASE#1.0086;I KAPPAB KINASE#1.0051;KINASE ACTIVITY#1.0026;B CELL#1.0009;TERMINAL DIFFERENTIATION#1.0001;DNA BINDING#0.9915;MACROPHAGE#0.9899;CELL DEATH#0.9891;COMPLEX I#0.9889;ACTIVATION OF NF-KAPPAB#0.9884;ENDOTHELIAL CELL#0.9880;NF-KAPPAB ACTIVATION#0.9879;T CELL#0.9865;KERATINOCYTE DIFFERENTIATION#0.9841;EPITHELIAL CELL#0.9831;TRANSACTIVATION#0.9826;CELL CYCLE#0.9813;CANCER CELL#0.9799;NF-KAPPAB INHIBITOR#0.9773;PROTEIN KINASE#0.9762;GROWTH FACTOR#0.9756;CELL PROLIFERATION#0.9750;GENE EXPRESSION#0.9747;MITOGEN ACTIVATED PROTEIN#0.9743;CYTOPLASM#0.9725;APOPTOTIC#0.9721;PRO-INFLAMMATORY#0.9707;APOPTOSIS#0.9691;INFLAMMATORY RESPONSE#0.9679;SQUAMOUS CELL CARCINOMA#0.9678;PROTEIN KINASE C#0.9675;SIGNAL TRANSDUCTION#0.9664;TOLL LIKE RECEPTOR#0.9645;SIGNALING PATHWAY#0.9640;TUMOR NECROSIS FACTOR#0.9632;IMMUNE RESPONSE#0.9625;BREAST CANCER#0.9608;KINASE INHIBITOR#0.9596;TRANSCRIPTION FACTOR#0.9547;NEMO BINDING DOMAIN#0.9522;NITRIC OXIDE#0.9508;PROTEASOME#0.9480;MONOCYTE#0.9462;LEUCINE#0.9444;SIGNALING CASCADE#0.9418;PROSTATE CANCER#0.9382;CELL GROWTH#0.9342;MAP KINASE#0.9325;ELECTROPHORETIC MOBILITY SHIFT#0.9251;BREAST CANCER CELL#0.9222;NF KAPPAB BINDING#0.9186;NITRIC OXIDE SYNTHASE#0.9154;UBIQUITIN#0.9083;TUMOR SUPPRESSOR#0.9028;SIGNALLING PATHWAY#0.9010;SIGNALING MOLECULE#0.8907;T-CELL LEUKEMIA#0.8878;INDUCIBLE NITRIC OXIDE#0.8832;SKIN CANCER#0.8822;CELL DEVELOPMENT#0.8810;REACTIVE OXYGEN SPECIES#0.8794;SMOOTH MUSCLE#0.8781;LYMPHOTOXIN BETA RECEPTOR#0.8733;MUSCLE CELL#0.8621;TRANSFORMING GROWTH FACTOR#0.8604;SMOOTH MUSCLE CELL#0.8405;TUMOR CELLS#0.8403;IFN-GAMMA#0.8396;RHEUMATOID ARTHRITIS#0.8352;TUMOUR NECROSIS FACTOR#0.8237;IKAPPAB KINASE ACTIVITY#0.8202;INTESTINAL EPITHELIAL CELL#0.8159;CELL CYCLE ARREST#0.8150;MAMMARY EPITHELIAL CELL#0.8100;INNATE IMMUNITY#0.8096;MOUSE EMBRYO FIBROBLASTS#0.8087;BETA-NF#0.8056;RECEPTOR INTERACTING PROTEIN#0.8042;GLUTATHIONE#0.7995;POLYMERASE CHAIN REACTION#0.7968;CELL MATURATION#0.7956;CATALYTIC ACTIVITY#0.7939;CELL SURFACE#0.7911;PHOSPHOLIPASE C#0.7859;OSTEOCLAST#0.7855;DNA FRAGMENTATION#0.7852;CARCINOGEN#0.7804;DENDRITIC CELL#0.7762;ALANINE#0.7750;IFN-ALPHA PRODUCTION#0.7741;MECHANISM OF ACTION#0.7578;TANK BINDING KINASE#0.7576;LUNG CANCER#0.7565;NONCANONICAL NF-KAPPAB SIGNALING#0.7479;INDUCTION OF APOPTOSIS#0.7470;STROMAL CELL#0.7446;COLORECTAL CANCER#0.7435;HEAT SHOCK PROTEIN#0.7334;CHONDROCYTE#0.7299;C TERMINAL DOMAIN#0.7259;MAMMARY GLAND#0.7254;BONE MARROW#0.7206;CELL MOTILITY#0.7201;DOXORUBICIN#0.7149;EPSTEIN BARR VIRUS#0.7126;INNATE IMMUNE RESPONSE#0.7014;ECTODERMAL DYSPLASIA#0.6972;EPIDERMAL GROWTH FACTOR#0.6969;TRANSFORMING GROWTH FACTOR BETA#0.6930;T CELL DEVELOPMENT#0.6916;STAUROSPORINE#0.6907;THYMOCYTE#0.6886;AKT SIGNALING#0.6871;RNA INTERFERENCE#0.6857;NEUTROPHIL#0.6814;RECEPTOR ACTIVATOR#0.6773;RETINOIC ACID#0.6759;HISTONE ACETYLATION#0.6752;ORGANOGENESIS#0.6738;MORPHOGENESIS#0.6686;ONCOGENIC#0.6660;STEM CELL#0.6646;MURINE EMBRYONIC FIBROBLASTS#0.6627;IFN REGULATORY FACTOR#0.6623;COLITIS#0.6548;ISCHEMIA#0.6519;INTERLEUKIN 1 RECEPTOR#0.6504;CYCLIN DEPENDENT KINASE#0.6449;CELL DIFFERENTIATION#0.6444;CYTOKINE PRODUCTION#0.6437;SIGNALOSOME#0.6420;CELL MIGRATION#0.6319;QUERCETIN#0.6231;COLORECTAL#0.6189;T LYMPHOCYTE#0.6100;IL-8 PRODUCTION#0.6088;OSTEOBLAST#0.6086;SKIN DEVELOPMENT#0.6053;CEREBRAL ISCHEMIA#0.6016
114803	DEUBIQUITINASE#1.1148;STEM CELL#1.1040;CELL DEVELOPMENT#1.1000;HEMATOPOIETIC STEM CELL#1.0757;B CELL#1.0499;HEMATOPOIESIS#1.0280;B CELL DEVELOPMENT#1.0043;BONE MARROW#0.9196;CELL DIFFERENTIATION#0.8776;T CELL#0.8350;PLASMA CELL#0.8030;TRANSCRIPTION FACTOR#0.8016;HEMATOPOIETIC CELL#0.7814;APOPTOSIS#0.7180;MESENCHYMAL STEM CELL#0.7114;HISTONE MODIFICATION#0.7101;PRO-INFLAMMATORY#0.7070;CELL PROLIFERATION#0.7033;SKIN ATROPHY#0.6776;LYMPHOCYTE DIFFERENTIATION#0.6528;COLORECTAL CANCER#0.6283;DNA BINDING#0.6280;QUIESCENCE#0.6242;IMMUNE RESPONSE#0.6179;MELANOCYTE#0.6127;THYMOCYTE#0.6124;COMMON MYELOID PROGENITOR#0.6095;MACROPHAGE#0.6027
114804	LIGASE ACTIVITY#0.8206;MAPK SIGNALING#0.8095;PRO-INFLAMMATORY#0.8005;UBIQUITIN#0.7990;CELL CYCLE#0.7968
114814	GONADOTROPIN RELEASING HORMONE#0.9918;TESTOSTERONE SECRETION#0.7442;LEYDIG CELL#0.7301;TESTOSTERONE#0.6911
114815	TYPE 2 DIABETES#1.0272;ALZHEIMER'S DISEASE#0.9966;INSULIN SECRETION#0.9418;AMYLOID PRECURSOR PROTEIN#0.7879;QUANTITATIVE TRAIT LOCUS#0.7865;2 DIABETES MELLITUS#0.7855;VACUOLAR PROTEIN SORTING#0.7849;DIABETES MELLITUS#0.7817;TYPE 2 DIABETES MELLITUS#0.7166;OBESE#0.6333;ENDOSOME#0.6127
114821	SIGNALING PATHWAY#0.6678
114822	ANTISENSE RNA#0.7405;PROTEIN KINASE#0.6203;CANCER CELL#0.6199;SPERM TAIL#0.6111
114824	FEMALE MEIOSIS#1.0101;APOPTOSIS SIGNALING#0.7389;MEIOSIS#0.7384;OOCYTE#0.7320;CANCER CELL#0.7084;APOPTOSIS#0.6336
114825	NURD COMPLEX#0.9761;HISTONE ACETYLATION#0.7474;NUCLEOSOME#0.7199;NEURAL CREST#0.7012
114826	BREAST CANCER#0.8331;TUMOR SUPPRESSOR#0.6940;TUMOR CELLS#0.6364
114836	B CELL#1.0511;NKT CELL#1.0423;CELL SURFACE#1.0391;CYTOTOXICITY#1.0241;T CELL#1.0129;SLAM ASSOCIATED PROTEIN#1.0055;CELL ACTIVATION#0.9919;IMMUNE RESPONSE#0.9904;AUTOIMMUNITY#0.9700;LYMPHOCYTE ACTIVATION#0.9470;CD4+ T CELL#0.9457;CD8+ T CELL#0.9381;NATURAL KILLER CELL#0.9147;CELL DEVELOPMENT#0.8985;LYMPHOPROLIFERATIVE DISEASE#0.8884;GERMINAL CENTER#0.8647;PERIPHERAL BLOOD#0.8625;T LYMPHOCYTE#0.8521;NK CELL ACTIVATION#0.8408;THYMOCYTE#0.8156;BONE MARROW#0.7951;B LYMPHOCYTE#0.7856;DENDRITIC CELL#0.7789;LYSIS#0.7605;ADAPTIVE IMMUNE RESPONSE#0.7579;T CELL ACTIVATION#0.7212;CYTOKINE PRODUCTION#0.7197;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7156;LUPUS ERYTHEMATOSUS#0.7154;NEUTROPHIL#0.6997;AUTOIMMUNE DISEASE#0.6917;IMMUNE SYSTEM#0.6853;T FOLLICULAR HELPER#0.6742;HEMATOPOIETIC CELL#0.6685;T CELL DEVELOPMENT#0.6671;RECEPTOR LIGAND#0.6632;IMMUNE CELL#0.6593;IFN-GAMMA#0.6582;CELL ADHESION#0.6580;TUMOR CELLS#0.6570;APOPTOSIS#0.6365;EXTRACELLULAR REGION#0.6174;PERITONEAL CAVITY#0.6117;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6076;LYMPHOCYTIC LEUKEMIA#0.6066
114876	OXYSTEROL BINDING#0.9627;LATE ENDOSOME#0.7630;CHOLESTEROL TRANSPORT#0.7314;ENDOSOME#0.6937;RELATED PROTEIN 1#0.6020
114879	OXYSTEROL BINDING#1.0490;ENDOPLASMIC RETICULUM#1.0282;PLASMA MEMBRANE#1.0017;CONTACT SITE#0.9851;CANCER CELL#0.9597;ER-PM CONTACT SITE#0.7915;CELL PROLIFERATION#0.7615;PHOSPHATIDYLSERINE#0.7539;LATE ENDOSOME#0.6888;ENDOSOME#0.6446;LIPID DROPLET#0.6376;PANCREATIC CANCER#0.6321;LUNG CANCER#0.6269
114880	OXYSTEROL BINDING#0.7762;ENDOPLASMIC RETICULUM#0.7526;ER-PM CONTACT SITE#0.7285;CHOLESTEROL HOMEOSTASIS#0.6933
114882	OXYSTEROL BINDING#1.0845;ENDOPLASMIC RETICULUM#1.0679;PLASMA MEMBRANE#0.9802;MACROPHAGE#0.8326;LIPID HOMEOSTASIS#0.8117;LIPID METABOLISM#0.7688;APOPTOSIS#0.6676;CHOLESTEROL EFFLUX#0.6496;CONTACT SITE#0.6138
114883	OXYSTEROL BINDING#0.8394;CEREBRAL INFARCTION#0.6092
114884	OXYSTEROL BINDING#0.9149;LIPID METABOLISM#0.8585;CELLULAR LIPID METABOLISM#0.6384
114885	OXYSTEROL BINDING#0.8494;LATE ENDOSOME#0.7836;GOLGI COMPLEX#0.6578
114897	RELATED PROTEIN 1#1.0702;TUMOR NECROSIS FACTOR#1.0558;TYPE 2 DIABETES#1.0256;ADIPOSE TISSUE#1.0054;GENE EXPRESSION#0.9090;SIGNALING PATHWAY#0.9000;DIABETES MELLITUS#0.8345;CORONARY ARTERY#0.8341;TYPE 2 DIABETES MELLITUS#0.8299;2 DIABETES MELLITUS#0.8298;OBESE#0.8253;APOPTOSIS#0.8107;ALDOSTERONE#0.7941;FATTY ACID OXIDATION#0.7883;CORONARY ARTERY DISEASE#0.7831;ARTERY DISEASE#0.7829;MYOCARDIAL INFARCTION#0.7506;INFLAMMATORY RESPONSE#0.7153;LIPID METABOLISM#0.7112;ARTERY#0.7047;HIGH FAT DIET#0.6960;MUSCLE CELL#0.6924;HYPERTENSION#0.6886;CARDIOMYOCYTE#0.6676;FASTING BLOOD GLUCOSE#0.6224;PROTEIN KINASE#0.6217;TYPE 2 DIABETIC#0.6196;SMOOTH MUSCLE CELL#0.6133;SMOOTH MUSCLE#0.6110;ENDOTHELIAL CELL#0.6097;DEHYDRATION#0.6022
114898	ADIPOSE TISSUE#0.8453
114899	ADIPOCYTE#1.0653;TUMOR NECROSIS FACTOR#1.0602;SIGNALING PATHWAY#1.0593;TYPE 2 DIABETES#1.0587;OBESE#1.0544;ADIPOSE TISSUE#1.0480;DIABETES MELLITUS#1.0403;APOPTOSIS#1.0356;LIPID METABOLISM#1.0237;GROWTH FACTOR#1.0152;PROTEIN KINASE#1.0133;TYPE 2 DIABETES MELLITUS#0.9972;2 DIABETES MELLITUS#0.9971;CARDIOMYOCYTE#0.9731;TRANSFORMING GROWTH FACTOR#0.9570;CELL PROLIFERATION#0.9548;ENDOTHELIAL CELL#0.9458;HIGH FAT DIET#0.9083;FATTY LIVER#0.9037;REACTIVE OXYGEN SPECIES#0.8967;PRO-INFLAMMATORY#0.8664;GLUCOSE METABOLISM#0.8305;TUMOUR NECROSIS FACTOR#0.8004;SMOOTH MUSCLE#0.7993;CORONARY ARTERY#0.7979;GENE EXPRESSION#0.7954;DIABETIC NEPHROPATHY#0.7713;INFLAMMATORY RESPONSE#0.7697;RECEPTOR AGONIST#0.7661;FATTY LIVER DISEASE#0.7605;LIVER DISEASE#0.7552;POLYMERASE CHAIN REACTION#0.7329;ARTERY#0.7307;ADIPOCYTE DIFFERENTIATION#0.7259;CORONARY ARTERY DISEASE#0.7198;ARTERY DISEASE#0.7196;TRANSCRIPTION FACTOR#0.7172;EXTRACELLULAR MATRIX#0.7167;APOPTOTIC#0.7106;CHONDROCYTE#0.6974;MONOCYTE#0.6923;TYPE 2 DIABETIC#0.6900;VASCULAR SMOOTH MUSCLE CELL#0.6874;MUSCLE CELL#0.6871;SMOOTH MUSCLE CELL#0.6841;CARDIOVASCULAR SYSTEM#0.6666;MITOGEN ACTIVATED PROTEIN#0.6366;C REACTIVE PROTEIN#0.6357;MACROPHAGE#0.6326;SKELETAL DEVELOPMENT#0.6210;LOW DENSITY LIPOPROTEIN#0.6162;NONALCOHOLIC FATTY LIVER DISEASE#0.6143;L-CYSTEINE#0.6136;VISCERAL ADIPOSE TISSUE#0.6093;MULTIPLE REGRESSION ANALYSIS#0.6074;GLUCOSE TOLERANCE TEST#0.6041;GLUCONEOGENESIS#0.6041;ENDOTHELIAL GROWTH FACTOR#0.6022;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6022;MYOCARDIAL INFARCTION#0.6001
114900	SIGNALING PATHWAY#0.7420;COLORECTAL CANCER#0.6096
114902	TUMOR NECROSIS FACTOR#1.0638;RETINAL DEGENERATION#1.0433;MACULAR DEGENERATION#1.0200;ADIPOSE TISSUE#0.9901;MUSCLE CELL#0.8304;ADIPOCYTE#0.8236;SKELETAL MUSCLE#0.8182;MYOCYTES#0.7916;OBESE#0.7606;ENDOTHELIAL CELL#0.7554;APOPTOSIS#0.7309;RETINAL PIGMENT EPITHELIUM#0.7185;LIPID METABOLISM#0.6325;FATTY ACID OXIDATION#0.6300;SMOOTH MUSCLE CELL#0.6209;SMOOTH MUSCLE#0.6186;PALMITATE#0.6090;MTDNA#0.6080
114904	SIGNALING PATHWAY#1.1002;TUMOR NECROSIS FACTOR#1.0824;CELL PROLIFERATION#0.8776;ADIPOCYTE#0.8627;APOPTOSIS#0.8109;HEPATOCELLULAR CARCINOMA#0.7937;ENDOTHELIAL CELL#0.7890;GROWTH FACTOR#0.7739;ADIPOGENESIS#0.7665;ADIPOSE TISSUE#0.7215;AKT SIGNALING#0.7123;OBESE#0.6549;MACROPHAGE#0.6511;PROTEIN KINASE#0.6506;WOUND HEALING#0.6366;CANCER CELL#0.6320;ADIPOCYTE PROLIFERATION#0.6182;CARDIOMYOCYTE#0.6075;LECTIN COMPLEMENT PATHWAY#0.6044;OVARIAN#0.6038
114905	ADIPOSE TISSUE#0.7778
114907	CARDIOMYOCYTE#1.0193;DIAPHRAGM#1.0121;UBIQUITIN#1.0120;SMOOTH MUSCLE#1.0097;UBIQUITIN PROTEIN LIGASE#1.0037;DEXAMETHASONE#1.0031;PROTEIN UBIQUITINATION#1.0005;PROTEIN BREAKDOWN#0.9976;POLYMERASE CHAIN REACTION#0.9974;MYOTUBE#0.9964;MYOSIN HEAVY CHAIN#0.9963;QUADRICEPS#0.9926;MUSCLE ATROPHY#0.9924;TRANSCRIPTION FACTOR#0.9920;UBIQUITIN PROTEASOME PATHWAY#0.9920;MUSCLE FIBRE#0.9909;AUTOPHAGY#0.9907;PROTEASOME PATHWAY#0.9902;PROTEIN KINASE#0.9891;PROTEASOME#0.9890;SKELETAL MUSCLE WASTING#0.9875;LEUCINE#0.9871;TARGET OF RAPAMYCIN#0.9862;CATABOLISM#0.9845;RAPAMYCIN#0.9844;PEROXISOME#0.9842;TUMOR NECROSIS FACTOR#0.9842;MYOBLAST#0.9840;PROTEIN DEGRADATION#0.9832;MUSCLE PROTEIN SYNTHESIS#0.9832;INSULIN-LIKE GROWTH FACTOR#0.9826;MYOGENESIS#0.9823;GENE EXPRESSION#0.9818;RIBOSOMAL PROTEIN#0.9808;UBIQUITIN PROTEASOME SYSTEM#0.9808;SIGNALLING PATHWAY#0.9807;MUSCLE HYPERTROPHY#0.9791;MUSCLE CELL#0.9779;CROSS SECTIONAL AREA#0.9764;MUSCLE FIBER#0.9757;SKELETAL MUSCLE ATROPHY#0.9755;APOPTOSIS#0.9751;GROWTH FACTOR#0.9750;20S PROTEASOME#0.9739;PROTEIN METABOLISM#0.9733;MYOPATHY#0.9732;TRANSFORMING GROWTH FACTOR#0.9719;CACHEXIA#0.9708;HINDLIMB#0.9703;CACHECTIC#0.9700;AKT SIGNALING#0.9685;SIGNALING PATHWAY#0.9682;WEIGHT LOSS#0.9681;PROTEIN CATABOLISM#0.9665;SKELETAL MUSCLE MASS#0.9661;MUSCLE WASTING#0.9654;TESTOSTERONE#0.9642;PROTEIN SYNTHESIS#0.9635;SKELETAL MUSCLE#0.9633;SKELETAL MUSCLE CELLS#0.9583;MUSCLE DAMAGE#0.9574;PROTEIN KINASE B#0.9554;TRANSLATION INITIATION#0.9517;BINDING PROTEIN 1#0.9510;REACTIVE OXYGEN SPECIES#0.9497;KIDNEY DISEASE#0.9390;CHRONIC KIDNEY DISEASE#0.9339;REGENERATION#0.9338;CANCER CELL#0.9333;MYOCYTES#0.9329;FACTOR I#0.9235;GLUCOCORTICOID RECEPTOR#0.9235;ADIPOSE TISSUE#0.9222;SKELETAL MUSCLE HYPERTROPHY#0.9215;NITRIC OXIDE#0.9203;MITOGEN ACTIVATED PROTEIN#0.9197;PRO-INFLAMMATORY#0.9190;LIGHT CHAIN 3#0.9179;CALCINEURIN#0.9162;WEIGHT GAIN#0.9147;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9130;INFLAMMATORY RESPONSE#0.9126;LYSINE#0.9099;CARDIAC MUSCLE#0.9085;MYOGENIC REGULATORY FACTOR#0.9052;CREATINE#0.9010;TRANSLATION INITIATION FACTOR#0.8962;APOPTOTIC#0.8961;CISPLATIN#0.8946;HYPOXIA#0.8917;BODY WEIGHT LOSS#0.8848;CELL DEATH#0.8839;QUANTITATIVE REAL TIME#0.8784;LYSOSOME#0.8758;CELL PROLIFERATION#0.8758;STREPTOZOTOCIN#0.8654;INSULIN RECEPTOR#0.8634;MUSCLE WEAKNESS#0.8621;MICROTUBULE ASSOCIATED PROTEIN#0.8539;CREATINE KINASE#0.8523;EUKARYOTIC INITIATION FACTOR#0.8482;SIGNAL TRANSDUCTION#0.8393;SUPEROXIDE DISMUTASE#0.8392;ENZYME ACTIVITY#0.8334;OBESE#0.8326;CELL CYCLE#0.8249;MUSCULAR ATROPHY#0.8206;MITOCHONDRIA#0.8167;HISTONE DEACETYLASE#0.8144;CASPASE-3 ACTIVITY#0.8136;GROWTH HORMONE#0.8136;HIGH FAT DIET#0.8069;ADENOCARCINOMA#0.8023;SCIATIC NERVE#0.7938;TUMOR SUPPRESSOR#0.7935;LEWIS LUNG CARCINOMA#0.7930;26S PROTEASOME#0.7908;REVERSE TRANSCRIPTION#0.7881;AUTOPHAGOSOME#0.7876;LUNG CARCINOMA#0.7850;DNA BINDING#0.7806;BODY WEIGHT GAIN#0.7803;EXTRACELLULAR MATRIX#0.7800;NADPH OXIDASE#0.7781;GLYCOGEN SYNTHASE KINASE#0.7770;MYOCARDIUM#0.7690;TYPE 2 DIABETES#0.7681;MUSCULAR DYSTROPHY#0.7666;CYTOCHROME C#0.7567;GLUTATHIONE#0.7566;RESVERATROL#0.7542;CHRONIC HEART FAILURE#0.7499;ANABOLISM#0.7486;UBIQUITIN LIGASE COMPLEX#0.7477;MICROTUBULE#0.7458;SIGNALING CASCADE#0.7453;MYOCARDIAL INFARCTION#0.7424;LEAN BODY MASS#0.7406;TRANSFORMING GROWTH FACTOR BETA#0.7401;CLENBUTEROL#0.7367;MUSCLE CONTRACTION#0.7349;MYOBLAST DIFFERENTIATION#0.7347;ANDROGEN RECEPTOR#0.7326;HEAT SHOCK PROTEIN#0.7316;SIMVASTATIN#0.7316;IFN-GAMMA#0.7277;TOXICITY#0.7112;CARDIOMYOPATHY#0.7039;LEVATOR ANI#0.7001;ARTERY#0.6989;ESSENTIAL AMINO ACID#0.6973;DIABETES MELLITUS#0.6959;TARGET OF RAPAMYCIN COMPLEX#0.6920;CORONARY ARTERY#0.6900;DNA DAMAGE RESPONSE#0.6851;SPINAL CORD#0.6820;NITRIC OXIDE SYNTHASE#0.6817;OVARIAN#0.6812;IGF BINDING#0.6762;TUMOUR NECROSIS FACTOR#0.6724;ADENOSINE#0.6717;LIPID METABOLISM#0.6716;RHEUMATOID ARTHRITIS#0.6705;RECEPTOR ANTAGONIST#0.6690;AUTOPHAGOSOME FORMATION#0.6653;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6636;INSULIN RECEPTOR SUBSTRATE#0.6592;STEM CELL#0.6577;RECEPTOR AGONIST#0.6551;KINASE ACTIVITY#0.6549;SARCOMERE#0.6545;ISCHEMIA#0.6430;SMOOTH MUSCLE CELL#0.6421;GLYCINE#0.6406;AGEING#0.6386;DEPHOSPHORYLATION#0.6321;MYOFIBRIL#0.6316;TOLL LIKE RECEPTOR#0.6307;ADENOSINE MONOPHOSPHATE#0.6258;GENE SILENCING#0.6245;HIBERNATION#0.6208;MUSCLE HOMEOSTASIS#0.6173;T CELL#0.6084;METHIONINE#0.6078;FORMOTEROL#0.6031
114908	CELL DEATH#0.8778;CELL SURFACE#0.8070;PLASMA MEMBRANE#0.6893
114960	TOTAL COLONIC AGANGLIONOSIS#0.8739
114971	CARDIOLIPIN#1.0023;PROTEIN TYROSINE PHOSPHATASE#0.9103;STEM CELL#0.8156;CANCER CELL#0.7952;MITOCHONDRION#0.7452;APOPTOSIS#0.7113;CELL CYCLE#0.7102;LIPID PHOSPHATASE#0.6588;INSULIN SECRETION#0.6364;CELL DEATH#0.6294
114990	SMOOTH MUSCLE CELL#0.8940;MUSCLE CELL#0.8931;SMOOTH MUSCLE#0.8918;GROWTH FACTOR#0.8573;VASCULAR SMOOTH MUSCLE CELL#0.7996;TRANSFORMING GROWTH FACTOR#0.7235;VASCULAR MORPHOGENESIS#0.6248;SIGNALING PATHWAY#0.6044
1149	DNA FRAGMENTATION FACTOR#1.0828;DNA FRAGMENTATION#1.0663;LIPID STORAGE#1.0458;CELL DEATH#1.0394;LIPID DROPLET#1.0206;ADIPOCYTE#1.0133;LIPOLYSIS#1.0117;BROWN ADIPOSE TISSUE#1.0052;APOPTOSIS#0.9966;OBESE#0.9952;GENE EXPRESSION#0.9905;WHITE ADIPOSE TISSUE#0.9900;ADIPOSE TISSUE#0.9872;HIGH FAT DIET#0.9811;LIPID METABOLISM#0.9793;ADIPOGENESIS#0.9229;PEROXISOME#0.9195;TRANSCRIPTION FACTOR#0.9107;DIET INDUCED OBESITY#0.9062;APOPTOTIC#0.8870;FATTY LIVER#0.8762;PROTEIN KINASE#0.8611;MAMMARY EPITHELIAL CELL#0.8522;SKELETAL MUSCLE#0.8476;EPITHELIAL CELL#0.8431;FATTY ACID OXIDATION#0.8163;LIPID DROPLET PROTEIN#0.8046;ADIPOCYTE DIFFERENTIATION#0.7999;TUMOR NECROSIS FACTOR#0.7824;ENERGY HOMEOSTASIS#0.7517;LIPOGENESIS#0.7384;TYPE 2 DIABETES#0.7318;CYTOCHROME C#0.7300;LIPID HOMEOSTASIS#0.7183;MITOCHONDRIA#0.7111;FAT CELL#0.6912;PREADIPOCYTE#0.6697;WEIGHT LOSS#0.6677;MAMMARY GLAND#0.6644;STEROL REGULATORY ELEMENT#0.6616;STEM CELL#0.6387;HORMONE SENSITIVE LIPASE#0.6362;SIGNALING PATHWAY#0.6052;FAT SPECIFIC PROTEIN#0.6004
114	ADENYLATE CYCLASE#1.0523;ADENYLATE#1.0306;PLASMA MEMBRANE#1.0186;LIPID RAFT#1.0172;SIGNALING PATHWAY#0.9850;PROTEIN KINASE#0.9772;CAMP SIGNALING#0.9679;ETHANOL#0.9659;GENE EXPRESSION#0.9054;LONG TERM POTENTIATION#0.8710;PROTEIN KINASE A#0.8652;CAM BINDING#0.8395;CYCLASE ACTIVITY#0.8269;TYPE 2 DIABETES#0.8252;FORSKOLIN#0.8212;SMOOTH MUSCLE#0.8047;NERVOUS SYSTEM#0.8039;CYCLIC AMP#0.7964;CAMP SYNTHESIS#0.7880;INSULIN SECRETION#0.7677;BETA CELL#0.7561;NMDA RECEPTOR#0.7530;CENTRAL NERVOUS SYSTEM#0.7482;SMOOTH MUSCLE CELL#0.7473;MUSCLE CELL#0.7464;SIGNAL TRANSDUCTION#0.7328;LONG TERM MEMORY#0.7238;MOOD DISORDER#0.7072;PROTEIN PROTEIN INTERACTION#0.7069;ADENYLYL CYCLASE ACTIVITY#0.6695;ANTERIOR CINGULATE CORTEX#0.6459;ADENOSINE#0.6411;CALMODULIN BINDING#0.6244;APOPTOSIS#0.6232;FOREBRAIN#0.6219;VASCULAR SMOOTH MUSCLE CELL#0.6146;DNA METHYLATION#0.6134;SIGNALLING PATHWAY#0.6054;PROTEIN PHOSPHATASE 2A#0.6037;PHOSPHATASE 2A#0.6033
115004	CYCLIC GUANOSINE MONOPHOSPHATE#1.0727;ADENOSINE MONOPHOSPHATE#1.0634;GUANOSINE#1.0537;DNA BINDING#1.0521;MITOCHONDRIAL DNA#1.0447;ADENOSINE#1.0393;ANTIVIRAL RESPONSE#1.0311;TYPE I IFN PRODUCTION#1.0277;MTDNA#1.0203;AUTOIMMUNE DISEASE#1.0151;AUTOPHAGY#1.0150;TOLL LIKE RECEPTOR#1.0147;HERPES SIMPLEX VIRUS#1.0100;DENDRITIC CELL#1.0096;SIGNALING PATHWAY#1.0094;HERPES SIMPLEX#1.0086;NUCLEIC ACID#1.0068;INNATE IMMUNITY#1.0053;MACROPHAGE#1.0042;INNATE IMMUNE RESPONSE#0.9997;CANCER CELL#0.9996;VIRAL INFECTION#0.9967;INTERFERON PRODUCTION#0.9963;PATTERN RECOGNITION RECEPTOR#0.9933;INNATE IMMUNE SYSTEM#0.9924;INFLAMMATORY RESPONSE#0.9906;IMMUNE RESPONSE#0.9889;GENE EXPRESSION#0.9874;T CELL#0.9860;TUMOR CELLS#0.9850;IMMUNE SYSTEM#0.9824;CELL DEATH#0.9798;INTERFERON REGULATORY FACTOR#0.9764;CYTOPLASM#0.9747;TRANSCRIPTION FACTOR#0.9743;TANK BINDING KINASE#0.9721;PRO-INFLAMMATORY#0.9716;IMMUNE CELL#0.9696;INTERFERON STIMULATED GENE#0.9649;TUBERCULOSIS#0.9624;SENESCENCE#0.9599;LUPUS ERYTHEMATOSUS#0.9452;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9412;IMMUNE EVASION#0.9367;HOST CELL#0.9303;ENDOPLASMIC RETICULUM#0.9222;BONE MARROW#0.9184;MITOCHONDRIAL DAMAGE#0.9178;B CELL#0.9132;APOPTOSIS#0.9126;AUTOIMMUNITY#0.9075;CYTOKINE PRODUCTION#0.9032;ADAPTIVE IMMUNE RESPONSE#0.8975;VIRAL REPLICATION#0.8787;CELL ACTIVATION#0.8765;RETINOIC ACID#0.8764;MONOCYTE#0.8739;EPITHELIAL CELL#0.8714;TYPE I INTERFERON PRODUCTION#0.8640;CELLULAR SENESCENCE#0.8616;SIGNALLING PATHWAY#0.8465;IFN REGULATORY FACTOR#0.8453;REVERSE TRANSCRIPTION#0.8436;MYELOID CELL#0.8143;UBIQUITIN#0.8127;APOPTOTIC#0.8022;SIGNALING CASCADE#0.7975;IFN STIMULATED GENES#0.7969;DNA REPAIR#0.7877;HEPATITIS B VIRUS#0.7739;HEPATITIS B#0.7721;PRIMARY HUMAN HEPATOCYTES#0.7653;PROTEIN KINASE#0.7563;ABSENT IN MELANOMA#0.7484;PERIPHERAL BLOOD#0.7385;GM-CSF#0.7260;CELL CYCLE#0.7232;COLORECTAL CANCER#0.7187;MITOCHONDRIA#0.7174;VIRAL GENOME#0.7121;KAPOSI'S SARCOMA#0.6826;BINDING PROTEIN 1#0.6758;DNA DAMAGE RESPONSE#0.6640;VACCINIA#0.6635;VIRION#0.6590;MITOSIS#0.6518;SIGNAL TRANSDUCTION#0.6515;T CELL ACTIVATION#0.6500;SIGNALING ADAPTOR#0.6437;CHLAMYDIA#0.6318;DSDNA BINDING#0.6263;GAP JUNCTION#0.6224;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6185;MONONUCLEAR CELLS#0.6174;TUMOR NECROSIS FACTOR#0.6155;MOUSE EMBRYONIC FIBROBLAST#0.6097
115019	CYSTIC FIBROSIS#1.0479;EPITHELIAL CELL#1.0309;OOCYTE#0.9843;CHLORIDE CHANNEL#0.9816;LUNG DISEASE#0.8908;CHLORIDE TRANSPORT#0.8444;PLASMA MEMBRANE#0.8258;ION TRANSPORT#0.8222;MECONIUM#0.7565;ILEUS#0.7548;PANCREATIC DAMAGE#0.6408;DUCTAL CELL#0.6389;GASTRIC ACID SECRETION#0.6319;ACID SECRETION#0.6291;AIRWAY EPITHELIAL CELL#0.6222
115024	7-METHYLGUANOSINE#0.7994
115106	HEALTHY EATING INDEX#1.0254
115111	IODIDE TRANSPORT#0.8426;EPITHELIAL CELL#0.8202;HYPOTHYROIDISM#0.8001;OOCYTE#0.6988;RENAL TUBULAR ACIDOSIS#0.6491;ACID SECRETION#0.6421;GASTRIC ACID SECRETION#0.6368
115201	AUTOPHAGY#1.0655;CANCER CELL#0.7418;NOTCH SIGNALING PATHWAY#0.6502;LUNG CANCER#0.6331;BREAST CANCER#0.6308;SIGNALING PATHWAY#0.6226
115207	POTASSIUM CHANNEL#1.0130;GASTROINTESTINAL STROMAL TUMOR#1.0123;GABA B RECEPTOR#0.8641;DISEASE FREE SURVIVAL#0.7107;ADEFOVIR DIPIVOXIL#0.6045
115209	COLLAGEN PEPTIDASE ACTIVITY#1.1099;DIPEPTIDYL-PEPTIDASE ACTIVITY#1.0885;TRIPEPTIDYL PEPTIDASE II#1.0629;PEPTIDASE COMPLEX#1.0615;SIGNAL PEPTIDE PEPTIDASE#1.0572;MITOCHONDRIAL PROCESSING#1.0544;TRIPEPTIDYL PEPTIDASE#1.0453;GLUCOSE-6-PHOSPHATE#1.0433;SERPIN#1.0412;PEPTIDASE INHIBITOR#1.0364;D-ALANINE#1.0354;PEPTIDASE ACTIVITY#1.0351;MEMBRANE ASSEMBLY#1.0298;SIGNAL PEPTIDASE COMPLEX#1.0296;MITOCHONDRIAL FUSION#1.0281;ESTERASE ACTIVITY#1.0266;PEPTIDASE B#1.0251;EPOXIDE HYDROLASE#1.0205;BACITRACIN#1.0198;COLLAGENASE#1.0183;PEPSTATIN#1.0156;CYTOCHROME BC1 COMPLEX#1.0152;THYLAKOID LUMEN#1.0151;CARBOXYPEPTIDASE A#1.0146;FIBROBLAST ACTIVATION PROTEIN#1.0139;APROTININ#1.0111;AMINOPEPTIDASE A#1.0102;THIORPHAN#1.0097;THYLAKOID#1.0092;FIBROBLAST ACTIVATION#1.0086;DIPEPTIDYL PEPTIDASE#1.0083;PENICILLIN BINDING#1.0074;CYSTATIN#1.0073;20S PROTEASOME#1.0063;POTASSIUM CHANNEL#1.0052;MITOCHONDRIAL INNER MEMBRANE#1.0038;PEPTIDE DEGRADATION#1.0036;INSULIN DEGRADING ENZYME#1.0035;PROTEASOME#1.0035;MIDGUT#1.0023;CAPTOPRIL#1.0023;TYPE IV PILUS#1.0019;L-LEUCINE#1.0008;MALTOSE BINDING#1.0004;OOCYTE MATURATION#1.0002;PHOSPHORAMIDON#1.0001;THYLAKOID MEMBRANE#0.9999;PENICILLIN#0.9999;ACID PHOSPHATASE#0.9989;BESTATIN#0.9971;SIGNAL PEPTIDE#0.9965;NEUTRAL ENDOPEPTIDASE 24.11#0.9963;HEAT SHOCK PROTEIN#0.9950;OOCYTE#0.9947;HYDROLASE ACTIVITY#0.9947;ALKALINE PHOSPHATASE#0.9940;CYTOCHROME C#0.9932;CELL ASSOCIATED#0.9931;PILUS#0.9924;SIGNAL RECOGNITION PARTICLE#0.9919;HEPATITIS C VIRUS#0.9909;DIPEPTIDYL PEPTIDASE IV#0.9904;PILUS ASSEMBLY#0.9904;MITOCHONDRIAL MATRIX#0.9904;HEPATITIS C#0.9901;ENDOPEPTIDASE 24.11#0.9897;ASPARTIC ACID#0.9895;LEUCINE#0.9890;BRUSH BORDER#0.9887;JEJUNUM#0.9886;CELL ENVELOPE#0.9886;LACTIC ACID BACTERIA#0.9885;CHLOROPLAST#0.9881;PUROMYCIN#0.9877;PERIPLASMIC SPACE#0.9872;MULTICATALYTIC PROTEINASE#0.9871;BRUSH BORDER MEMBRANE#0.9869;ABC TRANSPORTER#0.9869;MICROSOMAL MEMBRANE#0.9866;THYROTROPIN RELEASING HORMONE#0.9862;GLUTATHIONE#0.9862;26S PROTEASOME#0.9860;MODE OF ACTION#0.9857;TACHYKININ#0.9855;PROSTATE CANCER#0.9852;1,10-PHENANTHROLINE#0.9849;MALATE DEHYDROGENASE#0.9849;OPIOID PEPTIDE#0.9848;L-ALANINE#0.9844;LACTIC ACID#0.9836;ZINC BINDING#0.9834;ETHANOL#0.9834;MALTOSE#0.9831;AMINOPEPTIDASE P#0.9831;PROTEIN SECRETION#0.9829;ALLERGEN#0.9827;GLUTAMIC ACID#0.9823;BREAST CANCER#0.9822;C TERMINAL DOMAIN#0.9822;OPIOID RECEPTOR#0.9819;ENDOPEPTIDASE ACTIVITY#0.9816;PEPTIDOGLYCAN#0.9815;ATPASE ACTIVITY#0.9812;DIPEPTIDYL PEPTIDASE 4#0.9800;ATP BINDING#0.9800;SERUM ALBUMIN#0.9799;L-PROLINE#0.9799;CYTOPLASMIC MEMBRANE#0.9798;MITOCHONDRIAL MEMBRANE#0.9795;MAST CELL#0.9795;SKELETAL MUSCLE#0.9788;PEPTIDE HORMONE#0.9787;SPINAL CORD#0.9787;SOLUBLE FRACTION#0.9785;GLUTAMATE RECEPTOR#0.9784;ALPHA AMYLASE#0.9780;RECEPTOR AGONIST#0.9780;RESPIRATORY CHAIN#0.9779;PERIPLASM#0.9778;TRYPTOPHAN#0.9778;MALARIA#0.9778;ADENOSINE#0.9776;HCV CORE PROTEIN#0.9775;OVARIAN#0.9768;SALIVARY GLAND#0.9767;MICROSOME#0.9765;PEPTIDE TRANSPORT#0.9764;SUPEROXIDE DISMUTASE#0.9764;CATABOLISM#0.9761;ASPARTATE#0.9760;UBIQUITIN#0.9759;ENDOPLASMIC RETICULUM MEMBRANE#0.9758;MUSCLE CELL#0.9757;CELL ADHESION#0.9755;SMALL INTESTINE#0.9750;PROTEIN IMPORT#0.9748;BIOFILM FORMATION#0.9747;MECHANISM OF ACTION#0.9747;MEMBRANE FRACTION#0.9746;CELL WALL#0.9744;CELL SURFACE#0.9744;PROTEIN KINASE#0.9743;ANTIGEN PROCESSING#0.9740;PLASMA MEMBRANE#0.9740;PROTEIN SYNTHESIS#0.9731;TUBERCULOSIS#0.9731;APOPTOSIS#0.9726;ENDOTHELIAL CELL#0.9725;INFLAMMATORY RESPONSE#0.9724;ALANINE#0.9722;TYPE 2 DIABETES#0.9721;NALOXONE#0.9720;GLYCINE#0.9719;ISCHEMIA#0.9719;ER MEMBRANE#0.9719;SYNAPTIC MEMBRANE#0.9717;B CELL#0.9716;EPIDERMAL GROWTH FACTOR#0.9716;ANGIOTENSIN CONVERTING ENZYME#0.9715;SUBSTANCE P#0.9714;FERMENTATION#0.9713;PROTEIN DEGRADATION#0.9711;ANGIOGENESIS#0.9710;SECRETORY PATHWAY#0.9710;BONE MARROW#0.9707;CHAGAS DISEASE#0.9705;STEM CELL#0.9702;ENDOPLASMIC RETICULUM#0.9700;GROUP B STREPTOCOCCUS#0.9700;GLUTAMINE#0.9697;CELL GROWTH#0.9694;AMINOPEPTIDASE ACTIVITY#0.9693;ERYTHROCYTE#0.9692;NEUTROPHIL#0.9689;MITOCHONDRIA#0.9688;ASPARAGINE#0.9687;LYSINE#0.9683;CELL MEMBRANE#0.9683;RECEPTOR BINDING#0.9679;SIGNALING PATHWAY#0.9677;ARGININE#0.9676;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9671;LEUKOCYTE#0.9668;L-ARGININE#0.9668;PROTEASE ACTIVITY#0.9666;MACROPHAGE#0.9665;GLYCOSYLATION#0.9665;VIRULENCE#0.9662;RECEPTOR ANTAGONIST#0.9661;PILUS BIOGENESIS#0.9657;DIGESTION#0.9657;PEPTIDYL DIPEPTIDASE#0.9655;CELL DIVISION#0.9655;DNA BINDING#0.9653;SIGNAL TRANSDUCTION#0.9652;METHIONINE#0.9649;ATP HYDROLYSIS#0.9648;HISTIDINE#0.9648;PEPTIDE METABOLISM#0.9641;CELL PROLIFERATION#0.9641;T LYMPHOCYTE#0.9640;SMOOTH MUSCLE#0.9639;CELL DEATH#0.9639;RIBOSOME#0.9636;CATALYTIC ACTIVITY#0.9636;LUMINAL#0.9632;DIISOPROPYL FLUOROPHOSPHATE#0.9631;HOST CELL#0.9630;CENTRAL NERVOUS SYSTEM#0.9629;EPITHELIAL CELL#0.9628;SODIUM DODECYL SULFATE#0.9627;ALZHEIMER'S DISEASE#0.9625;EXTRACELLULAR MATRIX#0.9625;DODECYL SULFATE#0.9624;DOPAMINE#0.9624;T CELL#0.9621;TRANSCRIPTION FACTOR#0.9620;PEPTIDASE D#0.9619;COMPLEX I#0.9617;PROTEASE COMPLEX#0.9611;OUTER MEMBRANE#0.9610;LEUKOTRIENE A4 HYDROLASE#0.9609;LIVER DISEASE#0.9609;HYPERTENSION#0.9600;CANCER CELL#0.9598;GROWTH FACTOR#0.9598;N-ETHYLMALEIMIDE#0.9598;IMMUNE RESPONSE#0.9597;MOLECULAR FUNCTION#0.9597;REACTIVE OXYGEN SPECIES#0.9596;IMMUNE SYSTEM#0.9596;DIABETES MELLITUS#0.9595;N METHYLTRANSFERASE#0.9592;GROWTH HORMONE#0.9592;PROTEIN PROCESSING#0.9586;ADENOSINE DEAMINASE#0.9584;MUTAGENESIS#0.9583;PERIODONTITIS#0.9582;NITRIC OXIDE#0.9582;PHOSPHATASE ACTIVITY#0.9581;ENZYME INHIBITOR#0.9579;MITOCHONDRIAL FISSION#0.9579;OVARIAN CANCER#0.9574;ORGANELLE#0.9573;POST-TRANSLATIONAL MODIFICATION#0.9571;NERVOUS SYSTEM#0.9570;PROTEIN PROTEIN INTERACTION#0.9569;CYTOPLASM#0.9567;L-GLUTAMATE#0.9566;POLYMERASE CHAIN REACTION#0.9565;HUMAN IMMUNODEFICIENCY VIRUS#0.9564;CELL CYCLE#0.9564;ANTIGEN PRESENTATION#0.9564;CARBOXYPEPTIDASE ACTIVITY#0.9563;TOXICITY#0.9562;ASTROCYTE#0.9560;TUMOR CELLS#0.9555;OVIDUCT#0.9554;LECTIN#0.9553;REVERSE TRANSCRIPTION#0.9551;CONNECTIVE TISSUE#0.9550;ACE INHIBITOR#0.9546;STROMA#0.9536;TYPE 2 DIABETES MELLITUS#0.9536;2 DIABETES MELLITUS#0.9536;PROTEINASE INHIBITOR#0.9536;STROMAL CELL#0.9535;HYPOXIA#0.9533;LYSOSOME#0.9529;NUCLEOTIDE BINDING#0.9524;LYSIS#0.9518;ENZYME ACTIVITY#0.9512;GROUP A STREPTOCOCCUS#0.9510;CELL ACTIVATION#0.9495;GENE EXPRESSION#0.9490;LIPID MODIFICATION#0.9489;RHEUMATOID ARTHRITIS#0.9485;APOPTOTIC#0.9479;TUMOR NECROSIS FACTOR#0.9479;PALMITIC ACID#0.9473;PERIPHERAL BLOOD#0.9468;CYTOTOXICITY#0.9466;EXTRACELLULAR SPACE#0.9462;ARTERY#0.9461;UBIQUITIN PROTEASOME SYSTEM#0.9458;EXCRETION#0.9439;POSTTRANSLATIONAL MODIFICATION#0.9432;PROTEIN COMPLEX#0.9431;INTESTINAL MUCOSA#0.9429;ENTEROCYTE#0.9427;NEURODEGENERATIVE DISEASE#0.9426;PYROGLUTAMIC ACID#0.9418;MOLAR#0.9413;DELTA OPIOID RECEPTOR#0.9412;ATP SYNTHASE#0.9412;RETICULOCYTE#0.9392;BETA GALACTOSIDASE#0.9380;ANCHORING#0.9369;SUCROSE#0.9362;Z-PRO-PROLINAL#0.9359;SENESCENCE#0.9344;BETA GLUCOSIDASE#0.9342;L-PHENYLALANINE#0.9339;KERATINOCYTE#0.9326;INNER MITOCHONDRIAL MEMBRANE#0.9323;SITAGLIPTIN#0.9322;RESONANCE ENERGY TRANSFER#0.9299;PLASTID#0.9293;DPP IV ACTIVITY#0.9293;CARDIOMYOCYTE#0.9292;STRIATUM#0.9288;BLOOD BRAIN BARRIER#0.9281;COLORECTAL#0.9266;VALINE#0.9256;TRANSFORMING GROWTH FACTOR#0.9251;HYDROXYPROLINE#0.9250;RNA BINDING#0.9246;VASOPRESSIN#0.9244;L-LYSINE#0.9243;FERTILIZATION#0.9240;CELL DIFFERENTIATION#0.9239;CONJUGATION#0.9237;QUANTITATIVE REAL TIME#0.9237;AMINOPEPTIDASE II#0.9234;TUMOR SUPPRESSOR#0.9228;CYTOCHROME P450#0.9227;INDOMETHACIN#0.9214;T CELL ACTIVATION#0.9212;CHYMOSTATIN#0.9206;PEPTIDE TRANSPORTER#0.9204;PROTEIN DIGESTION#0.9194;CELL MIGRATION#0.9189;COLORECTAL CANCER#0.9180;COAGULATION#0.9178;PROGRAMMED CELL DEATH#0.9166;PALMITATE#0.9166;URINARY BLADDER#0.9164;SMOOTH MUSCLE CELL#0.9159;ACETYLCHOLINE#0.9150;TACHYKININ RECEPTOR#0.9149;CEREBRAL CORTEX#0.9132;EPOXIDE HYDROLASE ACTIVITY#0.9123;ADENYLATE#0.9122;DIPEPTIDYL PEPTIDASE 8#0.9121;LASER DESORPTION IONIZATION#0.9118;MONOCYTE#0.9095;ROUGH ENDOPLASMIC RETICULUM#0.9088;METAL BINDING#0.9084;ATROPINE#0.9083;GAMMA GLUTAMYLTRANSFERASE#0.9082;IMMUNE CELL#0.9060;VIRION#0.9058;BREAST CANCER CELL#0.9048;PEPTIDE BINDING#0.9034;PROTEIN QUALITY CONTROL#0.9027;STATIONARY PHASE#0.9024;SUMOYLATION#0.9010;HEPATOCELLULAR CARCINOMA#0.9004;ADENOCARCINOMA#0.8998;ACETIC ACID#0.8993;AUTOPHAGY#0.8982;PYRUVATE#0.8973;PROTEIN BINDING#0.8971;MECHANISMS OF ACTION#0.8964;PROSTATE-SPECIFIC MEMBRANE ANTIGEN#0.8962;BETA CELL#0.8958;PHAGOCYTOSIS#0.8950;ENDOTHELIUM#0.8950;CD8+ T CELL#0.8949;GERMINATION#0.8947;ISOLEUCINE#0.8946;PRO-INFLAMMATORY#0.8940;PROTEINASE ACTIVITY#0.8939;REGULATED INTRAMEMBRANE PROTEOLYSIS#0.8935;CHEMOTAXIS#0.8928;INSULIN SECRETION#0.8917;LUNG CANCER#0.8909;COLLAGENASE ACTIVITY#0.8889;COLON CANCER#0.8873;PROTEASOME PATHWAY#0.8866;BLOOD VESSEL#0.8866;ENDOPEPTIDASE INHIBITOR#0.8863;AMYLOID PRECURSOR PROTEIN#0.8861;SPORULATION#0.8854;GLYCERALDEHYDE-3-PHOSPHATE#0.8848;UTERUS#0.8845;STRUCTURE ACTIVITY RELATIONSHIP#0.8839;SUBSTANTIA NIGRA#0.8824;AMINOPEPTIDASE N ACTIVITY#0.8821;RESPIRATION#0.8820;TROPHOBLAST#0.8813;FIBRINOGEN#0.8799;WOUND HEALING#0.8790;CERVICAL#0.8789;SYNAPTOSOME#0.8785;MU OPIOID RECEPTOR#0.8781;RNA BINDING PROTEIN#0.8778;REGENERATION#0.8737;GASTROINTESTINAL TRACT#0.8730;NEURONAL CELLS#0.8726;NOXIOUS#0.8720;LYMPH NODE#0.8713;VILDAGLIPTIN#0.8710;CLOTTING#0.8698;VACUOLE#0.8698;PROTEIN BREAKDOWN#0.8696;ACE ACTIVITY#0.8683;NEURONAL CEROID LIPOFUSCINOSIS#0.8675;ALPHA-2 MACROGLOBULIN#0.8664;ALKALINE PHOSPHATASE ACTIVITY#0.8659;ALPHA 1-ANTITRYPSIN#0.8655;LINES OF EVIDENCE#0.8646;PHOSPHOLIPASE C#0.8642;PULMONARY ARTERY#0.8640;GERM CELL#0.8640;PROTEIN FOLDING#0.8639;FORMALIN#0.8638;COLLAGEN DEGRADATION#0.8630;MALIC ENZYME#0.8624;DETOXIFICATION#0.8622;MYOCARDIAL INFARCTION#0.8600;BIOLOGICAL PROCESS#0.8599;INTESTINAL ABSORPTION#0.8595;METFORMIN#0.8582;NUCLEIC ACID#0.8571;METAL CHELATING#0.8570;BORTEZOMIB#0.8548;MONONUCLEAR CELLS#0.8536;DIPEPTIDASE ACTIVITY#0.8530;HYPOXIC#0.8520;DIPEPTIDYL-PEPTIDASE IV ACTIVITY#0.8508;ALPHA GLUCOSIDASE#0.8508;FIBRONECTIN BINDING#0.8498;DENDRITIC CELL#0.8493;ROUGH MICROSOME#0.8485;OXYGENASE#0.8479;LOCALISATION#0.8479;TRANSCRIPTASE#0.8468;HYALURONIDASE#0.8463;WEIGHT GAIN#0.8458;CLP PROTEASE#0.8453;TRACHEA#0.8452;FACTOR I#0.8446;ION BINDING#0.8438;SUCCINATE#0.8434;PLASMA PROTEIN#0.8429;HEPARIN#0.8418;STREPTOKINASE#0.8409;UBIQUITIN PROTEASOME PATHWAY#0.8408;MORPHOGENESIS#0.8403;ADENYLATE KINASE#0.8392;MICROTUBULE#0.8392;AUTOLYSIS#0.8382;PROGESTERONE#0.8381;DIPEPTIDYL-AMINOPEPTIDASE IV#0.8377;ZINC FINGER PROTEIN#0.8367;EXTRACELLULAR MATRIX COMPONENT#0.8354;OTHER ORGANISM#0.8348;HISTAMINE#0.8343;PERIODONTAL DISEASE#0.8337;PROTEIN UNFOLDING#0.8333;MEMBRANE FUSION#0.8328;SIZE EXCLUSION CHROMATOGRAPHY#0.8326;TRANSLATION INITIATION#0.8318;OVULATION#0.8317;ATP BINDING CASSETTE#0.8289;OPTIC ATROPHY#0.8272;CYTOCHROME C RELEASE#0.8266;CRISTAE#0.8265;AUTOIMMUNE DISEASE#0.8255;PROGENITOR CELL#0.8253;PEPTIDASE ALPHA#0.8231;PROTEIN TRANSPORT#0.8229;POLYMORPHONUCLEAR LEUKOCYTES#0.8210;DNA SYNTHESIS#0.8200;MITOCHONDRIAL PROTEIN IMPORT#0.8196;ELECTRON TRANSPORT#0.8174;IMMUNOGLOBULIN G#0.8157;LEISHMANIASIS#0.8154;ACTION POTENTIAL#0.8148;ADIPOCYTE#0.8144;CELLULAR COMPONENT#0.8125;FRUCTOSE#0.8121;DEUBIQUITINASE#0.8117;CELLULAR LOCALIZATION#0.8105;MOLECULAR DYNAMICS SIMULATION#0.8096;TETRODOTOXIN#0.8087;PHOSPHOLIPASE A#0.8077;CELLULAR MEMBRANE#0.8076;NASAL MUCOSA#0.8071;TISSUE REMODELING#0.8071;ION CHANNEL#0.8070;SUCCINATE DEHYDROGENASE#0.8053;CHRONIC LIVER DISEASE#0.8053;CHOLINE#0.8052;HYALURONIC ACID#0.8034;PNEUMONIA#0.8021;BLOOD GLUCOSE LEVEL#0.8017;NMDA RECEPTOR#0.7992;OLIGOPEPTIDE TRANSPORT#0.7985;ENDOTHELIAL GROWTH FACTOR#0.7984;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7984;GRANULOCYTE#0.7982;PEPTIDYL DIPEPTIDASE A#0.7979;IFN-GAMMA#0.7976;NEURITE#0.7974;NELFINAVIR#0.7943;SEMINAL PLASMA#0.7941;PEPTIDE SYNTHESIS#0.7938;PALMITOYL#0.7932;CELIAC DISEASE#0.7927;CARRIE#0.7918;IMMUNE EVASION#0.7918;FRAGMENT LENGTH POLYMORPHISM#0.7918;RNA INTERFERENCE#0.7914;GLIAL CELL#0.7914;MULTIPLE SCLEROSIS#0.7911;ANGIOTENSIN RECEPTOR#0.7907;HORIZONTAL GENE TRANSFER#0.7898;PROTEIN TARGETING#0.7892;ENALAPRILAT#0.7891;ENDOCYTOSIS#0.7882;RIBOSOMAL PROTEIN#0.7879;LAMININ BINDING#0.7869;GM-CSF#0.7860;BETA-2#0.7852;PHOSPHODIESTERASE#0.7844;SPERMATOZOA#0.7838;INNATE IMMUNITY#0.7834;DUODENUM#0.7830;SIGNALLING PATHWAY#0.7823;CYTOCHROME B5#0.7822;ADIPOSE TISSUE#0.7806;CHAPERONE ACTIVITY#0.7804;NEUROBLASTOMA#0.7803;L-CYSTEINE#0.7792;L-TYROSINE#0.7786;BLOOD PLASMA#0.7783;INTESTINAL EPITHELIAL CELL#0.7778;RECEPTOR INTERNALIZATION#0.7769;L-LYS#0.7768;NORADRENALINE#0.7767;SODIUM DODECYL SULPHATE#0.7764;ADENYLATE CYCLASE#0.7758;GLUTAMATE DEHYDROGENASE#0.7747;ENZYME COMPLEX#0.7735;LIPID DROPLET#0.7722;MITOGEN ACTIVATED PROTEIN#0.7720;SCIATIC NERVE#0.7720;PROTEIN MATURATION#0.7707;GONADOTROPIN RELEASING HORMONE#0.7703;NERVE TERMINAL#0.7684;LIPID METABOLISM#0.7673;DNA REPAIR#0.7670;COLICIN#0.7668;STORAGE PROTEIN#0.7662;CYTOTOXIC T-LYMPHOCYTE#0.7658;ORNITHINE#0.7636;DEXAMETHASONE#0.7604;BLOOD COAGULATION#0.7598;ELECTRON TRANSFER#0.7589;GRANULOSA CELL#0.7580;QUORUM SENSING#0.7577;GLYCINE RECEPTOR#0.7563;COLLAGEN TYPE I#0.7558;SQUAMOUS CELL CARCINOMA#0.7546;LOPINAVIR#0.7542;SECRETORY GRANULE#0.7541;CARBOXYPEPTIDASE G2#0.7537;DIARRHEA#0.7534;CROHN'S DISEASE#0.7528;MULTIPLE SEQUENCE ALIGNMENT#0.7487;TYPE 2 DIABETIC#0.7478;KINASE ACTIVITY#0.7477;ENDOSOME#0.7476;INSULIN-LIKE GROWTH FACTOR#0.7473;CYTOCHROME C1#0.7472;MITOPHAGY#0.7464;SIGNALING MOLECULE#0.7459;VITAMIN E#0.7434;FIBRIL#0.7431;FRONTAL#0.7419;METABOLIC PROCESS#0.7418;G-CSF#0.7411;SURFACE PLASMON RESONANCE#0.7401;MICROVILLUS#0.7401;LINAGLIPTIN#0.7400;UNFOLDED PROTEIN RESPONSE#0.7399;CYTOCHROME C OXIDASE#0.7399;DNASE#0.7397;RIBOSOME BINDING#0.7383;NEUROTRANSMISSION#0.7380;TIGHT JUNCTION#0.7374;PROTEIN KINASE B#0.7373;CYSTIC FIBROSIS#0.7368;FIMBRIAE#0.7366;EDEMA#0.7366;LISINOPRIL#0.7357;RAPAMYCIN#0.7357;PARKINSON'S DISEASE#0.7356;ALKALINE PROTEASE#0.7355;HEART DISEASE#0.7354;LACTOSE#0.7339;ACIDIFICATION#0.7331;D-PHENYLALANINE#0.7323;MUSCLE WASTING#0.7318;BONE MARROW CELLS#0.7305;ANTIGEN PRESENTING CELLS#0.7299;GOLGI APPARATUS#0.7286;OOCYTE GROWTH#0.7285;BLEOMYCIN#0.7264;PYROGLUTAMYL PEPTIDASE II#0.7262;ISCHEMIA REPERFUSION INJURY#0.7255;DEUBIQUITINATING ENZYME#0.7246;RED BLOOD CELL#0.7243;KIDNEY DISEASE#0.7234;PROTEASOME COMPLEX#0.7233;PEPTIDASE BETA#0.7209;BETA N ACETYLGLUCOSAMINIDASE#0.7175;PITUITARY GLAND#0.7164;ANTIOXIDANT ACTIVITY#0.7163;TUMOR TISSUES#0.7156;WEIGHT LOSS#0.7145;DRUG RESISTANCE#0.7144;GAP JUNCTION#0.7144;MICROVILLUS MEMBRANE#0.7138;HUMAN BRONCHIAL EPITHELIAL#0.7130;CARBOHYDRATE METABOLISM#0.7128;SEMEN#0.7115;N ACYLTRANSFERASE#0.7114;THALAMUS#0.7101;MITOCHONDRION#0.7092;RESPIRATORY TRACT#0.7090;TRANSMISSION ELECTRON MICROSCOPY#0.7076;BONE RESORPTION#0.7075;MITOCHONDRIAL INTERMEMBRANE SPACE#0.7074;CHEMOKINE RECEPTOR#0.7073;INNATE IMMUNE RESPONSE#0.7073;OXIDOREDUCTASE ACTIVITY#0.7066;ESTRADIOL#0.7056;OXIDATIVE PHOSPHORYLATION#0.7047;SENSITIZATION#0.7044;OVARIES#0.7042;SCANNING ELECTRON MICROSCOPY#0.7040;DIPEPTIDE TRANSPORT#0.7017;FIBROBLAST GROWTH FACTOR#0.6997;PHARYNGITIS#0.6986;WHOLE GENOME SEQUENCING#0.6972;VASODILATOR#0.6970;NUCLEAR LOCALIZATION SIGNAL#0.6956;LEUKOENCEPHALOPATHY#0.6952;SCHWANN CELL#0.6951;SERINE PROTEASE ACTIVITY#0.6933;SERINE HYDROLASE#0.6932;5 FLUOROURACIL#0.6917;RENAL CELL CARCINOMA#0.6904;ER LUMEN#0.6902;CYTOCHROME B2#0.6899;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6893;BENZAMIDINE#0.6892;KAPPA OPIOID RECEPTOR#0.6877;RIESKE IRON-SULFUR PROTEIN#0.6865;VASOCONSTRICTOR#0.6859;NEPRILYSIN ACTIVITY#0.6855;PROTEIN METABOLISM#0.6843;GINGIVAL CREVICULAR FLUID#0.6840;METABOTROPIC GLUTAMATE RECEPTORS#0.6831;CELL ADHESION MOLECULE#0.6825;SUBMANDIBULAR GLAND#0.6810;CATHEPSIN B ACTIVITY#0.6804;XYLANASE#0.6796;KINASE INHIBITOR#0.6793;GENOTOXIC#0.6789;MEIOSIS#0.6785;NEUROLOGICAL DISORDER#0.6783;STREPTOZOTOCIN#0.6769;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6768;LARVAL DEVELOPMENT#0.6761;ADENINE#0.6756;INFLAMMATORY CELL#0.6751;TRANSFERASE ACTIVITY#0.6744;CANCER ASSOCIATED FIBROBLASTS#0.6741;COLONY-STIMULATING FACTOR#0.6741;INTESTINAL TRACT#0.6718;ESTROUS CYCLE#0.6712;HYPOGLYCEMIA#0.6708;TRYPANOSOMIASIS#0.6705;PARENCHYMA#0.6703;MUSCLE CONTRACTION#0.6683;ALVEOLAR MACROPHAGE#0.6669;FOLATE#0.6663;COLITIS#0.6660;GENE SILENCING#0.6660;RHEUMATIC FEVER#0.6658;DIABETIC NEPHROPATHY#0.6654;RELATED PROTEIN 1#0.6650;HEMATOPOIETIC CELL#0.6647;ATP BINDING CASSETTE TRANSPORTER#0.6646;SPERMATOGENESIS#0.6596;BENZYLPENICILLIN#0.6582;DEMENTIA#0.6582;AGEING#0.6575;UROKINASE#0.6566;PROTEOGLYCAN#0.6548;BETA GLUCURONIDASE#0.6547;D-AMPHETAMINE#0.6547;FLAGELLUM#0.6513;C FIBER#0.6507;NITRO-L-ARGININE#0.6505;GLUCOSE UPTAKE#0.6498;L-ARG#0.6487;MAP KINASE#0.6485;SIGNALING CASCADE#0.6485;PLASTOCYANIN#0.6473;OXIDATION REDUCTION#0.6468;CELL BOUND#0.6466;NEPHROPATHY#0.6465;OSTEOARTHRITIS#0.6447;IONOPHORE#0.6431;D-ASPARAGINE#0.6427;MILK PROTEIN#0.6427;NUCLEOTIDE BINDING DOMAIN#0.6427;FLUORESCEIN#0.6425;DEFENSE RESPONSE#0.6424;BIOTIN#0.6423;PANCREATITIS#0.6422;CELL FRACTION#0.6421;CELLULAR SENESCENCE#0.6412;THYMIDINE#0.6407;PHOTOSYSTEM#0.6395;MOUSE EMBRYONIC FIBROBLAST#0.6390;THYROID GLAND#0.6385;CHLAMYDIA#0.6381;SODIUM CHANNEL#0.6375;GLUCOSE HOMEOSTASIS#0.6375;CELL MOTILITY#0.6374;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6372;3,4-DICHLOROISOCOUMARIN#0.6368;HYPERGLYCEMIA#0.6364;CELL DEVELOPMENT#0.6363;HEPATOCYTE GROWTH FACTOR#0.6360;HEPATITIS B#0.6354;PYROGENIC#0.6350;CELL CYCLE ARREST#0.6344;LEUCIN#0.6339;GLYCOLYSIS#0.6337;PHOTOSYSTEM II#0.6335;PROTEIN KINASE C#0.6334;COLLAGEN METABOLISM#0.6323;PROTEIN CATABOLISM#0.6322;FERREDOXIN#0.6316;AMIDASE ACTIVITY#0.6289;MEPRIN#0.6288;NOCICEPTION#0.6285;OLFACTORY BULB#0.6281;HINDLIMB#0.6271;BUDDING#0.6264;L-METHIONINE#0.6261;GUANOSINE#0.6256;SEMINAL VESICLE#0.6252;HEMORRHAGIC#0.6246;PEPTIDE HYDROLASE ACTIVITY#0.6242;TESTOSTERONE#0.6226;OSTEOBLAST#0.6221;GAMMA SECRETASE COMPLEX#0.6219;PROSTATE SPECIFIC ANTIGEN#0.6211;SYNOVIAL FLUID#0.6202;ARGININE VASOPRESSIN#0.6197;TISSUE DAMAGE#0.6192;HUMAN BREAST CANCER#0.6182;INSULINOMA#0.6180;BREAST CANCER PATIENTS#0.6179;CARDIOMYOPATHY#0.6179;CAROTID ARTERY#0.6178;CACL2#0.6176;MICROVILLI#0.6175;PARATHYROID HORMONE#0.6164;ASCORBIC ACID#0.6161;CD4+ T CELL#0.6159;ATHEROSCLEROSIS#0.6150;HOE 140#0.6145;CORD BLOOD#0.6140;SERTOLI CELL#0.6138;NERVE ENDING#0.6130;RIBOSE#0.6125;VANCOMYCIN#0.6119;GAMMA SECRETASE INHIBITORS#0.6112;ESSENTIAL AMINO ACID#0.6112;STRUCTURAL ORGANIZATION#0.6109;CONNEXIN#0.6094;DIFFERENTIAL GENE EXPRESSION#0.6087;HYPOTENSIVE#0.6078;COLON CARCINOMA#0.6066;OVARIAN CARCINOMA#0.6063;ADRENAL GLAND#0.6057;ENKEPHALINASE ACTIVITY#0.6055;SITE 1 PROTEASE#0.6053;MITOCHONDRIAL CRISTAE#0.6043;19S REGULATORY PARTICLE#0.6042;ALPHA-1-ANTITRYPSIN PRECURSOR#0.6041;INFLAMMATORY BOWEL DISEASE#0.6040;CYCLIC AMP#0.6036;RETINOL#0.6031;MYOBLAST#0.6023;PERTUSSIS#0.6022
115265	SKELETAL MUSCLE#1.0299;DNA DAMAGE RESPONSE#0.9921;GENE EXPRESSION#0.8580;TARGET OF RAPAMYCIN#0.8361;PROTEIN SYNTHESIS#0.8268;RAPAMYCIN#0.7471;CELL DEATH#0.7109;TARGET OF RAPAMYCIN COMPLEX#0.6317
115286	S-ADENOSYLMETHIONINE#0.8148;CANCER CELL#0.7318
115290	CELL PROLIFERATION#0.8598;GENE EXPRESSION#0.8235;LUNG ADENOCARCINOMA#0.6323;HEPATOCELLULAR CARCINOMA#0.6254;LUNG CANCER#0.6234
115294	ANGLE-CLOSURE GLAUCOMA#1.0298;PRIMARY ANGLE-CLOSURE GLAUCOMA#1.0074;PRIMARY ANGLE CLOSURE#1.0057
1152	GLIAL CELL#1.0392;CREATINE KINASE#1.0320;CREATINE#1.0318;ENZYME ACTIVITY#1.0269;GENE EXPRESSION#0.9963;ASTROCYTE#0.9945;MYOCARDIAL INFARCTION#0.9851;ESTROGEN RECEPTOR#0.9691;SPINAL CORD#0.9535;ATP SYNTHASE#0.9484;NERVOUS SYSTEM#0.9463;CANCER CELL#0.9342;SKELETAL MUSCLE#0.9216;ACUTE MYOCARDIAL INFARCTION#0.9195;UTERUS#0.9150;PROTEIN KINASE#0.9091;CENTRAL NERVOUS SYSTEM#0.8999;OLIGODENDROCYTE#0.8661;ESTRADIOL#0.8359;CELL PROLIFERATION#0.8110;ADENOSINE#0.8029;EPITHELIAL CELL#0.8007;PYRUVATE KINASE#0.7947;REGENERATION#0.7938;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7755;CARDIAC MUSCLE#0.7700;OSTEOCLAST#0.7613;PYRUVATE#0.7560;KINASE ACTIVITY#0.7520;BRUSH BORDER#0.7344;HYPOXIA#0.7258;OVARIAN CANCER#0.7256;CREATINE KINASE ACTIVITY#0.7215;FATTY ACID BINDING#0.7133;HEAT SHOCK PROTEIN#0.7001;ENERGY HOMEOSTASIS#0.6960;BINDING PROTEIN 1#0.6952;COLON CANCER#0.6921;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.6902;PERIPHERAL BLOOD#0.6874;MUSCLE CELL#0.6783;GROWTH FACTOR#0.6744;CEREBRUM#0.6705;HEMORRHAGE#0.6699;MITOCHONDRIA#0.6596;TRANSCRIPTION FACTOR#0.6595;GLUTATHIONE#0.6520;TAMOXIFEN#0.6493;ATP REGENERATION#0.6472;TERMINAL WEB#0.6380;ARTERY#0.6354;CHLORAMPHENICOL#0.6252;NADH DEHYDROGENASE#0.6188;PROTEIN DISULFIDE ISOMERASE#0.6185;MYOBLAST#0.6184;MALATE DEHYDROGENASE#0.6156;HYPOXIC#0.6153;GESTATION#0.6147;MYOCARDIUM#0.6144;LASER DESORPTION IONIZATION#0.6104;OVARIAN#0.6058;ADENYLATE KINASE#0.6039
115330	SIGNALING PATHWAY#0.6627;VESICULAR STOMATITIS VIRUS#0.6233;HOST CELL#0.6096
115350	B CELL#1.1072;GERMINAL CENTER#0.7366;MATURE B-CELL NEOPLASM#0.6501;PERIPHERAL BLOOD#0.6433;GRAVES' DISEASE#0.6007
115352	SYSTEMIC LUPUS ERYTHEMATOSUS#1.0573;LUPUS ERYTHEMATOSUS#1.0570;B CELL#1.0460;RHEUMATOID ARTHRITIS#1.0451;AUTOIMMUNE DISEASE#1.0445;T CELL#1.0387;GRAVES' DISEASE#1.0088;AUTOIMMUNITY#1.0037;ENDOMETRIOSIS#0.9232;FRAGMENT LENGTH POLYMORPHISM#0.9000;TYPE 1 DIABETES#0.8430;HUMAN LEUKOCYTE ANTIGEN#0.8326;POLYMERASE CHAIN REACTION#0.8227;INFERTILITY#0.8129;AUTOIMMUNE THYROIDITIS#0.7869;MULTIPLE SCLEROSIS#0.7865;REGULATORY T CELL#0.7613;TRANSCRIPTION FACTOR#0.7287;GENE EXPRESSION#0.7210;LEUKOCYTE#0.7137;TREG CELL#0.6912;PLASMA CELL#0.6450;IMMUNE RESPONSE#0.6385;JUVENILE RHEUMATOID ARTHRITIS#0.6316;ALLERGIC RHINITIS#0.6131
115353	LUNG CANCER#0.8997;CANCER CELL#0.8953
115362	MACROPHAGE#0.8937;IMMUNE RESPONSE#0.7699;GENE EXPRESSION#0.7458;T CELL#0.6794;PERIPHERAL BLOOD#0.6505;PYROPTOSIS#0.6487;INFLUENZA A VIRUS#0.6347
115399	INTRAFLAGELLAR TRANSPORT#0.9334;DYNEIN#0.6884
1153	GLYCINE#1.0538;RNA BINDING PROTEIN#1.0499;RNA BINDING#1.0479;COLD SHOCK PROTEIN#1.0425;APOPTOSIS#0.9949;GENE EXPRESSION#0.9914;HEAT SHOCK PROTEIN#0.9769;ISCHEMIA#0.9504;CELL PROLIFERATION#0.9494;GROWTH FACTOR#0.9063;HYPOXIA#0.8973;RNA RECOGNITION MOTIF#0.8846;TRANSCRIPTION FACTOR#0.8409;POLYMERASE CHAIN REACTION#0.7822;QUANTITATIVE REAL TIME#0.7674;SIGNALING PATHWAY#0.7493;RNA CHAPERONE#0.7332;PRO-INFLAMMATORY#0.7303;CELL CYCLE#0.7286;CELL DEATH#0.7284;CYTOPLASM#0.7217;SIGNAL TRANSDUCTION#0.7165;INFLAMMATORY RESPONSE#0.7162;TRANSFORMING GROWTH FACTOR#0.6909;REACTIVE OXYGEN SPECIES#0.6906;TUMOR NECROSIS FACTOR#0.6896;CANCER CELL#0.6728;PROTEIN SYNTHESIS#0.6645;IMMUNE RESPONSE#0.6615;BINDING PROTEIN 1#0.6561;ARGININE#0.6547;STEM CELL#0.6497;APOPTOTIC#0.6444;CARDIAC ARREST#0.6421;NEUROPROTECTION#0.6377;OOCYTE#0.6354;BREAST CANCER#0.6288;GERM CELL#0.6254;NEURON APOPTOSIS#0.6185;IN VITRO MATURATION#0.6088;NUCLEIC ACID#0.6035;MACROPHAGE#0.6033
115416	MITOCHONDRIAL TRANSLATION#1.0892;MITOCHONDRIAL RIBOSOME#1.0546;RIBOSOME#0.8190;LARGE RIBOSOMAL SUBUNIT#0.7565;RIBOSOMAL SUBUNIT#0.7325
115426	CELL CYCLE#1.0808;DNA METHYLATION#1.0779;UBIQUITIN#1.0746;CELL CYCLE REGULATION#0.9288;CELL PROLIFERATION#0.8873;TUMOR SUPPRESSOR#0.8827;CANCER CELL#0.8181;DNA DAMAGE RESPONSE#0.7710;MTDNA#0.7689;MITOCHONDRIAL DNA#0.7681;STEM CELL#0.7277;EPITHELIAL MESENCHYMAL TRANSITION#0.6999;COLORECTAL CANCER#0.6957;GENE EXPRESSION#0.6933;ZINC FINGER PROTEIN#0.6268;HEPATITIS B VIRUS#0.6215;TUMOR TISSUES#0.6204;HEPATITIS B#0.6194
1154	AND SOCS BOX#1.0879;BREAST CANCER#1.0225;UBIQUITIN#1.0091;GM-CSF#1.0086;UBIQUITIN LIGASE COMPLEX#1.0049;CYTOKINE RECEPTOR#1.0033;DENDRITIC CELL#0.9978;CANCER CELL#0.9941;BC COMPLEX#0.9938;SIGNALING MOLECULE#0.9935;MONOCYTE#0.9933;SKELETAL MUSCLE#0.9928;EPITHELIAL CELL#0.9927;IFN-GAMMA#0.9885;MONONUCLEAR CELLS#0.9860;GROWTH HORMONE#0.9857;PROTEIN KINASE#0.9852;TUMOR SUPPRESSOR#0.9848;PROTEASOME#0.9848;PERIPHERAL BLOOD#0.9833;CYTOKINE PRODUCTION#0.9823;TOLL LIKE RECEPTOR#0.9820;IMMUNE SYSTEM#0.9809;IMMUNE RESPONSE#0.9805;SIGNAL TRANSDUCTION#0.9796;SIGNAL TRANSDUCER#0.9793;CELL PROLIFERATION#0.9789;SIGNALING PATHWAY#0.9788;ADIPOCYTE#0.9783;INNATE IMMUNITY#0.9783;T CELL#0.9782;MACROPHAGE#0.9779;POLYMERASE CHAIN REACTION#0.9767;TUMOR NECROSIS FACTOR#0.9763;INSULIN RECEPTOR#0.9745;GROWTH FACTOR#0.9738;INFLAMMATORY RESPONSE#0.9736;TUBERCULOSIS#0.9726;G-CSF#0.9718;STEM CELL#0.9705;BONE MARROW#0.9705;INSULIN-LIKE GROWTH FACTOR#0.9686;MAMMARY GLAND#0.9684;GENE EXPRESSION#0.9669;DNA BINDING#0.9669;APOPTOSIS#0.9668;TRANSCRIPTION FACTOR#0.9663;KINASE ACTIVITY#0.9655;PRO-INFLAMMATORY#0.9628;ADIPOSE TISSUE#0.9604;IMMUNE CELL#0.9587;BREAST CANCER CELL#0.9580;HEPATITIS B#0.9566;HEMATOPOIETIC CELL#0.9558;PLASMA MEMBRANE#0.9551;SIGNALING CASCADE#0.9545;INSULIN RECEPTOR SUBSTRATE#0.9500;NITRIC OXIDE#0.9495;B CELL#0.9475;GRANULOCYTE#0.9436;GROWTH HORMONE RECEPTOR#0.9396;CELL ACTIVATION#0.9384;CELL DIFFERENTIATION#0.9356;CELL CYCLE#0.9355;MITOGEN ACTIVATED PROTEIN#0.9347;COLONY-STIMULATING FACTOR#0.9346;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9328;RHEUMATOID ARTHRITIS#0.9234;ENDOTHELIAL CELL#0.9203;CELL SURFACE#0.9176;NERVOUS SYSTEM#0.9169;PROTEIN TYROSINE PHOSPHATASE#0.9123;SIGNALLING PATHWAY#0.9104;CD4+ T CELL#0.9081;REVERSE TRANSCRIPTION#0.9074;CD8+ T CELL#0.9068;CELL GROWTH#0.9001;APOPTOTIC#0.8904;INNATE IMMUNE RESPONSE#0.8904;LIGASE ACTIVITY#0.8873;PROGENITOR CELL#0.8858;MYELOPROLIFERATIVE NEOPLASM#0.8835;CENTRAL NERVOUS SYSTEM#0.8799;HEPATITIS C#0.8736;TRANSACTIVATION#0.8712;VON HIPPEL LINDAU#0.8703;MAP KINASE#0.8620;INDUCIBLE NITRIC OXIDE#0.8604;NITRIC OXIDE SYNTHASE#0.8575;TUMOR CELLS#0.8566;TH2 CELL#0.8519;GROWTH FACTOR RECEPTOR#0.8508;HEPATOCELLULAR CARCINOMA#0.8483;PROLACTIN RECEPTOR#0.8481;ERYTHROPOIETIN RECEPTOR#0.8477;HEPATITIS C VIRUS#0.8473;KINASE INHIBITOR#0.8471;CELL DEATH#0.8427;HEPATITIS B VIRUS#0.8408;T LYMPHOCYTE#0.8392;GRANULOCYTE COLONY STIMULATING FACTOR#0.8390;NEUTROPHIL#0.8387;LEUKOCYTE#0.8326;UROCANIC ACID#0.8294;ASTROCYTE#0.8288;ONCOGENIC#0.8270;T CELL ACTIVATION#0.8250;EPIDERMAL GROWTH FACTOR#0.8215;RETINOIC ACID#0.8168;LEUKEMIA INHIBITORY FACTOR#0.8164;TYPE 2 DIABETES#0.8126;TREG CELL#0.8112;BETA CELL#0.8106;PROTEIN TYROSINE KINASE#0.8102;ERYTHROID PROGENITOR#0.8043;DNA HYPERMETHYLATION#0.8023;INTESTINAL EPITHELIAL CELL#0.8009;ANTIVIRAL RESPONSE#0.7980;RETINOID X RECEPTOR#0.7940;REGENERATION#0.7938;IMMUNE EVASION#0.7878;AUTOIMMUNE DISEASE#0.7873;KERATINOCYTE#0.7823;MAST CELL#0.7802;PROTEIN PROTEIN INTERACTION#0.7786;INTRACELLULAR SIGNALING PATHWAY#0.7784;COMPLEX I#0.7738;RECEPTOR TYROSINE KINASE#0.7733;CYTOTOXICITY#0.7716;TH17 CELL#0.7672;MECHANISM OF ACTION#0.7631;RECEPTOR COMPLEX#0.7571;TRANSCRIPTASE#0.7509;IFN-BETA#0.7494;CHRONIC HEPATITIS B#0.7482;PANCREATIC ISLET#0.7437;MULTIPLE SCLEROSIS#0.7434;QUANTITATIVE REAL TIME#0.7431;OBESE#0.7425;ATHEROSCLEROSIS#0.7392;MYELOID LEUKEMIA#0.7319;HUMAN BREAST CANCER#0.7316;UBIQUITIN LIGASE ACTIVITY#0.7280;MYELOID CELL#0.7237;HEMATOPOIESIS#0.7118;RESPONSE TO CYTOKINE#0.7115;PROGESTERONE#0.7101;PATTERN RECOGNITION RECEPTOR#0.7047;MACROPHAGE ACTIVATION#0.7026;DIABETES MELLITUS#0.6952;POST-TRANSLATIONAL MODIFICATION#0.6937;CYTOPLASM#0.6936;TYPE 1 DIABETES#0.6930;GLUCOSE HOMEOSTASIS#0.6845;AUTOIMMUNITY#0.6834;OVARIAN#0.6817;TRANSFORMING GROWTH FACTOR#0.6810;T CELL DIFFERENTIATION#0.6783;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6724;REGULATORY T CELL#0.6721;TRANSIENT RECEPTOR POTENTIAL#0.6704;PROSTATE CANCER#0.6654;INSULIN SIGNALING PATHWAY#0.6652;HYPOXIA#0.6628;CELL MIGRATION#0.6602;PROTEIN DEGRADATION#0.6589;MUSCLE CELL#0.6535;CHEMOKINE PRODUCTION#0.6525;GENE SILENCING#0.6461;CHONDROCYTE#0.6439;FACTOR I#0.6421;ENDOPLASMIC RETICULUM#0.6419;LACTATION#0.6419;SQUAMOUS CELL CARCINOMA#0.6409;LYMPH NODE#0.6408;COLORECTAL#0.6406;LIPID METABOLISM#0.6314;BONE MARROW CELLS#0.6276;CELL DEVELOPMENT#0.6270;FAT CELL#0.6266;LYSINE#0.6247;RECEPTOR ANTAGONIST#0.6228;STROMAL CELL#0.6209;TUMOUR NECROSIS FACTOR#0.6146;GLIAL CELL#0.6143;ADAPTIVE IMMUNE RESPONSE#0.6139;JAK-STAT SIGNAL TRANSDUCTION#0.6118;ALLERGEN#0.6085;HISTONE ACETYLATION#0.6032
115509	HEPATOCELLULAR CARCINOMA#1.0171;NORMAL LIVER TISSUES#0.7452;REPORTER GENE ASSAY#0.7268;LIVER CANCER#0.7234;WOUND HEALING#0.7171
115548	CLATHRIN-MEDIATED ENDOCYTOSIS#0.8657;ENDOCYTOSIS#0.8648;PLASMA MEMBRANE#0.8276
115557	NUCLEOTIDE EXCHANGE FACTOR#1.0813;GUANINE#1.0671;SIGNALING PATHWAY#0.8771;RHOGEF#0.8748;NEURITE OUTGROWTH#0.7964;SMOOTH MUSCLE#0.7842;PLASMA MEMBRANE#0.7739;PHOSPHOLIPASE C#0.7718;CELL PROLIFERATION#0.6967;SKELETAL MUSCLE#0.6728;NEURITE#0.6574;HETEROTRIMERIC G-PROTEIN#0.6460;BLOOD VESSEL#0.6227;SMOOTH MUSCLE CELL#0.6151;MUSCLE CELL#0.6143
115572	HUMAN EMBRYONIC STEM#0.7621;PLURIPOTENT STEM CELL#0.7562;EMBRYONIC STEM CELL#0.7533;PROSTATE CANCER#0.7480;CELL CYCLE#0.7437;STEM CELL#0.7432;CELL PROLIFERATION#0.7427
115584	MYO-INOSITOL#1.0804;TYPE 2 DIABETES#1.0276;DIABETES MELLITUS#0.9430;OOCYTE#0.9133;EXCRETION#0.8495;SMALL INTESTINE#0.8141;TYPE 2 DIABETES MELLITUS#0.7882;2 DIABETES MELLITUS#0.7882;HISTIDINE#0.7350;GENE EXPRESSION#0.6888;GLUCOSE UPTAKE#0.6762;POTASSIUM CHANNEL#0.6748;INWARD RECTIFYING K+ CHANNEL#0.6500;GLUCOSE TRANSPORT#0.6488;GLUCOSE REABSORPTION#0.6463;RECEPTOR AGONIST#0.6190;BRUSH BORDER#0.6066
1155	TUBULIN FOLDING#1.1021;MICROTUBULE#0.9869;MICROTUBULE DYNAMICS#0.6628;HEPATIC ISCHEMIA REPERFUSION#0.6042
115650	CYCLOPHILIN#1.0443;TRANSITIONAL B CELL#1.0418;CELL MATURATION#1.0281;B CELL RECEPTOR#1.0220;MEMORY B CELL#1.0206;B CELL#1.0176;FLUPHENAZINE#1.0173;COMMON VARIABLE IMMUNODEFICIENCY#1.0020;B CELL DEVELOPMENT#1.0012;GERMINAL CENTER#0.9988;PLASMA CELL#0.9955;B CELL PROLIFERATION#0.9950;CELL SURFACE#0.9948;SIGNALING PATHWAY#0.9945;B LYMPHOCYTE#0.9934;PERIPHERAL BLOOD#0.9933;CELL DEVELOPMENT#0.9930;CELL ACTIVATION#0.9924;CELL PROLIFERATION#0.9893;T CELL#0.9888;B CELL LYMPHOMA#0.9885;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9883;LUPUS ERYTHEMATOSUS#0.9881;BONE MARROW#0.9874;TUMOR NECROSIS FACTOR#0.9861;B CELL ACTIVATION#0.9816;APOPTOSIS#0.9797;MULTIPLE MYELOMA#0.9796;AUTOIMMUNE DISEASE#0.9729;RHEUMATOID ARTHRITIS#0.9719;IMMUNE RESPONSE#0.9709;GENE EXPRESSION#0.9699;AUTOIMMUNITY#0.9658;DENDRITIC CELL#0.9640;B CELL HOMEOSTASIS#0.9637;MACROPHAGE#0.9591;TUMOUR NECROSIS FACTOR#0.9547;TRANSCRIPTION FACTOR#0.9449;MONOCYTE#0.9446;MARGINAL ZONE B#0.9404;CELL DIFFERENTIATION#0.9396;B CELL DIFFERENTIATION#0.9386;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9384;LYMPHOCYTIC LEUKEMIA#0.9377;MARGINAL ZONE B CELL#0.9296;B CELL DEPLETION#0.9240;ACTIVATED B CELL#0.9199;IMMUNE SYSTEM#0.9125;POLYMERASE CHAIN REACTION#0.8984;MONONUCLEAR CELLS#0.8983;TOLL LIKE RECEPTOR#0.8921;IMMUNE CELL#0.8831;ATHEROSCLEROSIS#0.8811;APOPTOTIC#0.8786;T LYMPHOCYTE#0.8767;DIFFUSE LARGE B-CELL LYMPHOMA#0.8715;RITUXIMAB#0.8658;NAIVE B CELL#0.8578;LYMPH NODE#0.8394;GERMINAL CENTER B#0.8374;FOLLICULAR B CELL#0.8236;GERMINAL CENTER B CELL#0.8230;FOLLICULAR LYMPHOMA#0.8068;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8031;HUMORAL IMMUNE RESPONSE#0.8001;REVERSE TRANSCRIPTION#0.7961;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7944;IFN-GAMMA#0.7939;NF-KAPPAB ACTIVATION#0.7866;LYMPHOID TISSUE#0.7819;CELL GROWTH#0.7782;HODGKIN'S LYMPHOMA#0.7751;CELL DEATH#0.7738;LYMPHOID CELL#0.7736;NON HODGKIN LYMPHOMA#0.7722;MULTIPLE SCLEROSIS#0.7691;T CELL ACTIVATION#0.7660;LUPUS NEPHRITIS#0.7544;LYMPHOCYTE DEVELOPMENT#0.7541;ANTIBODY PRODUCTION#0.7539;GROWTH FACTOR#0.7426;CD4+ T CELL#0.7251;CYTOTOXICITY#0.7215;REGULATORY B CELL#0.7132;INFLAMMATORY CELL#0.7062;T1 B CELL#0.7012;SWITCHED MEMORY B CELL#0.7009;CYTOKINE PRODUCTION#0.6877;B CELL SELECTION#0.6811;CD8+ T CELL#0.6756;NERVOUS SYSTEM#0.6729;REGULATORY T CELL#0.6541;MYELOID CELL#0.6504;RECEPTOR BINDING#0.6493;PLASMABLAST#0.6402;IL-10 PRODUCTION#0.6338;MEAN FLUORESCENCE INTENSITY#0.6166;T2 B CELL#0.6166;NEPHRITIS#0.6158;B CELL CHEMOTAXIS#0.6127;COLLAGEN INDUCED ARTHRITIS#0.6113;PROTEIN KINASE#0.6109;MYASTHENIA GRAVIS#0.6048
115653	T CELL#0.7774;PERIPHERAL BLOOD#0.7509;POLYMERASE CHAIN REACTION#0.7338;SEQUENCE SPECIFIC PRIMER#0.6470
115677	NITRIC OXIDE SYNTHASE#1.0983;NITRIC OXIDE#1.0873;ENDOTHELIAL NITRIC OXIDE#1.0830;ENDOTHELIAL CELL#1.0749;PLASMA MEMBRANE#1.0257;PRE-ECLAMPSIA#0.8155;ANGIOGENESIS#0.6253;ECLAMPSIA#0.6214;GENE EXPRESSION#0.6139
1156	CREATINE#0.6820;ERYTHROCYTE#0.6465
115701	GENE EXPRESSION#0.7477;DNA REPAIR#0.6216;STEM CELL#0.6145
115703	SYNAPSE DEVELOPMENT#0.7006;SIGNALING PATHWAY#0.6903;DENDRITIC SPINE#0.6821;NEURITE OUTGROWTH#0.6781;SOCIAL BEHAVIOR#0.6282;GLUCOSE TRANSPORT#0.6228;NERVE GROWTH FACTOR#0.6137;GROWTH FACTOR#0.6016
115708	TRNA BINDING#0.6942;COMPLEX I#0.6450;BLADDER UROTHELIAL CARCINOMA#0.6303
115727	MAST CELL#1.0563;NUCLEOTIDE EXCHANGE FACTOR#1.0139;GUANINE#0.9875;T CELL#0.8935;BONE MARROW#0.7349;PERIPHERAL BLOOD#0.7208;BONE MARROW CELLS#0.6519;RHEUMATOID ARTHRITIS#0.6466
115752	EXOSOME#0.9175
115761	TUMOR SUPPRESSOR#1.1107;OVARIAN CANCER#1.0665;CANCER CELL#1.0178;BREAST CANCER#1.0151;OVARIAN#0.9684;PROSTATE CANCER#0.8956;APOPTOSIS#0.8695;LUNG CANCER#0.8506;COLORECTAL CANCER#0.8378;MACROPHAGE ACTIVATION#0.8224;FAMILIAL BREAST CANCER#0.8202;APOPTOTIC#0.7850;COLORECTAL#0.7525;MACROPHAGE#0.6134
115811	ACROSOME#0.8910;ACROSOME REACTION#0.6011
115817	FETAL BRAIN#0.7085
115825	ENDOSOME#0.7569;EARLY ENDOSOME#0.7546;PLASMA MEMBRANE#0.7292;PROSTATE CANCER#0.6526;PROTEIN KINASE#0.6513;LIMB DEVELOPMENT#0.6165;ADIPOCYTE DIFFERENTIATION#0.6009
115827	EXOCYTOSIS#0.9926;GTP BINDING#0.9879;SYNAPTIC VESICLE#0.9098;NEUROTRANSMITTER RELEASE#0.7979;PLASMA MEMBRANE#0.7887;REGULATED EXOCYTOSIS#0.7702;CHROMAFFIN CELL#0.6454;CARDIAC MUSCLE#0.6338
115861	RETINITIS PIGMENTOSA#0.9979;PHOTORECEPTOR CELL#0.9351;RETINITIS#0.9084;RETINAL DISEASE#0.6023
1158	CREATINE#1.0291;CREATINE KINASE#1.0290;SKELETAL MUSCLE#0.9961;CARDIAC TROPONIN I#0.9781;FATTY ACID BINDING#0.9692;MYOCARDIAL INFARCTION#0.9185;ADENYLATE KINASE#0.8952;MYOCARDIUM#0.8934;MITOCHONDRIA#0.8914;ISCHEMIA#0.8850;GENE EXPRESSION#0.8521;PYRUVATE KINASE#0.8361;MYOGENIC CELL#0.8046;CORONARY ARTERY#0.7989;PYRUVATE#0.7978;M BAND#0.7952;MYOFIBRIL#0.7907;OXIDATIVE PHOSPHORYLATION#0.7720;CARDIOMYOCYTE#0.7563;ADENYLATE#0.7562;ARTERY#0.7380;LIGHT CHAIN 3#0.7188;MUSCLE CELL#0.7166;MYOTUBE#0.7125;M LINE#0.7076;POLYMERASE CHAIN REACTION#0.7033;MYOSIN HEAVY CHAIN#0.6860;C REACTIVE PROTEIN#0.6701;TUMOR NECROSIS FACTOR#0.6616;MUSCULAR DYSTROPHY#0.6561;ASPARTATE#0.6550;ATP SYNTHASE#0.6380;DIGESTION#0.6375;FRUCTOSE BISPHOSPHATE ALDOLASE#0.6366;GLYCERALDEHYDE-3-PHOSPHATE#0.6353;ENZYME ACTIVITY#0.6225;BINDING PROTEIN 3#0.6158;BRAIN NATRIURETIC PEPTIDE#0.6151;MITOCHONDRIAL MEMBRANE#0.6100;CARDIAC MUSCLE#0.6065
115908	CANCER CELL#1.0698;COLORECTAL CANCER#1.0684;CELL MIGRATION#1.0670;CELL PROLIFERATION#1.0630;GROWTH FACTOR#1.0470;SIGNALING PATHWAY#1.0374;LYMPH NODE#1.0367;TRANSFORMING GROWTH FACTOR#1.0336;COLORECTAL#1.0051;HEPATOCELLULAR CARCINOMA#0.9987;OVARIAN CANCER#0.9944;PCP PATHWAY#0.9860;STROMAL CELL#0.9839;GENE EXPRESSION#0.9792;OSTEOCLAST#0.9780;BONE FORMATION#0.9705;BREAST CANCER#0.9670;SMOOTH MUSCLE#0.9530;SQUAMOUS CELL CARCINOMA#0.9501;EXTRACELLULAR MATRIX#0.9426;DISEASE FREE SURVIVAL#0.9384;LYMPH NODE METASTASIS#0.9380;EPITHELIAL MESENCHYMAL TRANSITION#0.9196;POLYMERASE CHAIN REACTION#0.9179;OSTEOBLAST#0.9159;CERVICAL#0.9119;CELL CYCLE#0.9056;COLLAGEN TYPE I#0.9010;SMOOTH MUSCLE CELL#0.8917;MUSCLE CELL#0.8908;LUNG CANCER#0.8817;ADENOCARCINOMA#0.8716;BONE RESORPTION#0.8618;OVARIAN#0.8615;TRANSFORMING GROWTH FACTOR BETA#0.8561;APOPTOSIS#0.8436;QUANTITATIVE REAL TIME#0.8252;SCHWANN CELL#0.8168;CERVICAL CANCER#0.8143;EPITHELIAL OVARIAN CANCER#0.8083;CERVICAL SQUAMOUS CELL CARCINOMA#0.7905;REVERSE TRANSCRIPTION#0.7886;STEM CELL#0.7791;CELL POLARITY#0.7660;ANGIOGENESIS#0.7413;WNT-PCP SIGNALING PATHWAY#0.7128;BONE REMODELING#0.7080;PLANAR CELL POLARITY#0.7036;MACROPHAGE#0.6974;HEPATIC STELLATE CELL#0.6896;BONE MARROW#0.6820;ENDOTHELIAL GROWTH FACTOR#0.6794;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6794;WOUND HEALING#0.6662;TUMOR CELLS#0.6562;PROTEIN KINASE#0.6548;TISSUE REMODELING#0.6235;RNA INTERFERENCE#0.6173;COLON CANCER#0.6163;RHEUMATOID ARTHRITIS#0.6149;GASTROINTESTINAL STROMAL TUMOR#0.6119;INTRACELLULAR LOCALIZATION#0.6118;G1 PHASE#0.6046
115948	PRIMARY CILIARY DYSKINESIA#0.8876;SITUS INVERSUS#0.7567;MOTILE CILIA#0.7543;DYSKINESIA#0.6994
1159	CREATINE KINASE#1.0656;CREATINE#1.0621;MITOCHONDRIA#0.9536;SIGNALING PATHWAY#0.7876;ATP SYNTHASE#0.6407;MITOCHONDRIAL MEMBRANE#0.6382;CELL DEATH#0.6166
115	ADENYLATE CYCLASE#1.0681;ADENYLATE#1.0170;CYCLIC AMP#0.9479;CALCINEURIN#0.8958;PROTEIN KINASE#0.8759;GENE EXPRESSION#0.8253;SIGNALING PATHWAY#0.7799;ADRENERGIC RECEPTOR#0.7609;ISOPROTERENOL#0.7607;FORSKOLIN#0.7249;CAMP SIGNALING#0.6380;COLON CANCER#0.6088;DOPAMINE RECEPTOR#0.6073;PROTEIN KINASE C#0.6020
116028	POSITIVE PREDICTIVE VALUE#1.0320;DOUBLE HOLLIDAY JUNCTION#1.0055;TOPOISOMERASE#0.9786;NEGATIVE PREDICTIVE VALUE#0.9756;OVARIAN#0.8803;OVARIAN CANCER#0.7460;BLOOM SYNDROME#0.6755;HOMOLOGOUS RECOMBINATION#0.6566;PROTEIN COMPLEX#0.6346
116039	TRANSCRIPTION FACTOR#1.0622;MESENCHYME#1.0581;MORPHOGENESIS#1.0026;CELL PROLIFERATION#0.9252;PALATE DEVELOPMENT#0.9122;TOOTH DEVELOPMENT#0.8454;PALATAL SHELF#0.8149;KIDNEY DEVELOPMENT#0.8006;MOLAR#0.7999;GENE EXPRESSION#0.7321;LUNG SPECIFICATION#0.7098;OSTEOBLAST#0.7081;TOOTH MORPHOGENESIS#0.6991;CLEFT PALATE#0.6917;CELLULAR QUIESCENCE#0.6675;ORGAN GROWTH#0.6504;SIGNALING PATHWAY#0.6489;DENTAL PAPILLA#0.6435;SIGNALING MOLECULE#0.6330;CELL CYCLE#0.6101
116068	PEPTIDOGLYCAN BINDING#0.8275
116071	CANCER CELL#1.0911;TRANSCRIPTION FACTOR#1.0067;SQUAMOUS CELL CARCINOMA#0.9348;LEUCINE#0.9191;TUMOR SUPPRESSOR#0.8915;APOPTOSIS#0.8812;COLORECTAL CANCER#0.8798;MACROPHAGE#0.8752;T CELL#0.8607;COLORECTAL#0.8269;TONGUE SQUAMOUS CELL CARCINOMA#0.8209;PROSTATE CANCER#0.7905;GENE EXPRESSION#0.7725;COLON CANCER#0.7643;SIGNALING PATHWAY#0.7210;TUMOR TISSUES#0.7078;IMMUNE CELL#0.7066;CELL PROLIFERATION#0.6994;TUBERCULOSIS#0.6400;IFN-BETA#0.6356;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6325;EPITHELIAL TO MESENCHYMAL#0.6322;EPITHELIAL MESENCHYMAL TRANSITION#0.6286;HEPATOCELLULAR CARCINOMA#0.6244;LYMPH NODE#0.6223;CLASSICAL MACROPHAGE#0.6207;CELL CYCLE#0.6207;INFLAMMATORY RESPONSE#0.6161;DENDRITIC CELL#0.6135
116085	URATE TRANSPORT#1.0478;ORGANIC ANION TRANSPORTER#1.0430;URATE EXCRETION#1.0411;URATE#1.0399;ORGANIC CATION TRANSPORTER#1.0115;POLYMERASE CHAIN REACTION#1.0086;ATP BINDING CASSETTE#1.0030;OOCYTE#1.0019;ATP BINDING#1.0013;XANTHINE OXIDASE#1.0011;XANTHINE#0.9987;URIC ACID#0.9985;HYPERURICEMIA#0.9980;SERUM URIC ACID#0.9962;PROBENECID#0.9911;ALLOPURINOL#0.9815;CARNITINE TRANSPORTER#0.9798;EXCRETION#0.9773;EPITHELIAL CELL#0.9699;URIC ACID TRANSPORT#0.9691;OXONATE#0.9627;ACUTE KIDNEY INJURY#0.9255;RENAL REABSORPTION#0.9216;CARNITINE#0.9168;KIDNEY DISEASE#0.9057;LOSARTAN#0.9034;NEPHROLITHIASIS#0.8612;HYPERTENSION#0.8596;PROXIMAL TUBULAR CELL#0.8392;CHRONIC KIDNEY DISEASE#0.7905;GLOMERULAR FILTRATION#0.7718;BLOOD UREA NITROGEN#0.7473;GLOMERULAR FILTRATION RATE#0.7300;DNA METHYLATION#0.7248;TUBULAR EPITHELIAL CELL#0.7050;GENE EXPRESSION#0.6994;PROXIMAL TUBULE CELL#0.6887;BRUSH BORDER#0.6842;TOXICITY#0.6788;PERIPHERAL BLOOD#0.6709;REVERSE TRANSCRIPTION#0.6478;FRUCTOSE#0.6399;PURINE METABOLISM#0.6178;NEPHROPATHY#0.6172;HEPATOCYTE NUCLEAR FACTOR#0.6148;APOPTOSIS#0.6090;STRUCTURE ACTIVITY RELATIONSHIP#0.6088;URATE HOMEOSTASIS#0.6031;EPENDYMAL CELL#0.6024
116092	DNA BINDING#0.6883;CELL CYCLE#0.6706;LUNG CANCER#0.6301
116093	GASTRIC TISSUE#0.8221
1160	CREATINE KINASE#1.0551;CREATINE#1.0540;MITOCHONDRIA#0.9196;SKELETAL MUSCLE#0.9086;OXIDATIVE PHOSPHORYLATION#0.7295;GENE EXPRESSION#0.6984
116113	TRANSCRIPTION FACTOR#1.0333;PROSTATE CANCER#1.0120;CELL PROLIFERATION#0.9781;CANCER CELL#0.7792;GENE EXPRESSION#0.7547;AIRWAY EPITHELIUM#0.7130;BREAST CANCER#0.6501;ANTISENSE RNA#0.6410;CELL DEVELOPMENT#0.6230;CELL GROWTH#0.6105;APOPTOSIS#0.6056
116135	TUMOR SUPPRESSOR#1.0757;CANCER CELL#1.0020;GENE EXPRESSION#0.9664;LUNG CANCER#0.9290;ACUTE LEUKEMIA#0.9077;LEUCINE RICH REPEAT#0.9067;DNA METHYLATION#0.9013;LEUCINE#0.7429;CELL PROLIFERATION#0.7173;CELL CYCLE#0.7169;BREAST CARCINOMA#0.6463;BREAST CANCER#0.6382;RENAL CELL CARCINOMA#0.6367;POLYMERASE CHAIN REACTION#0.6227;5-AZA-2'-DEOXYCYTIDINE#0.6028;2'-DEOXYCYTIDINE#0.6024
116143	APOPTOSIS#0.7813;DYNEIN#0.7527;AXONEMAL DYNEIN HEAVY CHAIN#0.6795
116150	CANCER CELL#1.0929;BREAST CANCER#1.0796;ENDOTHELIAL CELL#1.0380;EPITHELIAL MESENCHYMAL TRANSITION#1.0074;BREAST CANCER CELL#1.0039;ANGIOGENESIS#0.9601;HEPATOCELLULAR CARCINOMA#0.9180;GLYCOSYLATION#0.9154;APOPTOSIS#0.8697;SMOOTH MUSCLE CELL#0.7721;MUSCLE CELL#0.7712;SMOOTH MUSCLE#0.7700;GROWTH FACTOR#0.7273;ESTROGEN RECEPTOR#0.7171;SIGNALING PATHWAY#0.7132;DOLICHOL BIOSYNTHESIS#0.7079;PLASMA MEMBRANE#0.7033;CONGENITAL DISORDER OF GLYCOSYLATION#0.6587;PROTEIN GLYCOSYLATION#0.6582;INVASIVE DUCTAL CARCINOMA#0.6370;CONGENITAL DISORDER#0.6319;CELL GROWTH#0.6314;TUMOR TISSUES#0.6271;VASCULAR SMOOTH MUSCLE CELL#0.6263;PARKINSON'S DISEASE#0.6242;BREAST CARCINOMA#0.6201;EPITHELIAL CELL#0.6192;CHEMOTAXIS#0.6158;TUMOR CELLS#0.6140;PROTEIN KINASE#0.6124
116151	ERYTHROID CELL#0.7486;FERROCHELATASE ACTIVITY#0.7396;HEME SYNTHESIS#0.7216
116154	PROTEIN PHOSPHATASE 1#0.8156;DNA METHYLATION#0.6822
116173	TUMOR SUPPRESSOR#1.1019;PROSTATE CANCER#0.9907;APOPTOSIS#0.9255;CELL PROLIFERATION#0.8524;CELL GROWTH#0.8472;MULTIPLE MYELOMA#0.8304;CANCER CELL#0.7245;BONE MARROW CELLS#0.6568;HEPATOCELLULAR CARCINOMA#0.6558;REVERSE TRANSCRIPTION#0.6526;POLYMERASE CHAIN REACTION#0.6501;BONE MARROW#0.6478;DEMETHYLATION#0.6361
1161	CYCLOSPORINE#1.0517;TRANSCRIPTION-COUPLED REPAIR#1.0300;COCKAYNE SYNDROME#1.0265;DNA REPAIR#1.0049;NUCLEOTIDE EXCISION REPAIR#0.9977;GENE EXPRESSION#0.9949;UBIQUITIN#0.9917;XERODERMA PIGMENTOSUM#0.9698;UBIQUITIN LIGASE COMPLEX#0.8814;PHOTOSENSITIVITY#0.8589;HEARING LOSS#0.8541;UV-SENSITIVE SYNDROME#0.8500;OXIDATIVE DNA DAMAGE#0.8290;RNA SYNTHESIS#0.8266;ATROPHIC GASTRITIS#0.7724;NEPHROTOXICITY#0.7635;AUTOSOMAL RECESSIVE DISEASE#0.7628;T CELL#0.7617;GENETIC DISORDER#0.7511;BASE EXCISION REPAIR#0.7482;AZATHIOPRINE#0.7447;MITOCHONDRIA#0.7364;TOXICITY#0.7332;HYPERSENSITIVITY#0.7305;DNA DAMAGE RESPONSE#0.7201;COCKAYNE SYNDROME B#0.7199;DNA REPAIR PROTEIN#0.7054;TRANSCRIPTION FACTOR#0.7027;SKIN CANCER#0.6696;CELL DEATH#0.6613;STEM CELL#0.6492;POLYMERASE CHAIN REACTION#0.6481;RESPONSE TO UV#0.6464;REACTIVE OXYGEN SPECIES#0.6320;PROTEASOME#0.6313;APOPTOSIS#0.6275;DNA BINDING#0.6270;MITOCHONDRIAL DNA#0.6265;CELL CYCLE#0.6160;MICROCEPHALY#0.6130;ORGAN OF CORTI#0.6104;HAIR CELL#0.6007
116225	MELANIN CONCENTRATING HORMONE#1.0340;ZINC FINGER PROTEIN#1.0246;CELL PROLIFERATION#0.7427
116228	CYTOCHROME C OXIDASE#0.9237;CYTOCHROME C#0.9171;EARLY ONSET DYSTONIA#0.6682;PROTEASE ACTIVITY#0.6028
116236	ADIPOSE TISSUE#0.8937;ADIPOCYTE#0.8349;GLUCOSE UPTAKE#0.8322;RESPONSE TO INSULIN#0.8191;FATTY ACID METABOLISM#0.8169;PALMITIC ACID#0.8165;ADRENERGIC RECEPTOR#0.8082
116238	NEURAL PLATE#0.8267;CALCIUM CHANNEL#0.8071
116255	MGAT ACTIVITY#1.0998;O ACYLTRANSFERASE#1.0899;GENE EXPRESSION#0.8533;TRIGLYCERIDE SYNTHESIS#0.8481;ADIPOSE TISSUE#0.8251;PEROXISOME#0.8139;OBESE#0.7701;HIGH FAT DIET#0.6289
116285	MITOCHONDRIA#0.9071;CONJUGATION#0.7796;GLYCINE#0.7303;BENZOIC ACID#0.7289;COENZYME A#0.7090;LIPOATE#0.6983;SALICYLIC ACID#0.6411;BREAST CARCINOMA#0.6171
116337	OSTEOBLAST#1.0560;GAP JUNCTION#1.0393;CHONDROCYTE#0.9670;OSTEOBLAST DIFFERENTIATION#0.9414;ENDOPLASMIC RETICULUM#0.9210;CELL SURFACE#0.9045;CONNEXIN#0.8681;CELL PROLIFERATION#0.8443;SKELETAL MUSCLE#0.8132;KERATINOCYTE DIFFERENTIATION#0.8037;SIGNALING PATHWAY#0.7916;SKELETAL DEVELOPMENT#0.7857;GENE EXPRESSION#0.7652;PLASMA MEMBRANE#0.7444;CELL CYCLE#0.7098;DENTAL PULP#0.7084;EXTRACELLULAR SPACE#0.7018;BONE FORMATION#0.6964;OSTEOGENESIS#0.6734;MINERALIZATION#0.6546;KERATINOCYTE#0.6506;GLYCOSYLATION#0.6336;MESENCHYMAL STROMAL CELL#0.6285;HUMAN DENTAL PULP#0.6273;AKT SIGNALING#0.6211;STROMAL CELL#0.6174;CELL GROWTH#0.6140
116362	RETINOL BINDING#1.0380;RETINOL#0.9830;ADIPOSE TISSUE#0.9639;GENE EXPRESSION#0.8510;RETINOIC ACID#0.6503
116369	GERM CELL#0.7959;ANNULUS#0.7763;SPERM ANNULUS#0.7563;MALE INFERTILITY#0.6574;SPERM CAPACITATION#0.6118
116372	GENE SILENCING#0.6893;TUMOR SUPPRESSOR#0.6823
116379	INTERLEUKIN-22 BINDING#1.1489;IL-22 BINDING#1.1256;DENDRITIC CELL#0.9744;T CELL#0.9260;MULTIPLE SCLEROSIS#0.7693;GENE EXPRESSION#0.7412;IMMUNE CELL#0.7067;EPITHELIAL CELL#0.6928;TUMOR NECROSIS FACTOR#0.6648;PSORIASIS#0.6581;CYTOKINE RECEPTOR#0.6559;MONOCYTE#0.6493;MACROPHAGE#0.6270;LUPUS NEPHRITIS#0.6257;TIGHT JUNCTION#0.6183;INFLAMMATORY BOWEL DISEASE#0.6172;NEUTROPHIL#0.6125
1163	BREAST CANCER#1.0577;BREAST CANCER CELL#1.0566;PROTEIN KINASE#1.0471;UBIQUITIN#1.0385;CANCER CELL#1.0377;MULTIPLE MYELOMA#1.0353;UBIQUITIN LIGASE COMPLEX#1.0295;S PHASE#1.0280;PROTEASOME#1.0211;CYCLIN DEPENDENT KINASE#1.0155;CELL CYCLE REGULATOR#1.0147;CELL CYCLE#1.0130;LYMPH NODE#1.0107;SQUAMOUS CELL CARCINOMA#1.0068;CELL PROLIFERATION#1.0067;CDK INHIBITOR#0.9969;HEPATOCELLULAR CARCINOMA#0.9955;APOPTOSIS#0.9938;GENE EXPRESSION#0.9816;KINASE INHIBITOR#0.9553;CYCLIN DEPENDENT KINASE INHIBITOR#0.9460;TUMOR SUPPRESSOR#0.9446;LUNG CANCER#0.9419;B CELL#0.9417;PLASMA CELL#0.9260;EPITHELIAL CELL#0.9168;STEM CELL#0.9164;KINASE ACTIVITY#0.9044;CELL CYCLE ARREST#0.8935;LYMPH NODE METASTASIS#0.8923;RNA INTERFERENCE#0.8751;BONE MARROW#0.8665;GROWTH FACTOR#0.8566;CELL DIVISION#0.8247;SIGNALING PATHWAY#0.8234;ONCOGENIC#0.8171;TUMOR CELLS#0.8039;COLORECTAL#0.7984;CELL DEATH#0.7892;ANION BINDING#0.7889;INTERPHASE#0.7793;BUDDING#0.7674;CELL GROWTH#0.7668;MITOTIC SPINDLE#0.7420;ORAL SQUAMOUS CELL CARCINOMA#0.7382;REVERSE TRANSCRIPTION#0.7322;POLYMERASE CHAIN REACTION#0.6908;STEM CELL TRANSPLANTATION#0.6894;SENESCENCE#0.6779;T CELL#0.6741;ADENOCARCINOMA#0.6705;M PHASE#0.6581;PROTEIN DEGRADATION#0.6397;SCF COMPLEX#0.6255;CELL CYCLE CHECKPOINT#0.6198;S-PHASE CHECKPOINT#0.6194;KINASE INHIBITOR P27#0.6191;MITOTIC ENTRY#0.6183;DNA ENDOREDUPLICATION#0.6181;HUMAN BREAST CANCER#0.6123;COPY NUMBER GAIN#0.6103;COLORECTAL CANCER#0.6092;COLORECTAL CARCINOMA#0.6011;LIVER CANCER#0.6007;MOLECULAR DYNAMICS SIMULATION#0.6006
116441	CELL GROWTH#0.7988;PANCREATIC CANCER#0.6915
116442	PARKINSON'S DISEASE#1.0557;INTELLECTUAL DISABILITY#1.0191;STEM CELL#0.8353;EARLY ONSET PARKINSONISM#0.7434;MENTAL RETARDATION#0.7155;ENDOPLASMIC RETICULUM#0.7072;EMBRYONIC STEM CELL#0.6326;BASAL GANGLIA CALCIFICATION#0.6099
116443	GLYCINE BINDING#1.0580;GLYCINE#1.0567;NMDA RECEPTOR#1.0271;GLUTAMATE RECEPTOR#1.0125;ASPARTATE#1.0048;GLYCINE RECEPTOR#0.9635;SYNAPTIC TRANSMISSION#0.9566;LIGAND BINDING DOMAIN#0.8926;GENE EXPRESSION#0.8588;ION CHANNEL#0.8542;SYNAPSE MATURATION#0.8359;CENTRAL NERVOUS SYSTEM#0.8119;NERVOUS SYSTEM#0.8109;D-SERINE#0.8105;OOCYTE#0.7753;DENDRITIC SPINE#0.7594;SPINAL CORD#0.7578;GLUTAMATE BINDING#0.7568;ISCHEMIA#0.7515;PROTEIN PHOSPHATASE 2A#0.7470;PHOSPHATASE 2A#0.7466;HUNTINGTON'S DISEASE#0.7450;AMPA RECEPTOR#0.7437;FOREBRAIN#0.7152;EXCITATORY SYNAPSE#0.6933;SIGNALING PATHWAY#0.6820;NEUROTRANSMISSION#0.6799;NEUROPROTECTION#0.6781;MEMANTINE#0.6763;IONOTROPIC GLUTAMATE RECEPTOR#0.6690;HYPOXIA#0.6590;PLASMA MEMBRANE#0.6556;HUMAN EMBRYONIC KIDNEY#0.6397;EMBRYONIC KIDNEY#0.6392;GLUTAMATERGIC SYNAPSE#0.6292;NICOTINE DEPENDENCE#0.6160;FOCAL CEREBRAL ISCHEMIA#0.6110;BRAIN DEVELOPMENT#0.6102;OLFACTORY BULB#0.6071;MICROTUBULE ASSOCIATED PROTEIN#0.6002
116444	NMDA RECEPTOR#1.0479;GLUTAMATE RECEPTOR#1.0008;ASPARTATE#0.9797;GLYCINE#0.9408;NERVOUS SYSTEM#0.7997;SPINAL CORD#0.7807;RECEPTOR COMPLEX#0.7763;GLYCINE BINDING#0.7480;CENTRAL NERVOUS SYSTEM#0.6785;GLYCINE RECEPTOR#0.6674;GLUTAMATE BINDING#0.6297
116447	TOPOISOMERASE#1.1068;MTDNA#1.0516;MITOCHONDRIA#1.0113;MITOCHONDRIAL DNA#0.9617;MTDNA REPLICATION#0.8184;MITOCHONDRIAL NUCLEOID#0.6406;LUNG CARCINOMA CELL LINES#0.6140;MITOCHONDRIAL PROTEIN SYNTHESIS#0.6116;SINGLE NUCLEOTIDE VARIANTS#0.6007;DNA TOPOISOMERASE#0.6004
116448	OLIGODENDROCYTE DEVELOPMENT#1.0408;OLIGODENDROCYTE DIFFERENTIATION#1.0368;TRANSCRIPTION FACTOR#1.0366;OLIGODENDROCYTE PROGENITOR CELL#1.0341;OLIGODENDROCYTE#1.0273;MYELINATION#1.0181;PROGENITOR CELL#1.0114;SPINAL CORD#1.0005;ASTROCYTE#0.9874;PRECURSOR CELL#0.9846;GENE EXPRESSION#0.9837;NERVOUS SYSTEM#0.9815;CENTRAL NERVOUS SYSTEM#0.9811;STEM CELL#0.9612;GROWTH FACTOR#0.9444;OLIGODENDROCYTE PRECURSOR CELL#0.9308;MULTIPLE SCLEROSIS#0.9253;OLIGODENDROGLIOMA#0.8651;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8604;NEURAL PROGENITOR CELL#0.8560;INTERNEURON#0.8534;CYTOPLASM#0.8512;NEURAL TUBE#0.8287;BONE MORPHOGENETIC PROTEIN#0.8208;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7903;CELL DIFFERENTIATION#0.7854;NEURAL STEM CELL#0.7695;OPTIC NERVE#0.7591;FOREBRAIN#0.7589;PLATELET-DERIVED GROWTH FACTOR#0.7510;NEURAL CELL#0.7384;GLIAL CELL#0.7345;ENCEPHALOMYELITIS#0.7284;GROWTH FACTOR RECEPTOR#0.7092;CELL PROLIFERATION#0.7055;DOWN SYNDROME#0.7048;REVERSE TRANSCRIPTION#0.7022;SPINAL CORD INJURY#0.6866;PROGESTERONE#0.6835;OLIGODENDROCYTE LINEAGE CELLS#0.6815;SIGNALING PATHWAY#0.6793;CEREBRAL CORTEX#0.6382;HYPOXIA#0.6291;SPINAL CORD DEVELOPMENT#0.6291;ISCHEMIA#0.6276;MYELIN FORMATION#0.6203;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.6038
116449	MAST CELL#0.9763;T CELL#0.9758;HEMATOPOIETIC CELL#0.8680;IFN-GAMMA#0.8337;B CELL#0.8026;MAST CELL DEGRANULATION#0.6172;NKT CELL#0.6113
116496	APOPTOSIS#0.9857;THYROID CARCINOMA#0.9655;THYROID LESIONS#0.7385;RENAL CARCINOMA#0.7267;GENE EXPRESSION#0.6731;RENAL INTERSTITIAL FIBROSIS#0.6581;FOLLICULAR ADENOMA#0.6449;CANCER CELL#0.6371;ENDOPLASMIC RETICULUM#0.6249;OBSTRUCTIVE NEPHROPATHY#0.6001
1164	CYCLIN DEPENDENT KINASE#1.0519;CELL CYCLE#1.0364;CELL PROLIFERATION#1.0266;GENE EXPRESSION#0.9911;PROTEIN KINASE#0.9885;CANCER CELL#0.9595;POLYMERASE CHAIN REACTION#0.9405;APOPTOSIS#0.8761;BREAST CANCER#0.8586;CELL GROWTH#0.8253;HEPATOCELLULAR CARCINOMA#0.8152;TUMOR SUPPRESSOR#0.8069;CELL CYCLE REGULATION#0.8011;CELL DIVISION#0.7914;MEIOSIS#0.7881;COLORECTAL CANCER#0.7628;REVERSE TRANSCRIPTION#0.7347;CELL CYCLE ARREST#0.7135;S PHASE#0.7074;COLORECTAL#0.6980;CELL CYCLE CONTROL#0.6975;ANAPHASE#0.6796;TUMOR CELLS#0.6423;KINASE BINDING#0.6359;S-PHASE CHECKPOINT#0.6329;METAPHASE#0.6319
116511	SIGNALING PATHWAY#0.7428;BONE CANCER#0.6611;TYPE 1A DIABETES#0.6380
116512	ALANINE#1.0282;BETA-ALANINE#0.9967;DORSAL ROOT GANGLION#0.7919;NOXIOUS#0.6792;ACTION POTENTIAL#0.6519;CALCIUM MOBILIZATION#0.6315;SPINAL CORD#0.6296;SMOOTH MUSCLE#0.6162
116519	LIPID DROPLET#1.0737;LIPOPROTEIN BINDING#1.0601;TRIGLYCERIDE METABOLISM#1.0577;BINDING PROTEIN 1#1.0391;TYPE 2 DIABETIC#1.0310;OBESE#1.0307;LIPOPROTEIN LIPASE#1.0260;LIPOPROTEIN METABOLISM#1.0258;PEROXISOME#1.0211;MYOCARDIAL INFARCTION#1.0201;CORONARY ARTERY DISEASE#1.0176;ARTERY DISEASE#1.0175;GENE EXPRESSION#1.0174;FRAGMENT LENGTH POLYMORPHISM#1.0167;CORONARY HEART DISEASE#1.0153;CORONARY ARTERY#1.0136;LIPID BINDING#1.0134;HEART DISEASE#1.0117;VERY-LOW-DENSITY LIPOPROTEIN#1.0103;POLYMERASE CHAIN REACTION#1.0100;TYPE 2 DIABETES#1.0095;ARTERY#1.0087;C-LEVEL#1.0047;CHYLOMICRON#1.0037;LIPID METABOLISM#0.9975;ATHEROSCLEROSIS#0.9936;DIABETES MELLITUS#0.9931;LOW DENSITY LIPOPROTEIN#0.9910;LIPOLYSIS#0.9885;HIGH DENSITY LIPOPROTEIN#0.9877;FATTY LIVER#0.9670;WEIGHT LOSS#0.9632;HYPERTENSION#0.9588;TYPE 2 DIABETES MELLITUS#0.9585;2 DIABETES MELLITUS#0.9585;LDL PARTICLE#0.9576;HEPATIC LIPASE#0.9554;LIPOPROTEIN PARTICLE#0.9540;TRANSCRIPTION FACTOR#0.9530;ATHEROSCLEROTIC#0.9519;FENOFIBRATE#0.9481;ALCOHOLIC FATTY LIVER#0.9370;FATTY LIVER DISEASE#0.9328;PANCREATITIS#0.9280;HEPARIN#0.9276;LIVER DISEASE#0.9276;RHOPTRY#0.9273;ADIPOSE TISSUE#0.9168;CATABOLISM#0.8924;ACUTE PANCREATITIS#0.8840;CELL SURFACE#0.8837;LDL RECEPTOR#0.8789;TRIGLYCERIDE HOMEOSTASIS#0.8775;RECEPTOR BINDING#0.8763;ATORVASTATIN#0.8749;HIGH FAT DIET#0.8654;FAMILIAL COMBINED HYPERLIPIDEMIA#0.8647;C REACTIVE PROTEIN#0.8511;LIVER REGENERATION#0.8455;VITAMIN E#0.8370;LIPID HOMEOSTASIS#0.8342;LIPASE ACTIVITY#0.8318;HEPATOMA CELLS#0.8252;LIPID TRANSPORT#0.8234;ADIPOCYTE#0.8178;SIGNAL PEPTIDE#0.8140;FRAMINGHAM HEART STUDY#0.8036;CEREBRAL INFARCTION#0.8008;CYTOSOLIC LIPID DROPLETS#0.7992;SYSTOLIC BLOOD PRESSURE#0.7978;MESENCHYMAL STEM CELL#0.7882;PROTEOGLYCAN#0.7876;LIPOPROTEIN LIPASE ACTIVITY#0.7869;STEM CELL#0.7813;SIGNALING PATHWAY#0.7780;ACUTE MYOCARDIAL INFARCTION#0.7712;IMPAIRED FASTING GLUCOSE#0.7609;LIVER X RECEPTOR#0.7529;ENDOPLASMIC RETICULUM#0.7515;BETA CELL#0.7391;RESPONSE TO FENOFIBRATE#0.7315;ACUTE CORONARY SYNDROME#0.7282;INTIMA MEDIA THICKNESS#0.7101;MINOR ALLELE FREQUENCY#0.7060;MINOR ALLELE FREQUENCIES#0.6919;LINEAR REGRESSION ANALYSIS#0.6789;T CELL#0.6783;REGENERATION#0.6719;CHOLESTEROL METABOLISM#0.6585;HDL BINDING#0.6455;VLDL CLEARANCE#0.6435;FENOFIBRIC ACID#0.6246;METFORMIN#0.6231;SKELETAL MUSCLE#0.6227;GENETICALLY ENGINEERED MICE#0.6196;RESPONSE TO STATIN#0.6129;PPAR SIGNALING PATHWAY#0.6077;TOTAL ENERGY INTAKE#0.6043;PLASMA PROTEIN#0.6022;HARDY WEINBERG EQUILIBRIUM#0.6020
116534	INTESTINAL SCHISTOSOMIASIS#0.7037
116535	ANGIOTENSIN RECEPTOR#0.6611;INTESTINAL SCHISTOSOMIASIS#0.6315
1165	CEREBELLAR ATAXIA#1.0295
116710	ONCOGENIC#0.6472
1167	CEREBELLAR ATAXIA#1.0122;LEUCINE RICH REPEAT#0.6359;5'-AMP#0.6356
116832	RIBOSOMAL PROTEIN#0.7038
116833	PARATHYROID HORMONE#0.7158
116835	ENDOTHELIAL CELL#1.0868;HEAT SHOCK PROTEIN#1.0801;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9289;HUMAN UMBILICAL VEIN#0.9282;UMBILICAL VEIN#0.9279;APOPTOSIS#0.9046;SPINAL CORD#0.8468;ANGIOGENESIS#0.8113;MYOCARDIAL INFARCTION#0.8042;MYOCARDIUM#0.7207;ISCHEMIA REPERFUSION INJURY#0.7177;INFLAMMATORY RESPONSE#0.7132;LUNG CANCER#0.7119;CEREBRAL ARTERY OCCLUSION#0.6660;MIDDLE CEREBRAL ARTERY#0.6646;CEREBRAL ARTERY#0.6643;ISCHEMIA#0.6603;ACTIVE CASPASE 3#0.6492;CELL DEATH#0.6236;ASTROCYTE#0.6138;SPINAL CORD ISCHEMIA#0.6043
116840	DAUGHTER CENTRIOLE#1.1350;CENTRIOLE#1.1013;CENTRIOLE DUPLICATION#1.0915;CENTROSOME#1.0560;MICROTUBULE#0.9981;SPINDLE ASSEMBLY#0.8546;CELL CYCLE#0.7781;CENTRIOLE ELONGATION#0.7214;MOTHER CENTRIOLE#0.7201;CENTROSOME DUPLICATION#0.6783;MICROTUBULE NUCLEATION#0.6497;MITOTIC SPINDLE#0.6336;INTERPHASE#0.6236;MICROTUBULE FORMATION#0.6066
116841	VASCULAR ADHESION PROTEIN#1.0450;LIVER DISEASE#0.9198;ENDOTHELIAL CELL#0.8913;LYMPH NODE#0.7592;ADVANCED GLYCATION END#0.7437;CHRONIC LIVER DISEASE#0.7117;DIABETIC RETINOPATHY#0.6641;MONOAMINE OXIDASE ACTIVITY#0.6576;C REACTIVE PROTEIN#0.6505;LYMPH NODE METASTASIS#0.6273;CARDIOVASCULAR RISK FACTOR#0.6220;EXOCYTOSIS#0.6175;COLORECTAL CANCER#0.6171;LEUKOCYTE#0.6106
116842	IMMUNE SYSTEM#0.9718;INNATE IMMUNE SYSTEM#0.9468;PRO-INFLAMMATORY#0.9099;JEJUNUM#0.9086;DUODENUM#0.8921;GENE EXPRESSION#0.8891;ACID PHOSPHATASE#0.8688;IMMUNE RESPONSE#0.8553;TRANSFORMING GROWTH FACTOR#0.8423;GROWTH FACTOR#0.8382;INNATE IMMUNITY#0.8351;SUPEROXIDE DISMUTASE#0.7587;GROWTH HORMONE#0.7465;GROWTH HORMONE SECRETAGOGUE#0.7241;TARGET OF RAPAMYCIN#0.7171;SMALL INTESTINE#0.7171;GLUTATHIONE#0.6799;TUMOR NECROSIS FACTOR#0.6633;GLUTATHIONE PEROXIDASE#0.6476;SUGAR TRANSPORTER#0.6435;MONOCYTE#0.6400;TIGHT JUNCTION#0.6167;MONONUCLEAR CELLS#0.6098;SIGNALING MOLECULE#0.6069
116843	MAJOR FACILITATOR SUPERFAMILY#0.6376
116844	LEUCINE#1.0575;ANGIOGENESIS#1.0515;COLORECTAL CANCER#1.0330;GROWTH FACTOR#1.0262;SIGNALING PATHWAY#1.0079;COLORECTAL#0.9961;OVARIAN CANCER#0.9785;ENDOTHELIAL CELL#0.9654;CANCER CELL#0.9551;C REACTIVE PROTEIN#0.9207;APOPTOSIS#0.9151;TYPE 2 DIABETES#0.9104;CELL PROLIFERATION#0.9091;CELL WALL#0.8891;CELL MIGRATION#0.8564;OVARIAN#0.8548;TRANSFORMING GROWTH FACTOR#0.8338;PANCREATIC CANCER#0.8321;ALPHA 1-ANTITRYPSIN#0.8267;GENE EXPRESSION#0.8178;CELL CYCLE#0.7992;PLASMA PROTEIN#0.7877;CYTOCHROME C#0.7660;RETINOL BINDING#0.7626;LUNG CANCER#0.7483;VITAMIN D BINDING#0.7173;RHEUMATOID ARTHRITIS#0.7122;APOPTOTIC#0.6917;ABDOMINAL PAIN#0.6884;HEPATOCELLULAR CARCINOMA#0.6873;EPIDERMAL GROWTH FACTOR#0.6752;GROWTH FACTOR RECEPTOR#0.6752;CELL WALL INTEGRITY#0.6745;URINARY PROTEIN#0.6697;NORMAL PRESSURE HYDROCEPHALUS#0.6608;BETA-2#0.6335;TUMOR NECROSIS FACTOR#0.6235;TUMOR TISSUES#0.6152;FACTOR I#0.6131;TRADITIONAL RISK FACTORS#0.6117;B CELL#0.6086;EPITHELIAL CELL#0.6082;RETINOL#0.6077
116931	INTELLECTUAL DISABILITY#0.6736
116933	SIGNALING PATHWAY#0.8958;PROLACTINOMA#0.6605;AUTOPHAGY#0.6475
116937	CHEMOTAXIS#0.6975;LEUKOCYTE#0.6253;CHEMOKINE RECEPTOR#0.6192
116969	TIM23 COMPLEX#0.6595
116983	GAP ACTIVITY#0.7221;NEURONAL MIGRATION#0.7051;NEURITE OUTGROWTH#0.7002;CEREBRAL CORTEX#0.6958;NERVOUS SYSTEM#0.6874
116984	FOCAL ADHESION#0.9708;GAP ACTIVITY#0.6800;ARF GAP ACTIVITY#0.6230
116985	TYPE 2 DIABETES#0.9678;GAP ACTIVITY#0.9020;GROWTH FACTOR#0.8826;EARLY ENDOSOME#0.7902;PLASMA MEMBRANE#0.7759;EPIDERMAL GROWTH FACTOR#0.7758;GROWTH FACTOR RECEPTOR#0.7758;ENDOSOME#0.7656;ANTISENSE RNA#0.7213;SIGNALING PATHWAY#0.7192;MESANGIAL CELL#0.7155;ARF GAP ACTIVITY#0.7000
116986	KINASE ACTIVITY#1.0345;CANCER CELL#1.0126;GTP BINDING#0.9372;GROWTH FACTOR#0.9155;APOPTOSIS#0.8995;PROTEIN KINASE#0.8937;PROSTATE CANCER#0.8237;GTPASE ACTIVITY#0.7819;CELL PROLIFERATION#0.7450;FOCAL ADHESION#0.7336;GUANINE#0.7257;ENDOSOME#0.7054;STEM CELL#0.6936;SIGNALING PATHWAY#0.6929;NUCLEOTIDE EXCHANGE FACTOR#0.6830;GENE EXPRESSION#0.6641;HIGH FAT DIET#0.6522;EPIDERMAL GROWTH FACTOR#0.6487;LIPID OXIDATION#0.6293;PI3K SIGNALING#0.6290;ADIPOSE TISSUE#0.6260;ROS GENERATION#0.6212;SQUAMOUS CELL CARCINOMA#0.6139;AKT SIGNALING#0.6133;GLUTAMATE RECEPTOR#0.6101;CELL DEATH#0.6046
116987	GAP ACTIVITY#0.7103;GTP BINDING#0.6964;PROTEIN COMPLEX#0.6530;ENDOCYTIC RECYCLING#0.6160
116988	AMPA RECEPTOR#0.6612;RECEPTOR COMPLEX#0.6587;NMDA RECEPTOR#0.6547
116	NEURAL STEM CELL#1.0638;CATECHOLAMINE SECRETION#1.0618;AMP FORMATION#1.0601;PINEAL GLAND#1.0575;GRANULOSA CELL#1.0567;GERM CELL#1.0513;RETINAL DEGENERATION#1.0508;CHROMAFFIN CELL#1.0482;NEURONAL CELL DEATH#1.0458;CAMP FORMATION#1.0450;MELATONIN#1.0449;PROGESTERONE#1.0445;BETA CELL#1.0443;NEURITE OUTGROWTH#1.0440;CANCER CELL#1.0437;ADENYLATE CYCLASE ACTIVITY#1.0431;PERIPHERAL NERVOUS SYSTEM#1.0428;RECEPTOR INTERNALIZATION#1.0424;HORMONE SECRETION#1.0415;INSULIN SECRETION#1.0411;TRAUMATIC BRAIN INJURY#1.0405;CASPASE-3 ACTIVITY#1.0394;CALCIUM CHANNEL#1.0393;PACAP RECEPTOR#1.0390;LUNG CANCER#1.0390;FEEDING BEHAVIOR#1.0374;ACID SECRETION#1.0370;NEUROBLASTOMA#1.0369;ETHANOL#1.0361;ARGININE VASOPRESSIN#1.0355;NEURITE#1.0351;HYPOXIA#1.0349;MAP KINASE#1.0338;TOXICITY#1.0336;HISTAMINE#1.0334;MIGRAINE#1.0319;ASTROCYTE#1.0318;NEURONAL CELLS#1.0315;RETINAL GANGLION CELL#1.0314;CEREBRAL ISCHEMIA#1.0312;SPINAL CORD#1.0312;BLOOD BRAIN BARRIER#1.0311;VASOPRESSIN#1.0303;KINASE INHIBITOR#1.0298;MAST CELL#1.0295;ADENYLATE CYCLASE#1.0295;ADENYLATE#1.0293;MACROPHAGE#1.0286;ADIPOCYTE#1.0281;GLIAL CELL#1.0277;ADRENAL MEDULLA#1.0277;NEUROPROTECTION#1.0274;OPTIC NERVE#1.0274;PRO-INFLAMMATORY#1.0270;ACETYLCHOLINE#1.0270;STEM CELL#1.0266;SUBSTANCE P#1.0266;CELL DIFFERENTIATION#1.0265;CYCLASE ACTIVITY#1.0263;NEUROBLAST#1.0261;VASODILATION#1.0257;REGENERATION#1.0256;URINARY BLADDER#1.0255;CELL CYCLE#1.0249;MEDULLARY CELL#1.0249;NMDA RECEPTOR#1.0246;OVARIAN#1.0241;GASTROINTESTINAL TRACT#1.0241;PANCREATIC ISLET#1.0239;NITRIC OXIDE SYNTHASE#1.0238;AMYGDALA#1.0235;IMMUNE SYSTEM#1.0229;HISTIDINE#1.0224;LEYDIG CELL#1.0223;GANGLION CELLS#1.0222;CAMP RESPONSE ELEMENT#1.0221;PITUITARY GLAND#1.0217;CORTICOTROPIN#1.0209;GROWTH HORMONE#1.0207;NERVE TERMINAL#1.0206;ISCHEMIA#1.0205;SPINAL CORD INJURY#1.0204;PARKINSON'S DISEASE#1.0201;VASODILATOR#1.0200;CEREBRAL CORTEX#1.0197;ADRENAL GLAND#1.0196;ACTION POTENTIAL#1.0182;BRAIN DEVELOPMENT#1.0178;REVERSE TRANSCRIPTION#1.0175;PHEOCHROMOCYTOMA#1.0165;INFLAMMATORY RESPONSE#1.0162;GLUCAGON SECRETION#1.0157;SUDDEN INFANT DEATH SYNDROME#1.0151;NEURODEGENERATIVE DISEASE#1.0149;CYCLIC ADENOSINE MONOPHOSPHATE#1.0146;NITRIC OXIDE#1.0144;CELL PROLIFERATION#1.0144;EPITHELIAL CELL#1.0141;RENAL ISCHEMIA REPERFUSION#1.0138;NERVE FIBER#1.0138;CENTRAL NERVOUS SYSTEM#1.0137;APOPTOTIC#1.0135;T CELL#1.0134;PROGENITOR CELL#1.0133;CAMP SIGNALING#1.0131;ADIPOSE TISSUE#1.0130;PHOSPHOLIPASE C#1.0129;ADENOSINE MONOPHOSPHATE#1.0129;DOPAMINE#1.0123;GONADOTROPIN RELEASING HORMONE#1.0121;CEREBELLAR GRANULE NEURON#1.0118;SCIATIC NERVE#1.0116;OOCYTE#1.0114;NERVOUS SYSTEM#1.0108;FOLLICLE STIMULATING HORMONE#1.0105;SMOOTH MUSCLE CELL#1.0103;SIGNALING CASCADE#1.0102;CERVICAL#1.0100;ISOPROTERENOL#1.0094;CELL DEATH#1.0090;ENDOTHELIAL CELL#1.0087;EPINEPHRINE#1.0085;SMOOTH MUSCLE#1.0077;APOPTOSIS#1.0077;ATROPINE#1.0076;PROTEIN KINASE C#1.0069;ARGININE#1.0067;SIGNALING PATHWAY#1.0067;IMMUNE RESPONSE#1.0062;FORSKOLIN#1.0061;POLYMERASE CHAIN REACTION#1.0060;OVULATION#1.0058;IL-6 PRODUCTION#1.0058;EPIDERMAL GROWTH FACTOR#1.0052;CIRCADIAN RHYTHM#1.0049;MITOGEN ACTIVATED PROTEIN#1.0048;CYCLIC AMP#1.0048;CILIARY GANGLION#1.0047;GROWTH FACTOR#1.0046;NERVE GROWTH FACTOR#1.0041;SYNAPTIC TRANSMISSION#1.0041;SIGNALLING PATHWAY#1.0035;CORTICOTROPIN-RELEASING FACTOR#1.0034;MUSCLE CELL#1.0032;TRANSCRIPTION FACTOR#1.0031;BLOOD VESSEL#1.0030;CHOLERA#1.0030;GENE EXPRESSION#1.0027;ADENOSINE#1.0027;IMMUNE CELL#1.0024;PROTEIN KINASE A#1.0023;PROTEIN SYNTHESIS#1.0009;ISOLEUCINE#1.0009;RECEPTOR ANTAGONIST#1.0005;STEROIDOGENESIS#0.9996;PERTUSSIS#0.9995;SIGNAL TRANSDUCTION#0.9992;INNERVATION#0.9987;NEUROTRANSMISSION#0.9975;DENTATE GYRUS#0.9965;INSULIN-LIKE GROWTH FACTOR#0.9962;MICTURITION#0.9956;ARTERY#0.9954;RETINAL DAMAGE#0.9947;INTRACELLULAR SIGNALING PATHWAY#0.9946;TUMOR NECROSIS FACTOR#0.9943;RECEPTOR AGONIST#0.9936;PROTEIN KINASE#0.9936;CARBACHOL#0.9933;PIGMENT EPITHELIAL CELL#0.9923;PLASMA MEMBRANE#0.9916;NOREPINEPHRINE#0.9915;CEREBRAL ARTERY#0.9914;L-ARGININE#0.9903;THYROTROPIN RELEASING HORMONE#0.9899;RETINAL PIGMENT EPITHELIAL#0.9897;EDEMA#0.9895;MECHANISM OF ACTION#0.9880;NITRO-L-ARGININE#0.9875;BONE MARROW#0.9866;PARATHYROID HORMONE#0.9853;FOREBRAIN#0.9840;NORADRENALINE#0.9830;TYPE 2 DIABETES#0.9829;NEUROENDOCRINE CELL#0.9815;KINASE ACTIVITY#0.9808;MONOCYTE#0.9805;DIABETIC RETINOPATHY#0.9802;GONAD#0.9801;ENERGY HOMEOSTASIS#0.9801;RECEPTOR BINDING#0.9797;CELL GROWTH#0.9795;ENDOCRINE CELL#0.9795;GASTRIC ACID SECRETION#0.9787;SPERMATOGENESIS#0.9782;DOPAMINERGIC NEURON#0.9776;NOCICEPTION#0.9768;NEUROGENESIS#0.9766;MECHANISMS OF ACTION#0.9761;APOPTOTIC CELL DEATH#0.9753;DIENCEPHALON#0.9746;DNA SYNTHESIS#0.9732;CRE BINDING#0.9728;ALZHEIMER'S DISEASE#0.9679;ACUTE PANCREATITIS#0.9673;TRANSCRIPTASE#0.9669;IFN-GAMMA#0.9663;TRANSFORMING GROWTH FACTOR#0.9649;CAMP RESPONSE ELEMENT BINDING#0.9649;LYMPHOID ORGANS#0.9648;ESTRADIOL#0.9645;MIDDLE CEREBRAL ARTERY#0.9635;NEUROTOXICITY#0.9630;PURKINJE CELL#0.9628;REACTIVE OXYGEN SPECIES#0.9626;GROWTH HORMONE SECRETION#0.9625;ADRENALINE#0.9614;PITUITARY ADENOMA#0.9594;PHOSPHODIESTERASE#0.9591;INFLAMMATORY CELL#0.9587;NIFEDIPINE#0.9582;CD4+ T CELL#0.9537;ESTROUS CYCLE#0.9535;CHOLINERGIC NEURON#0.9534;PHENYLETHANOLAMINE N METHYLTRANSFERASE#0.9501;ACINAR CELL#0.9497;HYPERACTIVITY#0.9495;TRANSACTIVATION#0.9492;N METHYLTRANSFERASE#0.9449;CALCIUM MOBILIZATION#0.9445;TESTOSTERONE#0.9439;TRANSIENT RECEPTOR POTENTIAL#0.9438;PARATHYROID#0.9434;PHOSPHODIESTERASE INHIBITOR#0.9428;MELATONIN SYNTHESIS#0.9424;ASPARTATE#0.9413;MEMBRANE DEPOLARIZATION#0.9413;STROMAL CELL#0.9398;CHOLINE#0.9380;MULTIPLE SCLEROSIS#0.9379;HYPOTHALAMIC PITUITARY ADRENAL#0.9375;ASTROCYTE DIFFERENTIATION#0.9359;SECRETIN RECEPTOR#0.9329;ADENYLATE CYCLASE ACTIVATION#0.9329;ACTH SECRETION#0.9324;CELL SURFACE#0.9306;ALDOSTERONE#0.9295;HYPOXIC#0.9291;TETRODOTOXIN#0.9273;SUBSTANTIA NIGRA#0.9270;PERIPHERAL NERVE#0.9267;GONADOTROPIN SECRETION#0.9228;PYRAMIDAL CELL#0.9206;LOWER URINARY TRACT#0.9205;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9194;RETINAL PIGMENT EPITHELIAL CELLS#0.9186;OLFACTORY BULB#0.9175;POST-TRAUMATIC STRESS DISORDER#0.9175;DUODENUM#0.9174;CELL MEMBRANE#0.9171;CHEMOKINE PRODUCTION#0.9167;PSYCHOMOTOR BEHAVIOR#0.9137;ION CHANNEL#0.9130;CELL MIGRATION#0.9125;HAIR CELL#0.9111;NEURONAL CELL BODIES#0.9099;TELENCEPHALON#0.9086;CAROTID ARTERY#0.9077;PERIPHERAL BLOOD#0.9064;ISCHEMIA REPERFUSION INJURY#0.9049;METHIONINE#0.9045;GALLBLADDER#0.9039;DNA BINDING#0.9038;CYSTITIS#0.9035;ACETYLCHOLINE RECEPTOR#0.9031;NEUROHORMONE#0.9002;PKC ACTIVATION#0.9000;CARDIOMYOCYTE#0.8971;SALIVARY GLAND#0.8964;CARDIOVASCULAR SYSTEM#0.8956;SENSITIZATION#0.8924;SIGNALING MOLECULE#0.8913;AMYLASE SECRETION#0.8900;PRECURSOR CELL#0.8887;STREPTOZOTOCIN#0.8871;NEUROPEPTIDE RECEPTOR#0.8870;THALAMUS#0.8860;CELLULAR LOCALIZATION#0.8853;LACRIMAL GLAND#0.8842;NEURAL CELL#0.8842;PREPULSE INHIBITION#0.8834;CAROTID ARTERY OCCLUSION#0.8831;PEPTIDE HORMONE#0.8823;ENDOTHELIUM#0.8801;HYPERTENSION#0.8798;LARGE INTESTINE#0.8792;NEUTROPHIL#0.8783;CEREBRAL ARTERY OCCLUSION#0.8774;LIPID METABOLISM#0.8768;INNER EAR#0.8764;STRIATUM#0.8749;THYMIDINE#0.8716;ADENYLYL CYCLASE ACTIVITY#0.8712;3-ISOBUTYL-1-METHYLXANTHINE#0.8706;CAFFEINE#0.8677;PANCREATITIS#0.8673;REPRODUCTIVE SYSTEM#0.8657;GUANYLATE CYCLASE#0.8644;PROSTATE CANCER#0.8636;RECEPTOR LIGAND#0.8605;CYTOTOXICITY#0.8576;PLATELET AGGREGATION#0.8574;DEXAMETHASONE#0.8565;CAMP SYNTHESIS#0.8552;NEUROTOXIC#0.8540;MYOCYTES#0.8534;FSH SECRETION#0.8520;OVARIES#0.8516;SIGNAL PEPTIDE#0.8515;BROWN ADIPOSE TISSUE#0.8471;IL-6 SECRETION#0.8466;ENDOCYTOSIS#0.8458;ANXIETY DISORDER#0.8434;TUMOR CELLS#0.8430;OOCYTE MATURATION#0.8430;DORSAL ROOT GANGLION#0.8409;ADRENAL CORTEX#0.8350;PANCREATIC CARCINOMA#0.8340;TACHYKININ#0.8314;MAMMARY GLAND#0.8297;GLUCOSE UPTAKE#0.8294;PROPRANOLOL#0.8282;MOTOR ACTIVITY#0.8274;B CELL#0.8270;COMMON CAROTID ARTERY#0.8264;MEDULLA OBLONGATA#0.8244;EXOCYTOSIS#0.8243;ENTERIC NERVOUS SYSTEM#0.8234;SUPEROXIDE DISMUTASE#0.8227;ADRENERGIC RECEPTOR#0.8219;GROWTH FACTOR RECEPTOR#0.8210;NICOTINIC ACETYLCHOLINE RECEPTOR#0.8191;LONG TERM POTENTIATION#0.8178;BREAST CANCER#0.8171;CYTOKINE PRODUCTION#0.8171;FIBROBLAST GROWTH FACTOR#0.8163;HIGH FAT DIET#0.8130;ENDOCRINE SYSTEM#0.8126;SODIUM NITROPRUSSIDE#0.8104;ENDOPLASMIC RETICULUM#0.8094;TH2 CELL#0.8085;CAROTID BODY#0.8080;GLUCOSE HOMEOSTASIS#0.8070;DNA FRAGMENTATION#0.8052;FORCED SWIM TEST#0.8046;4-AMINOPYRIDINE#0.8036;SMALL INTESTINE#0.8035;GLUTATHIONE#0.7997;LATERAL VENTRICLE#0.7989;OVARIAN FOLLICLE#0.7968;HYPERSENSITIVITY#0.7938;OPIOID PEPTIDE#0.7937;LANGERHANS CELL#0.7926;LATERAL SCLEROSIS#0.7920;DNA METHYLATION#0.7914;CATECHOLAMINE SYNTHESIS#0.7914;CYTOCHROME C#0.7903;SPERM MOTILITY#0.7901;CARDIAC ARREST#0.7895;NITROPRUSSIDE#0.7887;CORPUS LUTEUM#0.7877;THYROID GLAND#0.7853;SYNOVIAL FLUID#0.7851;PROTEIN KINASE A SIGNALING#0.7844;NEPHROTIC SYNDROME#0.7838;BREAST CANCER CELL#0.7837;FERTILIZATION#0.7824;FOCAL CEREBRAL ISCHEMIA#0.7824;INTERSTITIAL CELL#0.7820;SEPTUM#0.7815;GUANOSINE#0.7812;NEURONAL MIGRATION#0.7810;PROLACTIN SECRETION#0.7809;AKT SIGNALING#0.7804;MULTIPLE MYELOMA#0.7778;AMYOTROPHIC LATERAL SCLEROSIS#0.7768;TEAR SECRETION#0.7764;BETA-2#0.7761;GLUTAMATE RECEPTOR#0.7759;PROESTRUS#0.7758;EMBRYONIC STEM CELL#0.7755;CALCINEURIN#0.7751;CCK SECRETION#0.7735;DENDRITIC CELL#0.7735;ALDOSTERONE SECRETION#0.7713;T LYMPHOCYTE#0.7712;CATECHOLAMINE BIOSYNTHESIS#0.7709;ACROSOME#0.7684;NEPHROPATHY#0.7648;REGULATION OF GROWTH#0.7645;INTRACELLULAR SIGNAL TRANSDUCTION#0.7633;REGULATION OF FEEDING BEHAVIOR#0.7632;ANTIGEN PRESENTING CELLS#0.7624;STRUCTURE ACTIVITY RELATIONSHIP#0.7624;PROSTAGLANDIN E2#0.7621;OPTIC NERVE CRUSH#0.7610;CYCLOOXYGENASE PATHWAY#0.7587;MIDBRAIN#0.7578;INDOMETHACIN#0.7560;GESTATION#0.7553;HYPERGLYCEMIA#0.7551;ACTIVATOR PROTEIN 1#0.7520;REGULATION OF INSULIN SECRETION#0.7520;ENDOTHELIAL GROWTH FACTOR#0.7509;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7509;AUTOIMMUNE DISEASE#0.7506;GLUCAGON RECEPTOR#0.7503;OLIGODENDROCYTE#0.7489;BLOOD TESTIS BARRIER#0.7488;OLFACTORY RECEPTOR#0.7479;NOVEL OBJECT RECOGNITION#0.7471;HALOPERIDOL#0.7464;MELANOCYTE#0.7449;TOLL LIKE RECEPTOR#0.7443;HUMAN CORNEAL ENDOTHELIAL#0.7432;HETEROTRIMERIC G-PROTEIN#0.7429;RESPONSE TO HYPOXIA#0.7426;HATCHING#0.7403;ELEVATED PLUS MAZE#0.7397;RESPONSE TO STRESS#0.7390;SOCIAL BEHAVIOR#0.7375;DIPEPTIDYL PEPTIDASE#0.7362;ADENYLATE CYCLASE ACTIVATOR#0.7359;GASTRIC GLAND#0.7339;QUANTITATIVE REAL TIME#0.7324;NALOXONE#0.7311;ANGIOGENESIS#0.7301;NEUROHYPOPHYSIS#0.7295;STEM CELL PROLIFERATION#0.7278;CORTISOL#0.7270;TOOTH DEVELOPMENT#0.7261;LACTATION#0.7257;CYTOPLASM#0.7251;HINDBRAIN#0.7235;CGRP RECEPTOR#0.7228;OPIOID RECEPTOR#0.7191;DIABETIC NEPHROPATHY#0.7190;NERVE ENDING#0.7189;AMYLOID PRECURSOR PROTEIN#0.7188;AORTIC SMOOTH MUSCLE CELLS#0.7186;REGULATION OF GENE EXPRESSION#0.7181;CATION CHANNEL#0.7166;DIABETES MELLITUS#0.7156;EPIDIDYMIS#0.7152;STAUROSPORINE#0.7141;TRANSFORMING GROWTH FACTOR BETA#0.7125;PROGRAMMED CELL DEATH#0.7124;GLUCOSE METABOLISM#0.7121;MITOCHONDRIA#0.7108;STEROIDOGENIC FACTOR 1#0.7106;ADENYLATE CYCLASE INHIBITOR#0.7096;HYPERTHERMIA#0.7063;NEURAL PROGENITOR CELL#0.7053;DIURNAL#0.7031;LASER SCANNING MICROSCOPY#0.7021;CHANNEL ACTIVITY#0.7016;BIPOLAR DISORDER#0.7000;GUANINE#0.6997;PHOSPHOLIPASE C ACTIVATION#0.6993;OBESE#0.6989;STIMULATION OF GROWTH#0.6989;WEIGHT GAIN#0.6972;ADRENOCORTICOTROPIC HORMONE#0.6971;ACTION POTENTIAL FIRING#0.6966;ASSOCIATIVE LEARNING#0.6965;WEIGHT LOSS#0.6965;MOLAR#0.6945;SUCROSE#0.6944;FRONTAL#0.6932;RECEPTOR ACTIVITY#0.6927;LASER DESORPTION IONIZATION#0.6926;CELL PENETRATING PEPTIDE#0.6917;EDINGER-WESTPHAL NUCLEUS#0.6908;DIFFUSE AXONAL INJURY#0.6906;CATECHOLAMINE BIOSYNTHETIC#0.6899;SPINAL DORSAL HORN#0.6894;PRESYNAPTIC TERMINAL#0.6893;PHENTOLAMINE#0.6891;GLOMUS CELL#0.6850;INTERNEURON#0.6835;SECRETORY GRANULE#0.6835;GTP BINDING#0.6823;FORMALIN#0.6818;SCHWANN CELL#0.6816;URINARY SYSTEM#0.6813;OSTEOBLAST#0.6778;EXTRACELLULAR MATRIX#0.6776;LUTEINIZATION#0.6763;MELANOCORTIN RECEPTOR#0.6756;RESPIRATORY SYSTEM#0.6747;INGENUITY PATHWAY ANALYSIS#0.6741;INTESTINAL MOTILITY#0.6734;BRAIN ISCHEMIA#0.6725;BLOOD GLUCOSE LEVEL#0.6715;ION TRANSPORT#0.6697;RECEPTOR TYROSINE KINASE#0.6685;GI TRACT#0.6678;INTESTINAL TRACT#0.6668;QUANTITATIVE REVERSE TRANSCRIPTION#0.6666;HORMONE BINDING#0.6664;BRAIN EDEMA#0.6661;DOPAMINE RECEPTOR#0.6659;MICROVASCULAR ENDOTHELIAL CELL#0.6659;ATRIAL FIBRILLATION#0.6658;CISPLATIN#0.6657;BIOTIN#0.6636;HUNTINGTON'S DISEASE#0.6626;IL-10 PRODUCTION#0.6626;INNATE IMMUNITY#0.6626;FOCAL ADHESION KINASE#0.6607;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6607;INOSITOL PHOSPHATE FORMATION#0.6600;FOCAL ADHESION#0.6575;G1 PHASE#0.6572;RECEPTOR COMPLEX#0.6540;VERAPAMIL#0.6518;PUBERTY#0.6509;L-DOPA#0.6504;AMPA RECEPTOR#0.6498;ANORECTIC#0.6479;ADRENALINE SECRETION#0.6471;PROTEIN KINASE INHIBITOR#0.6461;HISTOGENESIS#0.6448;BRAIN DAMAGE#0.6447;SODIUM CHANNEL#0.6440;ADENINE#0.6440;SIGNAL TRANSDUCER#0.6409;5-HT SECRETION#0.6396;INDUCIBLE NITRIC OXIDE#0.6393;ALKALINE PHOSPHATASE#0.6384;CONTEXTUAL FEAR CONDITIONING#0.6350;ERGIC#0.6318;HYPERGLYCEMIC#0.6302;RESPONSE TO GLUCOSE#0.6300;GLOBAL CEREBRAL ISCHEMIA#0.6299;COGNITION#0.6279;KERATINIZATION#0.6278;SUPERIOR COLLICULUS#0.6274;NEURITE EXTENSION#0.6270;ZINC FINGER PROTEIN#0.6263;RETINAL ISCHEMIA#0.6259;L-TYPE CALCIUM CHANNEL#0.6253;EXTRACELLULAR REGULATED KINASE#0.6248;EARLY GROWTH RESPONSE#0.6241;TUBULAR EPITHELIAL CELL#0.6238;CASPASE ACTIVITY#0.6233;INTERNEURON MIGRATION#0.6227;MOOD DISORDER#0.6226;HEMORRHAGE#0.6224;MELANIN CONCENTRATING HORMONE#0.6216;CHANNEL INHIBITOR#0.6202;AMACRINE CELL#0.6202;SPERMATOCYTES#0.6196;NG-NITRO-L-ARGININE#0.6196;CILIARY NEUROTROPHIC FACTOR#0.6193;LUTEINIZING GRANULOSA CELL#0.6192;SERTOLI CELL#0.6189;LINES OF EVIDENCE#0.6185;CORTICOTROPHIN#0.6178;NICARDIPINE#0.6169;NOS INHIBITOR#0.6164;DODECYL SULFATE#0.6164;SODIUM DODECYL SULFATE#0.6164;LYMPH NODE#0.6141;MEMBRANE FRACTION#0.6140;OSTEOARTHRITIS#0.6135;RHEUMATOID ARTHRITIS#0.6132;NUCLEOTIDE BINDING#0.6131;ESTROGEN RECEPTOR#0.6130;CARDIOMYOPATHY#0.6127;TENSION TYPE HEADACHE#0.6122;DOXORUBICIN#0.6121;PEPTIDE SECRETION#0.6113;CORTICOSTERONE SECRETION#0.6112;URETHANE#0.6111;FACTOR I#0.6098;SUPERIOR FRONTAL GYRUS#0.6095;INSULINOMA#0.6093;ACTIVATION OF MAP KINASE#0.6088;TACHYCARDIA#0.6082;TOPICAL#0.6055;SWEAT GLAND#0.6053;VASOPRESSIN RECEPTOR#0.6051;GLYCINE#0.6043;STRESS URINARY INCONTINENCE#0.6041;LASER CAPTURE MICRODISSECTION#0.6035;DIPEPTIDYL PEPTIDASE IV#0.6030;OXYGEN GLUCOSE DEPRIVATION#0.6016;VOLTAGE-SENSITIVE CALCIUM CHANNEL#0.6007
117143	ADENOSINE DEAMINASE#1.0096;ADENOSINE#1.0096;2'-DEOXYADENOSINE#0.9971;ADENOSINE DEAMINASE ACTIVITY#0.9804;DEAMINASE ACTIVITY#0.9789;MONOCYTE#0.8674;DEOXYADENOSINE#0.8635;TUBERCULOSIS#0.8509;PERIPHERAL BLOOD#0.8470;TRANSCRIPTION FACTOR#0.8273;T CELL#0.8169;ADENINE#0.7908;PURINE METABOLISM#0.7678;CORONARY ARTERY DISEASE#0.7614;ARTERY DISEASE#0.7610;CORONARY ARTERY#0.7579;TYPE 1 DIABETES#0.7538;CELL-MEDIATED IMMUNITY#0.7133;ERYTHROCYTE#0.7038;ENZYME ACTIVITY#0.6894;DIABETES MELLITUS#0.6808;RHEUMATOID ARTHRITIS#0.6389;ACID PHOSPHATASE#0.6372;SEVERE COMBINED IMMUNODEFICIENCY#0.6372;MACROPHAGE#0.6331;PULMONARY TUBERCULOSIS#0.6121;IMMUNE SYSTEM#0.6050
117144	CATSPER CHANNEL#1.1041;PROGESTERONE#1.0729;CALCIUM CHANNEL#1.0613;CATION CHANNEL#1.0503;ION CHANNEL#1.0396;SPERM MOTILITY#1.0365;SPERMATOZOA#1.0341;GENE EXPRESSION#1.0267;FLAGELLUM#1.0090;ACROSOME REACTION#1.0058;FERTILIZATION#1.0019;SPERM TAIL#0.9953;SPERM FLAGELLUM#0.9933;INFERTILITY#0.9825;MALE INFERTILITY#0.9751;ACROSOME#0.9736;PLASMA MEMBRANE#0.9467;TRANSCRIPTION FACTOR#0.9299;SPERM COMPETITION#0.8617;INFERTILE#0.8519;ZONA PELLUCIDA#0.8378;SEMEN#0.7837;MIBEFRADIL#0.7249;OOCYTE#0.6981;POLYMERASE CHAIN REACTION#0.6974;CHANNEL ACTIVITY#0.6945;SPERMATOGENESIS#0.6904;SIGNALING PATHWAY#0.6839;SPERM CAPACITATION#0.6488;SOLUBLE ADENYLYL CYCLASE#0.6441;CYCLOPHOSPHAMIDE#0.6412;INTRACELLULAR ALKALINIZATION#0.6335;QUANTITATIVE REAL TIME#0.6178;CHEMOTAXIS#0.6151;SPERM ACTIVATION#0.6063;EPIDIDYMIS#0.6045
117145	APOPTOSIS#0.9507;PROTEIN KINASE B#0.9360;PROTEIN KINASE#0.9275;LUNG CANCER#0.9133;AKT SIGNALING#0.9019;MITOCHONDRIA#0.7930;CANCER CELL#0.7888;AKT BINDING#0.7734;TUMOR SUPPRESSOR#0.7534;ACYL COA THIOESTERASE#0.7497;SIGNALING PATHWAY#0.7186;HEAT SHOCK PROTEIN#0.7082;MITOCHONDRIAL LOCALIZATION#0.6504;PLASMA MEMBRANE#0.6263;APOPTOTIC#0.6221;CELL CYCLE#0.6176;ONCOGENIC#0.6073;PKB SIGNALING#0.6059;PROTEIN KINASE B SIGNALING#0.6049
117151	CELL SURFACE#0.6558;ENDOCYTOSIS#0.6329;PLASMA MEMBRANE#0.6248;SECRETORY PATHWAY#0.6222
117154	GENE EXPRESSION#0.8888;OVARIAN CANCER#0.8136;SKELETAL MUSCLE#0.7879;CANCER CELL#0.7740;OVARIAN#0.7225;TRANSCRIPTION FACTOR#0.7108;PERITONEAL MESOTHELIOMA#0.6184;FALLOPIAN TUBES#0.6048
117155	MALE INFERTILITY#0.9942;SPERM MOTILITY#0.9716;INFERTILITY#0.9398;CATION CHANNEL#0.9251;ION CHANNEL#0.8623;SPERMATOZOA#0.8575;FERTILIZATION#0.7682
117156	RELATED PROTEIN 1#1.1168;ALLERGIC AIRWAY INFLAMMATION#0.9754;EPITHELIAL CELL#0.9643;TRANSCRIPTION FACTOR#0.9428;CLARA CELL#0.9417;PULMONARY FIBROSIS#0.9404;GRAVES' DISEASE#0.9292;GENE EXPRESSION#0.8374;EMBRYONIC LUNG#0.8169;GROWTH FACTOR#0.8081;LUNG DEVELOPMENT#0.7166;ADENOCARCINOMA#0.7065;TRACHEA#0.6623;BLEOMYCIN#0.6167;INFLAMMATORY CELL#0.6123;RHINITIS#0.6086;SPUTUM#0.6086
117157	SLAM ASSOCIATED PROTEIN#1.0631;IMMUNE RESPONSE#1.0329;T CELL#0.9552;SIGNALING PATHWAY#0.9102;ADAPTIVE IMMUNE RESPONSE#0.8739;IMMUNE SYSTEM#0.8688;CYTOTOXICITY#0.8626;IMMUNE CELL#0.8546;NATURAL KILLER CELL#0.8468;INNATE IMMUNE SYSTEM#0.8211;B CELL#0.8135;CELL ACTIVATION#0.7976;DENDRITIC CELL#0.7941;LYMPHOCYTE ACTIVATION#0.7486;CELL SURFACE#0.7375;TRANSCRIPTION FACTOR#0.7229;SUPEROXIDE DISMUTASE#0.6847;NK CELL ACTIVATION#0.6830;HEMATOPOIETIC CELL#0.6451;SIGNAL TRANSDUCTION#0.6305;CELLULAR IMMUNE RESPONSE#0.6127;PHOSPHOLIPASE C#0.6041;INNATE IMMUNE RESPONSE#0.6033
117159	PROTEOLYSIS INDUCING FACTOR#1.0824;MYOTUBE#1.0746;SWEAT GLAND#1.0544;PROTEIN DEGRADATION#1.0424;PROTEASOME#1.0346;UBIQUITIN#1.0261;CANCER CELL#1.0244;CACHEXIA#1.0226;PROTEASOME PATHWAY#1.0209;PROTEIN SYNTHESIS#1.0207;CACHECTIC#1.0203;SKELETAL MUSCLE#1.0169;TRANSCRIPTION FACTOR#1.0162;EICOSAPENTAENOIC ACID#1.0088;BREAST CANCER#1.0044;PROTEIN KINASE#0.9995;SALICYLIC ACID#0.9954;WEIGHT LOSS#0.9929;UBIQUITIN PROTEASOME PATHWAY#0.9925;GENE EXPRESSION#0.9819;PROTEIN CATABOLISM#0.9443;TUMOR NECROSIS FACTOR#0.9320;CATABOLISM#0.9045;PANCREATIC CANCER#0.9018;ENZYME ACTIVITY#0.8930;PROSTATE CANCER#0.8824;ISCHEMIA#0.8703;SIGNALING PATHWAY#0.8627;MACROPHAGE#0.8584;MYOBLAST#0.8507;DCMP DEAMINASE#0.8497;MODE OF ACTION#0.8484;LUNG CANCER#0.8461;NITRIC OXIDE#0.8453;ASPIRIN#0.8385;FACTOR I#0.8065;HEART DISEASE#0.8001;ISCHEMIC HEART DISEASE#0.7996;IMMUNE SYSTEM#0.7887;TUMOUR NECROSIS FACTOR#0.7885;INNATE IMMUNITY#0.7882;MUSCLE WASTING#0.7804;MUSCLE ATROPHY#0.7791;ASYMMETRIC CELL DIVISION#0.7772;20S PROTEASOME#0.7771;INSULIN SYNTHESIS#0.7750;ADIPOSE TISSUE#0.7703;REACTIVE OXYGEN SPECIES#0.7567;CELL SURFACE#0.7561;GROWTH FACTOR#0.7528;BREAST CARCINOMA#0.7500;CELL DIVISION#0.7495;KERATINOCYTE#0.7351;INTERSTITIAL FLUID PRESSURE#0.7345;APOPTOSIS#0.7336;PHYTOCHROME INTERACTING FACTOR#0.7329;MONOCYTE#0.7174;LEAN BODY MASS#0.7142;IMMUNE RESPONSE#0.7129;COLD ISCHEMIA TIME#0.7063;ARTERY#0.7033;ANOREXIA#0.6973;ADENOCARCINOMA#0.6670;EUKARYOTIC INITIATION FACTOR#0.6584;ISOTRETINOIN#0.6527;SIGNALLING PATHWAY#0.6513;MUSCLE CELL#0.6489;SIGNAL TRANSDUCTION#0.6485;CELL DEATH#0.6470;DECEASED DONOR KIDNEY#0.6462;ANAPHYLAXIS#0.6358;LASER DESORPTION IONIZATION#0.6325;PRO-INFLAMMATORY#0.6290;ARACHIDONIC ACID#0.6284;MYOCARDIAL INFARCTION#0.6260;CELL ENVELOPE#0.6075;ALKALINE PHOSPHATASE#0.6046;ATOPIC DERMATITIS#0.6040;EXTRACELLULAR MATRIX#0.6037;TINEA PEDIS#0.6037;CELL GROWTH#0.6031
117166	GROWTH FACTOR#0.8310
117177	NUCLEOTIDE EXCHANGE FACTOR#1.0830;GUANINE#1.0681;CILIOGENESIS#1.0133;MOTHER CENTRIOLE#0.8616;CILIARY MEMBRANE#0.8065;PLASMA MEMBRANE#0.7531;CELL SURFACE#0.7007;TRANSPORT PROTEIN PARTICLE#0.6859;CENTRIOLE#0.6752;VESICULAR TRANSPORT#0.6646;CENTROSOME#0.6628;CILIUM#0.6446;CELL PROLIFERATION#0.6164
117178	CENTRIOLAR SATELLITE#1.0182;CENTROSOME#0.8150;CELL ADHESION#0.7625;SYNOVIAL SARCOMA#0.7592;MICROTUBULE ANCHORING#0.7194;ALPHA ACTININ BINDING#0.7126;ACTININ BINDING#0.7066;MICROTUBULE#0.6748;CENTRIOLE ASSEMBLY#0.6372;GROWTH FACTOR#0.6330;BASAL BODY#0.6015;ADHERENS JUNCTION#0.6003
117191	HYPHAL TIP#0.9536;SWELLING#0.6503
117194	MAST CELL DEGRANULATION#1.0622;ALLERGIC REACTION#1.0592;MAST CELL#1.0487;CELL ACTIVATION#1.0389;MAST CELL ACTIVATION#1.0335;SUBSTANCE P#1.0067;HISTAMINE#0.9874;DERMATITIS#0.9085;HYPERSENSITIVITY#0.8637;CONTACT DERMATITIS#0.7745;ANAPHYLAXIS#0.7557;EOSINOPHIL#0.7492;ANAPHYLACTIC#0.7309;IGE RECEPTOR#0.6749;CALCIUM MOBILIZATION#0.6721;ICATIBANT#0.6638;ATOPIC DERMATITIS#0.6453;SWELLING#0.6358;BASOPHIL#0.6325;RECEPTOR ANTAGONIST#0.6185;CELL SURFACE#0.6177;OPIOID RECEPTOR#0.6122;NERVOUS SYSTEM#0.6035
117245	N ACYLTRANSFERASE#0.6407
117246	RRNA PROCESSING#0.6895;O METHYLTRANSFERASE#0.6730
117247	PLASMA MEMBRANE#0.9824;TRYPTOPHAN#0.8836;EPITHELIAL CELL#0.8569;FACILITATED DIFFUSION#0.8462;GENE EXPRESSION#0.8385;THYROID GLAND#0.7925;SKELETAL MUSCLE#0.7613;AMINO ACID TRANSPORT#0.7470;THYROID HORMONE TRANSPORT#0.6899;HORMONE TRANSPORT#0.6861;TRIIODOTHYRONINE#0.6740;SMALL INTESTINE#0.6635;THYROID HORMONE RECEPTOR#0.6516;TRYPTOPHAN TRANSPORT#0.6200
117248	CATALYTIC ACTIVITY#0.6651
117283	SKELETAL MUSCLE#0.6735;MOTOR LEARNING#0.6479;FOCAL ADHESION#0.6207;ALZHEIMER'S DISEASE#0.6128
117285	HUMAN BETA DEFENSIN#0.7177;CELL MEMBRANE#0.6924
117286	KINESIN#1.0963;MICROTUBULE#1.0647;BUDDING#0.8875;MITOTIC SPINDLE#0.8328;MICROTUBULE DYNAMICS#0.7907;KINETOCHORE#0.7895;ANAPHASE#0.7857;SPINDLE DISASSEMBLY#0.7803;MICROTUBULE END#0.6682;KINETOCHORE MICROTUBULE#0.6160;MITOSIS#0.6120
117289	T CELL#1.0509;T CELL ACTIVATION#1.0009;CELL ACTIVATION#0.9985;RHEUMATOID ARTHRITIS#0.9380;CELIAC DISEASE#0.9267;CROHN'S DISEASE#0.7799;MULTIPLE SCLEROSIS#0.7470;AUTOIMMUNE DISEASE#0.7359;GENE EXPRESSION#0.7217;CELL DIFFERENTIATION#0.6152
1173	COATED VESICLE#1.0284;PROTEIN COMPLEX#1.0204;ENDOCYTOSIS#1.0166;CLATHRIN COATED VESICLE#1.0056;PLASMA MEMBRANE#1.0014;CLATHRIN ADAPTOR#0.9785;CELL SURFACE#0.9596;ADAPTIN#0.9522;COATED PIT#0.9506;CLATHRIN-COATED PIT#0.8557;KINASE ACTIVITY#0.8546;CLATHRIN-MEDIATED ENDOCYTOSIS#0.8277;COMPLEMENT ACTIVATION#0.7837;CLATHRIN COAT#0.7419;ADAPTOR PROTEIN 2#0.7125;GROWTH FACTOR#0.7092;PROTEIN KINASE#0.6846;CLATHRIN HEAVY CHAIN#0.6558;AP-2 ADAPTOR COMPLEX#0.6458;ATPASE COMPLEX#0.6337
1174	MEDNIK SYNDROME#1.0594;PROTEIN COMPLEX#0.8415;PLASMA MEMBRANE#0.7424;AP-1 COMPLEX#0.6104
117531	HAIR CELL#1.0642;INNER EAR#1.0458;HEARING LOSS#1.0334;HEARING IMPAIRMENT#1.0296;SENSORINEURAL HEARING LOSS#1.0097;OUTER HAIR CELL#0.9716;ION CHANNEL#0.9481;COCHLEA#0.9416;ORION#0.9413;SENSORY TRANSDUCTION#0.9346;NONSYNDROMIC DEAFNESS#0.7212;SHORT TANDEM REPEAT#0.6676;PLASMA MEMBRANE#0.6299
117532	HAIR CELL#1.0895;INNER EAR#0.9162;ION CHANNEL#0.8707;SENSORY TRANSDUCTION#0.8344;HEARING LOSS#0.6940;COCHLEA#0.6766;PTPASE ACTIVITY#0.6064
117579	CORTICOTROPIN-RELEASING FACTOR#1.0298;FOREBRAIN#0.9730;CORTICOTROPIN#0.9634;GENE EXPRESSION#0.9551;RECEPTOR BINDING#0.9436;AMYGDALA#0.9235;SEPTUM#0.9046;WEIGHT GAIN#0.8910;RECOMBINANT HUMAN RELAXIN#0.8725;LEUCINE RICH REPEAT#0.8679;ELEVATED PLUS MAZE#0.8576;CENTRAL NERVOUS SYSTEM#0.8342;NERVOUS SYSTEM#0.8332;INNERVATION#0.8291;PEPTIDE HORMONE#0.8273;LEUCINE#0.7486;BODY WEIGHT GAIN#0.7363;NERVE FIBER#0.7342;FEEDING BEHAVIOR#0.7211;CENTRAL GRAY#0.7060;GONADOTROPIN RELEASING HORMONE#0.6852;SUCROSE#0.6741;HYPOTHALAMIC PITUITARY ADRENAL#0.6362;ARGININE#0.6356;APOPTOSIS#0.6281;THALAMUS#0.6225;VASOPRESSIN#0.6190;FEEDING BEHAVIOUR#0.6154;SUBSTANTIA NIGRA#0.6147;SEROTONERGIC NEURON#0.6144;SPERM MOTILITY#0.6077;GABAERGIC NEURON#0.6038
117581	TRANSCRIPTION FACTOR#1.0130;BICEPS#1.0113;LIPID OXIDATION#1.0082;EPITHELIAL MESENCHYMAL TRANSITION#0.9932;STEM CELL#0.9895;CANCER CELL#0.9884;GENE EXPRESSION#0.9864;CERVICAL CANCER#0.9844;WEIGHT LOSS#0.9776;MESENCHYMAL CELL#0.9727;GROWTH FACTOR#0.9716;CELL PROLIFERATION#0.9710;OVARIAN CANCER#0.9601;EPITHELIAL TO MESENCHYMAL#0.9562;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9527;BREAST CANCER#0.9504;CELL MIGRATION#0.9483;MACROPHAGE#0.9477;OSTEOBLAST#0.9469;TUMOR SUPPRESSOR#0.9411;EPITHELIAL CELL#0.9361;SIGNALING PATHWAY#0.9332;LACTIC ACID#0.9322;LACTIC ACID BACTERIA#0.9273;APOPTOSIS#0.9272;SQUAMOUS CELL CARCINOMA#0.9268;MESENCHYMAL STEM CELL#0.9173;LYMPH NODE#0.9062;KIDNEY CANCER#0.9010;CERVICAL#0.8982;OVARIAN#0.8830;OLEIC ACID#0.8824;COLORECTAL CANCER#0.8738;POLYMERASE CHAIN REACTION#0.8690;VITAMIN E#0.8626;MESENCHYME#0.8351;ADIPOSE TISSUE#0.8241;CONNECTIVE TISSUE#0.8202;SKELETAL MUSCLE#0.8140;PRINCIPAL COMPONENT ANALYSIS#0.8085;PANCREATIC CANCER#0.7941;T CELL#0.7856;BONE FORMATION#0.7804;CELL CYCLE#0.7754;TONGUE SQUAMOUS CELL CARCINOMA#0.7630;DISEASE FREE SURVIVAL#0.7539;HISTONE ACETYLATION#0.7473;BONE MARROW#0.7421;SUBCUTANEOUS FAT THICKNESS#0.7414;TOCOPHEROL#0.7408;LYMPH NODE METASTASIS#0.7398;DERMIS#0.7369;CANCER STEM-LIKE CELL#0.7365;OSTEOGENESIS#0.7364;AGEING#0.7356;AVERAGE DAILY GAIN#0.7314;NEURAL CREST#0.7283;DNA BINDING#0.7220;COLORECTAL#0.7193;E BOX BINDING#0.7016;CELL GROWTH#0.6996;CONJUGATED LINOLEIC ACID#0.6986;CATHEPSIN B ACTIVITY#0.6953;TRANSFORMING GROWTH FACTOR#0.6831;PROGENITOR CELL#0.6819;BONE DEVELOPMENT#0.6795;FIBROBLAST GROWTH FACTOR#0.6683;LYSINE#0.6663;CANCER STEM CELL#0.6600;MONOUNSATURATED FATTY ACIDS#0.6578;SATURATED FATTY ACID#0.6523;WATER HOLDING CAPACITY#0.6493;IMMUNE RESPONSE#0.6456;STROMAL CELL#0.6452;FEMUR#0.6337;OSTEOBLAST DIFFERENTIATION#0.6324;ONCOGENIC#0.6317;HYPOXIA#0.6304;PROTEIN OXIDATION#0.6299;STROMA#0.6282;STEM CELL MARKER#0.6260;BREAST CANCER CELL#0.6250;LUNG CANCER#0.6249;TUMOR CELLS#0.6241;ANTHER DEVELOPMENT#0.6216;LIPOLYSIS#0.6114;CELL DIFFERENTIATION#0.6114;CHONDROCYTE#0.6104;PROTOPORPHYRIN IX#0.6101;HYPOXIA INDUCIBLE FACTOR#0.6005
117583	TIGHT JUNCTION#0.9481;CELL POLARITY#0.8297;COLORECTAL CANCER#0.6474;STEM CELL#0.6435;STEM CELL MAINTENANCE#0.6080
117584	ENDOCYTIC RECYCLING#1.0139;UBIQUITIN#0.8673;ENDOCYTIC RECYCLING COMPARTMENT#0.7057;UBIQUITIN PROTEIN LIGASE#0.6740;ERAD PATHWAY#0.6428;ENDOCYTIC VESICLE#0.6234;RECEPTOR COMPLEX#0.6053;NF-KAPPAB ACTIVATION#0.6041;POTASSIUM CHANNEL#0.6001
1175	FAMILIAL HYPOCALCIURIC HYPERCALCEMIA#1.0437;HYPERCALCEMIA#1.0063;PROTEIN COMPLEX#0.9917;CLATHRIN COAT#0.9818;HYPERPARATHYROIDISM#0.7939;PLASMA MEMBRANE#0.7881;ADAPTOR PROTEIN 2#0.7526;CLATHRIN COAT ASSEMBLY#0.6943;PRIMARY HYPERPARATHYROIDISM#0.6525;CLATHRIN ADAPTOR#0.6512;CINACALCET#0.6384;COPY NUMBER VARIATION#0.6369
1176	TYPE 2 DIABETES#0.6308
117854	ANTIVIRAL RESPONSE#0.9917;UBIQUITIN#0.9366;POLYUBIQUITIN#0.6531
1178	GALECTIN#1.0729;BASOPHIL#1.0598;EOSINOPHIL#1.0533;LYSOPHOSPHOLIPASE ACTIVITY#1.0379;GENE EXPRESSION#0.9828;CARBOHYDRATE BINDING#0.9494;NCRNA TRANSCRIPTION#0.9404;T CELL#0.9332;UDP GALACTOSE#0.9028;MAST CELL#0.8928;PERIPHERAL BLOOD#0.8725;MACROPHAGE#0.8573;NUCLEOSOME#0.8573;PLASMA MEMBRANE#0.8530;GLUCOSE REPRESSION#0.8503;CYTOPLASM#0.8384;SPECIFIC GRANULE#0.8344;CELL GROWTH#0.8328;TRANSCRIPTION FACTOR#0.8309;GALACTOSIDE BINDING#0.8222;PRIMARY GRANULE#0.8214;LECTIN#0.8167;CORD BLOOD#0.8165;GALACTOSE METABOLISM#0.8070;NEUROTOXIN#0.7869;HISTAMINE#0.7669;CELL SURFACE#0.7471;BETA GALACTOSIDASE#0.7079;BONE MARROW#0.7042;LACTOSE#0.6950;SPUTUM#0.6878;PROTEIN SYNTHESIS#0.6873;ANION CHANNEL#0.6819;LELOIR PATHWAY#0.6776;DNA BINDING#0.6762;CYTOPLASMIC VESICLE#0.6736;NEUTROPHIL#0.6731;URIDINE#0.6630;SECONDARY GRANULE#0.6559;DNASE I#0.6558;POLYMERASE CHAIN REACTION#0.6460;CELL CYCLE#0.6340;GLUTAMIC ACID#0.6324;CENTROMERE#0.6187;NUCLEOTIDE EXCISION REPAIR#0.6103
1179	CHANNEL REGULATOR#1.1150;GOBLET CELL#1.0519;MUCUS PRODUCTION#1.0449;CHLORIDE CHANNEL#1.0400;NIFLUMIC ACID#1.0274;CYSTIC FIBROSIS#1.0197;EPITHELIAL CELL#1.0175;GENE EXPRESSION#1.0170;SMOOTH MUSCLE#1.0169;COLORECTAL CANCER#1.0011;METAPLASIA#0.9975;AIRWAY EPITHELIAL CELL#0.9935;COLORECTAL#0.9611;HUMAN BRONCHIAL EPITHELIAL#0.9575;GOBLET CELL HYPERPLASIA#0.9545;CELL SURFACE#0.9185;MUCOUS#0.9050;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8968;GOBLET CELL METAPLASIA#0.8890;MUSCLE CELL#0.8878;BRONCHIAL EPITHELIAL CELLS#0.8877;IMMUNE RESPONSE#0.8868;CHANNEL ACTIVITY#0.8694;POLYMERASE CHAIN REACTION#0.8549;MACROPHAGE#0.8524;SMOOTH MUSCLE CELL#0.8516;MUCUS SECRETION#0.8492;CELL PROLIFERATION#0.8481;SIGNALING PATHWAY#0.8476;NASAL MUCOSA#0.8077;CELL DIFFERENTIATION#0.8047;ALLERGIC RHINITIS#0.8017;ION TRANSPORT#0.8009;AIRWAY EPITHELIUM#0.7946;INFLAMMATORY AIRWAY DISEASE#0.7884;ION CHANNEL#0.7703;T CELL#0.7501;HYPERTENSION#0.7428;EOSINOPHIL#0.7312;SPUTUM#0.7298;ANION CHANNEL#0.7289;SIGNALING MOLECULE#0.7152;PLASMA MEMBRANE#0.6922;NEUTROPHIL#0.6902;MUSCLE CONTRACTION#0.6845;PRO-INFLAMMATORY#0.6780;RHINITIS#0.6774;GROWTH FACTOR#0.6730;CHANNEL INHIBITOR#0.6652;SMOOTH MUSCLE CONTRACTION#0.6645;RESPIRATORY SYNCYTIAL VIRUS#0.6606;HISTAMINE#0.6559;MAST CELL#0.6555;INFLAMMATORY CELL#0.6551;ALLERGEN#0.6544;LUNG DISEASE#0.6386;INFLAMMATORY RESPONSE#0.6337;REGULATION OF MUCUS PRODUCTION#0.6150;INTERLEUKIN 9 RECEPTOR#0.6135;SMALL INTESTINE#0.6042
117	PACAP RECEPTOR#1.0291;POLYMERASE CHAIN REACTION#1.0112;GENE EXPRESSION#1.0090;PROTEIN KINASE#1.0032;SIGNAL TRANSDUCTION#0.9999;SIGNALING PATHWAY#0.9993;NERVOUS SYSTEM#0.9944;RECEPTOR ANTAGONIST#0.9928;ADENYLATE CYCLASE#0.9905;ADENYLATE#0.9902;ASTROCYTE#0.9825;PHOSPHOLIPASE C#0.9706;PROTEIN KINASE A#0.9630;REVERSE TRANSCRIPTION#0.9461;GROWTH FACTOR#0.9304;RECEPTOR AGONIST#0.9163;CENTRAL NERVOUS SYSTEM#0.9151;APOPTOSIS#0.9106;PROTEIN KINASE C#0.9041;STEM CELL#0.8838;CELL PROLIFERATION#0.8646;APOPTOTIC#0.8628;CANCER CELL#0.8349;POST-TRAUMATIC STRESS DISORDER#0.8304;CLASS B GPCR#0.8281;GRANULOSA CELL#0.7920;NEURITE OUTGROWTH#0.7716;ENDOPLASMIC RETICULUM#0.7712;GROWTH HORMONE#0.7636;PLASMA MEMBRANE#0.7604;MIGRAINE#0.7591;RECEPTOR INTERNALIZATION#0.7525;FORSKOLIN#0.7460;NEURITE#0.7452;CELL DIFFERENTIATION#0.7430;ENDOCYTOSIS#0.7333;SIGNALING CASCADE#0.7300;AMYGDALA#0.7295;CELL DEATH#0.7255;GONADOTROPIN RELEASING HORMONE#0.7254;ISCHEMIA#0.7198;NEURAL STEM CELL#0.7140;HYPOXIA#0.7130;DOPAMINE#0.7077;NITRIC OXIDE#0.7051;SUDDEN INFANT DEATH SYNDROME#0.6966;NEUROBLASTOMA#0.6914;CAMP RESPONSE ELEMENT#0.6834;NERVE GROWTH FACTOR#0.6795;GLIAL CELL#0.6794;PERIPHERAL NERVOUS SYSTEM#0.6792;CYCLIC AMP#0.6792;NEURODEGENERATIVE DISEASE#0.6787;NEUROPEPTIDE RECEPTOR#0.6717;LUNG CANCER#0.6717;MACROPHAGE#0.6677;ANXIETY DISORDER#0.6653;CEREBRAL CORTEX#0.6313;GANGLION CELLS#0.6205;SPINAL CORD#0.6197;SMOOTH MUSCLE#0.6181;NEUROGENESIS#0.6142;BRAIN DEVELOPMENT#0.6099;SOCIAL BEHAVIOR#0.6014
1180	MYOTONIA CONGENITA#1.0544;CHLORIDE CHANNEL#1.0350;MUSCLE FIBER#1.0344;SKELETAL MUSCLE#1.0240;SODIUM CHANNEL#1.0130;OOCYTE#1.0049;SARCOLEMMA#0.9936;ACTION POTENTIAL#0.9924;PROTEIN KINASE#0.9920;ION CHANNEL#0.9915;PROTEIN KINASE C#0.9718;MYOTONIC DYSTROPHY TYPE 1#0.9551;PLASMA MEMBRANE#0.9438;MUSCLE FIBRE#0.9278;GENETIC DISEASE#0.9232;MYOTONIC DYSTROPHY TYPE 2#0.8609;POLYMERASE CHAIN REACTION#0.8547;CHANNEL ACTIVITY#0.8196;MUSCLE WEAKNESS#0.8121;GENE EXPRESSION#0.8119;PARALYSIS#0.8009;ANTHRACENE#0.7742;MYOPATHY#0.7663;MUSCULAR DYSTROPHY#0.7188;MUSCLE HYPERTROPHY#0.7072;EPILEPSY#0.6942;ANION CHANNEL#0.6414;TRANSEPITHELIAL TRANSPORT#0.6390;HUMAN EMBRYONIC KIDNEY#0.6319;EMBRYONIC KIDNEY#0.6314;NIFLUMIC ACID#0.6121;ACIDIFICATION#0.6054;CYSTATHIONINE BETA SYNTHASE#0.6027
1181	LUBIPROSTONE#1.0952;TIGHT JUNCTION#1.0396;EPILEPSY#1.0352;CHLORIDE CHANNEL#1.0334;EPITHELIAL CELL#1.0259;OOCYTE#1.0238;ANION CHANNEL#1.0161;CYSTIC FIBROSIS#1.0160;POLYMERASE CHAIN REACTION#1.0095;ASTROCYTE#1.0095;SWELLING#1.0070;PLASMA MEMBRANE#1.0030;IDIOPATHIC GENERALIZED EPILEPSY#1.0001;LEUKOENCEPHALOPATHY#0.9929;ION CHANNEL#0.9916;CONSTIPATION#0.9803;PROTEIN KINASE#0.9692;CHANNEL ACTIVITY#0.9691;GENE EXPRESSION#0.9688;ALDOSTERONE#0.9660;CELL MEMBRANE#0.9473;LEUKODYSTROPHY#0.9416;POTASSIUM CHANNEL#0.9179;ACINAR CELL#0.9118;CELL PROLIFERATION#0.9032;GABA A RECEPTOR#0.9019;CELL JUNCTION#0.9009;ISCHEMIA#0.8917;CHLORIDE TRANSPORT#0.8568;SALIVARY GLAND#0.8517;ION TRANSPORT#0.8393;LUNG EPITHELIAL CELL#0.8140;REVERSE TRANSCRIPTION#0.8132;MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS#0.8040;IDIOPATHIC GENERALIZED EPILEPSIES#0.8017;SURFACE EPITHELIUM#0.8014;CELL SURFACE#0.7953;REGULATORY VOLUME DECREASE#0.7930;TRANSCRIPTION FACTOR#0.7803;ENDOCYTOSIS#0.7774;BENZOIC ACID#0.7605;PROTEIN KINASE A#0.7504;NERVOUS SYSTEM#0.7357;EPITHELIAL TISSUES#0.7196;COLITIS#0.7169;PROTEIN KINASE C#0.7146;PYRAMIDAL CELL#0.7122;ACTION POTENTIAL#0.7088;SODIUM CHANNEL#0.7032;DUCT CELL#0.7002;TRANSCRIPTASE#0.6899;ACIDIFICATION#0.6844;AIRWAY EPITHELIAL CELL#0.6807;DENTATE GYRUS#0.6781;ABSENCE EPILEPSY#0.6777;SMALL INTESTINE#0.6757;GROWTH FACTOR#0.6753;FORSKOLIN#0.6732;CHILDHOOD ABSENCE EPILEPSY#0.6649;LUNG DEVELOPMENT#0.6602;SIGNALING PATHWAY#0.6509;CELL CELL JUNCTION#0.6382;INTESTINAL MUCOSA#0.6354;CELL MIGRATION#0.6302;IRRITABLE BOWEL SYNDROME#0.6300;SMOOTH MUSCLE#0.6284;APOPTOSIS#0.6271;LUMINAL#0.6230;SODIUM BICARBONATE#0.6213;BLOOD VESSEL#0.6204;ENDOTHELIAL CELL#0.6171;JUVENILE MYOCLONIC EPILEPSY#0.6152;HUMAN EMBRYONIC KIDNEY#0.6117;CORNEAL ENDOTHELIUM#0.6115;EMBRYONIC KIDNEY#0.6112;CALCIUM CHANNEL#0.6084;ACTIN CYTOSKELETON#0.6078;BIPOLAR CELL#0.6032
1182	SYNAPTIC VESICLE#1.0738;SMOOTH MUSCLE#1.0399;CANCER CELL#1.0375;CELL MIGRATION#1.0362;SMOOTH MUSCLE CELL#1.0339;VASCULAR SMOOTH MUSCLE CELL#1.0339;MYOCYTES#1.0325;ANION CHANNEL#1.0321;MUSCLE CELL#1.0314;PLASMA MEMBRANE#1.0270;NADPH OXIDASE#1.0263;CHLORIDE CHANNEL#1.0259;POLYMERASE CHAIN REACTION#1.0232;CELL CYCLE#1.0212;APOPTOSIS#1.0203;EPITHELIAL CELL#1.0174;ACIDIFICATION#1.0173;CELL PROLIFERATION#1.0172;REGULATORY VOLUME DECREASE#1.0168;PROTEIN KINASE#1.0121;SWELLING#1.0034;ION CHANNEL#1.0028;GROWTH FACTOR#0.9992;ENDOSOME#0.9945;CYSTIC FIBROSIS#0.9837;S PHASE#0.9816;BREAST CANCER#0.9727;CELL MEMBRANE#0.9679;GENE EXPRESSION#0.9647;ENDOTHELIAL CELL#0.9633;ALLERGIC RHINITIS#0.9575;CAMKII#0.9546;REVERSE TRANSCRIPTION#0.9543;REACTIVE OXYGEN SPECIES#0.9364;SIGNALING PATHWAY#0.9307;HYPERTENSION#0.9298;BENZOIC ACID#0.9269;BETA CELL#0.9253;TRANSFORMING GROWTH FACTOR#0.9243;ARTERY#0.9097;OSTEOBLAST#0.9018;CHLORIDE TRANSPORT#0.8865;TAMOXIFEN#0.8802;PROTEIN KINASE C#0.8762;ENDOCYTOSIS#0.8656;APOPTOTIC#0.8446;POTASSIUM CHANNEL#0.8445;BREAST CANCER CELL#0.8417;CHANNEL ACTIVITY#0.8375;PULMONARY ARTERY#0.8306;DRUG RESISTANCE#0.8267;ISCHEMIA#0.8202;ROS GENERATION#0.8160;NIFLUMIC ACID#0.8096;TUMOR NECROSIS FACTOR#0.8069;RHINITIS#0.8029;INTRACELLULAR VESICLE#0.8025;ACINAR CELL#0.7788;INSULIN SECRETION#0.7737;LYSOSOME#0.7698;TRANSCRIPTASE#0.7665;CARDIOMYOCYTE#0.7650;OOCYTE#0.7636;NULL CELL#0.7608;TRANSFORMING GROWTH FACTOR BETA#0.7596;BASILAR ARTERY#0.7588;CISPLATIN#0.7549;SYNAPTIC TRANSMISSION#0.7518;TUMOR CELLS#0.7413;CYTOPLASM#0.7363;MACROPHAGE#0.7281;STEM CELL#0.7257;RESPIRATORY BURST#0.7153;ORGANELLE#0.7012;CORNEAL ENDOTHELIUM#0.6957;G1 PHASE#0.6931;NEUTROPHIL#0.6893;ION TRANSPORT#0.6854;17β-ESTRADIOL#0.6800;TRANSCRIPTION FACTOR#0.6704;INTRACELLULAR ORGANELLE#0.6651;SECRETORY GRANULE#0.6631;EXOCYTOSIS#0.6627;ENDOTHELIUM#0.6495;MEMBRANE DEPOLARIZATION#0.6394;CHANNEL INHIBITOR#0.6270;ANION EXCHANGER 1#0.6262;EOSINOPHIL#0.6256;AUTOPHAGY#0.6249;PROGENITOR CELL#0.6202;VSMC PROLIFERATION#0.6188;NERVOUS SYSTEM#0.6182;MEMBRANE FRACTION#0.6107;GENE SILENCING#0.6101;CORNEAL EPITHELIUM#0.6040
1183	CHLORIDE CHANNEL#1.0337;X CHROMOSOME#0.9713;PLASMA MEMBRANE#0.9225;EPITHELIAL CELL#0.8569;ION CHANNEL#0.8336;ACIDIFICATION#0.8314;CELL SURFACE#0.7735;ENDOSOME#0.7607;RECYCLING ENDOSOME#0.7231;MENTAL RETARDATION#0.6985;ANION CHANNEL#0.6750;SWELLING#0.6408;NEURITE OUTGROWTH#0.6162;ENDOCYTOSIS#0.6152;NEURONAL CELLS#0.6143;ENDOPLASMIC RETICULUM#0.6085
118424	UBIQUITIN#0.9665;HEPATOCELLULAR CARCINOMA#0.8454;ENDOPLASMIC RETICULUM#0.8078;PROTEASOME#0.6043
118425	PROSTATE CANCER#0.9966;CANCER CELL#0.7323;ATPASE ACTIVITY#0.7035;MYOFIBRIL#0.6222
118426	TUMOR SUPPRESSOR#0.6926;EWING SARCOMA#0.6821;COLORECTAL CARCINOMA#0.6692;COLORECTAL CANCER#0.6598
118429	ANTHRAX TOXIN RECEPTOR#1.0731;TUMOR ENDOTHELIAL MARKER#1.0632;ANKYLOSING SPONDYLITIS#1.0573;MORPHOGENESIS#1.0394;PORE FORMATION#1.0300;ENDOTHELIAL CELL#1.0121;SPONDYLITIS#1.0110;EXTRACELLULAR MATRIX#1.0110;ANGIOGENESIS#0.9955;HISTIDINE#0.9572;HISTIDINE BIOSYNTHESIS#0.9563;CELL SURFACE#0.9424;HAIR FOLLICLE#0.9258;MACROPHAGE#0.9119;HOST CELL#0.9094;EDEMA#0.9000;ANAGEN#0.8448;POLYMERASE CHAIN REACTION#0.8254;ENDOCYTOSIS#0.8052;CELL DIVISION#0.8036;SIGNALING PATHWAY#0.7974;STEM CELL#0.7894;TOXIN BINDING#0.7869;CANCER CELL#0.7263;RECEPTOR BINDING#0.7190;QUANTITATIVE REAL TIME#0.7102;GLUTAMINE#0.6939;TELOGEN#0.6827;CONNECTIVE TISSUE#0.6796;CELL MIGRATION#0.6774;GENE EXPRESSION#0.6768;INHIBITION OF CELL DIVISION#0.6397;GROWTH FACTOR#0.6361;PROTEIN PROTEIN INTERACTION#0.6358;PARTURITION#0.6352;ENDOPLASMIC RETICULUM#0.6232
118430	BREAST CANCER#1.0744;BREAST CANCER PATIENTS#0.9871;PERIPHERAL BLOOD#0.8960;CANCER CELL#0.7189;BREAST CANCER CELL#0.6980;LYMPH NODE#0.6710;BONE MARROW#0.6315;TRANSCRIPTION FACTOR#0.6300
118442	GERM CELL#0.6963;CAMP SIGNALING#0.6223
118460	EPITHELIAL CELL#1.0310;GENE EXPRESSION#0.8468;BRONCHIAL EPITHELIAL CELLS#0.7825;BREAST CANCER#0.7594;CANCER CELL#0.7197;BREAST CANCER CELL#0.7057;CELL SURFACE#0.7031;MAJOR DEPRESSIVE DISORDER#0.7006;GLUCOCORTICOID RECEPTOR#0.6914;PERIPHERAL BLOOD#0.6878;RETINOIC ACID#0.6460;GROWTH FACTOR#0.6391;POLYMERASE CHAIN REACTION#0.6305;HUMAN BRONCHIAL EPITHELIAL#0.6194;ION CHANNEL#0.6107;DNA METHYLATION#0.6098;EXOSOME#0.6084;IFN-GAMMA#0.6060;HUMAN BREAST CANCER#0.6057;ENDOPLASMIC RETICULUM#0.6023
118471	UTERUS#0.7917;CELL CYCLE#0.7329;PREGNANT UTERUS#0.6334;MITOTIC CHECKPOINT#0.6224;HUMAN WHOLE BLOOD#0.6202;17β-ESTRADIOL#0.6101;LIVER REGENERATION#0.6093
118490	CYTOCHROME C OXIDASE#0.9993;CYTOCHROME C#0.9936;SKELETAL MUSCLE#0.8896;MITOCHONDRIA#0.8089;HEME BINDING#0.6562;OXIDATIVE PHOSPHORYLATION#0.6494;FATTY ACID OXIDATION#0.6437
118491	OUTER DYNEIN ARM#0.8298;MOTILE CILIA#0.7872
1184	DENT DISEASE#1.0713;EARLY ENDOSOME#1.0637;CELL SURFACE#1.0482;PROXIMAL TUBULE CELL#1.0479;ENDOSOME#1.0452;ENDOCYTOSIS#1.0413;ACIDIFICATION#1.0377;RECEPTOR MEDIATED ENDOCYTOSIS#1.0324;CHLORIDE CHANNEL#1.0295;OOCYTE#1.0232;NEPHROLITHIASIS#1.0205;POLYMERASE CHAIN REACTION#1.0191;EPITHELIAL CELL#1.0190;PLASMA MEMBRANE#1.0183;RICKETS#1.0011;NEPHROCALCINOSIS#0.9960;PROTEINURIA#0.9950;FANCONI SYNDROME#0.9682;PROXIMAL TUBULAR CELL#0.9582;EXCRETION#0.9317;KIDNEY DISEASE#0.9112;ENDOPLASMIC RETICULUM#0.8936;GENE EXPRESSION#0.8815;CYSTIC FIBROSIS#0.8708;ION CHANNEL#0.8590;DUCT CELL#0.8565;BRUSH BORDER#0.8329;CHANNEL ACTIVITY#0.8080;LUMINAL#0.8018;ATP BINDING#0.7896;KIDNEY PROXIMAL TUBULE#0.7806;SWELLING#0.7792;LEUKOCYTE#0.7780;LYSOSOME#0.7717;REVERSE TRANSCRIPTION#0.7704;GROWTH FACTOR#0.7670;PODOCYTE#0.7646;INTRACELLULAR VESICLE#0.7569;CHRONIC KIDNEY DISEASE#0.7525;CHLORIDE TRANSPORT#0.7465;PROTON PUMP#0.7335;ANION CHANNEL#0.7326;UBIQUITIN#0.7323;HYPOPHOSPHATEMIA#0.7257;PARATHYROID HORMONE#0.7223;ION TRANSPORT#0.7122;ENDOCYTIC VESICLE#0.7080;NEPHRON#0.6939;GLYCOSYLATION#0.6904;RECYCLING ENDOSOME#0.6880;X CHROMOSOME#0.6792;TRANSCRIPTION FACTOR#0.6775;TUBULAR EPITHELIAL CELL#0.6567;PROTEIN UPTAKE#0.6548;ANION TRANSPORT#0.6362;CELL PROLIFERATION#0.6173;ORGANELLE#0.6058;UBIQUITIN PROTEIN LIGASE#0.6024;EPITHELIAL SODIUM CHANNEL#0.6018;GLOMERULAR FILTRATION#0.6003
1185	CHLORIDE CHANNEL#1.0360;PLASMA MEMBRANE#0.7939;OOCYTE#0.7152;CORNEAL EPITHELIUM#0.6416;HYPERTENSION#0.6104;HUMAN CORNEAL EPITHELIUM#0.6076
118611	TUMOR SUPPRESSOR#1.0274;BREAST CANCER#0.9931;BREAST CANCER CELL#0.6149;LUNG CANCER#0.6124;CANCER CELL#0.6081
118672	SELENOCYSTEINE#0.9983
1186	AUTOSOMAL RECESSIVE OSTEOPETROSIS#1.0562;OSTEOPETROSIS#1.0436;CHLORIDE CHANNEL#1.0399;ACIDIFICATION#1.0335;OSTEOCLAST#1.0256;LYSOSOME#1.0240;BONE RESORPTION#1.0159;LYSOSOMAL STORAGE DISEASE#0.9966;PLASMA MEMBRANE#0.9934;BONE MARROW#0.9546;PROTON PUMP#0.9388;OSTEOCLAST DIFFERENTIATION#0.9239;BONE FORMATION#0.8934;OSTEOPOROSIS#0.8877;BONE DISEASE#0.8684;STEM CELL#0.8582;CHLORIDE TRANSPORT#0.8408;BONE MINERAL DENSITY#0.8121;OOCYTE#0.8090;MACROPHAGE#0.8031;ENDOSOME#0.7899;GENE EXPRESSION#0.7839;NERVOUS SYSTEM#0.7837;LATE ENDOSOME#0.7782;ACID SECRETION#0.7420;CENTRAL NERVOUS SYSTEM#0.7287;POLYMERASE CHAIN REACTION#0.7266;TOOTH ERUPTION#0.7230;ENDOCYTOSIS#0.7151;ACID PHOSPHATASE#0.7124;MINERALIZATION#0.6925;RETINAL DEGENERATION#0.6870;COLONY-STIMULATING FACTOR#0.6836;LUMINAL#0.6588;TRANSCRIPTION FACTOR#0.6520;T CELL#0.6504;MONOCYTE#0.6395;TOOTH DEVELOPMENT#0.6273;OSTEOSCLEROSIS#0.6271;BONE DEVELOPMENT#0.6116;OSTEOBLAST#0.6033
118738	EPITHELIAL MESENCHYMAL TRANSITION#0.7199;CELL ADHESION#0.7138;SIGNALING PATHWAY#0.7088
118788	B CELL#1.0986;B CELL RECEPTOR#0.8266;MACROPHAGE#0.7908;SIGNALING PATHWAY#0.7887;B CELL DEVELOPMENT#0.7813;CELL DEVELOPMENT#0.7722;TOLL LIKE RECEPTOR#0.7515;INFLAMMATORY RESPONSE#0.7221;SIGNALING ADAPTOR#0.6578;T CELL#0.6333
1187	CHLORIDE CHANNEL#1.0356;NEPHRON#0.9900;AQUAPORIN#0.9144;CHLORIDE TRANSPORT#0.8777;OOCYTE#0.7584;PLASMA MEMBRANE#0.7578;COLLECTING DUCTS#0.7490;DIABETES INSIPIDUS#0.7468;TRANSEPITHELIAL CHLORIDE TRANSPORT#0.7150;INNER EAR#0.6984;WATER CHANNEL#0.6842;ZINC FINGER PROTEIN#0.6200;GENE EXPRESSION#0.6176;POLYMERASE CHAIN REACTION#0.6049
118812	PROTEIN BINDING#0.6006
118813	NEURITE OUTGROWTH#1.0798;NEURITE#1.0734;HEREDITARY SPASTIC PARAPLEGIA#1.0202;PARAPLEGIA#0.9293;ENDOPLASMIC RETICULUM#0.9226;CONTACT SITE#0.8615;NEURITE FORMATION#0.8113;ENDOSOME#0.7974;NEURITE EXTENSION#0.7333;PLASMA MEMBRANE#0.7137;VESICULAR TRANSPORT#0.6546;RNA INTERFERENCE#0.6395;KINESIN#0.6287
118856	BREAST CANCER#0.6442
1188	NEPHRON#1.0459;CHLORIDE CHANNEL#1.0378;GITELMAN SYNDROME#1.0143;HYPERTENSION#0.9998;THIAZIDE#0.9834;PLASMA MEMBRANE#0.9744;INNER EAR#0.9740;HYPOKALEMIA#0.9654;POTASSIUM CHANNEL#0.9562;COLLECTING DUCTS#0.9378;CHANNEL ACTIVITY#0.9179;OOCYTE#0.9177;FUROSEMIDE#0.8877;POTASSIUM CHLORIDE#0.8830;ESSENTIAL HYPERTENSION#0.8798;GENE EXPRESSION#0.8687;POLYMERASE CHAIN REACTION#0.8494;NEPHROCALCINOSIS#0.8433;ION CHANNEL#0.7883;EXCRETION#0.7540;BLOOD PRESSURE REGULATION#0.7470;LOOP OF HENLE#0.7448;BUMETANIDE#0.7426;CELLULAR LOCALIZATION#0.7417;HEARING LOSS#0.7397;CHLORIDE TRANSPORT#0.7273;CHLORIDE CHANNEL ACTIVITY#0.7178;EPITHELIAL CELL#0.6923;POLYURIA#0.6380;REVERSE TRANSCRIPTION#0.6245;PROTEINURIA#0.6040
118924	FOLATE#0.6428
118932	PROSTATE CANCER#0.6318;LUNG CANCER#0.6301;CELL PROLIFERATION#0.6264
118987	HUMAN IMMUNODEFICIENCY VIRUS#0.7566;MITOCHONDRIA#0.6546;LIPID TRANSPORT#0.6426;LATE ENDOSOME#0.6370;HERPES SIMPLEX VIRUS#0.6280;HERPES SIMPLEX#0.6274
118	ANGIOTENSIN CONVERTING ENZYME#1.0546;STEROL REGULATORY ELEMENT#1.0543;ADIPOCYTE#1.0511;TRANSCRIPTION FACTOR#1.0332;ALDOSTERONE#1.0327;ESSENTIAL HYPERTENSION#1.0229;HYPERTENSION#1.0196;NITRIC OXIDE#1.0148;SYSTOLIC BLOOD PRESSURE#1.0145;POLYMERASE CHAIN REACTION#1.0025;ADIPOSE TISSUE#1.0008;GENE EXPRESSION#0.9975;DNA METHYLATION#0.9838;PROTEIN KINASE#0.9834;BLOOD PRESSURE REGULATION#0.9812;ADRENERGIC RECEPTOR#0.9721;ENDOTHELIAL NITRIC OXIDE#0.9571;MYOCARDIAL INFARCTION#0.9528;NITRIC OXIDE SYNTHASE#0.9523;FATTY ACID SYNTHASE#0.9513;PREADIPOCYTE#0.9470;SODIUM TRANSPORT#0.9317;SPECTRIN#0.9252;ADIPOCYTE DIFFERENTIATION#0.9171;RENIN ACTIVITY#0.9139;OUABAIN#0.9030;PROTEIN KINASE C#0.9003;PEROXISOME#0.8952;ERYTHROCYTE#0.8951;ADIPOGENESIS#0.8894;EXCRETION#0.8882;ARTERY#0.8821;LIPOPROTEIN LIPASE#0.8728;ACTIN BINDING#0.8679;EPITHELIAL CELL#0.8632;HYDROCHLOROTHIAZIDE#0.8569;INTIMA MEDIA THICKNESS#0.8556;GROWTH FACTOR#0.8474;LIPID METABOLISM#0.8458;ACTIN BINDING PROTEIN#0.8247;RESPONSE TO DIURETIC#0.8238;NUCLEOTIDE BINDING#0.8052;PUMP ACTIVITY#0.7926;ENHANCER BINDING PROTEIN#0.7925;ENHANCER BINDING#0.7920;DNA BINDING#0.7871;THIAZIDE#0.7762;FAT CELL#0.7691;HEART DISEASE#0.7443;ION TRANSPORT#0.7365;T CELL#0.7364;SODIUM CHANNEL#0.7302;CORONARY ARTERY DISEASE#0.7293;ARTERY DISEASE#0.7290;ACTIN FILAMENT#0.7268;CORONARY ARTERY#0.7267;FRAGMENT LENGTH POLYMORPHISM#0.7065;GUANINE#0.7041;SIGNALING PATHWAY#0.7009;LUNG CANCER#0.6882;CARDIOVASCULAR RISK FACTOR#0.6852;CORONARY HEART DISEASE#0.6770;GLYCOGEN SYNTHASE KINASE#0.6758;ATHEROSCLEROSIS#0.6708;CELL MIGRATION#0.6691;SKELETON#0.6640;EPITHELIAL SODIUM CHANNEL#0.6625;ACTIN CYTOSKELETON#0.6519;LEUCINE#0.6485;TRANSMISSION DISEQUILIBRIUM TEST#0.6444;NEPHROPATHY#0.6358;ATPASE ACTIVITY#0.6340;PLASMA MEMBRANE#0.6306;BINDING PROTEIN 1#0.6245;CAROTID ARTERY#0.6091;RETINOIC ACID#0.6061;URIC ACID#0.6034;D-ALDOSTERONE#0.6029
119016	GAP ACTIVITY#0.8819;ACTIN CYTOSKELETON#0.7554;FOCAL ADHESION#0.7275;PLASMA MEMBRANE#0.6971;TRANS GOLGI NETWORK#0.6902;EARLY ENDOSOME#0.6573;ENDOSOME#0.6568;NUCLEOTIDE EXCHANGE FACTOR#0.6408;GTP BINDING#0.6402;GTP HYDROLYSIS#0.6291
1191	PHOSPHATIDYLINOSITOL BINDING#1.0792;OGX-011#1.0791;RETE TESTIS#1.0735;RENAL CELL CARCINOMA#1.0582;KIDNEY INJURY MOLECULE#1.0455;CELL AGGREGATION#1.0447;ALPHA-2 MACROGLOBULIN#1.0434;ALPHA 1-ANTITRYPSIN#1.0421;COMPLEMENT RECEPTOR#1.0413;SMOOTH MUSCLE CELL#1.0401;LIPID TRANSPORT#1.0398;PACLITAXEL#1.0384;FIBRINOGEN#1.0381;VASCULAR SMOOTH MUSCLE CELL#1.0370;CYSTATIN#1.0355;COLON CANCER#1.0330;SENESCENCE#1.0326;HEAT SHOCK PROTEIN#1.0308;RETINOL BINDING#1.0298;MEMBRANE ATTACK COMPLEX#1.0289;OVARIAN CANCER#1.0289;TISSUE REMODELING#1.0285;ENDOCRINE CELL#1.0282;EFFERENT DUCT#1.0280;TRANSFORMING GROWTH FACTOR BETA#1.0279;VITAMIN D BINDING#1.0278;MUSCLE CELL#1.0277;ENDOTHELIAL GROWTH FACTOR#1.0275;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0275;SMOOTH MUSCLE#1.0257;LUNG CANCER#1.0256;HEPATOCELLULAR CARCINOMA#1.0228;SERTOLI CELL#1.0224;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0214;GLYCOSYLATION#1.0204;LYSIS#1.0202;SPERMATOZOA#1.0198;TUBULAR EPITHELIAL CELL#1.0189;NEUTROPHIL#1.0181;CELL DIFFERENTIATION#1.0168;BREAST CANCER CELL#1.0168;ISCHEMIA#1.0168;DNA REPAIR#1.0166;APOPTOTIC CELL DEATH#1.0165;BETA CELL#1.0165;EPIDERMAL GROWTH FACTOR#1.0162;GLUTATHIONE#1.0151;INSULIN-LIKE GROWTH FACTOR#1.0150;C REACTIVE PROTEIN#1.0148;ASTROCYTE#1.0144;DNA FRAGMENTATION#1.0141;PROSTATE EPITHELIAL CELL#1.0139;TERMINAL COMPLEMENT COMPLEX#1.0139;ANAPLASTIC LARGE CELL LYMPHOMA#1.0139;SPINAL CORD#1.0138;TRANSFORMING GROWTH FACTOR#1.0134;SEMINAL PLASMA#1.0133;TESTOSTERONE#1.0129;BREAST CANCER#1.0128;CELL ADHESION#1.0126;NEUROBLASTOMA#1.0114;HIGH DENSITY LIPOPROTEIN#1.0108;BETA-2#1.0104;TUMOR CELLS#1.0101;EPIDIDYMIS#1.0100;DRUG RESISTANCE#1.0098;TUMOR NECROSIS FACTOR#1.0093;SEMINAL VESICLE#1.0090;GROWTH FACTOR BINDING#1.0087;CYTOCHROME C#1.0076;CYTOTOXICITY#1.0072;REGENERATION#1.0071;CYTOPLASM#1.0071;CHAPERONE ACTIVITY#1.0067;SQUAMOUS CELL CARCINOMA#1.0065;LOW DENSITY LIPOPROTEIN#1.0062;ATHEROSCLEROSIS#1.0053;MYOCARDIAL INFARCTION#1.0051;OVARIAN#1.0051;MONOCYTE#1.0049;ENDOCYTOSIS#1.0040;REVERSE TRANSCRIPTION#1.0039;COLORECTAL#1.0034;APOPTOTIC#1.0029;CANCER CELL#1.0029;PROGRAMMED CELL DEATH#1.0024;LYMPH NODE#1.0021;ANDROGEN RECEPTOR#1.0013;CISPLATIN#1.0012;PROSTATE CANCER#1.0012;RETINOL#1.0007;MILD COGNITIVE IMPAIRMENT#1.0001;STEM CELL#1.0001;CYTOLYSIS#1.0000;ONCOGENIC#0.9985;APOPTOSIS#0.9971;TYPE 2 DIABETES#0.9971;DIABETES MELLITUS#0.9971;DOCETAXEL#0.9971;PROTEIN KINASE#0.9970;CAUDA#0.9970;TUMOR SUPPRESSOR#0.9968;MAMMARY GLAND#0.9966;PLASMA MEMBRANE#0.9966;MACROPHAGE#0.9964;PROTEASOME#0.9963;COLORECTAL CANCER#0.9962;NEURODEGENERATIVE DISEASE#0.9956;ENDOTHELIAL CELL#0.9956;GROWTH FACTOR#0.9955;IMMUNE SYSTEM#0.9952;GERM CELL#0.9952;CELL CYCLE#0.9948;CAPUT#0.9945;FIBRIL#0.9942;ENDOPLASMIC RETICULUM#0.9940;EPITHELIAL CELL#0.9939;ADENOCARCINOMA#0.9937;GLIAL CELL#0.9932;LECTIN#0.9930;PROSTATE SPECIFIC ANTIGEN#0.9929;CELL GROWTH#0.9926;PLASMA PROTEIN#0.9926;CELL DEATH#0.9922;LUMINAL#0.9922;SEMEN#0.9915;PERIPHERAL BLOOD#0.9909;NERVOUS SYSTEM#0.9909;REACTIVE OXYGEN SPECIES#0.9907;BLOOD BRAIN BARRIER#0.9904;COMPLEMENT ACTIVATION#0.9901;TYPE 2 DIABETES MELLITUS#0.9899;2 DIABETES MELLITUS#0.9898;SIGNALING PATHWAY#0.9898;COMPLEMENT CASCADE#0.9897;HYPOXIA#0.9896;NEPHROTOXICITY#0.9886;POLYMERASE CHAIN REACTION#0.9886;CELL PROLIFERATION#0.9886;QUANTITATIVE REAL TIME#0.9885;GROWTH FACTOR RECEPTOR#0.9881;KIDNEY DISEASE#0.9876;T CELL#0.9874;SERUM AMYLOID A#0.9869;CENTRAL NERVOUS SYSTEM#0.9840;DEMENTIA#0.9839;ARTERY#0.9829;MONONUCLEAR CELLS#0.9826;ANGIOGENESIS#0.9823;LIPID METABOLISM#0.9816;TRANSCRIPTION FACTOR#0.9805;DENDRITIC CELL#0.9805;GLUTATHIONE PEROXIDASE#0.9793;ALZHEIMER'S DISEASE#0.9779;EXCRETION#0.9777;PROTEIN SYNTHESIS#0.9775;TOXICITY#0.9773;SERUM ALBUMIN#0.9773;RETINAL DEGENERATION#0.9772;EXTRACELLULAR MATRIX#0.9768;LYMPH NODE METASTASIS#0.9757;URETERAL OBSTRUCTION#0.9753;SPERMATOGENESIS#0.9753;FOLLICULAR DENDRITIC CELL#0.9742;AMYLOIDOSIS#0.9742;INHIBITION OF APOPTOSIS#0.9729;STREPTOZOTOCIN#0.9727;CERVICAL#0.9723;BLOOD UREA NITROGEN#0.9723;CERVICAL CANCER#0.9723;IMMUNE RESPONSE#0.9719;INDUCTION OF APOPTOSIS#0.9713;SIGNAL TRANSDUCTION#0.9709;GENE EXPRESSION#0.9694;FACTOR I#0.9694;NEPHROPATHY#0.9692;PARKINSON'S DISEASE#0.9691;LEUCINE#0.9687;COMPLEMENT FACTOR H#0.9674;BINDING PROTEIN 1#0.9673;HEART DISEASE#0.9673;FRONTAL#0.9645;DNA METHYLATION#0.9642;URINARY PROTEIN#0.9641;CARDIOMYOCYTE#0.9630;B CELL#0.9621;PROTEINURIA#0.9610;ACUTE KIDNEY INJURY#0.9606;CELL ADHESION MOLECULE#0.9605;PROGESTERONE#0.9604;CELL MEMBRANE#0.9600;ATHEROSCLEROTIC#0.9598;UBIQUITIN#0.9597;CORONARY ARTERY#0.9594;PANCREATITIS#0.9581;LIPOPROTEIN PARTICLE#0.9563;TRANSITIONAL CELL CARCINOMA#0.9558;UTERUS#0.9557;ESTRADIOL#0.9545;ERYTHROCYTE#0.9535;INFLAMMATORY RESPONSE#0.9532;GRANULOSA CELL#0.9514;HUMAN BREAST CANCER#0.9499;ELASTIC FIBER#0.9479;ESTROGEN RECEPTOR#0.9459;PANCREATIC CANCER#0.9435;ETHANOL#0.9427;AUTOPHAGY#0.9418;TISSUE DAMAGE#0.9416;FOLLICLE STIMULATING HORMONE#0.9411;CELL CYCLE ARREST#0.9407;SUPEROXIDE DISMUTASE#0.9405;PHOTORECEPTOR CELL#0.9392;NEUROTOXICITY#0.9384;ISCHEMIA REPERFUSION INJURY#0.9375;MITOCHONDRIA#0.9359;GENTAMICIN#0.9357;CELL SURFACE#0.9354;PITUITARY GLAND#0.9345;LUNG ADENOCARCINOMA#0.9331;INHIBIN#0.9325;MAMMARY EPITHELIAL CELL#0.9321;OBESE#0.9321;DEXAMETHASONE#0.9317;RETINOIC ACID#0.9274;CELLULAR LOCALIZATION#0.9271;AMYLOID PROTEIN#0.9255;AMYLOID PRECURSOR PROTEIN#0.9249;RECURRENCE FREE SURVIVAL#0.9234;DENTATE GYRUS#0.9223;LASER DESORPTION IONIZATION#0.9209;BREAST CARCINOMA#0.9208;HUMAN PROSTATE EPITHELIAL#0.9202;FATTY ACID BINDING#0.9192;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9176;NEURONAL CELLS#0.9165;UNILATERAL URETERAL OBSTRUCTION#0.9146;OVARIAN CARCINOMA#0.9144;APOPTOTIC PROCESS#0.9122;GALECTIN#0.9117;SIZE EXCLUSION CHROMATOGRAPHY#0.9100;PROTEIN KINASE C#0.9096;HYPERTENSION#0.9094;HISTONE DEACETYLASE#0.9094;BLOOD PLASMA#0.9091;AGEING#0.9081;SPERM MOTILITY#0.9076;CEREBRAL AMYLOID ANGIOPATHY#0.9075;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9072;COGNITION#0.9058;VERY-LOW-DENSITY LIPOPROTEIN#0.9054;BONE MARROW#0.9048;DOXORUBICIN#0.9044;HYPOXIC#0.9041;KINASE INHIBITOR#0.9022;CHRONIC KIDNEY DISEASE#0.8988;CELLULAR SENESCENCE#0.8986;DIGESTION#0.8983;EPITHELIAL OVARIAN CANCER#0.8955;INITIAL SEGMENT#0.8945;CELL MIGRATION#0.8939;RETINAL PIGMENT EPITHELIUM#0.8917;POLYCYSTIC KIDNEY DISEASE#0.8887;RECEPTOR ANTAGONIST#0.8868;GEMCITABINE#0.8863;EPITHELIAL MESENCHYMAL TRANSITION#0.8860;RETINAL PIGMENT EPITHELIAL#0.8859;DUCT CELL#0.8833;STEM CELL FACTOR#0.8822;MITOGEN ACTIVATED PROTEIN#0.8814;B CELL LYMPHOMA#0.8813;NITRIC OXIDE#0.8799;NEUROFIBRILLARY TANGLE#0.8795;THYMOCYTE#0.8777;ARTERY DISEASE#0.8774;LUPUS ERYTHEMATOSUS#0.8769;COAGULATION#0.8765;MULTIPLE SCLEROSIS#0.8747;MINI MENTAL STATE#0.8744;AGE RELATED MACULAR DEGENERATION#0.8744;MACULAR DEGENERATION#0.8740;NEURITE#0.8737;SMOOTH MUSCLE ACTIN#0.8735;NODULAR#0.8729;RNA INTERFERENCE#0.8725;NEURAL CELL#0.8717;CORONARY ARTERY DISEASE#0.8692;TRANSCRIPTASE#0.8679;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8679;STROMA#0.8675;PRO-INFLAMMATORY#0.8649;BLOOD VESSEL#0.8645;CHOROID PLEXUS#0.8632;HUMAN UMBILICAL VEIN#0.8613;UMBILICAL VEIN#0.8611;HISTIDINE#0.8591;PROTEIN PROTEIN INTERACTION#0.8577;CONNECTIVE TISSUE#0.8575;ACINAR CELL#0.8569;BASEMENT MEMBRANE#0.8554;LYSOSOME#0.8540;ORNITHINE DECARBOXYLASE#0.8538;LIVER DISEASE#0.8531;NECROTIC#0.8526;KIDNEY DAMAGE#0.8525;GIANT CELL TUMOR#0.8524;MOLAR#0.8523;FLUTAMIDE#0.8520;WEIGHT LOSS#0.8511;LEYDIG CELL#0.8503;MAGNETIC RESONANCE IMAGING#0.8491;POST-TRANSLATIONAL MODIFICATION#0.8486;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8483;RETINITIS PIGMENTOSA#0.8476;SIGNALLING PATHWAY#0.8463;TUMOR TISSUES#0.8453;METHIONINE#0.8450;POLY ADP RIBOSE#0.8445;RHEUMATOID ARTHRITIS#0.8444;NEUROPROTECTION#0.8439;PLATELET-DERIVED GROWTH FACTOR#0.8438;SKELETAL MUSCLE#0.8436;LIPOPROTEIN LIPASE#0.8429;RENAL FIBROSIS#0.8424;LEUKOCYTE#0.8418;PIGMENT EPITHELIAL CELL#0.8417;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8396;EPITHELIAL TO MESENCHYMAL#0.8394;LYMPH NODE METASTASES#0.8392;NODULE FORMATION#0.8388;INFLAMMATORY CELL#0.8373;MYCOSIS FUNGOIDES#0.8368;IMMUNOGLOBULIN G#0.8366;TIGHT JUNCTION#0.8359;RIBOSE#0.8357;HIGH FAT DIET#0.8353;OLIGODENDROCYTE#0.8350;CORONARY HEART DISEASE#0.8348;EXOSOME#0.8346;REGULATION OF APOPTOSIS#0.8329;OSTEOARTHRITIS#0.8329;AKT SIGNALING#0.8323;HEPARIN BINDING#0.8318;STROMAL CELL#0.8311;STRIATUM#0.8302;DNA BINDING#0.8297;AMYOTROPHIC LATERAL SCLEROSIS#0.8272;LATERAL SCLEROSIS#0.8272;MICROGLIAL CELL#0.8270;HEME OXYGENASE 1#0.8259;LDL RECEPTOR#0.8228;NEPHROTOXIC#0.8227;TOLL LIKE RECEPTOR#0.8226;PACHYTENE#0.8219;CHONDROCYTE#0.8194;SIGNAL TRANSDUCER#0.8179;REPLICATIVE SENESCENCE#0.8178;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8177;PROTEIN FOLDING#0.8175;RETINAL PIGMENT EPITHELIAL CELLS#0.8163;MULTIPLE REACTION MONITORING#0.8149;HEAT SHOCK FACTOR#0.8140;HYPOXIA INDUCIBLE FACTOR#0.8133;COLLECTING DUCTS#0.8131;BLADDER CARCINOMA#0.8113;PARENCHYMA#0.8111;TRANSACTIVATION#0.8101;SPERMATOCYTES#0.8086;SECRETORY PATHWAY#0.8075;LUMINAL EPITHELIAL CELL#0.8054;LACTATION#0.8048;PROTEIN COMPLEX#0.8042;OPTIC NERVE#0.8021;INFERTILITY#0.8014;NEPHRON#0.8014;HDL PARTICLE#0.7999;GLOMERULAR FILTRATION#0.7955;ENDOTHELIUM#0.7954;PROTEIN SECRETION#0.7954;MECHANISM OF ACTION#0.7944;SCAVENGER RECEPTOR#0.7935;MORPHOGENESIS#0.7931;ALPHA CELL#0.7927;EXTRACELLULAR SPACE#0.7920;EPILEPSY#0.7919;MITOCHONDRIAL MEMBRANE#0.7894;GENOTOXIC#0.7889;FOLLICULAR DENDRITIC CELL SARCOMA#0.7889;GENE SILENCING#0.7886;SODIUM DODECYL SULFATE#0.7881;DODECYL SULFATE#0.7880;ANDROGEN BINDING#0.7878;DENDRITIC CELL SARCOMA#0.7852;DNA REPAIR PROTEIN#0.7846;NEOADJUVANT HORMONE THERAPY#0.7842;5-AZA-2'-DEOXYCYTIDINE#0.7834;2'-DEOXYCYTIDINE#0.7829;DIABETIC RETINOPATHY#0.7805;HEPARIN#0.7799;ACTIVATOR PROTEIN 1#0.7795;TYPE 2 DIABETIC#0.7759;CAROTID ARTERY#0.7756;PERIPHERAL NERVE#0.7754;VASCULAR CELL#0.7710;SECRETORY CELL#0.7709;MAST CELL#0.7699;MICROTUBULE#0.7674;ENDOMETRIUM#0.7667;DIFFERENTIAL GENE EXPRESSION#0.7661;NEURONAL CELL DEATH#0.7660;EDEMA#0.7652;OXYGENASE#0.7644;TRAUMATIC BRAIN INJURY#0.7641;TRANSLATION INITIATION#0.7628;VASCULAR DEMENTIA#0.7613;RED NUCLEUS#0.7600;CILIARY BODY#0.7585;MESENCHYMAL STEM CELL#0.7575;CORNEAL EPITHELIUM#0.7567;NEPHRITIS#0.7555;CEREBRAL CORTEX#0.7517;EXFOLIATION SYNDROME#0.7514;ACROSOME#0.7501;PHAGOCYTOSIS#0.7497;COMPLEMENT ACTIVITY#0.7486;NEURAL RETINA#0.7457;ATP SYNTHASE#0.7448;KU70 BINDING#0.7437;72-HOURS#0.7433;GLOMERULONEPHRITIS#0.7432;TISSUE TRANSGLUTAMINASE#0.7428;CELL MOTILITY#0.7424;PROXIMAL TUBULAR EPITHELIAL#0.7406;CHOLESTEROL TRANSPORT#0.7390;CHOLESTEROL METABOLISM#0.7389;HISTONE DEACETYLASE INHIBITOR#0.7385;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7376;HODGKIN'S LYMPHOMA#0.7370;GOLGI APPARATUS#0.7369;MAMMARY GLAND INVOLUTION#0.7369;ENDOMETRIAL CARCINOMA#0.7364;ANGIOTENSIN CONVERTING ENZYME#0.7360;BETA GALACTOSIDASE#0.7355;PROTEIN DEGRADATION#0.7354;IFN-GAMMA#0.7333;MONOCYTE CHEMOTACTIC PROTEIN#0.7328;DNA SYNTHESIS#0.7327;OOCYTE#0.7325;VITAMIN A#0.7312;GRANULOCYTE#0.7305;COLORECTAL CARCINOMA#0.7299;ORNITHINE#0.7294;BOVINE SPONGIFORM ENCEPHALOPATHY#0.7290;CYPROTERONE ACETATE#0.7283;TENOSYNOVIAL GIANT CELL TUMOR#0.7277;OXALIPLATIN#0.7268;REPRODUCTIVE SYSTEM#0.7244;OVARIAN FOLLICLE#0.7239;VSMC PROLIFERATION#0.7224;CYTOCHROME C RELEASE#0.7213;ANTI APOPTOSIS#0.7212;RESPONSE TO TREATMENT#0.7208;TERMINAL DIFFERENTIATION#0.7207;TIGHT JUNCTION PROTEIN#0.7198;PLATELET ACTIVATING FACTOR#0.7177;PROSTATE CARCINOMA#0.7175;CELL CYCLE REGULATION#0.7174;PANCREATIC ADENOCARCINOMA#0.7170;LUNG FIBROBLASTS#0.7165;TEMPORAL LOBE#0.7157;CHRONIC HEART FAILURE#0.7151;FOLIC ACID#0.7149;CHEMOTAXIS#0.7125;CELL DIVISION#0.7116;SENSITIZATION#0.7114;CELL ACTIVATION#0.7111;MYOCYTES#0.7088;SURFACE EPITHELIUM#0.7073;RETINITIS#0.7064;STEROID BINDING#0.7060;GLOMERULAR FILTRATION RATE#0.7054;FIBRINOGEN GAMMA CHAIN#0.7035;CELLULAR GROWTH#0.7028;ESTROGENS#0.7008;CASPASE-3 ACTIVITY#0.6997;LIVER CIRRHOSIS#0.6994;PROTEOGLYCAN#0.6989;THYMIDINE#0.6989;HERPES SIMPLEX#0.6988;DIABETIC NEPHROPATHY#0.6964;INFERTILE#0.6962;ACID PHOSPHATASE#0.6957;AMYLOID FIBRIL FORMATION#0.6956;CHOLESTEROL EFFLUX#0.6941;EPITHELIAL CELL DIFFERENTIATION#0.6938;HEPATOCELLULAR CARCINOMA CELL#0.6926;ADIPOSE TISSUE#0.6923;INTRINSIC APOPTOSIS#0.6918;PROGENITOR CELL#0.6918;CORNEAL DYSTROPHY#0.6916;PHOSPHOLIPASE A2#0.6902;HEMORRHAGE#0.6896;CALCIUM CHANNEL#0.6888;DISEASE FREE SURVIVAL#0.6883;SIGNALING CASCADE#0.6882;GROWTH DIFFERENTIATION FACTOR#0.6875;BENIGN PROSTATE HYPERPLASIA#0.6867;ALKALINE PHOSPHATASE#0.6854;NITRIC OXIDE SYNTHASE#0.6852;PRION DISEASE#0.6831;MESANGIAL CELL#0.6812;GESTATION#0.6810;CEREBRAL ISCHEMIA#0.6797;GRAY MATTER VOLUME#0.6790;KERATINOCYTE#0.6790;INGENUITY PATHWAY ANALYSIS#0.6776;CYCLIC AMP#0.6771;1α,25-DIHYDROXYVITAMIN D3#0.6765;RETINAL DAMAGE#0.6755;MALE INFERTILITY#0.6743;URIC ACID#0.6721;NUCLEAR LAYER#0.6707;LDL PARTICLE#0.6702;NERVE GROWTH FACTOR#0.6699;AORTIC VALVE#0.6696;OBSTRUCTIVE NEPHROPATHY#0.6695;TISSUE GROWTH FACTOR#0.6691;MELANOMA CELL LINES#0.6684;HOST CELL#0.6680;LINEAR REGRESSION ANALYSIS#0.6671;PYRAMIDAL CELL#0.6668;HEMOLYSIS#0.6663;QUANTITATIVE REVERSE TRANSCRIPTION#0.6660;ATP BINDING CASSETTE#0.6655;CANCER STEM CELL#0.6653;DIPEPTIDYL PEPTIDASE#0.6648;MYELOID CELL#0.6646;BILE DUCT#0.6643;ATP BINDING#0.6640;RETINOBLASTOMA#0.6639;PULMONARY ARTERIAL HYPERTENSION#0.6638;OVARIES#0.6638;LATERAL VENTRICLE#0.6637;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6636;DIPEPTIDYL PEPTIDASE 4#0.6627;GLUTAMINE#0.6620;CELL CYCLE CONTROL#0.6619;ADVANCED PROSTATE CANCER#0.6607;MICROTUBULE ASSOCIATED PROTEIN#0.6578;PLASMA GLYCOPROTEIN#0.6577;LIPID RAFT#0.6548;FUCHS' ENDOTHELIAL DYSTROPHY#0.6541;PLATELET ACTIVATION#0.6529;INNATE IMMUNITY#0.6528;COLON ADENOCARCINOMA#0.6526;BREAST CANCER PATIENTS#0.6522;GLYCOPROTEIN COMPLEX#0.6512;THALAMUS#0.6505;HEPATITIS B#0.6502;PANCREAS REGENERATION#0.6498;HEPATITIS C#0.6494;RECEIVER OPERATOR CHARACTERISTIC#0.6487;VITAMIN E#0.6469;BORDERLINE OVARIAN TUMOR#0.6454;SYNOVIUM#0.6451;CELL ASSOCIATED#0.6425;PERIODONTITIS#0.6423;ACTINOMYCIN D#0.6421;ENDOPLASMIC RETICULUM STRESS#0.6416;SIGNAL PEPTIDE#0.6415;TOREMIFENE#0.6412;NF-KAPPAB ACTIVATION#0.6412;CREATINE KINASE#0.6403;COMPLEX I#0.6383;MAC FORMATION#0.6328;MDV3100#0.6323;DIHYDROTESTOSTERONE#0.6311;METAPLASIA#0.6308;NEUROTOXIC#0.6297;MILK PROTEIN#0.6295;GROWTH ARREST SPECIFIC#0.6292;QUIESCENCE#0.6281;INSULIN GROWTH FACTOR#0.6270;NONPAPILLARY RENAL CELL CARCINOMA#0.6262;HEALTHY CONTROL GROUP#0.6262;EXTRACELLULAR VESICLE#0.6259;BRAIN DAMAGE#0.6257;HEALTHY CONTROL SUBJECTS#0.6250;ARGININE#0.6243;TAMOXIFEN#0.6235;HEMANGIOMA#0.6232;HISTONE MODIFICATION#0.6226;GLUCOSE REGULATED PROTEIN#0.6223;GERMINAL CENTER#0.6221;RED BLOOD CELL#0.6217;SPINAL CORD INJURY#0.6210;RELATED PROTEIN 1#0.6208;IMMUNE CELL#0.6203;MYOCARDITIS#0.6202;DASATINIB#0.6176;MUCOUS#0.6175;MEGAKARYOCYTE#0.6162;ADIPOCYTE#0.6162;CELL CELL ADHESION#0.6152;INTERSTITIAL CELL#0.6151;MELATONIN#0.6141;PSORIASIS#0.6137;PANCREATIC ISLET#0.6124;OSTEOARTHRITIC CARTILAGE#0.6117;G1 PHASE#0.6114;MUSCLE CELL DIFFERENTIATION#0.6108;RECEPTOR BINDING#0.6104;SERPIN#0.6102;CYTOCHROME P450#0.6091;EPITHELIAL CELL APOPTOSIS#0.6086;IN VITRO ISCHEMIA#0.6083;DESMOPLASTIC MELANOMA#0.6077;RETINAL DEVELOPMENT#0.6070;METALLOPROTEINASE INHIBITOR#0.6069;STAUROSPORINE#0.6069;AUTOIMMUNE DISEASE#0.6061;GROWTH HORMONE#0.6056;LH RECEPTOR#0.6052;CLINICAL DEMENTIA RATING#0.6044;RETINAL HEMANGIOBLASTOMA#0.6040;COATED MEMBRANE#0.6033;ACTIVATED CASPASE 3#0.6028;BETA-HYDROXYSTEROID DEHYDROGENASE#0.6025;OXYGEN GLUCOSE DEPRIVATION#0.6025;CORNEAL ENDOTHELIAL CELL#0.6021;STATUS EPILEPTICUS#0.6014;INVASIVE CERVICAL CANCER#0.6002;DEFAULT MODE NETWORK#0.6002
1192	CHLORIDE CHANNEL#1.0525;PLASMA MEMBRANE#1.0515;CANCER CELL#1.0434;CHANNEL ACTIVITY#1.0352;ION CHANNEL#1.0350;CELL PROLIFERATION#1.0289;OVARIAN CANCER#1.0086;CELL CYCLE#1.0005;APOPTOSIS#0.9991;ION CHANNEL ACTIVITY#0.9984;ENDOTHELIAL CELL#0.9781;STEM CELL#0.9777;COLON CANCER#0.9691;GLUTATHIONE#0.9646;CELL MIGRATION#0.9517;ANION CHANNEL#0.9282;OVARIAN#0.9092;GALLBLADDER CANCER#0.9092;MACROPHAGE#0.9004;SQUAMOUS CELL CARCINOMA#0.8742;NUCLEAR MEMBRANE#0.8722;SIGNALING PATHWAY#0.8613;EPITHELIAL OVARIAN CANCER#0.8611;REACTIVE OXYGEN SPECIES#0.8467;GALLBLADDER#0.8455;CYTOPLASM#0.8245;RNA INTERFERENCE#0.8097;HEAT SHOCK PROTEIN#0.7544;ANGIOGENESIS#0.7460;ORAL SQUAMOUS CELL CARCINOMA#0.7407;HEPATOCELLULAR CARCINOMA#0.7349;POLYMERASE CHAIN REACTION#0.7246;CHLORIDE TRANSPORT#0.7026;LYMPH NODE#0.6946;METFORMIN#0.6913;GROWTH FACTOR#0.6910;ROS GENERATION#0.6875;MAPK SIGNALING#0.6871;LYMPH NODE METASTASIS#0.6844;GENE EXPRESSION#0.6830;SKELETAL MUSCLE#0.6793;PROTEIN KINASE#0.6768;COLORECTAL CANCER#0.6617;ENDOPLASMIC RETICULUM#0.6615;NADPH OXIDASE#0.6398;CELL GROWTH#0.6342;ADENOCARCINOMA#0.6330;MICROGLIAL CELL#0.6188;P38 MAPK SIGNALING#0.6136;CELL MEMBRANE#0.6121
119391	BREAST CANCER#1.0683;GLUTATHIONE#1.0195;POLYMERASE CHAIN REACTION#1.0189;FRAGMENT LENGTH POLYMORPHISM#1.0145;AGE AT ONSET#0.8804;DEHYDROASCORBATE#0.7945;ALZHEIMER'S DISEASE#0.7548;GLUTATHIONE TRANSFERASE#0.7513;OVARIAN CANCER#0.7433;SPERMATOZOA#0.7293;REACTIVE OXYGEN SPECIES#0.7148;DEHYDROASCORBATE REDUCTASE ACTIVITY#0.6919;DETOXIFICATION#0.6892;PARKINSON'S DISEASE#0.6631;COLORECTAL CANCER#0.6051
119392	SWI5-SFR1 COMPLEX#1.2073;HOMOLOGOUS RECOMBINATION#1.0384;MEIOSIS#0.8453;PROTEIN COMPLEX#0.8046;BUDDING#0.7747;REPLICATION PROTEIN A#0.7374;DOUBLE STRAND BREAK#0.6753;MEDIATOR COMPLEX#0.6505;DNA ANNEALING#0.6252
1193	RYANODINE RECEPTOR#0.9698;CHANNEL ACTIVITY#0.7969;GLUTATHIONE#0.7574;CHLORIDE CHANNEL#0.7571;GLUTATHIONE TRANSFERASE#0.6968;INTELLECTUAL DISABILITY#0.6758;X CHROMOSOME#0.6588
119504	C TERMINAL DOMAIN#0.6672;ANAPHASE PROMOTING COMPLEX#0.6245
119559	MACROCYTIC ANEMIA#0.6599;MITOCHONDRIAL DISEASE#0.6146
1195	PROTEIN KINASE#1.0483;MRNA SPLICING#1.0284;PRE-MRNA SPLICING#1.0232;ARGININE#1.0070;PROTEIN PHOSPHORYLATION#0.8954;NUCLEAR SPECKLE#0.8887;GENE EXPRESSION#0.8558;PROTEIN SPLICING#0.7953;ALZHEIMER'S DISEASE#0.7222;CANCER CELL#0.7158;KINASE INHIBITOR#0.7016;RNA PROCESSING#0.6539;APOPTOSIS#0.6216;BENZOTHIAZOLE#0.6202;TRANSCRIPTION FACTOR#0.6157
119682	OLFACTORY RECEPTOR#0.6026
1196	PROTEIN KINASE#0.9373;HIGH FAT DIET#0.7109;BREAST CANCER#0.7051;FATTY ACID OXIDATION#0.6362;OBESE#0.6143
119710	IFT A COMPLEX#1.3112;BBSOME#0.8981
1198	PROTEIN KINASE#0.9829;DUAL-SPECIFICITY PROTEIN KINASE#0.6805
119	HYPERTENSION#0.9887;ERYTHROCYTE#0.9105;PROTEIN KINASE#0.8910;RED BLOOD CELL#0.8552;SPECTRIN#0.8416;HEMOLYTIC ANEMIA#0.7748;PROTEIN KINASE C#0.7366;CALMODULIN BINDING#0.7045;SIGNALING PATHWAY#0.7028;ANEMIA#0.6282;SKELETON#0.6203;ACTIN FILAMENT#0.6195;ESSENTIAL HYPERTENSION#0.6166;PLASMA MEMBRANE#0.6110;GENE EXPRESSION#0.6082
11	N ACETYLTRANSFERASE#0.7917
120071	GLYCOSYLATION#0.9017;PROSTATE CANCER#0.8540;LAMININ BINDING#0.7079
1200	TRIPEPTIDYL PEPTIDASE#1.0633;LYSOSOMAL STORAGE DISORDER#1.0384;ADENO ASSOCIATED VIRUS#1.0310;NEURONAL CEROID LIPOFUSCINOSIS#1.0300;NEURODEGENERATIVE DISEASE#1.0254;PALMITOYL#1.0131;KINASE ACTIVITY#1.0058;CELL CYCLE ARREST#1.0045;G1 PHASE#0.9959;S PHASE#0.9945;TRANSCRIPTION FACTOR#0.9913;ENZYME ACTIVITY#0.9889;LYSOSOME#0.9884;CYCLIN DEPENDENT KINASE#0.9884;PROTEIN KINASE#0.9838;CELL CYCLE#0.9831;BUDDING#0.9814;CENTRAL NERVOUS SYSTEM#0.9750;NERVOUS SYSTEM#0.9740;LYSOSOMAL STORAGE DISEASE#0.9723;GENE EXPRESSION#0.9720;CELL DIVISION#0.9632;DNA REPLICATION#0.9599;ATP SYNTHASE#0.9555;DIPEPTIDYL PEPTIDASE#0.9368;UBIQUITIN#0.9274;CELL CYCLE REGULATION#0.9058;ENZYME REPLACEMENT THERAPY#0.8947;LEUKOCYTE#0.8855;DNA SYNTHESIS#0.8776;PEPSTATIN#0.8736;CELL GROWTH#0.8635;RETINAL DEGENERATION#0.8596;EPILEPSY#0.8448;MITOSIS#0.8394;MORPHOGENESIS#0.8234;PROTEIN DEGRADATION#0.8158;PROTEIN SYNTHESIS#0.8110;GLYCOSYLATION#0.7915;SIGNAL TRANSDUCTION#0.7854;M PHASE#0.7841;SKIN FIBROBLASTS#0.7124;BETA GALACTOSIDASE#0.7110;DRIED BLOOD SPOT#0.7042;PROTEASOME#0.6982;STEM CELL#0.6927;CDK INHIBITOR#0.6829;SIGNALING PATHWAY#0.6820;BLINDNESS#0.6631;APOPTOSIS#0.6596;CELL DEATH#0.6554;NEUROLOGICAL DISORDER#0.6522;CELL PROLIFERATION#0.6432;MEIOSIS#0.6378;PROTEIN KINASE ACTIVITY#0.6367;AUTOSOMAL RECESSIVE DISEASE#0.6342;PHEROMONE SIGNALING#0.6299;ENDOPEPTIDASE ACTIVITY#0.6241;ACTIN CYTOSKELETON#0.6213;NUCLEAR EXPORT#0.6101;ALPHA MANNOSIDASE#0.6025
120103	INTEGRIN LINKED KINASE#0.9413;ROOT HAIR#0.8383;MUSCLE CELL#0.8305;ROOT HAIR ELONGATION#0.7067;CELL MEMBRANE#0.6331;EPITHELIAL CELL#0.6285;CANCER CELL#0.6270;RAPAMYCIN#0.6200
120114	CELL POLARITY#0.7396;AMACRINE CELL#0.6526;PLANAR CELL POLARITY#0.6027
1201	PLASMA MEMBRANE#1.0359;RETINAL DEGENERATION#1.0330;NEURONAL CELLS#1.0296;LYSOSOMAL MEMBRANE#1.0288;APOPTOSIS#1.0250;NEURONAL CEROID LIPOFUSCINOSIS#1.0239;LYSOSOME#1.0192;NEURODEGENERATIVE DISEASE#1.0105;LYSOSOMAL STORAGE DISORDER#1.0100;CYCLIN DEPENDENT KINASE#1.0051;S PHASE#0.9992;VACUOLE#0.9990;LYSOSOMAL STORAGE DISEASE#0.9956;KINASE ACTIVITY#0.9946;BUDDING#0.9944;CELL CYCLE#0.9940;CELL DIVISION#0.9933;TRANSCRIPTION FACTOR#0.9892;CELL CYCLE ARREST#0.9877;G1 PHASE#0.9863;ENDOPLASMIC RETICULUM#0.9836;GENE EXPRESSION#0.9822;PROTEIN KINASE#0.9797;CELL GROWTH#0.9704;ENDOSOME#0.9595;CANCER CELL#0.9255;AUTOPHAGY#0.9252;ATP SYNTHASE#0.9020;CELL DEATH#0.8946;AMPA RECEPTOR#0.8889;NERVOUS SYSTEM#0.8622;PROTEIN SYNTHESIS#0.8558;LYMPHOBLAST#0.8418;ARGININE#0.8417;DNA REPLICATION#0.8410;GLUTAMATE RECEPTOR#0.8382;STEM CELL#0.8299;CELL PROLIFERATION#0.8250;ENZYME ACTIVITY#0.8109;BLINDNESS#0.8051;UBIQUITIN#0.8050;CELL WALL#0.8029;GLUTAMIC ACID#0.8013;FILAMENTOUS GROWTH#0.7950;ASTROCYTE#0.7919;MORPHOGENESIS#0.7877;ACID PHOSPHATASE#0.7870;MEIOSIS#0.7677;MITOCHONDRIA#0.7614;CENTRAL NERVOUS SYSTEM#0.7562;ADENO ASSOCIATED VIRUS#0.7511;INDUCED PLURIPOTENT STEM CELL#0.7500;PLURIPOTENT STEM CELL#0.7482;PRECURSOR CELL#0.7474;SIGNALLING PATHWAY#0.7469;RECEPTOR ACTIVITY#0.7448;RNA INTERFERENCE#0.7390;CELL DIVISION CYCLE#0.7384;AGE AT ONSET#0.7293;HISTONE DEACETYLASE#0.7281;PALMITOYL#0.7205;ENDOCYTOSIS#0.7046;ARGININE TRANSPORT#0.7001;DELTA CELL#0.6915;RNA BINDING#0.6901;LATE ENDOSOME#0.6814;OPTIC NERVE#0.6784;ATPASE ACTIVITY#0.6762;PROTEIN SECRETION#0.6759;LIPID RAFT#0.6747;POSTTRANSLATIONAL MODIFICATION#0.6737;EPILEPSY#0.6709;POLYMERASE CHAIN REACTION#0.6682;CELL SIZE CONTROL#0.6588;MITOSIS#0.6585;AMPA RECEPTOR ACTIVITY#0.6583;CYTOKINESIS#0.6362;APOPTOTIC#0.6307;CEREBRAL CORTEX#0.6254;CELL CYCLE CONTROL#0.6208;NITRIC OXIDE#0.6205;PROTEIN PROTEIN INTERACTION#0.6203;AUTOPHAGOSOME#0.6162;FLUPIRTINE#0.6132;MICROTUBULE#0.6112;SPORULATION#0.6083;RNA BINDING PROTEIN#0.6068;MITOTIC CELL CYCLE#0.6047;RECYCLING ENDOSOME#0.6034;PREMATURE TERMINATION CODON#0.6034;PROTEIN TRANSPORT#0.6012;RETINAL DISEASE#0.6002
120224	CANCER CELL#0.7595;PANCREATIC CANCER#0.6364;CELL CYCLE#0.6275;CELL PROLIFERATION#0.6264
120227	VITAMIN D BINDING#1.0484;7 DEHYDROCHOLESTEROL REDUCTASE#1.0467;VITAMIN D3#1.0341;CYTOCHROME P450#1.0243;VITAMIN D RECEPTOR#1.0135;RICKETS#1.0056;TYPE 1 DIABETES#1.0025;VITAMIN D METABOLISM#1.0021;VITAMIN D DEFICIENCY#0.9900;GENE EXPRESSION#0.9687;HEPATITIS C#0.9331;25-HYDROXYVITAMIN D3#0.9292;POLYMERASE CHAIN REACTION#0.8672;CHOLECALCIFEROL#0.8571;LEYDIG CELL#0.7971;HEPATITIS C VIRUS#0.7950;1α,25-DIHYDROXYVITAMIN D3#0.7928;MULTIPLE SCLEROSIS#0.7884;BONE MINERAL DENSITY#0.7751;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7673;CHRONIC HEPATITIS C#0.7644;COLORECTAL CANCER#0.7598;ACTIVE VITAMIN D#0.7390;HYDROXYLASE ACTIVITY#0.7301;VITAMIN D SYNTHESIS#0.7101;TYPE 2 DIABETES#0.7067;HIGH FAT DIET#0.6918;COLORECTAL#0.6894;LIVER DISEASE#0.6797;AUTOIMMUNE DISEASE#0.6642;VITAMIN D2#0.6355;DNA METHYLATION#0.6332;FRAGMENT LENGTH POLYMORPHISM#0.6243;NICOTINAMIDE#0.6240;ADENINE#0.6222;IMMUNE CELL#0.6012
120237	INTERNEURON#1.0679;TRANSCRIPTION FACTOR#1.0434;GLUTAMATERGIC NEURON#0.9287;SPINAL CORD#0.8627;RETICULAR FORMATION#0.8091;NERVOUS SYSTEM#0.7403;NEURAL TUBE#0.7019;PROGENITOR CELL#0.6949;CAJAL-RETZIUS CELL#0.6632;AMYGDALA#0.6107
120376	COLORECTAL CANCER#0.7505;TUMOR CELLS#0.6364;COLORECTAL#0.6181
1203	NEURONAL CEROID LIPOFUSCINOSIS#1.0354;LYSOSOME#1.0068;NEURODEGENERATIVE DISEASE#1.0041;ATP SYNTHASE#0.9573;LYSOSOMAL STORAGE DISEASE#0.9474;EPILEPSY#0.9364;NERVOUS SYSTEM#0.9242;CENTRAL NERVOUS SYSTEM#0.9188;ENDOPLASMIC RETICULUM#0.9040;PALMITOYL#0.9019;ENDOTHELIAL CELL#0.8568;TRIPEPTIDYL PEPTIDASE#0.8439;MENTAL RETARDATION#0.8258;GENE EXPRESSION#0.8020;DEMENTIA#0.7995;LEUKOCYTE#0.7858;BLINDNESS#0.7423;NEUROLOGICAL DISORDER#0.7378;BLOOD BRAIN BARRIER#0.7340;GLYCOSYLATION#0.7340;AGE AT ONSET#0.7149;INTERNEURON#0.7008;MITOCHONDRIAL MEMBRANE#0.6955;TIGHT JUNCTION#0.6855;STEM CELL#0.6821;LYSOSOMAL STORAGE DISORDER#0.6763;MAGNETIC RESONANCE IMAGING#0.6552;INDUCED PLURIPOTENT STEM CELL#0.6156;MICROVASCULAR ENDOTHELIAL CELL#0.6152;DRIED BLOOD SPOT#0.6148;PLURIPOTENT STEM CELL#0.6140;MOLECULAR FUNCTION#0.6059;FRONTOTEMPORAL DEMENTIA#0.6008
120425	OSTEOARTHRITIS#0.7209
120526	DIPHTHAMIDE#0.7190;IRON BINDING#0.6217
120528	BETA-2#0.8927;T CELL#0.6761;FORMALIN#0.6185
1207	ION CHANNEL#1.0732;CHLORIDE CHANNEL#1.0573;SWELLING#1.0377;PLASMA MEMBRANE#0.9979;REGULATORY VOLUME DECREASE#0.9482;EPITHELIAL CELL#0.8523;RESONANCE ENERGY TRANSFER#0.7970;RNA PROCESSING#0.7313;CELL MEMBRANE#0.7077;OOCYTE#0.6999
120892	SPORADIC PARKINSON DISEASE#1.0895;AUTOSOMAL DOMINANT PARKINSONISM#1.0857;LATE ONSET PARKINSON'S DISEASE#1.0765;VESICLE TRAFFICKING#1.0645;MONONUCLEAR CELLS#1.0559;NEURITE OUTGROWTH#1.0545;LEPROSY#1.0534;IMMUNE CELL#1.0512;GTPASE ACTIVITY#1.0482;GTP HYDROLYSIS#1.0437;PERIPHERAL BLOOD#1.0431;INFLAMMATORY RESPONSE#1.0430;PERIPHERAL BLOOD MONONUCLEAR CELLS#1.0426;SYNAPTIC VESICLE#1.0411;CROHN'S DISEASE#1.0394;DEPHOSPHORYLATION#1.0387;NEUROTOXICITY#1.0381;KINASE INHIBITOR#1.0368;MITOCHONDRIAL FISSION#1.0366;LEWY BODY PATHOLOGY#1.0363;NEURITE#1.0360;LEUCINE RICH REPEAT#1.0357;INDUCED PLURIPOTENT STEM CELL#1.0339;KINASE ACTIVITY#1.0334;SIGNAL TRANSDUCTION#1.0329;LEUCINE#1.0328;PLURIPOTENT STEM CELL#1.0312;GTP BINDING#1.0312;PROTEIN SYNTHESIS#1.0294;PROTEIN PROTEIN INTERACTION#1.0291;MICROTUBULE#1.0268;MULTIPLE SYSTEM ATROPHY#1.0265;ENDOCYTOSIS#1.0256;NEUROBLASTOMA#1.0252;TOXICITY#1.0244;MACROPHAGE#1.0225;IMMUNE SYSTEM#1.0222;STRIATUM#1.0206;STEM CELL#1.0205;PROTEIN KINASE#1.0187;CATALYTIC ACTIVITY#1.0184;LYSOSOME#1.0182;MITOGEN ACTIVATED PROTEIN#1.0144;AUTOPHAGY#1.0134;MYELOID CELL#1.0117;ENDOPLASMIC RETICULUM#1.0111;IMMUNE RESPONSE#1.0107;MICROTUBULE ASSOCIATED PROTEIN#1.0075;MIDBRAIN#1.0059;SIGNALING PATHWAY#1.0059;DENDRITIC CELL#1.0057;INFLAMMATORY BOWEL DISEASE#1.0048;APOPTOTIC#1.0046;SYNAPTIC VESICLE ENDOCYTOSIS#1.0038;B CELL#1.0026;GENE EXPRESSION#1.0023;LEWY BODY#1.0022;PARKINSON'S DISEASE#1.0018;VESICLE ENDOCYTOSIS#1.0008;MITOCHONDRIA#1.0001;APOPTOSIS#1.0000;CELL DEATH#0.9999;BACTERIAL ARTIFICIAL CHROMOSOME#0.9995;ESSENTIAL TREMOR#0.9981;UBIQUITIN#0.9981;LEWY BODY DISEASE#0.9971;POLYMERASE CHAIN REACTION#0.9971;PRO-INFLAMMATORY#0.9960;PROGRESSIVE SUPRANUCLEAR PALSY#0.9947;DOPAMINE#0.9939;IDIOPATHIC PARKINSON DISEASE#0.9930;L-DOPA#0.9928;BASAL GANGLIA#0.9920;AGE AT ONSET#0.9916;DOPAMINERGIC NEURON#0.9910;NEUROGENESIS#0.9878;REACTIVE OXYGEN SPECIES#0.9870;ALZHEIMER'S DISEASE#0.9860;SUBSTANTIA NIGRA#0.9856;DEMENTIA#0.9853;MONOCYTE#0.9846;NERVOUS SYSTEM#0.9836;NEUROTRANSMISSION#0.9822;PROTEASOME#0.9816;MITOPHAGY#0.9805;LEVODOPA#0.9804;OLFACTION#0.9788;CENTRAL NERVOUS SYSTEM#0.9778;NEUROTOXIC#0.9749;PROTEIN DEGRADATION#0.9748;SYNAPTIC TRANSMISSION#0.9703;CELL CYCLE#0.9694;CELLULAR LOCALIZATION#0.9693;SIGNALLING PATHWAY#0.9663;ENDOSOME#0.9660;NEURODEGENERATIVE DISEASE#0.9644;ASTROCYTE#0.9617;GUANINE#0.9569;AUTOPHAGOSOME#0.9562;HEAT SHOCK PROTEIN#0.9554;CYTOTOXICITY#0.9539;NEURONAL CELL DEATH#0.9539;DYSKINESIA#0.9519;EXOSOME#0.9508;MACROAUTOPHAGY#0.9424;NEUROPROTECTION#0.9416;MITOCHONDRIAL DNA#0.9321;ACTIN CYTOSKELETON#0.9318;TRANSCRIPTION FACTOR#0.9262;EARLY-ONSET PARKINSON'S DISEASE#0.9259;SYNUCLEINOPATHY#0.9246;NEUROFIBRILLARY TANGLE#0.9214;DOPAMINE RECEPTOR#0.9122;GROWTH FACTOR#0.9091;DEEP BRAIN STIMULATION#0.9091;DISEASE MODIFYING TREATMENT#0.9070;NEURAL CELL#0.9069;T CELL#0.9043;NEURONAL CELLS#0.9007;AMYOTROPHIC LATERAL SCLEROSIS#0.9007;LATERAL SCLEROSIS#0.9007;ORGANELLE#0.8970;EPITHELIAL CELL#0.8966;NEUROLOGICAL DISORDER#0.8929;NEUROTRANSMITTER RELEASE#0.8909;CHAPERONE MEDIATED AUTOPHAGY#0.8884;PROTEIN TRANSLATION#0.8883;NEURAL STEM CELL#0.8858;LATE ENDOSOME#0.8808;POSITRON EMISSION TOMOGRAPHY#0.8806;COMPLEX I#0.8783;NEUROMUSCULAR JUNCTION#0.8777;TOLL LIKE RECEPTOR#0.8769;NUCLEOTIDE BINDING#0.8739;SUBTHALAMIC NUCLEUS#0.8711;POSITIVE FAMILY HISTORY#0.8678;MIXED LINEAGE KINASE#0.8673;CEREBRAL CORTEX#0.8664;REGULATION OF AUTOPHAGY#0.8643;DISEASE MODIFYING THERAPIES#0.8621;RAPID EYE MOVEMENT#0.8600;MTDNA#0.8579;MITOCHONDRIAL MEMBRANE#0.8561;COLITIS#0.8554;REM SLEEP BEHAVIOR DISORDER#0.8467;ATP BINDING#0.8431;HEALTHY CONTROL SUBJECTS#0.8413;CELL PROLIFERATION#0.8380;SYNAPTIC VESICLE TRAFFICKING#0.8372;REVERSE TRANSCRIPTION#0.8343;LEUKOCYTE#0.8297;GLIAL CELL#0.8261;RETROMER COMPLEX#0.8201;NUCLEOTIDE EXCHANGE FACTOR#0.8198;INNATE IMMUNITY#0.8062;COGNITION#0.8056;TAUOPATHY#0.8034;LIPID RAFT#0.7996;BONE MARROW#0.7982;FRONTOTEMPORAL DEMENTIA#0.7977;RESPIRATORY CHAIN#0.7976;APOPTOTIC CELL DEATH#0.7952;RNA INTERFERENCE#0.7927;CYTOPLASMIC INCLUSION#0.7851;CHEMOTAXIS#0.7848;DYSTONIA#0.7842;RIBOSOMAL PROTEIN#0.7839;GOLGI APPARATUS#0.7824;UBIQUITIN PROTEASOME SYSTEM#0.7805;DNA BINDING#0.7732;MICROTUBULE DYNAMICS#0.7726;SMELL IDENTIFICATION TEST#0.7706;FIBRIL#0.7686;BREAST CANCER#0.7659;PROTEIN KINASE A#0.7632;MITOCHONDRIAL DEPOLARIZATION#0.7617;PRIMARY CORTICAL NEURON#0.7613;TUMOR NECROSIS FACTOR#0.7562;NEUROTOXIN#0.7550;STRUCTURE ACTIVITY RELATIONSHIP#0.7544;AMYLOID PRECURSOR PROTEIN#0.7492;MORPHOGENESIS#0.7489;CHAPERONE ACTIVITY#0.7476;MINI MENTAL STATE#0.7461;NUCLEAR ENVELOPE#0.7421;CYTOPLASM#0.7414;MICROGLIAL CELL#0.7402;FRONTAL#0.7400;TRAUMATIC BRAIN INJURY#0.7391;HYPERACTIVE#0.7383;PROGENITOR CELL#0.7358;EPIDERMAL GROWTH FACTOR#0.7347;PLASMA MEMBRANE#0.7309;MODE OF ACTION#0.7309;NITRIC OXIDE#0.7304;GLYCINE#0.7293;VACUOLAR PROTEIN SORTING#0.7291;LUPUS ERYTHEMATOSUS#0.7287;COPY NUMBER VARIATION#0.7260;PHAGOCYTOSIS#0.7154;MAP KINASE#0.7152;GROWTH FACTOR RECEPTOR#0.7147;BLOOD BRAIN BARRIER#0.7129;SENSE OF SMELL#0.7125;THALAMUS#0.7029;GUANOSINE#0.7018;UBIQUITIN PROTEIN LIGASE#0.7008;ADENOSINE#0.6979;PANETH CELL#0.6946;TRANSLATION INITIATION#0.6924;GENETIC ASSOCIATION STUDIES#0.6920;LEWY NEURITE#0.6918;SLEEPINESS#0.6912;AXONAL TRANSPORT#0.6879;PROTEIN KINASE ACTIVITY#0.6875;VOXEL BASED MORPHOMETRY#0.6839;INNERVATION#0.6813;CASEIN KINASE 1#0.6801;TRANS GOLGI NETWORK#0.6799;SIGNALING CASCADE#0.6794;NEURON SURVIVAL#0.6773;CELL DIFFERENTIATION#0.6767;SLEEP DISORDER#0.6764;CELL ADHESION#0.6757;FALSE DISCOVERY RATE#0.6729;CANCER CELL#0.6721;POST-TRANSLATIONAL MODIFICATION#0.6712;TRANSLATION INITIATION FACTOR#0.6707;SKIN CANCER#0.6690;MAPKKK ACTIVITY#0.6684;GOLGI COMPLEX#0.6680;EXOCYTOSIS#0.6662;CYCLIN DEPENDENT KINASE#0.6650;RAPAMYCIN#0.6628;ALANINE#0.6609;C TERMINAL DOMAIN#0.6597;B LYMPHOCYTE#0.6574;CONSTIPATION#0.6571;RETINOIC ACID#0.6562;CELL CYCLE ARREST#0.6558;CELL MIGRATION#0.6542;HYPERPHOSPHORYLATION#0.6496;AGEING#0.6478;ENDOPLASMIC RETICULUM STRESS#0.6446;OLFACTORY BULB#0.6445;ULCERATIVE COLITIS#0.6438;LEWY BODY FORMATION#0.6427;AGGRESOME#0.6333;CILIOGENESIS#0.6279;NEURAL PROGENITOR CELL#0.6275;WNT-PCP SIGNALING PATHWAY#0.6252;LIGHT CHAIN 3#0.6244;PROTEIN INTERACTION NETWORK#0.6211;OUTER MEMBRANE#0.6186;MAGNETIC RESONANCE IMAGING#0.6186;EARLY ONSET PARKINSONISM#0.6177;GRAY MATTER VOLUME#0.6150;LINES OF EVIDENCE#0.6150;NITRIC OXIDE SYNTHASE#0.6137;MEDIUM SPINY NEURONS#0.6109;QUANTITATIVE REAL TIME#0.6107;SYNAPTIC VESICLE RECYCLING#0.6074;AMYGDALA#0.6060;EXCESSIVE DAYTIME SLEEPINESS#0.6033;TO THE PROGRESSION#0.6025;MOUSE EMBRYONIC FIBROBLAST#0.6015;PROTEIN QUALITY CONTROL#0.6014;HUMAN EMBRYONIC KIDNEY#0.6008;EMBRYONIC KIDNEY#0.6003
1208	TRIGLYCERIDE LIPASE#1.0494;PHOSPHOLIPASE A2#1.0472;C TERMINAL DOMAIN#1.0450;LIPASE ACTIVITY#1.0105;DIGESTION#1.0049;LIPOLYSIS#1.0032;CATALYTIC ACTIVITY#0.9728;ENZYME ACTIVITY#0.9287;PANCREATITIS#0.9090;HIGH FAT DIET#0.8858;MOLAR#0.8738;LIPID DIGESTION#0.8588;ANCHORING#0.8558;OBESE#0.8498;ACUTE PANCREATITIS#0.8353;LIPASE BINDING#0.8156;COMPLEX I#0.8148;HIGH FAT FEEDING#0.8040;DUODENUM#0.7897;LIPID BINDING#0.7581;TYPE 2 DIABETES#0.7547;PHOSPHOLIPASE A#0.7353;TRYPTOPHAN#0.7323;STEATORRHEA#0.7272;AMYLASE ACTIVITY#0.6970;LIPID DROPLET#0.6944;OLEIC ACID#0.6828;LIPOPROTEIN LIPASE#0.6506;STREPTOZOTOCIN#0.6502;TRIGLYCERIDE LIPASE ACTIVITY#0.6428;TAUROCHOLATE#0.6042;DIABETES MELLITUS#0.6010
120939	ONCOGENIC#0.6472
1209	CLEFT LIP#0.7590
120	BILIARY ATRESIA#0.9629;HYPERTENSION#0.8514;GENE EXPRESSION#0.8340;PROTEIN KINASE#0.6032
1211	ENDOCYTOSIS#0.7882;COATED VESICLE#0.7562;CLATHRIN HEAVY CHAIN#0.7297
121214	ICHTHYOSIS#0.9812;AUTOSOMAL RECESSIVE CONGENITAL ICHTHYOSIS#0.9556;RETINOL#0.6391
121227	LEUCINE RICH REPEAT#1.0642;APOPTOSIS#1.0514;LEUCINE#1.0323;TUMOR SUPPRESSOR#0.9605;GROWTH FACTOR#0.8775;CELL CYCLE#0.8723;INNER EAR#0.8507;SIGNALING PATHWAY#0.8402;GENE SILENCING#0.8019;CELL PROLIFERATION#0.8008;GROWTH FACTOR RECEPTOR#0.7906;GENE EXPRESSION#0.7351;EPIDERMAL GROWTH FACTOR#0.7038;INNER EAR MORPHOGENESIS#0.6984;EAR MORPHOGENESIS#0.6926;RECEPTOR TYROSINE KINASE#0.6895;MORPHOGENESIS#0.6621;SQUAMOUS CELL CARCINOMA#0.6599;CERVICAL#0.6560;RNA INTERFERENCE#0.6302
121256	PANIC DISORDER#1.0443;T CELL#0.7751;VITELLOGENESIS#0.6435;ANXIETY DISORDER#0.6406
121260	HISTIDINE#1.0646;PEPTIDE TRANSPORTER#1.0320;OLIGOPEPTIDE TRANSPORTER#1.0292;L-HISTIDINE#0.9691;PLASMA MEMBRANE#0.9536;GENE EXPRESSION#0.9506;DENDRITIC CELL#0.8874;IMMUNE RESPONSE#0.8644;PHOSPHATE TRANSPORT#0.7499;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7427;LUPUS ERYTHEMATOSUS#0.7425;TOLL LIKE RECEPTOR#0.7206;POLYMERASE CHAIN REACTION#0.7056;INNATE IMMUNE RESPONSE#0.6441;PLASMACYTOID DENDRITIC CELL#0.6082
121268	CLEAR CELL RENAL CELL CARCINOMA#0.6425;RENAL CELL CARCINOMA#0.6305
121274	ZINC FINGER PROTEIN#0.8372
121278	SEROTONIN BIOSYNTHESIS#1.0683;RAPHE NUCLEI#1.0379;SEROTONIN RECEPTOR#1.0363;AMYGDALA#1.0330;SEROTONIN SYNTHESIS#1.0313;TRYPTOPHAN#1.0301;BIPOLAR DISORDER#1.0232;POLYMERASE CHAIN REACTION#1.0174;MIDBRAIN#1.0166;FLUOXETINE#1.0159;MAJOR DEPRESSIVE DISORDER#1.0147;ENZYME ACTIVITY#1.0068;SEROTONERGIC NEURON#1.0048;DOPAMINE#1.0037;PANIC DISORDER#1.0007;GENE EXPRESSION#0.9968;DEPRESSIVE SYMPTOMS#0.9955;ANXIETY DISORDER#0.9936;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9884;TRANSCRIPTION FACTOR#0.9870;O METHYLTRANSFERASE#0.9844;CENTRAL NERVOUS SYSTEM#0.9825;NERVOUS SYSTEM#0.9803;FRONTAL#0.9798;NEUROTRANSMISSION#0.9791;CITALOPRAM#0.9711;MOOD DISORDER#0.9710;HYPERACTIVITY#0.9672;CATECHOL O METHYLTRANSFERASE#0.9664;SEROTONIN REUPTAKE INHIBITOR#0.9651;TRYPTOPHAN 5 MONOOXYGENASE#0.9621;FORCED SWIM TEST#0.9609;PINEAL GLAND#0.9596;STRIATUM#0.9399;PROTEIN KINASE#0.9264;QUANTITATIVE REAL TIME#0.9239;AUTISM SPECTRUM DISORDER#0.9199;PAROXETINE#0.9170;ALCOHOL DEPENDENCE#0.9105;TRANSCRIPTIONAL CONTROL#0.8986;AGGRESSIVE BEHAVIOR#0.8892;RESPONSE TO ANTIDEPRESSANT#0.8846;PERSONALITY DISORDER#0.8828;5-HT RECEPTOR#0.8813;LOCUS COERULEUS#0.8796;BRAIN DEVELOPMENT#0.8762;ESTRADIOL#0.8761;ESTROGEN RECEPTOR#0.8616;OBSESSIVE COMPULSIVE DISORDER#0.8409;TAIL SUSPENSION TEST#0.8404;OPEN FIELD TEST#0.8403;NOREPINEPHRINE#0.8364;GLUCOCORTICOID RECEPTOR#0.8262;MEDIAL PREFRONTAL CORTEX#0.8223;5-HYDROXYTRYPTAMINE RECEPTOR#0.8194;ENTEROCHROMAFFIN CELL#0.8177;NEUROGENESIS#0.8169;RECEPTOR AGONIST#0.8156;HYPOXIA#0.8049;L-TRYPTOPHAN#0.8046;OVARIAN#0.7952;COGNITION#0.7924;PARANOID SCHIZOPHRENIA#0.7864;ELEVATED PLUS MAZE#0.7845;FOREBRAIN#0.7779;LINKED POLYMORPHIC REGION#0.7755;MELATONIN#0.7522;BLOOD BRAIN BARRIER#0.7400;MIGRAINE#0.7175;HYPOTHALAMIC PITUITARY ADRENAL#0.7156;RESPONSE TO TREATMENT#0.7078;SEROTONIN METABOLISM#0.7004;TYROSINE 3 MONOOXYGENASE#0.6993;REVERSE TRANSCRIPTION#0.6988;STEM CELL#0.6967;PARKINSON'S DISEASE#0.6855;ETHANOL#0.6842;17β-ESTRADIOL#0.6768;DOPAMINE RECEPTOR#0.6741;MOTOR ACTIVITY#0.6737;SUBSTANTIA NIGRA#0.6723;SEROTONIN RELEASE#0.6722;SIGNALING PATHWAY#0.6697;RECEPTOR BINDING#0.6647;ANTERIOR CINGULATE CORTEX#0.6577;DIURNAL#0.6508;ADENO ASSOCIATED VIRUS#0.6503;MAGNETIC RESONANCE IMAGING#0.6463;CHRONIC MILD STRESS#0.6324;HYDROXYLASE ACTIVITY#0.6307;GENETIC ASSOCIATION STUDIES#0.6279;HINDBRAIN#0.6248;ALZHEIMER'S DISEASE#0.6244;FEAR RESPONSE#0.6222;COCAINE DEPENDENCE#0.6114;HYPOXIC#0.6099;CORTISOL#0.6082;TESTOSTERONE#0.6081;FRAGMENT LENGTH POLYMORPHISM#0.6025;DNA METHYLATION#0.6003
1212	COATED VESICLE#1.0227;CLATHRIN HEAVY CHAIN#1.0220;ENDOCYTOSIS#0.9969;CLATHRIN COATED VESICLE#0.9964;PLASMA MEMBRANE#0.9316;CLATHRIN LIGHT CHAIN BINDING#0.8975;CLATHRIN-MEDIATED ENDOCYTOSIS#0.8785;ACTIN BINDING#0.7790;COATED PIT#0.6835;PROTEIN KINASE#0.6576;SYNAPTIC VESICLE#0.6482;VESICLE FORMATION#0.6459
121340	CORE BINDING FACTOR#1.0436;COLLAGEN TYPE I#1.0303;FACTOR I#1.0158;TRANSCRIPTION FACTOR#1.0148;ENDOTHELIAL GROWTH FACTOR#1.0135;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0135;BONE MINERALIZATION#1.0110;TOOTH DEVELOPMENT#1.0086;NODULE FORMATION#1.0076;DENTIN MATRIX PROTEIN#1.0070;MATRIX PROTEIN 1#1.0051;QUANTITATIVE REAL TIME#1.0043;RECEPTOR ACTIVATOR#1.0028;ODONTOBLAST DIFFERENTIATION#0.9943;ALKALINE PHOSPHATASE ACTIVITY#0.9927;ENDOCHONDRAL OSSIFICATION#0.9910;CHONDROCYTE#0.9909;PHOSPHATASE ACTIVITY#0.9908;OSTEOCYTE#0.9904;OSTEOBLAST DIFFERENTIATION#0.9897;INSULIN-LIKE GROWTH FACTOR#0.9891;ALKALINE PHOSPHATASE#0.9887;OSTEOBLAST#0.9880;REVERSE TRANSCRIPTION#0.9868;INTEGRIN BINDING#0.9863;POLYMERASE CHAIN REACTION#0.9859;CHONDROCYTE DIFFERENTIATION#0.9856;ACID PHOSPHATASE#0.9844;SMOOTH MUSCLE#0.9826;ALIZARIN RED S#0.9822;PARATHYROID HORMONE#0.9815;BONE MORPHOGENETIC PROTEIN#0.9800;MITOGEN ACTIVATED PROTEIN#0.9782;GENE EXPRESSION#0.9776;OSSIFICATION#0.9774;PEROXISOME#0.9767;OSTEOBLAST PROLIFERATION#0.9764;SKELETAL DEVELOPMENT#0.9763;BONE DEVELOPMENT#0.9745;MINERALIZATION#0.9745;ADIPOGENESIS#0.9738;HUMAN PERIODONTAL LIGAMENT#0.9735;FEMUR#0.9734;ADIPOCYTE#0.9733;CELL GROWTH#0.9727;DNA BINDING#0.9722;MARROW STROMAL CELLS#0.9721;ENDOTHELIAL CELL#0.9719;CARTILAGE FORMATION#0.9715;PROTEIN KINASE#0.9714;TRANSFORMING GROWTH FACTOR#0.9709;ALIZARIN RED STAINING#0.9707;BONE MARROW STROMAL CELL#0.9705;DEXAMETHASONE#0.9704;OSTEOGENESIS#0.9698;PROGENITOR CELL#0.9697;SKELETON#0.9697;MESENCHYMAL CELL#0.9693;SMOOTH MUSCLE CELL#0.9692;PARATHYROID#0.9691;MUSCLE CELL#0.9690;MESENCHYMAL STROMAL CELL#0.9682;HUMAN MESENCHYMAL STEM#0.9680;BONE MINERAL DENSITY#0.9676;BONE MARROW STROMAL#0.9675;EXTRACELLULAR MATRIX#0.9674;ADIPOSE-DERIVED STEM CELL#0.9669;VASCULAR SMOOTH MUSCLE CELL#0.9660;BONE REMODELING#0.9660;MAPK SIGNALING#0.9659;OSTEOGENIC CELL#0.9659;OSTEOCLAST DIFFERENTIATION#0.9649;GROWTH FACTOR#0.9645;STROMAL CELL#0.9636;CELL PROLIFERATION#0.9633;BONE CELLS#0.9632;BONE DISEASE#0.9627;DENTAL PULP#0.9626;PERIODONTAL LIGAMENT#0.9620;CELL DIFFERENTIATION#0.9614;APOPTOSIS#0.9613;TERMINAL DIFFERENTIATION#0.9606;ADIPOCYTE DIFFERENTIATION#0.9603;SIGNALING PATHWAY#0.9600;BONE FORMATION#0.9600;TIBIA#0.9598;BONE GROWTH#0.9592;BONE REGENERATION#0.9590;WNT SIGNALING PATHWAY#0.9587;OSTEOCLAST#0.9586;FIBROBLAST GROWTH FACTOR#0.9585;BONE MORPHOGENIC PROTEIN#0.9570;BONE RESORPTION#0.9564;ASCORBIC ACID#0.9558;BONE FORMATION RATE#0.9537;CHONDROGENESIS#0.9524;MESENCHYMAL STEM CELL#0.9514;BONE MARROW#0.9513;BONE MARROW CELLS#0.9509;SIGNALING MOLECULE#0.9493;ANGIOGENESIS#0.9486;CELL CYCLE#0.9483;STEM CELL#0.9480;OSTEOPOROSIS#0.9479;REGENERATION#0.9477;MOLAR#0.9468;TUMOR NECROSIS FACTOR#0.9463;SIGNALLING PATHWAY#0.9454;MESENCHYMAL PROGENITOR CELL#0.9451;TISSUE REGENERATION#0.9393;T CELL#0.9388;AKT SIGNALING#0.9374;TRABECULAR BONE VOLUME#0.9347;ADIPOSE TISSUE#0.9335;SMOOTH MUSCLE ACTIN#0.9311;BLOOD VESSEL#0.9311;CELL COUNTING KIT#0.9301;SCANNING ELECTRON MICROSCOPY#0.9290;PERIODONTAL LIGAMENT STEM CELL#0.9278;RAT BONE MARROW#0.9275;PRECURSOR CELL#0.9274;OSTEOGENESIS IMPERFECTA#0.9236;HYPOXIA#0.9225;ECTOPIC BONE FORMATION#0.9176;MYOBLAST#0.9160;CELL ADHESION#0.9154;TRANSACTIVATION#0.9145;MACROPHAGE#0.9114;HISTONE DEMETHYLASE#0.9097;INTRAMEMBRANOUS OSSIFICATION#0.9092;EMBRYONIC STEM CELL#0.9088;REACTIVE OXYGEN SPECIES#0.9065;MANDIBLE#0.9049;HUMAN DENTAL PULP#0.9049;SIGNAL TRANSDUCTION#0.8993;MINERAL APPOSITION RATE#0.8986;KINASE INHIBITOR#0.8985;MESENCHYME#0.8971;QUANTITATIVE REVERSE TRANSCRIPTION#0.8967;PROTEIN SYNTHESIS#0.8961;ESTROGEN RECEPTOR#0.8938;DENTAL PULP CELL#0.8860;BREAST CANCER#0.8856;STEM CELL DIFFERENTIATION#0.8855;ENHANCER BINDING#0.8827;LYSINE#0.8809;HYPOXIA INDUCIBLE FACTOR#0.8777;DENTAL PULP STEM CELL#0.8768;CYTOTOXICITY#0.8703;PERIOSTEUM#0.8697;CEMENTUM FORMATION#0.8618;RESPONSE TO BMP#0.8617;B CELL#0.8611;PROTEIN KINASE A#0.8602;ACTIVATING TRANSCRIPTION FACTOR#0.8557;GLYCOGEN SYNTHASE KINASE#0.8507;CHRONIC KIDNEY DISEASE#0.8500;KIDNEY DISEASE#0.8486;RNA INTERFERENCE#0.8470;OSTEOARTHRITIS#0.8438;CONNECTIVE TISSUE#0.8398;DENTINOGENESIS#0.8380;ENHANCER BINDING PROTEIN#0.8371;MATRIX GLA PROTEIN#0.8344;MARROW STEM CELLS#0.8320;BONE MARROW STEM CELL#0.8312;PERIODONTITIS#0.8301;AORTIC VALVE#0.8288;PERIPHERAL BLOOD#0.8281;UMBILICAL CORD#0.8280;ESTRADIOL#0.8255;REGULATION OF BONE FORMATION#0.8237;MAP KINASE#0.8226;RAPAMYCIN#0.8178;EPITHELIAL CELL#0.8170;WOUND HEALING#0.8160;HISTONE DEACETYLASE#0.8126;COLONY-STIMULATING FACTOR#0.8111;LOW DENSITY LIPOPROTEIN#0.8093;INHIBITION OF OSTEOBLAST DIFFERENTIATION#0.8038;DIABETES MELLITUS#0.8032;TRANSCRIPTASE#0.8028;MORPHOGENESIS#0.7982;MECHANISM OF ACTION#0.7959;QUERCETIN#0.7924;VITAMIN D RECEPTOR#0.7914;POST-TRANSLATIONAL MODIFICATION#0.7900;TAMOXIFEN#0.7823;APOPTOTIC#0.7816;TRANSFORMING GROWTH FACTOR BETA#0.7794;ORTHODONTIC TOOTH MOVEMENT#0.7777;PLATELET-DERIVED GROWTH FACTOR#0.7745;GAP JUNCTION#0.7732;BIOMINERALIZATION#0.7700;TRANSDIFFERENTIATION#0.7657;VERTEBRAE#0.7648;ACTIVATED T CELL#0.7634;OSTEOSARCOMA CELL LINES#0.7624;ODONTOGENESIS#0.7608;CELL MIGRATION#0.7605;PROTEASOME#0.7531;TOOTH MORPHOGENESIS#0.7466;NEURAL CREST#0.7456;HISTONE MODIFICATION#0.7434;OSTEOBLAST DEVELOPMENT#0.7424;MESENCHYMAL STEM CELL DIFFERENTIATION#0.7424;REGULATION OF OSTEOBLAST DIFFERENTIATION#0.7405;PRO-INFLAMMATORY#0.7400;EOSIN#0.7397;PARATHYROID HORMONE RECEPTOR#0.7360;SKELETAL MUSCLE#0.7318;UBIQUITIN#0.7272;RECEPTOR ANTAGONIST#0.7271;BMP SIGNALING PATHWAY#0.7226;GENE SILENCING#0.7217;ACTIVATED T-CELLS#0.7214;CELL ADHESION MOLECULE#0.7176;SUPEROXIDE DISMUTASE#0.7165;CELL DEATH#0.7161;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7142;PROTEIN PROTEIN INTERACTION#0.7133;FOCAL ADHESION#0.7131;HIGH BONE MASS#0.7006;IMMUNE RESPONSE#0.6996;FATTY ACID BINDING#0.6996;ADIPOSE STEM CELLS#0.6938;BONE VOLUME FRACTION#0.6876;GROWTH FACTOR RECEPTOR#0.6861;ADENOSINE#0.6825;ADULT STEM CELL#0.6778;VITAMIN D3#0.6772;PLURIPOTENT STEM CELL#0.6719;STROMAL STEM CELL#0.6692;RETINOIC ACID#0.6691;NITRIC OXIDE#0.6659;DUAL LUCIFERASE REPORTER#0.6643;CHONDROBLAST#0.6641;ENZYME ACTIVITY#0.6629;MURINE EMBRYONIC STEM#0.6611;MULTIPLE MYELOMA#0.6607;ENDOPLASMIC RETICULUM#0.6576;CELL SURFACE#0.6562;OSTEONECROSIS#0.6507;SENESCENCE#0.6463;OSTEOGENIC DIFFERENTIATION MEDIUM#0.6448;ELECTROPHORETIC MOBILITY SHIFT#0.6434;DNA METHYLATION#0.6405;PROTEIN KINASE C#0.6397;CYTOPLASM#0.6388;HYPOXIC#0.6372;TUMOR CELLS#0.6360;ATHEROSCLEROSIS#0.6351;17β-ESTRADIOL#0.6350;BORTEZOMIB#0.6297;COLLAGEN SYNTHESIS#0.6286;TISSUE REMODELING#0.6286;RHEUMATOID ARTHRITIS#0.6282;STEM CELL MARKER#0.6276;DIFFERENTIAL GENE EXPRESSION#0.6261;VASCULAR CELL#0.6248;MATRIX METALLOPROTEINASE 13#0.6241;AUTOPHAGY#0.6212;P38 MAPK SIGNALING#0.6177;MINERAL TRIOXIDE AGGREGATE#0.6172;ZINC FINGER PROTEIN#0.6170;RELATED PROTEIN 1#0.6142;STREPTOZOTOCIN#0.6134;PROTEIN KINASE D#0.6128;INDUCED PLURIPOTENT STEM CELL#0.6121;CLEIDOCRANIAL DYSPLASIA#0.6112;PARIETAL BONE#0.6098;HEMATOPOIETIC CELL#0.6096;CARTILAGE DEVELOPMENT#0.6058;DAYS OF DIFFERENTIATION#0.6024
121355	GERM CELL#0.7668;GENE EXPRESSION#0.7326;HUMAN HEPATOMA CELL LINES#0.6280;OVARIAN FOLLICLE#0.6083;LIVER CANCER#0.6015
121391	HAIR FOLLICLE#0.8969;ROOT SHEATH#0.8431
1213	CLATHRIN HEAVY CHAIN#1.0505;ADAPTIN#1.0453;CLATHRIN BINDING#1.0328;RNA INTERFERENCE#1.0201;CLATHRIN ADAPTOR#1.0101;CLATHRIN COAT#1.0042;CLATHRIN-DEPENDENT ENDOCYTOSIS#0.9956;CLATHRIN-COATED PIT#0.9925;COATED PIT#0.9922;COATED VESICLE#0.9901;CLATHRIN COATED VESICLE#0.9895;RECEPTOR MEDIATED ENDOCYTOSIS#0.9858;CLATHRIN-MEDIATED ENDOCYTOSIS#0.9856;ENDOCYTOSIS#0.9833;MITOSIS#0.9769;PLASMA MEMBRANE#0.9752;CHLORPROMAZINE#0.9750;ENDOSOME#0.9718;CELL SURFACE#0.9678;TRANS GOLGI NETWORK#0.9627;B CELL#0.9568;DOMINANT NEGATIVE MUTANT#0.9568;MITOTIC SPINDLE#0.9530;EARLY ENDOSOME#0.9512;GROWTH FACTOR#0.9418;OOCYTE#0.9286;EPITHELIAL CELL#0.9111;PROTEIN KINASE#0.9047;MICROTUBULE#0.9042;ORGANELLE#0.9011;CYTOPLASM#0.9007;VESICLE FORMATION#0.8862;SYNAPTIC VESICLE#0.8811;LYSOSOME#0.8778;VACUOLE#0.8754;CAVEOLAE#0.8669;EPIDERMAL GROWTH FACTOR#0.8668;CANCER CELL#0.8607;SPINDLE ASSEMBLY#0.8566;GENE EXPRESSION#0.8533;CLATHRIN TRISKELION#0.8475;GOLGI APPARATUS#0.8096;ANTISENSE RNA#0.8089;CELL CYCLE#0.7996;CHROMOSOME CONGRESSION#0.7978;MACROPHAGE#0.7959;ADAPTOR PROTEIN 2#0.7893;CELL PROLIFERATION#0.7803;HOST CELL#0.7787;HEAT SHOCK PROTEIN#0.7785;ANAPLASTIC LYMPHOMA KINASE#0.7762;SIGNAL TRANSDUCTION#0.7672;SPINDLE FORMATION#0.7661;SIGNALING PATHWAY#0.7650;PROTEIN KINASE C#0.7641;SKELETAL MUSCLE#0.7632;APOPTOSIS#0.7607;B CELL LYMPHOMA#0.7434;ACTIN CYTOSKELETON#0.7434;HEPATOCELLULAR CARCINOMA#0.7406;PROTEIN TRANSPORT#0.7374;PROTEIN PROTEIN INTERACTION#0.7365;UBIQUITIN#0.7358;VESICLE COAT#0.7291;MUTAGENESIS#0.7244;ENDOTHELIAL CELL#0.7231;GROWTH FACTOR RECEPTOR#0.7163;SECRETORY PATHWAY#0.7082;METAPHASE#0.6914;TRANSFERRIN RECEPTOR#0.6799;GENE SILENCING#0.6755;LATE ENDOSOME#0.6738;T CELL#0.6738;INFLAMMATORY MYOFIBROBLASTIC TUMOR#0.6676;SUCROSE#0.6594;GOLGI MEMBRANE#0.6583;ACTIN BINDING#0.6541;ENDOPLASMIC RETICULUM#0.6459;CHOLERA TOXIN B#0.6451;CELL GROWTH#0.6448;ENDOCYTIC VESICLE#0.6436;CLATHRIN CAGE#0.6422;CLATHRIN COAT ASSEMBLY#0.6402;EARLY ENDOSOME ANTIGEN#0.6352;HEPATITIS B#0.6288;POLYMERASE CHAIN REACTION#0.6263;EXOCYTOSIS#0.6215;ADAPTOR PROTEIN 1#0.6205;KINASE ACTIVITY#0.6149;PHAGOCYTOSIS#0.6132;VACUOLAR PROTEIN SORTING#0.6129;BUDDING#0.6059;SPINDLE POLE#0.6011
121441	MICROTUBULE NUCLEATION#1.0821;CENTROSOME#1.0788;MICROTUBULE#1.0514;SPINDLE ASSEMBLY#0.9984;GAMMA-TUBULIN RING COMPLEX#0.9699;MITOSIS#0.9272;MITOTIC SPINDLE#0.9264;SPINDLE FORMATION#0.9060;SPINDLE POLE#0.7922;SPINDLE MICROTUBULE#0.7539;TUBULIN COMPLEX#0.6591;CELL DIVISION#0.6307;BIPOLAR SPINDLE FORMATION#0.6099;PERICENTRIOLAR MATERIAL#0.6094
121506	ENDOPLASMIC RETICULUM#0.8722;PROTEIN DISULFIDE ISOMERASE#0.7809
121512	CHARCOT MARIE TOOTH#1.0831;ACTIN BINDING#1.0782;ACTIN FILAMENT#1.0549;MICROSPIKE FORMATION#1.0517;TOOTH DISEASE#1.0463;CHARCOT-MARIE-TOOTH DISEASE#1.0463;ACTIN FILAMENT BINDING#1.0368;ACTIN CYTOSKELETON#1.0183;F-ACTIN BINDING#1.0050;NUCLEOTIDE EXCHANGE FACTOR#0.9908;MICROSPIKE#0.9730;NEUROPATHY#0.9719;PERIPHERAL NERVE#0.8405;GUANINE#0.8097;ACTIN BINDING PROTEIN#0.7273;SCHWANN CELL#0.7102
121536	NEURAL CREST CELL#0.7320;NEURAL CREST#0.7268;POLYCOMB REPRESSIVE COMPLEX#0.7088;ZINC FINGER PROTEIN#0.6538;NUCLEOSOME BINDING#0.6213
121599	B CELL#1.0966;MACROPHAGE#1.0787;TRANSCRIPTION FACTOR#1.0235;B CELL DEVELOPMENT#0.9963;CELL DEVELOPMENT#0.9877;SALMONELLA PATHOGENICITY ISLAND#0.8212;VIRULENCE#0.7825;HOST CELL#0.7660;GENE EXPRESSION#0.7493;B LYMPHOCYTE#0.7472;SIGNAL TRANSDUCTION#0.6401;B CELL DIFFERENTIATION#0.6373;CELL DIFFERENTIATION#0.6256;BONE MARROW#0.6174
1215	TRYPTASE ACTIVITY#1.0624;CHYMASE ACTIVITY#1.0609;CHOLESTEROL EFFLUX#1.0538;CARBOXYPEPTIDASE A#1.0535;COLLAGEN SYNTHESIS#1.0471;TRANSFORMING GROWTH FACTOR BETA#1.0358;CHYMOSTATIN#1.0336;VASCULAR DISEASE#1.0292;MAST CELL GRANULE#1.0285;ABDOMINAL AORTIC ANEURYSM#1.0251;AORTIC ANEURYSM#1.0238;ACE ACTIVITY#1.0223;WOUND HEALING#1.0221;PROTEINASE INHIBITOR#1.0210;STRUCTURE ACTIVITY RELATIONSHIP#1.0206;TRANSFORMING GROWTH FACTOR#1.0202;HEPARIN#1.0176;PROTEOGLYCAN#1.0167;MAST CELL#1.0153;CAPTOPRIL#1.0147;CARDIOMYOPATHY#1.0134;ATHEROSCLEROTIC#1.0117;PULMONARY FIBROSIS#1.0113;SECRETORY GRANULE#1.0100;CARDIOMYOCYTE#1.0096;MYOCARDIAL INFARCTION#1.0088;NEUTROPHIL#1.0076;ATOPIC DERMATITIS#1.0070;ANGIOTENSIN CONVERTING ENZYME#1.0068;COLLAGEN TYPE I#1.0061;ACE INHIBITOR#1.0058;MAST CELL DENSITY#1.0058;HISTAMINE#1.0051;TISSUE REMODELING#1.0042;EPITHELIAL CELL#1.0037;DERMATITIS#1.0026;NEPHROPATHY#1.0017;ENZYME ACTIVITY#1.0016;POLYMERASE CHAIN REACTION#1.0013;MAST CELL ACTIVATION#1.0011;EXTRACELLULAR MATRIX#0.9988;MAST CELL DEGRANULATION#0.9987;ENDOTHELIAL CELL#0.9983;CORD BLOOD#0.9977;HYPERTENSION#0.9950;BLOOD VESSEL#0.9940;LEUKOCYTE#0.9939;SMOOTH MUSCLE CELL#0.9935;MYOCARDIUM#0.9935;DIABETIC NEPHROPATHY#0.9933;MUSCLE CELL#0.9930;ANGIOGENESIS#0.9925;GROWTH FACTOR#0.9919;T LYMPHOCYTE#0.9912;EOSINOPHIL#0.9901;CELL PROLIFERATION#0.9894;CELL ACTIVATION#0.9891;GENE EXPRESSION#0.9887;CONNECTIVE TISSUE#0.9880;ENZYME INHIBITOR#0.9871;HEART DISEASE#0.9870;RECEPTOR ANTAGONIST#0.9868;ATHEROSCLEROSIS#0.9862;ARTERY#0.9856;VASOCONSTRICTION#0.9853;MONONUCLEAR CELLS#0.9847;T CELL#0.9843;APOPTOSIS#0.9837;TUMOR NECROSIS FACTOR#0.9831;STEM CELL FACTOR#0.9829;SMOOTH MUSCLE#0.9826;IONOPHORE#0.9780;HIGH DENSITY LIPOPROTEIN#0.9777;MACROPHAGE#0.9765;CORONARY ARTERY#0.9765;BONE MARROW#0.9736;INFLAMMATORY RESPONSE#0.9733;SKELETAL MUSCLE#0.9729;SIGNALING PATHWAY#0.9714;STEM CELL#0.9710;SUBSTANCE P#0.9683;LYMPH NODE#0.9675;IGE RECEPTOR#0.9672;DERMIS#0.9671;BASEMENT MEMBRANE#0.9658;PERIPHERAL BLOOD#0.9657;FORMALIN#0.9647;INFLAMMATORY CELL#0.9638;VASCULAR SMOOTH MUSCLE CELL#0.9616;MASTOCYTOSIS#0.9597;ALLERGEN#0.9571;ALDOSTERONE#0.9563;CELL SURFACE#0.9557;HDL PARTICLE#0.9525;SERPIN#0.9521;ENDOTHELIUM#0.9494;NITRIC OXIDE#0.9487;FIBROBLAST GROWTH FACTOR#0.9477;PROTEASE ACTIVATED RECEPTOR#0.9454;ISCHEMIA#0.9441;IMMUNE RESPONSE#0.9413;ANAPHYLAXIS#0.9408;IMMUNE CELL#0.9382;PROTEASE ACTIVITY#0.9373;FOCAL ADHESION#0.9372;CARDIOVASCULAR SYSTEM#0.9361;BASOPHIL#0.9354;REVERSE TRANSCRIPTION#0.9336;ECZEMA#0.9332;PRO-INFLAMMATORY#0.9281;UTERUS#0.9259;CELL GROWTH#0.9255;BENZOIC ACID#0.9192;ANAPHYLACTIC#0.9183;CELL ADHESION#0.9145;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9138;ENDOTHELIAL GROWTH FACTOR#0.9137;SMOOTH MUSCLE ACTIN#0.9098;TONSIL#0.9005;KERATINOCYTE#0.8998;HYPERSENSITIVITY#0.8995;PULMONARY HYPERTENSION#0.8994;ANGIOTENSIN RECEPTOR#0.8991;MONOCYTE#0.8991;INFLAMMATORY BOWEL DISEASE#0.8966;EXOCYTOSIS#0.8950;KIDNEY DISEASE#0.8933;MYOCYTES#0.8905;PROGENITOR CELL#0.8870;CELL MIGRATION#0.8863;URTICARIA#0.8849;FIBROBLAST PROLIFERATION#0.8848;REACTIVE OXYGEN SPECIES#0.8846;CATALYTIC ACTIVITY#0.8843;DIGESTION#0.8824;URTICARIA PIGMENTOSA#0.8809;ALPHA-2 MACROGLOBULIN#0.8781;APROTININ#0.8666;PERITONEAL CAVITY#0.8662;ADVENTITIA#0.8660;SQUAMOUS CELL CARCINOMA#0.8658;HYPOXIA#0.8612;TYPE 2 DIABETES#0.8601;TRACHEA#0.8578;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8574;AIRWAY SMOOTH MUSCLE#0.8572;ALLERGIC REACTION#0.8541;MAST CELL TUMOR#0.8510;VASOCONSTRICTOR#0.8500;DIPEPTIDYL PEPTIDASE#0.8490;NASAL MUCOSA#0.8478;COAGULATION#0.8460;GASTROINTESTINAL TRACT#0.8396;UMBILICAL CORD#0.8385;HIGH CHOLESTEROL DIET#0.8366;STREPTOZOTOCIN#0.8365;CELL DEVELOPMENT#0.8362;DIABETES MELLITUS#0.8349;CROMOLYN#0.8320;JEJUNUM#0.8317;LOSARTAN#0.8305;PSORIASIS#0.8292;SMC APOPTOSIS#0.8283;ESSENTIAL HYPERTENSION#0.8251;ACUTE MYOCARDIAL INFARCTION#0.8240;RHINITIS#0.8214;COLITIS#0.8182;IMMUNE SYSTEM#0.8172;ACETAMIDE#0.8139;CYTOPLASM#0.8136;ALLERGIC RHINITIS#0.8135;MESANGIAL CELL#0.8122;CELL ASSOCIATED#0.8091;RHEUMATOID ARTHRITIS#0.8064;REGULATION OF BLOOD PRESSURE#0.8009;PERITONEUM#0.7965;EXTRACELLULAR MATRIX COMPONENT#0.7958;CAROTID ARTERY#0.7957;RENIN ACTIVITY#0.7929;BLEOMYCIN#0.7902;LISINOPRIL#0.7839;VASCULAR ENDOTHELIUM#0.7821;PULMONARY ARTERY#0.7817;PLATELET ACTIVATING FACTOR#0.7765;CELL MEMBRANE#0.7745;INTESTINAL MUCOSA#0.7732;MYOFIBROBLAST#0.7730;ARACHIDONIC ACID#0.7723;CELL DEATH#0.7671;PROTEIN KINASE#0.7664;HEPARIN BINDING#0.7659;ALPHA 1-ANTITRYPSIN#0.7586;PHOSPHORAMIDON#0.7576;SCLERODERMA#0.7558;GM-CSF#0.7557;APOPTOTIC#0.7555;SYSTOLIC BLOOD PRESSURE#0.7526;ATRIAL FIBRILLATION#0.7522;LIVER DISEASE#0.7521;VASCULITIS#0.7476;SKIN DISEASE#0.7468;CONGESTIVE HEART FAILURE#0.7463;SYSTEMIC MASTOCYTOSIS#0.7453;COLLAGENASE#0.7446;STROMA#0.7444;DIABETIC RETINOPATHY#0.7405;CONSTRICTION#0.7384;DIISOPROPYL FLUOROPHOSPHATE#0.7381;TOPICAL#0.7367;CYTOTOXIC T-LYMPHOCYTE#0.7362;GRANZYME H#0.7327;TUMOR CELLS#0.7243;NERVE FIBER#0.7231;REVERSE CHOLESTEROL TRANSPORT#0.7216;CANDESARTAN#0.7195;CHOLESTEROL TRANSPORT#0.7195;UMBILICAL CORD BLOOD#0.7104;BLOOD PRESSURE REGULATION#0.7099;LEFT VENTRICULAR MASS#0.7078;LDL PARTICLE#0.7074;ARTERIOLE#0.7051;GRANULOCYTE#0.7025;TRANSCRIPTION FACTOR#0.7024;PROTEASE S#0.7016;UROKINASE#0.7008;ISCHEMIA REPERFUSION INJURY#0.6983;CORONARY HEART DISEASE#0.6980;NATURAL KILLER CELL#0.6973;TUMOUR NECROSIS FACTOR#0.6964;TO THE PROGRESSION#0.6960;GLOMERULONEPHRITIS#0.6942;BREAST CANCER#0.6935;ARGININE#0.6873;KETOTIFEN#0.6843;CELLULAR LOCALIZATION#0.6841;VASCULAR CELL#0.6836;DUODENUM#0.6835;LOW DENSITY LIPOPROTEIN#0.6787;PULMONARY VASCULAR REMODELING#0.6767;URETERAL OBSTRUCTION#0.6712;SMALL INTESTINE#0.6706;FACTOR XA#0.6692;ADIPOSE TISSUE#0.6682;HYDROXYPROLINE#0.6680;MITOGEN ACTIVATED PROTEIN#0.6677;MAST CELL PROGENITOR#0.6674;SMOOTH MUSCLE CELL APOPTOSIS#0.6666;MUSCLE CELL APOPTOSIS#0.6650;HYPOXIC#0.6630;PARENCHYMA#0.6623;BLOOD GLUCOSE LEVEL#0.6622;LEFT ANTERIOR DESCENDING#0.6595;LICHEN PLANUS#0.6588;CELL MATURATION#0.6577;ALPHA-1-PROTEINASE INHIBITOR#0.6559;MAST CELL DIFFERENTIATION#0.6527;DILATED CARDIOMYOPATHY#0.6519;LYSINE#0.6515;HUMAN UMBILICAL VEIN#0.6472;UMBILICAL VEIN#0.6469;SENSITIZATION#0.6467;THROMBOSIS#0.6459;KERATOCONJUNCTIVITIS#0.6432;SIGNAL TRANSDUCTION#0.6431;ADENOCARCINOMA#0.6412;PLASMA MEMBRANE#0.6392;TRANSCRIPTASE#0.6371;LEFT VENTRICULAR REMODELING#0.6351;1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE#0.6304;CORONARY ARTERY BYPASS#0.6289;INTERSTITIAL CELL#0.6278;ARRHYTHMIA#0.6261;HEMATOPOIETIC CELL#0.6249;MACULAR HOLES#0.6227;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6226;CELL DIFFERENTIATION#0.6224;EOSINOPHIL MIGRATION#0.6197;ALLERGIC CONJUNCTIVITIS#0.6180;ANTI INFLAMMATORY DRUGS#0.6154;AT1 RECEPTOR BLOCKER#0.6143;LUNG DISEASE#0.6143;VASCULAR ENDOTHELIAL CELL#0.6139;CELL ADHESION MOLECULE#0.6118;NITRIC OXIDE SYNTHASE#0.6102;LYSIS#0.6066;EOSIN#0.6060;B CELL#0.6056;COLORECTAL#0.6027;RENAL ARTERY#0.6016
121601	ALDOSTERONE SECRETION#0.8570;CHLORIDE CHANNEL#0.6920;ALDOSTERONE#0.6373;ADRENAL GLAND#0.6012
121642	DNA REPAIR ENZYME#1.0914;DNA REPAIR#1.0588;3-METHYLCYTOSINE#1.0272;OXIDATIVE DEMETHYLATION#0.9112;DNA REPAIR PROTEIN#0.8626;DEMETHYLATION#0.8311;DNA ALKYLATION#0.7318;HISTONE DEMETHYLASE#0.7144;CELL CYCLE#0.7106;NUCLEIC ACID#0.7064;GLYCOSYLASE#0.6975;CANCER CELL#0.6739;CELL GROWTH#0.6150
121643	TRANSCRIPTION FACTOR#1.0586;AMACRINE CELL#0.9388;SPINAL CORD#0.9335;PROGENITOR CELL#0.8456;GENE EXPRESSION#0.7977;BREAST CANCER#0.7584;FACTOR I#0.7533;INTERNEURON#0.7510;NERVOUS SYSTEM#0.7176;MOTILE CILIA#0.6571;LUNG DEVELOPMENT#0.6410;PHOTORECEPTOR CELL#0.6373;CELL DIFFERENTIATION#0.6186;BREAST CANCER CELL#0.6186;RETINOGENESIS#0.6177;CANCER CELL#0.6138
121665	SIGNAL PEPTIDE PEPTIDASE#1.0713;SIGNAL PEPTIDE#1.0463;UBIQUITIN#1.0398;BUDDING#0.7393;FACT COMPLEX#0.6174
122042	GUBERNACULUM#1.0698;GERM CELL#1.0516;CRYPTORCHIDISM#1.0512;LEUCINE RICH REPEAT#1.0441;LEUCINE#1.0390;LEYDIG CELL#1.0069;PEPTIDE HORMONE#0.9760;SIGNALING PATHWAY#0.9741;GENE EXPRESSION#0.9738;RECEPTOR BINDING#0.9325;LOW DENSITY LIPOPROTEIN#0.9213;SERTOLI CELL#0.8710;OSTEOBLAST#0.8521;TESTOSTERONE#0.8476;CELL PROLIFERATION#0.8440;EPITHELIAL CELL#0.8372;UTERUS#0.8202;MESANGIAL CELL#0.7989;CAMP SIGNALING#0.7873;OOCYTE#0.7841;CELL SURFACE#0.7742;GROWTH FACTOR#0.7693;ESTROGEN RECEPTOR#0.7661;OVARIAN#0.7563;INFERTILITY#0.7399;SPERMATOGENESIS#0.7340;EPIDIDYMIS#0.7000;LH RECEPTOR#0.6950;THYROID CARCINOMA#0.6833;GRANULOSA CELL#0.6799;POLYMERASE CHAIN REACTION#0.6744;SPERMATOZOA#0.6565;ADENYLATE CYCLASE#0.6564;ANDROGEN RECEPTOR#0.6555;ENDOTHELIAL CELL#0.6511;PROGESTERONE#0.6481;APOPTOSIS#0.6446;BONE FORMATION#0.6313;TRANSCRIPTION FACTOR#0.6204;RANGE OF MOTION#0.6078;SMOOTH MUSCLE#0.6002
122060	NERVOUS SYSTEM#0.6920;STEM CELL#0.6883;MICROTUBULE PLUS END#0.6749
122199	APOPTOTIC#0.8463
122258	GERM CELL#0.9068;ACROSOME#0.6892;SPERMATOZOA#0.6845;FERTILIZATION#0.6826;ACROSOME REACTION#0.6011
1222	T CELL#0.6684
122402	GERM CELL#0.7192;LUNG CARCINOMA#0.6132;CELL CYCLE#0.6012
122481	ADENYLATE KINASE#1.0764;ADENYLATE#0.9290;PRIMARY CILIARY DYSKINESIA#0.7906;GENE EXPRESSION#0.6246;DYSKINESIA#0.6226
122525	BIPOLAR DISORDER#0.6723;COLORECTAL CANCER#0.6598;GENE EXPRESSION#0.6190
122618	M1 MACROPHAGE#0.6196;FOLIC ACID#0.6120;TUBULAR EPITHELIAL CELL#0.6115;GOLGI APPARATUS#0.6101;RHEUMATOID ARTHRITIS#0.6077;NUCLEIC ACID#0.6040;COLON CANCER#0.6014
122622	MYOPATHY#0.8619;GENE EXPRESSION#0.8026;SKELETAL MUSCLE#0.7475;NUCLEOTIDE BIOSYNTHESIS#0.6355;MARROW STROMAL CELLS#0.6090;BONE MARROW STROMAL CELL#0.6090;BONE MARROW STROMAL#0.6083
122651	EOSINOPHIL#0.6808
122664	HUMAN IMMUNODEFICIENCY VIRUS#0.6489;CELL CYCLE#0.6347
122706	T CELL#0.9848;CD8+ T CELL#0.9664;EPITHELIAL CELL#0.9469;THYMIC EPITHELIAL CELLS#0.9180;PROTEASOME#0.8685;THYMOCYTE#0.6732;REGULATION OF GENE EXPRESSION#0.6211;GENE EXPRESSION#0.6024
122769	LEUCINE RICH REPEAT#1.0779;LEUCINE#1.0681;CELL DEATH#0.8751;DNA REPLICATION#0.7938;AUTOIMMUNE DISEASE#0.7000;CELL CYCLE ARREST#0.6246;CELL CYCLE#0.6132
122786	HIPPO SIGNALING#0.9789;HIPPO SIGNALING PATHWAY#0.9509;SIGNALING PATHWAY#0.9228;SCIATIC NERVE#0.8168;PERIPHERAL NERVE#0.6432;APICAL CONSTRICTION#0.6362
122809	SIGNALING PATHWAY#0.7130;GENE EXPRESSION#0.6841;SIGNAL TRANSDUCER#0.6081
122830	N ACETYLTRANSFERASE#1.0726
122953	JUN DIMERIZATION PROTEIN#1.1039;LEUCINE#1.0430;HISTONE ACETYLATION#1.0393;TRANSCRIPTION FACTOR#1.0368;SENESCENCE#1.0151;DNA BINDING#1.0110;MOUSE EMBRYONIC FIBROBLAST#0.9689;REPLICATIVE SENESCENCE#0.9529;CELL CYCLE#0.9304;CANCER CELL#0.8775;APOPTOSIS#0.8535;GENE EXPRESSION#0.8481;HISTONE DEACETYLASE#0.8416;OSTEOCLAST#0.8359;ACTIVATING TRANSCRIPTION FACTOR#0.8226;HEPATOCELLULAR CARCINOMA#0.8131;T CELL#0.8093;PANCREATIC CARCINOMA#0.7832;ADIPOCYTE DIFFERENTIATION#0.7793;HISTONE CHAPERONE#0.7777;ONCOGENIC#0.7769;INHIBITION OF HISTONE ACETYLATION#0.7652;CELL PROLIFERATION#0.7526;STEM CELL#0.7508;PLURIPOTENT STEM CELL#0.7477;ACTIVATOR PROTEIN 1#0.7262;RETINOIC ACID#0.7043;HISTONE ACETYLTRANSFERASE#0.6995;OSTEOCLAST DIFFERENTIATION#0.6991;HISTONE MODIFICATION#0.6972;CAMP RESPONSE ELEMENT#0.6964;CELL DIFFERENTIATION#0.6892;HDAC3 COMPLEX#0.6850;POLYCOMB REPRESSIVE COMPLEXES#0.6699;PROGESTERONE#0.6699;TUMOR SUPPRESSOR#0.6674;NUCLEOSOME#0.6656;MUTAGENESIS#0.6439;AP-1 COMPLEX#0.6333;CELLULAR SENESCENCE#0.6269;LYSINE#0.6242;CYCLIC AMP#0.6211;PANCREATIC CANCER#0.6081;INDUCED PLURIPOTENT STEM CELL#0.6079;EPITHELIAL MESENCHYMAL TRANSITION#0.6042;BONE MARROW#0.6013;CELL DEATH#0.6009
122961	DEBRANCHING ENZYME#1.0249;IRON SULFUR CLUSTER#0.9339;STARCH SYNTHESIS#0.8992;COMPLEX I#0.8018;MITOCHONDRIA#0.7000;STARCH BIOSYNTHESIS#0.6993;GENE EXPRESSION#0.6686;PROTEIN MATURATION#0.6592
122970	PEROXISOMAL#0.7011;CANCER ASSOCIATED FIBROBLASTS#0.6370;PEROXISOME#0.6021
123016	BARDET BIEDL SYNDROME#1.0154;BBSOME#0.9932;RETINITIS PIGMENTOSA#0.9193;RETINAL DEGENERATION#0.8002;RETINITIS#0.7947;RIBOSOMAL PROTEIN#0.7906;POLYDACTYLY#0.7288;CILIUM#0.6561;INTRAFLAGELLAR TRANSPORT#0.6167
123036	LUNG CANCER#0.9054;CANCER CELL#0.9015;AKT SIGNALING#0.6939;SIGNALING PATHWAY#0.6841;BREAST CANCER#0.6705;P53 SIGNALING PATHWAY#0.6594
123041	AMELOGENESIS IMPERFECTA#1.0101;AMELOGENESIS#0.9900;ENAMEL FORMATION#0.7469;ALZHEIMER'S DISEASE#0.7467;PLASMA MEMBRANE#0.6773;CALCIUM TRANSPORT#0.6196
123096	ORNITHINE#0.7217;ARGININE#0.7130;MITOCHONDRIA#0.7027;CANCER CELL#0.6133
123099	OOCYTE#0.7947;ACETYLCHOLINE RECEPTOR#0.7188;ACETYLCHOLINE#0.6675;CHOLINE#0.6474;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6420;CERAMIDE SYNTHESIS#0.6407;CORONARY ARTERY#0.6153
1230	C CHEMOKINE RECEPTOR#1.0505;CC CHEMOKINE RECEPTOR#1.0328;MONOCYTE CHEMOTACTIC PROTEIN#1.0259;RECEPTOR ANTAGONIST#1.0204;MAST CELL#1.0168;CANCER CELL#1.0167;NEUTROPHIL#1.0151;CHEMOKINE RECEPTOR#1.0139;MYELOID CELL#1.0070;RHEUMATOID ARTHRITIS#1.0049;OSTEOCLAST#1.0034;IFN-GAMMA#1.0034;EOSINOPHIL#0.9983;CELL SURFACE#0.9981;LYMPH NODE#0.9973;CELL MIGRATION#0.9957;T LYMPHOCYTE#0.9952;SIGNALING PATHWAY#0.9951;CC CHEMOKINE LIGAND#0.9944;MONOCYTE#0.9929;MACROPHAGE INFLAMMATORY PROTEIN#0.9924;CHEMOTAXIS#0.9924;INFLAMMATORY CELL#0.9898;GROWTH FACTOR#0.9883;ENDOTHELIAL CELL#0.9879;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9871;MACROPHAGE#0.9865;PERIPHERAL BLOOD#0.9829;B CELL#0.9808;TUMOR NECROSIS FACTOR#0.9808;T CELL#0.9805;DENDRITIC CELL#0.9797;CD8+ T CELL#0.9796;CELL PROLIFERATION#0.9793;MONONUCLEAR CELLS#0.9788;IMMUNE CELL#0.9777;MULTIPLE SCLEROSIS#0.9776;BONE MARROW#0.9764;LEUKOCYTE#0.9763;STRUCTURE ACTIVITY RELATIONSHIP#0.9745;INFLAMMATORY RESPONSE#0.9740;PRO-INFLAMMATORY#0.9733;MULTIPLE MYELOMA#0.9712;IMMUNE RESPONSE#0.9712;POLYMERASE CHAIN REACTION#0.9694;GENE EXPRESSION#0.9689;PROTEIN KINASE#0.9650;HEPATOCELLULAR CARCINOMA#0.9603;STEM CELL#0.9597;APOPTOSIS#0.9501;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9495;STROMAL CELL#0.9445;ENDOMETRIOSIS#0.9413;CD4+ T CELL#0.9248;CELL ADHESION#0.9213;TRANSCRIPTION FACTOR#0.9179;PROGENITOR CELL#0.9148;REVERSE TRANSCRIPTION#0.9091;AUTOIMMUNE DISEASE#0.9082;TRANSFORMING GROWTH FACTOR#0.9044;TOLL LIKE RECEPTOR#0.9038;ASTROCYTE#0.8996;NERVOUS SYSTEM#0.8939;GRANULOCYTE#0.8938;ENDOTHELIUM#0.8908;COLONY-STIMULATING FACTOR#0.8893;CALCIUM MOBILIZATION#0.8883;CHEMOKINE RECEPTOR ANTAGONIST#0.8856;SMOOTH MUSCLE#0.8854;PERTUSSIS#0.8827;SIGNAL TRANSDUCTION#0.8796;ANGIOGENESIS#0.8780;IMMUNE SYSTEM#0.8762;CENTRAL NERVOUS SYSTEM#0.8685;OSTEOBLAST#0.8621;HUMAN IMMUNODEFICIENCY VIRUS#0.8590;TUMOR CELLS#0.8572;BONE DISEASE#0.8556;CYTOKINE RECEPTOR#0.8545;RECEPTOR INTERNALIZATION#0.8528;COLORECTAL CANCER#0.8495;CELL ACTIVATION#0.8490;GM-CSF#0.8408;RENAL FIBROSIS#0.8406;COLORECTAL#0.8399;MUSCLE CELL#0.8366;CELL WALL#0.8316;COLON CANCER#0.8304;BONE MARROW CELLS#0.8281;ATHEROSCLEROTIC#0.8207;CORD BLOOD#0.8183;QUANTITATIVE REAL TIME#0.8076;MESENCHYMAL STEM CELL#0.7997;SPINAL CORD#0.7995;SMOOTH MUSCLE CELL#0.7944;LIGNIN BIOSYNTHESIS#0.7917;MYELOID-DERIVED SUPPRESSOR CELL#0.7912;EPITHELIAL CELL#0.7912;MITOGEN ACTIVATED PROTEIN#0.7901;NEPHROPATHY#0.7882;BASOPHIL#0.7815;TISSUE DAMAGE#0.7815;MYOCARDIAL INFARCTION#0.7797;ATHEROSCLEROSIS#0.7791;TROPHOBLAST#0.7759;ENDOTHELIAL GROWTH FACTOR#0.7753;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7753;LIVER METASTASIS#0.7745;ACTIVATED T-CELLS#0.7680;RECEPTOR LIGAND#0.7678;ACTIVATED T CELL#0.7677;MYELOID LEUKEMIA#0.7646;DRAINING LYMPH NODE#0.7443;RECEPTOR ACTIVATOR#0.7424;MONOCYTE CHEMOTAXIS#0.7394;DIABETIC NEPHROPATHY#0.7390;BREAST CANCER#0.7378;NATURAL KILLER CELL#0.7332;HEPATITIS C#0.7326;CHEMOKINE PRODUCTION#0.7324;HEPATOMA CELLS#0.7270;HEMATOPOIETIC CELL#0.7252;EXTRACELLULAR MATRIX#0.7208;CHRONIC HEPATITIS C#0.7205;SIGNAL TRANSDUCER#0.7174;LUNG METASTASIS#0.7101;INNATE IMMUNE RESPONSE#0.7100;HERPES SIMPLEX VIRUS#0.7062;OSTEOCLAST DIFFERENTIATION#0.7058;HERPES SIMPLEX#0.7058;OPIOID RECEPTOR#0.7052;ANTIGEN PRESENTING CELLS#0.7014;BONE RESORPTION#0.7010;SQUAMOUS CELL CARCINOMA#0.7005;RECEPTOR BINDING#0.7000;LUNG CANCER#0.6995;CYTOKINE PRODUCTION#0.6987;LEUKOCYTE MIGRATION#0.6953;SIGNALING CASCADE#0.6943;CELL ADHESION MOLECULE#0.6931;TRANSFORMING GROWTH FACTOR BETA#0.6928;ARTERY#0.6889;PULMONARY FIBROSIS#0.6885;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6859;ALLERGIC AIRWAY DISEASE#0.6841;ALLERGEN#0.6810;PERIPHERAL BLOOD LEUKOCYTE#0.6766;ORAL SQUAMOUS CELL CARCINOMA#0.6731;ADIPOSE TISSUE#0.6717;CELL GROWTH#0.6704;HYPERSENSITIVITY#0.6674;EMBRYONIC KIDNEY#0.6613;RESPIRATORY SYNCYTIAL VIRUS#0.6588;MACROPHAGE DIFFERENTIATION#0.6554;HYPOXIA#0.6535;ALVEOLAR MACROPHAGE#0.6477;SIGNALING MOLECULE#0.6461;LEUKOCYTE TRAFFICKING#0.6402;DIPEPTIDYL PEPTIDASE IV#0.6342;DISEASE RESISTANCE#0.6340;HEPARIN#0.6314;DIPEPTIDYL PEPTIDASE#0.6303;PHOSPHOLIPASE C#0.6284;ALLERGIC ASTHMA#0.6269;CELL CYCLE#0.6231;ISCHEMIA#0.6185;VIRAL INFECTION#0.6128;STROMA#0.6082;CHEMOKINE BINDING#0.6061;MICROGLIAL CELL#0.6042;ARTIFICIAL NEURAL NETWORK#0.6035
123169	PAF1 COMPLEX#1.1005;GENE EXPRESSION#0.8527;COMPLEX I#0.8272;HETEROCHROMATIN#0.8003;PROTEIN COMPLEX#0.7550;CELLULAR QUIESCENCE#0.6107
123228	UBIQUITIN#0.9617;DENGUE HEMORRHAGIC FEVER#0.9290;HEMORRHAGIC#0.9159;YELLOW FEVER#0.8938;POLYMERASE CHAIN REACTION#0.8585;COP9 SIGNALOSOME#0.8302;DENGUE SHOCK SYNDROME#0.8075;B CELL#0.8025;INFLAMMATORY RESPONSE#0.7284;T CELL#0.7279;CONJUGATION#0.6830;SIGNALOSOME#0.6672;JAPANESE ENCEPHALITIS#0.6520;VOMITING#0.6219;RIO DE JANEIRO#0.6126;REVERSE TRANSCRIPTION#0.6025
123263	METHIONYL TRNA FORMYLTRANSFERASE#1.1564;MITOCHONDRIAL TRANSLATION#0.9685;PROTEIN SYNTHESIS#0.9358;MITOCHONDRIAL PROTEIN SYNTHESIS#0.8146;MITOCHONDRIA#0.7310;OXIDATIVE PHOSPHORYLATION#0.7195;RESPIRATORY CHAIN#0.6527;TRANSLATION INITIATION#0.6315
123264	ORGANIC SOLUTE TRANSPORTER#1.1245;PLASMA MEMBRANE#0.9959;FARNESOID X RECEPTOR#0.9850;BILE ACID TRANSPORT#0.8734;TAUROCHOLATE#0.8474;CHOLESTASIS#0.7658;ENTEROCYTE#0.7429;EPITHELIAL CELL#0.7293;OOCYTE#0.6564;BILE DUCT#0.6383
123283	THREONINE TRNA#1.0637;ROOT HAIR#0.6754
1232	C CHEMOKINE RECEPTOR#1.0621;EOSINOPHIL CHEMOTAXIS#1.0458;NASAL MUCOSA#1.0426;CC CHEMOKINE RECEPTOR#1.0395;EOSINOPHIL MIGRATION#1.0314;BASOPHIL#1.0292;CHEMOKINE RECEPTOR#1.0231;ALLERGIC RHINITIS#1.0208;GM-CSF#1.0158;BASOPHIL ACTIVATION#1.0148;EOSINOPHIL#1.0148;CC CHEMOKINE LIGAND#1.0147;MAST CELL#1.0137;TH2 CELL#1.0136;CELL SURFACE#1.0120;MONOCYTE CHEMOTACTIC PROTEIN#1.0096;STRUCTURE ACTIVITY RELATIONSHIP#1.0095;RHINITIS#1.0029;SIGNALING PATHWAY#1.0015;CHEMOTAXIS#1.0010;EPITHELIAL CELL#0.9978;MACROPHAGE INFLAMMATORY PROTEIN#0.9976;PROGENITOR CELL#0.9968;ATOPIC DERMATITIS#0.9951;CD4+ T CELL#0.9939;RECEPTOR ANTAGONIST#0.9936;GROWTH FACTOR#0.9931;ENDOTHELIAL CELL#0.9928;T LYMPHOCYTE#0.9914;IFN-GAMMA#0.9900;BONE MARROW#0.9877;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9876;B CELL#0.9874;MONOCYTE#0.9849;CELL MIGRATION#0.9848;ALLERGEN#0.9835;TRANSCRIPTION FACTOR#0.9834;INFLAMMATORY CELL#0.9833;APOPTOSIS#0.9818;NEUTROPHIL#0.9809;POLYMERASE CHAIN REACTION#0.9793;T CELL#0.9791;CD8+ T CELL#0.9771;STROMAL CELL#0.9769;PERIPHERAL BLOOD#0.9758;TUMOR NECROSIS FACTOR#0.9758;CANCER CELL#0.9752;MACROPHAGE#0.9746;DERMATITIS#0.9742;HUMAN IMMUNODEFICIENCY VIRUS#0.9738;TH1 CELL#0.9733;LYMPH NODE#0.9725;GENE EXPRESSION#0.9719;RHEUMATOID ARTHRITIS#0.9708;MONONUCLEAR CELLS#0.9707;REVERSE TRANSCRIPTION#0.9686;LEUKOCYTE#0.9675;ENDOTHELIAL GROWTH FACTOR#0.9669;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9665;SMOOTH MUSCLE#0.9652;CYTOKINE PRODUCTION#0.9650;GRANULOCYTE#0.9644;IMMUNE RESPONSE#0.9622;CALCIUM MOBILIZATION#0.9621;STEM CELL#0.9620;INFLAMMATORY RESPONSE#0.9607;ALLERGIC ASTHMA#0.9574;COLONY-STIMULATING FACTOR#0.9570;PROTEIN KINASE#0.9558;AGE RELATED MACULAR DEGENERATION#0.9540;MACULAR DEGENERATION#0.9535;ALLERGIC REACTION#0.9523;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9484;DENDRITIC CELL#0.9421;IMMUNE CELL#0.9405;PRO-INFLAMMATORY#0.9316;MITOGEN ACTIVATED PROTEIN#0.9301;NERVOUS SYSTEM#0.9272;IMMUNE SYSTEM#0.9265;CELL PROLIFERATION#0.9249;QUANTITATIVE REAL TIME#0.9102;T HELPER CELL#0.9096;CENTRAL NERVOUS SYSTEM#0.9075;TOLL LIKE RECEPTOR#0.9014;BASOPHIL ACTIVATION TEST#0.8997;HYPERSENSITIVITY#0.8972;CYTOKINE RECEPTOR#0.8870;PERTUSSIS#0.8797;ANGIOGENESIS#0.8796;RNA INTERFERENCE#0.8723;CELL ADHESION#0.8697;MUSCLE CELL#0.8694;PULMONARY EOSINOPHILIA#0.8657;RECEPTOR INTERNALIZATION#0.8637;ALLERGIC CONJUNCTIVITIS#0.8626;AIRWAY EPITHELIAL CELL#0.8551;CORD BLOOD#0.8522;ALLERGIC AIRWAY DISEASE#0.8475;SMOOTH MUSCLE CELL#0.8472;MAP KINASE#0.8467;ALLERGIC AIRWAY INFLAMMATION#0.8425;MULTIPLE SCLEROSIS#0.8424;HISTAMINE#0.8389;COLITIS#0.8380;BREAST CANCER#0.8357;BRONCHIAL EPITHELIAL CELLS#0.8245;CELL ACTIVATION#0.8206;CELL DEATH#0.8196;CHEMOKINE PRODUCTION#0.8158;DERMAL FIBROBLAST#0.8158;RECEPTOR LIGAND#0.8134;CYTOTOXICITY#0.8019;BONE MARROW CELLS#0.7974;TRANSFORMING GROWTH FACTOR#0.7974;PLASMA CELL#0.7961;SIGNAL TRANSDUCTION#0.7915;TROPISM#0.7899;PROSTATE CANCER#0.7789;EOSINOPHIL DEVELOPMENT#0.7762;PLATELET ACTIVATING FACTOR#0.7710;SELECTIN#0.7629;CORNEAL NEOVASCULARIZATION#0.7617;INTESTINAL MUCOSA#0.7608;AUTOIMMUNE DISEASE#0.7566;SENSITIZATION#0.7546;CELL ADHESION MOLECULE#0.7537;TYPE 1 DIABETES#0.7456;EOSINOPHIL DIFFERENTIATION#0.7434;EOSINOPHILIC ESOPHAGITIS#0.7421;REACTIVE OXYGEN SPECIES#0.7413;SIMIAN IMMUNODEFICIENCY VIRUS#0.7388;CONNECTIVE TISSUE#0.7379;ENDOTHELIUM#0.7365;LIPID BODY#0.7342;PERIPHERAL BLOOD LEUKOCYTE#0.7278;STEM CELL FACTOR#0.7268;REGULATORY T CELL#0.7232;RECEPTOR BINDING#0.7228;FLOW CYTOMETRY ANALYSIS#0.7200;TUMOR CELLS#0.7174;BLOOD VESSEL#0.7147;ASTROCYTE#0.7143;EOSINOPHIL ACTIVATION#0.7142;CONJUNCTIVITIS#0.7110;AIRWAY SMOOTH MUSCLE#0.7099;ACTIN POLYMERIZATION#0.7052;MONOCYTE DERIVED MACROPHAGE#0.7044;KERATINOCYTE#0.7028;SPUTUM#0.7015;ALANINE#0.7012;MYELOID CELL#0.6999;GROWTH FACTOR RECEPTOR#0.6980;TRANSCRIPTASE#0.6953;SMALL INTESTINE#0.6847;HUMAN DERMAL FIBROBLAST#0.6772;OVARIAN#0.6757;INTERLEUKIN 5 RECEPTOR#0.6757;WOUND HEALING#0.6742;VASCULAR CELL#0.6739;INFLAMMATORY BOWEL DISEASE#0.6732;GOBLET CELL#0.6611;LUNG DISEASE#0.6583;EXTRACELLULAR MATRIX#0.6538;AMD3100#0.6508;MICROVASCULAR ENDOTHELIAL CELL#0.6480;VASCULAR ENDOTHELIAL CELL#0.6461;SIGNAL TRANSDUCER#0.6437;B LYMPHOCYTE#0.6437;VIRAL INFECTION#0.6437;METHACHOLINE#0.6381;MAST CELL DEGRANULATION#0.6341;KAPOSI'S SARCOMA#0.6310;MEMORY T CELL#0.6300;TOPICAL#0.6293;ULCERATIVE COLITIS#0.6254;CELL DIFFERENTIATION#0.6247;EPSTEIN BARR VIRUS#0.6245;RESPIRATORY BURST#0.6215;LEUKOCYTE MIGRATION#0.6207;BLOOD BRAIN BARRIER#0.6117;ASPIRIN#0.6102;MUTAGENESIS#0.6069;CELIAC DISEASE#0.6063;HYPOXIA#0.6059;NORMAL CONTROL GROUP#0.6055;ESOPHAGITIS#0.6044
1233	C CHEMOKINE RECEPTOR#1.0508;CC CHEMOKINE RECEPTOR#1.0347;CC CHEMOKINE LIGAND#1.0337;TREG CELL#1.0275;MAST CELL#1.0253;PERIPHERAL T-CELL LYMPHOMA#1.0242;CUTANEOUS T CELL LYMPHOMA#1.0220;MYCOSIS FUNGOIDES#1.0220;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#1.0187;TH2 CELL#1.0162;ADULT T-CELL LEUKEMIA#1.0152;CHEMOKINE RECEPTOR#1.0130;T-CELL LEUKEMIA#1.0114;MEMORY T CELL#1.0085;TUMOR CELLS#1.0073;CORD BLOOD#1.0058;TH17 CELL#1.0033;SELECTIN#1.0021;T HELPER CELL#1.0001;CELL SURFACE#0.9999;BREAST CANCER#0.9988;ALLERGEN#0.9978;CD8+ T CELL#0.9974;CHEMOTAXIS#0.9964;CALCIUM MOBILIZATION#0.9958;ATOPIC DERMATITIS#0.9956;CANCER CELL#0.9951;SQUAMOUS CELL CARCINOMA#0.9940;T CELL#0.9929;T CELL MIGRATION#0.9926;TH1 CELL#0.9924;CD4+ T CELL#0.9914;CYTOTOXICITY#0.9906;DERMATITIS#0.9879;GROWTH FACTOR#0.9879;MACROPHAGE#0.9872;MACROPHAGE INFLAMMATORY PROTEIN#0.9869;B CELL#0.9866;LYMPH NODE#0.9859;T LYMPHOCYTE#0.9858;EOSINOPHIL#0.9857;IFN-GAMMA#0.9857;TRANSCRIPTION FACTOR#0.9853;LYMPHOID TISSUE#0.9846;REVERSE TRANSCRIPTION#0.9833;EPITHELIAL CELL#0.9831;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9816;SIGNALING PATHWAY#0.9815;HEALTHY CONTROL SUBJECTS#0.9807;CYTOKINE PRODUCTION#0.9803;MONONUCLEAR CELLS#0.9798;EFFECTOR T CELL#0.9793;PERIPHERAL BLOOD LYMPHOCYTES#0.9792;REGULATORY T CELL#0.9788;CELL MIGRATION#0.9788;LUNG CANCER#0.9780;CELL PROLIFERATION#0.9766;CELL ACTIVATION#0.9765;GENE EXPRESSION#0.9765;MONOCYTE#0.9763;POLYMERASE CHAIN REACTION#0.9759;PERIPHERAL BLOOD#0.9754;PSORIASIS#0.9750;STEM CELL TRANSPLANTATION#0.9745;RHEUMATOID ARTHRITIS#0.9744;IMMUNE CELL#0.9739;STEM CELL#0.9735;BONE MARROW#0.9735;KERATINOCYTE#0.9720;DENDRITIC CELL#0.9716;TUMOR NECROSIS FACTOR#0.9703;LEUKOCYTE#0.9694;INFLAMMATORY RESPONSE#0.9687;ALLERGIC ASTHMA#0.9664;HEMATOPOIETIC STEM CELL#0.9659;APOPTOSIS#0.9652;T CELL ACTIVATION#0.9637;IMMUNE RESPONSE#0.9626;IMMUNE SYSTEM#0.9624;ENDOTHELIAL CELL#0.9622;INFLAMMATORY CELL#0.9612;LYMPHOCYTE ANTIGEN#0.9593;CYTOTOXIC T-LYMPHOCYTE#0.9539;PRO-INFLAMMATORY#0.9529;HISTONE DEACETYLASE#0.9529;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9523;ALLERGIC AIRWAY INFLAMMATION#0.9522;HYPERSENSITIVITY#0.9509;TRANSFORMING GROWTH FACTOR#0.9496;NATURAL KILLER CELL#0.9462;DRAINING LYMPH NODE#0.9462;LYMPH NODE METASTASIS#0.9443;T CELL PROLIFERATION#0.9440;ENDOTHELIAL GROWTH FACTOR#0.9438;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9438;ANAPLASTIC LARGE CELL LYMPHOMA#0.9435;MULTIPLE SCLEROSIS#0.9429;ACTIVATED T CELL#0.9425;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9412;ACTIVATED T-CELLS#0.9392;NEUTROPHIL#0.9381;NAIVE T CELL#0.9377;HISTONE DEACETYLASE INHIBITOR#0.9327;STROMAL CELL#0.9313;GRAFT VERSUS HOST#0.9293;PROSTATE CANCER#0.9290;DERMIS#0.9281;PULMONARY FIBROSIS#0.9277;QUANTITATIVE REAL TIME#0.9253;ANTIGEN PRESENTING CELLS#0.9223;SKIN DISEASE#0.9219;PROGENITOR CELL#0.9216;NERVOUS SYSTEM#0.9204;AUTOIMMUNE DISEASE#0.9185;TUMOUR NECROSIS FACTOR#0.9159;THYMOCYTE#0.9088;BREAST CANCER CELL#0.9077;CENTRAL NERVOUS SYSTEM#0.9058;CD4+ MEMORY T CELL#0.9022;LUNG METASTASIS#0.9020;SYNOVIAL FLUID#0.8990;PROTEIN KINASE#0.8975;HUMAN IMMUNODEFICIENCY VIRUS#0.8930;TUBERCULOSIS#0.8925;RECEPTOR ANTAGONIST#0.8918;GM-CSF#0.8869;CELL DIFFERENTIATION#0.8851;WOUND HEALING#0.8846;LUPUS ERYTHEMATOSUS#0.8791;B CELL LYMPHOMA#0.8787;SPINAL CORD#0.8774;ALVEOLAR MACROPHAGE#0.8763;CYTOTOXIC T CELL#0.8761;COLORECTAL CANCER#0.8759;CELL DEATH#0.8752;MONOCYTE CHEMOTACTIC PROTEIN#0.8748;ANGIOGENESIS#0.8727;ENCEPHALOMYELITIS#0.8705;TUMOR TISSUES#0.8698;TRANSCRIPTASE#0.8671;BASOPHIL#0.8637;CYTOKINE SECRETION#0.8634;AUTOIMMUNITY#0.8632;MEMORY B CELL#0.8631;COLORECTAL#0.8578;SENSITIZATION#0.8567;HEPATOCELLULAR CARCINOMA#0.8557;APOPTOTIC#0.8516;ALLERGIC RHINITIS#0.8414;HEPATITIS B#0.8393;DISEASE FREE SURVIVAL#0.8381;STRUCTURE ACTIVITY RELATIONSHIP#0.8292;OVERALL RESPONSE RATE#0.8196;CD4+CD25+ REGULATORY T CELL#0.8193;LYMPHOID ORGANS#0.8191;RHINITIS#0.8157;CHEMOKINE PRODUCTION#0.8152;DIFFUSE LARGE B-CELL LYMPHOMA#0.8135;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8133;EFFECTOR MEMORY T CELL#0.8063;AMD3100#0.8062;RECEPTOR INTERNALIZATION#0.8042;IDIOPATHIC PULMONARY FIBROSIS#0.8001;LUNG DISEASE#0.8001;NKT CELL#0.7979;HEPATITIS B VIRUS#0.7961;RECEPTOR LIGAND#0.7919;CELL CHEMOTAXIS#0.7880;T-CELL NEOPLASM#0.7862;HYPOXIA#0.7850;CCR4 NOT COMPLEX#0.7778;DIPHTHERIA#0.7768;MESENCHYMAL STEM CELL#0.7714;CELL ADHESION#0.7696;ALLERGIC REACTION#0.7688;TOLL LIKE RECEPTOR#0.7617;IMMUNOTOXIN#0.7598;COLON CANCER#0.7582;OVARIAN CANCER#0.7534;PERIPHERAL BLOOD T-CELLS#0.7530;ADENOCARCINOMA#0.7492;LYMPHOCYTE ACTIVATION#0.7454;PHAGOCYTOSIS#0.7444;INNATE IMMUNITY#0.7433;OVARIAN#0.7423;MONOCYTE DERIVED DENDRITIC CELL#0.7395;HUMAN BREAST CANCER#0.7364;SIGNAL TRANSDUCER#0.7363;CELL GROWTH#0.7324;REGIONAL LYMPH NODE#0.7257;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7244;COLITIS#0.7197;IFN-BETA#0.7194;EPITHELIAL MESENCHYMAL TRANSITION#0.7171;PERTUSSIS#0.7160;PLASMACYTOID DENDRITIC CELL#0.7153;TARC PRODUCTION#0.7143;GRANULOCYTE#0.7119;LYMPHOCYTE HOMING#0.7074;CELL MEMBRANE#0.7068;TOXICITY#0.7053;HODGKIN'S LYMPHOMA#0.7002;HEPATITIS C#0.6990;CELL DEVELOPMENT#0.6981;CONTACT DERMATITIS#0.6930;BLEOMYCIN#0.6889;AIRWAY EPITHELIAL CELL#0.6867;ENDOTHELIUM#0.6829;LEUKOCYTE MIGRATION#0.6803;OSTEOCLAST#0.6776;NON HODGKIN LYMPHOMA#0.6764;IL-4 PRODUCTION#0.6748;CENTRAL MEMORY T CELL#0.6720;RNA INTERFERENCE#0.6709;TRANSFORMING GROWTH FACTOR BETA#0.6699;COLONY-STIMULATING FACTOR#0.6693;SWELLING#0.6652;ENDOCYTOSIS#0.6645;NASAL MUCOSA#0.6609;B LYMPHOCYTE#0.6552;TONSIL#0.6522;PNEUMONIA#0.6511;MESENTERIC LYMPH NODE#0.6493;INNATE IMMUNE RESPONSE#0.6484;FLOW CYTOMETRY ANALYSIS#0.6457;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6454;ADAPTIVE IMMUNE RESPONSE#0.6447;TYPE 1 DIABETES#0.6438;PROGRAMMED CELL DEATH#0.6437;RENAL CELL CARCINOMA#0.6437;OSTEOARTHRITIS#0.6432;EPSTEIN BARR VIRUS#0.6431;SIGNAL TRANSDUCTION#0.6390;UVEITIS#0.6358;CANINE ATOPIC DERMATITIS#0.6358;TH2 IMMUNE RESPONSE#0.6357;ADAPTIVE IMMUNE SYSTEM#0.6299;PURINE NUCLEOSIDE PHOSPHORYLASE#0.6281;CYTOKINE RECEPTOR#0.6281;MULTIPLE MYELOMA#0.6257;VIRAL INFECTION#0.6249;PLATELET AGGREGATION#0.6229;ADIPOSE TISSUE#0.6227;ALLERGIC CONTACT DERMATITIS#0.6226;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6225;VORINOSTAT#0.6195;MYELOID CELL#0.6190;MYOCARDIAL INFARCTION#0.6187;TOPICAL#0.6165;NATURAL KILLER T#0.6164;IMMUNE EVASION#0.6156;LYMPHOID CELL#0.6118;BRENTUXIMAB VEDOTIN#0.6101;T LYMPHOCYTE ACTIVATION#0.6090;MITOGEN ACTIVATED PROTEIN#0.6076;CELL CYCLE#0.6058;TONGUE CANCER#0.6015;ORAL SQUAMOUS CELL CARCINOMA#0.6000
1234	CCR5 MAB#1.1314;RIBOZYME#1.0527;CHEMOKINE BINDING#1.0473;CORECEPTOR ACTIVITY#1.0459;RANTES BINDING#1.0433;C CHEMOKINE RECEPTOR#1.0418;EXTRACELLULAR LOOP 2#1.0323;CC CHEMOKINE RECEPTOR#1.0299;MARAVIROC#1.0274;DIABETIC NEPHROPATHY#1.0259;TH1 CELL#1.0258;PROSTATE CANCER#1.0242;COLORECTAL CANCER#1.0204;OPIOID RECEPTOR#1.0189;RALTEGRAVIR#1.0186;WEST NILE VIRUS#1.0172;HYPOXIA#1.0171;ENTRY INTO HOST#1.0170;AMD3100#1.0169;CALCIUM MOBILIZATION#1.0154;ENFUVIRTIDE#1.0149;CHEMOKINE RECEPTOR#1.0147;BREAST CANCER CELL#1.0121;STRUCTURE ACTIVITY RELATIONSHIP#1.0109;CHEMOKINE RECEPTOR ANTAGONIST#1.0107;MONOCYTE CHEMOTACTIC PROTEIN#1.0107;NKT CELL#1.0100;ALVEOLAR MACROPHAGE#1.0088;GRAFT VERSUS HOST#1.0087;SYNOVIAL FLUID#1.0085;ENTRY INTO HOST CELL#1.0085;FRAGMENT LENGTH POLYMORPHISM#1.0078;ALANINE#1.0065;BREAST CANCER#1.0054;TYPE 2 DIABETES#1.0049;CC CHEMOKINE LIGAND#1.0047;RAPAMYCIN#1.0047;NEPHROPATHY#1.0044;HUMAN LEUKOCYTE ANTIGEN#1.0043;RECEPTOR ANTAGONIST#1.0042;HEMATOPOIETIC PROGENITOR CELL#1.0033;MACROPHAGE ACTIVATION#1.0019;CELL MEMBRANE#1.0016;SPINAL CORD#1.0007;MITOGEN ACTIVATED PROTEIN#1.0006;IFN-BETA#1.0002;PROGENITOR CELL#1.0001;RECEPTOR LIGAND#1.0000;ASTROCYTE#1.0000;THYMOCYTE#0.9994;TH2 CELL#0.9994;STEM CELL TRANSPLANTATION#0.9993;CANCER CELL#0.9990;MYELOID CELL#0.9988;CERVICAL#0.9988;COLORECTAL#0.9985;LANGERHANS CELL#0.9983;MEMORY T CELL#0.9982;IMMATURE DENDRITIC CELL#0.9980;MU OPIOID RECEPTOR#0.9976;T CELL MIGRATION#0.9974;TH17 CELL#0.9974;CHRONIC HEPATITIS C#0.9973;HEPATITIS C#0.9970;BREAST CANCER PATIENTS#0.9969;RECEPTOR BINDING#0.9968;CELL CELL FUSION#0.9966;RHEUMATOID ARTHRITIS#0.9964;CELL SURFACE#0.9959;CORD BLOOD#0.9955;HEPATITIS B#0.9949;EFFECTOR T CELL#0.9936;MACROPHAGE INFLAMMATORY PROTEIN#0.9936;TUBERCULOSIS#0.9935;STEM CELL TRANSPLANT#0.9934;VIRAL ENVELOPE#0.9933;MEMBRANE FUSION#0.9932;REVERSE TRANSCRIPTASE INHIBITOR#0.9925;TREG CELL#0.9919;ARTERY#0.9919;HOST CELL#0.9911;CORONARY ARTERY#0.9911;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9908;MOLECULAR DYNAMICS SIMULATION#0.9908;MAST CELL#0.9908;CHEMOTAXIS#0.9906;ENDOCYTOSIS#0.9903;TYPE 1 DIABETES#0.9902;PROTEIN KINASE#0.9902;PERIPHERAL BLOOD LEUKOCYTE#0.9896;ACTIVATED CD4+ T CELL#0.9895;CELL FUSION#0.9890;RITONAVIR#0.9887;LIPID RAFT#0.9885;T HELPER CELL#0.9884;HEPATITIS C VIRUS#0.9880;TROPISM#0.9878;LYMPHOID CELL#0.9877;CELL ASSOCIATED#0.9874;ATHEROSCLEROTIC#0.9873;TRANSFORMING GROWTH FACTOR#0.9872;MULTIPLE SCLEROSIS#0.9871;SIGNAL TRANSDUCTION#0.9870;CHEMOKINE PRODUCTION#0.9870;HEPATITIS B VIRUS#0.9868;OBESE#0.9865;DARUNAVIR#0.9865;MONOCYTE DERIVED DENDRITIC CELL#0.9862;MACROPHAGE#0.9857;HEMATOPOIETIC STEM CELL#0.9855;MUTAGENESIS#0.9855;MECHANISM OF ACTION#0.9855;PERIPHERAL BLOOD LYMPHOCYTES#0.9853;T CELL#0.9852;ACTIVATED T-CELLS#0.9849;IFN-GAMMA#0.9847;NATURAL KILLER CELL#0.9845;CD3+ T CELL#0.9845;PLASMA VIRAL LOAD#0.9845;EFAVIRENZ#0.9837;ATHEROSCLEROSIS#0.9835;T CELL ACTIVATION#0.9833;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.9833;PLASMA MEMBRANE#0.9832;SURFACE PLASMON RESONANCE#0.9831;PERTUSSIS#0.9829;ACTIVATED T CELL#0.9827;NITRIC OXIDE#0.9826;CHEMOKINE SECRETION#0.9826;POLYMERASE CHAIN REACTION#0.9823;CD4+ T CELL#0.9822;SIMIAN IMMUNODEFICIENCY VIRUS#0.9822;NEUTROPHIL#0.9821;LYMPHOID TISSUE#0.9819;GRANULOCYTE#0.9819;REGULATORY T CELL#0.9818;GM-CSF#0.9817;CELL MIGRATION#0.9817;MANNOSE RECEPTOR#0.9816;CD8+ T CELL#0.9815;TOLL LIKE RECEPTOR#0.9812;T CELL PROLIFERATION#0.9808;CYTOTOXIC T-LYMPHOCYTE#0.9808;EPITHELIAL CELL#0.9805;STEM CELL#0.9804;GROWTH FACTOR#0.9804;EFFECTOR MEMORY T CELL#0.9796;TUMOR NECROSIS FACTOR#0.9794;CYTOCHROME P450#0.9792;MONOCYTE#0.9789;TENOFOVIR#0.9782;ADIPOSE TISSUE#0.9782;HERPES SIMPLEX VIRUS#0.9781;T LYMPHOCYTE#0.9778;CELL ACTIVATION#0.9771;BONE MARROW#0.9771;HERPES SIMPLEX#0.9770;ENDOTHELIAL CELL#0.9770;SIGNALING PATHWAY#0.9763;PRO-INFLAMMATORY#0.9759;STROMAL CELL#0.9753;GLIAL CELL#0.9752;LUPUS ERYTHEMATOSUS#0.9752;HEMATOPOIETIC CELL#0.9751;COLONY-STIMULATING FACTOR#0.9747;VESICULAR STOMATITIS VIRUS#0.9747;CELL DEATH#0.9746;CELL DIFFERENTIATION#0.9741;HUMAN IMMUNODEFICIENCY VIRUS#0.9739;INFLAMMATORY CELL#0.9739;MONOCYTE DERIVED MACROPHAGE#0.9739;CD4+ MEMORY T CELL#0.9736;ADAPTIVE IMMUNE RESPONSE#0.9734;LEUKOCYTE#0.9734;TRANSCRIPTASE#0.9734;VIRION#0.9733;B CELL#0.9731;ZIDOVUDINE#0.9731;APOPTOSIS#0.9731;REVERSE TRANSCRIPTION#0.9726;TISSUE DAMAGE#0.9725;BLOOD BRAIN BARRIER#0.9709;COLITIS#0.9706;TRANSCRIPTION FACTOR#0.9703;TUMOR CELLS#0.9699;CYTOKINE PRODUCTION#0.9697;APOPTOTIC#0.9694;GLYCOSYLATION#0.9694;CYTOTOXICITY#0.9691;INNATE IMMUNITY#0.9691;CELL PROLIFERATION#0.9689;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9685;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9683;LEUKOCYTE TRAFFICKING#0.9680;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9680;LIVER DISEASE#0.9679;MONONUCLEAR CELLS#0.9676;IMMUNE CELL#0.9671;VIRAL INFECTION#0.9670;INFLAMMATORY RESPONSE#0.9668;DRUG RESISTANCE#0.9667;TICK-BORNE ENCEPHALITIS#0.9665;DRAINING LYMPH NODE#0.9660;LECTIN#0.9657;PERIPHERAL BLOOD#0.9650;EOSINOPHIL#0.9649;LYMPH NODE#0.9645;VIRAL REPLICATION#0.9642;STROMAL DERIVED FACTOR#0.9640;ANTIGEN PRESENTING CELLS#0.9639;PERIPHERAL BLOOD MONOCYTES#0.9639;TOXICITY#0.9635;LYMPHOID ORGANS#0.9634;DEMENTIA#0.9633;HEAT SHOCK PROTEIN#0.9632;CELL EXPANSION#0.9631;CENTRAL NERVOUS SYSTEM#0.9626;TRANSCRIPTION ACTIVATOR#0.9625;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9623;MYOCARDIAL INFARCTION#0.9619;AUTOIMMUNE DISEASE#0.9619;DENDRITIC CELL#0.9619;GENE EXPRESSION#0.9615;ENDOTHELIUM#0.9611;NERVOUS SYSTEM#0.9607;CYTOKINE RECEPTOR#0.9606;RECEPTOR INTERNALIZATION#0.9598;SULFATION#0.9598;MICROGLIAL CELL#0.9592;SMOOTH MUSCLE#0.9583;CELL-MEDIATED IMMUNITY#0.9568;EPSTEIN BARR VIRUS#0.9554;IMMUNE RESPONSE#0.9551;STOMATITIS#0.9548;QUANTITATIVE REAL TIME#0.9547;INFLAMMATORY BOWEL DISEASE#0.9544;SELECTIN#0.9540;HEALTHY CONTROL SUBJECTS#0.9540;IMMUNE SYSTEM#0.9539;JUVENILE IDIOPATHIC ARTHRITIS#0.9538;GENE SILENCING#0.9534;TOPICAL#0.9531;NUCLEIC ACID#0.9512;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9503;LAMIVUDINE#0.9502;TUMOUR NECROSIS FACTOR#0.9498;SYNCYTIUM FORMATION#0.9493;CELL CYCLE#0.9489;HYPERSENSITIVITY#0.9489;FALSE POSITIVE RATE#0.9485;CYTOTOXIC T CELL#0.9485;HEPATIC STELLATE CELL#0.9481;ISCHEMIA#0.9475;SIGNALLING PATHWAY#0.9469;SQUAMOUS CELL CARCINOMA#0.9468;T-1249#0.9455;PULMONARY TUBERCULOSIS#0.9451;TIPRANAVIR#0.9450;NAIVE T CELL#0.9448;PLAGUE#0.9448;CELLULAR IMMUNE RESPONSE#0.9440;VIRAL TRANSMISSION#0.9420;MECHANISMS OF ACTION#0.9401;ENCEPHALOMYELITIS#0.9400;CYCLOSPORINE#0.9387;HIGH FAT DIET#0.9386;RNA INTERFERENCE#0.9360;CELLULAR MEMBRANE#0.9359;EMTRICITABINE#0.9355;LUPUS NEPHRITIS#0.9354;FLOW CYTOMETRY ANALYSIS#0.9328;NEPHRITIS#0.9328;DNA BINDING#0.9314;TYPE 2 DIABETIC#0.9312;RESONANCE ENERGY TRANSFER#0.9306;SYNOVIUM#0.9302;PSORIASIS#0.9295;PLASMACYTOID DENDRITIC CELL#0.9290;HEMOPHILIA#0.9287;PIPERAZINE#0.9274;ENDOPLASMIC RETICULUM#0.9272;CHAGAS DISEASE#0.9261;VIRAL GLYCOPROTEIN#0.9237;ALZHEIMER'S DISEASE#0.9231;PROTEIN KINASE C#0.9228;MALARIA#0.9216;CYTOKINE SECRETION#0.9214;CELL ADHESION#0.9209;ANGIOGENESIS#0.9207;RECEPTOR COMPLEX#0.9202;FORESKIN#0.9181;BETA GALACTOSIDASE#0.9172;CHEMOATTRACTION#0.9160;HUMAN BREAST CANCER#0.9158;B LYMPHOCYTE#0.9153;LUNG DISEASE#0.9137;TROPHOBLAST#0.9128;ANTIGEN PRESENTATION#0.9117;ENDOSOME#0.9108;VIRUS LIKE PARTICLE#0.9108;NEVIRAPINE#0.9080;BONE MARROW CELLS#0.9067;MONOCYTE ACTIVATION#0.9063;CELL GROWTH#0.9059;HUMORAL IMMUNE RESPONSE#0.9057;MUSCLE CELL#0.9048;VACCINIA#0.9040;PARENTERAL#0.9040;SEMEN#0.9035;CROHN'S DISEASE#0.9034;T CELL HOMEOSTASIS#0.9007;LEISHMANIASIS#0.8962;T CELL DIFFERENTIATION#0.8959;CELL CHEMOTAXIS#0.8957;HEART DISEASE#0.8950;PROVIRUS#0.8934;MAP KINASE#0.8930;UMBILICAL CORD#0.8926;GROWTH FACTOR RECEPTOR#0.8908;SIGNAL TRANSDUCER#0.8907;IL-1RA#0.8899;PROTEOGLYCAN#0.8873;MYOCARDITIS#0.8868;SICKLE CELL DISEASE#0.8851;PRIMARY SCLEROSING CHOLANGITIS#0.8849;MYELOID DENDRITIC CELL#0.8848;INNATE IMMUNE RESPONSE#0.8846;DELAYED-TYPE HYPERSENSITIVITY#0.8838;SCLEROSING CHOLANGITIS#0.8836;LEUKOCYTE MIGRATION#0.8835;LYMPHOCYTE ACTIVATION#0.8800;HEPATOCELLULAR CARCINOMA#0.8791;ANTIVIRAL RESPONSE#0.8786;PERIODONTITIS#0.8784;CYTOPLASM#0.8775;INTESTINAL MUCOSA#0.8774;LOPINAVIR#0.8774;SIGNALING CASCADE#0.8740;ARGININE#0.8725;GLOMERULONEPHRITIS#0.8722;EXTRACELLULAR REGION#0.8711;CENTRAL MEMORY T CELL#0.8702;NITRIC OXIDE SYNTHASE#0.8692;EXTRACELLULAR MATRIX#0.8670;SARCOIDOSIS#0.8655;ARTERY DISEASE#0.8652;FOCAL ADHESION#0.8651;HYPERTENSION#0.8641;UVEITIS#0.8638;VIRAL LIFE CYCLE#0.8633;CLASSICAL MONOCYTE#0.8631;PERIPHERAL BLOOD T-CELLS#0.8619;MYELOID LEUKEMIA#0.8611;KINASE INHIBITOR#0.8598;MYELOID-DERIVED SUPPRESSOR CELL#0.8592;CAROTID ARTERY#0.8590;PERIPHERAL BLOOD CELLS#0.8589;INNATE IMMUNE SYSTEM#0.8582;T FOLLICULAR HELPER#0.8576;TRANSACTIVATION#0.8573;CORONARY ARTERY DISEASE#0.8564;ULCERATIVE COLITIS#0.8561;MODE OF ACTION#0.8561;SEXUALLY TRANSMITTED INFECTION#0.8553;IMMUNOGLOBULIN G#0.8541;CHEMOKINE RECEPTOR LIGAND#0.8537;NATURAL KILLER T#0.8535;FEMALE SEX WORKERS#0.8512;C REACTIVE PROTEIN#0.8506;CERVICAL CANCER#0.8497;OSTEOCLAST#0.8481;RILPIVIRINE#0.8477;HARDY WEINBERG EQUILIBRIUM#0.8462;MESENCHYMAL STEM CELL#0.8440;PNEUMONIA#0.8415;VIRULENCE#0.8405;SMOOTH MUSCLE CELL#0.8396;CERVIX#0.8385;LEUKOCYTE CHEMOTAXIS#0.8376;KIDNEY DISEASE#0.8369;CARDIOMYOPATHY#0.8369;IL-10 PRODUCTION#0.8343;REGENERATION#0.8341;ABACAVIR#0.8336;INDUCED PLURIPOTENT STEM CELL#0.8328;AIDS DEMENTIA COMPLEX#0.8326;CHRONIC HEPATITIS B#0.8318;PLURIPOTENT STEM CELL#0.8313;ENDOMETRIUM#0.8312;RESPONSE TO CHEMOKINE#0.8310;INTERMEDIATE MONOCYTE#0.8296;REACTIVE OXYGEN SPECIES#0.8294;NAIVE CD8+ T CELL#0.8289;COLON CANCER#0.8288;PROTEIN PROTEIN INTERACTION#0.8281;FATTY LIVER#0.8233;ATAZANAVIR#0.8222;UMBILICAL CORD BLOOD#0.8220;RANTES PRODUCTION#0.8158;GERMINAL CENTER#0.8120;NAIVE CD4+ T CELL#0.8105;FATTY LIVER DISEASE#0.8103;SECONDARY LYMPHOID ORGANS#0.8101;UTERUS#0.8090;IL-12 PRODUCTION#0.8086;CYCLOPHILIN#0.8079;DNA SYNTHESIS#0.8076;COLLAGEN INDUCED ARTHRITIS#0.8074;NEUROTOXICITY#0.8064;ADENOCARCINOMA#0.8051;SCIATIC NERVE#0.8051;HEPARIN#0.8045;INTERLEUKIN 1 RECEPTOR#0.8044;STROMA#0.8012;GASTROINTESTINAL TRACT#0.8006;INJECTION DRUG USERS#0.8004;JAPANESE ENCEPHALITIS#0.8003;ENDOMETRIOSIS#0.8002;BETA-2#0.7998;ACUTE MYELOID LEUKEMIA#0.7995;PROGESTERONE#0.7993;AKT SIGNALING#0.7990;FORMYL PEPTIDE RECEPTOR#0.7977;ACTIN POLYMERIZATION#0.7974;PERIPHERAL MONOCYTE#0.7960;NEUROPATHY#0.7950;AUTOIMMUNITY#0.7940;TUMOR TISSUES#0.7933;PULMONARY FIBROSIS#0.7911;INFLAMMATORY MONOCYTE#0.7890;DNA INTEGRATION#0.7868;ANGIOTENSIN CONVERTING ENZYME#0.7850;ALLERGEN#0.7827;RECYCLING ENDOSOME#0.7823;CHOLANGITIS#0.7819;DAYS POST INFECTION#0.7817;METASTATIC COLORECTAL CANCER#0.7812;ADIPOCYTE#0.7804;TNF PRODUCTION#0.7797;LIVER DAMAGE#0.7785;PARENCHYMA#0.7779;SEQUENCE SPECIFIC PRIMER#0.7759;KERATINOCYTE#0.7747;TRADITIONAL CHINESE MEDICINE#0.7731;SAQUINAVIR#0.7729;ENDOTHELIAL GROWTH FACTOR#0.7725;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7725;LYMPH NODE METASTASIS#0.7713;PRO 2000#0.7702;INDUCIBLE NITRIC OXIDE#0.7693;RESPONSE TO TREATMENT#0.7690;PANCREATIC CANCER#0.7663;DIABETES MELLITUS#0.7659;PROTEIN SYNTHESIS#0.7644;TONSIL#0.7592;CALCIUM SIGNALING#0.7587;FIBROCYTE#0.7562;THYMIDINE#0.7532;GENE CONVERSION#0.7529;RECEPTOR ACTIVITY#0.7523;CELL MATURATION#0.7515;TRANSCYTOSIS#0.7501;MACROPHAGE MIGRATION#0.7484;SIGNALING MOLECULE#0.7469;LUNG CANCER#0.7468;OVARIAN#0.7453;VISCERAL LEISHMANIASIS#0.7436;IMMUNE EVASION#0.7436;NATALIZUMAB#0.7433;TH1 IMMUNE RESPONSE#0.7417;EMBRYONIC KIDNEY#0.7398;HYPOXIC#0.7390;MAPK SIGNALING#0.7384;PLASMA CELL#0.7384;TOXOPLASMOSIS#0.7370;FOCAL ADHESION KINASE#0.7368;INTESTINAL EPITHELIAL CELL#0.7361;NEUROLOGICAL DISORDER#0.7357;QUANTITATIVE REVERSE TRANSCRIPTASE#0.7356;NEURONAL CELLS#0.7345;NATURAL KILLER T CELL#0.7345;MONOCYTE CHEMOTAXIS#0.7336;IMMUNE CELL MIGRATION#0.7334;TUMOR ASSOCIATED MACROPHAGE#0.7326;OVARIAN CANCER#0.7316;HYPOXIA INDUCIBLE FACTOR#0.7295;COMPLEX I#0.7286;MICROVASCULAR ENDOTHELIAL CELL#0.7286;CELL DEVELOPMENT#0.7266;SUPPORT VECTOR MACHINE#0.7266;DERMIS#0.7259;INDINAVIR#0.7233;SEMINAL PLASMA#0.7226;ACTIVATED CD8+ T CELL#0.7225;RENAL TRANSPLANT RECIPIENTS#0.7218;VARICELLA ZOSTER VIRUS#0.7207;CELL-MEDIATED IMMUNE RESPONSE#0.7204;N GLYCAN#0.7202;ASPARTATE#0.7193;RISK OF DEATH#0.7189;HEPATOTOXICITY#0.7189;ISOLEUCINE#0.7188;HUMAN EMBRYONIC KIDNEY#0.7187;MRNA TRANSCRIPTION#0.7187;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7180;WHITE BLOOD CELL#0.7155;ENDOTHELIAL PROGENITOR CELL#0.7147;COPY NUMBER VARIATION#0.7143;SPL7013#0.7140;VIRAL GENOME#0.7130;CELL KILLING#0.7127;CD4-CD28- T CELL#0.7123;HUMAN DENDRITIC CELL#0.7106;OLIGODENDROCYTE#0.7095;CIRCULATING RECOMBINANT FORM#0.7095;ACTIN CYTOSKELETON#0.7093;PROGRAMMED CELL DEATH#0.7084;CHEMOKINE ACTIVITY#0.7083;ION CHANNEL#0.7081;LUCIFERASE ACTIVITY#0.7062;CARRIE#0.7058;SYPHILIS#0.7046;CEREBRAL ISCHEMIA#0.7044;CCL5 PRODUCTION#0.7042;ACTIVATED MONOCYTES#0.7017;MEMORY B CELL#0.7016;MACROPHAGE CHEMOTAXIS#0.7016;PERIPHERAL NERVE#0.7013;NEURODEGENERATIVE DISEASE#0.6986;KAPOSI'S SARCOMA#0.6978;TRANSMEMBRANE RECEPTOR#0.6969;INTIMA MEDIA THICKNESS#0.6959;ALCOHOLIC FATTY LIVER#0.6957;SALIVARY GLAND#0.6950;ASPARTIC ACID#0.6947;HOMOLOGOUS RECOMBINATION#0.6932;LYMPHOCYTE ANTIGEN#0.6925;BOOSTED PROTEASE INHIBITOR#0.6924;CHLAMYDIA#0.6906;IMMUNE DYSFUNCTION#0.6902;FUMARATE#0.6863;VASCULAR DISEASE#0.6859;ADENOID CYSTIC CARCINOMA#0.6855;NELFINAVIR#0.6850;COATED PIT#0.6850;PHAGOCYTOSIS#0.6849;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.6848;DNA METHYLATION#0.6841;BENZOIC ACID#0.6838;CHRONIC HIV INFECTION#0.6835;PRIMARY BILIARY CIRRHOSIS#0.6827;TROPHOBLAST CELL#0.6801;SPERMATOZOA#0.6800;AORTIC ANEURYSM#0.6798;LYMPHOCYTE MIGRATION#0.6792;MONOCYTE DIFFERENTIATION#0.6792;SENSITIZATION#0.6792;SCHISTOSOMIASIS#0.6792;PULMONARY SARCOIDOSIS#0.6786;ILIAC LYMPH NODE#0.6778;CEREBRAL MALARIA#0.6769;ALTERNATIVELY ACTIVATED MACROPHAGES#0.6766;VITAMIN D RECEPTOR#0.6764;COMPOUND S#0.6752;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6746;IL-2 PRODUCTION#0.6713;HIV ASSOCIATED DEMENTIA#0.6701;DIGESTION#0.6683;ABDOMINAL AORTIC ANEURYSM#0.6666;PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY#0.6655;T-CELL LEUKEMIA#0.6650;HAEMATOPOIETIC STEM CELL#0.6648;CANCER ASSOCIATED FIBROBLASTS#0.6647;TRANSFORMING GROWTH FACTOR BETA#0.6637;RIBAVIRIN#0.6635;VENULE#0.6628;EPIDERMAL GROWTH FACTOR#0.6616;MANNOSE BINDING#0.6577;MESENCHYMAL CELL#0.6541;FACTOR S#0.6530;PROTEIN BINDING#0.6506;CYCLOSPORIN A#0.6503;CRESCENTIC GLOMERULONEPHRITIS#0.6493;WOUND HEALING#0.6483;NON HODGKIN LYMPHOMA#0.6468;KUPFFER CELL#0.6458;MACROPHAGE DIFFERENTIATION#0.6457;SEVERE COMBINED IMMUNODEFICIENCY#0.6441;ADENOSINE#0.6437;PRO-542#0.6428;RECTUM#0.6419;INTRACELLULAR SIGNALING PATHWAY#0.6419;TENOFOVIR DISOPROXIL FUMARATE#0.6413;TENOFOVIR DISOPROXIL#0.6411;SCAVENGER RECEPTOR#0.6408;ANTIBODY PRODUCTION#0.6403;VASCULITIS#0.6397;NEUROTOXIC#0.6385;ADRENERGIC RECEPTOR#0.6367;BLOOD VESSEL#0.6356;CELL ADHESION MOLECULE#0.6355;T CELL CHEMOTAXIS#0.6352;VIRAL ASSEMBLY#0.6346;MRNA EDITING#0.6329;FLOCK HOUSE VIRUS#0.6328;STAVUDINE#0.6275;MACROPHAGE POLARIZATION#0.6270;VALINE#0.6264;CCL2 SECRETION#0.6263;NON OBESE DIABETIC#0.6257;INTERFERON PRODUCTION#0.6249;MESENTERIC LYMPH NODE#0.6248;RESPONSE TO LPS#0.6248;STEM CELL FACTOR#0.6227;LYMPHOCYTE PROLIFERATION#0.6226;MEAN FLUORESCENCE INTENSITY#0.6225;PERIODONTAL DISEASE#0.6225;COMMON CAROTID ARTERY#0.6223;MENSTRUAL CYCLE#0.6220;M2 MACROPHAGE#0.6216;QUANTITATIVE REVERSE TRANSCRIPTION#0.6213;CCL5 BINDING#0.6205;TARGET OF RAPAMYCIN#0.6190;CHONDROSARCOMA#0.6189;NEUROBLASTOMA#0.6187;HUMAN LEUCOCYTE ANTIGEN#0.6178;BONE RESORPTION#0.6177;KAWASAKI DISEASE#0.6176;CORONARY HEART DISEASE#0.6176;CANCER STEM CELL#0.6159;PROSTAGLANDIN E2#0.6148;LEUKOCYTE ADHESION#0.6128;CALCINEURIN#0.6122;NON-CLASSICAL MONOCYTE#0.6121;C CHEMOKINE LIGAND#0.6114;RECEPTOR ACTIVATOR#0.6102;SKELETON#0.6083;LEUKOENCEPHALOPATHY#0.6079;BEHCET'S DISEASE#0.6079;ATOPIC DERMATITIS#0.6074;LINES OF EVIDENCE#0.6072;TYPE 2 DIABETES MELLITUS#0.6071;2 DIABETES MELLITUS#0.6071;RETINOIC ACID#0.6064;POST-TRANSLATIONAL MODIFICATION#0.6057;HOMOLOGY-DIRECTED REPAIR#0.6045;CLATHRIN-COATED PIT#0.6039;DIDANOSINE#0.6035;DRY EYE SYNDROME#0.6031
123591	NERVOUS SYSTEM#0.8978
1235	C CHEMOKINE RECEPTOR#1.0670;CC CHEMOKINE RECEPTOR#1.0539;CC CHEMOKINE LIGAND#1.0281;COLORECTAL CANCER#1.0267;IMMATURE DENDRITIC CELL#1.0259;CHEMOKINE RECEPTOR#1.0253;RETINOIC ACID#1.0229;CELL MIGRATION#1.0211;MEMORY T CELL#1.0190;RELATED ORPHAN RECEPTOR#1.0169;COLORECTAL#1.0166;MACROPHAGE INFLAMMATORY PROTEIN#1.0165;HEPATOCELLULAR CARCINOMA#1.0164;CANCER CELL#1.0145;HUMAN BETA DEFENSIN#1.0126;MEMORY B CELL#1.0125;TREG CELL#1.0115;PSORIASIS#1.0105;CELL SURFACE#1.0081;TH1 CELL#1.0079;TH17 CELL#1.0063;LYMPHOID TISSUE#1.0051;GROWTH FACTOR#1.0001;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9997;T LYMPHOCYTE#0.9996;MACROPHAGE#0.9995;IFN-GAMMA#0.9985;CD8+ T CELL#0.9981;CHEMOTAXIS#0.9978;B CELL#0.9975;GM-CSF#0.9973;T CELL#0.9960;COLITIS#0.9943;LANGERHANS CELL#0.9932;POLYMERASE CHAIN REACTION#0.9932;TRANSCRIPTION FACTOR#0.9927;CD4+ T CELL#0.9926;CELL DIFFERENTIATION#0.9919;ENDOTHELIAL CELL#0.9905;EPITHELIAL CELL#0.9893;T HELPER CELL#0.9890;CCL20 PRODUCTION#0.9886;MONONUCLEAR CELLS#0.9881;PRO-INFLAMMATORY#0.9878;EFFECTOR T CELL#0.9877;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9873;ULCERATIVE COLITIS#0.9864;LYMPHOID CELL#0.9858;TRANSFORMING GROWTH FACTOR#0.9855;LEUKOCYTE#0.9853;REGULATORY T CELL#0.9850;CELL PROLIFERATION#0.9846;ENCEPHALOMYELITIS#0.9840;CYTOKINE PRODUCTION#0.9837;BONE MARROW#0.9826;LYMPH NODE#0.9823;MONOCYTE#0.9822;RHEUMATOID ARTHRITIS#0.9816;MULTIPLE SCLEROSIS#0.9808;GENE EXPRESSION#0.9794;KERATINOCYTE#0.9794;INFLAMMATORY BOWEL DISEASE#0.9790;IL-17A PRODUCTION#0.9783;NEUTROPHIL#0.9783;IMMUNE CELL#0.9783;DENDRITIC CELL#0.9782;PERIPHERAL BLOOD#0.9780;IL-17 PRODUCTION#0.9776;SIGNALING PATHWAY#0.9732;BREAST CANCER#0.9728;CELL ACTIVATION#0.9726;EFFECTOR MEMORY T CELL#0.9719;INFLAMMATORY RESPONSE#0.9697;INFLAMMATORY CELL#0.9695;AUTOIMMUNE DISEASE#0.9692;TUMOR NECROSIS FACTOR#0.9666;IMMUNE SYSTEM#0.9653;IMMUNE RESPONSE#0.9650;TH2 CELL#0.9618;TUMOR TISSUES#0.9615;T CELL ACTIVATION#0.9601;ADAPTIVE IMMUNE RESPONSE#0.9585;NERVOUS SYSTEM#0.9558;CENTRAL NERVOUS SYSTEM#0.9546;RENAL CELL CARCINOMA#0.9519;CROHN'S DISEASE#0.9457;TOLL LIKE RECEPTOR#0.9412;APOPTOSIS#0.9403;LIVER METASTASIS#0.9383;AUTOIMMUNITY#0.9369;DRAINING LYMPH NODE#0.9360;STEM CELL#0.9358;QUANTITATIVE REAL TIME#0.9323;TUMOR CELLS#0.9307;REVERSE TRANSCRIPTION#0.9253;ANTIGEN PRESENTING CELLS#0.9233;T CELL PROLIFERATION#0.9228;GASTRIC MUCOSA#0.9152;CORD BLOOD#0.9127;STROMAL CELL#0.9103;DERMATITIS#0.9089;LUPUS ERYTHEMATOSUS#0.9046;INTESTINAL MUCOSA#0.9031;GRAFT VERSUS HOST#0.9019;GRANULOCYTE#0.8987;B LYMPHOCYTE#0.8960;NAIVE T CELL#0.8958;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8896;SQUAMOUS CELL CARCINOMA#0.8887;GERMINAL CENTER#0.8844;SYNOVIAL FLUID#0.8817;ANGIOGENESIS#0.8723;LYMPHOID ORGANS#0.8671;HYPERSENSITIVITY#0.8595;TUBERCULOSIS#0.8572;T CELL DIFFERENTIATION#0.8563;INNATE IMMUNITY#0.8536;NATURAL KILLER CELL#0.8520;ACTIVATED T CELL#0.8512;NAIVE CD4+ T CELL#0.8497;COLONY-STIMULATING FACTOR#0.8492;PLASMACYTOID DENDRITIC CELL#0.8457;PANCREATIC CANCER#0.8404;TUMOR ASSOCIATED MACROPHAGE#0.8384;COLON CANCER#0.8287;DERMIS#0.8197;CHEMOKINE PRODUCTION#0.8193;ALLERGEN#0.8170;INTESTINAL EPITHELIAL CELL#0.8142;RECEPTOR LIGAND#0.8133;ADENOCARCINOMA#0.8133;CELL DEVELOPMENT#0.8088;CYTOKINE SECRETION#0.8035;PLASMA CELL#0.8021;DELAYED-TYPE HYPERSENSITIVITY#0.7993;ACTIVATED T-CELLS#0.7974;CERVICAL#0.7945;WOUND HEALING#0.7939;BREAST CANCER PATIENTS#0.7917;CALCIUM MOBILIZATION#0.7890;LYMPHOID TISSUE INDUCER#0.7847;ATHEROSCLEROSIS#0.7837;CERVICAL CANCER#0.7801;MYELOID DENDRITIC CELL#0.7793;SMALL INTESTINE#0.7790;TH9 CELL#0.7775;CHEMOATTRACTION#0.7773;LIVER DISEASE#0.7770;CELL ADHESION#0.7746;FOLLICULAR HELPER T CELL#0.7708;ARYL HYDROCARBON RECEPTOR#0.7706;SYNOVIUM#0.7681;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7653;GASTROINTESTINAL TRACT#0.7651;IMIQUIMOD#0.7646;SELECTIN#0.7629;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7550;RETINOIC ACID RECEPTOR#0.7426;SPERM MOTILITY#0.7421;LUNG CANCER#0.7382;SKIN DISEASE#0.7271;ATOPIC DERMATITIS#0.7261;UMBILICAL CORD#0.7253;VIRAL INFECTION#0.7229;BLOOD VESSEL#0.7172;CUTANEOUS T CELL LYMPHOMA#0.7107;IL-22 PRODUCTION#0.7062;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7058;EPITHELIAL TO MESENCHYMAL#0.7056;MESENTERIC LYMPH NODE#0.7050;UMBILICAL CORD BLOOD#0.7037;CELL ASSOCIATED#0.7026;OSTEOBLAST#0.7021;NITRIC OXIDE#0.6970;GROWTH FACTOR RECEPTOR#0.6959;CHOROID PLEXUS#0.6905;CHEMOKINE RECEPTOR LIGAND#0.6895;COLORECTAL LIVER METASTASES#0.6872;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.6868;INNATE IMMUNE RESPONSE#0.6855;DISEASE FREE SURVIVAL#0.6833;STROMA#0.6830;ATHEROSCLEROTIC#0.6819;CYTOTOXICITY#0.6805;LEUKOCYTE HOMEOSTASIS#0.6797;COLLAGEN INDUCED ARTHRITIS#0.6794;TYPE 1 DIABETES#0.6761;TRANSCRIPTASE#0.6752;HUMAN IMMUNODEFICIENCY VIRUS#0.6719;CELL CHEMOTAXIS#0.6590;ACTIVATED CD4+ T CELL#0.6554;PROGENITOR CELL#0.6546;ASTROCYTE#0.6461;T FOLLICULAR HELPER#0.6439;LYMPH NODE METASTASIS#0.6437;GLOMERULONEPHRITIS#0.6427;TONSIL#0.6374;NEPHRITIS#0.6347;ADAPTIVE IMMUNE SYSTEM#0.6338;IL-17A SECRETION#0.6324;B CELL DIFFERENTIATION#0.6314;T CELL MIGRATION#0.6278;VIRAL REPLICATION#0.6271;TUMOUR NECROSIS FACTOR#0.6265;ENDOTHELIUM#0.6153;LYMPHOCYTE HOMEOSTASIS#0.6118;C CHEMOKINE LIGAND#0.6106;GASTRIC TISSUE#0.6101;PERTUSSIS#0.6092;CLINICALLY ISOLATED SYNDROME#0.6090;LYMPHOCYTE ANTIGEN#0.6084;EOSINOPHIL#0.6083;CELL DEATH#0.6075;SECONDARY LYMPHOID ORGANS#0.6033
123606	HEREDITARY SPASTIC PARAPLEGIA#1.0432;PARAPLEGIA#1.0360;ANGELMAN SYNDROME#0.9906;AMYOTROPHIC LATERAL SCLEROSIS#0.7738;LATERAL SCLEROSIS#0.7738;SPINAL CORD#0.7195;EARLY ENDOSOME#0.7023;NEURODEGENERATIVE DISEASE#0.6640;PRADER WILLI SYNDROME#0.6617;LUTEIN#0.6052
123688	LUNG CANCER#1.0965
1236	METASTATIC SQUAMOUS CELL CARCINOMA#1.0890;C CHEMOKINE RECEPTOR#1.0545;CC CHEMOKINE RECEPTOR#1.0480;LYMPH NODE METASTASIS#1.0359;CC CHEMOKINE LIGAND#1.0328;BREAST CANCER CELL#1.0303;SELECTIN#1.0301;CENTRAL MEMORY T CELL#1.0282;LUNG CANCER#1.0242;CHEMOKINE RECEPTOR#1.0227;MATURE DENDRITIC CELLS#1.0212;THYMOCYTE#1.0210;ENDOTHELIAL GROWTH FACTOR#1.0199;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0199;SQUAMOUS CELL CARCINOMA#1.0189;REGIONAL LYMPH NODE#1.0182;LYMPHATIC VESSEL#1.0179;EFFECTOR MEMORY T CELL#1.0154;T CELL MIGRATION#1.0138;EPITHELIAL MESENCHYMAL TRANSITION#1.0136;CANCER CELL#1.0102;TEM CELL#1.0101;LYMPHATIC ENDOTHELIAL CELL#1.0080;HYPOXIA#1.0077;MACROPHAGE INFLAMMATORY PROTEIN#1.0075;PROSTATE CANCER#1.0074;DENDRITIC CELL MIGRATION#1.0070;MESENTERIC LYMPH NODE#1.0065;SECONDARY LYMPHOID ORGANS#1.0050;BREAST CANCER#1.0043;LYMPHOCYTE HOMING#1.0005;LYMPHOID TISSUE#0.9994;CELL CYCLE#0.9989;CHEMOTAXIS#0.9977;SPHINGOSINE 1 PHOSPHATE#0.9961;NAIVE T CELL#0.9959;LYMPHOID ORGANS#0.9955;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9949;M2 MACROPHAGE#0.9943;SIGNALING PATHWAY#0.9943;TREG CELL#0.9934;QUANTITATIVE REAL TIME#0.9930;M1 MACROPHAGE#0.9929;MEMORY T CELL#0.9929;CELL SURFACE#0.9918;ENDOCYTOSIS#0.9905;IMMATURE DENDRITIC CELL#0.9896;T CELL DEVELOPMENT#0.9893;LYMPH NODE#0.9888;VENULE#0.9886;EFFECTOR T CELL#0.9883;PERIPHERAL LYMPH NODES#0.9878;ADENOCARCINOMA#0.9878;POLYMERASE CHAIN REACTION#0.9877;ENDOTHELIAL CELL#0.9876;PROTEIN KINASE#0.9873;DRAINING LYMPH NODE#0.9869;CELL DEVELOPMENT#0.9862;LYMPH NODE METASTASES#0.9862;TUMOR TISSUES#0.9859;ATHEROSCLEROSIS#0.9858;T CELL DIFFERENTIATION#0.9858;CELL MIGRATION#0.9852;CELL ADHESION#0.9847;SPHINGOSINE#0.9847;T CELL#0.9844;EPSTEIN BARR VIRUS#0.9838;CELL MATURATION#0.9831;T HELPER CELL#0.9831;CD8+ T CELL#0.9827;ACTIN POLYMERIZATION#0.9824;SIGNAL TRANSDUCTION#0.9822;B CELL#0.9818;GRAFT VERSUS HOST#0.9818;TUMOR CELLS#0.9813;REVERSE TRANSCRIPTION#0.9813;LYMPHOCYTIC LEUKEMIA#0.9811;MACROPHAGE#0.9810;PLASMACYTOID DENDRITIC CELL#0.9807;MYELOID CELL#0.9803;LYMPHOCYTE MIGRATION#0.9802;RHEUMATOID ARTHRITIS#0.9800;CELL DEATH#0.9798;TUMOR NECROSIS FACTOR#0.9795;TRANSFORMING GROWTH FACTOR#0.9791;MULTIPLE SCLEROSIS#0.9782;GERMINAL CENTER#0.9782;CD4+ T CELL#0.9781;GROWTH FACTOR#0.9780;ADIPOSE TISSUE#0.9780;STROMAL CELL#0.9779;MYELOID DENDRITIC CELL#0.9777;TH17 CELL#0.9777;APOPTOTIC#0.9776;CENTRAL NERVOUS SYSTEM#0.9773;ENDOTHELIUM#0.9763;PRO-INFLAMMATORY#0.9762;CORD BLOOD#0.9761;INFLAMMATORY RESPONSE#0.9756;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9756;TRANSCRIPTION FACTOR#0.9754;TH1 CELL#0.9754;T LYMPHOCYTE#0.9751;ATHEROSCLEROTIC#0.9751;APOPTOSIS#0.9744;NERVOUS SYSTEM#0.9742;NEUTROPHIL#0.9741;WOUND HEALING#0.9741;IFN-GAMMA#0.9740;HUMAN DENDRITIC CELL#0.9730;PHAGOCYTOSIS#0.9728;ACTIVATED T CELL#0.9726;ANTIGEN PRESENTATION#0.9719;T CELL ACTIVATION#0.9712;IMMUNE CELL#0.9712;B LYMPHOCYTE#0.9709;EPITHELIAL CELL#0.9709;PROSTAGLANDIN E2#0.9708;CELL DIFFERENTIATION#0.9706;REGULATORY T CELL#0.9706;LEUKOCYTE#0.9699;LANGERHANS CELL#0.9699;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9692;CYTOTOXIC T-LYMPHOCYTE#0.9688;IL-12 PRODUCTION#0.9686;COLORECTAL#0.9678;MANNOSE RECEPTOR#0.9677;STEM CELL#0.9673;GM-CSF#0.9669;ACTIVATED T-CELLS#0.9663;CELL ACTIVATION#0.9660;AUTOIMMUNITY#0.9660;GENE EXPRESSION#0.9658;LIVER X RECEPTOR#0.9656;STEM CELL TRANSPLANTATION#0.9654;TUBERCULOSIS#0.9649;AUTOIMMUNE DISEASE#0.9647;CYTOKINE SECRETION#0.9640;MONOCYTE DERIVED DENDRITIC CELL#0.9639;NAIVE CD4+ T CELL#0.9639;CYTOKINE PRODUCTION#0.9637;T CELL PROLIFERATION#0.9636;CELL PROLIFERATION#0.9633;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9624;CERVICAL#0.9622;MONONUCLEAR CELLS#0.9621;ADAPTIVE IMMUNE RESPONSE#0.9620;TOLL LIKE RECEPTOR#0.9608;TUMOR ANTIGEN#0.9602;PERIPHERAL BLOOD#0.9598;CYTOTOXICITY#0.9595;TUMOUR NECROSIS FACTOR#0.9592;DENDRITIC CELL#0.9588;COLONY-STIMULATING FACTOR#0.9587;MONOCYTE#0.9586;ORAL SQUAMOUS CELL CARCINOMA#0.9583;BONE MARROW#0.9583;VIRAL INFECTION#0.9583;COLORECTAL CANCER#0.9575;FIBROCYTE#0.9559;LUNG ADENOCARCINOMA#0.9555;INFLAMMATORY CELL#0.9553;CYTOTOXIC T CELL#0.9546;IL-10 PRODUCTION#0.9545;ANTIGEN PRESENTING CELLS#0.9536;GRANULOCYTE#0.9520;PERTUSSIS#0.9514;LYMPHANGIOGENESIS#0.9513;IMMUNE SYSTEM#0.9507;MITOGEN ACTIVATED PROTEIN#0.9505;ANGIOGENESIS#0.9499;NITRIC OXIDE#0.9474;IMMUNE RESPONSE#0.9472;CD4+ MEMORY T CELL#0.9472;HUMAN IMMUNODEFICIENCY VIRUS#0.9466;CELL EXPANSION#0.9464;PROGENITOR CELL#0.9441;NATURAL KILLER CELL#0.9430;MULTIPLE MYELOMA#0.9426;CELL MOTILITY#0.9382;HEMATOPOIETIC STEM CELL#0.9379;METASTATIC MELANOMA#0.9370;CELL CHEMOTAXIS#0.9361;MEMORY B CELL#0.9358;MACROPHAGE POLARIZATION#0.9341;ENCEPHALOMYELITIS#0.9310;ALLERGEN#0.9277;FINGOLIMOD#0.9260;DERMIS#0.9247;HEPATITIS B#0.9224;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9208;LUPUS ERYTHEMATOSUS#0.9206;PANCREATIC CANCER#0.9201;CCL19 BINDING#0.9191;HUMAN LEUKOCYTE ANTIGEN#0.9158;MAST CELL#0.9144;PLASMA CELL#0.9127;HYPERSENSITIVITY#0.9103;COLITIS#0.9070;NKT CELL#0.9052;CERVICAL CANCER#0.9048;HEPATITIS C#0.9045;MESENCHYMAL STEM CELL#0.9045;INNATE IMMUNITY#0.8980;OBESE#0.8973;EXTRACELLULAR MATRIX#0.8968;SMOOTH MUSCLE#0.8948;BREAST CANCER PATIENTS#0.8927;COLON CANCER#0.8925;BLOOD VESSEL#0.8923;LOW DENSITY LIPOPROTEIN#0.8922;CALCIUM MOBILIZATION#0.8922;T FOLLICULAR HELPER#0.8914;CELL DIVISION#0.8893;SENSITIZATION#0.8880;CELLULAR IMMUNE RESPONSE#0.8876;CELL-MEDIATED IMMUNITY#0.8860;TONSIL#0.8805;MYELOID LEUKEMIA#0.8784;SIGNALLING PATHWAY#0.8760;PULMONARY FIBROSIS#0.8738;IMMUNE CELL TRAFFICKING#0.8717;TRANSCRIPTASE#0.8695;INTERLEUKIN 7 RECEPTOR#0.8688;HEPATOCELLULAR CARCINOMA#0.8649;CD3+ T CELL#0.8649;RAPAMYCIN#0.8638;KINASE INHIBITOR#0.8638;LYMPHOCYTE ANTIGEN#0.8631;RECEPTOR LIGAND#0.8626;FLOW CYTOMETRY ANALYSIS#0.8613;CELL ADHESION MOLECULE#0.8597;TYPE 1 DIABETES#0.8582;LYMPHATIC SYSTEM#0.8579;MUSCLE FIBER#0.8570;CROHN'S DISEASE#0.8568;ARTERY#0.8559;NITRIC OXIDE SYNTHASE#0.8549;LEISHMANIASIS#0.8542;SALIVARY GLAND#0.8538;PARENCHYMA#0.8537;SYNOVIAL FLUID#0.8516;T CELL HOMEOSTASIS#0.8488;LYSIS#0.8452;HEPATITIS C VIRUS#0.8384;PERIPHERAL BLOOD MONOCYTES#0.8367;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8348;HUMAN BREAST CANCER#0.8343;VIRAL REPLICATION#0.8330;LYMPHOID CELL#0.8329;SMALL INTESTINE#0.8314;CD4+CD25+ REGULATORY T CELL#0.8311;LYMPHOCYTE PROLIFERATION#0.8293;CERVICAL LYMPH NODE#0.8289;HERPES SIMPLEX VIRUS#0.8263;HERPES SIMPLEX#0.8259;LECTIN#0.8218;GRAFT VERSUS LEUKEMIA#0.8213;MEDIASTINAL LYMPH NODE#0.8183;TRANSFORMING GROWTH FACTOR BETA#0.8183;POLYCHROMATIC FLOW CYTOMETRY#0.8181;LYMPHOCYTIC CHORIOMENINGITIS#0.8180;CORONARY ARTERY#0.8179;SENESCENCE#0.8145;BREAST CARCINOMA#0.8135;IFN-BETA#0.8114;TUMOR ASSOCIATED ANTIGEN#0.8095;PERIPHERAL BLOOD LYMPHOCYTES#0.8084;DRY EYE DISEASE#0.8080;LYMPHOCYTE ACTIVATION#0.8079;TH2 CELL#0.8067;SIGNALING MOLECULE#0.8061;PSORIASIS#0.8052;INDUCIBLE NITRIC OXIDE#0.8040;TOLERANCE INDUCTION#0.8039;METASTATIC LYMPH NODE#0.7983;LEUKOCYTE MIGRATION#0.7973;INNATE IMMUNE RESPONSE#0.7966;EOSINOPHIL#0.7929;ADJACENT NORMAL TISSUE#0.7923;CELL GROWTH#0.7922;PROGRAMMED CELL DEATH#0.7918;EYE DISEASE#0.7913;SIGNAL TRANSDUCER#0.7901;HIGH FAT DIET#0.7901;OVARIAN#0.7882;CANCER STEM-LIKE CELL#0.7865;SIMIAN IMMUNODEFICIENCY VIRUS#0.7864;IL-12 SECRETION#0.7862;THYMIC EPITHELIAL CELLS#0.7858;RECEPTOR AGONIST#0.7857;GASTRIC MUCOSA#0.7827;B CELL ACTIVATION#0.7804;ALLERGIC ASTHMA#0.7798;DNA BINDING#0.7708;LUMINAL#0.7706;FIBROBLASTIC RETICULAR CELLS#0.7701;DERMATITIS#0.7690;CHEMOKINE PRODUCTION#0.7689;DELAYED-TYPE HYPERSENSITIVITY#0.7662;PLASMA MEMBRANE#0.7662;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7643;CYTOPLASM#0.7605;RETINOIC ACID#0.7596;PERIPHERAL BLOOD T-CELLS#0.7596;TARGET OF RAPAMYCIN#0.7595;ACTIVATED B CELL#0.7558;SIGNALING CASCADE#0.7539;EPITHELIAL OVARIAN CARCINOMA#0.7497;SPINAL CORD#0.7491;INFLUENZA A VIRUS#0.7471;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7461;HEPATITIS B VIRUS#0.7424;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7421;POTASSIUM CHANNEL#0.7398;CORONARY ARTERY DISEASE#0.7391;ARTERY DISEASE#0.7389;NF-KAPPAB ACTIVATION#0.7357;METASTATIC BREAST CANCER#0.7356;ISCHEMIA#0.7346;AKT SIGNALING#0.7338;T CELL MEDIATED IMMUNITY#0.7320;BONE MARROW CELLS#0.7305;IL-10 SECRETION#0.7297;NAIVE CD8+ T CELL#0.7287;ORGAN DEVELOPMENT#0.7240;ADENOSINE#0.7236;INNATE IMMUNE SYSTEM#0.7217;ALVEOLAR MACROPHAGE#0.7208;COLORECTAL CARCINOMA#0.7200;RELATED PROTEIN 1#0.7195;B CELL LYMPHOMA#0.7184;T CELL CHEMOTAXIS#0.7174;OVARIAN CARCINOMA#0.7167;DIET INDUCED OBESITY#0.7147;IL-17 PRODUCTION#0.7143;TOXICITY#0.7137;TWO PHOTON MICROSCOPY#0.7133;IMMUNE SUPPRESSION#0.7114;IL-23 PRODUCTION#0.7068;ASTROCYTE#0.7062;PANCREATIC DUCTAL ADENOCARCINOMA#0.7020;HEAD AND NECK CANCER#0.7010;NECK CANCER#0.7010;ANTIGEN PROCESSING#0.7007;CELL ASSOCIATED#0.6984;HYPOXIA INDUCIBLE FACTOR#0.6971;INFLAMMATORY BOWEL DISEASE#0.6953;TOPICAL#0.6932;OVARIAN CANCER#0.6929;STROMA#0.6925;CROSS PRESENTATION#0.6916;TERMINAL DIFFERENTIATION#0.6916;ACTIN CYTOSKELETON#0.6894;HYPERTENSION#0.6880;MELANOMA CELL LINES#0.6840;MACROPHAGE MIGRATION#0.6839;MONOCYTE DIFFERENTIATION#0.6817;TELOMERE#0.6812;TH1 IMMUNE RESPONSE#0.6793;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6782;ACTIVATED CD4+ T CELL#0.6782;IFN-GAMMA SECRETION#0.6778;HUMAN UMBILICAL VEIN#0.6776;UMBILICAL VEIN#0.6773;B CELL DIFFERENTIATION#0.6753;KERATINOCYTE#0.6752;INTEGRIN ACTIVATION#0.6747;INTESTINAL MUCOSA#0.6745;CHRONIC HEPATITIS C#0.6731;INTRACELLULAR CYTOKINE STAINING#0.6706;REGENERATION#0.6703;MUSCLE CELL#0.6669;REACTIVE OXYGEN SPECIES#0.6646;HUMORAL IMMUNE RESPONSE#0.6622;ATOPIC DERMATITIS#0.6613;ALLERGIC AIRWAY INFLAMMATION#0.6609;MYELOID-DERIVED SUPPRESSOR CELL#0.6593;RESPIRATORY SYNCYTIAL VIRUS#0.6592;HEMATOPOIETIC CELL#0.6591;LONG TERM MEMORY#0.6589;NATURAL KILLER T#0.6589;ALANINE#0.6561;CHRONIC MYELOID LEUKEMIA#0.6542;PNEUMONIA#0.6500;TYROSINE KINASE INHIBITOR#0.6498;CHLAMYDIA#0.6480;CHIMERIC ANTIGEN RECEPTOR#0.6474;ORAL MUCOSA#0.6457;CELL-MEDIATED IMMUNE RESPONSE#0.6444;TRANSITIONAL B CELL#0.6418;SMOOTH MUSCLE CELL#0.6416;CANCER STEM CELL#0.6405;C CHEMOKINE LIGAND#0.6372;ILEITIS#0.6358;GENE EXPRESSION OMNIBUS#0.6345;SKIN DISEASE#0.6318;IMIQUIMOD#0.6306;ACUTE MYELOID LEUKEMIA#0.6286;LYMPHOPENIA#0.6268;MANTLE CELL LYMPHOMA#0.6261;VACCINIA#0.6251;SMOOTH MUSCLE ACTIN#0.6227;CONNECTIVE TISSUE#0.6220;BLOOD BRAIN BARRIER#0.6220;TUBE FORMATION#0.6215;PROTEIN KINASE C#0.6200;COMPLEX II#0.6191;IL-1RA#0.6191;PEPTIDOGLYCAN#0.6180;BRONCHIAL LYMPH NODE#0.6174;GASTRITIS#0.6170;RESPONSE TO CHEMOKINE#0.6152;INVASIVE ASPERGILLOSIS#0.6137;RESPONSE TO LPS#0.6131;PROTEIN KINASE B#0.6126;CELL CYCLE ARREST#0.6094;CELL WALL#0.6090;TISSUE DAMAGE#0.6086;TYROSINE KINASE 2#0.6085;PROTEIN PROTEIN INTERACTION#0.6077;HOST CELL#0.6073;AUTOIMMUNE GASTRITIS#0.6065;OSTEOARTHRITIS#0.6052;WHOLE BLOOD ASSAY#0.6043;METASTASIS TO LYMPH NODE#0.6040;CELL POLARIZATION#0.6040;VISCERAL LEISHMANIASIS#0.6037;COMMON VARIABLE IMMUNODEFICIENCY#0.6011;THYMOCYTE MIGRATION#0.6006;CHEMOKINE BINDING#0.6002;RENAL FIBROSIS#0.6000
123720	ACTIN NUCLEATION#1.0323;MICROTUBULE#0.9647;ACTIN POLYMERIZATION#0.9147;AUTOPHAGOSOME#0.8050;MEMBRANE TUBULATION#0.7692;ACTIN FILAMENT#0.7278;ASYMMETRIC CYTOKINESIS#0.7159;GOLGI APPARATUS#0.6694
123722	CHLOROPLAST#0.7497;SUPEROXIDE DISMUTASE#0.7447;CHLOROPLAST NUCLEOID#0.7411
123745	PHOSPHOLIPASE A2#0.7692
123787	MACROPHAGE#0.6820;FERMENTATION#0.6812;EMBRYO IMPLANTATION#0.6434;ELECTRON TRANSFER#0.6270;PROGESTERONE#0.6046
1237	CC CHEMOKINE RECEPTOR#1.0535;TH2 CELL#1.0475;EOSINOPHIL#1.0221;CHEMOKINE RECEPTOR#1.0193;MONOCYTE#1.0162;CD4+ T CELL#1.0106;CHEMOTAXIS#1.0082;MACROPHAGE#1.0072;DENDRITIC CELL#1.0041;MACROPHAGE INFLAMMATORY PROTEIN#1.0012;IFN-GAMMA#0.9985;T CELL#0.9974;ALLERGIC AIRWAY DISEASE#0.9967;PERIPHERAL BLOOD#0.9958;T LYMPHOCYTE#0.9943;TELOMERE#0.9940;IMMUNE RESPONSE#0.9907;LYMPH NODE#0.9765;LEUKOCYTE#0.9706;TREG CELL#0.9680;HUMAN IMMUNODEFICIENCY VIRUS#0.9631;REGULATORY T CELL#0.9472;ALLERGEN#0.9459;B CELL#0.9416;TH1 CELL#0.9323;MEMORY T CELL#0.9282;MOLLUSCUM CONTAGIOSUM#0.9218;MAST CELL#0.9196;GENE EXPRESSION#0.9195;CALCIUM MOBILIZATION#0.9194;LYMPHOID TISSUE#0.9082;THYMOCYTE#0.9071;MONONUCLEAR CELLS#0.9023;INFLAMMATORY RESPONSE#0.8937;ENDOTHELIAL CELL#0.8765;CC CHEMOKINE LIGAND#0.8665;CELL MIGRATION#0.8572;CELL ACTIVATION#0.8487;IMMUNE SYSTEM#0.8409;T CELL ACTIVATION#0.8396;TUMOR NECROSIS FACTOR#0.7984;ATOPIC DERMATITIS#0.7945;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7895;T HELPER CELL#0.7874;MALT LYMPHOMA#0.7731;NAIVE T CELL#0.7695;CELL SURFACE#0.7692;BONE MARROW#0.7689;POLYMERASE CHAIN REACTION#0.7598;CENTRAL NERVOUS SYSTEM#0.7497;APOPTOSIS#0.7493;NERVOUS SYSTEM#0.7487;REVERSE TRANSCRIPTION#0.7433;TOLL LIKE RECEPTOR#0.7413;KAPOSI'S SARCOMA#0.7318;CYTOKINE PRODUCTION#0.7305;REPLICATION FORK#0.7186;CD8+ T CELL#0.7069;SIGNALING PATHWAY#0.7029;DERMATITIS#0.6946;PERTUSSIS#0.6929;GROWTH FACTOR#0.6860;MULTIPLE SCLEROSIS#0.6805;INNATE IMMUNE RESPONSE#0.6742;KERATINOCYTE#0.6731;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6664;C CHEMOKINE RECEPTOR#0.6635;NEUTROPHIL#0.6478;REPLICATION FORK ARREST#0.6459;ANTIGEN PRESENTING CELLS#0.6353;STRUCTURE ACTIVITY RELATIONSHIP#0.6337;APOPTOTIC#0.6322;EXTRACELLULAR LOOP 2#0.6303;ALLERGIC ASTHMA#0.6287;TELOMERASE RNA#0.6229;T CELL MIGRATION#0.6133;CYTOKINE SECRETION#0.6113;RENAL CARCINOMA#0.6038;TUMOR CELLS#0.6029
123803	ASPARAGINE#0.9712;LONG TERM MEMORY#0.6683;PROTEIN DEGRADATION#0.6618;UBIQUITIN#0.6077;UBIQUITIN PROTEASOME PATHWAY#0.6045;PROTEASOME PATHWAY#0.6020
123811	CENTROSOME#0.8733;S PHASE#0.8445;CELL MIGRATION#0.8417;BASAL BODY#0.8325;MICROTUBULE#0.7623;PRIMARY CILIUM#0.6727;MULTIPLE MYELOMA#0.6567;MICROTUBULE DEPOLYMERIZATION#0.6402
123872	DYNEIN#1.0380;LEUCINE RICH REPEAT#0.9530;LEUCINE#0.8028;PRIMARY CILIARY DYSKINESIA#0.7370;C BOUTON#0.7053;MOTILE CILIA#0.6787
123876	VALPROIC ACID#0.7083
123879	S PHASE#0.7583;CELL CYCLE#0.7523;CELL GROWTH#0.6235
1238	CHEMOKINE RECEPTOR#1.0531;T CELL#1.0377;MACROPHAGE#0.9908;CC CHEMOKINE RECEPTOR#0.9833;INFLAMMATORY RESPONSE#0.9767;LEUKOCYTE#0.9629;B CELL#0.9455;IMMUNE RESPONSE#0.9358;LYMPH NODE#0.9352;SCAVENGER RECEPTOR#0.9220;PLASMABLAST#0.8805;BONE MARROW#0.8450;SMALL INTESTINE#0.8392;MONOCYTE#0.7729;LYMPHATIC VESSEL#0.7694;CELL DEVELOPMENT#0.7624;PERIPHERAL BLOOD#0.7562;SIGNALING PATHWAY#0.7504;DENDRITIC CELL#0.7476;PLASMA CELL#0.7355;ENDOTHELIAL CELL#0.7291;T LYMPHOCYTE#0.6998;LYMPHATIC ENDOTHELIAL CELL#0.6971;T CELL DEVELOPMENT#0.6937;CHEMOKINE BINDING#0.6844;PSORIASIS#0.6652;PRO-INFLAMMATORY#0.6593;NEUTROPHIL#0.6576;GROWTH FACTOR#0.6364;CELL MIGRATION#0.6300;MAMMARY GLAND#0.6205;BONE REMODELING#0.6121;MULTIPLE SCLEROSIS#0.6043
123904	NEURITE GROWTH#0.9255;NERVOUS SYSTEM#0.8978;NEURITE#0.6502
123920	TUMOR SUPPRESSOR#1.0645;TUMOR TISSUES#0.9784;CANCER CELL#0.9518;CELL GROWTH#0.8408;SQUAMOUS CELL CARCINOMA#0.8336;APOPTOSIS#0.7649;TESTICULAR CANCER#0.7352;DNA METHYLATION#0.7181;CELL CYCLE#0.7108;CELL CYCLE ARREST#0.6373;CELL MIGRATION#0.6357;CELL SURFACE#0.6328
123	LIPID DROPLET PROTEIN#1.0626;ADIPOCYTE DIFFERENTIATION#1.0444;FATTY ACID BINDING#1.0443;SEBACEOUS CARCINOMA#1.0369;FATTY ACID SYNTHASE#1.0329;ANDROGEN RECEPTOR#1.0292;TRIGLYCERIDE LIPASE#1.0231;LIPID DROPLET FORMATION#1.0229;HORMONE SENSITIVE LIPASE#1.0221;SKELETAL MUSCLE#1.0218;LIPID STORAGE#1.0142;ADIPOCYTE#1.0135;MACROPHAGE#1.0097;OLEIC ACID#1.0085;LIPID DROPLET#1.0063;STEROL REGULATORY ELEMENT#1.0056;RENAL CELL CARCINOMA#1.0040;LIPOLYSIS#1.0025;HIGH FAT DIET#1.0021;MAMMARY GLAND#1.0003;PEROXISOME#0.9984;LOW DENSITY LIPOPROTEIN#0.9955;LIPOGENESIS#0.9955;FATTY ACID OXIDATION#0.9947;PROTEIN KINASE#0.9946;FATTY LIVER#0.9925;ATHEROSCLEROSIS#0.9916;MAMMARY EPITHELIAL CELL#0.9889;QUANTITATIVE REAL TIME#0.9889;TRANSCRIPTION FACTOR#0.9878;FOAM CELL FORMATION#0.9866;FATTY LIVER DISEASE#0.9865;GROWTH FACTOR#0.9851;LIVER DISEASE#0.9848;CYTOPLASM#0.9846;HYPOXIA#0.9844;SIGNALING PATHWAY#0.9844;TROPHOBLAST#0.9831;EPITHELIAL CELL#0.9823;ADIPOSE TISSUE#0.9815;ENDOPLASMIC RETICULUM#0.9811;LIPID METABOLISM#0.9807;OOCYTE#0.9805;POLYMERASE CHAIN REACTION#0.9805;LIPID HOMEOSTASIS#0.9805;GENE EXPRESSION#0.9803;MONOCYTE#0.9681;APOPTOSIS#0.9675;ORGANELLE#0.9653;OBESE#0.9602;TUMOR CELLS#0.9598;AUTOPHAGY#0.9564;ATHEROSCLEROTIC#0.9535;ROSIGLITAZONE#0.9507;ADIPOGENESIS#0.9470;LACTATION#0.9432;PROTEASOME#0.9391;ADENOCARCINOMA#0.9381;SQUAMOUS CELL CARCINOMA#0.9346;ALCOHOLIC FATTY LIVER#0.9343;ACETYL COA CARBOXYLASE#0.9315;MITOCHONDRIA#0.9302;VACUOLE#0.9302;LIPOFIBROBLAST#0.9258;CANCER CELL#0.9241;LIPID SYNTHESIS#0.9219;TYPE 2 DIABETES#0.9173;BINDING PROTEIN 1#0.9141;GLUCOSE UPTAKE#0.9134;CELL DIFFERENTIATION#0.9129;CELL PROLIFERATION#0.9128;STEM CELL#0.9086;PALMITIC ACID#0.9075;CYTOSOLIC LIPID DROPLETS#0.9030;STEAROYL COA DESATURASE#0.9003;LIPOPROTEIN LIPASE#0.8948;COENZYME A#0.8942;STEARIC ACID#0.8930;SMOOTH MUSCLE#0.8868;LUNG ADENOCARCINOMA#0.8850;XANTHINE#0.8846;SEBACEOUS GLAND#0.8822;PLASMA MEMBRANE#0.8799;CELL DEATH#0.8789;AQUAPORIN#0.8715;PALMITATE#0.8678;PROTEIN KINASE A#0.8632;FACTOR XIIIA#0.8625;FATTY ACID SYNTHESIS#0.8595;FATTY ACID TRANSPORT#0.8581;CHOLESTEROL EFFLUX#0.8579;PREADIPOCYTE#0.8544;VERY-LOW-DENSITY LIPOPROTEIN#0.8521;BASAL CELL CARCINOMA#0.8490;ENHANCER BINDING PROTEIN#0.8473;BREAST CANCER#0.8470;ENHANCER BINDING#0.8468;KERATINOCYTE#0.8465;CARNITINE#0.8451;BASAL CELL#0.8444;LEYDIG CELL#0.8407;HEPATOMA CELLS#0.8274;HYPOXIA INDUCIBLE FACTOR#0.8271;SMOOTH MUSCLE ACTIN#0.8254;PRO-INFLAMMATORY#0.8236;FATTY ACID METABOLISM#0.8188;O ACYLTRANSFERASE#0.7985;BONE MARROW#0.7977;CELL GROWTH#0.7926;TUMOR NECROSIS FACTOR#0.7922;UBIQUITIN#0.7861;MYOTUBE#0.7851;WHITE ADIPOSE TISSUE#0.7848;INSULIN SECRETION#0.7844;GLUCOSE HOMEOSTASIS#0.7831;SEBACEOUS ADENOMA#0.7827;LIPOPHAGY#0.7758;REVERSE TRANSCRIPTION#0.7732;NONALCOHOLIC FATTY LIVER DISEASE#0.7717;TOLL LIKE RECEPTOR#0.7659;HYPOXIC#0.7631;INSULIN RECEPTOR#0.7585;ENDOTHELIAL GROWTH FACTOR#0.7568;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7568;HEAT SHOCK PROTEIN#0.7516;LIPID BINDING#0.7508;KIDNEY DISEASE#0.7481;PROGESTERONE#0.7467;ETHANOL#0.7455;DIET INDUCED OBESITY#0.7447;REACTIVE OXYGEN SPECIES#0.7435;LIPOSARCOMA#0.7400;TRIGLYCERIDE SYNTHESIS#0.7389;T CELL#0.7331;MUSCLE FIBER#0.7276;TRIGLYCERIDE STORAGE#0.7204;FORMALIN#0.7187;CLEAR CELL RENAL CELL CARCINOMA#0.7123;WEIGHT GAIN#0.7116;LIPID BODY#0.7110;REGULATION OF LIPID METABOLISM#0.7107;LIPID OXIDATION#0.7083;XANTHINE OXIDASE#0.7062;ARACHIDONIC ACID#0.7005;HEPATIC STELLATE CELL#0.6987;EPIDERMAL GROWTH FACTOR#0.6980;HEPATITIS C VIRUS#0.6862;HEPATITIS C#0.6854;RETINOID X RECEPTOR#0.6834;PERIPHERAL BLOOD#0.6816;MILK PROTEIN#0.6815;TROPHOBLAST CELL#0.6801;DIACYLGLYCEROL O ACYLTRANSFERASE#0.6762;LYSOSOME#0.6741;MUSCLE FIBRE#0.6738;PROTEASOME PATHWAY#0.6733;TRANSFORMING GROWTH FACTOR#0.6712;INFLAMMATORY RESPONSE#0.6709;CELL CYCLE#0.6697;BETA CELL#0.6639;MUSCLE CELL#0.6614;PROTEIN SYNTHESIS#0.6565;HIGH DENSITY LIPOPROTEIN#0.6554;SATURATED FATTY ACID#0.6505;BINDING PROTEIN 3#0.6502;ENTEROCYTE#0.6497;PHOSPHOLIPID SYNTHESIS#0.6448;HEPATOCELLULAR CARCINOMA#0.6442;EYELID#0.6405;DE NOVO LIPOGENESIS#0.6387;SEBOCYTE DIFFERENTIATION#0.6368;SKIN IRRITANT#0.6355;ER MEMBRANE#0.6343;2-CHLORO-5-NITRO-N-PHENYLBENZAMIDE#0.6335;IRRITANT#0.6306;BREAST CARCINOMA#0.6256;APOPTOTIC#0.6225;ENDOPLASMIC RETICULUM MEMBRANE#0.6144;DNA BINDING#0.6140;RETINOL#0.6124;GLYCOLYSIS#0.6111;CONJUGATED LINOLEIC ACID#0.6109;RENAL CARCINOMA#0.6106;PYRUVATE#0.6099;LYMPH NODE#0.6098;COLORECTAL#0.6073;LUNG EPITHELIAL CELL#0.6068;SUBCUTANEOUS ADIPOSE TISSUE#0.6068;SKIN IRRITATION#0.6061;GLUCOSE INTOLERANCE#0.6052;LIPID TRANSPORT#0.6048;FATTY ACID TRANSPORTER#0.6028;GRANULOSA CELL#0.6025;EMBRYO DEVELOPMENT#0.6012;MESENCHYMAL STEM CELL#0.6002;CYTOCHROME C#0.6001
124045	SPERMATOGENESIS#0.8047
124056	NADPH OXIDASE#1.0165;PLASMA MEMBRANE#0.9904;REACTIVE OXYGEN SPECIES#0.9893;EPITHELIAL CELL#0.9808;CANCER CELL#0.9565;COLON EPITHELIAL CELL#0.8800;ROS GENERATION#0.8199;COLON CANCER#0.7749;GENE EXPRESSION#0.7724;PROTEIN KINASE#0.7373;GROWTH FACTOR#0.6693;TUMOR NECROSIS FACTOR#0.6664;SMOOTH MUSCLE#0.6417;PROTEIN KINASE C#0.6326;NITRIC OXIDE#0.6305;NITRIC OXIDE SYNTHASE#0.6010
1240	CHEMOKINE RECEPTOR#1.0477;DENDRITIC CELL#1.0324;ADIPOCYTE#1.0311;MACROPHAGE#1.0300;PLASMACYTOID DENDRITIC CELL#1.0283;ADIPOSE TISSUE#1.0132;ENDOTHELIAL CELL#1.0112;GENE EXPRESSION#1.0097;INFLAMMATORY RESPONSE#1.0024;CHEMOTAXIS#1.0011;LEUKOCYTE#0.9990;MONOCYTE#0.9920;NEUTROPHIL#0.9774;SMOOTH MUSCLE#0.9757;OBESE#0.9723;IMMUNE RESPONSE#0.9702;SIGNALING PATHWAY#0.9648;ADIPOCYTE DIFFERENTIATION#0.9593;T CELL#0.9562;PRO-INFLAMMATORY#0.9469;CELL MIGRATION#0.9468;GRANULOSA CELL#0.9439;PSORIASIS#0.9323;TYPE 2 DIABETES#0.9282;GLUCOSE HOMEOSTASIS#0.9241;HIGH FAT DIET#0.9123;MUSCLE CELL#0.9094;ADIPOGENESIS#0.9083;BONE MARROW#0.9050;SMOOTH MUSCLE CELL#0.8715;QUANTITATIVE REAL TIME#0.8620;STEM CELL#0.8578;TUMOR NECROSIS FACTOR#0.8555;DIABETIC NEPHROPATHY#0.8509;SKELETAL MUSCLE#0.8494;EICOSAPENTAENOIC ACID#0.8464;FATTY LIVER#0.8413;ATHEROSCLEROSIS#0.8408;WHITE ADIPOSE TISSUE#0.8244;PROTEIN KINASE#0.8123;APOPTOSIS#0.8092;IMMUNE CELL#0.8005;HYPERTENSION#0.8003;GLUCOSE UPTAKE#0.7949;NATURAL KILLER CELL#0.7918;FORMYL PEPTIDE RECEPTOR#0.7910;RECEPTOR ANTAGONIST#0.7870;LIVER DISEASE#0.7702;PHAGOCYTOSIS#0.7690;APOPTOTIC#0.7648;PERIVASCULAR ADIPOSE TISSUE#0.7624;POLYMERASE CHAIN REACTION#0.7617;ATHEROSCLEROTIC#0.7576;URIC ACID#0.7563;FATTY LIVER DISEASE#0.7557;SPINAL CORD#0.7490;OVARIAN#0.7387;LIPID METABOLISM#0.7327;MESENCHYMAL STEM CELL#0.7284;IMMUNE SYSTEM#0.7104;CANCER CELL#0.7070;ANGIOGENESIS#0.6983;HUMAN ARTICULAR CHONDROCYTES#0.6949;ENDOTHELIUM#0.6930;M1 MACROPHAGE#0.6883;MONOCYTE DERIVED DENDRITIC CELL#0.6871;NEPHROPATHY#0.6861;NEUROBLASTOMA#0.6839;RETINOIC ACID#0.6820;LOW DENSITY LIPOPROTEIN#0.6750;TUMOR CELLS#0.6560;VASCULAR SMOOTH MUSCLE CELL#0.6549;CELL SURFACE#0.6498;ROSIGLITAZONE#0.6457;ARTERY#0.6457;CHONDROCYTE#0.6399;LEUKOTRIENE B4 RECEPTOR#0.6347;PERIODONTITIS#0.6326;GLUCOSE INTOLERANCE#0.6294;INFLAMMATORY CELL#0.6241;IMMATURE DENDRITIC CELL#0.6239;ALLERGIC AIRWAY INFLAMMATION#0.6208;SUBCUTANEOUS ADIPOSE TISSUE#0.6180;M2 MACROPHAGE#0.6180;CALCIUM MOBILIZATION#0.6091;DEMYELINATING DISEASE#0.6049
1241	CD8+ T CELL#1.0711;LEUKOTRIENE B4 RECEPTOR#1.0521;LEUKOTRIENE RECEPTOR#1.0411;LIPID TRANSPORT#1.0316;RECEPTOR ANTAGONIST#1.0308;MAST CELL#1.0224;T LYMPHOCYTE#1.0170;T CELL#1.0162;CELL SURFACE#1.0113;IMMUNE CELL#1.0069;PLATELET ACTIVATING FACTOR#1.0031;GENE EXPRESSION#1.0028;LEUKOCYTE#1.0012;NEUTROPHIL#1.0004;CANCER CELL#0.9999;PERIPHERAL BLOOD#0.9970;CHEMOTAXIS#0.9970;MONOCYTE#0.9956;MACROPHAGE#0.9940;ATHEROSCLEROSIS#0.9927;INFLAMMATORY RESPONSE#0.9896;CALCIUM MOBILIZATION#0.9889;SIGNALING PATHWAY#0.9876;IMMUNE RESPONSE#0.9819;EOSINOPHIL#0.9784;ARACHIDONIC ACID#0.9725;GRANULOCYTE#0.9694;APOPTOSIS#0.9656;DENDRITIC CELL#0.9642;SCAVENGER RECEPTOR#0.9579;ENDOTHELIAL CELL#0.9576;INFLAMMATORY CELL#0.9573;GROWTH FACTOR#0.9570;CHEMOKINE RECEPTOR#0.9510;PRO-INFLAMMATORY#0.9488;BONE MARROW#0.9434;RECEPTOR BINDING#0.9400;ALLERGEN#0.9314;REACTIVE OXYGEN SPECIES#0.9261;PROTEIN KINASE#0.9213;SPINAL CORD#0.9027;CELL MIGRATION#0.8968;EFFECTOR T CELL#0.8846;LEUKOTRIENE A4 HYDROLASE#0.8815;CD4+ T CELL#0.8808;NEUTROPHIL CHEMOTAXIS#0.8808;EPITHELIAL CELL#0.8730;LYMPH NODE#0.8623;SIGNAL TRANSDUCTION#0.8615;BLT RECEPTOR#0.8458;GM-CSF#0.8424;SMOOTH MUSCLE#0.8363;PHAGOCYTOSIS#0.8317;LIPOXYGENASE PATHWAY#0.8297;OSTEOCLAST#0.8289;TRANSFORMING GROWTH FACTOR#0.8267;NEUTROPHIL DEGRANULATION#0.8250;BENZOIC ACID#0.8092;B CELL#0.8036;COLITIS#0.8023;RHEUMATOID ARTHRITIS#0.8021;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8013;RECEPTOR INTERNALIZATION#0.7969;CYTOKINE PRODUCTION#0.7866;POLYMERASE CHAIN REACTION#0.7829;ADIPOSE TISSUE#0.7813;PHOSPHOLIPASE C#0.7804;TUMOR NECROSIS FACTOR#0.7772;MITOGEN ACTIVATED PROTEIN#0.7757;DEXAMETHASONE#0.7737;LEUKOTRIENE SYNTHESIS#0.7635;PSORIASIS#0.7599;P2Y RECEPTOR#0.7578;POLYMORPHONUCLEAR NEUTROPHIL#0.7562;POLYMORPHONUCLEAR LEUKOCYTES#0.7539;DERMATITIS#0.7537;SENSITIZATION#0.7520;ALVEOLAR MACROPHAGE#0.7500;HIGH DENSITY LIPOPROTEIN#0.7469;CYSTEINYL LEUKOTRIENE RECEPTOR#0.7452;PANCREATIC CANCER#0.7450;LIPID RAFT#0.7445;IFN-GAMMA#0.7411;NEUTROPHIL ACTIVATION#0.7351;INNATE IMMUNITY#0.7239;REVERSE TRANSCRIPTION#0.7177;CELL PROLIFERATION#0.7152;PERTUSSIS#0.7092;PROTEIN KINASE C#0.7012;ASPIRIN#0.7002;NEUTROPHIL MIGRATION#0.6979;BLEOMYCIN#0.6959;FURAN#0.6929;PULMONARY FIBROSIS#0.6925;MYELOPEROXIDASE ACTIVITY#0.6855;EICOSAPENTAENOIC ACID#0.6836;LTB4 SYNTHESIS#0.6832;CELL DEATH#0.6826;INFLAMMATORY BOWEL DISEASE#0.6774;PERITONITIS#0.6766;ISCHEMIA#0.6757;COLONY-STIMULATING FACTOR#0.6754;SMOOTH MUSCLE CELL#0.6748;MUSCLE CELL#0.6742;KINASE INHIBITOR#0.6467;NEUTROPHIL APOPTOSIS#0.6431;CONTACT DERMATITIS#0.6402;ARTERY#0.6321;ROS GENERATION#0.6311;CELL MEMBRANE#0.6292;MONONUCLEAR CELLS#0.6281;ARACHIDONIC ACID METABOLISM#0.6250;STEM CELL#0.6248;LEUKOTRIENE C4 SYNTHASE#0.6240;STRUCTURE ACTIVITY RELATIONSHIP#0.6206;LEUKOCYTE ACTIVATION#0.6181;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6179;PHOSPHOLIPASE A2#0.6179;CALCIUM SIGNALLING#0.6083;IL-13 PRODUCTION#0.6061;T CELL MIGRATION#0.6052;RED FLUORESCENT PROTEIN#0.6052;VASCULAR DISEASE#0.6050;CYTOKINETIC RING#0.6020;UNILATERAL URETERAL OBSTRUCTION#0.6015;ACUTE LUNG INJURY#0.6008;FORMYL PEPTIDE RECEPTOR#0.6006
124220	PANCREATIC ADENOCARCINOMA#1.1351;PANCREATIC CANCER#1.1134;CANCER CELL#1.0842;ADENOCARCINOMA#1.0690;SIGNALING PATHWAY#0.8868;COLORECTAL CANCER#0.8417;BREAST CANCER#0.8099;APOPTOSIS#0.7209;ZYMOGEN GRANULE#0.6866;COLORECTAL#0.6760;TOLL LIKE RECEPTOR#0.6482;TUMOR TISSUES#0.6476;CELL CYCLE#0.6396;SUGAR BINDING#0.6114;TLR4 SIGNALING PATHWAY#0.6086
124222	CELL PROLIFERATION#1.0548;HUMAN BREAST CANCER#0.7152;BREAST CANCER#0.7077;CANCER CELL#0.7065;PROTEIN DEGRADATION#0.6690;BREAST CANCER CELL#0.6605;LUNG CANCER#0.6580;PROGESTIN#0.6356
124274	CENTRAL NERVOUS SYSTEM#0.9573;NERVOUS SYSTEM#0.9559;CALCIUM MOBILIZATION#0.9100;L-TRYPTOPHAN#0.9068;L-PHENYLALANINE#0.9064;TRYPTOPHAN#0.8501;MUTAGENESIS#0.6620;ESSENTIAL AMINO ACID#0.6530;ADRENOCORTICOTROPIC HORMONE#0.6416;CHLOROPHYLL FLUORESCENCE#0.6037
1243	BASAL CELL CARCINOMA#1.0616;BASAL CELL#1.0548;DYSPLASTIC NEVUS#1.0488;SQUAMOUS CELL CARCINOMA#1.0412;SKIN CANCER#1.0394;NEVUS#1.0335;LYMPH NODE#1.0229;CELL CYCLE#0.9857;SENTINEL LYMPH NODE#0.9704;MELANOCYTE#0.9677;FAMILIAL MELANOMA#0.9356;METASTATIC MELANOMA#0.9280;IMMUNE RESPONSE#0.9135;UVEAL MELANOMA#0.8970;GENE EXPRESSION#0.8962;APOPTOSIS#0.8737;DNA REPAIR#0.8636;AGE AT DIAGNOSIS#0.8612;CYCLIN DEPENDENT KINASE#0.8481;TUMOR SUPPRESSOR#0.8411;POLYMERASE CHAIN REACTION#0.8371;CELL PROLIFERATION#0.8369;BREAST CANCER#0.8089;POSITRON EMISSION TOMOGRAPHY#0.7611;KINASE INHIBITOR#0.7555;NODULAR#0.7536;GROWTH FACTOR#0.7411;T CELL#0.7373;REGIONAL LYMPH NODE#0.7291;ANGIOGENESIS#0.7210;STANDARDIZED INCIDENCE RATE#0.7101;LYMPH NODE METASTASIS#0.7092;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7063;PERIPHERAL BLOOD#0.7036;DYSPLASTIC NEVUS SYNDROME#0.6992;HEPATOCELLULAR CARCINOMA#0.6360;LYMPH NODE METASTASES#0.6346;IMMUNE SYSTEM#0.6232;PROTEIN KINASE#0.6205;CANCER CELL#0.6154;VULVAR MELANOMA#0.6105;MITOGEN ACTIVATED PROTEIN#0.6035;CHROMATID#0.6029;YEAR SURVIVAL RATE#0.6027
124401	MOLECULAR DYNAMICS SIMULATION#0.6230
124404	ANNULUS#1.0764;GERM CELL#1.0257;SPERM ANNULUS#1.0237;MALE INFERTILITY#1.0078;INFERTILITY#0.9465;SPERMIOGENESIS#0.9236;GTP BINDING#0.9160;INFERTILE#0.8911;SPERMATOGENESIS#0.8638;SPERM HEAD#0.8552;NUCLEAR MEMBRANE#0.7142;SPERM MOTILITY#0.6838;SPERMATOZOA#0.6827;SPERM TAIL#0.6560;INTENTION TO TREAT#0.6457;TERMINAL DIFFERENTIATION#0.6380
124446	DEATH RECEPTOR#0.6863;APOPTOSIS#0.6670;LUNG CANCER#0.6378
124454	GLUTAMATE RECEPTOR#0.9746;L-GLUTAMATE#0.9486;LEUKOENCEPHALOPATHY#0.9246;AMPA RECEPTOR#0.9100;THALAMUS#0.8794;ANTICODON BINDING DOMAIN#0.8723;PROTEIN SYNTHESIS#0.8651;GLUTAMINE#0.8468;TRNA BINDING#0.8100;GATCAB#0.7699;NMDA RECEPTOR#0.7333;NERVOUS SYSTEM#0.6621;ASPARTATE#0.6309;GLUTAMATE BINDING#0.6249;TRANSFER RNA#0.6003
124491	CORONARY ARTERY DISEASE#0.7860;ARTERY DISEASE#0.7857;CORONARY ARTERY#0.7833;NUCLEAR ENVELOPE#0.7623
1244	DUBIN-JOHNSON SYNDROME#1.0606;MULTIDRUG RESISTANT PROTEIN#1.0478;CPT-11#1.0396;BRUSH BORDER#1.0355;CARBAMAZEPINE#1.0347;VESICULAR TRANSPORT#1.0325;BRUSH BORDER MEMBRANE#1.0314;RENAL TRANSPLANT RECIPIENTS#1.0302;ESTRADIOL-17BETA#1.0284;PRAVASTATIN#1.0271;DIPHOSPHATE#1.0238;ORGANIC CATION TRANSPORTER#1.0222;SAQUINAVIR#1.0220;SULFINPYRAZONE#1.0206;URIDINE#1.0192;CELL SURFACE#1.0184;EPILEPSY#1.0177;IRINOTECAN#1.0160;ORGANIC ANION TRANSPORTER#1.0150;ACTIVE TRANSPORTER#1.0146;OVARIAN CARCINOMA#1.0144;ORGANIC ANION TRANSPORT#1.0143;QUERCETIN#1.0136;VINBLASTINE#1.0135;INDOMETHACIN#1.0126;MULTIDRUG RESISTANCE PROTEIN#1.0122;RIFAMPICIN#1.0122;MYCOPHENOLIC ACID#1.0118;PROBENECID#1.0110;ENTEROCYTE#1.0099;PHENOBARBITAL#1.0075;ANION TRANSPORT#1.0071;MULTI DRUG RESISTANCE#1.0070;PROTEIN KINASE C#1.0064;TRANSCRIPTASE#1.0054;ESTRADIOL#1.0043;CYCLOSPORIN A#1.0042;ADENOSINE TRIPHOSPHATE#1.0041;JEJUNUM#1.0039;DIGOXIN#1.0029;DEXAMETHASONE#1.0028;TENOFOVIR#1.0025;BREAST CANCER#1.0022;PERIPHERAL BLOOD#1.0020;EFFLUX PUMP#1.0019;DOCETAXEL#1.0019;RITONAVIR#1.0009;CYCLOSPORIN#1.0007;QUANTITATIVE REAL TIME#1.0001;CELL MEMBRANE#0.9993;CYCLOSPORINE#0.9992;LUMINAL#0.9989;ROSUVASTATIN#0.9981;ATP BINDING CASSETTE TRANSPORTER#0.9979;ADENOSINE#0.9977;CISPLATIN#0.9972;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9968;SMALL INTESTINE#0.9967;OXALIPLATIN#0.9965;METHOTREXATE#0.9964;GLUTATHIONE#0.9957;ATPASE ACTIVITY#0.9956;OVARIAN#0.9950;CARCINOGEN#0.9945;FLUORESCEIN#0.9942;OVARIAN CANCER#0.9942;EXCRETION#0.9933;ETOPOSIDE#0.9931;TAMOXIFEN#0.9926;MEMBRANE TRANSPORT#0.9923;COLORECTAL#0.9918;INTESTINAL ABSORPTION#0.9915;RNA INTERFERENCE#0.9913;PROTEIN KINASE#0.9911;COLORECTAL CANCER#0.9904;VINCRISTINE#0.9904;TAUROCHOLATE#0.9902;MONONUCLEAR CELLS#0.9900;PANCREATIC CANCER#0.9898;PLASMA MEMBRANE#0.9894;TIGHT JUNCTION#0.9887;EZETIMIBE#0.9885;PEPTIDE TRANSPORTER#0.9881;PACLITAXEL#0.9876;LUNG CANCER#0.9872;LASER SCANNING MICROSCOPY#0.9872;INTRAHEPATIC CHOLESTASIS#0.9871;ABC TRANSPORTER#0.9867;POLYMERASE CHAIN REACTION#0.9866;BILE DUCT LIGATION#0.9861;FARNESOID X RECEPTOR#0.9860;CYTOCHROME P450#0.9859;TACROLIMUS#0.9850;DOXORUBICIN#0.9849;HEPATOCELLULAR CARCINOMA#0.9845;TRANSEPITHELIAL TRANSPORT#0.9844;HEPATOTOXICITY#0.9841;ENDOTHELIAL CELL#0.9836;EPITHELIAL CELL#0.9831;PREGNANE X RECEPTOR#0.9830;CHOLESTASIS#0.9829;VERAPAMIL#0.9829;LOPINAVIR#0.9828;ARSENITE#0.9825;DRUG TRANSPORT#0.9819;TOPOISOMERASE#0.9817;BLOOD BRAIN BARRIER#0.9817;STRUCTURE ACTIVITY RELATIONSHIP#0.9811;ALKALINE PHOSPHATASE#0.9807;SIMVASTATIN#0.9806;ATP BINDING CASSETTE#0.9803;REVERSE TRANSCRIPTION#0.9803;CONJUGATION#0.9799;ATP BINDING#0.9793;BILE DUCT#0.9787;CELL CYCLE#0.9784;HEPATOCYTE NUCLEAR FACTOR#0.9781;DRUG RESISTANCE#0.9770;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9762;GENE EXPRESSION#0.9761;DUODENUM#0.9760;DRUG METABOLISM#0.9759;DICLOFENAC#0.9750;SIGNALING PATHWAY#0.9744;DETOXIFICATION#0.9740;INTESTINAL EPITHELIAL CELL#0.9735;ADENOCARCINOMA#0.9727;CYTOTOXICITY#0.9717;URSODEOXYCHOLIC ACID#0.9705;TUMOR CELLS#0.9699;CANCER CELL#0.9696;MDR PROTEIN#0.9693;ORGANIC SOLUTE TRANSPORTER#0.9690;DNA REPAIR#0.9677;APOPTOSIS#0.9676;KIDNEY PROXIMAL TUBULE#0.9673;5 FLUOROURACIL#0.9668;TRANSCRIPTION FACTOR#0.9665;GLUCURONATE#0.9658;CYTOPLASM#0.9657;ACETAMINOPHEN#0.9652;TOXICITY#0.9638;STEM CELL#0.9636;NEUTROPENIA#0.9628;B CELL#0.9613;CELLULAR LOCALIZATION#0.9607;FLUOROURACIL#0.9602;GROWTH FACTOR#0.9593;PRIMARY HUMAN HEPATOCYTES#0.9583;SORAFENIB#0.9582;LIVER DISEASE#0.9582;CHOLIC ACID#0.9581;EMBRYONIC KIDNEY#0.9576;ALANINE#0.9576;KINASE INHIBITOR#0.9573;SANDWICH CULTURED HEPATOCYTES#0.9572;ATORVASTATIN#0.9572;TRANSPORTER ACTIVITY#0.9563;BILE ACID SYNTHESIS#0.9561;DIARRHEA#0.9558;HUMAN EMBRYONIC KIDNEY#0.9553;CYCLIC AMP#0.9553;RECEPTOR ANTAGONIST#0.9549;ERYTHROMYCIN#0.9529;PROXIMAL TUBULE CELL#0.9517;NEPHROTOXICITY#0.9515;RESVERATROL#0.9502;MEMBRANE FRACTION#0.9481;COLON CANCER#0.9465;RIFAMPIN#0.9445;NERVOUS SYSTEM#0.9431;CENTRAL NERVOUS SYSTEM#0.9419;APICAL PLASMA MEMBRANE#0.9416;MICROSOME#0.9396;REACTIVE OXYGEN SPECIES#0.9391;FATTY LIVER#0.9388;COPROPORPHYRIN I#0.9372;TOPOISOMERASE II#0.9368;COLCHICINE#0.9352;GLOMERULAR FILTRATION#0.9336;HEPATITIS C#0.9291;GEMCITABINE#0.9288;CELL DEATH#0.9250;BILE ACID TRANSPORT#0.9247;BILE ACID METABOLISM#0.9220;CELL PROLIFERATION#0.9195;GD-EOB-DTPA#0.9188;TUMOR NECROSIS FACTOR#0.9165;CAMPTOTHECIN#0.9159;BREAST CANCER CELL#0.9156;EMODIN#0.9145;GS-X PUMP#0.9136;FOLATE#0.9134;HIV PROTEASE INHIBITOR#0.9134;NITRIC OXIDE#0.9128;NEUTROPHIL#0.9118;ESTRONE#0.9114;GENISTEIN#0.9105;PITAVASTATIN#0.9104;MITOXANTRONE#0.9090;EPIRUBICIN#0.9074;PRIMARY ACTIVE TRANSPORTER#0.9074;MYCOPHENOLATE MOFETIL#0.9073;SULFASALAZINE#0.9073;INTRAHEPATIC CHOLESTASIS OF PREGNANCY#0.9066;ADVERSE DRUG REACTION#0.9052;TAUROCHOLIC ACID#0.9035;ENDOCYTOSIS#0.9005;GASTROINTESTINAL TRACT#0.9002;COLORECTAL ADENOCARCINOMA#0.9001;ETHINYLESTRADIOL#0.8997;GLOMERULAR FILTRATION RATE#0.8990;FUROSEMIDE#0.8971;ASPARTATE#0.8933;SQUAMOUS CELL CARCINOMA#0.8886;PENICILLIN G#0.8884;IMMUNOSUPPRESSANT#0.8883;DRUG DELIVERY SYSTEM#0.8868;T CELL#0.8854;PROXIMAL TUBULAR CELL#0.8853;OLMESARTAN#0.8803;INFLAMMATORY RESPONSE#0.8800;BILE DUCT LIGATED#0.8798;INTESTINAL MUCOSA#0.8769;ETHACRYNIC ACID#0.8762;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8761;AMINOHIPPURATE#0.8748;ISCHEMIA#0.8746;FEXOFENADINE#0.8727;ENDOPLASMIC RETICULUM#0.8722;LIVER DAMAGE#0.8700;PHASE II METABOLISM#0.8693;TELMISARTAN#0.8686;ARYL HYDROCARBON RECEPTOR#0.8674;HUMAN BREAST CANCER#0.8653;CELL GROWTH#0.8643;MYELOID LEUKEMIA#0.8642;MICROTUBULE#0.8634;PHENYTOIN#0.8632;NEUROTOXICITY#0.8621;QUINIDINE#0.8606;GALLBLADDER#0.8606;BOSENTAN#0.8542;EFAVIRENZ#0.8534;PEROXISOME#0.8523;TUBULAR EPITHELIAL CELL#0.8518;RNA BINDING#0.8514;GD-BOPTA#0.8506;FATTY LIVER DISEASE#0.8500;HEPATOMA CELLS#0.8490;FRAGMENT LENGTH POLYMORPHISM#0.8467;BREAST CANCER PATIENTS#0.8458;NUCLEOTIDE BINDING#0.8453;TAUROURSODEOXYCHOLATE#0.8447;VALPROIC ACID#0.8436;APOPTOTIC#0.8434;TROGLITAZONE#0.8432;TRADITIONAL CHINESE MEDICINE#0.8416;DNA BINDING#0.8407;CARBOPLATIN#0.8393;TENOFOVIR DISOPROXIL FUMARATE#0.8393;TENOFOVIR DISOPROXIL#0.8391;BONE MARROW#0.8388;CORNEAL EPITHELIUM#0.8386;REPORTER GENE ASSAY#0.8381;PROPANOIC ACID#0.8375;CELLULAR DETOXIFICATION#0.8341;QUANTITATIVE REVERSE TRANSCRIPTION#0.8330;GAMMA-GLUTAMYLCYSTEINE#0.8326;TOXICANT#0.8316;IRINOTECAN, CPT-11#0.8286;GLYCINE#0.8243;HUMAN IMMUNODEFICIENCY VIRUS#0.8241;RENAL CELL CARCINOMA#0.8223;HEPATOCELLULAR CARCINOMA CELL#0.8219;IVERMECTIN#0.8216;HISTONE DEACETYLASE#0.8200;CELL POLARITY#0.8184;OOCYTE#0.8183;HYPOXIA#0.8154;INTRACELLULAR VESICLE#0.8142;ZONULA OCCLUDENS#0.8127;ANTIOXIDANT RESPONSE ELEMENT#0.8125;KETOCONAZOLE#0.8102;SYNCYTIOTROPHOBLAST#0.8100;CIPROFLOXACIN#0.8100;ACUTE MYELOID LEUKEMIA#0.8095;LIVER CANCER#0.8082;OBSTRUCTIVE JAUNDICE#0.8078;CHENODEOXYCHOLIC ACID#0.8077;DIPEPTIDYL PEPTIDASE#0.8064;GLUCOCORTICOID RECEPTOR#0.8060;MITOCHONDRIAL MEMBRANE#0.8049;ESTROGEN RECEPTOR#0.8034;COLON ADENOCARCINOMA#0.8030;MUTAGENESIS#0.8028;SERUM ALBUMIN#0.7986;OBESE#0.7985;INTRACELLULAR MEMBRANE#0.7983;NOVOBIOCIN#0.7970;CIRCADIAN RHYTHM#0.7952;TYROSINE KINASE INHIBITOR#0.7951;NUCLEOTIDE BINDING DOMAIN#0.7950;TOPOTECAN#0.7944;VALPROATE#0.7932;ENHANCER BINDING PROTEIN#0.7930;ENHANCER BINDING#0.7925;ESTROGENS#0.7924;OCTREOTIDE#0.7912;SPIRONOLACTONE#0.7900;ETHYNYLESTRADIOL#0.7892;GLUCURONIDE TRANSPORT#0.7882;REVERSE TRANSCRIPTASE INHIBITOR#0.7873;ATAZANAVIR#0.7852;IMATINIB#0.7843;ATP HYDROLYSIS#0.7839;GLUTAMATE CYSTEINE LIGASE#0.7821;METASTATIC COLORECTAL CANCER#0.7818;ACTINOMYCIN D#0.7792;RNA BINDING PROTEIN#0.7783;MIDGUT#0.7782;PENICILLIN#0.7781;MAGNETIC RESONANCE IMAGING#0.7777;GREPAFLOXACIN#0.7753;MODE OF ACTION#0.7753;LEUCOVORIN#0.7740;EXTRACELLULAR SPACE#0.7738;SULFATION#0.7729;INDINAVIR#0.7650;BIBR 277#0.7638;DNA TOPOISOMERASE#0.7607;PROTEIN KINASE A#0.7606;ENDOTHELIN RECEPTOR#0.7600;ADEFOVIR#0.7587;ENZYME ACTIVITY#0.7585;GLIBENCLAMIDE#0.7583;SUPEROXIDE DISMUTASE#0.7567;OLIGOPEPTIDE TRANSPORTER#0.7553;INTESTINAL TRACT#0.7551;ACRYLIC ACID#0.7543;TRANSMEMBRANE TRANSPORT#0.7518;VP-16#0.7500;ADRIAMYCIN#0.7491;PREGNENOLONE#0.7479;PRIMARY BILIARY CIRRHOSIS#0.7475;PROGENITOR CELL#0.7473;DARUNAVIR#0.7471;CYCLOPHOSPHAMIDE#0.7458;KIDNEY TRANSPLANT RECIPIENTS#0.7451;CELLULAR MEMBRANE#0.7427;PROTEIN BINDING#0.7420;GENE SILENCING#0.7415;HUMAN INTESTINAL EPITHELIAL#0.7394;SUNITINIB#0.7366;TRABECTEDIN#0.7357;ADENOSINE MONOPHOSPHATE#0.7357;ACTIN FILAMENT#0.7350;GENTAMICIN#0.7286;XENOBIOTIC METABOLISM#0.7282;MEDIATED DRUG RESISTANCE#0.7279;FUMARATE#0.7232;NONALCOHOLIC FATTY LIVER DISEASE#0.7229;KUPFFER CELL#0.7227;METHOTREXATE TRANSPORT#0.7224;PORTAL VEIN#0.7222;COLORECTAL CARCINOMA#0.7206;HEME OXYGENASE 1#0.7197;QUANTITATIVE REVERSE TRANSCRIPTASE#0.7189;TROPHOBLAST#0.7184;DAUNORUBICIN#0.7184;PROTEIN TRANSPORTER#0.7182;LIVER X RECEPTOR#0.7181;OXYGENASE#0.7170;SUCROSE#0.7169;NUCLEAR ENVELOPE#0.7148;TESTOSTERONE#0.7148;LOW DENSITY LIPOPROTEIN#0.7135;VACUOLE#0.7130;SMALL HETERODIMER PARTNER#0.7110;RETINOID X RECEPTOR#0.7107;CYSTIC FIBROSIS#0.7059;DISEASE FREE SURVIVAL#0.7055;ZONULA OCCLUDENS 1#0.7054;LAMIVUDINE#0.7036;MITOGEN ACTIVATED PROTEIN#0.7024;MICAFUNGIN#0.7023;DIPEPTIDYL PEPTIDASE IV#0.7016;LIVER REGENERATION#0.7001;TIGHT JUNCTION PROTEIN#0.6989;COLON CARCINOMA#0.6970;THERAPEUTIC DRUG MONITORING#0.6969;ENDOTHELIUM#0.6964;ENZYME INHIBITOR#0.6951;TUMOR TISSUES#0.6943;RIBOZYME#0.6915;FLUVASTATIN#0.6890;HYPERTENSION#0.6886;PARA-AMINOHIPPURATE#0.6881;B CELL LYMPHOMA#0.6877;TRANSACTIVATION#0.6876;ABACAVIR#0.6872;CHOLANGIOCARCINOMA#0.6868;METHIONINE#0.6867;PLASMA PROTEIN#0.6860;RESPONSE TO PLATINUM#0.6859;TOXIN BINDING#0.6857;NITRIC OXIDE SYNTHASE#0.6848;CHOLANGITIS#0.6818;SCLEROSING CHOLANGITIS#0.6817;DRUG EXPORT#0.6805;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6805;BENZYLPENICILLIN#0.6779;ARSENIC TRIOXIDE#0.6779;LARGE INTESTINE#0.6749;PDZ BINDING MOTIF#0.6739;GEMFIBROZIL#0.6736;RNA EDITING#0.6727;VALSARTAN#0.6711;STATUS EPILEPTICUS#0.6703;PKC ACTIVATION#0.6703;CANCER STEM CELL#0.6695;BETA-ESTRADIOL#0.6692;LEUKOCYTE#0.6688;SIROLIMUS#0.6686;HEPATITIS C VIRUS#0.6678;CHOLINE#0.6668;TUMOR SUPPRESSOR#0.6647;TAXOL#0.6639;PROTEIN PROTEIN INTERACTION#0.6609;TUDCA#0.6602;ACUTE LIVER INJURY#0.6597;NUCLEAR HORMONE RECEPTOR#0.6590;REGENERATION#0.6589;MITOCHONDRIA#0.6584;PSEUDOXANTHOMA ELASTICUM#0.6577;PRIMARY SCLEROSING CHOLANGITIS#0.6571;KIDNEY DISEASE#0.6568;RHEUMATOID ARTHRITIS#0.6563;ERYTHROMYCIN METABOLISM#0.6553;LIVER CIRRHOSIS#0.6543;G1 PHASE#0.6528;MARAVIROC#0.6524;MYRICETIN#0.6524;HIGH FAT DIET#0.6516;BLOOD VESSEL#0.6506;CHOROID PLEXUS#0.6460;ANTI INFLAMMATORY DRUGS#0.6425;PROTEIN SYNTHESIS#0.6416;72-HOURS#0.6414;PROGESTERONE#0.6391;OXCARBAZEPINE#0.6390;GLUTATHIONE PEROXIDASE#0.6388;EXTRACELLULAR MATRIX#0.6366;UBIQUITIN#0.6361;LYMPH NODE#0.6355;MAJOR VAULT PROTEIN#0.6328;BILIRUBIN TRANSPORT#0.6311;CARNITINE#0.6288;PRAZOSIN#0.6285;AZITHROMYCIN#0.6282;MITOMYCIN C#0.6274;EPIGALLOCATECHIN#0.6260;ETHANOL#0.6256;EXTRAHEPATIC CHOLESTASIS#0.6246;YOLK SAC#0.6246;FAMILIAL INTRAHEPATIC CHOLESTASIS#0.6245;ADENOSINE 5'-TRIPHOSPHATE#0.6243;TAUROURSODEOXYCHOLIC ACID#0.6240;TROPHOBLAST CELL#0.6237;GLUTATHIONE METABOLISM#0.6235;ACUTE LIVER FAILURE#0.6235;RALOXIFENE#0.6231;BASOLATERAL PLASMA MEMBRANE#0.6225;THYMIDYLATE SYNTHASE#0.6222;MACROPHAGE#0.6215;PROTEASOME#0.6209;SENSITIZATION#0.6207;CIMETIDINE#0.6197;GESTATION#0.6196;MICROVILLI#0.6183;MICROVASCULAR ENDOTHELIAL CELL#0.6175;INTRACELLULAR LOCALIZATION#0.6157;METFORMIN#0.6139;ANGIOTENSIN CONVERTING ENZYME#0.6136;ELECTROPHORETIC MOBILITY SHIFT#0.6115;ACID SECRETION#0.6112;GLUTATHIONE TRANSPORT#0.6103;GYNECOLOGIC ONCOLOGY GROUP#0.6090;EMTRICITABINE#0.6061;NEUROTOXIC#0.6057;CHRONIC CHOLANGITIS#0.6057;SIGNAL TRANSDUCTION#0.6041;5-ASA#0.6033;INTRACELLULAR RETENTION#0.6028;NEPHROTOXIC#0.6019;DUCT CELL#0.6008;XENOBIOTIC TRANSPORT#0.6005;TELITHROMYCIN#0.6001
124540	MYELOID LEUKEMIA#1.0725;ACUTE MYELOID LEUKEMIA#1.0690;RNA BINDING PROTEIN#1.0409;RNA BINDING#1.0398;SIGNALING PATHWAY#1.0373;CANCER CELL#1.0309;STEM CELL#1.0269;CELL GROWTH#1.0162;GENE EXPRESSION#1.0067;CELL PROLIFERATION#0.9983;CELL CYCLE#0.9622;PROGENITOR CELL#0.9497;APOPTOSIS#0.9428;HEMATOPOIETIC STEM CELL#0.9178;ONCOGENIC#0.9144;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9004;CHRONIC MYELOID LEUKEMIA#0.8849;LUNG CANCER#0.8819;LYMPH NODE#0.8622;EPITHELIAL MESENCHYMAL TRANSITION#0.8560;TRANSCRIPTION FACTOR#0.8476;GERM CELL#0.8280;LYMPH NODE METASTASIS#0.8186;PANCREATIC CANCER#0.7714;POLYMERASE CHAIN REACTION#0.7697;CERVICAL CANCER#0.7672;CELL MIGRATION#0.7514;PRECURSOR CELL#0.7420;EPITHELIAL CELL#0.7323;LEUKEMIA STEM CELL#0.7207;EMBRYONIC STEM CELL#0.7181;HEMATOPOIETIC CELL#0.7033;COLORECTAL CANCER#0.6848;BREAST CANCER#0.6773;ADENOCARCINOMA#0.6637;CELL DEVELOPMENT#0.6382;DISEASE FREE SURVIVAL#0.6375;DRUG RESISTANCE#0.6305;SPERMATOGENESIS#0.6259;NEURAL PRECURSOR CELL#0.6188;SQUAMOUS CELL CARCINOMA#0.6144;LIVER CANCER#0.6071;MAPK SIGNALING#0.6067;MITHRAMYCIN#0.6062;CANCER STEM CELL#0.6015;ESTROGEN RECEPTOR#0.6004
124583	DESBUQUOIS DYSPLASIA#1.1161;PROTEOGLYCAN SYNTHESIS#0.7837;PROTEOGLYCAN#0.6765;OSSIFICATION#0.6518;PROSTATE CANCER#0.6310
124590	USHER SYNDROME#1.0522;PHOTORECEPTOR CELL#0.9788;HAIR CELL#0.9736;HEARING LOSS#0.9722;INNER EAR#0.9255;RETINITIS PIGMENTOSA#0.9002;RETINITIS#0.8229;PDZ BINDING MOTIF#0.7833;BLINDNESS#0.7797;STERILE ALPHA MOTIF#0.6666;HEARING IMPAIRMENT#0.6573;MALNUTRITION#0.6342;CELL CELL ADHESION#0.6223;STEREOCILIA BUNDLE#0.6117;CELL ADHESION#0.6099
124599	MYELOID CELL#0.7792;TOLL LIKE RECEPTOR#0.6653;LPS BINDING#0.6260
124602	KINESIN#0.7451;MICROTUBULE#0.7437;MICROTUBULE DEPOLYMERIZATION#0.7119
124626	ZONA PELLUCIDA#1.1040;GENE EXPRESSION#0.7319;DNA METHYLATION#0.7305
124641	TUMOR SUPPRESSOR#0.8803;SERINE HYDROLASE#0.7107
124739	BREAST CANCER#0.9872;BREAST CANCER CELL#0.7487;CELL CYCLE#0.7437;UBIQUITIN SPECIFIC PROTEASE#0.6691;CANCER CELL#0.6452
124783	ATP SYNTHASE#0.9653
124790	SMALL NUCLEAR RNA#0.7173
124801	STRESS GRANULE#0.6054
124808	COLORECTAL CANCER#1.1841;COLORECTAL#0.8485
124842	HAIR CELL#0.7666
124857	SKELETAL MUSCLE#0.8912;BREAST CANCER#0.8026;GROWTH FACTOR#0.6261
124872	SKELETAL MUSCLE#1.0968;MUSCULAR DYSTROPHY#1.0624;ERYTHROCYTE#1.0387;LECTIN#1.0322;BLOOD GROUP ANTIGEN#1.0197;GLYCOSYLATION#1.0142;GENE EXPRESSION#0.9921;T CELL#0.8750;CYTOTOXIC T CELL#0.8432;LARGE INTESTINE#0.8381;CELL SURFACE#0.8247;CANCER CELL#0.8075;DUCHENNE MUSCULAR DYSTROPHY#0.7928;EMBRYO IMPLANTATION#0.7848;ENDOTHELIAL CELL#0.7815;ADENO ASSOCIATED VIRUS#0.7082;ERYTHROCYTE MEMBRANES#0.7046;RED BLOOD CELL#0.6619;GLCNAC#0.6436;LIMB-GIRDLE MUSCULAR DYSTROPHY#0.6218;EPITHELIAL CELL#0.6142;VASCULAR ENDOTHELIAL CELL#0.6075;COLON CARCINOMA#0.6058
124912	LYSOZYME G#1.0312;CYSTATIN#0.9823;FERTILIZATION#0.8650;ACROSOME#0.8213;GENE EXPRESSION#0.8169;BETA-2#0.7702;SERUM ALBUMIN#0.7318;MACROPHAGE#0.6841;IMMUNE RESPONSE#0.6827;IMMUNE SYSTEM#0.6691;CANCER TESTIS ANTIGEN#0.6325;SPERMATOZOA#0.6026
124923	PROTEIN KINASE#0.6399
124925	DENDRITIC SPINE#0.7971;NEURONAL CELLS#0.7293;CELL SURFACE#0.7224;CEREBRAL CORTEX#0.6498;NEURITE#0.6400;FOREBRAIN#0.6288;MOTOR LEARNING#0.6130;AMACRINE CELL#0.6004
124935	GENE EXPRESSION#0.8424;SMALL INTESTINE#0.8065;AMINO ACID TRANSPORT#0.7439;OOCYTE#0.6248
124936	CYTOCHROME B5#0.9039;HEME BINDING#0.8523;PROGESTERONE#0.8084;CELL PROLIFERATION#0.7578;CERVICAL CANCER#0.6945;GENE EXPRESSION#0.6827;CELL CYCLE#0.6706;CERVICAL#0.6662;CELL GROWTH#0.6295
124944	BREAST CANCER#0.9285;CANCER CELL#0.9269;BREAST CANCER CELL#0.7373;CELL PROLIFERATION#0.6856;TRANSCRIPTION FACTOR#0.6040
124961	ZINC FINGER PROTEIN#0.9907;OSMOTIC STRESS RESPONSE#0.6931;SEED GERMINATION#0.6573
124976	SPHINGOSINE#1.0339;SPHINGOSINE 1 PHOSPHATE#1.0280;ENDOTHELIAL CELL#1.0039;T CELL#0.8750;EPITHELIAL CELL#0.8252;AUTOIMMUNE DISEASE#0.7697;LYMPH NODE#0.7666;CANCER CELL#0.7251;B CELL#0.6957;IMMUNE SYSTEM#0.6822;SPHINGOSINE KINASE 1#0.6480;BONE MARROW#0.6102;MORPHOGENESIS#0.6014
124995	RIBOSOMAL PROTEIN#0.8932;MITOCHONDRIAL RIBOSOME#0.7318;MITOCHONDRIAL PROTEIN SYNTHESIS#0.7148;PROTEIN SYNTHESIS#0.6840;RIBOSOME#0.6317
124997	CEREBELLAR ATAXIA#0.9072;MENTAL RETARDATION#0.8598;PURKINJE CELL#0.6358;PI3K COMPLEX#0.6336
124	ADH-1#1.0666;ALCOHOL METABOLISM#1.0316;RETINOL#1.0277;RETINOIC ACID#1.0274;PYRUVATE#1.0173;ENZYME ACTIVITY#1.0073;ETHANOL#1.0019;FERMENTATION#1.0013;PROTOPLAST#0.9871;VITAMIN A#0.9788;GENE EXPRESSION#0.9780;TRANSCRIPTION FACTOR#0.9772;HYPOXIA#0.9770;HYPOXIC#0.9547;TOXICITY#0.9321;POLYMERASE CHAIN REACTION#0.9232;DNA BINDING#0.9120;BETA GLUCURONIDASE#0.8998;LIVER DISEASE#0.8956;AUTOSOMAL DOMINANT HYPOCALCEMIA#0.8907;GLUTATHIONE#0.8849;MELPHALAN#0.8807;ETHANOL METABOLISM#0.8736;ETHANOL FERMENTATION#0.8640;ETHANOL OXIDATION#0.8480;ALCOHOL:NAD+ OXIDOREDUCTASE#0.8461;EXHERIN#0.8454;HOMOLOGOUS RECOMBINATION#0.8421;MUTAGENESIS#0.8391;RETINOID METABOLISM#0.8379;CYTOCHROME P450#0.8231;GLYCOLYSIS#0.8156;CENTROMERE#0.8044;VIRULENCE#0.7954;PYRAZOLE#0.7927;CANCER CELL#0.7608;CHRONIC ALCOHOL CONSUMPTION#0.7605;REACTIVE OXYGEN SPECIES#0.7558;ALPHA AMYLASE#0.7548;ALCOHOLIC FERMENTATION#0.7545;CELL GROWTH#0.7524;RESPIRATION#0.7521;GLYCERALDEHYDE-3-PHOSPHATE#0.7443;ALCOHOL DEHYDROGENASE ACTIVITY#0.7405;MITOCHONDRIA#0.7371;REVERSE TRANSCRIPTION#0.7358;OVARIAN#0.7305;DNASE I#0.7296;RETINOL METABOLISM#0.7266;CHLORAMPHENICOL#0.7257;RETINOL DEHYDROGENASE#0.7223;APOPTOSIS#0.7129;YEAST ALCOHOL DEHYDROGENASE#0.7082;STATIONARY PHASE#0.7004;FORMALDEHYDE DEHYDROGENASE#0.6985;GERMINATION#0.6931;CHLOROPLAST#0.6900;LIVER DAMAGE#0.6879;UBIQUITIN#0.6845;OVARIES#0.6693;GENE CONVERSION#0.6669;DETOXIFICATION#0.6575;FLUCONAZOLE#0.6563;MITOCHONDRIAL MEMBRANE#0.6560;ZINC BINDING#0.6548;DRUG RESISTANCE#0.6503;LACTIC ACID#0.6312;FRAGMENT LENGTH POLYMORPHISM#0.6279;DNA REPAIR#0.6200;VITAMIN A DEFICIENCY#0.6168;PHOSPHOGLYCERATE KINASE#0.6131;ALCOHOL DEPENDENCE#0.6089
125050	SMALL NUCLEAR RNA#0.7600;STEM CELL#0.7121
125058	DNA METHYLATION#0.6999;RECEPTOR RECYCLING#0.6810;TRANSFERRIN RECEPTOR#0.6580
125061	TRYPTOPHAN#1.0691;YOLK SAC#0.9749;L-TRYPTOPHAN#0.9170;TRYPTOPHAN METABOLISM#0.8077;THYMIDINE KINASE#0.6429;TERATOGEN#0.6319
125111	CONNEXIN#1.0655;GAP JUNCTION#1.0367;GAP JUNCTION CHANNEL#0.7257;TRANSCRIPTION FACTOR#0.7076;MYOCARDIUM#0.6255;CARDIOMYOCYTE#0.6167
125150	SHU COMPLEX#0.7155
125168	CELL PROLIFERATION#0.8960
125170	MITOCHONDRIAL FISSION#1.1045;MITOCHONDRIA#0.9482;RELATED PROTEIN 1#0.9273;OUTER MEMBRANE#0.8413;MITOCHONDRIAL FUSION#0.7967;MITOCHONDRIAL OUTER MEMBRANE#0.7913;APOPTOSIS#0.6970;SKELETAL MUSCLE#0.6346
125206	FRUCTOSE#0.8292
125228	MYOBLAST DIFFERENTIATION#0.8279;MUSCLE CELL#0.8001
125336	HEARING LOSS#1.0514;CORNEAL DYSTROPHY#0.9024;HEARING IMPAIRMENT#0.7528;HAIR CELL#0.6472
125476	INO80 COMPLEX#0.9275;CHROMATIN REMODELING#0.9002;NUCLEOSOME#0.8237;CHROMATIN REMODELING COMPLEX#0.7288;INO80 CHROMATIN REMODELING COMPLEX#0.6749;ATP HYDROLYSIS#0.6533
125488	MUSCLE CELL DIFFERENTIATION#0.9322;MAP KINASE#0.9062;CELL DIFFERENTIATION#0.9022;MUSCLE CELL#0.9004;SKELETAL MUSCLE#0.9004
1254	CHARCOT MARIE TOOTH#0.8644;NEUROPATHY#0.6938;WHOLE GENOME SEQUENCING#0.6664
1255	CORNEA PLANA#0.8160
1257	CARNEY COMPLEX#1.0882;MULTIPLE ENDOCRINE NEOPLASIA#1.0869;PITUITARY ADENOMA#1.0834;MULTIPLE ENDOCRINE NEOPLASIA TYPE 1#1.0831;PROTEIN KINASE A#1.0358;PROTEIN KINASE#1.0258;PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE#0.9683;NODULAR#0.8648;GROWTH HORMONE#0.8620;ACROMEGALY#0.8502;MCCUNE ALBRIGHT SYNDROME#0.8403;PEUTZ-JEGHERS SYNDROME#0.7951;SERTOLI CELL#0.7807;PITUITARY GLAND#0.7796;CHROMOSOMAL REGION#0.6997;TUMOR SUPPRESSOR#0.6902;RECEPTOR INTERACTING PROTEIN#0.6881;ARYL HYDROCARBON RECEPTOR#0.6846;DOYNE HONEYCOMB RETINAL DYSTROPHY#0.6457;OVARIAN#0.6393
125893	PSORIASIS#0.7233
1258	A-GLUTAMIC ACID#1.1088;GLUTAMIC ACID#1.0710;RETINITIS PIGMENTOSA#1.0359;RETINITIS#1.0188;CYCLIC NUCLEOTIDE GATED#1.0113;RETINAL DEGENERATION#1.0113;T CELL#0.8516;ION CHANNEL#0.7709;CATION CHANNEL#0.7670;PLASMA MEMBRANE#0.7359;PHOTOTRANSDUCTION#0.7005;CD4+ T CELL#0.6853;ALANINE#0.6849;GENE EXPRESSION#0.6529;REGULATORY T CELL#0.6422;GARP COMPLEX#0.6257;PHOSPHODIESTERASE#0.6245;OLFACTORY SENSORY NEURON#0.6244;OLFACTORY EPITHELIUM#0.6190;POLYMERASE CHAIN REACTION#0.6114
125931	SMALL INTESTINE#0.7595;PROSTATE CANCER#0.7144;CELL ADHESION MOLECULE#0.6253;CELL ADHESION#0.6233
125950	RNA RECOGNITION MOTIF#0.8518;POLYPYRIMIDINE TRACT BINDING#0.8468;FOCAL ADHESION#0.8042;RNA BINDING#0.6673;SKELETAL MUSCLE#0.6518;SMOOTH MUSCLE#0.6404;ANTIVIRAL RESPONSE#0.6033
125958	OLFACTORY RECEPTOR#0.9440;SENSORY PERCEPTION#0.6469
125972	ENDOPLASMIC RETICULUM#0.9421
125981	FOLLICLE STEM CELL#0.7045;HAIR FOLLICLE#0.6844;STEM CELL#0.6704;HAIR LOSS#0.6411
125988	MICOS COMPLEX#1.0632;CRISTAE#0.7877;CONTACT SITE#0.7478;CRISTA JUNCTION#0.6734;RESPIRATORY CHAIN#0.6402;LIVER DISEASE#0.6328
125997	METHYL CPG BINDING#0.8574;OOCYTE#0.6732;NURD COMPLEX#0.6012
1259	RIBOSOMAL PROTEIN#1.0375;CYCLIC NUCLEOTIDE GATED#1.0129;RETINITIS PIGMENTOSA#0.9949;ION CHANNEL#0.9647;GENE EXPRESSION#0.9628;CATION CHANNEL#0.9228;RETINITIS#0.9147;OOCYTE#0.8488;POLYMERASE CHAIN REACTION#0.7959;NUCLEOTIDE BINDING#0.6926;CYCLIC NUCLEOTIDE BINDING#0.6662;PHOTOTRANSDUCTION#0.6659;PLASMA MEMBRANE#0.6592;CYCLIC GUANOSINE MONOPHOSPHATE#0.6406
125	PANCREATITIS#1.0473;DRINKING BEHAVIOR#1.0450;ESOPHAGEAL CANCER#1.0448;ALCOHOLIC PANCREATITIS#1.0436;LIVER CIRRHOSIS#1.0364;ALCOHOLIC LIVER CIRRHOSIS#1.0247;RESPONSE TO ALCOHOL#1.0225;FRAGMENT LENGTH POLYMORPHISM#1.0193;ALCOHOL DEPENDENCE#1.0172;FLUSHING#1.0160;POLYMERASE CHAIN REACTION#1.0146;HEPATOCELLULAR CARCINOMA#1.0118;LIVER DISEASE#1.0102;ALCOHOL METABOLISM#1.0058;ALCOHOL USE DISORDER#1.0044;COLORECTAL CANCER#1.0014;ETHANOL METABOLISM#0.9998;SQUAMOUS CELL CARCINOMA#0.9982;BREAST CANCER#0.9957;CYTOCHROME P450#0.9951;ETHANOL#0.9949;COLORECTAL#0.9930;GENE EXPRESSION#0.9553;ADJUSTED ODDS RATIO#0.9351;CHRONIC LIVER DISEASE#0.9201;ALCOHOL DEGRADATION#0.8895;MULTIPLE LOGISTIC REGRESSION#0.8786;HEAD AND NECK CANCER#0.8779;NECK CANCER#0.8778;ETHANOL OXIDATION#0.8744;FERMENTATION#0.8552;BETA-2#0.8543;ADH-1#0.8519;RETINOL#0.8420;GLUTATHIONE#0.8402;LIVER DAMAGE#0.8305;TRANSCRIPTION FACTOR#0.8218;CARCINOGEN#0.8048;ACUTE PANCREATITIS#0.7952;MENTAL DISORDER#0.7925;OVARIAN CANCER#0.7870;DIGESTION#0.7485;LEUKOCYTE#0.7462;ACETALDEHYDE METABOLISM#0.7103;LIVER DEVELOPMENT#0.6872;HEPATITIS B#0.6856;STOMACH CANCER#0.6822;ESOPHAGUS#0.6817;RETINOIC ACID#0.6769;LUNG CANCER#0.6741;ENZYME ACTIVITY#0.6729;DOPAMINE#0.6658;CONDITIONAL LOGISTIC REGRESSION#0.6568;FATTY LIVER#0.6532;HARDY WEINBERG EQUILIBRIUM#0.6515;4-METHYLPYRAZOLE#0.6508;CELL PROLIFERATION#0.6460;DIGESTIVE TRACT#0.6336;BIRTH DEFECT#0.6319;HYPERTENSION#0.6298;TUMOR NECROSIS FACTOR#0.6171;OVARIAN#0.6158
126006	PURKINJE CELL#1.0596;BIPOLAR CELL#0.9544;GENE EXPRESSION#0.8798;GUANINE#0.7143;NUCLEOTIDE EXCHANGE FACTOR#0.7051;CELL DEVELOPMENT#0.6295
126014	DENDRITIC CELL#1.0414;ACID PHOSPHATASE#1.0319;ACTIVATED T CELL#1.0311;OSTEOCLAST#1.0290;ACTIVATED T-CELLS#1.0282;T CELL#1.0192;GENE EXPRESSION#1.0068;MONOCYTE#1.0031;TRANSCRIPTION FACTOR#0.9987;OSTEOCLAST DIFFERENTIATION#0.9863;RECEPTOR ACTIVATOR#0.9808;BONE MARROW#0.9758;BONE RESORPTION#0.9708;SIGNALING PATHWAY#0.9702;MACROPHAGE#0.9652;RHEUMATOID ARTHRITIS#0.9447;ENDOTHELIAL CELL#0.9272;OSTEOPOROSIS#0.9249;OSTEOBLAST#0.9069;CALCITONIN RECEPTOR#0.8952;MYELOID CELL#0.8846;AMBULATORY BLOOD PRESSURE#0.8652;BREAST CANCER#0.7757;POLYMERASE CHAIN REACTION#0.7725;BONE DISEASE#0.7650;LYMPH NODE#0.7561;HYPERTENSION#0.7447;LOW DENSITY LIPOPROTEIN#0.7331;GROWTH FACTOR#0.7299;MONONUCLEAR CELLS#0.7165;COLLAGEN BINDING#0.6820;RANDOMIZED CONTROLLED TRIAL#0.6725;ACUTE CORONARY SYNDROME#0.6698;PERIPHERAL BLOOD#0.6478;CELL SURFACE#0.6426;INHIBITION OF OSTEOCLAST DIFFERENTIATION#0.6328;BONE REMODELING#0.6066;INFLAMMATORY MONOCYTE#0.6040;MICROPHTHALMIA#0.6031;PERIODONTITIS#0.6009
126068	ZINC FINGER PROTEIN#0.9148
126074	SHU COMPLEX#1.0367;HOMOLOGOUS RECOMBINATION REPAIR#0.7200;HOMOLOGOUS RECOMBINATION#0.6783
1260	CYCLIC NUCLEOTIDE GATED#1.0209;ION CHANNEL#0.9880;CATION CHANNEL#0.9717;OLFACTORY EPITHELIUM#0.9314;SIGNAL TRANSDUCTION#0.9007;OLFACTORY SENSORY NEURON#0.8905;OLFACTORY RECEPTOR#0.8603;OLFACTORY BULB#0.7918;ENDOTHELIAL CELL#0.7046;VASCULAR ENDOTHELIAL CELL#0.6977;PHOSPHODIESTERASE#0.6832;HAIR CELL#0.6203;SMOOTH MUSCLE#0.6073
126129	CARNITINE#1.0532;ENERGY HOMEOSTASIS#1.0359;FATTY ACID OXIDATION#1.0347;ENDOPLASMIC RETICULUM#1.0338;CANCER CELL#0.9924;HIGH FAT DIET#0.9485;CELLULAR SENESCENCE#0.8333;SPATIAL LEARNING#0.8316;MITOCHONDRIA#0.7967;PALMITOYL#0.7647;TUMOR CELLS#0.7593;FATTY ACID METABOLISM#0.7474;SENESCENCE#0.7427;DIET INDUCED OBESITY#0.7178;LIPID METABOLISM#0.7007;WEIGHT GAIN#0.6949;CARNITINE PALMITOYL TRANSFERASE#0.6837;FATTY ACID SYNTHASE#0.6554;HYPOXIA#0.6445;REGULATION OF ENERGY HOMEOSTASIS#0.6431;PROTEIN KINASE#0.6285;GENE EXPRESSION#0.6276;GLYCOLYSIS#0.6146;LIPID DROPLET#0.6145;SIGNALING PATHWAY#0.6108
126133	URIC ACID#0.9394;PROTEIN PROTEIN INTERACTION#0.6644;SERUM URIC ACID#0.6038
126147	TRANSIT AMPLIFYING CELL#0.8520
1261	ACHROMATOPSIA#1.0503;CONE DYSTROPHY#1.0340;CYCLIC NUCLEOTIDE GATED#1.0307;CATION CHANNEL#1.0137;OPSIN#0.9612;PHOTOTRANSDUCTION#0.9595;BLINDNESS#0.9263;RETINAL DISEASE#0.8876;ION CHANNEL#0.8585;CYCLIC GUANOSINE MONOPHOSPHATE#0.8316;ORGAN OF CORTI#0.7828;HAIR CELL#0.7706;GUANOSINE#0.7524;CELL DEATH#0.7484;OOCYTE#0.7479;STEREOCILIA TIP LINK#0.7426;OPTICAL COHERENCE TOMOGRAPHY#0.7192;PHOSPHODIESTERASE#0.7059;BIPOLAR CELL#0.6976;ADENO ASSOCIATED VIRUS#0.6634;ENDOPLASMIC RETICULUM#0.6629;AMAUROSIS#0.6355;RETINAL DEGENERATION#0.6300;GENES OF INTEREST#0.6293;CONE ROD DYSTROPHY#0.6247;LEBER CONGENITAL AMAUROSIS#0.6169;GANGLION CELLS#0.6010;NUCLEOTIDE BINDING#0.6004
126206	OOCYTE#1.0451;GERM CELL#0.8807;LEUCINE RICH REPEAT#0.8569;GENE EXPRESSION#0.8207;EMBRYO DEVELOPMENT#0.8190;OVARIAN#0.7756;PREIMPLANTATION EMBRYO DEVELOPMENT#0.7291;LEUCINE#0.7271;FERTILIZATION#0.6948;PARATHYROID#0.6062
126208	RETROGRADE TRANSPORT VESICLE#0.7964;ENDOPLASMIC RETICULUM#0.7456;TRANSPORT VESICLE#0.6605
126259	T CELL#1.0746;CELL ACTIVATION#0.8763;T CELL ACTIVATION#0.8332;ENDOTHELIAL CELL#0.8284;IMMUNE CELL#0.8036;CELL ADHESION#0.7135;TUMOR CELLS#0.7100;IMMUNE RESPONSE#0.7066;T LYMPHOCYTE#0.6581;ENDOTHELIAL CELL-CELL ADHESION#0.6553
126282	CANCER CELL#1.1084;TUMOR NECROSIS FACTOR#1.0511;CELL DEATH#0.9481;SIGNALING PATHWAY#0.8745;APOPTOSIS#0.8389;CELL GROWTH#0.8363;LUNG CANCER#0.7967;BREAST CANCER#0.7938;HEPATOCELLULAR CARCINOMA#0.7096;CERVICAL CANCER#0.6363;T CELL#0.6345;BREAST CANCER CELL#0.6310
126295	LUNG CARCINOMA#0.6986;LUNG CANCER#0.6892;ZINC FINGER PROTEIN#0.6179
1262	CYCLIC NUCLEOTIDE GATED#0.9483;ION CHANNEL#0.7943;LATERAL WALL#0.6099;ORGAN OF CORTI#0.6026
126306	SKELETAL MUSCLE#1.1475;SARCOPLASMIC RETICULUM#1.1038;CALCIUM CHANNEL#0.8275;MALIGNANT HYPERTHERMIA#0.6490;CHANNEL ACTIVITY#0.6306
126321	CELL PROLIFERATION#0.9096
126326	HEARING LOSS#1.0560;SENSORINEURAL HEARING LOSS#0.8180;HEARING IMPAIRMENT#0.7000;NONSYNDROMIC DEAFNESS#0.6827
126328	COMPLEX I#1.0798;RESPIRATORY CHAIN#0.7315
126353	MITOTIC SPINDLE POSITIONING#1.1124;SPINDLE POSITIONING#1.0954;MITOTIC SPINDLE#1.0777;ROOT HAIR#1.0592;HAIR CELL#1.0249;MICROTUBULE#1.0223;TRANSCRIPTION FACTOR#1.0188;CELL DIVISION#0.9841;ASTRAL MICROTUBULE#0.9752;CELL DIFFERENTIATION#0.9744;SPINDLE ORIENTATION#0.9739;DYNEIN#0.9566;EPIDERMAL CELL DIFFERENTIATION#0.8509;CELL CORTEX#0.8423;CELL FATE DETERMINATION#0.8051;CELL POLARITY#0.7468;MITOSIS#0.7459;LATERAL INHIBITION#0.7368;CENTROSOME#0.7060;HAIR CELL DIFFERENTIATION#0.6925;ASYMMETRIC CELL DIVISION#0.6403;CELL MOVEMENT#0.6169;EPITHELIAL CELL#0.6119;ACTIN BINDING#0.6053;CELL CYCLE#0.6044
126364	LEUCINE RICH REPEAT#0.7762;AUTOPHAGY#0.7643;SIGNALING PATHWAY#0.7576;LEUKOCYTE DIFFERENTIATION#0.6765;HYPOXIC ISCHEMIC ENCEPHALOPATHY#0.6732;MYELOID CELL#0.6381;LEUCINE#0.6158
126374	PODOCYTE#0.9683;ADHERENS JUNCTION#0.9068;BASAL BODY#0.8783;CELL JUNCTION#0.7423;SLIT DIAPHRAGM#0.6654;CENTROSOME LOCALIZATION#0.6610;NEURAL TUBE#0.6483;CELL CELL JUNCTION#0.6462;MITOTIC SPINDLE ORIENTATION#0.6276;SPINDLE ORIENTATION#0.6092;HIPPO SIGNALING#0.6080
126393	SMOOTH MUSCLE RELAXATION#1.0550;CARDIOMYOCYTE#1.0466;SMOOTH MUSCLE#1.0383;PLATELET AGGREGATION#1.0359;SIGNALING PATHWAY#1.0328;APOPTOSIS#1.0270;PROTEIN KINASE#1.0267;ISCHEMIA REPERFUSION INJURY#1.0235;ISCHEMIA#1.0183;FORSKOLIN#1.0157;HEAT SHOCK PROTEIN#1.0079;ARTERY#1.0061;CAROTID ARTERY#0.9973;SKELETAL MUSCLE#0.9950;CHAPERONE ACTIVITY#0.9877;GROWTH FACTOR#0.9784;APOPTOTIC#0.9732;UMBILICAL ARTERY#0.9683;GENE EXPRESSION#0.9677;SIZE EXCLUSION CHROMATOGRAPHY#0.9666;HEPATOCELLULAR CARCINOMA#0.9430;POLYMERASE CHAIN REACTION#0.9271;ACTIN BINDING#0.9256;PROTEIN KINASE A#0.9247;MUSCLE CONTRACTION#0.9238;DEPHOSPHORYLATION#0.9146;CELL DEATH#0.9037;SMOOTH MUSCLE CONTRACTION#0.8970;MUSCLE CELL#0.8863;ACTIN BINDING PROTEIN#0.8534;PROTEIN TRANSDUCTION DOMAIN#0.8477;TRANSFORMING GROWTH FACTOR#0.8464;AKT SIGNALING#0.8409;SMOOTH MUSCLE CELL#0.8408;HEART DISEASE#0.8358;HISTAMINE#0.8152;THERMOTOLERANCE#0.8133;REGULATORY LIGHT CHAIN#0.8129;ALZHEIMER'S DISEASE#0.7984;ADULT RAT CARDIOMYOCYTES#0.7958;CYTOPLASM#0.7905;MYOCARDIAL INFARCTION#0.7660;NITROGLYCERIN#0.7623;CASPASE-3 ACTIVITY#0.7511;TOXICITY#0.7450;OVARIAN CANCER#0.7442;T CELL#0.7423;TRANSCRIPTION FACTOR#0.7391;INFLAMMATORY RESPONSE#0.7256;AUTOPHAGY#0.7186;ACTIN CYTOSKELETON#0.7114;NITRIC OXIDE#0.7012;HYPOXIA#0.7010;MYOCYTES#0.6937;CARDIOMYOPATHY#0.6935;PHOSPHODIESTERASE#0.6922;EXOSOME#0.6874;NEUROBLASTOMA#0.6860;FIBRIL#0.6851;OXYGEN GLUCOSE DEPRIVATION#0.6848;CELL MIGRATION#0.6728;AIRWAY SMOOTH MUSCLE#0.6643;ISOPROTERENOL#0.6564;CYTOCHROME C#0.6554;QUANTITATIVE REAL TIME#0.6554;REACTIVE OXYGEN SPECIES#0.6293;VASODILATION#0.6166;ASTROCYTE#0.6131;ANGIOGENESIS#0.6109;SODIUM NITROPRUSSIDE#0.6033;SPINAL CORD#0.6032
1263	KINASE ACTIVITY#1.0540;PROTEIN KINASE#1.0156;CELL CYCLE#1.0064;APOPTOSIS#1.0025;POLO BOX DOMAIN#0.9971;CELL PROLIFERATION#0.9966;GENE EXPRESSION#0.9892;MITOSIS#0.9834;CELL CYCLE ARREST#0.9833;HUMAN CORNEAL EPITHELIAL#0.9767;TUMOR SUPPRESSOR#0.9656;CANCER CELL#0.9580;SIGNALING PATHWAY#0.9421;HYPOXIC#0.9411;CORNEAL EPITHELIAL CELL#0.9366;HYPOXIA#0.9355;CELL DEATH#0.9249;EPITHELIAL CELL#0.9212;M PHASE#0.9134;CATABOLITE REPRESSION#0.9103;TRANSCRIPTION FACTOR#0.9038;CARBON CATABOLITE REPRESSION#0.8773;CENTROSOME#0.8756;INTEGRIN BINDING#0.8740;GROWTH FACTOR#0.8581;CELL DIVISION#0.8353;REGULATION OF CELL CYCLE#0.8336;CYTOKINESIS#0.8224;S PHASE#0.8092;DNA DAMAGE RESPONSE#0.7899;APOPTOTIC#0.7892;WOUND HEALING#0.7648;CELL CYCLE REGULATION#0.7605;UBIQUITIN#0.7589;CELL CYCLE CHECKPOINT#0.7575;CELL GROWTH#0.7413;MICROTUBULE#0.7389;BREAST CANCER#0.7301;SPINDLE POLE#0.7151;SIGNAL TRANSDUCTION#0.7093;DNA DAMAGE CHECKPOINT#0.7075;BINDING PROTEIN 1#0.6995;JUN PHOSPHORYLATION#0.6994;LUNG CARCINOMA#0.6847;KINASE INHIBITOR#0.6655;ATP BINDING#0.6566;MITOTIC SPINDLE#0.6433;PHOSPHATASE ACTIVITY#0.6383;MICROTUBULE DYNAMICS#0.6236;POLYMERASE CHAIN REACTION#0.6216;MURINE EMBRYONIC FIBROBLASTS#0.6216;MIDBODY#0.6186;GENOTOXIC#0.6056;MOUSE EMBRYONIC FIBROBLAST#0.6039
126410	ICHTHYOSIS#1.0436;AUTOSOMAL RECESSIVE CONGENITAL ICHTHYOSIS#0.9824;CYTOCHROME P450#0.8944;ARACHIDONIC ACID#0.6433
1264	MYOSIN HEAVY CHAIN#1.0621;SMOOTH MUSCLE ACTIN#1.0565;SMOOTH MUSCLE#1.0234;SMOOTH MUSCLE CELL#0.9965;MUSCLE CELL#0.9961;GROWTH FACTOR#0.9867;GENE EXPRESSION#0.9708;POLYMERASE CHAIN REACTION#0.9494;CELL PROLIFERATION#0.9316;VASCULAR SMOOTH MUSCLE CELL#0.9268;STEM CELL#0.9035;ENDOTHELIAL CELL#0.9025;NDC80 COMPLEX#0.8908;ACTIN BINDING#0.8713;APOPTOSIS#0.8357;TRANSFORMING GROWTH FACTOR#0.8282;ACTIN BINDING PROTEIN#0.8173;MESANGIAL CELL#0.8164;EXTRACELLULAR MATRIX#0.7711;TRANSCRIPTION FACTOR#0.7687;PROTEIN KINASE#0.7266;CENTROMERE#0.7256;SIGNALING PATHWAY#0.7197;REVERSE TRANSCRIPTION#0.7136;HYPERTENSION#0.6983;BONE FORMATION#0.6867;VSMC PROLIFERATION#0.6778;ACTIN CYTOSKELETON#0.6683;MICROTUBULE#0.6602;SERUM RESPONSE FACTOR#0.6399;DERMAL FIBROBLAST#0.6086;SKELETAL MUSCLE#0.6066;KINETOCHORE#0.6028
126520	TUMOR SUPPRESSOR#0.6306;CELL CYCLE#0.6242
126549	BREAST CANCER#0.8024;PLASMA MEMBRANE#0.7788;DNA DAMAGE RESPONSE#0.7140;NUCLEAR MEMBRANE#0.6571;FLIPPASE#0.6393;INNER NUCLEAR MEMBRANE#0.6023
126567	ENDOCRINE CELL#0.9140
1265	CELL PROLIFERATION#0.9451;SMOOTH MUSCLE#0.9133;ACTIN CYTOSKELETON#0.9098;CANCER CELL#0.8982;CELL MIGRATION#0.8366;PANCREATIC DUCTAL ADENOCARCINOMA#0.8038;APOPTOSIS#0.7334;CELL CYCLE#0.7166;GROWTH FACTOR#0.6709;ATHEROSCLEROSIS#0.6556;MACROPHAGE#0.6493;MUSCLE CELL#0.6335;PRO-INFLAMMATORY#0.6237;ADENOCARCINOMA#0.6021
126637	INTERMEDIATE FILAMENT ASSOCIATED PROTEIN#0.9062;INTERMEDIATE FILAMENT#0.8699;HAIR FOLLICLE#0.7237;INSULIN GLARGINE#0.6771;ROOT SHEATH#0.6437;DIABETES MELLITUS#0.6368;BASAL PLATE#0.6260;CONTINUOUS GLUCOSE MONITORING#0.6193
126638	CORNIFIED ENVELOPE#0.7209;EPIDERMAL DIFFERENTIATION COMPLEX#0.6556;CELL ENVELOPE#0.6188;INTERMEDIATE FILAMENT#0.6106
126668	BREAST CANCER#0.7435
126695	KERATINOCYTE DIFFERENTIATION#0.7210;KERATINOCYTE#0.6847;PROGENITOR CELL#0.6735;CELL PROLIFERATION#0.6681
1266	ACTIN BINDING#1.0146;ACTIN BINDING PROTEIN#0.8759;STRESS FIBER#0.8353;CELL FUSION#0.8092;CANCER CELL#0.7835;ACTIN CYTOSKELETON#0.7695;SMOOTH MUSCLE#0.7471;MUSCLE CELL#0.7248;GENE EXPRESSION#0.7109;CELL MOTILITY#0.6327;SKELETAL MUSCLE#0.6250;LYMPH NODE#0.6240;STRESS FIBER ASSEMBLY#0.6204;SIGNALING PATHWAY#0.6118;TROPHOBLAST#0.6109
126731	MICROTUBULE#0.7928;MICROTUBULE BINDING#0.6122;MITOTIC SPINDLE#0.6063
126792	CONNECTIVE TISSUE#1.0047;EHLERS-DANLOS SYNDROME#0.9692;GALACTOSYLTRANSFERASE I ACTIVITY#0.8175;SPONDYLOEPIMETAPHYSEAL DYSPLASIA#0.8077;GLYCOSAMINOGLYCAN BIOSYNTHESIS#0.7697;PROTEOGLYCAN#0.6712
1267	CNPASE ACTIVITY#1.0784;CYCLIC NUCLEOTIDE PHOSPHODIESTERASE#1.0501;PHOSPHODIESTERASE ACTIVITY#1.0451;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#1.0402;PHOSPHODIESTERASE#1.0343;GLUTAMINE#1.0246;CYCLIC AMP#1.0117;MICROTUBULE ASSOCIATED PROTEIN#1.0091;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0085;OLIGODENDROCYTE#1.0074;COMPACT MYELIN#1.0069;SCHWANN CELL#1.0044;MICROTUBULE#1.0040;NEUROFILAMENT#1.0038;CENTROMERE#1.0032;OLIGODENDROGLIAL CELLS#1.0028;CEREBRUM#1.0025;SCIATIC NERVE#1.0015;MITOCHONDRIA#1.0003;OPTIC NERVE#0.9995;TRANSCRIPTION FACTOR#0.9985;CEREBRAL CORTEX#0.9985;PROTEIN KINASE#0.9981;UDP GALACTOSE#0.9971;T CELL#0.9960;MYELIN FORMATION#0.9944;OLIGODENDROCYTE PROGENITOR CELL#0.9919;OLIGODENDROCYTE DIFFERENTIATION#0.9901;PERIPHERAL NERVE#0.9892;PLASMA MEMBRANE#0.9890;SULFATIDE#0.9872;MYELINOGENESIS#0.9860;MYELIN SHEATH#0.9854;SUCROSE#0.9840;PERIVENTRICULAR WHITE MATTER#0.9822;ADENOSINE#0.9818;OLIGODENDROCYTE PRECURSOR CELL#0.9807;PERIPHERAL NERVOUS SYSTEM#0.9800;ASTROCYTE#0.9791;NERVE FIBER#0.9787;MYELINATION#0.9769;SPINAL CORD#0.9757;DEMYELINATING DISEASE#0.9754;GLIAL CELL#0.9737;ENZYME ACTIVITY#0.9730;NEURAL STEM CELL#0.9725;PROGENITOR CELL#0.9724;PRECURSOR CELL#0.9720;STEM CELL#0.9717;GENE EXPRESSION#0.9707;GROWTH FACTOR#0.9707;CYTOPLASM#0.9685;MULTIPLE SCLEROSIS#0.9673;REGENERATION#0.9638;NERVOUS SYSTEM#0.9625;CENTRAL NERVOUS SYSTEM#0.9621;OLIGODENDROCYTE DEVELOPMENT#0.9610;MACROPHAGE#0.9590;OLFACTORY BULB#0.9538;PLATELET-DERIVED GROWTH FACTOR#0.9516;ENCEPHALOMYELITIS#0.9493;NEURAL CELL#0.9488;MEMBRANE FRACTION#0.9485;FOREBRAIN#0.9455;SPINAL CORD INJURY#0.9447;CELL PROLIFERATION#0.9442;SIGNALING PATHWAY#0.9426;ETHANOL#0.9401;OLIGODENDROCYTE LINEAGE CELLS#0.9360;CHOLINE#0.9347;FIBROBLAST GROWTH FACTOR#0.9340;ERYTHROCYTE#0.9313;GROWTH FACTOR RECEPTOR#0.9207;CELL CYCLE#0.9155;ISCHEMIA#0.9145;CELL DEATH#0.9116;GESTATION#0.9097;APOPTOSIS#0.9078;ALZHEIMER'S DISEASE#0.9072;NEUROGENESIS#0.9031;PHOSPHODIESTERASE I#0.9021;PROTEIN SYNTHESIS#0.9019;NITRIC OXIDE#0.9010;TOXICITY#0.8985;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8980;DODECYL SULFATE#0.8902;BRAIN DEVELOPMENT#0.8880;APOPTOTIC#0.8857;HYPOXIA#0.8855;POLYMERASE CHAIN REACTION#0.8827;SODIUM DODECYL SULFATE#0.8819;NERVOUS TISSUE#0.8712;NERVE GROWTH FACTOR#0.8693;MICROGLIAL CELL#0.8636;INSULIN-LIKE GROWTH FACTOR#0.8619;PROTEIN KINASE C#0.8593;EPIDERMAL GROWTH FACTOR#0.8589;FRONTAL#0.8579;ERYTHROCYTE MEMBRANES#0.8558;GLUTAMIC ACID#0.8370;CELL GROWTH#0.8178;THYMIDINE#0.8173;CELL SURFACE#0.8172;DIGESTION#0.8139;CELL DIFFERENTIATION#0.8131;CELL BODY#0.8131;DENTATE GYRUS#0.8116;KINETOCHORE#0.8071;STRIATUM#0.8059;PROTEOGLYCAN#0.8006;CYTOCHROME C#0.7939;WHITE MATTER INJURY#0.7901;PERMEABILITY TRANSITION PORE#0.7867;SMOOTH MUSCLE#0.7854;ARTERY#0.7837;HYPOTHYROIDISM#0.7777;NUCLEOSOME#0.7763;MIDDLE CEREBRAL ARTERY#0.7751;CEREBRAL ARTERY#0.7749;NITRIC OXIDE SYNTHASE#0.7709;TRANSMISSION ELECTRON MICROSCOPY#0.7653;MESENCHYMAL STEM CELL#0.7633;CYTOSKELETAL ELEMENT#0.7630;NASAL EPITHELIUM#0.7605;TRAUMATIC BRAIN INJURY#0.7566;CELL ADHESION#0.7510;SIGNAL TRANSDUCTION#0.7505;WHITE MATTER DAMAGE#0.7505;NEURITE#0.7490;FORSKOLIN#0.7458;NEUROPATHY#0.7446;UBIQUITIN#0.7344;EMBRYONIC BRAIN#0.7336;NEUROTOXICITY#0.7328;PROGESTERONE#0.7288;POLYNUCLEOTIDE KINASE ACTIVITY#0.7252;STROMAL CELL#0.7212;BLOOD BRAIN BARRIER#0.7138;CELL ADHESION MOLECULE#0.7083;PEROXISOMAL#0.7071;TRIIODOTHYRONINE#0.7051;KINASE ACTIVITY#0.6991;LIPID METABOLISM#0.6976;STEM CELL MARKER#0.6962;NEURAL PROGENITOR CELL#0.6954;BETA GALACTOSIDASE#0.6946;SWELLING#0.6939;LYSINE#0.6918;UMBILICAL CORD#0.6913;NEURODEGENERATIVE DISEASE#0.6881;FACTOR I#0.6879;INTERNEURON#0.6847;DEXAMETHASONE#0.6834;RNA BINDING#0.6828;LECTIN#0.6777;POSTSYNAPTIC DENSITY#0.6759;CEREBRAL ARTERY OCCLUSION#0.6750;OLIGODENDROGLIOMA#0.6748;ARA-C#0.6723;INTERNAL CAPSULE#0.6701;TRANSFORMING GROWTH FACTOR#0.6686;ATPASE ACTIVITY#0.6684;NEURAL STEM PROGENITOR#0.6681;INDUCIBLE NITRIC OXIDE#0.6675;REVERSE TRANSCRIPTION#0.6642;CEREBRAL ISCHEMIA#0.6632;GROWTH HORMONE#0.6600;GLUTATHIONE#0.6584;BONE MARROW#0.6516;ACID PHOSPHATASE#0.6496;LOCOMOTION#0.6475;COENZYME A#0.6441;RETINOIC ACID#0.6419;CERVICAL#0.6381;2'-DEOXYURIDINE#0.6309;AMYGDALA#0.6287;ACTIN FILAMENT#0.6250;CELL MEMBRANE#0.6240;ENDOPLASMIC RETICULUM#0.6231;RECEPTOR ANTAGONIST#0.6223;REACTIVE OXYGEN SPECIES#0.6221;MITOCHONDRIAL PERMEABILITY TRANSITION#0.6213;IMMUNE RESPONSE#0.6208;EXOSOME#0.6207;FETAL BRAIN#0.6174;ADENOSINE MONOPHOSPHATE#0.6169;PURKINJE CELL#0.6146;ATP BINDING#0.6146;HYPOXIC#0.6142;PERIPHERAL BLOOD#0.6136;COLCHICINE#0.6111
1268	SR 141716A#1.0643;GLUTAMATERGIC NEURON#1.0566;DELTA-9-THC#1.0463;SR141716#1.0436;GABAERGIC NEURON#1.0423;AXON TERMINAL#1.0406;MU OPIOID RECEPTOR#1.0383;IODOPHENYL#1.0372;GLUCOSE UPTAKE#1.0372;DOPAMINE D2 RECEPTOR#1.0355;DIET INDUCED OBESITY#1.0345;SR141716A#1.0338;PYRAZOLE#1.0316;CANNABIS DEPENDENCE#1.0295;RIMONABANT#1.0282;CEREBRAL ISCHEMIA#1.0255;DORSAL ROOT GANGLION#1.0253;RECEPTOR ACTIVITY#1.0242;POSITRON EMISSION TOMOGRAPHY#1.0237;CARDIOVASCULAR RISK FACTOR#1.0235;DENTATE GYRUS#1.0231;POSITIVE ALLOSTERIC MODULATOR#1.0205;NEUROTRANSMITTER RELEASE#1.0190;CANNABINOID RECEPTOR#1.0188;CANNABINOID RECEPTOR LIGAND#1.0187;GLUCOSE METABOLISM#1.0185;DOPAMINE RECEPTOR#1.0184;PLASMA MEMBRANE#1.0170;INTERNEURON#1.0156;MEDIAL PREFRONTAL CORTEX#1.0154;NALOXONE#1.0151;INDOLE#1.0147;ETHANOL#1.0145;TRANSIENT RECEPTOR POTENTIAL#1.0144;ASTROCYTE#1.0139;FOREBRAIN#1.0138;OPIOID RECEPTOR#1.0115;CONDITIONED PLACE PREFERENCE#1.0113;ADENOSINE#1.0113;ADRENERGIC RECEPTOR#1.0110;BASAL GANGLIA#1.0105;NEUROGENESIS#1.0103;ADIPOCYTE#1.0103;MUSCLE CELL#1.0099;POLYMERASE CHAIN REACTION#1.0098;PHOSPHOLIPASE D#1.0093;LIPOGENESIS#1.0085;CEREBRAL CORTEX#1.0080;SMOOTH MUSCLE#1.0075;RECEPTOR ANTAGONIST#1.0072;BASKET CELL#1.0062;REVERSE TRANSCRIPTION#1.0061;SKELETAL MUSCLE#1.0060;PERTUSSIS#1.0052;CELL SURFACE#1.0048;NEUROPROTECTION#1.0046;GLUCOSE HOMEOSTASIS#1.0046;RECEPTOR BINDING#1.0041;FATTY LIVER#1.0041;SENSITIZATION#1.0035;SMOOTH MUSCLE CELL#1.0033;CATION CHANNEL#1.0026;PYRAMIDAL CELL#1.0020;LOCOMOTION#1.0017;AMYGDALA#1.0015;MAP KINASE#1.0013;ADIPOSE TISSUE#1.0011;NMDA RECEPTOR#1.0010;OBESE#0.9991;TYPE 2 DIABETES#0.9987;NEUROTOXICITY#0.9979;NEURITE OUTGROWTH#0.9978;PEROXISOME#0.9977;ISCHEMIA#0.9975;WEIGHT LOSS#0.9973;RECEPTOR INTERACTING PROTEIN#0.9971;STRIATUM#0.9970;ADENYLATE CYCLASE#0.9968;MECHANISM OF ACTION#0.9964;HIGH FAT DIET#0.9957;RECEPTOR LIGAND#0.9954;SUBSTANCE ABUSE#0.9951;FRONTAL#0.9945;FORSKOLIN#0.9942;TRANSCRIPTION FACTOR#0.9941;STRUCTURE ACTIVITY RELATIONSHIP#0.9937;IMMUNE CELL#0.9935;DOPAMINE#0.9935;SYNAPTIC TRANSMISSION#0.9933;MACROPHAGE#0.9932;SUCROSE#0.9932;WEIGHT GAIN#0.9929;SPINAL CORD#0.9928;CANCER CELL#0.9927;ENDOGENOUS CANNABINOID SYSTEM#0.9926;EPILEPSY#0.9925;GROWTH FACTOR#0.9921;NEUROTRANSMISSION#0.9918;ARTERY#0.9916;LONG TERM DEPRESSION#0.9916;RECEPTOR AGONIST#0.9915;DELTA-9-TETRAHYDROCANNABINOL#0.9910;ACETYLCHOLINE#0.9907;NITRIC OXIDE SYNTHASE#0.9902;ANORECTIC#0.9894;MITOGEN ACTIVATED PROTEIN#0.9869;HEROIN#0.9866;LIVER DISEASE#0.9863;SIGNAL TRANSDUCTION#0.9862;EXCITATORY SYNAPSE#0.9854;GLUTAMATE RECEPTOR#0.9854;LIPID METABOLISM#0.9853;LONG TERM POTENTIATION#0.9853;PRO-INFLAMMATORY#0.9848;CENTRAL NERVOUS SYSTEM#0.9847;ELEVATED PLUS MAZE#0.9845;COLORECTAL CANCER#0.9845;NITRIC OXIDE#0.9843;ENDOTHELIAL CELL#0.9840;ENERGY HOMEOSTASIS#0.9837;PARKINSON'S DISEASE#0.9837;NERVOUS SYSTEM#0.9833;GENE EXPRESSION#0.9833;ALZHEIMER'S DISEASE#0.9830;NERVE TERMINAL#0.9830;NOCICEPTION#0.9828;SIGNALING PATHWAY#0.9821;TETRAHYDROCANNABINOL#0.9816;COGNITION#0.9816;MULTIPLE SCLEROSIS#0.9811;BODY WEIGHT GAIN#0.9807;B CELL#0.9796;ENDOPLASMIC RETICULUM#0.9796;T CELL#0.9792;CELL DEATH#0.9791;ARACHIDONIC ACID#0.9791;CELL PROLIFERATION#0.9785;EPITHELIAL CELL#0.9777;APOPTOSIS#0.9772;CALCIUM CHANNEL#0.9772;PROTEIN KINASE#0.9764;CYCLIC AMP#0.9763;APOPTOTIC#0.9748;BLOOD BRAIN BARRIER#0.9747;PRESYNAPTIC TERMINAL#0.9746;ASPARTATE#0.9746;ION CHANNEL#0.9741;TOXICITY#0.9736;SOCIAL BEHAVIOR#0.9732;NEURODEGENERATIVE DISEASE#0.9720;IMMUNE SYSTEM#0.9716;PERIPHERAL BLOOD#0.9715;ACTION POTENTIAL#0.9704;MEDIUM SPINY NEURONS#0.9698;GUANOSINE#0.9696;PROTEIN KINASE C#0.9696;GLUCOCORTICOID RECEPTOR#0.9687;ALCOHOL DEPENDENCE#0.9685;INFLAMMATORY RESPONSE#0.9673;GABA A RECEPTOR#0.9672;TUMOR NECROSIS FACTOR#0.9668;PROTEIN KINASE A#0.9664;METABOTROPIC GLUTAMATE RECEPTORS#0.9652;CANNABINOID RECEPTOR BINDING#0.9643;SUBSTANTIA NIGRA#0.9640;SIGNALING MOLECULE#0.9636;BONE FORMATION#0.9629;PROGENITOR CELL#0.9611;INSULIN SECRETION#0.9600;CELL CYCLE#0.9584;ADENYLATE#0.9584;ENDOTHELIUM#0.9580;STEM CELL#0.9579;MITOCHONDRIA#0.9573;CELL GROWTH#0.9566;FATTY LIVER DISEASE#0.9563;NOREPINEPHRINE#0.9563;MAGNETIC RESONANCE IMAGING#0.9554;POTASSIUM CHANNEL#0.9551;NEURITE#0.9548;SUBCUTANEOUS ADIPOSE TISSUE#0.9545;ESTRADIOL#0.9537;MIDBRAIN#0.9537;QUANTITATIVE REAL TIME#0.9537;SIGNALLING PATHWAY#0.9534;COLORECTAL#0.9533;MOTOR ACTIVITY#0.9526;PURKINJE CELL#0.9519;MIDDLE CEREBRAL ARTERY#0.9515;CEREBRAL ARTERY#0.9513;BIPOLAR CELL#0.9500;LIPID RAFT#0.9496;METHAMPHETAMINE#0.9494;NEURONAL CELLS#0.9473;FORMALIN#0.9458;MEMORY IMPAIRMENT#0.9450;VISCERAL ADIPOSE TISSUE#0.9450;FEEDING BEHAVIOR#0.9436;BRAIN DEVELOPMENT#0.9435;VANILLOID RECEPTOR 1#0.9426;RECEPTOR INTERNALIZATION#0.9407;CELL MIGRATION#0.9393;DOPAMINE D1 RECEPTOR#0.9371;BROWN ADIPOSE TISSUE#0.9364;BONE MARROW#0.9363;MOOD DISORDER#0.9362;STATUS EPILEPTICUS#0.9353;SUBSTANCE DEPENDENCE#0.9335;HYPOTHALAMIC PITUITARY ADRENAL#0.9326;HYPERGLYCEMIA#0.9325;L-DOPA#0.9322;HALOPERIDOL#0.9322;THALAMUS#0.9321;GASTROINTESTINAL TRACT#0.9318;HUMAN EMBRYONIC KIDNEY#0.9313;EMBRYONIC KIDNEY#0.9308;HYPERSENSITIVITY#0.9293;HYPERTENSION#0.9282;HYDROLASE INHIBITOR#0.9278;PERIPHERAL NERVOUS SYSTEM#0.9278;ANOREXIA#0.9276;HUNTINGTON'S DISEASE#0.9272;PHOSPHATIDYLETHANOLAMINE#0.9262;IRRITABLE BOWEL SYNDROME#0.9254;HYPERACTIVITY#0.9226;MOLECULAR DYNAMICS SIMULATION#0.9222;PROTEIN SYNTHESIS#0.9220;REACTIVE OXYGEN SPECIES#0.9220;LEUKOCYTE#0.9207;ADENOSINE MONOPHOSPHATE#0.9195;HYPOXIA#0.9179;BREAST CANCER#0.9163;PANCREATIC ISLET#0.9154;GLIAL CELL#0.9132;CELL ACTIVATION#0.9130;DIABETIC NEPHROPATHY#0.9125;HEPATIC STELLATE CELL#0.9114;IMMUNE RESPONSE#0.9113;BOUTON#0.9095;LIPASE INHIBITOR#0.9092;INDUCIBLE NITRIC OXIDE#0.9084;CEREBRAL ARTERY OCCLUSION#0.9083;DIABETES MELLITUS#0.9081;MAPK ACTIVATION#0.9069;EMESIS#0.9062;ARGININE#0.9061;MIGRAINE#0.9058;INSULIN RECEPTOR#0.9049;DENDRITIC SPINE#0.9027;SPERMATOZOA#0.9016;TELENCEPHALON#0.9011;DNA METHYLATION#0.9010;MONONUCLEAR CELLS#0.9010;PODOCYTE#0.9008;DOPAMINERGIC NEURON#0.9006;INNERVATION#0.9001;GABA B RECEPTOR#0.8999;PHOSPHOLIPASE C#0.8991;CORONARY ARTERY#0.8985;CELL MEMBRANE#0.8985;NEUROPATHY#0.8984;PERIPHERAL NERVE#0.8975;FOCAL CEREBRAL ISCHEMIA#0.8965;MONOCYTE#0.8947;MAST CELL#0.8910;GANGLION CELLS#0.8906;STROMAL CELL#0.8905;PROGESTERONE#0.8858;BETA CELL#0.8847;FEAR RESPONSE#0.8838;WOUND HEALING#0.8835;COLITIS#0.8832;OVARIAN#0.8826;SPATIAL LEARNING#0.8820;GROWTH HORMONE#0.8816;CYCLIC ADENOSINE MONOPHOSPHATE#0.8807;GROWTH FACTOR RECEPTOR#0.8795;TOPICAL#0.8786;HISTONE DISPLACEMENT#0.8758;SIGNALING CASCADE#0.8745;NERVE GROWTH FACTOR#0.8743;FORCED SWIM TEST#0.8742;NERVE FIBER#0.8741;CONTEXTUAL FEAR CONDITIONING#0.8716;HIGH DENSITY LIPOPROTEIN#0.8707;AKT SIGNALING#0.8696;ATHEROSCLEROSIS#0.8692;NEUROLOGICAL DISORDER#0.8688;VOMITING#0.8686;ALCOHOLIC FATTY LIVER#0.8685;SCIATIC NERVE#0.8675;RAPID EYE MOVEMENT#0.8671;TARGET OF RAPAMYCIN#0.8665;ANXIETY DISORDER#0.8665;ANOREXIA NERVOSA#0.8652;DIGESTION#0.8651;PILOCARPINE#0.8650;OLANZAPINE#0.8620;CRAVING#0.8620;OSTEOCLAST#0.8611;AGGRESSIVE BEHAVIOR#0.8605;INDOMETHACIN#0.8596;HABITUATION#0.8589;MUTAGENESIS#0.8589;REGULATION OF ENERGY HOMEOSTASIS#0.8584;LINES OF EVIDENCE#0.8516;CAUDATE NUCLEUS#0.8513;NUCLEUS ACCUMBENS CORE#0.8503;RETINAL GANGLION CELL#0.8502;CYTOPLASM#0.8494;NEPHROPATHY#0.8476;MICROGLIAL CELL#0.8473;L-ARGININE#0.8468;CHRONIC MILD STRESS#0.8459;OOCYTE#0.8454;NEUROBLASTOMA#0.8413;EDEMA#0.8385;4-METHYLPYRAZOLE#0.8375;MECHANISMS OF ACTION#0.8365;DERMATITIS#0.8339;HORMONE SECRETION#0.8338;FEEDING BEHAVIOUR#0.8336;GLUTAMIC ACID#0.8331;HIGH FREQUENCY STIMULATION#0.8330;ESTROGEN RECEPTOR#0.8320;POST-TRAUMATIC STRESS DISORDER#0.8315;NORADRENALINE#0.8310;GLUTAMATERGIC SYNAPSE#0.8310;CORTICOTROPIN#0.8305;MESANGIAL CELL#0.8298;ATOPIC DERMATITIS#0.8290;NOXIOUS#0.8284;EMETIC#0.8282;C TERMINAL DOMAIN#0.8237;TRANSCRIPTASE#0.8230;TRAUMATIC BRAIN INJURY#0.8225;ACETYLCHOLINE RECEPTOR#0.8214;ALANINE#0.8212;OSTEOBLAST#0.8196;MITOCHONDRIAL MEMBRANE#0.8176;STEROL REGULATORY ELEMENT#0.8174;SOMATOSTATIN RECEPTOR#0.8173;DORSOLATERAL PREFRONTAL CORTEX#0.8160;OLIGODENDROCYTE#0.8143;TEMPORAL LOBE#0.8091;RENAL FIBROSIS#0.8079;DRUG DEPENDENCE#0.8073;CONSTRICTION#0.8064;FIRST EPISODE PSYCHOSIS#0.8037;BLOOD VESSEL#0.8033;STREPTOZOTOCIN#0.8018;ENDOCYTOSIS#0.8018;KERATINOCYTE#0.8010;AUTOPHAGY#0.7980;1,2,4-TRIAZOLE#0.7974;ETHANOLAMINE#0.7951;GLUCOSE INTOLERANCE#0.7932;WHITE ADIPOSE TISSUE#0.7926;RAPAMYCIN#0.7921;PARALLEL FIBER#0.7907;CANNABIS ABUSE#0.7891;LIPOLYSIS#0.7868;OPEN FIELD TEST#0.7856;ENDOMETRIOSIS#0.7849;AMPK ACTIVITY#0.7847;OSTEOARTHRITIS#0.7847;SCHAFFER COLLATERAL#0.7836;NEUROFILAMENT#0.7828;TRANSFORMING GROWTH FACTOR#0.7820;CALCIUM MOBILIZATION#0.7820;MODE OF ACTION#0.7796;CORTISOL#0.7787;VASOPRESSIN#0.7786;SYSTOLIC BLOOD PRESSURE#0.7780;CELLULAR LOCALIZATION#0.7767;CYTOTOXICITY#0.7762;NICOTINE DEPENDENCE#0.7759;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7749;NEURAL CELL#0.7748;LIGAND BINDING POCKET#0.7746;CHROMATIN REMODELING#0.7743;COLON CANCER#0.7715;ACETIC ACID#0.7713;T LYMPHOCYTE#0.7705;ENZYME INHIBITOR#0.7695;LONG TERM MEMORY#0.7688;KIDNEY DISEASE#0.7669;GASTRIC EMPTYING#0.7653;RESPONSE TO STRESS#0.7650;TUMOR CELLS#0.7641;ANTERIOR CINGULATE CORTEX#0.7638;CATABOLISM#0.7637;POSITIVE ALLOSTERIC MODULATION#0.7625;DRONABINOL#0.7618;ACTIVATED T CELL#0.7605;OPEN-FIELD BEHAVIOR#0.7598;VASODILATION#0.7588;SEROTONERGIC NEURON#0.7584;ENCEPHALOMYELITIS#0.7572;KINASE INHIBITOR#0.7565;SEDATION#0.7563;RESONANCE ENERGY TRANSFER#0.7562;DEXAMETHASONE#0.7551;LYMPH NODE#0.7546;ASSOCIATIVE LEARNING#0.7526;CAMP RESPONSE ELEMENT#0.7524;COLONIC TRANSIT#0.7521;GLUTATHIONE#0.7519;CHOLINERGIC NEURON#0.7506;HAIR FOLLICLE#0.7495;OREXIN RECEPTOR#0.7491;NUCLEUS ACCUMBENS SHELL#0.7489;UREMIC TOXIN#0.7470;ADIPOCYTE DIFFERENTIATION#0.7466;TYPE 1 DIABETES#0.7449;GLYCINE#0.7439;CYCLASE ACTIVITY#0.7438;MORRIS WATER MAZE#0.7427;MELANIN CONCENTRATING HORMONE#0.7427;EMISSION COMPUTED TOMOGRAPHY#0.7413;SPERM MOTILITY#0.7388;PAIRED PULSE RATIO#0.7379;SYMMETRIC SYNAPSE#0.7374;NONALCOHOLIC FATTY LIVER DISEASE#0.7371;HUMAN ADIPOSE TISSUE#0.7361;PROTEIN PROTEIN INTERACTION#0.7354;OOCYTE MATURATION#0.7347;MOTOR LEARNING#0.7338;PACLITAXEL#0.7335;OSTEOBLAST DIFFERENTIATION#0.7315;FATTY ACID BINDING#0.7312;SYNAPTIC SIGNALING#0.7294;MOTOR BEHAVIOR#0.7289;LACTATION#0.7282;OVIDUCT#0.7272;CERVICAL#0.7250;TETRAHYDROLIPSTATIN#0.7247;HUMAN BREAST CANCER#0.7243;SULFONAMIDE#0.7225;SHORT TERM MEMORY#0.7216;CARBACHOL#0.7197;GLUCOSE TOLERANCE TEST#0.7189;RECEPTOR COMPLEX#0.7188;KINASE ACTIVITY#0.7154;HEART DISEASE#0.7149;SUPEROXIDE DISMUTASE#0.7147;AMPA RECEPTOR#0.7146;GTP BINDING#0.7137;CHOLINE#0.7124;ROSTRAL VENTROMEDIAL MEDULLA#0.7113;VAGAL AFFERENT NEURONS#0.7096;SUBSTANCE USE DISORDER#0.7091;CAMP RESPONSE ELEMENT BINDING#0.7088;D-AMPHETAMINE#0.7083;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7083;ENDOTHELIAL GROWTH FACTOR#0.7082;GLYCOGEN SYNTHASE KINASE#0.7068;CHRONIC CONSTRICTION INJURY#0.7060;LUNG CANCER#0.7059;CYCLOHEXANOL#0.7057;PROSTAGLANDIN E2#0.7051;DYSKINESIA#0.7044;CORONARY ARTERY DISEASE#0.7043;ARTERY DISEASE#0.7040;CYTOKINE PRODUCTION#0.7031;PIPERAZINE#0.7026;PULMONARY VEIN#0.7010;CHEMOTAXIS#0.6992;SYNAPTOSOME#0.6988;CAMP FORMATION#0.6983;HIPPOCAMPAL REGION#0.6980;HISTAMINE#0.6977;SKIN DISEASE#0.6976;TYPE 2 DIABETIC#0.6973;SPERM CAPACITATION#0.6956;BREAST CANCER CELL#0.6926;ENDOMETRIUM#0.6925;OPIOID PEPTIDE#0.6921;CELL ADHESION#0.6917;EPIDERMAL GROWTH FACTOR#0.6910;OLFACTORY BULB#0.6907;FATTY ACID OXIDATION#0.6906;UTERUS#0.6876;GESTATION#0.6855;PHENCYCLIDINE#0.6837;PROSTATE CARCINOMA#0.6829;VASODILATOR#0.6827;BRAIN DAMAGE#0.6827;HYPOTENSION#0.6815;BONE REMODELING#0.6813;JUXTAMEMBRANE#0.6801;DEPRESSANT#0.6788;BULIMIA NERVOSA#0.6786;AMACRINE CELL#0.6761;PREADIPOCYTE#0.6743;SEROTONIN RECEPTOR#0.6738;INSULIN-LIKE GROWTH FACTOR#0.6727;FATTY ACID SYNTHASE#0.6711;ACTH SECRETION#0.6702;ORAL GLUCOSE TOLERANCE#0.6699;ENDOPLASMIC RETICULUM STRESS#0.6697;SENESCENCE#0.6686;RNA INTERFERENCE#0.6684;BENZHYDRYL#0.6682;DIARRHEA#0.6678;SMALL INTESTINE#0.6673;TYPE 2 DIABETES MELLITUS#0.6668;2 DIABETES MELLITUS#0.6668;CHANNEL ACTIVITY#0.6662;CORNEAL EPITHELIAL CELL#0.6660;MYOCARDIAL INFARCTION#0.6649;MAPK SIGNALING#0.6645;ACTIVATED T-CELLS#0.6639;G1 PHASE#0.6632;EATING DISORDER#0.6614;MELANOMA CELL LINES#0.6612;NOVEL OBJECT RECOGNITION#0.6611;C FIBER#0.6607;FETAL ALCOHOL SPECTRUM DISORDER#0.6601;FETAL ALCOHOL SPECTRUM#0.6600;ANESTHETIC#0.6589;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6574;INHIBITION OF SYNAPTIC TRANSMISSION#0.6563;DECIDUAL CELL#0.6551;SPINAL CORD INJURY#0.6539;CAMP SIGNALING#0.6520;EXCITATORY POSTSYNAPTIC POTENTIAL#0.6505;OSTEOPOROSIS#0.6498;LOCALISATION#0.6495;ENZYME ACTIVITY#0.6490;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.6489;HETEROTRIMERIC G-PROTEIN#0.6460;NOS ACTIVITY#0.6451;LOCUS COERULEUS#0.6450;NALTREXONE#0.6446;NOS INHIBITOR#0.6444;SPERMATOGENESIS#0.6427;SODIUM CHANNEL#0.6407;NEUTROPHIL#0.6405;ENDOTHELIAL NITRIC OXIDE#0.6404;INHIBITORY SYNAPSE#0.6389;INFLAMMATORY BOWEL DISEASE#0.6386;HEPATITIS C#0.6382;PROSTATE CANCER#0.6366;STATISTICAL PARAMETRIC MAPPING#0.6364;CORTICOTROPHIN#0.6343;CERAMIDE SYNTHESIS#0.6331;BODY WEIGHT REDUCTION#0.6278;MESENTERIC ARTERY#0.6274;LIPID OXIDATION#0.6253;FAT CELL#0.6241;MYOFIBROBLAST#0.6235;PROTEIN KINASE B#0.6229;ANGIOGENESIS#0.6227;TARGET OF RAPAMYCIN COMPLEX#0.6221;ISCHEMIA REPERFUSION INJURY#0.6216;HEPARIN#0.6200;LIMBIC SYSTEM#0.6197;CYTOCHROME C#0.6196;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6194;MESENCHYMAL CELL#0.6191;HYDROLASE ACTIVITY#0.6191;TESTOSTERONE#0.6190;ROS GENERATION#0.6190;HINDBRAIN#0.6175;FORCED SWIMMING TEST#0.6161;LIPOPROTEIN LIPASE#0.6154;SEPTUM#0.6151;CARNITINE#0.6150;MAJOR DEPRESSIVE DISORDER#0.6144;TEMPORAL LOBE EPILEPSY#0.6134;MODULATION OF SYNAPTIC TRANSMISSION#0.6129;REGENERATION#0.6126;VOCAL LEARNING#0.6122;BENZIMIDAZOLE#0.6117;ADRENAL GLAND#0.6115;MATERNAL BEHAVIOUR#0.6102;BIOLUMINESCENCE#0.6096;ABDOMINAL PAIN#0.6094;REGULATION OF BONE REMODELING#0.6090;BONE CANCER#0.6089;COMPLEX I#0.6088;NITRO-L-ARGININE#0.6084;PHOSPHOLIPASE A2#0.6083;CORTICOTROPHIN RELEASING HORMONE#0.6065;HYPOTENSIVE#0.6060;GONAD#0.6059;CONTACT DERMATITIS#0.6034;ESTROGENS#0.6032;EARLY LIFE STRESS#0.6023;M1 MACROPHAGE#0.6019;COCAINE DEPENDENCE#0.6008;LIPID HOMEOSTASIS#0.6000
126961	S PHASE#1.0227;CELL CYCLE#1.0136;NUCLEOSOME#0.9544;GENE EXPRESSION#0.8708;LYSINE#0.8110;HISTONE MODIFICATION#0.7771;POST-TRANSLATIONAL MODIFICATION#0.7646;NUCLEOSOME ASSEMBLY#0.7141;TRANSCRIPTION FACTOR#0.6898;DNA REPLICATION#0.6885;STEM CELL#0.6828;EMBRYONIC STEM CELL#0.6640;MOUSE EMBRYONIC STEM#0.6457;HETEROCHROMATIN#0.6056
1269	CANNABINOID RECEPTOR LIGAND#1.0366;TRANSIENT RECEPTOR POTENTIAL#1.0347;SR 141716A#1.0277;CANNABINOID RECEPTOR#1.0216;ALZHEIMER'S DISEASE#1.0171;BONE MARROW#1.0169;SMOOTH MUSCLE#1.0165;OSTEOPOROSIS#1.0160;LIVER DISEASE#1.0158;ATHEROSCLEROSIS#1.0141;OPIOID RECEPTOR#1.0138;PERIPHERAL BLOOD#1.0131;RECEPTOR LIGAND#1.0127;PYRAZOLE#1.0122;SPINAL CORD#1.0122;GLIAL CELL#1.0116;RIMONABANT#1.0097;B CELL#1.0094;SR141716A#1.0094;OSTEOBLAST#1.0091;RECEPTOR AGONIST#1.0085;IMMUNE CELL#1.0073;STRUCTURE ACTIVITY RELATIONSHIP#1.0072;MACROPHAGE#1.0071;OSTEOCLAST#1.0066;RECEPTOR ANTAGONIST#1.0058;APOPTOSIS#1.0056;LEUKOCYTE#1.0047;RECEPTOR BINDING#1.0042;IMMUNE SYSTEM#1.0031;ISCHEMIA#1.0013;PROGENITOR CELL#1.0009;CELL ACTIVATION#0.9996;GENE EXPRESSION#0.9980;MONOCYTE#0.9972;IMMUNE RESPONSE#0.9949;MULTIPLE SCLEROSIS#0.9947;ENDOTHELIAL CELL#0.9946;TETRAHYDROCANNABINOL#0.9945;STEM CELL#0.9942;POLYMERASE CHAIN REACTION#0.9941;MICROGLIAL CELL#0.9940;T CELL#0.9928;PROTEIN KINASE#0.9899;CANCER CELL#0.9897;CENTRAL NERVOUS SYSTEM#0.9894;DELTA-9-TETRAHYDROCANNABINOL#0.9879;CELL PROLIFERATION#0.9877;NERVOUS SYSTEM#0.9866;PRO-INFLAMMATORY#0.9866;MITOGEN ACTIVATED PROTEIN#0.9852;INFLAMMATORY RESPONSE#0.9839;SIGNAL TRANSDUCTION#0.9834;NITRIC OXIDE#0.9823;SIGNALING PATHWAY#0.9809;DOPAMINE#0.9807;TUMOR NECROSIS FACTOR#0.9800;PHOSPHOLIPASE D#0.9755;NEURODEGENERATIVE DISEASE#0.9752;CELL DEATH#0.9747;BLOOD BRAIN BARRIER#0.9744;PULMONARY VEIN#0.9725;INDOLE#0.9721;NEUROPROTECTION#0.9682;RHEUMATOID ARTHRITIS#0.9672;OBESE#0.9617;APOPTOTIC#0.9615;GROWTH FACTOR#0.9589;PEROXISOME#0.9567;SR141716#0.9531;NEUTROPHIL#0.9523;T LYMPHOCYTE#0.9502;CELL MIGRATION#0.9450;NITRIC OXIDE SYNTHASE#0.9426;FORSKOLIN#0.9406;INFLAMMATORY CELL#0.9393;PERTUSSIS#0.9392;AUTOPHAGY#0.9368;RECEPTOR ACTIVITY#0.9365;COLITIS#0.9344;CELL CYCLE#0.9342;ASTROCYTE#0.9315;ATRIAL FIBRILLATION#0.9302;MAST CELL#0.9285;EDEMA#0.9245;HEPATITIS C#0.9177;MYOCARDIAL INFARCTION#0.9161;MUSCLE CELL#0.9150;ATHEROSCLEROTIC#0.9132;SMOOTH MUSCLE CELL#0.9115;TRAUMATIC BRAIN INJURY#0.9104;ADIPOSE TISSUE#0.9079;MESENCHYMAL STEM CELL#0.9070;B LYMPHOCYTE#0.9064;NEUROINFLAMMATORY RESPONSE#0.9046;BENZIMIDAZOLE#0.9046;MU OPIOID RECEPTOR#0.9032;ARACHIDONIC ACID#0.8977;DENDRITIC CELL#0.8915;ENDOGENOUS CANNABINOID SYSTEM#0.8901;POSITRON EMISSION TOMOGRAPHY#0.8881;MECHANISM OF ACTION#0.8862;LATERAL SCLEROSIS#0.8848;REACTIVE OXYGEN SPECIES#0.8840;FATTY LIVER#0.8834;MONONUCLEAR CELLS#0.8817;HIGH FAT DIET#0.8800;FORMALIN#0.8786;ENDOTHELIUM#0.8752;TRANSCRIPTION FACTOR#0.8748;BONE RESORPTION#0.8719;PACLITAXEL#0.8712;INFLAMMATORY BOWEL DISEASE#0.8701;BONE FORMATION#0.8693;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8692;NOCICEPTION#0.8691;PARKINSON'S DISEASE#0.8687;CELL MEMBRANE#0.8674;CELL SURFACE#0.8634;MOLECULAR DYNAMICS SIMULATION#0.8501;BREAST CANCER#0.8500;HYPOXIA#0.8487;AMYOTROPHIC LATERAL SCLEROSIS#0.8450;ARTERY#0.8423;ETHANOL#0.8384;GERMINAL CENTER#0.8373;WEIGHT GAIN#0.8364;NEUROGENESIS#0.8356;QUANTITATIVE REAL TIME#0.8335;HEPATIC STELLATE CELL#0.8280;ENCEPHALOMYELITIS#0.8277;HEAT SHOCK PROTEIN#0.8259;SENSITIZATION#0.8254;CD4+ T CELL#0.8209;HYPERSENSITIVITY#0.8202;DELTA-9-THC#0.8196;PODOCYTE#0.8173;CHEMOTAXIS#0.8162;MECHANISMS OF ACTION#0.8155;NEUROTOXICITY#0.8146;PHOSPHATIDYLETHANOLAMINE#0.8138;IFN-GAMMA#0.8133;BLOOD VESSEL#0.8080;CEREBRAL ISCHEMIA#0.8078;MUTAGENESIS#0.8074;NEUROPATHY#0.8010;BONE MINERAL DENSITY#0.7960;MEMORY B CELL#0.7957;CARDIOMYOCYTE#0.7919;NEURAL CELL#0.7835;RECEPTOR ACTIVATOR#0.7833;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7779;DIABETIC NEPHROPATHY#0.7778;HYPERTENSION#0.7702;2-OXOQUINOLINE#0.7689;OSTEOARTHRITIS#0.7621;FATTY LIVER DISEASE#0.7619;ACTIVATED MICROGLIAL CELLS#0.7605;HEMORRHAGE#0.7591;MYOFIBROBLAST#0.7584;ISCHEMIA REPERFUSION INJURY#0.7560;ADIPOCYTE#0.7541;REVERSE TRANSCRIPTION#0.7540;TUMOR CELLS#0.7529;KUPFFER CELL#0.7523;LENGTH OF STAY#0.7453;INDUCIBLE NITRIC OXIDE#0.7437;OOCYTE MATURATION#0.7434;LIVER REGENERATION#0.7415;SKELETAL MUSCLE#0.7406;PLASMA CELL#0.7393;EPITHELIAL CELL#0.7389;OUTER MEMBRANE#0.7354;AUTOIMMUNE DISEASE#0.7352;EXTRACELLULAR MATRIX#0.7327;CONDITIONED PLACE PREFERENCE#0.7318;OSTEOSARCOMA CELL LINES#0.7311;BREAST CANCER CELL#0.7279;DIGESTION#0.7278;REGENERATION#0.7240;TOXICITY#0.7232;CYCLASE ACTIVITY#0.7198;MEMORY IMPAIRMENT#0.7196;CELL DIFFERENTIATION#0.7184;NEUROLOGICAL DISORDER#0.7173;NEURONAL CELLS#0.7162;HEMATOPOIETIC CELL#0.7155;CHEMOKINE RECEPTOR#0.7153;SIGNALING MOLECULE#0.7148;TUMOUR NECROSIS FACTOR#0.7147;MODULATION OF MEMORY#0.7120;ACUTE LIVER INJURY#0.7117;MOLAR#0.7047;CHRONIC HEPATITIS C#0.7036;BRAIN DAMAGE#0.7014;OOCYTE#0.7003;ARRHYTHMIA#0.7001;BRAIN EDEMA#0.6991;MAP KINASE#0.6978;TRANSFORMING GROWTH FACTOR#0.6950;PAROXYSMAL ATRIAL FIBRILLATION#0.6942;METHAMPHETAMINE#0.6918;EPILEPSY#0.6906;STROMAL CELL#0.6900;TYPE 2 DIABETES#0.6884;BODY WEIGHT GAIN#0.6866;CYSTITIS#0.6853;CANNABINOID RECEPTOR BINDING#0.6796;ADENYLYL CYCLASE ACTIVITY#0.6792;SCIATIC NERVE#0.6768;DOPAMINERGIC NEURON#0.6764;ION CHANNEL#0.6718;DORSAL ROOT GANGLION#0.6704;CYTOKINE PRODUCTION#0.6703;DIABETES MELLITUS#0.6684;CELL DEVELOPMENT#0.6681;OSTEOCLAST DIFFERENTIATION#0.6679;LYMPH NODE#0.6679;HEPATITIS B#0.6655;PROTEIN KINASE C#0.6648;PROSTATE CANCER#0.6645;SQUAMOUS CELL CARCINOMA#0.6624;ETHANOLAMINE#0.6618;IRRITABLE BOWEL SYNDROME#0.6572;ESTROGEN RECEPTOR#0.6569;MALTOSE BINDING#0.6524;AKT SIGNALING#0.6493;GLUTATHIONE#0.6471;DERMATITIS#0.6469;KIDNEY DISEASE#0.6465;CEREBRAL ARTERY OCCLUSION#0.6459;PHAGOCYTOSIS#0.6457;MODE OF ACTION#0.6455;ACTIVATED T-CELLS#0.6452;ACTIVATED T CELL#0.6449;LYMPHOID TISSUE#0.6446;MIDDLE CEREBRAL ARTERY#0.6445;HEME OXYGENASE 1#0.6443;CEREBRAL ARTERY#0.6442;POTASSIUM CHANNEL#0.6438;OLIGODENDROCYTE#0.6437;CYCLIC AMP#0.6436;ISATIN#0.6430;KINASE ACTIVITY#0.6421;MINOCYCLINE#0.6379;MAST CELL ACTIVATION#0.6330;NEURAL PROGENITOR CELL#0.6295;STREPTOZOTOCIN#0.6294;ENERGY HOMEOSTASIS#0.6276;CYTOPLASM#0.6264;NEPHROPATHY#0.6258;OXYGENASE#0.6257;CATION CHANNEL#0.6233;GLUTAMATE RECEPTOR#0.6225;GLUCOCORTICOID RECEPTOR#0.6190;URINARY BLADDER#0.6179;EOSINOPHIL#0.6152;TRANSCRIPTASE#0.6147;ALANINE#0.6136;MACROPHAGE CHEMOTAXIS#0.6123;CELL GROWTH#0.6101;C FIBER#0.6096;DEPHOSPHORYLATION#0.6075;MYOCARDIUM#0.6063;HIGH CHOLESTEROL DIET#0.6062;IMMUNE THROMBOCYTOPENIC PURPURA#0.6052;PROGESTERONE#0.6039
126	PANCREATITIS#1.0636;BREAST CANCER#1.0529;FRAGMENT LENGTH POLYMORPHISM#1.0331;ALCOHOL DEPENDENCE#1.0166;POLYMERASE CHAIN REACTION#1.0132;LIVER DISEASE#1.0072;ETHANOL#1.0063;ALCOHOL METABOLISM#1.0059;VITAMIN A#1.0039;COLORECTAL#0.9954;CYTOCHROME P450#0.9860;ETHANOL METABOLISM#0.9709;DRINKING BEHAVIOR#0.9617;HEAD AND NECK CANCER#0.9590;NECK CANCER#0.9589;LIVER CIRRHOSIS#0.9549;GENE EXPRESSION#0.9494;SQUAMOUS CELL CARCINOMA#0.9326;ALCOHOLIC PANCREATITIS#0.9257;RETINOL#0.9173;ETHANOL OXIDATION#0.9093;ALCOHOL DEGRADATION#0.8982;RETINOIC ACID#0.8868;ALCOHOLIC LIVER CIRRHOSIS#0.8764;COLORECTAL CANCER#0.8720;MYOCARDIAL INFARCTION#0.8466;HIGH DENSITY LIPOPROTEIN#0.8458;CARCINOGEN#0.8431;HEART DISEASE#0.8248;GLUTATHIONE#0.7768;CORONARY HEART DISEASE#0.7750;ADH-1#0.7747;COLORECTAL ADENOMA#0.7649;ESOPHAGEAL CANCER#0.7498;TRANSCRIPTION FACTOR#0.7246;FLUSHING#0.7207;LUNG CANCER#0.7062;DETOXIFICATION#0.6560;ADJUSTED ODDS RATIO#0.6558;ALCOHOL USE DISORDER#0.6498;MULTIPLE LOGISTIC REGRESSION#0.6051;LIVER DEVELOPMENT#0.6049
127003	TOOTH DISEASE#0.9228;CHARCOT-MARIE-TOOTH DISEASE#0.9228;CHARCOT MARIE TOOTH#0.9193
127018	LIVER DISEASE#0.9897;FATTY LIVER DISEASE#0.9814;FATTY LIVER#0.9803;ALCOHOLIC FATTY LIVER#0.8854;OBESE#0.8500;ADIPOSE TISSUE#0.8112;WAIST HIP RATIO#0.7359;NONALCOHOLIC FATTY LIVER DISEASE#0.6775;TYPE 2 DIABETES#0.6344;DIET INDUCED OBESITY#0.6280
127062	COPPER BINDING#0.7757
1270	CNTF BINDING#1.1457;ASTROCYTE DIFFERENTIATION#1.0522;CILIARY GANGLION#1.0510;IL-11#1.0505;HUNTINGTON'S DISEASE#1.0359;MOTOR NEURON DISEASE#1.0347;OPSIN#1.0343;CILIARY NEUROTROPHIC FACTOR#1.0339;FACTOR I#1.0336;OBESE#1.0275;PHOTORECEPTOR CELL#1.0275;INSULIN-LIKE GROWTH FACTOR#1.0269;QUINOLINIC ACID#1.0266;LEUKEMIA INHIBITORY FACTOR#1.0243;RECEPTOR COMPLEX#1.0239;NEUROBLASTOMA#1.0228;NEURITE GROWTH#1.0218;ENDOTHELIAL GROWTH FACTOR#1.0216;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0216;NERVE FIBER#1.0212;RETINITIS PIGMENTOSA#1.0211;PLATELET-DERIVED GROWTH FACTOR#1.0206;WEIGHT LOSS#1.0175;NEURON SURVIVAL#1.0171;MUSCLE FIBER#1.0166;RETINITIS#1.0159;OLFACTORY BULB#1.0158;GLIAL CELL#1.0147;CHOLINERGIC NEURON#1.0139;TUMOR NECROSIS FACTOR#1.0136;RETINAL DEGENERATION#1.0135;SCHWANN CELL#1.0133;AXON REGENERATION#1.0126;COLONY-STIMULATING FACTOR#1.0122;TRANSFORMING GROWTH FACTOR#1.0120;EPIDERMAL GROWTH FACTOR#1.0120;FIBROBLAST GROWTH FACTOR#1.0111;GRANULOCYTE COLONY STIMULATING FACTOR#1.0105;RETINOIC ACID#1.0101;NERVE GROWTH FACTOR#1.0101;SCIATIC NERVE#1.0093;NEURITE#1.0086;ADIPOSE TISSUE#1.0067;DORSAL ROOT GANGLION#1.0065;ASTROCYTE#1.0065;STRIATUM#1.0064;NEURITE OUTGROWTH#1.0055;SKELETAL MUSCLE#1.0050;CYTOKINE RECEPTOR#1.0044;AMYOTROPHIC LATERAL SCLEROSIS#1.0041;LATERAL SCLEROSIS#1.0041;AXON GROWTH#1.0037;ADIPOCYTE#1.0029;TRANSFORMING GROWTH FACTOR BETA#1.0025;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0025;NEUROGENESIS#1.0023;DOPAMINE#1.0017;SIGNAL TRANSDUCER#1.0016;PERIPHERAL NERVE INJURY#1.0012;IFN-GAMMA#1.0010;NEUROPROTECTION#1.0004;NEURONAL CELLS#1.0004;OPTIC NERVE#0.9996;PRECURSOR CELL#0.9990;FOREBRAIN#0.9987;GROWTH FACTOR#0.9979;NEURAL STEM CELL#0.9976;DENTATE GYRUS#0.9975;MITOGEN ACTIVATED PROTEIN#0.9974;MESENCHYMAL STEM CELL#0.9969;OLIGODENDROCYTE#0.9966;ISCHEMIA#0.9966;SPINAL CORD INJURY#0.9964;PERIPHERAL NERVE#0.9962;OPTIC NERVE INJURY#0.9943;CHOLINE#0.9940;RETINAL GANGLION CELL#0.9934;GRANULOCYTE#0.9932;SIGNALLING PATHWAY#0.9929;CELL DIFFERENTIATION#0.9927;GANGLION CELLS#0.9913;NEURAL CELL#0.9912;ACETYLCHOLINE#0.9909;TRANSCRIPTION FACTOR#0.9908;OPTIC NERVE CRUSH#0.9906;REGENERATION#0.9905;POLYMERASE CHAIN REACTION#0.9903;REVERSE TRANSCRIPTION#0.9900;RECEPTOR ANTAGONIST#0.9891;SIGNALING PATHWAY#0.9884;PROTEIN SYNTHESIS#0.9883;NITRIC OXIDE#0.9882;GENE EXPRESSION#0.9880;NUCLEAR LAYER#0.9880;PERIPHERAL NERVOUS SYSTEM#0.9878;MACROPHAGE#0.9868;OLIGODENDROCYTE PRECURSOR CELL#0.9864;PROTEIN KINASE C#0.9858;SIGNAL TRANSDUCTION#0.9851;MULTIPLE SCLEROSIS#0.9848;NEUROPATHY#0.9847;FORSKOLIN#0.9840;CELL PROLIFERATION#0.9838;SPINAL CORD#0.9838;PROTEIN KINASE#0.9836;BONE MARROW#0.9833;LATERAL VENTRICLE#0.9832;CELL SURFACE#0.9828;MYELINATION#0.9819;BONE MORPHOGENETIC PROTEIN#0.9814;APOPTOSIS#0.9812;NEURODEGENERATIVE DISEASE#0.9794;PERIPHERAL BLOOD#0.9793;PROGENITOR CELL#0.9791;TOXICITY#0.9784;APOPTOTIC#0.9779;STEM CELL#0.9775;HEPATOCYTE GROWTH FACTOR#0.9769;CELL DEATH#0.9750;CEREBRAL CORTEX#0.9747;SIGNALING MOLECULE#0.9738;CYCLIC AMP#0.9737;CYTOPLASM#0.9737;SUBSTANCE P#0.9737;PARKINSON'S DISEASE#0.9737;NERVOUS SYSTEM#0.9734;INFLAMMATORY RESPONSE#0.9732;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9732;INNERVATION#0.9730;ENERGY HOMEOSTASIS#0.9719;SUBSTANTIA NIGRA#0.9710;ALZHEIMER'S DISEASE#0.9708;CENTRAL NERVOUS SYSTEM#0.9692;ENCEPHALOMYELITIS#0.9689;RECEPTOR BINDING#0.9667;OUTER NUCLEAR LAYER#0.9666;EMBRYONIC STEM CELL#0.9659;NEURAL PROGENITOR CELL#0.9658;ADENO ASSOCIATED VIRUS#0.9653;INTERLEUKIN 6 RECEPTOR#0.9636;EXTRACELLULAR MATRIX#0.9632;T CELL#0.9630;STROMAL CELL#0.9618;HIGH FAT DIET#0.9601;ACUTE PHASE RESPONSE#0.9595;MUSCLE CELL#0.9581;NEUROFILAMENT#0.9568;CERVICAL#0.9539;ACETYLCHOLINE RECEPTOR#0.9539;ANORECTIC#0.9528;CELLULAR LOCALIZATION#0.9524;EPITHELIAL CELL#0.9499;OLFACTORY ENSHEATHING CELL#0.9492;B CELL#0.9483;SWEAT GLAND#0.9475;NITRIC OXIDE SYNTHASE#0.9460;BETA CELL#0.9459;STREPTOZOTOCIN#0.9388;GROWTH FACTOR RECEPTOR#0.9362;NEUROTROPHIN RECEPTOR#0.9353;PRO-INFLAMMATORY#0.9352;IMMUNE RESPONSE#0.9348;KINASE INHIBITOR#0.9333;G-CSF#0.9307;NERVE TERMINAL#0.9305;CHROMAFFIN CELL#0.9298;CELL CYCLE#0.9251;SEPTUM#0.9247;CELL GROWTH#0.9203;MOTOR ENDPLATE#0.9194;FIMBRIA#0.9176;DOPAMINERGIC NEURON#0.9165;BONE MARROW STROMAL#0.9125;PANCREATIC ISLET#0.9079;RECEPTOR TYROSINE KINASE#0.9029;RETINAL DISEASE#0.9028;MUSCLE ATROPHY#0.9019;NEUROTOXICITY#0.8995;BIPOLAR CELL#0.8983;FACIAL NUCLEUS#0.8972;BLOOD BRAIN BARRIER#0.8938;AKT SIGNALING#0.8938;MUSCLE FIBRE#0.8907;TYPE 2 DIABETES#0.8873;MIDDLE CEREBRAL ARTERY#0.8852;CEREBRAL ARTERY#0.8849;MUTAGENESIS#0.8813;NEUROLOGICAL DISORDER#0.8809;ENDOTHELIAL CELL#0.8805;LEVATOR ANI#0.8777;BONE MARROW STROMAL CELL#0.8775;COMPLEX I#0.8766;MYOTUBE#0.8741;MOTOR NEURON DEGENERATION#0.8715;MACULAR DEGENERATION#0.8714;HEPATOMA CELLS#0.8709;MARROW STROMAL CELLS#0.8688;MECHANISM OF ACTION#0.8677;ARTERY#0.8667;CELL ADHESION#0.8664;WEIGHT GAIN#0.8628;CYTOKINE BINDING#0.8613;CELL ACTIVATION#0.8605;PROGRAMMED CELL DEATH#0.8587;MAP KINASE#0.8572;GROWTH HORMONE#0.8572;DIET INDUCED OBESITY#0.8554;NEURAL CREST#0.8531;MYOBLAST#0.8523;SUPERIOR COLLICULUS#0.8506;AGE RELATED MACULAR DEGENERATION#0.8498;BETA GALACTOSIDASE#0.8480;RECEPTOR AGONIST#0.8471;INTERNEURON#0.8438;WOUND HEALING#0.8434;MICROGLIAL CELL#0.8422;EPENDYMAL CELL#0.8395;TRANSCRIPTASE#0.8362;ANOREXIA#0.8357;NOREPINEPHRINE#0.8351;TRANSFORMING GROWTH FACTOR ALPHA#0.8326;RETINAL PIGMENT EPITHELIAL#0.8321;HINDLIMB#0.8258;SYNAPSE ELIMINATION#0.8220;MULLER CELL#0.8196;MONOCYTE#0.8146;KINASE ACTIVITY#0.8114;CACHEXIA#0.8113;INTRACELLULAR SIGNALING PATHWAY#0.8097;OLIGODENDROCYTE DIFFERENTIATION#0.8083;INDUCIBLE NITRIC OXIDE#0.8056;GLUCOSE UPTAKE#0.8054;CHOLINE ACETYLTRANSFERASE ACTIVITY#0.8045;TUMOUR NECROSIS FACTOR#0.8034;NEURONAL CELL DEATH#0.8021;ACETYLTRANSFERASE ACTIVITY#0.7999;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.7999;REGULATION OF ENERGY HOMEOSTASIS#0.7988;RETINAL DAMAGE#0.7948;RETINAL DEVELOPMENT#0.7898;ACTION POTENTIAL#0.7898;LIPID RAFT#0.7873;DNA BINDING#0.7856;ASTROCYTE ACTIVATION#0.7849;DIABETIC RETINOPATHY#0.7829;MICROTUBULE ASSOCIATED PROTEIN#0.7825;NEURONAL PROGENITOR CELL#0.7822;RETINAL PROGENITOR CELL#0.7817;CEREBRAL ISCHEMIA#0.7800;MICROTUBULE#0.7792;QUANTITATIVE REAL TIME#0.7792;PHOTORECEPTOR DEVELOPMENT#0.7784;RECEPTOR LIGAND#0.7762;ADENYLATE CYCLASE#0.7752;NEURONAL CELL BODIES#0.7743;MYOCYTES#0.7738;INNER NUCLEAR LAYER#0.7720;CONNEXIN#0.7688;LEARNING DISABILITY#0.7681;OPTICAL COHERENCE TOMOGRAPHY#0.7680;MEMORY IMPAIRMENT#0.7678;NEURAL PRECURSOR CELL#0.7659;PROTEIN TYROSINE PHOSPHATASE#0.7651;PHOSPHOLIPASE C#0.7632;HIPPOCAMPAL PROGENITOR CELLS#0.7579;PHOTOTRANSDUCTION#0.7534;DEMYELINATING DISEASE#0.7489;PURKINJE CELL#0.7431;CHOROID PLEXUS#0.7430;LOCUS COERULEUS#0.7427;FOCAL CEREBRAL ISCHEMIA#0.7405;DOPAMINE RECEPTOR#0.7390;FACTOR S#0.7389;ION CHANNEL#0.7386;GM-CSF#0.7381;SMOOTH MUSCLE#0.7378;PROTEIN TRANSDUCTION DOMAIN#0.7376;SIGNALING CASCADE#0.7350;DNA SYNTHESIS#0.7336;CELL MEMBRANE#0.7331;CACHECTIC#0.7300;NEUROTOXIC#0.7276;BETA CELL MASS#0.7267;OSTEOBLAST#0.7266;CROSS SECTIONAL AREA#0.7251;ALL TRANS RETINOIC ACID#0.7224;MAPK ACTIVATION#0.7198;CELL BODY#0.7191;GLUCOSE METABOLISM#0.7188;CELL ADHESION MOLECULE#0.7188;CEREBRAL ARTERY OCCLUSION#0.7164;GLIOGENESIS#0.7158;CYTOTOXICITY#0.7151;GENTAMICIN#0.7135;CARDIOMYOCYTE#0.7092;PLURIPOTENT STEM CELL#0.7090;TUMOR CELLS#0.7085;ASPARTATE#0.7061;ADRENAL MEDULLA#0.7059;PARALYSIS#0.7052;PLASMA MEMBRANE#0.7038;AXONAL TRANSPORT#0.7029;NEUROMUSCULAR JUNCTION#0.7006;ACHROMATOPSIA#0.6993;APOPTOTIC CELL DEATH#0.6971;SUPEROXIDE DISMUTASE#0.6924;PEROXISOME#0.6901;MYELIN SHEATH#0.6893;RESPONSE TO IL-6#0.6880;OCULAR HYPERTENSION#0.6833;MECHANISMS OF ACTION#0.6823;GLUTAMINE#0.6823;FIBRINOGEN#0.6810;NEURAL RETINA#0.6806;REACTIVE OXYGEN SPECIES#0.6781;PIGMENT EPITHELIAL CELL#0.6779;HEMATOPOIESIS#0.6753;SYNAPTIC TRANSMISSION#0.6745;AMYLOID PRECURSOR PROTEIN#0.6732;INTERMEDIATE FILAMENT#0.6724;PINEAL GLAND#0.6721;BONE FORMATION#0.6716;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6694;SIGNAL PEPTIDE#0.6679;HYPERTENSION#0.6677;NEURON DEATH#0.6641;ACINAR CELL#0.6630;URINARY BLADDER#0.6629;ADENYLATE#0.6605;NEUTROPHIL#0.6599;MUSCULAR ATROPHY#0.6597;HEPARIN#0.6587;SYNAPTOGENESIS#0.6550;OLIGODENDROCYTE PROGENITOR CELL#0.6535;INNER EAR#0.6516;IMMUNE SYSTEM#0.6510;CALCIUM CHANNEL#0.6468;PHOSPHATE BUFFERED SALINE#0.6460;PARENCHYMA#0.6453;TOPICAL#0.6443;CAMP RESPONSE ELEMENT#0.6441;TERMINAL DIFFERENTIATION#0.6440;MAPK SIGNALING#0.6426;MODE OF ACTION#0.6422;HYPOXIA#0.6407;INFLAMMATORY CELL#0.6398;NEURON DEVELOPMENT#0.6371;OXYGEN INDUCED RETINOPATHY#0.6361;NERVE DAMAGE#0.6347;NEUROBLAST#0.6341;STAUROSPORINE#0.6322;CORNEAL ENDOTHELIUM#0.6322;SPINAL MUSCULAR ATROPHY#0.6309;NEURITE REGENERATION#0.6299;RETINAL PIGMENT EPITHELIUM#0.6282;CHARCOT MARIE TOOTH#0.6280;ASTROCYTE DEVELOPMENT#0.6277;LINES OF EVIDENCE#0.6263;IL-6 PRODUCTION#0.6248;BRIMONIDINE#0.6217;SMOOTH MUSCLE CELL#0.6213;CAMP RESPONSE ELEMENT BINDING#0.6213;AMACRINE CELL#0.6211;FATTY ACID OXIDATION#0.6204;ISCHEMIA REPERFUSION INJURY#0.6204;BROWN ADIPOSE TISSUE#0.6165;STEM CELL FACTOR#0.6159;GROWTH CONE#0.6145;HEMATOPOIETIC CELL#0.6127;VASOPRESSIN#0.6126;CELL DIVISION#0.6122;OPTIC NERVE HEAD#0.6109;DEMENTIA#0.6083;PROTEASOME#0.6037;NEURAL STEM PROGENITOR#0.6026;SERUM AMYLOID A#0.6011;ADIPOCYTE DIFFERENTIATION#0.6002
1271	RECEPTOR COMPLEX#1.0475;LEUKEMIA INHIBITORY FACTOR#1.0324;CILIARY NEUROTROPHIC FACTOR#1.0252;NERVOUS SYSTEM#1.0231;SPINAL CORD#1.0130;SIGNAL TRANSDUCTION#0.9979;SKELETAL MUSCLE#0.9937;GROWTH FACTOR#0.9883;CYTOKINE RECEPTOR#0.9864;ASTROCYTE#0.9831;CNTF BINDING#0.9788;SIGNALING PATHWAY#0.9418;OPTIC NERVE#0.9317;PERIPHERAL NERVE#0.9241;GENE EXPRESSION#0.9218;SIGNAL TRANSDUCER#0.9169;CELL SURFACE#0.8812;REVERSE TRANSCRIPTION#0.8620;POLYMERASE CHAIN REACTION#0.8432;GLIAL CELL#0.8371;CENTRAL NERVOUS SYSTEM#0.8259;LIPID RAFT#0.8118;REGENERATION#0.7985;GANGLION CELLS#0.7981;STEM CELL#0.7517;NEURONAL CELLS#0.7372;NEUROGENESIS#0.7317;B CELL#0.7306;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7111;FACTOR I#0.7038;NERVE GROWTH FACTOR#0.6843;DENTATE GYRUS#0.6578;CELL DEATH#0.6501;NUCLEAR LAYER#0.6451;PHOTORECEPTOR CELL#0.6436;FIBROBLAST GROWTH FACTOR#0.6304;COMPLEX I#0.6264;CYTOKINE BINDING#0.6197;OLFACTORY BULB#0.6168
127247	AND SOCS BOX#0.6910
127262	SYNAPTIC VESICLE#0.9769;BICEPS#0.9646;TRICEPS#0.9362;PECTORALIS MAJOR#0.9124;MOTOR EVOKED POTENTIAL#0.8898;TRANSCRANIAL MAGNETIC STIMULATION#0.8670;ERECTOR SPINAE#0.8029;BONE MINERAL DENSITY#0.7884;HAMSTRING#0.7633;NERVOUS SYSTEM#0.7566;FOREARM#0.7213;IBANDRONATE#0.7067;PRIMARY MOTOR CORTEX#0.6952;PRESYNAPTIC TERMINAL#0.6835
127281	MYELIN SHEATH#0.7269;PROSTAGLANDIN F SYNTHASE#0.6288
127294	SARCOMERE ORGANIZATION#0.7197;M BAND#0.7001;STRIATED MUSCLE#0.6655
1272	CANCER CELL#1.0537;CELL ADHESION MOLECULE#1.0390;CELL ADHESION#1.0303;NEURAL CELL#0.9874;CELL SURFACE#0.9835;NERVOUS SYSTEM#0.9800;DEMYELINATING POLYNEUROPATHY#0.9679;CELL PROLIFERATION#0.9388;EPITHELIAL CELL#0.9261;LUNG ADENOCARCINOMA#0.9212;PLASMA MEMBRANE#0.9200;VISNA#0.9145;SIGNALING PATHWAY#0.8984;POLYNEUROPATHY#0.8906;SQUAMOUS CELL CARCINOMA#0.8789;GENE EXPRESSION#0.8784;NEUROPATHY#0.8684;TRANSCRIPTION FACTOR#0.8500;LUNG CANCER#0.8465;LYMPH NODE#0.8460;GROWTH FACTOR#0.8291;CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY#0.8230;EPITHELIAL MESENCHYMAL TRANSITION#0.8104;POLYMERASE CHAIN REACTION#0.8031;INTRAVENOUS IMMUNOGLOBULIN#0.8010;LYMPH NODE METASTASIS#0.7971;NEURITE#0.7950;MULTIPLE SCLEROSIS#0.7749;ADENOCARCINOMA#0.7631;TIGHT JUNCTION#0.7594;POLYRADICULONEUROPATHY#0.7561;CENTRAL NERVOUS SYSTEM#0.7546;PARANODE#0.7546;HUMAN IMMUNODEFICIENCY VIRUS#0.7508;OLIGODENDROCYTE#0.7508;PROSTATE CANCER#0.7342;NEURITE OUTGROWTH#0.7019;CELL MIGRATION#0.6551;EXTRACELLULAR MATRIX#0.6527;MICROTUBULE#0.6412;ENDOTHELIAL CELL#0.6326;NEUROMUSCULAR JUNCTION#0.6196;PRIMARY CILIUM#0.6186;AXON GUIDANCE#0.6048;ORAL SQUAMOUS CELL CARCINOMA#0.6039;CELL FUSION#0.6038
127343	CELL CYCLE#0.9693;MIDBRAIN#0.9221;TRANSCRIPTION FACTOR#0.9106;DIENCEPHALON#0.7643;GENE EXPRESSION#0.6793;NERVOUS SYSTEM#0.6582;SPINAL CORD#0.6418;HINDBRAIN#0.6283;PROGENITOR CELL#0.6274
127385	
127428	DNA METHYLATION#0.6772
127435	LEUCINE RICH REPEAT#1.0180;LEUCINE#0.8565;SIGNALING PATHWAY#0.6841;SMC PROLIFERATION#0.6588;DIABETIC NEPHROPATHY#0.6388;ADIPOSE TISSUE#0.6320;STEM CELL#0.6270
127534	ERYTHROKERATODERMIA VARIABILIS#1.0774;CONNEXIN#1.0411;GAP JUNCTION#1.0198;HEARING LOSS#0.9657;INNER EAR#0.7718;PLASMA MEMBRANE#0.6773;SKIN DISEASE#0.6732;POLYMERASE CHAIN REACTION#0.6643;HEARING IMPAIRMENT#0.6387;KERATINOCYTE#0.6274;LUNG CANCER#0.6112;GAP JUNCTION CHANNEL#0.6094;CELL MEMBRANE#0.6085;CANCER CELL#0.6033
127540	HIGH MOBILITY GROUP#1.0781;CELL PROLIFERATION#0.7547;TRANSCRIPTION FACTOR#0.7490;CANCER CELL#0.6464
127544	UBIQUITIN#0.9109;MACROPHAGE#0.8722;INNATE IMMUNITY#0.6828;INDUCIBLE NITRIC OXIDE#0.6239;NITRIC OXIDE SYNTHASE#0.6190;TUMOR CELLS#0.6162;NITRIC OXIDE#0.6159;T CELL#0.6122
127602	MICROSOME#0.6311;CYSTIC FIBROSIS#0.6200
127700	TUMOR SUPPRESSOR#1.1052;CELL PROLIFERATION#0.9993;APOPTOSIS#0.9504;HEPATOCELLULAR CARCINOMA#0.8935;TUMOR CELLS#0.8332;CANCER CELL#0.7873;SIGNALING PATHWAY#0.7610;NITRIC OXIDE#0.6753;CELL GROWTH#0.6534;CERVICAL CANCER#0.6335;LIVER CANCER#0.6269;OOCYTE#0.6159
127733	
1277	OTOSCLEROSIS#1.0575;VITAMIN D RECEPTOR#1.0336;COLLAGEN TYPE III#1.0270;COLLAGEN TYPE I#1.0253;PLATELET-DERIVED GROWTH FACTOR#1.0113;TISSUE GROWTH FACTOR#1.0104;DERMATOFIBROSARCOMA PROTUBERANS#1.0092;EHLERS-DANLOS SYNDROME#1.0081;SMOOTH MUSCLE ACTIN#1.0065;HUMAN DERMAL FIBROBLAST#1.0045;ESTROGEN RECEPTOR#1.0012;ALKALINE PHOSPHATASE#1.0004;OSTEOGENESIS IMPERFECTA#1.0000;TRANSCRIPTASE#0.9975;ENDOTHELIAL GROWTH FACTOR#0.9974;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9974;MATRIX METALLOPROTEINASE 1#0.9966;SMOOTH MUSCLE#0.9962;REVERSE TRANSCRIPTION#0.9957;HYPOXIA#0.9933;SKIN FIBROBLASTS#0.9929;GLYCINE#0.9919;QUANTITATIVE REAL TIME#0.9914;PHOSPHATASE ACTIVITY#0.9899;OSTEOGENESIS#0.9891;DERMAL FIBROBLAST#0.9885;ALKALINE PHOSPHATASE ACTIVITY#0.9882;OSTEOBLAST#0.9881;COLLAGENASE#0.9875;MATRIX METALLOPROTEINASE 13#0.9867;MINERALIZATION#0.9863;POLYMERASE CHAIN REACTION#0.9840;OSTEOBLAST DIFFERENTIATION#0.9838;BREAST CANCER#0.9837;HYDROXYPROLINE#0.9835;OSTEOCYTE#0.9832;TUMOR NECROSIS FACTOR#0.9824;BONE MORPHOGENETIC PROTEIN#0.9823;BLEOMYCIN#0.9815;LUNG FIBROBLASTS#0.9810;INSULIN-LIKE GROWTH FACTOR#0.9805;TRANSCRIPTION FACTOR#0.9799;PROTEIN KINASE#0.9793;CHONDROCYTE#0.9785;TRANSFORMING GROWTH FACTOR BETA#0.9785;BONE MINERAL DENSITY#0.9782;LOW BONE MASS#0.9780;COLLAGEN SYNTHESIS#0.9779;COLLAGEN TYPE II#0.9766;MYOFIBROBLAST#0.9760;CRUCIATE LIGAMENT#0.9758;PROTEIN PROTEIN INTERACTION#0.9756;DENTINOGENESIS IMPERFECTA#0.9754;ANGIOGENESIS#0.9751;OSTEOCLAST#0.9748;HEARING LOSS#0.9735;TRANSFORMING GROWTH FACTOR#0.9734;GROWTH FACTOR#0.9731;CELL CYCLE#0.9726;CANCER CELL#0.9722;FOCAL ADHESION#0.9720;CONNECTIVE TISSUE#0.9711;HEPATIC STELLATE CELL#0.9705;FIBROBLAST GROWTH FACTOR#0.9704;CELL MIGRATION#0.9701;STROMAL CELL#0.9692;MACROPHAGE#0.9690;PULMONARY FIBROSIS#0.9690;EXTRACELLULAR MATRIX COMPONENT#0.9689;BONE DISEASE#0.9688;OSTEOPOROSIS#0.9675;CELL GROWTH#0.9660;WOUND HEALING#0.9659;GENE EXPRESSION#0.9644;BONE RESORPTION#0.9641;DNA METHYLATION#0.9627;MUSCLE CELL#0.9625;DIGESTION#0.9624;APOPTOSIS#0.9622;GROWTH FACTOR RECEPTOR#0.9612;BONE FORMATION#0.9610;PARATHYROID HORMONE#0.9606;MONOCYTE#0.9604;ALIZARIN RED STAINING#0.9603;ADIPOSE TISSUE#0.9598;OSTEOARTHRITIS#0.9598;QUANTITATIVE REVERSE TRANSCRIPTION#0.9594;CELL PROLIFERATION#0.9593;CELL ADHESION#0.9591;FEMUR#0.9580;PRO-INFLAMMATORY#0.9577;SMOOTH MUSCLE CELL#0.9569;EXTRACELLULAR MATRIX#0.9569;CHONDROGENESIS#0.9567;ANTERIOR CRUCIATE LIGAMENT#0.9556;BONE MARROW#0.9548;SIGNALING PATHWAY#0.9546;DENTINOGENESIS#0.9539;EPITHELIAL CELL#0.9536;DUAL LUCIFERASE REPORTER#0.9530;DNA BINDING#0.9525;HIGH FAT DIET#0.9511;PROTEIN INTERACTION NETWORK#0.9508;PROTEOGLYCAN#0.9500;REGENERATION#0.9493;MESENCHYMAL STEM CELL#0.9490;STEM CELL#0.9485;LIVER DISEASE#0.9471;DEXAMETHASONE#0.9458;CELL DIFFERENTIATION#0.9457;REACTIVE OXYGEN SPECIES#0.9440;TUMOR CELLS#0.9435;LUNG CANCER#0.9418;PERIPHERAL BLOOD#0.9411;BONE MARROW STROMAL#0.9407;GENE EXPRESSION OMNIBUS#0.9404;INFLAMMATORY RESPONSE#0.9404;FIBRIL#0.9402;PROTEIN SYNTHESIS#0.9398;BONE REMODELING#0.9384;APOPTOTIC#0.9368;FORMALIN#0.9362;DERMIS#0.9360;PROGENITOR CELL#0.9339;BONE DEVELOPMENT#0.9337;FIBRILLAR COLLAGEN#0.9335;ENDOTHELIAL CELL#0.9330;SQUAMOUS CELL CARCINOMA#0.9310;KINASE INHIBITOR#0.9305;RNA INTERFERENCE#0.9297;RETINOIC ACID#0.9293;INTERVERTEBRAL DISC#0.9293;MESENCHYMAL CELL#0.9283;MITOGEN ACTIVATED PROTEIN#0.9281;PARATHYROID#0.9278;OSSIFICATION#0.9277;HUMAN MESENCHYMAL STEM#0.9267;FIBROBLAST PROLIFERATION#0.9266;INFLAMMATORY CELL#0.9256;FRAGMENT LENGTH POLYMORPHISM#0.9256;NUCLEUS PULPOSUS#0.9205;HYPERTENSION#0.9195;EPITHELIAL MESENCHYMAL TRANSITION#0.9176;RECEPTOR ACTIVATOR#0.9159;ENDOPLASMIC RETICULUM#0.9145;SKELETAL MUSCLE#0.9145;HYALURONAN#0.9134;TIBIA#0.9122;CHLORAMPHENICOL#0.9121;SCLERODERMA#0.9099;IMATINIB#0.9063;NODULE FORMATION#0.9058;NITRIC OXIDE#0.9049;BONE MARROW STROMAL CELL#0.9049;HIGH BONE MASS#0.9045;TUMOR TISSUES#0.9009;EOSIN#0.8998;MARROW STROMAL CELLS#0.8991;GENETIC DISORDER#0.8973;T CELL#0.8971;AKT SIGNALING#0.8953;BONE MINERALIZATION#0.8947;BONE REGENERATION#0.8920;ALANINE#0.8899;CELL ACTIVATION#0.8893;FATTY LIVER#0.8877;SKELETON#0.8838;HARDY WEINBERG EQUILIBRIUM#0.8819;OSTEOCLAST DIFFERENTIATION#0.8814;BILE DUCT#0.8780;DENTAL PULP#0.8776;ARTERY#0.8774;HYALURONIC ACID#0.8723;PERIODONTAL LIGAMENT#0.8701;CELL DEATH#0.8686;TISSUE REGENERATION#0.8676;ENZYME ACTIVITY#0.8649;ASCORBIC ACID#0.8647;HYALURONAN SYNTHASE#0.8635;ORAL SQUAMOUS CELL CARCINOMA#0.8633;ADIPOCYTE#0.8608;CHONDROCYTE PROLIFERATION#0.8591;BLOOD VESSEL#0.8591;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8569;FATTY LIVER DISEASE#0.8555;MESENCHYMAL STROMAL CELL#0.8541;HEPATIC STELLATE CELL ACTIVATION#0.8541;SKELETAL DEVELOPMENT#0.8524;MATRIX PROTEIN 1#0.8511;COLLAGEN METABOLISM#0.8493;IMMUNE RESPONSE#0.8492;OVARIAN#0.8462;FIBROSARCOMA#0.8450;BONE CELLS#0.8449;WNT SIGNALING PATHWAY#0.8431;KIDNEY DISEASE#0.8416;MOLAR#0.8397;SENESCENCE#0.8396;MYOFIBROBLAST DIFFERENTIATION#0.8379;DENTIN MATRIX PROTEIN#0.8346;MAPK SIGNALING#0.8335;VASCULAR SMOOTH MUSCLE CELL#0.8313;GLUTATHIONE#0.8308;GESTATION#0.8308;RENAL FIBROSIS#0.8306;AUTOPHAGY#0.8291;MYOCARDIAL INFARCTION#0.8290;PEROXISOME#0.8248;FACTOR I#0.8242;ACID PHOSPHATASE#0.8218;LOW DENSITY LIPOPROTEIN#0.8216;CELL SURFACE#0.8205;MUTAGENESIS#0.8181;SCOLIOSIS#0.8176;MENISCUS#0.8165;SIGNAL TRANSDUCTION#0.8155;IDIOPATHIC PULMONARY FIBROSIS#0.8110;REPORTER GENE ASSAY#0.8086;DEDIFFERENTIATION#0.8085;TISSUE REMODELING#0.8082;DNASE I#0.8073;BREAST CANCER CELL#0.8073;B CELL#0.8070;PROLYL 4-HYDROXYLASE#0.8066;ADENOCARCINOMA#0.8063;ARGININE#0.8061;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8056;LIVER CIRRHOSIS#0.8031;ASPARTATE#0.8029;FIBROBLAST ACTIVATION#0.8010;SIGNALLING PATHWAY#0.7952;EMBRYONIC STEM CELL#0.7949;ODONTOBLAST DIFFERENTIATION#0.7946;ESTROGEN RECEPTOR ALPHA#0.7939;NEUTROPHIL#0.7935;NUCLEUS PULPOSUS CELL#0.7928;TOXICITY#0.7926;STRESS FIBER#0.7920;CYTOCHROME P450#0.7886;PROTEIN KINASE C#0.7885;COLLAGEN BIOSYNTHESIS#0.7880;BILE DUCT LIGATION#0.7878;IFN-GAMMA#0.7874;NITRIC OXIDE SYNTHASE#0.7873;KNEE JOINT#0.7852;1α,25-DIHYDROXYVITAMIN D3#0.7836;CERVICAL#0.7831;LIPID DROPLET#0.7817;LEUKOCYTE#0.7809;TOOTH DEVELOPMENT#0.7807;ENDOCHONDRAL OSSIFICATION#0.7789;72-HOURS#0.7788;ADIPOSE-DERIVED STEM CELL#0.7771;HEPATOCELLULAR CARCINOMA#0.7769;SCANNING ELECTRON MICROSCOPY#0.7746;ALIZARIN RED S#0.7743;LYSINE#0.7732;LEIOMYOMA#0.7729;SIGNALING MOLECULE#0.7725;S PHASE#0.7688;PERIOSTEUM#0.7688;CYTOTOXICITY#0.7644;ESTRADIOL#0.7632;COLLAGEN TYPE IV#0.7626;PRECURSOR CELL#0.7623;GENE SILENCING#0.7621;SYNOVIUM#0.7616;BONE MARROW CELLS#0.7611;TYROSINE KINASE INHIBITOR#0.7605;DIFFERENTIAL GENE EXPRESSION#0.7555;ELECTROPHORETIC MOBILITY SHIFT#0.7551;CHRONIC KIDNEY DISEASE#0.7535;OSTEOBLAST PROLIFERATION#0.7528;HEAT SHOCK PROTEIN#0.7521;ADIPOGENESIS#0.7480;RECEPTOR ANTAGONIST#0.7466;LYMPH NODE#0.7464;OBESE#0.7455;HYPOXIC#0.7445;COLLAGEN DEGRADATION#0.7445;LIPID METABOLISM#0.7401;ROS GENERATION#0.7393;DNA METHYLTRANSFERASE#0.7359;RIBOZYME#0.7324;IMMUNE CELL#0.7313;ONCOGENIC#0.7310;TRABECULAR BONE VOLUME#0.7309;PLURIPOTENT STEM CELL#0.7307;BONE FORMATION RATE#0.7307;MORPHOGENESIS#0.7290;KERATINOCYTE#0.7278;RHEUMATOID ARTHRITIS#0.7269;IMATINIB MESYLATE#0.7266;SOFT TISSUE SARCOMA#0.7257;CARDIOMYOPATHY#0.7247;HUMAN ARTICULAR CHONDROCYTES#0.7233;COLLAGEN TYPE V#0.7185;HYPOXIA INDUCIBLE FACTOR#0.7185;MAGNETIC RESONANCE IMAGING#0.7172;HYPEROSTOSIS#0.7171;LUNG DISEASE#0.7118;INDUCIBLE NITRIC OXIDE#0.7113;PREMATURE TERMINATION CODON#0.7093;MECHANISM OF ACTION#0.7090;TERMINAL DIFFERENTIATION#0.7089;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7066;CALCITONIN RECEPTOR#0.7059;CHONDROCYTE DIFFERENTIATION#0.7058;SKELETAL SYSTEM#0.7036;COLORECTAL CANCER#0.7032;DIABETES MELLITUS#0.7024;CARDIOMYOCYTE#0.7008;LUCIFERASE ACTIVITY#0.6980;MAP KINASE#0.6943;VERTEBRAE#0.6941;COLON CANCER#0.6939;CELL ADHESION MOLECULE#0.6932;GROWTH HORMONE#0.6926;NONALCOHOLIC FATTY LIVER DISEASE#0.6902;COLORECTAL#0.6899;GRADIENT GEL ELECTROPHORESIS#0.6875;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6855;INDUCED PLURIPOTENT STEM CELL#0.6834;METHIONINE#0.6829;TYPE 2 DIABETES#0.6829;POST-TRANSLATIONAL MODIFICATION#0.6814;DNASE#0.6814;PIRFENIDONE#0.6810;TOPICAL#0.6801;CROHN'S DISEASE#0.6794;MESANGIAL CELL#0.6737;EXTRACELLULAR MATRIX ORGANIZATION#0.6733;THYROID CANCER#0.6726;CELL COUNTING KIT#0.6724;FIBRILLIN#0.6717;PELVIC ORGAN PROLAPSE#0.6715;BETA-2#0.6696;GENETIC DISEASE#0.6624;MESENCHYME#0.6619;NEPHROPATHY#0.6616;TRANSMISSION ELECTRON MICROSCOPY#0.6594;CHOLINE#0.6590;THYROID CARCINOMA#0.6538;OSTEOBLAST DEVELOPMENT#0.6502;HIGH RESOLUTION MELTING#0.6495;GENETIC ASSOCIATION STUDIES#0.6491;MANDIBLE#0.6459;17β-ESTRADIOL#0.6458;CARRIE#0.6455;TRANSCRIPTIONAL CONTROL#0.6441;TUMOUR NECROSIS FACTOR#0.6440;HEPATOCYTE GROWTH FACTOR#0.6408;STROMA#0.6398;BASEMENT MEMBRANE#0.6396;HISTONE DEACETYLASE#0.6394;HUMAN PERIODONTAL LIGAMENT#0.6379;FIBROCYTE#0.6352;ALCOHOLIC FATTY LIVER#0.6327;BONE MORPHOGENIC PROTEIN#0.6320;HIPPO SIGNALING#0.6310;DIAPHRAGM#0.6307;RETINOL#0.6305;HYPERTROPHIC SCAR FIBROBLASTS#0.6288;VERTEBRA#0.6264;ENDOPLASMIC RETICULUM STRESS#0.6246;LIVER DAMAGE#0.6246;MYOCARDIUM#0.6210;HOMOLOGOUS RECOMBINATION#0.6196;SUPEROXIDE DISMUTASE#0.6188;ETHANOL#0.6148;VITAMIN A#0.6111;HIPPO SIGNALING PATHWAY#0.6100;TOLL LIKE RECEPTOR#0.6058;PROSTATE CANCER#0.6052;TUMOR SUPPRESSOR#0.6046;EPIDERMAL GROWTH FACTOR#0.6043;PROTEINURIA#0.6041;THYMIDINE#0.6028;BRUCK SYNDROME#0.6027
127829	CELL PERIPHERY#0.7370
127833	EXOCYTOSIS#1.0249;NEUROTRANSMITTER RELEASE#1.0213;NEUROTOXIN#1.0164;NERVE TERMINAL#1.0137;SYNAPTIC VESICLE#1.0088;PLASMA MEMBRANE#0.9683;SYNAPTIC VESICLE PROTEIN#0.9638;MAST CELL#0.9477;CALYX OF HELD#0.8890;VESICLE FUSION#0.8669;NEUROMUSCULAR JUNCTION#0.8159;MEMBRANE FUSION#0.8063;ENDOCYTOSIS#0.8011;RECEPTOR BINDING#0.7934;TOXIN BINDING#0.7927;PROTEIN KINASE#0.7754;GOLGI APPARATUS#0.7708;GENE EXPRESSION#0.7636;LUMINAL#0.7520;FOREBRAIN#0.7409;INHIBITORY SYNAPSE#0.7014;SYNAPTIC TRANSMISSION#0.6896;ACETYLCHOLINE#0.6604;REGULATED EXOCYTOSIS#0.6581;ENDOPLASMIC RETICULUM#0.6578;BONT/A#0.6283;CONGENITAL MYASTHENIC SYNDROME#0.6173;AMACRINE CELL#0.6107;SYNAPTOSOME#0.6054;NERVOUS SYSTEM#0.6041
127845	LUNG CANCER#0.7994;BREAST CANCER#0.7966
1278	DENTAL FLUOROSIS#1.0712;IFN-GAMMA#1.0432;MATRIX METALLOPROTEINASE 1#1.0320;ACID PHOSPHATASE#1.0226;TYPE III PROCOLLAGEN#1.0214;BINDING PROTEIN 3#1.0187;FRAGMENT LENGTH POLYMORPHISM#1.0157;EHLERS-DANLOS SYNDROME#1.0155;ALKALINE PHOSPHATASE#1.0137;PROSTATE CANCER#1.0082;COLLAGEN TYPE I#1.0080;PROLYL 4-HYDROXYLASE#1.0061;SMOOTH MUSCLE ACTIN#1.0060;BONE MORPHOGENETIC PROTEIN#1.0036;OSTEOGENESIS IMPERFECTA#1.0027;TISSUE GROWTH FACTOR#1.0020;CHONDROCYTE#1.0000;PARATHYROID HORMONE#0.9998;LUNG FIBROBLASTS#0.9998;PARATHYROID#0.9991;ALKALINE PHOSPHATASE ACTIVITY#0.9982;PHOSPHATASE ACTIVITY#0.9974;IGF BINDING#0.9971;MESANGIAL CELL#0.9971;OSTEOGENESIS#0.9957;HEPATIC STELLATE CELL#0.9937;BONE FORMATION#0.9934;EXCRETION#0.9928;COLLAGEN FORMATION#0.9919;TUMOR NECROSIS FACTOR#0.9910;HUMAN DERMAL FIBROBLAST#0.9902;QUANTITATIVE REAL TIME#0.9902;GLYCINE#0.9891;BLEOMYCIN#0.9879;MYOFIBROBLAST#0.9874;HYDROXYPROLINE#0.9869;DENTINOGENESIS IMPERFECTA#0.9867;COLLAGEN DEGRADATION#0.9853;DERMAL FIBROBLAST#0.9844;INSULIN-LIKE GROWTH FACTOR#0.9841;SKIN FIBROBLASTS#0.9833;SCLERODERMA#0.9828;SMOOTH MUSCLE#0.9827;TRANSFORMING GROWTH FACTOR BETA#0.9808;DNA BINDING#0.9803;BONE TURNOVER MARKER#0.9800;REVERSE TRANSCRIPTION#0.9800;COLLAGENASE#0.9797;FIBRILLAR COLLAGEN#0.9793;BONE RESORPTION#0.9791;FACTOR I#0.9791;BONE DISEASE#0.9785;T CELL#0.9783;COLLAGEN METABOLISM#0.9780;MESENCHYMAL CELL#0.9776;OSTEOBLAST#0.9771;SMOOTH MUSCLE CELL#0.9769;MUSCLE CELL#0.9763;POLYMERASE CHAIN REACTION#0.9762;ESTRADIOL#0.9758;TRANSCRIPTION FACTOR#0.9755;PROTEIN SYNTHESIS#0.9753;EPITHELIAL CELL#0.9751;PROTEOGLYCAN#0.9750;ENDOTHELIAL CELL#0.9734;CELL PROLIFERATION#0.9733;TRANSFORMING GROWTH FACTOR#0.9731;GROWTH FACTOR BINDING#0.9726;DERMIS#0.9718;COLLAGEN SYNTHESIS#0.9701;FEMUR#0.9700;GROWTH HORMONE#0.9700;BREAST CANCER#0.9699;DEXAMETHASONE#0.9698;PROSTATE SPECIFIC ANTIGEN#0.9696;FIBRIL#0.9696;DIGESTION#0.9694;HEARING LOSS#0.9693;DENTINOGENESIS#0.9693;WOUND HEALING#0.9679;MINERALIZATION#0.9676;GROWTH FACTOR#0.9675;SIGNALING PATHWAY#0.9671;PROTEIN KINASE#0.9665;ENDOPLASMIC RETICULUM#0.9663;MACROPHAGE#0.9656;GENE EXPRESSION#0.9649;RETINOIC ACID#0.9642;BONE REMODELING#0.9642;MARFAN SYNDROME#0.9625;BASEMENT MEMBRANE#0.9614;CONNECTIVE TISSUE#0.9613;COLLAGEN BIOSYNTHESIS#0.9611;STEM CELL#0.9603;POST-TRANSLATIONAL MODIFICATION#0.9601;OSTEOBLAST DIFFERENTIATION#0.9595;MYOCARDIAL INFARCTION#0.9590;MITOGEN ACTIVATED PROTEIN#0.9574;MESENCHYMAL STEM CELL#0.9566;INTRACRANIAL ANEURYSM#0.9565;BONE MARROW#0.9561;EXTRACELLULAR MATRIX COMPONENT#0.9560;TESTOSTERONE#0.9560;OSTEOPOROSIS#0.9558;APOPTOSIS#0.9549;BONE MINERAL DENSITY#0.9539;PULMONARY FIBROSIS#0.9528;EXTRACELLULAR MATRIX#0.9521;LOW BONE MASS#0.9510;SMAD BINDING#0.9493;CHLORAMPHENICOL#0.9486;REGENERATION#0.9484;SODIUM DODECYL SULFATE#0.9482;DODECYL SULFATE#0.9481;OSTEOCLAST#0.9478;TRANSCRIPTASE#0.9478;FOCAL ADHESION#0.9478;STROMAL CELL#0.9459;CELL GROWTH#0.9423;CELL ADHESION#0.9421;GENETIC DISORDER#0.9421;REACTIVE OXYGEN SPECIES#0.9416;HYPERTENSION#0.9399;FIBROBLAST PROLIFERATION#0.9393;SIGNAL TRANSDUCTION#0.9380;CANCER CELL#0.9324;ASCORBIC ACID#0.9320;ACTIVATOR PROTEIN 1#0.9308;HYALURONAN#0.9301;PRO-INFLAMMATORY#0.9291;PROTEIN PROTEIN INTERACTION#0.9256;FIBROBLAST GROWTH FACTOR#0.9232;BONE MINERALIZATION#0.9212;BLOOD VESSEL#0.9212;TOPICAL#0.9166;C REACTIVE PROTEIN#0.9161;BONE CELLS#0.9127;ARGININE#0.9114;OSSIFICATION#0.9091;TRANSCRIPTIONAL CONTROL#0.9089;PLATELET-DERIVED GROWTH FACTOR#0.9060;THYMIDINE#0.9058;ARTERY#0.9058;VASCULAR SMOOTH MUSCLE CELL#0.9057;DNA METHYLATION#0.9044;STROMA#0.9000;INFLAMMATORY CELL#0.8987;INFLAMMATORY RESPONSE#0.8980;KERATINOCYTE#0.8975;VERTEBRAE#0.8971;CELL CYCLE#0.8969;TIBIA#0.8965;VITAMIN D RECEPTOR#0.8964;SKELETON#0.8962;GROWTH FACTOR RECEPTOR#0.8959;INFLAMMATORY BOWEL DISEASE#0.8927;MAP KINASE#0.8920;ETHANOL#0.8901;BETA-2#0.8879;BETA GALACTOSIDASE#0.8836;COLLAGEN TYPE III#0.8832;HEAT SHOCK PROTEIN#0.8831;RHEUMATOID ARTHRITIS#0.8816;CYSTIC FIBROSIS#0.8814;OVARIAN#0.8809;FOREARM#0.8785;QUANTITATIVE REVERSE TRANSCRIPTION#0.8774;OSTEOARTHRITIS#0.8756;CELL SURFACE#0.8745;KINASE INHIBITOR#0.8720;1α,25-DIHYDROXYVITAMIN D3#0.8705;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8692;ALANINE#0.8686;HYPERPARATHYROIDISM#0.8670;LIVER DISEASE#0.8655;CORTISOL#0.8654;ACUTE MYOCARDIAL INFARCTION#0.8623;ATHEROSCLEROTIC#0.8603;HORMONE BINDING#0.8595;HYPOXIA#0.8486;ESTROGEN RECEPTOR#0.8437;TRANSACTIVATION#0.8428;MAST CELL#0.8424;COLLAGEN TYPE II#0.8401;LYSINE#0.8394;VITAMIN D3#0.8384;INTERSTITIAL CELL#0.8372;RECEPTOR ACTIVATOR#0.8366;DIABETES MELLITUS#0.8346;DNA SYNTHESIS#0.8331;BONE REMODELLING#0.8331;EPIDERMAL GROWTH FACTOR#0.8301;SCOLIOSIS#0.8280;ENDOTHELIAL GROWTH FACTOR#0.8271;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8271;MYOCARDIUM#0.8255;DNASE I#0.8248;POSTTRANSLATIONAL MODIFICATION#0.8239;ASCORBATE#0.8226;CYTOPLASM#0.8214;MRNA SYNTHESIS#0.8126;ELECTROPHORETIC MOBILITY SHIFT#0.8118;DIABETIC NEPHROPATHY#0.8068;PERIPHERAL BLOOD#0.8059;ALIZARIN RED STAINING#0.8034;COLORECTAL CANCER#0.8029;LYMPH NODE#0.8015;OVARIAN CANCER#0.8009;TISSUE REMODELING#0.7957;COLORECTAL#0.7931;NEPHROPATHY#0.7919;HEPARIN#0.7914;FIBRILLIN#0.7898;ANGIOGENESIS#0.7886;ENZYME ACTIVITY#0.7872;OTHER COLLAGEN#0.7863;COLLAGEN BREAKDOWN#0.7831;MONOCYTE#0.7803;TRANSMISSION ELECTRON MICROSCOPY#0.7798;PERIODONTAL LIGAMENT#0.7776;KIDNEY DISEASE#0.7774;CELL DIFFERENTIATION#0.7768;GESTATION#0.7765;ADIPOCYTE#0.7761;ADENOCARCINOMA#0.7759;PRIMARY HYPERPARATHYROIDISM#0.7716;PROTEIN COMPLEX#0.7703;LEUKOCYTE#0.7680;MECHANISM OF ACTION#0.7674;BREAST CANCER PATIENTS#0.7662;PUBERTY#0.7624;HIGH BONE MASS#0.7582;ROUGH ENDOPLASMIC RETICULUM#0.7569;HEMORRHAGE#0.7560;QUANTITATIVE COMPUTED TOMOGRAPHY#0.7541;PROTEINASE ACTIVITY#0.7534;BONE FORMATION RATE#0.7521;PROTEIN KINASE C#0.7509;TYPE II PNEUMOCYTE#0.7492;ONE ALPHA#0.7489;TOXICITY#0.7476;ASPARTATE#0.7468;LOW DENSITY LIPOPROTEIN#0.7459;TAMOXIFEN#0.7417;TERIPARATIDE#0.7413;GENE EXPRESSION OMNIBUS#0.7389;SKELETAL DEVELOPMENT#0.7376;SCAVENGER RECEPTOR#0.7362;DNASE#0.7284;ATHEROSCLEROSIS#0.7259;EOSIN#0.7246;GALECTIN#0.7239;MENOPAUSE#0.7239;ERYTHROCYTE#0.7216;PULMONARY HYPERTENSION#0.7209;AKT SIGNALING#0.7187;MUTAGENESIS#0.7176;EXTRACELLULAR MATRIX ORGANIZATION#0.7156;HYALURONIC ACID#0.7147;RECEPTOR ANTAGONIST#0.7142;PAGET'S DISEASE OF BONE#0.7116;COLON CANCER#0.7106;ASPARTIC ACID#0.7087;CORNEAL ENDOTHELIAL CELL#0.7084;PULMONARY ARTERY#0.7077;MOLAR#0.7064;OTOSCLEROSIS#0.7054;FIBROBLAST ACTIVATION#0.7045;HEPATOCELLULAR CARCINOMA#0.7029;SQUAMOUS CELL CARCINOMA#0.7027;RNA SPLICING#0.7018;HYPERTROPHIC SCAR FIBROBLASTS#0.6979;LUCIFERASE ACTIVITY#0.6975;GLUTATHIONE#0.6949;CHRONIC KIDNEY DISEASE#0.6944;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6941;MOUSE MESANGIAL CELLS#0.6932;AORTIC ANEURYSM#0.6931;COLLAGENASE ACTIVITY#0.6928;CHONDROGENESIS#0.6882;CONNECTIVE TISSUE DISEASE#0.6879;COLITIS#0.6874;TUMOUR NECROSIS FACTOR#0.6873;MAGNETIC RESONANCE IMAGING#0.6844;HISTONE ACETYLTRANSFERASE#0.6839;ADIPOCYTE DIFFERENTIATION#0.6825;PREDNISONE#0.6823;VALINE#0.6821;TUMOR TISSUES#0.6802;CRUCIATE LIGAMENT#0.6743;SERUM ALBUMIN#0.6722;BRUCK SYNDROME#0.6716;GENE SILENCING#0.6715;LIVER CIRRHOSIS#0.6702;PROTEIN BINDING#0.6693;LUNG DISEASE#0.6693;PROSTATE CARCINOMA#0.6682;BRAIN NATRIURETIC PEPTIDE#0.6672;CELL ADHESION MOLECULE#0.6670;CARDIOMYOPATHY#0.6668;ADIPOSE TISSUE#0.6657;CELL MIGRATION#0.6655;SKELETAL MUSCLE#0.6651;MYOFIBROBLAST DIFFERENTIATION#0.6639;VITAMIN D DEFICIENCY#0.6568;72-HOURS#0.6548;NEUTROPHIL#0.6547;RETICULOCYTE#0.6535;CROHN'S DISEASE#0.6534;MULTIPLE MYELOMA#0.6527;MECHANISMS OF ACTION#0.6505;MESENCHYMAL STROMAL CELL#0.6445;ALL TRANS RETINOIC ACID#0.6431;REGULATION OF COLLAGEN SYNTHESIS#0.6423;MULTIPLE REGRESSION ANALYSIS#0.6423;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6416;CALLUS FORMATION#0.6394;B CELL#0.6387;LEUCINE#0.6387;SUPEROXIDE DISMUTASE#0.6364;LEFT VENTRICULAR REMODELING#0.6334;SMAD BINDING ELEMENT#0.6320;AORTIC VALVE#0.6278;AUTOPHAGY#0.6252;ALENDRONATE#0.6241;GLOBIN#0.6235;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6227;ANTERIOR CRUCIATE LIGAMENT#0.6215;PROGENITOR CELL#0.6193;AORTIC SMOOTH MUSCLE CELLS#0.6167;OSTEOCYTE#0.6164;CLODRONATE#0.6151;AGEING#0.6139;OBESE#0.6135;VENOUS BLOOD#0.6124;ALPHA 1-ANTITRYPSIN#0.6124;ULCERATIVE COLITIS#0.6119;PAMIDRONATE#0.6072;WEIGHT GAIN#0.6070;LUNG CANCER#0.6066;FACTOR XIIIA#0.6051;LUNG DEVELOPMENT#0.6021;USUAL INTERSTITIAL PNEUMONIA#0.6007
127933	PROTEIN KINASE#1.0238;CELL CYCLE#1.0048;GENE EXPRESSION#0.9327;CELL PROLIFERATION#0.7452;RNA RECOGNITION MOTIF#0.6352;CELL CYCLE REGULATOR#0.6249;C TERMINAL DOMAIN#0.6143
127943	B CELL#1.0520;GERMINAL CENTER B CELL#0.6825;GERMINAL CENTER B#0.6821;GERMINAL CENTER#0.6735;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6589;LYMPHOCYTIC LEUKEMIA#0.6580
1279	SMOOTH MUSCLE CELL#1.1842;MUSCLE CELL#1.1831;SMOOTH MUSCLE#1.1814
127	ADH-1#1.0962;ETHANOL#0.9642;PYRAZOLE#0.7585;ALCOHOL DEPENDENCE#0.7227;RETINOL#0.7179;RETINOIC ACID#0.6378
128077	CELL CYCLE#0.7437;CELL PROLIFERATION#0.7427;CANCER CELL#0.6452
1280	STICKLER SYNDROME#1.0388;COLLAGEN TYPE II#1.0327;MATRIX METALLOPROTEINASE 13#1.0318;COLLAGEN TYPE I#1.0136;REVERSE TRANSCRIPTION#1.0066;HIGH MOBILITY GROUP#1.0065;QUANTITATIVE REAL TIME#1.0041;GLYCINE#1.0033;RETINAL DETACHMENT#1.0010;SKELETAL DEVELOPMENT#1.0008;CHONDROCYTE PROLIFERATION#0.9986;CARTILAGE DEVELOPMENT#0.9980;MENISCUS#0.9965;CHONDROCYTE HYPERTROPHY#0.9905;FRAGMENT LENGTH POLYMORPHISM#0.9904;POLYMERASE CHAIN REACTION#0.9898;HYPOXIA#0.9888;CHONDROCYTE DIFFERENTIATION#0.9875;ACHONDROGENESIS#0.9863;CARTILAGE FORMATION#0.9845;CLEFT PALATE#0.9822;NITRIC OXIDE#0.9821;CHONDROCYTE#0.9818;BONE MORPHOGENETIC PROTEIN#0.9809;ENDOCHONDRAL OSSIFICATION#0.9789;PROTEOGLYCAN#0.9787;CHONDROGENESIS#0.9771;NOTOCHORD#0.9770;APOPTOSIS#0.9767;ALKALINE PHOSPHATASE#0.9766;GENE EXPRESSION#0.9766;OSSIFICATION#0.9758;HUMAN ARTICULAR CHONDROCYTES#0.9755;CHONDROGENIC CELL#0.9751;TRANSCRIPTION FACTOR#0.9743;OSTEOBLAST#0.9743;INTERVERTEBRAL DISC#0.9743;NUCLEUS PULPOSUS#0.9740;KNEE JOINT#0.9740;CELL PROLIFERATION#0.9731;TRANSFORMING GROWTH FACTOR#0.9718;MESENCHYMAL CELL#0.9708;BONE FORMATION#0.9707;OSTEOGENESIS#0.9686;EXTRACELLULAR MATRIX#0.9671;GROWTH FACTOR#0.9655;FIBROBLAST GROWTH FACTOR#0.9655;SIGNALING PATHWAY#0.9635;TUMOR NECROSIS FACTOR#0.9626;CONNECTIVE TISSUE#0.9610;PROTEIN KINASE#0.9610;OSTEOARTHRITIS#0.9595;PREMATURE TERMINATION CODON#0.9591;BONE MARROW#0.9578;FIBRIL#0.9578;DNA BINDING#0.9564;HEARING LOSS#0.9548;STROMAL CELL#0.9533;HUMAN MESENCHYMAL STEM#0.9527;REGENERATION#0.9517;SKELETON#0.9492;MESENCHYMAL STEM CELL#0.9473;FIBRILLAR COLLAGEN#0.9461;STEM CELL#0.9446;PROGENITOR CELL#0.9356;OSTEOARTHRITIC CARTILAGE#0.9356;BONE DEVELOPMENT#0.9331;MESENCHYME#0.9320;CHONDROSARCOMA#0.9319;HYPOXIA INDUCIBLE FACTOR#0.9315;SPONDYLOEPIMETAPHYSEAL DYSPLASIA#0.9307;DEDIFFERENTIATION#0.9296;INTERVERTEBRAL DISC DEGENERATION#0.9276;ENDOPLASMIC RETICULUM#0.9227;PARATHYROID HORMONE#0.9182;CELL DIFFERENTIATION#0.9180;PRO-INFLAMMATORY#0.9171;NUCLEUS PULPOSUS CELL#0.9170;HYPOXIC#0.9150;SYNOVIAL FLUID#0.9141;NEURAL CREST#0.9132;MINERALIZATION#0.9049;TRANSFORMING GROWTH FACTOR BETA#0.9024;ARGININE#0.8986;APOPTOTIC#0.8974;QUANTITATIVE REVERSE TRANSCRIPTION#0.8917;TRANSACTIVATION#0.8907;ADIPOSE TISSUE#0.8796;CARTILAGE HOMEOSTASIS#0.8712;INSULIN-LIKE GROWTH FACTOR#0.8708;MITOGEN ACTIVATED PROTEIN#0.8681;PROTEIN SYNTHESIS#0.8670;COLLAGENASE#0.8645;COLLAGEN SYNTHESIS#0.8636;CRUCIATE LIGAMENT#0.8547;PARATHYROID#0.8542;FEMUR#0.8495;MESENCHYMAL STROMAL CELL#0.8457;BONE GROWTH#0.8363;CELL CYCLE#0.8352;ANTERIOR CRUCIATE LIGAMENT#0.8301;RETINOIC ACID#0.8225;GROWTH FACTOR RECEPTOR#0.8171;MORPHOGENESIS#0.8078;TRANSCRIPTASE#0.8054;HYALURONIC ACID#0.8015;HIP JOINT#0.7888;INDUCIBLE NITRIC OXIDE#0.7776;ENHANCER BINDING#0.7764;L-RHAMNOSE#0.7717;VITAMIN D RECEPTOR#0.7671;GRADIENT GEL ELECTROPHORESIS#0.7596;RHAMNOSE BINDING#0.7561;DIGESTION#0.7543;SYNOVIUM#0.7531;CELL DEATH#0.7518;ADIPOSE-DERIVED STEM CELL#0.7432;SIGNALING MOLECULE#0.7431;INFLAMMATORY RESPONSE#0.7395;CERVICAL#0.7338;ACHONDROPLASIA#0.7303;BONE MARROW STROMAL#0.7262;OSTEOBLAST DIFFERENTIATION#0.7261;IFN-GAMMA#0.7252;TERMINAL DIFFERENTIATION#0.7251;ANNULUS FIBROSUS#0.7250;CAMPOMELIC DYSPLASIA#0.7243;CARTILAGE DISEASE#0.7159;NITRIC OXIDE SYNTHASE#0.7135;ENDOTHELIAL GROWTH FACTOR#0.7128;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7128;GLYCEROL TRANSPORT#0.7041;LECTIN#0.7032;BONE MARROW STROMAL CELL#0.7024;WNT SIGNALING PATHWAY#0.7019;HYALURONAN#0.6989;MULTIPLE EPIPHYSEAL DYSPLASIA#0.6958;NERVOUS SYSTEM#0.6947;LIMB DEVELOPMENT#0.6946;MARROW STROMAL CELLS#0.6930;PLASMA MEMBRANE#0.6875;NORMAL CONTROL GROUP#0.6868;IL-1RA#0.6856;COCHLEA#0.6804;ANNULUS#0.6792;PERIPHERAL BLOOD#0.6784;OTIC CAPSULE#0.6725;BONE MINERAL DENSITY#0.6719;FACTOR I#0.6699;NEOCARTILAGE#0.6696;RHEUMATOID ARTHRITIS#0.6693;BRACHYDACTYLY#0.6682;REACTIVE OXYGEN SPECIES#0.6676;SCOLIOSIS#0.6655;SKELETAL SYSTEM#0.6643;CENTRAL NERVOUS SYSTEM#0.6605;SIGNALLING PATHWAY#0.6604;MACROPHAGE#0.6592;TIBIA#0.6580;LEUKOCYTE#0.6578;NONSENSE MEDIATED DECAY#0.6573;PROTEOGLYCAN SYNTHESIS#0.6560;BLOOD VESSEL#0.6537;SHORT TANDEM REPEAT#0.6522;CELL GROWTH#0.6516;EXTRACELLULAR MATRIX COMPONENT#0.6492;VERTEBRAE#0.6488;ENHANCER BINDING PROTEIN#0.6469;ANGIOGENESIS#0.6443;CELL ADHESION#0.6387;OSTEONECROSIS#0.6383;AUTOLOGOUS CHONDROCYTE IMPLANTATION#0.6236;GESTATION#0.6224;DIASTROPHIC DYSPLASIA#0.6209;OSTEOCHONDRODYSPLASIA#0.6207;IMMUNE RESPONSE#0.6200;SENESCENCE#0.6184;OSTEOCLAST#0.6183;SENSORINEURAL HEARING LOSS#0.6173;CONGENITAL TOXOPLASMOSIS#0.6153;FLOOR PLATE#0.6134;CYCLIC TENSILE STRAIN#0.6116;PRECURSOR CELL#0.6114;PHOSPHATASE ACTIVITY#0.6114;GROWTH HORMONE#0.6113;TRANSMISSION ELECTRON MICROSCOPY#0.6111;HISTONE DEACETYLASE#0.6102;LOW BACK PAIN#0.6074;SIGNAL TRANSDUCTION#0.6071;SUGAR TRANSPORTER#0.6065;T CELL#0.6043;GENE LOOPING#0.6012
128153	SPERMATOGENESIS#0.9152;APOPTOSIS#0.9076;GERM CELL#0.6305
128178	HYPOHIDROTIC ECTODERMAL DYSPLASIA#1.0426;ECTODERMAL DYSPLASIA#1.0346;SWEAT GLAND#0.9531;TOOTH AGENESIS#0.9470;SIGNALING PATHWAY#0.9291;NF-KAPPAB ACTIVATION#0.8271;HAIR FOLLICLE#0.8054;TUMOR NECROSIS FACTOR#0.7116;TOOTH DEVELOPMENT#0.6898;DNA METHYLATION#0.6477;MORPHOGENESIS#0.6005
1281	COLLAGEN TYPE III#1.0577;TYPE III PROCOLLAGEN#1.0552;PELVIC ORGAN PROLAPSE#1.0292;COLLAGEN TYPE I#1.0246;TISSUE GROWTH FACTOR#1.0228;EHLERS-DANLOS SYNDROME#1.0226;SMOOTH MUSCLE ACTIN#1.0160;REVERSE TRANSCRIPTION#1.0076;AORTIC ANEURYSM#1.0073;CERVICAL ARTERY DISSECTION#1.0022;POLYMERASE CHAIN REACTION#1.0002;FIBRILLAR COLLAGEN#1.0000;HYDROXYPROLINE#0.9965;HEPATIC STELLATE CELL#0.9965;LUNG FIBROBLASTS#0.9952;SMOOTH MUSCLE#0.9929;SKIN FIBROBLASTS#0.9928;DERMAL FIBROBLAST#0.9927;ALKALINE PHOSPHATASE#0.9879;QUANTITATIVE REAL TIME#0.9871;COLLAGEN SYNTHESIS#0.9866;CONNECTIVE TISSUE#0.9863;GLYCINE#0.9855;TRANSFORMING GROWTH FACTOR BETA#0.9838;TRANSCRIPTION FACTOR#0.9821;TRANSFORMING GROWTH FACTOR#0.9806;OSTEOBLAST#0.9801;GROWTH FACTOR#0.9799;FOCAL ADHESION#0.9781;ENDOTHELIAL GROWTH FACTOR#0.9761;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9761;CELL PROLIFERATION#0.9734;SIGNALING PATHWAY#0.9729;MYOFIBROBLAST#0.9722;STEM CELL#0.9700;WOUND HEALING#0.9687;GENE EXPRESSION#0.9683;ARTERY#0.9659;PROTEIN KINASE#0.9654;MUSCLE CELL#0.9645;EXTRACELLULAR MATRIX#0.9638;SMOOTH MUSCLE CELL#0.9636;FIBRIL#0.9609;EXTRACELLULAR MATRIX COMPONENT#0.9606;BLOOD VESSEL#0.9592;MACROPHAGE#0.9582;CELL ADHESION#0.9550;CHONDROCYTE#0.9466;APOPTOSIS#0.9400;BASEMENT MEMBRANE#0.9395;CELL CYCLE#0.9381;PROTEIN PROTEIN INTERACTION#0.9264;FIBROBLAST GROWTH FACTOR#0.9214;OSTEOGENESIS IMPERFECTA#0.9181;MESENCHYMAL STEM CELL#0.9156;BLEOMYCIN#0.9100;CERVICAL#0.9080;CELL MIGRATION#0.9027;OSTEOGENESIS#0.8989;TRANSCRIPTASE#0.8985;CELL GROWTH#0.8926;PROTEIN SYNTHESIS#0.8881;EPITHELIAL CELL#0.8814;COLLAGENASE#0.8787;HUMAN DERMAL FIBROBLAST#0.8786;SKELETAL MUSCLE#0.8772;MARFAN SYNDROME#0.8734;FIBROBLAST PROLIFERATION#0.8684;REGENERATION#0.8683;ENDOTHELIAL CELL#0.8675;STROMAL CELL#0.8621;PULMONARY FIBROSIS#0.8620;BONE MARROW#0.8536;FRAGMENT LENGTH POLYMORPHISM#0.8523;MATRIX METALLOPROTEINASE 1#0.8489;DERMIS#0.8428;MONOCYTE#0.8402;HEMORRHAGE#0.8288;TUMOR NECROSIS FACTOR#0.8253;UTERUS#0.8252;PROTEIN INTERACTION NETWORK#0.8251;ANGIOGENESIS#0.8233;INSULIN-LIKE GROWTH FACTOR#0.8199;FIBRILLIN#0.8111;INTRACRANIAL ANEURYSM#0.8106;GLUTAMIC ACID#0.8094;PROTEIN KINASE C#0.8053;MITOGEN ACTIVATED PROTEIN#0.8049;PRO-INFLAMMATORY#0.7919;RENAL FIBROSIS#0.7899;STROMA#0.7885;MESANGIAL CELL#0.7869;MAPK SIGNALING#0.7851;HYPERTENSION#0.7814;SIGNAL TRANSDUCTION#0.7803;INFLAMMATORY RESPONSE#0.7802;DIGESTION#0.7776;BONE FORMATION#0.7763;THORACIC AORTIC ANEURYSM#0.7753;DNA BINDING#0.7740;PERIPHERAL BLOOD#0.7736;CELL ADHESION MOLECULE#0.7648;OVARIAN#0.7587;PROTEOGLYCAN#0.7571;PLATELET-DERIVED GROWTH FACTOR#0.7456;HIGH FAT DIET#0.7441;ENDOPLASMIC RETICULUM#0.7429;LOEYS-DIETZ SYNDROME#0.7425;GENETIC DISORDER#0.7412;MATRIX METALLOPROTEINASE 13#0.7359;BONE MORPHOGENETIC PROTEIN#0.7336;CONNECTIVE TISSUE DISEASE#0.7313;MYOCARDIAL INFARCTION#0.7312;CORONARY ARTERY#0.7286;SCLERODERMA#0.7254;LUNG DISEASE#0.7248;VASCULAR SMOOTH MUSCLE CELL#0.7234;TISSUE REMODELING#0.7151;DEXAMETHASONE#0.7149;ADIPOSE TISSUE#0.7126;MESENCHYMAL CELL#0.7124;QUANTITATIVE REVERSE TRANSCRIPTION#0.7123;CRUCIATE LIGAMENT#0.7094;OSTEOARTHRITIS#0.7075;DNASE I#0.7074;GENE EXPRESSION OMNIBUS#0.7056;URETERAL OBSTRUCTION#0.7024;RNA INTERFERENCE#0.7015;HYALURONAN SYNTHASE#0.7003;MINERALIZATION#0.6983;EXTRACELLULAR MATRIX ORGANIZATION#0.6914;CHLORAMPHENICOL#0.6896;OSTEOBLAST DIFFERENTIATION#0.6889;ANTERIOR CRUCIATE LIGAMENT#0.6836;MYOCARDIUM#0.6834;CELL DIFFERENTIATION#0.6826;RETINOIC ACID#0.6816;CHONDROGENESIS#0.6762;PROTEIN BINDING#0.6742;ADENOCARCINOMA#0.6737;T CELL#0.6667;KIDNEY DISEASE#0.6613;FACTOR I#0.6555;UNILATERAL URETERAL OBSTRUCTION#0.6550;LIVER DISEASE#0.6532;KNEE JOINT#0.6511;REPORTER GENE ASSAY#0.6481;SIGNALING MOLECULE#0.6448;TYPE 2 DIABETES#0.6408;NITRIC OXIDE#0.6405;SKELETAL DEVELOPMENT#0.6354;HYALURONAN#0.6342;ELECTROPHORETIC MOBILITY SHIFT#0.6338;VASCULAR DISEASE#0.6276;COLLAGEN TYPE II#0.6239;HYPOXIA#0.6238;BINDING PROTEIN 1#0.6217;DUAL LUCIFERASE REPORTER#0.6198;HYPERTROPHIC SCAR FIBROBLASTS#0.6177;COLLAGEN BIOSYNTHESIS#0.6114;DNASE#0.6113;IDIOPATHIC PULMONARY FIBROSIS#0.6055
128209	ZINC FINGER PROTEIN#1.0601;BREAST CANCER#1.0495;CANCER CELL#1.0297;TRANSCRIPTION FACTOR#0.9949;DNA BINDING#0.9764;BREAST CANCER CELL#0.9662;EPITHELIAL MESENCHYMAL TRANSITION#0.9649;CELL PROLIFERATION#0.9345;GENE EXPRESSION#0.9342;APOPTOSIS#0.9191;CELL CYCLE#0.8808;SIGNALING PATHWAY#0.8764;LYMPH NODE#0.8055;TUMOR NECROSIS FACTOR#0.7662;LUNG ADENOCARCINOMA#0.7626;B CELL#0.7525;TUMOR SUPPRESSOR#0.7343;CELL DEATH#0.7254;EPITHELIAL CELL#0.7125;POLYMERASE CHAIN REACTION#0.6928;CELL GROWTH#0.6828;LYMPH NODE METASTASIS#0.6807;CELL CYCLE ARREST#0.6635;STEM CELL#0.6330;ADENOCARCINOMA#0.6297;GROWTH FACTOR#0.6180;MCP-1 PRODUCTION#0.6154;HEPATOCELLULAR CARCINOMA#0.6117
128239	CANCER CELL#0.9679;HEPATOCELLULAR CARCINOMA#0.9512;CELL PROLIFERATION#0.9405;COLORECTAL CANCER#0.7673;COLORECTAL#0.6567;RNA INTERFERENCE#0.6329;BREAST CANCER CELL#0.6303;BREAST CANCER#0.6260;HEMATURIA#0.6224;EPITHELIAL CELL#0.6194;ACTOMYOSIN RING#0.6093
128240	APOLIPOPROTEIN A-I BINDING#1.1719;CHOLESTEROL EFFLUX#1.1235;LIPID RAFT#1.0643;MACROPHAGE#1.0101;ENDOTHELIAL CELL#0.9173;ANGIOGENESIS#0.9104;CHOLESTEROL TRANSPORT#0.8597;ATHEROSCLEROSIS#0.8239;HIGH DENSITY LIPOPROTEIN#0.7428;REVERSE CHOLESTEROL TRANSPORT#0.6741;FOAM CELL FORMATION#0.6470
128272	NUCLEOTIDE EXCHANGE FACTOR#0.7113;ADIPOCYTE DIFFERENTIATION#0.6386;MAPK SIGNALING#0.6335;LUNG CANCER#0.6234;RHOGEF#0.6066
1282	PORENCEPHALY#1.0846;COLLAGEN TYPE IV#1.0641;SMALL VESSEL DISEASE#1.0585;HEMORRHAGE#1.0451;ENDOTHELIAL CELL#1.0328;BASEMENT MEMBRANE#1.0153;GROWTH FACTOR#1.0102;ANGIOGENESIS#1.0085;LEUKOENCEPHALOPATHY#0.9955;NEPHROPATHY#0.9900;TRANSFORMING GROWTH FACTOR#0.9889;EXTRACELLULAR MATRIX#0.9832;ANTERIOR SEGMENT DYSGENESIS#0.9782;CANCER CELL#0.9715;GENE EXPRESSION#0.9697;MYOPATHY#0.9690;POLYMERASE CHAIN REACTION#0.9617;SIGNALING PATHWAY#0.9577;MESANGIAL CELL#0.9516;ARTERY#0.9512;CORONARY ARTERY#0.9343;HEMORRHAGIC#0.9266;APOPTOSIS#0.9229;SMOOTH MUSCLE#0.9200;ARTERY DISEASE#0.9119;CORONARY ARTERY DISEASE#0.8935;CEREBROVASCULAR DISEASE#0.8932;GLYCINE#0.8895;MUSCLE CELL#0.8841;CELL PROLIFERATION#0.8831;KIDNEY DISEASE#0.8769;TRANSFORMING GROWTH FACTOR BETA#0.8691;FOCAL ADHESION#0.8589;INTRACRANIAL ANEURYSM#0.8587;SMOOTH MUSCLE CELL#0.8463;REVERSE TRANSCRIPTION#0.8265;CEREBRAL HEMORRHAGE#0.8187;HYPERTENSION#0.8161;COLLAGEN TYPE I#0.8069;MYOCARDIAL INFARCTION#0.8019;EPILEPSY#0.8014;EPITHELIAL CELL#0.7970;TRANSCRIPTION FACTOR#0.7929;PROTEIN PROTEIN INTERACTION#0.7648;DIABETIC NEPHROPATHY#0.7626;INVASIVE DUCTAL CARCINOMA#0.7606;STEM CELL#0.7596;CEREBRAL PALSY#0.7236;CELL MIGRATION#0.7049;CELL ADHESION#0.7029;GENE EXPRESSION OMNIBUS#0.7024;QUANTITATIVE REAL TIME#0.6899;SQUAMOUS CELL CARCINOMA#0.6888;DEVELOPMENTAL DELAY#0.6879;LUNG CANCER#0.6870;COLORECTAL CANCER#0.6544;CONNECTIVE TISSUE#0.6515;MAGNETIC RESONANCE IMAGING#0.6379;TUMOR SUPPRESSOR#0.6274;COLORECTAL#0.6264;APOPTOTIC#0.6247;CREATINE KINASE#0.6234;WOUND HEALING#0.6170;SINGLE NUCLEOTIDE VARIANTS#0.6042;TUMOR NECROSIS FACTOR#0.6005
128338	AUTOPHAGY#1.0538;CELL DEATH#0.6581
128344	CILIOGENESIS#0.9558;PRIMARY CILIUM#0.9306;BASAL BODY#0.9074;CILIUM#0.8953;MICROTUBULE#0.8953;CENTROSOME#0.8493;PALATE DEVELOPMENT#0.8036;ORGANELLE#0.7981;CELL CYCLE#0.7977;CELL PROLIFERATION#0.7045;CENTRIOLAR SATELLITE#0.6753;CENTRIOLE#0.6605;CELL DIVISION#0.6263;INTRAFLAGELLAR TRANSPORT#0.6179;CELL MIGRATION#0.6085;KINESIN#0.6006
128408	TRANSCRIPTASE#0.9763;BIPOLAR CELL#0.9420;HUMAN IMMUNODEFICIENCY VIRUS#0.9339;TRANSCRIPTION FACTOR#0.9295;BETA-2#0.9236;NICOTINIC ACETYLCHOLINE RECEPTOR#0.8571;MUTAGENESIS#0.8548;ACETYLCHOLINE RECEPTOR#0.8547;ACETYLCHOLINE#0.7798;RNA BINDING#0.7154;DNASE I#0.6902;SIGNAL TRANSDUCTION#0.6664;OOCYTE#0.6584;GENE EXPRESSION#0.6571;CHEMICAL SHIFT PERTURBATION#0.6548;DRUG RESISTANCE#0.6232
128486	LIPID DROPLET#1.0249;ENDOPLASMIC RETICULUM#0.8905;LIPID DROPLET FORMATION#0.8784;SKELETAL MUSCLE#0.7033;GENE EXPRESSION#0.6343;ADIPOSE TISSUE#0.6159;ADIPOCYTE#0.6117
128497	AZOOSPERMIA#0.8631;SPERMATOCYTES#0.8602;SPERMATOGENESIS#0.8550
1284	COLLAGEN TYPE IV#1.0706;ANGIOGENESIS#1.0345;ENDOTHELIAL CELL#1.0314;APOPTOSIS#1.0176;BASEMENT MEMBRANE#1.0105;EXTRACELLULAR MATRIX#0.9828;HEMORRHAGE#0.9761;CELL PROLIFERATION#0.9750;GROWTH FACTOR#0.9653;GENE EXPRESSION#0.9647;SMALL VESSEL DISEASE#0.9533;PORENCEPHALY#0.9282;MYOCARDIAL INFARCTION#0.9223;CANCER CELL#0.9163;HYPOXIA#0.8807;SIGNALING PATHWAY#0.8662;CORONARY ARTERY#0.8612;CELL ADHESION#0.8438;FOCAL ADHESION#0.8369;ARTERY#0.8300;ENDOTHELIAL CELL PROLIFERATION#0.8142;POLYMERASE CHAIN REACTION#0.8009;ARTERY DISEASE#0.7923;T CELL#0.7914;HUMAN UMBILICAL VEIN#0.7914;UMBILICAL VEIN#0.7911;CORONARY ARTERY DISEASE#0.7775;CEREBROVASCULAR DISEASE#0.7740;CARDIOMYOCYTE#0.7560;PANCREATIC CANCER#0.7531;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7303;TUMOR CELLS#0.7287;BREAST CANCER#0.7081;TRANSCRIPTION FACTOR#0.7033;TUBE FORMATION#0.6987;MYOPATHY#0.6964;OVARIAN#0.6831;ENDOPLASMIC RETICULUM#0.6515;ISOPROTERENOL#0.6335;APOPTOTIC#0.6321;COLORECTAL#0.6256;ENDOTHELIAL GROWTH FACTOR#0.6219;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6219;HEART DISEASE#0.6081;COLORECTAL CANCER#0.6072;SQUAMOUS CELL CARCINOMA#0.6071;LUNG CANCER#0.6060
128506	OSTEOCLAST#1.0761;CELL FUSION#1.0751;DENDRITIC CELL#1.0499;ACID PHOSPHATASE#1.0272;OSTEOCLAST DIFFERENTIATION#1.0009;CELL CELL FUSION#0.9772;ACTIVATED T CELL#0.9735;T CELL#0.9651;BONE RESORPTION#0.9411;RECEPTOR ACTIVATOR#0.9232;SIGNALING PATHWAY#0.8824;OSTEOCLAST FUSION#0.8819;MACROPHAGE#0.8755;ACTIVATED T-CELLS#0.8748;GENE EXPRESSION#0.8739;BONE MARROW#0.7951
1285	AUTOSOMAL DOMINANT ALPORT SYNDROME#1.0785;COLLAGEN TYPE IV#1.0629;AUTOSOMAL RECESSIVE ALPORT SYNDROME#1.0557;ANGIOGENESIS#1.0248;ALPORT SYNDROME#1.0228;CELL PROLIFERATION#1.0181;X-LINKED ALPORT SYNDROME#1.0177;RENAL FIBROSIS#1.0133;ENDOTHELIAL CELL#1.0130;HEMATURIA#1.0117;APOPTOSIS#1.0104;NEPHROPATHY#1.0059;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#1.0015;KIDNEY DISEASE#1.0011;BASEMENT MEMBRANE#0.9918;PODOCYTE#0.9902;HEARING LOSS#0.9848;PROTEINURIA#0.9806;POLYMERASE CHAIN REACTION#0.9775;EXTRACELLULAR MATRIX#0.9757;GROWTH FACTOR#0.9720;GENE EXPRESSION#0.9626;NEPHRITIS#0.9528;ENDOTHELIAL CELL PROLIFERATION#0.9488;CHRONIC KIDNEY DISEASE#0.9349;SENSORINEURAL HEARING LOSS#0.9120;REVERSE TRANSCRIPTION#0.8668;TUMOR CELLS#0.8627;GLOMERULONEPHRITIS#0.8612;STEM CELL#0.8400;CANCER CELL#0.8386;MACROPHAGE#0.8282;VASCULAR ENDOTHELIAL CELL#0.8277;BLOOD VESSEL#0.8212;EPITHELIAL CELL#0.8127;ENDOTHELIUM#0.8060;ENDOTHELIAL GROWTH FACTOR#0.7982;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7982;BONE MARROW#0.7888;END STAGE RENAL FAILURE#0.7887;KERATOCONUS#0.7823;SIGNALING PATHWAY#0.7785;GLOMERULAR FILTRATION#0.7648;CELL GROWTH#0.7641;DIABETIC NEPHROPATHY#0.7612;RENAL CARCINOMA#0.7578;PROTEIN SYNTHESIS#0.7389;NEPHROTIC SYNDROME#0.7326;TUBE FORMATION#0.7087;X CHROMOSOME#0.7080;HUMAN UMBILICAL VEIN#0.7057;LUNG CANCER#0.7057;UMBILICAL VEIN#0.7055;SMOOTH MUSCLE#0.7051;LUNG CARCINOMA#0.6930;CISPLATIN#0.6822;HEME OXYGENASE 1#0.6735;GLOMERULAR FILTRATION BARRIER#0.6663;APOPTOTIC#0.6644;FIBROBLAST GROWTH FACTOR#0.6614;KIDNEY FAILURE#0.6607;TRANSCRIPTION FACTOR#0.6577;TUMOR TISSUES#0.6575;ANGIOTENSIN CONVERTING ENZYME#0.6492;WOUND HEALING#0.6488;TRANSFORMING GROWTH FACTOR#0.6355;MYCOPHENOLATE MOFETIL#0.6344;ALLERGIC AIRWAY DISEASE#0.6114;INTEGRIN BINDING#0.6040;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6005
128602	LUNG CANCER#1.0644;CANCER CELL#1.0202;LUNG CARCINOMA#0.6808;LEWIS LUNG CANCER#0.6789;T CELL#0.6521;CYTOTOXICITY#0.6473;TUMOR CELLS#0.6383;EPITHELIAL CELL#0.6218
128637	WARBURG MICRO SYNDROME#1.0208;ENDOPLASMIC RETICULUM#0.9464;SERTOLI CELL#0.8456;LIPID DROPLET#0.6560;ENDOPLASMIC RETICULUM STRESS#0.6048
128674	KALLMANN SYNDROME#1.0321;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM#1.0174;OLFACTORY BULB#1.0136;HYPOGONADOTROPIC HYPOGONADISM#1.0005;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9967;ENDOTHELIAL GROWTH FACTOR#0.9964;HYPOGONADISM#0.9956;GROWTH FACTOR#0.9927;SIGNALING PATHWAY#0.9679;CIRCADIAN RHYTHM#0.9538;ENDOTHELIAL CELL#0.9505;GONADOTROPIN RELEASING HORMONE#0.9480;NEURONAL MIGRATION#0.9336;ANGIOGENESIS#0.9313;NERVOUS SYSTEM#0.8964;CELL SURFACE#0.8893;PUBERTY#0.8801;FIBROBLAST GROWTH FACTOR#0.8488;GROWTH FACTOR RECEPTOR#0.8191;POLYMERASE CHAIN REACTION#0.8159;NEUROGENESIS#0.7601;HYPOPITUITARISM#0.7592;TROPHOBLAST#0.7276;ISOLATED HYPOGONADOTROPIC HYPOGONADISM#0.7265;CENTRAL NERVOUS SYSTEM#0.7246;COLORECTAL#0.7197;SPINAL CORD#0.7129;DELAYED PUBERTY#0.6971;REPRODUCTIVE SYSTEM#0.6905;MOOD DISORDER#0.6871;INFERTILITY#0.6786;SENSITIZATION#0.6729;GENE EXPRESSION#0.6617;HYPOXIA#0.6598;NOCICEPTION#0.6462;INTERNEURON#0.6438;MACROPHAGE#0.6371;CRYPTORCHIDISM#0.6186;MAJOR DEPRESSIVE DISORDER#0.6004
1286	AUTOSOMAL DOMINANT ALPORT SYNDROME#1.0822;COLLAGEN TYPE IV#1.0789;AUTOSOMAL RECESSIVE ALPORT SYNDROME#1.0545;X-LINKED ALPORT SYNDROME#1.0229;ALPORT SYNDROME#1.0203;HEMATURIA#1.0140;NEPHROPATHY#1.0062;BASEMENT MEMBRANE#0.9940;HEARING LOSS#0.9725;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.9724;PROTEINURIA#0.9681;KIDNEY DISEASE#0.9678;NEPHRITIS#0.9044;EXTRACELLULAR MATRIX#0.8889;POLYMERASE CHAIN REACTION#0.8797;SENSORINEURAL HEARING LOSS#0.8707;PODOCYTE#0.8384;KERATOCONUS#0.8027;GENE EXPRESSION#0.7966;FOCAL ADHESION#0.7496;CHRONIC KIDNEY DISEASE#0.6957;SIGNALING PATHWAY#0.6499;GLOMERULONEPHRITIS#0.6367;KIDNEY FAILURE#0.6131
128710	ICL REPAIR#0.6994
1287	OVARIAN CANCER#1.0572;LEIOMYOMATOSIS#1.0523;COLLAGEN TYPE IV#1.0512;X-LINKED ALPORT SYNDROME#1.0415;OVARIAN#1.0310;X CHROMOSOME#1.0267;ALPORT SYNDROME#1.0233;POLYMERASE CHAIN REACTION#1.0066;NEPHRITIS#0.9943;NEPHROPATHY#0.9875;HEMATURIA#0.9860;SENSORINEURAL HEARING LOSS#0.9824;BASEMENT MEMBRANE#0.9823;HEARING LOSS#0.9813;KIDNEY DISEASE#0.9683;PROTEINURIA#0.9680;GLYCINE#0.9602;SMOOTH MUSCLE#0.9561;AUTOSOMAL RECESSIVE ALPORT SYNDROME#0.9450;REVERSE TRANSCRIPTION#0.9069;GLOMERULONEPHRITIS#0.9005;PODOCYTE#0.8761;EXTRACELLULAR MATRIX#0.8617;END STAGE RENAL FAILURE#0.8449;PERIPHERAL BLOOD#0.8395;GENE EXPRESSION#0.8355;LEIOMYOMA#0.7726;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.7448;GENETIC DISEASE#0.7335;NEPHROTIC SYNDROME#0.7083;LEUKOCYTE#0.7022;SMOOTH MUSCLE CELL#0.6884;KIDNEY FAILURE#0.6884;MUSCLE CELL#0.6878;MENTAL RETARDATION#0.6814;SKIN FIBROBLASTS#0.6791;CHRONIC KIDNEY DISEASE#0.6617;EPITHELIAL CELL#0.6567;AUTOSOMAL DOMINANT ALPORT SYNDROME#0.6415;X CHROMOSOME INACTIVATION#0.6409;CHROMOSOME INACTIVATION#0.6406;GROWTH FACTOR#0.6260;ANGIOTENSIN CONVERTING ENZYME#0.6046;COLLAGEN NETWORK#0.6026
128821	CYSTATIN#0.7620;TESTIS DEVELOPMENT#0.7219
128822	CYSTATIN#1.0076;METALLO BETA LACTAMASE#0.7095;BONE MARROW STROMAL CELL#0.6278;BONE MARROW STROMAL#0.6272;STROMAL CELL#0.6161;BONE MARROW#0.6105
128853	DUAL SPECIFICITY PHOSPHATASE#0.8467;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.7138;SCHWANN CELL#0.6196
128859	GOLGI COMPLEX#0.8194;SECRETORY PATHWAY#0.8137
128866	MULTIVESICULAR BODY#1.0313;ABSCISSION#1.0277;BUDDING#0.9818;ENDOSOME#0.9376;MIDBODY#0.8767;CYTOKINESIS#0.8565;MEMBRANE FISSION#0.7478;TRANSCRIPTION FACTOR#0.7433;AUTOPHAGY#0.7072;INTERCELLULAR BRIDGE#0.6928;ESCRT III COMPLEX#0.6199;CELL DIVISION#0.6164;VIRION#0.6102
128869	DOCKING PROTEIN#1.0289;GROWTH FACTOR#1.0100;CELL CYCLE#0.9769;UROTHELIAL CELL CARCINOMA#0.8782;SIGNALING PATHWAY#0.8676;MITOGEN ACTIVATED PROTEIN#0.8649;PROTEIN KINASE#0.8619;RECEPTOR TYROSINE KINASE#0.8609;CANCER CELL#0.7981;GROWTH FACTOR RECEPTOR#0.7886;EPIDERMAL GROWTH FACTOR#0.7749;KINASE ACTIVITY#0.7385;CELL PROLIFERATION#0.7296;FIBROBLAST GROWTH FACTOR#0.6585;CELL CYCLE ARREST#0.6357;STEM CELL#0.6203
1288	LEIOMYOMATOSIS#1.0721;ALPORT SYNDROME#1.0539;BASEMENT MEMBRANE#0.9779;SMOOTH MUSCLE#0.9532;X-LINKED ALPORT SYNDROME#0.9253;X CHROMOSOME#0.8204;LEIOMYOMA#0.8037;COLLAGEN TYPE IV#0.7564;POLYMERASE CHAIN REACTION#0.6637;GENE EXPRESSION#0.6441;NEPHROPATHY#0.6273;HEARING LOSS#0.6135
128989	GOLGI ORGANIZATION#0.7177;ALTERNATING HEMIPLEGIA OF CHILDHOOD#0.6813
1289	COLLAGEN TYPE V#1.0959;EHLERS-DANLOS SYNDROME#1.0411;RANGE OF MOTION#1.0016;FIBRILLAR COLLAGEN#1.0001;CONNECTIVE TISSUE#0.9956;EXTRACELLULAR MATRIX#0.9855;GENE EXPRESSION#0.9830;CRUCIATE LIGAMENT#0.9733;ANTERIOR CRUCIATE LIGAMENT#0.9553;FIBRIL#0.9548;GROWTH FACTOR#0.9498;POLYMERASE CHAIN REACTION#0.9333;SIGNALING PATHWAY#0.8771;BREAST CANCER#0.8553;NAIL-PATELLA SYNDROME#0.8380;TRANSFORMING GROWTH FACTOR#0.8298;WOUND HEALING#0.8202;PROTEIN PROTEIN INTERACTION#0.8056;FOCAL ADHESION#0.7736;CENTRAL CORNEAL THICKNESS#0.7575;CELL ADHESION#0.7457;CANCER CELL#0.7424;TRANSCRIPTION FACTOR#0.7378;FRAGMENT LENGTH POLYMORPHISM#0.7268;KERATOCONUS#0.7190;QUADRICEPS#0.6952;CELL PROLIFERATION#0.6876;COLLAGEN TYPE I#0.6836;APOPTOSIS#0.6693;DERMAL FIBROBLAST#0.6591;PATELLA#0.6509;CELL CYCLE#0.6503;REVERSE TRANSCRIPTION#0.6333;QUANTITATIVE REAL TIME#0.6019
128	FORMALDEHYDE DEHYDROGENASE#1.0554;PROTEIN S-NITROSYLATION#1.0418;FORMATE#1.0392;GLUTATHIONE#1.0234;DETOXIFICATION#1.0095;ETHANOL#0.9917;ENZYME ACTIVITY#0.9845;NO HOMEOSTASIS#0.9834;NITRIC OXIDE#0.9787;REACTIVE NITROGEN SPECIES#0.9778;NITRIC OXIDE SYNTHASE#0.9754;FORMIC ACID#0.9717;REACTIVE OXYGEN SPECIES#0.9648;DNA REPAIR#0.9528;GENE EXPRESSION#0.9493;CATABOLISM#0.9486;METHYLAMINE#0.9281;TOXICITY#0.9218;TRANSCRIPTION FACTOR#0.9198;FDH I#0.9004;ARGININE#0.8799;SMOOTH MUSCLE#0.8728;SIGNALING PATHWAY#0.8707;MUTAGENESIS#0.8585;METHANOL METABOLISM#0.8541;S FORMYLGLUTATHIONE HYDROLASE#0.8395;SIGNAL TRANSDUCTION#0.8011;ASCORBATE#0.7953;CELL DEATH#0.7939;SIGNALING MOLECULE#0.7874;T CELL#0.7811;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7750;DEMETHYLATION#0.7739;POSTTRANSLATIONAL MODIFICATION#0.7661;SALICYLIC ACID#0.7559;MITOCHONDRIA#0.7545;ADENINE#0.7515;RESPIRATORY TRACT#0.7462;SKELETAL MUSCLE#0.7331;DEFENSE RESPONSE#0.7211;SARCOSINE OXIDASE#0.7190;DNA REPAIR PROTEIN#0.7141;CARCINOGEN#0.7088;HEPATOCELLULAR CARCINOMA#0.6944;GENOTOXIC#0.6909;QUANTITATIVE REAL TIME#0.6861;POST-TRANSLATIONAL MODIFICATION#0.6776;SUPEROXIDE DISMUTASE#0.6733;ADH-1#0.6587;CATALYTIC ACTIVITY#0.6542;NITRIC OXIDE METABOLISM#0.6528;NICOTINAMIDE#0.6522;APOPTOSIS#0.6510;INDUCIBLE NITRIC OXIDE#0.6487;CYSTIC FIBROSIS#0.6485;HYPOXIA#0.6475;INFLAMMATORY RESPONSE#0.6438;NITRIC OXIDE SIGNALING#0.6437;ALCOHOL DEHYDROGENASE ACTIVITY#0.6386;GERMINATION#0.6254;PROTEIN KINASE#0.6250;CARDIOMYOCYTE#0.6207;HYPOXIC#0.6207;KERATINOCYTE#0.6206;METHANOL OXIDATION#0.6198;POLYMERASE CHAIN REACTION#0.6182;BIOTIN#0.6039;DTMP SYNTHESIS#0.6034;BETA-2#0.6021
129025	HIPPO SIGNALING#0.7401;COLORECTAL CANCER#0.7145
1290	COLLAGEN TYPE V#1.0552;EHLERS-DANLOS SYNDROME#1.0279;CONNECTIVE TISSUE#0.9879;EXTRACELLULAR MATRIX#0.9865;GENE EXPRESSION#0.9719;FIBRILLAR COLLAGEN#0.9569;GROWTH FACTOR#0.8576;FIBRIL#0.8400;FOCAL ADHESION#0.7970;SIGNALING PATHWAY#0.7935;TRANSCRIPTION FACTOR#0.7029;PROTEIN PROTEIN INTERACTION#0.6999;QUANTITATIVE REAL TIME#0.6397;EXTRACELLULAR MATRIX ORGANIZATION#0.6208;WOUND HEALING#0.6070;CELL ADHESION#0.6053
129138	NUCLEOCYTOPLASMIC SHUTTLING#0.7617;SIGNALING PATHWAY#0.6854;ERYTHROID CELL#0.6187;NUCLEAR EXPORT#0.6181
1291	COLLAGEN TYPE VI#1.0554;VI-ALPHA#1.0445;BETHLEM MYOPATHY#1.0415;ULLRICH CONGENITAL MUSCULAR DYSTROPHY#1.0263;OSTEOGENESIS IMPERFECTA#1.0224;GLYCINE#1.0194;MYOPATHY#1.0152;OSTEOGENESIS#1.0127;CONGENITAL MUSCULAR DYSTROPHY#1.0045;COLLAGEN TYPE I#1.0026;MUSCULAR DYSTROPHY#0.9956;ARGININE#0.9930;GROWTH FACTOR#0.9925;CELL ADHESION#0.9855;OSSIFICATION#0.9853;COLLAGENASE#0.9806;BASEMENT MEMBRANE#0.9800;CONNECTIVE TISSUE#0.9766;POLYMERASE CHAIN REACTION#0.9760;GENE EXPRESSION#0.9710;FIBRIL#0.9672;DIGESTION#0.9655;EXTRACELLULAR MATRIX#0.9623;APOPTOSIS#0.9619;COLLAGEN TYPE IV#0.9581;SKELETAL MUSCLE#0.9477;DOWN SYNDROME#0.9430;DERMAL FIBROBLAST#0.9416;SKIN FIBROBLASTS#0.9401;BETA-2#0.9388;TRANSCRIPTION FACTOR#0.9365;EPITHELIAL CELL#0.9292;PROTEOGLYCAN#0.9248;CHONDROCYTE#0.9225;ENDOTHELIAL CELL#0.9222;EHLERS-DANLOS SYNDROME#0.9131;LYSINE#0.9081;FIBRILLAR COLLAGEN#0.9042;TRANSFORMING GROWTH FACTOR#0.8867;MUSCLE WEAKNESS#0.8806;TYPE III PROCOLLAGEN#0.8805;CERVICAL#0.8584;CANCER CELL#0.8498;REGENERATION#0.8467;WOUND HEALING#0.8384;SIGNAL PEPTIDE#0.8259;TRANSFORMING GROWTH FACTOR BETA#0.8251;ALKALINE PHOSPHATASE#0.8210;SIGNALING PATHWAY#0.8208;OTHER COLLAGEN#0.8199;OSTEOBLAST#0.8135;MUSCLE FIBER#0.8114;CELL PROLIFERATION#0.8111;PERIPHERAL BLOOD#0.8070;COLLAGEN SYNTHESIS#0.8061;CONGENITAL HEART DEFECTS#0.8058;BLOOD VESSEL#0.8001;AUTOPHAGY#0.7934;OSTEOARTHRITIS#0.7902;SODIUM DODECYL SULFATE#0.7856;DODECYL SULFATE#0.7855;ENDOPLASMIC RETICULUM#0.7820;REVERSE TRANSCRIPTION#0.7752;SMOOTH MUSCLE#0.7743;QUANTITATIVE REAL TIME#0.7743;MACROPHAGE#0.7718;PERMEABILITY TRANSITION PORE#0.7710;ADIPOSE TISSUE#0.7532;HYDROXYPROLINE#0.7497;HEPARIN#0.7317;PROTEIN PROTEIN INTERACTION#0.7239;BONE FORMATION#0.7235;CELL SURFACE#0.7204;SERUM ALBUMIN#0.7155;INSULIN-LIKE GROWTH FACTOR#0.7146;STROMAL CELL#0.7096;MICROFIBRIL#0.7078;MESENCHYMAL CELL#0.7025;SARCOPLASMIC RETICULUM#0.6974;CYCLOSPORIN A#0.6972;EPIDERMAL GROWTH FACTOR#0.6963;DERMIS#0.6907;CYCLOSPORIN#0.6886;COLLAGEN TYPE III#0.6883;STROMA#0.6873;STEM CELL#0.6861;MITOCHONDRIA#0.6816;ALANINE#0.6749;BINDING PROTEIN 1#0.6708;NERVOUS SYSTEM#0.6694;SCHWANN CELL#0.6671;CYCLOPHILIN#0.6599;MESENCHYME#0.6590;BONE RESORPTION#0.6464;CELL DIFFERENTIATION#0.6438;GESTATION#0.6435;MUSCLE CELL#0.6428;OSTEOPOROSIS#0.6414;LEUCINE#0.6405;EXTRACELLULAR MATRIX COMPONENT#0.6331;AMNIOTIC FLUID#0.6312;CELL CYCLE#0.6228;CELL ADHESION MOLECULE#0.6197;IMMUNOGLOBULIN RECEPTOR#0.6162;CELL MIGRATION#0.6105;PELVIC ORGAN PROLAPSE#0.6058;ALPHA 1-ANTITRYPSIN#0.6036;BONE MINERAL DENSITY#0.6011
129293	T CELL#0.7056;DENDRITIC CELL#0.6594
1292	BETHLEM MYOPATHY#1.0602;ULLRICH CONGENITAL MUSCULAR DYSTROPHY#1.0509;MYOPATHY#1.0293;CONGENITAL MUSCULAR DYSTROPHY#1.0249;MUSCULAR DYSTROPHY#1.0191;COLLAGEN TYPE VI#1.0125;EXTRACELLULAR MATRIX#0.9936;MUSCLE WEAKNESS#0.9114;GENE EXPRESSION#0.9033;VI-ALPHA#0.7532;CONNECTIVE TISSUE#0.7392;SKELETAL MUSCLE#0.6976;LIMB-GIRDLE MUSCULAR DYSTROPHY#0.6971
1293	VI-ALPHA#1.0982;COLLAGEN TYPE VI#1.0715;BETHLEM MYOPATHY#1.0692;ULLRICH CONGENITAL MUSCULAR DYSTROPHY#1.0526;MYOPATHY#1.0349;CONGENITAL MUSCULAR DYSTROPHY#1.0285;MUSCULAR DYSTROPHY#1.0217;EXTRACELLULAR MATRIX#0.9953;GENE EXPRESSION#0.9811;DYSTONIA#0.9577;MUSCLE WEAKNESS#0.8807;GROWTH FACTOR#0.8798;CELL PROLIFERATION#0.8505;ADIPOSE TISSUE#0.8498;SIGNALING PATHWAY#0.8228;CONNECTIVE TISSUE#0.7720;APOPTOSIS#0.7603;CELL ADHESION#0.7489;ADIPOCYTE#0.7405;CANCER CELL#0.7298;SKELETAL MUSCLE#0.7091;FOCAL ADHESION#0.6872;TRANSFORMING GROWTH FACTOR#0.6346;MACROPHAGE#0.6155;BASEMENT MEMBRANE#0.6116;POLYMERASE CHAIN REACTION#0.6011
129401	NPC ASSEMBLY#1.0641;NUCLEAR PORE#1.0300;NUCLEAR PORE COMPLEX#1.0085;PORE COMPLEX#1.0077;NUCLEAR ENVELOPE#0.9170;NUCLEAR MEMBRANE#0.8491;NUCLEAR PORE COMPLEXES#0.7243;SPINDLE ASSEMBLY#0.6387;NUCLEAR PORE COMPLEX ASSEMBLY#0.6387;PORE COMPLEX ASSEMBLY#0.6373
129446	ACTIN BINDING#1.0651;CARDIOMYOPATHY#0.8487;INTERCALATED DISC#0.8055;HAIR CELL#0.7832;STRIATED MUSCLE#0.6920;CUTICULAR PLATE#0.6917;INNER EAR#0.6508;Z DISC#0.6051
1294	GLYCINE#1.0377;RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA#1.0357;EPIDERMOLYSIS BULLOSA#1.0267;POLYMERASE CHAIN REACTION#1.0238;PREMATURE TERMINATION CODON#1.0234;ANCHORING#1.0143;FIBRIL#1.0131;SKIN DISEASE#1.0047;BLISTERING#1.0033;KERATINOCYTE#0.9999;GROWTH FACTOR#0.9990;DERMAL FIBROBLAST#0.9981;TRANSFORMING GROWTH FACTOR#0.9822;BASEMENT MEMBRANE#0.9806;STEM CELL#0.9785;TRANSCRIPTION FACTOR#0.9731;TRANSFORMING GROWTH FACTOR BETA#0.9447;DERMIS#0.9438;GENE EXPRESSION#0.9403;SQUAMOUS CELL CARCINOMA#0.9360;EXTRACELLULAR MATRIX#0.9356;ARGININE#0.9168;WOUND HEALING#0.8763;LAMINA DENSA#0.8359;MUCOUS#0.8298;BLISTERS#0.8263;GENETIC DISORDER#0.7189;HOMOLOGY-DIRECTED REPAIR#0.7139;PLURIPOTENT STEM CELL#0.6808;GENETIC DISEASE#0.6668;HUMAN DERMAL FIBROBLAST#0.6345;EPIDERMAL STEM CELL#0.6182;PERIPHERAL BLOOD#0.6163;COLLAGEN TYPE I#0.6113;INDUCED PLURIPOTENT STEM CELL#0.6024
129521	CIRCADIAN RHYTHM#1.0206;NERVOUS SYSTEM#0.8426;NEUROMEDIN U RECEPTOR#0.7840;FEEDING BEHAVIOR#0.7186;CENTRAL NERVOUS SYSTEM#0.6749;PROTEIN KINASE#0.6142
129530	T CELL#0.6526
129531	CYTOKINESIS#0.8451;ABSCISSION#0.7817
129563	EXOSOME#1.0093;MRNA DECAY#0.9578;STEM CELL#0.9148;RNA METABOLISM#0.7608;RNASE II#0.7531;MRNA DEGRADATION#0.7286;MOUSE EMBRYONIC STEM#0.7086;EMBRYONIC STEM CELL#0.7041;GENE EXPRESSION#0.6947;RNA BINDING#0.6740;NONSENSE-MEDIATED MRNA DECAY#0.6397;RNA DEGRADATION#0.6326;CANCER CELL#0.6251;HEPATOCELLULAR CARCINOMA#0.6182;CYTOPLASM#0.6092
1295	COLLAGEN TYPE VIII#1.0228;GENE EXPRESSION#0.9288;ENDOTHELIAL CELL#0.8802;MACULAR DEGENERATION#0.8559;EXTRACELLULAR MATRIX#0.8281;AGE RELATED MACULAR DEGENERATION#0.8100;MESANGIAL CELL#0.7575;CORNEAL DYSTROPHY#0.6913;GROWTH FACTOR#0.6620;POLYMERASE CHAIN REACTION#0.6443;DIABETIC NEPHROPATHY#0.6285;CELL PROLIFERATION#0.6132
129607	NUCLEOSIDE DIPHOSPHATE KINASE#1.0644;DIPHOSPHATE#1.0555;KINASE ACTIVITY#0.9955;THYMIDYLATE KINASE#0.9623;THYMIDINE#0.9310;NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY#0.9280;TUBERCULOSIS#0.8680;VIRULENCE#0.8639;THYMIDYLATE#0.8590;MACROPHAGE#0.8369;NDK ACTIVITY#0.7986;ADENYLATE KINASE#0.7839;THYMIDINE KINASE#0.7779;COENZYME A#0.7581;PYRUVATE KINASE#0.7572;GENE EXPRESSION#0.7522;SUPEROXIDE DISMUTASE#0.7521;HOST CELL#0.7463;SUCCINYL-COENZYME A#0.7314;PROTEIN SYNTHESIS#0.6821;PROTEIN KINASE#0.6809;SIGNAL TRANSDUCTION#0.6666;ADENYLATE#0.6648;HISTIDINE#0.6605;MTDNA SYNTHESIS#0.6559;DNA REPLICATION#0.6396;MITOCHONDRIA#0.6371;PYRUVATE#0.6292;CELL DEATH#0.6197
129642	LPAAT ACTIVITY#1.1027;LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE#1.0787;ACYLTRANSFERASE ACTIVITY#1.0387;ACID PHOSPHATASE#0.9319;ENDOPLASMIC RETICULUM#0.9208;PHOSPHATIDYLETHANOLAMINE#0.8221;KENNEDY PATHWAY#0.7940;COENZYME A#0.7827;LIPID METABOLISM#0.7248;PHOSPHOLIPID BIOSYNTHESIS#0.7134;PALMITOYL#0.6504;ACYL CARRIER PROTEIN#0.6180;ACYL CARRIER#0.6179;O ACYLTRANSFERASE#0.6048
129685	TENOFOVIR#1.0267;CELL CYCLE#1.0187;GENE EXPRESSION#0.9977;DNA BINDING#0.9889;TRANSCRIPTION FACTOR#0.9828;PREINITIATION COMPLEX#0.9747;TENOFOVIR DISOPROXIL FUMARATE#0.9720;TENOFOVIR DISOPROXIL#0.9717;HISTONE ACETYLTRANSFERASE#0.9694;TRANSCRIPTION INITIATION FACTOR#0.9539;B CELL#0.9365;TBP BINDING#0.9233;PROTEIN PROTEIN INTERACTION#0.9231;COMPLEX I#0.9158;MRNA TRANSCRIPTION#0.8601;FUMARATE#0.8322;RIBOSOMAL PROTEIN#0.8067;ACETYLTRANSFERASE ACTIVITY#0.8002;TRANSACTIVATION#0.7984;CELL GROWTH#0.7969;RRNA SYNTHESIS#0.7908;PROMOTER BINDING#0.7846;ACETYLTRANSFERASE COMPLEX#0.7556;GERM CELL#0.7481;EMTRICITABINE#0.7240;REGULATION OF GENE EXPRESSION#0.7142;PROTEIN CODING GENE#0.7141;MEDIATOR COMPLEX#0.6937;HEPATITIS B#0.6853;PROTEIN COMPLEX#0.6794;B LYMPHOCYTE#0.6743;GLUTAMINE#0.6553;CORE PROMOTER BINDING#0.6347;ESTROGEN RECEPTOR#0.6311;STEM CELL#0.6191;DOMINANT NEGATIVE MUTANT#0.6151;HISTONE ACETYLTRANSFERASE ACTIVITY#0.6113;CHROMATIN REMODELING#0.6055;NUCLEOSOME#0.6035;CELL PROLIFERATION#0.6025
1296	CORNEAL DYSTROPHY#1.0391;ENDOTHELIAL CELL#0.9863;COLLAGEN TYPE VIII#0.9591;CORNEAL ENDOTHELIUM#0.8918;ENDOTHELIUM#0.8837;CORNEAL ENDOTHELIAL CELL#0.8632;CENTRAL CORNEAL THICKNESS#0.8619;POSTERIOR POLYMORPHOUS CORNEAL DYSTROPHY#0.7951;POLYMERASE CHAIN REACTION#0.7564;FUCHS' ENDOTHELIAL DYSTROPHY#0.7503;EXTRACELLULAR MATRIX#0.7129;CELL ADHESION#0.7068;TRANSCRIPTION FACTOR#0.6617;GENE EXPRESSION#0.6585;MESANGIAL CELL#0.6121;DIABETIC NEPHROPATHY#0.6096;GROWTH FACTOR#0.6083;KERATOCONUS#0.6039
129787	OBESE#0.9817;ADIPOSE TISSUE#0.9126;TYPE 2 DIABETES#0.8884;STEM CELL#0.6813;GENE EXPRESSION#0.6278;NUCLEAR MEMBRANE#0.6184
1297	STICKLER SYNDROME#1.0365;EXTRACELLULAR MATRIX#0.9530;GENE EXPRESSION#0.9499;MULTIPLE EPIPHYSEAL DYSPLASIA#0.9211;OSTEOARTHRITIS#0.9009;CHONDROCYTE#0.8789;HEARING LOSS#0.8567;POLYMERASE CHAIN REACTION#0.8202;INTERVERTEBRAL DISC#0.7273;PROTEOGLYCAN#0.7265;BASEMENT MEMBRANE#0.6916;DNA METHYLATION#0.6908;COCHLEA#0.6439;INTERVERTEBRAL DISC DEGENERATION#0.6201;TRANSCRIPTION FACTOR#0.6198;OSTEOGENESIS IMPERFECTA#0.6091;BONE FORMATION#0.6069
129804	ENDOTHELIAL CELL#0.9003;CELL ADHESION#0.8529;TUBE FORMATION#0.7334;GROWTH FACTOR#0.6875;EXTRACELLULAR MATRIX#0.6520;HEPARIN#0.6270
129807	SIALIDASE ACTIVITY#0.9503;CELL SURFACE#0.9479;COLON CANCER#0.9307;CANCER CELL#0.8139;MACROPHAGE#0.7608;PLASMA MEMBRANE#0.7481;MITOCHONDRIAL MEMBRANE#0.7006;NEURITE FORMATION#0.6466;CELL ADHESION#0.6407;OUTER MITOCHONDRIAL MEMBRANE#0.6356;LYSOSOMAL LUMEN#0.6254;NEURITE#0.6015
129831	RETINOBLASTOMA#1.0591;TUMOR SUPPRESSOR#1.0515;RNA BINDING#1.0351;RNA BINDING PROTEIN#1.0142;CELL CYCLE#0.9713;HODGKIN'S LYMPHOMA#0.8635;MULTIPLE MYELOMA#0.8475;TRANSCRIPTION FACTOR#0.8349;PLASMA CELL#0.7770;GROWTH FACTOR#0.7670;APOPTOSIS#0.7466;SPINAL CORD#0.7367;B CELL#0.7163;CYTOPLASMIC INCLUSION#0.6992;CANCER CELL#0.6871;BONE MARROW#0.6849;GANGLION CELLS#0.6709;DNA BINDING#0.6390;CELL DEATH#0.6377;AMYOTROPHIC LATERAL SCLEROSIS#0.6316;LATERAL SCLEROSIS#0.6316;BIPOLAR CELL#0.6175;ANTISENSE RNA#0.6151;SOFT TISSUE SARCOMA#0.6146;INTERPHASE#0.6107;BINDING PROTEIN 1#0.6068;POLYMERASE CHAIN REACTION#0.6041;GENE EXPRESSION#0.6031
129868	NUCLEAR LAMINA#0.8296
129880	BARDET BIEDL SYNDROME#1.0345;BBSOME#0.9633;CILIOPATHY#0.7601
1298	MULTIPLE EPIPHYSEAL DYSPLASIA#1.0355;INTERVERTEBRAL DISC#1.0232;LUMBAR DISC DISEASE#0.9858;TRYPTOPHAN#0.9447;DISEASE RESISTANCE#0.9400;EXTRACELLULAR MATRIX#0.8279;OSTEOARTHRITIS#0.8269;POLYMERASE CHAIN REACTION#0.8182;CHONDROCYTE#0.7674;DNA METHYLATION#0.7400;STICKLER SYNDROME#0.7362;GENE EXPRESSION#0.7075;MAGNETIC RESONANCE IMAGING#0.6590;STEM CELL#0.6208;TRANSCRIPTION FACTOR#0.6025
1299	INTERVERTEBRAL DISC#1.0010;MULTIPLE EPIPHYSEAL DYSPLASIA#0.9823;EXTRACELLULAR MATRIX#0.8901;STICKLER SYNDROME#0.7996;LUMBAR DISC DISEASE#0.7888;TRYPTOPHAN#0.7744;HEARING LOSS#0.7633;VITAMIN D RECEPTOR#0.6930;OSTEOARTHRITIS#0.6622;INTERVERTEBRAL DISC DEGENERATION#0.6585;NUCLEUS PULPOSUS#0.6389
12	ALPHA-1 PROTEASE INHIBITOR#1.0603;ALPHA-1-PROTEINASE INHIBITOR#1.0465;SERUM AMYLOID A#1.0449;FACTOR VIII#1.0422;FIBRINOGEN#1.0411;C REACTIVE PROTEIN#1.0326;ALPHA 1-ANTITRYPSIN#1.0309;ALPHA-2 MACROGLOBULIN#1.0237;BETA-2#1.0205;LEUKOCYTE#1.0184;AMYLOID PROTEIN#1.0184;PROTEINASE INHIBITOR#1.0174;SERPIN#1.0167;UBIQUITIN#1.0163;PEPTIDASE INHIBITOR#1.0138;AMYLOID PRECURSOR PROTEIN#1.0133;MACROPHAGE#1.0067;DEMENTIA#1.0052;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0042;SMOOTH MUSCLE#1.0040;LIVER DISEASE#1.0010;ALZHEIMER'S DISEASE#1.0007;TUMOR CELLS#0.9987;PROSTATE SPECIFIC ANTIGEN#0.9983;ASTROCYTE#0.9961;ACID PHOSPHATASE#0.9960;SALIVARY GLAND#0.9948;CANCER CELL#0.9929;FIBROUS HISTIOCYTOMA#0.9891;TUMOR NECROSIS FACTOR#0.9883;NEUTROPHIL#0.9877;HISTIOCYTOMA#0.9863;MONOCYTE#0.9846;GROWTH FACTOR#0.9835;SIGNAL PEPTIDE#0.9832;PROSTATE CANCER#0.9825;MAST CELL#0.9814;EPITHELIAL CELL#0.9774;ACUTE PHASE RESPONSE#0.9771;ADENOCARCINOMA#0.9765;BREAST CANCER#0.9765;LYMPH NODE#0.9723;VASCULAR DEMENTIA#0.9685;CYTOPLASM#0.9685;PLASMA PROTEIN#0.9661;GENE EXPRESSION#0.9620;FIBRIL#0.9599;HISTIOCYTOSIS#0.9554;LECTIN#0.9476;POLYMERASE CHAIN REACTION#0.9460;MALIGNANT HISTIOCYTOSIS#0.9419;STROMAL CELL#0.9405;BONE MARROW#0.9396;ENDOTHELIAL CELL#0.9361;HEMORRHAGE#0.9352;FORMALIN#0.9344;T CELL#0.9316;HEPARIN#0.9314;INFLAMMATORY RESPONSE#0.9296;ALPHA 1-ANTITRYPSIN DEFICIENCY#0.9278;SODIUM DODECYL SULFATE#0.9228;DODECYL SULFATE#0.9227;PARKINSON'S DISEASE#0.9215;FACTOR XIIIA#0.9201;RHEUMATOID ARTHRITIS#0.9197;INCLUSION BODY#0.9189;NERVOUS SYSTEM#0.9117;BREAST CANCER CELL#0.9095;GRANULOCYTE#0.9027;ALKALINE PHOSPHATASE#0.9012;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9001;MOLAR#0.8992;ENDOPLASMIC RETICULUM#0.8978;SMOOTH MUSCLE ACTIN#0.8951;INCLUSION BODY MYOSITIS#0.8925;B CELL#0.8914;GLYCOSYLATION#0.8881;SERUM ALBUMIN#0.8752;HEPATOCELLULAR CARCINOMA#0.8688;IMMUNE RESPONSE#0.8668;CENTRAL NERVOUS SYSTEM#0.8659;CELL SURFACE#0.8568;CELL ADHESION#0.8564;CEREBROVASCULAR DISEASE#0.8525;LANGERHANS CELL#0.8523;PANCREATIC ELASTASE 2#0.8476;MYOCARDIAL INFARCTION#0.8461;MONONUCLEAR CELLS#0.8445;INTERMEDIATE FILAMENT#0.8444;DEXAMETHASONE#0.8426;HISTOGENESIS#0.8354;COAGULATION#0.8319;RETINOL#0.8308;BIOTIN#0.8305;MESENCHYMAL CELL#0.8303;ERYTHROCYTE#0.8284;EXTRACELLULAR MATRIX#0.8257;HUMAN BREAST CANCER#0.8236;LUNG DISEASE#0.8228;NEUROFILAMENT#0.8227;B LYMPHOCYTE#0.8216;HEPATOMA CELLS#0.8178;CYSTATIN#0.8156;GIANT CELL TUMOR#0.8125;STROMA#0.8111;ERYTHROCYTE SEDIMENTATION RATE#0.8105;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8072;SQUAMOUS CELL CARCINOMA#0.8040;BLOOD VESSEL#0.7979;PLEOMORPHIC ADENOMA#0.7979;PANCREATITIS#0.7963;RETINOL BINDING#0.7959;PROTEIN SYNTHESIS#0.7906;NEUROFIBRILLARY TANGLE#0.7853;MUSCLE FIBER#0.7829;MUSCLE CELL#0.7794;MYOSITIS#0.7785;OSTEOCLAST#0.7779;METHIONINE#0.7775;DNA PRIMASE#0.7745;CEREBRAL HEMORRHAGE#0.7741;SKELETAL MUSCLE#0.7730;POLYMYALGIA RHEUMATICA#0.7716;AMYLOIDOSIS#0.7702;ADENOID CYSTIC CARCINOMA#0.7506;INTRACRANIAL ANEURYSM#0.7488;CELL ADHESION MOLECULE#0.7487;ALVEOLAR MACROPHAGE#0.7408;T LYMPHOCYTE#0.7403;LUNG CANCER#0.7396;DNA SYNTHESIS#0.7307;PROTEOGLYCAN#0.7305;PANCREATIC CANCER#0.7208;LEUCINE#0.7184;ARGININE#0.7176;GIANT CELL ARTERITIS#0.7173;TISSUE DAMAGE#0.7160;FRAGMENT LENGTH POLYMORPHISM#0.7149;VITAMIN D BINDING#0.7126;PAROTID GLAND#0.7079;CREATINE KINASE#0.7024;OVARIAN#0.6994;LYMPHOID CELL#0.6994;INSULIN-LIKE GROWTH FACTOR#0.6977;PHAGOCYTOSIS#0.6959;ROUGH ENDOPLASMIC RETICULUM#0.6891;ASTROCYTOMA#0.6878;GLUTATHIONE#0.6806;URTICARIA#0.6801;MIDDLE EAR#0.6779;AGE AT ONSET#0.6765;STEM CELL#0.6760;AMNIOTIC FLUID#0.6708;CHONDROSARCOMA#0.6698;SPUTUM#0.6692;NODULAR#0.6675;CEREBRAL CORTEX#0.6673;PERIPHERAL BLOOD#0.6669;ENDOMETRIUM#0.6665;PROSTATE DISEASE#0.6643;HUMAN HEPATOMA CELL LINES#0.6603;LEIOMYOSARCOMA#0.6550;TRANSFORMING GROWTH FACTOR BETA#0.6544;TRANSFORMING GROWTH FACTOR#0.6525;CELL PROLIFERATION#0.6505;DERMIS#0.6504;PLATELET AGGREGATION#0.6497;PROTEIN KINASE#0.6482;DIGESTION#0.6465;APOPTOSIS#0.6463;INFLAMMATORY CELL#0.6416;DNA BINDING#0.6410;PLASMA CELL#0.6327;ESTRADIOL#0.6282;CREATINE#0.6262;SMOOTH MUSCLE CELL#0.6231;MULTIPLE LINEAR REGRESSION#0.6228;PROSTATE CARCINOMA#0.6197;HEMATOPOIETIC CELL#0.6191;SYNOVIAL FLUID#0.6177;SCHWANN CELL#0.6133;ESTROGEN RECEPTOR#0.6117;DENDRITIC CELL#0.6082;CHRONIC LIVER DISEASE#0.6011
130013	AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE#1.1499;3-HYDROXYANTHRANILATE#1.0829;TRYPTOPHAN#1.0439;KYNURENINE OXOGLUTARATE TRANSAMINASE#1.0388;PARKINSON'S DISEASE#1.0013;TRYPTOPHAN METABOLISM#0.9483;KYNURENINE 3 MONOOXYGENASE#0.9340;QUINOLINIC ACID#0.8551;NICOTINIC ACID#0.8376;NICOTINAMIDE#0.8344;NIACIN#0.8322;SMALL INTESTINE#0.8036;L-TRYPTOPHAN#0.7354;INDOLE#0.7321;DECARBOXYLASE ACTIVITY#0.7247;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7033;DIOXYGENASE ACTIVITY#0.6554;ADENINE#0.6410;PYRAZINAMIDE#0.6390;NICOTINATE PHOSPHORIBOSYLTRANSFERASE#0.6013
130026	SMOOTH MUSCLE#0.7118
130074	NEURITE OUTGROWTH#1.0883;NEURITE#1.0117;CENTRAL NERVOUS SYSTEM#0.7346;NERVOUS SYSTEM#0.7335;REGENERATION#0.7091
1300	CHONDROCYTE HYPERTROPHY#1.0308;COLLAGEN TYPE II#1.0030;ALKALINE PHOSPHATASE#1.0015;TRANSCRIPTION FACTOR#1.0012;CHONDROCYTE#0.9994;POLYMERASE CHAIN REACTION#0.9992;CHONDROCYTE DIFFERENTIATION#0.9918;GENE EXPRESSION#0.9908;GROWTH FACTOR#0.9866;OSTEOBLAST#0.9861;EXTRACELLULAR MATRIX#0.9861;ENDOCHONDRAL OSSIFICATION#0.9824;BONE FORMATION#0.9823;SKELETAL DEVELOPMENT#0.9809;CHONDROGENESIS#0.9792;OSSIFICATION#0.9789;MATRIX METALLOPROTEINASE 13#0.9767;PROTEOGLYCAN#0.9725;MESENCHYMAL STEM CELL#0.9699;OSTEOARTHRITIS#0.9695;BONE MARROW#0.9693;CHONDROCYTE PROLIFERATION#0.9686;STEM CELL#0.9645;MINERALIZATION#0.9553;SIGNALING PATHWAY#0.9530;TRANSFORMING GROWTH FACTOR#0.9397;CELL PROLIFERATION#0.9273;BONE MORPHOGENETIC PROTEIN#0.9233;REVERSE TRANSCRIPTION#0.9232;QUANTITATIVE REAL TIME#0.9225;PARATHYROID HORMONE#0.9094;APOPTOSIS#0.9050;REGENERATION#0.8983;TERMINAL DIFFERENTIATION#0.8908;HUMAN MESENCHYMAL STEM#0.8844;HYPOXIA#0.8825;OSTEOGENESIS#0.8809;PARATHYROID#0.8574;BONE GROWTH#0.8574;COLLAGEN TYPE I#0.8479;SKELETON#0.8330;CHONDROGENIC CELL#0.8322;HUMAN ARTICULAR CHONDROCYTES#0.7926;BONE DEVELOPMENT#0.7891;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7690;ENDOTHELIAL GROWTH FACTOR#0.7689;CARTILAGE DEVELOPMENT#0.7585;PROTEIN KINASE#0.7557;PROGENITOR CELL#0.7494;BREAST CANCER#0.7463;OSTEOBLAST DIFFERENTIATION#0.7340;FIBROBLAST GROWTH FACTOR#0.7276;STROMAL CELL#0.7196;MRNA DECAY#0.6999;MESENCHYMAL CELL#0.6983;CELL DIFFERENTIATION#0.6942;METAPHYSEAL DYSPLASIA#0.6878;COLLAGENASE#0.6823;HYPOXIA INDUCIBLE FACTOR#0.6798;CARTILAGE FORMATION#0.6766;ADIPOSE TISSUE#0.6305;ELECTROPHORETIC MOBILITY SHIFT#0.6231;CONNECTIVE TISSUE#0.6175;MENISCUS#0.6131;CELL DEATH#0.6012
130120	EPITHELIAL CELL#0.9443;PANCREATITIS#0.9397;GENE EXPRESSION#0.8995;REGENERATION#0.8396;LECTIN#0.7860;SMALL INTESTINE#0.7641;IMMUNE RESPONSE#0.7589;T CELL#0.7204;ACUTE PANCREATITIS#0.7041;INTESTINAL EPITHELIAL CELL#0.6835;LIVER DISEASE#0.6261;SIGNALING PATHWAY#0.6040
1301	STICKLER SYNDROME#1.0596;PRIMARY ANGLE-CLOSURE GLAUCOMA#1.0294;PRIMARY ANGLE CLOSURE#1.0275;ANGLE-CLOSURE GLAUCOMA#1.0232;FIBRILLAR COLLAGEN#1.0103;OVARIAN CANCER#0.9965;SIGNALING PATHWAY#0.9949;CANCER CELL#0.9881;EXTRACELLULAR MATRIX#0.9870;HEARING LOSS#0.9843;GENE EXPRESSION#0.9758;OSTEOARTHRITIS#0.9460;OVARIAN#0.9333;LUNG CANCER#0.9275;RHAMNOSE BINDING#0.9251;CISPLATIN#0.8795;GROWTH FACTOR#0.8750;STROMAL CELL#0.8714;LECTIN#0.8475;APOPTOSIS#0.8395;LYMPH NODE#0.8292;FOCAL ADHESION#0.8230;FIBRIL#0.8176;SENSORINEURAL HEARING LOSS#0.8126;ADENOCARCINOMA#0.8120;COLORECTAL#0.7979;EPITHELIAL CELL#0.7887;L-RHAMNOSE#0.7861;CELL PROLIFERATION#0.7861;CONNECTIVE TISSUE#0.7830;TRANSCRIPTION FACTOR#0.7813;BREAST CANCER#0.7692;CELL ADHESION#0.7449;INVASIVE CARCINOMA#0.7398;PANCREATIC CANCER#0.7327;REVERSE TRANSCRIPTION#0.7228;CHONDROCYTE#0.7034;COLON ADENOCARCINOMA#0.6889;PROTEIN PROTEIN INTERACTION#0.6820;TRANSFORMING GROWTH FACTOR#0.6627;SKELETAL DEVELOPMENT#0.6338;INTERVERTEBRAL DISC#0.6314;POLYMERASE CHAIN REACTION#0.6305;LUMBAR DISC HERNIATION#0.6247;CLEFT PALATE#0.6105;COLON CANCER#0.6084;COLORECTAL CANCER#0.6001;SQUAMOUS CELL CARCINOMA#0.6001
130271	PODOCYTE#0.7409;PODOCYTE FOOT#0.6957;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.6742;DIABETIC NEPHROPATHY#0.6667;FOCAL ADHESION#0.6663
1302	STICKLER SYNDROME#1.0592;CLEAVED CASPASE 3#1.0584;CASPASE-3 ACTIVITY#1.0448;POLY ADP RIBOSE#1.0436;RIBOSE#1.0425;CYTOCHROME C RELEASE#1.0247;CHONDROCYTE#1.0188;CYTOCHROME C#1.0097;CASPASE ACTIVATION#1.0055;DNA FRAGMENTATION#1.0033;HEARING LOSS#0.9958;CASPASE INHIBITOR#0.9957;HEARING IMPAIRMENT#0.9948;ACTIVE CASPASE 3#0.9887;MITOCHONDRIAL MEMBRANE#0.9866;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9854;APOPTOSIS#0.9848;PRO-INFLAMMATORY#0.9837;AUTOPHAGY#0.9836;APOPTOTIC#0.9802;GENE EXPRESSION#0.9800;APOPTOTIC CELL DEATH#0.9770;DEATH RECEPTOR#0.9757;CISPLATIN#0.9755;MITOCHONDRIA#0.9745;GROWTH FACTOR#0.9721;INDUCTION OF APOPTOSIS#0.9708;CELL CYCLE ARREST#0.9708;ROS GENERATION#0.9695;TRANSCRIPTION FACTOR#0.9692;PROTEIN KINASE#0.9672;TUMOR CELLS#0.9648;BREAST CANCER CELL#0.9641;CELL DEATH#0.9633;CELL PROLIFERATION#0.9624;SIGNALING PATHWAY#0.9621;LUNG CANCER#0.9618;CELL GROWTH#0.9617;BREAST CANCER#0.9602;CYTOTOXICITY#0.9597;CELL CYCLE#0.9589;REACTIVE OXYGEN SPECIES#0.9577;B CELL#0.9526;CANCER CELL#0.9481;PROPIDIUM#0.9456;ANTI APOPTOSIS#0.9421;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9415;DNA BINDING#0.9370;NITRIC OXIDE#0.9353;TUMOR NECROSIS FACTOR#0.9313;MITOGEN ACTIVATED PROTEIN#0.9237;HUMAN BREAST CANCER#0.9223;TOXICITY#0.9191;G1 PHASE#0.9188;COLON CANCER#0.9172;HEPATOCELLULAR CARCINOMA#0.9120;PROSTATE CANCER#0.9045;M PHASE#0.9038;T CELL#0.8987;DNA REPAIR#0.8958;MECHANISM OF ACTION#0.8945;PROTEASOME#0.8943;ENDOPLASMIC RETICULUM#0.8936;OSTEOARTHRITIS#0.8903;EXTRACELLULAR MATRIX#0.8873;FIBRILLAR COLLAGEN#0.8857;S PHASE#0.8807;POLYMERASE CHAIN REACTION#0.8732;B CELL LYMPHOMA#0.8731;COLORECTAL#0.8659;TUMOR SUPPRESSOR#0.8650;SUPEROXIDE DISMUTASE#0.8518;SIGNAL TRANSDUCTION#0.8458;COLORECTAL CANCER#0.8456;SENSORINEURAL HEARING LOSS#0.8439;ISCHEMIA#0.8430;ANGIOGENESIS#0.8429;PROGRAMMED CELL DEATH#0.8367;EPITHELIAL CELL#0.8250;KINASE INHIBITOR#0.8209;DOXORUBICIN#0.8193;ACTIVATED CASPASE 3#0.8176;PHOSPHATIDYLSERINE#0.8136;AKT SIGNALING#0.8093;PANCREATIC CANCER#0.8083;STAUROSPORINE#0.8062;GLUTATHIONE#0.8062;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.8049;ENDOTHELIAL CELL#0.8035;FLOW CYTOMETRY ANALYSIS#0.7957;NEUROBLASTOMA#0.7924;SIGNALING MOLECULE#0.7923;MITOCHONDRIAL PERMEABILITY TRANSITION#0.7829;NITRIC OXIDE SYNTHASE#0.7816;WOUND HEALING#0.7783;RESVERATROL#0.7764;SMOOTH MUSCLE#0.7739;APOPTOTIC PROCESS#0.7733;DRUG RESISTANCE#0.7715;CLEFT PALATE#0.7710;ENDOPLASMIC RETICULUM STRESS#0.7686;CASPASE ACTIVITY#0.7667;HEPATOCELLULAR CARCINOMA CELL#0.7626;PERIPHERAL BLOOD#0.7615;ELECTROPHORETIC MOBILITY SHIFT#0.7605;RHAMNOSE BINDING#0.7587;OVARIAN#0.7580;CASPASE-9 ACTIVITY#0.7578;MYELOID LEUKEMIA#0.7575;MAPK SIGNALING#0.7572;FIBRIL#0.7566;MACROPHAGE#0.7560;ADENOCARCINOMA#0.7548;ENZYME ACTIVITY#0.7547;OVARIAN CANCER#0.7538;HYPOXIA#0.7524;MAP KINASE#0.7456;MITOCHONDRIAL MEMBRANE DEPOLARIZATION#0.7397;PROTEIN KINASE C#0.7317;MEMBRANE DEPOLARIZATION#0.7297;INFLAMMATORY RESPONSE#0.7279;OSSIFICATION#0.7265;ATHEROSCLEROSIS#0.7254;CYCLIN DEPENDENT KINASE#0.7231;5 FLUOROURACIL#0.7169;MONOCYTE#0.7096;HISTONE DEACETYLASE#0.7006;RAPAMYCIN#0.6964;INTERVERTEBRAL DISC#0.6919;N-ACETYLCYSTEINE#0.6886;5-AMINOISOQUINOLINE#0.6858;DIABETIC NEPHROPATHY#0.6851;HEAT SHOCK PROTEIN#0.6837;ONCOGENIC#0.6826;MONONUCLEAR CELLS#0.6824;REVERSE TRANSCRIPTION#0.6822;MESOTHELIOMA CELL#0.6806;CERVICAL#0.6754;NEPHROPATHY#0.6749;MULTIPLE MYELOMA#0.6639;STEM CELL#0.6585;INDUCIBLE NITRIC OXIDE#0.6573;CONNECTIVE TISSUE#0.6571;INTRINSIC APOPTOTIC PATHWAY#0.6566;DEPHOSPHORYLATION#0.6563;BONE MARROW#0.6510;REGULATION OF APOPTOSIS#0.6508;GROWTH FACTOR RECEPTOR#0.6420;COLONY FORMATION ASSAY#0.6380;TRADITIONAL CHINESE MEDICINE#0.6364;PACLITAXEL#0.6333;CYTOPLASM#0.6297;TUMOR TISSUES#0.6275;HOMOLOGOUS RECOMBINATION#0.6256;DNA METHYLATION#0.6255;CHONDROGENESIS#0.6253;ESTROGEN RECEPTOR#0.6250;APOPTOTIC SIGNALING PATHWAY#0.6235;EXTERNALIZATION OF PHOSPHATIDYLSERINE#0.6235;BORTEZOMIB#0.6229;NECROTIC#0.6212;IMATINIB#0.6204;VITAMIN D RECEPTOR#0.6182;GLYCOGEN SYNTHASE KINASE#0.6181;FLUOROURACIL#0.6172;HUMAN ARTICULAR CHONDROCYTES#0.6153;NEURONAL CELLS#0.6134;LECTIN#0.6132;EWING SARCOMA#0.6104;INSULIN-LIKE GROWTH FACTOR#0.6100;COLLAGEN INDUCED ARTHRITIS#0.6008
130340	PSORIASIS#0.7909
130367	SPHINGOSINE 1 PHOSPHATE#1.0219;SPHINGOSINE#1.0072;ENDOPLASMIC RETICULUM#0.6488
130399	ACTIVIN RECEPTOR#1.0668;CANCER CELL#1.0529;APOPTOSIS#1.0323;SIGNALING PATHWAY#1.0303;ADIPOSE TISSUE#1.0296;CELL PROLIFERATION#1.0134;TRANSFORMING GROWTH FACTOR#1.0124;BETA CELL#1.0101;GROWTH FACTOR#1.0076;OVARIAN CANCER#1.0003;ADIPOCYTE#0.9922;BREAST CANCER#0.9743;NODAL SIGNALING#0.9417;TRANSFORMING GROWTH FACTOR BETA#0.9288;BREAST CANCER CELL#0.9109;OVARIAN#0.8935;TROPHOBLAST CELL#0.8726;PANCREATIC ISLET#0.8204;GENE EXPRESSION#0.8041;TROPHOBLAST#0.7933;LIPOLYSIS#0.7750;GROWTH FACTOR RECEPTOR#0.7707;STEM CELL#0.7456;EPITHELIAL CELL#0.7396;INSULIN SECRETION#0.7246;PROTEIN KINASE#0.7150;EPITHELIAL OVARIAN CANCER#0.7118;ADIPOCYTE DIFFERENTIATION#0.6951;GRANULOSA CELL#0.6945;CELL GROWTH#0.6846;OBESE#0.6701;CARDIOMYOCYTE#0.6410;BONE MORPHOGENETIC PROTEIN#0.6295;APOPTOTIC#0.6215;GENE SILENCING#0.6104
1303	GENE EXPRESSION#0.9943;EXTRACELLULAR MATRIX#0.9678;CONNECTIVE TISSUE#0.9501;GROWTH FACTOR#0.7935;MYOPATHY#0.7435;FIBRIL#0.6860;COLORECTAL CANCER#0.6369;ANTERIOR CRUCIATE LIGAMENT#0.6275;CRUCIATE LIGAMENT#0.6266
130497	TRANSCRIPTION FACTOR#1.0560;MESENCHYME#1.0085;KIDNEY DEVELOPMENT#0.9857;PROGENITOR CELL#0.9698;OOCYTE#0.9265;NEPHRON#0.9161;ENDODERM DEVELOPMENT#0.8785;STEM CELL#0.8493;GENE EXPRESSION#0.8448;ALANINE#0.8447;METANEPHRIC MESENCHYME#0.8098;CANCER CELL#0.8051;CELL MEMBRANE#0.7631;URETERIC BUD#0.7476;CELL CYCLE#0.7468;LUNG SPECIFICATION#0.7448;MORPHOGENESIS#0.7240;TONGUE MORPHOGENESIS#0.7008;SIGNALING PATHWAY#0.6881;PALATE DEVELOPMENT#0.6540;RETINOIC ACID#0.6382;PODOCYTE DEVELOPMENT#0.6365;HYDRONEPHROSIS#0.6128;TUMOR SUPPRESSOR#0.6060
130507	UBIQUITIN#0.8363;PROTEASOME#0.6441;USHER SYNDROME#0.6342;DNA REPAIR#0.6041
130557	OPSIN#0.6601
130560	SPERMATOGENESIS#0.8274;APOPTOSIS#0.6644
130574	NICOTINIC ACETYLCHOLINE RECEPTOR#0.7151;ACETYLCHOLINE RECEPTOR#0.7128;PLASMA MEMBRANE#0.6126
130589	UDP GALACTOSE#0.9318;GALACTOSE METABOLISM#0.8953;LELOIR PATHWAY#0.8826;LACTOSE#0.7853;BETA GALACTOSIDASE#0.6532;GALACTOSEMIA#0.6229
1305	CONGENITAL MYASTHENIC SYNDROME#0.9493;EXTRACELLULAR MATRIX#0.7718;NEUROMUSCULAR JUNCTION#0.7135;GENE EXPRESSION#0.6212;CANCER CELL#0.6175
130617	GROWTH FACTOR#0.6959;SIGNAL PEPTIDE#0.6580
1306	GENE EXPRESSION#0.9210;BASEMENT MEMBRANE#0.8966;EXTRACELLULAR MATRIX#0.8271;ENDOTHELIAL CELL#0.8251;ANGIOGENESIS#0.6403;GROWTH FACTOR#0.6378
130733	MYELOID CELL#0.8314;CYTOKINE PRODUCTION#0.8279;PRO-INFLAMMATORY#0.8005;MACROPHAGE#0.6142
130749	LIPID DROPLET#0.6602
1307	EXTRACELLULAR MATRIX#0.7272;GENE EXPRESSION#0.6228
130872	ATPASE ACTIVITY#0.6514
1308	C TERMINAL DOMAIN#1.0707;CICATRICIAL PEMPHIGOID#1.0465;MUCOUS MEMBRANE PEMPHIGOID#1.0360;JUNCTIONAL EPIDERMOLYSIS BULLOSA#1.0326;IMMUNOGLOBULIN G#1.0304;HEMIDESMOSOME#1.0232;AUTOIMMUNE BLISTERING DISEASE#1.0229;BULLOUS PEMPHIGOID#1.0151;EPIDERMOLYSIS BULLOSA#1.0131;ANCHORING#1.0113;MUCOUS#1.0048;KERATINOCYTE#1.0022;T CELL#1.0010;CELL SURFACE#0.9999;LAMINA DENSA#0.9991;BASAL CELL#0.9990;EPIDERMOLYSIS BULLOSA ACQUISITA#0.9970;BLISTERING#0.9961;LICHEN PLANUS#0.9953;SKIN DISEASE#0.9945;EPITHELIAL CELL#0.9897;PEMPHIGUS VULGARIS#0.9895;NEUTROPHIL#0.9892;PEMPHIGUS#0.9882;EOSINOPHIL#0.9862;MAST CELL#0.9859;EXTRACELLULAR MATRIX#0.9832;BLISTERS#0.9823;BASEMENT MEMBRANE#0.9823;COMPLEMENT ACTIVATION#0.9822;IMMUNE RESPONSE#0.9816;AUTOIMMUNE DISEASE#0.9733;CELL MATRIX ADHESION#0.9668;POLYMERASE CHAIN REACTION#0.9573;AUTOIMMUNE BULLOUS DISEASES#0.9515;DERMIS#0.9488;TOPICAL#0.9277;INTERMEDIATE FILAMENT#0.9229;AUTOIMMUNITY#0.9228;PREDNISOLONE#0.9219;ERYTHEMA#0.9209;B CELL#0.9196;GENE EXPRESSION#0.9068;STEM CELL#0.9005;CORNEAL DYSTROPHY#0.8981;PLASMA MEMBRANE#0.8808;INFLAMMATORY CELL#0.8763;MRNA DECAY#0.8733;MAST CELL DEGRANULATION#0.8727;ESOPHAGUS#0.8720;CELL ADHESION#0.8711;NONSENSE-MEDIATED MRNA DECAY#0.8651;SQUAMOUS CELL CARCINOMA#0.8607;PERIPHERAL BLOOD#0.8576;EPIDERMOLYSIS BULLOSA SIMPLEX#0.8556;DIPEPTIDYL PEPTIDASE#0.8416;CELL-MATRIX ADHESION MOLECULE#0.8210;HUMAN EPIDERMAL KERATINOCYTES#0.8099;PREMATURE TERMINATION CODON#0.8086;RECURRENT CORNEAL EROSION#0.7992;CELL MIGRATION#0.7920;GROWTH FACTOR#0.7903;PSORIASIS#0.7866;HAIR FOLLICLE#0.7742;INFLAMMATORY RESPONSE#0.7734;OESOPHAGUS#0.7725;CELL MEMBRANE#0.7618;FIBRIL#0.7584;DAPSONE#0.7407;LUPUS ERYTHEMATOSUS#0.7255;T LYMPHOCYTE#0.7210;ALOPECIA#0.6992;DERMATITIS#0.6950;GLYCINE#0.6879;PANCREATIC CANCER#0.6859;THIEL-BEHNKE CORNEAL DYSTROPHY#0.6808;TH2 CELL#0.6700;DEMENTIA#0.6679;CYTOPLASM#0.6663;CD4+ T CELL#0.6618;ALZHEIMER'S DISEASE#0.6605;DIPEPTIDYL PEPTIDASE 4#0.6527;REVERSE TRANSCRIPTION#0.6431;BASAL EPITHELIAL CELL#0.6338;PROTEIN PROTEIN INTERACTION#0.6261;FOLLICLE STEM CELL#0.6225;ORAL MUCOSA#0.6200;CONNECTIVE TISSUE#0.6138;IMMUNOSUPPRESSANT#0.6054;LAMININ RECEPTOR#0.6020
130916	TRANSCRIPTION TERMINATION FACTOR#0.9628;MITOCHONDRIAL TRANSCRIPTION#0.9110;MITOCHONDRIAL TRANSCRIPTION TERMINATION#0.8858;MITOCHONDRIAL RIBOSOME#0.7719;MITOCHONDRIA#0.6827;PROTEIN COMPLEX#0.6699;CELL PROLIFERATION#0.6599;RIBOSOME#0.6194
130951	GERM CELL#0.9065;GERM CELL DEVELOPMENT#0.6866;CELL DEVELOPMENT#0.6659;MEIOSIS#0.6118
130	ETHANOL#0.9043;FERMENTATION#0.7016;DTMP SYNTHESIS#0.6442
131096	TRANSCRIPTION FACTOR#0.9417;POTASSIUM CHANNEL#0.8774;CANCER CELL#0.8284;BREAST CANCER CELL#0.7900;BREAST CANCER#0.7846;CELL PROLIFERATION#0.7837;CELL GROWTH#0.7008;NERVOUS SYSTEM#0.6998;PROSTATE CANCER#0.6333
1310	CERAMIDE KINASE#0.6568;LEUCINE RICH REPEAT#0.6146
131118	PROTEIN IMPORT#1.0473;ATPASE ACTIVITY#1.0160;DILATED CARDIOMYOPATHY#1.0004;MITOCHONDRIA#0.9717;MITOCHONDRIAL MEMBRANE#0.9703;CARDIOMYOPATHY#0.9117;TIM23 COMPLEX#0.9103;MITOCHONDRIAL PROTEIN IMPORT#0.8491;INNER MITOCHONDRIAL MEMBRANE#0.8406;MITOCHONDRIAL INNER MEMBRANE#0.8218;HEAT SHOCK PROTEIN#0.7707;MITOCHONDRIAL IMPORT MOTOR#0.7248;MITOCHONDRIAL MATRIX#0.6862;3-METHYLGLUTACONIC ACIDURIA#0.6800;NUCLEOTIDE EXCHANGE FACTOR#0.6411;CELL GROWTH#0.6228
131149	INNER EAR#0.9965
131177	FORMYL PEPTIDE RECEPTOR#0.7052;NEUTROPHIL#0.6581;GLUCAGON SECRETION#0.6424;SMALL INTESTINE#0.6297
1311	INTRACELLULAR RETENTION#1.0481;MULTIPLE EPIPHYSEAL DYSPLASIA#1.0354;ENDOPLASMIC RETICULUM#1.0318;COLLAGEN TYPE II#1.0311;HYALURONAN#1.0298;COLLAGEN TYPE III#1.0298;ROUGH ENDOPLASMIC RETICULUM#1.0278;COLLAGEN TYPE I#1.0237;C REACTIVE PROTEIN#1.0194;BONE MORPHOGENETIC PROTEIN#1.0182;SYNOVIAL FLUID#1.0140;HYALURONIC ACID#1.0140;SMOOTH MUSCLE#1.0135;FIBRIL#1.0135;ANGIOGENESIS#1.0132;SMOOTH MUSCLE CELL#1.0129;MUSCLE CELL#1.0102;HEPATOCELLULAR CARCINOMA#1.0073;SYNOVIUM#1.0062;TUMOR NECROSIS FACTOR#1.0047;CELL DEATH#1.0035;CYCLIC CITRULLINATED PEPTIDE#1.0033;ERYTHROCYTE SEDIMENTATION RATE#1.0019;REVERSE TRANSCRIPTION#1.0003;JOINT DAMAGE#0.9993;ENDOTHELIAL CELL#0.9983;PROTEOGLYCAN#0.9967;SIGNALING PATHWAY#0.9965;SYNOVITIS#0.9959;BONE FORMATION#0.9953;TRANSCRIPTION FACTOR#0.9940;KNEE JOINT#0.9929;ALKALINE PHOSPHATASE#0.9914;CHONDROCYTE#0.9905;CHONDROGENESIS#0.9881;APOPTOSIS#0.9871;POLYMERASE CHAIN REACTION#0.9869;CELL PROLIFERATION#0.9846;GENE EXPRESSION#0.9844;CRUCIATE LIGAMENT#0.9828;MACROPHAGE#0.9823;TRANSFORMING GROWTH FACTOR#0.9821;RHEUMATOID ARTHRITIS#0.9800;ENDOTHELIAL GROWTH FACTOR#0.9788;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9788;GRANULIN EPITHELIN PRECURSOR#0.9776;CONNECTIVE TISSUE#0.9775;VASCULAR SMOOTH MUSCLE CELL#0.9773;EXTRACELLULAR MATRIX#0.9768;GROWTH FACTOR#0.9766;ANTERIOR CRUCIATE LIGAMENT#0.9729;OSTEOARTHRITIS#0.9722;MAGNETIC RESONANCE IMAGING#0.9714;REGENERATION#0.9703;BONE MARROW#0.9672;INSULIN-LIKE GROWTH FACTOR#0.9661;TUMOUR NECROSIS FACTOR#0.9659;OSSIFICATION#0.9631;MESENCHYMAL STEM CELL#0.9631;PROGENITOR CELL#0.9627;ERYTHROCYTE#0.9619;MENISCUS#0.9606;C TERMINAL DOMAIN#0.9594;STEM CELL#0.9583;COLLAGEN INDUCED ARTHRITIS#0.9557;COLLAGENASE#0.9478;CELL SURFACE#0.9468;PRO-INFLAMMATORY#0.9460;INTERVERTEBRAL DISC#0.9460;EXTRACELLULAR MATRIX COMPONENT#0.9458;CANCER CELL#0.9402;SEXUAL DYSFUNCTION#0.9401;JUVENILE IDIOPATHIC ARTHRITIS#0.9370;BREAST CANCER#0.9292;QUANTITATIVE REAL TIME#0.9263;CHONDROSARCOMA#0.9254;OSTEOBLAST#0.9228;WOUND HEALING#0.9202;BONE GROWTH#0.9175;CELL ADHESION#0.9122;B CELL#0.9084;EPIDERMAL GROWTH FACTOR#0.9037;T CELL#0.8955;DISEASE ACTIVITY SCORE#0.8938;TRANSFORMING GROWTH FACTOR BETA#0.8931;ARTERY#0.8910;SKELETAL DEVELOPMENT#0.8875;BONE RESORPTION#0.8870;NITRIC OXIDE#0.8819;JOINT SPACE NARROWING#0.8794;APOPTOTIC#0.8783;ATHEROSCLEROTIC#0.8741;PROSTATE CANCER#0.8732;COLON CANCER#0.8705;PROTEIN SYNTHESIS#0.8676;PSORIATIC ARTHRITIS#0.8665;IMMUNE RESPONSE#0.8662;HIP JOINT#0.8651;RECEPTOR ACTIVATOR#0.8632;MATRIX METALLOPROTEINASE 13#0.8628;INFLAMMATORY RESPONSE#0.8627;STROMAL CELL#0.8612;CHONDROCYTE PROLIFERATION#0.8609;DIGESTION#0.8606;DEDIFFERENTIATION#0.8600;ENDOCHONDRAL OSSIFICATION#0.8562;CARTILAGE FORMATION#0.8544;OSTEOARTHRITIC CARTILAGE#0.8526;INFLIXIMAB#0.8512;FIBRILLAR COLLAGEN#0.8458;EARLY RHEUMATOID ARTHRITIS#0.8434;HUMAN MESENCHYMAL STEM#0.8334;PANCREATIC CANCER#0.8299;NUCLEUS PULPOSUS#0.8286;ADIPOSE TISSUE#0.8251;HEPARIN#0.8249;PERIPHERAL BLOOD#0.8228;OSTEOCHONDRODYSPLASIA#0.8203;OSTEOGENESIS#0.8191;MYOFIBROBLAST#0.8163;CYTOPLASM#0.8105;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8078;FACTOR I#0.8067;ATHEROSCLEROSIS#0.8041;BLOOD VESSEL#0.8034;PROTEIN KINASE#0.8025;HYPOXIA#0.8003;MESENCHYMAL CELL#0.7992;TISSUE DAMAGE#0.7933;MATRIX GLA PROTEIN#0.7918;SWELLING#0.7903;FIBROBLAST GROWTH FACTOR#0.7902;ALPHA-2 MACROGLOBULIN#0.7850;FEMALE SEXUAL DYSFUNCTION#0.7848;MATRIX METALLOPROTEINASE 1#0.7844;COLLAGEN DEGRADATION#0.7836;JOINT PAIN#0.7825;OSTEOCLAST#0.7799;CELL ADHESION MOLECULE#0.7737;DIASTROPHIC DYSPLASIA#0.7723;CELL MIGRATION#0.7692;COLLAGEN SYNTHESIS#0.7677;BONE MINERAL DENSITY#0.7633;MONOCYTE#0.7615;CELL DIFFERENTIATION#0.7595;MITOGEN ACTIVATED PROTEIN#0.7529;COMPLEMENT ACTIVATION#0.7451;ACINAR CELL#0.7369;SCLERODERMA#0.7367;PROSTAGLANDIN E2#0.7356;INDUCED RENAL INJURY#0.7318;MEDULLOBLASTOMA#0.7301;LECTIN#0.7294;SPINAL CORD#0.7260;IL-1RA#0.7246;DERMAL FIBROBLAST#0.7238;DERMIS#0.7210;IMMUNOGLOBULIN G#0.7181;ASPARTIC ACID#0.7173;NERVOUS SYSTEM#0.7168;MINERALIZATION#0.7154;RANDOMIZED CONTROLLED TRIAL#0.7130;FIBRINOGEN#0.7127;COLLAGEN BINDING#0.7095;HEPARIN BINDING#0.7033;CHONDROCYTE DIFFERENTIATION#0.7023;PATELLA#0.7005;TIBIA#0.6990;FEMUR#0.6972;BASEMENT MEMBRANE#0.6966;PROTEIN FOLDING#0.6941;TUMOR CELLS#0.6940;TYPE 2 DIABETES#0.6938;CHONDROGENIC CELL#0.6927;EPITHELIAL CELL#0.6923;TRANSCRIPTASE#0.6878;GLUTATHIONE#0.6862;CARTILAGE DEVELOPMENT#0.6861;METHOTREXATE#0.6856;HUMAN ARTICULAR CHONDROCYTES#0.6832;REACTIVE ARTHRITIS#0.6831;RECEPTOR ANTAGONIST#0.6788;LASER DESORPTION IONIZATION#0.6739;PANCREATITIS#0.6736;RHEUMATIC DISEASE#0.6732;BECK DEPRESSION INVENTORY#0.6709;ENDOPLASMIC RETICULUM STRESS#0.6685;CENTRAL NERVOUS SYSTEM#0.6671;HEPATITIS C#0.6628;GROWTH FACTOR BINDING#0.6625;SCIATIC NERVE#0.6616;CATABOLISM#0.6611;EDEMA#0.6596;LIVER DISEASE#0.6555;INFLAMMATORY CELL#0.6533;CORONARY ARTERY#0.6500;ENDOTHELIUM#0.6473;UNFOLDED PROTEIN RESPONSE#0.6461;ADIPOGENESIS#0.6443;PLATELET-DERIVED GROWTH FACTOR#0.6425;AUTOIMMUNE DISEASE#0.6398;HYPERTENSION#0.6382;LEUCINE#0.6374;GUANIDINE#0.6302;ARTHROPATHY#0.6284;TOCILIZUMAB#0.6283;NEUROFILAMENT#0.6267;PSEUDOHYPHAL GROWTH#0.6248;GROUND REACTION FORCE#0.6243;PERIPHERAL NERVE#0.6218;CELL CYCLE#0.6175;VSMC DIFFERENTIATION#0.6162;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.6147;SCOLIOSIS#0.6145;CAROTID ARTERY#0.6141;TISSUE REGENERATION#0.6137;WHITE BLOOD CELL#0.6130;SCANNING ELECTRON MICROSCOPY#0.6117;RETINOIC ACID#0.6116;TOLL LIKE RECEPTOR#0.6107;NITRIC OXIDE SYNTHASE#0.6099;CELL GROWTH#0.6059;HYPERGLYCEMIA#0.6049;LUNG FIBROBLASTS#0.6020;IDIOPATHIC SCOLIOSIS#0.6003
1312	DOPAMINE DEGRADATION#1.1008;O-METHYLTRANSFERASE I#1.0998;DOPAMINE CATABOLISM#1.0640;O-METHYLTRANSFERASE ACTIVITY#1.0568;SEROTONIN RECEPTOR#1.0527;HEARING LOSS#1.0527;METHYLTRANSFERASE ACTIVITY#1.0459;HISTAMINE N METHYLTRANSFERASE#1.0456;DOPAMINE D4 RECEPTOR#1.0434;COMT I#1.0429;ENDOMETRIAL CANCER#1.0428;PHENYLETHANOLAMINE N METHYLTRANSFERASE#1.0422;TOLCAPONE#1.0405;LUNG CANCER#1.0404;QUERCETIN#1.0396;MU OPIOID RECEPTOR#1.0394;OPIOID RECEPTOR#1.0360;N METHYLTRANSFERASE#1.0353;ENTACAPONE#1.0349;MIGRAINE#1.0349;EATING DISORDER#1.0342;AMANTADINE#1.0327;CATECHOLAMINE METABOLISM#1.0324;CATECHOL O METHYLTRANSFERASE#1.0293;O METHYLTRANSFERASE#1.0288;2-METHOXYESTRADIOL#1.0276;FIBROMYALGIA#1.0271;PARGYLINE#1.0258;RED BLOOD CELL#1.0256;TRYPTOPHAN#1.0248;PROLINE DEHYDROGENASE#1.0233;VALINE#1.0221;TRAUMATIC BRAIN INJURY#1.0220;AGGRESSIVE BEHAVIOR#1.0214;CORTISOL#1.0213;PANIC DISORDER#1.0192;ADOMET#1.0186;ENDOMETRIOSIS#1.0184;3,4-DIHYDROXYBENZOIC ACID#1.0182;FRAGMENT LENGTH POLYMORPHISM#1.0178;ISOPRENALINE#1.0171;CATABOLISM#1.0171;DOPAMINE D2 RECEPTOR#1.0169;PROSTATE CANCER#1.0162;DOPAMINE METABOLISM#1.0162;ERYTHROCYTE#1.0161;L-DOPA#1.0159;OVARIAN CANCER#1.0152;CISPLATIN#1.0149;S-ADENOSYL-L-HOMOCYSTEINE#1.0145;CYTOCHROME P450#1.0137;S-ADENOSYL-L-METHIONINE#1.0118;DOPAMINE RECEPTOR#1.0116;LEVODOPA#1.0115;OBSESSIVE COMPULSIVE DISORDER#1.0109;PERSONALITY DISORDER#1.0100;ALCOHOL DEPENDENCE#1.0091;SELEGILINE#1.0088;MAJOR DEPRESSIVE DISORDER#1.0087;S-ADENOSYLMETHIONINE#1.0084;OTOTOXICITY#1.0080;GRAY MATTER VOLUME#1.0078;GLIAL CELL#1.0073;DORSOLATERAL PREFRONTAL CORTEX#1.0072;L-METHIONINE#1.0063;DEPRESSIVE SYMPTOMS#1.0058;GREEN TEA EXTRACT#1.0041;DETOXIFICATION#1.0040;ADRENERGIC RECEPTOR#1.0038;RECEPTOR AGONIST#1.0033;CANCER CELL#1.0030;MOOD DISORDER#1.0030;ESTROGEN METABOLISM#1.0021;CARBIDOPA#1.0020;GLUTATHIONE#1.0018;ANXIETY DISORDER#1.0010;AMYGDALA#1.0009;METHIONINE#1.0007;LEIOMYOMA#1.0006;METHYLDOPA#0.9998;DNA METHYLATION#0.9996;CATALYTIC ACTIVITY#0.9996;HEROIN#0.9995;CONJUGATION#0.9993;POLYMERASE CHAIN REACTION#0.9990;POSITRON EMISSION TOMOGRAPHY#0.9989;EPINEPHRINE#0.9988;3,4-DIHYDROXYPHENYLALANINE#0.9986;ADRENALINE#0.9984;ESTROGEN RECEPTOR#0.9981;BIPOLAR DISORDER#0.9978;FOLATE#0.9978;BREAST CANCER#0.9973;NORADRENALINE#0.9966;DOPAMINE#0.9965;ESTROGENS#0.9957;OVARIAN#0.9954;ANOREXIA NERVOSA#0.9954;COGNITION#0.9952;PROGESTERONE#0.9952;PSYCHOTIC DISORDER#0.9951;BREAST CANCER PATIENTS#0.9943;ALZHEIMER'S DISEASE#0.9941;CELL PROLIFERATION#0.9917;PERIPHERAL BLOOD#0.9913;FRONTAL#0.9904;LINKED POLYMORPHIC REGION#0.9903;NICOTINE DEPENDENCE#0.9894;VELOCARDIOFACIAL SYNDROME#0.9892;AGE AT ONSET#0.9883;EPIGALLOCATECHIN#0.9883;ENZYME ACTIVITY#0.9879;NOREPINEPHRINE#0.9874;HYPERTENSION#0.9871;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9864;MAGNETIC RESONANCE IMAGING#0.9862;ESTRADIOL#0.9846;HYPERACTIVITY#0.9844;COLORECTAL CANCER#0.9827;SMOOTH MUSCLE#0.9820;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9814;STRIATUM#0.9812;EXCRETION#0.9811;HISTAMINE#0.9811;NEUROTRANSMISSION#0.9795;BREAST CANCER SURVIVORS#0.9792;MENTAL DISORDER#0.9790;PARKINSON'S DISEASE#0.9790;HEROIN DEPENDENCE#0.9786;CONDUCT DISORDER#0.9779;STRESSFUL LIFE EVENTS#0.9774;DOPAMINERGIC NEURON#0.9773;DEMENTIA#0.9752;N ACETYLTRANSFERASE#0.9744;RECEPTOR ANTAGONIST#0.9741;APOMORPHINE#0.9740;METHYLPHENIDATE#0.9739;GENE EXPRESSION#0.9727;EPITHELIAL CELL#0.9724;REVERSE TRANSCRIPTION#0.9715;ARTERY#0.9714;TOXICITY#0.9712;ADJUSTED ODDS RATIO#0.9711;HALLUCINATIONS#0.9711;DIFFUSION TENSOR IMAGING#0.9695;DYSKINESIA#0.9691;GENETIC ASSOCIATION STUDIES#0.9683;BLOOD BRAIN BARRIER#0.9681;RESERPINE#0.9667;PREPULSE INHIBITION#0.9650;CENTRAL NERVOUS SYSTEM#0.9637;SUBSTANTIA NIGRA#0.9630;ESTROGEN RECEPTOR ALPHA#0.9627;DEFAULT MODE NETWORK#0.9609;MICROSOME#0.9594;SUBSTANCE ABUSE#0.9592;NERVOUS SYSTEM#0.9587;MEDIAL PREFRONTAL CORTEX#0.9586;SMOOTH MUSCLE CELL#0.9585;ADENOSINE#0.9581;MUSCLE CELL#0.9578;METHAMPHETAMINE#0.9575;STARTLE RESPONSE#0.9573;BETA-2#0.9556;NEUROLOGICAL DISORDER#0.9555;SIGNALING PATHWAY#0.9548;PRE-ECLAMPSIA#0.9547;MECHANISM OF ACTION#0.9541;VOXEL BASED MORPHOMETRY#0.9524;HUMAN BREAST CANCER#0.9522;VITAMIN B12#0.9508;HALOPERIDOL#0.9505;BREAST CANCER CELL#0.9498;GROWTH FACTOR#0.9486;DEEP BRAIN STIMULATION#0.9484;SUPEROXIDE DISMUTASE#0.9483;TEMPORAL LOBE#0.9482;ADRENAL GLAND#0.9480;ANTERIOR CINGULATE CORTEX#0.9466;CEREBRAL CORTEX#0.9459;COLORECTAL#0.9446;NITRIC OXIDE#0.9439;SUBSTANCE USE DISORDER#0.9415;TRANSMISSION DISEQUILIBRIUM TEST#0.9406;ANOREXIA#0.9402;DOPAMINE SYNTHESIS#0.9379;HARDY WEINBERG EQUILIBRIUM#0.9364;BASAL GANGLIA#0.9361;STRUCTURE ACTIVITY RELATIONSHIP#0.9353;BORDERLINE PERSONALITY DISORDER#0.9333;APOPTOSIS#0.9319;CLOZAPINE#0.9313;AUTISM SPECTRUM DISORDER#0.9312;FIRST EPISODE PSYCHOSIS#0.9312;BRAIN DEVELOPMENT#0.9263;TYPE 2 DIABETES#0.9259;CYTOTOXICITY#0.9238;DRUG METABOLISM#0.9231;LOW BACK PAIN#0.9231;RECEPTOR BINDING#0.9229;UTERUS#0.9227;MOLECULAR DYNAMICS SIMULATION#0.9204;SCHIZOPHRENIA SPECTRUM DISORDER#0.9203;VITAMIN E#0.9203;SPATIAL WORKING MEMORY#0.9199;HEALTHY CONTROL SUBJECTS#0.9195;ESTRONE#0.9188;BROMOCRIPTINE#0.9175;RISPERIDONE#0.9165;HORMONE METABOLISM#0.9160;ANTIDEPRESSANT TREATMENT RESPONSE#0.9153;RANDOMIZED CONTROLLED TRIAL#0.9141;HYDROXYLASE ACTIVITY#0.9119;MIDBRAIN#0.9101;GLUTAMATE RECEPTOR#0.9076;REACTIVE OXYGEN SPECIES#0.9063;LITHIUM#0.9059;OBESE#0.9049;ROPINIROLE#0.9027;PRAMIPEXOLE#0.9013;RESPONSE TO TREATMENT#0.9004;HYPERHOMOCYSTEINEMIA#0.8986;SEROTONIN REUPTAKE INHIBITOR#0.8985;ENDOTHELIAL CELL#0.8981;ASTROCYTE#0.8917;URIC ACID#0.8908;LEUKOCYTE#0.8902;ISOPROTERENOL#0.8880;MONOAMINE OXIDASE ACTIVITY#0.8875;MENOPAUSE#0.8864;GRANULOSA CELL#0.8862;GENERAL LINEAR MODEL#0.8862;ASCORBIC ACID#0.8859;17β-ESTRADIOL#0.8791;LINES OF EVIDENCE#0.8777;GREEN TEA CATECHIN#0.8773;ALEXITHYMIA#0.8764;ADENINE#0.8756;FALSE DISCOVERY RATE#0.8728;NERVE ENDING#0.8707;PLASMA MEMBRANE#0.8706;OXIDATIVE DNA DAMAGE#0.8700;ESTROGEN BIOSYNTHESIS#0.8682;URIDINE#0.8650;HEPATOTOXICITY#0.8647;DESIPRAMINE#0.8643;GENOTOXIC#0.8636;THALAMUS#0.8625;DIABETES MELLITUS#0.8602;RESPONSE TO MORPHINE#0.8599;BIPOLAR I DISORDER#0.8594;NEUROBLASTOMA#0.8581;HYPOTHALAMIC PITUITARY ADRENAL#0.8566;BETA-ESTRADIOL#0.8563;NEURODEGENERATIVE DISEASE#0.8555;ISCHEMIA#0.8551;DOPAMINE D3 RECEPTOR#0.8545;SMALL INTESTINE#0.8543;RASAGILINE#0.8529;CAFFEINE#0.8528;PROPRANOLOL#0.8494;SCHIZOAFFECTIVE DISORDER#0.8480;PROTEIN KINASE#0.8469;ASPARTATE#0.8454;CONTINUOUS PERFORMANCE TEST#0.8452;IRRITABLE BOWEL SYNDROME#0.8419;DNA REPAIR#0.8399;BETA ADRENOCEPTOR#0.8371;DNA METHYLTRANSFERASE#0.8365;MENSTRUAL CYCLE#0.8345;OXIDATIVE METABOLISM#0.8342;EARLY LIFE STRESS#0.8341;ENZYME INHIBITOR#0.8330;BLOOD VESSEL#0.8317;CORONARY ARTERY#0.8295;MILD COGNITIVE IMPAIRMENT#0.8286;SYNAPTIC CLEFT#0.8277;NICOTINE REPLACEMENT THERAPY#0.8275;HYPERACTIVE#0.8267;CARCINOGEN#0.8252;NEUROTOXICITY#0.8249;GLUCOCORTICOID RECEPTOR#0.8225;THIOPURINE S METHYLTRANSFERASE#0.8223;ECLAMPSIA#0.8223;TESTOSTERONE#0.8212;BLOOD PRESSURE REGULATION#0.8211;ANGIOTENSIN CONVERTING ENZYME#0.8211;DIARRHEA#0.8209;S METHYLTRANSFERASE#0.8194;TRAIL MAKING TEST#0.8163;DEPRESSION RATING SCALE#0.8162;NMDA RECEPTOR#0.8162;FOLIC ACID#0.8134;HYPOXIA#0.8120;IL-1RN#0.8116;NERVE TERMINAL#0.8071;SLEEPINESS#0.8067;NATRIURESIS#0.8063;MENARCHE#0.8061;SPINAL CORD#0.8044;GENE X ENVIRONMENT#0.8012;ENDOMETRIUM#0.8000;PARANOID SCHIZOPHRENIA#0.7995;NEUROTOXIC#0.7976;FENTANYL#0.7973;T CELL#0.7961;CAUDATE NUCLEUS#0.7960;OESTRADIOL#0.7952;RESPONSE TO CLOZAPINE#0.7929;HEART DISEASE#0.7921;PINEAL GLAND#0.7919;HYPERSENSITIVITY#0.7897;ACETYLCHOLINE#0.7888;CELL DEATH#0.7872;CELL GROWTH#0.7839;TUMOR NECROSIS FACTOR#0.7832;CELL CYCLE#0.7814;PROSTATE CARCINOMA#0.7810;ADRENAL MEDULLA#0.7808;FOREBRAIN#0.7792;CHRONIC SCHIZOPHRENIA#0.7774;OLANZAPINE#0.7756;TRANSIENT RECEPTOR POTENTIAL#0.7744;GILLES DE LA TOURETTE SYNDROME#0.7731;CHRONIC WIDESPREAD PAIN#0.7711;DOBUTAMINE#0.7709;SYSTOLIC BLOOD PRESSURE#0.7705;ACETIC ACID#0.7699;SULFATION#0.7696;GLUTAMIC ACID#0.7692;QUANTITATIVE REAL TIME#0.7689;BULIMIA NERVOSA#0.7687;DULOXETINE#0.7665;GESTATION#0.7606;MOTOR LEARNING#0.7596;UNCONDITIONAL LOGISTIC REGRESSION#0.7593;RESPONSE TO METHYLPHENIDATE#0.7587;APOPTOTIC#0.7578;VOMITING#0.7571;ACUTE CORONARY EVENTS#0.7569;ATP BINDING CASSETTE#0.7512;DNA SYNTHESIS#0.7508;ATP BINDING#0.7496;D-AMPHETAMINE#0.7495;NITRIC OXIDE SYNTHASE#0.7487;ETHANOL#0.7461;TRANSCRIPTION FACTOR#0.7456;L-DIHYDROXYPHENYLALANINE#0.7433;CHROMOSOMAL REGION#0.7430;FLUOXETINE#0.7420;PSORIASIS#0.7417;SUBTHALAMIC NUCLEUS#0.7398;GLYCINE#0.7383;SOLUBLE FRACTION#0.7365;PERGOLIDE#0.7356;DENTAL PULP#0.7337;MELANOCYTE#0.7330;DYSTONIA#0.7320;MYOCARDIAL INFARCTION#0.7318;CORPUS STRIATUM#0.7316;IMMUNE SYSTEM#0.7309;MULTIPLE LINEAR REGRESSION#0.7307;STEM CELL#0.7284;POST-TRAUMATIC STRESS DISORDER#0.7276;RESPONSE TO FLUOXETINE#0.7258;INFERIOR FRONTAL GYRUS#0.7254;ICI 182,780#0.7253;SOCIAL BEHAVIOR#0.7241;MICROTUBULE#0.7239;SIGNAL TRANSDUCTION#0.7235;DIZZINESS#0.7235;GUANINE#0.7224;PANCREATIC CANCER#0.7214;XENOBIOTIC METABOLISM#0.7199;PRESSURE PAIN THRESHOLD#0.7188;IOWA GAMBLING TASK#0.7187;POSTPARTUM DEPRESSION#0.7177;MODAFINIL#0.7158;CORD BLOOD#0.7154;ALANINE#0.7127;RESPONSE TO ANTIDEPRESSANT#0.7116;AGE AT MENARCHE#0.7112;HYPOXIC#0.7094;POLYCYCLIC AROMATIC HYDROCARBON#0.7091;DOPAMINE RECEPTOR D1#0.7078;THEORY OF MIND#0.7074;CONDITIONAL LOGISTIC REGRESSION#0.7020;CYTOPLASM#0.7018;DECARBOXYLASE ACTIVITY#0.7010;ROTIGOTINE#0.6987;LUMINAL#0.6970;CATECHOLAMINE CATABOLISM#0.6961;VENOUS BLOOD#0.6944;NEURONAL CELLS#0.6933;NARCOLEPSY#0.6921;INNERVATION#0.6917;METHADONE#0.6914;DUODENUM#0.6904;DEMETHYLATION#0.6885;IMIPRAMINE#0.6878;MAMMARY GLAND#0.6871;UTERINE FIBROID#0.6851;BETA-HYDROXYSTEROID DEHYDROGENASE#0.6850;NOCICEPTION#0.6849;GLUTAMATE DECARBOXYLASE#0.6838;NEUROPATHY#0.6792;SKIN FIBROBLASTS#0.6792;MECHANISMS OF ACTION#0.6787;MEMBRANE FRACTION#0.6782;MYOMETRIUM#0.6780;TRANSLATION INITIATION#0.6777;CERVICAL#0.6771;ADVERSE DRUG REACTION#0.6741;TOWER OF LONDON#0.6733;MUTAGENIC#0.6717;PERIPHERAL NERVOUS SYSTEM#0.6714;L-DOPS#0.6692;CABERGOLINE#0.6686;TYPE 2 DIABETES MELLITUS#0.6676;2 DIABETES MELLITUS#0.6676;VASCULAR DISEASE#0.6675;IMPULSE CONTROL DISORDER#0.6669;DIPHOSPHATE#0.6665;WEIGHT GAIN#0.6663;VASCULAR SMOOTH MUSCLE CELL#0.6661;ALPHA AMYLASE#0.6659;GREEN TEA POLYPHENOL#0.6644;SKELETAL MUSCLE#0.6644;PARTURITION#0.6639;ENDOTHELIAL NITRIC OXIDE#0.6627;HYPOTENSION#0.6623;THYMIDYLATE SYNTHASE#0.6623;HYPOXIA INDUCIBLE FACTOR#0.6617;DRINKING BEHAVIOR#0.6582;CHRONIC FATIGUE SYNDROME#0.6579;PAROXETINE#0.6574;ACUTE KIDNEY INJURY#0.6564;COLLAGEN SYNTHESIS#0.6552;MODE OF ACTION#0.6520;RESPONSE TO PAIN#0.6511;ATHEROSCLEROSIS#0.6509;DOPAMINE UPTAKE#0.6508;SICKLE CELL DISEASE#0.6499;LIMBIC SYSTEM#0.6486;RESPONSE TO ANTIPSYCHOTIC DRUG#0.6474;LINEAR MIXED MODEL#0.6473;MINOR ALLELE FREQUENCY#0.6469;GLUTATHIONE TRANSFERASE#0.6456;CANNABIS ABUSE#0.6450;DIGESTION#0.6443;SENSITIZATION#0.6428;RESPIRATORY CHAIN#0.6420;EXTRACELLULAR SPACE#0.6418;ECSTASY#0.6410;CIRCADIAN RHYTHM#0.6410;RANDOMIZED CLINICAL TRIAL#0.6408;CODEINE#0.6403;HORMONE BINDING#0.6402;VENLAFAXINE#0.6377;GENERALIZED ANXIETY DISORDER#0.6365;CELL MIGRATION#0.6358;RESPONSE TO DRUG#0.6336;NORADRENALINE UPTAKE#0.6334;TUMOR CELLS#0.6319;MOTOR BEHAVIOR#0.6289;PHEOCHROMOCYTOMA#0.6285;ABNORMAL INVOLUNTARY MOVEMENT#0.6273;WAKEFULNESS#0.6249;ESTROGEN RESPONSE ELEMENT#0.6244;TEMPOROMANDIBULAR JOINT DISORDER#0.6244;EPOXIDE HYDROLASE#0.6209;RESPONSE TO RISPERIDONE#0.6209;SERIAL REACTION TIME#0.6207;CONSTIPATION#0.6202;NEURAL TUBE#0.6201;REGION OF INTEREST#0.6189;OPPOSITIONAL DEFIANT DISORDER#0.6184;PUBERTY#0.6181;ESSENTIAL HYPERTENSION#0.6181;NOMIFENSINE#0.6176;ANGIOGENESIS#0.6166;COLON CANCER#0.6142;CHANGE FROM BASELINE#0.6122;SCHIZOPHRENIA 1#0.6112;TETRAHYDROCANNABINOL#0.6109;PROTEASOME#0.6105;CANINE MAMMARY TUMORS#0.6100;SEDATION#0.6094;TURNING BEHAVIOR#0.6086;LIVER DISEASE#0.6065;STRUCTURAL EQUATION MODELING#0.6064;ADIPOSE TISSUE#0.6059;ENDOPLASMIC RETICULUM#0.6057;RESPONSE TO AMPHETAMINE#0.6049;BINGE EATING DISORDER#0.6043;DELTA OPIOID RECEPTOR#0.6027;CHOLINE#0.6017;3,4-METHYLENEDIOXYMETHAMPHETAMINE#0.6013;NEURAL TUBE DEFECT#0.6009;JOINT DISORDER#0.6006
131375	SPERMATOZOA#0.6799;FERTILIZATION#0.6744;EPIDIDYMIS#0.6565;ACROSOMAL MEMBRANE#0.6170
131377	NEMALINE MYOPATHY#1.0900;MYOPATHY#1.0048;SKELETAL MUSCLE#0.8822;BTB DOMAIN#0.6364;RESPONSE TO TREATMENT#0.6045
131405	STEM CELL#1.0509;RNA BINDING#1.0341;RNA BINDING PROTEIN#1.0011;UBIQUITIN#0.9764;EMBRYONIC STEM CELL#0.9248;CELL PROLIFERATION#0.8986;OOCYTE GROWTH#0.8383;OOCYTE#0.8147;GENE EXPRESSION#0.8078;STEM CELL PROLIFERATION#0.7775;TRANSCRIPTION FACTOR#0.7727;LUNG CANCER#0.7451;GENE SILENCING#0.7310;NEURAL TUBE CLOSURE#0.7158;TUBE CLOSURE#0.7156;NEURAL TUBE#0.7021;CELL CYCLE#0.6628;DEVELOPMENTAL TIMING#0.6377;TERMINAL DIFFERENTIATION#0.6297
131450	MYELOID CELL#1.0567;MAST CELL#1.0257;CD4+ T CELL#1.0237;MONOCYTE#1.0172;MACROPHAGE#1.0153;DENDRITIC CELL#1.0121;CELL SURFACE#1.0114;SIGNALING PATHWAY#1.0091;IMMUNE RESPONSE#1.0053;PERIPHERAL BLOOD#1.0052;PRO-INFLAMMATORY#1.0034;T CELL#1.0007;INFLAMMATORY RESPONSE#0.9964;TUMOR CELLS#0.9914;IMMUNE CELL#0.9867;REGULATORY T CELL#0.9848;T LYMPHOCYTE#0.9744;CYTOKINE PRODUCTION#0.9714;GENE EXPRESSION#0.9711;BASOPHIL#0.9709;CELL ACTIVATION#0.9611;MULTIPLE SCLEROSIS#0.9590;BONE MARROW#0.9557;NERVOUS SYSTEM#0.9479;LEUKOCYTE#0.9464;TUMOR NECROSIS FACTOR#0.9437;IMMUNE SYSTEM#0.9296;STROMAL CELL#0.9256;CENTRAL NERVOUS SYSTEM#0.9237;MACROPHAGE ACTIVATION#0.9165;GLIAL CELL#0.9088;MICROGLIAL CELL#0.9021;AUTOIMMUNE DISEASE#0.8885;SPINAL CORD#0.8842;TROPHOBLAST#0.8826;B CELL#0.8780;CANCER CELL#0.8667;BASOPHIL ACTIVATION#0.8625;BREAST CANCER#0.8540;CD8+ T CELL#0.8331;RHEUMATOID ARTHRITIS#0.8329;GRANULOCYTE#0.8317;LYMPH NODE#0.8277;STEM CELL#0.8269;APOPTOSIS#0.8152;M2 MACROPHAGE#0.8111;ENDOTHELIAL CELL#0.8015;MONONUCLEAR CELLS#0.7985;NEUTROPHIL#0.7879;EPITHELIAL CELL#0.7713;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7702;PARKINSON'S DISEASE#0.7697;NEURODEGENERATIVE DISEASE#0.7654;POLYMERASE CHAIN REACTION#0.7625;MACROPHAGE POLARIZATION#0.7625;COLITIS#0.7619;COLLAGEN INDUCED ARTHRITIS#0.7593;ANTIGEN PRESENTING CELLS#0.7535;LYMPHOID CELL#0.7494;MAST CELL ACTIVATION#0.7462;NITRIC OXIDE#0.7431;HEPATOCELLULAR CARCINOMA#0.7252;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7239;CYTOTOXIC T-LYMPHOCYTE#0.7196;MYELOID-DERIVED SUPPRESSOR CELL#0.7028;NITRIC OXIDE SYNTHASE#0.6997;TREG CELL#0.6969;ENCEPHALOMYELITIS#0.6957;BLOOD VESSEL#0.6923;CELL PROLIFERATION#0.6883;MONOCYTE DERIVED MACROPHAGE#0.6875;GROWTH FACTOR#0.6869;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6795;LUPUS ERYTHEMATOSUS#0.6792;TRANSCRIPTION FACTOR#0.6764;BREAST CANCER CELL#0.6764;SPONTANEOUS ABORTION#0.6440;MANNOSE RECEPTOR#0.6406;TH2 CELL#0.6378;IMMUNE EVASION#0.6361;INDUCIBLE NITRIC OXIDE#0.6242;TOLL LIKE RECEPTOR#0.6185;EFFECTOR T CELL#0.6139;TH17 CELL#0.6127;T CELL ACTIVATION#0.6022;INFLAMMATORY CELL#0.6021;MONOCYTE DERIVED DENDRITIC CELL#0.6012;OSTEOCLAST#0.6005;COLONY-STIMULATING FACTOR#0.6003
131474	OXIDATIVE PROTEIN FOLDING#1.0409;MITOCHONDRIAL INTERMEMBRANE SPACE#1.0364;RESPIRATORY CHAIN#1.0345;PROTEIN IMPORT#1.0322;PROTEIN FOLDING#1.0295;MITOCHONDRIA#1.0151;CYTOCHROME C#0.9971;THIOL OXIDASE#0.9667;OUTER MEMBRANE#0.9495;COMPLEX I#0.9220;ELECTRON TRANSFER#0.9020;HYPOXIA#0.8598;MITOCHONDRIAL PROTEIN IMPORT#0.8152;GLUTATHIONE#0.7747;APOPTOSIS#0.7625;COPPER CHAPERONE#0.7076;C TERMINAL DOMAIN#0.6872;APOPTOSIS INDUCING FACTOR#0.6697;MEMBRANE OF MITOCHONDRIA#0.6431;LIVER REGENERATION#0.6369;CHAPERONE COMPLEX#0.6323;MITOCHONDRIAL RESPIRATORY CHAIN#0.6278;RESPIRATORY CHAIN COMPLEX#0.6256;METAL BINDING#0.6096;SUPEROXIDE DISMUTASE#0.6061
1314	COATOMER#1.0745;INSULIN SECRETION#1.0343;PROTEIN COMPLEX#1.0067;GASTRIC MUCOSA#0.9873;OBESE#0.9328;ENDOCRINE CELL#0.9062;SMOOTH MUSCLE#0.9031;COPPER HOMEOSTASIS#0.8859;BETA CELL#0.8715;COPPER CHAPERONE#0.8476;ANTISENSE RNA#0.8290;PEPTIDE HORMONE#0.8032;SIGNALING PATHWAY#0.7944;ENDOPLASMIC RETICULUM#0.7794;JEJUNUM#0.7770;PANCREATIC ISLET#0.7207;COATED VESICLE#0.7202;TYPE 2 DIABETES#0.7072;ARGININE#0.6669;SIGNALLING PATHWAY#0.6371;LYSINE#0.6351;COMPLEX I#0.6314;WHITE ADIPOSE TISSUE#0.6100;LIPID METABOLISM#0.6032;GASTROINTESTINAL TRACT#0.6012;ADIPOSE TISSUE#0.6010
131540	LUNG SQUAMOUS CELL CARCINOMA#0.7418;SQUAMOUS CELL CARCINOMA#0.7143;PALMITOYL#0.6464
131544	M PHASE#0.7617;LUNG CANCER#0.7544;CANCER CELL#0.7084
131566	SMOOTH MUSCLE#1.0201;SMOOTH MUSCLE CELL#0.9991;MUSCLE CELL#0.9983;CANCER CELL#0.9333;CELL PROLIFERATION#0.7902;GROWTH FACTOR#0.6674;LUNG CANCER#0.6417;GROWTH FACTOR RECEPTOR#0.6328;PROTEASOME DEGRADATION#0.6066
131578	LEUCINE RICH REPEAT#0.8815;CANCER CELL#0.7936;LEUCINE#0.7780;TUMOR ANTIGEN#0.6690;EXTRACELLULAR MATRIX#0.6469
1315	CLATHRIN COATED VESICLE#1.0732;COATOMER#1.0615;GOLGI MEMBRANE#1.0539;COATED VESICLE#1.0429;GOLGI APPARATUS#1.0189;GOLGI COMPLEX#1.0053;TRANS GOLGI NETWORK#0.9932;ENDOPLASMIC RETICULUM#0.9844;ADAPTIN#0.9725;PLASMA MEMBRANE#0.9642;CYTOPLASM#0.9438;GOLGI CISTERNAE#0.9420;GOLGI STACK#0.9391;TRANSPORT VESICLE#0.9074;MICROTUBULE#0.8900;PROTEIN COMPLEX#0.8852;ORGANELLE#0.8727;VESICULAR STOMATITIS VIRUS#0.8569;GTP BINDING#0.8530;SECRETORY PATHWAY#0.8522;VESICLE FORMATION#0.8492;COPPER CHAPERONE#0.8428;ENDOSOME#0.8350;PROTEIN TRANSPORT#0.8057;CELL SURFACE#0.7920;PROTEIN KINASE#0.7823;STOMATITIS#0.7616;ER TO GOLGI TRANSPORT#0.7612;COPPER HOMEOSTASIS#0.7516;MEMBRANE TRANSPORT#0.7439;INTRACELLULAR MEMBRANE#0.7439;COMPLEX I#0.7349;PROTEIN BINDING#0.7337;BUDDING#0.7270;VESICULAR-TUBULAR CLUSTER#0.7198;COPI VESICLE#0.7129;GUANINE#0.6819;PROTEIN KINASE C#0.6792;GUANOSINE#0.6603;ERGIC#0.6500;PROTEIN SECRETION#0.6433;VESICULAR TRANSPORT#0.6321;PERIPHERAL MEMBRANE PROTEIN#0.6197;PROTEIN PROTEIN INTERACTION#0.6131;PROTEIN SYNTHESIS#0.6046;HETEROTRIMERIC G-PROTEIN#0.6032
131601	REGULATION OF CELL DIVISION#0.6748;MEMBRANE TRANSPORT#0.6453;CELL DIVISION#0.6301;PLASMA MEMBRANE#0.6235
1316	OVARIAN CANCER#1.0481;TUMOR SUPPRESSOR#1.0457;COLORECTAL CANCER#1.0446;HEPATOCELLULAR CARCINOMA#1.0442;CELL DEATH#1.0393;ONCOGENIC#1.0347;PROSTATE CANCER#1.0347;LUNG CANCER#1.0295;COLORECTAL#1.0282;CELL PROLIFERATION#1.0212;BREAST CANCER#1.0198;CELL GROWTH#1.0159;CELL CYCLE#1.0159;GROWTH FACTOR#1.0147;TRANSCRIPTION FACTOR#1.0145;CANCER CELL#1.0142;APOPTOSIS#1.0107;APOPTOTIC#1.0088;DNA BINDING#1.0070;OVARIAN#1.0008;SIGNALING PATHWAY#0.9967;TRANSFORMING GROWTH FACTOR#0.9920;GENE EXPRESSION#0.9904;TRANSACTIVATION#0.9903;MACROPHAGE#0.9883;PROMOTER BINDING#0.9814;POLYMERASE CHAIN REACTION#0.9792;ANGIOGENESIS#0.9770;EPITHELIAL CELL#0.9735;FIBRINOGEN#0.9650;COLORECTAL CARCINOMA#0.9490;ENDOTHELIAL CELL#0.9472;SPLICE VARIANT 1#0.9433;PROTEIN KINASE#0.9342;CORE PROMOTER BINDING#0.9292;ZINC FINGER PROTEIN#0.9215;ADENOCARCINOMA#0.9189;SIGNAL TRANSDUCTION#0.9186;CYCLIN DEPENDENT KINASE#0.9147;HEPATIC STELLATE CELL#0.9126;T CELL#0.9111;CELL MIGRATION#0.9051;REVERSE TRANSCRIPTION#0.9048;LYMPH NODE#0.9034;BREAST CANCER CELL#0.9028;NITRIC OXIDE#0.8943;QUANTITATIVE REAL TIME#0.8835;MUSCLE CELL#0.8420;LUNG ADENOCARCINOMA#0.8413;FATTY LIVER#0.8363;CELL ACTIVATION#0.8328;ELECTROPHORETIC MOBILITY SHIFT#0.8294;SELECTIN#0.8272;CELL DIFFERENTIATION#0.8250;CELL CYCLE ARREST#0.8223;B CELL#0.8184;MITOGEN ACTIVATED PROTEIN#0.8129;HEPATOCELLULAR CARCINOMA CELL#0.8092;INDUCIBLE NITRIC OXIDE#0.8016;DNA METHYLATION#0.8011;NITRIC OXIDE SYNTHASE#0.7834;EXTRACELLULAR MATRIX#0.7801;LIVER DISEASE#0.7801;KINASE INHIBITOR#0.7680;PROSTATE CARCINOMA#0.7641;TROPHOBLAST#0.7575;PLACENTAL DEVELOPMENT#0.7572;PERIPHERAL BLOOD#0.7562;CISPLATIN#0.7559;CYCLIN DEPENDENT KINASE INHIBITOR#0.7492;VIRULENCE#0.7452;LIPID METABOLISM#0.7414;TRANSFORMING GROWTH FACTOR BETA#0.7410;INFLAMMATORY RESPONSE#0.7401;PLATELET AGGREGATION#0.7391;HYPOXIA#0.7333;FIBRINOGEN BINDING#0.7112;WOUND HEALING#0.7036;SMOOTH MUSCLE#0.7025;PROGENITOR CELL#0.6852;PROXIMAL TUBULE CELL#0.6800;TROPHOBLAST CELL#0.6756;TIGHT JUNCTION#0.6746;MRNA SPLICING#0.6745;INDUCTION OF APOPTOSIS#0.6732;SIGNALING CASCADE#0.6731;ACTIVATED T-CELLS#0.6699;ACTIVATED T CELL#0.6695;ADIPOGENESIS#0.6538;FATTY LIVER DISEASE#0.6513;FACTOR I#0.6480;THROMBIN RECEPTOR#0.6347;ADIPOCYTE#0.6343;ADIPOCYTE DIFFERENTIATION#0.6338;CLEAR CELL RENAL CELL CARCINOMA#0.6321;CYTOTROPHOBLAST#0.6316;ACTIVATING TRANSCRIPTION FACTOR#0.6310;C TERMINAL DOMAIN#0.6263;IMMUNE RESPONSE#0.6259;RENAL CELL CARCINOMA#0.6250;PRO-INFLAMMATORY#0.6249;DIABETES MELLITUS#0.6244;PEROXISOME#0.6200;ADIPOSE TISSUE#0.6171;PODOCYTE APOPTOSIS#0.6158;TUMOR CELLS#0.6153;CORNEAL EPITHELIAL CELL#0.6141;MORPHOGENESIS#0.6121;STEM CELL#0.6111;LYSINE#0.6104;CYTOPLASM#0.6090;SPECIFICITY PROTEIN 1#0.6075;LIVER CANCER#0.6062;MAP KINASE#0.6035;SMOOTH MUSCLE CELL#0.6004;ACUTE LIVER INJURY#0.6001
1317	ORGANIC CATION TRANSPORTER#1.0474;COPPER CHAPERONE#1.0429;METHIONINE#1.0397;METAL BINDING#1.0393;OVARIAN CARCINOMA#1.0302;PLASMA MEMBRANE#1.0243;DIVALENT METAL TRANSPORTER#1.0238;L-OHP#1.0226;CISPLATIN#1.0224;OVARIAN CANCER#1.0205;LUNG CANCER#1.0205;OXALIPLATIN#1.0188;CARBOPLATIN#1.0177;OVARIAN#1.0172;HIGH AFFINITY COPPER TRANSPORT#1.0160;COPPER HOMEOSTASIS#1.0099;GENE EXPRESSION#1.0071;TRANSCRIPTION FACTOR#1.0038;COPPER BINDING#0.9996;CANCER CELL#0.9993;EPITHELIAL CELL#0.9989;GLUTATHIONE#0.9960;CYTOTOXICITY#0.9950;SUPEROXIDE DISMUTASE#0.9923;HISTIDINE#0.9918;ENDOCYTOSIS#0.9906;CHOROID PLEXUS#0.9844;CELL SURFACE#0.9813;TUMOR CELLS#0.9734;DRUG RESISTANCE#0.9729;TOXICITY#0.9726;COPPER TRANSPORTING ATPASE#0.9705;CELL MEMBRANE#0.9552;APOPTOSIS#0.9455;POLYMERASE CHAIN REACTION#0.9408;C TERMINAL DOMAIN#0.9385;PROSTATE CANCER#0.8992;CELL PROLIFERATION#0.8971;DNA BINDING#0.8906;MAMMARY GLAND#0.8872;RESPONSE TO COPPER#0.8750;MOUSE EMBRYONIC FIBROBLAST#0.8721;CYTOCHROME C#0.8653;REVERSE TRANSCRIPTION#0.8629;CELL DEATH#0.8598;CYTOCHROME C OXIDASE#0.8595;CYTOPLASM#0.8594;INDUCTIVELY COUPLED PLASMA#0.8574;WILSON DISEASE#0.8438;COLORECTAL CANCER#0.8420;REACTIVE OXYGEN SPECIES#0.8363;EFFLUX PUMP#0.8321;PROTEASOME#0.8182;HYPOXIA#0.8181;NEUROTOXICITY#0.8175;IRON HOMEOSTASIS#0.7948;COLORECTAL#0.7921;DNA METHYLATION#0.7877;BREAST CANCER#0.7814;SPECIFICITY PROTEIN 1#0.7581;DETOXIFICATION#0.7548;ENDOTHELIAL CELL#0.7517;HAIR CELL#0.7508;TRANSFERRIN RECEPTOR#0.7420;BORTEZOMIB#0.7334;ION CHANNEL#0.7233;CBDCA#0.7204;OTOTOXICITY#0.7188;NEUROBLASTOMA#0.7176;ANGIOGENESIS#0.7164;EPITHELIAL OVARIAN CANCER#0.7126;MAMMARY EPITHELIAL CELL#0.7116;INTESTINAL EPITHELIAL CELL#0.7104;SIGNALING PATHWAY#0.7090;MOUSE EMBRYO FIBROBLASTS#0.7014;MENKES DISEASE#0.6961;ENTEROCYTE#0.6913;CELL GROWTH#0.6852;DUODENUM#0.6837;CELLULAR MEMBRANE#0.6791;METAL ION TRANSPORTER#0.6787;EXCRETION#0.6679;COPPER EXPORT#0.6645;IRON TRANSPORT#0.6600;CELL KILLING#0.6531;LOCALISATION#0.6522;CERVICAL#0.6339;VIRULENCE#0.6309;CERVICAL CANCER#0.6298;NEURODEGENERATIVE DISEASE#0.6289;QUANTITATIVE REAL TIME#0.6230;GLYCOSYLATION#0.6218;NERVOUS SYSTEM#0.6150;SUPEROXIDE DISMUTASE ACTIVITY#0.6115;DISEASE FREE SURVIVAL#0.6051;MITOCHONDRIA#0.6007
131870	PLASMA MEMBRANE#0.8865;CYTOCHROME C#0.8666;GOLGI APPARATUS#0.8501;ENDOPLASMIC RETICULUM#0.8429;ACID PHOSPHATASE#0.7832;DIPHOSPHATE#0.6679;GLUCOSE 6 PHOSPHATASE#0.6305;INOSINE#0.6223
131873	PITUITARY ADENOMA#0.6134;ATOPIC DERMATITIS#0.6120
131890	OPSIN#0.9309;ENHANCED S-CONE SYNDROME#0.6553;PROTEIN KINASE#0.6459
1318	PLASMA MEMBRANE#1.0669;CISPLATIN#1.0411;CELL SURFACE#0.9751;OVARIAN#0.9258;OVARIAN CARCINOMA#0.9011;CANCER CELL#0.8996;COPPER HOMEOSTASIS#0.8754;OVARIAN CANCER#0.8661;CALCITONIN RECEPTOR#0.8411;TRANSCRIPTION FACTOR#0.7836;CYTOTOXICITY#0.7463;COPPER TRANSPORTING ATPASE#0.7175;COPPER CHAPERONE#0.7097;TOXICITY#0.6391;LATE ENDOSOME#0.6217;CLEAR CELL RENAL CELL CARCINOMA#0.6215;HIGH AFFINITY COPPER TRANSPORT#0.6149;RENAL CELL CARCINOMA#0.6067
131920	SIGNET RING CELL#0.8571;CANCER CELL#0.7654;COLORECTAL CANCER#0.6950;TO TUMOUR PROGRESSION#0.6844;COLORECTAL#0.6707;POLYCYSTIC KIDNEY DISEASE#0.6560;ORAL SQUAMOUS CELL CARCINOMA#0.6501;COLORECTAL CARCINOMA#0.6490;KIDNEY DISEASE#0.6415;SQUAMOUS CELL CARCINOMA#0.6394
1319	SPINAL CORD#1.0665;SPINAL CORD INJURY#1.0487;UMBILICAL CORD#0.9882;CORD BLOOD#0.9632;CARBOHYDRATE RECOGNITION DOMAIN#0.9403;CARDIOLIPIN#0.9235;CONE ROD DYSTROPHY#0.8966;CONE-ROD DYSTROPHY 1#0.8388;REGENERATION#0.8295;UMBILICAL CORD BLOOD#0.7714;APOPTOSIS#0.7659;STEM CELL#0.7533;LECTIN#0.7440;MITOCHONDRIAL MEMBRANE#0.7387;CARDIOLIPIN SYNTHASE#0.7242;PHOTOSYSTEM I#0.7196;RETINITIS PIGMENTOSA#0.7072;CERVICAL#0.6806;LEBER CONGENITAL AMAUROSIS#0.6755;SCIATIC NERVE#0.6625;SUBARACHNOID SPACE#0.6506;GENE EXPRESSION#0.6347;AXON GROWTH#0.6166;PROTOPORPHYRIN IX#0.6071
131	ALCOHOL DEHYDROGENASE ACTIVITY#1.1029;RETINOL DEHYDROGENASE#1.0799;RETINOL#1.0559;RETINOIC ACID#1.0223;ETHANOL#1.0187;VITAMIN A#1.0104;GENE EXPRESSION#1.0007;ETHANOL METABOLISM#0.9843;RETINOL DEHYDROGENASE ACTIVITY#0.9768;ALCOHOL METABOLISM#0.9705;ALCOHOL DEPENDENCE#0.9428;CIMETIDINE#0.9194;RETINOL METABOLISM#0.9025;RETINOID METABOLISM#0.8999;FERMENTATION#0.8562;RECEPTOR ANTAGONIST#0.8550;GASTRIC MUCOSA#0.8427;RETINOL BINDING#0.8098;SMALL INTESTINE#0.7761;TOXICITY#0.7758;CYTOCHROME P450#0.7733;ALL-TRANS-RETINOL#0.7679;TRANS-RETINOL#0.7677;RETINAL DEHYDROGENASE#0.7573;EPITHELIAL CELL#0.7380;POLYMERASE CHAIN REACTION#0.7271;SQUAMOUS CELL CARCINOMA#0.7076;GASTROINTESTINAL TRACT#0.7034;ENZYME ACTIVITY#0.7004;ETHANOL OXIDATION#0.7001;VITAMIN A DEFICIENCY#0.6977;LIVER DISEASE#0.6907;GASTRIC EMPTYING#0.6883;GLYCINE#0.6538;ETHANOL FERMENTATION#0.6436;ESOPHAGUS#0.6422;TELOMERE#0.6381;FRAGMENT LENGTH POLYMORPHISM#0.6095;RETINAL PIGMENT EPITHELIAL#0.6034
132001	MITOCHONDRIA#0.8595;CARDIOLIPIN#0.8472;PHOSPHATIDYLSERINE#0.8419;PHOSPHOLIPID BIOSYNTHESIS#0.8182;TIM23 COMPLEX#0.7494;PHOSPHATIDATE CYTIDYLYLTRANSFERASE#0.6944;MITOCHONDRIAL MEMBRANE#0.6744;PHOSPHOLIPID BIOSYNTHETIC#0.6161
132014	INTERLEUKIN 17 RECEPTOR#0.7173;TH17 CELL#0.6481
132112	OLFACTORY RECEPTOR#0.7424;CELL DEATH#0.6425
132141	SPERM CAPACITATION#1.2184;ACROSOME REACTION#1.2066;ACROSOME#0.8618;SPERMATOZOA#0.8563;FERTILIZATION#0.8540
132158	CHLOROPLAST#0.8299;HYDROXYPYRUVATE REDUCTASE#0.7645;KINASE ACTIVITY#0.7281;PYRUVATE#0.7275;FRUCTOSE#0.7187;MITOCHONDRIA#0.7124;SUCROSE#0.6188
1321	SPINAL CORD#1.0894
132203	MOTILE CILIA#0.7536;CELL MEMBRANE#0.7158
132204	SYNAPTIC VESICLE#1.0948;SYNAPTIC VESICLE PROTEIN#1.0180;DORSAL ROOT GANGLION#0.6344;DENTATE GYRUS#0.6264;CENTRAL NERVOUS SYSTEM#0.6135;NERVOUS SYSTEM#0.6125
132243	OOCYTE#1.0681;GENE EXPRESSION#0.9667;SHOOT APICAL MERISTEM#0.8756;GERMINAL VESICLE#0.8493;CELL DIVISION#0.8136;FERTILIZATION#0.7865;EMBRYO DEVELOPMENT#0.7189;OOGENESIS#0.6599;OOCYTE MATURATION#0.6577;OXYSTEROL BINDING#0.6511;TWO-CELL STAGE#0.6430;DNA METHYLATION#0.6262
132299	OVARIAN CANCER#0.8675;OVARIAN#0.8473;LUNG ADENOCARCINOMA#0.7619;ADENOCARCINOMA#0.7579;HAIR FOLLICLE#0.6376;LUNG CANCER#0.6234;SIGNALING PATHWAY#0.6195;TRANSCRIPTION FACTOR#0.6194
132320	SODIUM CHANNEL#0.8645
1325	SOMATOSTATIN RECEPTOR#1.0220;OCTREOTIDE#1.0204;GROWTH HORMONE#0.9996;INTERNEURON#0.9927;INSULIN SECRETION#0.9921;IMMUNE CELL#0.9910;IMMUNE SYSTEM#0.9894;GENE EXPRESSION#0.9359;INFLAMMATORY RESPONSE#0.9230;CEREBRAL CORTEX#0.9082;CELL PROLIFERATION#0.8901;MACROPHAGE#0.8698;ENDOTHELIAL CELL#0.8371;ADENYLATE CYCLASE#0.8204;SIGNALING PATHWAY#0.8141;NERVOUS SYSTEM#0.8027;T CELL#0.7995;GROWTH FACTOR#0.7861;APOPTOSIS#0.7626;AUTOIMMUNE DISEASE#0.7543;ADENYLATE#0.7216;ACETYLCHOLINE#0.7157;PROTEIN KINASE#0.6986;CORTISOL#0.6867;DIABETIC RETINOPATHY#0.6856;FORSKOLIN#0.6836;DIABETES MELLITUS#0.6771;BETA CELL#0.6768;SMOOTH MUSCLE#0.6758;ALZHEIMER'S DISEASE#0.6581;HORMONE SECRETION#0.6577;REGULATORY T CELL#0.6554;VASCULAR SMOOTH MUSCLE CELL#0.6316;COLITIS#0.6311;SMOOTH MUSCLE CELL#0.6290;OBESE#0.6284;MUSCLE CELL#0.6283;COLLAGEN INDUCED ARTHRITIS#0.6012;CENTRAL NERVOUS SYSTEM#0.6006;HEALTHY CONTROL SUBJECTS#0.6004
132612	RHEUMATOID ARTHRITIS#0.9639;RNA BINDING#0.6557;AUTOIMMUNE DISEASE#0.6453;TYPE 1 DIABETES#0.6346
132625	TRANSCRIPTION FACTOR#1.0311;EMBRYONIC STEM CELL#1.0256;STEM CELL#1.0161;RETINOIC ACID#1.0088;STEM CELL MARKER#0.9909;GENE EXPRESSION#0.9810;ZINC FINGER PROTEIN#0.9766;MOUSE EMBRYONIC STEM#0.9687;PLURIPOTENT STEM CELL#0.9646;TERATOCARCINOMA#0.9329;HUMAN EMBRYONIC STEM#0.8249;MESENCHYMAL STEM CELL#0.8189;GERM CELL#0.8181;INNER CELL MASS#0.7750;ALKALINE PHOSPHATASE#0.7158;CANCER CELL#0.6995;SIGNALING PATHWAY#0.6651;GROWTH FACTOR#0.6574;DNA METHYLATION#0.6446;EPITHELIAL CELL#0.6400;MAURER'S CLEFT#0.6327;P38 MAPK SIGNALING#0.6226;INDUCED PLURIPOTENT STEM CELL#0.6197;HUMAN MESENCHYMAL STEM#0.6115;CELL DIFFERENTIATION#0.6100;MAPK SIGNALING#0.6066
132660	CELL CYCLE#1.0306;DNA BINDING#0.9920;GENE EXPRESSION#0.7360
132671	MITOCHONDRIA#1.0631;LYSOSOME#0.8812;REACTIVE OXYGEN SPECIES#0.8588;SPERMATOZOA#0.8102;SPERMATOGENESIS#0.8029;CANCER CELL#0.7862;MITOCHONDRIAL OUTER MEMBRANE#0.6603;ORGANELLE#0.6566;COLORECTAL CANCER#0.6431;OUTER MEMBRANE#0.6397;CYTOPLASM#0.6252;HYPOXIA#0.6016
1326	KINASE ACTIVITY#1.0595;MAP KINASE#1.0427;ONCOGENIC#1.0385;MACROPHAGE#1.0351;T CELL#1.0324;MEK KINASE ACTIVITY#1.0320;TOLL LIKE RECEPTOR#1.0308;SIGNALLING PATHWAY#1.0296;TUMOR NECROSIS FACTOR#1.0293;PROTEIN KINASE#1.0281;MITOGEN ACTIVATED PROTEIN#1.0258;SIGNALING PATHWAY#1.0254;IMMUNE RESPONSE#1.0219;MAP KINASE KINASE#1.0150;B CELL#1.0142;PRO-INFLAMMATORY#1.0131;INFLAMMATORY RESPONSE#1.0098;KINASE INHIBITOR#1.0092;EPITHELIAL CELL#1.0077;BONE MARROW#1.0072;GENE EXPRESSION#1.0065;NEUTROPHIL#1.0059;SIGNAL TRANSDUCTION#0.9991;TRANSCRIPTION FACTOR#0.9984;MONOCYTE#0.9980;CANCER CELL#0.9936;BREAST CANCER#0.9910;CELL PROLIFERATION#0.9879;APOPTOSIS#0.9872;IKAPPAB KINASE#0.9864;CD4+ T CELL#0.9801;GROWTH FACTOR#0.9763;ENDOTHELIAL CELL#0.9738;ADIPOSE TISSUE#0.9581;TNF-ALPHA PRODUCTION#0.9543;IMMUNE CELL#0.9409;MAPK ACTIVATION#0.9406;LUNG CANCER#0.9404;IKK COMPLEX#0.9374;CELL CYCLE#0.9326;CATALYTIC ACTIVITY#0.9295;TRANSACTIVATION#0.9259;NF-KAPPAB ACTIVATION#0.9198;MAPK SIGNALING#0.9145;CELL MIGRATION#0.9074;DENDRITIC CELL#0.9061;COLITIS#0.9050;MYELOID CELL#0.9020;INNATE IMMUNE RESPONSE#0.8964;PROVIRUS#0.8941;CYTOKINE PRODUCTION#0.8940;RHEUMATOID ARTHRITIS#0.8933;ACTIVATED T-CELLS#0.8920;ACTIVATED T CELL#0.8916;EPIDERMAL GROWTH FACTOR#0.8591;GROWTH FACTOR RECEPTOR#0.8401;CELL ACTIVATION#0.8149;IL-10 PRODUCTION#0.8142;DOMINANT NEGATIVE MUTANT#0.8090;AIRWAY EPITHELIAL CELL#0.8064;HIGH FAT DIET#0.8023;ADIPOCYTE#0.7995;MACROPHAGE ACTIVATION#0.7957;STEM CELL#0.7847;TUMOR CELLS#0.7813;RESPONSE TO LPS#0.7813;ACTIVATOR PROTEIN 1#0.7809;TUMOUR NECROSIS FACTOR#0.7741;TNF SECRETION#0.7594;PROTEIN KINASE C#0.7584;COLORECTAL CANCER#0.7582;TYPE I IFN PRODUCTION#0.7555;TYROSINE KINASE INHIBITOR#0.7526;G-CSF#0.7498;CYCLOSPORIN A#0.7478;HUMAN BREAST CANCER#0.7434;T LYMPHOCYTE#0.7426;UBIQUITIN#0.7378;TH2 CELL#0.7355;TUBERCULOSIS#0.7345;CALCINEURIN#0.7331;REGULATORY T CELL#0.7299;LIPOLYSIS#0.7235;PROTEASOME#0.7232;ALLERGIC AIRWAY INFLAMMATION#0.7034;COLORECTAL#0.6911;UBIQUITIN BINDING#0.6900;TUMOR SUPPRESSOR#0.6889;MAPK CASCADE#0.6887;ADENOCARCINOMA#0.6880;IONOPHORE#0.6843;TNF PRODUCTION#0.6811;RENAL CELL CARCINOMA#0.6780;CHEMOKINE RECEPTOR#0.6779;INNATE IMMUNITY#0.6772;LYMPH NODE#0.6729;ACTIVATION OF NF-KAPPAB#0.6572;AUTOIMMUNE DISEASE#0.6496;SQUAMOUS CELL CARCINOMA#0.6493;OBJECTIVE RESPONSE RATE#0.6401;DEATH RECEPTOR#0.6316;T CELL ACTIVATION#0.6282;MAPK ERK KINASE#0.6260;OSTEOBLAST#0.6260;ACTIVATED B CELL#0.6152;RESPONSE TO IL-1#0.6134;ENHANCER BINDING#0.6124;TH17 CELL#0.6112;PROSTAGLANDIN E2#0.6095;CELL DIFFERENTIATION#0.6064;MAP KINASE CASCADE#0.6062;STROMAL CELL#0.6058;HEPATOCELLULAR CARCINOMA#0.6048;IL-12 PRODUCTION#0.6042;OXIDATIVE BURST#0.6034
132724	LUNG CANCER#0.8997
132789	GLUCOSAMINE 6-PHOSPHATE#0.9206;TYPE 2 DIABETES#0.8849;GLUCOSAMINE#0.8079;ADIPOSE TISSUE#0.7290;OBESE#0.6907
1327	ATP SYNTHASE#1.0355;CYTOCHROME C OXIDASE#1.0348;CYTOCHROME C#1.0311;MITOCHONDRIAL TRANSCRIPTION#1.0310;NUCLEAR RESPIRATORY FACTOR#1.0188;TRANSCRIPTION FACTOR#1.0154;RESPIRATORY CHAIN#0.9977;MITOCHONDRIA#0.9914;OXIDATIVE PHOSPHORYLATION#0.9885;GENE EXPRESSION#0.9874;MITOCHONDRIAL DNA#0.9863;PEROXISOME#0.9833;MITOCHONDRIAL MEMBRANE#0.9820;SKELETAL MUSCLE#0.9784;REACTIVE OXYGEN SPECIES#0.9762;HYPOXIA#0.9708;PROTEIN KINASE#0.9607;ADIPOSE TISSUE#0.9399;MTDNA#0.9328;RESPIRATION#0.9263;CITRATE SYNTHASE ACTIVITY#0.8755;ELECTRON TRANSPORT#0.8649;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8611;MITOCHONDRIAL RESPIRATORY CHAIN#0.8447;OBESE#0.8235;ELECTRON TRANSPORT CHAIN#0.7944;APOPTOSIS#0.7781;CYTOCHROME C OXIDASE ACTIVITY#0.7668;QUANTITATIVE REAL TIME#0.7467;SUPEROXIDE DISMUTASE#0.7445;SUCCINATE DEHYDROGENASE#0.7351;POLYMERASE CHAIN REACTION#0.7032;MITOCHONDRIAL DAMAGE#0.7009;SIGNAL PEPTIDE#0.6978;PYRUVATE DEHYDROGENASE KINASE#0.6918;HYPOXIC#0.6914;AUTOPHAGY#0.6907;CELL DEATH#0.6893;FANCONI ANEMIA#0.6879;NADH DEHYDROGENASE#0.6876;COMPLEX I#0.6821;RNA BINDING#0.6763;BROWN ADIPOSE TISSUE#0.6590;HIGH FAT DIET#0.6541;SIGNALING PATHWAY#0.6474;MITOPHAGY#0.6396;PYRUVATE#0.6392;WEIGHT GAIN#0.6341;SUCCINATE#0.6196;COENZYME A#0.6121;MYOTUBE#0.6068;HYPOXIA INDUCIBLE FACTOR#0.6030
132851	SPERMATOGENESIS#0.9789;APOPTOSIS#0.8741;GONADOGENESIS#0.6867;OSTEOBLAST DIFFERENTIATION#0.6146
132864	CYTOPLASMIC POLYADENYLATION ELEMENT#1.0956;BREAST CANCER#0.9236;RNA BINDING#0.7411;CANCER CELL#0.7263;HUMAN BREAST CANCER#0.7195;RNA SPLICING#0.6530;DORSAL MOTOR NUCLEUS OF VAGUS#0.6419;BREAST CANCER CELL#0.6379;COLORECTAL CANCER#0.6373;TUMOR SUPPRESSOR#0.6364;RNA BINDING PROTEIN#0.6346
132884	ELLIS-VAN CREVELD SYNDROME#1.0676;POLYDACTYLY#0.9111;DYSOSTOSIS#0.8929;ACROFACIAL DYSOSTOSIS#0.8436;NEURAL CREST#0.7879;BONE DEVELOPMENT#0.7228;BASAL BODY#0.7167;ECTODERMAL DYSPLASIA#0.7107;CILIUM#0.6616;GROWTH FACTOR#0.6028
132949	LYSINE#0.7899;A-ALANINE#0.6514
132954	CATALYTIC ACTIVITY#0.9825;DENSITY FUNCTIONAL THEORY#0.8871;DIMETHYLFORMAMIDE#0.8454;TOLUENE#0.8237;ACETIC ACID#0.8052;MOLAR#0.8043;ETHANOL#0.7533;TRANSMISSION ELECTRON MICROSCOPY#0.7069;CANCER CELL#0.6564
1329	CYTOCHROME C OXIDASE#1.0533;CYTOCHROME C#1.0489;GENE EXPRESSION#0.9498;HYPOXIC#0.9208;RESPIRATORY CHAIN#0.9149;TRANSCRIPTION FACTOR#0.8698;MITOCHONDRIA#0.8355;BREAST CANCER#0.8015;RESPIRATION#0.7821;OXIDATIVE PHOSPHORYLATION#0.7471;ELECTRON TRANSPORT#0.7420;ATP SYNTHASE#0.7313;CYTOCHROME C OXIDASE ACTIVITY#0.6829;ELECTRON TRANSPORT CHAIN#0.6731;CANCER CELL#0.6094;POLYMERASE CHAIN REACTION#0.6028
132	5-IODOTUBERCIDIN#1.0630;DEOXYCYTIDINE KINASE#1.0511;ADENINE PHOSPHORIBOSYLTRANSFERASE#1.0453;KINASE INHIBITOR#1.0438;KINASE ACTIVITY#1.0410;AMP DEAMINASE#1.0406;ADENOSINE KINASE#1.0405;METHYLMERCAPTOPURINE RIBOSIDE#1.0381;ERYTHRO#1.0352;EQUILIBRATIVE NUCLEOSIDE TRANSPORTER#1.0352;ADENOSINE#1.0333;GUANINE PHOSPHORIBOSYLTRANSFERASE#1.0316;2'-DEOXYCOFORMYCIN#1.0313;ASTROCYTE#1.0308;ADENOSINE TRANSPORT#1.0289;ADENYLATE KINASE#1.0267;PURINE NUCLEOSIDE PHOSPHORYLASE#1.0250;DIPYRIDAMOLE#1.0242;PURINE SALVAGE#1.0214;NUCLEOSIDE TRANSPORT#1.0206;DEOXYADENOSINE#1.0200;ADENOSINE FORMATION#1.0159;ADENOSINE METABOLISM#1.0157;6-METHYLMERCAPTOPURINE RIBOSIDE#1.0150;ADENOSINE DEAMINASE#1.0139;STRUCTURE ACTIVITY RELATIONSHIP#1.0131;ADENOSINE MONOPHOSPHATE#1.0120;DEOXYCOFORMYCIN#1.0107;NUCLEOSIDE KINASE#1.0096;XANTHINE#1.0084;STEM CELL#1.0083;6-METHYLMERCAPTOPURINE#1.0081;GUANINE#1.0074;AK ACTIVITY#1.0056;EPILEPSY#1.0038;HYPOXANTHINE#1.0015;ERYTHROCYTE#1.0015;ENDOTHELIAL CELL#1.0003;DEAMINASE ACTIVITY#0.9982;ADENYLATE#0.9975;ADENINE#0.9973;METHIONINE#0.9954;ADENOSINE DEAMINASE ACTIVITY#0.9953;TUBERCULOSIS#0.9922;LYMPHOBLAST#0.9914;S-ADENOSYLMETHIONINE#0.9907;CELL DEATH#0.9894;PURINE METABOLISM#0.9860;ENZYME ACTIVITY#0.9841;INOSINE#0.9812;ISCHEMIA#0.9789;RECEPTOR AGONIST#0.9777;APOPTOSIS#0.9738;CYTOTOXICITY#0.9713;TOXICITY#0.9703;PROTEIN KINASE#0.9698;HYPOXIA#0.9676;GUANOSINE#0.9667;CELL GROWTH#0.9658;URIDINE#0.9632;GENE EXPRESSION#0.9631;DEOXYGUANOSINE KINASE#0.9604;RECEPTOR ANTAGONIST#0.9603;ADENINE ARABINOSIDE#0.9583;FORMYCIN#0.9568;ARA-A#0.9559;NITRIC OXIDE#0.9549;NUCLEOTIDASE ACTIVITY#0.9549;5' NUCLEOTIDASE ACTIVITY#0.9481;CATABOLISM#0.9459;THYMIDINE#0.9406;ADENOSINE SALVAGE#0.9376;SPINAL CORD#0.9350;CEREBRAL CORTEX#0.9345;DNA SYNTHESIS#0.9341;XANTHINE OXIDASE#0.9312;CELL PROLIFERATION#0.9305;T CELL#0.9269;2'-DEOXYADENOSINE#0.9220;RIBOSE#0.9179;5'-AMP#0.9174;NUCLEIC ACID#0.9118;HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE#0.9094;MECHANISM OF ACTION#0.9034;PERIPHERAL BLOOD#0.8985;THYMIDINE KINASE#0.8978;TEMPORAL LOBE#0.8914;TEMPORAL LOBE EPILEPSY#0.8902;MIDDLE CEREBRAL ARTERY#0.8864;CEREBRAL ARTERY#0.8860;RIBAVIRIN#0.8813;NERVOUS SYSTEM#0.8709;9-BETA-D-ARABINOFURANOSYLADENINE#0.8655;CANCER CELL#0.8652;FORMYCIN B#0.8628;ARTERY#0.8608;NUCLEOTIDE METABOLISM#0.8575;SYNAPTIC TRANSMISSION#0.8555;ASPARTATE#0.8547;T-LYMPHOBLAST#0.8505;CELL CYCLE#0.8485;S-ADENOSYL-L-HOMOCYSTEINE#0.8451;B CELL#0.8446;CYTOPLASM#0.8434;MESENCHYMAL STEM CELL#0.8412;CATALYTIC ACTIVITY#0.8387;DIPHOSPHATE#0.8367;STREPTOZOTOCIN#0.8224;THEOPHYLLINE#0.8218;STRIATUM#0.8184;CEREBRAL ARTERY OCCLUSION#0.8135;CENTRAL NERVOUS SYSTEM#0.8130;NUCLEOTIDE SYNTHESIS#0.8121;PROTEIN SYNTHESIS#0.7991;URIC ACID#0.7979;HYPOXIC#0.7892;FOREBRAIN#0.7867;NUCLEOTIDE FORMATION#0.7843;MUTAGENESIS#0.7804;CELL WALL#0.7684;LYMPHOID CELL#0.7673;EXCRETION#0.7603;CARDIOMYOCYTE#0.7589;CAFFEINE#0.7583;T LYMPHOCYTE#0.7576;NEUROPROTECTION#0.7552;CYCLIC AMP#0.7549;DEPHOSPHORYLATION#0.7508;ADENOSINE TRIPHOSPHATE#0.7485;FORMALIN#0.7434;PRO-INFLAMMATORY#0.7420;HUMAN MESENCHYMAL STEM#0.7410;B-LYMPHOBLAST#0.7402;ACID PHOSPHATASE#0.7396;MYOCARDIUM#0.7384;THYMOCYTE#0.7338;CYCLOPHILIN#0.7333;TOYOCAMYCIN#0.7330;MEMBRANE TRANSPORT#0.7324;HEPATOMA CELLS#0.7262;APOPTOTIC#0.7210;CELL SURFACE#0.7198;AICA-RIBOSIDE#0.7148;ADENYLATE CYCLASE#0.7115;MACROPHAGE#0.7110;ATP BINDING#0.7000;NEUROTRANSMISSION#0.6981;S-ADENOSYL-L-METHIONINE#0.6970;IMP DEHYDROGENASE#0.6961;SMOOTH MUSCLE#0.6959;LEUKOCYTE#0.6950;SIGNALING PATHWAY#0.6944;L-METHIONINE#0.6931;EXTRACELLULAR SPACE#0.6897;PYRUVATE#0.6840;LYMPHOBLASTOID CELLS#0.6827;STATUS EPILEPTICUS#0.6807;PROTEIN KINASE C#0.6710;PHOSPHORIBOSYL PYROPHOSPHATE#0.6704;TUMOR CELLS#0.6691;NICOTINAMIDE#0.6685;HIGH FAT DIET#0.6672;PROGENITOR CELL#0.6646;NEUTROPHIL#0.6596;N METHYLTRANSFERASE#0.6517;NMDA RECEPTOR#0.6449;TRYPTOPHAN#0.6442;NITRIC OXIDE SYNTHASE#0.6427;FRUCTOSE#0.6426;MUSCLE CELL#0.6412;VASODILATION#0.6340;GLYCINE#0.6319;NUCLEOTIDE BINDING#0.6288;CONCENTRATIVE NUCLEOSIDE TRANSPORTER#0.6271;INDUCTION OF APOPTOSIS#0.6270;2'-DEOXYCYTIDINE#0.6214;MYOCYTES#0.6211;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6207;GROWTH FACTOR#0.6204;TRANSCRIPTION FACTOR#0.6199;RNA INTERFERENCE#0.6151;HUMAN IMMUNODEFICIENCY VIRUS#0.6111;ACADESINE#0.6098;SIGNAL TRANSDUCTION#0.6090;AUTOPHAGY#0.6064;RNA SYNTHESIS#0.6051;MONOCYTE#0.6051;BRAIN DEVELOPMENT#0.6020
133060	TASTE RECEPTOR#0.8691;INNER EAR#0.7464;OTOLITH FORMATION#0.7110
133121	PHOSPHODIESTERASE#1.0263;CHOLINE#0.8649;GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE#0.7906;N GLYCAN#0.6636
133150	ARYL SULFOTRANSFERASE#0.9959;SMALL INTESTINE#0.6652
133308	SODIUM:HYDROGEN EXCHANGER#1.0922;OSTEOCLAST#0.9965;OSTEOCLAST DIFFERENTIATION#0.9363;INSULIN SECRETION#0.8516;PLASMA MEMBRANE#0.8100;BONE RESORPTION#0.6951
133396	CRL3 COMPLEX#1.1897;ONCOSTATIN M RECEPTOR#1.0666;CYTOKINE RECEPTOR#1.0631;ATOPIC DERMATITIS#0.9863;UBIQUITIN#0.9815;DERMATITIS#0.9413;T CELL#0.9408;MACROPHAGE#0.8693;IMMUNE RESPONSE#0.8360;EPITHELIAL CELL#0.8342;GROWTH FACTOR#0.8340;GENE EXPRESSION#0.8037;INFLAMMATORY RESPONSE#0.7925;CANCER CELL#0.7477;SIGNALING PATHWAY#0.7323;RECEPTOR COMPLEX#0.7117;SIGNAL TRANSDUCTION#0.7051;KERATINOCYTE#0.6989;TRANSCRIPTION FACTOR#0.6823;MONOCYTE#0.6784;PRO-INFLAMMATORY#0.6686;PROTEASOME#0.6332;CELL PROLIFERATION#0.6247;DENDRITIC CELL#0.6129;B CELL#0.6108
133418	LUPUS NEPHRITIS#1.0385;VIRAL ENVELOPE#1.0369;NEPHRITIS#1.0235;THYMOCYTE#1.0194;VIRION#1.0152;PLASMA MEMBRANE#1.0044;BONE MARROW#1.0008;CELL SURFACE#1.0007;T LYMPHOCYTE#0.9961;CELL MEMBRANE#0.9940;TUMOR CELLS#0.9935;GLYCOSYLATION#0.9926;CD8+ T CELL#0.9911;T CELL#0.9888;IMMUNE RESPONSE#0.9854;CANCER CELL#0.9825;CYTOTOXIC T-LYMPHOCYTE#0.9803;VIRAL GLYCOPROTEIN#0.9784;B CELL#0.9780;MACROPHAGE#0.9772;CELL SURFACE ANTIGEN#0.9746;TUMOR ANTIGEN#0.9714;GLOMERULONEPHRITIS#0.9689;HEPATITIS C#0.9657;HEPATITIS C VIRUS#0.9653;ERYTHROLEUKEMIA#0.9648;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9629;LUPUS ERYTHEMATOSUS#0.9627;SODIUM DODECYL SULFATE#0.9368;DODECYL SULFATE#0.9367;LYMPH NODE#0.9366;OOCYTE#0.9312;TRANSCRIPTASE#0.9203;VIRAL GENOME#0.9189;IFN-GAMMA#0.8933;CYTOTOXICITY#0.8876;CELL WALL#0.8845;RECEPTOR BINDING#0.8840;LYSIS#0.8817;APOPTOSIS#0.8790;PROVIRUS#0.8783;GENE EXPRESSION#0.8774;TROPISM#0.8737;TUMOR ASSOCIATED ANTIGEN#0.8691;PERIPHERAL BLOOD#0.8521;DENDRITIC CELL#0.8499;LYMPHOID CELL#0.8403;CD4+ T CELL#0.8387;POLYMERASE CHAIN REACTION#0.8329;DIGESTION#0.8317;ENDOPLASMIC RETICULUM#0.8250;LECTIN#0.8230;EPITHELIAL CELL#0.8225;GROWTH FACTOR#0.8113;HUMORAL IMMUNE RESPONSE#0.8012;BREAST CANCER#0.7881;BREAST CANCER CELL#0.7854;CELL FUSION#0.7838;ONCOGENIC#0.7838;VACCINIA#0.7823;HEMATOPOIETIC CELL#0.7803;SPINAL CORD#0.7772;NERVOUS SYSTEM#0.7718;METHIONINE#0.7641;PROTEIN SYNTHESIS#0.7568;NUCLEIC ACID#0.7451;ANTIBODY PRODUCTION#0.7446;COLON CARCINOMA#0.7437;AUTOIMMUNITY#0.7404;GM-CSF#0.7345;BONE MARROW CELLS#0.7264;HOST CELL#0.7248;SPOROTRICHOSIS#0.7227;AUTOIMMUNE DISEASE#0.7107;GLUCOSAMINE#0.7099;BUDDING#0.7073;PARALYSIS#0.7026;STEM CELL#0.6965;CELL ADHESION MOLECULE#0.6843;ANEMIA#0.6841;CELL ADHESION#0.6820;MUTAGENESIS#0.6768;HUMAN IMMUNODEFICIENCY VIRUS#0.6738;RESPONSE TO LPS#0.6731;AND NEW ZEALAND#0.6700;PROTEIN KINASE#0.6696;GLIAL CELL#0.6695;CYTOPLASM#0.6654;VIRUS LIKE PARTICLE#0.6630;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6589;PROSTATE CANCER#0.6490;GRANULOCYTE#0.6485;ENDOTHELIAL CELL#0.6422;CENTRAL NERVOUS SYSTEM#0.6314;ADENOCARCINOMA#0.6306;VIRAL INFECTION#0.6285;AMINO ACID IMPORT#0.6273;MEMBRANE FUSION#0.6228;ERYTHROID CELL#0.6227;THROMBOCYTOPENIA#0.6208;CELLULAR IMMUNE RESPONSE#0.6207;ARGININE#0.6165;Y CHROMOSOME#0.6077
133482	GLUTATHIONE PEROXIDASE#1.0492;SUPEROXIDE DISMUTASE#1.0487;GLUTATHIONE#1.0391;GLUTATHIONE TRANSFERASE#1.0287;DETOXIFICATION#1.0042;GONAD#1.0019;TOXICITY#0.9363;REACTIVE OXYGEN SPECIES#0.9355;CYTOCHROME P450#0.9183;ENZYME ACTIVITY#0.8871;POLYCYCLIC AROMATIC HYDROCARBON#0.8574;GENE EXPRESSION#0.8529;PERSISTENT ORGANIC POLLUTANT#0.7896;CONJUGATION#0.7625;NITRIC OXIDE#0.7612;CELL DEATH#0.7373;EPITHELIAL CELL#0.7202;CANCER CELL#0.7017;ORGANIC ANION TRANSPORTER#0.6951;ANION CHANNEL#0.6897;LYSOSOMAL MEMBRANE STABILITY#0.6853;LYSOSOMAL MEMBRANE#0.6626;APOPTOSIS#0.6506;CELL SURFACE#0.6494;GUAIACOL PEROXIDASE#0.6474;ASCORBATE#0.6412;CELL MEMBRANE#0.6220;TOTAL ANTIOXIDANT CAPACITY#0.6161;ETHACRYNIC ACID#0.6125;AMYL NITRITE#0.6042
133522	PEROXISOME#1.0464;ESTROGEN RECEPTOR#1.0371;TRANSCRIPTION FACTOR#1.0292;ESTROGEN RELATED RECEPTOR#1.0290;SKELETAL MUSCLE#1.0043;GENE EXPRESSION#0.9981;BREAST CANCER#0.9437;TYPE 2 DIABETES#0.9082;MUSCLE CELL#0.8900;FATTY ACID OXIDATION#0.8635;MITOCHONDRIAL DNA#0.8262;ADIPOSE TISSUE#0.8137;PPAR GAMMA COACTIVATOR#0.8045;OXIDATIVE PHOSPHORYLATION#0.8032;GLUCOSE METABOLISM#0.7401;REACTIVE OXYGEN SPECIES#0.7357;SIGNALING PATHWAY#0.7327;DIABETES MELLITUS#0.7164;MACROPHAGE#0.7096;NUCLEAR RESPIRATORY FACTOR#0.6994;FATTY LIVER#0.6935;TYPE 2 DIABETES MELLITUS#0.6829;2 DIABETES MELLITUS#0.6829;ADIPOGENESIS#0.6646;LIPID METABOLISM#0.6571;LIPOGENESIS#0.6479;CYTOCHROME C#0.6393;OXIDATIVE METABOLISM#0.6357;HYPOXIA#0.6320;ADIPOCYTE#0.6295;HIGH FAT DIET#0.6254;ATP SYNTHASE#0.6251;CANCER CELL#0.6247;OSTEOCLAST DIFFERENTIATION#0.6234;CYTOCHROME C OXIDASE#0.6212;MUSCLE FIBER#0.6196;MITOCHONDRIA#0.6178;ANKYLOSING SPONDYLITIS#0.6110;MTDNA#0.6091;17β-ESTRADIOL#0.6059;PROTEIN KINASE#0.6030
133558	GERM CELL#0.8065;FACTOR I#0.8033
133584	PHOTORECEPTOR RIBBON SYNAPSE#1.1214;RIBBON SYNAPSE#1.0771;NEUROMUSCULAR JUNCTION#0.9695;BIPOLAR CELL#0.9289;EXTRACELLULAR MATRIX#0.9154;BASAL LAMINA#0.8587;SYNAPTIC CLEFT#0.7880;MUSCLE CELL#0.7741;ACETYLCHOLINE RECEPTOR#0.7336;NERVOUS SYSTEM#0.6577;ACETYLCHOLINE#0.6207
133686	HYPERLYSINEMIA#0.7397;CHLOROPHYLL SYNTHESIS#0.6651;MITOCHONDRION#0.6556;STOMATAL CLOSURE#0.6412;CAM BINDING#0.6296
133688	UDP-GLUCURONIC ACID#0.7894;GLUCURONIC ACID#0.7880;URSODEOXYCHOLIC ACID#0.6543
133690	TYPE 1 DIABETES#0.7877
133746	ACTIN NUCLEATION#1.0913;ACTIN FILAMENT#1.0440;CELL MOTILITY#0.9649;ACTIN BINDING#0.8958;CYTOPLASM#0.8398;OOCYTE#0.7592;AUTOPHAGY#0.7455;CELL MIGRATION#0.7042;ACTIN POLYMERIZATION#0.6558;AUTOPHAGOSOME FORMATION#0.6470;OOCYTE MATURATION#0.6425;ANKYLOSING SPONDYLITIS#0.6419;TRANSCRIPTION FACTOR#0.6224;APOPTOSIS#0.6223;AUTOPHAGOSOME#0.6222;TRANSCRIPTION COFACTOR#0.6087
1337	CYTOCHROME C OXIDASE#1.0082;CYTOCHROME C#1.0024;SKELETAL MUSCLE#0.7942;4-HPR#0.6100
1339	CYTOCHROME C#1.0092;CYTOCHROME C OXIDASE#0.9962;RESPIRATORY CHAIN#0.7452;GENE EXPRESSION#0.7396;HEART MUSCLE#0.6633;SKELETAL MUSCLE#0.6590
133	ADRENOMEDULLIN BINDING#1.0863;AMNIOTIC FLUID#1.0773;DIABETIC RETINOPATHY#1.0595;BINDING PROTEIN 1#1.0584;ALDOSTERONE SECRETION#1.0475;CHROMAFFIN CELL#1.0427;ADRENOMEDULLIN RECEPTOR#1.0415;CYCLIC AMP#1.0414;PHEOCHROMOCYTOMA#1.0398;ADRENAL CORTEX#1.0380;ADRENAL MEDULLA#1.0377;ACUTE MYOCARDIAL INFARCTION#1.0375;PEPTIDE HORMONE#1.0361;MESANGIAL CELL#1.0352;PANCREATIC CANCER#1.0341;HYPOTENSIVE#1.0317;ADIPOSE TISSUE#1.0315;CONGESTIVE HEART FAILURE#1.0294;ESSENTIAL HYPERTENSION#1.0293;NITRIC-OXIDE SYNTHASE INHIBITOR#1.0279;CHRONIC HEART FAILURE#1.0268;OSTEOBLAST#1.0259;FIBROBLAST GROWTH FACTOR#1.0257;GASTRIC MUCOSA#1.0249;MESENTERIC ARTERY#1.0224;VASODILATOR#1.0217;BLOOD PRESSURE REGULATION#1.0189;OVARIAN#1.0183;CYCLIC ADENOSINE MONOPHOSPHATE#1.0182;LEYDIG CELL#1.0181;VASODILATATION#1.0181;VASCULAR ENDOTHELIUM#1.0177;HEMORRHAGE#1.0173;CARDIOVASCULAR SYSTEM#1.0167;ADENOSINE MONOPHOSPHATE#1.0166;CAMP FORMATION#1.0164;BRAIN NATRIURETIC PEPTIDE#1.0152;PULMONARY HYPERTENSION#1.0152;MYOCYTES#1.0149;MITOGEN ACTIVATED PROTEIN#1.0145;PITUITARY GLAND#1.0145;ADENYLATE CYCLASE#1.0142;VASODILATION#1.0136;CANCER CELL#1.0130;ADENYLATE#1.0130;SUBSTANCE P#1.0128;NOREPINEPHRINE#1.0127;GINGIVAL CREVICULAR FLUID#1.0126;AM BINDING#1.0126;VASOPRESSIN#1.0125;TYPE 2 DIABETES#1.0115;INSULIN SECRETION#1.0111;ADENOSINE#1.0110;SPINAL CORD#1.0105;PLATELET-DERIVED GROWTH FACTOR#1.0102;VASCULAR ENDOTHELIAL CELL#1.0086;VASOCONSTRICTOR#1.0086;CELL GROWTH#1.0077;MYOCARDIAL INFARCTION#1.0077;ENDOTHELIAL GROWTH FACTOR#1.0072;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0072;ACETYLCHOLINE#1.0070;NORADRENALINE#1.0069;ADRENAL GLAND#1.0065;VASCULAR SMOOTH MUSCLE CELL#1.0065;PERIPHERAL BLOOD#1.0061;TROPHOBLAST CELL#1.0060;ALDOSTERONE#1.0059;THYMIDINE#1.0058;ENDOMETRIUM#1.0056;RHEUMATOID ARTHRITIS#1.0052;CARDIOMYOCYTE#1.0044;OVARIAN CANCER#1.0030;RENIN ACTIVITY#1.0029;HYPOTENSION#1.0026;TROPHOBLAST#1.0023;NITRIC OXIDE SYNTHASE#1.0023;MONOCYTE#1.0018;GLOMERULAR FILTRATION#1.0017;DIABETES MELLITUS#1.0017;ISCHEMIA#1.0013;HISTAMINE#1.0013;GLOMERULAR FILTRATION RATE#1.0011;CALCITONIN LIKE RECEPTOR#1.0010;CENTRAL NERVOUS SYSTEM#1.0007;GESTATION#1.0005;PROTEIN KINASE A#1.0000;NITRIC OXIDE#1.0000;SIGNAL TRANSDUCTION#0.9995;ARGININE VASOPRESSIN#0.9993;APOPTOSIS#0.9989;ADIPOCYTE#0.9989;TRANSFORMING GROWTH FACTOR#0.9975;HEART DISEASE#0.9971;NATRIURESIS#0.9970;UMBILICAL VEIN#0.9970;MYOCARDIUM#0.9969;SMOOTH MUSCLE CELL#0.9968;CGRP RECEPTOR#0.9966;CORTISOL#0.9961;STEM CELL#0.9960;MUSCLE CELL#0.9951;HYPOXIA#0.9950;HUMAN UMBILICAL VEIN#0.9947;APOPTOTIC#0.9946;GROWTH FACTOR#0.9942;CALCITONIN RECEPTOR#0.9938;ISOPROTERENOL#0.9938;SMOOTH MUSCLE#0.9938;PULMONARY ARTERY#0.9933;ANGIOGENESIS#0.9929;HYPOXIA INDUCIBLE FACTOR#0.9928;MAST CELL#0.9927;POTASSIUM CHANNEL#0.9927;ACUTE HEART FAILURE#0.9923;PROGENITOR CELL#0.9922;EPITHELIAL CELL#0.9917;INDUCIBLE NITRIC OXIDE#0.9914;ISCHEMIA REPERFUSION INJURY#0.9913;FORSKOLIN#0.9911;ENDOTHELIUM#0.9911;SIGNALING PATHWAY#0.9909;UTERUS#0.9908;TUMOR NECROSIS FACTOR#0.9907;CORONARY ARTERY#0.9906;PROTEIN KINASE#0.9905;REVERSE TRANSCRIPTION#0.9905;ENDOTHELIAL CELL#0.9903;GLYCINE#0.9897;NITRO-L-ARGININE#0.9895;HYPOXIC#0.9894;NEUTROPHIL#0.9894;C REACTIVE PROTEIN#0.9893;MACROPHAGE#0.9891;CELL DEATH#0.9888;RECEPTOR ACTIVITY#0.9880;NERVOUS SYSTEM#0.9879;HYPERTENSION#0.9879;TUMOR CELLS#0.9876;SYSTOLIC BLOOD PRESSURE#0.9873;CELL PROLIFERATION#0.9873;L-ARGININE#0.9870;NEPHROPATHY#0.9869;COLITIS#0.9867;ARGININE#0.9855;INFLAMMATORY RESPONSE#0.9854;EXCRETION#0.9854;GUANYLATE CYCLASE#0.9847;ENDOTHELIAL NITRIC OXIDE#0.9841;TRANSCRIPTASE#0.9835;BREAST CANCER#0.9833;PRE-ECLAMPSIA#0.9833;ARTERY#0.9830;BLOOD VESSEL#0.9827;HINDLIMB#0.9821;PROLIFERATIVE DIABETIC RETINOPATHY#0.9816;KINASE INHIBITOR#0.9813;RECEPTOR ANTAGONIST#0.9802;VASOCONSTRICTION#0.9796;GENE EXPRESSION#0.9793;CONGENITAL HEART DISEASE#0.9780;ATHEROSCLEROSIS#0.9773;POLYMERASE CHAIN REACTION#0.9773;INDOMETHACIN#0.9768;GASTROINTESTINAL TRACT#0.9767;TRANSFORMING GROWTH FACTOR BETA#0.9766;PROLIFERATIVE VITREORETINOPATHY#0.9766;DIURESIS#0.9764;RECEPTOR BINDING#0.9759;PHENYLEPHRINE#0.9758;MIDDLE CEREBRAL ARTERY#0.9753;CEREBRAL ARTERY#0.9750;SMALL INTESTINE#0.9748;DNA SYNTHESIS#0.9741;ANGIOTENSIN CONVERTING ENZYME#0.9739;PENILE ERECTION#0.9736;LEFT VENTRICULAR MASS#0.9729;EXTRACELLULAR MATRIX#0.9720;PROTEIN KINASE C#0.9715;N-OMEGA-NITRO-L-ARGININE#0.9707;ASTROCYTE#0.9679;VASCULAR CELL#0.9678;NEUROBLASTOMA#0.9673;PROGESTERONE#0.9671;TRANSCRIPTION FACTOR#0.9659;REACTIVE OXYGEN SPECIES#0.9655;BONE MARROW#0.9650;LEUKOCYTE#0.9640;CELL SURFACE#0.9627;OBESE#0.9626;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9623;CELL MIGRATION#0.9619;BLOOD BRAIN BARRIER#0.9610;SKELETAL MUSCLE#0.9598;ARTERIOLE#0.9590;CATECHOLAMINE SECRETION#0.9588;MONONUCLEAR CELLS#0.9585;ATHEROSCLEROTIC#0.9581;PROSTATE CANCER#0.9573;TUMOUR NECROSIS FACTOR#0.9568;PROTEIN SYNTHESIS#0.9560;EDEMA#0.9552;KERATINOCYTE#0.9546;GLOMERULONEPHRITIS#0.9544;OVIDUCT#0.9542;PRO-INFLAMMATORY#0.9542;PLASMA MEMBRANE#0.9539;VENOUS BLOOD#0.9530;RETINAL PIGMENT EPITHELIAL#0.9530;REPRODUCTIVE SYSTEM#0.9530;CEREBRAL CORTEX#0.9517;BETA CELL#0.9514;RECEPTOR AGONIST#0.9508;ADRENOCORTICAL CARCINOMA#0.9492;DEXAMETHASONE#0.9476;LYMPHANGIOGENESIS#0.9449;NADPH OXIDASE#0.9447;T CELL#0.9444;ESTRADIOL#0.9437;OBSTRUCTIVE SLEEP APNEA#0.9432;NITRIC OXIDE SYNTHESIS#0.9428;PHOSPHODIESTERASE#0.9428;SLEEP APNEA#0.9415;CAROTID ARTERY#0.9408;ELECTROLYTE HOMEOSTASIS#0.9406;LYMPH NODE#0.9391;PERIODONTAL DISEASE#0.9377;THORACIC AORTA#0.9367;TESTOSTERONE#0.9367;REGENERATION#0.9343;PROSTACYCLIN#0.9326;STREPTOZOTOCIN#0.9302;GASTRIC EMPTYING#0.9294;CELL CYCLE#0.9292;VASCULAR DISEASE#0.9270;SYSTEMIC INFLAMMATORY RESPONSE#0.9248;HUMAN ADRENOCORTICAL CARCINOMA#0.9222;CROHN'S DISEASE#0.9218;GUANOSINE#0.9214;IMMUNE RESPONSE#0.9209;TYPE 2 DIABETES MELLITUS#0.9195;2 DIABETES MELLITUS#0.9195;SALMON CALCITONIN#0.9195;NG-NITRO-L-ARGININE#0.9189;ADENOCARCINOMA#0.9186;LEFT ATRIUM#0.9176;BREAST CANCER CELL#0.9169;ENDOTHELIAL CELL APOPTOSIS#0.9167;COLLAGEN SYNTHESIS#0.9167;MEDULLA OBLONGATA#0.9161;EPICARDIAL ADIPOSE TISSUE#0.9159;LIVER CIRRHOSIS#0.9129;PANCREATIC ISLET#0.9123;MEDULLARY CELL#0.9110;ECTOPIC PREGNANCY#0.9107;BRAIN DAMAGE#0.9106;PITUITARY ADENOMA#0.9087;HEPATIC STELLATE CELL#0.9085;CONNECTIVE TISSUE#0.9048;STROMA#0.9048;SEMINAL VESICLE#0.9028;EPINEPHRINE#0.9021;ENDOTHELIN RECEPTOR#0.9009;CARDIOVASCULAR RISK FACTOR#0.9004;INSULIN-LIKE GROWTH FACTOR#0.8971;GRANULOSA CELL#0.8960;MALIGNANT HYPERTENSION#0.8944;CORONARY ARTERY DISEASE#0.8922;ARTERY DISEASE#0.8920;STRUCTURE ACTIVITY RELATIONSHIP#0.8920;GLIBENCLAMIDE#0.8905;RECEPTOR COMPLEX#0.8872;AMYLIN RECEPTOR#0.8853;PERIODONTITIS#0.8852;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8838;DIABETIC NEPHROPATHY#0.8824;NERVE ENDING#0.8822;CHOROID PLEXUS#0.8814;CELL ADHESION#0.8812;SUPEROXIDE DISMUTASE#0.8807;CHLORIDE CHANNEL#0.8800;ACE INHIBITOR#0.8792;COMPLEMENT FACTOR H#0.8784;SODIUM NITROPRUSSIDE#0.8768;HEPATOCELLULAR CARCINOMA#0.8766;GLIAL CELL#0.8760;GROWTH DIFFERENTIATION FACTOR#0.8754;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8753;MECHANISM OF ACTION#0.8753;DNA FRAGMENTATION#0.8743;INTIMA MEDIA THICKNESS#0.8741;MUSCLE CONTRACTION#0.8740;RESPONSE TO HYPOXIA#0.8730;TACHYCARDIA#0.8716;ECLAMPSIA#0.8714;ASCITES#0.8714;HORMONE SECRETION#0.8701;HYPOTHALAMIC PITUITARY ADRENAL#0.8679;BONE FORMATION#0.8669;ETHANOL#0.8664;PHOSPHODIESTERASE INHIBITOR#0.8625;REGULATION OF BLOOD PRESSURE#0.8606;MESENCHYMAL STEM CELL#0.8596;INFLAMMATORY CELL#0.8594;L-NNA#0.8587;ADVENTITIA#0.8576;CALCIUM CHANNEL#0.8556;INFLAMMATORY BOWEL DISEASE#0.8552;MICROTUBULE#0.8545;PARATHYROID HORMONE#0.8533;CYCLIC GUANOSINE MONOPHOSPHATE#0.8518;LUNG CANCER#0.8518;FEMORAL VEIN#0.8501;TUBE FORMATION#0.8488;CARDIOMYOPATHY#0.8486;ADRENERGIC RECEPTOR#0.8484;ALVEOLAR MACROPHAGE#0.8457;TUMOR TISSUES#0.8432;ENDOTHELIAL PROGENITOR CELL#0.8410;ENDOCRINE CELL#0.8407;OMAPATRILAT#0.8398;CORTISOL SECRETION#0.8395;THIORPHAN#0.8386;MENSTRUAL CYCLE#0.8379;RESERPINE#0.8367;CEREBROVASCULAR DISEASE#0.8349;TISSUE GROWTH FACTOR#0.8339;CEREBRAL ISCHEMIA#0.8327;PULMONARY ARTERIAL HYPERTENSION#0.8315;CELL MEMBRANE#0.8305;CYCLASE ACTIVITY#0.8298;ORAL CAVITY#0.8295;IMMUNE CELL#0.8289;ENDOMETRIAL CANCER#0.8282;TYPE 2 DIABETIC#0.8264;MICROVASCULAR ENDOTHELIAL CELL#0.8228;HEAT SHOCK PROTEIN#0.8227;TAMOXIFEN#0.8227;PIGMENT EPITHELIAL CELL#0.8224;QUANTITATIVE REAL TIME#0.8191;WOUND HEALING#0.8182;BONE RESORPTION#0.8180;ACID SECRETION#0.8179;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8172;NITROPRUSSIDE#0.8171;CYTOPLASM#0.8170;TRAUMATIC BRAIN INJURY#0.8161;LYMPHATIC ENDOTHELIAL CELL#0.8161;NEUROTRANSMISSION#0.8150;PARATHYROID#0.8143;CGMP FORMATION#0.8135;RETINAL PIGMENT EPITHELIAL CELLS#0.8128;HEALTHY CONTROL SUBJECTS#0.8090;PERITUBULAR MYOID CELL#0.8052;PROTEINURIA#0.8047;ULCERATIVE COLITIS#0.8046;PEPTIDE SECRETION#0.8019;BONE GROWTH#0.8018;SARCOPLASMIC RETICULUM#0.8016;ISLET AMYLOID POLYPEPTIDE#0.7993;URETERAL OBSTRUCTION#0.7975;RENAL ARTERY#0.7969;ENDOPEPTIDASE INHIBITOR#0.7965;ISCHEMIC HEART DISEASE#0.7945;MAMMARY GLAND#0.7935;IMMUNE SYSTEM#0.7928;EPITHELIAL OVARIAN CANCER#0.7918;OSTEOPOROSIS#0.7914;CARBACHOL#0.7905;LUMINAL#0.7886;RIGHT ATRIUM#0.7859;CILIARY BODY#0.7858;CELL DIFFERENTIATION#0.7845;OSTEOCLAST#0.7840;SECRETORY GRANULE#0.7811;POLYCYSTIC OVARY SYNDROME#0.7809;TISSUE DAMAGE#0.7799;OPIOID PEPTIDE#0.7799;FOREARM#0.7798;PERTUSSIS#0.7794;FATTY ACID BINDING#0.7783;OXYGENASE#0.7773;STROMAL CELL#0.7773;PHENTOLAMINE#0.7756;UMBILICAL ARTERY#0.7754;EPIDERMAL GROWTH FACTOR#0.7753;RESPIRATORY DISTRESS#0.7753;COLON CANCER#0.7743;COR PULMONALE#0.7733;CYTOTROPHOBLAST#0.7732;GALECTIN#0.7725;HUMAN BREAST CANCER#0.7705;COLORECTAL#0.7685;MIGRAINE#0.7684;DOXORUBICIN#0.7641;SMOOTH MUSCLE ACTIN#0.7614;PROSTAGLANDIN E2#0.7603;DRUG RESISTANCE#0.7594;ACTINOMYCIN D#0.7592;RHEUMATIC FEVER#0.7591;RENOVASCULAR HYPERTENSION#0.7570;INTENSIVE CARE UNIT#0.7552;RECURRENT PREGNANCY LOSS#0.7517;CERVICAL#0.7501;GROWTH FACTOR RECEPTOR#0.7499;ACUTE LUNG INJURY#0.7493;GROWTH HORMONE#0.7491;OSTEOARTHRITIS#0.7479;LYMPHATIC VESSEL#0.7464;LIPID METABOLISM#0.7443;MAPK CASCADE#0.7441;MAP KINASE#0.7418;TUBULAR EPITHELIAL CELL#0.7417;GLUTATHIONE#0.7416;OOCYTE#0.7405;SIGNALLING PATHWAY#0.7393;UMBILICAL CORD#0.7391;TOXICITY#0.7384;ENZYME ACTIVITY#0.7369;OVARIAN CARCINOMA#0.7366;PROTEIN PHOSPHATASE 2A#0.7363;PHOSPHATASE 2A#0.7357;MACROPHAGE MIGRATION#0.7351;GENE SILENCING#0.7347;RENAL CELL CARCINOMA#0.7334;AMNION#0.7326;KINASE ACTIVITY#0.7314;LIPOLYSIS#0.7304;COMMUNITY ACQUIRED PNEUMONIA#0.7285;PERICYTE#0.7285;PNEUMONIA#0.7281;WEIGHT LOSS#0.7280;ADRENOMEDULLIN RECEPTOR ACTIVITY#0.7275;PEPTIDE SYNTHESIS#0.7251;PULMONARY VASCULAR REMODELING#0.7247;MULTIPLE REGRESSION ANALYSIS#0.7217;RESPIRATORY TRACT#0.7195;ESTROGEN RECEPTOR#0.7140;TYPE 1 DIABETES#0.7136;IFN-GAMMA#0.7130;NEUROPROTECTION#0.7124;CORD BLOOD#0.7121;SPERMATOZOA#0.7111;B CELL#0.7065;N-NITRO-L-ARGININE#0.7062;THYMIDINE PHOSPHORYLASE#0.7045;PROSTAGLANDIN E1#0.7043;PAPAVERINE#0.7039;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.7037;CYCLOSPORINE#0.7028;GASTRIC ULCER#0.7027;MONOCYTE DERIVED MACROPHAGE#0.7027;SYNCYTIOTROPHOBLAST#0.7011;MACULAR DEGENERATION#0.7006;SALIVARY GLAND#0.6986;CAPTOPRIL#0.6985;UROKINASE#0.6967;SMOOTH MUSCLE CELL PROLIFERATION#0.6955;MUSCLE CELL PROLIFERATION#0.6952;ENZYME INHIBITOR#0.6950;KIDNEY DISEASE#0.6946;SIGNALING CASCADE#0.6942;SLEEP APNEA SYNDROME#0.6941;GLYCOSYLATION#0.6929;FACTOR I#0.6927;SQUAMOUS CELL CARCINOMA#0.6919;ENDOPLASMIC RETICULUM#0.6914;EPITHELIAL BARRIER FUNCTION#0.6906;TYROSINE KINASE 1#0.6899;GLUCOSE METABOLISM#0.6879;UROKINASE PLASMINOGEN ACTIVATOR#0.6860;HUMAN PANCREATIC CANCER#0.6850;ADIPOCYTE DIFFERENTIATION#0.6829;T- PA#0.6820;AGE RELATED MACULAR DEGENERATION#0.6819;OVARIES#0.6817;LUNG DISEASE#0.6814;MORPHOGENESIS#0.6808;VIRULENCE#0.6806;INNATE IMMUNITY#0.6804;POSITIVE AIRWAY PRESSURE#0.6787;ISOPRENALINE#0.6785;ADRENALINE#0.6765;MALE REPRODUCTIVE SYSTEM#0.6754;AMNIOTIC MEMBRANE#0.6736;BETA ADRENOCEPTOR#0.6735;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6735;AREA UNDER CURVE#0.6727;DENTAL PULP STEM CELL#0.6726;GLYCERALDEHYDE-3-PHOSPHATE#0.6726;HUMAN ADIPOSE TISSUE#0.6724;ASPHYXIA#0.6716;ADENYLATE CYCLASE ACTIVITY#0.6715;LOSARTAN#0.6712;NERVE FIBER#0.6703;HEMORRHAGIC#0.6694;TIGHT JUNCTION#0.6694;MECHANISMS OF ACTION#0.6689;TRANSCRIPTIONAL CONTROL#0.6673;BLOOD PLASMA#0.6670;NEUROHORMONE#0.6669;CYTOKINE PRODUCTION#0.6666;EARLY GROWTH RESPONSE#0.6661;ALKALINE PHOSPHATASE#0.6659;SERTOLI CELL#0.6652;HEPATOCYTE GROWTH FACTOR#0.6650;MIDODRINE HYDROCHLORIDE#0.6648;DUODENUM#0.6648;STEROIDOGENESIS#0.6647;DENTAL PULP#0.6640;BONE MORPHOGENETIC PROTEIN#0.6636;RENAL FIBROSIS#0.6635;MYOFIBROBLAST#0.6626;RETINAL PIGMENT EPITHELIUM#0.6616;JEJUNUM#0.6599;CYTOTOXICITY#0.6581;DYSPNEA#0.6554;CEREBRAL ARTERY OCCLUSION#0.6554;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6553;LUPUS ERYTHEMATOSUS#0.6551;QUANTITATIVE REVERSE TRANSCRIPTION#0.6544;CELL ADHESION MOLECULE#0.6512;LOCUS COERULEUS#0.6506;PROSTATE CARCINOMA#0.6506;DNA BINDING#0.6496;LEIOMYOMA#0.6490;CHONDROCYTE#0.6476;DUCT CELL#0.6474;SMOOTH MUSCLE CONTRACTION#0.6474;PROTEIN KINASE INHIBITOR#0.6464;NOS INHIBITOR#0.6454;IONOPHORE#0.6452;CELLULAR GROWTH#0.6441;CDB-2914#0.6432;ACUTE CORONARY SYNDROME#0.6427;INTESTINAL EPITHELIAL CELL#0.6413;ACTIVATED T CELL#0.6397;TYROSINE KINASE INHIBITOR#0.6396;SYNCOPE#0.6333;RAYNAUD’S#0.6328;FETAL GROWTH RESTRICTION#0.6326;LYMPHATIC SYSTEM#0.6289;HYPERGLYCEMIA#0.6276;ENDOMETRIOSIS#0.6272;PODOCYTE#0.6269;FIBROBLAST PROLIFERATION#0.6266;CORONARY ARTERY BYPASS#0.6253;SMOOTH MUSCLE RELAXATION#0.6238;ACUTE KIDNEY INJURY#0.6235;AKT SIGNALING#0.6229;AUTOIMMUNE GLOMERULONEPHRITIS#0.6221;CORTICOTROPHIN#0.6218;ACETIC ACID#0.6205;METHACHOLINE#0.6198;PRIMARY PULMONARY HYPERTENSION#0.6178;PREADIPOCYTE#0.6173;JUGULAR VEIN#0.6172;REGULATORY T CELL#0.6170;MICROTUBULE ASSOCIATED PROTEIN#0.6165;OESTRADIOL#0.6162;NORMAL CONTROL GROUP#0.6152;ADRENOCORTICOTROPIC HORMONE#0.6126;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6120;TOLL LIKE RECEPTOR#0.6085;MECLOFENAMATE#0.6078;CAROTID BODY#0.6076;HUMAN NEUTROPHIL PEPTIDE#0.6064;ENDOTHELIUM-DERIVED RELAXING FACTOR#0.6063;UNILATERAL URETERAL OBSTRUCTION#0.6044;ALZHEIMER'S DISEASE#0.6043;GLYCOLYSIS#0.6040;BRAIN ENDOTHELIAL CELL#0.6038;CARDIAC RESYNCHRONIZATION THERAPY#0.6016;COAGULATION#0.6016;ACUTE ISCHEMIC STROKE#0.6015;LATE PREGNANCY#0.6010;ACUTE PYELONEPHRITIS#0.6006;AIRWAY SMOOTH MUSCLE#0.6001
1340	CYTOCHROME C#1.0551;CYTOCHROME C OXIDASE#1.0541;MITOCHONDRIA#0.6632
134111	UBIQUITIN#0.8718;LYSOSOME#0.7361;TUMOR SUPPRESSOR#0.6586
134145	ATP SYNTHASE#0.6975;METHYLTRANSFERASE ACTIVITY#0.6469;COLORECTAL CANCER#0.6251;CANCER CELL#0.6191
134147	HYDROLASE ACTIVITY#0.6674
134187	GERM CELL#0.7198
134218	RIBOSOME#0.9721;RIBOSOME BIOGENESIS#0.9584;RIBOSOMAL SUBUNIT#0.9138;60S RIBOSOMAL SUBUNIT#0.7590;LARGE RIBOSOMAL SUBUNIT#0.6296;FETAL BRAIN#0.6050
134265	ACTIN FILAMENT#1.1150;GENE EXPRESSION#0.8580;SPINDLE CELL SARCOMA#0.8295;FILAMENTOUS ACTIN#0.6959;CELL MIGRATION#0.6738;COLORECTAL CANCER#0.6735;LUNG CANCER#0.6717;CELL PROLIFERATION#0.6681
134266	PROTEIN IMPORT#0.8455
134288	GENE EXPRESSION#0.7939;CELL PROLIFERATION#0.6705
134353	U7 SNRNP#1.1606;RNA PROCESSING#0.9159;MRNA PROCESSING#0.8714;SMN COMPLEX#0.6796
134359	CENTRIOLE#0.7710;IDIOPATHIC SCOLIOSIS#0.7652;ADOLESCENT IDIOPATHIC SCOLIOSIS#0.6951;RETINITIS PIGMENTOSA#0.6132
134429	STEROL TRANSPORT#1.0675;ENDOPLASMIC RETICULUM#0.9521;CHOLESTEROL HOMEOSTASIS#0.9205;CHOLESTEROL BINDING#0.8276;STEROL REGULATORY ELEMENT#0.7867;STEROL BINDING#0.7604;CHOLESTEROL TRANSPORTER#0.7472;GENE EXPRESSION#0.7310;CHOLESTEROL METABOLISM#0.7190;PLASMA MEMBRANE#0.7056;ENDOCYTIC RECYCLING COMPARTMENT#0.6714;ENDOCYTIC RECYCLING#0.6577;MITOCHONDRIA#0.6386;LIPID BINDING#0.6260;INTRACELLULAR TRANSPORT#0.6259;STEROIDOGENESIS#0.6030
134430	PRIMARY OPEN ANGLE GLAUCOMA#1.0388;OPEN ANGLE GLAUCOMA#1.0328;OPTIC NERVE#0.8131;NORMAL TENSION GLAUCOMA#0.7759;SSU PROCESSOME#0.7654;BLINDNESS#0.7545;RRNA PROCESSING#0.7094;POLYMERASE CHAIN REACTION#0.6122
134466	CELL POLARITY#0.9151;OVARIAN CANCER#0.9035;CANCER CELL#0.8953;OVARIAN#0.6451
134492	CENTRIOLE AMPLIFICATION#0.7654;CENTRIOLE DUPLICATION#0.7193;SISTER CHROMATID COHESION#0.7019;ATPASE ACTIVITY#0.6814
134510	PROTEASOME#0.9079;26S PROTEASOME#0.8711;C TERMINAL DOMAIN#0.7991;PROTEASOME ASSEMBLY#0.7344;UBIQUITIN#0.6290
134526	ACETYL COA HYDROLASE#1.1893;COA HYDROLASE#1.1384;CALCIUM CHANNEL#0.7259
1345	CYTOCHROME C OXIDASE#1.0857;CYTOCHROME C#1.0800;GENE EXPRESSION#0.7518;ATP SYNTHASE#0.7229;OXIDATIVE PHOSPHORYLATION#0.6641;SKELETAL MUSCLE#0.6379
134637	TRANSACTIVATION#0.9771;DNA BINDING#0.8736;TUMOR SUPPRESSOR#0.7724;INOSINE#0.7688;APOPTOSIS#0.7657;TRANSCRIPTION FACTOR#0.7343;ADENOSINE#0.6312;GENE EXPRESSION#0.6163
1346	CYTOCHROME C OXIDASE#1.0639;CYTOCHROME C#1.0555;GENE EXPRESSION#0.9403;SKELETAL MUSCLE#0.9340;ADIPOCYTE#0.7604;ADIPOSE TISSUE#0.7596;CYTOCHROME C OXIDASE ACTIVITY#0.7271;WHITE ADIPOSE TISSUE#0.6424;DNA METHYLATION#0.6335;RESPIRATORY CHAIN#0.6255;CANCER CELL#0.6154;LUNG CANCER#0.6130
134701	SOMITE#0.8994;SOMITOGENESIS#0.6533;TRANSCRIPTION FACTOR#0.6324
134728	BINDING PROTEIN 1#0.7201;TUMOR NECROSIS FACTOR#0.7125;ACID MINE DRAINAGE#0.6448
1347	CYTOCHROME C#1.0207;CYTOCHROME C OXIDASE#1.0130;LEYDIG CELL#0.9042;RESPIRATORY CHAIN#0.8462;TESTOSTERONE#0.7225;GENE EXPRESSION#0.6604;OXIDATIVE PHOSPHORYLATION#0.6289;BARRETT'S ADENOCARCINOMA#0.6267
134864	METHAMPHETAMINE#1.0543;DOPAMINE#1.0270;NEUROTRANSMISSION#1.0083;SIGNALING PATHWAY#1.0000;B CELL#0.9390;SENSITIZATION#0.9313;ADRENERGIC RECEPTOR#0.9171;DOPAMINERGIC NEURON#0.9028;NOREPINEPHRINE#0.8937;BREAST CANCER#0.8713;CENTRAL NERVOUS SYSTEM#0.8711;DOPAMINE RECEPTOR#0.8704;NERVOUS SYSTEM#0.8700;CONDITIONED PLACE PREFERENCE#0.8591;PLASMA MEMBRANE#0.8435;STRIATUM#0.8410;HUMAN EMBRYONIC KIDNEY#0.8390;EMBRYONIC KIDNEY#0.8385;DOPAMINE UPTAKE#0.8129;HYPERACTIVITY#0.8021;INSULIN SECRETION#0.7790;SYNAPTOSOME#0.7760;DOPAMINE D2 RECEPTOR#0.7708;SECRETORY PATHWAY#0.7627;NEUROTOXICITY#0.7609;EPITHELIAL CELL#0.7589;ASTROCYTE#0.7578;XYLANASE#0.7478;PROTEIN KINASE#0.7435;BREAST CANCER PATIENTS#0.7312;APOPTOSIS#0.7134;PARKINSON'S DISEASE#0.7083;WAKEFULNESS#0.7081;3,4-METHYLENEDIOXYMETHAMPHETAMINE#0.6987;MECHANISM OF ACTION#0.6790;COGNITION#0.6388;ACETYLCHOLINE#0.6387;NEUROPROTECTION#0.6327;CELL SURFACE#0.6307;LOCOMOTION#0.6229;EATING BEHAVIOR#0.6160;RESONANCE ENERGY TRANSFER#0.6155;APICAL PLASMA MEMBRANE#0.6130;MODAFINIL#0.6076;PRIMARY BREAST CANCER#0.6037;T CELL#0.6034
134957	SYNTAXIN BINDING#1.1205;SNARE COMPLEX#1.0920;NEUROTRANSMITTER RELEASE#1.0716;EXOCYTOSIS#1.0656;SYNAPTIC TRANSMISSION#1.0474;SYNAPTIC VESICLE#1.0056;PLASMA MEMBRANE#0.9609;VESICLE FUSION#0.9601;N-ETHYLMALEIMIDE#0.9497;C TERMINAL DOMAIN#0.9485;SNARE BINDING#0.9155;INSULIN SECRETION#0.8601;ENDOTHELIAL CELL#0.8586;MEMBRANE FUSION#0.8541;LETHAL GIANT LARVAE#0.8005;CHROMAFFIN CELL#0.7752;VON WILLEBRAND DISEASE#0.7435;SYNTAXIN 1 BINDING#0.7412;THROMBOSIS#0.6858;BETA CELL#0.6234;DENTATE GYRUS#0.6134;SEQUESTERING#0.6101
1349	CYTOCHROME C OXIDASE#0.9269;CYTOCHROME C#0.9206;OXIDATIVE PHOSPHORYLATION#0.8079
134	KW-3902#1.1053;1,3-DIMETHYLXANTHINE#1.0559;DOPAMINE D1 RECEPTOR#1.0400;DIMETHYLXANTHINE#1.0391;ADENOSINE#1.0296;ETHANOL#1.0214;RECEPTOR LIGAND#1.0161;RECEPTOR BINDING#1.0132;RECEPTOR AGONIST#1.0108;RECEPTOR ANTAGONIST#1.0073;CAFFEINE#1.0044;RECEPTOR ACTIVITY#1.0033;CEREBRAL ISCHEMIA#1.0019;GLIBENCLAMIDE#1.0011;CYCLIC AMP#1.0000;XANTHINE#0.9992;PERTUSSIS#0.9985;NMDA RECEPTOR#0.9982;DOPAMINE#0.9978;SPINAL CORD#0.9978;POTASSIUM CHANNEL#0.9976;THEOPHYLLINE#0.9957;GLUTAMATE RECEPTOR#0.9934;PROTEIN KINASE C#0.9925;OPIOID RECEPTOR#0.9917;MYOCARDIUM#0.9905;HYPOXIA#0.9896;ISCHEMIA REPERFUSION INJURY#0.9895;CEREBRAL CORTEX#0.9881;PHOSPHOLIPASE C#0.9873;SYNAPTIC TRANSMISSION#0.9861;NITRIC OXIDE#0.9857;ADENYLATE CYCLASE#0.9847;ADENOSINE DEAMINASE#0.9823;ISCHEMIA#0.9810;LONG TERM POTENTIATION#0.9795;FORSKOLIN#0.9787;GENE EXPRESSION#0.9782;ACETYLCHOLINE#0.9782;NEUROTRANSMISSION#0.9778;PROTEIN KINASE#0.9774;ASTROCYTE#0.9770;MYOCYTES#0.9769;ADENYLATE#0.9760;NEUROPROTECTION#0.9749;SIGNAL TRANSDUCTION#0.9749;ASPARTATE#0.9721;SMOOTH MUSCLE#0.9697;HYPOXIC#0.9696;NERVOUS SYSTEM#0.9691;CENTRAL NERVOUS SYSTEM#0.9685;APOPTOSIS#0.9672;TUBULOGLOMERULAR FEEDBACK#0.9660;NERVE TERMINAL#0.9654;ADIPOCYTE#0.9652;GABA B RECEPTOR#0.9646;ISOPROTERENOL#0.9637;ARTERY#0.9624;STRIATUM#0.9619;GLOMERULAR FILTRATION#0.9592;EXCRETION#0.9588;DIPYRIDAMOLE#0.9567;ACTION POTENTIAL#0.9558;CORONARY ARTERY#0.9534;FOREBRAIN#0.9531;CYCLASE ACTIVITY#0.9519;GLOMERULAR FILTRATION RATE#0.9500;ADENOSINE KINASE#0.9448;4-AMINOPYRIDINE#0.9417;SIGNALING PATHWAY#0.9406;NITRIC OXIDE SYNTHASE#0.9363;KINASE INHIBITOR#0.9354;STRUCTURE ACTIVITY RELATIONSHIP#0.9342;CARDIOMYOCYTE#0.9341;PHOSPHODIESTERASE#0.9339;PROTEIN KINASE A#0.9248;BLOOD BRAIN BARRIER#0.9233;METABOTROPIC GLUTAMATE RECEPTORS#0.9226;DIURESIS#0.9215;BRADYCARDIA#0.9203;PYRAMIDAL CELL#0.9202;PURINOCEPTOR#0.9198;POLYMERASE CHAIN REACTION#0.9151;CALCIUM CHANNEL#0.9149;HYPOTENSION#0.9134;NALOXONE#0.9128;ADENOSINE MONOPHOSPHATE#0.9111;EPILEPSY#0.9080;NORADRENALINE#0.9077;BETA ADRENOCEPTOR#0.9056;EXCITATORY POSTSYNAPTIC POTENTIAL#0.8978;HISTAMINE#0.8969;ADRENERGIC RECEPTOR#0.8961;L-ARGININE#0.8950;MYOCARDIAL INFARCTION#0.8930;ADENINE#0.8921;GROWTH FACTOR#0.8890;SPINAL CORD INJURY#0.8828;P2 RECEPTOR#0.8816;TRANSCRIPTION FACTOR#0.8815;ARGININE#0.8797;PLASMA MEMBRANE#0.8767;VASOCONSTRICTION#0.8689;ACUTE HEART FAILURE#0.8660;ADENOSINE TRIPHOSPHATE#0.8637;SYNAPTOSOME#0.8637;LIPOLYSIS#0.8636;ARTERIOLE#0.8629;CARBAMAZEPINE#0.8611;MIDDLE CEREBRAL ARTERY#0.8604;CEREBRAL ARTERY#0.8602;TETRODOTOXIN#0.8566;MITOGEN ACTIVATED PROTEIN#0.8565;DECOMPENSATED HEART FAILURE#0.8565;NOCICEPTION#0.8564;VASODILATION#0.8533;CANCER CELL#0.8521;DENTATE GYRUS#0.8502;HYPERTENSION#0.8499;IB-MECA#0.8456;NEUROTRANSMITTER RELEASE#0.8428;GUANINE#0.8426;CYCLIC ADENOSINE MONOPHOSPHATE#0.8412;NITRO-L-ARGININE#0.8392;GUANOSINE#0.8361;PARKINSON'S DISEASE#0.8355;MUSCLE CELL#0.8339;ADENOSINE TRANSPORT#0.8337;REVERSE TRANSCRIPTION#0.8310;ENDOTHELIAL CELL#0.8291;SMOOTH MUSCLE CELL#0.8211;VASOPRESSIN#0.8177;NOREPINEPHRINE#0.8166;NUCLEOTIDE BINDING#0.8163;MECHANISM OF ACTION#0.8120;DOPAMINE D2 RECEPTOR#0.8110;ADENYLYL CYCLASE ACTIVITY#0.8095;CELL MEMBRANE#0.8071;FUROSEMIDE#0.7990;ATROPINE#0.7960;ARACHIDONIC ACID#0.7945;CERVICAL#0.7918;C FIBER#0.7908;ADENYLATE CYCLASE ACTIVITY#0.7896;ARRHYTHMIA#0.7893;TOXICITY#0.7892;ISOFLURANE#0.7884;ADIPOSE TISSUE#0.7875;SCHAFFER COLLATERAL#0.7861;ADENOSINE 5'-TRIPHOSPHATE#0.7851;NEUROTOXICITY#0.7823;ION CHANNEL#0.7756;BREAST CANCER#0.7734;CARBACHOL#0.7666;CEREBRAL ARTERY OCCLUSION#0.7666;CISPLATIN#0.7665;FOCAL CEREBRAL ISCHEMIA#0.7616;BRAIN DAMAGE#0.7605;CELL DEATH#0.7585;NOS INHIBITOR#0.7558;PHOSPHODIESTERASE INHIBITOR#0.7503;VASODILATOR#0.7493;BETA ADRENERGIC RECEPTOR#0.7491;GLYCINE#0.7475;GLUCOSE METABOLISM#0.7432;CHRONIC HEART FAILURE#0.7411;CELL SURFACE#0.7397;CONGESTIVE HEART FAILURE#0.7391;ACETIC ACID#0.7389;MEMORY IMPAIRMENT#0.7361;AMYGDALA#0.7320;CELL PROLIFERATION#0.7305;CONSTRICTION#0.7292;DOPAMINE RECEPTOR#0.7240;NATRIURESIS#0.7197;AMPA RECEPTOR#0.7187;WAKEFULNESS#0.7171;STEM CELL#0.7158;POSITRON EMISSION TOMOGRAPHY#0.7156;NEPHRON#0.7148;GLIAL CELL#0.7079;SCOPOLAMINE#0.7063;DEPRESSANT#0.6990;SIGNALLING PATHWAY#0.6963;INOSINE#0.6955;RESPIRATION#0.6939;SENSITIZATION#0.6924;BRAIN ISCHEMIA#0.6905;NUCLEOSIDE TRANSPORT#0.6900;THALAMUS#0.6880;INDUCIBLE NITRIC OXIDE#0.6829;LONG TERM DEPRESSION#0.6801;NEUTROPHIL#0.6784;HUMAN EMBRYONIC KIDNEY#0.6774;EMBRYONIC KIDNEY#0.6770;SURAMIN#0.6766;INDOMETHACIN#0.6756;VASODILATATION#0.6733;INCOORDINATION#0.6717;ENDOTHELIUM#0.6705;MAST CELL#0.6704;PROTEIN SYNTHESIS#0.6691;MACROPHAGE#0.6658;LITHIUM#0.6644;MYOCARDIAL STUNNING#0.6640;INHIBITION OF SYNAPTIC TRANSMISSION#0.6607;ERYTHRO#0.6577;INTERNEURON#0.6539;FORMALIN#0.6504;CONVULSION#0.6484;BACLOFEN#0.6484;CARDIOVASCULAR SYSTEM#0.6462;BLOOD VESSEL#0.6457;PERIPHERAL NERVE#0.6432;MONOCYTE#0.6408;DIABETES MELLITUS#0.6398;PAIRED PULSE FACILITATION#0.6397;INFLAMMATORY RESPONSE#0.6394;STREPTOZOTOCIN#0.6391;EPITHELIAL CELL#0.6383;BASAL GANGLIA#0.6343;PROPRANOLOL#0.6327;VASOCONSTRICTOR#0.6324;ACTION POTENTIAL DURATION#0.6315;GTP BINDING#0.6281;LEUKOCYTE#0.6270;CAFFEINE CITRATE#0.6270;MAP KINASE#0.6211;NEPHROPATHY#0.6196;CHOLINERGIC NEURON#0.6184;PROGENITOR CELL#0.6181;RETINAL GANGLION CELL#0.6172;YOHIMBINE#0.6135;TRICHLORMETHIAZIDE#0.6132;SKELETAL MUSCLE#0.6073;REACTIVE OXYGEN SPECIES#0.6066;RAPID EYE MOVEMENT#0.6065;RETINAL ISCHEMIA#0.6059;CALCITONIN SECRETION#0.6052;LEFT ANTERIOR DESCENDING#0.6024;PROTEIN KINASE A ACTIVITY#0.6023;HYPOTENSIVE#0.6018
1350	CYTOCHROME C OXIDASE#0.9801;CYTOCHROME C#0.9769;GENE EXPRESSION#0.7789
135112	BREAST CANCER#0.7861
135138	LEPROSY#1.0270;PARKINSON'S DISEASE#0.9963;MICROTUBULE#0.7748;AXONEME#0.7414;MOTILE CILIA#0.7276;MICROTUBULE SLIDING#0.6771;UBIQUITIN#0.6720;CILIARY MOTILITY#0.6527;GENE EXPRESSION#0.6479;EARLY ONSET PARKINSONISM#0.6454;CELL DEATH#0.6138
135152	NERVOUS SYSTEM#0.7358
1351	CYTOCHROME C OXIDASE#1.0400;CYTOCHROME C#1.0333;RESPIRATORY CHAIN#1.0319;MTDNA#1.0146;MITOCHONDRIA#0.9995;CANCER SPECIFIC SURVIVAL#0.9989;SKELETAL MUSCLE#0.9888;HEPATIC ENCEPHALOPATHY#0.9865;MITOCHONDRIAL DNA#0.9844;ADJUSTED HAZARD RATIO#0.9809;HEPATORENAL SYNDROME#0.9798;RECURRENCE FREE SURVIVAL#0.9791;SERUM ALBUMIN#0.9790;CHILD TURCOTTE PUGH#0.9780;LYMPH NODE METASTASIS#0.9769;TIME TO RECURRENCE#0.9755;COLD ISCHEMIA TIME#0.9754;INTERNATIONAL NORMALIZED RATIO#0.9752;PORTAL VEIN THROMBOSIS#0.9718;SPONTANEOUS BACTERIAL PERITONITIS#0.9699;NORMAL LIVER TISSUES#0.9694;RISK OF DEATH#0.9684;DISEASE FREE SURVIVAL#0.9684;GENE EXPRESSION#0.9680;HEART DISEASE#0.9678;BILE DUCT#0.9672;NATIONAL HEALTH INSURANCE#0.9668;CHRONIC LIVER FAILURE#0.9664;C REACTIVE PROTEIN#0.9658;ALKALINE PHOSPHATASE#0.9650;GLOMERULAR FILTRATION RATE#0.9650;GLOMERULAR FILTRATION#0.9647;PRIMARY BILIARY CIRRHOSIS#0.9642;PRIMARY SCLEROSING CHOLANGITIS#0.9640;ARTERY#0.9635;KIDNEY DISEASE#0.9634;ALCOHOLIC FATTY LIVER#0.9634;THROMBOSIS#0.9633;SCLEROSING CHOLANGITIS#0.9631;SORAFENIB#0.9631;ASCITES#0.9629;ISCHEMIA#0.9625;PORTAL VEIN#0.9624;ORTHOTOPIC LIVER TRANSPLANTATION#0.9606;ASPARTATE#0.9603;PORTAL HYPERTENSION#0.9600;COLORECTAL LIVER METASTASES#0.9595;TYPE 2 DIABETES#0.9595;OF LIVER TRANSPLANTATION#0.9594;HYPERTENSION#0.9592;ADVANCED LIVER DISEASE#0.9591;LYMPH NODE#0.9589;LIVER METASTASIS#0.9589;CHOLANGITIS#0.9587;DIABETES MELLITUS#0.9579;HEPATIC ARTERY#0.9574;VIRAL HEPATITIS#0.9569;CHRONIC KIDNEY DISEASE#0.9568;MEDIAN SURVIVAL TIME#0.9566;NONALCOHOLIC FATTY LIVER DISEASE#0.9563;GROWTH FACTOR#0.9562;COLON CANCER#0.9560;TUMOR NODE METASTASIS#0.9560;CORONARY ARTERY#0.9560;INTENSIVE CARE UNIT#0.9555;ALANINE#0.9555;CHRONIC HEPATITIS C#0.9553;TOXICITY#0.9553;METASTATIC COLORECTAL CANCER#0.9548;MEDIAN OVERALL SURVIVAL#0.9548;FATTY LIVER#0.9544;CHOLANGIOCARCINOMA#0.9542;NEUTROPHIL#0.9541;OVERALL SURVIVAL RATE#0.9532;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9531;CHRONIC HEPATITIS B#0.9529;OVERALL SURVIVAL TIME#0.9528;LIVER CIRRHOSIS#0.9526;CHRONIC LIVER DISEASE#0.9523;LUNG CANCER#0.9516;PANCREATIC CANCER#0.9515;FATTY LIVER DISEASE#0.9510;BREAST CANCER#0.9510;ADENOCARCINOMA#0.9509;LIVER CANCER#0.9502;ARTERY DISEASE#0.9502;T CELL#0.9499;YEAR SURVIVAL RATE#0.9497;RELAPSE FREE SURVIVAL#0.9494;PERITONITIS#0.9492;OR LIVER TRANSPLANTATION#0.9485;POLYMERASE CHAIN REACTION#0.9479;LUNG METASTASIS#0.9478;TUMOR TISSUES#0.9473;APOPTOSIS#0.9471;ADJUSTED RELATIVE RISK#0.9468;HEPATITIS B VIRUS#0.9447;HEPATITIS C VIRUS#0.9442;DISEASE SPECIFIC SURVIVAL#0.9436;HEPATITIS B#0.9430;LIVER DISEASE#0.9430;TIME TO PROGRESSION#0.9425;TACROLIMUS#0.9423;HEPATITIS C#0.9415;RESPIRATION#0.9413;COLORECTAL CANCER#0.9405;CORONARY ARTERY DISEASE#0.9405;COLORECTAL#0.9392;CHARLSON COMORBIDITY INDEX#0.9389;COLORECTAL LIVER METASTASIS#0.9359;INSTITUTIONAL REVIEW BOARD#0.9358;RED BLOOD CELL#0.9357;MYOCARDIAL INFARCTION#0.9344;HEPATOCELLULAR CARCINOMA#0.9337;PROSTATE CANCER#0.9331;HUMAN IMMUNODEFICIENCY VIRUS#0.9310;STEM CELL#0.9272;PERIPHERAL BLOOD#0.9247;CELL PROLIFERATION#0.9244;BLOOD LOSS#0.9242;ATRIAL FIBRILLATION#0.9238;REVERSE TRANSCRIPTION#0.9205;RENAL CELL CARCINOMA#0.9203;OBESE#0.9202;ANEMIA#0.9202;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9195;EVENT FREE SURVIVAL#0.9193;MAGNETIC RESONANCE IMAGING#0.9191;LIVER DAMAGE#0.9164;NEUROENDOCRINE TUMOR#0.9159;MITOCHONDRIAL MEMBRANE#0.9155;URSODEOXYCHOLIC ACID#0.9145;CANCER CELL#0.9144;LAMIVUDINE#0.9143;ACUTE LIVER FAILURE#0.9142;SUSTAINED VIROLOGICAL RESPONSE#0.9112;METASTATIC BREAST CANCER#0.9105;TRANSCRIPTION FACTOR#0.9104;QUANTITATIVE REAL TIME#0.9104;STANDARDIZED UPTAKE VALUE#0.9051;LYMPH NODE METASTASES#0.9041;HEMORRHAGE#0.9019;ELECTRON TRANSPORT#0.9007;ACUTE KIDNEY INJURY#0.8973;COLORECTAL CARCINOMA#0.8922;CORONARY HEART DISEASE#0.8912;OXIDATIVE PHOSPHORYLATION#0.8861;INCIDENCE RATE RATIO#0.8843;SUSTAINED VIROLOGIC RESPONSE#0.8842;BREAST CANCER PATIENTS#0.8825;MITOCHONDRIAL RESPIRATORY CHAIN#0.8818;AUTOIMMUNE HEPATITIS#0.8806;INFLAMMATORY RESPONSE#0.8765;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8762;PORTAL VEIN INVASION#0.8760;CHOLESTASIS#0.8747;TUMOR CELLS#0.8742;HIGH RISK PATIENTS#0.8740;INFLAMMATORY BOWEL DISEASE#0.8722;MULTIPLE REGRESSION ANALYSIS#0.8685;POSITRON EMISSION TOMOGRAPHY#0.8678;GALLBLADDER#0.8676;BONE MARROW#0.8674;GROWTH FACTOR RECEPTOR#0.8653;ELECTRON TRANSPORT CHAIN#0.8635;BILIARY ATRESIA#0.8592;TUMOR SUPPRESSOR#0.8586;OVARIAN#0.8577;HEPATOTOXICITY#0.8576;WHITE BLOOD CELL#0.8565;EPIDERMAL GROWTH FACTOR#0.8557;AGE AT DIAGNOSIS#0.8528;CONGESTIVE HEART FAILURE#0.8480;COAGULATION#0.8469;BILIARY TRACT#0.8445;ENZYME ACTIVITY#0.8428;GEMCITABINE#0.8400;METASTATIC RENAL CELL CARCINOMA#0.8369;ADIPOSE TISSUE#0.8344;SQUAMOUS CELL CARCINOMA#0.8331;GAMMA GLUTAMYLTRANSFERASE#0.8312;CELL CYCLE#0.8309;SUPEROXIDE DISMUTASE#0.8261;NEGATIVE PREDICTIVE VALUE#0.8260;CYCLOSPORINE#0.8256;CEREBROVASCULAR DISEASE#0.8253;SIGNALING PATHWAY#0.8246;OVARIAN CANCER#0.8218;PNEUMONIA#0.8216;ENTECAVIR#0.8208;TYPE 2 DIABETES MELLITUS#0.8170;2 DIABETES MELLITUS#0.8170;STANDARDIZED MORTALITY RATIO#0.8143;FLUOROURACIL#0.8132;LYMPH NODE INVOLVEMENT#0.8082;LIVER LESIONS#0.8070;ESOPHAGUS#0.8069;SYNCHRONOUS LIVER METASTASES#0.8049;KARNOFSKY PERFORMANCE STATUS#0.8043;METFORMIN#0.8036;CISPLATIN#0.8004;ALCOHOLIC HEPATITIS#0.7993;LYMPH NODE DISSECTION#0.7988;WEIGHT LOSS#0.7938;RIBAVIRIN#0.7933;ISCHEMIC HEART DISEASE#0.7931;TIME TO DEATH#0.7921;RANDOMIZED CONTROLLED TRIAL#0.7883;THROMBOCYTOPENIA#0.7839;CARDIOMYOPATHY#0.7833;LEUKOCYTE#0.7832;OXALIPLATIN#0.7816;ADJUSTED ODDS RATIO#0.7815;GLYCOLYSIS#0.7801;VASCULAR DISEASE#0.7787;NON HODGKIN LYMPHOMA#0.7760;RENAL REPLACEMENT THERAPY#0.7758;ETHANOL#0.7751;OBJECTIVE RESPONSE RATE#0.7741;KIDNEY CANCER#0.7692;HIGH DENSITY LIPOPROTEIN#0.7678;RESPONSE TO TREATMENT#0.7620;NATIONAL CANCER INSTITUTE#0.7597;ATP SYNTHESIS#0.7594;SUCCINATE#0.7572;NERVOUS SYSTEM#0.7553;RECTUM#0.7538;PARENCHYMA#0.7533;SYSTOLIC BLOOD PRESSURE#0.7523;ANGIOGENESIS#0.7486;IMMUNE RESPONSE#0.7474;LENGTH OF STAY#0.7464;REGIONAL LYMPH NODE#0.7455;ELECTRONIC MEDICAL RECORD#0.7419;MONOCYTE#0.7403;PYRUVATE#0.7393;REACTIVE OXYGEN SPECIES#0.7350;PROSTATE SPECIFIC ANTIGEN#0.7349;WARM ISCHEMIA TIME#0.7338;5 FLUOROURACIL#0.7333;STEM CELL TRANSPLANTATION#0.7325;GLUTATHIONE#0.7283;CELL DEATH#0.7272;WILCOXON RANK SUM#0.7256;COMMON TERMINOLOGY CRITERIA#0.7251;IRINOTECAN#0.7240;BEVACIZUMAB#0.7223;STOMACH CANCER#0.7206;ACUTE CELLULAR REJECTION#0.7190;MACROPHAGE#0.7182;GALLBLADDER CANCER#0.7164;AKAIKE INFORMATION CRITERION#0.7155;AUTOIMMUNE DISEASE#0.7151;CANCER RELATED DEATH#0.7138;RECEIVER OPERATOR CHARACTERISTIC#0.7132;PROTEIN KINASE#0.7112;SMOOTH MUSCLE#0.7104;TENOFOVIR#0.7098;BLOOD VESSEL#0.7081;ENDOTHELIAL GROWTH FACTOR#0.7060;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7060;MYOBLAST#0.7010;BEST SUPPORTIVE CARE#0.6997;SUCCINATE DEHYDROGENASE#0.6989;SOLID ORGAN TRANSPLANT#0.6976;POSITIVE PREDICTIVE VALUE#0.6966;ESTROGEN RECEPTOR#0.6914;RECURRENT HEPATITIS C#0.6892;METASTASIS FREE SURVIVAL#0.6886;CARDIOVASCULAR RISK FACTOR#0.6877;ABDOMINAL PAIN#0.6873;QUANTITATIVE REVERSE TRANSCRIPTION#0.6864;REGENERATION#0.6860;VITAMIN K#0.6830;ATHEROSCLEROSIS#0.6794;ADENINE#0.6792;HEPATIC VEIN#0.6789;DOXORUBICIN#0.6786;ALCOHOL USE DISORDER#0.6783;CELLULAR RESPIRATION#0.6752;CELL GROWTH#0.6723;IRON OVERLOAD#0.6716;ENDOMETRIAL CANCER#0.6704;WORLD HEALTH ORGANIZATION#0.6702;VIRAL INFECTION#0.6669;FOOD FREQUENCY QUESTIONNAIRE#0.6662;TIME TO TREATMENT#0.6636;PERITONEUM#0.6628;INTENTION TO TREAT#0.6628;MUSCLE FIBER#0.6625;PERIPHERAL VASCULAR DISEASE#0.6608;TO TUMOR RECURRENCE#0.6607;FATTY ACID BINDING#0.6604;PRO-INFLAMMATORY#0.6589;ACUTE MYOCARDIAL INFARCTION#0.6584;GENE EXPRESSION OMNIBUS#0.6573;RECURRENT HEPATOCELLULAR CARCINOMA#0.6573;PROTON PUMP#0.6567;EDEMA#0.6564;CERVICAL#0.6560;FASTING PLASMA GLUCOSE#0.6546;MITOCHONDRIAL TRANSCRIPTION#0.6496;INSULIN-LIKE GROWTH FACTOR#0.6485;PEROXISOME#0.6484;TRADITIONAL RISK FACTORS#0.6471;INNER MITOCHONDRIAL MEMBRANE#0.6458;VENA CAVA#0.6444;RESPIRATORY FAILURE#0.6428;SYSTEMIC INFLAMMATORY RESPONSE#0.6417;HYPOXIA#0.6410;TUBERCULOSIS#0.6383;COMPLEX I#0.6383;SERUM TOTAL BILIRUBIN#0.6363;RHEUMATOID ARTHRITIS#0.6361;TOTAL BILIRUBIN LEVEL#0.6353;CENTRAL NERVOUS SYSTEM#0.6347;PANCREATIC ADENOCARCINOMA#0.6327;PANCREATIC DUCTAL ADENOCARCINOMA#0.6312;EMBOLISM#0.6307;URINARY TRACT INFECTION#0.6268;LIKELIHOOD RATIO TEST#0.6262;CYTOPLASM#0.6238;ENZYME COMPLEX#0.6220;LEIGH DISEASE#0.6185;PREDNISONE#0.6177;EXCRETION#0.6176;MYCOPHENOLATE MOFETIL#0.6159;COLITIS#0.6144;MYOTUBE#0.6131;BUDD-CHIARI SYNDROME#0.6115;SKIN CANCER#0.6100;ESOPHAGEAL CANCER#0.6100;HUMAN LEUKOCYTE ANTIGEN#0.6085;NEW ONSET DIABETES#0.6083;FACTOR I#0.6076;PYRUVATE DEHYDROGENASE COMPLEX#0.6061;APPARENT DIFFUSION COEFFICIENT#0.6052;CD4+ T CELL#0.6039;DEHYDROGENASE COMPLEX#0.6030;OSTEOPOROSIS#0.6019
135228	SQUAMOUS CELL CARCINOMA#1.0643;KERATINOCYTE#1.0452;CELL SURFACE#1.0437;ENDOTHELIAL CELL#1.0398;GROWTH FACTOR#0.9912;EXTRACELLULAR MATRIX#0.9656;TRANSFORMING GROWTH FACTOR#0.9645;CANCER CELL#0.9623;ADENOCARCINOMA#0.9111;STEM CELL#0.9011;T CELL#0.8876;CELL PROLIFERATION#0.8805;GENE EXPRESSION#0.8790;B CELL#0.8199;PERIPHERAL BLOOD#0.8198;LUNG CANCER#0.7941;CELL GROWTH#0.7789;PANCREATIC CANCER#0.7613;HEMATOPOIETIC CELL#0.7585;ALPHA-2 MACROGLOBULIN#0.7585;POLYMERASE CHAIN REACTION#0.7476;BONE MARROW#0.7336;BREAST CANCER#0.7331;WOUND HEALING#0.6992;MYOEPITHELIAL CELL#0.6949;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6861;EPITHELIAL TO MESENCHYMAL#0.6859;BASAL CELL#0.6851;HEPATOCELLULAR CARCINOMA#0.6828;EPITHELIAL CELL#0.6539;SIGNALING PATHWAY#0.6531;THROMBOCYTOPENIA#0.6381;PSORIASIS#0.6364;TUMOR CELLS#0.6349;LYMPH NODE#0.6109;ORAL CAVITY#0.6077;PANCREATIC DUCTAL ADENOCARCINOMA#0.6034;SKIN FIBROBLASTS#0.6024
135250	T CELL#0.9217;TUMOR CELLS#0.8945;RETINOIC ACID#0.7814;CELL SURFACE#0.7080;CYTOTOXICITY#0.6708;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6558;SEQUENCE BASED TYPING#0.6485
135293	ORNITHINE#0.6527;LYSINE#0.6475
135295	HEPATOCELLULAR CARCINOMA#0.9016;CELL PROLIFERATION#0.8960
1352	HEME A BIOSYNTHESIS#1.0290;CYTOCHROME C OXIDASE#1.0241;CYTOCHROME C#1.0177;RESPIRATORY CHAIN#0.8821;OXIDATIVE PHOSPHORYLATION#0.8346;ELECTRON TRANSPORT#0.8244;MITOCHONDRIA#0.7799;SKELETAL MUSCLE#0.7415;COMPLEX I#0.7212;MITOCHONDRIAL DISEASE#0.7098;MTDNA#0.6515;MITOCHONDRIAL DNA#0.6473;ELECTRON TRANSPORT CHAIN#0.6361;MITOCHONDRIAL MEMBRANE#0.6342
135398	ORAL CANCER CELL#0.9289;ADJACENT NORMAL TISSUE#0.9149;CANCER CELL#0.8953
1353	CYTOCHROME C OXIDASE#0.9030;CYTOCHROME C#0.8967;COPPER BINDING#0.6969;BREAST CANCER#0.6258
135458	CELL CYCLE CHECKPOINT#0.6369;CELL CYCLE#0.6221
1355	CYTOCHROME C#1.0244;CYTOCHROME C OXIDASE#1.0231;RESPIRATORY CHAIN#0.8413;HYPERTROPHIC CARDIOMYOPATHY#0.8023;CARDIOMYOPATHY#0.7808;HEME A BIOSYNTHESIS#0.7549;MITOCHONDRIAL DNA#0.6253
135644	INFLAMMATORY RESPONSE#0.7208;TLR4 SIGNALING PATHWAY#0.7062;ACETIC ACID#0.6828;GASTROINTESTINAL TRACT#0.6790;IMMUNE RESPONSE#0.6687;SIGNALING PATHWAY#0.6678
135656	CRITICAL REGION 1#0.9726;PANCREATIC DUCTAL ADENOCARCINOMA#0.6380;CELL PROLIFERATION#0.6198
1356	SERTOLI CELL#1.0633;ALPHA-1 PROTEASE INHIBITOR#1.0602;CAERULOPLASMIN#1.0561;VITAMIN D BINDING#1.0558;THYROXINE BINDING#1.0502;CERULOPLASMIN ACTIVITY#1.0489;HORMONE BINDING#1.0473;FERROXIDASE ACTIVITY#1.0460;TOTAL OXIDANT STATUS#1.0438;IMMUNOGLOBULIN G#1.0423;SERUM AMYLOID A#1.0384;ACERULOPLASMINEMIA#1.0384;ERYTHROCYTE SEDIMENTATION RATE#1.0367;DIAMINE OXIDASE#1.0363;TOTAL ANTIOXIDANT STATUS#1.0353;TOTAL ANTIOXIDANT CAPACITY#1.0350;OXIDATIVE STRESS INDEX#1.0330;PULMONARY TUBERCULOSIS#1.0290;RETINOL BINDING#1.0280;FIBRINOGEN#1.0257;BETA-2#1.0250;ALPHA 1-ANTITRYPSIN#1.0242;CYTOCHROME C OXIDASE#1.0238;ALPHA-2 MACROGLOBULIN#1.0237;URIC ACID#1.0221;ASCORBIC ACID#1.0211;RETINOL#1.0202;ALPHA-TOCOPHEROL#1.0190;TUBERCULOSIS#1.0190;XANTHINE OXIDASE#1.0182;DIVALENT METAL TRANSPORTER#1.0172;CATALASE ACTIVITY#1.0171;MAMMARY GLAND#1.0163;CORTISOL#1.0159;BREAST CANCER#1.0151;PROTEINASE INHIBITOR#1.0148;PSORIASIS#1.0145;ASCORBATE#1.0145;C REACTIVE PROTEIN#1.0131;METAL BINDING#1.0119;FACTOR VIII#1.0114;TOCOPHEROL#1.0110;XANTHINE#1.0104;COPPER BINDING#1.0089;VITAMIN E#1.0087;VITAMIN A#1.0087;VITAMIN C#1.0064;CYTOCHROME C#1.0044;IRON BINDING#1.0038;AMYLOID PRECURSOR PROTEIN#1.0035;ANTIOXIDANT ACTIVITY#1.0028;ASTROCYTE#1.0028;GERM CELL#1.0016;GLUTATHIONE PEROXIDASE#1.0009;EXCRETION#1.0006;WHITE BLOOD CELL#1.0005;IRON TRANSPORT#1.0003;LUNG CANCER#1.0003;ALKALINE PHOSPHATASE#0.9994;SERUM ALBUMIN#0.9990;TYPE 2 DIABETES#0.9983;SUPEROXIDE DISMUTASE ACTIVITY#0.9978;HEART DISEASE#0.9975;ERYTHROCYTE#0.9972;ELECTRON TRANSFER#0.9963;GLUTATHIONE#0.9954;SYNOVIAL FLUID#0.9953;TRANSFERRIN RECEPTOR#0.9952;SUPEROXIDE DISMUTASE#0.9952;TUMOR NECROSIS FACTOR#0.9950;MONOCYTE#0.9943;ENDOTHELIUM#0.9940;HEMOLYSIS#0.9938;ENTEROCYTE#0.9930;PLASMA MEMBRANE#0.9924;BLOOD PLASMA#0.9920;MINERALIZATION#0.9919;LYSOZYME ACTIVITY#0.9912;CELL SURFACE#0.9909;RED BLOOD CELL#0.9906;ASPARTATE#0.9905;HYPOXIA#0.9903;LEUKOCYTE#0.9897;ESTRADIOL#0.9897;POLYPHENOL OXIDASE ACTIVITY#0.9893;NITRIC OXIDE#0.9881;ISCHEMIA#0.9876;IRON REGULATORY PROTEIN#0.9875;LEUCINE#0.9875;ALZHEIMER'S DISEASE#0.9874;NEUTROPHIL#0.9873;GROWTH FACTOR#0.9868;ALANINE#0.9867;LOW DENSITY LIPOPROTEIN#0.9863;PLASMA PROTEIN#0.9861;HEPATITIS B#0.9858;MENKES DISEASE#0.9857;OESTRADIOL#0.9852;PARKINSON'S DISEASE#0.9851;ALPHA-1-PROTEINASE INHIBITOR#0.9851;HIGH DENSITY LIPOPROTEIN#0.9848;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9848;D-PENICILLAMINE#0.9847;IRON OVERLOAD#0.9843;ENZYME ACTIVITY#0.9842;IRON HOMEOSTASIS#0.9840;PRIMARY BILIARY CIRRHOSIS#0.9838;RETINAL DEGENERATION#0.9829;MYOCARDIAL INFARCTION#0.9828;RHEUMATOID ARTHRITIS#0.9826;ENDOTHELIAL CELL#0.9825;HISTIDINE#0.9822;DOPAMINE#0.9816;LIVER CIRRHOSIS#0.9812;SLIT LAMP EXAMINATION#0.9811;NEURODEGENERATIVE DISEASE#0.9810;STORAGE PROTEIN#0.9809;PEROXIDASE ACTIVITY#0.9808;GESTATION#0.9803;PLASTOCYANIN#0.9796;DNA BINDING#0.9781;OBESE#0.9778;COPPER HOMEOSTASIS#0.9767;WILSON DISEASE#0.9763;CORD BLOOD#0.9763;CENTRAL NERVOUS SYSTEM#0.9758;PERIPHERAL BLOOD#0.9756;METHIONINE#0.9747;ESTROGENS#0.9741;ACUTE PHASE RESPONSE#0.9724;HYPERTENSION#0.9722;PENICILLAMINE#0.9722;SUBSTANTIA NIGRA#0.9720;CHRONIC LIVER DISEASE#0.9720;LACTATION#0.9719;LIVER DAMAGE#0.9717;EPITHELIAL CELL#0.9712;LYSIS#0.9710;TRANSCRIPTION FACTOR#0.9706;DIABETES MELLITUS#0.9706;MULTIPLE SCLEROSIS#0.9699;MUTAGENESIS#0.9698;BASAL GANGLIA#0.9696;NERVOUS SYSTEM#0.9692;TETRATHIOMOLYBDATE#0.9692;COAGULATION#0.9687;MACROPHAGE#0.9685;PROTEIN SYNTHESIS#0.9683;CELL MEMBRANE#0.9680;MAGNETIC RESONANCE IMAGING#0.9669;ATHEROSCLEROSIS#0.9664;LECTIN#0.9664;CREATINE KINASE#0.9659;ENDOPLASMIC RETICULUM#0.9654;MITOCHONDRIA#0.9652;ANEMIA#0.9642;DEMENTIA#0.9640;TESTOSTERONE#0.9637;AZURIN#0.9637;GENE EXPRESSION#0.9635;LIVER DISEASE#0.9634;OVARIAN#0.9632;ACUTE MYOCARDIAL INFARCTION#0.9631;INFLAMMATORY RESPONSE#0.9629;SMOOTH MUSCLE#0.9620;VENOUS BLOOD#0.9619;ANAEMIA#0.9608;RESPIRATORY BURST#0.9603;HEPATOCELLULAR CARCINOMA#0.9594;SODIUM DODECYL SULFATE#0.9590;DODECYL SULFATE#0.9589;IMMUNE SYSTEM#0.9583;REACTIVE OXYGEN SPECIES#0.9573;NITRIC OXIDE SYNTHASE#0.9569;CELL PROLIFERATION#0.9569;IMMUNE RESPONSE#0.9567;PRO-INFLAMMATORY#0.9563;AMNIOTIC FLUID#0.9561;CELL ADHESION#0.9553;GLYCOSYLATION#0.9551;ACID PHOSPHATASE#0.9546;PROGESTERONE#0.9543;WEIGHT GAIN#0.9541;HEMOLYTIC ANEMIA#0.9529;PARENTERAL#0.9529;BONE MARROW#0.9527;APOPTOSIS#0.9526;OVARIAN CANCER#0.9520;CANCER CELL#0.9506;TISSUE DAMAGE#0.9498;CERVICAL#0.9498;ASCITES#0.9494;PRE-ECLAMPSIA#0.9486;TOXICITY#0.9484;POLYMERASE CHAIN REACTION#0.9481;ANGIOTENSIN CONVERTING ENZYME#0.9473;ACUTE LIVER FAILURE#0.9465;DETOXIFICATION#0.9449;T CELL#0.9429;MACULAR DEGENERATION#0.9420;ANTIOXIDANT DEFENSE SYSTEM#0.9420;ISCHEMIA MODIFIED ALBUMIN#0.9417;TYPE 2 DIABETES MELLITUS#0.9417;2 DIABETES MELLITUS#0.9417;LUPUS ERYTHEMATOSUS#0.9412;DYSTONIA#0.9399;COPPER TRANSPORTING ATPASE#0.9387;MYELOPEROXIDASE ACTIVITY#0.9380;ELECTRON TRANSPORT#0.9380;LIPID METABOLISM#0.9375;SPINAL CORD#0.9363;ETHANOL#0.9349;COMPLEX I#0.9341;DEFICIENCY ANEMIA#0.9340;ARTERY#0.9331;HEAT SHOCK PROTEIN#0.9324;MOLAR#0.9321;IFN-GAMMA#0.9294;GRANULOCYTE#0.9294;HEME OXYGENASE 1#0.9288;ANGIOGENESIS#0.9285;CORTISOL BINDING#0.9284;ATHEROSCLEROTIC#0.9280;MONONUCLEAR CELLS#0.9279;GLIAL CELL#0.9264;CATALYTIC ACTIVITY#0.9255;OXYGENASE#0.9246;TYPE 2 DIABETIC#0.9243;KIDNEY DISEASE#0.9227;MALNUTRITION#0.9199;RESPIRATORY TRACT#0.9195;YOLK SAC#0.9182;GENETIC DISORDER#0.9175;PROTEINURIA#0.9162;CREATINE#0.9151;GAMMA GLUTAMYLTRANSFERASE#0.9150;CONNECTIVE TISSUE#0.9136;GLUCOSE-6-PHOSPHATE#0.9115;DIAMINE OXIDASE ACTIVITY#0.9114;FOLIC ACID#0.9111;SECRETORY PATHWAY#0.9104;PROTEIN OXIDATION#0.9098;INDUCTIVELY COUPLED PLASMA#0.9096;SIGNALING PATHWAY#0.9095;CELL DEATH#0.9094;LIPOPROTEIN OXIDATION#0.9077;REVERSE TRANSCRIPTION#0.9057;TRYPTOPHAN#0.9054;HEALTHY CONTROL SUBJECTS#0.9050;RETINOIC ACID#0.9048;LUPUS NEPHRITIS#0.9037;STREPTOZOTOCIN#0.9035;NEUTROPENIA#0.9020;CORONARY HEART DISEASE#0.9001;GASTROINTESTINAL TRACT#0.8972;INTESTINAL MUCOSA#0.8969;CYTOPLASM#0.8963;NEPHROTIC SYNDROME#0.8961;T LYMPHOCYTE#0.8958;MARKERS OF INFLAMMATION#0.8946;MALATE DEHYDROGENASE#0.8919;NEPHROPATHY#0.8917;RETICULOCYTE#0.8909;COPPER CHAPERONE#0.8909;BLOOD BRAIN BARRIER#0.8908;PNEUMONIA#0.8906;DIGESTION#0.8889;CEREBELLAR ATAXIA#0.8886;AGE RELATED MACULAR DEGENERATION#0.8878;FATTY LIVER#0.8847;QUANTITATIVE REAL TIME#0.8844;SMALL INTESTINE#0.8837;PROTEIN COMPLEX#0.8817;EDEMA#0.8806;SIDEROPHORE#0.8798;VIRAL HEPATITIS#0.8784;HEMOSIDEROSIS#0.8780;NEUROPATHY#0.8779;LOW IRON#0.8757;RESPIRATORY DISTRESS#0.8755;NEUROTOXICITY#0.8754;LYSINE#0.8752;IRON DEFICIENCY ANEMIA#0.8747;ADRENALINE#0.8731;CHOLESTASIS#0.8722;DEFEROXAMINE#0.8714;DNA PROTECTION#0.8712;VITAMIN B12#0.8702;CELL GROWTH#0.8698;CORONARY ARTERY#0.8697;FOLATE#0.8682;TUMOR CELLS#0.8674;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8673;MULTIPLE MYELOMA#0.8668;INDOMETHACIN#0.8664;BLOOD COAGULATION#0.8661;CLOTTING#0.8660;ANEMIC#0.8626;FETAL LIVER#0.8600;GOLGI APPARATUS#0.8582;NEPHRITIS#0.8576;CHRONIC HEPATITIS B#0.8540;EPIDERMAL GROWTH FACTOR#0.8527;AMYOTROPHIC LATERAL SCLEROSIS#0.8522;EPILEPSY#0.8522;LATERAL SCLEROSIS#0.8522;FACTOR I#0.8506;KUPFFER CELL#0.8469;CEREBRAL CORTEX#0.8468;MILD COGNITIVE IMPAIRMENT#0.8463;IRON ACQUISITION#0.8460;PHAGOCYTOSIS#0.8459;MULTIPLE REGRESSION ANALYSIS#0.8450;GLUTATHIONE PEROXIDASE ACTIVITY#0.8440;ATOMIC ABSORPTION SPECTROMETRY#0.8420;ETHINYL ESTRADIOL#0.8417;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8395;ENDOTHELIAL GROWTH FACTOR#0.8394;RETINITIS PIGMENTOSA#0.8370;FRONTAL#0.8367;MUSCLE CELL#0.8366;STEM CELL#0.8365;SIZE EXCLUSION CHROMATOGRAPHY#0.8365;NEUROLOGICAL DISORDER#0.8360;POLYRIBOSOME#0.8357;ADENOCARCINOMA#0.8338;LUNG DISEASE#0.8338;SQUAMOUS CELL CARCINOMA#0.8324;CARDIOVASCULAR RISK FACTOR#0.8320;SUCROSE#0.8315;ARGININE#0.8299;HYPERCHOLESTEROLEMIA#0.8295;REGENERATION#0.8281;LIPID OXIDATION#0.8252;POSITIVE PREDICTIVE VALUE#0.8246;CYTOTOXICITY#0.8239;MELATONIN#0.8236;EPINEPHRINE#0.8230;INNATE IMMUNITY#0.8225;HEPATOTOXICITY#0.8214;POLYMORPHONUCLEAR LEUKOCYTES#0.8209;BLOOD LOSS#0.8208;PANCREATITIS#0.8197;SKELETAL MUSCLE#0.8191;FRUCTOSE#0.8186;CYSTIC FIBROSIS#0.8167;WOUND HEALING#0.8162;THALAMUS#0.8154;HYPOXIA INDUCIBLE FACTOR#0.8145;ADENOHYPOPHYSIS#0.8145;KIDNEY INJURY MOLECULE#0.8127;COMPLEMENT FACTOR H#0.8099;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION#0.8094;72-HOURS#0.8054;BILE DUCT#0.8049;CARRIE#0.8048;CEREBRAL ISCHEMIA#0.8037;ECLAMPSIA#0.8032;HEPATOMA CELLS#0.8027;WEIGHT LOSS#0.8019;ARTERY DISEASE#0.8018;ION BINDING#0.7990;DEXAMETHASONE#0.7986;LASER DESORPTION IONIZATION#0.7963;TOTAL ANTIOXIDANT ACTIVITY#0.7948;HYPERGLYCEMIA#0.7939;HEPATITIS C#0.7917;IRON ASSIMILATION#0.7912;URATE#0.7910;INTESTINAL ABSORPTION#0.7908;ISCHEMIC HEART DISEASE#0.7905;HISTAMINE#0.7897;PARTURITION#0.7889;URINARY PROTEIN#0.7885;PHOSPHATASE ACTIVITY#0.7883;VERY-LOW-DENSITY LIPOPROTEIN#0.7882;HYPOXIC#0.7865;CORONARY ARTERY DISEASE#0.7860;AUTOIMMUNE DISEASE#0.7846;ADIPOSE TISSUE#0.7845;AUTOSOMAL RECESSIVE DISEASE#0.7840;HUMAN SERUM ALBUMIN#0.7839;RESPONSE TO COPPER#0.7826;CARDIOMYOPATHY#0.7823;SWELLING#0.7817;VALPROIC ACID#0.7808;PERIODONTITIS#0.7805;BIOMINERALIZATION#0.7802;DEVELOPMENTAL DELAY#0.7802;MULTIPLE LINEAR REGRESSION#0.7797;LEUKOPENIA#0.7778;HEMORRHAGE#0.7777;TRANSMISSION ELECTRON MICROSCOPY#0.7770;INNATE IMMUNE RESPONSE#0.7767;MONOCYTE CHEMOTACTIC PROTEIN#0.7759;GLYCINE#0.7744;TRANS GOLGI NETWORK#0.7736;GROWTH HORMONE#0.7720;DESOGESTREL#0.7717;TRIIODOTHYRONINE#0.7716;VASCULAR CELL#0.7703;HUMORAL IMMUNE RESPONSE#0.7701;UTERUS#0.7684;HYDROXYPROLINE#0.7641;SMOOTH MUSCLE CELL#0.7635;BETA-ESTRADIOL#0.7634;LINEAR REGRESSION ANALYSIS#0.7605;ALKALINE PHOSPHATASE ACTIVITY#0.7566;ERYTHROPOIESIS#0.7559;EXTRACELLULAR FLUIDS#0.7550;HYALURONIC ACID#0.7520;DIARRHEA#0.7507;GLOMERULAR FILTRATION#0.7496;LUTEAL PHASE#0.7477;LARYNX#0.7456;FREE ANDROGEN INDEX#0.7453;MASTITIS#0.7441;DUODENUM#0.7418;DRY MATTER INTAKE#0.7413;SUPROL#0.7402;HYPERSENSITIVITY#0.7396;ORGANELLE#0.7379;VIRULENCE#0.7379;LYSOSOME#0.7377;SEQUESTERING#0.7376;SYSTOLIC BLOOD PRESSURE#0.7370;BLOOD VESSEL#0.7364;HODGKIN'S LYMPHOMA#0.7363;MALARIA#0.7358;ADENOSINE#0.7353;LEVONORGESTREL#0.7342;RIBOSOMAL PROTEIN#0.7312;BINDING PROTEIN 1#0.7309;GENETIC DISEASE#0.7298;GLOMERULAR FILTRATION RATE#0.7295;MICROCYTIC ANEMIA#0.7289;INSULIN-LIKE GROWTH FACTOR#0.7272;OSTEOARTHRITIS#0.7268;CYSTATIN#0.7265;PLASMA GLYCOPROTEIN#0.7264;FOLLICULAR ADENOMA#0.7261;OF DIABETIC RATS#0.7215;PROTEIN KINASE#0.7202;ABDOMINAL PAIN#0.7190;PSORIATIC ARTHRITIS#0.7189;THROMBOCYTOPENIA#0.7186;FATTY LIVER DISEASE#0.7178;COMPLEMENT ACTIVATION#0.7178;SEMINAL PLASMA#0.7177;GLUTAMIC ACID#0.7165;JUGULAR VEIN#0.7151;STRIATUM#0.7136;COLON CANCER#0.7135;MECHANISM OF ACTION#0.7132;BLOOD UREA NITROGEN#0.7114;PROSTAGLANDIN D SYNTHASE#0.7111;CAUDATE NUCLEUS#0.7101;PANCREATIC CANCER#0.7095;FERRITIN LIGHT CHAIN#0.7094;TUMOUR NECROSIS FACTOR#0.7076;LYMPHOCYTE PROLIFERATION#0.7059;GLOMERULONEPHRITIS#0.7056;VASCULITIS#0.6995;MICROGLIAL CELL#0.6971;TRAUMATIC BRAIN INJURY#0.6960;RETINITIS#0.6957;LIVER CANCER#0.6954;APOPTOTIC#0.6942;GLUTAMINE#0.6895;LACTIC ACID#0.6887;ATN-224#0.6887;LABILE IRON POOL#0.6886;DRIED BLOOD SPOT#0.6883;THYMIDINE#0.6862;METAL ION BINDING#0.6861;PROTEIN METABOLISM#0.6850;POLYSOME#0.6834;PHENOTHIAZINE#0.6828;RESPONSE TO IRON#0.6827;MENINGITIS#0.6822;CYTOCHROME C OXIDASE ACTIVITY#0.6818;GAIT COMPLEX#0.6804;ANKYLOSING SPONDYLITIS#0.6800;CATABOLISM#0.6799;ISOPROTERENOL#0.6785;PROTEIN BINDING#0.6782;NORADRENALINE#0.6776;DIABETIC NEPHROPATHY#0.6757;ADRIAMYCIN#0.6756;OSTEOPOROSIS#0.6731;SOLUBLE TRANSFERRIN RECEPTOR#0.6728;B CELL#0.6726;BREAST DISEASE#0.6724;ACTIVATED PROTEIN C#0.6718;AUTISTIC#0.6715;CAROTENOID#0.6706;CELLULAR LOCALIZATION#0.6701;VASCULAR DEMENTIA#0.6695;DENSITY FUNCTIONAL THEORY#0.6682;PERIPHERAL MONONUCLEAR CELLS#0.6682;MANNITOL#0.6681;OLIGODENDROCYTE#0.6679;LINES OF EVIDENCE#0.6677;ACUTE CORONARY SYNDROME#0.6675;INFLAMMATORY BOWEL DISEASE#0.6669;AGEING#0.6665;HEMORRHAGIC#0.6652;BREAST CANCER PATIENTS#0.6647;DNA SYNTHESIS#0.6643;ORTHOTOPIC LIVER TRANSPLANTATION#0.6636;NEGATIVE PREDICTIVE VALUE#0.6632;MOUSE EMBRYONIC FIBROBLAST#0.6627;GLCNAC#0.6625;PERIPHERAL BLOOD LYMPHOCYTES#0.6622;IL-1RA#0.6620;ATRIAL FIBRILLATION#0.6606;HYPERTHYROIDISM#0.6597;CELL ADHESION MOLECULE#0.6589;SCLERODERMA#0.6518;VASCULAR DISEASE#0.6503;RENAL CELL CARCINOMA#0.6495;EXTRACELLULAR MATRIX#0.6460;HEPATITIS A#0.6452;ISOTHERMAL TITRATION CALORIMETRY#0.6446;SERUM URIC ACID#0.6442;TRADITIONAL RISK FACTORS#0.6440;ENDOCYTOSIS#0.6418;LUNG FIBROBLASTS#0.6414;BRUSH BORDER#0.6412;SIGNAL PEPTIDE#0.6386;CELL WALL#0.6384;NEURONAL CELLS#0.6382;ELECTROPHORETIC MOBILITY SHIFT#0.6375;LEUCINE AMINOPEPTIDASE ACTIVITY#0.6373;NOREPINEPHRINE#0.6361;OVULATION#0.6353;IMMUNE CELL#0.6345;RHEUMATISM#0.6339;LYMPH NODE#0.6328;OXIDATION REDUCTION#0.6301;AGE AT DIAGNOSIS#0.6293;HEPATIC ENCEPHALOPATHY#0.6283;AUTOIMMUNE HEPATITIS#0.6275;VITAMIN A DEFICIENCY#0.6264;HEALTHY CONTROL GROUP#0.6259;AGE AT ONSET#0.6235;RETINAL PIGMENT EPITHELIUM#0.6235;L-ASCORBATE#0.6199;PACHYTENE#0.6196;DUODENAL ULCER#0.6195;CHRONIC PYELONEPHRITIS#0.6189;PANCYTOPENIA#0.6186;GLIBENCLAMIDE#0.6177;CYTOCHROME P450#0.6176;HEPARIN#0.6171;GLUTATHIONE TRANSFERASE#0.6158;GROWTH FACTOR BINDING#0.6145;CYTOCHROME B#0.6100;PHOSPHOLIPASE A2#0.6092;PARATHYROID HORMONE#0.6092;HUNTINGTON'S DISEASE#0.6087;BRAIN DAMAGE#0.6079;BRONCHITIS#0.6072;MEMBRANE FRACTION#0.6071;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6064;TYPE 1 DIABETES#0.6049;DIURNAL#0.6048;PHENOBARBITAL#0.6048;GLUCOSE METABOLISM#0.6046;BETA CELL#0.6044;HEPATITIS C VIRUS#0.6044;AVERAGE DAILY GAIN#0.6039;PARENCHYMA#0.6019;LUMINAL#0.6001
1357	CARBOXYPEPTIDASE A#1.0540;MAST CELL#1.0309;PHOTOSYSTEM II#1.0251;CATALYTIC ACTIVITY#1.0167;PANCREATITIS#1.0109;ARGININE#1.0066;L-PHENYLALANINE#0.9985;PHOTOSYSTEM#0.9247;EPITHELIAL CELL#0.8938;GENE EXPRESSION#0.8627;PANCREATIC CANCER#0.8602;METHOTREXATE#0.8552;DIGESTION#0.8267;ACUTE PANCREATITIS#0.8167;MUTAGENESIS#0.8146;ACINAR CELL#0.7887;CYTOTOXICITY#0.7627;VIRULENCE#0.7191;TRANSCRIPTION FACTOR#0.7113;SECRETORY GRANULE#0.7103;ENZYME INHIBITOR#0.7085;ALANINE#0.6980;ACETIC ACID#0.6944;TUMOR CELLS#0.6863;ASPARTIC ACID#0.6795;LEUCINE#0.6719;ADENOSINE#0.6705;ADEPT#0.6573;L-TYROSINE#0.6380;ING-1#0.6299;CYSTIC FIBROSIS#0.6279;TOXICITY#0.6193;CELL DIFFERENTIATION#0.6161;RIBOSOME#0.6160;SALT TOLERANCE#0.6040;SULFAMIDE#0.6034;THYMIDYLATE SYNTHASE#0.6006
135892	ACID SECRETION#0.6523;OVARIAN CANCER#0.6417
1358	PHOTOSYSTEM II#0.8033;CARBOXYPEPTIDASE A#0.6914;PHOTOSYSTEM#0.6559;ARGININE#0.6448
135935	OOCYTE#1.0375;TRANSCRIPTION FACTOR#1.0355;GERM CELL#1.0251;PREMATURE OVARIAN FAILURE#1.0121;OVARIES#1.0118;OVARIAN#1.0110;OOGENESIS#0.9964;GENE EXPRESSION#0.9861;PRIMARY OVARIAN INSUFFICIENCY#0.9412;DNA BINDING#0.8670;OVARIAN FOLLICLE#0.8013;STEM CELL#0.6882;GRANULOSA CELL#0.6686;APOPTOSIS#0.6450;INFERTILITY#0.6344;POLYMERASE CHAIN REACTION#0.6001
1359	CARBOXYPEPTIDASE A#1.1116;MAST CELL#1.0529;SECRETORY GRANULE#1.0316;GENE EXPRESSION#0.8149;HEPARIN#0.8061;MAST CELL DEGRANULATION#0.6889;PROTEOGLYCAN#0.6762;BASOPHIL#0.6546;EOSINOPHIL#0.6381;MAST CELL GRANULE#0.6013
135	ADENOSINE#1.0243;ADRENERGIC RECEPTOR#1.0235;DOPAMINE D2 RECEPTOR#1.0178;SPINAL CORD#1.0140;MACROPHAGE#1.0134;HYPOXIA#1.0113;CAFFEINE#1.0098;RECEPTOR LIGAND#1.0080;RECEPTOR AGONIST#1.0079;ISCHEMIA REPERFUSION INJURY#1.0057;FOREBRAIN#1.0044;CELL ACTIVATION#1.0042;NEUROPROTECTION#1.0032;BASAL GANGLIA#1.0028;RECEPTOR ANTAGONIST#1.0026;IMMUNE CELL#1.0025;SIGNALING PATHWAY#1.0017;T CELL#1.0002;PROTEIN KINASE A#0.9994;L-DOPA#0.9988;GLUTAMATE RECEPTOR#0.9975;NKT CELL#0.9935;PARKINSON'S DISEASE#0.9927;ISCHEMIA#0.9926;RECEPTOR BINDING#0.9921;APOPTOSIS#0.9913;DOPAMINE#0.9907;IMMUNE RESPONSE#0.9900;DYSKINESIA#0.9895;NEUTROPHIL#0.9892;CELL DEATH#0.9889;CD4+ T CELL#0.9886;GROWTH FACTOR#0.9880;STRIATUM#0.9876;ADENOSINE DEAMINASE#0.9873;PROTEIN KINASE#0.9867;HUNTINGTON'S DISEASE#0.9865;INFLAMMATORY RESPONSE#0.9847;ALZHEIMER'S DISEASE#0.9839;TISSUE DAMAGE#0.9837;CYCLIC AMP#0.9823;DOPAMINE D1 RECEPTOR#0.9821;REGULATORY T CELL#0.9814;GENE EXPRESSION#0.9769;RECEPTOR-RECEPTOR INTERACTION#0.9753;PRO-INFLAMMATORY#0.9749;NERVE TERMINAL#0.9747;ENDOTHELIAL CELL#0.9747;TUMOR NECROSIS FACTOR#0.9743;NITRIC OXIDE#0.9731;CENTRAL NERVOUS SYSTEM#0.9720;ASTROCYTE#0.9716;NERVOUS SYSTEM#0.9715;XANTHINE#0.9710;PROTEIN KINASE C#0.9709;ADENOSINE MONOPHOSPHATE#0.9699;ETHANOL#0.9698;ARTERY#0.9686;SYNAPTIC TRANSMISSION#0.9685;BONE MARROW#0.9683;HYPOXIC#0.9661;DOPAMINE RECEPTOR#0.9644;WOUND HEALING#0.9644;CELL SURFACE#0.9621;TRANSCRIPTION FACTOR#0.9619;RESONANCE ENERGY TRANSFER#0.9615;NEURODEGENERATIVE DISEASE#0.9596;HALOPERIDOL#0.9594;POLYMERASE CHAIN REACTION#0.9588;CEREBRAL ISCHEMIA#0.9573;T LYMPHOCYTE#0.9567;CELL PROLIFERATION#0.9545;CEREBRAL CORTEX#0.9541;B CELL#0.9447;HYPERTENSION#0.9444;LEUKOCYTE#0.9436;APOPTOTIC#0.9403;SIGNAL TRANSDUCTION#0.9373;SENSITIZATION#0.9349;ACETYLCHOLINE#0.9344;NEUROTRANSMISSION#0.9335;ADENYLATE CYCLASE#0.9319;BRAIN DAMAGE#0.9317;MOLECULAR DYNAMICS SIMULATION#0.9266;CYCLIC ADENOSINE MONOPHOSPHATE#0.9260;VASODILATION#0.9233;PERIPHERAL BLOOD#0.9188;TOXICITY#0.9155;MONOCYTE#0.9145;LEVODOPA#0.9092;MEDIUM SPINY NEURONS#0.9091;DIPYRIDAMOLE#0.9083;SMOOTH MUSCLE#0.9041;ENDOTHELIAL GROWTH FACTOR#0.9032;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9032;CD8+ T CELL#0.8944;ANGIOGENESIS#0.8934;METHOTREXATE#0.8926;ASPARTATE#0.8913;FORSKOLIN#0.8910;DNA METHYLATION#0.8886;NEUROTOXICITY#0.8882;THEOPHYLLINE#0.8872;ANXIETY DISORDER#0.8871;MITOGEN ACTIVATED PROTEIN#0.8856;DERMAL FIBROBLAST#0.8785;MICROGLIAL CELL#0.8781;NMDA RECEPTOR#0.8771;NITRIC OXIDE SYNTHASE#0.8761;ATL146E#0.8713;MOTOR ACTIVITY#0.8701;GABAERGIC NEURON#0.8649;RECEPTOR ACTIVITY#0.8634;ADENYLATE#0.8604;QUINOLINIC ACID#0.8598;STRUCTURE ACTIVITY RELATIONSHIP#0.8594;MONONUCLEAR CELLS#0.8579;PHOSPHODIESTERASE#0.8563;MYELOID CELL#0.8526;MYOCARDIAL PERFUSION IMAGING#0.8503;SUBSTANCE P#0.8497;TREG CELL#0.8490;CYTOKINE PRODUCTION#0.8482;MECHANISM OF ACTION#0.8455;PANIC DISORDER#0.8431;LONG TERM POTENTIATION#0.8385;HEPATIC STELLATE CELL#0.8368;INFLAMMATORY CELL#0.8363;ARTERIOLE#0.8354;CORONARY ARTERY#0.8350;RHEUMATOID ARTHRITIS#0.8348;AUTOIMMUNE DISEASE#0.8344;PLASMA MEMBRANE#0.8339;TUMOR CELLS#0.8324;LIVER DAMAGE#0.8315;T CELL ACTIVATION#0.8231;CYTOCHROME P450#0.8199;AMYGDALA#0.8199;CANCER CELL#0.8167;INOSINE#0.8160;CHRONIC CEREBRAL HYPOPERFUSION#0.8135;NORADRENALINE#0.8134;GLIAL CELL#0.8089;AUTOPHAGY#0.8088;BIOLUMINESCENCE#0.8044;CAMP SIGNALING#0.8042;VASODILATOR#0.8020;ACUTE LUNG INJURY#0.8001;COLLAGEN INDUCED ARTHRITIS#0.7988;COGNITION#0.7967;BLEOMYCIN#0.7955;POSITRON EMISSION TOMOGRAPHY#0.7947;HYPERACTIVITY#0.7903;MYOCYTES#0.7855;EPITHELIAL CELL#0.7851;AGE AT ONSET#0.7827;CAMP RESPONSE ELEMENT#0.7769;TOLL LIKE RECEPTOR#0.7712;CANNABINOID RECEPTOR#0.7698;DOPAMINERGIC NEURON#0.7662;BONE FORMATION#0.7639;TRAUMATIC BRAIN INJURY#0.7626;CYCLASE ACTIVITY#0.7619;CAMP RESPONSE ELEMENT BINDING#0.7599;SPINAL CORD INJURY#0.7598;ADENINE#0.7594;BLOOD BRAIN BARRIER#0.7591;LOCOMOTION#0.7571;IFN-GAMMA#0.7538;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7538;TH17 CELL#0.7533;FRONTAL#0.7527;KINASE INHIBITOR#0.7504;REVERSE TRANSCRIPTION#0.7502;OLIGODENDROCYTE#0.7472;GUANINE#0.7464;TNF-ALPHA PRODUCTION#0.7459;PULMONARY ARTERY#0.7458;EDEMA#0.7429;ACTIVATED T-CELLS#0.7392;1,3,7-TRIMETHYLXANTHINE#0.7391;ACTIVATED T CELL#0.7388;AKT SIGNALING#0.7386;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7347;CELL DIFFERENTIATION#0.7346;NEURITE OUTGROWTH#0.7340;REACTIVE OXYGEN SPECIES#0.7325;TURNING BEHAVIOUR#0.7306;EPILEPSY#0.7291;MUSCLE CELL#0.7290;ADENOSINE TRIPHOSPHATE#0.7251;PLATELET AGGREGATION#0.7221;TNF PRODUCTION#0.7216;NUCLEUS ACCUMBENS SHELL#0.7195;MEMORY IMPAIRMENT#0.7193;BONE MARROW CELLS#0.7184;RAPID EYE MOVEMENT#0.7181;TOPICAL#0.7163;INTERNEURON#0.7136;WAKEFULNESS#0.7101;SMOOTH MUSCLE CELL#0.7063;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.7055;NEUROTRANSMITTER RELEASE#0.7045;P1 RECEPTOR#0.6993;ARGININE#0.6990;HYPOXIA INDUCIBLE FACTOR#0.6977;NKT CELL ACTIVATION#0.6953;VASODILATATION#0.6952;GANGLION CELLS#0.6940;LYMPH NODE#0.6938;COLLAGEN SYNTHESIS#0.6872;DOPAMINE D3 RECEPTOR#0.6850;SUBSTANTIA NIGRA#0.6845;RESERPINE#0.6835;OSTEOCLAST#0.6816;WHITE MATTER LESIONS#0.6813;PREPULSE INHIBITION#0.6803;NEUTROPHIL APOPTOSIS#0.6774;FOAM CELL FORMATION#0.6764;NEUROLOGICAL DISORDER#0.6737;ENDOTHELIAL NITRIC OXIDE#0.6727;MAST CELL#0.6708;REVERSE CHOLESTEROL TRANSPORT#0.6700;CYTOTOXICITY#0.6679;CHOLESTEROL TRANSPORT#0.6673;ADENOSINE FORMATION#0.6570;GLIBENCLAMIDE#0.6556;NATURAL KILLER T#0.6501;1,3-DIMETHYLXANTHINE#0.6467;T HELPER CELL#0.6458;SIGNALING MOLECULE#0.6434;T CELL PROLIFERATION#0.6434;QUANTITATIVE REAL TIME#0.6421;TRANSFORMING GROWTH FACTOR#0.6401;DENDRITIC CELL#0.6398;APOMORPHINE#0.6372;ADENOSINE KINASE#0.6360;UVEITIS#0.6335;NEUROTRANSMITTER RECEPTOR#0.6327;IMMUNE SYSTEM#0.6287;MACROPHAGE INFLAMMATORY PROTEIN#0.6286;PULMONARY ARTERIAL HYPERTENSION#0.6285;REGENERATION#0.6277;NITRO-L-ARGININE#0.6272;CEREBRAL ARTERY#0.6268;HUMAN DERMAL FIBROBLAST#0.6264;OLFACTORY BULB#0.6258;ALPHA2 ADRENERGIC RECEPTOR#0.6258;OSTEOBLAST#0.6252;L-ARGININE#0.6249;BLOOD VESSEL#0.6237;METHAMPHETAMINE#0.6219;INFLAMMATORY BOWEL DISEASE#0.6218;MAP KINASE#0.6215;ISOPROTERENOL#0.6211;3,4-DIHYDROXYPHENYLALANINE#0.6210;HYPOTENSION#0.6178;RETINAL GANGLION CELL#0.6176;IB-MECA#0.6145;PHOSPHOLIPASE C#0.6143;ENDOTHELIUM#0.6125;PERITONITIS#0.6113;GLUTAMATE HOMEOSTASIS#0.6102;CONSTRICTION#0.6093;ENCEPHALOMYELITIS#0.6083;HISTAMINE#0.6070;NEURITE#0.6066;STEM CELL#0.6057;MILD COGNITIVE IMPAIRMENT#0.6031;ADENYLYL CYCLASE ACTIVITY#0.6030;HYPOTENSIVE#0.6021;OCULAR HYPERTENSION#0.6006;PULMONARY FIBROSIS#0.6002
1360	PANCREATIC CARBOXYPEPTIDASE B#1.1260;ACUTE PANCREATITIS#1.0588;FIBRINOLYSIS#1.0502;PANCREATITIS#1.0433;LYSINE#1.0103;CARBOXYPEPTIDASE A#0.9985;ARGININE#0.9303;LYSIS#0.9290;T- PA#0.8800;GENE EXPRESSION#0.8746;PANCREATIC CANCER#0.8528;COAGULATION#0.8389;PLASMINOGEN ACTIVATION#0.8197;POLY ETHYLENE GLYCOL#0.7367;CELL SURFACE#0.7286;PLASMA CARBOXYPEPTIDASE B#0.6829;DIGESTION#0.6622;ACINAR CELL#0.6565;RNA BINDING#0.6313;CHROMAFFIN GRANULE#0.6153;CARBOXYPEPTIDASE ACTIVITY#0.6066;LYMPH NODE#0.6053;PANCREATIC CARCINOMA#0.6045;XANTHINE OXIDASE#0.6004
1361	PLASMA CARBOXYPEPTIDASE B#1.1380;REGULATION OF FIBRINOLYSIS#1.0627;BREAST CANCER#1.0550;INHIBITION OF FIBRINOLYSIS#1.0395;FIBRINOLYSIS#1.0347;T- PA#1.0219;LYSINE#1.0167;ACTIVATED PROTEIN C#1.0141;ARGININE#1.0102;FIBRINOGEN#1.0071;DISSEMINATED INTRAVASCULAR COAGULATION#1.0053;CORONARY ARTERY#1.0051;PLASMINOGEN ACTIVATION#1.0029;C REACTIVE PROTEIN#1.0028;ENDOTHELIAL CELL#1.0027;FACTOR VIII#1.0020;POLYMERASE CHAIN REACTION#1.0010;LYSIS#0.9998;MYOCARDIAL INFARCTION#0.9962;CORONARY ARTERY DISEASE#0.9932;CLOTTING#0.9925;ARTERY DISEASE#0.9923;ARTERY#0.9923;DIABETES MELLITUS#0.9860;THROMBOSIS#0.9856;COAGULATION#0.9850;GENE EXPRESSION#0.9848;BLOOD COAGULATION#0.9751;HEPARIN#0.9749;TYPE 2 DIABETES#0.9742;HEMOSTASIS#0.9722;THROMBOPLASTIN#0.9608;HEMOPHILIA#0.9504;MACROPHAGE#0.9499;BETA-2#0.9471;TYPE 2 DIABETIC#0.9460;HYPERTENSION#0.9439;CARBOXYPEPTIDASE ACTIVITY#0.9416;GROWTH FACTOR#0.9381;POLYCYSTIC OVARY SYNDROME#0.9319;PANCREATIC CARBOXYPEPTIDASE B#0.9307;VIRULENCE#0.9224;OBESE#0.9220;PLASMA PROTEIN#0.9184;FRAGMENT LENGTH POLYMORPHISM#0.9105;NEUTROPHIL#0.9054;ACUTE MYOCARDIAL INFARCTION#0.9004;SELECTIN#0.8965;NECROTIC#0.8920;UROKINASE#0.8845;FACTOR V LEIDEN#0.8786;HEART DISEASE#0.8694;ACUTE CORONARY SYNDROME#0.8689;CELL SURFACE#0.8663;INFLAMMATORY BOWEL DISEASE#0.8620;MONOCYTE#0.8614;THROMBOPHILIA#0.8602;BLOOD CLOT#0.8510;ATHEROSCLEROSIS#0.8363;CORONARY HEART DISEASE#0.8287;ALANINE#0.8267;CANCER CELL#0.8257;KIDNEY TRANSPLANT RECIPIENTS#0.8136;PLATELET AGGREGATION#0.8125;THROMBIN ACTIVITY#0.8103;ANTIPHOSPHOLIPID SYNDROME#0.8098;ENDOGENOUS THROMBIN POTENTIAL#0.7953;GESTATIONAL DIABETES#0.7877;GLYCOSYLATION#0.7862;COMPLEMENT ACTIVATION#0.7852;CARDIOVASCULAR RISK FACTOR#0.7842;WOUND HEALING#0.7803;INFLAMMATORY RESPONSE#0.7706;TYPE 2 DIABETES MELLITUS#0.7651;2 DIABETES MELLITUS#0.7651;HEALTHY CONTROL SUBJECTS#0.7646;DIARRHEA#0.7628;HYPOTHYROIDISM#0.7621;RECURRENT PREGNANCY LOSS#0.7611;DIRECT THROMBIN INHIBITOR#0.7581;PRO-INFLAMMATORY#0.7580;ANTICOAGULANT ACTIVITY#0.7546;BLOOD LOSS#0.7428;PLATELET ACTIVATION#0.7359;TYPE 1 DIABETES#0.7355;ACTIVATION OF COAGULATION#0.7348;HEMORRHAGE#0.7329;ATHEROSCLEROTIC#0.7321;ABDOMINAL AORTIC ANEURYSM#0.7308;AORTIC ANEURYSM#0.7285;RENAL TRANSPLANT RECIPIENTS#0.7259;CELL MIGRATION#0.7207;ADIPOSE TISSUE#0.7195;PULMONARY EMBOLISM#0.7165;EMBOLISM#0.7076;LOW DENSITY LIPOPROTEIN#0.6952;MIDDLE CEREBRAL ARTERY#0.6951;CEREBRAL ARTERY#0.6948;LEUKOCYTE#0.6935;PULMONARY HYPERTENSION#0.6868;DIABETIC NEPHROPATHY#0.6846;INTIMA MEDIA THICKNESS#0.6800;ACUTE ISCHEMIC STROKE#0.6794;CAROTID ARTERY#0.6772;AMNIOTIC FLUID#0.6726;BREAST CANCER CELL#0.6647;REGULATION OF COAGULATION#0.6589;PLASMIN ACTIVITY#0.6588;THROMBOCYTOPENIA#0.6546;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.6502;RECEPTOR ANTAGONIST#0.6457;VENA CAVA#0.6313;VASCULAR DISEASE#0.6278;HEMORRHAGIC#0.6264;NEPHROPATHY#0.6260;EPIDERMAL GROWTH FACTOR#0.6193;SYSTOLIC BLOOD PRESSURE#0.6154;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6115;MULTIPLE REGRESSION ANALYSIS#0.6030
136227	ASPIRIN#0.6933
136242	MALE INFERTILITY#0.7497;OVIDUCT#0.6915
136259	TYPE 2 DIABETES#1.0833;TRANSCRIPTION FACTOR#0.9563;TYPE 2 DIABETES MELLITUS#0.8889;2 DIABETES MELLITUS#0.8889;DIABETES MELLITUS#0.8845;GENE EXPRESSION#0.6807
1362	HEPATITIS B#1.0709;HEPATITIS B VIRUS#1.0706;TRANS GOLGI NETWORK#1.0517;SECRETORY PATHWAY#1.0500;CELL SURFACE#1.0032;ARGININE#0.9443;NITRIC OXIDE#0.8348;SHORT TANDEM REPEAT#0.8271;BREAST CANCER#0.8096;PLASMA MEMBRANE#0.7903;CANCER CELL#0.7547;BREAST CANCER CELL#0.7541;SECRETORY VESICLE#0.7150;CARBOXYPEPTIDASE A#0.7029;APOPTOSIS#0.6859;CELL PROLIFERATION#0.6791;PROSTATE CANCER#0.6170;PROTEIN PHOSPHATASE 2A#0.6151;PHOSPHATASE 2A#0.6147;SECRETORY GRANULE#0.6080;L-ARGININE#0.6059;ENDOSOME#0.6033
136319	PROTEIN SYNTHESIS#1.0818;MYOCYTES#1.0549;GENE EXPRESSION#0.9028;SKELETAL MUSCLE#0.8985;CELL GROWTH#0.8669;GROWTH FACTOR#0.8629;PROTEIN KINASE C#0.6940;MUSCLE CELL#0.6929;PROTEIN KINASE#0.6896;CARDIOMYOCYTE#0.6512;NF-KAPPAB ACTIVATION#0.6315
136371	OPEN ANGLE GLAUCOMA#1.1367;PRIMARY OPEN ANGLE GLAUCOMA#1.0917;NORMAL TENSION GLAUCOMA#0.7000;20S PROTEASOME#0.6265
1363	GUANIDINOETHYLMERCAPTOSUCCINIC ACID#1.1028;NEUROPEPTIDE PROCESSING#1.0665;REGULATED SECRETORY PATHWAY#1.0555;CHROMAFFIN GRANULE#1.0458;SECRETORY VESICLE#1.0340;PEPTIDE HORMONE#1.0272;PITUITARY GLAND#1.0263;OBESE#1.0241;SECRETORY PATHWAY#1.0205;BETA CELL#1.0203;ANGIOTENSIN CONVERTING ENZYME#1.0185;SECRETORY GRANULE#1.0132;NEUROENDOCRINE CELL#1.0131;NERVOUS SYSTEM#1.0125;CELL DEATH#1.0085;ENZYME ACTIVITY#1.0068;TRANS GOLGI NETWORK#0.9923;ENDOCRINE CELL#0.9868;ARGININE#0.9866;ADRENAL MEDULLA#0.9842;CANCER CELL#0.9820;ASTROCYTE#0.9782;GENE EXPRESSION#0.9580;ENDOPLASMIC RETICULUM#0.9554;SIGNALING PATHWAY#0.9531;STRIATUM#0.9441;CELL MIGRATION#0.9409;GROWTH FACTOR#0.9390;ISLETS OF LANGERHANS#0.9361;DOPAMINE#0.9349;CELL PROLIFERATION#0.9319;ETHANOL#0.9248;TYPE 2 DIABETES#0.9190;POLYMERASE CHAIN REACTION#0.9055;GLYCINE#0.9035;SUBSTANCE P#0.9014;CENTRAL NERVOUS SYSTEM#0.8792;MACROPHAGE#0.8642;NEUROENDOCRINE TUMOR#0.8597;LYSINE#0.8586;INSULINOMA#0.8564;CARBOXYPEPTIDASE ACTIVITY#0.8425;TUMOR TISSUES#0.8400;TRANSCRIPTION FACTOR#0.8348;INSULIN SECRETION#0.8297;ADRENAL GLAND#0.8264;GLUTAMIC ACID#0.8156;INSULIN RECEPTOR#0.8037;DIABETES MELLITUS#0.7848;GROWTH HORMONE#0.7688;ADIPOSE TISSUE#0.7684;T CELL#0.7586;CARBOXYPEPTIDASE A#0.7584;PROTEIN KINASE#0.7573;OPIOID PEPTIDE#0.7547;SIGNAL PEPTIDE#0.7519;PYRAMIDAL CELL#0.7502;MEMBRANE FRACTION#0.7456;PANCREATIC ISLET#0.7445;PHEOCHROMOCYTOMA#0.7437;APOPTOSIS#0.7434;SECRETORY GRANULE MEMBRANE#0.7426;PANCREATIC CANCER#0.7423;LYMPH NODE METASTASIS#0.7422;SHORT TANDEM REPEAT#0.7369;LYMPH NODE#0.7352;AXONAL TRANSPORT#0.7324;KINESIN#0.7320;VASOPRESSIN#0.7318;SPINAL CORD#0.7244;GOLGI APPARATUS#0.7071;TESTOSTERONE#0.7022;OPIOID RECEPTOR#0.6988;CEREBRAL CORTEX#0.6975;NERVE TERMINAL#0.6920;HIGH FAT DIET#0.6876;TESTOSTERONE PROPIONATE#0.6860;MICROTUBULE#0.6785;LIPID RAFT#0.6782;THYROTROPIN RELEASING HORMONE#0.6767;TUMOR CELLS#0.6754;ACID PHOSPHATASE#0.6742;PLASMA MEMBRANE#0.6738;NEUROPROTECTION#0.6726;SCIATIC NERVE#0.6713;COLORECTAL CANCER#0.6696;IFN-GAMMA#0.6634;DEXAMETHASONE#0.6557;MONOCYTE#0.6528;CELL CYCLE#0.6444;DENSE CORE VESICLE#0.6428;CHROMAFFIN GRANULE MEMBRANE#0.6370;FORSKOLIN#0.6354;CYTOCHROME B#0.6276;IMMUNE RESPONSE#0.6246;CELL MEMBRANE#0.6225;INSULIN PROCESSING#0.6213;ATHEROSCLEROSIS#0.6187;STEM CELL#0.6143;SEMINAL PLASMA#0.6121;PERIPHERAL MEMBRANE PROTEIN#0.6087;HEAT SHOCK PROTEIN#0.6030
1364	ZONULA OCCLUDENS 1#1.0540;CLOSTRIDIUM PERFRINGENS ENTEROTOXIN#1.0516;PANCREATIC CANCER#1.0487;OVARIAN CANCER#1.0353;ZONULA OCCLUDENS#1.0351;OVARIAN#1.0225;JUNCTIONAL ADHESION MOLECULE#1.0160;OVARIAN CARCINOMA#1.0120;BREAST CARCINOMA#1.0109;PLASMA MEMBRANE#1.0102;ADENOCARCINOMA#1.0074;ADHERENS JUNCTION#1.0064;SQUAMOUS CELL CARCINOMA#1.0051;CANCER CELL#1.0025;LYMPH NODE#0.9986;BREAST CANCER#0.9961;STEM CELL#0.9939;GROWTH FACTOR#0.9917;POLYMERASE CHAIN REACTION#0.9914;CELL MEMBRANE#0.9885;HUMAN PANCREATIC CANCER#0.9876;CELL ADHESION#0.9873;TIGHT JUNCTION PROTEIN#0.9873;EPIDERMAL GROWTH FACTOR#0.9864;CYTOTOXICITY#0.9859;EPITHELIAL BARRIER FUNCTION#0.9858;DNA METHYLATION#0.9852;COLORECTAL CANCER#0.9835;BREAST CANCER CELL#0.9828;TIGHT JUNCTION#0.9819;TUMOR CELLS#0.9808;ENDOMETRIUM#0.9806;TRANSCRIPTION FACTOR#0.9790;CELL JUNCTION#0.9789;CELL PROLIFERATION#0.9786;GROWTH FACTOR RECEPTOR#0.9781;SIGNALING PATHWAY#0.9778;APOPTOSIS#0.9777;COLORECTAL#0.9774;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.9744;DUCT CELL#0.9739;KERATINOCYTE#0.9738;GENE EXPRESSION#0.9730;INTESTINAL EPITHELIAL CELL#0.9715;CELL MIGRATION#0.9701;REVERSE TRANSCRIPTION#0.9698;EPITHELIAL CELL#0.9686;PROTEIN KINASE#0.9682;PROSTATE CANCER#0.9680;LYMPH NODE METASTASIS#0.9631;ALVEOLAR EPITHELIAL CELL#0.9535;QUANTITATIVE REAL TIME#0.9531;TRANSFORMING GROWTH FACTOR#0.9525;PROGESTERONE#0.9503;SMALL INTESTINE#0.9479;EPITHELIAL OVARIAN CANCER#0.9476;LUMINAL#0.9458;CYTOPLASM#0.9387;FLUORESCEIN#0.9352;COLITIS#0.9341;JEJUNUM#0.9332;IMMUNE RESPONSE#0.9329;ENDOTHELIAL CELL#0.9221;INTERCELLULAR JUNCTION#0.9219;CELL SURFACE#0.9193;EPITHELIAL MESENCHYMAL TRANSITION#0.9133;TUMOR NECROSIS FACTOR#0.9129;ACINAR CELL#0.9027;DISEASE FREE SURVIVAL#0.8956;LUNG ADENOCARCINOMA#0.8948;MITOGEN ACTIVATED PROTEIN#0.8868;GASTRIC MUCOSA#0.8848;FORMALIN#0.8836;APOPTOTIC#0.8792;ACUTE LUNG INJURY#0.8771;INFLAMMATORY BOWEL DISEASE#0.8745;ENDOMETRIAL CARCINOMA#0.8743;INFLAMMATORY RESPONSE#0.8722;PROSTATE STEM CELL#0.8636;TRANSCRIPTASE#0.8606;CELL ADHESION MOLECULE#0.8601;DIARRHEA#0.8589;STEM CELL ANTIGEN#0.8566;PANCREATIC DUCTAL ADENOCARCINOMA#0.8557;INTESTINAL MUCOSA#0.8524;SUBMANDIBULAR GLAND#0.8494;HEPATOCELLULAR CARCINOMA#0.8492;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8470;EPITHELIAL TO MESENCHYMAL#0.8468;ENDOMETRIAL CANCER#0.8452;METAPLASIA#0.8380;TRANSMISSION ELECTRON MICROSCOPY#0.8376;CISPLATIN#0.8326;ENTEROCYTE#0.8288;SALIVARY GLAND#0.8284;TOXICITY#0.8270;GASTRIC ADENOCARCINOMA#0.8192;INTERCELLULAR SPACE#0.8134;TRANSFORMING GROWTH FACTOR BETA#0.8106;INSOLUBLE FRACTION#0.8073;CELL POLARITY#0.8060;CELL CELL JUNCTION#0.8038;PROTEIN KINASE C#0.7992;CELL GROWTH#0.7977;LYMPHATIC VESSEL#0.7973;CYTOLYSIS#0.7971;MALIGNANT MESOTHELIOMA#0.7929;CELL CELL ADHESION#0.7894;TIGHT JUNCTION FORMATION#0.7875;CELL DIFFERENTIATION#0.7762;REACTIVE OXYGEN SPECIES#0.7745;PRO-INFLAMMATORY#0.7721;MAMMARY EPITHELIAL CELL#0.7716;MESOTHELIAL CELL#0.7613;PANCREATIC CARCINOMA#0.7611;UTERUS#0.7611;PROTEIN SYNTHESIS#0.7554;ANDROGEN RECEPTOR#0.7527;HEAT SHOCK PROTEIN#0.7507;INVASIVE CARCINOMA#0.7459;COLON CANCER#0.7446;HISTONE MODIFICATION#0.7437;CELL DEATH#0.7417;ESTROGEN RECEPTOR#0.7405;T CELL#0.7394;COLON CARCINOMA#0.7376;EXTRACELLULAR MATRIX#0.7356;ENDOMETRIAL ADENOCARCINOMA#0.7335;PROGENITOR CELL#0.7203;LUNG CANCER#0.7203;ENDOTHELIAL GROWTH FACTOR#0.7157;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7157;ALDOSTERONE#0.7135;KINASE INHIBITOR#0.7130;ULCERATIVE COLITIS#0.7128;ENDOCYTOSIS#0.7116;CELLULAR LOCALIZATION#0.7044;INTESTINAL MUCOSAL BARRIER#0.7041;HUMAN BREAST CANCER#0.7031;MANNITOL#0.7018;DESMOSOME#0.7004;METASTATIC CARCINOMA#0.6976;EDEMA#0.6967;DNA DEMETHYLATION#0.6963;HYPOXIA#0.6924;INSULIN-LIKE GROWTH FACTOR#0.6912;QUERCETIN#0.6905;METASTATIC ADENOCARCINOMA#0.6866;EMBRYO IMPLANTATION#0.6831;PAPILLARY CARCINOMA#0.6816;CELL CYCLE#0.6808;ALVEOLAR FLUID CLEARANCE#0.6768;LYMPHOID TISSUE#0.6759;RETINOIC ACID#0.6753;MENSTRUAL CYCLE#0.6726;CELL MOTILITY#0.6711;RENAL CELL CARCINOMA#0.6689;SURFACE EPITHELIUM#0.6664;LYSINE#0.6655;ALANINE#0.6650;TELOMERASE REVERSE TRANSCRIPTASE#0.6628;MAMMARY GLAND#0.6575;LIVER METASTASIS#0.6569;QUANTITATIVE REVERSE TRANSCRIPTION#0.6470;TOLL LIKE RECEPTOR#0.6428;NEPHRON#0.6360;GASTROINTESTINAL TRACT#0.6339;LUTEAL PHASE#0.6299;INFLAMMATORY CELL#0.6264;SIGNAL TRANSDUCTION#0.6242;ENDOMETRIOSIS#0.6235;LASER SCANNING MICROSCOPY#0.6222;APICAL JUNCTION#0.6201;ATOPIC DERMATITIS#0.6191;MEMBRANE FRACTION#0.6189;RESPONSE TO PROGESTERONE#0.6173;SMOOTH MUSCLE#0.6164;HOST CELL#0.6157;CROHN'S DISEASE#0.6140;DEMETHYLATION#0.6113;THYROID TRANSCRIPTION FACTOR#0.6112;BLOOD VESSEL#0.6112;MORPHOGENESIS#0.6094;EPITHELIAL TISSUES#0.6075;MYOSIN LIGHT-CHAIN KINASE#0.6069;ESOPHAGEAL CANCER#0.6042;DISORIENTATION#0.6041;SMOOTH MUSCLE ACTIN#0.6015;PULMONARY EDEMA#0.6014;AMNIOTIC MEMBRANE#0.6009;AKT SIGNALING#0.6004
1365	ZONULA OCCLUDENS 1#1.0585;CLOSTRIDIUM PERFRINGENS ENTEROTOXIN#1.0504;ZONULA OCCLUDENS#1.0420;PROSTATE CANCER#1.0313;OVARIAN#1.0289;OVARIAN CANCER#1.0253;JUNCTIONAL ADHESION MOLECULE#1.0155;ADENOCARCINOMA#1.0124;SERTOLI CELL#1.0093;OVARIAN CARCINOMA#1.0062;CELL ADHESION#1.0025;CANCER CELL#1.0004;TIGHT JUNCTION PROTEIN#0.9958;BREAST CANCER#0.9948;PROTEIN KINASE#0.9927;POLYMERASE CHAIN REACTION#0.9914;BLOOD BRAIN BARRIER#0.9904;GENE EXPRESSION#0.9871;EPIDERMAL GROWTH FACTOR#0.9864;TIGHT JUNCTION#0.9857;ENDOTHELIAL CELL#0.9851;PLASMA MEMBRANE#0.9843;LUMINAL#0.9833;GROWTH FACTOR#0.9826;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.9789;APOPTOSIS#0.9773;EPITHELIAL BARRIER FUNCTION#0.9762;BREAST CARCINOMA#0.9761;SIGNALING PATHWAY#0.9734;EPITHELIAL CELL#0.9729;ADHERENS JUNCTION#0.9699;TUMOR NECROSIS FACTOR#0.9675;ANDROGEN RECEPTOR#0.9666;MYOSIN LIGHT-CHAIN KINASE#0.9626;CYTOTOXICITY#0.9615;TRANSCRIPTION FACTOR#0.9570;CELL MIGRATION#0.9505;ALVEOLAR EPITHELIAL CELL#0.9433;GROWTH FACTOR RECEPTOR#0.9416;EPITHELIAL MESENCHYMAL TRANSITION#0.9384;IMMUNE RESPONSE#0.9366;CELL ADHESION MOLECULE#0.9356;MITOGEN ACTIVATED PROTEIN#0.9331;COLORECTAL#0.9316;STEM CELL#0.9297;CELL PROLIFERATION#0.9286;BLOOD TESTIS BARRIER#0.9231;JEJUNUM#0.9224;INTESTINAL EPITHELIAL CELL#0.9216;TRANSFORMING GROWTH FACTOR#0.9207;SUPEROXIDE DISMUTASE#0.9100;TUMOR CELLS#0.9099;CELL MEMBRANE#0.9074;QUANTITATIVE REAL TIME#0.9003;GERM CELL#0.8997;GLUTATHIONE#0.8995;CELL SURFACE#0.8973;TIGHT JUNCTION FORMATION#0.8958;INFLAMMATORY RESPONSE#0.8954;LYMPH NODE#0.8946;COLITIS#0.8910;COLORECTAL CANCER#0.8875;GLUTATHIONE PEROXIDASE#0.8831;CELL JUNCTION#0.8697;PRO-INFLAMMATORY#0.8649;BREAST CANCER CELL#0.8633;SMALL INTESTINE#0.8612;FATTY ACID BINDING#0.8609;INFLAMMATORY BOWEL DISEASE#0.8556;SIGNALING MOLECULE#0.8536;SPERMATOGENESIS#0.8526;LUNG CANCER#0.8487;TARGET OF RAPAMYCIN#0.8455;CELL CELL ADHESION#0.8438;CELL POLARITY#0.8376;ACINAR CELL#0.8375;INTERCELLULAR JUNCTION#0.8347;MOUTH DISEASE#0.8224;EDEMA#0.8218;CYTOPLASM#0.8200;EPITHELIAL OVARIAN CANCER#0.8191;NEUTROPHIL#0.8138;FOOT AND MOUTH DISEASE#0.8069;INTESTINAL MUCOSA#0.8064;EPITHELIAL TO MESENCHYMAL#0.8060;COLON CANCER#0.8055;SALIVARY GLAND#0.8051;SQUAMOUS CELL CARCINOMA#0.7964;T CELL#0.7908;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7893;FLUORESCEIN#0.7887;COLORECTAL CARCINOMA#0.7874;REACTIVE OXYGEN SPECIES#0.7825;MAMMARY GLAND#0.7814;MAMMARY EPITHELIAL CELL#0.7710;ALKALINE PHOSPHATASE#0.7652;ENDOMETRIUM#0.7638;TRANSCRIPTASE#0.7614;INTERCELLULAR SPACE#0.7600;PAPILLARY CARCINOMA#0.7537;RAPAMYCIN#0.7510;BRAIN ENDOTHELIAL CELL#0.7507;TRANSMISSION ELECTRON MICROSCOPY#0.7485;DIARRHEA#0.7443;AKT SIGNALING#0.7437;SUBMANDIBULAR GLAND#0.7429;LUNG ADENOCARCINOMA#0.7419;ADJACENT NORMAL TISSUE#0.7419;CYTOLYSIS#0.7367;TOLL LIKE RECEPTOR#0.7235;REVERSE TRANSCRIPTION#0.7222;LUNG CARCINOMA#0.7210;CHOROID PLEXUS#0.6933;SPERMATOCYTES#0.6916;GOBLET CELL#0.6913;LACTATION#0.6897;AQUAPORIN#0.6897;ENTEROCYTE#0.6891;INSOLUBLE FRACTION#0.6838;ENDOMETRIAL CANCER#0.6822;VIRUS LIKE PARTICLE#0.6817;BIOTIN#0.6760;PROGESTERONE#0.6745;CISPLATIN#0.6738;PANCREATIC CANCER#0.6711;INTESTINAL DAMAGE#0.6671;RENAL CELL CARCINOMA#0.6657;OVARIAN SURFACE EPITHELIUM#0.6633;DUODENUM#0.6585;BLOOD VESSEL#0.6578;CELL CELL JUNCTION#0.6572;MACROPHAGE#0.6564;SURFACE EPITHELIUM#0.6564;FORMALIN#0.6511;BASAL CELL#0.6497;CELL DIFFERENTIATION#0.6441;KINASE INHIBITOR#0.6434;CENTRAL NERVOUS SYSTEM#0.6427;KERATINOCYTE#0.6427;NERVOUS SYSTEM#0.6418;EXTRACELLULAR LOOP 2#0.6322;GASTROINTESTINAL TRACT#0.6294;HEAT SHOCK PROTEIN#0.6242;APOPTOTIC#0.6232;PSORIASIS#0.6227;GASTRIC MUCOSA#0.6205;ACID PHOSPHATASE#0.6150;ENDOTHELIAL GROWTH FACTOR#0.6143;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6143;ESOPHAGUS#0.6138;IMMUNE SYSTEM#0.6113;COLORECTAL ADENOCARCINOMA#0.6101;SUCROSE#0.6095;METASTATIC ADENOCARCINOMA#0.6043;AMNIOTIC MEMBRANE#0.6032
136647	CELL CYCLE#0.9206;CELL CYCLE ARREST#0.8426
1366	COLORECTAL CANCER#1.0451;COLORECTAL#1.0447;SQUAMOUS CELL CARCINOMA#1.0297;LUNG CANCER#1.0269;LYMPH NODE#1.0257;COLON CANCER#1.0159;ADENOCARCINOMA#1.0139;RENAL CELL CARCINOMA#1.0111;NEPHRON#1.0099;ZONULA OCCLUDENS#1.0065;POLYMERASE CHAIN REACTION#1.0063;EPITHELIAL BARRIER FUNCTION#1.0026;CANCER CELL#0.9998;SIGNALING PATHWAY#0.9985;BREAST CANCER#0.9921;GENE EXPRESSION#0.9911;TIGHT JUNCTION PROTEIN#0.9893;EPITHELIAL MESENCHYMAL TRANSITION#0.9877;APOPTOSIS#0.9867;GROWTH FACTOR#0.9855;CHROMOPHOBE RENAL CELL CARCINOMA#0.9852;CELL ADHESION#0.9828;CELL PROLIFERATION#0.9828;CELL JUNCTION#0.9812;TIGHT JUNCTION#0.9769;CELL MEMBRANE#0.9769;EPITHELIAL CELL#0.9768;ORAL SQUAMOUS CELL CARCINOMA#0.9761;HEPATOCELLULAR CARCINOMA#0.9760;ENDOTHELIAL CELL#0.9744;BREAST CARCINOMA#0.9697;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.9658;LUMINAL#0.9647;TRANSCRIPTION FACTOR#0.9633;STEM CELL#0.9624;CELL CELL ADHESION#0.9593;PANCREATIC CANCER#0.9564;PLASMA MEMBRANE#0.9561;LYMPH NODE METASTASIS#0.9509;CELL ADHESION MOLECULE#0.9499;CELL MIGRATION#0.9482;PROTEIN KINASE#0.9447;TUMOR CELLS#0.9427;BREAST CANCER CELL#0.9418;OVARIAN#0.9353;CELL CELL JUNCTION#0.9310;EPITHELIAL TO MESENCHYMAL#0.9302;JUNCTIONAL ADHESION MOLECULE#0.9273;REVERSE TRANSCRIPTION#0.9261;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9249;CELL SURFACE#0.9084;CYTOPLASM#0.9065;OVARIAN CANCER#0.9002;QUANTITATIVE REAL TIME#0.8971;TUMOR SUPPRESSOR#0.8873;MAMMARY GLAND#0.8821;ADHERENS JUNCTION#0.8819;CLOSTRIDIUM PERFRINGENS ENTEROTOXIN#0.8803;EPIDERMAL GROWTH FACTOR#0.8710;OVARIAN CARCINOMA#0.8659;CELL POLARITY#0.8444;CLEAR CELL RENAL CELL CARCINOMA#0.8428;CERVICAL#0.8420;SMALL INTESTINE#0.8403;GROWTH FACTOR RECEPTOR#0.8367;HEPATITIS C VIRUS#0.8345;HEPATITIS C#0.8335;FORMALIN#0.8255;DISEASE FREE SURVIVAL#0.8151;ANDROGEN RECEPTOR#0.8132;LYMPH NODE METASTASES#0.8079;PROSTATE CANCER#0.7981;KERATINOCYTE#0.7969;FLUORESCEIN#0.7948;THYROID CARCINOMA#0.7858;COLON CARCINOMA#0.7746;DUODENUM#0.7697;NEOPLASTIC TISSUES#0.7696;ALVEOLAR EPITHELIAL CELL#0.7646;REGIONAL LYMPH NODE#0.7640;CELL DIFFERENTIATION#0.7631;STEM CELL MARKER#0.7530;ZONULA OCCLUDENS 1#0.7527;PAPILLARY RENAL CELL CARCINOMA#0.7470;HUMAN BREAST CANCER#0.7465;GERM CELL#0.7423;INTESTINAL CRYPT#0.7408;RENAL ONCOCYTOMA#0.7303;LIVER METASTASIS#0.7297;SERTOLI CELL#0.7258;PROTEIN KINASE C#0.7245;MEMBRANE MICRODOMAIN#0.7187;INTESTINAL EPITHELIAL CELL#0.7165;COLITIS#0.7143;COLORECTAL CARCINOMA#0.7098;LOCALISATION#0.7066;CHOLANGIOCARCINOMA#0.7065;AQUAPORIN#0.6980;CELL CYCLE#0.6979;GASTRIC ADENOCARCINOMA#0.6866;TUMOR NECROSIS FACTOR#0.6838;ENDOMETRIAL ADENOCARCINOMA#0.6827;INVASIVE DUCTAL CARCINOMA#0.6815;HEPATOCYTE NUCLEAR FACTOR#0.6811;LYMPH NODE INVOLVEMENT#0.6808;CORNEAL EPITHELIUM#0.6795;BILE DUCT#0.6791;CARCINOMA IN SITU#0.6742;ADJACENT NORMAL TISSUE#0.6739;TUMOR TISSUES#0.6731;PROSTATE SPECIFIC ANTIGEN#0.6714;WOUND HEALING#0.6714;TRANSCRIPTASE#0.6684;CYTOTOXICITY#0.6662;IMMUNE RESPONSE#0.6616;MITOGEN ACTIVATED PROTEIN#0.6579;TRANSFORMING GROWTH FACTOR#0.6574;TO TUMOR PROGRESSION#0.6568;PROGESTERONE#0.6531;DIARRHEA#0.6527;SALIVARY GLAND#0.6507;FOCAL ADHESION#0.6489;SIGNAL TRANSDUCTION#0.6442;METAPLASTIC CARCINOMA#0.6313;STROMAL CELL#0.6280;EXOSOME#0.6239;ENDOMETRIUM#0.6236;ESTROGEN RECEPTOR#0.6168;JEJUNUM#0.6151;GASTRIC EPITHELIUM#0.6061;BASAL CELL#0.6056;MAPK SIGNALING#0.6053;MAMMARY EPITHELIUM#0.6024;EPITHELIAL OVARIAN CARCINOMA#0.6005;LUNG SQUAMOUS CELL CARCINOMA#0.6000
1368	PEPTIDE HORMONE#0.9764;PLASMA MEMBRANE#0.9735;ANGIOTENSIN CONVERTING ENZYME#0.9588;MACROPHAGE#0.9542;CELL SURFACE#0.9461;ENDOTHELIAL CELL#0.9425;GROWTH FACTOR#0.9401;ARGININE#0.8958;DIPEPTIDYL PEPTIDASE#0.8698;PHOSPHOLIPASE C#0.8557;DIPEPTIDYL PEPTIDASE IV#0.8268;LIPOSARCOMA#0.8206;CELL MEMBRANE#0.8100;ENDOPEPTIDASE 24.11#0.8086;MONOCYTE#0.8063;MEMBRANE FRACTION#0.7744;GENE EXPRESSION#0.7744;CARBOXYPEPTIDASE ACTIVITY#0.7620;STROMAL CELL#0.7573;ATYPICAL LIPOMATOUS TUMOR#0.7401;PROGENITOR CELL#0.7374;EPITHELIAL CELL#0.7338;NEUTRAL ENDOPEPTIDASE 24.11#0.7064;PERIPHERAL BLOOD#0.6962;NITRIC OXIDE#0.6944;RENAL CELL CARCINOMA#0.6841;LYSINE#0.6799;ALVEOLAR TYPE I#0.6426;RECEPTOR ANTAGONIST#0.6381;LIPOMA#0.6361;EPIDERMAL GROWTH FACTOR#0.6135;GROWTH FACTOR RECEPTOR#0.6127;C TERMINAL DOMAIN#0.6052;MYELOID CELL#0.6003
136991	APOPTOSIS#1.0074;HEPATITIS E#1.0034;HEPATITIS E VIRUS#1.0031;DIARRHEA#0.9958;HOST CELL#0.9811;VIRAL REPLICATION#0.9747;VIRION#0.9740;CYTOPLASM#0.9715;VIRAL GENOME#0.9694;GERM CELL#0.9592;GENE EXPRESSION#0.9448;APOPTOTIC#0.9303;VIRULENCE#0.9201;POLYMERASE CHAIN REACTION#0.9164;REVERSE TRANSCRIPTION#0.9134;PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME#0.8967;DNA REPLICATION#0.8865;LEUCINE#0.8833;STERILE ALPHA MOTIF#0.8253;ION CHANNEL#0.8045;HEPATOMA CELLS#0.8027;NUCLEOCAPSID#0.7900;IMMUNE RESPONSE#0.7738;VIRAL INFECTION#0.7719;TRANSCRIPTASE#0.7708;ENDOPLASMIC RETICULUM#0.7688;PERIPHERAL BLOOD#0.7422;UBIQUITIN#0.7380;GLYCOSYLATION#0.7366;NUCLEAR EXPORT#0.7301;EPITHELIAL CELL#0.7163;VIRAL DNA REPLICATION#0.7055;T LYMPHOCYTE#0.6944;POSTTRANSLATIONAL MODIFICATION#0.6932;SIGNALING PATHWAY#0.6821;CELL CYCLE#0.6754;MUTAGENESIS#0.6547;MACROPHAGE#0.6460;VIRAL HEPATITIS#0.6425;GASTROENTERITIS#0.6311;SIGNAL TRANSDUCTION#0.6215
1369	ARGININE#1.0366;LYSINE#1.0208;ANGIOTENSIN CONVERTING ENZYME#1.0206;L-ARGININE#0.9826;ENDOPEPTIDASE 24.11#0.9636;CAPTOPRIL#0.9583;FIBRINOLYSIS#0.9254;AMINOPEPTIDASE P#0.9174;NEUTRAL ENDOPEPTIDASE 24.11#0.9042;L-LYSINE#0.8669;ACE INHIBITOR#0.8648;NITRIC OXIDE#0.8557;COAGULATION#0.8525;PLASMA CARBOXYPEPTIDASE B#0.8281;COMPLEMENT ACTIVATION#0.8271;HYPERTENSION#0.7830;EXCRETION#0.7515;ANGIOEDEMA#0.7515;ACE ACTIVITY#0.7363;ENZYME INHIBITOR#0.7349;LEUCINE#0.7266;BREAST CANCER#0.7239;PHOSPHORAMIDON#0.7230;CREATINE KINASE#0.7168;CARBOXYPEPTIDASE ACTIVITY#0.7133;ENZYME ACTIVITY#0.7095;RECEPTOR ANTAGONIST#0.6919;RECEPTOR AGONIST#0.6858;HISTAMINE#0.6802;SUBSTANCE P#0.6362;KININASE II ACTIVITY#0.6224;LYSIS#0.6192;ENALAPRILAT#0.6155;ESSENTIAL HYPERTENSION#0.6143;CATALYTIC ACTIVITY#0.6118;UMBILICAL VEIN#0.6114;RHEUMATOID ARTHRITIS#0.6089
136	ADENOSINE#1.0405;ISCHEMIA#1.0240;HYPOXIA#1.0132;RECEPTOR ANTAGONIST#1.0071;RECEPTOR AGONIST#1.0059;GENE EXPRESSION#0.9743;HYPOXIC#0.9549;PROTEIN KINASE#0.9367;CANCER CELL#0.8991;ENDOTHELIAL CELL#0.8977;INFLAMMATORY CELL#0.8893;HYPOXIA INDUCIBLE FACTOR#0.8861;SIGNALING PATHWAY#0.8770;SMOOTH MUSCLE#0.8337;T CELL#0.8308;POLYMERASE CHAIN REACTION#0.8293;CYCLIC AMP#0.8227;HYPERTENSION#0.8145;EPITHELIAL CELL#0.8019;NEUTROPHIL#0.7971;MACROPHAGE#0.7918;GROWTH FACTOR#0.7885;MYOCARDIAL INFARCTION#0.7716;HYALURONAN#0.7668;CELL GROWTH#0.7490;TRANSCRIPTION FACTOR#0.7393;DIABETIC NEPHROPATHY#0.7377;APOPTOSIS#0.7371;ERYTHROCYTE#0.7365;CELL PROLIFERATION#0.7291;BREAST CANCER#0.7073;CIRCADIAN RHYTHM#0.7006;ISCHEMIA REPERFUSION INJURY#0.6815;NITRIC OXIDE#0.6802;ADENOSINE DEAMINASE#0.6733;ACUTE LUNG INJURY#0.6593;PROTEIN KINASE A#0.6566;NEPHROPATHY#0.6556;XANTHINE#0.6533;MICROVASCULAR ENDOTHELIAL CELL#0.6400;MYELOID CELL#0.6376;CELL SURFACE#0.6332;SIGNALING MOLECULE#0.6223;HYALURONAN SYNTHASE#0.6189;LEUKOCYTE#0.6160;LUNG DISEASE#0.6059;5-HT SECRETION#0.6007;TUMOR NECROSIS FACTOR#0.6007;CELL CYCLE#0.6000
137075	CANCER CELL#0.7848;GENE EXPRESSION#0.7271;COLORECTAL CANCER#0.6557;ATROPHIC GASTRITIS#0.6097
137196	MYELOID LEUKEMIA#0.9454;ACUTE MYELOID LEUKEMIA#0.8746;RETINOIC ACID#0.6245;IMATINIB#0.6090
1371	CYTOCHROME C OXIDASE#1.0676;UROPORPHYRINOGEN DECARBOXYLASE#1.0666;COPROPORPHYRINOGEN OXIDASE#1.0662;CYTOCHROME C#1.0640;HEREDITARY COPROPORPHYRIA#1.0631;HEME BIOSYNTHETIC#1.0513;HEME BIOSYNTHESIS#1.0495;PORPHYRIA#1.0204;AMINOLEVULINIC ACID#1.0159;MITOCHONDRIA#1.0077;PROTOPORPHYRIN IX#0.9826;HEME SYNTHESIS#0.9624;GENE EXPRESSION#0.9539;PORPHOBILINOGEN#0.9500;ENZYME ACTIVITY#0.9431;EXCRETION#0.9279;AMINOLEVULINATE#0.9272;COPROPORPHYRIN III#0.9198;URATE#0.9073;MITOCHONDRION#0.9017;DELTA-AMINOLEVULINIC ACID#0.8871;RESPIRATORY CHAIN#0.8746;HAEM BIOSYNTHESIS#0.8607;HYDROXYMETHYLBILANE SYNTHASE#0.8366;APOPTOSIS#0.8086;ACUTE INTERMITTENT PORPHYRIA#0.8016;RED BLOOD CELL#0.8009;5-AMINOLEVULINIC ACID#0.7990;ADJUSTED HAZARD RATIO#0.7974;MITOCHONDRIAL INTERMEMBRANE SPACE#0.7830;REACTIVE OXYGEN SPECIES#0.7808;IL-8 SECRETION#0.7662;TRANSCRIPTION FACTOR#0.7581;RESPIRATION#0.7560;ERYTHROCYTE#0.7493;KIDNEY DISEASE#0.7439;TOXICITY#0.7327;VARIEGATE PORPHYRIA#0.7314;ERYTHROLEUKEMIA#0.7282;SUPEROXIDE DISMUTASE#0.7263;COPPER CHAPERONE#0.7123;ORGANELLE#0.7041;HYPERURICEMIA#0.6894;ALA-PDT#0.6846;ACUTE PORPHYRIA#0.6801;CELL DEATH#0.6749;POLYMERASE CHAIN REACTION#0.6746;PORPHYRIN SYNTHESIS#0.6683;URIC ACID#0.6652;ELECTRON TRANSPORT#0.6616;ANAEMIA#0.6409;UROPORPHYRINOGEN III SYNTHASE#0.6390;MITOCHONDRIAL MEMBRANE#0.6214;PORPHYRIA CUTANEA TARDA#0.6154;ELECTRON TRANSPORT CHAIN#0.6146;HYPERTENSION#0.6097;MALIGNANT BRAIN TUMOR#0.6047;EPITHELIAL CELL#0.6007
137362	L-ASPARTATE#0.9300
137392	CELL PROLIFERATION#0.6088
1373	CARBAMOYL PHOSPHATE SYNTHASE#1.0703;ASPARTATE CARBAMOYLTRANSFERASE#1.0551;ORNITHINE CARBAMOYLTRANSFERASE#1.0476;ORNITHINE#1.0343;ARGININOSUCCINATE#1.0331;UREA CYCLE#1.0296;ASPARTATE#1.0273;GLUTAMINE#1.0167;L-GLUTAMATE#1.0096;MITOCHONDRIA#1.0040;GENE EXPRESSION#0.9996;UREA CYCLE DISORDER#0.9995;ARGININE#0.9982;N-ACETYL-L-GLUTAMATE#0.9907;CITRULLINE#0.9764;GLUTAMATE DEHYDROGENASE#0.9590;TRANSCRIPTION FACTOR#0.9388;ARGININOSUCCINATE LYASE#0.9360;CITRULLINE SYNTHESIS#0.9077;DETOXIFICATION#0.9074;CANCER CELL#0.9022;ARGININOSUCCINATE SYNTHASE#0.8833;ALANINE#0.8782;GLUCOSE 6 PHOSPHATASE#0.8605;L-ARGININE#0.8598;ATP SYNTHASE#0.8379;MITOCHONDRIAL MATRIX#0.7995;GLYCINE#0.7830;PHOSPHOENOLPYRUVATE#0.7801;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.7707;SMALL INTESTINE#0.7319;CELL GROWTH#0.7266;ENZYME ACTIVITY#0.7166;LIVER DISEASE#0.6966;VALPROIC ACID#0.6930;LIVER DAMAGE#0.6779;CYCLIC AMP#0.6778;HEPATOMA CELLS#0.6628;NITRIC OXIDE#0.6495;L-ASPARTATE#0.6486;URIDINE#0.6419;EXCRETION#0.6375;HEPATOCELLULAR CARCINOMA#0.6307;ENHANCER BINDING PROTEIN#0.6278;ENHANCER BINDING#0.6274;N-CARBAMYL-L-GLUTAMATE#0.6157;FETAL LIVER#0.6143;ENTEROCYTE#0.6038;HEPATOCYTE NUCLEAR FACTOR#0.6032;ACUTE LIVER INJURY#0.6026
137492	HEPATOCELLULAR CARCINOMA#1.0914;RELATED PROTEIN 1#1.0562;GROWTH FACTOR#0.8810;EPIDERMAL GROWTH FACTOR#0.8227;GROWTH FACTOR RECEPTOR#0.7845;VACUOLAR PROTEIN SORTING#0.7567;EPITHELIAL MESENCHYMAL TRANSITION#0.7296;OVARIAN CANCER#0.7270;CELL PROLIFERATION#0.7213;OVARIAN#0.6754;ESCRT I COMPLEX#0.6538;SQUAMOUS CELL CARCINOMA#0.6473;CANCER CELL#0.6425;SIGNALING PATHWAY#0.6338
1374	ACYL COA DEHYDROGENASE#1.0569;ACYL COA OXIDASE#1.0515;CARNITINE PALMITOYL TRANSFERASE#1.0458;FATTY ACID TRANSLOCASE#1.0431;MITOCHONDRIAL OUTER MEMBRANE#1.0404;OUTER MEMBRANE#1.0398;CARNITINE PALMITOYLTRANSFERASE I#1.0353;HORMONE SENSITIVE LIPASE#1.0334;FATTY ACID TRANSPORT#1.0276;PALMITOYL#1.0271;FATTY ACID BINDING#1.0248;CARNITINE#1.0236;L-CARNITINE#1.0218;PHOSPHOENOLPYRUVATE CARBOXYKINASE#1.0196;CYTOCHROME P450#1.0195;COENZYME A#1.0189;ACYLCARNITINE#1.0181;BREAST CANCER#1.0154;LIPOPROTEIN LIPASE#1.0145;OUTER MITOCHONDRIAL MEMBRANE#1.0127;MITOCHONDRIAL MEMBRANE#1.0107;ACETYL COA CARBOXYLASE#1.0107;LIPID OXIDATION#1.0107;BINDING PROTEIN 1#1.0082;PYRUVATE DEHYDROGENASE KINASE#1.0058;PYRUVATE#1.0044;MITOCHONDRIA#1.0039;PALMITATE#1.0006;GLUCOSE 6 PHOSPHATASE#0.9998;FATTY ACID SYNTHASE#0.9987;STEROL REGULATORY ELEMENT#0.9979;PEROXISOME#0.9975;FATTY ACID OXIDATION#0.9972;PHOSPHOENOLPYRUVATE#0.9972;FATTY ACID BETA-OXIDATION#0.9957;LIPOLYSIS#0.9943;FATTY ACID SYNTHESIS#0.9933;SKELETAL MUSCLE#0.9914;T CELL#0.9909;STEAROYL COA DESATURASE#0.9891;PEROXISOMAL#0.9886;CANCER CELL#0.9883;GROWTH FACTOR#0.9874;PROTEIN KINASE#0.9855;ENZYME ACTIVITY#0.9847;LIPID DROPLET#0.9822;SIGNALING PATHWAY#0.9816;DNA METHYLATION#0.9813;LOW DENSITY LIPOPROTEIN#0.9811;ADIPOCYTE#0.9803;GLYCOLYSIS#0.9799;REACTIVE OXYGEN SPECIES#0.9790;FATTY ACID METABOLISM#0.9789;TRANSCRIPTION FACTOR#0.9789;POLYMERASE CHAIN REACTION#0.9788;CATABOLISM#0.9771;APOPTOSIS#0.9770;LIPOGENESIS#0.9760;GLUCONEOGENESIS#0.9757;BREAST CANCER CELL#0.9748;ADIPOSE TISSUE#0.9741;GLUCOSE UPTAKE#0.9739;GENE EXPRESSION#0.9735;GLUCOSE METABOLISM#0.9727;DIET INDUCED OBESITY#0.9679;OBESE#0.9657;OLEIC ACID#0.9644;NONALCOHOLIC FATTY LIVER DISEASE#0.9643;DE NOVO LIPOGENESIS#0.9643;FRUCTOSE#0.9641;WHITE ADIPOSE TISSUE#0.9633;ALCOHOLIC FATTY LIVER#0.9622;LIPID METABOLISM#0.9614;WEIGHT GAIN#0.9605;ENDOPLASMIC RETICULUM#0.9603;FATTY LIVER DISEASE#0.9588;TYPE 2 DIABETES#0.9585;HIGH FAT DIET#0.9575;FATTY LIVER#0.9574;BODY WEIGHT GAIN#0.9553;REVERSE TRANSCRIPTION#0.9539;LIVER DISEASE#0.9538;BROWN ADIPOSE TISSUE#0.9504;LIPID SYNTHESIS#0.9502;FENOFIBRATE#0.9482;WEIGHT LOSS#0.9476;FATTY ACID TRANSPORTER#0.9467;HIGH DENSITY LIPOPROTEIN#0.9463;PALMITIC ACID#0.9438;CELL PROLIFERATION#0.9436;ADENOSINE#0.9405;OXIDATIVE METABOLISM#0.9397;CELL DEATH#0.9367;ALANINE#0.9360;MALIC ENZYME#0.9314;CYTOCHROME C#0.9310;LIVER X RECEPTOR#0.9293;QUANTITATIVE REAL TIME#0.9260;TRIGLYCERIDE SYNTHESIS#0.9249;TUMOR NECROSIS FACTOR#0.9244;MACROPHAGE#0.9222;INSULIN SECRETION#0.9206;HEPATIC LIPID CONTENT#0.9189;SUPEROXIDE DISMUTASE#0.9178;BETA CELL#0.9153;DIABETES MELLITUS#0.9055;HYPOGLYCEMIA#0.9022;ENHANCER BINDING PROTEIN#0.9003;ENHANCER BINDING#0.8998;LACTATION#0.8991;CARNITINE PALMITOYLTRANSFERASE II#0.8979;VERY-LOW-DENSITY LIPOPROTEIN#0.8977;GLUCOSE-6-PHOSPHATE#0.8951;GLUCOSE HOMEOSTASIS#0.8928;MUSCLE CELL#0.8924;TRIGLYCERIDE LIPASE#0.8922;MYOTUBE#0.8871;LIPID CATABOLISM#0.8855;TYPE 2 DIABETIC#0.8828;O ACYLTRANSFERASE#0.8785;TRICARBOXYLIC ACID CYCLE#0.8759;LIPID METABOLIC#0.8741;ENERGY HOMEOSTASIS#0.8711;ASPARTATE#0.8661;GLUTATHIONE#0.8645;CLOFIBRATE#0.8609;TOXICITY#0.8603;LIPID HOMEOSTASIS#0.8592;PROSTATE CANCER#0.8589;GLUCOSE INTOLERANCE#0.8580;OXIDATIVE PHOSPHORYLATION#0.8569;LOW FAT DIET#0.8568;HYPERGLYCEMIA#0.8560;MALONYL COA DECARBOXYLASE#0.8541;HYPOXIA#0.8539;PLASMA MEMBRANE#0.8479;EPITHELIAL CELL#0.8458;DIACYLGLYCEROL O ACYLTRANSFERASE#0.8400;ADENOSINE MONOPHOSPHATE#0.8381;CHOLINE#0.8340;MITOCHONDRIAL MATRIX#0.8306;CATALYTIC ACTIVITY#0.8293;RESPIRATION#0.8249;EPIDIDYMAL ADIPOSE TISSUE#0.8248;BLOOD GLUCOSE LEVEL#0.8218;FATTY ACID BIOSYNTHESIS#0.8208;PRO-INFLAMMATORY#0.8186;CHOLESTEROL METABOLISM#0.8154;CYTOCHROME C OXIDASE#0.8122;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8105;MICROSOME#0.8096;HUMAN BREAST CANCER#0.8080;CELL GROWTH#0.8060;LIPID TRANSPORT#0.8048;INFLAMMATORY RESPONSE#0.8029;PERIPHERAL BLOOD#0.8021;NERVOUS SYSTEM#0.7998;MECHANISM OF ACTION#0.7978;SATURATED FATTY ACID#0.7963;ATHEROSCLEROSIS#0.7941;CYCLIC AMP#0.7904;CONTACT SITE#0.7895;STREPTOZOTOCIN#0.7880;APOPTOTIC#0.7835;INSULIN RECEPTOR#0.7829;ADENOSINE TRIPHOSPHATE#0.7797;RESVERATROL#0.7784;ETHANOL#0.7770;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7755;FAT PAD#0.7709;PYRUVATE CARBOXYLASE#0.7653;SUBCUTANEOUS ADIPOSE TISSUE#0.7643;FIBROBLAST GROWTH FACTOR#0.7623;SUCROSE#0.7599;LYSINE#0.7597;INSULIN-LIKE GROWTH FACTOR#0.7549;CARDIOMYOCYTE#0.7521;ENDOTHELIAL CELL#0.7463;GESTATION#0.7430;MEMORY T CELL#0.7425;ATP BINDING CASSETTE#0.7386;ATP BINDING#0.7370;ACYLTRANSFERASE ACTIVITY#0.7339;MONOCYTE#0.7325;TYPE 2 DIABETES MELLITUS#0.7299;2 DIABETES MELLITUS#0.7299;EICOSAPENTAENOIC ACID#0.7284;PANCREATIC ISLET#0.7241;MONOUNSATURATED FATTY ACIDS#0.7201;AMPK ACTIVITY#0.7194;CELL CYCLE#0.7168;STEM CELL#0.7167;SKELETAL MUSCLE CELLS#0.7157;EOSIN#0.7154;CARDIOMYOPATHY#0.7137;GLUCOSE TOLERANCE TEST#0.7110;ADIPOGENESIS#0.7084;ARACHIDONIC ACID#0.7009;DEXAMETHASONE#0.6963;NITRIC OXIDE#0.6957;MONONUCLEAR CELLS#0.6956;CELLULAR METABOLISM#0.6942;PREADIPOCYTE#0.6834;GLUTATHIONE PEROXIDASE#0.6827;OCTANOATE#0.6823;HEPATOCELLULAR CARCINOMA#0.6814;PERHEXILINE#0.6781;HEART MUSCLE#0.6761;PYRUVATE KINASE#0.6725;TARGET OF RAPAMYCIN#0.6719;ISCHEMIA#0.6705;LDL RECEPTOR#0.6703;TUBULAR EPITHELIAL CELL#0.6667;TRIGLYCERIDE METABOLISM#0.6655;METHIONINE#0.6615;CARBOHYDRATE METABOLISM#0.6613;INSULIN RECEPTOR SUBSTRATE#0.6600;REGULATION OF LIPID METABOLISM#0.6571;HEPATITIS C#0.6532;INSULIN TOLERANCE TEST#0.6521;FATTY ACID CATABOLISM#0.6503;MALONYL-COENZYME A#0.6492;AUTOPHAGY#0.6383;MYOCYTES#0.6315;RAPAMYCIN#0.6303;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6302;ORGANIC CATION TRANSPORTER#0.6296;FATTY ACID DEGRADATION#0.6287;NUCLEAR RESPIRATORY FACTOR#0.6280;TRANSCRIPTASE#0.6279;INNER MITOCHONDRIAL MEMBRANE#0.6276;ELECTROPHORETIC MOBILITY SHIFT#0.6202;CARDIAC MUSCLE#0.6181;RESPIRATORY CHAIN#0.6180;EXCRETION#0.6168;OXYGENASE#0.6165;QUANTITATIVE REVERSE TRANSCRIPTION#0.6164;PARTURITION#0.6148;CARNITINE TRANSPORTER#0.6119;CARNITINE SHUTTLE#0.6075;GLUTAMINE#0.6063;CONJUGATED LINOLEIC ACID#0.6032;LIVER DAMAGE#0.6011
137529	INVASIVE CARCINOMA#1.2008;BREAST CANCER#1.1796
1375	CARNITINE PALMITOYL TRANSFERASE#1.0707;CARNITINE PALMITOYLTRANSFERASE I#1.0638;PALMITOYL#1.0433;CARNITINE#1.0352;MAST CELL#1.0116;FATTY ACID OXIDATION#1.0102;PEROXISOME#1.0095;ADIPOSE TISSUE#1.0000;SKELETAL MUSCLE#0.9999;ACETYL COA CARBOXYLASE#0.9940;NARCOLEPSY#0.9934;MITOCHONDRIA#0.9915;GENE EXPRESSION#0.9909;WHITE ADIPOSE TISSUE#0.9901;LIPID METABOLISM#0.9851;FATTY ACID METABOLISM#0.9776;PROTEIN KINASE#0.9708;HIGH FAT DIET#0.9632;ADIPOCYTE#0.9573;MITOCHONDRIAL MEMBRANE#0.9553;TRANSCRIPTION FACTOR#0.9189;COENZYME A#0.9182;SIGNALING PATHWAY#0.9158;FATTY ACID TRANSPORT#0.9126;GLUCOSE UPTAKE#0.9108;BROWN ADIPOSE TISSUE#0.8950;OBESE#0.8917;L-CARNITINE#0.8902;PYRUVATE#0.8757;FATTY ACID BINDING#0.8669;LIPOGENESIS#0.8624;LIPID OXIDATION#0.8607;ACYLCARNITINE#0.8452;ACYL COA DEHYDROGENASE#0.8333;LIPOLYSIS#0.8314;FATTY ACID SYNTHASE#0.8240;PALMITATE#0.7952;GROWTH FACTOR#0.7946;DIET INDUCED OBESITY#0.7794;MYOTUBE#0.7722;ACYL COA OXIDASE#0.7615;POLYMERASE CHAIN REACTION#0.7491;WEIGHT GAIN#0.7324;CATALYTIC ACTIVITY#0.7264;PYRUVATE DEHYDROGENASE KINASE#0.7244;OOCYTE#0.7220;OXIDATIVE METABOLISM#0.7136;OUTER MITOCHONDRIAL MEMBRANE#0.7124;INSULIN RECEPTOR#0.7104;TYPE 2 DIABETES#0.7053;LIPOPROTEIN LIPASE#0.7047;REACTIVE OXYGEN SPECIES#0.6902;APOPTOSIS#0.6878;MUSCLE CELL#0.6788;CYTOCHROME C#0.6769;FATTY ACID TRANSLOCASE#0.6720;GLUCOSE METABOLISM#0.6661;SUBCUTANEOUS ADIPOSE TISSUE#0.6609;CARDIOMYOCYTE#0.6597;LOW FAT DIET#0.6444;OXIDATIVE PHOSPHORYLATION#0.6277;QUANTITATIVE REAL TIME#0.6231;TRIGLYCERIDE LIPASE#0.6217;HORMONE SENSITIVE LIPASE#0.6025
137682	COMPLEX I#1.0306
137695	HUMAN BREAST CANCER#0.7191;ENDOPLASMIC RETICULUM#0.7142;BREAST CANCER#0.7099
1376	CONTINUOUS PERFORMANCE TEST#1.0617;CARNITINE PALMITOYLTRANSFERASE II#1.0612;ACYL COA DEHYDROGENASE#1.0585;ACYL COA OXIDASE#1.0431;CARNITINE PALMITOYLTRANSFERASE I#1.0404;MYOGLOBINURIA#1.0401;CARNITINE PALMITOYL TRANSFERASE#1.0344;CARNITINE#1.0291;ACYLCARNITINE#1.0237;L-CARNITINE#1.0229;COENZYME A#1.0168;PALMITOYL#1.0133;MITOCHONDRIAL MEMBRANE#1.0107;MYOPATHY#1.0046;ACETYL COA CARBOXYLASE#1.0035;PEROXISOME#0.9998;BEZAFIBRATE#0.9973;FATTY ACID OXIDATION#0.9969;ENZYME ACTIVITY#0.9927;MITOCHONDRIA#0.9915;FATTY ACID METABOLISM#0.9915;ADIPOSE TISSUE#0.9848;SKELETAL MUSCLE#0.9843;FATTY ACID SYNTHASE#0.9835;FATTY ACID BINDING#0.9816;GENE EXPRESSION#0.9791;LIPID METABOLISM#0.9758;HIGH FAT DIET#0.9703;PALMITATE#0.9654;FATTY ACID TRANSPORTER#0.9612;VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY#0.9610;PROTEIN KINASE#0.9592;POLYMERASE CHAIN REACTION#0.9442;TRANSCRIPTION FACTOR#0.9381;FATTY ACID TRANSPORT#0.9365;INNER MITOCHONDRIAL MEMBRANE#0.9329;HYPOGLYCEMIA#0.9320;CREATINE KINASE#0.9278;CATALYTIC ACTIVITY#0.9269;LIPOGENESIS#0.9157;LIPID DROPLET#0.9111;ADIPOCYTE#0.9070;PALMITIC ACID#0.9060;OUTER MEMBRANE#0.8998;SKIN FIBROBLASTS#0.8956;FATTY LIVER#0.8924;CREATINE#0.8907;PEROXISOMAL#0.8882;LIPID OXIDATION#0.8643;BROWN ADIPOSE TISSUE#0.8588;LIPOLYSIS#0.8587;CANCER CELL#0.8585;APOPTOSIS#0.8541;PYRUVATE#0.8540;FATTY ACID BETA-OXIDATION#0.8482;STEROL REGULATORY ELEMENT#0.8337;MITOCHONDRIAL MATRIX#0.8227;REACTIVE OXYGEN SPECIES#0.8218;MYOTUBE#0.8169;GLUCOSE UPTAKE#0.8017;MUSCLE WEAKNESS#0.7993;ADENOSINE#0.7991;CARDIOMYOPATHY#0.7985;LIVER DISEASE#0.7947;WHITE ADIPOSE TISSUE#0.7843;MITOCHONDRIAL INNER MEMBRANE#0.7802;CATABOLISM#0.7787;HORMONE SENSITIVE LIPASE#0.7667;CELL DEATH#0.7633;CARNITINE SHUTTLE#0.7550;FATTY ACID SYNTHESIS#0.7546;GROWTH FACTOR#0.7508;LOW DENSITY LIPOPROTEIN#0.7441;FATTY LIVER DISEASE#0.7421;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7417;GLUCOSE METABOLISM#0.7365;CHOLINE#0.7351;SIGNALING PATHWAY#0.7309;STEAROYL COA DESATURASE#0.7289;CELL PROLIFERATION#0.7204;COMPLEX I#0.7184;CARNITINE TRANSPORTER#0.6962;REVERSE TRANSCRIPTION#0.6927;OXIDATIVE PHOSPHORYLATION#0.6907;FATTY ACID TRANSLOCASE#0.6903;GLYCOLYSIS#0.6872;PERHEXILINE#0.6834;RESPIRATORY CHAIN#0.6798;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.6786;CARDIOMYOCYTE#0.6765;OOCYTE#0.6761;WEIGHT GAIN#0.6755;ADENOSINE MONOPHOSPHATE#0.6744;OBESE#0.6669;FENOFIBRATE#0.6644;MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY#0.6603;MAGNETIC RESONANCE IMAGING#0.6588;MUSCLE CELL#0.6568;LOW FAT DIET#0.6559;TUMOR NECROSIS FACTOR#0.6551;PRO-INFLAMMATORY#0.6451;ASPARTATE#0.6445;DIABETES MELLITUS#0.6434;LIPID STORAGE#0.6387;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.6356;ORGANIC CATION TRANSPORTER#0.6339;LYSINE#0.6330;MUSCLE PHOSPHORYLASE#0.6305;HEPATOCELLULAR CARCINOMA#0.6271;TYPE 2 DIABETES#0.6117;HYPOXIA#0.6078;OUTER MITOCHONDRIAL MEMBRANE#0.6050;MUSCLE FIBER#0.6044
137735	ACTIN BINDING#0.9978;SMOOTH MUSCLE#0.7412;MUSCLE CELL#0.6684;SMOOTH MUSCLE CELL#0.6674;CENTRAL NERVOUS SYSTEM#0.6037;NERVOUS SYSTEM#0.6019
137835	IMMUNE RESPONSE#0.8967
137868	SARCOGLYCAN COMPLEX#0.8088;MUSCULAR DYSTROPHY#0.6738
137872	COLORECTAL#0.6952;COLORECTAL CANCER#0.6859;ADJACENT NORMAL TISSUE#0.6387;DNA METHYLATION#0.6260;ETHANOL#0.6257;BREAST CANCER#0.6240;CELL PROLIFERATION#0.6233;NORMAL COLORECTAL MUCOSA#0.6005
137886	MEMBRANE FUSION#0.7655;MITOSIS#0.6804;GOLGI REASSEMBLY#0.6403;SPINDLE ORIENTATION#0.6291;REGULATION OF CELL GROWTH#0.6143
1378	PODOCYTE#1.0547;SECRETORY VESICLE#1.0474;BLOOD GROUP ANTIGEN#1.0410;FRAGMENT LENGTH POLYMORPHISM#1.0401;ROSETTING#1.0321;COMPLEMENT RECEPTOR#1.0244;IMMUNE COMPLEX CLEARANCE#1.0217;MALARIA#1.0194;B CELL ACTIVATION#1.0190;PLASMA MEMBRANE#1.0161;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0140;ERYTHROCYTE#1.0132;LUPUS ERYTHEMATOSUS#1.0131;CELL BOUND#1.0122;SMOOTH MUSCLE ACTIN#1.0099;FACTOR I#1.0080;RED BLOOD CELL#1.0062;SMOOTH MUSCLE#1.0038;COMPLEMENT CASCADE#1.0032;CELL ACTIVATION#1.0018;EOSINOPHIL#1.0008;POLYMORPHONUCLEAR LEUKOCYTES#1.0006;OXIDATIVE BURST#0.9992;PHAGOCYTOSIS#0.9992;T LYMPHOCYTE#0.9964;VIRAL INFECTION#0.9964;B CELL#0.9959;GRANULOCYTE#0.9957;TUMOR CELLS#0.9956;MONOCYTE#0.9949;NEUTROPHIL#0.9920;B LYMPHOCYTE#0.9917;POLYMERASE CHAIN REACTION#0.9901;LEUKOCYTE#0.9896;IMMUNOGLOBULIN G#0.9885;LYSIS#0.9877;MAST CELL#0.9872;ALZHEIMER'S DISEASE#0.9868;RHEUMATOID ARTHRITIS#0.9859;NEPHRITIS#0.9857;ANEMIA#0.9844;MEMBRANE ATTACK COMPLEX#0.9843;FOLLICULAR DENDRITIC CELL#0.9839;GROWTH FACTOR#0.9838;GERMINAL CENTER#0.9823;T CELL#0.9815;CELL SURFACE#0.9814;ENDOTHELIAL CELL#0.9800;CELL MEMBRANE#0.9795;DENDRITIC CELL#0.9795;EPSTEIN BARR VIRUS#0.9787;PERIPHERAL BLOOD#0.9784;OPSONIZATION#0.9782;FOLLICULAR DENDRITIC CELL SARCOMA#0.9778;PLASMA MEMBRANE EXPRESSION#0.9777;GENE EXPRESSION#0.9765;COMPLEMENT ACTIVATION#0.9762;MACROPHAGE#0.9761;MONONUCLEAR CELLS#0.9756;DENDRITIC CELL SARCOMA#0.9753;LUPUS NEPHRITIS#0.9742;LECTIN#0.9738;GLOMERULONEPHRITIS#0.9733;EPITHELIAL CELL#0.9720;BONE MARROW#0.9705;PLASMA CELL#0.9676;IMMUNE RESPONSE#0.9614;TONSIL#0.9606;LYMPH NODE#0.9597;CELL PROLIFERATION#0.9592;LIVER DISEASE#0.9583;STROMAL CELL#0.9564;AUTOIMMUNE DISEASE#0.9555;STEM CELL#0.9543;CEREBRAL MALARIA#0.9531;IMMUNE SYSTEM#0.9528;IFN-GAMMA#0.9515;TUMOR NECROSIS FACTOR#0.9470;INFLAMMATORY CELL#0.9461;INFLAMMATORY RESPONSE#0.9459;HUMORAL IMMUNE RESPONSE#0.9438;ACUTE LEUKEMIA#0.9414;RESPIRATORY BURST#0.9398;B CELL LYMPHOMA#0.9371;FLUORESCEIN#0.9359;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9358;DISEASE FREE SURVIVAL#0.9352;HUMAN IMMUNODEFICIENCY VIRUS#0.9347;PERIPHERAL BLOOD CELLS#0.9294;CELL ADHESION#0.9290;CELL DIFFERENTIATION#0.9249;SPECIFIC GRANULE#0.9238;STEM CELL TRANSPLANTATION#0.9237;NEUTROPHIL ACTIVATION#0.9213;PERIPHERAL BLOOD MONOCYTES#0.9203;DEMENTIA#0.9202;GM-CSF#0.9195;DESMOSOME#0.9154;CYTOPLASM#0.9142;RETICULOCYTE#0.9131;APOPTOSIS#0.9123;COMPLEMENT ACTIVITY#0.9115;HEMATOPOIETIC CELL#0.9108;HERPES SIMPLEX#0.9074;PHOSPHATIDYLINOSITOL BINDING#0.9055;MYELOID LEUKEMIA#0.9001;SERUM ALBUMIN#0.8995;CELL ASSOCIATED#0.8979;STROMA#0.8974;CORD BLOOD#0.8968;ANAEMIA#0.8948;CD4+ T CELL#0.8926;PROTEIN KINASE#0.8905;C REACTIVE PROTEIN#0.8903;LYMPHOID TISSUE#0.8851;UMBILICAL VEIN#0.8851;HUMAN UMBILICAL VEIN#0.8770;ALKALINE PHOSPHATASE#0.8763;BETA-2#0.8741;PLASMODIUM FALCIPARUM MALARIA#0.8704;SELECTIN#0.8700;MANNOSE BINDING#0.8692;FACTOR VIII#0.8688;APOPTOTIC#0.8680;CELL ADHESION MOLECULE#0.8662;HEMOLYTIC ANEMIA#0.8632;CYTOTOXICITY#0.8626;TOXICITY#0.8624;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.8607;HEMATOPOIETIC STEM CELL#0.8602;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8570;MEAN FLUORESCENCE INTENSITY#0.8564;ARA-C#0.8556;POLYMORPHONUCLEAR NEUTROPHIL#0.8548;ENDOTHELIUM#0.8532;PRO-INFLAMMATORY#0.8530;CELL GROWTH#0.8527;ENDOCYTOSIS#0.8527;ACUTE MYELOID LEUKEMIA#0.8517;LEUKOCYTE ACTIVATION#0.8477;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8469;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8433;LANGERHANS CELL#0.8430;GROWTH FACTOR RECEPTOR#0.8415;AUTOIMMUNITY#0.8415;LYMPHOCYTIC LEUKEMIA#0.8376;MYELOID CELL#0.8367;MUTAGENESIS#0.8354;GLYCOSYLATION#0.8351;ANTIGEN PRESENTING CELLS#0.8336;CYTOPLASMIC REGION#0.8275;HEPATITIS B#0.8241;TISSUE DAMAGE#0.8235;CYCLOPHOSPHAMIDE#0.8224;BASEMENT MEMBRANE#0.8224;FETAL KIDNEY#0.8216;RETINOIC ACID#0.8204;COLONY-STIMULATING FACTOR#0.8173;COMPLEMENT RECEPTOR 3#0.8130;LEUKEMIA FREE SURVIVAL#0.8125;FOLLICULAR LYMPHOMA#0.8109;ANTIGEN PRESENTATION#0.8076;CERVICAL#0.8049;MANNOSE BINDING LECTIN#0.8045;SYNOVIAL FLUID#0.8044;DIGESTION#0.8033;COMPLEMENT FACTOR H#0.8020;MONOCYTE DERIVED MACROPHAGE#0.7972;HOST CELL#0.7971;REGULATORY T CELL#0.7935;G-CSF#0.7921;AGEING#0.7915;HERPES SIMPLEX VIRUS#0.7909;PERIPHERAL BLOOD LYMPHOCYTES#0.7907;CORONARY ARTERY#0.7897;MILD COGNITIVE IMPAIRMENT#0.7863;CELL SURFACE ANTIGEN#0.7858;RHEUMATIC DISEASE#0.7838;PRION DISEASE#0.7803;MULTIPLE SCLEROSIS#0.7787;PROTEIN SYNTHESIS#0.7786;TUBERCULOSIS#0.7785;SIGNAL PEPTIDE#0.7769;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7768;B CELL RECEPTOR#0.7766;LYMPHOID CELL#0.7727;SEVERE MALARIAL ANEMIA#0.7684;MEMBRANE FRACTION#0.7659;ADAPTIVE IMMUNE RESPONSE#0.7652;HEMOLYSIS#0.7629;INNATE IMMUNITY#0.7629;ARTERY#0.7615;IMMUNE CELL#0.7602;VASCULAR CELL#0.7565;HEMOGLOBINURIA#0.7550;HEMATOPOIETIC CELL TRANSPLANTATION#0.7526;CELL CYCLE#0.7503;CHEMOTAXIS#0.7477;ERYTHROCYTE MEMBRANES#0.7467;NODULAR#0.7451;ALVEOLAR MACROPHAGE#0.7444;ASTROCYTE#0.7427;BLOOD VESSEL#0.7411;LEUKOCYTE ADHESION#0.7407;DNA BINDING#0.7391;HEPATITIS C#0.7375;TRANSCRIPTION FACTOR#0.7362;DODECYL SULFATE#0.7358;SODIUM DODECYL SULFATE#0.7358;CENTRAL NERVOUS SYSTEM#0.7313;EXOCYTOSIS#0.7308;NERVOUS SYSTEM#0.7304;REACTIVE OXYGEN SPECIES#0.7267;ANAPLASTIC LYMPHOMA KINASE#0.7215;SURFACE PLASMON RESONANCE#0.7163;HYPOXIA#0.7136;HODGKIN'S LYMPHOMA#0.7100;B CELL PROLIFERATION#0.7081;PROTEIN KINASE C#0.7049;FACTOR XIIIA#0.7011;ECULIZUMAB#0.7004;CELL WALL#0.6983;FACTOR D#0.6956;GROWTH PATTERN#0.6919;MEMORY B CELL#0.6889;EVENT FREE SURVIVAL#0.6874;GELATINASE GRANULE#0.6838;GLOMERULUS#0.6832;MAGNETIC RESONANCE IMAGING#0.6808;TRANSCRIPTASE#0.6793;CORONARY ARTERY DISEASE#0.6784;ARTERY DISEASE#0.6782;AZUROPHIL GRANULE#0.6746;GRAFT VERSUS HOST#0.6724;COLLAGEN INDUCED ARTHRITIS#0.6715;WHITE BLOOD CELL#0.6703;OOCYTE#0.6702;CYTOKINE PRODUCTION#0.6684;TOLL LIKE RECEPTOR#0.6682;TRANSFERRIN RECEPTOR#0.6679;MYOCARDIAL INFARCTION#0.6676;SIGNAL TRANSDUCTION#0.6665;ERYTHROPOIESIS#0.6659;CHEMOKINE RECEPTOR#0.6656;T CELL ACTIVATION#0.6651;NERVE GROWTH FACTOR#0.6649;OPSONIN RECEPTOR#0.6630;TERMINAL COMPLEMENT COMPLEX#0.6605;LYMPHOID ORGANS#0.6584;LINES OF EVIDENCE#0.6566;REDUCED INTENSITY CONDITIONING#0.6565;AGE RELATED MACULAR DEGENERATION#0.6506;MACULAR DEGENERATION#0.6501;MYASTHENIA GRAVIS#0.6492;BASOPHIL#0.6487;SIGNALING PATHWAY#0.6485;COAGULATION#0.6475;HEPATITIS C VIRUS#0.6459;SECONDARY GRANULE#0.6446;MYELODYSPLASTIC SYNDROME#0.6438;CD8+ T CELL#0.6438;RETINOBLASTOMA#0.6431;BUSULFAN#0.6399;COMPLEMENT BINDING#0.6363;MALIGNANT LYMPHOMA#0.6304;MINIMAL RESIDUAL DISEASE#0.6294;VIRULENCE#0.6290;HYDRALAZINE#0.6278;B CELL DIFFERENTIATION#0.6276;PLATELET ACTIVATING FACTOR#0.6274;GLOMERULAR EPITHELIAL CELL#0.6268;TRANSPLANT RELATED MORTALITY#0.6254;VASCULITIS#0.6253;THALASSEMIA#0.6239;TUMOUR NECROSIS FACTOR#0.6235;COMPLEX I#0.6232;PNEUMONIA#0.6231;LYSINE#0.6228;SALIVARY GLAND#0.6218;PHAGOSOME-LYSOSOME FUSION#0.6207;REVERSE TRANSCRIPTION#0.6207;PROTEINURIA#0.6174;NEPHROPATHY#0.6167;ISCHEMIA#0.6145;LUNG CANCER#0.6127;PHAGOSOME#0.6123;SURFACE IGM#0.6052;LYSOSOME#0.6046;TRANSACTIVATION#0.6046;JUVENILE RHEUMATOID ARTHRITIS#0.6005
137902	MRNA DECAY#0.9582;POLYSOME#0.8831;PEROXIDASE ACTIVITY#0.6619;RELAPSE FREE SURVIVAL#0.6009
137964	ENDOPLASMIC RETICULUM#0.9327;GENE EXPRESSION#0.9248;O ACYLTRANSFERASE#0.9111;ADIPOSE TISSUE#0.9109;LIPID DROPLET#0.8797;GLYCEROLIPID SYNTHESIS#0.8632;LACTATION#0.8035;MAMMARY EPITHELIAL CELL#0.7891;EPITHELIAL CELL#0.7803;MAMMARY GLAND#0.7738;ADIPOCYTE#0.7536;LIPID DROPLET FORMATION#0.6690;HIGH FAT DIET#0.6524;LIPID METABOLISM#0.6502;FATTY ACID OXIDATION#0.6445;MAMMARY EPITHELIUM#0.6350;FATTY ACID SYNTHESIS#0.6161
137970	APOPTOSIS#0.9854;CANCER CELL#0.7942;TUMOR SUPPRESSOR#0.7233;NETRIN RECEPTOR#0.6976;COLORECTAL CANCER#0.6811;NEUROBLASTOMA#0.6660;CELL MIGRATION#0.6311
1379	FETAL LIVER#0.6615;LYMPHOID TISSUE#0.6572;BONE MARROW#0.6450
138009	COLORECTAL CANCER#0.7480
138046	ADJACENT NORMAL TISSUE#0.7045;GENE EXPRESSION#0.6029
138050	N ACETYLTRANSFERASE#1.1061;MUCOPOLYSACCHARIDOSIS#1.0209;MUCOPOLYSACCHARIDOSIS III#0.7552;CYSTIC FIBROSIS#0.6514
138065	INFLAMMATORY BOWEL DISEASE#0.9117;UBIQUITIN#0.8534;LYSOSOME#0.7161;ER STRESS-INDUCED APOPTOSIS#0.6664;VESICLE FORMATION#0.6597;COLLECTING DUCTS#0.6531;CASPASE ACTIVATION#0.6429;CELL GROWTH#0.6295
1380	COMPLEMENT RECEPTOR#1.0230;RECEPTOR COMPLEX#1.0146;MARGINAL ZONE B CELL#1.0136;SMOOTH MUSCLE ACTIN#1.0127;SIGNAL TRANSDUCTION#1.0120;MARGINAL ZONE B#1.0119;FOLLICULAR B CELL#1.0081;B CELL ACTIVATION#1.0076;B CELL RECEPTOR#1.0073;B CELL DEVELOPMENT#1.0071;EPITHELIAL CELL#1.0020;B CELL#1.0009;MEMORY B CELL#1.0009;CD8+ T CELL#1.0009;GROWTH FACTOR RECEPTOR#1.0008;SMOOTH MUSCLE#0.9989;B CELL PROLIFERATION#0.9984;B LYMPHOCYTE#0.9980;ANTIGEN PRESENTATION#0.9977;CELL DEVELOPMENT#0.9972;HUMORAL IMMUNE RESPONSE#0.9966;TUMOR CELLS#0.9964;CELL MEMBRANE#0.9950;VIRION#0.9935;B CELL DIFFERENTIATION#0.9934;CELL ACTIVATION#0.9926;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9926;SURFACE IGM#0.9923;COMPLEMENT ACTIVATION#0.9918;AUTOIMMUNITY#0.9896;COMMON VARIABLE IMMUNODEFICIENCY#0.9895;PLASMA MEMBRANE#0.9894;FOLLICULAR DENDRITIC CELL#0.9886;ERYTHROCYTE#0.9885;TRANSITIONAL B CELL#0.9871;GROWTH FACTOR#0.9859;CD4+ T CELL#0.9855;CORD BLOOD#0.9852;EPSTEIN BARR VIRUS#0.9839;DIFFUSE LARGE B-CELL LYMPHOMA#0.9839;CELL GROWTH#0.9836;CELL SURFACE#0.9833;TONSIL#0.9824;CELL ASSOCIATED#0.9823;PERIPHERAL BLOOD LYMPHOCYTES#0.9819;T LYMPHOCYTE#0.9816;DENDRITIC CELL#0.9794;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9792;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9790;LUPUS ERYTHEMATOSUS#0.9785;AUTOIMMUNE DISEASE#0.9783;STROMAL CELL#0.9782;MONONUCLEAR CELLS#0.9776;CELL DIFFERENTIATION#0.9775;GERMINAL CENTER#0.9775;LEUKOCYTE#0.9774;REGULATORY T CELL#0.9772;MONOCYTE#0.9767;FACTOR I#0.9763;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9762;FOLLICULAR DENDRITIC CELL SARCOMA#0.9759;FOLLICULAR LYMPHOMA#0.9757;ADAPTIVE IMMUNE RESPONSE#0.9755;NEUTROPHIL#0.9747;CELL PROLIFERATION#0.9747;SIGNALING PATHWAY#0.9745;PLASMA CELL#0.9737;LYMPHOCYTIC LEUKEMIA#0.9735;TRANSCRIPTION FACTOR#0.9735;HODGKIN'S LYMPHOMA#0.9735;MACROPHAGE#0.9734;APOPTOSIS#0.9726;LYMPHOID TISSUE#0.9724;DENDRITIC CELL SARCOMA#0.9720;T CELL#0.9714;LYMPHOID CELL#0.9712;GENE EXPRESSION#0.9706;RHEUMATOID ARTHRITIS#0.9706;IMMUNE CELL#0.9698;NODULAR#0.9691;B CELL LYMPHOMA#0.9686;THYMOCYTE#0.9682;HUMAN IMMUNODEFICIENCY VIRUS#0.9681;CD3+ T CELL#0.9677;NAIVE B CELL#0.9673;LYMPHOCYTE ACTIVATION#0.9673;BURKITT LYMPHOMA#0.9671;PERIPHERAL BLOOD#0.9666;CELL CYCLE#0.9664;LANGERHANS CELL#0.9651;IMMUNE RESPONSE#0.9651;POLYMERASE CHAIN REACTION#0.9642;ACTIVATED B CELL#0.9638;LYMPH NODE#0.9625;IMMUNE SYSTEM#0.9616;GERMINAL CENTER B#0.9613;ENDOTHELIAL CELL#0.9608;LECTIN#0.9601;CELL MATURATION#0.9596;IFN-GAMMA#0.9590;ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA#0.9587;IGE RECEPTOR#0.9584;GERMINAL CENTER B CELL#0.9561;BONE MARROW#0.9558;LYMPHOBLASTOID CELLS#0.9554;DNA BINDING#0.9548;DESMOSOME#0.9534;B LYMPHOCYTE ACTIVATION#0.9533;STEM CELL#0.9510;CYTOPLASM#0.9508;VIRAL INFECTION#0.9508;INFLAMMATORY CELL#0.9492;PROTEIN KINASE#0.9490;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9490;LYMPHOID ORGANS#0.9477;TUMOR NECROSIS FACTOR#0.9477;FACTOR VIII#0.9476;GRANULOCYTE#0.9464;STEM CELL TRANSPLANTATION#0.9428;COMPLEX I#0.9407;CERVICAL#0.9334;SALIVARY GLAND#0.9331;ANTIGEN PRESENTING CELLS#0.9329;APOPTOTIC#0.9321;MALIGNANT LYMPHOMA#0.9312;INNATE IMMUNITY#0.9270;CELL SURFACE ANTIGEN#0.9233;VIRAL REPLICATION#0.9205;LYMPHOCYTE PROLIFERATION#0.9203;HOST CELL#0.9179;SWITCHED MEMORY B CELL#0.9168;LYMPHOPROLIFERATIVE DISEASE#0.9147;LYMPHOMA CELL LINES#0.9120;ANTIBODY PRODUCTION#0.9111;MAST CELL#0.9111;ACUTE LEUKEMIA#0.9106;ANAPLASTIC LYMPHOMA KINASE#0.9078;MUTAGENESIS#0.9078;HEMATOPOIETIC CELL#0.9075;MYELOID LEUKEMIA#0.9058;HEMATOPOIETIC STEM CELL#0.9039;CELL DEATH#0.9036;CYTOTOXICITY#0.9010;RECEPTOR BINDING#0.9005;B CELL DEPLETION#0.9000;TROPISM#0.8997;T HELPER CELL#0.8975;PHAGOCYTOSIS#0.8947;PLASMABLAST#0.8947;NATURAL KILLER CELL#0.8903;CELL ADHESION#0.8902;NERVOUS SYSTEM#0.8875;PERIPHERAL T-CELL LYMPHOMA#0.8872;LIPID RAFT#0.8859;WHITE BLOOD CELL#0.8855;RITUXIMAB#0.8850;HEPATITIS C#0.8841;CERVICAL LYMPH NODE#0.8801;ACUTE MYELOID LEUKEMIA#0.8798;GLYCOSYLATION#0.8784;DISEASE FREE SURVIVAL#0.8779;CYCLOPHOSPHAMIDE#0.8758;MULTIPLE SCLEROSIS#0.8728;MAC FORMATION#0.8721;GRAFT VERSUS HOST#0.8674;S PHASE#0.8658;SCRAPIE#0.8616;NON HODGKIN LYMPHOMA#0.8602;TOLL LIKE RECEPTOR#0.8595;MYELOID CELL#0.8592;T CELL ACTIVATION#0.8581;MULTIPLE MYELOMA#0.8569;CENTRAL NERVOUS SYSTEM#0.8559;EOSINOPHIL#0.8549;EOSIN#0.8527;ALLERGEN#0.8504;T-CELL LEUKEMIA#0.8504;GLUTATHIONE#0.8496;HEPATITIS C VIRUS#0.8470;STROMA#0.8441;DNA SYNTHESIS#0.8440;B LYMPHOCYTE PROLIFERATION#0.8424;REVERSE TRANSCRIPTION#0.8413;THYMIDINE#0.8399;GROWTH PATTERN#0.8370;PROGENITOR CELL#0.8365;PRO-INFLAMMATORY#0.8349;EPIDERMAL GROWTH FACTOR#0.8281;DERMIS#0.8258;FINE NEEDLE ASPIRATION#0.8238;GASTROINTESTINAL TRACT#0.8198;LYSIS#0.8151;CHEMOKINE RECEPTOR#0.8147;LINES OF EVIDENCE#0.8065;PRION DISEASE#0.8044;MESENTERIC LYMPH NODE#0.8027;LEUKEMIA FREE SURVIVAL#0.8000;INNATE IMMUNE SYSTEM#0.7993;ATYPICAL MEMORY B CELL#0.7969;ADAPTIVE IMMUNE SYSTEM#0.7956;BLOOD VESSEL#0.7950;PROTEIN KINASE C#0.7943;UMBILICAL CORD#0.7931;SELECTIN#0.7928;IMMUNOGLOBULIN PRODUCTION#0.7913;ONCOGENIC#0.7911;RECEPTOR LIGAND#0.7896;NUCLEAR MATRIX#0.7887;FACTOR XIIIA#0.7822;BETA-2#0.7791;CYTOKINE PRODUCTION#0.7785;INFLAMMATORY RESPONSE#0.7763;SIGNALLING PATHWAY#0.7737;COMPLEMENT CASCADE#0.7721;MALARIA#0.7701;CELL ADHESION MOLECULE#0.7693;ANEMIA#0.7667;SYNOVIAL FLUID#0.7659;TREG CELL#0.7654;MEMBRANE ATTACK COMPLEX#0.7639;VIRAL ENVELOPE#0.7617;TOXICITY#0.7613;COMPLEMENT ALTERNATIVE PATHWAY#0.7605;UMBILICAL CORD BLOOD#0.7592;PERIPHERAL BLOOD LEUKOCYTE#0.7566;TRANSCRIPTASE#0.7553;ROSETTING#0.7535;VENULE#0.7467;MARGINAL ZONE LYMPHOMA#0.7463;ACTIVATED T-CELLS#0.7424;ACTIVATED T CELL#0.7421;CYTIDINE DEAMINASE#0.7415;ASTROCYTE#0.7385;TRANSFERRIN RECEPTOR#0.7361;TRANSACTIVATION#0.7334;SURFACE PLASMON RESONANCE#0.7315;VIRAL GENE EXPRESSION#0.7294;TISSUE DAMAGE#0.7281;MANTLE CELL LYMPHOMA#0.7265;ENDOCYTOSIS#0.7264;BIOTIN#0.7260;OVARIAN CANCER#0.7253;RETINOBLASTOMA#0.7197;FLOW CYTOMETRY ANALYSIS#0.7157;HUMAN HERPES VIRUS#0.7139;REGULATORY B CELL#0.7097;IMMUNOGLOBULIN G#0.7085;BONE MARROW CELLS#0.7077;GESTATION#0.7077;ADULT T-CELL LEUKEMIA#0.7067;VIRAL GLYCOPROTEIN#0.7027;AGE RELATED MACULAR DEGENERATION#0.7001;MACULAR DEGENERATION#0.6996;MEAN FLUORESCENCE INTENSITY#0.6995;KERATINOCYTE#0.6989;HERPES SIMPLEX VIRUS#0.6971;HERPES SIMPLEX#0.6968;OVARIAN#0.6967;INFLAMMATORY BOWEL DISEASE#0.6958;TUMOUR NECROSIS FACTOR#0.6947;RED BLOOD CELL#0.6943;MALT LYMPHOMA#0.6928;COMPLEMENT FACTOR H#0.6902;PLASMA CELL DIFFERENTIATION#0.6888;FORMALIN#0.6888;INFECTIOUS MONONUCLEOSIS#0.6824;MOLECULAR DYNAMICS SIMULATION#0.6808;LYMPHOCYTE DEVELOPMENT#0.6797;NERVE GROWTH FACTOR#0.6783;TUMOR SUPPRESSOR#0.6777;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.6764;LYMPHOCYTE ANTIGEN#0.6763;ISCHEMIA#0.6757;IGG ANTIBODY#0.6752;SURFACE IGD#0.6690;LIGAND BINDING DOMAIN#0.6678;ANAPLASTIC LARGE CELL LYMPHOMA#0.6656;MINIMAL RESIDUAL DISEASE#0.6646;LYMPHOBLAST#0.6644;FLUORESCEIN#0.6605;SMALL INTESTINE#0.6590;BCR ENDOCYTOSIS#0.6571;ESTROGEN RECEPTOR#0.6509;DIGESTION#0.6484;CANCER CELL#0.6474;EVENT FREE SURVIVAL#0.6454;MEDIASTINUM#0.6449;B CELL HOMEOSTASIS#0.6438;CYTOTOXIC T CELL#0.6426;SPINAL CORD#0.6423;LYMPHOID CELL LINES#0.6413;GERMINAL CENTER FORMATION#0.6402;BUSULFAN#0.6391;ISOTYPE SWITCHING#0.6356;VIRAL RECEPTOR#0.6355;NEPHRITIS#0.6311;LACRIMAL GLAND#0.6304;ANTIGEN BINDING#0.6294;MYASTHENIA GRAVIS#0.6289;COLLAGEN INDUCED ARTHRITIS#0.6288;CRYOGLOBULINEMIA#0.6272;CELL-MEDIATED IMMUNITY#0.6270;MEMORY T CELL#0.6261;T CELL PROLIFERATION#0.6239;BCR COMPLEX#0.6231;KINASE ACTIVITY#0.6195;ALANINE#0.6192;CYTIDINE#0.6182;HEMATOPOIETIC CELL TRANSPLANTATION#0.6179;CALCIUM MOBILIZATION#0.6174;THROMBOCYTOPENIA#0.6172;PLASMACYTOID DENDRITIC CELL#0.6145;SUPEROXIDE DISMUTASE#0.6145;CASTLEMAN DISEASE#0.6144;VIRAL GENOME#0.6135;SWELLING#0.6128;CELL EXPANSION#0.6124;DRAINING LYMPH NODE#0.6124;TERMINAL DIFFERENTIATION#0.6112;PROGRAMMED CELL DEATH#0.6085;LYMPHOBLASTIC LYMPHOMA#0.6024
138151	RETURN TO WORK#0.6612;NURD COMPLEX#0.6473;PHOTOSYSTEM II#0.6280
138162	DNA DAMAGE RESPONSE#0.7438
1381	BINDING PROTEIN 1#1.0636;DNA METHYLATION#1.0500;RETINOIC ACID BINDING#1.0416;NEURAL CREST#1.0397;RETINOL#1.0300;RETINOL BINDING#1.0297;KERATINOCYTE#1.0273;RETINOIC ACID#1.0266;NEURAL CREST CELL#1.0179;RETINOID X RECEPTOR#1.0134;NERVOUS SYSTEM#1.0085;RETINOIC ACID RECEPTOR#1.0085;ALL TRANS RETINOIC ACID#1.0059;NEURAL TUBE#1.0023;STEM CELL#1.0015;COLORECTAL CANCER#0.9967;FATTY ACID BINDING#0.9967;RETINOID BINDING#0.9954;COLORECTAL#0.9935;CANCER CELL#0.9917;LIPID BINDING PROTEIN#0.9917;HINDBRAIN#0.9890;POLYMERASE CHAIN REACTION#0.9862;LIPID BINDING#0.9854;VITAMIN A#0.9840;DERMIS#0.9780;GROWTH FACTOR#0.9775;GENE EXPRESSION#0.9746;TOPICAL#0.9721;UTERUS#0.9662;SQUAMOUS CELL CARCINOMA#0.9636;9-CIS-RETINOIC ACID#0.9562;SIGNALING PATHWAY#0.9558;EPITHELIAL CELL#0.9471;TERATOGENIC#0.9452;CENTRAL NERVOUS SYSTEM#0.9398;SPINAL CORD#0.9394;MESENCHYME#0.9352;ACUTE PROMYELOCYTIC LEUKEMIA#0.9310;PROTEIN KINASE#0.9293;EMBRYONAL CARCINOMA#0.9227;ADIPOCYTE#0.9221;CELL PROLIFERATION#0.8975;CYTOPLASM#0.8933;CELL DIFFERENTIATION#0.8923;NEUROBLASTOMA#0.8921;ADIPOCYTE DIFFERENTIATION#0.8916;SUCROSE#0.8906;SERTOLI CELL#0.8896;GERM CELL#0.8859;OVARIAN#0.8850;AMACRINE CELL#0.8780;BREAST CANCER#0.8779;EMBRYONIC STEM CELL#0.8756;COLON CANCER#0.8743;MORPHOGENESIS#0.8683;CELL CYCLE#0.8607;VITAMIN A DEFICIENCY#0.8385;APOPTOSIS#0.8324;CHROMATIN REMODELING#0.8171;TRANSCRIPTION FACTOR#0.7992;TERATOCARCINOMA#0.7902;RETINOID METABOLISM#0.7870;GESTATION#0.7766;REVERSE TRANSCRIPTION#0.7760;CATABOLISM#0.7645;LACRIMAL GLAND#0.7616;SMOOTH MUSCLE#0.7569;MECHANISM OF ACTION#0.7476;ADENOCARCINOMA#0.7471;RESPONSE TO RETINOIC ACID#0.7457;RETINOIC ACID METABOLISM#0.7446;NEUROGENESIS#0.7373;BREAST CANCER CELL#0.7350;MESENCHYMAL CELL#0.7299;4-OXORETINOL#0.7237;CELL GROWTH#0.7234;STROMAL CELL#0.7215;QUANTITATIVE REAL TIME#0.7215;CYTOCHROME P450#0.7192;OVARIAN CARCINOMA#0.7104;ALL-TRANS-RETINOL#0.7072;TRANS-RETINOL#0.7071;REGULATION OF CELLULAR#0.7044;PATTERN FORMATION#0.6998;BASAL CELL CARCINOMA#0.6956;BASAL CELL#0.6909;RHOMBOMERE#0.6905;REGENERATION#0.6872;RETINOBLASTOMA#0.6797;COLORECTAL CARCINOMA#0.6758;STROMA#0.6712;SIGNAL TRANSDUCTION#0.6577;PROTEIN KINASE C#0.6469;MANTLE LAYER#0.6427;ETRETINATE#0.6401;MOLAR#0.6358;ACITRETIN#0.6346;DERMAL FIBROBLAST#0.6327;CAMKII#0.6305;HAIR FOLLICLE#0.6290;TUMOR CELLS#0.6266;OVARIAN CANCER#0.6265;MOYAMOYA DISEASE#0.6102;SODIUM DODECYL SULFATE#0.6057;DODECYL SULFATE#0.6056;NUCLEOSIDE DIPHOSPHATE KINASE#0.6056;LIGAND BINDING POCKET#0.6053;MAMMARY GLAND#0.6048;HEPATOCELLULAR CARCINOMA#0.6003
1382	FATTY ACID BINDING#1.0603;RETINOIC ACID BINDING#1.0520;RETINOL#1.0312;RETINOIC ACID#1.0301;RETINOL BINDING#1.0290;CANCER CELL#1.0285;RETINOIC ACID RECEPTOR#1.0264;KERATINOCYTE#1.0143;ALL TRANS RETINOIC ACID#1.0105;LIPID BINDING PROTEIN#1.0032;RETINOID X RECEPTOR#1.0032;BREAST CANCER#1.0029;APOPTOSIS#1.0002;LIPID BINDING#0.9963;DERMAL FIBROBLAST#0.9904;GENE EXPRESSION#0.9829;SIGNALING PATHWAY#0.9828;LUNG CANCER#0.9673;VITAMIN A#0.9433;POLYMERASE CHAIN REACTION#0.9425;CELL PROLIFERATION#0.9216;BREAST CANCER CELL#0.9213;TRANSCRIPTION FACTOR#0.9155;STEM CELL#0.8858;PEROXISOME#0.8795;RNA BINDING#0.8471;REVERSE TRANSCRIPTION#0.8429;CELL GROWTH#0.8419;RETINOID BINDING#0.8331;TOPICAL#0.8282;GROWTH FACTOR#0.8256;EPITHELIAL CELL#0.8205;SQUAMOUS CELL CARCINOMA#0.8183;9-CIS-RETINOIC ACID#0.8172;ADENOCARCINOMA#0.8130;CELL DIFFERENTIATION#0.7987;NEUROBLASTOMA#0.7946;RNA BINDING PROTEIN#0.7689;STROMAL CELL#0.7508;QUANTITATIVE REAL TIME#0.7462;BINDING PROTEIN 1#0.7306;TUMOR SUPPRESSOR#0.7291;RESVERATROL#0.7253;SIGNAL TRANSDUCTION#0.7249;CYTOCHROME P450#0.7243;CYTOPLASM#0.7058;KERATINOCYTE DIFFERENTIATION#0.7056;DNA METHYLATION#0.6936;MYOBLAST DIFFERENTIATION#0.6915;ESTROGEN RECEPTOR#0.6831;PANCREATIC DUCTAL ADENOCARCINOMA#0.6809;MUTAGENESIS#0.6735;ADIPOCYTE DIFFERENTIATION#0.6653;APOPTOTIC#0.6632;RETINAL DEHYDROGENASE#0.6621;REGULATION OF CELLULAR#0.6607;SKIN FIBROBLASTS#0.6575;OVARIAN#0.6522;TUMOR CELLS#0.6499;SEBACEOUS GLAND#0.6468;HUMAN BREAST CANCER#0.6338;ADIPOCYTE#0.6273;TERMINAL DIFFERENTIATION#0.6132;SPONTANEOUS ABORTION#0.6066
138307	EPIDIDYMIS#0.7632
138428	VACUOLAR MEMBRANE#0.6130
138429	CANCER CELL#0.7509;CERVICAL CANCER#0.7217;KINASE ACTIVITY#0.7161
138474	MALE MEIOSIS#0.6939;COLORECTAL CANCER#0.6487
1384	CARNITINE ACETYLTRANSFERASE ACTIVITY#1.0961;ACETYLTRANSFERASE ACTIVITY#1.0640;CARNITINE#1.0443;COA HYDROLASE#1.0343;CLOFIBRATE#1.0315;PALMITOYL#1.0309;CHOLINE#1.0253;ACETYLCARNITINE#1.0251;ACYL COA OXIDASE#1.0217;L-CARNITINE#1.0214;PEROXISOMAL#1.0182;PYRUVATE#1.0175;COENZYME A#1.0144;ACYLCARNITINE#1.0051;PEROXISOME PROLIFERATION#1.0032;PEROXISOME#1.0023;SKELETAL MUSCLE#1.0003;MITOCHONDRIA#0.9940;FATTY ACID OXIDATION#0.9887;ACETYL-L-CARNITINE#0.9741;ENZYME ACTIVITY#0.9559;MITOCHONDRIAL MEMBRANE#0.9493;ACETYLCHOLINE#0.9463;FATTY ACID BETA-OXIDATION#0.9395;ADIPOSE TISSUE#0.9243;ENOYL COA HYDRATASE#0.9154;MITOCHONDRIAL MATRIX#0.9043;HIGH FAT DIET#0.8732;CARNITINE PALMITOYLTRANSFERASE I#0.8731;ACETYL COA HYDROLASE#0.8696;GENE EXPRESSION#0.8608;FATTY ACID METABOLISM#0.8551;COASH#0.8185;ORGANIC CATION TRANSPORTER#0.8124;ENDOPLASMIC RETICULUM#0.7953;MALATE DEHYDROGENASE#0.7928;LIPID METABOLISM#0.7887;GLUCOSE-6-PHOSPHATE#0.7867;MALIC ENZYME#0.7817;BROWN ADIPOSE TISSUE#0.7786;ORGANELLE#0.7732;GLUTAMATE DEHYDROGENASE#0.7548;PALMITOYL COA OXIDASE#0.7404;MITOCHONDRION#0.7230;BEZAFIBRATE#0.7226;CATALASE ACTIVITY#0.6933;TCA CYCLE#0.6858;FENOFIBRATE#0.6803;GLUTATHIONE#0.6783;SPERMATOZOA#0.6749;PYRUVATE DEHYDROGENASE COMPLEX#0.6694;CHOLINE ACETYLTRANSFERASE ACTIVITY#0.6687;HYDROLASE ACTIVITY#0.6672;DEHYDROGENASE COMPLEX#0.6663;HEART MUSCLE#0.6587;COA HYDROLASE ACTIVITY#0.6512;NICARDIPINE#0.6498;CYTOPLASM#0.6432;ACONITATE HYDRATASE#0.6409;CHLORAMPHENICOL#0.6394;OLEIC ACID#0.6349;OBESE#0.6349;ACYL COA HYDROLASE#0.6305;PALMITATE#0.6280;ALZHEIMER'S DISEASE#0.6262;ACETIC ACID#0.6196;URATE OXIDASE#0.6182;PYRUVATE OXIDATION#0.6132;TOXICITY#0.6085;INNER MITOCHONDRIAL MEMBRANE#0.6069;CHENODEOXYCHOLIC ACID#0.6064;ACETYLCHOLINE SYNTHESIS#0.6006
1385	CREB ACTIVATOR#1.1185;CREB INHIBITOR#1.1012;CILOSTAZOL#1.0595;ANGIOMATOID FIBROUS HISTIOCYTOMA#1.0529;TRANSCRIPTION COACTIVATOR#1.0474;CAMKIV#1.0473;ACTIVATION OF CREB#1.0457;DRINKING BEHAVIOR#1.0441;PKA C#1.0415;SALT INDUCIBLE KINASE#1.0371;LONG TERM FACILITATION#1.0370;RESPONSE TO CAMP#1.0335;CAMP-RESPONSIVE ELEMENT BINDING#1.0308;KETAMINE#1.0299;SERTOLI CELL#1.0297;BINDING PROTEIN 1#1.0294;CRE BINDING#1.0293;EXTRACELLULAR REGULATED KINASE#1.0279;TROPOMYOSIN RECEPTOR KINASE#1.0271;CREB BINDING#1.0268;FIBROUS HISTIOCYTOMA#1.0257;ACTIVATING TRANSCRIPTION FACTOR#1.0240;METASTATIC MELANOMA#1.0232;SERUM RESPONSE FACTOR#1.0230;CAMKII#1.0225;CAMP RESPONSE ELEMENT BINDING#1.0212;RIBOSOMAL S6 KINASE#1.0210;DOMINANT NEGATIVE MUTANT#1.0207;PROTEIN PHOSPHATASE 1#1.0205;RESVERATROL#1.0170;DNA-PROTEIN COMPLEX#1.0167;IL-10 PRODUCTION#1.0167;CLEAR CELL SARCOMA#1.0159;MORPHINE DEPENDENCE#1.0159;CAMP RESPONSE ELEMENT#1.0158;IMIPRAMINE#1.0146;LITHIUM#1.0142;SPINAL DORSAL HORN#1.0141;MEMBRANE DEPOLARIZATION#1.0131;EARLY GROWTH RESPONSE#1.0129;B CELL LYMPHOMA#1.0128;VSMC PROLIFERATION#1.0128;PROTEIN KINASE A ACTIVITY#1.0124;GENISTEIN#1.0124;FRONTAL#1.0118;CELLULAR TRANSCRIPTION#1.0117;AMPA RECEPTOR#1.0114;HEPATITIS B VIRUS#1.0107;NALOXONE#1.0100;MELATONIN#1.0087;HYPOXIA INDUCIBLE FACTOR#1.0079;GM-CSF#1.0075;SCOPOLAMINE#1.0074;CYCLIC ADENOSINE MONOPHOSPHATE#1.0074;NUCLEUS ACCUMBENS SHELL#1.0069;ACTIVATOR PROTEIN 1#1.0067;PROTEIN KINASE B#1.0067;ACUTE MYELOID LEUKEMIA#1.0064;CHONDROCYTE#1.0060;CYCLIC AMP#1.0060;HEPATITIS B#1.0054;MYELOID LEUKEMIA#1.0052;ADENOSINE MONOPHOSPHATE#1.0048;DOPAMINE D1 RECEPTOR#1.0047;OVARIAN CANCER#1.0043;VIRAL TRANSCRIPTION#1.0042;BETA CELL#1.0042;L-DOPA#1.0041;CALCINEURIN#1.0041;SIGNAL TRANSDUCER#1.0035;SCHWANN CELL#1.0030;METHAMPHETAMINE#1.0029;TETRACYCLINE#1.0029;HERPES SIMPLEX#1.0028;HISTIOCYTOMA#1.0024;HERPES SIMPLEX VIRUS#1.0023;AUTOPHAGY#1.0015;SIGNALLING CASCADE#1.0014;AMYGDALA#1.0012;ADIPOCYTE DIFFERENTIATION#1.0005;SEVOFLURANE#1.0004;IL-8 PRODUCTION#1.0001;IFN-GAMMA#0.9998;DENDRITIC SPINE#0.9998;CONDITIONED PLACE PREFERENCE#0.9996;ISOPROTERENOL#0.9994;ENHANCER BINDING PROTEIN#0.9987;TRANSCRIPTION FACTOR#0.9986;HUMAN IMMUNODEFICIENCY VIRUS#0.9985;SPERMATOGENESIS#0.9985;ADIPOGENESIS#0.9983;PROTEIN COMPLEX#0.9983;POSTSYNAPTIC DENSITY#0.9982;DEPHOSPHORYLATION#0.9977;PROPOFOL#0.9977;MESANGIAL CELL#0.9974;SPINAL CORD#0.9974;ENHANCER BINDING#0.9972;HISTONE ACETYLTRANSFERASE#0.9972;HYPOXIA#0.9972;MYELOID CELL#0.9971;LONG TERM MEMORY#0.9968;CALCIUM SIGNALING#0.9968;NUCLEAR IMPORT#0.9968;LEYDIG CELL#0.9967;MEDIAL PREFRONTAL CORTEX#0.9966;AKT SIGNALING#0.9966;TARGET OF RAPAMYCIN#0.9965;OLFACTORY BULB#0.9962;STEROID RECEPTOR COACTIVATOR#0.9960;BETA-2#0.9960;CLEAVED CASPASE 3#0.9959;THYROID HORMONE RECEPTOR#0.9957;GRANULOSA CELL#0.9955;MELANIN SYNTHESIS#0.9952;SHORT TERM MEMORY#0.9952;GENE SILENCING#0.9950;MAPK CASCADE#0.9948;IL-6 PRODUCTION#0.9948;FLUOXETINE#0.9947;GLUCOSE 6 PHOSPHATASE#0.9946;PROSTATE CANCER#0.9944;ETHANOL#0.9942;METFORMIN#0.9941;RAPAMYCIN#0.9941;CARDIOMYOCYTE#0.9938;CAMP SIGNALLING#0.9938;HYPOXIC#0.9937;DNA BINDING#0.9937;FOREBRAIN#0.9934;LUNG CANCER#0.9934;OPIOID RECEPTOR#0.9933;LUNG EPITHELIAL CELL#0.9933;SCIATIC NERVE#0.9933;CEREBRAL CORTEX#0.9933;A-GEL#0.9929;ELECTROPHORETIC MOBILITY SHIFT#0.9928;ISOFLURANE#0.9924;CONTEXTUAL FEAR CONDITIONING#0.9923;GERM CELL#0.9923;HISTONE ACETYLATION#0.9920;CYTOCHROME C#0.9919;NMDA RECEPTOR#0.9919;ACTIVATED T CELL#0.9919;GLYCOGEN SYNTHASE KINASE#0.9917;ACTIVATED T-CELLS#0.9915;OLIGODENDROCYTE#0.9914;GLUCONEOGENESIS#0.9911;ADENOSINE#0.9909;MAP KINASE#0.9896;GLUCOCORTICOID RECEPTOR#0.9892;LEUCINE#0.9891;METASTATIC MELANOMA CELLS#0.9891;GLUCOSE HOMEOSTASIS#0.9888;ESTRADIOL#0.9887;HEME OXYGENASE 1#0.9887;HEPATOMA CELLS#0.9880;TRANSCRIPTIONAL CONTROL#0.9879;DOPAMINERGIC NEURON#0.9878;CELL ADHESION MOLECULE#0.9877;PREADIPOCYTE#0.9875;CEREBRAL ISCHEMIA#0.9875;ACETYLTRANSFERASE ACTIVITY#0.9874;DENTATE GYRUS#0.9870;PROTEIN KINASE A#0.9869;NEUROPROTECTION#0.9867;VIRAL GENE EXPRESSION#0.9867;MOOD DISORDER#0.9867;RETINOIC ACID#0.9865;DOPAMINE RECEPTOR#0.9865;FACTOR I#0.9865;T CELL ACTIVATION#0.9861;MAPK SIGNALING#0.9858;FOCAL CEREBRAL ISCHEMIA#0.9858;REPORTER GENE ASSAY#0.9858;FORSKOLIN#0.9857;NEUTROPHIL#0.9857;MAJOR DEPRESSIVE DISORDER#0.9856;SIGNALLING PATHWAY#0.9856;DNA SYNTHESIS#0.9852;ANGIOGENESIS#0.9852;TROPOMYOSIN RELATED KINASE#0.9850;CYCLOSPORIN A#0.9849;PROTEIN KINASE A SIGNALING#0.9848;ALANINE#0.9847;NEURITE OUTGROWTH#0.9847;EPIDERMAL GROWTH FACTOR#0.9847;STRIATUM#0.9846;PHOSPHOLIPASE C#0.9844;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9843;NUCLEAR EXPORT#0.9842;ENDOTHELIAL GROWTH FACTOR#0.9842;TRANSCRIPTION FACTOR BINDING#0.9841;RNA INTERFERENCE#0.9839;PROGESTERONE#0.9835;MAPK ACTIVATION#0.9834;TRANSACTIVATION#0.9834;COMPLEX I#0.9834;PLATELET-DERIVED GROWTH FACTOR#0.9834;SENSITIZATION#0.9833;LUCIFERASE ACTIVITY#0.9833;SYNAPTIC TRANSMISSION#0.9833;B LYMPHOCYTE#0.9832;UBIQUITIN#0.9832;HUNTINGTON'S DISEASE#0.9831;DNASE I#0.9831;ERK CASCADE#0.9830;GLUTAMINE#0.9827;NEURAL CELL#0.9827;DNASE#0.9827;B CELL#0.9825;3'-5'-CYCLIC ADENOSINE MONOPHOSPHATE#0.9825;ISCHEMIA REPERFUSION INJURY#0.9825;NEUROGENESIS#0.9823;EPSTEIN BARR VIRUS#0.9822;KERATINOCYTE#0.9822;GROWTH FACTOR RECEPTOR#0.9820;ANDROGEN RECEPTOR#0.9819;MICROPHTHALMIA#0.9817;GROWTH HORMONE#0.9817;ADIPOCYTE#0.9816;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.9814;BONE FORMATION#0.9814;SIGNALING CASCADE#0.9814;NADPH OXIDASE#0.9813;TESTOSTERONE#0.9813;NEURAL STEM CELL#0.9813;REGULATION OF GENE EXPRESSION#0.9811;CAFFEINE#0.9810;RECEPTOR TYROSINE KINASE#0.9809;CELL ADHESION#0.9809;FOLLICLE STIMULATING HORMONE#0.9809;ASTROCYTE#0.9807;ISCHEMIA#0.9806;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9806;CAMP SIGNALING#0.9805;HISTAMINE#0.9805;CELL DEVELOPMENT#0.9804;CELL ACTIVATION#0.9804;CYCLIN DEPENDENT KINASE#0.9803;ONCOGENIC#0.9800;COLORECTAL CANCER#0.9797;PROTEIN PROTEIN INTERACTION#0.9796;AIRWAY EPITHELIAL CELL#0.9796;ACUTE LEUKEMIA#0.9793;INSULIN-LIKE GROWTH FACTOR#0.9791;MYOCYTES#0.9790;CYCLASE ACTIVITY#0.9789;GLUTAMATE RECEPTOR#0.9788;DOPAMINE#0.9788;DEXAMETHASONE#0.9788;CIRCADIAN RHYTHM#0.9787;MELATONIN BIOSYNTHESIS#0.9786;FORCED SWIM TEST#0.9785;REGENERATION#0.9784;ACTIVATED B CELL#0.9783;PROTEIN KINASE#0.9781;LIPID METABOLISM#0.9780;CELL DIFFERENTIATION#0.9779;BREAST CANCER CELL#0.9779;HISTONE DEACETYLASE#0.9777;CAAT ENHANCER BINDING#0.9776;NEURITE#0.9776;INTRACELLULAR SIGNALING PATHWAY#0.9775;VASCULAR SMOOTH MUSCLE CELL#0.9774;PROTEIN KINASE C#0.9774;OXYGENASE#0.9773;P38 MAPK SIGNALING#0.9772;GLIAL CELL#0.9771;CHROMATIN REMODELING#0.9770;ADENYLATE CYCLASE#0.9770;PANCREATIC ISLET#0.9769;PINEAL GLAND#0.9768;MICROTUBULE#0.9767;VIRAL REPLICATION#0.9764;CELL CYCLE ARREST#0.9764;CALCIUM CHANNEL#0.9764;LYSINE#0.9763;PHOSPHATASE ACTIVITY#0.9763;L-TYPE CALCIUM CHANNEL#0.9762;PROTEASOME#0.9760;STROMAL CELL#0.9759;ACTION POTENTIAL#0.9759;ADENYLATE#0.9758;OSTEOBLAST#0.9757;ARGININE#0.9757;STEROIDOGENESIS#0.9756;MITOGEN ACTIVATED PROTEIN#0.9755;ASPARTATE#0.9755;PHOSPHOENOLPYRUVATE#0.9755;CEREBRAL ARTERY OCCLUSION#0.9755;PROTEIN BINDING#0.9755;HOST CELL#0.9754;CHOLINE#0.9754;BETA GALACTOSIDASE#0.9752;OSTEOCLAST#0.9752;NUCLEAR RESPIRATORY FACTOR#0.9751;SIGNALING PATHWAY#0.9750;HIPPOCAMPAL DENTATE GYRUS#0.9749;EPILEPSY#0.9749;HISTONE DEACETYLASE INHIBITOR#0.9748;OVARIAN#0.9747;SPATIAL LEARNING#0.9746;NEUROBLASTOMA#0.9746;TRANSCRIPTASE#0.9745;REVERSE TRANSCRIPTION#0.9745;GLUCOSE METABOLISM#0.9744;OXYGEN GLUCOSE DEPRIVATION#0.9744;DNA METHYLATION#0.9743;PEROXISOME#0.9743;CELL MIGRATION#0.9742;MONONUCLEAR CELLS#0.9742;HYPERGLYCEMIA#0.9740;MIDDLE CEREBRAL ARTERY#0.9740;NERVE GROWTH FACTOR#0.9740;KINASE INHIBITOR#0.9739;CANCER CELL#0.9738;MEMORY IMPAIRMENT#0.9737;LONG TERM POTENTIATION#0.9736;CYTOTOXICITY#0.9734;CEREBRAL ARTERY#0.9734;SMOOTH MUSCLE CELL#0.9733;FIBROBLAST GROWTH FACTOR#0.9733;BRAIN DEVELOPMENT#0.9732;COLORECTAL#0.9732;NF-KAPPAB ACTIVATION#0.9730;MACROPHAGE#0.9729;ADRENERGIC RECEPTOR#0.9729;TRANSFORMING GROWTH FACTOR BETA#0.9728;MELANOCYTE#0.9727;GLUTATHIONE#0.9727;INDUCIBLE NITRIC OXIDE#0.9727;NEURONAL CELL DEATH#0.9726;MUTAGENESIS#0.9726;DNA REPAIR#0.9725;MUSCLE CELL#0.9725;SMOOTH MUSCLE#0.9724;CORTICOTROPIN#0.9724;TAIL SUSPENSION TEST#0.9723;PRECURSOR CELL#0.9723;SUPEROXIDE DISMUTASE#0.9722;VASOPRESSIN#0.9722;TRANSCRIPTION ACTIVATOR#0.9721;BETA ADRENERGIC RECEPTOR#0.9721;SUBSTANTIA NIGRA#0.9721;LOCUS COERULEUS#0.9721;TROPHOBLAST#0.9720;LONG TERM DEPRESSION#0.9720;NEURONAL CELLS#0.9719;S PHASE#0.9717;HEPATOCELLULAR CARCINOMA#0.9716;T LYMPHOCYTE#0.9714;PROGENITOR CELL#0.9714;SALIVARY GLAND#0.9714;GLUCOSE UPTAKE#0.9713;SIGNALING MOLECULE#0.9712;PROTEIN KINASE INHIBITOR#0.9712;SYNAPTOGENESIS#0.9712;POSTTRANSLATIONAL MODIFICATION#0.9710;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9709;MIDBRAIN#0.9708;T-CELL LEUKEMIA#0.9705;LEUKOCYTE#0.9703;OSTEOCLAST DIFFERENTIATION#0.9703;QUANTITATIVE REAL TIME#0.9703;CELLULAR GROWTH#0.9700;PROTEIN PHOSPHORYLATION#0.9698;BREAST CANCER#0.9698;EPITHELIAL CELL#0.9697;NEUROTOXICITY#0.9695;RELATED PROTEIN 1#0.9694;APOPTOTIC#0.9693;PROMOTER BINDING#0.9693;SKELETAL MUSCLE#0.9693;NOREPINEPHRINE#0.9693;NEUROTRANSMISSION#0.9692;T CELL#0.9691;TRANSFORMING GROWTH FACTOR#0.9689;POLYMERASE CHAIN REACTION#0.9689;TUMOR CELLS#0.9687;POST-TRANSLATIONAL MODIFICATION#0.9687;COGNITION#0.9686;STEROIDOGENIC FACTOR 1#0.9686;TUMOR SUPPRESSOR#0.9685;INSULIN SECRETION#0.9684;CELL PROLIFERATION#0.9684;APOPTOSIS#0.9682;METABOTROPIC GLUTAMATE RECEPTORS#0.9681;PHOSPHODIESTERASE INHIBITOR#0.9681;BRONCHIAL EPITHELIAL CELLS#0.9681;KINASE ACTIVITY#0.9680;DORSAL ROOT GANGLION#0.9679;SUCROSE#0.9677;CHLORAMPHENICOL#0.9676;ACETYLCHOLINE#0.9676;CELL GROWTH#0.9675;TYROSINASE ACTIVITY#0.9675;BONE MARROW#0.9668;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9663;PRO-INFLAMMATORY#0.9663;GENE EXPRESSION#0.9662;PHOSPHODIESTERASE#0.9662;ACETYLCHOLINE RECEPTOR#0.9662;MONOCYTE#0.9661;INTRACELLULAR SIGNAL TRANSDUCTION#0.9660;ADULT T-CELL LEUKEMIA#0.9660;MICROTUBULE ASSOCIATED PROTEIN#0.9659;PROTEIN SYNTHESIS#0.9658;ADENOCARCINOMA#0.9658;PROSTAGLANDIN E2#0.9657;ADULT HIPPOCAMPAL NEUROGENESIS#0.9656;ELEVATED PLUS MAZE#0.9655;ESTROGEN RECEPTOR#0.9654;BIPOLAR DISORDER#0.9651;OPEN FIELD TEST#0.9649;SIGNAL TRANSDUCTION#0.9648;FACTOR S#0.9648;HUMAN BREAST CANCER#0.9647;MITOCHONDRIA#0.9645;RECEPTOR AGONIST#0.9644;PHEOCHROMOCYTOMA#0.9643;FORCED SWIMMING TEST#0.9642;HEPATIC STELLATE CELL#0.9638;CYTOPLASM#0.9638;HEMATOPOIETIC CELL#0.9637;GROWTH FACTOR#0.9632;NITRIC OXIDE#0.9628;LINES OF EVIDENCE#0.9627;DENDRITIC CELL#0.9627;NITRIC OXIDE SYNTHASE#0.9625;MICROGLIAL CELL#0.9623;HYPERTENSION#0.9621;17β-ESTRADIOL#0.9620;MECHANISMS OF ACTION#0.9619;TOXICITY#0.9619;INSULIN RECEPTOR#0.9619;PERIPHERAL BLOOD#0.9617;TRAUMATIC BRAIN INJURY#0.9617;ADIPOSE TISSUE#0.9617;TYROSINE KINASE INHIBITOR#0.9616;DEMENTIA#0.9615;BRAIN DAMAGE#0.9613;TOLL LIKE RECEPTOR#0.9612;ARTERY#0.9610;PARATHYROID HORMONE#0.9608;ENDOTHELIAL CELL#0.9607;CYTOKINE PRODUCTION#0.9606;ENDOPLASMIC RETICULUM#0.9605;CELL CYCLE#0.9604;THYMIDINE#0.9601;HIGH FAT DIET#0.9600;INDUCTION OF APOPTOSIS#0.9599;HEAT SHOCK PROTEIN#0.9597;HEMATOPOIESIS#0.9597;SEROTONIN REUPTAKE INHIBITOR#0.9596;HYPERSENSITIVITY#0.9595;NOVEL OBJECT RECOGNITION#0.9593;MEMORY LOSS#0.9592;CELL DEATH#0.9590;PLASMA MEMBRANE#0.9588;FORMALIN#0.9588;APOPTOTIC CELL DEATH#0.9585;INFLAMMATORY RESPONSE#0.9584;PHOSPHATASE 2A#0.9584;INTRACELLULAR SIGNALING CASCADE#0.9583;CORTICOTROPIN-RELEASING FACTOR#0.9579;STEM CELL#0.9575;MECHANISM OF ACTION#0.9574;PANCREATIC CANCER#0.9568;TUMOR NECROSIS FACTOR#0.9568;RIBOSOMAL PROTEIN#0.9564;PKC ACTIVITY#0.9564;AMYLOID PRECURSOR PROTEIN#0.9563;TRANSIENT RECEPTOR POTENTIAL#0.9563;CARBACHOL#0.9561;IMMUNE CELL#0.9559;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9559;ANISOMYCIN#0.9558;CASPASE-3 ACTIVITY#0.9557;INTESTINAL EPITHELIAL CELL#0.9555;TYPE 2 DIABETES#0.9554;EXTRACELLULAR MATRIX#0.9552;NEUROLOGICAL DISORDER#0.9550;MITOCHONDRIAL MEMBRANE#0.9549;CHRONIC MILD STRESS#0.9546;HALOPERIDOL#0.9546;NICOTINIC ACETYLCHOLINE RECEPTOR#0.9546;RETINOIC ACID RECEPTOR#0.9540;ATHEROSCLEROSIS#0.9537;PARKINSON'S DISEASE#0.9537;CENTRAL NERVOUS SYSTEM#0.9536;OBESE#0.9536;CELL SURFACE#0.9535;MORRIS WATER MAZE#0.9533;MOUSE EMBRYONIC FIBROBLAST#0.9530;RECEPTOR ANTAGONIST#0.9529;NERVOUS SYSTEM#0.9528;PARATHYROID#0.9527;HYPOTHALAMIC PITUITARY ADRENAL#0.9526;DIABETES MELLITUS#0.9522;ADENOSINE 5'-MONOPHOSPHATE#0.9520;ARACHIDONIC ACID#0.9520;IMMUNE RESPONSE#0.9519;REACTIVE OXYGEN SPECIES#0.9518;CANNABINOID RECEPTOR#0.9516;PROGRAMMED CELL DEATH#0.9512;CHRONIC CEREBRAL HYPOPERFUSION#0.9511;IMMUNE SYSTEM#0.9505;HISTONE ACETYLTRANSFERASE ACTIVITY#0.9497;ALZHEIMER'S DISEASE#0.9489;PROTEIN PHOSPHATASE 2A#0.9489;MESENCHYMAL STEM CELL#0.9487;DNA REPLICATION#0.9485;ASSOCIATIVE LEARNING#0.9478;TUBERCULOSIS#0.9476;NEURODEGENERATIVE DISEASE#0.9473;KAPOSI'S SARCOMA#0.9473;HISTONE MODIFICATION#0.9471;ASPARTIC ACID#0.9468;GLUTATHIONE PEROXIDASE#0.9467;PHOSPHATASE INHIBITOR#0.9465;NEURAL PROGENITOR CELL#0.9464;CALCINEURIN ACTIVITY#0.9462;HYPERPHOSPHORYLATION#0.9459;MYOBLAST#0.9452;GANGLION CELLS#0.9450;OOCYTE#0.9446;UMBILICAL VEIN#0.9439;MICROVASCULAR ENDOTHELIAL CELL#0.9436;TREG CELL#0.9434;TRADITIONAL CHINESE MEDICINE#0.9432;ADRENAL CORTEX#0.9431;VASCULAR ENDOTHELIAL CELL#0.9428;ENERGY HOMEOSTASIS#0.9424;RECEPTOR ACTIVATOR#0.9414;TYROSINE KINASE RECEPTOR#0.9414;PROTEIN KINASE G#0.9408;CELL CYCLE REGULATION#0.9407;GONADOTROPIN RELEASING HORMONE#0.9406;ALKALINE PHOSPHATASE#0.9405;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9405;ION CHANNEL#0.9400;PROTEIN KINASE CASCADE#0.9398;CORTISOL#0.9395;WOUND HEALING#0.9394;CAROTID ARTERY#0.9394;CYCLOSPORIN#0.9393;IL-11#0.9382;RHEUMATOID ARTHRITIS#0.9382;STEROL REGULATORY ELEMENT#0.9377;TRANSCRIPTION REGULATOR#0.9373;RETINAL GANGLION CELL#0.9373;LIVER CANCER#0.9367;CD4+ T CELL#0.9364;SKELETAL MUSCLE CELLS#0.9364;LYMPH NODE#0.9363;PKCALPHA#0.9362;MYOTUBE#0.9360;SIMVASTATIN#0.9359;COLON CANCER#0.9357;RESPONSE TO STRESS#0.9346;TRANSCRIPTION COFACTOR#0.9345;MEDIUM SPINY NEURONS#0.9345;RESPONSE TO ANTIDEPRESSANT#0.9344;PERIPHERAL NERVE#0.9341;PULMONARY ARTERY#0.9341;COGNITIVE DISORDER#0.9339;HUMAN UMBILICAL VEIN#0.9333;SENESCENCE#0.9333;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9331;NORADRENALINE#0.9326;BONE RESORPTION#0.9324;PRIMARY CORTICAL NEURON#0.9316;GLOBIN#0.9315;DENDRITIC SPINE DENSITY#0.9311;MULTIPLE SCLEROSIS#0.9310;INTERNEURON#0.9309;GUANOSINE#0.9302;OBJECT RECOGNITION TEST#0.9299;INSULIN RECEPTOR SUBSTRATE#0.9297;ALDOSTERONE#0.9296;OSTEOBLAST DIFFERENTIATION#0.9295;ONCOGENESIS#0.9287;SPECIFICITY PROTEIN 1#0.9286;EMBRYONIC KIDNEY#0.9284;ANTERIOR CINGULATE CORTEX#0.9273;CISPLATIN#0.9262;BROWN ADIPOSE TISSUE#0.9257;EMBRYONIC STEM CELL#0.9254;CELL MEMBRANE#0.9254;ESTROGENS#0.9248;STAUROSPORINE#0.9247;TUMOR TISSUES#0.9240;SUCROSE PREFERENCE TEST#0.9240;MRNA TRANSCRIPTION#0.9239;NEUROTOXIC#0.9237;GLYCOLYSIS#0.9228;CYTOCHROME P450#0.9226;SMC PROLIFERATION#0.9226;PHOSPHATASE AND TENSIN HOMOLOG#0.9219;EPITHELIAL MESENCHYMAL TRANSITION#0.9212;ACINAR CELL#0.9209;IMPAIRED MEMORY#0.9206;PERTUSSIS#0.9206;ACTIVATION OF NF-KAPPAB#0.9204;COLONY-STIMULATING FACTOR#0.9194;GASTROINTESTINAL TRACT#0.9194;MAPK SIGNALLING#0.9191;ENZYME ACTIVITY#0.9187;CAMP FORMATION#0.9187;AMNION#0.9186;CHRONIC CONSTRICTION INJURY#0.9169;CORTICAL CELL#0.9165;GRANULOCYTE#0.9164;TERMINAL DIFFERENTIATION#0.9143;PROTEIN TYROSINE PHOSPHATASE#0.9140;PROPRANOLOL#0.9137;DNA FRAGMENTATION#0.9135;POTASSIUM CHANNEL#0.9133;VIRAL GENOME#0.9133;HUMAN BRONCHIAL EPITHELIAL#0.9130;METHYL CPG BINDING#0.9128;THALAMUS#0.9128;ENDOTHELIUM#0.9120;THYMOCYTE#0.9118;HYPERACTIVITY#0.9117;OVULATION#0.9112;OLIGODENDROCYTE DIFFERENTIATION#0.9109;ADENOSINE TRIPHOSPHATE#0.9106;MAPK ERK KINASE#0.9098;VIRION#0.9092;PYRUVATE#0.9091;AUTOIMMUNE DISEASE#0.9091;PODOCYTE#0.9089;SPINAL CORD INJURY#0.9085;POLY ADP RIBOSE#0.9083;FATTY ACID OXIDATION#0.9073;TYPE 2 DIABETES MELLITUS#0.9073;2 DIABETES MELLITUS#0.9073;GESTATION#0.9073;DOXORUBICIN#0.9071;MENTAL RETARDATION#0.9071;NUCLEAR LOCALIZATION SIGNAL#0.9070;CONSTRICTION#0.9066;RESPIRATION#0.9058;NF KAPPAB BINDING#0.9057;STREPTOZOTOCIN#0.9051;SQUAMOUS CELL CARCINOMA#0.9050;HYPOTHYROIDISM#0.9049;PROTEIN TYROSINE KINASE#0.9041;DOXYCYCLINE#0.9038;SPHINGOSINE 1 PHOSPHATE#0.9015;GUANINE#0.9010;HUMAN EMBRYONIC KIDNEY#0.8999;WHITE ADIPOSE TISSUE#0.8998;NUCLEOSOME#0.8997;LIPOLYSIS#0.8996;DUAL LUCIFERASE REPORTER#0.8996;RUBINSTEIN TAYBI SYNDROME#0.8975;VIRAL INFECTION#0.8973;G1 PHASE#0.8970;ROFLUMILAST#0.8969;C TERMINAL DOMAIN#0.8968;LUNG ADENOCARCINOMA#0.8962;PI3K SIGNALING#0.8955;BONE MORPHOGENETIC PROTEIN#0.8950;PKC ACTIVATION#0.8950;OXIDATIVE PHOSPHORYLATION#0.8943;SCHAFFER COLLATERAL#0.8942;RIBOSE#0.8932;HEPATOCYTE NUCLEAR FACTOR#0.8930;D-ASPARTIC ACID#0.8926;CERVICAL#0.8926;RYANODINE RECEPTOR#0.8925;ADENYLYL CYCLASE ACTIVITY#0.8925;FOCAL ADHESION#0.8922;LIVER DISEASE#0.8920;CAMP MEDIATED SIGNALING#0.8913;ANXIETY DISORDER#0.8913;GLUTAMIC ACID#0.8908;NEURON SURVIVAL#0.8907;QUERCETIN#0.8906;ESOPHAGEAL CANCER#0.8906;KIDNEY DISEASE#0.8898;NEUROENDOCRINE CELL#0.8893;NEPHROPATHY#0.8886;COLITIS#0.8882;CELL DIVISION#0.8877;BRAIN ISCHEMIA#0.8876;FOCAL ADHESION KINASE#0.8873;RECEPTOR BINDING#0.8873;TROPICAL SPASTIC PARAPARESIS#0.8873;CELL NUCLEUS#0.8867;GABA A RECEPTOR#0.8862;HEROIN#0.8861;LIVER REGENERATION#0.8856;HIGH FREQUENCY STIMULATION#0.8843;ADENO ASSOCIATED VIRUS#0.8834;RNA BINDING#0.8832;CYTOCHROME C RELEASE#0.8832;RESONANCE ENERGY TRANSFER#0.8832;IMMATURE NEURON#0.8827;AQUAPORIN#0.8823;MELATONIN RECEPTOR#0.8822;BDNF SIGNALLING PATHWAY#0.8818;HABITUATION#0.8811;ATHEROSCLEROTIC#0.8807;SPHINGOSINE#0.8802;OSTEOPOROSIS#0.8800;FATTY LIVER#0.8799;CAMP BINDING#0.8798;PROTEIN KINASE D#0.8791;IONOPHORE#0.8790;LUNG FIBROBLASTS#0.8779;INHIBITION OF GSK#0.8774;RESPIRATORY CHAIN#0.8772;MELATONIN SYNTHESIS#0.8768;INTERFERON REGULATORY FACTOR#0.8760;THYMIDINE KINASE#0.8758;CELL CYCLE REGULATOR#0.8758;TYROSINE RECEPTOR KINASE#0.8756;INNATE IMMUNE RESPONSE#0.8751;DNA DAMAGE RESPONSE#0.8739;LOW DENSITY LIPOPROTEIN#0.8732;EDEMA#0.8731;CEREBELLAR GRANULE NEURON#0.8728;CEREBRAL INFARCTION#0.8720;DESIPRAMINE#0.8708;INHIBITION OF PHOSPHORYLATION#0.8706;ARSENITE#0.8704;RESPONSE TO GLUCAGON#0.8704;HEMORRHAGE#0.8703;5-HT RECEPTOR#0.8699;TRANSLATION INITIATION#0.8681;DEPRESSIVE SYMPTOMS#0.8673;MINERALIZATION#0.8671;SOLUBLE ADENYLYL CYCLASE#0.8670;LIGAND BINDING DOMAIN#0.8657;MTDNA#0.8655;T- PA#0.8654;OPTIC NERVE#0.8654;CHANNEL ACTIVITY#0.8648;3-ISOBUTYL-1-METHYLXANTHINE#0.8638;SYNAPTIC FACILITATION#0.8627;INHIBIN#0.8625;DRUG RESISTANCE#0.8622;NUCLEIC ACID#0.8614;RECEPTOR ACTIVITY#0.8598;BETA ADRENOCEPTOR#0.8596;TUMOUR NECROSIS FACTOR#0.8594;INFLAMMATORY CELL#0.8585;BLOOD BRAIN BARRIER#0.8584;N ACETYLTRANSFERASE#0.8573;SILENT INFORMATION REGULATOR#0.8569;CALCIUM MOBILIZATION#0.8567;INTRACELLULAR LOCALIZATION#0.8560;MYOCYTE ENHANCER FACTOR#0.8560;HEMATOPOIETIC STEM CELL#0.8559;COMMON CAROTID ARTERY#0.8558;REGULATORY T CELL#0.8555;DONEPEZIL#0.8547;EPINEPHRINE#0.8543;MYELINATION#0.8540;DIABETIC NEPHROPATHY#0.8540;VASCULAR ENDOTHELIUM#0.8538;SEQUENCE SPECIFIC DNA BINDING#0.8531;GASTRIC ADENOCARCINOMA#0.8530;BONE MARROW CELLS#0.8523;DEMETHYLATION#0.8511;ACTIVE CASPASE 3#0.8501;2'-DEOXYURIDINE#0.8491;ELECTRON TRANSPORT#0.8491;LIPOGENESIS#0.8486;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8480;ENDOPLASMIC RETICULUM STRESS#0.8479;ACTINOMYCIN D#0.8468;M PHASE#0.8467;AMNESIA#0.8463;PROTEIN KINASE ACTIVITY#0.8460;MENTAL DISORDER#0.8458;UNFOLDED PROTEIN RESPONSE#0.8454;NEUROTRANSMITTER RELEASE#0.8448;EUKARYOTIC INITIATION FACTOR#0.8447;MITOCHONDRIAL TRANSCRIPTION#0.8444;BASAL GANGLIA#0.8444;SUMOYLATION#0.8430;VASCULAR CELL#0.8427;YES ASSOCIATED PROTEIN#0.8426;GAP JUNCTION#0.8424;XANTHINE OXIDASE#0.8420;CHEMOKINE RECEPTOR#0.8419;ANESTHETIC#0.8416;TAMOXIFEN#0.8415;CYCLIC GUANOSINE MONOPHOSPHATE#0.8414;BLOOD GLUCOSE LEVEL#0.8410;PROTEIN DEGRADATION#0.8410;BONE CANCER#0.8407;SOLUBLE GUANYLYL CYCLASE#0.8407;CONDITIONED TASTE AVERSION#0.8400;MIXED LINEAGE LEUKEMIA#0.8393;CATALYTIC ACTIVITY#0.8389;HIPPOCAMPAL REGION#0.8376;CYCLIC NUCLEOTIDE PHOSPHODIESTERASE#0.8375;CHROMATIN MODIFICATION#0.8366;ANTI APOPTOSIS#0.8366;RESPONSE TO GLUCOSE#0.8358;NEUROBLAST#0.8357;SOCIAL DEFEAT STRESS#0.8357;STATUS EPILEPTICUS#0.8355;MODE OF ACTION#0.8353;QUIESCENCE#0.8352;PERIPHERAL NERVE INJURY#0.8350;MORPHOGENESIS#0.8350;ADENYLATE CYCLASE INHIBITOR#0.8347;INNATE IMMUNITY#0.8340;OSTEOBLAST PROLIFERATION#0.8336;HIPPOCAMPAL PROGENITOR CELLS#0.8332;KAPPA OPIOID RECEPTOR#0.8329;MOTOR ACTIVITY#0.8326;TH2 CELL#0.8326;REGULATION OF PKA#0.8321;QUANTITATIVE REVERSE TRANSCRIPTION#0.8316;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8310;FATTY ACID SYNTHASE#0.8306;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.8306;STEM CELL FACTOR#0.8304;AP-1 COMPLEX#0.8276;TISSUE DAMAGE#0.8275;PKCDELTA#0.8264;CONNECTIVE TISSUE#0.8262;NEUROTRANSMITTER RECEPTOR#0.8259;SYSTEM DEVELOPMENT#0.8232;RETINOBLASTOMA#0.8226;PROVIRUS#0.8225;GLYCOSYLATION#0.8223;HISTONE H4 ACETYLATION#0.8221;CHROMAFFIN CELL#0.8220;MU OPIOID RECEPTOR#0.8217;LUNG DISEASE#0.8214;METHIONINE#0.8213;MOUSE EMBRYONIC STEM#0.8209;OSTEOGENESIS#0.8198;CELL BODY#0.8192;T CELL DEVELOPMENT#0.8186;THYROTROPIN RELEASING HORMONE#0.8185;HEART DISEASE#0.8183;ADENINE#0.8180;RECEPTOR LIGAND#0.8178;REGULATION OF CELL PROLIFERATION#0.8178;ROSIGLITAZONE#0.8176;TERATOCARCINOMA#0.8157;CONSTITUTIVELY ACTIVE MUTANT#0.8143;BETA-ESTRADIOL#0.8140;PROSTACYCLIN#0.8137;MELANOMA CELL LINES#0.8137;NEUROTROPHIN RECEPTOR#0.8136;GENOTOXIC#0.8136;TINNITUS#0.8133;MAP KINASE KINASE#0.8123;HUMAN AIRWAY EPITHELIAL#0.8120;ENHANCEOSOME#0.8111;SMALL AIRWAY EPITHELIAL#0.8098;ENDOMETRIOSIS#0.8091;NUCLEAR HORMONE RECEPTOR#0.8088;ADRENAL GLAND#0.8085;MYOCARDIAL INFARCTION#0.8082;CHRONIC UNPREDICTABLE STRESS#0.8079;VEGF SIGNALING#0.8071;CITALOPRAM#0.8069;CELLULAR METABOLISM#0.8068;TROPHOBLAST CELL#0.8067;SILDENAFIL#0.8064;BONE MARROW STROMAL#0.8059;SALICYLATE#0.8058;SMOOTH MUSCLE CELL PROLIFERATION#0.8058;MUSCLE CELL PROLIFERATION#0.8055;MYOGENESIS#0.8054;INDOMETHACIN#0.8051;OLFACTORY LEARNING#0.8045;CAMP-MEDIATED SIGNAL TRANSDUCTION#0.8039;MITOPHAGY#0.8032;HISTONE H3 ACETYLATION#0.8028;PYRAMIDAL CELL#0.8027;PEPTIDE HORMONE#0.8024;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8016;HIGH MOBILITY GROUP#0.8007;NEUROFILAMENT#0.8006;PHOSPHOLIPASE A2#0.8000;ACTIVATION OF NMDA RECEPTOR#0.7998;HEPATOCYTE GROWTH FACTOR#0.7995;LH RECEPTOR#0.7978;VARICELLA ZOSTER VIRUS#0.7973;INTRACELLULAR SIGNAL TRANSDUCTION PATHWAY#0.7973;HYPERGLYCEMIC#0.7969;DNA POLYMERASE BETA#0.7957;NIMODIPINE#0.7952;SPATIAL WORKING MEMORY#0.7950;ALL TRANS RETINOIC ACID#0.7944;NERVOUS SYSTEM DEVELOPMENT#0.7943;NEURITE EXTENSION#0.7932;LYMPHOID CELL#0.7929;ADENYLYL CYCLASE INHIBITOR#0.7924;PROTEIN KINASE A ACTIVATION#0.7919;NIFEDIPINE#0.7916;IL-6 SECRETION#0.7911;SUBSTANCE P#0.7903;TRANSCRIPTION FACTOR ACTIVITY#0.7894;LYMPHOCYTE PROLIFERATION#0.7893;BREAST CANCER PATIENTS#0.7892;BETA2 ADRENERGIC RECEPTOR#0.7885;CORTICOTROPHIN#0.7881;PERIPHERAL NERVOUS SYSTEM#0.7878;THYROID CARCINOMA#0.7874;VALPROIC ACID#0.7868;ESTROGEN RECEPTOR ALPHA#0.7865;GLYCINE#0.7865;IL-2 PRODUCTION#0.7863;NEURAL STEM PROGENITOR#0.7861;MAP KINASE CASCADE#0.7856;INNERVATION#0.7847;MAST CELL#0.7846;RNA BINDING PROTEIN#0.7845;PROTEIN DNA COMPLEX#0.7827;VITAMIN E#0.7824;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7818;OVARIES#0.7817;CLASSICAL CONDITIONING#0.7814;MITOSIS#0.7809;MOLECULAR FUNCTION#0.7807;EMBRYONAL CARCINOMA#0.7806;CARDIOMYOPATHY#0.7806;NEUROINFLAMMATORY RESPONSE#0.7803;CORONARY ARTERY#0.7801;DEPRESSANT#0.7799;AIRWAY SMOOTH MUSCLE#0.7796;LIRAGLUTIDE#0.7792;ATAXIA TELANGIECTASIA#0.7789;EXOCYTOSIS#0.7783;ARYL HYDROCARBON RECEPTOR#0.7779;CHRONIC NICOTINE EXPOSURE#0.7777;PROTEIN KINASE ACTIVATION#0.7777;NOCICEPTION#0.7775;PROXIMAL TUBULAR CELL#0.7771;NICOTINAMIDE#0.7766;ADRENOCORTICOTROPIC HORMONE#0.7765;MITOCHONDRIAL DNA#0.7762;VASCULAR DISEASE#0.7758;CANCER STEM CELL#0.7758;ENDOTHELIAL NITRIC OXIDE#0.7756;PHOSPHOLIPASE A#0.7749;BASE EXCISION REPAIR#0.7748;FATTY LIVER DISEASE#0.7748;POST SYNAPTIC DENSITY#0.7747;BIOLUMINESCENCE#0.7740;PROXIMAL TUBULE CELL#0.7740;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7739;EPITHELIAL TO MESENCHYMAL#0.7737;OPIATE DEPENDENCE#0.7734;MARROW STROMAL CELLS#0.7728;MYOCARDIUM#0.7727;ACUTE LUNG INJURY#0.7719;PULMONARY HYPERTENSION#0.7719;HEALTHY CONTROL SUBJECTS#0.7718;NICOTINE DEPENDENCE#0.7716;NOXIOUS#0.7708;ANTIOXIDANT ACTIVITY#0.7700;ACTIN CYTOSKELETON#0.7699;BINDING PROTEIN 3#0.7694;HYPOGLYCEMIA#0.7694;DIET INDUCED OBESITY#0.7694;CLENBUTEROL#0.7692;EMODIN#0.7690;ASPIRIN#0.7686;SEROTONERGIC NEURON#0.7685;GINKGO BILOBA#0.7678;LOCOMOTION#0.7671;ANCHORING#0.7659;RENAL CELL CARCINOMA#0.7650;XANTHINE#0.7639;DNA BENDING#0.7634;LUNG DEVELOPMENT#0.7632;AROMATASE ACTIVITY#0.7629;REGULATION OF CELLULAR#0.7625;PROTEASOME PATHWAY#0.7624;ADRENAL MEDULLA#0.7624;SUBMANDIBULAR GLAND#0.7618;FRUCTOSE#0.7613;SERUM ALBUMIN#0.7607;NUCLEOTIDE EXCHANGE FACTOR#0.7604;INSULINOMA#0.7593;CHOLINERGIC NEURON#0.7591;HISTIDINE#0.7590;LIPID RAFT#0.7589;GROWTH FACTOR BINDING#0.7589;ANTISENSE RNA#0.7587;ROS GENERATION#0.7587;AXON REGENERATION#0.7584;PLURIPOTENT STEM CELL#0.7577;CORPUS LUTEUM#0.7565;DUCT CELL#0.7564;PROTEIN INTERACTION NETWORK#0.7561;L-ARGININE#0.7555;5-AZA-2'-DEOXYCYTIDINE#0.7553;NEUROTOXIN#0.7553;3',5'-CYCLIC AMP#0.7550;BENZYL ALCOHOL#0.7550;2'-DEOXYCYTIDINE#0.7549;PARS TUBERALIS#0.7547;VASCULAR DEMENTIA#0.7542;ACETYL COA CARBOXYLASE#0.7528;RNA SYNTHESIS#0.7527;CELLULAR LOCALIZATION#0.7521;RESPONSE TO FORSKOLIN#0.7515;OLANZAPINE#0.7512;WNT SIGNALING PATHWAY#0.7500;CYSTIC FIBROSIS#0.7498;VIRAL DNA REPLICATION#0.7491;MUCOEPIDERMOID CARCINOMA#0.7490;PALMITATE#0.7478;MESENCHYMAL CELL#0.7478;PAROXETINE#0.7474;SITAGLIPTIN#0.7466;GLOBAL CEREBRAL ISCHEMIA#0.7464;NEURITE GROWTH#0.7459;CHONDROGENESIS#0.7444;OBJECT RECOGNITION TASK#0.7433;GLUTAMATERGIC NEURON#0.7430;LIPID HOMEOSTASIS#0.7425;STROMA#0.7408;MACROPHAGE POLARIZATION#0.7407;BONE MARROW STROMAL CELL#0.7404;DOPAMINE D2 RECEPTOR#0.7403;GLCNAC#0.7402;NEUROFIBRILLARY TANGLE#0.7400;GLUCOSE TRANSPORT#0.7395;CYTOCHROME C OXIDASE#0.7393;DNA METHYLTRANSFERASE#0.7390;HEAT SHOCK FACTOR#0.7381;COLON CARCINOMA#0.7379;LUNG CARCINOMA#0.7372;PKCEPSILON#0.7369;ADENYLATE CYCLASE ACTIVITY#0.7363;FEEDING BEHAVIOR#0.7357;CYCLOSPORINE#0.7351;OF DIABETIC RATS#0.7350;HORMONE SYNTHESIS#0.7344;C FIBER#0.7332;RETINAL DEGENERATION#0.7332;CERVICAL CANCER#0.7329;AMITRIPTYLINE#0.7318;GINSENG#0.7312;PROGESTERONE SYNTHESIS#0.7309;ISOQUINOLINE#0.7305;CELL MOTILITY#0.7304;HOMOLOGOUS RECOMBINATION#0.7300;TF BINDING#0.7296;NECROTIC#0.7294;WEIGHT GAIN#0.7285;SYNAPTIC VESICLE#0.7276;BERBERINE#0.7275;MALIGNANT GLIOMA#0.7262;PROTEIN COMPLEX FORMATION#0.7262;NEUROPATHY#0.7250;SMOOTH MUSCLE ACTIN#0.7247;HISTONE DEACETYLATION#0.7246;ESTROGEN RESPONSE ELEMENT#0.7241;PROTEIN KINASE C ACTIVATION#0.7240;GONAD#0.7229;OPERANT CONDITIONING#0.7229;BLOOD VESSEL#0.7227;INSULIN SIGNALING PATHWAY#0.7225;CARRIE#0.7219;5'-ADENOSINE MONOPHOSPHATE#0.7217;UBIQUITIN PROTEASOME PATHWAY#0.7215;CATABOLISM#0.7210;ATAXIA TELANGIECTASIA MUTATED#0.7202;ACTIVATION OF MAP KINASE#0.7188;CATION CHANNEL#0.7187;CELL FUSION#0.7185;ARIPIPRAZOLE#0.7183;DEACETYLASE ACTIVITY#0.7183;GLUCOSE INTOLERANCE#0.7177;ADENYLATE CYCLASE ACTIVATOR#0.7176;INDUCED PLURIPOTENT STEM CELL#0.7168;LOSARTAN#0.7157;CAROTID ARTERY LIGATION#0.7157;SODIUM NITROPRUSSIDE#0.7154;FARNESOID X RECEPTOR#0.7150;RNA SPLICING#0.7147;WEIGHT LOSS#0.7139;INHIBITION OF CELL PROLIFERATION#0.7128;VALPROATE#0.7127;GENE EXPRESSION OMNIBUS#0.7123;DIFFERENTIAL GENE EXPRESSION#0.7112;LYMPHOCYTE ACTIVATION#0.7112;CLOZAPINE#0.7110;MEK ACTIVITY#0.7102;CASPASE ACTIVATION#0.7100;SOCIAL BEHAVIOR#0.7084;COENZYME A#0.7077;TRANSCRIPTIONAL TRANSACTIVATION#0.7070;TRANSCRIPTION FACTOR COMPLEX#0.7065;ERYTHROID CELL#0.7063;CASEIN KINASE 2#0.7059;ETOPOSIDE#0.7059;NORMAL CONTROL GROUP#0.7058;DERMAL FIBROBLAST#0.7049;MYOSIN HEAVY CHAIN#0.7042;LUTEINIZATION#0.7033;SELECTIN#0.7027;ARGININE VASOPRESSIN#0.7026;MACROPHAGE DIFFERENTIATION#0.7024;ENDOCYTOSIS#0.7023;VIRULENCE#0.7022;CHOLERA#0.7021;EXENATIDE#0.7011;ICI 182,780#0.6994;MIGRAINE#0.6990;ALCOHOL DEPENDENCE#0.6985;BERAPROST#0.6974;CELLULAR COMPONENT#0.6953;NONALCOHOLIC FATTY LIVER DISEASE#0.6950;RETINAL PIGMENT EPITHELIUM#0.6949;NUCLEUS ACCUMBENS CORE#0.6948;TH17 CELL#0.6944;MONOCYTE CHEMOTACTIC PROTEIN#0.6942;TEMPORAL LOBE#0.6936;THYROID CANCER#0.6935;CARDIOVASCULAR SYSTEM#0.6934;CYTOKINE SECRETION#0.6930;RECEPTOR COMPLEX#0.6924;DIPEPTIDYL PEPTIDASE#0.6921;NITROPRUSSIDE#0.6919;DENTAL PULP#0.6898;PHOTORECEPTOR CELL#0.6892;PREINITIATION COMPLEX#0.6886;POSTNATAL DAY 7#0.6877;BASAL SYNAPTIC TRANSMISSION#0.6875;DIGESTION#0.6870;SEPTUM#0.6867;CARNITINE#0.6866;CELL PENETRATING PEPTIDE#0.6855;DELTA OPIOID RECEPTOR#0.6827;T CELL PROLIFERATION#0.6825;MITOCHONDRIAL FISSION#0.6822;RESPONSE TO HYPOXIA#0.6820;MAGNETIC RESONANCE IMAGING#0.6820;INFLAMMATORY BOWEL DISEASE#0.6816;SMALL INTESTINE#0.6813;FIBROBLAST PROLIFERATION#0.6810;SPERMATOCYTES#0.6804;ANCHORAGE INDEPENDENT GROWTH#0.6804;STEROID SYNTHESIS#0.6803;RESPONSE TO CYCLIC AMP#0.6797;DYNEIN LIGHT CHAIN#0.6795;YOHIMBINE#0.6789;ACETYLCHOLINESTERASE ACTIVITY#0.6786;PROTEIN SECRETION#0.6781;SEDATION#0.6775;DOUBLE TRANSGENIC MICE#0.6764;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6759;LUPUS ERYTHEMATOSUS#0.6757;ORGANELLE#0.6756;AMYOTROPHIC LATERAL SCLEROSIS#0.6756;LATERAL SCLEROSIS#0.6756;PREPULSE INHIBITION#0.6749;POST-TRAUMATIC STRESS DISORDER#0.6748;GLUTAMATERGIC SYNAPSE#0.6747;MITOCHONDRIAL ELECTRON TRANSPORT#0.6741;PROTEIN PHOSPHATASE INHIBITOR#0.6740;INGENUITY PATHWAY ANALYSIS#0.6727;PREGNENOLONE#0.6725;L-CYSTEINE#0.6697;COLLAGENASE#0.6697;OVARIAN FOLLICLE#0.6696;REGULATION OF CELL CYCLE#0.6694;RETINOID X RECEPTOR#0.6691;NEUROMUSCULAR JUNCTION#0.6685;ZINC FINGER PROTEIN#0.6683;CLEAR CELL CARCINOMA#0.6682;CELL MATURATION#0.6681;CHANNEL INHIBITOR#0.6681;INTERSTITIAL CELL#0.6680;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6673;RESPONSE TO GM-CSF#0.6666;ADVANCED GLYCATION END#0.6665;CAROTID ARTERY OCCLUSION#0.6662;DISEASE FREE SURVIVAL#0.6652;PROPIDIUM#0.6651;DRUG DEPENDENCE#0.6650;CHORIOCARCINOMA#0.6646;ISOPRENALINE#0.6644;MACROPHAGE MIGRATION#0.6642;DYNEIN#0.6633;CDK INHIBITOR#0.6627;NFAT BINDING#0.6626;STEROID BIOSYNTHESIS#0.6611;IL-1RA#0.6602;DIAZEPAM#0.6602;NUCLEAR EXPORT SIGNAL#0.6588;FLUORESCEIN#0.6586;RIBOSOME#0.6582;SKIN CANCER#0.6580;MUSCLE CONTRACTION#0.6577;RAPID EYE MOVEMENT#0.6570;OSTEOARTHRITIS#0.6552;NUCLEAR LAYER#0.6548;LATERAL VENTRICLE#0.6537;RESPONSE TO LPS#0.6536;VIRAL LATENCY#0.6532;TUBE FORMATION#0.6509;JUN PHOSPHORYLATION#0.6506;PITUITARY ADENOMA#0.6493;SKIN FIBROBLASTS#0.6493;PUBERTY#0.6489;HUMAN ARTICULAR CHONDROCYTES#0.6482;GABA B RECEPTOR#0.6478;REGULATORY FACTOR X#0.6472;TRYPTOPHAN#0.6467;NULL CELL#0.6463;ADENOSINE DEAMINASE#0.6451;RESPONSE TO EXERCISE#0.6450;THROMBIN RECEPTOR#0.6449;ACTIVATION OF GLUCONEOGENESIS#0.6447;LYMPHOBLAST#0.6444;DIURNAL#0.6441;T CELL FACTOR#0.6439;PENICILLAMINE#0.6435;FEMUR#0.6434;GABAERGIC NEURON#0.6429;HETEROTRIMERIC G-PROTEIN#0.6424;PALATE DEVELOPMENT#0.6421;CHEMOTAXIS#0.6416;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6410;TOLUENE#0.6409;INTERLEUKIN 2 RECEPTOR#0.6404;BROWN ADIPOCYTE DIFFERENTIATION#0.6399;PILOCARPINE#0.6398;CYTOKINE RECEPTOR#0.6397;CELL CYCLE CONTROL#0.6394;MACROPHAGE INFLAMMATORY PROTEIN#0.6392;SPATIAL REFERENCE MEMORY#0.6391;PULMONARY FIBROSIS#0.6388;NEURAL CREST#0.6378;BASAL CELL#0.6378;VOLTAGE-SENSITIVE CALCIUM CHANNEL#0.6375;COFFIN-LOWRY SYNDROME#0.6364;RESPONSE TO NICOTINE#0.6364;MOLAR#0.6347;CHRONIC NEUROPATHIC PAIN#0.6340;ENHANCEMENT OF MEMORY#0.6336;BRAIN DISEASE#0.6329;MEMANTINE#0.6328;GINSENOSIDE RG1#0.6322;REGULATION OF SYNAPTIC PLASTICITY#0.6314;MOTOR LEARNING#0.6307;MYOBLAST PROLIFERATION#0.6307;NUTRIENT SENSING#0.6301;COCHLEAR NUCLEUS#0.6290;GLUCOSAMINE#0.6274;SHAM OPERATION GROUP#0.6273;NEURON DIFFERENTIATION#0.6272;IFN REGULATORY FACTOR#0.6270;ATORVASTATIN#0.6266;JNK SIGNALING PATHWAY#0.6260;TETRODOTOXIN#0.6260;DNA REPAIR ENZYME#0.6256;MULTIPLE MYELOMA#0.6249;RETT SYNDROME#0.6246;SEROTONIN RECEPTOR#0.6240;DOWN SYNDROME#0.6232;SMALL HETERODIMER PARTNER#0.6228;GUANYLATE CYCLASE#0.6227;TO THE PROGRESSION#0.6226;TISSUE GROWTH FACTOR#0.6225;NEPHRON#0.6220;EICOSAPENTAENOIC ACID#0.6219;MACROPHAGE ACTIVATION#0.6215;OBJECT RECOGNITION MEMORY#0.6213;LIPID DROPLET#0.6211;MAMMARY EPITHELIAL CELL#0.6211;HYPOXIA RESPONSE ELEMENT#0.6210;IMMUNOSUPPRESSANT#0.6208;PHENYLEPHRINE#0.6207;DDAVP#0.6206;MESOTHELIAL CELL#0.6204;SMOOTH MUSCLE CELL MIGRATION#0.6203;TUBULAR EPITHELIAL CELL#0.6203;MUSCLE CELL MIGRATION#0.6201;ERYTHROLEUKEMIA#0.6199;NUCLEOTIDE BINDING#0.6195;NATURAL KILLER CELL#0.6182;PAPILLOMA#0.6182;EXTRASKELETAL MYXOID CHONDROSARCOMA#0.6176;PACAP RECEPTOR#0.6175;TACROLIMUS#0.6174;OLEIC ACID#0.6171;HISTONE DEMETHYLASE#0.6158;VACCINIA#0.6158;PARTURITION#0.6157;MYXOID CHONDROSARCOMA#0.6157;NEUROBLAST DIFFERENTIATION#0.6155;OPIOID PEPTIDE#0.6151;NUCLEAR TRANSPORT#0.6150;HYPERACTIVE#0.6149;LACTATION#0.6135;RESPONSE TO LEPTIN#0.6135;L-GLUTAMATE#0.6133;LIMBIC SYSTEM#0.6127;PROTEIN TRANSLATION#0.6126;GENE REGULATORY NETWORK#0.6122;SORAFENIB#0.6116;VASODILATOR#0.6104;CONJUGATION#0.6102;POLYCYSTIC KIDNEY DISEASE#0.6091;MITOCHONDRIAL GENE EXPRESSION#0.6083;PROTEIN TRANSDUCTION DOMAIN#0.6081;AUTISM SPECTRUM DISORDER#0.6077;FEED FORWARD LOOP#0.6070;SARCOPLASMIC RETICULUM#0.6062;SODIUM CHANNEL#0.6059;TCR COMPLEX#0.6045;DEDIFFERENTIATION#0.6044;SPARED NERVE INJURY#0.6042;MATERNAL BEHAVIOR#0.6041;CHRONIC RESTRAINT STRESS#0.6023;SENESCENCE ACCELERATED MOUSE#0.6018;CD8+ T CELL#0.6014;REGULATION OF AUTOPHAGY#0.6010;RESPONSE TO MORPHINE#0.6006;DETOXIFICATION#0.6005;NEUROLOGICAL DEFICIT SCORE#0.6002
1386	IFN-BETA#1.0403;ACTIVATING TRANSCRIPTION FACTOR#1.0389;CRE BINDING#1.0345;CAMP RESPONSE ELEMENT BINDING#1.0281;LUNG CANCER#1.0271;DOMINANT NEGATIVE MUTANT#1.0232;TRANSACTIVATION#1.0197;TRANSCRIPTION FACTOR#1.0171;CAMP-RESPONSIVE ELEMENT BINDING#1.0141;LEUCINE#1.0100;KINASE ACTIVITY#1.0044;DNA BINDING#1.0043;CYCLIC AMP#1.0042;ACTIVATOR PROTEIN 1#1.0037;CANCER CELL#1.0035;CAMP RESPONSE ELEMENT#1.0033;MAP KINASE#1.0008;CHONDROCYTE#1.0000;TRANSFORMING GROWTH FACTOR#0.9986;CREB BINDING#0.9986;ELECTROPHORETIC MOBILITY SHIFT#0.9958;BREAST CANCER#0.9922;ENHANCER BINDING#0.9877;EPITHELIAL CELL#0.9874;CELL PROLIFERATION#0.9855;GROWTH FACTOR#0.9844;ENDOTHELIAL CELL#0.9836;APOPTOSIS#0.9823;T CELL#0.9822;CELL DEATH#0.9817;ENHANCER BINDING PROTEIN#0.9811;TUMOR NECROSIS FACTOR#0.9810;CELL CYCLE#0.9807;PROTEIN KINASE C#0.9775;TRANSFORMING GROWTH FACTOR BETA#0.9747;MITOGEN ACTIVATED PROTEIN#0.9745;HISTONE DEACETYLASE#0.9742;PROTEIN KINASE#0.9733;SIGNALING PATHWAY#0.9722;MACROPHAGE#0.9704;SIGNAL TRANSDUCTION#0.9695;PROTEIN KINASE A#0.9683;GENE EXPRESSION#0.9672;CELL GROWTH#0.9665;KINASE INHIBITOR#0.9632;SIGNAL TRANSDUCER#0.9506;TUMOR CELLS#0.9495;JUN PHOSPHORYLATION#0.9481;NITRIC OXIDE#0.9466;APOPTOTIC#0.9447;SIGNALING CASCADE#0.9443;FACTOR I#0.9442;TRANSCRIPTIONAL CONTROL#0.9283;PROTEIN PROTEIN INTERACTION#0.9270;SELECTIN#0.9245;POLYMERASE CHAIN REACTION#0.9229;IFN-GAMMA#0.9223;BETA CELL#0.9215;MAPK SIGNALING#0.9210;SIGNALLING PATHWAY#0.9200;REACTIVE OXYGEN SPECIES#0.9142;ONCOGENIC#0.9136;CYCLIC ADENOSINE MONOPHOSPHATE#0.9092;ADENOSINE MONOPHOSPHATE#0.9072;B CELL#0.9048;NERVOUS SYSTEM#0.9048;PRO-INFLAMMATORY#0.9037;TRANSCRIPTION FACTOR BINDING#0.8966;MONOCYTE#0.8961;RETINOIC ACID#0.8945;IMMUNE RESPONSE#0.8918;ADENOSINE#0.8904;NITRIC OXIDE SYNTHASE#0.8709;ISCHEMIA#0.8669;GLUTATHIONE#0.8651;PANCREATIC CANCER#0.8635;INFLAMMATORY RESPONSE#0.8628;SKELETAL MUSCLE#0.8587;DRUG RESISTANCE#0.8584;ENHANCEOSOME#0.8519;PROSTATE CANCER#0.8516;CELL MIGRATION#0.8510;BREAST CANCER CELL#0.8495;CYTOPLASM#0.8480;T-CELL LEUKEMIA#0.8422;ONCOGENESIS#0.8371;EPIDERMAL GROWTH FACTOR#0.8337;TOLL LIKE RECEPTOR#0.8295;TUMOR SUPPRESSOR#0.8275;DENDRITIC CELL#0.8208;MAPK ACTIVATION#0.8207;INTERFERON REGULATORY FACTOR#0.8162;CENTRAL NERVOUS SYSTEM#0.8156;CELL ADHESION#0.8143;MAPK CASCADE#0.8105;ADIPOSE TISSUE#0.8095;JNK SIGNALING PATHWAY#0.8037;HISTONE ACETYLATION#0.8020;MUTAGENESIS#0.8008;AP-1 COMPLEX#0.8002;PEROXISOME#0.7963;HYPOXIA#0.7922;DNA REPAIR#0.7917;AMINO ACID RESPONSE#0.7899;HISTONE ACETYLTRANSFERASE#0.7897;RESPONSE TO STRESS#0.7885;PROTEASOME#0.7868;FORSKOLIN#0.7856;UBIQUITIN#0.7855;DNA DAMAGE RESPONSE#0.7853;PROTEIN COMPLEX#0.7823;LONG TERM MEMORY#0.7759;INTESTINAL EPITHELIAL CELL#0.7707;PROTEIN SYNTHESIS#0.7643;ADIPOCYTE#0.7620;STEM CELL#0.7616;BONE MARROW#0.7548;GROWTH FACTOR RECEPTOR#0.7540;MUSCLE CELL#0.7528;T LYMPHOCYTE#0.7524;DNASE I#0.7506;HIGH MOBILITY GROUP#0.7441;S PHASE#0.7423;CYTOCHROME C#0.7416;MYOMETRIUM#0.7336;EXTRACELLULAR MATRIX#0.7313;DENTATE GYRUS#0.7253;T- PA#0.7228;BINDING PROTEIN 1#0.7216;OSTEOBLAST#0.7131;IFN REGULATORY FACTOR#0.7120;SIGNALING MOLECULE#0.7111;JUN DIMERIZATION PROTEIN#0.7104;SMOOTH MUSCLE CELL#0.7089;SMOOTH MUSCLE#0.7074;LEUKOCYTE#0.7035;COLLAGENASE#0.7025;QUANTITATIVE REAL TIME#0.6986;CELL DIFFERENTIATION#0.6979;CELLULAR TRANSCRIPTION#0.6872;MAP KINASE ACTIVITY#0.6857;GLIAL CELL#0.6837;HEPATOCELLULAR CARCINOMA#0.6813;CHLORAMPHENICOL#0.6810;PROTEIN BINDING#0.6754;ACTIVATION OF NF-KAPPAB#0.6746;GM-CSF#0.6736;BETA-2#0.6691;CYTOKINE PRODUCTION#0.6624;NF-KAPPAB ACTIVATION#0.6601;DNASE#0.6585;HEPATITIS B VIRUS#0.6577;HEPATITIS B#0.6562;P38 MAPK SIGNALING#0.6555;ENDOTHELIAL GROWTH FACTOR#0.6548;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6548;MITOCHONDRIA#0.6517;RETINOBLASTOMA#0.6474;ACTIVATED T CELL#0.6472;INDUCIBLE NITRIC OXIDE#0.6460;COMPLEX I#0.6456;EPITHELIAL MESENCHYMAL TRANSITION#0.6454;MITOCHONDRIAL MEMBRANE#0.6441;ANGIOGENESIS#0.6298;PROTEIN PHOSPHATASE 2A#0.6274;NERVE GROWTH FACTOR#0.6273;PHOSPHATASE 2A#0.6271;CARDIOMYOCYTE#0.6270;MICROTUBULE#0.6263;REGENERATION#0.6254;PROGENITOR CELL#0.6252;NEURITE#0.6240;BROWN ADIPOSE TISSUE#0.6207;HUMAN UROTHELIAL CELLS#0.6198;CAAT ENHANCER BINDING#0.6137;MECHANISM OF ACTION#0.6113;COLORECTAL CANCER#0.6105;MELANOCYTE#0.6103;MYOCYTES#0.6087;IL-8 PRODUCTION#0.6084;CARDIOMYOCYTE DIFFERENTIATION#0.6065;MOUSE EMBRYONIC FIBROBLAST#0.6061;ACTIVATION OF CREB#0.6029;RESPONSE TO GROWTH FACTOR#0.6011
1387	HISTONE ACETYL TRANSFERASE#1.0479;TRANSCRIPTION COACTIVATOR#1.0439;CREB BINDING#1.0338;HISTONE ACETYLTRANSFERASE ACTIVITY#1.0270;RUBINSTEIN TAYBI SYNDROME#1.0257;ENHANCEOSOME#1.0256;STEROID RECEPTOR COACTIVATOR#1.0254;LONG TERM MEMORY#1.0246;HISTIDINE#1.0241;CELLULAR TRANSCRIPTION#1.0195;CRE BINDING#1.0194;ACETYLTRANSFERASE ACTIVITY#1.0151;PROTEIN BINDING#1.0146;HISTONE H3 ACETYLATION#1.0132;IFN-GAMMA#1.0127;C TERMINAL DOMAIN#1.0115;CAMP-RESPONSIVE ELEMENT BINDING#1.0105;HISTONE ACETYLTRANSFERASE#1.0105;ACUTE MYELOID LEUKEMIA#1.0092;IFN-BETA#1.0078;HYPOXIA INDUCIBLE FACTOR#1.0074;MYELOID LEUKEMIA#1.0073;HYPOXIA#1.0053;NUCLEAR HORMONE RECEPTOR#1.0047;B CELL LYMPHOMA#1.0018;ACTIVATION OF CREB#1.0013;NUCLEOSOME#1.0013;ARGININE#1.0009;MIXED LINEAGE LEUKEMIA#0.9966;ENHANCER BINDING#0.9965;PROTEIN ACETYLATION#0.9942;HYPOXIC#0.9932;ENHANCER BINDING PROTEIN#0.9929;BINDING PROTEIN 1#0.9922;PROTEIN COMPLEX#0.9919;HEPATOCYTE NUCLEAR FACTOR#0.9907;RNA INTERFERENCE#0.9901;HISTONE ACETYLATION#0.9900;TRANSACTIVATION#0.9893;SUMOYLATION#0.9882;CAMP RESPONSE ELEMENT BINDING#0.9882;T-CELL LEUKEMIA#0.9881;RETINOIC ACID RECEPTOR#0.9879;GLUCOCORTICOID RECEPTOR#0.9879;COMPLEX I#0.9868;LYSINE#0.9868;PROTEASOME#0.9856;CAMP RESPONSE ELEMENT#0.9854;DNA REPAIR#0.9852;ADENOSINE#0.9849;CHROMATIN MODIFICATION#0.9844;PROTEIN KINASE C#0.9842;SMOOTH MUSCLE#0.9841;MENTAL RETARDATION#0.9834;UBIQUITIN#0.9832;LUNG CANCER#0.9825;CYCLIC AMP#0.9824;CELL DIFFERENTIATION#0.9820;B CELL#0.9818;CYCLIC ADENOSINE MONOPHOSPHATE#0.9815;INTERFERON REGULATORY FACTOR#0.9815;THYROID HORMONE RECEPTOR#0.9811;HISTONE MODIFICATION#0.9811;ADENOSINE MONOPHOSPHATE#0.9798;RETINOIC ACID#0.9796;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9796;LIGAND BINDING DOMAIN#0.9794;SIGNAL TRANSDUCTION#0.9793;PROTEIN PROTEIN INTERACTION#0.9789;CHROMATIN REMODELING#0.9786;MAP KINASE#0.9784;PROTEIN KINASE A#0.9783;S PHASE#0.9782;PROSTATE CANCER#0.9779;HEMATOPOIESIS#0.9774;MUSCLE CELL#0.9764;POST-TRANSLATIONAL MODIFICATION#0.9752;MITOGEN ACTIVATED PROTEIN#0.9749;KINASE INHIBITOR#0.9748;SIGNAL TRANSDUCER#0.9748;HISTONE DEACETYLASE INHIBITOR#0.9747;ESTROGEN RECEPTOR#0.9744;BONE MARROW#0.9739;FOLLICULAR LYMPHOMA#0.9735;CELL DEVELOPMENT#0.9734;TRANSCRIPTION FACTOR BINDING#0.9734;ONCOGENIC#0.9731;DIFFUSE LARGE B-CELL LYMPHOMA#0.9728;APOPTOTIC#0.9727;T CELL#0.9724;DNA BINDING#0.9722;TUMOR SUPPRESSOR#0.9721;CELL DEATH#0.9715;ANDROGEN RECEPTOR#0.9714;HUNTINGTON'S DISEASE#0.9714;TRANSFORMING GROWTH FACTOR#0.9714;TRANSCRIPTIONAL CONTROL#0.9713;INTELLECTUAL DISABILITY#0.9712;PEROXISOME#0.9712;REGULATION OF GENE EXPRESSION#0.9710;SIGNALLING PATHWAY#0.9709;MUTAGENESIS#0.9707;POLYMERASE CHAIN REACTION#0.9703;SIGNALING CASCADE#0.9701;STEM CELL#0.9696;CYCLIN DEPENDENT KINASE#0.9696;VIRAL TRANSCRIPTION#0.9694;BREAST CANCER#0.9693;HISTONE DEACETYLASE#0.9692;PROTEIN KINASE#0.9689;MACROPHAGE#0.9686;GLUTATHIONE#0.9679;COLORECTAL CANCER#0.9665;CELL PROLIFERATION#0.9663;TUMOR NECROSIS FACTOR#0.9662;ALZHEIMER'S DISEASE#0.9661;GERMINAL CENTER#0.9658;TRANSCRIPTION FACTOR#0.9657;CYTOPLASM#0.9656;BREAST CANCER CELL#0.9655;LEUCINE#0.9649;APOPTOSIS#0.9645;PROGESTERONE#0.9644;TOXICITY#0.9644;HISTONE METHYLTRANSFERASE#0.9644;CELL GROWTH#0.9642;CANCER CELL#0.9636;PROGENITOR CELL#0.9635;TRANSFORMING GROWTH FACTOR BETA#0.9633;INFLAMMATORY RESPONSE#0.9625;IMMUNE RESPONSE#0.9624;CELL CYCLE ARREST#0.9622;EPITHELIAL CELL#0.9621;CELL CYCLE#0.9619;FACTOR I#0.9605;SIGNALING PATHWAY#0.9604;ESTROGEN RECEPTOR ALPHA#0.9598;MYELODYSPLASTIC SYNDROME#0.9592;GENE EXPRESSION#0.9583;GROWTH FACTOR#0.9576;NEURODEGENERATIVE DISEASE#0.9571;MEDIATOR COMPLEX#0.9566;NERVOUS SYSTEM#0.9549;INTRINSICALLY DISORDERED PROTEIN#0.9539;RNA HELICASE#0.9534;VIRAL REPLICATION#0.9528;IFN REGULATORY FACTOR#0.9512;EPSTEIN BARR VIRUS#0.9508;HUMAN IMMUNODEFICIENCY VIRUS#0.9503;TUMOR CELLS#0.9497;ENDOTHELIAL CELL#0.9477;HEMATOPOIETIC STEM CELL#0.9477;GROWTH FACTOR RECEPTOR#0.9475;POSTTRANSLATIONAL MODIFICATION#0.9470;NEUROGENESIS#0.9459;SMOOTH MUSCLE CELL#0.9458;RNA BINDING#0.9456;PERIPHERAL BLOOD#0.9448;ACETYLASE ACTIVITY#0.9428;RETINOBLASTOMA#0.9425;SEQUENCE SPECIFIC DNA BINDING#0.9389;ACTIVATOR PROTEIN 1#0.9385;DNA METHYLATION#0.9382;COLORECTAL#0.9380;STEROID HORMONE RECEPTOR#0.9342;MONOCYTE#0.9336;COLON CANCER#0.9331;T LYMPHOCYTE#0.9327;KINASE ACTIVITY#0.9324;ANGIOGENESIS#0.9319;ELECTROPHORETIC MOBILITY SHIFT#0.9316;ESTRADIOL#0.9312;CELL CYCLE REGULATION#0.9297;PRO-INFLAMMATORY#0.9276;REVERSE TRANSCRIPTION#0.9266;VIRAL INFECTION#0.9245;RETINOID X RECEPTOR#0.9238;TRANSFERASE ACTIVITY#0.9207;DNA REPLICATION#0.9201;FORSKOLIN#0.9201;PROTEIN RECRUITMENT#0.9169;HOST CELL#0.9163;ZINC BINDING#0.9153;BETA CELL#0.9122;AMYGDALA#0.9117;CENTRAL NERVOUS SYSTEM#0.9065;HISTONE ACETYLASE ACTIVITY#0.9052;CELL ACTIVATION#0.9042;SQUAMOUS CELL CARCINOMA#0.9037;NEURAL TUBE#0.9036;T CELL FACTOR#0.9021;RECEPTOR INTERACTING PROTEIN#0.8999;GERM CELL#0.8988;SKELETAL MUSCLE#0.8964;REACTIVE OXYGEN SPECIES#0.8958;GLOBIN#0.8932;ADENOCARCINOMA#0.8924;EMBRYONIC STEM CELL#0.8923;OVARIAN#0.8902;ACTIVATING TRANSCRIPTION FACTOR#0.8900;DOMINANT NEGATIVE MUTANT#0.8894;CARDIOMYOCYTE#0.8891;HUMAN BREAST CANCER#0.8886;NF-KAPPAB ACTIVATION#0.8872;NEUROLOGICAL DISORDER#0.8872;SWI-SNF COMPLEX#0.8837;KERATINOCYTE#0.8828;SPINAL CORD#0.8828;ACUTE LEUKEMIA#0.8823;LUNG ADENOCARCINOMA#0.8810;CEREBRAL CORTEX#0.8793;NMDA RECEPTOR#0.8786;CYCLIN DEPENDENT KINASE INHIBITOR#0.8786;CAMP SIGNALING#0.8779;HISTONE H4 ACETYLATION#0.8769;HEMATOPOIETIC CELL#0.8755;P53 BINDING#0.8753;GLUTAMINE#0.8751;REPORTER GENE ASSAY#0.8740;NUCLEAR EXPORT#0.8723;KAPOSI'S SARCOMA#0.8723;ADULT T-CELL LEUKEMIA#0.8702;EXTRACELLULAR MATRIX#0.8696;NUCLEAR IMPORT#0.8683;VIRAL GENE EXPRESSION#0.8672;ONCOGENESIS#0.8669;EPIDERMAL GROWTH FACTOR#0.8642;TRANSCRIPTION COFACTOR#0.8632;ALANINE#0.8621;CELL ADHESION#0.8573;GENE SILENCING#0.8562;CELL MIGRATION#0.8559;HISTONE DEACETYLATION#0.8537;REGENERATION#0.8510;GENOTOXIC#0.8472;DNA DAMAGE RESPONSE#0.8466;HEPATOCELLULAR CARCINOMA#0.8453;FACTOR INHIBITING HIF#0.8448;FIBROBLAST GROWTH FACTOR#0.8440;PROTEIN SYNTHESIS#0.8439;PATTERN FORMATION#0.8430;MONOCYTIC LEUKEMIA#0.8427;WNT SIGNALING PATHWAY#0.8426;GLYCOGEN SYNTHASE KINASE#0.8362;TRANSCRIPTASE#0.8287;PROTEIN INTERACTION NETWORK#0.8273;SERUM RESPONSE FACTOR#0.8270;PML NB#0.8262;CELL CYCLE CONTROL#0.8251;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8250;DOUBLE STRAND BREAK#0.8215;TAMOXIFEN#0.8208;GLUCONEOGENESIS#0.8177;ISCHEMIA#0.8163;OSTEOBLAST#0.8126;POLY ADP RIBOSE#0.8118;LONG TERM POTENTIATION#0.8094;NUCLEAR BODY#0.8085;ZINC FINGER PROTEIN#0.8075;HERPES SIMPLEX#0.8074;G1 PHASE#0.8064;TRANSCRIPTION ACTIVATOR#0.8055;TRANSCRIPTION FACTOR COMPLEX#0.8054;B CELL DEVELOPMENT#0.8022;IMMUNE SYSTEM#0.8014;FOREBRAIN#0.8010;NULL CELL#0.7982;PROTEASOME PATHWAY#0.7973;DEXAMETHASONE#0.7957;ERYTHROID CELL#0.7952;MOUSE EMBRYONIC STEM#0.7950;MECHANISM OF ACTION#0.7938;RNA BINDING PROTEIN#0.7918;MYELOID CELL#0.7917;HISTONE CHAPERONE#0.7916;MULTIPLE MYELOMA#0.7915;CELL SURFACE#0.7913;T CELL ACTIVATION#0.7899;ETHANOL#0.7874;MONONUCLEAR CELLS#0.7865;SENESCENCE#0.7849;PREINITIATION COMPLEX#0.7844;STEROIDOGENIC FACTOR 1#0.7838;MOUSE EMBRYONIC FIBROBLAST#0.7830;CD8+ T CELL#0.7825;PROMOTER BINDING#0.7821;MOLECULAR DYNAMICS SIMULATION#0.7809;DEACETYLASE ACTIVITY#0.7802;PROVIRUS#0.7799;ADENYLATE CYCLASE#0.7795;RESONANCE ENERGY TRANSFER#0.7759;SEQUESTERING#0.7756;ADIPOCYTE#0.7730;TRANSCRIPTION REGULATOR#0.7714;MAPK SIGNALING#0.7710;QUANTITATIVE REAL TIME#0.7707;CATALYTIC ACTIVITY#0.7696;RECEPTOR TYROSINE KINASE#0.7686;RECEPTOR TRANSACTIVATION#0.7683;RIBOSOMAL S6 KINASE#0.7650;NITRIC OXIDE#0.7647;TERMINAL DIFFERENTIATION#0.7634;ROSIGLITAZONE#0.7629;MAMMARY GLAND#0.7604;CYTOTOXICITY#0.7602;PLASMA CELL#0.7597;CONGENITAL DISORDER#0.7590;TRANSCRIPTIONAL CO-REGULATOR#0.7588;RESPONSE TO HYPOXIA#0.7583;HERPES SIMPLEX VIRUS#0.7577;NUCLEAR LOCALIZATION SIGNAL#0.7551;DNA SYNTHESIS#0.7546;CHROMATIN REMODELLING#0.7527;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7513;CYTOKINE PRODUCTION#0.7482;CHROMATIN BINDING#0.7460;MORPHOGENESIS#0.7449;RNA HELICASE A#0.7441;MAMMARY EPITHELIAL CELL#0.7435;CHONDROCYTE#0.7406;ANTIVIRAL RESPONSE#0.7344;GLUTAMIC ACID#0.7338;TYROSINE KINASE INHIBITOR#0.7279;METHYLTRANSFERASE ACTIVITY#0.7271;B LYMPHOCYTE#0.7257;LYMPH NODE#0.7247;NEUROBLASTOMA#0.7236;B CELL RECEPTOR#0.7234;SMAD BINDING#0.7230;SPATIAL LEARNING#0.7226;THYMINE DNA GLYCOSYLASE#0.7223;ALL TRANS RETINOIC ACID#0.7217;INNATE IMMUNE RESPONSE#0.7193;BONE MORPHOGENETIC PROTEIN#0.7180;LIPID METABOLISM#0.7177;METFORMIN#0.7175;RECEPTOR BINDING#0.7175;OVARIAN CANCER#0.7173;IMMUNE EVASION#0.7169;TOPOISOMERASE II#0.7156;MEDULLOBLASTOMA#0.7120;RIBOSE#0.7110;ACTIVATION OF NF-KAPPAB#0.7098;DEMETHYLATION#0.7085;ENZYME ACTIVITY#0.7084;VITAMIN D RECEPTOR#0.7076;GLUCOSE HOMEOSTASIS#0.7072;AKT SIGNALING#0.7061;APOPTOTIC CELL DEATH#0.7059;TUMOR TISSUES#0.7056;CHROMATIN ORGANIZATION#0.7056;CHROMATIN REMODELING COMPLEX#0.7053;INSULIN-LIKE GROWTH FACTOR#0.7027;COPY NUMBER ALTERATION#0.7027;HETEROCHROMATIN#0.6997;COGNITION#0.6997;ANTIGEN PRESENTATION#0.6993;MEMORY IMPAIRMENT#0.6982;HISTONE DEMETHYLASE#0.6981;RECEPTOR ACTIVITY#0.6976;MICROCEPHALY#0.6927;RHEUMATOID ARTHRITIS#0.6926;ENDOTHELIAL GROWTH FACTOR#0.6904;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6904;RECEPTOR ANTAGONIST#0.6902;VASCULAR SMOOTH MUSCLE CELL#0.6874;PHOSPHODIESTERASE#0.6872;UBIQUITIN PROTEASOME PATHWAY#0.6857;MELANOMA CELL LINES#0.6833;GENETIC DISORDER#0.6827;PROTEIN DEGRADATION#0.6822;CALCINEURIN#0.6808;PROTEIN TYROSINE PHOSPHATASE#0.6793;STROMAL CELL#0.6783;NUCLEAR RECEPTOR SUPERFAMILY#0.6778;ADIPOSE TISSUE#0.6774;ISOTHERMAL TITRATION CALORIMETRY#0.6755;ADENYLATE#0.6725;DOXORUBICIN#0.6721;MYELOPROLIFERATIVE NEOPLASM#0.6701;CANCER STEM CELL#0.6695;DENTATE GYRUS#0.6694;CDK INHIBITOR#0.6692;CARDIAC DEVELOPMENT#0.6683;GESTATION#0.6683;GLYCOSYLASE#0.6663;LEUKOCYTE#0.6632;ESTROGEN RESPONSE ELEMENT#0.6626;LUCIFERASE ACTIVITY#0.6614;HISTONE METHYLATION#0.6608;ADIPOCYTE DIFFERENTIATION#0.6566;GENETIC DISEASE#0.6561;HISTONE DEACETYLASE ACTIVITY#0.6548;NEURONAL CELLS#0.6531;DNASE#0.6530;CATENIN COMPLEX#0.6520;RECEPTOR AGONIST#0.6505;ASTROCYTE#0.6488;CELLULAR HOMEOSTASIS#0.6465;DEPHOSPHORYLATION#0.6453;CAMKIV#0.6449;MUSCULAR ATROPHY#0.6445;DNASE I#0.6431;PROTEIN METHYLTRANSFERASE#0.6426;CIRCADIAN RHYTHM#0.6426;SPERMATOGENESIS#0.6412;AMYOTROPHIC LATERAL SCLEROSIS#0.6399;LATERAL SCLEROSIS#0.6398;EPILEPSY#0.6393;DRUG RESISTANCE#0.6391;SIGNALING MOLECULE#0.6388;VIRION#0.6384;AUTOIMMUNE DISEASE#0.6375;NEURONAL INTRANUCLEAR INCLUSIONS#0.6372;TOPOISOMERASE#0.6369;CD4+ T CELL#0.6367;TRAP COMPLEX#0.6347;ACUTE MONOCYTIC LEUKEMIA#0.6323;IKAPPAB KINASE#0.6299;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.6280;CELL PHYSIOLOGY#0.6279;PYRUVATE#0.6275;STRIATUM#0.6269;STEROL REGULATORY ELEMENT#0.6264;NITRIC OXIDE SYNTHASE#0.6256;HEPATOMA CELLS#0.6244;HIGH MOBILITY GROUP#0.6242;RIBOZYME#0.6240;GRANULOSA CELL#0.6236;EPITHELIAL MESENCHYMAL TRANSITION#0.6221;HEPATITIS B#0.6215;ENERGY HOMEOSTASIS#0.6210;CELL ADHESION MOLECULE#0.6207;MAGNETIC RESONANCE SPECTROSCOPY#0.6199;COLONY-STIMULATING FACTOR#0.6197;HOMOLOGOUS RECOMBINATION#0.6191;DOPAMINE#0.6187;TYPE 2 DIABETES#0.6187;MYOGENESIS#0.6172;MORRIS WATER MAZE#0.6136;DNA METHYLTRANSFERASE#0.6126;PROTEIN KINASE B#0.6120;RECEPTOR LIGAND#0.6119;CYTOKINE RECEPTOR#0.6109;CELL DIVISION#0.6102;CELL MEMBRANE#0.6083;COENZYME A#0.6082;INDUCTION OF APOPTOSIS#0.6071;MELANOCYTE#0.6041;PLASMA MEMBRANE#0.6039;NUCLEAR TRANSPORT#0.6032;OOCYTE#0.6025;ACUTE MYELOID LEUKAEMIA#0.6020;VALPROIC ACID#0.6002
1388	TRANSCRIPTION FACTOR#0.9262;HETEROTRIMERIC G-PROTEIN#0.8758;SIGNALING PATHWAY#0.7729;ACTIVATING TRANSCRIPTION FACTOR#0.7434;CAMP RESPONSE ELEMENT BINDING#0.6351;CAMP RESPONSE ELEMENT#0.6259;DNA BINDING#0.6244
138948	CELL PROLIFERATION#0.7181;MAPK SIGNALING#0.6818;APOPTOSIS#0.6095
1390	ACTIVATING TRANSCRIPTION FACTOR#1.0581;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0428;LUPUS ERYTHEMATOSUS#1.0426;CAMP-RESPONSIVE ELEMENT BINDING#1.0420;PINEAL GLAND#1.0302;MELATONIN#1.0284;CAMP RESPONSE ELEMENT#1.0271;SPERMATOGENESIS#1.0263;DNA BINDING#1.0255;GERM CELL#1.0254;T CELL#1.0251;GROWTH FACTOR#1.0211;POLYMERASE CHAIN REACTION#1.0192;CAMP SIGNALING#1.0183;CAMP RESPONSE ELEMENT BINDING#1.0177;CRE BINDING#1.0169;TRANSCRIPTION FACTOR#1.0143;PROTEIN KINASE A#1.0052;CELL DEATH#1.0051;APOPTOSIS#1.0050;FORSKOLIN#1.0047;SERTOLI CELL#1.0031;SIGNALING PATHWAY#1.0022;CYCLIC AMP#1.0021;PROTEIN KINASE#0.9983;MELATONIN SYNTHESIS#0.9969;IL-2 PRODUCTION#0.9908;GENE EXPRESSION#0.9884;T LYMPHOCYTE#0.9866;SIGNAL TRANSDUCTION#0.9845;BETA CELL#0.9839;ADENOSINE#0.9794;GRANULOSA CELL#0.9735;MALE INFERTILITY#0.9697;ADENOSINE MONOPHOSPHATE#0.9638;CYCLIC ADENOSINE MONOPHOSPHATE#0.9598;LEUCINE#0.9540;ELECTROPHORETIC MOBILITY SHIFT#0.9502;CARDIOMYOCYTE#0.9500;REVERSE TRANSCRIPTION#0.9446;N ACETYLTRANSFERASE#0.9337;SIGNALLING PATHWAY#0.9336;INFERTILITY#0.9331;REGULATORY T CELL#0.9225;CIRCADIAN RHYTHM#0.9211;CELL DIFFERENTIATION#0.9171;PROSTATE CANCER#0.9151;CD4+ T CELL#0.9136;ADRENAL GLAND#0.9076;CREB BINDING#0.8947;SPERMIOGENESIS#0.8888;CELL CYCLE#0.8827;APOPTOTIC#0.8773;NEUROENDOCRINE CELL#0.8766;EFFECTOR T CELL#0.8737;ATRIAL FIBRILLATION#0.8594;PROTEIN SYNTHESIS#0.8525;CELL PROLIFERATION#0.8513;ADRENERGIC RECEPTOR#0.8436;TRANSACTIVATION#0.8406;FOLLICLE STIMULATING HORMONE#0.8329;ADENYLATE CYCLASE#0.8302;HYPERGLYCEMIA#0.8279;PHOSPHODIESTERASE#0.8224;SPERMATID DEVELOPMENT#0.8189;ACTIVATED T CELL#0.8159;MACROPHAGE#0.8067;UBIQUITIN#0.8050;MITOGEN ACTIVATED PROTEIN#0.7976;PROGRAMMED CELL DEATH#0.7907;TRANSCRIPTIONAL CONTROL#0.7893;CELL GROWTH#0.7835;PERIPHERAL BLOOD#0.7824;PROTEIN BINDING#0.7732;PANIC DISORDER#0.7685;CAMP SIGNALLING#0.7654;RECEPTOR ANTAGONIST#0.7541;NERVOUS SYSTEM#0.7461;INFERTILE#0.7418;IMMUNE RESPONSE#0.7339;BETA ADRENERGIC RECEPTOR#0.7283;CELL ACTIVATION#0.7264;CANCER CELL#0.7219;SPERMATOZOA#0.7188;ADIPOCYTE#0.7182;GLUCOSE UPTAKE#0.7104;ADENYLATE#0.7090;VASCULAR SMOOTH MUSCLE CELL#0.7087;TRANSCRIPTION REPRESSOR#0.7076;SMOOTH MUSCLE CELL#0.7058;MUSCLE CELL#0.7051;SMOOTH MUSCLE#0.7040;MYOCYTES#0.6857;DENTATE GYRUS#0.6765;HOMOLOGOUS RECOMBINATION#0.6761;DIABETIC NEPHROPATHY#0.6761;NERVE GROWTH FACTOR#0.6741;PARATHYROID HORMONE#0.6725;RESPONSE TO CAMP#0.6701;MYOCARDIAL INFARCTION#0.6665;OOCYTE#0.6659;OSTEOBLAST#0.6571;RETINOIC ACID#0.6547;TRANSCRIPTIONAL ATTENUATION#0.6511;CELL SURFACE#0.6510;SPERMATOCYTES#0.6508;AUTOIMMUNE DISEASE#0.6474;PROTEASOME#0.6466;NOREPINEPHRINE#0.6453;ADRENAL CORTEX#0.6356;MYOCARDIUM#0.6322;T CELL ACTIVATION#0.6295;BONE MARROW#0.6276;THYMOCYTE#0.6253;ACTIVATOR PROTEIN 1#0.6251;DNA METHYLATION#0.6202;ISOPROTERENOL#0.6156;TH17 CELL#0.6084;EPIDERMAL GROWTH FACTOR#0.6023;MONONUCLEAR CELLS#0.6013
139135	CANCER TESTIS ANTIGEN#1.1292;T CELL#1.0833;B CELL LYMPHOMA#0.9227;B CELL#0.9157;DIFFUSE LARGE B-CELL LYMPHOMA#0.8162;MULTIPLE MYELOMA#0.6664;T HELPER CELL#0.6094;CIRCADIAN RHYTHM#0.6082
139189	HYPOSPADIAS#1.1247;DIACYLGLYCEROL KINASE#1.1009;GENITAL TUBERCLE#0.7368
139212	DYNEIN#0.8072;SPERMATOGENIC CELLS#0.7746
139285	X CHROMOSOME#1.0865;TUMOR SUPPRESSOR#1.0644;PLASMA MEMBRANE#0.9998;CANCER CELL#0.9169;SIGNALING PATHWAY#0.9047;COLORECTAL CANCER#0.9002;COLORECTAL#0.8908;GENE EXPRESSION#0.8109;KIDNEY CANCER#0.8074;ADENOMATOUS POLYPOSIS COLI#0.8006;TRANSCRIPTION FACTOR#0.7838;INTELLECTUAL DISABILITY#0.7806;PERIPHERAL BLOOD#0.7415;STEM CELL#0.7088;WNT SIGNALING PATHWAY#0.6704;CELL CYCLE#0.6411;SIGNALLING PATHWAY#0.6089;PRECURSOR CELL#0.6070;CELL CYCLE ARREST#0.6037
1392	CORTICOTROPIN-RELEASING HORMONE SECRETION#1.1059;CORTICOTROPIN-RELEASING FACTOR SECRETION#1.0992;CRF RECEPTOR BINDING#1.0903;CORTICOTROPIN-RELEASING FACTOR BINDING#1.0770;CRF SECRETION#1.0687;CLIMBING FIBER#1.0659;FACTOR 2 RECEPTOR#1.0643;SEROTONIN RELEASE#1.0590;PREPULSE INHIBITION#1.0567;CRH BINDING#1.0556;CRH SECRETION#1.0535;COLONIC TRANSIT#1.0532;DESMOPRESSIN#1.0512;CORTICOTROPIN-RELEASING HORMONE BINDING#1.0503;MAST CELL DEGRANULATION#1.0496;ARGININE VASOTOCIN#1.0466;ADRENOCORTICOTROPIC HORMONE SECRETION#1.0463;ENDOTHELIAL GROWTH FACTOR#1.0462;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0462;ADENYLATE CYCLASE ACTIVITY#1.0461;DIURETIC HORMONE#1.0454;CRF BINDING#1.0432;DDAVP#1.0424;LEYDIG CELL#1.0418;UMBILICAL CORD#1.0394;VASOTOCIN#1.0389;ACID SECRETION#1.0381;STROMAL CELL#1.0364;CORD BLOOD#1.0359;AMNIOTIC FLUID#1.0359;ALPRAZOLAM#1.0357;RESPONSE TO RESTRAINT STRESS#1.0353;AMP FORMATION#1.0352;AMACRINE CELL#1.0350;GASTRIC ACID SECRETION#1.0346;MICTURITION#1.0327;HEROIN#1.0323;EARLY LIFE ADVERSITY#1.0322;CANCER CELL#1.0285;CYCLASE ACTIVITY#1.0283;DELAYED GASTRIC EMPTYING#1.0279;DEFECATION#1.0278;BREAST CANCER CELL#1.0271;INSULIN TOLERANCE TEST#1.0269;MEDULLA OBLONGATA#1.0266;ENDOMETRIUM#1.0264;ANOREXIC#1.0251;DECIDUALIZATION#1.0248;CORTICOTROPIN-RELEASING FACTOR#1.0246;TACHYKININ#1.0246;REGULATION OF ACTH SECRETION#1.0235;CHROMAFFIN CELL#1.0224;PYRAMIDAL CELL#1.0224;GASTRIC MOTILITY#1.0223;DECIDUA#1.0220;MU OPIOID RECEPTOR#1.0220;TSH SECRETION#1.0217;OLFACTORY CORTEX#1.0215;CORTICOTROPIN#1.0214;MELANIN CONCENTRATING HORMONE#1.0212;GABA B RECEPTOR#1.0212;MYOMETRIUM#1.0204;OLFACTORY BULB#1.0203;CARBACHOL#1.0203;MSH SECRETION#1.0199;BREAST CANCER#1.0198;ACOUSTIC STARTLE RESPONSE#1.0192;TROPHOBLAST#1.0188;GONADOTROPIN SECRETION#1.0186;MELANOCORTIN RECEPTOR#1.0186;ADENYLYL CYCLASE ACTIVITY#1.0182;PEPTIDE SECRETION#1.0179;MAST CELL#1.0178;EXPLORATORY BEHAVIOR#1.0177;T LYMPHOCYTE#1.0172;SOCIAL DEFEAT STRESS#1.0171;DEHYDROEPIANDROSTERONE SULFATE#1.0167;FACTOR I#1.0160;URETHANE#1.0159;SYNAPTIC TRANSMISSION#1.0159;MELATONIN#1.0156;METAMORPHOSIS#1.0154;ARACHIDONIC ACID#1.0154;ADRENAL MEDULLA#1.0153;CYCLIC ADENOSINE MONOPHOSPHATE#1.0150;ISOPROTERENOL#1.0149;COLITIS#1.0148;EDINGER-WESTPHAL NUCLEUS#1.0145;GLUCOCORTICOID SECRETION#1.0144;ADRENOCORTICOTROPIN SECRETION#1.0143;SYNCYTIOTROPHOBLAST#1.0140;PURKINJE CELL#1.0139;FACTOR S#1.0138;COLCHICINE#1.0137;MAST CELL ACTIVATION#1.0137;CARDIOVASCULAR SYSTEM#1.0134;TELENCEPHALON#1.0133;ENDOTHELIAL CELL#1.0124;KAPPA OPIOID RECEPTOR#1.0123;ANORECTIC#1.0123;INTERNEURON#1.0123;ARGININE VASOPRESSIN#1.0123;ADENOSINE MONOPHOSPHATE#1.0121;CAMP RESPONSE ELEMENT BINDING#1.0121;SUBSTANCE P#1.0121;THYROTROPIN RELEASING HORMONE#1.0120;PENTAGASTRIN#1.0119;GASTRIC EMPTYING#1.0115;GONADOTROPIN RELEASING HORMONE#1.0115;HISTIDINE#1.0112;PARS INTERMEDIA#1.0110;UTERUS#1.0107;ADDISON'S DISEASE#1.0106;STARTLE RESPONSE#1.0106;PENTOBARBITAL#1.0105;NEUROHORMONE#1.0104;TROPHOBLAST CELL#1.0104;LIMBIC SYSTEM#1.0102;NIFEDIPINE#1.0102;MELANOCYTE#1.0102;PANIC DISORDER#1.0102;LATE PREGNANCY#1.0101;REPRODUCTIVE SYSTEM#1.0101;SEROTONERGIC NEURON#1.0099;ADRENALINE#1.0097;GABAERGIC NEURON#1.0095;PHEOCHROMOCYTOMA#1.0092;AXON TERMINAL#1.0089;DNA METHYLATION#1.0088;EPITHELIAL CELL#1.0087;ACTION POTENTIAL#1.0087;ETHANOL#1.0087;VASOPRESSIN#1.0085;CAMP RESPONSE ELEMENT#1.0083;LYSINE#1.0082;HYPOXIA#1.0082;CYCLIC AMP#1.0079;AXONAL TRANSPORT#1.0076;METHIONINE#1.0074;SIGNALLING PATHWAY#1.0072;NERVE FIBER#1.0068;PHOSPHOLIPASE C#1.0064;GROWTH HORMONE SECRETION#1.0063;CAMP FORMATION#1.0062;POSTPARTUM DEPRESSION#1.0058;DENDRITIC CELL#1.0058;NERVE GROWTH FACTOR#1.0057;HORMONE BINDING#1.0056;NALTREXONE#1.0055;IMIPRAMINE#1.0055;OPIOID PEPTIDE#1.0054;KERATINOCYTE#1.0053;CALCIUM CHANNEL#1.0053;METYRAPONE#1.0052;PROTEIN KINASE A#1.0051;NMDA RECEPTOR#1.0051;LOCOMOTION#1.0050;BENZODIAZEPINE RECEPTOR#1.0047;ARGININE#1.0047;CHLORDIAZEPOXIDE#1.0046;GROOMING BEHAVIOR#1.0045;CLONIDINE#1.0045;YOHIMBINE#1.0043;HINDBRAIN#1.0043;DEHYDRATION#1.0043;GASTRIC MUCOSA#1.0042;ACROMEGALY#1.0039;RAPHE NUCLEI#1.0034;ADENYLATE CYCLASE#1.0034;NERVE TERMINAL#1.0033;HYPOTENSION#1.0032;MACROPHAGE#1.0031;ADENYLATE#1.0031;ALCOHOL DEPENDENCE#1.0029;HUMAN EMBRYONIC KIDNEY#1.0028;PROTEIN SYNTHESIS#1.0026;EARLY LIFE STRESS#1.0026;EPINEPHRINE#1.0025;CEREBRAL CORTEX#1.0025;EMBRYONIC KIDNEY#1.0024;CORTISOL SYNTHESIS#1.0024;DENDRITIC SPINE#1.0024;HALOPERIDOL#1.0023;NALOXONE#1.0022;BROWN ADIPOSE TISSUE#1.0021;SPINAL CORD#1.0021;MOTOR ACTIVITY#1.0020;SOMATOSTATIN RECEPTOR#1.0020;MUSCLE CELL#1.0018;DIAZEPAM#1.0017;SMOOTH MUSCLE CELL#1.0014;NITROPRUSSIDE#1.0010;MITOGEN ACTIVATED PROTEIN#1.0009;CERVICAL#1.0009;ASTROCYTE#1.0008;SIGNALING CASCADE#1.0008;MAJOR DEPRESSIVE EPISODE#1.0007;ACTH SECRETION#1.0006;GABA A RECEPTOR#1.0005;INNERVATION#1.0005;HISTAMINE#1.0003;SOCIAL BEHAVIOR#1.0001;RECEPTOR BINDING#0.9997;RETINOIC ACID#0.9996;FRONTAL#0.9995;ANOREXIA NERVOSA#0.9993;RECEPTOR ACTIVITY#0.9993;HYPOTENSIVE#0.9993;LOCUS COERULEUS#0.9992;ADENOSINE#0.9992;PARTURITION#0.9991;ACETYLCHOLINE#0.9989;HYPOGLYCEMIA#0.9988;FORSKOLIN#0.9987;ADRENAL ADENOMA#0.9987;STRUCTURE ACTIVITY RELATIONSHIP#0.9986;CATECHOLAMINE SECRETION#0.9985;MONONUCLEAR CELLS#0.9985;PROSTAGLANDIN E2#0.9984;HEAT SHOCK PROTEIN#0.9984;BLOOD VESSEL#0.9984;HAIR FOLLICLE#0.9983;CELL ACTIVATION#0.9983;AMYGDALA#0.9983;FLUOXETINE#0.9982;DOPAMINE RECEPTOR#0.9981;ATROPINE#0.9981;EDEMA#0.9977;NITRO-L-ARGININE#0.9976;MAP KINASE#0.9976;NEURONAL CELL BODIES#0.9974;APOPTOSIS#0.9973;MONOCYTE#0.9972;ADENOHYPOPHYSIS#0.9971;STRIATUM#0.9971;MEDIAL PREFRONTAL CORTEX#0.9971;DEHYDROEPIANDROSTERONE#0.9970;WAKEFULNESS#0.9966;VENOUS BLOOD#0.9965;CYTOTOXICITY#0.9965;PROPRANOLOL#0.9965;LEUKOCYTE#0.9964;LATERAL VENTRICLE#0.9961;RHEUMATOID ARTHRITIS#0.9960;INTERLEUKIN 1 RECEPTOR#0.9960;ESTROGENS#0.9959;STEROIDOGENESIS#0.9958;INDOMETHACIN#0.9956;ERGIC#0.9956;HYPOPHYSIS#0.9956;NEUROHYPOPHYSIS#0.9955;DRUG DEPENDENCE#0.9953;PROTEIN KINASE C#0.9953;CYTOKINE PRODUCTION#0.9953;INFLAMMATORY RESPONSE#0.9952;PRAZOSIN#0.9951;RECEPTOR LIGAND#0.9951;NOREPINEPHRINE#0.9950;DEMENTIA#0.9949;HABITUATION#0.9949;GASTROINTESTINAL TRACT#0.9948;L-ARGININE#0.9946;OPIOID RECEPTOR#0.9945;EATING DISORDER#0.9944;INSULIN SECRETION#0.9944;OVARIAN#0.9943;LONG TERM POTENTIATION#0.9943;SKELETAL MUSCLE#0.9941;IMMUNE CELL#0.9940;MIDBRAIN#0.9940;DIABETES INSIPIDUS#0.9938;ANDROSTENEDIONE#0.9937;MECHANISMS OF ACTION#0.9936;MENSTRUAL CYCLE#0.9936;ADRENERGIC RECEPTOR#0.9935;LUTEINIZING HORMONE SECRETION#0.9935;GUANYLATE CYCLASE#0.9935;HYPERTHERMIA#0.9933;NEUROBLASTOMA#0.9932;CORTISOL#0.9931;CELL MEMBRANE#0.9931;NITRIC OXIDE#0.9927;SIGNALING PATHWAY#0.9927;VASOPRESSIN SECRETION#0.9926;LYMPHOCYTE PROLIFERATION#0.9925;PERIPHERAL BLOOD#0.9924;ANOREXIA#0.9924;RESERPINE#0.9924;MECHANISM OF ACTION#0.9923;CITALOPRAM#0.9920;NORADRENALINE#0.9920;LATERAL HYPOTHALAMIC AREA#0.9917;HYPERSENSITIVITY#0.9917;GLUTAMATE RECEPTOR#0.9916;TRYPTOPHAN#0.9916;ANXIETY DISORDER#0.9915;N METHYLTRANSFERASE#0.9915;PEPTIDE HORMONE#0.9912;PYROGENIC#0.9912;PROTEIN KINASE#0.9910;COLORECTAL#0.9910;DEXAMETHASONE#0.9909;ASPARTATE#0.9908;SIGNAL TRANSDUCTION#0.9907;SEPTUM#0.9905;ISCHEMIA#0.9900;PERTUSSIS#0.9900;FEAR POTENTIATED STARTLE#0.9897;CORTISOL SECRETION#0.9895;NEUROTRANSMISSION#0.9894;ADRENOCORTICOTROPIC HORMONE#0.9891;ESTROGEN RECEPTOR#0.9890;CELLULAR LOCALIZATION#0.9889;MAJOR DEPRESSIVE DISORDER#0.9888;REVERSE TRANSCRIPTION#0.9888;GLUCOCORTICOID RECEPTOR#0.9886;BIPOLAR DISORDER#0.9883;RESPONSE TO STRESS#0.9883;HYPERACTIVITY#0.9882;PHENYLETHANOLAMINE N METHYLTRANSFERASE#0.9882;RECEPTOR ANTAGONIST#0.9882;DNA BINDING#0.9877;ALZHEIMER'S DISEASE#0.9876;PRO-INFLAMMATORY#0.9875;NITRIC OXIDE SYNTHASE#0.9874;FOREBRAIN#0.9872;ALDOSTERONE#0.9871;FEEDING BEHAVIOR#0.9870;EXCRETION#0.9870;OVULATION#0.9870;SMOOTH MUSCLE#0.9869;DOPAMINE#0.9869;CUSHING'S SYNDROME#0.9869;SENSITIZATION#0.9867;IL-1RA#0.9866;BETA ADRENOCEPTOR#0.9863;DEPRESSIVE SYMPTOMS#0.9862;AMNION#0.9862;CORTICOTROPIN SECRETION#0.9861;DENTATE GYRUS#0.9859;GLUTAMIC ACID#0.9859;PROGESTERONE#0.9859;CORTICOSTERONE SECRETION#0.9856;FOLLICULAR PHASE#0.9855;OPEN FIELD TEST#0.9854;FORCED SWIM TEST#0.9852;PLASMA MEMBRANE#0.9851;OBESE#0.9850;GENE EXPRESSION#0.9849;TACHYCARDIA#0.9842;CORTICOTROPHIN RELEASING HORMONE#0.9841;DIENCEPHALON#0.9841;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9840;TRANSCRIPTASE#0.9840;NOXIOUS#0.9840;ESTRADIOL#0.9837;GLIAL CELL#0.9837;ADRENAL CORTEX#0.9837;RECEPTOR AGONIST#0.9836;THALAMUS#0.9836;BETA ADRENERGIC RECEPTOR#0.9834;HORMONE SECRETION#0.9833;ESTRIOL#0.9829;FORCED SWIMMING TEST#0.9827;HYPERACTIVE#0.9827;PITUITARY ADENOMA#0.9826;COGNITION#0.9826;GROWTH HORMONE#0.9826;AMENORRHEA#0.9825;FOLLICLE STIMULATING HORMONE#0.9824;DIABETES MELLITUS#0.9823;DOPAMINERGIC NEURON#0.9822;TUMOR CELLS#0.9821;IMMUNE RESPONSE#0.9821;IRRITABLE BOWEL SYNDROME#0.9821;ALCOHOL USE DISORDER#0.9820;DIURNAL#0.9819;TETRODOTOXIN#0.9819;TRANSCRIPTION FACTOR#0.9818;PARATHYROID HORMONE#0.9818;HYPOTHALAMUS PITUITARY ADRENAL#0.9817;FENFLURAMINE#0.9815;CONDITIONED PLACE PREFERENCE#0.9813;QUANTITATIVE REAL TIME#0.9812;HEALTHY CONTROL SUBJECTS#0.9811;EPILEPSY#0.9811;CYTOPLASM#0.9810;LACTATION#0.9806;RESPONSE TO INSULIN#0.9806;BODY WEIGHT GAIN#0.9805;POLYMERASE CHAIN REACTION#0.9804;DIARRHEA#0.9800;LUNG CANCER#0.9800;MOOD DISORDER#0.9798;CONVULSANT#0.9797;TUMOR NECROSIS FACTOR#0.9796;SUCROSE#0.9793;INFLAMMATORY CELL#0.9792;ESTROUS CYCLE#0.9792;GESTATION#0.9791;ENDOMETRIOSIS#0.9790;CELL PROLIFERATION#0.9789;BETA-2#0.9786;SODIUM NITROPRUSSIDE#0.9785;RAPID EYE MOVEMENT#0.9782;CELL WALL#0.9781;ARTERY#0.9779;TESTOSTERONE#0.9778;ENERGY HOMEOSTASIS#0.9777;NEUTROPHIL#0.9775;OVARIES#0.9775;ADIPOSE TISSUE#0.9775;CAUDATE NUCLEUS#0.9773;MATERNAL BEHAVIOR#0.9770;VERAPAMIL#0.9770;GROWTH FACTOR#0.9770;LEUKEMIA INHIBITORY FACTOR#0.9768;PITUITARY GLAND#0.9763;CHOLINE#0.9760;CIRCADIAN RHYTHM#0.9757;MOLAR#0.9757;CENTRAL NERVOUS SYSTEM#0.9756;CANNABINOID RECEPTOR#0.9754;ADRENAL GLAND#0.9754;BETA CELL#0.9750;GUANINE#0.9750;LEUCINE#0.9749;POST-TRAUMATIC STRESS DISORDER#0.9744;MENTAL DISORDER#0.9743;LINES OF EVIDENCE#0.9743;PHENTOLAMINE#0.9740;HYPOTHYROIDISM#0.9734;NERVOUS SYSTEM#0.9732;NEUROENDOCRINE CELL#0.9732;T CELL#0.9729;OBSESSIVE COMPULSIVE DISORDER#0.9727;ELEVATED PLUS MAZE#0.9724;SEROTONIN REUPTAKE INHIBITOR#0.9721;HYDROXYLASE ACTIVITY#0.9721;CORTICOTROPHIN#0.9719;VASODILATOR#0.9715;NOCICEPTION#0.9715;CELL DEATH#0.9714;PROLACTIN SECRETION#0.9712;HYPERGLYCEMIA#0.9707;HYDROCORTISONE#0.9703;CENTRAL EXTENDED AMYGDALA#0.9702;BLASTOCYST IMPLANTATION#0.9696;CHLORPROMAZINE#0.9694;HYPERTENSION#0.9689;INTRACELLULAR SIGNALING PATHWAY#0.9689;RETINOBLASTOMA#0.9688;HYPOPITUITARISM#0.9688;STEM CELL#0.9685;NERVE ENDING#0.9682;WEIGHT GAIN#0.9681;INSULIN-LIKE GROWTH FACTOR#0.9679;CRAVING#0.9678;BLOOD BRAIN BARRIER#0.9674;GLUCOSE METABOLISM#0.9671;ANESTHETIC#0.9671;JUGULAR VEIN#0.9671;PROSTAGLANDIN SYNTHESIS#0.9670;NEUROENDOCRINE TUMOR#0.9665;LUTEOLYSIS#0.9664;HIGH FAT DIET#0.9664;HYPOTHALAMIC PITUITARY ADRENAL#0.9653;PUBERTY#0.9652;APOPTOTIC#0.9651;WEIGHT LOSS#0.9651;ACTH-SECRETING PITUITARY ADENOMA#0.9650;SECRETORY GRANULE#0.9647;IMMUNE SYSTEM#0.9645;CYPROHEPTADINE#0.9644;HEMORRHAGE#0.9642;B CELL#0.9641;ENDOCRINE SYSTEM#0.9639;MODE OF ACTION#0.9637;ENDOTHELIUM#0.9628;PARKINSON'S DISEASE#0.9625;STROMA#0.9621;HALOTHANE#0.9611;ATOPIC DERMATITIS#0.9608;MAGNETIC RESONANCE IMAGING#0.9607;OCTREOTIDE#0.9602;ISOLEUCINE#0.9598;CHORION#0.9592;TRIIODOTHYRONINE#0.9592;PARATHYROID#0.9591;CHRONIC MILD STRESS#0.9589;ANDROGEN RECEPTOR#0.9587;TOXICITY#0.9586;RESPIRATION#0.9586;NATURAL KILLER CELL#0.9584;NUCLEUS ACCUMBENS SHELL#0.9564;KINASE INHIBITOR#0.9564;LYMPH NODE#0.9562;ILEUS#0.9559;SIGNALING MOLECULE#0.9557;PHOSPHOLIPASE A2#0.9557;OOCYTE#0.9556;IFN-GAMMA#0.9555;MULTIPLE SCLEROSIS#0.9552;GDP BINDING#0.9543;B LYMPHOCYTE#0.9541;ION CHANNEL#0.9540;PROTEIN PHOSPHORYLATION#0.9526;AUTOIMMUNE DISEASE#0.9523;BLOOD PLASMA#0.9520;ADRENAL HYPERPLASIA#0.9519;VASODILATION#0.9512;BODY WEIGHT LOSS#0.9510;CELL SURFACE#0.9499;SUBSTANTIA NIGRA#0.9491;GLUCOCORTICOID SYNTHESIS#0.9490;PSORIASIS#0.9489;CHOLINERGIC NEURON#0.9486;MIFEPRISTONE#0.9474;CAMP SIGNALING#0.9470;VASOPRESSIN RECEPTOR#0.9462;DUODENUM#0.9459;SUBSTANCE ABUSE#0.9453;SCIATIC NERVE#0.9451;CAFFEINE#0.9442;CYSTITIS#0.9437;GUANOSINE#0.9422;DERMATITIS#0.9416;PHOSPHODIESTERASE#0.9416;FEAR RESPONSE#0.9416;FSH SECRETION#0.9413;MICROGLIAL CELL#0.9400;DIURESIS#0.9400;CHOLERA#0.9399;INTERSTITIAL CYSTITIS#0.9396;BOUTON#0.9395;PRE-ECLAMPSIA#0.9394;ACETIC ACID#0.9391;PROESTRUS#0.9389;MEMBRANE DEPOLARIZATION#0.9387;FIBROMYALGIA#0.9385;ENDOCYTOSIS#0.9376;ENZYME ACTIVITY#0.9374;BROMOCRIPTINE#0.9372;ACUTE LIVER INJURY#0.9368;ACETYLCHOLINE RECEPTOR#0.9366;CYTOCHROME P450#0.9365;EXTRACELLULAR MATRIX#0.9360;MEMORY IMPAIRMENT#0.9356;CYTOTROPHOBLAST#0.9355;LOPERAMIDE#0.9346;INHIBITION OF GONADOTROPIN SECRETION#0.9341;TAIL SUSPENSION TEST#0.9320;CLIMBING FIBRE#0.9317;RNA INTERFERENCE#0.9315;PHENYLEPHRINE#0.9303;TECTUM#0.9301;INFLAMMATORY BOWEL DISEASE#0.9294;EPINEPHRINE SECRETION#0.9293;SWELLING#0.9286;BETAMETHASONE#0.9279;N-OMEGA-NITRO-L-ARGININE#0.9275;NITRIC-OXIDE SYNTHASE INHIBITOR#0.9262;KETOCONAZOLE#0.9260;CLASS B GPCR#0.9258;ALANINE#0.9243;CELL BODY#0.9241;KINASE ACTIVITY#0.9223;DELTA OPIOID RECEPTOR#0.9212;CALCIUM SIGNALING#0.9207;RESPONSE TO TRH#0.9203;MATERNAL AGGRESSION#0.9202;REGULATION OF APPETITE#0.9195;ACTIVATOR PROTEIN 1#0.9194;ENDOPLASMIC RETICULUM#0.9194;ENTERIC NERVOUS SYSTEM#0.9186;RECEPTOR COMPLEX#0.9184;TEGMENTUM#0.9183;HYPOXIC#0.9176;NICOTINIC ACETYLCHOLINE RECEPTOR#0.9175;GLUTAMATERGIC NEURON#0.9174;POLYCYSTIC OVARY SYNDROME#0.9173;VASODILATATION#0.9170;PERSONALITY DISORDER#0.9167;DECIDUAL CELL#0.9156;POTASSIUM CHANNEL#0.9145;PEPTIDE SYNTHESIS#0.9143;AGGRESSIVE BEHAVIOR#0.9138;MAPK SIGNALING#0.9123;PITUITARY-DEPENDENT CUSHING'S DISEASE#0.9110;BASAL GANGLIA#0.9110;ENDOCRINE CELL#0.9110;TOLL LIKE RECEPTOR#0.9107;BRETYLIUM#0.9088;BRAIN EDEMA#0.9086;POSITRON EMISSION TOMOGRAPHY#0.9082;C REACTIVE PROTEIN#0.9082;GLUCOSE TOLERANCE TEST#0.9081;ADIPOCYTE#0.9077;RESPONSE TO LPS#0.9075;FK506 BINDING PROTEIN#0.9039;FK506 BINDING#0.9037;FEMALE REPRODUCTIVE SYSTEM#0.9035;CEREBRAL ISCHEMIA#0.9031;CHRONIC FATIGUE SYNDROME#0.9027;ORAL GLUCOSE TOLERANCE#0.9026;HATCHING#0.9014;NEUROHYPOPHYSEAL HORMONE#0.9010;D-AMPHETAMINE#0.9008;BIOTIN#0.9004;METHOXAMINE#0.8998;NEUROTOXIC#0.8996;NEUROPROTECTION#0.8996;TRANSFORMING GROWTH FACTOR#0.8993;CORONAL#0.8985;OREXIN RECEPTOR#0.8983;RESPONSE TO ANTIDEPRESSANT#0.8976;OXYTOCIN SECRETION#0.8974;SMALL INTESTINE#0.8974;ABDOMINAL PAIN#0.8955;NEUROSECRETORY VESICLE#0.8955;SUBSTANCE USE DISORDER#0.8953;SOMATOSTATIN SECRETION#0.8947;RESPONSE TO ETHER#0.8945;FETAL BRAIN#0.8943;REGULATION OF FEEDING BEHAVIOR#0.8937;NEURODEGENERATIVE DISEASE#0.8933;PLACENTAL MEMBRANES#0.8926;ANGIOGENESIS#0.8914;UMBILICAL CORD BLOOD#0.8902;GLUCOSE HOMEOSTASIS#0.8891;L-NNA#0.8891;RU486#0.8890;SEROTONIN RECEPTOR#0.8876;URINARY BLADDER#0.8868;LUTEAL PHASE#0.8857;MITOCHONDRIA#0.8854;NEURONAL CELLS#0.8844;LITHIUM#0.8829;NEUROTOXIN#0.8825;PERIPHERAL NERVE#0.8818;NEUROGENESIS#0.8811;SIGNAL PEPTIDE#0.8810;CORTICAL CELL#0.8795;PREDNISOLONE#0.8793;SIGNAL TRANSDUCER#0.8786;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8785;DESIPRAMINE#0.8761;REACTIVE OXYGEN SPECIES#0.8752;MUSCLE CONTRACTION#0.8752;PROTEIN PROTEIN INTERACTION#0.8750;AGEING#0.8744;IONOPHORE#0.8737;BETA-ESTRADIOL#0.8733;PERIPHERAL NERVOUS SYSTEM#0.8731;BLOOD GLUCOSE LEVEL#0.8730;RETICULAR FORMATION#0.8730;3'-5'-CYCLIC ADENOSINE MONOPHOSPHATE#0.8729;OXYGENASE#0.8690;THYROID HORMONE RECEPTOR#0.8687;REGULATION OF ENERGY HOMEOSTASIS#0.8685;THYMIDINE#0.8683;OXYTOCIN RECEPTOR#0.8682;NEUROPEPTIDE RECEPTOR#0.8680;ENDOGENOUS DEPRESSION#0.8660;GRANULOSA CELL#0.8659;SKIN DISEASE#0.8642;METHAMPHETAMINE#0.8634;IL-6 PRODUCTION#0.8633;THYROID CARCINOMA#0.8632;5-HT RECEPTOR#0.8622;ECLAMPSIA#0.8614;SYSTOLIC BLOOD PRESSURE#0.8612;CAMKII#0.8612;ANTERIOR CINGULATE CORTEX#0.8610;HISTONE DEACETYLASE#0.8605;TUMOUR NECROSIS FACTOR#0.8603;PHOSPHODIESTERASE INHIBITOR#0.8594;HEART RATE VARIABILITY#0.8592;MUTAGENESIS#0.8590;LOSS OF CONTROL#0.8584;EATING BEHAVIOR#0.8583;GENETICALLY ENGINEERED MICE#0.8579;ACUTE PHASE RESPONSE#0.8576;GENERALIZED ANXIETY DISORDER#0.8575;MIDLINE#0.8571;COCAINE DEPENDENCE#0.8571;CARDIOMYOCYTE#0.8542;NEMBUTAL#0.8529;SYNOVIUM#0.8524;DENSE CORE VESICLE#0.8514;TYPE 2 DIABETES#0.8505;CHRONIC UNPREDICTABLE STRESS#0.8498;L-GLUTAMATE#0.8496;ALKALINE PHOSPHATASE#0.8487;SYNOVIAL FLUID#0.8484;HYPOGONADISM#0.8484;ALDOSTERONE SECRETION#0.8479;GONAD#0.8473;HISTIDINE DECARBOXYLASE#0.8468;DIAZEPAM BINDING#0.8468;LYMPHOID ORGANS#0.8462;SERUM ALBUMIN#0.8461;NICOTINE DEPENDENCE#0.8460;LOW BIRTH WEIGHT#0.8457;TRANSCRIPTIONAL CONTROL#0.8453;SECRETORY PATHWAY#0.8445;RESPONSE TO IL-1#0.8437;NUCLEOTIDE BINDING#0.8434;RESPONSE TO VASOPRESSIN#0.8433;ULCERATIVE COLITIS#0.8431;THECAL CELL#0.8417;LAMINA TERMINALIS#0.8415;APPETITE SUPPRESSION#0.8400;RENIN ACTIVITY#0.8393;WHITE BLOOD CELL#0.8383;INSOMNIA#0.8376;MULTIPLE ENDOCRINE NEOPLASIA#0.8365;FORCED SWIM STRESS#0.8344;OSTEOPOROSIS#0.8344;DIGESTION#0.8335;SEDATION#0.8323;PANCREATIC ISLET#0.8320;SEBACEOUS GLAND#0.8314;FORMALIN#0.8312;GROWTH HORMONE SECRETAGOGUE#0.8307;ACTINOMYCIN D#0.8302;AMPA RECEPTOR#0.8300;JEJUNUM#0.8299;CONTEXTUAL FEAR CONDITIONING#0.8297;THYROID GLAND#0.8297;SPONTANEOUS PRETERM BIRTH#0.8295;SCALP#0.8291;MYOCYTES#0.8291;ANGIOTENSIN CONVERTING ENZYME#0.8290;ENTEROCHROMAFFIN CELL#0.8285;ADRENOCORTICAL HYPERPLASIA#0.8273;VALPROATE#0.8260;PEROXISOME#0.8244;HEART DISEASE#0.8242;ESTROGEN RECEPTOR ALPHA#0.8232;BETA-HYDROXYSTEROID DEHYDROGENASE#0.8229;HEMOCYTE#0.8228;NEUROTOXICITY#0.8228;UMBILICAL ARTERY#0.8215;SECRETORY CELL#0.8215;D-FENFLURAMINE#0.8204;CENTRAL GRAY#0.8200;RESPONSE TO DEXAMETHASONE#0.8197;MORRIS WATER MAZE#0.8190;SEROTONIN METABOLISM#0.8187;CATECHOLAMINE SYNTHESIS#0.8158;CEREBRAL ARTERY#0.8156;INHIBIN#0.8152;HAIR CYCLE#0.8149;SUCROSE PREFERENCE TEST#0.8143;GANGLIOCYTOMA#0.8141;MEDULLARY CELL#0.8141;CONDITIONED PLACE AVERSION#0.8138;ADRENOCORTICOTROPIN-RELEASING HORMONE#0.8137;MESENTERIC LYMPH NODE#0.8136;HYPERPROLACTINEMIA#0.8123;PREDNISONE#0.8123;SQUAMOUS CELL CARCINOMA#0.8117;CHOROID PLEXUS#0.8116;CAMP SYNTHESIS#0.8115;NEUROPATHY#0.8110;IONOTROPIC GLUTAMATE RECEPTOR#0.8105;OESTRADIOL#0.8103;AREA UNDER CURVE#0.8100;IL-6 SECRETION#0.8097;QUIESCENCE#0.8096;DIET INDUCED OBESITY#0.8091;STRESSFUL LIFE EVENTS#0.8086;EPIDERMAL GROWTH FACTOR#0.8083;SODIUM PENTOBARBITAL#0.8068;UMBILICAL VEIN#0.8064;TRYPTOPHAN HYDROXYLASE ACTIVITY#0.8058;CREB BINDING#0.8049;SYNAPTIC VESICLE#0.8040;PROTEIN SECRETION#0.8036;ION TRANSPORT#0.8035;SUPEROXIDE DISMUTASE#0.8022;ELECTROPHORETIC MOBILITY SHIFT#0.8020;MIDDLE CEREBRAL ARTERY#0.8020;CHLORAMPHENICOL#0.8015;HORMONE SYNTHESIS#0.8011;BRAIN DEVELOPMENT#0.8007;PARS NERVOSA#0.7987;HAIR GROWTH#0.7975;LIPID METABOLISM#0.7970;LONG TERM DEPRESSION#0.7954;LIDOCAINE#0.7947;ANTIDIURETIC HORMONE#0.7944;SLEEP DISORDER#0.7924;HUNTINGTON'S DISEASE#0.7898;ADENOCARCINOMA#0.7892;3RD VENTRICLE#0.7890;ADRENOCORTICOTROPIC HORMONE DEFICIENCY#0.7883;STEROID SYNTHESIS#0.7868;NODULAR#0.7858;3BETA-HYDROXYSTEROID DEHYDROGENASE#0.7858;QUANTITATIVE REVERSE TRANSCRIPTION#0.7836;STREPTOZOTOCIN#0.7832;BUSPIRONE#0.7827;FLUMAZENIL#0.7823;PARABRACHIAL NUCLEI#0.7817;MOTOR BEHAVIOR#0.7809;CHILDHOOD TRAUMA QUESTIONNAIRE#0.7803;FEEDING BEHAVIOUR#0.7802;BONE MARROW#0.7798;CORTICOSTERONE BINDING#0.7773;INTENSIVE CARE UNIT#0.7753;PEPTIDE BINDING#0.7743;VALPROIC ACID#0.7731;GI TRACT#0.7730;GLYCINE#0.7720;VOMITING#0.7720;METOCLOPRAMIDE#0.7708;MORPHINE SULFATE#0.7703;ASSOCIATIVE LEARNING#0.7699;BRAIN NATRIURETIC PEPTIDE#0.7686;T LYMPHOCYTE PROLIFERATION#0.7684;RESPONSE TO ETHANOL#0.7677;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7674;NEGATIVE PREDICTIVE VALUE#0.7672;CHORIOCARCINOMA#0.7672;LUPUS ERYTHEMATOSUS#0.7672;ALOPECIA#0.7671;YELLOW FLUORESCENT PROTEIN#0.7670;CATABOLISM#0.7666;MALAISE#0.7656;FLUORESCEIN#0.7650;CHOLESTASIS#0.7643;INDUCIBLE NITRIC OXIDE#0.7639;INTESTINAL MOTILITY#0.7637;PAROXETINE#0.7632;CRE BINDING#0.7623;SERIAL REACTION TIME#0.7591;MALNUTRITION#0.7585;DIESTRUS#0.7572;CYCLIC GUANOSINE MONOPHOSPHATE#0.7563;HYPERTHYROIDISM#0.7562;GLUCOSE UPTAKE#0.7558;CORTISOL BINDING#0.7557;INHIBITION OF GROWTH#0.7555;2-DEOXY-D-GLUCOSE#0.7551;STIMULATION OF SECRETION#0.7543;NORMAL CONTROL GROUP#0.7532;CONDITIONED TASTE AVERSION#0.7531;CHRONIC SOCIAL DEFEAT#0.7526;ASYMMETRIC SYNAPSE#0.7521;RESPONSE TO COCAINE#0.7513;MEMBRANE FRACTION#0.7512;SYMMETRIC SYNAPSE#0.7503;ENCEPHALOMYELITIS#0.7489;TEMPORAL LOBE#0.7489;EYELID#0.7488;COSYNTROPIN#0.7486;VISCERA#0.7481;GLUTAMATE DECARBOXYLASE#0.7480;PKC ACTIVITY#0.7475;CELL GROWTH#0.7442;DERMAL FIBROBLAST#0.7441;DIHYDROTESTOSTERONE#0.7439;SEASONAL AFFECTIVE DISORDER#0.7436;CACHEXIA#0.7433;MIANSERIN#0.7431;GASTROINTESTINAL SYSTEM#0.7429;CELL DIFFERENTIATION#0.7428;INSULINOMA#0.7418;NORDIHYDROGUAIARETIC ACID#0.7411;EXCITATORY SYNAPSE#0.7408;PROGESTERONE SECRETION#0.7400;WHITE ADIPOSE TISSUE#0.7385;CALCIUM MOBILIZATION#0.7378;OVARIAN FOLLICLE#0.7375;17β-ESTRADIOL#0.7369;CONNEXIN#0.7363;LUNG DEVELOPMENT#0.7359;4-AMINOPYRIDINE#0.7358;KETAMINE#0.7352;ESTRUS#0.7350;OF DIABETIC RATS#0.7346;MUSCLE ATROPHY#0.7337;SULPIRIDE#0.7321;FERTILIZATION#0.7305;PROTEIN BINDING#0.7291;SEROTONIN SYNTHESIS#0.7286;ACTION POTENTIAL FIRING#0.7284;AIRWAY SMOOTH MUSCLE#0.7276;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.7275;PLASMA PROTEIN#0.7275;DRINKING BEHAVIOR#0.7274;REGULATION OF GENE EXPRESSION#0.7273;CORPUS LUTEUM#0.7263;SPIRONOLACTONE#0.7261;GUANYLATE CYCLASE INHIBITOR#0.7253;CELL CYCLE#0.7251;IL-10 PRODUCTION#0.7249;CUNEATE NUCLEUS#0.7243;SHORT TERM MEMORY#0.7234;NEUROTRANSMITTER RECEPTOR#0.7226;FIBROBLAST GROWTH FACTOR#0.7218;NEURITE#0.7211;BENZIMIDAZOLE#0.7207;NEONATAL RAT CARDIOMYOCYTES#0.7197;AMINOGLUTETHIMIDE#0.7185;MORPHINE DEPENDENCE#0.7180;CERVICAL CANCER#0.7180;RETINOIC ACID RECEPTOR#0.7155;N-ACETYL SEROTONIN#0.7144;QUETIAPINE#0.7139;TRANSMEMBRANE RECEPTOR#0.7138;BETA GALACTOSIDASE#0.7135;TYPE 1 DIABETES#0.7134;RANDOMIZED CONTROLLED TRIAL#0.7134;TRANSFORMING GROWTH FACTOR BETA#0.7115;REPORTER GENE ASSAY#0.7101;NEUROPEPTIDE HORMONE#0.7100;CELL MIGRATION#0.7097;CONGENITAL ADRENAL HYPERPLASIA#0.7094;FLINDERS SENSITIVE LINE#0.7094;POSITIVE PREDICTIVE VALUE#0.7091;INFERTILITY#0.7078;MELANCHOLIA#0.7059;SPATIAL LEARNING#0.7058;SUBSTANCE P RECEPTOR#0.7045;GLUTAMINE#0.7039;FETAL GROWTH RESTRICTION#0.7034;OSTEOARTHRITIS#0.7034;SODIUM CHANNEL#0.7033;CORONARY ARTERY#0.7032;FRONTAL LOBE EPILEPSY#0.7015;L-TYPE CALCIUM CHANNEL#0.7009;DESMETHYLIMIPRAMINE#0.7008;PREGNENOLONE#0.7006;AMITRIPTYLINE#0.7001;L-TRYPTOPHAN#0.6992;PKC ACTIVATION#0.6982;PROSTACYCLIN#0.6976;LOCALISATION#0.6967;NEUROFILAMENT#0.6960;AND BODY COMPOSITION#0.6957;THYMOCYTE#0.6954;DEPRESSION RATING SCALE#0.6949;CAMP-RESPONSIVE ELEMENT BINDING#0.6943;GLUTAMATERGIC SYNAPSE#0.6941;D-ARGININE#0.6936;GLUCOSE INTOLERANCE#0.6931;GAP JUNCTION#0.6927;CHRONIC RESTRAINT STRESS#0.6917;CALCINEURIN#0.6916;GANGLION CELLS#0.6913;BRADYCARDIA#0.6913;PERCEIVED STRESS SCALE#0.6905;PARAFORMALDEHYDE#0.6904;OLIVOPONTOCEREBELLAR ATROPHY#0.6903;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6893;WOUND HEALING#0.6879;SERTRALINE#0.6878;EXPLORATORY BEHAVIOUR#0.6878;LATERAL PREOPTIC AREA#0.6870;MENOPAUSE#0.6863;CELL ADHESION#0.6860;GRANULOCYTE#0.6856;RESPONSE TO FORSKOLIN#0.6849;NEURAL CELL#0.6845;SOCIAL BEHAVIOUR#0.6844;LARGE BOWEL TRANSIT#0.6838;PROLACTINOMA#0.6820;PREMATURE LABOR#0.6818;PINEAL GLAND#0.6816;CONVULSION#0.6810;PROGESTIN#0.6806;RIMONABANT#0.6798;PROTEIN KINASE A SIGNALING#0.6797;PROTEIN KINASE ACTIVITY#0.6789;METHADONE#0.6787;NOREPINEPHRINE SECRETION#0.6783;EXOCYTOSIS#0.6778;VASOCONSTRICTION#0.6761;PARALLEL FIBER#0.6753;VASCULAR ENDOTHELIUM#0.6753;MOTOR LEARNING#0.6749;ADENOSINE 5'-MONOPHOSPHATE#0.6736;ESTRADIOL BENZOATE#0.6735;CARBAMAZEPINE#0.6729;INFERIOR COLLICULUS#0.6725;TPA ACTIVITY#0.6721;PANCREATIC NEUROENDOCRINE TUMOR#0.6713;SHAKING#0.6708;2-DEOXYGLUCOSE#0.6704;EXCITATORY POSTSYNAPTIC POTENTIAL#0.6699;RESPONSE TO ALCOHOL#0.6696;SCHAFFER COLLATERAL#0.6695;REPRODUCTIVE BEHAVIOR#0.6674;DOPAMINE D1 RECEPTOR#0.6669;BILE DUCT#0.6668;LUCIFERASE ACTIVITY#0.6667;CEREBRAL ARTERY OCCLUSION#0.6662;MECAMYLAMINE#0.6653;TERMINAL BOUTON#0.6651;TIGHT JUNCTION#0.6642;PREMATURITY#0.6639;TETRAHYDROCANNABINOL#0.6613;PROTEIN KINASE B#0.6600;ACTIVATED T-CELLS#0.6594;INFUNDIBULUM#0.6591;ACTIVATED T CELL#0.6591;AUTISM SPECTRUM DISORDER#0.6581;ARRHYTHMIA#0.6581;3-ISOBUTYL-1-METHYLXANTHINE#0.6577;BINDING PROTEIN 1#0.6567;ETOMIDATE#0.6563;CONSTRICTION#0.6561;ALOPECIA AREATA#0.6555;DYSPEPSIA#0.6554;RECEPTOR INTERNALIZATION#0.6552;HORMONE ACTIVITY#0.6551;ANDROGEN SECRETION#0.6539;FAT PAD#0.6536;LUMINAL#0.6534;CROMOLYN#0.6507;TRAUMATIC BRAIN INJURY#0.6500;DEPRESSANT#0.6491;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6487;MIGRAINE#0.6485;ATP BINDING#0.6481;HUMAN UMBILICAL VEIN#0.6480;TESTOSTERONE SECRETION#0.6479;SECRETORY VESICLE#0.6475;ATHEROSCLEROSIS#0.6474;LONG TERM MEMORY#0.6473;HYPERGLYCEMIC#0.6469;COMPLEX I#0.6468;S PHASE#0.6465;SENESCENCE#0.6463;HUMAN IMMUNODEFICIENCY VIRUS#0.6462;OUTER LAYER#0.6461;DEPHOSPHORYLATION#0.6451;GELONIN#0.6442;RICIN#0.6440;GASTRO#0.6436;CILIARY NEUROTROPHIC FACTOR#0.6418;MUSCLE WASTING#0.6410;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6404;SIZE EXCLUSION CHROMATOGRAPHY#0.6390;NECROTIC#0.6379;REGULATION OF SLEEP#0.6361;AMYLOID PRECURSOR PROTEIN#0.6361;PERIPHERAL BLOOD LYMPHOCYTES#0.6351;MYOCARDIUM#0.6337;ENURESIS#0.6336;BACLOFEN#0.6321;RESPONSE TO FOOD#0.6320;OPEN-FIELD BEHAVIOR#0.6316;LEUPROLIDE ACETATE#0.6303;TETRAETHYLAMMONIUM#0.6299;ADVERSE PREGNANCY OUTCOME#0.6291;ESCITALOPRAM#0.6288;CHORIOAMNIONITIS#0.6286;CHEWING#0.6276;NOVEL OBJECT RECOGNITION#0.6267;NOMEGA-NITRO-L-ARGININE#0.6266;PAINFUL BLADDER SYNDROME#0.6261;ADENYLATE CYCLASE INHIBITOR#0.6251;STEROID HORMONE RECEPTOR#0.6250;RUPTURE OF MEMBRANES#0.6250;GASTRIC ULCER#0.6242;FLUSHING#0.6242;GENE X ENVIRONMENT#0.6238;PROTEIN KINASE C ACTIVATION#0.6234;PHENELZINE#0.6231;ALLERGIC REACTION#0.6220;LOW FAT DIET#0.6214;FIMBRIA#0.6213;DENDRITIC TREE#0.6213;PLATELET ACTIVATING FACTOR#0.6207;HISTONE ACETYLATION#0.6198;HYPERANDROGENISM#0.6197;STEROID BIOSYNTHESIS#0.6190;MEDROXYPROGESTERONE ACETATE#0.6186;GLUTATHIONE#0.6183;AMP SYNTHESIS#0.6174;ALLERGEN#0.6172;CONNECTIVE TISSUE#0.6168;CYTOTOXIN#0.6160;CATALASE ACTIVITY#0.6149;POTASSIUM CHLORIDE#0.6144;LEUPROLIDE#0.6137;ALPHA1 ADRENERGIC RECEPTOR#0.6134;SOMATIZATION DISORDER#0.6121;72-HOURS#0.6121;HINDLIMB#0.6120;LASER SCANNING MICROSCOPY#0.6113;NOS INHIBITOR#0.6104;VISUAL ANALOG SCALE#0.6102;MAPK ACTIVATION#0.6095;MULTIPLE REGRESSION ANALYSIS#0.6088;ASPARTIC ACID#0.6088;LINEAR REGRESSION ANALYSIS#0.6084;GHRELIN SECRETION#0.6083;RESPONSE TO TREATMENT#0.6076;ECZEMA#0.6068;ALLATOSTATIN#0.6061;TRADITIONAL CHINESE MEDICINE#0.6059;OVIDUCT#0.6047;NEUROLOGICAL DISORDER#0.6047;DOXORUBICIN#0.6042;CORONARY HEART DISEASE#0.6030;RED BLOOD CELL#0.6021;AUTOPHAGY#0.6020;TACHYCARDIC#0.6017;BETA1 ADRENERGIC RECEPTOR#0.6014;REGULATED SECRETORY PATHWAY#0.6013
139322	MICOS COMPLEX#1.0533;CRISTAE#0.9302;MINOS COMPLEX#0.8707;CONTACT SITE#0.7769;CARDIOLIPIN#0.7593;CARDIOLIPIN BINDING#0.7054
139341	MITOPHAGY#1.0825;MITOCHONDRIAL FISSION#1.0759;HYPOXIA#1.0542;MITOCHONDRIA#1.0423;HYPOXIC#1.0392;APOPTOSIS#0.9848;AUTOPHAGY#0.9675;MITOCHONDRIAL OUTER MEMBRANE#0.9647;OUTER MEMBRANE#0.9561;MITOCHONDRIAL MEMBRANE#0.9424;OUTER MITOCHONDRIAL MEMBRANE#0.9067;RESPONSE TO HYPOXIA#0.8901;CARDIOMYOCYTE#0.8409;DEPHOSPHORYLATION#0.8234;ER MEMBRANE#0.7810;ISCHEMIA#0.7783;CELL DEATH#0.7678;CANCER CELL#0.7488;ISCHEMIA REPERFUSION INJURY#0.7315;ENDOPLASMIC RETICULUM#0.6965;INFLAMMATORY RESPONSE#0.6951;LIGHT CHAIN 3#0.6575;MICROTUBULE ASSOCIATED PROTEIN#0.6327
1393	CORTICOTROPIN-RELEASING HORMONE BINDING#1.1034;CRH BINDING#1.0807;CRF BINDING#1.0711;HORMONE BINDING#1.0650;CORTICOTROPIN-RELEASING FACTOR BINDING#1.0560;AMYGDALA#1.0290;CORTICOTROPHIN RELEASING HORMONE#1.0269;CORTISOL#1.0247;CORTICOTROPHIN#1.0124;GENE EXPRESSION#1.0106;CORTICOTROPIN#1.0082;CORTICOTROPIN-RELEASING FACTOR#1.0030;HYPOTHALAMIC PITUITARY ADRENAL#0.9751;AMNIOTIC FLUID#0.9589;NERVOUS SYSTEM#0.9336;CENTRAL NERVOUS SYSTEM#0.9291;GESTATION#0.9267;RECEPTOR ANTAGONIST#0.9236;RECEPTOR AGONIST#0.9196;PARTURITION#0.9154;DEXAMETHASONE#0.8714;GLUCOCORTICOID RECEPTOR#0.8633;MYOMETRIUM#0.8263;CUSHING'S SYNDROME#0.8028;OBESE#0.7961;ADDISON'S DISEASE#0.7796;ACTH SECRETION#0.7766;ASTROCYTE#0.7591;ALZHEIMER'S DISEASE#0.7556;BIPOLAR DISORDER#0.7386;RESPONSE TO STRESS#0.7371;UMBILICAL CORD#0.7358;FORSKOLIN#0.7336;SIGNALING PATHWAY#0.7064;DOPAMINE#0.7060;ALCOHOL USE DISORDER#0.6943;WEIGHT GAIN#0.6941;POLYMERASE CHAIN REACTION#0.6727;ADRENOCORTICOTROPIC HORMONE#0.6680;DNA METHYLATION#0.6537;REVERSE TRANSCRIPTION#0.6502;PROTEIN KINASE#0.6477;SEBACEOUS GLAND#0.6469;ELEVATED PLUS MAZE#0.6410;ESTRADIOL#0.6337;MATERNAL AGGRESSION#0.6335;DEPRESSIVE SYMPTOMS#0.6158;SECRETORY GRANULE#0.6154;GLUTAMIC ACID#0.6121;MATERNAL BEHAVIOR#0.6095;HYPOTHALAMUS PITUITARY ADRENAL#0.6058;OVARIAN#0.6006
139411	INTELLECTUAL DISABILITY#1.0331;AUTISM SPECTRUM DISORDER#1.0265
1394	CRH BINDING#1.0538;SENSITIZATION#1.0407;HYPOXIA#1.0304;ETHANOL#1.0278;FOREBRAIN#1.0276;CRF BINDING#1.0177;VASOPRESSIN#1.0162;OPIOID RECEPTOR#1.0156;SOCIAL DEFEAT STRESS#1.0153;GLUCOCORTICOID RECEPTOR#1.0136;RECEPTOR BINDING#1.0122;DEPRESSIVE SYMPTOMS#1.0098;PITUITARY GLAND#1.0096;MAST CELL#1.0090;CORTICOTROPIN-RELEASING FACTOR#1.0071;EARLY LIFE STRESS#1.0047;ARGININE VASOPRESSIN#1.0040;ACTH SECRETION#1.0039;CORTICOTROPHIN RELEASING HORMONE#1.0031;RECEPTOR AGONIST#1.0014;RECEPTOR ANTAGONIST#1.0014;POLYMERASE CHAIN REACTION#1.0000;CORTICOTROPIN#0.9994;DOPAMINE#0.9989;AMYGDALA#0.9968;PROTEIN KINASE A#0.9962;ARGININE#0.9941;RECEPTOR LIGAND#0.9935;PROTEIN KINASE#0.9922;ADRENOCORTICOTROPIC HORMONE#0.9911;SIGNAL TRANSDUCTION#0.9904;SIGNALING PATHWAY#0.9904;LOCUS COERULEUS#0.9888;CORTICOTROPHIN#0.9887;REVERSE TRANSCRIPTION#0.9884;ANXIETY DISORDER#0.9861;MAJOR DEPRESSIVE DISORDER#0.9860;PANIC DISORDER#0.9860;CORTISOL#0.9859;TRANSCRIPTION FACTOR#0.9858;GROWTH FACTOR#0.9857;GENE EXPRESSION#0.9831;CELL PROLIFERATION#0.9831;HYPERSENSITIVITY#0.9827;ADENYLATE CYCLASE#0.9824;RESPONSE TO STRESS#0.9815;IRRITABLE BOWEL SYNDROME#0.9793;PLASMA MEMBRANE#0.9788;SEPTUM#0.9773;CENTRAL NERVOUS SYSTEM#0.9772;APOPTOSIS#0.9768;ADRENAL GLAND#0.9765;ELEVATED PLUS MAZE#0.9742;NERVOUS SYSTEM#0.9740;SMOOTH MUSCLE#0.9732;COLORECTAL#0.9708;KERATINOCYTE#0.9706;PROTEIN KINASE C#0.9684;DEXAMETHASONE#0.9662;SYNAPTIC TRANSMISSION#0.9660;FK506 BINDING#0.9659;ALCOHOL DEPENDENCE#0.9646;PURKINJE CELL#0.9643;FK506 BINDING PROTEIN#0.9641;HYPOTHALAMIC PITUITARY ADRENAL#0.9624;MOOD DISORDER#0.9609;FLUOXETINE#0.9577;CELL SURFACE#0.9561;NEUROTRANSMISSION#0.9559;HYPOTHALAMUS PITUITARY ADRENAL#0.9553;MEDIAL PREFRONTAL CORTEX#0.9541;ADENYLATE#0.9539;ALZHEIMER'S DISEASE#0.9538;SIGNAL PEPTIDE#0.9516;WEIGHT LOSS#0.9507;CYCLIC AMP#0.9473;POST-TRAUMATIC STRESS DISORDER#0.9428;GASTRIC EMPTYING#0.9425;NOREPINEPHRINE#0.9422;IMMUNE RESPONSE#0.9418;DNA METHYLATION#0.9409;FEEDING BEHAVIOR#0.9403;COLITIS#0.9387;PERIPHERAL BLOOD#0.9372;TROPHOBLAST#0.9350;HUMAN EMBRYONIC KIDNEY#0.9339;EMBRYONIC KIDNEY#0.9335;FRONTAL#0.9316;CLASS B GPCR#0.9284;LINKED POLYMORPHIC REGION#0.9280;ALCOHOL USE DISORDER#0.9275;GESTATION#0.9262;MYOMETRIUM#0.9259;CANCER CELL#0.9211;MELANOCORTIN RECEPTOR#0.9188;ESTROGEN RECEPTOR#0.9176;WEIGHT GAIN#0.9138;TOXICITY#0.9134;PDZ BINDING MOTIF#0.9118;QUANTITATIVE REAL TIME#0.9090;T CELL#0.9060;STRESSFUL LIFE EVENTS#0.9053;MATERNAL BEHAVIOR#0.9004;CORTICOSTERONE SECRETION#0.9000;IMMUNE CELL#0.8996;OLFACTORY BULB#0.8982;ADRENERGIC RECEPTOR#0.8972;ANOREXIA#0.8941;STARTLE RESPONSE#0.8922;IMMUNE SYSTEM#0.8902;OVARIAN#0.8854;DOPAMINE RECEPTOR#0.8826;SIGNALLING PATHWAY#0.8825;PYRAMIDAL CELL#0.8818;MIDBRAIN#0.8806;STRUCTURE ACTIVITY RELATIONSHIP#0.8785;PRO-INFLAMMATORY#0.8782;MACROPHAGE#0.8746;MITOGEN ACTIVATED PROTEIN#0.8744;GASTROINTESTINAL TRACT#0.8702;VASOPRESSIN RECEPTOR#0.8700;ENDOCYTOSIS#0.8694;STRIATUM#0.8689;MUSCLE CELL#0.8644;NITRIC OXIDE#0.8634;CYCLASE ACTIVITY#0.8621;SUCROSE#0.8586;SMOOTH MUSCLE CELL#0.8545;SOCIAL BEHAVIOR#0.8539;BREAST CANCER#0.8520;NORADRENALINE#0.8517;BIPOLAR DISORDER#0.8515;GENE X ENVIRONMENT#0.8512;LEYDIG CELL#0.8499;HYPERACTIVITY#0.8483;TUMOR NECROSIS FACTOR#0.8434;INFLAMMATORY RESPONSE#0.8366;EPITHELIAL CELL#0.8354;MATERNAL AGGRESSION#0.8314;SKELETAL MUSCLE#0.8314;CONDITIONED PLACE PREFERENCE#0.8297;HORMONE BINDING#0.8292;ENDOTHELIAL CELL#0.8282;DENDRITIC SPINE#0.8277;OPEN FIELD TEST#0.8273;CARDIOVASCULAR SYSTEM#0.8259;PHOSPHOLIPASE C#0.8234;CALCIUM CHANNEL#0.8227;BLOOD BRAIN BARRIER#0.8225;FORCED SWIM TEST#0.8225;DENTATE GYRUS#0.8218;INTERNEURON#0.8182;BODY WEIGHT GAIN#0.8176;ADENYLATE CYCLASE ACTIVITY#0.8131;APOPTOTIC#0.8111;NMDA RECEPTOR#0.8088;LOCOMOTION#0.8088;ENDOPLASMIC RETICULUM#0.8053;RECEPTOR INTERNALIZATION#0.8052;RESPONSE TO ANTIDEPRESSANT#0.8027;GROWTH HORMONE#0.8027;CALCIUM SIGNALING#0.7964;CRF RECEPTOR BINDING#0.7957;COGNITION#0.7950;GLUTAMATE RECEPTOR#0.7896;CEREBRAL CORTEX#0.7890;CHROMAFFIN CELL#0.7879;BLOOD VESSEL#0.7873;CELL MIGRATION#0.7851;ENDOMETRIUM#0.7826;SYNAPTIC FACILITATION#0.7813;RECEPTOR ACTIVITY#0.7786;CAMP RESPONSE ELEMENT#0.7782;STEROIDOGENESIS#0.7762;MELANOCYTE#0.7714;HYPERTENSION#0.7695;SEROTONIN REUPTAKE INHIBITOR#0.7693;PSORIASIS#0.7690;RESONANCE ENERGY TRANSFER#0.7662;ABDOMINAL PAIN#0.7650;ISCHEMIA#0.7647;CAMP FORMATION#0.7617;ENDOTHELIAL GROWTH FACTOR#0.7591;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7591;MAST CELL DEGRANULATION#0.7564;HYPOXIC#0.7539;BASAL GANGLIA#0.7526;YOHIMBINE#0.7521;TRANSCRIPTASE#0.7506;MUTAGENESIS#0.7486;ACOUSTIC STARTLE RESPONSE#0.7478;THALAMUS#0.7467;LIMBIC SYSTEM#0.7462;PEPTIDE HORMONE#0.7462;TESTOSTERONE#0.7430;GABAERGIC NEURON#0.7429;CORTICOTROPIN-RELEASING HORMONE BINDING#0.7422;SEROTONIN RECEPTOR#0.7420;MENTAL DISORDER#0.7379;CHRONIC MILD STRESS#0.7352;ESTRADIOL#0.7340;CHILDHOOD TRAUMA QUESTIONNAIRE#0.7340;PARTURITION#0.7300;HISTAMINE#0.7297;CELL MEMBRANE#0.7290;ADENOSINE#0.7239;GLIAL CELL#0.7185;CAMP RESPONSE ELEMENT BINDING#0.7180;CEREBRAL ISCHEMIA#0.7173;THYROID GLAND#0.7164;NEUROBLASTOMA#0.7151;NALTREXONE#0.7138;ADIPOSE TISSUE#0.7108;HEROIN#0.7079;CORTICOTROPIN-RELEASING FACTOR BINDING#0.7067;CAMP SIGNALING#0.7043;DEFECATION#0.7025;INNERVATION#0.7017;ENERGY HOMEOSTASIS#0.7006;PUBERTY#0.6994;SIGNALING CASCADE#0.6963;THECAL CELL#0.6873;AGGRESSIVE BEHAVIOR#0.6871;PEPTIDE BINDING#0.6866;FORSKOLIN#0.6859;YELLOW FLUORESCENT PROTEIN#0.6776;BENZODIAZEPINE RECEPTOR#0.6716;DIAZEPAM#0.6701;RNA INTERFERENCE#0.6698;HIGH FAT DIET#0.6698;NOCICEPTION#0.6693;ADRENAL CORTEX#0.6578;LONG TERM POTENTIATION#0.6576;STEM CELL#0.6555;DIURNAL#0.6547;PROSTATE CANCER#0.6543;SPINAL CORD#0.6519;OXYTOCIN RECEPTOR#0.6487;ULCERATIVE COLITIS#0.6485;SUBSTANTIA NIGRA#0.6479;ASPARTATE#0.6473;LATERAL VENTRICLE#0.6468;CELLULAR LOCALIZATION#0.6455;CELL WALL#0.6423;ACTION POTENTIAL#0.6422;SUBSTANCE P#0.6413;EDEMA#0.6403;ANDROGEN RECEPTOR#0.6402;LACTATION#0.6398;CELL ADHESION#0.6393;PROGESTERONE#0.6390;HISTIDINE#0.6386;DELAYED GASTRIC EMPTYING#0.6383;POST NATAL DAY#0.6380;BONE MARROW#0.6377;CELL DEATH#0.6356;EATING DISORDER#0.6340;EPIDIDYMIS#0.6315;EPINEPHRINE#0.6310;DERMATITIS#0.6304;MECHANISM OF ACTION#0.6287;HAIR FOLLICLE#0.6280;ASTROCYTE#0.6271;HYPOGLYCEMIA#0.6264;ANGIOGENESIS#0.6256;RIBOSOMAL PROTEIN#0.6224;GRANULOSA CELL#0.6223;ESTROGEN RECEPTOR ALPHA#0.6213;RESPONSE TO CORTICOSTEROID#0.6208;INSULIN SECRETION#0.6199;MOTOR ACTIVITY#0.6186;CELL ADHESION MOLECULE#0.6114;BREAST CANCER CELL#0.6103;EARLY LIFE ADVERSITY#0.6094;T-TYPE CALCIUM CHANNEL#0.6085;CONDITIONED PLACE AVERSION#0.6060;ASSOCIATIVE LEARNING#0.6054;COLITIS ASSOCIATED CANCER#0.6049;CHRONIC SOCIAL DEFEAT#0.6047;OOCYTE#0.6036;ACID SECRETION#0.6001
139538	CIRCADIAN RHYTHM#0.7653;MELATONIN#0.6349
139596	CYTOSINE DEAMINASE#1.0735;URACIL#1.0639;PYRIMIDINE SALVAGE#1.0639;CANCER CELL#1.0615;5-FLUOROCYTOSINE#1.0504;5 FLUOROURACIL#1.0360;FLUOROURACIL#1.0319;5-FLUOROURIDINE#1.0121;URIDINE#0.9858;PROSTATE CANCER#0.9460;GENE EXPRESSION#0.9200;COLON CANCER#0.9091;URIDINE-5'-MONOPHOSPHATE#0.8756;URIDINE KINASE#0.7457;PROSTATE-SPECIFIC MEMBRANE ANTIGEN#0.6980;MAGNETIC RESONANCE SPECTROSCOPY#0.6958;CYTOTOXICITY#0.6848;CYTOSINE DEAMINASE ACTIVITY#0.6848;DEAMINASE ACTIVITY#0.6344;TUMOR CELLS#0.6278;5-PHOSPHORIBOSYL 1-PYROPHOSPHATE#0.6252;THYMIDINE KINASE#0.6058
1395	SKELETAL MUSCLE#1.0385;SMOOTH MUSCLE#1.0136;AMYGDALA#1.0100;RECEPTOR ANTAGONIST#1.0024;CORTICOTROPHIN#1.0011;CORTICOTROPHIN RELEASING HORMONE#1.0000;GENE EXPRESSION#0.9933;CORTICOTROPIN-RELEASING FACTOR#0.9927;GLUCOCORTICOID RECEPTOR#0.9886;CORTICOTROPIN#0.9875;RESPONSE TO STRESS#0.9870;NERVOUS SYSTEM#0.9815;SIGNALING PATHWAY#0.9812;POLYMERASE CHAIN REACTION#0.9789;CRF BINDING#0.9779;HYPOTHALAMIC PITUITARY ADRENAL#0.9766;PROTEIN KINASE#0.9742;CENTRAL NERVOUS SYSTEM#0.9730;GROWTH FACTOR#0.9585;MUSCLE CELL#0.9563;PITUITARY GLAND#0.9370;APOPTOSIS#0.9336;CRH BINDING#0.9243;COLITIS#0.9210;TRANSCRIPTION FACTOR#0.9205;ETHANOL#0.9163;TROPHOBLAST#0.9058;SEPTUM#0.9026;ELEVATED PLUS MAZE#0.8998;EPITHELIAL CELL#0.8915;CARDIOMYOCYTE#0.8880;RECEPTOR AGONIST#0.8759;MYOMETRIUM#0.8694;PROTEIN KINASE A#0.8684;CYTOKINE RECEPTOR#0.8640;SMOOTH MUSCLE CELL#0.8545;HIGH FAT DIET#0.8539;VASOPRESSIN#0.8530;ADRENAL GLAND#0.8452;QUANTITATIVE REAL TIME#0.8448;ENDOTHELIAL CELL#0.8408;REVERSE TRANSCRIPTION#0.8376;FOREBRAIN#0.8349;ANGIOGENESIS#0.8336;PANIC DISORDER#0.8286;HYPOXIA#0.8181;ADRENOCORTICOTROPIC HORMONE#0.8177;ESTROGEN RECEPTOR#0.8115;CANCER CELL#0.8063;SOCIAL BEHAVIOR#0.7923;DOPAMINE#0.7869;ANXIETY DISORDER#0.7853;CELL PROLIFERATION#0.7802;BLOOD VESSEL#0.7778;CELL CYCLE#0.7770;ANORECTIC#0.7763;DNA METHYLATION#0.7708;PRO-INFLAMMATORY#0.7562;THYROID GLAND#0.7499;CARDIOVASCULAR SYSTEM#0.7459;IRRITABLE BOWEL SYNDROME#0.7456;ARGININE VASOPRESSIN#0.7444;WEIGHT LOSS#0.7418;CELL MIGRATION#0.7418;HYPERTENSION#0.7351;TROPHOBLAST CELL#0.7334;RECEPTOR LIGAND#0.7294;PHOSPHOLIPASE C#0.7280;GASTROINTESTINAL TRACT#0.7278;ADIPOSE TISSUE#0.7244;PROSTATE CANCER#0.7218;B CELL#0.7191;FK506 BINDING PROTEIN#0.7165;FK506 BINDING#0.7163;SPINAL CORD#0.7044;ARGININE#0.6935;ISCHEMIA REPERFUSION INJURY#0.6891;EPIDIDYMIS#0.6843;INFLAMMATORY RESPONSE#0.6762;SYNAPTIC TRANSMISSION#0.6756;PROTEIN KINASE C#0.6750;FORCED SWIM TEST#0.6584;MYOCARDIUM#0.6569;GASTRIC EMPTYING#0.6553;CALCIUM CHANNEL#0.6553;ENDOCYTOSIS#0.6483;COLORECTAL#0.6479;GASTRIC MOTILITY#0.6395;TRANSCRIPTASE#0.6328;ISCHEMIA#0.6326;MEDIAL PREFRONTAL CORTEX#0.6326;ESTROGENS#0.6248;FEEDING BEHAVIOR#0.6223;ADIPOCYTE#0.6206;IMMUNE SYSTEM#0.6131;IMMUNE RESPONSE#0.6111;HORMONE BINDING#0.6071;RECEPTOR BINDING#0.6032;STARTLE RESPONSE#0.6020
139604	PLURIPOTENT STEM CELL#0.6816
139628	CANCER CELL#1.0960;CELL PROLIFERATION#1.0903;BREAST CANCER#0.8450;PROSTATE CANCER#0.8129;SIGNALING PATHWAY#0.7303;MEDULLOBLASTOMA#0.6963;TRANSCRIPTION FACTOR#0.6537;EPITHELIAL MESENCHYMAL TRANSITION#0.6463;CELL GROWTH#0.6451;OVARIAN CANCER#0.6436;LUNG CANCER#0.6317;HEDGEHOG SIGNALING PATHWAY#0.6028
1396	BREAST CANCER#0.7896;SIGNALING PATHWAY#0.7600;SMOOTH MUSCLE#0.7380;COLORECTAL CANCER#0.7062;GENE EXPRESSION#0.6548;MUSCLE CELL#0.6194;CANCER CELL#0.6123
139716	MACROPHAGE DIFFERENTIATION#0.9783;MACROPHAGE#0.7955;GROWTH FACTOR#0.7313;BINDING PROTEIN 3#0.6510;CELL PROLIFERATION#0.6363;GRB2 ASSOCIATED BINDER#0.6240;DOCKING PROTEIN#0.6109
139728	BREAST CANCER#0.8607;PROTEIN KINASE#0.7729;CELL CYCLE#0.7009;SIGNALING PATHWAY#0.6786;CANCER CELL#0.6783;ADJACENT NORMAL TISSUE#0.6387;MAMMARY EPITHELIAL CELL#0.6364;MAMMARY GLAND#0.6322;HUMAN BREAST CANCER#0.6298;BREAST CANCER CELL#0.6259;EPITHELIAL CELL#0.6209
139741	ACTIN RELATED PROTEIN#0.6067
139760	ENTEROENDOCRINE CELL#1.0523;TYPE 2 DIABETES MELLITUS#1.0491;2 DIABETES MELLITUS#1.0490;RECEPTOR AGONIST#1.0462;DIABETES MELLITUS#1.0447;GLUCOSE HOMEOSTASIS#1.0369;INSULIN SECRETION#1.0360;TYPE 2 DIABETES#1.0299;BETA CELL#1.0270;PANCREATIC ISLET#1.0231;GASTROINTESTINAL TRACT#0.9766;CANNABINOID RECEPTOR#0.9474;STRUCTURE ACTIVITY RELATIONSHIP#0.9245;SMALL INTESTINE#0.9211;ORAL GLUCOSE TOLERANCE#0.9195;APD668#0.9165;WEIGHT LOSS#0.9034;GLUCOSE TOLERANCE TEST#0.8594;GENE EXPRESSION#0.8424;GASTRIC EMPTYING#0.8280;BLOOD GLUCOSE LEVEL#0.8208;OBESE#0.7939;HORMONE SECRETION#0.7886;HYPOGLYCEMIA#0.7451;PEROXISOME#0.7438;SITAGLIPTIN#0.7365;METFORMIN#0.7197;STREPTOZOTOCIN#0.7144;ENDOCRINE CELL#0.7012;SIGNALING PATHWAY#0.6981;GLUCAGON SECRETION#0.6947;GLUCOSE METABOLISM#0.6837;ION CHANNEL#0.6798;LINAGLIPTIN#0.6589;HIGH FAT DIET#0.6551;CELL PROLIFERATION#0.6501;HYPERGLYCEMIC#0.6418;INSULINOMA#0.6393;ADENYLATE CYCLASE#0.6323;PROTEIN KINASE#0.6202;ALPHA CELL#0.6089;DIPEPTIDYL PEPTIDASE#0.6061;ION TRANSPORT#0.6003
1397	SMOOTH MUSCLE#0.9645;SMOOTH MUSCLE CELL#0.9022;MUSCLE CELL#0.9015;VASCULAR SMOOTH MUSCLE CELL#0.7772;GENE EXPRESSION#0.7006;SQUAMOUS CELL CARCINOMA#0.6296
139818	NUCLEOTIDE EXCHANGE FACTOR#1.0316;GUANINE#0.9885;B CELL#0.9627;BONE MARROW#0.7773;CYTOKINESIS#0.6941;T CELL#0.6840;GERMINAL CENTER B CELL#0.6602;GERMINAL CENTER B#0.6599;GERMINAL CENTER#0.6535;IMMUNE RESPONSE#0.6380
1398	P38 MAPK SIGNALING#1.0830;SIGNALING ADAPTOR#1.0480;MAPK ACTIVATION#1.0464;SH3 DOMAIN BINDING#1.0423;MAPK SIGNALING#1.0416;MEMBRANE RUFFLING#1.0412;ACTIN POLYMERIZATION#1.0344;LUNG CANCER#1.0331;DOCKING PROTEIN#1.0254;INSULIN-LIKE GROWTH FACTOR#1.0227;CELL MOTILITY#1.0216;GUANINE#1.0212;NUCLEOTIDE EXCHANGE FACTOR#1.0186;FACTOR I#1.0132;DOMINANT NEGATIVE MUTANT#1.0129;LIPID RAFT#1.0123;FOCAL ADHESION KINASE#1.0110;SIGNALING MOLECULE#1.0105;MAP KINASE#1.0102;APOPTOTIC#1.0091;PHOSPHOLIPASE C#1.0089;INSULIN RECEPTOR#1.0083;FOCAL ADHESION#1.0064;T CELL ACTIVATION#1.0054;CELL ACTIVATION#1.0039;EPIDERMAL GROWTH FACTOR#1.0037;SIGNALLING PATHWAY#1.0029;CELL MIGRATION#0.9999;T LYMPHOCYTE#0.9989;CELL DEATH#0.9983;MITOGEN ACTIVATED PROTEIN#0.9964;SMOOTH MUSCLE#0.9964;PHAGOCYTOSIS#0.9954;KINASE INHIBITOR#0.9946;PROTEIN KINASE#0.9937;GROWTH FACTOR RECEPTOR#0.9934;BREAST CANCER#0.9934;T CELL#0.9931;HOST CELL#0.9928;TRANSCRIPTION FACTOR#0.9909;CELL CYCLE#0.9908;PROTEIN KINASE C#0.9902;SRC FAMILY KINASE#0.9896;B CELL#0.9883;SIGNALING CASCADE#0.9883;ONCOGENIC#0.9882;SIGNALING PATHWAY#0.9882;CANCER CELL#0.9880;NERVE GROWTH FACTOR#0.9877;KINASE ACTIVITY#0.9875;ACTIN CYTOSKELETON#0.9874;CELL ADHESION#0.9870;APOPTOSIS#0.9854;SIGNAL TRANSDUCTION#0.9853;ANCHORAGE INDEPENDENT GROWTH#0.9843;PROTEIN TYROSINE KINASE#0.9841;RECEPTOR TYROSINE KINASE#0.9840;ENDOTHELIAL CELL#0.9832;MACROPHAGE#0.9828;CELL SURFACE#0.9809;MUSCLE CELL#0.9799;GROWTH FACTOR#0.9796;TRANSACTIVATION#0.9789;CELL GROWTH#0.9784;EPITHELIAL CELL#0.9779;GENE EXPRESSION#0.9776;RNA INTERFERENCE#0.9767;CELL PROLIFERATION#0.9757;REACTIVE OXYGEN SPECIES#0.9751;HEPATOCYTE GROWTH FACTOR#0.9676;PLASMA MEMBRANE#0.9672;EXTRACELLULAR MATRIX#0.9671;MEMBRANE RUFFLE#0.9655;IMMUNE RESPONSE#0.9648;HEMATOPOIETIC CELL#0.9619;DEPHOSPHORYLATION#0.9603;TUMOR NECROSIS FACTOR#0.9603;PROTEIN PROTEIN INTERACTION#0.9580;PROTEIN BINDING#0.9532;SIGNAL TRANSDUCER#0.9498;GLUTATHIONE#0.9488;TUMOR CELLS#0.9481;ADHERENS JUNCTION#0.9471;MAPKK#0.9430;SMOOTH MUSCLE CELL#0.9429;PLATELET-DERIVED GROWTH FACTOR#0.9428;STRESS FIBER#0.9406;INSULIN RECEPTOR SUBSTRATE#0.9380;BREAST CANCER CELL#0.9343;TOLL LIKE RECEPTOR#0.9301;PROTEIN TYROSINE PHOSPHATASE#0.9301;JUN KINASE#0.9290;RUFFLE#0.9249;INFLUENZA A VIRUS#0.9156;VIRAL INFECTION#0.9103;EPSTEIN BARR VIRUS#0.9050;NF-KAPPAB ACTIVATION#0.9037;EPHRIN#0.9023;MYOBLAST#0.9022;HERPES SIMPLEX VIRUS#0.9010;HERPES SIMPLEX#0.9007;CATALYTIC ACTIVITY#0.8973;NEURITE#0.8939;TUMOR SUPPRESSOR#0.8929;ADENOCARCINOMA#0.8929;ENDOTHELIAL GROWTH FACTOR#0.8862;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8862;PHOSPHOTYROSINE BINDING#0.8860;INFLAMMATORY RESPONSE#0.8849;CYTOPLASM#0.8833;COMPLEX I#0.8814;OVARIAN#0.8770;NITRIC OXIDE#0.8768;TRANSFORMING GROWTH FACTOR#0.8765;BONE MARROW#0.8753;ACTIVATED T CELL#0.8718;GROWTH HORMONE#0.8712;HUMAN UMBILICAL VEIN#0.8708;UMBILICAL VEIN#0.8706;HEPATITIS C#0.8701;TYROSINE KINASE INHIBITOR#0.8698;OVARIAN CANCER#0.8694;DNA BINDING#0.8692;CELL DIFFERENTIATION#0.8682;PERIPHERAL BLOOD#0.8654;DNA SYNTHESIS#0.8617;KAPOSI'S SARCOMA#0.8610;HEPATITIS C VIRUS#0.8610;PROSTATE CANCER#0.8539;MORPHOGENESIS#0.8528;FIBROBLAST GROWTH FACTOR#0.8472;POLYMERASE CHAIN REACTION#0.8423;VIRAL REPLICATION#0.8396;ACTIVATED T-CELLS#0.8396;NEUTROPHIL#0.8359;FK506 BINDING PROTEIN#0.8307;FK506 BINDING#0.8304;NERVOUS SYSTEM#0.8243;CD4+ T CELL#0.8218;PROTEIN SYNTHESIS#0.8200;MUTAGENESIS#0.8182;SKELETAL MUSCLE#0.8142;HUMAN IMMUNODEFICIENCY VIRUS#0.8139;ENGULFMENT OF APOPTOTIC CELL#0.8132;PROTEIN COMPLEX#0.8117;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8114;ROS GENERATION#0.8098;LEUKOCYTE#0.8086;MONOCYTE#0.8031;HYPERPHOSPHORYLATION#0.8013;OSTEOCLAST DIFFERENTIATION#0.7940;APOPTOTIC CELL DEATH#0.7922;VIRION#0.7916;CELL MEMBRANE#0.7895;ENDOCYTOSIS#0.7891;DENDRITIC CELL#0.7805;HEPATITIS B#0.7741;CALCINEURIN#0.7725;ACTIVATING TRANSCRIPTION FACTOR#0.7715;ADIPOCYTE#0.7708;RECEPTOR COMPLEX#0.7691;P38 MAPK SIGNALLING#0.7672;INNATE IMMUNE RESPONSE#0.7658;ACTIVATION OF MAP KINASE#0.7657;WOUND HEALING#0.7636;EXTRACELLULAR REGULATED KINASE#0.7616;INHIBITION OF CELL MIGRATION#0.7539;MAPK SIGNALLING#0.7536;GRB2 ASSOCIATED BINDER#0.7535;NEURITE OUTGROWTH#0.7506;VIRULENCE#0.7461;PHOSPHATASE ACTIVITY#0.7430;IMMUNE CELL#0.7426;INTERLEUKIN 1 RECEPTOR#0.7415;GTP BINDING#0.7413;CYCLOPHILIN#0.7412;IFN-GAMMA#0.7380;MOUSE EMBRYO FIBROBLASTS#0.7346;SYNOVIAL SARCOMA#0.7330;CYTOTOXICITY#0.7295;P21 ACTIVATED KINASE#0.7285;CARDIOMYOCYTE#0.7266;FENRETINIDE#0.7259;ANGIOGENESIS#0.7251;GENE SILENCING#0.7240;EPITHELIAL MESENCHYMAL TRANSITION#0.7232;STEM CELL#0.7173;AKT SIGNALING#0.7168;CYCLOSPORIN A#0.7128;OSTEOCLAST#0.7064;MAP KINASE CASCADE#0.7060;UBIQUITIN#0.7009;HEPATITIS B VIRUS#0.6997;CYCLIN DEPENDENT KINASE#0.6992;VASCULAR SMOOTH MUSCLE CELL#0.6984;CYTOSKELETON ORGANIZATION#0.6968;LYMPH NODE#0.6947;HYPOXIA#0.6936;ACTIN CYTOSKELETON ORGANIZATION#0.6911;GUANINE EXCHANGE FACTOR#0.6885;LISSENCEPHALY#0.6844;CHEMOTAXIS#0.6841;LUNG ADENOCARCINOMA#0.6841;PROTEASOME#0.6835;AUTOPHAGY#0.6832;EPITHELIAL OVARIAN CARCINOMA#0.6790;HYALURONIC ACID#0.6790;ACTIVATION OF NF-KAPPAB#0.6772;INNATE IMMUNITY#0.6727;OVARIAN CARCINOMA#0.6703;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6653;EPITHELIAL TO MESENCHYMAL#0.6651;TOXICITY#0.6621;IMMUNE SYSTEM#0.6596;INTEGRIN LIGAND#0.6592;ACTIN FILAMENT#0.6589;MYELOID LEUKEMIA#0.6554;DEVELOPMENTAL DELAY#0.6541;PROGENITOR CELL#0.6540;NITRIC OXIDE SYNTHASE#0.6539;MAPK CASCADE#0.6532;VIRAL GENOME#0.6504;JNK CASCADE#0.6439;IMMUNOPHILIN#0.6394;AVIAN INFLUENZA#0.6381;CELL MOVEMENT#0.6340;TYROSINE KINASE RECEPTOR#0.6303;GLUCOSE TRANSPORT#0.6299;CENTRAL NERVOUS SYSTEM#0.6291;DEATH RECEPTOR#0.6281;CYCLOSPORIN#0.6270;RESONANCE ENERGY TRANSFER#0.6268;MYOCARDITIS#0.6260;PROTEIN KINASE B#0.6249;CAMKII#0.6244;PROTEIN KINASE A#0.6232;MOUSE EMBRYONIC FIBROBLAST#0.6191;EFFECTOR T CELL#0.6186;BRAIN DEVELOPMENT#0.6175;MYOBLAST FUSION#0.6170;T CELL MIGRATION#0.6135;JNK SIGNALING PATHWAY#0.6105;MECHANISM OF ACTION#0.6098;SERUM RESPONSE FACTOR#0.6087;BORNA DISEASE#0.6081;FOCAL CONTACT#0.6068;PANCREATIC DUCTAL ADENOCARCINOMA#0.6030;ADENO ASSOCIATED VIRUS#0.6027;RESPONSE TO INSULIN#0.6001
1399	GUANINE#1.0481;NUCLEOTIDE EXCHANGE FACTOR#1.0427;HEMATOPOIETIC CELL#1.0335;BREAST CANCER#1.0324;CELL PROLIFERATION#1.0275;FOCAL ADHESION#1.0248;CANCER CELL#1.0245;LUNG CANCER#1.0192;T CELL#1.0130;IMATINIB#1.0113;GROWTH FACTOR#1.0045;SIGNALING PATHWAY#1.0009;SIGNAL TRANSDUCTION#0.9984;APOPTOSIS#0.9954;CHRONIC MYELOID LEUKEMIA#0.9917;MYELOID LEUKEMIA#0.9870;B CELL#0.9838;GROWTH FACTOR RECEPTOR#0.9837;CELL CYCLE#0.9822;KINASE ACTIVITY#0.9819;KINASE INHIBITOR#0.9810;CELL ADHESION#0.9795;CELL MIGRATION#0.9591;TYROSINE KINASE INHIBITOR#0.9544;BREAST CANCER CELL#0.9473;SIGNALING CASCADE#0.9466;CELL GROWTH#0.9461;PROTEIN KINASE#0.9357;RECEPTOR TYROSINE KINASE#0.9189;SRC FAMILY KINASE#0.9116;ONCOGENIC#0.9111;EPITHELIAL CELL#0.9000;CERVICAL CANCER#0.8960;GENE EXPRESSION#0.8933;MYELOID CELL#0.8894;SIGNALING MOLECULE#0.8785;LYMPH NODE#0.8659;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8504;IMATINIB MESYLATE#0.8316;DASATINIB#0.8297;EPIDERMAL GROWTH FACTOR#0.8157;NEUTROPHIL#0.8145;BONE MARROW#0.8139;PERIPHERAL BLOOD#0.7997;ADHERENS JUNCTION#0.7971;SQUAMOUS CELL CARCINOMA#0.7936;HOST CELL#0.7896;FIBROBLAST GROWTH FACTOR#0.7862;DNA BINDING#0.7851;SIGNALING ADAPTOR#0.7816;CELL ACTIVATION#0.7673;ADENOCARCINOMA#0.7673;DNA COPY NUMBER#0.7659;DIGEORGE SYNDROME#0.7653;STEM CELL#0.7570;OVARIAN#0.7559;PROTEIN TYROSINE KINASE#0.7553;CERVICAL#0.7535;LUNG ADENOCARCINOMA#0.7506;CELL MOTILITY#0.7482;WOUND HEALING#0.7474;OVARIAN CANCER#0.7471;GUANINE EXCHANGE FACTOR#0.7303;INSULIN-LIKE GROWTH FACTOR#0.7264;HUMAN BREAST CANCER#0.7264;EPITHELIAL MESENCHYMAL TRANSITION#0.7245;DOMINANT NEGATIVE MUTANT#0.7162;MAP KINASE#0.7159;RNA INTERFERENCE#0.7077;T LYMPHOCYTE#0.7069;TUMOR SUPPRESSOR#0.7033;SIGNAL TRANSDUCER#0.7007;EPITHELIAL OVARIAN CARCINOMA#0.6901;A-GEL#0.6840;ACTIN CYTOSKELETON#0.6817;OVARIAN CARCINOMA#0.6761;PLATELET AGGREGATION#0.6742;AKT SIGNALING#0.6736;MACROPHAGE#0.6682;ANCHORAGE INDEPENDENT GROWTH#0.6636;BRAIN DEVELOPMENT#0.6612;HEPATOCYTE GROWTH FACTOR#0.6598;DEPHOSPHORYLATION#0.6559;HEPATOCELLULAR CARCINOMA#0.6491;CELL DEATH#0.6477;INFLUENZA A VIRUS#0.6397;PROTEIN PROTEIN INTERACTION#0.6338;GLUTATHIONE#0.6331;LYMPH NODE METASTASIS#0.6279;OUTFLOW TRACT#0.6203;CARDIAC ABNORMALITIES#0.6121;COPY NUMBER GAIN#0.6095;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6071;FACTOR I#0.6055;COLONY-STIMULATING FACTOR#0.6046;PI3K SIGNALING#0.6021;GENE COPY NUMBER#0.6014
13	PHENACETIN#1.1003;FLUTAMIDE#1.0379;MICROSOME#0.9652;HYDROLASE ACTIVITY#0.9610;RIFAMYCIN#0.8681;ENZYME ACTIVITY#0.8262;RIFAMPICIN#0.8259;GASTROINTESTINAL TRACT#0.6225;VINBLASTINE#0.6183
140032	RIBOSOMAL PROTEIN#0.6150
1400	LUNG CANCER#1.0015;MITOCHONDRIAL FISSION#0.9929;CANCER CELL#0.9908;NERVOUS SYSTEM#0.9710;GROWTH CONE#0.9477;MITOCHONDRIA#0.9070;APOPTOSIS#0.8466;NEURITE#0.8343;CELL DEATH#0.7879;NEURITE OUTGROWTH#0.7829;NEURONAL MIGRATION#0.7789;AXON GUIDANCE#0.7704;SIGNALING PATHWAY#0.7310;MITOCHONDRIAL DIVISION#0.7175;RELATED PROTEIN 1#0.7094;AUTOPHAGY#0.6934;SIGNAL TRANSDUCTION#0.6586;GROWTH CONE COLLAPSE#0.6443;ACTIN CYTOSKELETON#0.6395;GLYCOGEN SYNTHASE KINASE#0.6345;POLYMERASE CHAIN REACTION#0.6268;CELL PROLIFERATION#0.6120;MICROTUBULE#0.6069;OLFACTORY BULB#0.6058;GENE EXPRESSION#0.6035;LUNG ADENOCARCINOMA#0.6027
1401	PROTEIN BODY#1.0594;TNF-R2#1.0571;CAERULOPLASMIN#1.0568;C REACTION PROTEIN#1.0543;TUMOR NECROSIS FACTOR RECEPTOR 2#1.0531;CREATINE KINASE ACTIVITY#1.0453;SOLUBLE LEPTIN RECEPTOR#1.0389;TIMI RISK SCORE#1.0372;THYMIDINE KINASE#1.0371;CLARA CELL#1.0358;SILENT BRAIN INFARCTION#1.0358;TERMINAL COMPLEMENT COMPLEX#1.0343;FULL BLOOD COUNT#1.0338;SALIVARY FLOW RATE#1.0330;PLACENTAL GROWTH FACTOR#1.0324;MICROCYTIC ANEMIA#1.0312;CORONARY CALCIUM SCORE#1.0302;AGGRESSIVE PERIODONTITIS#1.0283;TYROSINE KINASE 1#1.0276;KARNOFSKY PERFORMANCE STATUS#1.0274;FIELD EFFECT TRANSISTOR#1.0265;ALPHA-1-PROTEINASE INHIBITOR#1.0254;AMYLOID PROTEIN#1.0247;SURFACTANT PROTEIN D#1.0242;PHOSPHOCHOLINE#1.0237;NEOPTERIN#1.0236;8-HYDROXY-2'-DEOXYGUANOSINE#1.0235;PHOSPHORYLETHANOLAMINE#1.0229;HYPERGAMMAGLOBULINEMIA#1.0226;B NATRIURETIC PEPTIDE#1.0224;CLOZAPINE#1.0213;HARVEY BRADSHAW INDEX#1.0213;TOTAL OXIDANT STATUS#1.0207;SEVELAMER#1.0205;PHYSICIAN GLOBAL ASSESSMENT#1.0204;PATIENT GLOBAL ASSESSMENT#1.0200;LACTIC ACID#1.0198;INSULIN GROWTH FACTOR#1.0197;CIRCULATING ENDOTHELIAL CELL#1.0184;TENDER JOINT COUNT#1.0184;METHYLMALONIC ACID#1.0183;NF-KAPPAB ACTIVATION#1.0181;BRAIN INFARCTION#1.0176;VIRAL MENINGITIS#1.0176;PYURIA#1.0176;GINGIVAL CREVICULAR FLUID#1.0175;CLINICAL ACTIVITY SCORE#1.0172;ERYTHROCYTE SEDIMENTATION RATE#1.0170;FASTING SERUM GLUCOSE#1.0169;ALPHA-2 MACROGLOBULIN#1.0166;SERUM AMYLOID A#1.0162;POSTPRANDIAL PLASMA GLUCOSE#1.0162;C REACTIVE PROTEIN#1.0162;FLUVASTATIN#1.0158;REMNANT LIKE PARTICLE#1.0157;POST OPERATIVE DAY#1.0156;SWOLLEN JOINT COUNT#1.0155;MAJOR CARDIAC EVENTS#1.0149;COLORECTAL ADENOMA#1.0148;FASTING BLOOD SUGAR#1.0147;PROTEIN BINDING#1.0147;CELLULAR ADHESION MOLECULE#1.0139;LPS BINDING#1.0132;KINASE ACTIVITY#1.0132;COMPLEMENT FACTOR H#1.0130;ALPHA 1-ANTITRYPSIN#1.0129;TOTAL BILIRUBIN LEVEL#1.0127;NUCLEOSOME#1.0121;OSWESTRY DISABILITY INDEX#1.0120;COMPLEMENT ACTIVITY#1.0118;RAMIPRIL#1.0115;IL-11#1.0114;T- PA#1.0113;SOLUBLE TRANSFERRIN RECEPTOR#1.0113;COLORECTAL LIVER METASTASES#1.0112;ERYTHROCYTE#1.0111;FIBRINOGEN#1.0108;L-CARNITINE#1.0106;C1-INH#1.0102;RESPIRATORY BURST#1.0099;ISCHEMIA MODIFIED ALBUMIN#1.0096;FASTING SERUM INSULIN#1.0096;GALECTIN#1.0093;LIPOPOLYSACCHARIDE BINDING#1.0093;PARAOXONASE ACTIVITY#1.0086;NERVE GROWTH FACTOR#1.0086;TOTAL ANTIOXIDANT STATUS#1.0086;LIVER METASTASIS#1.0085;CYSTATIN#1.0083;SURFACE PLASMON RESONANCE#1.0081;FACTOR D#1.0078;BLOOD UREA NITROGEN#1.0078;CARDIAC TROPONIN I#1.0078;THROMBOCYTOSIS#1.0077;CITRULLINE#1.0077;MIGRAINE#1.0076;MELATONIN#1.0074;CLEAR CELL RENAL CELL CARCINOMA#1.0073;LEPROSY#1.0071;COMPLETE BLOOD COUNT#1.0070;INTRA ABDOMINAL PRESSURE#1.0070;WHITE BLOOD CELL#1.0068;MATRIX METALLOPROTEINASE-8#1.0067;MONOCYTE CHEMOTACTIC PROTEIN#1.0065;ACUTE PHYSIOLOGY SCORE#1.0064;RENIN ACTIVITY#1.0062;DEHYDROEPIANDROSTERONE SULFATE#1.0061;CHRONIC SUBCLINICAL INFLAMMATION#1.0058;SERUM TOTAL BILIRUBIN#1.0055;IL-1RA#1.0053;OPSONIZATION#1.0052;THYMIDINE#1.0052;DRIED BLOOD SPOT#1.0052;IRON BINDING#1.0049;ACTIVATED PROTEIN C#1.0049;DISEASE SPECIFIC SURVIVAL#1.0049;CORONARY ARTERY ENDOTHELIAL CELLS#1.0048;BRAIN NATRIURETIC PEPTIDE#1.0047;INTERNATIONAL NORMALIZED RATIO#1.0043;LOW-DENSITY LIPOPROTEIN PARTICLE#1.0042;ERYTHROCYTE AGGREGATION#1.0041;LAPAROSCOPIC SLEEVE GASTRECTOMY#1.0039;CORONARY STENT IMPLANTATION#1.0036;ARYLESTERASE ACTIVITY#1.0036;THROMBOPLASTIN#1.0035;PYRIDOXAL 5-PHOSPHATE#1.0035;ADRENOCORTICOTROPIC HORMONE#1.0034;VITAMIN D BINDING#1.0032;CORTISOL#1.0031;GAMMA GLUTAMYLTRANSFERASE#1.0030;BINDING PROTEIN 3#1.0030;LOVASTATIN#1.0030;CANAKINUMAB#1.0028;HEART ATTACK#1.0027;CREATINE KINASE#1.0026;OXIDATIVE STRESS INDEX#1.0024;TOTAL SHARP SCORE#1.0024;ROS GENERATION#1.0022;FACTOR VIII#1.0020;TOTAL ANTIOXIDANT CAPACITY#1.0020;HORMONE BINDING#1.0020;PROTEINASE INHIBITOR#1.0020;PAROXYSMAL ATRIAL FIBRILLATION#1.0018;SUBSTANCE P#1.0018;IGF BINDING#1.0012;ACUTE RESPIRATORY INFECTION#1.0010;MYELOID RELATED PROTEIN#1.0008;VITAMIN B12#1.0007;ANDROSTENEDIONE#1.0006;CREATINE#1.0006;GROWTH DIFFERENTIATION FACTOR#1.0006;FREE ANDROGEN INDEX#1.0003;LYMPHOCYTE PROLIFERATION#1.0002;ENDOMETRIAL CANCER#1.0002;SELECTIN#1.0000;ADENOSINE DEAMINASE#1.0000;MALNUTRITION INFLAMMATION SCORE#1.0000;VIRAL PNEUMONIA#0.9999;MATRIX METALLOPROTEINASE 1#0.9998;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9998;PLATELET ACTIVATING FACTOR#0.9996;VASCULAR CELL#0.9995;FENOFIBRATE#0.9994;HYPOXIA INDUCIBLE FACTOR#0.9992;PITAVASTATIN#0.9991;INVASIVE MECHANICAL VENTILATION#0.9990;PNEUMONIA SEVERITY INDEX#0.9990;TRANSFERRIN RECEPTOR#0.9987;PNEUMOCOCCAL PNEUMONIA#0.9987;URIC ACID#0.9987;CELL ADHESION MOLECULE#0.9987;ALPHA-1 PROTEASE INHIBITOR#0.9987;GROWTH FACTOR BINDING#0.9986;ESTRONE#0.9985;PROSTAGLANDIN E2#0.9984;MINI NUTRITIONAL ASSESSMENT#0.9984;PROTEIN KINASE C#0.9982;EPWORTH SLEEPINESS SCALE#0.9981;URATE#0.9981;ASEPTIC MENINGITIS#0.9979;SERIOUS BACTERIAL INFECTION#0.9978;ADRENALINE#0.9977;LEFT ATRIAL VOLUME#0.9977;EXHALED NITRIC OXIDE#0.9976;PROTEIN CATABOLIC#0.9975;HEART RATE RECOVERY#0.9975;CHARLSON COMORBIDITY INDEX#0.9974;ORAL SQUAMOUS CELL CARCINOMA#0.9973;ROSIGLITAZONE#0.9972;LEFT ATRIAL DIAMETER#0.9972;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9971;EPINEPHRINE#0.9971;INTERLEUKIN 2 RECEPTOR#0.9969;PROSTATE SPECIFIC ANTIGEN#0.9969;MACROPHAGE INFLAMMATORY PROTEIN#0.9968;NOREPINEPHRINE#0.9968;FOLATE#0.9967;CYCLIC CITRULLINATED PEPTIDE#0.9966;HYALURONAN#0.9965;HEPATOMA CELLS#0.9962;CARNITINE#0.9962;PRE-ECLAMPSIA#0.9961;ECLAMPSIA#0.9960;ACUTE CORONARY EVENTS#0.9960;CARDIAC SYNDROME X#0.9960;HUMAN UMBILICAL VEIN#0.9959;ALDOSTERONE#0.9958;FOLLICLE STIMULATING HORMONE#0.9958;LATE ONSET SEPSIS#0.9957;BETA-2#0.9957;ALPHA-TOCOPHEROL#0.9957;TRYPSINOGEN ACTIVATION#0.9956;CHORIOAMNIONITIS#0.9956;TOTAL FAT MASS#0.9953;BARE METAL STENT#0.9953;CAROTID ARTERY PLAQUE#0.9952;INTIMA MEDIAL THICKNESS#0.9951;CELL ADHESION#0.9951;CAROTENOID#0.9949;TOTAL ENERGY INTAKE#0.9948;JOINT SWELLING#0.9947;TUBULAR EPITHELIAL CELL#0.9947;MYELOPEROXIDASE ACTIVITY#0.9945;CARDIAC RISK FACTORS#0.9945;OBSTRUCTIVE SLEEP APNOEA#0.9944;RESPONSE TO IL-6#0.9943;PARATHYROID HORMONE#0.9943;LYMPHOPENIA#0.9942;RETINOL#0.9942;NORADRENALINE#0.9942;BIOTIN#0.9942;MUTAGENESIS#0.9942;STRESSFUL LIFE EVENTS#0.9941;ATHEROSCLEROSIS RISK FACTORS#0.9941;LUTEIN#0.9940;VISCERAL FAT AREA#0.9940;SOFT TISSUE SARCOMA#0.9939;HEALTH ASSESSMENT QUESTIONNAIRE#0.9938;PARATHYROID#0.9937;AORTIC VALVE STENOSIS#0.9936;DEHYDROEPIANDROSTERONE#0.9936;DISEASE ACTIVITY SCORE#0.9936;VASCULAR DEMENTIA#0.9936;PHOSPHOLIPASE A#0.9936;UMBILICAL VEIN#0.9936;HYALURONIC ACID#0.9935;EXHALED BREATH CONDENSATE#0.9935;END SYSTOLIC VOLUME#0.9934;PHOSPHOLIPASE A2#0.9934;ROSUVASTATIN#0.9934;KYPHOSIS#0.9933;ALBUMIN CREATININE RATIO#0.9933;TRUNK FAT MASS#0.9932;INSULIN RESISTANCE INDEX#0.9932;AMNIOTIC FLUID#0.9932;PERIPHERAL BLOOD LEUKOCYTE#0.9932;INSOMNIA#0.9932;PLATELET-DERIVED GROWTH FACTOR#0.9932;HEPATOCYTE GROWTH FACTOR#0.9931;ALKALINE PHOSPHATASE#0.9929;MANNOSE BINDING#0.9929;PYRIDOXAL#0.9928;RECEIVER OPERATOR CURVE#0.9928;INTIMAL MEDIAL THICKNESS#0.9927;BACTERIAL MENINGITIS#0.9925;CORONARY ARTERY CALCIUM#0.9924;RHEUMATIC FEVER#0.9924;HUMAN SERUM ALBUMIN#0.9923;MANNOSE BINDING LECTIN#0.9922;SYPHILIS#0.9921;HISTIDINE#0.9919;CERVICAL CANCER#0.9919;MALARIA#0.9918;METASTATIC RENAL CELL CARCINOMA#0.9917;ABDOMINAL FAT MASS#0.9916;MACROPHAGE CHEMOATTRACTANT PROTEIN#0.9916;PERIPHERAL ARTERIAL TONOMETRY#0.9916;VITAMIN B6#0.9916;RETINOL BINDING#0.9915;HEALTHY EATING INDEX#0.9914;FASTING BLOOD GLUCOSE#0.9912;PEARSON CORRELATION COEFFICIENT#0.9912;XANTHINE OXIDASE#0.9910;SLEEPINESS#0.9910;POSTOPERATIVE ATRIAL FIBRILLATION#0.9910;PENTOXIFYLLINE#0.9909;URINARY PROTEIN#0.9909;ALVEOLAR MACROPHAGE#0.9909;IMMUNOGLOBULIN G#0.9908;FATTY ACID BINDING#0.9907;TOCOPHEROL#0.9907;BLOOD PLASMA#0.9906;LOSARTAN#0.9905;LEUKOCYTE ADHESION#0.9904;DIVERTICULITIS#0.9904;POLYMORPHONUCLEAR NEUTROPHIL#0.9904;TUMOR NECROSIS FACTOR#0.9904;LIMIT OF DETECTION#0.9903;INTERLEUKIN 1 RECEPTOR#0.9901;AGGLUTINATION#0.9899;TUBERCULOUS MENINGITIS#0.9898;EPITHELIAL OVARIAN CANCER#0.9898;ENDOMETRIOSIS#0.9897;LACTULOSE#0.9897;LEUKOPENIA#0.9896;ALANINE#0.9893;DALLAS HEART STUDY#0.9893;INSULIN-LIKE GROWTH FACTOR#0.9893;PLASMODIUM FALCIPARUM MALARIA#0.9892;TRANSFORMING GROWTH FACTOR BETA#0.9892;APPENDICITIS#0.9891;CHLAMYDIA PNEUMONIA#0.9891;AGE RELATED MACULAR DEGENERATION#0.9891;SPONTANEOUS BACTERIAL PERITONITIS#0.9891;SLEEP DISORDERED BREATHING#0.9890;SERUM ALBUMIN#0.9890;IGG ANTIBODY#0.9890;RESPONSE TO CORTICOSTEROID#0.9890;ACUTE AORTIC DISSECTION#0.9889;TESTOSTERONE#0.9889;ASPARTATE#0.9889;TRIIODOTHYRONINE#0.9888;FUNISITIS#0.9888;POINT OF CARE#0.9888;UMBILICAL CORD BLOOD#0.9887;FOLLICULAR PHASE#0.9887;FRAMINGHAM RISK SCORE#0.9885;LYMPH NODE METASTASIS#0.9885;BRACHIAL ARTERY DIAMETER#0.9884;MUCOSITIS#0.9882;RETICULOCYTE#0.9881;TUMOR NODE METASTASIS#0.9881;OESTRADIOL#0.9880;ASCORBIC ACID#0.9879;AMLODIPINE#0.9879;CELL WALL#0.9878;GINGIVITIS#0.9878;BREAST CANCER SURVIVORS#0.9878;LUTEAL PHASE#0.9878;ASYMMETRIC DIMETHYLARGININE#0.9877;COMPLEMENT CASCADE#0.9877;PERCENT BODY FAT#0.9876;TREG CELL#0.9876;ALPHA-1-ANTIPROTEINASE#0.9876;MYELOID CELL#0.9876;PROBING POCKET DEPTH#0.9876;CHEMOTAXIS#0.9876;EUGLYCEMIC HYPERINSULINEMIC CLAMP#0.9876;ADJUSTED RELATIVE RISK#0.9875;ACUTE ISCHAEMIC STROKE#0.9873;DISEASE SEVERITY SCORE#0.9871;TUMOUR NECROSIS FACTOR#0.9870;MACULAR DEGENERATION#0.9869;GM-CSF#0.9867;HUMAN LEUKOCYTE ANTIGEN#0.9866;INSULIN SENSITIVITY INDEX#0.9865;LEUKOCYTE#0.9864;MANNAN BINDING#0.9864;CHOLESTEROL EFFLUX#0.9864;JOINT SPACE NARROWING#0.9863;NATURAL KILLER CELL#0.9863;FAT MASS INDEX#0.9863;DIAGNOSTIC ODDS RATIO#0.9863;MILD ACUTE PANCREATITIS#0.9862;CHAGAS DISEASE#0.9860;BASOPHIL#0.9858;ANXIETY DISORDER#0.9857;PIOGLITAZONE#0.9856;PROGESTIN#0.9855;PHAGOCYTOSIS#0.9854;COMPLEMENT ACTIVATION#0.9854;DIURNAL#0.9853;GLUTATHIONE PEROXIDASE#0.9852;HISTAMINE#0.9852;INTERLEUKIN 6 RECEPTOR#0.9851;TRANSFORMING GROWTH FACTOR#0.9851;SMALL VESSEL DISEASE#0.9851;BEZAFIBRATE#0.9850;METASTATIC COLORECTAL CANCER#0.9850;BACTERIURIA#0.9849;TOTAL BODY FAT#0.9848;PYREXIA#0.9848;WAIST HIP RATIO#0.9848;LYMPH NODE INVOLVEMENT#0.9847;BACTERIAL PNEUMONIA#0.9846;ESOPHAGEAL CARCINOMA#0.9846;VENTILATOR ASSOCIATED PNEUMONIA#0.9845;CYTOKINE RECEPTOR#0.9845;ADVANCED PANCREATIC CANCER#0.9845;FLOW MEDIATED VASODILATION#0.9844;QUERCETIN#0.9844;PRIMARY HEALTH CARE#0.9844;END DIASTOLIC VOLUME#0.9844;INDUCIBLE NITRIC OXIDE#0.9844;NEUTROPHIL CHEMOTAXIS#0.9843;FASTING GLUCOSE LEVELS#0.9843;RESVERATROL#0.9842;CATALYTIC ACTIVITY#0.9842;ACUTE OTITIS MEDIA#0.9841;ASPIRATION PNEUMONIA#0.9839;UMBILICAL CORD#0.9839;HYDRONEPHROSIS#0.9839;PROTEIN OXIDATION#0.9838;PROSTACYCLIN#0.9838;VALSARTAN#0.9837;SUBJECTIVE GLOBAL ASSESSMENT#0.9836;LDL PARTICLE#0.9836;HEPATITIS A#0.9835;UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR#0.9835;SUPEROXIDE DISMUTASE#0.9835;PROGESTERONE#0.9835;VISUAL ANALOGUE SCALE#0.9835;ANTIBODIES TO INFLIXIMAB#0.9835;PANCYTOPENIA#0.9834;SERUM URIC ACID#0.9834;SYSTOLIC HEART FAILURE#0.9834;BACTERIAL SEPSIS#0.9834;MICROPARTICLE#0.9834;CHRONIC HEPATITIS B#0.9833;CHOLINE#0.9832;ABDOMINAL ADIPOSE TISSUE#0.9831;ABATACEPT#0.9831;REGULAR PHYSICAL ACTIVITY#0.9831;DNA METHYLATION#0.9830;CONTRAST INDUCED NEPHROPATHY#0.9830;RAYNAUD’S#0.9830;BIPOLAR DISORDER#0.9829;IN STENT RESTENOSIS#0.9829;LOWER URINARY TRACT#0.9827;WHEEZING#0.9827;DIAGNOSTIC CORONARY ANGIOGRAPHY#0.9827;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.9826;LIPOPROTEIN PARTICLE#0.9826;BONE TURNOVER MARKER#0.9825;FRUCTOSE#0.9825;MAP KINASE#0.9825;URTICARIA#0.9825;GLASGOW COMA SCALE#0.9823;VESICOURETERAL REFLUX#0.9823;LUPUS NEPHRITIS#0.9823;NEUTROPHIL#0.9822;HODGKIN'S LYMPHOMA#0.9822;CHANGE FROM BASELINE#0.9821;RALOXIFENE#0.9821;RHEUMATIC HEART DISEASE#0.9821;EZETIMIBE#0.9819;TONSILLITIS#0.9819;FOLIC ACID#0.9819;COMMUNITY BASED STUDY#0.9819;DISEASE ACTIVITY INDEX#0.9819;Q FEVER#0.9816;STRUCTURAL EQUATION MODELING#0.9814;RECURRENCE FREE SURVIVAL#0.9814;GENERAL LINEAR MODEL#0.9814;FASTING PLASMA GLUCOSE#0.9814;PHOSPHATE BUFFERED SALINE#0.9814;GOLIMUMAB#0.9813;ESTROGENS#0.9813;SERUM LEPTIN LEVEL#0.9813;CERTOLIZUMAB PEGOL#0.9813;VISUAL ANALOG SCALE#0.9813;TRYPTOPHAN#0.9812;MONOCYTE ACTIVATION#0.9812;RUPTURE OF MEMBRANES#0.9811;ENDOTHELIAL CELL ACTIVATION#0.9811;ESTRADIOL#0.9810;ANDROID#0.9810;NIACIN#0.9809;L-ARGININE#0.9808;CAROTID ARTERY STENOSIS#0.9808;SYSTEMIC INFLAMMATORY REACTION#0.9808;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9808;ALPHA AMYLASE#0.9807;LIVER CANCER#0.9807;COLORECTAL CARCINOMA#0.9807;ALPHA LINOLENIC ACID#0.9806;MEAN PLATELET VOLUME#0.9805;VAN DER HEIJDE#0.9805;PHYSICAL ACTIVITY LEVEL#0.9805;UROKINASE PLASMINOGEN ACTIVATOR#0.9805;MENSTRUAL CYCLE#0.9804;CELLULITIS#0.9804;SIMVASTATIN#0.9804;ENDOTHELIAL GROWTH FACTOR#0.9804;SUNITINIB#0.9803;FREE LIGHT CHAIN#0.9803;VASCULAR SMOOTH MUSCLE CELL#0.9803;NADPH OXIDASE#0.9802;TRICEPS#0.9802;BLEEDING ON PROBING#0.9802;MACROPHAGE MIGRATION#0.9802;INFLAMMATORY RHEUMATIC DISEASE#0.9801;VIGOROUS PHYSICAL ACTIVITY#0.9800;MIGRATION INHIBITORY FACTOR#0.9800;VITAMIN C#0.9800;BRUCELLOSIS#0.9800;THROMBOCYTOPENIA#0.9800;FRAMINGHAM HEART STUDY#0.9800;WEIGHTED MEAN DIFFERENCE#0.9799;EARLY LIFE ADVERSITY#0.9799;NUTRITIONAL RISK INDEX#0.9799;IFN-GAMMA#0.9799;FAMILIAL HYPERCHOLESTEROLEMIA#0.9798;HEMATOPOIETIC CELL TRANSPLANTATION#0.9798;TEMPORAL ARTERITIS#0.9797;SLEEP APNEA SYNDROME#0.9797;EOSINOPHIL#0.9797;CORONARY FLOW RESERVE#0.9797;GENERAL HEALTH QUESTIONNAIRE#0.9796;HEME OXYGENASE 1#0.9796;DRUG ELUTING STENT#0.9796;HEART RATE VARIABILITY#0.9795;USTEKINUMAB#0.9794;THROMBOPHILIA#0.9794;PELVIC INFLAMMATORY DISEASE#0.9794;LARGE ARTERY ATHEROSCLEROSIS#0.9793;EPIDERMAL GROWTH FACTOR#0.9792;BODY WEIGHT LOSS#0.9791;STANDARDIZED MEAN DIFFERENCE#0.9789;G-CSF#0.9789;PERIPHERAL BLOOD LYMPHOCYTES#0.9789;HEAT SHOCK PROTEIN#0.9788;PRAVASTATIN#0.9787;VERY-LOW-DENSITY LIPOPROTEIN#0.9786;MEASLES#0.9786;BODY FAT PERCENTAGE#0.9785;ACID PHOSPHATASE#0.9785;CELECOXIB#0.9785;HERPES SIMPLEX VIRUS#0.9784;TELOMERE#0.9784;MATURITY-ONSET DIABETES OF THE YOUNG#0.9784;MANNAN BINDING LECTIN#0.9783;VITAMIN K#0.9783;LYSINE#0.9782;MALIGNANT PLEURAL EFFUSION#0.9782;CORD BLOOD#0.9782;ENDOTHELIAL NITRIC OXIDE#0.9781;HIGH MOBILITY GROUP#0.9780;IBUPROFEN#0.9779;MILD COGNITIVE IMPAIRMENT#0.9778;TELMISARTAN#0.9778;FETAL INFLAMMATORY RESPONSE#0.9778;FOAM CELL FORMATION#0.9777;LEUKOCYTE TELOMERE LENGTH#0.9777;LYSIS#0.9776;PLATELET AGGREGATION#0.9775;CAROTID STENOSIS#0.9775;TOTAL KNEE REPLACEMENT#0.9774;SKELETAL MUSCLE MASS#0.9773;ANKLE BRACHIAL INDEX#0.9773;GLUTAMINE#0.9773;ACUTE LEUKEMIA#0.9773;CLINICAL ATTACHMENT LOSS#0.9773;FLOW MEDIATED DILATATION#0.9772;VASCULAR ENDOTHELIAL CELL#0.9772;FLOW MEDIATED DILATION#0.9772;COLLAGEN TYPE I#0.9772;ABCIXIMAB#0.9771;GLUTATHIONE#0.9771;POSITIVE LIKELIHOOD RATIO#0.9770;GLUCOCORTICOID RECEPTOR#0.9770;GENERALIZED LINEAR MODEL#0.9770;XANTHINE#0.9769;CONTROL GROUP 1#0.9769;TENOSYNOVITIS#0.9769;MITOGEN ACTIVATED PROTEIN#0.9768;OVARIAN CANCER#0.9768;ANTIPHOSPHOLIPID SYNDROME#0.9767;PERIPHERAL BLOOD MONOCYTES#0.9767;ANAKINRA#0.9767;TOTAL SLEEP TIME#0.9767;SINUSITIS#0.9766;LEFT VENTRICULAR REMODELING#0.9766;FORCED VITAL CAPACITY#0.9765;CANCER SPECIFIC SURVIVAL#0.9765;ENHANCED COMPUTED TOMOGRAPHY#0.9765;PHOSPHOLIPASE A2 ACTIVITY#0.9765;CENTRAL VENOUS CATHETER#0.9764;CYSTITIS#0.9764;UVEITIS#0.9763;ATHEROSCLEROTIC RISK FACTORS#0.9763;QUADRICEPS#0.9763;IL-6 PRODUCTION#0.9763;DEPRESSIVE SYMPTOMS#0.9762;PERIODONTITIS#0.9762;OXIDATIVE DNA DAMAGE#0.9762;VIRAL HEPATITIS#0.9762;EPSTEIN BARR VIRUS#0.9761;MEDIASTINITIS#0.9761;PHARYNGITIS#0.9761;RESIDUAL RENAL FUNCTION#0.9760;ATORVASTATIN#0.9760;HEMATURIA#0.9759;STANDARD DEVIATION SCORE#0.9758;PYRUVATE#0.9758;BINDING PROTEIN 1#0.9758;VENA CAVA#0.9758;CARDIOLIPIN#0.9758;PULMONARY EDEMA#0.9758;LACTATION#0.9757;DIABETIC FOOT ULCER#0.9757;CORONARY ANEURYSM#0.9757;HERPES SIMPLEX#0.9757;LOW DISEASE ACTIVITY#0.9757;CONJUGATED LINOLEIC ACID#0.9756;THALASSEMIA#0.9756;PATIENT HEALTH QUESTIONNAIRE#0.9755;POLYCLONAL HYPERGAMMAGLOBULINEMIA#0.9753;POLYMORPHONUCLEAR LEUKOCYTES#0.9753;COMPOSITE END POINT#0.9752;MEDICAL RESEARCH COUNCIL#0.9752;72-HOURS#0.9752;RENAL CELL CARCINOMA#0.9752;GROWTH FACTOR RECEPTOR#0.9752;PSORIASIS#0.9751;SUPEROXIDE DISMUTASE ACTIVITY#0.9751;CELL MEMBRANE#0.9751;RESPONSE TO EXERCISE#0.9750;CORONARY STENOSIS#0.9750;RECEIVER OPERATING CURVE#0.9750;BODY FAT MASS#0.9750;HEMOLYSIS#0.9749;TNF PRODUCTION#0.9748;MOLAR#0.9748;HIGH DENSITY LIPOPROTEIN#0.9748;VASCULAR RISK FACTORS#0.9748;VASCULAR ENDOTHELIAL FUNCTION#0.9747;MONOCYTE#0.9747;HEMATOPOIETIC CELL#0.9746;CELL CYCLE#0.9746;RECEPTOR ANTAGONIST#0.9745;VENOUS BLOOD#0.9744;ASCITES#0.9744;RECEPTOR ACTIVATOR#0.9744;MONOCYTE DERIVED MACROPHAGE#0.9744;CHRONIC HEPATITIS C#0.9743;GRAFT VERSUS HOST#0.9743;VASOPRESSIN#0.9743;LOW FAT DIET#0.9742;ANTERIOR CRUCIATE LIGAMENT#0.9742;SPINAL CORD INJURY#0.9741;CIRCULATING ENDOTHELIAL PROGENITOR#0.9741;PULMONARY TUBERCULOSIS#0.9740;CAFFEINE#0.9740;CORONARY ARTERY STENOSIS#0.9740;TELOMERASE ACTIVITY#0.9739;DIMERCAPTOSUCCINIC ACID#0.9739;MEMBRANE ATTACK COMPLEX#0.9738;RANGE OF MOTION#0.9738;ASCORBATE#0.9738;HIGH POWER FIELD#0.9738;RESTING ENERGY EXPENDITURE#0.9738;INTESTINAL OBSTRUCTION#0.9738;GLUCOSE HOMEOSTASIS#0.9737;PERIPHERAL MONOCYTE#0.9737;ADVERSE CLINICAL OUTCOME#0.9737;TARGET ORGAN DAMAGE#0.9737;INTERMITTENT CLAUDICATION#0.9737;LINEAR MIXED EFFECTS#0.9736;ORAL CAVITY#0.9736;SIGNAL TRANSDUCER#0.9736;DOPAMINE#0.9735;RISK OF RELAPSE#0.9735;COMMON CAROTID ARTERIES#0.9735;CLOPIDOGREL#0.9734;AMERICAN HEART ASSOCIATION#0.9734;OTITIS MEDIA#0.9733;LEFT VENTRICULAR MASS#0.9733;ILEUS#0.9733;AORTITIS#0.9733;THERAPEUTIC DRUG MONITORING#0.9732;MAJOR DEPRESSIVE DISORDER#0.9731;KUPFFER CELL#0.9731;PROSTATE CANCER#0.9731;PLASMA PROTEIN#0.9731;DECOMPENSATED HEART FAILURE#0.9731;DIABETIC RETINOPATHY#0.9731;ARGININE#0.9730;CHOLECYSTITIS#0.9729;HARRIS HIP SCORE#0.9729;HYPOGLYCEMIA#0.9729;SARCOIDOSIS#0.9729;NEUTROPENIA#0.9728;PATTERN RECOGNITION RECEPTOR#0.9727;MULTINOMIAL LOGISTIC REGRESSION#0.9727;PNEUMOCOCCAL CONJUGATE VACCINE#0.9727;CARDIOVASCULAR HEALTH STUDY#0.9726;CYTOCHROME C#0.9726;LOW DENSITY LIPOPROTEIN#0.9725;CD14++CD16- MONOCYTE#0.9725;HEART AND SOUL#0.9724;BREAST CANCER PATIENTS#0.9724;ANGIOEDEMA#0.9724;T CELL ACTIVATION#0.9723;METABOLIC ACIDOSIS#0.9723;SPUTUM#0.9722;COMPUTED TOMOGRAPHY ANGIOGRAPHY#0.9722;INJURY SEVERITY SCORE#0.9721;UROKINASE#0.9721;AORTIC VALVE DISEASE#0.9721;TARGET VESSEL REVASCULARIZATION#0.9720;SYSTOLIC BLOOD PRESSURE#0.9720;EVERY OTHER DAY#0.9720;PERICARDITIS#0.9719;SCAVENGER RECEPTOR#0.9719;CEREBRAL INFARCTION#0.9718;CARBOHYDRATE METABOLISM#0.9718;HYPERURICEMIA#0.9718;TRANSIENT ISCHEMIC ATTACK#0.9718;ESOPHAGEAL CANCER#0.9718;PROTEIN METABOLISM#0.9718;PERIPHERAL VASCULAR DISEASE#0.9717;LECTIN#0.9717;CRITICAL LIMB ISCHEMIA#0.9717;TOCILIZUMAB#0.9717;AGE AT ONSET#0.9716;BRONCHITIS#0.9716;BRONCHIECTASIS#0.9716;CHLAMYDIA#0.9716;VITAMIN A DEFICIENCY#0.9715;MENINGITIS#0.9715;VITAMIN E#0.9715;VITAMIN D3#0.9715;SITAGLIPTIN#0.9715;PULMONARY VEIN#0.9714;ACUTE PYELONEPHRITIS#0.9714;POSITIVE AIRWAY PRESSURE#0.9714;DEPRESSION RATING SCALE#0.9714;END OF TREATMENT#0.9713;FORCED EXPIRATORY VOLUME#0.9713;CRUCIATE LIGAMENT#0.9713;SALIVARY GLAND#0.9713;AS MYOCARDIAL INFARCTION#0.9713;GASTRIC BYPASS SURGERY#0.9712;CORONARY ATHEROSCLEROTIC PLAQUE#0.9712;FLUORESCEIN#0.9712;LEFT ATRIUM#0.9711;MUSCLE DAMAGE#0.9711;AORTIC VALVE REPLACEMENT#0.9711;CORONARY ARTERY LESIONS#0.9711;SYSTEMIC AUTOIMMUNE DISEASE#0.9711;BETA CELL#0.9710;PATIENT REPORTED OUTCOME#0.9710;ACUTE HEART FAILURE#0.9710;RECEIVER OPERATOR CHARACTERISTIC#0.9710;CYTOTOXICITY#0.9709;GROWTH FACTOR#0.9709;AND VISCERAL FAT#0.9709;NEGATIVE LIKELIHOOD RATIO#0.9709;SQUAMOUS CELL CARCINOMA#0.9709;GASTRITIS#0.9709;METFORMIN#0.9708;LIPID LOWERING AGENT#0.9708;HEPATOCYTE NUCLEAR FACTOR#0.9707;SUDDEN CARDIAC DEATH#0.9707;CLINICAL ATTACHMENT LEVEL#0.9706;T HELPER CELL#0.9706;ANGIOTENSIN RECEPTOR BLOCKER#0.9705;AZITHROMYCIN#0.9703;JOINT PAIN#0.9703;AMBULATORY BLOOD PRESSURE#0.9702;TYPE 1 DIABETIC#0.9702;PANCREATIC CANCER#0.9701;PROTEINURIA#0.9701;CERVIX#0.9701;LIPOPROTEIN METABOLISM#0.9701;MULTIVARIATE LINEAR REGRESSION#0.9701;HIP JOINT#0.9701;GROUP B STREPTOCOCCUS#0.9701;CD8+ T CELL#0.9701;CAROTID ARTERY DISEASE#0.9700;EPILEPSY#0.9700;PATTERN RECOGNITION MOLECULES#0.9699;HEAD AND NECK CANCER#0.9699;ENZYME INHIBITOR#0.9699;NECK CANCER#0.9699;KIDNEY FAILURE#0.9699;CONGENITAL HEART DISEASE#0.9699;VITAMIN A#0.9699;NEOPLASTIC DISEASE#0.9698;ANTERIOR UVEITIS#0.9698;ERYTHROPOIESIS STIMULATING AGENT#0.9698;SEPTIC ARTHRITIS#0.9698;BLOOD GLUCOSE LEVEL#0.9697;GASTROENTERITIS#0.9697;HYPOXIC#0.9696;TRAUMATIC BRAIN INJURY#0.9696;SEVERE PAIN#0.9696;INFECTIVE ENDOCARDITIS#0.9696;ADVERSE PREGNANCY OUTCOME#0.9695;AMERICAN DIABETES ASSOCIATION#0.9695;WHITE MATTER LESIONS#0.9694;TYROSINE KINASE INHIBITOR#0.9694;GLYCOSYLATION#0.9693;POSITIVE FAMILY HISTORY#0.9692;ANTI-INFLAMMATORY RESPONSE#0.9692;NITRIC OXIDE#0.9691;CASTLEMAN DISEASE#0.9691;CLOTTING#0.9690;AREA UNDER CURVE#0.9690;TH17 CELL#0.9690;OXYGENASE#0.9689;NITROGLYCERIN#0.9689;ANGIOTENSIN CONVERTING ENZYME#0.9689;CHOLESTASIS#0.9688;STABLE ANGINA PECTORIS#0.9687;CORONARY ARTERY CALCIFICATION#0.9687;RECEPTOR AGONIST#0.9687;HYPERTHERMIA#0.9687;MALIGNANT LYMPHOMA#0.9687;PERICARDIAL EFFUSION#0.9687;EPICARDIAL ADIPOSE TISSUE#0.9685;TISSUE DOPPLER IMAGING#0.9685;BLOOD LOSS#0.9684;SICKLE CELL DISEASE#0.9684;LIVER CIRRHOSIS#0.9684;NEUTROPHIL ACTIVATION#0.9684;KIDNEY TRANSPLANT RECIPIENTS#0.9683;CIRCADIAN RHYTHM#0.9683;PERIPHERAL ARTERY DISEASE#0.9682;INCREASED BLOOD PRESSURE#0.9682;ACUTE ISCHEMIC STROKE#0.9682;DEXAMETHASONE#0.9682;NECROTIZING FASCIITIS#0.9681;BLOOD CIRCULATION#0.9681;FIBROBLAST GROWTH FACTOR#0.9681;BACTERIAL INFECTIOUS DISEASE#0.9681;TACHYCARDIA#0.9680;MINI MENTAL STATE#0.9680;PROTEIN KINASE#0.9680;LDL RECEPTOR#0.9680;LOW BACK PAIN#0.9679;COLORECTAL#0.9679;JUVENILE RHEUMATOID ARTHRITIS#0.9678;N-ACETYLCYSTEINE#0.9678;RENAL ARTERY#0.9677;HYPERHOMOCYSTEINEMIA#0.9677;PARKINSON'S DISEASE#0.9677;LOW DOSE ASPIRIN#0.9676;PROSTATITIS#0.9676;BIOELECTRICAL IMPEDANCE ANALYSIS#0.9676;ADVANCED GLYCATION END#0.9676;ARTHROPATHY#0.9676;SLEEP DISORDER#0.9676;SIGNAL TRANSDUCTION#0.9675;MOOD DISORDER#0.9675;BLOOD BRAIN BARRIER#0.9674;GESTATIONAL DIABETES MELLITUS#0.9674;MATRIX GLA PROTEIN#0.9674;AEROBIC EXERCISE TRAINING#0.9674;SYNOVIAL FLUID#0.9673;CONTROLLED CLINICAL TRIALS#0.9673;OBSTRUCTIVE LUNG DISEASE#0.9673;ANGIOTENSIN RECEPTOR#0.9673;EPITHELIAL CELL#0.9673;MYOCARDITIS#0.9673;SMOOTH MUSCLE CELL#0.9672;CHEMOKINE RECEPTOR#0.9672;ENDOTHELIAL PROGENITOR CELL#0.9672;RED BLOOD CELL#0.9671;CHOLANGITIS#0.9671;GLOMERULAR FILTRATION RATE#0.9671;BECK DEPRESSION INVENTORY#0.9671;BRONCHIOLITIS#0.9670;APNEA HYPOPNEA INDEX#0.9670;ALLOPURINOL#0.9670;IRRITABLE BOWEL SYNDROME#0.9670;LOW BIRTH WEIGHT#0.9670;PULSE WAVE VELOCITY#0.9670;NITRIC OXIDE SYNTHASE#0.9670;EXCRETION#0.9670;ANAEMIA#0.9670;ENZYME ACTIVITY#0.9669;REACTIVE ARTHRITIS#0.9669;GLOMERULAR FILTRATION#0.9669;PRINCIPAL COMPONENT ANALYSIS#0.9669;HEPATITIS B VIRUS#0.9669;COGNITION#0.9669;PROTEIN METABOLIC#0.9669;SURGICAL SITE INFECTION#0.9669;CARDIOMYOCYTE#0.9668;TAKAYASU'S ARTERITIS#0.9668;DIABETES HEART STUDY#0.9668;SULPHASALAZINE#0.9668;LEUKOCYTE ACTIVATION#0.9668;MYOSITIS#0.9667;FIBROMYALGIA#0.9667;ACE INHIBITOR#0.9667;JOINT DAMAGE#0.9667;ACETYLSALICYLIC ACID#0.9667;DIPHOSPHATE#0.9667;UREMIC TOXIN#0.9667;LEFLUNOMIDE#0.9667;BEHCET'S DISEASE#0.9666;ACUTE INFLAMMATORY RESPONSE#0.9666;PERIODONTAL DISEASE#0.9666;GENERALIZED ESTIMATING EQUATION#0.9665;SHORTNESS OF BREATH#0.9665;DIFFUSE LARGE B-CELL LYMPHOMA#0.9665;PANCREATIC DUCTAL ADENOCARCINOMA#0.9665;PYELONEPHRITIS#0.9664;CARDIO VASCULAR DISEASE#0.9664;PORTAL VEIN#0.9664;LIPID LOWERING THERAPY#0.9663;FACTOR I#0.9663;ENDOTHELIUM DEPENDENT VASODILATATION#0.9662;ACUTE PHASE RESPONSE#0.9661;GLUCOSE TOLERANCE STATUS#0.9661;RISK OF DEATH#0.9661;OVERALL SURVIVAL RATE#0.9661;INTERNAL CAROTID ARTERY#0.9659;BLOOD COAGULATION#0.9659;DISEASE FREE SURVIVAL#0.9659;ARTERIOSCLEROSIS#0.9659;ALCOHOLIC HEPATITIS#0.9658;PULMONARY ARTERY#0.9658;MENTAL DISORDER#0.9657;CONDITIONAL LOGISTIC REGRESSION#0.9657;AGE AT DIAGNOSIS#0.9656;AMPHOTERICIN B#0.9656;PROTEIN SYNTHESIS#0.9655;HEPATOCELLULAR CARCINOMA#0.9655;TOTAL KNEE ARTHROPLASTY#0.9655;COENZYME A#0.9655;LINEAR MIXED MODEL#0.9654;LEUCINE#0.9654;PERIPHERAL ARTERIAL DISEASE#0.9654;GROWTH HORMONE#0.9654;RANDOMIZED CONTROL TRIAL#0.9653;TO BACKGROUND RATIO#0.9653;CALCIUM CHANNEL#0.9653;CHOLECALCIFEROL#0.9652;DOXYCYCLINE#0.9652;NEPHROTIC SYNDROME#0.9652;MAST CELL#0.9652;PLASMA MEMBRANE#0.9652;VASODILATATION#0.9652;LIPID OXIDATION#0.9652;ADAPTIVE IMMUNE RESPONSE#0.9651;CYTOPENIA#0.9651;LENGTH OF STAY#0.9651;DICLOFENAC#0.9651;MUSCLE CELL#0.9650;MENOPAUSE#0.9650;CEREBRAL ISCHEMIA#0.9650;MACROPHAGE ACTIVATION#0.9650;LIMB ISCHEMIA#0.9649;CATALASE ACTIVITY#0.9649;METASTATIC PROSTATE CANCER#0.9649;TRADITIONAL RISK FACTORS#0.9648;EVERY OTHER WEEK#0.9648;POLYMYALGIA RHEUMATICA#0.9648;BREAST CANCER#0.9648;SLEEP APNEA#0.9647;DEHYDRATION#0.9647;DILATED CARDIOMYOPATHY#0.9647;SERUM ADIPONECTIN LEVELS#0.9647;HDL PARTICLE#0.9646;LEVOTHYROXINE#0.9646;ADJUSTED HAZARD RATIO#0.9645;WILCOXON RANK SUM#0.9645;CELL MIGRATION#0.9645;PULMONARY ARTERIAL HYPERTENSION#0.9644;DNA BINDING#0.9644;NORMAL CONTROL GROUP#0.9644;PERIPHERAL BLOOD CELLS#0.9643;HEPARIN BINDING#0.9643;FAT FREE MASS#0.9643;ACTIVATION OF COAGULATION#0.9642;GRANULOCYTE#0.9642;HYPERINSULINEMIC EUGLYCEMIC CLAMP#0.9642;MEDROXYPROGESTERONE ACETATE#0.9641;ADULT-ONSET STILL'S DISEASE#0.9641;EVENT FREE SURVIVAL#0.9640;AORTIC VALVE#0.9640;TOTAL HIP ARTHROPLASTY#0.9640;RESPIRATORY TRACT INFECTION#0.9640;PERITONITIS#0.9640;GRANULOCYTE COLONY STIMULATING FACTOR#0.9640;GRANULOMATOSIS WITH POLYANGIITIS#0.9640;GESTATIONAL DIABETES#0.9639;ENDOPLASMIC RETICULUM#0.9639;LEAN BODY MASS#0.9639;TISSUE DAMAGE#0.9639;COLORECTAL CANCER#0.9638;FEMORAL VEIN#0.9638;HEARING LOSS#0.9638;PROTEIN ENERGY WASTING#0.9637;ESTROGEN RECEPTOR#0.9637;CARDIAC ARREST#0.9637;CANCER CELL#0.9637;MAGNETIC RESONANCE SPECTROSCOPY#0.9637;FATALITY#0.9636;MULTIPLE ORGAN DYSFUNCTION#0.9636;IMPAIRED FASTING GLUCOSE#0.9636;LETHARGY#0.9636;METRONIDAZOLE#0.9635;OBSTRUCTIVE SLEEP APNEA#0.9634;COMPLEMENT RECEPTOR#0.9634;VASODILATION#0.9634;FALSE DISCOVERY RATE#0.9633;STANDARDIZED UPTAKE VALUE#0.9633;MODIFIED SHARP SCORE#0.9633;ESSENTIAL HYPERTENSION#0.9633;KINASE INHIBITOR#0.9633;RIMONABANT#0.9633;CARDIAC MAGNETIC RESONANCE#0.9632;HEPATITIS B#0.9632;METASTASIS FREE SURVIVAL#0.9632;HIGH CARDIOVASCULAR RISK#0.9632;DIPEPTIDYL PEPTIDASE#0.9631;HYPERANDROGENISM#0.9630;STROMAL CELL#0.9630;ADJUSTED ODDS RATIO#0.9630;DEMENTIA#0.9630;ADENOSINE#0.9630;OPTICAL COHERENCE TOMOGRAPHY#0.9629;MUSCLE WEAKNESS#0.9629;EMISSION COMPUTED TOMOGRAPHY#0.9628;COLON CANCER#0.9628;CACHEXIA#0.9628;DIGESTION#0.9628;MORBID OBESITY#0.9628;CHRONIC LIVER DISEASE#0.9627;VISCERAL ADIPOSE TISSUE#0.9627;FINE NEEDLE ASPIRATION#0.9626;MITRAL VALVE#0.9626;COLONY-STIMULATING FACTOR#0.9626;ISCHEMIC HEART DISEASE#0.9626;NEPHRITIS#0.9626;KNEE JOINT#0.9626;SIROLIMUS#0.9626;RHEUMATISM#0.9626;PREMATURITY#0.9626;CEREBROVASCULAR DISEASE#0.9626;OSTEOCLAST#0.9625;MARKERS OF INFLAMMATION#0.9625;HYDROXYCHLOROQUINE#0.9625;COLCHICINE#0.9624;ACUTE LUNG INJURY#0.9624;VIRAL INFECTION#0.9624;LINES OF EVIDENCE#0.9623;CD4+ T CELL#0.9622;ATRIAL FIBRILLATION#0.9622;SEPTUM#0.9622;SKIN RASH#0.9622;HYPOTHALAMIC PITUITARY ADRENAL#0.9621;SIROLIMUS ELUTING STENT#0.9621;LOW MOLECULAR WEIGHT HEPARIN#0.9621;CELL SURFACE#0.9621;BONE DISEASE#0.9620;ACETIC ACID#0.9619;CELL ACTIVATION#0.9619;PULMONARY EMBOLISM#0.9619;PLATELET ACTIVATION MARKERS#0.9619;CYCLOSPORIN#0.9618;ANKYLOSING SPONDYLITIS#0.9618;HIGH CHOLESTEROL DIET#0.9618;CYTOPLASM#0.9618;ELECTRONIC MEDICAL RECORD#0.9618;EXENATIDE#0.9617;SMOOTH MUSCLE#0.9617;TRANS FATTY ACID#0.9617;LIMITS OF DETECTION#0.9616;SPONDYLOARTHROPATHY#0.9616;SCLERODERMA#0.9616;CYTOCHROME P450#0.9615;SATURATED FATTY ACID#0.9615;ANTIOXIDANT ACTIVITY#0.9615;WALL MOTION SCORE#0.9614;IRON HOMEOSTASIS#0.9614;TRANSCRIPTASE#0.9614;SUBCUTANEOUS FAT AREA#0.9614;PLATELET ACTIVATION#0.9614;HYPERGLYCEMIC#0.9613;VASODILATOR#0.9612;FIBRINOLYSIS#0.9612;ANEMIA#0.9612;HEPATITIS C VIRUS#0.9612;INNATE IMMUNITY#0.9612;INNATE IMMUNE RESPONSE#0.9611;MYCOPHENOLATE MOFETIL#0.9611;SPONTANEOUS PRETERM DELIVERY#0.9611;GLUCOSE UPTAKE#0.9611;GROUND GLASS OPACITIES#0.9610;INNATE IMMUNE SYSTEM#0.9610;TOLL LIKE RECEPTOR#0.9610;COLLAGEN INDUCED ARTHRITIS#0.9610;PULMONARY HYPERTENSION#0.9610;PANCREATITIS#0.9610;UREMIA#0.9609;PROTEIN PROTEIN INTERACTION#0.9609;INSTITUTIONAL REVIEW BOARD#0.9609;APOPTOTIC#0.9608;TRANSCRIPTION FACTOR#0.9608;GEMCITABINE#0.9608;SIGNALLING PATHWAY#0.9607;IMPAIRED GLUCOSE METABOLISM#0.9606;OLMESARTAN#0.9606;LUNG CANCER#0.9606;TAMOXIFEN#0.9606;VASCULAR ENDOTHELIAL DYSFUNCTION#0.9605;RESPIRATORY SYNCYTIAL VIRUS#0.9605;ENDOCARDITIS#0.9605;MULTIPLE REGRESSION ANALYSIS#0.9604;ETANERCEPT#0.9604;ASPIRIN#0.9604;ACTIVATION OF NF-KAPPAB#0.9604;SPONDYLITIS#0.9603;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.9603;ACUTE PANCREATITIS#0.9603;ARACHIDONIC ACID#0.9603;HEALTHY CONTROL GROUP#0.9603;VITAMIN D RECEPTOR#0.9601;IRON OVERLOAD#0.9601;CEREBRAL ARTERY#0.9601;SEVERE ACUTE PANCREATITIS#0.9601;INTRACLASS CORRELATION COEFFICIENT#0.9600;RENAL TRANSPLANT RECIPIENTS#0.9600;TRADITIONAL CHINESE MEDICINE#0.9600;SKIN DISEASE#0.9599;MULTIPLE SCLEROSIS#0.9599;ANOREXIA#0.9599;HEPATITIS C#0.9599;DIFFUSION WEIGHTED IMAGING#0.9598;MYOCYTES#0.9598;BODY WEIGHT GAIN#0.9598;GIANT CELL ARTERITIS#0.9598;IMMUNE DYSFUNCTION#0.9597;COMMUNITY ACQUIRED PNEUMONIA#0.9597;THORACIC AORTA#0.9597;HIDRADENITIS SUPPURATIVA#0.9597;TIMI FRAME COUNT#0.9597;HYPOXIA#0.9597;LIVER DAMAGE#0.9596;METHYLPREDNISOLONE PULSE THERAPY#0.9596;MINOCYCLINE#0.9596;ADALIMUMAB#0.9595;HYPOTENSION#0.9595;HYPERTHYROIDISM#0.9595;GALLBLADDER#0.9595;RESPIRATION#0.9595;HEPARIN#0.9594;B LYMPHOCYTE#0.9594;ACUTE MYOCARDIAL INFARCTION#0.9594;BONE MARROW EDEMA#0.9594;SUCROSE#0.9594;WARFARIN#0.9594;CISPLATIN#0.9593;EICOSAPENTAENOIC ACID#0.9593;THALIDOMIDE#0.9593;DISSEMINATED INTRAVASCULAR COAGULATION#0.9592;POLYARTERITIS NODOSA#0.9592;FRAGMENT LENGTH POLYMORPHISM#0.9592;PLASMA CELL#0.9592;INTERNATIONAL DIABETES FEDERATION#0.9591;INTESTINAL PERFORATION#0.9591;LYMPHADENITIS#0.9591;BASEMENT MEMBRANE#0.9591;POLYCYSTIC OVARIAN SYNDROME#0.9590;ORAL GLUCOSE TOLERANCE#0.9590;HEMATOPOIETIC STEM CELL#0.9590;IMMUNOSUPPRESSANT#0.9590;LINEAR REGRESSION ANALYSIS#0.9590;RESPONSE TO METHOTREXATE#0.9590;CORONARY ARTERY ABNORMALITIES#0.9590;ANEMIC#0.9589;NECROTIC#0.9589;IMIPENEM#0.9589;CERVICAL#0.9588;PELVIS#0.9588;MTDNA#0.9588;WHITE ADIPOSE TISSUE#0.9588;ACUTE INSULIN RESPONSE#0.9587;HYDROCORTISONE#0.9587;BILIARY TRACT#0.9587;RHEUMATIC DISEASE#0.9587;ACETYLCHOLINE#0.9587;GENTAMICIN#0.9586;DELAYED CEREBRAL ISCHEMIA#0.9586;PROGENITOR CELL#0.9586;NORMAL GLUCOSE TOLERANCE#0.9586;VISCERAL FAT MASS#0.9586;GLUCOSE INTOLERANCE#0.9585;SPINAL CORD#0.9584;HYPOGONADISM#0.9583;ENDOTHELIAL CELL#0.9583;C-LEVEL#0.9582;INTIMA MEDIA THICKNESS#0.9582;VASCULAR ENDOTHELIUM#0.9582;ALZHEIMER'S DISEASE#0.9581;CARDIOMYOPATHY#0.9581;IGG BINDING#0.9580;FOREARM#0.9580;YEAR SURVIVAL RATE#0.9580;ADIPOSE TISSUE MASS#0.9580;CONSTIPATION#0.9580;LARGE VESSEL VASCULITIS#0.9580;HEMOSTASIS#0.9579;COAGULATION#0.9579;TUMOR CELLS#0.9578;MULTIPLE LOGISTIC REGRESSION#0.9578;INSULIN SECRETION#0.9578;DUCTUS ARTERIOSUS#0.9578;PULMONARY FIBROSIS#0.9578;GLUCOSE TOLERANCE TEST#0.9578;WHITE MATTER HYPERINTENSITIES#0.9578;HYPOTHYROIDISM#0.9577;BODY SURFACE AREA#0.9577;MEDIAN SURVIVAL TIME#0.9577;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9577;AND BODY COMPOSITION#0.9576;ENHANCER BINDING#0.9576;ADVERSE DRUG REACTION#0.9575;DYSPNEA#0.9575;TACROLIMUS#0.9574;CLINDAMYCIN#0.9574;INFLIXIMAB#0.9574;RELAPSE FREE SURVIVAL#0.9574;SULFASALAZINE#0.9574;COMMON CAROTID ARTERY#0.9573;EARLY ENTERAL NUTRITION#0.9573;TUBERCULOSIS#0.9573;MANNITOL#0.9573;SYNOVIUM#0.9573;PROTEIN-ENERGY MALNUTRITION#0.9572;CYCLOSPORINE#0.9572;PURPURA#0.9571;SENSITIZATION#0.9571;POSITIVE PREDICTIVE VALUE#0.9570;RANDOM EFFECT MODEL#0.9570;SODIUM NITROPRUSSIDE#0.9570;MULTIPLE LINEAR REGRESSION#0.9569;RESPIRATORY TRACT#0.9569;RENAL REPLACEMENT THERAPY#0.9569;APHTHOUS STOMATITIS#0.9569;RESPONSE TO TREATMENT#0.9568;PENICILLAMINE#0.9568;EMBOLISM#0.9568;PNEUMONIA#0.9568;OVARIAN#0.9567;LEFT ANTERIOR DESCENDING#0.9567;MAGNETIC RESONANCE ANGIOGRAPHY#0.9567;NEGATIVE PREDICTIVE VALUE#0.9567;T LYMPHOCYTE#0.9567;TYPE 2 DIABETIC#0.9567;LIPOPROTEIN LIPASE#0.9566;NORMAL FASTING GLUCOSE#0.9566;ACTIVATED MONOCYTES#0.9565;INTERSTITIAL LUNG DISEASE#0.9565;DERMATOMYOSITIS#0.9565;HYPERSENSITIVITY#0.9565;HEPATIC ENCEPHALOPATHY#0.9565;GASTRO#0.9564;OSTEOMYELITIS#0.9564;CELL DEATH#0.9564;ESOPHAGUS#0.9564;ASPHYXIA#0.9564;ENHANCER BINDING PROTEIN#0.9563;ASPERGILLOSIS#0.9562;METHIONINE#0.9562;AMYLOIDOSIS#0.9562;REACTIVE OXYGEN SPECIES#0.9562;ABDOMINAL AORTIC ANEURYSM#0.9562;CORONARY ARTERY BYPASS#0.9561;B CELL LYMPHOMA#0.9561;MODIFIED RANKIN SCALE#0.9561;PUBERTY#0.9561;CIPROFLOXACIN#0.9561;POLYCYSTIC KIDNEY DISEASE#0.9561;PATENT DUCTUS ARTERIOSUS#0.9561;ERYTHEMA#0.9560;SYNOVITIS#0.9560;CACHECTIC#0.9560;CHOLESTEROL TRANSPORT#0.9560;SENESCENCE#0.9560;THYROIDITIS#0.9559;ACUTE CORONARY SYNDROME#0.9559;DENDRITIC CELL#0.9559;PERCUTANEOUS CORONARY INTERVENTION#0.9558;FASCIITIS#0.9558;NITROPRUSSIDE#0.9558;STANDARD OF CARE#0.9558;DIPEPTIDYL PEPTIDASE 4#0.9557;OLEIC ACID#0.9557;CONGESTIVE HEART FAILURE#0.9557;PRO-INFLAMMATORY#0.9557;BONE RESORPTION#0.9556;THYROID GLAND#0.9556;RIFAMPICIN#0.9556;MECHANISMS OF ACTION#0.9555;SUBCUTANEOUS ADIPOSE TISSUE#0.9555;MIDDLE CEREBRAL ARTERY#0.9555;VANCOMYCIN#0.9555;TO THE PROGRESSION#0.9554;ISCHEMIA REPERFUSION INJURY#0.9554;MALAISE#0.9554;T CELL#0.9554;ACUTE KIDNEY INJURY#0.9554;PREDNISONE#0.9554;CONJUNCTIVITIS#0.9553;DIGESTIVE TRACT#0.9553;RHINITIS#0.9552;ANESTHETIC#0.9552;HYPERGLYCEMIA#0.9552;SIGNALING PATHWAY#0.9552;LYMPHOCYTE ACTIVATION#0.9552;PLASMA ANTIOXIDANT CAPACITY#0.9552;MEAN FLUORESCENCE INTENSITY#0.9551;MYELODYSPLASTIC SYNDROME#0.9551;WEIGHT GAIN#0.9550;LUMINAL#0.9550;AUTOIMMUNITY#0.9550;TYPE 1 DIABETES#0.9549;ANTIBODY ASSOCIATED VASCULITIS#0.9549;SKELETAL MUSCLE#0.9549;CEFTRIAXONE#0.9549;HEMOLYTIC ANEMIA#0.9549;TYPE 1 DIABETES MELLITUS#0.9549;MONOUNSATURATED FATTY ACIDS#0.9548;CANDESARTAN#0.9548;IRRITATION#0.9548;ALLERGIC REACTION#0.9548;ADENOCARCINOMA#0.9548;CELL-MEDIATED IMMUNITY#0.9548;GLASGOW OUTCOME SCALE#0.9547;REGENERATION#0.9546;MUSCLE WASTING#0.9546;END STAGE RENAL FAILURE#0.9545;FIBROUS CAP THICKNESS#0.9545;CONNECTIVE TISSUE DISEASE#0.9544;INDOMETHACIN#0.9544;VASCULAR DISEASE#0.9543;DIABETIC NEPHROPATHY#0.9543;RIGHT UPPER QUADRANT#0.9542;FRONTAL#0.9542;HEPATOCELLULAR ADENOMA#0.9542;CELL PROLIFERATION#0.9542;AMOXICILLIN#0.9542;IDIOPATHIC PULMONARY FIBROSIS#0.9542;URINARY TRACT INFECTION#0.9541;CYSTIC FIBROSIS#0.9541;SWELLING#0.9541;INTESTINAL DISEASE#0.9541;VOMITING#0.9541;ERYTHROPOIESIS#0.9541;PERIPHERAL BLOOD#0.9540;HYPERCHOLESTEROLEMIA#0.9540;ARRHYTHMIA#0.9540;CORONARY HEART DISEASE#0.9540;AZATHIOPRINE#0.9539;HYPERTENSION#0.9539;MYELOID LEUKEMIA#0.9538;REGULATORY T CELL#0.9538;STEM CELL TRANSPLANTATION#0.9538;SPIRONOLACTONE#0.9538;MYOCARDIUM#0.9538;INCIDENCE RATE RATIO#0.9538;ENDOTHELIAL CELL DYSFUNCTION#0.9538;IMPAIRED GLUCOSE TOLERANCE#0.9537;ACUTE MYELOID LEUKEMIA#0.9537;25-HYDROXYVITAMIN D3#0.9537;MEDROXYPROGESTERONE#0.9536;GRAM NEGATIVE BACTERIAL#0.9536;TNF-ALPHA PRODUCTION#0.9536;IMMUNE CELL#0.9536;APOPTOSIS#0.9536;EXTRACELLULAR MATRIX#0.9536;SEDATION#0.9536;PREDNISOLONE#0.9536;AGEING#0.9535;PHYSICAL COMPONENT SUMMARY#0.9535;PEROXISOME#0.9535;ETHANOL#0.9535;ESTIMATED BLOOD LOSS#0.9534;CYCLOSPORIN A#0.9534;POLYCYSTIC OVARY SYNDROME#0.9533;ALCOHOLIC FATTY LIVER#0.9533;WOUND HEALING#0.9532;BRAIN DAMAGE#0.9532;MYCOPLASMA PNEUMONIAE PNEUMONIA#0.9532;CROHN'S DISEASE#0.9531;CROSS SECTIONAL AREA#0.9531;FACTOR V LEIDEN#0.9531;LEISHMANIASIS#0.9531;RITUXIMAB#0.9531;HYPERPARATHYROIDISM#0.9531;CAROTID ARTERY#0.9531;BILE DUCT#0.9530;VIRULENCE#0.9530;LIPOIC ACID#0.9529;HEMORRHAGE#0.9529;MACROPHAGE#0.9528;IRON DEFICIENCY ANEMIA#0.9528;CELIAC DISEASE#0.9527;GESTATION#0.9527;ADULT TREATMENT PANEL#0.9525;AMPICILLIN#0.9525;GENE EXPRESSION#0.9524;DIURESIS#0.9523;CATABOLISM#0.9522;CHRONIC HEART FAILURE#0.9521;DEFICIENCY ANEMIA#0.9521;QUANTITATIVE REAL TIME#0.9521;LICHEN PLANUS#0.9520;ACUTE REJECTION EPISODE#0.9519;ABDOMINAL PAIN#0.9518;ENDOGENOUS THROMBIN POTENTIAL#0.9518;WEIGHT LOSS#0.9518;DIABETIC KIDNEY DISEASE#0.9517;PARENCHYMA#0.9517;LYMPH NODE#0.9517;SYSTEMIC INFLAMMATORY RESPONSE#0.9516;HEALTHY CONTROL SUBJECTS#0.9516;HIGH RISK PATIENTS#0.9515;REVERSE TRANSCRIPTION#0.9515;MEDIAN OVERALL SURVIVAL#0.9515;WORLD HEALTH ORGANIZATION#0.9514;BONE MINERAL DENSITY#0.9514;MYOCARDIAL INFARCTION#0.9513;NECROTIZING#0.9513;BLOOD VESSEL#0.9513;ACETYLCYSTEINE#0.9513;CLINICAL PRACTICE GUIDELINE#0.9512;ACADEMIC MEDICAL CENTER#0.9512;HEART DISEASE#0.9511;SMALL INTESTINE#0.9510;KAWASAKI DISEASE#0.9509;LOSS OF APPETITE#0.9508;LITHIUM#0.9508;INTENTION TO TREAT#0.9508;RESPIRATORY DISTRESS#0.9508;MULTIPLE MYELOMA#0.9507;CONNECTIVE TISSUE#0.9507;NODULAR#0.9506;LIPOLYSIS#0.9506;RESPIRATORY FAILURE#0.9506;ADVANCED GLYCATION ENDPRODUCT#0.9506;NEPHROPATHY#0.9506;NEUROPATHY#0.9505;OBESE#0.9505;TOPICAL#0.9504;ADIPOCYTE#0.9503;FAMILIAL MEDITERRANEAN FEVER#0.9503;GLUCOSE METABOLISM#0.9502;POST-TRAUMATIC STRESS DISORDER#0.9502;FOOD FREQUENCY QUESTIONNAIRE#0.9502;MEDICAL OUTCOMES STUDY#0.9501;AORTIC ANEURYSM#0.9501;STOMATITIS#0.9500;BONE FORMATION#0.9499;COLLAGENASE#0.9498;MALNUTRITION#0.9497;HUMAN IMMUNODEFICIENCY VIRUS#0.9496;BOWEL OBSTRUCTION#0.9496;PENICILLIN#0.9496;EOSIN#0.9495;FEMUR#0.9494;HEMORRHAGIC#0.9494;FATTY LIVER#0.9494;THROMBOSIS#0.9494;VITAMIN D DEFICIENCY#0.9492;CARDIOVASCULAR RISK FACTOR#0.9492;ENDOTHELIUM#0.9492;LUPUS ERYTHEMATOSUS#0.9492;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9492;AORTIC VALVE CALCIFICATION#0.9492;B CELL#0.9490;LATE PREGNANCY#0.9489;INTER QUARTILE RANGE#0.9488;CHOLANGIOCARCINOMA#0.9486;CORONARY ARTERY DISEASE#0.9486;THYROID CARCINOMA#0.9486;OSTEOARTHRITIS#0.9486;PIPERACILLIN#0.9485;ISCHEMIA#0.9485;NUCLEIC ACID#0.9485;ANTI INFLAMMATORY DRUGS#0.9484;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9484;NEPHROTOXICITY#0.9483;CORONARY ARTERY#0.9483;PROTEIN SECRETION#0.9483;COLLAGEN DISEASE#0.9483;ARTERY DISEASE#0.9483;IL-6 SECRETION#0.9483;RANDOMISED CONTROLLED TRIAL#0.9483;EARLY RHEUMATOID ARTHRITIS#0.9481;SLEEP APNOEA SYNDROME#0.9480;PERCEIVED STRESS SCALE#0.9480;MASTITIS#0.9480;LYMPH NODE DISSECTION#0.9479;ANGIOGENESIS#0.9478;D-PENICILLAMINE#0.9478;NORMAL TENSION GLAUCOMA#0.9476;PROPOFOL#0.9475;MECHANISM OF ACTION#0.9475;LUNG DISEASE#0.9475;STEM CELL#0.9474;INFLAMMATORY CELL INFILTRATION#0.9474;CYTOKINE PRODUCTION#0.9474;ENDOTHELIAL MICROPARTICLE#0.9472;BASAL GANGLIA#0.9472;KIDNEY DAMAGE#0.9472;OSTEOPOROSIS#0.9472;VASCULITIS#0.9471;IGM ANTIBODY#0.9471;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9470;INGUINAL HERNIA#0.9470;JUVENILE IDIOPATHIC ARTHRITIS#0.9470;GROUND GLASS OPACITY#0.9469;PSORIATIC ARTHRITIS#0.9469;BONE MARROW#0.9469;DIARRHEA#0.9468;STANDARDISED MEAN DIFFERENCE#0.9467;LIPID METABOLISM#0.9466;AMPHOTERICIN#0.9466;CELL GROWTH#0.9465;COUGHING#0.9465;LASER DESORPTION IONIZATION#0.9465;ADIPOSE TISSUE#0.9465;RECTUM#0.9464;EDEMA#0.9464;INFERTILITY#0.9464;NONALCOHOLIC FATTY LIVER DISEASE#0.9463;GLASGOW COMA SCORE#0.9463;MITOCHONDRIAL DNA#0.9463;POSITRON EMISSION TOMOGRAPHY#0.9462;INFLAMMATORY CELL#0.9462;FUNCTIONAL INDEPENDENCE MEASURE#0.9462;METHYLPREDNISOLONE#0.9462;TIBIA#0.9461;ARTERY#0.9460;COLITIS#0.9459;PREMATURE LABOR#0.9459;CARDIOVASCULAR SYSTEM#0.9458;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9457;INTRAVENOUS IMMUNOGLOBULIN#0.9457;IMPLANTABLE CARDIOVERTER DEFIBRILLATOR#0.9456;TYPE 2 DIABETES MELLITUS#0.9456;DIABETES MELLITUS#0.9456;ATHEROSCLEROTIC#0.9456;2 DIABETES MELLITUS#0.9455;PARENTERAL#0.9455;STREPTOZOTOCIN#0.9453;SECONDARY HYPERPARATHYROIDISM#0.9453;DEFECATION#0.9453;GLOMERULONEPHRITIS#0.9452;SUBACUTE THYROIDITIS#0.9452;TUBERCULIN SKIN TEST#0.9451;BRADYCARDIA#0.9451;ATHEROSCLEROSIS#0.9450;ULCERATIVE COLITIS#0.9450;CYTOKINE SECRETION#0.9449;M2 MACROPHAGE#0.9449;LEVOFLOXACIN#0.9448;CYCLOPHOSPHAMIDE#0.9447;HUMAN WHOLE BLOOD#0.9447;LIVER DISEASE#0.9447;GASTROINTESTINAL TRACT#0.9447;CENTRAL NERVOUS SYSTEM#0.9445;SEROTONIN REUPTAKE INHIBITOR#0.9444;INVASIVE FUNGAL INFECTION#0.9444;POLYMYOSITIS#0.9444;VENTRICULAR ASSIST DEVICE#0.9442;INTENSIVE CARE UNIT#0.9441;HOST CELL#0.9441;MONONUCLEAR CELLS#0.9441;INFLAMMATORY RESPONSE#0.9440;INTESTINAL MUCOSA#0.9440;RANDOMIZED CLINICAL TRIAL#0.9440;CARRIE#0.9439;RAPID DIAGNOSTIC TEST#0.9437;TYPE 2 DIABETES#0.9437;MEROPENEM#0.9436;OXIDATIVE METABOLISM#0.9435;PROTON PUMP#0.9435;HYPERACTIVITY#0.9435;DERMATITIS#0.9434;LYME DISEASE#0.9434;HIGH FAT DIET#0.9434;FATTY LIVER DISEASE#0.9433;MAJOR ADVERSE EVENT#0.9432;INTERVENTRICULAR SEPTUM#0.9432;INTENT TO TREAT#0.9431;SERIOUS ADVERSE EVENT#0.9431;R/AMP#0.9431;CHRONIC INFLAMMATORY RESPONSE#0.9430;PERITONEUM#0.9430;SQUAMOUS CELL CANCER#0.9428;MAGNETIC RESONANCE IMAGING#0.9428;NUMBNESS#0.9427;BODY MASS INDICES#0.9427;STEM CELL TRANSPLANT#0.9426;OSTEOBLAST#0.9426;INTERVERTEBRAL DISC#0.9426;GLIMEPIRIDE#0.9426;CELL DIFFERENTIATION#0.9425;PROTON PUMP INHIBITOR#0.9424;LEPTOSPIROSIS#0.9423;LOWER LEG#0.9420;GENISTEIN#0.9419;AUTOIMMUNE DISEASE#0.9418;BONE MORPHOGENETIC PROTEIN#0.9417;BLOOD PRESSURE HOMEOSTASIS#0.9417;SAPHO SYNDROME#0.9417;VORICONAZOLE#0.9416;UNINTENTIONAL WEIGHT LOSS#0.9414;NERVOUS SYSTEM#0.9412;LYMPH NODE METASTASES#0.9412;TOXICITY#0.9411;LOW IRON#0.9410;CLARITHROMYCIN#0.9410;CALCITRIOL#0.9410;PROTEASOME#0.9410;VERTEBRAE#0.9407;METHOTREXATE#0.9407;BONE REMODELING#0.9406;INTERNATIONAL STAGING SYSTEM#0.9405;INFLAMMATORY BOWEL DISEASE#0.9404;UTERUS#0.9403;FIBRIL#0.9403;CARDIAC MUSCLE#0.9402;THYROXINE BINDING#0.9402;AORTIC ATHEROSCLEROSIS#0.9402;CORTICOTROPIN#0.9400;DEAMINASE ACTIVITY#0.9398;MESENTERIC ARTERY#0.9394;RESPONSE TO STRESS#0.9391;INSULIN RECEPTOR#0.9390;HEARING IMPAIRMENT#0.9389;PEDICLE#0.9389;REVERSE CHOLESTEROL TRANSPORT#0.9388;ACTIVATED T CELL#0.9388;NEURODEGENERATIVE DISEASE#0.9386;KIDNEY TRANSPLANT PATIENTS#0.9386;CARDIOVASCULAR MAGNETIC RESONANCE#0.9386;IMMUNE RESPONSE#0.9384;DOCETAXEL#0.9384;METASTATIC MELANOMA#0.9381;POLYMERASE CHAIN REACTION#0.9381;ATHEROSCLEROTIC HEART DISEASE#0.9378;IMMUNE SYSTEM#0.9377;KIDNEY DISEASE#0.9376;CHRONIC KIDNEY DISEASE#0.9376;NORMAL BODY MASS#0.9374;BREAST CARCINOMA#0.9370;PALMITIC ACID#0.9369;ALLERGEN#0.9369;PLATELET MONOCYTE AGGREGATES#0.9368;DIZZINESS#0.9368;TARGET LESION REVASCULARIZATION#0.9367;NEW ONSET DIABETES#0.9367;RANDOMIZED CONTROLLED TRIAL#0.9366;ESSENTIAL THROMBOCYTHEMIA#0.9365;PROTEOGLYCAN#0.9363;BRONCHOPULMONARY DYSPLASIA#0.9361;OXIDATIVE BURST#0.9360;LACK OF EFFICACY#0.9359;L-THYROXINE#0.9358;MYOPATHY#0.9357;MITOCHONDRIA#0.9356;PSYCHOTIC DISORDER#0.9356;MACROPHAGE ACTIVATION SYNDROME#0.9356;HYDROCEPHALUS#0.9354;PERINDOPRIL#0.9353;RESPONSE TO STATIN#0.9350;BLOOD PLATELETS#0.9349;GERIATRIC DEPRESSION SCALE#0.9347;PRIMARY CARE PHYSICIAN#0.9343;ERYTHROMYCIN#0.9342;OSSIFICATION#0.9337;GROUP A STREPTOCOCCUS#0.9337;SORAFENIB#0.9336;IL-8 PRODUCTION#0.9333;ALPHA LIPOIC ACID#0.9332;RHEUMATOID ARTHRITIS#0.9330;INCONTINENCE#0.9330;LOCALISATION#0.9329;HYPERPHOSPHATEMIA#0.9325;PLEURISY#0.9323;CEFOTAXIME#0.9323;ARTERIOLE#0.9320;SCANNING ELECTRON MICROSCOPY#0.9317;ALVEOLAR BONE LOSS#0.9315;GRAY MATTER VOLUME#0.9314;ACROMEGALY#0.9314;CORONARY MICROVASCULAR DYSFUNCTION#0.9313;HARDY WEINBERG EQUILIBRIUM#0.9312;RESPIRATORY SYSTEM#0.9311;HERPES ZOSTER#0.9311;HEPATOTOXICITY#0.9309;RITONAVIR#0.9307;HUMAN LEUCOCYTE ANTIGEN#0.9305;FENTANYL#0.9305;KARNOFSKY PERFORMANCE SCORE#0.9305;PERITONEAL CAVITY#0.9303;TEICOPLANIN#0.9303;OLANZAPINE#0.9302;INTERLEUKIN-6 PRODUCTION#0.9301;OBSTRUCTIVE JAUNDICE#0.9300;IMMUNE SUPPRESSION#0.9300;GUANOSINE#0.9299;AT-17#0.9297;PHOSPHATIDYLSERINE#0.9297;CANCER SPECIFIC MORTALITY#0.9296;OVARIES#0.9296;CHRONIC LIVER FAILURE#0.9295;CD3+ T CELL#0.9292;GLYCINE#0.9292;M1 MACROPHAGE#0.9290;ABDOMINAL VISCERAL FAT#0.9290;RESPONSE TO ACETYLCHOLINE#0.9290;GENETIC ASSOCIATION STUDIES#0.9288;BICEPS#0.9287;NEUTROPHIL GRANULOCYTES#0.9285;SOLUBLE FRACTION#0.9283;MULTICENTRIC CASTLEMAN DISEASE#0.9283;EARLY LIFE STRESS#0.9280;FEMORAL NECK FRACTURE#0.9279;CERVICAL LYMPH NODE#0.9277;LEFT ATRIAL APPENDAGE#0.9275;ORCHITIS#0.9273;MUCOUS#0.9269;CERIVASTATIN#0.9269;ABSOLUTE RISK REDUCTION#0.9267;FLOW CYTOMETRY ANALYSIS#0.9267;QUANTITATIVE REVERSE TRANSCRIPTION#0.9267;INTENSIVE INSULIN THERAPY#0.9264;NATIONAL UNIVERSITY HOSPITAL#0.9264;HIGH TOTAL CHOLESTEROL#0.9263;PERCENT ATHEROMA VOLUME#0.9262;METHACHOLINE#0.9257;SJOGREN'S SYNDROME#0.9254;HYPOTENSIVE#0.9254;AMBIENT AIR POLLUTION#0.9251;FACTOR S#0.9251;LIMIT OF QUANTIFICATION#0.9249;PERIPHERAL MONONUCLEAR CELLS#0.9248;DOXORUBICIN#0.9247;ANNULUS#0.9245;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS#0.9242;5 FLUOROURACIL#0.9240;BACTERIAL VAGINOSIS#0.9239;PORTAL HYPERTENSION#0.9237;OVERALL RESPONSE RATE#0.9235;ACTIVATED T-CELLS#0.9235;JAPANESE ORTHOPAEDIC ASSOCIATION#0.9235;TH1 CELL#0.9233;PACLITAXEL#0.9231;DNA FRAGMENTATION#0.9230;IRBESARTAN#0.9230;FALSE POSITIVE RATE#0.9229;METASTATIC BREAST CANCER#0.9228;KETAMINE#0.9223;5-ASA#0.9222;ILIAC ARTERY#0.9221;LOW GLYCEMIC INDEX#0.9220;ALLERGIC RHINITIS#0.9220;OOCYTE#0.9219;RESPONSE TO TNF#0.9218;PARAPLEGIA#0.9215;LACRIMAL GLAND#0.9214;MYOCARDIAL PERFUSION IMAGING#0.9211;PARTIAL LEAST SQUARE#0.9210;MIDLINE#0.9209;TONSIL#0.9208;ADVANCED GASTRIC CANCER#0.9208;LONE ATRIAL FIBRILLATION#0.9206;CARDIAC ALLOGRAFT VASCULOPATHY#0.9205;MOLECULAR TARGETED THERAPY#0.9204;IRRITABILITY#0.9203;COMPLEX I#0.9203;MENINGOENCEPHALITIS#0.9202;DIET INDUCED OBESITY#0.9200;POWER DOPPLER ULTRASOUND#0.9196;RISK FACTORS ONLY#0.9193;BLINDNESS#0.9191;ADAPTIVE IMMUNE SYSTEM#0.9190;STROMA#0.9189;SYSTEMIC ENDOTHELIAL DYSFUNCTION#0.9186;PARALYSIS#0.9182;ATP BINDING#0.9182;ENERGY HOMEOSTASIS#0.9181;CYCLIC AMP#0.9178;NEUROLOGICAL DISORDER#0.9177;TAZOBACTAM#0.9176;MALIGNANT PLEURAL MESOTHELIOMA#0.9175;HYDROXYPROLINE#0.9173;THYROXIN#0.9173;SUBCUTANEOUS ABDOMINAL FAT#0.9173;LINEZOLID#0.9172;HYPERCALCEMIA#0.9171;T CELL PROLIFERATION#0.9162;ROFECOXIB#0.9159;ISONIAZID#0.9157;TRIMETHOPRIM#0.9155;CELL AGGREGATION#0.9153;PEROXIDASE ACTIVITY#0.9150;CHINESE HERBAL MEDICINE#0.9150;DERMIS#0.9149;INSULIN TOLERANCE TEST#0.9143;CLOSTRIDIUM DIFFICILE INFECTION#0.9143;SENSITIZER#0.9143;MESENCHYMAL STEM CELL#0.9142;TIREDNESS#0.9140;CLINICAL RESEARCH CENTER#0.9139;INSULIN METABOLISM#0.9139;LIKELIHOOD RATIO TEST#0.9139;ADENINE#0.9136;URINE ALBUMIN EXCRETION#0.9136;KIDNEY INJURY MOLECULE#0.9135;DODECYL SULFATE#0.9131;SODIUM DODECYL SULFATE#0.9131;COLLAGEN DEGRADATION#0.9126;SCRUB TYPHUS#0.9126;SIGNALING MOLECULE#0.9121;TESTICULAR CANCER#0.9121;GLUCOSAMINE#0.9119;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.9119;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.9119;HYPOXIC ISCHEMIC ENCEPHALOPATHY#0.9118;RISPERIDONE#0.9117;RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS#0.9116;QUANTITATIVE COMPUTED TOMOGRAPHY#0.9113;ANKLE JOINT#0.9112;STREPTOKINASE#0.9109;ERYTHROCYTE MEMBRANES#0.9108;CASE FATALITY RATE#0.9105;TYPE III PROCOLLAGEN#0.9102;INFECTIOUS MONONUCLEOSIS#0.9101;FLUOROURACIL#0.9101;OUTER MEMBRANE#0.9099;NICOTINAMIDE#0.9098;T-CELL LEUKEMIA#0.9093;PERIPHERAL LEUKOCYTES#0.9092;INTERNATIONAL PROGNOSTIC INDEX#0.9087;ELECTROPHORETIC MOBILITY SHIFT#0.9086;GLUCOSE METABOLIC#0.9086;INJECTION SITE REACTIONS#0.9084;CORONARY THROMBOSIS#0.9084;SMALL VESSEL VASCULITIS#0.9083;RIGHT ATRIUM#0.9083;POLYNEUROPATHY#0.9083;LIVER FAT CONTENT#0.9080;VALVULAR HEART DISEASE#0.9079;HEALTH CARE SYSTEM#0.9078;SEVERE ADVERSE EVENTS#0.9075;NEUROFIBRILLARY TANGLE#0.9075;COMMON COLD#0.9067;APPARENT DIFFUSION COEFFICIENT#0.9066;HEART FAILURE HOSPITALIZATION#0.9066;VIRGIN OLIVE OIL#0.9064;TISSUE GROWTH FACTOR#0.9063;VASOCONSTRICTION#0.9063;TYPHUS#0.9063;LONG TERM CARE#0.9061;CYCLIC GUANOSINE MONOPHOSPHATE#0.9058;CHRONIC FATIGUE SYNDROME#0.9058;HYDROCHLOROTHIAZIDE#0.9057;TRANSIENT ISCHAEMIC ATTACK#0.9057;PARTURITION#0.9055;ETHINYL ESTRADIOL#0.9055;CYTOKINE ACTIVITY#0.9052;FERTILIZATION#0.9049;ABNORMAL GLUCOSE METABOLISM#0.9045;STATISTICALLY SIGNIFICANTLY DIFFERENT#0.9043;CLAVULANIC ACID#0.9041;ACETAMINOPHEN#0.9040;TIROFIBAN#0.9038;QUANTITATIVE CORONARY ANGIOGRAPHY#0.9037;ENOXAPARIN#0.9037;SUPEROXIDE RELEASE#0.9032;MCP-1 PRODUCTION#0.9032;SPONTANEOUS PRETERM BIRTH#0.9029;ADULT RESPIRATORY DISTRESS SYNDROME#0.9028;ENCEPHALOMYELITIS#0.9027;TISSUE REMODELING#0.9025;MEDIASTINUM#0.9023;OVULATION#0.9022;LATE GADOLINIUM ENHANCEMENT#0.9022;RAPAMYCIN#0.9022;SKELETON#0.9021;EPIGALLOCATECHIN#0.9020;CRESCENTIC GLOMERULONEPHRITIS#0.9019;INFLAMMATORY MONOCYTE#0.9017;DUODENUM#0.9012;ESSENTIAL AMINO ACID#0.9012;HIDRADENITIS#0.9004;DIABETIC KETOACIDOSIS#0.8999;GRAVES' DISEASE#0.8994;URETER#0.8993;MECONIUM#0.8991;CAROTID ARTERY ATHEROSCLEROSIS#0.8990;POTASSIUM CHLORIDE#0.8990;INTESTINAL TUBERCULOSIS#0.8987;MINIMALLY INVASIVE SURGERY#0.8986;SIGNAL PEPTIDE#0.8985;THORACIC AORTIC ANEURYSM#0.8984;GONADOTROPIN RELEASING HORMONE#0.8981;TUMORAL NECROSIS FACTOR#0.8980;DRUG RESISTANCE#0.8980;PROTEIN KINASE B#0.8980;RESTLESS LEGS SYNDROME#0.8979;ACUTE CHOLANGITIS#0.8978;INFLUENZA A VIRUS#0.8974;ARGININE VASOPRESSIN#0.8974;NON HODGKIN LYMPHOMA#0.8973;THIAMINE#0.8972;CARDIAC TAMPONADE#0.8969;HELLP SYNDROME#0.8967;COLONIC DISEASE#0.8967;QUARTZ CRYSTAL MICROBALANCE#0.8965;RIGHT VENTRICULAR DYSFUNCTION#0.8961;CELL CYCLE ARREST#0.8958;STRUCTURAL HEART DISEASE#0.8957;SENSORINEURAL HEARING LOSS#0.8950;LUMBAR DISC HERNIATION#0.8950;QUINOLINIC ACID#0.8939;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.8934;N GLYCAN#0.8933;SELF REPORT QUESTIONNAIRE#0.8929;MESALAZINE#0.8929;LOWER BODY FAT#0.8928;FETAL GROWTH RESTRICTION#0.8926;ISOPROTERENOL#0.8921;CASPASE-3 ACTIVITY#0.8917;INTESTINAL TRACT#0.8917;SEVERE ACUTE RESPIRATORY SYNDROME#0.8914;SULFAMETHOXAZOLE#0.8914;MUSCLE ATROPHY#0.8914;INTERNATIONAL WORKING GROUP#0.8912;JEJUNUM#0.8908;CARDIAC COMPUTED TOMOGRAPHY#0.8908;TUBE FORMATION#0.8907;VISCERAL LEISHMANIASIS#0.8906;ADRENERGIC RECEPTOR#0.8905;AMYGDALA#0.8899;PROTEIN BREAKDOWN#0.8898;NOS ACTIVITY#0.8897;RESPONSE TO INTERLEUKIN-6#0.8893;TETRACYCLINE#0.8891;CERVICAL ADENITIS#0.8890;PHOSPHODIESTERASE#0.8883;AMIKACIN#0.8883;LATERAL SCLEROSIS#0.8881;INVASIVE BREAST CANCER#0.8879;COLLAGEN SYNTHESIS#0.8878;END ORGAN DAMAGE#0.8878;HEMOLYTIC UREMIC SYNDROME#0.8874;POPULATION ATTRIBUTABLE RISK#0.8870;CHLOROQUINE#0.8869;FIRST EPISODE PSYCHOSIS#0.8869;CHOLESTEROL SYNTHESIS#0.8868;WEIGHT FOR AGE#0.8867;OVERALL SURVIVAL TIME#0.8863;LYMPHOCYTIC LEUKEMIA#0.8859;GLUTATHIONE PEROXIDASE ACTIVITY#0.8858;JUGULAR VEIN#0.8857;PROLIFERATIVE DIABETIC RETINOPATHY#0.8855;CIGARETTES PER DAY#0.8853;MIDDLE EAR#0.8851;VITAMIN K ANTAGONIST#0.8850;HOSPITAL BASED STUDY#0.8848;VIRAL GASTROENTERITIS#0.8845;EXCESSIVE DAYTIME SLEEPINESS#0.8844;CYTOMETRIC BEAD ARRAY#0.8844;PALMITATE#0.8840;UMBILICAL ARTERY#0.8836;IL-1 PRODUCTION#0.8836;VARICELLA ZOSTER VIRUS#0.8830;WHITE MATTER HYPERINTENSITY#0.8827;ADULT T-CELL LEUKEMIA#0.8825;CARDIAC RESYNCHRONIZATION THERAPY#0.8823;OSELTAMIVIR#0.8816;ANAESTHETIC#0.8815;NITROGEN OXIDE#0.8814;CILOSTAZOL#0.8812;FLUCONAZOLE#0.8810;LIPOPROTEIN OXIDATION#0.8809;HUMORAL IMMUNE RESPONSE#0.8808;LUNG LESIONS#0.8807;HUMAN PRIMARY HEPATOCYTES#0.8807;CREATININE CLEARANCE RATE#0.8806;SHOULDER JOINT#0.8803;CONVULSION#0.8802;PALMITOLEIC ACID#0.8800;ECZEMA#0.8796;PROGRAMMED CELL DEATH#0.8794;NITROGLYCERINE#0.8794;AUTOPHAGY#0.8793;MALONALDEHYDE#0.8789;EPTIFIBATIDE#0.8788;CHYLOMICRON#0.8788;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8786;MODE OF ACTION#0.8786;MUSCLE CELL PROLIFERATION#0.8784;ATOPIC DERMATITIS#0.8781;VISCERAL FAT ACCUMULATION#0.8779;VASOCONSTRICTOR#0.8773;25-HYDROXYCHOLECALCIFEROL#0.8772;ETOPOSIDE#0.8771;SOLUBLE VASCULAR ENDOTHELIAL#0.8770;ANKYLOSIS#0.8757;FLUID RETENTION#0.8754;RETINAL ARTERY OCCLUSION#0.8752;CANDIDIASIS#0.8749;PROTEIN CATABOLISM#0.8747;CYTOTOXIC T-LYMPHOCYTE#0.8747;HEALTH CARE PROVIDER#0.8745;CAROTID ARTERY STENTING#0.8745;AIR DISPLACEMENT PLETHYSMOGRAPHY#0.8744;AUTOIMMUNE HEPATITIS#0.8744;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8737;AMYOTROPHIC LATERAL SCLEROSIS#0.8735;SIBUTRAMINE#0.8734;MAGNESIUM SULFATE#0.8732;ANTERIOR ISCHEMIC OPTIC NEUROPATHY#0.8729;DEHISCENCE#0.8728;NEUTROPHIL APOPTOSIS#0.8726;ADENOSINE DEAMINASE ACTIVITY#0.8724;PELVIC GIRDLE#0.8724;THYROTOXICOSIS#0.8723;PLATELET AGGREGATION RATE#0.8723;PENILE CANCER#0.8717;ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY#0.8717;FAT CELL#0.8714;SPIRAL COMPUTED TOMOGRAPHY#0.8709;MELPHALAN#0.8708;SC ADIPOSE TISSUE#0.8707;BRIEF PAIN INVENTORY#0.8706;GASTRIC ULCER#0.8705;SMOOTH MUSCLE CELL PROLIFERATION#0.8704;CEREBRAL HEMORRHAGE#0.8703;MITRAL VALVE DISEASE#0.8702;MENARCHE#0.8701;MEMORY T CELL#0.8700;VERTEBRA#0.8699;ROOT MEAN SQUARE#0.8698;ANTIGEN PRESENTING CELLS#0.8698;ACALCULOUS CHOLECYSTITIS#0.8696;BURDEN OF DISEASE#0.8695;MILK PROTEIN#0.8693;DIABETIC NEUROPATHY#0.8692;MYOCARDIAL PERFORMANCE INDEX#0.8692;ADJUSTABLE GASTRIC BANDING#0.8688;TARGET OF RAPAMYCIN#0.8688;SCLEROTIC#0.8687;RELATIVE RISK REDUCTION#0.8683;LEFT ATRIAL DIMENSION#0.8681;ALOPECIA#0.8681;SCLEROSING CHOLANGITIS#0.8670;L-ALANINE#0.8665;ANOREXIA NERVOSA#0.8664;PANCREATIC ADENOCARCINOMA#0.8662;INSULIN RESISTANCE INDICES#0.8661;BLOOD CLOTTING#0.8660;CHLORAMPHENICOL#0.8659;COMPREHENSIVE GERIATRIC ASSESSMENT#0.8658;HYPEROSTOSIS#0.8656;CORTISOL SECRETION#0.8655;SICKLE CELL ANEMIA#0.8655;ILEITIS#0.8654;HUMAN ADIPOSE TISSUE#0.8650;MASSIVE WEIGHT LOSS#0.8649;L-LYSINE#0.8646;GENERALIZED ANXIETY DISORDER#0.8645;BEVACIZUMAB#0.8645;SCALP#0.8644;ENALAPRIL#0.8640;MYO-INOSITOL#0.8638;CALCULATED FREE TESTOSTERONE#0.8636;SKIN PRICK TEST#0.8635;CANCER RELATED FATIGUE#0.8633;EXCESS WEIGHT LOSS#0.8632;CHOLESTEROL METABOLISM#0.8632;RESISTANCE EXERCISE TRAINING#0.8632;LEUKEMIA INHIBITORY FACTOR#0.8628;ALLERGIC ASTHMA#0.8627;LYMPHOID CELL#0.8617;RIO DE JANEIRO#0.8617;TIGHT JUNCTION#0.8614;TRANSMISSION ELECTRON MICROSCOPY#0.8611;SIZE EXCLUSION CHROMATOGRAPHY#0.8607;MEDIASTINAL LYMPH NODE#0.8601;IMPAIRED GLUCOSE REGULATION#0.8599;MOUTH DISEASE#0.8595;CEREBRAL ARTERY OCCLUSION#0.8592;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8590;INULIN#0.8589;PERTUSSIS#0.8587;SALICYLATE#0.8586;PALPITATION#0.8586;PRIMARY HUMAN HEPATOCYTES#0.8586;INSULIN RECEPTOR SUBSTRATE#0.8582;DIPYRIDAMOLE#0.8580;PNEUMOTHORAX#0.8580;MICROVASCULAR ENDOTHELIAL CELL#0.8580;SUCCINATE#0.8578;SCROTUM#0.8574;OPEN ANGLE GLAUCOMA#0.8570;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8570;QUALITY OF CARE#0.8568;LIPODYSTROPHY#0.8566;ENDOSCOPIC SUBMUCOSAL DISSECTION#0.8565;SILICOSIS#0.8564;DIAMINE OXIDASE#0.8563;ABACAVIR#0.8563;D-LACTIC ACID#0.8562;RESTLESS#0.8562;MYOCARDIAL INFARCT SIZE#0.8562;COLLAGEN TYPE II#0.8560;DELAYED-TYPE HYPERSENSITIVITY#0.8559;REACTIVE OXYGEN SPECIES GENERATION#0.8556;PEPTIDE HORMONE#0.8555;BLOOD STASIS SYNDROME#0.8555;UNCONDITIONAL LOGISTIC REGRESSION#0.8554;STANDARD UPTAKE VALUE#0.8554;VASCULAR ADHESION PROTEIN#0.8552;MUMPS#0.8551;DIPLOPIA#0.8549;CALCINEURIN#0.8547;ADVENTITIA#0.8547;OMENTUM#0.8544;PHLEBOTOMY#0.8544;ANGINAL#0.8543;NEUTROPHIL MIGRATION#0.8541;ENTHESOPATHY#0.8541;INDUCTIVELY COUPLED PLASMA#0.8539;INFERTILE#0.8539;THROMBOPHLEBITIS#0.8538;RED YEAST RICE#0.8538;MACROPHAGE POLARIZATION#0.8535;MENSTRUATION#0.8531;METOPROLOL#0.8529;MILIARY TUBERCULOSIS#0.8525;PANCREATIC ISLET#0.8522;OPTIC DISC#0.8520;LACTOSE#0.8520;LIPASE ACTIVITY#0.8519;PULMONARY SARCOIDOSIS#0.8515;BUDESONIDE#0.8509;GEOMETRIC MEAN RATIO#0.8508;ALEXITHYMIA#0.8506;THYROID CANCER#0.8505;AMINOSALICYLIC ACID#0.8503;EXCESS BODY WEIGHT#0.8500;RESPONSE TO LPS#0.8500;LACTATE DEHYDROGENASE ACTIVITY#0.8500;ASCENDING COLON#0.8498;MENTAL COMPONENT SUMMARY#0.8497;EPIDIDYMITIS#0.8496;MEDIAN BODY#0.8496;INTESTINAL DAMAGE#0.8493;LUNG DAMAGE#0.8492;DICLOFENAC SODIUM#0.8484;COGNITIVE DISORDER#0.8483;MAPK SIGNALING#0.8482;PRETERM PREMATURE RUPTURE OF THE MEMBRANES#0.8482;NOXIOUS#0.8481;LEAVE ONE OUT#0.8473;PRIMARY SCLEROSING CHOLANGITIS#0.8471;ENTEROCYTE#0.8471;LARGE INTESTINE#0.8467;CEFTAZIDIME#0.8466;NEGATIVE CONTROL GROUP#0.8454;RUXOLITINIB#0.8453;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8450;STEARIC ACID#0.8448;PARACETAMOL#0.8446;MULTI ORGAN FAILURE#0.8444;CORONAL#0.8442;HEMATOPOIESIS#0.8442;TENOFOVIR#0.8440;REDUCED HEART RATE#0.8439;DOWN SYNDROME#0.8436;GI TRACT#0.8435;COMPUTED TOMOGRAPHIC ANGIOGRAPHY#0.8428;NATURAL KILLER T#0.8426;ANDROGEN DEPRIVATION THERAPY#0.8424;SCHIZOAFFECTIVE DISORDER#0.8422;REVERSE TRANSCRIPTASE INHIBITOR#0.8422;MUSCLE FIBER#0.8421;PRESSURE PAIN THRESHOLD#0.8419;TEMPORAL LOBE#0.8418;CHEWING#0.8416;PROTEIN CARBONYL CONTENT#0.8414;DYSPEPSIA#0.8407;MYELOFIBROSIS#0.8407;CELLULAR COMPONENT#0.8401;NEPHROPATHIA EPIDEMICA#0.8400;CLAVULANATE#0.8392;MESENTERIC LYMPH NODE#0.8389;MEDICAL DISORDER#0.8385;DIASTOLIC HEART FAILURE#0.8381;RUBELLA#0.8379;CHONDROCYTE#0.8377;ATP BINDING CASSETTE#0.8377;GLYCOCALYX#0.8376;TUMOR NECROTIC FACTOR#0.8376;PHOSPHOLIPASE D#0.8374;KERATINOCYTE#0.8373;FATTY ACID SYNTHASE#0.8370;AMNIOTIC MEMBRANE#0.8368;CEFAZOLIN#0.8367;EARLY GASTRIC CANCER#0.8367;ITCHING#0.8366;IGA ANTIBODY#0.8365;GLYBURIDE#0.8363;GRADIENT GEL ELECTROPHORESIS#0.8363;CONFUSION ASSESSMENT METHOD#0.8358;TRANSACTIVATION#0.8357;LUNG ADENOCARCINOMA#0.8346;PYODERMA GANGRENOSUM#0.8345;OMALIZUMAB#0.8343;MESOTHELIAL CELL#0.8339;INTRAHEPATIC CHOLANGIOCARCINOMA#0.8338;NARCOTIC#0.8335;PROPRANOLOL#0.8334;GLUCOSE-6-PHOSPHATE#0.8334;MIXED CONNECTIVE TISSUE DISEASE#0.8332;ERYSIPELAS#0.8332;VULNERABLE ATHEROSCLEROTIC PLAQUE#0.8331;TESTOSTERONE REPLACEMENT THERAPY#0.8323;DISEASE MODIFYING DRUGS#0.8323;TISSUE DOPPLER ECHOCARDIOGRAPHY#0.8321;FORMALIN#0.8321;SUBCLAVIAN ARTERY#0.8318;PROTEINA#0.8317;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8315;BONE MARROW ASPIRATE#0.8311;AUTISM SPECTRUM DISORDER#0.8310;FIXED EFFECT MODEL#0.8306;HEMORRHAGIC FEVER WITH RENAL SYNDROME#0.8305;OPTIC NERVE#0.8305;ANURIA#0.8304;PORTAL VEIN THROMBOSIS#0.8302;BREATHLESSNESS#0.8300;AXIAL SKELETON#0.8299;VERTIGO#0.8298;BRAIN DEVELOPMENT#0.8298;NAPROXEN#0.8298;MAJOR DEPRESSIVE EPISODE#0.8296;ADRENAL GLAND#0.8292;PROTEIN COMPLEX#0.8292;RENAL FIBROSIS#0.8291;LARGE ARTERIES#0.8288;DEXMEDETOMIDINE#0.8288;CHILDHOOD TRAUMA QUESTIONNAIRE#0.8284;TOTAL ATHEROMA VOLUME#0.8283;MITRAL ANNULAR CALCIFICATION#0.8283;LUCIFERASE ACTIVITY#0.8283;CAUSE SPECIFIC SURVIVAL#0.8281;ENDOTOXIN ACTIVITY#0.8275;5-AMINOSALICYLIC ACID#0.8274;BONE MARROW CELLS#0.8274;NEUROPROTECTION#0.8272;MAXIMUM TOLERATED DOSE#0.8272;RELAPSING POLYCHONDRITIS#0.8266;CYTOTOXIC T CELL#0.8265;BLURRED VISION#0.8265;CIRCULATING PROGENITOR CELL#0.8264;ADVANCED HEART FAILURE#0.8263;CORONARY FLOW VELOCITY#0.8263;REFUSAL#0.8260;NORMOCYTIC ANEMIA#0.8257;UBIQUITIN#0.8253;MINIMUM INHIBITORY CONCENTRATION#0.8250;REGION OF INTEREST#0.8248;TH2 CELL#0.8244;CELLULAR IMMUNE RESPONSE#0.8243;FIXED DOSE COMBINATION#0.8239;TENDINITIS#0.8236;VALINE#0.8228;RESPONSE TO ENDOTOXIN#0.8225;NATALIZUMAB#0.8222;PENICILLIN G#0.8222;MYELOID-DERIVED SUPPRESSOR CELL#0.8222;GLUTAMIC ACID#0.8222;NITRIC-OXIDE SYNTHASE INHIBITOR#0.8222;GLIBENCLAMIDE#0.8217;OVARIAN HYPERSTIMULATION SYNDROME#0.8214;LOW DETECTION LIMIT#0.8209;ANGIOTENSIN TYPE 1#0.8209;LUNG EPITHELIAL CELL#0.8206;UPPER GASTROINTESTINAL BLEEDING#0.8203;ELASTASE ACTIVITY#0.8202;PHOSPHATE METABOLISM#0.8201;POLYCYTHEMIA VERA#0.8200;SEVOFLURANE#0.8197;ORLISTAT#0.8194;ASTROCYTE#0.8190;PLEURA#0.8185;SPOTTED FEVER#0.8181;RESPONSE TO LIPOPOLYSACCHARIDE#0.8179;VILDAGLIPTIN#0.8179;ANTIGEN BINDING#0.8173;HEPATIC LIPASE#0.8167;EOSINOPHILIC PNEUMONIA#0.8159;STREPTOMYCIN#0.8155;ATOMIC ABSORPTION SPECTROMETRY#0.8155;ACE ACTIVITY#0.8155;NEPHROLITHIASIS#0.8154;CARDIAC ABNORMALITIES#0.8154;ATP BINDING CASSETTE TRANSPORTER#0.8154;SYNCOPE#0.8146;PEAK SYSTOLIC VELOCITY#0.8145;PHOSPHATIDYLETHANOLAMINE#0.8144;PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME#0.8141;6-MERCAPTOPURINE#0.8140;COLLAGEN BINDING#0.8139;METAPLASIA#0.8139;REMICADE#0.8138;EFFECTOR T CELL#0.8134;ACUTE LIVER FAILURE#0.8134;DNASE#0.8133;SEVERE SYSTEMIC INFLAMMATION#0.8132;LEPROMATOUS LEPROSY#0.8129;PYODERMA#0.8129;STERNUM#0.8125;STEM CELL FACTOR#0.8124;SERPIN#0.8123;ADVANCED COLORECTAL CANCER#0.8123;EARLY TO LATE#0.8119;NATIONAL HEALTH SERVICE#0.8119;CHOLELITHIASIS#0.8114;CEFUROXIME#0.8110;MINOR ALLELE FREQUENCY#0.8109;MAJOR CORONARY EVENTS#0.8108;FACTOR XA#0.8099;EYELID#0.8098;TRIAMCINOLONE#0.8096;MEGAKARYOCYTE#0.8096;IL-8 SECRETION#0.8095;GASTRIC DILATATION#0.8084;ESCITALOPRAM#0.8080;INDOLE#0.8079;TREATMENT RESISTANT DEPRESSION#0.8072;BAYER#0.8072;GASTRIC ADENOCARCINOMA#0.8069;ENDOTHELIAL CELL APOPTOSIS#0.8068;EFAVIRENZ#0.8062;VASOMOTION#0.8061;VINCRISTINE#0.8059;TIME TO RECURRENCE#0.8057;ACUTE LIVER INJURY#0.8050;CC CHEMOKINE RECEPTOR#0.8049;GERMINAL CENTER#0.8045;THYMIDINE KINASE 1#0.8034;LYMPH NODE RATIO#0.8027;LUNG CARCINOMA#0.8027;NO BINDING#0.8027;REGIONS OF INTEREST#0.8025;CALCIUM CARBONATE#0.8024;RENAL CELL CANCER#0.8024;PROCTITIS#0.8023;SEVERE PRE-ECLAMPSIA#0.8023;AGRANULOCYTOSIS#0.8022;REGIONAL LYMPH NODE#0.8018;DNA COPY NUMBER#0.8017;CONSTRICTION#0.8017;MERCAPTOPURINE#0.8013;RIFAMPIN#0.8013;MIGRAINE WITH AURA#0.8011;SIGNALING CASCADE#0.8011;PYROGENIC#0.8010;GLYCERYL TRINITRATE#0.8010;GASTRIC EMPTYING#0.8008;CONJUGATION#0.8007;EVEROLIMUS#0.8005;BETAMETHASONE#0.8005;LIPID HOMEOSTASIS#0.8003;RETINOIC ACID#0.7999;VLDL PARTICLE#0.7999;OVARIAN CYST#0.7992;MUSCLE PROTEIN SYNTHESIS#0.7989;MICRO-K#0.7986;FERMENTATION#0.7986;ACTIVATED B CELL#0.7986;COLON CARCINOMA#0.7983;ACTIVE VITAMIN D#0.7983;1α,25-DIHYDROXYVITAMIN D3#0.7978;GOITER#0.7978;TRANSVERSE COLON#0.7976;GLYCOGEN SYNTHASE KINASE#0.7975;PRADER WILLI SYNDROME#0.7972;AUTONOMIC NEUROPATHY#0.7971;PHOSPHATASE ACTIVITY#0.7967;FATTY ACID OXIDATION#0.7966;HYDROXYUREA#0.7966;PERIPARTUM CARDIOMYOPATHY#0.7963;PIROXICAM#0.7961;PLATELET FUNCTION ANALYZER#0.7961;TUMOR TISSUES#0.7959;SCOLIOSIS#0.7959;VENTRICULAR REPOLARIZATION#0.7957;TIME TO RELAPSE#0.7956;HYPOKALEMIA#0.7956;MITOCHONDRIAL MEMBRANE#0.7947;ATPASE ACTIVITY#0.7944;TOXIC SHOCK SYNDROME#0.7937;BODY WEIGHT RATIO#0.7935;TICAGRELOR#0.7934;BERBERINE#0.7928;TROGLITAZONE#0.7927;PAROTID GLAND#0.7924;CRYSTALLOID#0.7923;AMBIENT PARTICULATE MATTER#0.7921;BRONCHIOLITIS OBLITERANS#0.7919;ACUTE MYOCARDITIS#0.7919;TRYPTOPHAN METABOLISM#0.7917;OSTEOCLAST DIFFERENTIATION#0.7915;B CELL ACTIVATION#0.7915;17β-ESTRADIOL#0.7911;LCAT ACTIVITY#0.7910;DRUG METABOLISM#0.7904;ASTHENIA#0.7895;PERIPROCEDURAL MYOCARDIAL INFARCTION#0.7895;DOBUTAMINE#0.7894;SHARED DECISION MAKING#0.7892;THYMOCYTE#0.7891;ADENOSINE TRIPHOSPHATE#0.7889;GENETIC DISORDER#0.7888;OXALIPLATIN#0.7886;TYPHOID FEVER#0.7883;SEXUAL DYSFUNCTION#0.7883;ENDOPLASMIC RETICULUM STRESS#0.7882;PROSTATE DISEASE#0.7880;PANCREATIC DAMAGE#0.7878;PLACENTAL ABRUPTION#0.7876;ACETYLCHOLINE RECEPTOR#0.7874;AMIODARONE#0.7874;BRAIN EDEMA#0.7873;TICK-BORNE ENCEPHALITIS#0.7872;TISSUE TRANSGLUTAMINASE#0.7870;URINARY SYSTEM#0.7868;GASTRIC MUCOSA#0.7867;GASTROSCHISIS#0.7860;TOBRAMYCIN#0.7859;VERTEBRAL ARTERY#0.7858;OMEPRAZOLE#0.7858;TIME TO DEATH#0.7858;BEST SUPPORTIVE CARE#0.7854;LUNG METASTASIS#0.7852;PYRUVATE KINASE#0.7848;GROWTH PATTERN#0.7848;SMOOTH MUSCLE ACTIN#0.7841;LIPID RAFT#0.7841;AMINOTRANSFERASE ACTIVITY#0.7839;NEUROTOXICITY#0.7832;GINGIVA#0.7830;NEGATIVE ENERGY BALANCE#0.7827;ACANTHOSIS NIGRICANS#0.7824;TETRAHYDROBIOPTERIN#0.7823;MINISTRY OF HEALTH#0.7817;HUMAN HERPES VIRUS#0.7816;PYROGEN#0.7816;NEPHROTOXIC#0.7815;METOPROLOL SUCCINATE#0.7813;LIPID METABOLIC#0.7812;ICODEXTRIN#0.7808;SOLID ORGAN TRANSPLANTATION#0.7806;LUNG INJURY SCORE#0.7805;NIPPLE ASPIRATE FLUID#0.7804;BRONCHOPNEUMONIA#0.7803;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7800;BABESIOSIS#0.7797;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7793;AUTOIMMUNE THYROIDITIS#0.7792;COGNITIVE BEHAVIORAL THERAPY#0.7791;LYMPHOID TISSUE#0.7790;PRE-OP#0.7787;PERICARDIUM#0.7784;CHRONIC RESPIRATORY DISEASE#0.7781;CALCIUM CHLORIDE#0.7781;THROMBIN RECEPTOR#0.7780;CHRONIC ALLOGRAFT NEPHROPATHY#0.7776;ORTHOTOPIC LIVER TRANSPLANTATION#0.7776;LIMITS OF AGREEMENT#0.7774;NORETHISTERONE#0.7768;PRIMARY BILIARY CIRRHOSIS#0.7767;PRIMARY TUBERCULOSIS#0.7765;ARTERIOSCLEROSIS OBLITERANS#0.7765;GINSENG#0.7760;HYPERTROPHIC CARDIOMYOPATHY#0.7758;EVIDENCE BASED MEDICINE#0.7757;ACUTE DIARRHEA#0.7754;TIME TO PROGRESSION#0.7754;HAMSTRING#0.7752;GLUCOSE DEGRADATION#0.7751;ETHYLENEDIAMINETETRAACETIC ACID#0.7751;FATTY ACID METABOLISM#0.7747;DIFFERENTIATED THYROID CARCINOMA#0.7746;INVASIVE ASPERGILLOSIS#0.7743;NATIONAL DEATH INDEX#0.7735;EMTRICITABINE#0.7733;RENAL ISCHEMIA REPERFUSION#0.7731;VENTRICULAR SEPTAL DEFECT#0.7723;LIVER X RECEPTOR#0.7719;SPINAL STENOSIS#0.7719;TRASTUZUMAB#0.7715;MANIA RATING SCALE#0.7714;TOTAL NUCLEATED CELL#0.7709;PRIMARY CARE SETTINGS#0.7707;TRICUSPID VALVE#0.7707;ACUTE PULMONARY EMBOLISM#0.7705;TOXOPLASMOSIS#0.7704;RENAL VEIN#0.7698;ADIPOGENESIS#0.7697;BRAIN LESIONS#0.7693;INTESTINAL ABSORPTION#0.7692;OXYGEN METABOLISM#0.7692;ITRACONAZOLE#0.7691;TYROSINE KINASE RECEPTOR#0.7689;LOCALIZED SURFACE PLASMON#0.7687;OF DIABETIC RATS#0.7686;HIGH-DENSITY LIPOPROTEIN PARTICLE#0.7684;ACTIVATED T LYMPHOCYTES#0.7679;SULCUS#0.7675;TRANSFERASE ACTIVITY#0.7671;CARPAL TUNNEL SYNDROME#0.7670;SIALIC ACID BINDING#0.7666;MELIOIDOSIS#0.7665;P-CRESOL#0.7665;SUBSTANCE USE DISORDER#0.7662;URINARY BLADDER#0.7660;GREEN TEA EXTRACT#0.7657;MESALAMINE#0.7655;AUTOIMMUNE RHEUMATIC DISEASES#0.7655;LIGHT TRANSMISSION AGGREGOMETRY#0.7653;LEVOSIMENDAN#0.7652;PHEOCHROMOCYTOMA#0.7651;AMENORRHEA#0.7647;HYPERTENSIVE HEART DISEASE#0.7646;ADENINE DINUCLEOTIDE PHOSPHATE#0.7646;IL-10 PRODUCTION#0.7639;FLUSHING#0.7634;BONE REMODELLING#0.7631;M PHASE#0.7628;CONGENITAL HEART DEFECTS#0.7620;LIPOGENESIS#0.7617;MULTIPLE REACTION MONITORING#0.7615;DIFFUSION TENSOR IMAGING#0.7614;AGITATION#0.7612;REACTIVE NITROGEN SPECIES#0.7612;GLUCONEOGENESIS#0.7611;CEREBRAL ATHEROSCLEROSIS#0.7609;EPIDIDYMAL ADIPOSE TISSUE#0.7604;C TERMINAL DOMAIN#0.7603;HAEMATOPOIETIC STEM CELL#0.7602;GEMFIBROZIL#0.7599;NIFEDIPINE#0.7596;CLASSICAL MONOCYTE#0.7595;BACTERIAL ENDOCARDITIS#0.7594;MEAL TOLERANCE TEST#0.7593;NITRIC OXIDE SYNTHESIS#0.7591;PANIC DISORDER#0.7583;POSITIVE SURGICAL MARGIN#0.7579;CONTINUOUS GLUCOSE MONITORING#0.7579;DISEASE MODIFYING THERAPY#0.7577;ANABO
140258	GLYCINE#0.8520
140290	CELL CYCLE#0.8966;LEUCINE#0.7246;HEPATOCELLULAR CARCINOMA#0.7116;CELL GROWTH#0.7095;SPERMATOGENIC CELLS#0.6864;PROTEIN KINASE#0.6543;TUMOR SUPPRESSOR#0.6112
140451	SUBMANDIBULAR GLAND#0.6981;GROWTH FACTOR#0.6944;SIGNALING PATHWAY#0.6262
140453	GENE EXPRESSION#0.9939;EPITHELIAL CELL#0.9887;ADENOCARCINOMA#0.9766;GOBLET CELL#0.9727;CANCER CELL#0.9620;SMALL INTESTINE#0.9567;GALLBLADDER#0.9095;COLON CANCER#0.9064;POLYMERASE CHAIN REACTION#0.9063;ENTEROCYTE#0.8846;INTESTINAL EPITHELIAL CELL#0.8606;BREAST CANCER#0.8600;CELL MIGRATION#0.8045;HISTONE H3-K9 MODIFICATION#0.7985;GROWTH FACTOR#0.7896;GASTROINTESTINAL TRACT#0.7797;EPIDERMAL GROWTH FACTOR#0.7643;COLITIS#0.7597;DNA METHYLATION#0.7594;GLYCOCALYX#0.7522;MUCUS LAYER#0.7510;BILE DUCT#0.7423;GLYCOSYLATION#0.7364;CELL PROLIFERATION#0.7319;REVERSE TRANSCRIPTION#0.7274;COLORECTAL#0.6966;LUNG CANCER#0.6956;CELL SURFACE#0.6940;TRANSCRIPTION FACTOR#0.6845;MIDDLE EAR#0.6758;METAPLASIA#0.6681;LUMINAL#0.6436;MUCOUS#0.6410;PANCREATIC CANCER#0.6392;APOPTOSIS#0.6365;LYMPH NODE#0.6348;OVARIAN#0.6184;SURFACE EPITHELIUM#0.6067;C TERMINAL DOMAIN#0.6028
140456	TERMINAL DIFFERENTIATION#0.6595;ENDOPLASMIC RETICULUM#0.6485
140459	ORAL SQUAMOUS CELL CARCINOMA#0.7644;SQUAMOUS CELL CARCINOMA#0.7557;INSULIN RECEPTOR#0.7193
140461	AND SOCS BOX#0.6844;LUNG CARCINOMA#0.6552;LUNG ADENOCARCINOMA#0.6548;LUNG CANCER#0.6483
140462	CREATINE KINASE#1.0251;AND SOCS BOX#0.9971;CREATINE#0.8969;UBIQUITIN#0.7998;ANKYRIN REPEAT DOMAIN#0.6980
140464	OVARIAN DEVELOPMENT#0.6552;GONAD#0.6462
140465	SKELETAL MUSCLE#0.7538
140467	ZINC FINGER PROTEIN#0.8146
140469	ACTIN BINDING#0.6771
1404	HYALURONAN#1.0496;PROTEOGLYCAN#1.0275;PERINEURONAL NET#0.9964;EXTRACELLULAR MATRIX#0.9849;CHONDROCYTE#0.9792;GENE EXPRESSION#0.9786;COLLAGEN TYPE II#0.9697;GROWTH FACTOR#0.9633;HYALURONIC ACID#0.9237;CHONDROGENESIS#0.8970;CHONDROITIN SULFATE PROTEOGLYCAN#0.8904;TRANSFORMING GROWTH FACTOR#0.8873;CREATINE#0.8820;RHEUMATOID ARTHRITIS#0.8675;POLYMERASE CHAIN REACTION#0.8537;HYALURONAN BINDING#0.8414;OSTEOARTHRITIS#0.8405;TRANSCRIPTION FACTOR#0.8346;STEM CELL#0.8338;CREATINE TRANSPORTER#0.8152;CHLOROPHYLL SYNTHESIS#0.8135;PROTEIN KINASE#0.7967;APOPTOSIS#0.7947;EXTRACELLULAR MATRIX COMPONENT#0.7712;HYALURONATE#0.7543;ENDOPLASMIC RETICULUM#0.7406;GRANULOSA CELL#0.7336;NERVOUS SYSTEM#0.7200;TRANSFORMING GROWTH FACTOR BETA#0.7076;CENTRAL NERVOUS SYSTEM#0.6960;BONE FORMATION#0.6941;CELL ADHESION#0.6916;AGAT DEFICIENCY#0.6843;CELL DEATH#0.6740;DNA BINDING#0.6514;BONE MARROW#0.6488;GLYCINE AMIDINOTRANSFERASE#0.6397;REVERSE TRANSCRIPTION#0.6331;CELL SURFACE#0.6321;MESENCHYMAL CELL#0.6231;DNA DAMAGE CHECKPOINT#0.6210;IMMUNE RESPONSE#0.6200;JUVENILE RHEUMATOID ARTHRITIS#0.6139;HEART DEVELOPMENT#0.6084
140564	T CELL#0.8746;CYTIDINE DEAMINASE#0.8686;CYTIDINE#0.7821;HUMAN IMMUNODEFICIENCY VIRUS#0.7530;CYTOSINE DEAMINASE#0.6881;VIRAL REPLICATION#0.6775;APOBEC#0.6582;GENE EXPRESSION#0.6514;MRNA EDITING#0.6366;SIMIAN IMMUNODEFICIENCY VIRUS#0.6222;VIRAL GENOME#0.6207;VIRION#0.6098
140576	CANCER CELL#0.8586;BREAST CANCER#0.8408;TRANSCRIPTION FACTOR#0.7196;ADIPOGENESIS#0.6825;HUMAN BREAST CANCER#0.6497;BREAST CANCER PATIENTS#0.6493;LIPID METABOLISM#0.6482;PROTEIN KINASE#0.6415;BREAST CANCER CELL#0.6370;ADIPOCYTE#0.6254;HUMAN CERVICAL CARCINOMA#0.6097;ALIZARIN RED S#0.6090
140578	LECTIN#0.8672;CANCER CELL#0.8255;DELTA E#0.7079;LUNG CANCER#0.6553;SPINAL MUSCULAR ATROPHY#0.6457;MUSCULAR ATROPHY#0.6440;CELL MATURATION#0.6057
140596	HUMAN BETA DEFENSIN#0.8923;COPY NUMBER VARIATION#0.7831;POLYMERASE CHAIN REACTION#0.7048;EPITHELIAL CELL#0.6605
140606	SELENOCYSTEINE#0.9487;GENE EXPRESSION#0.9183;GLUTATHIONE PEROXIDASE#0.8518;GLUTATHIONE#0.7849;ENDOPLASMIC RETICULUM#0.7833;ANTIOXIDANT ACTIVITY#0.7564;REDOX ACTIVITY#0.6499;ALZHEIMER'S DISEASE#0.6458;HEPATOCELLULAR CARCINOMA#0.6281;PEROXIDASE ACTIVITY#0.6277
140609	PROTEIN KINASE#1.0484;CELL CYCLE#1.0415;NLRP3 INFLAMMASOME ACTIVATION#1.0308;MITOSIS#1.0177;MITOTIC SPINDLE#0.9482;MICROTUBULE#0.9275;CYTOKINESIS#0.8462;MACROPHAGE#0.8245;CENTROSOME#0.8007;CELL DIVISION#0.7949;SPINDLE FORMATION#0.7812;SPINDLE ASSEMBLY#0.7583;TARGET OF RAPAMYCIN#0.7520;CELL PROLIFERATION#0.7435;SPINDLE ORGANIZATION#0.7388;CELL CYCLE ARREST#0.6964;SPINDLE POLE#0.6615;PYROPTOSIS#0.6581;CENTRIOLE DUPLICATION#0.6488;MITOTIC SPINDLE ORGANIZATION#0.6125;HEPATOCELLULAR CARCINOMA#0.6115;KINASE ACTIVITY#0.6060;DENDRITE MORPHOGENESIS#0.6011
140625	ACTIN RELATED PROTEIN#0.6427
140628	AORTIC VALVE#1.0222;TRANSCRIPTION FACTOR#1.0036;GENE EXPRESSION#0.9968;BICUSPID AORTIC VALVE#0.9857;COLORECTAL#0.9495;COLORECTAL CANCER#0.9474;CARDIAC DEVELOPMENT#0.9299;DNA METHYLATION#0.9234;CARDIOMYOCYTE#0.9195;METHYLATION SPECIFIC PCR#0.9094;POLYMERASE CHAIN REACTION#0.8890;CARDIOGENESIS#0.8772;ENDODERM FORMATION#0.8735;CONGENITAL HEART DISEASE#0.8681;HEART DEVELOPMENT#0.8608;TUMOR SUPPRESSOR#0.8596;HEART DISEASE#0.8589;CELL DIFFERENTIATION#0.8255;RENAL CELL CARCINOMA#0.8221;MORPHOGENESIS#0.7736;EPITHELIAL CELL#0.7516;CANCER CELL#0.7484;CELL GROWTH#0.7430;DNA BINDING#0.7419;LUNG CANCER#0.7313;STEM CELL#0.7295;ENDODERM DEVELOPMENT#0.7236;CELL PROLIFERATION#0.7224;APOPTOSIS#0.7175;METHYLATION SPECIFIC POLYMERASE#0.7150;BREAST CANCER#0.7097;EMBRYONIC HEART#0.6993;GASTRULATION#0.6836;ATRIAL FIBRILLATION#0.6816;NITRIC OXIDE#0.6763;HEPATOCELLULAR CARCINOMA#0.6743;ELECTROPHORETIC MOBILITY SHIFT#0.6692;TERMINAL DIFFERENTIATION#0.6594;ENDOTHELIAL CELL#0.6569;FAMILIAL ATRIAL FIBRILLATION#0.6533;CPG ISLAND METHYLATION#0.6469;HEPATOCYTE NUCLEAR FACTOR#0.6396;ENDOCARDIAL CELL#0.6313;VENTRICULAR SEPTAL DEFECT#0.6278;EMBRYONIC STEM CELL#0.6226;SMOOTH MUSCLE#0.6070;TRICUSPID AORTIC VALVES#0.6054
140679	BOUTON#1.0510;AXON TERMINAL#1.0387;GLUTAMATE DECARBOXYLASE#1.0270;GLYCINE#1.0252;GLUTAMIC ACID#1.0232;SYNAPTIC VESICLE#1.0129;GABA A RECEPTOR#1.0095;INHIBITORY SYNAPSE#1.0088;GABAERGIC NEURON#1.0085;NERVE TERMINAL#1.0075;DENTATE GYRUS#0.9959;NEUROTRANSMISSION#0.9931;INTERNEURON#0.9926;SPINAL CORD#0.9905;CEREBRAL CORTEX#0.9886;SYNAPTIC TRANSMISSION#0.9770;PRESYNAPTIC TERMINAL#0.9768;ACETYLCHOLINE#0.9762;DOPAMINE#0.9726;NERVOUS SYSTEM#0.9629;PYRAMIDAL CELL#0.9523;NEUROTRANSMITTER TRANSPORTER#0.9481;CENTRAL NERVOUS SYSTEM#0.9272;GENE EXPRESSION#0.9255;GLUTAMATE RECEPTOR#0.9224;TRANSCRIPTION FACTOR#0.9168;FOREBRAIN#0.9073;ERGIC#0.9038;SYNAPTIC VESICLE PROTEIN#0.9019;INNERVATION#0.8919;PLASMA MEMBRANE#0.8908;EXCITATORY SYNAPSE#0.8864;GLUTAMATERGIC NEURON#0.8782;STRIATUM#0.8705;CLEFT PALATE#0.8539;GLYCINE RECEPTOR#0.8439;RECEPTOR AGONIST#0.8423;SYNAPTOSOME#0.8417;BETA CELL#0.8408;NMDA RECEPTOR#0.8285;GLUTAMATERGIC SYNAPSE#0.8274;NEUROTRANSMITTER RELEASE#0.8181;EPILEPSY#0.8169;AMYGDALA#0.8143;ASTROCYTE#0.8125;POTASSIUM CHLORIDE#0.8103;CHOLINERGIC NEURON#0.8081;SECRETORY GRANULE#0.8010;SUBSTANTIA NIGRA#0.8000;EXOCYTOSIS#0.7985;ISCHEMIA#0.7936;GABA B RECEPTOR#0.7932;CHOLINE#0.7866;THALAMUS#0.7838;ASYMMETRIC SYNAPSE#0.7825;ASPARTATE#0.7720;ALPHA CELL#0.7603;CALCIUM CHANNEL#0.7484;PURKINJE CELL#0.7473;OLFACTORY BULB#0.7316;GROWTH FACTOR#0.7314;ACTION POTENTIAL#0.7050;ALZHEIMER'S DISEASE#0.6915;SPINAL DORSAL HORN#0.6910;FRONTAL#0.6900;ESTROGEN RECEPTOR#0.6756;MIDBRAIN#0.6693;MEDIAL PREFRONTAL CORTEX#0.6687;AMPA RECEPTOR#0.6657;BIPOLAR CELL#0.6584;STEM CELL#0.6549;DENDRITIC SPINE#0.6530;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6503;COCHLEAR NUCLEUS#0.6344;TRANSMEMBRANE TRANSPORTER#0.6301;ORGANELLE#0.6227;YELLOW FLUORESCENT PROTEIN#0.6174;PERINEURONAL NET#0.6151;BASKET CELL#0.6130;SYMMETRIC SYNAPSE#0.6117;ESTRADIOL#0.6109;POSTSYNAPTIC DENSITY#0.6054;NEURAL CELL#0.6008
140683	PAROTID GLAND#1.0580;SALIVARY GLAND#1.0407;SUBMANDIBULAR GLAND#0.9424;ACINAR CELL#0.9340;SUBLINGUAL GLAND#0.9212;NASAL EPITHELIUM#0.8983;SECRETORY GRANULE#0.8664;GENE EXPRESSION#0.7342;LUNG CANCER#0.7180;LIPOPOLYSACCHARIDE BINDING#0.7071;LPS BINDING#0.7004;PROTEASE ACTIVITY#0.6916;LYMPH NODE#0.6842;LACRIMAL GLAND#0.6546;ORAL CAVITY#0.6469;AUTOIMMUNE DISEASE#0.6412
140685	TRANSCRIPTION FACTOR#1.1090;DENDRITIC CELL#1.0270;PROSTATE CANCER#0.9489;MONOCYTE#0.8228;BONE MARROW#0.8086;MACROPHAGE#0.7357;GM-CSF#0.7182;PROGENITOR CELL#0.7141;IMMUNE CELL#0.7086;T CELL#0.6891;LEUKEMIA INHIBITORY FACTOR#0.6477;ENDOTHELIAL CELL#0.6319;LAMINAR SHEAR STRESS#0.6071;CROSS PRIMING#0.6061
140687	O GLYCAN#1.0453;GLCNAC#1.0346;T CELL#0.8844;SELECTIN#0.7993;CELL SURFACE#0.7667;N-ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY#0.7155;ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY#0.7142;GLYCOSYLATION#0.7064;ENZYME ACTIVITY#0.6490;N GLYCAN#0.6238
140690	CANCER TESTIS ANTIGEN#1.0751;OVARIAN CANCER#1.0702;BREAST CANCER#1.0690;LUNG CANCER#1.0657;TRANSCRIPTION FACTOR#1.0520;GERM CELL#1.0514;CANCER CELL#1.0504;DNA METHYLATION#1.0494;DNA BINDING#1.0453;GENE EXPRESSION#1.0359;OVARIAN#1.0304;DNA HYPOMETHYLATION#0.9966;STEM CELL#0.9851;BREAST CANCER CELL#0.9315;EPITHELIAL OVARIAN CANCER#0.9110;TUMOR CELLS#0.8988;CANCER STEM CELL#0.8859;BREAST CANCER PATIENTS#0.8421;SPERMATOGENESIS#0.8304;CELL PROLIFERATION#0.8235;DEMETHYLATION#0.7960;REVERSE TRANSCRIPTION#0.7827;5-AZA-2'-DEOXYCYTIDINE#0.7792;2'-DEOXYCYTIDINE#0.7787;BREAST DISEASE#0.7678;TUMOR SUPPRESSOR#0.7548;CERVICAL CANCER#0.7478;IMPRINTING CONTROL REGION#0.7432;SIGNALING PATHWAY#0.7395;SQUAMOUS CELL CARCINOMA#0.7238;EPITHELIAL CELL#0.7195;POLYMERASE CHAIN REACTION#0.7189;CHROMATIN ORGANIZATION#0.6871;APOPTOSIS#0.6844;STEM CELL MARKER#0.6755;ENDOMETRIAL CANCER#0.6750;HEPATOCELLULAR CARCINOMA#0.6665;COLORECTAL#0.6314;CERVICAL#0.6224;UTERINE CANCER#0.6152;MEIOSIS#0.6002
140691	APOPTOSIS#0.9459;CELL DEATH#0.6471;STEM CELL MARKER#0.6105;MICROGLIAL CELL#0.6100;BRAIN DEVELOPMENT#0.6083;APOPTOTIC CELL DEATH#0.6044;GERM CELL#0.6038
1406	SPINAL CORD#1.0680;CONE ROD DYSTROPHY#1.0542;PHOTORECEPTOR DEVELOPMENT#1.0454;OPSIN#1.0314;PINEAL GLAND#1.0298;TRANSCRIPTION FACTOR#1.0233;LEBER CONGENITAL AMAUROSIS#1.0229;NEURAL RETINA#1.0194;AMAUROSIS#1.0161;BIPOLAR CELL#1.0146;DNA BINDING#1.0130;RETINITIS PIGMENTOSA#1.0072;TRANSACTIVATION#1.0044;RETINITIS#1.0011;PHOTORECEPTOR CELL#1.0009;NEURAL RETINA LEUCINE#0.9983;GENE EXPRESSION#0.9970;RETINAL DEVELOPMENT#0.9968;RETINOBLASTOMA#0.9963;PHOTOTRANSDUCTION#0.9938;STEM CELL#0.9919;RETINAL DEGENERATION#0.9919;RETINAL DISEASE#0.9858;LEUCINE#0.9757;NUCLEAR LAYER#0.9674;RETINOID BINDING#0.9639;BLINDNESS#0.9462;PROGENITOR CELL#0.9159;PLURIPOTENT STEM CELL#0.8708;TERMINAL DIFFERENTIATION#0.8665;EYE DEVELOPMENT#0.8579;OUTER NUCLEAR LAYER#0.8444;HUMAN EMBRYONIC STEM#0.8388;EMBRYONIC STEM CELL#0.8336;CELL DIFFERENTIATION#0.8308;INNER NUCLEAR LAYER#0.8259;RETINAL PIGMENT EPITHELIUM#0.8196;RETINAL PROGENITOR CELL#0.8071;POLYMERASE CHAIN REACTION#0.8025;ELECTROPHORETIC MOBILITY SHIFT#0.7894;RETINOIC ACID#0.7650;PHOSPHODIESTERASE#0.7549;RETINAL GANGLION CELL#0.7341;MELATONIN SYNTHESIS#0.7286;MELATONIN#0.7240;REGENERATION#0.7197;NERVOUS SYSTEM#0.7128;GANGLION CELLS#0.7087;OPTICAL COHERENCE TOMOGRAPHY#0.7026;DERMAL FIBROBLAST#0.6966;CELL DEVELOPMENT#0.6810;CELL CYCLE#0.6752;GROWTH FACTOR#0.6731;PRECURSOR CELL#0.6591;RETINAL STEM CELLS#0.6380;INDUCED PLURIPOTENT STEM CELL#0.6366;PHOTORECEPTOR OUTER SEGMENT#0.6356;CELL FATE DETERMINATION#0.6279;MUTAGENESIS#0.6137
140706	ENDOTHELIAL CELL#0.7796
140707	SIGNAL TRANSMISSION#0.6983;B CELL#0.6700
140710	AUTOPHAGY#0.8114;MICROTUBULE ASSOCIATED PROTEIN#0.6176
140730	RNA BINDING#0.9131;MEIOSIS#0.9096;RNA BINDING PROTEIN#0.8174;SPORULATION#0.6984;MEIOSIS II#0.6240
140732	SPERMATOZOA#1.0600;SPERMATOGENESIS#1.0139;NUCLEAR ENVELOPE#0.8779;SPERM HEAD#0.8216;ACROSOME#0.6938;GERM CELL#0.6461
140733	RIBOSE#0.7849;DNA REPAIR#0.7698;COLORECTAL CANCER#0.7493;COLORECTAL#0.6888;KABUKI SYNDROME#0.6589;THYROID ASSOCIATED ORBITOPATHY#0.6324
140735	DYNEIN LIGHT CHAIN#1.0875;DYNEIN#1.0790;NMDA RECEPTOR#0.6316
140739	NEDD8 ACTIVATING ENZYME#0.9774;PROTEIN NEDDYLATION#0.8867;UBIQUITIN#0.8671;CANCER CELL#0.7308;LUNG CANCER#0.7300
140766	EXTRACELLULAR MATRIX#0.8161;OSTEOARTHRITIS#0.8086;HEPATOCELLULAR CARCINOMA#0.8062;GENE EXPRESSION#0.6179
140767	SECRETORY PATHWAY#1.0306;ENDOPLASMIC RETICULUM#1.0109;VESICULAR STOMATITIS VIRUS#0.9852;STOMATITIS#0.9477;NEURITE#0.9279;HUMAN IMMUNODEFICIENCY VIRUS#0.9272;VESICULAR TRANSPORT#0.9254;TRANSPORT VESICLE#0.8943;NEURITE EXTENSION#0.8876;PROTEIN TRANSPORT#0.7931;COATOMER#0.7724;VIRION#0.7431;T CELL#0.7425;GOLGI APPARATUS#0.7174;NEURAL CELL#0.6986;MICROTUBULE#0.6661;MACROPHAGE#0.6454;SYNCYTIUM FORMATION#0.6366;CD4+ T CELL#0.6245;IFN-BETA#0.6229
140775	AUTOPHAGY#1.0097;AMYOTROPHIC LATERAL SCLEROSIS#0.8680;LATERAL SCLEROSIS#0.8679;LYSOSOME#0.8174;PROTEIN COMPLEX#0.7352;FRONTOTEMPORAL DEMENTIA#0.6968;CHROMOSOME REGION#0.6719;AUTOIMMUNITY#0.6343;DEMENTIA#0.6069;AXONAL TRANSPORT#0.6050;TISSUE HOMEOSTASIS#0.6021
1407	RIBOSOMAL PROTEIN#1.0283;PINEAL GLAND#1.0213;QUANTITATIVE REAL TIME#1.0190;FLOWERING#1.0076;POLYMERASE CHAIN REACTION#1.0073;MELATONIN#1.0016;FLAVIN#1.0009;PHOTOMORPHOGENESIS#0.9992;TOXICITY#0.9920;BRUSH BORDER MEMBRANE#0.9909;PERIPHERAL BLOOD#0.9896;BRUSH BORDER#0.9878;DIURNAL#0.9863;RESPONSE TO BLUE LIGHT#0.9803;ADIPOSE TISSUE#0.9799;TRANSCRIPTION FACTOR#0.9796;SIGNALING PATHWAY#0.9770;CIRCADIAN RHYTHM#0.9661;PROTEIN KINASE#0.9637;MIDGUT#0.9608;GENE EXPRESSION#0.9604;SIGNAL TRANSDUCTION#0.9459;DNA BINDING#0.9426;PARS TUBERALIS#0.9398;CELL CYCLE#0.9330;DNA REPAIR#0.9218;BREAST CANCER#0.9201;N ACETYLTRANSFERASE#0.9061;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8993;LYMPHOCYTIC LEUKEMIA#0.8983;REVERSE TRANSCRIPTION#0.8958;ELECTRON TRANSFER#0.8943;DNA METHYLATION#0.8938;MONONUCLEAR CELLS#0.8926;ETIOLATION#0.8907;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8859;ATP BINDING#0.8803;BIPOLAR DISORDER#0.8664;TRYPTOPHAN#0.8579;UBIQUITIN#0.8557;FLAVIN ADENINE DINUCLEOTIDE#0.8525;APOPTOSIS#0.8500;SKELETAL MUSCLE#0.8489;COLORECTAL CANCER#0.8350;DNA PHOTOLYASE#0.8335;TOXIN BINDING#0.8314;HIGH FAT DIET#0.8274;MELATONIN RECEPTOR#0.8233;COLORECTAL#0.8231;ARYL HYDROCARBON RECEPTOR#0.8117;DIABETES MELLITUS#0.8117;TRANSACTIVATION#0.8097;AUXIN TRANSPORT#0.8020;ADRENAL GLAND#0.7970;RELATED ORPHAN RECEPTOR#0.7932;STOMATAL OPENING#0.7913;MUTAGENESIS#0.7880;GLUCONEOGENESIS#0.7866;HYPOXIA#0.7833;PITUITARY GLAND#0.7816;CHLOROPLAST#0.7800;HYPERTENSION#0.7726;OBESE#0.7663;OOCYTE#0.7576;BIOLUMINESCENCE#0.7558;LITHIUM#0.7555;LIPID METABOLISM#0.7537;NERVOUS SYSTEM#0.7477;ADENINE#0.7468;LEUKOCYTE#0.7439;MODE OF ACTION#0.7399;RETINOIC ACID#0.7371;CELL DEATH#0.7331;DNA REPAIR ENZYME#0.7322;ALDOSTERONE#0.7312;RNA INTERFERENCE#0.7225;PHOTOTROPISM#0.7155;TRANSCRIPTASE#0.7153;MELATONIN SYNTHESIS#0.7138;TYPE 2 DIABETES#0.7071;CELL PROLIFERATION#0.7049;INSULIN SECRETION#0.7020;AUXIN SIGNALING#0.6994;CIRCADIAN BEHAVIOR#0.6977;PLASTID#0.6945;C TERMINAL DOMAIN#0.6945;CYTOPLASM#0.6914;40S RIBOSOMAL SUBUNIT#0.6888;PORE FORMATION#0.6829;RIBOSOMAL SUBUNIT#0.6768;PHOTOSYNTHESIS#0.6762;GANGLION CELLS#0.6755;PEROXISOME#0.6754;SIGNALLING PATHWAY#0.6745;PHYTOCHROME INTERACTING FACTOR#0.6724;SPORULATION#0.6710;CANCER CELL#0.6671;MAGNETORECEPTION#0.6667;FRAGMENT LENGTH POLYMORPHISM#0.6495;RETINAL GANGLION CELL#0.6489;GERMINATION#0.6454;STEM CELL#0.6389;PROTEASOME#0.6355;LEUCINE#0.6305;ENERGY HOMEOSTASIS#0.6289;PROTEIN PROTEIN INTERACTION#0.6266;ELECTRON TRANSPORT#0.6239;GROWTH FACTOR#0.6200;CASEIN KINASE 1#0.6180;OVARIAN#0.6171;MECHANISM OF ACTION#0.6135;PROSTATE CANCER#0.6126;ANION CHANNEL#0.6078;ESTROUS CYCLE#0.6042;PHOTOSYSTEM II#0.6028
140803	CHANNEL ACTIVITY#1.0544;CATION CHANNEL#1.0423;TRANSIENT RECEPTOR POTENTIAL#1.0224;ION CHANNEL#1.0216;EPITHELIAL CELL#1.0101;CELL SURFACE#1.0089;PROTEIN KINASE#1.0030;GROWTH FACTOR#0.9974;MAGNESIUM TRANSPORT#0.9838;GENE EXPRESSION#0.9815;EXCRETION#0.9778;PLASMA MEMBRANE#0.9711;EPIDERMAL GROWTH FACTOR#0.9697;KINASE ACTIVITY#0.9389;CELL PROLIFERATION#0.9197;HYPERTENSION#0.8897;TYPE 2 DIABETES#0.8594;ISCHEMIA#0.8515;INTESTINAL ABSORPTION#0.8172;NEURAL TUBE#0.7994;POLYMERASE CHAIN REACTION#0.7972;NEURAL TUBE CLOSURE#0.7836;TUBE CLOSURE#0.7833;DIABETES MELLITUS#0.7596;B CELL#0.7588;SMOOTH MUSCLE#0.7514;CELL GROWTH#0.7494;KIDNEY DISEASE#0.7318;SIGNALING PATHWAY#0.7277;ALDOSTERONE#0.7072;LARGE INTESTINE#0.7042;ESTRADIOL#0.6817;ESTROGEN RECEPTOR ACTIVITY#0.6397;TYPE 2 DIABETES MELLITUS#0.6361;2 DIABETES MELLITUS#0.6361;PRIMARY HYPOMAGNESEMIA#0.6313;PROTEIN KINASE C#0.6285;PROTON PUMP INHIBITOR#0.6284;PROTON PUMP#0.6268;PARATHYROID HORMONE#0.6196;NEURAL TUBE DEFECT#0.6087;NEPHRON#0.6055;RECEPTOR ACTIVITY#0.6008;MAMMARY EPITHELIAL CELL#0.6005
140807	HAIR FOLLICLE#0.8457;ROOT SHEATH#0.8344;GENE EXPRESSION#0.7440;CELL PROLIFERATION#0.6252
140809	APOPTOSIS#1.0174;TRANSCRIPTION FACTOR#1.0042;REACTIVE OXYGEN SPECIES#0.9958;LUNG CANCER#0.9902;GLUTATHIONE#0.9860;CANCER CELL#0.9801;GENE EXPRESSION#0.9755;CELL DEATH#0.9649;MITOCHONDRIA#0.9413;SIGNALING PATHWAY#0.8744;APOPTOTIC#0.8660;CELL PROLIFERATION#0.8642;GLUTATHIONE PEROXIDASE#0.8253;SUPEROXIDE DISMUTASE#0.8209;COLORECTAL CANCER#0.8074;SQUAMOUS CELL CARCINOMA#0.8073;ASTROCYTE#0.8049;OXIDATIVE STRESS RESPONSE#0.7910;TOXICITY#0.7711;ANTIOXIDANT RESPONSE ELEMENT#0.7463;CEREBRAL ISCHEMIA#0.7438;HEME OXYGENASE 1#0.7379;CELL CYCLE#0.7348;CERVICAL#0.7278;SIGNAL TRANSDUCTION#0.6981;ISCHEMIA#0.6924;ADRENAL GLAND#0.6869;CYTOCHROME C#0.6817;OXYGENASE#0.6816;OXYGEN GLUCOSE DEPRIVATION#0.6752;MACROPHAGE#0.6369;COLORECTAL#0.6339;GLUTAMATE CYSTEINE LIGASE#0.6307;CERVICAL SQUAMOUS CELL CARCINOMA#0.6238;ACTIVATOR PROTEIN 1#0.6224;MITOCHONDRIAL MEMBRANE#0.6167;SKIN CANCER#0.6095;CYTOCHROME C RELEASE#0.6088;CERVICAL CANCER#0.6052;ANTIOXIDANT ACTIVITY#0.6018
140821	OTITIS MEDIA#0.6532;CITRIC ACID#0.6514
140823	REACTIVE OXYGEN SPECIES#1.0707;LUNG CANCER#1.0448;CANCER CELL#1.0236;MITOCHONDRIA#0.9593;CELL DEATH#0.9463;CELL PROLIFERATION#0.8794;MALIGNANT PLEURAL EFFUSION#0.8512;MITOCHONDRIAL MEMBRANE#0.8089;APOPTOSIS#0.7636;MONOCYTE#0.7602;TUMOR TISSUES#0.7145;DISEASE FREE SURVIVAL#0.6990;CELL CYCLE#0.6918;TUMOR CELLS#0.6673;SIGNALING PATHWAY#0.6659;ROS GENERATION#0.6320;MITOCHONDRIAL FUSION#0.6278;MITOCHONDRIAL INNER MEMBRANE#0.6261;IMMUNE RESPONSE#0.6114;GENE EXPRESSION#0.6047
140825	UBIQUITIN LIGASE COMPLEX#0.8039;MYOSIN HEAVY CHAIN#0.7587;UBIQUITIN#0.7278
140838	CELL SURFACE#0.7449
140851	PLATELET ACTIVATION#0.6825
140862	CELL SURFACE#0.9665;APOPTOSIS#0.9627;ANGIOGENESIS#0.9018;ENDOTHELIAL CELL#0.8576
140883	CANCER CELL#0.7420
140885	CYTOPLASMIC REGION#1.0781;EXTRACELLULAR REGION#1.0517;MACROPHAGE FUSION#1.0449;MYELOID CELL#1.0402;PROTEIN TYROSINE PHOSPHATASE#1.0339;CELL SURFACE#1.0200;PHAGOCYTOSIS#1.0198;MACROPHAGE#1.0180;CELL ADHESION#1.0106;SMOOTH MUSCLE#1.0103;MONOCYTE#1.0082;CELL PROLIFERATION#1.0033;SIGNALING PATHWAY#0.9989;RED BLOOD CELL#0.9988;LEUKOCYTE#0.9977;GROWTH FACTOR#0.9970;MUSCLE CELL#0.9963;PERIPHERAL BLOOD#0.9940;T CELL#0.9940;DENDRITIC CELL#0.9937;SMOOTH MUSCLE CELL#0.9927;NEUTROPHIL#0.9890;PLASMA MEMBRANE#0.9868;CELL MIGRATION#0.9838;BONE MARROW#0.9830;ENDOTHELIAL CELL#0.9830;B CELL#0.9820;MONONUCLEAR CELLS#0.9814;IMMUNE CELL#0.9811;STEM CELL#0.9797;HEMATOPOIETIC CELL#0.9785;MAP KINASE#0.9751;GENE EXPRESSION#0.9745;IMMUNE SYSTEM#0.9744;TOLL LIKE RECEPTOR#0.9713;CELL ACTIVATION#0.9697;SRC FAMILY KINASE#0.9695;IMMUNE RESPONSE#0.9694;PROTEIN KINASE#0.9621;VASCULAR SMOOTH MUSCLE CELL#0.9619;INSULIN-LIKE GROWTH FACTOR#0.9575;SIGNAL TRANSDUCTION#0.9563;LYMPH NODE#0.9550;FACTOR I#0.9422;INFLAMMATORY RESPONSE#0.9396;NEURITE OUTGROWTH#0.9392;T LYMPHOCYTE#0.9346;NEURITE#0.9294;APOPTOTIC#0.9239;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9147;MITOGEN ACTIVATED PROTEIN#0.9114;ANTIGEN PRESENTING CELLS#0.9095;RECEPTOR TYROSINE KINASE#0.9030;CD8+ T CELL#0.8841;HOST CELL#0.8840;INHIBITION OF PHAGOCYTOSIS#0.8838;EXTRACELLULAR MATRIX#0.8826;ERYTHROCYTE#0.8801;OSTEOCLAST#0.8765;PROTEIN TYROSINE KINASE#0.8703;NERVOUS SYSTEM#0.8701;MAST CELL#0.8666;HEMATOPOIETIC STEM CELL#0.8657;TUMOR NECROSIS FACTOR#0.8620;APOPTOSIS#0.8590;TUMOR CELLS#0.8509;EPITHELIAL CELL#0.8489;PROGENITOR CELL#0.8445;CD4+ T CELL#0.8416;CANCER CELL#0.8339;IFN-GAMMA#0.8311;MAPK ACTIVATION#0.8261;DEPHOSPHORYLATION#0.8253;FOCAL ADHESION#0.8245;SIGNALING MOLECULE#0.8154;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8101;GLYCOSYLATION#0.8074;ANCHORAGE INDEPENDENT GROWTH#0.8003;SELF RECOGNITION#0.7936;ALVEOLAR MACROPHAGE#0.7913;CELL COMMUNICATION#0.7863;GRANULOCYTE#0.7832;CELL GROWTH#0.7816;REGULATION OF CELL MIGRATION#0.7802;SH2 DOMAIN BINDING#0.7748;T CELL ACTIVATION#0.7708;SKELETAL MUSCLE#0.7672;BREAST CANCER#0.7649;AUTOIMMUNE DISEASE#0.7592;FOCAL ADHESION KINASE#0.7485;INNATE IMMUNE SYSTEM#0.7450;CYTOKINE PRODUCTION#0.7449;CENTRAL NERVOUS SYSTEM#0.7386;HEMOLYTIC ANEMIA#0.7293;HYPERGLYCEMIA#0.7252;GROWTH HORMONE#0.7243;ADIPOSE TISSUE#0.7178;HEPATOCELLULAR CARCINOMA#0.7170;ANEMIA#0.7132;CARDIOMYOCYTE#0.7028;COLONY-STIMULATING FACTOR#0.7008;ADAPTIVE IMMUNE RESPONSE#0.6999;COMPLEMENT RECEPTOR#0.6958;LANGERHANS CELL#0.6932;ACTIVATION OF MAP KINASE#0.6879;MYELOID LEUKEMIA#0.6875;LIGAND BINDING DOMAIN#0.6781;COMPLEX I#0.6722;EOSINOPHIL HOMEOSTASIS#0.6719;LEUKOCYTE DIFFERENTIATION#0.6708;MESENTERIC LYMPH NODE#0.6665;AUTOIMMUNE HEMOLYTIC ANEMIA#0.6647;INNATE IMMUNE RESPONSE#0.6614;CELL DEATH#0.6561;REGULATION OF PHAGOCYTOSIS#0.6547;INNATE IMMUNITY#0.6544;STRESS FIBER#0.6532;LYMPHOID TISSUE#0.6493;INSULIN RECEPTOR#0.6491;NITRIC OXIDE#0.6490;MALE SEX DETERMINATION#0.6268;TRANSCRIPTION FACTOR#0.6249;HEMATOPOIESIS#0.6139;AKT SIGNALING#0.6055;CELL MOTILITY#0.6054;B LYMPHOCYTE#0.6028
140886	POLY-A BINDING#0.8841
140890	RNA RECOGNITION MOTIF#0.7921;ARGININE#0.6757
1408	FLOWERING#1.0356;RESPONSE TO BLUE LIGHT#1.0264;BREAST CANCER#1.0237;POLYMERASE CHAIN REACTION#1.0171;FLAVIN#0.9992;TRANSCRIPTION FACTOR#0.9989;MELATONIN#0.9972;QUANTITATIVE REAL TIME#0.9949;DIURNAL#0.9871;PINEAL GLAND#0.9803;CIRCADIAN RHYTHM#0.9744;SIGNALING PATHWAY#0.9735;CELL CYCLE#0.9697;GENE EXPRESSION#0.9612;TYPE 2 DIABETES#0.9420;PERIPHERAL BLOOD#0.9257;PROTEIN KINASE#0.9224;TOXICITY#0.9177;PHOTOMORPHOGENESIS#0.9174;PLASMA MEMBRANE#0.9002;UBIQUITIN#0.8984;COLORECTAL CANCER#0.8779;SKELETAL MUSCLE#0.8698;CANCER CELL#0.8587;ADRENAL GLAND#0.8462;SIGNAL TRANSDUCTION#0.8345;APOPTOSIS#0.8223;CELL PROLIFERATION#0.8218;COLORECTAL#0.8156;DNA REPAIR#0.8121;PROTEIN PROTEIN INTERACTION#0.8029;RIBOSOMAL PROTEIN#0.7924;BREAST CANCER PATIENTS#0.7850;DNA METHYLATION#0.7834;KINASE ACTIVITY#0.7572;STOMATAL OPENING#0.7560;INSULIN SECRETION#0.7545;ADIPOSE TISSUE#0.7544;NUCLEAR LOCALIZATION SIGNAL#0.7490;ALDOSTERONE#0.7334;HYPERTENSION#0.7297;ADRENAL CORTEX#0.7297;GLUCOSE HOMEOSTASIS#0.7278;N ACETYLTRANSFERASE#0.7252;ARYL HYDROCARBON RECEPTOR#0.7222;GROWTH FACTOR#0.7190;BIOLUMINESCENCE#0.7048;PROTEASOME#0.7043;REVERSE TRANSCRIPTION#0.6919;HIGH FAT DIET#0.6863;GLUCOSE METABOLISM#0.6779;APOPTOTIC#0.6766;NERVOUS SYSTEM#0.6728;C TERMINAL DOMAIN#0.6721;OOCYTE#0.6622;CHLOROPLAST#0.6592;GLYCOGEN SYNTHASE KINASE#0.6547;ELECTRON TRANSPORT#0.6500;DIAPAUSE#0.6455;DNA REPAIR ENZYME#0.6353;MELATONIN SYNTHESIS#0.6277;DNA BINDING#0.6260;26S PROTEASOME#0.6253;MAGNETORECEPTION#0.6246;ESTROGEN RECEPTOR#0.6151;PHOTOTROPISM#0.6131;LIPID METABOLISM#0.6129;NUCLEAR LAYER#0.6094;PEROXISOME#0.6080
140901	STRESS FIBER#0.6944;CELL CYCLE#0.6797;ENDOTHELIAL CELL#0.6797;S PHASE#0.6282
140902	SKELETAL MUSCLE#0.6588;CELL PROLIFERATION#0.6544
140913	BIOFILM FORMATION#0.6789
140947	DENDRITIC CELL#1.1309;MELATONIN BIOSYNTHESIS#0.6961;N ACETYLTRANSFERASE#0.6652
1409	HEAT SHOCK PROTEIN#0.9971;ARGININE#0.9758;TRANSCRIPTION FACTOR#0.9485;CHAPERONE ACTIVITY#0.9061;EPITHELIAL CELL#0.8929;POLYMERASE CHAIN REACTION#0.8466;HUMAN LENS EPITHELIAL#0.8177;GENE EXPRESSION#0.7736;APOPTOSIS#0.7705;GAP JUNCTION#0.7371;EYE LENS#0.7316;BLINDNESS#0.6827;AUTOSOMAL DOMINANT CATARACT#0.6456;AGE RELATED MACULAR DEGENERATION#0.6209;MACULAR DEGENERATION#0.6203
140	MAST CELL#1.0406;IB-MECA#1.0335;ADENOSINE#1.0285;SIGNALING PATHWAY#1.0207;PROTEIN KINASE#1.0050;RECEPTOR AGONIST#1.0047;RECEPTOR ANTAGONIST#1.0022;BONE MARROW#1.0001;ISCHEMIA#0.9993;APOPTOSIS#0.9942;RECEPTOR LIGAND#0.9859;PERIPHERAL BLOOD#0.9786;TUMOR NECROSIS FACTOR#0.9759;GENE EXPRESSION#0.9643;CELL GROWTH#0.9503;MONONUCLEAR CELLS#0.9388;CELL DEATH#0.9173;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9090;CANCER CELL#0.8973;INFLAMMATORY RESPONSE#0.8926;RHEUMATOID ARTHRITIS#0.8923;STRUCTURE ACTIVITY RELATIONSHIP#0.8911;NEUTROPHIL#0.8696;MECHANISM OF ACTION#0.8659;HYPOXIA#0.8586;HISTAMINE#0.8470;INFLAMMATORY CELL#0.8428;ADENOSINE DEAMINASE#0.8385;CELL SURFACE#0.8285;CELL CYCLE#0.8212;CELL PROLIFERATION#0.8126;TNF-ALPHA PRODUCTION#0.8083;NITRIC OXIDE#0.8023;XANTHINE#0.7954;SIGNAL TRANSDUCTION#0.7875;MITOGEN ACTIVATED PROTEIN#0.7864;RIBOSE#0.7755;MACROPHAGE#0.7725;ISCHEMIA REPERFUSION INJURY#0.7666;APOPTOTIC#0.7629;DORSAL ROOT GANGLION#0.7544;IL-1 PRODUCTION#0.7533;SIGNALLING PATHWAY#0.7473;PROTEIN KINASE C#0.7454;COLITIS#0.7426;POLYMERASE CHAIN REACTION#0.7247;ASTROCYTE#0.7045;TRANSCRIPTION FACTOR#0.7038;PRO-INFLAMMATORY#0.7032;RENAL FIBROSIS#0.6992;HYPOTENSIVE#0.6985;MAST CELL DEGRANULATION#0.6937;MONOCYTE#0.6864;ULCERATIVE COLITIS#0.6788;TUMOR CELLS#0.6758;PERTUSSIS#0.6604;CEREBRAL ISCHEMIA#0.6535;NERVOUS SYSTEM#0.6525;RECEPTOR BINDING#0.6511;CONSTRICTION#0.6390;MICROGLIAL CELL#0.6358;OXALIPLATIN#0.6336;KINASE INHIBITOR#0.6306;CELL CYCLE ARREST#0.6300;INDUCTION OF APOPTOSIS#0.6223;SPINAL CORD#0.6199;HYPOTENSION#0.6173;NF-KAPPAB ACTIVATION#0.6094;CHRONIC NEUROPATHIC PAIN#0.6082;THEOPHYLLINE#0.6047;IODOPHENYL#0.6032;STEM CELL#0.6005
1410	CARDIOMYOCYTE#1.0420;ASTROCYTE#1.0311;CARDIOMYOPATHY#1.0230;CHAPERONE ACTIVITY#1.0212;HEAT SHOCK PROTEIN#1.0155;APOPTOSIS#1.0148;T CELL#1.0075;MULTIPLE SCLEROSIS#1.0043;SIGNALING PATHWAY#1.0039;MYOPATHY#1.0016;SKELETAL MUSCLE#0.9882;MYOFIBRILLAR MYOPATHY#0.9828;TRANSCRIPTION FACTOR#0.9825;GENE EXPRESSION#0.9654;BREAST CANCER#0.9570;APOPTOTIC#0.9516;ISCHEMIA#0.9333;CANCER CELL#0.9289;MACROPHAGE#0.9267;NEURODEGENERATIVE DISEASE#0.9229;CELL DEATH#0.8997;POLYMERASE CHAIN REACTION#0.8918;ENDOTHELIAL CELL#0.8893;EPITHELIAL CELL#0.8759;NERVOUS SYSTEM#0.8745;PROTEIN KINASE#0.8730;AUTOPHAGY#0.8607;EPITHELIAL MESENCHYMAL TRANSITION#0.8416;ENCEPHALOMYELITIS#0.8382;COLORECTAL CANCER#0.8373;INFLAMMATORY RESPONSE#0.8357;POSTERIOR POLAR CATARACT#0.8241;SPINAL CORD#0.8223;CENTRAL NERVOUS SYSTEM#0.8157;IMMUNE RESPONSE#0.8068;MITOCHONDRIA#0.8025;CELL ADHESION#0.7999;INTERMEDIATE FILAMENT#0.7935;OVARIAN CANCER#0.7872;PROTEASOME#0.7779;MYOCYTES#0.7677;HEART DISEASE#0.7648;AGGRESOME#0.7609;STEM CELL#0.7475;PRO-INFLAMMATORY#0.7454;LUNG CANCER#0.7446;MITOGEN ACTIVATED PROTEIN#0.7430;GROWTH FACTOR#0.7390;CELL CYCLE#0.7254;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7121;OLIGODENDROCYTE#0.6920;EXTRACELLULAR MATRIX#0.6883;EXOSOME#0.6858;UBIQUITIN#0.6815;COLORECTAL#0.6809;QUANTITATIVE REAL TIME#0.6751;EYE LENS#0.6705;CELL PROLIFERATION#0.6461;MYOCARDIUM#0.6368;HEAT SHOCK FACTOR#0.6326;ANGIOGENESIS#0.6310;STROMAL CELL#0.6303;TOLL LIKE RECEPTOR#0.6261;OVARIAN#0.6222;CYTOTOXICITY#0.6221;ENDOPLASMIC RETICULUM#0.6202;NEONATAL RAT CARDIOMYOCYTES#0.6201;ALZHEIMER'S DISEASE#0.6158;TOXICITY#0.6100;TUMOR TISSUES#0.6091;ISCHEMIA REPERFUSION INJURY#0.6082;BREAST CANCER CELL#0.6048;TUMOR NECROSIS FACTOR#0.6031
1411	TRANSCRIPTION FACTOR#0.7776;ASTROCYTE#0.7242;POSTERIOR POLAR CATARACT#0.6499
1413	TRANSCRIPTION FACTOR#0.6713
1414	TRANSCRIPTION FACTOR#0.8295;GENE EXPRESSION#0.7830;GAP JUNCTION#0.7293;AUTOSOMAL DOMINANT CATARACT#0.6295
1415	GENE CONVERSION#0.9751;EYE LENS#0.9256;TRANSCRIPTION FACTOR#0.8044;GAP JUNCTION#0.7746;AUTOSOMAL DOMINANT CATARACT#0.7501;GENE EXPRESSION#0.6803;POLYMERASE CHAIN REACTION#0.6657;BLINDNESS#0.6410
1416	GENE CONVERSION#0.6043
1417	TRANSCRIPTION FACTOR#0.6840
1419	WEIGHT LOSS#0.6595
141	RIBOSE#1.0563;ARGININE#1.0433;POLY ADP RIBOSE#0.7328;CELL SURFACE#0.7117;ERYTHROCYTE#0.6495
1420	GAP JUNCTION#0.7552;TRANSCRIPTION FACTOR#0.6473
1421	PHYCOBILISOME#1.0292;PHOTOSYSTEM I#1.0040;CAROTENOID#1.0037;PHOTOSYSTEM II#1.0027;PHOTOINHIBITION#1.0007;PHOTOSYSTEM#1.0007;REACTION CENTER#0.9920;ELECTRON TRANSPORT#0.9890;PHOTOSYNTHESIS#0.9772;ELECTRON TRANSFER#0.9740;THYLAKOID MEMBRANE#0.9471;CHLOROPHYLL A#0.9430;THYLAKOID#0.9249;CHLOROPHYLL FLUORESCENCE#0.9061;RHEUMATOID ARTHRITIS#0.8546;PHOTOSYSTEM II REACTION CENTER#0.8544;GAP JUNCTION#0.8185;GENE EXPRESSION#0.8111;TRANSCRIPTION FACTOR#0.7170;ENERGY DISSIPATION#0.7002;PROTEIN SYNTHESIS#0.6770;POLYMERASE CHAIN REACTION#0.6740;CHLOROPLAST#0.6576;MUTAGENESIS#0.6527;REACTIVE OXYGEN SPECIES#0.6462;PHOTOPROTECTION#0.6402;PLASTOCYANIN#0.6375;HETEROCYST DIFFERENTIATION#0.6342
142678	UBIQUITIN#1.0948;ZINC FINGER PROTEIN#0.8992;UBIQUITIN PROTEIN LIGASE#0.8569;NOTCH LIGAND#0.6942;B CELL#0.6616;ACTIN BINDING#0.6418;CELL DEATH#0.6214
142679	APOPTOSIS#0.8665;MITOGEN ACTIVATED PROTEIN#0.7808;PROTEIN KINASE#0.7774;CHONDROCYTE#0.6913;CLEAVED CASPASE 3#0.6695
142680	HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA#1.1158;RICKETS#1.0672;HYPOPHOSPHATEMIA#0.9864;BRUSH BORDER#0.9303;BRUSH BORDER MEMBRANE#0.9005;PARATHYROID HORMONE#0.8602;FIBROBLAST GROWTH FACTOR#0.8161;GROWTH FACTOR#0.8111;PARATHYROID#0.7827;NEPHROLITHIASIS#0.7664;NEPHROCALCINOSIS#0.7505;PROXIMAL TUBULAR CELL#0.6793;PHOSPHATE TRANSPORT#0.6661;OSTEOMALACIA#0.6636
142683	VIRAL ENCEPHALITIS#0.6173
142685	SKELETAL MUSCLE#0.9405;AND SOCS BOX#0.8249;BETA ADRENERGIC RECEPTOR#0.7077;ADRENERGIC RECEPTOR#0.7007;RECEPTOR AGONIST#0.6964;MYOBLAST#0.6782;MYOBLAST DIFFERENTIATION#0.6663;PROTEIN DEGRADATION#0.6488;MUSCLE FIBER#0.6486;PROTEIN SYNTHESIS#0.6406;MITOGEN ACTIVATED PROTEIN#0.6389;PROTEIN KINASE#0.6341
1427	TRANSCRIPTION FACTOR#0.7084
142827	AMP BINDING#0.6142
142891	SPHINGOMYELIN SYNTHASE#1.0541;CELL DEATH#0.8223;CERAMIDE BIOSYNTHESIS#0.6529;CATALYTIC ACTIVITY#0.6461
1428	THYROID HORMONE BINDING#1.0931;HORMONE BINDING#1.0687;TRIIODOTHYRONINE#0.8181;GENE EXPRESSION#0.7945;GLYCOLIPID METABOLISM#0.6278;NONSYNDROMIC DEAFNESS#0.6175
142910	LIPOATE#0.6217
142940	PSEUDOURIDINE SYNTHASE#1.0077;DYSKERATOSIS CONGENITA#0.6386
1429	GLUTATHIONE#0.8145;QUINONE REDUCTASE ACTIVITY#0.7044
142	PARP-DEPENDENT CELL DEATH#1.1003;NU1025#1.0960;PARTHANATOS#1.0593;DNA FRAGMENTATION FACTOR#1.0508;BENZIMIDAZOLE#1.0425;DNA LIGASE#1.0386;SYNTHETASE ACTIVITY#1.0365;METFORMIN#1.0342;SINGLE STRAND BREAK REPAIR#1.0335;ACTIVE CASPASE 3#1.0276;PRIMARY PERITONEAL CANCER#1.0269;CLEAVED CASPASE 3#1.0253;RESPONSE TO OXIDATIVE STRESS#1.0250;ACTIVATED CASPASE 3#1.0244;PROGRAMMED NECROSIS#1.0240;DNA POLYMERASE BETA#1.0224;MINOCYCLINE#1.0216;DIPHOSPHATE#1.0211;DIABETIC NEUROPATHY#1.0210;DNA REPAIR ENZYME#1.0199;EWING SARCOMA#1.0182;NULL CELL#1.0176;POLY ADP RIBOSE#1.0176;RIBOSE#1.0175;MYOCYTES#1.0153;ARSENITE#1.0132;RESPONSE TO PLATINUM#1.0119;BRAIN DAMAGE#1.0103;ADENOSINE#1.0100;CENTROSOME#1.0093;DNASE#1.0088;RECURRENT OVARIAN CANCER#1.0087;SINGLE STRAND BREAK#1.0074;NUCLEAR MATRIX#1.0074;ACTIVATION OF APOPTOSIS#1.0073;MELATONIN#1.0073;NECROPTOSIS#1.0072;MITOCHONDRIAL MEMBRANE DEPOLARIZATION#1.0069;CATALYTIC ACTIVITY#1.0066;BLEOMYCIN#1.0061;ADENOSINE TRIPHOSPHATE#1.0060;CHROMATIN REMODELING#1.0058;CASPASE-INDEPENDENT APOPTOSIS#1.0057;MITOCHONDRIA MEMBRANE POTENTIAL#1.0057;DNA DEGRADATION#1.0052;BETA CELL#1.0051;SPORADIC BREAST CANCER#1.0049;NUCLEOSOME#1.0043;NADPH OXIDASE#1.0034;LUPUS ERYTHEMATOSUS#1.0033;MITOMYCIN C#1.0028;CASPASE-INDEPENDENT CELL DEATH#1.0028;SPINAL CORD#1.0028;MITOCHONDRIAL DEPOLARIZATION#1.0027;MOUSE EMBRYONIC FIBROBLAST#1.0027;CEREBRAL CORTEX#1.0022;ADVANCED OVARIAN CANCER#1.0019;CASPASE ACTIVITY#1.0018;TOPOTECAN#1.0012;NECROTIC CELL DEATH#1.0011;OXALIPLATIN#0.9996;HOMOLOGOUS RECOMBINATION REPAIR#0.9994;REGULATION OF GENE EXPRESSION#0.9989;CYTOCHROME C RELEASE#0.9989;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9989;HYPERSENSITIVITY#0.9988;RECEPTOR INTERACTING PROTEIN#0.9985;REGULATION OF DNA REPAIR#0.9985;PROTEIN MODIFICATION#0.9984;DNA METHYLATION#0.9980;STAUROSPORINE#0.9976;TELOMERE#0.9975;PHOSPHATIDYLSERINE#0.9975;HYPERTHERMIA#0.9974;QUERCETIN#0.9971;NEPHROPATHY#0.9971;SELECTIN#0.9970;NMDA RECEPTOR#0.9969;FOCAL CEREBRAL ISCHEMIA#0.9967;NEUROPATHY#0.9966;TRAUMATIC BRAIN INJURY#0.9964;NAD BINDING#0.9961;INTRINSIC APOPTOSIS#0.9959;NAD METABOLISM#0.9957;DNA REPAIR PROTEIN#0.9955;CASPASE-3 ACTIVITY#0.9953;CHROMATID#0.9953;TISSUE DAMAGE#0.9952;B CELL LYMPHOMA#0.9951;COLITIS#0.9949;EXTRINSIC APOPTOSIS#0.9949;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.9946;PROTEIN COMPLEX#0.9945;NEURONAL CELL DEATH#0.9944;MYOCARDIAL INFARCTION#0.9943;IRINOTECAN#0.9939;BASE EXCISION REPAIR#0.9935;ELECTRON TRANSPORT#0.9935;MEMBRANE DEPOLARIZATION#0.9935;MITOCHONDRIAL DAMAGE#0.9933;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9932;APOPTOSIS INDUCING FACTOR#0.9931;CARDIAC ARREST#0.9929;EPITHELIAL MESENCHYMAL TRANSITION#0.9927;ENZYME ACTIVITY#0.9926;NUCLEAR MORPHOLOGY#0.9925;TEMOZOLOMIDE#0.9925;DNA REPAIR DEFICIENCY#0.9922;CYTOCHROME C#0.9921;GERM CELL#0.9921;HISTONE MODIFICATION#0.9915;HYPERGLYCEMIA#0.9914;HIGH MOBILITY GROUP#0.9913;HYPOXIC#0.9912;GLYCOLYSIS#0.9910;OXIDATIVE DNA DAMAGE#0.9907;NICOTINAMIDE#0.9906;DNA TOPOISOMERASE#0.9905;ENDOMETRIAL CANCER#0.9905;ATAXIA TELANGIECTASIA MUTATED#0.9904;CARBOPLATIN#0.9903;NUCLEOLUS#0.9901;REPLICATION FORK#0.9901;MITOCHONDRIAL DNA#0.9900;LEUKOCYTE#0.9897;ORAL CANCER CELL#0.9891;GLYCOSYLASE#0.9891;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9889;CEREBRAL ISCHEMIA#0.9889;DNA FRAGMENTATION#0.9888;DOUBLE-STRAND BREAK REPAIR#0.9885;SORAFENIB#0.9885;INHIBITION OF DNA REPAIR#0.9884;PERIPHERAL BLOOD LYMPHOCYTES#0.9883;APOPTOTIC PROCESS#0.9881;PROTEIN PROTEIN INTERACTION#0.9881;GLIAL CELL#0.9881;DNA DAMAGE CHECKPOINT#0.9881;C TERMINAL DOMAIN#0.9879;GEMCITABINE#0.9878;MITOTIC CATASTROPHE#0.9877;RESVERATROL#0.9874;ENDOTHELIAL GROWTH FACTOR#0.9874;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9874;MELANOMA CELL LINES#0.9872;CEREBRAL ARTERY OCCLUSION#0.9870;CELL DIFFERENTIATION#0.9869;DNA REPAIR#0.9868;NECROTIC#0.9868;INTRINSIC APOPTOTIC PATHWAY#0.9867;MYOCARDIUM#0.9860;ISCHEMIA REPERFUSION INJURY#0.9858;ISCHEMIA#0.9857;TYPE 1 DIABETES#0.9855;TOPOISOMERASE#0.9854;SPINAL CORD INJURY#0.9853;BORTEZOMIB#0.9852;CELLULAR METABOLISM#0.9850;DNA BINDING#0.9848;OVARIAN CANCER#0.9845;ARGININE#0.9843;MITOCHONDRIAL PERMEABILITY TRANSITION#0.9843;REGENERATION#0.9841;DOCETAXEL#0.9841;CASPASE ACTIVATION#0.9833;ATAXIA TELANGIECTASIA#0.9832;OVARIAN#0.9832;LIGHT CHAIN 3#0.9832;ATHEROSCLEROSIS#0.9830;CELL MEMBRANE#0.9826;ADENINE#0.9825;HISTONE ACETYLATION#0.9825;BLOOD BRAIN BARRIER#0.9823;DIABETES MELLITUS#0.9823;AUTOIMMUNE DISEASE#0.9820;CAMPTOTHECIN#0.9819;GENOTOXIC#0.9818;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9816;NF-KAPPAB ACTIVATION#0.9816;HOMOLOGOUS RECOMBINATION#0.9816;METASTATIC BREAST CANCER#0.9816;SMOOTH MUSCLE CELL#0.9814;RESPONSE TO TREATMENT#0.9814;MIDDLE CEREBRAL ARTERY#0.9813;PROXIMAL TUBULAR CELL#0.9812;TOPOISOMERASE II#0.9810;ANTI APOPTOSIS#0.9810;TAXOL#0.9808;CEREBRAL ARTERY#0.9808;CELL KILLING#0.9808;ENDOTHELIUM#0.9807;MITOMYCIN#0.9806;HETEROCHROMATIN#0.9805;BIOTIN#0.9804;INDUCIBLE NITRIC OXIDE#0.9804;EPITHELIAL OVARIAN CANCER#0.9803;3-METHYLADENINE#0.9801;ASTROCYTE#0.9801;LYSINE#0.9799;NUCLEOTIDE EXCISION REPAIR#0.9796;OXYGEN GLUCOSE DEPRIVATION#0.9796;CISPLATIN#0.9794;DNA METHYLTRANSFERASE#0.9792;CELL CYCLE CHECKPOINT#0.9791;STRUCTURE ACTIVITY RELATIONSHIP#0.9791;STREPTOZOTOCIN#0.9789;HYPOXIA INDUCIBLE FACTOR#0.9788;NUCLEIC ACID#0.9788;FANCONI ANEMIA#0.9788;POSTTRANSLATIONAL MODIFICATION#0.9786;TOLL LIKE RECEPTOR#0.9784;PROTEIN BINDING#0.9783;CARDIOMYOCYTE#0.9782;LIVER CANCER#0.9782;BEVACIZUMAB#0.9782;PROGENITOR CELL#0.9781;CANCER STEM CELL#0.9781;CELL CYCLE REGULATOR#0.9780;DOPAMINE#0.9776;DIABETIC RETINOPATHY#0.9776;PACLITAXEL#0.9775;APOPTOTIC DNA FRAGMENTATION#0.9774;MEMBRANE BLEBBING#0.9773;COLON CARCINOMA#0.9771;INFLAMMATORY CELL#0.9771;MONOCYTE#0.9771;ETOPOSIDE#0.9771;ENDOTHELIAL CELL DYSFUNCTION#0.9771;RESPIRATION#0.9771;OXIDATIVE PHOSPHORYLATION#0.9771;QUANTITATIVE REAL TIME#0.9771;SENSITIZATION#0.9770;APOPTOSIS#0.9769;PERMEABILITY TRANSITION PORE#0.9769;MUSCLE CELL#0.9768;SENSITIZER#0.9767;ANTISENSE RNA#0.9764;PROTEIN KINASE C#0.9764;EMBRYONIC STEM CELL#0.9763;CYCLOPHOSPHAMIDE#0.9762;CHONDROCYTE#0.9762;MICROTUBULE ASSOCIATED PROTEIN#0.9761;THYROID CANCER#0.9760;OVARIAN CARCINOMA#0.9759;PROTEASE ACTIVITY#0.9758;TRANSFORMING GROWTH FACTOR#0.9757;NEURONAL CELLS#0.9756;NEUTROPHIL#0.9753;ADENINE DINUCLEOTIDE PHOSPHATE#0.9750;DNA SYNTHESIS#0.9749;PYRUVATE#0.9748;DIABETIC NEPHROPATHY#0.9747;SENESCENCE#0.9747;ETHANOL#0.9747;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9746;KERATINOCYTE#0.9746;MONONUCLEAR CELLS#0.9745;CARDIOMYOPATHY#0.9744;POST-TRANSLATIONAL MODIFICATION#0.9744;BREAST CARCINOMA#0.9743;MRN COMPLEX#0.9743;GLYCOGEN SYNTHASE KINASE#0.9743;WERNER SYNDROME#0.9741;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9739;PRO-INFLAMMATORY#0.9739;DNA DAMAGE RESPONSE#0.9737;ROS FORMATION#0.9737;CELLULAR SENESCENCE#0.9736;ANDROGEN RECEPTOR#0.9734;HYPOXIA#0.9734;B CELL#0.9732;EDEMA#0.9732;ASPARTATE#0.9732;HUMAN UMBILICAL VEIN#0.9732;DEXAMETHASONE#0.9732;MUTAGENESIS#0.9732;DNA REPLICATION#0.9731;THYMOCYTE#0.9731;SMOOTH MUSCLE#0.9731;CAFFEINE#0.9730;HOST CELL#0.9727;DOXORUBICIN#0.9725;INFLAMMATORY RESPONSE#0.9725;RAPAMYCIN#0.9725;UMBILICAL VEIN#0.9725;RETINOBLASTOMA#0.9724;STANDARD OF CARE#0.9724;BRAIN ISCHEMIA#0.9722;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9721;GENE SILENCING#0.9720;PROTEIN KINASE B#0.9719;HEME OXYGENASE 1#0.9719;BINDING PROTEIN 1#0.9718;NITRIC OXIDE SYNTHASE#0.9717;NEUROTOXICITY#0.9716;AUTOPHAGY#0.9715;REVERSE TRANSCRIPTION#0.9713;RNA BINDING#0.9711;MITOCHONDRIAL MEMBRANE#0.9711;ELECTROPHORETIC MOBILITY SHIFT#0.9711;TARGET OF RAPAMYCIN#0.9709;MACROPHAGE#0.9706;ORGANELLE#0.9706;RHEUMATOID ARTHRITIS#0.9706;MITOSIS#0.9705;MYELOID CELL#0.9704;CELL CYCLE REGULATION#0.9702;AGEING#0.9701;SIGNALING MOLECULE#0.9701;RNA INTERFERENCE#0.9701;TELOMERASE ACTIVITY#0.9701;72-HOURS#0.9701;DIPHTHERIA#0.9700;OXYGENASE#0.9699;ACTINOMYCIN D#0.9698;CASPASE INHIBITOR#0.9697;PERIPHERAL BLOOD#0.9696;HIGH FAT DIET#0.9696;HYPERTENSION#0.9694;HUMAN PANCREATIC CANCER#0.9694;IMMUNE CELL#0.9693;PARKINSON'S DISEASE#0.9693;CERVICAL CANCER#0.9691;CENTRAL NERVOUS SYSTEM#0.9689;ATHEROSCLEROTIC#0.9688;CELL ADHESION#0.9687;SKELETAL MUSCLE#0.9687;HEREDITARY BREAST CANCER#0.9687;SIGNALING CASCADE#0.9687;TRANSACTIVATION#0.9685;PROPIDIUM#0.9685;L-CYSTEINE#0.9684;8-HYDROXY-2'-DEOXYGUANOSINE#0.9684;SIGNALLING PATHWAY#0.9684;CDK INHIBITOR#0.9683;GENOTOXICITY#0.9678;IMMUNE RESPONSE#0.9678;NEUROPROTECTION#0.9677;TYPE 2 DIABETES#0.9676;POLYMERASE CHAIN REACTION#0.9675;COMPLEX I#0.9674;CATABOLISM#0.9674;NICOTINIC ACID#0.9673;HEPATOTOXICITY#0.9672;IFN-GAMMA#0.9672;CHLOROQUINE#0.9672;APOPTOTIC CELL DEATH#0.9671;MAP KINASE#0.9670;THYMIDINE#0.9670;HEAT SHOCK PROTEIN#0.9669;TRANSCRIPTASE#0.9669;IMMUNE SYSTEM#0.9669;PHOTORECEPTOR CELL#0.9668;ENDOTHELIAL CELL#0.9668;CELL DEATH#0.9667;APOPTOTIC SIGNALING PATHWAY#0.9666;CELL SURFACE#0.9666;T CELL#0.9665;PANCREATIC CANCER#0.9664;PLASMA MEMBRANE#0.9663;ADVANCED PROSTATE CANCER#0.9662;APOPTOTIC BODY#0.9662;BLEBBING#0.9658;TYROSINE KINASE INHIBITOR#0.9658;GLYCERALDEHYDE-3-PHOSPHATE#0.9657;APOPTOTIC#0.9656;CYTOPLASM#0.9656;LUNG ADENOCARCINOMA#0.9656;DNA METABOLISM#0.9654;PANCREATIC DUCTAL ADENOCARCINOMA#0.9654;MAXIMUM TOLERATED DOSE#0.9653;TUMOR TISSUES#0.9652;BREAST CANCER PATIENTS#0.9651;LYMPH NODE#0.9651;FLUOROURACIL#0.9650;FIBROBLAST GROWTH FACTOR#0.9650;PROTEIN SYNTHESIS#0.9649;5 FLUOROURACIL#0.9648;DOUBLE STRAND BREAK#0.9646;TAMOXIFEN#0.9646;INHIBITION OF CELL PROLIFERATION#0.9646;PROSTATE CANCER#0.9645;MITOCHONDRIA#0.9643;G2 PHASE#0.9643;BREAST CANCER#0.9643;NEPHROTOXICITY#0.9642;MISMATCH REPAIR#0.9642;PROTEASOME#0.9641;PROGRAMMED CELL DEATH#0.9640;ADRIAMYCIN#0.9639;5-AMINOISOQUINOLINE#0.9639;NEUROBLASTOMA#0.9638;NITRIC OXIDE#0.9637;GROWTH FACTOR RECEPTOR#0.9636;CERVICAL#0.9635;MYELOPEROXIDASE ACTIVITY#0.9631;RESPONSE TO GENOTOXIC STRESS#0.9631;MODE OF ACTION#0.9631;INSULIN-LIKE GROWTH FACTOR#0.9630;WOUND HEALING#0.9630;UBIQUITIN#0.9630;NERVOUS SYSTEM#0.9628;CELL DIVISION#0.9628;CYCLIN DEPENDENT KINASE INHIBITOR#0.9628;DNA REPAIR CAPACITY#0.9626;APOPTOSIS SIGNALING#0.9626;T LYMPHOCYTE#0.9625;PANCREATITIS#0.9625;CLEAVAGE OF LAMIN#0.9624;AUTOPHAGOSOME#0.9624;INHIBITION OF APOPTOSIS#0.9623;TUMOUR NECROSIS FACTOR#0.9622;DEPHOSPHORYLATION#0.9622;GENE EXPRESSION#0.9621;DEATH RECEPTOR#0.9620;MULTIPLE MYELOMA CELLS#0.9619;ACUTE MYELOID LEUKEMIA#0.9619;ARTERY#0.9619;ROS GENERATION#0.9619;MAPK SIGNALING#0.9617;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9616;TUMOR CELLS#0.9614;SUBEROYLANILIDE HYDROXAMIC ACID#0.9611;NEURODEGENERATIVE DISEASE#0.9610;EPIDERMAL GROWTH FACTOR#0.9609;ANGIOGENESIS#0.9606;LUNG CARCINOMA#0.9601;VORINOSTAT#0.9601;DENDRITIC CELL#0.9601;NECK CANCER#0.9599;VASCULAR CELL#0.9599;MAPK ACTIVATION#0.9596;ALZHEIMER'S DISEASE#0.9594;SIGNAL TRANSDUCTION#0.9593;THYROID CARCINOMA#0.9593;COLONY FORMATION ASSAY#0.9591;ORAL SQUAMOUS CELL CARCINOMA#0.9590;PROTEIN KINASE#0.9589;MECHANISMS OF ACTION#0.9588;LUMINAL#0.9588;S PHASE#0.9587;CARCINOGEN#0.9586;TRANSCRIPTION FACTOR#0.9586;SPERMATOGENESIS#0.9586;DIGESTION#0.9586;KINASE ACTIVITY#0.9584;MECHANISM OF ACTION#0.9584;DEMETHYLATION#0.9584;MALIGNANT GLIOMA#0.9583;SUPEROXIDE DISMUTASE#0.9583;RECEPTOR TYROSINE KINASE#0.9582;CELL COUNTING KIT#0.9581;BREAST CANCER CELL#0.9580;INDUCTION OF APOPTOSIS#0.9579;BONE MARROW#0.9579;GLIOBLASTOMA MULTIFORME#0.9577;MITOGEN ACTIVATED PROTEIN#0.9576;TRANSMISSION ELECTRON MICROSCOPY#0.9576;UNFOLDED PROTEIN RESPONSE#0.9574;FLOW CYTOMETRY ANALYSIS#0.9574;OF DIABETIC RATS#0.9573;MICROTUBULE#0.9573;EPSTEIN BARR VIRUS#0.9572;ACETYLCYSTEINE#0.9571;STEM CELL#0.9570;HEPATOCELLULAR CARCINOMA CELL#0.9570;ACUTE LUNG INJURY#0.9569;NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE#0.9567;REACTIVE OXYGEN SPECIES GENERATION#0.9567;REGULATORY T CELL#0.9565;ANEMIA#0.9565;METASTATIC MELANOMA#0.9564;HISTONE DEACETYLASE#0.9564;HEAD AND NECK CANCER#0.9562;CYCLIN DEPENDENT KINASE#0.9562;RECEPTOR ANTAGONIST#0.9561;RNA BINDING PROTEIN#0.9559;RETINOIC ACID#0.9557;TRADITIONAL CHINESE MEDICINE#0.9557;N-ACETYLCYSTEINE#0.9556;HUMAN BREAST CANCER#0.9556;TUMOR GROWTH INHIBITION#0.9554;AKT SIGNALING#0.9552;TUMOR SUPPRESSOR#0.9551;G1 PHASE#0.9551;ARA-C#0.9551;CORONARY ARTERY#0.9550;TUBE FORMATION#0.9549;HISTONE DEACETYLASE INHIBITOR#0.9548;GROWTH FACTOR#0.9547;PROGESTERONE#0.9545;TRASTUZUMAB#0.9544;LUNG CANCER#0.9543;ESTROGEN RECEPTOR#0.9542;SIGNAL TRANSDUCER#0.9541;STROMAL CELL#0.9540;RESPONSE TO IONIZING RADIATION#0.9540;GLUTATHIONE#0.9538;MYELOID LEUKEMIA#0.9536;CELL MIGRATION#0.9534;ENDOPLASMIC RETICULUM STRESS#0.9533;CYTOTOXICITY#0.9530;KINASE INHIBITOR#0.9529;EXTRACELLULAR MATRIX#0.9528;EXTRINSIC APOPTOTIC PATHWAY#0.9528;COLORECTAL#0.9527;MTDNA#0.9526;TUMOR NECROSIS FACTOR#0.9525;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9522;COLORECTAL CANCER#0.9521;ADVANCED BREAST CANCER#0.9520;EPITHELIAL CELL#0.9520;MULTIPLE MYELOMA#0.9518;ONCOGENIC#0.9518;AUTOPHAGIC CELL DEATH#0.9513;CD4+ T CELL#0.9512;ADENOCARCINOMA#0.9511;SQUAMOUS CELL CARCINOMA#0.9510;SKIN CANCER#0.9509;TOXICITY#0.9506;LYMPHOCYTIC LEUKEMIA#0.9504;GLUTATHIONE PEROXIDASE#0.9504;NUCLEAR CHROMATIN#0.9501;ACTIVATING TRANSCRIPTION FACTOR#0.9501;SCIATIC NERVE#0.9497;ACTIVATOR PROTEIN 1#0.9496;CELL CYCLE#0.9496;M PHASE#0.9496;COLON CANCER#0.9494;REACTIVE OXYGEN SPECIES#0.9491;CANCER CELL#0.9490;OLIGODENDROCYTE#0.9489;CELL CYCLE CONTROL#0.9488;STRAND DISPLACEMENT#0.9488;CELL CYCLE ARREST#0.9487;DRUG RESISTANCE#0.9485;DEATH RECEPTOR 5#0.9484;ACUTE KIDNEY INJURY#0.9482;ADIPOSE TISSUE#0.9481;HEPATOCELLULAR CARCINOMA#0.9479;CPT-11#0.9478;PROSTATE CARCINOMA#0.9476;ENDOPLASMIC RETICULUM#0.9474;ACUTE PANCREATITIS#0.9474;MELPHALAN#0.9474;ESTRADIOL#0.9473;ALANINE#0.9472;PROTEIN OXIDATION#0.9470;PHOSPHODIESTERASE#0.9469;ZINC FINGER PROTEIN#0.9464;ER STRESS RESPONSE#0.9464;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9464;COLORECTAL CARCINOMA#0.9461;SIGNALING PATHWAY#0.9460;HEPATOMA CELLS#0.9458;VASCULAR ENDOTHELIAL CELL#0.9458;ACETYLCHOLINE#0.9458;WEIGHT LOSS#0.9456;REGULATION OF APOPTOSIS#0.9453;STRIATUM#0.9453;CELL PROLIFERATION#0.9452;CELL GROWTH#0.9444;VASCULAR SMOOTH MUSCLE CELL#0.9440;CHRONIC HEART FAILURE#0.9439;CELL ADHESION MOLECULE#0.9437;DNA HELICASE#0.9434;HEMORRHAGE#0.9426;CELLULAR LOCALIZATION#0.9425;RIBOSOME BIOGENESIS#0.9423;ENZYME INHIBITOR#0.9422;NEUTROPENIA#0.9422;RIBOSOME#0.9417;METASTATIC PROSTATE CANCER#0.9417;NEUROTOXIC#0.9416;ATP FORMATION#0.9409;MITOTIC SPINDLE#0.9396;MYOBLAST#0.9395;IMATINIB#0.9394;MANTLE CELL LYMPHOMA#0.9392;MITOCHONDRION#0.9391;CELL CYCLE PHASE#0.9389;SODIUM NITROPRUSSIDE#0.9387;LIVER DISEASE#0.9386;CHRONIC MYELOID LEUKEMIA#0.9379;THROMBOCYTOPENIA#0.9377;NEURON DEATH#0.9377;HUMAN IMMUNODEFICIENCY VIRUS#0.9366;CANCER RELATED DEATH#0.9364;MITOCHONDRIAL TRANSLOCATION#0.9356;L-ARGININE#0.9354;CYTOCHROME P450#0.9348;REGULATION OF CELLULAR#0.9346;BERBERINE#0.9346;HYDROXYUREA#0.9345;ACTIVATION OF NF-KAPPAB#0.9337;SOFT TISSUE SARCOMA#0.9336;ADIPOCYTE#0.9335;TRANSIENT RECEPTOR POTENTIAL#0.9328;HOMOLOGY-DIRECTED REPAIR#0.9327;HEMORRHAGIC#0.9325;ENHANCER BINDING#0.9322;CELL NUCLEUS#0.9320;FRAGMENT LENGTH POLYMORPHISM#0.9317;INHIBITION OF CELL GROWTH#0.9314;EXTERNALIZATION OF PHOSPHATIDYLSERINE#0.9305;PANCREATIC ISLET#0.9304;CREATINE KINASE#0.9302;CHROMATIN MODIFICATION#0.9299;GLUCOSE REGULATED PROTEIN#0.9298;MULTIPLE SCLEROSIS#0.9288;SWELLING#0.9273;ANTIOXIDANT ACTIVITY#0.9269;VIRAL INFECTION#0.9268;CELL ACTIVATION#0.9259;OSTEOBLAST#0.9246;INSULIN SECRETION#0.9245;INNATE IMMUNE RESPONSE#0.9234;RENAL CELL CARCINOMA#0.9224;B LYMPHOCYTE#0.9213;RECEPTOR AGONIST#0.9212;CREATINE#0.9209;SMOOTH MUSCLE ACTIN#0.9204;CHROMATIN REMODELLING#0.9204;DOSE LIMITING TOXICITIES#0.9200;RIBOSOMAL PROTEIN#0.9196;ENDOTHELIAL NITRIC OXIDE#0.9190;DNA CONDENSATION#0.9190;PROTEIN DEGRADATION#0.9189;ADENOSINE MONOPHOSPHATE#0.9174;ADP-RIBOSE BINDING#0.9173;NERVE GROWTH FACTOR#0.9167;DNA POLYMERASE ALPHA#0.9164;MYELOID CELL LEUKEMIA#0.9162;FLUORESCEIN#0.9161;INDOLE#0.9158;MAMMARY EPITHELIAL CELL#0.9153;LINES OF EVIDENCE#0.9148;PEROXYNITRITE DECOMPOSITION CATALYST#0.9143;PERIPHERAL NERVE#0.9142;ANOIKIS#0.9142;ASCITES#0.9136;ACTIVATED T-CELLS#0.9133;MESENCHYMAL STEM CELL#0.9133;X CHROMOSOME#0.9132;ACTIVATED T CELL#0.9130;MYELODYSPLASTIC SYNDROME#0.9123;DISEASE FREE SURVIVAL#0.9121;DNA INTEGRATION#0.9117;FATTY LIVER#0.9114;SPERMATOCYTES#0.9111;LAPATINIB#0.9111;TELOMERE MAINTENANCE#0.9111;BLOOD VESSEL#0.9102;PHOSPHOLIPASE C#0.9095;DOPAMINERGIC NEURON#0.9088;MUTAGENIC#0.9088;DNA DEMETHYLATION#0.9086;MICROVASCULAR ENDOTHELIAL CELL#0.9086;NAD SYNTHESIS#0.9075;LYSOSOME#0.9074;PHOSPHOLIPASE A2#0.9072;HEPATITIS B#0.9072;TETRACYCLINE#0.9067;ASPARTIC ACID#0.9065;HUMAN BRONCHIAL EPITHELIAL#0.9065;CELLULAR METABOLIC#0.9063;ERLOTINIB#0.9052;OBJECTIVE RESPONSE RATE#0.9052;MEMORY IMPAIRMENT#0.9051;GLUTAMINE#0.9051;TELOMERASE REVERSE TRANSCRIPTASE#0.9050;ENHANCER BINDING PROTEIN#0.9049;MENADIONE#0.9047;PROTEIN ADP RIBOSYLATION#0.9046;CERVIX#0.9039;T-CELL LEUKEMIA#0.9039;FORMALIN#0.9035;FOCAL ADHESION#0.9024;SUBSTANTIA NIGRA#0.9023;NITROPRUSSIDE#0.9017;NON-SMALL CELL LUNG CARCINOMA#0.9010;RNA SYNTHESIS#0.9005;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8998;MOUSE EMBRYONIC STEM#0.8993;OSTEOCLAST#0.8990;BRONCHIAL EPITHELIAL CELLS#0.8989;EPIGALLOCATECHIN#0.8980;FLOW CYTOMETRY ASSAY#0.8973;ISOQUINOLINE#0.8964;AUTOPHAGOSOME FORMATION#0.8963;LIVER DAMAGE#0.8962;CYCLOSPORIN A#0.8962;ARSENIC TRIOXIDE#0.8960;S-PHASE CHECKPOINT#0.8955;HYPOGLYCEMIA#0.8951;XERODERMA PIGMENTOSUM#0.8951;SKIN FIBROBLASTS#0.8945;GENISTEIN#0.8938;POSITRON EMISSION TOMOGRAPHY#0.8935;LYSIS#0.8935;CELECOXIB#0.8934;ENDOMETRIAL CARCINOMA#0.8933;CYTOKINE PRODUCTION#0.8931;ASCORBATE#0.8930;ESOPHAGEAL CANCER#0.8930;NEUROLOGICAL DISORDER#0.8926;PROTEIN PHOSPHORYLATION#0.8923;REGULATION OF CELL CYCLE#0.8918;MICRONUCLEUS#0.8918;OSTEOSARCOMA CELL LINES#0.8916;HISTONE ACETYLTRANSFERASE#0.8913;VACUOLE#0.8913;NEURAL STEM CELL#0.8908;TROPHOBLAST#0.8900;LEUCINE#0.8887;NIACIN#0.8887;ATP BINDING#0.8879;METAPHASE#0.8865;DIMETHYL SULFOXIDE#0.8858;RESPIRATORY CHAIN#0.8854;FACTOR I#0.8846;ENCEPHALOMYELITIS#0.8839;CAROTID ARTERY#0.8831;GM-CSF#0.8823;BREAST CANCER MODEL#0.8812;EXECUTION PHASE OF APOPTOSIS#0.8808;GLUTAMATE RECEPTOR#0.8805;PANCREATIC ADENOCARCINOMA#0.8798;ALLERGIC AIRWAY INFLAMMATION#0.8780;LONG TERM MEMORY#0.8771;OXIDATIVE METABOLISM#0.8770;ASPHYXIA#0.8749;LATERAL SCLEROSIS#0.8736;PLURIPOTENT STEM CELL#0.8734;ANCHORAGE INDEPENDENT GROWTH#0.8728;METHIONINE#0.8722;HISTONE METHYLTRANSFERASE#0.8721;NUCLEOPLASM#0.8721;TOPICAL#0.8718;PLASMA MEMBRANE INTEGRITY#0.8718;GRANULOSA CELL#0.8716;MOLAR#0.8696;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8691;ANTI HER2#0.8689;CELLULAR HOMEOSTASIS#0.8689;HEPATIC STELLATE CELL#0.8688;MICROGLIAL CELL#0.8686;EUKARYOTIC INITIATION FACTOR#0.8685;CASPASE-9 ACTIVITY#0.8683;ARACHIDONIC ACID#0.8679;CRYSTAL VIOLET#0.8678;INVASIVE BREAST CANCER#0.8673;KIDNEY DISEASE#0.8666;FAMILIAL BREAST CANCER#0.8660;NAD SALVAGE#0.8656;DENTATE GYRUS#0.8651;ENZALUTAMIDE#0.8649;INTESTINAL EPITHELIAL CELL#0.8648;DIARRHEA#0.8646;SINGLE CELL GEL#0.8641;OUTER MEMBRANE#0.8640;MESOTHELIOMA CELL#0.8639;BAFILOMYCIN A1#0.8635;JNK SIGNALING PATHWAY#0.8629;VALPROIC ACID#0.8620;REPLICATION PROTEIN A#0.8618;HEPATITIS B VIRUS#0.8616;PHOSPHATASE AND TENSIN HOMOLOG#0.8613;RHABDOMYOSARCOMA#0.8611;VITAMIN E#0.8610;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.8600;LIPID METABOLISM#0.8593;LUNG EPITHELIAL CELL#0.8589;ALL TRANS RETINOIC ACID#0.8584;PROSTATE SPECIFIC ANTIGEN#0.8582;HISTONE H3 ACETYLATION#0.8577;FLAP ENDONUCLEASE#0.8569;MITOXANTRONE#0.8568;CHOLANGIOCARCINOMA#0.8567;VIRAL REPLICATION#0.8566;NUCLEASE ACTIVITY#0.8564;AMYOTROPHIC LATERAL SCLEROSIS#0.8552;TRABECTEDIN#0.8551;ADVANCED GLYCATION END#0.8550;VITAMIN D RECEPTOR#0.8544;CYCLOSPORINE#0.8544;ESTROGEN RECEPTOR ALPHA#0.8542;RESPONSE TO RADIATION#0.8542;MESANGIAL CELL#0.8534;TRANSCRIPTIONAL CONTROL#0.8531;SCHWANN CELL#0.8529;LINEAR ENERGY TRANSFER#0.8529;DETOXIFICATION#0.8524;CYTOTOXIN#0.8514;PHEOCHROMOCYTOMA#0.8512;NUCLEOSOME BINDING#0.8512;VP-16#0.8507;17β-ESTRADIOL#0.8500;SUMOYLATION#0.8494;REACTIVE NITROGEN SPECIES#0.8486;GEFITINIB#0.8483;BREAST ADENOCARCINOMA#0.8482;BLOOD UREA NITROGEN#0.8479;MELANOCYTE#0.8478;ELECTRON TRANSPORT CHAIN#0.8476;VINCRISTINE#0.8473;MUTAGEN#0.8471;NOS INHIBITOR#0.8468;NAD BIOSYNTHESIS#0.8456;LOW DENSITY LIPOPROTEIN#0.8450;DNA EXCISION#0.8444;NUCLEAR EXPORT#0.8441;CELL MOTILITY#0.8429;COCKAYNE SYNDROME#0.8422;LIVER REGENERATION#0.8422;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8416;FOCAL ADHESION KINASE#0.8410;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8409;ASCORBIC ACID#0.8405;PI3K SIGNALING#0.8404;FATTY LIVER DISEASE#0.8402;MITOTIC CHECKPOINT#0.8401;HEMATOPOIETIC CELL#0.8384;INFLAMMATORY BOWEL DISEASE#0.8381;SMALL INTESTINE#0.8381;EARLY BREAST CANCER#0.8381;FRONTAL#0.8380;INTRACELLULAR SIGNALING PATHWAY#0.8376;NEUROGENESIS#0.8365;ASPIRIN#0.8359;SIGNALLING CASCADE#0.8356;LYMPHOBLASTOID CELLS#0.8354;CASPASE-8 ACTIVITY#0.8352;SUNITINIB#0.8351;MITOCHONDRIAL CELL DEATH#0.8344;OOCYTE#0.8341;MITOCHONDRIAL MEMBRANE PERMEABILITY#0.8339;THEOPHYLLINE#0.8336;INDUCED PLURIPOTENT STEM CELL#0.8319;MAGNETIC RESONANCE IMAGING#0.8318;LYMPH NODE METASTASIS#0.8308;URACIL#0.8307;CALPAIN ACTIVITY#0.8305;MAMMARY GLAND#0.8298;PALMITATE#0.8292;DAUNORUBICIN#0.8290;LITHIUM#0.8290;EXCRETION#0.8283;BONE MARROW STROMAL CELL#0.8281;MARROW STROMAL CELLS#0.8280;EOSIN#0.8278;BONE MARROW STROMAL#0.8277;TRYPTOPHAN#0.8251;ONCOGENESIS#0.8235;METHAMPHETAMINE#0.8232;PRIMARY CORTICAL NEURON#0.8230;ACIDIFICATION#0.8229;HEPATOCYTE APOPTOSIS#0.8229;CREB BINDING#0.8224;BRAIN EDEMA#0.8222;PKCDELTA#0.8221;OSTEOARTHRITIS#0.8219;P38 MAPK SIGNALING#0.8216;RNA PROCESSING#0.8215;RNA HELICASE#0.8212;HYPERGLYCEMIC#0.8210;THORACIC AORTA#0.8204;COLON ADENOCARCINOMA#0.8196;ADIPOGENESIS#0.8187;CIRCADIAN RHYTHM#0.8179;CENTROMERE#0.8177;CYCLOSPORIN#0.8175;GUANINE#0.8174;GLUTAMIC ACID#0.8167;BONE MARROW CELLS#0.8166;MAINTENANCE OF GENOME INTEGRITY#0.8166;ACTIN CYTOSKELETON#0.8163;SALIVARY GLAND#0.8155;CELLULAR GROWTH#0.8150;NITRO-L-ARGININE#0.8141;MITOPHAGY#0.8137;DEACETYLASE ACTIVITY#0.8125;MEDULLOBLASTOMA#0.8124;ACT D#0.8123;2'-DEOXYURIDINE#0.8114;PYRAMIDAL CELL#0.8113;RETINAL DEGENERATION#0.8112;RENAL ISCHEMIA REPERFUSION#0.8104;PODOCYTE#0.8096;ZINC BINDING#0.8091;EMBRYONIC KIDNEY#0.8087;TRANSLATION INITIATION#0.8084;MITOCHONDRIAL ELECTRON TRANSPORT#0.8083;LYMPHOMA CELL LINES#0.8067;XANTHINE#0.8063;APOPTOTIC PROGRAM#0.8058;PLASMA CELL#0.8054;CELL DEVELOPMENT#0.8049;XANTHINE OXIDASE#0.8046;2'-DEOXYCYTIDINE#0.8035;VOMITING#0.8023;RETINAL GANGLION CELL#0.8016;RETINAL DAMAGE#0.8015;VASCULAR DISEASE#0.8015;TISSUE HOMEOSTASIS#0.8006;PROTEIN TYROSINE KINASE#0.8003;MENINGITIS#0.8002;ACETAMIDE#0.7999;MITOCHONDRIAL RESPIRATORY CHAIN#0.7984;LOCALISATION#0.7983;RENAL CARCINOMA#0.7982;CD8+ T CELL#0.7979;GENETICALLY ENGINEERED MOUSE#0.7973;PROTEASOME PATHWAY#0.7971;DNA RECOMBINATION#0.7952;ANAPLASTIC THYROID CARCINOMA#0.7942;P53 BINDING#0.7942;VITAMIN C#0.7930;DACARBAZINE#0.7915;CYTOKINESIS#0.7912;HUNTINGTON'S DISEASE#0.7899;FOLATE#0.7897;CORONARY ARTERY DISEASE#0.7897;OBESE#0.7896;ARTERY DISEASE#0.7895;DIABETIC PERIPHERAL NEUROPATHY#0.7893;WNT SIGNALING PATHWAY#0.7892;DOMINANT NEGATIVE MUTANT#0.7889;HEART DISEASE#0.7887;PULMONARY FIBROSIS#0.7883;5-AZA-2'-DEOXYCYTIDINE#0.7879;CARDIOVASCULAR SYSTEM#0.7875;YEAR SURVIVAL RATE#0.7873;PHOSPHATASE 2A#0.7872;CELLULAR NECROSIS#0.7872;PXD101#0.7871;PROTEIN TYROSINE PHOSPHATASE#0.7860;POST-TRANSLATIONAL PROTEIN MODIFICATION#0.7856;ION CHANNEL#0.7844;INHIBITION OF GLYCOLYSIS#0.7838;CHROMATIN BINDING#0.7825;MITOCHONDRIAL OUTER MEMBRANE#0.7825;ER STRESS-INDUCED APOPTOSIS#0.7801;P53 SIGNALING PATHWAY#0.7799;TOXICANT#0.7787;EVEROLIMUS#0.7780;CONTROLLED CORTICAL IMPACT#0.7777;RETINAL DISEASE#0.7772;DNA REPAIR SYNTHESIS#0.7770;HERPES SIMPLEX#0.7757;CYTIDINE DEAMINASE#0.7756;CONJUGATION#0.7755;COPY NUMBER ALTERATION#0.7755;NEURAL CELL#0.7755;DEMENTIA#0.7754;INDUCES CANCER#0.7752;AUTOPHAGIC VACUOLE#0.7751;LUNG FIBROBLASTS#0.7741;PROTEIN KINASE A#0.7740;MOLECULAR FUNCTION#0.7735;ABIRATERONE#0.7722;DNASE I#0.7715;PERIODONTITIS#0.7715;CYTIDINE#0.7713;MEDIAN OVERALL SURVIVAL#0.7710;RESONANCE ENERGY TRANSFER#0.7706;ENERGY HOMEOSTASIS#0.7702;ACUTE PROMYELOCYTIC LEUKEMIA#0.7702;PROTEIN PHOSPHATASE 2A#0.7698;17-DMAG#0.7694;QUANTITATIVE REVERSE TRANSCRIPTION#0.7692;CERVICAL CANCER CELL LINES#0.7686;ADENOSINE PHOSPHATE#0.7682;TESTOSTERONE#0.7680;ENDONUCLEASE ACTIVITY#0.7678;CARRIE#0.7678;PIPERAZIN#0.7666;INFERTILITY#0.7666;INDOMETHACIN#0.7664;MAST CELL#0.7662;NAD SALVAGE PATHWAY#0.7662;FACTOR INHIBITING HIF#0.7660;C-LEVEL#0.7657;GERMINAL CELLS#0.7655;CASPASE-1 ACTIVITY#0.7654;RNA METABOLISM#0.7650;NF-KAPPAB INHIBITOR#0.7646;PROSTATE EPITHELIAL CELL#0.7646;CORTICAL CELL#0.7644;CLEAR CELL CARCINOMA#0.7641;ATP SYNTHESIS#0.7637;ACETAMINOPHEN#0.7634;HEXANE#0.7629;CONSTRICTION#0.7606;PROGRAMMED NECROTIC CELL DEATH#0.7605;DUAL LUCIFERASE REPORTER#0.7602;MALE INFERTILITY#0.7595;MORRIS WATER MAZE#0.7592;SUCCINATE#0.7580;HODGKIN'S LYMPHOMA#0.7579;REPLICATION FORK PROTECTION#0.7578;SKIN DISEASE#0.7574;20S PROTEASOME#0.7574;TYPE 2 DIABETIC#0.7568;ATPASE ACTIVITY#0.7567;PROSTAGLANDIN E2#0.7563;HEMATOPOIETIC STEM CELL#0.7557;MALIGNANT PLEURAL MESOTHELIOMA#0.7557;OXIDATIVE DNA LESIONS#0.7553;TELOMERIC REPEAT BINDING#0.7551;OLEIC ACID#0.7543;HEAT SHOCK FACTOR#0.7543;NICOTINAMIDE MONONUCLEOTIDE#0.7539;GENOTOXINS#0.7535;CELLULAR DNA DAMAGE RESPONSE#0.7532;FLUDARABINE#0.7521;ACINAR CELL#0.7521;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7512;EPITHELIAL TO MESENCHYMAL#0.7511;MOLECULAR DYNAMICS SIMULATION#0.7503;AMYLOID PRECURSOR PROTEIN#0.7491;INDUCED RENAL INJURY#0.7482;ACUTE LEUKEMIA#0.7482;T CELL APOPTOSIS#0.7452;INSULIN RECEPTOR#0.7448;TYPE 2 DIABETES MELLITUS#0.7444;2 DIABETES MELLITUS#0.7444;QUINOLINIC ACID#0.7439;HIGH THROUGHPUT SCREEN#0.7438;BENZOIC ACID#0.7433;METHOTREXATE#0.7417;MYOTUBE#0.7405;TRANSLATION INITIATION FACTOR#0.7398;VASODILATION#0.7397;NORMAL BREAST TISSUE#0.7397;LUCIFERASE ACTIVITY#0.7393;DIFFUSE LARGE B-CELL LYMPHOMA#0.7393;ENDOTHELIAL PROGENITOR CELL#0.7385;BILE DUCT#0.7379;HERPES SIMPLEX VIRUS#0.7378;ATP BINDING CASSETTE#0.7365;CALCIUM CHANNEL#0.7364;FIBROSARCOMA#0.7360;GLUCOSE METABOLISM#0.7358;RECEPTOR LIGAND#0.7356;MESOTHELIAL CELL#0.7348;RENAL FIBROSIS#0.7340;GRANULOCYTE#0.7339;RIBOSOMAL RNA#0.7332;FATTY ACID SYNTHASE#0.7317;NATIONAL CANCER INSTITUTE#0.7312;FRUCTOSE#0.7310;TERMINAL DIFFERENTIATION#0.7310;SERTOLI CELL#0.7308;PROTEIN ACETYLATION#0.7297;VIRULENCE#0.7294;ACUTE MYOCARDIAL INFARCTION#0.7290;GELDANAMYCIN#0.7285;PEROXISOME#0.7281;PROTEIN DEACETYLASE#0.7271;HISTONE CHAPERONE#0.7266;FLAVOPIRIDOL#0.7265;VASCULAR ENDOTHELIUM#0.7263;TUBULAR EPITHELIAL CELL#0.7253;SPERMATOZOA#0.7249;LUNG DISEASE#0.7248;GRAVES' DISEASE#0.7238;CHEMOKINE RECEPTOR#0.7238;CHINESE HERBAL MEDICINE#0.7233;GAP ACTIVITY#0.7231;HISTONE DEMETHYLASE#0.7228;TRANSCRIPTION ACTIVATOR#0.7226;TOCOPHEROL#0.7224;MALIGNANT MESOTHELIOMA#0.7222;TRANSFORMING GROWTH FACTOR BETA#0.7221;SPECTRIN#0.7220;GERM CELL TUMORS#0.7219;BURKITT LYMPHOMA#0.7219;TCA CYCLE#0.7211;ALKALINE PHOSPHATASE#0.7210;CACHEXIA#0.7209;SPINDLE ASSEMBLY#0.7201;LECTIN#0.7199;POLYCYCLIC AROMATIC HYDROCARBON#0.7192;RESPONSE TO TNF#0.7189;COMPARATIVE GENOMIC HYBRIDIZATION#0.7186;ACTIVATED B CELL#0.7184;1α,25-DIHYDROXYVITAMIN D3#0.7183;ACTIVATION OF DNA REPAIR#0.7179;MOUSE EMBRYO FIBROBLASTS#0.7172;INTERPHASE#0.7158;REGULATED NECROSIS#0.7158;RESPONSE TO BLEOMYCIN#0.7148;PERICENTRIC HETEROCHROMATIN#0.7148;EMODIN#0.7135;EPITHELIAL OVARIAN CARCINOMA#0.7127;PLATELET AGGREGATION#0.7120;CHOLINE#0.7119;REPLICATIVE SENESCENCE#0.7106;HUMAN GASTRIC CARCINOMA#0.7099;HUMAN EMBRYONIC KIDNEY#0.7088;ISOPROTERENOL#0.7083;CIRCULATING TUMOR CELL#0.7070;PERTUZUMAB#0.7064;NATURAL KILLER CELL#0.7062;GESTATION#0.7052;FOREBRAIN#0.7047;DEATH-INDUCING SIGNALING COMPLEX#0.7044;PYROPTOSIS#0.7044;CELLULAR OXIDATIVE STRESS#0.7034;ETHYL ACETATE EXTRACT#0.7030;LOW DOSE RATE#0.7030;CHONDROSARCOMA#0.7029;ENDOMETRIOID ENDOMETRIAL CANCER#0.7018;GLUCOSE UPTAKE#0.7016;V-D-J RECOMBINATION#0.7006;ANAEMIA#0.7003;METHYLTRANSFERASE ACTIVITY#0.6991;HIGH RESOLUTION MELTING#0.6988;IONOPHORE#0.6985;ANAPHASE#0.6983;TYPE 1 DIABETIC#0.6973;BODY WEIGHT LOSS#0.6968;ANTI EGFR#0.6964;RENAL CANCER CELLS#0.6963;THYMIDYLATE SYNTHASE#0.6959;COLLAGEN INDUCED ARTHRITIS#0.6958;ALCOHOLIC FATTY LIVER#0.6955;PROMOTER BINDING#0.6947;CYTARABINE#0.6943;THYMOCYTE APOPTOSIS#0.6942;CATION CHANNEL#0.6938;CELL EXPANSION#0.6933;ADJUSTED ODDS RATIO#0.6926;REGULATION OF CELL DEATH#0.6926;BETA GALACTOSIDASE#0.6921;HYPERPHOSPHORYLATION#0.6920;PICEATANNOL#0.6917;HEPATOCYTE GROWTH FACTOR#0.6912;STROMA#0.6908;COMPOUND 6#0.6904;MYOFIBROBLAST#0.6903;CARCINOGENICITY#0.6903;TIGHT JUNCTION#0.6900;RANDOMIZED CONTROLLED TRIAL#0.6892;GLUCOCORTICOID RECEPTOR#0.6891;MOLECULAR TARGETED THERAPY#0.6891;HEPATITIS C#0.6888;OVARIAN SURFACE EPITHELIAL#0.6885;EXONUCLEASE ACTIVITY#0.6880;THYMIDINE KINASE#0.6875;CARCINOMA IN SITU#0.6874;RESPONSE TO STRESS#0.6873;EPILEPSY#0.6867;LEFT ANTERIOR DESCENDING#0.6852;CLASS SWITCH RECOMBINATION#0.6850;MESENCHYMAL CELL#0.6847;ANTHRACENE#0.6846;TERATOCARCINOMA#0.6842;LYMPHOPENIA#0.6841;DNA COPY NUMBER#0.6838;ALLERGEN#0.6832;UBIQUITIN PROTEASOME PATHWAY#0.6825;LYMPHOBLAST#0.6812;INTRACELLULAR LOCALIZATION#0.6802;SYNAPSIS#0.6801;TO THE PROGRESSION#0.6799;HIGH RISK NEUROBLASTOMA#0.6792;CYCLOPHILIN#0.6789;SYSTEMIC INFLAMMATORY RESPONSE#0.6787;CAMP RESPONSE ELEMENT#0.6782;ENDOTHELIAL CELL PROLIFERATION#0.6781;CHROMOSOME SEGREGATION#0.6776;HYPERACTIVITY#0.6775;TUMOR GROWTH DELAY#0.6773;ACUTE RENAL INJURY#0.6772;DILATED CARDIOMYOPATHY#0.6767;IRON OVERLOAD#0.6765;CHROMATIN ORGANIZATION#0.6743;BRAIN CANCER#0.6739;ENDOMETRIAL ADENOCARCINOMA#0.6738;CANCER STEM-LIKE CELL#0.6730;INHIBITION OF ANGIOGENESIS#0.6725;VIRAL DNA REPLICATION#0.6720;C REACTIVE PROTEIN#0.6712;INTRACELLULAR ORGANELLE#0.6711;ASTROCYTE ACTIVATION#0.6702;KAPOSI'S SARCOMA#0.6694;CEREBRAL INFARCTION#0.6693;DIET INDUCED OBESITY#0.6692;DEATH RECEPTOR 4#0.6686;2-CDA#0.6681;OVERALL RESPONSE RATE#0.6680;MAGNETIC RESONANCE SPECTROSCOPY#0.6679;HAIR CELL#0.6674;UVEAL MELANOMA#0.6673;URINARY BLADDER#0.6669;PHOSPHATE BUFFERED SALINE#0.6668;ARYL HYDROCARBON RECEPTOR#0.6666;NERVE FIBER#0.6666;DUCTAL CARCINOMA IN SITU#0.6664;CHEMOKINE PRODUCTION#0.6662;ANTI INFLAMMATORY DRUGS#0.6657;DNA LIGATION#0.6655;PRECURSOR CELL#0.6655;RECEPTOR ACTIVATOR#0.6655;INHIBITION OF BER#0.6651;HISTAMINE#0.6647;APOPTOSOME#0.6641;T CELL PROLIFERATION#0.6639;OVARIES#0.6633;INTEGRIN LINKED KINASE#0.6632;CYTOTOXIC T-LYMPHOCYTE#0.6632;WEIGHT GAIN#0.6626;DERMAL FIBROBLAST#0.6619;HIGH RISK PATIENTS#0.6618;LEYDIG CELL#0.6616;INHIBITION OF GROWTH#0.6615;ADVANCED PANCREATIC CANCER#0.6609;CYCLE INHIBITOR P21#0.6607;SPHINGOSINE#0.6606;IL-10 PRODUCTION#0.6601;PROTEIN UBIQUITINATION#0.6588;TREG CELL#0.6586;PLATIN#0.6584;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.6580;AGE AT DIAGNOSIS#0.6573;ABT-263#0.6571;ANDROGEN DEPRIVATION THERAPY#0.6545;HISTIDINE#0.6537;SUCROSE#0.6536;UBIQUITIN PROTEASOME SYSTEM#0.6528;BLADDER CARCINOMA#0.6526;CALCIUM SIGNALING#0.6526;MUTAGENICITY#0.6524;INFLAMMATORY CELL INFILTRATION#0.6524;CAMP RESPONSE ELEMENT BINDING#0.6514;INHIBITION OF PHOSPHORYLATION#0.6511;NUCLEOID#0.6509;MITOCHONDRIAL FUSION#0.6508;DNA POLYMERASE ACTIVITY#0.6507;PAPILLOMA#0.6506;NON HODGKIN LYMPHOMA#0.6502;AMPK ACTIVITY#0.6498;MIXED LINEAGE KINASE#0.6490;CIS-DIAMMINEDICHLOROPLATINUM#0.6489;SKELETON#0.6484;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6475;VEMURAFENIB#0.6466;NEURITE#0.6463;STATUS EPILEPTICUS#0.6463;SEQUENCE SPECIFIC DNA BINDING#0.6461;PATHOLOGICAL COMPLETE RESPONSE#0.6454;REGULATION OF AUTOPHAGY#0.6452;OSTEOCLAST DIFFERENTIATION#0.6443;REGULATION OF MRNA#0.6442;CEREBELLAR GRANULE NEURON#0.6440;CELL PHYSIOLOGY#0.6439;MITOCHONDRIAL FISSION#0.6436;TNF-ALPHA PRODUCTION#0.6435;FDURD#0.6434;NEUROTOXIN#0.6429;TRANSMISSION ELECTRON MICROSCOPE#0.6427;MYELOPROLIFERATIVE NEOPLASM#0.6420;MUSCLE FIBER#0.6407;PANCREATIC CARCINOMA#0.6406;XERODERMA PIGMENTOSUM GROUP A#0.6399;CELL MATURATION#0.6394;PYKNOSIS#0.6392;ADJACENT NORMAL TISSUE#0.6387;REPORTER GENE ASSAY#0.6381;DEOXYADENOSINE#0.6373;ESOPHAGUS#0.6365;SPECIFICITY PROTEIN 1#0.6364;CETUXIMAB#0.6360;OTOTOXICITY#0.6357;DEATH RECEPTOR-MEDIATED APOPTOSIS#0.6354;FLUORO JADE B#0.6351;CONNECTIVE TISSUE#0.6345;CHROMATINOLYSIS#0.6343;RITUXIMAB#0.6342;HEPATITIS C VIRUS#0.6341;LEWIS LUNG CARCINOMA#0.6321;RESPONSE TO UV#0.6312;DEFEROXAMINE#0.6307;GASTRIC ADENOCARCINOMA#0.6291;PROTEIN KINASE INHIBITOR#0.6291;MITOTIC ENTRY#0.6278;THYMIDYLATE#0.6278;CHROMATIN ASSEMBLY#0.6276;ENDOTHELIAL CELL APOPTOSIS#0.6274;PROTEIN FOLDING#0.6269;PERICYTE#0.6269;URIDINE#0.6262;DNA TOPOISOMERASE II#0.6259;EXTRACELLULAR REGULATED KINASE#0.6251;MTOR COMPLEX#0.6239;PIPERAZINE#0.6238;PHAGOCYTOSIS#0.6233;LOW DOSE RADIATION#0.6232;OXIDATIVE STRESS RESPONSE#0.6231;CALCINEURIN#0.6229;GLYCINE#0.6227;CELL FRACTION#0.6225;AIRWAY EPITHELIAL CELL#0.6213;NEUROENDOCRINE TUMOR#0.6210;ATORVASTATIN#0.6207;SERUM ALBUMIN#0.6202;PROPRANOLOL#0.6199;NF KAPPAB BINDING#0.6198;NEPHRITIS#0.6197;GANGLION CELLS#0.6193;INFLUENZA A VIRUS#0.6192;HEMATOPOIESIS#0.6185;T CELL DIFFERENTIATION#0.6180;ACTIN FILAMENT#0.6173;T CELL ACTIVATION#0.6167;CLINICAL BENEFIT RATE#0.6167;RESPONSE TO ACETYLCHOLINE#0.6160;HEMORRHAGIC CYSTITIS#0.6157;STEM CELL TRANSPLANTATION#0.6156;HOST-PATHOGEN INTERACTION#0.6154;SWISS ALBINO MICE#0.6137;GENTAMICIN#0.6136;NITRIC-OXIDE SYNTHASE INHIBITOR#0.6129;CELL CYCLE MODULATION#0.6127;SITE OF DNA DAMAGE#0.6123;METHYLATION SPECIFIC PCR#0.6104;STREPTOZOCIN#0.6101;LONG TERM POTENTIATION#0.6085;OPTIC NERVE#0.6085;ACUTE ISCHEMIC STROKE#0.6082;THIOREDOXIN REDUCTASE 1#0.6079;BASAL CELL#0.6073;FOLIC ACID#0.6069;SPHINGOSINE 1 PHOSPHATE#0.6067;HISTONE METHYLTRANSFERASE ACTIVITY#0.6062;STEM CELL MARKER#0.6061;ACTIVATION OF NMDA RECEPTOR#0.6061;DNA ALKYLATION#0.6060;ASTROCYTOMA#0.6059;BLOOD GLUCOSE LEVEL#0.6048;LYMPHOID CELL#0.6039;HUMAN CERVICAL CARCINOMA#0.6031;OVARIAN SURFACE EPITHELIAL CELL#0.6027;OVARIAN CLEAR CELL CARCINOMA#0.6023;COLCHICINE#0.6022;MITOCHONDRIAL ELECTRON TRANSPORT CHAIN#0.6022;ELONGATION FACTOR 1ALPHA#0.6017;NIJMEGEN BREAKAGE SYNDROME#0.6010
143098	CELL POLARITY#0.6953;TIGHT JUNCTION FORMATION#0.6921;MAGUK#0.6913;TIGHT JUNCTION#0.6557;BONE MINERAL DENSITY#0.6547
143162	EPITHELIAL CELL#0.7928;TIGHT JUNCTION#0.7282;PERIPHERAL MEMBRANE PROTEIN#0.7059;LEUCINE RICH REPEAT#0.6863;NMDA RECEPTOR#0.6794
143187	SNARE COMPLEX#1.0327;SYNAPTIC VESICLE#0.9341;N-ETHYLMALEIMIDE#0.8457;TRANS GOLGI NETWORK#0.8160;ENDOSOME#0.7905;COLORECTAL CANCER#0.7864;COLORECTAL#0.7582;PLASMA MEMBRANE#0.6973;MEMBRANE FUSION#0.6611;NEUROTRANSMITTER RELEASE#0.6419;DENSE CORE VESICLE#0.6358;RNA INTERFERENCE#0.6347;SECRETORY VESICLE#0.6293;LUNG CANCER#0.6142
1431	CARNITINE PALMITOYL TRANSFERASE#1.0486;6 PHOSPHOFRUCTOKINASE#1.0467;ACONITATE HYDRATASE#1.0410;CITRATE SYNTHASE ACTIVITY#1.0359;ACYL COA DEHYDROGENASE#1.0358;GLYCOGEN PHOSPHORYLASE#1.0352;FUMARATE HYDRATASE#1.0350;GLUTAMATE DEHYDROGENASE#1.0285;ALPHA GLUCOSIDASE#1.0264;CYTOCHROME C OXIDASE ACTIVITY#1.0254;MALATE DEHYDROGENASE#1.0241;GLYCERALDEHYDE-3-PHOSPHATE#1.0227;ATP SYNTHASE#1.0225;PYRUVATE CARBOXYLASE#1.0219;OUTER MEMBRANE#1.0212;SUCCINATE DEHYDROGENASE#1.0190;MITOCHONDRIAL MATRIX#1.0188;FATTY ACID SYNTHASE#1.0186;CYTOCHROME C OXIDASE#1.0181;DNA COPY NUMBER#1.0179;PEROXISOMAL#1.0176;PYRUVATE DEHYDROGENASE COMPLEX#1.0168;NICOTINAMIDE ADENINE DINUCLEOTIDE#1.0166;NADH DEHYDROGENASE#1.0156;PYRUVATE KINASE#1.0140;PHOSPHOENOLPYRUVATE CARBOXYKINASE#1.0137;MALIC ENZYME#1.0120;CITRIC ACID CYCLE#1.0115;RESPIRATORY CHAIN COMPLEX#1.0115;ADENYLATE KINASE#1.0115;DEHYDROGENASE COMPLEX#1.0100;CYTOCHROME C#1.0100;TCA CYCLE#1.0084;FUMARATE#1.0081;NICOTINAMIDE#1.0079;CREATINE KINASE#1.0077;LACTATE DEHYDROGENASE ACTIVITY#1.0077;DIAPHRAGM#1.0065;PALMITOYL#1.0064;GLUCOSE-6-PHOSPHATE#1.0059;MITOCHONDRIAL TRANSCRIPTION#1.0049;HEXOKINASE ACTIVITY#1.0047;NUCLEAR RESPIRATORY FACTOR#1.0041;RENATURATION#1.0035;KREBS CYCLE#1.0034;COENZYME A#1.0026;SUCCINATE#1.0016;CITRIC ACID#1.0001;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9998;CARNITINE#0.9989;MTDNA#0.9989;GLYOXYLATE CYCLE#0.9988;MITOCHONDRIAL INNER MEMBRANE#0.9984;PHOSPHOENOLPYRUVATE#0.9983;CEREBRAL CORTEX#0.9978;COMPLEX III#0.9964;ELECTRON TRANSFER#0.9959;STRIATUM#0.9959;ACETYL COA CARBOXYLASE#0.9958;CHAPERONE ACTIVITY#0.9952;CREATINE#0.9949;TRICARBOXYLIC ACID CYCLE#0.9944;ADENOSINE TRIPHOSPHATE#0.9943;PALMITATE#0.9928;FRAGMENT LENGTH POLYMORPHISM#0.9928;COMPLEX II#0.9922;PYRUVATE#0.9909;ADENINE#0.9908;ATP SYNTHESIS#0.9903;RESPIRATORY CHAIN#0.9900;FRUCTOSE#0.9899;ASPARTATE#0.9896;ELECTRON TRANSPORT CHAIN#0.9888;HEART MUSCLE#0.9886;SPOTTED FEVER#0.9881;QUADRICEPS#0.9876;COMPLEX I#0.9866;MITOCHONDRIAL RESPIRATORY CHAIN#0.9863;CARNITINE PALMITOYLTRANSFERASE I#0.9847;POLYMERASE CHAIN REACTION#0.9843;MITOCHONDRIAL DNA#0.9839;LIPOPROTEIN LIPASE#0.9833;ADENYLATE#0.9831;ELECTRON TRANSPORT#0.9828;GLUTAMINE#0.9827;MITOCHONDRIAL MEMBRANE#0.9812;FATTY ACID BINDING#0.9809;PEROXISOME#0.9805;MYOSIN HEAVY CHAIN#0.9801;MYOCARDIUM#0.9798;ENDOPLASMIC RETICULUM#0.9793;ATPASE ACTIVITY#0.9791;GLUTATHIONE PEROXIDASE#0.9785;ADENOSINE#0.9783;ALANINE#0.9773;COLD ACCLIMATION#0.9766;ADIPOCYTE#0.9766;RESPONSE TO EXERCISE#0.9758;CARDIAC MUSCLE#0.9747;RESPIRATION#0.9747;KINASE ACTIVITY#0.9745;PHOSPHOFRUCTOKINASE ACTIVITY#0.9744;GLYCOLYSIS#0.9738;SUPEROXIDE DISMUTASE#0.9738;HYPOXIA#0.9737;SMOOTH MUSCLE#0.9735;TRICEPS#0.9730;TRANSCRIPTION FACTOR#0.9729;FATTY ACID METABOLISM#0.9719;MUSCLE FIBRE#0.9719;CARDIOLIPIN#0.9711;OXIDATIVE METABOLISM#0.9709;HINDLIMB#0.9696;GLUTATHIONE#0.9696;LYSINE#0.9690;ADIPOSE TISSUE#0.9690;FATTY ACID OXIDATION#0.9686;CROSS SECTIONAL AREA#0.9685;WEIGHT LOSS#0.9682;MUSCLE ADAPTATION#0.9678;GLUCOSE METABOLISM#0.9676;CATABOLISM#0.9671;PROTEIN KINASE#0.9670;OXIDATIVE PHOSPHORYLATION#0.9667;GROWTH FACTOR#0.9656;OBESE#0.9653;HYPOXIC#0.9637;GLUCOSE UPTAKE#0.9637;MITOCHONDRIA#0.9632;ENZYME ACTIVITY#0.9620;NITRIC OXIDE#0.9614;MUSCLE FIBER#0.9614;HEAT SHOCK PROTEIN#0.9607;MITOCHONDRIAL ELECTRON TRANSPORT#0.9607;LIPID METABOLISM#0.9606;SUCROSE#0.9605;HIGH FAT DIET#0.9596;ETHANOL#0.9595;ISCHEMIA#0.9594;CARBOHYDRATE METABOLISM#0.9593;SARCOPLASMIC RETICULUM#0.9587;APOPTOSIS#0.9586;MUSCLE CELL#0.9577;CHOLINE#0.9576;ACETIC ACID#0.9574;PROTEIN SYNTHESIS#0.9568;NITRIC OXIDE SYNTHASE#0.9568;DIPHOSPHATE#0.9565;GENE EXPRESSION#0.9564;GLUCOSE TRANSPORT#0.9563;MYOTUBE#0.9560;ORGANELLE#0.9557;GLUCONEOGENESIS#0.9556;3 HYDROXYBUTYRATE DEHYDROGENASE#0.9551;CELL GROWTH#0.9549;REACTIVE OXYGEN SPECIES#0.9538;GLUTEUS MEDIUS#0.9536;TYPE 2 DIABETES#0.9534;TOXICITY#0.9532;ALDOSTERONE#0.9531;ARGININE#0.9527;WHITE ADIPOSE TISSUE#0.9526;SKELETAL MUSCLE#0.9518;PYRUVATE OXIDATION#0.9510;PROTEIN FOLDING#0.9507;CYTOPLASM#0.9489;MUTAGENESIS#0.9486;ACONITASE ACTIVITY#0.9456;ADENOSINE MONOPHOSPHATE#0.9453;GLUCOSE TOLERANCE TEST#0.9453;L-CARNITINE#0.9446;LIPID OXIDATION#0.9443;ENDOTHELIAL GROWTH FACTOR#0.9441;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9441;WEIGHT GAIN#0.9436;PENTOSE PHOSPHATE PATHWAY#0.9417;SIGNALING PATHWAY#0.9412;FATTY ACID SYNTHESIS#0.9398;MITOCHONDRIAL DAMAGE#0.9392;MYOPATHY#0.9384;MUSCLE ATROPHY#0.9375;FERMENTATION#0.9374;PERIPHERAL BLOOD#0.9372;SKELETAL MUSCLE ADAPTATION#0.9368;BROWN ADIPOSE TISSUE#0.9367;RESPIRATORY CHAIN COMPLEX I#0.9365;MITOCHONDRIAL ELECTRON TRANSPORT CHAIN#0.9351;L-TYROSINE#0.9341;CELL DEATH#0.9324;LEUCINE#0.9324;CARDIOMYOCYTE#0.9322;ARTERY#0.9315;MITOCHONDRIAL DISEASE#0.9306;ANION CHANNEL#0.9297;BODY WEIGHT RATIO#0.9296;ANAEROBIC GLYCOLYSIS#0.9274;REGENERATION#0.9266;CATALYTIC ACTIVITY#0.9264;APOPTOTIC#0.9252;MITOCHONDRION#0.9245;RESVERATROL#0.9228;CYTOCHROME OXIDASE ACTIVITY#0.9194;AEROBIC EXERCISE TRAINING#0.9164;DIABETES MELLITUS#0.9161;FATTY ACID TRANSLOCASE#0.9160;PHOSPHOGLYCERATE KINASE#0.9156;SUPEROXIDE DISMUTASE ACTIVITY#0.9151;LACTIC ACID#0.9138;SPINAL CORD#0.9130;URINARY BLADDER#0.9116;COA HYDROLASE#0.9111;QUANTITATIVE REAL TIME#0.9084;L LACTATE DEHYDROGENASE#0.9069;LYMPH NODE#0.9064;BETA GLUCURONIDASE#0.9063;CREATINE KINASE ACTIVITY#0.9053;MYOCARDIAL INFARCTION#0.9043;MONONUCLEAR CELLS#0.9030;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9019;MITOCHONDRIAL GENE EXPRESSION#0.9011;CATALASE ACTIVITY#0.9003;INTERGENIC SPACER REGION#0.8994;MACROPHAGE#0.8990;ACETYLCHOLINE#0.8983;EGG ACTIVATION#0.8981;MYOCYTES#0.8980;ACID PHOSPHATASE#0.8969;ORAL GLUCOSE TOLERANCE#0.8949;CHRONIC HEART FAILURE#0.8938;SUCCINATE DEHYDROGENASE COMPLEX#0.8915;MUSCLE CONTRACTION#0.8908;CARDIOMYOPATHY#0.8891;PYRUVATE DEHYDROGENASE KINASE#0.8884;MAGNETIC RESONANCE SPECTROSCOPY#0.8870;MYOBLAST#0.8846;CHAPERONIN#0.8834;GLYCOGENOLYSIS#0.8831;L-LYSINE#0.8826;MITOCHONDRIAL PROLIFERATION#0.8815;REVERSE TRANSCRIPTION#0.8803;DIGESTION#0.8788;TYPE 2 DIABETIC#0.8787;CYTOCHROME B#0.8777;LYASE ACTIVITY#0.8767;CRISTAE#0.8764;GLYCINE#0.8761;AUTOPHAGY#0.8749;HYPOXIA INDUCIBLE FACTOR#0.8746;CANCER CELL#0.8737;ENZYME COMPLEX#0.8722;LIPOGENESIS#0.8710;OXOGLUTARATE DEHYDROGENASE COMPLEX#0.8694;SYNAPTOSOME#0.8693;TRANSMISSION ELECTRON MICROSCOPY#0.8691;ALZHEIMER'S DISEASE#0.8679;NERVOUS SYSTEM#0.8668;SKELETAL MUSCLE CELLS#0.8651;INTERMEDIARY METABOLISM#0.8612;MESENTERIC LYMPH NODE#0.8599;CORONARY ARTERY#0.8587;MUSCULAR DYSTROPHY#0.8581;EXCRETION#0.8566;ACETYLCARNITINE#0.8540;HEART DISEASE#0.8536;AGEING#0.8501;B CELL#0.8501;CATABOLITE REPRESSION#0.8461;CELLULAR METABOLISM#0.8461;MITOPHAGY#0.8455;MUSCLE WEAKNESS#0.8454;MUSCLE DAMAGE#0.8432;OXYGEN TRANSPORT#0.8423;FATTY ACID TRANSPORT#0.8419;SIZE EXCLUSION CHROMATOGRAPHY#0.8418;TRIIODOTHYRONINE#0.8407;MITOCHONDRIAL PROTEIN SYNTHESIS#0.8406;GLYOXYSOME#0.8399;RECTUS ABDOMINIS#0.8394;LIPID DROPLET#0.8382;ENERGY HOMEOSTASIS#0.8381;ADRENERGIC RECEPTOR#0.8375;ORGANIC ACID METABOLISM#0.8371;FATTY ACID TRANSPORTER#0.8363;SODIUM DODECYL SULFATE#0.8328;DODECYL SULFATE#0.8327;TYPHUS#0.8307;MAGNETIC RESONANCE IMAGING#0.8280;LACTATE METABOLISM#0.8276;PYRUVATE KINASE ACTIVITY#0.8263;ACETATE METABOLISM#0.8257;CELL CYCLE#0.8246;ISOCITRATE DEHYDROGENASE ACTIVITY#0.8244;TUMOR NECROSIS FACTOR#0.8242;METHIONINE#0.8225;SKIN FIBROBLASTS#0.8202;CLENBUTEROL#0.8193;CELL MEMBRANE#0.8139;BODY WEIGHT GAIN#0.8128;DUCHENNE MUSCULAR DYSTROPHY#0.8123;RESPIRATORY CHAIN FUNCTION#0.8116;MYOFIBRIL#0.8097;COASH#0.8066;CELL PROLIFERATION#0.8035;NEURODEGENERATIVE DISEASE#0.8015;CENTRAL NERVOUS SYSTEM#0.7975;SWELLING#0.7959;FRONTAL#0.7957;STRIATED MUSCLE#0.7946;MONOCYTE#0.7942;C OXIDASE I#0.7930;PLASMA MEMBRANE#0.7904;CITRATE METABOLISM#0.7903;ENDOTHELIAL NITRIC OXIDE#0.7891;GLUCOSE INTOLERANCE#0.7891;HYPERTENSION#0.7878;SMALL INTESTINE#0.7877;FAT FREE MASS#0.7863;ANGIOGENESIS#0.7828;SIGNAL TRANSDUCTION#0.7816;GERMINATION#0.7809;COA LIGASE#0.7790;CELL DIVISION#0.7770;L-ARGININE#0.7769;MUSCLE WASTING#0.7769;UBIQUITIN#0.7753;GLUCOSE 6 PHOSPHATASE#0.7742;MITOCHONDRIAL GENOME#0.7734;FERTILIZATION#0.7707;TYPE 2 DIABETES MELLITUS#0.7699;2 DIABETES MELLITUS#0.7699;VIRULENCE#0.7696;GLUTAMATE METABOLISM#0.7695;STREPTOZOTOCIN#0.7690;OXYGENASE#0.7689;PARKINSON'S DISEASE#0.7688;ALKALINE PHOSPHATASE#0.7685;CORTISOL#0.7683;PYRUVATE METABOLISM#0.7661;FAT PAD#0.7649;ALPHA-KETOGLUTARATE DEHYDROGENASE COMPLEX#0.7646;MITOGEN ACTIVATED PROTEIN#0.7642;T CELL#0.7642;PROTEIN OXIDATION#0.7618;GLUCOSE HOMEOSTASIS#0.7609;MITOCHONDRIAL FUSION#0.7591;LATISSIMUS DORSI#0.7589;INSULIN SECRETION#0.7582;INNER MITOCHONDRIAL MEMBRANE#0.7559;TRYPTOPHAN#0.7555;RIBOSOMAL PROTEIN#0.7514;RIBOSOME#0.7493;LYMPHOID ORGANS#0.7487;NITROGEN FIXATION#0.7465;SIMVASTATIN#0.7422;MODE OF ACTION#0.7398;PROTEASOME#0.7394;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7362;STEROL REGULATORY ELEMENT#0.7361;STATIONARY PHASE#0.7323;HYPERGLYCEMIA#0.7323;FATTY LIVER#0.7319;PEROXIDASE ACTIVITY#0.7316;GUANIDINE#0.7313;OUABAIN#0.7311;SODIUM NITROPRUSSIDE#0.7302;PYRUVATE DEHYDROGENASE ACTIVITY#0.7282;HYPERINSULINEMIC EUGLYCEMIC CLAMP#0.7273;HISTIDINE#0.7271;AMYOTROPHIC LATERAL SCLEROSIS#0.7267;LATERAL SCLEROSIS#0.7267;LOCOMOTION#0.7224;LIPOLYSIS#0.7214;TRANSCRIPTASE#0.7210;INOSINE#0.7210;SCIATIC NERVE#0.7193;HEALTHY CONTROL SUBJECTS#0.7190;METFORMIN#0.7173;HYPOTHYROIDISM#0.7173;RIBOSOMAL RNA#0.7168;HOST CELL#0.7166;DIET INDUCED OBESITY#0.7128;MELATONIN#0.7115;MOLAR#0.7096;ASTROCYTE#0.7077;SENESCENCE#0.7047;MUSCLE HYPERTROPHY#0.7034;AMPK ACTIVITY#0.7028;BRAIN CORTEX#0.7023;HORMONE SENSITIVE LIPASE#0.7012;ACYLCARNITINE#0.7010;THIOKINASE#0.7001;VISCERAL ADIPOSE TISSUE#0.6990;2-OXOGLUTARATE DEHYDROGENASE COMPLEX#0.6979;PALMITIC ACID#0.6979;DILATED CARDIOMYOPATHY#0.6970;MALATE DEHYDROGENASE ACTIVITY#0.6950;ENDOCARDITIS#0.6947;SUBCUTANEOUS ADIPOSE TISSUE#0.6925;CHLOROPLAST#0.6914;PERMEABILITY TRANSITION PORE#0.6910;INSULIN-LIKE GROWTH FACTOR#0.6904;TUMOR CELLS#0.6888;ENDOTHELIAL CELL#0.6882;LACTATION#0.6876;GLUTAMIC ACID#0.6873;MTDNA REPLICATION#0.6846;ACIDIFICATION#0.6844;ASCORBATE#0.6832;GLYCOLATE OXIDASE#0.6829;ISOPROTERENOL#0.6795;CELL WALL#0.6795;DETOXIFICATION#0.6792;MUSCLE PROTEIN SYNTHESIS#0.6790;DEXAMETHASONE#0.6763;INTERNAL TRANSCRIBED SPACER#0.6723;SUCCINATE DEHYDROGENASE ACTIVITY#0.6717;ATP HYDROLYSIS#0.6712;HATCHING#0.6703;MOLECULAR DYNAMICS SIMULATION#0.6703;MAMMARY GLAND#0.6692;CYCLOSPORIN A#0.6692;GLUTAMINE METABOLISM#0.6690;ADENINE DINUCLEOTIDE PHOSPHATE#0.6669;MITOCHONDRIAL RESPIRATORY COMPLEX#0.6665;ACETYL COA HYDROLASE#0.6664;INSULIN RECEPTOR#0.6664;LACTIC ACIDOSIS#0.6663;HISTONE DEACETYLASE#0.6661;SKELETAL MUSCLE MASS#0.6660;ESTROGEN RELATED RECEPTOR#0.6641;LITHIUM#0.6632;FAT CELL#0.6625;BIPOLAR DISORDER#0.6603;PROTEIN DISULFIDE ISOMERASE#0.6582;SIGNALLING PATHWAY#0.6557;CYTOCHROME C REDUCTASE ACTIVITY#0.6549;LIVER DISEASE#0.6547;GUANIDINIUM CHLORIDE#0.6546;QUERCETIN#0.6520;CELLULAR METABOLIC#0.6509;EPINEPHRINE#0.6508;TARGET OF RAPAMYCIN#0.6502;COA METABOLISM#0.6495;HIGH FAT FEEDING#0.6483;DNA BINDING#0.6476;HYPERTHYROIDISM#0.6469;AMINOTRANSFERASE ACTIVITY#0.6467;5'-AMP#0.6464;CYTOCHROME C OXIDASE COMPLEX#0.6457;BLOOD GLUCOSE LEVEL#0.6447;RELATED PROTEIN 1#0.6436;CITRATE TRANSPORT#0.6423;LIPASE ACTIVITY#0.6422;BETA GALACTOSIDASE#0.6406;VITAMIN E#0.6394;VALPROATE#0.6337;ISOMERASE ACTIVITY#0.6329;SATURATED FATTY ACID#0.6315;PROTEIN DEGRADATION#0.6287;LOW FAT DIET#0.6281;C TERMINAL DOMAIN#0.6279;ATP BINDING#0.6268;NUCLEOSIDE DIPHOSPHATE KINASE#0.6266;SIGNALING MOLECULE#0.6264;GESTATION#0.6246;BICEPS#0.6239;FASTING PLASMA GLUCOSE#0.6236;INFLAMMATORY RESPONSE#0.6232;NITROPRUSSIDE#0.6220;IMMUNE RESPONSE#0.6219;HEME OXYGENASE 1#0.6218;ACYL COA OXIDASE#0.6197;FRUCTOSE -6-PHOSPHATE#0.6195;OPTIC NERVE#0.6193;GUANIDINE HYDROCHLORIDE#0.6190;OTHER ORGANISM#0.6161;PHAGOCYTOSIS#0.6143;LYSIS#0.6142;NOREPINEPHRINE#0.6137;LIPID SYNTHESIS#0.6127;VITAMIN C#0.6123;ENDOTHELIUM#0.6121;AND BODY COMPOSITION#0.6118;BONE MARROW#0.6099;HUNTINGTON'S DISEASE#0.6097;ASPARTIC ACID#0.6088;POSTTRANSLATIONAL MODIFICATION#0.6086;SYSTOLIC BLOOD PRESSURE#0.6056;RETICULOCYTE#0.6043;IMMUNE SYSTEM#0.6027;PERIPHERAL ARTERIAL DISEASE#0.6016
143241	SPERMIOGENESIS#0.6009
143244	COLORECTAL CANCER#0.9014;COLORECTAL#0.6458
143279	PRION DISEASE#0.9383;PROSTATE CANCER#0.6251;ALZHEIMER'S DISEASE#0.6237;CANCER CELL#0.6191;CREUTZFELDT JAKOB DISEASE#0.6130;UBIQUITIN#0.6115
143282	FIBROBLAST GROWTH FACTOR BINDING#0.8424;FIBROBLAST GROWTH FACTOR#0.8232;GROWTH FACTOR#0.8177;GROWTH FACTOR BINDING#0.8105;BINDING PROTEIN 3#0.7811
1432	SCIO-469#1.0999;INHIBITOR OF P38 KINASE#1.0891;P38 CASCADE#1.0697;WERNER SYNDROME#1.0600;P38 MAPK CASCADE#1.0521;RANTES PRODUCTION#1.0460;PROPOFOL#1.0458;KINASE ACTIVATOR#1.0446;JUN KINASE#1.0429;P38 MAPK SIGNALLING#1.0397;LIDOCAINE#1.0377;CASEIN KINASE 1#1.0354;MAP KINASE ACTIVITY#1.0352;P53 SIGNALING PATHWAY#1.0300;5'-AMP#1.0295;MELATONIN#1.0267;EXTRACELLULAR REGULATED KINASE#1.0251;INHIBITION OF PHOSPHORYLATION#1.0236;PROTEIN KINASE ACTIVITY#1.0235;JNK CASCADE#1.0232;MAPK SIGNAL TRANSDUCTION#1.0217;ACTIVATED B CELL#1.0201;CAMKII#1.0194;PROTEIN KINASE INHIBITOR#1.0180;GINSENOSIDE RB1#1.0175;BERBERINE#1.0170;MYOSIN LIGHT-CHAIN KINASE#1.0157;ACTIVATION OF CREB#1.0155;PROTEIN KINASE ACTIVATION#1.0150;DEDIFFERENTIATION#1.0145;MAP KINASE#1.0145;AUTOPHAGIC CELL DEATH#1.0131;INHIBITORY KAPPA B#1.0130;JUN PHOSPHORYLATION#1.0120;MRNA STABILIZATION#1.0113;NEUTROPHIL APOPTOSIS#1.0108;ATORVASTATIN#1.0107;P38 MAPK SIGNALING#1.0107;ANISOMYCIN#1.0101;PKCDELTA#1.0099;MYOCYTE ENHANCER FACTOR#1.0098;MINOCYCLINE#1.0098;FLUVASTATIN#1.0097;ACTIVATION OF APOPTOSIS#1.0096;MAPK SIGNALLING#1.0091;CHONDROGENESIS#1.0087;PODOCYTE#1.0087;MYOBLAST DIFFERENTIATION#1.0069;PALMITATE#1.0066;MITOGEN ACTIVATED PROTEIN#1.0063;JNK SIGNALING PATHWAY#1.0063;OXALIPLATIN#1.0063;ARSENITE#1.0062;CAMP-RESPONSIVE ELEMENT BINDING#1.0060;MAP KINASE CASCADE#1.0058;MYOGENESIS#1.0057;THYMOCYTE#1.0053;IL-4 PRODUCTION#1.0052;SIMVASTATIN#1.0048;RICIN#1.0044;METFORMIN#1.0042;PROTEIN KINASE#1.0042;VITAMIN C#1.0039;MCP-1 PRODUCTION#1.0036;SODIUM CHANNEL#1.0035;P21 ACTIVATED KINASE#1.0033;CELECOXIB#1.0031;MIXED LINEAGE KINASE#1.0025;ACINAR CELL#1.0025;PROTEIN KINASE B#1.0020;HYPERPHOSPHORYLATION#1.0016;SORAFENIB#1.0015;PODOCYTE APOPTOSIS#1.0009;MAP KINASE KINASE#1.0001;INTERLEUKIN-6 PRODUCTION#1.0001;GLUCOSE TRANSPORT#1.0001;RIBOSOMAL S6 KINASE#1.0001;SPINAL DORSAL HORN#1.0001;NUCLEAR EXPORT#0.9998;IL-12 PRODUCTION#0.9998;SCHWANN CELL#0.9996;MYRICETIN#0.9996;MAPKK#0.9993;PYRAZOLE#0.9989;CALYCULIN A#0.9988;CELL CYCLE CHECKPOINT#0.9988;RESVERATROL#0.9987;SB220025#0.9986;ENDOTHELIAL CELL MIGRATION#0.9984;CALCINEURIN#0.9981;RIBOSOMAL PROTEIN#0.9978;ACTIVATING TRANSCRIPTION FACTOR#0.9978;CEREBELLAR GRANULE NEURON#0.9973;ENDOTHELIAL CELL APOPTOSIS#0.9973;SRC FAMILY KINASE#0.9972;PROTEIN KINASE CASCADE#0.9972;HUMAN WHOLE BLOOD#0.9971;MAPK CASCADE#0.9970;FOCAL ADHESION KINASE#0.9969;IL-8 SECRETION#0.9965;INTERFERON REGULATORY FACTOR#0.9964;RESPONSE TO TNF#0.9959;CHONDROCYTE DIFFERENTIATION#0.9957;MAPK ACTIVATION#0.9953;GERM CELL#0.9953;PROTEIN KINASE D#0.9949;CYTOKINE SYNTHESIS#0.9949;ENTEROCYTE#0.9945;G-CSF#0.9941;SIGNALLING CASCADE#0.9940;JNK SIGNALLING PATHWAY#0.9937;CISPLATIN#0.9930;KUPFFER CELL#0.9930;ZONULA OCCLUDENS#0.9929;OVARIAN CARCINOMA#0.9928;KINASE INHIBITOR#0.9927;TARGET OF RAPAMYCIN#0.9925;BETA-2#0.9924;TNF SECRETION#0.9924;ACUTE PANCREATITIS#0.9924;PROTEIN PHOSPHATASE 2A#0.9922;ASPIRIN#0.9922;IL-10 SECRETION#0.9920;GRANULOSA CELL#0.9920;PHOSPHATASE 2A#0.9920;NF-KAPPAB INHIBITOR#0.9919;RESPONSE TO UV#0.9918;MAP KINASE PHOSPHATASE#0.9915;IL-10 PRODUCTION#0.9915;RESPONSE TO STRESS#0.9913;TANK BINDING KINASE#0.9913;ANOIKIS#0.9913;INTRACELLULAR SIGNAL TRANSDUCTION PATHWAY#0.9913;MACROPHAGE APOPTOSIS#0.9911;LIPID RAFT#0.9910;AUTOPHAGY#0.9909;ACTIVIN RECEPTOR#0.9908;SALICYLATE#0.9908;APOPTOSIS SIGNALING#0.9906;BASOPHIL#0.9904;CAMP RESPONSE ELEMENT BINDING#0.9902;ATAXIA TELANGIECTASIA MUTATED#0.9901;HYALURONAN#0.9900;CRE BINDING#0.9898;HEPATOCYTE PROLIFERATION#0.9896;MAPK ERK KINASE#0.9893;ACTIVATED CASPASE 3#0.9893;MAPK SIGNALING#0.9892;POTASSIUM CHANNEL#0.9892;ATAXIA TELANGIECTASIA#0.9891;IL-8 PRODUCTION#0.9889;IL-1RA#0.9889;IKAPPAB KINASE#0.9888;ROSIGLITAZONE#0.9888;NEURITE OUTGROWTH#0.9888;ADENOSINE MONOPHOSPHATE#0.9888;SENESCENCE#0.9888;CATALYTIC ACTIVITY#0.9888;INTRACELLULAR SIGNALING CASCADE#0.9887;KINASE ACTIVITY#0.9887;PROTEIN KINASE A#0.9886;REACTIVE OXYGEN SPECIES GENERATION#0.9885;CASPASE ACTIVITY#0.9885;ROS FORMATION#0.9885;REGULATION OF CELL CYCLE#0.9884;PACLITAXEL#0.9883;FIBROBLAST PROLIFERATION#0.9881;CEREBRAL CORTEX#0.9880;IFN-BETA#0.9879;ACTIVE CASPASE 3#0.9877;NEUTROPHIL ACTIVATION#0.9877;BETA ADRENERGIC RECEPTOR#0.9875;PROTEIN KINASE C#0.9875;ADIPOCYTE DIFFERENTIATION#0.9873;PROTEIN KINASE G#0.9872;QUERCETIN#0.9872;FORMALIN#0.9872;ISOPROTERENOL#0.9868;ADENINE DINUCLEOTIDE PHOSPHATE#0.9868;MONOCYTE DERIVED DENDRITIC CELL#0.9867;ZONULA OCCLUDENS 1#0.9867;NEUTROPHIL CHEMOTAXIS#0.9866;OXIDATIVE STRESS RESPONSE#0.9865;DENTAL PULP CELL#0.9863;JANUS ACTIVATED KINASE#0.9862;ACTIN POLYMERIZATION#0.9862;CERVICAL CANCER#0.9861;B CELL LYMPHOMA#0.9859;ACTIVATION OF MAP KINASE#0.9859;NEUTROPHIL MIGRATION#0.9858;HUMAN AIRWAY EPITHELIAL#0.9858;PALMITIC ACID#0.9857;AU RICH ELEMENT#0.9857;MYOTUBE#0.9856;FOCAL ADHESION#0.9855;INTRACELLULAR SIGNAL TRANSDUCTION#0.9854;CHONDROCYTE#0.9852;STAUROSPORINE#0.9852;LIPOIC ACID#0.9852;IL-6 SECRETION#0.9852;INHIBITION OF CELL PROLIFERATION#0.9852;PROTEOGLYCAN SYNTHESIS#0.9851;GENISTEIN#0.9850;CAMP RESPONSE ELEMENT#0.9848;IL-1 PRODUCTION#0.9847;ANTI-INFLAMMATORY RESPONSE#0.9847;PROTEIN DEGRADATION#0.9846;CHRONIC CONSTRICTION INJURY#0.9845;MESANGIAL CELL#0.9845;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9844;PANCREATIC CANCER#0.9843;ANTI APOPTOSIS#0.9843;RESPIRATORY BURST#0.9842;CONSTITUTIVELY ACTIVE MUTANT#0.9841;HUMAN DENTAL PULP#0.9841;PANCREATITIS#0.9841;MARROW STROMAL CELLS#0.9840;BONE MARROW STROMAL CELL#0.9840;ASTROCYTE ACTIVATION#0.9839;CHONDROSARCOMA#0.9839;NEUROTROPHIN RECEPTOR#0.9838;DOXYCYCLINE#0.9838;FIBRINOGEN#0.9838;GLUCOSE REGULATED PROTEIN#0.9838;M2 MACROPHAGE#0.9836;CYCLIC ADENOSINE MONOPHOSPHATE#0.9836;CLEAVED CASPASE 3#0.9835;NEURITE#0.9834;AKT SIGNALING#0.9834;HEPATOCELLULAR CARCINOMA CELL#0.9833;BINDING PROTEIN 1#0.9832;TNF PRODUCTION#0.9831;ADRENERGIC RECEPTOR#0.9831;DOMINANT NEGATIVE MUTANT#0.9831;CALCIUM MOBILIZATION#0.9831;GLUTAMATE RECEPTOR#0.9831;EUKARYOTIC INITIATION FACTOR#0.9831;LONG TERM POTENTIATION#0.9830;BONE MARROW STROMAL#0.9830;GLUCOSE UPTAKE#0.9829;BREAST CARCINOMA#0.9828;OSTEOGENESIS#0.9828;PHENYLEPHRINE#0.9828;ARSENIC TRIOXIDE#0.9828;FOAM CELL FORMATION#0.9828;APOPTOTIC SIGNALING PATHWAY#0.9827;INHIBITION OF APOPTOSIS#0.9826;MUSCLE ATROPHY#0.9826;NEUTRAL SPHINGOMYELINASE#0.9825;CELLULAR SENESCENCE#0.9823;PERIPHERAL NERVE INJURY#0.9822;MESOTHELIAL CELL#0.9822;OVARIAN CANCER#0.9822;PHOSPHODIESTERASE#0.9822;NMDA RECEPTOR#0.9822;GLYCOGEN SYNTHASE KINASE#0.9822;DUAL SPECIFICITY PHOSPHATASE#0.9821;TRANSLATION INITIATION#0.9821;GINSENOSIDE RG1#0.9820;DENTAL PULP#0.9820;PHOSPHOLIPASE C#0.9819;TNF-ALPHA SECRETION#0.9819;PERIODONTAL LIGAMENT#0.9819;EPINEPHRINE#0.9819;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9819;OOCYTE#0.9816;OSTEOBLAST DIFFERENTIATION#0.9816;ACTIVATION OF NF-KAPPAB#0.9816;RESPONSE TO IL-1#0.9815;POLYMORPHONUCLEAR LEUKOCYTES#0.9815;DORSAL ROOT GANGLION#0.9814;CYCLOSPORIN A#0.9814;MATRIX METALLOPROTEINASE 1#0.9813;SMALL INTESTINE#0.9813;NOCICEPTION#0.9813;TH1 CELL#0.9812;GLUTAMINE#0.9811;AIRWAY SMOOTH MUSCLE#0.9810;IL-2 PRODUCTION#0.9810;NUCLEUS PULPOSUS CELL#0.9809;COLLAGEN TYPE I#0.9809;CORNEAL EPITHELIAL CELL#0.9807;INTERLEUKIN 1 RECEPTOR#0.9807;PKC ACTIVATION#0.9806;MYOSIN HEAVY CHAIN#0.9805;ALVEOLAR EPITHELIAL CELL#0.9804;ENDOTHELIAL PROGENITOR CELL#0.9804;SPINAL CORD INJURY#0.9803;SIGNAL TRANSDUCER#0.9803;CHEMOKINE PRODUCTION#0.9803;RAPAMYCIN#0.9803;ASCORBIC ACID#0.9803;SCAVENGER RECEPTOR#0.9802;NICOTINAMIDE#0.9802;LUNG FIBROBLASTS#0.9801;INSULIN RECEPTOR SUBSTRATE#0.9800;OXIDATIVE BURST#0.9800;PLATELET ACTIVATION#0.9800;MYOBLAST#0.9800;PRIMARY RESPONSE GENE#0.9797;TLR4 SIGNALING PATHWAY#0.9796;PROXIMAL TUBULAR CELL#0.9796;SUBSTANCE P#0.9796;DENTATE GYRUS#0.9795;CALCIUM CHANNEL#0.9795;CELL CYCLE REGULATION#0.9794;EOSINOPHIL#0.9794;PHOSPHOLIPASE A#0.9794;VSMC PROLIFERATION#0.9794;CANNABINOID RECEPTOR#0.9793;NF KAPPAB BINDING#0.9793;MACROPHAGE POLARIZATION#0.9793;STRUCTURE ACTIVITY RELATIONSHIP#0.9792;PI3K SIGNALING#0.9791;SELECTIN#0.9791;TNF-ALPHA PRODUCTION#0.9790;IL-6 PRODUCTION#0.9790;TIGHT JUNCTION PROTEIN#0.9790;ADENINE#0.9789;TROPHOBLAST#0.9789;ATP BINDING#0.9789;MOUSE EMBRYONIC FIBROBLAST#0.9788;INTERLEUKIN 8 PRODUCTION#0.9787;RESPONSE TO OXIDATIVE STRESS#0.9787;CD8+ T CELL#0.9787;DOXORUBICIN#0.9785;NUCLEUS PULPOSUS#0.9785;SPINAL CORD#0.9785;MYELOPEROXIDASE ACTIVITY#0.9784;DNA DAMAGE RESPONSE#0.9784;EMODIN#0.9783;HUMAN PANCREATIC CANCER#0.9780;GENE SILENCING#0.9780;DEPHOSPHORYLATION#0.9779;RECEPTOR INTERACTING PROTEIN#0.9778;TYPE 2 DIABETIC#0.9778;ARGINASE ACTIVITY#0.9776;PULMONARY ARTERY#0.9776;ORAL CANCER CELL#0.9776;MELANOCYTE#0.9776;CALCIUM SIGNALING#0.9776;PEMPHIGUS#0.9774;RENAL FIBROSIS#0.9774;OSTEOBLAST#0.9774;COLLAGEN SYNTHESIS#0.9774;HUMAN PERIODONTAL LIGAMENT#0.9774;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9772;ENDOCYTOSIS#0.9772;HEMATOPOIETIC CELL#0.9769;PROTEIN TYROSINE KINASE#0.9769;NEONATAL RAT CARDIOMYOCYTES#0.9769;OLIGODENDROCYTE#0.9767;EARLY GROWTH RESPONSE#0.9767;NOREPINEPHRINE#0.9767;ADENOSINE TRIPHOSPHATE#0.9766;GAP JUNCTION#0.9766;TIGHT JUNCTION#0.9765;CELL MOTILITY#0.9764;ER STRESS RESPONSE#0.9764;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.9764;EMBRYONIC KIDNEY#0.9763;CYTOCHROME P450#0.9762;RETINOBLASTOMA#0.9762;CEREBRAL ISCHEMIA#0.9761;VITAMIN E#0.9761;HEPATOMA CELLS#0.9760;EXOCYTOSIS#0.9759;NUCLEAR IMPORT#0.9759;APOPTOTIC PROCESS#0.9758;ETOPOSIDE#0.9758;RNA BINDING#0.9757;MESENCHYMAL CELL#0.9756;RESPONSE TO CYTOKINE#0.9756;FLUID SHEAR STRESS#0.9755;GLOBIN#0.9755;SCIATIC NERVE#0.9755;IFN-GAMMA#0.9754;NADPH OXIDASE#0.9753;INDOLE#0.9753;AMYLOID PRECURSOR PROTEIN#0.9753;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9753;ADIPOGENESIS#0.9752;STRESS FIBER#0.9752;PHOSPHATASE INHIBITOR#0.9752;TUBULAR EPITHELIAL CELL#0.9752;FORSKOLIN#0.9751;UROKINASE#0.9751;REGULATION OF CELLULAR#0.9751;UROKINASE PLASMINOGEN ACTIVATOR#0.9750;SKELETAL MUSCLE CELLS#0.9750;ACTIN FILAMENT#0.9749;CASPASE ACTIVATION#0.9749;ENDOTHELIAL NITRIC OXIDE#0.9748;TH2 CELL#0.9748;GM-CSF#0.9748;ACTIVATED MICROGLIAL CELLS#0.9748;PKC ACTIVITY#0.9747;EPITHELIAL TO MESENCHYMAL#0.9746;HYPOXIA#0.9746;CATABOLISM#0.9745;PLATELET AGGREGATION#0.9744;LIVER CANCER#0.9744;AUTOPHAGOSOME#0.9744;AORTIC SMOOTH MUSCLE CELLS#0.9743;RNA BINDING PROTEIN#0.9742;ACUTE LIVER INJURY#0.9742;NF-KAPPAB ACTIVATION#0.9742;MITOCHONDRIAL PERMEABILITY TRANSITION#0.9742;PHOSPHOLIPASE A2#0.9741;PROTEIN SECRETION#0.9741;SPHINGOSINE#0.9741;RESPONSE TO LIPOPOLYSACCHARIDE#0.9740;MOUSE EMBRYONIC STEM#0.9739;HUMAN ARTICULAR CHONDROCYTES#0.9739;PLATELET ACTIVATING FACTOR#0.9737;SIGNALLING PATHWAY#0.9737;MORPHOGENESIS#0.9736;RESPONSE TO LPS#0.9736;VEGF PRODUCTION#0.9736;HERPES SIMPLEX VIRUS#0.9734;ALVEOLAR MACROPHAGE#0.9734;QUANTITATIVE REVERSE TRANSCRIPTION#0.9733;OF DIABETIC RATS#0.9731;CYCLIC AMP#0.9731;BETA CELL#0.9730;ALLERGEN#0.9730;MYOCYTES#0.9730;GLUCOCORTICOID RECEPTOR#0.9730;INTERLEUKIN-6 SYNTHESIS#0.9729;CHEMOTAXIS#0.9729;ASTROCYTE#0.9729;HEMORRHAGE#0.9729;ION CHANNEL#0.9729;EMBRYONIC STEM CELL#0.9728;HERPES SIMPLEX#0.9728;OVARIAN#0.9727;EPSTEIN BARR VIRUS#0.9727;IONOPHORE#0.9727;OPIOID RECEPTOR#0.9725;DEATH RECEPTOR#0.9724;HUMAN EMBRYONIC KIDNEY#0.9723;B CELL#0.9723;IMATINIB#0.9723;INFLUENZA A VIRUS#0.9723;ROS GENERATION#0.9723;MUSCLE CONTRACTION#0.9721;MITOCHONDRIAL DEPOLARIZATION#0.9720;MITOSIS#0.9720;STEM CELL FACTOR#0.9719;MULTIPLE MYELOMA#0.9718;REGULATION OF APOPTOSIS#0.9718;TRANSLATION INITIATION FACTOR#0.9718;VASOCONSTRICTION#0.9717;SUPEROXIDE ANION GENERATION#0.9717;MYOFIBROBLAST#0.9717;ALL TRANS RETINOIC ACID#0.9717;HYPOXIC#0.9716;CARDIOMYOCYTE#0.9715;SUBSTANTIA NIGRA#0.9715;LEUKOCYTE ADHESION#0.9715;TESTOSTERONE#0.9715;HEPATOCYTE GROWTH FACTOR#0.9714;LUNG CARCINOMA#0.9714;CERVICAL#0.9714;HEPATOCYTE APOPTOSIS#0.9714;HEAT SHOCK PROTEIN#0.9713;HEMORRHAGIC#0.9713;INSULIN RECEPTOR#0.9713;AIRWAY EPITHELIAL CELL#0.9713;VIRAL REPLICATION#0.9712;B LYMPHOCYTE#0.9712;PROGESTERONE#0.9712;TRAUMATIC BRAIN INJURY#0.9711;CYTOCHROME C RELEASE#0.9711;CHONDROCYTE HYPERTROPHY#0.9711;17β-ESTRADIOL#0.9710;MINERALIZATION#0.9709;DIABETIC NEPHROPATHY#0.9709;GALECTIN#0.9708;PERIPHERAL NERVE#0.9708;BRONCHIAL EPITHELIAL CELLS#0.9708;L-CYSTEINE#0.9707;T- PA#0.9706;MITOCHONDRIAL TRANSLOCATION#0.9706;MICROPHTHALMIA#0.9706;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.9706;GANGLION CELLS#0.9704;COLON CARCINOMA#0.9704;STEROIDOGENESIS#0.9704;ACTIN CYTOSKELETON#0.9704;PREADIPOCYTE#0.9703;HUMAN MESENCHYMAL STEM#0.9703;SPHINGOSINE 1 PHOSPHATE#0.9703;OXYGEN GLUCOSE DEPRIVATION#0.9703;TISSUE GROWTH FACTOR#0.9702;HEPATITIS B#0.9701;INTESTINAL EPITHELIAL CELL#0.9700;HEMATOPOIETIC STEM CELL#0.9700;SIGNALING MOLECULE#0.9699;PSORIASIS#0.9698;T CELL PROLIFERATION#0.9698;ADENOSINE#0.9698;ADENYLATE CYCLASE#0.9698;ACTIVATOR PROTEIN 1#0.9697;HUMAN DERMAL FIBROBLAST#0.9697;LUNG EPITHELIAL CELL#0.9697;TRANSACTIVATION#0.9697;MONOCYTE CHEMOTACTIC PROTEIN#0.9697;MICROTUBULE ASSOCIATED PROTEIN#0.9697;NEPHROTOXICITY#0.9696;LUNG ADENOCARCINOMA#0.9695;ALDOSTERONE#0.9694;CELL KILLING#0.9694;GENOTOXIC#0.9693;SIGNALING CASCADE#0.9692;RETINAL GANGLION CELL#0.9691;HEPATOTOXICITY#0.9691;RETINOIC ACID#0.9689;ERK CASCADE#0.9689;AQUAPORIN#0.9689;CIGARETTE SMOKE EXTRACT#0.9689;CASPASE-3 ACTIVITY#0.9688;ESTRADIOL#0.9688;INSULIN SIGNALING PATHWAY#0.9687;DOPAMINERGIC NEURON#0.9687;HUMAN BRONCHIAL EPITHELIAL#0.9687;ENDOTHELIAL CELL ACTIVATION#0.9687;DERMAL FIBROBLAST#0.9686;HUMAN EPIDERMAL KERATINOCYTES#0.9686;TUBERCULOSIS#0.9685;APOPTOSIS#0.9684;COMPLEX I#0.9684;COLLAGENASE#0.9684;CYCLOSPORIN#0.9683;INDOMETHACIN#0.9683;PROTEIN PHOSPHORYLATION#0.9683;PERTUSSIS#0.9683;HEPARIN#0.9682;PROSTATE CANCER#0.9682;TAXOL#0.9681;AIRWAY EPITHELIUM#0.9681;NEUROPATHY#0.9681;PROTEIN TYROSINE PHOSPHATASE#0.9681;MATRIX METALLOPROTEINASE 13#0.9681;DEXAMETHASONE#0.9681;MIGRATION INHIBITORY FACTOR#0.9680;ADENYLATE#0.9680;OSTEOCLAST#0.9679;CONSTRICTION#0.9679;TUBE FORMATION#0.9678;MYELOID CELL#0.9678;N-ACETYLCYSTEINE#0.9678;HISTAMINE#0.9678;NEUTROPHIL#0.9677;HYPOXIA INDUCIBLE FACTOR#0.9676;INDUCTION OF APOPTOSIS#0.9675;PKCALPHA#0.9675;ALPHA LIPOIC ACID#0.9675;ACUTE KIDNEY INJURY#0.9675;PROTEOGLYCAN#0.9674;SKIN FIBROBLASTS#0.9674;CONNEXIN#0.9673;CD4+ T CELL#0.9673;HEPATIC STELLATE CELL#0.9673;CYTOKINE SECRETION#0.9672;MICROVASCULAR ENDOTHELIAL CELL#0.9672;NEUROINFLAMMATORY RESPONSE#0.9671;ACETYLCYSTEINE#0.9671;TYROSINE KINASE INHIBITOR#0.9671;MONOCYTE DERIVED MACROPHAGE#0.9671;DNA SYNTHESIS#0.9670;PHEOCHROMOCYTOMA#0.9669;SIGNALING PATHWAY#0.9669;ESTROGEN RECEPTOR#0.9665;ACTIVATED T-CELLS#0.9665;PATTERN RECOGNITION RECEPTOR#0.9665;BREAST CANCER CELL#0.9665;CYCLIN DEPENDENT KINASE INHIBITOR#0.9665;GLYCINE#0.9664;METHIONINE#0.9663;ENDOPLASMIC RETICULUM STRESS#0.9661;RECEPTOR LIGAND#0.9661;UNFOLDED PROTEIN RESPONSE#0.9660;TRANSFORMING GROWTH FACTOR BETA#0.9660;MAST CELL#0.9660;SMOOTH MUSCLE CELL MIGRATION#0.9660;BONE CANCER#0.9659;MUSCLE CELL MIGRATION#0.9658;KETAMINE#0.9658;MAMMARY GLAND#0.9657;ADIPOCYTE#0.9657;OSTEOCLAST DIFFERENTIATION#0.9656;C REACTIVE PROTEIN#0.9656;UMBILICAL CORD#0.9656;TRANSCRIPTIONAL CONTROL#0.9655;LUCIFERASE ACTIVITY#0.9655;ENHANCER BINDING PROTEIN#0.9655;MACROPHAGE MIGRATION#0.9655;ACTIVATED T CELL#0.9654;ETHANOL#0.9654;COLLAGEN INDUCED ARTHRITIS#0.9653;FIBROBLAST GROWTH FACTOR#0.9653;MICROTUBULE#0.9652;ISCHEMIA REPERFUSION INJURY#0.9652;HYPERSENSITIVITY#0.9652;MAMMARY EPITHELIAL CELL#0.9651;NEURONAL CELL DEATH#0.9651;ACETYLCHOLINE#0.9651;NUCLEOTIDE BINDING#0.9649;ENHANCER BINDING#0.9648;DOPAMINE#0.9648;FACTOR I#0.9648;XANTHINE#0.9647;LIVER DAMAGE#0.9647;BLOOD BRAIN BARRIER#0.9646;SENSITIZATION#0.9646;GROWTH FACTOR RECEPTOR#0.9646;NEURAL CELL#0.9646;PEPTIDOGLYCAN#0.9645;CHLOROQUINE#0.9645;PROTEASOME#0.9645;BREAST CANCER#0.9645;CAROTID ARTERY#0.9645;REGULATORY T CELL#0.9644;NITRO-L-ARGININE#0.9643;MICROPARTICLE#0.9643;L-ARGININE#0.9640;KERATINOCYTE#0.9639;SERTOLI CELL#0.9639;PROTEIN PROTEIN INTERACTION#0.9638;CHROMATIN REMODELING#0.9638;XANTHINE OXIDASE#0.9637;COLON CANCER#0.9637;MICROGLIAL CELL#0.9637;STROMAL CELL#0.9636;LIGHT CHAIN 3#0.9636;PROTEASE ACTIVATED RECEPTOR#0.9636;ATPASE ACTIVITY#0.9635;ENZYME ACTIVITY#0.9634;SQUAMOUS CELL CARCINOMA#0.9634;BONE MARROW CELLS#0.9633;CASPASE INHIBITOR#0.9633;HUMAN BREAST CANCER#0.9633;NEPHROPATHY#0.9633;CELL DIFFERENTIATION#0.9632;APOPTOSIS INDUCING FACTOR#0.9632;GLUCOSE METABOLISM#0.9631;TRANSIENT RECEPTOR POTENTIAL#0.9631;GRANULOCYTE COLONY STIMULATING FACTOR#0.9631;EPITHELIAL MESENCHYMAL TRANSITION#0.9631;HEPATITIS C#0.9630;NUCLEOTIDE EXCHANGE FACTOR#0.9629;GUANOSINE#0.9629;T LYMPHOCYTE#0.9629;PHAGOCYTOSIS#0.9629;INSULIN-LIKE GROWTH FACTOR#0.9629;NERVE GROWTH FACTOR#0.9629;BASEMENT MEMBRANE#0.9629;LIPID METABOLISM#0.9628;SWELLING#0.9628;PROTEINURIA#0.9627;SKIN CANCER#0.9627;UBIQUITIN#0.9627;CELLULAR LOCALIZATION#0.9626;SILDENAFIL#0.9626;MYOCARDIUM#0.9626;HISTONE DEACETYLASE INHIBITOR#0.9626;PROTEIN COMPLEX#0.9626;MODE OF ACTION#0.9625;T CELL ACTIVATION#0.9624;PROXIMAL TUBULAR EPITHELIAL#0.9624;FIBROBLAST LIKE SYNOVIOCYTES#0.9624;GLIAL CELL#0.9623;INSULIN SECRETION#0.9623;ENDOTHELIAL CELL PROLIFERATION#0.9623;CORD BLOOD#0.9623;DNA REPLICATION#0.9622;ANTIOXIDANT RESPONSE ELEMENT#0.9622;RETINAL PIGMENT EPITHELIAL#0.9621;HYPERGLYCEMIA#0.9621;LYSINE#0.9621;IL-11#0.9621;NEURAL STEM CELL#0.9621;BONE FORMATION#0.9621;CELL DIVISION#0.9620;MUTAGENESIS#0.9619;ALLERGIC RHINITIS#0.9619;COLORECTAL CANCER#0.9618;G2 PHASE#0.9618;SODIUM NITROPRUSSIDE#0.9617;IL-1 SECRETION#0.9616;PROGENITOR CELL#0.9616;SMOOTH MUSCLE ACTIN#0.9615;PRECURSOR CELL#0.9615;CARDIOMYOPATHY#0.9613;APOPTOTIC CELL DEATH#0.9612;RECEPTOR TYROSINE KINASE#0.9612;SKELETAL MUSCLE#0.9612;TOCOPHEROL#0.9612;BRAIN EDEMA#0.9612;CANCER STEM CELL#0.9612;HUMAN INTESTINAL EPITHELIAL#0.9611;ANGIOTENSIN CONVERTING ENZYME#0.9611;PLATELET-DERIVED GROWTH FACTOR#0.9611;ANTI INFLAMMATORY DRUGS#0.9610;POST-TRANSLATIONAL MODIFICATION#0.9610;BONE MORPHOGENETIC PROTEIN#0.9609;TUMOUR NECROSIS FACTOR#0.9609;MYOCARDIAL INFARCTION#0.9608;NEURONAL CELLS#0.9607;DRUG RESISTANCE#0.9607;CYTOCHROME C#0.9607;GRANULOCYTE#0.9607;REPORTER GENE ASSAY#0.9606;HEME OXYGENASE 1#0.9605;PHOSPHATIDYLSERINE#0.9604;MACROPHAGE ACTIVATION#0.9604;COLORECTAL#0.9603;CREATINE KINASE#0.9602;HYPERGLYCEMIC#0.9602;ULCERATIVE COLITIS#0.9602;RETINAL ENDOTHELIAL CELLS#0.9601;MUSCLE CELL PROLIFERATION#0.9601;MACROPHAGE INFLAMMATORY PROTEIN#0.9601;CEREBRAL ARTERY OCCLUSION#0.9601;COLITIS#0.9600;ADAPTIVE IMMUNE RESPONSE#0.9600;SYSTEMIC INFLAMMATORY RESPONSE#0.9600;ISCHEMIA#0.9600;SMOOTH MUSCLE CELL PROLIFERATION#0.9600;DNA REPAIR#0.9599;HOST CELL#0.9599;PERIPHERAL BLOOD MONOCYTES#0.9599;EPIDERMAL GROWTH FACTOR#0.9599;CELL ADHESION MOLECULE#0.9599;IFN REGULATORY FACTOR#0.9598;VASCULAR CELL#0.9598;CELL CYCLE ARREST#0.9597;ENDOPLASMIC RETICULUM#0.9597;INTRACELLULAR SIGNALING PATHWAY#0.9597;FLOW CYTOMETRY ANALYSIS#0.9597;SYNOVIUM#0.9597;HISTONE ACETYLATION#0.9596;CROHN'S DISEASE#0.9595;IKAPPAB PHOSPHORYLATION#0.9595;METHOTREXATE#0.9595;CYTOKINE PRODUCTION#0.9594;BETA GALACTOSIDASE#0.9593;LOSARTAN#0.9593;VEGF SIGNALING#0.9593;VASCULAR ENDOTHELIAL CELL#0.9593;GINSENG#0.9592;DIABETIC RETINOPATHY#0.9592;RNA INTERFERENCE#0.9591;HEPARIN BINDING#0.9591;AGEING#0.9590;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9590;NEUROPROTECTION#0.9589;ADVANCED GLYCATION END#0.9589;INFLAMMATORY CELL INFILTRATION#0.9589;TRANSCRIPTION FACTOR#0.9589;CELL CELL ADHESION#0.9589;CELL MIGRATION#0.9589;RESPIRATORY DISTRESS#0.9589;HEPATOCELLULAR CARCINOMA#0.9588;MESENCHYMAL STEM CELL#0.9586;ENDOTHELIAL CELL#0.9586;ARGININE#0.9585;BONE DISEASE#0.9585;CARDIOMYOCYTE DIFFERENTIATION#0.9584;PROGRAMMED CELL DEATH#0.9583;TYPE 1 DIABETES#0.9583;RESPONSE TO HYPOXIA#0.9583;CONNECTIVE TISSUE#0.9583;CEREBRAL ARTERY#0.9583;PULMONARY FIBROSIS#0.9583;OXYGENASE#0.9582;BLOOD VESSEL#0.9582;NEUROTOXIC#0.9581;TRANSFORMING GROWTH FACTOR#0.9581;GM-CSF PRODUCTION#0.9581;HEPATITIS B VIRUS#0.9580;ONCOGENIC#0.9580;HIGH MOBILITY GROUP#0.9580;GUANINE#0.9580;PHOSPHATASE ACTIVITY#0.9580;ARACHIDONIC ACID#0.9580;G1 PHASE#0.9579;MEMORY IMPAIRMENT#0.9579;DNA BINDING#0.9579;LUNG CANCER#0.9579;PERIODONTAL DISEASE#0.9579;HUMAN IMMUNODEFICIENCY VIRUS#0.9578;T CELL#0.9578;NITROPRUSSIDE#0.9578;CYCLIN DEPENDENT KINASE#0.9578;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9577;ACUTE MYOCARDIAL INFARCTION#0.9576;LYMPH NODE#0.9575;ADENOCARCINOMA#0.9574;NECROTIC CELL DEATH#0.9573;PROTOPORPHYRIN IX#0.9573;CIGARETTE SMOKE EXPOSURE#0.9573;TYPE 2 DIABETES MELLITUS#0.9573;VIRAL INFECTION#0.9573;ACTINOMYCIN D#0.9572;5 FLUOROURACIL#0.9572;2 DIABETES MELLITUS#0.9572;POLY ADP RIBOSE#0.9571;RECEPTOR ACTIVATOR#0.9571;S PHASE#0.9571;LINES OF EVIDENCE#0.9571;AUTOIMMUNITY#0.9571;MRNA TRANSCRIPTION#0.9570;MYELOID LEUKEMIA#0.9570;RIBOSE#0.9570;MITOCHONDRIA#0.9569;HUMAN DENDRITIC CELL#0.9569;LECTIN#0.9569;TOPICAL#0.9568;MIDDLE CEREBRAL ARTERY#0.9567;GLUTATHIONE PEROXIDASE#0.9567;SIGNAL TRANSDUCTION#0.9566;OLEIC ACID#0.9566;PROTEASOME PATHWAY#0.9566;CYSTIC FIBROSIS#0.9565;REGENERATION#0.9565;CHEMOKINE RECEPTOR#0.9565;NEUROBLASTOMA#0.9565;PULMONARY HYPERTENSION#0.9565;TUMOR SUPPRESSOR#0.9564;NEUROTOXICITY#0.9564;LDL RECEPTOR#0.9564;CELL COUNTING KIT#0.9563;EXOSOME#0.9563;PEROXISOME#0.9562;ARTERIOLE#0.9562;ACUTE LUNG INJURY#0.9561;LUNG DISEASE#0.9561;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9561;CELL ADHESION#0.9560;ANESTHETIC#0.9560;HISTONE DEACETYLASE#0.9560;APOPTOTIC#0.9559;ERYTHROID PROGENITOR#0.9559;CELL DEATH#0.9559;ANTIGEN PRESENTING CELLS#0.9559;MONOCYTE#0.9559;ENDOTHELIAL GROWTH FACTOR#0.9559;VITAMIN D RECEPTOR#0.9558;FATTY ACID OXIDATION#0.9558;PERIODONTITIS#0.9558;PROTEIN SYNTHESIS#0.9557;DIABETIC NEUROPATHY#0.9557;ICI 182,780#0.9557;LIVER REGENERATION#0.9557;HYPERTHERMIA#0.9556;THYMIDINE#0.9556;SMOOTH MUSCLE CELL#0.9555;POLYMORPHONUCLEAR NEUTROPHIL#0.9555;CELL WALL#0.9554;CREATINE#0.9553;COLONY-STIMULATING FACTOR#0.9553;ASPARTATE#0.9552;CELL CYCLE CONTROL#0.9551;STEM CELL#0.9551;CELL CYCLE#0.9551;CAFFEINE#0.9551;FIBROSARCOMA#0.9551;VASCULAR SMOOTH MUSCLE CELL#0.9551;EPIGALLOCATECHIN#0.9550;CDK INHIBITOR#0.9550;MUSCLE CELL#0.9550;NECROTIC#0.9550;MACROPHAGE#0.9549;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9549;OBESE#0.9549;KIDNEY DISEASE#0.9548;ALKALINE PHOSPHATASE ACTIVITY#0.9548;CYTOPLASM#0.9548;HEART DISEASE#0.9548;FILAMENTOUS ACTIN#0.9547;INTERVERTEBRAL DISC#0.9547;HEPATITIS C VIRUS#0.9547;ADIPOSE TISSUE#0.9545;HIGH FAT DIET#0.9544;BONE REMODELING#0.9544;CELLULAR GROWTH#0.9543;ERYTHROCYTE#0.9543;RELATED PROTEIN 1#0.9543;ALLERGIC REACTION#0.9542;CANCER CELL#0.9541;SMOOTH MUSCLE#0.9541;EOSIN#0.9540;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9538;BODY SURFACE AREA#0.9538;TERMINAL DIFFERENTIATION#0.9538;THROMBOSIS#0.9538;LATERAL SCLEROSIS#0.9538;HEMATOPOIESIS#0.9538;DNA FRAGMENTATION#0.9537;PLASMA MEMBRANE#0.9537;MORRIS WATER MAZE#0.9536;M PHASE#0.9535;MULTIPLE SCLEROSIS#0.9533;DEXTRAN SULFATE SODIUM#0.9532;LYSOSOME#0.9531;AMYOTROPHIC LATERAL SCLEROSIS#0.9531;MRNA DECAY#0.9531;DENDRITIC CELL#0.9530;CREB BINDING#0.9529;DERMATITIS#0.9528;ANTIOXIDANT ACTIVITY#0.9528;TRANSCRIPTASE#0.9528;TH17 CELL#0.9528;SERUM ALBUMIN#0.9527;HUMAN CORNEAL EPITHELIAL#0.9525;LEFT ANTERIOR DESCENDING#0.9524;ACID PHOSPHATASE#0.9524;PIGMENT EPITHELIAL CELL#0.9524;CELL ACTIVATION#0.9523;ACETYLCHOLINE RECEPTOR#0.9523;ANTIVIRAL RESPONSE#0.9522;RECEPTOR COMPLEX#0.9521;VENTRICULAR CARDIOMYOCYTE#0.9519;SKIN DISEASE#0.9516;RECEPTOR AGONIST#0.9516;POSTTRANSLATIONAL MODIFICATION#0.9516;ALLERGIC ASTHMA#0.9515;NITRIC OXIDE SYNTHASE#0.9515;LEUCINE#0.9515;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9515;HUMAN UMBILICAL VEIN#0.9515;COAGULATION#0.9515;CELL DEVELOPMENT#0.9514;STREPTOZOTOCIN#0.9514;CELL MEMBRANE#0.9514;TLR SIGNALING PATHWAY#0.9513;LEUKOCYTE#0.9513;UMBILICAL VEIN#0.9513;VALPROIC ACID#0.9512;EPITHELIAL CELL#0.9512;INDUCIBLE NITRIC OXIDE#0.9512;ACTIN BINDING#0.9511;GLYCOLYSIS#0.9511;GASTRIC EPITHELIAL CELLS#0.9510;SPINAL NERVE LIGATION#0.9510;TETRACYCLINE#0.9510;TUMOR CELLS#0.9509;RHEUMATOID ARTHRITIS#0.9508;ELECTRON TRANSPORT#0.9507;TOLL LIKE RECEPTOR#0.9506;INNATE IMMUNITY#0.9506;LOW DENSITY LIPOPROTEIN#0.9505;RECEPTOR ANTAGONIST#0.9505;BONE RESORPTION#0.9504;MONONUCLEAR CELLS#0.9504;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9503;NATURAL KILLER CELL#0.9501;NEUROLOGICAL DISORDER#0.9501;HUMAN PULMONARY ARTERY#0.9501;PRO-INFLAMMATORY#0.9501;REACTIVE OXYGEN SPECIES#0.9500;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9500;ORGANELLE#0.9499;STRIATUM#0.9499;INFLAMMATORY BOWEL DISEASE#0.9499;GROWTH FACTOR#0.9499;TAMOXIFEN#0.9499;ATOPIC DERMATITIS#0.9499;ALKALINE PHOSPHATASE#0.9498;CARCINOGEN#0.9498;AUTOIMMUNE DISEASE#0.9498;GENE EXPRESSION#0.9498;VIRULENCE#0.9497;MITOCHONDRIAL DAMAGE#0.9496;TRANSMISSION ELECTRON MICROSCOPY#0.9496;GLOMERULONEPHRITIS#0.9495;EARLY TIME POINT#0.9495;TYPE 2 DIABETES#0.9495;ACETIC ACID#0.9494;VASCULAR ENDOTHELIUM#0.9494;GLUTATHIONE#0.9493;RIBOSOME#0.9493;INTRINSIC APOPTOTIC PATHWAY#0.9492;BLOOD UREA NITROGEN#0.9492;PROTEIN BINDING#0.9492;PROSTAGLANDIN E2#0.9491;ELECTROPHORETIC MOBILITY SHIFT#0.9491;OSTEOARTHRITIS#0.9491;MITOCHONDRIAL MEMBRANE#0.9490;VITAMIN D3#0.9489;CORONARY ARTERY#0.9488;ENDOTHELIUM#0.9488;ALANINE#0.9486;OSTEOPOROSIS#0.9486;LIVER DISEASE#0.9483;HISTONE ACETYLTRANSFERASE#0.9481;GASTRIC MUCOSA#0.9481;PROPIDIUM#0.9481;PRIMARY CORTICAL NEURON#0.9480;MUSCLE WASTING#0.9480;INNATE IMMUNE SYSTEM#0.9479;TYROSINE KINASE 2#0.9478;SUPEROXIDE DISMUTASE#0.9477;WEIGHT LOSS#0.9476;3-METHYLADENINE#0.9476;NITRIC OXIDE#0.9476;ANGIOGENESIS#0.9475;ACTIN BINDING PROTEIN#0.9475;DIABETES MELLITUS#0.9475;MITOCHONDRIAL DNA#0.9475;GTP BINDING#0.9475;CELL GROWTH#0.9474;DEMENTIA#0.9474;CHRONIC KIDNEY DISEASE#0.9474;TUMOR NECROSIS FACTOR#0.9474;CYTOTOXICITY#0.9473;ENCEPHALOMYELITIS#0.9473;CELL PROLIFERATION#0.9473;MECHANISM OF ACTION#0.9473;CELL CYCLE REGULATOR#0.9472;TISSUE DAMAGE#0.9471;ARTERY#0.9471;PNEUMONIA#0.9470;EDEMA#0.9469;PERIPHERAL BLOOD#0.9468;SERUM RESPONSE FACTOR#0.9467;TOXICITY#0.9467;PROXIMAL TUBULE CELL#0.9467;INFLAMMATORY RESPONSE#0.9466;QUANTITATIVE REAL TIME#0.9466;DIPHOSPHATE#0.9465;LEUKOCYTE MIGRATION#0.9465;ACUTE INFLAMMATORY RESPONSE#0.9465;HYPERTENSION#0.9464;WOUND HEALING#0.9464;FLUORESCEIN#0.9463;MYELODYSPLASTIC SYNDROME#0.9462;CXCL10 PRODUCTION#0.9461;ACUTE CORONARY SYNDROME#0.9460;ENZYME INHIBITOR#0.9460;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9460;TRADITIONAL CHINESE MEDICINE#0.9459;WHITE ADIPOSE TISSUE#0.9459;INNATE IMMUNE RESPONSE#0.9458;CELL SURFACE#0.9457;NOS INHIBITOR#0.9455;ANEMIA#0.9455;INFLAMMATORY CELL#0.9454;PROTEIN KINASE R#0.9453;MECHANISMS OF ACTION#0.9452;PERMEABILITY TRANSITION PORE#0.9450;BONE MARROW#0.9450;SYNOVIAL FLUID#0.9449;VASCULAR DISEASE#0.9449;NEURON APOPTOSIS#0.9445;CALCITRIOL#0.9445;2-DEOXYGLUCOSE#0.9444;VACUOLE#0.9443;PARKINSON'S DISEASE#0.9442;MANNITOL#0.9441;NOXIOUS#0.9441;OPTIC NERVE#0.9440;PHOSPHOLIPASE D#0.9439;NEPHRITIS#0.9437;SURFACE PLASMON RESONANCE#0.9436;HEPATIC ISCHEMIA REPERFUSION#0.9436;MRNA SYNTHESIS#0.9435;ATHEROSCLEROTIC#0.9434;MYOFIBROBLAST DIFFERENTIATION#0.9433;REVERSE TRANSCRIPTION#0.9432;MUSCLE FIBER#0.9431;LONG TERM DEPRESSION#0.9430;IMMUNE CELL#0.9429;RESPONSE TO CISPLATIN#0.9427;ENDOSOME#0.9426;FLUOXETINE#0.9425;ALZHEIMER'S DISEASE#0.9424;LUNG METASTASIS#0.9424;BRAIN DAMAGE#0.9424;FATTY LIVER#0.9423;MEMBRANE FRACTION#0.9419;BLISTERING#0.9417;DIET INDUCED OBESITY#0.9416;PROTEIN PHOSPHATASE 1#0.9415;SYNAPTIC TRANSMISSION#0.9415;COENZYME A#0.9414;CENTRAL NERVOUS SYSTEM#0.9413;MEMBRANE BLEBBING#0.9413;M1 MACROPHAGE#0.9409;POLYMERASE CHAIN REACTION#0.9409;INHIBITION OF CELL GROWTH#0.9408;C CHEMOKINE RECEPTOR#0.9407;PANCREATIC ISLET#0.9405;ACUTE MYELOID LEUKEMIA#0.9405;EXTRACELLULAR MATRIX#0.9405;RETINAL PIGMENT EPITHELIAL CELLS#0.9404;CARDIOVASCULAR SYSTEM#0.9403;NERVOUS SYSTEM#0.9402;IMMUNE SYSTEM#0.9399;TELOMERE#0.9398;MAST CELL ACTIVATION#0.9398;CCL20 PRODUCTION#0.9398;PLURIPOTENT STEM CELL#0.9398;ANDROGEN RECEPTOR#0.9398;REGULATION OF GENE EXPRESSION#0.9396;RENAL CELL CARCINOMA#0.9396;ALLERGIC AIRWAY INFLAMMATION#0.9395;SEVERE ACUTE PANCREATITIS#0.9395;DIARRHEA#0.9393;IMMUNE RESPONSE#0.9387;DORMANCY#0.9385;SAPK SIGNALING PATHWAY#0.9385;CYTOKINE RECEPTOR#0.9384;BRAIN ISCHEMIA#0.9383;ACIDIFICATION#0.9383;ATHEROSCLEROSIS#0.9381;RETINOIC ACID RECEPTOR#0.9381;CELL FUSION#0.9379;NEURODEGENERATIVE DISEASE#0.9377;2-METHOXYESTRADIOL#0.9377;MYOBLAST PROLIFERATION#0.9376;TYROSINASE ACTIVITY#0.9375;PIOGLITAZONE#0.9375;GUANYLATE CYCLASE#0.9374;URIC ACID#0.9374;ADHERENS JUNCTION#0.9374;HIGH DENSITY LIPOPROTEIN#0.9371;ISOFLURANE#0.9370;IL-17 PRODUCTION#0.9367;RENAL ISCHEMIA REPERFUSION#0.9366;BORTEZOMIB#0.9362;UBIQUITIN PROTEASOME SYSTEM#0.9361;RHINITIS#0.9358;CYTOKINE BIOSYNTHESIS#0.9358;T HELPER CELL#0.9355;HYPERACTIVE#0.9352;FIBROSARCOMA CELLS#0.9350;MAST CELL DEGRANULATION#0.9350;MRNA DEGRADATION#0.9349;PHOSPHATASE AND TENSIN HOMOLOG#0.9348;NICOTINIC ACETYLCHOLINE RECEPTOR#0.9348;TUMOR TISSUES#0.9344;PYRUVATE#0.9340;NEUROGENESIS#0.9339;ENDOMETRIOSIS#0.9338;SKELETAL MUSCLE ATROPHY#0.9336;FRUCTOSE#0.9336;VASODILATOR#0.9335;BRAIN ENDOTHELIAL CELL#0.9326;DOCETAXEL#0.9324;NEUROFIBRILLARY TANGLE#0.9323;OUTER MEMBRANE#0.9322;C TERMINAL DOMAIN#0.9319;PROSTAGLANDIN E SYNTHASE#0.9317;CORONARY ARTERY DISEASE#0.9314;QUIESCENCE#0.9313;NEUROTOXIN#0.9313;ARTERY DISEASE#0.9313;TYROSINE KINASE RECEPTOR#0.9313;MIDBRAIN#0.9311;TEMOZOLOMIDE#0.9310;ACTIVATED MONOCYTES#0.9309;FATTY ACID SYNTHASE#0.9308;SYSTOLIC BLOOD PRESSURE#0.9306;SYNAPTIC VESICLE#0.9302;THORACIC AORTA#0.9296;COLONIC EPITHELIAL CELLS#0.9296;TISSUE HOMEOSTASIS#0.9295;ENERGY HOMEOSTASIS#0.9284;PULMONARY EDEMA#0.9283;ANCHORAGE INDEPENDENT GROWTH#0.9282;ALPHA-TOCOPHEROL#0.9278;CELL ASSOCIATED#0.9277;DETOXIFICATION#0.9276;NEURITE EXTENSION#0.9272;ETANERCEPT#0.9270;CROSS SECTIONAL AREA#0.9269;CAMP SIGNALING#0.9269;ESTROGEN RECEPTOR ALPHA#0.9268;EPITHELIAL CELL APOPTOSIS#0.9265;ARE BINDING#0.9264;NOCODAZOLE#0.9261;LYMPHOID CELL#0.9251;NARINGENIN#0.9249;MENADIONE#0.9245;LUPUS ERYTHEMATOSUS#0.9245;BLOOD GLUCOSE LEVEL#0.9244;OSSIFICATION#0.9241;LUMINAL#0.9241;FRONTAL#0.9241;NEUROFILAMENT#0.9240;NORMAL CONTROL GROUP#0.9235;RESPIRATION#0.9233;DNA METHYLATION#0.9230;GLUCOSE HOMEOSTASIS#0.9229;72-HOURS#0.9229;ELECTRON TRANSPORT CHAIN#0.9226;RED BLOOD CELL#0.9224;CHRONIC MYELOID LEUKEMIA#0.9222;ARYL HYDROCARBON RECEPTOR#0.9222;MEMBRANE DEPOLARIZATION#0.9221;MITOCHONDRIA MEMBRANE POTENTIAL#0.9220;PEMPHIGUS VULGARIS#0.9217;GASTROINTESTINAL TRACT#0.9212;LPS BINDING#0.9207;2'-DEOXYURIDINE#0.9205;GROWTH HORMONE#0.9205;MELANIN SYNTHESIS#0.9203;BODY WEIGHT RATIO#0.9201;MONOCYTE ACTIVATION#0.9201;ISCHEMIC HEART DISEASE#0.9200;SENSITIZER#0.9199;LYMPHOCYTE PROLIFERATION#0.9197;MYOSIN PHOSPHATASE#0.9197;1α,25-DIHYDROXYVITAMIN D3#0.9195;5-HT UPTAKE#0.9194;INTESTINAL MUCOSA#0.9193;SUCROSE#0.9193;STROMA#0.9191;TISSUE REMODELING#0.9191;CAVEOLAE#0.9189;AMPK ACTIVITY#0.9188;B CELL RECEPTOR#0.9185;FLUOROURACIL#0.9184;INHIBITION OF LTP#0.9184;GLUCOSAMINE#0.9182;LYMPHOCYTIC LEUKEMIA#0.9179;LEYDIG CELL#0.9178;MYELINATION#0.9173;RUTIN#0.9171;PARTURITION#0.9168;DYNEIN#0.9166;FATTY LIVER DISEASE#0.9162;INFLIXIMAB#0.9161;IMATINIB MESYLATE#0.9160;IMMUNE SUPPRESSION#0.9159;BLEBBING#0.9154;PANCREATIC STELLATE CELL#0.9145;ADRIAMYCIN#0.9144;INTRINSIC APOPTOSIS#0.9143;CHOLINE#0.9143;WEIGHT GAIN#0.9142;MASTITIS#0.9131;CELLULAR OXIDATIVE STRESS#0.9131;LITHIUM#0.9130;PHAGOSOME#0.9129;LYMPHOCYTE ACTIVATION#0.9125;INTERMEDIATE FILAMENT#0.9124;DUCT CELL#0.9120;COLON EPITHELIAL CELL#0.9118;ASCITES#0.9117;CELL COMMUNICATION#0.9115;LUNG MICROVASCULAR ENDOTHELIAL#0.9113;UBIQUITIN PROTEASOME PATHWAY#0.9111;NODULE FORMATION#0.9107;LEFT VENTRICULAR REMODELING#0.9107;BLOOD TESTIS BARRIER#0.9106;BONE REGENERATION#0.9102;LYSIS#0.9101;ANAPHYLAXIS#0.9101;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9101;CELL MATURATION#0.9098;CRESCENTIC GLOMERULONEPHRITIS#0.9095;CYCLOSPORINE#0.9091;BROWN ADIPOSE TISSUE#0.9090;CONTACT DERMATITIS#0.9090;HINDLIMB#0.9087;INSOLUBLE FRACTION#0.9086;ER STRESS-INDUCED APOPTOSIS#0.9081;C FIBER#0.9081;MOLAR#0.9079;GLIOBLASTOMA MULTIFORME#0.9076;MALARIA#0.9076;GELDANAMYCIN#0.9069;BILE DUCT#0.9068;MYELOID CELL LEUKEMIA#0.9067;PARENCHYMA#0.9062;GLUTAMATE CYSTEINE LIGASE#0.9061;PROTEIN TRANSLATION#0.9060;DOUBLE STRAND BREAK#0.9058;ASTROCYTOMA#0.9058;PULMONARY ARTERIAL HYPERTENSION#0.9054;RESPONSE TO GROWTH FACTOR#0.9054;DIMETHYL SULFOXIDE#0.9048;IMMUNOSUPPRESSANT#0.9043;RITUXIMAB#0.9037;MOTHERS AGAINST DECAPENTAPLEGIC#0.9036;AMPA RECEPTOR#0.9035;ALLOPURINOL#0.9029;BRAIN NATRIURETIC PEPTIDE#0.9026;INDUCTION OF CYTOKINES#0.9026;OXIDATIVE DNA DAMAGE#0.9026;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9026;CELLULAR RESPONSE TO STRESS#0.9021;BLEOMYCIN#0.9012;MACULAR DEGENERATION#0.9009;STEM CELL DIFFERENTIATION#0.9001;PROTEIN STABILIZATION#0.8998;TARGET ORGAN DAMAGE#0.8996;RAT BONE MARROW#0.8996;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.8991;RESONANCE ENERGY TRANSFER#0.8990;DIGESTION#0.8990;HEMOCYTE#0.8982;POLYCYCLIC AROMATIC HYDROCARBON#0.8982;PROTEIN KINASE ACTIVATOR#0.8982;DNA DAMAGE CHECKPOINT#0.8981;TROPHOBLAST CELL#0.8980;DILATED CARDIOMYOPATHY#0.8978;MICROFILAMENT#0.8976;DISEASE ACTIVITY INDEX#0.8976;RESPONSE TO INSULIN#0.8973;PARATHYROID HORMONE#0.8968;HESPERETIN#0.8966;ASPARTIC ACID#0.8960;AGE RELATED MACULAR DEGENERATION#0.8959;KERATINOCYTE PROLIFERATION#0.8959;EXTRACELLULAR MATRIX COMPONENT#0.8953;ANTIGEN PRESENTATION#0.8953;ENDOCHONDRAL OSSIFICATION#0.8953;ALVEOLAR BONE LOSS#0.8950;AMITRIPTYLINE#0.8949;KERATINOCYTE DIFFERENTIATION#0.8949;INGENUITY PATHWAY ANALYSIS#0.8948;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8948;OXIDATIVE PHOSPHORYLATION#0.8947;RESPIRATORY TRACT#0.8945;HUMAN MAMMARY EPITHELIAL#0.8944;TOTAL ANTIOXIDANT CAPACITY#0.8942;SATURATED FATTY ACID#0.8940;LIVER X RECEPTOR#0.8937;HUMAN LENS EPITHELIAL#0.8930;CENTROSOME#0.8926;HYDROXYPROLINE#0.8925;CORONARY ARTERY ENDOTHELIAL CELLS#0.8925;BUPIVACAINE#0.8920;PICEATANNOL#0.8919;HETEROTRIMERIC G-PROTEIN#0.8919;KNEE JOINT#0.8917;MELANOMA DIFFERENTIATION ASSOCIATED#0.8914;FOCAL CEREBRAL ISCHEMIA#0.8912;INTEGRIN LINKED KINASE#0.8907;MOLECULAR DYNAMICS SIMULATION#0.8906;VASODILATION#0.8906;GESTATION#0.8904;METAPHASE#0.8903;GOBLET CELL#0.8899;GLUCOSE INTOLERANCE#0.8898;KERATINOCYTE MIGRATION#0.8892;HELLP SYNDROME#0.8885;ESOPHAGEAL CANCER#0.8883;EPITHELIAL BARRIER FUNCTION#0.8880;PHAGOSOME MATURATION#0.8868;ATP BINDING CASSETTE#0.8868;DISCOIDIN DOMAIN RECEPTOR#0.8865;BONE GROWTH#0.8864;DUAL LUCIFERASE REPORTER#0.8863;CARDIAC MUSCLE#0.8856;AXONAL TRANSPORT#0.8856;PROTEINASE ACTIVATED RECEPTOR#0.8850;PALMITOYL#0.8848;CHEMOKINE SECRETION#0.8844;CORONARY HEART DISEASE#0.8844;RECEPTOR TRANSACTIVATION#0.8842;CELL NUCLEUS#0.8839;PERITONEAL MESOTHELIAL CELLS#0.8836;BIOTIN#0.8829;HEMATOPOIETIC PROGENITOR CELL#0.8827;INTRACELLULAR LOCALIZATION#0.8819;FORMYL PEPTIDE RECEPTOR#0.8818;ACTIVATION OF SIGNAL TRANSDUCTION#0.8813;TRANSENDOTHELIAL ELECTRICAL RESISTANCE#0.8813;GLYCOSYLATION#0.8812;LANGERHANS CELL#0.8808;HISTONE MODIFICATION#0.8807;CARNITINE#0.8806;EXCRETION#0.8804;REPLICATIVE SENESCENCE#0.8802;SALIVARY GLAND#0.8798;HYPERACTIVITY#0.8792;BASAL CELL#0.8789;THROMBIN RECEPTOR#0.8788;INTERSTITIAL CELL#0.8787;MYOCARDITIS#0.8787;UTERUS#0.8782;GLUCONEOGENESIS#0.8782;HUMAN GASTRIC CARCINOMA#0.8781;MRNA BINDING#0.8781;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8778;BONE MINERAL DENSITY#0.8777;EPIRUBICIN#0.8774;CANCER RELATED DEATH#0.8773;LOCALISATION#0.8773;RETINAL PIGMENT EPITHELIUM#0.8764;CORONARY ARTERY LIGATION#0.8762;VSMC DIFFERENTIATION#0.8761;GREEN TEA POLYPHENOL#0.8758;ENTRY INTO MITOSIS#0.8756;ACETYL COA CARBOXYLASE#0.8753;IL-13 PRODUCTION#0.8750;ERYTHROID CELL#0.8744;FLOW CYTOMETRY ASSAY#0.8744;NAIVE T CELL#0.8741;CATION CHANNEL#0.8739;CASEIN KINASE 2#0.8732;BONE MORPHOGENIC PROTEIN#0.8731;TELOMERASE ACTIVITY#0.8726;UMBILICAL CORD BLOOD#0.8726;CELLULAR ADHESION MOLECULE#0.8726;LYMPH NODE METASTASIS#0.8716;GINKGO BILOBA#0.8713;P2 RECEPTOR#0.8712;ONCOGENESIS#0.8712;GRAM NEGATIVE BACTERIAL#0.8710;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.8705;8-HYDROXY-2'-DEOXYGUANOSINE#0.8698;PERICYTE#0.8696;CORTICOTROPIN#0.8695;PROSTACYCLIN#0.8689;SPUTUM#0.8686;NUCLEOTIDE EXCISION REPAIR#0.8677;KERATIN FILAMENT#0.8676;MYOCARDIAL INFARCT SIZE#0.8664;GROWTH FACTOR BINDING#0.8660;NUCLEIC ACID#0.8651;URINARY BLADDER#0.8649;FARNESYL#0.8649;LUPUS NEPHRITIS#0.8645;ALLERGIC AIRWAY DISEASE#0.8643;GERMINAL CENTER#0.8639;GEMCITABINE#0.8638;AMYLOID PROTEIN#0.8637;APOPTOTIC PROGRAM#0.8636;EICOSAPENTAENOIC ACID#0.8628;PULMONARY VASCULAR REMODELING#0.8624;MIDAZOLAM#0.8624;ANTIPHOSPHOLIPID SYNDROME#0.8621;PLASMA CELL#0.8621;FACTOR S#0.8621;BRANCHING MORPHOGENESIS#0.8613;ISOQUINOLINE#0.8607;CERAMIDE FORMATION#0.8607;LYMPHOMA CELL LINES#0.8605;RESPIRATORY SYNCYTIAL VIRUS#0.8602;C-LEVEL#0.8598;AUTOPHAGOSOME FORMATION#0.8592;NECROPTOSIS#0.8589;MULTIPLE MYELOMA CELLS#0.8588;BODY WEIGHT LOSS#0.8586;ENDOMETRIUM#0.8581;HIGH CHOLESTEROL DIET#0.8579;TRYPTOPHAN#0.8577;SPINDLE ASSEMBLY#0.8575;IMMUNE EVASION#0.8571;NADPH OXIDASE COMPLEX#0.8566;TUMOR NECROSIS FACTOR PRODUCTION#0.8562;ALLERGIC CONTACT DERMATITIS#0.8560;PROTEIN OXIDATION#0.8555;INHIBITION OF ROS GENERATION#0.8539;COLCHICINE#0.8537;CASPASE-INDEPENDENT CELL DEATH#0.8533;SURAMIN#0.8529;TYPE 1 DIABETIC#0.8529;MELANOMA CELL LINES#0.8522;ACUTE LUNG INFLAMMATION#0.8519;CORNEAL ENDOTHELIUM#0.8516;COLONY FORMATION ASSAY#0.8515;REGULATION OF CELL PROLIFERATION#0.8514;RECEPTOR BINDING#0.8512;THYROID CANCER#0.8509;CONDITIONED PLACE AVERSION#0.8508;EFFECTOR T CELL#0.8507;DEXTRAN SODIUM SULFATE#0.8506;CHONDROCYTE PROLIFERATION#0.8504;LIPOXYGENASE PATHWAY#0.8503;GASTRITIS#0.8498;CYTOTOXIC T-LYMPHOCYTE#0.8491;EPITHELIAL CELL PROLIFERATION#0.8488;THALIDOMIDE#0.8488;MULTIPLE ORGAN DYSFUNCTION#0.8485;NEURON DEATH#0.8481;ATPASE INHIBITOR#0.8480;MACROPHAGE DIFFERENTIATION#0.8479;IDIOPATHIC PULMONARY FIBROSIS#0.8476;COMPLEMENT RECEPTOR#0.8475;HUMAN SERUM ALBUMIN#0.8469;CASPASE-1 ACTIVITY#0.8468;OXIDATIVE METABOLISM#0.8462;TISSUE REGENERATION#0.8457;CHINESE HERBAL MEDICINE#0.8454;BUDESONIDE#0.8453;SMOOTH MUSCLE CONTRACTION#0.8448;CELL CHEMOTAXIS#0.8448;IMIQUIMOD#0.8446;SEVOFLURANE#0.8436;KINASE BINDING#0.8436;CELL EXPANSION#0.8435;TOXICANT#0.8434;SUPEROXIDE DISMUTASE ACTIVITY#0.8425;ACUTE PROMYELOCYTIC LEUKEMIA#0.8422;T CELL DEVELOPMENT#0.8419;IRON OVERLOAD#0.8418;TRANSCRIPTION FACTOR ACTIVITY#0.8416;MITOCHONDRIAL MEMBRANE DEPOLARIZATION#0.8415;HUMAN EMBRYONIC STEM#0.8415;BINDING PROTEIN 3#0.8407;LUTEIN#0.8407;SARCOPLASMIC RETICULUM#0.8406;LUNG DAMAGE#0.8403;EIF4E BINDING#0.8401;LOVASTATIN#0.8398;LACTIC ACID#0.8397;ARRHYTHMIA#0.8396;HYALURONIC ACID#0.8395;DENTAL PULP STEM CELL#0.8394;GRAFT VERSUS HOST#0.8393;5'-ADENOSINE MONOPHOSPHATE#0.8389;PERITONITIS#0.8388;H POST INFECTION#0.8387;CC CHEMOKINE RECEPTOR#0.8386;THEOPHYLLINE#0.8385;DEFENSE RESPONSE#0.8382;HCV CORE PROTEIN#0.8381;TACROLIMUS#0.8379;FEMUR#0.8376;JNK INTERACTING PROTEIN#0.8375;INDUCED RENAL INJURY#0.8370;ESOPHAGUS#0.8369;SMC PROLIFERATION#0.8363;CELLULAR METABOLISM#0.8363;SPERMATOGENESIS#0.8362;ACTIVATION-INDUCED CELL DEATH#0.8356;CELL JUNCTION#0.8356;TH1 IMMUNE RESPONSE#0.8355;PROPRANOLOL#0.8355;LIPOLYSIS#0.8354;B CELL ACTIVATION#0.8349;T CELL DIFFERENTIATION#0.8348;REACTIVE NITROGEN SPECIES#0.8346;CHANNEL ACTIVITY#0.8345;TAUROCHOLATE#0.8345;CHRONIC HEART FAILURE#0.8340;COLLAGEN TYPE II#0.8340;FULL THICKNESS BURN#0.8337;CHOLESTASIS#0.8335;HYPERCHOLESTEROLEMIA#0.8335;PAPILLOMA#0.8333;FIBROBLAST MIGRATION#0.8332;NILOTINIB#0.8330;PERIPHERAL NERVOUS SYSTEM#0.8329;URIDINE#0.8322;SPATIAL LEARNING#0.8321;MU OPIOID RECEPTOR#0.8316;METASTATIC BREAST CANCER#0.8316;PARATHYROID#0.8311;LIPOGENESIS#0.8310;COMMON CAROTID ARTERY#0.8307;RESPIRATORY CHAIN#0.8304;CYTOCHROME C OXIDASE#0.8304;VITAMIN A#0.8304;WHITE BLOOD CELL#0.8302;NUCLEAR MORPHOLOGY#0.8293;OSTEOSARCOMA CELL LINES#0.8282;SHAM OPERATION GROUP#0.8282;PANCREATIC DUCTAL ADENOCARCINOMA#0.8282;PROTEASE ACTIVITY#0.8281;PROTEIN CARBONYL CONTENT#0.8281;IMMATURE DENDRITIC CELL#0.8280;HEAT SHOCK FACTOR#0.8278;MUSCLE CELL DIFFERENTIATION#0.8277;NLRP3 INFLAMMASOME ACTIVATION#0.8273;ENDOTHELIAL CELL DYSFUNCTION#0.8264;SYNAPTOSOME#0.8263;COLORECTAL CARCINOMA#0.8262;AMINOGUANIDINE#0.8261;RETINAL DISEASE#0.8257;PROSTATE EPITHELIAL CELL#0.8256;BREAST CANCER PATIENTS#0.8240;ADVANCED GLYCATION ENDPRODUCT#0.8238;DIAZOXIDE#0.8237;PROSTATE CARCINOMA#0.8230;TRANSCRIPTION FACTOR BINDING#0.8225;TO THE PROGRESSION#0.8224;REGULATION OF INFLAMMATORY RESPONSE#0.8223;GLYCOGEN SYNTHESIS#0.8219;SERUM AMYLOID A#0.8218;EXENATIDE#0.8216;B CELL PROLIFERATION#0.8214;EOSINOPHIL CHEMOTAXIS#0.8213;NF-KAPPAB CASCADE#0.8209;EPITHELIAL SODIUM CHANNEL#0.8207;IFN-GAMMA SECRETION#0.8205;SPERMINE#0.8201;CYCLOPHOSPHAMIDE#0.8200;CONDITIONED PLACE PREFERENCE#0.8198;NON-SMALL CELL LUNG CARCINOMA#0.8197;EPILEPSY#0.8193;CONJUGATION#0.8190;SPARED NERVE INJURY#0.8184;AORTIC VALVE#0.8184;RENAL CARCINOMA#0.8181;IL-27 PRODUCTION#0.8175;BETA ADRENOCEPTOR#0.8173;OSMOTIC RESPONSE#0.8160;CHOLESTEROL EFFLUX#0.8158;MUTAGENIC#0.8156;REACTIVE OXYGEN SPECIES FORMATION#0.8156;RESPONSE TO GENOTOXIC STRESS#0.8152;GLIBENCLAMIDE#0.8150;CONGESTIVE HEART FAILURE#0.8145;ADENO ASSOCIATED VIRUS#0.8142;REGULATION OF MRNA#0.8140;IBUPROFEN#0.8138;INDUCED PLURIPOTENT STEM CELL#0.8137;IGE RECEPTOR#0.8133;GALACTOSIDASE ACTIVITY#0.8128;SYNOVITIS#0.8123;RESPONSE TO TREATMENT#0.8123;KOREAN RED GINSENG#0.8122;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.8116;PHOSPHOENOLPYRUVATE#0.8112;PORE FORMATION#0.8111;DASATINIB#0.8107;HISTONE H3 ACETYLATION#0.8106;NULL CELL#0.8105;FIBRIL#0.8102;GLOMERULAR FILTRATION#0.8098;CELL BODY#0.8098;ETHYL ACETATE EXTRACT#0.8097;TRANSVERSE AORTIC CONSTRICTION#0.8097;ERYTHROPOIESIS#0.8096;INTEGRIN ACTIVATION#0.8093;MALIGNANT GLIOMA#0.8091;PERITONEAL CAVITY#0.8091;STEROL REGULATORY ELEMENT#0.8088;NORDIHYDROGUAIARETIC ACID#0.8087;HEMOLYSIS#0.8084;INTERFERON STIMULATED GENE#0.8083;SOLUBLE FRACTION#0.8079;IMMUNE DYSFUNCTION#0.8067;NECROTIZING#0.8063;LUNG ENDOTHELIAL CELLS#0.8062;VINCRISTINE#0.8060;LYMPHOID TISSUE#0.8059;CARBACHOL#0.8055;PANCREATIC CARCINOMA#0.8054;FLUTICASONE PROPIONATE#0.8046;BILE DUCT LIGATION#0.8044;KAPOSI'S SARCOMA#0.8039;FOLLICLE STIMULATING HORMONE#0.8035;CELLULAR HOMEOSTASIS#0.8024;LEUKEMIA INHIBITORY FACTOR#0.8014;PHOSPHOLIPID SCRAMBLING#0.8014;OSTEOBLAST PROLIFERATION#0.8009;CYCLIC MECHANICAL STRETCH#0.8007;ELLAGIC ACID#0.8003;EARLY BRAIN INJURY#0.8001;PARACRINE SIGNALING#0.8000;ADULT RAT CARDIOMYOCYTES#0.7999;LIPID DROPLET#0.7994;HEAD AND NECK CANCER#0.7994;NECK CANCER#0.7993;ALIZARIN RED STAINING#0.7992;DEFEROXAMINE#0.7988;PROTEIN KINASE C ACTIVATION#0.7987;METASTATIC MELANOMA#0.7986;MONOCYTE DIFFERENTIATION#0.7977;CHANNEL INHIBITOR#0.7975;MUSCULAR DYSTROPHY#0.7972;HUMAN HEPATOMA CELL LINES#0.7968;DERMIS#0.7962;INSULINOMA#0.7956;HYDROGEN PEROXIDE-INDUCED APOPTOSIS#0.7956;PHOSPHODIESTERASE INHIBITOR#0.7954;PINEAL GLAND#0.7952;DRUG BINDING#0.7948;MITOTIC ENTRY#0.7945;MOUSE EMBRYO FIBROBLASTS#0.7938;COLLAGEN TYPE IV#0.7934;ZINC FINGER PROTEIN#0.7932;LYASE ACTIVITY#0.7928;PHENOTYPIC SWITCHING#0.7926;CORNEAL ENDOTHELIAL CELL#0.7925;PHOSPHATE BUFFERED SALINE#0.7925;BONE MARROW FAILURE#0.7923;MTDNA#0.7922;ATP BINDING CASSETTE TRANSPORTER#0.7920;MICROGLIAL CELL ACTIVATION#0.7919;RADICAL SCAVENGING ACTIVITY#0.7911;BRUSH BORDER#0.7910;MACROPHAGE CHEMOTAXIS#0.7910;COLLAGEN DEGRADATION#0.7903;MITOCHONDRIAL ELECTRON TRANSPORT#0.7903;MRNA DESTABILIZATION#0.7894;FLAVOPIRIDOL#0.7892;LUNG INJURY SCORE#0.7888;CHRONIC CEREBRAL HYPOPERFUSION#0.7887;BONE CELLS#0.7882;OSTEOARTHRITIC CARTILAGE#0.7875;OUABAIN#0.7874;DIFFERENTIAL GENE EXPRESSION#0.7873;VX-702#0.7871;BUDDING#0.7860;GREEN TEA EXTRACT#0.7859;SALVIA MILTIORRHIZA BUNGE#0.7857;HISTIDINE#0.7854;ALIZARIN RED S#0.7853;PROTEIN PHOSPHATASE ACTIVITY#0.7853;EMBRYO DEVELOPMENT#0.7848;GINKGO BILOBA EXTRACT#0.7840;HUMAN BETA DEFENSIN#0.7837;MITOTIC CATASTROPHE#0.7834;REGULATION OF AUTOPHAGY#0.7834;SIGNAL TRANSMISSION#0.7827;RETINAL DEGENERATION#0.7823;P2Y RECEPTOR#0.7815;LIPOPROTEIN LIPASE#0.7815;SULINDAC#0.7815;GEFITINIB#0.7814;METAPLASIA#0.7813;THYROID CARCINOMA#0.7812;SKELETAL DEVELOPMENT#0.7808;CONTACT INHIBITION#0.7807;TREG CELL#0.7803;ETHYL ACETATE FRACTION#0.7802;INFLAMMATORY MONOCYTE#0.7799;AUTOPHAGIC DEATH#0.7790;RHEUMATIC DISEASE#0.7786;RECEPTOR INTERNALIZATION#0.7785;HUMAN PROXIMAL TUBULAR#0.7782;CPT-11#0.7766;MUSCLE HYPERTROPHY#0.7764;FANCONI ANEMIA#0.7755;VASCULITIS#0.7754;EARLY ENDOSOME#0.7754;BRAIN WATER CONTENT#0.7739;NERVE DAMAGE#0.7735;PERIPHERAL BLOOD LYMPHOCYTES#0.7735;CAROTENOID#0.7733;TOPOISOMERASE#0.7732;CEREBRAL INFARCTION#0.7727;MOTOR ACTIVITY#0.7724;PERIPHERAL BLOOD LEUKOCYTE#0.7720;HORMONE SENSITIVE LIPASE#0.7716;PERIPHERAL BLOOD T-CELLS#0.7714;CELL PHYSIOLOGY#0.7711;MESENTERIC LYMPH NODE#0.7710;ACUTE LIVER FAILURE#0.7704;PURKINJE CELL#0.7699;HAIR CELL#0.7697;HUNTINGTON'S DISEASE#0.7696;MANNOSE RECEPTOR#0.7694;LEISHMANIASIS#0.7690;VISCERAL ADIPOSE TISSUE#0.7690;FENRETINIDE#0.7689;MEMORY T CELL#0.7685;RESPONSE TO ENDOTOXIN#0.7682;NUCLEOSOME#0.7678;RALOXIFENE#0.7677;HUMAN LEUKOCYTE ANTIGEN#0.7675;LYMPHANGIOGENESIS#0.7668;SCUTELLARIA BAICALENSIS GEORGI#0.7667;SKELETON#0.7666;HESPERIDIN#0.7665;HYDROCORTISONE#0.7663;RESPONSE TO OSMOTIC STRESS#0.7662;FAT CELL#0.7660;DESMOSOME#0.7656;NEUROTRANSMISSION#0.7652;OSTEOCLAST PRECURSOR CELL#0.7649;T LYMPHOCYTE ACTIVATION#0.7643;VSMC APOPTOSIS#0.7641;MONOCYTIC LEUKEMIA#0.7641;PKCEPSILON#0.7641;SUMOYLATION#0.7640;DIAPHRAGM#0.7635;MURINE EMBRYONIC FIBROBLASTS#0.7628;MONOCYTE CHEMOTAXIS#0.7626;TROGLITAZONE#0.7626;HEMOLYTIC UREMIC SYNDROME#0.7621;EYE DISEASE#0.7616;COMPLEX II#0.7615;COLON MUCOSA#0.7614;MIDDLE EAR#0.7611;COLON ADENOCARCINOMA#0.7609;FENOFIBRATE#0.7601;PROSTAGLANDIN SYNTHESIS#0.7601;LASER SCANNING MICROSCOPY#0.7598;RETINOID X RECEPTOR#0.7592;SPHINGOSINE KINASE 1#0.7590;AORTIC ANEURYSM#0.7589;CELL-MEDIATED IMMUNE RESPONSE#0.7583;ALCOHOLIC FATTY LIVER#0.7583;LIPOPOLYSACCHARIDE BINDING#0.7580;RECEPTOR ACTIVITY#0.7575;CHRONIC INFLAMMATORY RESPONSE#0.7572;CORTICOTROPIN-RELEASING FACTOR#0.7570;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.7568;BRONCHITIS#0.7568;ORNITHINE DECARBOXYLASE#0.7567;HUMAN CERVICAL CARCINOMA#0.7566;HEART MUSCLE#0.7565;MYOGENIC CELL#0.7562;NK CELL DIFFERENTIATION#0.7557;IL-23 PRODUCTION#0.7555;INTENSIVE CARE UNIT#0.7554;CACHEXIA#0.7554;GLUTAMIC ACID#0.7554;HIGH OSMOLARITY GLYCEROL#0.7548;HUMAN TRABECULAR MESHWORK#0.7547;ETHANE#0.7546;MITOCHONDRIAL RESPIRATORY CHAIN#0.7541;COLORECTAL ADENOCARCINOMA#0.7536;PHOSPHATASE I#0.7533;DENDRITIC SPINE#0.7532;SYNAPTIC VESICLE PROTEIN#0.7526;LAMINAR SHEAR STRESS#0.7526;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7525;ANION CHANNEL#0.7522;GOLGI APPARATUS#0.7517;INFLAMMATORY AIRWAY DISEASE#0.7512;NONALCOHOLIC FATTY LIVER DISEASE#0.7511;SECRETORY VESICLE#0.7508;RESPONSE TO PMA#0.7508;MITOCHONDRION#0.7500;CHRONIC LIVER DISEASE#0.7500;ERYTHROLEUKEMIA#0.7498;EXTRACELLULAR VESICLE#0.7496;TRANSDIFFERENTIATION#0.7496;PML NB#0.7495;COMPLEMENT ACTIVATION#0.7494;NEURAL CREST#0.7491;CEREBROVASCULAR DISEASE#0.7485;ERYTHROBLAST#0.7476;RESPONSE TO IONIZING RADIATION#0.7475;SODIUM DODECYL SULFATE#0.7468;SATELLITE GLIAL CELLS#0.7467;NUCLEAR RESPIRATORY FACTOR#0.7467;DODECYL SULFATE#0.7467;CYTOMETRIC BEAD ARRAY#0.7465;CYCLE INHIBITOR P21#0.7464;GLUTATHIONE SYNTHESIS#0.7459;MESOTHELIOMA CELL#0.7458;BETA-NF#0.7453;SCANNING ELECTRON MICROSCOPY#0.7452;NERVE FIBER#0.7449;INFERTILITY#0.7446;INHIBITION OF OSTEOCLAST DIFFERENTIATION#0.7445;PERIODONTAL LIGAMENT STEM CELL#0.7441;AUTOPHAGIC VACUOLE#0.7441;INTRACELLULAR ACIDIFICATION#0.7437;MYELOID DENDRITIC CELL#0.7436;BASOPHIL ACTIVATION#0.7435;UNILATERAL URETERAL OBSTRUCTION#0.7435;PLASMA PROTEIN#0.7434;T CELL APOPTOSIS#0.7432;RAT NEONATAL CARDIOMYOCYTES#0.7432;BRAIN CORTEX#0.7431;CELL MORPHOGENESIS#0.7429;VEGF SIGNALING PATHWAY#0.7427;PUROMYCIN#0.7426;URETERAL OBSTRUCTION#0.7425;ENDOTHELIN A RECEPTOR#0.7424;LIRAGLUTIDE#0.7422;CYTOSKELETON ORGANIZATION#0.7416;NUCLEAR EXPORT SIGNAL#0.7411;GROWTH DIFFERENTIATION FACTOR#0.7409;ADENOSINE 5'-MONOPHOSPHATE#0.7409;VASOPRESSIN#0.7407;CYCLIC GUANOSINE MONOPHOSPHATE#0.7406;ADIPOSE-DERIVED STEM CELL#0.7405;EVERY OTHER DAY#0.7405;SPINDLE ASSEMBLY CHECKPOINT#0.7402;ACETYLTRANSFERASE ACTIVITY#0.7397;MESENCHYMAL STROMAL CELL#0.7395;BROWN ADIPOCYTE DIFFERENTIATION#0.7394;BRUSH BORDER MEMBRANE#0.7393;SUBEROYLANILIDE HYDROXAMIC ACID#0.7383;CHOLESTEROL METABOLISM#0.7381;IL-12 SECRETION#0.7381;EXTRACELLULARLY REGULATED KINASE#0.7378;INSULIN GROWTH FACTOR#0.7371;ORAL SQUAMOUS CELL CARCINOMA#0.7369;CIRCADIAN RHYTHM#0.7365;CHRONIC NEUROPATHIC PAIN#0.7364;RENAL INTERSTITIAL FIBROSIS#0.7357;ROFLUMILAST#0.7356;COGNITION#0.7355;CAMPTOTHECIN#0.7348;PROTEIN INTERACTION NETWORK#0.7348;STEM CELL TRANSPLANTATION#0.7347;GONADOTROPIN RELEASING HORMONE#0.7346;NEPHRON#0.7332;ARECA NUT EXTRACT#0.7328;MUSCLE FIBRE#0.7327;INTERLEUKIN-6 SECRETION#0.7323;ESTROGENS#0.7321;PERIPHERAL BLOOD CELLS#0.7321;PRE-ECLAMPSIA#0.7319;ESOPHAGEAL EPITHELIAL CELLS#0.7317;RHABDOMYOSARCOMA#0.7312;AMNION#0.7304;LYMPHOID ORGANS#0.7304;CYTOTOXIN#0.7303;TNF BIOSYNTHESIS#0.7299;STEM CELL MARKER#0.7296;RESPONSE TO SORBITOL#0.7295;HYPOTENSION#0.7294;FATTY ACID BINDING#0.7294;MACROPHAGE PROLIFERATION#0.7293;NEOMYCIN#0.7291;POSTSYNAPTIC DENSITY#0.7289;CYTOKINESIS#0.7289;FURAN#0.7288;PIRFENIDONE#0.7288;PROTEIN MODIFICATION#0.7288;GINGIVAL EPITHELIAL CELLS#0.7288;PATHOGEN RECOGNITION RECEPTOR#0.7286;TRABECULAR MESHWORK CELLS#0.7280;FATTY ACID METABOLISM#0.7274;IL-4 SECRETION#0.7271;MARKERS OF INFLAMMATION#0.7262;TRANSFERASE INHIBITOR#0.7259;MEMBRANE RUFFLING#0.7259;CHOLERA#0.7259;COCHLEA#0.7246;CARDIOMYOCYTE PROLIFERATION#0.7246;DENDRITIC CELL DIFFERENTIATION#0.7242;BLOOD RETINAL BARRIER#0.7240;SPHINGOSINE KINASE INHIBITOR#0.7238;ONCOGENE INDUCED SENESCENCE#0.7233;INTESTINAL STEM CELL#0.7227;OPIOID PEPTIDE#0.7226;GAMMA-GLUTAMYLCYSTEINE#0.7226;FILOPODIA FORMATION#0.7224;ERK2 CASCADE#0.7221;SPECIFIC PROTEIN 1#0.7219;CHROMATIN REMODELING COMPLEX#0.7214;CANCER STEM-LIKE CELL#0.7211;MESENCHYME#0.7210;STEM CELL PROLIFERATION#0.7207;CORTICAL CELL#0.7201;NORADRENALINE#0.7201;INTERFERON PRODUCTION#0.7200;ERLOTINIB#0.7200;LACRIMAL GLAND#0.7199;L-TYPE CALCIUM CHANNEL#0.7198;BUTENOIC ACID#0.7196;MUSCLE STEM CELL#0.7194;GASTRIC ULCER#0.7190;NITRIC OXIDE SYNTHESIS#0.7184;AUTOIMMUNE HEPATITIS#0.7184;ISLETS OF LANGERHANS#0.7181;REPRODUCTIVE SYSTEM#0.7181;GINKGOLIDE-B#0.7177;RNA SYNTHESIS#0.7174;MITOCHONDRIAL ELECTRON TRANSPORT CHAIN#0.7171;I KAPPAB KINASE#0.7169;SEVERE ACUTE RESPIRATORY SYNDROME#0.7168;CC CHEMOKINE LIGAND#0.7165;CELLULAR MEMBRANE#0.7163;LEUCINE RICH REPEAT#0.7161;NUCLEAR LOCALIZATION SIGNAL#0.7159;ORAL MUCOSA#0.7156;PROTEIN FOLDING#0.7155;WNT SIGNALING PATHWAY#0.7154;CHOLANGIOCARCINOMA#0.7151;ORGANOGENESIS#0.7150;MYOBLAST FUSION#0.7139;DIPYRIDAMOLE#0.7135;BRAIN DEVELOPMENT#0.7135;HOST-PATHOGEN INTERACTION#0.7132;INTERLEUKIN 12 PRODUCTION#0.7130;TUDCA#0.7129;ROSUVASTATIN#0.7122;LEUKOTRIENE BIOSYNTHESIS#0.7119;MAGNETIC RESONANCE IMAGING#0.7109;MUCUS PRODUCTION#0.7101;ANAPHASE#0.7088;MITOCHONDRIAL TRANSCRIPTION#0.7088;CELLULAR COMPONENT#0.7083;IRRITANT#0.7076;LEWIS LUNG CARCINOMA#0.7076;CYCLOPHILIN#0.7071;BONE MARROW MICROENVIRONMENT#0.7071;SCAVENGER RECEPTOR A#0.7070;ACTIN CYTOSKELETON REORGANIZATION#0.7068;BLOOD COAGULATION#0.7067;CELL CELL JUNCTION#0.7057;S-PHASE CHECKPOINT#0.7053;NASAL MUCOSA#0.7052;CAROTID ARTERY LIGATION#0.7052;T CELL ANERGY#0.7049;DEATH RECEPTOR 5#0.7048;MOLECULAR FUNCTION#0.7045;HEME DEGRADATION#0.7042;OOCYTE MATURATION#0.7042;ORNITHINE#0.7036;ACUTE PHASE RESPONSE#0.7035;FIBRINOGEN BINDING#0.7031;INTERLEUKIN-8 SECRETION#0.7031;LYMPHOCYTE APOPTOSIS#0.7030;RETINAL ISCHEMIA#0.7029;LAMININ RECEPTOR#0.7025;HIGH GLUCOSE LEVEL#0.7023;ANTHRACENE#0.7023;CCL5 PRODUCTION#0.7019;OBSTRUCTIVE LUNG DISEASE#0.7018;CRYSTAL VIOLET#0.6998;MITOCHONDRIAL CELL DEATH#0.6989;BURKITT LYMPHOMA#0.6985;OTITIS MEDIA#0.6967;INTERFERON GAMMA PRODUCTION#0.6964;ACUTE HEPATIC INJURY#0.6962;SIGNALOSOME#0.6961;MAPK BINDING#0.6956;INTESTINAL TRACT#0.6951;ABDOMINAL AORTIC ANEURYSM#0.6947;SPERMATOZOA#0.6947;TRADITIONAL CHINESE MEDICINAL#0.6946;VIRION#0.6944;EPITHELIAL GROWTH FACTOR#0.6944;MICROVESICLE#0.6941;L-DOPA#0.6934;MUSCULAR ATROPHY#0.6932;KAPPA OPIOID RECEPTOR#0.6930;EXTRACELLULAR SPACE#0.6923;TELOMERASE REVERSE TRANSCRIPTASE#0.6920;MALONALDEHYDE#0.6918;DEGRADATION OF CYCLIN#0.6916;FOLIC ACID#0.6916;ADALIMUMAB#0.6912;IP-10 PRODUCTION#0.6911;VENULE#0.6910;DIPEPTIDYL PEPTIDASE#0.6903;GLUCOSE TOLERANCE TEST#0.6896;CANDESARTAN#0.6895;TRANSFERRIN RECEPTOR#0.6895;HOMOLOGOUS RECOMBINATION#0.6895;PORE FORMING TOXINS#0.6894;GENTAMICIN#0.6879;NALOXONE#0.6874;ILOPROST#0.6870;IKK COMPLEX#0.6869;MEK ACTIVITY#0.6866;DEXMEDETOMIDINE#0.6866;RESPONSE TO IL-12#0.6862;TRANSCRIPTION FACTOR COMPLEX#0.6859;NUCLEAR HORMONE RECEPTOR#0.6854;TUMOR ASSOCIATED MACROPHAGE#0.6853;ACTIVATED PROTEIN C#0.6851;AKT SIGNAL TRANSDUCTION#0.6850;AMYGDALA#0.6840;TRANSFORMING GROWTH FACTOR ALPHA#0.6837;SALVIANOLIC ACID B#0.6835;BODY WEIGHT GAIN#0.6827;HAEM OXYGENASE 1#0.6827;ASYMMETRIC DIMETHYLARGININE#0.6825;INTEGRIN BINDING#0.6823;REACTIVE OXIDATIVE SPECIES#0.6821;GENOTOXICITY#0.6819;NUCLEAR TRANSPORT#0.6819;PRAZOSIN#0.6816;MELATONIN RECEPTOR#0.6816;MACROAUTOPHAGY#0.6813;TIBIA#0.6812;BENZOIC ACID#0.6812;FARNESOID X RECEPTOR#0.6809;NOTCH SIGNALING PATHWAY#0.6807;HEXANE#0.6804;ACTION POTENTIAL#0.6798;DRUG DELIVERY SYSTEM#0.6786;PROTEIN PHOSPHATASE INHIBITOR#0.6780;OLIGODENDROCYTE DIFFERENTIATION#0.6780;LIPID BINDING#0.6770;ACTIN DEPOLYMERIZATION#0.6770;REPRODUCTIVE TOXICITY#0.6766;CNS DEVELOPMENT#0.6765;BMP SIGNALING PATHWAY#0.6764;L-GLUTAMINE#0.6755;BETA2 ADRENERGIC RECEPTOR#0.6748;SCHISTOSOMIASIS#0.6746;CELL AGING#0.6745;GLOBAL CEREBRAL ISCHEMIA#0.6740;MENINGITIS#0.6736;GRANULOMA FORMATION#0.6734;IFN STIMULATED GENES#0.6732;NATRIURETIC PEPTIDE RECEPTOR#0.6723;ANGIOTENSIN TYPE 1#0.6722;L-CARNITINE#0.6721;IRINOTECAN#0.6720;REGULATION OF PKC#0.6720;F-ACTIN BINDING#0.6717;NEURON SURVIVAL#0.6715;PERITONEUM#0.6713;CEP-1347#0.6713;CALCITONIN RECEPTOR#0.6709;ARACHIDONIC ACID METABOLISM#0.6707;CELL POLARIZATION#0.6703;L-PHENYLALANINE#0.6700;LYSOSOMAL MEMBRANE#0.6699;CORNEAL EPITHELIUM#0.6696;OTOTOXICITY#0.6695;ISOQUINOLINE ALKALOID#0.6694;MEGAKARYOCYTE#0.6692;MOUSE MESANGIAL CELLS#0.6689;LIGASE ACTIVITY#0.6688;TARGET OF RAPAMYCIN COMPLEX#0.6687;EPOXIDE HYDROLASE#0.6685;PAW WITHDRAWAL THRESHOLD#0.6682;MYELOID-DERIVED SUPPRESSOR CELL#0.6680;COMPLEX III#0.6678;INTRAVENOUS IMMUNOGLOBULIN#0.6678;BLADDER SMOOTH MUSCLE#0.6676;LACTATION#0.6674;ORGAN OF CORTI#0.6674;HIBERNATION#0.6673;KIDNEY INJURY MOLECULE#0.6672;PANCREATIC ADENOCARCINOMA#0.6669;LIGAND BINDING DOMAIN#0.6668;GLOMERULUS#0.6662;VERAPAMIL#0.6662;ORAL EPITHELIAL CELLS#0.6657;RESPONSE TO HYDROGEN PEROXIDE#0.6656;NIFEDIPINE#0.6639;LIVER CIRRHOSIS#0.6636;VENOUS BLOOD#0.6635;ACE INHIBITOR#0.6632;APOPTOTIC DNA FRAGMENTATION#0.6627;ATTRACTANT#0.6626;REGULATION OF GLUCOSE TRANSPORT#0.6624;HSP90-CDC37 CHAPERONE COMPLEX#0.6624;GLUCOSE-6-PHOSPHATE#0.6616;STI-571#0.6614;STRESS FIBRE#0.6613;UVEITIS#0.6612;TUMOR GROWTH FACTOR#0.6609;URINARY BLADDER CANCER#0.6605;CHEMOKINESIS#0.6601;ANKLE JOINT#0.6599;MYOCARDIAL STUNNING#0.6594;TETRODOTOXIN#0.6589;UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR#0.6587;ENDOMETRIAL EPITHELIAL CELLS#0.6585;CAMP SIGNALLING#0.6580;MESENTERIC ARTERY#0.6577;INTESTINAL MUCOSAL BARRIER#0.6573;AVIAN INFLUENZA#0.6572;17-DMAG#0.6570;MYCOPHENOLIC ACID#0.6568;PENTOXIFYLLINE#0.6568;SODIUM TRANSPORT#0.6568;MIDGUT#0.6558;METALLOPROTEINASE INHIBITOR#0.6556;BETA CELL MASS#0.6555;RESPONSE TO HEAT#0.6554;HUMAN CORD BLOOD#0.6553;TYROSINE KINASE 1#0.6553;FIBROBLAST ACTIVATION#0.6553;SULFASALAZINE#0.6553;FASTING BLOOD GLUCOSE#0.6549;PI3-KINASE ACTIVITY#0.6544;RESPONSE TO EXERCISE#0.6543;CROTONALDEHYDE#0.6540;CYSTITIS#0.6527;NITRIC-OXIDE SYNTHASE INHIBITOR#0.6527;LEVOBUPIVACAINE#0.6521;BONE DEVELOPMENT#0.6515;S-ADENOSYLMETHIONINE#0.6514;26S PROTEASOME#0.6508;INVASIVE BREAST CANCER#0.6503;T-CELL LEUKEMIA#0.6495;CALCINEURIN ACTIVITY#0.6493;VP-16#0.6493;NEPHROTOXIC#0.6493;ANTIBODY PRODUCTION#0.6492;ACUTE RENAL INJURY#0.6490;GROWTH CONE#0.6487;OLMESARTAN#0.6487;CONJUGATED LINOLEIC ACID#0.6483;AXON REGENERATION#0.6482;AGI-1067#0.6480;HEALTHY CONTROL SUBJECTS#0.6480;VASCULAR ENDOTHELIAL DYSFUNCTION#0.6479;NEUROLOGICAL DEFICIT SCORE#0.6475;CORONARY ARTERY BYPASS#0.6474;ARGININE VASOPRESSIN#0.6467;RESPONSE TO ISCHEMIA#0.6466;LIMB ISCHEMIA#0.6465;PORTAL VEIN#0.6463;PERIPHERAL MONOCYTE#0.6455;ADULT RESPIRATORY DISTRESS SYNDROME#0.6455;LIPID KINASE#0.6452;GLOMERULAR FILTRATION RATE#0.6449;HYPERHOMOCYSTEINEMIA#0.6444;PROTEIN KINASE C ACTIVITY#0.6443;FOLATE#0.6439;BETA-GALACTOSIDASE ACTIVITY#0.6437;INHIBITORY KAPPAB KINASE#0.6433;AMILORIDE#0.6432;NATURAL KILLER T#0.6432;ACID SPHINGOMYELINASE#0.6427;GASTRIC TISSUE#0.6417;GERMINAL VESICLE#0.6413;JEJUNUM#0.6413;MUSCLE DAMAGE#0.6413;MITOGENIC ACTIVITY#0.6409;VISCERAL LEISHMANIASIS#0.6409;MYOPATHY#0.6409;ADENOSINE 5'-TRIPHOSPHATE#0.6409;RYANODINE RECEPTOR#0.6408;TRANSMISSION ELECTRON MICROSCOPE#0.6408;TISSUE DEVELOPMENT#0.6405;FIBRINOLYSIS#0.6404;TOLUENE#0.6404;VASOCONSTRICTOR#0.6404;PLACENTAL GROWTH FACTOR#0.6399;AMD3100#0.6398;RESPONSE TO HYPERTONICITY#0.6396;LAPATINIB#0.6395;SEROTONIN REUPTAKE INHIBITOR#0.6387;SUPEROXIDE RELEASE#0.6387;ERYTHEMA#0.6384;CARDIAC ARREST#0.6384;ADENOSINE DEAMINASE#0.6383;ACETAMINOPHEN#0.6383;MUSCLE WEAKNESS#0.6375;TOPOISOMERASE II#0.6374;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6374;CHLORIDE CHANNEL#0.6372;LOCOMOTION#0.6372;ALA-PDT#0.6369;NERVE TERMINAL#0.6359;NEPHROTIC SYNDROME#0.6358;HEME CATABOLISM#0.6357;CAMKIV#0.6344;CSF SECRETION#0.6338;MIP-2 PRODUCTION#0.6337;MACROPHAGE CHEMOATTRACTANT PROTEIN#0.6335;DUODENUM#0.6335;KINASE INHIBITOR PROTEIN#0.6333;PROTEIN KINASE A SIGNALING#0.6329;FERMENTATION#0.6325;CERAMIDE SYNTHESIS#0.6322;REGULATION OF IMMUNE RESPONSE#0.6319;HEMATOPOIETIC CELL KINASE#0.6317;URATE#0.6314;OPTIC NERVE INJURY#0.6313;EOSINOPHIL ACTIVATION#0.6298;SEROTONIN UPTAKE#0.6297;EUKARYOTIC ELONGATION FACTOR#0.6288;MURAL CELL#0.6287;CORTISOL#0.6287;EPITHELIAL CELL MORPHOGENESIS#0.6286;PRIMARY EFFUSION LYMPHOMA#0.6285;ROPIVACAINE#0.6279;INTESTINAL DISEASE#0.6279;IL-18 PRODUCTION#0.6276;COLORECTAL ADENOCARCINOMA CELLS#0.6275;DENTINOGENESIS#0.6274;L-LYSINE#0.6271;POLY-A BINDING#0.6271;ION TRANSPORT#0.6270;4-HYDROXYTAMOXIFEN#0.6267;CELL CELL FUSION#0.6267;QUORUM SENSING#0.6263;HIGH THROUGHPUT SCREEN#0.6262;STRESS GRANULE#0.6261;URINARY PROTEIN#0.6260;DNA DEGRADATION#0.6259;INTESTINAL CRYPT#0.6254;EPITHELIAL STEM CELL#0.6253;ENDOMETRIAL CANCER#0.6250;INHIBITION OF CYTOKINE PRODUCTION#0.6249;GLCNAC#0.6249;VASCULAR ENDOTHELIAL CADHERIN#0.6247;METAMORPHOSIS#0.6246;RESPONSE TO CHEMICAL#0.6243;INVARIANT NATURAL KILLER#0.6241;ACTIVATION OF GROWTH#0.6238;SUCCINATE#0.6236;CELL CYCLE PHASE#0.6235;VASCULAR DEMENTIA#0.6234;MITOTIC CHECKPOINT#0.6232;ILEUS#0.6229;VIRAL PROTEIN SYNTHESIS#0.6226;NEUTROPHIL DEGRANULATION#0.6222;REGULATION OF CYTOKINE PRODUCTION#0.6219;PRAVASTATIN#0.6218;COLISTIN#0.6218;NUCLEAR MEMBRANE#0.6214;NEURAL PROGENITOR CELL#0.6214;KERATINOCYTE APOPTOSIS#0.6208;PROTON PUMP#0.6207;VENA CAVA#0.6199;RIBOSOME BIOGENESIS#0.6196;MONOCYTE PROLIFERATION#0.6195;MUSCLE ADAPTATION#0.6186;IGF BINDING#0.6184;DEPRESSIVE SYMPTOMS#0.6183;MEDULLARY CELL#0.6183;PULMONARY TOXICITY#0.6179;HIGH CONTENT SCREENING#0.6179;MUSCLE SATELLITE CELL#0.6173;ANAPLASTIC LARGE CELL LYMPHOMA#0.6173;FETAL BRAIN#0.6172;EMBRYONIC LUNG#0.6170;EMBRYOID BODY#0.6167;CHRONIC HEPATITIS B#0.6165;CILOSTAZOL#0.6163;SOLUBLE EPOXIDE HYDROLASE#0.6160;INTERVERTEBRAL DISC DEGENERATION#0.6157;FIBROBLAST APOPTOSIS#0.6155;RHEUMATISM#0.6154;DIESEL EXHAUST PARTICLE#0.6151;NEWCASTLE DISEASE#0.6147;NEURONAL CELL APOPTOSIS#0.6145;ISCHEMIC REPERFUSION INJURY#0.6141;SPERM MOTILITY#0.6140;RNA HELICASE#0.6140;DECIDUAL CELL#0.6138;BREAST ADENOCARCINOMA#0.6136;OUTER HAIR CELL#0.6136;INTRACELLULAR ALKALINIZATION#0.6132;DIABETIC KIDNEY DISEASE#0.6132;RETINOL#0.6131;SYNOVIAL SARCOMA#0.6131;MITOCHONDRIAL OUTER MEMBRANE#0.6119;PROSTAGLANDIN E1#0.6119;LEUKOCYTE ACTIVATION#0.6116;NUCLEOTIDE BINDING DOMAIN#0.6109;MINERAL TRIOXIDE AGGREGATE#0.6109;CLONIDINE#0.6109;SOLUBLE GUANYLYL CYCLASE#0.6108;PKCZETA#0.6107;DEUBIQUITINATING ENZYME#0.6102;ACTIVATED CD4+ T CELL#0.6100;TUBULOGENESIS#0.6096;BLINDNESS#0.6092;MAP KINASE BINDING#0.6092;PRINCIPAL COMPONENT ANALYSIS#0.6090;COLONY-FORMING CELL#0.6081;INHIBITION OF INFLAMMATORY RESPONSE#0.6076;ADAPTIVE IMMUNE SYSTEM#0.6075;CENTRIOLAR SATELLITE#0.6072;TELMISARTAN#0.6070;CELLULAR LOCALISATION#0.6058;ADJACENT NORMAL TISSUE#0.6051;DRAINING LYMPH NODE#0.6049;PLACENTATION#0.6048;STROMELYSIN#0.6048;ORAL CAVITY#0.6047;ANILINE#0.6037;RESPONSE TO ETOPOSIDE#0.6031;ANTIOXIDANT RESPONSIVE ELEMENT#0.6026;LATRUNCULIN B#0.6012;EOSINOPHIL MIGRATION#0.6012;APOPTOTIC BODY#0.6011;ENHANCED GENE EXPRESSION#0.6007;AURANOFIN#0.6005;SURFACE IGM#0.6004
143384	CELL CYCLE#1.0676;COLORECTAL CANCER#0.9851;CELL PROLIFERATION#0.9826;CANCER CELL#0.9469;APOPTOSIS#0.8609;COLORECTAL#0.7913;DRUG RESISTANCE#0.6669;S PHASE#0.6652;SIGNALING PATHWAY#0.6597;DEOXYCHOLIC ACID#0.6331;LUNG CANCER#0.6001
143425	EXOCYTOSIS#0.8882;BETA CELL#0.8112;DENSE CORE VESICLE#0.7615
143458	AMYLOID PRECURSOR PROTEIN#0.8078;LOW DENSITY LIPOPROTEIN#0.7917
143471	MEIOSIS I#0.7728;M PHASE#0.7553
1434	CELLULAR APOPTOSIS SUSCEPTIBILITY#1.0978;CHROMOSOME SEGREGATION#1.0730;APOPTOSIS#1.0410;COLORECTAL#1.0288;CANCER CELL#1.0225;CELL PROLIFERATION#1.0083;COLORECTAL CANCER#1.0079;PROTEIN CA#1.0038;CELL CYCLE#0.9963;GENE EXPRESSION#0.9845;NUCLEAR TRANSPORT#0.9818;CYTOPLASM#0.9597;PROGESTERONE#0.9478;IMPORTIN#0.9456;BREAST CANCER#0.9404;ESTRADIOL#0.9315;LYMPH NODE#0.9106;OVARIAN#0.9002;WEIGHT GAIN#0.8818;POTASSIUM CHANNEL#0.8710;LYMPH NODE METASTASIS#0.8535;MITOSIS#0.8361;ETHANOL#0.8346;TUMOR CELLS#0.8315;NUCLEAR IMPORT#0.8307;NUCLEAR EXPORT#0.8226;APOPTOTIC#0.8195;VACUOLAR MEMBRANE#0.8066;COLON CANCER#0.8019;ACTION POTENTIAL#0.7965;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7895;ESTROUS CYCLE#0.7862;BLADDER UROTHELIAL CARCINOMA#0.7841;VACUOLE#0.7757;GROWTH FACTOR#0.7638;OOCYTE#0.7637;HEAT SHOCK PROTEIN#0.7570;OVARIAN CARCINOMA#0.7499;DNA BINDING#0.7428;TESTOSTERONE#0.7419;MALARIA#0.7394;STEM CELL#0.7226;TUMOR NECROSIS FACTOR#0.7192;ERYTHROCYTE#0.7183;HOST CELL#0.6898;BREAST CANCER CELL#0.6792;SIGNALING PATHWAY#0.6729;OVARIAN CANCER#0.6675;PARASITOPHOROUS VACUOLE#0.6645;GLUTATHIONE#0.6563;HEPATOCELLULAR CARCINOMA#0.6530;TRANSCRIPTION FACTOR#0.6494;GESTATION#0.6341;DNA COPY NUMBER#0.6160;CELL GROWTH#0.6134;CORTISOL#0.6126;CELL DEATH#0.6125;ACETIC ACID#0.6079;GERM CELL#0.6053
143501	INTENTION TO TREAT#0.8023;RANDOMISED CONTROLLED TRIAL#0.7805
143503	OLFACTORY RECEPTOR#1.0517;PROSTATE CANCER#1.0510;GENE EXPRESSION#0.6768;CELLULAR SENESCENCE#0.6038;INTESTINAL MUCOSA#0.6015
143570	DNA REPAIR#0.8291;COLORECTAL CANCER#0.7558;CANCER CELL#0.7509;CELL CYCLE#0.7102
1435	TENOSYNOVIAL GIANT CELL TUMOR#1.0759;M-CSF PRODUCTION#1.0743;RESPONSE TO M-CSF#1.0739;AMNIOTIC FLUID#1.0674;CSF SECRETION#1.0566;PIGMENTED VILLONODULAR SYNOVITIS#1.0472;GRANULOSA CELL#1.0470;VILLONODULAR SYNOVITIS#1.0466;MONOCYTE PROLIFERATION#1.0396;MONOCYTE CHEMOTACTIC PROTEIN#1.0374;MESANGIAL CELL#1.0333;IL-11#1.0327;NEPHRITIS#1.0315;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0292;IL-1RA#1.0284;KUPFFER CELL#1.0253;UROKINASE#1.0247;LUPUS NEPHRITIS#1.0237;LEUKEMIA INHIBITORY FACTOR#1.0226;G1 PHASE#1.0214;G-CSF#1.0209;EPITHELIAL OVARIAN CANCER#1.0201;PROTEOGLYCAN#1.0187;BONE MARROW MONOCYTE#1.0187;PROTEIN TYROSINE KINASE#1.0187;COLONY-STIMULATING FACTOR#1.0160;OVARIAN CANCER#1.0159;MAMMARY GLAND#1.0158;TOOTH ERUPTION#1.0151;MACROPHAGE INFLAMMATORY PROTEIN#1.0147;SRC FAMILY KINASE#1.0145;CERVICAL CANCER#1.0144;OVARIAN#1.0141;GM-CSF#1.0141;TUBULAR EPITHELIAL CELL#1.0140;MAMMARY GLAND DEVELOPMENT#1.0130;GIANT CELL TUMOR#1.0128;STEM CELL FACTOR#1.0125;MYELOID PROGENITOR CELL#1.0118;PLATELET-DERIVED GROWTH FACTOR#1.0115;TROPHOBLAST#1.0113;MACROPHAGE MIGRATION#1.0113;BREAST CARCINOMA#1.0111;GLAND DEVELOPMENT#1.0111;MACROPHAGE PROLIFERATION#1.0106;C REACTIVE PROTEIN#1.0103;RECEPTOR ACTIVATOR#1.0096;GRANULOCYTE COLONY STIMULATING FACTOR#1.0094;OVARIAN CARCINOMA#1.0093;DNA SYNTHESIS#1.0091;MACROPHAGE#1.0087;MONOCYTE DIFFERENTIATION#1.0080;SELECTIN#1.0070;OSTEOCLAST PRECURSOR CELL#1.0064;IMATINIB#1.0060;ASTROCYTE#1.0060;EPIDERMAL GROWTH FACTOR#1.0053;TUMOUR NECROSIS FACTOR#1.0053;OSTEOCLAST DEVELOPMENT#1.0045;MICROGLIAL CELL#1.0043;VASCULAR CELL#1.0038;BREAST CANCER PATIENTS#1.0032;TROPHOBLAST CELL#1.0024;VEGF PRODUCTION#1.0021;UTERUS#1.0019;DECIDUAL CELL#1.0016;FIBROBLAST GROWTH FACTOR#1.0008;ENDOTHELIAL GROWTH FACTOR#1.0008;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0008;MEMBRANE RUFFLING#1.0001;ALVEOLAR MACROPHAGE#0.9998;OSTEOCLAST#0.9996;IFN-BETA#0.9995;ENDOMETRIUM#0.9990;S PHASE#0.9990;BLAST CELL#0.9989;INSULIN-LIKE GROWTH FACTOR#0.9988;ADENOCARCINOMA#0.9988;MACROPHAGE DIFFERENTIATION#0.9988;IFN-GAMMA#0.9987;CORD BLOOD#0.9981;PROTEIN SYNTHESIS#0.9977;PERTUSSIS#0.9975;THYMIDINE#0.9972;TYROSINE KINASE RECEPTOR#0.9969;GRANULOCYTE#0.9969;SMOOTH MUSCLE CELL#0.9957;OSTEOPETROSIS#0.9957;PROSTATE CANCER#0.9955;PERITONEAL CAVITY#0.9951;CELL ADHESION MOLECULE#0.9950;SPINAL CORD#0.9945;PERIPHERAL BLOOD MONOCYTES#0.9944;LUNG CANCER#0.9943;NEUTROPENIA#0.9941;MUSCLE CELL#0.9937;CALCITONIN RECEPTOR#0.9935;MARROW STROMAL CELLS#0.9935;PHOSPHOLIPASE C#0.9933;PLACENTAL DEVELOPMENT#0.9932;1α,25-DIHYDROXYVITAMIN D3#0.9931;THROMBOCYTOPENIA#0.9930;RECEPTOR TYROSINE KINASE#0.9928;TRANSFORMING GROWTH FACTOR#0.9927;CHEMOTAXIS#0.9927;MONOCYTE#0.9926;PROSTAGLANDIN E2#0.9924;LANGERHANS CELL#0.9923;TRANSFORMING GROWTH FACTOR BETA#0.9922;BONE MARROW CELLS#0.9916;BONE MARROW STROMAL CELL#0.9915;TRANSCRIPTASE#0.9914;REACTIVE OXYGEN SPECIES#0.9910;FOAM CELL FORMATION#0.9910;DEXAMETHASONE#0.9909;PLASMA MEMBRANE#0.9907;RECEPTOR ANTAGONIST#0.9905;M2 MACROPHAGE#0.9900;BONE MARROW STROMAL#0.9899;SMOOTH MUSCLE#0.9897;COLONY-FORMING CELL#0.9895;PROTEIN TYROSINE PHOSPHATASE#0.9891;WHITE BLOOD CELL#0.9891;VITAMIN D3#0.9889;PROTEIN SECRETION#0.9888;PROGESTERONE#0.9887;STROMA#0.9885;ARACHIDONIC ACID#0.9882;GESTATION#0.9882;OOCYTE#0.9877;EPITHELIAL CELL#0.9874;ACUTE MYELOID LEUKEMIA#0.9870;MONOCYTE DERIVED MACROPHAGE#0.9870;CYTOKINE RECEPTOR#0.9869;CEREBRAL CORTEX#0.9868;UROKINASE PLASMINOGEN ACTIVATOR#0.9863;CHEMOKINE RECEPTOR#0.9861;PROTEIN KINASE C#0.9860;LOW DENSITY LIPOPROTEIN#0.9859;MACROPHAGE ACTIVATION#0.9857;SCAVENGER RECEPTOR#0.9857;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9856;MOLAR#0.9856;SYNOVITIS#0.9855;VASCULAR SMOOTH MUSCLE CELL#0.9852;CYCLIC AMP#0.9851;KINASE ACTIVITY#0.9851;UMBILICAL CORD#0.9850;TYROSINE KINASE INHIBITOR#0.9849;KINASE INHIBITOR#0.9847;BREAST CANCER#0.9843;MESENCHYMAL CELL#0.9841;RETINOIC ACID#0.9840;CD4+ T CELL#0.9838;MACROPHAGE POLARIZATION#0.9837;GROWTH FACTOR#0.9836;BREAST CANCER CELL#0.9828;ENDOCYTOSIS#0.9828;STROMAL CELL#0.9827;MYELOID CELL#0.9826;PRECURSOR CELL#0.9825;TNF PRODUCTION#0.9824;CELL CYCLE#0.9824;NITRIC OXIDE#0.9823;5 FLUOROURACIL#0.9823;BONE MARROW#0.9823;MONONUCLEAR CELLS#0.9821;CELL DEVELOPMENT#0.9820;TUMOR NECROSIS FACTOR#0.9815;SIGNAL TRANSDUCER#0.9810;RECEPTOR BINDING#0.9810;FETAL LIVER#0.9807;MAST CELL#0.9806;CELL DEATH#0.9806;CELL SURFACE#0.9804;CELL ADHESION#0.9802;CENTRAL NERVOUS SYSTEM#0.9801;CANCER CELL#0.9801;SYNOVIAL FLUID#0.9799;ALZHEIMER'S DISEASE#0.9799;MYELOID LEUKEMIA#0.9798;CELL MEMBRANE#0.9797;TUMOR CELLS#0.9794;TUMOR ASSOCIATED MACROPHAGE#0.9794;PHAGOCYTOSIS#0.9791;CORONARY ARTERY#0.9791;OSTEOBLAST#0.9791;CYTOTOXICITY#0.9789;VASCULAR ENDOTHELIAL CELL#0.9787;SIGNALLING PATHWAY#0.9785;INFLAMMATORY CELL#0.9784;OSTEOCLAST DIFFERENTIATION#0.9781;MAP KINASE#0.9781;HEPATOCYTE GROWTH FACTOR#0.9776;PARATHYROID HORMONE#0.9775;APOPTOTIC#0.9773;PROGENITOR CELL#0.9773;ATHEROSCLEROTIC#0.9773;LYMPH NODE#0.9771;NATURAL KILLER CELL#0.9769;REVERSE TRANSCRIPTION#0.9768;NEUTROPHIL#0.9765;PERIPHERAL BLOOD#0.9764;RAT BONE MARROW#0.9762;MEGAKARYOCYTE#0.9759;FEMUR#0.9758;TOLL LIKE RECEPTOR#0.9757;HYPOXIA#0.9756;QUANTITATIVE REAL TIME#0.9755;HEMATOPOIETIC PROGENITOR CELL#0.9754;FACTOR I#0.9754;SYNOVIUM#0.9754;APOPTOSIS#0.9750;ALKALINE PHOSPHATASE#0.9747;LIGAND BINDING DOMAIN#0.9746;CELL GROWTH#0.9745;PARATHYROID#0.9743;MYELOID-DERIVED SUPPRESSOR CELL#0.9742;ENDOTHELIAL CELL#0.9741;REGENERATION#0.9737;NERVOUS SYSTEM#0.9736;HEPATOCELLULAR CARCINOMA#0.9735;M1 MACROPHAGE#0.9729;RESPIRATORY BURST#0.9728;MITOGEN ACTIVATED PROTEIN#0.9726;CELL DIFFERENTIATION#0.9724;INNATE IMMUNITY#0.9723;ACTIVATED T-CELLS#0.9717;ARTERY#0.9717;SIGNAL TRANSDUCTION#0.9712;B LYMPHOCYTE#0.9708;CELL PROLIFERATION#0.9708;POLYMERASE CHAIN REACTION#0.9707;CD8+ T CELL#0.9707;MENSTRUAL CYCLE#0.9704;ACTIVATED T CELL#0.9704;ESTRADIOL#0.9703;CERVICAL#0.9701;BLOOD VESSEL#0.9701;ATHEROSCLEROSIS#0.9697;HEMATOPOIETIC CELL#0.9697;CELL MIGRATION#0.9697;T CELL PROLIFERATION#0.9695;ANGIOGENESIS#0.9694;HEMATOPOIETIC STEM CELL#0.9689;HEMATOPOIESIS#0.9685;PROTEIN KINASE#0.9684;B CELL#0.9682;STEM CELL#0.9681;CYTOPLASM#0.9681;GROWTH FACTOR RECEPTOR#0.9681;ADIPOSE TISSUE#0.9674;OSTEOBLAST DIFFERENTIATION#0.9670;PRO-INFLAMMATORY#0.9670;GENE EXPRESSION#0.9669;T LYMPHOCYTE#0.9668;ESTROUS CYCLE#0.9668;WOUND HEALING#0.9668;ANTIGEN PRESENTING CELLS#0.9665;DENDRITIC CELL#0.9665;RESPONSE TO LPS#0.9664;BONE REMODELING#0.9662;SIGNALING PATHWAY#0.9655;MAMMARY EPITHELIAL CELL#0.9651;ENDOMETRIAL CANCER#0.9651;ACID PHOSPHATASE#0.9650;MESENCHYMAL STEM CELL#0.9646;GLIAL CELL#0.9645;CYTOKINE PRODUCTION#0.9641;CONNECTIVE TISSUE#0.9639;PERIODONTITIS#0.9636;ACTINOMYCIN D#0.9635;EXTRACELLULAR MATRIX#0.9634;COLORECTAL CANCER#0.9629;RECEPTOR LIGAND#0.9627;MIGRATION INHIBITORY FACTOR#0.9626;FLUOROURACIL#0.9626;CELL ACTIVATION#0.9622;PERIODONTAL LIGAMENT#0.9620;FACTOR S#0.9619;T CELL#0.9618;HUMAN BREAST CANCER#0.9615;PHOSPHOLIPASE A2#0.9610;CELL FUSION#0.9606;TRANSCRIPTION FACTOR#0.9605;OSTEOARTHRITIS#0.9603;BETA-2#0.9602;IMMUNE SYSTEM#0.9596;LEUKOCYTE#0.9595;AKT SIGNALING#0.9593;DNA BINDING#0.9592;HUMAN IMMUNODEFICIENCY VIRUS#0.9589;BONE RESORPTION#0.9587;SIGNALING MOLECULE#0.9585;BONE FORMATION#0.9585;INFLAMMATORY RESPONSE#0.9584;KIDNEY DISEASE#0.9579;TERMINAL DIFFERENTIATION#0.9579;ONCOGENIC#0.9568;CYTOKINE SECRETION#0.9562;AUTOIMMUNE DISEASE#0.9561;ENDOMETRIOSIS#0.9560;BONE MINERAL DENSITY#0.9558;NITRIC OXIDE SYNTHASE#0.9555;MANNOSE RECEPTOR#0.9554;IL-6 PRODUCTION#0.9545;THYMOCYTE#0.9542;BONE DISEASE#0.9541;DECIDUA#0.9540;CELL CYCLE ARREST#0.9538;IMMUNE RESPONSE#0.9538;RHEUMATOID ARTHRITIS#0.9536;IMMUNE CELL#0.9532;TOXICITY#0.9525;ADIPOCYTE#0.9525;ERYTHROCYTE#0.9518;BONE CELLS#0.9506;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.9502;ISCHEMIA#0.9500;OVULATION#0.9499;TUMOR TISSUES#0.9492;RUFFLE#0.9491;OSTEOPOROSIS#0.9489;NADPH OXIDASE#0.9462;CELL ASSOCIATED#0.9460;CYTOTROPHOBLAST#0.9459;MYOCARDIAL INFARCTION#0.9453;LUNG CARCINOMA#0.9450;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9447;EXCRETION#0.9441;BONE MORPHOGENETIC PROTEIN#0.9422;CYCLIN DEPENDENT KINASE#0.9414;EOSINOPHIL#0.9410;ANEMIA#0.9404;ACTIN CYTOSKELETON#0.9395;TIBIA#0.9394;COLORECTAL#0.9389;COLLAGEN INDUCED ARTHRITIS#0.9386;PANCREATIC CARCINOMA#0.9385;OSTEOGENESIS#0.9380;NF-KAPPAB ACTIVATION#0.9371;SQUAMOUS CELL CARCINOMA#0.9365;COLITIS#0.9345;GRANULOMA FORMATION#0.9339;CORONARY ARTERY DISEASE#0.9339;ARTERY DISEASE#0.9337;VIRAL INFECTION#0.9331;MULTIPLE MYELOMA#0.9327;ARA-C#0.9315;ENDOMETRIAL ADENOCARCINOMA#0.9311;HEMOPOIESIS#0.9308;ACTIN POLYMERIZATION#0.9304;MACROPINOCYTOSIS#0.9296;CHONDROCYTE#0.9291;RENAL CELL CARCINOMA#0.9275;ROOT RESORPTION#0.9271;MYELODYSPLASTIC SYNDROME#0.9271;REGULATORY T CELL#0.9268;MRNA DECAY#0.9261;CELL DIVISION#0.9254;INDOMETHACIN#0.9245;PANCREATIC CANCER#0.9238;YOLK SAC#0.9237;AUTOPHAGY#0.9230;IL-10 PRODUCTION#0.9203;72-HOURS#0.9201;NERVE GROWTH FACTOR#0.9200;LECTIN#0.9198;T CELL ACTIVATION#0.9194;ADENOSINE#0.9179;MYOBLAST#0.9177;MECHANISM OF ACTION#0.9172;INTERLEUKIN 1 RECEPTOR#0.9161;INDUCIBLE NITRIC OXIDE#0.9155;CYCLOPHOSPHAMIDE#0.9153;HOST CELL#0.9139;OXYGENASE#0.9132;CD14++CD16- MONOCYTE#0.9132;GROWTH HORMONE#0.9101;CYSTIC TERATOMA#0.9099;T-CELL LEUKEMIA#0.9098;ENDOTHELIUM#0.9035;INFLAMMATORY BOWEL DISEASE#0.9035;ENZYME ACTIVITY#0.9032;GERM CELL#0.9023;DIGESTION#0.9021;BLADDER CARCINOMA#0.9017;ESTROGEN RECEPTOR#0.9014;INNATE IMMUNE RESPONSE#0.8997;MUTAGENESIS#0.8993;LYSOSOME#0.8983;PHOSPHATASE ACTIVITY#0.8983;KERATINOCYTE#0.8981;OSTEOCYTE#0.8964;CELL FRACTION#0.8963;CYTOSINE ARABINOSIDE#0.8930;CHROMATIN REMODELING#0.8917;MESOTHELIAL CELL#0.8912;EPSTEIN BARR VIRUS#0.8897;GLUCOSE UPTAKE#0.8892;SERUM ALBUMIN#0.8890;CELL EXPANSION#0.8879;HYPOXIC#0.8866;RESPONSE TO LIPOPOLYSACCHARIDE#0.8845;SKELETON#0.8844;LUPUS ERYTHEMATOSUS#0.8842;UMBILICAL CORD BLOOD#0.8830;TYROSINE KINASE DOMAIN#0.8816;ORTHODONTIC TOOTH MOVEMENT#0.8812;CISPLATIN#0.8806;SKELETAL MUSCLE#0.8786;TISSUE DAMAGE#0.8772;CASPASE ACTIVATION#0.8745;ACTIVATED MONOCYTES#0.8738;LEYDIG CELL#0.8737;GROWTH FACTOR BINDING#0.8730;ATPASE ACTIVITY#0.8722;NEOPTERIN#0.8721;ADULT T-CELL LEUKEMIA#0.8721;TUMOR SUPPRESSOR#0.8708;CELL MOTILITY#0.8694;ACUTE PROMYELOCYTIC LEUKEMIA#0.8694;ACUTE LEUKEMIA#0.8673;LUNG ADENOCARCINOMA#0.8667;PERIPHERAL NERVE#0.8662;BONE MARROW MICROENVIRONMENT#0.8655;CHORIOCARCINOMA#0.8652;HEME OXYGENASE 1#0.8648;RAPAMYCIN#0.8639;APOPTOTIC CELL DEATH#0.8633;TISSUE REMODELING#0.8628;MOUSE MESANGIAL CELLS#0.8606;ANCHORAGE INDEPENDENT GROWTH#0.8599;MAPK ACTIVATION#0.8593;MYELOID CELL LINES#0.8592;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8580;SODIUM DODECYL SULFATE#0.8554;DODECYL SULFATE#0.8553;MARROW STEM CELLS#0.8550;INSULIN RECEPTOR#0.8549;BONE MARROW STEM CELL#0.8541;IL-6 SECRETION#0.8536;STEM CELL TRANSPLANTATION#0.8535;LYMPHOID CELL#0.8529;EMBRYONIC STEM CELL#0.8517;GLOMERULONEPHRITIS#0.8489;PODOSOME#0.8481;MYOFIBROBLAST#0.8480;SCANNING ELECTRON MICROSCOPY#0.8479;ARGININE#0.8474;INDUCTION OF APOPTOSIS#0.8471;LYSIS#0.8469;ALANINE#0.8453;METASTATIC BREAST CANCER#0.8451;LACTATION#0.8441;IONOPHORE#0.8436;PERITONEUM#0.8428;LDL RECEPTOR#0.8424;ELECTROPHORETIC MOBILITY SHIFT#0.8416;FORSKOLIN#0.8409;LIVER DISEASE#0.8404;OSTEOCLAST FUSION#0.8386;PROTEIN KINASE A#0.8359;ACTIVATOR PROTEIN 1#0.8356;CYCLOSPORIN A#0.8344;INTRACELLULAR SIGNALING PATHWAY#0.8332;ENDOPLASMIC RETICULUM#0.8327;CHRONIC MYELOMONOCYTIC LEUKEMIA#0.8323;MORPHOGENESIS#0.8318;MINERALIZATION#0.8311;UMBILICAL VEIN#0.8311;PERIODONTAL DISEASE#0.8308;DISEASE FREE SURVIVAL#0.8306;HIGH CHOLESTEROL DIET#0.8302;COLON CANCER#0.8296;SERUM AMYLOID A#0.8276;TISSUE HOMEOSTASIS#0.8270;MONOCYTIC LEUKEMIA#0.8268;ASCITES#0.8237;NEURONAL REMODELING#0.8236;PLURIPOTENT STEM CELL#0.8227;SIGNALING CASCADE#0.8226;REGULATION OF OSTEOCLAST DIFFERENTIATION#0.8197;RESPONSE TO TREATMENT#0.8174;SIGNAL PEPTIDE#0.8172;JUXTAMEMBRANE#0.8157;HEART DISEASE#0.8153;PULMONARY FIBROSIS#0.8131;SCHWANN CELL#0.8127;INFERTILITY#0.8127;B CELL APOPTOSIS#0.8097;MECHANISMS OF ACTION#0.8091;MICROPARTICLE#0.8075;CLODRONATE#0.8066;GLOMERULUS#0.8064;AUTOCRINE SIGNALING#0.8046;MEMBRANE FRACTION#0.8038;PROGRAMMED CELL DEATH#0.8034;METASTATIC MELANOMA#0.8034;TREG CELL#0.8033;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8025;GRANULOCYTE DIFFERENTIATION#0.7999;PERIPHERAL MONOCYTE#0.7988;TNF-ALPHA PRODUCTION#0.7978;NEPHROPATHY#0.7966;FLOW CYTOMETRY ANALYSIS#0.7965;MENINGITIS#0.7937;LIVER REGENERATION#0.7936;MAPK SIGNALING#0.7935;MYELOID CELL DIFFERENTIATION#0.7932;BONE GROWTH#0.7918;CELLULAR LOCALIZATION#0.7915;PERIPHERAL BLOOD CELLS#0.7906;PLATELET ACTIVATING FACTOR#0.7879;HEMATOPOIETIC PRECURSOR CELL#0.7878;CYCLIN DEPENDENT KINASE INHIBITOR#0.7873;HYPERCALCEMIA#0.7856;GENE SILENCING#0.7854;FOCAL ADHESION#0.7847;FIBROBLAST LIKE SYNOVIOCYTES#0.7843;HYPOXIA INDUCIBLE FACTOR#0.7840;BASEMENT MEMBRANE#0.7839;CELL BOUND#0.7819;STAUROSPORINE#0.7815;CELL SURFACE ANTIGEN#0.7811;DENTAL PULP#0.7795;PURKINJE CELL#0.7793;ENDOMETRIAL CARCINOMA#0.7792;INFERTILE#0.7789;BONE REMODELLING#0.7788;CD3+ T CELL#0.7783;PLASMA CELL#0.7776;CROHN'S DISEASE#0.7762;ROS GENERATION#0.7751;LEIOMYOSARCOMA#0.7748;RESPONSE TO IL-1#0.7746;REGULATION OF GENE EXPRESSION#0.7746;MACROPHAGE CHEMOTAXIS#0.7746;ACTIVATION OF NF-KAPPAB#0.7744;PRIMARY GROWTH#0.7730;ANTIGEN PRESENTATION#0.7724;MATURE CYSTIC TERATOMA#0.7710;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7702;ADAPTIVE IMMUNE RESPONSE#0.7692;HYPERSENSITIVITY#0.7687;MACROPHAGE CHEMOATTRACTANT PROTEIN#0.7663;RNA INTERFERENCE#0.7661;PARACRINE SIGNALING#0.7658;CYCLOSPORIN#0.7648;COMPLEMENT RECEPTOR#0.7641;MESENCHYMAL STROMAL CELL#0.7635;CORPUS LUTEUM#0.7616;HUMAN CORD BLOOD#0.7615;IMATINIB MESYLATE#0.7613;ALL TRANS RETINOIC ACID#0.7608;GRAFT VERSUS HOST#0.7607;NEGATIVE PREDICTIVE VALUE#0.7605;ERYTHROID PROGENITOR#0.7605;NODULE FORMATION#0.7578;HUMAN UMBILICAL VEIN#0.7577;MULTIPLE SCLEROSIS#0.7575;DERMAL FIBROBLAST#0.7569;CALCINEURIN#0.7568;MICROPHTHALMIA#0.7553;PARENCHYMA#0.7552;SENSITIZATION#0.7548;SWELLING#0.7543;OSTEOCLAST PROLIFERATION#0.7541;TUBE FORMATION#0.7539;MYOTUBE#0.7536;INNATE IMMUNE SYSTEM#0.7533;RECEPTOR ACTIVITY#0.7525;ENCEPHALOMYELITIS#0.7513;RECEPTOR DEGRADATION#0.7507;SOFT TISSUE SARCOMA#0.7507;DECIDUALIZATION#0.7497;DELAYED GASTRIC EMPTYING#0.7481;CYTOTOXIC T-LYMPHOCYTE#0.7476;ATP BINDING#0.7475;BONE DEVELOPMENT#0.7457;MEMBRANE RUFFLE#0.7457;BRANCHING MORPHOGENESIS#0.7432;PANETH CELL#0.7432;OSSIFICATION#0.7425;HISTAMINE#0.7399;PROTEIN KINASE B#0.7392;VIRAL REPLICATION#0.7387;HEPARIN#0.7387;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7383;LYMPH NODE METASTASES#0.7376;L-ARGININE#0.7370;RNA SYNTHESIS#0.7368;HIGH FAT DIET#0.7359;TISSUE GROWTH FACTOR#0.7356;RESPONSE TO IL-3#0.7355;CELL KILLING#0.7348;SMALL INTESTINE#0.7333;HODGKIN'S LYMPHOMA#0.7332;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7306;PREGNANT UTERUS#0.7301;DENDRITIC CELL DIFFERENTIATION#0.7289;HEAT SHOCK PROTEIN#0.7285;SPLENIC RED PULP#0.7268;ATTRACTANT#0.7266;THYMIC EPITHELIAL CELLS#0.7258;ACIDIFICATION#0.7250;ALENDRONATE#0.7241;APLASTIC ANEMIA#0.7235;PSORIATIC ARTHRITIS#0.7230;EMBRYO DEVELOPMENT#0.7208;RESPONSE TO TNF#0.7193;DUAL LUCIFERASE REPORTER#0.7187;INCISORS#0.7186;GLUTATHIONE#0.7183;PAGET'S DISEASE OF BONE#0.7180;ADENOSINE MONOPHOSPHATE#0.7179;GTP BINDING#0.7174;COLLAGENASE#0.7160;TRANSFORMING GROWTH FACTOR ALPHA#0.7158;BINDING PROTEIN 1#0.7154;RECEPTOR AGONIST#0.7137;FOCAL ADHESION KINASE#0.7135;CELL CYCLE CONTROL#0.7131;TESTOSTERONE#0.7122;PROTEIN PHOSPHORYLATION#0.7118;GASTRIC EMPTYING#0.7117;POSITIVE PREDICTIVE VALUE#0.7116;ISCHEMIA REPERFUSION INJURY#0.7089;SENESCENCE#0.7088;GLYCOSYLATION#0.7083;METHIONINE#0.7080;DEMENTIA#0.7080;FACIAL NUCLEUS#0.7051;BACTERIAL MENINGITIS#0.7042;OSTEOCLAST MATURATION#0.7042;IMMATURE MYELOID CELL#0.7023;FLUCONAZOLE#0.7012;SUBSTANCE P#0.7010;PLACENTAL GROWTH FACTOR#0.7002;PRIMARY BREAST CANCER#0.6993;AUTOIMMUNITY#0.6990;PI3K SIGNALING#0.6988;TERATOMA#0.6983;ANKYLOSING SPONDYLITIS#0.6978;STROMAL DERIVED FACTOR#0.6978;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6970;ACUTE KIDNEY INJURY#0.6966;PATTERN RECOGNITION RECEPTOR#0.6965;ECTODOMAIN CLEAVAGE#0.6963;ALKALINE PHOSPHATASE ACTIVITY#0.6959;PROTEASOME#0.6957;CYCLIC ADENOSINE MONOPHOSPHATE#0.6956;COLLAGEN TYPE I#0.6954;LYSINE#0.6946;IMMUNOGLOBULIN G#0.6943;OBESE#0.6942;QUANTITATIVE REVERSE TRANSCRIPTION#0.6935;TRANSACTIVATION#0.6919;MACROPINOSOME#0.6917;B CELL LYMPHOMA#0.6913;DNA METHYLATION#0.6911;PARKINSON'S DISEASE#0.6900;FIBRINOGEN#0.6882;DIABETES MELLITUS#0.6879;KAWASAKI DISEASE#0.6861;GLUCOSE METABOLISM#0.6850;PEROXISOME#0.6836;2-DEOXYGLUCOSE#0.6827;LUNG METASTASIS#0.6826;TYROSINE AUTOPHOSPHORYLATION#0.6822;AMPH-B#0.6814;PROTEIN PHOSPHATASE 2A#0.6808;FERTILIZATION#0.6806;PHOSPHATASE 2A#0.6804;INTERLEUKIN 2 RECEPTOR#0.6794;MRNA SPLICING#0.6793;TUBERCULOSIS#0.6791;LUNG CARCINOMA CELL LINES#0.6790;ASPERGILLOSIS#0.6788;LACTIC ACID#0.6785;VASCULAR DISEASE#0.6784;OLIGODENDROCYTE#0.6776;RED BLOOD CELL#0.6767;MYOCARDIUM#0.6767;TISSUE DEVELOPMENT#0.6766;CANDIDIASIS#0.6756;HUMAN PERIODONTAL LIGAMENT#0.6754;HIGH DENSITY LIPOPROTEIN#0.6742;NEOPLASTIC DISEASE#0.6736;GROWTH OF CELL#0.6735;MONOCYTE DERIVED DENDRITIC CELL#0.6729;ACID SPHINGOMYELINASE#0.6719;STEM CELL MARKER#0.6714;NEURON SURVIVAL#0.6713;IMMUNE SUPPRESSION#0.6710;ACTIVATED B CELL#0.6710;AMPHOTERICIN B#0.6702;GERM CELL TUMORS#0.6691;T HELPER CELL#0.6687;CLASSICAL MONOCYTE#0.6686;LYMPHOID TISSUE#0.6676;TYPE 1 DIABETES#0.6675;TRABECULAR BONE VOLUME#0.6671;CANCER STEM CELL#0.6668;LUNG DISEASE#0.6667;ADULT BONE MARROW#0.6666;FOLLICULAR PHASE#0.6662;DOMINANT NEGATIVE MUTANT#0.6651;BLOOD BRAIN BARRIER#0.6650;CELECOXIB#0.6645;ALTERNATIVELY ACTIVATED MACROPHAGES#0.6640;ASCORBIC ACID#0.6633;CHLORAMPHENICOL#0.6632;ENDOTHELIAL PROGENITOR CELL#0.6632;PODOCYTE#0.6629;ASPARTATE#0.6624;SUPEROXIDE DISMUTASE#0.6618;BONE REGENERATION#0.6607;PROTEIN DEGRADATION#0.6607;AORTIC SMOOTH MUSCLE CELLS#0.6603;COAGULATION#0.6583;CYCLOSPORINE#0.6578;PERIPHERAL NERVE INJURY#0.6575;CHEMOKINE PRODUCTION#0.6572;IL-12 PRODUCTION#0.6561;ERYTHROID CELL#0.6547;LYMPHOCYTE PROLIFERATION#0.6510;GLYCOLYSIS#0.6492;WISKOTT ALDRICH SYNDROME#0.6484;SIMVASTATIN#0.6483;SPERMATOGONIAL STEM CELL#0.6479;MONOCYTE ACTIVATION#0.6479;HAEMATOPOIETIC STEM CELL#0.6473;CROSS SECTIONAL AREA#0.6468;BONE TURNOVER MARKER#0.6455;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.6446;CHOLERA#0.6444;GROWTH DIFFERENTIATION FACTOR#0.6442;INTERMEDIATE MONOCYTE#0.6439;DNA FORMATION#0.6428;DNA FRAGMENTATION#0.6415;CELLULAR COMPONENT#0.6414;GLYCERALDEHYDE-3-PHOSPHATE#0.6403;PERITONITIS#0.6380;SALIVARY GLAND#0.6375;MESANGIUM#0.6354;OVARIES#0.6351;REGULATED INTRAMEMBRANE PROTEOLYSIS#0.6349;C-SIS#0.6321;RESPONSE TO GM-CSF#0.6320;HEMATOPOIETIC ORGANS#0.6320;RESPONSE TO G-CSF#0.6316;MYOCARDITIS#0.6277;GENISTEIN#0.6276;PSORIASIS#0.6267;TRANSMISSION ELECTRON MICROSCOPY#0.6267;ENDOMETRIAL EPITHELIAL CELLS#0.6266;CALCITRIOL#0.6266;PACLITAXEL#0.6264;DEPHOSPHORYLATION#0.6261;SYNCYTIOTROPHOBLAST#0.6261;NAIVE T CELL#0.6253;IMMUNE EVASION#0.6248;HEMORRHAGE#0.6239;C CHEMOKINE RECEPTOR#0.6228;REGULATION OF HEMATOPOIESIS#0.6225;MYELOBLAST#0.6221;ACUTE CORONARY SYNDROME#0.6217;HERPES SIMPLEX VIRUS#0.6213;HERPES SIMPLEX#0.6210;LYMPHOCYTIC LEUKEMIA#0.6209;VEGF-AS#0.6200;PLASMA PROTEIN#0.6199;RECEPTOR INTERACTING PROTEIN#0.6196;RECEPTOR MEDIATED ENDOCYTOSIS#0.6192;MATRIX METALLOPROTEINASE 1#0.6189;NEUROBLASTOMA#0.6189;COMPLEX I#0.6188;LOW DENSITY ARRAYS#0.6187;CYTOKINE SYNTHESIS#0.6187;LUNG FIBROBLASTS#0.6178;BRAIN DEVELOPMENT#0.6176;MANDIBLE#0.6168;UBIQUITIN#0.6168;INFLAMMATORY MONOCYTE#0.6167;MITOGENIC ACTIVITY#0.6156;IL-1 PRODUCTION#0.6155;IGF BINDING#0.6154;ENHANCER BINDING#0.6150;CELL DEDIFFERENTIATION#0.6134;FAT PAD#0.6108;BETA GALACTOSIDASE#0.6100;OVIDUCT#0.6068;INHIBITION OF BONE RESORPTION#0.6053;VSMC APOPTOSIS#0.6052;CHRONIC KIDNEY DISEASE#0.6047;WEIGHT LOSS#0.6042;MAMMARY EPITHELIUM#0.6041;LIPID METABOLISM#0.6039;GALECTIN#0.6035;KINASE INSERT DOMAIN#0.6030;MALARIA#0.6026;ASPIRIN#0.6016;HYPERTENSION#0.6013;ADAPTOR PROTEIN 2#0.6007;VIRULENCE#0.6005
143662	CANCER CELL#0.7655;COLORECTAL#0.6681;POLYMERASE CHAIN REACTION#0.6479;GROWTH FACTOR#0.6358;CELL SURFACE#0.6302;CELL PROLIFERATION#0.6284;HEPATOCELLULAR CARCINOMA#0.6252;TROPHOBLAST#0.6230
143684	NUCLEAR SPECKLE#1.2197
143686	REACTIVE OXYGEN SPECIES#0.8770;TRANSCRIPTION FACTOR#0.8658;SKELETAL MUSCLE#0.7973;GENE EXPRESSION#0.7555;GATOR2 COMPLEX#0.7036;AUTOPHAGY#0.6931;TARGET OF RAPAMYCIN#0.6847;SIGNALING PATHWAY#0.6759;CANCER CELL#0.6681;APOPTOSIS#0.6372;RAPAMYCIN#0.6233;LIPID METABOLISM#0.6152;CERAMIDE KINASE#0.6018;LEUCINE#0.6002
143689	DNA METHYLATION#1.0503;GERM CELL#1.0267;DE NOVO DNA METHYLATION#0.9437;CANCER CELL#0.9208;SPERMATOGENESIS#0.9171;STEM CELL#0.8679;GENE EXPRESSION#0.7888;BREAST CANCER#0.7428;CYTOPLASM#0.7348;GENE SILENCING#0.7171;GERM CELL DEVELOPMENT#0.6785;CELL DEVELOPMENT#0.6673;MEIOSIS#0.6143;RENAL CELL CARCINOMA#0.6122;CYTOPLASMIC STRESS GRANULE#0.6076;INFERTILITY#0.6005;EPITHELIAL CELL#0.6004
1436	C-SIS#1.0598;BREAST CARCINOMA#1.0454;FIMBRIAE#1.0376;TROPHOBLAST#1.0318;IMATINIB#1.0301;LEUKOENCEPHALOPATHY#1.0288;TYROSINE KINASE RECEPTOR#1.0277;TYROSINE KINASE DOMAIN#1.0271;BREAST CANCER CELL#1.0254;MAMMARY EPITHELIAL CELL#1.0245;SRC FAMILY KINASE#1.0241;PERTUSSIS#1.0238;RESPONSE TO M-CSF#1.0187;G-CSF#1.0168;STEM CELL FACTOR#1.0144;OVARIAN#1.0143;FETAL LIVER#1.0140;OVARIAN CANCER#1.0120;IFN-GAMMA#1.0108;SMOOTH MUSCLE CELL#1.0103;MUSCLE CELL#1.0093;MACROPHAGE PROLIFERATION#1.0091;PLATELET-DERIVED GROWTH FACTOR#1.0089;EPITHELIAL CELL#1.0085;SIGNALLING PATHWAY#1.0074;EPIDERMAL GROWTH FACTOR#1.0067;KINASE INSERT DOMAIN#1.0065;RETINOIC ACID#1.0058;GRANULOCYTE COLONY STIMULATING FACTOR#1.0051;SMOOTH MUSCLE#1.0037;PROTEIN TYROSINE KINASE#1.0034;COLONY-STIMULATING FACTOR#1.0034;KINASE ACTIVITY#1.0021;OSTEOCLAST#1.0019;GROWTH FACTOR RECEPTOR#1.0014;TUMOR ASSOCIATED MACROPHAGE#1.0013;ENDOTHELIAL GROWTH FACTOR#1.0012;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0012;CHORIOCARCINOMA#1.0000;LIGAND BINDING DOMAIN#0.9995;MACROPHAGE DIFFERENTIATION#0.9980;GM-CSF#0.9977;RECEPTOR TYROSINE KINASE#0.9974;ONCOGENIC#0.9966;CYTOKINE RECEPTOR#0.9965;PROTEIN KINASE C#0.9964;CANCER CELL#0.9963;KINASE INHIBITOR#0.9962;MYELOID PROGENITOR CELL#0.9957;BREAST CANCER#0.9950;OSTEOCLAST DIFFERENTIATION#0.9942;SPINAL CORD#0.9940;TRANSFORMING GROWTH FACTOR#0.9934;ALZHEIMER'S DISEASE#0.9933;MACROPHAGE#0.9933;SIGNAL TRANSDUCTION#0.9931;TYROSINE KINASE INHIBITOR#0.9920;LEUKODYSTROPHY#0.9910;MYELOID CELL#0.9888;CELL CYCLE#0.9882;INFLAMMATORY MONOCYTE#0.9880;PRECURSOR CELL#0.9879;CELL SURFACE#0.9878;CELL DIFFERENTIATION#0.9877;ACUTE MYELOID LEUKEMIA#0.9873;B CELL#0.9871;MONOCYTE#0.9868;M2 MACROPHAGE#0.9865;IMATINIB MESYLATE#0.9864;POLYMERASE CHAIN REACTION#0.9862;RECEPTOR ACTIVATOR#0.9859;HEMATOPOIETIC CELL#0.9847;PROTEIN KINASE#0.9829;TRANSCRIPTION FACTOR#0.9827;MONONUCLEAR CELLS#0.9827;APOPTOSIS#0.9826;STROMAL CELL#0.9825;MITOGEN ACTIVATED PROTEIN#0.9819;NEUTROPHIL#0.9819;ENDOCYTOSIS#0.9813;TUMOR CELLS#0.9809;GRANULOCYTE#0.9806;RHEUMATOID ARTHRITIS#0.9798;ACID PHOSPHATASE#0.9797;BONE MARROW CELLS#0.9787;CELL GROWTH#0.9785;ADENOCARCINOMA#0.9784;MYELODYSPLASTIC SYNDROME#0.9783;SUNITINIB#0.9780;PROGENITOR CELL#0.9779;FIBROBLAST GROWTH FACTOR#0.9776;SIGNALING PATHWAY#0.9769;DENDRITIC CELL#0.9768;PHAGOCYTOSIS#0.9764;MYELOID LEUKEMIA#0.9763;T LYMPHOCYTE#0.9763;CELL ADHESION#0.9762;GROWTH FACTOR#0.9757;PERIPHERAL BLOOD#0.9745;BONE RESORPTION#0.9740;MYELOID-DERIVED SUPPRESSOR CELL#0.9740;ENDOTHELIAL CELL#0.9733;STEM CELL#0.9728;MAMMARY GLAND#0.9721;CELL DEATH#0.9716;T CELL#0.9709;HEMATOPOIESIS#0.9709;OSTEOBLAST#0.9704;LUNG CANCER#0.9700;LANGERHANS CELL#0.9695;TUMOR NECROSIS FACTOR#0.9694;MULTIPLE SCLEROSIS#0.9692;INFLAMMATORY RESPONSE#0.9681;LEUKOCYTE#0.9679;BONE MARROW#0.9678;CELL PROLIFERATION#0.9677;PRO-INFLAMMATORY#0.9663;NERVOUS SYSTEM#0.9661;CENTRAL NERVOUS SYSTEM#0.9659;HEMATOPOIETIC PROGENITOR CELL#0.9659;GENE EXPRESSION#0.9657;ANCHORAGE INDEPENDENT GROWTH#0.9639;ANGIOGENESIS#0.9634;CYTOKINE PRODUCTION#0.9626;TRANSFORMING GROWTH FACTOR BETA#0.9625;CELL MIGRATION#0.9622;IMMUNE CELL#0.9612;PHOSPHOLIPASE C#0.9609;INTERNAL TANDEM DUPLICATION#0.9607;TUMOR SUPPRESSOR#0.9583;HEPATOCELLULAR CARCINOMA#0.9576;DEMENTIA#0.9568;PROTEIN SYNTHESIS#0.9557;IMMUNE SYSTEM#0.9557;PLASMA MEMBRANE#0.9547;HEMATOPOIETIC STEM CELL#0.9545;IMMUNE RESPONSE#0.9544;MACROPHAGE MIGRATION#0.9533;GIANT CELL TUMOR#0.9528;JUXTAMEMBRANE#0.9517;VASCULAR SMOOTH MUSCLE CELL#0.9485;LYMPH NODE#0.9468;TOLL LIKE RECEPTOR#0.9464;CHEMOKINE RECEPTOR#0.9463;YOLK SAC#0.9453;STROMA#0.9452;OVARIAN CARCINOMA#0.9420;APOPTOTIC#0.9398;INNATE IMMUNITY#0.9384;ASTROCYTE#0.9382;PROSTATE CANCER#0.9371;VIRULENCE#0.9331;PERIPHERAL BLOOD MONOCYTES#0.9319;PIGMENTED VILLONODULAR SYNOVITIS#0.9317;VILLONODULAR SYNOVITIS#0.9311;DNA SYNTHESIS#0.9297;SIGNALING MOLECULE#0.9290;TENOSYNOVIAL GIANT CELL TUMOR#0.9271;MAGNETIC RESONANCE IMAGING#0.9232;TERMINAL DIFFERENTIATION#0.9188;LYMPHOID CELL#0.9170;PROTEIN TYROSINE PHOSPHATASE#0.9158;OSTEOCLAST PRECURSOR CELL#0.9157;LUNG CARCINOMA#0.9142;RENAL CELL CARCINOMA#0.9122;MICROGLIAL CELL#0.9115;CD8+ T CELL#0.9113;BONE REMODELING#0.9113;TRANSCRIPTASE#0.9110;B LYMPHOCYTE#0.9102;HUMAN BREAST CANCER#0.9099;NITRIC OXIDE#0.9083;MAST CELL#0.9066;REVERSE TRANSCRIPTION#0.9057;MONOCYTE DERIVED MACROPHAGE#0.9056;CERVICAL#0.9029;SIGNAL TRANSDUCER#0.9021;CELL DEVELOPMENT#0.9014;SCAVENGER RECEPTOR#0.9012;GLIAL CELL#0.9001;MONOCYTE DIFFERENTIATION#0.8997;EXTRACELLULAR MATRIX#0.8993;BLOOD VESSEL#0.8990;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8987;TUMOR TISSUES#0.8984;REGULATED INTRAMEMBRANE PROTEOLYSIS#0.8972;CHEMOTAXIS#0.8947;NEURODEGENERATIVE DISEASE#0.8917;BONE DISEASE#0.8900;ALVEOLAR MACROPHAGE#0.8885;DEXAMETHASONE#0.8880;BONE FORMATION#0.8871;S PHASE#0.8836;ACUTE MYELOID LEUKAEMIA#0.8749;PANCREATIC CANCER#0.8744;MACROPHAGE ACTIVATION#0.8724;RECEPTOR LIGAND#0.8704;INFLAMMATORY CELL#0.8698;BLADDER CARCINOMA#0.8675;INSULIN RECEPTOR#0.8651;CEREBRAL CORTEX#0.8650;ATHEROSCLEROSIS#0.8622;SYNOVITIS#0.8594;OSTEOPOROSIS#0.8574;RECEPTOR ACTIVITY#0.8573;CERVICAL CANCER#0.8572;FACTOR I#0.8567;QUANTITATIVE REAL TIME#0.8545;TROPHOBLAST CELL#0.8540;BREAST CARCINOMA CELL LINES#0.8525;UROKINASE#0.8489;CD4+ T CELL#0.8445;KUPFFER CELL#0.8419;ACTIVATED T CELL#0.8331;G1 PHASE#0.8327;CELL DIVISION#0.8321;MAP KINASE#0.8320;ISCHEMIA#0.8318;MACROPHAGE POLARIZATION#0.8276;T CELL PROLIFERATION#0.8273;ANTIGEN PRESENTING CELLS#0.8269;MOLAR#0.8256;VITAMIN D3#0.8254;WOUND HEALING#0.8249;CELL MEMBRANE#0.8243;MAMMARY GLAND DEVELOPMENT#0.8241;REGENERATION#0.8229;EPSTEIN BARR VIRUS#0.8223;GLAND DEVELOPMENT#0.8221;ADIPOSE TISSUE#0.8188;AUTOIMMUNE DISEASE#0.8177;INSULIN-LIKE GROWTH FACTOR#0.8175;SQUAMOUS CELL CARCINOMA#0.8174;HODGKIN'S LYMPHOMA#0.8170;ENDOMETRIUM#0.8165;ERYTHROPOIETIN RECEPTOR#0.8148;TYROSINE AUTOPHOSPHORYLATION#0.8131;CLASSICAL HODGKIN LYMPHOMA#0.8123;MYOBLAST#0.8120;ACUTE LEUKEMIA#0.8106;CELL ACTIVATION#0.8100;DIPHTHERIA#0.8093;DNA BINDING#0.8092;LYMPHOID TISSUE#0.8089;PERIPHERAL NERVE#0.8081;TOXICITY#0.8080;SIGNALING CASCADE#0.8067;PANETH CELL#0.8062;BLAST CELL#0.8033;SYNOVIUM#0.7995;PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS#0.7975;MUTAGENESIS#0.7965;ATHEROSCLEROTIC#0.7964;UTERUS#0.7955;ORTHODONTIC TOOTH MOVEMENT#0.7944;RECEPTOR DEGRADATION#0.7924;THYMIDINE#0.7922;ACTIVATED T-CELLS#0.7921;ENDOMETRIAL ADENOCARCINOMA#0.7920;WHITE MATTER LESIONS#0.7917;MEGAKARYOCYTE#0.7885;CALCITONIN RECEPTOR#0.7837;PTDINS-3-KINASE ACTIVITY#0.7837;MANNOSE RECEPTOR#0.7835;ENCEPHALOMYELITIS#0.7819;NITRIC OXIDE SYNTHASE#0.7769;FRAGMENT LENGTH POLYMORPHISM#0.7766;ENDOTHELIUM#0.7761;PROSTAGLANDIN E2#0.7738;DNA METHYLATION#0.7738;MYELOID CELL LINES#0.7690;DASATINIB#0.7679;CORD BLOOD#0.7620;ATP BINDING#0.7614;ROOT RESORPTION#0.7613;PROTEIN KINASE ACTIVITY#0.7612;ENDOMETRIOSIS#0.7576;MYELOBLAST#0.7565;IMMUNE SUPPRESSION#0.7563;INTESTINAL STEM CELL#0.7502;REACTIVE OXYGEN SPECIES#0.7469;MYOGENIC CELL#0.7467;FRONTAL#0.7461;PACLITAXEL#0.7427;PARKINSON'S DISEASE#0.7386;COLONY-FORMING CELL#0.7374;PERIPHERAL MONOCYTE#0.7338;HEPARIN BINDING#0.7332;ERYTHROCYTE#0.7318;ALKALINE PHOSPHATASE#0.7269;LEUKEMIA INHIBITORY FACTOR#0.7245;MALIGNANT HISTIOCYTOSIS#0.7243;EPILEPSY#0.7238;OSTEOPETROSIS#0.7233;CLEAR CELL RENAL CELL CARCINOMA#0.7232;CYTOTOXICITY#0.7214;ABT-869#0.7208;STEM CELL TRANSPLANTATION#0.7197;FETAL LIVER KINASE#0.7192;ELECTROPHORETIC MOBILITY SHIFT#0.7190;GLUCOCORTICOID RECEPTOR#0.7179;EPITHELIAL OVARIAN CANCER#0.7166;GASTROINTESTINAL STROMAL TUMOR#0.7163;ANTIGEN PRESENTATION#0.7148;CLASSICAL MONOCYTE#0.7147;GERM CELL#0.7138;RETINOBLASTOMA#0.7123;CELL ADHESION MOLECULE#0.7108;OOCYTE#0.7107;LYMPHOCYTIC LEUKEMIA#0.7079;MONOCYTIC LEUKEMIA#0.7076;RESPONSE TO G-CSF#0.7074;DECIDUAL CELL#0.7073;BREAST CANCER PATIENTS#0.7059;ERYTHROID PROGENITOR#0.7033;GESTATION#0.7018;CELL SURFACE ANTIGEN#0.7011;PULMONARY FIBROSIS#0.7010;NEUROBLASTOMA#0.7004;RIBOSOMAL PROTEIN#0.6996;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6991;CROHN'S DISEASE#0.6989;LUNG ADENOCARCINOMA#0.6988;DISCOIDIN DOMAIN RECEPTOR#0.6976;COLLAGEN INDUCED ARTHRITIS#0.6952;BLOOD BRAIN BARRIER#0.6945;UBIQUITIN#0.6934;OLIGODENDROCYTE#0.6914;LOW DENSITY LIPOPROTEIN#0.6913;ESTERASE ACTIVITY#0.6890;OSTEOCLAST DEVELOPMENT#0.6886;RESPIRATORY BURST#0.6868;PERITONEAL CAVITY#0.6857;ENDOMETRIAL CARCINOMA#0.6849;HAEMATOPOIETIC STEM CELL#0.6819;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6817;REGULATORY T CELL#0.6802;HISTIOCYTOSIS#0.6797;TRANSACTIVATION#0.6789;COLITIS#0.6786;ARTERY#0.6759;1α,25-DIHYDROXYVITAMIN D3#0.6744;OSTEOARTHRITIS#0.6738;DRUG RESISTANCE#0.6699;GLUTATHIONE#0.6694;BASEMENT MEMBRANE#0.6690;COLORECTAL CANCER#0.6665;HEPATOMA CELLS#0.6657;ACTIN CYTOSKELETON#0.6654;RECEPTOR ANTAGONIST#0.6652;STRUCTURE ACTIVITY RELATIONSHIP#0.6631;INNATE IMMUNE RESPONSE#0.6595;TISSUE REMODELING#0.6578;KINASE BINDING#0.6573;ARACHIDONIC ACID#0.6559;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6545;SYNCYTIOTROPHOBLAST#0.6545;MULTIPLE MYELOMA#0.6536;EXTRACELLULAR REGION#0.6497;ADENOSINE#0.6491;REGULATION OF GENE EXPRESSION#0.6490;OBESE#0.6474;TRANSMEMBRANE RECEPTOR#0.6466;FLOW CYTOMETRY ANALYSIS#0.6443;HEMATOPOIETIC TISSUES#0.6429;C TERMINAL DOMAIN#0.6409;T CELL ACTIVATION#0.6397;VIRAL INFECTION#0.6397;CLODRONATE#0.6391;LIVER DISEASE#0.6390;COLORECTAL#0.6379;ANEMIA#0.6353;CHRONIC MYELOID LEUKEMIA#0.6322;MICROGLIAL CELL PROLIFERATION#0.6271;CHRONIC MYELOMONOCYTIC LEUKEMIA#0.6250;ERYTHROID CELL#0.6246;LACTATION#0.6245;CYCLOPHOSPHAMIDE#0.6235;RECEPTOR BINDING#0.6224;SWELLING#0.6220;MAPK SIGNALING#0.6207;PLACENTAL DEVELOPMENT#0.6168;MORPHOGENESIS#0.6163;EPITHELIAL MESENCHYMAL TRANSITION#0.6158;EDEMA#0.6157;STEM CELL MARKER#0.6151;ALL TRANS RETINOIC ACID#0.6143;METHIONINE#0.6132;LIPID KINASE#0.6081;MECHANISM OF ACTION#0.6064;LYMPHOMA CELL LINES#0.6041;TRICUSPID VALVE#0.6038;ANTISENSE RNA#0.6020;HYPOXIA#0.6012;CYTOPLASM#0.6011
1437	GM-CSF RECEPTOR COMPLEX#1.1016;FELTY'S SYNDROME#1.0686;PEGFILGRASTIM#1.0553;RESPONSE TO GM-CSF#1.0542;RECOMBINANT HUMAN GM-CSF#1.0542;SURFACTANT HOMEOSTASIS#1.0513;CSF SECRETION#1.0414;TRICOM#1.0391;IL-3 BINDING#1.0383;DIPHTHERIA#1.0381;GM-CSF PRODUCTION#1.0367;RESPONSE TO G-CSF#1.0351;NEOPTERIN#1.0332;AMNIOTIC FLUID#1.0301;ZIDOVUDINE#1.0291;HISTAMINE SYNTHESIS#1.0286;RESPONSE TO IL-3#1.0285;G-CSF PRODUCTION#1.0282;ADVANCED BREAST CANCER#1.0277;GV1001#1.0277;TRANSFORMING GROWTH FACTOR ALPHA#1.0274;THALIDOMIDE#1.0272;EPIRUBICIN#1.0270;LEUCOVORIN#1.0268;HIGH RISK NEUROBLASTOMA#1.0255;IL-11#1.0231;THYMOCYTE PROLIFERATION#1.0227;MACROPHAGE PROLIFERATION#1.0217;GM-CSF#1.0201;AMIFOSTINE#1.0199;MACROPHAGE MIGRATION#1.0199;NEUTROPHIL MIGRATION#1.0186;MONOCYTE CHEMOTACTIC PROTEIN#1.0186;MONOCYTE ACTIVATION#1.0184;IL-1 PRODUCTION#1.0177;AGRANULOCYTOSIS#1.0174;MITOXANTRONE#1.0174;MIGRATION INHIBITORY FACTOR#1.0172;LITHIUM#1.0171;IFOSFAMIDE#1.0166;COLONY-STIMULATING FACTOR#1.0160;GRANULOCYTE#1.0159;PERIPHERAL MONOCYTE#1.0156;PENTOXIFYLLINE#1.0149;IL-8 SECRETION#1.0143;BLADDER CARCINOMA#1.0142;METASTATIC COLORECTAL CANCER#1.0139;G-CSF#1.0136;GERM CELL#1.0128;MRNA STABILIZATION#1.0124;MACROPHAGE#1.0118;BUDESONIDE#1.0118;COLORECTAL CARCINOMA#1.0117;EOSINOPHIL DIFFERENTIATION#1.0114;MACROPHAGE CHEMOATTRACTANT PROTEIN#1.0112;LEWIS LUNG CARCINOMA#1.0109;ARA-C#1.0108;VINORELBINE#1.0106;INTERLEUKIN 3 RECEPTOR#1.0101;NEUTROPHIL CHEMOTAXIS#1.0100;IL-1RA#1.0100;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0095;SEMINAL PLASMA#1.0087;MYELOID CELL DIFFERENTIATION#1.0081;RESPONSE TO TNF#1.0078;BLEOMYCIN#1.0078;PULMONARY ALVEOLAR PROTEINOSIS#1.0077;INTERLEUKIN 5 RECEPTOR#1.0074;LARGE GRANULAR LYMPHOCYTE#1.0067;T-CELL GROWTH FACTOR#1.0067;LEUKEMIA INHIBITORY FACTOR#1.0063;MALIGNANT LYMPHOMA#1.0060;NKT CELL#1.0058;THYMIDINE KINASE#1.0056;SPINAL CORD INJURY#1.0053;ISOTRETINOIN#1.0053;RESPONSE TO IL-1#1.0052;VITAMIN D3#1.0052;GLUCOSE UPTAKE#1.0050;PACLITAXEL#1.0048;OOCYTE#1.0047;FIBROBLAST GROWTH FACTOR#1.0046;MESOTHELIAL CELL#1.0045;GRANULOCYTE COLONY STIMULATING FACTOR#1.0045;IFN-BETA#1.0043;DOCETAXEL#1.0033;HYDROXYUREA#1.0031;PLATELET-DERIVED GROWTH FACTOR#1.0031;GROWTH OF CELL#1.0030;AIRWAY SMOOTH MUSCLE#1.0029;AMPHOTERICIN B#1.0028;M-CSF PRODUCTION#1.0027;CYTOSINE ARABINOSIDE#1.0027;FOWLPOX#1.0022;STEM CELL FACTOR#1.0021;AMPHOTERICIN#1.0021;CYTARABINE#1.0021;HEPATOCYTE GROWTH FACTOR#1.0018;SPUTUM#1.0016;LUNG METASTASIS#1.0015;LEUKOTRIENE SYNTHESIS#1.0015;RESPONSE TO M-CSF#1.0014;RAT BONE MARROW#1.0012;MYASTHENIA GRAVIS#1.0011;2-DEOXYGLUCOSE#1.0011;SARCOIDOSIS#1.0011;M1 MACROPHAGE#1.0010;GEMCITABINE#1.0005;MACROPHAGE INFLAMMATORY PROTEIN#1.0004;INSULIN-LIKE GROWTH FACTOR#1.0003;GANCICLOVIR#1.0002;RESPONSE TO LIPOPOLYSACCHARIDE#0.9999;OXIDATIVE METABOLISM#0.9996;DOXORUBICIN#0.9995;CARBOPLATIN#0.9995;PERIPHERAL BLOOD MONOCYTES#0.9994;INTERLEUKIN 2 RECEPTOR#0.9993;ETHANOL#0.9993;ALVEOLAR EPITHELIAL CELL#0.9991;PERIPHERAL BLOOD LEUKOCYTE#0.9989;KUPFFER CELL#0.9987;JUVENILE MYELOMONOCYTIC LEUKEMIA#0.9987;PHOSPHOLIPASE D#0.9987;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9980;FIBROBLAST LIKE SYNOVIOCYTES#0.9979;INHIBITION OF APOPTOSIS#0.9978;ENDOTHELIAL GROWTH FACTOR#0.9978;ERYTHROLEUKEMIA#0.9977;CYTOKINE ACTIVITY#0.9976;TROPHOBLAST#0.9975;FOLLICULAR LYMPHOMA#0.9975;STAUROSPORINE#0.9974;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.9974;SOFT TISSUE SARCOMA#0.9974;METASTATIC BREAST CANCER#0.9970;OXIDATIVE BURST#0.9969;GENISTEIN#0.9969;RECEPTOR COMPLEX#0.9967;RECEPTOR BINDING#0.9967;COLON CARCINOMA#0.9965;LUNG CARCINOMA#0.9965;PROSTATE CARCINOMA#0.9965;MITOGENIC ACTIVITY#0.9964;NEUROBLASTOMA#0.9964;EOSINOPHIL MIGRATION#0.9964;ARTERIOGENESIS#0.9962;FACTOR I#0.9961;HEMATOPOIETIC PRECURSOR CELL#0.9960;HEAD AND NECK CANCER#0.9959;NECK CANCER#0.9959;MYELOBLAST#0.9959;METASTATIC RENAL CELL CARCINOMA#0.9958;AU RICH ELEMENT#0.9958;INFLAMMATORY MONOCYTE#0.9957;PHOSPHOLIPASE A2#0.9956;NERVE GROWTH FACTOR#0.9955;NEUTROPHIL APOPTOSIS#0.9954;BONE MARROW STEM CELL#0.9953;CROSS PRESENTATION#0.9952;MUCOSITIS#0.9951;APLASTIC ANEMIA#0.9950;CD3+ T CELL#0.9948;KERATINOCYTE PROLIFERATION#0.9948;PERIPHERAL MONONUCLEAR CELLS#0.9948;PROTEIN SECRETION#0.9946;CHRONIC MYELOMONOCYTIC LEUKEMIA#0.9945;MONOCYTIC LEUKEMIA#0.9943;VIRUS LIKE PARTICLE#0.9943;TUMOUR NECROSIS FACTOR#0.9943;HERPES SIMPLEX VIRUS#0.9942;ETOPOSIDE#0.9942;VACCINIA#0.9939;LUNG FIBROBLASTS#0.9938;CROSS PRIMING#0.9937;DAUNORUBICIN#0.9935;VINCRISTINE#0.9935;TROPHOBLAST CELL#0.9935;MYELOID CELL LINES#0.9934;TESTICULAR CANCER#0.9932;KEYHOLE LIMPET HEMOCYANIN#0.9932;UTERUS#0.9931;CISPLATIN#0.9928;SELECTIN#0.9926;PREDNISONE#0.9926;DECIDUAL CELL#0.9924;FLUTICASONE PROPIONATE#0.9924;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9921;IFN-GAMMA#0.9921;HERPES SIMPLEX#0.9919;RANDOMIZED CLINICAL TRIAL#0.9919;MARROW STEM CELLS#0.9918;COLON CANCER#0.9916;IL-10 SECRETION#0.9914;MELPHALAN#0.9914;RAPAMYCIN#0.9913;MELANOMA CELL LINES#0.9912;HEPATITIS C#0.9911;IL-8 PRODUCTION#0.9911;TH17 CELL#0.9910;CROHN'S DISEASE#0.9906;PLATELET ACTIVATING FACTOR#0.9906;TUMOR NECROSIS FACTOR#0.9906;1α,25-DIHYDROXYVITAMIN D3#0.9902;EMBRYO DEVELOPMENT#0.9898;PERTUSSIS#0.9898;CHONDROCYTE#0.9896;OSTEOCLAST DIFFERENTIATION#0.9895;TNF-ALPHA PRODUCTION#0.9895;IL-6 SECRETION#0.9895;M2 MACROPHAGE#0.9895;HISTAMINE#0.9895;BLAST CELL#0.9895;RESPIRATORY BURST#0.9893;PROMYELOCYTE#0.9893;CATABOLISM#0.9893;IMIQUIMOD#0.9890;HUMAN CORD BLOOD#0.9888;ERYTHROPOIETIN RECEPTOR#0.9887;ARTERY DISEASE#0.9887;KERATINOCYTE#0.9887;SIMIAN IMMUNODEFICIENCY VIRUS#0.9887;FLUOROURACIL#0.9886;TNF SECRETION#0.9886;CHOLERA#0.9885;SERUM ALBUMIN#0.9884;RANDOMIZED CONTROLLED TRIAL#0.9884;HEPARIN#0.9883;HEMOCYANIN#0.9883;EOSINOPHIL#0.9882;ACUTE MYELOID LEUKAEMIA#0.9881;MYELOID PROGENITOR CELL#0.9881;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9880;RETINOIC ACID RECEPTOR#0.9879;ANTIBODY PRODUCTION#0.9878;INTRAVENOUS IMMUNOGLOBULIN#0.9878;LEUKOPENIA#0.9878;DENDRITIC CELL DIFFERENTIATION#0.9877;MYOFIBROBLAST#0.9876;NEUTROPHIL ACTIVATION#0.9876;MACROPHAGE DIFFERENTIATION#0.9876;HAEMOPOIESIS#0.9876;MONOCYTE DIFFERENTIATION#0.9875;CYCLIC AMP#0.9875;METASTATIC COLORECTAL CARCINOMA#0.9873;DEMENTIA#0.9873;REGULATION OF HEMATOPOIESIS#0.9873;CANDIDIASIS#0.9872;RESPONSE TO PMA#0.9871;PROTEIN KINASE A#0.9869;BONE MARROW FAILURE#0.9866;BLOOD PROGENITOR CELL#0.9866;ACTINOMYCIN D#0.9866;GLYCOSYLATION#0.9865;ACTIVATED T LYMPHOCYTES#0.9865;IMATINIB#0.9864;LEUKOTRIENE BIOSYNTHESIS#0.9864;EPIDERMAL GROWTH FACTOR#0.9864;RITUXIMAB#0.9864;CYTOLYSIS#0.9863;MITOMYCIN#0.9862;ASTROCYTE#0.9861;GROWTH HORMONE#0.9861;OSTEOCLAST#0.9859;SUBSTANCE P#0.9859;HEPARIN BINDING#0.9859;PROTEOGLYCAN#0.9858;IMMATURE DENDRITIC CELL#0.9858;STEM CELL PROLIFERATION#0.9858;SIGNAL PEPTIDE#0.9857;ENDOMETRIUM#0.9856;DACARBAZINE#0.9856;SYNOVIUM#0.9856;CIRCULATING PROGENITOR CELL#0.9853;TOPICAL#0.9853;DNA SYNTHESIS#0.9851;MENINGITIS#0.9851;OVARIAN CARCINOMA#0.9850;MAPK ACTIVATION#0.9849;BASOPHIL#0.9849;PERITONEAL CAVITY#0.9849;HYALURONIC ACID#0.9849;TRANSFORMING GROWTH FACTOR BETA#0.9848;INDOMETHACIN#0.9846;SCAVENGER RECEPTOR#0.9845;IL-3 PRODUCTION#0.9845;SUPEROXIDE ANION GENERATION#0.9844;5 FLUOROURACIL#0.9844;MITOMYCIN C#0.9844;IL-1 BETA PRODUCTION#0.9844;PREDNISOLONE#0.9843;TRANSFORMING GROWTH FACTOR#0.9842;FETAL LIVER#0.9841;MICROGLIAL CELL#0.9841;BREAST CANCER PATIENTS#0.9841;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9841;MALARIA#0.9841;LUNG EPITHELIAL CELL#0.9840;MONOCYTE#0.9840;BETA-2#0.9839;ALVEOLAR MACROPHAGE#0.9838;DEXAMETHASONE#0.9838;INTERLEUKIN 1 RECEPTOR#0.9838;CYCLOPHOSPHAMIDE#0.9836;MYOCARDIAL INFARCTION#0.9836;PROTEIN TYROSINE KINASE#0.9836;ESTRADIOL#0.9835;HEPATITIS B VIRUS#0.9835;SPINAL CORD#0.9833;TH1 IMMUNE RESPONSE#0.9832;PANCYTOPENIA#0.9832;ACTIVATED MONOCYTES#0.9832;DERMAL FIBROBLAST#0.9832;NEUTROPENIA#0.9832;VP-16#0.9831;EOSINOPHIL ACTIVATION#0.9831;FERTILIZATION#0.9830;RENAL CELL CARCINOMA#0.9829;NEUTROPHIL DIFFERENTIATION#0.9828;TNF PRODUCTION#0.9826;HUMAN SERUM ALBUMIN#0.9826;PROSTAGLANDIN E2#0.9825;T-CELL LEUKEMIA#0.9825;PROSTATE CANCER#0.9824;HYPOTENSION#0.9823;STEM CELL TRANSPLANT#0.9823;IMMUNOGLOBULIN G#0.9823;FLUCONAZOLE#0.9823;GLIAL CELL#0.9822;PANCREATIC ADENOCARCINOMA#0.9822;MICROPARTICLE#0.9822;NASAL MUCOSA#0.9821;SMOOTH MUSCLE CELL#0.9820;MYELODYSPLASTIC SYNDROME#0.9820;HEPATITIS B#0.9820;INFLUENZA A VIRUS#0.9818;BREAST CARCINOMA#0.9817;HEMOPOIESIS#0.9817;CORTISOL#0.9817;IL-6 PRODUCTION#0.9817;MUSCLE CELL#0.9816;IMMATURE MYELOID CELL#0.9816;IONOPHORE#0.9816;METHOTREXATE#0.9815;CYCLOSPORIN A#0.9815;IFN-GAMMA SECRETION#0.9814;IL-12 SECRETION#0.9814;BACTERIAL MENINGITIS#0.9812;SUPEROXIDE RELEASE#0.9811;METHYLPREDNISOLONE#0.9810;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9810;MYELOPEROXIDASE ACTIVITY#0.9809;MESENTERIC LYMPH NODE#0.9809;LOW DENSITY LIPOPROTEIN#0.9808;THYMOCYTE#0.9807;HUMAN AIRWAY EPITHELIAL#0.9806;KAPOSI'S SARCOMA#0.9805;ARACHIDONIC ACID#0.9805;IGE RECEPTOR#0.9805;POLYMORPHONUCLEAR NEUTROPHIL#0.9804;TYROSINE KINASE RECEPTOR#0.9803;ENDOTHELIAL PROGENITOR CELL#0.9803;BUSULFAN#0.9802;ACID PHOSPHATASE#0.9801;HEPATITIS C VIRUS#0.9801;ALL TRANS RETINOIC ACID#0.9801;PHOSPHATE BUFFERED SALINE#0.9801;BONE MARROW CELLS#0.9799;EOSINOPHILIC PNEUMONIA#0.9799;NEUTROPHIL#0.9799;RECEPTOR ACTIVATOR#0.9799;GLOBIN#0.9798;INDUCIBLE NITRIC OXIDE#0.9798;CSF FLOW#0.9796;ASPERGILLOSIS#0.9796;METASTATIC MELANOMA#0.9796;MACROPHAGE POLARIZATION#0.9796;MONOCYTE DERIVED MACROPHAGE#0.9796;RETINOIC ACID#0.9793;PROSTATE SPECIFIC ANTIGEN#0.9792;OSTEOBLAST#0.9792;PANCREATIC CANCER#0.9790;ACTIVATOR PROTEIN 1#0.9790;MAP KINASE#0.9790;FORSKOLIN#0.9789;MEGAKARYOCYTE PROGENITOR CELL#0.9789;QUANTITATIVE REVERSE TRANSCRIPTION#0.9788;SYNOVIAL FLUID#0.9787;NADPH OXIDASE#0.9786;LUMINAL#0.9786;ALLERGIC AIRWAY INFLAMMATION#0.9786;HYDROCORTISONE#0.9785;COMPLEMENT RECEPTOR#0.9785;HUMAN BRONCHIAL EPITHELIAL#0.9785;PHOSPHATASE ACTIVITY#0.9784;CYCLOSPORIN#0.9783;TOLEROGENIC DENDRITIC CELLS#0.9783;CELL FRACTION#0.9782;TERMINAL DIFFERENTIATION#0.9782;TUMOR ASSOCIATED MACROPHAGE#0.9780;PHOSPHODIESTERASE#0.9780;BRONCHIAL EPITHELIAL CELLS#0.9779;72-HOURS#0.9778;NF-KAPPAB ACTIVATION#0.9777;LYMPHOCYTE ACTIVATION#0.9777;ADULT BONE MARROW#0.9776;LEUKOCYTE ADHESION#0.9775;ALANINE#0.9774;LYMPHOCYTIC LEUKEMIA#0.9773;POLYMORPHONUCLEAR LEUKOCYTES#0.9773;MALIGNANT GLIOMA#0.9772;TUMOR CELL LYSATE#0.9772;MATURE DENDRITIC CELLS#0.9770;BREAST CANCER CELL#0.9769;SUCRALFATE#0.9769;RESPONSE TO LPS#0.9768;CHRONIC HEPATITIS B#0.9768;MEGAKARYOCYTE#0.9767;ANAEMIA#0.9767;VASCULAR CELL#0.9766;PSORIASIS#0.9765;MANNOSE RECEPTOR#0.9765;BLOOD BRAIN BARRIER#0.9764;ACUTE LEUKEMIA#0.9763;ACUTE MYOCARDIAL INFARCTION#0.9762;TYROSINE KINASE INHIBITOR#0.9762;SIGNALLING PATHWAY#0.9761;RESPONSE TO CYTOKINE#0.9761;CYCLIN DEPENDENT KINASE#0.9761;WOUND HEALING#0.9760;WHITE BLOOD CELL#0.9759;MYELOID DENDRITIC CELL#0.9758;L-ARGININE#0.9758;PROTEIN SYNTHESIS#0.9757;BETA GALACTOSIDASE#0.9755;PERIPHERAL BLOOD CELLS#0.9755;PULMONARY FIBROSIS#0.9755;MRNA DEGRADATION#0.9754;HODGKIN'S LYMPHOMA#0.9753;IL-4 PRODUCTION#0.9753;B CELL LYMPHOMA#0.9752;MAXIMUM TOLERATED DOSE#0.9751;C REACTIVE PROTEIN#0.9751;LEISHMANIASIS#0.9751;QUANTITATIVE REAL TIME#0.9751;HEAT SHOCK PROTEIN#0.9750;HISTONE ACETYLATION#0.9750;TRANSACTIVATION#0.9750;PANCREATIC CARCINOMA#0.9749;IMMUNE SUPPRESSION#0.9749;CERVICAL CANCER#0.9749;NITRIC OXIDE SYNTHASE#0.9748;COLORECTAL#0.9747;ADVANCED PROSTATE CANCER#0.9746;MYELOCYTE#0.9746;KINASE ACTIVITY#0.9746;APOPTOTIC CELL DEATH#0.9744;CYCLOSPORINE#0.9743;CHRONIC HEPATITIS C#0.9743;OVARIAN CANCER#0.9742;CYTOKINE SYNTHESIS#0.9742;PARATHYROID HORMONE#0.9742;MEDIAN SURVIVAL TIME#0.9741;BREAST CANCER#0.9741;CORONARY ARTERY#0.9740;CERVICAL#0.9739;RENAL CELL CANCER#0.9738;WEIGHT LOSS#0.9737;OVARIAN#0.9736;THEOPHYLLINE#0.9736;MESENCHYMAL CELL#0.9736;HYPOXIA#0.9736;CELL KILLING#0.9736;ACTIVATED B CELL#0.9736;LYMPHOCYTE ANTIGEN#0.9735;RECEPTOR AGONIST#0.9733;ISCHEMIA#0.9732;LUNG CANCER#0.9732;OSTEOARTHRITIS#0.9732;NECROTIC#0.9730;GROWTH FACTOR#0.9728;ADENOSINE#0.9726;ERYTHROID CELL#0.9725;ERYTHROID PROGENITOR#0.9725;MAMMARY GLAND#0.9725;BASEMENT MEMBRANE#0.9724;NON HODGKIN LYMPHOMA#0.9723;OBESE#0.9723;ACUTE MYELOID LEUKEMIA#0.9723;BONE MARROW STROMAL CELL#0.9723;CELLULAR IMMUNE RESPONSE#0.9723;COLITIS#0.9722;VIRAL REPLICATION#0.9722;HISTONE DEACETYLASE#0.9722;INJECTION SITE REACTIONS#0.9721;COLLAGEN INDUCED ARTHRITIS#0.9721;RECEPTOR ANTAGONIST#0.9721;INDUCTION OF APOPTOSIS#0.9720;RECEPTOR LIGAND#0.9720;PERITONITIS#0.9720;ALZHEIMER'S DISEASE#0.9719;CHRONIC MYELOID LEUKEMIA#0.9719;ADENOSINE MONOPHOSPHATE#0.9719;PRECURSOR CELL#0.9718;ERYTHROPOIESIS#0.9718;ANTI HER2#0.9717;SMOOTH MUSCLE#0.9717;BONE MARROW MICROENVIRONMENT#0.9717;MYELOID CELL#0.9716;MUTAGENESIS#0.9716;CELL ASSOCIATED#0.9715;SUPEROXIDE DISMUTASE#0.9715;MARROW STROMAL CELLS#0.9715;PROTEIN KINASE C#0.9714;S PHASE#0.9712;BONE MARROW STROMAL#0.9712;SIGNALING CASCADE#0.9712;HEALTHY CONTROL SUBJECTS#0.9710;TH1 CELL#0.9710;CYTOPENIA#0.9709;BRONCHITIS#0.9709;MACROPHAGE ACTIVATION#0.9709;ERYTHROBLAST#0.9709;MINIMAL RESIDUAL DISEASE#0.9708;COLORECTAL CANCER#0.9706;CORONARY ARTERY DISEASE#0.9706;LANGERHANS CELL#0.9705;UMBILICAL CORD BLOOD#0.9705;TUMOR TISSUES#0.9705;TRASTUZUMAB#0.9705;BLOOD PLASMA#0.9704;FIBROSARCOMA#0.9704;STEM CELL#0.9703;CORD BLOOD#0.9703;PROTEIN PHOSPHORYLATION#0.9703;GROWTH REGULATED ONCOGENE#0.9703;AIRWAY EPITHELIUM#0.9702;IL-2 PRODUCTION#0.9702;CAPILLARY LEAK SYNDROME#0.9701;KINASE INHIBITOR#0.9700;HUMAN UMBILICAL VEIN#0.9699;DIESEL EXHAUST PARTICLE#0.9698;RESPIRATORY FAILURE#0.9698;DNA FRAGMENTATION#0.9697;PLASMA MEMBRANE#0.9697;HISTIOCYTOSIS#0.9697;FACTOR S#0.9695;CONNECTIVE TISSUE#0.9694;BONE MARROW#0.9694;MICROVASCULAR ENDOTHELIAL CELL#0.9694;MAST CELL#0.9693;MELANOCYTE#0.9693;GESTATION#0.9693;AIRWAY EPITHELIAL CELL#0.9693;OXYGENASE#0.9692;SIGNAL TRANSDUCER#0.9692;ENDOTHELIUM#0.9692;REGENERATION#0.9691;PROGESTERONE#0.9691;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9691;COLONY-FORMING CELL#0.9690;RESPONSE TO IL-2#0.9689;CUTANEOUS LEISHMANIASIS#0.9689;VASCULAR ENDOTHELIAL CELL#0.9689;THYMIDINE#0.9689;PROGRAMMED CELL DEATH#0.9688;CYSTIC FIBROSIS#0.9688;PRO-INFLAMMATORY#0.9688;INTERSTITIAL LUNG DISEASE#0.9687;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9686;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9686;ALLERGEN#0.9684;PEPTIDOGLYCAN#0.9683;TUBERCULOSIS#0.9683;HYPERSENSITIVITY RESPONSE#0.9682;EPSTEIN BARR VIRUS#0.9682;GRANULOMA FORMATION#0.9682;ACUTE LUNG INJURY#0.9682;NAIVE CD4+ T CELL#0.9682;STEM CELL TRANSPLANTATION#0.9682;CHEMOTAXIS#0.9682;ALKALINE PHOSPHATASE#0.9681;SWELLING#0.9680;HAIRY CELL LEUKEMIA#0.9679;PHAGOCYTOSIS#0.9678;RESPONSE TO TREATMENT#0.9678;GRANULOCYTE-MONOCYTE PROGENITOR#0.9678;ALLERGIC ASTHMA#0.9677;IL-12 PRODUCTION#0.9677;TUMOR CELLS#0.9676;EVENT FREE SURVIVAL#0.9676;RESPIRATORY DISTRESS#0.9676;UMBILICAL CORD#0.9675;EPITHELIAL CELL#0.9675;GLUCOCORTICOID RECEPTOR#0.9675;MULTIPLE MYELOMA#0.9674;DNA BINDING#0.9674;DNA METHYLATION#0.9674;T CELL DEVELOPMENT#0.9674;UMBILICAL VEIN#0.9674;CELL ADHESION MOLECULE#0.9674;CELL SURFACE ANTIGEN#0.9673;CANCER CELL#0.9673;CELL MIGRATION#0.9673;MYELOID LEUKEMIA#0.9672;CELL GROWTH#0.9672;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9672;ADENOCARCINOMA#0.9672;SQUAMOUS CELL CARCINOMA#0.9672;INTESTINAL EPITHELIAL CELL#0.9671;HYPEREOSINOPHILIC SYNDROME#0.9671;FLOW CYTOMETRY ANALYSIS#0.9671;TISSUE REMODELING#0.9671;FLUDARABINE#0.9670;PERIPHERAL BLOOD LYMPHOCYTES#0.9670;LUNG DISEASE#0.9670;HUMORAL IMMUNE RESPONSE#0.9669;APOPTOSIS#0.9669;SERIOUS ADVERSE EVENT#0.9669;LIPID METABOLISM#0.9668;STROMAL CELL#0.9668;REVERSE TRANSCRIPTION#0.9668;DRAINING LYMPH NODE#0.9668;HEMORRHAGE#0.9667;T CELL DIFFERENTIATION#0.9667;PROTEIN TYROSINE PHOSPHATASE#0.9666;ARGININE#0.9666;RETICULOCYTE#0.9665;ARTERY#0.9665;CELL DIVISION#0.9665;IL-10 PRODUCTION#0.9664;N-ACETYLCYSTEINE#0.9663;REGIONAL LYMPH NODE#0.9663;THYROID CARCINOMA#0.9662;ENZYME ACTIVITY#0.9660;SIGNAL TRANSDUCTION#0.9660;HEMATOPOIETIC PROGENITOR CELL#0.9660;MECHANISMS OF ACTION#0.9659;LYMPHOCYTE PROLIFERATION#0.9659;PATTERN RECOGNITION RECEPTOR#0.9658;ALLERGIC RHINITIS#0.9658;RED BLOOD CELL#0.9657;EFFECTOR T CELL#0.9657;PNEUMONIA#0.9657;MECHANISM OF ACTION#0.9657;ACTIVATED T-CELLS#0.9656;LIVER DISEASE#0.9656;MONONUCLEAR CELLS#0.9656;DIMETHYL SULFOXIDE#0.9655;GLUTATHIONE#0.9655;PLASMACYTOID DENDRITIC CELL#0.9654;SIGNALING MOLECULE#0.9654;PERIODONTITIS#0.9654;OVERALL RESPONSE RATE#0.9653;CELL EXPANSION#0.9653;TRANSCRIPTASE#0.9653;ATOPIC DERMATITIS#0.9653;DIGESTION#0.9653;NITRIC OXIDE#0.9652;RHINITIS#0.9651;SENSITIZATION#0.9651;ACUTE PROMYELOCYTIC LEUKEMIA#0.9651;CELL WALL#0.9650;TH2 CELL#0.9649;ANTIGEN PROCESSING#0.9647;PROGENITOR CELL#0.9647;BLOOD VESSEL#0.9647;ACTIVATED T CELL#0.9646;CC CHEMOKINE RECEPTOR#0.9645;CYTOKINE RECEPTOR#0.9645;DERMIS#0.9644;BONE RESORPTION#0.9644;FOLINIC ACID#0.9644;CELL DEVELOPMENT#0.9643;LYMPHOID CELL#0.9643;TREG CELL#0.9642;BONE MARROW ASPIRATE#0.9641;CLOZAPINE#0.9640;COMPLEX I#0.9640;ENDOTHELIAL CELL#0.9640;ALLERGIC REACTION#0.9639;ANEMIA#0.9639;T HELPER CELL#0.9639;IL-5 PRODUCTION#0.9639;IN VITRO MATURATION#0.9638;TRANSFERRIN RECEPTOR#0.9637;ENCEPHALOMYELITIS#0.9636;MODE OF ACTION#0.9636;PHOSPHOLIPASE C#0.9634;HEMATOPOIETIC CELL#0.9634;RECEPTOR TYROSINE KINASE#0.9633;HEPATOCELLULAR CARCINOMA#0.9633;GLUCOSE TRANSPORT#0.9632;CALCIUM MOBILIZATION#0.9632;PERIPHERAL BLOOD#0.9631;PROTEASE ACTIVATED RECEPTOR#0.9631;PLASMA CELL#0.9631;STROMA#0.9628;CELL-MEDIATED IMMUNE RESPONSE#0.9627;GLUTAMINE#0.9626;RESPIRATORY TRACT#0.9625;NEUROTOXIN#0.9625;MITOGEN ACTIVATED PROTEIN#0.9623;ASPARTATE#0.9623;CELL MATURATION#0.9623;VASCULAR ENDOTHELIUM#0.9623;ANGIOGENESIS#0.9622;ELECTROPHORETIC MOBILITY SHIFT#0.9622;TYPE 1 DIABETES#0.9620;DERMATITIS#0.9620;HYPERSENSITIVITY#0.9620;HIGH RISK PATIENTS#0.9619;CHEMOKINE RECEPTOR#0.9619;HAEMATOPOIETIC STEM CELL#0.9619;ATHEROSCLEROTIC#0.9618;LECTIN#0.9616;CHEMOKINE PRODUCTION#0.9616;ADIPOSE TISSUE#0.9616;DISEASE FREE SURVIVAL#0.9614;HYPOXIC#0.9613;IL-2 SECRETION#0.9613;CELL MEMBRANE#0.9613;LYMPHOID ORGANS#0.9612;NEDOCROMIL#0.9610;ERYTHROCYTE#0.9610;APOPTOTIC#0.9609;MULTIPLE SCLEROSIS#0.9609;CELL CYCLE#0.9606;PROTEIN KINASE#0.9605;LYSINE#0.9605;CYCLIC ADENOSINE MONOPHOSPHATE#0.9605;VISCERAL LEISHMANIASIS#0.9604;MEMORY T CELL#0.9604;DIARRHEA#0.9603;AUTOIMMUNITY#0.9603;TUMOR ASSOCIATED ANTIGEN#0.9602;DEATH RECEPTOR#0.9602;INNER CELL MASS#0.9601;B LYMPHOCYTE#0.9601;RHEUMATOID ARTHRITIS#0.9601;TNF-ALPHA SECRETION#0.9599;THROMBOCYTOPENIA#0.9599;JAPANESE ENCEPHALITIS#0.9599;TIME TO PROGRESSION#0.9599;GRAFT VERSUS HOST#0.9598;REACTIVE OXYGEN SPECIES#0.9597;FIBROBLAST PROLIFERATION#0.9597;ANTIGEN PRESENTATION#0.9595;INTERFERON REGULATORY FACTOR#0.9594;ASCITES#0.9594;SODIUM DODECYL SULFATE#0.9593;DODECYL SULFATE#0.9592;MYELOID-DERIVED SUPPRESSOR CELL#0.9592;PARENTERAL#0.9592;TUMOR ANTIGEN#0.9591;LYSIS#0.9591;PARKINSON'S DISEASE#0.9591;HUMAN IMMUNODEFICIENCY VIRUS#0.9589;DRUG RESISTANCE#0.9589;CYTOMETRIC BEAD ARRAY#0.9589;CELL-MEDIATED IMMUNITY#0.9589;TOLL LIKE RECEPTOR#0.9586;T CELL ACTIVATION#0.9584;ERYTHEMA#0.9584;HUMAN DENDRITIC CELL#0.9583;REGULATORY T CELL#0.9583;ADRIAMYCIN#0.9582;MESENCHYMAL STROMAL CELL#0.9582;G1 PHASE#0.9582;MEDIAN OVERALL SURVIVAL#0.9582;HOST CELL#0.9580;CD4+ T CELL#0.9580;PROPIDIUM#0.9580;RNA INTERFERENCE#0.9578;HEMATOPOIESIS#0.9578;RECEPTOR INTERNALIZATION#0.9577;VENOUS BLOOD#0.9577;GROWTH FACTOR RECEPTOR#0.9577;DENDRITIC CELL#0.9577;CELL ADHESION#0.9575;CELL DIFFERENTIATION#0.9575;INNATE IMMUNITY#0.9575;EDEMA#0.9574;MESENCHYMAL STEM CELL#0.9574;ORAL CAVITY#0.9573;POLYMERASE CHAIN REACTION#0.9573;B CELL#0.9572;ERYTHROID PRECURSOR#0.9572;CYTOTOXICITY#0.9571;HUMAN LEUKOCYTE ANTIGEN#0.9571;ONCOGENIC#0.9571;ENDOCYTOSIS#0.9570;PEROXISOME#0.9570;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9569;CHRONIC GRANULOMATOUS DISEASE#0.9569;SIGNALING PATHWAY#0.9569;INFLAMMATORY CELL#0.9568;METHIONINE#0.9567;COAGULATION#0.9566;LYMPHOID TISSUE#0.9565;TISSUE DAMAGE#0.9564;PROTEASOME#0.9563;NAIVE T CELL#0.9561;MONOCYTE DERIVED DENDRITIC CELL#0.9560;VOMITING#0.9560;MOLAR#0.9559;INNATE IMMUNE SYSTEM#0.9558;SYSTEMIC INFLAMMATORY RESPONSE#0.9558;HYPERTENSION#0.9557;CELL PROLIFERATION#0.9557;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9556;INFLAMMATORY BOWEL DISEASE#0.9555;MAP KINASE ACTIVITY#0.9555;CELL DEATH#0.9554;SPLENIC DENDRITIC CELL#0.9554;TOXICITY#0.9553;COLON ADENOCARCINOMA#0.9551;LEUKOCYTE#0.9550;T CELL#0.9550;GENE EXPRESSION#0.9549;PARENCHYMA#0.9547;LUPUS ERYTHEMATOSUS#0.9547;CHORIOCARCINOMA#0.9546;FLUORESCEIN#0.9546;TUMOR SUPPRESSOR#0.9543;ATHEROSCLEROSIS#0.9542;DECIDUA#0.9541;GASTROINTESTINAL TRACT#0.9541;HEMATOPOIETIC STEM CELL#0.9539;DENDRITIC CELL PROGENITOR#0.9537;DELAYED-TYPE HYPERSENSITIVITY#0.9537;HUMAN BREAST CANCER#0.9537;CD8+ T CELL#0.9536;NATURAL KILLER CELL#0.9535;CYTOTOXIC T-LYMPHOCYTE#0.9533;T LYMPHOCYTE ACTIVATION#0.9532;CELL CYCLE ARREST#0.9531;PARATHYROID#0.9530;CYTOTOXIC T CELL#0.9530;CIPROFLOXACIN#0.9530;UROKINASE#0.9529;OLIGODENDROCYTE#0.9528;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9528;SEVERE COMBINED IMMUNODEFICIENCY#0.9527;GUANINE#0.9527;PERIPHERAL BLOOD T-CELLS#0.9527;HIGH MOBILITY GROUP#0.9523;LYMPH NODE#0.9523;NEURAL CELL#0.9522;T CELL PROLIFERATION#0.9520;CELL SURFACE#0.9519;CONVENTIONAL DENDRITIC CELL#0.9518;CYTOKINE BINDING#0.9518;CYTOPLASM#0.9518;INTRACELLULAR SIGNALING PATHWAY#0.9517;TRANSCRIPTION FACTOR#0.9517;CELL ACTIVATION#0.9516;AUTOIMMUNE DISEASE#0.9515;LEUCINE#0.9515;LYSOSOME#0.9511;TACROLIMUS#0.9511;BETA CELL#0.9509;VIRULENCE#0.9509;CALCINEURIN#0.9507;AKT SIGNALING#0.9506;MYOCARDITIS#0.9505;COLLAGENASE#0.9503;T LYMPHOCYTE#0.9499;CYTOKINE SECRETION#0.9498;ESTROGEN RECEPTOR#0.9497;PLURIPOTENT STEM CELL#0.9497;DOSE LIMITING TOXICITIES#0.9496;INNATE IMMUNE RESPONSE#0.9495;STANDARD OF CARE#0.9493;FIBRINOGEN#0.9492;INTENSIVE CARE UNIT#0.9490;EXTRACELLULAR MATRIX#0.9490;DYSPNEA#0.9489;NEUTROPHIL DEGRANULATION#0.9487;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9486;ADAPTIVE IMMUNE RESPONSE#0.9483;VIRAL INFECTION#0.9482;IMMUNE DYSFUNCTION#0.9481;CENTRAL NERVOUS SYSTEM#0.9480;VASCULITIS#0.9480;NUCLEOTIDE BINDING#0.9479;THYROIDITIS#0.9479;ANTIGEN PRESENTING CELLS#0.9479;RNA BINDING#0.9477;NERVOUS SYSTEM#0.9477;IMMUNE CELL#0.9477;ULCERATIVE COLITIS#0.9477;ACUTE INFLAMMATORY RESPONSE#0.9476;NUCLEIC ACID#0.9475;VASCULAR SMOOTH MUSCLE CELL#0.9475;BECLOMETHASONE#0.9471;GERM CELL TUMORS#0.9469;BIOTIN#0.9469;NEUTROPHIL GRANULOCYTES#0.9469;RESVERATROL#0.9468;EOSINOPHIL CHEMOTAXIS#0.9468;ADENO ASSOCIATED VIRUS#0.9465;TRYPTOPHAN#0.9463;MRNA TRANSCRIPTION#0.9457;ADIPOCYTE#0.9453;PERITONEUM#0.9451;SKELETAL MUSCLE#0.9450;EMBRYONIC STEM CELL#0.9450;G0 PHASE#0.9450;HEME OXYGENASE 1#0.9449;HEMORRHAGIC#0.9446;FEMUR#0.9445;ACTIN POLYMERIZATION#0.9439;ACTIVATION OF NF-KAPPAB#0.9439;IGG ANTIBODY#0.9438;CONTACT DERMATITIS#0.9432;ANTI APOPTOSIS#0.9431;INFLAMMATORY RESPONSE#0.9430;RANDOMISED CONTROLLED TRIAL#0.9430;FLUID RETENTION#0.9429;RESPIRATORY SYNCYTIAL VIRUS#0.9427;CELLULAR GROWTH#0.9426;CYTOKINE PRODUCTION#0.9426;MITOCHONDRIA#0.9425;STOMATITIS#0.9425;GROWTH PATTERN#0.9424;IMMUNE RESPONSE#0.9424;DNASE#0.9424;BETA ADRENOCEPTOR#0.9422;EOSINOPHIL DEGRANULATION#0.9422;ACTIVATED CD4+ T CELL#0.9422;CELLULAR ADHESION MOLECULE#0.9419;ENDOMETRIOSIS#0.9419;NEUROFILAMENT#0.9418;VINBLASTINE#0.9412;TH2 IMMUNE RESPONSE#0.9412;PROTEIN KINASE INHIBITOR#0.9405;SMALL INTESTINE#0.9405;THROMBOSIS#0.9403;EXOCYTOSIS#0.9400;VITAMIN C#0.9399;HISTIDINE#0.9393;OXALIPLATIN#0.9388;OUTER MEMBRANE#0.9386;THROMBOCYTOSIS#0.9385;IL-13 PRODUCTION#0.9382;EPOETIN ALFA#0.9382;SKIN FIBROBLASTS#0.9380;SENESCENCE#0.9380;IMMUNE SYSTEM#0.9377;NEURODEGENERATIVE DISEASE#0.9376;AZITHROMYCIN#0.9373;TOTAL NUCLEATED CELL#0.9370;NEOMYCIN#0.9370;LIPOSOMAL AMPHOTERICIN B#0.9369;TOLERANCE INDUCTION#0.9368;BONE MARROW ENDOTHELIAL#0.9366;TRANSITIONAL CELL CARCINOMA#0.9364;ADULT T-CELL LEUKEMIA#0.9364;DIABETES MELLITUS#0.9358;CYTOCHROME C#0.9353;SKIN DISEASE#0.9352;LUNG ADENOCARCINOMA#0.9351;TONSIL#0.9348;DONOR LYMPHOCYTE INFUSION#0.9348;MAGNETIC RESONANCE IMAGING#0.9348;MICROTUBULE#0.9339;GRAFT VERSUS LEUKEMIA#0.9337;GLIOBLASTOMA MULTIFORME#0.9335;REGULATION OF IMMUNE RESPONSE#0.9334;ADAPTIVE IMMUNE SYSTEM#0.9333;MRNA DECAY#0.9330;NEUROLOGICAL DISORDER#0.9329;RESPONSE TO PAF#0.9329;NF KAPPAB BINDING#0.9329;GLYCOLYSIS#0.9327;CANCER STEM CELL#0.9326;INFLIXIMAB#0.9325;LANGERHANS CELL HISTIOCYTOSIS#0.9316;L-LYSINE#0.9316;URIDINE#0.9315;ANTI INFLAMMATORY DRUGS#0.9311;AUTOIMMUNE THYROIDITIS#0.9310;MEGAKARYOCYTIC LEUKEMIA#0.9308;ADVANCED OVARIAN CANCER#0.9304;WORLD HEALTH ORGANIZATION#0.9303;TEMOZOLOMIDE#0.9303;GUANOSINE#0.9302;ATTRACTANT#0.9302;JAPANESE ENCEPHALITIS VIRUS#0.9297;SURFACE PLASMON RESONANCE#0.9296;CYCLIN DEPENDENT KINASE INHIBITOR#0.9289;ASTROCYTOMA#0.9282;CHLORAMPHENICOL#0.9282;TRANSMISSION ELECTRON MICROSCOPY#0.9280;GINGIVAL CREVICULAR FLUID#0.9280;TRANSCRIPTIONAL CONTROL#0.9278;GOBLET CELL#0.9277;CAMP RESPONSE ELEMENT#0.9272;THYMIC EPITHELIAL CELLS#0.9268;DNASE I#0.9267;VITAMIN A#0.9265;MARKERS OF INFLAMMATION#0.9263;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.9260;OBJECTIVE RESPONSE RATE#0.9255;LYMPHOPENIA#0.9251;EVERY OTHER DAY#0.9249;EARLY GROWTH RESPONSE#0.9247;ENDOPLASMIC RETICULUM#0.9246;IMATINIB MESYLATE#0.9239;METAPHASE#0.9237;EXOSOME#0.9233;PAPILLOMA#0.9233;CHLAMYDIA#0.9233;GINSENG#0.9232;CD4+CD25+ REGULATORY T CELL#0.9228;TYPE 2 DIABETES#0.9227;SUNITINIB#0.9224;DENDRITIC CELL SUBSETS#0.9220;PULMONARY TUBERCULOSIS#0.9216;RABIES#0.9215;T LYMPHOCYTE PROLIFERATION#0.9214;RENAL CARCINOMA#0.9213;MIDDLE EAR#0.9213;MENSTRUAL CYCLE#0.9210;INDUCTION OF CYTOKINES#0.9210;NATURAL KILLER T#0.9208;IMMUNOSUPPRESSANT#0.9205;WEIGHT GAIN#0.9205;TROPHECTODERM#0.9199;REGULATION OF GENE EXPRESSION#0.9197;BODY SURFACE AREA#0.9196;PHOSPHATASE INHIBITOR#0.9191;NEURONAL CELLS#0.9190;CILIARY NEUROTROPHIC FACTOR#0.9186;MESANGIAL CELL#0.9186;LYMPHOID LEUKEMIA#0.9184;BONE FORMATION#0.9183;GALECTIN#0.9171;MCP-1 PRODUCTION#0.9171;EXCRETION#0.9170;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9170;RESPONSE TO INTERLEUKIN-3#0.9166;RNA BINDING PROTEIN#0.9164;INFLAMMATORY CELL INFILTRATION#0.9160;HYPOXIA INDUCIBLE FACTOR#0.9157;MELATONIN#0.9156;BRAIN LESIONS#0.9155;HEPATOMA CELLS#0.9151;INTERFERON GAMMA PRODUCTION#0.9151;CEREBRAL ARTERY#0.9147;ARGINASE ACTIVITY#0.9144;ADENYLATE CYCLASE#0.9144;IN VITRO PRODUCED#0.9136;BRUCELLOSIS#0.9133;HIGH DENSITY LIPOPROTEIN#0.9128;ACETYLCHOLINE#0.9124;SCANNING ELECTRON MICROSCOPY#0.9123;INTRACELLULAR CYTOKINE STAINING#0.9122;HYPERCALCEMIA#0.9121;MAPK SIGNALING#0.9120;VORICONAZOLE#0.9120;FORMOTEROL#0.9120;EPITHELIAL OVARIAN CANCER#0.9115;APOPTOSIS OF NEUTROPHILS#0.9115;M PHASE#0.9114;INSEMINATION#0.9106;FUNCTIONAL DIFFERENTIATION#0.9105;CC CHEMOKINE LIGAND#0.9103;HYALURONIDASE#0.9102;ENHANCER BINDING#0.9102;SALMETEROL#0.9095;HUMAN LEUCOCYTE ANTIGEN#0.9092;NEUROPATHY#0.9086;MAST CELL ACTIVATION#0.9084;MYELOFIBROSIS#0.9081;CHOLINE#0.9080;QUINOLINIC ACID#0.9076;ASPIRIN#0.9073;ANTITHYMOCYTE GLOBULIN#0.9071;BONE MARROW CELL PROLIFERATION#0.9069;TELOMERASE ACTIVITY#0.9068;B CELL PROLIFERATION#0.9067;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.9066;HYPERTHERMIA#0.9065;ESOPHAGEAL CANCER#0.9059;ACETYLCYSTEINE#0.9056;INTENTION TO TREAT#0.9055;POLYCYTHEMIA#0.9051;ADVANCED GLYCATION END#0.9047;B CELL ACTIVATION#0.9045;OVIDUCT#0.9044;UVEITIS#0.9044;HAEMOPOIETIC STEM CELLS#0.9043;IL-1 SECRETION#0.9043;CAMP RESPONSE ELEMENT BINDING#0.9017;INTERFERON PRODUCTION#0.9014;KETOCONAZOLE#0.9013;GROWTH FACTOR BINDING#0.9004;ANTI-IL-2#0.8999;BACTERIAL PNEUMONIA#0.8996;IMMUNE CELL ACTIVATION#0.8994;PREGNANT UTERUS#0.8993;EVERY OTHER WEEK#0.8988;RESPONSE TO IL-4#0.8985;IDIOPATHIC PULMONARY FIBROSIS#0.8977;BONE MARROW MONOCYTE#0.8975;ENHANCER BINDING PROTEIN#0.8975;PERIODONTAL DISEASE#0.8975;MIDDLE CEREBRAL ARTERY#0.8971;CELL POLARIZATION#0.8961;IRRITANT#0.8955;GROWTH FACTOR ACTIVITY#0.8954;NOTCH LIGAND#0.8953;HISTIDINE DECARBOXYLASE#0.8951;GOOD MANUFACTURING PRACTICE#0.8950;PBMC PROLIFERATION#0.8949;CERVIX#0.8945;TUBE FORMATION#0.8941;BLASTOCYST DEVELOPMENT#0.8936;LIPID RAFT#0.8935;NATIONAL CANCER INSTITUTE#0.8934;HEMATOPOIETIC TISSUES#0.8933;CRYPTOCOCCAL MENINGITIS#0.8930;MITOCHONDRIAL MEMBRANE#0.8927;CHEMOKINE SECRETION#0.8927;POLYCYTHEMIA VERA#0.8925;TRADITIONAL CHINESE MEDICINE#0.8920;CAROTID ARTERY#0.8920;HIGH FAT DIET#0.8919;YOLK SAC#0.8918;CETIRIZINE#0.8918;LEPROSY#0.8916;ANTIGEN PROCESSING AND PRESENTATION#0.8916;COLCHICINE#0.8915;PANCREATIC DUCTAL ADENOCARCINOMA#0.8913;INFERTILITY#0.8912;OSTEOPOROSIS#0.8912;INTERLEUKIN-1 PRODUCTION#0.8907;LYMPHOBLAST#0.8904;CELL FUSION#0.8898;INVASIVE FUNGAL INFECTION#0.8896;UBIQUITIN#0.8896;GROWTH REGULATOR#0.8894;PROTEASE ACTIVITY#0.8892;ANTI-INFLAMMATORY RESPONSE#0.8890;PROTEIN KINASE C ACTIVATION#0.8889;INTESTINAL MUCOSA#0.8887;MYOCARDIUM#0.8883;GRANULOCYTE DIFFERENTIATION#0.8881;PLACENTAL DEVELOPMENT#0.8874;PLERIXAFOR#0.8871;RIBOSOME#0.8871;NON OBESE DIABETIC#0.8869;FACTOR VIII#0.8868;TRAUMATIC BRAIN INJURY#0.8868;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.8859;CYTOSINE DEAMINASE#0.8856;SPECIFIC GRANULE#0.8852;IKAPPAB KINASE#0.8850;TUMOR GROWTH INHIBITION#0.8849;SECONDARY LYMPHOID ORGANS#0.8840;AUTOPHAGY#0.8835;CHOROID PLEXUS#0.8835;MYELOID SUPPRESSOR CELLS#0.8833;SUCROSE#0.8832;RESPONSE TO GROWTH FACTOR#0.8827;CLARITHROMYCIN#0.8824;LINES OF EVIDENCE#0.8823;SMOOTH MUSCLE ACTIN#0.8821;COLONY FORMATION ASSAY#0.8820;CASPASE ACTIVATION#0.8813;N GLYCAN#0.8810;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8805;GLUCOSE METABOLISM#0.8805;CIRCADIAN RHYTHM#0.8803;CASPASE INHIBITOR#0.8801;HISTAMINE RECEPTOR#0.8793;HYPERGLYCEMIA#0.8793;VASCULAR DISEASE#0.8789;NEUROPROTECTION#0.8786;CYTOPLASMIC REGION#0.8785;YEAR SURVIVAL RATE#0.8775;SPECIFIC GROWTH RATE#0.8774;URINARY BLADDER#0.8769;LYMPHOPROLIFERATIVE DISEASE#0.8768;OSTEOPETROSIS#0.8767;BONE MORPHOGENETIC PROTEIN#0.8766;CARDIOMYOPATHY#0.8765;AGGLUTINATION#0.8754;PROGENITOR STEM CELL#0.8749;COLLAGEN SYNTHESIS#0.8745;CELLULAR COMPONENT#0.8741;ALLERGIC AIRWAY DISEASE#0.8741;ADENYLATE#0.8738;DIFFUSE LARGE B-CELL LYMPHOMA#0.8738;AMILORIDE#0.8737;T CELL MEDIATED IMMUNITY#0.8736;T CELL ANERGY#0.8735;TUBULAR EPITHELIAL CELL#0.8733;SERUM AMYLOID A#0.8732;POSITRON EMISSION TOMOGRAPHY#0.8729;DEMYELINATING DISEASE#0.8727;GAMMA DELTA T CELL#0.8719;MYELOID STEM CELL#0.8718;INTERLEUKIN 6 RECEPTOR#0.8711;MENINGOENCEPHALITIS#0.8710;RELATED ORPHAN RECEPTOR#0.8702;VESICULAR STOMATITIS VIRUS#0.8699;THIOTEPA#0.8698;HYDROXYPROLINE#0.8698;THYROID CANCER#0.8695;AMYOTROPHIC LATERAL SCLEROSIS#0.8694;GENE SILENCING#0.8694;LATERAL SCLEROSIS#0.8693;CHRONIC LEUKEMIA#0.8690;ANTIVIRAL RESPONSE#0.8688;SEMINAL VESICLE#0.8686;PROTEIN COMPLEX#0.8685;CONJUGATION#0.8680;CEREBRAL ISCHEMIA#0.8680;CEREBRAL ARTERY OCCLUSION#0.8678;TREATMENT RELATED MORTALITY#0.8676;HYPAQUE#0.8670;HUMAN DERMAL FIBROBLAST#0.8660;ESTERASE ACTIVITY#0.8657;RNA SYNTHESIS#0.8655;EOSINOPHIL DEVELOPMENT#0.8647;BRAIN DAMAGE#0.8638;IL-23 PRODUCTION#0.8637;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.8632;MEGAKARYOCYTE DEVELOPMENT#0.8627;NK CELL ACTIVATION#0.8623;ACUTE LYMPHOCYTIC LEUKEMIA#0.8615;TAMOXIFEN#0.8615;CHEMOKINESIS#0.8614;MENINGES#0.8610;INTERLEUKIN-6 PRODUCTION#0.8607;WHOLE BONE MARROW#0.8605;HYDROCEPHALUS#0.8603;AIDS RELATED COMPLEX#0.8598;RELAPSE FREE SURVIVAL#0.8591;GRANULOSA CELL#0.8584;TARGET OF RAPAMYCIN#0.8577;CONTROLLED CLINICAL TRIALS#0.8572;INTRACELLULAR ALKALINIZATION#0.8566;QUERCETIN#0.8561;MAPK CASCADE#0.8561;CHROMATIN REMODELING#0.8560;LTB4 SYNTHESIS#0.8554;MAST CELL DIFFERENTIATION#0.8549;ZINC FINGER PROTEIN#0.8547;HUMAN NASAL EPITHELIAL#0.8544;LIPOXYGENASE PATHWAY#0.8540;HUMAN IMMUNE SYSTEM#0.8534;ANTI-CD33#0.8532;SYNOVITIS#0.8531;EPIDOXORUBICIN#0.8524;THYMOSIN ALPHA 1#0.8523;LIVER DAMAGE#0.8520;COLLAGEN TYPE I#0.8519;DARBEPOETIN ALFA#0.8517;BLASTOCYST FORMATION#0.8517;TISSUE REGENERATION#0.8514;METHACHOLINE#0.8513;SKIN CANCER#0.8510;LPS BINDING#0.8505;CYTOTROPHOBLAST#0.8494;ROS GENERATION#0.8493;FOLLICLE STIMULATING HORMONE#0.8491;PERIPHERAL NERVE#0.8490;IL-1 BINDING#0.8490;GREEN FLUORESCENCE PROTEIN#0.8485;EMBRYO IMPLANTATION#0.8473;PARALYSIS#0.8469;MACROPHAGE FUSION#0.8468;LIMB ISCHEMIA#0.8467;REPORTER GENE ASSAY#0.8466;ACUTE PHASE RESPONSE#0.8462;ORGANELLE#0.8460;UVEAL MELANOMA#0.8460;PURPURA#0.8459;RETINAL PIGMENT EPITHELIAL#0.8453;CASPASE-3 ACTIVITY#0.8450;LIVER CANCER#0.8448;LOW BIRTH WEIGHT#0.8444;DEXTRAN SULFATE SODIUM#0.8443;ANEMIC#0.8439;SALICYLATE#0.8425;INTERSTITIAL CELL#0.8407;ADVANCED PANCREATIC CANCER#0.8407;GRAM NEGATIVE BACTERIAL#0.8394;TROPISM#0.8392;CARCINOGEN#0.8390;ADRENOCORTICOTROPIC HORMONE#0.8388;ANTIPORT#0.8384;LEUKOTRIENE RECEPTOR#0.8381;PROTEIN KINASE B#0.8380;ASEPTIC MENINGITIS#0.8379;HUMAN EPIDERMAL KERATINOCYTES#0.8378;GLUTATHIONE PEROXIDASE#0.8375;ADENINE#0.8365;RECEPTOR MEDIATED ENDOCYTOSIS#0.8365;IFN REGULATORY FACTOR#0.8364;MUCUS PRODUCTION#0.8355;PHOSPHATIDYLSERINE#0.8352;COMPLETE BLOOD COUNT#0.8342;EXTRACELLULAR REGION#0.8341;MALIGNANT MESOTHELIOMA#0.8339;SINUSITIS#0.8332;GLOMERULONEPHRITIS#0.8328;SEMEN#0.8326;PROSTAGLANDIN E1#0.8326;ADENOSINE TRIPHOSPHATE#0.8320;NEOPLASTIC DISEASE#0.8319;SEVERE CONGENITAL NEUTROPENIA#0.8317;PKC ACTIVATION#0.8316;MEMORY B CELL#0.8310;HYALURONAN#0.8305;ALEMTUZUMAB#0.8305;PERIPHERAL ARTERY DISEASE#0.8295;OPTIC NERVE#0.8292;BETA-ESTRADIOL#0.8291;DEPHOSPHORYLATION#0.8288;SALIVARY GLAND#0.8283;ACETYLCHOLINE RECEPTOR#0.8282;LEUKOCYTE MIGRATION#0.8275;MINOCYCLINE#0.8264;PERIPHERAL LEUKOCYTES#0.8259;BASAL CELL#0.8258;MESOTHELIOMA CELL#0.8257;LARGE CELL CARCINOMA#0.8257;FORMYL PEPTIDE RECEPTOR#0.8255;MODIFIED VACCINIA ANKARA#0.8251;TIGHT JUNCTION#0.8249;EPITHELIAL MESENCHYMAL TRANSITION#0.8241;PRINCIPAL COMPONENT ANALYSIS#0.8240;METASTATIC CARCINOMA#0.8235;CATALYTIC ACTIVITY#0.8233;DNA REPAIR#0.8224;RETINAL PIGMENT EPITHELIAL CELLS#0.8223;KIDNEY DISEASE#0.8222;IMMUNEX#0.8222;IMMUNOGLOBULIN PRODUCTION#0.8222;MONTELUKAST#0.8219;LACTATION#0.8217;LUCIFERASE ACTIVITY#0.8216;INVASIVE ASPERGILLOSIS#0.8214;MEAN FLUORESCENCE INTENSITY#0.8213;PIGMENT EPITHELIAL CELL#0.8212;REGULATION OF MRNA#0.8208;MASTITIS#0.8205;NEPHRITIS#0.8205;ILEAL DISEASE#0.8202;ACQUIRED IMMUNE RESPONSE#0.8194;CHIMERIC ANTIGEN RECEPTOR#0.8187;AIDS-RELATED KAPOSI'S SARCOMA#0.8179;ENDOMETRIAL CANCER#0.8175;NEURAL STEM CELL#0.8168;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8168;RENAL TRANSPLANT RECIPIENTS#0.8166;EPITHELIAL TO MESENCHYMAL#0.8165;LIVER METASTASIS#0.8157;ILEITIS#0.8148;ORAL EPITHELIAL CELLS#0.8147;NEUPOGEN#0.8144;CELL MOTILITY#0.8144;GLIOSARCOMA#0.8139;CEREBRAL CORTEX#0.8130;FERMENTATION#0.8115;PLATELET AGGREGATION#0.8111;ACID PHOSPHATASE ACTIVITY#0.8111;PLASMA PROTEIN#0.8110;SICKLE CELL DISEASE#0.8109;PROSTACYCLIN#0.8105;CIGARETTE SMOKE EXTRACT#0.8104;ORAL MUCOSA#0.8103;NEUROTOXICITY#0.8091;HEART DISEASE#0.8086;GASTRIC EPITHELIAL CELLS#0.8080;MRNA SYNTHESIS#0.8077;INFERTILE#0.8077;OTITIS MEDIA#0.8076;CORNEAL EPITHELIAL CELL#0.8075;GERMINAL CENTER#0.8071;MUCOSAL IMMUNE RESPONSE#0.8069;PROTEIN KINASE ACTIVATION#0.8062;LOCOMOTION#0.8058;PROTEIN BIOSYNTHESIS#0.8057;COLONIC EPITHELIAL CELLS#0.8056;BEVACIZUMAB#0.8049;CORE BINDING FACTOR#0.8041;IFN-ALPHA PRODUCTION#0.8038;RETINOBLASTOMA#0.8038;HYPERACTIVE#0.8035;MYELOPROLIFERATIVE NEOPLASM#0.8029;CLASSICAL MONOCYTE#0.8027;TISSUE HOMEOSTASIS#0.8026;CALCIUM CHANNEL#0.8026;RESPIRATORY TRACT INFECTION#0.8025;CD8+ CYTOTOXIC T CELL#0.8024;QS-21#0.8021;COMPLEMENT DEPENDENT CYTOTOXICITY#0.8008;VALPROIC ACID#0.8008;PYODERMA GANGRENOSUM#0.8007;ECZEMA#0.8007;LIVER CIRRHOSIS#0.8003;PANCREATIC ISLET#0.8001;ANAPLASTIC THYROID CARCINOMA#0.7996;SUBSTANTIA NIGRA#0.7992;AMNION#0.7988;IGE ANTIBODY#0.7985;NARCOLEPSY#0.7983;GRANULOCYTE ACTIVATION#0.7982;HELPER T-LYMPHOCYTE#0.7980;BREAST CANCER MODEL#0.7980;INFLAMMATORY AIRWAY DISEASE#0.7974;MITOSIS#0.7974;SIMVASTATIN#0.7973;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7963;TUMOR GROWTH FACTOR#0.7962;HEMATOPOIETIC ORGANS#0.7961;INTERLEUKIN 4 RECEPTOR#0.7957;MACROPINOCYTOSIS#0.7952;RETINOID X RECEPTOR#0.7939;DIFFERENTIAL GENE EXPRESSION#0.7937;TROPHECTODERM CELL#0.7932;SECONDARY GRANULE#0.7931;MRNA BINDING#0.7931;PINOCYTOSIS#0.7930;VEGF PRODUCTION#0.7927;PLASMA MEMBRANE EXPRESSION#0.7927;METASTATIC LYMPH NODE#0.7925;ALKALINE PHOSPHATASE ACTIVITY#0.7924;OBSTRUCTIVE JAUNDICE#0.7923;MEMBRANE FRACTION#0.7912;EPITHELIAL CELL PROLIFERATION#0.7910;PANCREATITIS#0.7910;IRINOTECAN#0.7909;CHLORHEXIDINE#0.7908;DOPAMINE#0.7906;MAP KINASE KINASE#0.7903;PROSTAGLANDIN SYNTHESIS#0.7895;REGULATION OF CELLULAR#0.7891;PROTEIN KINASE ACTIVITY#0.7891;NULL CELL#0.7890;NMDA RECEPTOR#0.7890;SENTINEL LYMPH NODE#0.7888;DOPAMINERGIC NEURON#0.7887;ARE BINDING#0.7885;NATURAL KILLER T CELL#0.7884;INTRACELLULAR SIGNAL TRANSDUCTION#0.7881;PHOSPHOLIPASE A#0.7881;CALCITRIOL#0.7878;IL-4 SECRETION#0.7871;REGULATION OF CYTOKINE PRODUCTION#0.7871;DC HOMEOSTASIS#0.7869;DIPHOSPHATE#0.7869;IL-5 BINDING#0.7868;HEPATOCELLULAR CARCINOMA CELL#0.7866;PHOSPHODIESTERASE INHIBITOR#0.7863;ENDOTHELIAL CELL PROLIFERATION#0.7858;INDUCED PLURIPOTENT STEM CELL#0.7851;FOLATE#0.7851;LDL RECEPTOR#0.7850;SENSITIZER#0.7846;TELOMERASE REVERSE TRANSCRIPTASE#0.7844;COMMON TOXICITY CRITERIA#0.7841;PROTEIN TYROSINE KINASE ACTIVITY#0.7838;HISTONE DEACETYLASE INHIBITOR#0.7836;DILATED CARDIOMYOPATHY#0.7835;TELOMERE#0.7833;GUANIDINE#0.7829;LENALIDOMIDE#0.7822;HEMATOPOIETIC STEM CELL PROLIFERATION#0.7812;VIRAL ENCEPHALITIS#0.7809;EARLY TIME POINT#0.7807;INGENUITY PATHWAY ANALYSIS#0.7807;CHAGAS DISEASE#0.7794;TESTOSTERONE#0.7793;PI3K SIGNALING#0.7790;SICKLE CELL ANEMIA#0.7783;MATRIX METALLOPROTEINASE 1#0.7782;EYE DISEASE#0.7782;ADENYLATE CYCLASE ACTIVITY#0.7778;END OF TREATMENT#0.7776;INTERLEUKIN 12 PRODUCTION#0.7771;GENTAMICIN#0.7771;SQUAMOUS CELL CANCER#0.7770;FORCED EXPIRATORY VOLUME#0.7768;OVERALL SURVIVAL RATE#0.7768;FACTOR XIIIA#0.7760;METAPLASIA#0.7757;SEX CHROMOSOME#0.7755;KILLER ACTIVITY#0.7751;ARACHIDONIC ACID METABOLISM#0.7750;VIRION#0.7746;TETRACYCLINE#0.7742;IDARUBICIN#0.7734;DOXYCYCLINE#0.7732;SIGNALLING CASCADE#0.7730;CHOLINERGIC NEURON#0.7730;PNEUMOCOCCAL PNEUMONIA#0.7724;MEASLES#0.7724;GUANYLATE CYCLASE#0.7724;CYSTATIN#0.7723;PROTEIN PROTEIN INTERACTION#0.7719;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7718;ATP BINDING#0.7717;SOMATIC CELL COUNT#0.7711;FOOT AND MOUTH DISEASE#0.7709;NATALIZUMAB#0.7707;MOUTH DISEASE#0.7706;SIZE EXCLUSION CHROMATOGRAPHY#0.7706;TISSUE GROWTH FACTOR#0.7701;SCHWANN CELL#0.7699;ARSENIC TRIOXIDE#0.7694;APOPTOTIC PROCESS#0.7694;BACTERIAL SEPSIS#0.7694;LIGAND BINDING DOMAIN#0.7693;RESPONSE TO SCF#0.7693;SORAFENIB#0.7693;SPERMATOZOA#0.7692;LYMPH NODE METASTASES#0.7686;PARAFORMALDEHYDE#0.7685;SRC FAMILY KINASE#0.7679;TRANSMEMBRANE RECEPTOR#0.7677;ESTROUS CYCLE#0.7670;CIGARETTE SMOKE EXPOSURE#0.7667;ALLERGIC CONTACT DERMATITIS#0.7667;CYCLASE ACTIVITY#0.7664;RESPONSE TO ERYTHROPOIETIN#0.7662;TIME TO TREATMENT#0.7661;PHAGOSOME#0.7653;B CELL DEPLETION#0.7651;MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN#0.7650;BRONCHIOLITIS#0.7640;PREMATURITY#0.7640;GLYCINE#0.7639;BINDING PROTEIN 1#0.7637;EPIDERMOLYSIS BULLOSA ACQUISITA#0.7633;T CELL CYTOKINE PRODUCTION#0.7633;CREATINE KINASE#0.7631;HIV ASSOCIATED DEMENTIA#0.7629;DEXTRAN SODIUM SULFATE#0.7627;NF-KAPPAB INHIBITOR#0.7624;MULTIPLE ORGAN DYSFUNCTION#0.7621;INTERFERON GAMMA RECEPTOR#0.7621;EXPERIMENTAL AUTOIMMUNE MYOCARDITIS#0.7616;FOAM CELL FORMATION#0.7615;H POST INFECTION#0.7607;MYCOPHENOLATE MOFETIL#0.7604;IMMUNE EVASION#0.7594;ESOPHAGITIS#0.7591;CUTANEOUS T CELL LYMPHOMA#0.7590;INTEGRIN ACTIVATION#0.7590;STROMAL DERIVED FACTOR#0.7586;NECROTIZING#0.7585;URTICARIA#0.7579;SUPPRESSOR T CELL#0.7567;COMPLEMENT ACTIVATION#0.7567;GI TRACT#0.7567;CELL CYCLE REGULATION#0.7565;MANTLE CELL LYMPHOMA#0.7553;BLOOD UREA NITROGEN#0.7550;HUMAN CORNEAL EPITHELIAL#0.7550;NEUROMYELITIS OPTICA#0.7550;GLUTAMIC ACID#0.7545;SURFACTANT PROTEIN C#0.7537;SMALL CELL CARCINOMA#0.7537;MALAISE#0.7534;OROPHARYNGEAL CANDIDIASIS#0.7533;IL-17 PRODUCTION#0.7531;CALCITONIN RECEPTOR#0.7526;CRYPTOCOCCOSIS#0.7521;OSTEOCLAST DEVELOPMENT#0.7519;ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS#0.7519;OLEIC ACID#0.7501;NOREPINEPHRINE#0.7501;EPITHELIAL BARRIER FUNCTION#0.7500;DASATINIB#0.7499;GLYCOGEN STORAGE DISEASE#0.7499;VIRAL MENINGITIS#0.7499;DEOXYTHYMIDINE#0.7497;PULMONARY SARCOIDOSIS#0.7493;CELLULAR LOCALIZATION#0.7492;LASER SCANNING MICROSCOPY#0.7487;ACIDIFICATION#0.7485;VITAMIN D RECEPTOR#0.7484;EXTRACELLULAR MATRIX COMPONENT#0.7484;BETA2 ADRENOCEPTOR#0.7483;TO THE PROGRESSION#0.7478;RETINOL#0.7475;URIC ACID#0.7475;ADRENERGIC RECEPTOR#0.7472;PERICYTE#0.7471;DIHYDROFOLATE REDUCTASE#0.7470;GASTRITIS#0.7462;DNA REPLICATION#0.7460;MALIGNANT PLEURAL EFFUSION#0.7457;TRANSLATION INITIATION#0.7451;MYELOID CELL DEVELOPMENT#0.7440;INTERLEUKIN 8 PRODUCTION#0.7428;FRAGMENT LENGTH POLYMORPHISM#0.7426;ESSENTIAL THROMBOCYTHEMIA#0.7421;ALLOPURINOL#0.7419;PRIMARY RESPONSE GENE#0.7407;MONOBLAST#0.7406;CARRIE#0.7405;COLORECTAL LIVER METASTASES#0.7399;MICROTUBULE ASSOCIATED PROTEIN#0.7386;SOLUBLE FRACTION#0.7384;ACUTE MONOCYTIC LEUKEMIA#0.7380;CELL CYCLE REGULATOR#0.7376;RECURRENCE FREE SURVIVAL#0.7375;ALUMINUM HYDROXIDE#0.7370;ABDOMINAL PAIN#0.7368;SIALIC ACID BINDING#0.7365;BETA GLUCURONIDASE#0.7355;ERYTHROCYTE SEDIMENTATION RATE#0.7351;PITUITARY GLAND#0.7350;VITAMIN B12#0.7346;TYROSINE KINASE DOMAIN#0.7345;AUTOIMMUNE GASTRITIS#0.7340;LIVER REGENERATION#0.7339;EFFECTOR MEMORY T CELL#0.7338;OESTRUS#0.7338;REGULATION OF APOPTOSIS#0.7326;TAXOL#0.7324;NODULAR#0.7322;ESTRUS#0.7322;PARTURITION#0.7314;CD14++CD16- MONOCYTE#0.7314;AMIKACIN#0.7308;ALPHA 1-ANTITRYPSIN#0.7307;TANDEM ZINC FINGER#0.7304;OPSONIZATION#0.7302;DEMETHYLATION#0.7288;NOTCH RECEPTOR#0.7287;EOSIN#0.7285;CACHEXIA#0.7278;PYRUVATE#0.7275;VIRAL GENOME#0.7271;HOMOLOGOUS RECOMBINATION#0.7270;MALARIA VACCINE#0.7269;CREATINE#0.7262;SCHISTOSOMIASIS#0.7261;PULMONARY HYPERTENSION#0.7244;PENICILLIN#0.7241;CYSTEINYL LEUKOTRIENE RECEPTOR#0.7238;RETINITIS#0.7237;AZATHIOPRINE#0.7236;LEUKOCYTE ACTIVATION#0.7232;SPHINGOSINE#0.7220;XANTHINE#0.7213;LYME DISEASE#0.7195;FLOW CYTOMETRY ASSAY#0.7192;RAPID EYE MOVEMENT#0.7190;URINARY TRACT INFECTION#0.7179;T CELL POLARIZATION#0.7172;INGUINAL LYMPH NODE#0.7172;SR 31747#0.7168;PHOSPHOCHOLINE#0.7166;OVARIES#0.7166;MEMBRANE DEPOLARIZATION#0.7165;DISEASE ACTIVITY INDEX#0.7163;URATE#0.7162;KIDNEY CANCER#0.7158;MAPK SIGNALLING#0.7155;MOUSE EMBRYONIC FIBROBLAST#0.7150;BORTEZOMIB#0.7145;PRIMARY EPITHELIAL CELLS#0.7145;CBDCA#0.7143;METFORMIN#0.7141;ACUTE PANCREATITIS#0.7141;RIBOSE#0.7141;PLACENTAL GROWTH FACTOR#0.7138;NEGATIVE PREDICTIVE VALUE#0.7135;CAMP SIGNALING#0.7132;L-PHENYLALANINE#0.7130;LEWIS LUNG CANCER#0.7128;EPILEPSY#0.7128;IGG1 ANTIBODY#0.7128;ORNITHINE#0.7124;SKIN CARCINOMA#0.7123;COMMON MYELOID PROGENITOR#0.7113;SCLERODERMA#0.7111;EXHALED NITRIC OXIDE#0.7110;EPIDERMOLYSIS BULLOSA#0.7105;MALNUTRITION#0.7104;TYPE 2 DIABETES MELLITUS#0.7103;2 DIABETES MELLITUS#0.7103;MYCOPHENOLIC ACID#0.7100;GROUND GLASS OPACITIES#0.7093;LIMIT OF DETECTION#0.7085;DAYS POST INFECTION#0.7082;DERMAL DENDRITIC CELLS#0.7081;SKIN RASH#0.7080;FLUSHING#0.7079;CHILDHOOD LEUKEMIA#0.7077;DISEASE CONTROL RATE#0.7072;RETINAL GANGLION CELL#0.7072;INCLUSION BODY#0.7070;SPONTANEOUS ABORTION#0.7068;MELANOCYTE DIFFERENTIATION#0.7065;CHEMOATTRACTION#0.7059;PLATELET ACTIVATION#0.7058;BLOOD CIRCULATION#0.7056;HATCHING#0.7053;SODIUM STIBOGLUCONATE#0.7049;DECITABINE#0.7040;RANTES PRODUCTION#0.7039;PLASMACYTOMA#0.7035;HEPATOTOXICITY#0.7035;HAS ACTIVITY#0.7026;TOCILIZUMAB#0.7021;SALBUTAMOL#0.7017;RELATIVE GENE EXPRESSION#0.7015;OVULATION#0.7014;HEMOLYTIC ANEMIA#0.7012;INTERFERON RECEPTOR#0.7004;FRONTAL#0.7002;PROTEIN BINDING#0.6995;FOCAL ADHESION#0.6992;JOINT DAMAGE#0.6987;GINGIVAL EPITHELIAL CELLS#0.6986;ARSENITE#0.6985;FANCONI ANEMIA#0.6983;CHRONIC KIDNEY DISEASE#0.6981;TOXOPLASMOSIS#0.6980;MALIGNANT BRAIN TUMOR#0.6970;LUNG DAMAGE#0.6966;IGE BINDING#0.6965;BIRTH DEFECT#0.6962;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.6960;HISTAMINE FORMATION#0.6955;HISTAMINE SECRETION#0.6953;COMPLEX II#0.6951;STEM CELL DIFFERENTIATION#0.6949;AMYLOIDOSIS#0.6948;CERVICAL LYMPH NODE#0.6947;AGEING#0.6946;ACYCLOVIR#0.6945;VENA CAVA#0.6941;AZACYTIDINE#0.6940;PULMONARY EDEMA#0.6940;CHANGE FROM BASELINE#0.6938;PRIMARY GRANULE#0.6938;CHRONIC HEART FAILURE#0.6934;DIAMOND BLACKFAN ANEMIA#0.6928;CYTOKINE INDUCED KILLER CELL#0.6928;PEROXIDASE ACTIVITY#0.6924;LUNG CARCINOMA CELL LINES#0.6923;FORMALIN#0.6922;FIBROSARCOMA CELLS#0.6920;BONE REMODELING#0.6920;HAIR FOLLICLE#0.6917;BASAL GANGLIA#0.6912;DIABETIC RETINOPATHY#0.6908;GTP BINDING#0.6901;EMBRYONIC KIDNEY#0.6899;IMMUNOTOXIN#0.6898;ATRIAL FIBRILLATION#0.6897;ASCORBIC ACID#0.6895;NK CELL MEDIATED CYTOTOXICITY#0.6894;X CHROMOSOME#0.6891;GROUP B STREPTOCOCCUS#0.6890;LUNG GROWTH#0.6888;WHOLE BLOOD ASSAY#0.6881;ALTERNATIVELY ACTIVATED MACROPHAGES#0.6874;TYPE 1 DIABETIC#0.6865;CYTOCHROME P450#0.6864;INHIBITION OF CYTOKINE PRODUCTION#0.6861;PROTEINURIA#0.6858;STRIATUM#0.6852;VITAMIN B12 BINDING#0.6846;MOMETASONE#0.6842;CAROTID ARTERY OCCLUSION#0.6840;BLASTOMERE#0.6840;ANGIOGENIC GROWTH FACTORS#0.6837;T CELL APOPTOSIS#0.6829;PKCALPHA#0.6829;IGM ANTIBODY#0.6821;MYELITIS#0.6820;ESTROGENS#0.6820;ANAPHYLACTIC#0.6816;LEIOMYOSARCOMA#0.6812;IN VITRO FERTILIZED#0.6801;FACTOR 2 RECEPTOR#0.6800;DEFENSE RESPONSE#0.6799;TUMOR NECROSIS FACTOR PRODUCTION#0.6794;INTERFERON ALFA-2B#0.6790;INHIBITION OF CELL PROLIFERATION#0.6788;PYODERMA#0.6785;FUMARATE#0.6785;MACROPHAGE APOPTOSIS#0.6785;PYROGEN#0.6782;HEMOGLOBIN SYNTHESIS#0.6778;POSACONAZOLE#0.6775;SERPIN#0.6773;DOMINANT NEGATIVE MUTANT#0.6771;DENTAL PULP#0.6767;COGNITION#0.6765;FGF-7#0.6754;DIURNAL#0.6747;ACTIVATION OF CREB#0.6745;ATP BINDING CASSETTE#0.6745;AP-1 COMPLEX#0.6734;INVARIANT NATURAL KILLER#0.6734;ASTROCYTE ACTIVATION#0.6731;ACUTE KIDNEY INJURY#0.6730;SURFACTANT PROTEIN D#0.6727;HISTOPLASMOSIS#0.6723;DENDRITIC CELL THERAPY#0.6722;PROLACTIN RECEPTOR#0.6721;VINDESINE#0.6717;CHONDROITIN SULFATE PROTEOGLYCAN#0.6716;PROTEIN KINASE CALPHA#0.6716;LYMPHOCYTIC CHORIOMENINGITIS#0.6712;C CHEMOKINE RECEPTOR#0.6710;METASTASIS FREE SURVIVAL#0.6709;IFN-TAU PRODUCTION#0.6706;C-LEVEL#0.6701;INHIBITION OF GROWTH#0.6697;MEDROXYPROGESTERONE ACETATE#0.6695;NICOTINAMIDE#0.6674;CEFTRIAXONE#0.6664;CYTOMEGALOVIRUS RETINITIS#0.6660;OESTRADIOL#0.6657;ORNITHINE DECARBOXYLASE#0.6656;CONGESTIVE HEART FAILURE#0.6642;GASTRIC MUCOSA#0.6640;BILE DUCT#0.6634;KERATITIS#0.6630;IRRITATION#0.6628;POLY ETHYLENE GLYCOL#0.6626;BASOPHIL DEGRANULATION#0.6626;CASPOFUNGIN#0.6616;COMMON CAROTID ARTERY#0.6606;T-LYMPHOBLAST#0.6601;GOBLET CELL HYPERPLASIA#0.6583;HINDLIMB#0.6582;NO BINDING#0.6575;NUCLEOSOME#0.6573;MANNITOL#0.6573;IMMUNE THROMBOCYTOPENIC PURPURA#0.6563;INTERFERON SECRETION#0.6562;INTESTINAL DAMAGE#0.6561;HYPERPHOSPHORYLATION#0.6561;INTENT TO TREAT#0.6558;HUMAN WHOLE BLOOD#0.6557;AZIDOTHYMIDINE#0.6555;INTERLEUKIN 2 PRODUCTION#0.6550;ORAL SQUAMOUS CELL CARCINOMA#0.6544;TRANSMISSION ELECTRON MICROSCOPE#0.6538;NEPHROPATHY#0.6538;IGG2A ANTIBODY#0.6532;A-GEL#0.6531;CELL MOVEMENT#0.6530;ALBUTEROL#0.6528;BODY WEIGHT LOSS#0.6523;HEAD AND NECK CARCINOMA#0.6522;FALSE DISCOVERY RATE#0.6519;ANTIGEN BINDING#0.6518;RISK OF RELAPSE#0.6515;DOWN SYNDROME#0.6507;MAJOR ADVERSE EVENT#0.6506;CHOLESTEROL EFFLUX#0.6506;RIBOZYME#0.6504;GLYCERALDEHYDE-3-PHOSPHATE#0.6494;HISTONE MODIFICATION#0.6491;INFLAMMATORY BREAST CANCER#0.6490;LINEAR REGRESSION ANALYSIS#0.6482;GLYCOGEN SYNTHASE KINASE#0.6474;INHIBITION OF NEUTROPHIL APOPTOSIS#0.6474;SEXUALLY TRANSMITTED INFECTION#0.6472;TIOTROPIUM BROMIDE#0.6462;NASAL EPITHELIUM#0.6461;ISCHEMIA REPERFUSION INJURY#0.6457;ROS FORMATION#0.6457;WILCOXON RANK SUM#0.6453;ISOLEUCINE#0.6452;CLINICAL PRACTICE GUIDELINE#0.6452;HUMAN BETA DEFENSIN#0.6448;PARACRINE SIGNALING#0.6445;CYTOXAN#0.6438;GLYCERO-3-PHOSPHOCHOLINE#0.6436;PROTEIN TRANSLATION#0.6433;NEURAL PROGENITOR CELL#0.6432;HERCEPTIN#0.6431;L-TRYPTOPHAN#0.6422;STATIONARY PHASE#0.6421;ENDOMETRIAL CARCINOMA#0.6421;MORPHOGENESIS#0.6420;HOST-PATHOGEN INTERACTION#0.6420;BLINDNESS#0.6419;LYMPHANGIOGENESIS#0.6418;APC ACTIVATION#0.6416;RNA STABILIZATION#0.6414;HEPATIC ARTERY#0.6411;HIGH CHOLESTEROL DIET#0.6405;VASCULOGENESIS#0.6402;METASTATIC PROSTATE CANCER#0.6400;ENDOTHELIN RECEPTOR#0.6391;RIFAMPICIN#0.6391;CAPECITABINE#0.6390;B CELL DIFFERENTIATION#0.6387;ACUTE CORONARY SYNDROME#0.6385;PLATELET FORMATION#0.6384;FATALITY#0.6382;ADENOSINE DEAMINASE#0.6382;CHLOROQUINE#0.6375;PROPRANOLOL#0.6372;PRIMARY BREAST CANCER#0.6372;INTERLEUKIN-4 PRODUCTION#0.6369;PROTEINASE INHIBITOR#0.6368;CCL17 PRODUCTION#0.6364;L-CYSTEINE#0.6363;ANESTHETIC#0.6359;NITRO-L-ARGININE#0.6343;MENOPAUSE#0.6333;IN VIVO ELECTROPORATION#0.6333;STRUCTURE ACTIVITY RELATIONSHIP#0.6331;ANOREXIA#0.6328;DYSKERATOSIS CONGENITA#0.6316;VACUOLE#0.6314;RIFAMPIN#0.6312;ENDOCARDITIS#0.6299;RESPONSE TO ENDOTOXIN#0.6293;PULMONARY TOXICITY#0.6291;SIALYLATION#0.6289;MOUSE TRACHEAL EPITHELIAL#0.6287;PSORIATIC ARTHRITIS#0.6286;RENAL CANCER CELLS#0.6286;STEM CELL ANTIGEN#0.6282;INTRINSIC ASTHMA#0.6268;DEOXYCYTIDINE KINASE#0.6268;BOSENTAN#0.6267;REGULATION OF NEUTROPHIL APOPTOSIS#0.6266;EPIGALLOCATECHIN#0.6265;PYREXIA#0.6262;CEREBRAL MALARIA#0.6261;PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME#0.6257;PARACOCCIDIOIDOMYCOSIS#0.6256;COLON EPITHELIAL CELL#0.6255;TRIAMCINOLONE ACETONIDE#0.6253;5-FLUOROCYTOSINE#0.6251;ARYL HYDROCARBON RECEPTOR#0.6248;JUVENILE IDIOPATHIC ARTHRITIS#0.6243;1,25-DIHYDROXYCHOLECALCIFEROL#0.6238;PANETH CELL#0.6234;SQUAMOUS INTRAEPITHELIAL LESION#0.6233;ENDOTHELIAL CELL MIGRATION#0.6233;DEXRAZOXANE#0.6224;METRONIDAZOLE#0.6223;POLY ADP RIBOSE#0.6223;ERLOTINIB#0.6223;PROANGIOGENIC CELL#0.6219;CD4+ MEMORY T CELL#0.6217;PKC ACTIVITY#0.6213;CARDIOMYOCYTE#0.6205;ACTIVATING TRANSCRIPTION FACTOR#0.6205;LACTIC ACID#0.6187;STEM CELL MARKER#0.6187;HUMAN EMBRYONIC KIDNEY#0.6184;MEMBRANE TYPE 1#0.6179;HEMOSTASIS#0.6175;ERYTHRO#0.6173;AGE AT DIAGNOSIS#0.6170;ANTIOXIDANT ACTIVITY#0.6170;NECROBIOSIS LIPOIDICA#0.6167;SUBARACHNOID SPACE#0.6162;LACK OF EFFICACY#0.6160;ENDOSOME#0.6158;CORD BLOOD TRANSPLANTATION#0.6154;BIOLUMINESCENCE#0.6153;COMMON VARIABLE IMMUNODEFICIENCY#0.6153;MICROGLIAL CELL ACTIVATION#0.6148;LYMPH NODE METASTASIS#0.6148;T- PA#0.6137;HYPERTHYROIDISM#0.6134;CHRONIC LIVER DISEASE#0.6132;GYNECOLOGIC ONCOLOGY GROUP#0.6131;COLLAGEN TYPE IV#0.6130;DNA DEMETHYLATION#0.6129;NUCLEUS PULPOSUS#0.6118;MACROPHAGE CYTOKINE PRODUCTION#0.6116;NEUROINFLAMMATORY RESPONSE#0.6116;ZONA PELLUCIDA#0.6113;RECEPTOR ACTIVITY#0.6106;BACILLE CALMETTE GUERIN#0.6105;ANTISENSE RNA#0.6102;SMOOTH MUSCLE CELL PROLIFERATION#0.6102;FOLLICULAR DENDRITIC CELL#0.6099;MUSCLE CELL PROLIFERATION#0.6099;AZUROPHIL GRANULE#0.6092;EICOSAPENTAENOIC ACID#0.6090;LATERAL VENTRICLE#0.6089;OSTEOGENESIS#0.6087;INHIBITION OF CELL GROWTH#0.6086;GROWTH HORMONE RECEPTOR#0.6083;EPINEPHRINE#0.6083;MAST CELL PROGENITOR#0.6082;INTRON A#0.6076;LENGTH OF STAY#0.6070;OLOPATADINE#0.6068;THYMOCYTE APOPTOSIS#0.6067;KNEE JOINT#0.6062;GEFITINIB#0.6055;RU486#0.6055;LUNG MICROVASCULAR ENDOTHELIAL#0.6054;CYSTITIS#0.6050;EXTRACELLULAR SPACE#0.6049;LIDOCAINE#0.6049;EOTAXIN PRODUCTION#0.6047;VERY-LOW-DENSITY LIPOPROTEIN#0.6044;OPIOID RECEPTOR#0.6042;CARBIMAZOLE#0.6040;PULMONARY ARTERY#0.6028;URACIL#0.6021;PULMONARY EOSINOPHILIA#0.6016;PNEUMOCOCCAL MENINGITIS#0.6015;LOW DOSE RATE#0.6015;THALASSEMIA#0.6012;HYPOTENSIVE#0.6011;ADULT RESPIRATORY DISTRESS SYNDROME#0.6003;ANEMIA OF PREMATURITY#0.6001
143872	SMOOTH MUSCLE#0.9224;HYPERTENSION#0.8640;SMOOTH MUSCLE CELL#0.6657;MUSCLE CELL#0.6650;GAP ACTIVITY#0.6366;METASTASIS FREE SURVIVAL#0.6289;CELL MOTILITY#0.6139;CELL MIGRATION#0.6059
1438	GM-CSF#1.0398;CYTOKINE RECEPTOR#1.0121;PULMONARY ALVEOLAR PROTEINOSIS#1.0119;MACROPHAGE#1.0031;GRANULOCYTE#1.0031;COLONY-STIMULATING FACTOR#1.0026;MONOCYTE#0.9916;GROWTH FACTOR#0.9702;BONE MARROW#0.9536;CELL SURFACE#0.9476;RECEPTOR COMPLEX#0.9309;STEM CELL#0.9231;SIGNALING PATHWAY#0.9216;NEUTROPHIL#0.9180;SIGNAL TRANSDUCTION#0.8981;MYELOID CELL#0.8934;HEMATOPOIETIC CELL#0.8836;B CELL#0.8784;MYELOID LEUKEMIA#0.8728;CELL PROLIFERATION#0.8687;T CELL#0.8671;X CHROMOSOME#0.8580;POLYMERASE CHAIN REACTION#0.8430;ALVEOLAR MACROPHAGE#0.8377;PERIPHERAL BLOOD#0.8231;PROGENITOR CELL#0.8169;Y CHROMOSOME#0.7984;FACTOR 2 RECEPTOR#0.7937;SEX CHROMOSOME#0.7815;DENDRITIC CELL#0.7742;IMMUNE RESPONSE#0.7166;INTERLEUKIN 3 RECEPTOR#0.7075;LEUKOCYTE#0.6933;STEM CELL FACTOR#0.6874;SIGNAL TRANSDUCER#0.6846;CYTOPLASMIC REGION#0.6674;GRANULOCYTE COLONY STIMULATING FACTOR#0.6633;TUMOR NECROSIS FACTOR#0.6519;TRANSCRIPTION FACTOR#0.6501;GENE EXPRESSION#0.6486;LUNG DISEASE#0.6283;ERYTHROPOIETIN RECEPTOR#0.6049
143903	HYALURONAN#1.0656;LECTIN#0.7616;TALIN BINDING#0.7102;MEMBRANE RUFFLE#0.6806;TIGHT JUNCTION#0.6603;RNA INTERFERENCE#0.6577;MALIGNANT GLIOMA#0.6040
143941	HEAT SHOCK PROTEIN#0.7128;PROLIFERATIVE VITREORETINOPATHY#0.6910;BREAST CANCER#0.6553
1439	GM-CSF#1.0640;COLONY-STIMULATING FACTOR#1.0400;PULMONARY ALVEOLAR PROTEINOSIS#1.0262;STEM CELL#1.0025;MACROPHAGE#0.9744;FACTOR 2 RECEPTOR#0.9523;CYTOKINE RECEPTOR#0.9239;GRANULOCYTE#0.9221;LEUKEMIA STEM CELL#0.8886;GROWTH FACTOR#0.8651;GENE EXPRESSION#0.8151;BONE MARROW#0.7707;PROGENITOR CELL#0.7413;T CELL#0.6874;LEUKOCYTE#0.6077
143	POLY ADP RIBOSE#1.0592;RIBOSE#1.0533;MAJOR VAULT PROTEIN#1.0420;UNTRANSLATED RNA#1.0032;CELL CYCLE#0.9550;APOPTOSIS#0.9226;BREAST CANCER#0.9084;CANCER CELL#0.8687;CARDIOMYOCYTE#0.7954;DNA REPAIR#0.7306;CELL PROLIFERATION#0.6388;SYNTHETASE ACTIVITY#0.6257;MYOCARDIAL INFARCTION#0.6232;EMBRYONIC STEM CELL#0.6145;STEM CELL#0.6062
1440	G-CSF BINDING#1.0986;HOMOHARRINGTONINE#1.0672;FELTY'S SYNDROME#1.0621;G-CSF PRODUCTION#1.0457;RESPONSE TO G-CSF#1.0448;ANAPLASTIC CARCINOMA#1.0427;LIPOSOMAL AMPHOTERICIN B#1.0415;CLADRIBINE#1.0404;CSF SECRETION#1.0396;NEUTROPHIL DIFFERENTIATION#1.0374;FOCAL CEREBRAL ISCHEMIA#1.0363;EPIDOXORUBICIN#1.0350;CLOZAPINE#1.0341;CAPILLARY LEAK SYNDROME#1.0337;DECITABINE#1.0336;MONOCYTE CHEMOTACTIC PROTEIN#1.0330;TBO-FILGRASTIM#1.0321;PLERIXAFOR#1.0314;HUMAN SERUM ALBUMIN#1.0296;NEUPOGEN#1.0295;PLEOMORPHIC CARCINOMA#1.0287;TOXIC EPIDERMAL NECROLYSIS#1.0279;METHIMAZOLE#1.0252;BLADDER CARCINOMA#1.0245;TRAUMATIC BRAIN INJURY#1.0241;GRANULOCYTE DIFFERENTIATION#1.0236;IL-11#1.0222;MALIGNANT MESOTHELIOMA#1.0219;AMD3100#1.0216;GRANULOCYTE COLONY STIMULATING FACTOR#1.0211;G-CSF#1.0201;AMNIOTIC FLUID#1.0199;IL-1RA#1.0197;COLONY-STIMULATING FACTOR#1.0188;MACROPHAGE INFLAMMATORY PROTEIN#1.0188;SPINAL CORD INJURY#1.0186;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0182;GRANULOCYTE#1.0180;PARATHYROID HORMONE#1.0179;IDARUBICIN#1.0177;PARATHYROID#1.0176;ADENOSQUAMOUS CARCINOMA#1.0174;NKT CELL#1.0173;FACTOR I#1.0170;SCIATIC NERVE#1.0163;PEGFILGRASTIM#1.0159;LIVER REGENERATION#1.0154;LEUKEMIA INHIBITORY FACTOR#1.0153;CEREBRAL ISCHEMIA#1.0152;NEUROGENESIS#1.0144;CPT-11#1.0143;MATCHED SIBLING DONOR#1.0142;GROWTH HORMONE#1.0133;AORTITIS#1.0132;INTERLEUKIN 1 RECEPTOR#1.0131;NEUROPROTECTION#1.0128;NEUTROPHIL APOPTOSIS#1.0126;FIBROBLAST GROWTH FACTOR#1.0125;CIPROFLOXACIN#1.0124;CHRONIC LIVER FAILURE#1.0123;PLATELET-DERIVED GROWTH FACTOR#1.0117;INSULIN-LIKE GROWTH FACTOR#1.0115;ACUTE ISCHEMIC STROKE#1.0113;IL-6 PRODUCTION#1.0113;ACUTE MYOCARDIAL INFARCTION#1.0110;ENDOMETRIUM#1.0107;IMATINIB#1.0104;ERYTHROPOIESIS STIMULATING AGENT#1.0101;RECEPTOR AGONIST#1.0093;INTRAVENOUS IMMUNOGLOBULIN#1.0092;HAEMOPOIETIC STEM CELLS#1.0092;CYTARABINE#1.0091;GM-CSF#1.0090;PARKINSON'S DISEASE#1.0088;INFERTILE#1.0088;LEFT VENTRICULAR REMODELING#1.0087;METHIONINE#1.0083;CRITICAL LIMB ISCHEMIA#1.0081;HEPATOCYTE GROWTH FACTOR#1.0077;KERATINOCYTE#1.0072;TROPHOBLAST CELL#1.0066;NERVE GROWTH FACTOR#1.0065;AMPHOTERICIN B#1.0062;STEM CELL FACTOR#1.0060;NEURAL STEM CELL#1.0056;AMIFOSTINE#1.0056;AMPHOTERICIN#1.0053;ARA-C#1.0050;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0049;INFLAMMATORY BREAST CANCER#1.0045;TROPHOBLAST#1.0044;ENDOTHELIAL GROWTH FACTOR#1.0044;AMYOTROPHIC LATERAL SCLEROSIS#1.0039;LATERAL SCLEROSIS#1.0039;NEUTROPHIL MIGRATION#1.0034;CIRCULATING PROGENITOR CELL#1.0029;AUTOLOGOUS STEM CELLS#1.0028;INDOMETHACIN#1.0025;PROTEIN TYROSINE KINASE#1.0025;VINORELBINE#1.0023;ALL TRANS RETINOIC ACID#1.0022;HINDLIMB#1.0021;VP-16#1.0019;FLUDARABINE#1.0017;SPINAL CORD#1.0016;CARDIOMYOCYTE#1.0015;TERMINAL DIFFERENTIATION#1.0008;ENHANCER BINDING PROTEIN#1.0008;RECEPTOR BINDING#1.0006;ENHANCER BINDING#1.0004;PERITONITIS#1.0003;LENALIDOMIDE#1.0001;CEREBRAL ARTERY OCCLUSION#0.9997;EMBRYO IMPLANTATION#0.9995;MALIGNANT PLEURAL MESOTHELIOMA#0.9990;MARROW STEM CELLS#0.9990;NADPH OXIDASE#0.9989;ACUTE LUNG INJURY#0.9986;BONE MARROW STEM CELL#0.9985;AGRANULOCYTOSIS#0.9984;TUMOUR NECROSIS FACTOR#0.9984;GLYCOGEN STORAGE DISEASE#0.9982;HEPATOCELLULAR CARCINOMA#0.9979;CERVICAL CANCER#0.9979;MAP KINASE#0.9974;CYTOSINE ARABINOSIDE#0.9973;NEUTROPHIL ACTIVATION#0.9972;MYELOID PROGENITOR CELL#0.9971;MYOCARDIAL INFARCTION#0.9970;PULMONARY TOXICITY#0.9969;RESPIRATORY BURST#0.9962;SIGNAL TRANSDUCER#0.9958;HYPERCALCEMIA#0.9957;DACARBAZINE#0.9956;NEUTROPHIL CHEMOTAXIS#0.9956;RETINOIC ACID#0.9955;PLATELET AGGREGATION#0.9954;CBDCA#0.9952;EPIDERMAL GROWTH FACTOR#0.9951;STROMAL DERIVED FACTOR#0.9951;DNA SYNTHESIS#0.9949;PERIPHERAL BLOOD CELLS#0.9949;LEUCOVORIN#0.9947;MYELOPEROXIDASE ACTIVITY#0.9945;OOCYTE#0.9944;LIMB ISCHEMIA#0.9944;CORTISOL#0.9943;ISCHEMIA REPERFUSION INJURY#0.9942;IMMATURE MYELOID CELL#0.9940;AMYLOIDOSIS#0.9940;EPIRUBICIN#0.9938;HYPOXIC#0.9936;VASCULAR ENDOTHELIAL CELL#0.9936;CORD BLOOD TRANSPLANTATION#0.9934;HEPATITIS B#0.9934;RECEPTOR ANTAGONIST#0.9932;TOPOTECAN#0.9932;METHYLPREDNISOLONE#0.9928;ADENOSINE#0.9928;PROTEIN SYNTHESIS#0.9927;BACTERIAL PNEUMONIA#0.9926;ACUTE PROMYELOCYTIC LEUKEMIA#0.9924;HEPARIN#0.9923;MAMMARY GLAND#0.9923;DENTAL PULP#0.9923;BONE FORMATION#0.9923;FETAL LIVER#0.9922;IFOSFAMIDE#0.9921;ASTROCYTE#0.9920;MENINGITIS#0.9919;LARGE CELL CARCINOMA#0.9919;IFN-GAMMA#0.9919;GLYCOSYLATION#0.9917;ALVEOLAR MACROPHAGE#0.9915;BLAST CELL#0.9914;EVERY OTHER DAY#0.9914;PANCREATIC CANCER#0.9913;MITOMYCIN C#0.9913;HAEMATOPOIETIC STEM CELL#0.9913;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.9911;CILIARY NEUROTROPHIC FACTOR#0.9911;MITOXANTRONE#0.9910;ISCHEMIC HEART DISEASE#0.9905;GANCICLOVIR#0.9903;CEREBRAL PALSY#0.9903;THYMOCYTE#0.9902;MECHANISMS OF ACTION#0.9901;VINDESINE#0.9901;ACUTE MYELOID LEUKAEMIA#0.9901;ATHEROSCLEROTIC#0.9901;ETHANOL#0.9901;PNEUMOCOCCAL PNEUMONIA#0.9899;PYODERMA GANGRENOSUM#0.9899;BLEOMYCIN#0.9899;OSTEOCLAST#0.9898;INDUCIBLE NITRIC OXIDE#0.9898;HEART DISEASE#0.9898;TUMOR NECROSIS FACTOR#0.9898;SEVERE CONGENITAL NEUTROPENIA#0.9898;REGULATORY T CELL#0.9897;MALIGNANT LYMPHOMA#0.9896;MIDDLE CEREBRAL ARTERY#0.9894;POLYMORPHONUCLEAR NEUTROPHIL#0.9893;LUNG CARCINOMA#0.9892;2-CDA#0.9889;MACROPHAGE#0.9888;CHRONIC GRANULOMATOUS DISEASE#0.9888;SERUM ALBUMIN#0.9887;PERCUTANEOUS CORONARY INTERVENTION#0.9886;CEREBRAL ARTERY#0.9885;SELECTIN#0.9884;MYELOID CELL LINES#0.9882;NITRIC OXIDE SYNTHASE#0.9881;ZIDOVUDINE#0.9880;OSTEOBLAST#0.9880;MYELOBLAST#0.9880;PRECURSOR CELL#0.9879;TNF-ALPHA PRODUCTION#0.9877;CROHN'S DISEASE#0.9875;ADRIAMYCIN#0.9874;RANDOMISED CONTROLLED TRIAL#0.9874;HYDROXYUREA#0.9873;OXIDATIVE BURST#0.9871;MESENCHYMAL CELL#0.9870;BORTEZOMIB#0.9870;MOZOBIL#0.9870;RAPAMYCIN#0.9870;POLYMORPHONUCLEAR LEUKOCYTES#0.9870;CELL ADHESION MOLECULE#0.9869;APLASTIC ANEMIA#0.9868;ALZHEIMER'S DISEASE#0.9867;TYPE 1 DIABETES#0.9867;EPITHELIAL OVARIAN CANCER#0.9867;BONE MARROW STROMAL CELL#0.9867;BREAST CARCINOMA#0.9866;VASCULAR CELL#0.9866;BLOOD PROGENITOR CELL#0.9861;T CELL ACTIVATION#0.9860;LIVER CIRRHOSIS#0.9855;RANDOMIZED CLINICAL TRIAL#0.9855;SOFT TISSUE SARCOMA#0.9855;DAUNORUBICIN#0.9854;ISCHEMIA#0.9854;NEUTROPHIL GRANULOCYTES#0.9854;VINBLASTINE#0.9851;RANDOMIZED CONTROLLED TRIAL#0.9851;HEMOPOIESIS#0.9850;SKELETAL MUSCLE#0.9850;CHRONIC MYELOID LEUKEMIA#0.9848;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9847;SICKLE CELL DISEASE#0.9847;TRANSITIONAL CELL CARCINOMA#0.9845;ERYTHROID CELL#0.9845;BONE MARROW STROMAL#0.9845;CYCLOSPORIN#0.9842;CYCLOSPORIN A#0.9842;PENTOXIFYLLINE#0.9840;BRAIN EDEMA#0.9840;PROSTAGLANDIN E2#0.9839;BONE RESORPTION#0.9837;G1 PHASE#0.9837;ACUTE LYMPHOCYTIC LEUKEMIA#0.9837;PROGENITOR STEM CELL#0.9836;HUMAN CORD BLOOD#0.9835;MITOMYCIN#0.9835;ANTITHYMOCYTE GLOBULIN#0.9834;FERTILIZATION#0.9833;ADVANCED GASTRIC CANCER#0.9831;EARLY BREAST CANCER#0.9830;COLITIS#0.9825;CARDIOMYOPATHY#0.9825;MARROW STROMAL CELLS#0.9825;IRINOTECAN#0.9824;MYELOID-DERIVED SUPPRESSOR CELL#0.9824;DONOR LYMPHOCYTE INFUSION#0.9824;ADIPOSE TISSUE#0.9822;UMBILICAL CORD BLOOD#0.9821;OVARIAN CARCINOMA#0.9820;CYTOPLASMIC REGION#0.9819;NEUROBLASTOMA#0.9819;ACUTE PANCREATITIS#0.9818;DEXAMETHASONE#0.9817;ARTERIOGENESIS#0.9814;ALCOHOLIC HEPATITIS#0.9813;SERUM AMYLOID A#0.9812;AKT SIGNALING#0.9812;PULMONARY EDEMA#0.9809;PHOSPHATE BUFFERED SALINE#0.9809;CYCLOPHOSPHAMIDE#0.9807;IMATINIB MESYLATE#0.9807;KAWASAKI DISEASE#0.9807;SEVERE ADVERSE EVENTS#0.9806;TRANSFORMING GROWTH FACTOR#0.9806;CYTOKINE RECEPTOR#0.9806;CARMUSTINE#0.9805;72-HOURS#0.9804;REDUCED INTENSITY CONDITIONING#0.9804;CHEMOKINE RECEPTOR#0.9804;TISSUE REGENERATION#0.9803;COMPLETE BLOOD COUNT#0.9802;MUSCLE CELL#0.9801;MYELOCYTE#0.9801;SMOOTH MUSCLE CELL#0.9800;NON HODGKIN LYMPHOMA#0.9800;HUMAN IMMUNODEFICIENCY VIRUS#0.9799;BLOOD BRAIN BARRIER#0.9797;GERM CELL TUMORS#0.9796;CHEMOTAXIS#0.9795;NITRIC OXIDE#0.9793;PACLITAXEL#0.9791;BETA-2#0.9789;CEREBRAL INFARCTION#0.9788;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9787;CORD BLOOD#0.9787;VASCULAR SMOOTH MUSCLE CELL#0.9787;SIGNALING MOLECULE#0.9785;RENAL CELL CARCINOMA#0.9785;MATCHED RELATED DONOR#0.9785;LIVER DISEASE#0.9784;MITOGEN ACTIVATED PROTEIN#0.9782;TAXOL#0.9782;MYOCARDIUM#0.9782;FOLINIC ACID#0.9782;STEM CELL#0.9781;RITUXIMAB#0.9781;VASCULITIS#0.9779;UMBILICAL CORD#0.9779;THIOTEPA#0.9778;ADVANCED BREAST CANCER#0.9778;PERIPHERAL BLOOD LEUKOCYTE#0.9777;FOLLICULAR LYMPHOMA#0.9776;IMMUNE SUPPRESSION#0.9776;URINARY BLADDER#0.9775;COLON CANCER#0.9775;CANCER CELL#0.9774;CELL ADHESION#0.9773;PERIPHERAL BLOOD MONOCYTES#0.9773;TRANSFORMING GROWTH FACTOR BETA#0.9772;FACTOR S#0.9772;LYMPHOID CELL#0.9771;LEUKOPENIA#0.9768;MONOCYTE#0.9768;CERVICAL#0.9766;CHRONIC HEART FAILURE#0.9765;ADVANCED OVARIAN CANCER#0.9765;ETOPOSIDE#0.9764;HEMATOPOIETIC CELL TRANSPLANTATION#0.9763;EPOETIN ALFA#0.9763;ALKALINE PHOSPHATASE#0.9762;RESPONSE TO GM-CSF#0.9762;ASPERGILLOSIS#0.9761;GRAFT VERSUS LEUKEMIA#0.9761;ENDOMETRIAL CANCER#0.9761;T CELL PROLIFERATION#0.9760;PERIPHERAL BLOOD#0.9760;TESTICULAR CANCER#0.9760;CELL ACTIVATION#0.9759;NEUTROPENIA#0.9759;TOTAL NUCLEATED CELL#0.9757;HYPOXIA#0.9756;RESPIRATORY DISTRESS#0.9756;TRASTUZUMAB#0.9755;MESENCHYMAL STEM CELL#0.9755;BODY SURFACE AREA#0.9754;PULMONARY FIBROSIS#0.9754;DOCETAXEL#0.9753;SEVERE COMBINED IMMUNODEFICIENCY#0.9750;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9750;REGENERATION#0.9749;HAEMOPOIESIS#0.9748;SMOOTH MUSCLE#0.9747;CELL FRACTION#0.9746;IMMUNOSUPPRESSANT#0.9746;PROTEIN SECRETION#0.9744;PARENTERAL#0.9744;CELL MIGRATION#0.9744;RESPONSE TO TREATMENT#0.9743;APOPTOTIC#0.9742;MYELOID CELL#0.9742;SENSITIZATION#0.9742;ERYTHROPOIESIS#0.9742;CELL EXPANSION#0.9741;ALANINE#0.9741;HIGH RISK PATIENTS#0.9741;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9741;APOPTOSIS#0.9739;WOUND HEALING#0.9737;HUMAN LEUKOCYTE ANTIGEN#0.9736;HUMAN UMBILICAL VEIN#0.9736;NECROTIZING#0.9735;ANAEMIA#0.9735;UMBILICAL VEIN#0.9735;GESTATION#0.9735;HODGKIN'S LYMPHOMA#0.9734;FLUCONAZOLE#0.9733;GEMCITABINE#0.9733;BREAST CANCER CELL#0.9731;THROMBOSIS#0.9731;STRIATUM#0.9730;ACUTE MYELOID LEUKEMIA#0.9730;MULTIPLE SCLEROSIS#0.9729;GRAVES' DISEASE#0.9728;KINASE ACTIVITY#0.9727;NEUTROPHIL#0.9726;BONE MARROW MICROENVIRONMENT#0.9726;NECK CANCER#0.9725;INFLAMMATORY BOWEL DISEASE#0.9725;ACTINOMYCIN D#0.9723;SQUAMOUS CELL CARCINOMA#0.9723;THYROID CARCINOMA#0.9723;SIGNALING CASCADE#0.9723;ARTERY DISEASE#0.9722;KINASE INHIBITOR#0.9722;EPITHELIAL CELL#0.9721;PREDNISOLONE#0.9721;PELVIS#0.9720;METASTATIC BREAST CANCER#0.9720;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9720;ANGIOGENESIS#0.9719;GLUTATHIONE#0.9719;RESPONSE TO LPS#0.9718;QUANTITATIVE REAL TIME#0.9718;DOXORUBICIN#0.9717;ERYTHROID PROGENITOR#0.9717;MAXIMUM TOLERATED DOSE#0.9716;RESPIRATORY FAILURE#0.9716;S PHASE#0.9716;COLORECTAL CANCER#0.9715;THYMIDINE#0.9715;MYELODYSPLASTIC SYNDROME#0.9713;BONE MARROW CELLS#0.9712;BUSULFAN#0.9712;HEAD AND NECK CANCER#0.9710;LYMPHOCYTIC LEUKEMIA#0.9710;PRIMARY BREAST CANCER#0.9710;ENDOTHELIAL PROGENITOR CELL#0.9710;PSORIASIS#0.9709;ACUTE LIVER FAILURE#0.9709;TELOMERE#0.9708;PROMYELOCYTE#0.9708;LITHIUM#0.9708;MULTIPLE MYELOMA#0.9707;C REACTIVE PROTEIN#0.9706;MYELOID LEUKEMIA#0.9705;BONE MARROW FAILURE#0.9705;PREDNISONE#0.9705;PRO-INFLAMMATORY#0.9704;MELPHALAN#0.9704;DIFFUSE LARGE B-CELL LYMPHOMA#0.9702;STEM CELL TRANSPLANT#0.9701;IMMUNOGLOBULIN G#0.9701;SIGNAL TRANSDUCTION#0.9701;MYCOPHENOLATE MOFETIL#0.9701;PROTEIN KINASE C#0.9701;CYTOKINE SECRETION#0.9699;MUTAGENESIS#0.9699;CISPLATIN#0.9697;LYSIS#0.9696;OPTIC NERVE#0.9696;HEMORRHAGIC#0.9695;STANDARD OF CARE#0.9695;OXALIPLATIN#0.9695;HEPATITIS C#0.9694;HEMATOPOIETIC PROGENITOR CELL#0.9694;BLOOD VESSEL#0.9694;NATURAL KILLER CELL#0.9693;STROMAL CELL#0.9693;REVERSE TRANSCRIPTION#0.9693;DENDRITIC CELL#0.9693;PROTEIN KINASE#0.9692;ACUTE LEUKEMIA#0.9692;PHAGOCYTOSIS#0.9691;PROGENITOR CELL#0.9691;MEGAKARYOCYTE#0.9690;SIGNALING PATHWAY#0.9690;MAST CELL#0.9689;CYTOPLASM#0.9689;VINCRISTINE#0.9689;HYPERSENSITIVITY#0.9689;CYTOTOXICITY#0.9687;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9687;HYPERTENSION#0.9686;LUPUS ERYTHEMATOSUS#0.9686;ACUTE PHASE RESPONSE#0.9684;ENDOTHELIUM#0.9684;TRANSCRIPTASE#0.9684;OVULATION#0.9683;LUNG CANCER#0.9683;ENDOTHELIAL CELL#0.9682;THALASSEMIA#0.9682;CARBOPLATIN#0.9681;5 FLUOROURACIL#0.9681;GROWTH FACTOR#0.9681;SERIOUS ADVERSE EVENT#0.9680;CHRONIC NEUTROPHILIC LEUKEMIA#0.9680;PLASMA CELL#0.9680;BREAST CANCER PATIENTS#0.9679;PERITONEAL CAVITY#0.9678;COAGULATION#0.9678;MECHANISM OF ACTION#0.9678;PERIPHERAL MONONUCLEAR CELLS#0.9677;CORONARY ARTERY DISEASE#0.9676;T-CELL LEUKEMIA#0.9676;FLUOROURACIL#0.9674;GERM CELL#0.9674;TUMOR CELLS#0.9672;CELL PROLIFERATION#0.9672;DIABETES MELLITUS#0.9670;MONONUCLEAR CELLS#0.9670;CYCLOSPORINE#0.9669;CELL SURFACE#0.9665;CELL GROWTH#0.9664;CYSTIC FIBROSIS#0.9664;PNEUMONIA#0.9663;PERIPHERAL NERVE#0.9662;CELL DEVELOPMENT#0.9661;CERVIX#0.9661;CHORIOAMNIONITIS#0.9660;GROWTH FACTOR RECEPTOR#0.9659;COLORECTAL#0.9659;IL-1 BINDING#0.9659;VANCOMYCIN#0.9659;PLASMA MEMBRANE#0.9657;CD8+ T CELL#0.9657;BRAIN DAMAGE#0.9657;BREAST CANCER#0.9657;PANCYTOPENIA#0.9655;ATHEROSCLEROSIS#0.9654;EDEMA#0.9654;TISSUE DAMAGE#0.9654;CELL DEATH#0.9654;PROSTATE CANCER#0.9654;MINIMAL RESIDUAL DISEASE#0.9654;ULCERATIVE COLITIS#0.9653;OVARIAN#0.9652;OVARIAN CANCER#0.9649;CELL CYCLE#0.9648;CHRONIC HEPATITIS C#0.9648;HEMORRHAGE#0.9648;IRINOTECAN, CPT-11#0.9647;CD3+ T CELL#0.9647;STROMA#0.9646;B CELL LYMPHOMA#0.9644;ARGININE#0.9643;THALIDOMIDE#0.9643;CD4+ T CELL#0.9642;TREATMENT RELATED MORTALITY#0.9641;TRANSPLANT RELATED MORTALITY#0.9640;COLONY-FORMING CELL#0.9640;BONE MARROW#0.9639;TACROLIMUS#0.9637;ANTIGEN PRESENTING CELLS#0.9637;MESENCHYMAL STROMAL CELL#0.9636;EOSINOPHIL#0.9634;B LYMPHOCYTE#0.9634;POSITRON EMISSION TOMOGRAPHY#0.9633;WHITE BLOOD CELL#0.9633;CORONARY ARTERY#0.9632;REGULATION OF HEMATOPOIESIS#0.9630;METHOTREXATE#0.9630;BONE MARROW ASPIRATE#0.9627;RETICULOCYTE#0.9627;PANCREATITIS#0.9627;TOPOISOMERASE#0.9623;TREG CELL#0.9622;INNATE IMMUNITY#0.9620;MENSTRUAL CYCLE#0.9619;CONGESTIVE HEART FAILURE#0.9619;TRANSFERRIN RECEPTOR#0.9618;T CELL#0.9617;LEUKOCYTE#0.9616;SYSTEMIC INFLAMMATORY RESPONSE#0.9614;CYTOPENIA#0.9614;GALLBLADDER#0.9614;INTENSIVE CARE UNIT#0.9613;RIBAVIRIN#0.9612;MICROVASCULAR ENDOTHELIAL CELL#0.9612;INTENT TO TREAT#0.9610;HEMATOPOIETIC STEM CELL#0.9608;RHEUMATOID ARTHRITIS#0.9608;ARRHYTHMIA#0.9606;OSTEOPOROSIS#0.9605;NEURODEGENERATIVE DISEASE#0.9603;REACTIVE OXYGEN SPECIES#0.9601;B CELL#0.9600;SUPEROXIDE DISMUTASE#0.9600;DOSE LIMITING TOXICITIES#0.9599;THROMBOCYTOSIS#0.9599;WORLD HEALTH ORGANIZATION#0.9598;MAGNETIC RESONANCE IMAGING#0.9598;RESPIRATORY TRACT#0.9597;CELL DIFFERENTIATION#0.9595;GENE EXPRESSION#0.9595;RECEPTOR LIGAND#0.9594;INFLAMMATORY CELL#0.9592;CENTRAL NERVOUS SYSTEM#0.9591;TOLL LIKE RECEPTOR#0.9591;DNA BINDING#0.9589;CYCLIC HEMATOPOIESIS#0.9586;ARTERY#0.9584;DENTAL PULP STEM CELL#0.9583;HEMATOPOIETIC CELL#0.9583;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9582;RED BLOOD CELL#0.9578;END OF TREATMENT#0.9578;HEMATOPOIESIS#0.9578;PLURIPOTENT STEM CELL#0.9576;NERVOUS SYSTEM#0.9575;INNATE IMMUNE RESPONSE#0.9575;ADENOCARCINOMA#0.9575;ACTIVATED T CELL#0.9574;T LYMPHOCYTE#0.9573;ERYTHEMA#0.9572;VIRAL INFECTION#0.9572;ERYTHROCYTE#0.9571;ADULT BONE MARROW#0.9569;DIMETHYL SULFOXIDE#0.9567;GASTROINTESTINAL TRACT#0.9565;ACTIVATED T-CELLS#0.9564;GRAFT VERSUS HOST#0.9564;ANEMIA#0.9564;ABDOMINAL PAIN#0.9563;STEM CELLS TRANSPLANTATION#0.9562;IMMUNE CELL#0.9561;RELAPSE FREE SURVIVAL#0.9561;CENTRAL VENOUS CATHETER#0.9559;ESOPHAGEAL CANCER#0.9558;NATIONAL CANCER INSTITUTE#0.9557;EXTRACELLULAR MATRIX#0.9555;OBESE#0.9554;AUTOIMMUNE DISEASE#0.9551;DILATED CARDIOMYOPATHY#0.9551;RECEPTOR COMPLEX#0.9550;HEMOGLOBINURIA#0.9548;WEIGHT LOSS#0.9546;TUBERCULOSIS#0.9546;PROGESTERONE#0.9544;HEPATITIS C VIRUS#0.9543;CELL DIVISION#0.9543;L-ARGININE#0.9542;STEM CELL TRANSPLANTATION#0.9541;TRANSCRIPTION FACTOR#0.9540;ALLERGIC REACTION#0.9537;STOMATITIS#0.9537;ANOREXIA#0.9536;INTENTION TO TREAT#0.9532;PROGRAMMED CELL DEATH#0.9530;TOPOISOMERASE II#0.9527;GERM CELL CANCER#0.9525;ADIPOCYTE#0.9525;TYPE 2 DIABETES#0.9521;MYELOFIBROSIS#0.9520;SMALL CELL CARCINOMA#0.9517;OBJECTIVE RESPONSE RATE#0.9515;ASTHENIA#0.9513;INTERNATIONAL PROGNOSTIC INDEX#0.9512;EPSTEIN BARR VIRUS#0.9511;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.9511;RISK OF RELAPSE#0.9511;MUCOSITIS#0.9508;DISSEMINATED INTRAVASCULAR COAGULATION#0.9503;POLYMERASE CHAIN REACTION#0.9502;NEUROTOXICITY#0.9502;HEAT SHOCK PROTEIN#0.9501;MEDIAN SURVIVAL TIME#0.9501;ALOPECIA#0.9501;OVERALL SURVIVAL RATE#0.9500;CYTOKINE PRODUCTION#0.9500;MITOCHONDRIA#0.9497;EVENT FREE SURVIVAL#0.9497;ACQUIRED APLASTIC ANEMIA#0.9496;ELECTROPHORETIC MOBILITY SHIFT#0.9491;IMMUNE SYSTEM#0.9491;CONJUGATION#0.9490;LIVER DAMAGE#0.9484;CANDIDIASIS#0.9484;INFLAMMATORY RESPONSE#0.9483;ASCITES#0.9483;DYSPNEA#0.9475;MACROPHAGE ACTIVATION#0.9475;MEMORY T CELL#0.9474;ARSENIC TRIOXIDE#0.9470;TAXOTERE#0.9470;FLOW CYTOMETRY ANALYSIS#0.9467;COMMON TOXICITY CRITERIA#0.9465;LUNG DISEASE#0.9464;CELL SURFACE ANTIGEN#0.9459;NECROTIC#0.9455;TOXICITY#0.9450;CYTOCHROME C#0.9450;YEAR SURVIVAL RATE#0.9447;TIME TO PROGRESSION#0.9447;NEUROPATHY#0.9446;THROMBOCYTOPENIA#0.9446;BASOPHIL#0.9445;HISTAMINE#0.9445;TO TUMOR PROGRESSION#0.9441;SPONTANEOUS PRETERM BIRTH#0.9439;HEMATOPOIETIC PRECURSOR CELL#0.9435;LYMPH NODE#0.9432;DIARRHEA#0.9431;PHOSPHATASE ACTIVITY#0.9430;TOPICAL#0.9427;CELL MATURATION#0.9425;VOMITING#0.9425;IMMUNE RESPONSE#0.9424;ENTEROCYTE#0.9423;ADULT T-CELL LEUKEMIA#0.9422;INNATE IMMUNE SYSTEM#0.9419;LENGTH OF STAY#0.9419;DRUG RESISTANCE#0.9418;MEDIAN OVERALL SURVIVAL#0.9416;PYODERMA#0.9413;LEUKEMIA FREE SURVIVAL#0.9409;NEUTROPHIL HOMEOSTASIS#0.9407;CARCINOSARCOMA#0.9407;2-CHLORODEOXYADENOSINE#0.9406;LEUKOCYTE ADHESION#0.9405;MEDULLOBLASTOMA#0.9405;IN STENT RESTENOSIS#0.9402;VASCULOGENESIS#0.9401;CABAZITAXEL#0.9400;CEFTAZIDIME#0.9398;ANEMIC#0.9396;ENDOPLASMIC RETICULUM#0.9391;HAIRY CELL LEUKEMIA#0.9390;ACUTE KIDNEY INJURY#0.9389;DISEASE FREE SURVIVAL#0.9385;OVERALL RESPONSE RATE#0.9384;INDUCTION OF APOPTOSIS#0.9381;GLIAL CELL#0.9377;ADULT STEM CELL#0.9376;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9374;FEMUR#0.9374;FANCONI ANEMIA#0.9368;MODE OF ACTION#0.9363;SWELLING#0.9358;WEIGHT GAIN#0.9357;TH17 CELL#0.9356;CAROTID ARTERY#0.9355;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9353;SIGNALLING PATHWAY#0.9351;HOST CELL#0.9348;MESOTHELIAL CELL#0.9343;ORTHOTOPIC LIVER TRANSPLANTATION#0.9343;HYPOTENSION#0.9342;KUPFFER CELL#0.9341;CELL MEMBRANE#0.9341;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9340;AUTOPHAGY#0.9338;EWING SARCOMA#0.9332;GLOMERULONEPHRITIS#0.9331;ACUTE INFLAMMATORY RESPONSE#0.9331;PERIPHERAL BLOOD LYMPHOCYTES#0.9330;ERYTHROBLAST#0.9327;LECTIN#0.9319;RETINOIC ACID RECEPTOR#0.9318;TRIMETHOPRIM#0.9311;TYROSINE KINASE INHIBITOR#0.9309;SUPEROXIDE RELEASE#0.9308;PLASMACYTOID DENDRITIC CELL#0.9304;POLY ETHYLENE GLYCOL#0.9302;PLACENTAL GROWTH FACTOR#0.9298;AIRWAY EPITHELIAL CELL#0.9295;DOPAMINERGIC NEURON#0.9294;FIBROUS HISTIOCYTOMA#0.9292;RETINAL GANGLION CELL#0.9289;INVASIVE FUNGAL INFECTION#0.9280;HIGH FAT DIET#0.9280;LEFT ANTERIOR DESCENDING#0.9272;EXCRETION#0.9268;MELIOIDOSIS#0.9267;GEMTUZUMAB OZOGAMICIN#0.9263;BACTERIAL SEPSIS#0.9263;CONTROLLED CLINICAL TRIALS#0.9262;GASTRIC ADENOSQUAMOUS CARCINOMA#0.9258;CHONDROCYTE#0.9257;ALKALINE PHOSPHATASE ACTIVITY#0.9257;MEDICAL RESEARCH COUNCIL#0.9252;TAMOXIFEN#0.9251;HISTIDINE#0.9250;PYELONEPHRITIS#0.9246;BLOOD CIRCULATION#0.9243;CANCER STEM CELL#0.9243;APOPTOTIC CELL DEATH#0.9239;ADVANCED PANCREATIC CANCER#0.9237;DENTATE GYRUS#0.9223;ACUTE LIVER INJURY#0.9221;PATHOLOGIC COMPLETE RESPONSE#0.9221;ESOPHAGUS#0.9215;INTERLEUKIN 2 RECEPTOR#0.9213;CELL CYCLE ARREST#0.9213;SULFAMETHOXAZOLE#0.9212;VIRULENCE#0.9206;LYSINE#0.9193;ACTIN POLYMERIZATION#0.9189;TIME TO TREATMENT#0.9187;CYCLIN DEPENDENT KINASE#0.9182;IFN-BETA#0.9182;VENOUS BLOOD#0.9179;PROCARBAZINE#0.9178;ADAPTIVE IMMUNE RESPONSE#0.9177;ERYTHROID PRECURSOR#0.9177;AUTOIMMUNITY#0.9176;MANTLE CELL LYMPHOMA#0.9173;ESTROGEN RECEPTOR#0.9167;VASCULAR ENDOTHELIUM#0.9167;DERMATITIS#0.9161;COLON CARCINOMA#0.9157;HYPERTHERMIA#0.9157;SIGNAL PEPTIDE#0.9156;TNF PRODUCTION#0.9156;CYTOTOXIC T-LYMPHOCYTE#0.9156;PEGYLATED LIPOSOMAL DOXORUBICIN#0.9154;ONCOGENIC#0.9150;ADULT RESPIRATORY DISTRESS SYNDROME#0.9147;ANAPLASTIC THYROID CARCINOMA#0.9147;IMMUNE DYSFUNCTION#0.9134;SPUTUM#0.9134;HYDROCORTISONE#0.9133;LYMPHOID LEUKEMIA#0.9130;CLINICAL PRACTICE GUIDELINE#0.9128;HEAD AND NECK CARCINOMA#0.9125;SYNOVIAL FLUID#0.9123;ESTRADIOL#0.9121;STANDARD MEDICAL THERAPY#0.9119;DIGESTION#0.9119;GM-CSF PRODUCTION#0.9116;SKIN RASH#0.9115;Y CHROMOSOME#0.9111;RISK OF DEATH#0.9103;INVASIVE ASPERGILLOSIS#0.9100;FULL DONOR CHIMERISM#0.9091;MACROPHAGE DIFFERENTIATION#0.9091;ANTIGEN PRESENTATION#0.9085;MYOBLAST#0.9079;METAPHASE#0.9078;SECONDARY GRANULE#0.9076;CYTOTOXIC T CELL#0.9071;CIRCADIAN RHYTHM#0.9065;RESPONSE TO CYTOKINE#0.9060;SHWACHMAN DIAMOND SYNDROME#0.9051;GENISTEIN#0.9050;BACTERIAL MENINGITIS#0.9049;BUSULPHAN#0.9037;SENESCENCE#0.9036;SITAGLIPTIN#0.9035;INTERLEUKIN 3 RECEPTOR#0.9033;DENDRITIC CELL SUBSETS#0.9029;FLUID RETENTION#0.9028;CLOFARABINE#0.9024;STREPTOZOTOCIN#0.9022;ASTROCYTOMA#0.9018;CAPECITABINE#0.9015;INHIBITION OF APOPTOSIS#0.9013;BODY WEIGHT LOSS#0.9006;NEPHROTOXICITY#0.9003;PANCREATIC CARCINOMA#0.9003;PLATELET ACTIVATION#0.9001;ETOPOSIDE PHOSPHATE#0.8999;PERITONEUM#0.8990;MONOCYTE DERIVED MACROPHAGE#0.8981;MASTITIS#0.8980;END DIASTOLIC VOLUME#0.8977;RECURRENT OVARIAN CANCER#0.8972;POLYCYTHEMIA#0.8971;MICROGLIAL CELL#0.8969;TRANSFORMING GROWTH FACTOR ALPHA#0.8965;TOCOPHEROL#0.8964;MINOCYCLINE#0.8961;POLYCYTHEMIA VERA#0.8958;EMESIS#0.8958;GLUCOSE UPTAKE#0.8957;LIVE BIRTH RATE#0.8953;LIVER METASTASIS#0.8951;NEURAL CELL#0.8950;CYSTITIS#0.8950;EMBRYONIC STEM CELL#0.8945;VITAMIN D3#0.8945;RESPIRATORY TRACT INFECTION#0.8944;M PHASE#0.8944;VASCULAR DISEASE#0.8943;PLASMA PROTEIN#0.8939;MUSCLE DAMAGE#0.8935;MYOCARDITIS#0.8933;HYPOXIA INDUCIBLE FACTOR#0.8932;SMALL INTESTINE#0.8931;DOPAMINE#0.8908;ASSISTED REPRODUCTIVE TECHNOLOGY#0.8907;ENDOCYTOSIS#0.8901;TRANSPLANTATION RELATED MORTALITY#0.8894;CELL KILLING#0.8892;LOW MOLECULAR WEIGHT HEPARIN#0.8889;COMPLEMENT ACTIVATION#0.8885;PERIODONTITIS#0.8883;SODIUM DODECYL SULFATE#0.8878;DODECYL SULFATE#0.8877;NEOPLASTIC DISEASE#0.8869;LIGAND BINDING DOMAIN#0.8862;MYOFIBROBLAST#0.8856;PANCREATIC ADENOCARCINOMA#0.8854;FAILURE FREE SURVIVAL#0.8850;UTERINE CERVICAL CANCER#0.8838;INJECTION SITE REACTIONS#0.8834;CHRONIC MYELOMONOCYTIC LEUKEMIA#0.8830;PURPURA#0.8828;UROKINASE#0.8828;MALARIA#0.8817;NEURITE OUTGROWTH#0.8809;CONTROLLED CORTICAL IMPACT#0.8799;FACTOR VIII#0.8796;CIRCULATING ENDOTHELIAL PROGENITOR#0.8795;BIOTIN#0.8794;PROPYLTHIOURACIL#0.8792;ORAL CAVITY#0.8792;SUCCINATE#0.8791;CREATINE#0.8789;STEM CELL PROLIFERATION#0.8788;LYMPH NODE METASTASIS#0.8782;LOW BIRTH WEIGHT#0.8775;GALLBLADDER CANCER#0.8766;LEUKEMIC STEM CELL#0.8765;ASPIRIN#0.8764;MESENTERIC LYMPH NODE#0.8761;FIBROSARCOMA#0.8758;ENZYME ACTIVITY#0.8747;MYOCYTES#0.8746;SIZE EXCLUSION CHROMATOGRAPHY#0.8743;ENCEPHALOMYELITIS#0.8738;STEM CELL MARKER#0.8727;IMIPENEM#0.8727;HEALTHY CONTROL SUBJECTS#0.8724;CHEMOKINE PRODUCTION#0.8715;TUBULAR EPITHELIAL CELL#0.8702;EOSIN#0.8700;MALAISE#0.8700;ASCENDING COLON#0.8696;ENDOTHELIAL NITRIC OXIDE#0.8695;PERIPHERAL ARTERIAL DISEASE#0.8685;GENTAMICIN#0.8681;ALEMTUZUMAB#0.8681;LYMPHOPENIA#0.8680;ADVERSE DRUG REACTION#0.8674;IL-4 PRODUCTION#0.8669;HISTIOCYTOMA#0.8668;UNRELATED CORD BLOOD#0.8668;MUSCULAR DYSTROPHY#0.8665;URINARY TRACT INFECTION#0.8662;BRONCHIAL EPITHELIAL CELLS#0.8657;HUMAN BRONCHIAL EPITHELIAL#0.8648;LARGE GRANULAR LYMPHOCYTE#0.8643;DNA FRAGMENTATION#0.8641;SMOOTH MUSCLE ACTIN#0.8640;CONSTIPATION#0.8638;MYELOID CELL DIFFERENTIATION#0.8637;INTRACELLULAR SIGNALING PATHWAY#0.8635;PORTAL VEIN#0.8627;VORICONAZOLE#0.8626;TICLOPIDINE#0.8618;COLCHICINE#0.8616;PREMATURITY#0.8608;PNEUMOCOCCAL MENINGITIS#0.8602;OSTEOGENESIS#0.8601;ERYTHROPOIETIN RECEPTOR#0.8600;ACID PHOSPHATASE#0.8600;FIBRINOGEN#0.8600;BRAIN ISCHEMIA#0.8587;PATHOLOGICAL COMPLETE RESPONSE#0.8585;AGE AT DIAGNOSIS#0.8581;ANTI APOPTOSIS#0.8580;LOW DENSITY LIPOPROTEIN#0.8575;LEUCINE#0.8569;BEST SUPPORTIVE CARE#0.8564;RHABDOMYOSARCOMA#0.8561;LEUCOSTIM#0.8554;UTERUS#0.8544;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8540;METASTATIC MELANOMA#0.8538;RESPONSE TO ENDOTOXIN#0.8537;GLOMERULAR FILTRATION#0.8533;BLOOD LOSS#0.8528;ADJUSTED ODDS RATIO#0.8526;ENDOCARDITIS#0.8521;BLOOD PLASMA#0.8518;ALPHA-TOCOPHEROL#0.8510;MALTOSE BINDING#0.8507;CARRIE#0.8506;SPATIAL LEARNING#0.8502;LYMPHOPROLIFERATIVE DISEASE#0.8495;AMIKACIN#0.8491;ASPARTATE#0.8486;BONE MORPHOGENETIC PROTEIN#0.8485;RAT BONE MARROW#0.8479;DECIDUAL CELL#0.8478;HUMAN LEUCOCYTE ANTIGEN#0.8477;RESPONSE TO LIPOPOLYSACCHARIDE#0.8474;MEGAKARYOCYTE PROGENITOR CELL#0.8470;LUNG METASTASIS#0.8468;GRANULOSA CELL#0.8459;TRANSDIFFERENTIATION#0.8452;DYSKERATOSIS CONGENITA#0.8451;NATURAL KILLER T#0.8444;M2 MACROPHAGE#0.8435;GLUTAMINE#0.8434;G0 PHASE#0.8430;END SYSTOLIC VOLUME#0.8428;POSITIVE PREDICTIVE VALUE#0.8427;ISCHEMIC HEART FAILURE#0.8422;VITAMIN E#0.8418;BONE REMODELING#0.8418;TH2 CELL#0.8404;LYMPH NODE METASTASES#0.8402;LEIOMYOSARCOMA#0.8399;CEREBRAL HEMORRHAGE#0.8399;CHLORODEOXYADENOSINE#0.8399;CELL WALL#0.8398;OVERALL SURVIVAL TIME#0.8397;IL-8 SECRETION#0.8396;PROSTATE SPECIFIC ANTIGEN#0.8394;HEPATITIS B VIRUS#0.8385;ACTIVATED MONOCYTES#0.8380;DISEASE ACTIVITY INDEX#0.8360;CYTOKINE SYNTHESIS#0.8354;AZATHIOPRINE#0.8349;ADENOSINE DEAMINASE#0.8344;HIGH RISK NEUROBLASTOMA#0.8339;RECURRENT PREGNANCY LOSS#0.8336;CREATINE KINASE#0.8329;PERIPHERAL LEUKOCYTES#0.8313;TH1 CELL#0.8311;ALPHA 1-ANTITRYPSIN#0.8307;PULMONARY HYPERTENSION#0.8295;ELECTRONIC MEDICAL RECORD#0.8295;EFFECTOR T CELL#0.8293;NEUROLOGICAL DISORDER#0.8286;HEMORRHAGIC CYSTITIS#0.8282;ARTERIOSCLEROSIS OBLITERANS#0.8278;TUMOR SUPPRESSOR#0.8273;LYMPHOBLASTIC LYMPHOMA#0.8273;BEVACIZUMAB#0.8271;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.8269;MITOCHONDRIAL MEMBRANE#0.8264;ANOREXIA NERVOSA#0.8262;SUCROSE#0.8257;TIME TO RESPONSE#0.8253;CYCLIC AMP#0.8236;CORONARY ARTERY BYPASS#0.8234;OSTEOCYTE#0.8234;PARENCHYMA#0.8213;GANGLION CELLS#0.8212;ANAPLASTIC LARGE CELL LYMPHOMA#0.8210;HEMATOPOIETIC ORGANS#0.8206;AIDS RELATED COMPLEX#0.8193;INFLAMMATORY CELL INFILTRATION#0.8189;HISTONE DEACETYLASE#0.8187;CONNECTIVE TISSUE#0.8183;GRAFT VERSUS TUMOR#0.8183;NEPHROPATHY#0.8174;CELL ASSOCIATED#0.8173;TIBIA#0.8172;TACHYCARDIA#0.8170;EVERY OTHER WEEK#0.8163;DIPEPTIDYL PEPTIDASE#0.8158;NEURITE#0.8153;MAPK ACTIVATION#0.8150;ANTERIOR ISCHEMIC OPTIC NEUROPATHY#0.8150;COMMUNITY ACQUIRED PNEUMONIA#0.8149;REGIONAL LYMPH NODE#0.8147;ASEPTIC MENINGITIS#0.8146;ADENINE#0.8142;CLINICAL COMPLETE RESPONSE#0.8140;BASEMENT MEMBRANE#0.8140;DEXRAZOXANE#0.8131;BONE MINERAL DENSITY#0.8128;DEMENTIA#0.8128;COMMON MYELOID PROGENITOR#0.8120;OFLOXACIN#0.8118;COMPLEMENT RECEPTOR#0.8111;PRIMARY GRANULE#0.8109;INFERTILITY#0.8089;CEFTRIAXONE#0.8089;QUIESCENCE#0.8084;T HELPER CELL#0.8080;OSTEOMYELITIS#0.8078;C CHEMOKINE RECEPTOR#0.8078;MULTI ORGAN FAILURE#0.8065;HERPES SIMPLEX#0.8061;KAPOSI'S SARCOMA#0.8059;NUCLEIC ACID#0.8050;KARNOFSKY PERFORMANCE STATUS#0.8040;RESPONSE TO IL-1#0.8038;ANAPHYLAXIS#0.8038;PLATELET ACTIVATING FACTOR#0.8030;POEMS SYNDROME#0.8025;LOWER LIMB ISCHEMIA#0.8018;HIND LIMB ISCHEMIA#0.8015;SIROLIMUS#0.8012;MYELOID STEM CELL#0.8010;COLLAGEN INDUCED ARTHRITIS#0.8010;UBIQUITIN#0.8009;HEPARIN BINDING#0.8003;METASTATIC CARCINOMA#0.8001;MULTIPLE REGRESSION ANALYSIS#0.8000;WALL MOTION SCORE#0.7991;RECEPTOR ACTIVATOR#0.7986;GLUCOSE-6-PHOSPHATE#0.7984;SPINAL CORD ISCHEMIA#0.7976;HEPATOTOXICITY#0.7971;MOLAR#0.7965;LACTATION#0.7961;ERYTHROCYTE SEDIMENTATION RATE#0.7961;DEXTRAN SULFATE SODIUM#0.7956;OSTEOARTHRITIS#0.7949;FLUDARABINE PHOSPHATE#0.7939;SIROLIMUS ELUTING STENT#0.7932;NEGATIVE PREDICTIVE VALUE#0.7921;BETA THALASSEMIA#0.7918;EMBOLISM#0.7913;MAJOR ADVERSE EVENT#0.7911;VIRAL REPLICATION#0.7906;IL-8 PRODUCTION#0.7906;NOREPINEPHRINE#0.7906;CHILD TURCOTTE PUGH#0.7897;TRYPTOPHAN#0.7896;RESPIRATORY SYNCYTIAL VIRUS#0.7894;CELLULITIS#0.7893;ARACHIDONIC ACID#0.7892;INFECTIVE ENDOCARDITIS#0.7892;LUNG INJURY SCORE#0.7889;MIGRATION INHIBITORY FACTOR#0.7883;GLIOBLASTOMA MULTIFORME#0.7880;LEUKEMIA STEM CELL#0.7870;IL-1RN#0.7864;ATTRACTANT#0.7860;INTESTINAL EPITHELIAL CELL#0.7845;TUMOR ANTIGEN#0.7845;HYPOGLYCEMIA#0.7838;PROTEIN KINASE A#0.7835;FOLLICLE STIMULATING HORMONE#0.7833;FLUORESCEIN#0.7831;CELLULAR COMPONENT#0.7828;DNA METHYLATION#0.7827;COMPLETE DONOR CHIMERISM#0.7797;CHAGAS DISEASE#0.7795;SULFASALAZINE#0.7785;NATURAL KILLER T CELL#0.7784;PROTEINURIA#0.7780;MUCORMYCOSIS#0.7780;LUNG FIBROBLASTS#0.7780;OPSONIN RECEPTOR#0.7769;MONOCYTIC LEUKEMIA#0.7769;GRAM NEGATIVE BACTERIAL#0.7765;CORE BINDING FACTOR#0.7761;HUMAN NEUTROPHIL ANTIGEN#0.7751;SPERMATOGENESIS#0.7751;MEMBRANE DEPOLARIZATION#0.7749;CIRCULATING TUMOR CELL#0.7739;MEAN FLUORESCENCE INTENSITY#0.7729;TUMOR ASSOCIATED MACROPHAGE#0.7728;CONGENITAL DISORDER#0.7721;TYPE 2 DIABETES MELLITUS#0.7719;2 DIABETES MELLITUS#0.7719;DECIDUA#0.7714;RABBIT ATG#0.7714;HEMATURIA#0.7713;DIPYRIDAMOLE#0.7699;TUBE FORMATION#0.7697;ADENOSINE MONOPHOSPHATE#0.7683;QUANTITATIVE REVERSE TRANSCRIPTASE#0.7682;SUBSTANTIA NIGRA#0.7676;HEMATOPOIETIC CELL TRANSPLANT#0.7675;MICROTUBULE#0.7671;MYELOID CELL DEVELOPMENT#0.7669;CHORIOCARCINOMA#0.7665;EPITHELIAL OVARIAN CARCINOMA#0.7658;GLOBIN#0.7658;HYPERTHYROIDISM#0.7656;ITRACONAZOLE#0.7652;L-PAM#0.7651;HYALURONIDASE#0.7650;LYMPHOBLAST#0.7643;CILASTATIN#0.7636;HEPATIC ARTERY#0.7635;MICROPARTICLE#0.7632;JEJUNUM#0.7626;MACROPHAGE CHEMOATTRACTANT PROTEIN#0.7617;CYTOXAN#0.7617;ANGIOTENSIN CONVERTING ENZYME#0.7616;PROPIDIUM#0.7615;TRANSACTIVATION#0.7614;NEOMYCIN#0.7613;RANDOMIZED CONTROL TRIAL#0.7605;MYOCARDIAL INFARCT SIZE#0.7605;IL-1 PRODUCTION#0.7602;PERIPHERAL MONOCYTE#0.7595;MULTIPLE ORGAN DYSFUNCTION#0.7594;MYOTUBE#0.7592;MARKERS OF INFLAMMATION#0.7590;THYMIDINE KINASE#0.7587;LUMINAL#0.7586;GYNECOLOGIC ONCOLOGY GROUP#0.7581;LYMPHOCYTE PROLIFERATION#0.7579;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7579;MONOCYTE ACTIVATION#0.7576;NAVELBINE#0.7575;TELOMERASE ACTIVITY#0.7574;TENIPOSIDE#0.7558;GROWTH FACTOR BINDING#0.7555;PANCREATIC ISLET#0.7554;PROTEIN FOLDING#0.7549;IONOPHORE#0.7519;GUANIDINE#0.7513;SEVERE ACUTE PANCREATITIS#0.7507;MULTIPOTENT PROGENITOR CELL#0.7506;DIABETIC FOOT ULCER#0.7506;ERYTHROLEUKEMIA#0.7504;DIHYDROFOLATE REDUCTASE#0.7501;ARTERIOSCLEROSIS#0.7500;SURFACE PLASMON RESONANCE#0.7499;EPINEPHRINE#0.7498;ACTIVATED PROTEIN C#0.7494;HERPES ZOSTER#0.7494;MEROPENEM#0.7493;DEPHOSPHORYLATION#0.7486;AZITHROMYCIN#0.7476;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7472;CHRONIC LIVER DISEASE#0.7470;BETA GALACTOSIDASE#0.7458;IL-10 PRODUCTION#0.7452;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7438;PERITONEAL CARCINOMA#0.7436;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.7436;ANTI-INFLAMMATORY RESPONSE#0.7430;LYMPH NODE DISSECTION#0.7422;URETER#0.7401;ADRENOCORTICOTROPIC HORMONE#0.7401;PERIODONTAL DISEASE#0.7393;MYCOPHENOLIC ACID#0.7387;ACTIVATED B CELL#0.7384;TYROSINE KINASE RECEPTOR#0.7377;GENETIC DISORDER#0.7374;IL-17 PRODUCTION#0.7372;RECOMBINANT HUMAN GM-CSF#0.7371;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7370;SCANNING ELECTRON MICROSCOPY#0.7369;CYCLIN DEPENDENT KINASE INHIBITOR#0.7368;RESPONSE TO TNF#0.7367;DIPEPTIDYL PEPTIDASE IV#0.7366;ENDOTHELIAL CELL PROLIFERATION#0.7361;NF-KAPPAB ACTIVATION#0.7356;DISEASE CONTROL RATE#0.7354;MAPK SIGNALING#0.7354;TOLERANCE INDUCTION#0.7342;GLOMERULAR FILTRATION RATE#0.7342;DERMIS#0.7341;RECEPTOR MEDIATED ENDOCYTOSIS#0.7334;ELASTASE ACTIVITY#0.7332;NEURAL PROGENITOR CELL#0.7331;NON-SMALL CELL LUNG CARCINOMA#0.7329;CASPASE ACTIVATION#0.7329;INSTITUTIONAL REVIEW BOARD#0.7324;MODIFIED RANKIN SCALE#0.7321;SRC FAMILY KINASE#0.7321;HEARING LOSS#0.7319;GENETIC DISEASE#0.7307;CELLULAR IMMUNE RESPONSE#0.7298;EMISSION COMPUTED TOMOGRAPHY#0.7295;HIGH MOBILITY GROUP#0.7289;CLARITHROMYCIN#0.7281;PATTERN RECOGNITION RECEPTOR#0.7267;LYMPHOID ORGANS#0.7267;ADVANCED HEART FAILURE#0.7262;PENICILLIN#0.7248;ACYCLOVIR#0.7243;RETICULAR DYSGENESIS#0.7237;FATALITY#0.7235;ESOPHAGITIS#0.7233;SQUAMOUS CELL CANCER#0.7219;CD4+CD25+ REGULATORY T CELL#0.7201;GALLBLADDER CARCINOMA#0.7199;SUSTAINED VIROLOGICAL RESPONSE#0.7199;GALECTIN#0.7195;DRUG ELUTING STENT#0.7185;SORAFENIB#0.7183;HEMOLYSIS#0.7181;HEMOLYTIC ANEMIA#0.7180;VIRAL HEPATITIS#0.7174;VITAMIN B12#0.7169;CELL-MEDIATED IMMUNITY#0.7167;AIRWAY SMOOTH MUSCLE#0.7163;MERCAPTOPURINE#0.7156;INTERLEUKIN 6 RECEPTOR#0.7154;HISTONE DEACETYLASE INHIBITOR#0.7154;HERPES SIMPLEX VIRUS#0.7146;URIC ACID#0.7141;COLON ADENOCARCINOMA#0.7137;APOPTOSIS OF NEUTROPHILS#0.7135;VALGANCICLOVIR#0.7133;JUGULAR VEIN#0.7133;SHORT TANDEM REPEAT#0.7132;OTITIS MEDIA#0.7127;MALTOSE#0.7126;CHRONIC KIDNEY DISEASE#0.7124;6-MERCAPTOPURINE#0.7115;MACROPHAGE MIGRATION#0.7115;NICOTINAMIDE#0.7114;ALLERGEN#0.7113;KIDNEY DISEASE#0.7111;LYMPH NODE INVOLVEMENT#0.7103;SCIENCE CITATION INDEX#0.7084;PERIPHERAL ARTERY DISEASE#0.7083;RESPONSE TO M-CSF#0.7078;WILLINGNESS TO PAY#0.7073;CNS TOXICITY#0.7071;NEUROECTODERMAL TUMOR#0.7064;MITOSIS#0.7054;CETUXIMAB#0.7050;ENDOMETRIOSIS#0.7050;PROTEASOME#0.7045;GOOD MANUFACTURING PRACTICE#0.7045;OXIDATIVE METABOLISM#0.7040;RECEPTOR-LIGAND COMPLEX#0.7038;ANTIBODY PRODUCTION#0.7030;DNA REPAIR#0.7029;RECURRENT ENDOMETRIAL CANCER#0.7026;FUNCTIONAL DIFFERENTIATION#0.7025;HYALURONIC ACID#0.7025;BLOOD UREA NITROGEN#0.7022;DIABETIC RETINOPATHY#0.7021;RESPONSE TO GROWTH FACTOR#0.7010;ADJUVANT BREAST CANCER#0.7007;HYPERGLYCEMIA#0.7004;ACTIVATION OF MAP KINASE#0.7001;GROWTH REGULATED ONCOGENE#0.6994;RESPONSE TO IL-3#0.6988;THYMOGLOBULIN#0.6984;MYELOID DENDRITIC CELL#0.6982;COMPLEMENT CASCADE#0.6982;PKC ACTIVATION#0.6964;OSTEONECROSIS#0.6959;KNEE JOINT#0.6957;ADAPTIVE IMMUNE SYSTEM#0.6955;COMMON CAROTID ARTERY#0.6951;CEFEPIME#0.6948;AZACYTIDINE#0.6947;ENDOMETRIAL CARCINOMA#0.6939;ERYTHROPOIETIN STIMULATING AGENT#0.6938;PANCREATIC DUCTAL ADENOCARCINOMA#0.6938;ALVEOLAR EPITHELIAL CELL#0.6935;CYTOCHROME C RELEASE#0.6929;DERMAL FIBROBLAST#0.6913;DISABILITY STATUS SCALE#0.6911;PROTEIN PHOSPHORYLATION#0.6908;CAMPATH#0.6907;ESOPHAGEAL CARCINOMA#0.6907;DEATH RECEPTOR#0.6903;ALLOIMMUNIZATION#0.6899;QUANTITATIVE REVERSE TRANSCRIPTION#0.6896;PROTEIN TYROSINE PHOSPHATASE#0.6895;RENAL REPLACEMENT THERAPY#0.6891;AMPH-B#0.6888;CHANGE FROM BASELINE#0.6884;MELOXICAM#0.6879;HAS ACTIVITY#0.6874;FUNISITIS#0.6866;CHRONIC MYOCARDIAL INFARCTION#0.6864;TAXOL A#0.6864;PULMONARY EMBOLISM#0.6853;REPORTER GENE ASSAY#0.6852;R/AMP#0.6845;METASTATIC COLORECTAL CANCER#0.6843;CASPASE-3 ACTIVITY#0.6835;TRADITIONAL CHINESE MEDICINE#0.6827;TH2 IMMUNE RESPONSE#0.6825;PANCREATIC ADENOSQUAMOUS CARCINOMA#0.6815;POLYNEUROPATHY#0.6813;GAMMA DELTA T CELL#0.6800;GLUTATHIONE PEROXIDASE#0.6796;DRUG DELIVERY SYSTEM#0.6792;RECEPTOR TYROSINE KINASE#0.6790;WHIM SYNDROME#0.6781;CHRONIC HEPATITIS B#0.6771;HYPERSPLENISM#0.6767;CHLORAMPHENICOL#0.6767;NODULAR#0.6765;OXYGENASE#0.6761;CORD BLOOD TRANSPLANT#0.6759;RECURRENCE FREE SURVIVAL#0.6757;ATORVASTATIN#0.6756;PROTEIN BINDING#0.6748;CARDIAC MAGNETIC RESONANCE#0.6747;SIDEROBLASTIC ANEMIA#0.6747;ANKLE BRACHIAL INDEX#0.6739;WHOLE BONE MARROW#0.6736;MUSCLE FIBER#0.6732;POSACONAZOLE#0.6730;HUMAN WHOLE BLOOD#0.6724;SALIVARY GLAND#0.6711;OPTIC NERVE CRUSH#0.6710;SCLERODERMA#0.6705;INCLUSION BODY#0.6704;SEMINOMA#0.6701;SUBARACHNOID SPACE#0.6696;NAIVE T CELL#0.6677;LANGERHANS CELL#0.6676;MEMORY IMPAIRMENT#0.6675;MEMBRANE TYPE 1#0.6674;1α,25-DIHYDROXYVITAMIN D3#0.6670;LUNG EPITHELIAL CELL#0.6670;ARTERIOLE#0.6669;ONDANSETRON#0.6667;PEMETREXED#0.6660;EXTRACELLULAR REGION#0.6657;IL-2 PRODUCTION#0.6655;INDUCED PLURIPOTENT STEM CELL#0.6651;PERIPHERAL NERVE INJURY#0.6650;PARTURITION#0.6647;PARALYSIS#0.6647;PYREXIA#0.6644;TYROSINE KINASE 2#0.6640;OVARIAN SQUAMOUS CELL CARCINOMA#0.6636;SILDENAFIL#0.6636;TRANSMISSION ELECTRON MICROSCOPY#0.6629;PROTEIN KINASE INHIBITOR#0.6629;GENE SILENCING#0.6629;GLUCOSE METABOLISM#0.6627;TUMOR TISSUES#0.6624;EMBRYO DEVELOPMENT#0.6622;ETANERCEPT#0.6622;CAMPTOTHECIN#0.6614;COMPLEX I#0.6609;HEMATOPOIETIC TISSUES#0.6607;SUBSTANCE P#0.6605;DEHYDRATION#0.6602;MYELOID NEOPLASM#0.6601;INTERFERON STIMULATED GENE#0.6591;THYROID CANCER#0.6586;ACETYLCYSTEINE#0.6585;DIFFERENTIAL GENE EXPRESSION#0.6572;SYNOVIAL SARCOMA#0.6555;ANTI-VLA4#0.6555;NON OBESE DIABETIC#0.6554;TERATOMA#0.6552;LUNG DAMAGE#0.6549;NEUROMYELITIS OPTICA#0.6545;CHRONIC LEUKEMIA#0.6529;MEGAKARYOCYTE-ERYTHROID PROGENITOR#0.6527;RENATURATION#0.6525;DENDRITIC CELL DIFFERENTIATION#0.6525;RANDOMISED CLINICAL TRIALS#0.6525;LUNG LARGE CELL CARCINOMA#0.6521;AORTIC VALVE#0.6519;MICONAZOLE#0.6515;ELTROMBOPAG#0.6515;MYELOPROLIFERATIVE NEOPLASM#0.6508;SOLID ORGAN TRANSPLANTATION#0.6499;WHOLE BLOOD ASSAY#0.6492;COLORECTAL CARCINOMA#0.6483;STAUROSPORINE#0.6482;MONOCYTE DIFFERENTIATION#0.6475;PEROXISOME#0.6475;CARDIAC MUSCLE#0.6472;ADRENERGIC RECEPTOR#0.6471;BONE MARROW CELL PROLIFERATION#0.6467;SULFAMETHOXAZOLE & TRIMETHOPRIM#0.6459;MITOGENIC ACTIVITY#0.6456;CYTOMETRIC BEAD ARRAY#0.6452;INTERLEUKIN-6 PRODUCTION#0.6449;SUSTAINED VIROLOGIC RESPONSE#0.6448;GINGIVITIS#0.6445;CYTOCHROME P450#0.6444;OVARIES#0.6441;EXOSOME#0.6441;VARICELLA ZOSTER VIRUS#0.6439;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.6436;CELL POLARIZATION#0.6429;M1 MACROPHAGE#0.6424;INTERFERON GAMMA PRODUCTION#0.6417;HUMAN DENDRITIC CELL#0.6417;SUCRALFATE#0.6410;CHOLANGIOCARCINOMA#0.6404;REGULATION OF APOPTOSIS#0.6396;ACETIC ACID#0.6394;EOSINOPHILIC PNEUMONIA#0.6389;RITODRINE#0.6386;NORMAL CONTROL GROUP#0.6383;PROTON PUMP#0.6378;N-ACETYLCYSTEINE#0.6370;CELLULAR GROWTH#0.6369;CRYPTOCOCCAL MENINGITIS#0.6369;ADVERSE DRUG EVENT#0.6368;FERMENTATION#0.6367;CICLOSPORIN#0.6366;CASPOFUNGIN#0.6361;LINEAR REGRESSION ANALYSIS#0.6360;DONOR SELECTION#0.6355;DORSAL ROOT GANGLION#0.6352;PERICYTE#0.6351;NEURONAL CELLS#0.6347;DIED OF DISEASE#0.6345;ASCORBIC ACID#0.6343;PHOSPHOLIPASE C#0.6341;ADULT SOFT TISSUE SARCOMA#0.6339;FERRITIN LIGHT CHAIN#0.6330;IL-17 SECRETION#0.6323;DIPHOSPHATE#0.6320;ESSENTIAL THROMBOCYTHEMIA#0.6308;DANAZOL#0.6307;NATALIZUMAB#0.6305;METRONIDAZOLE#0.6273;LIPOPOLYSACCHARIDE BINDING#0.6267;CELLULAR ADHESION MOLECULE#0.6265;HEALTH CARE SYSTEM#0.6264;GALL BLADDER#0.6246;EFFECTOR MEMORY T CELL#0.6245;BURKITT LYMPHOMA#0.6243;HEMOLYTIC UREMIC SYNDROME#0.6238;VISUAL ANALOG SCALE#0.6235;SPLENIC INFARCTION#0.6230;GUANOSINE#0.6221;INTEGRIN ACTIVATION#0.6219;GRANULOMATOUS DERMATITIS#0.6218;LARYNX#0.6217;YOLK SAC#0.6216;L-LYSINE#0.6213;SPINAL CORD INJURIES#0.6207;INTRAHEPATIC CHOLANGIOCARCINOMA#0.6197;CEREBROVASCULAR DISEASE#0.6195;MYOSIN HEAVY CHAIN#0.6187;HEMOSTASIS#0.6182;PROPRANOLOL#0.6181;CARDIAC ARREST#0.6173;HOMOLOGOUS RECOMBINATION#0.6171;CALCINEURIN#0.6170;ENDOSOME#0.6166;MACROPHAGE POLARIZATION#0.6163;ETHAMBUTOL#0.6159;BILE DUCT#0.6157;LIPOSARCOMA#0.6156;TARGET OF RAPAMYCIN#0.6155;SICKLE CELL ANEMIA#0.6153;ANGIOGENIC GROWTH FACTORS#0.6148;CARDIOTOXIN#0.6148;JOINT PAIN#0.6147;THYMIC EPITHELIAL CELLS#0.6144;MEDIASTINUM#0.6143;MULTIPOTENT STEM CELL#0.6141;ACETYLCHOLINE#0.6139;HUMAN AIRWAY EPITHELIAL#0.6138;IBUPROFEN#0.6133;MOXIFLOXACIN#0.6129;GALLIUM NITRATE#0.6128;WILCOXON RANK SUM#0.6128;PEPTIDOGLYCAN#0.6119;PERTUSSIS#0.6119;COLLAGENASE#0.6116;ADENYLATE CYCLASE#0.6109;OLIGODENDROCYTE#0.6107;NEURONAL STEM CELL#0.6105;THORACIC AORTA#0.6098;C TERMINAL DOMAIN#0.6090;FOLIC ACID#0.6085;NEURONAL CELL DEATH#0.6081;HISTONE MODIFICATION#0.6078;NASAL MUCOSA#0.6077;INVASIVE PULMONARY ASPERGILLOSIS#0.6065;BARE METAL STENT#0.6047;ADVANCED LIVER DISEASE#0.6046;GINSENG#0.6044;LUNG TRANSPLANT RECIPIENTS#0.6043;DIPHTHERIA#0.6041;AQUAPORIN#0.6036;LEUKOCYTE DIFFERENTIATION#0.6034;PARESTHESIA#0.6024;PERITONEAL MESOTHELIAL CELLS#0.6023;PERICARDIAL MESOTHELIOMA#0.6022;BREAST CONSERVING SURGERY#0.6021;CEFUROXIME#0.6020;PERICARDIAL EFFUSION#0.6018;LARGE VESSEL VASCULITIS#0.6012;PIPERACILLIN#0.6004;LIPID METABOLISM#0.6003
144100	PRIMARY ANGLE-CLOSURE GLAUCOMA#1.0795;PRIMARY ANGLE CLOSURE#1.0777;ADHERENS JUNCTION#1.0773;ANGLE-CLOSURE GLAUCOMA#1.0733;EPITHELIAL CELL#1.0234;TIGHT JUNCTION#0.8887;HYPERTENSION#0.8265;ZONULA ADHAERENS#0.7924;PROTEIN COMPLEX#0.7078;ZONULA ADHERENS#0.7061;MICROTUBULE#0.6842;CYTOSKELETAL ADAPTOR#0.6808;APICAL JUNCTIONAL COMPLEX#0.6770;ENDOTHELIUM#0.6556;METANEPHRIC ADENOMA#0.6194
144108	HISTONE CHAPERONE#0.8918;DNA BINDING#0.8125;NUCLEOSOME#0.7336;HISTONE BINDING#0.6456;CASEIN KINASE 2#0.6333
144125	OLFACTORY RECEPTOR#0.7030;HUMAN OLFACTORY RECEPTOR#0.6764
144165	CELL POLARITY#1.0365;PLANAR CELL POLARITY#1.0347;EPILEPSY#0.9924;PCP PATHWAY#0.9787;SIGNALING PATHWAY#0.9322;GENE EXPRESSION#0.8821;NEURITE#0.7771;PROGRESSIVE MYOCLONUS EPILEPSY#0.7411;CELL MIGRATION#0.7383;SIGNALING MOLECULE#0.7174;NEURITE OUTGROWTH#0.7147;NEUROBLASTOMA#0.7007;TRANSCRIPTION FACTOR#0.6873;NEURAL TUBE#0.6693;CELL GROWTH#0.6459;CLEFT PALATE#0.6271;BREAST CANCER#0.6204;AUTISM SPECTRUM DISORDER#0.6157;ROBINOW SYNDROME#0.6132;WNT SIGNALING PATHWAY#0.6120;NERVOUS SYSTEM#0.6116;FOCAL ADHESION#0.6106;EYELID#0.6057;CANCER CELL#0.6017
144195	DEHYDROASCORBIC ACID#0.6881;CREATINE METABOLISM#0.6631;INFLAMMATORY BOWEL DISEASE#0.6533;ALZHEIMER'S DISEASE#0.6479
1441	CHRONIC NEUTROPHILIC LEUKEMIA#1.0573;G-CSF#1.0402;ATYPICAL CHRONIC MYELOID LEUKEMIA#1.0328;SEVERE CONGENITAL NEUTROPENIA#1.0187;ONCOGENIC#1.0186;RECEPTOR BINDING#1.0181;RESPONSE TO G-CSF#1.0106;CHRONIC MYELOID LEUKEMIA#1.0076;RECEPTOR AGONIST#1.0070;MYELOID CELL#1.0070;POLYMERASE CHAIN REACTION#1.0058;ACUTE MYELOID LEUKEMIA#1.0023;GM-CSF#1.0006;NEUTROPENIA#0.9988;SIGNAL TRANSDUCTION#0.9983;MYELOID LEUKEMIA#0.9982;CYTOPLASMIC REGION#0.9965;CYTOKINE RECEPTOR#0.9951;CELL SURFACE#0.9939;MYELOPROLIFERATIVE NEOPLASM#0.9906;PROGENITOR CELL#0.9892;MYELODYSPLASTIC SYNDROME#0.9829;NEUTROPHIL#0.9809;HEMATOPOIETIC CELL#0.9806;SIGNAL TRANSDUCER#0.9800;APOPTOSIS#0.9776;MACROPHAGE#0.9757;STEM CELL#0.9747;GROWTH FACTOR#0.9739;CELL PROLIFERATION#0.9727;PERIPHERAL BLOOD#0.9714;SIGNALING PATHWAY#0.9701;COLONY-STIMULATING FACTOR#0.9699;BONE MARROW#0.9695;BONE MARROW CELLS#0.9676;GRANULOCYTE#0.9657;GRANULOCYTE COLONY STIMULATING FACTOR#0.9648;GENE EXPRESSION#0.9608;T CELL#0.9593;MONOCYTE#0.9588;HEMATOPOIETIC STEM CELL#0.9540;CELL CYCLE#0.9425;TRANSCRIPTION FACTOR#0.9290;PROTEIN KINASE#0.9088;HEMATOPOIESIS#0.9068;LEUKOCYTE#0.8969;MAP KINASE#0.8852;HEMATOPOIETIC PROGENITOR CELL#0.8816;TUMOR CELLS#0.8697;RUXOLITINIB#0.8696;CORD BLOOD#0.8675;PRECURSOR CELL#0.8659;ACUTE LEUKEMIA#0.8583;TUMOR NECROSIS FACTOR#0.8540;MONONUCLEAR CELLS#0.8518;G-CSF BINDING#0.8400;GROWTH FACTOR RECEPTOR#0.8369;RECEPTOR COMPLEX#0.8328;MYELOID NEOPLASM#0.8280;CELL GROWTH#0.8257;WORLD HEALTH ORGANIZATION#0.8174;RETINOIC ACID#0.8145;STEM CELL TRANSPLANTATION#0.8057;DENDRITIC CELL#0.7933;KINASE INHIBITOR#0.7932;CENTRAL NERVOUS SYSTEM#0.7843;NERVOUS SYSTEM#0.7833;CANCER CELL#0.7820;BONE MARROW FAILURE#0.7791;B CELL#0.7771;GROWTH HORMONE#0.7769;ENDOTHELIAL CELL#0.7766;IMMUNE RESPONSE#0.7634;G-CSF PRODUCTION#0.7619;CHRONIC MYELOMONOCYTIC LEUKEMIA#0.7570;BLAST CELL#0.7543;ALL TRANS RETINOIC ACID#0.7526;REVERSE TRANSCRIPTION#0.7391;APOPTOTIC#0.7326;CELL ACTIVATION#0.7254;PROTEIN TYROSINE KINASE#0.7232;CELL DEATH#0.7228;INTRACELLULAR PART#0.7084;TRANSCRIPTASE#0.7054;MYELOID PROGENITOR CELL#0.7005;ENHANCER BINDING#0.6803;SURFACE PLASMON RESONANCE#0.6719;WHITE BLOOD CELL#0.6668;GLYCOSYLATION#0.6652;STEM CELL FACTOR#0.6645;ENHANCER BINDING PROTEIN#0.6527;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6520;ACUTE MYELOID LEUKAEMIA#0.6333;SQUAMOUS CELL CARCINOMA#0.6249;NEUTROPHIL DIFFERENTIATION#0.6122;CYCLIC HEMATOPOIESIS#0.6100;PROMYELOCYTE#0.6006
144203	OVARIAN CANCER#0.7242;CELL MIGRATION#0.6738;CELL PROLIFERATION#0.6681
144233	RNA METHYLTRANSFERASE#1.0992;BREAST CANCER#1.0394
144245	DOFETILIDE#0.8216;GLYCOSYLATION#0.7010
1442	OESTRIOL#1.0833;ESTRIOL#1.0549;PLASMA PROTEIN#1.0436;ALKALINE PHOSPHATASE#1.0417;CYCLOSPORINE#1.0288;PROGESTERONE#1.0254;ESTRADIOL#1.0174;INSULIN-LIKE GROWTH FACTOR#1.0161;LATE PREGNANCY#1.0107;GROWTH FACTOR#1.0077;TROPHOBLAST CELL#1.0067;GROWTH HORMONE#1.0067;AMNIOTIC FLUID#1.0045;SYNCYTIOTROPHOBLAST#0.9903;PROLACTIN RECEPTOR#0.9894;TROPHOBLAST#0.9870;CELL PROLIFERATION#0.9860;FACTOR I#0.9804;CYTOTROPHOBLAST#0.9783;MAMMARY GLAND#0.9769;GENE EXPRESSION#0.9764;CHORIOCARCINOMA#0.9756;GESTATION#0.9747;DIABETES MELLITUS#0.9746;TUMOR CELLS#0.9628;OESTRADIOL#0.9612;CORTISOL#0.9537;HIGH DENSITY LIPOPROTEIN#0.9478;FETAL GROWTH RETARDATION#0.9334;GERM CELL#0.9317;PRE-ECLAMPSIA#0.9229;RECEPTOR BINDING#0.9211;TRANSCRIPTION FACTOR#0.9165;TESTOSTERONE#0.9144;PITUITARY GROWTH HORMONE#0.9132;PLACENTAL SITE TROPHOBLASTIC TUMOR#0.9117;POLYMERASE CHAIN REACTION#0.9064;GESTATIONAL DIABETES#0.9061;EPIDERMAL GROWTH FACTOR#0.8913;ECLAMPSIA#0.8836;OVARIAN#0.8829;DOPAMINE#0.8792;ESTROGENS#0.8777;INSULIN SECRETION#0.8736;BETA CELL#0.8609;PROTEIN KINASE#0.8578;PANCREATIC ISLET#0.8280;FOLLICLE STIMULATING HORMONE#0.8257;CELL SURFACE#0.8075;BREAST CANCER#0.8065;HYPERTENSION#0.8043;PLACENTAL INSUFFICIENCY#0.8019;UTERUS#0.7980;CELL MEMBRANE#0.7939;REVERSE TRANSCRIPTION#0.7895;PLACENTAL DEVELOPMENT#0.7883;MOLAR#0.7706;GROWTH HORMONE RECEPTOR#0.7682;ADIPOSE TISSUE#0.7642;DNA SYNTHESIS#0.7569;CYCLOSPORIN#0.7560;RETINOIC ACID#0.7390;T CELL#0.7357;ENDOMETRIUM#0.7352;DEXAMETHASONE#0.7328;EPITHELIAL CELL#0.7295;FETAL DISTRESS#0.7273;THYMIDINE#0.7218;MACROPHAGE#0.7172;GESTATIONAL DIABETES MELLITUS#0.7133;TACROLIMUS#0.7114;INHIBIN#0.7073;LACTATION#0.7056;SODIUM DODECYL SULFATE#0.7010;DODECYL SULFATE#0.7009;DECIDUA#0.6979;PROTEIN SYNTHESIS#0.6978;SIGNAL TRANSDUCTION#0.6964;DIGESTION#0.6962;MONOCYTE#0.6938;BROMOCRIPTINE#0.6921;TROPHOBLASTIC NEOPLASM#0.6920;SMOOTH MUSCLE#0.6896;ARTERY#0.6891;B CELL#0.6785;HORMONE BINDING#0.6758;MALARIA#0.6746;CYCLIC AMP#0.6737;GLUCOSE METABOLISM#0.6695;SIGNALING PATHWAY#0.6682;APOPTOSIS#0.6674;GROWTH FACTOR RECEPTOR#0.6639;CANCER CELL#0.6521;EXCRETION#0.6519;SILVER RUSSELL SYNDROME#0.6461;GERM CELL TUMORS#0.6251;PERIPHERAL BLOOD#0.6228;PARATHYROID HORMONE#0.6142;ENDOTHELIAL GROWTH FACTOR#0.6127;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6127;CALCINEURIN#0.6110;CELL DIFFERENTIATION#0.6107;FETAL GROWTH RESTRICTION#0.6103;PROLACTIN SECRETION#0.6053
144321	MULTIPLE MYELOMA#0.9074
144347	SKELETAL DEVELOPMENT#0.6952
144348	ORGAN OF CORTI#0.6502;ZINC FINGER PROTEIN#0.6386
1443	BETA CELL#1.0478;MAMMARY GLAND#1.0057;GROWTH HORMONE#1.0055;PROLACTIN RECEPTOR#0.9653;GENE EXPRESSION#0.9493;RECEPTOR BINDING#0.9448;PROGESTERONE#0.9440;CELL PROLIFERATION#0.9439;INSULIN SECRETION#0.9425;EPITHELIAL CELL#0.8781;GROWTH FACTOR#0.8776;TROPHOBLAST#0.8532;GESTATION#0.8176;MITOGENIC ACTIVITY#0.8021;SIGNAL TRANSDUCTION#0.8012;BREAST CANCER#0.7967;CELL MEMBRANE#0.7905;APOPTOSIS#0.7854;CAM BINDING#0.7759;MAMMARY EPITHELIAL CELL#0.7709;CELL SURFACE#0.7217;CELL CYCLE#0.7210;MAP KINASE#0.6946;TROPHOBLAST CELL#0.6920;CANCER CELL#0.6604;CELL GROWTH#0.6490;ADIPOSE TISSUE#0.6313;PROTEIN KINASE#0.6304;PROTEIN BINDING#0.6259;TROPHOBLAST GIANT CELLS#0.6246;TESTOSTERONE#0.6154;TRANSCRIPTION FACTOR#0.6153;FUNCTIONAL DIFFERENTIATION#0.6115;LH RECEPTOR#0.6095;PITUITARY GROWTH HORMONE#0.6061;HORMONE BINDING#0.6045;CORPUS LUTEUM#0.6018
144406	EPITHELIAL MESENCHYMAL TRANSITION#0.8242;ESOPHAGEAL SQUAMOUS CARCINOMA#0.6686;CELL PROLIFERATION#0.6610;SQUAMOUS CELL CARCINOMA#0.6192;BREAST CANCER#0.6148
144453	SMOOTH MUSCLE#0.9345;SMOOTH MUSCLE CELL#0.8109;MUSCLE CELL#0.8102;ENDOPLASMIC RETICULUM#0.6856;VASCULAR SMOOTH MUSCLE CELL#0.6652;CHLORIDE CHANNEL#0.6622
144455	DNA BINDING#1.0288;TRANSCRIPTION FACTOR#1.0219;CELL CYCLE#1.0178;CELL PROLIFERATION#0.9834;S PHASE#0.9450;GENE EXPRESSION#0.8955;BREAST CANCER#0.8823;APOPTOSIS#0.8790;TUMOR SUPPRESSOR#0.8134;CANCER CELL#0.8082;SQUAMOUS CELL CARCINOMA#0.8081;CELL CYCLE ARREST#0.8048;DNA REPAIR#0.8047;DRUG RESISTANCE#0.7483;SIGNALING PATHWAY#0.7401;DNA DAMAGE RESPONSE#0.7114;KERATINOCYTE#0.6965;CELL GROWTH#0.6690;DOXORUBICIN#0.6448;ANGIOGENESIS#0.6443;DNA REPLICATION#0.6364;STEM CELL#0.6173;ONCOGENIC#0.6038;CELL DEATH#0.6001
144481	PROSTATE CANCER#0.9014;CELL GROWTH#0.8991;CANCER CELL#0.8953;APOPTOSIS#0.6411
1444	GROWTH HORMONE#1.0374
144501	COLORECTAL CARCINOMA#0.6288
144568	TOPOISOMERASE II#1.0422;OTITIS MEDIA#1.0364;DRUG RESISTANCE#1.0174;TOPOISOMERASE#1.0134;CANCER CELL#0.9988;TUMOR CELLS#0.9765;BREAST CANCER#0.9720;EFFLUX PUMP#0.9698;ACUTE LEUKEMIA#0.9579;VERAPAMIL#0.9573;MULTI DRUG RESISTANCE#0.9551;GROWTH FACTOR#0.9496;PLASMA MEMBRANE#0.9492;DOXORUBICIN#0.9381;APOPTOSIS#0.9365;CYTOTOXICITY#0.9283;TRANSLATION INITIATION#0.9254;BONE MARROW#0.9152;CELL CYCLE#0.9142;TRANSLATION INITIATION FACTOR#0.8697;MIDDLE EAR#0.8636;LUNG CANCER#0.8490;EPIDERMAL GROWTH FACTOR#0.8432;PROTEIN KINASE#0.8274;VINCRISTINE#0.8272;ALPHA-2 MACROGLOBULIN#0.8266;VARICELLA ZOSTER VIRUS#0.8217;BREAST CANCER CELL#0.8198;GLUTATHIONE#0.7917;GROWTH FACTOR RECEPTOR#0.7897;APOPTOTIC#0.7782;HUMAN BREAST CANCER#0.7690;CELL SURFACE#0.7646;MULTIDRUG RESISTANCE PROTEIN#0.7618;BLAST CELL#0.7608;CELL PROLIFERATION#0.7473;ADRIAMYCIN#0.7467;DAUNORUBICIN#0.7391;CELL GROWTH#0.7294;MONONUCLEAR CELLS#0.7294;OVARIAN#0.7227;MULTIPLE MYELOMA#0.7149;OVARIAN CANCER#0.7124;IDARUBICIN#0.6927;EUKARYOTIC INITIATION FACTOR#0.6885;CYTOPLASM#0.6601;MYELOID LEUKEMIA#0.6539;DNA TOPOISOMERASE#0.6299;MEMBRANE TRANSPORT#0.6206;GENE EXPRESSION#0.6150;GLUTATHIONE TRANSFERASE#0.6075;MULTIDRUG TRANSPORT#0.6063;STATIONARY PHASE#0.6031
1445	KINASE ACTIVITY#1.0106;PROTEIN KINASE C#1.0104;LIPID RAFT#1.0101;T CELL#1.0058;FOCAL ADHESION KINASE#1.0055;BREAST CANCER CELL#1.0025;MAP KINASE#1.0020;B CELL#1.0000;TYROSINE KINASE INHIBITOR#0.9973;KINASE INHIBITOR#0.9970;SRC FAMILY KINASE#0.9962;PROTEIN TYROSINE KINASE#0.9956;CATALYTIC ACTIVITY#0.9955;BREAST CANCER#0.9943;FOCAL ADHESION#0.9938;PROTEIN TYROSINE PHOSPHATASE#0.9932;MITOGEN ACTIVATED PROTEIN#0.9909;GROWTH FACTOR RECEPTOR#0.9876;PLASMA MEMBRANE#0.9874;DEPHOSPHORYLATION#0.9869;CANCER CELL#0.9820;CELL GROWTH#0.9819;EPIDERMAL GROWTH FACTOR#0.9812;PROTEIN KINASE#0.9810;EPITHELIAL CELL#0.9797;CELL PROLIFERATION#0.9789;CELL MIGRATION#0.9785;ENDOTHELIAL CELL#0.9784;RECEPTOR TYROSINE KINASE#0.9777;CELL ACTIVATION#0.9719;GROWTH FACTOR#0.9715;SIGNAL TRANSDUCTION#0.9706;HYPERTENSION#0.9700;CELL ADHESION#0.9694;GENE EXPRESSION#0.9684;SMOOTH MUSCLE#0.9683;APOPTOSIS#0.9680;SIGNALING PATHWAY#0.9666;SIGNALING MOLECULE#0.9640;COLON CANCER#0.9562;PLATELET-DERIVED GROWTH FACTOR#0.9509;OSTEOCLAST#0.9479;DOMINANT NEGATIVE MUTANT#0.9448;BONE RESORPTION#0.9371;ONCOGENIC#0.9270;T CELL ACTIVATION#0.9267;MACROPHAGE#0.9263;MUSCLE CELL#0.9248;TUMOR CELLS#0.9148;SIGNAL TRANSDUCER#0.9132;CELL CYCLE#0.9081;ESTROGEN RECEPTOR#0.9044;HUMAN BREAST CANCER#0.8986;TOLL LIKE RECEPTOR#0.8985;CELL SURFACE#0.8977;NITRIC OXIDE#0.8943;ACTIN CYTOSKELETON#0.8864;SMOOTH MUSCLE CELL#0.8852;TRANSCRIPTION FACTOR#0.8820;REACTIVE OXYGEN SPECIES#0.8815;ANCHORAGE INDEPENDENT GROWTH#0.8800;NERVOUS SYSTEM#0.8773;CELL DEATH#0.8772;NEURITE OUTGROWTH#0.8707;FIBROBLAST GROWTH FACTOR#0.8702;EXTRACELLULAR MATRIX#0.8689;NADPH OXIDASE#0.8687;CELL MOTILITY#0.8647;T LYMPHOCYTE#0.8583;MONOCYTE#0.8556;PROTEIN KINASE A#0.8547;PHOSPHOLIPASE C#0.8534;SIGNALING CASCADE#0.8318;MAPK ACTIVATION#0.8288;SIGNALLING PATHWAY#0.8263;PHOSPHATASE ACTIVITY#0.8255;ENDOTHELIAL GROWTH FACTOR#0.8206;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8206;STEM CELL#0.8190;IMMUNE RESPONSE#0.8188;STRUCTURE ACTIVITY RELATIONSHIP#0.8117;APOPTOTIC#0.8095;HEAT SHOCK PROTEIN#0.8090;NEURITE#0.8037;MITOSIS#0.8034;BREAST CARCINOMA#0.7978;ADENOCARCINOMA#0.7881;COLON CARCINOMA#0.7798;KERATINOCYTE#0.7742;CELL MEMBRANE#0.7738;ANGIOGENESIS#0.7733;MUTAGENESIS#0.7693;TOXICITY#0.7594;PHOSPHATASE INHIBITOR#0.7529;FOCAL CONTACT#0.7515;TUMOR SUPPRESSOR#0.7506;DNA SYNTHESIS#0.7463;MOLECULAR DYNAMICS SIMULATION#0.7420;CALCIUM CHANNEL#0.7356;STROMAL CELL#0.7321;OVARIAN#0.7297;ESTROGEN RECEPTOR ALPHA#0.7286;HEMATOPOIETIC CELL#0.7250;TRANSFORMING GROWTH FACTOR#0.7211;DNA BINDING#0.7148;TRANSACTIVATION#0.7123;ATP BINDING#0.7119;PROTEIN PROTEIN INTERACTION#0.7116;INTESTINAL EPITHELIAL CELL#0.7070;CAVEOLAE#0.7070;MEMBRANE FRACTION#0.7033;PROTEIN TYROSINE KINASE ACTIVITY#0.7023;GELDANAMYCIN#0.6986;EPITHELIAL MESENCHYMAL TRANSITION#0.6853;INSULIN RECEPTOR#0.6743;AUTOIMMUNITY#0.6741;RNA INTERFERENCE#0.6740;RECEPTOR ANTAGONIST#0.6709;TUMOR NECROSIS FACTOR#0.6536;GENISTEIN#0.6481;MECHANISM OF ACTION#0.6448;NITRIC OXIDE SYNTHASE#0.6437;PERIPHERAL BLOOD#0.6417;BONE MARROW#0.6408;ESTRADIOL#0.6399;CELL DEVELOPMENT#0.6279;AUTOIMMUNE DISEASE#0.6265;PARATHYROID HORMONE#0.6262;ADIPOSE TISSUE#0.6220;VASCULAR SMOOTH MUSCLE CELL#0.6131;CHANNEL INHIBITOR#0.6117;ENDOPLASMIC RETICULUM#0.6107;CHLORIDE CHANNEL#0.6074;KINASE BINDING#0.6027;MAPK SIGNALING#0.6023;DASATINIB#0.6020
144699	UBIQUITIN#0.8106;LEUCINE RICH REPEAT#0.6889;BONE REGENERATION#0.6340;BREAST CANCER#0.6148
1446	MILK PROTEIN#1.0179;GENE EXPRESSION#0.9875;MAMMARY GLAND#0.9827;LACTATION#0.9728;COAGULATION#0.8574;PROTEIN SYNTHESIS#0.8313;EPITHELIAL CELL#0.8205;MAMMARY EPITHELIAL CELL#0.8128;GM-CSF#0.7669;LACTOSE#0.7043;PROTEIN KINASE#0.6128
144715	SPINA BIFIDA#0.6914;G1 PHASE#0.6659
1447	MILK PROTEIN#1.0200;GENE EXPRESSION#0.9979;MAMMARY EPITHELIAL CELL#0.9846;MAMMARY GLAND#0.9844;EPITHELIAL CELL#0.9821;LACTATION#0.8786;SIGNALING PATHWAY#0.8621;COAGULATION#0.8226;PROTEIN SYNTHESIS#0.7597;CELL GROWTH#0.7377;CELL PROLIFERATION#0.7354;TRANSCRIPTION FACTOR#0.7350;LACTOSE#0.7314;POLYMERASE CHAIN REACTION#0.7311;PROLACTIN RECEPTOR#0.7291;DAYS IN MILK#0.7142;SIGNAL TRANSDUCER#0.6861;GROWTH FACTOR#0.6360
144811	LEPROSY#1.0137;JUVENILE IDIOPATHIC ARTHRITIS#0.9820;CROHN'S DISEASE#0.9751;MACROPHAGE#0.8294;INFLAMMATORY BOWEL DISEASE#0.7674
1448	MILK PROTEIN#1.0126;GENE EXPRESSION#0.9416;COAGULATION#0.9400;MAMMARY GLAND#0.8642;POLYMERASE CHAIN REACTION#0.8255;DAYS IN MILK#0.7393;LACTATION#0.6957;EPITHELIAL CELL#0.6869;MAMMARY EPITHELIAL CELL#0.6655;LACTOSE#0.6554;TRANSCRIPTION FACTOR#0.6085
145173	PETERS PLUS SYNDROME#1.1572;UDP-GAL#0.8802;PETERS ANOMALY#0.8539;GLYCOSYLATION#0.8486;GLCNAC#0.7523;O GLYCAN#0.7280
145226	RETINOL DEHYDROGENASE#1.0863;RETINOL#1.0706;LEBER CONGENITAL AMAUROSIS#1.0593;RETINAL DEGENERATION#1.0585;AMAUROSIS#1.0483;PHOTORECEPTOR CELL#1.0033;RETINITIS PIGMENTOSA#0.9858;RETINITIS#0.9149;RETINOIC ACID#0.9089;PHOTORECEPTOR INNER SEGMENT#0.7986;RETINAL DISEASE#0.7910;OPTICAL COHERENCE TOMOGRAPHY#0.7741;RETINAL DEHYDROGENASE#0.7444;ALL-TRANS-RETINOL#0.7128;TRANS-RETINOL#0.7126;CELL DEATH#0.7046;APOPTOSIS#0.6239;RETINOL BINDING#0.6146
145258	TRANSCRIPTION FACTOR#1.0316;PRIMITIVE STREAK#0.9630;CRANIOFACIAL DEVELOPMENT#0.8465;STEM CELL#0.8406;TYMPANIC RING#0.8069;GASTRULATION#0.7903;GENE EXPRESSION#0.7715;CELL MIGRATION#0.7666;GROWTH FACTOR#0.6862;EMBRYONIC STEM CELL#0.6542;NERVOUS SYSTEM#0.6117;DNA BINDING#0.6047
145264	SERPIN#1.0748;RETINOL BINDING#1.0667;RETINOL#1.0620;VISCERAL ADIPOSE TISSUE#1.0585;C REACTIVE PROTEIN#1.0581;GESTATIONAL DIABETES#1.0554;APOPTOSIS#1.0554;FASTING PLASMA GLUCOSE#1.0547;CORONARY ARTERY#1.0528;GESTATIONAL DIABETES MELLITUS#1.0488;TUMOR NECROSIS FACTOR#1.0472;GENE EXPRESSION#1.0429;LOW DENSITY LIPOPROTEIN#1.0400;SMOOTH MUSCLE#1.0379;CORONARY ARTERY DISEASE#1.0325;POLYCYSTIC OVARY SYNDROME#1.0315;FATTY LIVER#1.0310;ROS GENERATION#1.0288;ARTERY DISEASE#1.0285;ARTERY#1.0282;OBESE#1.0263;TYPE 2 DIABETES MELLITUS#1.0256;2 DIABETES MELLITUS#1.0256;WEIGHT LOSS#1.0250;ENDOTHELIAL CELL#1.0244;ATHEROSCLEROSIS#1.0242;GLUCOSE METABOLISM#1.0233;INSULIN RESISTANCE INDEX#1.0210;HIGH DENSITY LIPOPROTEIN#1.0207;METFORMIN#1.0185;TYPE 2 DIABETES#1.0180;ADIPOSE TISSUE#1.0180;ADIPOCYTE#1.0177;LIPID METABOLISM#1.0169;DIABETES MELLITUS#1.0163;TYPE 2 DIABETIC#1.0138;SIGNALING PATHWAY#1.0108;SMOOTH MUSCLE CELL#1.0098;LIVER DISEASE#1.0096;MUSCLE CELL#1.0063;FATTY LIVER DISEASE#1.0052;FATTY ACID BINDING#1.0045;HIGH FAT DIET#0.9914;GROWTH FACTOR#0.9863;VASCULAR SMOOTH MUSCLE CELL#0.9820;WHITE ADIPOSE TISSUE#0.9813;INFLAMMATORY RESPONSE#0.9796;SUBCUTANEOUS ADIPOSE TISSUE#0.9727;PROTEIN KINASE#0.9515;SYSTOLIC BLOOD PRESSURE#0.9364;NONALCOHOLIC FATTY LIVER DISEASE#0.9274;ANOREXIA NERVOSA#0.9236;NITRIC OXIDE#0.9127;VASCULAR CELL#0.9065;POLYMERASE CHAIN REACTION#0.9052;PSORIASIS#0.8912;VASCULAR ENDOTHELIAL CELL#0.8869;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8737;MONOCYTE#0.8672;HYPERTENSION#0.8561;PRO-INFLAMMATORY#0.8543;ACUTE MYOCARDIAL INFARCTION#0.8465;MULTIPLE REGRESSION ANALYSIS#0.8423;MYOCARDIAL INFARCTION#0.8367;ATHEROSCLEROTIC#0.8338;AND VISCERAL FAT#0.8319;CARDIOVASCULAR RISK FACTOR#0.8287;FIBROBLAST GROWTH FACTOR#0.8250;REACTIVE OXYGEN SPECIES#0.8126;GLOMERULAR FILTRATION RATE#0.8013;ACUTE CORONARY SYNDROME#0.8012;GLOMERULAR FILTRATION#0.8009;ANOREXIA#0.8007;SIGNALLING PATHWAY#0.7957;GLUCOSE INTOLERANCE#0.7796;LINEAR REGRESSION ANALYSIS#0.7771;SOLUBLE LEPTIN RECEPTOR#0.7743;TUMOUR NECROSIS FACTOR#0.7731;MACROPHAGE#0.7716;ENDOMETRIAL CANCER#0.7542;FASTING BLOOD GLUCOSE#0.7492;CORD BLOOD#0.7491;HUMAN UMBILICAL VEIN#0.7478;UMBILICAL VEIN#0.7474;PLASMA MEMBRANE#0.7409;NORMAL GLUCOSE TOLERANCE#0.7381;ALCOHOLIC FATTY LIVER#0.7356;INTIMA MEDIA THICKNESS#0.7306;PROTEIN KINASE B#0.7283;SKELETAL MUSCLE#0.7267;WAIST HIP RATIO#0.7026;MULTIVARIATE LINEAR REGRESSION#0.7022;INSULIN SENSITIVITY INDEX#0.6914;HEPATITIS C#0.6903;GINGIVAL CREVICULAR FLUID#0.6851;MESENTERIC ARTERY#0.6808;PERIPHERAL BLOOD#0.6701;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6689;MONONUCLEAR CELLS#0.6673;DIURNAL#0.6533;INSULIN RECEPTOR#0.6520;PERIODONTITIS#0.6394;IMPAIRED GLUCOSE TOLERANCE#0.6379;BONE MINERAL DENSITY#0.6320;HEPARIN BINDING#0.6312;WEIGHT GAIN#0.6311;EPICARDIAL ADIPOSE TISSUE#0.6290;POSTPRANDIAL PLASMA GLUCOSE#0.6278;MESENTERIC ADIPOSE TISSUE#0.6262;NEPHROPATHY#0.6251;ENDOPLASMIC RETICULUM#0.6245;SLEEP APNEA#0.6147;PEROXISOME#0.6139;OMENTAL ADIPOSE TISSUE#0.6133;CORONARY ARTERY STENOSIS#0.6130;PROTEINASE INHIBITOR#0.6123;ABDOMINAL ADIPOSE TISSUE#0.6116;ENDOPLASMIC RETICULUM STRESS#0.6107;VERY-LOW-DENSITY LIPOPROTEIN#0.6095;BODY FAT MASS#0.6004
145270	BREAST CANCER CELL#1.0350;TUMOR CELLS#1.0318;CELL DEATH#1.0297;APOPTOSIS#1.0281;BREAST CANCER#1.0281;AORTIC VALVE#1.0227;ANCHORING#1.0190;MYOCARDIAL INFARCTION#1.0188;CANCER CELL#1.0171;FOLLICULAR LYMPHOMA#0.9983;CELL MEMBRANE#0.9926;TUMOR SUPPRESSOR#0.9708;AORTIC VALVE REPLACEMENT#0.9554;CELL CYCLE#0.9453;DNA BINDING#0.9271;RITUXIMAB#0.9238;NEUROMUSCULAR JUNCTION#0.9183;LUNG CANCER#0.9145;GENE EXPRESSION#0.9136;APOPTOTIC#0.9003;THYROID CANCER#0.8763;TOXICITY#0.8716;CHOLINERGIC NEURON#0.8517;HUMAN BREAST CANCER#0.8491;SIGNALING PATHWAY#0.8427;ACETYLCHOLINE#0.8401;DECOMPENSATED HEART FAILURE#0.8351;RANDOMIZED CONTROLLED TRIAL#0.8026;NERVOUS SYSTEM#0.7991;CISPLATIN#0.7885;CYTOTOXICITY#0.7759;ACUTE MYOCARDIAL INFARCTION#0.7747;DNA METHYLATION#0.7735;TRANSACTIVATION#0.7674;INDUCTION OF APOPTOSIS#0.7451;PLASMA MEMBRANE#0.7434;CELL GROWTH#0.7192;OVARIAN CANCER#0.7135;CELL CYCLE ARREST#0.6900;CYTOCHROME C#0.6893;ANOREXIA NERVOSA#0.6875;N-ACETYLCYSTEINE#0.6804;MUSCLE FIBER#0.6790;CELL PROLIFERATION#0.6767;OVARIAN#0.6688;SPINAL CORD#0.6543;ADRIAMYCIN#0.6306;MEMBRANE RAFT#0.6253;EFFECTIVE ORIFICE AREA#0.6235;DOXORUBICIN#0.6232;BONE MARROW#0.6221;MECHANISM OF ACTION#0.6201;TRANSCRIPTION FACTOR#0.6127;ENDOCARDITIS#0.6032;PROSTATE CANCER#0.6031;CENTRAL NERVOUS SYSTEM#0.6019;EATING DISORDER#0.6012
1452	LUNG CANCER#1.0596;CASEIN KINASE 1#1.0529;PROTEIN KINASE#1.0155;CIRCADIAN RHYTHM#1.0066;GENE EXPRESSION#0.9860;SIGNALING PATHWAY#0.9682;CANCER CELL#0.9547;GLYCOGEN SYNTHASE KINASE#0.9501;CELL PROLIFERATION#0.9359;TUMOR SUPPRESSOR#0.9323;MYELODYSPLASTIC SYNDROME#0.9214;APOPTOSIS#0.9194;CELL CYCLE#0.9145;TRANSCRIPTION FACTOR#0.9074;SIGNAL TRANSDUCTION#0.9073;KINASE ACTIVITY#0.9054;PROTEIN KINASE A#0.8627;CYCLIN DEPENDENT KINASE#0.8395;T CELL#0.8276;ALZHEIMER'S DISEASE#0.8162;UBIQUITIN#0.8145;DEPHOSPHORYLATION#0.7953;CASEIN KINASE 2#0.7804;GROWTH FACTOR#0.7790;HYPERPHOSPHORYLATION#0.7723;CELL GROWTH#0.7694;RNA INTERFERENCE#0.7669;KINASE INHIBITOR#0.7602;TUMOR CELLS#0.7468;STEM CELL#0.7415;RNA HELICASE#0.6831;PROTEIN KINASE C#0.6749;MAP KINASE#0.6736;LENALIDOMIDE#0.6715;BETA-CATENIN DESTRUCTION COMPLEX#0.6692;PROTEIN PHOSPHATASE 1#0.6610;MITOGEN ACTIVATED PROTEIN#0.6496;WNT SIGNALING PATHWAY#0.6391;CALCINEURIN#0.6183;NUCLEAR EXPORT#0.6143;SIGNALLING PATHWAY#0.6009
145376	PROTEIN PHOSPHATASE 1#0.7986
1453	CASEIN KINASE 1#1.0912;CIRCADIAN RHYTHM#1.0142;PROTEIN KINASE#0.9764;KINASE ACTIVITY#0.8343;CANCER CELL#0.7855;BREAST CANCER#0.7222;MICROTUBULE#0.6831;CELL CYCLE#0.6621;APOPTOSIS#0.6618;ALZHEIMER'S DISEASE#0.6444;DNA REPAIR#0.6046
145482	CELL DEATH#0.8409;ADIPOCYTE DIFFERENTIATION#0.6782;PANCREATIC CANCER#0.6101
1454	CASEIN KINASE 1#1.0790;CIRCADIAN RHYTHM#1.0115;GENE EXPRESSION#0.9419;BREAST CANCER#0.9197;SIGNALING PATHWAY#0.8833;BIPOLAR DISORDER#0.8211;KINASE ACTIVITY#0.8117;PROTEIN KINASE#0.8074;CANCER CELL#0.7352;POLYMERASE CHAIN REACTION#0.7313;METHAMPHETAMINE#0.7249;GLYCOGEN SYNTHASE KINASE#0.7133;TRANSCRIPTION FACTOR#0.6678;PROSTATE CANCER#0.6658;WNT SIGNALING PATHWAY#0.6483;DNA REPLICATION#0.6188;D-AMPHETAMINE#0.6182;CELL CYCLE#0.6051;OVARIAN CANCER#0.6029;OPIOID RECEPTOR#0.6026
145508	CENTRIOLE#0.7309;PRIMARY CILIUM#0.6604
145553	UBIQUITIN PROTEIN LIGASE#0.6635
1455	CASEIN KINASE 1#0.7063;FOLLICULAR ADENOMA#0.6474;PAPILLARY THYROID CARCINOMA#0.6337;THYROID CARCINOMA#0.6267
145645	TELOMERE#0.9615;NUCLEAR ENVELOPE#0.8035;TELOMERE COMPLEX#0.7651;MEIOSIS#0.6239
145741	TYPE 2 DIABETES#0.8762
145781	NMDA RECEPTOR#0.7416
1457	SENESCENCE#1.0378;CELLULAR SENESCENCE#1.0356;PROTEIN KINASE C#1.0346;PROTEIN KINASE A#1.0311;PROTEIN KINASE#1.0269;NUCLEAR MATRIX#1.0139;HEPARIN#1.0118;CASEIN KINASE 2#1.0098;GROWTH FACTOR#1.0087;BREAST CANCER#1.0047;PROSTATE CANCER#1.0005;DNA BINDING#0.9928;CELL GROWTH#0.9920;KINASE INHIBITOR#0.9914;BENZIMIDAZOLE#0.9860;CANCER CELL#0.9845;C TERMINAL DOMAIN#0.9825;NUCLEAR IMPORT#0.9817;CELL PROLIFERATION#0.9808;CELL CYCLE#0.9806;SIGNAL TRANSDUCTION#0.9795;MUTAGENESIS#0.9793;PHOSPHATASE 2A#0.9791;GENE EXPRESSION#0.9789;CATALYTIC ACTIVITY#0.9788;ALANINE#0.9781;PROTEIN PHOSPHORYLATION#0.9778;CYTOPLASM#0.9768;SIGNALING PATHWAY#0.9763;EPITHELIAL CELL#0.9735;ONCOGENIC#0.9720;TOPOISOMERASE#0.9713;TRANSLATION INITIATION#0.9711;GROWTH FACTOR RECEPTOR#0.9702;CELL DEATH#0.9701;APOPTOSIS#0.9695;EMODIN#0.9686;KINASE ACTIVITY#0.9682;RIBOSOMAL PROTEIN#0.9679;TRANSCRIPTION FACTOR#0.9663;COLON CANCER#0.9660;PROTEIN PHOSPHATASE 2A#0.9646;APOPTOTIC#0.9638;PROTEASOME#0.9621;ATP BINDING#0.9618;TUMOR CELLS#0.9617;CELL DIVISION#0.9607;DEPHOSPHORYLATION#0.9599;SURFACE PLASMON RESONANCE#0.9591;REACTIVE OXYGEN SPECIES#0.9589;TRANSLATION INITIATION FACTOR#0.9554;BETA-2#0.9544;SPERMINE#0.9544;MITOGEN ACTIVATED PROTEIN#0.9489;PROTEIN COMPLEX#0.9451;PLASMA MEMBRANE#0.9413;ASPARTIC ACID#0.9410;OOCYTE#0.9405;MAP KINASE#0.9401;TOPOISOMERASE II#0.9401;STEM CELL#0.9391;NUCLEAR LOCALIZATION SIGNAL#0.9344;CYCLIN DEPENDENT KINASE#0.9324;PROTEIN SYNTHESIS#0.9315;RNA INTERFERENCE#0.9309;ENDOTHELIAL CELL#0.9185;ENDOPLASMIC RETICULUM#0.9123;PHOSPHATASE ACTIVITY#0.9104;CELL SURFACE#0.9100;T CELL#0.9088;INDUCTION OF APOPTOSIS#0.9062;PROTEIN PROTEIN INTERACTION#0.9039;MITOSIS#0.9019;TRANSACTIVATION#0.9018;TUMOR SUPPRESSOR#0.8989;MICROTUBULE#0.8985;SQUAMOUS CELL CARCINOMA#0.8868;PROTEIN KINASE ACTIVITY#0.8857;EPIDERMAL GROWTH FACTOR#0.8855;LUNG CANCER#0.8839;POST-TRANSLATIONAL MODIFICATION#0.8833;CIRCADIAN RHYTHM#0.8816;STRUCTURE ACTIVITY RELATIONSHIP#0.8811;ENZYME ACTIVITY#0.8763;MULTIPLE MYELOMA#0.8717;UBIQUITIN#0.8696;BREAST CANCER CELL#0.8666;CELL CYCLE REGULATION#0.8622;INDOLE#0.8548;COLORECTAL#0.8494;S PHASE#0.8486;DOUBLE STRAND BREAK#0.8381;CELL POLARITY#0.8379;ANGIOGENESIS#0.8304;TOXICITY#0.8145;PROTEIN KINASE INHIBITOR#0.8128;PROTEIN TYROSINE KINASE#0.8119;DIGESTION#0.8105;HISTONE DEACETYLASE#0.8092;HUMAN BREAST CANCER#0.8092;LYSINE#0.8055;SIGNALLING PATHWAY#0.8054;DNA REPLICATION#0.7992;CELL ADHESION#0.7961;COLORECTAL CANCER#0.7918;GLUTATHIONE#0.7784;DNA DAMAGE RESPONSE#0.7753;DNA REPAIR#0.7744;MITOCHONDRIA#0.7717;IMPORTIN#0.7702;ADENOSINE#0.7665;HYPERPHOSPHORYLATION#0.7626;DNA SYNTHESIS#0.7585;GLUTAMIC ACID#0.7580;POSTTRANSLATIONAL MODIFICATION#0.7565;CELL CYCLE ARREST#0.7553;ALKALINE PHOSPHATASE#0.7542;MACROPHAGE#0.7540;BENZOIC ACID#0.7453;MICROTUBULE ASSOCIATED PROTEIN#0.7448;DRUG RESISTANCE#0.7426;TUMOR NECROSIS FACTOR#0.7384;CYSTIC FIBROSIS#0.7371;CISPLATIN#0.7320;CYTOTOXICITY#0.7285;HEAT SHOCK PROTEIN#0.7205;INSULIN RECEPTOR#0.7204;CELLULAR GROWTH#0.7199;CELL MIGRATION#0.7197;KERATINOCYTE#0.7130;DOMINANT NEGATIVE MUTANT#0.7129;BUDDING#0.7117;RNA BINDING#0.7093;SIGNALING CASCADE#0.7087;TUMOR ANTIGEN#0.7025;GLYCOGEN SYNTHASE KINASE#0.6937;VIRION#0.6864;SPECIFIC PROTEIN 1#0.6841;OUTER MEMBRANE#0.6831;VIRAL INFECTION#0.6830;VESICULAR STOMATITIS VIRUS#0.6784;SERUM RESPONSE FACTOR#0.6765;SUCROSE#0.6751;COMPLEX I#0.6708;SKELETAL MUSCLE#0.6701;RETICULOCYTE#0.6680;GROWTH CONE#0.6678;ASPARTATE#0.6631;RRNA SYNTHESIS#0.6607;NUCLEAR TRANSPORT#0.6581;G1 PHASE#0.6561;POLYMERASE CHAIN REACTION#0.6502;CHANNEL ACTIVITY#0.6469;HIGH MOBILITY GROUP#0.6460;PROTEIN BINDING#0.6446;ALZHEIMER'S DISEASE#0.6400;EQUILIBRATIVE NUCLEOSIDE TRANSPORTER#0.6386;5S RRNA BINDING#0.6316;DNA TOPOISOMERASE#0.6295;CELLULAR LOCALIZATION#0.6281;NEOPLASTIC DISEASE#0.6271;ELECTROPHORETIC MOBILITY SHIFT#0.6263;SALICYLIC ACID#0.6252;RECEPTOR TYROSINE KINASE#0.6246;HUMAN IMMUNODEFICIENCY VIRUS#0.6239;GENE SILENCING#0.6231;CELL DIVISION CYCLE#0.6224;INFLAMMATORY RESPONSE#0.6170;HYPOXIA#0.6161;VIRAL REPLICATION#0.6116;CERVICAL#0.6087;RIBOSOME#0.6068;DOXORUBICIN#0.6061
145837	PROSTATE CANCER#0.9055;CELL GROWTH#0.6574;BREAST CANCER#0.6553
145864	GENE EXPRESSION#0.6843
145873	TRANSCRIPTION FACTOR#1.0642;SOMITE#1.0406;SOMITOGENESIS#1.0378;SPONDYLOCOSTAL DYSOSTOSIS#0.9601;SIGNALING PATHWAY#0.9403;DYSOSTOSIS#0.9187;NOTCH SIGNALING PATHWAY#0.8715;GENE EXPRESSION#0.8351;NOTCH SIGNALLING PATHWAY#0.7272;AXIAL SKELETON#0.7258;SIGNALLING PATHWAY#0.6990;VERTEBRAE#0.6531;NOTCH LIGAND#0.6189
145942	MANCHETTE#0.8024;MICROTUBULE#0.7579
145946	PLATELET-DERIVED GROWTH FACTOR#0.9063;GROWTH FACTOR RECEPTOR#0.8996;GROWTH FACTOR#0.8934;SPERMATOGENESIS#0.6835
145957	DIABETES MELLITUS#1.0796;ADIPOSE TISSUE#1.0634;TYPE 2 DIABETES#1.0616;ADIPOCYTE#1.0285;TYPE 2 DIABETES MELLITUS#1.0199;2 DIABETES MELLITUS#1.0199;GROWTH FACTOR#1.0127;FATTY LIVER#0.9732;OBESE#0.9697;BROWN ADIPOSE TISSUE#0.9592;EPIDERMAL GROWTH FACTOR#0.9482;GENE EXPRESSION#0.9125;FATTY LIVER DISEASE#0.8754;LIVER DISEASE#0.8703;WHITE ADIPOSE TISSUE#0.7725;ALCOHOLIC FATTY LIVER#0.7705;C REACTIVE PROTEIN#0.7591;LIPOGENESIS#0.7345;HIGH DENSITY LIPOPROTEIN#0.7065;LIPID METABOLISM#0.6959;BLOOD VESSEL#0.6920;BREAST CANCER#0.6743;ANGIOGENESIS#0.6429;GESTATIONAL DIABETES MELLITUS#0.6270;GESTATIONAL DIABETES#0.6239;DIET INDUCED OBESITY#0.6149;CORONARY ARTERY DISEASE#0.6133;ARTERY DISEASE#0.6130;CORONARY ARTERY#0.6106;HIGH FAT DIET#0.6083;PROSTATE CANCER#0.6056
1459	GLOBOZOOSPERMIA#0.7271
146057	SPINOCEREBELLAR ATAXIA TYPE 11#1.1325;CILIOGENESIS#1.0610;CENTRIOLE#0.8707;MICROTUBULE#0.8324;CEREBELLAR ATAXIA#0.8013;BASAL BODY#0.7937;PROTEIN KINASE#0.7915;KINASE ACTIVITY#0.7689;MOTHER CENTRIOLE#0.7611;CELL PROLIFERATION#0.7505;OOCYTE#0.6524;NEURODEGENERATIVE DISEASE#0.6192;CELL MEMBRANE#0.6191
146059	CONGENITAL DYSERYTHROPOIETIC ANEMIA#1.0729;ANEMIA#1.0098;NEUTROPENIA#1.0070;THROMBOCYTOPENIA#1.0060;ERYTHROPOIESIS#0.9934;TOXICITY#0.9837;BONE MARROW#0.9837;ERYTHROBLAST#0.9775;MACROCYTIC ANEMIA#0.9147;DIARRHEA#0.8942;VOMITING#0.8555;ERYTHROID PRECURSOR#0.8376;IRON OVERLOAD#0.8126;BETA THALASSEMIA#0.7681;THALASSEMIA#0.7669;S PHASE#0.7387;HEMOLYTIC ANEMIA#0.6764;HETEROCHROMATIN#0.6699;CARBOPLATIN#0.6616;PERSISTENT PULMONARY HYPERTENSION#0.6245;PULMONARY HYPERTENSION#0.6192;EPITHELIAL CELL#0.6097
1460	YOLK GRANULE#1.0820;YOLK PROTEIN#1.0363;CASEIN KINASE 2#1.0232;SERUM ALBUMIN#1.0213;HISTONE KINASE#1.0171;DEPHOSPHORYLATION#1.0163;OOCYTE#1.0095;CYTOCHROME C#1.0014;LYSINE#0.9997;PROTEIN KINASE ACTIVITY#0.9920;HEPARIN#0.9911;PROTEIN KINASE#0.9846;KINASE ACTIVITY#0.9819;CYCLIC AMP#0.9814;ENZYME ACTIVITY#0.9733;SKELETAL MUSCLE#0.9733;ALKALINE PHOSPHATASE#0.9644;IRON BINDING#0.9524;SODIUM DODECYL SULFATE#0.9487;DODECYL SULFATE#0.9486;SPERMINE#0.9384;ACID PHOSPHATASE#0.9129;KINASE INHIBITOR#0.9119;RIBOSOMAL PROTEIN#0.9089;ESTRADIOL#0.8928;PROTEIN KINASE INHIBITOR#0.8902;ANTIOXIDANT ACTIVITY#0.8821;SUCROSE#0.8690;GLYCOGEN SYNTHASE KINASE#0.8667;EPITHELIAL CELL#0.8643;CELL SURFACE#0.8594;DIGESTION#0.8579;ADENOSINE#0.8544;PROTEIN PHOSPHORYLATION#0.8542;PHOSPHATASE ACTIVITY#0.8299;PHOSPHORYLASE KINASE#0.8294;PLASMA MEMBRANE#0.8073;RIBOFLAVIN BINDING#0.7932;MINERALIZATION#0.7888;GENE EXPRESSION#0.7616;MOLAR#0.7559;ARGININE#0.7528;LIPID OXIDATION#0.7493;INTESTINAL EPITHELIAL CELL#0.7447;PROTEIN KINASE A#0.7407;PHOSPHOPROTEIN PHOSPHATASE#0.7394;CASEIN KINASE 1#0.7361;PROTEIN KINASE C#0.7235;BONE FORMATION#0.7229;SPERMIDINE#0.7186;ASCORBIC ACID#0.7087;SOLUBLE FRACTION#0.7076;COATED VESICLE#0.7057;TRANSFER RNA#0.6988;EPILEPSY#0.6756;METAL BINDING#0.6543;L-LYSINE#0.6532;N-ETHYLMALEIMIDE#0.6509;METHIONINE#0.6490;CANCER CELL#0.6462;LOW DENSITY LIPOPROTEIN#0.6440;BETA-2#0.6288;SIGNAL PEPTIDE#0.6257;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6229;OSTEOBLAST#0.6192;LAYER BY LAYER#0.6183;RNA SYNTHESIS#0.6086;PROTEIN PHOSPHATASE ACTIVITY#0.6046;HUMAN INTESTINAL EPITHELIAL#0.6007
146167	L-HISTIDINE#0.6896;L-GLUTAMINE#0.6869;L-ALANINE#0.6811;L-ARGININE#0.6529;CONGENITAL NYSTAGMUS#0.6281;GLUTAMINE#0.6017
146183	INNER EAR#0.9861;HEARING LOSS#0.9293;HEARING IMPAIRMENT#0.6408
146198	ZINC FINGER PROTEIN#0.6893;THYROID HORMONE RECEPTOR#0.6772;DNA BINDING#0.6631;TRANSCRIPTION FACTOR#0.6628
146206	T CELL#0.9929;CELL MIGRATION#0.7993;LEUCINE RICH REPEAT#0.6597;LEUCINE#0.6316
146223	TUMOR SUPPRESSOR#0.8092;CELL GROWTH#0.7679;CELL CYCLE#0.7375;CLEAR CELL RENAL CELL CARCINOMA#0.6648;RENAL CELL CARCINOMA#0.6562;CELL PROLIFERATION#0.6487;O CELL#0.6391;SPERM MOTILITY#0.6190;M PHASE#0.6091;COLORECTAL CANCER#0.6018
146225	SPERMATOGENESIS#0.9477;REPRODUCTIVE SYSTEM#0.7429;TESTOSTERONE#0.6844;VARICOCELE#0.6603;INITIATION OF MEIOSIS#0.6593;CYCLOPHOSPHAMIDE#0.6354;MALE REPRODUCTIVE SYSTEM#0.6189;REPRODUCTIVE TOXICITY#0.6165;SPERMATOGENIC CELLS#0.6141;ACROSOME REACTION#0.6100
146227	SPINOCEREBELLAR ATAXIA TYPE 31#1.1471;CEREBELLAR ATAXIA#1.0355;PURKINJE CELL#1.0187;SPINOCEREBELLAR ATAXIA TYPE 6#0.8162;AUTOSOMAL DOMINANT CEREBELLAR ATAXIA#0.7696
146279	ESTERASE ACTIVITY#0.6701;COLON CANCER#0.6517;CANCER CELL#0.6427
1462	HYALURONATE#1.0654;COLLAGEN TYPE II#1.0578;CHONDROITIN SULPHATE PROTEOGLYCAN#1.0525;HYALURONAN BINDING#1.0506;ELASTIC FIBER#1.0495;LEIOMYOMA#1.0435;DENTAL PULP#1.0411;FIBRILLIN#1.0382;HYALURONAN SYNTHASE#1.0360;COLLAGEN TYPE I#1.0353;INTRACRANIAL ANEURYSM#1.0349;OVARIAN CANCER#1.0288;DERMIS#1.0254;STROMA#1.0254;CHONDROITIN SULFATE PROTEOGLYCAN#1.0253;HYALURONIC ACID#1.0217;HYALURONAN#1.0197;BREAST CANCER#1.0193;MESENCHYME#1.0184;STROMAL CELL#1.0172;NEURAL CREST CELL#1.0147;CHONDROGENESIS#1.0136;SMOOTH MUSCLE ACTIN#1.0128;SPINAL CORD#1.0128;HAIR FOLLICLE#1.0117;OVARIAN#1.0104;PROTEOGLYCAN#1.0094;EPIDERMAL GROWTH FACTOR#1.0090;T CELL#1.0088;PROSTATE CANCER#1.0084;ALKALINE PHOSPHATASE#1.0080;LECTIN#1.0070;ANGIOGENESIS#1.0065;BASEMENT MEMBRANE#1.0056;CANCER CELL#1.0052;MESENCHYMAL CELL#1.0051;DERMAL FIBROBLAST#1.0050;HYALURONIDASE#1.0043;TUMOR CELLS#1.0038;NEURAL CREST#1.0036;PLATELET-DERIVED GROWTH FACTOR#1.0027;VASCULAR SMOOTH MUSCLE CELL#1.0021;EXTRACELLULAR MATRIX COMPONENT#1.0019;QUANTITATIVE REAL TIME#1.0014;MACROPHAGE#0.9989;TRANSFORMING GROWTH FACTOR BETA#0.9984;CELL ADHESION#0.9974;APOPTOSIS#0.9974;CELL MIGRATION#0.9974;MORPHOGENESIS#0.9970;CELL DIFFERENTIATION#0.9967;NEURITE#0.9951;TUMOR NECROSIS FACTOR#0.9946;GRANULOSA CELL#0.9941;SMOOTH MUSCLE CELL#0.9940;FIBROBLAST GROWTH FACTOR#0.9938;NEURITE OUTGROWTH#0.9936;INTERVERTEBRAL DISC#0.9933;SMOOTH MUSCLE#0.9930;EPITHELIAL CELL#0.9923;CELL GROWTH#0.9922;INFLAMMATORY RESPONSE#0.9917;NUCLEUS PULPOSUS#0.9917;CHONDROCYTE#0.9913;CELL SURFACE#0.9912;TRANSFORMING GROWTH FACTOR#0.9909;POLYMERASE CHAIN REACTION#0.9904;BREAST CANCER CELL#0.9900;MUSCLE CELL#0.9898;MELANOMA CELL LINES#0.9896;CENTRAL NERVOUS SYSTEM#0.9894;ATHEROSCLEROSIS#0.9892;NERVOUS SYSTEM#0.9886;CONNECTIVE TISSUE#0.9884;WOUND HEALING#0.9883;SIGNALING PATHWAY#0.9881;BONE MARROW#0.9879;BLOOD VESSEL#0.9876;ATHEROSCLEROTIC#0.9874;MONOCYTE#0.9855;DIGESTION#0.9855;ENDOTHELIAL CELL#0.9854;CELL PROLIFERATION#0.9841;GROWTH FACTOR#0.9835;REVERSE TRANSCRIPTION#0.9812;MYOFIBROBLAST#0.9795;TRANSCRIPTION FACTOR#0.9778;SULFATION#0.9777;SELECTIN#0.9775;STEM CELL#0.9739;ASTROCYTE#0.9735;EXTRACELLULAR MATRIX#0.9723;MICROFIBRIL#0.9717;GENE EXPRESSION#0.9703;OLIGODENDROCYTE#0.9695;REGENERATION#0.9690;NEURAL CREST CELL MIGRATION#0.9650;TRANSCRIPTASE#0.9648;KERATINOCYTE#0.9635;LYMPH NODE#0.9630;CELL ADHESION MOLECULE#0.9618;GROWTH FACTOR RECEPTOR#0.9613;LEUCINE#0.9562;PROTEOGLYCAN SYNTHESIS#0.9560;LUNG FIBROBLASTS#0.9547;ADENOCARCINOMA#0.9540;FIBRIL#0.9527;OOCYTE#0.9526;MYELOID CELL#0.9511;LEUKOCYTE#0.9426;CELL MOTILITY#0.9426;ENDOTHELIAL GROWTH FACTOR#0.9418;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9418;MOLAR#0.9398;OPTIC NERVE#0.9391;HYPOXIA#0.9277;ARTERY#0.9221;VASCULAR DISEASE#0.9200;PROGENITOR CELL#0.9183;IMMUNE RESPONSE#0.9103;HYALURONIC ACID BINDING#0.9082;OSTEOBLAST#0.9025;TISSUE GROWTH FACTOR#0.9001;ASTROCYTOMA#0.8983;PERINEURONAL NET#0.8940;HEPATOCELLULAR CARCINOMA#0.8938;PROGESTERONE#0.8938;COLON CANCER#0.8933;LOW DENSITY LIPOPROTEIN#0.8919;CELL DEATH#0.8909;DERMAL PAPILLA CELL#0.8887;SCHWANN CELL#0.8875;TOLL LIKE RECEPTOR#0.8875;SQUAMOUS CELL CARCINOMA#0.8870;MYOCARDIUM#0.8824;PROTEIN KINASE#0.8769;INSULIN-LIKE GROWTH FACTOR#0.8763;CELL ASSOCIATED#0.8737;HEPARIN#0.8711;ELASTIC FIBRE#0.8706;INFLAMMATORY CELL#0.8682;PROTEIN SYNTHESIS#0.8670;ANNULUS FIBROSUS#0.8669;COLORECTAL#0.8644;OVULATION#0.8586;AORTIC VALVE#0.8581;BASAL EPITHELIAL CELL#0.8562;MESENCHYMAL STEM CELL#0.8556;ANNULUS#0.8549;HAIR GROWTH#0.8512;CELL CYCLE#0.8484;PERIODONTAL LIGAMENT#0.8467;COLORECTAL CANCER#0.8454;COLLAGEN SYNTHESIS#0.8418;C TERMINAL DOMAIN#0.8404;BREAST CARCINOMA#0.8402;MATRIX METALLOPROTEINASE 1#0.8362;CUMULUS OOCYTE COMPLEX#0.8350;MITRAL VALVE#0.8320;ANAGEN#0.8319;EXTRACELLULAR SPACE#0.8290;INTERSTITIAL CELL#0.8287;LYMPH NODE METASTASIS#0.8276;ENDOTHELIUM#0.8273;CORONARY ARTERY#0.8216;OUTFLOW TRACT#0.8176;AORTIC ANEURYSM#0.8155;AORTIC SMOOTH MUSCLE CELLS#0.8148;VOCAL FOLD#0.8113;CEREBRAL CORTEX#0.8096;LUNG DISEASE#0.8078;MYOMETRIUM#0.8051;PRO-INFLAMMATORY#0.8032;HEART DEVELOPMENT#0.7994;SPINAL CORD INJURY#0.7980;HYALURONAN SYNTHESIS#0.7971;PERIPHERAL NERVE#0.7965;COLON CARCINOMA#0.7946;GLIAL CELL#0.7935;SCIATIC NERVE#0.7933;LUNG CANCER#0.7909;PANCREATIC CANCER#0.7899;GLUCOSAMINE#0.7868;PARENCHYMA#0.7859;CERVICAL CANCER#0.7853;FIBROBLAST PROLIFERATION#0.7840;DORSAL ROOT GANGLION#0.7835;TRANSCRIPTIONAL CONTROL#0.7812;POST-TRANSLATIONAL MODIFICATION#0.7812;MAMMARY GLAND#0.7775;CERVICAL#0.7760;COLLAGENASE#0.7754;SKELETAL MUSCLE#0.7727;TUMOR SUPPRESSOR#0.7726;CYTOPLASM#0.7709;PROSTAGLANDIN ENDOPEROXIDE SYNTHASE#0.7683;COLLAGEN TYPE III#0.7675;SKIN FIBROBLASTS#0.7636;MYOBLAST FUSION#0.7618;SENESCENCE#0.7563;VASCULAR CELL#0.7562;MONONUCLEAR CELLS#0.7561;RETINOIC ACID#0.7560;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7555;IN SITU CARCINOMA#0.7536;TISSUE MORPHOGENESIS#0.7527;BASAL LAMINA#0.7510;MESOTHELIOMA CELL#0.7475;NEURITE GROWTH#0.7444;FOCAL ADHESION#0.7441;CELL MEMBRANE#0.7417;AXON GROWTH#0.7415;PERIPHERAL NERVOUS SYSTEM#0.7400;TISSUE REMODELING#0.7370;EPITHELIAL OVARIAN CANCER#0.7362;APOPTOTIC#0.7351;ALVEOLAR MACROPHAGE#0.7335;SIGNALING MOLECULE#0.7319;EMBRYO IMPLANTATION#0.7303;MYOGENESIS#0.7301;CILIARY BODY#0.7284;OSTEOARTHRITIS#0.7281;MYOCARDIAL INFARCTION#0.7272;MYOBLAST#0.7266;AMIODARONE#0.7236;INVASIVE CARCINOMA#0.7226;BONE MORPHOGENETIC PROTEIN#0.7216;FERTILIZATION#0.7212;NEURAL CELL#0.7190;DISEASE FREE SURVIVAL#0.7170;TRANSMISSION ELECTRON MICROSCOPY#0.7097;ESTRADIOL#0.7093;GESTATION#0.7011;DENTAL PULP CELL#0.6971;NEOPLASTIC TISSUES#0.6941;GLYCERALDEHYDE-3-PHOSPHATE#0.6869;ADVENTITIA#0.6869;HAIR CYCLE#0.6860;UMBILICAL CORD#0.6836;CHONDROCYTE PROLIFERATION#0.6818;COLLAGEN TYPE IV#0.6816;MULTIPLE SCLEROSIS#0.6804;MESENCHYMAL EPITHELIAL TRANSITION#0.6800;HUMAN DERMAL FIBROBLAST#0.6791;PERIPHERAL BLOOD#0.6786;HEPARIN BINDING#0.6777;MESANGIAL CELL#0.6773;CARDIOMYOCYTE#0.6768;GLYCOSYLATION#0.6748;NUCLEUS PULPOSUS CELL#0.6743;T CELL FACTOR#0.6731;FACTOR I#0.6701;KINASE INHIBITOR#0.6686;LYMPHOID CELL#0.6675;TRABECULAR MESHWORK CELLS#0.6673;UTERUS#0.6606;RNA INTERFERENCE#0.6591;HYPOXIC#0.6588;FIBRILLAR COLLAGEN#0.6552;REACTIVE OXYGEN SPECIES#0.6518;NITRIC OXIDE#0.6512;EXTRACELLULAR MATRIX ASSEMBLY#0.6502;PRECURSOR CELL#0.6493;NEURAL TUBE#0.6476;OVARIES#0.6466;LOCALISATION#0.6458;DENDRITIC CELL#0.6447;T LYMPHOCYTE#0.6440;TUMOR TISSUES#0.6426;THORACIC AORTIC ANEURYSM#0.6402;EMBRYONIC HEART#0.6370;AXON REGENERATION#0.6357;OVARIAN FOLLICLE#0.6310;FACTOR XIIIA#0.6300;LUNG METASTASIS#0.6278;ASCORBIC ACID#0.6277;SULPHATION#0.6259;EPITHELIAL MESENCHYMAL TRANSITION#0.6256;CRUCIATE LIGAMENT#0.6243;MANDIBLE#0.6239;RISK OF DEATH#0.6236;IMMUNE CELL#0.6233;HAIR FOLLICLE DEVELOPMENT#0.6230;INTERVERTEBRAL DISC DEGENERATION#0.6221;PALATAL SHELF#0.6219;HYPOXIA INDUCIBLE FACTOR#0.6218;HUMAN TRABECULAR MESHWORK#0.6174;INNERVATION#0.6168;CATABOLISM#0.6167;ENDOCARDIAL CELL#0.6142;EMBRYONIC STEM CELL#0.6140;CARTILAGE FORMATION#0.6132;FOCAL CONTACT#0.6120;LIMB DEVELOPMENT#0.6108;MYELIN SHEATH#0.6058;TUMOR ASSOCIATED MACROPHAGE#0.6048;METANEPHRIC MESENCHYME#0.6021
146395	AMPA RECEPTOR#0.9788;SYNAPTIC TRANSMISSION#0.8741
1463	NERVOUS TISSUE#1.0772;HYALURONAN#1.0368;NEURITE OUTGROWTH#1.0283;BIPOLAR DISORDER#1.0254;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0240;CHONDROITIN SULFATE PROTEOGLYCAN#1.0229;CELL ADHESION MOLECULE#1.0195;CELL ADHESION#1.0178;NEURITE#1.0166;PROTEOGLYCAN#1.0165;PERINEURONAL NET#1.0148;ASTROCYTE#1.0147;HYALURONAN BINDING#1.0090;NEURAL CELL#1.0076;SPINAL CORD#1.0057;LIVER DISEASE#0.9981;CHONDROITIN SULPHATE PROTEOGLYCAN#0.9925;FATTY LIVER#0.9908;EXTRACELLULAR MATRIX#0.9842;FATTY LIVER DISEASE#0.9832;GENE EXPRESSION#0.9811;CENTRAL NERVOUS SYSTEM#0.9784;NERVOUS SYSTEM#0.9773;REGENERATION#0.9764;PROTEIN TYROSINE PHOSPHATASE#0.9748;SPINAL CORD INJURY#0.9711;AXON GROWTH#0.9684;CELL SURFACE#0.9580;GROWTH FACTOR#0.9502;POLYMERASE CHAIN REACTION#0.9105;ALCOHOLIC FATTY LIVER#0.8972;CEREBRAL CORTEX#0.8802;LECTIN#0.8645;HYALURONIC ACID#0.8638;AXON REGENERATION#0.8631;DENTATE GYRUS#0.8621;ISCHEMIA#0.8536;NEURITE GROWTH#0.8335;BRAIN DEVELOPMENT#0.8240;HEPARIN#0.8009;HEPARIN BINDING#0.7966;NEURITE EXTENSION#0.7959;GLIAL CELL#0.7706;MIDDLE CEREBRAL ARTERY#0.7564;CEREBRAL ARTERY#0.7562;CEREBRAL ISCHEMIA#0.7555;OLIGODENDROCYTE#0.7478;RETINAL GANGLION CELL#0.7376;OPTIC NERVE#0.7367;CEREBRAL ARTERY OCCLUSION#0.7364;GANGLION CELLS#0.7328;NERVE FIBER#0.7279;REVERSE TRANSCRIPTION#0.7223;CELL MIGRATION#0.7166;EPIDERMAL GROWTH FACTOR#0.7045;C TERMINAL DOMAIN#0.6958;ARTERY#0.6909;TRANSFORMING GROWTH FACTOR#0.6901;SCHWANN CELL#0.6886;NONALCOHOLIC FATTY LIVER DISEASE#0.6868;CELL PROLIFERATION#0.6793;ALKALINE PHOSPHATASE#0.6756;DIGESTION#0.6694;PERIPHERAL NERVE#0.6612;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.6502;NODE OF RANVIER#0.6325;BONE MARROW#0.6283;STROMAL CELL#0.6071
146433	RHEUMATOID ARTHRITIS#1.0497;SYNOVIAL FLUID#1.0478;MYELOID CELL#1.0418;LANGERHANS CELL#1.0369;COLONY-STIMULATING FACTOR#1.0263;OSTEOCLAST#1.0257;MONOCYTE#1.0224;GINGIVAL CREVICULAR FLUID#1.0198;BONE MARROW#1.0183;MACROPHAGE#1.0158;PERIODONTITIS#1.0158;PERIPHERAL BLOOD#0.9948;GM-CSF#0.9828;TUMOR NECROSIS FACTOR#0.9793;GENE EXPRESSION#0.9786;PROTEIN TYROSINE PHOSPHATASE#0.9771;PRO-INFLAMMATORY#0.9736;GROWTH FACTOR#0.9679;T CELL#0.9595;MONONUCLEAR CELLS#0.9591;EPITHELIAL CELL#0.9536;SIGNALING PATHWAY#0.9440;CANCER CELL#0.9336;IMMUNE RESPONSE#0.9211;LUPUS NEPHRITIS#0.9205;STEM CELL#0.9080;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9022;TUMOR ASSOCIATED MACROPHAGE#0.9018;CELL SURFACE#0.8992;IMMUNE CELL#0.8990;PERIODONTAL DISEASE#0.8985;AUTOIMMUNE DISEASE#0.8971;APOPTOSIS#0.8946;MACROPHAGE DIFFERENTIATION#0.8942;C REACTIVE PROTEIN#0.8797;LUNG CANCER#0.8517;ENDOTHELIAL CELL#0.8426;KINASE INHIBITOR#0.8281;OSTEOBLAST#0.8251;NERVOUS SYSTEM#0.8174;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8039;LUPUS ERYTHEMATOSUS#0.8035;CELL PROLIFERATION#0.8027;CELL MIGRATION#0.7994;TH17 CELL#0.7983;RECEPTOR ACTIVATOR#0.7975;ALZHEIMER'S DISEASE#0.7873;NEPHRITIS#0.7757;CENTRAL NERVOUS SYSTEM#0.7661;B CELL#0.7594;OSTEOARTHRITIS#0.7593;SALIVARY GLAND#0.7581;NEUTROPHIL#0.7552;DENDRITIC CELL#0.7531;OVARIAN CANCER#0.7520;STROMAL CELL#0.7511;POLYMERASE CHAIN REACTION#0.7437;HEPATIC STELLATE CELL#0.7378;MACROPHAGE POLARIZATION#0.7247;ANGIOGENESIS#0.7211;INFLAMMATORY RESPONSE#0.7060;DISEASE ACTIVITY SCORE#0.7046;CORONARY ARTERY DISEASE#0.6952;ARTERY DISEASE#0.6950;CORONARY ARTERY#0.6931;IL-11#0.6893;HEPATITIS B VIRUS#0.6828;HEPATITIS B#0.6810;INTESTINAL EPITHELIAL CELL#0.6805;SIGNALLING PATHWAY#0.6757;COLORECTAL CANCER#0.6733;CELL DIFFERENTIATION#0.6530;OSTEOCLAST DIFFERENTIATION#0.6422;ERYTHROCYTE SEDIMENTATION RATE#0.6342;NEUROTOXICITY#0.6307;SKIN EPIDERMIS#0.6291;HEPATOCELLULAR CARCINOMA#0.6289;COLORECTAL#0.6274;OVARIAN#0.6268;MONOCYTE DIFFERENTIATION#0.6167;INSULIN DEGRADING ENZYME#0.6155;TUMOUR NECROSIS FACTOR#0.6118;G-CSF#0.6116;INTERSTITIAL LUNG DISEASE#0.6068;CHRONIC APICAL PERIODONTITIS#0.6059;RECEPTOR TYROSINE KINASE#0.6035;PROGENITOR CELL#0.6015;ENHANCER BINDING#0.6006;1α,25-DIHYDROXYVITAMIN D3#0.6002;HEPATOMA CELLS#0.6000
146434	ZINC FINGER PROTEIN#0.6452;DNA METHYLATION#0.6086
146456	INSULIN SECRETION#0.7867;PANCREATIC ISLET#0.6554;GENE EXPRESSION#0.6479
1464	CHONDROITIN SULPHATE PROTEOGLYCAN#1.0643;SMOOTH MUSCLE ACTIN#1.0479;AXON GROWTH#1.0424;CHONDROITIN SULFATE PROTEOGLYCAN#1.0395;OLIGODENDROCYTE PRECURSOR CELL#1.0390;OLIGODENDROCYTE PROGENITOR CELL#1.0340;PERICYTE#1.0338;PROTEOGLYCAN#1.0335;BREAST CANCER#1.0320;SMOOTH MUSCLE#1.0308;CELL SURFACE#1.0287;T CELL#1.0247;OLIGODENDROCYTE#1.0242;GLIAL CELL#1.0224;GROWTH FACTOR RECEPTOR#1.0183;PLATELET-DERIVED GROWTH FACTOR#1.0183;PRECURSOR CELL#1.0179;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0171;MACROPHAGE#1.0153;SMOOTH MUSCLE CELL#1.0153;MUSCLE CELL#1.0147;MURAL CELL#1.0141;PROGENITOR CELL#1.0140;CANCER CELL#1.0135;CELL ADHESION#1.0114;ASTROCYTE#1.0097;TUMOR CELLS#1.0084;SPINAL CORD INJURY#1.0084;STEM CELL MARKER#1.0082;SPINAL CORD#1.0077;CELL PROLIFERATION#1.0054;SIGNALING PATHWAY#1.0022;BLOOD VESSEL#1.0010;NEURITE#1.0000;GENE EXPRESSION#0.9991;PERIPHERAL NERVE#0.9976;TRANSCRIPTION FACTOR#0.9976;EXTRACELLULAR MATRIX#0.9968;NEURITE OUTGROWTH#0.9963;MYELINATION#0.9959;CELL MIGRATION#0.9935;MELANOMA CELL LINES#0.9924;CEREBRAL CORTEX#0.9909;NERVOUS SYSTEM#0.9908;GROWTH FACTOR#0.9905;CENTRAL NERVOUS SYSTEM#0.9901;ENDOTHELIAL CELL#0.9893;AXON REGENERATION#0.9862;APOPTOSIS#0.9842;REGENERATION#0.9829;MICROGLIAL CELL#0.9829;MULTIPLE SCLEROSIS#0.9799;OPTIC NERVE#0.9796;STEM CELL#0.9781;NEURAL CELL#0.9775;BONE MARROW#0.9771;ANGIOGENESIS#0.9767;CELL MOTILITY#0.9748;STROMAL CELL#0.9694;BLOOD BRAIN BARRIER#0.9655;MESENCHYMAL STEM CELL#0.9601;IMMUNOTOXIN#0.9593;GLUTAMATE RECEPTOR#0.9551;FIBROBLAST GROWTH FACTOR#0.9528;BASEMENT MEMBRANE#0.9521;SCHWANN CELL#0.9507;SKELETAL MUSCLE#0.9507;HYPOXIA#0.9503;NEURAL STEM CELL#0.9479;UVEAL MELANOMA#0.9472;B CELL#0.9430;CELL MEMBRANE#0.9409;CELL ADHESION MOLECULE#0.9401;CHIMERIC ANTIGEN RECEPTOR#0.9370;STROMA#0.9277;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9264;CELL DEATH#0.9233;VASCULAR SMOOTH MUSCLE CELL#0.9221;AMPA RECEPTOR#0.9163;PROLYL 4-HYDROXYLASE#0.9096;CELL CYCLE#0.9081;MYOFIBROBLAST#0.9063;ENDOTHELIAL GROWTH FACTOR#0.9038;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9038;GLIOBLASTOMA MULTIFORME#0.8996;WOUND HEALING#0.8983;EPIDERMAL GROWTH FACTOR#0.8972;ARTERY#0.8957;EPITHELIAL CELL#0.8907;ARTERIOLE#0.8880;SCIATIC NERVE#0.8853;ENCEPHALOMYELITIS#0.8826;NEURAL PROGENITOR CELL#0.8798;POLYMERASE CHAIN REACTION#0.8784;MYELOID CELL#0.8764;ISCHEMIA#0.8761;LECTIN#0.8733;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8699;BASAL LAMINA#0.8698;TRANSFORMING GROWTH FACTOR#0.8690;LEUKOCYTE#0.8647;MYELIN SHEATH#0.8609;BREAST CANCER CELL#0.8608;CELL GROWTH#0.8605;IMMUNE RESPONSE#0.8567;ALKALINE PHOSPHATASE#0.8523;PARENCHYMA#0.8482;SOFT TISSUE SARCOMA#0.8468;MIDDLE CEREBRAL ARTERY#0.8401;CEREBRAL ARTERY#0.8398;DEMYELINATING DISEASE#0.8388;PROTEIN KINASE#0.8336;CHONDROCYTE#0.8293;CELL SURFACE ANTIGEN#0.8270;PERIPHERAL NERVOUS SYSTEM#0.8244;ENDOTHELIUM#0.8242;PERIPHERAL BLOOD#0.8223;CELL BODY#0.8182;CONNECTIVE TISSUE#0.8123;NEURITE GROWTH#0.8081;OLIGODENDROGLIAL PROGENITOR CELLS#0.8078;TUMOR NECROSIS FACTOR#0.8044;OLIGODENDROCYTE DIFFERENTIATION#0.8001;CEREBRAL ARTERY OCCLUSION#0.7971;METASTATIC MELANOMA#0.7968;CEREBELLAR GRANULE NEURON#0.7961;SIGNAL TRANSDUCTION#0.7926;PHOSPHODIESTERASE#0.7884;TUMOR ANTIGEN#0.7863;MORPHOGENESIS#0.7757;PLASMA MEMBRANE#0.7729;CHONDROSARCOMA#0.7642;GROWTH CONE#0.7610;OLIGODENDROCYTE LINEAGE CELLS#0.7591;TUBE FORMATION#0.7573;EXOSOME#0.7530;ASTROCYTOMA#0.7528;APOPTOTIC#0.7509;CANCER STEM CELL#0.7457;HAIR FOLLICLE#0.7453;HEMATOPOIETIC CELL#0.7421;CELL POLARITY#0.7416;STRESS FIBER#0.7416;FOREBRAIN#0.7395;CYTOTOXICITY#0.7286;OSTEOBLAST#0.7285;TIGHT JUNCTION#0.7259;ACTIN CYTOSKELETON#0.7255;LYSIS#0.7234;VENULE#0.7219;BREAST CARCINOMA#0.7207;MESENCHYMAL CELL#0.7204;ACTION POTENTIAL#0.7191;BREAST CANCER PATIENTS#0.7167;MYOGENIC CELL#0.7128;CELL ASSOCIATED#0.7056;CEREBRAL ISCHEMIA#0.7020;ALZHEIMER'S DISEASE#0.7001;PRO-INFLAMMATORY#0.6916;VASCULAR CELL#0.6874;VASCULAR ENDOTHELIAL CELL#0.6873;CELL DIFFERENTIATION#0.6843;COLLAGEN BINDING#0.6839;MONOCYTE#0.6832;T LYMPHOCYTE#0.6807;EPHRIN#0.6805;INTEGRIN ACTIVATION#0.6787;GALECTIN#0.6781;EMBRYONIC STEM CELL#0.6776;ANCHORAGE INDEPENDENT GROWTH#0.6759;FOCAL ADHESION#0.6756;CELL DIVISION#0.6747;INTERVERTEBRAL DISC#0.6736;NMDA RECEPTOR#0.6704;NITRIC OXIDE#0.6702;THYMIDINE#0.6681;MYELOID LEUKEMIA#0.6680;HYPOXIC#0.6678;SQUAMOUS CELL CARCINOMA#0.6675;ACUTE MYELOID LEUKEMIA#0.6640;INSULIN-LIKE GROWTH FACTOR#0.6561;ADIPOCYTE#0.6537;NEURONAL CELLS#0.6528;NEUROFILAMENT#0.6506;TRAUMATIC BRAIN INJURY#0.6495;NERVE FIBER#0.6489;IMMUNE CELL#0.6434;SPINAL CORD LESIONS#0.6428;KINASE INHIBITOR#0.6316;BRAIN DAMAGE#0.6294;IMMUNE SYSTEM#0.6253;OLIGODENDROGLIOMA#0.6242;NEUROGENESIS#0.6228;CELL ACTIVATION#0.6228;CYTOPLASM#0.6186;MICROTUBULE ASSOCIATED PROTEIN#0.6186;RECEPTOR TYROSINE KINASE#0.6164;VASCULAR MORPHOGENESIS#0.6101;DEATH RECEPTOR#0.6051
146556	THYROID TRANSCRIPTION FACTOR#0.9230;TRANSCRIPTION FACTOR#0.8956
1465	C REACTIVE PROTEIN#1.0496;GLYCINE#1.0294;SMOOTH MUSCLE#1.0142;FOCAL ADHESION#0.9947;TRANSCRIPTION FACTOR#0.9921;CELL ADHESION#0.9834;GENE EXPRESSION#0.9730;FIBRINOGEN#0.9639;SKELETAL MUSCLE#0.9613;MUSCLE CELL#0.9603;PROTEIN PROTEIN INTERACTION#0.9521;ACTIN CYTOSKELETON#0.9464;DNA BINDING#0.9338;CANCER CELL#0.9326;GROWTH FACTOR#0.9154;ZINC BINDING#0.9100;T CELL#0.9076;CYSTATIN#0.9044;SIGNAL TRANSDUCTION#0.9014;SMOOTH MUSCLE CELL#0.9002;BREAST CANCER#0.8972;LUMINAL#0.8835;ACTIN FILAMENT#0.8817;CROHN'S DISEASE#0.8708;ACTIN BINDING#0.8587;CELL PROLIFERATION#0.8512;APOPTOSIS#0.8439;CYTOPLASM#0.8423;SIGNALING PATHWAY#0.8254;POTATO VIRUS X#0.8038;TUMOR SUPPRESSOR#0.7972;URIC ACID#0.7884;CAMP BINDING#0.7788;ENDOTHELIAL CELL#0.7669;PERIPHERAL BLOOD#0.7659;CELL MIGRATION#0.7618;COMPLEMENT ACTIVITY#0.7462;REACTIVE OXYGEN SPECIES#0.7414;STRESS FIBER#0.7271;CELL GROWTH#0.7246;CELL DEATH#0.7239;CELL CYCLE#0.7238;PROSTATE CANCER#0.7192;ARTERY#0.7166;PROTEIN KINASE#0.7162;MYOBLAST#0.7104;ZINC FINGER PROTEIN#0.7092;WHITE BLOOD CELL#0.7064;CELL MOVEMENT#0.6809;CARDIAC MUSCLE#0.6784;EXTRACELLULAR MATRIX#0.6748;NEUTROPHIL#0.6740;EPITHELIAL CELL#0.6736;TUMOUR NECROSIS FACTOR#0.6691;VASCULAR SMOOTH MUSCLE CELL#0.6621;STEM CELL#0.6572;POLYMERASE CHAIN REACTION#0.6570;KERATINOCYTE#0.6569;COMPLEMENT RESPONSE#0.6507;TRANSACTIVATION#0.6455;IMMUNE RESPONSE#0.6453;TUMOR NECROSIS FACTOR#0.6443;LEUKOCYTE#0.6422;HEPATIC STELLATE CELL#0.6341;MUTAGENESIS#0.6337;ADHERENS JUNCTION#0.6316;ACUTE PHASE RESPONSE#0.6259;BONE FORMATION#0.6253;ERYTHROPOIESIS#0.6245;REGENERATION#0.6230;ANDROGEN RECEPTOR#0.6201;ACTIN BINDING PROTEIN#0.6130
146664	GLCNAC#0.8425;N GLYCAN#0.8425;GLYCOSYLATION#0.8378;NEURITE OUTGROWTH#0.8167;NEURITE#0.6198
1466	SMOOTH MUSCLE#1.0756;GLYCINE#1.0699;SMOOTH MUSCLE CELL#1.0684;MUSCLE CELL#1.0649;VASCULAR SMOOTH MUSCLE CELL#1.0091;GROWTH FACTOR#0.9692;GENE EXPRESSION#0.8588;HEPATIC STELLATE CELL#0.8410;TRANSCRIPTION FACTOR#0.8046;SERUM RESPONSE FACTOR#0.7837;SMOOTH MUSCLE ACTIN#0.7725;MUSCLE LIM PROTEIN#0.7002;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6979;POLYMERASE CHAIN REACTION#0.6650;ACTIN CYTOSKELETON#0.6540;TRANSFORMING GROWTH FACTOR#0.6437;ACTIN FILAMENT#0.6318;AORTIC SMOOTH MUSCLE CELLS#0.6274;STRESS FIBER#0.6249;CANCER CELL#0.6217;SIGNALING PATHWAY#0.6146;BREAST CANCER#0.6101
146712	BETA-2#1.0502;TRANSFORMING GROWTH FACTOR#1.0244;GROWTH FACTOR#1.0215;TRANSFORMING GROWTH FACTOR BETA#1.0190;EXTRACELLULAR MATRIX#0.9744;CELL SURFACE#0.9740;CELL ADHESION#0.9719;ENDOTHELIAL CELL#0.9372;SIGNALING PATHWAY#0.9368;SMOOTH MUSCLE#0.9337;PROTEIN KINASE#0.9255;ADRENERGIC RECEPTOR#0.8768;FOCAL ADHESION#0.8513;SODIUM CHANNEL#0.8089;EPITHELIAL CELL#0.8014;T CELL#0.8008;BETA ADRENOCEPTOR#0.7860;APOPTOSIS#0.7851;CANCER CELL#0.7848;GENE EXPRESSION#0.7634;BREAST CANCER#0.7490;INTEGRIN ACTIVATION#0.6946;BREAST CANCER CELL#0.6854;SKELETAL MUSCLE#0.6777;MITOGEN ACTIVATED PROTEIN#0.6772;KERATINOCYTE#0.6547;CELL MIGRATION#0.6538;POLYMERASE CHAIN REACTION#0.6508;OOCYTE#0.6394;BASEMENT MEMBRANE#0.6375;PROTEIN KINASE C#0.6350;ANGIOGENESIS#0.6344;MUSCLE CELL#0.6343;ADIPOCYTE#0.6298;FOCAL ADHESION KINASE#0.6295;T LYMPHOCYTE#0.6282;HAIR FOLLICLE#0.6026;SCHWANN CELL#0.6006;TUMOR CELLS#0.6001
146713	FLUORO JADE B#1.0486;NEUROFILAMENT#1.0341;MICROTUBULE ASSOCIATED PROTEIN#1.0262;RNA BINDING#1.0250;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0175;RNA BINDING PROTEIN#1.0146;ACTIVE CASPASE 3#1.0122;MICROTUBULE#1.0094;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#1.0093;CYTOPLASM#0.9948;OLIGODENDROCYTE#0.9937;HYPOXIA#0.9927;NITRIC OXIDE#0.9910;NEURAL CELL#0.9906;NEUROBLAST#0.9901;SUBSTANTIA NIGRA#0.9886;FRONTAL#0.9857;IMMATURE NEURON#0.9840;NEURITE#0.9833;2'-DEOXYURIDINE#0.9830;NEURONAL CELLS#0.9818;NEURAL STEM CELL#0.9806;ASTROCYTE#0.9792;CLEAVED CASPASE 3#0.9786;CEREBRAL CORTEX#0.9771;GLIAL CELL#0.9769;CELL CYCLE#0.9759;DENTATE GYRUS#0.9756;MACROPHAGE#0.9745;OLFACTORY BULB#0.9745;INTERNEURON#0.9737;SPINAL CORD#0.9735;HYPOXIC#0.9729;TRANSCRIPTION FACTOR#0.9724;TUMOR CELLS#0.9710;STRIATUM#0.9709;NEURONAL CELL DEATH#0.9697;PROTEIN KINASE#0.9696;APOPTOSIS#0.9693;FOCAL CEREBRAL ISCHEMIA#0.9686;EPILEPSY#0.9679;HIPPOCAMPAL DENTATE GYRUS#0.9671;NEUROGENESIS#0.9661;CELL PROLIFERATION#0.9657;ISCHEMIA#0.9652;CELL ADHESION#0.9651;PROGENITOR CELL#0.9649;APOPTOTIC#0.9645;NITRIC OXIDE SYNTHASE#0.9630;CELL ADHESION MOLECULE#0.9627;ALZHEIMER'S DISEASE#0.9625;FOREBRAIN#0.9615;DNA METHYLATION#0.9615;NEUROPROTECTION#0.9614;STEM CELL#0.9610;ENDOTHELIAL CELL#0.9603;CENTRAL NERVOUS SYSTEM#0.9602;HUNTINGTON'S DISEASE#0.9601;CEREBRAL ARTERY OCCLUSION#0.9599;CEREBRAL ISCHEMIA#0.9591;NEURITE OUTGROWTH#0.9590;NERVOUS SYSTEM#0.9583;SIGNALING PATHWAY#0.9575;TRAUMATIC BRAIN INJURY#0.9571;MIDDLE CEREBRAL ARTERY#0.9567;CEREBRAL ARTERY#0.9565;TEMPORAL LOBE#0.9565;GROWTH FACTOR#0.9559;REGENERATION#0.9538;PARKINSON'S DISEASE#0.9535;GENE EXPRESSION#0.9527;CELL DEATH#0.9524;PURKINJE CELL#0.9511;DOPAMINE#0.9511;NEURAL PROGENITOR CELL#0.9506;SPINAL CORD INJURY#0.9499;ARTERY#0.9486;EOSIN#0.9482;NEURODEGENERATIVE DISEASE#0.9475;CELL BODY#0.9459;BRAIN DAMAGE#0.9457;MITOCHONDRIA#0.9456;BONE MARROW#0.9454;BLOOD BRAIN BARRIER#0.9385;PYRAMIDAL CELL#0.9384;NMDA RECEPTOR#0.9379;GLUTAMATE RECEPTOR#0.9373;AMYGDALA#0.9362;ASPARTATE#0.9338;GANGLION CELLS#0.9326;BRAIN CORTEX#0.9314;ENDOPLASMIC RETICULUM#0.9293;DNA FRAGMENTATION#0.9289;TEMPORAL LOBE EPILEPSY#0.9269;BRAIN DEVELOPMENT#0.9261;THALAMUS#0.9240;MICROGLIAL CELL#0.9236;CHOLINE#0.9234;MORRIS WATER MAZE#0.9227;DOPAMINERGIC NEURON#0.9213;LATERAL VENTRICLE#0.9210;PERIPHERAL NERVE#0.9207;TUMOR NECROSIS FACTOR#0.9199;NUCLEAR MEMBRANE#0.9162;GLOBAL CEREBRAL ISCHEMIA#0.9160;REACTIVE OXYGEN SPECIES#0.9156;MESENCHYMAL STEM CELL#0.9138;MITOGEN ACTIVATED PROTEIN#0.9113;POLYMERASE CHAIN REACTION#0.9089;BIOTIN#0.9076;GLUTAMIC ACID#0.9057;NEURONAL PROGENITOR CELL#0.9051;TRANSIENT CEREBRAL ISCHEMIA#0.9045;AMYLOID PRECURSOR PROTEIN#0.9035;PRO-INFLAMMATORY#0.9014;ADULT HIPPOCAMPAL NEUROGENESIS#0.8978;UBIQUITIN#0.8978;INFLAMMATORY RESPONSE#0.8961;CAROTID ARTERY#0.8904;RECEPTOR ANTAGONIST#0.8899;PRECURSOR CELL#0.8850;DENDRITIC SPINE#0.8833;DORSAL ROOT GANGLION#0.8829;APOPTOTIC CELL DEATH#0.8820;PARENCHYMA#0.8794;BRAIN ISCHEMIA#0.8777;ATPASE ACTIVITY#0.8740;NUCLEAR MATRIX#0.8699;ENDOTHELIAL GROWTH FACTOR#0.8692;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8692;PROGRAMMED CELL DEATH#0.8668;BASAL GANGLIA#0.8665;MAGNETIC RESONANCE IMAGING#0.8643;CONTROLLED CORTICAL IMPACT#0.8630;NERVE GROWTH FACTOR#0.8626;GESTATION#0.8618;SCIATIC NERVE#0.8589;CYTOCHROME C#0.8585;PROPIDIUM#0.8585;NEUROTOXICITY#0.8572;GLUTAMINE#0.8556;DNA BINDING#0.8545;HERPES SIMPLEX VIRUS#0.8544;HERPES SIMPLEX#0.8541;MIDBRAIN#0.8541;SUPEROXIDE DISMUTASE#0.8530;NEUROLOGICAL DISORDER#0.8527;ISCHEMIA REPERFUSION INJURY#0.8512;DEMENTIA#0.8511;CAMP RESPONSE ELEMENT BINDING#0.8508;CAMP RESPONSE ELEMENT#0.8497;STATUS EPILEPTICUS#0.8463;CELL SURFACE#0.8412;RETINOIC ACID#0.8354;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8347;ADENOSINE#0.8347;HIPPOCAMPAL REGION#0.8313;ENZYME ACTIVITY#0.8311;AUTOPHAGY#0.8308;HEMORRHAGE#0.8276;LASER SCANNING MICROSCOPY#0.8271;EDEMA#0.8245;SIGNAL TRANSDUCTION#0.8235;STROMAL CELL#0.8185;THYMIDINE#0.8171;PLASMA MEMBRANE#0.8164;T CELL#0.8137;BLOOD VESSEL#0.8121;QUINOLINIC ACID#0.8095;SUCROSE#0.8049;DNA REPAIR#0.8041;SPATIAL LEARNING#0.8033;PHOSPHODIESTERASE#0.7966;GABAERGIC NEURON#0.7965;CYCLIC AMP#0.7891;FETAL BRAIN#0.7884;NEURONAL CELL BODIES#0.7852;8-HYDROXY-2'-DEOXYGUANOSINE#0.7823;COMMON CAROTID ARTERY#0.7811;ACETYLCHOLINE#0.7798;MEMORY IMPAIRMENT#0.7786;B CELL#0.7768;NEURONAL MIGRATION#0.7768;KINASE ACTIVITY#0.7766;CORONAL#0.7726;EMBRYONIC STEM CELL#0.7720;MRNA SPLICING#0.7679;CELLULAR LOCALIZATION#0.7660;TOXICITY#0.7632;PEROXISOMAL#0.7610;ADENO ASSOCIATED VIRUS#0.7464;FORMALIN#0.7444;ACETYLCHOLINE RECEPTOR#0.7443;PHOSPHOLIPASE D#0.7410;SYNAPTOGENESIS#0.7362;NERVE FIBER#0.7332;TRANSMISSION ELECTRON MICROSCOPY#0.7320;AMYOTROPHIC LATERAL SCLEROSIS#0.7311;LATERAL SCLEROSIS#0.7311;NEURAL PRECURSOR CELL#0.7309;CORTICAL CELL#0.7299;NUCLEAR ENVELOPE#0.7257;COENZYME A#0.7208;EXTRACELLULAR MATRIX#0.7180;DIGESTION#0.7177;NERVOUS TISSUE#0.7158;ESTRADIOL#0.7113;ETHANOL#0.7075;NEUROTOXIN#0.7068;SPINAL DORSAL HORN#0.7057;ROSTRAL MIGRATORY STREAM#0.7047;ORGANELLE#0.7044;POSTSYNAPTIC DENSITY#0.7040;NEUROBLAST DIFFERENTIATION#0.7040;NUCLEAR LAYER#0.7037;OXYGEN GLUCOSE DEPRIVATION#0.7036;TRANSFORMING GROWTH FACTOR#0.7019;RETINAL GANGLION CELL#0.7007;OPTIC NERVE#0.7000;HIGH MOBILITY GROUP#0.6991;S PHASE#0.6964;FIBROBLAST GROWTH FACTOR#0.6952;SMOOTH MUSCLE#0.6924;PRE-MRNA SPLICING#0.6890;PERIPHERAL NERVOUS SYSTEM#0.6855;NEUROBLASTOMA#0.6849;NEUROTOXIC#0.6834;RETICULAR FORMATION#0.6827;HEAT SHOCK PROTEIN#0.6808;RNA SYNTHESIS#0.6763;SWELLING#0.6748;STEM CELL MARKER#0.6745;LIGHT CHAIN 3#0.6735;CAROTID ARTERY OCCLUSION#0.6725;TISSUE DAMAGE#0.6715;PLATELET ACTIVATING FACTOR#0.6700;NEUROPATHY#0.6690;ESTROGEN RECEPTOR#0.6683;URIDINE#0.6676;BRAIN EDEMA#0.6670;PROTEASOME#0.6628;METHYL CPG BINDING#0.6619;COGNITION#0.6618;ACTIVATED CASPASE 3#0.6614;LYSOSOME#0.6606;RECEPTOR AGONIST#0.6591;INTERMEDIATE FILAMENT#0.6570;ROUGH ENDOPLASMIC RETICULUM#0.6483;MYELINATION#0.6459;OLEIC ACID#0.6455;PEROXISOME#0.6455;SYNAPTIC TRANSMISSION#0.6448;GLUTATHIONE#0.6433;SMOOTH MUSCLE ACTIN#0.6430;LUNG CANCER#0.6428;DNA REPLICATION#0.6416;LITHIUM#0.6330;MOTOR ACTIVITY#0.6302;SYNAPTIC VESICLE#0.6275;SCHWANN CELL#0.6270;GLUTAMATE DECARBOXYLASE#0.6249;TELENCEPHALON#0.6213;EMBRYONIC BRAIN#0.6201;URIDINE 5'-TRIPHOSPHATE#0.6200;AXONAL TRANSPORT#0.6197;NEURONAL INTRANUCLEAR INCLUSIONS#0.6170;PHOSPHATE BUFFERED SALINE#0.6133;FOCAL CORTICAL DYSPLASIA#0.6132;NEUROFIBRILLARY TANGLE#0.6129;SYNAPTOSOME#0.6112;ACTION POTENTIAL#0.6106;RNA RECOGNITION MOTIF#0.6105;ASTROCYTOMA#0.6097;PHOSPHOLIPASE D ACTIVITY#0.6082;REGIONS OF INTEREST#0.6080;MECHANISM OF ACTION#0.6080;CELL MEMBRANE#0.6079;REVERSE TRANSCRIPTION#0.6067;AMACRINE CELL#0.6060;MICROSOME#0.6053;IMMUNE RESPONSE#0.6048;CEREBRAL INFARCTION#0.6033;ANGIOGENESIS#0.6022;OLIGODENDROGLIOMA#0.6019;GLUCOSE REPRESSION#0.6009
146722	MYELOID CELL#1.0760;MAST CELL#1.0634;MACROPHAGE#0.9952;T CELL#0.9619;CELL SURFACE#0.9363;MONOCYTE#0.9161;DENDRITIC CELL#0.8657;EOSINOPHIL#0.8508;NEUTROPHIL#0.8201;CYTOKINE PRODUCTION#0.8111;CELL ACTIVATION#0.8026;BONE MARROW#0.7937;PHAGOCYTOSIS#0.7917;INFLAMMATORY RESPONSE#0.7630;APOPTOTIC#0.7462;MAST CELL ACTIVATION#0.7202;EOSINOPHIL HOMEOSTASIS#0.7049;PHOSPHATIDYLSERINE#0.7046;LEUKOCYTE#0.7025;AUTOIMMUNE DISEASE#0.6905;IMMUNE RESPONSE#0.6620;LYSIS#0.6298;MICROGLIAL CELL#0.6183;PERIPHERAL BLOOD#0.6100;MULTIPLE SCLEROSIS#0.6066;ADIPOSE TISSUE#0.6044;CELL DEATH#0.6013
146754	DYNEIN#0.7472
146760	NERVOUS SYSTEM#0.7805;REGENERATION#0.7147
146771	CELL ADHESION MOLECULE#0.9635;CELL ADHESION#0.9607;GERM CELL#0.8951;TUMOR SUPPRESSOR#0.6475;SPERMATOCYTES#0.6082
146802	METFORMIN#1.0434;ORGANIC CATION TRANSPORTER#1.0275;ORGANIC ANION TRANSPORTER#0.9877;CIMETIDINE#0.9752;BRUSH BORDER#0.9707;BRUSH BORDER MEMBRANE#0.9268;RESPONSE TO METFORMIN#0.9073;EXCRETION#0.9035;HUMAN EMBRYONIC KIDNEY#0.8747;EMBRYONIC KIDNEY#0.8743;BREAST CANCER#0.8731;CISPLATIN#0.8704;TRIMETHOPRIM#0.8578;EPITHELIAL CELL#0.8097;RENAL TUBULAR SECRETION#0.8096;GLOMERULAR FILTRATION#0.8072;TETRAETHYLAMMONIUM#0.7757;TOXICITY#0.6538;PYRIMETHAMINE#0.6498;TYPE 2 DIABETES#0.6393;CARNITINE#0.6322;LUMINAL#0.6228;OXALIPLATIN#0.6134;PROXIMAL TUBULE CELL#0.6088;RENAL CELL CARCINOMA#0.6044
146849	GERM CELL#0.7534
146852	SPERM TAIL#0.9491;OUTER DENSE FIBER#0.7188;CHRONIC MYELOID LEUKEMIA#0.6209;MYELOID LEUKEMIA#0.6122;POLYMERASE CHAIN REACTION#0.6105
146862	THICK FILAMENT#1.0960;STRIATED MUSCLE#1.0632;BODY WALL MUSCLE#1.0204;SKELETAL MUSCLE#1.0194;MUSCLE CELL#0.9741;MYOSIN HEAVY CHAIN#0.9709;SARCOMERE#0.9475;MYOFIBRIL#0.9190;MYOSIN THICK FILAMENT#0.9046;GENE EXPRESSION#0.8993;HEAT SHOCK PROTEIN#0.8462;A BAND#0.8401;CARDIAC MUSCLE#0.8295;MYOSIN BINDING#0.8107;NON-MUSCLE MYOSIN#0.8027;CYTOKINESIS#0.7778;CHAPERONE ACTIVITY#0.7050;Z LINE#0.6299;MYOSIN COMPLEX#0.6290;PARALYSIS#0.6110
146880	CELL PROLIFERATION#0.7788;CELL CYCLE#0.7437;LUNG CANCER#0.6483
146894	ENDOTHELIAL CELL#0.9386;AMBULATORY BLOOD PRESSURE#0.6100
1468	DICARBOXYLATE CARRIER#1.1311;MITOCHONDRIA#0.9511;CANCER CELL#0.8667;MITOCHONDRIAL MEMBRANE#0.8247;GLUTATHIONE#0.8170;MITOCHONDRIAL INNER MEMBRANE#0.7595;FATTY ACID SYNTHESIS#0.6362;APOPTOSIS#0.6328;CELL GROWTH#0.6208;CITRATE TRANSPORT#0.6176
146909	KINESIN#1.0633;CELL CYCLE#0.9677;MICROTUBULE#0.9643;MITOSIS#0.8150;CELL PROLIFERATION#0.7489;ASTRAL MICROTUBULE#0.6804;LUNG ADENOCARCINOMA#0.6443;INTERPHASE#0.6371;SPINDLE POSITIONING#0.6320;MICROTUBULE END#0.6280;MITOTIC ENTRY#0.6137;CELL DIVISION#0.6015
146956	MUS81-EME1 COMPLEX#1.1293;REPLICATION FORK#1.0364;DNA REPAIR#1.0279;HOMOLOGOUS RECOMBINATION#0.9995;DOUBLE STRAND BREAK#0.9892;S PHASE#0.9615;ENDONUCLEASE COMPLEX#0.9447;DNA REPLICATION#0.9095;FANCONI ANEMIA#0.9007;ENDONUCLEASE ACTIVITY#0.8685;CHROMATID#0.8539;CHROMOSOME SEGREGATION#0.8253;MITOSIS#0.8142;ICL REPAIR#0.7960;CELL CYCLE#0.7686;DNA DAMAGE RESPONSE#0.7662;ANEMIA#0.7611;CANCER CELL#0.7375;COMPLEX I#0.7357;RESOLUTION OF RECOMBINATION INTERMEDIATES#0.7158;TOPOISOMERASE#0.7035;DNA HELICASE#0.6984;MEIOSIS#0.6744;FANCONI ANEMIA COMPLEMENTATION GROUP A#0.6289
1469	CYSTATIN#1.0655;CANCER CELL#1.0244;COLORECTAL CANCER#0.9907;CELL PROLIFERATION#0.9781;EPITHELIAL CELL#0.9198;COLORECTAL#0.9041;PROTEINASE INHIBITOR#0.8539;BREAST CANCER#0.8053;BREAST CANCER CELL#0.7451;GENE EXPRESSION#0.6992;CELLULAR SENESCENCE#0.6988;SQUAMOUS CELL CARCINOMA#0.6881;SENESCENCE#0.6454;SUBMANDIBULAR GLAND#0.6240;ALLERGIC RHINITIS#0.6130;PANCREATIC CANCER#0.6116;GLUTATHIONE#0.6091;BURNING MOUTH SYNDROME#0.6072;COLON CANCER#0.6055;LUNG CANCER#0.6022;CELL DEATH#0.6005
146	ADRENERGIC RECEPTOR#1.0556;RECEPTOR ANTAGONIST#1.0521;PHENYLEPHRINE#0.9635;PRAZOSIN#0.9566;NORADRENALINE#0.9510;SMOOTH MUSCLE#0.9078;TAMSULOSIN#0.8033;RECEPTOR AGONIST#0.7523;GENE EXPRESSION#0.7194;PROTEIN KINASE#0.7145;SIGNALING PATHWAY#0.7143;DECANE#0.7032;ARTERY#0.6766;NOREPINEPHRINE#0.6383;PROTEIN KINASE C#0.6146;DOMPERIDONE#0.6037
147007	V-ATPASE ASSEMBLY#0.8017;VACUOLAR MEMBRANE#0.7754;ENDOPLASMIC RETICULUM#0.7143;ATPASE COMPLEX#0.6633;GLYCOSYLATION#0.6057;ATPASE ACTIVITY#0.6000
147040	TUMOR SUPPRESSOR#0.9796;RETINOIC ACID#0.7771
1470	PROTEINASE INHIBITOR#1.0866;CYSTATIN#1.0642;SUBMANDIBULAR GLAND#0.8612;SALIVARY GLAND#0.6828;ISOPROTERENOL#0.6770;BREAST CANCER#0.6048
147111	CELL SURFACE#0.7972;SIGNALING PATHWAY#0.7833;BONE FORMATION#0.7057;GENE EXPRESSION#0.6796;CORTICAL BONE THICKNESS#0.6693;STEM CELL#0.6521;SYNAPTIC SIGNALING#0.6521;PANETH CELL#0.6436;FUNCTIONAL DIFFERENTIATION#0.6423;PROTEOGLYCAN#0.6332
147138	EPIDERMODYSPLASIA VERRUCIFORMIS#1.0668;SQUAMOUS CELL CARCINOMA#0.9516;SKIN CANCER#0.9262;T CELL#0.8764;KERATINOCYTE#0.8474;CERVICAL CANCER#0.7513;SKIN CARCINOMA#0.6401;CERVICAL#0.6324;SIGNALING PATHWAY#0.6082
147166	IMMUNE RESPONSE#0.8967
147179	ACTIN FILAMENT#0.9829;WASP INTERACTING PROTEIN#0.6972;ACTIN CROSS-LINKING ACTIVITY#0.6950;MICROSPIKE FORMATION#0.6867;PLATELET-DERIVED GROWTH FACTOR#0.6566;EPITHELIAL CELL#0.6492;GROWTH FACTOR#0.6461;ACTIN CYTOSKELETON#0.6073;AIRWAY EPITHELIAL CELL#0.6007
147183	HAIR FOLLICLE#0.9490;ROOT SHEATH#0.8231
147199	RESPIRATORY TRACT INFECTION#0.7319;OVARIAN CARCINOMA#0.7242;RESPIRATORY TRACT#0.7237
1471	RETINOL BINDING#1.0400;VANCOMYCIN#1.0395;LIVER CIRRHOSIS#1.0375;RETINOL#1.0358;SEMINAL PLASMA#1.0347;GALECTIN#1.0336;AMYLOID PRECURSOR PROTEIN#1.0328;GROWTH DIFFERENTIATION FACTOR#1.0289;RISK OF DEATH#1.0282;ASYMMETRIC DIMETHYLARGININE#1.0274;AMYLOID PROTEIN#1.0269;CYSTATIN#1.0265;BETA-2#1.0265;CEREBRAL HEMORRHAGE#1.0263;RENAL TRANSPLANT RECIPIENTS#1.0262;BREAST CANCER#1.0258;OSTEOCLAST#1.0251;KIDNEY INJURY MOLECULE#1.0250;FIBRINOGEN#1.0249;C-LEVEL#1.0246;IOTHALAMATE#1.0246;FATTY ACID BINDING#1.0242;BRAIN NATRIURETIC PEPTIDE#1.0202;ENDOTHELIAL GROWTH FACTOR#1.0201;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0201;CATHEPSIN B ACTIVITY#1.0178;RESIDUAL RENAL FUNCTION#1.0177;PROTEINASE INHIBITOR#1.0177;BLOOD UREA NITROGEN#1.0158;FOLATE#1.0155;ALPHA-2 MACROGLOBULIN#1.0145;SERUM URIC ACID#1.0140;CANCER CELL#1.0135;ASTROCYTE#1.0133;URIC ACID#1.0130;CEREBRAL INFARCTION#1.0128;TRANSFORMING GROWTH FACTOR#1.0126;ALKALINE PHOSPHATASE#1.0123;AMYLOIDOSIS#1.0119;NEUTROPHIL#1.0114;RHEUMATOID ARTHRITIS#1.0108;DENDRITIC CELL#1.0093;TUMOR NECROSIS FACTOR#1.0089;KIDNEY TRANSPLANT RECIPIENTS#1.0085;ALBUMIN CREATININE RATIO#1.0085;FIBRIL#1.0080;PULSE WAVE VELOCITY#1.0071;CEREBRAL AMYLOID ANGIOPATHY#1.0068;ESTIMATE GLOMERULAR FILTRATION#1.0060;C REACTIVE PROTEIN#1.0059;TYPE 2 DIABETIC#1.0057;HEMORRHAGE#1.0052;WHITE BLOOD CELL#1.0049;SERUM ALBUMIN#1.0046;MONOCYTE#1.0040;PARATHYROID HORMONE#1.0039;INTIMA MEDIA THICKNESS#1.0035;72-HOURS#1.0033;ACUTE CORONARY SYNDROME#1.0025;TRANSFORMING GROWTH FACTOR BETA#1.0025;URINARY PROTEIN#1.0016;CONTRAST INDUCED NEPHROPATHY#1.0008;GLUTATHIONE#1.0007;ACUTE HEART FAILURE#1.0006;MACULAR DEGENERATION#0.9995;CISPLATIN#0.9994;CREATINE#0.9993;INULIN#0.9991;BLOOD PLASMA#0.9982;MULTIPLE REGRESSION ANALYSIS#0.9982;IOHEXOL#0.9979;ACUTE MYOCARDIAL INFARCTION#0.9979;ALANINE#0.9976;SERUM AMYLOID A#0.9972;PARATHYROID#0.9967;AMYOTROPHIC LATERAL SCLEROSIS#0.9967;LATERAL SCLEROSIS#0.9967;VITAMIN B12#0.9966;T CELL#0.9964;CREATININE CLEARANCE RATE#0.9962;FIBROBLAST GROWTH FACTOR#0.9962;ACUTE ISCHEMIC STROKE#0.9957;N-ACETYLCYSTEINE#0.9951;VASCULAR DISEASE#0.9947;CREATINE KINASE#0.9942;LEUKOCYTE#0.9941;ADJUSTED HAZARD RATIO#0.9941;KIDNEY FAILURE#0.9938;TYPE 2 DIABETES MELLITUS#0.9938;2 DIABETES MELLITUS#0.9938;MULTIPLE LINEAR REGRESSION#0.9937;CORONARY ARTERY BYPASS#0.9936;HIGH DENSITY LIPOPROTEIN#0.9936;PERCUTANEOUS CORONARY INTERVENTION#0.9928;SPINAL CORD#0.9928;MACROPHAGE#0.9926;GLOMERULAR FILTRATION#0.9916;CORONARY ARTERY DISEASE#0.9916;AORTIC ANEURYSM#0.9911;GLOMERULAR FILTRATION RATE#0.9909;DIABETIC KIDNEY DISEASE#0.9906;GROWTH FACTOR#0.9905;ATHEROSCLEROTIC#0.9904;LEFT VENTRICULAR MASS#0.9894;ARTERY DISEASE#0.9893;LINEAR REGRESSION ANALYSIS#0.9890;SYSTOLIC BLOOD PRESSURE#0.9890;PARKINSON'S DISEASE#0.9887;ADJUSTED ODDS RATIO#0.9882;SUPEROXIDE DISMUTASE#0.9881;BONE RESORPTION#0.9876;CARDIOVASCULAR HEALTH STUDY#0.9874;LIVER DISEASE#0.9871;LOW DENSITY LIPOPROTEIN#0.9868;EXCRETION#0.9862;ADIPOSE TISSUE#0.9861;SMOOTH MUSCLE#0.9860;HEPATORENAL SYNDROME#0.9859;ALZHEIMER'S DISEASE#0.9850;BODY SURFACE AREA#0.9848;CORONARY ARTERY#0.9844;CORONARY HEART DISEASE#0.9844;ENDOTHELIAL CELL#0.9843;CHOROID PLEXUS#0.9841;CARDIOVASCULAR RISK FACTOR#0.9839;MULTIVARIATE LINEAR REGRESSION#0.9839;ATHEROSCLEROSIS#0.9836;CENTRAL NERVOUS SYSTEM#0.9836;LUNG CANCER#0.9834;POLYMERASE CHAIN REACTION#0.9817;OBESE#0.9815;RECEIVER OPERATOR CHARACTERISTIC#0.9815;TYPE 1 DIABETES#0.9807;CHRONIC HEART FAILURE#0.9807;NERVOUS SYSTEM#0.9806;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9805;AGE RELATED MACULAR DEGENERATION#0.9802;KIDNEY DAMAGE#0.9802;ATRIAL FIBRILLATION#0.9794;ABDOMINAL AORTIC ANEURYSM#0.9793;TYPE 2 DIABETES#0.9788;BLOOD VESSEL#0.9788;EPITHELIAL CELL#0.9781;ACETYLCYSTEINE#0.9780;NEURODEGENERATIVE DISEASE#0.9777;TRADITIONAL RISK FACTORS#0.9772;MYOCARDIAL INFARCTION#0.9769;AND BODY COMPOSITION#0.9768;ARTERY#0.9768;DEMENTIA#0.9767;GLOMERULUS#0.9766;AMBULATORY BLOOD PRESSURE#0.9766;CELL DEATH#0.9766;CORD BLOOD#0.9765;PERIPHERAL BLOOD#0.9764;STEM CELL#0.9762;BONE MARROW#0.9762;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9760;MULTIPLE SCLEROSIS#0.9759;NEPHROTOXICITY#0.9758;LUPUS ERYTHEMATOSUS#0.9758;PROTEINURIA#0.9744;HEART AND SOUL#0.9744;INSULIN-LIKE GROWTH FACTOR#0.9743;EXTRACELLULAR MATRIX#0.9738;PERIPHERAL ARTERIAL DISEASE#0.9737;CELL ADHESION#0.9736;SMOOTH MUSCLE CELL#0.9735;MUSCLE CELL#0.9732;DIABETES MELLITUS#0.9732;MINI MENTAL STATE#0.9722;NITRIC OXIDE#0.9722;SLEEP APNEA#0.9721;MARKERS OF INFLAMMATION#0.9720;CELL ADHESION MOLECULE#0.9719;PRE-ECLAMPSIA#0.9716;HEART DISEASE#0.9712;CELL PROLIFERATION#0.9710;ACUTE KIDNEY INJURY#0.9706;B CELL#0.9702;DIABETIC NEPHROPATHY#0.9702;MILD COGNITIVE IMPAIRMENT#0.9698;APOPTOSIS#0.9696;RENAL REPLACEMENT THERAPY#0.9696;CHRONIC KIDNEY DISEASE#0.9689;NEPHROPATHY#0.9687;INTENSIVE CARE UNIT#0.9670;GENE EXPRESSION#0.9667;SPINAL CORD INJURY#0.9664;ACUTE RENAL INJURY#0.9662;KIDNEY DISEASE#0.9661;INFLAMMATORY RESPONSE#0.9650;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9650;HEPATITIS C#0.9642;LASER DESORPTION IONIZATION#0.9635;ANGIOTENSIN CONVERTING ENZYME#0.9631;HYPERTENSION#0.9630;CAROTID ARTERY#0.9622;TENOFOVIR#0.9617;SIGNAL PEPTIDE#0.9613;BONE MINERAL DENSITY#0.9613;ISCHEMIA#0.9610;PLASMA PROTEIN#0.9610;PROXIMAL TUBULAR CELL#0.9596;RANDOMIZED CONTROLLED TRIAL#0.9576;NEPHROTOXIC#0.9566;OBSTRUCTIVE SLEEP APNEA#0.9548;GENTAMICIN#0.9540;TOXICITY#0.9529;OVARIAN CANCER#0.9528;PODOCYTE#0.9526;NEPHRITIS#0.9503;TUMOR CELLS#0.9500;COLORECTAL CANCER#0.9480;PROTEASE ACTIVITY#0.9468;ENZYME INHIBITOR#0.9460;GROWTH FACTOR BINDING#0.9460;ASPARTATE#0.9457;MAGNETIC RESONANCE IMAGING#0.9430;UBIQUITIN#0.9427;PERIPHERAL ARTERY DISEASE#0.9425;GINGIVAL CREVICULAR FLUID#0.9417;WEIGHT LOSS#0.9412;MULTIPLE LOGISTIC REGRESSION#0.9410;ADVANCED GLYCATION END#0.9409;HUMAN IMMUNODEFICIENCY VIRUS#0.9407;RENAL ARTERY#0.9402;NEGATIVE PREDICTIVE VALUE#0.9399;DECOMPENSATED HEART FAILURE#0.9389;ESSENTIAL HYPERTENSION#0.9382;DELAYED GRAFT FUNCTION#0.9376;AORTIC VALVE#0.9322;ANEMIA#0.9311;MULTIPLE MYELOMA#0.9305;URINE ALBUMIN EXCRETION#0.9272;INFLAMMATORY CELL#0.9265;ISCHEMIA REPERFUSION INJURY#0.9255;CORONARY ARTERY CALCIFICATION#0.9242;CARDIAC RESYNCHRONIZATION THERAPY#0.9222;POSITIVE PREDICTIVE VALUE#0.9221;BASEMENT MEMBRANE#0.9190;VASCULAR RISK FACTORS#0.9189;HEPATITIS B#0.9180;VASCULAR CELL#0.9162;FASTING PLASMA GLUCOSE#0.9159;CONGENITAL HEART DISEASE#0.9157;PERIODONTITIS#0.9141;HYPERTHYROIDISM#0.9139;RECEIVER OPERATING CURVE#0.9114;OVARIAN#0.9105;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9087;NEPHRON#0.9075;VENOUS BLOOD#0.9064;CONGESTIVE HEART FAILURE#0.9058;IMMUNE RESPONSE#0.9046;WHITE MATTER LESIONS#0.9045;PROSTATE CANCER#0.9037;NEUROLOGICAL DISORDER#0.9029;EXTRACELLULAR FLUIDS#0.9017;LIMITS OF AGREEMENT#0.9012;SKELETAL MUSCLE#0.9004;AUTOPHAGY#0.8997;MONOCYTE CHEMOTACTIC PROTEIN#0.8996;ASCITES#0.8990;APOPTOTIC#0.8984;GESTATIONAL DIABETES MELLITUS#0.8975;GLOMERULONEPHRITIS#0.8967;GESTATIONAL DIABETES#0.8945;OSTEOPOROSIS#0.8937;ATORVASTATIN#0.8934;HEALTHY CONTROL SUBJECTS#0.8927;CORONARY ARTERY CALCIUM#0.8915;CYTOPLASM#0.8911;ESOPHAGEAL CANCER#0.8911;ENDOPLASMIC RETICULUM#0.8905;PHOSPHOLIPASE A2#0.8900;HEMORRHAGIC#0.8892;SIGNALING PATHWAY#0.8879;ENZYME ACTIVITY#0.8877;B CELL LYMPHOMA#0.8875;ECLAMPSIA#0.8861;LOW BIRTH WEIGHT#0.8838;FOLIC ACID#0.8837;GAMMA GLUTAMYLTRANSFERASE#0.8809;LEUCINE#0.8805;SECRETORY PATHWAY#0.8794;GESTATION#0.8775;ERYTHROCYTE#0.8763;NATIONAL KIDNEY FOUNDATION#0.8762;STEM CELL TRANSPLANTATION#0.8762;HYPOXIA#0.8736;IMMUNOGLOBULIN G#0.8724;DIGESTION#0.8719;NEURONAL CELLS#0.8712;AMNIOTIC FLUID#0.8706;RENAL FIBROSIS#0.8703;TYPE 1 DIABETES MELLITUS#0.8702;TYPE 1 DIABETIC#0.8698;URATE#0.8693;SERPIN#0.8664;ALPHA 1-ANTITRYPSIN#0.8657;ARGININE#0.8657;COLORECTAL#0.8625;PROGESTERONE#0.8616;LEAN BODY MASS#0.8607;KIDNEY TRANSPLANT PATIENTS#0.8598;PRO-INFLAMMATORY#0.8598;SELECTIN#0.8583;QUANTITATIVE REAL TIME#0.8566;DIABETIC RETINOPATHY#0.8565;ALDOSTERONE#0.8549;HEMATOPOIETIC STEM CELL#0.8546;NEUROFILAMENT#0.8533;VASCULAR DEMENTIA#0.8528;BREAST CANCER CELL#0.8524;HIGH RISK PATIENTS#0.8512;TESTOSTERONE#0.8488;LYSOSOME#0.8463;MATRIX METALLOPROTEINASE 1#0.8458;FASTING BLOOD GLUCOSE#0.8447;RENAL FILTRATION#0.8442;FRAMINGHAM RISK SCORE#0.8431;ANGIOGENESIS#0.8426;UROKINASE#0.8420;AREA UNDER CURVE#0.8407;SYSTOLIC HEART FAILURE#0.8405;CONNECTIVE TISSUE#0.8404;CARDIAC TROPONIN I#0.8404;DENTATE GYRUS#0.8391;CHRONIC LIVER DISEASE#0.8372;ARTERIOLE#0.8371;ESOPHAGEAL CARCINOMA#0.8367;DEXAMETHASONE#0.8365;PERIODONTAL DISEASE#0.8353;ALVEOLAR MACROPHAGE#0.8340;TUMOUR NECROSIS FACTOR#0.8327;MITRAL VALVE#0.8305;COMPUTED TOMOGRAPHY ANGIOGRAPHY#0.8286;GLIAL CELL#0.8281;NEURONAL CELL DEATH#0.8257;LENGTH OF STAY#0.8252;LUPUS NEPHRITIS#0.8243;TRANSCRIPTION FACTOR#0.8229;ADVERSE CLINICAL OUTCOME#0.8228;LIPID METABOLISM#0.8219;CEREBROVASCULAR DISEASE#0.8211;ACETIC ACID#0.8207;EPILEPSY#0.8188;SEMINAL VESICLE#0.8186;ROOT MEAN SQUARE#0.8186;INDUCED RENAL INJURY#0.8173;PROTEINASE ACTIVITY#0.8144;SPINA BIFIDA#0.8130;MEAN SQUARE ERROR#0.8129;FRAGMENT LENGTH POLYMORPHISM#0.8096;CEREBRAL ARTERY#0.8088;CARBOPLATIN#0.8080;STREPTOZOTOCIN#0.8060;MUSCULAR DYSTROPHY#0.8044;GINGIVITIS#0.8043;ESTRADIOL#0.8033;PROTEOGLYCAN#0.8032;GOLGI APPARATUS#0.8032;PROTEIN KINASE#0.8030;TUBULAR EPITHELIAL CELL#0.8026;COAGULATION#0.7986;SKELETAL MUSCLE MASS#0.7981;METFORMIN#0.7962;TRANSCRIPTASE#0.7931;COGNITION#0.7896;PEARSON CORRELATION COEFFICIENT#0.7891;NEUROPATHY#0.7886;METHIONINE#0.7879;SQUAMOUS CELL CARCINOMA#0.7848;HYPOTHYROIDISM#0.7846;PLASMA MEMBRANE#0.7839;GROWTH HORMONE#0.7839;LYMPH NODE#0.7834;AUTOIMMUNE DISEASE#0.7829;ANKLE BRACHIAL INDEX#0.7794;EXTRACELLULAR SPACE#0.7784;GENERALIZED ESTIMATING EQUATION#0.7778;PROSTAGLANDIN D SYNTHASE#0.7777;RENAL ISCHEMIA REPERFUSION#0.7764;ISCHEMIC HEART DISEASE#0.7758;UMBILICAL CORD#0.7755;CHRONIC LIVER FAILURE#0.7749;EPIDIDYMIS#0.7747;LUNG DISEASE#0.7745;A-SOL#0.7744;RESPIRATORY DISTRESS#0.7716;DIPEPTIDYL PEPTIDASE#0.7695;VITAMIN D BINDING#0.7695;SODIUM DODECYL SULFATE#0.7679;DODECYL SULFATE#0.7678;NITRIC OXIDE SYNTHASE#0.7671;COLLAGENASE#0.7670;ROSUVASTATIN#0.7663;MITOCHONDRIA#0.7661;CELL SURFACE#0.7655;POLYCYSTIC KIDNEY DISEASE#0.7647;CHRONIC HEPATITIS C#0.7603;TUMOR TISSUES#0.7579;URINARY TRACT INFECTION#0.7572;SICKLE CELL DISEASE#0.7564;OSTEOARTHRITIS#0.7562;FREE LIGHT CHAIN#0.7553;RETINAL PIGMENT EPITHELIUM#0.7539;DIURESIS#0.7533;POPULATION PHARMACOKINETIC MODEL#0.7523;ANTIGEN PRESENTATION#0.7503;MONONUCLEAR CELLS#0.7495;PROGENITOR CELL#0.7483;FENOFIBRATE#0.7471;FACTOR D#0.7457;CALCINEURIN#0.7448;APNEA HYPOPNEA INDEX#0.7442;WAIST HIP RATIO#0.7441;AMPHOTERICIN B#0.7425;RANDOMIZED CLINICAL TRIAL#0.7420;SURFACE PLASMON RESONANCE#0.7408;GLUTAMINE#0.7405;INSULIN RESISTANCE INDEX#0.7403;ORTHOTOPIC LIVER TRANSPLANTATION#0.7395;SERTOLI CELL#0.7374;GLYCOSYLATION#0.7372;DIGOXIN#0.7367;THALASSEMIA#0.7354;POLYCYSTIC OVARY SYNDROME#0.7347;CYSTIC FIBROSIS#0.7312;LIMIT OF DETECTION#0.7311;GLUTATHIONE PEROXIDASE#0.7293;STROMAL CELL#0.7289;SODIUM BICARBONATE#0.7286;HEAT SHOCK PROTEIN#0.7280;TACROLIMUS#0.7277;LEGUMAIN ACTIVITY#0.7271;REACTIVE OXYGEN SPECIES#0.7271;LINEAR MIXED MODEL#0.7258;EPIDERMAL GROWTH FACTOR#0.7258;LEWY BODY#0.7250;AGEING#0.7247;RED BLOOD CELL#0.7230;LEUKOENCEPHALOPATHY#0.7227;RENAL CELL CARCINOMA#0.7211;FUROSEMIDE#0.7205;TOTAL ANTIOXIDANT STATUS#0.7202;MULTIPLE SYSTEM ATROPHY#0.7197;HYPERGLYCEMIA#0.7182;DEPRESSIVE SYMPTOMS#0.7165;EXTRACELLULAR VESICLE#0.7159;LYMPHOSARCOMA#0.7157;MYCOPHENOLATE MOFETIL#0.7145;TO THE PROGRESSION#0.7141;REVERSE TRANSCRIPTION#0.7124;CYSTEINE PROTEASE ACTIVITY#0.7123;CYTOTOXICITY#0.7116;CELL MIGRATION#0.7110;MOLECULAR DYNAMICS SIMULATION#0.7109;ENDOMETRIUM#0.7103;END STAGE RENAL FAILURE#0.7091;PITUITARY ADENOMA#0.7089;SALIVARY GLAND#0.7049;RITONAVIR#0.7015;N-TERMINAL BINDING#0.6994;TOTAL ANTIOXIDANT CAPACITY#0.6974;CHRONIC HEPATITIS B#0.6953;NEUROFIBRILLARY TANGLE#0.6952;PROTEIN DEGRADATION#0.6941;HEPATITIS B VIRUS#0.6928;HYPERHOMOCYSTEINEMIA#0.6913;IMMUNE CELL#0.6911;CATABOLISM#0.6909;LUMINAL#0.6870;ACE INHIBITOR#0.6856;HEPARIN#0.6842;ORAL CAVITY#0.6819;CIMETIDINE#0.6798;SMALL VESSEL DISEASE#0.6795;NEUROGENESIS#0.6785;MESANGIAL CELL#0.6784;HORMONE BINDING#0.6772;PAROTID GLAND#0.6765;AMYLOID FIBRIL FORMATION#0.6765;APROTININ#0.6760;FABRY DISEASE#0.6739;IRON OVERLOAD#0.6727;MUSCLE WASTING#0.6727;IMMATURE DENDRITIC CELL#0.6726;CLARA CELL#0.6720;ACUTE PANCREATITIS#0.6712;DUCHENNE MUSCULAR DYSTROPHY#0.6702;ANGIOTENSIN RECEPTOR#0.6699;HUMAN BREAST CANCER#0.6673;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.6662;ERYTHROCYTE SEDIMENTATION RATE#0.6634;MITOGEN ACTIVATED PROTEIN#0.6632;DEHYDROEPIANDROSTERONE SULFATE#0.6624;REGENERATION#0.6624;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6612;END DIASTOLIC VOLUME#0.6606;NEURAL CELL#0.6605;HERPES SIMPLEX#0.6603;PURPURA#0.6587;GRAVES' DISEASE#0.6580;SUBMANDIBULAR GLAND#0.6568;COLON CARCINOMA#0.6559;ADJUSTED RELATIVE RISK#0.6549;NEOPTERIN#0.6537;METHYLPREDNISOLONE#0.6519;PROXIMAL TUBULE CELL#0.6511;HYPOTENSION#0.6504;ETHYLENEDIAMINETETRAACETIC ACID#0.6504;CEREBRAL CORTEX#0.6499;RECEPTOR ANTAGONIST#0.6464;COLLAGEN TYPE I#0.6459;LOSARTAN#0.6441;PARENCHYMA#0.6440;ANGIOTENSIN RECEPTOR BLOCKER#0.6433;TISSUE GROWTH FACTOR#0.6428;BONE DISEASE#0.6418;MEPRIN#0.6412;NEUROGENIC BLADDER#0.6403;CYCLOSPORINE#0.6390;CORTISOL#0.6381;HEPATOCYTE GROWTH FACTOR#0.6376;MAJOR ADVERSE EVENT#0.6365;RENIN ACTIVITY#0.6363;COLISTIN#0.6355;IMMUNE SYSTEM#0.6341;CELL ACTIVATION#0.6338;OXIDATIVE STRESS INDEX#0.6338;EMTRICITABINE#0.6290;POST OPERATIVE DAY#0.6286;EXOSOME#0.6280;TISSUE DAMAGE#0.6270;COMPLETE BLOOD COUNT#0.6269;LEISHMANIASIS#0.6260;OLMESARTAN#0.6255;SOLUBLE TRANSFERRIN RECEPTOR#0.6250;UROKINASE PLASMINOGEN ACTIVATOR#0.6232;NEURAL STEM CELL#0.6225;FAMILIAL DANISH DEMENTIA#0.6204;CATHEPSIN S ACTIVITY#0.6197;HIGH FAT DIET#0.6191;HEAD AND NECK CANCER#0.6189;NECK CANCER#0.6189;CYCLOSPORIN A#0.6184;TRAUMATIC BRAIN INJURY#0.6180;VITAMIN D3#0.6168;EVEROLIMUS#0.6157;CD4+ T CELL#0.6152;NEUROENDOCRINE CELL#0.6148;LOWER MOTOR NEURON#0.6147;TRANSFERRIN RECEPTOR#0.6146;FOOD FREQUENCY QUESTIONNAIRE#0.6142;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.6139;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.6139;FOLLICLE STIMULATING HORMONE#0.6135;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6126;ENDOSOME#0.6120;IFN-GAMMA#0.6111;ADENOCARCINOMA#0.6107;POLYNEUROPATHY#0.6105;HEART FAILURE HOSPITALIZATION#0.6096;ACID PHOSPHATASE#0.6089;OLMESARTAN MEDOXOMIL#0.6080;MALNUTRITION#0.6080;SLEEP APNEA SYNDROME#0.6076;FANCONI SYNDROME#0.6070;HYDROXYUREA#0.6067;PROTEIN SYNTHESIS#0.6059;EPITHELIAL GROWTH FACTOR#0.6057;CATHEPSIN L ACTIVITY#0.6051;DEHYDRATION#0.6047;STEERED MOLECULAR DYNAMICS#0.6043;TROPHOBLAST#0.6034;METHOTREXATE#0.6030;NEURITE#0.6020;ADENINE#0.6017;VISCERAL LEISHMANIASIS#0.6004
1472	SUBMANDIBULAR GLAND#1.0676;CYSTATIN#1.0644;PROTEINASE INHIBITOR#1.0628;GENE EXPRESSION#1.0048;ISOPROTERENOL#0.9835;NERVOUS SYSTEM#0.9519;SALIVARY GLAND#0.9197;FACTOR S#0.8634;ALPHA 1-ANTITRYPSIN#0.8260;PAROTID GLAND#0.7672;CLARA CELL#0.7038;ALPHA AMYLASE#0.6516;SALIVARY FLOW RATE#0.6444;LACRIMAL GLAND#0.6340;POLYMERASE CHAIN REACTION#0.6085;ACINAR CELL#0.6073
147323	GERM CELL#0.9085;NERVOUS SYSTEM#0.9009;STEROIDOGENESIS#0.6589;PURKINJE CELL#0.6572;DOMOIC ACID#0.6382;HYPOTHYROIDISM#0.6324;DNA REPAIR PROTEIN#0.6021
147339	EPSTEIN BARR VIRUS#0.6300
147372	HENNEKAM SYNDROME#1.0767;LYMPHANGIOGENESIS#1.0529;GROWTH FACTOR#1.0012;LYMPHEDEMA#0.9981;ENDOTHELIAL GROWTH FACTOR#0.9195;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9195;LYMPHATIC VESSEL#0.8746;ENDOTHELIAL CELL#0.8399;LYMPHATIC ENDOTHELIAL CELL#0.8285;CARDINAL VEIN#0.7899;ANGIOGENESIS#0.7158;EXTRACELLULAR MATRIX#0.6993;BREAST CANCER#0.6969;SEPTUM TRANSVERSUM#0.6274;STEM CELL#0.6169;CANCER CELL#0.6104;VASCULATURE DEVELOPMENT#0.6064
147381	SPINAL CORD#0.7758;PURKINJE CELL#0.6183
1473	CYSTATIN#1.0931;PAROTID GLAND#0.7877;COLON CANCER#0.7751;PROTEINASE INHIBITOR#0.7586;TUMOR SUPPRESSOR#0.7045;CANCER CELL#0.6297;BONE RESORPTION#0.6281
147409	AUTOSOMAL RECESSIVE HYPOTRICHOSIS#1.1075;HYPOTRICHOSIS#1.0919;MONILETHRIX#1.0701;HAIR FOLLICLE#1.0624;PEMPHIGUS#0.8445;DESMOSOME#0.8134;CELL ADHESION#0.7364;SCALP#0.7292;PEMPHIGUS VULGARIS#0.6712
147495	CANCER CELL#0.8342;ADENOMATOSIS POLYPOSIS COLI#0.7688;HAIR FOLLICLE#0.7181;SIGNALING PATHWAY#0.6829;HAIR FOLLICLE CELL#0.6182
1474	HAIR FOLLICLE#1.0479;PROTEINASE INHIBITOR#1.0428;LEGUMAIN ACTIVITY#1.0385;CYSTATIN#1.0264;OSTEOCLAST#1.0012;BREAST CANCER#0.9948;CANCER CELL#0.9903;PROTEINASE ACTIVITY#0.9733;TUMOR SUPPRESSOR#0.9618;SUBMANDIBULAR GLAND#0.9599;GENE EXPRESSION#0.9521;EPITHELIAL CELL#0.9484;BONE RESORPTION#0.9403;MACROPHAGE#0.9327;BREAST CANCER CELL#0.9020;KERATINOCYTE#0.8670;FACTOR XIIIA#0.8658;POLYMERASE CHAIN REACTION#0.8588;FIBRINOGEN#0.8410;ISOPROTERENOL#0.8254;DENDRITIC CELL#0.8127;BASEMENT MEMBRANE#0.8126;CORNIFICATION#0.8038;ALPHA-2 MACROGLOBULIN#0.8035;SQUAMOUS CELL CARCINOMA#0.8011;IMMUNE RESPONSE#0.7732;LYMPH NODE#0.7666;GLOMERULAR FILTRATION#0.7606;SODIUM DODECYL SULFATE#0.7597;DODECYL SULFATE#0.7596;SWEAT GLAND#0.7574;SEMINAL PLASMA#0.7552;NEUTROPHIL#0.7549;PEPSTATIN#0.7511;LEUKOCYTE#0.7464;SIGNAL PEPTIDE#0.7300;PROTEASE ACTIVITY#0.7076;GLYCINE#0.7066;GLOMERULAR FILTRATION RATE#0.6970;DIGESTION#0.6939;CHLOROQUINE#0.6858;CELL ENVELOPE#0.6843;CELL SURFACE#0.6728;SIGNALING PATHWAY#0.6670;APOPTOSIS#0.6588;TUMOR CELLS#0.6568;LUNG CARCINOMA#0.6561;T LYMPHOCYTE#0.6457;CELL DEATH#0.6444;LEUCINE#0.6434;GLYCOSYLATION#0.6351;ICHTHYOSIS#0.6340;BONE MARROW#0.6262;PROSTATE CANCER#0.6251;ACID PHOSPHATASE#0.6166;CELL GROWTH#0.6155;SKIN BARRIER FUNCTION#0.6067;CYTOPLASM#0.6006;EXTRACELLULAR MATRIX#0.6004
1475	PERCEIVED STRESS SCALE#1.0921;CYSTATIN#1.0398;SQUAMOUS CELL CARCINOMA#1.0264;PROTEINASE INHIBITOR#1.0243;KERATINOCYTE#1.0151;BREAST CANCER#0.9909;GENE EXPRESSION#0.9670;CANCER CELL#0.9277;PROSTATE CANCER#0.9037;APOPTOSIS#0.8854;LYMPH NODE#0.8845;CELL ENVELOPE#0.8834;LUNG CANCER#0.8558;PSORIASIS#0.8516;TUMOR CELLS#0.8336;EPITHELIAL CELL#0.8281;CATHEPSIN B ACTIVITY#0.8248;ATOPIC DERMATITIS#0.7937;DISEASE FREE SURVIVAL#0.7699;CELL CELL ADHESION#0.7574;MACROPHAGE INFLAMMATORY PROTEIN#0.7554;CELL ADHESION#0.7432;ICHTHYOSIS#0.7424;SUPEROXIDE DISMUTASE#0.7383;ADENOCARCINOMA#0.7248;NEUTROPHIL#0.7222;ALLERGEN#0.7218;MACROPHAGE#0.7165;FATTY ACID BINDING#0.7124;BASAL CELL#0.7109;FIBRIL#0.6961;BREAST CARCINOMA#0.6777;EXTRACELLULAR MATRIX#0.6773;TUMOR TISSUES#0.6731;PEELING SKIN SYNDROME#0.6630;PROTEIN KINASE#0.6519;LUNG CARCINOMA#0.6339;LOCAL RECURRENCE FREE#0.6284;DERMATITIS#0.6282;CYTOPLASM#0.6213;PEELING#0.6104;PROTEASE ACTIVITY#0.6051;MYOEPITHELIAL CELL#0.6048;BREAST CANCER CELL#0.6047;CELL GROWTH#0.6027
147686	ZINC FINGER PROTEIN#0.8632;MAPK SIGNALING#0.7564;SIGNALING PATHWAY#0.7424
1476	AMYLOID FIBRIL FORMATION#1.0666;FIBRIL#1.0632;PROGRESSIVE MYOCLONUS EPILEPSY#1.0533;CYSTATIN#1.0439;EPILEPSY#1.0274;APOPTOSIS#1.0264;PROTEINASE INHIBITOR#1.0233;MACROPHAGE#1.0024;CANCER CELL#0.9979;GENE EXPRESSION#0.9807;OVARIAN#0.9399;CELL DEATH#0.9297;GROWTH FACTOR#0.9132;TUMOR CELLS#0.8928;EPITHELIAL CELL#0.8918;SQUAMOUS CELL CARCINOMA#0.8892;PRO-INFLAMMATORY#0.8889;HEPATOCELLULAR CARCINOMA#0.8818;POLYMERASE CHAIN REACTION#0.8709;OVARIAN CANCER#0.8639;NEURODEGENERATIVE DISEASE#0.8532;MONOCYTE#0.8478;LYSOSOME#0.8440;SIGNALING PATHWAY#0.8412;LYMPH NODE#0.8319;NERVOUS SYSTEM#0.8311;TOXICITY#0.8272;LYMPH NODE METASTASIS#0.8049;JUVENILE MYOCLONIC EPILEPSY#0.8021;BONE RESORPTION#0.7951;BREAST CANCER#0.7829;HOMOLOGOUS RECOMBINATION#0.7733;DIFFUSION TENSOR IMAGING#0.7656;IMMUNE RESPONSE#0.7655;COLORECTAL#0.7521;CYTOPLASM#0.7500;MONOCYTE DERIVED MACROPHAGE#0.7493;CELL PROLIFERATION#0.7478;SUPEROXIDE DISMUTASE#0.7206;CENTRAL NERVOUS SYSTEM#0.7205;BONE MARROW#0.7193;CELL SURFACE#0.7034;ALZHEIMER'S DISEASE#0.6951;AGE AT ONSET#0.6933;LUNG CANCER#0.6775;CELL CYCLE#0.6759;TRANSFORMING GROWTH FACTOR#0.6699;MITOCHONDRIA#0.6694;TRANSMISSION ELECTRON MICROSCOPY#0.6496;AUTOPHAGY#0.6480;REACTIVE OXYGEN SPECIES#0.6466;TRANSCRANIAL MAGNETIC STIMULATION#0.6445;SENSITIZATION#0.6342;NEUTROPHIL#0.6318;LIVER DISEASE#0.6273;OSTEOCLAST#0.6243;SERPIN#0.6198;ASTROCYTE#0.6119;PORE FORMATION#0.6058;GLIAL CELL#0.6040
147700	KINESIN LIGHT CHAIN#1.0946;KINESIN#1.0921;SPERM TAIL#1.0230;MICROTUBULE#0.8037;OUTER DENSE FIBER#0.7613;MITOCHONDRIA#0.6180;NUCLEAR MIGRATION#0.6130
147719	LUNG CANCER#0.7603;CEREBROVASCULAR DISEASE#0.6473
147727	CELL PROLIFERATION#0.6856
147744	SPERM-OOCYTE FUSION#0.8881;ACROSOME REACTION#0.8236;PROTEIN COMPLEX#0.8080
147746	PROTEIN KINASE#0.9055
147798	FATTY LIVER DISEASE#0.7311;FATTY LIVER#0.7299;LIVER DISEASE#0.7269
1477	MRNA PROCESSING#0.6420;RNA PROCESSING#0.6392
147841	NDC80 COMPLEX#1.1064;KINETOCHORE#1.0670;MICROTUBULE#1.0208;CHROMOSOME SEGREGATION#0.9028;CELL GROWTH#0.8840;CELL PROLIFERATION#0.8620;APOPTOSIS#0.8563;MICROTUBULE BINDING#0.8526;KINETOCHORE MICROTUBULE#0.8333;SPINDLE MICROTUBULE#0.8120;KINETOCHORE-MICROTUBULE ATTACHMENT#0.8026;LUNG ADENOCARCINOMA#0.7993;CENTROMERE#0.7689;LUNG CANCER#0.7614;CELL CYCLE#0.7457;HEPATOCELLULAR CARCINOMA#0.7385;CELL DIVISION#0.7237;MITOSIS#0.7206;SPINDLE POLE#0.6575;ANAPLASTIC THYROID CANCER#0.6522;KINETOCHORE LOCALIZATION#0.6435;SPINDLE CHECKPOINT#0.6363;THYROID CANCER#0.6323;DNA REPLICATION#0.6293;COMPLEX I#0.6165;CANCER CELL#0.6111;ADENOCARCINOMA#0.6031
147872	TELOMERE#0.8945;DYNEIN#0.7657;CHROMOSOME MOVEMENT#0.7510;NUCLEAR ENVELOPE#0.6973;NUCLEAR MEMBRANE#0.6924;SPINDLE FORMATION#0.6457;GERMINAL VESICLE#0.6421;MEIOTIC CHROMOSOME#0.6193
1478	GERM CELL#1.0507;RNA BINDING#1.0335;B CELL#0.9762;GENE EXPRESSION#0.9757;CELL CYCLE#0.9110;MRNA 3' END PROCESSING#0.8772;CSTF COMPLEX#0.8364;RNA BINDING PROTEIN#0.8174;U7 SNRNP#0.8164;RNA RECOGNITION MOTIF#0.8041;MRNA PROCESSING#0.7934;S PHASE#0.7440;MRNA POLYADENYLATION#0.7430;CELL GROWTH#0.7396;NERVOUS SYSTEM#0.7386;CELL DIFFERENTIATION#0.7045;X CHROMOSOME#0.6928;TRANSCRIPTION FACTOR#0.6870;CANCER CELL#0.6852;RNA PROCESSING#0.6514;C TERMINAL DOMAIN#0.6477;POLYPYRIMIDINE TRACT BINDING#0.6404;B CELL DIFFERENTIATION#0.6194;MEIOSIS#0.6146
147906	CANCER CELL#0.6680;LUNG CANCER#0.6493;COLORECTAL CANCER#0.6407;UNILATERAL URETERAL OBSTRUCTION#0.6083;URETERAL OBSTRUCTION#0.6065;RENAL FIBROSIS#0.6011
147912	TRANSCRIPTION FACTOR#1.0260;PROTEIN KINASE#0.9619;SKELETAL MUSCLE#0.9305;MYOTONIC DYSTROPHY TYPE 1#0.7723;CARDIAC CONDUCTION#0.7425;GENE EXPRESSION#0.7240;POLYMERASE CHAIN REACTION#0.6883
147923	APOPTOSIS#0.9644;ZINC FINGER PROTEIN#0.7958;RRNA SYNTHESIS#0.6963
147945	GROUP A STREPTOCOCCUS#0.7841;SIGNALING PATHWAY#0.7289;AUTOPHAGOSOME#0.6584;LEUCINE RICH REPEAT#0.6245
147947	RESPONSE TO SIMVASTATIN#1.2534;SIMVASTATIN#0.8574
147948	CERVICAL#1.0762;DNA METHYLATION#1.0431;SQUAMOUS CELL CARCINOMA#0.9804;CERVICAL CANCER#0.8978;ZINC FINGER PROTEIN#0.8820;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.8790;METHYLATION SPECIFIC PCR#0.8048;QUANTITATIVE METHYLATION SPECIFIC#0.7204;CERVICAL ADENOCARCINOMA#0.6876;ADENOCARCINOMA#0.6144;TUMOR TISSUES#0.6009
147968	ACYL COA DEHYDROGENASE#0.6503;ATP SYNTHASE#0.6427;GTP BINDING#0.6361;GLUTATHIONE PEROXIDASE#0.6277
147991	MANNOSYLATION#0.8325;MANNOSYLTRANSFERASE ACTIVITY#0.7927
1479	CSTF COMPLEX#0.7443;RNA BINDING#0.7411;AUXIN SIGNALING#0.6131;MRNA 3' END PROCESSING#0.6040
147	ADRENERGIC RECEPTOR#1.0217;PHENYLEPHRINE#1.0058;PRAZOSIN#0.9910;NORADRENALINE#0.9503;NOREPINEPHRINE#0.9212;SMOOTH MUSCLE#0.9175;GENE EXPRESSION#0.8342;PROTEIN KINASE#0.8330;METHOXAMINE#0.8306;SMOOTH MUSCLE CELL#0.8080;MUSCLE CELL#0.8071;TAMSULOSIN#0.8019;PHENTOLAMINE#0.7813;NIFEDIPINE#0.7780;CEREBRAL CORTEX#0.7587;PROTEIN KINASE C#0.7290;EPINEPHRINE#0.6791;ARTERY#0.6576;VASOCONSTRICTION#0.6453;VENA CAVA#0.6117;ALPHA1 ADRENERGIC RECEPTOR#0.6104
148014	DNA METHYLATION#0.7960
148022	PRIMARY RESPONSE GENE#1.0545;AUTOPHAGY#1.0372;IFN-BETA#1.0286;INTERLEUKIN 1 RECEPTOR#1.0263;NF-KAPPAB ACTIVATION#1.0231;IFN REGULATORY FACTOR#1.0222;SIGNALING ADAPTOR#1.0178;RECEPTOR INTERACTING PROTEIN#1.0175;SIGNALLING PATHWAY#1.0165;TLR SIGNALING PATHWAY#1.0136;INTERFERON PRODUCTION#1.0112;TANK BINDING KINASE#1.0103;ENDOSOME#1.0095;TLR4 SIGNALING PATHWAY#1.0059;INTERFERON REGULATORY FACTOR#1.0032;ISCHEMIA#1.0025;B CELL#1.0001;MITOGEN ACTIVATED PROTEIN#0.9998;SIGNALING MOLECULE#0.9994;SIGNALING CASCADE#0.9961;NEUTROPHIL#0.9945;SIGNAL TRANSDUCTION#0.9916;SIGNALING PATHWAY#0.9914;ACTIVATION OF NF-KAPPAB#0.9910;CYTOKINE PRODUCTION#0.9903;PROTEIN KINASE#0.9882;ANTIVIRAL RESPONSE#0.9882;APOPTOSIS#0.9873;CELL DEATH#0.9868;TRANSCRIPTION FACTOR#0.9854;ENDOTHELIAL CELL#0.9850;IFN-BETA PRODUCTION#0.9848;MYELOID CELL#0.9843;PLASMA MEMBRANE#0.9842;EPITHELIAL CELL#0.9824;MACROPHAGE#0.9808;CD4+ T CELL#0.9806;GENE EXPRESSION#0.9798;MONOCYTE#0.9787;HEPATITIS C#0.9786;PRO-INFLAMMATORY#0.9780;DENDRITIC CELL#0.9756;T CELL#0.9755;RETINOIC ACID#0.9750;BONE MARROW#0.9749;PATTERN RECOGNITION RECEPTOR#0.9723;TUMOR NECROSIS FACTOR#0.9720;CELL ACTIVATION#0.9717;TOLL LIKE RECEPTOR#0.9711;REACTIVE OXYGEN SPECIES#0.9711;ADAPTIVE IMMUNE RESPONSE#0.9710;APOPTOTIC#0.9702;INFLAMMATORY RESPONSE#0.9699;HEPATITIS C VIRUS#0.9699;INNATE IMMUNE SYSTEM#0.9695;RESPONSE TO LPS#0.9690;NITRIC OXIDE#0.9689;IMMUNE CELL#0.9687;VIRAL INFECTION#0.9675;INNATE IMMUNE RESPONSE#0.9671;LYMPH NODE#0.9653;CELL SURFACE#0.9651;UBIQUITIN#0.9651;PERIPHERAL BLOOD#0.9646;INNATE IMMUNITY#0.9641;VIRAL REPLICATION#0.9636;STEM CELL#0.9632;TYPE I INTERFERON PRODUCTION#0.9613;IMMUNE RESPONSE#0.9603;IMMUNE SYSTEM#0.9600;NLRP3 INFLAMMASOME ACTIVATION#0.9591;NECROPTOSIS#0.9568;MONONUCLEAR CELLS#0.9485;CD8+ T CELL#0.9463;ISCHEMIA REPERFUSION INJURY#0.9418;TYPE I IFN PRODUCTION#0.9414;MELANOMA DIFFERENTIATION ASSOCIATED#0.9363;ENDOCYTOSIS#0.9348;HOST CELL#0.9295;KINASE ACTIVITY#0.9291;CEREBRAL ISCHEMIA#0.9255;HERPES SIMPLEX#0.9231;GROWTH FACTOR#0.9206;T LYMPHOCYTE#0.9176;NITRIC OXIDE SYNTHASE#0.9134;TNF PRODUCTION#0.9108;NERVOUS SYSTEM#0.9100;RESVERATROL#0.9099;HEMATOPOIETIC CELL#0.9085;IFN-GAMMA#0.9076;INTESTINAL EPITHELIAL CELL#0.9072;INDUCIBLE NITRIC OXIDE#0.9035;FOAM CELL FORMATION#0.8939;CELL PROLIFERATION#0.8928;MYELOID DENDRITIC CELL#0.8919;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8911;ARTERY#0.8879;CENTRAL NERVOUS SYSTEM#0.8857;POLYMERASE CHAIN REACTION#0.8756;ANTIGEN PRESENTING CELLS#0.8726;HEAT SHOCK PROTEIN#0.8701;INFLUENZA A VIRUS#0.8665;LEUKOCYTE#0.8652;T CELL ACTIVATION#0.8599;ACUTE LUNG INJURY#0.8570;RNA HELICASE#0.8565;PHAGOCYTOSIS#0.8560;MAP KINASE#0.8516;CYTOKINE SECRETION#0.8509;HEPATITIS B#0.8488;TOXICITY#0.8447;TH17 CELL#0.8431;TLR3 SIGNALING PATHWAY#0.8423;ATHEROSCLEROSIS#0.8392;TISSUE DAMAGE#0.8360;HIGH MOBILITY GROUP#0.8321;HERPES SIMPLEX VIRUS#0.8265;CANCER CELL#0.8218;COLITIS#0.8154;LUNG ENDOTHELIAL CELLS#0.8150;PNEUMONIA#0.8135;IL-6 PRODUCTION#0.8115;NUCLEIC ACID#0.8075;LPS BINDING#0.8065;INFLAMMATORY CELL#0.7988;NADPH OXIDASE#0.7960;REVERSE TRANSCRIPTION#0.7879;GRAM NEGATIVE BACTERIAL#0.7878;MAPK ACTIVATION#0.7874;CYTOPLASM#0.7860;CELL WALL#0.7844;ETHANOL#0.7819;HEPATITIS B VIRUS#0.7795;AIRWAY EPITHELIAL CELL#0.7790;LOW DENSITY LIPOPROTEIN#0.7738;ASTROCYTE#0.7737;ENDOPLASMIC RETICULUM#0.7707;KUPFFER CELL#0.7707;TH1 CELL#0.7699;INTERFERON RECEPTOR#0.7698;SMOOTH MUSCLE#0.7696;CYTOTOXICITY#0.7608;KERATINOCYTE#0.7604;TUMOR CELLS#0.7601;NUCLEOTIDE BINDING#0.7598;HIGH FAT DIET#0.7572;TUBERCULOSIS#0.7440;LEUCINE RICH REPEAT#0.7420;ADIPOSE TISSUE#0.7412;SIGNAL TRANSDUCER#0.7372;MACROPHAGE ACTIVATION#0.7367;ALLERGIC AIRWAY DISEASE#0.7366;LIVER DISEASE#0.7350;CLASS SWITCHING#0.7345;IKAPPAB KINASE#0.7308;PROTEASOME#0.7306;HEPATOCELLULAR CARCINOMA#0.7303;CHEMOKINE PRODUCTION#0.7302;VIRULENCE#0.7277;RECEPTOR COMPLEX#0.7250;OUTER MEMBRANE#0.7240;IL-1 PRODUCTION#0.7238;MAST CELL#0.7205;MUTAGENESIS#0.7191;CELLULAR IMMUNE RESPONSE#0.7189;MYOCARDITIS#0.7166;TUMOUR NECROSIS FACTOR#0.7152;RECEPTOR LIGAND#0.7112;CROSS PRIMING#0.7110;T HELPER CELL#0.7053;IMMUNE EVASION#0.7040;LEUCINE#0.7014;HEMATOPOIETIC STEM CELL#0.7012;IL-1 SECRETION#0.6951;TRANSFORMING GROWTH FACTOR#0.6947;PROTEIN TYROSINE PHOSPHATASE#0.6944;RESPIRATORY SYNCYTIAL VIRUS#0.6907;VACCINIA#0.6886;BRAIN DAMAGE#0.6876;CEREBRAL ARTERY OCCLUSION#0.6871;INTRACELLULAR SIGNALING PATHWAY#0.6869;MIDDLE CEREBRAL ARTERY#0.6858;CEREBRAL ARTERY#0.6856;GENE SILENCING#0.6855;T CELL PROLIFERATION#0.6851;CYTOTOXIC T-LYMPHOCYTE#0.6844;RNA INTERFERENCE#0.6835;ALANINE#0.6832;OBESE#0.6807;CELL MATURATION#0.6768;MICROGLIAL CELL#0.6759;PROGRAMMED NECROSIS#0.6740;CERVICAL#0.6722;MESANGIAL CELL#0.6704;SPINAL CORD#0.6697;PERITONITIS#0.6655;ALLERGEN#0.6609;REGENERATION#0.6578;NATURAL KILLER CELL#0.6551;INTERFERON STIMULATED GENE#0.6538;HUMAN DENDRITIC CELL#0.6525;MACROPHAGE POLARIZATION#0.6525;HEMORRHAGE#0.6525;PLASMACYTOID DENDRITIC CELL#0.6494;SMALL INTESTINE#0.6486;CASPASE INHIBITOR#0.6482;HUMORAL IMMUNE RESPONSE#0.6470;G-CSF#0.6445;AUTOIMMUNE DISEASE#0.6415;DNA BINDING#0.6414;CELL CYCLE#0.6393;RESPONSE TO DSRNA#0.6354;AUTOPHAGOSOME#0.6341;PROTEASE ACTIVITY#0.6301;PALMITATE#0.6299;LIPID RAFT#0.6298;ALVEOLAR MACROPHAGE#0.6282;SIGNALLING CASCADE#0.6265;QUANTITATIVE REAL TIME#0.6245;HYPOXIA#0.6219;EARLY ENDOSOME#0.6214;REPORTER GENE ASSAY#0.6186;SIGNALOSOME#0.6179;CCL2 PRODUCTION#0.6178;CELL DIFFERENTIATION#0.6167;SMOOTH MUSCLE CELL#0.6119;MUSCLE CELL#0.6113;EXTRACELLULAR MATRIX#0.6080;RAPAMYCIN#0.6070;CROSS PRESENTATION#0.6050;CORNEAL EPITHELIUM#0.6012;BINDING PROTEIN 1#0.6010
148066	ER MEMBRANE#0.7337;UBIQUITIN#0.6385
148113	TYPE 2 DIABETES#0.7246;EXTRACELLULAR MATRIX#0.6256;RESPONSE TO STATIN#0.6090
148252	TUMOR SUPPRESSOR#1.0475;NUCLEOTIDE EXCHANGE FACTOR#0.7153;RENAL CELL CARCINOMA#0.6610;METASTATIC PANCREATIC ADENOCARCINOMA#0.6533;GUANINE#0.6137;PANCREATIC ADENOCARCINOMA#0.6085
148266	TRANSCRIPTION FACTOR#1.0618;DNA BINDING#1.0523;RESPONSE TO ZINC#1.0515;ZINC HOMEOSTASIS#1.0488;GENE EXPRESSION#0.9866;ZINC UPTAKE#0.8731;ZINC FINGER PROTEIN#0.7549;ZINC BINDING#0.7263;VIRULENCE#0.6695;FACTOR I#0.6438
148281	EXOCYTOSIS#0.8618;ACROSOME REACTION#0.7104
1482	MYOCYTE ENHANCER FACTOR#1.0467;CARDIAC TROPONIN I#1.0348;CARDIAC CONDUCTION#1.0297;SERUM RESPONSE FACTOR#1.0289;CARDIAC MORPHOGENESIS#1.0228;ATRIAL SEPTAL DEFECT#1.0220;TETRALOGY OF FALLOT#1.0181;HEART FORMATION#1.0131;T CELL#1.0115;MYOSIN HEAVY CHAIN#1.0106;ATRIOVENTRICULAR BLOCK#1.0086;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0085;CARDIAC MUSCLE#1.0076;TRANSCRIPTION FACTOR#1.0054;VENTRICULAR SEPTAL DEFECT#1.0047;POLYMERASE CHAIN REACTION#1.0029;CONGENITAL HEART DISEASE#1.0025;DNA BINDING#1.0016;CONNEXIN#1.0007;EMBRYONIC HEART#0.9987;CARDIAC PROGENITOR CELL#0.9983;CARDIOMYOCYTE DIFFERENTIATION#0.9962;PRECURSOR CELL#0.9956;CONGENITAL HEART DEFECTS#0.9939;MORPHOGENESIS#0.9936;CARDIOGENESIS#0.9905;CARDIAC DEVELOPMENT#0.9895;OUTFLOW TRACT#0.9885;SINUS VENOSUS#0.9877;HEART DEVELOPMENT#0.9875;HEART DISEASE#0.9865;AZACYTIDINE#0.9855;SMOOTH MUSCLE CELL#0.9849;SMOOTH MUSCLE#0.9849;REVERSE TRANSCRIPTION#0.9841;PERIPHERAL BLOOD#0.9829;CARDIOMYOPATHY#0.9826;BONE MORPHOGENETIC PROTEIN#0.9821;SKELETAL MUSCLE#0.9819;ION CHANNEL#0.9814;HUMAN EMBRYONIC STEM#0.9812;LATERAL PLATE MESODERM#0.9804;CONGENITAL HYPOTHYROIDISM#0.9803;ENDOTHELIAL CELL#0.9788;CELL DIFFERENTIATION#0.9787;MUSCLE CELL#0.9783;TRANSACTIVATION#0.9783;MYOCYTES#0.9781;ATRIAL FIBRILLATION#0.9779;SMOOTH MUSCLE ACTIN#0.9777;CARDIOMYOCYTE#0.9764;GENE EXPRESSION#0.9757;PROGENITOR CELL#0.9735;MOUSE EMBRYONIC STEM#0.9735;ARRHYTHMIA#0.9730;DUAL LUCIFERASE REPORTER#0.9719;SIGNALING PATHWAY#0.9694;APOPTOSIS#0.9691;PLURIPOTENT STEM CELL#0.9691;PYLORIC SPHINCTER#0.9677;MYOCARDIUM#0.9675;INDUCED PLURIPOTENT STEM CELL#0.9658;MURINE EMBRYONIC STEM#0.9639;GROWTH FACTOR#0.9638;CARDIAC STEM CELLS#0.9629;MYOCARDIAL INFARCTION#0.9626;TOXICITY#0.9619;CELL PROLIFERATION#0.9617;EMBRYONIC STEM CELL#0.9615;GAP JUNCTION#0.9612;BONE MARROW#0.9598;CARDIOMYOCYTE PROLIFERATION#0.9592;MESENCHYMAL STEM CELL#0.9589;HISTONE DEACETYLASE#0.9575;SEPTUM#0.9571;REGENERATION#0.9543;STEM CELL#0.9526;CELL CYCLE#0.9501;HEART MORPHOGENESIS#0.9495;PROTEIN KINASE#0.9466;ARTERY#0.9420;RETINOIC ACID#0.9415;EMBRYOID BODY#0.9406;DILATED CARDIOMYOPATHY#0.9399;ACTION POTENTIAL#0.9391;FIBROBLAST GROWTH FACTOR#0.9357;HYPOTHYROIDISM#0.9323;STROMAL CELL#0.9323;QUANTITATIVE REAL TIME#0.9273;TRANSFORMING GROWTH FACTOR#0.9257;BIRTH DEFECT#0.9244;CARDIAC LOOPING#0.9214;DNA METHYLATION#0.9184;CARDIOVASCULAR SYSTEM#0.9118;VENTRICULAR CARDIOMYOCYTE#0.9078;GENE REGULATORY NETWORK#0.9060;CELL SURFACE#0.9020;UMBILICAL CORD#0.8979;RNA BINDING PROTEIN#0.8973;RNA BINDING#0.8957;CORONARY ARTERY#0.8877;SIGNALING MOLECULE#0.8875;SUDDEN CARDIAC DEATH#0.8852;PHARYNX#0.8835;NEURAL CREST#0.8832;ZINC FINGER PROTEIN#0.8820;MYOGENESIS#0.8775;TERMINAL DIFFERENTIATION#0.8725;ORGANOGENESIS#0.8695;HISTONE ACETYLATION#0.8663;TRANSCRIPTASE#0.8614;STEM CELL DIFFERENTIATION#0.8474;SEPTATION#0.8459;AORTIC VALVE#0.8455;LYSINE#0.8427;ANGIOGENESIS#0.8409;HISTONE MODIFICATION#0.8407;ENDOTHELIAL GROWTH FACTOR#0.8339;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8339;EMBRYONAL CARCINOMA#0.8316;ENDOTHELIUM#0.8316;SAN DEVELOPMENT#0.8311;ADULT STEM CELL#0.8295;SARCOMERE#0.8254;EXTRACELLULAR MATRIX#0.8244;ATRIOVENTRICULAR SEPTAL DEFECT#0.8241;HYPERTROPHIC PYLORIC STENOSIS#0.8231;MONONUCLEAR CELLS#0.8205;CYTOPLASM#0.8200;CYCLIC NUCLEOTIDE GATED#0.8199;BACTERIAL ARTIFICIAL CHROMOSOME#0.8199;WNT SIGNALING PATHWAY#0.8180;PYLORIC STENOSIS#0.8124;ADIPOSE TISSUE#0.8115;HOLT-ORAM SYNDROME#0.8085;ELECTROPHORETIC MOBILITY SHIFT#0.8076;RESPONSE TO OXIDATIVE STRESS#0.8010;BICUSPID AORTIC VALVE#0.7992;RAT BONE MARROW#0.7991;C TERMINAL DOMAIN#0.7980;BRAIN NATRIURETIC PEPTIDE#0.7943;PROTEIN PROTEIN INTERACTION#0.7928;CALCIUM CHANNEL#0.7908;FERTILIZATION#0.7892;REACTIVE OXYGEN SPECIES#0.7886;ISCHEMIA#0.7851;ADIPOSE-DERIVED STEM CELL#0.7826;THYROID GLAND#0.7799;MITOGEN ACTIVATED PROTEIN#0.7728;DOUBLE OUTLET RIGHT VENTRICLE#0.7716;STEM CELL ANTIGEN#0.7715;BLOOD VESSEL#0.7710;HYPOPLASTIC LEFT HEART#0.7696;GASTRULATION#0.7690;CELL GROWTH#0.7687;MYOTUBE#0.7634;HYPOXIA#0.7578;CARDIAC ABNORMALITIES#0.7577;STEM CELL MARKER#0.7571;DOXORUBICIN#0.7562;FACTOR I#0.7555;HYPOPLASTIC LEFT HEART SYNDROME#0.7521;THYROID TRANSCRIPTION FACTOR#0.7461;PULMONARY ARTERY#0.7459;HEMATOPOIETIC CELL#0.7435;EDEMA#0.7430;MUTAGENESIS#0.7419;BREAST CANCER#0.7395;NITRIC OXIDE#0.7389;DIMETHYL SULFOXIDE#0.7378;VASCULOGENESIS#0.7364;YOLK SAC#0.7276;NERVOUS SYSTEM#0.7275;TRANSCRIPTION FACTOR BINDING#0.7267;PULMONARY VEIN#0.7219;CARDIOVASCULAR PROGENITOR CELL#0.7210;TRANSFORMING GROWTH FACTOR BETA#0.7207;KINASE INHIBITOR#0.7184;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7182;MESODERM FORMATION#0.7160;APOPTOTIC#0.7157;BONE MARROW CELLS#0.7101;PATENT DUCTUS ARTERIOSUS#0.7094;DUCTUS ARTERIOSUS#0.7053;STRIATED MUSCLE#0.7039;MESENCHYMAL CELL#0.7001;VASCULAR SMOOTH MUSCLE CELL#0.6972;BRADYCARDIA#0.6961;CELL ADHESION#0.6951;MESENCHYMAL STROMAL CELL#0.6940;DOMINANT NEGATIVE MUTANT#0.6864;SARCOPLASMIC RETICULUM#0.6864;INSULIN-LIKE GROWTH FACTOR#0.6862;HEART LOOPING#0.6850;HISTONE H3 ACETYLATION#0.6843;CELL DEATH#0.6785;MESENCHYME#0.6784;TAMOXIFEN#0.6750;CHROMATIN REMODELING#0.6748;STEM CELL TRANSPLANTATION#0.6722;INTERCALATED DISC#0.6712;TERATOMA#0.6711;BMP SIGNALING PATHWAY#0.6704;UBIQUITIN#0.6671;EBSTEIN ANOMALY#0.6624;MAST CELL#0.6585;SIGNAL TRANSDUCTION#0.6582;MYOBLAST#0.6541;GESTATION#0.6523;SYSTEM DEVELOPMENT#0.6504;ACUTE MYOCARDIAL INFARCTION#0.6436;NEONATAL RAT CARDIOMYOCYTES#0.6406;PROSTATE CANCER#0.6392;FORAMEN OVALE#0.6369;UMBILICAL CORD BLOOD#0.6354;ISCHEMIC HEART DISEASE#0.6352;TRICUSPID VALVE#0.6338;HEART MUSCLE#0.6328;MYOFILAMENT#0.6320;CORD BLOOD#0.6320;RNA INTERFERENCE#0.6308;TRANSDIFFERENTIATION#0.6294;RNA HELICASE#0.6293;COPY NUMBER VARIATION#0.6282;REPORTER GENE ASSAY#0.6261;SUMOYLATION#0.6230;MIDLINE#0.6223;FOREGUT#0.6177;CANCER CELL#0.6145;SINGLE NUCLEOTIDE VARIANTS#0.6115;AMNIOTIC FLUID#0.6017
148327	TRANSCRIPTION FACTOR#1.0720;CAMP-RESPONSIVE ELEMENT BINDING#1.0324;UNFOLDED PROTEIN RESPONSE#1.0126;ENDOPLASMIC RETICULUM#0.9883;BINDING PROTEIN 1#0.9773;BREAST CANCER#0.9222;CELL PROLIFERATION#0.9149;GENE EXPRESSION#0.8331;APOPTOSIS#0.7965;ANDROGEN RECEPTOR#0.7701;CANCER CELL#0.7677;PROSTATE CANCER#0.7196;BINDING PROTEIN 3#0.6362;AXON GROWTH#0.6359;GERM CELL#0.6220;TRANSFORMING GROWTH FACTOR#0.6163;ENDOPLASMIC RETICULUM STRESS#0.6144;GROWTH FACTOR#0.6111;NERVOUS SYSTEM#0.6093
1483	PROSTATE CANCER#0.6731;PLASMA MEMBRANE#0.6195
148479	GENE EXPRESSION#0.9964;GOBLET CELL#0.9328;VIRAL GENE EXPRESSION#0.8672;EPITHELIAL CELL#0.7924;DNA DAMAGE RESPONSE#0.7884;OVARIAN CANCER#0.7835;CELL DIFFERENTIATION#0.7145;OVARIAN#0.6797;STEM CELL DIFFERENTIATION#0.6487;HOST CELL#0.6445;MITOTIC CHROMOSOME CONDENSATION#0.6335;STEM CELL#0.6224;TRANSCRIPTIONAL CO-REGULATOR#0.6134
1484	MILLER-DIEKER LISSENCEPHALY SYNDROME#0.6280
148523	PLATELET AGGREGATION#1.0502;CIRCADIAN RHYTHM#0.8543;VALPROATE#0.7502
148581	RIDDLE SYNDROME#0.6152
1485	SYNOVIAL SARCOMA#1.0735;LIPOSARCOMA#1.0682;OVARIAN CANCER#1.0571;SQUAMOUS CELL CARCINOMA#1.0490;MYXOID LIPOSARCOMA#1.0464;OVARIAN#1.0411;CD4+ T CELL#1.0351;CROSS PRESENTATION#1.0344;CD8+ T CELL#1.0300;REVERSE TRANSCRIPTION#1.0259;LUNG CANCER#1.0208;DENDRITIC CELL#1.0165;HEPATOCELLULAR CARCINOMA#1.0141;CANCER TESTIS ANTIGEN#1.0138;T CELL#1.0133;TUMOR ANTIGEN#1.0132;PERIPHERAL BLOOD#1.0118;TUMOR CELLS#1.0077;IFN-GAMMA#1.0077;POLYMERASE CHAIN REACTION#1.0055;TUMOR ASSOCIATED ANTIGEN#1.0022;T LYMPHOCYTE#0.9990;METASTATIC MELANOMA#0.9973;IMMUNE RESPONSE#0.9958;CANCER CELL#0.9921;GERM CELL#0.9921;GENE EXPRESSION#0.9815;HUMORAL IMMUNE RESPONSE#0.9750;REGULATORY T CELL#0.9613;PROSTATE CANCER#0.9586;BREAST CANCER#0.9570;CYTOTOXIC T-LYMPHOCYTE#0.9522;CELLULAR IMMUNE RESPONSE#0.9399;5-AZA-2'-DEOXYCYTIDINE#0.9309;2'-DEOXYCYTIDINE#0.9304;B CELL#0.9237;EPITHELIAL OVARIAN CANCER#0.9180;ADENOCARCINOMA#0.9159;VACCINIA#0.8848;STEM CELL#0.8840;MULTIPLE MYELOMA#0.8698;TREG CELL#0.8558;MONONUCLEAR CELLS#0.8421;TUMOR TISSUES#0.8068;ANTIGEN PRESENTING CELLS#0.8058;MELANOCYTE DIFFERENTIATION#0.8051;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7988;FOWLPOX#0.7937;LYMPH NODE#0.7698;MELANOCYTE#0.7572;CYTOTOXIC T CELL#0.7498;GM-CSF#0.7464;BONE MARROW#0.7421;IMMUNE SYSTEM#0.7286;ESOPHAGEAL CANCER#0.7169;CHONDROSARCOMA#0.6960;GERM CELL TUMORS#0.6897;X CHROMOSOME#0.6838;GROWTH FACTOR#0.6700;DNA METHYLATION#0.6644;MELANOMA CELL LINES#0.6584;EFFECTOR T CELL#0.6572;SOFT TISSUE SARCOMA#0.6416;TH1 CELL#0.6373;QUANTITATIVE REAL TIME#0.6312;PLEOMORPHIC LIPOSARCOMA#0.6282;RENAL CELL CARCINOMA#0.6239;T CELL ACTIVATION#0.6233;CELL ACTIVATION#0.6215;IMMUNE CELL#0.6215;PLASMA CELL#0.6206;DELAYED-TYPE HYPERSENSITIVITY#0.6154;PRIMARY CUTANEOUS MELANOMA#0.6144;PERIPHERAL NERVE#0.6099;PROTEASOME#0.6085;ADENOID CYSTIC CARCINOMA#0.6069;IGG ANTIBODY#0.6014
148641	HYPERTENSION#0.7094;THIAMINE#0.6366
1486	GLCNAC#0.9806;N-ACETYL-D-GLUCOSAMINE#0.7934;CHITINASE ACTIVITY#0.7730;STEM CELL#0.7672;CYTOTROPHOBLAST#0.7561;GLUCOSAMINE#0.7555;TROPHOBLAST#0.6804;CHITIN BINDING#0.6690;BETA N ACETYLGLUCOSAMINIDASE#0.6154;GENE EXPRESSION#0.6119;OUTER MEMBRANE#0.6090
148713	HOST CELL#0.9230;BIOFILM FORMATION#0.8611;CELL CYCLE#0.7960;OSTEOBLAST#0.7935;IMMUNE SYSTEM#0.6313
148738	REPULSIVE GUIDANCE MOLECULE#1.0616;SKELETAL MUSCLE#1.0577;TRANSFERRIN RECEPTOR#1.0382;CELL SURFACE#1.0381;IRON REGULATORY PROTEIN#1.0380;BONE MORPHOGENETIC PROTEIN#1.0307;PLASMA MEMBRANE#1.0297;SIGNALING PATHWAY#1.0144;GENE EXPRESSION#1.0108;IRON OVERLOAD#0.9971;IRON HOMEOSTASIS#0.9932;ANEMIA#0.9805;ERYTHROPOIESIS#0.9443;IRON DEFICIENCY ANEMIA#0.9419;DEFICIENCY ANEMIA#0.9417;MACROPHAGE#0.9384;POLYMERASE CHAIN REACTION#0.9299;RESPONSE TO IRON#0.9157;PHLEBOTOMY#0.8935;LIVER DISEASE#0.8701;CARDIOMYOPATHY#0.8678;BMP SIGNALING PATHWAY#0.8606;BONE MORPHOGENIC PROTEIN#0.8598;IRON TRANSPORT#0.8528;DIVALENT METAL TRANSPORTER#0.8314;GENETIC DISORDER#0.8259;HYPOXIA#0.8010;HYPOGONADISM#0.7997;TUMOR NECROSIS FACTOR#0.7836;GROWTH FACTOR#0.7642;ENTEROCYTE#0.7632;THALASSEMIA#0.7512;CELL MEMBRANE#0.7430;SOLUBLE TRANSFERRIN RECEPTOR#0.7358;GROWTH DIFFERENTIATION FACTOR#0.7317;MUSCLE CELL#0.7037;CELL ASSOCIATED#0.6760;MOTHERS AGAINST DECAPENTAPLEGIC#0.6681;PEPTIDE HORMONE#0.6422;C REACTIVE PROTEIN#0.6230;BETA THALASSEMIA#0.6091;SIGNAL TRANSDUCTION#0.6021
148753	NEUROBLASTOMA#0.8539;TUMOR CELLS#0.6703;BONE MARROW#0.6698;CELL PROLIFERATION#0.6011
148756	CELLULAR SENESCENCE#0.6534;CELL PROLIFERATION#0.6342;PROTEIN KINASE#0.6341;CANCER CELL#0.6335
148789	MUSCULAR DYSTROPHY#0.9590;CONGENITAL MUSCULAR DYSTROPHY#0.8822;HYDROCEPHALUS#0.7849;GLYCOSYLATION#0.7204;TUMOR TISSUES#0.6009
1487	BINDING PROTEIN 1#1.0616;C-TERMINAL BINDING#1.0472;CARBOXYL-TERMINAL BINDING#1.0269;BREAST CANCER#1.0253;HISTONE DEACETYLASE#1.0194;TUMOR SUPPRESSOR#1.0121;CANCER CELL#1.0110;GENE EXPRESSION#1.0019;TRANSCRIPTION FACTOR#0.9968;APOPTOSIS#0.9964;CELL PROLIFERATION#0.9657;CELL CYCLE#0.9332;BREAST CANCER CELL#0.9325;PROTEIN KINASE#0.9217;ONCOGENIC#0.9214;PROSTATE CANCER#0.9076;EPITHELIAL MESENCHYMAL TRANSITION#0.9004;MEMBRANE FISSION#0.8730;DNA BINDING#0.8517;SIGNALING PATHWAY#0.8426;MACROPINOCYTOSIS#0.8321;CELL ADHESION#0.8211;EPITHELIAL CELL#0.8192;NERVOUS SYSTEM#0.8126;GROWTH FACTOR#0.8008;CELL MIGRATION#0.7847;HUMAN BREAST CANCER#0.7789;SUMOYLATION#0.7469;CYTOPLASM#0.7286;GOLGI MEMBRANE#0.7285;RIBBON SYNAPSE#0.7203;T CELL#0.7057;APOPTOTIC#0.6922;P21 ACTIVATED KINASE#0.6909;CHROMATIN REMODELING#0.6844;DRUG RESISTANCE#0.6813;GOLGI COMPLEX#0.6640;LYSINE#0.6394;MITOSIS#0.6384;HYPOXIC#0.6299;RETINOL DEHYDROGENASE#0.6251;EXPLORATION BEHAVIOR#0.6220;HIGH FAT DIET#0.6115;LIPID STORAGE#0.6114;OVARIAN CANCER#0.6104;HYPOXIA#0.6098
148811	DNA METHYLATION#0.8403;ADIPOCYTE#0.6384;QUANTITATIVE TRAIT LOCUS#0.6166
148867	GOLGI APPARATUS#1.1052;ZINC TRANSPORT#0.9999;ZINC HOMEOSTASIS#0.9335;GENE EXPRESSION#0.9008;ALKALINE PHOSPHATASE#0.8762;LEYDIG CELL#0.7898;SKELETAL MUSCLE#0.7770;INSULIN SECRETION#0.7722;SECRETORY PATHWAY#0.7477;WEIGHT GAIN#0.7469;CARDIOMYOCYTE#0.7348;SIGNALING PATHWAY#0.7076;APOPTOSIS#0.6981;SMALL INTESTINE#0.6977;BODY WEIGHT GAIN#0.6334;QUANTITATIVE TRAIT LOCUS#0.6319;EPITHELIAL CELL#0.6234;MUSCLE CELL#0.6135;MITOCHONDRIA#0.6043
1488	SYNAPTIC RIBBON#1.0640;C-TERMINAL BINDING#1.0578;CANCER CELL#1.0326;RIBBON SYNAPSE#1.0310;CELL PROLIFERATION#1.0297;HAIR CELL#1.0187;PRESYNAPTIC RIBBON#1.0182;BIPOLAR CELL#1.0085;CELL MIGRATION#1.0085;PROSTATE CANCER#1.0042;STEM CELL#0.9915;TRANSCRIPTION FACTOR#0.9894;SYNAPTIC VESICLE#0.9802;GENE EXPRESSION#0.9754;APOPTOSIS#0.9661;BREAST CANCER#0.9616;OVARIAN CANCER#0.9452;AVERAGE DAILY GAIN#0.9402;SUBCUTANEOUS FAT THICKNESS#0.9152;SQUAMOUS CELL CARCINOMA#0.9041;ONCOGENIC#0.8939;EPITHELIAL MESENCHYMAL TRANSITION#0.8939;HISTONE DEACETYLASE#0.8890;SIGNALING PATHWAY#0.8842;BINDING PROTEIN 1#0.8806;T CELL#0.8746;GLUTAMATE RECEPTOR#0.8672;GROWTH FACTOR#0.8479;NERVOUS SYSTEM#0.8379;PROTEIN KINASE#0.8368;WEIGHT GAIN#0.8318;EMBRYONIC STEM CELL#0.8301;GANGLION CELLS#0.8289;CELL CYCLE#0.8267;EXOCYTOSIS#0.8161;PHOTORECEPTOR RIBBON SYNAPSE#0.8118;TUMOR SUPPRESSOR#0.7978;OVARIAN#0.7948;CYTOPLASM#0.7792;CALCIUM CHANNEL#0.7686;DNA BINDING#0.7685;AMPA RECEPTOR#0.7645;BREAST CANCER CELL#0.7529;POSTSYNAPTIC DENSITY#0.7335;OVARIAN CARCINOMA#0.7285;COCHLEA#0.7263;GLUTEUS MEDIUS#0.7038;CENTRAL NERVOUS SYSTEM#0.6955;RNA INTERFERENCE#0.6898;INNER EAR#0.6839;DNA REPAIR#0.6684;AMACRINE CELL#0.6600;ADIPOGENESIS#0.6537;RETINAL GANGLION CELL#0.6529;PROTEIN COMPLEX#0.6514;LONGISSIMUS DORSI MUSCLE#0.6478;NADH BINDING#0.6399;LIPID OXIDATION#0.6391;LPAAT ACTIVITY#0.6347;SYNAPTIC TRANSMISSION#0.6194;EPITHELIAL OVARIAN CARCINOMA#0.6077
148930	HAIR CELL#1.1973;KINOCILIUM#0.9090
148932	HYPERTENSION#0.6442
148979	TRANSCRIPTION FACTOR#1.0481;STEM CELL#0.9855;PLURIPOTENT STEM CELL#0.9398;INDUCED PLURIPOTENT STEM CELL#0.8934;GENE EXPRESSION#0.8605;HYPOXIA INDUCIBLE FACTOR#0.8068;ZINC FINGER PROTEIN#0.7227;SIGNALING PATHWAY#0.6164;HYPOXIC#0.6136;HYPOXIA#0.6107
1489	IL-11#1.0642;ENDOTHELIAL CELL#1.0592;CILIARY NEUROTROPHIC FACTOR#1.0479;LEUKEMIA INHIBITORY FACTOR#1.0357;HYPERTENSION#1.0354;TUMOR NECROSIS FACTOR#1.0350;MYOCYTES#1.0341;CARDIOMYOCYTE#1.0320;ADIPOSE TISSUE#1.0287;PROTEIN SYNTHESIS#1.0252;HEART DISEASE#1.0218;SIGNALING PATHWAY#1.0195;TRANSCRIPTION FACTOR#1.0193;GLIAL CELL#1.0192;BRAIN NATRIURETIC PEPTIDE#1.0183;APOPTOSIS#1.0181;MYOCARDIAL INFARCTION#1.0177;ISCHEMIA#1.0136;GROWTH FACTOR#1.0131;STEM CELL#1.0117;CELL DEATH#1.0116;INSULIN-LIKE GROWTH FACTOR#1.0093;MUSCLE CELL#1.0086;MYOCARDIUM#1.0077;PROTEIN KINASE#1.0071;SMOOTH MUSCLE#1.0059;HYPERTENSIVE HEART DISEASE#1.0057;GENE EXPRESSION#1.0032;LEFT VENTRICULAR MASS#1.0011;APOPTOTIC#0.9998;TRANSFORMING GROWTH FACTOR#0.9983;SIGNAL TRANSDUCER#0.9973;CONGESTIVE HEART FAILURE#0.9937;SKELETAL MUSCLE#0.9912;MITOGEN ACTIVATED PROTEIN#0.9842;CYTOKINE RECEPTOR#0.9768;SMOOTH MUSCLE CELL#0.9719;ESSENTIAL HYPERTENSION#0.9712;CELL SURFACE#0.9661;CORONARY ARTERY#0.9606;SIGNALLING PATHWAY#0.9561;NERVOUS SYSTEM#0.9558;SIGNAL TRANSDUCTION#0.9547;OBESE#0.9531;ADIPOCYTE#0.9512;ARTERY#0.9498;RECEPTOR COMPLEX#0.9492;GALECTIN#0.9465;POLYMERASE CHAIN REACTION#0.9445;CELL PROLIFERATION#0.9390;MAP KINASE#0.9329;HEAT SHOCK PROTEIN#0.9296;DNA BINDING#0.9270;MONOCYTE#0.9235;EMBRYONIC STEM CELL#0.9213;NITRIC OXIDE#0.9099;BONE MARROW#0.9098;ISCHEMIA REPERFUSION INJURY#0.9079;ACUTE MYOCARDIAL INFARCTION#0.9032;MESENCHYMAL STEM CELL#0.9029;OSTEOBLAST#0.8986;REGENERATION#0.8964;T CELL#0.8951;HYPOXIA#0.8924;SPINAL CORD#0.8917;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8875;HUMAN UMBILICAL VEIN#0.8866;UMBILICAL VEIN#0.8862;EPITHELIAL CELL#0.8852;INSULIN RECEPTOR#0.8806;CARDIOMYOPATHY#0.8735;WOUND HEALING#0.8659;MACROPHAGE#0.8654;ENDOTHELIAL GROWTH FACTOR#0.8618;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8618;C REACTIVE PROTEIN#0.8613;TROPHOBLAST#0.8607;LIVER REGENERATION#0.8470;OSTEOCLAST#0.8433;HYPOXIC#0.8427;MOUSE EMBRYONIC STEM#0.8427;MOTOR NEURON DISEASE#0.8120;MONONUCLEAR CELLS#0.8044;CORONARY ARTERY BYPASS#0.7993;MYOFIBROBLAST#0.7992;VASCULAR SMOOTH MUSCLE CELL#0.7967;ULCERATIVE COLITIS#0.7946;FACTOR I#0.7943;CHRONIC HEART FAILURE#0.7916;PERIPHERAL BLOOD#0.7904;FIBROBLAST GROWTH FACTOR#0.7767;CARDIOVASCULAR SYSTEM#0.7743;INFLAMMATORY RESPONSE#0.7661;EXTRACELLULAR MATRIX#0.7656;HUMAN CARDIAC FIBROBLASTS#0.7627;CANCER CELL#0.7622;TROPHECTODERM#0.7618;DILATED CARDIOMYOPATHY#0.7512;MUSCLE FIBER#0.7470;ASTROCYTE#0.7446;HEPATOMA CELLS#0.7409;INSULIN SECRETION#0.7409;REVERSE TRANSCRIPTION#0.7387;PHOSPHATE BUFFERED SALINE#0.7303;ESTROGEN RECEPTOR#0.7168;ALDOSTERONE#0.7165;B CELL#0.7154;ANGIOGENESIS#0.7134;COLITIS#0.7122;MYOSIN HEAVY CHAIN#0.7059;GLUCOSE METABOLISM#0.7040;REACTIVE OXYGEN SPECIES#0.7020;NADPH OXIDASE#0.6887;CHRONIC KIDNEY DISEASE#0.6875;ATHEROSCLEROSIS#0.6863;KIDNEY DISEASE#0.6859;SWEAT GLAND#0.6808;BONE FORMATION#0.6790;PULSE WAVE VELOCITY#0.6767;IMMUNE RESPONSE#0.6715;LIVER DISEASE#0.6697;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6692;CELL MIGRATION#0.6690;VASCULAR ENDOTHELIAL CELL#0.6683;CORD BLOOD#0.6681;MYOTUBE#0.6487;CELL GROWTH#0.6448;CELL CYCLE#0.6438;GLIOGENESIS#0.6435;STREPTOZOTOCIN#0.6326;AIRWAY SMOOTH MUSCLE#0.6308;LUNG FIBROBLASTS#0.6302;CARDIAC MUSCLE#0.6280;NEURONAL CELLS#0.6251;BREAST CANCER#0.6240;WEIGHT GAIN#0.6237;VALVULAR HEART DISEASE#0.6236;CARDIOGENESIS#0.6236;OSTEOBLAST DIFFERENTIATION#0.6232;LIPID METABOLISM#0.6227;MUTAGENESIS#0.6189;SIGNALING CASCADE#0.6189;JANUS ACTIVATED KINASE#0.6149;HISTONE BINDING#0.6140;GROWTH DIFFERENTIATION FACTOR#0.6132;ASTROCYTE DIFFERENTIATION#0.6121;COLLAGEN SYNTHESIS#0.6086;TOXICITY#0.6077;HEPATOCYTE GROWTH FACTOR#0.6044;PRECURSOR CELL#0.6041;NOREPINEPHRINE#0.6041;CALPAIN ACTIVITY#0.6030;MURINE EMBRYONIC STEM#0.6008
148	TAMSULOSIN#1.0294;ADRENERGIC RECEPTOR#1.0290;NORADRENALINE#0.9940;PHENYLEPHRINE#0.9928;PRAZOSIN#0.9849;SMOOTH MUSCLE#0.9833;NOREPINEPHRINE#0.9494;METHOXAMINE#0.9239;LOWER URINARY TRACT#0.9144;CEREBRAL CORTEX#0.8857;ARTERY#0.8518;NIFEDIPINE#0.8389;SILODOSIN#0.8032;VASOCONSTRICTION#0.8025;ALPHA ADRENOCEPTOR#0.7871;URETHRA#0.7804;TERAZOSIN#0.7710;POLYMERASE CHAIN REACTION#0.7512;PROTEIN KINASE#0.7510;PHENTOLAMINE#0.7504;OXYMETAZOLINE#0.7367;PROTEIN KINASE C#0.7322;RECEPTOR ANTAGONIST#0.7309;MYOCARDIUM#0.7139;BENIGN PROSTATIC OBSTRUCTION#0.6932;DOXAZOSIN#0.6894;EXCRETION#0.6708;BETA ADRENOCEPTOR#0.6594;CLONIDINE#0.6479;RECEPTOR AGONIST#0.6347;BLADDER OUTLET OBSTRUCTION#0.6137;THORACIC AORTA#0.6016
149018	LATE CORNIFIED ENVELOPE#1.0767;CORNIFIED ENVELOPE#0.9610;ATOPIC DERMATITIS#0.6592
149041	RNA BINDING PROTEIN#1.0721;RNA BINDING#1.0683;T CELL#1.0449;CELL ACTIVATION#1.0182;AUTOIMMUNE DISEASE#0.9977;UBIQUITIN#0.9785;AUTOIMMUNITY#0.9734;T CELL ACTIVATION#0.9696;CELL DIFFERENTIATION#0.9583;B CELL#0.9526;IMMUNE RESPONSE#0.9468;MRNA DECAY#0.9076;GENE EXPRESSION#0.8928;IMMUNE SYSTEM#0.8628;GERMINAL CENTER#0.8220;MRNA DEGRADATION#0.7784;T FOLLICULAR HELPER#0.7780;FOLLICULAR HELPER T CELL#0.7356;CD4+ T CELL#0.7282;STRESS GRANULE#0.7124;TREG CELL#0.7008;T HELPER CELL#0.6980;CCR4 NOT COMPLEX#0.6427;SMALL INTESTINE#0.6160;SIGNALLING PATHWAY#0.6150
149076	TERMINAL DIFFERENTIATION#1.0984;TRANSCRIPTION FACTOR#1.0812;VULVA#0.7707;GENE EXPRESSION#0.7570;EGG LAYING#0.7379;MORPHOGENESIS#0.6750
1490	CCN2 PRODUCTION#1.1239;CTGF PRODUCTION#1.0886;IL-11#1.0678;SMAD BINDING#1.0616;GRANULOSA CELL#1.0577;NEPHROBLASTOMA#1.0575;PERITONEAL MESOTHELIAL CELLS#1.0466;COLLAGEN TYPE III#1.0448;GINGIVAL OVERGROWTH#1.0421;SIMVASTATIN#1.0398;PULMONARY ARTERY#1.0396;ENDOCHONDRAL OSSIFICATION#1.0392;LUCIFERASE ACTIVITY#1.0377;HEPARIN BINDING#1.0367;HUMAN PROXIMAL TUBULAR#1.0363;VASCULAR ENDOTHELIAL CELL#1.0351;LUNG EPITHELIAL CELL#1.0348;CHONDROCYTE DIFFERENTIATION#1.0341;NUCLEUS PULPOSUS#1.0339;IFN-GAMMA#1.0334;AIRWAY SMOOTH MUSCLE#1.0295;PULMONARY VASCULAR REMODELING#1.0295;TISSUE GROWTH FACTOR#1.0290;FACTOR I#1.0289;CHONDROGENESIS#1.0285;COLLAGEN TYPE IV#1.0281;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0279;NUCLEUS PULPOSUS CELL#1.0276;OSTEOGENESIS#1.0273;OSTEOBLAST DIFFERENTIATION#1.0263;MONOCYTE CHEMOTACTIC PROTEIN#1.0263;CONNECTIVE TISSUE#1.0260;BILIARY ATRESIA#1.0257;MESOTHELIAL CELL#1.0253;CAFFEINE#1.0252;GROWTH REGULATOR#1.0249;OSSIFICATION#1.0239;MAPK SIGNALING#1.0239;INTERVERTEBRAL DISC#1.0237;HEPATITIS B#1.0229;COLLAGEN TYPE I#1.0229;HYPERTROPHIC SCAR FIBROBLASTS#1.0226;OF DIABETIC RATS#1.0223;BRAIN NATRIURETIC PEPTIDE#1.0222;MATRIX METALLOPROTEINASE 1#1.0219;PROXIMAL TUBULAR CELL#1.0211;HEPARIN#1.0210;PERICYTE#1.0206;GROWTH FACTOR#1.0204;PROLIFERATIVE DIABETIC RETINOPATHY#1.0199;PLATELET-DERIVED GROWTH FACTOR#1.0195;PANCREATIC CANCER#1.0194;RNA INTERFERENCE#1.0187;CHONDROCYTE#1.0186;GROWTH FACTOR BINDING#1.0185;PANCREATIC STELLATE CELL#1.0184;BETA-2#1.0181;FIBROBLAST GROWTH FACTOR#1.0178;TUBE FORMATION#1.0174;MAP KINASE#1.0163;HUMAN DERMAL FIBROBLAST#1.0159;ATHEROSCLEROTIC#1.0158;QUANTITATIVE REVERSE TRANSCRIPTION#1.0145;PROTEIN SYNTHESIS#1.0142;ASTROCYTE#1.0140;PROXIMAL TUBULAR EPITHELIAL#1.0138;ACTIN CYTOSKELETON#1.0136;ENDOTHELIAL GROWTH FACTOR#1.0136;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0135;PODOCYTE#1.0126;GENE SILENCING#1.0123;VASCULAR CELL#1.0118;CELL ADHESION MOLECULE#1.0116;DNA SYNTHESIS#1.0115;DIABETIC RETINOPATHY#1.0114;LOSARTAN#1.0112;ROSIGLITAZONE#1.0103;TISSUE REMODELING#1.0101;HEPATOCYTE GROWTH FACTOR#1.0099;FOCAL ADHESION#1.0096;TRANSDIFFERENTIATION#1.0095;LUNG FIBROBLASTS#1.0094;MYOFIBROBLAST DIFFERENTIATION#1.0092;FIBROBLAST PROLIFERATION#1.0091;CARTILAGE DEVELOPMENT#1.0089;KERATINOCYTE#1.0087;COLORECTAL CANCER#1.0083;SQUAMOUS CELL CARCINOMA#1.0080;PIOGLITAZONE#1.0071;OSTEOBLAST#1.0070;FOCAL ADHESION KINASE#1.0066;DEXAMETHASONE#1.0066;MESANGIAL CELL#1.0061;COLLAGEN SYNTHESIS#1.0059;LYMPH NODE#1.0056;SKIN FIBROBLASTS#1.0054;PERIODONTAL LIGAMENT#1.0045;TRANSFORMING GROWTH FACTOR BETA#1.0045;HYPOXIC#1.0043;INSULIN-LIKE GROWTH FACTOR#1.0042;TRANSCRIPTASE#1.0042;STRESS FIBER#1.0036;RHEUMATOID ARTHRITIS#1.0031;ADVANCED GLYCATION END#1.0030;EPIDERMAL GROWTH FACTOR#1.0029;MESENCHYMAL CELL#1.0025;HEAT SHOCK PROTEIN#1.0021;HYPOXIA INDUCIBLE FACTOR#1.0020;MYOCYTES#1.0020;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0020;LOW DENSITY LIPOPROTEIN#1.0019;RAPAMYCIN#1.0013;PROGENITOR CELL#1.0012;PROTEIN KINASE C#1.0008;INTEGRIN LINKED KINASE#1.0007;SPHINGOSINE 1 PHOSPHATE#1.0004;BONE MORPHOGENETIC PROTEIN#1.0001;SURFACE PLASMON RESONANCE#0.9999;SKELETAL MUSCLE#0.9999;BONE FORMATION#0.9998;LUNG CANCER#0.9996;PULMONARY HYPERTENSION#0.9993;SMOOTH MUSCLE ACTIN#0.9992;PROTEOGLYCAN#0.9991;HYPOXIA#0.9991;TUBULAR EPITHELIAL CELL#0.9989;OVARIAN#0.9988;FIBROBLAST ACTIVATION#0.9986;TUMOR NECROSIS FACTOR#0.9981;TRANSFORMING GROWTH FACTOR#0.9979;MONOCYTE#0.9976;MINERALIZATION#0.9973;BLOOD VESSEL#0.9972;TUMOUR NECROSIS FACTOR#0.9970;FORSKOLIN#0.9968;S PHASE#0.9967;CELL ADHESION#0.9966;HIPPO SIGNALING#0.9965;SIGNALING CASCADE#0.9965;AKT SIGNALING#0.9964;BREAST CANCER CELL#0.9963;MYOBLAST#0.9963;OSTEOARTHRITIS#0.9963;SIGNALING MOLECULE#0.9957;RENAL INTERSTITIAL FIBROSIS#0.9957;GROWTH FACTOR RECEPTOR#0.9955;DIABETIC KIDNEY DISEASE#0.9953;RETINAL PIGMENT EPITHELIAL#0.9951;GLOMERULONEPHRITIS#0.9949;REVERSE TRANSCRIPTION#0.9949;ANGIOGENESIS#0.9947;DNA BINDING#0.9939;DERMAL FIBROBLAST#0.9939;VASCULAR SMOOTH MUSCLE CELL#0.9939;QUANTITATIVE REAL TIME#0.9938;CELL GROWTH#0.9934;ISCHEMIA REPERFUSION INJURY#0.9933;CYTOPLASM#0.9933;COLLAGEN VOLUME FRACTION#0.9932;SMAD BINDING ELEMENT#0.9931;C TERMINAL DOMAIN#0.9931;MUSCULAR DYSTROPHY#0.9925;STROMA#0.9925;STROMAL CELL#0.9923;SCLERODERMA#0.9921;ALDOSTERONE#0.9920;ISCHEMIA#0.9919;B CELL#0.9918;REPORTER GENE ASSAY#0.9918;ALKALINE PHOSPHATASE#0.9917;SMOOTH MUSCLE#0.9914;MITOGEN ACTIVATED PROTEIN#0.9912;SMOOTH MUSCLE CELL#0.9912;SENESCENCE#0.9912;COLORECTAL#0.9909;SKELETAL DEVELOPMENT#0.9908;SIGNALLING PATHWAY#0.9908;MYOCARDIUM#0.9907;MUSCLE CELL#0.9904;MENISCUS#0.9903;NADPH OXIDASE#0.9902;HEPATIC STELLATE CELL#0.9898;SPHINGOSINE#0.9897;TRANSACTIVATION#0.9896;EXTRACELLULAR MATRIX COMPONENT#0.9895;HEPATOCELLULAR CARCINOMA#0.9892;KINASE INHIBITOR#0.9888;VSMC PROLIFERATION#0.9878;WOUND HEALING#0.9878;HYDROXYPROLINE#0.9876;SIGNAL TRANSDUCER#0.9876;REGENERATION#0.9876;PROTEIN KINASE B#0.9873;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9873;BREAST CANCER#0.9873;CELL MIGRATION#0.9872;POLYMERASE CHAIN REACTION#0.9869;GALECTIN#0.9866;CHONDROSARCOMA#0.9865;HIPPO SIGNALING PATHWAY#0.9863;SIGNAL TRANSDUCTION#0.9860;PERITONEUM#0.9859;BLEOMYCIN#0.9858;CARDIOMYOCYTE#0.9854;RENAL FIBROSIS#0.9852;DERMIS#0.9851;MYOFIBROBLAST#0.9851;EPITHELIAL CELL#0.9851;ENDOTHELIAL CELL#0.9851;HUMAN UMBILICAL VEIN#0.9849;VASCULAR DISEASE#0.9848;EPITHELIAL TO MESENCHYMAL#0.9848;PEROXISOME#0.9848;TUMOR CELLS#0.9846;PRO-INFLAMMATORY#0.9845;CELL DIFFERENTIATION#0.9844;PROSTAGLANDIN E2#0.9843;UMBILICAL VEIN#0.9841;ATHEROSCLEROSIS#0.9839;PROTEIN KINASE#0.9839;ANCHORAGE INDEPENDENT GROWTH#0.9836;CELL PROLIFERATION#0.9834;OSTEOCLAST#0.9832;ADIPOCYTE#0.9832;HUMAN BREAST CANCER#0.9832;T CELL#0.9829;MESENCHYMAL STEM CELL#0.9827;DRUG RESISTANCE#0.9826;CELL SURFACE#0.9824;BRONCHIAL EPITHELIAL CELLS#0.9821;IDIOPATHIC PULMONARY FIBROSIS#0.9817;OVARIAN CANCER#0.9816;CHRONIC ALLOGRAFT NEPHROPATHY#0.9812;SPINAL CORD#0.9804;CANCER CELL#0.9800;EXCRETION#0.9800;UNILATERAL URETERAL OBSTRUCTION#0.9799;MYOCARDIAL INFARCTION#0.9797;PULMONARY FIBROSIS#0.9797;ATRIAL FIBRILLATION#0.9797;URETERAL OBSTRUCTION#0.9795;TAMOXIFEN#0.9793;DIABETIC NEPHROPATHY#0.9791;NITRIC OXIDE#0.9788;BASEMENT MEMBRANE#0.9788;ANGIOTENSIN CONVERTING ENZYME#0.9786;NEUTROPHIL#0.9782;TYPE 1 DIABETES#0.9781;TYPE 2 DIABETIC#0.9778;CELL DEATH#0.9776;CELL CYCLE#0.9772;BONE MARROW#0.9765;GLOMERULAR FILTRATION#0.9764;URINARY PROTEIN#0.9764;MAST CELL#0.9763;APOPTOTIC#0.9762;STEM CELL#0.9759;BLOOD UREA NITROGEN#0.9757;SIGNALING PATHWAY#0.9756;LUNG DEVELOPMENT#0.9755;LIVER DISEASE#0.9752;ARTERY#0.9749;NEPHROPATHY#0.9749;ESTROGEN RECEPTOR#0.9748;MACROPHAGE#0.9746;NORMAL CONTROL GROUP#0.9744;EPITHELIAL MESENCHYMAL TRANSITION#0.9744;EXTRACELLULAR MATRIX#0.9743;BILE DUCT#0.9740;GENE EXPRESSION#0.9738;ASCORBIC ACID#0.9738;ACTIVIN RECEPTOR#0.9737;INFLAMMATORY CELL#0.9735;TOLL LIKE RECEPTOR#0.9734;INFLAMMATORY RESPONSE#0.9733;LUNG DISEASE#0.9733;TRANSCRIPTION FACTOR#0.9730;YES ASSOCIATED PROTEIN#0.9728;APOPTOSIS#0.9728;TUMOR SUPPRESSOR#0.9723;PIGMENT EPITHELIAL CELL#0.9719;RECEPTOR ANTAGONIST#0.9717;CELL ACTIVATION#0.9715;TYPE 1 DIABETIC#0.9711;SUPEROXIDE DISMUTASE#0.9704;MICROVASCULAR ENDOTHELIAL CELL#0.9703;PROTEINURIA#0.9701;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9691;NERVOUS SYSTEM#0.9686;LIVER CIRRHOSIS#0.9686;TYPE 2 DIABETES#0.9677;HEPATITIS C#0.9675;EOSIN#0.9672;GLOMERULAR FILTRATION RATE#0.9671;ENDOMETRIUM#0.9665;CARDIOMYOPATHY#0.9663;SPIRONOLACTONE#0.9659;HEART DISEASE#0.9657;REACTIVE OXYGEN SPECIES#0.9656;SPECIFIC PROTEIN 1#0.9650;ENDOTHELIUM#0.9648;HYALURONIC ACID#0.9647;GLUTATHIONE#0.9647;CHRONIC LIVER DISEASE#0.9646;DIABETES MELLITUS#0.9645;HYPERTENSION#0.9640;KIDNEY DISEASE#0.9639;CHRONIC KIDNEY DISEASE#0.9626;BONE MORPHOGENIC PROTEIN#0.9615;EMBRYONIC LUNG#0.9606;ADENOCARCINOMA#0.9605;TROPHOBLAST#0.9604;OVAL CELL#0.9598;RETINAL PIGMENT EPITHELIAL CELLS#0.9597;HYPERGLYCEMIA#0.9596;PROTEIN SECRETION#0.9596;STREPTOZOTOCIN#0.9591;CORONARY ARTERY#0.9590;FIBROCYTE#0.9588;TOOTH DEVELOPMENT#0.9584;PROSTATE CANCER#0.9583;TARGET OF RAPAMYCIN#0.9579;TISSUE REGENERATION#0.9574;IGF BINDING#0.9571;CELL CYCLE ARREST#0.9560;MECHANISM OF ACTION#0.9557;COLLAGENASE#0.9539;NITRIC OXIDE SYNTHASE#0.9533;LEUKOCYTE#0.9530;DILATED CARDIOMYOPATHY#0.9521;DENTAL PULP#0.9516;CHONDROCYTE PROLIFERATION#0.9509;NEPHRITIS#0.9503;MYOSIN HEAVY CHAIN#0.9501;ENALAPRIL#0.9499;ACTIVATOR PROTEIN 1#0.9498;ACTIN POLYMERIZATION#0.9484;CHEMOKINE RECEPTOR#0.9474;PROLIFERATIVE VITREORETINOPATHY#0.9468;CANCER ASSOCIATED FIBROBLASTS#0.9464;ALVEOLAR EPITHELIAL CELL#0.9455;CROHN'S DISEASE#0.9453;PROTEASE ACTIVATED RECEPTOR#0.9452;PDZ BINDING MOTIF#0.9451;EARLY GROWTH RESPONSE#0.9451;HIGH FAT DIET#0.9451;INTERSTITIAL CELL#0.9441;CHEMOTAXIS#0.9435;ADIPOSE TISSUE#0.9434;ONCOGENIC#0.9426;RETINOIC ACID#0.9418;DUCHENNE MUSCULAR DYSTROPHY#0.9412;MESENCHYME#0.9404;SYNOVIAL FLUID#0.9401;INFLAMMATORY CELL INFILTRATION#0.9396;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9394;PROTEIN KINASE A#0.9387;72-HOURS#0.9387;PANCREATITIS#0.9384;BEVACIZUMAB#0.9377;JNK SIGNALING PATHWAY#0.9376;PIRFENIDONE#0.9370;MORPHOGENESIS#0.9365;ROS GENERATION#0.9361;TOXICITY#0.9349;CYCLOSPORINE#0.9340;SYSTOLIC BLOOD PRESSURE#0.9334;ADENOSINE#0.9332;ELECTROPHORETIC MOBILITY SHIFT#0.9326;ORAL SQUAMOUS CELL CARCINOMA#0.9323;MICROTUBULE#0.9296;TRABECULAR MESHWORK CELLS#0.9286;IMMUNE CELL#0.9285;CYCLIN DEPENDENT KINASE#0.9279;PHENYTOIN#0.9273;ETHANOL#0.9273;BILE DUCT LIGATION#0.9238;DOXORUBICIN#0.9225;CHRONIC HEPATITIS B#0.9224;DENTAL PULP CELL#0.9208;COAGULATION#0.9199;SUBSTANCE P#0.9158;IMMUNE RESPONSE#0.9154;HUMAN BRONCHIAL EPITHELIAL#0.9149;EPLERENONE#0.9143;OPEN ANGLE GLAUCOMA#0.9136;CONSTRICTION#0.9108;BONE REGENERATION#0.9107;VERTEPORFIN#0.9103;LYMPH NODE METASTASIS#0.9096;HEPATITIS B VIRUS#0.9093;SERUM ALBUMIN#0.9088;FLUVASTATIN#0.9087;CARDIOVASCULAR SYSTEM#0.9060;KIDNEY DAMAGE#0.9058;ILOPROST#0.9051;TRANSVERSE AORTIC CONSTRICTION#0.9049;HUMAN DENTAL PULP#0.9048;RECEPTOR COMPLEX#0.9030;KINASE ACTIVITY#0.9030;HUMAN TRABECULAR MESHWORK#0.9022;BONE REMODELING#0.9022;BRONCHOPULMONARY DYSPLASIA#0.9013;MAMMARY EPITHELIAL CELL#0.9012;T LYMPHOCYTE#0.8990;TISSUE DEVELOPMENT#0.8982;DENDRITIC CELL#0.8978;INTRAMEMBRANOUS OSSIFICATION#0.8977;PRIMARY OPEN ANGLE GLAUCOMA#0.8970;OSTEOCYTE#0.8952;AUTOPHAGY#0.8948;TERMINAL DIFFERENTIATION#0.8944;CENTRAL NERVOUS SYSTEM#0.8943;EXOSOME#0.8924;INDUCIBLE NITRIC OXIDE#0.8920;MECHANISMS OF ACTION#0.8916;OOCYTE#0.8916;ATORVASTATIN#0.8908;ADENINE#0.8907;SHAM OPERATION GROUP#0.8906;PARATHYROID HORMONE#0.8901;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8863;HUMAN LENS EPITHELIAL#0.8859;N-ACETYLCYSTEINE#0.8844;EPIGALLOCATECHIN#0.8837;ADIPOCYTE DIFFERENTIATION#0.8833;PARENCHYMA#0.8812;ESTRADIOL#0.8802;PULMONARY ARTERIAL HYPERTENSION#0.8801;INTERVERTEBRAL DISC DEGENERATION#0.8795;TO THE PROGRESSION#0.8790;RETINAL DETACHMENT#0.8790;BRANCHING MORPHOGENESIS#0.8785;RECEPTOR ACTIVATOR#0.8782;KNEE JOINT#0.8777;DOMINANT NEGATIVE MUTANT#0.8772;ENHANCER BINDING PROTEIN#0.8764;RETINAL PIGMENT EPITHELIUM#0.8761;ENHANCER BINDING#0.8759;NIFEDIPINE#0.8755;GROWTH DIFFERENTIATION FACTOR#0.8749;OBESE#0.8739;ALANINE#0.8738;IRBESARTAN#0.8736;RECEPTOR AGONIST#0.8734;OBSTRUCTIVE NEPHROPATHY#0.8729;DNA METHYLATION#0.8728;EXTRA CELLULAR MATRIX#0.8728;MONONUCLEAR CELLS#0.8720;COLCHICINE#0.8714;DIGESTION#0.8713;COLONY-STIMULATING FACTOR#0.8710;HEPATOMA CELLS#0.8709;DISEASE FREE SURVIVAL#0.8708;CYTOCHROME P450#0.8705;FASTING BLOOD GLUCOSE#0.8694;G1 PHASE#0.8665;THYROID CARCINOMA#0.8655;ISOPROTERENOL#0.8649;CANDESARTAN#0.8649;GESTATION#0.8635;LOVASTATIN#0.8629;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8622;PROTEOGLYCAN SYNTHESIS#0.8609;PANCREATIC DUCTAL ADENOCARCINOMA#0.8592;BETA CELL#0.8584;PRECURSOR CELL#0.8570;FACTOR S#0.8570;GLUTATHIONE PEROXIDASE#0.8557;THYMIDINE#0.8555;MARROW STROMAL CELLS#0.8555;BONE MARROW STROMAL CELL#0.8555;BONE MARROW STROMAL#0.8550;PROXIMAL TUBULE CELL#0.8546;TISSUE DAMAGE#0.8544;TISSUE HOMEOSTASIS#0.8535;AORTIC SMOOTH MUSCLE CELLS#0.8533;NICOTINAMIDE#0.8530;LUMINAL#0.8516;SERUM RESPONSE FACTOR#0.8515;COLITIS#0.8499;ANGIOTENSIN RECEPTOR#0.8487;INTERSTITIAL LUNG DISEASE#0.8486;CROSS SECTIONAL AREA#0.8474;OVULATION#0.8472;LIVER DAMAGE#0.8470;MOTHERS AGAINST DECAPENTAPLEGIC#0.8467;NOTOCHORD#0.8464;RECEPTOR TYROSINE KINASE#0.8443;UTERUS#0.8442;RIBOZYME#0.8439;ADIPOGENESIS#0.8438;HEPATIC PROGENITOR CELL#0.8437;MYOTUBE#0.8432;HEPATIC STELLATE CELL ACTIVATION#0.8411;GALLBLADDER#0.8402;ENDOPLASMIC RETICULUM#0.8386;ALKALINE PHOSPHATASE ACTIVITY#0.8383;MACULAR DEGENERATION#0.8383;CELLULAR SENESCENCE#0.8360;PHOSPHATASE ACTIVITY#0.8351;CYTOTOXICITY#0.8347;SELECTIN#0.8340;B CELL LYMPHOMA#0.8337;CORNEAL EPITHELIAL CELL#0.8330;ULCERATIVE COLITIS#0.8325;TROPHOBLAST CELL#0.8316;ANGIOTENSIN TYPE 1#0.8276;BLANK CONTROL GROUP#0.8272;ARTERIOLE#0.8264;PERIPHERAL BLOOD#0.8262;SPHINGOSINE KINASE 1#0.8257;ENDOTHELIN RECEPTOR#0.8253;DIASTOLIC HEART FAILURE#0.8242;LEUCINE#0.8234;OVARIAN FOLLICLE#0.8220;PROTEIN PROTEIN INTERACTION#0.8218;LUNG ADENOCARCINOMA#0.8216;COLLAGEN TYPE II#0.8210;BONE DEVELOPMENT#0.8209;ACE INHIBITOR#0.8209;TUMOR GROWTH FACTOR#0.8208;PACLITAXEL#0.8205;LDL RECEPTOR#0.8205;SCLEROTIC#0.8200;OXYGENASE#0.8182;JUN PHOSPHORYLATION#0.8179;HYALURONAN#0.8164;SIGNALLING CASCADE#0.8161;ADENINE DINUCLEOTIDE PHOSPHATE#0.8148;IMMUNE SYSTEM#0.8139;MUSCLE FIBER#0.8133;C REACTIVE PROTEIN#0.8116;HEME OXYGENASE 1#0.8113;LEIOMYOMA#0.8106;HISTONE DEACETYLASE#0.8094;COLON CANCER#0.8093;TYPE III PROCOLLAGEN#0.8086;SMOOTH MUSCLE CELL PROLIFERATION#0.8086;MUSCLE CELL PROLIFERATION#0.8082;MOUSE MESANGIAL CELLS#0.8082;OPTIC NERVE#0.8076;SKELETAL MUSCLE CELLS#0.8074;PRAVASTATIN#0.8072;MYOCARDITIS#0.8072;CLEAVED CASPASE 3#0.8067;ACETYLCYSTEINE#0.8066;AORTIC ANEURYSM#0.8058;DERMAL PAPILLA CELL#0.8054;MYOMETRIUM#0.8053;MOUSE EMBRYONIC FIBROBLAST#0.8047;SKIN DISEASE#0.8046;CELL ASSOCIATED#0.8036;GLIAL CELL#0.8034;CYSTEIN#0.8033;CELL DEVELOPMENT#0.8026;BLINDNESS#0.8023;CALCINEURIN#0.8015;PROLIFERATIVE GLOMERULONEPHRITIS#0.7996;LYSINE#0.7993;HEPATOCYTE APOPTOSIS#0.7963;CRESCENTIC GLOMERULONEPHRITIS#0.7961;ROOT SHEATH#0.7940;PARATHYROID#0.7938;LOCALISATION#0.7933;ASPARTATE#0.7929;MAPK ACTIVATION#0.7925;MACROPHAGE INFLAMMATORY PROTEIN#0.7911;PLASMA MEMBRANE#0.7905;FORMALIN#0.7888;TUMOR TISSUES#0.7876;ANTISENSE RNA#0.7865;T CELL FACTOR#0.7864;ENZYME INHIBITOR#0.7861;MATRIX METALLOPROTEINASE 13#0.7856;P38 MAPK SIGNALING#0.7846;PAPILLARY THYROID CARCINOMA#0.7832;DIFFERENTIAL GENE EXPRESSION#0.7826;QUANTITATIVE REVERSE TRANSCRIPTASE#0.7825;SYNOVIUM#0.7812;OLIGODENDROCYTE#0.7802;AGE RELATED MACULAR DEGENERATION#0.7799;COENZYME A#0.7783;GLYCOSYLATION#0.7780;CHRONIC HEPATITIS C#0.7765;AUTOIMMUNE DISEASE#0.7758;PLURIPOTENT STEM CELL#0.7758;DEDIFFERENTIATION#0.7757;BODY WEIGHT RATIO#0.7752;VITAMIN E#0.7741;GLUCOCORTICOID RECEPTOR#0.7741;UBIQUITIN#0.7740;HIGH MOBILITY GROUP#0.7733;CELL MOTILITY#0.7727;LEFT ANTERIOR DESCENDING#0.7724;ANTERIOR CRUCIATE LIGAMENT#0.7719;BREAST CANCER PATIENTS#0.7713;CRUCIATE LIGAMENT#0.7709;PALATE DEVELOPMENT#0.7702;CYTOCHROME C#0.7690;ORAL SUBMUCOUS FIBROSIS#0.7686;TYPE 2 DIABETES MELLITUS#0.7672;2 DIABETES MELLITUS#0.7672;END STAGE RENAL FAILURE#0.7669;HUMAN MESENCHYMAL STEM#0.7650;OSTEOCLAST DIFFERENTIATION#0.7648;SRC FAMILY KINASE#0.7645;RESPONSE TO BLEOMYCIN#0.7644;ALPHA-TOCOPHEROL#0.7642;HAIR FOLLICLE#0.7615;MESENCHYMAL STROMAL CELL#0.7602;PROGESTERONE#0.7602;POSTERIOR CAPSULE OPACIFICATION#0.7600;BONE RESORPTION#0.7596;LEFT VENTRICULAR MASS#0.7590;DNA FRAGMENTATION#0.7581;PERTUSSIS#0.7578;CARPAL TUNNEL SYNDROME#0.7553;EDEMA#0.7549;GLYCOLYSIS#0.7536;INTRACELLULAR SIGNALING PATHWAY#0.7528;HEPATITIS C VIRUS#0.7515;ANOIKIS#0.7505;TELMISARTAN#0.7498;GROWTH HORMONE#0.7494;TYROSINE KINASE RECEPTOR#0.7486;FATTY LIVER#0.7464;HUMAN PERIODONTAL LIGAMENT#0.7463;NF-KAPPAB ACTIVATION#0.7461;CHOLESTASIS#0.7448;ACTIVATED T CELL#0.7447;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7446;ENDOMETRIOSIS#0.7442;PHOSPHODIESTERASE#0.7437;MITRAL VALVE#0.7433;MANNITOL#0.7433;QUERCETIN#0.7424;NODULE FORMATION#0.7422;CYCLIN DEPENDENT KINASE INHIBITOR#0.7417;ALVEOLARIZATION#0.7408;GALLBLADDER CANCER#0.7407;LIVER CANCER#0.7406;PROTEASOME#0.7396;CAROTID ARTERY#0.7391;ADRENERGIC RECEPTOR#0.7389;INDUCTION OF APOPTOSIS#0.7383;VALSARTAN#0.7374;GLOMERULUS#0.7373;HUMAN PROXIMAL TUBULE#0.7365;LIVER REGENERATION#0.7365;PROTEASE ACTIVITY#0.7364;BINDING PROTEIN 3#0.7353;TRADITIONAL CHINESE MEDICINE#0.7346;KERATINOCYTE MIGRATION#0.7338;ACTIVATED T-CELLS#0.7325;RECEPTOR BINDING#0.7303;BLOOD GLUCOSE LEVEL#0.7295;ARECOLINE#0.7280;NEUROBLASTOMA#0.7246;RESPONSE TO HYPOXIA#0.7229;RELATED PROTEIN 1#0.7218;ARRHYTHMIA#0.7203;RESPIRATORY DISTRESS#0.7182;TRANSMISSION ELECTRON MICROSCOPY#0.7181;BASAL LAMINA#0.7170;BREAST CARCINOMA#0.7164;MAGNETIC RESONANCE IMAGING#0.7162;GLYCERALDEHYDE-3-PHOSPHATE#0.7160;MAMMARY GLAND#0.7160;ENDOMETRIAL CANCER#0.7149;MANDIBLE#0.7136;GINGIVA#0.7133;ESTROUS CYCLE#0.7119;OVARIES#0.7109;HUMAN CARDIAC FIBROBLASTS#0.7075;OLMESARTAN#0.7071;ALL TRANS RETINOIC ACID#0.7068;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7062;LEFT VENTRICULAR REMODELING#0.7049;AMINOGUANIDINE#0.7048;CELL DIVISION#0.7038;HUMAN PANCREATIC CANCER#0.7019;8-HYDROXY-2'-DEOXYGUANOSINE#0.7017;MITOGENIC ACTIVITY#0.7013;CONNECTIVE TISSUE DISEASE#0.7010;POLYCYSTIC KIDNEY DISEASE#0.6998;GENISTEIN#0.6995;M2 MACROPHAGE#0.6992;METFORMIN#0.6990;ACTIVATING TRANSCRIPTION FACTOR#0.6988;CHRONIC HEART FAILURE#0.6982;INDUCED PLURIPOTENT STEM CELL#0.6981;HISTONE ACETYLATION#0.6978;SCIATIC NERVE#0.6972;HEPATOCELLULAR CARCINOMA CELL#0.6970;CELL COUNTING KIT#0.6970;REGULATION OF GENE EXPRESSION#0.6965;ADENO ASSOCIATED VIRUS#0.6961;REGULATION OF CELL PROLIFERATION#0.6951;VASCULAR ENDOTHELIUM#0.6951;CEREBRAL CORTEX#0.6943;BONE GROWTH#0.6940;CYCLIC AMP#0.6940;ACID PHOSPHATASE#0.6932;NOREPINEPHRINE#0.6909;L-CYSTEINE#0.6904;ENZYME ACTIVITY#0.6899;THYROID CANCER#0.6881;RECEPTOR LIGAND#0.6878;MODE OF ACTION#0.6877;CHINESE HERBAL MEDICINE#0.6869;NERVE GROWTH FACTOR#0.6855;EPITHELIAL CELL PROLIFERATION#0.6846;DENTINOGENESIS#0.6846;TISSUE TRANSGLUTAMINASE#0.6838;SKELETAL TISSUES#0.6835;MYELINATION#0.6834;LIPID METABOLISM#0.6830;OSTEOBLAST PROLIFERATION#0.6818;CYCLOSPORIN A#0.6813;PANCREAS DEVELOPMENT#0.6800;CISPLATIN#0.6797;DABIGATRAN#0.6790;ACUTE KIDNEY INJURY#0.6789;ACTINOMYCIN D#0.6786;INFLAMMATORY BOWEL DISEASE#0.6785;GROWTH FACTOR ACTIVITY#0.6784;FATTY LIVER DISEASE#0.6778;MESANGIUM#0.6772;OXYGEN INDUCED RETINOPATHY#0.6771;ADIPOSE-DERIVED STEM CELL#0.6766;SLIT DIAPHRAGM#0.6765;ENDOCYTOSIS#0.6761;HEPATOCYTE PROLIFERATION#0.6758;THORACIC AORTIC ANEURYSM#0.6750;ALZHEIMER'S DISEASE#0.6750;WEIGHT LOSS#0.6750;CHOLANGIOCARCINOMA#0.6731;CELL COMMUNICATION#0.6729;LYMPHANGIOGENESIS#0.6727;TROPHECTODERM#0.6712;VEGF PRODUCTION#0.6711;MRNA SYNTHESIS#0.6706;ACETAMINOPHEN#0.6703;HUMAN CORNEAL EPITHELIAL#0.6700;ADENOSINE MONOPHOSPHATE#0.6689;CALCIUM CHANNEL#0.6688;GLYCOGEN SYNTHASE KINASE#0.6687;ENDOTHELIAL NITRIC OXIDE#0.6678;FLUORESCEIN#0.6678;PROTEIN COMPLEX#0.6675;ANDROGEN RECEPTOR#0.6674;DEPHOSPHORYLATION#0.6674;ESTROGENS#0.6663;BILE DUCT LIGATED#0.6658;DOXYCYCLINE#0.6655;IL-6 PRODUCTION#0.6645;LINES OF EVIDENCE#0.6644;TOCOPHEROL#0.6638;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6633;FIBRIL#0.6613;GM-CSF#0.6610;PORTAL HYPERTENSION#0.6572;CYTOKINE PRODUCTION#0.6553;SIROLIMUS#0.6542;SKELETAL SYSTEM#0.6524;ENDOTHELIN A RECEPTOR#0.6522;PHENYLEPHRINE#0.6504;TROGLITAZONE#0.6496;PROSTACYCLIN#0.6496;BONE CELLS#0.6493;DNA REPAIR#0.6492;VIRAL HEPATITIS#0.6488;NEGATIVE CONTROL GROUP#0.6476;NEURODEGENERATIVE DISEASE#0.6470;LASER CAPTURE MICRODISSECTION#0.6468;ARGININE#0.6464;ELASTIC FIBER#0.6451;OVARIAN CARCINOMA#0.6451;MUTAGENESIS#0.6441;TRANSCRIPTION FACTOR BINDING#0.6436;FORESKIN#0.6432;RHABDOMYOSARCOMA#0.6430;MITOMYCIN C#0.6428;AMYOTROPHIC LATERAL SCLEROSIS#0.6420;LATERAL SCLEROSIS#0.6420;MENSTRUAL CYCLE#0.6413;PROTEINASE INHIBITOR#0.6410;CASPASE-3 ACTIVITY#0.6409;SCANNING ELECTRON MICROSCOPY#0.6398;INSULIN RECEPTOR#0.6384;PERINDOPRIL#0.6361;ENDOSOME#0.6356;RELATIVE GENE EXPRESSION#0.6334;FIBRILLAR COLLAGEN#0.6313;NEUROPATHY#0.6306;RETINAL DISEASE#0.6275;PREADIPOCYTE#0.6263;AORTIC VALVE#0.6263;DIAPHRAGM#0.6252;NODULAR#0.6241;PERITONEAL CAVITY#0.6239;STAUROSPORINE#0.6239;NEUROENDOCRINE TUMOR#0.6230;NF-KAPPAB INHIBITOR#0.6229;LUPUS NEPHRITIS#0.6227;MELANOMA CELL LINES#0.6217;UMBILICAL CORD#0.6208;CIGARETTE SMOKE EXTRACT#0.6203;ALIZARIN RED STAINING#0.6195;UNILATERAL URETERIC OBSTRUCTION#0.6189;CORTISOL#0.6189;INTERFERON REGULATORY FACTOR#0.6183;ALVEOLAR MACROPHAGE#0.6183;NEPHROTOXICITY#0.6177;CHLORHEXIDINE GLUCONATE#0.6161;MACROPHAGE CHEMOATTRACTANT PROTEIN#0.6135;OXIDATIVE PHOSPHORYLATION#0.6117;RHEUMATIC HEART DISEASE#0.6114;FIBRILLIN#0.6110;RIBOSOMAL PROTEIN#0.6105;ACUTE MYOCARDIAL INFARCTION#0.6100;PROTEIN BINDING#0.6098;L-ARGININE#0.6082;ENDOPLASMIC RETICULUM STRESS#0.6081;SIGNAL PEPTIDE#0.6080;TELOMERIC SILENCING#0.6076;EGFR SIGNALING PATHWAY#0.6070;NUCLEIC ACID#0.6061;HYPERGLYCEMIC#0.6055;FEMUR#0.6052;INSULIN GROWTH FACTOR#0.6050;BOSENTAN#0.6043;SKELETON#0.6039;ANGIOGENIC GROWTH FACTORS#0.6036;CORONARY ARTERY LIGATION#0.6030;PULMONARY ARTERY HYPERTENSION#0.6027;FIBRINOGEN#0.6001
149111	AMPA RECEPTOR#0.8397;GLUTAMATE RECEPTOR#0.6277
1491	3 MERCAPTOPYRUVATE SULFURTRANSFERASE#1.0853;LYASE ACTIVITY#1.0711;CYSTATHIONINE GAMMA LYASE#1.0517;METHIONINE ADENOSYLTRANSFERASE#1.0446;CYSTATHIONINE BETA SYNTHASE#1.0423;PYRIDOXAL 5-PHOSPHATE#1.0291;PYRIDOXAL PHOSPHATE#1.0287;TRANSSULFURATION#1.0280;L-METHIONINE#1.0232;PYRIDOXAL#1.0229;L-CYSTEINE#1.0152;VITAMIN B6#1.0021;METHIONINE#0.9984;SMOOTH MUSCLE CELL#0.9980;MUSCLE CELL#0.9964;GENE EXPRESSION#0.9909;SMOOTH MUSCLE#0.9871;L-CYSTINE#0.9859;CARDIOVASCULAR SYSTEM#0.9857;GLUTATHIONE#0.9834;NITRIC OXIDE#0.9786;ALANINE#0.9771;ENZYME ACTIVITY#0.9766;S-ADENOSYLMETHIONINE#0.9734;PYRUVATE#0.9706;LYASE INHIBITOR#0.9698;HYPERTENSION#0.9606;ARTERY#0.9489;REACTIVE OXYGEN SPECIES#0.9483;GLYCINE#0.9458;VASCULAR SMOOTH MUSCLE CELL#0.9452;GLUTATHIONE SYNTHESIS#0.9442;O-ACETYLSERINE#0.9417;NITRIC OXIDE SYNTHASE#0.9376;ISCHEMIA#0.9337;APOPTOSIS#0.9332;ENDOTHELIAL CELL#0.9278;L-ALANINE#0.9273;ENDOTHELIUM#0.9224;SULFIDE PRODUCTION#0.9100;CANCER CELL#0.9073;CATABOLISM#0.9062;L-HOMOSERINE#0.8963;CELL DEATH#0.8951;CYSTEINE SYNTHESIS#0.8864;SIGNALING MOLECULE#0.8858;SULFUR METABOLISM#0.8765;DETOXIFICATION#0.8658;INFLAMMATORY RESPONSE#0.8648;TRANSCRIPTION FACTOR#0.8567;HYPERHOMOCYSTEINEMIA#0.8525;POLYMERASE CHAIN REACTION#0.8480;METHIONINE METABOLISM#0.8428;TOXICITY#0.8379;GLIBENCLAMIDE#0.8335;MACROPHAGE#0.8322;CELL PROLIFERATION#0.8269;ISCHEMIA REPERFUSION INJURY#0.8190;CYSTEINE METABOLISM#0.8187;CYSTEINE DIOXYGENASE#0.8088;RHODANESE ACTIVITY#0.8058;THORACIC AORTA#0.8039;ARGININE#0.8007;LYMPHOID CELL#0.7970;ESSENTIAL AMINO ACID#0.7882;GROWTH FACTOR#0.7871;HYPOXIA#0.7828;VASODILATOR#0.7730;L-ARGININE#0.7672;ACUTE PANCREATITIS#0.7628;ASPARTATE#0.7623;HYPOXIC#0.7558;PULMONARY HYPERTENSION#0.7505;CYSTEINE BIOSYNTHESIS#0.7467;ENDOPLASMIC RETICULUM#0.7441;PROTEIN KINASE#0.7344;CELL GROWTH#0.7318;GAMMA-GLUTAMYLCYSTEINE#0.7309;HOMOCYSTEINE METABOLISM#0.7018;BETA CELL#0.6951;EXCRETION#0.6919;OXYGENASE#0.6856;PYRIDOXINE#0.6846;PANCREATITIS#0.6756;POTASSIUM CHANNEL#0.6749;VASCULAR ENDOTHELIUM#0.6739;TUMOR CELLS#0.6709;CYSTATHIONINE BETA-SYNTHASE ACTIVITY#0.6665;MITOCHONDRIA#0.6656;CAROTID BODY#0.6652;APOPTOTIC#0.6642;NITRO-L-ARGININE#0.6611;GLUTATHIONE METABOLISM#0.6605;METHIONINE SYNTHASE#0.6595;MYOCARDIUM#0.6567;CORONARY ARTERY#0.6492;GLYCINE N METHYLTRANSFERASE#0.6486;SULFUR AMINO ACID METABOLISM#0.6482;ATHEROSCLEROSIS#0.6481;REVERSE TRANSCRIPTION#0.6440;ADIPOSE TISSUE#0.6434;SIGNALING PATHWAY#0.6405;L-SERINE#0.6396;ADIPOCYTE#0.6322;N METHYLTRANSFERASE#0.6299;EPITHELIAL CELL#0.6240;IMMUNE RESPONSE#0.6223;LACTATION#0.6220;LYMPHOID CELL LINES#0.6172;CLEAR CELL CARCINOMA#0.6126;VASODILATION#0.6111;LYSINE#0.6077;ESSENTIAL HYPERTENSION#0.6037
149233	INTERLEUKIN 23 RECEPTOR#1.0628;COLORECTAL CANCER#1.0350;RELATED ORPHAN RECEPTOR#1.0344;RETINOIC ACID#1.0237;RECEPTOR COMPLEX#1.0191;ANKYLOSING SPONDYLITIS#1.0131;SPONDYLITIS#1.0125;COLORECTAL#1.0119;IL-17 PRODUCTION#1.0087;PSORIASIS#1.0085;POLYMERASE CHAIN REACTION#1.0085;AUTOPHAGY#1.0032;FRAGMENT LENGTH POLYMORPHISM#1.0032;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0030;LUPUS ERYTHEMATOSUS#1.0028;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0017;LYMPHOID CELL#0.9983;PSORIATIC ARTHRITIS#0.9958;CROHN'S DISEASE#0.9932;RHEUMATOID ARTHRITIS#0.9927;ULCERATIVE COLITIS#0.9915;CYTOKINE RECEPTOR#0.9911;TH17 CELL#0.9900;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9896;SIGNAL TRANSDUCER#0.9892;MULTIPLE SCLEROSIS#0.9886;MONONUCLEAR CELLS#0.9886;COLITIS#0.9885;TH1 CELL#0.9885;GENE EXPRESSION#0.9867;CD4+ T CELL#0.9863;TRANSCRIPTION FACTOR#0.9862;CELL DIFFERENTIATION#0.9857;MACROPHAGE#0.9856;INFLAMMATORY BOWEL DISEASE#0.9853;T CELL#0.9844;SIGNALING PATHWAY#0.9830;IFN-GAMMA#0.9817;LYMPH NODE#0.9809;CD8+ T CELL#0.9770;AUTOIMMUNITY#0.9770;PRO-INFLAMMATORY#0.9754;AUTOIMMUNE DISEASE#0.9749;PERIPHERAL BLOOD#0.9747;MEMORY T CELL#0.9710;DENDRITIC CELL#0.9709;IMMUNE RESPONSE#0.9701;LEUKOCYTE#0.9646;IL-17A PRODUCTION#0.9633;REGULATORY T CELL#0.9631;UVEITIS#0.9574;CELL SURFACE#0.9553;INFLAMMATORY RESPONSE#0.9528;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9520;T HELPER CELL#0.9517;TUMOR NECROSIS FACTOR#0.9507;T LYMPHOCYTE#0.9472;GROWTH FACTOR#0.9402;CHEMOKINE RECEPTOR#0.9347;CYTOKINE PRODUCTION#0.9347;STEM CELL#0.9306;EPITHELIAL CELL#0.9263;BEHCET'S DISEASE#0.9244;ENCEPHALOMYELITIS#0.9240;IMMUNE SYSTEM#0.9235;IMMUNE CELL#0.9156;CELIAC DISEASE#0.9096;NAIVE CD4+ T CELL#0.9089;CELL PROLIFERATION#0.9083;HUMAN LEUKOCYTE ANTIGEN#0.9082;SIGNAL TRANSDUCTION#0.9074;B CELL#0.8952;IL-22 PRODUCTION#0.8948;NAIVE T CELL#0.8945;IL-23 RECEPTOR COMPLEX#0.8943;TRANSFORMING GROWTH FACTOR#0.8943;TUBERCULOSIS#0.8893;TOLL LIKE RECEPTOR#0.8880;TREG CELL#0.8858;COPY NUMBER VARIATION#0.8821;GM-CSF#0.8807;INNATE IMMUNITY#0.8739;MONOCYTE#0.8647;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8632;APOPTOSIS#0.8592;SYNOVIAL FLUID#0.8557;RETINOIC ACID RECEPTOR#0.8538;NEUTROPHIL#0.8512;PULMONARY TUBERCULOSIS#0.8449;CYTOKINE BINDING#0.8383;BONE MARROW#0.8349;GASTROINTESTINAL TRACT#0.8346;IL-23 PRODUCTION#0.8341;HEPATOCELLULAR CARCINOMA#0.8310;ADAPTIVE IMMUNE RESPONSE#0.8261;CELL ACTIVATION#0.7991;HEALTHY CONTROL SUBJECTS#0.7986;SKIN DISEASE#0.7978;TH2 CELL#0.7958;ENDOPLASMIC RETICULUM#0.7942;ATHEROSCLEROSIS#0.7888;INNATE IMMUNE RESPONSE#0.7788;LEPROSY#0.7698;THYROIDITIS#0.7519;STEM CELL TRANSPLANTATION#0.7463;ALLERGIC RHINITIS#0.7445;ESOPHAGEAL CANCER#0.7433;ARYL HYDROCARBON RECEPTOR#0.7425;LYMPH NODE METASTASES#0.7425;COLORECTAL CARCINOMA#0.7404;LUNG CANCER#0.7355;WHOLE GENOME ASSOCIATION#0.7292;TRANSFORMING GROWTH FACTOR BETA#0.7222;CYTOKINE SECRETION#0.7135;NKT CELL#0.7075;USTEKINUMAB#0.6992;INFLAMMATORY CELL#0.6989;TUMOR CELLS#0.6978;BREAST CANCER#0.6969;GRAFT VERSUS HOST#0.6878;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.6874;CANCER CELL#0.6765;MYELOID CELL#0.6745;LIVER DISEASE#0.6740;PATTERN RECOGNITION RECEPTOR#0.6620;OVARIAN CANCER#0.6607;SQUAMOUS CELL CARCINOMA#0.6590;INTESTINAL EPITHELIAL CELL#0.6587;CORD BLOOD#0.6568;QUANTITATIVE REAL TIME#0.6561;IL-10 PRODUCTION#0.6493;ACTIVATED T-CELLS#0.6471;ACTIVATED T CELL#0.6468;TYPE 1 DIABETES#0.6461;CELL DEVELOPMENT#0.6451;INTERLEUKIN 12 RECEPTOR#0.6340;SARCOIDOSIS#0.6338;T CELL ACTIVATION#0.6331;GRAVES' DISEASE#0.6317;THYMOCYTE#0.6286;NUCLEAR HORMONE RECEPTOR#0.6283;TUMOUR NECROSIS FACTOR#0.6270;POPULATION ATTRIBUTABLE RISK#0.6233;CD4+ MEMORY T CELL#0.6217;CORONARY ARTERY#0.6211;INTESTINAL MUCOSA#0.6196;LYMPHOID TISSUE#0.6179;AGE AT DIAGNOSIS#0.6163;INFLIXIMAB#0.6127;C CHEMOKINE RECEPTOR#0.6123;ANTERIOR UVEITIS#0.6120;KIDNEY TRANSPLANT PATIENTS#0.6011;LUPUS NEPHRITIS#0.6008
149371	EXOCYST#1.0858;EXOCYST COMPLEX#1.0756;PLASMA MEMBRANE#0.9798;EXOCYTOSIS#0.7773;CELL GROWTH#0.7012;SECRETORY VESICLE#0.6977;PROTEIN COMPLEX#0.6565;CELL SURFACE#0.6531;CYCLIN DEPENDENT KINASE#0.6240;C TERMINAL DOMAIN#0.6199
1493	GRAPE SEED EXTRACT#1.0659;ABATACEPT#1.0488;BELATACEPT#1.0480;CTLA4-IG#1.0475;TGF-BETA PRODUCTION#1.0397;T LYMPHOCYTE ACTIVATION#1.0379;ENDOCYTOSIS#1.0358;DERMATITIS HERPETIFORMIS#1.0346;T CELL HOMEOSTASIS#1.0290;DEATH RECEPTOR#1.0285;ALLERGIC RHINITIS#1.0278;LYMPHOCYTE ANTIGEN#1.0271;CELL ASSOCIATED#1.0236;PROTEIN TYROSINE PHOSPHATASE#1.0235;PRIMARY BILIARY CIRRHOSIS#1.0234;ACTIVATED T LYMPHOCYTES#1.0233;CTLA4IG#1.0215;CYTOTOXIC T-LYMPHOCYTE#1.0213;GLUTEN FREE DIET#1.0189;PROGRAMMED CELL DEATH#1.0188;LYMPHOPROLIFERATIVE DISEASE#1.0176;T CELL APOPTOSIS#1.0158;CELIAC DISEASE#1.0154;PERIPHERAL BLOOD T-CELLS#1.0152;LYMPHOCYTE ACTIVATION#1.0151;IMMUNOLOGICAL SYNAPSE#1.0142;EXTRACELLULAR REGION#1.0140;CERVICAL CANCER#1.0131;T LYMPHOCYTE#1.0130;T CELL COSTIMULATION#1.0094;TUMOUR NECROSIS FACTOR#1.0080;FRAGMENT LENGTH POLYMORPHISM#1.0077;ANKYLOSING SPONDYLITIS#1.0074;HEPATITIS B VIRUS#1.0074;CELL DEATH#1.0074;MALARIA#1.0070;ADDISON'S DISEASE#1.0069;AUTOIMMUNE THYROIDITIS#1.0060;ULCERATIVE COLITIS#1.0055;ORAL TOLERANCE#1.0038;T CELL ANERGY#1.0029;PSORIASIS#1.0028;CHIMERIC ANTIGEN RECEPTOR#1.0021;GERMINAL CENTER#1.0021;RHINITIS#1.0020;GM-CSF#1.0011;AUTOIMMUNE HEPATITIS#1.0006;CHRONIC HEPATITIS B#1.0005;MYASTHENIA GRAVIS#1.0004;NAIVE CD4+ T CELL#1.0000;B LYMPHOCYTE#0.9998;QUANTITATIVE REAL TIME#0.9985;TREG CELL#0.9982;ACTIVATED T-CELLS#0.9981;SIGNALING MOLECULE#0.9977;CYTOPLASMIC REGION#0.9975;TUMOR TISSUES#0.9971;HUMORAL IMMUNE RESPONSE#0.9969;RECEPTOR LIGAND#0.9969;ACTIVATED T CELL#0.9968;CELL SURFACE#0.9966;COLONY-STIMULATING FACTOR#0.9965;IL-10 PRODUCTION#0.9965;HUMAN LEUKOCYTE ANTIGEN#0.9964;HEPATITIS B#0.9961;PROSTATE CANCER#0.9959;COLON CANCER#0.9954;IL-2 PRODUCTION#0.9952;HEALTHY CONTROL SUBJECTS#0.9948;TYPE 1 DIABETES MELLITUS#0.9946;TYPE 2 DIABETES#0.9943;PANCREATIC CANCER#0.9935;GRAVES' DISEASE#0.9932;METASTATIC MELANOMA#0.9932;CELL EXPANSION#0.9926;CELL-MEDIATED IMMUNE RESPONSE#0.9921;T CELL DIFFERENTIATION#0.9919;IL-2 SECRETION#0.9917;CELL CYCLE#0.9915;TRANSFORMING GROWTH FACTOR BETA#0.9915;TH1 CELL#0.9915;T CELL ACTIVATION#0.9914;PERIPHERAL BLOOD LYMPHOCYTES#0.9914;CYCLOSPORIN A#0.9913;T HELPER CELL#0.9905;HEMATOPOIETIC STEM CELL#0.9904;HEPATITIS C#0.9903;CYTOTOXIC T CELL#0.9902;GRANULOCYTE#0.9897;INTERLEUKIN 2 RECEPTOR#0.9894;HEAD AND NECK CANCER#0.9893;TUMOR NECROSIS FACTOR#0.9893;OVARIAN#0.9891;B CELL LYMPHOMA#0.9891;POLYMERASE CHAIN REACTION#0.9891;T CELL#0.9889;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9887;STEM CELL TRANSPLANTATION#0.9884;NECK CANCER#0.9884;IL-4 PRODUCTION#0.9881;CELL ACTIVATION#0.9879;LUPUS ERYTHEMATOSUS#0.9877;MULTIPLE SCLEROSIS#0.9874;TYPE 1 DIABETIC#0.9868;TYPE 1 DIABETES#0.9866;CHEMOKINE RECEPTOR#0.9864;RAPAMYCIN#0.9863;CROHN'S DISEASE#0.9862;SIGNAL TRANSDUCTION#0.9860;RENAL CELL CANCER#0.9853;TH2 CELL#0.9852;SIGNAL TRANSDUCER#0.9851;SENSITIZATION#0.9851;APOPTOTIC#0.9848;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9847;TRANSFORMING GROWTH FACTOR#0.9846;THYMOCYTE#0.9843;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9843;CD4+ REGULATORY T CELL#0.9843;IL-10 SECRETION#0.9842;TRYPTOPHAN#0.9842;ACTIVATED CD4+ T CELL#0.9842;ALLERGEN#0.9841;DERMATITIS#0.9840;MYELOID-DERIVED SUPPRESSOR CELL#0.9836;HODGKIN'S LYMPHOMA#0.9836;TOLERANCE INDUCTION#0.9834;ENCEPHALOMYELITIS#0.9833;TRYPTOPHAN CATABOLISM#0.9833;HUMAN IMMUNODEFICIENCY VIRUS#0.9832;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9832;ENDOTHELIAL GROWTH FACTOR#0.9830;MYELOID CELL#0.9828;LYMPHOID ORGANS#0.9828;CELL GROWTH#0.9825;LYMPHOCYTIC LEUKEMIA#0.9823;CORD BLOOD#0.9822;COLLAGEN INDUCED ARTHRITIS#0.9820;THYROIDITIS#0.9818;OVARIAN CANCER#0.9817;MECHANISMS OF ACTION#0.9816;REVERSE TRANSCRIPTION#0.9811;HEPATITIS C VIRUS#0.9810;INFLAMMATORY BOWEL DISEASE#0.9808;UVEITIS#0.9806;CERVICAL#0.9804;T CELL PROLIFERATION#0.9802;CELL DIFFERENTIATION#0.9802;DIABETES MELLITUS#0.9802;TUMOR ANTIGEN#0.9799;ANTIBODY PRODUCTION#0.9797;MYOCARDITIS#0.9795;ENDOTHELIAL CELL#0.9790;STANDARD OF CARE#0.9788;TH17 CELL#0.9786;TOLL LIKE RECEPTOR#0.9785;BREAST CANCER#0.9777;LIVER DISEASE#0.9776;APOPTOSIS#0.9775;CELL ADHESION#0.9774;HYPOTHYROIDISM#0.9774;SPONTANEOUS ABORTION#0.9774;TUMOR ASSOCIATED ANTIGEN#0.9773;PROTEIN KINASE#0.9773;VEMURAFENIB#0.9771;VIRAL INFECTION#0.9770;LYMPHOCYTE PROLIFERATION#0.9769;RHEUMATOID ARTHRITIS#0.9767;CELL MEMBRANE#0.9761;CD4+ T CELL#0.9758;ANTIGEN PRESENTING CELLS#0.9758;DRAINING LYMPH NODE#0.9758;ADOPTIVE CELL TRANSFER#0.9757;MEMORY T CELL#0.9755;MECHANISM OF ACTION#0.9755;MYELOID LEUKEMIA#0.9753;ANTIGEN PRESENTATION#0.9753;ADENOCARCINOMA#0.9753;ACUTE MYELOID LEUKEMIA#0.9750;IFN-GAMMA#0.9747;MESENCHYMAL STEM CELL#0.9745;STEM CELL#0.9742;EPITHELIAL CELL#0.9739;CD3+ T CELL#0.9737;GRAFT VERSUS HOST#0.9737;CELL PROLIFERATION#0.9737;N GLYCAN#0.9732;HUMAN LEUCOCYTE ANTIGEN#0.9731;RENAL CELL CARCINOMA#0.9730;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9729;CELL-MEDIATED IMMUNITY#0.9729;GROWTH FACTOR#0.9725;IMMUNE SUPPRESSION#0.9723;EFFECTOR T CELL#0.9722;HYPERSENSITIVITY#0.9722;CD4+CD25+ REGULATORY T CELL#0.9721;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9716;AUTOIMMUNITY#0.9716;ADOPTIVE CELL THERAPY#0.9713;CD8+ T CELL#0.9710;ADENOSINE#0.9710;IMMUNE EVASION#0.9708;COLITIS#0.9707;COLORECTAL CANCER#0.9706;NAIVE T CELL#0.9705;DIARRHEA#0.9703;SIGNALING PATHWAY#0.9699;SUPPRESSOR T CELL#0.9698;LUNG CANCER#0.9698;LEUKOCYTE#0.9697;CYCLOSPORIN#0.9697;AUTOIMMUNE DISEASE#0.9697;B CELL#0.9696;HEPATOCELLULAR CARCINOMA#0.9694;TRANSCRIPTION FACTOR#0.9687;KINASE INHIBITOR#0.9687;GROWTH FACTOR RECEPTOR#0.9686;MONOCYTE#0.9685;TYROSINE KINASE INHIBITOR#0.9684;IMMUNE DYSFUNCTION#0.9683;MITOGEN ACTIVATED PROTEIN#0.9682;EOSINOPHIL#0.9682;TISSUE DAMAGE#0.9682;CYTOKINE PRODUCTION#0.9681;BETA CELL#0.9680;SKIN CANCER#0.9679;SQUAMOUS CELL CARCINOMA#0.9674;CYTOTOXICITY#0.9673;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9670;CYTOKINE SECRETION#0.9664;ANEMIA#0.9664;IMMUNOGLOBULIN G#0.9662;COLORECTAL#0.9661;MULTIPLE MYELOMA#0.9657;ACTIVATION-INDUCED CELL DEATH#0.9657;NEUTROPHIL#0.9657;BEHCET'S DISEASE#0.9657;LYMPH NODE#0.9656;PRO-INFLAMMATORY#0.9653;BONE MARROW#0.9653;NATURAL KILLER CELL#0.9651;TUBERCULOSIS#0.9650;DNA METHYLATION#0.9648;INFLAMMATORY CELL#0.9646;GENE EXPRESSION#0.9645;MONONUCLEAR CELLS#0.9644;COMMON VARIABLE IMMUNODEFICIENCY#0.9640;B CELL ACTIVATION#0.9635;REGULATORY T CELL#0.9631;T CELL MEDIATED IMMUNITY#0.9629;ADAPTIVE IMMUNE RESPONSE#0.9627;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9626;LYMPHOID TISSUE#0.9622;HEMATOPOIETIC CELL#0.9616;PANCREATIC ISLET#0.9615;SIGNAL PEPTIDE#0.9613;TUMOR CELLS#0.9612;RESPONDER T CELL#0.9611;MACROPHAGE#0.9608;OBJECTIVE RESPONSE RATE#0.9607;ALLERGIC ASTHMA#0.9606;IMMUNE RESPONSE#0.9605;PERIPHERAL BLOOD#0.9602;DENDRITIC CELL#0.9601;T FOLLICULAR HELPER#0.9591;CANCER CELL#0.9590;LEISHMANIASIS#0.9590;EPSTEIN BARR VIRUS#0.9588;KIDNEY TRANSPLANT RECIPIENTS#0.9585;IMMUNOTOXIN#0.9583;INFLAMMATORY RESPONSE#0.9572;CENTRAL NERVOUS SYSTEM#0.9561;TOXICITY#0.9559;TRANSMISSION DISEQUILIBRIUM TEST#0.9555;MEDIAN OVERALL SURVIVAL#0.9551;ACTIVATED B CELL#0.9551;CELLULAR IMMUNE RESPONSE#0.9540;NERVOUS SYSTEM#0.9538;INFLIXIMAB#0.9537;ALANINE#0.9536;REGULATION OF IMMUNE RESPONSE#0.9523;IMMUNE CELL#0.9513;ADAPTIVE IMMUNE SYSTEM#0.9512;IMMUNE SYSTEM#0.9509;DEXAMETHASONE#0.9503;MESENTERIC LYMPH NODE#0.9498;AGE AT DIAGNOSIS#0.9487;HUMAN DENDRITIC CELL#0.9487;TUMOR ASSOCIATED MACROPHAGE#0.9483;DISEASE FREE SURVIVAL#0.9478;LUNG CARCINOMA#0.9474;CHRONIC HEPATITIS C#0.9473;INNATE IMMUNITY#0.9465;C REACTIVE PROTEIN#0.9456;NEPHRITIS#0.9455;REGULATORY T LYMPHOCYTES#0.9453;CYCLOPHOSPHAMIDE#0.9448;METASTATIC RENAL CELL CARCINOMA#0.9438;EPIDERMAL GROWTH FACTOR#0.9429;TRANSCRIPTASE#0.9405;SPONDYLITIS#0.9404;GLUTAMIC ACID#0.9403;CELL MOTILITY#0.9397;ANGIOGENESIS#0.9376;LYSIS#0.9375;CELL MIGRATION#0.9374;GLYCOSYLATION#0.9369;CELL DEVELOPMENT#0.9362;MISMATCH REPAIR#0.9336;LYMPHOPROLIFERATIVE SYNDROME#0.9335;VIRAL REPLICATION#0.9330;CALCINEURIN#0.9327;STROMAL CELL#0.9325;GASTROINTESTINAL TRACT#0.9320;ESOPHAGEAL CANCER#0.9312;HOST CELL#0.9299;SIGNALLING PATHWAY#0.9296;PLASMA MEMBRANE#0.9283;RECEPTOR BINDING#0.9269;CELL DIVISION#0.9260;BREAST CANCER PATIENTS#0.9256;LUNG ADENOCARCINOMA#0.9244;SEQUENCE SPECIFIC PRIMER#0.9235;VASCULITIS#0.9211;RECEPTOR ANTAGONIST#0.9208;RITUXIMAB#0.9192;HYPERTHYROIDISM#0.9181;OSTEOCLAST#0.9171;SARCOIDOSIS#0.9165;CHROMOSOMAL REGION#0.9160;BREAST CARCINOMA#0.9150;ONCOGENIC#0.9149;NATURAL REGULATORY T CELL#0.9121;TARGET OF RAPAMYCIN#0.9112;RHEUMATIC DISEASE#0.9101;MATURE DENDRITIC CELLS#0.9099;CYCLOSPORINE#0.9096;EXHAUSTED T CELL#0.9096;RANDOMIZED CONTROLLED TRIAL#0.9095;ALOPECIA AREATA#0.9092;VITAMIN D RECEPTOR#0.9077;NATURAL KILLER T#0.9032;ATHEROSCLEROSIS#0.9026;LIPID RAFT#0.9022;CELL MATURATION#0.9008;AGE AT ONSET#0.9005;T CELL CO-STIMULATION#0.8992;MELANOMA CELL LINES#0.8982;CELL ADHESION MOLECULE#0.8964;PLASMACYTOID DENDRITIC CELL#0.8957;NEPHROTIC SYNDROME#0.8955;RELAPSE FREE SURVIVAL#0.8952;DELAYED-TYPE HYPERSENSITIVITY#0.8947;MELANOCYTE#0.8939;DIGESTION#0.8939;IMMATURE DENDRITIC CELL#0.8920;SKIN DISEASE#0.8915;INTERFERON GAMMA PRODUCTION#0.8904;TISSUE TRANSGLUTAMINASE#0.8898;METHOTREXATE#0.8898;BREAST CANCER CELL#0.8896;RENAL TRANSPLANT RECIPIENTS#0.8872;TACROLIMUS#0.8851;MODE OF ACTION#0.8849;SYNOVIAL FLUID#0.8841;LYMPHOID CELL#0.8832;CATABOLISM#0.8813;LYMPH NODE METASTASIS#0.8808;APLASTIC ANEMIA#0.8795;PERIODONTITIS#0.8789;LEPROSY#0.8789;ADIPOSE TISSUE#0.8784;ALKALINE PHOSPHATASE#0.8782;PANCREATITIS#0.8779;OVERALL RESPONSE RATE#0.8776;INTERLEUKIN 2 PRODUCTION#0.8776;HUMAN IMMUNE SYSTEM#0.8752;COLON CARCINOMA#0.8746;UMBILICAL CORD#0.8736;VISCERAL LEISHMANIASIS#0.8735;MAST CELL#0.8716;SMALL INTESTINE#0.8715;PLASMA CELL#0.8708;ADENO ASSOCIATED VIRUS#0.8675;FLOW CYTOMETRY ANALYSIS#0.8674;UMBILICAL CORD BLOOD#0.8668;THYMIDINE#0.8645;LINES OF EVIDENCE#0.8645;RANDOMIZED CLINICAL TRIAL#0.8640;SALIVARY GLAND#0.8619;NKT CELL#0.8590;ATOPIC DERMATITIS#0.8566;ALOPECIA#0.8563;DILATED CARDIOMYOPATHY#0.8541;TOPICAL#0.8538;CHROMOSOME REGION#0.8529;PHOSPHATASE ACTIVITY#0.8526;MALIGNANT MESOTHELIOMA#0.8526;OBESE#0.8520;GLOMERULONEPHRITIS#0.8516;GALECTIN#0.8508;WEIGHT LOSS#0.8508;DRUG RESISTANCE#0.8497;NON-SMALL CELL LUNG CARCINOMA#0.8476;REACTIVE OXYGEN SPECIES#0.8468;THROMBOCYTOPENIA#0.8456;MUCOSAL IMMUNE RESPONSE#0.8446;CYTOPLASM#0.8441;GLUTATHIONE#0.8432;RECEPTOR COMPLEX#0.8429;T CELL MIGRATION#0.8423;RESPONSE TO TREATMENT#0.8418;KIDNEY CANCER#0.8403;SELECTIN#0.8397;THYROTROPIN RECEPTOR#0.8394;LUPUS NEPHRITIS#0.8391;PEMPHIGUS#0.8387;SECONDARY LYMPHOID ORGANS#0.8379;MONOCYTE DERIVED DENDRITIC CELL#0.8377;INTERFERON PRODUCTION#0.8371;LYSOSOME#0.8366;IFN-BETA#0.8353;LUNG DISEASE#0.8340;PURPURA#0.8327;IMMUNOSUPPRESSANT#0.8326;SENESCENCE#0.8324;STROMA#0.8320;YEAR SURVIVAL RATE#0.8310;PI3K SIGNALING#0.8284;GENETIC ASSOCIATION STUDIES#0.8275;INDUCTION OF APOPTOSIS#0.8273;JUVENILE IDIOPATHIC ARTHRITIS#0.8269;PANCREATIC DUCTAL ADENOCARCINOMA#0.8261;HEAT SHOCK PROTEIN#0.8256;THYROID GLAND#0.8255;DEMETHYLATION#0.8252;PROTEINURIA#0.8209;PERIPHERAL BLOOD CELLS#0.8204;ETANERCEPT#0.8203;CD8+ REGULATORY T CELL#0.8197;HEPATOTOXICITY#0.8184;LYMPHOPENIA#0.8168;KIDNEY TRANSPLANT PATIENTS#0.8168;RED BLOOD CELL#0.8162;ACETYLCHOLINE RECEPTOR#0.8157;SCHISTOSOMIASIS#0.8156;HEART DISEASE#0.8155;MUTAGENESIS#0.8143;CHOLANGITIS#0.8124;LECTIN#0.8114;PROTEIN KINASE C#0.8111;NEPHROPATHY#0.8097;VACCINIA#0.8096;NITRIC OXIDE#0.8089;NATURAL KILLER T CELL#0.8082;HYPERTENSION#0.8080;ACUTE REJECTION EPISODE#0.8063;LYSINE#0.8058;EXTRACELLULAR MATRIX#0.8042;DACARBAZINE#0.8041;HYPERACTIVITY#0.8038;OVARIAN CARCINOMA#0.8027;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8026;MULTIFACTOR DIMENSIONALITY REDUCTION#0.8004;VIRAL HEPATITIS#0.8003;PSORIATIC ARTHRITIS#0.7999;HISTONE DEACETYLASE#0.7994;CELL RECOGNITION#0.7993;M2 MACROPHAGE#0.7986;CETUXIMAB#0.7984;HARDY WEINBERG EQUILIBRIUM#0.7980;IL-1RA#0.7975;LYMPHOCYTIC CHORIOMENINGITIS#0.7968;STEM CELL TRANSPLANT#0.7965;UVEAL MELANOMA#0.7965;RNA INTERFERENCE#0.7963;CISPLATIN#0.7960;MINIMAL CHANGE DISEASE#0.7956;INTRACELLULAR VESICLE#0.7948;HEALTHY CONTROL GROUP#0.7904;FALSE DISCOVERY RATE#0.7903;CANCER RELATED DEATH#0.7903;72-HOURS#0.7901;SURFACE PLASMON RESONANCE#0.7893;ORAL SQUAMOUS CELL CARCINOMA#0.7893;PREDNISONE#0.7878;HYPERSENSITIVITY RESPONSE#0.7864;HEMATOPOIETIC CELL TRANSPLANTATION#0.7858;CANCER STEM CELL#0.7843;ESTROGEN RECEPTOR#0.7841;BEVACIZUMAB#0.7840;INNATE IMMUNE RESPONSE#0.7839;MYELODYSPLASTIC SYNDROME#0.7838;TOLEROGENIC DENDRITIC CELLS#0.7837;CHAGAS DISEASE#0.7821;TNF PRODUCTION#0.7784;DISEASE CONTROL RATE#0.7747;PROTEIN KINASE B#0.7737;DABRAFENIB#0.7733;GLIOBLASTOMA MULTIFORME#0.7732;IL-5 PRODUCTION#0.7728;MYCOPHENOLATE MOFETIL#0.7724;THYROID CARCINOMA#0.7723;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7718;LUNG METASTASIS#0.7714;SUNITINIB#0.7708;EXOSOME#0.7705;EFFECTOR MEMORY T CELL#0.7695;ACUTE LEUKEMIA#0.7695;CUTANEOUS LEISHMANIASIS#0.7690;CLASSICAL HODGKIN LYMPHOMA#0.7685;PROTEIN PROTEIN INTERACTION#0.7657;HYPOXIA#0.7652;MALIGNANT PLEURAL MESOTHELIOMA#0.7640;IGG ANTIBODY#0.7633;CD4+ T HELPER CELL#0.7629;MEDIAN SURVIVAL TIME#0.7629;HEMOLYTIC ANEMIA#0.7624;NEUROPATHY#0.7606;INNATE IMMUNE SYSTEM#0.7599;PNEUMONIA#0.7597;RECEPTOR TYROSINE KINASE#0.7569;RECURRENCE FREE SURVIVAL#0.7569;MAGNETIC RESONANCE IMAGING#0.7563;CELL FRACTION#0.7559;TOCILIZUMAB#0.7553;PERIODONTAL DISEASE#0.7549;DOSE LIMITING TOXICITIES#0.7547;TUMOR SUPPRESSOR#0.7542;PHAGOCYTOSIS#0.7529;TONSIL#0.7516;DEATH RECEPTOR LIGAND#0.7515;CYCLIN DEPENDENT KINASE#0.7493;LENALIDOMIDE#0.7480;MUSCLE CELL#0.7480;POSITRON EMISSION TOMOGRAPHY#0.7476;AUTOPHAGY#0.7465;INDUCED REGULATORY T CELL#0.7458;KINASE ACTIVITY#0.7455;ENDOMETRIOSIS#0.7451;GUANINE#0.7450;ENDOCRINE SYSTEM#0.7433;TRAMETINIB#0.7431;CARDIOMYOPATHY#0.7429;NODULAR#0.7399;ACETYLCHOLINE#0.7362;ARTERY#0.7346;PACLITAXEL#0.7341;HEPATITIS A#0.7340;PHOSPHATE BUFFERED SALINE#0.7334;SIMIAN IMMUNODEFICIENCY VIRUS#0.7322;BETA GALACTOSIDASE#0.7319;BILE DUCT#0.7316;ANTIOXIDANT ACTIVITY#0.7310;TYPE 1A DIABETES#0.7309;VENOUS BLOOD#0.7308;T CELL DEVELOPMENT#0.7305;LANGERHANS CELL#0.7295;SIGNALING CASCADE#0.7293;NUCLEIC ACID#0.7288;DEPRESSIVE SYMPTOMS#0.7282;UBIQUITIN#0.7279;RENAL CARCINOMA#0.7223;VITAMIN E#0.7223;HYPERGLYCEMIA#0.7209;GESTATION#0.7209;FIBROSARCOMA#0.7207;PANCREATIC ADENOCARCINOMA#0.7206;OVERALL SURVIVAL RATE#0.7202;CHRONIC LIVER DISEASE#0.7178;PULMONARY TUBERCULOSIS#0.7166;COATED PIT#0.7161;INTRACELLULAR CYTOKINE STAINING#0.7146;BONE MARROW CELLS#0.7140;AUTOIMMUNE POLYGLANDULAR SYNDROME#0.7137;BIPOLAR DISORDER#0.7131;T-CELL LEUKEMIA#0.7111;ANTERIOR UVEITIS#0.7090;GENE EXPRESSION OMNIBUS#0.7082;SPINAL CORD#0.7062;IMATINIB#0.7058;GENE SILENCING#0.7034;T LYMPHOCYTE PROLIFERATION#0.7023;PITUITARY GLAND#0.7015;FACTOR VIII#0.7013;NON OBESE DIABETIC#0.7004;IFN-GAMMA SECRETION#0.7003;KERATINOCYTE#0.6969;MICROGLIAL CELL#0.6964;LIVER CANCER#0.6934;GOITER#0.6924;EVERY OTHER DAY#0.6912;RETINOIC ACID#0.6903;BLOOD BRAIN BARRIER#0.6901;LEA29Y#0.6893;SKELETAL MUSCLE#0.6883;CROSS PRESENTATION#0.6859;ABDOMINAL PAIN#0.6851;ORTHOTOPIC LIVER TRANSPLANTATION#0.6851;MUCOSAL MELANOMA#0.6850;TYPE 2 DIABETES MELLITUS#0.6836;2 DIABETES MELLITUS#0.6836;CUTANEOUS T CELL LYMPHOMA#0.6833;S PHASE#0.6830;PRIMARY BREAST CANCER#0.6815;ISOTYPE SWITCHING#0.6809;REGIONAL LYMPH NODE#0.6802;DIFFUSE LARGE B-CELL LYMPHOMA#0.6800;ALLERGIC REACTION#0.6792;GENETIC DISEASE#0.6782;CYTOPENIA#0.6765;NK CELL ACTIVATION#0.6753;TUMOR GROWTH DELAY#0.6753;FACTOR I#0.6751;G1 PHASE#0.6734;ALLERGIC AIRWAY INFLAMMATION#0.6730;NODULAR GOITER#0.6729;PARACOCCIDIOIDOMYCOSIS#0.6727;AGGRESSIVE PERIODONTITIS#0.6709;MAXIMUM TOLERATED DOSE#0.6703;MEAN FLUORESCENCE INTENSITY#0.6703;GEMCITABINE#0.6698;CELL KILLING#0.6690;ORAL CAVITY#0.6689;CLATHRIN-MEDIATED ENDOCYTOSIS#0.6685;COATED VESICLE#0.6683;CLATHRIN COATED VESICLE#0.6677;PROSTATE SPECIFIC ANTIGEN#0.6674;T CELL RECEPTOR COMPLEX#0.6671;TRANS GOLGI NETWORK#0.6654;OSTEOGENESIS#0.6642;AUTOIMMUNE HEMOLYTIC ANEMIA#0.6638;ISCHEMIA#0.6633;RECEPTOR AGONIST#0.6628;DNA BINDING#0.6628;SORAFENIB#0.6627;DASATINIB#0.6618;VASCULAR CELL#0.6606;SCHWANN CELL#0.6600;GASTRITIS#0.6590;LIPID METABOLISM#0.6584;PERIPHERAL T-CELL LYMPHOMA#0.6572;ENDOTHELIUM#0.6570;SPUTUM#0.6567;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME#0.6566;CELL POLARIZATION#0.6561;LIGASE DETECTION REACTION#0.6559;INTRAVENOUS IMMUNOGLOBULIN#0.6552;INTERLEUKIN 7 RECEPTOR#0.6551;SIROLIMUS#0.6539;ERYTHROCYTE#0.6529;GASTRIC ADENOCARCINOMA#0.6527;LIVER METASTASIS#0.6522;TIGHT JUNCTION#0.6515;LUMINAL#0.6511;THYROTOXICOSIS#0.6508;ACTIVATED CD8+ T CELL#0.6502;LYMPHOCYTE APOPTOSIS#0.6494;NASAL MUCOSA#0.6478;SOLID ORGAN TRANSPLANTATION#0.6468;ATHEROSCLEROTIC#0.6463;ADVANCED PROSTATE CANCER#0.6449;MRNA TRANSCRIPTION#0.6432;BORTEZOMIB#0.6409;METASTATIC COLORECTAL CANCER#0.6407;EDEMA#0.6406;PARALYSIS#0.6404;AXITINIB#0.6400;CELL SURFACE ANTIGEN#0.6399;HISTONE DEACETYLASE INHIBITOR#0.6395;KIDNEY DISEASE#0.6382;DOXORUBICIN#0.6382;THYROID CANCER#0.6377;HERPES SIMPLEX#0.6375;THYMOGLOBULIN#0.6360;MYOCARDIUM#0.6328;CORD BLOOD TRANSPLANTATION#0.6320;ADALIMUMAB#0.6307;INVARIANT NATURAL KILLER#0.6301;SERIOUS ADVERSE EVENT#0.6293;IMMUNOGLOBULIN PRODUCTION#0.6272;IGG1 ANTIBODY#0.6268;NEOPLASTIC DISEASE#0.6264;NEUTROPENIA#0.6256;B CELL DEVELOPMENT#0.6247;STREPTOZOTOCIN#0.6246;DIFFERENTIAL GENE EXPRESSION#0.6236;RIBAVIRIN#0.6235;LEUCINE#0.6235;FOLLICULAR HELPER T CELL#0.6229;PROTEASOME#0.6226;ASCITES#0.6202;TRASTUZUMAB#0.6201;OSTEOCLAST DIFFERENTIATION#0.6197;LIGAND BINDING DOMAIN#0.6183;TH1 IMMUNE RESPONSE#0.6181;BETA-2#0.6179;MERKEL CELL#0.6172;DNA REPAIR#0.6172;CELL CYCLE ARREST#0.6172;CANCER TESTIS ANTIGEN#0.6157;CLASS SWITCHING#0.6144;FORCED EXPIRATORY VOLUME#0.6133;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.6112;HISTONE MODIFICATION#0.6107;FOLLICULAR LYMPHOMA#0.6096;RECEPTOR ACTIVATOR#0.6094;CLATHRIN ADAPTOR#0.6078;BLISTERING#0.6076;ACUTE KIDNEY INJURY#0.6067;METASTATIC BREAST CANCER#0.6064;PANCREATIC LYMPH NODE#0.6057;WINDOW OF IMPLANTATION#0.6056;ENDOPLASMIC RETICULUM#0.6039;FIXED EFFECT MODEL#0.6012;THYMIC EPITHELIAL CELLS#0.6007;FORMALIN#0.6001
149428	APOPTOSIS#1.0256;CELL PROLIFERATION#0.8665;APOPTOTIC#0.7182;HEPATOCELLULAR CARCINOMA#0.6569;GENE EXPRESSION#0.6408;HEPATOCELLULAR CARCINOMA CELL#0.6051
149461	NEPHROCALCINOSIS#1.0671;TIGHT JUNCTION#1.0379;TIGHT JUNCTION PROTEIN#1.0282;GENE EXPRESSION#0.8008;EPITHELIAL CELL#0.7023;LOOP OF HENLE#0.6841;RETINAL PIGMENT EPITHELIUM#0.6808;KIDNEY DISEASE#0.6776;SCHWANN CELL#0.6183
149465	VAN DER WOUDE SYNDROME#0.8611
149466	RECYCLING ENDOSOME#1.2086;PLASMA MEMBRANE#1.1824;ENDOSOME#0.8542
149563	BREAST CANCER#1.0565
1495	TUMOR SUPPRESSOR#1.0161;CELL ADHESION#0.9939;GENE EXPRESSION#0.9137;DIFFUSE GASTRIC CANCER#0.9075;ADHERENS JUNCTION#0.8925;MYELOID LEUKEMIA#0.8730;ACUTE MYELOID LEUKEMIA#0.8409;CANCER CELL#0.8276;COLORECTAL CANCER#0.8154;CELL PROLIFERATION#0.7535;CELL CELL ADHESION#0.6979;MYELODYSPLASTIC SYNDROME#0.6798;COLORECTAL#0.6797;BREAST CANCER#0.6716;TIGHT JUNCTION#0.6240;ACTIN CYTOSKELETON#0.6240;SIGNET RING CELL#0.6199;SCHWANN CELL#0.6142;COLON CANCER#0.6039;EXTRACELLULAR MATRIX#0.6008
149603	HEPATOCELLULAR CARCINOMA#0.9226;GROWTH FACTOR#0.8390;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7107;EPITHELIAL TO MESENCHYMAL#0.7104;HEPATOCELLULAR CARCINOMA CELL#0.6613;HEPATITIS B#0.6531
149628	BREAST CANCER CELL#0.6573;BREAST CANCER#0.6530;CANCER CELL#0.6518;VIRAL GENE EXPRESSION#0.6163;HERPES SIMPLEX VIRUS#0.6012;HERPES SIMPLEX#0.6006
149685	ADIPOGENESIS#1.0460;ADIPOCYTE#0.9816;ADIPOCYTE DIFFERENTIATION#0.8843;ADIPOSE TISSUE#0.8630;TRANSCRIPTION FACTOR#0.6261;PEROXISOME#0.6079
149699	GONOCYTE#0.6728
1496	NERVOUS SYSTEM#0.9652;CELL ADHESION#0.9127;SPINAL CORD#0.7506;SCIATIC NERVE#0.7169;DENDRITIC SPINE#0.7043;GENE EXPRESSION#0.6611;CELL ADHESION MOLECULE#0.6393;NEURAL TUBE#0.6234
149708	FLOWERING#0.6999
149775	DNA METHYLATION#1.0074;DIFFERENTIALLY METHYLATED REGION#0.8930;IMPRINTING CONTROL REGION#0.7877
1497	CYSTINOSIS#1.0627;NEPHROPATHIC#1.0390;LYSOSOMAL STORAGE DISORDER#1.0147;LYSOSOMAL MEMBRANE#1.0125;LYSOSOME#1.0115;FANCONI SYNDROME#0.9919;CYSTEAMINE#0.9873;LYSOSOMAL STORAGE DISEASE#0.9829;STEM CELL#0.9608;EPITHELIAL CELL#0.8559;BONE MARROW#0.8549;PROXIMAL TUBULAR EPITHELIAL#0.7994;TUBULAR EPITHELIAL CELL#0.7924;PROXIMAL TUBULAR CELL#0.7642;HEMATOPOIETIC STEM CELL#0.7566;AUTOSOMAL RECESSIVE DISEASE#0.7429;POLYMERASE CHAIN REACTION#0.7317;LYSOSOMAL TRANSPORT#0.6967;GLUTATHIONE#0.6560;REACTIVE OXYGEN SPECIES#0.6388;LEUKOCYTE#0.6214;GENETIC DISORDER#0.6042
149830	PRION DISEASE#0.7392
1498	COLORECTAL CANCER#0.9014;COLORECTAL#0.6458
149951	CELL PROLIFERATION#1.0386;HEPATOCELLULAR CARCINOMA#1.0287;SIGNALING PATHWAY#0.8536;CXCL10 PRODUCTION#0.6771;IKK COMPLEX#0.6505;CELL CYCLE ARREST#0.6217;CELL CYCLE#0.6150
149954	NITRIC OXIDE#0.8686;ENDOTHELIAL NITRIC OXIDE#0.6855;NITRIC OXIDE SYNTHASE#0.6812;PRO-INFLAMMATORY#0.6638;MONOCYTE#0.6396
149986	INSULIN SECRETION#0.6779
149992	PROSTATE CANCER#0.7480
149998	PHOSPHOLIPASE A1#1.0767;CANCER TESTIS ANTIGEN#0.6566
1499	BETA-CATENIN DEGRADATION COMPLEX#1.1560;BETA-CATENIN-TCF4 COMPLEX#1.1306;CATENIN-TCF4 COMPLEX#1.1105;BETA-CATENIN DESTRUCTION COMPLEX#1.1086;BETA-CATENIN-TCF COMPLEX#1.0915;HARDERIAN GLAND#1.0576;BETA CATENIN BINDING#1.0549;CADHERIN BINDING#1.0547;PAPILLARY CRANIOPHARYNGIOMA#1.0432;LIVER DEVELOPMENT#1.0404;MESOTHELIOMA CELL#1.0397;SULINDAC#1.0366;ZONULA OCCLUDENS 1#1.0363;WINGLESS SIGNALING PATHWAY#1.0360;ESTROGEN RECEPTOR ALPHA#1.0345;ZONULA ADHERENS#1.0344;PROTEASOME PATHWAY#1.0343;IMPORTIN#1.0339;LYMPHOID ENHANCER FACTOR#1.0317;ENDODERM FORMATION#1.0308;SOLUBLE FRACTION#1.0307;CRANIOPHARYNGIOMA#1.0297;ADENOID CYSTIC CARCINOMA#1.0294;VASCULAR ENDOTHELIAL CADHERIN#1.0289;PITUITARY ADENOMA#1.0266;ZONULA OCCLUDENS#1.0257;THYMOCYTE#1.0252;INSOLUBLE FRACTION#1.0233;INTRACELLULAR LOCALIZATION#1.0232;SYNOVIAL SARCOMA#1.0230;HEPATOCYTE PROLIFERATION#1.0228;REPORTER GENE ASSAY#1.0223;GALECTIN#1.0218;INTERCALATED DISC#1.0211;T CELL FACTOR#1.0209;CREB BINDING#1.0204;HEPATOMA CELLS#1.0194;NEURITE OUTGROWTH#1.0192;PANETH CELL#1.0190;INTEGRIN LINKED KINASE#1.0190;UBIQUITIN LIGASE COMPLEX#1.0188;MYOGENESIS#1.0177;CELL PERIPHERY#1.0173;COLONIC EPITHELIAL CELLS#1.0171;CELL ADHESION COMPLEX#1.0171;LIVER REGENERATION#1.0164;HEPATOBLASTOMA#1.0160;TRANSACTIVATION#1.0154;ADIPOGENESIS#1.0153;ASPIRIN#1.0153;GRANULOSA CELL#1.0150;CELLULAR LOCALIZATION#1.0136;SOLID PSEUDOPAPILLARY NEOPLASM#1.0131;POLY ADP RIBOSE#1.0130;CELECOXIB#1.0128;MELANOMA CELL LINES#1.0122;UBIQUITIN PROTEASOME PATHWAY#1.0119;TRANSCRIPTION FACTOR COMPLEX#1.0118;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0118;CHONDROCYTE#1.0115;INTESTINAL CRYPT#1.0115;ENHANCER BINDING#1.0113;SERTOLI CELL#1.0107;TRANSDIFFERENTIATION#1.0105;LOCALISATION#1.0103;INHIBITION OF GSK#1.0100;NUCLEAR EXPORT#1.0100;FOCAL ADHESION KINASE#1.0099;AXIS SPECIFICATION#1.0098;HAIR FOLLICLE#1.0091;APC BINDING#1.0091;DEPHOSPHORYLATION#1.0091;INDUCIBLE NITRIC OXIDE#1.0086;SIGNALLING CASCADE#1.0081;CONTACT INHIBITION#1.0081;INTESTINAL STEM CELL#1.0080;RETINOBLASTOMA#1.0078;BLASTOMERE#1.0074;RIBOSE#1.0074;CANONICAL WNT SIGNALING PATHWAY#1.0073;PHOSPHATASE 2A#1.0072;NLS BINDING#1.0072;LEPROSY#1.0067;HYPOXIA INDUCIBLE FACTOR#1.0066;TOOTH DEVELOPMENT#1.0065;PLANAR CELL POLARITY#1.0064;PREADIPOCYTE#1.0061;PARATHYROID ADENOMA#1.0055;DEDIFFERENTIATION#1.0054;NITRIC OXIDE SYNTHASE#1.0054;CELL MEMBRANE#1.0052;INTERCALATED DISK#1.0048;ENDOMETRIOSIS#1.0047;CELL FATE SPECIFICATION#1.0046;MEDULLOBLASTOMA#1.0046;T CELL#1.0045;PARATHYROID#1.0043;NUCLEAR TRANSPORT#1.0042;BETA CELL#1.0041;PROTEIN DEGRADATION#1.0041;BUDDING#1.0039;ABERRANT CRYPT FOCI#1.0032;PROTEIN COMPLEX#1.0032;CATENIN COMPLEX#1.0030;MIDBRAIN#1.0026;BASAL CELL CARCINOMA#1.0025;ENTEROCYTE#1.0025;HEPATOCELLULAR CARCINOMA CELL#1.0024;GLUTAMINE#1.0023;ESOPHAGEAL CANCER#1.0022;NEURITE#1.0021;C TERMINAL DOMAIN#1.0021;LITHIUM#1.0019;ANDROGEN RECEPTOR#1.0017;ENDOMETRIAL CARCINOMA#1.0014;CELL CYCLE REGULATOR#1.0014;PROTEASOME#1.0013;ACINAR CELL#1.0012;SIGNAL TRANSDUCER#1.0009;PROTEIN PHOSPHATASE 2A#1.0008;STATISTICALLY SIGNIFICANT DIFFERENCE#1.0007;SUBMANDIBULAR GLAND#1.0005;LIVER METASTASIS#1.0005;CELL-CELL ADHERENS JUNCTION#1.0004;LUNG CARCINOMA#1.0003;CONTACT SITE#0.9998;COLORECTAL ADENOMA#0.9997;CONNEXIN#0.9996;B CELL#0.9992;CHONDROCYTE DIFFERENTIATION#0.9990;HYPERPHOSPHORYLATION#0.9990;METASTATIC MELANOMA#0.9988;MELANOCYTE#0.9985;INVASIVE DUCTAL CARCINOMA#0.9983;GLYCOGEN SYNTHASE KINASE#0.9983;ADENOMATOUS POLYPOSIS COLI#0.9982;BILE DUCT#0.9980;EPITHELIAL CELL PROLIFERATION#0.9980;CHONDROGENESIS#0.9979;GALLBLADDER#0.9971;NUCLEAR IMPORT#0.9971;AMELOBLASTOMA#0.9970;GLUCOCORTICOID RECEPTOR#0.9967;DEXAMETHASONE#0.9966;ELECTROPHORETIC MOBILITY SHIFT#0.9965;NEURAL PROGENITOR CELL#0.9963;HYPOXIA#0.9962;T CELL DEVELOPMENT#0.9962;AKT SIGNALING#0.9962;UBIQUITIN#0.9961;FATTY ACID BINDING#0.9960;HEPATOCELLULAR ADENOMA#0.9960;BETA GALACTOSIDASE#0.9959;MYELOID LEUKEMIA#0.9958;CENTROSOME#0.9958;LUCIFERASE ACTIVITY#0.9956;WNT RECEPTOR#0.9954;SMOOTH MUSCLE ACTIN#0.9952;TROPHOBLAST#0.9952;ORAL SQUAMOUS CELL CARCINOMA#0.9950;INDOMETHACIN#0.9950;INTESTINAL EPITHELIAL CELL#0.9947;ADHERENS JUNCTION#0.9940;HUMAN EMBRYONIC KIDNEY#0.9939;COLORECTAL ADENOCARCINOMA#0.9938;MYOCARDIUM#0.9938;CYTOPLASM#0.9936;INTESTINAL MUCOSA#0.9934;THYROID CANCER#0.9934;CELL NUCLEUS#0.9932;SOMITE#0.9929;CELL DEVELOPMENT#0.9924;PROSTATE CANCER#0.9924;INVASIVE GROWTH#0.9922;OSTEOBLAST DIFFERENTIATION#0.9920;TUMOR TISSUES#0.9917;COLON CARCINOMA#0.9916;METAPLASIA#0.9914;CELL CELL JUNCTION#0.9911;MULTIPLE MYELOMA#0.9910;COLORECTAL CARCINOMA#0.9909;EMBRYONIC KIDNEY#0.9909;PEPTIDE BINDING#0.9905;OSTEOBLAST#0.9905;CYCLIC AMP#0.9905;METHYLATION SPECIFIC PCR#0.9904;ENDOMETRIAL CANCER#0.9904;NEURAL CELL#0.9903;LEUCINE RICH REPEAT#0.9902;PHOSPHATASE ACTIVITY#0.9899;PEROXISOME#0.9896;GENE SILENCING#0.9894;GERM CELL#0.9894;NEUROGENESIS#0.9892;HEPATITIS B VIRUS#0.9892;ESOPHAGUS#0.9892;TISSUE HOMEOSTASIS#0.9889;EPIDERMAL STEM CELL#0.9888;HIGH MOBILITY GROUP#0.9887;ASYMMETRIC CELL DIVISION#0.9885;ENDOMETRIUM#0.9885;LYMPH NODE METASTASES#0.9884;OSTEOGENESIS#0.9883;STRESS FIBER#0.9883;DNA SYNTHESIS#0.9882;ESTROGEN RECEPTOR#0.9882;BIOTIN#0.9882;THYROID CARCINOMA#0.9882;ADRENOCORTICAL CARCINOMA#0.9880;SIGNALING CASCADE#0.9880;INVASIVE CARCINOMA#0.9878;NEURAL CREST#0.9878;LUNG ADENOCARCINOMA#0.9878;OVARIAN CARCINOMA#0.9876;NITRIC OXIDE#0.9875;RECEPTOR COMPLEX#0.9872;PROTEIN KINASE C#0.9872;HISTONE DEACETYLASE#0.9871;BASAL CELL#0.9870;PAPILLARY THYROID CARCINOMA#0.9869;NEURAL CREST CELL#0.9869;PRECURSOR CELL#0.9868;PLEOMORPHIC ADENOMA#0.9868;DNA BINDING#0.9867;ONCOGENESIS#0.9867;PROGESTERONE#0.9866;HUMAN BREAST CANCER#0.9864;HEMATOPOIETIC STEM CELL#0.9863;PROTEIN TYROSINE PHOSPHATASE#0.9863;SIGNALLING PATHWAY#0.9863;TIGHT JUNCTION PROTEIN#0.9863;PODOCYTE#0.9862;NEUROENDOCRINE TUMOR#0.9862;CARDIOMYOCYTE#0.9861;SALIVARY GLAND#0.9859;OOCYTE#0.9858;SIGNET RING CELL#0.9858;APOPTOTIC CELL DEATH#0.9853;LEPROMATOUS LEPROSY#0.9853;WNT SIGNALING PATHWAY#0.9851;UTERUS#0.9851;HEPATOCYTE NUCLEAR FACTOR#0.9850;MYOFIBROBLAST#0.9849;NOTOCHORD#0.9848;RELATED PROTEIN 1#0.9848;CELL JUNCTION#0.9845;CERVICAL CANCER#0.9845;LOW DENSITY LIPOPROTEIN#0.9844;FACTOR I#0.9844;LIVER CANCER#0.9841;ENDOTHELIAL GROWTH FACTOR#0.9841;CELL FATE DETERMINATION#0.9840;PROTEIN KINASE A#0.9839;TUBULAR EPITHELIAL CELL#0.9839;CERVICAL#0.9838;CHRONIC MYELOID LEUKEMIA#0.9837;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9837;FOCAL ADHESION#0.9835;INTRACELLULAR SIGNALING PATHWAY#0.9834;MAMMARY EPITHELIAL CELL#0.9833;EPSTEIN BARR VIRUS#0.9833;ESTRADIOL#0.9833;MISMATCH REPAIR#0.9833;GONAD#0.9833;GRANULOSA CELL TUMOR#0.9833;GLUTATHIONE#0.9833;DOMINANT NEGATIVE MUTANT#0.9832;CYCLIN DEPENDENT KINASE#0.9831;INTERCELLULAR JUNCTION#0.9830;RENAL CELL CARCINOMA#0.9829;PLASMA MEMBRANE#0.9829;MYOBLAST#0.9827;KERATINOCYTE#0.9827;RETINOIC ACID#0.9825;GOBLET CELL#0.9825;BREAST CARCINOMA#0.9823;ADIPOCYTE#0.9823;CYTOCHROME C#0.9823;GASTRIC ADENOCARCINOMA#0.9822;GAP JUNCTION#0.9822;ONCOGENIC#0.9821;HEPATITIS B#0.9819;DISEASE FREE SURVIVAL#0.9819;CHROMATIN REMODELING#0.9818;PROTEIN SYNTHESIS#0.9816;VITAMIN D RECEPTOR#0.9816;TERMINAL DIFFERENTIATION#0.9816;DESMOSOME#0.9816;OVARIAN#0.9815;CASEIN KINASE 1#0.9814;CERVIX#0.9813;COLON CANCER#0.9813;GROWTH FACTOR RECEPTOR#0.9811;SMOOTH MUSCLE CELL#0.9810;ACTIN CYTOSKELETON#0.9810;ACTIVATED T CELL#0.9810;INSULIN-LIKE GROWTH FACTOR#0.9809;EPIDERMAL GROWTH FACTOR#0.9807;TYROSINE KINASE RECEPTOR#0.9807;CHOLANGIOCARCINOMA#0.9805;NODULAR#0.9803;SQUAMOUS CELL CARCINOMA#0.9803;STEM CELL MARKER#0.9802;SEX DETERMINATION#0.9802;AGGRESSIVE BEHAVIOR#0.9801;TRANSFORMING GROWTH FACTOR BETA#0.9800;ANCHORAGE INDEPENDENT GROWTH#0.9799;SIGNALING PATHWAY#0.9797;MAP KINASE#0.9796;EMBRYONIC STEM CELL#0.9795;MAMMARY GLAND#0.9795;CELL-CELL ADHESION MOLECULE#0.9795;TRANSCRIPTASE#0.9794;NEUROBLASTOMA#0.9794;MUSCLE CELL#0.9793;TRANSCRIPTION FACTOR#0.9793;NUCLEAR LOCALIZATION SIGNAL#0.9793;SMOOTH MUSCLE#0.9792;GASTRULATION#0.9792;HUMAN UMBILICAL VEIN#0.9791;CARCINOMA IN SITU#0.9791;UMBILICAL VEIN#0.9789;CYTOPLASMIC MEMBRANE#0.9787;ACUTE MYELOID LEUKEMIA#0.9787;CELL EXPANSION#0.9785;CELL POLARITY#0.9785;PROSTATE CARCINOMA#0.9785;CELL CYCLE ARREST#0.9784;BREAST CANCER PATIENTS#0.9784;CELL CELL ADHESION#0.9783;COMPLEX I#0.9783;BONE MORPHOGENETIC PROTEIN#0.9782;CELL DIVISION#0.9782;RECURRENCE FREE SURVIVAL#0.9781;MITOCHONDRIA#0.9780;NEUTROPHIL#0.9780;MESENCHYME#0.9780;QUANTITATIVE REAL TIME#0.9780;TRANSCRIPTIONAL CONTROL#0.9779;TARGET OF RAPAMYCIN#0.9778;COLORECTAL#0.9778;HEPATOCYTE GROWTH FACTOR#0.9774;RNA INTERFERENCE#0.9773;HEAT SHOCK PROTEIN#0.9773;ACTIN FILAMENT#0.9772;COLON EPITHELIUM#0.9771;BREAST CANCER CELL#0.9771;ENDOCHONDRAL OSSIFICATION#0.9771;LEUKOCYTE#0.9770;PANCREATIC CANCER#0.9768;PROGENITOR CELL#0.9762;TRANSMEMBRANE RECEPTOR#0.9761;MESENCHYMAL CELL#0.9760;NORMAL COLORECTAL MUCOSA#0.9760;SIGNAL TRANSDUCTION#0.9758;OVARIES#0.9758;LYMPH NODE METASTASIS#0.9758;LUNG CANCER#0.9758;ENHANCER BINDING PROTEIN#0.9758;SKELETAL MUSCLE#0.9756;CELL ACTIVATION#0.9754;ISCHEMIA#0.9754;LDL RECEPTOR#0.9753;REGENERATION#0.9752;PROSTATE SPECIFIC ANTIGEN#0.9751;RETINOID X RECEPTOR#0.9751;MITOSIS#0.9749;PROTEIN PROTEIN INTERACTION#0.9748;EPITHELIAL TISSUES#0.9746;EPITHELIAL CELL-CELL ADHESION#0.9745;NUCLEOTIDE EXCHANGE FACTOR#0.9744;S PHASE#0.9743;OVARIAN CANCER#0.9741;PROSTAGLANDIN E2#0.9738;CELL ADHESION#0.9736;SIGNALING MOLECULE#0.9736;PROTEIN KINASE B#0.9736;INDUCTION OF APOPTOSIS#0.9735;LYSINE#0.9734;PANCREATIC ADENOCARCINOMA#0.9733;KINASE ACTIVITY#0.9733;BONE FORMATION#0.9733;SPINAL CORD#0.9733;PATTERN FORMATION#0.9732;STROMAL CELL#0.9729;ACTIN BINDING#0.9728;FORMALIN#0.9728;FIBROBLAST GROWTH FACTOR#0.9728;MITOTIC SPINDLE#0.9727;HEPATOCELLULAR CARCINOMA#0.9725;CAMP RESPONSE ELEMENT BINDING#0.9725;GROWTH PATTERN#0.9724;TIGHT JUNCTION#0.9724;FRAGMENT LENGTH POLYMORPHISM#0.9724;POLYMERASE CHAIN REACTION#0.9721;CAMP RESPONSE ELEMENT#0.9720;OSSIFICATION#0.9719;COLORECTAL CANCER#0.9718;PROTEIN BINDING#0.9718;MAMMARY EPITHELIUM#0.9716;EPITHELIAL MESENCHYMAL TRANSITION#0.9716;ENDOTHELIUM#0.9715;LUMINAL#0.9715;CANCER CELL#0.9714;ENDOTHELIAL CELL#0.9714;TUMOR SUPPRESSOR#0.9713;MAPK SIGNALING#0.9713;GASTRIC MUCOSA#0.9713;ULCERATIVE COLITIS#0.9712;SEBACEOUS GLAND#0.9712;PHOSPHOLIPASE C#0.9710;COLITIS#0.9709;IFN-GAMMA#0.9709;CANCER STEM CELL#0.9709;MESENCHYMAL STEM CELL#0.9709;BREAST CANCER#0.9707;MICROTUBULE#0.9706;INTERMEDIATE FILAMENT#0.9706;ADENOCARCINOMA#0.9705;MONONUCLEAR CELLS#0.9705;ALKALINE PHOSPHATASE#0.9703;REVERSE TRANSCRIPTION#0.9702;MINERALIZATION#0.9702;RECEPTOR TYROSINE KINASE#0.9701;ENDOPLASMIC RETICULUM#0.9701;GASTROINTESTINAL TRACT#0.9699;MACROPHAGE#0.9694;LINES OF EVIDENCE#0.9694;SCHWANN CELL#0.9693;INFLAMMATORY RESPONSE#0.9693;CELL DIFFERENTIATION#0.9693;TUMOR CELLS#0.9689;FAMILIAL ADENOMATOUS POLYPOSIS#0.9685;OSTEOCYTE#0.9685;CELL ADHESION MOLECULE#0.9684;TRANSFORMING GROWTH FACTOR#0.9683;MUTAGENESIS#0.9679;NEPHRON#0.9679;WNT INHIBITORY FACTOR#0.9678;LYMPH NODE#0.9677;OSTEOCLAST#0.9676;CELL SURFACE#0.9675;SMALL INTESTINE#0.9674;BLOOD VESSEL#0.9671;CELL MOVEMENT#0.9670;MITOGEN ACTIVATED PROTEIN#0.9668;LEUCINE#0.9667;CELL PROLIFERATION#0.9664;OSTEOARTHRITIS#0.9664;COLON ADENOCARCINOMA#0.9663;TYROSINE KINASE INHIBITOR#0.9661;PERIPHERAL BLOOD#0.9660;PROTEIN KINASE#0.9660;WOUND HEALING#0.9660;INHIBITORY FACTOR 1#0.9659;CELL MOTILITY#0.9658;VASCULAR SMOOTH MUSCLE CELL#0.9658;TUMOR NECROSIS FACTOR#0.9656;KINESIN#0.9654;CARCINOGEN#0.9653;HAIR FOLLICLE DEVELOPMENT#0.9653;HEPATITIS C#0.9653;SPERMATOGENESIS#0.9653;NEURONAL CELLS#0.9652;CANCER SPECIFIC SURVIVAL#0.9652;STEM CELL#0.9651;STEM CELL DIFFERENTIATION#0.9650;CELL CYCLE#0.9649;NEURAL TUBE#0.9649;ADENOMATOSIS POLYPOSIS COLI#0.9647;MORPHOGENESIS#0.9647;VSMC PROLIFERATION#0.9647;ADIPOCYTE DIFFERENTIATION#0.9646;CELL GROWTH#0.9645;CYTOCHROME P450#0.9645;KIDNEY DISEASE#0.9645;CORPUS LUTEUM#0.9645;PANCREATIC DUCTAL ADENOCARCINOMA#0.9645;HEMATOPOIETIC CELL#0.9643;CENTRAL NERVOUS SYSTEM#0.9641;APOPTOTIC#0.9640;TOXICITY#0.9640;APOPTOSIS#0.9640;SKELETON#0.9640;NEUROTOXICITY#0.9639;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9639;ORGANOGENESIS#0.9637;IMATINIB#0.9637;COMPARATIVE GENOMIC HYBRIDIZATION#0.9636;GENE EXPRESSION#0.9635;ALZHEIMER'S DISEASE#0.9631;GUANINE#0.9630;CELL MIGRATION#0.9630;REACTIVE OXYGEN SPECIES#0.9628;PULMONARY FIBROSIS#0.9628;EPITHELIAL CELL#0.9628;STROMA#0.9627;COLON ADENOMA#0.9627;CELL DEATH#0.9626;GROWTH FACTOR#0.9625;EPITHELIAL TO MESENCHYMAL#0.9624;ASTROCYTOMA#0.9622;RNA BINDING#0.9621;PROTEOGLYCAN#0.9620;MYOCYTES#0.9619;RAPAMYCIN#0.9618;KINASE INHIBITOR#0.9616;CONSTITUTIVELY ACTIVE MUTANT#0.9614;ZINC FINGER PROTEIN#0.9610;SKELETAL DEVELOPMENT#0.9609;VACUOLE#0.9609;DNA METHYLATION#0.9605;PERIPHERAL NERVE#0.9604;ANTI INFLAMMATORY DRUGS#0.9602;PROTEIN TYROSINE KINASE#0.9601;OLIGODENDROCYTE#0.9598;EPITHELIAL CELL DIFFERENTIATION#0.9598;BASEMENT MEMBRANE#0.9594;BONE MARROW#0.9593;MICROTUBULE ASSOCIATED PROTEIN#0.9593;M PHASE#0.9589;CONNECTIVE TISSUE#0.9585;TRANSMISSION ELECTRON MICROSCOPY#0.9585;STEROIDOGENIC FACTOR 1#0.9585;QUANTITATIVE REVERSE TRANSCRIPTION#0.9579;AIRWAY EPITHELIAL CELL#0.9578;CASPASE INHIBITOR#0.9576;YEAR SURVIVAL RATE#0.9576;ARTERY#0.9576;ANGIOGENESIS#0.9574;OSTEOPOROSIS#0.9569;COLLAGEN TYPE I#0.9568;IMMUNE RESPONSE#0.9567;INFLAMMATORY BOWEL DISEASE#0.9565;SENESCENCE#0.9558;DIGESTION#0.9558;BINDING PROTEIN 1#0.9555;MECHANISM OF ACTION#0.9554;MICROVASCULAR ENDOTHELIAL CELL#0.9553;ADIPOSE TISSUE#0.9551;ALDOSTERONE#0.9549;GESTATION#0.9545;MEMBRANE FRACTION#0.9541;ENDOCRINE CELL#0.9541;WNT CANONICAL PATHWAY#0.9538;DERMIS#0.9535;DNA FRAGMENTATION#0.9535;G1 PHASE#0.9532;TO TUMOR PROGRESSION#0.9531;PARATHYROID HORMONE#0.9531;HISTOGENESIS#0.9530;72-HOURS#0.9526;ALANINE#0.9525;DERMAL FIBROBLAST#0.9524;ADRENAL GLAND#0.9520;RNA BINDING PROTEIN#0.9519;ACINAR CELL CARCINOMA#0.9518;GLAND DEVELOPMENT#0.9514;EXTRACELLULAR MATRIX#0.9514;MOUSE EMBRYONIC FIBROBLAST#0.9514;NERVOUS SYSTEM#0.9513;PANCREATOBLASTOMA#0.9513;INTELLECTUAL DISABILITY#0.9502;LIVER DISEASE#0.9500;MOUSE EMBRYONIC STEM#0.9499;SOLID PSEUDOPAPILLARY TUMOR#0.9488;IMMUNE SYSTEM#0.9487;ASTROCYTE#0.9486;POLYCYSTIC KIDNEY DISEASE#0.9482;DRUG RESISTANCE#0.9481;NUCLEIC ACID#0.9480;CELLULAR GROWTH#0.9478;ENDOCYTOSIS#0.9475;CARDIOMYOPATHY#0.9473;INSULIN RECEPTOR#0.9471;CONVERGENT EXTENSION#0.9469;RETINOIC ACID RECEPTOR#0.9468;AMYLOID PRECURSOR PROTEIN#0.9465;DNA REPAIR#0.9464;EPITHELIAL OVARIAN CANCER#0.9462;CLEAR CELL CARCINOMA#0.9461;ADRENAL CORTEX#0.9461;PHOSPHATASE AND TENSIN HOMOLOG#0.9458;CELL COMMUNICATION#0.9452;T LYMPHOCYTE#0.9449;ACTIVATED T-CELLS#0.9446;TAMOXIFEN#0.9444;NUCLEAR EXPORT SIGNAL#0.9442;MESODERM FORMATION#0.9442;CISPLATIN#0.9440;POST-TRANSLATIONAL MODIFICATION#0.9435;OVAL CELL#0.9435;EPITHELIAL CELL MIGRATION#0.9434;COPY NUMBER ALTERATION#0.9429;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9429;MONOCYTE#0.9429;MYOCARDIAL INFARCTION#0.9428;PLATELET-DERIVED GROWTH FACTOR#0.9424;HEPATITIS C VIRUS#0.9423;HEMATOPOIESIS#0.9417;SOLITARY FIBROUS TUMOR#0.9407;AUTOPHAGY#0.9405;SEQUESTERING#0.9404;LIMB DEVELOPMENT#0.9400;PROGRAMMED CELL DEATH#0.9393;HETEROTRIMERIC G-PROTEIN#0.9389;CARDIOGENESIS#0.9388;NEURAL STEM CELL#0.9385;CYTOTOXICITY#0.9381;LUNG METASTASIS#0.9381;PI3K SIGNALING#0.9380;OSTEOCLAST DIFFERENTIATION#0.9380;CELL AGGREGATION#0.9380;NEUROENDOCRINE CARCINOMA#0.9376;TELOMERASE REVERSE TRANSCRIPTASE#0.9374;DENDRITIC CELL#0.9366;ESOPHAGEAL CARCINOMA#0.9364;ARGININE#0.9362;HOST CELL#0.9361;INHIBITION OF APOPTOSIS#0.9356;EARLY GASTRIC CANCER#0.9354;TONGUE CANCER#0.9352;JUXTAMEMBRANE#0.9346;ACTIN POLYMERIZATION#0.9345;GENISTEIN#0.9340;VASCULAR ENDOTHELIAL CELL#0.9335;PANCREAS DEVELOPMENT#0.9334;NEURODEGENERATIVE DISEASE#0.9327;2'-DEOXYCYTIDINE#0.9318;DOPAMINE#0.9304;FOREBRAIN#0.9302;ANCHORING#0.9302;HUMAN MESENCHYMAL STEM#0.9300;PRIMITIVE STREAK#0.9299;METHYLATION SPECIFIC POLYMERASE#0.9298;INFERTILITY#0.9298;LARGE INTESTINE#0.9298;HIGH GRADE DYSPLASIA#0.9298;NULL CELL#0.9297;5-AZA-2'-DEOXYCYTIDINE#0.9291;RECEPTOR ANTAGONIST#0.9289;ADENOSINE#0.9289;ALKALINE PHOSPHATASE ACTIVITY#0.9288;BRANCHING MORPHOGENESIS#0.9277;MARROW STROMAL CELLS#0.9276;NF-KAPPAB ACTIVATION#0.9270;RECTUM#0.9264;COLON EPITHELIAL CELL#0.9263;VASCULAR CELL#0.9262;TOPOISOMERASE#0.9259;BONE MARROW STROMAL#0.9259;AGE AT DIAGNOSIS#0.9257;UVEAL MELANOMA#0.9257;MECHANISMS OF ACTION#0.9251;MICROFILAMENT#0.9247;TESTOSTERONE#0.9243;LUNG DEVELOPMENT#0.9236;TUBE FORMATION#0.9231;CHONDROCYTE HYPERTROPHY#0.9221;FIBROMA#0.9220;BONE DEVELOPMENT#0.9218;DOXYCYCLINE#0.9218;PANCREATIC CARCINOMA#0.9216;HISTONE ACETYLTRANSFERASE#0.9208;CATALYTIC ACTIVITY#0.9204;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9203;BLOOD BRAIN BARRIER#0.9199;FOCAL CONTACT#0.9199;DNA METHYLTRANSFERASE#0.9195;UBIQUITIN PROTEASOME SYSTEM#0.9195;TUMOUR NECROSIS FACTOR#0.9191;MESANGIAL CELL#0.9191;DENTATE GYRUS#0.9189;DEATH RECEPTOR#0.9187;PROTEIN PHOSPHORYLATION#0.9183;NEUROPROTECTION#0.9182;HUMAN EMBRYONIC STEM#0.9179;CARRIE#0.9178;STEROIDOGENESIS#0.9175;LYNCH SYNDROME#0.9163;COLON MUCOSA#0.9152;BRAIN DEVELOPMENT#0.9146;MICROPHTHALMIA#0.9141;NEURAL PRECURSOR CELL#0.9134;OVARIAN FOLLICLE#0.9133;LATERAL PLASMA MEMBRANE#0.9132;TOLL LIKE RECEPTOR#0.9127;TUBERCULOSIS#0.9115;BONE MARROW STROMAL CELL#0.9115;SPECTRIN#0.9110;LIGAND BINDING DOMAIN#0.9106;IMMUNE CELL#0.9104;CELL CYCLE REGULATION#0.9101;LEYDIG CELL#0.9091;ASPARTATE#0.9086;EMBRYO DEVELOPMENT#0.9085;FERTILIZATION#0.9084;TISSUE DEVELOPMENT#0.9082;INSULIN RECEPTOR SUBSTRATE#0.9077;CORTISOL#0.9077;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9076;DIFFERENTIAL GENE EXPRESSION#0.9075;OSTEOBLAST PROLIFERATION#0.9072;INHIBIN#0.9071;GLIAL CELL#0.9061;NOTCH SIGNALING PATHWAY#0.9061;CELL CYCLE CONTROL#0.9060;ACID PHOSPHATASE#0.9060;GROWTH CONE#0.9059;HAIR CELL#0.9057;SKIN CANCER#0.9055;NEPHROPATHY#0.9053;KIDNEY DEVELOPMENT#0.9051;ANOIKIS#0.9046;FATTY ACID SYNTHASE#0.9045;FILAMENTOUS ACTIN#0.9043;CANCER RELATED DEATH#0.9041;GLYCOSYLATION#0.9029;MEMBRANE RUFFLE#0.9025;MALIGNANT MESOTHELIOMA#0.9022;VALPROIC ACID#0.9019;NUCLEAR PORE#0.9017;CEREBRAL CORTEX#0.9015;ANAGEN#0.9009;CENTROSOME SEPARATION#0.9008;STROMAL SARCOMA#0.9004;HEDGEHOG SIGNALING PATHWAY#0.8997;CELL MATRIX ADHESION#0.8996;EPHRIN#0.8993;TESTIS DEVELOPMENT#0.8990;FOLLICLE STIMULATING HORMONE#0.8986;COLUMNAR#0.8985;OBESE#0.8983;THYMIDINE#0.8981;CARDIAC DEVELOPMENT#0.8977;LEUKEMIC STEM CELL#0.8975;PAPILLARY THYROID CANCER#0.8972;ENDOMETRIOID ENDOMETRIAL CARCINOMA#0.8966;URETERIC BUD#0.8962;HEART DEVELOPMENT#0.8961;ENDOMETRIAL STROMAL SARCOMA#0.8959;INHIBITION OF CELL GROWTH#0.8957;LYSOSOME#0.8956;PITUITARY GLAND#0.8956;STEM CELL LIKE#0.8955;LIVER CIRRHOSIS#0.8944;CELLULAR MEMBRANE#0.8943;INVASIVE BREAST CARCINOMA#0.8942;LYMPH NODE INVOLVEMENT#0.8937;MYOTUBE#0.8932;ACTIVATOR PROTEIN 1#0.8930;MELANOCYTE DIFFERENTIATION#0.8928;SRC FAMILY KINASE#0.8923;ACETYLCHOLINE RECEPTOR#0.8922;CYCLIN DEPENDENT KINASE INHIBITOR#0.8922;STEM CELL MAINTENANCE#0.8912;FINE NEEDLE ASPIRATION#0.8909;ROOT SHEATH#0.8907;BONE CELLS#0.8901;ALL TRANS RETINOIC ACID#0.8901;MAMMARY GLAND DEVELOPMENT#0.8899;EPITHELIAL BARRIER FUNCTION#0.8899;HEAD AND NECK CANCER#0.8898;NECK CANCER#0.8897;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8897;BONE MINERAL DENSITY#0.8896;TETRACYCLINE#0.8896;HAIR GROWTH#0.8895;MYOSIN HEAVY CHAIN#0.8894;LUNG FIBROBLASTS#0.8893;GENE REGULATORY NETWORK#0.8889;INTESTINAL CANCER#0.8888;TISSUE MORPHOGENESIS#0.8886;MYOEPITHELIAL CELL#0.8882;REGULATION OF CELL PROLIFERATION#0.8878;CARDIOMYOCYTE DIFFERENTIATION#0.8877;DIABETIC NEPHROPATHY#0.8877;LANGERHANS CELL#0.8874;PHOSPHATASE INHIBITOR#0.8870;TROGLITAZONE#0.8870;LASER SCANNING MICROSCOPY#0.8867;CAMKII#0.8866;PULMONARY BLASTOMA#0.8863;DUCT CELL#0.8862;HUMAN IMMUNODEFICIENCY VIRUS#0.8858;PARACOCCIDIOIDOMYCOSIS#0.8857;HIGH FAT DIET#0.8856;REGIONAL LYMPH NODE#0.8851;BORTEZOMIB#0.8850;ACTIN BINDING PROTEIN#0.8847;NEMO LIKE KINASE#0.8847;GASTROINTESTINAL STROMAL TUMOR#0.8845;HUMAN PANCREATIC CANCER#0.8844;QUERCETIN#0.8840;OOGENESIS#0.8827;MOLECULAR FUNCTION#0.8824;TERATOCARCINOMA#0.8823;DESMOSOME ASSEMBLY#0.8819;HAIR FOLLICLE MORPHOGENESIS#0.8811;GASTRIC EPITHELIAL CELLS#0.8811;REGULATION OF CELL ADHESION#0.8806;INFLAMMATORY CELL#0.8805;MAGNETIC RESONANCE IMAGING#0.8804;STEM CELL PROLIFERATION#0.8802;TIGHT JUNCTION FORMATION#0.8799;MESENCHYMAL PROGENITOR CELL#0.8783;OVARIAN DEVELOPMENT#0.8768;INVASIVE BREAST CANCER#0.8768;ORGANELLE#0.8760;ADJACENT NORMAL TISSUE#0.8758;CARCINOSARCOMA#0.8749;FURROW#0.8744;HISTONE DEACETYLASE INHIBITOR#0.8743;RECEPTOR LIGAND#0.8733;EPITHELIAL STEM CELL#0.8726;LECTIN#0.8722;PARENCHYMA#0.8716;NMDA RECEPTOR#0.8714;BONE RESORPTION#0.8705;FIBROBLAST PROLIFERATION#0.8701;PLANAR CELL POLARITY PATHWAY#0.8697;PHENOBARBITAL#0.8692;VON HIPPEL LINDAU#0.8691;BMP SIGNALING PATHWAY#0.8690;PRO-INFLAMMATORY#0.8684;POLYCYSTIN#0.8682;EMBRYONAL CARCINOMA#0.8681;NEPHROBLASTOMA#0.8671;MUCOEPIDERMOID CARCINOMA#0.8669;ANAPLASTIC THYROID CARCINOMA#0.8660;WORLD HEALTH ORGANIZATION#0.8656;HYPOXIC#0.8650;ARYL HYDROCARBON RECEPTOR#0.8639;CHORIOCARCINOMA#0.8638;CELL WALL#0.8636;CHONDROCYTE PROLIFERATION#0.8636;CYTOPLASMIC REGION#0.8633;NEUROBLAST#0.8616;GALLBLADDER CANCER#0.8615;BETA SELECTION#0.8609;HYALURONAN#0.8609;BILIARY TRACT#0.8604;RENAL CARCINOMA#0.8603;EOSIN#0.8603;UBIQUITIN-DEPENDENT PROTEOLYSIS#0.8602;ENDOSOME#0.8594;GASTRITIS#0.8589;GALLBLADDER CARCINOMA#0.8579;X CHROMOSOME#0.8577;BIPOLAR DISORDER#0.8576;KERATINOCYTE DIFFERENTIATION#0.8574;CHRONIC LIVER DISEASE#0.8570;TELENCEPHALON#0.8558;INHIBITION OF CELL PROLIFERATION#0.8558;UROKINASE#0.8557;BONE REMODELING#0.8556;VIRAL INFECTION#0.8550;BRONCHIAL EPITHELIAL CELLS#0.8547;PKCALPHA#0.8540;REGULATION OF GENE EXPRESSION#0.8536;DIHYDROTESTOSTERONE#0.8535;MAST CELL#0.8534;STEM CELL FACTOR#0.8532;TYPE 2 DIABETES#0.8532;PROTEIN STABILIZATION#0.8522;KARYOPHERIN#0.8521;DELTAN#0.8515;EYE DEVELOPMENT#0.8513;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.8511;HEPATOBLAST#0.8504;RESVERATROL#0.8504;DIABETES MELLITUS#0.8501;INVASIVE LOBULAR CARCINOMA#0.8495;ACETYLTRANSFERASE ACTIVITY#0.8493;KERATINOCYTE PROLIFERATION#0.8491;NERVE GROWTH FACTOR#0.8488;PCP PATHWAY#0.8485;DOXORUBICIN#0.8471;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.8471;TROPHOBLAST CELL#0.8464;OVERALL SURVIVAL RATE#0.8459;PROTEASOME DEGRADATION#0.8459;CHROMOSOMAL REGION#0.8456;SUPEROXIDE DISMUTASE#0.8454;ORAL CAVITY#0.8453;FOREGUT#0.8436;INULIN#0.8434;SURFACE EPITHELIUM#0.8418;SCANNING ELECTRON MICROSCOPY#0.8413;CLEAVED CASPASE 3#0.8410;CASPASE-3 ACTIVITY#0.8409;DEXTRAN SULFATE SODIUM#0.8408;ACUTE LEUKEMIA#0.8404;VELOCARDIOFACIAL SYNDROME#0.8397;OVULATION#0.8397;METASTATIC PROSTATE CANCER#0.8391;MIDLINE#0.8388;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8387;COLORECTUM#0.8385;INTERPHASE#0.8381;NUCLEAR ENVELOPE#0.8381;ADHERENS JUNCTION FORMATION#0.8379;FEMUR#0.8373;CORONARY ARTERY#0.8359;LARYNGEAL CARCINOMA#0.8355;CELL POLARIZATION#0.8355;SOFT TISSUE SARCOMA#0.8342;PAPILLARY CARCINOMA#0.8337;POSTSYNAPTIC DENSITY#0.8334;EDEMA#0.8334;RENAL FIBROSIS#0.8333;ORAL CANCER CELL#0.8327;PYRAMIDAL CELL#0.8325;GONADOTROPIN RELEASING HORMONE#0.8317;LYMPHOCYTIC LEUKEMIA#0.8316;CYTOKINESIS#0.8312;MUCINOUS NEOPLASM#0.8308;GANGLION CELLS#0.8303;FRONTAL#0.8301;FIBROSARCOMA#0.8296;GOLGI APPARATUS#0.8295;HYPERTENSION#0.8294;GROWTH FACTOR BINDING#0.8286;NEURITE EXTENSION#0.8285;GLYCINE#0.8268;BLADDER ADENOCARCINOMA#0.8267;MATRIX METALLOPROTEINASE 1#0.8259;BONE MORPHOGENIC PROTEIN#0.8257;EPIBLAST#0.8255;SYNAPTIC VESICLE#0.8242;COPY NUMBER CHANGE#0.8237;SOMITOGENESIS#0.8233;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8226;CASPASE ACTIVITY#0.8225;AIRWAY EPITHELIUM#0.8216;CASEIN KINASE 2#0.8214;BLASTOMA#0.8211;TUMOR NODE METASTASIS#0.8211;STEM CELL RENEWAL#0.8205;SPERMATOCYTES#0.8204;THYROID HORMONE RECEPTOR#0.8204;GENE EXPRESSION OMNIBUS#0.8197;HISTAMINE#0.8190;COPY NUMBER VARIATION#0.8183;NEURAL PLATE#0.8160;MENSTRUAL CYCLE#0.8152;PROSTATE EPITHELIAL CELL#0.8151;INNER EAR#0.8147;PLASMA CELL#0.8136;EVENT FREE SURVIVAL#0.8132;BARRETT'S ESOPHAGUS#0.8121;EPIDIDYMIS#0.8117;TOPOISOMERASE II#0.8117;HIGH BONE MASS#0.8098;PROTEIN LOCALIZATION#0.8096;C REACTIVE PROTEIN#0.8093;ACTIVATION OF NF-KAPPAB#0.8089;RECEPTOR ACTIVATOR#0.8087;HOMOLOGOUS RECOMBINATION#0.8075;LUNG ACINAR ADENOCARCINOMA#0.8073;MOOD DISORDER#0.8072;CELL PHYSIOLOGY#0.8067;HIGH POWER FIELD#0.8063;IKAPPAB KINASE#0.8061;CHROMOSOME SEGREGATION#0.8059;SMAD BINDING#0.8059;NEUROMUSCULAR JUNCTION#0.8053;KAPOSI'S SARCOMA#0.8052;INTERSTITIAL CELL#0.8050;VITAMIN A#0.8043;PARKINSON'S DISEASE#0.8041;RELAPSE FREE SURVIVAL#0.8034;DERMAL PAPILLA CELL#0.8031;DYNEIN#0.8023;FETAL LIVER#0.8017;DUODENUM#0.8017;HAIR CYCLE#0.8009;INTRAHEPATIC CHOLANGIOCARCINOMA#0.8007;IMATINIB MESYLATE#0.8005;NOTCH RECEPTOR#0.8002;MEDIATOR COMPLEX#0.7996;B LYMPHOCYTE#0.7994;RIBOSOMAL PROTEIN#0.7991;CPG ISLAND METHYLATION#0.7984;SUMOYLATION#0.7983;ACETYLCHOLINE#0.7979;DEMETHYLATION#0.7976;MULTIPLE MYELOMA CELLS#0.7972;AER FORMATION#0.7972;GRANULOCYTE#0.7970;STOMACH CANCER#0.7969;MEMBRANE TYPE 1#0.7952;BRAIN ENDOTHELIAL CELL#0.7950;OVIDUCT#0.7948;DIFFERENTIATED THYROID CARCINOMA#0.7945;RUFFLE#0.7940;POSTTRANSLATIONAL MODIFICATION#0.7939;ENDOTHELIAL CELL MIGRATION#0.7935;HYPERACTIVE#0.7933;RNA SPLICING#0.7932;SESSILE SERRATED ADENOMA#0.7930;MYOMETRIUM#0.7917;RNA HELICASE#0.7914;NOTCH LIGAND#0.7914;SMOOTH MUSCLE CELL PROLIFERATION#0.7913;NON-SMALL CELL LUNG CARCINOMA#0.7911;MUSCLE CELL PROLIFERATION#0.7910;ORAL MUCOSA#0.7910;MESENCHYMAL STROMAL CELL#0.7905;EPITHELIAL MESENCHYMAL TRANSFORMATION#0.7894;LENS DEVELOPMENT#0.7892;SURFACE PLASMON RESONANCE#0.7885;ENZYME ACTIVITY#0.7881;CD8+ T CELL#0.7880;LEIOMYOSARCOMA#0.7878;CERVICAL ADENOCARCINOMA#0.7874;VASCULAR ENDOTHELIUM#0.7873;LUNG EPITHELIAL CELL#0.7871;2-METHOXYESTRADIOL#0.7863;PSORIASIS#0.7852;LUTEAL PHASE#0.7849;CASPASE ACTIVATION#0.7847;DNA REPLICATION#0.7845;REGULATION OF GSK#0.7842;BETA-2#0.7837;DIFFUSE GASTRIC CANCER#0.7835;TROPHECTODERM#0.7828;ADVANCED COLORECTAL CANCER#0.7825;ENDOMETRIAL STROMAL TUMOR#0.7823;ADULT STEM CELL#0.7819;ATHEROSCLEROSIS#0.7814;PDZ BINDING MOTIF#0.7811;SERTOLI CELL TUMOR#0.7810;MITOCHONDRIAL MEMBRANE#0.7809;NEUROEPITHELIAL CELL#0.7808;ACUTE MYELOID LEUKAEMIA#0.7798;GLYCOLYSIS#0.7797;AIRWAY SMOOTH MUSCLE#0.7792;QUIESCENCE#0.7777;CORNEAL EPITHELIUM#0.7774;RECEPTOR ACTIVITY#0.7773;PROTEIN KINASE CALPHA#0.7771;CELLULAR ADHESION MOLECULE#0.7762;DUCTAL CARCINOMA IN SITU#0.7754;BLADDER CARCINOMA#0.7748;REGULATION OF CELLULAR#0.7738;DEXTRAN SODIUM SULFATE#0.7737;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.7733;TERATOMA#0.7733;HEMATOPOIETIC PROGENITOR CELL#0.7730;TISSUE REMODELING#0.7722;STRIATUM#0.7720;HEPATOCYTE DIFFERENTIATION#0.7719;RETINAL PIGMENT EPITHELIUM#0.7718;BONE MARROW CELLS#0.7712;HEPARIN#0.7712;MICROCEPHALY#0.7700;NORMAL LIVER TISSUES#0.7695;LIPOSARCOMA#0.7695;CELL CORTEX#0.7692;CHROMATIN REMODELLING#0.7692;RETINAL DEVELOPMENT#0.7683;HEPATIC STELLATE CELL#0.7679;PEMPHIGUS#0.7675;CHONDROITIN SULFATE PROTEOGLYCAN#0.7646;PANCREATITIS#0.7644;INNATE IMMUNITY#0.7644;FASCIITIS#0.7643;SECRETORY CELL#0.7635;ADRIAMYCIN#0.7630;ADRENAL HYPERPLASIA#0.7624;ISOTHERMAL TITRATION CALORIMETRY#0.7623;WHOLE GENOME SEQUENCING#0.7621;MURINE EMBRYONIC STEM#0.7617;APICAL JUNCTION#0.7610;NEURONAL MIGRATION#0.7602;T-CELL LEUKEMIA#0.7593;NOCODAZOLE#0.7592;INTRACELLULAR SIGNALING CASCADE#0.7588;PHAGOCYTOSIS#0.7584;DENDRITIC SPINE#0.7583;IDIOPATHIC PULMONARY FIBROSIS#0.7571;ORGAN FORMATION#0.7571;CROHN'S DISEASE#0.7564;TRANSFORMING GROWTH FACTOR ALPHA#0.7555;LIPID METABOLISM#0.7548;INSULIN SECRETION#0.7534;OXYGENASE#0.7526;BILIARY TRACT CANCER#0.7523;PROSTATE DEVELOPMENT#0.7519;STRESS FIBRE#0.7518;BLEOMYCIN#0.7517;TRANSLATION INITIATION#0.7506;PULMONARY NEUROENDOCRINE TUMOR#0.7506;PULMONARY ARTERY#0.7505;TRANSENDOTHELIAL ELECTRICAL RESISTANCE#0.7505;SPINDLE ORIENTATION#0.7503;DOPAMINERGIC NEURON#0.7502;AXON GUIDANCE#0.7490;CELL DEDIFFERENTIATION#0.7488;PAPILLOMA#0.7483;B CELL LYMPHOMA#0.7480;PERIPHERAL BLOOD LEUKOCYTE#0.7479;CILIATED CELL#0.7471;ENDOTHELIAL CELL PROLIFERATION#0.7467;EPILEPSY#0.7466;DECIDUALIZATION#0.7460;SIGNAL TRANSMISSION#0.7458;HUMAN MAMMARY EPITHELIAL#0.7453;MALIGNANT BRAIN TUMOR#0.7451;HUMAN GASTRIC CARCINOMA#0.7441;METASTATIC LYMPH NODE#0.7441;JUNCTIONAL ADHESION MOLECULE#0.7437;ANAPLASTIC THYROID CANCER#0.7437;LASER CAPTURE MICRODISSECTION#0.7433;EPIGALLOCATECHIN#0.7429;LIGASE ACTIVITY#0.7428;METANEPHRIC MESENCHYME#0.7424;NEUROTOXIC#0.7421;TISSUE REGENERATION#0.7403;CHOROID PLEXUS#0.7401;TISSUE GROWTH FACTOR#0.7399;HISTONE MODIFICATION#0.7389;MOUSE EMBRYO FIBROBLASTS#0.7387;DILATED CARDIOMYOPATHY#0.7384;OTIC PLACODE#0.7382;UMBILICAL CORD#0.7379;TUBERCULOID LEPROSY#0.7374;HYPERSENSITIVITY#0.7374;LATERAL VENTRICLE#0.7373;CHOLESTASIS#0.7368;MICROTUBULE BINDING#0.7368;CEREBRAL ISCHEMIA#0.7367;GLCNAC#0.7364;EXCITATORY SYNAPSE#0.7362;MUSCLE HYPERTROPHY#0.7359;MYELOID CELL#0.7356;LOCALIZED PROSTATE CANCER#0.7356;ETHANOL#0.7351;PORTAL VEIN#0.7346;MUCINOUS ADENOCARCINOMA#0.7336;HUMAN BRONCHIAL EPITHELIAL#0.7335;ADVANCED GASTRIC CANCER#0.7330;ENAMEL ORGAN#0.7329;MERKEL CELL#0.7326;COLITIS ASSOCIATED CANCER#0.7325;VULVA#0.7322;MICROVILLI#0.7322;GONAD DEVELOPMENT#0.7315;C-TERMINAL BINDING#0.7315;NEUROFIBRILLARY TANGLE#0.7313;AQUAPORIN#0.7306;CELL MORPHOGENESIS#0.7298;RETINAL PIGMENT EPITHELIAL#0.7298;HUMAN HEPATOMA CELL LINES#0.7295;AXIS DETERMINATION#0.7288;TO THE PROGRESSION#0.7286;ARSENIC TRIOXIDE#0.7282;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7279;SODIUM DODECYL SULFATE#0.7275;DODECYL SULFATE#0.7274;CHONDROSARCOMA#0.7269;PRIMARY EFFUSION LYMPHOMA#0.7268;DENTAL LAMINA#0.7267;RECEPTOR AGONIST#0.7264;GENOTOXIC#0.7261;MIDGUT#0.7257;CYTOTROPHOBLAST#0.7254;GALLBLADDER ADENOMA#0.7254;PERITONEUM#0.7250;DOCKING PROTEIN#0.7240;PEMPHIGUS VULGARIS#0.7239;PROTEIN INTERACTION NETWORK#0.7216;NORMAL BREAST TISSUE#0.7209;ACTIN BUNDLING#0.7203;SYSTEM DEVELOPMENT#0.7198;TUBEROUS SCLEROSIS#0.7197;2'-DEOXYURIDINE#0.7190;FOLLICULAR ADENOMA#0.7189;CELL FUSION#0.7189;MANDIBLE#0.7185;ADHERENS JUNCTION DISASSEMBLY#0.7174;TRANSCRIPTION REGULATOR#0.7173;HISTONE ACETYLATION#0.7173;CAVEOLAE#0.7172;INTERMEDIATE FILAMENT CYTOSKELETON#0.7170;SCF COMPLEX#0.7160;TRANSCRIPTION ACTIVATOR#0.7159;ACTIVATION OF GSK#0.7155;HEART FORMATION#0.7153;STAUROSPORINE#0.7145;NEURAL ECTODERM#0.7144;CELIAC DISEASE#0.7141;LIVER NEOPLASM#0.7138;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7132;PACLITAXEL#0.7129;ARACHIDONIC ACID#0.7126;PHOSPHODIESTERASE#0.7124;GROWTH HORMONE#0.7118;CHOLECYSTITIS#0.7106;GLUCOSE METABOLISM#0.7105;COLONY FORMATION ASSAY#0.7104;DELAMINATION#0.7101;KERATINOCYTE MIGRATION#0.7100;CALCINEURIN#0.7097;ROOT HAIR#0.7074;NADPH OXIDASE#0.7066;INDOLE#0.7062;MICROTUBULE PLUS END#0.7055;OSTEOSARCOMA CELL LINES#0.7039;CHRONIC HEPATITIS B#0.7039;SKIN DISEASE#0.7038;MOLAR#0.7035;THALIDOMIDE#0.7032;EPITHELIAL CARCINOMA#0.7029;ATROPHIC GASTRITIS#0.7028;DEUBIQUITINATING ENZYME#0.7024;ECTODERMAL DYSPLASIA#0.7024;GOBLET CELL CARCINOID#0.7016;SCLEROSING HEMANGIOMA#0.7016;URINARY BLADDER#0.7015;P21 ACTIVATED KINASE#0.7013;CORD BLOOD#0.7011;UBIQUITIN LIGASE ACTIVITY#0.7004;SQUAMOUS CELL CANCER#0.7004;DEVELOPMENTAL PROCESS#0.7003;ION CHANNEL#0.7003;METASTATIC COLORECTAL ADENOCARCINOMA#0.6999;ALOPECIA#0.6998;LOCALIZATION OF CELL#0.6998;NODAL SIGNALING#0.6997;HUMAN PAPILLOMA VIRUS#0.6988;TELOMERE#0.6983;COLONY-STIMULATING FACTOR#0.6982;GERM CELL TUMORS#0.6978;ETOPOSIDE#0.6962;COLLAGENASE#0.6957;ALVEOLAR EPITHELIAL CELL#0.6956;EXTRACELLULAR MATRIX COMPONENT#0.6946;PRIMARY CUTANEOUS MELANOMA#0.6938;YELLOW FLUORESCENT PROTEIN#0.6935;NEOPLASTIC TISSUES#0.6934;CELL MATURATION#0.6933;FOLLICLE STEM CELL#0.6920;MICROTUBULE DYNAMICS#0.6920;TISSUE MICROARRAY ANALYSIS#0.6917;NUCLEOTIDE BINDING#0.6916;SCIATIC NERVE#0.6912;VIRAL REPLICATION#0.6905;PEUTZ-JEGHERS SYNDROME#0.6901;TOOTH MORPHOGENESIS#0.6896;ANAPLASTIC MENINGIOMA#0.6896;KNEE JOINT#0.6886;INFERTILE#0.6885;AUTOIMMUNE DISEASE#0.6882;WNT RECEPTOR COMPLEX#0.6879;FETAL KIDNEY#0.6871;FACTOR S#0.6862;RIBOSOME#0.6857;ENDOMETRIAL ADENOCARCINOMA#0.6855;NEUROFILAMENT#0.6851;PROXIMAL TUBULAR EPITHELIAL#0.6849;FIBROUS HISTIOCYTOMA#0.6844;CYTOPLASMIC INCLUSION#0.6831;SCALP#0.6821;FOLLICULAR THYROID CARCINOMA#0.6801;HEPATIC STEM CELL#0.6789;BASAL EPITHELIAL CELL#0.6789;HOMOTYPIC CELL-CELL ADHESION#0.6782;OVARIAN SURFACE EPITHELIUM#0.6781;PERIODONTAL LIGAMENT#0.6778;PROTEASE ACTIVATED RECEPTOR#0.6776;ANAPLASTIC CARCINOMA#0.6774;EUKARYOTIC INITIATION FACTOR#0.6771;ADENOSQUAMOUS CARCINOMA#0.6768;LACTATION#0.6767;LIVER LESIONS#0.6758;PLACENTATION#0.6757;HYPERPARATHYROIDISM#0.6757;VESICULAR TRANSPORT#0.6748;BONE FORMATION RATE#0.6746;UTERINE CERVICAL CANCER#0.6745;INSULIN GROWTH FACTOR#0.6740;CAMP-RESPONSIVE ELEMENT BINDING#0.6740;DIFFUSE ASTROCYTOMA#0.6734;HISTONE ACETYLTRANSFERASE ACTIVITY#0.6732;OTHER ORGANISM#0.6705;RHABDOMYOSARCOMA#0.6704;PROTEIN TRANSLATION#0.6695;PKC ACTIVATION#0.6694;MRNA SPLICING#0.6693;CELLULAR COMPONENT#0.6681;CELL CELL SIGNALING#0.6676;SPERMATOZOA#0.6676;SURFACE ECTODERM#0.6671;CIRCADIAN RHYTHM#0.6671;METASTATIC ADENOCARCINOMA#0.6671;BONE DISEASE#0.6671;AXON GROWTH#0.6667;INTESTINAL DEVELOPMENT#0.6658;HAIR FOLLICLE CELL#0.6654;PANCREATIC ISLET#0.6650;5 FLUOROURACIL#0.6648;CDK INHIBITOR#0.6638;DELAYED-TYPE HYPERSENSITIVITY#0.6635;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.6622;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.6621;VIRULENCE#0.6619;INTERLEUKIN 1 RECEPTOR#0.6618;ROSIGLITAZONE#0.6616;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.6611;GUANYLATE KINASE#0.6611;DORSAL CLOSURE#0.6607;MONOCYTE CHEMOTACTIC PROTEIN#0.6602;HERPES SIMPLEX#0.6597;DUCTAL BREAST CANCER#0.6592;INHIBITION OF ADIPOGENESIS#0.6588;FORSKOLIN#0.6574;PINEAL GLAND#0.6569;ADENINE#0.6565;PERIPHERAL NERVOUS SYSTEM#0.6563;ABDOMINAL PAIN#0.6563;WATER CHANNEL#0.6560;COLLECTING DUCTS#0.6558;CHAGAS DISEASE#0.6547;GALACTOSIDASE ACTIVITY#0.6545;ROFECOXIB#0.6538;HISTIDINE#0.6537;PROTEASOMAL PATHWAY#0.6535;FLUID SHEAR STRESS#0.6533;METHIONINE#0.6532;PROTEIN CODING GENE#0.6529;AU RICH ELEMENT#0.6523;METASTATIC COLORECTAL CANCER#0.6522;TELOMERASE ACTIVITY#0.6518;LARGE CELL NEUROENDOCRINE CARCINOMA#0.6517;STRIATED MUSCLE#0.6514;SECRETORY PATHWAY#0.6512;BONE MARROW MICROENVIRONMENT#0.6508;OLFACTORY BULB#0.6507;CARTILAGE DEVELOPMENT#0.6505;GENETIC DISORDER#0.6500;BLOOD TESTIS BARRIER#0.6490;TRANSCRIPTION FACTOR ACTIVITY#0.6488;CARDIAC MUSCLE#0.6486;LOW BONE MASS#0.6477;MESENCHYMAL EPITHELIAL TRANSITION#0.6477;DIED OF DISEASE#0.6468;REGULATORY T CELL#0.6468;PROSTATE ADENOCARCINOMA#0.6459;ENTEROCYTE DIFFERENTIATION#0.6454;ACTIN FILAMENT BINDING#0.6453;ORNITHINE#0.6446;HIGH RESOLUTION MELTING#0.6435;CUSHING'S SYNDROME#0.6422;ANTI APOPTOSIS#0.6419;ARRHYTHMIA#0.6414;SKIN STEM CELL#0.6408;REGULATION OF APOPTOSIS#0.6403;PHOTORECEPTOR CELL#0.6397;LEUKEMIA INHIBITORY FACTOR#0.6395;MUCOUS#0.6394;DUAL LUCIFERASE REPORTER#0.6394;CONSTRICTION#0.6391;LUNG SPECIFICATION#0.6380;LIPID DROPLET#0.6377;FLOW CYTOMETRY ANALYSIS#0.6375;RETINOL#0.6360;ADRENERGIC RECEPTOR#0.6355;HERPES SIMPLEX VIRUS#0.6351;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6348;T CELL ACTIVATION#0.6346;SENSITIZATION#0.6343;INTERCELLULAR SPACE#0.6341;MEMBRANE-ASSOCIATED GUANYLATE KINASE#0.6330;HEPATIC PROGENITOR CELL#0.6324;RHEUMATOID ARTHRITIS#0.6323;VACUOLAR MEMBRANE#0.6320;ROOT DEVELOPMENT#0.6314;BIRTH DEFECT#0.6314;RENAL CANCER CELLS#0.6311;EYELID#0.6297;CRANIOFACIAL DEVELOPMENT#0.6295;PROSTATE EPITHELIUM#0.6293;LARYNX#0.6290;FEMALE SEX DETERMINATION#0.6281;DUCTAL CELL#0.6273;METASTASIS FREE SURVIVAL#0.6266;ADHERENS JUNCTION ASSEMBLY#0.6265;VALPROATE#0.6258;EMBRYO IMPLANTATION#0.6256;VEGF SIGNALING#0.6255;GERM CELL DEVELOPMENT#0.6254;MYOGENIC CELL#0.6252;CIGARETTE SMOKE EXTRACT#0.6250;ATYPICAL TERATOID RHABDOID TUMOR#0.6249;LUNG DISEASE#0.6247;ICI 182,780#0.6246;BASAL LAMINA#0.6239;DIGESTIVE TRACT#0.6232;SUCROSE#0.6231;REPRODUCTIVE SYSTEM#0.6230;CALCIUM SIGNALING#0.6223;1α,25-DIHYDROXYVITAMIN D3#0.6222;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.6219;HINDBRAIN#0.6216;PRIMARY HYPERPARATHYROIDISM#0.6216;PAROTID GLAND#0.6210;MITOTIC SPINDLE ORIENTATION#0.6207;RHOPTRY#0.6207;SERINE KINASE ACTIVITY#0.6206;PRIMARY PULMONARY ADENOCARCINOMA#0.6206;PROTEIN PHOSPHATASE 1#0.6204;LENS MORPHOGENESIS#0.6202;HEAT SHOCK FACTOR#0.6194;EMBRYONIC LUNG#0.6190;MITOCHONDRIAL DNA#0.6186;CANCER SPECIFIC MORTALITY#0.6185;GLUTAMIC ACID#0.6184;PANCREATIC NEUROENDOCRINE TUMOR#0.6180;INNATE IMMUNE RESPONSE#0.6175;OSTEONECROSIS#0.6175;CALCIUM CHANNEL#0.6175;PARACRINE SIGNALING#0.6168;CARDIOMYOCYTE GROWTH#0.6158;ACTIVATION OF GEF#0.6158;REGULATION OF CELL GROWTH#0.6157;OUTFLOW TRACT#0.6156;YES ASSOCIATED PROTEIN#0.6154;SEX CHROMOSOME#0.6153;PRIMITIVE STREAK FORMATION#0.6145;DIPEPTIDYL PEPTIDASE#0.6144;METAPLASTIC CARCINOMA#0.6143;IB-MECA#0.6142;SINGLE NUCLEOTIDE VARIANTS#0.6141;HUMAN DERMAL FIBROBLAST#0.6125;GTPASE ACTIVITY#0.6125;GLYCOGEN SYNTHASE ACTIVITY#0.6123;NEURAL RETINA#0.6122;ORGAN DEVELOPMENT#0.6121;TYPE 1 DIABETES#0.6119;ALPHA 1-ANTITRYPSIN#0.6112;DNA COPY NUMBER#0.6109;OSTEOBLAST DEVELOPMENT#0.6104;SEPTUM#0.6100;DEATH RECEPTOR-MEDIATED APOPTOSIS#0.6092;CELL ASSOCIATED#0.6085;FLUORESCEIN#0.6085;ALVEOLOGENESIS#0.6081;ADVANCED GLYCATION END#0.6080;HEMANGIOMA#0.6080;SORAFENIB#0.6073;AUTISM SPECTRUM DISORDER#0.6070;NEURONAL CELL DEATH#0.6065;CELL COUNTING KIT#0.6063;MESENCHYMAL TO EPITHELIAL TRANSITION#0.6058;CHOLINE#0.6053;NERVE FIBER#0.6045;ACTIN FILAMENT ORGANIZATION#0.6033;GLUTAMATE RECEPTOR#0.6030;PROTEIN COMPLEX FORMATION#0.6028;LOCKED NUCLEIC ACID#0.6027;ATP BINDING#0.6027;MYOGENIC REGULATORY FACTOR#0.6026;VACUOLE FUSION#0.6026;EAR DEVELOPMENT#0.6022;ANTISENSE MORPHOLINO OLIGONUCLEOTIDE#0.6020;TASTE BUD#0.6019;SKIN DEVELOPMENT#0.6019;VITAMIN C BIOSYNTHESIS#0.6015;VSMC APOPTOSIS#0.6014;PAPILLARY ADENOCARCINOMA#0.6014;SERUM ALBUMIN#0.6013;CANINE MAMMARY TUMORS#0.6008
14	ENDOTHELIAL CELL#1.0547;CELL MIGRATION#0.8953;CANCER CELL#0.8713;ANGIOGENESIS#0.7390;SMOOTH MUSCLE CELL#0.7388;MUSCLE CELL#0.7379;SMOOTH MUSCLE#0.7366;TUBE FORMATION#0.6713;ENDOTHELIAL CELL MIGRATION#0.6649;BREAST CANCER CELL#0.6621;BREAST CANCER#0.6579;MUSCLE FIBER#0.6075;NF-KAPPAB ACTIVATION#0.6072;VASCULAR ENDOTHELIAL CELL#0.6051
150000	ABC TRANSPORTER#0.7981
150084	JUNCTIONAL ADHESION MOLECULE#1.0507;CELL ADHESION#0.9249;EPITHELIAL CELL#0.9209;GROWTH FACTOR#0.8511;TIGHT JUNCTION#0.8504;CELL ADHESION MOLECULE#0.8265;SLIT DIAPHRAGM#0.7775;INTESTINAL EPITHELIAL CELL#0.6862;HEPATOCYTE GROWTH FACTOR#0.6846;HEMATOPOIETIC CELL#0.6250;GERM CELL#0.6247;PROGENITOR CELL#0.6194;STEM CELL#0.6145
150094	SALT INDUCIBLE KINASE#1.0601;CANCER CELL#1.0283;PROTEIN KINASE#1.0221;CAMP RESPONSE ELEMENT#1.0188;SIGNALING PATHWAY#1.0183;GENE EXPRESSION#1.0128;TRANSCRIPTION FACTOR#1.0097;CAMP RESPONSE ELEMENT BINDING#0.9850;CYTOPLASM#0.9542;HISTONE DEACETYLASE#0.9493;TRANSCRIPTION COACTIVATOR#0.9309;ADRENAL GLAND#0.9250;KINASE ACTIVITY#0.8862;FATTY LIVER#0.8810;ATPASE ACTIVITY#0.8809;CAMP SIGNALING#0.8681;CRE BINDING#0.8526;TUMOR SUPPRESSOR#0.8484;NUCLEAR EXPORT#0.8314;SODIUM TRANSPORT#0.8174;PROTEIN KINASE A#0.8077;KINASE INHIBITOR#0.7949;TUMOR CELLS#0.7768;CATALYTIC ACTIVITY#0.7697;GROWTH FACTOR#0.7693;CELL CYCLE#0.7632;APOPTOSIS#0.7613;STEROIDOGENESIS#0.7605;DEPHOSPHORYLATION#0.7593;MACROPHAGE#0.7556;CELL PROLIFERATION#0.7473;TYPE 2 DIABETES#0.7471;STAUROSPORINE#0.7470;FORSKOLIN#0.7444;MUSCLE CELL#0.7154;UBIQUITIN#0.7120;PLASMA MEMBRANE#0.7119;DENDRITE SELF-AVOIDANCE#0.7008;PINEAL GLAND#0.6945;SKELETAL MUSCLE#0.6878;ADRENOCORTICOTROPIC HORMONE#0.6849;LUNG CANCER#0.6812;TRANSFORMING GROWTH FACTOR#0.6618;GLUCONEOGENESIS#0.6451;GLUCOSE METABOLISM#0.6398;LIPOGENESIS#0.6387;SMOOTH MUSCLE#0.6351;EPITHELIAL MESENCHYMAL TRANSITION#0.6159;VASCULAR SMOOTH MUSCLE CELL#0.6153;SMOOTH MUSCLE CELL#0.6124;BREAST CANCER#0.6103;STEM CELL#0.6091;IL-10 PRODUCTION#0.6079;ALCOHOLIC FATTY LIVER#0.6034;PRECURSOR CELL#0.6029;INSULIN SECRETION#0.6008
1500	CADHERIN BINDING#1.0770;JUXTAMEMBRANE#1.0578;VASCULAR ENDOTHELIAL CADHERIN#1.0447;CELL MOTILITY#1.0399;LUNG CANCER#1.0321;ENDOCYTOSIS#1.0303;SQUAMOUS CELL CARCINOMA#1.0274;INFLAMMATORY RESPONSE#1.0261;CELL MEMBRANE#1.0249;CYTOPLASM#1.0207;CELL CELL JUNCTION#1.0204;PROTEIN KINASE C#1.0157;CELL SURFACE#1.0148;PANCREATIC CANCER#1.0141;PLASMA MEMBRANE#1.0139;GROWTH FACTOR RECEPTOR#1.0126;CATENIN COMPLEX#1.0121;CELL JUNCTION#1.0104;TRANSCRIPTION FACTOR#1.0089;PROTEIN KINASE#1.0079;LYMPH NODE#1.0072;LYMPH NODE METASTASIS#1.0066;ADHERENS JUNCTION#1.0059;ADENOCARCINOMA#1.0026;CELL PROLIFERATION#1.0017;FOCAL ADHESION#1.0014;TIGHT JUNCTION#0.9978;CELL CELL ADHESION#0.9966;ACTIN CYTOSKELETON#0.9966;ENDOTHELIAL CELL#0.9953;CELL MIGRATION#0.9947;BREAST CANCER#0.9942;GROWTH FACTOR#0.9940;EPIDERMAL GROWTH FACTOR#0.9940;DEPHOSPHORYLATION#0.9940;SIGNALING PATHWAY#0.9940;CANCER CELL#0.9913;SRC FAMILY KINASE#0.9905;CELL ADHESION#0.9878;MICROTUBULE#0.9860;INTERCELLULAR JUNCTION#0.9842;EPITHELIAL CELL#0.9840;KINASE ACTIVITY#0.9820;HEPATOCELLULAR CARCINOMA#0.9794;PROTEIN TYROSINE KINASE#0.9788;CELL ADHESION MOLECULE#0.9769;TUMOR CELLS#0.9738;SIGNAL TRANSDUCTION#0.9733;CELL GROWTH#0.9722;BREAST CANCER CELL#0.9711;KERATINOCYTE#0.9708;TUMOR SUPPRESSOR#0.9649;CELL CYCLE#0.9609;GENE EXPRESSION#0.9607;DESMOSOME#0.9604;EPITHELIAL TO MESENCHYMAL#0.9603;APOPTOSIS#0.9577;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9576;PROTEIN COMPLEX#0.9554;MORPHOGENESIS#0.9545;EPITHELIAL MESENCHYMAL TRANSITION#0.9513;GTPASE ACTIVITY#0.9449;T CELL#0.9394;PANCREATIC CARCINOMA#0.9389;BRONCHIAL EPITHELIAL CELLS#0.9360;CELLULAR LOCALIZATION#0.9358;ONCOGENIC#0.9340;COLORECTAL#0.9192;POLYMERASE CHAIN REACTION#0.9142;RECEPTOR TYROSINE KINASE#0.9061;PROSTATE CANCER#0.9051;ACTIN FILAMENT#0.9028;PROTEIN TYROSINE PHOSPHATASE#0.8846;KINASE INHIBITOR#0.8807;COLON CANCER#0.8765;BREAST CARCINOMA#0.8735;HUMAN BRONCHIAL EPITHELIAL#0.8707;NEUTROPHIL#0.8704;HUMAN UMBILICAL VEIN#0.8652;UMBILICAL VEIN#0.8650;EPITHELIAL TISSUES#0.8633;INVASIVE LOBULAR CARCINOMA#0.8583;CELL-CELL ADHESION MOLECULE#0.8578;LUNG SQUAMOUS CELL CARCINOMA#0.8555;COLORECTAL CANCER#0.8478;ENDOTHELIUM#0.8403;FOCAL ADHESION KINASE#0.8287;NEURAL CREST#0.8244;LYMPH NODE METASTASES#0.8227;HUMAN CORNEAL ENDOTHELIAL#0.8158;PROTEIN PROTEIN INTERACTION#0.8128;MACROPHAGE#0.8126;COMPLEX I#0.8091;LOBULAR NEOPLASIA#0.8064;OVARIAN CANCER#0.7925;SALIVARY GLAND#0.7916;CELL POLARITY#0.7899;OVARIAN#0.7890;NUCLEAR EXPORT#0.7879;MICROVASCULAR ENDOTHELIAL CELL#0.7866;ANGIOGENESIS#0.7837;SMOOTH MUSCLE#0.7816;STEM CELL#0.7806;CONTACT INHIBITION#0.7787;DNA BINDING#0.7779;ZONULA ADHERENS#0.7690;ANOIKIS#0.7653;NEURAL CREST CELL#0.7621;WOUND HEALING#0.7618;CELL AGGREGATION#0.7510;ADENOMATOUS POLYPOSIS COLI#0.7488;MESENCHYMAL CELL#0.7468;HEPATOCELLULAR CARCINOMA CELL#0.7458;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7449;NUCLEAR IMPORT#0.7440;HODGKIN'S LYMPHOMA#0.7432;EXTRACELLULAR MATRIX#0.7366;INVASIVE DUCTAL CARCINOMA#0.7325;STRESS FIBER#0.7297;ORAL SQUAMOUS CELL CARCINOMA#0.7280;COLON CARCINOMA#0.7280;PLATELET-DERIVED GROWTH FACTOR#0.7249;TIGHT JUNCTION PROTEIN#0.7233;CELL DIFFERENTIATION#0.7226;CARDIOMYOCYTE#0.7224;SCHWANN CELL#0.7220;ENDOTHELIAL GROWTH FACTOR#0.7215;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7215;ULCERATIVE COLITIS#0.7203;ESTROGEN RECEPTOR#0.7158;NERVOUS SYSTEM#0.7052;CELL ADHESION COMPLEX#0.7031;RNA INTERFERENCE#0.7003;SYNAPSE DEVELOPMENT#0.6889;GASTRULATION#0.6877;LUNG ADENOCARCINOMA#0.6868;PROSTATE CARCINOMA#0.6839;LIPID RAFT#0.6821;PROTEIN KINASE ACTIVITY#0.6783;PKC ACTIVATION#0.6783;LOBULAR BREAST CANCER#0.6775;SYNAPTIC VESICLE#0.6741;MUSCLE CELL#0.6740;BASAL CELL#0.6729;REVERSE TRANSCRIPTION#0.6716;ACINAR CELL#0.6699;MITOSIS#0.6634;ARTERY#0.6605;BLOOD BRAIN BARRIER#0.6569;CENTRAL NERVOUS SYSTEM#0.6534;PULMONARY SCLEROSING HEMANGIOMA#0.6507;NEURITE#0.6487;LEUKOCYTE#0.6418;SCLEROSING HEMANGIOMA#0.6373;GLUTATHIONE#0.6284;T LYMPHOCYTE#0.6213;TRANSLATION INITIATION#0.6195;VASCULAR ENDOTHELIAL CELL#0.6180;TUMOR TISSUES#0.6175;GERM CELL#0.6174;SPECTRIN#0.6169;CELL PERIPHERY#0.6121;CLATHRIN-DEPENDENT ENDOCYTOSIS#0.6092;ALANINE#0.6074;RESPONSE TO ENDOTOXIN#0.6049;CONTACT SITE#0.6037
150142	NEURONAL CELLS#0.9083;BONE MORPHOGENETIC PROTEIN#0.9064;STEM CELL#0.8966
150159	PLASMA MEMBRANE#1.0404;SPERM MOTILITY#0.6348;DNA METHYLATION#0.6238
1501	GENE EXPRESSION#0.9356;CELL ADHESION#0.8481;INTELLECTUAL DISABILITY#0.7858;PROSTATE CANCER#0.6425
150209	APOPTOSIS INDUCING FACTOR#1.0941;APOPTOSIS#0.9790;LYMPH NODE METASTASIS#0.6238;LYMPH NODE#0.6170;BREAST CANCER#0.6148
150244	COLORECTAL CANCER#0.9014;COLORECTAL#0.6458
150274	ATPASE ACTIVITY#1.0626;IRON SULFUR CLUSTER#1.0524;CHLOROPLAST#0.9335;IRON-SULFUR CLUSTER ASSEMBLY#0.9275;MITOCHONDRIA#0.8671;FERREDOXIN#0.8280;CYSTEINE DESULFURASE#0.6925;MITOCHONDRIAL MATRIX#0.6786;IRON HOMEOSTASIS#0.6358;RNA INTERFERENCE#0.6152;ATP HYDROLYSIS#0.6133
150280	LUNG CANCER#0.8612;OOCYTE#0.6797;MEIOSIS#0.6386
150290	DUAL SPECIFICITY PHOSPHATASE#0.9092;PHOSPHATASE ACTIVITY#0.6786;PROTEIN TYROSINE PHOSPHATASE#0.6011
150353	PERIODONTAL LIGAMENT#1.0648;ORAL SQUAMOUS CARCINOMA#1.0518;ORAL CANCER CELL#1.0428;APOPTOSIS#1.0078;CELL MIGRATION#1.0078;CYTOTOXICITY#1.0027;CANCER CELL#1.0005;CELL GROWTH#0.9989;CELL PROLIFERATION#0.9948;ORAL SQUAMOUS CELL CARCINOMA#0.9886;SQUAMOUS CELL CARCINOMA#0.9828;APOPTOTIC#0.9790;GROWTH FACTOR#0.9778;TUMOR CELLS#0.9752;CELL DEATH#0.9708;EPITHELIAL CELL#0.9703;CELL CYCLE#0.9676;KERATINOCYTE#0.9614;GENE EXPRESSION#0.9567;EPIDERMAL GROWTH FACTOR#0.9546;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9507;TONGUE CANCER#0.9431;POLYMERASE CHAIN REACTION#0.9315;TONGUE SQUAMOUS CELL CARCINOMA#0.9117;GROWTH FACTOR RECEPTOR#0.9095;SIGNALING PATHWAY#0.9081;HEAD AND NECK CANCER#0.8944;NECK CANCER#0.8943;WOUND HEALING#0.8880;DNA FRAGMENTATION#0.8776;IMMUNE CELL#0.8676;CERVICAL#0.8676;CISPLATIN#0.8425;EPITHELIAL MESENCHYMAL TRANSITION#0.8391;LYMPH NODE#0.8348;ENDOTHELIAL CELL#0.8227;ENDOPLASMIC RETICULUM#0.8139;KINASE INHIBITOR#0.7708;SUBMANDIBULAR GLAND#0.7707;EXTRACELLULAR MATRIX#0.7704;INDUCTION OF APOPTOSIS#0.7673;APOPTOTIC CELL DEATH#0.7618;CETUXIMAB#0.7607;REACTIVE OXYGEN SPECIES#0.7592;TRANSCRIPTION FACTOR#0.7477;ENDOTHELIAL GROWTH FACTOR#0.7151;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7151;MYOMA#0.7046;ORAL CAVITY#0.6971;G1 PHASE#0.6942;M PHASE#0.6942;HYPOXIA#0.6903;GEFITINIB#0.6903;BREAST CANCER#0.6880;TOXICITY#0.6870;BASEMENT MEMBRANE#0.6850;ADENOCARCINOMA#0.6714;TUMOR SUPPRESSOR#0.6675;FOCAL ADHESION#0.6601;MITOCHONDRIA#0.6596;CYTOPLASM#0.6453;CELL ADHESION#0.6318;ANGIOGENESIS#0.6292;CYTOCHROME C#0.6273;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6241;MITOCHONDRIAL MEMBRANE#0.6228;STROMAL CELL#0.6220;TRANSCRIPTASE#0.6130;CELL CYCLE ARREST#0.6004
150356	CHONDROCYTE DIFFERENTIATION#0.7403
150365	MICROTUBULE SEVERING#1.1315;MEIOTIC SPINDLE#1.1250;MICROTUBULE SEVERING ACTIVITY#1.0909;MICROTUBULE#1.0893;MEIOSIS#1.0586;MITOSIS#1.0296;SPINDLE FORMATION#0.9978;OOCYTE#0.9856;MITOTIC SPINDLE#0.9044;UBIQUITIN#0.8681;MEIOTIC CHROMOSOME#0.7940;COMPLEX I#0.7871;KATANIN COMPLEX#0.7393;CELL CYCLE#0.7317;SPINDLE POLE#0.7099;DOUBLE STRAND BREAK#0.6760;DNA REPAIR#0.6222;CYTOPLASMIC STREAMING#0.6195
150372	CALCINEURIN-NFAT SIGNALING PATHWAY#0.7017;T CELL#0.6875;BONE MARROW#0.6755;B CELL#0.6624;B CELL DEVELOPMENT#0.6361;CELL DEVELOPMENT#0.6255;BONE RESORPTION#0.6248;SIGNALING PATHWAY#0.6137
1503	CTP SYNTHASE#1.0923;CYTIDINE#1.0541;GLUTAMINE#1.0315;PROTEIN KINASE#0.9986;PROTEIN KINASE A#0.9051;STEM CELL#0.8978;CTP SYNTHESIS#0.8829;GLUTAMINASE ACTIVITY#0.8533;CTP SYNTHETASE ACTIVITY#0.8510;INOSINE#0.8343;SYNTHETASE ACTIVITY#0.8338;CTP FORMATION#0.7802;CELL GROWTH#0.7776;CANCER CELL#0.7663;PROTEIN KINASE C#0.7550;URIDINE#0.7491;L-GLUTAMINE#0.7468;T CELL#0.7102;NUCLEOTIDE BIOSYNTHESIS#0.7030;PROTEIN KINASE A ACTIVITY#0.6292;IMP DEHYDROGENASE#0.6256;5-OXO-L-NORLEUCINE#0.6241;SMC PROLIFERATION#0.6177;CATALYTIC ACTIVITY#0.6152;THYMIDYLATE SYNTHASE#0.6044
150468	MITOTIC SPINDLE#0.6906;CELL CYCLE#0.6753;SPINDLE FORMATION#0.6515;BIPOLAR DISORDER#0.6318;LUNG ADENOCARCINOMA#0.6265
150483	SPERMATOZOA#0.9079;PAPILLARY THYROID CANCER#0.6263;SPERM MOTILITY#0.6205;THYROID CANCER#0.6141;CELL PROLIFERATION#0.6002
1504	PANCREATITIS#0.6686;TRYPSIN ACTIVITY#0.6088
150538	IMMUNE CELL#0.7491
150572	HISTONE METHYLTRANSFERASE#1.0992;SKELETAL MUSCLE#1.0722;TRANSCRIPTION FACTOR#1.0225;CARDIAC MUSCLE#1.0178;GENE EXPRESSION#0.9320;MUSCLE CELL#0.9071;LYSINE#0.9062;HEART DEVELOPMENT#0.8957;CARDIOMYOCYTE#0.8884;MYOFIBRIL#0.8492;STRIATED MUSCLE#0.8074;SARCOMERE#0.7956;METHYLTRANSFERASE ACTIVITY#0.7596;MYOGENESIS#0.7128;SARCOMEROGENESIS#0.7075;CARDIAC DEVELOPMENT#0.6838;HISTONE METHYLTRANSFERASE ACTIVITY#0.6621;MYOBLAST DIFFERENTIATION#0.6390;CHROMATIN REMODELING#0.6358;HISTONE DEACETYLASE#0.6310;SERUM RESPONSE FACTOR#0.6268;GROWTH FACTOR#0.6233;MUSCLE CONTRACTION#0.6200;T CELL#0.6114
150677	INNER EAR#1.1209;FIBROCYTE#0.9833;COCHLEA#0.8568;CENTRAL NERVOUS SYSTEM#0.6770;NERVOUS SYSTEM#0.6756;CISPLATIN#0.6335
150678	FLOWER DEVELOPMENT#0.6585
150684	WILSON DISEASE#1.0568;COPPER HOMEOSTASIS#1.0509;CANCER CELL#0.9957;UBIQUITIN#0.9605;APOPTOSIS#0.9450;EXCRETION#0.9347;HYPOXIA#0.9226;GENE EXPRESSION#0.9136;EPITHELIAL CELL#0.8932;SODIUM TRANSPORT#0.8914;TRANSCRIPTION FACTOR#0.8373;COPPER BINDING#0.8309;MYELOID CELL#0.7682;HYPOXIA INDUCIBLE FACTOR#0.7616;CELL SURFACE#0.7371;CELL CYCLE#0.6979;EPITHELIAL SODIUM CHANNEL#0.6972;CELL PROLIFERATION#0.6972;SODIUM CHANNEL#0.6898;COPPER EXPORT#0.6694;INFLAMMATORY RESPONSE#0.6647;PROTEASOME#0.6616;APOPTOTIC#0.6588;POLYMERASE CHAIN REACTION#0.6563;TRANS GOLGI NETWORK MEMBRANE#0.6416;T CELL#0.6110;TRANS GOLGI NETWORK#0.6101;LIVER DISEASE#0.6081
150696	PLASMA MEMBRANE#0.9300;EPITHELIAL CELL#0.8135;BASOLATERAL PLASMA MEMBRANE#0.6579;FERROPTOSIS#0.6475;BASAL PLASMA MEMBRANE#0.6332;CAVEOLAE#0.6320;CANCER CELL#0.6287;FLUID-PHASE ENDOCYTOSIS#0.6217;CHOLESTEROL BINDING#0.6081
1506	CARFILZOMIB#1.0295;GRANULOCYTE#1.0257;MAST CELL#1.0181;PROSTATE SPECIFIC ANTIGEN#1.0166;26S PROTEASOME#1.0142;PROTEASOME#1.0121;ESTERASE ACTIVITY#1.0117;MULTICATALYTIC PROTEINASE#1.0111;NEUTROPHIL#1.0102;SECRETORY GRANULE#1.0080;L-PHENYLALANINE#1.0071;20S PROTEASOME#1.0066;PEPTIDASE ACTIVITY#1.0059;CHYMOSTATIN#1.0034;MIDGUT#0.9993;LEUKOCYTE#0.9986;SERINE PROTEASE ACTIVITY#0.9942;PROTEASE ACTIVITY#0.9940;SUBMANDIBULAR GLAND#0.9902;PROTEINASE ACTIVITY#0.9899;BORTEZOMIB#0.9890;ENZYME ACTIVITY#0.9862;PROSTATE CANCER#0.9860;LEUCINE#0.9857;CATALYTIC ACTIVITY#0.9857;SERPIN#0.9828;ARGININE#0.9799;PROTEINASE INHIBITOR#0.9774;COLLAGENASE#0.9768;BREAST CANCER#0.9755;PROTEIN SYNTHESIS#0.9752;MULTIPLE MYELOMA#0.9737;EPITHELIAL CELL#0.9727;L-LYSINE#0.9720;DIGESTION#0.9712;T CELL#0.9707;CELL DEATH#0.9703;LYSINE#0.9698;SKELETAL MUSCLE#0.9687;APOPTOTIC#0.9678;CANCER CELL#0.9678;UBIQUITIN PROTEASOME PATHWAY#0.9676;MAST CELL GRANULE#0.9667;APOPTOSIS#0.9666;CYTOTOXICITY#0.9659;PROTEASOME PATHWAY#0.9653;DODECYL SULFATE#0.9652;SODIUM DODECYL SULFATE#0.9652;PROTEIN DEGRADATION#0.9645;UBIQUITIN PROTEASOME SYSTEM#0.9627;GENE EXPRESSION#0.9598;CELL CYCLE#0.9585;UBIQUITIN#0.9566;3,4-DICHLOROISOCOUMARIN#0.9538;GROWTH FACTOR#0.9538;POLYMORPHONUCLEAR LEUKOCYTES#0.9537;GLUTATHIONE#0.9498;PROTEIN BREAKDOWN#0.9459;ALANINE#0.9455;CELL SURFACE#0.9452;ALZHEIMER'S DISEASE#0.9435;HEPATITIS C#0.9425;TUMOR CELLS#0.9419;CELL GROWTH#0.9412;APROTININ#0.9404;HEPATITIS C VIRUS#0.9399;CELL PROLIFERATION#0.9392;ETHANOL#0.9391;TOXICITY#0.9375;ENDOPLASMIC RETICULUM#0.9342;HYDROLASE ACTIVITY#0.9339;DIISOPROPYL FLUOROPHOSPHATE#0.9311;HEPARIN#0.9297;PERIPHERAL BLOOD#0.9251;REACTIVE OXYGEN SPECIES#0.9248;MACROPHAGE#0.9228;FIBRINOGEN#0.9183;PROTEASE COMPLEX#0.9159;VIRULENCE#0.9137;SPERMATOZOA#0.9137;POLYMERASE CHAIN REACTION#0.9135;ACROSOME REACTION#0.9128;CHYMASE ACTIVITY#0.9126;BREAST CANCER CELL#0.9117;PROTEASE S#0.9099;CONNECTIVE TISSUE#0.9082;FERTILIZATION#0.9052;DEXAMETHASONE#0.9044;TRANSCRIPTION FACTOR#0.9037;ENZYME INHIBITOR#0.9023;APOPTOTIC CELL DEATH#0.9020;HUMAN TISSUE KALLIKREIN#0.9013;INDUCTION OF APOPTOSIS#0.8960;OUTER MEMBRANE#0.8954;PLASMA MEMBRANE#0.8944;MEMBRANE FRACTION#0.8942;INFLAMMATORY RESPONSE#0.8923;PROTEIN KINASE#0.8921;IMMUNE RESPONSE#0.8879;SEMINAL PLASMA#0.8861;L-TYROSINE#0.8819;SEVERE ACUTE RESPIRATORY SYNDROME#0.8809;QUERCETIN#0.8733;MUTAGENESIS#0.8689;COMPLEX I#0.8618;HEAT SHOCK PROTEIN#0.8608;ERYTHROCYTE#0.8592;PROTEASOME COMPLEX#0.8586;SQUAMOUS CELL CARCINOMA#0.8566;ACROSOME#0.8544;ALPHA 1-ANTITRYPSIN#0.8522;TRYPTOPHAN#0.8510;MECHANISM OF ACTION#0.8483;ANGIOGENESIS#0.8470;ALKALINE PHOSPHATASE#0.8461;HISTAMINE#0.8442;EXTRACELLULAR MATRIX#0.8414;COAGULATION#0.8397;VIRAL REPLICATION#0.8374;ALPHA-2 MACROGLOBULIN#0.8372;TUMOR NECROSIS FACTOR#0.8352;MECHANISMS OF ACTION#0.8334;MUSCLE ATROPHY#0.8330;ANGIOTENSIN CONVERTING ENZYME#0.8324;KERATINOCYTE#0.8306;HISTIDINE#0.8305;ENDOTHELIAL CELL#0.8279;HUMAN BREAST CANCER#0.8272;MUSCLE WASTING#0.8270;T LYMPHOCYTE#0.8229;SUBSTANCE P#0.8188;STRUCTURE ACTIVITY RELATIONSHIP#0.8140;EOSINOPHIL#0.8129;L-ARGININE#0.8128;UNFOLDED PROTEIN RESPONSE#0.8116;PROTEIN DIGESTION#0.8096;POLY ADP RIBOSE#0.8086;BONE MARROW#0.8081;SIGNAL PEPTIDE#0.8073;SIGNALING PATHWAY#0.8071;MULTIPLE MYELOMA CELLS#0.8029;PEPTIDE HYDROLASE ACTIVITY#0.8015;OVARIAN#0.7950;ALKALINE PROTEASE#0.7945;DNA FRAGMENTATION#0.7923;SALIVARY GLAND#0.7906;DIPEPTIDYL PEPTIDASE#0.7810;SODIUM DODECYL SULPHATE#0.7795;MOLAR#0.7764;AUTOPHAGY#0.7747;IFN-GAMMA#0.7743;RITONAVIR#0.7720;ENZYME COMPLEX#0.7705;MONOCYTE#0.7647;COLON CANCER#0.7596;SUPEROXIDE DISMUTASE#0.7593;RIBOSE#0.7579;CYTOPLASM#0.7552;PARKINSON'S DISEASE#0.7538;BASEMENT MEMBRANE#0.7536;N-ETHYLMALEIMIDE#0.7468;B CELL#0.7446;NATURAL KILLER CELL#0.7426;MITOCHONDRIAL MEMBRANE#0.7419;CELL CYCLE ARREST#0.7407;EPIGALLOCATECHIN#0.7401;MONONUCLEAR CELLS#0.7390;SIGNAL TRANSDUCTION#0.7385;CARDIOMYOCYTE#0.7350;PERIODONTITIS#0.7330;LYSIS#0.7307;SEMEN#0.7296;PERIODONTAL DISEASE#0.7255;AMYLOID PRECURSOR PROTEIN#0.7211;INFLAMMATORY CELL#0.7188;PROTEOGLYCAN#0.7187;OOCYTE#0.7174;INSULIN-LIKE GROWTH FACTOR#0.7173;TUMOR SUPPRESSOR#0.7167;METHIONINE#0.7125;UROKINASE#0.7119;CELL ASSOCIATED#0.7106;NITRIC OXIDE#0.7029;GLYCINE#0.7005;CASPASE INHIBITOR#0.7003;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6964;FIBRINOLYSIS#0.6962;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6940;CALPAIN ACTIVITY#0.6938;PEPSTATIN#0.6901;ANTIGEN PRESENTATION#0.6898;ISCHEMIA#0.6883;VELCADE#0.6877;CATABOLISM#0.6853;RNA INTERFERENCE#0.6814;COLORECTAL#0.6810;OVARIAN CANCER#0.6804;IMMUNE SYSTEM#0.6789;MITOCHONDRIA#0.6711;CROSS SECTIONAL AREA#0.6709;GLUTATHIONE PEROXIDASE#0.6708;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6706;ANTIGEN PROCESSING#0.6657;GLUTAMINE#0.6636;ASPARTIC ACID#0.6632;CARBOXYPEPTIDASE A#0.6560;PROTEIN CATABOLISM#0.6546;ALPHA-1-PROTEINASE INHIBITOR#0.6531;1,10-PHENANTHROLINE#0.6507;LARVAL DEVELOPMENT#0.6410;PROTEIN QUALITY CONTROL#0.6400;AZUROPHIL GRANULE#0.6398;CYTOCHROME C#0.6395;TRANSFORMING GROWTH FACTOR#0.6377;PROTEIN METABOLISM#0.6375;PROTEINASE A#0.6368;NEUTROPHIL GRANULOCYTES#0.6329;IONOPHORE#0.6311;CYTOTOXIC T-LYMPHOCYTE#0.6304;AMYOTROPHIC LATERAL SCLEROSIS#0.6300;LATERAL SCLEROSIS#0.6300;NEURODEGENERATIVE DISEASE#0.6289;BLOOD COAGULATION#0.6270;SMALL INTESTINE#0.6236;CHYMOTRYPSIN ACTIVITY#0.6214;CELL MIGRATION#0.6198;COLORECTAL CANCER#0.6196;RNA HELICASE#0.6190;ALLERGEN#0.6149;TISSUE DAMAGE#0.6132;CASPASE ACTIVATION#0.6122;EGG ACTIVATION#0.6086;LENALIDOMIDE#0.6059;LYSOSOME#0.6047;FARNESYLTRANSFERASE ACTIVITY#0.6045;PROTEIN OXIDATION#0.6037
150726	NEURONAL MIGRATION#0.6876;PARKINSON'S DISEASE#0.6012
150737	IFT B COMPLEX#0.9435;INTRAFLAGELLAR TRANSPORT#0.6059
150763	GERM CELL#0.8446;MITOCHONDRIAL OUTER MEMBRANE#0.8077;OUTER MEMBRANE#0.7985;SPERMATOGENESIS#0.7496;ENDOPLASMIC RETICULUM#0.6880;APOPTOSIS#0.6665;ARACHIDONIC ACID#0.6456
1508	ANDROID#1.0505;CYSTEINE PROTEASE ACTIVITY#1.0487;NITROXOLINE#1.0486;EXOPEPTIDASE ACTIVITY#1.0473;PYROGENIC#1.0472;CATHEPSIN B ACTIVITY#1.0424;TRYPSINOGEN ACTIVATION#1.0423;HEMOGLOBIN HYDROLYSIS#1.0416;DIPEPTIDYL PEPTIDASE#1.0298;ZYMOGEN GRANULE#1.0293;BETA GLUCURONIDASE#1.0276;UROKINASE PLASMINOGEN ACTIVATOR#1.0272;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#1.0223;HEMOGLOBIN DEGRADATION#1.0220;BLEOMYCIN#1.0216;SECRETORY GRANULE#1.0207;BETA GALACTOSIDASE#1.0204;LYSOSOMAL MEMBRANE PERMEABILIZATION#1.0204;PROTEASE S#1.0184;CARBOXYPEPTIDASE ACTIVITY#1.0167;ALPHA-2 MACROGLOBULIN#1.0164;LATE ENDOSOME#1.0162;LIGHT CHAIN 3#1.0157;CATHEPSIN H ACTIVITY#1.0145;20S PROTEASOME#1.0127;COLORECTAL CARCINOMA#1.0124;CHONDROCYTE#1.0122;ENDOPEPTIDASE ACTIVITY#1.0122;DIPEPTIDYL PEPTIDASE IV#1.0121;L-PROLINE#1.0111;WEIGHT LOSS#1.0100;CATHEPSIN L ACTIVITY#1.0085;UROKINASE#1.0078;AUTOLYSOSOME#1.0075;THIOL PROTEASE INHIBITOR#1.0075;L-CYSTEINE#1.0071;CHYMOSTATIN#1.0065;ACID PHOSPHATASE#1.0064;CYSTATIN#1.0054;CATHEPSIN D ACTIVITY#1.0053;COLORECTAL CANCER#1.0050;OSTEOCLAST#1.0044;DOXORUBICIN#1.0033;GINGIVAL CREVICULAR FLUID#1.0032;COLLAGENASE#1.0031;OOCYTE#1.0029;SECRETORY VESICLE#1.0022;RANDOMIZED CONTROLLED TRIAL#1.0019;LYSOSOMAL MEMBRANE#1.0016;COLORECTAL#1.0001;GROUP A STREPTOCOCCUS#0.9995;OVARIAN CANCER#0.9989;ETHANOL#0.9989;HEAT SHOCK PROTEIN#0.9984;ALVEOLAR MACROPHAGE#0.9983;SENESCENCE#0.9973;IL-1 SECRETION#0.9971;ALKALINE PHOSPHATASE#0.9966;N-ETHYLMALEIMIDE#0.9961;CYSTIC FIBROSIS#0.9958;COLON CARCINOMA#0.9958;IL-1 PRODUCTION#0.9954;PROTEASE ACTIVITY#0.9951;ALLERGEN#0.9951;MICROTUBULE ASSOCIATED PROTEIN#0.9938;SPINAL CORD#0.9934;HEPATOCELLULAR CARCINOMA#0.9932;MAST CELL#0.9932;PEPSTATIN#0.9931;ACTIVITY BASED PROBES#0.9919;ACINAR CELL#0.9919;APROTININ#0.9918;ACIDIFICATION#0.9917;CHAGAS DISEASE#0.9914;L-ARGININE#0.9909;ASPARAGINE#0.9907;PANCREATIC CANCER#0.9906;MUSCULAR DYSTROPHY#0.9906;NLRP3 INFLAMMASOME ACTIVATION#0.9906;TUMOR TISSUES#0.9902;COLLAGENASE ACTIVITY#0.9893;SYNOVIAL FLUID#0.9890;ANGIOGENESIS#0.9887;METALLOPROTEASE INHIBITOR#0.9887;HUMAN BREAST CANCER#0.9887;AUTOPHAGIC VACUOLE#0.9887;ANTIGEN PROCESSING#0.9886;PROSTATE CANCER#0.9883;CYTOCHROME C RELEASE#0.9881;LYMPH NODE METASTASIS#0.9879;CEREBRAL ISCHEMIA#0.9875;COLON CANCER#0.9873;ASPARTATE#0.9872;KERATINOCYTE#0.9871;PROTEASOME#0.9871;RHEUMATOID ARTHRITIS#0.9866;PROTEOGLYCAN#0.9865;ENDOSOME#0.9865;GENE SILENCING#0.9865;BASEMENT MEMBRANE#0.9861;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9860;C REACTIVE PROTEIN#0.9857;MEMBRANE FRACTION#0.9853;UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR#0.9853;MYOBLAST#0.9851;SUPEROXIDE DISMUTASE#0.9848;HYPOXIA#0.9847;BREAST CANCER CELL#0.9844;CELL MIGRATION#0.9843;YOLK PROTEIN#0.9833;ATHEROSCLEROTIC#0.9832;SERPIN#0.9829;MICROTUBULE#0.9828;LUNG CANCER#0.9828;VALINE#0.9827;PARENCHYMA#0.9827;CHLOROQUINE#0.9827;CYTOCHROME C#0.9825;COLLAGEN DEGRADATION#0.9822;MAMMARY GLAND#0.9821;STRUCTURE ACTIVITY RELATIONSHIP#0.9820;LUNG CARCINOMA#0.9819;OVARIAN#0.9818;CASPASE ACTIVATION#0.9818;SALIVARY GLAND#0.9816;ALPHA 1-ANTITRYPSIN#0.9814;LYSINE#0.9812;APOPTOSIS INDUCING FACTOR#0.9811;PANCREATITIS#0.9810;BREAST CARCINOMA#0.9808;VIRAL REPLICATION#0.9806;PROTEASE INHIBITOR ACTIVITY#0.9805;INSULIN-LIKE GROWTH FACTOR#0.9805;CONNECTIVE TISSUE#0.9804;ADENOCARCINOMA#0.9803;PROTEIN KINASE C#0.9803;SMOOTH MUSCLE CELL#0.9802;PERIODONTITIS#0.9799;SECRETORY PATHWAY#0.9799;MITOGEN ACTIVATED PROTEIN#0.9797;PROTEIN BREAKDOWN#0.9795;LYSOSOME#0.9792;MIDGUT#0.9791;AUTOPHAGOSOME#0.9789;BONE RESORPTION#0.9788;LEUKOCYTE#0.9787;BREAST CANCER#0.9787;ASPARTIC ACID#0.9786;UBIQUITIN#0.9786;1,10-PHENANTHROLINE#0.9779;FIBRINOGEN#0.9775;HISTIDINE#0.9774;CHROMAFFIN GRANULE#0.9773;CELLULAR LOCALIZATION#0.9772;DIPEPTIDYL CARBOXYPEPTIDASE ACTIVITY#0.9772;POLY ADP RIBOSE#0.9769;ASTROCYTE#0.9768;PROTEINASE ACTIVITY#0.9767;LECTIN#0.9765;MITOCHONDRIAL MEMBRANE#0.9764;T LYMPHOCYTE#0.9762;SQUAMOUS CELL CARCINOMA#0.9761;STROMAL CELL#0.9760;RECEPTOR ANTAGONIST#0.9760;MODE OF ACTION#0.9760;SMOOTH MUSCLE#0.9755;NEUTROPHIL#0.9754;ANTIGEN PRESENTATION#0.9753;IFN-GAMMA#0.9752;TRANSFORMING GROWTH FACTOR#0.9751;TUMOR CELLS#0.9750;LEUCINE#0.9748;AORTIC ANEURYSM#0.9748;RNA INTERFERENCE#0.9747;REVERSE TRANSCRIPTION#0.9745;CELL ADHESION#0.9742;CASPASE INHIBITOR#0.9741;OSTEOARTHRITIS#0.9741;CEREBRAL CORTEX#0.9740;DNA FRAGMENTATION#0.9739;VACUOLE#0.9739;LYMPH NODE#0.9737;HYPERTENSION#0.9736;HYPERAMYLASEMIA#0.9736;NECROTIC#0.9735;ACUTE PANCREATITIS#0.9732;AUTOPHAGY#0.9731;MUSCLE CELL#0.9730;ARGININE#0.9730;CATALYTIC ACTIVITY#0.9730;AMYLOID PRECURSOR PROTEIN#0.9729;CELL DIFFERENTIATION#0.9727;PEPTIDASE ACTIVITY#0.9726;MONONUCLEAR CELLS#0.9725;ISCHEMIA#0.9724;CELL MEMBRANE#0.9722;GLUTATHIONE#0.9720;RIBOSE#0.9720;ENDOTHELIAL CELL#0.9718;MECHANISM OF ACTION#0.9718;MALARIA#0.9717;CYCLIC AMP#0.9716;INFLAMMATORY CELL#0.9716;IMMUNE EVASION#0.9715;BIOTIN#0.9714;EXTRACELLULAR MATRIX COMPONENT#0.9712;ENZYME INHIBITOR#0.9709;MALATE DEHYDROGENASE#0.9708;GERMINATION#0.9707;MONOCYTE#0.9705;EXCRETION#0.9704;APOPTOSIS#0.9703;SKELETAL MUSCLE#0.9702;ATHEROSCLEROSIS#0.9701;B CELL#0.9701;MITOCHONDRIA#0.9700;SODIUM DODECYL SULFATE#0.9700;ALANINE#0.9699;PLASMA MEMBRANE#0.9698;ENDOCYTOSIS#0.9698;ERYTHROCYTE#0.9697;CASPASE-3 ACTIVITY#0.9695;DODECYL SULFATE#0.9695;MACROPHAGE#0.9691;PROGRAMMED CELL DEATH#0.9690;IMMUNOGLOBULIN G#0.9690;CATABOLISM#0.9690;NEUROTOXICITY#0.9689;PROTEIN DEGRADATION#0.9688;CELL WALL#0.9687;RIBOSOMAL PROTEIN#0.9685;NEURONAL CELL DEATH#0.9685;IMMUNE CELL#0.9684;EXTRACELLULAR MATRIX#0.9677;VIRULENCE#0.9677;NITRIC OXIDE#0.9676;GLYCOSYLATION#0.9674;TYPE 2 DIABETES#0.9673;DIGESTION#0.9673;SCHISTOSOMIASIS#0.9672;REACTIVE OXYGEN SPECIES#0.9672;SPINAL CORD INJURY#0.9671;PHAGOCYTOSIS#0.9669;PROTEIN KINASE#0.9668;QUANTITATIVE REAL TIME#0.9668;PROTEINASE INHIBITOR#0.9667;SIGNAL PEPTIDE#0.9665;HOST CELL#0.9664;GLYCINE#0.9664;SERINE PROTEASE ACTIVITY#0.9662;NEUROBLASTOMA#0.9662;CAVEOLAE#0.9661;FIBRIL#0.9661;CALPAIN ACTIVITY#0.9660;CELL CYCLE#0.9659;ANTIGEN PRESENTING CELLS#0.9658;GROWTH FACTOR#0.9655;APOPTOTIC CELL DEATH#0.9654;EXOCYTOSIS#0.9652;SERUM ALBUMIN#0.9651;CYTOPLASM#0.9651;SIGNAL TRANSDUCTION#0.9650;PERIPHERAL BLOOD#0.9650;CELL DEATH#0.9650;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9650;CONJUGATION#0.9647;MOLAR#0.9647;TUMOR NECROSIS FACTOR#0.9646;TRAUMATIC BRAIN INJURY#0.9645;GLUTAMINE#0.9644;DEATH RECEPTOR#0.9639;CANCER CELL#0.9639;HEMOCYTE#0.9636;CELL PROLIFERATION#0.9635;DENDRITIC CELL#0.9635;OSTEOPOROSIS#0.9635;PARATHYROID#0.9632;CELL SURFACE#0.9632;CD4+ T CELL#0.9630;TRANSCRIPTION FACTOR#0.9629;HEPATOCYTE APOPTOSIS#0.9628;ENZYME ACTIVITY#0.9627;AMINOPEPTIDASE ACTIVITY#0.9626;EXTRACELLULAR SPACE#0.9622;POLYMERASE CHAIN REACTION#0.9622;OSTEOBLAST#0.9622;SUCROSE#0.9622;HEALTH CARE PROVIDER#0.9621;APOPTOTIC#0.9621;C-LEVEL#0.9620;BREAST CANCER PATIENTS#0.9619;CENTRAL NERVOUS SYSTEM#0.9618;DEMENTIA#0.9618;T CELL#0.9615;INNATE IMMUNITY#0.9615;HEPATOMA CELLS#0.9613;EPITHELIAL CELL#0.9613;DNA BINDING#0.9612;SKIN FIBROBLASTS#0.9607;LUNG ADENOCARCINOMA#0.9606;EDEMA#0.9605;ENDOPLASMIC RETICULUM#0.9604;PRO-INFLAMMATORY#0.9604;LEAF SENESCENCE#0.9602;MOLECULAR DYNAMICS SIMULATION#0.9600;LYSOSOMAL PROTEOLYSIS#0.9600;CELL ACTIVATION#0.9599;IMMUNE SYSTEM#0.9594;METHIONINE#0.9591;3-METHYLADENINE#0.9591;LOW DENSITY LIPOPROTEIN#0.9589;CYTOTOXICITY#0.9589;ARTERY#0.9582;NECROTIC CELL DEATH#0.9580;NERVOUS SYSTEM#0.9580;ALKALINE PROTEASE#0.9579;SIGNALING MOLECULE#0.9578;WOUND HEALING#0.9578;SPECTRIN#0.9577;ALZHEIMER'S DISEASE#0.9576;MUTAGENESIS#0.9576;PARATHYROID HORMONE#0.9576;INDUCTION OF APOPTOSIS#0.9573;OVARIAN CARCINOMA#0.9568;INFLAMMATORY RESPONSE#0.9566;CITRULLINE#0.9566;CISPLATIN#0.9565;IMMUNE RESPONSE#0.9565;NEURODEGENERATIVE DISEASE#0.9561;ORGANELLE#0.9560;SOLUBLE FRACTION#0.9560;TOLL LIKE RECEPTOR#0.9559;CELL GROWTH#0.9558;CELL ASSOCIATED#0.9558;L-LYSINE#0.9558;TISSUE DAMAGE#0.9556;LUNG DISEASE#0.9556;HEPARIN#0.9554;PROTEIN SYNTHESIS#0.9551;SIGNALING PATHWAY#0.9549;BONE MARROW#0.9545;RAPAMYCIN#0.9543;STEM CELL#0.9540;MONOCYTE DERIVED MACROPHAGE#0.9538;TRANSMISSION ELECTRON MICROSCOPY#0.9537;GLIAL CELL#0.9537;HYDROXYPROLINE#0.9535;GLUTATHIONE PEROXIDASE#0.9535;EPIDERMAL GROWTH FACTOR#0.9535;CELL CYCLE ARREST#0.9534;LEISHMANIASIS#0.9530;HYALURONIC ACID#0.9529;PHOSPHOLIPASE A2#0.9526;GENE EXPRESSION#0.9522;CYTOKINE PRODUCTION#0.9518;SENSITIZATION#0.9517;DEUBIQUITINATING ENZYME#0.9515;MULTIPLE SCLEROSIS#0.9515;PROTEASE ACTIVATED RECEPTOR#0.9513;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9511;ENDOTHELIAL GROWTH FACTOR#0.9510;SPUTUM#0.9508;CEREBRAL ARTERY#0.9507;TOXICITY#0.9502;SMALL INTESTINE#0.9498;PARKINSON'S DISEASE#0.9492;MIDDLE CEREBRAL ARTERY#0.9490;TUMOR SUPPRESSOR#0.9489;MYOCARDIAL INFARCTION#0.9487;GLYCERALDEHYDE-3-PHOSPHATE#0.9485;BLOOD BRAIN BARRIER#0.9483;STROMA#0.9482;LYSOSOME MEMBRANE#0.9478;COLLAGEN TYPE I#0.9477;AUTOLYSIS#0.9476;INNATE IMMUNE RESPONSE#0.9473;TRANSCRIPTASE#0.9467;NEURITE#0.9451;GLOMERULAR FILTRATION#0.9447;PROTEIN CATABOLISM#0.9446;GRANULOCYTE#0.9443;PLASMA PROTEIN#0.9438;TARGET OF RAPAMYCIN#0.9437;PYROPTOSIS#0.9437;ABDOMINAL AORTIC ANEURYSM#0.9432;METAMORPHOSIS#0.9431;VIRAL INFECTION#0.9430;PHAGOSOME#0.9429;NERVE GROWTH FACTOR#0.9428;DEXAMETHASONE#0.9428;RED BLOOD CELL#0.9425;DIABETES MELLITUS#0.9423;COGNITIVE BEHAVIORAL THERAPY#0.9416;TRYPANOSOMIASIS#0.9412;PHOSPHATIDYLSERINE#0.9409;CASPASE-INDEPENDENT CELL DEATH#0.9409;NEUROTOXIC#0.9405;T CELL PROLIFERATION#0.9402;AMYLOID PROTEIN#0.9399;RECEPTOR BINDING#0.9397;FACTOR I#0.9393;LASER DESORPTION IONIZATION#0.9392;NEURONAL CELLS#0.9391;ROS GENERATION#0.9388;TIGHT JUNCTION#0.9382;CYTOTOXIC T-LYMPHOCYTE#0.9379;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9378;COAGULATION#0.9377;CYCLOSPORIN A#0.9375;AUTOPHAGOSOME FORMATION#0.9374;AUTOIMMUNE DISEASE#0.9372;BLOOD VESSEL#0.9372;GOLGI APPARATUS#0.9368;GLUTAMIC ACID#0.9364;TRYPTOPHAN#0.9364;INTESTINAL EPITHELIAL CELL#0.9361;DRUG DELIVERY SYSTEM#0.9345;CERVICAL#0.9340;REGENERATION#0.9321;HEART DISEASE#0.9321;PLATELET AGGREGATION#0.9320;KINASE INHIBITOR#0.9318;ZYMOGEN ACTIVATION#0.9312;GLOMERULAR FILTRATION RATE#0.9312;ALPHA MANNOSIDASE#0.9304;ASTROCYTOMA#0.9294;MICROGLIAL CELL#0.9294;DRUG RESISTANCE#0.9290;VITAMIN E#0.9278;CELL MOTILITY#0.9275;PROTEIN PROCESSING#0.9266;NMDA RECEPTOR#0.9261;EPILEPSY#0.9259;SYNOVIUM#0.9256;SIGNALLING PATHWAY#0.9254;SURFACE PLASMON RESONANCE#0.9245;S PHASE#0.9245;MAP KINASE#0.9236;MYOTUBE#0.9230;C TERMINAL DOMAIN#0.9229;VASCULAR SMOOTH MUSCLE CELL#0.9227;CELL KILLING#0.9222;MECHANISMS OF ACTION#0.9220;IONOPHORE#0.9211;NEUROPROTECTION#0.9206;PACLITAXEL#0.9202;SERUM AMYLOID A#0.9194;LYSIS#0.9190;BAFILOMYCIN A1#0.9188;PYCNODYSOSTOSIS#0.9176;HEMORRHAGE#0.9158;HEPATITIS E VIRUS#0.9151;PROGESTERONE#0.9149;HEPATITIS E#0.9140;FATTY ACID BINDING#0.9137;PHOSPHATASE ACTIVITY#0.9137;ELASTASE ACTIVITY#0.9136;NEUROLOGICAL DISORDER#0.9121;LUMINAL#0.9116;CEREBRAL ARTERY OCCLUSION#0.9106;KIDNEY DISEASE#0.9102;PROTEIN METABOLISM#0.9098;NECROTIZING#0.9095;PROTEASE BINDING#0.9094;SEVERE ACUTE RESPIRATORY SYNDROME#0.9088;POST-TRANSLATIONAL MODIFICATION#0.9085;NUCLEIC ACID#0.9083;NUCLEOTIDE BINDING#0.9078;BIOFILM FORMATION#0.9068;FRUCTOSE#0.9065;HEMORRHAGIC#0.9064;NITRIC OXIDE SYNTHASE#0.9053;MYOFIBRIL#0.9045;LINES OF EVIDENCE#0.9042;NECROTIZING FASCIITIS#0.9039;VIRION#0.9039;COLLAGENASE IV#0.9030;CASPASE ACTIVITY#0.9021;COLITIS#0.9010;LIPID METABOLISM#0.9007;OBESE#0.9001;GLUTAMATE RECEPTOR#0.8998;FORMALIN#0.8997;TRYPSIN ACTIVITY#0.8989;HYPOXIC#0.8986;CARDIOMYOCYTE#0.8985;STORAGE PROTEIN#0.8981;BILE DUCT#0.8974;ENDOPLASMIC RETICULUM STRESS#0.8974;CELL PERIPHERY#0.8971;L-PHENYLALANINE#0.8969;COMPLEX I#0.8969;FIBROSARCOMA#0.8960;PROTEIN COMPLEX#0.8960;CERVIX#0.8958;DIISOPROPYL FLUOROPHOSPHATE#0.8954;ORAL SQUAMOUS CELL CARCINOMA#0.8947;TISSUE REMODELING#0.8946;LIVER DISEASE#0.8944;CLOTTING#0.8937;CHROMAFFIN CELL#0.8931;GROWTH FACTOR RECEPTOR#0.8927;HUMAN AFRICAN TRYPANOSOMIASIS#0.8924;LIMB-GIRDLE MUSCULAR DYSTROPHY#0.8924;MICROVASCULAR ENDOTHELIAL CELL#0.8922;CATHEPSIN K ACTIVITY#0.8914;SEED GERMINATION#0.8913;INDOMETHACIN#0.8912;OOCYTE MATURATION#0.8905;SWELLING#0.8903;BASAL CELL#0.8903;AMELANOTIC MELANOMA#0.8902;MUSCLE FIBER#0.8900;HYDROLASE ACTIVITY#0.8896;OUTER MEMBRANE#0.8894;HUMAN UMBILICAL VEIN#0.8885;UMBILICAL VEIN#0.8883;MUSCLE WASTING#0.8876;APOPTOTIC PROCESS#0.8872;PROTEASOME PATHWAY#0.8872;GOLGI COMPLEX#0.8862;KUPFFER CELL#0.8860;BONE REMODELING#0.8858;PROGRESSIVE MYOCLONUS EPILEPSY#0.8857;CYSTEIN#0.8845;L-LEUCINE#0.8836;FERTILIZATION#0.8829;AMYLOIDOSIS#0.8828;BONE FORMATION#0.8820;PERIODONTAL DISEASE#0.8818;FOLATE#0.8814;HUMAN SERUM ALBUMIN#0.8806;ONCOGENIC#0.8806;BETA N ACETYLGLUCOSAMINIDASE#0.8805;MIDDLE EAR#0.8798;ADIPOCYTE#0.8796;L-ARG#0.8793;HISTAMINE#0.8787;RECEPTOR AGONIST#0.8783;UBIQUITIN PROTEASOME SYSTEM#0.8782;INNATE IMMUNE SYSTEM#0.8770;SODIUM DODECYL SULPHATE#0.8770;MELANOMA CELL LINES#0.8761;FLUORESCEIN#0.8753;THYROID CARCINOMA#0.8744;LIVER DAMAGE#0.8743;HEPATITIS C#0.8735;BINDING PROTEIN 1#0.8734;SEMINAL PLASMA#0.8729;STRIATUM#0.8727;CHEMOTAXIS#0.8727;AMYOTROPHIC LATERAL SCLEROSIS#0.8722;LATERAL SCLEROSIS#0.8722;TRIPEPTIDYL PEPTIDASE#0.8709;WEIGHT GAIN#0.8707;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8704;TRANSFORMING GROWTH FACTOR BETA#0.8693;PROTEIN DISULFIDE ISOMERASE#0.8693;SLEEPING SICKNESS#0.8685;RETINAL PIGMENT EPITHELIAL#0.8684;TISSUE INVASION#0.8681;PEPTIDE BINDING#0.8677;CARBOXYPEPTIDASE A#0.8677;CARBACHOL#0.8665;INTESTINAL MUCOSA#0.8664;LEGUMAIN ACTIVITY#0.8661;PHOSPHORAMIDON#0.8658;DERMAL FIBROBLAST#0.8650;ADENOSINE#0.8650;PYRUVATE KINASE#0.8643;TUBERCULOSIS#0.8643;INSULIN DEGRADING ENZYME#0.8641;VASCULAR CELL#0.8634;PEPTIDASE INHIBITOR#0.8629;YOLK SAC#0.8628;CYCLOSPORIN#0.8622;ELECTROPHORETIC MOBILITY SHIFT#0.8620;BRAIN ISCHEMIA#0.8611;AGEING#0.8601;RETINOIC ACID#0.8600;CARRIE#0.8593;PNEUMONIA#0.8570;EOSINOPHIL#0.8569;CYTOCHROME C OXIDASE#0.8567;ISCHEMIA REPERFUSION INJURY#0.8566;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8566;MEMBRANE FUSION#0.8562;POSTTRANSLATIONAL MODIFICATION#0.8562;YOLK GRANULE#0.8561;PROTEIN PROTEIN INTERACTION#0.8559;LYMPH NODE METASTASES#0.8547;ASCITES#0.8544;EPIDIDYMIS#0.8544;MESANGIAL CELL#0.8538;COENZYME A#0.8537;KNEE JOINT#0.8536;HERPES SIMPLEX#0.8524;L-ALANINE#0.8521;SALICYLIC ACID#0.8519;TOPOISOMERASE#0.8511;DISEASE FREE SURVIVAL#0.8508;ACID SPHINGOMYELINASE#0.8505;GM-CSF#0.8501;NUTRIENT UPTAKE#0.8496;CREATINE#0.8492;DISEASE RESISTANCE#0.8484;NEPHROPATHY#0.8480;GESTATION#0.8478;OVARIES#0.8464;ANGIOTENSIN CONVERTING ENZYME#0.8446;HYPERSENSITIVITY#0.8442;MOUSE EMBRYONIC FIBROBLAST#0.8435;LIVER CANCER#0.8430;PROTEASE COMPLEX#0.8429;CELL DIVISION#0.8417;HERPES SIMPLEX VIRUS#0.8412;HUMAN IMMUNODEFICIENCY VIRUS#0.8404;GASTROINTESTINAL TRACT#0.8400;INDUCIBLE NITRIC OXIDE#0.8389;SPHINGOSINE#0.8385;HEPATITIS C VIRUS#0.8384;LYMPH NODE INVOLVEMENT#0.8381;BIPOLAR DISORDER#0.8352;GALECTIN#0.8349;SCANNING ELECTRON MICROSCOPY#0.8349;MYELOID CELL#0.8345;CHOLANGIOCARCINOMA#0.8342;BRONCHIAL EPITHELIAL CELLS#0.8342;EARLY ENDOSOME#0.8337;ENDOTHELIUM#0.8332;RESONANCE ENERGY TRANSFER#0.8330;FOCAL CEREBRAL ISCHEMIA#0.8329;INTRACELLULAR LOCALIZATION#0.8321;ESTROGEN RECEPTOR#0.8313;BRAIN DAMAGE#0.8301;GERM CELL#0.8297;ADIPOSE TISSUE#0.8267;INTRACELLULAR TRANSPORT#0.8265;COLONY-STIMULATING FACTOR#0.8262;TO THE PROGRESSION#0.8260;HISTONE DEACETYLASE#0.8260;TRANSITIONAL CELL CARCINOMA#0.8256;CAMPTOTHECIN#0.8252;AMYLASE SECRETION#0.8241;UBIQUITIN PROTEASOME PATHWAY#0.8233;TRANS GOLGI NETWORK#0.8230;LASER SCANNING MICROSCOPY#0.8222;HUMAN BRONCHIAL EPITHELIAL#0.8218;VENEZUELAN EQUINE ENCEPHALITIS#0.8217;NEOPLASTIC DISEASE#0.8215;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8212;ENDOMETRIUM#0.8209;TUMOUR NECROSIS FACTOR#0.8205;PIPERAZINE#0.8193;EQUINE ENCEPHALITIS#0.8189;SIZE EXCLUSION CHROMATOGRAPHY#0.8187;TUBE FORMATION#0.8186;ADVANCED GLYCATION END#0.8185;FORSKOLIN#0.8183;APP METABOLISM#0.8170;NADPH OXIDASE#0.8169;FOCAL ADHESION#0.8169;GROWTH FACTOR BINDING#0.8161;CERVICAL CANCER#0.8159;PROXIMAL TUBULE CELL#0.8154;GEMCITABINE#0.8148;OXIDATIVE BURST#0.8140;DEFENSE RESPONSE#0.8134;GROWTH HORMONE#0.8129;LOCALISATION#0.8128;CORONARY ARTERY#0.8118;CELL ADHESION MOLECULE#0.8115;PULMONARY FIBROSIS#0.8099;NEUROFIBRILLARY TANGLE#0.8098;POLYUBIQUITIN#0.8090;ADAPTIVE IMMUNE RESPONSE#0.8089;HOST-PATHOGEN INTERACTION#0.8087;STAUROSPORINE#0.8084;G1 PHASE#0.8074;STATIONARY PHASE#0.8070;PHAGOLYSOSOME#0.8065;PROLYL ENDOPEPTIDASE ACTIVITY#0.8063;ACTIVATED T CELL#0.8060;LEUCINE RICH REPEAT#0.8057;HAIR FOLLICLE#0.8055;MITOCHONDRIAL DAMAGE#0.8054;RECEPTOR MEDIATED ENDOCYTOSIS#0.8054;METASTATIC MELANOMA#0.8047;CORONARY HEART DISEASE#0.8045;CELLULAR MEMBRANE#0.8040;CALCINEURIN#0.8027;ESTRADIOL#0.8026;FASCIITIS#0.8018;PHOSPHOLIPASE C#0.8016;SMOOTH MUSCLE ACTIN#0.8016;AMYLASE ACTIVITY#0.8016;LAMININ BINDING#0.8000;ACTINOMYCIN D#0.7990;PROXIMAL TUBULAR CELL#0.7989;MYOCYTES#0.7987;PROGENITOR CELL#0.7986;PYRUVATE#0.7984;POLY ETHYLENE GLYCOL#0.7979;DERMATITIS#0.7973;BETA-2#0.7972;LACRIMAL GLAND#0.7965;INVASION OF HOST#0.7957;REGULATION OF APOPTOSIS#0.7924;DIGESTIVE TRACT#0.7920;TROPICAL CALCIFIC PANCREATITIS#0.7910;ACTIVATED T-CELLS#0.7910;PARASITOPHOROUS VACUOLE#0.7909;BRUSH BORDER#0.7899;MITOCHONDRIAL MEMBRANE PERMEABILIZATION#0.7896;TOXIC SHOCK SYNDROME#0.7894;CD8+ T CELL#0.7892;TROPHOBLAST#0.7880;CHROMOSOME SEGREGATION#0.7868;LYSOSOMAL PROTEIN DEGRADATION#0.7862;VITAMIN B6#0.7855;BONE MINERAL DENSITY#0.7854;ATP BINDING#0.7854;ATOPIC DERMATITIS#0.7854;T CELL ACTIVATION#0.7846;HIGH MOBILITY GROUP#0.7846;HIGH FAT DIET#0.7846;LEWIS LUNG CARCINOMA#0.7839;CYTOCHROME P450#0.7836;ARACHIDONIC ACID#0.7824;CHRONIC KIDNEY DISEASE#0.7823;ALCOHOLIC PANCREATITIS#0.7799;LUNG METASTASIS#0.7797;BLOOD PLASMA#0.7776;MYOSIN HEAVY CHAIN#0.7762;ACTIN CYTOSKELETON#0.7758;UTERUS#0.7756;PRECURSOR CELL#0.7755;URINARY BLADDER#0.7750;ACTIVATED CASPASE 3#0.7750;SIGNALING CASCADE#0.7747;PITUITARY ADENOMA#0.7744;DEPHOSPHORYLATION#0.7743;MYOBLAST FUSION#0.7741;DIGESTIVE VACUOLE#0.7738;DNA SYNTHESIS#0.7736;PROTEINASE A#0.7732;UMBILICAL CORD#0.7723;PATTERN RECOGNITION RECEPTOR#0.7722;BESTATIN#0.7720;BUDDING#0.7719;PROTEASE 3C#0.7709;PROTEIN KINASE B#0.7697;CHIKUNGUNYA#0.7684;GLUCOSE METABOLISM#0.7678;DIARRHEA#0.7672;ACTIN FILAMENT#0.7672;IN VITRO MATURATION#0.7663;VASCULAR DISEASE#0.7659;BLADDER CARCINOMA#0.7640;LYMPHOCYTE ANTIGEN#0.7637;PROTEIN MODIFICATION#0.7636;ANCHORING#0.7630;BASOPHIL#0.7626;ALPHA-1-PROTEINASE INHIBITOR#0.7625;RECEPTOR INTERACTING PROTEIN#0.7624;PROTEIN SECRETION#0.7613;OTITIS MEDIA#0.7607;PEPTIDE HORMONE#0.7602;BENZOPHENONE#0.7593;GUANINE#0.7590;SKIN CANCER#0.7589;PROPIDIUM#0.7587;ESOPHAGEAL CANCER#0.7580;HUMAN PANCREATIC CANCER#0.7578;PHOSPHOGLYCERATE KINASE#0.7576;LIVER CIRRHOSIS#0.7576;CREATINE KINASE#0.7572;EPITHELIAL MESENCHYMAL TRANSITION#0.7569;CHROMATID#0.7567;MICROSOME#0.7563;ATP SYNTHASE#0.7560;DNA REPAIR#0.7552;GLUCOSE-6-PHOSPHATE#0.7551;THYROID GLAND#0.7549;MYOPATHY#0.7547;B LYMPHOCYTE#0.7542;CYCLOSPORINE#0.7538;MYOCARDIUM#0.7521;ASCORBIC ACID#0.7515;CALCIUM CHANNEL#0.7495;NEURITE OUTGROWTH#0.7491;MACULAR DEGENERATION#0.7489;CEREBRAL HEMORRHAGE#0.7484;NEURONAL CEROID LIPOFUSCINOSIS#0.7479;APOPTOTIC SIGNALING PATHWAY#0.7476;PEPTIDYL DIPEPTIDASE#0.7471;HOMOLOGOUS RECOMBINATION#0.7470;DIABETIC NEPHROPATHY#0.7466;REGULATED SECRETORY PATHWAY#0.7464;CYCLIN DEPENDENT KINASE#0.7450;TRANSACTIVATION#0.7447;PEROXISOME#0.7447;HYALURONIDASE#0.7438;26S PROTEASOME#0.7435;OTHER ORGANISM#0.7433;STERILITY#0.7415;HEALTH CARE SYSTEM#0.7401;INTEGRIN BINDING#0.7396;RETINOL#0.7390;N-ACETYLCYSTEINE#0.7390;KERATOCONUS#0.7385;REGIONAL LYMPH NODE#0.7383;ALPHA AMYLASE#0.7380;PHOSPHODIESTERASE#0.7366;INVASIVE DUCTAL CARCINOMA#0.7362;CUMULUS OOCYTE COMPLEXES#0.7361;OXYGEN GLUCOSE DEPRIVATION#0.7355;BENZENESULFONYL#0.7350;GUANIDINE#0.7348;CATHEPSIN S ACTIVITY#0.7327;STREPTOZOTOCIN#0.7322;EOSIN#0.7309;ENAMEL ORGAN#0.7304;LUNG FIBROBLASTS#0.7299;MAPK SIGNALING#0.7296;ORTHODONTIC TOOTH MOVEMENT#0.7275;HIGH DENSITY LIPOPROTEIN#0.7256;RIBOSOME#0.7256;THALAMUS#0.7255;PROTEIN BINDING#0.7255;FLUID SHEAR STRESS#0.7251;MITOCHONDRIAL DEPOLARIZATION#0.7247;INHIBITION OF PROTEOLYSIS#0.7239;VISCERAL LEISHMANIASIS#0.7233;ACETYLCHOLINE#0.7233;MYELOID LEUKEMIA#0.7231;IGE BINDING#0.7227;THYMOCYTE#0.7226;COLORECTAL ADENOMA#0.7220;GLOBIN#0.7218;NECROPTOSIS#0.7207;ORNITHINE#0.7204;CILIARY BODY#0.7203;COLON ADENOCARCINOMA#0.7197;DIFFERENTIAL GENE EXPRESSION#0.7197;LUNG EPITHELIAL CELL#0.7190;GLIOBLASTOMA MULTIFORME#0.7188;GENTAMICIN#0.7161;RETICULOCYTE#0.7160;PLATELET ACTIVATION#0.7158;ISLETS OF LANGERHANS#0.7154;PROTEINURIA#0.7152;ATPASE ACTIVITY#0.7152;ACETYLCHOLINE RECEPTOR#0.7152;INVASIVE CARCINOMA#0.7151;ESSENTIAL AMINO ACID#0.7149;DETOXIFICATION#0.7142;COGNITION#0.7141;OTITIS MEDIA WITH EFFUSION#0.7136;GINGIVA#0.7129;KINASE ACTIVITY#0.7117;FACTOR XA#0.7113;AMNIOTIC FLUID#0.7113;INTRACELLULAR VESICLE#0.7111;MACROAUTOPHAGY#0.7109;LARVAL DEVELOPMENT#0.7109;HUMORAL IMMUNE RESPONSE#0.7104;CYTOTOXIC T CELL#0.7093;PROTEIN TYROSINE PHOSPHATASE#0.7086;OVARIAN FOLLICLE#0.7069;PROTEIN DIGESTION#0.7067;DIPEPTIDYL-PEPTIDASE ACTIVITY#0.7062;HEPATITIS B#0.7061;PSORIASIS#0.7056;SUBSTANCE P#0.7054;SECRETION OF LYSOSOMAL ENZYMES#0.7031;TUBULAR EPITHELIAL CELL#0.7029;JNK SIGNALING PATHWAY#0.7027;THYMIDINE#0.7019;GUANIDINE HYDROCHLORIDE#0.7014;POLLEN DEVELOPMENT#0.7006;SUBMANDIBULAR GLAND#0.6976;DNASE#0.6972;METHOTREXATE#0.6962;TRYPANOTHIONE#0.6957;METAPHASE#0.6949;SPHINGOSINE 1 PHOSPHATE#0.6948;PANCREATIC DUCTAL ADENOCARCINOMA#0.6946;BLOOD GLUCOSE LEVEL#0.6940;UNFOLDED PROTEIN RESPONSE#0.6932;GLYCOGEN SYNTHASE KINASE#0.6919;ACTIVE CASPASE 3#0.6907;AGMATINE#0.6907;B CELL LYMPHOMA#0.6904;TAUROCHOLATE#0.6904;GLUCOSE REGULATED PROTEIN#0.6902;NALOXONE#0.6901;MAGNETIC RESONANCE IMAGING#0.6895;INTRACELLULAR ORGANELLE#0.6878;PHOSPHATIDYLETHANOLAMINE#0.6874;AUTOPHAGIC CELL DEATH#0.6865;MYOBLAST DIFFERENTIATION#0.6861;RETINAL PIGMENT EPITHELIAL CELLS#0.6844;STROMELYSIN#0.6834;PIGMENT EPITHELIAL CELL#0.6833;SCRAPIE#0.6821;INSULINOMA#0.6820;DEUBIQUITINASE#0.6817;MUSCLE ATROPHY#0.6811;PHYSICAL ACTIVITY LEVEL#0.6802;POINT OF CARE#0.6802;CASPASE-1 ACTIVITY#0.6797;LIPID RAFT#0.6796;AGE RELATED MACULAR DEGENERATION#0.6794;BLOOD COAGULATION#0.6789;CARDIOMYOPATHY#0.6782;NF-KAPPAB ACTIVATION#0.6777;INFLAMMATORY BREAST CANCER#0.6761;ENDOMETRIAL CANCER#0.6758;UBIQUITIN SPECIFIC PROTEASE#0.6756;ION CHANNEL#0.6756;ACID PHOSPHATASE ACTIVITY#0.6754;NUCLEAR MORPHOLOGY#0.6745;ALPHA GALACTOSIDASE#0.6729;FOREBRAIN#0.6726;RENIN ACTIVITY#0.6718;ALCOHOL USE DISORDER#0.6706;SKELETON#0.6706;METAL BINDING#0.6705;OLEIC ACID#0.6695;EMBRYO DEVELOPMENT#0.6691;ALLERGIC RHINITIS#0.6683;ISOPROTERENOL#0.6678;HEPARIN BINDING#0.6670;ABC TRANSPORTER#0.6665;ACROMEGALY#0.6663;ADENYLATE#0.6661;RNA HELICASE#0.6658;VASCULAR ENDOTHELIAL CELL#0.6649;CYCLOPHOSPHAMIDE#0.6647;PROSTAGLANDIN E2#0.6641;DECIDUA#0.6640;SIGNAL TRANSDUCER#0.6639;MORPHOGENESIS#0.6627;FIBROBLAST GROWTH FACTOR#0.6615;CHLOROPLAST#0.6608;JEJUNUM#0.6608;MITOCHONDRIAL DNA#0.6605;VITAMIN C#0.6604;CELLULAR HOMEOSTASIS#0.6602;ACUTE PHASE RESPONSE#0.6589;FOOT AND MOUTH DISEASE#0.6589;MOUTH DISEASE#0.6586;RETINAL PIGMENT EPITHELIUM#0.6584;DAYS POST INFECTION#0.6577;NEPHRON#0.6577;NEUROTOXIN#0.6573;CARCINOGEN#0.6566;OXYGENASE#0.6544;SPHINGOSINE KINASE 1#0.6531;PARASITISM#0.6522;GOBLET CELL#0.6519;PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME#0.6517;QUANTITATIVE REVERSE TRANSCRIPTION#0.6500;ETOPOSIDE#0.6490;OVULATION#0.6484;MINERALIZATION#0.6483;NUCLEOTIDE BINDING DOMAIN#0.6478;COLORECTAL ADENOCARCINOMA#0.6473;5 FLUOROURACIL#0.6470;DENTAL PULP#0.6462;HATCHING#0.6460;ATPASE INHIBITOR#0.6440;DYNAMIC LIGHT SCATTERING#0.6418;ADRENAL MEDULLA#0.6418;SARCOMERE#0.6416;MENTAL HEALTH SERVICES#0.6416;TRANSIENT RECEPTOR POTENTIAL#0.6413;NUCLEAR MEMBRANE#0.6412;TUMOR ASSOCIATED MACROPHAGE#0.6411;RETINAL DEGENERATION#0.6408;CELL EXPANSION#0.6402;POLYMORPHONUCLEAR LEUKOCYTES#0.6399;HISTONE DEACETYLASE INHIBITOR#0.6396;PHOSPHATE BUFFERED SALINE#0.6396;MENINGITIS#0.6394;HUMAN EMBRYONIC KIDNEY#0.6384;HEMOSTASIS#0.6383;SCAVENGER RECEPTOR#0.6383;RESPONSE TO TREATMENT#0.6380;EMBRYONIC KIDNEY#0.6380;HOST CELL INVASION#0.6363;PROTEIN KINASE A#0.6354;NEUROFILAMENT#0.6343;MITOSIS#0.6323;CYSTICERCOSIS#0.6310;TRANSIENT CEREBRAL ISCHEMIA#0.6301;CYTOTOXIN#0.6300;ACTIVATION OF APOPTOSIS#0.6289;FIBROSARCOMA CELLS#0.6285;AIRWAY EPITHELIAL CELL#0.6284;ENDOPROTEASE ACTIVITY#0.6276;CYCLOPHILIN#0.6273;RHINITIS#0.6271;BORTEZOMIB#0.6271;LYSOSOMAL STORAGE DISEASE#0.6271;ACETYLCYSTEINE#0.6268;ESOPHAGUS#0.6267;CYTOKINE SECRETION#0.6266;SKULL BASE CHORDOMA#0.6265;ACETIC ACID#0.6265;TRANSMISSION ELECTRON MICROSCOPE#0.6262;REACTIVE OXYGEN SPECIES GENERATION#0.6256;PELVIC LYMPH NODE#0.6255;INTESTINAL TRACT#0.6249;CHOLINE#0.6239;CELL FUSION#0.6235;PHOSPHOLIPASE A#0.6230;MITOCHONDRIAL INTERMEMBRANE SPACE#0.6229;EUKARYOTIC INITIATION FACTOR#0.6228;PHOSPHATASE INHIBITOR#0.6222;INFLAMMASOME COMPLEX#0.6216;RECYCLING ENDOSOME#0.6213;HEPATIC STELLATE CELL#0.6213;BRAIN CORTEX#0.6207;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6207;SERTOLI CELL#0.6206;PROSTAGLANDIN SYNTHESIS#0.6204;METASTATIC BREAST CANCER#0.6201;TRANSFERRIN RECEPTOR#0.6181;OPIOID PEPTIDE#0.6181;CELLULAR SENESCENCE#0.6180;TYPE 2 DIABETES MELLITUS#0.6173;2 DIABETES MELLITUS#0.6173;METALLOPROTEINASE INHIBITOR#0.6165;TRADITIONAL CHINESE MEDICINE#0.6164;NEPHROTOXICITY#0.6151;COLLAGEN BREAKDOWN#0.6142;DIHYDROFOLATE REDUCTASE#0.6132;IL-8 PRODUCTION#0.6131;PEPTIDE SYNTHESIS#0.6131;RENAL CELL CARCINOMA#0.6126;PROSTATE CARCINOMA#0.6115;HEPATOCYTE GROWTH FACTOR#0.6113;STRUCTURAL EQUATION MODELING#0.6112;DIPHOSPHATE#0.6106;URINARY PROTEIN#0.6105;MEMBRANE DEGRADATION#0.6104;MYELOID ZINC FINGER#0.6103;MTDNA#0.6097;MALE PRONUCLEUS#0.6095;FRONTAL#0.6092;PROTON PUMP#0.6086;BRAIN DEVELOPMENT#0.6085;PULMONARY ARTERY#0.6082;CELLULAR COMPONENT#0.6078;TIGHT JUNCTION PROTEIN#0.6077;PROTEIN FOLDING#0.6066;CELLULAR IMMUNE RESPONSE#0.6062;RECEPTOR ACTIVATOR#0.6057;NODULE DEVELOPMENT#0.6049;AUTOPHAGOSOME-LYSOSOME FUSION#0.6043;ANAPHASE#0.6041;COLCHICINE#0.6036;INTERLEUKIN-1 PRODUCTION#0.6036;PARAGONIMIASIS#0.6024;ORAL CANCER CELL#0.6018;PD150606#0.6015;SEBACEOUS GLAND#0.6002
150921	STROMAL CELL#0.9033;TRANSCRIPTION FACTOR#0.9031;DECIDUALIZATION#0.6633;PROGESTERONE#0.6464
150946	INSULIN-LIKE GROWTH FACTOR#0.9015;GROWTH FACTOR#0.9013;NEUROBLASTOMA#0.6493
150962	PSEUDOURIDINE SYNTHASE#1.0337;APOPTOSIS#0.6224;TRNA BINDING#0.6134;MIRNA PROCESSING#0.6098
1509	COLLAGENASE IV#1.0679;ALPHA MANNOSIDASE#1.0586;PROTEINASE A#1.0527;CATHEPSIN D ACTIVITY#1.0478;UROKINASE PLASMINOGEN ACTIVATOR#1.0445;ALPHA GLUCOSIDASE#1.0426;BETA N ACETYLGLUCOSAMINIDASE#1.0423;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0356;BETA GLUCURONIDASE#1.0339;BETA GLUCOSIDASE#1.0338;ACID SPHINGOMYELINASE#1.0331;BETA GALACTOSIDASE#1.0316;HEAT SHOCK PROTEIN#1.0278;ALPHA 1-ANTITRYPSIN#1.0277;T- PA#1.0237;ACID PHOSPHATASE#1.0225;BREAST DISEASE#1.0223;GASTRIC MUCOSA#1.0217;LIGHT CHAIN 3#1.0209;UROKINASE#1.0201;DNASE#1.0198;COLORECTAL CANCER#1.0193;DEPRESSANT#1.0186;LYSOSOMAL MEMBRANE PERMEABILIZATION#1.0180;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#1.0179;GALECTIN#1.0175;CYSTATIN#1.0168;COLLAGENASE#1.0167;COLORECTAL#1.0157;LYMPH NODE METASTASES#1.0156;OVARIAN CANCER#1.0147;PRIMARY BREAST CANCER#1.0147;GROWTH FACTOR RECEPTOR#1.0137;MICROTUBULE ASSOCIATED PROTEIN#1.0136;EPIDERMAL GROWTH FACTOR#1.0131;KUPFFER CELL#1.0126;ANGIOTENSIN CONVERTING ENZYME#1.0115;TRANSFERRIN RECEPTOR#1.0108;PROSTATE CANCER#1.0099;ALVEOLAR MACROPHAGE#1.0087;ESTROGENS#1.0082;ASPARTATE#1.0074;LYMPH NODE INVOLVEMENT#1.0069;PHAGOSOME#1.0065;OVARIAN#1.0057;AUTOLYSIS#1.0044;PROGESTERONE#1.0042;UBIQUITIN#1.0033;SQUAMOUS CELL CARCINOMA#1.0031;S PHASE#1.0029;CASPASE ACTIVATION#1.0023;CATHEPSIN B ACTIVITY#1.0013;STROMAL CELL#1.0011;YOLK PROTEIN#1.0010;BASEMENT MEMBRANE#1.0009;PROTEOGLYCAN#1.0006;DISEASE FREE SURVIVAL#1.0004;INSULIN-LIKE GROWTH FACTOR#0.9999;TAMOXIFEN#0.9999;ASTROCYTE#0.9993;HYALURONIC ACID#0.9989;CEREBRAL CORTEX#0.9986;OOCYTE#0.9983;ANTIGEN PROCESSING#0.9982;MICROTUBULE#0.9965;LYMPH NODE METASTASIS#0.9962;EARLY ENDOSOME#0.9960;DENDRITIC CELL#0.9960;RETINAL PIGMENT EPITHELIAL#0.9958;ALKALINE PHOSPHATASE#0.9956;NEURONAL CEROID LIPOFUSCINOSIS#0.9956;BREAST CANCER PATIENTS#0.9950;PROTEINASE ACTIVITY#0.9949;NEUTROPHIL#0.9944;PEPSTATIN#0.9943;SUPEROXIDE DISMUTASE#0.9939;CREATINE#0.9937;RENIN ACTIVITY#0.9933;HYPOXIA#0.9930;LEUKOCYTE#0.9928;CYTOCHROME C#0.9927;PROTEASOME#0.9921;LATE ENDOSOME#0.9918;AUTOPHAGIC VACUOLE#0.9917;ESTRADIOL#0.9912;MAMMARY GLAND#0.9909;ADENOCARCINOMA#0.9909;CATABOLISM#0.9896;INTRACELLULAR LOCALIZATION#0.9892;RETINAL PIGMENT EPITHELIUM#0.9890;GROWTH FACTOR#0.9886;ACID PHOSPHATASE ACTIVITY#0.9883;BREAST CANCER#0.9881;BREAST CANCER CELL#0.9873;ACIDIFICATION#0.9867;SPINAL CORD#0.9867;LEUCINE#0.9866;LYSOSOMAL MEMBRANE#0.9860;CHLOROQUINE#0.9857;SECONDARY LYSOSOME#0.9856;GLYCOSYLATION#0.9855;PHOSPHATASE ACTIVITY#0.9854;CREATINE KINASE#0.9849;PROTEINASE INHIBITOR#0.9844;BREAST CARCINOMA#0.9842;METHIONINE#0.9841;DIGESTION#0.9841;ENDOMETRIAL CANCER#0.9838;SIGNAL PEPTIDE#0.9836;TRANSFORMING GROWTH FACTOR#0.9835;HUMAN BREAST CANCER#0.9832;LUMINAL#0.9831;PROTEASE ACTIVITY#0.9830;TRANSCRIPTION FACTOR#0.9830;LYMPH NODE#0.9829;GLUTATHIONE#0.9829;MITOCHONDRIAL MEMBRANE#0.9825;CELL ADHESION#0.9823;STROMA#0.9820;LUNG CANCER#0.9811;MONOCYTE#0.9803;VACUOLE#0.9803;AMYLOID PRECURSOR PROTEIN#0.9801;ERYTHROCYTE#0.9799;LYSOSOME#0.9797;CELL MIGRATION#0.9794;TUMOR CELLS#0.9793;LARYNGEAL CARCINOMA#0.9790;SMOOTH MUSCLE#0.9787;POLYMERASE CHAIN REACTION#0.9785;ALKALINE PROTEASE#0.9785;TRANS GOLGI NETWORK#0.9784;REVERSE TRANSCRIPTION#0.9784;SERUM ALBUMIN#0.9781;PHAGOCYTOSIS#0.9781;PROTEIN DEGRADATION#0.9777;B CELL#0.9775;ENDOSOME#0.9773;CANCER CELL#0.9773;ESTROGEN RECEPTOR#0.9771;PERIPHERAL BLOOD#0.9770;PROTEIN KINASE#0.9769;NEURODEGENERATIVE DISEASE#0.9768;ALZHEIMER'S DISEASE#0.9767;ALANINE#0.9766;FORMALIN#0.9765;EXOCYTOSIS#0.9763;EXTRACELLULAR MATRIX#0.9761;AUTOPHAGY#0.9759;MYOCARDIUM#0.9758;CYTOPLASM#0.9756;BONE MARROW#0.9756;PHAGOLYSOSOME#0.9748;AUTOPHAGOSOME#0.9747;ENDOTHELIAL CELL#0.9746;MAST CELL#0.9745;DODECYL SULFATE#0.9741;SKELETAL MUSCLE#0.9739;APOPTOSIS#0.9739;UTERUS#0.9739;CELL GROWTH#0.9736;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9736;MACROPHAGE#0.9735;ARTERY#0.9734;LOW DENSITY LIPOPROTEIN#0.9730;MUSCLE CELL#0.9730;CENTRAL NERVOUS SYSTEM#0.9727;SODIUM DODECYL SULFATE#0.9723;CARDIOMYOCYTE#0.9721;CORONARY ARTERY#0.9721;T CELL#0.9721;RNA INTERFERENCE#0.9718;ISCHEMIA#0.9718;ANGIOGENESIS#0.9717;NERVOUS SYSTEM#0.9717;AUTOLYSOSOME#0.9712;MENSTRUAL CYCLE#0.9707;MITOCHONDRIA#0.9705;CONNECTIVE TISSUE#0.9704;APOPTOTIC#0.9703;SOLUBLE FRACTION#0.9703;EPITHELIAL CELL#0.9696;SIGNALING PATHWAY#0.9696;PIGMENT EPITHELIAL CELL#0.9695;DIPEPTIDYL PEPTIDASE#0.9693;GENE EXPRESSION#0.9690;ORGANELLE#0.9689;PROTEIN BREAKDOWN#0.9689;CELL DEATH#0.9688;ASPARTIC ACID#0.9683;INFLAMMATORY CELL#0.9682;TOXICITY#0.9675;IMMUNE RESPONSE#0.9673;ENZYME ACTIVITY#0.9668;SUCROSE#0.9667;PLASMA MEMBRANE#0.9666;REACTIVE OXYGEN SPECIES#0.9663;PARKINSON'S DISEASE#0.9659;CELL SURFACE#0.9658;CELL CYCLE#0.9656;ENDOPLASMIC RETICULUM#0.9647;FIBROBLAST GROWTH FACTOR#0.9645;ALPHA-2 MACROGLOBULIN#0.9640;NITRIC OXIDE#0.9639;ENDOCYTOSIS#0.9637;SECRETORY PATHWAY#0.9635;CELL PROLIFERATION#0.9632;GLIAL CELL#0.9627;GROWTH FACTOR BINDING#0.9625;SMOOTH MUSCLE CELL#0.9624;COLORECTAL ADENOCARCINOMA#0.9621;CYTOTOXICITY#0.9621;INTRACELLULAR TRANSPORT#0.9619;HEPARIN#0.9608;EXCRETION#0.9608;PROTEIN SYNTHESIS#0.9603;GOLGI APPARATUS#0.9600;CYTOCHROME C RELEASE#0.9599;HOST CELL#0.9592;CELL MEMBRANE#0.9589;HEPATOCELLULAR CARCINOMA#0.9586;LYSOSOMAL PROTEOLYSIS#0.9585;LYSOSOMAL STORAGE DISEASE#0.9573;TRIPEPTIDYL PEPTIDASE#0.9572;DEMENTIA#0.9570;COATED VESICLE#0.9566;SECRETORY GRANULE#0.9565;PROTEIN KINASE C#0.9564;TUMOR NECROSIS FACTOR#0.9553;ENDOMETRIUM#0.9550;COLORECTAL CARCINOMA#0.9549;RETINAL PIGMENT EPITHELIAL CELLS#0.9545;CATALYTIC ACTIVITY#0.9536;EXTRACELLULAR MATRIX COMPONENT#0.9535;RHEUMATOID ARTHRITIS#0.9533;RETINOIC ACID#0.9508;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9504;PROGRAMMED CELL DEATH#0.9499;PROGESTIN#0.9498;COLON CANCER#0.9496;HYPOXIC#0.9482;LYSINE#0.9482;PROTEIN METABOLISM#0.9478;STEM CELL#0.9459;ENDOTHELIAL GROWTH FACTOR#0.9450;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9450;ENZYME INHIBITOR#0.9439;SYNOVIAL FLUID#0.9437;RAPAMYCIN#0.9437;PHOTORECEPTOR OUTER SEGMENT#0.9433;IMMUNE SYSTEM#0.9415;GANGLION CELLS#0.9410;INVASIVE BREAST CANCER#0.9400;SKIN FIBROBLASTS#0.9382;NEUROBLASTOMA#0.9379;OVARIAN CARCINOMA#0.9371;DNA SYNTHESIS#0.9369;LECTIN#0.9348;FRONTAL#0.9339;INTESTINAL MUCOSA#0.9336;INVASIVE DUCTAL CARCINOMA#0.9333;STRUCTURE ACTIVITY RELATIONSHIP#0.9331;GLUTATHIONE PEROXIDASE#0.9327;ENDOMETRIAL ADENOCARCINOMA#0.9323;ANTIGEN PRESENTATION#0.9322;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9321;REGENERATION#0.9319;AMYLOID PROTEIN#0.9309;PROTEIN CATABOLISM#0.9291;GOLGI MEMBRANE#0.9291;CELL ADHESION MOLECULE#0.9287;SENESCENCE#0.9284;CERVICAL#0.9274;ARGININE#0.9269;MITOGENIC ACTIVITY#0.9268;INFILTRATING DUCTAL CARCINOMA#0.9268;HEMORRHAGIC#0.9263;ICI 182,780#0.9257;KERATINOCYTE#0.9254;RELAPSE FREE SURVIVAL#0.9246;INFLAMMATORY RESPONSE#0.9240;INVASIVE BREAST CARCINOMA#0.9240;DNA FRAGMENTATION#0.9218;TUMOR TISSUES#0.9215;KINASE ACTIVITY#0.9215;MYOCARDIAL INFARCTION#0.9211;EXTRACELLULAR SPACE#0.9207;LUNG ADENOCARCINOMA#0.9206;TRANSMISSION ELECTRON MICROSCOPY#0.9200;BIOTIN#0.9199;LASER DESORPTION IONIZATION#0.9188;ETHANOL#0.9185;TARGET OF RAPAMYCIN#0.9179;GLCNAC#0.9172;BAFILOMYCIN A1#0.9162;OSTEOARTHRITIS#0.9147;HISTAMINE#0.9144;THYMIDINE KINASE#0.9136;MAMMARY EPITHELIAL CELL#0.9126;3-METHYLADENINE#0.9117;ATP SYNTHASE#0.9116;APOPTOTIC CELL DEATH#0.9104;PHAGOSOME MATURATION#0.9102;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9095;STREPTOZOTOCIN#0.9093;ACINAR CELL#0.9086;MIDGUT#0.9081;THYMIDINE#0.9077;DNA BINDING#0.9070;MUTAGENESIS#0.9066;RECEPTOR ANTAGONIST#0.9062;ENDOTHELIUM#0.9031;QUANTITATIVE REAL TIME#0.9025;CELL DIFFERENTIATION#0.9022;SAPOSIN#0.9009;ENDOMETRIAL CARCINOMA#0.8981;PYRUVATE KINASE#0.8973;DRUG RESISTANCE#0.8965;SIGNAL TRANSDUCTION#0.8953;PYRUVATE#0.8942;SALIVARY GLAND#0.8930;OSTEOCLAST#0.8925;FIBRIL#0.8925;IFN-GAMMA#0.8903;MACROAUTOPHAGY#0.8899;ESTROGEN RECEPTOR ALPHA#0.8870;PROSTATE SPECIFIC ANTIGEN#0.8860;HYALURONIDASE#0.8848;ATHEROSCLEROTIC#0.8837;AORTIC ANEURYSM#0.8835;PEPSIN INHIBITOR#0.8826;PROSTATE CARCINOMA#0.8783;MECHANISM OF ACTION#0.8776;POST-TRANSLATIONAL MODIFICATION#0.8759;VASCULAR SMOOTH MUSCLE CELL#0.8746;CELL ASSOCIATED#0.8742;NEUROFILAMENT#0.8740;PARATHYROID HORMONE#0.8734;PLATELET-DERIVED GROWTH FACTOR#0.8731;PROTEIN DISULFIDE ISOMERASE#0.8729;GOLGI COMPLEX#0.8720;MONOCYTE DERIVED MACROPHAGE#0.8708;MITOGEN ACTIVATED PROTEIN#0.8702;LYSIS#0.8700;TUMOR SUPPRESSOR#0.8696;HYPERTENSION#0.8696;CELLULAR LOCALIZATION#0.8688;CALPAIN ACTIVITY#0.8685;HEPARIN BINDING#0.8673;ESTROGEN RESPONSE ELEMENT#0.8664;INDUCTION OF APOPTOSIS#0.8658;MALARIA#0.8638;PANCREATIC CANCER#0.8634;T LYMPHOCYTE#0.8626;LIPID METABOLISM#0.8624;NEUROTOXICITY#0.8604;STROMELYSIN#0.8602;NEURONAL CELL DEATH#0.8597;PRO-INFLAMMATORY#0.8591;MYOCYTES#0.8575;MONONUCLEAR CELLS#0.8554;HYPOXIA INDUCIBLE FACTOR#0.8553;SMALL INTESTINE#0.8551;LYSOSOMAL STORAGE DISORDER#0.8548;AMYLOIDOSIS#0.8543;SECRETORY VESICLE#0.8538;TRANSFORMING GROWTH FACTOR BETA#0.8534;RECEPTOR MEDIATED ENDOCYTOSIS#0.8529;COLLAGEN TYPE IV#0.8526;ATHEROSCLEROSIS#0.8520;TUBERCULOSIS#0.8491;BETA N ACETYLHEXOSAMINIDASE#0.8487;BLOOD PLASMA#0.8483;URINARY BLADDER#0.8464;MEMBRANE FRACTION#0.8462;VIRULENCE#0.8457;MICROGLIAL CELL#0.8451;BASAL CELL#0.8435;DOXORUBICIN#0.8431;HYDROXYPROLINE#0.8417;INVASIVE GROWTH#0.8408;FLUORESCEIN#0.8405;RECURRENCE FREE SURVIVAL#0.8372;BONE RESORPTION#0.8365;HYDROLASE ACTIVITY#0.8363;MOUSE EMBRYONIC FIBROBLAST#0.8335;BLOOD VESSEL#0.8333;LIPID DROPLET#0.8328;NEUROFIBRILLARY TANGLE#0.8324;VERY-LOW-DENSITY LIPOPROTEIN#0.8318;CHONDROCYTE#0.8317;CREUTZFELDT JAKOB DISEASE#0.8300;ASCITES#0.8276;EPIDIDYMIS#0.8276;HEART MUSCLE#0.8262;FATTY ACID BINDING#0.8261;ARYL HYDROCARBON RECEPTOR#0.8251;STEROID HORMONE RECEPTOR#0.8245;TYPE 2 DIABETES#0.8231;PURKINJE CELL#0.8215;NECROTIC#0.8213;LIVER DISEASE#0.8194;NITRIC OXIDE SYNTHASE#0.8185;AUTOPHAGOSOME FORMATION#0.8182;SWELLING#0.8181;BLOOD BRAIN BARRIER#0.8176;PARATHYROID#0.8169;GROWTH HORMONE#0.8161;PANCREATITIS#0.8127;CILIARY BODY#0.8115;ROUGH ENDOPLASMIC RETICULUM#0.8112;COLON CARCINOMA#0.8110;OSTEOBLAST#0.8109;KNEE JOINT#0.8102;HEXOSAMINIDASE A#0.8071;ADVANCED GLYCATION END#0.8068;ALPHA-TOCOPHEROL#0.8051;CAUDATE NUCLEUS#0.8046;NADPH OXIDASE#0.8043;IGF BINDING#0.8042;HEPATOMA CELLS#0.8034;ENDOPEPTIDASE ACTIVITY#0.8022;HUMAN SERUM ALBUMIN#0.8009;KINASE INHIBITOR#0.8007;NEOPLASTIC TISSUES#0.7997;BETA-ESTRADIOL#0.7993;BLOOD PLATELETS#0.7973;GLUCOSAMINE#0.7968;SUBSTANTIA NIGRA#0.7949;WOUND HEALING#0.7925;GLUCOSE REGULATED PROTEIN#0.7921;MESENTERIC ARTERY#0.7914;CARDIOMYOPATHY#0.7903;GLYCINE#0.7882;HEMORRHAGE#0.7882;ASCORBIC ACID#0.7861;LOCALISATION#0.7859;MANNOSE RECEPTOR#0.7849;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7835;BLADDER CARCINOMA#0.7832;RENAL CELL CARCINOMA#0.7831;ALPHA L FUCOSIDASE#0.7830;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.7797;CARDIOTOXIC#0.7794;FIBRINOGEN#0.7777;ANTIGEN PRESENTING CELLS#0.7776;EARLY ENDOSOME ANTIGEN#0.7769;MYOMETRIUM#0.7757;THYROID CARCINOMA#0.7749;VASCULAR CELL#0.7745;OESTRADIOL#0.7734;LINES OF EVIDENCE#0.7731;TRANSFORMING GROWTH FACTOR ALPHA#0.7729;INTERSTITIAL CELL#0.7721;INNATE IMMUNE RESPONSE#0.7719;ANDROGEN RECEPTOR#0.7706;NEURITE#0.7698;PROTEASE S#0.7695;MUSCLE FIBER#0.7695;TOCOPHEROL#0.7693;PROTEIN COMPLEX#0.7684;CASPASE-INDEPENDENT CELL DEATH#0.7683;PLASMA PROTEIN#0.7678;CANCER SPECIFIC SURVIVAL#0.7677;AGGRESSIVE BEHAVIOR#0.7651;MULTIPLE SCLEROSIS#0.7637;AMNIOTIC FLUID#0.7624;TRANSCRIPTASE#0.7616;AGEING#0.7611;CLATHRIN COATED VESICLE#0.7603;HUMAN LEUKOCYTE ANTIGEN#0.7601;NEURONAL CELLS#0.7600;COATED MEMBRANE#0.7595;HEMOGLOBIN HYDROLYSIS#0.7593;TISSUE DAMAGE#0.7592;RIBOSE#0.7585;PROTEIN PROTEIN INTERACTION#0.7582;CYCLIC AMP#0.7580;PROTEIN PROCESSING#0.7580;THYROID GLAND#0.7576;LUTEAL PHASE#0.7564;HISTIDINE#0.7556;AGE RELATED MACULAR DEGENERATION#0.7552;MACULAR DEGENERATION#0.7548;PHOTORECEPTOR CELL#0.7536;UBIQUITIN PROTEASOME SYSTEM#0.7536;DOPAMINERGIC NEURON#0.7535;VITAMIN E#0.7500;TROPHOBLAST#0.7489;MYOFIBRIL#0.7486;SUBSTANCE P#0.7480;RECEPTOR BINDING#0.7476;GASTRIC ADENOCARCINOMA#0.7411;ALPHA-1-PROTEINASE INHIBITOR#0.7411;TRANSLATION ELONGATION FACTOR#0.7409;CERVICAL CANCER#0.7407;SCHWANN CELL#0.7402;DEXAMETHASONE#0.7397;LYMPHOID TISSUE#0.7393;GESTATION#0.7392;TRANSLATION ELONGATION#0.7389;APOPTOSIS INDUCING FACTOR#0.7385;ISCHEMIA REPERFUSION INJURY#0.7378;ADIPOCYTE#0.7364;LUNG CARCINOMA#0.7359;ADJACENT NORMAL TISSUE#0.7358;KIDNEY DISEASE#0.7355;TRANSACTIVATION#0.7322;SIGNAL TRANSDUCER#0.7307;FACTOR I#0.7294;ASTROCYTOMA#0.7292;CASPASE-3 ACTIVITY#0.7291;INTIMA MEDIA THICKNESS#0.7286;AUTOPHAGIC CELL DEATH#0.7279;COLLAGEN DEGRADATION#0.7272;INTRACELLULAR VESICLE#0.7268;ALPHA GALACTOSIDASE#0.7257;PEROXISOME#0.7256;COLCHICINE#0.7251;HYPOTENSION#0.7240;TRANSITIONAL CELL CARCINOMA#0.7227;INVASIVE CARCINOMA#0.7227;EARLY BREAST CANCER#0.7226;PENTOBARBITAL#0.7212;RETINAL DEGENERATION#0.7212;CASPASE INHIBITOR#0.7206;GRANULOCYTE#0.7202;NOREPINEPHRINE#0.7201;YOLK GRANULE#0.7199;ACETIC ACID#0.7193;LIVER DAMAGE#0.7185;METASTATIC MELANOMA#0.7181;POLY ADP RIBOSE#0.7176;MILK PROTEIN#0.7169;RESVERATROL#0.7168;LIVER CIRRHOSIS#0.7168;CASPASE-INDEPENDENT APOPTOSIS#0.7160;WEIGHT GAIN#0.7154;CELL FRACTION#0.7151;CYTOCHROME P450#0.7144;HEART DISEASE#0.7137;THORACIC DUCT#0.7131;CYCLIN DEPENDENT KINASE#0.7102;BUDDING#0.7077;POLYMORPHONUCLEAR LEUKOCYTES#0.7076;NEUROPROTECTION#0.7073;20S PROTEASOME#0.7067;STRIATUM#0.7057;ATPASE INHIBITOR#0.7053;ENDOCYTIC VESICLE#0.7048;SEMINAL PLASMA#0.7025;YOLK SAC#0.7012;ADIPOSE TISSUE#0.7009;TOPOISOMERASE II#0.6992;PEPTIDE BINDING#0.6987;INDOMETHACIN#0.6978;METAMORPHOSIS#0.6977;COLLAGEN BIOSYNTHESIS#0.6973;LYSOSOMAL MEMBRANE STABILITY#0.6963;CARDIAC MUSCLE#0.6958;POSTTRANSLATIONAL MODIFICATION#0.6953;LYSOSOME MEMBRANE#0.6952;L-PHENYLALANINE#0.6952;RETINOL#0.6944;NEOPLASTIC DISEASE#0.6943;NEURAL CELL#0.6941;DIPEPTIDYL PEPTIDASE IV#0.6926;UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR#0.6915;MAGNETIC RESONANCE IMAGING#0.6913;SYNOVIUM#0.6910;HUMAN IMMUNODEFICIENCY VIRUS#0.6907;ADENOSINE#0.6882;SODIUM DODECYL SULPHATE#0.6861;SMOOTH MUSCLE ACTIN#0.6860;EPILEPSY#0.6855;TUMOUR NECROSIS FACTOR#0.6853;ARYLSULFATASE B#0.6840;N-ETHYLMALEIMIDE#0.6826;EOSIN#0.6819;MYOSIN HEAVY CHAIN#0.6811;METASTATIC BREAST CANCER#0.6805;LDL RECEPTOR#0.6805;VALINE#0.6804;CALCINEURIN#0.6799;VITAMIN A#0.6791;GERM CELL#0.6783;MICROTUBULE DEPOLYMERIZATION#0.6777;OVARIES#0.6775;HERPES SIMPLEX#0.6766;CARBOXYPEPTIDASE A#0.6765;DOPAMINE#0.6757;COATED PIT#0.6752;CALCITRIOL#0.6744;INTRACELLULAR MEMBRANE#0.6741;URINARY KALLIKREIN#0.6741;CATHEPSIN L ACTIVITY#0.6737;ASPARAGINE#0.6734;REGULATION OF APOPTOSIS#0.6730;ISORENIN#0.6708;L-CYSTEINE#0.6702;C-LEVEL#0.6696;MELANOCYTE#0.6692;OXIDATIVE BURST#0.6686;GLOBIN#0.6677;EFFERENT DUCT#0.6665;GLUCOCEREBROSIDASE ACTIVITY#0.6654;LACTIC ACID#0.6653;CORPUS LUTEUM#0.6652;SERTOLI CELL#0.6645;COLONY-STIMULATING FACTOR#0.6638;SCIATIC NERVE#0.6615;HERPES SIMPLEX VIRUS#0.6611;LASER SCANNING MICROSCOPY#0.6561;CARCINOMA IN SITU#0.6550;72-HOURS#0.6529;MYOPATHY#0.6515;CORONARY ARTERY DISEASE#0.6510;ARTERY DISEASE#0.6508;HYDROCORTISONE#0.6499;RED BLOOD CELL#0.6496;GLUTAMINE#0.6468;RISK OF RELAPSE#0.6467;CYTOCHROME B5#0.6455;CYCLOSPORIN A#0.6452;GLUCOSE 6 PHOSPHATASE#0.6443;UMBILICAL CORD#0.6441;CELLULAR MEMBRANE#0.6436;JEJUNUM#0.6431;MICROSOME#0.6428;SERUM AMYLOID A#0.6421;CATECHOL O METHYLTRANSFERASE#0.6421;PEPTIDE HORMONE#0.6419;ENDOLYSOSOME#0.6416;O METHYLTRANSFERASE#0.6412;ACTINOMYCIN D#0.6411;STAUROSPORINE#0.6409;ZYMOGEN ACTIVATION#0.6407;FATTY LIVER#0.6381;HEME OXYGENASE 1#0.6381;CHLORAMPHENICOL#0.6379;EPITHELIAL MESENCHYMAL TRANSITION#0.6376;ARACHIDONIC ACID#0.6372;COMPLEX I#0.6367;IONOPHORE#0.6363;SPHINGOLIPID ACTIVATOR PROTEIN#0.6363;CD4+ T CELL#0.6349;CAUDA#0.6348;AUTOPHAGOLYSOSOME#0.6333;COAGULATION#0.6328;CELLULAR HOMEOSTASIS#0.6324;LARYNX#0.6288;PLATELET AGGREGATION#0.6276;NORMAL BREAST TISSUE#0.6276;ETOPOSIDE#0.6274;DEDIFFERENTIATION#0.6271;SERPIN#0.6264;ABDOMINAL AORTIC ANEURYSM#0.6257;TISSUE HOMEOSTASIS#0.6251;RNASE II#0.6246;OXYGENASE#0.6241;PROXIMAL TUBULAR CELL#0.6239;GLUCURONIDASE ACTIVITY#0.6238;ASPARTYL PROTEASE ACTIVITY#0.6228;SPINAL CORD INJURY#0.6224;LAMININ RECEPTOR#0.6206;URINARY PROTEIN#0.6205;BASAL LAMINA#0.6203;KININOGENASE#0.6200;AMYOTROPHIC LATERAL SCLEROSIS#0.6199;LATERAL SCLEROSIS#0.6199;FOREBRAIN#0.6198;L-ARGININE#0.6196;SYNAPTIC VESICLE#0.6190;PEPTIDASE ACTIVITY#0.6186;VITELLOGENESIS#0.6178;TRANSLATION INITIATION FACTOR#0.6177;INCLUSION BODY#0.6172;SECRETION OF LYSOSOMAL ENZYMES#0.6164;EPSTEIN BARR VIRUS#0.6162;NORLEUCINE#0.6152;L IDURONIDASE#0.6151;TRANSLATION INITIATION#0.6149;FACTOR VIII#0.6146;PROSTACYCLIN#0.6133;CYTOKINE PRODUCTION#0.6133;LEFT ANTERIOR DESCENDING#0.6131;DEPHOSPHORYLATION#0.6119;TRYPTOPHAN#0.6110;NOCODAZOLE#0.6101;FACTOR S#0.6088;OPSIN#0.6086;MACROPHAGE APOPTOSIS#0.6078;MODE OF ACTION#0.6069;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6060;HUMAN UMBILICAL VEIN#0.6055;ENTEROCYTE#0.6054;UMBILICAL VEIN#0.6054;1-DEOXYNOJIRIMYCIN#0.6053;NEUTROPHIL APOPTOSIS#0.6049;GONAD#0.6048;SPHINGOSINE#0.6042;CELL ACTIVATION#0.6035;TOPOISOMERASE#0.6028;PHOSPHODIESTERASE#0.6015;VASOPRESSIN#0.6006
150	ADRENERGIC RECEPTOR#1.0332;GUANFACINE#1.0274;TYPE 2 DIABETES#1.0220;ATTENTION DEFICIT HYPERACTIVITY DISORDER#1.0058;HYPERACTIVITY#1.0007;OXYMETAZOLINE#1.0002;DEXMEDETOMIDINE#0.9992;NOREPINEPHRINE#0.9937;CLONIDINE#0.9906;EPINEPHRINE#0.9710;INSULIN SECRETION#0.9689;YOHIMBINE#0.9663;DOPAMINE#0.9650;PROTEIN KINASE#0.9531;GENE EXPRESSION#0.9527;PRAZOSIN#0.9525;METHYLPHENIDATE#0.9490;RECEPTOR AGONIST#0.9310;NERVOUS SYSTEM#0.9303;SIGNALING PATHWAY#0.9236;PERTUSSIS#0.9165;FRAGMENT LENGTH POLYMORPHISM#0.9101;RESPONSE TO METHYLPHENIDATE#0.9034;BETA-2#0.8863;PROTEIN KINASE C#0.8771;POLYMERASE CHAIN REACTION#0.8610;RESPONSE TO MPH#0.8610;ALPHA2 ADRENERGIC RECEPTOR#0.8427;NORADRENALINE#0.8314;SPINAL CORD#0.8155;FRONTAL#0.8135;PLATELET AGGREGATION#0.7830;WEIGHT GAIN#0.7735;DOPAMINE RECEPTOR#0.7666;HYPERTENSION#0.7640;ADRENALINE#0.7634;CYCLIC AMP#0.7557;TESTOSTERONE#0.7548;PANCREATIC ISLET#0.7512;GROWTH FACTOR#0.7383;GTPASE ACTIVITY#0.7382;ALPHA ADRENOCEPTOR#0.7269;LIPOLYSIS#0.7260;ADENOSINE#0.7033;CENTRAL NERVOUS SYSTEM#0.6957;LOCUS COERULEUS#0.6850;ADIPOCYTE#0.6842;CORTISOL#0.6779;MAPK ACTIVATION#0.6765;SIGNAL TRANSDUCTION#0.6653;GUANINE#0.6606;CYCLASE ACTIVITY#0.6553;CEREBRAL CORTEX#0.6513;BETA ADRENERGIC RECEPTOR#0.6373;CLOZAPINE#0.6350;EPITHELIAL CELL#0.6279;PHOSPHOLIPASE C#0.6273;SPATIAL WORKING MEMORY#0.6235;PKC ACTIVATION#0.6137;CONTINUOUS PERFORMANCE TEST#0.6117
151056	LYSOPHOSPHOLIPASE ACTIVITY#1.1001;PHOSPHOLIPASE A2#1.0610;PHOSPHOLIPASE A#1.0561;VIRULENCE#1.0288;GENE EXPRESSION#1.0074;PHOSPHOLIPASE C#0.9888;PHOSPHOLIPASE B ACTIVITY#0.9847;MACROPHAGE#0.9789;CELL WALL#0.9500;BRUSH BORDER#0.9409;PLASMA MEMBRANE#0.9362;PHOSPHOLIPASE ACTIVITY#0.9294;CELL ASSOCIATED#0.8974;PHOSPHOLIPASE A1#0.8912;POLYMERASE CHAIN REACTION#0.8281;EPITHELIAL CELL#0.8259;HOST CELL#0.7964;BRUSH BORDER MEMBRANE#0.7766;CANDIDIASIS#0.7418;CELL SURFACE#0.7125;PALMITOYL#0.7017;ENZYME ACTIVITY#0.6951;IMMUNE RESPONSE#0.6841;LIPASE ACTIVITY#0.6745;PHOSPHATIDYLETHANOLAMINE#0.6601;ARACHIDONIC ACID#0.6576;GLYCOSYLATION#0.6424;GRANULOCYTE#0.6310;PROTEIN KINASE#0.6280;CELL WALL INTEGRITY#0.6170
1510	ANTIGEN PROCESSING#1.0641;GASTRIC MUCOSA#1.0465;MACROPHAGE#1.0414;ERYTHROCYTE#1.0304;EPITHELIAL CELL#1.0293;DENDRITIC CELL#1.0272;IMMUNE SYSTEM#1.0176;GENE EXPRESSION#0.9922;T CELL#0.9895;CANCER CELL#0.9881;PEPSTATIN#0.9863;ADENOCARCINOMA#0.9807;IMMUNE RESPONSE#0.9598;ANTIGEN PRESENTATION#0.9533;APOPTOSIS#0.9470;ENDOPLASMIC RETICULUM#0.9339;PANCREATIC DUCTAL ADENOCARCINOMA#0.9146;CELL SURFACE#0.9032;NEUTROPHIL#0.8902;B CELL#0.8862;LANGERHANS CELL#0.8550;LYSOSOME#0.8484;MUCOUS CELLS#0.8369;BONE MARROW#0.8145;CELL ADHESION#0.8010;MUCOUS#0.7935;PANCREATIC CANCER#0.7903;GASTRIC ADENOCARCINOMA#0.7849;POLYMERASE CHAIN REACTION#0.7843;PYLORIC GLAND#0.7787;MAMMARY GLAND#0.7544;CELL PROLIFERATION#0.7465;LYMPH NODE#0.7287;PROTEASE ACTIVITY#0.7152;ERYTHROCYTE MEMBRANES#0.7083;URINARY BLADDER#0.6993;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6942;KERATINOCYTE#0.6850;INTRACELLULAR LOCALIZATION#0.6843;ATOPIC DERMATITIS#0.6833;ALPHA-2 MACROGLOBULIN#0.6812;TOLL LIKE RECEPTOR#0.6770;PANCREATITIS#0.6725;ENZYME ACTIVITY#0.6575;ASPARTIC ACID#0.6575;METAPLASIA#0.6432;LEUKOCYTE#0.6346;LYMPHOID TISSUE#0.6322;IMMUNE CELL#0.6279;ORGANELLE#0.6169;CARBOXYPEPTIDASE A#0.6154;MICROGLIAL CELL#0.6146;HUMAN EMBRYONIC KIDNEY#0.6139;EMBRYONIC KIDNEY#0.6134;PULMONARY EMPHYSEMA#0.6132;LYSOSOMAL MEMBRANE#0.6073;ENDOSOME#0.6051;TUMOR NECROSIS FACTOR#0.6050;GLYCOSYLATION#0.6002
151112	DEATH RECEPTOR#1.1942;UBIQUITIN#0.8498;APOPTOSIS#0.8439
151126	B CELL APOPTOSIS#0.6705;B CELL#0.6158
151176	ERYTHROPOIESIS#1.0289;ERYTHROBLAST#1.0219;IRON OVERLOAD#1.0172;ANEMIA#1.0122;IRON HOMEOSTASIS#1.0097;BONE MARROW#0.9966;THALASSEMIA#0.9904;TRANSFERRIN RECEPTOR#0.9334;RED BLOOD CELL#0.8191;GENE EXPRESSION#0.8121;ERYTHROID CELL#0.7720;ERYTHROPOIESIS STIMULATING AGENT#0.7587;DEFICIENCY ANEMIA#0.7382;ERYTHROID PRECURSOR#0.7309;HEMOGLOBIN SYNTHESIS#0.7213;IRON DEFICIENCY ANEMIA#0.7137;BLOOD LOSS#0.6941;HYPOXIA#0.6906;BONE MORPHOGENETIC PROTEIN#0.6898;KIDNEY DISEASE#0.6703;SKELETAL MUSCLE#0.6616;RESPONSE TO ERYTHROPOIETIN#0.6450
151194	LYSINE#0.8207
151195	PROGENITOR CELL#0.7481
1511	CATHEPSIN G ACTIVITY#1.1024;AZUROPHIL GRANULE#1.0382;NEUTROPHIL SERINE PROTEASE#1.0285;COLLAGENASE#1.0269;PLATELET AGGREGATION#1.0256;PLATELET ACTIVATION#1.0238;MAST CELL#1.0189;UROKINASE#1.0100;NEUTROPHIL#1.0098;MYELOID CELL#1.0087;PRIMARY GRANULE#1.0086;SELECTIN#1.0060;FACTOR XA#1.0052;FIBRINOGEN#1.0041;ALPHA-1-PROTEINASE INHIBITOR#1.0035;PROTEASE ACTIVATED RECEPTOR#1.0027;ALPHA-2 MACROGLOBULIN#1.0025;LEUKOCYTE#1.0020;T CELL#1.0016;PROTEASE ACTIVITY#1.0012;PROTEIN KINASE#0.9993;ULCERATIVE COLITIS#0.9987;ELASTASE ACTIVITY#0.9983;ALPHA 1-ANTITRYPSIN#0.9977;GRANULOCYTE#0.9976;POLYMORPHONUCLEAR NEUTROPHIL#0.9971;SERPIN#0.9968;HEPARIN#0.9955;ENDOTHELIAL CELL#0.9954;POLYMORPHONUCLEAR LEUKOCYTES#0.9936;COAGULATION#0.9932;ANGIOTENSIN CONVERTING ENZYME#0.9917;RHEUMATOID ARTHRITIS#0.9906;MONONUCLEAR CELLS#0.9906;GROWTH FACTOR#0.9899;MONOCYTE#0.9891;SPUTUM#0.9885;CELL SURFACE#0.9874;TISSUE DAMAGE#0.9866;APOPTOSIS#0.9848;CONNECTIVE TISSUE#0.9839;B CELL#0.9826;EXTRACELLULAR MATRIX#0.9821;PROTEOGLYCAN#0.9817;DIGESTION#0.9812;BONE MARROW#0.9807;MACROPHAGE#0.9792;CATALYTIC ACTIVITY#0.9789;COLITIS#0.9783;T LYMPHOCYTE#0.9783;PROTEINASE INHIBITOR#0.9780;NEUTROPHIL GRANULE PROTEIN#0.9772;BREAST CANCER#0.9767;PLASMA MEMBRANE#0.9766;PERIPHERAL BLOOD#0.9765;BASEMENT MEMBRANE#0.9763;MYELOID LEUKEMIA#0.9748;EPITHELIAL CELL#0.9732;C REACTIVE PROTEIN#0.9720;CHEMOTAXIS#0.9703;INFLAMMATORY CELL#0.9698;PROMYELOCYTE#0.9691;IMMUNE RESPONSE#0.9684;INFLAMMATORY RESPONSE#0.9635;PERIODONTITIS#0.9632;CYSTIC FIBROSIS#0.9625;ENZYME INHIBITOR#0.9624;CELL ACTIVATION#0.9598;GENE EXPRESSION#0.9574;APROTININ#0.9574;ENDOTHELIUM#0.9552;DODECYL SULFATE#0.9550;SODIUM DODECYL SULFATE#0.9531;ENZYME ACTIVITY#0.9491;CD4+ T CELL#0.9480;PHAGOCYTOSIS#0.9469;DIPEPTIDYL PEPTIDASE#0.9466;CHYMOSTATIN#0.9457;TUMOR NECROSIS FACTOR#0.9454;CLOTTING#0.9426;THROMBIN RECEPTOR#0.9422;MOLAR#0.9420;VASCULITIS#0.9406;PROTEIN KINASE C#0.9406;SYNOVIAL FLUID#0.9375;CELL ADHESION#0.9297;LUNG DISEASE#0.9291;POLYMERASE CHAIN REACTION#0.9281;DENDRITIC CELL#0.9253;ALANINE#0.9216;CYTOTOXICITY#0.9211;NEUTROPHIL ACTIVATION#0.9162;CANCER CELL#0.9150;DIISOPROPYL FLUOROPHOSPHATE#0.9140;EOSINOPHIL#0.9130;LYSINE#0.9114;STEM CELL#0.9093;HUMAN UMBILICAL VEIN#0.9082;UMBILICAL VEIN#0.9080;STROMELYSIN#0.9075;CELL DEATH#0.9071;PRO-INFLAMMATORY#0.9059;CYTOTOXIC T-LYMPHOCYTE#0.9047;BETA GLUCURONIDASE#0.9038;COLLAGENASE ACTIVITY#0.8984;ELASTIN DEGRADATION#0.8978;PHOSPHOLIPASE C#0.8966;ANTI INFLAMMATORY DRUGS#0.8961;SPECIFIC GRANULE#0.8939;IMMUNE SYSTEM#0.8925;REACTIVE OXYGEN SPECIES#0.8918;INFLAMMATORY BOWEL DISEASE#0.8917;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8891;G-CSF#0.8891;IMMUNE CELL#0.8849;GLYCOSYLATION#0.8830;ARTERY#0.8828;METHIONINE#0.8826;TUMOR CELLS#0.8825;ALPHA-1 PROTEASE INHIBITOR#0.8804;CROHN'S DISEASE#0.8797;SERINE PROTEASE ACTIVITY#0.8781;NEUTROPHIL GRANULOCYTES#0.8773;THROMBOSIS#0.8770;NEUTROPHIL ELASTASE INHIBITOR#0.8741;INNATE IMMUNITY#0.8731;PLATELET ACTIVATING FACTOR#0.8729;ATHEROSCLEROTIC#0.8728;CELL PROLIFERATION#0.8725;L-PHENYLALANINE#0.8676;SURFACE PLASMON RESONANCE#0.8666;LYSOSOME#0.8625;HEPARIN BINDING#0.8617;ALVEOLAR MACROPHAGE#0.8612;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8612;COLONY-STIMULATING FACTOR#0.8610;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8557;LYSIS#0.8556;CALCIUM MOBILIZATION#0.8543;SIGNAL TRANSDUCTION#0.8541;TRANSFORMING GROWTH FACTOR#0.8541;BLOOD VESSEL#0.8510;OUTER MEMBRANE#0.8482;SMOOTH MUSCLE#0.8368;ARGININE#0.8352;ATHEROSCLEROSIS#0.8296;ANTIGEN PRESENTING CELLS#0.8284;ACUTE MYELOID LEUKEMIA#0.8274;ACUTE PROMYELOCYTIC LEUKEMIA#0.8267;WOUND HEALING#0.8252;PSORIASIS#0.8237;AMYLOID PRECURSOR PROTEIN#0.8237;MUSCLE CELL#0.8201;LUNG CANCER#0.8185;ISCHEMIA#0.8135;ARACHIDONIC ACID#0.8087;SKIN CHYMOTRYPTIC PROTEINASE#0.8081;RETINOIC ACID#0.8077;CELL MEMBRANE#0.8068;LEUCINE#0.8041;STRUCTURE ACTIVITY RELATIONSHIP#0.7994;AORTIC ANEURYSM#0.7990;PROGENITOR CELL#0.7958;PROTEASE S#0.7934;SIGNALING PATHWAY#0.7928;CORONARY ARTERY#0.7872;L-LYSINE#0.7831;S PHASE#0.7803;NITRIC OXIDE#0.7771;LUPUS ERYTHEMATOSUS#0.7766;GINGIVAL CREVICULAR FLUID#0.7738;SEROTONIN RELEASE#0.7737;SODIUM DODECYL SULPHATE#0.7716;MYOCARDIAL INFARCTION#0.7697;SQUAMOUS CELL CARCINOMA#0.7693;HISTAMINE#0.7674;ANTIGEN PROCESSING#0.7657;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.7598;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7589;RESPIRATORY DISTRESS#0.7557;GINGIVITIS#0.7499;CARDIOMYOCYTE#0.7471;1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE#0.7450;PLASMA PROTEIN#0.7430;SMOOTH MUSCLE CELL#0.7403;RECEPTOR ANTAGONIST#0.7400;ALZHEIMER'S DISEASE#0.7394;CREATINE KINASE#0.7382;NEUTROPHIL DEGRANULATION#0.7373;PERIODONTAL DISEASE#0.7362;PROTEINASE ACTIVITY#0.7343;PROTEIN SYNTHESIS#0.7337;NEUTROPHIL CHEMOTAXIS#0.7329;GRANZYME H#0.7328;SUPEROXIDE DISMUTASE#0.7322;HUMAN BREAST CANCER#0.7296;SUBSTANCE P#0.7279;ERYTHROCYTE#0.7231;GRANULOCYTE COLONY STIMULATING FACTOR#0.7219;RESPIRATORY BURST#0.7205;LYMPH NODE#0.7152;NATURAL KILLER CELL#0.7146;TUBERCULOSIS#0.7135;ACID PHOSPHATASE#0.7126;SECRETORY GRANULE#0.7124;BLOOD COAGULATION#0.7114;PULMONARY EMPHYSEMA#0.7098;LEUKOCYTE ADHESION#0.7060;PROSTACYCLIN#0.7009;CHEDIAK-HIGASHI SYNDROME#0.7005;GLOMERULONEPHRITIS#0.7003;WHITE BLOOD CELL#0.7000;CD8+ T CELL#0.6972;REVERSE TRANSCRIPTION#0.6935;SERUM ALBUMIN#0.6930;BONE MARROW CELLS#0.6921;LUNG DAMAGE#0.6917;ACUTE LUNG INJURY#0.6855;CYTOKINE PRODUCTION#0.6812;ASTROCYTE#0.6809;INTERVERTEBRAL DISC#0.6805;ETHANOL#0.6773;APOPTOTIC#0.6761;ISCHEMIA REPERFUSION INJURY#0.6737;CELL CELL ADHESION#0.6703;VIRULENCE#0.6688;CELL MIGRATION#0.6685;GLYCERALDEHYDE-3-PHOSPHATE#0.6650;FACTOR VIII#0.6617;ABDOMINAL AORTIC ANEURYSM#0.6605;EXTRACELLULAR SPACE#0.6593;CARBOXYPEPTIDASE A#0.6569;BREAST CANCER CELL#0.6556;DEFIBROTIDE#0.6555;FIBRINOLYSIS#0.6551;PRIMARY SCLEROSING CHOLANGITIS#0.6545;GM-CSF#0.6544;MUCOUS#0.6543;SCLEROSING CHOLANGITIS#0.6534;BRONCHIECTASIS#0.6533;AUTOIMMUNE DISEASE#0.6512;CREATINE#0.6508;VALINE#0.6499;PERIPHERAL BLOOD MONOCYTES#0.6483;VASCULAR ENDOTHELIAL CELL#0.6482;FOCAL ADHESION#0.6481;IONOPHORE#0.6439;FIBRIL#0.6432;FACTOR D#0.6319;MATRIX METALLOPROTEINASE 1#0.6284;ANOIKIS#0.6265;MECHANISMS OF ACTION#0.6251;COMPLEX I#0.6240;EPIDERMAL GROWTH FACTOR#0.6211;IFN-GAMMA#0.6170;IMMATURE MYELOID CELL#0.6155;OSTEOCLAST#0.6145;CYSTATIN#0.6089;CELL AGGREGATION#0.6082;ESTERASE ACTIVITY#0.6077;EDEMA#0.6046;HUMAN NEUTROPHIL PEPTIDE#0.6044;GLUTATHIONE#0.6027
151230	ACTIN CYTOSKELETON REMODELING#0.7579;ACTIN CYTOSKELETON#0.7213
151242	PROTEIN PHOSPHATASE 1#1.0761;CELL CYCLE#0.6559;NEURITE GROWTH#0.6140
151246	CENTROMERE#1.0591;MEIOSIS#1.0247;MEIOSIS I#1.0196;KINETOCHORE#0.9805;CHROMOSOME SEGREGATION#0.9303;MITOSIS#0.8750;CHROMATID#0.8604;MEIOSIS II#0.8571;ANAPHASE#0.8121;OOCYTE#0.7665;SISTER CHROMATID COHESION#0.7029;CHROMOSOME CONGRESSION#0.6639;SUBTELOMERE#0.6486;CHROMOSOME BIORIENTATION#0.6360;PROPHASE#0.6303
1512	CATHEPSIN H ACTIVITY#1.1284;AMINOPEPTIDASE ACTIVITY#1.0386;CYSTATIN#1.0124;CATHEPSIN B ACTIVITY#0.9926;LYSOSOME#0.9918;PROTEINASE INHIBITOR#0.9866;GROWTH FACTOR#0.9268;EPITHELIAL CELL#0.9212;GENE EXPRESSION#0.9205;MACROPHAGE#0.9163;VACUOLE#0.8990;PROTEIN DEGRADATION#0.8885;EXTRACELLULAR MATRIX#0.8838;ARGININE#0.8410;CANCER CELL#0.8392;PROTEASE ACTIVITY#0.8185;DIPEPTIDYL PEPTIDASE#0.8083;ENZYME ACTIVITY#0.8037;TYPE II PNEUMOCYTE#0.7689;TUMOR CELLS#0.7597;ALVEOLAR EPITHELIAL CELL#0.7483;SECRETORY GRANULE#0.7454;IMMUNE RESPONSE#0.7452;SKELETAL MUSCLE#0.7356;POLYMERASE CHAIN REACTION#0.7229;PROTEINASE ACTIVITY#0.7207;SENESCENCE#0.7052;ENDOPEPTIDASE ACTIVITY#0.6917;ACID PHOSPHATASE#0.6907;ALPHA AMYLASE#0.6828;COLLAGENASE#0.6743;L-ARGININE#0.6688;SIGNAL PEPTIDE#0.6584;DIGESTION#0.6521;BREAST CANCER#0.6499;LEUCINE#0.6356;BETA GLUCURONIDASE#0.6327;PROTOPLAST#0.6227;T CELL#0.6141;TRIPEPTIDYL PEPTIDASE#0.6119;TRANS GOLGI NETWORK#0.6053;PROSTATE CANCER#0.6015
151306	PLASMA MEMBRANE#1.0594;EPITHELIAL CELL#1.0527;CELL SURFACE#1.0517;MACROPHAGE#1.0488;ENDOTHELIAL CELL#1.0471;ENTEROENDOCRINE CELL#1.0426;BROWN ADIPOSE TISSUE#1.0401;FARNESOID X RECEPTOR#1.0389;CELL PROLIFERATION#1.0348;ENERGY HOMEOSTASIS#1.0343;GALLBLADDER#1.0270;ADIPOSE TISSUE#1.0250;GLUCOSE HOMEOSTASIS#1.0247;PROTEIN KINASE#1.0217;GROWTH FACTOR#1.0189;INFLAMMATORY RESPONSE#1.0188;CHOLIC ACID#1.0182;STRUCTURE ACTIVITY RELATIONSHIP#1.0182;NUCLEAR HORMONE RECEPTOR#1.0181;HIGH FAT DIET#1.0170;GENE EXPRESSION#1.0162;CHENODEOXYCHOLIC ACID#1.0135;GLUCOSE METABOLISM#1.0120;SIGNALING PATHWAY#1.0112;LIPID METABOLISM#1.0100;CANCER CELL#1.0098;SKELETAL MUSCLE#1.0093;PRO-INFLAMMATORY#1.0091;MONOCYTE#1.0090;BILE ACID METABOLISM#1.0066;FIBROBLAST GROWTH FACTOR#1.0037;BILE DUCT#1.0027;DEOXYCHOLIC ACID#1.0019;CHOLANGIOCYTE PROLIFERATION#1.0017;CHOLESTASIS#1.0015;APOPTOSIS#1.0011;TYPE 2 DIABETES#0.9999;VITAMIN D RECEPTOR#0.9998;SIGNALING MOLECULE#0.9957;KUPFFER CELL#0.9907;FATTY LIVER#0.9900;LIVER DISEASE#0.9885;RECEPTOR AGONIST#0.9861;BILE ACID SYNTHESIS#0.9860;SMALL INTESTINE#0.9858;FATTY LIVER DISEASE#0.9857;SCLEROSING CHOLANGITIS#0.9845;URSODEOXYCHOLIC ACID#0.9835;OBESE#0.9815;ATHEROSCLEROSIS#0.9807;SPHINGOSINE 1 PHOSPHATE#0.9796;INSULIN SECRETION#0.9785;DIABETES MELLITUS#0.9752;PREGNANE X RECEPTOR#0.9741;PRIMARY SCLEROSING CHOLANGITIS#0.9727;CYTOKINE PRODUCTION#0.9641;HYPERGLYCEMIA#0.9639;TYPE 2 DIABETES MELLITUS#0.9622;2 DIABETES MELLITUS#0.9622;GASTROINTESTINAL TRACT#0.9606;CHOLANGITIS#0.9567;DIGESTION#0.9530;CELL MEMBRANE#0.9507;WEIGHT LOSS#0.9468;NITRIC OXIDE#0.9462;WHITE ADIPOSE TISSUE#0.9383;ALCOHOLIC FATTY LIVER#0.9325;DIET INDUCED OBESITY#0.9305;PORTAL HYPERTENSION#0.9243;COLITIS#0.9233;POLYMERASE CHAIN REACTION#0.9178;KIDNEY DISEASE#0.9142;TRANSCRIPTION FACTOR#0.9089;ACINAR CELL#0.9079;CAMP SIGNALING#0.9020;SIGNALLING PATHWAY#0.8963;BILE DUCT LIGATION#0.8948;ADENOCARCINOMA#0.8831;TUDCA#0.8807;SPHINGOSINE#0.8784;LIVER DAMAGE#0.8781;INFLAMMATORY BOWEL DISEASE#0.8779;COLONIC TRANSIT#0.8659;IMMUNE CELL#0.8511;PROTEIN KINASE A#0.8467;DIPEPTIDYL PEPTIDASE#0.8455;MESANGIAL CELL#0.8450;SMOOTH MUSCLE#0.8417;CHOLANGIOCARCINOMA#0.8403;ADIPOCYTE#0.8386;MUSCLE CELL#0.8314;NITRIC OXIDE SYNTHASE#0.8204;CHOLESTEROL HOMEOSTASIS#0.8194;CHOLESTEROL METABOLISM#0.8104;DIABETIC NEPHROPATHY#0.8052;RENAL FIBROSIS#0.8028;HYPERTENSION#0.7965;LIVER REGENERATION#0.7925;CARDIOMYOCYTE#0.7903;POLYCYSTIC LIVER DISEASE#0.7890;REGENERATION#0.7841;MITOGEN ACTIVATED PROTEIN#0.7813;KIDNEY CANCER#0.7610;VASODILATION#0.7578;PRIMARY CILIUM#0.7563;REVERSE TRANSCRIPTION#0.7536;CAMP FORMATION#0.7535;GROWTH FACTOR RECEPTOR#0.7524;SIGNALING CASCADE#0.7425;LYMPH NODE METASTASIS#0.7421;HEPATITIS B#0.7420;PERIPHERAL BLOOD#0.7415;OBSTRUCTIVE JAUNDICE#0.7414;TRIAMTERENE#0.7356;ORAL GLUCOSE TOLERANCE#0.7303;NEPHROPATHY#0.7297;CYCLIC ADENOSINE MONOPHOSPHATE#0.7280;CARBOHYDRATE METABOLISM#0.7265;ADENOSINE MONOPHOSPHATE#0.7261;INNATE IMMUNITY#0.7210;ENDOPLASMIC RETICULUM#0.7179;T CELL#0.7160;TUMOR NECROSIS FACTOR#0.7156;LYMPH NODE#0.7153;TAUROURSODEOXYCHOLIC ACID#0.7005;REACTIVE OXYGEN SPECIES#0.7003;NERVOUS SYSTEM#0.6987;IMMUNE SYSTEM#0.6942;TOXICITY#0.6940;EPIDERMAL GROWTH FACTOR#0.6838;BREAST CANCER#0.6820;EPITHELIAL CELL PROLIFERATION#0.6790;GLUCOSE TOLERANCE TEST#0.6786;ADENYLATE CYCLASE#0.6740;INTRAHEPATIC CHOLESTASIS#0.6716;SPINAL CORD#0.6697;DENDRITIC CELL#0.6693;CELL DIFFERENTIATION#0.6648;NONALCOHOLIC FATTY LIVER DISEASE#0.6522;TRANSACTIVATION#0.6519;GLUCOSE UPTAKE#0.6498;CYCLIC AMP#0.6491;LOW DENSITY LIPOPROTEIN#0.6441;LIPID HOMEOSTASIS#0.6378;GASTRIC EMPTYING#0.6362;CHRONIC LIVER DISEASE#0.6341;ADENOSINE#0.6319;LUMINAL#0.6306;REGULATION OF GLUCOSE METABOLISM#0.6261;REGULATION OF ENERGY HOMEOSTASIS#0.6214;BARRETT'S ESOPHAGUS#0.6167;INTRAHEPATIC CHOLESTASIS OF PREGNANCY#0.6165;RECEPTOR ANTAGONIST#0.6159;TRANSMEMBRANE RECEPTOR#0.6112;INTESTINAL EPITHELIAL CELL#0.6077;APOPTOTIC#0.6073;MUSCLE HYPERTROPHY#0.6027;GALL BLADDER#0.6010;INTESTINAL MOTILITY#0.6004;HIGH GRADE DYSPLASIA#0.6002
151354	DNA REPAIR#0.7043;LIGASE ACTIVITY#0.6682;COLON CANCER#0.6517;CELL MIGRATION#0.6490
1513	CATHEPSIN K ACTIVITY#1.0846;PYCNODYSOSTOSIS#1.0665;CALCITONIN RECEPTOR#1.0469;COLLAGENASE#1.0237;CYSTATIN#1.0154;DENDRITIC CELL#1.0143;COLLAGEN DEGRADATION#1.0124;ROOT RESORPTION#1.0103;OSTEOPETROSIS#1.0031;ACTIVATED T-CELLS#1.0023;ACTIVATED T CELL#1.0021;OSTEOCLAST#1.0020;SMOOTH MUSCLE#1.0016;SQUAMOUS CELL CARCINOMA#1.0008;BREAST CANCER CELL#0.9999;ACID PHOSPHATASE#0.9978;BREAST CANCER#0.9978;LYSOSOME#0.9949;OSTEOARTHRITIS#0.9947;OSTEOCYTE#0.9944;TUMOR CELLS#0.9941;DENOSUMAB#0.9933;EPITHELIAL CELL#0.9927;T CELL#0.9923;ENZYME ACTIVITY#0.9913;CHONDROCYTE#0.9912;ALENDRONATE#0.9903;REVERSE TRANSCRIPTION#0.9898;INHIBITION OF BONE RESORPTION#0.9885;SMOOTH MUSCLE ACTIN#0.9875;COLLAGENASE ACTIVITY#0.9874;BONE REMODELLING#0.9872;QUANTITATIVE REAL TIME#0.9860;ENDOTHELIAL CELL#0.9849;CRUCIATE LIGAMENT#0.9834;BONE TURNOVER MARKER#0.9829;BONE MARROW CELLS#0.9828;COLLAGEN TYPE I#0.9821;POLYMERASE CHAIN REACTION#0.9817;COLLAGEN INDUCED ARTHRITIS#0.9811;CANCER CELL#0.9809;ALKALINE PHOSPHATASE#0.9808;PARATHYROID HORMONE#0.9808;GENE EXPRESSION#0.9803;PARATHYROID#0.9794;ATHEROSCLEROSIS#0.9793;EXTRACELLULAR MATRIX#0.9777;TIBIA#0.9765;BONE RESORPTION#0.9762;ATHEROSCLEROTIC#0.9758;APOPTOSIS#0.9757;TRANSCRIPTION FACTOR#0.9756;BONE CELLS#0.9752;CELL FUSION#0.9749;OSTEOCLAST PRECURSOR CELL#0.9745;PERIODONTITIS#0.9741;STROMAL CELL#0.9733;TUMOR NECROSIS FACTOR#0.9720;BONE REMODELING#0.9715;CHLORIDE CHANNEL#0.9706;TRANSFORMING GROWTH FACTOR#0.9699;PRECURSOR CELL#0.9694;PROSTATE CANCER#0.9693;CALCINEURIN#0.9692;OSTEOBLAST DIFFERENTIATION#0.9687;GROWTH FACTOR#0.9687;MINERALIZATION#0.9677;RENAL CELL CARCINOMA#0.9666;BONE MINERAL DENSITY#0.9661;PROTEASE ACTIVITY#0.9654;TOLL LIKE RECEPTOR#0.9651;OSTEOPOROSIS#0.9648;MONONUCLEAR CELLS#0.9644;BONE FORMATION#0.9628;STEM CELL#0.9625;OSTEOCLAST DIFFERENTIATION#0.9625;RECEPTOR ACTIVATOR#0.9621;SYNOVIUM#0.9621;MECHANISM OF ACTION#0.9617;FEMUR#0.9606;COLONY-STIMULATING FACTOR#0.9598;OSTEOBLAST#0.9598;MITOGEN ACTIVATED PROTEIN#0.9590;MONOCYTE#0.9583;RHEUMATOID ARTHRITIS#0.9566;PERIPHERAL BLOOD#0.9565;PHOSPHATASE ACTIVITY#0.9557;CELL PROLIFERATION#0.9557;BONE MARROW#0.9556;BONE DISEASE#0.9555;PROTEIN KINASE#0.9551;MACROPHAGE#0.9547;CYTOPLASM#0.9544;SIGNALING PATHWAY#0.9513;PROGENITOR CELL#0.9503;OSTEOGENESIS#0.9501;REACTIVE OXYGEN SPECIES#0.9485;IMMUNE RESPONSE#0.9466;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9458;PROTEINASE INHIBITOR#0.9435;SKELETON#0.9431;MICROPHTHALMIA#0.9430;PRO-INFLAMMATORY#0.9421;CELL DIFFERENTIATION#0.9414;FIBRIL#0.9394;BONE MORPHOGENETIC PROTEIN#0.9375;CYTOTOXICITY#0.9361;PERIODONTAL LIGAMENT#0.9334;PERIVASCULAR EPITHELIOID CELL#0.9299;CARBONIC ANHYDRASE 2#0.9294;NEUTROPHIL#0.9266;OSTEOSCLEROSIS#0.9264;ZOLEDRONIC ACID#0.9256;INFLAMMATORY RESPONSE#0.9255;IMMUNE SYSTEM#0.9238;PERIODONTAL DISEASE#0.9191;TRABECULAR BONE VOLUME#0.9140;ACIDIFICATION#0.9126;ADIPOCYTE DIFFERENTIATION#0.9118;ADIPOCYTE#0.9111;ESTROGEN RECEPTOR#0.9108;PLASMA MEMBRANE#0.9105;FIBROBLAST GROWTH FACTOR#0.9075;OSTEOARTHRITIC CARTILAGE#0.9062;STROMA#0.9032;KNEE JOINT#0.9017;KINASE INHIBITOR#0.8997;APOPTOTIC#0.8984;REGENERATION#0.8973;DIGESTION#0.8968;MAPK SIGNALING#0.8941;HIGH FAT DIET#0.8923;ALKALINE PHOSPHATASE ACTIVITY#0.8921;ENDOTHELIAL GROWTH FACTOR#0.8900;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8900;MATRIX METALLOPROTEINASE 1#0.8874;SIGNALING MOLECULE#0.8863;TRANSCRIPTASE#0.8829;TRANSFORMING GROWTH FACTOR BETA#0.8807;MOLAR#0.8782;INSULIN-LIKE GROWTH FACTOR#0.8741;PROTON PUMP#0.8726;GINGIVAL CREVICULAR FLUID#0.8716;ADIPOSE TISSUE#0.8662;SCANNING ELECTRON MICROSCOPY#0.8642;MARROW STROMAL CELLS#0.8628;ORTHODONTIC TOOTH MOVEMENT#0.8625;ANTERIOR CRUCIATE LIGAMENT#0.8570;MUSCLE CELL#0.8544;ESTRADIOL#0.8520;BONE MARROW STROMAL CELL#0.8519;BONE MARROW STROMAL#0.8515;MESENCHYMAL CELL#0.8498;VERTEBRAE#0.8491;MESENCHYMAL STEM CELL#0.8484;MAP KINASE#0.8467;INFLAMMATORY CELL#0.8463;SMOOTH MUSCLE CELL#0.8440;BONE REGENERATION#0.8433;SYNOVIAL FLUID#0.8432;LOW DENSITY LIPOPROTEIN#0.8409;B CELL#0.8398;MATRIX METALLO PROTEINASE#0.8372;TRADITIONAL CHINESE MEDICINE#0.8334;TERIPARATIDE#0.8326;AUTOPHAGY#0.8301;SIGNALLING PATHWAY#0.8248;GLUTATHIONE#0.8235;INHIBITION OF OSTEOCLAST DIFFERENTIATION#0.8218;OSSIFICATION#0.8207;MECHANISMS OF ACTION#0.8194;OSTEOCLAST FUSION#0.8149;ARTERY#0.8127;EXTRACELLULAR SPACE#0.8123;AORTIC ANEURYSM#0.8094;GENETIC DISORDER#0.8083;TUMOUR NECROSIS FACTOR#0.8069;ALVEOLAR SOFT PART SARCOMA#0.8044;QUANTITATIVE COMPUTED TOMOGRAPHY#0.8021;CONNECTIVE TISSUE#0.7965;HYPOXIA#0.7957;LEUCINE#0.7941;TARGET OF RAPAMYCIN#0.7923;CELL CYCLE#0.7921;RECEPTOR ANTAGONIST#0.7874;NERVOUS SYSTEM#0.7867;CELL ADHESION#0.7848;ACTIVATOR PROTEIN 1#0.7845;DEXAMETHASONE#0.7842;CELL SURFACE#0.7839;OBESE#0.7836;SKULL BASE CHORDOMA#0.7834;MOLECULAR DYNAMICS SIMULATION#0.7804;DEMINERALIZATION#0.7787;ORAL SQUAMOUS CELL CARCINOMA#0.7771;BONE MARROW MONOCYTE#0.7768;SIGNAL TRANSDUCTION#0.7766;NITRIC OXIDE#0.7756;LUNG CANCER#0.7751;VACUOLE#0.7738;BLOOD VESSEL#0.7689;TOXICITY#0.7677;MATRIX METALLOPROTEINASE 13#0.7656;CARDIOMYOCYTE#0.7643;BONE FORMATION RATE#0.7630;CELL MIGRATION#0.7591;MONOCYTE DERIVED MACROPHAGE#0.7584;IFN-GAMMA#0.7561;CHEMOKINE RECEPTOR#0.7550;MYOCARDIAL INFARCTION#0.7544;OSTEOCLAST DEVELOPMENT#0.7504;LEUKOCYTE#0.7497;ABDOMINAL AORTIC ANEURYSM#0.7489;VITAMIN D3#0.7459;HEART MUSCLE#0.7427;SIGNALING CASCADE#0.7414;HYDROXYPROLINE#0.7385;BONE GROWTH#0.7374;M2 MACROPHAGE#0.7364;MANDIBLE#0.7362;CELL CELL FUSION#0.7346;PEROXISOME#0.7340;OSTEOCLAST MATURATION#0.7337;RAPAMYCIN#0.7337;PROTEOGLYCAN#0.7298;ALVEOLAR BONE LOSS#0.7208;MULTIPLE MYELOMA#0.7207;BONE DEVELOPMENT#0.7195;OSTEONECROSIS#0.7166;BRONCHIAL EPITHELIAL CELLS#0.7164;PROTEIN SYNTHESIS#0.7156;TISSUE REMODELING#0.7116;PROTEINASE ACTIVITY#0.7108;BONE MINERALIZATION#0.7052;IMMUNE CELL#0.7047;ANGIOGENESIS#0.7044;ANKYLOSING SPONDYLITIS#0.7044;ENDOPLASMIC RETICULUM#0.7040;DERMAL FIBROBLAST#0.7004;ARGININE#0.6968;CORONARY ARTERY#0.6949;CYTOKINE PRODUCTION#0.6945;RECEPTOR AGONIST#0.6937;CELL GROWTH#0.6922;REGULATION OF OSTEOCLAST DIFFERENTIATION#0.6922;PROTEIN DEGRADATION#0.6917;CELL DEATH#0.6913;ENDOCHONDRAL OSSIFICATION#0.6905;LUNG DISEASE#0.6905;GIANT CELL TUMOR#0.6866;PROSTATE CARCINOMA#0.6855;SKIN FIBROBLASTS#0.6830;BONE MORPHOGENIC PROTEIN#0.6796;PULMONARY FIBROSIS#0.6749;BONE VOLUME FRACTION#0.6713;WEIGHT GAIN#0.6712;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6704;EOSIN#0.6684;RAT BONE MARROW#0.6677;CYANAMIDE#0.6674;LYMPH NODE#0.6654;ACID PHOSPHATASE ACTIVITY#0.6651;PERIVASCULAR EPITHELIOID CELL TUMOR#0.6646;HYPOXIC#0.6621;C REACTIVE PROTEIN#0.6606;TRANSMISSION ELECTRON MICROSCOPY#0.6603;WOUND HEALING#0.6583;OVARIAN#0.6577;DIABETES MELLITUS#0.6563;PERIOSTEUM#0.6557;ELASTASE ACTIVITY#0.6529;SWELLING#0.6522;FACTOR I#0.6520;STREPTOZOTOCIN#0.6458;CENTRAL NERVOUS SYSTEM#0.6414;MAST CELL#0.6406;SYNOVITIS#0.6397;ANGIOMYOLIPOMA#0.6347;EXCRETION#0.6264;VERTEBRA#0.6261;OSTEOLYTIC BONE DISEASE#0.6226;COLLAGEN TYPE II#0.6202;LASER SCANNING MICROSCOPY#0.6176;ALVEOLAR MACROPHAGE#0.6140;QUANTITATIVE REVERSE TRANSCRIPTION#0.6137;CATALYTIC ACTIVITY#0.6118;ADVANCED GLYCATION END#0.6112;ANGIOTENSIN CONVERTING ENZYME#0.6108;ENZYME INHIBITOR#0.6093;CARBOXYPEPTIDASE ACTIVITY#0.6088;BASEMENT MEMBRANE#0.6086;ADIPOGENESIS#0.6067;CHANNEL INHIBITOR#0.6059;FIBRILLAR COLLAGEN#0.6012;BONE MARROW MICROENVIRONMENT#0.6009;GINGIVAL EPITHELIAL CELLS#0.6005
151449	GROWTH FACTOR#1.0401;BONE MORPHOGENETIC PROTEIN#1.0288;STEM CELL#1.0206;ROOF PLATE#1.0178;GENE EXPRESSION#1.0052;MESENCHYMAL STEM CELL#0.9974;GROWTH DIFFERENTIATION FACTOR#0.9961;TRANSFORMING GROWTH FACTOR#0.9887;BONE MARROW#0.9669;ASCORBIC ACID#0.9423;ALKALINE PHOSPHATASE#0.9175;REGENERATION#0.8889;CHONDROCYTE#0.8160;BONE MORPHOGENIC PROTEIN#0.7892;SIGNALING PATHWAY#0.7719;TRANSCRIPTION FACTOR#0.7130;TISSUE REGENERATION#0.7129;FIBROBLAST GROWTH FACTOR#0.7040;BONE FORMATION#0.6923;COLLAGEN TYPE I#0.6799;ALKALINE PHOSPHATASE ACTIVITY#0.6690;PHOSPHATASE ACTIVITY#0.6661;TRANSFORMING GROWTH FACTOR BETA#0.6335;CHOROID PLEXUS#0.6292;PROGENITOR CELL#0.6275
151473	GASTROINTESTINAL TRACT#0.6789;CELLULAR LOCALIZATION#0.6531;MAMMARY GLAND#0.6212
1514	CATHEPSIN L ACTIVITY#1.0662;SECRETORY VESICLE#1.0545;L-CYSTEINE#1.0537;SERTOLI CELL#1.0375;PODOCYTE#1.0367;LUNG CANCER#1.0287;ALVEOLAR MACROPHAGE#1.0197;OVARIAN CANCER#1.0168;GERM CELL#1.0163;UROKINASE#1.0143;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#1.0122;HAIR FOLLICLE#1.0110;ACID PHOSPHATASE#1.0096;BREAST CANCER CELL#1.0092;PROTEINASE ACTIVITY#1.0076;BONE RESORPTION#1.0066;PROTEASOME#1.0064;CELL MIGRATION#1.0057;COLORECTAL#1.0052;LYSOSOMAL MEMBRANE#1.0046;OSTEOCLAST#1.0045;VACUOLE#1.0040;CATHEPSIN B ACTIVITY#1.0036;CD4+ T CELL#1.0025;BREAST CANCER#1.0014;CELL PROLIFERATION#1.0000;COLLAGENASE#1.0000;AUTOPHAGY#0.9999;CYTOCHROME C#0.9997;B CELL#0.9993;SERPIN#0.9990;LYMPH NODE#0.9990;RHEUMATOID ARTHRITIS#0.9985;CELL CYCLE#0.9981;CYSTATIN#0.9979;GROWTH FACTOR#0.9972;ANGIOGENESIS#0.9968;ENDOSOME#0.9948;TRANSCRIPTION FACTOR#0.9942;ENDOTHELIAL CELL#0.9928;MIDGUT#0.9925;TUMOR CELLS#0.9913;CANCER CELL#0.9883;OVARIAN#0.9879;BASEMENT MEMBRANE#0.9879;UBIQUITIN#0.9875;RNA INTERFERENCE#0.9872;VIRULENCE#0.9864;PROTEASE ACTIVITY#0.9851;MONOCYTE#0.9847;CYTOPLASM#0.9839;APOPTOSIS#0.9835;APOPTOTIC#0.9828;SQUAMOUS CELL CARCINOMA#0.9815;REVERSE TRANSCRIPTION#0.9812;T CELL#0.9811;GLUTATHIONE#0.9811;SIGNAL PEPTIDE#0.9806;EPITHELIAL CELL#0.9801;KERATINOCYTE#0.9800;LYSOSOME#0.9799;SKELETAL MUSCLE#0.9799;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9798;DIGESTION#0.9798;MACROPHAGE#0.9790;SIGNALING PATHWAY#0.9790;ANTIGEN PRESENTATION#0.9788;PROTEIN DEGRADATION#0.9784;NEUTROPHIL#0.9782;POLYMERASE CHAIN REACTION#0.9776;EXTRACELLULAR MATRIX#0.9767;PROTEINASE INHIBITOR#0.9763;COLORECTAL CANCER#0.9761;ENZYME ACTIVITY#0.9745;CELL DEATH#0.9745;PROTEIN KINASE#0.9737;FASCIOLIASIS#0.9730;BETA GLUCURONIDASE#0.9729;ANTIGEN PROCESSING#0.9727;CELL SURFACE#0.9726;BONE MARROW#0.9719;IMMUNE RESPONSE#0.9712;LYSOSOMAL MEMBRANE PERMEABILIZATION#0.9710;ENDOPLASMIC RETICULUM#0.9704;PEPSTATIN#0.9704;MUSCLE CELL#0.9678;HOST CELL#0.9677;IMMUNE SYSTEM#0.9672;DENDRITIC CELL#0.9667;PROTEIN SYNTHESIS#0.9658;GENE EXPRESSION#0.9646;FATTY ACID BINDING#0.9637;LEUCINE#0.9623;IFN-GAMMA#0.9615;PLASMA MEMBRANE#0.9610;MUSCLE ATROPHY#0.9605;INSULIN-LIKE GROWTH FACTOR#0.9568;HEAT SHOCK PROTEIN#0.9554;MUTAGENESIS#0.9538;ARGININE#0.9536;OOCYTE#0.9534;PERIPHERAL BLOOD#0.9508;ANTIGEN PRESENTING CELLS#0.9502;DRUG RESISTANCE#0.9475;DODECYL SULFATE#0.9462;PROGESTERONE#0.9435;SODIUM DODECYL SULFATE#0.9431;CYSTEINE PROTEASE ACTIVITY#0.9404;SPINAL CORD#0.9404;AUTOPHAGOSOME#0.9403;SEVERE ACUTE RESPIRATORY SYNDROME#0.9399;CELL ADHESION#0.9349;IMMUNE EVASION#0.9345;SMOOTH MUSCLE#0.9305;RECEPTOR BINDING#0.9304;COLLAGEN DEGRADATION#0.9299;AUTOPHAGIC VACUOLE#0.9283;ADENOCARCINOMA#0.9279;T LYMPHOCYTE#0.9272;DERMAL FIBROBLAST#0.9261;COLORECTAL CARCINOMA#0.9242;ENDOCYTOSIS#0.9232;EPITHELIAL MESENCHYMAL TRANSITION#0.9212;PROTEINURIA#0.9203;PROTEOGLYCAN#0.9184;METHIONINE#0.9180;ASTROCYTE#0.9172;ACIDIFICATION#0.9167;STEM CELL#0.9151;CYTOTOXICITY#0.9150;CONNECTIVE TISSUE#0.9149;QUANTITATIVE REAL TIME#0.9136;TUMOR TISSUES#0.9128;UROKINASE PLASMINOGEN ACTIVATOR#0.9124;DILATED CARDIOMYOPATHY#0.9104;REACTIVE OXYGEN SPECIES#0.9095;MAST CELL#0.9090;PEPTIDE HORMONE#0.9089;CERVICAL#0.9058;TRANSFORMING GROWTH FACTOR#0.9053;SECRETORY PATHWAY#0.9053;PRO-INFLAMMATORY#0.9006;TOXICITY#0.8983;ALANINE#0.8968;GLYCOSYLATION#0.8964;ATHEROSCLEROSIS#0.8959;TUMOR NECROSIS FACTOR#0.8954;SUPEROXIDE DISMUTASE#0.8930;ENDOMETRIUM#0.8927;PANCREATITIS#0.8918;PROTEIN BREAKDOWN#0.8898;ATHEROSCLEROTIC#0.8897;ORGANELLE#0.8884;CHAGAS DISEASE#0.8874;ASPARAGINE#0.8848;ENDOTHELIAL GROWTH FACTOR#0.8829;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8829;INFLAMMATORY RESPONSE#0.8821;CYTOTOXIC T-LYMPHOCYTE#0.8821;LEUKOCYTE#0.8815;NERVOUS SYSTEM#0.8811;ARTERY#0.8791;OPIOID PEPTIDE#0.8762;KIDNEY DISEASE#0.8742;ISCHEMIA#0.8727;MOUSE EMBRYONIC FIBROBLAST#0.8700;PARKINSON'S DISEASE#0.8685;VASCULAR CELL#0.8684;LYMPHOCYTE ANTIGEN#0.8652;LYSINE#0.8633;COLONY-STIMULATING FACTOR#0.8623;BREAST CANCER PATIENTS#0.8612;MUSCLE WASTING#0.8595;MECHANISM OF ACTION#0.8594;CATALYTIC ACTIVITY#0.8584;CARDIOMYOPATHY#0.8574;INNATE IMMUNITY#0.8562;FIBROBLAST GROWTH FACTOR#0.8561;LIGHT CHAIN 3#0.8556;CORONARY HEART DISEASE#0.8553;VIRION#0.8548;CELL GROWTH#0.8541;LATE ENDOSOME#0.8518;MITOCHONDRIA#0.8508;CHONDROCYTE#0.8500;ACTIN CYTOSKELETON#0.8489;HEART DISEASE#0.8487;LUMINAL#0.8454;PROSTATE CANCER#0.8433;TRYPSINOGEN ACTIVATION#0.8407;MEMBRANE FUSION#0.8376;DISEASE FREE SURVIVAL#0.8366;HUMAN BREAST CANCER#0.8331;EXCRETION#0.8330;HISTIDINE#0.8308;PEPTIDASE INHIBITOR#0.8300;MONONUCLEAR CELLS#0.8298;IMMUNE CELL#0.8296;SMOOTH MUSCLE CELL#0.8289;SERUM ALBUMIN#0.8280;HEPARIN#0.8269;GESTATION#0.8268;AORTIC ANEURYSM#0.8261;MATRIX METALLOPROTEINASE 1#0.8215;INFLAMMATORY CELL#0.8196;MITOGEN ACTIVATED PROTEIN#0.8182;S PHASE#0.8174;CATABOLISM#0.8167;YOLK PROTEIN#0.8156;REGULATED SECRETORY PATHWAY#0.8117;HAIR FOLLICLE MORPHOGENESIS#0.8111;PUROMYCIN#0.8107;PACLITAXEL#0.8090;GROWTH FACTOR BINDING#0.8078;DNA FRAGMENTATION#0.8069;MOLECULAR DYNAMICS SIMULATION#0.8057;METAMORPHOSIS#0.8036;GLYCINE#0.8028;HYPOXIA#0.8025;GRANULOCYTE#0.7992;PROGENITOR CELL#0.7991;PANCREATIC CANCER#0.7980;CELL MEMBRANE#0.7946;20S PROTEASOME#0.7893;CORONARY ARTERY#0.7883;CHLOROQUINE#0.7828;MYOFIBRIL#0.7816;CATHEPSIN D ACTIVITY#0.7774;ACINAR CELL#0.7772;GRANULOSA CELL#0.7765;HEPATOCELLULAR CARCINOMA#0.7743;SKELETAL MUSCLE ATROPHY#0.7743;MICROVASCULAR ENDOTHELIAL CELL#0.7733;L-ARGININE#0.7728;LECTIN#0.7716;DEXAMETHASONE#0.7709;PROGRAMMED CELL DEATH#0.7703;CHROMAFFIN CELL#0.7691;HEMOCYTE#0.7676;ADIPOSE TISSUE#0.7675;ALZHEIMER'S DISEASE#0.7666;SENESCENCE#0.7656;3-METHYLADENINE#0.7650;T CELL SELECTION#0.7648;ETHANOL#0.7642;FIBRINOGEN#0.7636;CERVICAL CANCER#0.7627;ZYMOGEN ACTIVATION#0.7622;STRUCTURE ACTIVITY RELATIONSHIP#0.7618;DNA REPAIR#0.7595;GLYCERALDEHYDE-3-PHOSPHATE#0.7588;IMMUNOGLOBULIN G#0.7588;OOCYTE MATURATION#0.7586;BLOOD BRAIN BARRIER#0.7560;HUMAN DERMAL FIBROBLAST#0.7556;MICROTUBULE ASSOCIATED PROTEIN#0.7540;C TERMINAL DOMAIN#0.7537;MYOBLAST#0.7518;CYTOCHROME C OXIDASE#0.7517;CENTRAL NERVOUS SYSTEM#0.7507;LEISHMANIASIS#0.7487;CATHEPSIN H ACTIVITY#0.7486;MICROTUBULE#0.7474;AUTOLYSIS#0.7463;BAFILOMYCIN A1#0.7455;SECRETORY GRANULE#0.7449;MIDDLE EAR#0.7440;STEROID HORMONE RECEPTOR#0.7419;ENZYME INHIBITOR#0.7416;BLOOD VESSEL#0.7391;CELL DIFFERENTIATION#0.7386;SIGNAL TRANSDUCTION#0.7382;CELL CYCLE ARREST#0.7358;ENDOPEPTIDASE ACTIVITY#0.7354;MULTIPLE SCLEROSIS#0.7323;SPERMATOGENESIS#0.7299;THYMIC EPITHELIAL CELLS#0.7297;HYDROXYPROLINE#0.7284;GRANULOCYTE COLONY STIMULATING FACTOR#0.7274;DNA SYNTHESIS#0.7255;CELL FUSION#0.7253;PROTEASE S#0.7231;EPITHELIAL OVARIAN CANCER#0.7224;THYMOCYTE#0.7222;MYOSIN HEAVY CHAIN#0.7219;T HELPER CELL#0.7213;MUSCLE FIBER#0.7210;LYSOSOMAL PROTEOLYSIS#0.7203;TISSUE DAMAGE#0.7197;TUMOR ASSOCIATED MACROPHAGE#0.7188;BREAST CARCINOMA#0.7178;INTRACELLULAR LOCALIZATION#0.7176;TRANSFORMING GROWTH FACTOR BETA#0.7173;STROMAL CELL#0.7171;LYMPH NODE METASTASIS#0.7171;INNATE IMMUNE RESPONSE#0.7124;CARDIOMYOCYTE#0.7110;ANGIOTENSIN CONVERTING ENZYME#0.7110;LOW DENSITY LIPOPROTEIN#0.7077;MONOCYTE DERIVED MACROPHAGE#0.7034;ARSENITE#0.7032;EPIDERMAL GROWTH FACTOR#0.7026;BIOTIN#0.7010;UTERUS#0.7000;MYOCARDIUM#0.6990;ACTIVITY BASED PROBES#0.6974;TUMOUR NECROSIS FACTOR#0.6968;LUNG CARCINOMA#0.6963;CYSTEIN#0.6948;OUTER CAPSID#0.6946;FIBRIL#0.6943;TOLL LIKE RECEPTOR#0.6935;MORPHOGENESIS#0.6927;BLOOD PLASMA#0.6920;OVULATION#0.6902;NEUROBLASTOMA#0.6900;PHAGOCYTOSIS#0.6880;PROTEIN DIGESTION#0.6859;GROWTH FACTOR RECEPTOR#0.6847;CASPASE INHIBITOR#0.6844;CASPASE-3 ACTIVITY#0.6809;VIRAL INFECTION#0.6804;MITOCHONDRIAL MEMBRANE#0.6799;PARATHYROID HORMONE#0.6788;REGENERATION#0.6780;STROMELYSIN#0.6771;CISPLATIN#0.6740;MAMMARY GLAND#0.6721;HISTONE DEACETYLASE#0.6707;CEREBRAL CORTEX#0.6707;TRANSMISSION ELECTRON MICROSCOPY#0.6697;INTERFERON STIMULATED GENE#0.6692;MONOCYTE CHEMOTACTIC PROTEIN#0.6690;ALPHA-2 MACROGLOBULIN#0.6676;MYOCARDIAL INFARCTION#0.6664;ACUTE CORONARY SYNDROME#0.6651;CALPAIN ACTIVITY#0.6643;NECROTIC#0.6631;HYPERTENSION#0.6581;TYPE 2 DIABETES#0.6578;EXTRACELLULAR SPACE#0.6573;BENZOPHENONE#0.6569;PROXIMAL TUBULE CELL#0.6545;CATHEPSIN S ACTIVITY#0.6540;DIABETIC NEPHROPATHY#0.6540;VIRAL GLYCOPROTEIN#0.6534;C REACTIVE PROTEIN#0.6505;OSTEOARTHRITIS#0.6505;TUMOR SUPPRESSOR#0.6497;ASPARTATE#0.6493;ORAL SQUAMOUS CELL CARCINOMA#0.6483;EARLY ENDOSOME#0.6477;EXTRACELLULAR MATRIX COMPONENT#0.6452;INNATE IMMUNE SYSTEM#0.6434;DIPEPTIDYL PEPTIDASE#0.6433;AMYLOID PRECURSOR PROTEIN#0.6418;PLATELET-DERIVED GROWTH FACTOR#0.6408;RETINOIC ACID#0.6397;CELL ADHESION MOLECULE#0.6396;GLOMERULAR FILTRATION#0.6392;RAPAMYCIN#0.6360;PROTEIN PROCESSING#0.6319;LOCALISATION#0.6305;GALECTIN#0.6296;ABDOMINAL AORTIC ANEURYSM#0.6294;FERTILIZATION#0.6286;SPERMATOCYTES#0.6283;COLLAGENASE ACTIVITY#0.6256;LUNG EPITHELIAL CELL#0.6247;SALIVARY GLAND#0.6243;CELL DEVELOPMENT#0.6233;FLUSHING#0.6227;SURFACE PLASMON RESONANCE#0.6219;HYPOXIC#0.6216;HEPARANASE ACTIVITY#0.6210;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6208;NEPHROPATHY#0.6207;CYCLIC AMP#0.6181;COLON CANCER#0.6171;OSTEOPOROSIS#0.6134;C-LEVEL#0.6127;TISSUE REMODELING#0.6126;MECHANISMS OF ACTION#0.6115;WEIGHT GAIN#0.6108;HUMAN AFRICAN TRYPANOSOMIASIS#0.6095;TRYPANOSOMIASIS#0.6075;PARACRINE SIGNALING#0.6073;CATHEPSIN K ACTIVITY#0.6070;ALKALINE PHOSPHATASE#0.6056;TRYPTOPHAN#0.6044;TISSUE INVASION#0.6039;CARDIAC CONTRACTION#0.6027;ADENOSINE#0.6021;BASAL LAMINA#0.6019
151531	URIDINE PHOSPHORYLASE#0.7680;URIDINE#0.6003
151534	CELL MIGRATION#0.6738;LUNG CANCER#0.6717
1515	CYSTATIN#0.9563;ENDOTHELIAL CELL#0.9069;GENE EXPRESSION#0.8584;CORNEAL EPITHELIUM#0.8366;KERATINOCYTE#0.8129;EXTRACELLULAR MATRIX#0.7408;EPITHELIAL CELL#0.7152;HAIR FOLLICLE#0.7035;POLYMERASE CHAIN REACTION#0.6887;SECRETORY VESICLE#0.6570
151613	ZINC FINGER 2#0.9656;CANCER TESTIS ANTIGEN#0.9296
151636	UBIQUITIN#0.9416;DNA DAMAGE RESPONSE#0.8580;DNA REPAIR#0.8038;B CELL#0.7026;POLY ADP RIBOSE#0.6466;MULTIPLE MYELOMA CELLS#0.6118;MARROW STROMAL CELLS#0.6011;BONE MARROW STROMAL CELL#0.6011;BONE MARROW STROMAL#0.6004
151647	CERVICAL#1.0817;CERVICAL CANCER#1.0275;DNA METHYLATION#0.9875;QUANTITATIVE METHYLATION SPECIFIC#0.8287;METHYLATION SPECIFIC PCR#0.8157;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.7461;MACROPHAGE#0.6599;CERVICAL CANCER SCREENING#0.6059
151648	PROTEIN PHOSPHATASE 2A#1.0660;PHOSPHATASE 2A#1.0656;CENTROMERE#1.0434;MEIOSIS I#1.0404;KINETOCHORE#1.0335;MEIOSIS#1.0308;PROPHASE#1.0167;CELL CYCLE#1.0149;BUDDING#1.0139;MITOSIS#1.0130;SISTER CHROMATID COHESION#1.0129;ANAPHASE#1.0088;CHROMATID#1.0064;CHROMOSOME SEGREGATION#1.0009;MICROTUBULE#0.9952;MEIOSIS II#0.9897;SPINDLE ASSEMBLY#0.9818;SPINDLE CHECKPOINT#0.9758;COHESIN COMPLEX#0.9694;METAPHASE#0.9647;SPINDLE ASSEMBLY CHECKPOINT#0.9531;KINETOCHORE MICROTUBULE#0.9527;CANCER CELL#0.9479;CENTROSOME#0.9368;CELL DIVISION#0.9326;SPINDLE POLE#0.9303;MITOTIC CHROMOSOME#0.9174;HETEROCHROMATIN#0.8578;MEIOTIC CHROMOSOME#0.8546;BREAST CANCER#0.8456;CHROMOSOME BIORIENTATION#0.8386;RNA INTERFERENCE#0.8348;INTERPHASE#0.8261;KINETOCHORE-MICROTUBULE ATTACHMENT#0.8168;APOPTOSIS#0.8163;ANAPHASE PROMOTING COMPLEX#0.8095;CELL PROLIFERATION#0.8089;CENTRIOLE#0.8060;OOCYTE#0.8049;COLORECTAL CANCER#0.7948;LUNG CANCER#0.7934;HISTONE H2A PHOSPHORYLATION#0.7680;CHROMOSOMAL PASSENGER COMPLEX#0.7555;CYCLIN DEPENDENT KINASE#0.7525;PROSTATE CANCER#0.7325;CHROMOSOME CONGRESSION#0.7150;MICROTUBULE DYNAMICS#0.7114;SPINDLE MICROTUBULE#0.7111;HETEROCHROMATIN PROTEIN 1#0.7016;GENE EXPRESSION#0.6804;COLON CANCER#0.6799;KINASE ACTIVITY#0.6633;BIPOLAR ATTACHMENT#0.6558;MITOTIC SPINDLE#0.6452;CHROMOSOME SEPARATION#0.6449;INTESTINAL PSEUDO-OBSTRUCTION#0.6387;COLORECTAL#0.6302;CENTROMERIC HETEROCHROMATIN#0.6289;SET BINDING#0.6006
151742	PROTEIN KINASE#0.7216;PROTEIN PHOSPHATASE 1#0.6710;SIGNALING PATHWAY#0.6587;GOLGI MEMBRANE#0.6227;CONTACT SITE#0.6161;ENDOPLASMIC RETICULUM#0.6054
151827	RIBOSOME BIOGENESIS#0.7358;PLURIPOTENT STEM CELL#0.7226;STEM CELL#0.7096
151871	STEM CELL#1.0390;PLURIPOTENT STEM CELL#0.8818;EMBRYONIC STEM CELL#0.8543;LYMPH NODE METASTASIS#0.7898;LYMPH NODE#0.7828;GENE EXPRESSION#0.7327;MOUSE EMBRYONIC STEM#0.6887;CANCER TESTIS ANTIGEN#0.6722;TRANSCRIPTION FACTOR#0.6659;COLORECTAL CANCER#0.6199;LUNG CANCER#0.6185;TUMOR CELLS#0.6174
151887	ADIPOSE TISSUE#0.9959;TUMOR SUPPRESSOR#0.9924;SMOOTH MUSCLE CELL#0.9479;SMOOTH MUSCLE#0.9452;MUSCLE CELL#0.9326;CANCER CELL#0.8594;COLORECTAL#0.8466;ADIPOCYTE DIFFERENTIATION#0.8346;APOPTOSIS#0.8290;VASCULAR SMOOTH MUSCLE CELL#0.8266;COLORECTAL CANCER#0.8225;ADIPOCYTE#0.8188;THYROID CARCINOMA#0.7838;GENE EXPRESSION#0.7634;OBESE#0.7484;GLUCOSE HOMEOSTASIS#0.6198;LIPOPROTEIN LIPASE#0.6194;MAMMARY GLAND#0.6186;SPORULATION#0.6089
151888	T LYMPHOCYTE#1.0482;B CELL#1.0470;T CELL#1.0358;CD8+ T CELL#1.0008;IMMUNE RESPONSE#0.9934;DENDRITIC CELL#0.9343;CD4+ T CELL#0.9318;PERIPHERAL BLOOD#0.9144;CELL ACTIVATION#0.9104;CELL SURFACE#0.8703;T CELL ACTIVATION#0.8577;REGULATORY T CELL#0.8305;CYTOKINE PRODUCTION#0.8294;CELL PROLIFERATION#0.8264;SIGNALING PATHWAY#0.7310;T CELL PROLIFERATION#0.7077;CELL EXPANSION#0.6960;LYMPHOCYTE ACTIVATION#0.6943;TREG CELL#0.6757;TUMOR NECROSIS FACTOR#0.6713;IMMUNE CELL#0.6628;AUTOIMMUNE DISEASE#0.6606;IMMUNE SYSTEM#0.6145;NKT CELL#0.6126
151903	CELL GROWTH#0.6886
151987	PROTEIN PHOSPHATASE 4#0.9570;LUNG CANCER#0.6629;NEURONAL CELLS#0.6088
151	ADRENERGIC RECEPTOR#1.0537;HYPERTENSION#0.8367;AMYGDALA#0.7771;POLYMERASE CHAIN REACTION#0.7183;TYPE 2 DIABETES#0.7059;NOREPINEPHRINE#0.6257;LONG TERM MEMORY#0.6242
152002	LUNG ADENOCARCINOMA#0.8727;ADENOCARCINOMA#0.6591;CELL PROLIFERATION#0.6198;CANCER CELL#0.6191
152006	CELL GROWTH#0.8517;UBIQUITIN#0.7508;GENE EXPRESSION#0.6684;UBIQUITIN PROTEIN LIGASE#0.6382;PROTEIN TYROSINE PHOSPHATASE#0.6228;HEPATOCELLULAR CARCINOMA#0.6144;COLORECTAL CANCER#0.6142;TRANSFORMING GROWTH FACTOR#0.6126;LUNG CANCER#0.6124;CANCER CELL#0.6081;GROWTH FACTOR#0.6062
152007	RELATED PROTEIN 1#0.9565;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7363;EPITHELIAL TO MESENCHYMAL#0.7360;ZINC BINDING#0.6670;EPITHELIAL CELL#0.6377;SIGNALING PATHWAY#0.6367
1520	CATHEPSIN S ACTIVITY#1.1013;AORTIC ANEURYSM#1.0350;ABDOMINAL AORTIC ANEURYSM#1.0264;CYSTATIN#1.0247;IFN-GAMMA#1.0227;BREAST CANCER#1.0205;ANTIGEN PRESENTATION#1.0167;ADIPOSE TISSUE#1.0153;EPITHELIAL CELL#1.0130;PYRAZOLE#1.0121;CANCER CELL#1.0121;ATHEROSCLEROTIC#1.0114;ATHEROSCLEROSIS#1.0107;GROWTH FACTOR#1.0105;APOPTOSIS#1.0092;AUTOIMMUNE DISEASE#1.0090;OBESE#1.0083;PROTEASE ACTIVATED RECEPTOR#1.0077;ENDOTHELIAL CELL#1.0058;CELL MIGRATION#1.0041;ANTIGEN PRESENTING CELLS#1.0016;AUTOPHAGY#1.0010;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9960;ANGIOGENESIS#0.9954;DENDRITIC CELL#0.9941;TUMOR NECROSIS FACTOR#0.9938;CD4+ T CELL#0.9933;MACROPHAGE#0.9907;B CELL#0.9898;MONOCYTE#0.9892;EXTRACELLULAR MATRIX#0.9849;ANTIGEN PROCESSING#0.9838;RHEUMATOID ARTHRITIS#0.9833;T CELL#0.9828;GENE EXPRESSION#0.9802;IMMUNE RESPONSE#0.9739;LYSOSOME#0.9728;SIGNALING PATHWAY#0.9716;SMOOTH MUSCLE#0.9705;MUSCLE CELL#0.9661;SMOOTH MUSCLE CELL#0.9650;POLYMERASE CHAIN REACTION#0.9608;CYSTIC FIBROSIS#0.9560;LACRIMAL GLAND#0.9479;PRO-INFLAMMATORY#0.9424;BASEMENT MEMBRANE#0.9363;ARTERY#0.9349;CELL ADHESION#0.9331;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9325;CELL SURFACE#0.9212;PROTEASE ACTIVITY#0.9186;INFLAMMATORY RESPONSE#0.9120;HEPATOCELLULAR CARCINOMA#0.9082;CELL DEATH#0.9061;IMMUNE CELL#0.9042;C REACTIVE PROTEIN#0.9011;DIGESTION#0.8992;COLORECTAL#0.8977;SPINAL CORD#0.8903;CELL ADHESION MOLECULE#0.8895;CELL ACTIVATION#0.8823;BONE MARROW#0.8782;VASCULAR SMOOTH MUSCLE CELL#0.8735;NEUTROPHIL#0.8724;VASCULAR CELL#0.8562;MULTIPLE SCLEROSIS#0.8506;TUMOR CELLS#0.8463;LUNG DISEASE#0.8458;CELL PROLIFERATION#0.8456;PLASMA MEMBRANE#0.8451;TRANSCRIPTION FACTOR#0.8450;LEUKOCYTE#0.8436;MYOCARDIAL INFARCTION#0.8405;ENDOSOME#0.8388;MAST CELL#0.8320;ELASTIN DEGRADATION#0.8318;CORONARY ARTERY#0.8299;LYMPH NODE#0.8283;TOLL LIKE RECEPTOR#0.8261;REVERSE TRANSCRIPTION#0.8218;PHAGOSOME#0.8196;RETINAL PIGMENT EPITHELIAL#0.8185;HIGH DENSITY LIPOPROTEIN#0.8175;CATALYTIC ACTIVITY#0.8141;NERVE GROWTH FACTOR#0.8100;TRANSFORMING GROWTH FACTOR#0.8067;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8033;IMMUNE SYSTEM#0.8001;NERVOUS SYSTEM#0.7927;HEART DISEASE#0.7822;NITRIC OXIDE#0.7790;ENDOTHELIAL GROWTH FACTOR#0.7786;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7786;ALZHEIMER'S DISEASE#0.7765;ANTIGEN PROCESSING AND PRESENTATION#0.7763;TUMOR ASSOCIATED MACROPHAGE#0.7631;INFLAMMATORY CELL#0.7625;ADIPOCYTE#0.7580;CEREBRAL INFARCTION#0.7511;INHIBITION OF CAT#0.7487;RNA EDITING#0.7484;INTERLEUKIN 1 RECEPTOR#0.7473;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7428;C-LEVEL#0.7423;PERIPHERAL NERVE#0.7421;COLLAGEN DEGRADATION#0.7362;LDL PARTICLE#0.7290;ALVEOLAR MACROPHAGE#0.7262;AUTOIMMUNITY#0.7240;RECEPTOR ANTAGONIST#0.7208;QUANTITATIVE REAL TIME#0.7172;OSTEOCLAST#0.7053;CELL MOTILITY#0.7047;MACROPHAGE MIGRATION#0.6923;LUNG CANCER#0.6917;PANCREATIC CANCER#0.6861;AORTIC VALVE#0.6851;CENTRAL NERVOUS SYSTEM#0.6836;PROTEINASE INHIBITOR#0.6789;HUMAN ADIPOSE TISSUE#0.6774;APOPTOTIC#0.6768;WOUND HEALING#0.6768;IL-1RA#0.6754;ENZYME ACTIVITY#0.6730;TYPE 2 DIABETES#0.6722;PSORIASIS#0.6712;CORONARY HEART DISEASE#0.6709;PROTEIN KINASE#0.6699;CORONARY ARTERY DISEASE#0.6696;ARTERY DISEASE#0.6694;COLORECTAL CARCINOMA#0.6687;ENDOPLASMIC RETICULUM#0.6682;LOW DENSITY LIPOPROTEIN#0.6555;KERATINOCYTE#0.6536;B LYMPHOCYTE#0.6472;BREAST CANCER CELL#0.6452;COLORECTAL CANCER#0.6435;PULMONARY EMPHYSEMA#0.6411;CROSS PRESENTATION#0.6399;NON OBESE DIABETIC#0.6376;PROTEIN DEGRADATION#0.6312;ACINAR CELL#0.6306;ATORVASTATIN#0.6249;PEPTIDE BINDING#0.6233;OUTER CAPSID#0.6219;TUBE FORMATION#0.6207;T CELL ACTIVATION#0.6174;LUPUS NEPHRITIS#0.6085;ELASTASE ACTIVITY#0.6076;TH1 CELL#0.6057;CORONARY STENOSIS#0.6037
152100	CYTOCHROME C OXIDASE BIOGENESIS#0.8013;CYTOCHROME C OXIDASE#0.6938;CYTOCHROME C#0.6870
152110	BREAST CANCER#0.6791;RESPONSE TO UV#0.6307
152137	HEARING LOSS#0.6803;MICROTUBULE BASED#0.6684;INNER EAR#0.6455;EPIDERMAL GROWTH FACTOR#0.6300;GROWTH FACTOR#0.6238
152185	CANNABINOID RECEPTOR#1.0190;RECEPTOR AGONIST#0.8990;TETRAHYDROCANNABINOL#0.8980;T CELL#0.8637;TOXICITY#0.7946;ANTIOXIDANT ACTIVITY#0.7513;CENTRIOLE#0.7347;CATHINONE#0.6881;ACTION POTENTIAL#0.6773;QUERCETIN#0.6299;CENTRIOLE ELONGATION#0.6177
152189	TUMOR SUPPRESSOR#0.8013;GROWTH FACTOR#0.7865;CELL PROLIFERATION#0.7695;APOPTOSIS#0.7279;EPIDERMAL GROWTH FACTOR#0.6948;GROWTH FACTOR RECEPTOR#0.6948;METASTATIC RENAL CELL CARCINOMA#0.6053;CLEAR CELL RENAL CELL CARCINOMA#0.6049
1521	T CELL#0.8715;T LYMPHOCYTE#0.7273;GENE EXPRESSION#0.6509;IMMUNE CELL#0.6415;CD8+ T CELL#0.6415;ENDOPLASMIC RETICULUM#0.6405;ER LOCALIZATION#0.6322;AUTOIMMUNE GASTRITIS#0.6311;GASTROESOPHAGEAL REFLUX DISEASE#0.6126;LATE ENDOSOME#0.6029;INFLUENZA A VIRUS#0.6023
152206	CENTRIOLAR SATELLITE#0.9684;MICROTUBULE#0.6476
152273	ENDOTHELIAL CELL#0.9934;ENDOTHELIAL GROWTH FACTOR#0.8942;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8942;GROWTH FACTOR#0.8891;BREAST CANCER#0.7826;ANGIOGENESIS#0.7360;NUCLEOTIDE EXCHANGE FACTOR#0.6993;LYMPH NODE METASTASES#0.6459;LYMPH NODE#0.6362;STEM CELL#0.6344;COPY NUMBER CHANGE#0.6088
1522	CARBOXYPEPTIDASE ACTIVITY#1.0803;T CELL#1.0371;MACROPHAGE#1.0216;BETA-2#1.0103;IMMUNE RESPONSE#1.0039;CANCER CELL#0.9373;EXTRACELLULAR MATRIX#0.9035;EPITHELIAL CELL#0.8450;DENDRITIC CELL#0.8449;TUMOR CELLS#0.8319;CELL ADHESION#0.8229;GENE EXPRESSION#0.8200;IMMUNE CELL#0.8062;GASTRIC EPITHELIAL CELLS#0.7812;TUBERCULOSIS#0.7696;ERGIC#0.7625;T LYMPHOCYTE#0.7363;MONOCYTE#0.7302;CELL MIGRATION#0.7175;PROSTATE CANCER#0.6986;APOPTOSIS#0.6921;MICROGLIAL CELL#0.6885;COLORECTAL#0.6872;CYSTATIN#0.6859;T CELL ACTIVATION#0.6830;CELL ACTIVATION#0.6805;LYSOSOME#0.6660;ENDOPLASMIC RETICULUM#0.6576;OOCYTE#0.6408;T CELL MIGRATION#0.6318;SIGNALING PATHWAY#0.6304;L-PROLINE#0.6211;COLORECTAL CANCER#0.6143;CELLULAR SENESCENCE#0.6053;AMYLOID PRECURSOR PROTEIN#0.6042;PARKINSON'S DISEASE#0.6004
152330	CELL ADHESION MOLECULE#1.0290;CELL ADHESION#1.0269;AUTISM SPECTRUM DISORDER#0.9006;COMPARATIVE GENOMIC HYBRIDIZATION#0.7279;3P- SYNDROME#0.6997;MENTAL RETARDATION#0.6960;DEVELOPMENTAL DELAY#0.6841;GENE EXPRESSION#0.6734;NEURONAL CELL ADHESION#0.6674;OLFACTORY BULB#0.6146;NERVOUS SYSTEM#0.6119;BRAIN DEVELOPMENT#0.6105
1523	NEUROTROPHIN RECEPTOR#1.0754;DNA BINDING#1.0435;S PHASE#1.0403;CHOLINE#1.0287;KINASE INHIBITOR#1.0233;TUMOR SUPPRESSOR#1.0195;TRANSCRIPTION FACTOR#1.0188;B CELL#1.0168;CELL CYCLE#1.0152;CELL MOTILITY#1.0120;BREAST CANCER#1.0119;CELL PROLIFERATION#1.0118;CELL MIGRATION#1.0060;NUCLEAR MATRIX#1.0058;EPITHELIAL CELL#1.0045;MAMMARY GLAND#1.0033;APOPTOSIS#1.0021;KIDNEY DEVELOPMENT#1.0015;DNA REPLICATION#0.9995;ONCOGENIC#0.9991;LIPID KINASE#0.9982;GENE EXPRESSION#0.9978;PROTEIN KINASE#0.9969;AKT SIGNALING#0.9960;T CELL#0.9958;FACTOR I#0.9920;CANCER CELL#0.9913;GROWTH FACTOR#0.9889;PI3K SIGNALING#0.9870;SIGNALING PATHWAY#0.9776;ELECTROPHORETIC MOBILITY SHIFT#0.9760;KINASE ACTIVITY#0.9748;CELL DEATH#0.9724;PROTEIN KINASE B#0.9703;GOLGI MEMBRANE#0.9659;TUMOR CELLS#0.9650;PLASMA MEMBRANE#0.9640;TRANSFORMING GROWTH FACTOR#0.9549;LUNG CANCER#0.9549;CEREBRAL CORTEX#0.9540;PANCREATIC CANCER#0.9539;CELL GROWTH#0.9535;GROWTH FACTOR RECEPTOR#0.9530;ENDOPLASMIC RETICULUM#0.9487;MYELOID LEUKEMIA#0.9433;BONE MARROW#0.9411;STEM CELL#0.9355;GOLGI APPARATUS#0.9332;EPITHELIAL MESENCHYMAL TRANSITION#0.9313;SIGNAL TRANSDUCTION#0.9204;NEUTROPHIL#0.9200;MACROPHAGE#0.9150;KINASE INHIBITOR P27#0.9117;GOLGI COMPLEX#0.9044;DNASE I#0.8889;DNA REPAIR#0.8866;CELL SURFACE#0.8864;MUTAGENESIS#0.8807;LEIOMYOMA#0.8797;KIDNEY DISEASE#0.8783;POLYCYSTIC KIDNEY DISEASE#0.8711;APOPTOTIC#0.8701;HISTONE DEACETYLASE#0.8540;CELL DIFFERENTIATION#0.8506;CELL DIVISION#0.8505;RECEPTOR TYROSINE KINASE#0.8401;INTESTINAL EPITHELIAL CELL#0.8391;PHOSPHATIDYLETHANOLAMINE#0.8371;TERMINAL DIFFERENTIATION#0.8357;ANEMIA#0.8351;MITOGEN ACTIVATED PROTEIN#0.8348;BINDING PROTEIN 1#0.8338;CELL DEVELOPMENT#0.8256;TUMOR NECROSIS FACTOR#0.8194;SIGNALING CASCADE#0.8177;CYTOPLASM#0.8120;DNA POLYMERASE ALPHA#0.8054;REACTIVE OXYGEN SPECIES#0.7939;INSULIN RECEPTOR#0.7936;LUNG FIBROBLASTS#0.7925;PHOSPHATIDYLSERINE#0.7920;CDP CHOLINE PATHWAY#0.7894;LIPID KINASE ACTIVITY#0.7854;SIGNALLING PATHWAY#0.7845;ANGIOGENESIS#0.7843;COLORECTAL CANCER#0.7809;DNASE#0.7806;PROSTATE CANCER#0.7778;SMOOTH MUSCLE#0.7762;ETHANOLAMINE#0.7739;P110 BINDING#0.7626;MITOCHONDRIA#0.7599;INSULIN-LIKE GROWTH FACTOR#0.7599;HEMATOPOIETIC CELL#0.7589;CATALYTIC ACTIVITY#0.7587;OVARIAN#0.7557;ANAEMIA#0.7492;ACUTE MYELOID LEUKEMIA#0.7465;DOMINANT NEGATIVE MUTANT#0.7443;BASE EXCISION REPAIR#0.7423;OVARIAN CANCER#0.7393;CYCLIN DEPENDENT KINASE#0.7393;COMPLEX I#0.7392;BREAST CANCER CELL#0.7374;POLYMERASE CHAIN REACTION#0.7339;GLUTATHIONE#0.7292;OXIDATIVE DNA DAMAGE#0.7278;INSULIN RECEPTOR SUBSTRATE#0.7221;ENHANCER BINDING PROTEIN#0.7216;ENHANCER BINDING#0.7212;EPIDERMAL GROWTH FACTOR#0.7209;RNA INTERFERENCE#0.7196;FRONTAL#0.7179;MITOSIS#0.7149;NERVOUS SYSTEM#0.7121;KENNEDY PATHWAY#0.7073;SMOOTH MUSCLE ACTIN#0.7044;TRANSACTIVATION#0.7012;DRUG RESISTANCE#0.7008;KERATINOCYTE#0.6990;PROGENITOR CELL#0.6979;TOLL LIKE RECEPTOR#0.6925;CELL CYCLE CONTROL#0.6905;MYELOID NEOPLASM#0.6884;TRANS GOLGI NETWORK#0.6775;OSTEOBLAST#0.6757;PROTEIN PROTEIN INTERACTION#0.6745;TRANSFORMING GROWTH FACTOR BETA#0.6731;GLOBIN#0.6648;IMMUNE RESPONSE#0.6594;CELL CYCLE ARREST#0.6571;RAPAMYCIN#0.6555;ADENOCARCINOMA#0.6535;COLON CANCER#0.6501;LEUKOCYTE#0.6498;PROTEIN KINASE C#0.6486;MYELOID CELL#0.6473;COG COMPLEX#0.6440;COLORECTAL#0.6422;B CELL RECEPTOR#0.6334;TARGET OF RAPAMYCIN#0.6279;CELL CYCLE REGULATION#0.6254;PHOSPHOLIPID BIOSYNTHESIS#0.6249;HUMAN BREAST CANCER#0.6249;T LYMPHOCYTE#0.6247;CHICKEN ANEMIA VIRUS#0.6193;REVERSE TRANSCRIPTION#0.6180;CATHEPSIN L ACTIVITY#0.6178;DNA SYNTHESIS#0.6160;INTERNEURON#0.6121;DEPHOSPHORYLATION#0.6106;ENDOCYTOSIS#0.6098;THYMIDINE#0.6092;ENDOTHELIAL CELL#0.6087;IDIOPATHIC PULMONARY FIBROSIS#0.6080;EMBRYONIC KIDNEY#0.6053;PULMONARY FIBROSIS#0.6038;LIVER DEVELOPMENT#0.6015;PHOSPHOCHOLINE#0.6009
152404	CELL ADHESION MOLECULE#0.9366;CELL ADHESION#0.9336;T CELL#0.6541;SERTOLI CELL#0.6005
152485	TELOMERE#0.6937
1524	CORONARY ARTERY DISEASE#1.0460;ARTERY DISEASE#1.0425;CORONARY ARTERY#1.0410;CAROTID ARTERY#1.0398;RETINAL DEGENERATION#1.0238;CD8+ T CELL#1.0186;CHEMOKINE RECEPTOR#1.0174;INFLAMMATORY MONOCYTE#1.0168;REVERSE TRANSCRIPTION#1.0168;CANCER CELL#1.0162;C CHEMOKINE RECEPTOR#1.0159;LEUKOCYTE ADHESION#1.0129;ATHEROSCLEROTIC#1.0124;T LYMPHOCYTE#1.0120;RESPIRATORY SYNCYTIAL VIRUS#1.0090;B CELL#1.0084;SMOOTH MUSCLE CELL#1.0080;CLASSICAL MONOCYTE#1.0073;ARTERY#1.0070;SMOOTH MUSCLE#1.0064;CELL ADHESION#1.0058;NATURAL KILLER CELL#1.0058;CELL MIGRATION#1.0053;MONOCYTE#1.0048;COLITIS#1.0029;MACULAR DEGENERATION#1.0027;SPINAL CORD#1.0026;MUSCLE CELL#1.0020;ISCHEMIA#1.0017;AGE RELATED MACULAR DEGENERATION#1.0009;INFLAMMATORY CELL#1.0002;CHEMOTAXIS#0.9999;MONONUCLEAR CELLS#0.9997;MYELOID CELL#0.9988;TOLL LIKE RECEPTOR#0.9982;MICROGLIAL CELL#0.9976;HYPOXIA#0.9975;ASTROCYTE#0.9972;SIGNALING PATHWAY#0.9957;NEUROTOXICITY#0.9956;EPITHELIAL CELL#0.9955;POLYMERASE CHAIN REACTION#0.9952;NEUTROPHIL#0.9950;CYTOKINE PRODUCTION#0.9950;CC CHEMOKINE RECEPTOR#0.9944;ATHEROSCLEROSIS#0.9934;MULTIPLE SCLEROSIS#0.9933;CD4+ T CELL#0.9924;T CELL#0.9918;RHEUMATOID ARTHRITIS#0.9911;MACROPHAGE#0.9909;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9900;ENDOTHELIUM#0.9900;CELL SURFACE#0.9886;PHAGOCYTOSIS#0.9883;STROMAL CELL#0.9880;TUMOR CELLS#0.9879;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9875;DENDRITIC CELL#0.9865;LEUKOCYTE#0.9864;PROTEIN KINASE#0.9864;ANGIOGENESIS#0.9860;PRO-INFLAMMATORY#0.9855;BONE MARROW#0.9852;LYMPH NODE#0.9844;TUMOR NECROSIS FACTOR#0.9841;ENDOTHELIAL CELL#0.9819;APOPTOSIS#0.9808;ALZHEIMER'S DISEASE#0.9807;GROWTH FACTOR#0.9802;PERIPHERAL BLOOD#0.9798;STEM CELL#0.9791;MITOGEN ACTIVATED PROTEIN#0.9782;IFN-GAMMA#0.9772;IMMUNE RESPONSE#0.9748;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9744;IMMUNE CELL#0.9712;CENTRAL NERVOUS SYSTEM#0.9706;CD4-CD28- T CELL#0.9691;CELL PROLIFERATION#0.9691;PARENCHYMA#0.9682;INFLAMMATORY RESPONSE#0.9681;NERVOUS SYSTEM#0.9680;CELL DEATH#0.9657;PROGENITOR CELL#0.9647;APOPTOTIC#0.9636;GENE EXPRESSION#0.9634;MYOCARDIAL INFARCTION#0.9623;MIDDLE CEREBRAL ARTERY#0.9618;CEREBRAL ARTERY#0.9616;INNATE IMMUNE RESPONSE#0.9612;IMMUNE SYSTEM#0.9600;CELL ACTIVATION#0.9599;PROSTATE CANCER#0.9589;NEURODEGENERATIVE DISEASE#0.9577;ADENOCARCINOMA#0.9576;INFLAMMATORY BOWEL DISEASE#0.9561;NON-CLASSICAL MONOCYTE#0.9541;KIDNEY DISEASE#0.9532;RECEPTOR ANTAGONIST#0.9523;ADIPOSE TISSUE#0.9520;CEREBRAL ISCHEMIA#0.9501;HYPERTENSION#0.9493;SIGNALLING PATHWAY#0.9493;HUMAN IMMUNODEFICIENCY VIRUS#0.9489;LUNG CANCER#0.9488;M2 MACROPHAGE#0.9482;SCIATIC NERVE#0.9470;QUANTITATIVE REAL TIME#0.9461;PERIPHERAL NERVE#0.9455;NITRIC OXIDE#0.9451;CROHN'S DISEASE#0.9440;NEUROTOXIC#0.9398;INTIMA MEDIA THICKNESS#0.9397;TRANSCRIPTION FACTOR#0.9396;ENCEPHALOMYELITIS#0.9388;COLONY-STIMULATING FACTOR#0.9384;WOUND HEALING#0.9361;RETINAL PIGMENT EPITHELIUM#0.9333;BILE DUCT#0.9284;TRANSFORMING GROWTH FACTOR#0.9276;ACUTE CORONARY SYNDROME#0.9274;MESENTERIC LYMPH NODE#0.9264;NEUROGENESIS#0.9253;SIGNAL TRANSDUCTION#0.9252;PANCREATIC CANCER#0.9237;INTERMEDIATE MONOCYTE#0.9211;CELL DIFFERENTIATION#0.9184;INNATE IMMUNITY#0.9179;GLIAL CELL#0.9143;OSTEOCLAST#0.9138;BREAST CANCER#0.9118;NEUROPROTECTION#0.9110;CEREBRAL ARTERY OCCLUSION#0.9062;CELL ADHESION MOLECULE#0.9034;CHEMOATTRACTION#0.9027;SPINAL CORD INJURY#0.9008;REACTIVE OXYGEN SPECIES#0.9005;ADAPTIVE IMMUNE RESPONSE#0.9000;TYPE 2 DIABETES#0.8931;HYPOXIC#0.8908;HIGH FAT DIET#0.8885;FRAGMENT LENGTH POLYMORPHISM#0.8872;LEUKOCYTE MIGRATION#0.8803;INTESTINAL MUCOSA#0.8775;TISSUE DAMAGE#0.8770;PANCREATIC DUCTAL ADENOCARCINOMA#0.8764;SALIVARY GLAND#0.8749;MACROPHAGE INFLAMMATORY PROTEIN#0.8746;CHRONIC KIDNEY DISEASE#0.8729;VASCULAR SMOOTH MUSCLE CELL#0.8705;SPINAL DORSAL HORN#0.8702;LUNG DISEASE#0.8692;MESENCHYMAL STEM CELL#0.8684;HYPERSENSITIVITY#0.8625;OVARIAN#0.8617;CYTOTOXICITY#0.8611;NEPHROPATHY#0.8590;CD14++CD16- MONOCYTE#0.8552;ENDOTHELIAL GROWTH FACTOR#0.8548;MONOCYTE DERIVED MACROPHAGE#0.8512;PERTUSSIS#0.8480;AMYOTROPHIC LATERAL SCLEROSIS#0.8477;LATERAL SCLEROSIS#0.8477;VASCULAR ENDOTHELIAL CELL#0.8476;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8433;COMMON CAROTID ARTERY#0.8413;OLIGODENDROCYTE#0.8408;VASCULITIS#0.8396;VASCULAR ENDOTHELIUM#0.8373;LEUKOCYTE TRAFFICKING#0.8343;RECEPTOR LIGAND#0.8248;DENTATE GYRUS#0.8226;VASCULAR CELL#0.8217;EXTRACELLULAR MATRIX#0.8172;TRAUMATIC BRAIN INJURY#0.8171;MACROPHAGE ACTIVATION#0.8099;ASPIRIN#0.8094;GRANULOCYTE#0.8092;LYMPHOID TISSUE#0.8079;CELL CYCLE#0.8075;PARKINSON'S DISEASE#0.8044;GLOBAL CEREBRAL ISCHEMIA#0.8042;NEUROPATHY#0.8038;TH1 CELL#0.7988;ISCHEMIA REPERFUSION INJURY#0.7942;FLOW CYTOMETRY ANALYSIS#0.7935;MAST CELL#0.7935;HUMAN AIRWAY EPITHELIAL#0.7911;DIABETES MELLITUS#0.7899;UMBILICAL VEIN#0.7898;B CELL LYMPHOMA#0.7893;STATUS EPILEPTICUS#0.7878;PRIMARY BILIARY CIRRHOSIS#0.7863;HEPATOCELLULAR CARCINOMA#0.7861;TNF PRODUCTION#0.7861;GLOMERULONEPHRITIS#0.7859;BRAIN DAMAGE#0.7855;NEUROINFLAMMATORY RESPONSE#0.7840;TUBULAR EPITHELIAL CELL#0.7826;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7817;BLOOD BRAIN BARRIER#0.7815;BLOOD VESSEL#0.7802;ULCERATIVE COLITIS#0.7788;SUBSTANTIA NIGRA#0.7782;ALVEOLAR MACROPHAGE#0.7780;BONE MARROW CELLS#0.7770;CHEMOKINE RECEPTOR ANTAGONIST#0.7770;DIPHTHERIA TOXIN RECEPTOR#0.7760;SMALL INTESTINE#0.7754;SELECTIN#0.7748;C REACTIVE PROTEIN#0.7715;PERIPHERAL NERVE INJURY#0.7712;PERIPHERAL MONOCYTE#0.7699;M1 MACROPHAGE#0.7689;ACUTE PULMONARY EMBOLISM#0.7686;LYMPHOID ORGANS#0.7679;CC CHEMOKINE LIGAND#0.7663;AIRWAY EPITHELIAL CELL#0.7641;LEUKOCYTE CHEMOTAXIS#0.7637;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7627;LUPUS ERYTHEMATOSUS#0.7625;TO THE PROGRESSION#0.7602;T CELL PROLIFERATION#0.7578;CYTOTOXIC T CELL#0.7555;LIVER DISEASE#0.7546;GLUCOSE INTOLERANCE#0.7543;CELL GROWTH#0.7525;REGENERATION#0.7495;MYELOID-DERIVED SUPPRESSOR CELL#0.7478;CHOROID PLEXUS#0.7444;HEMORRHAGE#0.7432;CEREBRAL INFARCTION#0.7429;DIET INDUCED OBESITY#0.7427;CELL CELL ADHESION#0.7407;SCAVENGER RECEPTOR#0.7399;PLATELET ACTIVATION#0.7385;BONE CANCER#0.7375;SKELETAL MUSCLE#0.7363;HUMAN UMBILICAL VEIN#0.7363;OVARIAN CARCINOMA#0.7358;CORNEAL NEOVASCULARIZATION#0.7343;HAIR CELL#0.7253;PEROXISOME#0.7245;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.7240;SYNAPTIC TRANSMISSION#0.7232;VASCULAR DISEASE#0.7221;PULMONARY EMBOLISM#0.7215;PRECURSOR CELL#0.7214;AUTOIMMUNE DISEASE#0.7201;CANDIDIASIS#0.7159;HEPATITIS C#0.7152;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7148;PSORIASIS#0.7141;HEMATOPOIETIC CELL#0.7088;RESVERATROL#0.7086;REGULATORY T CELL#0.7078;MAPK ACTIVATION#0.7027;CHRONIC CONSTRICTION INJURY#0.7026;ACUTE MYOCARDIAL INFARCTION#0.7015;PLASMA CELL#0.7013;STROMA#0.7011;DORSAL ROOT GANGLION#0.7006;T HELPER CELL#0.7004;VIRAL INFECTION#0.6974;TOXICITY#0.6972;BREAST CANCER CELL#0.6972;OPTIC NERVE#0.6945;MINOCYCLINE#0.6940;BONE MARROW ENDOTHELIAL#0.6933;QUANTITATIVE REVERSE TRANSCRIPTION#0.6932;MONOCYTE ACTIVATION#0.6931;UVEITIS#0.6903;TWO PHOTON MICROSCOPY#0.6900;CEREBROVASCULAR DISEASE#0.6877;CYTOPLASM#0.6876;SENSITIZATION#0.6816;GM-CSF#0.6802;T CELL MIGRATION#0.6797;KUPFFER CELL#0.6783;CIGARETTE SMOKE EXPOSURE#0.6782;INTEGRIN ACTIVATION#0.6782;RESPONSE TO LPS#0.6769;DOPAMINERGIC NEURON#0.6756;MEMORY T CELL#0.6745;INNATE IMMUNE SYSTEM#0.6735;CILIARY BODY#0.6733;OBESE#0.6727;SYNOVIAL FLUID#0.6704;CELL MEMBRANE#0.6692;DIABETIC NEPHROPATHY#0.6664;INSULIN SECRETION#0.6646;OSTEOARTHRITIS#0.6618;T CELL ACTIVATION#0.6549;MESANGIAL CELL#0.6509;SYNOVIUM#0.6503;EOSINOPHIL#0.6497;MACROPHAGE MIGRATION#0.6483;MONOCYTE CHEMOTACTIC PROTEIN#0.6477;HYPOXIA INDUCIBLE FACTOR#0.6476;CYTOKINE RECEPTOR#0.6472;EFFECTOR T CELL#0.6469;ATOPIC DERMATITIS#0.6460;ANTIGEN PRESENTING CELLS#0.6427;CLODRONATE#0.6410;OSTEOBLAST#0.6404;BRONCHIOLITIS#0.6384;DIPHTHERIA#0.6357;MACROPHAGE DIFFERENTIATION#0.6339;RESPIRATORY TRACT#0.6332;TAMOXIFEN#0.6291;NKT CELL#0.6280;CELL EXPANSION#0.6263;ACTIVATED T-CELLS#0.6261;ACTIVATED T CELL#0.6258;SMC PROLIFERATION#0.6254;DNA METHYLATION#0.6203;RETINAL PIGMENT EPITHELIAL#0.6197;ENDOMETRIOSIS#0.6195;CYTOTOXIC T-LYMPHOCYTE#0.6182;TROPHOBLAST#0.6170;PACLITAXEL#0.6163;CYTOKINE SECRETION#0.6159;CONNECTIVE TISSUE#0.6129;TROPISM#0.6111;CHRONIC UNPREDICTABLE STRESS#0.6073;TUBERCULOSIS#0.6063;METHIONINE#0.6061;TRANSCRIPTASE#0.6041;COLORECTAL#0.6038;PRION DISEASE#0.6014;MANNOSE RECEPTOR#0.6012;NEPHRITIS#0.6006;OLFACTORY BULB#0.6003
152503	GASTRULATION#0.7545;MESODERMAL PROGENITOR CELL#0.6645;RETINOIC ACID#0.6359;NEURAL ECTODERM#0.6125
152518	SPECIFIC LANGUAGE IMPAIRMENT#0.8294
152519	ORAL SQUAMOUS CELL CARCINOMA#0.7586;DISEASE FREE SURVIVAL#0.7531;SQUAMOUS CELL CARCINOMA#0.7479
152559	GOLGI APPARATUS#1.1040;CANCER CELL#1.1011;TUMOR SUPPRESSOR#1.0984;SIGNALING PATHWAY#1.0917;CELL PROLIFERATION#1.0864;PROGESTIN#1.0279;AKT SIGNALING#0.9617;AUTOPHAGY#0.8836;ADJACENT NORMAL TISSUE#0.8426;PROSTATE CANCER#0.8303;LUNG CANCER#0.8287;BREAST CANCER#0.8262;HEPATOCELLULAR CARCINOMA#0.7854;EPITHELIAL MESENCHYMAL TRANSITION#0.7336;LIPID METABOLISM#0.7041;SQUAMOUS CELL CARCINOMA#0.6994;MITOGEN ACTIVATED PROTEIN#0.6991;PROTEIN KINASE#0.6983;CELL CYCLE#0.6963;LIPID METABOLISM DISORDER#0.6523;LYMPH NODE#0.6477;ESOPHAGEAL CANCER#0.6300;MESANGIAL CELL#0.6285;CHOLESTEROL HOMEOSTASIS#0.6279;BREAST CANCER CELL#0.6205;GROWTH FACTOR#0.6065
152573	TUMOR SUPPRESSOR#0.7215;LUNG ADENOCARCINOMA#0.6806;COLORECTAL CANCER#0.6735;CELL CYCLE#0.6692
152586	N GLYCAN#1.0082;GERM CELL#0.7875
1525	TIGHT JUNCTION#0.9702;CANCER CELL#0.9512;CELL SURFACE#0.9089;EPITHELIAL CELL#0.8809;GENE EXPRESSION#0.7592;BREAST CANCER#0.7417;B CELL#0.7402;CELL ADHESION#0.7168;VIRAL RECEPTOR#0.7099;T CELL#0.7004;TROPISM#0.6918;MYOCARDITIS#0.6819;PODOCYTE DEVELOPMENT#0.6307;ENDOTHELIAL CELL#0.6086;CONSTITUTIVE ANDROSTANE RECEPTOR#0.6060
152789	MICROTUBULE#0.9884;GABA B RECEPTOR#0.8175;GENE EXPRESSION#0.6931;LYMPHOID CELL#0.6608;RNA INTERFERENCE#0.6577;T CELL#0.6488;AUTISM SPECTRUM DISORDER#0.6100
152816	AMELOGENESIS IMPERFECTA#0.8279;AMELOGENESIS#0.7094
152831	ADIPOSE TISSUE#1.0308;GROWTH FACTOR RECEPTOR#1.0242;FIBROBLAST GROWTH FACTOR#1.0063;GROWTH FACTOR#1.0030;COLONIC TRANSIT#0.9654;ADIPOCYTE#0.9008;RECEPTOR COMPLEX#0.8918;OBESE#0.8809;GENE EXPRESSION#0.8791;WHITE ADIPOSE TISSUE#0.8341;PLASMA MEMBRANE#0.7675;SIGNALING PATHWAY#0.7356;LIPID METABOLISM#0.7086;HEPATOCELLULAR CARCINOMA#0.6916;BILE ACID METABOLISM#0.6811;HEPARIN#0.6732;BILE ACID SYNTHESIS#0.6577;HIGH FAT DIET#0.6357
152877	BREAST CANCER#0.7795;NEURAL TUBE#0.7602;BREAST CANCER CELL#0.7487;CANCER CELL#0.7420
1528	CYTOCHROME B#1.0649;CYTOCHROME B5#1.0609;CYTOCHROME P450#1.0255;CYTOCHROME C#0.9587;LYASE ACTIVITY#0.9327;ADRENAL GLAND#0.9049;MICROSOME#0.8904;CYTOCHROME B5 REDUCTASE#0.8700;GENE EXPRESSION#0.6999;ELECTRON TRANSFER#0.6658;ADRENAL CORTEX#0.6250;INHIBITION OF SEED GERMINATION#0.6139;DETOXIFICATION#0.6102;ANDROSTENEDIONE#0.6024
152926	CATABOLISM#0.9247;MAPLE SYRUP URINE DISEASE#0.9205;DEHYDROGENASE COMPLEX#0.9141;PHOSPHATASE ACTIVITY#0.7168;ALPHA KETOACID DEHYDROGENASE#0.6514;APOPTOSIS#0.6386;CELL DEATH#0.6278;DEPHOSPHORYLATION#0.6209
152992	O METHYLTRANSFERASE#0.9146
152	ADRENERGIC RECEPTOR#1.0294;GENE EXPRESSION#0.8140;NOREPINEPHRINE#0.7803;DEXMEDETOMIDINE#0.7165;CEREBRAL CORTEX#0.6914;DOPAMINE#0.6233;CLONIDINE#0.6054;SPINAL CORD#0.6030
153020	NUCLEOTIDE EXCHANGE FACTOR#0.8268;GUANINE#0.7344;EARLY ENDOSOME#0.6006
153090	TUMOR SUPPRESSOR#1.0664;PROSTATE CANCER#1.0578;CELL PROLIFERATION#1.0433;CANCER CELL#1.0337;APOPTOSIS#1.0307;EPITHELIAL CELL#1.0142;GENE EXPRESSION#1.0128;CELL GROWTH#1.0065;STEM CELL#0.9888;BRAIN DEVELOPMENT#0.9670;LUNG CANCER#0.9475;ENDOTHELIAL CELL#0.9463;CELL DEATH#0.9234;SIGNALING PATHWAY#0.9087;COLORECTAL CANCER#0.9071;LYMPH NODE#0.8679;BREAST CANCER#0.8450;EPITHELIAL MESENCHYMAL TRANSITION#0.8378;CELL CYCLE#0.8313;COLORECTAL#0.8284;CELL MIGRATION#0.8238;ONCOGENIC#0.8212;NEURONAL MIGRATION#0.8200;ACTIN FILAMENT#0.8174;5-AZA-2'-DEOXYCYTIDINE#0.8070;2'-DEOXYCYTIDINE#0.8065;HEPATOCELLULAR CARCINOMA#0.7968;APOPTOTIC#0.7880;ABDOMINAL AORTIC ANEURYSM#0.7866;VASCULAR ENDOTHELIAL CELL#0.7860;AORTIC ANEURYSM#0.7843;TRANSITIONAL CELL CARCINOMA#0.7775;GROWTH FACTOR#0.7621;METHYLATION SPECIFIC PCR#0.7600;TUMOR NECROSIS FACTOR#0.7302;ANGIOGENESIS#0.7152;DOUBLE STRAND BREAK#0.7104;OVARIAN#0.7087;CORONARY HEART DISEASE#0.6840;OVARIAN CANCER#0.6815;HEART DISEASE#0.6810;DENDRITE DEVELOPMENT#0.6424;LYMPH NODE METASTASIS#0.6365;RECURRENCE FREE SURVIVAL#0.6100;SIGNALLING PATHWAY#0.6016
153129	ARGININE#1.0466;TARGET OF RAPAMYCIN#0.8176;LYSOSOME#0.7597;RAPAMYCIN#0.7085;RAGULATOR COMPLEX#0.6973;TARGET OF RAPAMYCIN COMPLEX#0.6764;ESSENTIAL AMINO ACID#0.6468;GENE EXPRESSION#0.6005
153201	GLYCINE#0.7937;ADIPOCYTE#0.7534;OOCYTE#0.7046;DISTAL TIP CELL MIGRATION#0.6933;CELL SURFACE#0.6872;L-PROLINE#0.6316;LYTIC VACUOLE#0.6223;CELL MIGRATION#0.6223;MUSCLE CELL#0.6039
153218	SUPPRESSION SUBTRACTIVE HYBRIDIZATION#0.9596;HEPATITIS B VIRUS#0.9133;HEPATITIS B#0.9109;PEPTIDASE INHIBITOR#0.6571;APOPTOSIS#0.6545;HEPATOBLASTOMA#0.6029
153222	TYPE 2 DIABETES#0.9085;AUTOPHAGY#0.7816;ENDOPLASMIC RETICULUM STRESS#0.7375;ENDOPLASMIC RETICULUM#0.7302;CELL CYCLE#0.7270;CELL PROLIFERATION#0.7262;SIGNALING PATHWAY#0.6480;S PHASE#0.6445;GRANULOSA CELL APOPTOSIS#0.6336;GALLBLADDER CARCINOMA#0.6195
153241	CENTRIOLE ELONGATION#1.0883;CENTRIOLE#1.0746;DAUGHTER CENTRIOLE#0.9627;CENTRIOLE DUPLICATION#0.7671;CILIOPATHY#0.7554;ASPHYXIATING THORACIC DYSTROPHY#0.7484;JOUBERT SYNDROME#0.7189;INTERKINETIC NUCLEAR MIGRATION#0.7172;MICROTUBULE#0.6984;NUCLEAR MIGRATION#0.6873;MICROTUBULE BINDING#0.6698;CILIOGENESIS#0.6483;MICROTUBULE FORMATION#0.6363
153443	SERUM RESPONSE FACTOR#1.0618;BINDING PROTEIN 1#0.7262;RIBOSOME BIOGENESIS#0.6592;PAGET'S DISEASE OF BONE#0.6076
1534	CYTOCHROME B561#1.0804;CHROMAFFIN GRANULE MEMBRANE#1.0708;VESICLE MEMBRANE#1.0465;DOPAMINE#1.0458;CHROMAFFIN GRANULE#1.0439;CYTOCHROME B#1.0412;ASCORBATE#1.0363;ELECTRON TRANSFER#1.0337;SECRETORY VESICLE#1.0172;ASCORBIC ACID#1.0089;ELECTRON TRANSPORT#0.9829;ADRENAL MEDULLA#0.9719;CYTOCHROME C#0.9517;PLASMA MEMBRANE#0.9496;SECRETORY GRANULE#0.9150;REACTION CENTER#0.8846;DOPAMINE BETA MONOOXYGENASE#0.8503;CHROMAFFIN CELL#0.8367;TUMOR SUPPRESSOR#0.7976;NEUROSECRETORY VESICLE#0.7428;NOREPINEPHRINE#0.7113;CYTOCHROME B566#0.6905;DENSE CORE VESICLE#0.6827;ELECTRON CARRIER#0.6763;OXIDOREDUCTASE COMPLEX#0.6666;MYXOTHIAZOL#0.6663;ORGANELLE#0.6447;CYTOCHROME B5#0.6137;NERVE TERMINAL#0.6011
153527	SPLICEOSOME#0.7017
153562	TRICELLULAR TIGHT JUNCTION#1.0826;BICELLULAR TIGHT JUNCTION#1.0640;HEARING LOSS#1.0401;TIGHT JUNCTION PROTEIN#1.0343;TIGHT JUNCTION#1.0153;ZONULA OCCLUDENS#1.0132;EPITHELIAL CELL#1.0062;JUNCTIONAL ADHESION MOLECULE#0.9931;CHAPERONIN#0.9633;ENDOTHELIAL CELL#0.9507;HAIR CELL#0.9448;INNER EAR#0.9414;CELL MEMBRANE#0.9148;LIPOLYSIS#0.8993;CANCER CELL#0.8589;EPITHELIAL BARRIER FUNCTION#0.8381;PANCREATIC CANCER#0.8265;ZONULA OCCLUDENS 1#0.7947;NONSYNDROMIC DEAFNESS#0.7864;ADHERENS JUNCTION#0.7792;ADENOCARCINOMA#0.7594;TRANSCRIPTION FACTOR#0.7106;EPITHELIAL MESENCHYMAL TRANSITION#0.6877;CELL DEATH#0.6871;PLASMA MEMBRANE#0.6849;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.6819;CELL PROLIFERATION#0.6801;CYTOPLASM#0.6797;APOPTOSIS#0.6749;EPITHELIAL TISSUES#0.6685;GENE EXPRESSION#0.6538;CELL CELL JUNCTION#0.6478;CELL JUNCTION#0.6436;PANCREATIC ADENOCARCINOMA#0.6118;POSTTRANSLATIONAL MODIFICATION#0.6077;SCHWANN CELL#0.6069;BASAL CELL#0.6060;PARANODAL LOOP#0.6022
153572	T CELL#1.0731;IMMUNE RESPONSE#0.9560;DENDRITIC CELL#0.9376;GENE EXPRESSION#0.9280;SQUAMOUS CELL CARCINOMA#0.9045;TRANSCRIPTION FACTOR#0.8999;T LYMPHOCYTE#0.8750;TUMOR ANTIGEN#0.8706;CYCLOPHOSPHAMIDE#0.8114;HEAD AND NECK CANCER#0.8113;INDOMETHACIN#0.8113;NECK CANCER#0.8112;CELL PROLIFERATION#0.8057;PERIPHERAL BLOOD#0.7754;B CELL#0.7593;BREAST CANCER#0.7466;SQUAMOUS CELL CANCER#0.7388;TALPHA1#0.6978;EPITHELIAL CELL#0.6455;APOPTOSIS#0.6382;DNA METHYLATION#0.6266;LYMPH NODE#0.6226
153579	T CELL#0.9996;COMPLEX I#0.6577;GENE EXPRESSION#0.6014
1535	CYTOCHROME B-245#1.0979;FLAVOCYTOCHROME B558#1.0864;CYTOCHROME B#1.0459;CORONARY ARTERY DISEASE#1.0288;ARTERY DISEASE#1.0287;CORONARY ARTERY#1.0182;REVERSE TRANSCRIPTION#1.0158;RESPIRATORY BURST#1.0131;FRAGMENT LENGTH POLYMORPHISM#1.0119;NADPH OXIDASE COMPLEX#1.0111;NADPH OXIDASE#1.0033;ROS GENERATION#1.0013;DIABETIC NEPHROPATHY#1.0008;POLYMERASE CHAIN REACTION#1.0004;ENDOTHELIAL NITRIC OXIDE#1.0000;B CELL#0.9998;ADENINE DINUCLEOTIDE PHOSPHATE#0.9969;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9959;PLASMA MEMBRANE#0.9952;ARTERY#0.9948;GLUTATHIONE PEROXIDASE#0.9947;MONOCYTE#0.9943;NICOTINAMIDE#0.9937;CHRONIC GRANULOMATOUS DISEASE#0.9925;ADENINE#0.9920;NITRIC OXIDE SYNTHASE#0.9911;MACROPHAGE#0.9899;GLUTATHIONE#0.9883;NEUTROPHIL#0.9871;GENE EXPRESSION#0.9866;TRANSFORMING GROWTH FACTOR#0.9856;HYPOXIA#0.9834;DIABETES MELLITUS#0.9833;SMOOTH MUSCLE#0.9832;SUPEROXIDE DISMUTASE#0.9829;VASCULAR SMOOTH MUSCLE CELL#0.9822;GROWTH FACTOR#0.9811;VASCULAR CELL#0.9801;INDUCIBLE NITRIC OXIDE#0.9795;ENDOTHELIAL CELL#0.9795;SMOOTH MUSCLE CELL#0.9783;MUSCLE CELL#0.9781;APOPTOSIS#0.9760;ENDOTHELIUM#0.9753;TYPE 1 DIABETES#0.9749;HYPERTENSION#0.9745;ATHEROSCLEROSIS#0.9741;NITRIC OXIDE#0.9738;NEPHROPATHY#0.9732;TYPE 2 DIABETES#0.9731;ALDOSTERONE#0.9721;PROTEIN KINASE#0.9713;TUMOR NECROSIS FACTOR#0.9704;MYOCARDIAL INFARCTION#0.9703;MITOGEN ACTIVATED PROTEIN#0.9688;SIGNALING PATHWAY#0.9674;LOW DENSITY LIPOPROTEIN#0.9664;HEART DISEASE#0.9653;LEUKOCYTE#0.9622;SYSTOLIC BLOOD PRESSURE#0.9593;REACTIVE OXYGEN SPECIES#0.9523;TYPE 2 DIABETIC#0.9520;ACETYLCHOLINE#0.9503;PERIPHERAL BLOOD#0.9486;ATHEROSCLEROTIC#0.9465;CELL PROLIFERATION#0.9446;CORONARY HEART DISEASE#0.9424;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9335;XANTHINE OXIDASE#0.9334;TRANSCRIPTION FACTOR#0.9323;TISSUE GROWTH FACTOR#0.9299;VASCULAR DISEASE#0.9237;ANGIOTENSIN CONVERTING ENZYME#0.9235;T CELL#0.9225;INFLAMMATORY RESPONSE#0.9185;HIGH FAT DIET#0.9157;RECEPTOR ANTAGONIST#0.9139;EPITHELIAL CELL#0.9129;CANDESARTAN#0.9115;TRANSCRIPTASE#0.9080;HUMAN UMBILICAL VEIN#0.9030;UMBILICAL VEIN#0.9028;IFN-GAMMA#0.9012;PRO-INFLAMMATORY#0.8957;XANTHINE#0.8940;CONNECTIVE TISSUE#0.8886;L-ARGININE#0.8867;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8825;ENZYME COMPLEX#0.8802;APOPTOTIC#0.8771;PROTEIN KINASE C#0.8765;ENDOTHELIAL GROWTH FACTOR#0.8700;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8700;SIGNAL TRANSDUCTION#0.8699;THORACIC AORTA#0.8695;B LYMPHOCYTE#0.8676;RESPIRATORY-BURST OXIDASE#0.8638;KIDNEY DISEASE#0.8617;STREPTOZOTOCIN#0.8615;ARGININE#0.8600;ENDOPLASMIC RETICULUM#0.8589;ENZYME ACTIVITY#0.8588;CELL ADHESION#0.8467;CELL GROWTH#0.8363;ATORVASTATIN#0.8354;CELL MEMBRANE#0.8289;BLOOD VESSEL#0.8247;TOLL LIKE RECEPTOR#0.8220;OF DIABETIC RATS#0.8128;MAP KINASE#0.8122;BREAST CANCER#0.8106;EXCRETION#0.8057;REACTIVE OXYGEN SPECIES GENERATION#0.8045;IMMUNE RESPONSE#0.8036;CELL ADHESION MOLECULE#0.7917;CANCER CELL#0.7865;CHRONIC KIDNEY DISEASE#0.7845;ESSENTIAL HYPERTENSION#0.7827;SQUAMOUS CELL CARCINOMA#0.7825;TUMOUR NECROSIS FACTOR#0.7804;NITRO-L-ARGININE#0.7796;BONE MARROW#0.7788;OXYGENASE#0.7773;COMPLEX I#0.7744;ELECTRON TRANSFER#0.7697;MICROVASCULAR ENDOTHELIAL CELL#0.7685;GRANULOCYTE#0.7663;CYTOCHROME C#0.7650;LOSARTAN#0.7615;STEM CELL#0.7599;B CELL LYMPHOMA#0.7595;ADVANCED GLYCATION END#0.7585;MEMBRANE FRACTION#0.7584;CEREBROVASCULAR DISEASE#0.7566;QUANTITATIVE REAL TIME#0.7560;AUTOPHAGY#0.7512;INTIMA MEDIA THICKNESS#0.7476;ANGIOGENESIS#0.7472;PULMONARY HYPERTENSION#0.7465;OBESE#0.7462;ROS FORMATION#0.7431;CLEAVED CASPASE 3#0.7417;SIGNALING MOLECULE#0.7342;TYPE 2 DIABETES MELLITUS#0.7340;2 DIABETES MELLITUS#0.7340;LEFT VENTRICULAR MASS#0.7272;ELECTRON TRANSPORT#0.7236;VASODILATION#0.7192;HEME OXYGENASE 1#0.7190;OXIDATIVE BURST#0.7188;CELL ACTIVATION#0.7150;CARDIOVASCULAR SYSTEM#0.7140;HYPERGLYCEMIA#0.7113;PEROXISOME#0.7105;PROTEINURIA#0.7067;CAROTID ARTERY#0.7013;LIVER DISEASE#0.7009;GLOMERULAR FILTRATION RATE#0.7007;GLOMERULAR FILTRATION#0.7004;PHAGOCYTOSIS#0.6978;MONONUCLEAR CELLS#0.6907;ACUTE MYOCARDIAL INFARCTION#0.6858;AEROBIC EXERCISE TRAINING#0.6854;FATTY LIVER#0.6851;POLY ADP RIBOSE#0.6849;MUTAGENESIS#0.6846;OBSTRUCTIVE SLEEP APNEA#0.6845;PLATELET-DERIVED GROWTH FACTOR#0.6841;LECTIN#0.6838;SLEEP APNEA#0.6832;EXTRACELLULAR MATRIX#0.6823;C REACTIVE PROTEIN#0.6819;VITAMIN E#0.6789;MESANGIAL CELL#0.6770;ADVENTITIA#0.6756;FATTY LIVER DISEASE#0.6710;CARDIOMYOCYTE#0.6709;TRANSFORMING GROWTH FACTOR BETA#0.6680;X-LINKED CHRONIC GRANULOMATOUS DISEASE#0.6673;ISCHEMIA#0.6643;EPLERENONE#0.6550;CARDIOVASCULAR RISK FACTOR#0.6518;TOTAL ANTIOXIDANT CAPACITY#0.6508;MYOCARDIUM#0.6494;MULTIPLE LOGISTIC REGRESSION#0.6493;SUPEROXIDE RELEASE#0.6454;ADENOSINE#0.6449;8-HYDROXY-2'-DEOXYGUANOSINE#0.6364;HYPERCHOLESTEROLEMIA#0.6334;SODIUM NITROPRUSSIDE#0.6308;NON HODGKIN LYMPHOMA#0.6304;HEME BINDING#0.6275;VASCULAR ENDOTHELIAL DYSFUNCTION#0.6264;NORMAL CONTROL GROUP#0.6261;CATALASE ACTIVITY#0.6239;CELL SURFACE#0.6219;GTP BINDING#0.6195;GLUTAMATE CYSTEINE LIGASE#0.6141;COENZYME A#0.6137;CAROTID BODY#0.6133;TRADITIONAL RISK FACTORS#0.6092;CELL DEATH#0.6082;INTRACRANIAL ANEURYSM#0.6013;SPECIFIC GRANULE#0.6000
153657	CYTOKINESIS#0.8583
1536	CYTOCHROME B-245#1.0933;FLAVOCYTOCHROME B558#1.0701;RESPIRATORY-BURST OXIDASE#1.0400;CYTOCHROME B#1.0363;CLEAVED CASPASE 3#1.0362;X CHROMOSOME#1.0349;IFN-GAMMA#1.0323;MITOCHONDRIAL DAMAGE#1.0298;PLATELET ACTIVATION#1.0273;X-LINKED CHRONIC GRANULOMATOUS DISEASE#1.0249;LIPID RAFT#1.0245;NMDA RECEPTOR#1.0208;PHAGOSOME#1.0195;ENZYME COMPLEX#1.0166;NADPH OXIDASE COMPLEX#1.0117;ETHANOL#1.0107;CELL MEMBRANE#1.0091;SPINAL CORD#1.0087;INDUCIBLE NITRIC OXIDE#1.0067;NADPH BINDING#1.0032;OXIDATIVE BURST#1.0030;B CELL#1.0026;CAMKII#1.0026;AUTOPHAGY#1.0023;REACTIVE OXYGEN SPECIES GENERATION#1.0016;NADPH OXIDASE#1.0015;COMPLEX I#1.0006;INFLUENZA A VIRUS#1.0002;MYELOID CELL#0.9997;CYTOCHROME C#0.9972;RESPIRATORY BURST#0.9971;CARDIOMYOCYTE#0.9958;REVERSE TRANSCRIPTION#0.9957;ASTROCYTE#0.9952;ROS FORMATION#0.9949;HEME OXYGENASE 1#0.9948;CHRONIC GRANULOMATOUS DISEASE#0.9939;SENESCENCE#0.9937;SKELETAL MUSCLE#0.9935;MYOCARDIUM#0.9929;CELL ADHESION MOLECULE#0.9922;POLYMERASE CHAIN REACTION#0.9920;ELECTRON TRANSFER#0.9919;HYPOXIA INDUCIBLE FACTOR#0.9916;HYPOXIC#0.9915;PHOSPHOLIPASE A2#0.9914;MICROGLIAL CELL#0.9905;PLASMA MEMBRANE#0.9903;MICROVASCULAR ENDOTHELIAL CELL#0.9901;SELECTIN#0.9899;B LYMPHOCYTE#0.9892;GLUTATHIONE PEROXIDASE#0.9892;ALDOSTERONE#0.9889;ROS GENERATION#0.9884;TRAUMATIC BRAIN INJURY#0.9883;OXYGENASE#0.9881;T CELL#0.9881;ADENINE DINUCLEOTIDE PHOSPHATE#0.9881;NEUTROPHIL#0.9878;DENDRITIC CELL#0.9875;VASCULAR CELL#0.9873;MELATONIN#0.9871;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9869;FLOW MEDIATED DILATION#0.9868;ENDOTHELIAL NITRIC OXIDE#0.9865;NEUROTOXICITY#0.9862;CEREBRAL ISCHEMIA#0.9861;SMOOTH MUSCLE ACTIN#0.9860;PERIPHERAL BLOOD#0.9855;MYOCYTES#0.9855;APOPTOTIC#0.9853;NICOTINAMIDE#0.9850;RECEPTOR ANTAGONIST#0.9849;CELL ACTIVATION#0.9847;BONE MARROW#0.9846;ADENINE#0.9840;TOLL LIKE RECEPTOR#0.9840;PROTEIN KINASE C#0.9839;MACROPHAGE#0.9835;NITRIC OXIDE SYNTHASE#0.9835;HYPOXIA#0.9835;POLY ADP RIBOSE#0.9833;ENZYME ACTIVITY#0.9829;INNATE IMMUNITY#0.9828;SIGNALLING PATHWAY#0.9824;XANTHINE OXIDASE#0.9823;QUANTITATIVE REAL TIME#0.9823;GRANULOCYTE#0.9821;CELL ADHESION#0.9820;CELL DEATH#0.9814;INFLAMMATORY CELL#0.9814;PULMONARY ARTERY#0.9813;L-CYSTEINE#0.9811;PHAGOCYTOSIS#0.9809;MIDDLE CEREBRAL ARTERY#0.9809;DNA BINDING#0.9808;CELL SURFACE#0.9807;ENDOTHELIAL GROWTH FACTOR#0.9807;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9807;MYOCARDIAL INFARCTION#0.9806;CEREBRAL ARTERY#0.9806;EOSINOPHIL#0.9804;ANGIOGENESIS#0.9803;TRANSFORMING GROWTH FACTOR#0.9798;EPITHELIAL CELL#0.9798;BLOOD VESSEL#0.9794;ARTERIOLE#0.9793;LEUKOCYTE#0.9789;MONOCYTE#0.9789;XANTHINE#0.9783;PROGENITOR CELL#0.9782;HINDLIMB#0.9781;MITOCHONDRIA#0.9779;GLUTATHIONE#0.9777;CANCER CELL#0.9772;ARACHIDONIC ACID#0.9772;VASCULAR SMOOTH MUSCLE CELL#0.9771;IMMUNE CELL#0.9766;MICROTUBULE#0.9763;DIABETIC RETINOPATHY#0.9761;ISCHEMIA REPERFUSION INJURY#0.9758;ADENOSINE#0.9753;HIGH FAT DIET#0.9748;HUMAN UMBILICAL VEIN#0.9746;EXCRETION#0.9744;OBESE#0.9743;UMBILICAL VEIN#0.9742;ISCHEMIA#0.9741;BLOOD BRAIN BARRIER#0.9738;APOPTOSIS#0.9738;GENE EXPRESSION#0.9737;SIGNALING CASCADE#0.9734;ATHEROSCLEROTIC#0.9729;8-HYDROXY-2'-DEOXYGUANOSINE#0.9728;MITOGEN ACTIVATED PROTEIN#0.9727;SUPEROXIDE DISMUTASE#0.9722;ADIPOSE TISSUE#0.9718;LOW DENSITY LIPOPROTEIN#0.9716;TUMOR NECROSIS FACTOR#0.9711;MONONUCLEAR CELLS#0.9710;INNATE IMMUNE RESPONSE#0.9709;MUSCLE CELL#0.9708;ENDOTHELIUM#0.9707;SMOOTH MUSCLE CELL#0.9706;CEREBRAL ARTERY OCCLUSION#0.9706;MYOSIN HEAVY CHAIN#0.9705;CELL PROLIFERATION#0.9703;EDEMA#0.9702;CONNECTIVE TISSUE#0.9701;ACETYLCHOLINE#0.9699;TRANSCRIPTION FACTOR#0.9697;ENDOPLASMIC RETICULUM#0.9694;ENDOTHELIAL CELL#0.9694;INFLAMMATORY RESPONSE#0.9692;FATTY LIVER#0.9692;NERVOUS SYSTEM#0.9691;SMOOTH MUSCLE#0.9690;CELL MIGRATION#0.9688;BRAIN DAMAGE#0.9687;SIGNALING PATHWAY#0.9682;NITRIC OXIDE#0.9679;PRO-INFLAMMATORY#0.9679;PROTEIN KINASE#0.9678;SUPEROXIDE RELEASE#0.9678;ENDOSOME#0.9677;STEM CELL#0.9676;PARKINSON'S DISEASE#0.9673;TOXICITY#0.9672;PODOCYTE#0.9667;VASCULAR DISEASE#0.9665;MAPK SIGNALING#0.9664;ENDOTHELIAL PROGENITOR CELL#0.9658;VITAMIN E#0.9653;IMMUNE RESPONSE#0.9640;ATRIAL FIBRILLATION#0.9639;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9638;GROWTH FACTOR#0.9636;CARDIOMYOPATHY#0.9635;TISSUE DAMAGE#0.9634;ARTERY#0.9622;CENTRAL NERVOUS SYSTEM#0.9617;SIGNAL TRANSDUCTION#0.9616;CAROTID BODY#0.9616;CORONARY ARTERY#0.9612;HYPERGLYCEMIA#0.9606;REACTIVE OXYGEN SPECIES#0.9606;STREPTOZOTOCIN#0.9603;CROSS PRESENTATION#0.9600;ARGININE#0.9600;CYTOKINE PRODUCTION#0.9587;PEROXISOME#0.9586;N-ACETYLCYSTEINE#0.9577;NEURODEGENERATIVE DISEASE#0.9576;MESANGIAL CELL#0.9573;KIDNEY DISEASE#0.9572;ATHEROSCLEROSIS#0.9569;SYSTOLIC BLOOD PRESSURE#0.9568;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9564;NEUROPROTECTION#0.9563;CD4+ T CELL#0.9558;L-ARGININE#0.9557;TISSUE GROWTH FACTOR#0.9552;LIVER DISEASE#0.9549;ALZHEIMER'S DISEASE#0.9548;DIABETIC NEPHROPATHY#0.9545;TUBE FORMATION#0.9543;HYPERTENSION#0.9543;CELL CYCLE#0.9542;NEPHROPATHY#0.9539;MITOCHONDRIAL MEMBRANE#0.9538;GLIAL CELL#0.9527;PALMITATE#0.9524;IMMUNE SYSTEM#0.9522;SIGNALING MOLECULE#0.9520;TYPE 2 DIABETES#0.9513;CONSTRICTION#0.9500;LOSARTAN#0.9491;ELECTRON TRANSPORT#0.9482;ALVEOLAR MACROPHAGE#0.9479;DOXORUBICIN#0.9464;ACUTE LUNG INJURY#0.9447;ANGIOTENSIN CONVERTING ENZYME#0.9442;CAROTID ARTERY#0.9441;EXTRACELLULAR MATRIX#0.9436;CYTOTOXICITY#0.9426;DOPAMINERGIC NEURON#0.9401;PHENYLEPHRINE#0.9401;AUTOIMMUNITY#0.9398;MAP KINASE#0.9374;CYTOPLASM#0.9374;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9362;FATTY LIVER DISEASE#0.9357;GROWTH FACTOR RECEPTOR#0.9353;MACROPHAGE ACTIVATION#0.9339;BRAIN EDEMA#0.9327;DIABETES MELLITUS#0.9319;RIBOSE#0.9287;ACETYLCYSTEINE#0.9286;CELL GROWTH#0.9278;LYSOSOME#0.9278;NLRP3 INFLAMMASOME ACTIVATION#0.9278;PLATELET AGGREGATION#0.9276;T LYMPHOCYTE#0.9274;ANTIGEN PROCESSING#0.9266;AUTOIMMUNE DISEASE#0.9259;ACIDIFICATION#0.9243;CARDIOVASCULAR SYSTEM#0.9240;REGENERATION#0.9238;HYPERCHOLESTEROLEMIA#0.9218;HEMATOPOIETIC CELL#0.9207;MESENCHYMAL STEM CELL#0.9200;MEMBRANE FRACTION#0.9192;MYELOID LEUKEMIA#0.9184;INFLAMMATORY BOWEL DISEASE#0.9181;ATORVASTATIN#0.9179;TRANSFORMING GROWTH FACTOR BETA#0.9164;NOREPINEPHRINE#0.9147;NITRO-L-ARGININE#0.9144;VASODILATOR#0.9142;POLYMORPHONUCLEAR LEUKOCYTES#0.9136;PNEUMONIA#0.9134;SPINAL CORD INJURY#0.9118;APOPTOTIC CELL DEATH#0.9084;KINASE INHIBITOR#0.9084;TIGHT JUNCTION#0.9067;ANGIOTENSIN TYPE 1#0.9056;HOST CELL#0.9054;ALANINE#0.9051;TYPE 1 DIABETES#0.9040;MAPK ACTIVATION#0.9037;NOS ACTIVITY#0.9036;MUTAGENESIS#0.9032;LECTIN#0.9031;CHRONIC KIDNEY DISEASE#0.9024;VASCULAR ENDOTHELIAL CELL#0.9022;ENDOPLASMIC RETICULUM STRESS#0.9009;NEURONAL CELLS#0.9001;LUNG CANCER#0.8986;SODIUM NITROPRUSSIDE#0.8985;RENAL FIBROSIS#0.8984;HEART DISEASE#0.8984;THORACIC AORTA#0.8979;THROMBOSIS#0.8966;ADVANCED GLYCATION END#0.8965;VASOCONSTRICTION#0.8954;ASPARTATE#0.8949;CASPASE-3 ACTIVITY#0.8942;TRANSIENT RECEPTOR POTENTIAL#0.8940;DIET INDUCED OBESITY#0.8934;CISPLATIN#0.8933;SUPEROXIDE DISMUTASE ACTIVITY#0.8925;GM-CSF#0.8914;BONE MARROW CELLS#0.8871;MUSCULAR DYSTROPHY#0.8860;GLUCOSE UPTAKE#0.8859;EPSTEIN BARR VIRUS#0.8842;FLAVIN#0.8839;ARRHYTHMIA#0.8818;SLEEP APNEA#0.8815;INSULIN SECRETION#0.8801;KERATINOCYTE#0.8794;LIVER DAMAGE#0.8787;PERIPHERAL NERVE INJURY#0.8767;PROTEIN KINASE B#0.8766;COLITIS#0.8754;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8752;PROTEIN COMPLEX#0.8749;ANTIOXIDANT ACTIVITY#0.8747;PHOSPHOLIPASE A#0.8730;HEMATOPOIETIC STEM CELL#0.8725;HEMORRHAGE#0.8706;SARCOPLASMIC RETICULUM#0.8703;PERIPHERAL NERVE#0.8697;ARTERY DISEASE#0.8688;SUBSTANTIA NIGRA#0.8685;DIAPHORASE ACTIVITY#0.8658;VASODILATION#0.8658;DUCHENNE MUSCULAR DYSTROPHY#0.8645;NITROPRUSSIDE#0.8643;MYOFIBROBLAST#0.8636;ADIPOCYTE#0.8631;OXYGEN GLUCOSE DEPRIVATION#0.8625;RESVERATROL#0.8622;MEMBRANE DEPOLARIZATION#0.8620;PULMONARY HYPERTENSION#0.8608;BLOOD UREA NITROGEN#0.8602;PLURIPOTENT STEM CELL#0.8589;DNA FRAGMENTATION#0.8573;PROTEIN TYROSINE PHOSPHATASE#0.8573;CHEMOTAXIS#0.8541;STROMAL CELL#0.8534;VIRULENCE#0.8529;ELECTRON TRANSPORT CHAIN#0.8524;VASODILATATION#0.8523;TUBERCULOSIS#0.8509;INDUCED PLURIPOTENT STEM CELL#0.8500;NF-KAPPAB ACTIVATION#0.8488;TUBULAR EPITHELIAL CELL#0.8479;GENE SILENCING#0.8472;LUMINAL#0.8468;LDL RECEPTOR#0.8468;GTP BINDING#0.8465;TRANSCRIPTASE#0.8442;GLYCOSYLATION#0.8439;LYMPH NODE#0.8417;COLONY-STIMULATING FACTOR#0.8409;BREAST CANCER#0.8394;CATALASE ACTIVITY#0.8363;REACTIVE OXIDANT SPECIES#0.8362;MITOCHONDRIAL ELECTRON TRANSPORT#0.8355;BETA CELL#0.8349;NUCLEOTIDE BINDING#0.8340;RAPAMYCIN#0.8323;WOUND HEALING#0.8322;NECROTIC#0.8305;CELL DIFFERENTIATION#0.8304;TARGET OF RAPAMYCIN#0.8302;TREG CELL#0.8302;RHEUMATOID ARTHRITIS#0.8283;PROTEINURIA#0.8281;INFLAMMATORY CELL INFILTRATION#0.8250;KUPFFER CELL#0.8240;AMYOTROPHIC LATERAL SCLEROSIS#0.8239;HISTIDINE#0.8239;LATERAL SCLEROSIS#0.8238;P38 MAPK SIGNALING#0.8232;RYANODINE RECEPTOR#0.8215;AKT SIGNALING#0.8179;RNA INTERFERENCE#0.8166;HISTAMINE#0.8155;RESPIRATION#0.8149;ADVENTITIA#0.8136;EPIDERMAL GROWTH FACTOR#0.8136;HYPERSENSITIVITY#0.8105;RETINOIC ACID#0.8096;ACTIN CYTOSKELETON#0.8065;VASCULAR ENDOTHELIUM#0.8052;T CELL ACTIVATION#0.8051;NEUROTOXIC#0.8041;CD8+ T CELL#0.8031;ALCOHOLIC FATTY LIVER#0.8024;RESPONSE TO ANGIOTENSIN#0.8015;VALSARTAN#0.8015;PROPOFOL#0.8012;INNATE IMMUNE SYSTEM#0.7976;CHONDROCYTE#0.7960;RECEPTOR AGONIST#0.7936;MECHANISM OF ACTION#0.7935;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7927;TOTAL ANTIOXIDANT CAPACITY#0.7923;CYTOKINE SECRETION#0.7920;STRIATUM#0.7918;ACUTE MYOCARDIAL INFARCTION#0.7913;DIAPHRAGM#0.7912;ENDOCYTOSIS#0.7907;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7895;LUPUS ERYTHEMATOSUS#0.7893;DAYS POST INJURY#0.7890;PROSTATE CANCER#0.7870;ASPIRIN#0.7866;PROTEIN OXIDATION#0.7859;MULTIPLE SCLEROSIS#0.7856;ENDOTHELIAL CELL DYSFUNCTION#0.7853;CONTROLLED CORTICAL IMPACT#0.7851;CROSS SECTIONAL AREA#0.7836;MITOCHONDRIAL FISSION#0.7827;ALVEOLAR EPITHELIAL CELL#0.7823;PROMYELOCYTE#0.7818;AGEING#0.7814;KIDNEY DAMAGE#0.7802;COENZYME A#0.7797;STEM CELL TRANSPLANTATION#0.7794;TUMOUR NECROSIS FACTOR#0.7780;LIPID METABOLISM#0.7776;BRAIN NATRIURETIC PEPTIDE#0.7758;SPECIFIC GRANULE#0.7751;MONOCYTE DERIVED MACROPHAGE#0.7746;PHOSPHOLIPASE C#0.7725;GLUCOSE METABOLISM#0.7719;PANCREATIC ISLET#0.7709;ESTROGEN RECEPTOR#0.7704;GRANULOMA FORMATION#0.7703;CORONARY ARTERY DISEASE#0.7681;PARENCHYMA#0.7650;SPIRONOLACTONE#0.7650;GLUCOSE TRANSPORT#0.7642;MYELOPEROXIDASE ACTIVITY#0.7636;INHIBITION OF ROS GENERATION#0.7634;VITAMIN C#0.7630;CHANNEL ACTIVITY#0.7625;AORTIC SMOOTH MUSCLE CELLS#0.7623;MUSCLE FIBER#0.7621;GUANOSINE#0.7612;SIMVASTATIN#0.7608;CEREBRAL CORTEX#0.7587;HEAT SHOCK PROTEIN#0.7581;NONALCOHOLIC FATTY LIVER DISEASE#0.7579;HEPATOCELLULAR CARCINOMA#0.7560;MARKERS OF INFLAMMATION#0.7559;OXIDATIVE STRESS RESPONSE#0.7557;MITOCHONDRIAL DNA#0.7548;INTERNEURON#0.7543;RETINAL ENDOTHELIAL CELLS#0.7538;HEPATIC STELLATE CELL#0.7532;HISTONE DEACETYLASE#0.7529;FLAVIN ADENINE DINUCLEOTIDE#0.7526;BREAST CANCER CELL#0.7525;CORONARY ARTERY LIGATION#0.7503;MAST CELL#0.7500;CHRONIC INTERMITTENT HYPOXIA#0.7485;KETAMINE#0.7482;ESTRADIOL#0.7475;MYELOID-DERIVED SUPPRESSOR CELL#0.7470;IL-17 PRODUCTION#0.7440;EXOSOME#0.7434;CREATINE KINASE#0.7409;UBIQUITIN#0.7385;CELLULAR LOCALIZATION#0.7363;VASOCONSTRICTOR#0.7358;TETRAHYDROBIOPTERIN#0.7351;EARLY BRAIN INJURY#0.7350;REACTIVE OXYGEN SPECIES FORMATION#0.7343;MEMBRANE RAFT#0.7341;BONE MARROW STROMAL CELL#0.7331;BONE MARROW STROMAL#0.7325;SPATIAL LEARNING#0.7321;RESPIRATORY CHAIN#0.7319;LEUCINE#0.7318;LINEAR REGRESSION ANALYSIS#0.7313;POST-TRANSLATIONAL MODIFICATION#0.7293;MIDBRAIN#0.7292;DOPAMINE#0.7255;DEXAMETHASONE#0.7255;NEUTROPHIL APOPTOSIS#0.7237;TIGHT JUNCTION PROTEIN#0.7230;AORTIC ANEURYSM#0.7227;INTRACELLULAR SIGNALING PATHWAY#0.7222;RESPIRATORY DISTRESS#0.7213;MEMORY IMPAIRMENT#0.7210;72-HOURS#0.7203;TYPE 2 DIABETIC#0.7200;ALLERGIC ASTHMA#0.7190;INTERFERON REGULATORY FACTOR#0.7182;PRECURSOR CELL#0.7174;GLYCOLYSIS#0.7174;VACUOLE#0.7172;OBSTRUCTIVE SLEEP APNEA#0.7167;COLON CANCER#0.7162;C REACTIVE PROTEIN#0.7136;FAD BINDING#0.7121;RENOVASCULAR HYPERTENSION#0.7119;CHEMOKINE RECEPTOR#0.7108;AQUAPORIN#0.7100;ANTIGEN PRESENTING CELLS#0.7057;WHITE BLOOD CELL#0.7053;SCIATIC NERVE#0.7049;SIGNAL TRANSDUCER#0.7047;CYTOCHROME P450#0.7034;INCREASED BLOOD PRESSURE#0.7034;LIGHT CHAIN 3#0.7017;PROTEIN DISULFIDE ISOMERASE#0.7017;TUMOR CELLS#0.7007;CYCLOSPORINE#0.7007;DIMETHYL SULFOXIDE#0.7007;ENCEPHALOMYELITIS#0.7001;FORMYL PEPTIDE RECEPTOR#0.7000;HEPATIC ISCHEMIA REPERFUSION#0.6988;DEMENTIA#0.6980;LINAGLIPTIN#0.6980;ADAPTIVE IMMUNE RESPONSE#0.6967;DIPEPTIDYL PEPTIDASE#0.6967;MYOBLAST#0.6964;WEIGHT LOSS#0.6935;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6933;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6903;EPITHELIAL TO MESENCHYMAL#0.6901;PRIMARY IMMUNODEFICIENCY DISEASE#0.6880;TRANSMISSION ELECTRON MICROSCOPY#0.6859;ACUTE ISCHEMIC STROKE#0.6855;COLON EPITHELIAL CELL#0.6852;PKC ACTIVATION#0.6844;SUPEROXIDE ANION GENERATION#0.6834;NEPHROTOXICITY#0.6832;SCAVENGER RECEPTOR#0.6830;SWELLING#0.6820;INTIMA MEDIA THICKNESS#0.6812;TRANSACTIVATION#0.6802;GUANINE#0.6788;PHOSPHODIESTERASE#0.6788;MYELOID CELL LINES#0.6758;POLYMORPHONUCLEAR NEUTROPHIL#0.6741;GLUCOSE INTOLERANCE#0.6740;DERMAL FIBROBLAST#0.6737;T CELL PROLIFERATION#0.6706;ANTI APOPTOSIS#0.6703;MONOCYTE CHEMOTACTIC PROTEIN#0.6677;B CELL LYMPHOMA#0.6675;PROTEIN SYNTHESIS#0.6658;ALLERGEN#0.6653;MICROTUBULE ASSOCIATED PROTEIN#0.6646;GASTRIC MUCOSA#0.6640;OSTEOCLAST#0.6609;RETINAL ISCHEMIA#0.6600;TYPE 2 DIABETES MELLITUS#0.6575;2 DIABETES MELLITUS#0.6575;X CHROMOSOME INACTIVATION#0.6535;CHROMOSOME INACTIVATION#0.6532;POTASSIUM CHANNEL#0.6517;EMBRYONIC STEM CELL#0.6498;RESPONSE TO OXIDATIVE STRESS#0.6476;HIGH CHOLESTEROL DIET#0.6459;FOCAL CEREBRAL ISCHEMIA#0.6459;SKELETAL MUSCLE CELLS#0.6449;METHIONINE#0.6437;INSULIN RECEPTOR#0.6434;MORRIS WATER MAZE#0.6420;CELL CYCLE ARREST#0.6419;CONNEXIN#0.6409;AMYLOID PRECURSOR PROTEIN#0.6406;PLATELET-DERIVED GROWTH FACTOR#0.6387;RECEPTOR TYROSINE KINASE#0.6382;G-CSF#0.6382;REACTIVE NITROGEN SPECIES#0.6376;N-NITRO-L-ARGININE#0.6372;MITOCHONDRIAL ELECTRON TRANSPORT CHAIN#0.6338;BENZOIC ACID#0.6295;NEUTROPHIL ACTIVATION#0.6285;CREATINE#0.6277;MYELOID PROGENITOR CELL#0.6271;MACROPINOCYTOSIS#0.6266;TO THE PROGRESSION#0.6264;PEROXIDASE ACTIVITY#0.6261;TNF PRODUCTION#0.6260;NUCLEOTIDE BINDING DOMAIN#0.6260;MUSCLE ATROPHY#0.6258;ANGIOTENSIN RECEPTOR#0.6254;CARDIAC MUSCLE#0.6251;RETINAL GANGLION CELL#0.6251;GENETIC DISORDER#0.6242;ALISKIREN#0.6240;NEUROGENESIS#0.6232;CELL WALL#0.6227;BRONCHIAL EPITHELIAL CELLS#0.6224;GLYCOGEN SYNTHASE KINASE#0.6222;GLUTAMATE DECARBOXYLASE#0.6216;IL-1 PRODUCTION#0.6177;IONOPHORE#0.6170;COLLAGEN INDUCED ARTHRITIS#0.6160;FRUCTOSE#0.6141;NUCLEOTIDE EXCHANGE FACTOR#0.6138;SPERMATOZOA#0.6138;AORTIC SINUS#0.6131;NEURONAL CELL DEATH#0.6108;EMBRYONIC KIDNEY#0.6098;FLOW MEDIATED DILATATION#0.6096;ACUTE KIDNEY INJURY#0.6095;CYCLIN DEPENDENT KINASE#0.6093;REGULATORY T CELL#0.6092;CAVEOLAE#0.6089;G6PD ACTIVITY#0.6080;ADRENERGIC RECEPTOR#0.6080;NEBIVOLOL#0.6077;PROTEIN KINASE A#0.6072;ACUTE MYELOID LEUKEMIA#0.6068;ASTROCYTE ACTIVATION#0.6065;NEONATAL RAT CARDIOMYOCYTES#0.6040;ANTI-INFLAMMATORY RESPONSE#0.6030;SPINAL DORSAL HORN#0.6026;COLLAGEN RELATED PEPTIDE#0.6022;SENSITIZATION#0.6020;INFLAMMATORY MONOCYTE#0.6015;TESTOSTERONE#0.6015;HYDROGEN PEROXIDE GENERATION#0.6012;LEFT VENTRICULAR REMODELING#0.6004
153733	IGM ANTIBODY#0.9932;B CELL#0.7889;CELL DEATH#0.7883;APOPTOSIS#0.6760;APOPTOTIC CELL DEATH#0.6465;GENE EXPRESSION#0.6372;SURFACE IGM#0.6228;BURKITT LYMPHOMA#0.6090
153768	GENE EXPRESSION#0.6200
153769	PROTEIN PHOSPHATASE 1 BINDING#1.1298;PROTEIN PHOSPHATASE 1#1.1163;APOPTOSIS#0.6720;MYOTUBE DIFFERENTIATION#0.6452;DENDRITIC SPINE#0.6025
1537	CYTOCHROME C1#1.0539;RIESKE IRON-SULFUR PROTEIN#1.0494;COMPLEX III#1.0345;CYTOCHROME B#1.0282;CYTOCHROME BC1 COMPLEX#1.0151;ELECTRON TRANSFER#1.0092;MITOCHONDRIAL MEMBRANE#1.0063;SUCCINATE#1.0054;ELECTRON TRANSPORT#1.0052;IRON SULFUR CLUSTER#0.9992;CYTOCHROME C#0.9974;RESPIRATORY CHAIN#0.9968;HEME BINDING#0.9955;CYTOCHROME C OXIDASE#0.9934;COMPLEX I#0.9889;MITOCHONDRIA#0.9802;MYXOTHIAZOL#0.9777;MITOCHONDRIAL RESPIRATORY CHAIN#0.9654;INNER MITOCHONDRIAL MEMBRANE#0.9510;ASCORBATE#0.9480;OXIDATION REDUCTION#0.9468;MITOCHONDRIAL INNER MEMBRANE#0.9366;RESPIRATION#0.9343;CYTOCHROME F#0.9278;DODECYL SULFATE#0.9270;CYTOCHROME B2#0.9075;REACTION CENTER#0.8703;SODIUM DODECYL SULFATE#0.8677;MITOCHONDRIAL CYTOCHROME BC1 COMPLEX#0.8623;OUTER MEMBRANE#0.8591;MITOCHONDRIAL COMPLEX III#0.8580;METHIONINE#0.8536;CYTOCHROME C REDUCTASE ACTIVITY#0.8533;UBIQUINONE BINDING#0.8461;LYSINE#0.8355;MITOCHONDRIAL INTERMEMBRANE SPACE#0.7936;HISTIDINE#0.7890;CYTOCHROME B6#0.7805;ELECTRON TRANSFER ACTIVITY#0.7740;OXIDATIVE PHOSPHORYLATION#0.7325;OXIDOREDUCTASE COMPLEX#0.7239;ELECTRON TRANSPORT CHAIN#0.7119;SUCCINATE DEHYDROGENASE#0.6846;CYTOCHROME B5#0.6826;MITOCHONDRIAL ELECTRON TRANSPORT#0.6732;CHLOROPLAST#0.6630;OXIDOREDUCTASE ACTIVITY#0.6468;APOPTOSIS#0.6463;GENE EXPRESSION#0.6434;ENZYME COMPLEX#0.6403;ATP SYNTHASE#0.6284;RIESKE IRON-SULPHUR PROTEIN#0.6165;MUTAGENESIS#0.6034;STRUCTURAL ORGANIZATION#0.6006
153830	UBIQUITIN#0.7315
1539	SPERM HEAD#0.7881;ACTIN BINDING PROTEIN#0.6412;ACTIN BINDING#0.6373
153	NEBIVOLOL#1.0676;BETAXOLOL#1.0626;BETA1 ADRENERGIC RECEPTOR#1.0528;PRACTOLOL#1.0526;BISOPROLOL#1.0522;DOBUTAMINE#1.0333;DILATED CARDIOMYOPATHY#1.0268;BEVANTOLOL#1.0240;ESSENTIAL HYPERTENSION#1.0238;METOPROLOL#1.0201;TERBUTALINE#1.0200;BETA1 ADRENOCEPTOR#1.0159;ATENOLOL#1.0139;CARDIOMYOPATHY#1.0106;MYOCYTES#1.0061;CARVEDILOL#1.0047;BETA-2#1.0003;HEART DISEASE#0.9996;CYCLIC AMP#0.9987;PINDOLOL#0.9971;ADRENERGIC RECEPTOR#0.9966;PROCATEROL#0.9939;PROTEIN KINASE#0.9938;CHRONIC HEART FAILURE#0.9937;ANGIOTENSIN CONVERTING ENZYME#0.9931;SALBUTAMOL#0.9929;ADENYLATE CYCLASE#0.9909;RECEPTOR ANTAGONIST#0.9901;DOPAMINE#0.9895;CORONARY ARTERY#0.9893;ALPHA ADRENOCEPTOR#0.9883;NORADRENALINE#0.9882;ADENYLATE#0.9876;ISOPRENALINE#0.9875;ADRENALINE#0.9866;GENE EXPRESSION#0.9854;ISOPROTERENOL#0.9852;MYOCARDIAL INFARCTION#0.9852;HYPOTENSIVE#0.9845;MYOCARDIUM#0.9838;HYPERTENSION#0.9827;TACHYCARDIA#0.9825;NOREPINEPHRINE#0.9809;BETA ADRENERGIC RECEPTOR#0.9792;PROPRANOLOL#0.9786;ARTERY#0.9777;PRAZOSIN#0.9774;BETA2 ADRENERGIC RECEPTOR#0.9755;TRACHEA#0.9748;RENIN ACTIVITY#0.9736;ADIPOSE TISSUE#0.9717;SYSTOLIC BLOOD PRESSURE#0.9715;EPINEPHRINE#0.9704;SIGNALING PATHWAY#0.9696;CALCIUM CHANNEL#0.9684;BETA ADRENOCEPTOR#0.9673;SMOOTH MUSCLE#0.9635;POLYMERASE CHAIN REACTION#0.9576;FORSKOLIN#0.9557;ADENOSINE#0.9554;PHENYLEPHRINE#0.9547;SKELETAL MUSCLE#0.9540;CARDIOMYOCYTE#0.9516;FENOTEROL#0.9511;HYPOTENSION#0.9507;CONGESTIVE HEART FAILURE#0.9479;ADIPOCYTE#0.9465;NERVOUS SYSTEM#0.9454;LIPOLYSIS#0.9435;SIGNAL TRANSDUCTION#0.9390;PROTEIN KINASE A#0.9350;ARRHYTHMIA#0.9342;GROWTH FACTOR#0.9293;VASODILATOR#0.9286;PHENTOLAMINE#0.9265;RECEPTOR AGONIST#0.9257;ISCHEMIA#0.9222;BETA2 ADRENOCEPTOR#0.9067;VERAPAMIL#0.9048;YOHIMBINE#0.9044;VASODILATION#0.9020;CYCLASE ACTIVITY#0.8956;RIGHT ATRIUM#0.8913;ADRENOCEPTOR ACTIVITY#0.8832;LABETALOL#0.8811;NITRIC OXIDE#0.8768;EXCRETION#0.8762;CLONIDINE#0.8748;ENDOTHELIUM#0.8731;APOPTOSIS#0.8716;CORONARY ARTERY DISEASE#0.8692;ARTERY DISEASE#0.8691;CARDIOVASCULAR SYSTEM#0.8677;TIMOLOL#0.8669;PHOSPHODIESTERASE#0.8577;ATROPINE#0.8509;VASOCONSTRICTION#0.8356;HISTAMINE#0.8337;NADOLOL#0.8327;CELL SURFACE#0.8311;ALDOSTERONE#0.8194;RECEPTOR BINDING#0.8152;ACEBUTOLOL#0.8147;RHEUMATIC HEART DISEASE#0.8136;ENZYME INHIBITOR#0.8111;ADENOSINE MONOPHOSPHATE#0.7978;FRAGMENT LENGTH POLYMORPHISM#0.7941;ERYTHROCYTE#0.7930;NIFEDIPINE#0.7928;CARBACHOL#0.7918;BRADYCARDIA#0.7769;SALMETEROL#0.7763;RESERPINE#0.7678;ATRIAL FIBRILLATION#0.7634;ALPRENOLOL#0.7608;PLASMA MEMBRANE#0.7594;ACUTE MYOCARDIAL INFARCTION#0.7594;BLOOD VESSEL#0.7562;SOTALOL#0.7558;CYTOCHROME P450#0.7543;POTASSIUM CHANNEL#0.7507;UTERUS#0.7496;CYCLIC ADENOSINE MONOPHOSPHATE#0.7486;DESIPRAMINE#0.7460;ESMOLOL#0.7455;ACTION POTENTIAL#0.7454;ACINAR CELL#0.7405;ACE INHIBITOR#0.7400;LOW DENSITY LIPOPROTEIN#0.7334;METOPROLOL SUCCINATE#0.7329;CEREBRAL CORTEX#0.7328;SENSITIZATION#0.7314;T CELL#0.7300;PORTAL VEIN#0.7256;PERTUSSIS#0.7227;ISCHEMIC HEART DISEASE#0.7201;DOBUTAMINE STRESS ECHOCARDIOGRAPHY#0.7200;NERVE TERMINAL#0.7187;OBESE#0.7185;GLIBENCLAMIDE#0.7184;ACETYLCHOLINE#0.7087;ADENYLATE CYCLASE ACTIVITY#0.7060;CORONARY HEART DISEASE#0.6997;PHENOXYBENZAMINE#0.6950;CLENBUTEROL#0.6917;CORONARY ARTERY BYPASS#0.6886;SMOOTH MUSCLE CELL#0.6816;MUSCLE CELL#0.6810;ARGININE#0.6802;MITRAL VALVE#0.6800;HYPERTHYROIDISM#0.6762;PULMONARY ARTERY#0.6747;ADENYLYL CYCLASE ACTIVITY#0.6671;VASODILATATION#0.6662;ADENYLATE CYCLASE ACTIVATION#0.6629;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6438;GLOMERULAR FILTRATION RATE#0.6428;GLOMERULAR FILTRATION#0.6425;PHOSPHODIESTERASE INHIBITOR#0.6327;BOPINDOLOL#0.6307;FOREARM#0.6241;ADENYLYL CYCLASE ACTIVATION#0.6166;DOPAMINE RECEPTOR#0.6138;CHAGAS DISEASE#0.6069;RESONANCE ENERGY TRANSFER#0.6032;DIGOXIN#0.6029
154043	ALDOSTERONE#0.6916;UVEAL MELANOMA#0.6217
154064	RELAPSE FREE SURVIVAL#0.6142
154075	GROWTH FACTOR#0.6658;VEGF PRODUCTION#0.6033
154091	MAMMARY GLAND#1.0663;PLASMA MEMBRANE#1.0378;SKELETAL MUSCLE#1.0328;CELL SURFACE#1.0245;EPITHELIAL CELL#1.0202;ADIPOSE TISSUE#1.0193;GLUCOSE UPTAKE#1.0116;CANCER CELL#1.0024;GLUCOSE TRANSPORT#1.0019;FRUCTOSE#0.9739;SUGAR TRANSPORTER#0.9348;BREAST CANCER#0.9297;ADIPOCYTE#0.9120;GLUCOSE METABOLISM#0.8910;GENE EXPRESSION#0.8806;OOCYTE#0.8751;SUGAR TRANSPORT#0.8521;MAMMARY EPITHELIAL CELL#0.8470;BREAST CANCER CELL#0.8100;LACTATION#0.8039;TYPE 2 DIABETES#0.7886;GLUCOSE HOMEOSTASIS#0.7813;CYTOPLASM#0.7735;HYPOXIA#0.7720;PROSTATE CANCER#0.7384;2-DEOXY-D-GLUCOSE#0.7187;RESPONSE TO INSULIN#0.7115;PROTEIN KINASE#0.7039;SMALL INTESTINE#0.6878;FRUCTOSE TRANSPORT#0.6551;GROWTH FACTOR#0.6533;ENTEROCYTE#0.6429;INSULIN RECEPTOR#0.6419;FRUCTOSE UPTAKE#0.6415;POLYMERASE CHAIN REACTION#0.6313;COLLECTING DUCTS#0.6171;LEYDIG CELL#0.6090
1540	DEUBIQUITINATION#1.0579;DEUBIQUITINATING ENZYME#1.0505;DEUBIQUITINASE#1.0501;DEUBIQUITINASE ACTIVITY#1.0457;NF-KAPPAB ACTIVATION#1.0423;POLYUBIQUITIN#1.0420;TUMOR SUPPRESSOR#1.0382;SPIRADENOMA#1.0221;NECROPTOSIS#1.0197;T CELL#1.0173;GROWTH FACTOR#1.0068;TUMOR NECROSIS FACTOR#1.0048;EPITHELIAL CELL#1.0043;UBIQUITIN#1.0040;CELL PROLIFERATION#1.0008;B CELL#1.0006;SIGNALING PATHWAY#1.0001;DYNAMIC LIGHT SCATTERING#0.9999;BASAL CELL#0.9964;RECEPTOR INTERACTING PROTEIN#0.9962;MICROTUBULE#0.9947;MACROPHAGE#0.9923;TRANSCRIPTION FACTOR#0.9919;LYSINE#0.9915;CELL DEATH#0.9910;IMMUNE RESPONSE#0.9907;ENDOTHELIAL CELL#0.9904;APOPTOSIS#0.9888;SQUAMOUS CELL CARCINOMA#0.9874;TEM CELL#0.9861;CANCER CELL#0.9854;ANTIVIRAL RESPONSE#0.9837;PROTEIN KINASE#0.9826;CELL MIGRATION#0.9819;GENE EXPRESSION#0.9797;INFLAMMATORY RESPONSE#0.9748;CELL CYCLE#0.9735;CELL DEVELOPMENT#0.9729;IKAPPAB KINASE#0.9713;TOLL LIKE RECEPTOR#0.9685;FIBRIL#0.9629;APOPTOTIC#0.9627;TRANSFORMING GROWTH FACTOR#0.9611;CYTOPLASM#0.9602;BASAL CELL CARCINOMA#0.9581;PERIPHERAL BLOOD#0.9446;SALIVARY GLAND#0.9327;BONE MARROW#0.9327;MONOCYTE#0.9309;RNA INTERFERENCE#0.9244;HEPATOCELLULAR CARCINOMA#0.9241;PRO-INFLAMMATORY#0.9235;SCALP#0.9208;REACTIVE OXYGEN SPECIES#0.9070;ANGIOGENESIS#0.9006;CENTROSOME#0.9004;SIGNALLING PATHWAY#0.9000;CYTOTOXICITY#0.8996;CELL SURFACE#0.8994;POLYMERASE CHAIN REACTION#0.8986;MITOGEN ACTIVATED PROTEIN#0.8954;BREAST CANCER#0.8841;CATALYTIC ACTIVITY#0.8820;DENDRITIC CELL#0.8689;CONJUGATION#0.8582;LUNG CANCER#0.8566;SIGNAL TRANSDUCTION#0.8561;AUTOSOMAL DOMINANT DISEASE#0.8482;TUMOR CELLS#0.8468;L-LYSINE#0.8467;TOXICITY#0.8463;PROTEASOME#0.8441;SKIN CANCER#0.8390;SMOOTH MUSCLE#0.8342;HISTONE DEACETYLASE#0.8325;CD4+ T CELL#0.8292;MICROTUBULE DYNAMICS#0.8289;CD8+ T CELL#0.8269;C TERMINAL DOMAIN#0.8264;CELL GROWTH#0.8257;POSTSYNAPTIC DENSITY#0.8243;ADENOID CYSTIC CARCINOMA#0.8217;ERYTHROCYTE#0.8132;B LYMPHOCYTE#0.8082;CILIOGENESIS#0.8054;CELL ACTIVATION#0.8050;STEM CELL#0.8048;ONCOGENIC#0.8048;ADENOCARCINOMA#0.8042;ACTIVATION OF NF-KAPPAB#0.8001;SIGNAL PEPTIDE#0.7966;SPECIFIC SURFACE AREA#0.7923;PROGRAMMED NECROSIS#0.7878;INNATE IMMUNE RESPONSE#0.7814;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7790;HUMAN UMBILICAL VEIN#0.7784;UMBILICAL VEIN#0.7782;OUTER MEMBRANE#0.7664;INNATE IMMUNITY#0.7641;COMPLEX I#0.7640;CELL MEMBRANE#0.7627;CISPLATIN#0.7578;MITOCHONDRIA#0.7511;T CELL DEVELOPMENT#0.7455;KERATINOCYTE#0.7437;COLITIS#0.7418;TUBULAR EPITHELIAL CELL#0.7415;SCANNING ELECTRON MICROSCOPY#0.7400;ORAL SQUAMOUS CELL CARCINOMA#0.7361;VASCULAR SMOOTH MUSCLE CELL#0.7328;MUSCLE CELL#0.7271;AUTOPHAGY#0.7264;RETINOIC ACID#0.7202;CELL DIVISION#0.7156;OSTEOCLAST#0.7137;SMOOTH MUSCLE CELL#0.7095;CONNECTIVE TISSUE#0.7092;IMMUNE CELL#0.7076;ONCOGENESIS#0.7060;THYMOCYTE#0.6993;MITOSIS#0.6991;LYMPH NODE#0.6944;ARGININE#0.6934;ALKALINE PHOSPHATASE#0.6895;MIXED LINEAGE KINASE#0.6865;MIDDLE EAR#0.6851;ENDOPLASMIC RETICULUM#0.6814;POSTTRANSLATIONAL MODIFICATION#0.6785;HAIR FOLLICLE#0.6765;TOPICAL#0.6746;GLYCINE#0.6716;EXTRACELLULAR MATRIX#0.6709;B CELL DEVELOPMENT#0.6700;T LYMPHOCYTE#0.6688;REGULATORY T CELL#0.6658;S PHASE#0.6653;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6588;MITOTIC SPINDLE#0.6551;NECROTIC#0.6541;SPERMATOGENESIS#0.6538;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6499;THO COMPLEX#0.6499;TUMOR TISSUES#0.6493;CELL WALL#0.6457;VIRAL INFECTION#0.6441;CHOLESTEATOMA#0.6434;HYPOXIA#0.6399;PNEUMONIA#0.6316;ORGANELLE#0.6311;OSTEOCLAST DIFFERENTIATION#0.6288;GLUTAMIC ACID#0.6274;MULTIPLE MYELOMA#0.6266;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6252;LYMPHOCYTIC LEUKEMIA#0.6244;BLOOD VESSEL#0.6231;PAROTID GLAND#0.6228;REVERSE TRANSCRIPTION#0.6113;PLASMA MEMBRANE#0.6080;SPINDLE ORIENTATION#0.6067;INTESTINAL EPITHELIAL CELL#0.6005
154141	O ACYLTRANSFERASE#0.7100;LIPID METABOLISM#0.6015
154150	GROWTH FACTOR#0.6618
154197	SPERMATOGENESIS#0.6105
154215	T CELL#0.8378;PROSTATE CANCER#0.6550;TUMOR SUPPRESSOR#0.6543;PANCREATIC CANCER#0.6101;CELL MIGRATION#0.6059
154288	OOCYTE#1.0161;MOLAR#0.8253;RECURRENT PREGNANCY LOSS#0.6593;DNA METHYLATION#0.6334
1543	MALE INFERTILITY#1.0576;BETA-NF#1.0405;CERVICAL CANCER#1.0398;ARYL HYDROCARBON HYDROXYLASE ACTIVITY#1.0381;ENDOMETRIOSIS#1.0360;PROTEIN KINASE C#1.0353;MALIGNANT HYPERTENSION#1.0335;ESOPHAGEAL CANCER#1.0325;CORONARY ARTERY DISEASE#1.0295;ARTERY DISEASE#1.0293;HUMAN MAMMARY EPITHELIAL#1.0277;CERVICAL#1.0271;OMEPRAZOLE#1.0239;FETAL LIVER#1.0224;CATECHOL O METHYLTRANSFERASE#1.0212;ENDOMETRIAL CANCER#1.0210;O METHYLTRANSFERASE#1.0204;MAMMARY EPITHELIAL CELL#1.0199;RESPONSE TO TCDD#1.0199;INFERTILITY#1.0197;AHR COMPLEX#1.0186;CIGARETTE SMOKE CONDENSATE#1.0175;VALINE#1.0172;LUNG CARCINOMA#1.0169;CORONARY ARTERY#1.0163;GLUTATHIONE TRANSFERASE#1.0155;BREAST CARCINOMA#1.0139;ARSENITE#1.0133;ORAL SQUAMOUS CELL CARCINOMA#1.0129;PROTEIN SYNTHESIS#1.0121;GENISTEIN#1.0111;SMALL INTESTINE#1.0109;QUERCETIN#1.0091;PHENACETIN#1.0087;N ACETYLTRANSFERASE#1.0082;HEAD AND NECK CANCER#1.0079;AMINOPYRINE#1.0079;QUANTITATIVE REVERSE TRANSCRIPTASE#1.0066;NECK CANCER#1.0064;TRYPTOPHAN#1.0061;ACTINOMYCIN D#1.0059;PROSTATE CANCER#1.0053;ANILINE#1.0045;HYPOXIA#1.0042;HEME OXYGENASE 1#1.0039;MONOOXYGENASE ACTIVITY#1.0033;LUNG CANCER#1.0029;RESVERATROL#1.0025;PRIMARY HUMAN HEPATOCYTES#1.0025;RIFAMPICIN#1.0019;COLORECTAL#1.0018;FRAGMENT LENGTH POLYMORPHISM#1.0012;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0009;EPOXIDE HYDROLASE#1.0006;COLORECTAL CANCER#1.0005;ELECTROPHORETIC MOBILITY SHIFT#0.9994;REVERSE TRANSCRIPTION#0.9993;OVARIAN CANCER#0.9992;PERIPHERAL BLOOD LYMPHOCYTES#0.9990;CATALYTIC ACTIVITY#0.9989;DNA METHYLATION#0.9986;ISOLEUCINE#0.9984;BETA-NAPHTHOFLAVONE#0.9983;ESTROGEN METABOLISM#0.9982;HYPERTENSION#0.9981;MAMMARY GLAND#0.9980;HEPATOMA CELLS#0.9977;RECEPTOR COMPLEX#0.9972;LEUKOCYTE#0.9971;TRANSFORMING GROWTH FACTOR#0.9968;CYTOCHROME B5#0.9965;RETINOIC ACID#0.9962;CHLORZOXAZONE#0.9961;ALPHA-TOCOPHEROL#0.9957;POLYCYSTIC OVARY SYNDROME#0.9946;BREAST CANCER PATIENTS#0.9942;HEAT SHOCK PROTEIN#0.9940;LUCIFERASE ACTIVITY#0.9939;P-NITROPHENOL#0.9928;ENZYME ACTIVITY#0.9927;RECEPTOR BINDING#0.9924;HUMAN BREAST CANCER#0.9924;CYTOCHROME C#0.9918;CAFFEINE#0.9917;TUMOR NECROSIS FACTOR#0.9915;TRANSCRIPTASE#0.9914;DEMETHYLATION#0.9910;PROTEIN KINASE#0.9909;ENDOTHELIAL CELL#0.9908;SQUAMOUS CELL CARCINOMA#0.9899;B CELL#0.9893;DEMETHYLASE ACTIVITY#0.9884;ARTERY#0.9884;MYELOID LEUKEMIA#0.9882;BENZIMIDAZOLE#0.9881;METYRAPONE#0.9874;OXYGENASE#0.9872;HORMONE METABOLISM#0.9870;ANTHRACENE#0.9870;QUANTITATIVE REAL TIME#0.9869;POLYMERASE CHAIN REACTION#0.9868;KINASE INHIBITOR#0.9868;BODY WEIGHT LOSS#0.9864;KERATINOCYTE#0.9863;GLUTATHIONE PEROXIDASE#0.9861;ESTRONE#0.9860;OXIDATIVE DNA DAMAGE#0.9858;STRUCTURE ACTIVITY RELATIONSHIP#0.9858;NARINGENIN#0.9857;BENZOTHIAZOLE#0.9854;ESTROGEN RECEPTOR ALPHA#0.9853;MUTAGENESIS#0.9850;INDOLE#0.9849;COLON CANCER#0.9848;SUPEROXIDE DISMUTASE#0.9847;HYDROXYLASE ACTIVITY#0.9846;PRO-INFLAMMATORY#0.9840;GALLBLADDER CANCER#0.9839;MONOCYTE#0.9839;TUMOR CELLS#0.9830;CORD BLOOD#0.9829;HUMAN BRONCHIAL EPITHELIAL#0.9827;KETOCONAZOLE#0.9827;TRANSACTIVATION#0.9826;17β-ESTRADIOL#0.9826;HEPATOCELLULAR CARCINOMA#0.9825;ERYTHROMYCIN#0.9820;RECEPTOR LIGAND#0.9818;BREAST CANCER CELL#0.9812;TOLUENE#0.9812;MUTAGENICITY#0.9809;SIGNAL TRANSDUCTION#0.9809;BREAST CANCER#0.9807;ARACHIDONIC ACID#0.9806;LUNG ADENOCARCINOMA#0.9805;BONE MARROW#0.9804;HISTONE DEACETYLASE#0.9800;GLUTATHIONE#0.9800;MICRONUCLEUS#0.9798;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9794;OXIDATIVE METABOLISM#0.9788;BUFURALOL#0.9788;PERIPHERAL BLOOD#0.9787;TOPICAL#0.9787;THEOPHYLLINE#0.9786;CHLORAMPHENICOL#0.9783;OVARIAN#0.9778;ENVIRONMENTAL TOBACCO SMOKE#0.9777;QUINIDINE#0.9777;DNA REPAIR#0.9773;ARYLAMINE#0.9773;ADENOCARCINOMA#0.9772;CANCER CELL#0.9770;DEXAMETHASONE#0.9769;ESTROGENS#0.9768;NITRIC OXIDE#0.9766;RECEPTOR ANTAGONIST#0.9766;ESTRADIOL#0.9764;DNA BINDING#0.9763;XENOBIOTIC METABOLIZING ENZYME#0.9762;ADJUSTED ODDS RATIO#0.9762;PHENOBARBITAL#0.9762;OXIDATIVE STRESS RESPONSE#0.9761;MACROPHAGE#0.9760;BETA-ESTRADIOL#0.9758;PROGESTERONE#0.9757;CARCINOGENICITY#0.9754;TYROSINE KINASE INHIBITOR#0.9754;WEIGHT LOSS#0.9744;MICROSOME#0.9744;MITOCHONDRIA#0.9742;GENE EXPRESSION#0.9742;EXCRETION#0.9737;MECHANISM OF ACTION#0.9731;TRANSCRIPTIONAL CONTROL#0.9730;GROWTH FACTOR#0.9728;MUTAGEN#0.9727;PREGNANE X RECEPTOR#0.9724;ENDOPLASMIC RETICULUM#0.9722;POLYCYCLIC AROMATIC HYDROCARBON#0.9719;ALL TRANS RETINOIC ACID#0.9719;CYTOCHROME P450#0.9715;GENOTOXICITY#0.9715;MUTAGENIC#0.9715;XENOBIOTIC METABOLISM#0.9714;EPIDERMAL GROWTH FACTOR#0.9708;GESTATION#0.9703;PARENCHYMA#0.9700;UTERUS#0.9700;REPORTER GENE ASSAY#0.9700;LIVER DISEASE#0.9698;ETHANOL#0.9695;CELL DEATH#0.9694;CYTOTOXICITY#0.9693;ARYL HYDROCARBON RECEPTOR#0.9691;INTESTINAL EPITHELIAL CELL#0.9690;CONJUGATION#0.9689;SIGNALING PATHWAY#0.9688;BRONCHIAL EPITHELIAL CELLS#0.9688;INFLAMMATORY RESPONSE#0.9687;INTESTINAL MUCOSA#0.9686;TOXICANT#0.9686;GLUCOCORTICOID RECEPTOR#0.9683;CELL GROWTH#0.9682;RECEPTOR AGONIST#0.9682;IMMUNE RESPONSE#0.9682;ESTROGEN RECEPTOR#0.9680;SMOOTH MUSCLE#0.9677;SULFAPHENAZOLE#0.9674;APOPTOSIS#0.9668;APOPTOTIC#0.9666;DETOXIFICATION#0.9666;TESTOSTERONE#0.9665;EPITHELIAL CELL#0.9661;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9659;PERSISTENT ORGANIC POLLUTANT#0.9657;CELL CYCLE ARREST#0.9655;HEPATOTOXICITY#0.9655;GENOTOXIC#0.9647;CELL CYCLE#0.9644;CELL PROLIFERATION#0.9636;T CELL#0.9629;PEROXISOME#0.9627;REACTIVE OXYGEN SPECIES#0.9626;CARCINOGEN#0.9619;STEM CELL#0.9612;MUSCLE CELL#0.9599;ATHEROSCLEROSIS#0.9596;SMOOTH MUSCLE CELL#0.9595;MEPHENYTOIN#0.9589;DRUG METABOLISM#0.9582;DRUG RESISTANCE#0.9576;2-METHOXYESTRADIOL#0.9576;PROTEIN BINDING#0.9574;MITOGEN ACTIVATED PROTEIN#0.9567;RNA SYNTHESIS#0.9567;TRANSCRIPTION FACTOR#0.9556;TRANSFERASE ACTIVITY#0.9542;TROLEANDOMYCIN#0.9539;IMMUNE SYSTEM#0.9534;N-ACETYLCYSTEINE#0.9533;COUMARIN 7 HYDROXYLASE#0.9531;QUANTITATIVE REVERSE TRANSCRIPTION#0.9529;TUMOR SUPPRESSOR#0.9528;TAMOXIFEN#0.9523;WHITE BLOOD CELL#0.9515;BERBERINE#0.9511;RIO DE JANEIRO#0.9508;DIMETHYL SULFOXIDE#0.9503;TOXICITY#0.9499;LIVER DAMAGE#0.9499;TOLBUTAMIDE#0.9499;NIFEDIPINE#0.9492;CELL DIFFERENTIATION#0.9488;WARFARIN#0.9482;S PHASE#0.9475;ADIPOSE TISSUE#0.9473;DIESEL EXHAUST PARTICLE#0.9465;CYTOPLASM#0.9463;ACUTE LEUKEMIA#0.9448;PROTEIN TYROSINE KINASE#0.9440;ROS GENERATION#0.9440;ALVEOLAR MACROPHAGE#0.9435;QUININE#0.9429;IMMUNOTOXICITY#0.9378;IN UTERO EXPOSURE#0.9346;ANDROGEN RECEPTOR#0.9306;LUNG DISEASE#0.9296;LYMPH NODE#0.9294;TOCOPHEROL#0.9276;MODE OF ACTION#0.9273;CATABOLISM#0.9270;URIDINE#0.9266;PROGENITOR CELL#0.9238;CYTOCHROME B#0.9229;THYROID CANCER#0.9228;DEBRISOQUINE#0.9226;WEIGHT GAIN#0.9222;DIGESTION#0.9222;GROWTH FACTOR RECEPTOR#0.9212;LOW BIRTH WEIGHT#0.9211;COLON CARCINOMA#0.9207;MONONUCLEAR CELLS#0.9206;HEME BINDING#0.9205;SIGNALLING PATHWAY#0.9183;ACUTE MYELOID LEUKEMIA#0.9166;MENADIONE#0.9164;PHENANTHRENE#0.9162;ENDOMETRIUM#0.9160;ELLAGIC ACID#0.9149;ORAL MUCOSA#0.9146;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9139;VITAMIN A#0.9132;RENAL CELL CARCINOMA#0.9131;ORAL CAVITY#0.9129;FURAN#0.9125;ROS FORMATION#0.9118;ENDOTHELIAL GROWTH FACTOR#0.9117;GALLBLADDER#0.9117;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9117;MIDAZOLAM#0.9115;IMMUNE CELL#0.9111;DUODENUM#0.9109;LYMPHOBLASTOID CELLS#0.9079;GRANULOSA CELL#0.9070;NITRIC OXIDE SYNTHASE#0.9067;HYPOXIA INDUCIBLE FACTOR#0.9032;GASTROINTESTINAL TRACT#0.9032;VASCULAR ENDOTHELIAL CELL#0.9026;ACETYLCYSTEINE#0.9020;PARKINSON'S DISEASE#0.9002;URINARY BLADDER#0.8991;HISTONE ACETYLATION#0.8985;PREGNENOLONE#0.8980;COLORECTAL ADENOMA#0.8973;POLY ADP RIBOSE#0.8969;INFERTILE#0.8958;LIPID METABOLISM#0.8951;BODY WEIGHT GAIN#0.8925;HYPOXIC#0.8916;OVARIES#0.8907;THIABENDAZOLE#0.8902;ISONIAZID#0.8891;T LYMPHOCYTE#0.8887;GEFITINIB#0.8887;STROMAL CELL#0.8879;NERVOUS SYSTEM#0.8865;SUCROSE#0.8864;ALDO KETO REDUCTASE#0.8846;CYCLOPHOSPHAMIDE#0.8842;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8813;ALKALINE PHOSPHATASE#0.8812;CYCLIN DEPENDENT KINASE#0.8805;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8801;ALANINE#0.8784;SOLUBLE EPOXIDE HYDROLASE#0.8782;NUCLEOTIDE EXCISION REPAIR#0.8778;ABC TRANSPORTER#0.8768;ETHYLMORPHINE#0.8755;A-GEL#0.8752;GLUTATHIONE S-TRANSFERASE ACTIVITY#0.8752;GUANINE#0.8732;BREAST ADENOCARCINOMA#0.8728;NICOTINAMIDE#0.8726;FERTILIZATION#0.8725;GINKGO BILOBA EXTRACT#0.8724;MULTIFACTOR DIMENSIONALITY REDUCTION#0.8711;MITOCHONDRIAL MEMBRANE#0.8710;UNCONDITIONAL LOGISTIC REGRESSION#0.8708;GINKGO BILOBA#0.8705;CIMETIDINE#0.8686;CISPLATIN#0.8685;ENTEROCYTE#0.8674;ANTIOXIDANT RESPONSE ELEMENT#0.8666;FLAVIN#0.8661;ASCORBIC ACID#0.8648;BASAL CELL#0.8647;M PHASE#0.8638;MICROSOMAL MEMBRANE#0.8626;LEIOMYOMA#0.8610;PROTEASOME#0.8604;ACETAMINOPHEN#0.8599;CELL ADHESION#0.8594;PHENOBARBITONE#0.8573;HARDY WEINBERG EQUILIBRIUM#0.8568;IMMUNOTOXIC#0.8561;DOXORUBICIN#0.8544;THYMIDINE#0.8541;DNA SYNTHESIS#0.8534;TUMOR TISSUES#0.8523;DIFFERENTIAL GENE EXPRESSION#0.8520;BODY WEIGHT RATIO#0.8509;MECHANISMS OF ACTION#0.8508;THYMOCYTE#0.8507;ANTIOXIDANT ACTIVITY#0.8488;ERYTHROCYTE#0.8478;CELL SURFACE#0.8474;CYTOCHROME C REDUCTASE ACTIVITY#0.8453;AROMATIC HYDROCARBON METABOLISM#0.8443;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8440;CHEWING#0.8435;ESTROGEN BIOSYNTHESIS#0.8431;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8413;STEROIDOGENESIS#0.8406;ARISTOLOCHIC ACID I#0.8396;EICOSAPENTAENOIC ACID#0.8390;ESOPHAGUS#0.8373;NEUTROPHIL#0.8368;ESOPHAGEAL CARCINOMA#0.8352;ADRENAL GLAND#0.8345;HYPOSPADIAS#0.8343;RETINOL#0.8342;MULTIPLE LINEAR REGRESSION#0.8341;EPOXIDE HYDROLASE ACTIVITY#0.8341;ANGIOGENESIS#0.8334;ADENINE DINUCLEOTIDE PHOSPHATE#0.8334;CELL DIVISION#0.8321;ADENINE#0.8318;ATP BINDING#0.8309;CARDIOMYOCYTE#0.8294;FACTOR I#0.8292;GERM CELL#0.8291;LUPUS ERYTHEMATOSUS#0.8289;HUMAN EPIDERMAL KERATINOCYTES#0.8287;EXTRACELLULAR MATRIX#0.8263;CLARA CELL#0.8257;MRNA STABILIZATION#0.8253;ORPHENADRINE#0.8251;DICLOFENAC#0.8242;SERUM ALBUMIN#0.8235;DIPHOSPHATE#0.8235;CLOTRIMAZOLE#0.8234;CHROMATID#0.8218;ARYLAMINE N ACETYLTRANSFERASE#0.8218;AIRWAY EPITHELIAL CELL#0.8217;RUTIN#0.8213;WASTING SYNDROME#0.8190;ATP BINDING CASSETTE#0.8190;HYPOXANTHINE#0.8188;CENTRAL NERVOUS SYSTEM#0.8185;BENZPHETAMINE#0.8179;HYDROLASE ACTIVITY#0.8178;MEMBRANE FRACTION#0.8171;RIBOSE#0.8168;VITAMIN E#0.8166;ENZYME INHIBITOR#0.8150;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8147;ENDOTHELIUM#0.8146;RETINOID X RECEPTOR#0.8136;MULTIPLE REGRESSION ANALYSIS#0.8116;CELL CYCLE REGULATION#0.8116;VITAMIN C#0.8105;LIVER CANCER#0.8103;NEPHROPATHY#0.8094;BETA-HYDROXYSTEROID DEHYDROGENASE#0.8092;STOMACH CANCER#0.8088;BILE DUCT#0.8086;CELL CYCLE CONTROL#0.8074;HISTONE MODIFICATION#0.8066;ASTROCYTE#0.8061;GLIAL CELL#0.8051;UMBILICAL CORD#0.8048;RED BLOOD CELL#0.8019;4-HYDROXYTAMOXIFEN#0.8003;SEBACEOUS GLAND#0.8001;TRIIODOTHYRONINE#0.7999;ASPARTATE#0.7991;FLAVIN CONTAINING MONOOXYGENASE#0.7988;TRANSFORMING GROWTH FACTOR BETA#0.7986;BLOOD VESSEL#0.7975;AMIODARONE#0.7970;LIGAND BINDING DOMAIN#0.7969;RECURRENT PREGNANCY LOSS#0.7954;TH17 CELL#0.7954;DNA REPAIR ENZYME#0.7951;RESPIRATORY TRACT#0.7950;DNA DAMAGE RESPONSE#0.7947;MOLAR#0.7942;G1 PHASE#0.7933;ACETYLTRANSFERASE ACTIVITY#0.7931;ICI 182,780#0.7930;SIGNALING CASCADE#0.7926;CHRONIC MYELOID LEUKEMIA#0.7923;CORTISOL#0.7918;LACTATION#0.7916;ELECTRON TRANSFER#0.7914;ARGININE#0.7910;LARYNX#0.7892;ESTROGEN CATABOLISM#0.7872;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7871;LUNG EPITHELIAL CELL#0.7867;INDUCIBLE NITRIC OXIDE#0.7864;DEXTROMETHORPHAN#0.7854;L-TRYPTOPHAN#0.7831;8-HYDROXY-2'-DEOXYGUANOSINE#0.7788;RESPONSE TO TREATMENT#0.7780;PRIMAQUINE#0.7777;GONAD#0.7769;EARLY LIFE STAGES#0.7764;TROPHOBLAST#0.7756;PANCREATIC CANCER#0.7755;OLFACTORY BULB#0.7747;ARACHIDONIC ACID METABOLISM#0.7735;CEREBRAL CORTEX#0.7720;MULTIPLE LOGISTIC REGRESSION#0.7711;VIRAL INFECTION#0.7709;DELTA-9-THC#0.7697;STAUROSPORINE#0.7695;DNA METHYLTRANSFERASE#0.7688;TOLL LIKE RECEPTOR#0.7671;FLUVOXAMINE#0.7660;CELL MIGRATION#0.7635;PORPHYRIA#0.7632;PTERYGIUM#0.7613;PYRAZOLE#0.7609;SINGLE STRAND BREAK#0.7603;LIVER X RECEPTOR#0.7596;OOCYTE#0.7595;LIVER PROGENITOR CELL#0.7593;MOLECULAR DYNAMICS SIMULATION#0.7591;STEROID HORMONE RECEPTOR#0.7587;UMBILICAL CORD BLOOD#0.7571;PROTON PUMP#0.7563;MOUSE EMBRYONIC FIBROBLAST#0.7547;PACLITAXEL#0.7543;SINGLE CELL GEL#0.7526;EDEMA#0.7526;MAP KINASE#0.7520;B LYMPHOCYTE#0.7518;EMBRYONIC STEM CELL#0.7507;NUCLEIC ACID#0.7506;INDUCTION OF APOPTOSIS#0.7501;DIGESTIVE TRACT#0.7497;PROPRANOLOL#0.7479;METHIONINE#0.7468;PROTEIN PROTEIN INTERACTION#0.7467;LARYNGEAL CARCINOMA#0.7461;SKIN FIBROBLASTS#0.7461;GREEN TEA EXTRACT#0.7454;RESPONSE TO 3-METHYLCHOLANTHRENE#0.7449;SULFATION#0.7440;LANSOPRAZOLE#0.7427;NODULAR#0.7415;AGE AT DIAGNOSIS#0.7405;LEYDIG CELL#0.7399;OVARIAN FOLLICLE#0.7397;PROTON PUMP INHIBITOR#0.7377;ARISTOLOCHIC ACID NEPHROPATHY#0.7373;5-AZA-2'-DEOXYCYTIDINE#0.7357;GROWTH HORMONE#0.7357;2'-DEOXYCYTIDINE#0.7352;KINASE ACTIVITY#0.7351;L-CYSTEINE#0.7341;GELDANAMYCIN#0.7338;GLYCERALDEHYDE-3-PHOSPHATE#0.7337;FACTOR S#0.7336;TYPE 2 DIABETES#0.7335;RECEPTOR ACTIVITY#0.7334;CHROMATIN REMODELING#0.7333;CYCLIN DEPENDENT KINASE INHIBITOR#0.7332;PRESSURE NATRIURESIS#0.7330;CLOFIBRATE#0.7313;ESTROGEN SYNTHESIS#0.7288;6BETA-HYDROXYLASE ACTIVITY#0.7280;TIN-MESOPORPHYRIN#0.7271;VASCULAR DISEASE#0.7266;FATTY LIVER#0.7264;BRONCHOPULMONARY DYSPLASIA#0.7255;COMPLEX I#0.7250;CONDITIONAL LOGISTIC REGRESSION#0.7248;SKELETAL MUSCLE#0.7247;PNEUMONIA#0.7241;4-DIMETHYLAMINOANTIPYRINE#0.7226;GRANISETRON#0.7224;EPIGALLOCATECHIN#0.7196;ENDOMETRIAL CARCINOMA#0.7194;HISTONE DEACETYLASE INHIBITOR#0.7188;ENHANCER BINDING PROTEIN#0.7184;ENHANCER BINDING#0.7180;RESPONSE TO DIOXIN#0.7179;ASPARAGINE#0.7174;BENZYL ALCOHOL#0.7166;JEJUNUM#0.7162;UMBILICAL VEIN#0.7158;REPRODUCTIVE TOXICITY#0.7152;RNA INTERFERENCE#0.7143;VASCULAR SMOOTH MUSCLE CELL#0.7143;RHEUMATOID ARTHRITIS#0.7138;DENDRITIC CELL#0.7119;PLASMA MEMBRANE#0.7113;IFN-GAMMA#0.7092;FEMALE BREAST CANCER#0.7074;ORNITHINE#0.7069;TOPOISOMERASE#0.7044;DOUBLE STRAND BREAK#0.7034;BIRTH DEFECT#0.7000;AMINOLEVULINIC ACID#0.6997;METAPLASIA#0.6992;TERATOGENIC#0.6988;ORAL SUBMUCOUS FIBROSIS#0.6984;THYROID HORMONE RECEPTOR#0.6978;CARRIE#0.6976;MOUSE EMBRYO FIBROBLASTS#0.6960;HEPATOCELLULAR CARCINOMA CELL#0.6951;LYSINE#0.6942;CHILDHOOD LEUKEMIA#0.6938;PSORIASIS#0.6932;MRNA TRANSCRIPTION#0.6929;MELATONIN#0.6910;CIGARETTE SMOKE EXPOSURE#0.6901;DERMATITIS#0.6881;RESPIRATORY DISTRESS#0.6877;FETAL GROWTH RESTRICTION#0.6866;SKIN DISEASE#0.6859;NEURONAL CELLS#0.6856;GINSENG#0.6845;COLON ADENOCARCINOMA#0.6839;GM-CSF#0.6839;SOLUBLE FRACTION#0.6824;TETRAHYDROCANNABINOL#0.6812;PKC ACTIVITY#0.6812;IMATINIB#0.6797;FATTY LIVER DISEASE#0.6788;SIGNALING MOLECULE#0.6767;HEART DISEASE#0.6751;AMINOANTHRACENE#0.6746;EGF BINDING#0.6742;PAPILLOMA#0.6740;CAROTENOID#0.6724;HEPATOCELLULAR ADENOMA#0.6707;LYMPHOBLAST#0.6704;LIVER CIRRHOSIS#0.6689;FOLATE#0.6669;PERIPHERAL BLOOD MONOCYTES#0.6657;PROTEIN KINASE A#0.6653;ORNITHINE DECARBOXYLASE#0.6651;UROPORPHYRINOGEN DECARBOXYLASE#0.6650;KIDNEY DISEASE#0.6647;DERMAL FIBROBLAST#0.6641;BRAIN NATRIURETIC PEPTIDE#0.6640;OVARIAN CARCINOMA#0.6628;ANDROSTENEDIONE#0.6621;POSTTRANSLATIONAL MODIFICATION#0.6613;REPRODUCTIVE SYSTEM#0.6612;AIRBORNE PARTICULATE MATTER#0.6603;NADPH:CYTOCHROME C REDUCTASE ACTIVITY#0.6596;BETA-2#0.6593;HUMAN HEPATOMA CELL LINES#0.6593;MITOCHONDRIAL DNA#0.6593;HEPATITIS C#0.6589;CHOROID PLEXUS#0.6588;COLON EPITHELIAL CELL#0.6565;DOMINANT NEGATIVE MUTANT#0.6565;ISCHEMIA#0.6551;5,6-BENZOFLAVONE#0.6550;LEUCINE#0.6545;UBIQUITIN#0.6536;DIABETES MELLITUS#0.6523;EMBRYONIC KIDNEY#0.6522;VITAMIN D RECEPTOR#0.6514;ORGANOGENESIS#0.6507;TOLUENE METABOLISM#0.6494;BLOOD BRAIN BARRIER#0.6488;GLUTAMATE CYSTEINE LIGASE#0.6486;PERIPHERAL LEUKOCYTES#0.6484;26S PROTEASOME#0.6448;CLEFT PALATE#0.6439;ARYL HYDROCARBON RECEPTOR ACTIVITY#0.6438;GENOTOXINS#0.6432;LYMPHOID CELL#0.6422;SENSITIZATION#0.6417;CALCIUM CHANNEL#0.6411;CHRONIC KIDNEY DISEASE#0.6402;CARDIOVASCULAR SYSTEM#0.6399;REGULATION OF GENE EXPRESSION#0.6396;PITUITARY GLAND#0.6392;CHLORAMPHENICOL ACETYLTRANSFERASE ACTIVITY#0.6388;CIRCADIAN RHYTHM#0.6387;HUMAN PRIMARY HEPATOCYTES#0.6385;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6368;HUMAN UMBILICAL VEIN#0.6363;OVULATION#0.6352;ADIPOCYTE#0.6350;RIFAMPIN#0.6348;AUTOIMMUNE DISEASE#0.6347;CELL ADHESION MOLECULE#0.6339;NEUROTOXICITY#0.6337;BREAST CELL LINES#0.6334;STEROID METABOLISM#0.6322;ENDOCRINE SYSTEM#0.6316;OBESE#0.6313;SPORADIC BREAST CANCER#0.6306;T CELL DIFFERENTIATION#0.6306;CIGARETTE SMOKE EXTRACT#0.6293;OESTRADIOL#0.6284;GENE CONVERSION#0.6263;CIGARETTES PER DAY#0.6256;SULINDAC#0.6237;HUMAN EMBRYONIC KIDNEY#0.6223;MICROTUBULE#0.6223;TROGLITAZONE#0.6191;LYMPHOID TISSUE#0.6190;LUMINAL#0.6178;VERAPAMIL#0.6160;PUBERTY#0.6151;MENOPAUSE#0.6137;BASAL CELL CARCINOMA#0.6131;SENESCENCE#0.6129;METHYLATION SPECIFIC PCR#0.6125;THYMIDINE KINASE#0.6121;AGE AT ONSET#0.6118;DACARBAZINE#0.6118;HODGKIN'S LYMPHOMA#0.6099;SOY PROTEIN ISOLATE#0.6095;SKIN CANCER#0.6082;ANTIOXIDANT RESPONSIVE ELEMENT#0.6065;CPG ISLAND METHYLATION#0.6047;INSULIN-LIKE GROWTH FACTOR#0.6045;SIGNAL TRANSDUCER#0.6042;DEHYDROEPIANDROSTERONE#0.6035;VITAMIN DEFICIENCY#0.6033;SWISS ALBINO MICE#0.6033;ENDOCRINE DISRUPTING CHEMICAL#0.6031;PULMONARY TOXICITY#0.6007
1544	TIZANIDINE#1.0947;CALVIN CYCLE#1.0600;TACRINE#1.0581;SUPRAMOLECULAR COMPLEX#1.0547;CIPROFLOXACIN#1.0483;CHLOROPLAST#1.0398;OLANZAPINE#1.0385;LIDOCAINE#1.0325;FLUVOXAMINE#1.0313;MEXILETINE#1.0299;XANTHINE OXIDASE#1.0298;PHENACETIN#1.0292;FLUTAMIDE#1.0262;XANTHINE#1.0253;GLYCERALDEHYDE-3-PHOSPHATE#1.0246;MELATONIN#1.0245;BUPROPION#1.0239;DULOXETINE#1.0220;N ACETYLTRANSFERASE#1.0213;THEOPHYLLINE#1.0210;BETA-NF#1.0210;BUFURALOL#1.0195;CAFFEINE#1.0194;METOPROLOL#1.0189;CLOZAPINE#1.0187;BERBERINE#1.0184;PARACETAMOL#1.0183;DICLOFENAC#1.0179;LOSARTAN#1.0175;CHLORZOXAZONE#1.0154;DEXTROMETHORPHAN#1.0141;ARYLAMINE#1.0136;MEPHENYTOIN#1.0127;OMEPRAZOLE#1.0112;SULFAPHENAZOLE#1.0098;INTRINSICALLY DISORDERED PROTEIN#1.0086;TOLBUTAMIDE#1.0082;PROPRANOLOL#1.0073;CLOPIDOGREL#1.0069;COUMARIN 7 HYDROXYLASE#1.0068;DEBRISOQUINE#1.0060;FRAGMENT LENGTH POLYMORPHISM#1.0051;MIDAZOLAM#1.0034;COLORECTAL#1.0033;QUERCETIN#1.0028;QUANTITATIVE REAL TIME#1.0023;IMIPRAMINE#1.0020;RIFAMPICIN#1.0019;PAROXETINE#1.0012;DAPSONE#0.9985;WARFARIN#0.9983;AMODIAQUINE#0.9982;COLORECTAL CANCER#0.9977;TROLEANDOMYCIN#0.9975;LYMPHOBLASTOID CELLS#0.9971;RESVERATROL#0.9970;DEMETHYLATION#0.9967;LUNG CANCER#0.9962;DEMETHYLASE ACTIVITY#0.9958;QUINIDINE#0.9939;NIFEDIPINE#0.9935;RIFAMPIN#0.9933;CARBAMAZEPINE#0.9930;PRIMARY HUMAN HEPATOCYTES#0.9925;EPOXIDE HYDROLASE#0.9923;CYTOCHROME B5#0.9921;HEPATOMA CELLS#0.9919;P-NITROPHENOL#0.9912;BETA-NAPHTHOFLAVONE#0.9909;ESTRADIOL#0.9905;MOLAR#0.9904;SMALL INTESTINE#0.9896;PACLITAXEL#0.9886;ACETAMINOPHEN#0.9884;ETHANOL#0.9880;ERYTHROMYCIN#0.9879;MUTAGENICITY#0.9875;DIMETHYLXANTHINE#0.9874;CATALYTIC ACTIVITY#0.9868;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9858;DEBRISOQUIN#0.9851;REVERSE TRANSCRIPTION#0.9847;ARACHIDONIC ACID#0.9844;GLUTATHIONE TRANSFERASE#0.9838;DYSKINESIA#0.9828;ANILINE#0.9822;URIDINE#0.9821;POLYMERASE CHAIN REACTION#0.9807;ENZYME ACTIVITY#0.9805;ERLOTINIB#0.9799;QUININE#0.9798;OXYGENASE#0.9797;FLUOXETINE#0.9795;INDOLE#0.9793;DNA BINDING#0.9790;EPITHELIAL CELL#0.9784;MUTAGENIC#0.9780;PHENOBARBITAL#0.9779;MUTAGEN#0.9775;KETOCONAZOLE#0.9774;XENOBIOTIC METABOLIZING ENZYME#0.9773;TESTOSTERONE#0.9769;PREGNANE X RECEPTOR#0.9769;ANTHRACENE#0.9763;PARKINSON'S DISEASE#0.9756;CYTOCHROME P450 ACTIVITY#0.9755;OXIDATIVE METABOLISM#0.9752;ADENOCARCINOMA#0.9745;TRANSCRIPTASE#0.9740;HYDROXYLASE ACTIVITY#0.9739;HEPATOCELLULAR CARCINOMA#0.9733;PROSTATE CANCER#0.9732;DEXAMETHASONE#0.9731;STRUCTURE ACTIVITY RELATIONSHIP#0.9728;BREAST CANCER#0.9725;PROTEIN BINDING#0.9723;POLYCYCLIC AROMATIC HYDROCARBON#0.9719;CONJUGATION#0.9718;FLAVIN CONTAINING MONOOXYGENASE#0.9718;GENE EXPRESSION#0.9711;ARYL HYDROCARBON RECEPTOR#0.9710;CYTOCHROME C#0.9709;ESTROGEN RECEPTOR#0.9708;GENOTOXICITY#0.9706;SEROTONIN REUPTAKE INHIBITOR#0.9703;PORPHYRIA#0.9702;ANTIPYRINE#0.9695;SERTRALINE#0.9686;MICROSOME#0.9681;EXCRETION#0.9681;HEPATOTOXICITY#0.9679;TICLOPIDINE#0.9675;TRANSCRIPTION FACTOR#0.9670;HEME OXYGENASE 1#0.9666;ISONIAZID#0.9664;XENOBIOTIC METABOLISM#0.9660;CANCER CELL#0.9660;GROWTH FACTOR#0.9657;LIVER DISEASE#0.9648;PORPHYRIA CUTANEA TARDA#0.9647;GLUTATHIONE#0.9646;CARCINOGEN#0.9643;CARCINOGENICITY#0.9637;FLAVIN#0.9634;APOPTOSIS#0.9634;MUTAGENESIS#0.9632;PHENYTOIN#0.9630;GENOTOXIC#0.9626;CYTOTOXICITY#0.9614;GLUTATHIONE PEROXIDASE#0.9613;DETOXIFICATION#0.9603;ALANINE#0.9600;HYPERTENSION#0.9585;PLASMA PROTEIN#0.9585;SIGNALING PATHWAY#0.9576;TRADITIONAL CHINESE MEDICINE#0.9573;ST. JOHN'S WORT#0.9572;CYTOCHROME P450#0.9563;HUMAN PRIMARY HEPATOCYTES#0.9563;TOXICANT#0.9562;CITALOPRAM#0.9556;SUPEROXIDE DISMUTASE#0.9550;CYTOCHROME B#0.9549;NITRIC OXIDE#0.9549;DRUG METABOLISM#0.9543;CELL CYCLE#0.9533;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9533;CELL PROLIFERATION#0.9518;TOXICITY#0.9517;DIPHOSPHATE#0.9491;ADIPOSE TISSUE#0.9481;TOLUENE#0.9471;STEM CELL#0.9470;THEOBROMINE#0.9468;ESTROGENS#0.9453;TAMOXIFEN#0.9453;SULPHAPHENAZOLE#0.9451;ENDOPLASMIC RETICULUM#0.9445;REACTIVE OXYGEN SPECIES#0.9442;RECEPTOR ANTAGONIST#0.9425;HALOPERIDOL#0.9416;DIAZEPAM#0.9406;GINSENG#0.9397;GENISTEIN#0.9394;MIRTAZAPINE#0.9393;NARROW THERAPEUTIC INDEX#0.9387;PROTON PUMP INHIBITOR#0.9364;NICOTINAMIDE#0.9358;PROTON PUMP#0.9345;HYPOXIA#0.9337;ACETIC ACID#0.9334;VERAPAMIL#0.9314;ASPARTATE#0.9310;ADVERSE DRUG REACTION#0.9304;LANSOPRAZOLE#0.9288;TUMOR NECROSIS FACTOR#0.9288;KINASE INHIBITOR#0.9280;RISPERIDONE#0.9276;DRUG METABOLIC#0.9267;PROPAFENONE#0.9264;SPARTEINE#0.9252;CIMETIDINE#0.9250;SQUAMOUS CELL CARCINOMA#0.9249;VENLAFAXINE#0.9244;GINKGO BILOBA#0.9226;RECEPTOR AGONIST#0.9212;ADENINE#0.9207;METHADONE#0.9204;DNA REPAIR#0.9198;HEPATITIS B#0.9196;THERAPEUTIC DRUG MONITORING#0.9187;RITONAVIR#0.9176;MECHANISM OF ACTION#0.9175;LIVER DAMAGE#0.9172;GEOMETRIC MEAN RATIO#0.9143;AMINOPYRINE#0.9141;NEW CHEMICAL ENTITIES#0.9140;DESIPRAMINE#0.9136;PROGESTERONE#0.9132;ROFECOXIB#0.9117;ARYLAMINE N ACETYLTRANSFERASE#0.9117;RHEUMATOID ARTHRITIS#0.9099;WEIGHT GAIN#0.9096;OBESE#0.9084;THIABENDAZOLE#0.9083;ESTROGEN METABOLISM#0.9071;TRANYLCYPROMINE#0.9052;ALPRAZOLAM#0.9049;HEPATOCYTE NUCLEAR FACTOR#0.9044;OVARIAN#0.9043;RETINOIC ACID#0.9031;HEPATITIS C#0.9027;REPORTER GENE ASSAY#0.9013;O METHYLTRANSFERASE#0.9005;LIPID METABOLISM#0.8994;ENOXACIN#0.8987;RESPIRATORY TRACT#0.8979;PROTEIN KINASE#0.8956;GESTATION#0.8950;DOPAMINE#0.8891;FETAL LIVER#0.8872;ADENOSINE#0.8827;HIGH FAT DIET#0.8819;ACETYLTRANSFERASE ACTIVITY#0.8815;COMPLEX I#0.8815;LYMPHOBLAST#0.8814;EPIDERMAL GROWTH FACTOR#0.8811;PEROXISOME#0.8810;DIGOXIN#0.8805;SULFATION#0.8789;ETHANOL OXIDATION#0.8778;ALPHA-TOCOPHEROL#0.8770;ANTIOXIDANT ACTIVITY#0.8767;ENDOTHELIAL CELL#0.8764;LEFLUNOMIDE#0.8752;PHASE II METABOLISM#0.8739;OVARIAN CANCER#0.8736;BREAST CANCER CELL#0.8723;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8713;BILE DUCT#0.8700;VITAMIN K#0.8699;B CELL#0.8689;4-METHYLPYRAZOLE#0.8683;N-ACETYLCYSTEINE#0.8670;DNA METHYLATION#0.8641;TRANSFERASE ACTIVITY#0.8631;RILUZOLE#0.8630;ALZHEIMER'S DISEASE#0.8625;INFLAMMATORY RESPONSE#0.8601;MICRONUCLEUS#0.8598;VACCINIA#0.8592;DIMETHYL SULFOXIDE#0.8591;COLON CANCER#0.8572;DIABETES MELLITUS#0.8548;SELEGILINE#0.8542;GROWTH HORMONE#0.8516;SIGNAL TRANSDUCTION#0.8515;CYCLOPHOSPHAMIDE#0.8506;AMINOLEVULINIC ACID#0.8505;RECEPTOR LIGAND#0.8493;SERUM ALBUMIN#0.8490;CHLORPROMAZINE#0.8463;LIVER CIRRHOSIS#0.8462;MYOCARDIAL INFARCTION#0.8416;ADENINE DINUCLEOTIDE PHOSPHATE#0.8412;HEAT SHOCK PROTEIN#0.8401;SOLID PHASE EXTRACTION#0.8363;MITOCHONDRIA#0.8360;AXITINIB#0.8360;URINARY BLADDER#0.8356;ADJUSTED ODDS RATIO#0.8328;TRANSACTIVATION#0.8326;AMIODARONE#0.8319;BREAST CANCER PATIENTS#0.8309;MAMMARY GLAND#0.8299;PROPOFOL#0.8276;CORTISOL#0.8271;ARISTOLOCHIC ACID I#0.8266;ITRACONAZOLE#0.8243;ROPIVACAINE#0.8239;FATTY LIVER#0.8239;XANTHINE OXIDASE ACTIVITY#0.8238;MALARIA#0.8236;MENSTRUAL CYCLE#0.8229;APOPTOTIC#0.8195;MELATONIN METABOLISM#0.8170;PHENOTHIAZINE#0.8153;ENDOTHELIAL GROWTH FACTOR#0.8147;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8147;AMITRIPTYLINE#0.8129;PRIMAQUINE#0.8126;KUPFFER CELL#0.8120;TRYPTOPHAN#0.8117;COLORECTAL ADENOMA#0.8100;FLUCONAZOLE#0.8097;GUANINE#0.8070;AMINOANTHRACENE#0.8038;CELL DEATH#0.8037;GREEN TEA EXTRACT#0.8004;CLOMIPRAMINE#0.7993;6BETA-HYDROXYLASE ACTIVITY#0.7955;NARINGENIN#0.7952;ORGANIC CATION TRANSPORTER#0.7948;TERFENADINE#0.7933;GLUCOCORTICOID RECEPTOR#0.7923;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7904;LUCIFERASE ACTIVITY#0.7903;EFAVIRENZ#0.7901;CATECHOL O METHYLTRANSFERASE#0.7901;GROWTH FACTOR RECEPTOR#0.7899;NERVOUS SYSTEM#0.7890;TYPE 2 DIABETES#0.7885;PROMAZINE#0.7884;MENADIONE#0.7884;SPONTANEOUS ABORTION#0.7881;ESTRONE#0.7880;BREAST CARCINOMA#0.7869;MICONAZOLE#0.7868;UTERUS#0.7863;ACETYLCYSTEINE#0.7854;THIORIDAZINE#0.7802;QUANTITATIVE REVERSE TRANSCRIPTION#0.7787;TUMOR CELLS#0.7775;MECHANISMS OF ACTION#0.7774;ARYL HYDROCARBON HYDROXYLASE ACTIVITY#0.7773;SUCROSE#0.7769;ZOLPIDEM#0.7766;ALKALINE PHOSPHATASE#0.7739;TIENILIC ACID#0.7734;MOLECULAR DYNAMICS SIMULATION#0.7723;DRIED BLOOD SPOT#0.7723;PERIPHERAL BLOOD#0.7721;HISTONE DEACETYLASE#0.7710;LINEAR REGRESSION ANALYSIS#0.7705;ALDEHYDE OXIDASE#0.7694;LIVER CANCER#0.7692;PROTEIN SYNTHESIS#0.7687;PREGNENOLONE#0.7686;GEMFIBROZIL#0.7647;BENZPHETAMINE#0.7631;TRIAZOLAM#0.7629;ORGANIC ANION TRANSPORTER#0.7605;RESPONSE TO CAFFEINE#0.7601;CHLORAMPHENICOL#0.7582;MULTIDRUG RESISTANCE PROTEIN#0.7569;RETINOL#0.7567;CENTRAL NERVOUS SYSTEM#0.7479;HUMAN BREAST CANCER#0.7476;RECURRENT PREGNANCY LOSS#0.7472;CALCIUM CHANNEL#0.7456;ACENOCOUMAROL#0.7445;ACUTE LIVER INJURY#0.7444;ETHINYL ESTRADIOL#0.7439;TOCOPHEROL#0.7418;DIGESTION#0.7416;ROFLUMILAST#0.7414;PANTOPRAZOLE#0.7409;ENDOMETRIAL CANCER#0.7408;PHOSPHODIESTERASE#0.7401;MACROPHAGE#0.7380;NUCLEOTIDE EXCISION REPAIR#0.7360;CELL GROWTH#0.7349;GESTODENE#0.7348;LATE PREGNANCY#0.7341;ELECTRON TRANSFER#0.7299;ZILEUTON#0.7294;DISULFIRAM#0.7292;MITOGEN ACTIVATED PROTEIN#0.7280;ELECTROPHORETIC MOBILITY SHIFT#0.7277;NEFAZODONE#0.7267;PROTEIN PROTEIN INTERACTION#0.7264;ASCORBIC ACID#0.7264;REGENERATION#0.7244;RESPONSE TO TCDD#0.7242;METROPROLOL#0.7236;BONE MARROW#0.7219;HEPATOCELLULAR ADENOMA#0.7196;CHRONIC LIVER DISEASE#0.7193;ALL TRANS RETINOIC ACID#0.7189;LEVOMEPROMAZINE#0.7187;HEPATITIS B VIRUS#0.7178;QUETIAPINE#0.7177;HORMONE METABOLISM#0.7163;TYROSINE KINASE INHIBITOR#0.7161;MOCLOBEMIDE#0.7154;INTRINSICALLY UNSTRUCTURED PROTEIN#0.7148;MULTIPLE LINEAR REGRESSION#0.7128;NOREPINEPHRINE REUPTAKE#0.7087;IMMUNE RESPONSE#0.7079;CYCLOSPORINE#0.7062;72-HOURS#0.7059;5-AMINOLEVULINIC ACID#0.7055;ENZYME INHIBITOR#0.7040;BENZIMIDAZOLE#0.7026;BETA-ESTRADIOL#0.6983;OXIDATIVE STRESS RESPONSE#0.6982;IRON DEXTRAN#0.6954;SURFACE PLASMON RESONANCE#0.6951;UROPORPHYRINOGEN DECARBOXYLASE#0.6937;CYCLOSPORIN#0.6927;S PHASE#0.6916;HEPATOCELLULAR CARCINOMA CELL#0.6898;OXIDATIVE DNA DAMAGE#0.6897;LACTATION#0.6892;DACARBAZINE#0.6882;SEDATION#0.6876;CARBON FIXATION#0.6873;HISTAMINE#0.6873;NORFLOXACIN#0.6871;PICEATANNOL#0.6859;DOXORUBICIN#0.6857;PLURIPOTENT STEM CELL#0.6851;LEVOFLOXACIN#0.6838;LIMIT OF DETECTION#0.6825;CYTOPLASM#0.6825;HUMAN IMMUNODEFICIENCY VIRUS#0.6823;NOREPINEPHRINE#0.6807;TUMOR SUPPRESSOR#0.6804;ALBENDAZOLE#0.6792;GENE CONVERSION#0.6773;NEPHROPATHY#0.6769;MULTIPLE REACTION MONITORING#0.6766;CELL CYCLE ARREST#0.6765;PHENOBARBITONE#0.6748;PENTOXIFYLLINE#0.6746;FLURBIPROFEN#0.6744;ACUTE LIVER FAILURE#0.6740;5-MEO-DIPT#0.6714;MAJOR DEPRESSIVE DISORDER#0.6708;HYPOXANTHINE#0.6708;NODULAR#0.6705;TROGLITAZONE#0.6688;PROGUANIL#0.6688;MODE OF ACTION#0.6676;ANDROGEN RECEPTOR#0.6668;NORTRIPTYLINE#0.6664;STROMAL CELL#0.6657;ROPINIROLE#0.6655;CHOLANGIOCARCINOMA#0.6640;AGOMELATINE#0.6639;ARGININE#0.6631;P-CRESOL#0.6604;RESPONSE TO CLOZAPINE#0.6586;B-LYMPHOBLAST#0.6569;NOREPINEPHRINE REUPTAKE INHIBITOR#0.6548;BLOOD PLASMA#0.6532;RECEPTOR COMPLEX#0.6527;MIPOMERSEN SODIUM#0.6512;ZOLMITRIPTAN#0.6507;GLUTATHIONE S-TRANSFERASE ACTIVITY#0.6506;HEPATITIS C VIRUS#0.6498;5 FLUOROURACIL#0.6493;DOVITINIB#0.6480;NITRIC OXIDE SYNTHASE#0.6473;TRIACETYLOLEANDOMYCIN#0.6470;1,3,7-TRIMETHYLXANTHINE#0.6468;GLUCURONIC ACID#0.6463;CHINESE HERBAL MEDICINE#0.6462;ROSIGLITAZONE#0.6461;T CELL#0.6437;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6432;REPAGLINIDE#0.6423;MULTIPLE REGRESSION ANALYSIS#0.6413;SIMVASTATIN#0.6409;PRIMARY METABOLISM#0.6391;POMALIDOMIDE#0.6390;FATTY LIVER DISEASE#0.6388;N-ACETYLTRANSFERASE ACTIVITY#0.6388;CYCLIN DEPENDENT KINASE#0.6374;EMBRYONIC STEM CELL#0.6373;SALVIANOLIC ACID B#0.6373;FORMIC ACID#0.6356;ARRHYTHMIA#0.6354;ORPHENADRINE#0.6348;METYRAPONE#0.6345;PRO-INFLAMMATORY#0.6343;DIMETHYL SULPHOXIDE#0.6338;THYMIDINE#0.6337;PLASTID#0.6321;NAPROXEN#0.6307;ENTEROCYTE#0.6271;GASTROINTESTINAL TRACT#0.6266;OLOMOUCINE II#0.6259;GLYCINE#0.6243;GEFITINIB#0.6238;BODY WEIGHT GAIN#0.6237;RESPONSE TO 3-METHYLCHOLANTHRENE#0.6233;MEMBRANE FRACTION#0.6224;ARISTOLOCHIC ACID NEPHROPATHY#0.6217;CIGARETTE SMOKE EXPOSURE#0.6216;CLOFIBRATE#0.6207;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6206;STREPTOZOTOCIN#0.6190;COLON CARCINOMA#0.6184;GLUCOSE-6-PHOSPHATE#0.6181;MICROSOMAL MEMBRANE#0.6176;AUTOIMMUNE HEPATITIS#0.6168;TRANSFORMING GROWTH FACTOR#0.6164;C REACTIVE PROTEIN#0.6161;ASPIRIN#0.6152;AMINOLEVULINATE#0.6152;PHENANTHRENE#0.6148;PANCREATIC CANCER#0.6147;FLECAINIDE#0.6147;NEUROTOXICITY#0.6141;AFLATOXIN B1 METABOLISM#0.6123;METHAMPHETAMINE#0.6113;ACTINOMYCIN D#0.6111;HYPERFORIN#0.6105;CHRONIC HEPATITIS C#0.6104;BREAST CELL LINES#0.6099;PYRAZOLE#0.6083;L-ARGININE#0.6077;ATP BINDING CASSETTE#0.6068;HEPATOCYTE GROWTH FACTOR#0.6066;ATP BINDING#0.6054;BLOOD BRAIN BARRIER#0.6049;VITAMIN DEFICIENCY#0.6047;UREMIC TOXIN#0.6046;LIMIT OF QUANTIFICATION#0.6035;FRUCTOSE#0.6034;CHLORAMPHENICOL ACETYLTRANSFERASE ACTIVITY#0.6027;ANGIOGENESIS#0.6023;SMOOTH MUSCLE#0.6015;ROSUVASTATIN#0.6005
1545	DOCETAXEL#1.0593;JUVENILE GLAUCOMA#1.0369;PRIMARY CONGENITAL GLAUCOMA#1.0360;CATECHOL O METHYLTRANSFERASE#1.0348;O METHYLTRANSFERASE#1.0342;ENDOMETRIAL CANCER#1.0330;RESVERATROL#1.0243;FRAGMENT LENGTH POLYMORPHISM#1.0207;DRUG RESISTANCE#1.0191;OVARIAN CANCER#1.0189;COLORECTAL CANCER#1.0186;PETERS ANOMALY#1.0184;PROSTATE CANCER#1.0173;PRIMARY OPEN ANGLE GLAUCOMA#1.0157;BETA-NAPHTHOFLAVONE#1.0153;REVERSE TRANSCRIPTION#1.0145;COLORECTAL#1.0145;TUMOR CELLS#1.0144;OPEN ANGLE GLAUCOMA#1.0142;CATALYTIC ACTIVITY#1.0112;HUMAN BREAST CANCER#1.0099;17β-ESTRADIOL#1.0097;EPOXIDE HYDROLASE#1.0085;MAMMARY GLAND#1.0062;LUNG CANCER#1.0055;SMOOTH MUSCLE CELL#1.0050;SMOOTH MUSCLE#1.0048;ESTROGEN METABOLISM#1.0047;RETINOIC ACID#1.0043;SQUAMOUS CELL CARCINOMA#1.0033;MUSCLE CELL#1.0028;XENOBIOTIC METABOLIZING ENZYME#1.0017;ENZYME ACTIVITY#1.0008;ANTHRACENE#0.9986;BONE MARROW#0.9984;2-METHOXYESTRADIOL#0.9983;POLYMERASE CHAIN REACTION#0.9981;T CELL#0.9976;TRANSFORMING GROWTH FACTOR#0.9967;GLUTATHIONE#0.9961;HUMAN MAMMARY EPITHELIAL#0.9957;OVARIAN#0.9950;BREAST CANCER PATIENTS#0.9945;BREAST CANCER CELL#0.9942;HYPERTENSION#0.9937;PERIPHERAL BLOOD#0.9935;MAMMARY EPITHELIAL CELL#0.9923;ESTRADIOL#0.9916;MACROPHAGE#0.9913;QUANTITATIVE REAL TIME#0.9912;TRANSCRIPTASE#0.9911;ENDOTHELIAL CELL#0.9902;XENOBIOTIC METABOLISM#0.9898;PROTEIN KINASE#0.9896;DNA BINDING#0.9891;STROMAL CELL#0.9882;QUERCETIN#0.9874;GROWTH FACTOR#0.9872;ESTROGENS#0.9866;CANCER CELL#0.9864;BREAST CANCER#0.9860;CYTOCHROME P450#0.9852;MICROSOME#0.9832;ARACHIDONIC ACID#0.9832;TESTOSTERONE#0.9830;GENOTOXIC#0.9830;ESTROGEN RECEPTOR#0.9807;ADENOCARCINOMA#0.9806;APOPTOSIS#0.9798;LEUKOCYTE#0.9785;GRANULOSA CELL#0.9781;CARCINOGENICITY#0.9779;EPITHELIAL CELL#0.9777;ESTRONE#0.9773;DETOXIFICATION#0.9763;CYTOTOXICITY#0.9755;STEM CELL#0.9754;SIGNALING PATHWAY#0.9754;CARCINOGEN#0.9752;B CELL#0.9747;GENE EXPRESSION#0.9747;ARYL HYDROCARBON RECEPTOR#0.9736;OXIDATIVE METABOLISM#0.9734;SUPEROXIDE DISMUTASE#0.9729;REACTIVE OXYGEN SPECIES#0.9724;DNA METHYLATION#0.9717;CELL PROLIFERATION#0.9710;CELL CYCLE#0.9709;TRANSCRIPTION FACTOR#0.9686;POLYCYCLIC AROMATIC HYDROCARBON#0.9678;MUTAGENIC#0.9676;CELL DEATH#0.9659;DRUG METABOLISM#0.9659;HYDROXYLASE ACTIVITY#0.9653;ANGIOGENESIS#0.9648;EXTRACELLULAR MATRIX#0.9643;PROGESTERONE#0.9643;TOXICITY#0.9617;APOPTOTIC#0.9599;CELL GROWTH#0.9570;OESTRADIOL#0.9548;ENDOMETRIUM#0.9543;RECEPTOR AGONIST#0.9526;PRO-INFLAMMATORY#0.9517;KERATINOCYTE#0.9500;IMMUNE RESPONSE#0.9491;ENDOMETRIOSIS#0.9489;GENISTEIN#0.9489;ESTROGEN RECEPTOR ALPHA#0.9476;DNA REPAIR#0.9416;UTERUS#0.9415;INDOLE#0.9409;GENOTOXICITY#0.9402;HORMONE METABOLISM#0.9324;ANTERIOR SEGMENT DYSGENESIS#0.9303;TRANSACTIVATION#0.9301;TUMOR TISSUES#0.9299;BRONCHIAL EPITHELIAL CELLS#0.9247;INFLAMMATORY RESPONSE#0.9245;BREAST CARCINOMA#0.9228;OXYGENASE#0.9224;MENOPAUSE#0.9223;MITOCHONDRIA#0.9197;NITRIC OXIDE#0.9169;HUMAN BRONCHIAL EPITHELIAL#0.9133;TOXICANT#0.9123;KINASE INHIBITOR#0.9101;BLINDNESS#0.9100;MELATONIN#0.9091;MITOGEN ACTIVATED PROTEIN#0.9051;OPTIC NERVE#0.9036;TUMOR NECROSIS FACTOR#0.9031;TAMOXIFEN#0.9018;BETA-ESTRADIOL#0.9015;EYE DEVELOPMENT#0.9003;MOUSE EMBRYO FIBROBLASTS#0.8968;RECEPTOR ANTAGONIST#0.8965;GINKGO BILOBA#0.8953;HIGH FAT DIET#0.8938;RECEPTOR LIGAND#0.8926;MUTAGENESIS#0.8926;PACLITAXEL#0.8913;PERIPHERAL BLOOD LYMPHOCYTES#0.8864;RENAL CELL CARCINOMA#0.8819;CONJUGATION#0.8811;OVARIES#0.8811;LUCIFERASE ACTIVITY#0.8808;HEPATOMA CELLS#0.8799;SMALL INTESTINE#0.8689;HEPATOCELLULAR CARCINOMA#0.8685;ANIRIDIA#0.8677;MONOCYTE#0.8662;RETINOL#0.8651;PROGENITOR CELL#0.8647;SIGNAL TRANSDUCTION#0.8634;ESTROGEN BIOSYNTHESIS#0.8604;QUANTITATIVE REVERSE TRANSCRIPTION#0.8588;STRUCTURE ACTIVITY RELATIONSHIP#0.8584;ADIPOSE TISSUE#0.8554;ALDO KETO REDUCTASE#0.8517;CELL CYCLE ARREST#0.8501;DEMETHYLATION#0.8492;PRIMARY HUMAN HEPATOCYTES#0.8466;MUTAGEN#0.8437;TRANSFORMING GROWTH FACTOR BETA#0.8435;OXIDATIVE DNA DAMAGE#0.8400;LUNG ADENOCARCINOMA#0.8394;CILIARY BODY#0.8381;CISPLATIN#0.8362;MORPHOGENESIS#0.8352;ANDROGEN RECEPTOR#0.8322;EXCRETION#0.8294;DOXORUBICIN#0.8278;CELL DIFFERENTIATION#0.8238;BERBERINE#0.8220;VASCULAR SMOOTH MUSCLE CELL#0.8211;ICI 182,780#0.8178;ANTERIOR CHAMBER ANGLE#0.8174;CELL MIGRATION#0.8168;MENARCHE#0.8155;LYMPH NODE#0.8150;OXIDATIVE STRESS RESPONSE#0.8141;REPORTER GENE ASSAY#0.8117;CYCLIN DEPENDENT KINASE#0.8049;N ACETYLTRANSFERASE#0.7981;S PHASE#0.7964;AGE AT ONSET#0.7960;COLON CANCER#0.7949;SYSTOLIC BLOOD PRESSURE#0.7939;AXENFELD RIEGER SYNDROME#0.7934;ADJUSTED ODDS RATIO#0.7922;CYTOPLASM#0.7893;ONCOGENIC#0.7806;MUTAGENICITY#0.7766;ARTERY#0.7750;LEYDIG CELL#0.7665;ATHEROSCLEROSIS#0.7632;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7629;GINKGO BILOBA EXTRACT#0.7594;AGE AT DIAGNOSIS#0.7576;ORAL SQUAMOUS CELL CARCINOMA#0.7565;LEUCINE#0.7563;ESTROGEN SYNTHESIS#0.7557;17BETA OESTRADIOL#0.7551;APOPTOTIC CELL DEATH#0.7537;MECHANISM OF ACTION#0.7532;ENDOTHELIUM#0.7494;PERIPHERAL LEUKOCYTES#0.7445;HEME OXYGENASE 1#0.7434;PRIMARY ANGLE CLOSURE#0.7426;5-AZA-2'-DEOXYCYTIDINE#0.7409;2'-DEOXYCYTIDINE#0.7404;ADENINE DINUCLEOTIDE PHOSPHATE#0.7399;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7395;RESPONSE TO TCDD#0.7385;AGE AT MENARCHE#0.7379;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7378;VASCULAR CELL#0.7362;PROTEIN KINASE C#0.7355;IN UTERO EXPOSURE#0.7350;ESTROUS CYCLE#0.7343;BONE MARROW STROMAL CELL#0.7341;BONE MARROW STROMAL#0.7337;ESOPHAGUS#0.7319;ADIPOGENESIS#0.7318;MONONUCLEAR CELLS#0.7315;ENDOTHELIAL GROWTH FACTOR#0.7311;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7311;LEIOMYOMA#0.7304;TRYPTOPHAN#0.7254;NITRIC OXIDE SYNTHASE#0.7243;CARDIOVASCULAR SYSTEM#0.7226;NEURAL CREST#0.7218;DIESEL EXHAUST PARTICLE#0.7209;STEROIDOGENESIS#0.7208;CYCLIN DEPENDENT KINASE INHIBITOR#0.7184;VALINE#0.7170;PEROXISOME#0.7169;ARACHIDONIC ACID METABOLISM#0.7165;N-ACETYLCYSTEINE#0.7163;OESTROGEN METABOLISM#0.7129;HISTONE DEACETYLASE#0.7127;HEAT SHOCK PROTEIN#0.7110;HYPOXIA#0.7051;TUMOR SUPPRESSOR#0.7038;FLUTAMIDE#0.7038;CELL ADHESION#0.7014;CATABOLISM#0.7014;ATP BINDING CASSETTE#0.6973;LUNG CARCINOMA#0.6972;ATP BINDING#0.6958;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6950;IMMUNOTOXICITY#0.6945;IMMUNE CELL#0.6936;ALL TRANS RETINOIC ACID#0.6927;ADRENAL GLAND#0.6917;ESTROGEN CATABOLISM#0.6905;POLY ADP RIBOSE#0.6902;BETA-HYDROXYSTEROID DEHYDROGENASE#0.6890;LIPID METABOLISM#0.6883;DIMETHYL SULFOXIDE#0.6873;LUNG EPITHELIAL CELL#0.6868;COPY NUMBER VARIATION#0.6861;4-HYDROXYTAMOXIFEN#0.6830;ARYLAMINE#0.6826;ADIPOCYTE#0.6807;BREAST ADENOCARCINOMA#0.6802;STEROID SYNTHESIS#0.6795;LIVER DISEASE#0.6772;PULMONARY ARTERIAL HYPERTENSION#0.6754;TETRACYCLINE#0.6728;ACTINOMYCIN D#0.6727;DEXAMETHASONE#0.6725;PRIMARY ANGLE-CLOSURE GLAUCOMA#0.6718;RENAL CELL CANCER#0.6708;ADENINE#0.6695;CYTOCHROME C#0.6681;ANGLE-CLOSURE GLAUCOMA#0.6663;NERVOUS SYSTEM#0.6650;MELTING CURVE ANALYSIS#0.6558;ENDOMETRIAL CARCINOMA#0.6521;GESTATION#0.6507;EPIDERMAL GROWTH FACTOR#0.6502;GROWTH FACTOR RECEPTOR#0.6502;NADPH OXIDASE#0.6468;FETAL LIVER#0.6460;HEAD AND NECK CANCER#0.6453;NECK CANCER#0.6452;DNA DAMAGE RESPONSE#0.6437;HORMONE BINDING#0.6436;ALVEOLAR MACROPHAGE#0.6429;MOLECULAR DYNAMICS SIMULATION#0.6425;MECHANISMS OF ACTION#0.6411;TYROSINE KINASE INHIBITOR#0.6410;PROTEASOME#0.6392;BREAST CELL LINES#0.6389;ENDOPLASMIC RETICULUM#0.6381;T LYMPHOCYTE#0.6381;OPTIC NERVE HEAD#0.6363;HEME BINDING#0.6343;ORAL MUCOSA#0.6267;ABC TRANSPORTER#0.6262;ARYL HYDROCARBON HYDROXYLASE ACTIVITY#0.6258;URINARY BLADDER#0.6238;RENAL FIBROSIS#0.6228;SIGNALLING PATHWAY#0.6226;MEDULLOBLASTOMA#0.6210;TUMOR ANTIGEN#0.6207;NORMAL TENSION GLAUCOMA#0.6199;PROTEIN KINASE A#0.6198;RNA INTERFERENCE#0.6187;GLIAL CELL#0.6187;ACETYLCYSTEINE#0.6175;BETA-NF#0.6171;CELL CYCLE CONTROL#0.6165;CYCLOPHOSPHAMIDE#0.6150;URINARY SYSTEM CANCER#0.6141;RECEPTOR BINDING#0.6116;TOLL LIKE RECEPTOR#0.6099;CIGARETTE SMOKE EXTRACT#0.6083;NICOTINAMIDE#0.6070;METHYLATION SPECIFIC POLYMERASE#0.6069;IMMUNE SYSTEM#0.6059;PREGNANE X RECEPTOR#0.6041;BLADDER CARCINOMA#0.6033;SOLUBLE EPOXIDE HYDROLASE#0.6027;PROSTATE CARCINOMA#0.6010
154661	BONE MARROW#0.6856;MAPK SIGNALLING#0.6577;BREAST CARCINOMA#0.6373;LIVER DISEASE#0.6331;LYMPH NODE#0.6295;EPITHELIAL CELL#0.6276
154664	ABC TRANSPORTER#0.8955;BIPOLAR DISORDER#0.7977;ATP BINDING CASSETTE#0.7635;ATP BINDING#0.7620;MAJOR DEPRESSIVE DISORDER#0.6520
154743	BONE MARROW#0.6132
154754	GENE CONVERSION#0.6698;BREAST CANCER#0.6442
154790	CELL SURFACE#0.8983
154791	B CELL#1.0234;B LYMPHOCYTE#0.9512;PERIPHERAL BLOOD#0.6305
154796	ENDOTHELIAL CELL#1.0657;CANCER CELL#1.0474;ANGIOGENESIS#1.0447;TIGHT JUNCTION#1.0445;YES ASSOCIATED PROTEIN#1.0401;CELL MIGRATION#1.0392;CELL PROLIFERATION#1.0284;BREAST CANCER#1.0168;HIPPO SIGNALING#1.0023;GROWTH FACTOR#0.9936;EPITHELIAL CELL#0.9926;TUBE FORMATION#0.9919;SIGNALING PATHWAY#0.9706;PDZ BINDING MOTIF#0.9666;TUMOR SUPPRESSOR#0.9646;CELL JUNCTION#0.9206;GENE EXPRESSION#0.9004;BREAST CANCER CELL#0.8995;ENDOTHELIAL CELL MIGRATION#0.8932;CELL POLARITY#0.8810;BLOOD VESSEL#0.8807;CELL MOTILITY#0.8712;CYTOPLASM#0.8693;ACTIN BINDING#0.8607;LIPID BINDING#0.8264;STEM CELL#0.8106;CELL GROWTH#0.8096;UBIQUITIN#0.7913;PROTEIN COMPLEX#0.7744;PROTEIN KINASE#0.7506;POLYMERASE CHAIN REACTION#0.7132;CELL ADHESION#0.7006;CELL CELL JUNCTION#0.7002;ACTIN CYTOSKELETON#0.6959;LUNG CANCER#0.6851;APOPTOSIS#0.6644;ONCOGENIC#0.6461;LIVER CANCER#0.6459;TRANSCRIPTION FACTOR#0.6267;CELL SURFACE#0.6145;ANGIOSTATIN BINDING#0.6089;CELL CELL ADHESION#0.6075;ENDOTHELIAL GROWTH FACTOR#0.6068;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6068;DISEASE FREE SURVIVAL#0.6058;MAPK SIGNALING#0.6039
154807	VITAMIN K#1.1308;WARFARIN#0.9466;PROTEIN CARBOXYLATION#0.7631;VITAMIN K ANTAGONIST#0.6231
154810	ENDOTHELIAL CELL#1.0151;ANGIOGENESIS#0.8356;TIGHT JUNCTION#0.8355;BREAST CANCER#0.7732;CANCER CELL#0.6966;PDZ BINDING MOTIF#0.6612;EPITHELIAL CELL#0.6427;YES ASSOCIATED PROTEIN#0.6342;PROTEIN COMPLEX#0.6298;CELL JUNCTION#0.6294;CERVICAL CANCER#0.6227;UBIQUITIN#0.6224;CELL MIGRATION#0.6139;BUDDING#0.6101
154860	CELL PROLIFERATION#1.0679;CELL CYCLE#1.0290;ANTISENSE RNA#1.0097;EPITHELIAL MESENCHYMAL TRANSITION#1.0064;SIGNALING PATHWAY#0.9590;CANCER CELL#0.9296;LUNG ADENOCARCINOMA#0.8587;SQUAMOUS CELL CARCINOMA#0.8520;ADJACENT NORMAL TISSUE#0.8239;COLORECTAL#0.8125;ONCOGENIC#0.7881;COLORECTAL CANCER#0.7874;APOPTOSIS#0.7444;POLYMERASE CHAIN REACTION#0.7418;ADENOCARCINOMA#0.7220;HEPATOCELLULAR CARCINOMA#0.7181;EPITHELIAL CELL#0.7147;QUANTITATIVE REAL TIME#0.6645;LYMPH NODE METASTASIS#0.6475;COLORECTAL CARCINOMA#0.6472;LYMPH NODE#0.6434;HUMAN LENS EPITHELIAL#0.6053
154881	EPILEPSY#1.0040;POTASSIUM CHANNEL#0.9995;PROGRESSIVE MYOCLONUS EPILEPSY#0.8797;NEURONAL CEROID LIPOFUSCINOSIS#0.7860
1548	COUMARIN 7-HYDROXYLASE ACTIVITY#1.0894;XANTHINE OXIDASE#1.0730;METHOXSALEN#1.0663;COUMARIN 7 HYDROXYLASE#1.0626;N ACETYLTRANSFERASE#1.0481;PHENACETIN#1.0395;CHLORZOXAZONE#1.0379;NICOTINE METABOLISM#1.0370;BUPROPION#1.0365;DEXTROMETHORPHAN#1.0359;MEPHENYTOIN#1.0340;XANTHINE#1.0336;HYDROXYLASE ACTIVITY#1.0334;EFAVIRENZ#1.0331;TOLBUTAMIDE#1.0286;CAFFEINE#1.0260;P-NITROPHENOL#1.0251;NASAL MUCOSA#1.0208;LUNG CANCER#1.0206;NICOTINE DEPENDENCE#1.0191;CIGARETTES PER DAY#1.0168;EPOXIDE HYDROLASE#1.0163;MIDAZOLAM#1.0163;VALPROIC ACID#1.0158;5 FLUOROURACIL#1.0141;PYRAZOLE#1.0137;POLYMERASE CHAIN REACTION#1.0050;CATALYTIC ACTIVITY#1.0048;ENZYME ACTIVITY#1.0025;LETROZOLE#1.0013;TESTOSTERONE#0.9986;PHENOBARBITAL#0.9954;FLUOROURACIL#0.9849;DEMETHYLATION#0.9849;CARCINOGEN#0.9846;MICROSOME#0.9817;GENE EXPRESSION#0.9803;LIVER DISEASE#0.9803;QUINIDINE#0.9781;GLUTATHIONE#0.9774;KETOCONAZOLE#0.9734;TOXICITY#0.9728;DICLOFENAC#0.9693;CYTOCHROME P450#0.9685;DRUG METABOLISM#0.9657;EXCRETION#0.9636;PILOCARPINE#0.9619;SQUAMOUS CELL CARCINOMA#0.9608;FRAGMENT LENGTH POLYMORPHISM#0.9514;MUTAGENIC#0.9501;SULFAPHENAZOLE#0.9495;NICOTINE REPLACEMENT THERAPY#0.9459;ADENOCARCINOMA#0.9451;TRANSCRIPTION FACTOR#0.9448;PREGNANE X RECEPTOR#0.9430;BUFURALOL#0.9305;STRUCTURE ACTIVITY RELATIONSHIP#0.9280;XENOBIOTIC METABOLISM#0.9254;ETHANOL#0.9226;PRIMARY HUMAN HEPATOCYTES#0.9218;COLORECTAL CANCER#0.9213;NIFEDIPINE#0.9193;OXIDATIVE METABOLISM#0.9151;LYMPHOBLASTOID CELLS#0.9151;TROLEANDOMYCIN#0.9130;ERYTHROMYCIN#0.9071;MUTAGENICITY#0.9059;TOXICANT#0.8999;COLORECTAL#0.8976;DIMETHYLXANTHINE#0.8962;XENOBIOTIC METABOLIZING ENZYME#0.8936;BREAST CANCER#0.8899;ESOPHAGUS#0.8806;DETOXIFICATION#0.8732;CONJUGATION#0.8723;CONSTITUTIVE ANDROSTANE RECEPTOR#0.8710;RESPIRATORY TRACT#0.8616;INDOLE#0.8605;MUTAGEN#0.8587;ESOPHAGEAL CANCER#0.8529;TRANSCRIPTASE#0.8502;RIFAMPICIN#0.8496;TRANYLCYPROMINE#0.8495;OMEPRAZOLE#0.8370;BETA-NAPHTHOFLAVONE#0.8364;CYTOTOXICITY#0.8355;MUTAGENESIS#0.8354;POLYCYCLIC AROMATIC HYDROCARBON#0.8345;HEPATOCELLULAR CARCINOMA#0.8345;EPITHELIAL CELL#0.8326;AMODIAQUINE#0.8318;DEXAMETHASONE#0.8267;DOPAMINE#0.8261;SMALL INTESTINE#0.8211;REVERSE TRANSCRIPTION#0.8178;LUNG ADENOMA#0.8171;ACETYLCHOLINE RECEPTOR#0.8082;METASTATIC GASTRIC CANCER#0.8037;ARYL HYDROCARBON RECEPTOR#0.8029;LINES OF EVIDENCE#0.7960;NICOTINIC ACETYLCHOLINE RECEPTOR#0.7947;PACLITAXEL#0.7894;FLAVIN CONTAINING MONOOXYGENASE#0.7877;HALOTHANE#0.7851;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7797;DEMETHYLASE ACTIVITY#0.7764;FLAVIN#0.7680;ISONIAZID#0.7640;HEPATOTOXICITY#0.7630;GENE CONVERSION#0.7608;URIDINE#0.7567;WARFARIN#0.7557;ANILINE#0.7544;ESTRADIOL#0.7502;GENOTOXIC#0.7460;PERIPHERAL BLOOD#0.7387;TAMOXIFEN#0.7385;ACETYLCHOLINE#0.7344;METYRAPONE#0.7250;DEBRISOQUINE#0.7170;HUMAN IMMUNODEFICIENCY VIRUS#0.7077;CYCLOPHOSPHAMIDE#0.6938;SELEGILINE#0.6880;NEUTROPENIA#0.6854;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6829;MACROPHAGE#0.6777;ADVERSE DRUG REACTION#0.6689;REACTIVE OXYGEN SPECIES#0.6677;CANCER CELL#0.6657;MENSTRUAL CYCLE#0.6640;ORPHENADRINE#0.6633;MENTHOL#0.6589;4-METHYLPYRAZOLE#0.6457;RIFAMPIN#0.6368;DEXMEDETOMIDINE#0.6328;GENE COPY NUMBER#0.6259;DNA REPAIR#0.6240;OXALIPLATIN#0.6240;DOPAMINE RECEPTOR#0.6215;DRUG METABOLIC#0.6191;ESTROGEN RECEPTOR#0.6190;LIVER DAMAGE#0.6164;TUMOR CELLS#0.6137;CYTOCHROME P450 ACTIVITY#0.6126;OLFACTORY EPITHELIUM#0.6095;THYMIDINE PHOSPHORYLASE#0.6085;MOLAR#0.6072;DIARRHEA#0.6066;DIMETHYL SULFOXIDE#0.6051
1549	CYTOCHROME P450#0.9601;GENE CONVERSION#0.6579;CANCER CELL#0.6052
154	PROCATEROL#1.0413;CLENBUTEROL#1.0411;RITODRINE#1.0378;BETAXOLOL#1.0367;FORMOTEROL#1.0359;SALMETEROL#1.0356;BISOPROLOL#1.0352;PRACTOLOL#1.0294;BETA-2#1.0275;ALBUTEROL#1.0221;BETA2 ADRENERGIC RECEPTOR#1.0212;FENOTEROL#1.0193;ESSENTIAL HYPERTENSION#1.0185;PINDOLOL#1.0160;VASODILATION#1.0158;B CELL#1.0114;NITRIC OXIDE#1.0106;TERBUTALINE#1.0100;DOBUTAMINE#1.0088;CARVEDILOL#1.0087;GLYCINE#1.0086;MYOCYTES#1.0058;AIRWAY SMOOTH MUSCLE#1.0057;VASODILATOR#1.0052;T CELL#1.0051;FRAGMENT LENGTH POLYMORPHISM#1.0037;SALBUTAMOL#1.0032;PROTEIN KINASE A#1.0030;APOPTOSIS#1.0022;SMOOTH MUSCLE CELL#1.0021;LIPOLYSIS#1.0020;BETA2 ADRENOCEPTOR#1.0015;BREAST CANCER#1.0007;PORTAL VEIN#1.0007;THEOPHYLLINE#1.0000;ADRENERGIC RECEPTOR#0.9997;ANGIOTENSIN CONVERTING ENZYME#0.9997;PLASMA MEMBRANE#0.9993;ALPRENOLOL#0.9991;DOPAMINE RECEPTOR#0.9983;MONOCYTE#0.9982;LEUKOCYTE#0.9975;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9968;MONONUCLEAR CELLS#0.9964;ATENOLOL#0.9961;METOPROLOL#0.9961;OBESE#0.9961;ADRENOCEPTOR ACTIVITY#0.9960;ARGININE#0.9958;MUSCLE CELL#0.9957;PERTUSSIS#0.9957;PROTEIN KINASE#0.9954;PERIPHERAL BLOOD#0.9949;POLYMERASE CHAIN REACTION#0.9943;TRACHEA#0.9921;HYPERTENSION#0.9913;SKELETAL MUSCLE#0.9910;GENE EXPRESSION#0.9910;MAST CELL#0.9908;SIGNALING PATHWAY#0.9900;HYPOTENSION#0.9899;CELL SURFACE#0.9887;VASODILATATION#0.9886;TIMOLOL#0.9882;CYCLIC AMP#0.9879;CORONARY ARTERY#0.9873;RECEPTOR BINDING#0.9873;CARBACHOL#0.9871;ISOPRENALINE#0.9870;ADIPOSE TISSUE#0.9862;ADRENALINE#0.9859;FAT CELL#0.9855;METHACHOLINE#0.9854;MYOCARDIUM#0.9854;ADENYLYL CYCLASE ACTIVITY#0.9851;ADIPOCYTE#0.9848;ADENYLATE#0.9844;ADENYLATE CYCLASE#0.9844;SIGNAL TRANSDUCTION#0.9843;PHENTOLAMINE#0.9836;CYCLASE ACTIVITY#0.9833;EPINEPHRINE#0.9833;SOTALOL#0.9823;UTERUS#0.9822;ISOPROTERENOL#0.9820;SMOOTH MUSCLE#0.9819;GLUCOCORTICOID RECEPTOR#0.9816;TACHYCARDIA#0.9812;YOHIMBINE#0.9809;CARDIOMYOPATHY#0.9809;DOPAMINE#0.9807;HISTAMINE#0.9798;PHOSPHODIESTERASE#0.9797;PRAZOSIN#0.9786;EPITHELIAL CELL#0.9783;MYOCARDIAL INFARCTION#0.9776;CANCER CELL#0.9770;RECEPTOR ANTAGONIST#0.9765;RECEPTOR AGONIST#0.9757;GROWTH FACTOR#0.9750;ADENOSINE MONOPHOSPHATE#0.9746;FORCED EXPIRATORY VOLUME#0.9742;FORSKOLIN#0.9725;PHENYLEPHRINE#0.9722;PROPRANOLOL#0.9719;CLONIDINE#0.9719;ARTERY#0.9715;EOSINOPHIL#0.9711;BETA ADRENERGIC RECEPTOR#0.9708;ALPHA ADRENOCEPTOR#0.9702;ADENYLATE CYCLASE ACTIVITY#0.9698;NORADRENALINE#0.9693;HYPOTENSIVE#0.9691;NOREPINEPHRINE#0.9684;ENDOTHELIUM#0.9681;ADENOSINE#0.9681;CELL MEMBRANE#0.9674;ENDOCYTOSIS#0.9663;ACETYLCHOLINE#0.9637;BETA ADRENOCEPTOR#0.9631;CALCIUM CHANNEL#0.9627;SYSTOLIC BLOOD PRESSURE#0.9623;NERVOUS SYSTEM#0.9613;NITRIC OXIDE SYNTHASE#0.9600;SENSITIZATION#0.9579;CYCLIC ADENOSINE MONOPHOSPHATE#0.9562;NADOLOL#0.9534;VASOCONSTRICTION#0.9527;INSULIN SECRETION#0.9482;CONGESTIVE HEART FAILURE#0.9479;FOREARM#0.9428;CHRONIC HEART FAILURE#0.9400;EPHEDRINE#0.9395;TYPE 2 DIABETES#0.9370;CELL PROLIFERATION#0.9363;RIGHT ATRIUM#0.9331;ATROPINE#0.9320;TOPICAL#0.9309;ERYTHRO#0.9298;PHOSPHODIESTERASE INHIBITOR#0.9289;CARDIOVASCULAR SYSTEM#0.9250;IPRATROPIUM BROMIDE#0.9244;BOPINDOLOL#0.9243;PROSTAGLANDIN E2#0.9219;GTP HYDROLYSIS#0.9193;GLUTAMIC ACID#0.9142;KETOTIFEN#0.9140;NERVE TERMINAL#0.9095;LABETALOL#0.9049;DIABETES MELLITUS#0.9035;HIGH DENSITY LIPOPROTEIN#0.9000;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8999;TRANSCRIPTION FACTOR#0.8958;RECEPTOR INTERNALIZATION#0.8951;ALLERGEN#0.8950;ADENYLYL CYCLASE ACTIVATION#0.8942;ENDOTHELIAL CELL#0.8940;MYOMETRIUM#0.8935;LUNG DISEASE#0.8878;PHENOXYBENZAMINE#0.8876;CARDIOMYOCYTE#0.8871;OPIOID RECEPTOR#0.8868;NEUTROPHIL#0.8868;DEXAMETHASONE#0.8862;IPRATROPIUM#0.8857;MACROPHAGE#0.8851;CORONARY ARTERY DISEASE#0.8839;MECHANISM OF ACTION#0.8839;BETA1 ADRENOCEPTOR#0.8837;ARTERY DISEASE#0.8837;NIFEDIPINE#0.8790;HUMAN EMBRYONIC KIDNEY#0.8789;NEUROBLASTOMA#0.8785;EMBRYONIC KIDNEY#0.8784;PLATELET ACTIVATING FACTOR#0.8773;PROSTATE CANCER#0.8755;BLOOD VESSEL#0.8742;ARRHYTHMIA#0.8734;ENDOSOME#0.8731;B LYMPHOCYTE#0.8729;GLUTAMINE#0.8707;BETA1 ADRENERGIC RECEPTOR#0.8703;BREAST CANCER CELL#0.8670;ACID SECRETION#0.8665;ISCHEMIA#0.8661;HEART DISEASE#0.8640;GLUCOSE METABOLISM#0.8613;GASTRIC ACID SECRETION#0.8599;EXCRETION#0.8578;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8573;NEUROTRANSMISSION#0.8545;CORTISOL#0.8542;DILATED CARDIOMYOPATHY#0.8524;ENDOTHELIAL NITRIC OXIDE#0.8494;DESIPRAMINE#0.8494;RESERPINE#0.8491;IFN-GAMMA#0.8483;KERATINOCYTE#0.8474;VASOCONSTRICTOR#0.8472;LOW DENSITY LIPOPROTEIN#0.8429;ERYTHROCYTE#0.8404;IMMUNE RESPONSE#0.8403;ETHANOL#0.8388;DEPHOSPHORYLATION#0.8384;OVARIAN#0.8378;RESPIRATORY TRACT#0.8357;AND BODY COMPOSITION#0.8333;CAMP FORMATION#0.8323;T LYMPHOCYTE#0.8299;XANTHINE#0.8292;BONE RESORPTION#0.8271;INNERVATION#0.8263;VASOPRESSIN#0.8217;INFLAMMATORY RESPONSE#0.8202;SMOOTH MUSCLE RELAXATION#0.8201;OBSTRUCTIVE LUNG DISEASE#0.8194;ENZYME INHIBITOR#0.8189;LIPID METABOLISM#0.8171;TOXICITY#0.8162;TIOTROPIUM#0.8161;MUSCLE CONTRACTION#0.8156;VERAPAMIL#0.8123;CORONARY ARTERY BYPASS#0.8111;RECEPTOR ACTIVITY#0.8102;AMP FORMATION#0.8093;RECEPTOR LIGAND#0.8081;CYSTIC FIBROSIS#0.8070;RITODRINE HYDROCHLORIDE#0.8068;SPINAL CORD#0.8033;SUBSTANCE P#0.8025;NITROPRUSSIDE#0.8007;PULMONARY ARTERY#0.7987;GUANINE#0.7975;WEIGHT LOSS#0.7969;HARDY WEINBERG EQUILIBRIUM#0.7966;MENSTRUAL CYCLE#0.7962;CEREBRAL CORTEX#0.7961;ALANINE#0.7950;SODIUM NITROPRUSSIDE#0.7939;HALOPERIDOL#0.7898;HYPOGLYCEMIA#0.7890;PROTEIN KINASE C#0.7882;RENIN ACTIVITY#0.7877;GUANOSINE#0.7867;MITOGEN ACTIVATED PROTEIN#0.7862;MITRAL VALVE#0.7853;CAPTOPRIL#0.7810;TH2 CELL#0.7809;ADRENAL MEDULLA#0.7793;GESTATION#0.7793;HYPOXIA#0.7782;METHOXAMINE#0.7777;CENTRAL NERVOUS SYSTEM#0.7757;ALLERGIC ASTHMA#0.7756;MITRAL VALVE DISEASE#0.7751;CD8+ T CELL#0.7747;GM-CSF#0.7705;PROSTAGLANDIN E1#0.7696;BUDESONIDE#0.7693;2-BUTANOL#0.7650;NUCLEOTIDE BINDING#0.7627;RESONANCE ENERGY TRANSFER#0.7557;ATHEROSCLEROSIS#0.7537;IMMUNE CELL#0.7519;N-ETHYLMALEIMIDE#0.7519;GENETIC ASSOCIATION STUDIES#0.7510;RESPONSE TO EXERCISE#0.7500;FORCED VITAL CAPACITY#0.7498;BROWN ADIPOSE TISSUE#0.7455;ALVEOLAR MACROPHAGE#0.7454;SUBCUTANEOUS ADIPOSE TISSUE#0.7443;CILIARY BODY#0.7440;COATED PIT#0.7432;PARENCHYMA#0.7426;APOMORPHINE#0.7413;O METHYLTRANSFERASE#0.7394;MUTAGENESIS#0.7393;WHEEZING#0.7387;ACEBUTOLOL#0.7359;INDOMETHACIN#0.7352;GRAVES' DISEASE#0.7329;SIGNALLING PATHWAY#0.7326;HEPATOCELLULAR CARCINOMA#0.7303;REVERSE TRANSCRIPTION#0.7293;NERVE ENDING#0.7251;INDACATEROL#0.7242;INCREASED BLOOD PRESSURE#0.7217;CROMOGLYCATE#0.7199;HYPERACTIVITY#0.7194;L-ARGININE#0.7190;N METHYLTRANSFERASE#0.7186;BETA3 ADRENERGIC RECEPTOR#0.7177;IMMUNE SYSTEM#0.7164;LUNG CANCER#0.7145;TUMOR NECROSIS FACTOR#0.7135;CELL CYCLE#0.7113;PEROXISOME#0.7112;MECHANISMS OF ACTION#0.7064;URETHANE#0.7064;MUSCLE ATROPHY#0.7036;MULTIPLE LINEAR REGRESSION#0.6991;FLUTICASONE PROPIONATE#0.6982;CERVICAL#0.6978;ACUTE CORONARY SYNDROME#0.6975;HEALTHY CONTROL SUBJECTS#0.6974;ACETYLCHOLINE RECEPTOR#0.6962;MODE OF ACTION#0.6961;ENDOCYTIC VESICLE#0.6930;STRIATUM#0.6922;ANGIOGENESIS#0.6916;ENDOTHELIAL GROWTH FACTOR#0.6909;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6909;SALIVA SECRETION#0.6906;HORMONE SENSITIVE LIPASE#0.6893;BLOOD PRESSURE REGULATION#0.6890;OXPRENOLOL#0.6797;ALDOSTERONE#0.6790;CARDIOVASCULAR RISK FACTOR#0.6789;GLUTATHIONE#0.6770;SMOOTH MUSCLE CONTRACTION#0.6768;HYPOKALEMIA#0.6760;OVARIAN CANCER#0.6757;CHANNEL ACTIVITY#0.6744;CARDIAC MUSCLE#0.6723;RESPONSE TO CATECHOLAMINE#0.6713;L-ISOPROTERENOL#0.6685;IGE RECEPTOR#0.6685;LINEAR REGRESSION ANALYSIS#0.6672;ADENYLATE CYCLASE ACTIVATION#0.6656;BRADYCARDIA#0.6647;OCULAR HYPOTENSION#0.6643;HYPERSENSITIVITY#0.6621;TH1 CELL#0.6609;ENZYME ACTIVITY#0.6565;DNA METHYLATION#0.6547;HYPERTHYROIDISM#0.6520;PROTEIN SYNTHESIS#0.6506;RESPONSE TO STRESS#0.6499;PROGESTERONE#0.6488;5-HT RECEPTOR#0.6459;MAP KINASE#0.6445;POLYMORPHONUCLEAR LEUKOCYTES#0.6435;WEIGHT GAIN#0.6394;QUANTITATIVE REAL TIME#0.6390;MELATONIN#0.6389;GROWTH HORMONE#0.6383;CYTOCHROME P450#0.6374;OUABAIN#0.6330;MEMBRANE FRACTION#0.6238;OSTEOBLAST#0.6218;GLIBENCLAMIDE#0.6212;TYPE 2 DIABETES MELLITUS#0.6177;2 DIABETES MELLITUS#0.6176;MOTOR ACTIVITY#0.6169;HINDLIMB#0.6169;MOLAR#0.6162;PREDNISONE#0.6162;SIGNALING CASCADE#0.6108;POTASSIUM CHANNEL#0.6107;CYTOKINE PRODUCTION#0.6063;OPEN ANGLE GLAUCOMA#0.6035;RESPIRATORY TRACT INFECTION#0.6011
155038	T CELL#0.8131;B CELL#0.6797;LYMPHOCYTE DEVELOPMENT#0.6496;BONE MARROW#0.6214
155054	SIGNALING PATHWAY#1.1785
155061	PARKINSON'S DISEASE#0.9438;ZINC FINGER PROTEIN#0.9196;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6087;EPITHELIAL TO MESENCHYMAL#0.6083;GLYCOGEN SYNTHASE KINASE#0.6076
155184	FRUCTOSE#0.8845;FRUCTOSE TRANSPORT#0.8465;SMALL INTESTINE#0.8247;GLUCOSE TRANSPORT#0.7831;ENDOPLASMIC RETICULUM#0.6472;SUGAR TRANSPORTER#0.6219
1551	MICROSOMAL P-450#1.0587;CYTOCHROME B5 REDUCTASE#1.0447;BETA-NF#1.0399;BETA-HYDROXYSTEROID DEHYDROGENASE#1.0332;LANOSTEROL#1.0328;NADPH OXIDATION#1.0327;4-METHYLPYRAZOLE#1.0303;ETHANOL OXIDATION#1.0287;FLAVIN CONTAINING MONOOXYGENASE#1.0277;PYRAZOLE#1.0254;THEOPHYLLINE#1.0241;CAMPHOR#1.0232;STEROID HYDROXYLASE#1.0227;ANTIPYRINE#1.0224;WARFARIN#1.0224;DEHYDROEPIANDROSTERONE#1.0214;LEYDIG CELL#1.0212;FETAL LIVER#1.0209;GROWTH HORMONE#1.0201;DEBRISOQUINE#1.0175;MEPHENYTOIN#1.0173;CLOTRIMAZOLE#1.0169;HEME BINDING#1.0169;CIMETIDINE#1.0163;RIFAMPICIN#1.0136;ALDOSTERONE#1.0130;HEXOBARBITAL#1.0121;XANTHINE OXIDASE#1.0103;EPOXIDE HYDROLASE#1.0096;ARACHIDONIC ACID#1.0093;KETOCONAZOLE#1.0082;ADRENAL CORTEX#1.0059;NIFEDIPINE#1.0057;CYTOCHROME C#1.0046;MONOOXYGENASE ACTIVITY#1.0043;ELECTRON TRANSFER#1.0041;ADRENAL GLAND#1.0025;MICONAZOLE#1.0022;CLARA CELL#1.0019;P-NITROPHENOL#1.0019;CYCLOSPORINE#1.0016;ETHYLMORPHINE#1.0012;AMINOPYRINE#1.0005;ANILINE#1.0002;21-HYDROXYLASE ACTIVITY#1.0001;METYRAPONE#1.0001;FLAVIN#0.9995;PROGESTERONE#0.9994;BETA-NAPHTHOFLAVONE#0.9991;CYTOCHROME B5#0.9990;RETINOIC ACID#0.9989;SMALL INTESTINE#0.9987;CORTISOL#0.9980;ACETAMINOPHEN#0.9980;ETHANOL#0.9979;XENOBIOTIC METABOLIZING ENZYME#0.9976;OXIDATIVE METABOLISM#0.9975;ANDROSTENEDIONE#0.9974;CYCLOPHOSPHAMIDE#0.9963;DEMETHYLASE ACTIVITY#0.9959;CYTOCHROME C REDUCTASE ACTIVITY#0.9959;GRANULOSA CELL#0.9954;CYTOCHROME B#0.9943;MICROSOMAL MEMBRANE#0.9943;MUTAGENESIS#0.9939;TROLEANDOMYCIN#0.9935;ELECTRON TRANSPORT#0.9934;OVARIAN#0.9929;PREGNENOLONE#0.9924;PHENOBARBITONE#0.9922;CYTOCHROME P-450SCC#0.9920;MOLAR#0.9919;BENZPHETAMINE#0.9902;GESTATION#0.9898;STEROIDOGENESIS#0.9897;MUTAGENIC#0.9896;ERYTHROMYCIN#0.9896;MUTAGEN#0.9878;DEMETHYLATION#0.9870;CATALYTIC ACTIVITY#0.9865;POLYMERASE CHAIN REACTION#0.9861;MITOCHONDRIA#0.9857;POLYCYCLIC AROMATIC HYDROCARBON#0.9855;HYDROXYLASE ACTIVITY#0.9850;GROWTH FACTOR#0.9849;TRANSCRIPTION FACTOR#0.9844;PHENOBARBITAL#0.9842;OXYGENASE#0.9836;DETOXIFICATION#0.9835;ESTRADIOL#0.9833;NITRIC OXIDE#0.9832;TESTOSTERONE#0.9825;XENOBIOTIC METABOLISM#0.9822;MICROSOME#0.9822;DEXAMETHASONE#0.9822;SODIUM DODECYL SULFATE#0.9819;DODECYL SULFATE#0.9818;XANTHINE#0.9817;ESTROGENS#0.9814;ENDOPLASMIC RETICULUM#0.9810;LIVER DISEASE#0.9804;CARCINOGEN#0.9799;LIDOCAINE#0.9792;REVERSE TRANSCRIPTION#0.9780;EPITHELIAL CELL#0.9775;ENZYME ACTIVITY#0.9764;MUTAGENICITY#0.9760;GLUTATHIONE#0.9751;ANTHRACENE#0.9744;NADPH OXIDASE#0.9742;HEPATOTOXICITY#0.9736;NADPH:CYTOCHROME C REDUCTASE ACTIVITY#0.9729;DRUG METABOLISM#0.9727;CAFFEINE#0.9727;GENE EXPRESSION#0.9723;CONJUGATION#0.9703;CYTOCHROME P450#0.9701;SUPEROXIDE DISMUTASE#0.9698;CYTOPLASM#0.9689;AROMATASE ACTIVITY#0.9682;NEPHRON#0.9681;TRANSFERASE ACTIVITY#0.9674;PLASMA MEMBRANE#0.9671;CLOFIBRATE#0.9671;VITAMIN D3#0.9668;AMINOLEVULINIC ACID#0.9665;OXIDATION REDUCTION#0.9651;EXCRETION#0.9641;TOXICITY#0.9640;ADENINE DINUCLEOTIDE PHOSPHATE#0.9633;NUCLEIC ACID#0.9625;GENOTOXIC#0.9609;TRIACETYLOLEANDOMYCIN#0.9607;HEPATOCELLULAR CARCINOMA#0.9600;VITAMIN A#0.9599;CO BINDING#0.9595;ISONIAZID#0.9594;PROTEIN SYNTHESIS#0.9586;HEPATOMA CELLS#0.9575;CYTOTOXICITY#0.9573;BUFURALOL#0.9572;MITOCHONDRIAL MEMBRANE#0.9565;OVARIES#0.9561;HISTIDINE#0.9558;ARYL HYDROCARBON HYDROXYLASE ACTIVITY#0.9549;PROTEIN KINASE#0.9546;MEMBRANE FRACTION#0.9542;REACTIVE OXYGEN SPECIES#0.9518;RECEPTOR ANTAGONIST#0.9503;ARACHIDONIC ACID EPOXYGENASE#0.9489;GLUCOCORTICOID RECEPTOR#0.9478;NICOTINAMIDE#0.9464;ALANINE#0.9456;MECHANISM OF ACTION#0.9455;DNA BINDING#0.9451;METHIONINE#0.9443;FERREDOXIN#0.9435;INDOMETHACIN#0.9431;5,6-BENZOFLAVONE#0.9429;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9423;PHENYTOIN#0.9421;SMOOTH ENDOPLASMIC RETICULUM#0.9406;QUINIDINE#0.9405;ESTRONE#0.9404;HYDROGEN PEROXIDE FORMATION#0.9393;GLUCOSE 6 PHOSPHATASE#0.9391;CORPUS LUTEUM#0.9382;DIGESTION#0.9377;ARACHIDONIC ACID METABOLISM#0.9374;NITRIC OXIDE SYNTHASE#0.9372;PEROXISOMAL#0.9360;ESTROGEN RECEPTOR#0.9359;CHLORAMPHENICOL#0.9349;HALOTHANE#0.9335;PREGNANE X RECEPTOR#0.9335;STRUCTURE ACTIVITY RELATIONSHIP#0.9306;COUMARIN 7 HYDROXYLASE#0.9298;TOLBUTAMIDE#0.9294;ADENINE#0.9289;MIDAZOLAM#0.9278;LYASE ACTIVITY#0.9273;STEROID METABOLISM#0.9256;IMIPRAMINE#0.9253;THECA INTERNA CELL#0.9248;PHENACETIN#0.9233;GLUTATHIONE TRANSFERASE#0.9219;AMINOGLUTETHIMIDE#0.9209;GLUTATHIONE PEROXIDASE#0.9202;GENE CONVERSION#0.9194;ARTERIOLE#0.9185;CARCINOGENICITY#0.9183;AZOREDUCTASE ACTIVITY#0.9183;ARGININE#0.9160;SMOOTH MUSCLE#0.9148;PENTOBARBITAL#0.9135;BETA-2#0.9117;HEME OXYGENASE ACTIVITY#0.9110;BETA-ESTRADIOL#0.9099;N ACETYLTRANSFERASE#0.9093;NADPH ADRENODOXIN REDUCTASE#0.9073;STEROID BIOSYNTHESIS#0.9071;DELTA-AMINOLEVULINIC ACID#0.9056;VITAMIN E#0.9039;TRANSCRIPTASE#0.9035;ASCORBIC ACID#0.9018;BREAST CANCER#0.8994;ENZYME INHIBITOR#0.8973;HEME SYNTHESIS#0.8971;NUCLEAR ENVELOPE#0.8970;GENOTOXICITY#0.8961;ER MEMBRANE#0.8960;PUBERTY#0.8884;ALKALINE PHOSPHATASE#0.8872;ASPARTATE#0.8870;MENADIONE#0.8824;L-ARGININE#0.8818;FACTOR I#0.8814;SPARTEINE#0.8799;ENDOTHELIAL CELL#0.8769;CYCLIC AMP#0.8734;CELL PROLIFERATION#0.8719;HEPATOCYTE NUCLEAR FACTOR#0.8703;ETHYL ISOCYANIDE#0.8700;ERGOSTEROL#0.8698;HYPERTENSION#0.8682;OVARIAN FOLLICLE#0.8661;LIVER DAMAGE#0.8650;25-HYDROXYVITAMIN D3#0.8646;ADRENAL HYPERPLASIA#0.8640;CHLORZOXAZONE#0.8635;TRYPTOPHAN#0.8584;GLUTATHIONE S-TRANSFERASE ACTIVITY#0.8574;TIENILIC ACID#0.8571;ITRACONAZOLE#0.8561;TAMOXIFEN#0.8548;TUMOR CELLS#0.8546;VITAMIN C#0.8497;TUMOR NECROSIS FACTOR#0.8485;ALL TRANS RETINOIC ACID#0.8478;DIAZEPAM#0.8388;HYPOXIA#0.8385;LUNG CANCER#0.8384;ORGANELLE#0.8331;NEPHROTOXICITY#0.8321;STEROID 5 ALPHA REDUCTASE#0.8318;COMPLEX I#0.8290;PITUITARY GLAND#0.8278;SIGNALING PATHWAY#0.8266;CELL CYCLE#0.8246;PARACETAMOL#0.8204;INSULIN-LIKE GROWTH FACTOR#0.8197;URIDINE#0.8179;ENDOTHELIUM#0.8159;CONGENITAL ADRENAL HYPERPLASIA#0.8143;SODIUM DODECYL SULPHATE#0.8135;N-ACETYLCYSTEINE#0.8132;ROUGH ENDOPLASMIC RETICULUM#0.8118;ELECTRON CARRIER#0.8115;ELECTRON TRANSPORT CHAIN#0.8111;TOCOPHEROL#0.8108;ERYTHROCYTE#0.8103;HEME METABOLISM#0.8096;DEHYDROEPIANDROSTERONE SULFATE#0.8091;INTESTINAL MUCOSA#0.8082;HYPOXIC#0.8068;TERATOGENIC#0.8059;INTERSTITIAL CELL#0.8051;1-BENZYLIMIDAZOLE#0.8046;GOLGI APPARATUS#0.8042;HYDROLASE ACTIVITY#0.8040;EPOXIDE HYDROLASE ACTIVITY#0.8034;SERTOLI CELL#0.7994;ANESTHETIC#0.7988;CELL FRACTION#0.7960;PROTEIN BINDING#0.7954;PEROXISOME#0.7942;SOLUBLE FRACTION#0.7941;TACROLIMUS#0.7920;LEUCINE#0.7896;1,2,4-TRIAZOLE#0.7892;AMINOLEVULINATE#0.7891;IMMUNE RESPONSE#0.7890;GLYCINE#0.7824;RETINOL#0.7787;PHOTOLYSIS#0.7780;DIMETHYL SULFOXIDE#0.7743;NERVOUS SYSTEM#0.7727;ERGOSTEROL BIOSYNTHESIS#0.7719;INNER MITOCHONDRIAL MEMBRANE#0.7682;ADENOSINE#0.7678;PROTOPORPHYRIN IX#0.7670;ASCORBATE#0.7647;CATABOLISM#0.7644;ENDOMETRIUM#0.7638;ALPHA-TOCOPHEROL#0.7638;BODY WEIGHT RATIO#0.7626;REGENERATION#0.7613;ENZYME COMPLEX#0.7604;APOPTOSIS#0.7577;VALPROATE#0.7543;INDOLE#0.7512;ARYLAMINE#0.7510;RIFAMPIN#0.7508;ENDOPLASMIC RETICULUM MEMBRANE#0.7505;PROTEIN KINASE C#0.7494;KETAMINE#0.7469;GONAD#0.7464;3BETA-HYDROXYSTEROID DEHYDROGENASE#0.7456;METHIMAZOLE#0.7454;GLOMERULUS#0.7434;PROPRANOLOL#0.7417;STREPTOZOTOCIN#0.7414;PARENCHYMA#0.7408;FLUCONAZOLE#0.7405;GAMMA GLUTAMYLTRANSFERASE#0.7397;LIPID METABOLISM#0.7375;CHANNEL ACTIVITY#0.7355;PALMITATE#0.7348;BONE MARROW#0.7339;OMEGA-HYDROXYLASE ACTIVITY#0.7318;ORGANOGENESIS#0.7308;ACETYLCYSTEINE#0.7306;CHRONIC LIVER DISEASE#0.7284;SULFAPHENAZOLE#0.7254;GLUTETHIMIDE#0.7230;IFN-GAMMA#0.7193;DESFERRIOXAMINE#0.7190;CYTOCHROME B5 REDUCTASE ACTIVITY#0.7187;EMBRYOTOXIC#0.7179;PHOSPHATASE ACTIVITY#0.7177;CISPLATIN#0.7173;DRUG RESISTANCE#0.7156;SALICYLATE#0.7156;PRIMARY HUMAN HEPATOCYTES#0.7149;IMMUNOGLOBULIN G#0.7138;ALAS ACTIVITY#0.7132;COUMARIN 7-HYDROXYLASE ACTIVITY#0.7115;VASODILATOR#0.7112;OXYGEN BINDING#0.7109;PHOSPHATIDYLETHANOLAMINE#0.7093;PHENANTHRENE#0.7092;ESTRIOL#0.7091;ANDROGEN RECEPTOR#0.7089;PORPHYRIA#0.7088;PHOSPHATIDYLSERINE#0.7074;GLUTAMINE#0.7060;CONSTITUTIVE ANDROSTANE RECEPTOR#0.7041;HORMONE METABOLISM#0.7003;VASOCONSTRICTOR#0.6994;GESTODENE#0.6979;VACCINIA#0.6977;ACTINOMYCIN D#0.6962;FK-506#0.6949;QUERCETIN#0.6940;CARBAMAZEPINE#0.6939;VIRAL INFECTION#0.6928;RECEPTOR BINDING#0.6922;STATIONARY PHASE#0.6921;STEROID SYNTHESIS#0.6918;ECONAZOLE#0.6910;PROSTATE CANCER#0.6908;EXTRACELLULAR MATRIX#0.6901;ARYL HYDROCARBON RECEPTOR#0.6899;TRANSFORMING GROWTH FACTOR#0.6890;DISULFIRAM#0.6885;CHOLINE#0.6884;CYCLOSPORIN#0.6883;STEM CELL#0.6883;POLYSOME#0.6852;MUSCLE CELL#0.6829;METHADONE#0.6829;NODULAR#0.6816;ENFLURANE#0.6791;HEPATOTOXIN#0.6775;LEUKOCYTE#0.6772;FOLLICLE STIMULATING HORMONE#0.6768;ARTERY#0.6750;BETA GLUCURONIDASE#0.6729;DRUG BINDING#0.6714;NADH DEHYDROGENASE#0.6699;LYSINE#0.6693;NUCLEAR MEMBRANE#0.6688;STROMAL CELL#0.6665;GROWTH HORMONE SECRETION#0.6648;CENTRAL NERVOUS SYSTEM#0.6629;CELL DEATH#0.6622;HORMONE SECRETION#0.6618;ORPHENADRINE#0.6604;19-NORANDROSTENEDIONE#0.6580;MENSTRUAL CYCLE#0.6569;PEROXIDASE ACTIVITY#0.6555;HEXANE#0.6552;ERGOSTEROL SYNTHESIS#0.6551;NITRO-L-ARGININE#0.6527;PROTEIN PROTEIN INTERACTION#0.6507;TETRAHYDROCANNABINOL#0.6501;DICARBOXYLIC ACID#0.6495;HAEM BIOSYNTHESIS#0.6473;RANITIDINE#0.6455;72-HOURS#0.6455;CANCER CELL#0.6450;DIURNAL#0.6441;GLIAL CELL#0.6417;PACLITAXEL#0.6415;CYCLOSPORIN A#0.6406;4-ANDROSTENE-3,17-DIONE#0.6385;TRIIODOTHYRONINE#0.6377;GLUCOSE-6-PHOSPHATE#0.6371;SODIUM DODECYLSULFATE#0.6346;CELL GROWTH#0.6342;MACROPHAGE#0.6338;TOLUENE#0.6293;SMOOTH ER#0.6292;PARGYLINE#0.6277;CHOLESTEROL BIOSYNTHESIS#0.6277;SUCROSE#0.6263;NASAL MUCOSA#0.6261;CYCLOHEXANE#0.6243;SERUM ALBUMIN#0.6236;CYTOCHROME C OXIDASE#0.6226;RIBOSOME#0.6221;TESTOSTERONE PROPIONATE#0.6217;COLLAGENASE#0.6210;SWISS ALBINO MICE#0.6210;OLFACTORY LOBE#0.6199;ASTROCYTE#0.6185;ATPASE ACTIVITY#0.6177;ADENOCARCINOMA#0.6169;MALATE DEHYDROGENASE#0.6143;T CELL#0.6143;CAPTOPRIL#0.6138;DIETHYLSTILBESTROL#0.6113;DELTA-9-TETRAHYDROCANNABINOL#0.6100;SPIRONOLACTONE#0.6099;LYMPHOBLAST#0.6071;GLUCOSE-6-PHOSPHATASE ACTIVITY#0.6068;INHIBITION OF ENZYME ACTIVITY#0.6066;STEROID HYDROXYLASE ACTIVITY#0.6059;FRAGMENT LENGTH POLYMORPHISM#0.6059;DELTA-9-THC#0.6054;DIOL FORMATION#0.6029;SR-4233#0.6029;SIGNAL TRANSDUCTION#0.6028;DOXORUBICIN#0.6025;METHIONINE SYNTHASE REDUCTASE#0.6011
155370	COLORECTAL CANCER#0.7368;DISEASE FREE SURVIVAL#0.6960;GENE CONVERSION#0.6409
1553	RESPIRATORY TRACT#1.0723;LUNG CANCER#1.0463;CARCINOGEN#1.0408;NASAL MUCOSA#1.0249;CYTOCHROME P450#1.0041;TOXICITY#1.0016;MICROSOME#1.0012;LUNG ADENOCARCINOMA#0.9258;RESPIRATORY SYSTEM#0.9091;EPITHELIAL CELL#0.9006;POLYMERASE CHAIN REACTION#0.9002;ADENOCARCINOMA#0.8968;NICOTINE METABOLISM#0.8560;CYTOTOXICITY#0.8419;HEAD AND NECK CANCER#0.8181;NECK CANCER#0.8180;HUMAN BRONCHIAL EPITHELIAL#0.7904;TOXICANT#0.7222;DEMETHYLATION#0.7066;CATALYTIC ACTIVITY#0.6846;APOPTOSIS#0.6624;ENZYME ACTIVITY#0.6582;PHENACETIN#0.6565;LUNG ADENOMA#0.6428;NON-SMALL CELL LUNG CARCINOMA#0.6132;GLUTATHIONE#0.6097;LUNG CARCINOMA#0.6059;BRONCHIAL EPITHELIAL CELLS#0.6047
155435	PEPSIN INHIBITOR#1.0536;SIZE EXCLUSION CHROMATOGRAPHY#0.6747;INFLAMMATORY RESPONSE#0.6466
155465	BREAST CANCER#1.0026;T CELL#0.8756;CANCER CELL#0.8189;OVARIAN CANCER#0.8128;OVARIAN#0.8069;PROTEIN DISULFIDE ISOMERASE#0.7850;BREAST CANCER CELL#0.7639;GENE EXPRESSION#0.7355;POLYMERASE CHAIN REACTION#0.7355;CILIATED CELL#0.6247;INTERNAL TRANSCRIBED SPACER#0.6247;OVARIAN CARCINOMA#0.6105
1555	NICOTINE METABOLISM#1.0629;PROPOFOL#1.0588;SIBUTRAMINE#1.0574;KETAMINE#1.0569;TICLOPIDINE#1.0562;METHADONE#1.0526;THIOTEPA#1.0493;ORPHENADRINE#1.0473;BUFURALOL#1.0409;SELEGILINE#1.0400;BUPROPION#1.0377;CHLORZOXAZONE#1.0343;NEVIRAPINE#1.0341;FRAGMENT LENGTH POLYMORPHISM#1.0308;EFAVIRENZ#1.0300;DEXTROMETHORPHAN#1.0298;CLOPIDOGREL#1.0290;PHENACETIN#1.0275;MEPHENYTOIN#1.0253;HUMAN PRIMARY HEPATOCYTES#1.0244;CATALYTIC ACTIVITY#1.0228;RIFAMPIN#1.0171;IFOSFAMIDE#1.0133;TOLBUTAMIDE#1.0102;OMEPRAZOLE#1.0094;SERTRALINE#1.0084;DICLOFENAC#1.0076;DEMETHYLATION#1.0052;CYCLOPHOSPHAMIDE#1.0050;TAMOXIFEN#1.0031;MIDAZOLAM#1.0030;DEMETHYLASE ACTIVITY#1.0005;RIFAMPICIN#1.0003;ETHANOL#0.9994;PHENOBARBITAL#0.9983;PRIMARY HUMAN HEPATOCYTES#0.9979;STRUCTURE ACTIVITY RELATIONSHIP#0.9972;NIFEDIPINE#0.9960;BETA-NAPHTHOFLAVONE#0.9943;PRASUGREL#0.9932;CENTRAL NERVOUS SYSTEM#0.9931;P-NITROPHENOL#0.9928;REVERSE TRANSCRIPTASE INHIBITOR#0.9927;NERVOUS SYSTEM#0.9922;KETOCONAZOLE#0.9904;RITONAVIR#0.9902;POLYMERASE CHAIN REACTION#0.9889;PHENYTOIN#0.9886;DEXAMETHASONE#0.9877;TESTOSTERONE#0.9870;BREAST CANCER#0.9868;TROLEANDOMYCIN#0.9865;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9855;HYDROXYLASE ACTIVITY#0.9854;XENOBIOTIC METABOLISM#0.9851;CAFFEINE#0.9835;PREGNANE X RECEPTOR#0.9831;THERAPEUTIC DRUG MONITORING#0.9827;ENZYME ACTIVITY#0.9826;EPOXIDE HYDROLASE#0.9822;HEPATOTOXICITY#0.9788;TRANSCRIPTASE#0.9776;OXIDATIVE METABOLISM#0.9767;HUMAN IMMUNODEFICIENCY VIRUS#0.9757;CYTOTOXICITY#0.9755;GLUCOCORTICOID RECEPTOR#0.9746;ARYL HYDROCARBON RECEPTOR#0.9744;XENOBIOTIC METABOLIZING ENZYME#0.9735;GENE EXPRESSION#0.9734;TUBERCULOSIS#0.9730;DETOXIFICATION#0.9712;MICROSOME#0.9712;GLUTATHIONE#0.9708;CARCINOGEN#0.9700;TRANSACTIVATION#0.9696;ISONIAZID#0.9693;REVERSE TRANSCRIPTION#0.9688;PROTEIN KINASE#0.9672;QUINIDINE#0.9670;TRANSCRIPTION FACTOR#0.9653;DRUG METABOLISM#0.9644;AMODIAQUINE#0.9635;REPORTER GENE ASSAY#0.9617;RETINOID X RECEPTOR#0.9608;CYTOCHROME B5#0.9603;TOXICITY#0.9601;CYTOCHROME P450#0.9600;SULFAPHENAZOLE#0.9551;MALARIA#0.9534;EXCRETION#0.9513;URIDINE#0.9479;METHADONE MAINTENANCE TREATMENT#0.9475;COUMARIN 7 HYDROXYLASE#0.9421;GROWTH FACTOR#0.9413;PACLITAXEL#0.9380;GENOTOXIC#0.9378;ADVERSE DRUG REACTION#0.9344;SMALL INTESTINE#0.9312;CLOTRIMAZOLE#0.9212;BENZPHETAMINE#0.9196;QUANTITATIVE REAL TIME#0.9193;PHENOBARBITONE#0.9183;CELL PROLIFERATION#0.9179;CANCER CELL#0.9171;HEPATOCYTE NUCLEAR FACTOR#0.9147;RESPONSE TO TREATMENT#0.9144;T CELL#0.9139;STEM CELL#0.9124;DNA SYNTHESIS#0.9090;CARBAMAZEPINE#0.9062;CONJUGATION#0.9045;ARTEMETHER#0.9013;DIPHOSPHATE#0.9009;PEROXISOME#0.8997;TUMOR CELLS#0.8961;EPITHELIAL CELL#0.8956;PERIPHERAL BLOOD#0.8955;LUMEFANTRINE#0.8900;PREGNENOLONE#0.8890;ATP BINDING CASSETTE#0.8852;ATP BINDING#0.8835;MUTAGENESIS#0.8833;TOXICANT#0.8795;ESTRADIOL#0.8745;PROSTATE CANCER#0.8725;POLYCYCLIC AROMATIC HYDROCARBON#0.8668;CYTOCHROME P450 ACTIVITY#0.8583;OPIOID RECEPTOR#0.8569;LUNG CANCER#0.8524;SIGNALING PATHWAY#0.8523;CELL CYCLE#0.8519;WARFARIN#0.8499;ERYTHROMYCIN#0.8471;ANILINE#0.8432;MODE OF ACTION#0.8405;ANESTHETIC#0.8388;METYRAPONE#0.8378;THEOPHYLLINE#0.8376;FLAVIN CONTAINING MONOOXYGENASE#0.8369;FLAVIN#0.8353;ANDROSTENEDIONE#0.8350;BREAST CANCER PATIENTS#0.8337;FRONTAL#0.8336;NITRIC OXIDE#0.8313;ESTROGEN RECEPTOR#0.8293;NEUROTOXICITY#0.8208;NOR-LAAM#0.8182;METOPROLOL#0.8159;NEUROTOXIC#0.8112;VORICONAZOLE#0.8105;HEPATOCELLULAR CARCINOMA#0.8090;DRUG RESISTANCE#0.8028;MUTAGENIC#0.8011;PROTON PUMP INHIBITOR#0.8007;PROTON PUMP#0.7986;DOXORUBICIN#0.7978;REACTIVE OXYGEN SPECIES#0.7926;NICOTINE DEPENDENCE#0.7897;CLARA CELL#0.7889;MINOR ALLELE FREQUENCY#0.7860;HYPERSENSITIVITY#0.7852;VALPROIC ACID#0.7845;72-HOURS#0.7824;CELL DEATH#0.7821;LIVER DISEASE#0.7779;ASPARTATE#0.7776;DIAZEPAM#0.7751;LYMPHOBLAST#0.7693;APOPTOSIS#0.7692;GEOMETRIC MEAN RATIO#0.7671;HYPOXIA#0.7624;LOSARTAN#0.7617;MUTAGENICITY#0.7610;MACROPHAGE#0.7608;NEW CHEMICAL ENTITIES#0.7604;CYTOCHROME C#0.7600;NELFINAVIR#0.7591;ENDOPLASMIC RETICULUM#0.7582;HEPATOMA CELLS#0.7571;MINOR ALLELE FREQUENCIES#0.7508;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7501;DRUG METABOLIC#0.7493;DIGESTION#0.7483;CYTOPLASM#0.7479;PROGESTERONE#0.7473;METROPROLOL#0.7462;MYELOID LEUKEMIA#0.7448;ACETAMINOPHEN#0.7398;ALANINE#0.7385;ITRACONAZOLE#0.7363;TENOFOVIR#0.7301;MECHANISM OF ACTION#0.7276;POPULATION PHARMACOKINETIC MODEL#0.7261;OVARIAN#0.7230;ORGANIC ANION TRANSPORTER#0.7212;RESPIRATORY TRACT#0.7202;VITAMIN D RECEPTOR#0.7201;CALCIUM CHANNEL#0.7193;REPAGLINIDE#0.7185;ACUTE LEUKEMIA#0.7183;RECEPTOR AGONIST#0.7180;DNA BINDING#0.7168;PLATELET AGGREGATION#0.7122;OXYGENASE#0.7119;MEPHOBARBITAL#0.7095;4-HYDROXYTAMOXIFEN#0.7081;STYRENE METABOLISM#0.7064;SUPEROXIDE DISMUTASE#0.7026;DIMETHYL SULFOXIDE#0.7020;NICOTINIC ACETYLCHOLINE RECEPTOR#0.7018;ACETYLCHOLINE RECEPTOR#0.6992;ABC TRANSPORTER#0.6977;PROTEIN BINDING#0.6965;LASER DESORPTION IONIZATION#0.6924;ELECTRON TRANSFER#0.6922;AMINOPYRINE#0.6891;GINKGO BILOBA#0.6839;HEROIN#0.6825;POSITIVE PREDICTIVE VALUE#0.6817;SULFATION#0.6788;LYMPHOBLASTOID CELLS#0.6780;ACUTE MYELOID LEUKEMIA#0.6777;ENDOTHELIAL CELL#0.6758;GENOTOXICITY#0.6723;CNS TOXICITY#0.6711;LUPUS NEPHRITIS#0.6706;HEPATITIS C#0.6677;ATORVASTATIN#0.6669;ADIPOSE TISSUE#0.6662;EPIDERMAL GROWTH FACTOR#0.6655;GINKGO BILOBA EXTRACT#0.6636;CLOFIBRATE#0.6609;BUPRENORPHINE#0.6559;QUERCETIN#0.6543;MUTAGEN#0.6514;VERAPAMIL#0.6511;MULTIPLE LINEAR REGRESSION#0.6447;CARCINOGENICITY#0.6439;6BETA-HYDROXYLASE ACTIVITY#0.6430;HEPATITIS C VIRUS#0.6406;RETINOIC ACID#0.6388;FARNESOID X RECEPTOR#0.6363;B CELL#0.6362;RESPONSE TO DRUG#0.6360;NICARDIPINE#0.6355;PHASE II METABOLISM#0.6286;ANTHRACENE#0.6275;JEJUNUM#0.6273;ENHANCER BINDING PROTEIN#0.6225;ARACHIDONIC ACID#0.6225;FLUCONAZOLE#0.6223;ENHANCER BINDING#0.6220;HIGH FAT DIET#0.6220;MITOGEN ACTIVATED PROTEIN#0.6197;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6190;TUMOR NECROSIS FACTOR#0.6179;MONONUCLEAR CELLS#0.6178;FLUVASTATIN#0.6143;BETA-NF#0.6076;DUODENUM#0.6071;SR-4233#0.6070;RECEPTOR ANTAGONIST#0.6046;ATAZANAVIR#0.6042
1556	CYTOCHROME P450#0.8060;CONSTITUTIVE ANDROSTANE RECEPTOR#0.7492;PHENOBARBITAL#0.7104;DNA SYNTHESIS#0.6412;GENE EXPRESSION#0.6313
1557	CILOSTAZOL#1.0636;PROGUANIL#1.0622;CLOBAZAM#1.0594;ESCITALOPRAM#1.0567;TICLOPIDINE#1.0437;THALIDOMIDE#1.0430;BUFURALOL#1.0393;METHADONE#1.0366;IMIPRAMINE#1.0340;VORICONAZOLE#1.0337;CORONARY HEART DISEASE#1.0332;DEBRISOQUINE#1.0326;CHLORZOXAZONE#1.0317;RENAL TRANSPLANT RECIPIENTS#1.0304;AMITRIPTYLINE#1.0302;RABEPRAZOLE#1.0289;ESOMEPRAZOLE#1.0284;MEPHENYTOIN#1.0284;PHENACETIN#1.0264;N ACETYLTRANSFERASE#1.0262;DIAZEPAM#1.0260;BUPROPION#1.0257;BREAST CANCER PATIENTS#1.0246;CLOPIDOGREL#1.0227;FRAGMENT LENGTH POLYMORPHISM#1.0227;LANSOPRAZOLE#1.0224;FLUVOXAMINE#1.0218;FLUOXETINE#1.0215;RESPONSE TO CLOPIDOGREL#1.0212;METOPROLOL#1.0208;DICLOFENAC#1.0208;TAMOXIFEN#1.0203;LOSARTAN#1.0202;VENLAFAXINE#1.0201;PANTOPRAZOLE#1.0196;NIFEDIPINE#1.0195;LIVER DISEASE#1.0186;NELFINAVIR#1.0185;SPARTEINE#1.0176;SERTRALINE#1.0171;AMODIAQUINE#1.0165;DEXTROMETHORPHAN#1.0155;FLUCONAZOLE#1.0148;TICAGRELOR#1.0144;OMEPRAZOLE#1.0142;ACUTE MYOCARDIAL INFARCTION#1.0136;CITALOPRAM#1.0135;TACROLIMUS#1.0129;CAFFEINE#1.0120;PRASUGREL#1.0119;TOLBUTAMIDE#1.0094;PHENYTOIN#1.0089;HEART DISEASE#1.0079;SULFAPHENAZOLE#1.0074;CLOZAPINE#1.0072;HYDROXYLASE ACTIVITY#1.0062;POINT OF CARE#1.0060;CORONARY ARTERY DISEASE#1.0059;MIDAZOLAM#1.0053;ARTERY DISEASE#1.0046;HIGH RESOLUTION MELTING#1.0045;INVASIVE FUNGAL INFECTION#1.0044;RIFAMPICIN#1.0044;CATALYTIC ACTIVITY#1.0042;POLYMERASE CHAIN REACTION#1.0035;ACID SECRETION#1.0029;DEMETHYLATION#1.0015;CORONARY STENT IMPLANTATION#1.0008;WARFARIN#0.9996;DRUG ELUTING STENT#0.9994;EPILEPSY#0.9983;HIGH PLATELET REACTIVITY#0.9977;PAROXETINE#0.9971;DIABETES MELLITUS#0.9949;CORONARY ARTERY#0.9947;CLARITHROMYCIN#0.9945;CYCLOPHOSPHAMIDE#0.9941;TRANYLCYPROMINE#0.9941;ARACHIDONIC ACID#0.9938;QUINIDINE#0.9931;PERCUTANEOUS CORONARY INTERVENTION#0.9926;ARTERY#0.9923;PHENOBARBITAL#0.9921;THROMBOSIS#0.9915;ITRACONAZOLE#0.9908;TESTOSTERONE#0.9899;ENZYME ACTIVITY#0.9897;TROLEANDOMYCIN#0.9892;GASTROESOPHAGEAL REFLUX DISEASE#0.9886;ESOPHAGITIS#0.9883;BREAST CANCER#0.9871;AMOXICILLIN#0.9864;OXIDATIVE METABOLISM#0.9862;FAMOTIDINE#0.9861;TRANSCRIPTION FACTOR#0.9856;PROTON PUMP INHIBITOR#0.9855;PLATELET AGGREGATION#0.9854;EFAVIRENZ#0.9849;PROTON PUMP#0.9846;ACUTE CORONARY SYNDROME#0.9837;RITONAVIR#0.9834;GASTRIC ACID SECRETION#0.9828;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9810;NORTRIPTYLINE#0.9810;MULTIPLE MYELOMA#0.9802;MYOCARDIAL INFARCTION#0.9800;LEVOFLOXACIN#0.9798;KETOCONAZOLE#0.9788;THERAPEUTIC DRUG MONITORING#0.9785;PERIPHERAL BLOOD#0.9778;SEROTONIN REUPTAKE INHIBITOR#0.9770;PLATELET REACTIVITY INDEX#0.9767;VALPROIC ACID#0.9764;PRIMARY HUMAN HEPATOCYTES#0.9759;DIPHOSPHATE#0.9756;GENE EXPRESSION#0.9749;METRONIDAZOLE#0.9744;ADVERSE DRUG REACTION#0.9742;VITAMIN K#0.9738;ASPIRIN#0.9736;URIDINE#0.9734;HYPERTENSION#0.9719;ENDOMETRIOSIS#0.9717;PACLITAXEL#0.9712;DAPSONE#0.9709;DRUG METABOLISM#0.9690;PROGESTERONE#0.9688;EXCRETION#0.9683;MICROSOME#0.9682;DESIPRAMINE#0.9673;HEPATOTOXICITY#0.9672;GLUTATHIONE#0.9672;GASTRIC ULCER#0.9664;DRUG RESISTANCE#0.9663;CARBAMAZEPINE#0.9662;ADENOSINE#0.9649;HIGH RISK PATIENTS#0.9637;ST. JOHN'S WORT#0.9633;CYTOCHROME P450#0.9621;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9616;RECEPTOR ANTAGONIST#0.9612;PROTEIN BINDING#0.9600;TOXICITY#0.9589;VASODILATOR#0.9585;SMALL INTESTINE#0.9560;HEPATOCELLULAR CARCINOMA#0.9554;INTENTION TO TREAT#0.9552;PROPRANOLOL#0.9544;GASTRITIS#0.9544;MOCLOBEMIDE#0.9542;ERYTHROMYCIN#0.9537;PREGNANE X RECEPTOR#0.9518;CEREBROVASCULAR DISEASE#0.9515;MULTIPLE LOGISTIC REGRESSION#0.9506;STEM CELL#0.9500;MAJOR DEPRESSIVE DISORDER#0.9483;PEPTIC ULCER DISEASE#0.9466;TYPE 2 DIABETES#0.9464;GEOMETRIC MEAN RATIO#0.9458;DETOXIFICATION#0.9433;LIGHT TRANSMITTANCE AGGREGOMETRY#0.9427;CLOMIPRAMINE#0.9417;XENOBIOTIC METABOLISM#0.9410;LUNG CANCER#0.9401;CYTOCHROME P450 ACTIVITY#0.9360;P-NITROPHENOL#0.9343;THEOPHYLLINE#0.9337;TRANSIENT ISCHEMIC ATTACK#0.9272;ESTROGEN RECEPTOR#0.9262;RIFAMPIN#0.9248;DUODENAL ULCER#0.9245;CARISOPRODOL#0.9243;DEMETHYLASE ACTIVITY#0.9241;CIMETIDINE#0.9230;SIMVASTATIN#0.9213;CONJUGATION#0.9193;ACENOCOUMAROL#0.9148;ROSUVASTATIN#0.9112;DEBRISOQUIN#0.9109;COUMARIN 7 HYDROXYLASE#0.9099;MAXIMAL PLATELET AGGREGATION#0.9098;REVERSE TRANSCRIPTION#0.9096;SQUAMOUS CELL CARCINOMA#0.9093;PLASMA PROTEIN#0.9075;FLAVIN CONTAINING MONOOXYGENASE#0.9057;NARROW THERAPEUTIC INDEX#0.9057;MALARIA#0.9048;CYTOCHROME B5#0.9006;NEW CHEMICAL ENTITIES#0.8992;HARDY WEINBERG EQUILIBRIUM#0.8968;AXITINIB#0.8952;CORTISOL#0.8923;CARCINOGEN#0.8917;NERVOUS SYSTEM#0.8898;ASPERGILLOSIS#0.8894;SIBUTRAMINE#0.8889;FLAVIN#0.8876;TRANSCRIPTASE#0.8872;REVERSE TRANSCRIPTASE INHIBITOR#0.8866;LEUKOCYTE#0.8846;SULPHAPHENAZOLE#0.8837;MUTAGENESIS#0.8824;DIGOXIN#0.8819;ISONIAZID#0.8804;BORTEZOMIB#0.8804;RANDOMIZED CONTROLLED TRIAL#0.8804;GASTRO#0.8776;MULTIPLE REGRESSION ANALYSIS#0.8774;MELATONIN#0.8720;ATRIAL FIBRILLATION#0.8711;ALPRAZOLAM#0.8694;HUMAN IMMUNODEFICIENCY VIRUS#0.8675;DIGESTION#0.8637;LYMPHOBLASTOID CELLS#0.8634;EPOXIDE HYDROLASE#0.8617;GROWTH FACTOR#0.8590;ACETAMINOPHEN#0.8590;GINKGO BILOBA#0.8588;STEM CELL TRANSPLANTATION#0.8568;TRIAZOLAM#0.8566;LIGHT TRANSMISSION AGGREGOMETRY#0.8556;ATP BINDING CASSETTE#0.8555;STRUCTURE ACTIVITY RELATIONSHIP#0.8546;INVASIVE ASPERGILLOSIS#0.8542;ATP BINDING#0.8540;HEMATOPOIETIC STEM CELL#0.8532;DRAVET SYNDROME#0.8501;CENTRAL NERVOUS SYSTEM#0.8491;LYMPHOBLAST#0.8488;PLATELET ACTIVATION#0.8471;XANTHINE OXIDASE#0.8458;INTERNATIONAL NORMALIZED RATIO#0.8455;ESTRADIOL#0.8443;ETHANOL#0.8424;SELEGILINE#0.8419;DEXAMETHASONE#0.8409;POPULATION PHARMACOKINETIC MODEL#0.8402;CARDIOVASCULAR RISK FACTOR#0.8398;QUERCETIN#0.8379;ADJUSTED HAZARD RATIO#0.8363;VENOUS BLOOD#0.8347;O-DESMETHYLVENLAFAXINE#0.8312;4-HYDROXYTAMOXIFEN#0.8307;RHEUMATOID ARTHRITIS#0.8303;AMINOPYRINE#0.8282;C REACTIVE PROTEIN#0.8256;XENOBIOTIC METABOLIZING ENZYME#0.8229;LUPUS ERYTHEMATOSUS#0.8161;RISPERIDONE#0.8160;RESPONSE TO DRUG#0.8154;FLUNITRAZEPAM#0.8114;CODEINE#0.8108;MULTIDRUG RESISTANCE PROTEIN#0.8089;CYCLOSPORINE#0.8084;RESPONSE TO TREATMENT#0.8069;CYTOTOXICITY#0.8068;RECEPTOR AGONIST#0.8064;LINEAR REGRESSION ANALYSIS#0.8045;ENDOTHELIAL CELL#0.7983;HEMORRHAGIC#0.7974;DRUG METABOLIC#0.7956;SOLID PHASE EXTRACTION#0.7931;GLUCOCORTICOID RECEPTOR#0.7895;DYSPEPSIA#0.7882;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7877;VERAPAMIL#0.7866;GLICLAZIDE#0.7834;COLORECTAL#0.7803;DEPRESSIVE SYMPTOMS#0.7802;SELECTIN#0.7798;ACUTE ISCHEMIC STROKE#0.7788;ENZYME INHIBITOR#0.7785;OBESE#0.7763;RANDOMIZED CLINICAL TRIAL#0.7759;LORATADINE#0.7749;ADJUSTED ODDS RATIO#0.7749;THIORIDAZINE#0.7730;LOW DOSE ASPIRIN#0.7723;IBUPROFEN#0.7708;LIVER CIRRHOSIS#0.7704;MONTE CARLO SIMULATION#0.7677;QUININE#0.7669;ADVERSE CLINICAL OUTCOME#0.7648;FELBAMATE#0.7630;DIARRHEA#0.7629;COPY NUMBER VARIATION#0.7606;HYPOXIA#0.7583;HEPATITIS B#0.7582;FLURBIPROFEN#0.7566;MEPHOBARBITAL#0.7561;ADENINE#0.7547;INFLAMMATORY RESPONSE#0.7540;STANDARD OF CARE#0.7522;ATORVASTATIN#0.7516;PHASE II METABOLISM#0.7493;INTRACRANIAL ANEURYSM#0.7479;REPAGLINIDE#0.7462;MICONAZOLE#0.7442;SERIOUS ADVERSE EVENT#0.7440;BETA-NAPHTHOFLAVONE#0.7434;PROSTATE CANCER#0.7430;NEUTROPENIA#0.7404;BLOOD BRAIN BARRIER#0.7391;BISMUTH#0.7390;MECHANISM OF ACTION#0.7378;QUANTITATIVE REAL TIME#0.7371;OVARIAN#0.7367;OXCARBAZEPINE#0.7366;CHRONIC KIDNEY DISEASE#0.7346;ANTI INFLAMMATORY DRUGS#0.7341;CYTOCHROME B#0.7338;SULFATION#0.7335;KIDNEY DISEASE#0.7331;DRUG TRANSPORT#0.7281;IRINOTECAN#0.7275;LEFLUNOMIDE#0.7217;DOPAMINE#0.7215;TRADITIONAL CHINESE MEDICINE#0.7208;CEREBRAL INFARCTION#0.7194;HISTAMINE#0.7190;CHRONIC LIVER DISEASE#0.7190;ESOPHAGUS#0.7187;CALCIUM CHANNEL#0.7181;HEPATITIS B VIRUS#0.7162;LIMIT OF QUANTIFICATION#0.7153;TUMOR NECROSIS FACTOR#0.7116;XANTHINE#0.7091;ANXIETY DISORDER#0.7086;CYTOCHROME C#0.7080;LINEAR MIXED EFFECTS#0.7075;GLYBURIDE#0.7066;ARTEMETHER#0.7059;QUAZEPAM#0.7038;MODAFINIL#0.7036;LUPUS NEPHRITIS#0.7019;INTESTINAL ABSORPTION#0.6996;CELL CYCLE#0.6992;CARRIE#0.6971;MULTIPLE LINEAR REGRESSION#0.6965;CATABOLISM#0.6925;PARKINSON'S DISEASE#0.6914;MOLAR#0.6912;CAROTID ARTERY STENTING#0.6909;METROPROLOL#0.6908;BLOOD STASIS SYNDROME#0.6907;ESTROGEN CATABOLISM#0.6893;ATOMOXETINE#0.6843;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6819;KINASE INHIBITOR#0.6815;IL-1RN#0.6813;LIGASE DETECTION REACTION#0.6807;VALPROATE#0.6790;METHADONE MAINTENANCE TREATMENT#0.6786;MIRTAZAPINE#0.6782;TERBINAFINE#0.6781;MELTING CURVE ANALYSIS#0.6780;ESSENTIAL TREMOR#0.6775;ATAZANAVIR#0.6770;ACETYLSALICYLIC ACID#0.6752;WEIGHT GAIN#0.6749;GASTRO ESOPHAGEAL REFLUX#0.6744;5-MEO-DIPT#0.6730;DOXEPIN#0.6722;PSORIASIS#0.6698;FORMIC ACID#0.6664;ASTEMIZOLE#0.6646;COLORECTAL CANCER#0.6640;SICKLE CELL DISEASE#0.6627;ISCHEMIA#0.6625;TYPE 2 DIABETES MELLITUS#0.6615;2 DIABETES MELLITUS#0.6614;TOPIRAMATE#0.6609;GEMFIBROZIL#0.6593;UPPER GASTROINTESTINAL BLEEDING#0.6588;ADENINE DINUCLEOTIDE PHOSPHATE#0.6559;PARACETAMOL#0.6552;CAROTID ARTERY#0.6549;ALANINE#0.6544;S METHYLTRANSFERASE#0.6532;MIPOMERSEN SODIUM#0.6528;CELECOXIB#0.6518;5 FLUOROURACIL#0.6502;RISK OF DEATH#0.6479;ALZHEIMER'S DISEASE#0.6475;ENTEROCYTE#0.6439;HUMAN PRIMARY HEPATOCYTES#0.6402;MONTELUKAST#0.6386;ISOQUINOLINE ALKALOID#0.6384;TUBERCULOSIS#0.6381;AMIODARONE#0.6373;HEPATITIS C#0.6369;GROWTH FACTOR RECEPTOR#0.6345;LOW DENSITY LIPOPROTEIN#0.6342;ROFLUMILAST#0.6341;THIOPURINE S METHYLTRANSFERASE#0.6321;OBSESSIVE COMPULSIVE DISORDER#0.6318;DESOGESTREL#0.6316;PIOGLITAZONE#0.6302;ORGANIC ANION TRANSPORTER#0.6291;NICOTINAMIDE#0.6280;HYPERFORIN#0.6252;ZOLPIDEM#0.6247;ISCHEMIC HEART DISEASE#0.6247;NEPHRITIS#0.6235;HEXOBARBITAL#0.6220;CANCER CELL#0.6216;TERFENADINE#0.6209;ASPARTATE#0.6177;ENDOTHELIAL GROWTH FACTOR#0.6173;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6173;DISEASE FREE SURVIVAL#0.6160;APOPTOSIS#0.6141;NEFAZODONE#0.6141;BLOOD PLATELET AGGREGATION#0.6109;FLUOROURACIL#0.6073;HALOPERIDOL#0.6070;GLIBENCLAMIDE#0.6068;CHLORAMPHENICOL#0.6052;HIV PROTEASE INHIBITOR#0.6023;OSPEMIFENE#0.6013
1558	PACLITAXEL METABOLISM#1.0768;MONTELUKAST#1.0764;IBUPROFEN#1.0657;AMODIAQUINE#1.0645;PIOGLITAZONE#1.0625;CLOPIDOGREL#1.0587;TRIMETHOPRIM#1.0580;REPAGLINIDE#1.0565;ROSIGLITAZONE#1.0562;GEMFIBROZIL#1.0529;CHLORZOXAZONE#1.0514;CERIVASTATIN#1.0449;BUPROPION#1.0440;DEXTROMETHORPHAN#1.0414;QUERCETIN#1.0381;PACLITAXEL#1.0349;IMATINIB#1.0344;DICLOFENAC#1.0320;MEPHENYTOIN#1.0277;PHENACETIN#1.0222;DEMETHYLATION#1.0196;TOLBUTAMIDE#1.0149;MIDAZOLAM#1.0143;HYDROXYLASE ACTIVITY#1.0137;POLYMERASE CHAIN REACTION#1.0127;OMEPRAZOLE#1.0115;RETINOIC ACID#1.0101;SULFAPHENAZOLE#1.0101;RIFAMPICIN#1.0081;KETOCONAZOLE#0.9957;OXIDATIVE METABOLISM#0.9945;FLUVASTATIN#0.9933;TESTOSTERONE#0.9928;ARACHIDONIC ACID#0.9917;ENZYME ACTIVITY#0.9848;EPOXIDE HYDROLASE#0.9810;PREGNANE X RECEPTOR#0.9807;DRUG METABOLISM#0.9768;MICROSOME#0.9766;BREAST CANCER#0.9710;GENE EXPRESSION#0.9704;TOXICITY#0.9694;TYPE 2 DIABETES#0.9673;ITRACONAZOLE#0.9670;BUFURALOL#0.9661;CYTOCHROME P450#0.9622;WARFARIN#0.9598;OVARIAN CANCER#0.9589;RIFAMPIN#0.9555;QUINIDINE#0.9526;EXCRETION#0.9491;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9484;TROLEANDOMYCIN#0.9481;KINASE INHIBITOR#0.9424;ENDOTHELIAL CELL#0.9381;CATALYTIC ACTIVITY#0.9356;AMIODARONE#0.9268;LOSARTAN#0.9228;PHENOBARBITAL#0.9228;PRIMARY HUMAN HEPATOCYTES#0.9220;RECEPTOR ANTAGONIST#0.9141;MALARIA#0.8986;FRAGMENT LENGTH POLYMORPHISM#0.8958;SOLUBLE EPOXIDE HYDROLASE#0.8942;CAFFEINE#0.8898;HYPERTENSION#0.8874;TAXOL#0.8860;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8813;TROGLITAZONE#0.8811;MULTIPLE MYELOMA#0.8807;DIABETES MELLITUS#0.8804;OVARIAN#0.8803;BREAST CANCER PATIENTS#0.8707;CYTOCHROME B5#0.8703;SIMVASTATIN#0.8620;VERAPAMIL#0.8598;MYOCARDIAL INFARCTION#0.8586;PROSTATE CANCER#0.8357;TACROLIMUS#0.8291;RENAL TRANSPLANT RECIPIENTS#0.8264;GEOMETRIC MEAN RATIO#0.8176;GLUCOCORTICOID RECEPTOR#0.8163;CHLOROQUINE#0.8154;ALL TRANS RETINOIC ACID#0.8146;ATORVASTATIN#0.8137;REVERSE TRANSCRIPTION#0.8076;TAMOXIFEN#0.8068;NIFEDIPINE#0.8027;NEUROPATHY#0.7966;HEPATOCELLULAR CARCINOMA#0.7929;CORONARY ARTERY#0.7886;NEUROTOXICITY#0.7827;URIDINE#0.7822;COUMARIN 7 HYDROXYLASE#0.7658;PLASMA PROTEIN#0.7658;TYPE 2 DIABETES MELLITUS#0.7649;2 DIABETES MELLITUS#0.7649;DABRAFENIB#0.7648;HEPATOTOXICITY#0.7642;ATP BINDING CASSETTE#0.7585;ATP BINDING#0.7569;OSTEONECROSIS#0.7536;ESTRADIOL#0.7432;GLUTATHIONE#0.7416;DESLORATADINE#0.7412;ROSUVASTATIN#0.7403;CYCLOPHOSPHAMIDE#0.7379;AMINOPYRINE#0.7336;ERYTHROMYCIN#0.7281;EFAVIRENZ#0.7257;CARBAMAZEPINE#0.7243;ADVERSE DRUG REACTION#0.7181;PEROXISOME#0.7143;ETHANOL#0.7118;ARTERY#0.7084;NARROW THERAPEUTIC INDEX#0.7029;DEXAMETHASONE#0.7027;PROTEIN BINDING#0.7002;REACTIVE OXYGEN SPECIES#0.6958;LOVASTATIN#0.6927;DOCETAXEL#0.6888;ENZALUTAMIDE#0.6877;5-MEO-DIPT#0.6846;RITONAVIR#0.6845;XENOBIOTIC METABOLISM#0.6832;SMALL INTESTINE#0.6826;ISONIAZID#0.6817;PRAVASTATIN#0.6724;FLAVIN CONTAINING MONOOXYGENASE#0.6715;ANTI INFLAMMATORY DRUGS#0.6711;ZOPICLONE#0.6709;DEMETHYLASE ACTIVITY#0.6689;EVEROLIMUS#0.6678;KIDNEY DISEASE#0.6653;DIAZEPAM#0.6597;LEUKOTRIENE RECEPTOR#0.6586;METHADONE#0.6553;ZAFIRLUKAST#0.6542;TRIAZOLAM#0.6509;DETOXIFICATION#0.6451;DNA REPAIR#0.6436;GLYBURIDE#0.6422;APOPTOSIS#0.6377;FLAVIN#0.6362;CARBOPLATIN#0.6361;ABIRATERONE#0.6342;LUNG CANCER#0.6295;FETAL LIVER#0.6282;GLUCURONIC ACID#0.6251;TRANSCRIPTION FACTOR#0.6211;CELL PROLIFERATION#0.6167;COENZYME A#0.6129;ENDOPLASMIC RETICULUM#0.6124;ETHINYL ESTRADIOL#0.6112;FLUCONAZOLE#0.6043;RECURRENCE FREE SURVIVAL#0.6039;NILOTINIB#0.6039;ELECTRON TRANSFER#0.6024;LYMPHOBLASTOID CELLS#0.6024
1559	LORNOXICAM#1.0872;TIENILIC ACID#1.0851;SULPHAPHENAZOLE#1.0622;DAPSONE#1.0542;FLUVASTATIN#1.0497;PHENPROCOUMON#1.0477;NAPROXEN#1.0455;FLURBIPROFEN#1.0454;GLIMEPIRIDE#1.0454;BOSENTAN#1.0445;CELECOXIB#1.0426;ACENOCOUMAROL#1.0411;FLUOXETINE#1.0372;LOSARTAN#1.0371;VORICONAZOLE#1.0356;NATEGLINIDE#1.0323;GLYBURIDE#1.0310;BUFURALOL#1.0309;SULFAPHENAZOLE#1.0307;AMIODARONE#1.0289;IBUPROFEN#1.0277;DICLOFENAC#1.0275;VALPROIC ACID#1.0261;FLUCONAZOLE#1.0256;TOLBUTAMIDE#1.0226;IRBESARTAN#1.0225;PHENYTOIN#1.0223;ROSUVASTATIN#1.0208;PHENACETIN#1.0208;BUPROPION#1.0192;CHLORZOXAZONE#1.0190;BODY SURFACE AREA#1.0186;N ACETYLTRANSFERASE#1.0185;DEXTROMETHORPHAN#1.0182;FRAGMENT LENGTH POLYMORPHISM#1.0181;WARFARIN#1.0181;ANTI INFLAMMATORY DRUGS#1.0176;AMODIAQUINE#1.0172;GLICLAZIDE#1.0165;GLIBENCLAMIDE#1.0160;MEPHENYTOIN#1.0154;METOPROLOL#1.0152;GLIPIZIDE#1.0150;COLORECTAL CANCER#1.0118;TAMOXIFEN#1.0118;COLORECTAL#1.0116;CAFFEINE#1.0110;STRUCTURE ACTIVITY RELATIONSHIP#1.0099;FLUVOXAMINE#1.0094;MULTIPLE LINEAR REGRESSION#1.0089;ENDOTHELIAL CELL#1.0088;CONSTITUTIVE ANDROSTANE RECEPTOR#1.0084;ITRACONAZOLE#1.0075;VITAMIN K#1.0073;EPILEPSY#1.0066;SERUM ALBUMIN#1.0056;PACLITAXEL#1.0051;MIDAZOLAM#1.0047;OMEPRAZOLE#1.0046;CLOPIDOGREL#1.0044;NIFEDIPINE#1.0034;DIAZEPAM#1.0026;RIFAMPICIN#1.0021;RIFAMPIN#1.0017;QUINIDINE#1.0010;CATALYTIC ACTIVITY#0.9997;TICLOPIDINE#0.9996;ASPIRIN#0.9993;DEBRISOQUINE#0.9987;SERTRALINE#0.9977;EPOXIDE HYDROLASE#0.9976;MULTIPLE REGRESSION ANALYSIS#0.9972;QUERCETIN#0.9967;RITONAVIR#0.9964;TROLEANDOMYCIN#0.9961;DEMETHYLATION#0.9961;VITAMIN K ANTAGONIST#0.9950;POLYMERASE CHAIN REACTION#0.9932;HEMORRHAGE#0.9930;SIMVASTATIN#0.9925;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9923;PRIMARY HUMAN HEPATOCYTES#0.9915;ARACHIDONIC ACID#0.9907;SMALL INTESTINE#0.9888;PREGNANE X RECEPTOR#0.9885;ENZYME ACTIVITY#0.9879;PHENOBARBITAL#0.9870;TESTOSTERONE#0.9866;ERYTHROMYCIN#0.9856;KETOCONAZOLE#0.9854;OXIDATIVE METABOLISM#0.9848;HYDROXYLASE ACTIVITY#0.9838;NARROW THERAPEUTIC INDEX#0.9821;URIDINE#0.9815;GEMFIBROZIL#0.9812;METHADONE#0.9810;XENOBIOTIC METABOLISM#0.9802;TYPE 2 DIABETES#0.9798;ATORVASTATIN#0.9787;LYMPHOBLASTOID CELLS#0.9783;CYCLOPHOSPHAMIDE#0.9781;CONJUGATION#0.9779;ATRIAL FIBRILLATION#0.9771;P-NITROPHENOL#0.9766;MUTAGENESIS#0.9765;HEART DISEASE#0.9759;MYOCARDIAL INFARCTION#0.9754;LINEAR REGRESSION ANALYSIS#0.9751;THROMBOSIS#0.9744;DIABETES MELLITUS#0.9743;DEMETHYLASE ACTIVITY#0.9720;HEPATOTOXICITY#0.9720;RECEPTOR ANTAGONIST#0.9718;MICROSOME#0.9714;BREAST CANCER#0.9712;EXCRETION#0.9708;CARCINOGEN#0.9706;ADVERSE DRUG REACTION#0.9701;THEOPHYLLINE#0.9701;GLUCOCORTICOID RECEPTOR#0.9700;CARBAMAZEPINE#0.9696;DIPHOSPHATE#0.9686;GLUTATHIONE#0.9684;ETHANOL#0.9683;TRANSCRIPTION FACTOR#0.9682;GENE EXPRESSION#0.9675;ROSIGLITAZONE#0.9666;INTERNATIONAL NORMALIZED RATIO#0.9665;PROGESTERONE#0.9653;DRUG METABOLISM#0.9652;GEOMETRIC MEAN RATIO#0.9625;CYTOCHROME P450#0.9617;HYPOXIA#0.9611;HYPERTENSION#0.9600;S-FLURBIPROFEN#0.9599;MELOXICAM#0.9599;BREAST CANCER PATIENTS#0.9596;CYTOCHROME P450 ACTIVITY#0.9590;ACETAMINOPHEN#0.9587;COUMARINS#0.9560;DEXAMETHASONE#0.9549;PROTEIN BINDING#0.9544;PIOGLITAZONE#0.9538;APREPITANT#0.9537;TOXICITY#0.9532;TYPE 2 DIABETES MELLITUS#0.9509;2 DIABETES MELLITUS#0.9509;REVERSE TRANSCRIPTION#0.9506;LANSOPRAZOLE#0.9467;TRANSCRIPTASE#0.9466;PROTON PUMP#0.9458;ST. JOHN'S WORT#0.9452;DETOXIFICATION#0.9428;HYPERSENSITIVITY#0.9423;PLASMA PROTEIN#0.9419;VERAPAMIL#0.9417;CYTOTOXICITY#0.9409;MICONAZOLE#0.9388;LIVER DISEASE#0.9382;PROTON PUMP INHIBITOR#0.9379;GAMMA GLUTAMYL CARBOXYLASE#0.9375;LUNG CANCER#0.9373;TRIAZOLAM#0.9370;PIROXICAM#0.9369;DRUG RESISTANCE#0.9365;GINKGO BILOBA#0.9355;DIGOXIN#0.9342;ESTROGEN RECEPTOR#0.9336;SEROTONIN REUPTAKE INHIBITOR#0.9333;LOVASTATIN#0.9327;THERAPEUTIC DRUG MONITORING#0.9310;ARTERY#0.9299;CARVEDILOL#0.9296;XENOBIOTIC METABOLIZING ENZYME#0.9289;MOLECULAR DYNAMICS SIMULATION#0.9284;PAROXETINE#0.9281;ZAFIRLUKAST#0.9252;EFAVIRENZ#0.9240;COAGULATION#0.9232;BETA-NAPHTHOFLAVONE#0.9214;REPAGLINIDE#0.9204;DRUG METABOLIC#0.9202;PROPOFOL#0.9174;INDOMETHACIN#0.9166;ENDOTHELIUM#0.9154;PITAVASTATIN#0.9141;CORONARY ARTERY#0.9132;HARDY WEINBERG EQUILIBRIUM#0.9130;PRAVASTATIN#0.9118;HEMORRHAGIC#0.9086;CYTOCHROME B5#0.9077;REVERSE TRANSCRIPTASE INHIBITOR#0.9072;ESTRADIOL#0.9066;XANTHINE OXIDASE#0.9019;COLORECTAL ADENOMA#0.8998;HEPATOCYTE NUCLEAR FACTOR#0.8995;LYMPHOBLAST#0.8977;MYRICETIN#0.8946;HYPOGLYCEMIA#0.8935;ANGIOGENESIS#0.8928;NITRIC OXIDE#0.8924;MONTELUKAST#0.8921;COUMARIN 7 HYDROXYLASE#0.8912;TRANYLCYPROMINE#0.8908;TETRAHYDROCANNABINOL#0.8844;NEW CHEMICAL ENTITIES#0.8819;POLYCYCLIC AROMATIC HYDROCARBON#0.8815;SOLUBLE EPOXIDE HYDROLASE#0.8815;PLATELET AGGREGATION#0.8761;GROWTH FACTOR#0.8758;FLAVIN#0.8677;TRADITIONAL CHINESE MEDICINE#0.8660;ENTEROCYTE#0.8626;PULMONARY EMBOLISM#0.8608;RHEUMATOID ARTHRITIS#0.8605;TYPE 2 DIABETIC#0.8576;RANDOMIZED CONTROLLED TRIAL#0.8574;ADJUSTED ODDS RATIO#0.8573;TROGLITAZONE#0.8569;DIGESTION#0.8568;HEPATOCELLULAR CARCINOMA#0.8565;VALPROATE#0.8563;GINSENG#0.8540;TERFENADINE#0.8535;ANTICOAGULANT ACTIVITY#0.8516;PARACETAMOL#0.8512;PERIPHERAL BLOOD#0.8509;CALCIUM CHANNEL#0.8508;MULTIDRUG RESISTANCE PROTEIN#0.8497;KINASE INHIBITOR#0.8497;FETAL LIVER#0.8486;ACUTE CORONARY SYNDROME#0.8464;PHASE II METABOLISM#0.8464;HYPERFORIN#0.8436;RESPONSE TO DRUG#0.8433;CLOZAPINE#0.8427;CODEINE#0.8388;CELL PROLIFERATION#0.8367;ANILINE#0.8337;4-HYDROXYTAMOXIFEN#0.8327;FLAVIN CONTAINING MONOOXYGENASE#0.8311;EMBOLISM#0.8276;TACROLIMUS#0.8275;CYCLOSPORINE#0.8263;HIGH RESOLUTION MELTING#0.8228;TORASEMIDE#0.8200;CYTOCHROME B#0.8188;CORONARY ARTERY DISEASE#0.8178;ARTERY DISEASE#0.8176;NICOTINAMIDE#0.8161;HEPATITIS C#0.8148;XANTHINE#0.8125;IFOSFAMIDE#0.8108;COENZYME A#0.8104;MAJOR DEPRESSIVE DISORDER#0.8096;ARACHIDONIC ACID EPOXYGENASE#0.8071;ARYL HYDROCARBON RECEPTOR#0.8049;CLOTTING#0.8048;KIDNEY DISEASE#0.8021;HUMAN IMMUNODEFICIENCY VIRUS#0.8019;VALSARTAN#0.7992;KETAMINE#0.7991;ISONIAZID#0.7969;FACTOR V LEIDEN#0.7963;VENLAFAXINE#0.7943;CITALOPRAM#0.7927;THIOPURINE S METHYLTRANSFERASE#0.7925;PRASUGREL#0.7923;LEUKOCYTE#0.7919;RETINOIC ACID#0.7915;TELMISARTAN#0.7913;S METHYLTRANSFERASE#0.7898;DRUG TRANSPORT#0.7791;SULFAMETHOXAZOLE#0.7788;TUBE FORMATION#0.7777;NICARDIPINE#0.7773;METFORMIN#0.7752;REACTIVE OXYGEN SPECIES#0.7734;OXYGENASE#0.7732;ELECTRON TRANSFER#0.7717;MOLAR#0.7702;SULFONAMIDE#0.7699;IRINOTECAN#0.7685;FEXOFENADINE#0.7681;PROTEIN KINASE#0.7650;SILDENAFIL#0.7612;CLARITHROMYCIN#0.7588;QUANTITATIVE REAL TIME#0.7572;PROSTATE CANCER#0.7568;HEPATOMA CELLS#0.7548;TUMOR CELLS#0.7532;OPIOID RECEPTOR#0.7532;PROTEIN PROTEIN INTERACTION#0.7519;HUMAN SERUM ALBUMIN#0.7502;EPITHELIAL CELL#0.7473;CYCLOSPORIN#0.7462;ARACHIDONIC ACID METABOLISM#0.7459;LOW DENSITY LIPOPROTEIN#0.7445;STEM CELL#0.7432;SPARTEINE#0.7429;DESIPRAMINE#0.7418;URIC ACID#0.7417;ATHEROSCLEROSIS#0.7416;TRIMETHOPRIM#0.7410;AMITRIPTYLINE#0.7390;LIMIT OF QUANTIFICATION#0.7385;CANDESARTAN#0.7379;APOPTOSIS#0.7336;CERIVASTATIN#0.7324;HIV PROTEASE INHIBITOR#0.7322;IMIPRAMINE#0.7310;PHENOBARBITONE#0.7307;MELATONIN#0.7302;OF ANTICOAGULATION THERAPY#0.7288;ALDEHYDE OXIDASE#0.7279;PROPRANOLOL#0.7252;VASCULAR DISEASE#0.7249;METROPROLOL#0.7243;TUBERCULOSIS#0.7225;RESVERATROL#0.7218;HYPOXIC#0.7202;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7199;ALL TRANS RETINOIC ACID#0.7196;CONGESTIVE HEART FAILURE#0.7195;VITAMIN D RECEPTOR#0.7176;RECEPTOR AGONIST#0.7159;GLOMERULAR FILTRATION#0.7158;MECHANISM OF ACTION#0.7157;ADENINE#0.7156;SICKLE CELL DISEASE#0.7155;RANDOMIZED CLINICAL TRIAL#0.7132;MULTIVARIATE LINEAR REGRESSION#0.7129;TENOXICAM#0.7122;NELFINAVIR#0.7107;QUININE#0.7069;ALPRAZOLAM#0.7054;ETHINYL ESTRADIOL#0.7049;MELTING CURVE ANALYSIS#0.7015;FENOFIBRATE#0.7008;ORPHENADRINE#0.6987;ADENINE DINUCLEOTIDE PHOSPHATE#0.6978;ESSENTIAL HYPERTENSION#0.6973;LUCIFERASE ACTIVITY#0.6962;ATP BINDING CASSETTE#0.6942;MODE OF ACTION#0.6941;ATP BINDING#0.6927;TRANSACTIVATION#0.6910;CELL MEMBRANE#0.6906;REPORTER GENE ASSAY#0.6905;SERIOUS ADVERSE EVENT#0.6885;HEPATIC NUCLEAR FACTOR#0.6883;GESTODENE#0.6882;HUMAN PRIMARY HEPATOCYTES#0.6871;CIPROFLOXACIN#0.6846;CAPECITABINE#0.6845;GASTROINTESTINAL TRACT#0.6845;4-METHYLPYRAZOLE#0.6844;MYOPATHY#0.6843;COLCHICINE#0.6830;PERCUTANEOUS CORONARY INTERVENTION#0.6827;BLOOD GLUCOSE LEVEL#0.6810;UPPER GASTROINTESTINAL BLEEDING#0.6810;CELL DEATH#0.6810;ANGIOTENSIN RECEPTOR#0.6802;SULFATION#0.6768;ALZHEIMER'S DISEASE#0.6752;ARGININE#0.6750;LOPINAVIR#0.6749;ESTRONE#0.6744;CELL CYCLE#0.6737;TUMOR NECROSIS FACTOR#0.6737;ADVERSE DRUG EVENT#0.6731;SIGNALING PATHWAY#0.6730;5-MEO-DIPT#0.6729;TRIACETYLOLEANDOMYCIN#0.6716;STANDARD OF CARE#0.6704;LIVER CIRRHOSIS#0.6688;ENZYME INHIBITOR#0.6676;CHRONIC KIDNEY DISEASE#0.6663;LASER DESORPTION IONIZATION#0.6657;PEROXISOME#0.6641;IMMUNE RESPONSE#0.6619;COUMADIN#0.6617;SQUAMOUS CELL CARCINOMA#0.6589;ACETYLSALICYLIC ACID#0.6579;QUAZEPAM#0.6552;CLOTRIMAZOLE#0.6549;OBESE#0.6548;FLUOROURACIL#0.6546;CYCLOSPORIN A#0.6537;NERVOUS SYSTEM#0.6527;MIPOMERSEN SODIUM#0.6527;RESPONSE TO TREATMENT#0.6510;HEPATITIS C VIRUS#0.6506;MEAN ABSOLUTE ERROR#0.6494;ASPARTATE#0.6473;GLUCURONIC ACID#0.6471;MESTRANOL#0.6470;SMOOTH MUSCLE#0.6468;BONE MARROW#0.6463;CANCER CELL#0.6450;SOLID PHASE EXTRACTION#0.6449;THIORIDAZINE#0.6447;NEUTROPENIA#0.6443;HALOPERIDOL#0.6423;AGOMELATINE#0.6421;CIMETIDINE#0.6418;HIGH FAT DIET#0.6416;VOMITING#0.6404;GLOMERULAR FILTRATION RATE#0.6382;FORMIC ACID#0.6363;ASTEMIZOLE#0.6334;ACYL GLUCURONIDATION#0.6326;RESPONSE TO CLOPIDOGREL#0.6290;VASODILATION#0.6282;RUXOLITINIB#0.6275;DOXORUBICIN#0.6255;ENZALUTAMIDE#0.6255;MINOR ALLELE FREQUENCIES#0.6249;CENTRAL NERVOUS SYSTEM#0.6237;DUODENUM#0.6219;5 FLUOROURACIL#0.6203;ORAL ANTICOAGULATION THERAPY#0.6203;ALDOSTERONE#0.6152;NAPHTHALENE METABOLISM#0.6149;DIMETHYL SULFOXIDE#0.6147;CELL MIGRATION#0.6129;EMBRYONIC KIDNEY#0.6120;MERCAPTOPURINE#0.6116;BERBERINE#0.6106;POTASSIUM CHANNEL#0.6087;ACETIC ACID#0.6082;VENOUS BLOOD#0.6079;POPULATION PHARMACOKINETIC MODEL#0.6070;TYROSINE KINASE INHIBITOR#0.6053;C REACTIVE PROTEIN#0.6049;SR-4233#0.6030;INFLAMMATORY RESPONSE#0.6025;ABACAVIR#0.6024;OSPEMIFENE#0.6012;CORTISOL#0.6006;NALTREXONE HYDROCHLORIDE#0.6005
155	BETA3 ADRENERGIC RECEPTOR#1.0629;TYPE 2 DIABETES#1.0308;FAT CELL#1.0249;ADRENERGIC RECEPTOR#1.0231;DIABETES MELLITUS#1.0200;CYCLIC AMP#1.0169;LIPOLYSIS#1.0155;SMOOTH MUSCLE#1.0117;BROWN ADIPOSE TISSUE#1.0112;POLYMERASE CHAIN REACTION#1.0110;WEIGHT LOSS#1.0099;BETA-2#1.0099;ISOPRENALINE#1.0076;ADIPOSE TISSUE#1.0071;ADIPOCYTE#1.0056;WHITE ADIPOSE TISSUE#1.0052;SALBUTAMOL#1.0015;OBESE#0.9985;TYPE 2 DIABETES MELLITUS#0.9965;2 DIABETES MELLITUS#0.9965;WEIGHT GAIN#0.9944;BETA ADRENOCEPTOR#0.9935;PROPRANOLOL#0.9916;GENE EXPRESSION#0.9914;MIRABEGRON#0.9860;PEROXISOME#0.9838;SUBCUTANEOUS ADIPOSE TISSUE#0.9787;ISOPROTERENOL#0.9780;LIPID METABOLISM#0.9730;NOREPINEPHRINE#0.9721;BETA ADRENERGIC RECEPTOR#0.9675;HYPERTENSION#0.9549;FRAGMENT LENGTH POLYMORPHISM#0.9516;INSULIN SECRETION#0.9420;NORADRENALINE#0.9333;BETA3 ADRENOCEPTOR#0.9304;SKELETAL MUSCLE#0.9244;PROTEIN KINASE#0.9125;SIGNAL TRANSDUCTION#0.9099;NITRIC OXIDE#0.9090;GROWTH FACTOR#0.9000;ARGININE#0.8960;NERVOUS SYSTEM#0.8717;BUPRANOLOL#0.8706;VISCERAL ADIPOSE TISSUE#0.8678;DOBUTAMINE#0.8645;TRYPTOPHAN#0.8397;HIGH DENSITY LIPOPROTEIN#0.8303;AND BODY COMPOSITION#0.8098;DNA METHYLATION#0.7922;ADRENALINE#0.7782;BREAST CANCER#0.7772;HORMONE SENSITIVE LIPASE#0.7765;GESTATIONAL DIABETES#0.7653;FOLIC ACID#0.7521;TYPE 2 DIABETIC#0.7414;ADENOSINE#0.7323;T CELL#0.7308;GLUCOSE TOLERANCE TEST#0.7297;SIGNALING PATHWAY#0.7219;PHOSPHODIESTERASE#0.7210;HIGH FAT DIET#0.7142;ARTERY#0.7112;ADENYLATE CYCLASE#0.7045;GESTATIONAL DIABETES MELLITUS#0.6991;NADOLOL#0.6805;ORAL GLUCOSE TOLERANCE#0.6798;URIC ACID#0.6751;REVERSE TRANSCRIPTION#0.6744;LOW DENSITY LIPOPROTEIN#0.6735;INSULIN RECEPTOR#0.6735;TUMOR NECROSIS FACTOR#0.6683;DIET INDUCED OBESITY#0.6658;ENDOTHELIAL GROWTH FACTOR#0.6635;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6635;RECEPTOR ANTAGONIST#0.6579;ATENOLOL#0.6566;IMPAIRED GLUCOSE TOLERANCE#0.6342;CYCLIC ADENOSINE MONOPHOSPHATE#0.6335;BETA2 ADRENOCEPTOR#0.6325;ADENOSINE MONOPHOSPHATE#0.6316;NUCLEOTIDE BINDING#0.6270;TERBUTALINE#0.6256;STROMAL VASCULAR CELLS#0.6206;BODY WEIGHT GAIN#0.6199;SYSTOLIC BLOOD PRESSURE#0.6161;TOTAL BODY FAT#0.6109;GLUCOCORTICOID RECEPTOR#0.6056;BETA2 ADRENERGIC RECEPTOR#0.6027
1562	CYTOCHROME P450#0.9999;DRUG METABOLISM#0.9280;POLYMERASE CHAIN REACTION#0.9020;MEPHENYTOIN#0.8919;MICROSOME#0.8419;GENE EXPRESSION#0.7961;ENZYME ACTIVITY#0.7412;WARFARIN#0.6569;TOLBUTAMIDE#0.6462;ACENOCOUMAROL#0.6014;TOXICITY#0.6009
1564	CYTOCHROME P450#0.9325;CODEINE#0.7374;COPY NUMBER VARIATION#0.7130;GENE CONVERSION#0.6289
1565	PERHEXILINE#1.0792;ATOMOXETINE#1.0751;TERBINAFINE#1.0679;FLECAINIDE#1.0642;GEFITINIB#1.0639;TOLTERODINE#1.0625;OXYMORPHONE#1.0602;TIMOLOL#1.0573;DULOXETINE#1.0570;ONDANSETRON#1.0553;DEBRISOQUIN#1.0541;O-DESMETHYLVENLAFAXINE#1.0511;1-HYDROXYLASE ACTIVITY#1.0497;THIORIDAZINE#1.0488;XANTHINE OXIDASE#1.0486;ARIPIPRAZOLE#1.0473;DONEPEZIL#1.0469;9-HYDROXYRISPERIDONE#1.0468;OXYCODONE#1.0456;PERPHENAZINE#1.0440;PRIMAQUINE#1.0439;CARVEDILOL#1.0431;NEUROLEPTIC MALIGNANT SYNDROME#1.0407;PROPAFENONE#1.0402;EARLY BREAST CANCER#1.0402;COPY NUMBER VARIATION#1.0389;GENE COPY NUMBER#1.0385;MIRABEGRON#1.0381;BUFURALOL#1.0378;CODEINE#1.0353;HYDROMORPHONE#1.0342;DESVENLAFAXINE#1.0332;DEBRISOQUINE#1.0309;METHADONE#1.0294;MIRTAZAPINE#1.0294;NORTRIPTYLINE#1.0292;PAROXETINE#1.0279;ESCITALOPRAM#1.0276;RISPERIDONE#1.0276;CHLORZOXAZONE#1.0270;SPARTEINE#1.0267;TAMOXIFEN#1.0267;BUPROPION#1.0252;METOPROLOL#1.0251;DESIPRAMINE#1.0246;BISOPROLOL#1.0243;N ACETYLTRANSFERASE#1.0238;HALOPERIDOL#1.0237;FLUOXETINE#1.0229;RECURRENCE FREE SURVIVAL#1.0216;SULFAPHENAZOLE#1.0210;CHRONIC HEPATITIS C#1.0204;LOSARTAN#1.0203;DEMETHYLASE ACTIVITY#1.0200;VENLAFAXINE#1.0196;PROPRANOLOL#1.0194;DEXTROMETHORPHAN#1.0194;PHENACETIN#1.0194;SERTRALINE#1.0183;DOPAMINE FORMATION#1.0182;DYSKINESIA#1.0172;QUININE#1.0169;IMIPRAMINE#1.0166;QUINIDINE#1.0154;AMITRIPTYLINE#1.0150;MEPHENYTOIN#1.0142;DICLOFENAC#1.0127;MEXILETINE#1.0116;4-HYDROXYTAMOXIFEN#1.0114;CLOZAPINE#1.0090;DIPHENHYDRAMINE#1.0089;BREAST CANCER PATIENTS#1.0089;AUTOIMMUNE HEPATITIS#1.0089;FLUVOXAMINE#1.0083;T CELL#1.0082;TOLBUTAMIDE#1.0080;OLANZAPINE#1.0079;CAFFEINE#1.0079;HEPATITIS C#1.0076;OMEPRAZOLE#1.0070;AMIODARONE#1.0070;PARKINSON'S DISEASE#1.0063;FRAGMENT LENGTH POLYMORPHISM#1.0057;HYDROXYLASE ACTIVITY#1.0053;SIMVASTATIN#1.0051;LUNG CANCER#1.0046;XANTHINE#1.0032;CITALOPRAM#1.0029;NARROW THERAPEUTIC INDEX#1.0029;PERIPHERAL BLOOD#1.0023;NIFEDIPINE#1.0014;ATP BINDING CASSETTE#1.0010;THEOPHYLLINE#1.0002;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.9996;ATP BINDING#0.9995;DEMETHYLATION#0.9995;MIDAZOLAM#0.9988;AMODIAQUINE#0.9979;BREAST CANCER#0.9976;ITRACONAZOLE#0.9974;SQUAMOUS CELL CARCINOMA#0.9969;POLYMERASE CHAIN REACTION#0.9961;CLOMIPRAMINE#0.9956;RITONAVIR#0.9954;DISEASE FREE SURVIVAL#0.9946;CIMETIDINE#0.9941;ALZHEIMER'S DISEASE#0.9936;XENOBIOTIC METABOLISM#0.9935;WARFARIN#0.9935;ENZYME ACTIVITY#0.9923;DAPSONE#0.9920;NEBIVOLOL#0.9917;CHLORPROMAZINE#0.9912;METHAMPHETAMINE#0.9907;ADRENERGIC RECEPTOR#0.9900;ECSTASY#0.9893;CATALYTIC ACTIVITY#0.9890;3,4-METHYLENEDIOXYMETHAMPHETAMINE#0.9889;RIFAMPICIN#0.9880;GLUTATHIONE#0.9873;CENTRAL NERVOUS SYSTEM#0.9866;NEUROTOXIN#0.9860;STRUCTURE ACTIVITY RELATIONSHIP#0.9858;TROLEANDOMYCIN#0.9854;MAJOR DEPRESSIVE DISORDER#0.9843;OXIDATIVE METABOLISM#0.9842;DOPAMINE#0.9839;TESTOSTERONE#0.9831;CONJUGATION#0.9827;ERYTHROMYCIN#0.9826;OXYGENASE#0.9823;TICLOPIDINE#0.9818;DETOXIFICATION#0.9812;RIFAMPIN#0.9811;OPIOID RECEPTOR#0.9810;NERVOUS SYSTEM#0.9810;HEPATOCYTE NUCLEAR FACTOR#0.9810;THERAPEUTIC DRUG MONITORING#0.9805;HEPATOTOXICITY#0.9796;KETOCONAZOLE#0.9793;CARBAMAZEPINE#0.9789;ETHANOL#0.9789;URIDINE#0.9786;LUPUS ERYTHEMATOSUS#0.9783;SEROTONIN REUPTAKE INHIBITOR#0.9776;DEMENTIA#0.9771;LIVER DISEASE#0.9771;LYMPHOBLASTOID CELLS#0.9769;CORTISOL#0.9758;ADVERSE DRUG REACTION#0.9755;HEPATITIS C VIRUS#0.9749;REVERSE TRANSCRIPTION#0.9747;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9737;MICROSOME#0.9729;CARCINOGEN#0.9722;LEUKOCYTE#0.9720;SMALL INTESTINE#0.9720;CYTOTOXICITY#0.9719;PROTEIN BINDING#0.9716;RECEPTOR AGONIST#0.9713;PHENYTOIN#0.9708;PROSTATE CANCER#0.9708;P-NITROPHENOL#0.9707;SULPHAPHENAZOLE#0.9706;PROGESTERONE#0.9706;QUETIAPINE#0.9705;XENOBIOTIC METABOLIZING ENZYME#0.9703;VOMITING#0.9702;MUTAGENESIS#0.9700;PACLITAXEL#0.9699;GENE EXPRESSION#0.9697;CYTOCHROME P450#0.9696;DRUG METABOLISM#0.9696;ESTROGEN RECEPTOR#0.9688;PHENOBARBITAL#0.9685;NOREPINEPHRINE REUPTAKE#0.9682;EXCRETION#0.9681;TERFENADINE#0.9679;MALARIA#0.9676;HYPERTENSION#0.9672;PRIMARY HUMAN HEPATOCYTES#0.9672;DEXTROMETHORPHAN HYDROBROMIDE#0.9664;TRANSCRIPTASE#0.9654;TRANSCRIPTION FACTOR#0.9651;CHLOROQUINE#0.9644;GENE CONVERSION#0.9642;DRUG METABOLIC#0.9638;RECEPTOR ANTAGONIST#0.9638;TRAZODONE#0.9635;LEVOMEPROMAZINE#0.9635;WEIGHT GAIN#0.9629;EPOXIDE HYDROLASE#0.9618;METOCLOPRAMIDE#0.9612;BUPRENORPHINE#0.9610;PLASMA PROTEIN#0.9604;GEOMETRIC MEAN RATIO#0.9604;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9603;TOXICITY#0.9595;NOREPINEPHRINE#0.9593;ALPRAZOLAM#0.9593;MOLAR#0.9586;CYTOCHROME P450 ACTIVITY#0.9578;DOXEPIN#0.9567;VERAPAMIL#0.9563;ENZYME INHIBITOR#0.9548;FLAVIN CONTAINING MONOOXYGENASE#0.9545;NOREPINEPHRINE REUPTAKE INHIBITOR#0.9544;RESPONSE TO TREATMENT#0.9531;PREGNANE X RECEPTOR#0.9529;COUMARIN 7 HYDROXYLASE#0.9525;CLOPIDOGREL#0.9525;GALANTAMINE#0.9482;ENDOPLASMIC RETICULUM#0.9467;ACETAMINOPHEN#0.9464;ST. JOHN'S WORT#0.9462;ESTRADIOL#0.9461;FLUCONAZOLE#0.9461;GROWTH FACTOR#0.9459;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9444;ATRIAL FIBRILLATION#0.9429;DOLASETRON#0.9424;DIPHOSPHATE#0.9416;FLAVIN#0.9383;PIPERAZINE#0.9352;BLOOD BRAIN BARRIER#0.9350;MECHANISM OF ACTION#0.9345;DRUG RESISTANCE#0.9335;DEXAMETHASONE#0.9328;BERBERINE#0.9324;PIMOZIDE#0.9296;DIGOXIN#0.9279;METHIONINE#0.9270;NEFAZODONE#0.9266;DILTIAZEM#0.9253;SMALL HETERODIMER PARTNER#0.9240;BETA ADRENOCEPTOR#0.9230;HYPERACTIVITY#0.9229;DIABETES MELLITUS#0.9211;QUERCETIN#0.9203;PARACETAMOL#0.9190;ANILINE#0.9188;PALIPERIDONE#0.9165;MOCLOBEMIDE#0.9122;TYPE 2 DIABETES#0.9117;DIAZEPAM#0.9100;MITOCHONDRIA#0.9091;DEPRESSIVE SYMPTOMS#0.9072;NEW CHEMICAL ENTITIES#0.9071;CYTOCHROME B5#0.9062;RANDOMIZED CONTROLLED TRIAL#0.9041;METASTATIC BREAST CANCER#0.9028;DIGESTION#0.9024;HEART DISEASE#0.9013;ANTITUSSIVE#0.8997;LEWY BODY#0.8982;ARRHYTHMIA#0.8957;HUMAN IMMUNODEFICIENCY VIRUS#0.8953;ARYLAMINE N ACETYLTRANSFERASE#0.8952;IMMUNE RESPONSE#0.8929;LYMPHOBLAST#0.8905;SEDATION#0.8888;ERLOTINIB#0.8879;HISTAMINE#0.8877;ALCOHOL USE DISORDER#0.8872;METHADONE MAINTENANCE TREATMENT#0.8869;SOLID PHASE EXTRACTION#0.8861;TRANYLCYPROMINE#0.8828;CANCER CELL#0.8826;NICOTINE METABOLISM#0.8820;FENTANYL#0.8809;ARYLAMINE#0.8804;QUANTITATIVE REAL TIME#0.8802;OVER THE COUNTER#0.8790;DOPAMINE D2 RECEPTOR#0.8785;HEALTHY CONTROL SUBJECTS#0.8771;NITRIC OXIDE#0.8759;SUBSTANTIA NIGRA#0.8753;GROWTH FACTOR RECEPTOR#0.8751;CERVICAL#0.8727;ANXIETY DISORDER#0.8726;EPILEPSY#0.8725;CELECOXIB#0.8724;MIANSERIN#0.8708;CATECHOL O METHYLTRANSFERASE#0.8705;O METHYLTRANSFERASE#0.8696;PHASE II METABOLISM#0.8695;COLORECTAL#0.8688;BRADYCARDIA#0.8680;DIZZINESS#0.8675;DOPAMINE RECEPTOR#0.8655;CLARITHROMYCIN#0.8652;HEPATOCELLULAR CARCINOMA#0.8648;AUTOIMMUNE DISEASE#0.8637;TOREMIFENE#0.8634;AUTISM SPECTRUM DISORDER#0.8632;DEPRESSION RATING SCALE#0.8629;BIPOLAR DISORDER#0.8624;ORGANIC CATION TRANSPORTER#0.8624;PROTON PUMP INHIBITOR#0.8623;HEAD AND NECK CANCER#0.8616;NECK CANCER#0.8616;ANASTROZOLE#0.8606;PROTON PUMP#0.8605;MELATONIN#0.8579;COPY NUMBER VARIANTS#0.8575;EPITHELIAL CELL#0.8572;ETHYLMORPHINE#0.8570;TRIAZOLAM#0.8550;MOLECULAR DYNAMICS SIMULATION#0.8546;RESPONSE TO DRUG#0.8541;GINSENG#0.8526;SERIOUS ADVERSE EVENT#0.8518;GRANISETRON#0.8513;DNA REPAIR#0.8503;SEROTONIN RECEPTOR#0.8501;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8493;CELL PROLIFERATION#0.8488;EPIDERMAL GROWTH FACTOR#0.8477;MICONAZOLE#0.8474;HARDY WEINBERG EQUILIBRIUM#0.8471;MULTIPLE REGRESSION ANALYSIS#0.8444;PROMETHAZINE#0.8444;HYPERPROLACTINEMIA#0.8441;VENOUS BLOOD#0.8426;LIVER DAMAGE#0.8421;CHLORPHENIRAMINE#0.8407;ESSENTIAL HYPERTENSION#0.8396;RHEUMATOID ARTHRITIS#0.8395;ANTIPYRINE#0.8388;CYCLOPHOSPHAMIDE#0.8387;IRINOTECAN#0.8328;REACTIVE OXYGEN SPECIES#0.8314;ANKYLOSING SPONDYLITIS#0.8305;FLURBIPROFEN#0.8283;GINKGO BILOBA#0.8276;PROGUANIL#0.8262;IBUPROFEN#0.8260;MU OPIOID RECEPTOR#0.8242;CERVICAL CANCER#0.8235;SCHIZOAFFECTIVE DISORDER#0.8230;SIGNALING PATHWAY#0.8222;GASTROINTESTINAL TRACT#0.8221;ZIPRASIDONE#0.8211;MENSTRUAL CYCLE#0.8196;TRADITIONAL CHINESE MEDICINE#0.8183;METOPROLOL SUCCINATE#0.8169;LORATADINE#0.8136;NICOTINAMIDE#0.8131;LIMIT OF QUANTIFICATION#0.8128;TAMSULOSIN#0.8119;NEUROTOXICITY#0.8118;ADJUVANT HORMONAL THERAPY#0.8116;APOPTOSIS#0.8102;CLOMIPHENE#0.8098;FESOTERODINE#0.8098;BUFOTENINE#0.8094;CALCIUM CHANNEL#0.8090;VITAMIN K#0.8074;SEROTONIN UPTAKE#0.8053;CYCLOSPORINE#0.8040;BREAST CARCINOMA#0.8032;RETINOIC ACID#0.8016;COLORECTAL CANCER#0.8002;ARACHIDONIC ACID#0.8001;KINASE INHIBITOR#0.7990;REBOXETINE#0.7980;PLASMODIUM VIVAX MALARIA#0.7979;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7964;SUPEROXIDE DISMUTASE#0.7959;DELAVIRDINE#0.7949;INDOLE#0.7928;TIENILIC ACID#0.7918;MUTAGENICITY#0.7907;REPAGLINIDE#0.7899;MONONUCLEAR CELLS#0.7898;BASAL CELL#0.7892;AZELASTINE#0.7889;PHENOTHIAZINE#0.7887;LYMPH NODE#0.7829;ISONIAZID#0.7827;SULFATION#0.7826;ALANINE#0.7825;ADENINE DINUCLEOTIDE PHOSPHATE#0.7813;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7791;TACRINE#0.7784;AGE AT ONSET#0.7779;BETA-NAPHTHOFLAVONE#0.7778;NORADRENALINE#0.7766;BASAL CELL CARCINOMA#0.7757;ASPARTATE#0.7743;NEUROTOXIC#0.7737;ADJUSTED HAZARD RATIO#0.7734;METROPROLOL#0.7726;LARYNX CANCER#0.7721;DNA METHYLATION#0.7717;MULTIPLE SCLEROSIS#0.7714;STEM CELL#0.7712;ASTEMIZOLE#0.7702;TRYPTOPHAN#0.7686;CORONARY ARTERY#0.7681;PLASMA MEMBRANE#0.7667;B CELL#0.7657;IMATINIB#0.7649;DIARRHEA#0.7646;EFAVIRENZ#0.7642;MINI MENTAL STATE#0.7639;LATE PREGNANCY#0.7638;MENSTRUAL CYCLE PHASE#0.7635;OBESE#0.7625;POPULATION PHARMACOKINETIC MODEL#0.7585;ORGANIC ANION TRANSPORTER#0.7580;ADENINE#0.7577;ADENOCARCINOMA#0.7574;GLOMERULAR FILTRATION#0.7568;WHITE BLOOD CELL#0.7567;CONSTIPATION#0.7562;GLYCINE#0.7543;MYOCARDIAL INFARCTION#0.7541;LIDOCAINE#0.7536;DRY MOUTH#0.7533;TOXICANT#0.7533;CLINICAL GLOBAL IMPRESSION#0.7525;STRIATUM#0.7507;HEROIN#0.7499;OBSESSIVE COMPULSIVE DISORDER#0.7491;BREAST CANCER CELL#0.7486;CATHINONE#0.7480;YOHIMBINE#0.7478;NEUROPATHY#0.7466;LIMIT OF QUANTITATION#0.7460;POLYCYCLIC AROMATIC HYDROCARBON#0.7435;LARYNX#0.7425;POSITIVE PREDICTIVE VALUE#0.7421;QUINIDINE SULFATE#0.7412;VALINE#0.7411;CD8+ T CELL#0.7395;CLOMIPHENE CITRATE#0.7391;COGNITION#0.7391;BUSPIRONE#0.7369;SLEEP APNEA#0.7365;MULTIPLE SYSTEM ATROPHY#0.7365;SEXUAL DYSFUNCTION#0.7351;RESPONSE TO ANTIDEPRESSANT#0.7346;ABIRATERONE#0.7320;DIHYDROMORPHINE#0.7300;TYROSINE KINASE INHIBITOR#0.7296;B-LYMPHOBLAST#0.7281;TOPICAL#0.7269;GLUCOSE-6-PHOSPHATE#0.7261;TRAMADOL HYDROCHLORIDE#0.7260;TRANSACTIVATION#0.7259;ADVERSE DRUG EVENT#0.7253;LANSOPRAZOLE#0.7246;SUCCINATE#0.7226;BREAST INTERNATIONAL GROUP#0.7213;PROCAINAMIDE#0.7204;5-MEO-DIPT#0.7200;GENOTOXIC#0.7200;STANDARD OF CARE#0.7198;GLUTATHIONE TRANSFERASE#0.7193;ADJUVANT BREAST CANCER#0.7192;GEMFIBROZIL#0.7182;MECHANISMS OF ACTION#0.7167;OBSTRUCTIVE SLEEP APNEA#0.7158;INVASIVE BREAST CANCER#0.7136;ABNORMAL INVOLUNTARY MOVEMENT#0.7123;CLONIDINE#0.7123;MULTIPLE LINEAR REGRESSION#0.7122;SMOOTH MUSCLE#0.7110;BONE MARROW#0.7105;TUMOR NECROSIS FACTOR#0.7102;INFLAMMATORY BOWEL DISEASE#0.7085;OPIATE DEPENDENCE#0.7065;SELEGILINE#0.7060;6BETA-HYDROXYLASE ACTIVITY#0.7015;GROWTH HORMONE#0.7005;ATORVASTATIN#0.7004;5-HT RECEPTOR#0.6991;NEGATIVE PREDICTIVE VALUE#0.6964;WORLD HEALTH ORGANIZATION#0.6952;DEFINED DAILY DOSE#0.6948;DUODENUM#0.6945;ABC TRANSPORTER#0.6941;SEROTONIN SYNTHESIS#0.6924;NEVIRAPINE#0.6918;2 DIABETES MELLITUS#0.6908;COLON CANCER#0.6902;MEMANTINE#0.6896;CONSTITUTIVE ANDROSTANE RECEPTOR#0.6884;3,4-METHYLENEDIOXYAMPHETAMINE#0.6863;ARTERY#0.6854;MAJOR DEPRESSIVE EPISODE#0.6840;SPONDYLITIS#0.6831;ILOPERIDONE#0.6830;CINACALCET#0.6820;NICARDIPINE#0.6816;CILOSTAZOL#0.6812;RIVASTIGMINE#0.6812;72-HOURS#0.6799;THIOPURINE S METHYLTRANSFERASE#0.6790;SYSTOLIC BLOOD PRESSURE#0.6773;AUTOIMMUNITY#0.6767;S METHYLTRANSFERASE#0.6765;ELECTRONIC HEALTH RECORD#0.6765;CELL CYCLE#0.6724;VALPROIC ACID#0.6720;ROSIGLITAZONE#0.6704;GENOTOXICITY#0.6693;CARTEOLOL#0.6660;VITAMIN D RECEPTOR#0.6629;CELL GROWTH#0.6625;REVERSE TRANSCRIPTASE INHIBITOR#0.6583;NALOXONE#0.6583;CYSTIC FIBROSIS#0.6581;ORPHENADRINE#0.6572;COMPLEX I#0.6566;ENCAINIDE#0.6547;SERTINDOLE#0.6531;GREEN TEA EXTRACT#0.6524;CYTOCHROME B#0.6522;LIVER CIRRHOSIS#0.6516;FLUVASTATIN#0.6507;MIPOMERSEN SODIUM#0.6502;LINEAR MIXED EFFECTS#0.6487;SEVERE PAIN#0.6478;HEME BINDING#0.6476;CORONARY HEART DISEASE#0.6474;ETHINYL ESTRADIOL#0.6470;8-AMINOQUINOLINE#0.6470;L-DOPA#0.6462;HIGH RESOLUTION MELTING#0.6461;NARCOTIC#0.6454;CHRONIC HEART FAILURE#0.6421;ELECTRON TRANSFER#0.6408;TACHYCARDIA#0.6406;INSOMNIA#0.6406;ALL TRANS RETINOIC ACID#0.6404;FATTY LIVER#0.6381;MEPYRAMINE#0.6376;ALDEHYDE OXIDASE#0.6360;FORMIC ACID#0.6351;CHRONIC SCHIZOPHRENIA#0.6342;MACROPHAGE#0.6316;OXYBUTYNIN#0.6308;BLOOD PLASMA#0.6287;NEUROTRANSMITTER RECEPTOR#0.6284;PRIMARY METABOLISM#0.6277;CLINICAL PRACTICE GUIDELINE#0.6249;MOOD DISORDER#0.6242;HYPERFORIN#0.6240;DAPOXETINE#0.6225;MICROSOMAL MEMBRANE#0.6219;INTESTINAL MUCOSA#0.6212;PROTEIN KINASE#0.6207;SINGLE NUCLEOTIDE VARIANTS#0.6201;TYPE 2 DIABETES MELLITUS#0.6189;GLOMERULAR FILTRATION RATE#0.6189;MILNACIPRAN#0.6187;DIMETHYL SULFOXIDE#0.6179;CYTOCHROME C#0.6177;ROSUVASTATIN#0.6176;DOPAMINERGIC NEURON#0.6166;MRNA SPLICING#0.6165;LOPINAVIR#0.6154;MULTIPLE REACTION MONITORING#0.6150;MULTIDRUG RESISTANCE PROTEIN#0.6149;OVARIAN CANCER#0.6125;MENTAL DISORDER#0.6114;OVARIAN#0.6100;GESTATION#0.6091;TUBERCULOSIS#0.6089;ADJUSTED ODDS RATIO#0.6082;HALOFANTRINE#0.6072;FELODIPINE#0.6064;SUBSTRATE REDUCTION THERAPY#0.6062;FRONTAL#0.6060;PANTOPRAZOLE#0.6059;COENZYME A#0.6058;HUMAN PRIMARY HEPATOCYTES#0.6058;COMPOUND S#0.6051;RANITIDINE#0.6049;RECEPTOR BINDING#0.6044;BUPRANOLOL#0.6043;MYELOID LEUKEMIA#0.6036;CARRIE#0.6032;DRUG DEPENDENCE#0.6031;RESVERATROL#0.6029;MINOR ALLELE FREQUENCY#0.6022;FLUOROURACIL#0.6018;DIMETHYLTRYPTAMINE#0.6002
156	BETA-ARK 1#1.1884;PAROXETINE#1.0834;SPINAL CORD#1.0628;DOMINANT NEGATIVE MUTANT#1.0461;EPITHELIAL CELL#1.0442;MACROPHAGE#1.0331;NEUTROPHIL#1.0296;ISCHEMIA#1.0279;BETA-2#1.0234;MYOCARDIAL INFARCTION#1.0219;MUSCARINIC ACETYLCHOLINE RECEPTOR#1.0209;SMOOTH MUSCLE CELL#1.0203;ACETYLCHOLINE RECEPTOR#1.0197;CARDIOMYOCYTE#1.0195;CELL MIGRATION#1.0175;BETA ADRENERGIC RECEPTOR#1.0171;MU OPIOID RECEPTOR#1.0171;MUSCLE CELL#1.0168;PROTEASOME#1.0166;GENE EXPRESSION#1.0163;ENDOTHELIAL CELL#1.0162;SMOOTH MUSCLE#1.0119;CELL PROLIFERATION#1.0119;KINASE INHIBITOR#1.0089;HISTAMINE#1.0085;HIGH FAT DIET#1.0081;HUMAN EMBRYONIC KIDNEY#1.0077;MYOCYTES#1.0073;EMBRYONIC KIDNEY#1.0073;EPIDERMAL GROWTH FACTOR#1.0069;CELL GROWTH#1.0066;HYPERTENSION#1.0063;KINASE ACTIVITY#1.0060;NITRIC OXIDE SYNTHASE#1.0054;DOPAMINE#1.0054;TYPE 2 DIABETES#1.0041;MITOGEN ACTIVATED PROTEIN#1.0036;NITRIC OXIDE#1.0035;GROWTH FACTOR RECEPTOR#1.0011;PROTEIN KINASE C#0.9997;BETA2 ADRENERGIC RECEPTOR#0.9990;OPIOID RECEPTOR#0.9989;HETEROTRIMERIC G-PROTEIN#0.9988;PKC ACTIVITY#0.9981;DELTA OPIOID RECEPTOR#0.9978;APOPTOSIS#0.9978;ACETYLCHOLINE#0.9971;MYOCARDIUM#0.9968;RECEPTOR INTERNALIZATION#0.9967;GROWTH FACTOR#0.9965;ADRENERGIC RECEPTOR#0.9959;PHOSPHOLIPASE C#0.9942;ENDOCYTOSIS#0.9936;PROTEIN KINASE A#0.9934;RESONANCE ENERGY TRANSFER#0.9927;PRO-INFLAMMATORY#0.9927;CHEMOKINE RECEPTOR#0.9906;PLATELET-DERIVED GROWTH FACTOR#0.9898;PLASMA MEMBRANE#0.9891;SKELETAL MUSCLE#0.9888;PROTEIN KINASE#0.9883;SIGNALING PATHWAY#0.9871;SIGNAL TRANSDUCTION#0.9854;ISOPROTERENOL#0.9846;RECEPTOR AGONIST#0.9837;ADENOSINE#0.9814;CELL MEMBRANE#0.9807;HYPOXIA#0.9805;CELL SURFACE#0.9798;MITOCHONDRIA#0.9761;CHEMOTAXIS#0.9747;C TERMINAL DOMAIN#0.9747;PROTEASOME PATHWAY#0.9725;T CELL#0.9681;CYCLASE ACTIVITY#0.9679;CHRONIC HEART FAILURE#0.9664;GLUTAMATE RECEPTOR#0.9648;NERVOUS SYSTEM#0.9613;CORONARY ARTERY#0.9611;TUMOR NECROSIS FACTOR#0.9608;INSULIN RECEPTOR#0.9604;ARTERY#0.9600;NOREPINEPHRINE#0.9537;ENDOTHELIAL NITRIC OXIDE#0.9532;PERIPHERAL BLOOD#0.9531;LEUKOCYTE#0.9503;PERTUSSIS#0.9494;MAP KINASE#0.9452;SIGNALLING PATHWAY#0.9450;SIGNALING CASCADE#0.9432;ENDOTHELIUM#0.9411;FORSKOLIN#0.9408;CYCLIC AMP#0.9404;POLYMERASE CHAIN REACTION#0.9403;ADRENAL GLAND#0.9398;ADENYLYL CYCLASE ACTIVITY#0.9395;MUTAGENESIS#0.9391;EPINEPHRINE#0.9328;ACUTE MYOCARDIAL INFARCTION#0.9280;BONE MARROW#0.9275;HISTAMINE RECEPTOR#0.9234;MEMBRANE FRACTION#0.9232;INFLAMMATORY RESPONSE#0.9221;RECEPTOR TYROSINE KINASE#0.9198;CAMP FORMATION#0.9153;DOPAMINE D2 RECEPTOR#0.9080;HEPATOCELLULAR CARCINOMA#0.9044;RHEUMATOID ARTHRITIS#0.9040;KINASE INHIBITOR PROTEIN#0.9030;SIGNALING MOLECULE#0.9028;VASCULAR SMOOTH MUSCLE CELL#0.9022;UBIQUITIN#0.9010;IMMUNE CELL#0.9000;NEUTROPHIL MIGRATION#0.8981;CELL CYCLE#0.8972;MITOCHONDRIAL LOCALIZATION#0.8927;OSTEOBLAST#0.8919;MICROTUBULE#0.8911;PROTEIN KINASE B#0.8853;GUANINE#0.8826;CYTOPLASM#0.8776;TYPE 2 DIABETIC#0.8771;AKT SIGNALING#0.8737;CATALYTIC ACTIVITY#0.8730;BETA-ARK 2#0.8716;CANCER CELL#0.8710;BRAIN DAMAGE#0.8672;RECEPTOR ANTAGONIST#0.8668;BETA ADRENOCEPTOR#0.8664;CHROMAFFIN CELL#0.8655;SEROTONIN REUPTAKE INHIBITOR#0.8639;RHODOPSIN KINASE#0.8632;ANGIOGENESIS#0.8614;ALANINE#0.8593;TRANSCRIPTION FACTOR#0.8574;BIOLUMINESCENCE#0.8543;VASOCONSTRICTOR#0.8484;MYELOID CELL#0.8471;AIRWAY SMOOTH MUSCLE#0.8446;MONONUCLEAR CELLS#0.8445;MONOCYTE#0.8413;LYMPH NODE#0.8365;APOPTOTIC#0.8358;ISCHEMIA REPERFUSION INJURY#0.8303;SPHINGOSINE 1 PHOSPHATE#0.8300;ASTROCYTE#0.8298;GLUCOSE UPTAKE#0.8292;CARDIOMYOPATHY#0.8289;PHOSPHODIESTERASE#0.8288;DOPAMINE RECEPTOR#0.8141;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8130;MULTIPLE SCLEROSIS#0.8099;ISOPRENALINE#0.8095;HEART DISEASE#0.8087;METABOTROPIC GLUTAMATE RECEPTORS#0.8075;CELL DEATH#0.8055;ADENOSINE MONOPHOSPHATE#0.8030;INSULIN RECEPTOR SUBSTRATE#0.8029;WEIBEL PALADE BODY#0.7991;MAST CELL#0.7967;CLATHRIN-COATED PIT#0.7961;CLONIDINE#0.7957;HEPARIN#0.7950;SUCROSE#0.7946;GLUTATHIONE#0.7936;COATED PIT#0.7930;RECEPTOR RECYCLING#0.7927;REACTIVE OXYGEN SPECIES#0.7918;INSULIN-LIKE GROWTH FACTOR#0.7913;ENDOSOME#0.7893;REVERSE TRANSCRIPTION#0.7881;FRONTAL#0.7872;B CELL#0.7855;SENSITIZATION#0.7849;GLUCOSE HOMEOSTASIS#0.7847;ETORPHINE#0.7836;TRANSMEMBRANE RECEPTOR#0.7794;NUCLEOTIDE BINDING#0.7791;RNA INTERFERENCE#0.7788;RECEPTOR ACTIVITY#0.7785;ADIPOSE TISSUE#0.7781;RECEPTOR BINDING#0.7768;TUBULIN DEACETYLASE#0.7743;ADIPOCYTE#0.7720;RECEPTOR DEGRADATION#0.7699;CYCLIC ADENOSINE MONOPHOSPHATE#0.7692;PROTEIN PROTEIN INTERACTION#0.7649;SYSTOLIC BLOOD PRESSURE#0.7607;CALCIUM SIGNALING#0.7582;SPHINGOSINE#0.7574;NEUROBLASTOMA#0.7540;CORONARY ARTERY LIGATION#0.7522;FIBROBLAST LIKE SYNOVIOCYTES#0.7518;SUBSTANCE P#0.7499;STEM CELL#0.7492;IMMUNE RESPONSE#0.7466;DOPAMINE D1 RECEPTOR#0.7466;CELL MOTILITY#0.7439;RECEPTOR COMPLEX#0.7407;SERTOLI CELL#0.7396;DORSAL ROOT GANGLION#0.7370;TRANSACTIVATION#0.7318;CAMP SIGNALING#0.7315;HYPERACTIVITY#0.7303;CHEMOKINE PRODUCTION#0.7301;CALCIUM MOBILIZATION#0.7296;HEART DEVELOPMENT#0.7285;CARDIAC ARREST#0.7279;PROSTAGLANDIN E2#0.7225;TOLL LIKE RECEPTOR#0.7196;CARBACHOL#0.7179;HYPERPHOSPHORYLATION#0.7106;HISTONE DEACETYLASE#0.7017;EXOCYTOSIS#0.7014;DEPHOSPHORYLATION#0.6973;SARCOPLASMIC RETICULUM#0.6960;CONGESTIVE HEART FAILURE#0.6957;ALZHEIMER'S DISEASE#0.6952;BETA2 ADRENOCEPTOR#0.6949;VASOCONSTRICTION#0.6935;SEQUESTERING#0.6921;ENDOTHELIN RECEPTOR#0.6903;DIABETES MELLITUS#0.6890;VASODILATION#0.6868;GLYCOGEN SYNTHASE KINASE#0.6857;ADENYLATE CYCLASE#0.6852;EPITHELIAL CELL MIGRATION#0.6849;WOUND HEALING#0.6811;HEAT SHOCK PROTEIN#0.6805;BREAST CANCER#0.6763;PHENYLEPHRINE#0.6753;MAPK CASCADE#0.6733;AUTOPHAGY#0.6730;MACROPHAGE ACTIVATION#0.6721;MICROGLIAL CELL#0.6717;OBESE#0.6700;NADPH OXIDASE#0.6681;COMPLEX I#0.6676;VASODILATOR#0.6675;CLATHRIN-MEDIATED ENDOCYTOSIS#0.6657;MICROTUBULE ASSOCIATED PROTEIN#0.6637;CYTOKINE PRODUCTION#0.6591;PORTAL HYPERTENSION#0.6570;GTP BINDING#0.6530;CAMKII#0.6474;BRAIN NATRIURETIC PEPTIDE#0.6474;SIGNAL TRANSDUCER#0.6445;ALPHA2 ADRENOCEPTOR#0.6443;CONSTRICTION#0.6426;TAMOXIFEN#0.6424;NORADRENALINE#0.6415;VASCULAR ENDOTHELIAL DYSFUNCTION#0.6357;FLUOXETINE#0.6347;NEUROTRANSMISSION#0.6323;STRIATUM#0.6294;LINES OF EVIDENCE#0.6288;ALDOSTERONE#0.6272;ETHANOL#0.6264;ATP BINDING#0.6231;CAMP RESPONSE ELEMENT#0.6182;KAPPA OPIOID RECEPTOR#0.6172;SOMATOSTATIN RECEPTOR#0.6159;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6154;HUMAN UMBILICAL VEIN#0.6150;UMBILICAL VEIN#0.6148;CEREBRAL CORTEX#0.6148;FORMYL PEPTIDE RECEPTOR#0.6124;BLOOD VESSEL#0.6100;PARATHYROID HORMONE#0.6098;MYOBLAST#0.6095;MAPK ACTIVATION#0.6029;GANGLION CELLS#0.6023
1571	BENZENE METABOLISM#1.0753;ETHANOL OXIDATION#1.0516;TCE METABOLISM#1.0457;DISULFIRAM#1.0425;BUFURALOL#1.0380;HALOTHANE#1.0375;4-METHYLPYRAZOLE#1.0372;BUPROPION#1.0351;CHLORZOXAZONE#1.0322;PYRAZOLE#1.0316;N ACETYLTRANSFERASE#1.0298;P-NITROPHENOL#1.0289;PHENACETIN#1.0272;PROTEASOME#1.0248;TOLUENE#1.0247;ANILINE#1.0245;DEXTROMETHORPHAN#1.0242;ROS GENERATION#1.0212;MEPHENYTOIN#1.0205;OMEPRAZOLE#1.0166;PERIPHERAL BLOOD LYMPHOCYTES#1.0165;TOLBUTAMIDE#1.0155;QUERCETIN#1.0154;DICLOFENAC#1.0149;THEOPHYLLINE#1.0141;CAFFEINE#1.0138;HEPATIC STELLATE CELL#1.0134;PARACETAMOL#1.0126;HEPATOMA CELLS#1.0125;FRAGMENT LENGTH POLYMORPHISM#1.0124;ESOPHAGEAL CANCER#1.0113;COLORECTAL CANCER#1.0112;NADPH OXIDASE#1.0111;LUNG CANCER#1.0106;SULFAPHENAZOLE#1.0097;ISONIAZID#1.0087;ASTROCYTE#1.0075;ARACHIDONIC ACID#1.0064;NIFEDIPINE#1.0062;ETHANOL#1.0061;LIVER CIRRHOSIS#1.0054;STYRENE METABOLISM#1.0052;HEME OXYGENASE 1#1.0052;DEMETHYLASE ACTIVITY#1.0047;EPOXIDE HYDROLASE#1.0043;CATALYTIC ACTIVITY#1.0042;QUINIDINE#1.0035;ETHANOL METABOLISM#1.0035;COLORECTAL#1.0035;GERM CELL#1.0033;MIDAZOLAM#1.0033;CHRONIC HEPATITIS C#1.0032;GLUTATHIONE TRANSFERASE#1.0029;ALCOHOL METABOLISM#1.0022;INDUCIBLE NITRIC OXIDE#1.0018;OXIDATIVE DNA DAMAGE#1.0016;MUTAGENICITY#1.0004;BETA-NAPHTHOFLAVONE#0.9997;OBESE#0.9982;AUTOPHAGY#0.9979;KUPFFER CELL#0.9979;CLARA CELL#0.9967;NITRIC OXIDE SYNTHASE#0.9966;ERYTHROMYCIN#0.9958;OXYGENASE#0.9951;RESVERATROL#0.9943;DEMETHYLATION#0.9936;HYDROXYLASE ACTIVITY#0.9930;MITOGEN ACTIVATED PROTEIN#0.9924;LIVER CANCER#0.9923;TROLEANDOMYCIN#0.9923;TRANSCRIPTASE#0.9918;PRO-INFLAMMATORY#0.9918;UBIQUITIN#0.9916;CELL PROLIFERATION#0.9916;CYTOCHROME B5#0.9914;MITOCHONDRIAL DAMAGE#0.9910;NITRIC OXIDE#0.9910;HEPATOTOXIN#0.9909;RESPONSE TO ETHANOL#0.9909;CYTOTOXICITY#0.9907;REVERSE TRANSCRIPTION#0.9907;KETOCONAZOLE#0.9907;GENOTOXICITY#0.9904;OXIDATIVE METABOLISM#0.9887;PROTEIN KINASE#0.9885;PEROXISOME#0.9885;XENOBIOTIC METABOLIZING ENZYME#0.9878;TUBERCULOSIS#0.9875;SQUAMOUS CELL CARCINOMA#0.9875;DIGESTION#0.9874;CHRONIC ALCOHOL CONSUMPTION#0.9873;HEPATITIS C#0.9872;EPITHELIAL CELL#0.9869;CYTOCHROME C#0.9864;POLYMERASE CHAIN REACTION#0.9863;ENZYME ACTIVITY#0.9860;ARYL HYDROCARBON RECEPTOR#0.9860;DEBRISOQUINE#0.9858;MUTAGEN#0.9853;MUTAGENIC#0.9852;MITOCHONDRIA#0.9850;LIPID METABOLISM#0.9850;GROWTH FACTOR#0.9847;ENDOPLASMIC RETICULUM#0.9846;MONONUCLEAR CELLS#0.9843;REACTIVE OXYGEN SPECIES#0.9838;PERIPHERAL BLOOD#0.9836;ACETAMINOPHEN#0.9817;SIGNALING PATHWAY#0.9816;RIFAMPICIN#0.9816;RETINOIC ACID#0.9815;CARCINOGENICITY#0.9809;DNA REPAIR#0.9808;PHENOBARBITAL#0.9808;CONJUGATION#0.9807;PREGNANE X RECEPTOR#0.9804;QUANTITATIVE REAL TIME#0.9802;FETAL LIVER#0.9796;BREAST CANCER#0.9790;XENOBIOTIC METABOLISM#0.9779;HEPATOCELLULAR CARCINOMA#0.9779;DETOXIFICATION#0.9779;ACUTE LIVER INJURY#0.9779;HEPATOTOXICITY#0.9779;TOXICANT#0.9776;TESTOSTERONE#0.9775;MUTAGENESIS#0.9774;METHIONINE#0.9771;N-ACETYLCYSTEINE#0.9768;MICROSOME#0.9767;NONALCOHOLIC FATTY LIVER DISEASE#0.9753;DNA METHYLATION#0.9753;ALCOHOLIC FATTY LIVER#0.9748;POLYCYCLIC AROMATIC HYDROCARBON#0.9746;MITOCHONDRIAL MEMBRANE#0.9746;XANTHINE OXIDASE#0.9744;CYTOCHROME B#0.9743;GENE EXPRESSION#0.9737;GLUTATHIONE PEROXIDASE#0.9737;CELL DEATH#0.9736;HIGH FAT DIET#0.9735;PROTEIN KINASE C#0.9734;LIVER DAMAGE#0.9732;PANCREATITIS#0.9731;CYTOCHROME P450#0.9729;GLUTATHIONE#0.9727;PRIMARY HUMAN HEPATOCYTES#0.9724;BONE MARROW#0.9723;TRANSCRIPTION FACTOR#0.9722;TOXICITY#0.9721;COUMARIN 7 HYDROXYLASE#0.9720;DAPSONE#0.9720;TUMOR NECROSIS FACTOR#0.9719;AMINOPYRINE#0.9716;SUPEROXIDE DISMUTASE#0.9715;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9715;APOPTOSIS#0.9708;DEXAMETHASONE#0.9707;CARCINOGEN#0.9706;APOPTOTIC#0.9705;STEROL REGULATORY ELEMENT#0.9703;GENOTOXIC#0.9702;ALCOHOL DEPENDENCE#0.9700;MACROPHAGE#0.9699;FATTY LIVER#0.9698;GROWTH HORMONE#0.9688;DNA FRAGMENTATION#0.9687;FATTY ACID OXIDATION#0.9684;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9670;INDOLE#0.9668;FATTY LIVER DISEASE#0.9660;EXCRETION#0.9656;SMALL INTESTINE#0.9650;INFLAMMATORY RESPONSE#0.9647;CANCER CELL#0.9644;ADIPOSE TISSUE#0.9642;LIVER DISEASE#0.9631;CISPLATIN#0.9628;ROS FORMATION#0.9623;MAP KINASE#0.9618;COLON CANCER#0.9602;ASPARTATE#0.9593;HEPATOCYTE NUCLEAR FACTOR#0.9593;ALKALINE PHOSPHATASE#0.9589;DRUG METABOLISM#0.9586;PACLITAXEL#0.9583;ALANINE#0.9576;PARKINSON'S DISEASE#0.9576;ACETYLCYSTEINE#0.9561;STEM CELL#0.9540;ANESTHETIC#0.9520;ADENOCARCINOMA#0.9507;T CELL#0.9491;TRANSFORMING GROWTH FACTOR#0.9490;SIGNAL TRANSDUCTION#0.9484;PLASMA MEMBRANE#0.9456;CELL CYCLE#0.9452;GESTATION#0.9442;VITAMIN E#0.9441;VITAMIN C#0.9439;PROTEIN BINDING#0.9432;MICRONUCLEUS#0.9423;SEVOFLURANE#0.9419;B CELL#0.9414;ST. JOHN'S WORT#0.9409;RIO DE JANEIRO#0.9401;HYPOXIA#0.9396;HEAD AND NECK CANCER#0.9376;NECK CANCER#0.9375;CLOFIBRATE#0.9373;DIMETHYL SULFOXIDE#0.9372;ESOPHAGUS#0.9363;DRUG-INDUCED HEPATITIS#0.9362;DRUG METABOLIC#0.9362;PROTEASOME COMPLEX#0.9362;WARFARIN#0.9359;CYTOCHROME P450 ACTIVITY#0.9357;ACUTE LIVER FAILURE#0.9344;LEUKOCYTE#0.9337;IMMUNE RESPONSE#0.9337;HEPATOCYTE APOPTOSIS#0.9317;ANTIOXIDANT ACTIVITY#0.9311;TRADITIONAL CHINESE MEDICINE#0.9305;NECROTIC#0.9293;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9285;NEUROTOXICITY#0.9267;MONOCYTE#0.9266;URETHANE#0.9265;URIDINE#0.9243;XANTHINE#0.9240;WHITE BLOOD CELL#0.9239;CATABOLISM#0.9238;MICROSOMAL MEMBRANE#0.9237;RIFAMPIN#0.9235;NICOTINAMIDE#0.9214;MOLECULAR DYNAMICS SIMULATION#0.9202;HEAT SHOCK PROTEIN#0.9149;ADJUSTED ODDS RATIO#0.9149;FLAVIN#0.9145;PROTEIN STABILIZATION#0.9122;TOLUENE METABOLISM#0.9103;HYPERGLYCEMIA#0.9084;REGENERATION#0.9072;STREPTOZOTOCIN#0.9071;ADENINE#0.9033;TOLL LIKE RECEPTOR#0.9028;DRINKING BEHAVIOR#0.9015;INFLAMMATORY CELL#0.9003;RETINOL#0.8995;STRUCTURE ACTIVITY RELATIONSHIP#0.8951;CHOLINE#0.8940;ENDOPLASMIC RETICULUM STRESS#0.8937;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8933;CARNITINE#0.8931;CASPASE-3 ACTIVITY#0.8929;HEPATOCYTE PROLIFERATION#0.8923;TOCOPHEROL#0.8919;HEXANE#0.8913;S-ADENOSYL-L-METHIONINE#0.8902;PEROXISOMAL#0.8893;NEPHROTOXICITY#0.8887;FATTY ACID METABOLISM#0.8882;ADENINE DINUCLEOTIDE PHOSPHATE#0.8875;CENTRAL NERVOUS SYSTEM#0.8867;FATTY ACID SYNTHASE#0.8864;DIABETES MELLITUS#0.8861;NERVOUS SYSTEM#0.8857;L-METHIONINE#0.8856;BILE DUCT#0.8854;AMINOTRANSFERASE ACTIVITY#0.8851;GINSENG#0.8832;ELECTRON TRANSFER#0.8829;ARYLAMINE#0.8814;ALPHA-TOCOPHEROL#0.8786;CHRONIC LIVER DISEASE#0.8786;PHENYTOIN#0.8782;ACYL COA OXIDASE#0.8782;CLEAVED CASPASE 3#0.8775;SENSITIZATION#0.8766;OVARIAN#0.8736;HEPATITIS B#0.8733;CELL ACTIVATION#0.8711;FLAVIN CONTAINING MONOOXYGENASE#0.8710;CELL GROWTH#0.8691;ISCHEMIA#0.8681;HEPATITIS C VIRUS#0.8656;SMOOTH MUSCLE#0.8643;ARACHIDONIC ACID METABOLISM#0.8643;TOTAL ANTIOXIDANT CAPACITY#0.8620;ESTRADIOL#0.8617;DIMETHYLFORMAMIDE#0.8612;ALCOHOLIC HEPATITIS#0.8584;METOPROLOL#0.8525;PROSTATE CANCER#0.8507;KINASE INHIBITOR#0.8504;PALMITIC ACID#0.8500;NEUTROPHIL#0.8478;SULPHAPHENAZOLE#0.8469;GLYCINE#0.8460;ERYTHROCYTE#0.8451;SPERMATOGENESIS#0.8406;CHROMATID#0.8406;4-NITROCATECHOL#0.8404;ANTIOXIDANT DEFENSE SYSTEM#0.8401;TOTAL ENTERAL NUTRITION#0.8383;MITOCHONDRIAL PERMEABILITY TRANSITION#0.8366;PROGESTERONE#0.8364;GLUTAMATE CYSTEINE LIGASE#0.8360;ASCORBIC ACID#0.8342;BLOOD UREA NITROGEN#0.8324;MELATONIN#0.8299;DEBRISOQUIN#0.8295;DNA BINDING#0.8292;LOW DENSITY LIPOPROTEIN#0.8281;LIVER REGENERATION#0.8275;CYTOCHROME C OXIDASE#0.8265;TYPE 2 DIABETES#0.8260;VALPROIC ACID#0.8251;QUININE#0.8251;SMOOTH MUSCLE ACTIN#0.8239;PROTEIN KINASE B#0.8196;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8168;PULMONARY TUBERCULOSIS#0.8158;ALCOHOLIC LIVER CIRRHOSIS#0.8158;FRONTAL#0.8152;OLEIC ACID#0.8121;SUBSTANTIA NIGRA#0.8119;ORGANIC ANION TRANSPORTER#0.8117;SINGLE STRAND BREAK#0.8114;CHLORAL HYDRATE#0.8107;ADVERSE DRUG REACTION#0.8105;CYCLOSPORINE#0.8090;ARYLAMINE N ACETYLTRANSFERASE#0.8089;ORAL CAVITY#0.8086;TRIACETYLOLEANDOMYCIN#0.8077;ACETYL COA CARBOXYLASE#0.8069;DIPHOSPHATE#0.8057;PLASMA PROTEIN#0.8046;CERVICAL#0.8029;PHASE II METABOLISM#0.7998;MECHANISM OF ACTION#0.7995;ENDOTHELIAL CELL#0.7989;LIDOCAINE#0.7986;CYCLOPHOSPHAMIDE#0.7956;ACUTE HEPATIC INJURY#0.7944;ARTERY#0.7941;S-ADENOSYLMETHIONINE#0.7934;ALANINE AMINOTRANSFERASE ACTIVITY#0.7901;ETHYL CARBAMATE#0.7888;B CELL LYMPHOMA#0.7880;MODE OF ACTION#0.7868;TICLOPIDINE#0.7865;CYTOKINE PRODUCTION#0.7864;LUNG ADENOCARCINOMA#0.7848;TRIMETHADIONE#0.7846;TRANYLCYPROMINE#0.7846;LIPOGENESIS#0.7825;METABOLIC OXIDATIVE STRESS#0.7809;PROTEIN MODIFICATION#0.7797;LYMPHOBLAST#0.7754;GENISTEIN#0.7736;VALINE#0.7732;ACUTE LEUKEMIA#0.7732;STOMACH CANCER#0.7728;CARDIOMYOPATHY#0.7726;GAMMA-GLUTAMYLCYSTEINE#0.7723;ADENOSINE#0.7705;SKELETAL MUSCLE#0.7699;LYMPHOBLASTOID CELLS#0.7681;HIGH DENSITY LIPOPROTEIN#0.7672;FOLATE#0.7659;RAPAMYCIN#0.7650;HARDY WEINBERG EQUILIBRIUM#0.7650;SULFATION#0.7607;MECHANISMS OF ACTION#0.7597;HEPATITIS B VIRUS#0.7597;PROTEIN KINASE A#0.7586;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7559;VENOUS BLOOD#0.7539;RETINOID X RECEPTOR#0.7536;HEPATOCYTE GROWTH FACTOR#0.7532;GLIAL CELL#0.7530;COENZYME A#0.7529;TISSUE DAMAGE#0.7526;NUCLEIC ACID#0.7521;AMODIAQUINE#0.7511;TUMOR SUPPRESSOR#0.7499;INSULIN RECEPTOR#0.7495;SIGNALING MOLECULE#0.7492;VOLATILE ORGANIC COMPOUND#0.7490;DEHYDRATION#0.7479;IL-1RN#0.7470;BODY WEIGHT RATIO#0.7461;GLUCOSE UPTAKE#0.7449;OVARIES#0.7424;HYPERTENSION#0.7420;CYTOCHROME C RELEASE#0.7420;LIPID DROPLET#0.7419;LUNG DISEASE#0.7411;TAMOXIFEN#0.7401;EOSIN#0.7399;COLON MUCOSA#0.7399;ELECTROPHORETIC MOBILITY SHIFT#0.7396;L-CARNITINE#0.7390;GLUTAMINE#0.7385;TUMOUR NECROSIS FACTOR#0.7380;FATTY ACID SYNTHESIS#0.7379;ACUTE KIDNEY INJURY#0.7378;BETA-NF#0.7369;IMMUNE SYSTEM#0.7362;DOPAMINE#0.7360;NEURONAL CELLS#0.7358;OESOPHAGUS#0.7357;VERAPAMIL#0.7356;TRANSFERASE ACTIVITY#0.7346;VIRAL HEPATITIS#0.7305;LIVER LESIONS#0.7295;WEIGHT GAIN#0.7267;CARBAMAZEPINE#0.7254;CYTOPLASM#0.7243;ETHYLBENZENE#0.7234;PROXIMAL TUBULAR CELL#0.7233;NASAL MUCOSA#0.7226;SPERMATOZOA#0.7213;LOW BIRTH WEIGHT#0.7201;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7196;ORPHENADRINE#0.7183;ISOFLURANE#0.7178;GASTROINTESTINAL TRACT#0.7176;ENZYME INHIBITOR#0.7171;ANAESTHETIC#0.7146;INFLAMMATORY CELL INFILTRATION#0.7137;PREGNENOLONE#0.7114;ALCOHOLIC PANCREATITIS#0.7111;CELL SURFACE#0.7095;FRUCTOSE#0.7083;BENZYL ALCOHOL#0.7072;PROTEIN SYNTHESIS#0.7071;GINKGO BILOBA#0.7041;KIDNEY DAMAGE#0.7015;GELDANAMYCIN#0.6992;COPY NUMBER VARIATION#0.6982;ANTIGEN PRESENTATION#0.6974;COLLAGEN TYPE I#0.6972;L-CYSTEINE#0.6971;PHOSPHOLIPASE A2#0.6966;CHOLINE DEFICIENT DIET#0.6954;ALL TRANS RETINOIC ACID#0.6954;TYPE 2 DIABETIC#0.6946;MITOCHONDRIAL DNA#0.6941;L-ARGININE#0.6938;PARENCHYMA#0.6932;WEIGHT LOSS#0.6919;ESTROGEN RECEPTOR#0.6909;CLOTRIMAZOLE#0.6909;PYRUVATE#0.6908;IFN-GAMMA#0.6905;RECEPTOR ANTAGONIST#0.6896;MENADIONE#0.6887;GROWTH FACTOR RECEPTOR#0.6886;8-HYDROXY-2'-DEOXYGUANOSINE#0.6865;TUMOR TISSUES#0.6863;DOXORUBICIN#0.6861;ORGANELLE#0.6858;NEW CHEMICAL ENTITIES#0.6851;REPRODUCTIVE TOXICITY#0.6827;MULTIPLE REGRESSION ANALYSIS#0.6817;PORTAL VEIN#0.6817;METYRAPONE#0.6797;TRANSCRIPTIONAL CONTROL#0.6793;HORMONE METABOLISM#0.6760;CIPRO#0.6745;HCV CORE PROTEIN#0.6741;HEART DISEASE#0.6738;NEUROTOXIC#0.6724;ATPASE ACTIVITY#0.6699;VIRAL REPLICATION#0.6695;TRANSACTIVATION#0.6681;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6672;CAROTENOID#0.6655;B-LYMPHOBLAST#0.6636;DIAZEPAM#0.6626;C REACTIVE PROTEIN#0.6624;MONOCYTE DERIVED MACROPHAGE#0.6598;MICONAZOLE#0.6581;HODGKIN'S LYMPHOMA#0.6564;FLUVOXAMINE#0.6544;SERUM ALBUMIN#0.6533;EPIGALLOCATECHIN#0.6530;FURAN#0.6522;BETA CELL#0.6521;RESPIRATORY SYSTEM CANCER#0.6521;SOLUBLE EPOXIDE HYDROLASE#0.6504;PROTEIN PROTEIN INTERACTION#0.6504;MYELOID LEUKEMIA#0.6493;OF DIABETIC RATS#0.6491;EPIDERMAL GROWTH FACTOR#0.6470;ORAL SQUAMOUS CELL CARCINOMA#0.6455;ITRACONAZOLE#0.6454;ARGININE#0.6443;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6437;SUCROSE#0.6430;MULTIPLE LOGISTIC REGRESSION#0.6422;LYSINE#0.6415;ACTIVATION OF NF-KAPPAB#0.6415;REPORTER GENE ASSAY#0.6410;INSULIN RECEPTOR SUBSTRATE#0.6409;BINDING PROTEIN 1#0.6391;MYRICETIN#0.6378;CHEWING#0.6355;METABOLIC PROCESS#0.6321;BERBERINE#0.6307;PROTEIN OXIDATION#0.6274;RECEPTOR INTERACTING PROTEIN#0.6273;1,2,4-TRIAZOLE#0.6267;CYTOCHROME B5 REDUCTASE#0.6259;ADIPOCYTE#0.6237;HISTONE MODIFICATION#0.6202;ENFLURANE#0.6201;CERVICAL CANCER#0.6198;COLCHICINE#0.6180;RESPONSE TO ALCOHOL#0.6180;P-CRESOL#0.6173;EXTRACELLULAR MATRIX#0.6170;TARGET OF RAPAMYCIN#0.6153;SATURATED FATTY ACID#0.6141;ACUTE PHASE RESPONSE#0.6137;ALCOHOLIC CARDIOMYOPATHY#0.6132;CORONARY ARTERY#0.6126;CD4+ T CELL#0.6126;ELECTRON TRANSPORT#0.6122;ULCERATIVE COLITIS#0.6103;NF-KAPPAB ACTIVATION#0.6077;SINGLE CELL GEL#0.6074;HUMAN PRIMARY HEPATOCYTES#0.6068;1-HYDROXYLASE ACTIVITY#0.6065;CYCLOLEUCINE#0.6057;CYCLOHEXANOL#0.6053;FACTOR I#0.6044;UNCONDITIONAL LOGISTIC REGRESSION#0.6039;PROGENITOR CELL#0.6033;LACTATION#0.6028;ORAL SUBMUCOUS FIBROSIS#0.6007
157285	PROTEIN KINASE#0.9303;URIC ACID#0.8864;DOPAMINE#0.8819;ASCORBIC ACID#0.8718;DODECYL SULFATE#0.8667;SODIUM DODECYL SULFATE#0.8667;GROWTH FACTOR#0.8286;STRIATUM#0.8065;PARGYLINE#0.8060;KINASE ACTIVITY#0.8008;ENZYME ACTIVITY#0.7676;EPITHELIAL CELL#0.7667;EXCRETION#0.7650;GENE EXPRESSION#0.7511;SIGNALING PATHWAY#0.7218;FIBRINOGEN#0.7089;DIFFERENTIAL PULSE VOLTAMMETRY#0.7086;DNA BINDING#0.6860;CELL PROLIFERATION#0.6752;ETHANOL#0.6522;SUCROSE#0.6365;HEPARIN#0.6339;DIGESTION#0.6237;SIZE EXCLUSION CHROMATOGRAPHY#0.6218;ARACHIDONIC ACID#0.6045
1572	CYTOCHROME P450#1.0112;RESPIRATORY TRACT#0.9712;TOXICITY#0.9638;CYTOTOXICITY#0.8526;GENE EXPRESSION#0.7614;POLYMERASE CHAIN REACTION#0.7274;LUNG CANCER#0.7252;MODE OF ACTION#0.7028;TCE METABOLISM#0.6769;EPITHELIAL CELL#0.6744;GLUTATHIONE#0.6693;CARCINOGEN#0.6281;BENZENE METABOLISM#0.6226
157310	PHOSPHATIDYLETHANOLAMINE BINDING#1.1180;PHOSPHATIDYLETHANOLAMINE#1.0991;CANCER CELL#1.0925;BREAST CANCER#1.0577;LUNG CANCER#1.0538;APOPTOSIS#1.0497;CELL PROLIFERATION#0.9825;BREAST CANCER CELL#0.9512;APOPTOTIC#0.9406;TUMOR CELLS#0.8788;TUMOR NECROSIS FACTOR#0.8712;SIGNALING PATHWAY#0.8701;CELL GROWTH#0.8449;PROSTATE CANCER#0.8255;B CELL#0.7891;LYMPH NODE#0.7178;CELL CYCLE#0.7018;RNA INTERFERENCE#0.6369;ESTROGEN RECEPTOR#0.6263;OVARIAN CANCER#0.6205;CISPLATIN#0.6071;CYTOTOXICITY#0.6031
157313	CELL DIVISION CYCLE#1.0352;CELL DIVISION#1.0214;NUCLEAR ENVELOPE#0.9700;CELL CYCLE#0.9157;ANAPHASE#0.8853;PROTEIN PHOSPHATASE 1#0.8380;CELL PROLIFERATION#0.7471;MITOTIC EXIT#0.7405;DEPHOSPHORYLATION#0.7278;ADENOCARCINOMA#0.7221;SQUAMOUS CELL CARCINOMA#0.7189;PANCREATIC DUCTAL ADENOCARCINOMA#0.6511;LUNG ADENOCARCINOMA#0.6465;G1 PHASE#0.6456;TUMOR TISSUES#0.6451;APOPTOSIS#0.6450;SPINDLE ORIENTATION#0.6119
157378	INTERCALATED DISC#0.7842;MITOCHONDRIAL ENCEPHALOMYOPATHY#0.7643;MITOCHONDRIAL INNER MEMBRANE#0.7374;INNER MITOCHONDRIAL MEMBRANE#0.6395;MITOCHONDRIAL MEMBRANE#0.6276
1573	ASTEMIZOLE#1.0994;ARACHIDONIC ACID EPOXYGENASE#1.0921;CORONARY ARTERY DISEASE#1.0699;ARTERY DISEASE#1.0696;CORONARY ARTERY#1.0658;TERFENADINE#1.0428;ARTERY#1.0390;APOPTOSIS#1.0382;CARDIOMYOCYTE#1.0278;ENDOTHELIAL CELL#1.0226;EPOXIDE HYDROLASE#1.0205;SOLUBLE EPOXIDE HYDROLASE#1.0199;MICROSOME#1.0198;POLYMERASE CHAIN REACTION#1.0187;CARDIOVASCULAR SYSTEM#1.0187;SIGNALING PATHWAY#1.0173;ARACHIDONIC ACID#1.0122;DRUG METABOLISM#1.0089;HYPERTENSION#1.0017;CYTOCHROME P450#0.9865;CELL PROLIFERATION#0.9824;SMOOTH MUSCLE#0.9805;TELMISARTAN#0.9771;DEMETHYLATION#0.9732;ENDOTHELIUM#0.9729;CANCER CELL#0.9720;SMALL INTESTINE#0.9676;ARACHIDONIC ACID METABOLISM#0.9669;ISCHEMIA#0.9634;MACROPHAGE#0.9593;HIGH FAT DIET#0.9487;PROTEIN KINASE#0.9480;MYOCARDIAL INFARCTION#0.9334;ESSENTIAL HYPERTENSION#0.9265;SMOOTH MUSCLE CELL#0.9244;MUSCLE CELL#0.9237;TRANSCRIPTION FACTOR#0.9222;AMIODARONE#0.9207;GROWTH FACTOR#0.8916;GENE EXPRESSION#0.8733;ANGIOGENESIS#0.8660;TUMOR NECROSIS FACTOR#0.8565;ALBENDAZOLE#0.8446;DANAZOL#0.8304;MITOGEN ACTIVATED PROTEIN#0.8273;ADENO ASSOCIATED VIRUS#0.8226;TUMOR TISSUES#0.8172;NITRIC OXIDE#0.8139;ACTIVATOR PROTEIN 1#0.8080;ISCHEMIA REPERFUSION INJURY#0.8044;HYPOXIA#0.8037;EPITHELIAL CELL#0.7984;INFLAMMATORY RESPONSE#0.7958;FRAGMENT LENGTH POLYMORPHISM#0.7880;DRONEDARONE#0.7687;MACROPHAGE POLARIZATION#0.7636;REACTIVE OXYGEN SPECIES#0.7622;VASCULAR ENDOTHELIAL CELL#0.7619;REVERSE TRANSCRIPTION#0.7612;EXCRETION#0.7427;HUMAN INTESTINAL MICROSOMES#0.7367;PEROXISOME#0.7360;VASCULAR ENDOTHELIUM#0.7340;TOXICITY#0.7330;TUMOR CELLS#0.7218;AKT SIGNALING#0.7016;HEART DISEASE#0.6898;KETOCONAZOLE#0.6859;BREAST CANCER#0.6858;DOXORUBICIN#0.6841;PULMONARY ARTERY#0.6800;CORONARY HEART DISEASE#0.6725;FATTY ACID METABOLISM#0.6579;MIDAZOLAM#0.6442;RIVAROXABAN#0.6399;PHENOBARBITAL#0.6274;ATHEROSCLEROSIS#0.6269;TRANSACTIVATION#0.6268;MYOCYTES#0.6265;MONOCYTE#0.6211;ASTROCYTE#0.6132;VASODILATOR#0.6071;OXYGENASE#0.6059;ENDOPLASMIC RETICULUM#0.6037
157506	RETINOL DEHYDROGENASE#1.0741;RETINOL#1.0655;RETINOIC ACID#1.0304;VITAMIN A#1.0071;ALL-TRANS-RETINOL#0.9874;TRANS-RETINOL#0.9872;ALL TRANS RETINOIC ACID#0.9024;GENE EXPRESSION#0.8804;RETINOL BINDING#0.7884;SIGNALING PATHWAY#0.7022;RETINAL PIGMENT EPITHELIUM#0.6441;LIPID DROPLET#0.6214;SALIVARY GLAND#0.6128;RETINAL DEHYDROGENASE#0.6085;RETINOID METABOLISM#0.6024;VITAMIN A METABOLISM#0.6018
157567	EMBRYO IMPLANTATION#0.6950
157570	ROBERTS SYNDROME#1.1169;SISTER CHROMATID COHESION#1.0713;CHROMATID#1.0502;S PHASE#1.0286;DNA REPLICATION#1.0201;CELL CYCLE#0.9807;COHESIN COMPLEX#0.9198;CHROMOSOME SEGREGATION#0.8810;APOPTOSIS#0.7650;MEIOSIS#0.7586;MITOSIS#0.7447;CELL PROLIFERATION#0.7257;GENE EXPRESSION#0.7172;CORNELIA DE LANGE SYNDROME#0.6935;MCM COMPLEX#0.6582;HETEROCHROMATIN#0.6376;MITOTIC CHROMOSOME#0.6366;CENTROMERE#0.6246
157574	TUMOR SUPPRESSOR#0.8253
157638	PROSTATE CANCER#0.7788;APOPTOSIS SIGNALING#0.6119;LUNG METASTASIS#0.6022
157657	RETINITIS PIGMENTOSA#0.9025;CONE ROD DYSTROPHY#0.8275;RETINITIS#0.7684;RETINAL DEGENERATION#0.6467;PHOSPHORUS METABOLISM#0.6208;PHOTORECEPTOR OUTER SEGMENT#0.6082
157680	NEUTROPENIA#0.9694;VACUOLAR PROTEIN SORTING#0.9315;MICROCEPHALY#0.9050;MENTAL RETARDATION#0.8620;GROUP B STREPTOCOCCUS#0.8514;INTELLECTUAL DISABILITY#0.8500;DEVELOPMENTAL DELAY#0.8256;COPY NUMBER VARIATION#0.7332;DELTA E#0.6573;GOLGI APPARATUS#0.6459;MONOCYTE#0.6366;GOLGI COMPLEX#0.6209
157695	SPERMATOGENESIS#0.7608;SPERMATOGENIC CELLS#0.7584;AGE RELATED MACULAR DEGENERATION#0.7030;MACULAR DEGENERATION#0.7022;TESTIS DEVELOPMENT#0.6280
1576	CHOLESTEROL 25 HYDROXYLASE#1.0894;ALFENTANIL#1.0638;ERYTHROMYCIN A#1.0597;DELAVIRDINE#1.0569;APREPITANT#1.0556;NOR-LAAM#1.0531;6BETA-HYDROXYLASE ACTIVITY#1.0525;BUPRENORPHINE#1.0523;TICAGRELOR#1.0494;REPAGLINIDE#1.0490;TELITHROMYCIN#1.0490;KETAMINE#1.0489;MIBEFRADIL#1.0477;QUETIAPINE#1.0470;HYPERFORIN#1.0467;PACLITAXEL METABOLISM#1.0463;TRIACETYLOLEANDOMYCIN#1.0450;OXYCODONE#1.0445;ARIPIPRAZOLE#1.0436;POSACONAZOLE#1.0433;BOSENTAN#1.0431;ZOLPIDEM#1.0427;BUDESONIDE#1.0408;CISAPRIDE#1.0405;NEFAZODONE#1.0396;GESTODENE#1.0389;9-HYDROXYRISPERIDONE#1.0382;XANTHINE OXIDASE#1.0374;BUSPIRONE#1.0370;AMPRENAVIR#1.0365;TELAPREVIR#1.0352;CILOSTAZOL#1.0351;ALPRAZOLAM#1.0350;FENTANYL#1.0348;DAPSONE#1.0337;FELODIPINE#1.0334;LIDOCAINE#1.0334;LAPATINIB#1.0328;TRIAZOLAM#1.0326;ETOPOSIDE#1.0324;DOMPERIDONE#1.0305;RIFABUTIN#1.0294;HUMAN INTESTINAL MICROSOMES#1.0292;METHADONE#1.0288;EVEROLIMUS#1.0285;TROGLITAZONE#1.0284;1-HYDROXYLASE ACTIVITY#1.0284;MARAVIROC#1.0283;FEXOFENADINE#1.0282;SILDENAFIL#1.0269;SORAFENIB#1.0261;TROLEANDOMYCIN#1.0254;RIVAROXABAN#1.0254;NICARDIPINE#1.0253;QUININE#1.0249;ALDEHYDE OXIDASE#1.0248;METYRAPONE#1.0244;TERFENADINE#1.0239;BOSUTINIB#1.0235;GEFITINIB#1.0234;CICLOSPORIN#1.0232;ERLOTINIB#1.0231;LANSOPRAZOLE#1.0229;ASTEMIZOLE#1.0226;MULTIDRUG RESISTANCE PROTEIN#1.0224;BORTEZOMIB#1.0222;ETHINYL ESTRADIOL#1.0222;VINCRISTINE#1.0219;PIOGLITAZONE#1.0218;LOSARTAN#1.0213;CIPROFLOXACIN#1.0212;AMODIAQUINE#1.0211;CLARITHROMYCIN#1.0208;SIROLIMUS#1.0207;AMLODIPINE#1.0202;INDINAVIR#1.0188;NELFINAVIR#1.0182;ITRACONAZOLE#1.0178;BERBERINE#1.0177;LOVASTATIN#1.0176;VORICONAZOLE#1.0171;RISPERIDONE#1.0166;TICLOPIDINE#1.0166;SUNITINIB#1.0165;IFOSFAMIDE#1.0161;HUMAN PRIMARY HEPATOCYTES#1.0161;BUPROPION#1.0160;FLUVASTATIN#1.0159;DRUG METABOLIC#1.0157;DOCETAXEL#1.0156;DRONEDARONE#1.0154;RESVERATROL#1.0150;CLOZAPINE#1.0150;CLOPIDOGREL#1.0149;NIFEDIPINE#1.0149;RIFAMPIN#1.0148;CERIVASTATIN#1.0145;DILTIAZEM#1.0141;OXYMORPHONE#1.0138;ATAZANAVIR#1.0137;BUFURALOL#1.0134;MIDAZOLAM#1.0133;AMIODARONE#1.0133;AZITHROMYCIN#1.0129;DEXTROMETHORPHAN#1.0129;N ACETYLTRANSFERASE#1.0126;IMATINIB#1.0125;MICONAZOLE#1.0122;ENTEROCYTE#1.0118;COLCHICINE#1.0117;SAQUINAVIR#1.0117;ERYTHROMYCIN#1.0116;EFAVIRENZ#1.0115;RALOXIFENE#1.0113;TOCOPHEROL#1.0111;DICLOFENAC#1.0101;HEPATOMA CELLS#1.0098;DIAZEPAM#1.0098;QUERCETIN#1.0096;DARUNAVIR#1.0093;COLON CARCINOMA#1.0088;PHENACETIN#1.0088;RITONAVIR#1.0086;ATORVASTATIN#1.0086;IRINOTECAN#1.0086;VITAMIN D3#1.0086;TACROLIMUS#1.0085;CYTOCHROME B#1.0082;FLUCONAZOLE#1.0081;KETOCONAZOLE#1.0079;P-NITROPHENOL#1.0076;CHLORZOXAZONE#1.0075;HALOPERIDOL#1.0072;NEVIRAPINE#1.0069;FLUVOXAMINE#1.0068;TAMOXIFEN#1.0068;ISONIAZID#1.0067;PAZOPANIB#1.0066;XANTHINE#1.0064;FRAGMENT LENGTH POLYMORPHISM#1.0064;HIV PROTEASE INHIBITOR#1.0064;ELECTRON TRANSFER#1.0062;METOPROLOL#1.0060;MEPHENYTOIN#1.0058;INTESTINAL MUCOSA#1.0054;RIFAMPICIN#1.0053;NARINGENIN#1.0052;ELECTROPHORETIC MOBILITY SHIFT#1.0052;PITAVASTATIN#1.0052;MIFEPRISTONE#1.0050;HEPATOCYTE NUCLEAR FACTOR#1.0050;SIMVASTATIN#1.0045;PACLITAXEL#1.0041;LUCIFERASE ACTIVITY#1.0041;CORTISOL#1.0039;FETAL LIVER#1.0034;CAFFEINE#1.0034;COUMARIN 7 HYDROXYLASE#1.0033;CLOTRIMAZOLE#1.0033;DEMETHYLASE ACTIVITY#1.0032;SULFAPHENAZOLE#1.0031;ZIPRASIDONE#1.0030;ROSIGLITAZONE#1.0030;GINSENG#1.0030;4-HYDROXYTAMOXIFEN#1.0027;LOPINAVIR#1.0026;CARBAMAZEPINE#1.0024;SERTRALINE#1.0020;CYCLOSPORINE#1.0014;ROSUVASTATIN#1.0014;TESTOSTERONE#1.0011;CYCLOSPORIN A#1.0011;VENLAFAXINE#1.0010;OMEPRAZOLE#1.0009;TOLBUTAMIDE#1.0006;ORGANIC ANION TRANSPORTER#1.0004;VERAPAMIL#1.0003;HYDROXYLASE ACTIVITY#0.9998;HIGH FAT DIET#0.9997;VITAMIN D RECEPTOR#0.9994;EFFLUX PUMP#0.9994;TRANSACTIVATION#0.9994;OBESE#0.9991;SULPHAPHENAZOLE#0.9989;IMIPRAMINE#0.9988;FLUOXETINE#0.9982;GEMFIBROZIL#0.9980;CATALYTIC ACTIVITY#0.9979;METHYLPREDNISOLONE#0.9976;DEBRISOQUINE#0.9976;LOPERAMIDE#0.9973;REPORTER GENE ASSAY#0.9973;ATP BINDING CASSETTE#0.9972;ROPIVACAINE#0.9971;RETINOID X RECEPTOR#0.9969;BREAST CANCER PATIENTS#0.9964;KIDNEY TRANSPLANT RECIPIENTS#0.9956;JEJUNUM#0.9954;SMALL INTESTINE#0.9954;ATP BINDING#0.9952;GINKGO BILOBA#0.9948;CYTOCHROME B5#0.9947;PAROXETINE#0.9945;LYMPHOBLAST#0.9942;PREGNENOLONE#0.9941;ALPHA-TOCOPHEROL#0.9939;DEMETHYLATION#0.9939;PREDNISOLONE#0.9939;ANILINE#0.9937;RENAL TRANSPLANT RECIPIENTS#0.9935;LYMPHOBLASTOID CELLS#0.9933;CYCLOSPORIN#0.9928;EPOXIDE HYDROLASE#0.9925;PHENYTOIN#0.9924;PROGESTERONE#0.9917;MUTAGENESIS#0.9912;PRAVASTATIN#0.9911;DEXAMETHASONE#0.9910;CALCIUM CHANNEL#0.9909;CIMETIDINE#0.9909;VINBLASTINE#0.9908;OXCARBAZEPINE#0.9907;RILPIVIRINE#0.9906;NEW CHEMICAL ENTITIES#0.9905;DIMETHYL SULFOXIDE#0.9903;XENOBIOTIC METABOLIZING ENZYME#0.9901;PREGNANE X RECEPTOR#0.9901;QUINIDINE#0.9900;VITAMIN E#0.9899;DESIPRAMINE#0.9898;POPULATION PHARMACOKINETIC MODEL#0.9896;DUODENUM#0.9896;THEOPHYLLINE#0.9893;QUANTITATIVE REAL TIME#0.9893;ETHANOL#0.9886;ORPHENADRINE#0.9884;PRIMARY HUMAN HEPATOCYTES#0.9883;ABC TRANSPORTER#0.9882;DIGOXIN#0.9881;ST. JOHN'S WORT#0.9879;APIXABAN#0.9878;MENSTRUAL CYCLE#0.9877;ADENOCARCINOMA#0.9877;VALPROIC ACID#0.9875;OXIDATIVE METABOLISM#0.9874;DRUG TRANSPORT#0.9870;DIPHOSPHATE#0.9869;MYRICETIN#0.9863;FLAVIN CONTAINING MONOOXYGENASE#0.9862;WARFARIN#0.9861;ACETAMINOPHEN#0.9859;1α,25-DIHYDROXYVITAMIN D3#0.9858;CPT-11#0.9858;ENZYME ACTIVITY#0.9854;URIDINE#0.9852;GLUCOCORTICOID RECEPTOR#0.9852;CYCLOPHOSPHAMIDE#0.9850;CATABOLISM#0.9848;RU486#0.9847;RANOLAZINE#0.9841;CALCINEURIN#0.9838;PROSTATE CANCER#0.9835;BOCEPREVIR#0.9828;BETA-NAPHTHOFLAVONE#0.9827;PHENOBARBITAL#0.9826;PRASUGREL#0.9818;PROTEASOME#0.9815;MOLAR#0.9808;PROTEIN PROTEIN INTERACTION#0.9807;ETHINYLESTRADIOL#0.9805;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9804;INTESTINAL ABSORPTION#0.9803;OXYGENASE#0.9803;MYOPATHY#0.9803;CITALOPRAM#0.9798;CHOLESTASIS#0.9798;LIGNOCAINE#0.9798;OVARIAN CANCER#0.9797;STRUCTURE ACTIVITY RELATIONSHIP#0.9797;ESTRADIOL#0.9796;UBIQUITIN#0.9789;COLON CANCER#0.9788;ACUTE CORONARY SYNDROME#0.9788;TUMOR NECROSIS FACTOR#0.9788;NARROW THERAPEUTIC INDEX#0.9787;POLYMERASE CHAIN REACTION#0.9786;ENDOPLASMIC RETICULUM#0.9782;PARACETAMOL#0.9781;COLON ADENOCARCINOMA#0.9780;DRUG RESISTANCE#0.9778;ENZYME INHIBITOR#0.9774;GROWTH HORMONE#0.9773;MYELOID LEUKEMIA#0.9770;ARACHIDONIC ACID#0.9769;FATTY LIVER#0.9766;CHRONIC LIVER DISEASE#0.9766;FLAVIN#0.9765;PEROXISOME#0.9765;REVERSE TRANSCRIPTION#0.9764;RIFAMYCIN#0.9763;IMMUNOSUPPRESSANT#0.9762;CELL DEATH#0.9761;LIVER CIRRHOSIS#0.9755;PROTEIN KINASE#0.9755;PERIPHERAL BLOOD#0.9752;TAXOL#0.9750;TRAZODONE#0.9750;ARTEMETHER#0.9747;RETINOIC ACID#0.9744;SUPEROXIDE DISMUTASE#0.9744;DOXORUBICIN#0.9743;AFRICAN AMERICAN MEN#0.9743;INFLAMMATORY RESPONSE#0.9741;MACROPHAGE#0.9740;PLATELET AGGREGATION#0.9740;MICROSOME#0.9738;CELL CYCLE#0.9737;TUMOR CELLS#0.9736;XENOBIOTIC METABOLISM#0.9736;DEHYDROEPIANDROSTERONE#0.9736;ONDANSETRON#0.9736;CHRONIC MYELOID LEUKEMIA#0.9731;POLYCYCLIC AROMATIC HYDROCARBON#0.9730;GENE EXPRESSION#0.9730;CYTOCHROME P450 ACTIVITY#0.9729;REVERSE TRANSCRIPTASE INHIBITOR#0.9727;KIDNEY DISEASE#0.9724;STEROID RECEPTOR COACTIVATOR#0.9722;DNA BINDING#0.9717;CYTOTOXICITY#0.9716;SEROTONIN REUPTAKE INHIBITOR#0.9713;GENOTOXICITY#0.9713;EPITHELIAL CELL#0.9713;AMINOPYRINE#0.9712;CELL PROLIFERATION#0.9712;RABEPRAZOLE#0.9711;PROTON PUMP INHIBITOR#0.9710;TRANSCRIPTASE#0.9708;OVARIAN#0.9707;ESOMEPRAZOLE#0.9706;HEPATOTOXICITY#0.9706;TOLTERODINE#0.9701;INDOLE#0.9700;LIGAND BINDING DOMAIN#0.9698;ANDROGEN RECEPTOR#0.9698;GASTROINTESTINAL TRACT#0.9696;ESTROGEN RECEPTOR#0.9694;NEUROTOXICITY#0.9694;PROTON PUMP#0.9693;ALZHEIMER'S DISEASE#0.9691;DETOXIFICATION#0.9690;HEPATOCELLULAR CARCINOMA#0.9689;CLOBAZAM#0.9689;PANTOPRAZOLE#0.9687;OPIOID RECEPTOR#0.9686;MULTIPLE LINEAR REGRESSION#0.9686;NITRIC OXIDE#0.9682;COLORECTAL#0.9682;DNA REPAIR#0.9679;TRADITIONAL CHINESE MEDICINE#0.9679;RHEUMATOID ARTHRITIS#0.9679;NEPHROTOXICITY#0.9678;METRONIDAZOLE#0.9677;PHASE II METABOLISM#0.9674;HEPATITIS C VIRUS#0.9673;TUBERCULOSIS#0.9671;REACTIVE OXYGEN SPECIES#0.9670;CANCER CELL#0.9668;DASATINIB#0.9666;COENZYME A#0.9664;MONTELUKAST#0.9662;AMITRIPTYLINE#0.9659;STEROID METABOLISM#0.9658;TYPE 2 DIABETES#0.9658;MOLECULAR DYNAMICS SIMULATION#0.9656;DRUG METABOLISM#0.9656;CODEINE#0.9655;HEART DISEASE#0.9650;CONJUGATION#0.9649;CARCINOGEN#0.9648;ARYL HYDROCARBON RECEPTOR#0.9647;SIGNALING PATHWAY#0.9646;PERCUTANEOUS CORONARY INTERVENTION#0.9645;TYROSINE KINASE INHIBITOR#0.9644;HEPATITIS C#0.9642;EPILEPSY#0.9639;ATRIAL FIBRILLATION#0.9638;ADVERSE DRUG REACTION#0.9637;KIDNEY TRANSPLANT PATIENTS#0.9637;EMBRYONIC KIDNEY#0.9636;VITAMIN K#0.9635;RECEPTOR BINDING#0.9635;KINASE INHIBITOR#0.9634;BREAST CANCER#0.9632;GENOTOXIC#0.9631;GLUTATHIONE#0.9625;CELL GROWTH#0.9623;CYTOCHROME P450#0.9622;TRANSCRIPTION FACTOR#0.9621;RECEPTOR LIGAND#0.9621;LIVER DISEASE#0.9619;THERAPEUTIC DRUG MONITORING#0.9615;RECEPTOR AGONIST#0.9609;PORTAL VEIN#0.9605;LUNG CANCER#0.9604;ANDROSTENEDIONE#0.9603;CORTISOL METABOLISM#0.9601;GLOMERULAR FILTRATION#0.9599;APOPTOSIS#0.9598;HYPERCHOLESTEROLEMIA#0.9597;GEOMETRIC MEAN RATIO#0.9597;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9596;EPIDERMAL GROWTH FACTOR#0.9595;RECEPTOR ANTAGONIST#0.9594;CHENODEOXYCHOLIC ACID#0.9594;MALARIA#0.9590;SERUM ALBUMIN#0.9587;NICOTINAMIDE#0.9587;PHENPROCOUMON#0.9585;DIABETES MELLITUS#0.9585;LOW DENSITY LIPOPROTEIN#0.9583;BONE MARROW#0.9583;COLORECTAL CANCER#0.9580;C REACTIVE PROTEIN#0.9580;HUMAN EMBRYONIC KIDNEY#0.9578;GLOMERULAR FILTRATION RATE#0.9578;ALKALINE PHOSPHATASE#0.9577;ALANINE#0.9575;EXCRETION#0.9575;PROTEIN BINDING#0.9573;LINEAR REGRESSION ANALYSIS#0.9572;BLOOD BRAIN BARRIER#0.9567;NEUTROPENIA#0.9566;72-HOURS#0.9563;SOLID PHASE EXTRACTION#0.9562;HUMAN IMMUNODEFICIENCY VIRUS#0.9562;ARTERY#0.9562;LIVER DAMAGE#0.9560;VOMITING#0.9556;HYDROCORTISONE#0.9554;ADENOSINE#0.9552;SEDATION#0.9548;HYPERTENSION#0.9547;PLASMA PROTEIN#0.9547;MUTAGENIC#0.9546;GLUTATHIONE PEROXIDASE#0.9544;HISTONE DEACETYLASE#0.9544;ARRHYTHMIA#0.9540;MIRTAZAPINE#0.9538;GROWTH FACTOR RECEPTOR#0.9537;MECHANISM OF ACTION#0.9536;GROWTH FACTOR#0.9535;DOPAMINE#0.9532;MIRABEGRON#0.9529;ASPARTATE#0.9528;CENTRAL NERVOUS SYSTEM#0.9527;ESTRONE#0.9526;ANDROGEN METABOLISM#0.9523;LORATADINE#0.9521;LEVONORGESTREL#0.9521;CORONARY ARTERY#0.9521;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9517;LIPID METABOLISM#0.9516;MONONUCLEAR CELLS#0.9514;GENISTEIN#0.9510;DIARRHEA#0.9506;SERIOUS ADVERSE EVENT#0.9505;PLURIPOTENT STEM CELL#0.9504;NERVOUS SYSTEM#0.9503;FURAN#0.9492;TOXICITY#0.9491;ALL TRANS RETINOIC ACID#0.9487;PIPERAZINE#0.9485;T CELL#0.9483;SULFATION#0.9482;PREDNISONE#0.9480;STEM CELL#0.9476;ADENINE DINUCLEOTIDE PHOSPHATE#0.9476;ABIRATERONE#0.9473;ENDOTHELIAL CELL#0.9472;TOLVAPTAN#0.9466;ETHYLMORPHINE#0.9458;MECHANISMS OF ACTION#0.9456;FARNESOID X RECEPTOR#0.9453;NILOTINIB#0.9448;MULTI DRUG RESISTANCE#0.9436;IMMUNE RESPONSE#0.9428;LEUKOCYTE#0.9424;PROPOFOL#0.9424;GESTATION#0.9420;HYPOXIA#0.9411;FACTOR XA#0.9409;INTESTINAL TRACT#0.9406;FATTY LIVER DISEASE#0.9403;NUCLEAR HORMONE RECEPTOR#0.9401;RESPONSE TO DRUG#0.9395;BILE DUCT#0.9394;ADENINE#0.9393;CELECOXIB#0.9393;HEPATITIS B#0.9388;BENZIMIDAZOLE#0.9385;DRUG BINDING#0.9382;TAMSULOSIN#0.9374;HEPATOCELLULAR CARCINOMA CELL#0.9371;INDUCED PLURIPOTENT STEM CELL#0.9369;TRANYLCYPROMINE#0.9363;CYTOCHROME C#0.9350;PROPAFENONE#0.9349;LUMEFANTRINE#0.9348;THROMBOSIS#0.9344;N-ACETYLCYSTEINE#0.9342;PROTEIN SYNTHESIS#0.9340;LIVER X RECEPTOR#0.9335;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9332;TOPICAL#0.9323;BILE ACID SYNTHESIS#0.9321;ACUTE MYELOID LEUKEMIA#0.9320;RUXOLITINIB#0.9314;GLIBENCLAMIDE#0.9310;TENOFOVIR#0.9306;APOPTOTIC#0.9305;TUMOR TISSUES#0.9301;PROPRANOLOL#0.9299;UREMIC TOXIN#0.9298;OLANZAPINE#0.9297;ISCHEMIA#0.9295;ALBENDAZOLE#0.9294;TYPE 2 DIABETES MELLITUS#0.9293;2 DIABETES MELLITUS#0.9293;GLUTATHIONE TRANSFERASE#0.9288;IBUPROFEN#0.9286;DONEPEZIL#0.9286;CYCLIN DEPENDENT KINASE#0.9280;BREAST CANCER CELL#0.9275;INTESTINAL EPITHELIAL CELL#0.9274;CYSTIC FIBROSIS#0.9268;BODY SURFACE AREA#0.9267;SKELETAL MUSCLE#0.9265;ENDOMETRIAL CANCER#0.9257;GLYCOPROTEIN TRANSPORT#0.9251;GLYBURIDE#0.9242;ANTIOXIDANT ACTIVITY#0.9225;SPARTEINE#0.9220;MAXIMUM TOLERATED DOSE#0.9217;PHOSPHODIESTERASE#0.9215;RENAL CELL CARCINOMA#0.9210;HISTAMINE#0.9210;GINKGOLIDE A#0.9206;DEBRISOQUIN#0.9198;TEMAZEPAM#0.9194;MITOGEN ACTIVATED PROTEIN#0.9190;CYTOPLASM#0.9188;GINKGO BILOBA EXTRACT#0.9184;WEIGHT GAIN#0.9183;VINORELBINE#0.9183;IVACAFTOR#0.9182;BROMOCRIPTINE#0.9180;NEUROTOXIC#0.9178;MYOCARDIAL INFARCTION#0.9178;CHOLESTEROL METABOLISM#0.9178;RAPAMYCIN#0.9178;PRO-INFLAMMATORY#0.9174;CISPLATIN#0.9173;INFLAMMATORY BOWEL DISEASE#0.9167;BLOOD PLASMA#0.9165;ANTIPYRINE#0.9161;CORONARY ARTERY DISEASE#0.9159;ARTERY DISEASE#0.9157;FIBROBLAST GROWTH FACTOR#0.9155;NEUTROPHIL#0.9154;ETHOSUXIMIDE#0.9154;QUANTITATIVE REVERSE TRANSCRIPTION#0.9153;CELL MEMBRANE#0.9153;PROTEIN KINASE C#0.9151;ASPIRIN#0.9148;RESPIRATORY TRACT#0.9142;TOXICANT#0.9140;ENHANCER BINDING PROTEIN#0.9137;ETHYNYLESTRADIOL#0.9135;ENHANCER BINDING#0.9132;URSODEOXYCHOLIC ACID#0.9130;PHENOBARBITONE#0.9128;PERAMPANEL#0.9128;GLYCINE#0.9124;TEMSIROLIMUS#0.9123;NUCLEAR RECEPTOR SUPERFAMILY#0.9119;DABIGATRAN#0.9107;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9106;FLUNITRAZEPAM#0.9105;MULTIPLE REGRESSION ANALYSIS#0.9103;DIPEPTIDYL PEPTIDASE#0.9092;HORMONE METABOLISM#0.9083;ESTROGEN RECEPTOR ALPHA#0.9082;BETA-NF#0.9075;CELLULAR LOCALIZATION#0.9067;ATP BINDING CASSETTE TRANSPORTER#0.9064;THROMBOCYTOPENIA#0.9048;WEIGHT LOSS#0.9043;ACUTE KIDNEY INJURY#0.9039;HIGH DENSITY LIPOPROTEIN#0.9038;METFORMIN#0.9028;PROTEIN DEGRADATION#0.9024;HYPOTENSION#0.9020;MULTIPLE MYELOMA#0.9014;ENDOTHELIN RECEPTOR#0.9009;ESTROGENS#0.9006;SOLID ORGAN TRANSPLANTATION#0.9006;RECEPTOR TYROSINE KINASE#0.9004;COLITIS#0.9002;TADALAFIL#0.8997;ROXITHROMYCIN#0.8995;PIMOZIDE#0.8989;LINEAR MIXED EFFECTS#0.8986;ACETIC ACID#0.8980;MITOTANE#0.8978;ENZALUTAMIDE#0.8973;MUTAGENICITY#0.8971;ORGANIC CATION TRANSPORTER#0.8970;TRYPTOPHAN#0.8968;DOSE LIMITING TOXICITIES#0.8962;ENDOTHELIAL GROWTH FACTOR#0.8949;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8949;EXTRACELLULAR MATRIX#0.8948;CHLORAMPHENICOL#0.8945;FLURBIPROFEN#0.8944;RIFAPENTINE#0.8942;LINES OF EVIDENCE#0.8940;MYCOPHENOLIC ACID#0.8924;PROGUANIL#0.8924;REGORAFENIB#0.8920;STEROIDOGENESIS#0.8917;AXITINIB#0.8907;MYCOPHENOLATE MOFETIL#0.8904;LIMIT OF QUANTIFICATION#0.8901;DIGESTION#0.8899;GI TRACT#0.8895;B CELL#0.8885;DUAL LUCIFERASE REPORTER#0.8881;MICROTUBULE#0.8877;HEPATITIS B VIRUS#0.8873;CARBOPLATIN#0.8872;MONOOXYGENASE ACTIVITY#0.8870;CHRONIC KIDNEY DISEASE#0.8867;SUFENTANIL#0.8862;FK-506#0.8855;CHLORPROMAZINE#0.8847;FORMIC ACID#0.8844;COMPOUND S#0.8844;INSOMNIA#0.8841;GLUCURONIC ACID#0.8837;MITOCHONDRIA#0.8822;SYSTOLIC BLOOD PRESSURE#0.8818;NEUROPATHY#0.8817;GASTROINTESTINAL STROMAL TUMOR#0.8817;RESPONSE TO CLOPIDOGREL#0.8815;MESENCHYMAL STEM CELL#0.8807;ANESTHETIC#0.8805;HEMATOPOIETIC STEM CELL#0.8799;INTERNATIONAL NORMALIZED RATIO#0.8797;DIZZINESS#0.8796;ETHANOL OXIDATION#0.8786;MICAFUNGIN#0.8786;CARCINOGENICITY#0.8784;MEFLOQUINE#0.8780;PROGESTIN#0.8778;NONALCOHOLIC FATTY LIVER DISEASE#0.8775;CUSHING'S SYNDROME#0.8775;NITRIC OXIDE SYNTHASE#0.8772;KUPFFER CELL#0.8772;ORGAN TRANSPLANT RECIPIENTS#0.8764;TARGET OF RAPAMYCIN#0.8762;AZELASTINE#0.8762;MODE OF ACTION#0.8761;VENOUS BLOOD#0.8759;THIORIDAZINE#0.8743;ACETYLCYSTEINE#0.8740;SIGNALLING PATHWAY#0.8739;ADENOSINE TRIPHOSPHATE#0.8732;SIGNAL TRANSDUCTION#0.8729;CREATINE KINASE#0.8726;BENZPHETAMINE#0.8726;LURASIDONE#0.8726;CROHN'S DISEASE#0.8723;4-METHYLPYRAZOLE#0.8722;CORONARY HEART DISEASE#0.8721;PROGENITOR CELL#0.8712;DNA SYNTHESIS#0.8711;PRIMARY METABOLISM#0.8710;ZOPICLONE#0.8706;HEPATIC NUCLEAR FACTOR#0.8686;ETHYL ACETATE EXTRACT#0.8674;MODAFINIL#0.8668;ELETRIPTAN#0.8654;TOPOISOMERASE#0.8650;CREATINE#0.8647;RESPONSE TO TREATMENT#0.8629;METASTATIC BREAST CANCER#0.8615;CHINESE HERBAL MEDICINE#0.8613;STEM CELL TRANSPLANTATION#0.8611;EMODIN#0.8610;SMOOTH MUSCLE#0.8609;TERBINAFINE#0.8598;ZONISAMIDE#0.8596;EMTRICITABINE#0.8593;RANITIDINE#0.8584;BEDAQUILINE#0.8572;LIVER CANCER#0.8556;REBOXETINE#0.8548;LAMOTRIGINE#0.8544;ERGOTAMINE#0.8544;ZAFIRLUKAST#0.8528;IMATINIB MESYLATE#0.8524;ERYTHROMYCIN METABOLISM#0.8515;SELEGILINE#0.8509;HYPOXIC#0.8507;ANEMIA#0.8507;METHAMPHETAMINE#0.8498;EPIGALLOCATECHIN#0.8491;BETA-2#0.8486;GRANISETRON#0.8486;THIOTEPA#0.8484;FIXED DOSE COMBINATION#0.8478;NATEGLINIDE#0.8472;STABLE ISOTOPE LABELED#0.8471;ADRENAL GLAND#0.8468;SIBUTRAMINE#0.8467;MUTAGEN#0.8466;O METHYLTRANSFERASE#0.8462;SOLID ORGAN TRANSPLANT#0.8458;FELBAMATE#0.8458;METHADONE MAINTENANCE TREATMENT#0.8449;PRINCIPAL COMPONENT ANALYSIS#0.8445;MULTIPLE REACTION MONITORING#0.8427;5 FLUOROURACIL#0.8425;RESONANCE ENERGY TRANSFER#0.8420;PUBERTY#0.8419;LIVER DEVELOPMENT#0.8412;ENDOCRINE DISRUPTING CHEMICAL#0.8400;ALDO KETO REDUCTASE#0.8385;FLUTAMIDE#0.8384;TRANSPORTER ACTIVITY#0.8377;OVER THE COUNTER#0.8345;RUTIN#0.8331;TACRINE#0.8327;EMBRYONIC STEM CELL#0.8321;BETWEEN SUBJECT VARIABILITY#0.8316;TIENILIC ACID#0.8308;GREEN TEA EXTRACT#0.8307;ADRENERGIC RECEPTOR#0.8299;LOW BIRTH WEIGHT#0.8296;ESTROGEN METABOLISM#0.8292;COAGULATION#0.8291;OREXIN RECEPTOR#0.8287;TRIMETHOPRIM#0.8287;GINKGOLIDE-B#0.8285;QUAZEPAM#0.8281;HEXANE#0.8276;HEME BINDING#0.8269;COLORECTAL ADENOCARCINOMA#0.8268;INDOMETHACIN#0.8258;MONOCYTE#0.8255;ELACRIDAR#0.8252;LIMIT OF DETECTION#0.8250;BOOSTED PROTEASE INHIBITOR#0.8246;SOMNOLENCE#0.8243;HISTONE DEACETYLASE INHIBITOR#0.8241;TORSADES DE POINTES#0.8238;FESOTERODINE#0.8237;NAPROXEN#0.8225;FLUOROURACIL#0.8223;CHOLESTEROL BIOSYNTHESIS#0.8222;HYDROMORPHONE#0.8211;HYPERSENSITIVITY#0.8209;MENOPAUSE#0.8205;CLOFIBRATE#0.8196;PIPERAZIN#0.8189;CINACALCET#0.8185;NORTRIPTYLINE#0.8184;ARGININE#0.8182;NORETHINDRONE#0.8174;RALTEGRAVIR#0.8166;LIMIT OF QUANTITATION#0.8155;VALPROATE#0.8150;PARKINSON'S DISEASE#0.8136;HEAT SHOCK PROTEIN#0.8135;METABOLIC PROCESS#0.8134;LYSINE#0.8133;FACTOR I#0.8120;ABDOMINAL PAIN#0.8087;MENSTRUAL CYCLE PHASE#0.8073;1,8-CINEOLE#0.8071;REGENERATION#0.8067;PROTEIN KINASE INHIBITOR#0.8067;PULMONARY ARTERIAL HYPERTENSION#0.8053;SULFONAMIDE#0.8052;SMALL HETERODIMER PARTNER#0.8045;LACTATION#0.8044;ADJUSTED ODDS RATIO#0.8044;EPIPODOPHYLLOTOXIN#0.8044;CATECHOL O METHYLTRANSFERASE#0.8040;ENDOTHELIUM#0.8035;CONSTIPATION#0.8035;3,4-METHYLENEDIOXYMETHAMPHETAMINE#0.8021;ARSENITE#0.8020;SOY PROTEIN ISOLATE#0.8005;CHRONIC HEPATITIS C#0.8002;O-DESMETHYLVENLAFAXINE#0.7985;VIRAL INFECTION#0.7976;MIGRAINE#0.7969;LAMIVUDINE#0.7964;PHENOTHIAZINE#0.7960;TOPIRAMATE#0.7954;VANDETANIB#0.7946;OSTEONECROSIS#0.7944;VITAMIN K ANTAGONIST#0.7944;VITAMIN D METABOLISM#0.7929;STREPTOZOTOCIN#0.7921;B-LYMPHOBLAST#0.7921;HEPATOCYTE GROWTH FACTOR#0.7920;TIGHT JUNCTION#0.7918;MICROSOMAL MEMBRANE#0.7914;TIPRANAVIR#0.7911;RANDOMIZED CONTROLLED TRIAL#0.7910;TENOFOVIR DISOPROXIL#0.7909;IRINOTECAN, CPT-11#0.7908;CLONAZEPAM#0.7906;HOST CELL#0.7901;NALOXONE#0.7880;HEMORRHAGE#0.7877;CHOLESTEROL SYNTHESIS#0.7874;RIBAVIRIN#0.7870;VITAMIN D DEFICIENCY#0.7864;DEOXYCHOLIC ACID#0.7843;ANTI INFLAMMATORY DRUGS#0.7842;RECEPTOR ACTIVATOR#0.7840;AUTOIMMUNE DISEASE#0.7825;PARENTERAL#0.7820;ROFLUMILAST#0.7817;METHOTREXATE#0.7812;CELL SURFACE#0.7799;OESTRADIOL#0.7791;HUMAN EMBRYONIC STEM#0.7790;SAXAGLIPTIN#0.7783;STANDARD OF CARE#0.7777;MELATONIN#0.7777;RESPONSE TO DOCETAXEL#0.7765;LOMITAPIDE#0.7756;HEME OXYGENASE 1#0.7754;ATPASE ACTIVITY#0.7753;ALVEOLAR MACROPHAGE#0.7746;INDUCIBLE NITRIC OXIDE#0.7734;ALISKIREN#0.7730;OSTEOPOROSIS#0.7725;HEPATOCYTE DIFFERENTIATION#0.7720;PERIPHERAL BLOOD LYMPHOCYTES#0.7719;TOREMIFENE#0.7717;MEMBRANE FRACTION#0.7709;STEROID HYDROXYLASE#0.7697;DNA METHYLATION#0.7689;FORSKOLIN#0.7671;P-CRESOL#0.7670;RESPONSE TO SIMVASTATIN#0.7669;RNA INTERFERENCE#0.7665;SUPPORT VECTOR MACHINE#0.7660;NOREPINEPHRINE REUPTAKE#0.7646;INSULIN-LIKE GROWTH FACTOR#0.7643;TORSADE DE POINTES#0.7639;LYMPH NODE#0.7635;PROTEASOMAL PATHWAY#0.7630;CHOLESTEROL HOMEOSTASIS#0.7624;ZIDOVUDINE#0.7618;DIHYDROERGOTAMINE#0.7617;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.7613;HARDY WEINBERG EQUILIBRIUM#0.7612;ENDOMETRIUM#0.7608;MAJOR DEPRESSIVE DISORDER#0.7607;DROWSINESS#0.7605;ESCITALOPRAM#0.7596;ANGIOGENESIS#0.7568;SOLUBLE FRACTION#0.7561;MENTHOL#0.7558;RHINITIS#0.7551;CABAZITAXEL#0.7550;SERTINDOLE#0.7548;URIDINE-5'-DIPHOSPHATE#0.7536;ATHEROSCLEROSIS#0.7529;FLUCLOXACILLIN#0.7527;FOSAMPRENAVIR#0.7521;DOPAMINE RECEPTOR#0.7511;STEM CELL TRANSPLANT#0.7506;NORMAL BREAST TISSUE#0.7490;BIPOLAR DISORDER#0.7489;HYPERGLYCEMIA#0.7481;1,2,4-TRIAZOLE#0.7454;NOREPINEPHRINE#0.7449;BENZODIAZEPINE RECEPTOR#0.7443;BILE ACID METABOLISM#0.7431;ANXIETY DISORDER#0.7425;SQUAMOUS CELL CARCINOMA#0.7421;LIPID LOWERING AGENT#0.7392;ANTHRACENE#0.7389;ANASTROZOLE#0.7388;LARGE INTESTINE#0.7385;ETORICOXIB#0.7384;MICRONUCLEUS#0.7377;TAUROCHOLATE#0.7361;GASTRO#0.7357;GUANFACINE#0.7353;IFN-GAMMA#0.7352;RESPIRATORY TRACT INFECTION#0.7345;SEROTONIN RECEPTOR#0.7345;ACETAMIDE#0.7341;PNEUMONIA#0.7333;ACUTE PHASE RESPONSE#0.7331;CELL ADHESION#0.7330;EDEMA#0.7318;LUMINAL#0.7311;BETA TESTOSTERONE#0.7308;TETRAHYDROCANNABINOL#0.7302;CARRIE#0.7297;CLOMIPRAMINE#0.7290;ALLERGIC RHINITIS#0.7282;ETHINYLOESTRADIOL#0.7280;COMPLEX I#0.7270;BLOOD UREA NITROGEN#0.7268;DAUNORUBICIN#0.7267;ANAPLASTIC LYMPHOMA KINASE#0.7267;NITRENDIPINE#0.7260;TOLL LIKE RECEPTOR#0.7256;DULOXETINE#0.7255;CHOLIC ACID#0.7238;SKIN RASH#0.7234;PONATINIB#0.7225;ALMOTRIPTAN#0.7223;OSTEOMALACIA#0.7206;DISULFIRAM#0.7201;TOCILIZUMAB#0.7192;DIPEPTIDYL PEPTIDASE 4#0.7189;NUCLEAR RECEPTOR BINDING#0.7186;FUMARATE#0.7183;COLON MUCOSA#0.7182;QUANTITATIVE REVERSE TRANSCRIPTASE#0.7182;ACETYLCHOLINE#0.7177;TENOFOVIR DISOPROXIL FUMARATE#0.7173;ACYL GLUCURONIDATION#0.7162;LUTEAL PHASE#0.7161;PYRAZOLE#0.7140;PANCREATIC CANCER#0.7127;ADVERSE DRUG EVENT#0.7118;HALOTHANE#0.7111;NADPH OXIDATION#0.7103;BILE ACID BIOSYNTHESIS#0.7095;STROMAL CELL#0.7087;SECOND GENERATION ANTIPSYCHOTICS#0.7079;RESPONSE TO STATIN#0.7070;ESOPHAGUS#0.7060;ELLAGIC ACID#0.7055;SULFAMETHOXAZOLE#0.7052;HISTONE MODIFICATION#0.7050;PROBENECID#0.7048;PROTEIN DATA BANK#0.7040;BEZAFIBRATE#0.7022;GLUTAMINE#0.7020;PEPTIDE TRANSPORTER#0.7011;HUMAN BREAST CANCER#0.7003;ION CHANNEL#0.7003;DIGESTIVE TRACT#0.6980;ADIPOSE TISSUE#0.6979;TRANSFERASE ACTIVITY#0.6973;TRANSFORMING GROWTH FACTOR#0.6970;CALCITRIOL#0.6957;VIRAL HEPATITIS#0.6956;DIPEPTIDYL PEPTIDASE IV#0.6955;RIFAXIMIN#0.6953;PSORIASIS#0.6953;DRY MOUTH#0.6953;TOPOISOMERASE II#0.6941;LIVER REGENERATION#0.6938;CONGESTIVE HEART FAILURE#0.6926;CLINDAMYCIN#0.6921;BACTERIAL ARTIFICIAL CHROMOSOME#0.6920;ACTINOMYCIN D#0.6919;UMBILICAL CORD#0.6919;PROSTATE SPECIFIC ANTIGEN#0.6918;INTENSIVE CARE UNIT#0.6913;STEVENS-JOHNSON SYNDROME#0.6913;THYROID CANCER#0.6913;BETA GALACTOSIDASE#0.6911;TIZANIDINE#0.6909;MAMMARY GLAND#0.6903;HUMAN SERUM ALBUMIN#0.6902;SUCCINATE#0.6901;LYMPH NODE METASTASIS#0.6899;RELATIVE STANDARD DEVIATION#0.6899;NISOLDIPINE#0.6895;TRABECTEDIN#0.6892;MITOCHONDRIAL MEMBRANE#0.6890;DISEASE FREE SURVIVAL#0.6889;TRIAMCINOLONE ACETONIDE#0.6878;S PHASE#0.6878;DISOPYRAMIDE#0.6874;NIMODIPINE#0.6870;HEALTHY CONTROL SUBJECTS#0.6853;ACENOCOUMAROL#0.6846;CELLULAR DETOXIFICATION#0.6838;AMPHOTERICIN B#0.6824;NEW ONSET DIABETES#0.6818;UDP-GLUCURONIC ACID#0.6811;DRUG DELIVERY SYSTEM#0.6806;PARATHYROID HORMONE#0.6803;NORADRENALINE#0.6797;GENE EXPRESSION OMNIBUS#0.6790;RANDOMIZED CLINICAL TRIAL#0.6784;CO BINDING#0.6783;LORAZEPAM#0.6783;METHIMAZOLE#0.6776;PLATELET ACTIVATION#0.6772;AMOXICILLIN#0.6758;ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION#0.6757;GLUCOSE METABOLISM#0.6750;PROTEIN PHOSPHORYLATION#0.6748;LIVER CARCINOMA#0.6747;BRENTUXIMAB VEDOTIN#0.6742;BENZOFURAN#0.6723;PHENANTHRENE#0.6720;PERMETHRIN#0.6714;NOREPINEPHRINE REUPTAKE INHIBITOR#0.6710;OXYBUTYNIN#0.6708;RETINOL#0.6703;ATHEROSCLEROTIC#0.6701;LANOSTEROL#0.6698;NAPHTHALENE METABOLISM#0.6694;TRIAMCINOLONE#0.6688;DEPRESSIVE SYMPTOMS#0.6682;CELLULAR METABOLISM#0.6682;PALMITOYL#0.6681;ISCHEMIC HEART DISEASE#0.6672;ALDOSTERONE#0.6671;VAN DER WAALS#0.6671;5-MEO-DIPT#0.6661;SURFACE PLASMON RESONANCE#0.6659;HORMONE SECRETION#0.6654;LIGAND BINDING POCKET#0.6652;ULCERATIVE COLITIS#0.6650;EZETIMIBE#0.6647;LYMPHOCYTIC LEUKEMIA#0.6645;NITRAZEPAM#0.6644;METROPROLOL#0.6638;PLATELET-DERIVED GROWTH FACTOR#0.6634;ASPERGILLOSIS#0.6631;CELIAC DISEASE#0.6628;OF DIABETIC RATS#0.6625;CELL DIFFERENTIATION#0.6613;FAMOTIDINE#0.6609;TETRACYCLINE#0.6605;MONTE CARLO SIMULATION#0.6590;CEREBROVASCULAR DISEASE#0.6588;DABIGATRAN ETEXILATE#0.6584;DESLORATADINE#0.6583;SOLIFENACIN#0.6577;DEHYDRATION#0.6575;SULPHATION#0.6566;WORLD HEALTH ORGANIZATION#0.6566;UDENAFIL#0.6566;ACUTE LIVER FAILURE#0.6553;COLLAGENASE#0.6551;PRIMARY BREAST CANCER#0.6549;METASTATIC RENAL CELL CARCINOMA#0.6540;GREEN TEA CATECHIN#0.6536;FENOFIBRATE#0.6519;FLUTICASONE PROPIONATE#0.6510;GALANTAMINE#0.6508;OXAZEPAM#0.6497;CHLOROQUINE#0.6484;17 ALPHA-ETHYNYLESTRADIOL#0.6482;HEPATOBLASTOMA#0.6478;ENDOMETRIOSIS#0.6477;CINEOLE#0.6470;SALIVARY GLAND#0.6465;MEPERIDINE#0.6460;MEAN ABSOLUTE ERROR#0.6459;DRIED BLOOD SPOT#0.6458;EXEMESTANE#0.6457;PARTIAL LEAST SQUARE#0.6457;CYTOKINE PRODUCTION#0.6457;MINOR ALLELE FREQUENCY#0.6433;CLOFAZIMINE#0.6418;NORGESTIMATE#0.6413;ADJUSTED HAZARD RATIO#0.6413;CHANGE FROM BASELINE#0.6410;LATE PREGNANCY#0.6405;YOHIMBINE#0.6402;ROPINIROLE#0.6402;PRANLUKAST#0.6397;TENIPOSIDE#0.6391;MUCOSITIS#0.6378;REGULATION OF GENE EXPRESSION#0.6377;LEVOMEPROMAZINE#0.6371;NEUROBLASTOMA#0.6363;COLORECTAL ADENOCARCINOMA CELLS#0.6354;CORD BLOOD#0.6351;ASTROCYTE#0.6347;ERIBULIN#0.6341;MULTIPLE SCLEROSIS#0.6336;ANGIOTENSIN CONVERTING ENZYME#0.6336;DEXTROMETHORPHAN HYDROBROMIDE#0.6317;IMMUNE SYSTEM#0.6315;ENDOCRINE SYSTEM#0.6298;ACETAL#0.6296;CAMPTOTHECIN#0.6280;CABOZANTINIB#0.6270;INTERFERON STIMULATED GENE#0.6261;FLUTICASONE FUROATE#0.6240;PHOSPHATIDYLSERINE#0.6235;MU OPIOID RECEPTOR#0.6231;NEPHROTOXIC#0.6230;DABRAFENIB#0.6223;DIRECT RENIN INHIBITOR#0.6215;FAMILIAL MEDITERRANEAN FEVER#0.6211;HEROIN#0.6205;OLOMOUCINE II#0.6205;AGED GARLIC EXTRACT#0.6200;SYNCOPE#0.6190;ACUTE ISCHEMIC STROKE#0.6187;BREAST CARCINOMA#0.6173;ASTHENIA#0.6172;VEMURAFENIB#0.6172;ACYL COA OXIDASE#0.6164;GLUTATHIONE S-TRANSFERASE ACTIVITY#0.6159;IVERMECTIN#0.6146;LIPID LOWERING THERAPY#0.6145;LINAGLIPTIN#0.6145;MEDROXYPROGESTERONE ACETATE#0.6139;LUNG ADENOCARCINOMA#0.6130;LEVETIRACETAM#0.6126;CORTISOL BINDING#0.6117;MELOXICAM#0.6115;VISUAL ANALOG SCALE#0.6101;IRBESARTAN#0.6099;ACID SECRETION#0.6094;L-CYSTEINE#0.6093;COLLAGEN TYPE I#0.6092;MENARCHE#0.6086;ALPHA 1-ANTITRYPSIN#0.6073;DICLOXACILLIN#0.6073;MALIGNANT GLIOMA#0.6072;TOCOPHEROL METABOLISM#0.6070;DEMENTIA#0.6067;PARATHYROID#0.6066;VITAMIN A#0.6060;CHEMOKINE RECEPTOR#0.6053;PULMONARY HYPERTENSION#0.6053;MELTING CURVE ANALYSIS#0.6050;MILNACIPRAN#0.6046;CAROTENOID#0.6045;BENZYL ALCOHOL#0.6044;ISRADIPINE#0.6032;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6031;NAFCILLIN#0.6016;CELL CYCLE ARREST#0.6013;TOXIC EPIDERMAL NECROLYSIS#0.6010;25-HYDROXYVITAMIN D3#0.6004
157724	ASPARTATE#0.6200;MALTOSE#0.6029
157739	L-THREONINE#1.1006;GLYCINE#0.9434;L-SERINE#0.7134;UDP GALACTOSE#0.6445;MITOCHONDRIA#0.6320;CATALYTIC ACTIVITY#0.6132
157753	AUTOPHAGY#0.8775;ANXIETY DISORDER#0.6427;LIVER CANCER#0.6341;LUNG CANCER#0.6234;TUMOR CELLS#0.6220
157777	STRAND INVASION#0.9452
1577	AMLODIPINE#1.0602;VINCRISTINE#1.0463;TAMOXIFEN#1.0394;FENTANYL#1.0355;SIMVASTATIN#1.0344;ACUTE LEUKEMIA#1.0285;FRAGMENT LENGTH POLYMORPHISM#1.0274;SIROLIMUS#1.0270;CLOPIDOGREL#1.0261;TACROLIMUS#1.0254;DEXTROMETHORPHAN#1.0231;IMATINIB#1.0213;DILTIAZEM#1.0213;ATORVASTATIN#1.0212;RENAL TRANSPLANT RECIPIENTS#1.0184;RITONAVIR#1.0155;ALPRAZOLAM#1.0148;DRUG RESISTANCE#1.0145;NEPHROTOXICITY#1.0141;KIDNEY TRANSPLANT RECIPIENTS#1.0140;CATALYTIC ACTIVITY#1.0136;NIFEDIPINE#1.0135;PACLITAXEL#1.0131;MIDAZOLAM#1.0111;POPULATION PHARMACOKINETIC MODEL#1.0101;KIDNEY TRANSPLANT PATIENTS#1.0089;CARBAMAZEPINE#1.0076;VORICONAZOLE#1.0064;CYCLOSPORINE#1.0063;MYELOID LEUKEMIA#1.0061;HYPERTENSION#1.0038;POLYMERASE CHAIN REACTION#1.0026;ERYTHROMYCIN#1.0019;PREGNANE X RECEPTOR#1.0010;PROSTATE CANCER#1.0005;ATP BINDING CASSETTE#1.0004;ATP BINDING#0.9989;DEMETHYLATION#0.9986;CHRONIC MYELOID LEUKEMIA#0.9977;RISPERIDONE#0.9970;TESTOSTERONE#0.9935;EFAVIRENZ#0.9934;ALFENTANIL#0.9933;FETAL LIVER#0.9932;ENZYME ACTIVITY#0.9927;KETOCONAZOLE#0.9923;THERAPEUTIC DRUG MONITORING#0.9916;PLATELET AGGREGATION#0.9887;STEM CELL#0.9879;METHADONE#0.9879;PERIPHERAL BLOOD#0.9874;BREAST CANCER PATIENTS#0.9871;DEXAMETHASONE#0.9870;DOCETAXEL#0.9865;ADENOSINE TRIPHOSPHATE#0.9864;MYCOPHENOLATE MOFETIL#0.9863;SMALL INTESTINE#0.9855;RIFAMPICIN#0.9855;GLOMERULAR FILTRATION RATE#0.9852;CICLOSPORIN#0.9850;OMEPRAZOLE#0.9850;GLOMERULAR FILTRATION#0.9848;BREAST CANCER#0.9842;DRUG METABOLISM#0.9839;RIFAMPIN#0.9830;CORTISOL#0.9810;OXIDATIVE METABOLISM#0.9780;LUNG CANCER#0.9778;CALCINEURIN#0.9774;IMMUNOSUPPRESSANT#0.9765;GENE EXPRESSION#0.9759;MICROSOME#0.9756;SOLID ORGAN TRANSPLANTATION#0.9722;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9704;COLORECTAL CANCER#0.9683;CYTOCHROME P450#0.9669;NARROW THERAPEUTIC INDEX#0.9648;ITRACONAZOLE#0.9645;LANSOPRAZOLE#0.9643;TOXICITY#0.9616;TRANSCRIPTASE#0.9615;CYTOCHROME B5#0.9611;NEUROTOXICITY#0.9610;ADVERSE DRUG REACTION#0.9597;GLUCOCORTICOID RECEPTOR#0.9590;ADENOSINE#0.9588;EVEROLIMUS#0.9563;EXCRETION#0.9563;GLUTATHIONE#0.9551;CYCLOPHOSPHAMIDE#0.9463;ATAZANAVIR#0.9414;HYDROXYLASE ACTIVITY#0.9410;OVARIAN CANCER#0.9379;GEFITINIB#0.9361;HEMATOPOIETIC STEM CELL#0.9357;9-HYDROXYRISPERIDONE#0.9352;FLUCONAZOLE#0.9333;SYSTOLIC BLOOD PRESSURE#0.9331;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9318;SUNITINIB#0.9277;WARFARIN#0.9273;PREDNISOLONE#0.9266;TROLEANDOMYCIN#0.9262;MONONUCLEAR CELLS#0.9193;REVERSE TRANSCRIPTION#0.9186;NEUTROPENIA#0.9144;TOLBUTAMIDE#0.9117;IRINOTECAN#0.9110;INDINAVIR#0.9105;TRANSCRIPTION FACTOR#0.9102;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9071;GROWTH FACTOR#0.9065;MEPHENYTOIN#0.9060;CARCINOGEN#0.9059;PHENOBARBITAL#0.9046;EPITHELIAL CELL#0.9032;COLORECTAL#0.9021;OXYCODONE#0.9013;STEM CELL TRANSPLANTATION#0.9009;DIABETES MELLITUS#0.8989;DIPHOSPHATE#0.8987;ACUTE REJECTION EPISODE#0.8938;EFFLUX PUMP#0.8926;VERAPAMIL#0.8898;HEPATOCELLULAR CARCINOMA#0.8897;QUININE#0.8889;HEPATOTOXICITY#0.8881;QUETIAPINE#0.8868;SAQUINAVIR#0.8856;DETOXIFICATION#0.8855;CILOSTAZOL#0.8839;MULTIPLE REGRESSION ANALYSIS#0.8827;ERLOTINIB#0.8800;ALVEOLAR MACROPHAGE#0.8740;XENOBIOTIC METABOLISM#0.8723;MULTIPLE LINEAR REGRESSION#0.8713;LAPATINIB#0.8676;URIDINE#0.8667;LOPINAVIR#0.8666;OVARIAN#0.8649;QUINIDINE#0.8633;CLOZAPINE#0.8589;KINASE INHIBITOR#0.8572;CANCER CELL#0.8530;BODY SURFACE AREA#0.8525;PROGESTERONE#0.8518;HUMAN IMMUNODEFICIENCY VIRUS#0.8503;EPILEPSY#0.8497;ABC TRANSPORTER#0.8495;TYROSINE KINASE INHIBITOR#0.8491;KIDNEY DISEASE#0.8474;PHENYTOIN#0.8442;ULCERATIVE COLITIS#0.8397;ACUTE CORONARY SYNDROME#0.8370;LINEAR REGRESSION ANALYSIS#0.8362;DELAYED GRAFT FUNCTION#0.8361;NEUROPATHY#0.8356;ACUTE REJECTION RATE#0.8339;PRIMARY HUMAN HEPATOCYTES#0.8337;ESTROGEN RECEPTOR#0.8333;ROSUVASTATIN#0.8328;CYTOTOXICITY#0.8323;BUPROPION#0.8317;NEVIRAPINE#0.8316;QUANTITATIVE REAL TIME#0.8312;PROTON PUMP INHIBITOR#0.8301;PROTON PUMP#0.8283;HARDY WEINBERG EQUILIBRIUM#0.8256;HALOPERIDOL#0.8250;ADENOCARCINOMA#0.8246;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8202;MYCOPHENOLIC ACID#0.8199;PREDNISONE#0.8136;ENTEROCYTE#0.8108;BONE MARROW#0.8089;RECEPTOR ANTAGONIST#0.8088;MACROPHAGE#0.8073;MARAVIROC#0.8023;SERUM ALBUMIN#0.8014;CLARITHROMYCIN#0.7978;SOLID ORGAN TRANSPLANT#0.7948;CALCIUM CHANNEL#0.7891;EPOXIDE HYDROLASE#0.7882;MULTIDRUG RESISTANCE PROTEIN#0.7880;CHLORZOXAZONE#0.7874;PERCUTANEOUS CORONARY INTERVENTION#0.7849;T CELL#0.7848;PROGRAF#0.7841;RENAL CELL CARCINOMA#0.7808;HEPATITIS C#0.7794;NEPHROTIC SYNDROME#0.7786;RESPONSE TO TREATMENT#0.7780;RESPONSE TO STATIN#0.7766;CAFFEINE#0.7766;RESPONSE TO CLOPIDOGREL#0.7763;DOXORUBICIN#0.7732;ALANINE#0.7703;MELTING CURVE ANALYSIS#0.7690;LOVASTATIN#0.7670;HIGH RESOLUTION MELTING#0.7603;SILDENAFIL#0.7570;CYTOCHROME B#0.7510;HIV PROTEASE INHIBITOR#0.7509;MULTI DRUG RESISTANCE#0.7460;CONNECTIVE TISSUE DISEASE#0.7438;SAXAGLIPTIN#0.7425;CYCLOSPORIN A#0.7419;STEM CELL TRANSPLANT#0.7390;CHRONIC KIDNEY DISEASE#0.7347;ARIPIPRAZOLE#0.7335;ESTRADIOL#0.7334;THYROID CANCER#0.7320;ACUTE KIDNEY INJURY#0.7317;GROWTH FACTOR RECEPTOR#0.7310;CYCLOSPORIN#0.7298;COLON MUCOSA#0.7290;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7285;CONNECTIVE TISSUE#0.7274;CARBOPLATIN#0.7230;DRUG TRANSPORT#0.7182;PRASUGREL#0.7161;NELFINAVIR#0.7143;COLITIS#0.7126;DAUNORUBICIN#0.7095;LUPUS ERYTHEMATOSUS#0.7094;DUODENUM#0.7054;QUERCETIN#0.6999;PHENACETIN#0.6980;SQUAMOUS CELL CARCINOMA#0.6929;CLOTRIMAZOLE#0.6914;IMMUNE RESPONSE#0.6908;AXITINIB#0.6895;TICAGRELOR#0.6868;CONJUGATION#0.6856;MYOPATHY#0.6852;MYOCARDIAL INFARCTION#0.6793;SORAFENIB#0.6775;LEUKOCYTE#0.6772;NERVOUS SYSTEM#0.6771;DICLOFENAC#0.6764;ORGANIC ANION TRANSPORTER#0.6746;ASPIRIN#0.6729;TRIAZOLAM#0.6673;CORONARY ARTERY#0.6672;VALPROIC ACID#0.6667;LUNG ADENOCARCINOMA#0.6648;APOPTOSIS#0.6624;ANDROGEN METABOLISM#0.6601;GEOMETRIC MEAN RATIO#0.6585;CALCINEURIN INHIBITOR NEPHROTOXICITY#0.6577;VINORELBINE#0.6528;CENTRAL NERVOUS SYSTEM#0.6503;DEHYDROEPIANDROSTERONE#0.6491;RABEPRAZOLE#0.6485;DIARRHEA#0.6465;VITAMIN K#0.6460;LASER DESORPTION IONIZATION#0.6442;ALZHEIMER'S DISEASE#0.6420;SIBUTRAMINE#0.6420;CORONARY ARTERY DISEASE#0.6410;ARTERY DISEASE#0.6409;TOLVAPTAN#0.6379;BUFURALOL#0.6371;FELODIPINE#0.6370;ACUTE CELLULAR REJECTION#0.6369;FLUVASTATIN#0.6342;DEMETHYLASE ACTIVITY#0.6339;VARDENAFIL#0.6335;DIAZEPAM#0.6300;ESTRONE#0.6291;NICARDIPINE#0.6289;ETOPOSIDE#0.6274;6BETA-HYDROXYLASE ACTIVITY#0.6268;EPIDERMAL GROWTH FACTOR#0.6265;ORGAN TRANSPLANT RECIPIENTS#0.6265;BLOOD PRESSURE REGULATION#0.6259;COENZYME A#0.6246;DNA REPAIR#0.6222;RESPONSE TO DRUG#0.6217;MULTIFACTOR DIMENSIONALITY REDUCTION#0.6215;C-LEVEL#0.6214;LINEAR MIXED EFFECTS#0.6208;CELL GROWTH#0.6198;TUMOR TISSUES#0.6198;HEPATOCYTE NUCLEAR FACTOR#0.6186;RHEUMATOID ARTHRITIS#0.6169;IFOSFAMIDE#0.6154;GROWTH HORMONE#0.6139;POST OPERATIVE DAY#0.6134;UDENAFIL#0.6132;OPIOID RECEPTOR#0.6131;RANDOMIZED CONTROLLED TRIAL#0.6123;DISEASE FREE SURVIVAL#0.6089;FLAVIN#0.6087;HEPATITIS C VIRUS#0.6086;REGULATION OF BLOOD PRESSURE#0.6082;CPT-11#0.6079;TYPE 2 DIABETES#0.6059;LOW DENSITY LIPOPROTEIN#0.6052;SEDATION#0.6052;FEXOFENADINE#0.6038;4-HYDROXYTAMOXIFEN#0.6032
157848	TRANSCRIPTION FACTOR#1.0311;GASTRIC EPITHELIAL CELLS#1.0112;EPITHELIAL CELL#0.9869;B CELL#0.7258;HINDBRAIN#0.7027;TUMOR SUPPRESSOR#0.6399
157855	POTASSIUM CHANNEL#0.9604;MEMBRANE HYPERPOLARIZATION#0.8734;ACROSOME REACTION#0.8531;ION CHANNEL#0.8448;LEUCINE RICH REPEAT#0.8423;FERTILIZATION#0.8399;SPERM CAPACITATION#0.7674;ACROSOME#0.7478;SPERMATOZOA#0.7280;COMPLEX I#0.7089;CATSPER CHANNEL#0.7074;LEUCINE#0.6759
157869	COR PULMONALE#0.7995
1578	TACROLIMUS#0.9204;POLYMERASE CHAIN REACTION#0.6445
157922	SPECTRIN#0.9648;MICROTUBULE#0.7288;NEURITE OUTGROWTH#0.6148
157956	ANAPHASE PROMOTING COMPLEX#1.0647;ANAPHASE#1.0583;CELL CYCLE#0.9229;SPINDLE CHECKPOINT#0.9116;MITOSIS#0.8915;UBIQUITIN#0.6790;MEIOSIS II#0.6751;MEIOSIS#0.6749;BUDDING#0.6593;S PHASE#0.6362;MICROTUBULE#0.6086
1579	OMEGA-HYDROXYLASE ACTIVITY#1.0841;HYDROXYLASE ACTIVITY#1.0512;HYPERTENSION#1.0379;ESSENTIAL HYPERTENSION#1.0213;ARACHIDONIC ACID#1.0029;MICROSOME#1.0006;CYTOCHROME P450#0.9811;GENE EXPRESSION#0.9741;CORONARY ARTERY DISEASE#0.9577;ARTERY DISEASE#0.9574;CORONARY ARTERY#0.9508;PEROXISOME#0.9479;CLOFIBRATE#0.9273;ARTERY#0.8603;POLYMERASE CHAIN REACTION#0.8414;ACYL COA OXIDASE#0.8331;CATALYTIC ACTIVITY#0.7695;ARACHIDONIC ACID METABOLISM#0.7531;DRUG METABOLISM#0.7480;REGULATION OF BLOOD PRESSURE#0.7417;LIPID METABOLISM#0.6523;PEROXISOMAL#0.6443;RETINOIC ACID#0.6338;SYSTOLIC BLOOD PRESSURE#0.6255;REVERSE TRANSCRIPTION#0.6222;ETHANOL#0.6168;GROWTH HORMONE#0.6079;VASOCONSTRICTOR#0.6038
157	BETA-ARK 2#1.1839;BETA ADRENERGIC RECEPTOR#1.0297;ADRENERGIC RECEPTOR#1.0211;OPIOID RECEPTOR#1.0184;BIPOLAR DISORDER#1.0055;PROTEIN KINASE#0.9905;BETA-2#0.9888;PLASMA MEMBRANE#0.9508;SMOOTH MUSCLE#0.9506;MU OPIOID RECEPTOR#0.9302;PROTEIN KINASE C#0.8804;FENTANYL#0.8743;DOPAMINE#0.8591;KAPPA OPIOID RECEPTOR#0.8134;GENE EXPRESSION#0.8132;BETA-ARK 1#0.7898;AIRWAY SMOOTH MUSCLE#0.7682;MYOCYTES#0.7618;L-DOPA#0.7541;SIGNAL TRANSDUCTION#0.7534;PROTEIN KINASE A#0.7350;STRIATUM#0.7297;PROSTATE CANCER#0.7287;CHEMOKINE RECEPTOR#0.7217;OOCYTE#0.7077;RECEPTOR INTERNALIZATION#0.7039;MITOGEN ACTIVATED PROTEIN#0.7020;WHIM SYNDROME#0.7001;KINASE ACTIVITY#0.6943;ENDOCYTOSIS#0.6938;PHOSPHOLIPASE C#0.6889;CANCER CELL#0.6746;HETEROTRIMERIC G-PROTEIN#0.6441;LEUKOCYTE#0.6389;SIGNALING PATHWAY#0.6380;SMOOTH MUSCLE CELL#0.6336;MUSCLE CELL#0.6329;POLYMERASE CHAIN REACTION#0.6325;PHOSPHOLIPASE C ACTIVITY#0.6213;LOCUS COERULEUS#0.6191;MAST CELL#0.6120;OLFACTORY EPITHELIUM#0.6117;RECEPTOR AGONIST#0.6085
158038	LEUCINE RICH REPEAT#0.9908;PARKINSON'S DISEASE#0.9250;LEUCINE#0.8793;ESSENTIAL TREMOR#0.6884;RECEPTOR INTERACTING PROTEIN#0.6699
158056	ENDOSOME#0.9235;EPITHELIAL CELL#0.8242;INTESTINAL EPITHELIAL CELL#0.6647
158062	EPIDIDYMIS#1.0640;GENE EXPRESSION#0.9263;CAPUT#0.8001;CAUDA#0.7485;SPERMATOZOA#0.6601
1580	CYTOCHROME P450#1.0101;MICROSOME#0.9731;POLYMERASE CHAIN REACTION#0.9729;GENE EXPRESSION#0.9711;REVERSE TRANSCRIPTION#0.9027;CYTOTOXICITY#0.9002;TOXICITY#0.8955;SMALL INTESTINE#0.8016;MUTAGENIC#0.7942;T CELL#0.7530;DIABETIC NEPHROPATHY#0.7437;HEME BINDING#0.7361;CORNEAL EPITHELIUM#0.7008;CARCINOGEN#0.7002;LUNG CANCER#0.6906;CELL DEATH#0.6833;TUMOR CELLS#0.6799;ARACHIDONIC ACID#0.6430;HYPOXIC#0.6385;HYPOXIA#0.6359;EPITHELIAL CELL#0.6275;CORNEAL NEOVASCULARIZATION#0.6269;TRANSCRIPTION FACTOR#0.6267;MESANGIAL CELL#0.6053
158158	CIGARETTE SMOKE EXTRACT#0.6248;INTRACELLULAR LOCALIZATION#0.6133;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6043;MITOCHONDRIAL MEMBRANE#0.6018
1581	BILE ACID BIOSYNTHETIC#1.0730;CHOLESTEROL CATABOLISM#1.0381;SCAVENGER RECEPTOR#1.0367;HYDROXYLASE ACTIVITY#1.0362;ATP BINDING CASSETTE TRANSPORTER#1.0343;BILE ACID BIOSYNTHESIS#1.0265;HEPATOMA CELLS#1.0246;SMALL HETERODIMER PARTNER#1.0240;DIURNAL#1.0227;LIVER RECEPTOR HOMOLOG#1.0201;ATORVASTATIN#1.0198;HEPATOCYTE NUCLEAR FACTOR#1.0194;LIVER X RECEPTOR#1.0192;ATP BINDING CASSETTE#1.0182;ATP BINDING#1.0169;CYTOCHROME P450#1.0150;BILE ACID SYNTHESIS#1.0123;COENZYME A#1.0115;LDL RECEPTOR#1.0107;CATABOLISM#1.0103;FATTY ACID SYNTHASE#1.0098;CHOLESTYRAMINE#1.0094;MICROSOME#1.0082;BILE ACID BINDING#1.0079;STEROL REGULATORY ELEMENT#1.0078;TAUROCHOLATE#1.0075;HMG-COA REDUCTASE ACTIVITY#1.0036;CHOLESTEROL DEGRADATION#1.0030;CIRCADIAN RHYTHM#1.0013;PEROXISOME#1.0008;ENZYME ACTIVITY#0.9968;PROTEIN KINASE#0.9932;HIGH CHOLESTEROL DIET#0.9911;FIBROBLAST GROWTH FACTOR#0.9909;CHENODEOXYCHOLIC ACID#0.9906;POLYMERASE CHAIN REACTION#0.9903;CHOLESTEROL BIOSYNTHESIS#0.9902;CHOLESTEROL SYNTHESIS#0.9901;FARNESOID X RECEPTOR#0.9896;TUMOR NECROSIS FACTOR#0.9887;TRANSCRIPTION FACTOR#0.9881;CHOLESTEROL EFFLUX#0.9876;INTESTINAL CHOLESTEROL ABSORPTION#0.9872;GALLSTONE FORMATION#0.9852;GLUTATHIONE#0.9851;GROWTH FACTOR#0.9844;CHOLESTEROL HOMEOSTASIS#0.9841;DEOXYCHOLIC ACID#0.9840;REVERSE TRANSCRIPTION#0.9833;GENE EXPRESSION#0.9815;REVERSE CHOLESTEROL TRANSPORT#0.9813;CHOLESTEROL TRANSPORT#0.9808;CHOLIC ACID#0.9799;SIGNALING PATHWAY#0.9788;ACETYL COA CARBOXYLASE#0.9785;SMALL INTESTINE#0.9779;GALLBLADDER#0.9775;LOW DENSITY LIPOPROTEIN#0.9769;FATTY LIVER#0.9768;EXCRETION#0.9767;HYPERCHOLESTEROLEMIA#0.9767;URSODEOXYCHOLIC ACID#0.9761;CHOLESTEROL METABOLISM#0.9759;BILE ACID METABOLISM#0.9759;PREGNANE X RECEPTOR#0.9701;BILE DUCT#0.9686;CHOLESTASIS#0.9668;TAUROCHOLIC ACID#0.9665;ACAT ACTIVITY#0.9662;LIPOGENESIS#0.9640;FATTY LIVER DISEASE#0.9639;ATHEROSCLEROSIS#0.9633;HIGH DENSITY LIPOPROTEIN#0.9632;VERY-LOW-DENSITY LIPOPROTEIN#0.9628;HIGH FAT DIET#0.9619;LIPID METABOLISM#0.9618;ADIPOSE TISSUE#0.9604;DEXAMETHASONE#0.9579;LIVER DISEASE#0.9571;ORGANIC SOLUTE TRANSPORTER#0.9563;RETINOID X RECEPTOR#0.9557;LIPID HOMEOSTASIS#0.9502;TRANSACTIVATION#0.9500;C-LEVEL#0.9437;WEIGHT GAIN#0.9431;PRIMARY HUMAN HEPATOCYTES#0.9431;OBESE#0.9392;STEM CELL#0.9384;DNA BINDING#0.9379;LIVER DAMAGE#0.9370;QUANTITATIVE REAL TIME#0.9356;ATHEROSCLEROTIC#0.9349;HEPATOTOXICITY#0.9304;BILE ACID SECRETION#0.9290;BILE ACID FORMATION#0.9285;MACROPHAGE#0.9235;LIVER REGENERATION#0.9198;ALCOHOLIC FATTY LIVER#0.9191;TOXICITY#0.9145;STEROL 27-HYDROXYLASE ACTIVITY#0.9134;ACID SECRETION#0.9125;HEPATIC NUCLEAR FACTOR#0.9108;LIPOPROTEIN METABOLISM#0.9066;CHOLESTEROL 7ALPHA-HYDROXYLASE ACTIVITY#0.9063;GROWTH FACTOR RECEPTOR#0.9050;DIABETES MELLITUS#0.9045;BINDING PROTEIN 1#0.9029;LIPOPROTEIN LIPASE#0.9012;ADENOSINE#0.9011;HUMAN PRIMARY HEPATOCYTES#0.8999;BILE ACID TRANSPORT#0.8925;STEROID DEHYDROGENASE#0.8894;INTRAHEPATIC CHOLESTASIS#0.8807;PROTEIN KINASE C#0.8800;ASCORBIC ACID#0.8760;HEPATOCELLULAR CARCINOMA#0.8759;O ACYLTRANSFERASE#0.8715;TYPE 2 DIABETES#0.8697;EMBRYONIC STEM CELL#0.8670;REGENERATION#0.8653;ADENOSINE TRIPHOSPHATE#0.8640;PRAVASTATIN#0.8595;FATTY ACID SYNTHESIS#0.8551;PRO-INFLAMMATORY#0.8550;GLUCONEOGENESIS#0.8518;CHOLESTEROL O ACYLTRANSFERASE#0.8484;INTESTINAL ABSORPTION#0.8406;DRUG METABOLISM#0.8382;BODY WEIGHT GAIN#0.8377;ALKALINE PHOSPHATASE#0.8341;GLUCOSE METABOLISM#0.8339;DIET INDUCED OBESITY#0.8327;APOPTOSIS#0.8252;HEPATOCYTE GROWTH FACTOR#0.8247;ALANINE#0.8219;GLYCINE#0.8219;NUCLEAR HORMONE RECEPTOR#0.8211;NONALCOHOLIC FATTY LIVER DISEASE#0.8180;BILE DUCT LIGATION#0.8142;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.8140;RETINOIC ACID#0.8129;FATTY ACID OXIDATION#0.8124;HISTONE DEACETYLASE#0.8055;CHOLESTEROL ESTERIFICATION#0.8049;HEART DISEASE#0.7965;ADENOSINE MONOPHOSPHATE#0.7923;DETOXIFICATION#0.7915;CHOLESTEROL UPTAKE#0.7897;PROGESTERONE#0.7891;MUTAGENESIS#0.7850;CONSTITUTIVE ANDROSTANE RECEPTOR#0.7833;CORONARY HEART DISEASE#0.7820;CHOLESTEROL BIOSYNTHETIC#0.7796;COLON CANCER#0.7780;SIMVASTATIN#0.7778;CARNITINE#0.7749;CHOLESTEROL TRANSPORTER#0.7742;LANOSTEROL#0.7735;PROTEIN SYNTHESIS#0.7731;MITOGEN ACTIVATED PROTEIN#0.7722;HYPOTHYROIDISM#0.7692;LIPID METABOLIC#0.7646;TRIACYLGLYCEROL TRANSPORT#0.7639;TAURO#0.7538;NITRIC OXIDE#0.7536;ESTRADIOL#0.7494;CHOLELITHIASIS#0.7492;SUPEROXIDE DISMUTASE#0.7491;COLORECTAL ADENOMA#0.7475;OLEIC ACID#0.7470;COLORECTAL CANCER#0.7456;ASPARTATE#0.7455;COLORECTAL#0.7444;MRNA DECAY#0.7438;MECHANISM OF ACTION#0.7418;TRADITIONAL CHINESE MEDICINE#0.7388;CATALYTIC ACTIVITY#0.7357;GESTATION#0.7346;LACTATION#0.7328;ELECTROPHORETIC MOBILITY SHIFT#0.7326;VITAMIN D RECEPTOR#0.7314;BEZAFIBRATE#0.7273;DNASE I#0.7186;HISTONE ACETYLATION#0.7183;ENDOPLASMIC RETICULUM#0.7180;PHENOBARBITAL#0.7163;COLITIS#0.7118;ARTERY#0.7097;CONJUGATION#0.7060;CORONARY ARTERY#0.7057;LIPID SYNTHESIS#0.7046;FATTY ACID METABOLISM#0.7028;PPAR SIGNALING PATHWAY#0.7009;RECEPTOR ACTIVITY#0.7005;STEAROYL COA DESATURASE#0.7002;ETHANOL#0.7000;DEPHOSPHORYLATION#0.6985;TRANSCRIPTIONAL CONTROL#0.6945;FARNESYL#0.6889;MECHANISMS OF ACTION#0.6886;DIGESTION#0.6883;SIGNALING MOLECULE#0.6879;PHOSPHOENOLPYRUVATE#0.6869;REPORTER GENE ASSAY#0.6853;THYROID HORMONE RECEPTOR#0.6769;FATTY ACID BINDING#0.6743;FRAGMENT LENGTH POLYMORPHISM#0.6707;HEPATOCELLULAR CARCINOMA CELL#0.6700;STREPTOZOTOCIN#0.6691;INFLAMMATORY RESPONSE#0.6673;EPITHELIAL CELL#0.6563;CORONARY ARTERY DISEASE#0.6542;ARTERY DISEASE#0.6540;MULTIDRUG RESISTANCE PROTEIN#0.6503;RIFAMPICIN#0.6491;PORTAL VEIN#0.6464;ABC TRANSPORTER#0.6458;ENHANCER BINDING PROTEIN#0.6453;ENHANCER BINDING#0.6448;MITOCHONDRIA#0.6442;STEROL CARRIER PROTEIN#0.6419;RECEPTOR BINDING#0.6415;ENDOTHELIAL CELL#0.6415;FENOFIBRATE#0.6374;GLUCOSE HOMEOSTASIS#0.6326;RECEPTOR AGONIST#0.6293;ENERGY HOMEOSTASIS#0.6276;ENTEROCYTE#0.6263;CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.6257;VITAMIN E#0.6232;SUCROSE#0.6232;CELL DIFFERENTIATION#0.6225;ACYLTRANSFERASE ACTIVITY#0.6218;CELL PROLIFERATION#0.6192;CELL DEATH#0.6180;STEROL TRANSPORTER#0.6154;ADENINE#0.6145;LIPID DROPLET#0.6010
1582	CHOLIC ACID#1.0358;BILE ACID SYNTHESIS#1.0307;SMALL HETERODIMER PARTNER#1.0178;CHENODEOXYCHOLIC ACID#1.0081;CYTOCHROME P450#1.0069;GENE EXPRESSION#0.9994;BILE ACID METABOLISM#0.9965;FARNESOID X RECEPTOR#0.9957;BILE ACID BIOSYNTHESIS#0.9739;CHOLESTASIS#0.9432;LIVER DISEASE#0.9261;EXCRETION#0.9249;CHOLESTEROL METABOLISM#0.9183;TRANSCRIPTION FACTOR#0.9114;HIGH FAT DIET#0.8977;LIPID METABOLISM#0.8701;TAUROCHOLATE#0.8088;FATTY LIVER#0.7591;WEIGHT GAIN#0.7487;FATTY LIVER DISEASE#0.7389;CHOLESTEROL SYNTHESIS#0.7203;TAUROCHOLIC ACID#0.7045;TYPE 2 DIABETES#0.6925;FIBROBLAST GROWTH FACTOR#0.6671;HEPATOCYTE NUCLEAR FACTOR#0.6643;BILE ACID BIOSYNTHETIC#0.6636;GROWTH FACTOR#0.6623;STEROL REGULATORY ELEMENT#0.6622;HEPATOTOXICITY#0.6615;SMALL INTESTINE#0.6574;PEROXISOME#0.6505;COENZYME A#0.6347;SIGNALING PATHWAY#0.6181;DRUG METABOLISM#0.6148;INTESTINAL CHOLESTEROL ABSORPTION#0.6147;PROTEIN KINASE#0.6002
158326	BASEMENT MEMBRANE#1.0830;FRASER SYNDROME#1.0811;EXTRACELLULAR MATRIX#1.0745;RENAL AGENESIS#0.9885;CONGENITAL DIAPHRAGMATIC HERNIA#0.8096;DIAPHRAGM#0.7165;INFLAMMATORY RESPONSE#0.6996;MESENCHYMAL CELL#0.6381;RECEPTOR COMPLEX#0.6298;GENE EXPRESSION#0.6274;EYELID#0.6222;PRO-INFLAMMATORY#0.6212;RECTAL PROLAPSE#0.6179;SIGNAL TRANSDUCTION#0.6143
158376	CELL PROLIFERATION#1.0213;TUMOR SUPPRESSOR#0.9061;LUNG CANCER#0.8990;APOPTOSIS#0.8809;SIGNALING PATHWAY#0.7260;CARDIOLIPIN SYNTHASE#0.6686;EPITHELIAL MESENCHYMAL TRANSITION#0.6590;SKELETAL MUSCLE#0.6518;CANCER CELL#0.6477;SKIN MELANOMA#0.6311;HYPOXIA#0.6299;O CELL#0.6247
158381	SIDEROPHORE#0.6645
1583	STEROID DEHYDROGENASE#1.0668;CYTOCHROME P450SCC#1.0533;VITAMIN D3#1.0410;BETA-HYDROXYSTEROID DEHYDROGENASE#1.0365;3BETA-HYDROXYSTEROID DEHYDROGENASE#1.0357;SCAVENGER RECEPTOR#1.0323;ELECTRON TRANSFER#1.0273;INNER MITOCHONDRIAL MEMBRANE#1.0259;AMINOGLUTETHIMIDE#1.0257;STEROID HYDROXYLASE#1.0250;LH RECEPTOR#1.0198;CYTOCHROME P450#1.0156;STEROID BIOSYNTHESIS#1.0136;PROGESTERONE BIOSYNTHESIS#1.0130;LUTEINIZING HORMONE RECEPTOR#1.0129;FERREDOXIN#1.0101;HORMONE SYNTHESIS#1.0089;PROGESTERONE SECRETION#1.0082;HORMONE BIOSYNTHESIS#1.0078;QUANTITATIVE REAL TIME#1.0071;PROGESTERONE SYNTHESIS#1.0058;CHOLESTEROL TRANSPORT#1.0053;PREGNENOLONE#1.0036;REVERSE TRANSCRIPTION#1.0031;MITOCHONDRIAL MEMBRANE#1.0030;BREAST CANCER#1.0030;TROPHOBLAST#1.0010;TESTOSTERONE SECRETION#0.9981;STEROIDOGENIC FACTOR 1#0.9979;LUTEAL PHASE#0.9975;CYCLIC AMP#0.9949;STEROID SYNTHESIS#0.9933;TROPHOBLAST CELL#0.9931;ANDROGEN BIOSYNTHESIS#0.9922;ESTROGEN RECEPTOR#0.9914;ADRENAL CORTEX#0.9907;INTERSTITIAL CELL#0.9905;LEYDIG CELL#0.9904;MITOCHONDRIA#0.9902;GLIAL CELL#0.9893;ENZYME ACTIVITY#0.9892;ADRENAL HYPERPLASIA#0.9892;FORSKOLIN#0.9886;CATALYTIC ACTIVITY#0.9872;LOW DENSITY LIPOPROTEIN#0.9871;KERATINOCYTE#0.9865;POLYMERASE CHAIN REACTION#0.9862;LUTEINIZATION#0.9857;PROTEIN KINASE C#0.9856;DEXAMETHASONE#0.9832;INSULIN-LIKE GROWTH FACTOR#0.9828;ANDROGEN RECEPTOR#0.9827;ADENOSINE MONOPHOSPHATE#0.9819;CORTISOL#0.9817;FACTOR I#0.9817;ALDOSTERONE#0.9814;GONAD#0.9802;MUTAGENESIS#0.9802;CYCLIC ADENOSINE MONOPHOSPHATE#0.9798;OVARIAN FOLLICLE#0.9791;GRANULOSA CELL#0.9788;PROGESTERONE#0.9787;SERTOLI CELL#0.9781;CYTOCHROME B5#0.9778;ENDOPLASMIC RETICULUM#0.9777;PROTEIN KINASE A#0.9773;ADRENAL GLAND#0.9768;ESTROUS CYCLE#0.9764;REGULATION OF STEROIDOGENESIS#0.9763;STEROID METABOLISM#0.9762;ADDISON'S DISEASE#0.9762;GESTATION#0.9755;17β-ESTRADIOL#0.9750;PROTEIN SYNTHESIS#0.9747;ADENOSINE#0.9743;DEHYDROEPIANDROSTERONE#0.9741;CORPUS LUTEUM#0.9740;TESTOSTERONE#0.9740;POLYCYSTIC OVARY SYNDROME#0.9717;ANDROSTENEDIONE#0.9715;TRANSCRIPTION FACTOR#0.9713;OVARIES#0.9708;PROTEIN KINASE#0.9700;FOLLICLE STIMULATING HORMONE#0.9698;ANDROGEN SYNTHESIS#0.9697;GENE EXPRESSION#0.9696;OOCYTE#0.9691;CELL DIFFERENTIATION#0.9687;OUTER MITOCHONDRIAL MEMBRANE#0.9673;GERM CELL#0.9669;STEROIDOGENESIS#0.9665;CORTISOL SYNTHESIS#0.9660;HYDROXYLASE ACTIVITY#0.9656;CELL PROLIFERATION#0.9654;CELL CYCLE#0.9643;GROWTH FACTOR#0.9640;GLUCOCORTICOID RECEPTOR#0.9638;ESTROGENS#0.9633;APOPTOSIS#0.9631;TUMOR CELLS#0.9627;ESTRADIOL#0.9625;ELECTRON TRANSPORT#0.9623;OVARIAN#0.9620;REACTIVE OXYGEN SPECIES#0.9618;OVULATION#0.9614;CORTICOTROPIN#0.9612;SIGNALING PATHWAY#0.9592;INHIBIN#0.9590;CORTISOL SECRETION#0.9588;TRANSFORMING GROWTH FACTOR#0.9583;SPERMATOGENESIS#0.9578;EPITHELIAL CELL#0.9577;THECAL CELL#0.9575;TRANSCRIPTASE#0.9570;SIGNAL TRANSDUCTION#0.9554;TOXICITY#0.9528;REPRODUCTIVE TOXICITY#0.9508;TESTICULAR DEVELOPMENT#0.9506;REPRODUCTIVE SYSTEM#0.9496;NERVOUS SYSTEM#0.9494;PROTEIN PROTEIN INTERACTION#0.9490;DNA METHYLATION#0.9490;CHOLESTEROL BINDING#0.9475;ADRENOCORTICAL CARCINOMA#0.9469;SEX DIFFERENTIATION#0.9450;INFERTILITY#0.9428;BENZODIAZEPINE RECEPTOR#0.9414;LIPID DROPLET#0.9402;FERTILIZATION#0.9392;CHOLESTEROL METABOLISM#0.9382;CAMP SIGNALING#0.9359;ENDOCRINE SYSTEM#0.9353;DIHYDROTESTOSTERONE#0.9339;ADRENOCORTICOTROPIC HORMONE#0.9330;CELL DEVELOPMENT#0.9319;CONGENITAL ADRENAL HYPERPLASIA#0.9318;MECHANISM OF ACTION#0.9308;TRANSACTIVATION#0.9303;PROSTATE CANCER#0.9301;T CELL#0.9299;CYTOPLASM#0.9281;SUPEROXIDE DISMUTASE#0.9231;OESTRADIOL#0.9217;MELATONIN#0.9213;ESTROGEN SYNTHESIS#0.9212;APOPTOTIC#0.9206;STEM CELL#0.9174;STEROID BIOSYNTHETIC#0.9155;PUBERTY#0.9154;HORMONE SECRETION#0.9152;HYPERANDROGENISM#0.9139;GLUTATHIONE#0.9136;CONTACT SITE#0.9107;THECA INTERNA CELL#0.9103;CELL GROWTH#0.9094;VITAMIN D3 METABOLISM#0.8969;PROGESTIN#0.8958;DNA BINDING#0.8941;ENDOCRINE DISRUPTING CHEMICAL#0.8906;KINASE INHIBITOR#0.8905;TRILOSTANE#0.8881;CORTICAL CELL#0.8864;STEROL CARRIER PROTEIN#0.8863;AROMATASE ACTIVITY#0.8856;TRANSFORMING GROWTH FACTOR BETA#0.8836;ADENYLATE CYCLASE#0.8776;IN UTERO EXPOSURE#0.8761;BONE MORPHOGENETIC PROTEIN#0.8745;ESTRONE#0.8708;POLYCYSTIC OVARIAN SYNDROME#0.8701;KETOCONAZOLE#0.8691;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8669;FIBROBLAST GROWTH FACTOR#0.8668;CARDIOLIPIN#0.8666;GROWTH HORMONE#0.8663;DIGITOXIN#0.8654;OVARIAN DEVELOPMENT#0.8649;NITRIC OXIDE#0.8624;STEM LEYDIG CELL#0.8589;TESTIS DEVELOPMENT#0.8583;MALE REPRODUCTIVE SYSTEM#0.8580;ESTRUS#0.8563;HUMAN ADRENOCORTICAL CARCINOMA#0.8526;LACTATION#0.8523;SPERMATOZOA#0.8523;CELL DEATH#0.8505;PERIPHERAL BENZODIAZEPINE RECEPTOR#0.8504;VITAMIN D RECEPTOR#0.8500;PURKINJE CELL#0.8491;HYPOTHALAMIC PITUITARY ADRENAL#0.8470;COENZYME A#0.8463;DIGOXIN#0.8461;RECEPTOR ANTAGONIST#0.8459;SPINAL CORD#0.8455;CAMP SYNTHESIS#0.8449;LYASE ACTIVITY#0.8445;EPIDERMAL GROWTH FACTOR#0.8438;LUTEIN#0.8436;LUTEOLYSIS#0.8417;CYTOCHROME P-450SCC#0.8414;CHOLERA#0.8412;LDL RECEPTOR#0.8403;CANCER CELL#0.8393;GONADOTROPIN RELEASING HORMONE#0.8371;GRANULOSA CELL DIFFERENTIATION#0.8356;BLOOD VESSEL#0.8353;FOLLICULAR PHASE#0.8320;INTERRENAL GLAND#0.8312;SYNCYTIOTROPHOBLAST#0.8298;RETINOIC ACID#0.8255;PROGESTERONE FORMATION#0.8247;MITOGEN ACTIVATED PROTEIN#0.8236;ESTRADIOL-17BETA#0.8231;CYTOTROPHOBLAST#0.8208;STROMAL CELL#0.8191;ESTRADIOL SECRETION#0.8164;SEX DETERMINATION#0.8164;ADIPOSE TISSUE#0.8164;VITAMIN D2#0.8155;CAMP RESPONSE ELEMENT#0.8107;EPIDIDYMIS#0.8104;ANDROGEN SECRETION#0.8068;GLUCOCORTICOID SYNTHESIS#0.8064;CORTICOSTERONE SECRETION#0.8057;IRON SULFUR CLUSTER#0.8051;SPERMATOGENIC CELLS#0.7999;ERGOSTEROL#0.7981;NADPH ADRENODOXIN REDUCTASE#0.7936;LUTEINIZING GRANULOSA CELL#0.7923;GRANULOSA CELL PROLIFERATION#0.7900;ADENYLATE#0.7859;PEROXISOME#0.7839;MECHANISMS OF ACTION#0.7808;1α,25-DIHYDROXYVITAMIN D3#0.7794;PROTEIN BINDING#0.7787;ASTROCYTE#0.7783;HYPERTENSION#0.7782;TUMOR NECROSIS FACTOR#0.7752;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7747;PROSTAGLANDIN E2#0.7743;ENDOMETRIUM#0.7731;CYTOCHROME C#0.7721;GLUTATHIONE PEROXIDASE#0.7693;CONGENITAL ADRENAL INSUFFICIENCY#0.7684;SMOOTH ENDOPLASMIC RETICULUM#0.7679;PARTURITION#0.7654;HATCHING#0.7645;REGULATION OF MRNA#0.7642;CHORIOCARCINOMA#0.7640;MITOCHONDRIAL INNER MEMBRANE#0.7635;ETHANOL#0.7574;ENDOTHELIAL CELL#0.7573;ESTROGEN BIOSYNTHESIS#0.7493;SEBACEOUS GLAND#0.7484;OOCYTE MATURATION#0.7478;JUN PHOSPHORYLATION#0.7474;HEME BINDING#0.7462;REGENERATION#0.7439;TOXICANT#0.7408;CHOLESTEROL SYNTHESIS#0.7403;LEYDIG CELL DIFFERENTIATION#0.7385;GROWTH FACTOR RECEPTOR#0.7377;HISTONE MODIFICATION#0.7351;DOMINANT NEGATIVE MUTANT#0.7332;STEROID FORMATION#0.7301;MICROSOME#0.7299;OLIGODENDROCYTE#0.7290;GENISTEIN#0.7279;UTERUS#0.7277;DIABETES MELLITUS#0.7266;CAMP RESPONSE ELEMENT BINDING#0.7237;CD8+ T CELL#0.7236;HYPOGONADISM#0.7227;3-BETA-HSD ACTIVITY#0.7217;CRISTAE#0.7205;ASPARTATE#0.7161;RESPONSE TO STRESS#0.7113;CORTISOL BIOSYNTHESIS#0.7099;STROMA#0.7092;ETHANE#0.7082;SIGNALING CASCADE#0.7067;FETAL BRAIN#0.7061;WEIGHT GAIN#0.7040;YOLK SYNCYTIAL LAYER#0.7032;SCHWANN CELL#0.7012;ACTINOMYCIN D#0.6984;CHOLESTEROL IMPORT#0.6979;CEREBRAL CORTEX#0.6978;MODE OF ACTION#0.6969;LIPID METABOLISM#0.6942;DEHYDROEPIANDROSTERONE SULFATE#0.6938;CUMULUS OOCYTE COMPLEXES#0.6932;PREMATURE OVARIAN FAILURE#0.6928;METYRAPONE#0.6895;HYPOXIA#0.6881;CHOLESTEROL TRANSPORTER#0.6829;OUTER MEMBRANE#0.6829;CELLULAR LOCALIZATION#0.6824;HEAT SHOCK PROTEIN#0.6796;ANION CHANNEL#0.6773;ENZYME COMPLEX#0.6733;OBESE#0.6712;INSULIN RECEPTOR#0.6694;SIGNALING MOLECULE#0.6692;TROPHOBLAST GIANT CELLS#0.6686;TYPE 2 DIABETES#0.6679;PRO-INFLAMMATORY#0.6667;ENDOTHELIAL GROWTH FACTOR#0.6662;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6662;25-HYDROXYVITAMIN D3#0.6650;IMMUNE RESPONSE#0.6646;DIENCEPHALON#0.6582;ANGIOGENESIS#0.6563;MENSTRUAL CYCLE#0.6562;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.6549;GONAD DEVELOPMENT#0.6462;CORTICOTROPIN-RELEASING FACTOR#0.6446;TROPHOBLAST GIANT CELL DIFFERENTIATION#0.6428;LYSINE#0.6427;MACROPHAGE#0.6409;ADIPOCYTE#0.6395;SPERMATOCYTES#0.6382;ETOMIDATE#0.6365;HORMONE METABOLISM#0.6358;AUTOIMMUNE POLYGLANDULAR SYNDROME#0.6352;ELECTRON CARRIER#0.6345;ALDOSTERONE SECRETION#0.6320;STEROID HORMONE RECEPTOR#0.6310;ELECTROPHORETIC MOBILITY SHIFT#0.6306;OUABAIN#0.6306;PROLACTIN RECEPTOR#0.6297;ESTROGEN RECEPTOR ALPHA#0.6270;DIETHYLSTILBESTROL#0.6258;CIRCADIAN RHYTHM#0.6257;ENHANCER BINDING PROTEIN#0.6255;ROS GENERATION#0.6252;ENHANCER BINDING#0.6250;GENETIC DISORDER#0.6247;ANTI MULLERIAN HORMONE#0.6238;FLUTAMIDE#0.6227;AUTOIMMUNE DISEASE#0.6215;FRAGMENT LENGTH POLYMORPHISM#0.6189;SCIATIC NERVE#0.6185;SPERM MOTILITY#0.6147;X CHROMOSOME#0.6140;SIGNAL TRANSDUCER#0.6114;DEFINITIVE ZONE CELL#0.6098;HIGH DENSITY LIPOPROTEIN#0.6083;CAMP-RESPONSIVE ELEMENT BINDING#0.6074;CUSHING'S SYNDROME#0.6030
158452	CELL PROLIFERATION#0.7091
158471	PROSTATE CANCER#0.9280;NEUROBLASTOMA#0.8767;LEIOMYOSARCOMA#0.7825;APOPTOSIS#0.7750;SPINAL CORD#0.6441;RETINOIC ACID#0.6407;CANCER CELL#0.6335;TUMOR SUPPRESSOR#0.6291
1584	CORTISOL SYNTHESIS#1.0547;GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM#1.0432;CORTISOL BIOSYNTHESIS#1.0323;METYRAPONE#1.0251;HYDROXYLASE ACTIVITY#1.0139;POLYMERASE CHAIN REACTION#1.0103;CUSHING'S SYNDROME#1.0093;CYTOCHROME P450#1.0058;CONGENITAL ADRENAL HYPERPLASIA#1.0050;STEROIDOGENIC FACTOR 1#1.0026;ALDOSTERONE#0.9993;CORTISOL#0.9986;ADRENAL HYPERPLASIA#0.9977;ADRENAL CORTEX#0.9931;MITOCHONDRIA#0.9887;GENE EXPRESSION#0.9854;ENZYME ACTIVITY#0.9840;ADRENAL GLAND#0.9814;EPITHELIAL CELL#0.9807;3BETA-HYDROXYSTEROID DEHYDROGENASE#0.9802;STEROIDOGENESIS#0.9771;ADRENOCORTICOTROPIC HORMONE#0.9751;HYPERTENSION#0.9629;DEXAMETHASONE#0.9623;PROTEIN KINASE#0.9618;CORTISOL SECRETION#0.9583;PROGESTERONE#0.9576;ALDOSTERONE SECRETION#0.9557;TUMOR CELLS#0.9514;ESSENTIAL HYPERTENSION#0.9484;ADRENOCORTICAL CARCINOMA#0.9478;GENE CONVERSION#0.9433;TRANSCRIPTION FACTOR#0.9380;TESTOSTERONE#0.9361;GLUCOCORTICOID RECEPTOR#0.9246;ELECTRON TRANSFER#0.9235;GLUCOCORTICOID SYNTHESIS#0.9193;ESTRADIOL#0.9131;ANDROSTENEDIONE#0.9074;ADRENAL ADENOMA#0.8996;RECEPTOR ANTAGONIST#0.8872;GLUCOCORTICOID BIOSYNTHESIS#0.8870;STEROID SYNTHESIS#0.8847;BETA-HYDROXYSTEROID DEHYDROGENASE#0.8847;GROWTH FACTOR#0.8756;REVERSE TRANSCRIPTION#0.8722;RENIN ACTIVITY#0.8703;FORSKOLIN#0.8698;HYPOTHALAMIC PITUITARY ADRENAL#0.8566;EXCRETION#0.8440;STEROID BIOSYNTHESIS#0.8422;WOUND HEALING#0.8315;PROTEIN KINASE A#0.8143;PUBERTY#0.8132;HYPOKALEMIA#0.8105;GONAD#0.8065;CONGESTIVE HEART FAILURE#0.8057;STEROID HYDROXYLASE#0.8030;CORTICAL CELL#0.7921;SIGNALING PATHWAY#0.7916;PRECOCIOUS PUBERTY#0.7879;MUTAGENESIS#0.7769;ETOMIDATE#0.7693;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.7554;TOXICITY#0.7433;SPIRONOLACTONE#0.7311;KETOCONAZOLE#0.7302;DNA METHYLATION#0.7175;ADRENOCORTICAL HYPERPLASIA#0.7122;CORTICOTROPIN#0.7061;LEYDIG CELL#0.7051;FRAGMENT LENGTH POLYMORPHISM#0.7049;HUMAN ADRENOCORTICAL CARCINOMA#0.7013;PERIPHERAL BLOOD#0.6993;HYDROCORTISONE#0.6934;HORMONE BIOSYNTHESIS#0.6886;PREGNENOLONE#0.6793;QUANTITATIVE REAL TIME#0.6739;OVARIAN#0.6735;NERVOUS SYSTEM#0.6731;STEROID METABOLISM#0.6728;MITOTANE#0.6721;CYTOCHROME P450SCC#0.6688;17β-ESTRADIOL#0.6645;CYTOCHROME P-450SCC#0.6541;PROTEIN KINASE C#0.6496;CENTRAL NERVOUS SYSTEM#0.6483;PRIMARY HYPERALDOSTERONISM#0.6483;CALCIUM CHANNEL#0.6481;PROSTATE CANCER#0.6436;MINERALOCORTICOID SYNTHESIS#0.6424;STRUCTURE ACTIVITY RELATIONSHIP#0.6298;DEHYDROEPIANDROSTERONE#0.6048;POSITRON EMISSION TOMOGRAPHY#0.6026
158506	UBIQUITIN#0.8317;LUNG CANCER#0.6301
158511	CANCER TESTIS ANTIGEN#0.6159
158521	CANCER CELL#1.0094;CANCER TESTIS ANTIGEN#0.9611;CELL PROLIFERATION#0.6843;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6420;EPITHELIAL TO MESENCHYMAL#0.6417;T CELL#0.6246
158584	LIPID DROPLET#0.6099
1585	ATRIAL FIBRILLATION#1.0526;GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM#1.0436;HYPOALDOSTERONISM#1.0409;GENE CONVERSION#1.0302;ANGIOTENSIN CONVERTING ENZYME#1.0277;ALDOSTERONE#1.0231;CONGESTIVE HEART FAILURE#1.0207;CYTOCHROME P450#1.0191;HYDROXYLASE ACTIVITY#1.0159;FRAGMENT LENGTH POLYMORPHISM#1.0116;STEROIDOGENIC FACTOR 1#1.0063;POLYMERASE CHAIN REACTION#1.0033;ESSENTIAL HYPERTENSION#1.0012;PROTEIN KINASE C#0.9975;GENE EXPRESSION#0.9974;DIABETIC NEPHROPATHY#0.9947;NEPHROPATHY#0.9946;TRANSCRIPTION FACTOR#0.9943;SPIRONOLACTONE#0.9942;ALDOSTERONE SECRETION#0.9941;PROTEIN KINASE#0.9937;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.9931;RECEPTOR ANTAGONIST#0.9919;CALCIUM CHANNEL#0.9914;SIGNALING PATHWAY#0.9911;CORTISOL SYNTHESIS#0.9910;ANGIOTENSIN RECEPTOR#0.9898;ADRENOCORTICAL CARCINOMA#0.9890;ADRENAL CORTEX#0.9889;BETA-HYDROXYSTEROID DEHYDROGENASE#0.9847;REVERSE TRANSCRIPTION#0.9840;GROWTH FACTOR#0.9835;CONGENITAL ADRENAL HYPERPLASIA#0.9828;EXCRETION#0.9824;ARTERY#0.9793;CORTISOL#0.9785;ADRENAL GLAND#0.9785;NITRIC OXIDE#0.9783;HUMAN ADRENOCORTICAL CARCINOMA#0.9780;HYPERTENSION#0.9764;ADRENAL HYPERPLASIA#0.9764;3BETA-HYDROXYSTEROID DEHYDROGENASE#0.9751;SODIUM CHANNEL#0.9742;ADRENOCORTICOTROPIC HORMONE#0.9733;EPITHELIAL SODIUM CHANNEL#0.9724;DEXAMETHASONE#0.9691;STEROIDOGENESIS#0.9688;SYSTOLIC BLOOD PRESSURE#0.9687;RENIN ACTIVITY#0.9656;MYOCARDIAL INFARCTION#0.9644;PROGESTERONE#0.9590;FORSKOLIN#0.9576;LEFT VENTRICULAR MASS#0.9555;CUSHING'S SYNDROME#0.9540;MITOCHONDRIA#0.9514;EPLERENONE#0.9465;ADRENAL ADENOMA#0.9455;ENDOTHELIAL CELL#0.9455;DIABETES MELLITUS#0.9450;CORTISOL BIOSYNTHESIS#0.9433;TUMOR CELLS#0.9426;NERVOUS SYSTEM#0.9413;TRANSCRIPTASE#0.9393;TRANSFORMING GROWTH FACTOR#0.9376;SMOOTH MUSCLE#0.9375;STEROID HYDROXYLASE#0.9331;TESTOSTERONE#0.9286;KIDNEY DISEASE#0.9279;MUSCLE CELL#0.9279;ENZYME ACTIVITY#0.9270;ADIPOSE TISSUE#0.9268;SMOOTH MUSCLE CELL#0.9241;CORONARY ARTERY#0.9226;ESTRADIOL#0.9204;PROTEIN KINASE A#0.9197;HEART DISEASE#0.9184;ENZYME INHIBITOR#0.9171;CENTRAL NERVOUS SYSTEM#0.9164;QUANTITATIVE REAL TIME#0.9139;SECONDARY HYPERTENSION#0.9038;HYPOKALEMIA#0.8997;CHRONIC KIDNEY DISEASE#0.8965;RESPONSE TO ANGIOTENSIN#0.8962;PRIMARY HYPERALDOSTERONISM#0.8928;CORTISOL SECRETION#0.8916;PERIPHERAL BLOOD#0.8902;GONAD#0.8777;CARDIOMYOPATHY#0.8761;LOSARTAN#0.8642;PREGNENOLONE#0.8586;NITRIC OXIDE SYNTHASE#0.8584;CALCIUM SIGNALING#0.8573;CELL PROLIFERATION#0.8566;STEROID SYNTHESIS#0.8556;GLUCOCORTICOID RECEPTOR#0.8381;CORONARY ARTERY DISEASE#0.8375;ARTERY DISEASE#0.8373;ENDOTHELIAL NITRIC OXIDE#0.8362;BLOOD PRESSURE REGULATION#0.8333;NIFEDIPINE#0.8233;CORTICAL CELL#0.8192;DIGESTION#0.8175;ALDOSTERONE RENIN RATIO#0.8150;POTASSIUM CHANNEL#0.8142;D-ALDOSTERONE#0.7987;METYRAPONE#0.7953;REGULATION OF BLOOD PRESSURE#0.7932;DILATED CARDIOMYOPATHY#0.7851;ANDROSTENEDIONE#0.7850;ATHEROSCLEROSIS#0.7844;CAMP RESPONSE ELEMENT#0.7840;ANGIOTENSIN TYPE 1#0.7769;APOPTOSIS#0.7748;ALDOSTERONE RECEPTOR#0.7683;PROSTATE CANCER#0.7677;HYDROCHLOROTHIAZIDE#0.7613;TYPE 2 DIABETES#0.7597;BLOOD VESSEL#0.7518;CAROTID ARTERY#0.7482;AMBULATORY BLOOD PRESSURE#0.7469;GESTATION#0.7449;VASCULAR SMOOTH MUSCLE CELL#0.7442;CARDIOMYOCYTE#0.7404;DNA METHYLATION#0.7399;SIGNALLING PATHWAY#0.7396;CARDIOVASCULAR RISK FACTOR#0.7333;REACTIVE OXYGEN SPECIES#0.7327;MEMBRANE DEPOLARIZATION#0.7282;HEME BINDING#0.7268;STEROID BIOSYNTHESIS#0.7223;Y CHROMOSOME#0.7215;BREAST CANCER#0.7148;HYPERTROPHIC CARDIOMYOPATHY#0.7140;RECEPTOR AGONIST#0.7132;ARGININE#0.7098;MESANGIAL CELL#0.7043;TOXICITY#0.7016;CAPTOPRIL#0.7013;MITOCHONDRIAL MEMBRANE#0.6968;VALSARTAN#0.6942;ADRENERGIC RECEPTOR#0.6847;TRANSACTIVATION#0.6817;DOXYCYCLINE#0.6807;TYPE 2 DIABETIC#0.6759;CAMP SIGNALING#0.6756;ANGIOTENSIN RECEPTOR BLOCKER#0.6744;ION CHANNEL#0.6717;MULTIFACTOR DIMENSIONALITY REDUCTION#0.6690;SIGNAL TRANSDUCTION#0.6682;FLUDROCORTISONE#0.6638;TUMOR NECROSIS FACTOR#0.6620;LEUKOCYTE#0.6613;17β-ESTRADIOL#0.6609;MUTAGENESIS#0.6599;HORMONE BIOSYNTHESIS#0.6558;HIGH DENSITY LIPOPROTEIN#0.6526;HYPOXIA#0.6495;REGENERATION#0.6483;HARDY WEINBERG EQUILIBRIUM#0.6481;MINERALOCORTICOID RECEPTOR BLOCKER#0.6474;PROTEINURIA#0.6427;AMINOPEPTIDASE A#0.6358;APPARENT MINERALOCORTICOID EXCESS#0.6336;CHRONIC HEART FAILURE#0.6300;ADRENAL VEIN SAMPLING#0.6262;GLUCOSE HOMEOSTASIS#0.6240;PIOGLITAZONE#0.6235;WATER HOMEOSTASIS#0.6230;TORASEMIDE#0.6198;TRILOSTANE#0.6133;NADPH OXIDASE#0.6115;ADIPOCYTE#0.6093;SYSTOLIC HEART FAILURE#0.6040
1586	ANDROGEN FORMATION#1.0745;ENDOMETRIAL CANCER#1.0617;ENDOMETRIOSIS#1.0435;LYASE INHIBITOR#1.0392;ELECTRON TRANSFER#1.0363;BETA-HYDROXYSTEROID DEHYDROGENASE#1.0361;CATECHOL O METHYLTRANSFERASE#1.0345;CYTOCHROME B#1.0344;ESTROGEN BIOSYNTHESIS#1.0343;CYTOCHROME B5#1.0338;3BETA-HYDROXYSTEROID DEHYDROGENASE#1.0336;O METHYLTRANSFERASE#1.0335;THECAL CELL#1.0315;STEROID HYDROXYLASE#1.0307;ABIRATERONE#1.0301;LH RECEPTOR#1.0294;AGE AT MENARCHE#1.0240;FRAGMENT LENGTH POLYMORPHISM#1.0217;KETOCONAZOLE#1.0214;ANDROGEN BIOSYNTHESIS#1.0213;ENZALUTAMIDE#1.0208;LYASE ACTIVITY#1.0207;HORMONE BIOSYNTHESIS#1.0174;CYTOCHROME C#1.0172;STEROID BIOSYNTHESIS#1.0172;ANDROSTENEDIONE SECRETION#1.0170;SCAVENGER RECEPTOR#1.0134;HYDROXYLASE ACTIVITY#1.0116;CYTOCHROME P450#1.0115;ANDROGEN SYNTHESIS#1.0106;INTERSTITIAL CELL#1.0097;STEROID METABOLISM#1.0096;MENARCHE#1.0082;CORTISOL SYNTHESIS#1.0082;BREAST CANCER#1.0078;FORSKOLIN#1.0075;STEROIDOGENIC FACTOR 1#1.0071;ESTROGEN METABOLISM#1.0067;POLYMERASE CHAIN REACTION#1.0058;MICROSOME#1.0055;INHIBIN#1.0051;LUTEINIZING HORMONE RECEPTOR#1.0044;HORMONE SYNTHESIS#1.0041;DOCETAXEL#1.0039;OVARIAN FOLLICLE#1.0031;LEIOMYOMA#1.0030;HORMONE METABOLISM#1.0026;ENDOPLASMIC RETICULUM#1.0024;ANDROGEN SECRETION#1.0024;LEYDIG CELL#1.0024;ENZYME ACTIVITY#1.0010;CONGENITAL ADRENAL HYPERPLASIA#0.9984;STEROID SYNTHESIS#0.9978;PREGNENOLONE#0.9964;ESTROGEN SYNTHESIS#0.9957;REVERSE TRANSCRIPTION#0.9957;CYCLIC AMP#0.9956;PROSTATE CANCER#0.9953;INSULIN-LIKE GROWTH FACTOR#0.9944;PROTEIN KINASE A#0.9943;PROTEIN KINASE#0.9936;CATALYTIC ACTIVITY#0.9933;QUANTITATIVE REAL TIME#0.9918;ADRENAL HYPERPLASIA#0.9907;HYPERANDROGENISM#0.9898;17β-ESTRADIOL#0.9895;TESTOSTERONE SECRETION#0.9891;CANCER CELL#0.9879;GONAD#0.9878;OVARIAN CANCER#0.9873;ESTROGEN RECEPTOR#0.9869;GRANULOSA CELL#0.9866;ADVANCED PROSTATE CANCER#0.9864;BREAST CANCER PATIENTS#0.9846;SEX DIFFERENTIATION#0.9844;MUTAGENESIS#0.9842;TUMOR CELLS#0.9839;PROTEIN KINASE C#0.9834;ANDROGEN RECEPTOR#0.9828;OOCYTE#0.9824;CUSHING'S SYNDROME#0.9816;OVARIES#0.9814;ASTROCYTE#0.9812;ANDROSTENEDIONE#0.9800;ADRENAL GLAND#0.9800;SERTOLI CELL#0.9799;ADRENAL CORTEX#0.9799;FOLLICLE STIMULATING HORMONE#0.9798;GESTATION#0.9789;TRANSCRIPTION FACTOR#0.9788;CORTISOL#0.9783;SIGNALING PATHWAY#0.9779;POLYCYSTIC OVARY SYNDROME#0.9776;HYPOKALEMIA#0.9770;ESTROGENS#0.9763;PROGESTERONE#0.9757;PREDNISONE#0.9750;HYPERTENSION#0.9743;DEHYDROEPIANDROSTERONE#0.9739;MECHANISM OF ACTION#0.9736;NERVOUS SYSTEM#0.9735;GROWTH FACTOR#0.9726;HUMAN ADRENOCORTICAL CARCINOMA#0.9724;RECEPTOR ANTAGONIST#0.9722;OVARIAN#0.9718;ALDOSTERONE#0.9718;ADRENOCORTICAL CARCINOMA#0.9713;CORPUS LUTEUM#0.9712;DIHYDROTESTOSTERONE#0.9712;CELL PROLIFERATION#0.9709;TESTOSTERONE#0.9708;SPERMATOGENESIS#0.9707;DEHYDROEPIANDROSTERONE SULFATE#0.9706;PROSTATE SPECIFIC ANTIGEN#0.9705;GERM CELL#0.9703;ESTRADIOL#0.9689;TRANSFORMING GROWTH FACTOR#0.9684;GENE EXPRESSION#0.9682;AMENORRHEA#0.9673;TROPHOBLAST#0.9666;STEROIDOGENESIS#0.9665;PUBERTY#0.9653;ANDROGEN METABOLISM#0.9651;SIGNAL TRANSDUCTION#0.9634;PERIPHERAL BLOOD#0.9625;PROSTATE CARCINOMA#0.9622;CORTISOL SECRETION#0.9606;THECA INTERNA CELL#0.9595;ANDROGEN DEPRIVATION THERAPY#0.9585;DEXAMETHASONE#0.9580;ESTRONE#0.9567;FACTOR I#0.9564;INFERTILITY#0.9535;PROTEIN SYNTHESIS#0.9525;APOPTOSIS#0.9517;BONE MINERAL DENSITY#0.9509;TOXICITY#0.9494;CORTISOL BIOSYNTHESIS#0.9490;OOCYTE MATURATION#0.9486;MENSTRUAL CYCLE#0.9473;STEM CELL#0.9469;ADRENAL ADENOMA#0.9429;STEROID BIOSYNTHETIC#0.9428;ADRENOCORTICOTROPIC HORMONE#0.9424;METASTATIC PROSTATE CANCER#0.9380;MECHANISMS OF ACTION#0.9370;POLYCYSTIC OVARIAN SYNDROME#0.9358;DNA METHYLATION#0.9337;CELL CYCLE#0.9333;CELL GROWTH#0.9328;HORMONE BINDING#0.9327;MITOCHONDRIA#0.9323;FLUTAMIDE#0.9321;TROPHOBLAST CELL#0.9318;STEM LEYDIG CELL#0.9302;TRANSACTIVATION#0.9292;TRANSFORMING GROWTH FACTOR BETA#0.9288;OVULATION#0.9280;REGULATION OF STEROIDOGENESIS#0.9279;KINASE INHIBITOR#0.9272;METFORMIN#0.9255;GONADOTROPIN RELEASING HORMONE#0.9246;STROMAL CELL#0.9245;CELL DIFFERENTIATION#0.9242;ADIPOSE TISSUE#0.9237;REPRODUCTIVE TOXICITY#0.9220;DRUG METABOLISM#0.9217;MENOPAUSE#0.9202;STROMA#0.9153;ADENOSINE#0.9116;CELL DEVELOPMENT#0.9104;HYPOGONADISM#0.9098;CYTOCHROME P450SCC#0.9069;REPRODUCTIVE SYSTEM#0.9055;ADENINE#0.9011;OVARIAN DEVELOPMENT#0.8989;SEX DETERMINATION#0.8961;RESVERATROL#0.8918;OESTRADIOL#0.8914;PROGESTIN#0.8912;GLUCOCORTICOID SYNTHESIS#0.8870;FETAL GROWTH RESTRICTION#0.8849;SPINAL CORD#0.8835;ESTROUS CYCLE#0.8823;APOPTOTIC#0.8729;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8719;CHOLESTEROL TRANSPORT#0.8717;CABAZITAXEL#0.8679;HYPOSPADIAS#0.8645;ADENINE DINUCLEOTIDE PHOSPHATE#0.8639;FLAVODOXIN#0.8610;GLUTATHIONE#0.8598;ENZYME INHIBITOR#0.8590;STEROID DEHYDROGENASE#0.8587;ESTRADIOL-17BETA#0.8576;MITOGEN ACTIVATED PROTEIN#0.8547;ENDOCRINE SYSTEM#0.8498;ENDOCRINE DISRUPTING CHEMICAL#0.8489;ESTROGEN RECEPTOR ALPHA#0.8482;OBESE#0.8475;MALE BREAST CANCER#0.8458;AROMATASE ACTIVITY#0.8456;TESTIS DEVELOPMENT#0.8454;TRANSCRIPTASE#0.8433;DHEA SECRETION#0.8431;TESTICULAR DEVELOPMENT#0.8431;RETINOIC ACID#0.8427;FERTILIZATION#0.8425;TUMOR NECROSIS FACTOR#0.8396;CAMP SIGNALING#0.8393;MACROPHAGE#0.8356;CORONARY ARTERY DISEASE#0.8355;ARTERY DISEASE#0.8353;CORONARY ARTERY#0.8334;HEME BINDING#0.8330;FOLLICULAR PHASE#0.8326;OSTEOPOROSIS#0.8309;EPITHELIAL CELL#0.8265;PSEUDOHERMAPHRODITISM#0.8226;GROWTH FACTOR RECEPTOR#0.8222;GLUCOCORTICOID RECEPTOR#0.8214;ADDISON'S DISEASE#0.8203;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.8198;ALZHEIMER'S DISEASE#0.8185;DNA BINDING#0.8181;PROTEIN PROTEIN INTERACTION#0.8179;ALDO KETO REDUCTASE#0.8177;LUNG CANCER#0.8160;REACTIVE OXYGEN SPECIES#0.8139;DEMETHYLATION#0.8122;STEROID HORMONE RECEPTOR#0.8116;ARGININE#0.8116;AGE AT ONSET#0.8115;COLORECTAL CANCER#0.8070;XENOBIOTIC METABOLISM#0.8065;AFRICAN AMERICAN MEN#0.8024;ESSENTIAL HYPERTENSION#0.7941;HYPOTHALAMIC PITUITARY ADRENAL#0.7925;FETAL GONAD#0.7909;SYSTOLIC BLOOD PRESSURE#0.7909;DRUG RESISTANCE#0.7886;NICOTINAMIDE#0.7870;EXCRETION#0.7857;ADIPOCYTE#0.7840;SPERMATOZOA#0.7820;UNCONDITIONAL LOGISTIC REGRESSION#0.7810;RENIN ACTIVITY#0.7796;MITOCHONDRIAL MEMBRANE#0.7787;ANTLEY-BIXLER SYNDROME#0.7771;GROWTH HORMONE#0.7757;LYMPH NODE#0.7754;CELLULAR LOCALIZATION#0.7734;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7724;STRUCTURE ACTIVITY RELATIONSHIP#0.7709;HISTONE DEACETYLASE#0.7700;MDV3100#0.7678;PROGESTERONE METABOLISM#0.7673;CORTICAL CELL#0.7666;LUTEAL PHASE#0.7656;VITAMIN D RECEPTOR#0.7637;UTERUS#0.7574;PHENOTYPIC SWITCHING#0.7560;CYTOTOXICITY#0.7544;CARCINOGEN#0.7516;ASTROCYTE ACTIVATION#0.7493;SPERMATOCYTES#0.7480;MALE INFERTILITY#0.7464;STEROID 5 ALPHA REDUCTASE#0.7424;21-HYDROXYLASE ACTIVITY#0.7412;FIBROBLAST GROWTH FACTOR#0.7394;ALDOSTERONE SECRETION#0.7382;CYCLIC ADENOSINE MONOPHOSPHATE#0.7380;ADENOSINE MONOPHOSPHATE#0.7362;NON HODGKIN LYMPHOMA#0.7359;DELAYED PUBERTY#0.7341;NITRIC OXIDE#0.7319;STEROID 5ALPHA-REDUCTASE#0.7317;GENISTEIN#0.7299;MOLAR#0.7279;PANCREATIC CANCER#0.7257;ARTERY#0.7234;COLORECTAL#0.7233;CORTICOTROPIN#0.7182;DIABETES MELLITUS#0.7161;PEROXISOME#0.7161;RHEUMATOID ARTHRITIS#0.7146;CYTOPLASM#0.7145;SKELETAL MALFORMATION#0.7141;INSULIN RECEPTOR#0.7116;FEMALE BREAST CANCER#0.7115;COPY NUMBER VARIATION#0.7039;3-BETA-HSD ACTIVITY#0.7016;IGF BINDING#0.7011;TAMOXIFEN#0.7005;AGE OF MENARCHE#0.6999;ADJUSTED ODDS RATIO#0.6988;HORMONE SECRETION#0.6972;GLUCOCORTICOID BIOSYNTHESIS#0.6958;LEUKOCYTE#0.6956;BONE MORPHOGENETIC PROTEIN#0.6953;NITRIC OXIDE SYNTHASE#0.6936;DNA REPAIR#0.6931;CIRCULATING TUMOR CELL#0.6923;ENDOPLASMIC RETICULUM MEMBRANE#0.6920;METYRAPONE#0.6919;PERIPHERAL BLOOD LYMPHOCYTES#0.6903;BINDING PROTEIN 1#0.6900;B CELL#0.6899;HYDROCORTISONE#0.6841;EXTRACELLULAR MATRIX#0.6828;IN UTERO EXPOSURE#0.6822;DIGESTION#0.6821;ESTRUS#0.6819;ADENYLATE CYCLASE#0.6812;LIPID METABOLISM#0.6794;SMOOTH ENDOPLASMIC RETICULUM#0.6786;AUTOSOMAL RECESSIVE DISEASE#0.6767;ADVANCED BREAST CANCER#0.6742;HATCHING#0.6724;PEPTIDE HORMONE#0.6724;MODE OF ACTION#0.6701;CELL ADHESION#0.6672;PERIPHERAL NERVE INJURY#0.6670;RECEPTOR AGONIST#0.6669;CENTRAL NERVOUS SYSTEM#0.6665;SCIATIC NERVE#0.6648;PERIPHERAL NERVE#0.6633;MYOMETRIUM#0.6624;EMBRYONIC STEM CELL#0.6620;ACTIVIN RECEPTOR#0.6610;PERIPHERAL NERVOUS SYSTEM#0.6599;HARDY WEINBERG EQUILIBRIUM#0.6585;AT NATURAL MENOPAUSE#0.6565;GONADAL DYSGENESIS#0.6545;SPHINGOSINE#0.6513;PROGESTERONE SECRETION#0.6508;DUODENUM#0.6506;EPIDIDYMIS#0.6498;LYSINE#0.6477;MEIOSIS#0.6476;BONE MARROW#0.6457;ARYL HYDROCARBON RECEPTOR#0.6441;ETHANE#0.6441;FACTOR S#0.6429;REGENERATION#0.6427;MALE REPRODUCTIVE SYSTEM#0.6418;AUTOIMMUNE POLYGLANDULAR SYNDROME#0.6407;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6399;LOW DENSITY LIPOPROTEIN#0.6348;CLOTRIMAZOLE#0.6296;ROSIGLITAZONE#0.6277;MELATONIN#0.6275;LIGAND BINDING DOMAIN#0.6265;BROMINATED FLAME RETARDANT#0.6264;GONAD DEVELOPMENT#0.6249;OLIGODENDROCYTE#0.6233;TYPE 2 DIABETES#0.6193;HEPATOCELLULAR CARCINOMA#0.6182;SEMINAL VESICLE#0.6145;GLIAL CELL#0.6144;LUCIFERASE ACTIVITY#0.6144;IL-1RN#0.6143;LEUCINE#0.6123;TUMOR TISSUES#0.6111;INSULIN SECRETION#0.6106;BENIGN PROSTATE HYPERPLASIA#0.6105;CHLORAMPHENICOL#0.6078;FLAVIN#0.6077;HIGH DENSITY LIPOPROTEIN#0.6075;MICROSOMAL MEMBRANE#0.6058;ENDOMETRIUM#0.6057;PROGESTERONE SYNTHESIS#0.6050;LEUPROLIDE#0.6028;SPERM MOTILITY#0.6017
158747	MONOCYTE#0.7308;CELL CHEMOTAXIS#0.6899;CONTACT SITE#0.6805;BREAST CANCER CELL#0.6605;NEUTROPHIL#0.6570;BREAST CANCER#0.6553;CANCER CELL#0.6537
158763	TRANSCRIPTION FACTOR#0.7178
1587	ZONA PELLUCIDA#1.0227;FERTILIZATION#1.0073;OVIDUCT#0.9287;GERM CELL#0.8940;SPERMATOZOA#0.8135;INFERTILE#0.6606;SPERMATOGENESIS#0.6144
158800	CANCER CELL#0.7692;GERM CELL#0.6541;HUMAN BREAST CANCER#0.6534
158809	BREAST CANCER#0.7099
158833	FATTY ACID SYNTHASE#1.0756;STEROL REGULATORY ELEMENT#1.0433;ACETYL COA CARBOXYLASE#1.0147;GENE EXPRESSION#0.9736;LIPID DROPLET#0.9574;PEROXISOME#0.9177;LOW DENSITY LIPOPROTEIN#0.9042;TRIGLYCERIDE SYNTHESIS#0.8585;LIPID METABOLISM#0.8526;TRIGLYCERIDE LIPASE#0.8525;PROTEIN KINASE#0.8359;CARNITINE#0.8198;VERY-LOW-DENSITY LIPOPROTEIN#0.8153;FATTY LIVER#0.8105;COENZYME A#0.7876;LIPOGENESIS#0.7438;LIVER DISEASE#0.7390;ENDOPLASMIC RETICULUM#0.7323;STEAROYL COA DESATURASE#0.7305;FATTY LIVER DISEASE#0.7183;NIACIN#0.6927;SATURATED FATTY ACID#0.6797;ADIPOCYTE#0.6630;TUMOR NECROSIS FACTOR#0.6582;TRANSCRIPTION FACTOR#0.6384;FATTY ACID OXIDATION#0.6368;ADIPOSE TISSUE#0.6261;BINDING PROTEIN 1#0.6221;HORMONE SENSITIVE LIPASE#0.6204;FATTY ACID SYNTHESIS#0.6169;HIGH FAT DIET#0.6152
158835	RETINOL#1.1017;VITAMIN A#1.0137;O ACYLTRANSFERASE#0.8525;RETINOL BINDING#0.8364;MICROSOME#0.7684;RETINOIC ACID#0.6628;ALL-TRANS-RETINOL#0.6603;TRANS-RETINOL#0.6601;HEPATIC STELLATE CELL#0.6380
158866	EXCITATORY SYNAPSE#0.6351
158880	DEUBIQUITINATING ENZYME#0.7205;DNA DAMAGE RESPONSE#0.6684;BREAST CANCER#0.6553
1588	RESPONSE TO AROMATASE INHIBITOR#1.1012;TESTOLACTONE#1.0719;4-OH-A#1.0671;PROGESTERONE RECEPTOR MODULATOR#1.0453;STEROID DEHYDROGENASE#1.0448;ESTROGEN SULFOTRANSFERASE#1.0404;SKIN FIBROBLASTS#1.0394;ENZYME COMPLEX#1.0364;MELATONIN#1.0355;PREADIPOCYTE#1.0340;O METHYLTRANSFERASE#1.0336;IDIOPATHIC SHORT STATURE#1.0336;CATECHOL O METHYLTRANSFERASE#1.0336;4-ANDROSTENE-3,17-DIONE#1.0335;4-HYDROXYANDROSTENEDIONE#1.0323;NORMAL BREAST TISSUE#1.0304;AROMATASE ACTIVITY#1.0292;ANDROGEN DEPRIVATION THERAPY#1.0288;3BETA-HYDROXYSTEROID DEHYDROGENASE#1.0286;HUMAN ADIPOSE TISSUE#1.0273;CATALYTIC ACTIVITY#1.0260;INDOLE#1.0250;HUMAN ADRENOCORTICAL CARCINOMA#1.0231;PROSTAGLANDIN E2#1.0229;OESTRADIOL SECRETION#1.0222;RADIAL GLIAL CELL#1.0218;RESVERATROL#1.0213;1,2,4-TRIAZOLE#1.0205;DANAZOL#1.0199;GRANULOSA CELL TUMOR#1.0176;CHORIOCARCINOMA#1.0170;LIMBIC SYSTEM#1.0167;LUTEINIZING HORMONE RECEPTOR#1.0159;DIENCEPHALON#1.0155;SYNCYTIOTROPHOBLAST#1.0148;ANTHRACENE#1.0148;AMINOGLUTETHIMIDE#1.0140;CYTOCHROME P450#1.0136;LEIOMYOMA#1.0135;MALE BREAST CANCER#1.0135;FINASTERIDE#1.0130;KETOCONAZOLE#1.0130;PACHYTENE#1.0120;LEYDIG CELL TUMOR#1.0118;17BETA OESTRADIOL#1.0117;ESTROGEN SECRETION#1.0112;RETINOID X RECEPTOR#1.0110;TOREMIFENE#1.0109;ENDOMETRIAL STROMAL SARCOMA#1.0103;CYCLIC AMP#1.0102;FLUTAMIDE#1.0101;BREAST INTERNATIONAL GROUP#1.0097;ENZYME INHIBITOR#1.0096;TRANSCRIPTIONAL CONTROL#1.0095;STROMAL SARCOMA#1.0092;ESTROGEN BIOSYNTHESIS#1.0092;ASTROCYTE#1.0091;METHYLTESTOSTERONE#1.0086;ADJUVANT BREAST CANCER#1.0086;BETA-HYDROXYSTEROID DEHYDROGENASE#1.0084;CYPROTERONE ACETATE#1.0081;ESTROGEN FORMATION#1.0080;MICONAZOLE#1.0077;STRUCTURE ACTIVITY RELATIONSHIP#1.0075;ARIMIDEX#1.0071;ESTRADIOL SECRETION#1.0068;THECAL CELL#1.0065;BONE MATURATION#1.0059;GYNECOMASTIA#1.0055;LH RECEPTOR#1.0054;ENDOMETRIAL CARCINOMA#1.0052;POSITRON EMISSION TOMOGRAPHY#1.0051;MEGESTROL ACETATE#1.0049;GENISTEIN#1.0049;TUMOR TISSUES#1.0043;EVEROLIMUS#1.0043;LUTEIN#1.0043;ADRENOCORTICAL CARCINOMA#1.0042;FOREBRAIN#1.0042;MICROSOME#1.0034;MEGESTROL#1.0032;HORMONE BIOSYNTHESIS#1.0031;MCCUNE ALBRIGHT SYNDROME#1.0030;MYOMETRIUM#1.0030;HAIR LOSS#1.0028;HISTONE MODIFICATION#1.0027;CYTOTROPHOBLAST#1.0026;BREAST CANCER SURVIVORS#1.0026;STEROIDOGENIC FACTOR 1#1.0025;ANDROGEN METABOLISM#1.0022;ANDROGEN SYNTHESIS#1.0021;GOSERELIN#1.0021;FETAL LIVER#1.0019;TELENCEPHALON#1.0018;ADENINE DINUCLEOTIDE PHOSPHATE#1.0016;PRECOCIOUS PUBERTY#1.0015;GLUCOCORTICOID RECEPTOR#1.0015;CEREBRAL CORTEX#1.0015;STROMAL CELL#1.0012;OXYGENASE#1.0009;SPINE SYNAPSE#1.0008;THECA INTERNA CELL#1.0007;DEXAMETHASONE#1.0007;GRANULOSA CELL PROLIFERATION#1.0006;CYPROTERONE#1.0001;ESTROGEN SYNTHESIS#1.0001;CELLULAR LOCALIZATION#1.0001;CONTROLLED OVARIAN STIMULATION#0.9999;EXEMESTANE#0.9998;MUTAGENESIS#0.9998;LETROZOLE#0.9996;4-ANDROSTENEDIONE#0.9994;PROTEIN SYNTHESIS#0.9991;TROPHOBLAST CELL#0.9991;ICI 182,780#0.9990;STEROID HORMONE RECEPTOR#0.9990;CAMP RESPONSE ELEMENT#0.9990;ENDOMETRIOSIS#0.9990;GLIAL CELL#0.9989;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9986;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.9986;RELAPSE FREE SURVIVAL#0.9985;AGGRESSIVE BEHAVIOR#0.9984;DNA METHYLATION#0.9983;ESTROGEN RECEPTOR 2#0.9983;FULVESTRANT#0.9976;DENOSUMAB#0.9974;BENZOFURAN#0.9969;ESTRADIOL BENZOATE#0.9969;SEXUAL DYSFUNCTION#0.9969;HYDROXYLASE ACTIVITY#0.9968;ADIPOSE TISSUE#0.9968;HYPOXIA#0.9965;MYOMA#0.9964;RECEPTOR AGONIST#0.9964;LAPATINIB#0.9964;INHIBIN#0.9963;ENZYME ACTIVITY#0.9960;NITRIC OXIDE SYNTHASE#0.9959;5ALPHA DIHYDROTESTOSTERONE#0.9959;QUANTITATIVE REVERSE TRANSCRIPTION#0.9956;OESTRONE SULPHATE#0.9955;ANASTROZOLE#0.9954;ESTRIOL#0.9953;REPRODUCTIVE BEHAVIOR#0.9953;CLOMIPHENE#0.9950;TROPHOBLAST#0.9950;ZOLEDRONIC ACID#0.9948;OESTRONE#0.9943;SPINAL CORD#0.9943;CONGENITAL ADRENAL HYPERPLASIA#0.9939;HEPATOCELLULAR CARCINOMA#0.9933;METFORMIN#0.9933;SPERMATOCYTES#0.9933;DENTATE GYRUS#0.9932;ANABOLIC ANDROGENIC STEROID#0.9931;OSTEOBLAST#0.9931;ADRENAL HYPERPLASIA#0.9931;TRANSCRIPTASE#0.9930;TRANSFORMING GROWTH FACTOR BETA#0.9929;FETAL BRAIN#0.9928;PROGESTERONE SYNTHESIS#0.9928;TAMOXIFEN#0.9925;SULFATASE ACTIVITY#0.9924;CLOMIPHENE CITRATE#0.9923;AMYGDALA#0.9923;TESTIS DEVELOPMENT#0.9921;PROTEIN KINASE C#0.9918;HISTONE DEACETYLASE#0.9917;LUNG CANCER#0.9917;BETA-2#0.9915;OVARIAN CARCINOMA#0.9914;ENDOPLASMIC RETICULUM#0.9913;NEUROPROTECTION#0.9912;LEYDIG CELL#0.9908;FASLODEX#0.9905;PROTEIN KINASE A#0.9905;ANDROGEN BINDING#0.9902;SPERMATOZOA#0.9902;TYROSINE KINASE INHIBITOR#0.9900;SERTOLI CELL#0.9897;MAMMARY GLAND#0.9896;RALOXIFENE#0.9893;SEX DIFFERENTIATION#0.9892;ADENOSINE#0.9892;ESTRADIOL-17BETA#0.9889;ADJUVANT HORMONAL THERAPY#0.9888;NITRIC OXIDE#0.9884;STEROID BIOSYNTHESIS#0.9883;ENDOMETRIUM#0.9881;GRANULOSA CELL#0.9881;RETINOIC ACID#0.9880;DNA SYNTHESIS#0.9879;PITUITARY GLAND#0.9879;JOINT PAIN#0.9876;VITELLOGENESIS#0.9875;HUMAN BREAST CANCER#0.9875;MEDROXYPROGESTERONE ACETATE#0.9873;TRANSFORMING GROWTH FACTOR#0.9873;CONTRALATERAL BREAST CANCER#0.9872;TUMOR NECROSIS FACTOR#0.9872;MEDROXYPROGESTERONE#0.9871;TRANSACTIVATION#0.9871;HORMONE SYNTHESIS#0.9870;BREAST CANCER#0.9870;QUANTITATIVE REAL TIME#0.9870;BREAST CARCINOMA#0.9869;LUTEINIZATION#0.9867;FORSKOLIN#0.9865;SKELETON#0.9863;HORMONE METABOLISM#0.9862;EPIDIDYMIS#0.9858;MIDBRAIN#0.9855;HINDBRAIN#0.9852;ESTROGEN RECEPTOR ALPHA#0.9852;CELECOXIB#0.9852;5.ALPHA.-DIHYDROTESTOSTERONE#0.9852;BRAIN DEVELOPMENT#0.9851;ADIPOCYTE#0.9850;HAIR FOLLICLE#0.9849;SPERM MOTILITY#0.9849;AMENORRHEA#0.9849;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9849;ALZHEIMER'S DISEASE#0.9848;RHEUMATOID ARTHRITIS#0.9846;REVERSE TRANSCRIPTION#0.9844;COLORECTAL CANCER#0.9842;RECEPTOR ANTAGONIST#0.9842;ADVANCED BREAST CANCER#0.9841;VITAMIN D3#0.9840;ENDOTHELIAL GROWTH FACTOR#0.9838;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9838;TESTOSTERONE PROPIONATE#0.9837;ENDOMETRIAL CANCER#0.9837;RECEPTOR BINDING#0.9836;TRASTUZUMAB#0.9835;FRAGMENT LENGTH POLYMORPHISM#0.9835;GONADOTROPIN RELEASING HORMONE#0.9834;DUCTAL CARCINOMA IN SITU#0.9834;NEUROGENESIS#0.9832;OVARIAN DEVELOPMENT#0.9832;ESTROGENS#0.9831;CALCITRIOL#0.9831;MALE INFERTILITY#0.9831;17-METHYLTESTOSTERONE#0.9831;SEMEN#0.9830;HEME BINDING#0.9830;ANDROGEN RECEPTOR#0.9829;GLUTATHIONE#0.9828;PROGESTIN#0.9827;GRANULOSA CELL DIFFERENTIATION#0.9827;PROSTATE CANCER#0.9827;SMOOTH MUSCLE CELL#0.9823;STEROID METABOLISM#0.9822;TESTICULAR DEVELOPMENT#0.9822;ESTROGEN METABOLISM#0.9820;QUERCETIN#0.9819;PARTURITION#0.9817;INTERSTITIAL CELL#0.9817;DOPAMINE#0.9816;STANDARD OF CARE#0.9812;MUSCLE CELL#0.9809;ADRENAL CORTEX#0.9808;ENDOCRINE DISRUPTING CHEMICAL#0.9807;ADENOSINE MONOPHOSPHATE#0.9807;COMPLEX I#0.9807;RANDOMIZED CLINICAL TRIAL#0.9807;SEX DETERMINATION#0.9806;ANDROSTENEDIONE#0.9805;CYTOCHROME C#0.9804;KINASE INHIBITOR#0.9804;EARLY BREAST CANCER#0.9802;PROLACTINOMA#0.9800;POLYMERASE CHAIN REACTION#0.9800;PROGESTERONE SECRETION#0.9800;OESTRADIOL#0.9800;GONAD#0.9795;OVARIAN CYST#0.9794;STEROID SYNTHESIS#0.9794;PEROXISOME#0.9790;OBESE#0.9786;GROWTH HORMONE#0.9786;17β-ESTRADIOL#0.9784;MACROPHAGE#0.9782;ESTRONE SULFATE#0.9780;ENDOTHELIAL CELL#0.9780;HATCHING#0.9779;CYTOTOXICITY#0.9777;BREAST CANCER CELL#0.9776;STROMA#0.9776;BETA-ESTRADIOL#0.9773;ADRENAL GLAND#0.9770;OLFACTORY BULB#0.9768;IGF BINDING#0.9768;CYTOPLASM#0.9768;RANDOMIZED CONTROLLED TRIAL#0.9767;DRUG RESISTANCE#0.9766;BREAST CONSERVING SURGERY#0.9766;GONADOTROPIN SECRETION#0.9765;CARCINOMA IN SITU#0.9765;POLYCYSTIC OVARIAN SYNDROME#0.9764;PRIMARY BREAST CANCER#0.9761;MONOCYTE#0.9761;PROESTRUS#0.9759;INFERTILE#0.9758;FIBROBLAST GROWTH FACTOR#0.9757;SKELETAL MUSCLE#0.9756;LATE PREGNANCY#0.9755;GESTATION#0.9755;ETHINYLESTRADIOL#0.9754;OVARIAN CANCER#0.9754;ENHANCER BINDING#0.9753;DIETHYLSTILBESTROL#0.9753;ESTROGEN RECEPTOR#0.9752;ADENYLATE CYCLASE#0.9752;HYPERANDROGENISM#0.9750;CYCLIN DEPENDENT KINASE#0.9748;ENHANCER BINDING PROTEIN#0.9746;COLORECTAL#0.9745;GERM CELL#0.9745;FACTOR S#0.9745;SUPEROXIDE DISMUTASE#0.9740;SEPTUM#0.9740;OOCYTE MATURATION#0.9739;FEMALE BREAST CANCER#0.9738;ESTRONE#0.9738;5 FLUOROURACIL#0.9737;SIGNALLING PATHWAY#0.9737;CARCINOGEN#0.9734;RANDOMISED CONTROLLED TRIAL#0.9733;BONE REMODELING#0.9733;FLUOROURACIL#0.9732;FSH SECRETION#0.9732;TESTOSTERONE#0.9732;INVASIVE DUCTAL CARCINOMA#0.9732;PUBERTY#0.9731;METASTATIC BREAST CANCER#0.9731;GLUCOSE METABOLISM#0.9730;GENE EXPRESSION#0.9730;CAPECITABINE#0.9729;LIPID METABOLISM#0.9729;WHITE ADIPOSE TISSUE#0.9727;CENTRAL NERVOUS SYSTEM#0.9726;ARYL HYDROCARBON RECEPTOR#0.9726;CANCER CELL#0.9725;BREAST CANCER PATIENTS#0.9725;MODE OF ACTION#0.9725;EPITHELIAL CELL#0.9723;ENDOMETRIOID ENDOMETRIAL CANCER#0.9722;CAMP RESPONSE ELEMENT BINDING#0.9722;PREGNENOLONE#0.9722;TYPE 2 DIABETES#0.9722;TARGET OF RAPAMYCIN#0.9718;ISCHEMIA#0.9718;METHADONE#0.9715;FOLLICULAR PHASE#0.9714;HYPOGONADOTROPIC HYPOGONADISM#0.9712;ANDROGEN BIOSYNTHESIS#0.9711;MITOGEN ACTIVATED PROTEIN#0.9708;SPERMATOGENESIS#0.9707;MECHANISM OF ACTION#0.9707;TUMOR CELLS#0.9706;OVARIAN FOLLICLE#0.9706;HYPOGONADISM#0.9706;RAPAMYCIN#0.9702;PERIPHERAL BLOOD#0.9701;ESTROUS CYCLE#0.9701;COGNITION#0.9699;HIGH RISK PATIENTS#0.9698;ADENOCARCINOMA#0.9698;ACTINOMYCIN D#0.9696;OVARIAN#0.9695;ESTRADIOL#0.9695;NEURONAL CELLS#0.9694;CORPUS LUTEUM#0.9694;CYCLIC ADENOSINE MONOPHOSPHATE#0.9694;ELECTRON TRANSFER#0.9693;RESPONSE TO TREATMENT#0.9693;PRO-INFLAMMATORY#0.9693;THYMIDINE#0.9693;FORMALIN#0.9691;MITOCHONDRIA#0.9690;ADENINE#0.9690;NERVOUS SYSTEM#0.9690;ANGIOGENESIS#0.9689;HORMONE BINDING#0.9688;INVASIVE BREAST CANCER#0.9685;SEMINAL VESICLE#0.9684;PROTEIN KINASE#0.9684;BONE TURNOVER MARKER#0.9683;CYCLOPHOSPHAMIDE#0.9681;ARTERY#0.9681;HORMONE SECRETION#0.9679;ANTI INFLAMMATORY DRUGS#0.9679;BONE MINERAL DENSITY#0.9678;CORTISOL#0.9678;IMMUNE SYSTEM#0.9677;LUTEAL PHASE#0.9677;FACTOR I#0.9672;SUBCUTANEOUS ADIPOSE TISSUE#0.9671;REPORTER GENE ASSAY#0.9671;DNA BINDING#0.9670;MENOPAUSE#0.9669;PACLITAXEL#0.9668;PLATELET-DERIVED GROWTH FACTOR#0.9668;OSTEOPOROSIS#0.9667;FOLLICLE STIMULATING HORMONE#0.9666;MECHANISMS OF ACTION#0.9665;STEROID 5 ALPHA REDUCTASE#0.9663;OVARIAN HYPERSTIMULATION SYNDROME#0.9663;DIHYDROTESTOSTERONE#0.9663;DEHYDROEPIANDROSTERONE SULFATE#0.9660;EPIDERMAL GROWTH FACTOR#0.9660;CELL MATURATION#0.9658;SIGNAL TRANSDUCTION#0.9657;HISTONE DEACETYLASE INHIBITOR#0.9657;ALDOSTERONE#0.9656;FAT PAD#0.9656;MENSTRUAL CYCLE#0.9655;INSULIN-LIKE GROWTH FACTOR#0.9653;ESTRUS#0.9651;BREAST CANCER MODEL#0.9649;CHRONIC PELVIC PAIN#0.9648;GONAD DEVELOPMENT#0.9647;PEUTZ-JEGHERS SYNDROME#0.9645;OVARIES#0.9644;ARGININE#0.9644;BONE MARROW#0.9644;LOW DENSITY LIPOPROTEIN#0.9643;NATIONAL CANCER INSTITUTE#0.9642;ANOVULATION#0.9642;HEART DISEASE#0.9642;CERVICAL#0.9638;TOPICAL#0.9636;OVULATION#0.9635;BONE GROWTH#0.9633;PREMATURE OVARIAN FAILURE#0.9630;VASOTOCIN#0.9630;CELL GROWTH#0.9629;TRANSCRIPTION FACTOR#0.9629;GROWTH FACTOR RECEPTOR#0.9627;RESPONSE TO GONADOTROPIN#0.9627;DOCETAXEL#0.9626;RISK OF RELAPSE#0.9625;SMOOTH MUSCLE#0.9624;CLINICAL BENEFIT RATE#0.9624;CELL DEVELOPMENT#0.9622;CYTOCHROME P450SCC#0.9621;ANTI HER2#0.9619;REPRODUCTIVE SYSTEM#0.9619;HYPERTENSION#0.9618;CELL DIFFERENTIATION#0.9617;POLYCYSTIC OVARY SYNDROME#0.9615;CELL DEATH#0.9615;SEX CHROMOSOME#0.9614;ESTRONE SULPHATE#0.9614;REPRODUCTIVE TOXICITY#0.9613;Y CHROMOSOME#0.9613;ENDOCRINE SYSTEM#0.9611;WEIGHT GAIN#0.9610;LUMINAL#0.9609;ESTROGEN RESPONSE ELEMENT#0.9607;BONE FORMATION#0.9607;TIME TO TREATMENT#0.9606;LEUPROLIDE#0.9606;LUCIFERASE ACTIVITY#0.9605;ALKALINE PHOSPHATASE#0.9604;DISEASE FREE SURVIVAL#0.9603;UTERUS#0.9602;INSEMINATION#0.9602;OVERALL RESPONSE RATE#0.9600;ADENYLATE#0.9600;BONE RESORPTION#0.9599;AND BODY COMPOSITION#0.9598;TIME TO PROGRESSION#0.9596;CHONDROCYTE#0.9595;PROGESTERONE#0.9595;PHOSPHODIESTERASE#0.9593;TESTOSTERONE SECRETION#0.9585;STEM CELL#0.9585;DAYS POST FERTILIZATION#0.9585;CELL PROLIFERATION#0.9585;RECURRENCE FREE SURVIVAL#0.9579;GROWTH FACTOR#0.9578;OOCYTE#0.9577;BONE MORPHOGENETIC PROTEIN#0.9573;DOXORUBICIN#0.9572;INFERTILITY#0.9570;UTERINE FIBROID#0.9565;STEROIDOGENESIS#0.9565;DEHYDROEPIANDROSTERONE#0.9564;SEROTONIN REUPTAKE INHIBITOR#0.9562;METAMORPHOSIS#0.9560;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9560;IN VITRO MATURATION#0.9559;APOPTOSIS#0.9555;APOPTOTIC#0.9554;SIGNALING PATHWAY#0.9549;OBJECTIVE RESPONSE RATE#0.9549;MEIOSIS#0.9547;METHOTREXATE#0.9542;CELL ADHESION#0.9541;SERTOLI CELL TUMOR#0.9541;ENDOMETRIAL ADENOCARCINOMA#0.9539;OOGENESIS#0.9537;CELL CYCLE#0.9536;19-NORANDROSTENEDIONE#0.9535;SULFONAMIDE#0.9535;EXCRETION#0.9535;BLOOD VESSEL#0.9532;WEIGHT LOSS#0.9530;THROMBOSIS#0.9529;PROTON PUMP INHIBITOR#0.9529;VASCULAR CELL#0.9528;FRONTAL#0.9527;HYDROCORTISONE#0.9525;PROGENITOR CELL#0.9524;LYMPH NODE#0.9522;CHOLERA#0.9522;CARDIOVASCULAR SYSTEM#0.9521;LACTATION#0.9518;SERIOUS ADVERSE EVENT#0.9516;FERTILIZATION#0.9514;PROSTATE CARCINOMA#0.9513;ANTI MULLERIAN HORMONE#0.9511;PROTON PUMP#0.9510;REACTIVE OXYGEN SPECIES#0.9510;NICOTINAMIDE#0.9510;MAGNETIC RESONANCE IMAGING#0.9510;TOXICITY#0.9509;EXTRACELLULAR MATRIX#0.9509;IMMUNE RESPONSE#0.9502;VITAMIN D RECEPTOR#0.9501;ANDROSTANEDIONE#0.9498;TUMOR SUPPRESSOR#0.9489;PLASMA MEMBRANE#0.9480;HIGH DENSITY LIPOPROTEIN#0.9479;REGULATION OF STEROIDOGENESIS#0.9477;BREAST CARCINOMA CELL LINES#0.9473;OVARY DEVELOPMENT#0.9460;LIGAND BINDING DOMAIN#0.9460;DIESTRUS#0.9455;CONNECTIVE TISSUE#0.9454;TERRITORIAL AGGRESSION#0.9450;LEVONORGESTREL#0.9449;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9447;PATIENT REPORTED OUTCOME#0.9446;T CELL#0.9446;DIABETES MELLITUS#0.9434;EPILEPSY#0.9431;CLOTRIMAZOLE#0.9429;LYASE ACTIVITY#0.9429;EMBRYO DEVELOPMENT#0.9427;ETHANOL#0.9427;BRIEF PAIN INVENTORY#0.9422;COURTSHIP BEHAVIOR#0.9419;TESTOSTERONE ENANTHATE#0.9414;CATABOLISM#0.9413;CLINICAL PRACTICE GUIDELINE#0.9411;INTENTION TO TREAT#0.9410;SENTINEL LYMPH NODE#0.9409;GASTRIC MUCOSA#0.9409;MICROTUBULE#0.9405;TOPOISOMERASE#0.9405;LIVE BIRTH RATE#0.9400;5-BETA-DIHYDROTESTOSTERONE#0.9399;BEVACIZUMAB#0.9399;MAP KINASE#0.9391;TEMPORAL LOBE#0.9384;4-HYDROXYTAMOXIFEN#0.9380;OESTRUS#0.9377;C REACTIVE PROTEIN#0.9372;CELL MIGRATION#0.9358;HEAT SHOCK PROTEIN#0.9357;PROSTATE SPECIFIC ANTIGEN#0.9356;OOCYTE DEVELOPMENT#0.9349;COPULATION#0.9349;OXYTOCIN RECEPTOR#0.9345;FEMUR#0.9335;MENARCHE#0.9335;CARPAL TUNNEL SYNDROME#0.9320;OSTEOCLAST#0.9319;ABDOMINAL ADIPOSE TISSUE#0.9308;LUTEOLYSIS#0.9306;ETHYNYLESTRADIOL#0.9304;PROTEIN KINASE B#0.9304;INNERVATION#0.9302;HYPERSENSITIVITY#0.9298;ELECTROPHORETIC MOBILITY SHIFT#0.9296;LEUKOCYTE#0.9293;LIVER RECEPTOR HOMOLOG#0.9290;RESPONSE TO ESTROGEN#0.9288;STEROID RECEPTOR COACTIVATOR#0.9268;INSULIN RECEPTOR#0.9264;RECEPTOR TYROSINE KINASE#0.9258;PREMATURE MENOPAUSE#0.9253;ASPARTATE#0.9252;STROMAL VASCULAR CELLS#0.9246;NERVE GROWTH FACTOR#0.9245;TRIIODOTHYRONINE#0.9240;GLYPHOSATE#0.9226;TESTOSTERONE REPLACEMENT THERAPY#0.9225;MINERALIZATION#0.9224;OSTEOARTHRITIS#0.9217;CONTROLLED CLINICAL TRIALS#0.9216;BREAST DISEASE#0.9216;SIGNALING CASCADE#0.9201;MAMMARY EPITHELIAL CELL#0.9198;SHORT TANDEM REPEAT#0.9191;3-BETA-HSD ACTIVITY#0.9180;ENDOCRINE DISRUPTING COMPOUNDS#0.9179;IMMUNE CELL#0.9173;GENOTOXIC#0.9160;QUINONE REDUCTASE 2#0.9156;STEROID BINDING#0.9141;GROWTH FACTOR BINDING#0.9135;PROGESTERONE BIOSYNTHESIS#0.9123;LUNG ADENOCARCINOMA#0.9120;SOCIAL BEHAVIOR#0.9119;CERVICAL CANCER#0.9112;RESPONSE TO TESTOSTERONE#0.9109;INFLAMMATORY RESPONSE#0.9105;ADJUSTED ODDS RATIO#0.9104;LARVAL DEVELOPMENT#0.9101;TRANSFORMING GROWTH FACTOR ALPHA#0.9091;RECEPTOR ACTIVATOR#0.9087;B CELL#0.9078;BOUTON#0.9077;LEIOMYOSARCOMA#0.9076;72-HOURS#0.9074;END OF TREATMENT#0.9073;1α,25-DIHYDROXYVITAMIN D3#0.9072;ESTROGEN BINDING#0.9071;GLUTATHIONE PEROXIDASE#0.9071;BLOOD PLASMA#0.9067;REPRODUCTIVE BEHAVIOUR#0.9066;ANDROGEN SECRETION#0.9059;SIGNALING MOLECULE#0.9058;VITAMIN D DEFICIENCY#0.9056;PRIMARY BREAST TUMORS#0.9052;PROTEIN PROTEIN INTERACTION#0.9052;GERM CELL DEVELOPMENT#0.9051;CORONARY HEART DISEASE#0.9045;DENDRITIC SPINE#0.9044;CELL MEMBRANE#0.9041;ENDOTHELIUM#0.9037;EPITHELIAL OVARIAN CANCER#0.9036;COUMARINS#0.9032;ESTROGEN RELATED RECEPTOR#0.9030;17β-OESTRADIOL#0.9028;CORONARY ARTERY#0.9013;LOCALISATION#0.9011;INSOMNIA#0.9010;LEUPROLIDE ACETATE#0.9001;PROGESTERONE-RECEPTOR POSITIVE BREAST CANCER#0.8994;LOW BONE MASS#0.8993;CISPLATIN#0.8992;BODY WEIGHT GAIN#0.8989;MOLECULAR DYNAMICS SIMULATION#0.8988;GLUCOSE INTOLERANCE#0.8982;ALOPECIA#0.8978;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.8970;GEMCITABINE#0.8966;CELL CYCLE ARREST#0.8962;STEROID BIOSYNTHETIC#0.8960;OVIDUCT#0.8953;AGE AT MENARCHE#0.8953;NARINGENIN#0.8941;TOXICANT#0.8940;SQUAMOUS CELL CARCINOMA#0.8936;NORETHINDRONE#0.8927;AGE AT DIAGNOSIS#0.8924;SALIVARY GLAND#0.8924;MYOCARDIAL INFARCTION#0.8912;CORONARY ARTERY DISEASE#0.8912;ARTERY DISEASE#0.8910;GEFITINIB#0.8904;TRANSLATION INITIATION#0.8901;HERCEPTIN#0.8900;PROSTATIC HYPERTROPHY#0.8875;DEMETHYLATION#0.8869;NOCICEPTION#0.8865;RISEDRONATE#0.8854;DNA REPAIR#0.8848;DIARRHEA#0.8845;LINES OF EVIDENCE#0.8837;BICALUTAMIDE#0.8824;S PHASE#0.8822;MAPK SIGNALING#0.8813;BINDING PROTEIN 1#0.8810;HYPOTHYROIDISM#0.8807;LASER CAPTURE MICRODISSECTION#0.8798;CANCER RELATED DEATH#0.8786;TECTUM#0.8783;MEDIAN OVERALL SURVIVAL#0.8778;VINORELBINE#0.8768;BONE CELLS#0.8757;DELAYED PUBERTY#0.8757;ROSIGLITAZONE#0.8749;DIGESTION#0.8745;SKELETAL RELATED EVENTS#0.8743;ASCORBIC ACID#0.8742;NOREPINEPHRINE#0.8726;ORNITHINE DECARBOXYLASE#0.8714;BONE DISEASE#0.8713;RNA INTERFERENCE#0.8704;METASTATIC PROSTATE CANCER#0.8699;METHIONINE#0.8695;ACTIVATING TRANSCRIPTION FACTOR#0.8695;MALE REPRODUCTIVE SYSTEM#0.8691;D-ASPARTIC ACID#0.8689;TROGLITAZONE#0.8687;ADJUSTED HAZARD RATIO#0.8683;GROWTH DIFFERENTIATION FACTOR#0.8681;SPERMIOGENESIS#0.8671;ASPIRIN#0.8667;OSTEONECROSIS#0.8660;RECEPTOR ACTIVITY#0.8654;DOUBLE TRANSGENIC MICE#0.8650;HIGH FAT DIET#0.8637;PIOGLITAZONE#0.8627;MEMBRANE ESTROGEN RECEPTOR#0.8625;ADIPOGENESIS#0.8622;MESENCHYMAL CELL#0.8619;SENTINEL NODE BIOPSY#0.8618;LUPUS ERYTHEMATOSUS#0.8611;TIME TO RECURRENCE#0.8609;KERATINOCYTE#0.8593;OESTROGEN METABOLISM#0.8592;TUMOUR NECROSIS FACTOR#0.8589;L-TYROSINE#0.8588;COLON CANCER#0.8583;ASPARTIC ACID#0.8579;EPIRUBICIN#0.8576;ONCOGENIC#0.8572;SERTOLI CELL PROLIFERATION#0.8557;PURKINJE CELL#0.8553;DEPRESSIVE SYMPTOMS#0.8549;PROTEIN PHOSPHORYLATION#0.8548;OOCYTE GROWTH#0.8545;X CHROMOSOME#0.8539;LIVER CANCER#0.8535;PEPTIDE HORMONE#0.8531;RISK OF DEATH#0.8531;TRADITIONAL CHINESE MEDICINE#0.8530;SYNTHETASE ACTIVITY#0.8526;MIFEPRISTONE#0.8521;PROTEIN BINDING#0.8521;HYPERPROLACTINEMIA#0.8520;VASOPRESSIN#0.8514;INDUCTION OF APOPTOSIS#0.8513;GLUCOSE HOMEOSTASIS#0.8512;UBIQUITIN#0.8501;CYTOCHROME B5#0.8500;POLYCYCLIC AROMATIC HYDROCARBON#0.8496;CUMULUS OOCYTE COMPLEXES#0.8490;PAPILLOMA#0.8471;LANOSTEROL#0.8446;MENSTRUATION#0.8443;ENZYME MODULATOR#0.8441;LONG TERM POTENTIATION#0.8427;L-CYSTEINE#0.8414;HYPERACTIVITY#0.8411;IL-6 PRODUCTION#0.8406;LYMPH NODE METASTASIS#0.8400;CAMP FORMATION#0.8391;NORADRENALINE#0.8384;SENSITIZER#0.8380;HESPERETIN#0.8380;SUBSTANCE P#0.8372;SCALP#0.8371;GONADOTROPHIN SECRETION#0.8371;DRUG METABOLISM#0.8368;HEALTH CARE PROVIDER#0.8364;ATHEROSCLEROSIS#0.8360;BIOTIN#0.8357;OVARIAN FOLLICLE DEVELOPMENT#0.8334;DOPAMINE RECEPTOR#0.8323;VOMITING#0.8322;ECONAZOLE#0.8320;BASAL CELL#0.8314;THYROID HORMONE RECEPTOR#0.8313;CONJUGATION#0.8306;PERITONEUM#0.8303;VENOUS BLOOD#0.8302;VASCULITIS#0.8300;BONE REMODELLING#0.8299;PLACENTAL DEVELOPMENT#0.8290;LIPID DROPLET#0.8287;DEMENTIA#0.8276;LUTEINIZING GRANULOSA CELL#0.8272;CELL SURFACE#0.8270;RECURRENT ENDOMETRIAL CANCER#0.8257;GLUTAMATE RECEPTOR#0.8255;NIMESULIDE#0.8254;FLUOXETINE#0.8248;RU486#0.8244;LIMIT OF DETECTION#0.8243;CYTOKINE PRODUCTION#0.8242;GONADOGENESIS#0.8232;AGEING#0.8230;UTERINE CANCER#0.8224;BRAIN DAMAGE#0.8215;INDOMETHACIN#0.8210;REGULATION OF GONADOTROPIN SECRETION#0.8193;ANEMIA#0.8190;TIBIA#0.8189;NEURODEGENERATIVE DISEASE#0.8182;SMOOTH ENDOPLASMIC RETICULUM#0.8181;NEUROBLASTOMA#0.8177;AUTOPHAGY#0.8173;RECEPTOR LIGAND#0.8163;ADIPOCYTE DIFFERENTIATION#0.8162;VASCULAR DISEASE#0.8162;RETINOIC ACID RECEPTOR#0.8158;LIVER DISEASE#0.8154;AKT SIGNALING#0.8154;NEUTROPENIA#0.8145;EGG LAYING#0.8133;COLLAGENASE#0.8119;CELL DIVISION#0.8119;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8116;HYPOXIA INDUCIBLE FACTOR#0.8115;THALAMUS#0.8115;PRESYNAPTIC BOUTON#0.8108;NEURAL STEM CELL#0.8091;HYPOXIC#0.8090;MOLAR#0.8085;CAMP-RESPONSIVE ELEMENT BINDING#0.8083;WORLD HEALTH ORGANIZATION#0.8082;RECEPTOR FORMATION#0.8074;NORETHISTERONE#0.8065;DECIDUALIZATION#0.8060;PYRAZOLE#0.8057;G1 PHASE#0.8057;DIFFERENTIAL GENE EXPRESSION#0.8053;MAMMOGRAPHIC BREAST DENSITY#0.8052;PROSTATE DISEASE#0.8049;CREB BINDING#0.8047;MATING BEHAVIOR#0.8040;OVERALL SURVIVAL RATE#0.8036;MEDICATION POSSESSION RATIO#0.8035;TAMOXIFEN CITRATE#0.8026;CRYPTORCHIDISM#0.8023;OVARIAN DYSFUNCTION#0.8020;TOPOISOMERASE II#0.8016;HAIR GROWTH#0.8006;CELL CYCLE REGULATION#0.8002;FATTY LIVER#0.7998;SPIRONOLACTONE#0.7993;GAMETOGENESIS#0.7978;PAROXETINE#0.7964;INDUCIBLE NITRIC OXIDE#0.7962;STERILITY#0.7954;BONE MINERALIZATION#0.7938;GLAND DEVELOPMENT#0.7932;SERUM LEPTIN LEVEL#0.7920;ETHINYL ESTRADIOL#0.7918;PLACENTAL CHORIOCARCINOMA#0.7916;PLASMA PROTEIN#0.7905;PTK/ZK#0.7904;EDEMA#0.7903;CHLORAMPHENICOL#0.7901;SIGNAL TRANSDUCER#0.7897;STRIATUM#0.7897;ESTROGEN-RECEPTOR NEGATIVE BREAST CANCER#0.7897;MEMORY IMPAIRMENT#0.7892;FENRETINIDE#0.7882;PARATHYROID HORMONE#0.7881;TOLL LIKE RECEPTOR#0.7879;INTERNEURON#0.7870;NEURITE#0.7869;WOUND HEALING#0.7868;PARKINSON'S DISEASE#0.7864;BREAST CONSERVING THERAPY#0.7855;STATIONARY PHASE#0.7850;ESTRADIOL VALERATE#0.7849;ARACHIDONIC ACID#0.7838;PREPULSE INHIBITION#0.7833;2-METHOXYESTRADIOL#0.7827;NANDROLONE#0.7823;LYMPH NODE METASTASES#0.7820;ENDOTHELIAL NITRIC OXIDE#0.7816;PSEUDOHERMAPHRODITISM#0.7807;MITOCHONDRIAL MEMBRANE#0.7803;NEUROTRANSMISSION#0.7800;ANDROGEN RECEPTOR BINDING#0.7799;LUNG CARCINOMA#0.7797;MENORRHAGIA#0.7796;PROTEIN KINASE INHIBITOR#0.7791;CELL ADHESION MOLECULE#0.7791;INTENT TO TREAT#0.7770;INVASIVE CARCINOMA#0.7764;HYPERGLYCEMIA#0.7754;PATHOLOGICAL COMPLETE RESPONSE#0.7752;SYNAPTOGENESIS#0.7750;5-AZA-2'-DEOXYCYTIDINE#0.7739;HYPOSPADIAS#0.7737;ASSISTED REPRODUCTIVE TECHNOLOGIES#0.7736;2'-DEOXYCYTIDINE#0.7734;VITAMIN A#0.7733;PITUITARY ADENOMA#0.7732;AUTOIMMUNE DISEASE#0.7718;OVARIAN DISEASE#0.7717;CYCLIN DEPENDENT KINASE INHIBITOR#0.7712;ATHEROSCLEROTIC#0.7703;PORTAL VEIN#0.7700;ASSISTED REPRODUCTIVE TECHNOLOGY#0.7695;20ALPHA-HYDROXYSTEROID DEHYDROGENASE#0.7681;AZOOSPERMIA#0.7670;UMBILICAL VEIN#0.7669;REGENERATION#0.7668;ALDO KETO REDUCTASE#0.7666;ARGININE VASOTOCIN#0.7663;NEUROTOXIN#0.7661;EQUINE CHORIONIC GONADOTROPIN#0.7653;DNA FRAGMENTATION#0.7639;FUNCTIONAL DIFFERENTIATION#0.7596;2'-DEOXYURIDINE#0.7587;ACADEMIC MEDICAL CENTER#0.7583;SUCROSE#0.7580;BINDING PROTEIN 3#0.7576;BROMOCRIPTINE#0.7575;AT-17#0.7573;EARLY LIFE STAGES#0.7560;PHENOBARBITAL#0.7557;VASCULAR ENDOTHELIAL CELL#0.7554;ACID PHOSPHATASE#0.7553;VITAMIN E#0.7553;CIRCULATING TUMOR CELL#0.7545;FORMIC ACID#0.7543;AGE AT ONSET#0.7542;FARNESOID X RECEPTOR#0.7538;MESENCHYMAL STEM CELL#0.7533;GINKGO BILOBA#0.7529;BUSERELIN#0.7528;17-ETHINYLESTRADIOL#0.7527;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7524;METYRAPONE#0.7524;SEBACEOUS GLAND#0.7520;MONONUCLEAR CELLS#0.7513;DNA POLYMERASE ALPHA#0.7511;ORNITHINE#0.7507;LYMPH NODE INVOLVEMENT#0.7505;SYNAPTIC BOUTON#0.7497;ANDROGEN INSENSITIVITY SYNDROME#0.7492;CALCINEURIN#0.7486;INSULIN RECEPTOR SUBSTRATE#0.7481;FREE ANDROGEN INDEX#0.7480;MULTIPLE LINEAR REGRESSION#0.7480;AMP FORMATION#0.7469;STEROID 5ALPHA-REDUCTASE#0.7450;XENOBIOTIC METABOLISM#0.7444;CANCER SPECIFIC SURVIVAL#0.7431;STEROID HORMONE SECRETION#0.7422;PHOSPHODIESTERASE INHIBITOR#0.7412;CRE BINDING#0.7411;TESTICULAR CANCER#0.7399;CHOLESTEROL METABOLISM#0.7394;SERTRALINE#0.7391;INTRACELLULAR SIGNALING PATHWAY#0.7389;RAD001#0.7383;HISTONE ACETYLATION#0.7379;ALENDRONATE#0.7377;ARTERIOVENOUS MALFORMATION#0.7371;BODY FAT MASS#0.7368;STOMATITIS#0.7367;CLOMIFENE#0.7365;ATYPICAL DUCTAL HYPERPLASIA#0.7364;ARGININE VASOPRESSIN#0.7357;TRYPTOPHAN#0.7355;ADVERSE DRUG REACTION#0.7354;UTERINE HORN#0.7354;GRANULOSA CELL APOPTOSIS#0.7348;NMDA RECEPTOR#0.7348;NUCLEIC ACID#0.7346;CHANGE FROM BASELINE#0.7341;STEROID FORMATION#0.7334;DEPHOSPHORYLATION#0.7324;STEROL REGULATORY ELEMENT#0.7319;PROLACTIN SECRETION#0.7314;ADRENERGIC RECEPTOR#0.7312;CAMP SIGNALING#0.7307;ALL TRANS RETINOIC ACID#0.7302;DOPAMINE D1 RECEPTOR#0.7298;ESTROGEN RECEPTOR BINDING#0.7296;THEOPHYLLINE#0.7294;VERTEBRAE#0.7273;FSH ACTIVITY#0.7265;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7261;XANTHINE#0.7246;CENTRAL GRAY#0.7238;FSH-B#0.7235;GONOCYTE#0.7235;MELATONIN RECEPTOR#0.7226;KINASE ACTIVITY#0.7212;CUSHING'S SYNDROME#0.7203;ADRENAL CARCINOMA#0.7195;CORTICOTROPIN#0.7193;EMBRYONIC BRAIN#0.7192;NEUROPATHY#0.7188;MALE SEX DETERMINATION#0.7184;CELL FRACTION#0.7180;ASTROCYTE ACTIVATION#0.7171;VAGINITIS#0.7170;PERTUZUMAB#0.7158;GLUCOSE UPTAKE#0.7145;POLY ADP RIBOSE#0.7139;ORGANELLE#0.7137;IN UTERO EXPOSURE#0.7137;ER DEGRADATION#0.7136;BASEMENT MEMBRANE#0.7134;CARDIOVASCULAR RISK FACTOR#0.7132;SATURATED FATTY ACID#0.7126;LYMPH NODE DISSECTION#0.7123;VISCERAL ADIPOSE TISSUE#0.7122;LEUCINE#0.7113;METHYLTRIENOLONE#0.7108;ANTLEY-BIXLER SYNDROME#0.7105;PERITONEAL CAVITY#0.7103;MESONEPHROS#0.7091;SCAVENGER RECEPTOR#0.7087;IL-11#0.7083;RANDOMISED CLINICAL TRIALS#0.7079;T LYMPHOCYTE#0.7077;DETOXIFICATION#0.7072;CHOLESTEROL BIOSYNTHESIS#0.7071;RIBOSOMAL PROTEIN#0.7070;H POST FERTILIZATION#0.7062;CANCER STEM CELL#0.7062;TYPE II POLYKETIDE SYNTHASE#0.7056;SPATIAL LEARNING#0.7050;GONADAL DYSGENESIS#0.7042;NORMAL BODY MASS#0.7030;YEAR SURVIVAL RATE#0.7030;PARENCHYMA#0.7025;HYPERCHOLESTEROLEMIA#0.7021;PROTEASOME#0.7018;VAGINAL DISCHARGE#0.7016;MORPHOGENESIS#0.7012;ESSENTIAL HYPERTENSION#0.7012;HYPOPHYSIS#0.7011;17-BETA-HSD ACTIVITY#0.7001;EPITHELIAL MESENCHYMAL TRANSITION#0.7000;MAMMARY EPITHELIUM#0.6994;ADRENOCORTICOTROPIC HORMONE#0.6990;MAMMARY GLAND DEVELOPMENT#0.6989;GERMINAL VESICLE#0.6985;CORTICAL CELL#0.6985;W CHROMOSOME#0.6980;SECRETORY CELL#0.6971;PARATHYROID#0.6956;ANCHORAGE INDEPENDENT GROWTH#0.6952;INNER EAR#0.6951;TRANSCRIPTION FACTOR BINDING#0.6934;CELLULAR COMPONENT#0.6932;DNASE#0.6931;PYRAMIDAL CELL#0.6928;HYPOTHALAMIC PITUITARY ADRENAL#0.6912;ISOPROTERENOL#0.6911;LUNG DISEASE#0.6897;COENZYME A#0.6893;POST-TRANSLATIONAL MODIFICATION#0.6892;SERTOLI-LEYDIG CELL TUMOR#0.6889;TRILOSTANE#0.6888;VISUAL ANALOG SCALE#0.6877;MITOSIS#0.6872;TELOMERASE ACTIVITY#0.6867;PULMONARY EMBOLISM#0.6859;HYPERCALCEMIA#0.6853;EFFERENT DUCT#0.6834;LYSINE#0.6824;GRAPE SEED EXTRACT#0.6819;YOLK SAC#0.6803;L-ARGININE#0.6798;CERVIX#0.6796;ERLOTINIB#0.6794;NEUROTOXIC#0.6769;CIRCADIAN RHYTHM#0.6769;CARRIE#0.6765;GENETIC SEX DETERMINATION#0.6751;DENSITY FUNCTIONAL THEORY#0.6730;ELECTRONIC MEDICAL RECORD#0.6728;VENOUS THROMBOEMBOLIC EVENTS#0.6692;METALLOPROTEINASE INHIBITOR#0.6685;CHOLESTEROL SYNTHESIS#0.6681;CORE NEEDLE BIOPSY#0.6673;BIFONAZOLE#0.6662;EPITHELIAL CELL PROLIFERATION#0.6655;INCONTINENCE#0.6650;GLUCOSE TOLERANCE TEST#0.6644;CALCIUM CHANNEL#0.6641;MIDDLE CEREBRAL ARTERY#0.6640;CEREBRAL ARTERY#0.6638;GLUTAMIC ACID#0.6637;UNCONDITIONAL LOGISTIC REGRESSION#0.6633;SMOOTH MUSCLE ACTIN#0.6625;B CELL LYMPHOMA#0.6621;RIBOSE#0.6616;PARENTAL BEHAVIOR#0.6613;SEMINOMA#0.6610;SOLID PHASE EXTRACTION#0.6599;LEAN BODY MASS#0.6598;COURTSHIP BEHAVIOUR#0.6587;EVENT FREE SURVIVAL#0.6581;ASCITES#0.6577;EMBOLISM#0.6576;ORAL SQUAMOUS CELL CARCINOMA#0.6575;LIFE YEAR GAINED#0.6571;ABIRATERONE#0.6569;NEOADJUVANT HORMONE THERAPY#0.6567;BREAST CELL LINES#0.6564;STEROID HYDROXYLASE#0.6563;AXON TERMINAL#0.6559;PATERNAL BEHAVIOR#0.6555;CELL FUSION#0.6552;RESPONSE TO ESTRADIOL#0.6551;OVARIAN SURFACE EPITHELIAL#0.6551;CHOROID PLEXUS#0.6550;CAUDA#0.6547;M PHASE#0.6541;BETA TESTOSTERONE#0.6535;PROSTAGLANDIN SYNTHESIS#0.6532;GABA A RECEPTOR#0.6527;PHOSPHATASE AND TENSIN HOMOLOG#0.6523;3BETA-HYDROXY STEROID DEHYDROGENASE#0.6516;HYDROGEN BOND ACCEPTOR#0.6515;ESTRADIOL BINDING#0.6506;RESPONSE TO HORMONE#0.6493;TIME SINCE MENOPAUSE#0.6486;DNASE I#0.6485;PARENTERAL#0.6481;DECIDUA#0.6479;THYROID GLAND#0.6479;PROGESTERONE METABOLISM#0.6473;QUANTITATIVE COMPUTED TOMOGRAPHY#0.6468;EARLY GROWTH RESPONSE#0.6462;IMMATURE SERTOLI CELL#0.6456;PATHOLOGIC COMPLETE RESPONSE#0.6448;TTNPB#0.6442;ENDOMETRIAL DISEASE#0.6433;NUCLEAR RECEPTOR SUPERFAMILY#0.6433;INVASIVE BREAST CARCINOMA#0.6430;CAPUT#0.6428;FAT FREE MASS#0.6424;FATTY ACID SYNTHASE#0.6418;HEMORRHAGE#0.6416;MEMBRANE FRACTION#0.6405;GESTODENE#0.6397;TO THE PROGRESSION#0.6394;ANTRAL FOLLICLE COUNT#0.6394;GROWTH PATTERN#0.6392;DYSPNEA#0.6392;FLUSHING#0.6389;INHIBIN SECRETION#0.6385;CEREBRAL ARTERY OCCLUSION#0.6374;CLEAVED CASPASE 3#0.6369;LINEAR REGRESSION ANALYSIS#0.6367;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6358;NERVE FIBER#0.6345;CABERGOLINE#0.6339;RED BLOOD CELL#0.6331;LUTEINIZING HORMONE SECRETION#0.6325;POSITIVE FEEDBACK MECHANISM#0.6325;VASCULAR SMOOTH MUSCLE CELL#0.6320;INVASIVE LOBULAR CARCINOMA#0.6315;SENESCENCE#0.6311;HEXANE#0.6290;OVARIAN VEIN#0.6274;CORTISOL SYNTHESIS#0.6271;LINEAR MIXED MODEL#0.6260;CONGESTIVE HEART FAILURE#0.6257;TO TUMOR PROGRESSION#0.6243;OVARIAN CORTEX#0.6239;HEMORRHAGIC#0.6237;CYSTADENOCARCINOMA#0.6224;DYDROGESTERONE#0.6218;MIGRAINE#0.6212;CELL CYCLE REGULATOR#0.6209;TADALAFIL#0.6206;AFINITOR#0.6205;REGULATION OF GENE EXPRESSION#0.6198;MORRIS WATER MAZE#0.6196;DEHYDRATION#0.6195;MAMMARY FAT PAD#0.6191;CYTOCHROME B#0.6190;VALPROIC ACID#0.6186;ENDOCRINE CELL#0.6185;PHOSPHOLIPASE A2#0.6182;TELOMERE#0.6179;GENE SILENCING#0.6177;MULTIPLE MYELOMA#0.6169;PERSISTENT ORGANIC POLLUTANT#0.6168;ENDOPLASMIC RETICULUM MEMBRANE#0.6162;FATTY LIVER DISEASE#0.6161;BENIGN PROSTATE HYPERPLASIA#0.6154;URINARY BLADDER#0.6152;REGULATION OF MRNA#0.6150;FOREARM#0.6148;ACROSOME#0.6140;ANOREXIA#0.6137;UMBILICAL CORD#0.6132;BENZOPHENONE#0.6131;T-CELL LEUKEMIA#0.6129;ERYTHEMA#0.6127;ACTIN CYTOSKELETON#0.6120;LOWER URINARY TRACT#0.6115;SYSTEM DEVELOPMENT#0.6114;IMMUNOGLOBULIN G#0.6105;SURFACE EPITHELIUM#0.6100;LEUKEMIA INHIBITORY FACTOR#0.6100;HYPERPARATHYROIDISM#0.6090;GLYCERALDEHYDE-3-PHOSPHATE#0.6088;STANOZOLOL#0.6087;SYNAPTOSOME#0.6085;FALSE DISCOVERY RATE#0.6084;ALANINE#0.6083;SYNOVIAL FLUID#0.6081;HISTIDINE#0.6078;CYCLOSPORIN A#0.6075;ETOMIDATE#0.6072;CUMULUS OOCYTE COMPLEX#0.6069;PROTEIN DEGRADATION#0.6068;FORESKIN#0.6064;KLINEFELTER'S SYNDROME#0.6063;FINE NEEDLE ASPIRATION#0.6061;LATE ONSET HYPOGONADISM#0.6059;SEXUAL DISORDER#0.6058;FEMALE REPRODUCTIVE SYSTEM#0.6049;TERMINAL DIFFERENTIATION#0.6049;IN VITRO FERTILISATION#0.6041;INHIBIN BETA-A#0.6030;ENDOMETRIOID ENDOMETRIAL CARCINOMA#0.6013;HEREDITARY BREAST CANCER#0.6013;DUTASTERIDE#0.6008;LATERAL PREOPTIC AREA#0.6005
158983	MALE INFERTILITY#1.2195;INFERTILITY#1.0556;MITOTIC CHROMOSOME#0.7191;SPERMATOGENESIS#0.6289
1589	21-HYDROXYLASE ACTIVITY#1.0357;ADDISON'S DISEASE#1.0240;FRAGMENT LENGTH POLYMORPHISM#1.0193;CORTISOL BIOSYNTHESIS#1.0168;3BETA-HYDROXYSTEROID DEHYDROGENASE#1.0146;GENE CONVERSION#1.0139;HYDROXYLASE ACTIVITY#1.0136;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0128;DIGESTION#1.0099;POLYMERASE CHAIN REACTION#1.0069;MICROSOME#1.0052;CONGENITAL ADRENAL HYPERPLASIA#1.0017;ADRENAL HYPERPLASIA#1.0004;CYTOCHROME P450#0.9975;ADRENAL CORTEX#0.9928;PROTEIN KINASE#0.9921;HYPERANDROGENISM#0.9916;ENZYME ACTIVITY#0.9884;CORTISOL SYNTHESIS#0.9839;ALDOSTERONE#0.9823;GENE EXPRESSION#0.9823;EXTRACELLULAR MATRIX#0.9820;ADRENAL GLAND#0.9816;GENETIC DISEASE#0.9807;HUMAN LEUKOCYTE ANTIGEN#0.9775;STEROIDOGENESIS#0.9762;PROGESTERONE#0.9746;LEUKOCYTE#0.9732;CORTISOL#0.9714;POLYCYSTIC OVARY SYNDROME#0.9712;STEROID HYDROXYLASE#0.9641;COPY NUMBER VARIATION#0.9627;ANDROSTENEDIONE#0.9593;STEROID BIOSYNTHESIS#0.9591;TESTOSTERONE#0.9586;PUBERTY#0.9583;TRANSCRIPTION FACTOR#0.9555;DEXAMETHASONE#0.9513;AUTOSOMAL RECESSIVE DISEASE#0.9410;DEHYDROEPIANDROSTERONE#0.9396;GENETIC DISORDER#0.9369;CHORIONIC VILLUS#0.9364;PRECOCIOUS PUBERTY#0.9321;GESTATION#0.9313;ADRENOCORTICOTROPIC HORMONE#0.9308;OVARIAN#0.9264;HYDROCORTISONE#0.9253;STEROID SYNTHESIS#0.9236;AUTOIMMUNE DISEASE#0.9194;CARRIE#0.9148;TUMOR CELLS#0.9076;HORMONE BIOSYNTHESIS#0.8942;ENDOPLASMIC RETICULUM#0.8919;ESTRADIOL#0.8913;STEROIDOGENIC FACTOR 1#0.8811;PERIPHERAL BLOOD#0.8752;ADRENOCORTICAL CARCINOMA#0.8731;INFERTILITY#0.8664;CLINICAL PRACTICE GUIDELINE#0.8569;BETA-HYDROXYSTEROID DEHYDROGENASE#0.8561;HYPERTENSION#0.8515;ANDROGEN RECEPTOR#0.8489;LEYDIG CELL#0.8406;PREGNENOLONE#0.8178;STEROID METABOLISM#0.8136;FORSKOLIN#0.8095;CORTISOL SECRETION#0.8081;EHLERS-DANLOS SYNDROME#0.8056;SIGNALING PATHWAY#0.8033;OVARIES#0.8017;GENE COPY NUMBER#0.7834;CUSHING'S SYNDROME#0.7802;CYCLIC AMP#0.7798;ABIRATERONE#0.7655;EXCRETION#0.7648;CORTICOTROPIN#0.7620;ELECTRON TRANSFER#0.7610;GONAD#0.7587;DEHYDROEPIANDROSTERONE SULFATE#0.7518;CYTOCHROME B5#0.7459;UREA CYCLE#0.7444;MITOCHONDRIA#0.7411;QUANTITATIVE REAL TIME#0.7353;ANTLEY-BIXLER SYNDROME#0.7336;HUMAN ADRENOCORTICAL CARCINOMA#0.7245;AUTOIMMUNE POLYGLANDULAR SYNDROME#0.7215;CONNECTIVE TISSUE#0.7204;GLUCOCORTICOID SYNTHESIS#0.7191;DNA BINDING#0.7188;DIABETES MELLITUS#0.7032;HEME BINDING#0.6946;POSITIVE PREDICTIVE VALUE#0.6866;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.6821;GLUCOCORTICOID RECEPTOR#0.6721;ANDROGEN SYNTHESIS#0.6710;ALDOSTERONE SECRETION#0.6530;GROWTH FACTOR#0.6490;MUTAGENESIS#0.6461;ADRENAL REST TUMOR#0.6386;GLUCOCORTICOID BIOSYNTHESIS#0.6379;DRIED BLOOD SPOT#0.6262;CHOLESTEROL TRANSPORT#0.6244;CYTOCHROME C#0.6240;LYASE ACTIVITY#0.6221;RESVERATROL#0.6195;FOLLICULAR PHASE#0.6169;MOLECULAR DYNAMICS SIMULATION#0.6162;LEUCINE#0.6152;HYPOTHALAMIC PITUITARY ADRENAL#0.6136;RENIN ACTIVITY#0.6110;TOXICITY#0.6109;ANDROGEN SECRETION#0.6104;DRUG METABOLISM#0.6026
158	PURINE METABOLISM#1.0273;ADENOSINE#1.0150;ADENINE#1.0136;FUMARATE#1.0073;AUTISTIC#1.0048;MENTAL RETARDATION#0.9944;INOSINE#0.9856;HYPOXANTHINE#0.9555;EPILEPSY#0.9535;AMP DEAMINASE#0.9197;ADENOSINE 5'-MONOPHOSPHATE#0.9078;ADENOSINE MONOPHOSPHATE#0.8764;ADENOSINE DEAMINASE#0.8647;ARGININOSUCCINATE LYASE#0.8606;GUANINE#0.8590;ADENYLATE#0.8502;SKELETAL MUSCLE#0.8488;LYASE ACTIVITY#0.8450;PURINE NUCLEOSIDE PHOSPHORYLASE#0.8299;DEVELOPMENTAL DELAY#0.8093;UREA CYCLE#0.7876;ARGININOSUCCINATE#0.7861;MOLYBDENUM COFACTOR#0.7841;ASPARTATE#0.7674;SKIN FIBROBLASTS#0.7592;RIBOSE#0.7564;ADENINE PHOSPHORIBOSYLTRANSFERASE#0.7444;ERYTHROCYTE#0.7428;MOLYBDENUM COFACTOR DEFICIENCY#0.7352;ENZYME ACTIVITY#0.7301;MUTAGENESIS#0.6617;NUCLEOTIDE SALVAGE#0.6566;DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY#0.6429;ADENYLATE KINASE#0.6427;XANTHINE#0.6415;GUANINE PHOSPHORIBOSYLTRANSFERASE#0.6370;ARGININE#0.6248;PYRIMIDINE METABOLISM#0.6050;HISTIDINE#0.6009
1590	GENE CONVERSION#1.0304;ADRENAL HYPERPLASIA#0.9802;CONGENITAL ADRENAL HYPERPLASIA#0.9799;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9699;POLYMERASE CHAIN REACTION#0.9495;FRAGMENT LENGTH POLYMORPHISM#0.8520;CORTISOL#0.8276;DIGESTION#0.8247;CYTOCHROME P450#0.7500;HUMAN LEUKOCYTE ANTIGEN#0.7091;21-HYDROXYLASE ACTIVITY#0.6984;HYDROXYLASE ACTIVITY#0.6730;ENZYME ACTIVITY#0.6421;LEUKOCYTE#0.6253
1591	LHCII#1.0516;NEPHROLITHIASIS#1.0394;LIGHT-HARVESTING COMPLEX#1.0360;LUNG CANCER#1.0276;VITAMIN D BINDING#1.0267;CATABOLISM#1.0184;ENZYME ACTIVITY#1.0175;HYPERCALCEMIA#1.0171;NEPHROCALCINOSIS#1.0158;CALCITRIOL#1.0154;25-HYDROXYVITAMIN D3#1.0139;ACTIVE VITAMIN D#1.0138;COLORECTAL CANCER#1.0135;POLYMERASE CHAIN REACTION#1.0135;CYTOCHROME P450#1.0126;COLON CANCER#1.0091;PHOTOSYSTEM#1.0087;KERATINOCYTE#1.0082;PHOTOSYSTEM II#1.0065;COLORECTAL#1.0062;GENISTEIN#1.0047;CANCER CELL#1.0037;TRANSACTIVATION#1.0032;PROSTATE CANCER#1.0030;CHLOROPHYLL A#1.0023;HYDROXYLASE ACTIVITY#0.9993;KETOCONAZOLE#0.9972;BREAST CANCER#0.9961;VITAMIN D3#0.9953;RETINOID X RECEPTOR#0.9937;1α,25-DIHYDROXYVITAMIN D3#0.9917;OSTEOBLAST#0.9900;GENE EXPRESSION#0.9897;PROTEIN KINASE#0.9896;KIDNEY DISEASE#0.9895;CHRONIC KIDNEY DISEASE#0.9880;THYROID CANCER#0.9870;BREAST CANCER CELL#0.9868;VITAMIN D METABOLISM#0.9854;EPITHELIAL CELL#0.9849;DNA METHYLATION#0.9834;SIGNALING PATHWAY#0.9832;VITAMIN D RECEPTOR#0.9799;ENDOTHELIAL CELL#0.9786;CELL PROLIFERATION#0.9778;GROWTH FACTOR#0.9773;TUMOR CELLS#0.9747;PARATHYROID#0.9733;REVERSE TRANSCRIPTION#0.9727;VITAMIN D DEFICIENCY#0.9696;PARATHYROID HORMONE#0.9690;MACROPHAGE#0.9681;RICKETS#0.9665;FIBROBLAST GROWTH FACTOR#0.9665;ADENOCARCINOMA#0.9665;TRANSCRIPTION FACTOR#0.9649;APOPTOSIS#0.9634;VITAMIN D CATABOLISM#0.9561;MONOCYTE#0.9421;CELL GROWTH#0.9361;MINERALIZATION#0.9300;VITAMIN D3 METABOLISM#0.9259;EXCRETION#0.9229;MULTIPLE SCLEROSIS#0.9218;PREGNANE X RECEPTOR#0.9195;THYLAKOID#0.9189;TOXICITY#0.9158;QUANTITATIVE REAL TIME#0.9151;IMMUNE RESPONSE#0.9116;CELL DIFFERENTIATION#0.9086;VDR BINDING#0.9064;SPERMATOZOA#0.8996;DUODENUM#0.8979;ENDOCRINE SYSTEM#0.8874;PROTEIN SYNTHESIS#0.8870;PERIPHERAL BLOOD#0.8840;HYPERPARATHYROIDISM#0.8774;CHOLECALCIFEROL#0.8689;THYLAKOID MEMBRANE#0.8683;REACTION CENTER#0.8632;CAROTENOID#0.8535;ED-71#0.8505;RETINOIC ACID#0.8500;MECHANISM OF ACTION#0.8493;BONE MINERAL DENSITY#0.8421;OSTEOPOROSIS#0.8421;TYPE 1 DIABETES#0.8402;T CELL#0.8352;BONE CELLS#0.8320;AUTOIMMUNE DISEASE#0.8284;1,25-DIHYDROXYCHOLECALCIFEROL#0.8236;OSTEOMALACIA#0.8180;OVARIAN#0.8126;SECONDARY HYPERPARATHYROIDISM#0.8125;SMALL INTESTINE#0.8106;MAMMARY GLAND#0.8103;PHOTOSYNTHESIS#0.8077;MITOGEN ACTIVATED PROTEIN#0.8076;SKIN CANCER#0.8033;PAPILLARY THYROID CANCER#0.7997;LIGHT HARVESTING COMPLEX II#0.7984;HUMAN BREAST CANCER#0.7947;BONE MINERALIZATION#0.7934;PRO-INFLAMMATORY#0.7917;HISTONE MODIFICATION#0.7878;COMPLEX II#0.7860;PHOTOSYSTEM I#0.7838;CHLOROPHYLL B#0.7755;DENDRITIC CELL#0.7744;ESTROGEN RECEPTOR#0.7717;LYMPH NODE#0.7705;VITAMIN D SYNTHESIS#0.7670;DNA BINDING#0.7627;ADIPOSE TISSUE#0.7625;HUMAN EMBRYONIC KIDNEY#0.7605;EMBRYONIC KIDNEY#0.7600;5-AZA-2'-DEOXYCYTIDINE#0.7595;XANTHOPHYLL#0.7591;2'-DEOXYCYTIDINE#0.7590;STEM CELL#0.7550;SEMEN#0.7503;ELECTRON TRANSPORT#0.7461;DIABETES MELLITUS#0.7415;HISTONE DEACETYLASE#0.7379;LUNG ADENOCARCINOMA#0.7342;DEXAMETHASONE#0.7308;SQUAMOUS CELL CARCINOMA#0.7307;HEPATOCELLULAR CARCINOMA#0.7286;ANTENNA COMPLEX#0.7281;PHOTOPROTECTION#0.7265;BONE FORMATION#0.7230;RESPONSE TO VITAMIN#0.7211;THYROID CARCINOMA#0.7210;ALKALINE PHOSPHATASE#0.7209;HEPATITIS C#0.7209;VIOLAXANTHIN#0.7168;VITAMIN D3 RECEPTOR#0.7131;OBESE#0.7105;HYPERTENSION#0.7088;STROMAL CELL#0.7085;OSTEOCYTE#0.7084;RIFAMPIN#0.7080;TUMOR SUPPRESSOR#0.7069;SKIN FIBROBLASTS#0.7063;CELL CYCLE#0.7052;RESPONSE TO VITAMIN D#0.7015;BREAST CARCINOMA#0.7003;INCREASED COPY NUMBER#0.6886;APOPTOTIC#0.6872;ADIPOCYTE#0.6838;INFERTILE#0.6799;COLORECTAL ADENOMA#0.6790;LIGAND BINDING DOMAIN#0.6768;COPY NUMBER VARIATION#0.6748;MYELOID LEUKEMIA#0.6716;FERREDOXIN#0.6701;PROTEIN COMPLEX#0.6696;CALCIDIOL#0.6690;SKELETON#0.6650;B CELL#0.6636;HYPERVITAMINOSIS D#0.6603;IMMUNE SYSTEM#0.6598;MYOTUBE#0.6554;MUTAGENESIS#0.6500;BONE REMODELING#0.6483;TROPHOBLAST#0.6482;TRANSIENT RECEPTOR POTENTIAL#0.6458;PSORIASIS#0.6420;NONPHOTOCHEMICAL QUENCHING#0.6327;CALCIFEDIOL#0.6319;VITAMIN D2#0.6316;25-HYDROXYCHOLECALCIFEROL#0.6290;RIBOSOME RECYCLING#0.6285;CHLOROPLAST#0.6281;GLUCOCORTICOID RECEPTOR#0.6268;PARICALCITOL#0.6248;HEPATITIS C VIRUS#0.6228;LYMPH NODE METASTASIS#0.6195;CHLOROPHYLL BINDING#0.6172;PROTEIN KINASE C#0.6126;PLASMA MEMBRANE#0.6115;CHLOROPHYLL FLUORESCENCE#0.6109;COPY NUMBER INCREASE#0.6095;MUSCLE CELL#0.6088;SIGNAL TRANSDUCTION#0.6085;TRANSCRIPTASE#0.6066;GESTATION#0.6059;COLON CARCINOMA#0.6017
159296	TRANSCRIPTION FACTOR#1.0717;B CELL#1.0651;INFLAMMATORY BOWEL DISEASE#1.0234;CROHN'S DISEASE#1.0172;LYMPHOID TISSUE#1.0075;ULCERATIVE COLITIS#0.9943;COLITIS#0.9541;ENDOTHELIAL CELL#0.8993;GENE EXPRESSION#0.8287;LYMPH NODE#0.7453;T CELL#0.6946;TOOTH MORPHOGENESIS#0.6496;LYMPHOCYTE HOMING#0.6297;MICROVASCULAR ENDOTHELIAL CELL#0.6195;LYMPHOID CELL#0.6176;CANCER CELL#0.6021
1592	LHCII#1.0519;RETINOIC ACID METABOLISM#1.0348;LIGHT-HARVESTING COMPLEX#1.0344;CYTOCHROME P450#1.0229;CATABOLISM#1.0192;RETINOL#1.0159;CHLOROPHYLL A#1.0051;PHOTOSYSTEM#0.9994;STEM CELL#0.9974;PHOTOSYSTEM II#0.9974;RETINOIC ACID#0.9958;RETINOIC ACID RECEPTOR#0.9939;ALL TRANS RETINOIC ACID#0.9926;CELL DIFFERENTIATION#0.9902;BREAST CANCER#0.9846;LIGHT HARVESTING COMPLEX II#0.9819;RETINOL BINDING#0.9812;HINDBRAIN#0.9804;GENE EXPRESSION#0.9799;XANTHOPHYLL#0.9789;VITAMIN A#0.9769;SIGNALING PATHWAY#0.9676;TRANSCRIPTION FACTOR#0.9673;GERM CELL#0.9582;COMPLEX II#0.9531;CANCER CELL#0.9499;CELL PROLIFERATION#0.9409;REACTION CENTER#0.9362;CAROTENOID#0.9330;RETINOID X RECEPTOR#0.9319;APOPTOSIS#0.9279;THYLAKOID#0.9228;ONCOGENIC#0.9209;HYDROXYLASE ACTIVITY#0.9202;RETINOIC ACID BINDING#0.9186;RETINOL METABOLISM#0.9153;POLYMERASE CHAIN REACTION#0.9121;MORPHOGENESIS#0.9054;EMBRYONIC STEM CELL#0.9039;RETINOID METABOLISM#0.8991;SPINA BIFIDA#0.8991;UTERUS#0.8971;PHOTOSYSTEM I#0.8905;BREAST CARCINOMA#0.8817;VIOLAXANTHIN#0.8812;THYLAKOID MEMBRANE#0.8609;CHLOROPLAST#0.8528;NEUROBLASTOMA#0.8504;PHOTOSYNTHESIS#0.8495;NONPHOTOCHEMICAL QUENCHING#0.8420;GROWTH FACTOR#0.8402;ENERGY DISSIPATION#0.8382;MEIOSIS#0.8382;BREAST CANCER CELL#0.8361;ACUTE PROMYELOCYTIC LEUKEMIA#0.8335;SPINAL CORD#0.8178;RETINAL DEHYDROGENASE#0.8112;MESENCHYME#0.8095;TERATOGENIC#0.8087;XANTHOPHYLL CYCLE#0.7881;4-HPR#0.7866;RETINOL DEHYDROGENASE#0.7816;KERATINOCYTE#0.7791;QUANTITATIVE REAL TIME#0.7776;LUTEIN#0.7775;EPITHELIAL CELL#0.7767;TAIL BUD#0.7695;VITAMIN A DEFICIENCY#0.7633;CHLOROPHYLL BINDING#0.7600;VERTEBRAE#0.7480;CHLOROPHYLL FLUORESCENCE#0.7451;NERVOUS SYSTEM#0.7446;SIGNALING MOLECULE#0.7412;CHLOROPHYLL B#0.7364;EMBRYONAL CARCINOMA#0.7357;GASTRULATION#0.7303;FETAL LIVER#0.7280;STROMA#0.7242;NEURAL PLATE#0.7205;SQUAMOUS CELL CARCINOMA#0.7200;ELECTRON TRANSPORT#0.7086;NEURAL CREST#0.7079;REACTION CENTRE#0.7046;OVARIAN#0.7045;TUMOR CELLS#0.6998;ALL-TRANS-RETINOL#0.6961;TRANS-RETINOL#0.6959;STROMAL CELL#0.6861;CELL CYCLE#0.6839;BONE MARROW#0.6823;BENZOIC ACID#0.6819;EMBRYO IMPLANTATION#0.6803;RHOMBOMERE#0.6719;REVERSE TRANSCRIPTION#0.6695;PHOTOPROTECTION#0.6678;KETOCONAZOLE#0.6622;FOREBRAIN#0.6564;REGENERATION#0.6550;STEM CELL MARKER#0.6523;BINDING PROTEIN 1#0.6499;SMOOTH MUSCLE#0.6450;OSTEOBLAST#0.6296;4-OXORETINOL#0.6289;HEAD DEVELOPMENT#0.6289;MICROSOME#0.6286;LYME DISEASE#0.6270;CELL DEATH#0.6259;STRUCTURE ACTIVITY RELATIONSHIP#0.6252;ELECTRON TRANSPORT RATE#0.6231;PEROXISOME#0.6228;CERVICAL#0.6099;LATERAL PLATE MESODERM#0.6059;NEURAL CREST CELL#0.6050
159371	
1593	STEROL 27-HYDROXYLASE ACTIVITY#1.1236;LIPID STORAGE#1.0403;CEREBROTENDINOUS XANTHOMATOSIS#1.0392;BILE ACID BIOSYNTHESIS#1.0385;LIPID STORAGE DISEASE#1.0367;ALKALINE PHOSPHATASE#1.0360;XANTHOMATOSIS#1.0360;CHOLESTEROL EFFLUX#1.0258;HYDROXYLASE ACTIVITY#1.0248;BILE ACID SYNTHESIS#1.0216;BONE RESORPTION#1.0122;CHOLESTEROL HOMEOSTASIS#1.0121;VITAMIN D3#1.0120;MITOCHONDRIA#1.0093;MACROPHAGE#1.0090;BONE FORMATION#1.0090;PARATHYROID#1.0072;LIVER X RECEPTOR#1.0070;25-HYDROXYVITAMIN D3#1.0068;CYTOCHROME P450#1.0066;PARATHYROID HORMONE#1.0054;VITAMIN D RECEPTOR#1.0040;ATP BINDING#1.0026;BILE ACID BIOSYNTHETIC#1.0020;ENZYME ACTIVITY#1.0019;BONE TURNOVER MARKER#1.0019;VITAMIN D METABOLISM#1.0007;CHOLIC ACID#0.9968;CHOLESTEROL SYNTHESIS#0.9949;CHOLESTEROL METABOLISM#0.9933;ATP BINDING CASSETTE#0.9889;BREAST CANCER#0.9876;LOW DENSITY LIPOPROTEIN#0.9868;CANCER CELL#0.9854;POLYMERASE CHAIN REACTION#0.9840;GROWTH FACTOR#0.9833;CHENODEOXYCHOLIC ACID#0.9816;GENE EXPRESSION#0.9792;ATHEROSCLEROSIS#0.9785;COENZYME A#0.9737;BILE ACID METABOLISM#0.9725;EXCRETION#0.9684;CHOLESTEROL TRANSPORT#0.9684;VITAMIN D DEFICIENCY#0.9673;BONE MINERAL DENSITY#0.9668;OSTEOPOROSIS#0.9653;MONOCYTE#0.9606;PROSTATE CANCER#0.9575;LDL RECEPTOR#0.9534;TRANSCRIPTION FACTOR#0.9532;CHOLESTEROL 7ALPHA-HYDROXYLASE ACTIVITY#0.9529;ATP BINDING CASSETTE TRANSPORTER#0.9525;FARNESOID X RECEPTOR#0.9519;LIPID METABOLISM#0.9422;ESTROGEN RECEPTOR#0.9339;CHOLESTASIS#0.9198;MRNA SPLICING#0.9195;CHOLECALCIFEROL#0.9188;1α,25-DIHYDROXYVITAMIN D3#0.9175;CALCITRIOL#0.9172;MONOCYTE DERIVED MACROPHAGE#0.9161;VITAMIN D BINDING#0.9155;ACID PHOSPHATASE#0.9079;ATHEROSCLEROTIC#0.9068;BONE MARROW#0.9066;CELL PROLIFERATION#0.8990;PRE-MRNA SPLICING#0.8946;OBESE#0.8878;HIGH DENSITY LIPOPROTEIN#0.8869;CATABOLISM#0.8829;DIARRHEA#0.8784;BONE REMODELING#0.8765;CHOLESTEROL BIOSYNTHESIS#0.8693;VITAMIN D2#0.8678;AUTOSOMAL RECESSIVE DISEASE#0.8627;REVERSE CHOLESTEROL TRANSPORT#0.8597;SCAVENGER RECEPTOR#0.8575;LIVER DISEASE#0.8520;SIGNALING PATHWAY#0.8446;REVERSE TRANSCRIPTION#0.8339;ENDOTHELIAL CELL#0.8253;MICROSOME#0.8208;RETINOIC ACID#0.8184;BILE DUCT#0.8150;ACTIVE VITAMIN D#0.8143;HEPATOCYTE NUCLEAR FACTOR#0.8080;NERVOUS SYSTEM#0.8042;CYCLOSPORIN A#0.8033;PEROXISOME#0.8016;SMALL HETERODIMER PARTNER#0.7961;HYPERCHOLESTEROLEMIA#0.7940;FIBROBLAST GROWTH FACTOR#0.7938;HEPATITIS C#0.7827;HIGH FAT DIET#0.7745;CHOLESTEROL CATABOLISM#0.7742;GALLBLADDER#0.7667;CYCLOSPORIN#0.7665;MITOCHONDRIAL MEMBRANE#0.7663;INNER MITOCHONDRIAL MEMBRANE#0.7627;FEMUR#0.7583;ANDROGEN RECEPTOR#0.7571;DEXAMETHASONE#0.7567;SECONDARY HYPERPARATHYROIDISM#0.7511;VITAMIN D3 METABOLISM#0.7484;DEMENTIA#0.7453;HYPERPARATHYROIDISM#0.7437;MENTAL RETARDATION#0.7404;CYCLOPHOSPHAMIDE#0.7362;GLUTATHIONE#0.7343;CEREBELLAR ATAXIA#0.7316;TAUROCHOLATE#0.7285;ESTRADIOL#0.7272;BLOOD BRAIN BARRIER#0.7236;KIDNEY DISEASE#0.7230;EPITHELIAL CELL#0.7189;PROGESTERONE#0.7127;MAGNETIC RESONANCE IMAGING#0.7101;ADIPOSE TISSUE#0.7087;ENDOTHELIUM#0.7042;RICKETS#0.7014;ARTERY#0.6999;INSULIN-LIKE GROWTH FACTOR#0.6979;STEROID DEHYDROGENASE#0.6908;PRO-INFLAMMATORY#0.6908;TESTOSTERONE#0.6856;KERATINOCYTE#0.6852;PREGNANE X RECEPTOR#0.6816;RETINOID X RECEPTOR#0.6754;CHRONIC KIDNEY DISEASE#0.6735;ALVEOLAR MACROPHAGE#0.6721;SKIN CANCER#0.6690;TOXICITY#0.6678;STEROL REGULATORY ELEMENT#0.6625;MULTIPLE SCLEROSIS#0.6571;MUTAGENESIS#0.6542;TIBIA#0.6540;HEPATITIS C VIRUS#0.6504;7 DEHYDROCHOLESTEROL REDUCTASE#0.6489;SPINAL CORD#0.6435;ASTROCYTE#0.6428;CENTRAL NERVOUS SYSTEM#0.6413;GLUCOCORTICOID RECEPTOR#0.6247;URSODEOXYCHOLIC ACID#0.6215;T CELL#0.6213;AGE RELATED MACULAR DEGENERATION#0.6201;MACULAR DEGENERATION#0.6196;CHOLESTYRAMINE#0.6191;SMALL INTESTINE#0.6160;NEUROPATHY#0.6129;BONE DISEASE#0.6041;CHOLESTEROL TRANSPORTER#0.6021
1594	25-HYDROXYVITAMIN D3#1.0293;VITAMIN D BINDING#1.0224;RICKETS#1.0198;MACROPHAGE#1.0150;MONOCYTE#1.0142;ACTIVE VITAMIN D#1.0115;TYPE 1 DIABETES#1.0091;RETINOID X RECEPTOR#1.0078;VITAMIN D RECEPTOR#1.0077;25-HYDROXYCHOLECALCIFEROL#1.0077;CYTOCHROME P450#1.0065;HYDROXYLASE ACTIVITY#1.0048;CALCITRIOL#1.0047;POLYMERASE CHAIN REACTION#1.0046;T CELL#1.0039;HYPERCALCEMIA#0.9999;DNA METHYLATION#0.9995;EPITHELIAL CELL#0.9994;DENDRITIC CELL#0.9989;VDR BINDING#0.9983;KERATINOCYTE#0.9978;PROSTATE CANCER#0.9974;BREAST CANCER#0.9938;MULTIPLE SCLEROSIS#0.9931;OSTEOBLAST#0.9926;VITAMIN D3 METABOLISM#0.9923;GENE EXPRESSION#0.9922;CHONDROCYTE#0.9919;LIGAND BINDING DOMAIN#0.9905;TRANSCRIPTION FACTOR#0.9899;CANCER CELL#0.9888;VITAMIN D3#0.9885;COLORECTAL CANCER#0.9884;SIGNALING PATHWAY#0.9879;FIBROBLAST GROWTH FACTOR#0.9874;COLORECTAL#0.9862;PARATHYROID#0.9846;1α,25-DIHYDROXYVITAMIN D3#0.9836;CATABOLISM#0.9826;GROWTH FACTOR#0.9822;PARATHYROID HORMONE#0.9815;VITAMIN D METABOLISM#0.9809;DIABETES MELLITUS#0.9798;CHOLECALCIFEROL#0.9789;IMMUNE CELL#0.9764;TRANSACTIVATION#0.9762;VITAMIN D DEFICIENCY#0.9757;IMMUNE SYSTEM#0.9757;MITOCHONDRIA#0.9756;ENDOCRINE SYSTEM#0.9752;BREAST CANCER CELL#0.9751;CELL PROLIFERATION#0.9744;IMMUNE RESPONSE#0.9743;AUTOIMMUNE DISEASE#0.9740;MUSCLE CELL#0.9721;ENZYME ACTIVITY#0.9712;PROTEIN KINASE#0.9710;HYPERPARATHYROIDISM#0.9709;CELL GROWTH#0.9690;VITAMIN D SYNTHESIS#0.9680;DNA BINDING#0.9643;1,25-DIHYDROXYCHOLECALCIFEROL#0.9623;APOPTOSIS#0.9606;CELL DIFFERENTIATION#0.9583;BONE FORMATION#0.9562;SECONDARY HYPERPARATHYROIDISM#0.9543;KIDNEY DISEASE#0.9522;MAMMARY GLAND#0.9516;ADIPOSE TISSUE#0.9502;COLON CANCER#0.9500;CHRONIC KIDNEY DISEASE#0.9495;SKELETAL MUSCLE#0.9484;VITAMIN D3 RECEPTOR#0.9464;MINERALIZATION#0.9420;BONE MINERAL DENSITY#0.9373;OSTEOBLAST DIFFERENTIATION#0.9263;B CELL#0.9252;KETOCONAZOLE#0.9187;REVERSE TRANSCRIPTION#0.9158;OSTEOCLAST#0.9130;ESTROGEN RECEPTOR#0.9106;GRAVES' DISEASE#0.9054;RETINOIC ACID#0.9037;PRO-INFLAMMATORY#0.9031;ALKALINE PHOSPHATASE#0.9025;BONE CELLS#0.8969;TUMOR NECROSIS FACTOR#0.8935;ADIPOCYTE#0.8905;EXCRETION#0.8885;TOLL LIKE RECEPTOR#0.8868;CALCIDIOL#0.8867;PARATHYROID GLAND#0.8858;TUMOR CELLS#0.8843;QUANTITATIVE REAL TIME#0.8803;TROPHOBLAST#0.8802;SIGNAL TRANSDUCTION#0.8782;COLITIS#0.8776;OBESE#0.8760;TUBERCULOSIS#0.8746;INFLAMMATORY RESPONSE#0.8708;PERIPHERAL BLOOD#0.8698;TYPE 1 DIABETES MELLITUS#0.8680;MAST CELL#0.8598;ADDISON'S DISEASE#0.8591;OSTEOPOROSIS#0.8570;PLASMA MEMBRANE#0.8559;SMOOTH MUSCLE#0.8553;SKIN CANCER#0.8535;HEPATITIS C#0.8508;OSTEOCYTE#0.8447;INNATE IMMUNE RESPONSE#0.8391;BONE RESORPTION#0.8389;FERREDOXIN#0.8386;ESTRADIOL#0.8358;BONE MINERALIZATION#0.8255;1-HYDROXYLASE ACTIVITY#0.8248;STROMAL CELL#0.8235;OVARIAN#0.8221;STEM CELL#0.8169;GENISTEIN#0.8113;BONE MARROW#0.8111;NEPHRON#0.8091;PTH SECRETION#0.8087;OVARIAN CANCER#0.8011;INNATE IMMUNITY#0.8003;OSTEOMALACIA#0.7922;INFLAMMATORY BOWEL DISEASE#0.7892;SMOOTH MUSCLE CELL#0.7887;MAMMARY EPITHELIAL CELL#0.7825;LACTATION#0.7741;HYPOPHOSPHATEMIA#0.7728;NERVOUS SYSTEM#0.7692;CELL CYCLE#0.7688;ALOPECIA#0.7680;CALCIUM CHANNEL#0.7647;NORMAL BREAST TISSUE#0.7610;SMALL INTESTINE#0.7605;TUMOR SUPPRESSOR#0.7570;SPERMATOZOA#0.7493;PROXIMAL TUBULE CELL#0.7467;MECHANISM OF ACTION#0.7428;LUNG CANCER#0.7410;TOXICITY#0.7408;BONE GROWTH#0.7406;HYPERPHOSPHATEMIA#0.7369;PHOSPHATE METABOLISM#0.7352;VITAMIN D BIOSYNTHESIS#0.7329;ENDOTHELIAL CELL#0.7326;ANGIOGENESIS#0.7296;CENTRAL NERVOUS SYSTEM#0.7295;BONE DEVELOPMENT#0.7275;ERYTHROID CELL#0.7223;HEPATITIS C VIRUS#0.7215;GLIOBLASTOMA MULTIFORME#0.7209;PROTEIN KINASE C#0.7201;THYROIDITIS#0.7179;GLOBIN#0.7089;SQUAMOUS CELL CARCINOMA#0.7072;TRANSCRIPTASE#0.6990;PROTEIN KINASE A#0.6929;FRAGMENT LENGTH POLYMORPHISM#0.6924;VASCULAR SMOOTH MUSCLE CELL#0.6923;THYROID CANCER#0.6850;HORMONE BINDING#0.6848;MITOCHONDRIAL MEMBRANE#0.6820;RETINOIC ACID RECEPTOR#0.6795;PSORIASIS#0.6757;GESTATION#0.6727;SARCOIDOSIS#0.6721;MOLECULAR DYNAMICS SIMULATION#0.6696;ADENOCARCINOMA#0.6692;MELANOMA CELL LINES#0.6687;WEIGHT GAIN#0.6679;TUMOR TISSUES#0.6673;HUMAN PROXIMAL TUBULE#0.6647;GLUTATHIONE#0.6623;MAP KINASE#0.6611;TRANSIENT RECEPTOR POTENTIAL#0.6585;RIBAVIRIN#0.6573;LIGAND BINDING POCKET#0.6570;MYOTUBE#0.6551;MONONUCLEAR CELLS#0.6536;DECIDUA#0.6525;PROXIMAL TUBULAR CELL#0.6522;VITAMIN D2#0.6480;RESPONSE TO VITAMIN#0.6474;RECEPTOR ACTIVATOR#0.6473;FORSKOLIN#0.6444;APOPTOTIC#0.6443;HISTONE DEACETYLASE#0.6433;ANDROGEN RECEPTOR#0.6427;MESENCHYMAL STEM CELL#0.6423;CD4+ T CELL#0.6421;CALCIUM TRANSPORT#0.6369;CYTOPLASM#0.6282;SKELETON#0.6270;HUMAN BREAST CANCER#0.6261;GLOMERULAR FILTRATION RATE#0.6259;GLOMERULAR FILTRATION#0.6256;DNA SYNTHESIS#0.6255;TESTOSTERONE#0.6244;INTESTINAL ABSORPTION#0.6218;RESPONSE TO VITAMIN D#0.6203;ANTIGEN PRESENTING CELLS#0.6202;HEPATOCELLULAR CARCINOMA#0.6198;FRUCTOSE#0.6188;REGULATION OF GENE EXPRESSION#0.6184;AUTOIMMUNITY#0.6170;HYPERTENSION#0.6160;HEME BINDING#0.6114;COLORECTAL ADENOMA#0.6087;PARATHYROID ADENOMA#0.6081
1595	CHOLESTEROL SYNTHESIS#1.0474;ERGOSTEROL BIOSYNTHESIS#1.0470;LANOSTEROL#1.0469;STEROL BIOSYNTHESIS#1.0362;CHOLESTEROL BIOSYNTHESIS#1.0359;TUBERCULOSIS#1.0357;ERGOSTEROL#1.0273;CHAGAS DISEASE#1.0272;POSACONAZOLE#1.0239;VORICONAZOLE#1.0162;MEIOSIS#1.0159;KETOCONAZOLE#1.0154;CYTOCHROME P450#1.0147;STEROL REGULATORY ELEMENT#1.0052;ITRACONAZOLE#1.0041;DEMETHYLATION#1.0009;FLUCONAZOLE#1.0004;GERM CELL#0.9917;CELL MEMBRANE#0.9901;DEMETHYLASE ACTIVITY#0.9900;MODE OF ACTION#0.9862;MECHANISM OF ACTION#0.9837;GENE EXPRESSION#0.9806;OOCYTE#0.9722;SQUALENE SYNTHASE#0.9699;STRUCTURE ACTIVITY RELATIONSHIP#0.9687;TOXICITY#0.9608;TRANSCRIPTION FACTOR#0.9530;STEROL BIOSYNTHETIC#0.9529;DRUG RESISTANCE#0.9413;GRANULOSA CELL#0.9188;CHOLESTEROL BIOSYNTHETIC#0.9148;ATP BINDING CASSETTE#0.9085;ATP BINDING#0.9068;EFFLUX PUMP#0.8988;POLYMERASE CHAIN REACTION#0.8968;MOLECULAR DYNAMICS SIMULATION#0.8941;CHOLESTEROL METABOLISM#0.8810;FARNESYL DIPHOSPHATE#0.8777;MUTAGENESIS#0.8593;CLOTRIMAZOLE#0.8525;STEROID BIOSYNTHESIS#0.8485;DRUG METABOLISM#0.8469;OVARIAN#0.8259;FARNESYL#0.8253;LIPID METABOLISM#0.8245;AMPHOTERICIN B#0.8138;DIPHOSPHATE#0.7716;CATALYTIC ACTIVITY#0.7622;ERGOSTEROL BIOSYNTHETIC#0.7475;STEROIDOGENESIS#0.7426;VIRULENCE#0.7409;STEROL SYNTHESIS#0.7402;MICONAZOLE#0.7333;CANDIDIASIS#0.7254;MINIMUM INHIBITORY CONCENTRATION#0.7116;FARNESYL DIPHOSPHATE SYNTHASE#0.7083;AMPHOTERICIN#0.7082;RETINOIC ACID#0.7024;OOCYTE MATURATION#0.6942;LEISHMANIASIS#0.6912;ENDOPLASMIC RETICULUM#0.6851;ERGOSTEROL SYNTHESIS#0.6821;MACROPHAGE#0.6637;HIGH FAT DIET#0.6594;OVARIES#0.6573;PLASMA MEMBRANE#0.6566;CYTOCHROME B5#0.6379;LANOSTEROL SYNTHASE#0.6356;GONAD#0.6329;ASPERGILLOSIS#0.6294;GENE SILENCING#0.6286;LOW DENSITY LIPOPROTEIN#0.6258;FOLLICLE STIMULATING HORMONE#0.6248;ANTLEY-BIXLER SYNDROME#0.6244;MINIMAL INHIBITORY CONCENTRATION#0.6160;PRIMARY HUMAN HEPATOCYTES#0.6011
159963	SMALL INTESTINE#0.8071;INTESTINAL TRACT#0.6698;T CELL#0.6488;DIGESTIVE TRACT#0.6068
159989	TUMOR SUPPRESSOR#0.8617;CANCER CELL#0.7991;PAPILLARY THYROID CARCINOMA#0.7522;THYROID CARCINOMA#0.7468;REVERSE TRANSCRIPTION#0.7404;ADJACENT NORMAL TISSUE#0.6753;THYROID CANCER#0.6713;HEPATOCELLULAR CARCINOMA#0.6645
159	INOSINE#0.8842;ASPARTATE#0.8284;ADENOSINE#0.7139;AMP SYNTHESIS#0.6831;ADENINE#0.6820
15	AANAT ACTIVITY#1.0849;MELATONIN BIOSYNTHETIC#1.0682;N-ACETYLTRANSFERASE ACTIVITY#1.0496;MELATONIN BIOSYNTHESIS#1.0408;N ACETYLTRANSFERASE#1.0399;ACETYLTRANSFERASE ACTIVITY#1.0395;O METHYLTRANSFERASE#1.0308;MELATONIN FORMATION#1.0250;MELATONIN#1.0237;CYCLIC AMP#1.0131;TRYPTOPHAN#1.0130;MELATONIN RECEPTOR#1.0125;DOPAMINE#1.0104;PHOTORECEPTOR CELL#1.0099;MELATONIN SYNTHESIS#1.0097;PROTEIN KINASE#1.0071;ARYLAMINE#1.0058;NAT ACTIVITY#1.0039;PINEAL GLAND#1.0036;ADRENERGIC RECEPTOR#1.0023;ARYLAMINE N ACETYLTRANSFERASE#1.0011;DOPAMINE RECEPTOR#0.9986;DIURNAL#0.9964;TRANSCRIPTION FACTOR#0.9934;BETA ADRENERGIC RECEPTOR#0.9900;NOREPINEPHRINE#0.9881;CIRCADIAN RHYTHM#0.9877;COENZYME A#0.9864;ISOPROTERENOL#0.9854;ENZYME ACTIVITY#0.9793;GENE EXPRESSION#0.9791;POLYMERASE CHAIN REACTION#0.9754;FORSKOLIN#0.9678;ADENOSINE#0.9585;PROTEIN SYNTHESIS#0.9574;RECEPTOR AGONIST#0.9491;REVERSE TRANSCRIPTION#0.9333;N-ACETYL-5-METHOXYTRYPTAMINE#0.9178;ADENYLATE CYCLASE#0.9067;CHLOROPLAST#0.8954;NERVOUS SYSTEM#0.8946;CALCIUM CHANNEL#0.8946;CERVICAL#0.8823;PROTEIN KINASE A#0.8776;CYTOPLASM#0.8744;CAMP RESPONSE ELEMENT#0.8653;RECEPTOR ANTAGONIST#0.8645;SIGNALING PATHWAY#0.8571;BREAST CANCER#0.8557;INDOLE#0.8498;MITOGEN ACTIVATED PROTEIN#0.8446;PROPRANOLOL#0.8430;ADENYLATE#0.8262;PROTEIN KINASE C#0.8239;NORADRENALINE#0.8213;PHOSPHODIESTERASE#0.8174;CAMP RESPONSE ELEMENT BINDING#0.7981;OOCYTE#0.7867;BETA ADRENOCEPTOR#0.7865;EPITHELIAL CELL#0.7757;SYNAPTIC RIBBON#0.7722;DEPHOSPHORYLATION#0.7604;GAP JUNCTION#0.7408;CILIARY BODY#0.7358;SIGNAL TRANSDUCTION#0.7315;OPSIN#0.7280;PINEAL HORMONE#0.7202;PHOSPHODIESTERASE INHIBITOR#0.7185;IMMUNE SYSTEM#0.7145;ACETIC ACID#0.7029;ADENOSINE MONOPHOSPHATE#0.6971;INNERVATION#0.6894;MITOCHONDRIA#0.6838;PROTEASOME#0.6836;CENTRAL NERVOUS SYSTEM#0.6826;ALKALINE PHOSPHATASE#0.6820;L-GLUTAMATE#0.6779;NEUROHORMONE#0.6724;INSULIN RECEPTOR#0.6692;METHYLTRANSFERASE ACTIVITY#0.6368;HYDROXYINDOLE O-METHYLTRANSFERASE ACTIVITY#0.6361;EPINEPHRINE#0.6349;L-ISOPROTERENOL#0.6337;MACROPHAGE#0.6235;CYCLIC ADENOSINE MONOPHOSPHATE#0.6209;GANGLION CELLS#0.6191;O-METHYLTRANSFERASE ACTIVITY#0.6164
160065	EPIDIDYMIS#0.7938;SEMINAL VESICLE#0.6821;ACROSOME REACTION#0.6281
1600	SRC FAMILY KINASE#1.0602;APOE RECEPTOR#1.0412;VERY-LOW-DENSITY LIPOPROTEIN#1.0398;SIGNALING CASCADE#1.0357;LOW DENSITY LIPOPROTEIN#1.0269;BRAIN DEVELOPMENT#1.0167;AMYLOID PRECURSOR PROTEIN#1.0164;SIGNAL TRANSDUCTION#1.0124;SIGNALING PATHWAY#1.0101;AMACRINE CELL#1.0091;CEREBRAL CORTEX#1.0088;NEURONAL MIGRATION#1.0035;PHOSPHOTYROSINE BINDING#0.9990;EXTRACELLULAR MATRIX#0.9853;NERVOUS SYSTEM#0.9829;CENTRAL NERVOUS SYSTEM#0.9586;GENE EXPRESSION#0.9414;CELL SURFACE#0.9224;SIGNALLING PATHWAY#0.9040;CELL MIGRATION#0.8987;PLASMA MEMBRANE#0.8931;CAJAL-RETZIUS CELL#0.8928;ALZHEIMER'S DISEASE#0.8882;PROGENITOR CELL#0.8863;SPINAL CORD#0.8750;EMBRYONIC BRAIN#0.8711;SIGNALING MOLECULE#0.8627;ENDOCYTOSIS#0.8599;PURKINJE CELL#0.8377;FOREBRAIN#0.8273;PROTEIN KINASE#0.8119;OLFACTORY BULB#0.7967;IN UTERO ELECTROPORATION#0.7888;INTERNEURON#0.7737;NEURON MIGRATION#0.7705;NEURITE#0.7684;RECEPTOR BINDING#0.7628;PHOSPHOINOSITIDE BINDING#0.7623;NEUROGENESIS#0.7548;VLDL RECEPTOR#0.7483;NEUROBLAST#0.7169;DOCKING PROTEIN#0.7118;EMBRYONIC BRAIN DEVELOPMENT#0.7104;CYCLIN DEPENDENT KINASE#0.7079;RETINAL PROGENITOR CELL#0.6984;DENTATE GYRUS#0.6875;SOMAL TRANSLOCATION#0.6626;EPITHELIAL CELL#0.6546;TRANSCRIPTION FACTOR#0.6486;ENTEROCYTE#0.6342;NOXIOUS#0.6339;DENDRITIC SPINE#0.6297;CELL ADHESION#0.6177;ADHERENS JUNCTION#0.6159;UBIQUITIN#0.6150;ACTIN CYTOSKELETON#0.6108;NUCLEOCYTOPLASMIC SHUTTLING#0.6094
1601	PLATELET AGGREGATION#1.0646;OVARIAN#1.0508;SIGNAL TRANSDUCTION#1.0494;OVARIAN CANCER#1.0487;TUMOR SUPPRESSOR#1.0471;ENDOTHELIAL CELL#1.0407;ENDOCYTOSIS#1.0377;EPITHELIAL CELL#1.0340;CELL GROWTH#1.0304;OVARIAN CARCINOMA#1.0282;PROSTATE CANCER#1.0273;BREAST CANCER#1.0245;GROWTH FACTOR#1.0237;CLATHRIN ADAPTOR#1.0196;PHOSPHOTYROSINE BINDING#1.0179;PROTEIN KINASE#1.0161;CANCER CELL#1.0121;CELL PROLIFERATION#1.0077;CELL MIGRATION#1.0032;TRANSFORMING GROWTH FACTOR#1.0025;MAMMARY EPITHELIAL CELL#0.9999;LUNG CANCER#0.9918;PLASMA MEMBRANE#0.9905;SIGNALING PATHWAY#0.9900;CELL SURFACE#0.9887;STEM CELL#0.9786;GENE EXPRESSION#0.9776;MACROPHAGE#0.9688;LOW DENSITY LIPOPROTEIN#0.9667;APOPTOSIS#0.9611;CLATHRIN-MEDIATED ENDOCYTOSIS#0.9610;POLYMERASE CHAIN REACTION#0.9608;BREAST CANCER CELL#0.9600;TRANSFORMING GROWTH FACTOR BETA#0.9562;COATED PIT#0.9505;T CELL#0.9459;FIBRINOGEN#0.9447;BASEMENT MEMBRANE#0.9424;TRANSCRIPTION FACTOR#0.9382;RETINOIC ACID#0.9339;CELL ADHESION#0.9260;PLATELET ACTIVATION#0.9229;CENTRAL NERVOUS SYSTEM#0.9172;NERVOUS SYSTEM#0.9135;OVARIAN SURFACE EPITHELIAL#0.9067;SULFATIDE#0.9000;LDL RECEPTOR#0.8996;EMBRYONIC STEM CELL#0.8694;LYMPH NODE#0.8523;ENDODERM CELL#0.8516;GROWTH FACTOR RECEPTOR#0.8468;SPINAL CORD#0.8427;METHYLATION SPECIFIC PCR#0.8383;PROTEIN KINASE C#0.8262;OVARIAN SURFACE EPITHELIUM#0.8140;EPITHELIAL MESENCHYMAL TRANSITION#0.8094;FOCAL ADHESION#0.8043;SURFACE EPITHELIUM#0.8037;ADRENAL GLAND#0.8030;TUMOR CELLS#0.8013;CELL CYCLE#0.8007;INNER CELL MASS#0.7998;CLATHRIN COAT#0.7879;DENDRITIC CELL#0.7862;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7690;EPITHELIAL TO MESENCHYMAL#0.7688;MITOGEN ACTIVATED PROTEIN#0.7626;CLATHRIN-COATED PIT#0.7600;COATED VESICLE#0.7566;AIRWAY EPITHELIAL CELL#0.7560;MAPK ACTIVATION#0.7556;SULFATIDE BINDING#0.7524;PANCREATIC CANCER#0.7500;MEGAKARYOCYTE#0.7401;CLATHRIN COATED VESICLE#0.7384;CERVICAL CANCER#0.7300;5-AZA-2'-DEOXYCYTIDINE#0.7161;2'-DEOXYCYTIDINE#0.7156;OVARIAN SURFACE EPITHELIAL CELL#0.7025;ENDOSOME#0.7012;HUMAN AIRWAY EPITHELIAL#0.6912;ANGIOGENESIS#0.6897;PROXIMAL TUBULE CELL#0.6893;BONE MARROW#0.6876;ACTIN FILAMENT#0.6839;RECEPTOR MEDIATED ENDOCYTOSIS#0.6834;AUTOPHAGY#0.6833;ALDOSTERONE#0.6815;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6781;SQUAMOUS CELL CARCINOMA#0.6746;APOPTOTIC#0.6700;ADENOCARCINOMA#0.6669;CELL DIFFERENTIATION#0.6566;GLUTATHIONE#0.6462;TERMINAL WEB#0.6381;KIDNEY DISEASE#0.6332;COLORECTAL CANCER#0.6299;QUANTITATIVE REAL TIME#0.6221;CELL DEATH#0.6187;RECEPTOR BINDING#0.6091;MYOSIN VI BINDING#0.6043;VITAMIN D BINDING#0.6023
1602	BREAST CANCER#1.0611;CELL FATE DETERMINATION#1.0592;CANCER CELL#1.0320;CELL CYCLE#1.0298;CELL PROLIFERATION#1.0288;GROWTH FACTOR#1.0147;SIGNALING PATHWAY#1.0088;TRANSCRIPTION FACTOR#0.9953;TUMOR SUPPRESSOR#0.9862;GENE EXPRESSION#0.9855;LUNG CANCER#0.9553;TRANSFORMING GROWTH FACTOR#0.9462;LYMPH NODE#0.9386;SQUAMOUS CELL CARCINOMA#0.9215;HEPATOCELLULAR CARCINOMA#0.9069;STEM CELL#0.9041;APOPTOSIS#0.8794;DNA SYNTHESIS#0.8591;COLORECTAL CANCER#0.8562;LYMPH NODE METASTASIS#0.8288;LUNG ADENOCARCINOMA#0.8219;BREAST CANCER CELL#0.7827;EPITHELIAL CELL#0.7795;EPITHELIAL MESENCHYMAL TRANSITION#0.7734;DNA BINDING#0.7694;OVARIAN CANCER#0.7641;PROGENITOR CELL#0.7588;POLYMERASE CHAIN REACTION#0.7348;ADENOCARCINOMA#0.7330;EYE DEVELOPMENT#0.7119;HUMAN BREAST CANCER#0.7040;COLORECTAL#0.6921;ESTROGEN RECEPTOR#0.6920;NERVOUS SYSTEM#0.6819;CELL GROWTH#0.6646;CELLULAR GROWTH#0.6441;DNA METHYLATION#0.6425;PROSTATE CANCER#0.6401;TONGUE SQUAMOUS CELL CARCINOMA#0.6255;LIMB DEVELOPMENT#0.6233;BASAL CELL#0.6087;ENDOMETRIAL CANCER#0.6059;PANCREATIC CANCER#0.6053;CANCER STEM CELL#0.6026
160335	PRIMARY OPEN ANGLE GLAUCOMA#0.6887;OPEN ANGLE GLAUCOMA#0.6876;HEARING LOSS#0.6783
160364	MYELOID CELL#1.0747;LECTIN#1.0700;T CELL#1.0644;STEM CELL#1.0598;ACUTE MYELOID LEUKEMIA#1.0403;MYELOID LEUKEMIA#1.0392;DENDRITIC CELL#0.9829;LEUKEMIC STEM CELL#0.9783;BONE MARROW#0.9698;HEMATOPOIETIC STEM CELL#0.9683;CELL ASSOCIATED#0.8418;CHIMERIC ANTIGEN RECEPTOR#0.8390;MONOCYTE#0.8361;PROGENITOR CELL#0.8333;PERIPHERAL BLOOD#0.8296;URIC ACID#0.8269;LEUKEMIA STEM CELL#0.7560;RHEUMATOID ARTHRITIS#0.7481;GRANULOCYTE#0.7464;STEM CELL MARKER#0.7307;NEUTROPHIL#0.6730;MINIMAL RESIDUAL DISEASE#0.6574;CELL DEATH#0.6446;TUMOR CELLS#0.6405;MACROPHAGE#0.6304;URATE#0.6221;BLAST CELL#0.6178;B CELL#0.6115;CANCER STEM CELL#0.6111;CYTOTOXICITY#0.6038;CELL SURFACE#0.6029
160365	DENDRITIC CELL#1.0602;CELL ASSOCIATED#0.8353;CD4+ T CELL#0.8013;LECTIN#0.8011;B CELL#0.7976;T CELL#0.7940;MONOCYTE#0.6874
1603	CELL DEATH#1.0474;APOPTOTIC#1.0412;APOPTOSIS#1.0316;ANTHER DEHISCENCE#1.0168;PROGRAMMED CELL DEATH#0.9908;GLYCOSYLATION#0.9694;OST COMPLEX#0.9198;GENE EXPRESSION#0.9127;T CELL#0.8738;APOPTOTIC CELL DEATH#0.8712;DEHISCENCE#0.8497;ENDOPLASMIC RETICULUM#0.8210;CELL CYCLE#0.8198;OLIGOSACCHARYLTRANSFERASE COMPLEX#0.7992;TRANSCRIPTION FACTOR#0.7490;DNA FRAGMENTATION#0.6424;DAM1 COMPLEX#0.6111
160418	INHIBITORY SYNAPSE#0.7191;LISSENCEPHALY#0.7108
160428	FOLATE#0.7558;FORMYLTETRAHYDROFOLATE DEHYDROGENASE#0.7377
1604	COLORECTAL CANCER#1.0402;C1-INH#1.0388;COLORECTAL#1.0349;PERIPHERAL BLOOD CELLS#1.0338;CYTOLYSIS#1.0303;IFN-GAMMA#1.0245;LIPID RAFT#1.0226;UMBILICAL VEIN#1.0224;LUNG CANCER#1.0222;BREAST CANCER#1.0211;VIRION#1.0199;BLOOD GROUP ANTIGEN#1.0186;HUMAN UMBILICAL VEIN#1.0170;PHOSPHOLIPASE C#1.0152;RITUXIMAB#1.0140;CD8+ T CELL#1.0136;ERYTHROCYTE#1.0120;PROTEIN KINASE#1.0105;COMPLEMENT ACTIVITY#1.0095;COMPLEMENT RECEPTOR#1.0091;ANCHORING#1.0056;NEUTROPHIL#1.0054;GRANULOCYTE#1.0051;RED BLOOD CELL#1.0047;TUMOR CELLS#1.0038;COMPLEMENT CASCADE#1.0030;CANCER CELL#1.0023;MEMBRANE ATTACK COMPLEX#1.0015;T LYMPHOCYTE#1.0009;COMPLEMENT DEPENDENT CYTOTOXICITY#1.0006;CELL MEMBRANE#1.0006;LYSIS#1.0003;CELL ADHESION#0.9998;ENDOTHELIUM#0.9998;INTESTINAL EPITHELIAL CELL#0.9991;MONOCYTE#0.9980;HOST CELL#0.9979;T CELL ACTIVATION#0.9970;PROTEIN-LOSING ENTEROPATHY#0.9965;POLYMERASE CHAIN REACTION#0.9957;CELL SURFACE#0.9951;PLASMA MEMBRANE#0.9948;HEMOLYSIS#0.9934;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9932;LUPUS ERYTHEMATOSUS#0.9930;TUMOR NECROSIS FACTOR#0.9930;CELL ADHESION MOLECULE#0.9922;PERIPHERAL BLOOD#0.9919;EPITHELIAL CELL#0.9910;CELL ACTIVATION#0.9908;MONONUCLEAR CELLS#0.9905;ENDOTHELIAL CELL#0.9904;APLASTIC ANEMIA#0.9902;GROWTH FACTOR#0.9893;B LYMPHOCYTE#0.9884;LEUKOCYTE#0.9881;CYTOTOXICITY#0.9880;RECEPTOR COMPLEX#0.9877;COMPLEMENT ACTIVATION#0.9865;HEMOGLOBINURIA#0.9864;T CELL#0.9863;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.9860;FACTOR I#0.9858;MALARIA#0.9846;B CELL#0.9842;SIGNAL TRANSDUCTION#0.9840;VASCULAR ENDOTHELIUM#0.9840;ANAEMIA#0.9836;105AD7#0.9830;GENE EXPRESSION#0.9829;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9820;APOPTOSIS#0.9819;HEMATOPOIETIC CELL#0.9812;COLON CANCER#0.9809;HEMOLYTIC ANEMIA#0.9795;CD4+ T CELL#0.9777;IMMUNE RESPONSE#0.9771;RHEUMATOID ARTHRITIS#0.9749;BONE MARROW#0.9730;ANEMIA#0.9712;MACROPHAGE#0.9711;THROMBOSIS#0.9710;COAGULATION#0.9704;MEAN FLUORESCENCE INTENSITY#0.9703;FIBROBLAST LIKE SYNOVIOCYTES#0.9701;STROMA#0.9699;SIGNALING PATHWAY#0.9685;TROPHOBLAST#0.9682;RETICULOCYTE#0.9672;SUCROSE#0.9669;INFLAMMATORY RESPONSE#0.9666;EPIDERMAL GROWTH FACTOR#0.9664;BREAST CANCER CELL#0.9643;STEM CELL#0.9631;HEMATOPOIETIC STEM CELL#0.9629;DENDRITIC CELL#0.9623;GLYCOSYLATION#0.9617;CELL PROLIFERATION#0.9606;MYELODYSPLASTIC SYNDROME#0.9604;SPERMATOZOA#0.9590;AUTOIMMUNE DISEASE#0.9578;IMMUNE SYSTEM#0.9577;C3 CONVERTASE ACTIVITY#0.9571;ECULIZUMAB#0.9571;CERVICAL#0.9547;TRANSCRIPTION FACTOR#0.9541;STROMAL CELL#0.9511;CELL ASSOCIATED#0.9510;HYPOXIA#0.9501;PROTEIN KINASE C#0.9466;ENDOMETRIUM#0.9425;PROGENITOR CELL#0.9424;APOPTOTIC#0.9419;AUTOIMMUNITY#0.9411;TISSUE DAMAGE#0.9389;FLOW CYTOMETRY ANALYSIS#0.9359;CYCLOPHOSPHAMIDE#0.9334;BONE MARROW FAILURE#0.9324;CELL DEATH#0.9315;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9282;ALKALINE PHOSPHATASE#0.9278;CERVICAL CANCER#0.9244;ADENOCARCINOMA#0.9242;MYASTHENIA GRAVIS#0.9223;RECEPTOR BINDING#0.9209;ADAPTIVE IMMUNE RESPONSE#0.9201;PROGESTERONE#0.9199;PRO-INFLAMMATORY#0.9142;PROTEIN SYNTHESIS#0.9119;LECTIN#0.9112;NITRIC OXIDE#0.9085;REVERSE TRANSCRIPTION#0.9082;HUMAN INTESTINAL EPITHELIAL#0.9077;OVARIAN#0.9076;PHAGOCYTOSIS#0.9057;LYMPHOCYTIC LEUKEMIA#0.9040;EXTRACELLULAR MATRIX#0.9036;ISCHEMIA#0.8995;MELANOMA CELL LINES#0.8994;CYCLOSPORINE#0.8981;LYMPH NODE#0.8980;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8976;SQUAMOUS CELL CARCINOMA#0.8955;ASTROCYTE#0.8900;GROWTH HORMONE#0.8823;PERIPHERAL BLOOD LYMPHOCYTES#0.8814;CELL BOUND#0.8811;NATURAL KILLER CELL#0.8780;WHITE BLOOD CELL#0.8777;MITOGEN ACTIVATED PROTEIN#0.8760;CYTOPENIA#0.8756;OPSONIZATION#0.8737;CELL CYCLE#0.8732;ELASTIC FIBER#0.8703;TOLL LIKE RECEPTOR#0.8677;ACROSOME#0.8668;BRUSH BORDER#0.8649;PROSTATE CANCER#0.8645;PLASMA CELL#0.8611;THROMBOCYTOPENIA#0.8557;SKELETAL MUSCLE#0.8541;DIGESTION#0.8537;AGE RELATED MACULAR DEGENERATION#0.8517;MACULAR DEGENERATION#0.8513;MYOCARDITIS#0.8491;SMOOTH MUSCLE#0.8478;REGULATION OF COMPLEMENT ACTIVATION#0.8474;COMPLEMENT FACTOR H#0.8456;ATORVASTATIN#0.8454;GROWTH FACTOR RECEPTOR#0.8416;ULCERATIVE COLITIS#0.8401;ERYTHROCYTE MEMBRANES#0.8397;T CELL PROLIFERATION#0.8394;CYCLOSPORIN A#0.8381;FIMBRIAE#0.8365;INNATE IMMUNITY#0.8332;ACROSOMAL MEMBRANE#0.8317;NERVOUS SYSTEM#0.8284;TRANSCRIPTASE#0.8275;MAST CELL#0.8257;HEPATITIS C#0.8243;MULTIPLE SCLEROSIS#0.8215;NEPHRITIS#0.8205;RHABDOMYOSARCOMA#0.8110;HODGKIN'S LYMPHOMA#0.8109;PROTEIN TYROSINE KINASE#0.8108;ISCHEMIA REPERFUSION INJURY#0.8087;VIRAL INFECTION#0.8078;KIDNEY DISEASE#0.8062;COLITIS#0.8048;SYNOVIUM#0.8046;IMMUNE CELL#0.8030;CELL DIFFERENTIATION#0.8025;ENDOTHELIAL GROWTH FACTOR#0.8022;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8022;CYCLOSPORIN#0.8017;TRANSMEMBRANE RECEPTOR#0.7978;CELL KILLING#0.7965;GASTRIC EPITHELIAL CELLS#0.7964;TRASTUZUMAB#0.7915;BLOOD VESSEL#0.7908;LYMPHOID CELL#0.7905;CENTRAL NERVOUS SYSTEM#0.7854;MYELOID CELL#0.7817;MESANGIAL CELL#0.7817;SELECTIN#0.7800;VASCULAR CELL#0.7793;MECHANISM OF ACTION#0.7778;MEMBRANE ATTACK COMPLEX FORMATION#0.7777;PANCYTOPENIA#0.7775;NEURONAL CELLS#0.7753;HEPATITIS C VIRUS#0.7733;VIRULENCE#0.7723;TUMOUR NECROSIS FACTOR#0.7714;TRANSFORMING GROWTH FACTOR#0.7709;INHIBITION OF COMPLEMENT ACTIVATION#0.7689;INFLAMMATORY CELL#0.7617;FLUORESCEIN#0.7610;PHOSPHOLIPASE D#0.7601;PERIPHERAL BLOOD LEUKOCYTE#0.7599;VIRAL RECEPTOR#0.7548;INNATE IMMUNE RESPONSE#0.7525;BIOTIN#0.7513;EDEMA#0.7511;EXTRACELLULAR REGION#0.7510;MANNOSE BINDING#0.7508;PANCREATIC ISLET#0.7502;PROXIMAL TUBULAR EPITHELIAL#0.7488;CAVEOLAE#0.7486;UVEAL MELANOMA#0.7479;LUMINAL#0.7445;BETA CELL#0.7441;ACETYLCHOLINE RECEPTOR#0.7438;PROTEINURIA#0.7436;LACRIMAL GLAND#0.7426;INTESTINAL MUCOSA#0.7403;ACTIVATED T CELL#0.7400;MESOTHELIAL CELL#0.7382;INNATE IMMUNE SYSTEM#0.7372;HEME OXYGENASE 1#0.7370;BREAST CARCINOMA#0.7360;HOST CELL SURFACE#0.7357;MICROVESICLE#0.7348;OXYGENASE#0.7345;HUMAN IMMUNODEFICIENCY VIRUS#0.7339;MANNOSE BINDING LECTIN#0.7308;ATHEROSCLEROSIS#0.7249;ACUTE LEUKEMIA#0.7236;CELLULAR MEMBRANE#0.7214;HEMOLYTIC UREMIC SYNDROME#0.7202;TRANSCRIPTIONAL CONTROL#0.7193;BASEMENT MEMBRANE#0.7191;ENDOCYTOSIS#0.7176;PHOSPHATIDYLSERINE#0.7167;EPSTEIN BARR VIRUS#0.7163;ARTERY#0.7145;VASCULAR ENDOTHELIAL CELL#0.7143;MEMBRANE RAFT#0.7142;GLOMERULONEPHRITIS#0.7103;MECHANISMS OF ACTION#0.7079;MYCOPHENOLATE SODIUM#0.7070;INNER ACROSOMAL MEMBRANE#0.7061;COLONY-STIMULATING FACTOR#0.7053;VACUOLE#0.7047;MUSCLE CELL#0.7043;TUBULAR EPITHELIAL CELL#0.7040;HEMORRHAGIC#0.7018;SIGNAL PEPTIDE#0.7016;THYMOCYTE#0.7016;POLYMORPHONUCLEAR LEUKOCYTES#0.7004;TIGHT JUNCTION#0.7002;HEMORRHAGE#0.7001;SURFACE PLASMON RESONANCE#0.7000;TERMINAL COMPLEMENT COMPLEX#0.6999;FIBRINOGEN#0.6997;CELL DEVELOPMENT#0.6996;PODOCYTE#0.6979;STEM CELL TRANSPLANTATION#0.6975;OSTEOARTHRITIS#0.6950;COLORECTAL CARCINOMA#0.6926;SMALL AIRWAY EPITHELIAL#0.6897;COMPLEMENT RECEPTOR 3#0.6896;ANGIOGENESIS#0.6882;DETERGENT RESISTANT MEMBRANE#0.6851;TOXICITY#0.6850;BONE MARROW CELLS#0.6812;HYPOXIC#0.6812;ENDOTHELIAL CELL ACTIVATION#0.6804;EXOSOME#0.6800;HEPARIN#0.6796;GLIAL CELL#0.6792;MICROTUBULE#0.6785;MEASLES#0.6775;RENAL ISCHEMIA REPERFUSION#0.6760;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6758;MAC FORMATION#0.6754;LASER CAPTURE MICRODISSECTION#0.6744;SYNCYTIOTROPHOBLAST#0.6704;DERMATITIS#0.6700;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6699;AIRWAY EPITHELIAL CELL#0.6696;ETHANOLAMINE#0.6679;MYOCARDIAL INFARCTION#0.6678;C REACTIVE PROTEIN#0.6662;RNA INTERFERENCE#0.6650;TUMOR TISSUES#0.6642;SPINAL CORD#0.6629;OOCYTE#0.6622;TROPISM#0.6571;VIRAL CAPSID#0.6543;ANTITHYMOCYTE GLOBULIN#0.6540;COMPLEX I#0.6536;SMOOTH MUSCLE CELL#0.6517;HUMAN LEUKOCYTE ANTIGEN#0.6447;ANTIGEN PRESENTING CELLS#0.6415;CYTOKINE PRODUCTION#0.6406;KERATINOCYTE#0.6393;ENDOPLASMIC RETICULUM#0.6385;GASTRIC EPITHELIUM#0.6316;LPS RECEPTOR COMPLEX#0.6308;GLOMERULUS#0.6306;ENDOSOME#0.6305;CHONDROCYTE#0.6290;VESICULAR STOMATITIS VIRUS#0.6281;ACETYLCHOLINE#0.6280;CHLORAMPHENICOL#0.6278;FOLLICULAR LYMPHOMA#0.6270;COMPLEMENT BINDING#0.6238;VIRAL ENVELOPE#0.6209;UTERUS#0.6203;ACTINOMYCIN D#0.6201;CHRONIC KIDNEY DISEASE#0.6196;CMC-544#0.6180;PHOSPHATASE ACTIVITY#0.6180;URINARY TRACT INFECTION#0.6150;MUTAGENESIS#0.6131;INFLAMMATORY BOWEL DISEASE#0.6125;NEPHROTOXIC#0.6125;GM-CSF#0.6118;AGGLUTINATION#0.6117;ATYPICAL HEMOLYTIC-UREMIC SYNDROME#0.6111;ISLETS OF LANGERHANS#0.6063;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.6047;ANTIBODY MEDIATED REJECTION#0.6045
1605	ALPHA-DYSTROGLYCAN BINDING#1.1559;DYSTROGLYCAN BINDING#1.0916;BETA-DYSTROGLYCAN BINDING#1.0839;SEED GERMINATION#1.0603;SCHWANN CELL#1.0523;LAMININ BINDING#1.0446;DYSTROGLYCAN COMPLEX#1.0429;HEPARIN#1.0369;SARCOGLYCAN COMPLEX#1.0355;PERIPHERAL NERVE#1.0318;MANNOSYLATION#1.0299;SPECTRIN#1.0286;BASAL LAMINA#1.0269;CELL MEMBRANE#1.0263;GLYCOSYLATION#1.0201;LYMPHOCYTIC CHORIOMENINGITIS#1.0136;CARDIAC MUSCLE#1.0095;WALKER-WARBURG SYNDROME#1.0090;CELL SURFACE#1.0081;CONGENITAL MUSCULAR DYSTROPHIES#1.0074;PLASMA MEMBRANE#1.0046;ACETYLCHOLINE RECEPTOR#1.0019;SARCOLEMMA#1.0018;DYSTROPHIN GLYCOPROTEIN COMPLEX#0.9989;GERMINATION#0.9972;MYOTUBE#0.9970;ACETYLCHOLINE#0.9955;GLYCOPROTEIN COMPLEX#0.9950;BASEMENT MEMBRANE#0.9949;TRANSCRIPTION FACTOR#0.9936;CENTRAL NERVOUS SYSTEM#0.9931;EXTRACELLULAR MATRIX#0.9904;MUSCLE FIBER#0.9901;LIMB-GIRDLE MUSCULAR DYSTROPHY#0.9889;MUSCLE CELL#0.9874;NEUROMUSCULAR JUNCTION#0.9872;NITRIC OXIDE#0.9869;SKELETAL MUSCLE#0.9865;CONGENITAL MUSCULAR DYSTROPHY#0.9852;NERVOUS SYSTEM#0.9831;BRAIN DISEASE#0.9812;NITRIC OXIDE SYNTHASE#0.9805;CREATINE KINASE#0.9794;PROTEIN COMPLEX#0.9789;NEURONAL MIGRATION#0.9779;COMPLEX I#0.9769;O GLYCAN#0.9768;DUCHENNE MUSCULAR DYSTROPHY#0.9747;DYSTROPHIN-ASSOCIATED GLYCOPROTEIN COMPLEX#0.9743;MUSCULAR DYSTROPHY#0.9741;BECKER MUSCULAR DYSTROPHY#0.9726;EPITHELIAL CELL#0.9702;FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY#0.9679;POSTTRANSLATIONAL MODIFICATION#0.9659;ACTIN CYTOSKELETON#0.9614;MENTAL RETARDATION#0.9614;CELL ADHESION#0.9572;REGENERATION#0.9546;CREATINE#0.9534;MUSCLE WEAKNESS#0.9532;LASSA FEVER#0.9485;MYOPATHY#0.9413;BLOOD VESSEL#0.9286;FOCAL ADHESION#0.9037;RECEPTOR CLUSTERING#0.9002;LAMININ RECEPTOR#0.8983;CYTOPLASM#0.8956;GLIAL CELL#0.8934;C TERMINAL DOMAIN#0.8928;SMOOTH MUSCLE#0.8883;SCIATIC NERVE#0.8858;ANCHORING#0.8810;MYOBLAST#0.8733;MUSCLE FIBRE#0.8716;CARDIOMYOPATHY#0.8703;STRIATED MUSCLE#0.8694;ASTROCYTE#0.8681;PROTEOGLYCAN#0.8642;LECTIN#0.8575;DIAPHRAGM#0.8366;DILATED CARDIOMYOPATHY#0.8216;GROWTH FACTOR#0.8206;MYELIN SHEATH#0.8199;LISSENCEPHALY#0.8185;SIGNAL TRANSDUCTION#0.8148;POST-TRANSLATIONAL MODIFICATION#0.8114;SULFATIDE#0.8082;PODOCYTE#0.8028;MYOSIN HEAVY CHAIN#0.7976;PERIPHERAL MEMBRANE PROTEIN#0.7934;APOPTOSIS#0.7812;CAVEOLAE#0.7807;CELL ADHESION MOLECULE#0.7786;MUTAGENESIS#0.7766;AQUAPORIN#0.7581;CONGENITAL DISORDER#0.7567;PROTEIN KINASE#0.7550;MITOGEN ACTIVATED PROTEIN#0.7368;POSTSYNAPTIC MEMBRANE#0.7242;GENE EXPRESSION#0.7193;MANNOSYLTRANSFERASE ACTIVITY#0.7130;PROTEIN GLYCOSYLATION#0.7128;NEUROMUSCULAR DISEASE#0.7111;CANCER CELL#0.7065;COSTAMERE#0.6967;AUTOSOMAL RECESSIVE LIMB-GIRDLE MUSCULAR DYSTROPHY#0.6965;INCLUSION BODY#0.6955;CARDIOMYOCYTE#0.6934;GLCNAC#0.6910;OUTER MEMBRANE#0.6879;ENDOTHELIAL CELL#0.6820;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY#0.6777;POSTSYNAPTIC SPECIALIZATION#0.6744;MAGNETIC RESONANCE IMAGING#0.6739;CELL PROLIFERATION#0.6697;GOLGI APPARATUS#0.6626;T CELL#0.6527;TRANSFERRIN RECEPTOR#0.6486;CEREBRAL CORTEX#0.6460;CELL MIGRATION#0.6435;SPINAL CORD#0.6434;MYOCYTES#0.6430;POLYMERASE CHAIN REACTION#0.6407;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6324;ENDOPLASMIC RETICULUM#0.6260;SKELETAL MUSCLE CELLS#0.6239;MUSCLE CONTRACTION#0.6212;PERIPHERAL NERVOUS SYSTEM#0.6167;SYNAPTOGENESIS#0.6146;CERVICAL#0.6079
160622	NUCLEOTIDE EXCHANGE FACTOR#0.9788;GLUTAMATE RECEPTOR#0.9717;SPINAL CORD#0.8656;GOLGI STACK#0.8587;METABOTROPIC GLUTAMATE RECEPTORS#0.8586;GUANINE#0.8490;CEREBRAL PALSY#0.8307;GOLGI MEMBRANE#0.8206;MITRAL VALVE#0.8167;SPINAL CORD INJURY#0.7894;PLASMA MEMBRANE#0.7853;PROTEIN COMPLEX#0.7757;PDZ BINDING MOTIF#0.7657;CELL SURFACE#0.7593;RETINOIC ACID#0.7404;GENE EXPRESSION#0.7337;GOLGI CISTERNAE#0.7187;PRIMARY MOTOR CORTEX#0.7126;HEPARIN BINDING#0.6762;NERVOUS SYSTEM#0.6752;GOLGI RIBBON#0.6656;FORELIMB#0.6360;POSTSYNAPTIC DENSITY#0.6353;FRONTAL#0.6148;REGIONS OF INTEREST#0.6002
1606	DIACYLGLYCEROL KINASE#1.0540;T CELL#1.0512;PLASMA MEMBRANE#1.0251;GROWTH FACTOR#0.9952;PROTEIN KINASE#0.9594;CELL ACTIVATION#0.9349;T LYMPHOCYTE#0.9330;T CELL ACTIVATION#0.9036;PROTEIN KINASE C#0.8737;SIGNALING PATHWAY#0.8424;D-ALPHA-TOCOPHEROL#0.8395;ACTIVATION-INDUCED CELL DEATH#0.7962;ALPHA-TOCOPHEROL#0.7840;DGK ACTIVITY#0.7581;CELL DEATH#0.7429;GENE EXPRESSION#0.7085;KINASE ACTIVITY#0.6893;LIPID KINASE#0.6488;APOPTOSIS#0.6377;MEMBRANE RUFFLING#0.6333;CYTOPLASM#0.6261;HEPATOCYTE GROWTH FACTOR#0.6138;NF-KAPPAB ACTIVATION#0.6094;CELL MIGRATION#0.6080;EPITHELIAL CELL#0.6003
160728	TUMOR SUPPRESSOR#1.0686;COLON CANCER#1.0660;CANCER CELL#1.0421;EPITHELIAL CELL#1.0210;OOCYTE#1.0167;DNA METHYLATION#0.9965;PYRUVATE#0.9683;HISTONE DEACETYLASE#0.9668;COLORECTAL CANCER#0.9449;GENE EXPRESSION#0.9318;BRUSH BORDER#0.9007;FERMENTATION#0.8980;INTESTINAL TRACT#0.8887;IBUPROFEN#0.8876;COLORECTAL#0.8817;APOPTOSIS#0.8668;PLASMA MEMBRANE#0.8546;TUMOR TISSUES#0.8543;URATE#0.8511;THYROID CARCINOMA#0.8135;METHYLATION SPECIFIC PCR#0.8028;TRANSCRIPTION FACTOR#0.7922;SIGNALING PATHWAY#0.7892;LUMINAL#0.7815;PANCREATIC CANCER#0.7621;PAPILLARY THYROID CARCINOMA#0.7480;PROSTATE CANCER#0.7367;COLON MUCOSA#0.7150;TUMOR CELLS#0.7146;THYROID GLAND#0.7126;SMALL INTESTINE#0.7084;CELL CYCLE#0.7033;THYROID CANCER#0.6864;BREAST CANCER#0.6606;COLONIC EPITHELIAL CELLS#0.6469;COLON ADENOMA#0.6307;POLYMERASE CHAIN REACTION#0.6246;HISTONE DEACETYLATION#0.6183;CELL DEATH#0.6031;CELL PROLIFERATION#0.6025;GENE SILENCING#0.6002
160762	DYNEIN#0.7016;ADENYLATE KINASE#0.6452;OUTER DYNEIN ARM#0.6102
1607	DGK ACTIVITY#1.1257;T CELL#1.0657;SIGNAL TRANSDUCTION#1.0237;DIACYLGLYCEROL KINASE#1.0223;PLASMA MEMBRANE#1.0033;PROTEIN KINASE#0.9668;PROTEIN KINASE C#0.9560;INSULIN SECRETION#0.8606;CYTOPLASM#0.8538;SKELETAL MUSCLE#0.8508;SIGNALING PATHWAY#0.8489;PHOSPHOLIPASE C#0.8294;DENDRITIC SPINE#0.8233;GROWTH FACTOR#0.8118;TYPE 2 DIABETES#0.8118;CELL CYCLE#0.8088;CELL DEVELOPMENT#0.7743;GENE EXPRESSION#0.7701;SIGNALING MOLECULE#0.7619;CELL PROLIFERATION#0.7548;ATP BINDING#0.7383;KINASE ACTIVITY#0.7361;STRIATUM#0.7324;LIPID KINASE#0.7291;LIPID METABOLISM#0.7183;MEDIUM SPINY NEURONS#0.7043;MYOBLAST#0.6965;SPHINGOSINE#0.6423;NEUTROPHIL#0.6352;IMMUNE RESPONSE#0.6276;AMPA RECEPTOR#0.6123;SIGNALING CASCADE#0.6016
160851	DIACYLGLYCEROL KINASE#1.1305;BIPOLAR DISORDER#1.1158;MANNOSE METABOLISM#0.6903;GALACTOSE METABOLISM#0.6262
160857	LEPROSY#0.7600
1608	DIACYLGLYCEROL KINASE#1.1030;PLASMA MEMBRANE#0.9368;GROWTH FACTOR#0.8349;PROTEIN KINASE#0.7576;CYTOPLASM#0.7417;LAMELLIPODIUM FORMATION#0.6407;PROTEIN KINASE C#0.6341;EPIDERMAL GROWTH FACTOR#0.6328
1609	DIACYLGLYCEROL KINASE#1.0949;DGK ACTIVITY#0.8823;PARKINSON'S DISEASE#0.6358;NUCLEAR SPECKLE#0.6043
160	PROTEIN COMPLEX#0.8993;HUMAN IMMUNODEFICIENCY VIRUS#0.8208;ENDOCYTOSIS#0.6948;ADAPTIN#0.6492;CLATHRIN COATED VESICLE#0.6456;COATED VESICLE#0.6411
161003	ERYTHROCYTE#0.8839
1610	D-CYSTEINE#1.1013;D-SERINE METABOLISM#1.0817;D ASPARTATE OXIDASE#1.0759;D-SERINE DEGRADATION#1.0598;CEPHALOSPORIN C#1.0561;URATE OXIDASE#1.0533;URATE#1.0416;SERINE RACEMASE#1.0388;FLAVIN ADENINE DINUCLEOTIDE#1.0374;D-SERINE#1.0317;D-PROLINE#1.0296;D-LEUCINE#1.0284;D-ALANINE#1.0261;ADENINE#1.0188;PEROXISOMAL#1.0176;ALANINE#1.0121;SPINAL CORD#1.0120;ACYL COA OXIDASE#1.0118;ASTROCYTE#1.0108;ARGININE#1.0091;GLUTAMATE RECEPTOR#1.0054;FLAVIN#1.0046;RIBOFLAVIN BINDING#1.0043;L-SERINE#1.0032;MUTAGENESIS#1.0032;AMYOTROPHIC LATERAL SCLEROSIS#1.0017;NMDA RECEPTOR#1.0013;GLYCINE#1.0009;LATERAL SCLEROSIS#1.0004;D-TRYPTOPHAN#0.9990;BIPOLAR DISORDER#0.9981;DIAMINE OXIDASE#0.9980;CATALYTIC ACTIVITY#0.9974;GENE EXPRESSION#0.9971;XANTHINE OXIDASE#0.9949;NERVOUS SYSTEM#0.9944;PEROXISOME#0.9938;LEUCINE#0.9931;FAD BINDING#0.9927;PYRUVATE#0.9904;REACTIVE OXYGEN SPECIES#0.9904;CENTRAL NERVOUS SYSTEM#0.9899;ASPARTATE#0.9898;NEUROTRANSMISSION#0.9891;VALINE#0.9877;ENZYME ACTIVITY#0.9865;METHIONINE#0.9860;D-METHIONINE#0.9825;ASPARTIC ACID#0.9811;TRYPTOPHAN#0.9801;DOPAMINE#0.9757;XANTHINE#0.9719;D-ASPARTIC ACID#0.9705;CATALASE ACTIVITY#0.9694;D-ARGININE#0.9635;LYSINE#0.9617;L-ALANINE#0.9611;EPITHELIAL CELL#0.9586;POLYMERASE CHAIN REACTION#0.9521;HISTIDINE#0.9495;L-DOPA#0.9438;FORMALIN#0.9414;L-PHENYLALANINE#0.9317;CATABOLISM#0.9266;D-PHENYLALANINE#0.9134;GLIAL CELL#0.9101;CELL DEATH#0.9097;3 MERCAPTOPYRUVATE SULFURTRANSFERASE#0.8997;MITOCHONDRIA#0.8994;APOPTOSIS#0.8983;L-CYSTEINE#0.8927;ORGANELLE#0.8901;GLUTATHIONE#0.8879;TOXICITY#0.8851;ELECTRON TRANSFER#0.8847;SARCOSINE OXIDASE#0.8822;D-LYSINE#0.8778;MECHANISM OF ACTION#0.8766;FOREBRAIN#0.8761;ALKALINE PHOSPHATASE#0.8741;GLUCOSE 6 PHOSPHATASE#0.8678;RECEPTOR ANTAGONIST#0.8657;L-PROLINE#0.8609;LONG TERM POTENTIATION#0.8524;CYTOTOXICITY#0.8308;GLUTAMATE DEHYDROGENASE#0.8132;PALMITOYL#0.8122;PALMITOYL COA OXIDASE#0.8011;FERMENTATION#0.7967;URATE OXIDASE ACTIVITY#0.7956;ACID PHOSPHATASE#0.7944;D-SERINE SYNTHESIS#0.7938;GUANIDINE HYDROCHLORIDE#0.7922;GLYCOLATE OXIDASE#0.7876;SUPEROXIDE DISMUTASE#0.7792;CHLORPROMAZINE#0.7708;MOLECULAR DYNAMICS SIMULATION#0.7676;L-GLUTAMATE#0.7653;FLAVODOXIN#0.7363;COMPLEX I#0.7319;FRONTAL#0.7314;ALZHEIMER'S DISEASE#0.7291;BENZOIC ACID#0.7267;ISCHEMIA#0.7263;L-VALINE#0.7263;SYNAPTIC TRANSMISSION#0.7245;GLUTAMINE#0.7203;SIGNALING PATHWAY#0.7159;SMALL INTESTINE#0.7150;REVERSE TRANSCRIPTION#0.7137;PEROXISOMAL MEMBRANE#0.7116;SUCCINATE DEHYDROGENASE#0.7072;TUMOR CELLS#0.6942;NEUTROPHIL#0.6933;STRUCTURE ACTIVITY RELATIONSHIP#0.6927;CYSTEAMINE#0.6854;SUCROSE#0.6845;GUANIDINE#0.6811;D-ASPARTATE OXIDASE ACTIVITY#0.6796;ASPARTATE OXIDASE ACTIVITY#0.6773;COGNITION#0.6767;LINES OF EVIDENCE#0.6746;CELL WALL#0.6732;DIGESTION#0.6702;D-CYCLOSERINE#0.6697;PYRIDOXAL 5-PHOSPHATE#0.6642;PYRUVIC ACID#0.6635;NERVOUS TISSUE#0.6521;HISTAMINE#0.6466;CYTOCHROME C#0.6424;L-LEUCINE#0.6360;CYCLOSERINE#0.6352;SUCCINATE#0.6283;CLOFIBRATE#0.6261;CLOZAPINE#0.6247;ENDOPLASMIC RETICULUM#0.6230;NITRIC OXIDE#0.6213;BINDING PROTEIN 1#0.6205;PEROXISOMAL MATRIX#0.6203;STRIATUM#0.6187;CELL SURFACE#0.6170;MOLAR#0.6165;URIC ACID#0.6157;L-NNA#0.6122;LEUKOCYTE#0.6113;CARNITINE#0.6092;CANCER CELL#0.6082;GLUTAMATE DECARBOXYLASE#0.6067;AUTOPHAGY#0.6049;PREPULSE INHIBITION#0.6046;PYRIDOXAL#0.6038;BONE CANCER#0.6000
161142	SPERM MOTILITY#0.9186;SPERMATOZOA#0.6535
161176	NUCLEAR ENVELOPE#1.0469;INTERMEDIATE FILAMENT#0.9919;NUCLEAR MEMBRANE#0.8067;ENDOTHELIAL CELL#0.7992;NUCLEOSKELETON#0.6574;OUTER NUCLEAR MEMBRANE#0.6501;MUSCLE CELL#0.6337;CENTROSOME#0.6235
161198	ENDOTHELIAL CELL#1.0834;ANGIOGENESIS#1.0534;LECTIN#1.0455;MRNA CAPPING#1.0127;MRNA GUANYLYLTRANSFERASE#1.0082;SPROUTING ANGIOGENESIS#0.8230;TUBE FORMATION#0.7744;CELL MIGRATION#0.6997;TRIPHOSPHATASE ACTIVITY#0.6429;CELL GROWTH#0.6075
1611	RETINOIC ACID RECEPTOR#1.0645;RETINOIC ACID#1.0588;DNA METHYLTRANSFERASE#1.0537;PROTEIN KINASE#1.0397;AUTOPHAGY#1.0252;PROGRAMMED CELL DEATH#1.0237;LUNG CANCER#1.0197;METHYLATION SPECIFIC POLYMERASE#1.0123;APOPTOSIS#1.0114;CELL DEATH#1.0061;SIGNALING PATHWAY#1.0048;SQUAMOUS CELL CARCINOMA#1.0021;METHYLATION SPECIFIC PCR#0.9997;TUMOR SUPPRESSOR#0.9980;APOPTOTIC#0.9979;B CELL#0.9904;GLUTATHIONE#0.9897;POLYMERASE CHAIN REACTION#0.9881;ADENOMATOUS POLYPOSIS COLI#0.9863;TUMOR NECROSIS FACTOR#0.9830;CANCER CELL#0.9815;GENE EXPRESSION#0.9711;BREAST CANCER#0.9643;DNA REPAIR#0.9607;CERVICAL#0.9566;ADENOCARCINOMA#0.9565;GROWTH FACTOR#0.9323;T CELL#0.9175;KINASE ACTIVITY#0.9158;CELL CYCLE#0.9130;DNA METHYLATION#0.9110;SIGNAL TRANSDUCTION#0.9078;CELL ADHESION#0.9067;ENDOMETRIAL ADENOCARCINOMA#0.9007;CELL PROLIFERATION#0.8898;MULTIPLE MYELOMA#0.8845;CATALYTIC ACTIVITY#0.8843;TUMOR CELLS#0.8599;EPITHELIAL CELL#0.8400;B CELL LYMPHOMA#0.8365;LYMPH NODE#0.8359;5-AZA-2'-DEOXYCYTIDINE#0.8348;2'-DEOXYCYTIDINE#0.8343;APOPTOTIC CELL DEATH#0.8300;TRANSCRIPTION FACTOR#0.8232;CELL GROWTH#0.8173;CERVICAL CANCER#0.8170;ISCHEMIA#0.7915;MEMBRANE BLEBBING#0.7795;ZIPPER INTERACTING PROTEIN#0.7686;CYTOPLASM#0.7650;ALZHEIMER'S DISEASE#0.7478;AUTOPHAGIC CELL DEATH#0.7422;COLORECTAL#0.7415;REVERSE TRANSCRIPTION#0.7404;OVARIAN#0.7349;ACUTE LEUKEMIA#0.7301;HUMAN BREAST CANCER#0.7281;BLEBBING#0.7204;MYELOID LEUKEMIA#0.7081;GENE SILENCING#0.7067;COLORECTAL CANCER#0.7026;NERVOUS SYSTEM#0.7006;IFN-GAMMA#0.6962;ACUTE MYELOID LEUKEMIA#0.6905;PERIPHERAL BLOOD#0.6861;NEURONAL CELL DEATH#0.6836;DEPHOSPHORYLATION#0.6792;INTERFERON REGULATORY FACTOR#0.6778;CYCLIN DEPENDENT KINASE#0.6747;CPG ISLAND METHYLATION#0.6648;CYTOCHROME C#0.6615;PROTEIN KINASE A#0.6508;OVARIAN CARCINOMA#0.6336;MITOCHONDRIAL MEMBRANE#0.6318;UBIQUITIN#0.6109;5 FLUOROURACIL#0.6076;CEREBRAL ISCHEMIA#0.6009;SQUAMOUS CELL CANCER#0.6006
161247	LIPID DROPLET#0.8976;TRANSCRIPTION FACTOR#0.7704
161253	GTP BINDING#1.0514;CALCIUM CHANNEL#1.0389;CHANNEL ACTIVITY#0.9490;NERVOUS SYSTEM#0.8447;N-TYPE CALCIUM CHANNEL#0.8198;EXCITATORY SYNAPSE#0.8004;SYNAPSE DEVELOPMENT#0.7923;PLASMA MEMBRANE#0.7866;CAMKII#0.7551;CALCIUM CHANNEL ACTIVITY#0.7212;CELL SURFACE#0.6956;CELL PROLIFERATION#0.6940;GENE EXPRESSION#0.6717
1612	RETINOIC ACID RECEPTOR#1.0531;RETINOIC ACID#1.0445;PROTEIN KINASE#1.0345;AUTOPHAGY#1.0332;CATALYTIC ACTIVITY#1.0323;METHYLATION SPECIFIC POLYMERASE#1.0318;CERVICAL CANCER#1.0318;CERVICAL#1.0296;COLORECTAL CANCER#1.0254;NMDA RECEPTOR#1.0251;ALZHEIMER'S DISEASE#1.0241;DNA METHYLTRANSFERASE#1.0241;CELL DEATH#1.0167;MEMBRANE BLEBBING#1.0125;TRANSCRIPTION FACTOR#1.0121;COLORECTAL#1.0108;LYMPH NODE#1.0094;KINASE ACTIVITY#1.0093;POLYMERASE CHAIN REACTION#1.0089;B CELL LYMPHOMA#1.0087;B CELL#1.0067;METHYLATION SPECIFIC PCR#1.0051;BREAST CANCER#1.0049;APOPTOTIC#1.0038;APOPTOSIS#1.0027;SIGNALING PATHWAY#1.0018;ADENOCARCINOMA#1.0015;PERIPHERAL BLOOD#1.0014;DNA REPAIR#1.0005;QUANTITATIVE METHYLATION SPECIFIC#1.0000;CELL CYCLE#0.9987;LUNG CANCER#0.9967;CANCER CELL#0.9953;CPG ISLAND METHYLATION#0.9934;TUMOR SUPPRESSOR#0.9925;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9915;LYMPHOCYTIC LEUKEMIA#0.9896;SQUAMOUS CELL CARCINOMA#0.9865;BONE MARROW#0.9815;GENE EXPRESSION#0.9778;RENAL CELL CARCINOMA#0.9761;DNA METHYLATION#0.9735;DEMETHYLATION#0.9711;DNA HYPERMETHYLATION#0.9695;DIFFUSE LARGE B-CELL LYMPHOMA#0.9587;BLEBBING#0.9581;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9580;GROWTH FACTOR#0.9576;GENE SILENCING#0.9570;OVARIAN#0.9555;SIGNAL TRANSDUCTION#0.9524;TUMOR NECROSIS FACTOR#0.9516;KINASE INHIBITOR#0.9487;TUMOR TISSUES#0.9451;TUMOR CELLS#0.9442;LYMPH NODE METASTASIS#0.9442;PROGRAMMED CELL DEATH#0.9409;CELL PROLIFERATION#0.9331;OVARIAN CANCER#0.9290;CELL GROWTH#0.9287;5-AZA-2'-DEOXYCYTIDINE#0.9266;2'-DEOXYCYTIDINE#0.9262;DEPHOSPHORYLATION#0.9192;EPITHELIAL CELL#0.9188;NEURONAL CELL DEATH#0.9181;CYCLIN DEPENDENT KINASE#0.9078;MYELOID LEUKEMIA#0.9068;CYCLIN DEPENDENT KINASE INHIBITOR#0.9066;STEM CELL#0.8909;PROTEIN PROTEIN INTERACTION#0.8848;QUANTITATIVE REAL TIME#0.8811;MYELODYSPLASTIC SYNDROME#0.8787;IMMUNE RESPONSE#0.8786;GLUTATHIONE#0.8722;ISCHEMIA#0.8710;AUTOPHAGIC CELL DEATH#0.8637;CELL ADHESION#0.8621;CELL CYCLE CONTROL#0.8560;REVERSE TRANSCRIPTION#0.8478;COLON CANCER#0.8376;NEURODEGENERATIVE DISEASE#0.8312;TRANSITIONAL CELL CARCINOMA#0.8301;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.8271;HIGH RESOLUTION MELTING#0.8208;PROSTATE CANCER#0.8157;DISEASE FREE SURVIVAL#0.8101;ENDOPLASMIC RETICULUM#0.8073;REGULATION OF AUTOPHAGY#0.8068;SPUTUM#0.8060;ANOIKIS#0.8039;PARKINSON'S DISEASE#0.7973;PROTEASOME#0.7932;ADENOMATOUS POLYPOSIS COLI#0.7916;UBIQUITIN#0.7909;ORAL SQUAMOUS CELL CARCINOMA#0.7806;NERVOUS SYSTEM#0.7802;THYROID CANCER#0.7794;MULTIPLE MYELOMA#0.7779;HEAD AND NECK CANCER#0.7777;NECK CANCER#0.7777;HISTONE DEACETYLASE#0.7762;MICROTUBULE#0.7733;ALLELE SPECIFIC EXPRESSION#0.7729;GASTRIC MUCOSA#0.7722;ACUTE MYELOID LEUKEMIA#0.7668;CHOLANGIOCARCINOMA#0.7558;T CELL#0.7479;PROTEIN COMPLEX#0.7435;AUTOPHAGOSOME#0.7434;CERVIX#0.7376;FOLLICULAR LYMPHOMA#0.7312;LEUCINE RICH REPEAT#0.7257;SIGNALING CASCADE#0.7209;MITOCHONDRIA#0.7122;PROTEIN PHOSPHATASE 2A#0.7117;PHOSPHATASE 2A#0.7113;GTP BINDING#0.7087;PROTEIN KINASE D#0.7034;GASTRIC ADENOCARCINOMA#0.6932;PANCREATIC CANCER#0.6855;CAMKII#0.6849;CISPLATIN#0.6845;BREAST CANCER PATIENTS#0.6775;CLEAR CELL RENAL CELL CARCINOMA#0.6745;TIME TO PROGRESSION#0.6737;MITOGEN ACTIVATED PROTEIN#0.6722;CEREBRAL ISCHEMIA#0.6719;NORMAL CERVICAL TISSUE#0.6718;INFLAMMATORY RESPONSE#0.6714;RNA INTERFERENCE#0.6703;IFN-GAMMA#0.6661;EPSTEIN BARR VIRUS#0.6599;HYPERMETHYLATION OF CPG ISLAND#0.6558;METAPLASIA#0.6524;LIQUID BASED CYTOLOGY#0.6496;PROTEIN DEGRADATION#0.6487;BREAST CANCER CELL#0.6450;HEPATOCELLULAR CARCINOMA#0.6435;DNA BINDING#0.6430;ISCHEMIA REPERFUSION INJURY#0.6264;INNATE IMMUNE RESPONSE#0.6264;LUNG ADENOCARCINOMA#0.6187;NEUTROPHIL#0.6150;CENTRAL NERVOUS SYSTEM#0.6105;COLITIS#0.6096;LEUCINE#0.6093;ASPARTATE#0.6072;AUTOPHAGOSOME FORMATION#0.6043;ISOMERASE ACTIVITY#0.6030;APOPTOTIC CELL DEATH#0.6016
161357	CELL ADHESION#0.6962;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6461;LUPUS ERYTHEMATOSUS#0.6458;INHIBITORY SYNAPSE#0.6409;CELL CYCLE#0.6383;APOPTOSIS#0.6143
1613	ZIPPER INTERACTING PROTEIN#1.1022;PROTEIN KINASE#1.0495;SMOOTH MUSCLE#1.0404;APOPTOSIS#1.0376;MUSCLE CELL#1.0375;LEUCINE#1.0363;TRANSCRIPTION FACTOR#1.0311;SMOOTH MUSCLE CELL#1.0261;MUSCLE CONTRACTION#1.0113;CELL DEATH#1.0026;SMOOTH MUSCLE CONTRACTION#0.9942;REGULATORY LIGHT CHAIN#0.9777;KINASE ACTIVITY#0.9753;AUTOPHAGY#0.9702;INTEGRIN LINKED KINASE#0.9623;MYOSIN PHOSPHATASE#0.9536;GENE EXPRESSION#0.9429;DNA BINDING#0.9421;SIGNALING PATHWAY#0.9341;APOPTOTIC#0.9195;MYOSIN LIGHT-CHAIN KINASE#0.9117;PROTEIN KINASE C#0.9099;HYPERTENSION#0.8632;TUMOR SUPPRESSOR#0.8468;CELL CYCLE#0.8453;KINASE INHIBITOR#0.8229;CYTOPLASM#0.8194;ACTIN FILAMENT#0.7999;MEMBRANE BLEBBING#0.7987;ARTERY#0.7826;MESENTERIC ARTERY#0.7758;VASCULAR SMOOTH MUSCLE CELL#0.7722;CELL PROLIFERATION#0.7650;PHOSPHATASE INHIBITOR#0.7585;ENDOPLASMIC RETICULUM#0.7540;ATP BINDING#0.7385;CELL GROWTH#0.7288;ONCOGENIC#0.7149;T CELL#0.7101;CANCER CELL#0.7006;CYTOKINESIS#0.6961;C TERMINAL DOMAIN#0.6863;CELL DIVISION#0.6845;PHOSPHATASE ACTIVITY#0.6838;MAST CELL#0.6636;SENSITIZATION#0.6594;BLEBBING#0.6505;NEMO LIKE KINASE#0.6434;TRANSACTIVATION#0.6433;ACTIN CYTOSKELETON#0.6398;STRESS FIBER#0.6395;CONTRACTILE RING#0.6275;T CELL FACTOR#0.6136;CELL DIVISION CYCLE#0.6126;ENDOPLASMIC RETICULUM STRESS#0.6032;FOCAL ADHESION#0.6008
161424	SMALL RIBOSOMAL SUBUNIT#0.8405;RNA BINDING#0.8312;RIBOSOMAL SUBUNIT#0.7013;PRERIBOSOME#0.6278
161436	GLIAL CELL#0.6356
161497	HEARING LOSS#1.0354;COPY NUMBER VARIATION#0.9428;SENSORINEURAL HEARING LOSS#0.9339;HEARING IMPAIRMENT#0.9163;HAIR CELL#0.9135;INNER EAR#0.8938;OUTER HAIR CELL#0.8042
161514	GERM CELL#0.7875;SPERMIOGENESIS#0.7768
161582	NEURONAL MIGRATION#1.0817;DYSLEXIA#1.0754;ESTROGEN RECEPTOR#0.9452;SHORT TERM MEMORY#0.7936;BREAST CANCER#0.7682;DYNEIN#0.7448;INNER DYNEIN ARM#0.7422;RNA INTERFERENCE#0.7252;SPATIAL LEARNING#0.6158
1615	SPINAL CORD#1.0385;GATCAB#1.0299;ADENYLATE#1.0148;LEUKOENCEPHALOPATHY#0.9938;ASPARAGINE#0.9868;ASPARTATE#0.9710;ASPARTIC ACID#0.9703;PROTEIN SYNTHESIS#0.9304;ANTICODON BINDING DOMAIN#0.8633;MULTISYNTHETASE COMPLEX#0.7423;LYSINE#0.7250;MOLECULAR DYNAMICS SIMULATION#0.6709;SYNTHETASE ACTIVITY#0.6652;MITOCHONDRIA#0.6603;MAGNETIC RESONANCE IMAGING#0.6542;HISTIDINE#0.6203;LEUKODYSTROPHY#0.6145
1616	FAS BINDING#1.1064;ALPHA THALASSEMIA#1.0685;HISTONE CHAPERONE#1.0621;CHROMATIN REMODELING#1.0573;MENTAL RETARDATION#1.0560;PML NB#1.0556;THALASSEMIA#1.0529;NUCLEAR BODY#1.0463;HISTONE DEACETYLASE#1.0459;HETEROCHROMATIN#1.0431;PML NUCLEAR BODY#1.0339;TELOMERE#1.0313;CYTOPLASM#1.0262;SUMOYLATION#1.0260;PANCREATIC NEUROENDOCRINE TUMOR#1.0211;APOPTOSIS#1.0192;ONCOGENIC#1.0174;CELL DEATH#1.0144;TUMOR SUPPRESSOR#1.0123;APOPTOTIC#1.0083;CHROMATIN REMODELING COMPLEX#1.0078;CANCER CELL#1.0076;NEUROENDOCRINE TUMOR#1.0076;SIGNALING PATHWAY#1.0045;UBIQUITIN#1.0044;TRANSCRIPTION FACTOR#1.0039;CELL CYCLE#1.0021;GENE EXPRESSION#1.0021;VIRAL GENE EXPRESSION#0.9930;CELL PROLIFERATION#0.9908;DEATH RECEPTOR#0.9891;VIRAL REPLICATION#0.9781;VIRAL GENOME#0.9754;HERPES SIMPLEX VIRUS#0.9693;HERPES SIMPLEX#0.9689;TELOMERE MAINTENANCE#0.9625;CHROMATIN REMODELLING#0.9509;TRANSACTIVATION#0.9457;RNA INTERFERENCE#0.9423;PROTEASOME#0.9423;PROTEIN KINASE#0.9382;B CELL#0.9333;DNA METHYLATION#0.9209;CHROMATIN ASSEMBLY#0.9206;GROWTH FACTOR#0.9179;VIRAL INFECTION#0.9160;OVARIAN CANCER#0.9034;IMMUNE RESPONSE#0.9026;CELL GROWTH#0.8871;HOST CELL#0.8818;TRANSCRIPTIONAL CONTROL#0.8809;VIRION#0.8798;DNA REPAIR#0.8763;DNA BINDING#0.8745;PROTEIN PROTEIN INTERACTION#0.8648;CHAPERONE COMPLEX#0.8566;TARGET OF RAPAMYCIN#0.8532;T CELL#0.8485;OVARIAN#0.8449;LYSINE#0.8270;PROSTATE CANCER#0.8206;ADENOCARCINOMA#0.8108;SIGNAL TRANSDUCTION#0.8089;GLUCOCORTICOID RECEPTOR#0.8043;ANTIVIRAL RESPONSE#0.8030;TELOMERE MAINTENANCE MECHANISM#0.8018;CENTROMERE#0.7980;TRANSFORMING GROWTH FACTOR#0.7977;B LYMPHOCYTE#0.7925;TUMOR CELLS#0.7918;TUMOR NECROSIS FACTOR#0.7913;SQUAMOUS CELL CARCINOMA#0.7847;LYMPH NODE#0.7754;NUCLEOSOME#0.7749;STEM CELL#0.7732;S PHASE#0.7703;DNA REPLICATION#0.7699;SENESCENCE#0.7660;PROSTATE SPECIFIC ANTIGEN#0.7482;TRANSFORMING GROWTH FACTOR BETA#0.7454;NUCLEAR EXPORT#0.7453;C TERMINAL DOMAIN#0.7442;SIGNAL TRANSDUCER#0.7424;RAPAMYCIN#0.7405;TELOMERASE ACTIVITY#0.7332;PERICENTRIC HETEROCHROMATIN#0.7313;NUCLEAR LOCALIZATION SIGNAL#0.7265;NUCLEAR DOT#0.7252;EPITHELIAL CELL#0.7216;HEAT SHOCK PROTEIN#0.7191;CREB BINDING#0.7136;CYTOCHROME C#0.7055;KINASE ACTIVITY#0.7053;ATP-DEPENDENT CHROMATIN REMODELING#0.6931;JUN KINASE#0.6926;ACTIVATION OF APOPTOSIS#0.6857;LUNG CANCER#0.6840;NUCLEAR MEMBRANE#0.6816;CONJUGATION#0.6800;TRANSCRIPTASE#0.6750;COLON CANCER#0.6717;DNA DAMAGE RESPONSE#0.6621;TELOMERASE REVERSE TRANSCRIPTASE#0.6546;REVERSE TRANSCRIPTION#0.6509;POST-TRANSLATIONAL MODIFICATION#0.6489;LYMPH NODE METASTASIS#0.6482;COMPLEX I#0.6478;WORLD HEALTH ORGANIZATION#0.6340;DISEASE FREE SURVIVAL#0.6309;MYELOID LEUKEMIA#0.6269;MITOSIS#0.6244;POSTTRANSLATIONAL MODIFICATION#0.6229;ENDOTHELIAL CELL#0.6225;JUN PHOSPHORYLATION#0.6216;CELL CYCLE ARREST#0.6183;EMBRYONIC STEM CELL#0.6161;MACROPHAGE#0.6157;OVARIAN SURFACE EPITHELIAL#0.6097;CELL KILLING#0.6087
161725	DENDRITIC SPINE#0.6858;DENDRITIC SPINE DENSITY#0.6463
161742	GROWTH FACTOR#1.0174;ENDOTHELIAL CELL#1.0099;MITOGEN ACTIVATED PROTEIN#0.9953;PROTEIN KINASE#0.9944;MAPK SIGNALING#0.9914;ANGIOGENESIS#0.9830;CELL PROLIFERATION#0.9645;SIGNALING PATHWAY#0.9324;ENDOTHELIAL GROWTH FACTOR#0.9008;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9008;BONE MARROW#0.8715;STEM CELL#0.8618;POLYMERASE CHAIN REACTION#0.8476;GENE EXPRESSION#0.7926;STRESS FIBER#0.7733;MAST CELL#0.7626;HEMATOPOIETIC CELL#0.7602;PROGENITOR CELL#0.7519;PLASMA MEMBRANE#0.7494;MAPK SIGNALLING#0.7026;MAP KINASE#0.7023;T CELL#0.6943;APOPTOSIS#0.6753;TUMOR SUPPRESSOR#0.6571;MORPHOGENESIS#0.6424;FIBROBLAST GROWTH FACTOR#0.6398;VASCULAR ENDOTHELIAL CELL#0.6319;NEUROFIBROMA#0.6305;QUANTITATIVE REAL TIME#0.6294;RELATED PROTEIN 1#0.6237;BONE MARROW CELLS#0.6054;CYTOKINE PRODUCTION#0.6010
1617	RNA BINDING PROTEIN#1.0382;RNA BINDING#1.0374;GERM CELL DEVELOPMENT#1.0312;AZOOSPERMIA#1.0279;CELL DEVELOPMENT#1.0194;GERM CELL#1.0127;Y CHROMOSOME#1.0097;INFERTILE#1.0045;SERTOLI CELL#1.0036;POLYMERASE CHAIN REACTION#1.0022;GENE COPY NUMBER#0.9992;SPERMATOGENESIS#0.9982;MALE INFERTILITY#0.9978;INFERTILITY#0.9903;GENE EXPRESSION#0.9902;MEIOSIS#0.9792;SEMEN#0.9752;SERTOLI CELL-ONLY SYNDROME#0.9743;GAMETOGENESIS#0.9713;RNA RECOGNITION MOTIF#0.9686;SPERMATOZOA#0.9592;STEM CELL#0.9532;QUANTITATIVE REAL TIME#0.9008;REVERSE TRANSCRIPTION#0.8790;PRIMORDIAL GERM CELL#0.8701;OLIGOSPERMIA#0.8556;PERIPHERAL BLOOD#0.8546;SPERMATOCYTES#0.8268;X CHROMOSOME#0.8196;OOCYTE#0.7917;SINGLE NUCLEOTIDE VARIANTS#0.7899;OOGENESIS#0.7839;LEUKOCYTE#0.7758;SEX CHROMOSOME#0.7641;EMBRYONIC STEM CELL#0.7441;GONAD#0.7436;CRYPTORCHIDISM#0.7343;STERILITY#0.7191;CYTOPLASM#0.7181;ASSISTED REPRODUCTION TECHNIQUES#0.7154;FERTILIZATION#0.6950;CELL DIVISION#0.6594;CELL CYCLE#0.6487;TESTOSTERONE#0.6466;GERM PLASM#0.6201;GERMINAL CELLS#0.6178;FRAGMENT LENGTH POLYMORPHISM#0.6095;GENE CONVERSION#0.6016
161823	ADENOSINE DEAMINASE#1.0811;ADENOSINE#1.0054;AMP DEAMINASE#0.6361
161835	BREAST CANCER#1.0634;CANCER CELL#1.0339;ALZHEIMER'S DISEASE#0.8867;BREAST CANCER CELL#0.7957;ISOLEUCINE#0.7559;APOPTOSIS#0.7070;RNASE P#0.6586;BREAST CANCER PATIENTS#0.6311;QUANTITATIVE REAL TIME#0.6293;CELL DEATH#0.6243
161882	FRIEND OF GATA#1.0888;ZINC FINGER PROTEIN#1.0739;FOG 3#1.0713;NURD COMPLEX#1.0600;C-TERMINAL BINDING#1.0472;MEGAKARYOCYTE#1.0285;MAST CELL#1.0250;ERYTHROID CELL#1.0197;DNA BINDING#1.0178;GERM CELL#1.0143;GLOBIN#1.0141;ERYTHROPOIESIS#1.0131;TRANSCRIPTION FACTOR#1.0077;GENE EXPRESSION#1.0059;CELL DIFFERENTIATION#0.9553;STEM CELL#0.9487;HEMATOPOIESIS#0.9480;NUCLEOSOME#0.9388;T CELL#0.9251;SPERMATOGENESIS#0.9233;RED BLOOD CELL#0.9027;ERYTHROCYTE#0.8845;THROMBOCYTOPENIA#0.8844;CELL DEVELOPMENT#0.8772;HEMATOPOIETIC CELL#0.8618;ANEMIA#0.8537;SEX DETERMINATION#0.8441;ERYTHROID PROGENITOR#0.8087;CHROMATIN REMODELING#0.7913;PROGENITOR CELL#0.7871;NAIVE T CELL#0.7685;BONE MARROW#0.7406;RNA BINDING#0.7368;PROTEIN PROTEIN INTERACTION#0.7360;HEMATOPOIETIC STEM CELL#0.7348;MEGAKARYOCYTE DIFFERENTIATION#0.7323;CD4+ T CELL#0.7294;OOCYTE#0.7020;EOSINOPHIL#0.6984;SIGNAL TRANSDUCTION#0.6933;TH2 CELL#0.6832;COMPLEX I#0.6805;GENE SILENCING#0.6805;RBC DEVELOPMENT#0.6717;DEFINITIVE ERYTHROPOIESIS#0.6690;CELL PROLIFERATION#0.6630;OOGENESIS#0.6587;EMBRYONIC STEM CELL#0.6571;PRIMITIVE ERYTHROPOIESIS#0.6445;CARDIAC DEVELOPMENT#0.6433;NURF COMPLEX#0.6341;CORD BLOOD#0.6279;MEGAKARYOCYTE DEVELOPMENT#0.6212;GROWTH FACTOR#0.6163;APOPTOSIS#0.6118;TRANSACTIVATION#0.6031
1618	AZOOSPERMIA#1.0356;GERM CELL DEVELOPMENT#1.0338;GAMETOGENESIS#1.0331;RNA BINDING PROTEIN#1.0300;RNA BINDING#1.0243;DNA METHYLATION#1.0235;CELL DEVELOPMENT#1.0225;Y CHROMOSOME#1.0204;GERM CELL#1.0194;SYNAPTONEMAL COMPLEX#1.0164;MEIOSIS#1.0159;INFERTILE#1.0153;MALE INFERTILITY#1.0119;PRIMORDIAL GERM CELL#1.0089;RETINOIC ACID#1.0062;OOCYTE#1.0062;POLYMERASE CHAIN REACTION#1.0053;SPERMATOGENESIS#1.0003;CELL DIFFERENTIATION#0.9977;GONAD#0.9963;SPERMATOCYTES#0.9945;OOGENESIS#0.9934;INFERTILITY#0.9923;SPERMATOGONIAL STEM CELL#0.9913;EMBRYONIC STEM CELL#0.9896;GENE EXPRESSION#0.9863;TRANSCRIPTION FACTOR#0.9793;STEM CELL#0.9784;REVERSE TRANSCRIPTION#0.9784;OVARIAN#0.9726;CYTOPLASM#0.9613;SERTOLI CELL#0.9503;GERM PLASM#0.9351;HUMAN EMBRYONIC STEM#0.9207;MESENCHYMAL STEM CELL#0.9119;OVARIES#0.9111;ALKALINE PHOSPHATASE#0.8951;SPERMATOZOA#0.8760;BONE MARROW#0.8747;PROPHASE#0.8700;GROWTH FACTOR#0.8637;OOCYTE MATURATION#0.8581;AMNIOTIC FLUID#0.8563;CELL CYCLE#0.8535;PLURIPOTENT STEM CELL#0.8458;STERILITY#0.8355;ZONA PELLUCIDA#0.8256;GERMLINE STEM CELL#0.7973;GROWTH DIFFERENTIATION FACTOR#0.7842;APOPTOSIS#0.7546;BONE MORPHOGENETIC PROTEIN#0.7418;RNA RECOGNITION MOTIF#0.7373;CORPUS LUTEUM#0.7361;GRANULOSA CELL#0.7333;CELL PROLIFERATION#0.7257;GONOCYTE#0.7197;FERTILIZATION#0.7116;CELL MATURATION#0.6821;OOCYTE DEVELOPMENT#0.6707;MOUSE EMBRYONIC STEM#0.6699;TRANSCRIPTASE#0.6530;POLY-A BINDING#0.6426;LEYDIG CELL#0.6381;GESTATION#0.6380;GLIAL CELL#0.6229;ENTRY INTO MEIOSIS#0.6221;PACHYTENE#0.6149;SIGNALING PATHWAY#0.6142;SEX DIFFERENTIATION#0.6069;TESTOSTERONE#0.6050;BASEMENT MEMBRANE#0.6017
161	PROTEIN COMPLEX#0.7439;NEUROFIBRILLARY TANGLE#0.6098
1620	TUMOR SUPPRESSOR#1.0599;CANCER CELL#0.9002;CHROMOSOME REGION#0.8002;LUNG CANCER#0.7868;DNA METHYLATION#0.7579;BREAST CANCER#0.7570;CELL CYCLE#0.7529;DENTATE GYRUS#0.7078;NERVOUS SYSTEM#0.6718;HYPERACTIVITY#0.6611;5-AZA-2'-DEOXYCYTIDINE#0.6607;2'-DEOXYCYTIDINE#0.6602;AUTISM SPECTRUM DISORDER#0.6338;TRANSITIONAL CELL CARCINOMA#0.6303;DNA METHYLTRANSFERASE#0.6229;NEURONAL CELLS#0.6212;RETINOIC ACID#0.6142;TUMOR CELLS#0.6140
1621	MIGRAINE#1.0639;DOPAMINE BETA MONOOXYGENASE#1.0612;CYTOCHROME B561#1.0557;NOREPINEPHRINE SYNTHESIS#1.0537;MONOOXYGENASE ACTIVITY#1.0499;CYTOCHROME B#1.0462;DOPAMINE BETA-HYDROXYLASE ACTIVITY#1.0437;DISULFIRAM#1.0364;CHROMAFFIN GRANULE MEMBRANE#1.0328;GLOMUS CELL#1.0321;HYDROXYLASE ACTIVITY#1.0319;CATECHOL O METHYLTRANSFERASE#1.0317;O METHYLTRANSFERASE#1.0316;NITRIC OXIDE SYNTHASE#1.0281;PHENYLETHANOLAMINE N METHYLTRANSFERASE#1.0259;TRYPTOPHAN#1.0256;AXONAL TRANSPORT#1.0249;DOPAMINE#1.0243;ASCORBIC ACID#1.0229;N METHYLTRANSFERASE#1.0224;NITRIC OXIDE#1.0215;SCIATIC NERVE#1.0213;CAROTID BODY#1.0172;PHEOCHROMOCYTOMA#1.0138;ETHANOL#1.0133;RENIN ACTIVITY#1.0129;CATECHOLAMINE BIOSYNTHETIC#1.0126;GLUTAMIC ACID#1.0119;CHROMAFFIN GRANULE#1.0111;IMMUNOTOXIN#1.0099;MEDULLA OBLONGATA#1.0097;NOREPINEPHRINE BIOSYNTHESIS#1.0093;ESSENTIAL HYPERTENSION#1.0091;ESTROGEN RECEPTOR#1.0090;ASCORBATE#1.0082;L-DOPA#1.0077;CYCLIC AMP#1.0070;ELECTRON TRANSFER#1.0059;DOPAMINE RECEPTOR#1.0056;CHOLINE#1.0034;EXCRETION#1.0014;NEUROBLASTOMA#1.0013;POLYMERASE CHAIN REACTION#1.0011;SECRETORY GRANULE#1.0002;RESERPINE#0.9998;CATECHOLAMINE SYNTHESIS#0.9987;EXOCYTOSIS#0.9986;PHENOXYBENZAMINE#0.9985;CATECHOLAMINE BIOSYNTHESIS#0.9984;NEUROFILAMENT#0.9982;ADRENAL GLAND#0.9978;OLFACTORY BULB#0.9977;MYOCARDIAL INFARCTION#0.9968;CORTISOL#0.9964;PROTEIN KINASE#0.9949;HYPOTENSIVE#0.9946;CHROMAFFIN CELL#0.9939;SUBSTANCE P#0.9937;NERVE GROWTH FACTOR#0.9936;SYMPATHETIC GANGLION#0.9935;AXON TERMINAL#0.9925;PINEAL GLAND#0.9925;SYNAPTIC VESICLE#0.9920;ADRENALINE#0.9915;NERVE FIBER#0.9915;GANGLION CELLS#0.9912;ACETYLCHOLINE#0.9909;HYPOTENSION#0.9906;NOREPINEPHRINE#0.9906;MEDULLARY CELL#0.9902;EPINEPHRINE#0.9895;CATECHOLAMINE METABOLISM#0.9890;ADRENAL MEDULLA#0.9884;SUCROSE#0.9883;NORADRENALINE#0.9871;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9868;CLONIDINE#0.9865;GENE EXPRESSION#0.9859;DYSKINESIA#0.9857;ALDOSTERONE#0.9850;L-THREO-3,4-DIHYDROXYPHENYLSERINE#0.9848;PROTEIN KINASE A#0.9847;PLASMA MEMBRANE#0.9847;HYPERTENSION#0.9843;NERVE ENDING#0.9841;GROWTH FACTOR#0.9837;FRONTAL#0.9837;CEREBRAL CORTEX#0.9834;CERVICAL#0.9833;ALZHEIMER'S DISEASE#0.9831;PROPRANOLOL#0.9828;TRANSCRIPTION FACTOR#0.9822;ESTRADIOL#0.9810;ARTERY#0.9805;HYPERACTIVITY#0.9803;LOCUS COERULEUS#0.9801;TYROSINE HYDROXYLASE ACTIVITY#0.9800;SPINAL CORD#0.9792;CHOLINERGIC NEURON#0.9785;ADRENERGIC RECEPTOR#0.9777;DOPAMINERGIC NEURON#0.9767;CATECHOLAMINE SECRETION#0.9767;DYSTONIA#0.9765;NEURAL CREST#0.9764;SUPEROXIDE DISMUTASE#0.9759;NERVE TERMINAL#0.9758;NEURONAL CELL BODIES#0.9754;ENZYME ACTIVITY#0.9752;PARKINSON'S DISEASE#0.9746;AMYGDALA#0.9742;BLOOD VESSEL#0.9733;VASOPRESSIN#0.9720;STRIATUM#0.9717;ADENYLATE CYCLASE#0.9705;BETA ADRENERGIC RECEPTOR#0.9701;MIDBRAIN#0.9698;RECEPTOR ANTAGONIST#0.9693;CAMP RESPONSE ELEMENT#0.9687;CENTRAL NERVOUS SYSTEM#0.9683;NEUROTOXIN#0.9683;SECRETORY VESICLE#0.9682;HISTIDINE#0.9679;SUBSTANTIA NIGRA#0.9675;NEUROTRANSMISSION#0.9664;SMOOTH MUSCLE#0.9663;CONDUCT DISORDER#0.9660;MECHANISM OF ACTION#0.9648;GESTATION#0.9647;MULTIPLE SYSTEM ATROPHY#0.9646;INNERVATION#0.9637;ERYTHROCYTE#0.9637;D-AMPHETAMINE#0.9629;COLCHICINE#0.9620;FOREBRAIN#0.9619;BOUTON#0.9615;NERVOUS SYSTEM#0.9613;MENSTRUAL CYCLE#0.9607;ADRENAL CORTEX#0.9601;METHIONINE#0.9599;SALIVARY GLAND#0.9595;CELL SURFACE#0.9584;PERIPHERAL NERVOUS SYSTEM#0.9560;ADENYLATE#0.9531;ADENOSINE#0.9502;ADIPOSE TISSUE#0.9497;CELL BODY#0.9496;NEUROPATHY#0.9485;CORTICOTROPIN#0.9476;RETICULAR FORMATION#0.9452;BROWN ADIPOSE TISSUE#0.9444;CONGESTIVE HEART FAILURE#0.9425;DOPAMINE METABOLISM#0.9415;PARGYLINE#0.9413;HINDBRAIN#0.9410;3,4-DIHYDROXYPHENYLALANINE#0.9408;THALAMUS#0.9404;HALOPERIDOL#0.9397;CONNECTIVE TISSUE#0.9397;RECEPTOR AGONIST#0.9394;MOTOR ACTIVITY#0.9382;DENSE CORE VESICLE#0.9375;REVERSE TRANSCRIPTION#0.9366;CORTICOTROPIN-RELEASING FACTOR#0.9362;PROTEIN KINASE C#0.9361;RETROGRADE AXONAL TRANSPORT#0.9344;ORGANELLE#0.9304;COCAINE DEPENDENCE#0.9284;FRAGMENT LENGTH POLYMORPHISM#0.9267;NEURITE#0.9256;ACUTE MYOCARDIAL INFARCTION#0.9223;CYTOCHROME C#0.9202;FORSKOLIN#0.9166;LECTIN#0.9156;SIGNALING PATHWAY#0.9144;HYPOXIA#0.9115;NEURAL CREST CELL#0.9107;SPINAL DORSAL HORN#0.9093;OVARIAN#0.9081;DODECYL SULFATE#0.9076;DESIPRAMINE#0.9075;GRANULAR VESICLE#0.9071;ALCOHOL DEPENDENCE#0.9017;STEM CELL#0.8995;NEURONAL CELLS#0.8992;ARTERIOLE#0.8975;DOPAMINE SYNTHESIS#0.8966;BIPOLAR DISORDER#0.8959;URINARY BLADDER#0.8947;MITOCHONDRIA#0.8946;BIOTIN#0.8927;REGENERATION#0.8917;SYNAPTOSOME#0.8905;PHENTOLAMINE#0.8902;NEUROENDOCRINE CELL#0.8899;PRAZOSIN#0.8887;VESICLE MEMBRANE#0.8885;LEUCINE#0.8878;AUTONOMIC NEUROPATHY#0.8860;PERIPHERAL NERVE#0.8852;MENKES DISEASE#0.8837;SODIUM DODECYL SULFATE#0.8835;YOHIMBINE#0.8820;HEMORRHAGE#0.8779;HEALTHY CONTROL SUBJECTS#0.8759;DENTATE GYRUS#0.8755;SYSTOLIC BLOOD PRESSURE#0.8755;TESTOSTERONE#0.8751;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8741;SEPTUM#0.8733;ENDOPLASMIC RETICULUM#0.8726;GLYCINE#0.8721;BETA ADRENOCEPTOR#0.8715;PITUITARY GLAND#0.8706;CONSTRICTION#0.8704;ESTROUS CYCLE#0.8693;GLIAL CELL#0.8656;TRANSACTIVATION#0.8654;CATALYTIC ACTIVITY#0.8646;ENDOCRINE CELL#0.8606;BASILAR ARTERY#0.8600;AXOPLASMIC TRANSPORT#0.8587;HISTAMINE#0.8582;HYPOGLYCEMIA#0.8578;LITHIUM#0.8560;FUMARATE#0.8547;GROWTH HORMONE#0.8515;DNA BINDING#0.8508;MESENTERIC ARTERY#0.8490;SIGNAL PEPTIDE#0.8487;PROGESTERONE#0.8470;GUANETHIDINE#0.8462;COGNITION#0.8448;ADRENOCORTICOTROPIC HORMONE#0.8442;N-HYDROXYGUANIDINE#0.8427;CYTOPLASM#0.8425;PIMOZIDE#0.8420;MUSCLE CELL#0.8386;MONOAMINE OXIDASE ACTIVITY#0.8370;TOXICITY#0.8357;N-ETHYLMALEIMIDE#0.8347;VASOCONSTRICTION#0.8346;QUANTITATIVE REAL TIME#0.8324;MICROTUBULE#0.8323;ENTERIC NERVOUS SYSTEM#0.8320;METHYLDOPA#0.8318;DEXAMETHASONE#0.8280;TACHYCARDIA#0.8271;NEUROSECRETORY VESICLE#0.8263;L-DOPS#0.8256;DOPAMINE UPTAKE#0.8225;CORD BLOOD#0.8221;MELATONIN#0.8220;CYTOCHROME C OXIDASE#0.8203;RAPHE NUCLEI#0.8200;CATECHOLAMINE UPTAKE#0.8195;SEROTONERGIC NEURON#0.8161;HYPOTHYROIDISM#0.8159;HEART DISEASE#0.8159;L-TYROSINE#0.8153;PROTEIN SYNTHESIS#0.8138;P-CRESOL#0.8135;MEDIAL PREFRONTAL CORTEX#0.8126;NEUROLOGICAL DISORDER#0.8120;TELENCEPHALON#0.8102;EPILEPSY#0.8101;WEIGHT GAIN#0.8080;BLOOD PLASMA#0.8058;NERVE TRUNK#0.8027;STREPTOZOTOCIN#0.8017;ATROPINE#0.7990;DEMENTIA#0.7981;BETA-2#0.7937;ELECTRON TRANSPORT#0.7922;LASER SCANNING MICROSCOPY#0.7917;OPIOID PEPTIDE#0.7905;B CELL#0.7897;PERIPHERAL BLOOD#0.7895;APOMORPHINE#0.7895;HYPOTHALAMIC PITUITARY ADRENAL#0.7886;ARGININE#0.7885;SECRETORY GRANULE MEMBRANE#0.7873;DIENCEPHALON#0.7870;BLOOD BRAIN BARRIER#0.7852;DECARBOXYLASE ACTIVITY#0.7844;LYSIS#0.7837;IONOPHORE#0.7778;SMOOTH MUSCLE CELL#0.7753;PROXIMAL DENDRITE#0.7741;ISOLEUCINE#0.7739;THYROTROPIN RELEASING HORMONE#0.7739;OVULATION#0.7723;INSULIN-LIKE GROWTH FACTOR#0.7710;ALPHA ADRENOCEPTOR#0.7697;NEUROTOXIC#0.7678;PARENCHYMA#0.7654;DOPAMINE D2 RECEPTOR#0.7637;DIGESTION#0.7624;CIRCADIAN RHYTHM#0.7619;METHYLTRANSFERASE ACTIVITY#0.7617;ACETIC ACID#0.7614;TEGMENTUM#0.7601;SEMINAL VESICLE#0.7597;UTERUS#0.7569;IMIPRAMINE#0.7565;NOREPINEPHRINE UPTAKE#0.7557;MEMBRANE FRACTION#0.7550;NEUROBLAST#0.7537;PHENYLEPHRINE#0.7468;CAUDATE NUCLEUS#0.7465;DIABETIC AUTONOMIC NEUROPATHY#0.7422;TYROSINE 3 MONOOXYGENASE#0.7385;CORONAL#0.7383;ARGININE VASOPRESSIN#0.7366;ALANINE#0.7365;CAMP RESPONSE ELEMENT BINDING#0.7356;UMBILICAL CORD#0.7340;HALOTHANE#0.7337;GONADOTROPIN RELEASING HORMONE#0.7333;GLUCOCORTICOID RECEPTOR#0.7320;BONE MORPHOGENETIC PROTEIN#0.7317;COPPER BINDING#0.7294;DURA MATER#0.7269;NICOTINE DEPENDENCE#0.7242;OBESE#0.7235;GOLGI APPARATUS#0.7204;NEURAL CELL#0.7186;SYMMETRIC SYNAPSE#0.7182;INFERIOR COLLICULUS#0.7157;ISOPROTERENOL#0.7120;MICROTUBULE ASSOCIATED PROTEIN#0.7115;RETINOIC ACID#0.7080;ENDOGENOUS DEPRESSION#0.7072;HYDRALAZINE#0.7045;DIESTRUS#0.7040;CHOLERA#0.7011;CELL DEATH#0.6993;ADVENTITIA#0.6988;LEYDIG CELL#0.6972;SCHWANN CELL#0.6961;ASTROCYTE#0.6957;BLOOD PRESSURE REGULATION#0.6956;ACETYLCHOLINE RECEPTOR#0.6943;PHOSPHODIESTERASE#0.6935;SEROTONIN RECEPTOR#0.6933;RECEPTOR BINDING#0.6923;LOCOMOTION#0.6923;PTOSIS#0.6904;PROESTRUS#0.6884;PYRAZOLE#0.6879;GLYCOSYLATION#0.6860;HYPERACTIVE#0.6859;MYOCARDIUM#0.6858;PYRROLOQUINOLINE QUINONE#0.6851;CALCIUM CHANNEL#0.6848;CARBIDOPA#0.6839;RESPONSE TO STRESS#0.6833;COCHLEA#0.6832;PHENYLETHANOLAMINE N-METHYLTRANSFERASE ACTIVITY#0.6832;DIABETES MELLITUS#0.6828;CARDIOVASCULAR SYSTEM#0.6815;NORADRENALINE UPTAKE#0.6800;SECONDARY HYPERTENSION#0.6798;DERMIS#0.6797;GENETIC DISORDER#0.6788;DOPAMINE D4 RECEPTOR#0.6767;POST-TRANSLATIONAL MODIFICATION#0.6766;SWEAT GLAND#0.6765;STRUCTURE ACTIVITY RELATIONSHIP#0.6763;CYSTEAMINE#0.6729;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6706;REGULATION OF GENE EXPRESSION#0.6703;LINES OF EVIDENCE#0.6695;COCAINE ABUSE#0.6682;N-METHYLTRANSFERASE ACTIVITY#0.6672;SOLUBLE FRACTION#0.6665;PARANOID SCHIZOPHRENIA#0.6639;L-DIHYDROXYPHENYLALANINE#0.6636;ACTION POTENTIAL#0.6630;CORTICAL CELL#0.6599;GROWTH FACTOR RECEPTOR#0.6581;GABAERGIC NEURON#0.6578;CATABOLISM#0.6578;FEEDING BEHAVIOR#0.6576;NEUROTROPHIN RECEPTOR#0.6574;LATERAL VENTRICLE#0.6566;ACETYLCHOLINESTERASE ACTIVITY#0.6561;ALPHA2 ADRENOCEPTOR#0.6547;LIMBIC SYSTEM#0.6541;CYSTIC FIBROSIS#0.6537;EPINEPHRINE SYNTHESIS#0.6537;LOCALISATION#0.6490;TRANSMISSION DISEQUILIBRIUM TEST#0.6489;MUTAGENESIS#0.6478;AGE AT ONSET#0.6477;TUMOR CELLS#0.6467;OXYGENASE#0.6462;HISTIDINE DECARBOXYLASE#0.6460;METHAMPHETAMINE#0.6442;PROSTAGLANDIN E2#0.6431;NEUROTRANSMITTER RELEASE#0.6430;PURKINJE CELL#0.6426;ADENINE#0.6418;1-BENZYLIMIDAZOLE#0.6418;CAUDAL HALF#0.6409;ESTRUS#0.6404;OPIOID RECEPTOR#0.6399;TETRODOTOXIN#0.6386;APOPTOSIS#0.6377;NEUROTRANSMITTER BIOSYNTHETIC#0.6355;GTP CYCLOHYDROLASE I#0.6351;NERVOUS TISSUE#0.6283;MOLAR#0.6266;MYOCYTES#0.6260;RIBOSOME#0.6256;PENTOBARBITAL#0.6254;SIGNAL TRANSDUCTION#0.6239;EPITHELIAL CELL#0.6226;STATIONARY PHASE#0.6224;ELECTROPHORETIC MOBILITY SHIFT#0.6218;PARAFORMALDEHYDE#0.6217;MESENTERY#0.6216;ENZYME INHIBITOR#0.6214;NEUROTOXICITY#0.6201;LARYNX#0.6188;LESCH-NYHAN SYNDROME#0.6179;CELL ADHESION#0.6178;IMMUNE SYSTEM#0.6177;IMMUNE RESPONSE#0.6156;DIURNAL#0.6152;BLEOMYCIN#0.6149;FACTOR I#0.6142;DORSAL ROOT GANGLION#0.6093;OOCYTE#0.6080;FLUOXETINE#0.6075;CILIARY GANGLION#0.6073;PERSONALITY DISORDER#0.6067;CELL MEMBRANE#0.6043;LYSOSOME#0.6019;BONE MARROW#0.6018;ACETYLTRANSFERASE ACTIVITY#0.6001
162239	ZINC FINGER PROTEIN#1.0164;TRANSCRIPTION FACTOR#0.8124;GENE EXPRESSION#0.7003;SEXUAL REPRODUCTION#0.6232;AXON GUIDANCE#0.6049;RNA INTERFERENCE#0.6033
1622	GABA A RECEPTOR#1.0594;FATTY ACID BINDING#1.0554;DIAZEPAM BINDING#1.0542;COENZYME A#1.0521;DRUG DEPENDENCE#1.0468;STEROIDOGENESIS#1.0463;DIAZEPAM#1.0453;ASTROCYTE#1.0414;PERIPHERAL BENZODIAZEPINE RECEPTOR#1.0370;RECEPTOR COMPLEX#1.0261;GLIAL CELL#1.0228;LIPID BINDING PROTEIN#1.0218;INSULIN SECRETION#1.0216;LIPID METABOLISM#1.0214;CEREBRAL CORTEX#1.0213;ACYL-COA METABOLISM#1.0157;LIPID BINDING#1.0143;MITOCHONDRIA#1.0119;BENZODIAZEPINE RECEPTOR#1.0117;CENTRAL NERVOUS SYSTEM#1.0110;GENE EXPRESSION#1.0075;MITOCHONDRIAL MEMBRANE#1.0068;NERVOUS SYSTEM#1.0064;COA METABOLISM#1.0040;LEYDIG CELL#0.9874;ADRENAL GLAND#0.9856;EPITHELIAL CELL#0.9842;FATTY-ACYL-COA BINDING#0.9806;PREGNENOLONE#0.9777;ENDOPLASMIC RETICULUM#0.9749;FLUMAZENIL#0.9739;RECEPTOR ANTAGONIST#0.9621;RECEPTOR AGONIST#0.9619;FATTY ACID METABOLISM#0.9610;ETHANOL#0.9511;PEROXISOME#0.9444;PANCREATIC ISLET#0.9336;PALMITOYL#0.9330;APOPTOSIS#0.9220;INNER MITOCHONDRIAL MEMBRANE#0.9146;CORTICOTROPIN#0.9136;CELL PROLIFERATION#0.9125;CYTOPLASM#0.9110;PLASMA MEMBRANE#0.9092;GERM CELL#0.9072;FLUNITRAZEPAM#0.8969;PROTEIN KINASE#0.8958;TRANSCRIPTION FACTOR#0.8950;CALCIUM CHANNEL#0.8908;CCK SECRETION#0.8884;STEROL CARRIER PROTEIN#0.8872;POLYMERASE CHAIN REACTION#0.8783;HARDERIAN GLAND#0.8705;PROGESTERONE#0.8541;CHOLESTEROL TRANSPORT#0.8513;AUTOPHAGY#0.8410;NEUROTRANSMISSION#0.8342;ADRENAL CORTEX#0.8324;STEROID BIOSYNTHESIS#0.8307;HEPATIC ENCEPHALOPATHY#0.8261;RECEPTOR LIGAND#0.8214;STEROID SYNTHESIS#0.8164;OUTER MITOCHONDRIAL MEMBRANE#0.8052;ADIPOCYTE#0.7897;MIDGUT#0.7891;BENZODIAZEPINE RECEPTOR LIGAND#0.7861;GASTROINTESTINAL TRACT#0.7836;ALZHEIMER'S DISEASE#0.7790;ACETYLCHOLINE#0.7758;DIGESTION#0.7718;PROTOPORPHYRIN IX#0.7658;CANCER CELL#0.7632;STEROL REGULATORY ELEMENT#0.7618;FATTY ACID SYNTHESIS#0.7533;MAGNETIC RESONANCE SPECTROSCOPY#0.7502;ENERGY HOMEOSTASIS#0.7496;OPIOID RECEPTOR#0.7452;NICOTINIC ACETYLCHOLINE RECEPTOR#0.7427;PHOSPHOLIPASE C#0.7423;HEPATOMA CELLS#0.7411;ACETYLCHOLINE RECEPTOR#0.7397;SIGNALING PATHWAY#0.7358;PROTEIN KINASE C#0.7234;ACYL COA HYDROLASE#0.7154;HEPATOCYTE NUCLEAR FACTOR#0.7112;LUMINAL#0.7090;OBESE#0.7068;COA HYDROLASE#0.7014;ADENYLATE CYCLASE#0.6974;CERAMIDE SYNTHESIS#0.6950;PHOSPHATIDIC ACID BIOSYNTHESIS#0.6926;PLASTID#0.6911;ANION CHANNEL#0.6881;GABA B RECEPTOR#0.6875;TESTOSTERONE#0.6869;STEM CELL#0.6807;ADENOCARCINOMA#0.6756;ADIPOSE TISSUE#0.6738;NMDA RECEPTOR#0.6726;TUMOR CELLS#0.6662;HIGH FAT DIET#0.6657;SKELETAL MUSCLE#0.6621;FEEDING BEHAVIOR#0.6612;EPENDYMAL CELL#0.6592;MECHANISM OF ACTION#0.6585;LIPID SYNTHESIS#0.6557;OUTER MEMBRANE#0.6492;EPILEPSY#0.6438;MYRISTOYL-COA#0.6346;DEMENTIA#0.6311;ACETYL COA CARBOXYLASE#0.6298;MAMMARY GLAND#0.6249;NEURONAL CELLS#0.6248;INTESTINAL MUCOSA#0.6223;SMALL INTESTINE#0.6185;PANIC DISORDER#0.6173;LIPID TRANSPORT#0.6145;ADIPOCYTE DIFFERENTIATION#0.6080;PHOSPHOLIPID SYNTHESIS#0.6054;CELL MEMBRANE#0.6017;DNA SYNTHESIS#0.6014;ENZYME ACTIVITY#0.6011;PROTEIN FOLDING#0.6004
162394	RENAL CELL CARCINOMA#0.8846;CANCER CELL#0.8351;LUNG CANCER#0.7399;NEGATIVE CONTROL GROUP#0.6236;GASTRIC MUCOSA#0.6118;GENE SILENCING#0.6094;CELL MIGRATION#0.6022
162417	ARGININE BIOSYNTHESIS#1.0655;UREA CYCLE#1.0413;L-GLUTAMATE#1.0299;ORNITHINE#1.0286;ARGININE#1.0264;N-CARBAMYLGLUTAMATE#1.0047;L-ARGININE#0.9905;UREA CYCLE DISORDER#0.9898;SMALL INTESTINE#0.9219;N ACETYLTRANSFERASE#0.9217;COENZYME A#0.8922;ARGININE BIOSYNTHETIC#0.8635;ARGININOSUCCINATE LYASE#0.8492;N-CARBAMYL-L-GLUTAMATE#0.8279;CITRULLINE#0.7849;ARGININOSUCCINATE#0.7488;CARBAMOYL PHOSPHATE SYNTHASE#0.7133;ORNITHINE CARBAMOYLTRANSFERASE#0.6785;ARGININOSUCCINIC ACIDURIA#0.6779;GENE EXPRESSION#0.6758;GLUTAMINE#0.6690;STABLE ISOTOPE DILUTION#0.6386;TUBERCULOSIS#0.6382;MITOCHONDRIA#0.6365;CATALYTIC ACTIVITY#0.6320;N-ACETYL-L-GLUTAMATE#0.6173
162427	NEURITE OUTGROWTH#0.8104
162466	MINERALIZATION#1.0924;PHOSPHOCHOLINE#1.0791;ALKALINE PHOSPHATASE#0.9609;OSTEOBLAST#0.9323;CHONDROCYTE#0.9295;BONE MINERALIZATION#0.7315;SKELETON#0.7007;GENE EXPRESSION#0.6974;OSSIFICATION#0.6619;DNA METHYLATION#0.6571;DENTIN MINERALIZATION#0.6568;OSTEOMALACIA#0.6479;ENAMEL MINERALIZATION#0.6116;CEMENTUM FORMATION#0.6090
162494	ENDOPLASMIC RETICULUM#0.7712;CHOLESTEROL BINDING#0.6532
162514	CAMPHOR#1.0750;KERATINOCYTE#1.0465;CATION CHANNEL#1.0198;HAIR GROWTH#1.0068;ION CHANNEL#1.0067;SKIN DISEASE#1.0064;DERMATITIS#0.9965;NOCICEPTION#0.9947;NOXIOUS#0.9944;TRANSIENT RECEPTOR POTENTIAL#0.9908;SENSITIZATION#0.9868;EPITHELIAL CELL#0.9567;OOCYTE#0.9470;MENTHOL#0.9041;GROWTH FACTOR#0.9004;PLASMA MEMBRANE#0.8988;ATOPIC DERMATITIS#0.8913;CELL DEATH#0.8852;CHANNEL ACTIVITY#0.8769;WOUND HEALING#0.8674;DORSAL ROOT GANGLION#0.8665;ENDOTHELIAL CELL#0.8585;GENE EXPRESSION#0.8406;ITCHING#0.7804;ISOPENTENYL PYROPHOSPHATE#0.7771;MAST CELL#0.7618;ENDOTHELIUM#0.7548;SPINAL CORD#0.7477;TOPICAL#0.7476;ANKYRIN REPEAT DOMAIN#0.7339;CELL CYCLE#0.7251;SIGNALING PATHWAY#0.7197;POLYMERASE CHAIN REACTION#0.7026;PROTEIN KINASE#0.6965;HAIR FOLLICLE#0.6844;SMOOTH MUSCLE#0.6775;FARNESYL#0.6703;CAMKII#0.6367;EGG ACTIVATION#0.6265;CALCIUM CHANNEL#0.6248;1,8-CINEOL#0.6245;NITRIC OXIDE#0.6197;INTRACELLULAR ACIDIFICATION#0.6108;HYPERSENSITIVITY#0.6071;CELL PROLIFERATION#0.6039;OOCYTE MATURATION#0.6021;CORNEAL EPITHELIAL CELL#0.6020
162515	TYPE 2 DIABETES#1.1280;LIPID METABOLISM#0.6578
162517	INVASIVE DUCTAL CARCINOMA#0.6318;BREAST CANCER#0.6097;CELL PROLIFERATION#0.6088
162540	SIGNAL PEPTIDE PEPTIDASE#0.8750;SIGNAL PEPTIDE#0.8482;VESICULAR TRANSPORT#0.7069;GERM CELL#0.6372
162605	ROOT SHEATH#0.7508;HAIR FOLLICLE#0.6390
1627	ACTIN BINDING PROTEIN#1.0394;ACTIN BINDING#1.0393;ACTIN FILAMENT#1.0038;DENDRITIC SPINE#0.9280;GROWTH CONE#0.8750;ACTIN FILAMENT BUNDLE#0.8570;APICAL ES#0.8195;MICROTUBULE#0.7712;ACTIN CYTOSKELETON#0.7709;F-ACTIN BINDING#0.7576;EPITHELIAL CELL#0.7070;GENE EXPRESSION#0.6909;BASAL ES#0.6755;TERMINAL WEB#0.6509;ACTIN RELATED PROTEIN#0.6450;MICROTUBULE PLUS END#0.6411;MYOBLAST DIFFERENTIATION#0.6341;NEURONAL MIGRATION#0.6339;CHAIN MIGRATION#0.6256;MUSCLE CONTRACTION#0.6220;CELL BODY#0.6182;STEM CELL#0.6140;NEUROBLAST#0.6055;CANCER CELL#0.6030
1628	DBP BINDING#1.0784;VITAMIN D BINDING#1.0734;PROMOTER BINDING#1.0654;DNA BINDING#1.0459;LEUCINE#1.0179;TRANSCRIPTION FACTOR#1.0168;HEPATIC LEUKEMIA FACTOR#1.0022;TRANSACTIVATION#0.9964;ADIPOSE TISSUE#0.9945;SERUM ALBUMIN#0.9931;CIRCADIAN RHYTHM#0.9882;DIURNAL#0.9827;HYPERTENSION#0.9738;GENE EXPRESSION#0.9729;EXCRETION#0.9615;ENHANCER BINDING PROTEIN#0.9342;ENHANCER BINDING#0.9337;PANCREATIC ISLET#0.9112;POLYMERASE CHAIN REACTION#0.8920;PARATHYROID HORMONE#0.8677;SKELETAL MUSCLE#0.8633;TYPE 2 DIABETES#0.8445;CYTOCHROME P450#0.8157;GROWTH FACTOR#0.7819;ADIPOCYTE#0.7629;PARATHYROID#0.7518;CELL CYCLE#0.7462;OBESE#0.7420;KIDNEY DISEASE#0.7380;DNASE I#0.7096;TOXICITY#0.6958;C REACTIVE PROTEIN#0.6954;GESTATION#0.6908;GLOMERULAR FILTRATION RATE#0.6904;GLOMERULAR FILTRATION#0.6901;AMBULATORY BLOOD PRESSURE#0.6877;ROR BINDING#0.6850;VITAMIN D3#0.6767;CANCER CELL#0.6757;MELATONIN#0.6702;HEPATOCYTE NUCLEAR FACTOR#0.6693;DRUG METABOLISM#0.6673;DIABETES MELLITUS#0.6653;TYPE 2 DIABETIC#0.6645;ARYL HYDROCARBON RECEPTOR#0.6540;DNA REPLICATION#0.6504;TRANS-DDP#0.6347;LIVER DISEASE#0.6281;REVERSE TRANSCRIPTION#0.6182;DETOXIFICATION#0.6153;HUMAN SERUM ALBUMIN#0.6061;BIPOLAR DISORDER#0.6035;SIGNALING PATHWAY#0.6001
162963	DNA METHYLATION#0.7347
162967	ZINC FINGER PROTEIN#0.7259
162979	ZINC FINGER PROTEIN#0.7001;GERM CELL#0.6894;STEM CELL#0.6890;MYELOID LEUKEMIA#0.6513;DNA BINDING#0.6483
162989	APOPTOSIS#0.8822;ACTIVE CASPASE 3#0.6432;TRANSCRIPTION FACTOR#0.6194;DEATH RECEPTOR#0.6084
1629	DEHYDROGENASE COMPLEX#1.0430;MAPLE SYRUP URINE DISEASE#1.0338;ALPHA KETOACID DEHYDROGENASE#1.0038;PRIMARY BILIARY CIRRHOSIS#0.9727;PYRUVATE DEHYDROGENASE COMPLEX#0.9553;PYRUVATE#0.9414;LIPOIC ACID#0.9192;MITOCHONDRIA#0.8268;POLYMERASE CHAIN REACTION#0.8092;2-OXOGLUTARATE DEHYDROGENASE COMPLEX#0.6774;OXOGLUTARATE DEHYDROGENASE COMPLEX#0.6741;ENZYME COMPLEX#0.6721;DIHYDROLIPOYL DEHYDROGENASE#0.6416;SKELETAL MUSCLE#0.6166;DNA REPLICATION#0.6030
162	ADRENAL MEDULLA#1.0339;OPIOID PEPTIDE#0.9336;ADAPTIN#0.9016;SPINAL DORSAL HORN#0.8941;SPINAL CORD#0.8280;OPIOID RECEPTOR#0.8020;FORMALIN#0.6635;ADAPTOR PROTEIN 2#0.6071;AP-1 COMPLEX#0.6043;NALOXONE#0.6041;PAW WITHDRAWAL LATENCY#0.6019
163049	CARDIOMYOCYTE#0.8513;APOPTOSIS#0.8439
163059	PROSTATE CANCER#0.6881;CANCER CELL#0.6838
163087	SIGNALING PATHWAY#0.8958
1630	NETRIN RECEPTOR#1.0582;COLORECTAL CARCINOMA#1.0295;TRANSMEMBRANE RECEPTOR#1.0260;DOPAMINE#1.0232;FLOOR PLATE#1.0224;CELL ADHESION MOLECULE#1.0217;COLORECTAL#1.0202;CELL SURFACE#1.0200;POLYMERASE CHAIN REACTION#1.0200;ADENOMATOUS POLYPOSIS COLI#1.0192;TUMOR SUPPRESSOR#1.0186;COLORECTAL CANCER#1.0182;CELL ADHESION#1.0155;GROWTH CONE#1.0154;PLASMA MEMBRANE#1.0152;LIVER METASTASIS#1.0147;APOPTOSIS#1.0140;NEURITE OUTGROWTH#1.0133;CANCER CELL#1.0088;REVERSE TRANSCRIPTION#1.0088;AXON GROWTH#1.0082;MIDLINE#1.0082;NEURITE#1.0082;NEURAL CELL#1.0060;AXON GUIDANCE#1.0059;GENE EXPRESSION#1.0048;SPINAL CORD#1.0046;AXON GUIDANCE RECEPTOR#1.0023;SIGNALING PATHWAY#0.9998;BREAST CANCER#0.9985;CELL DEATH#0.9984;ADENOCARCINOMA#0.9927;RECEPTOR COMPLEX#0.9923;NEUROBLASTOMA#0.9912;COLON CANCER#0.9892;NEURONAL MIGRATION#0.9892;OVARIAN#0.9883;PROTEIN KINASE#0.9881;AXON BRANCHING#0.9879;NERVOUS SYSTEM#0.9876;GROWTH FACTOR#0.9873;CENTRAL NERVOUS SYSTEM#0.9811;FOREBRAIN#0.9811;CELL MIGRATION#0.9790;SQUAMOUS CELL CARCINOMA#0.9638;REGENERATION#0.9572;AXON EXTENSION#0.9566;STEM CELL#0.9555;TUMOR CELLS#0.9540;FOCAL ADHESION#0.9525;OVARIAN CANCER#0.9516;CELL PROLIFERATION#0.9512;SRC FAMILY KINASE#0.9430;SYSTEM DEVELOPMENT#0.9429;APOPTOTIC#0.9406;OPTIC NERVE#0.9372;NERVOUS SYSTEM DEVELOPMENT#0.9344;FRAGMENT LENGTH POLYMORPHISM#0.9305;MEDIAL PREFRONTAL CORTEX#0.9275;TRANSCRIPTION FACTOR#0.9190;EPITHELIAL CELL#0.9182;LYMPH NODE#0.9126;RETINAL GANGLION CELL#0.9080;MORPHOGENESIS#0.9074;OLFACTORY BULB#0.9072;AXON PATHFINDING#0.9035;INNERVATION#0.8983;MISMATCH REPAIR#0.8942;ANGIOGENESIS#0.8935;SUBSTANTIA NIGRA#0.8851;CHEMOATTRACTION#0.8831;QUANTITATIVE METHYLATION SPECIFIC#0.8829;TRANSCRIPTASE#0.8802;CHROMOSOMAL REGION#0.8781;FOCAL ADHESION KINASE#0.8773;CELL CYCLE#0.8692;LIPID RAFT#0.8669;CELL GROWTH#0.8578;PERIPHERAL NERVE#0.8527;COLORECTAL ADENOCARCINOMA#0.8521;INTERNEURON#0.8518;ENDOTHELIAL CELL#0.8352;AXONAL GROWTH CONE#0.8321;COLORECTAL ADENOMA#0.8078;REPULSIVE GUIDANCE MOLECULE#0.7963;MYELODYSPLASTIC SYNDROME#0.7936;GANGLION CELLS#0.7883;BASEMENT MEMBRANE#0.7833;METHYLATION SPECIFIC POLYMERASE#0.7783;ACTIN CYTOSKELETON#0.7780;EXTRACELLULAR MATRIX#0.7758;NUCLEOTIDE EXCHANGE FACTOR#0.7732;LUNG CANCER#0.7623;SIGNALING CASCADE#0.7587;EXOCYTOSIS#0.7563;ANTISENSE RNA#0.7514;FAMILIAL ADENOMATOUS POLYPOSIS#0.7444;ENDOMETRIAL CANCER#0.7444;TRANSFORMING GROWTH FACTOR#0.7433;OLIGODENDROCYTE#0.7418;PROGENITOR CELL#0.7412;OPTIC DISC#0.7396;DNA REPAIR#0.7382;MICROTUBULE#0.7373;B CELL#0.7357;PROTEIN SYNTHESIS#0.7323;SIGNAL TRANSDUCTION#0.7319;UBIQUITIN#0.7314;NEURAL TUBE#0.7291;COLON CARCINOMA#0.7279;PROTEASOME PATHWAY#0.7278;PRIMARY BREAST CANCER#0.7257;HINDBRAIN#0.7240;ISCHEMIA#0.7201;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7154;NEURON MIGRATION#0.7117;SCIATIC NERVE#0.7071;MIDBRAIN#0.7034;CELL DIFFERENTIATION#0.7017;NITRIC OXIDE#0.6901;PRECURSOR CELL#0.6877;STRIATUM#0.6866;PROTEIN KINASE A#0.6860;TRANSFORMING GROWTH FACTOR BETA#0.6851;GUANINE#0.6851;AMACRINE CELL#0.6768;OVARIAN CARCINOMA#0.6732;DNA METHYLTRANSFERASE#0.6729;BREAST CARCINOMA#0.6701;ATTRACTANT#0.6645;PERIPHERAL NERVOUS SYSTEM#0.6617;NEURITE GROWTH#0.6573;CELL BODY#0.6526;TUMOR TISSUES#0.6520;BLOOD VESSEL#0.6497;BRAIN DEVELOPMENT#0.6496;CEREBRAL ARTERY OCCLUSION#0.6484;MIDDLE CEREBRAL ARTERY#0.6471;CEREBRAL ARTERY#0.6469;PANCREATIC CANCER#0.6467;CELL MEMBRANE#0.6449;AXON SHAFT#0.6394;PRIMARY CORTICAL NEURON#0.6374;DOWN SYNDROME#0.6338;LYMPH NODE METASTASIS#0.6251;S PHASE#0.6242;RECEPTOR LIGAND#0.6237;COMPARATIVE GENOMIC HYBRIDIZATION#0.6220;COLITIS#0.6217;SCHWANN CELL#0.6198;PROTEASOME#0.6184;ENDOTHELIAL GROWTH FACTOR#0.6181;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6181;HEPARIN#0.6176;RETINAL DEVELOPMENT#0.6153;ENTERIC NERVOUS SYSTEM#0.6100;FILOPODIA FORMATION#0.6079;EPITHELIAL OVARIAN CANCER#0.6056;NEUROBLAST#0.6002
163126	HISTONE DEACETYLASE#0.6681
163131	ZINC FINGER PROTEIN#0.9148;CHONDROCYTE#0.6500
163175	SCHWANN CELL#1.0000;NERVOUS SYSTEM#0.9366;LEUCINE#0.9320;MYELINATION#0.9235;LEUCINE RICH REPEAT#0.7614;PERIPHERAL NERVE#0.7580;EPILEPSY#0.7331;CHILDHOOD ABSENCE EPILEPSY#0.6433;ABSENCE EPILEPSY#0.6230
163183	HEARING LOSS#0.9692;HAIR CELL#0.9344;LINC COMPLEX#0.7347;OUTER HAIR CELL#0.7219;NUCLEAR MEMBRANE#0.7087;KINESIN#0.6070
163255	ZINC FINGER PROTEIN#0.8146
1632	FATTY ACID OXIDATION#0.8713;PEROXISOMAL#0.6604;COENZYME A#0.6576
1633	DEOXYCYTIDINE KINASE ACTIVITY#1.0802;2-CDA#1.0684;THYMIDINE KINASE 1#1.0635;ARA-A#1.0594;CLOFARABINE#1.0581;DEOXYGUANOSINE KINASE#1.0563;ADENOSINE KINASE#1.0547;THYMIDINE KINASE 2#1.0485;2-CHLORODEOXYADENOSINE#1.0461;EQUILIBRATIVE NUCLEOSIDE TRANSPORTER#1.0457;T-LYMPHOBLAST#1.0430;DEOXYCYTIDINE KINASE#1.0421;CHLORODEOXYADENOSINE#1.0402;ENZYME ACTIVITY#1.0336;CYTIDINE DEAMINASE#1.0291;KINASE ACTIVITY#1.0252;CLADRIBINE#1.0243;2'-DEOXYCYTIDINE#1.0231;ARA-C#1.0217;2-CHLORO-2'-DEOXYADENOSINE#1.0201;THYMIDINE KINASE#1.0197;2'-DEOXYADENOSINE#1.0197;5-AZA-2'-DEOXYCYTIDINE#1.0195;POLYMERASE CHAIN REACTION#1.0192;LYMPHOBLAST#1.0189;GEMCITABINE#1.0168;QUANTITATIVE REAL TIME#1.0167;CYTIDINE#1.0134;NUCLEOSIDE KINASE#1.0129;CYTARABINE#1.0121;HERPES SIMPLEX VIRUS#1.0117;DEOXYADENOSINE#1.0116;HERPES SIMPLEX#1.0114;DIDEOXYCYTIDINE#1.0106;ARABINOFURANOSYLCYTOSINE#1.0105;THYMIDINE#1.0078;ADENOSINE#1.0047;LYMPHOID CELL#1.0042;PANCREATIC CANCER#1.0030;URIDINE#1.0012;DECITABINE#1.0010;LYMPHOCYTIC LEUKEMIA#1.0006;ADENOSINE DEAMINASE#1.0002;CELL CYCLE#0.9999;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9996;B CELL#0.9988;S PHASE#0.9972;GENE EXPRESSION#0.9969;CYTOSINE ARABINOSIDE#0.9967;PERIPHERAL BLOOD#0.9963;BONE MARROW#0.9961;ACUTE MYELOID LEUKEMIA#0.9943;FLUDARABINE#0.9941;MYELOID LEUKEMIA#0.9913;CANCER CELL#0.9911;LUNG CANCER#0.9910;DNA METHYLATION#0.9906;NUCLEOSIDE TRANSPORT#0.9889;T CELL#0.9871;DRUG RESISTANCE#0.9861;DNA SYNTHESIS#0.9849;ADENOCARCINOMA#0.9823;TUMOR CELLS#0.9807;PROTEIN KINASE#0.9807;MONONUCLEAR CELLS#0.9797;APOPTOSIS#0.9788;TOXICITY#0.9785;CYTOTOXICITY#0.9782;CELL PROLIFERATION#0.9782;THYMIDYLATE#0.9771;DNA REPAIR#0.9768;PURINE NUCLEOSIDE PHOSPHORYLASE#0.9761;DEOXYTHYMIDINE#0.9738;BREAST CANCER#0.9705;GUANINE#0.9694;CELL DEATH#0.9686;MITOCHONDRIA#0.9650;NUCLEOSIDE SALVAGE#0.9610;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9599;DIPHOSPHATE#0.9526;DEAMINASE ACTIVITY#0.9457;HUMAN IMMUNODEFICIENCY VIRUS#0.9405;CELL GROWTH#0.9404;5 FLUOROURACIL#0.9391;MECHANISM OF ACTION#0.9291;TRANSCRIPTASE#0.9287;CONCENTRATIVE NUCLEOSIDE TRANSPORTER#0.9236;DCMP DEAMINASE#0.9184;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9124;BLAST CELL#0.9117;ADENINE#0.9092;OVARIAN CANCER#0.9079;KINASE INHIBITOR#0.9067;OVARIAN#0.9064;MITOCHONDRIAL DNA#0.9030;DNA POLYMERASE ALPHA#0.9012;ETOPOSIDE#0.9002;AZACYTIDINE#0.8996;CYTOSINE DEAMINASE#0.8974;CISPLATIN#0.8964;PEMETREXED#0.8926;THYMIDYLATE SYNTHASE#0.8889;ACUTE MYELOID LEUKAEMIA#0.8863;CATALYTIC ACTIVITY#0.8814;POSITRON EMISSION TOMOGRAPHY#0.8808;HUMAN PANCREATIC CANCER#0.8795;B LYMPHOCYTE#0.8792;FLUOROURACIL#0.8783;TROXACITABINE#0.8742;INDUCTION OF APOPTOSIS#0.8612;B-LYMPHOBLAST#0.8601;LYMPH NODE#0.8569;ARA ATP#0.8382;DISEASE FREE SURVIVAL#0.8374;TRANSCRIPTION FACTOR#0.8325;MUTAGENESIS#0.8295;2'-DEOXYURIDINE#0.8286;THYMIDINE KINASE ACTIVITY#0.8255;GUANOSINE#0.8215;PANCREATIC ADENOCARCINOMA#0.8181;NUCLEOTIDE METABOLISM#0.8157;HEPATITIS B#0.8155;RESPONSE TO GEMCITABINE#0.8077;REVERSE TRANSCRIPTION#0.8054;NUCLEIC ACID#0.8020;DNA REPLICATION#0.8017;TOPOISOMERASE#0.7913;PACLITAXEL#0.7844;THYMIDYLATE KINASE#0.7808;LUNG CARCINOMA#0.7800;NUCLEOTIDASE ACTIVITY#0.7773;HYPOXANTHINE#0.7736;STEM CELL#0.7730;CELL KILLING#0.7725;T LYMPHOCYTE#0.7715;HYDROXYUREA#0.7712;CELLULAR METABOLISM#0.7681;ANABOLISM#0.7655;5' NUCLEOTIDASE ACTIVITY#0.7607;RIBONUCLEOTIDE REDUCTASE ACTIVITY#0.7597;ACUTE LEUKEMIA#0.7591;PROTEIN SYNTHESIS#0.7574;GENOTOXIC#0.7555;PANCREATIC DUCTAL ADENOCARCINOMA#0.7504;PROTEIN KINASE C#0.7460;TOPOISOMERASE II#0.7437;TUMOR TISSUES#0.7391;DNA HYPOMETHYLATION#0.7370;MACROPHAGE#0.7343;APOPTOTIC#0.7204;SQUAMOUS CELL CARCINOMA#0.7201;DGK ACTIVITY#0.7156;EPITHELIAL CELL#0.7082;LAMIVUDINE#0.7035;CTP FORMATION#0.6981;DEOXYCOFORMYCIN#0.6961;THYMIDINE PHOSPHORYLASE#0.6951;MULTIDRUG RESISTANCE PROTEIN#0.6928;GROWTH FACTOR#0.6928;DOXORUBICIN#0.6880;9-BETA-D-ARABINOFURANOSYLADENINE#0.6859;METHOTREXATE#0.6857;HAIRY CELL LEUKEMIA#0.6839;BETA-2#0.6833;DFDCYD#0.6820;CYTIDINE DEAMINASE ACTIVITY#0.6768;FOLLICULAR LYMPHOMA#0.6764;MITOCHONDRIAL TOXICITY#0.6755;GM-CSF#0.6689;LYMPHOID CELL LINES#0.6658;BREAST CANCER CELL#0.6656;RNA SYNTHESIS#0.6633;MECHANISMS OF ACTION#0.6583;NEUTROPENIA#0.6568;COLON CANCER#0.6551;THYMINE#0.6543;PYRIMIDINE SALVAGE#0.6504;DNA PRIMASE#0.6502;LYMPHOID TISSUE#0.6468;POST-TRANSLATIONAL MODIFICATION#0.6459;ATP BINDING#0.6448;HEMATOPOIETIC STEM CELL#0.6446;LEUKOCYTE#0.6382;URACIL#0.6374;DAUNORUBICIN#0.6327;MYELODYSPLASTIC SYNDROME#0.6304;DNA METHYLTRANSFERASE#0.6298;NUCLEOSIDE METABOLISM#0.6280;HYPOXIA#0.6259;THYMOCYTE#0.6191;MAXIMUM TOLERATED DOSE#0.6180;PERIPHERAL BLOOD LYMPHOCYTES#0.6180;HEPATITIS B VIRUS#0.6137;LYMPHOCYTE DEVELOPMENT#0.6122;VINCRISTINE#0.6115;LOW DOSE RATE#0.6104;ADVANCED PANCREATIC CANCER#0.6080;PURINE METABOLISM#0.6072;LYMPHOBLASTOID CELLS#0.6033;PERIAMPULLARY ADENOCARCINOMA#0.6007
163404	ACID PHOSPHATASE#0.8430
163486	TH2 CELL#0.6443;T CELL#0.6401
1634	CHONDROITIN SULPHATE PROTEOGLYCAN#1.0501;FIBRILLIN#1.0500;AUTOPHAGY#1.0492;BREAST CARCINOMA#1.0489;COLLAGEN BINDING#1.0463;COLLAGEN TYPE III#1.0441;FIBRILLAR COLLAGEN#1.0413;ENDOCYTOSIS#1.0407;TROPHOBLAST#1.0329;RECEPTOR TYROSINE KINASE#1.0323;CORNEAL DYSTROPHY#1.0322;ENDOTHELIAL GROWTH FACTOR#1.0271;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0271;MATRIX METALLOPROTEINASE 1#1.0262;COLLAGEN TYPE II#1.0255;MYOBLAST#1.0245;MYOGENIC CELL#1.0243;MESANGIAL CELL#1.0237;LEUCINE RICH REPEAT#1.0225;LYME DISEASE#1.0223;PROSTATE CANCER#1.0197;TUMOR SUPPRESSOR#1.0183;CYCLIN DEPENDENT KINASE#1.0180;LUNG CANCER#1.0176;TUBE FORMATION#1.0156;ELASTIC FIBER#1.0148;BREAST CANCER CELL#1.0130;SPINAL CORD#1.0126;ATHEROSCLEROTIC#1.0125;ANGIOGENESIS#1.0123;EPIDERMAL GROWTH FACTOR#1.0123;CANCER CELL#1.0121;LEUCINE#1.0111;PERIODONTAL LIGAMENT#1.0106;STROMA#1.0105;DIABETIC NEPHROPATHY#1.0105;SMOOTH MUSCLE ACTIN#1.0098;VOCAL FOLD#1.0095;DERMAL FIBROBLAST#1.0095;PROTEOGLYCAN#1.0093;COLLAGEN TYPE I#1.0090;QUANTITATIVE REAL TIME#1.0089;GROWTH FACTOR RECEPTOR#1.0087;SKIN FIBROBLASTS#1.0081;KINASE INHIBITOR#1.0063;FIBROBLAST GROWTH FACTOR#1.0057;KNEE JOINT#1.0042;HEPARIN#1.0041;CHONDROITIN SULFATE PROTEOGLYCAN#1.0037;TUMOR CELLS#1.0036;HYALURONIC ACID#1.0035;TISSUE GROWTH FACTOR#1.0033;COLLAGEN SYNTHESIS#1.0028;BONE MORPHOGENETIC PROTEIN#1.0025;CELL GROWTH#1.0020;CELL MIGRATION#1.0009;FIBRIL#1.0009;ALKALINE PHOSPHATASE#1.0003;ADENO ASSOCIATED VIRUS#1.0001;BREAST CANCER#0.9999;EHLERS-DANLOS SYNDROME#0.9997;SIGNALING PATHWAY#0.9994;COLON CANCER#0.9988;TRANSCRIPTASE#0.9977;INSULIN-LIKE GROWTH FACTOR#0.9976;SIGNALING MOLECULE#0.9970;DERMIS#0.9969;HYALURONAN#0.9964;ADIPOSE TISSUE#0.9961;PROTEIN KINASE#0.9949;COLLAGENASE#0.9947;TUMOR NECROSIS FACTOR#0.9943;ENDOTHELIAL CELL#0.9934;MYOFIBROBLAST#0.9922;PROTEIN SYNTHESIS#0.9920;LOW DENSITY LIPOPROTEIN#0.9912;TRANSCRIPTION FACTOR#0.9911;EPITHELIAL CELL#0.9910;REVERSE TRANSCRIPTION#0.9909;SKELETAL MUSCLE#0.9908;CELL ADHESION#0.9905;CELL CYCLE#0.9904;APOPTOSIS#0.9901;MESENCHYMAL CELL#0.9898;TRANSFORMING GROWTH FACTOR BETA#0.9892;BLOOD VESSEL#0.9887;MINERALIZATION#0.9886;VASCULAR SMOOTH MUSCLE CELL#0.9884;OVARIAN#0.9881;GESTATION#0.9865;PROGENITOR CELL#0.9861;POLYMERASE CHAIN REACTION#0.9859;NEPHROPATHY#0.9858;TRANSFORMING GROWTH FACTOR#0.9857;PLATELET-DERIVED GROWTH FACTOR#0.9853;MACROPHAGE#0.9850;FIBRIL ORGANIZATION#0.9850;SMOOTH MUSCLE CELL#0.9850;ARTERY#0.9846;SMOOTH MUSCLE#0.9844;GLOMERULONEPHRITIS#0.9841;BASEMENT MEMBRANE#0.9841;CELL PROLIFERATION#0.9840;GLYCOSYLATION#0.9838;OSTEOBLAST#0.9835;MUSCLE CELL#0.9831;EXTRACELLULAR MATRIX COMPONENT#0.9829;SULFATION#0.9827;ATHEROSCLEROSIS#0.9823;BONE FORMATION#0.9823;WOUND HEALING#0.9822;TYROSINE KINASE RECEPTOR#0.9808;GROWTH FACTOR#0.9804;CONNECTIVE TISSUE#0.9798;CELL SURFACE#0.9797;TRANSMISSION ELECTRON MICROSCOPY#0.9795;RETINOIC ACID#0.9784;SQUAMOUS CELL CARCINOMA#0.9778;FACTOR I#0.9777;PROTEOGLYCAN SYNTHESIS#0.9776;CELL DIFFERENTIATION#0.9775;DODECYL SULFATE#0.9767;SODIUM DODECYL SULFATE#0.9767;MORPHOGENESIS#0.9761;STROMAL CELL#0.9750;CHONDROCYTE#0.9749;TUMOR TISSUES#0.9735;GENE EXPRESSION#0.9731;T CELL#0.9728;DIGESTION#0.9713;OSTEOARTHRITIS#0.9703;NERVOUS SYSTEM#0.9698;INTERVERTEBRAL DISC#0.9696;TGF-BETA BINDING#0.9689;BONE MARROW#0.9689;MESENCHYMAL STEM CELL#0.9683;EXTRACELLULAR MATRIX#0.9661;GROWTH FACTOR BINDING#0.9651;IMMUNE RESPONSE#0.9643;REGENERATION#0.9642;DECIDUA#0.9641;MYOTUBE#0.9626;KERATINOCYTE#0.9618;HAIR FOLLICLE#0.9611;HYPERTROPHIC SCAR FIBROBLASTS#0.9611;STEM CELL#0.9608;CRUCIATE LIGAMENT#0.9605;TUBULAR EPITHELIAL CELL#0.9604;CHONDROGENESIS#0.9584;MICROFIBRIL#0.9579;CENTRAL NERVOUS SYSTEM#0.9527;BLEOMYCIN#0.9520;SIGNAL TRANSDUCTION#0.9519;CELL ASSOCIATED#0.9513;APOPTOTIC#0.9503;NUCLEUS PULPOSUS#0.9499;ENDOPLASMIC RETICULUM#0.9480;OSSIFICATION#0.9472;MITOGEN ACTIVATED PROTEIN#0.9471;HYPOXIA#0.9461;PANCREATIC CANCER#0.9455;HYALURONAN SYNTHASE#0.9417;COLLAGEN NETWORK#0.9413;COLORECTAL#0.9404;GUANIDINE#0.9393;TISSUE REGENERATION#0.9392;ANTERIOR CRUCIATE LIGAMENT#0.9387;GLYCOSAMINOGLYCAN SYNTHESIS#0.9367;COLLAGEN TYPE IV#0.9367;MENISCUS#0.9360;QUANTITATIVE REVERSE TRANSCRIPTION#0.9358;REGULATION OF COLLAGEN FIBRILLOGENESIS#0.9349;LUNG FIBROBLASTS#0.9338;HYDROXYPROLINE#0.9322;COLORECTAL CANCER#0.9322;CATABOLISM#0.9312;HYALURONAN BINDING#0.9298;MUSCULAR DYSTROPHY#0.9271;PROLIFERATIVE VITREORETINOPATHY#0.9267;MYOBLAST PROLIFERATION#0.9267;HEPATOCYTE GROWTH FACTOR#0.9252;MYOGENESIS#0.9251;BETA-2#0.9249;CELL DEATH#0.9208;LYMPH NODE#0.9174;KIDNEY DISEASE#0.9171;INFLAMMATORY CELL#0.9161;CYCLIN DEPENDENT KINASE INHIBITOR#0.9161;GLUCOSAMINE#0.9149;HEPARIN BINDING#0.9137;COLLAGEN TYPE VI#0.9121;MESENCHYME#0.9110;ADIPOCYTE#0.9103;INFLAMMATORY RESPONSE#0.9086;NITRIC OXIDE#0.9071;PULMONARY FIBROSIS#0.9023;OSTEOGENESIS#0.9014;TOLL LIKE RECEPTOR#0.8997;CERVICAL#0.8994;MOLAR#0.8993;MATRIX GLA PROTEIN#0.8972;LECTIN#0.8967;GRANULOSA CELL#0.8953;DECIDUAL CELL#0.8935;PERIPHERAL BLOOD#0.8928;PROGESTERONE#0.8928;SCIATIC NERVE#0.8926;TISSUE REMODELING#0.8922;UMBILICAL CORD#0.8888;CYTOPLASM#0.8879;IMMUNE CELL#0.8869;HYALURONIC ACID BINDING#0.8821;MYOCARDIAL INFARCTION#0.8809;ENDOMETRIUM#0.8807;METHIONINE#0.8805;SCANNING ELECTRON MICROSCOPY#0.8796;ONCOGENIC#0.8796;IFN-GAMMA#0.8760;ADENOCARCINOMA#0.8752;POST-TRANSLATIONAL MODIFICATION#0.8744;MITRAL VALVE#0.8741;BONE MARROW STROMAL#0.8732;PROTEOGLYCAN METABOLISM#0.8727;CHONDROSARCOMA#0.8722;DEXAMETHASONE#0.8713;MATRIX METALLOPROTEINASE 13#0.8710;ADVENTITIA#0.8703;STROMAL DYSTROPHY#0.8684;LYSINE#0.8662;AXON GROWTH#0.8656;MAST CELL#0.8650;TISSUE HOMEOSTASIS#0.8624;MUSCLE WEAKNESS#0.8615;RECEPTOR MEDIATED ENDOCYTOSIS#0.8590;PRECURSOR CELL#0.8573;KINASE ACTIVITY#0.8560;COLONY-STIMULATING FACTOR#0.8553;AIRWAY SMOOTH MUSCLE#0.8546;ENDOTHELIUM#0.8546;C TERMINAL DOMAIN#0.8538;SPINAL CORD INJURIES#0.8527;EXTRACELLULAR SPACE#0.8513;GUANIDINIUM CHLORIDE#0.8511;OVARIAN CANCER#0.8502;COLLAGEN TYPE V#0.8498;STRESS URINARY INCONTINENCE#0.8471;LEUKOCYTE#0.8460;MONOCYTE#0.8457;BONE CELLS#0.8449;CELLULAR GROWTH#0.8420;FIBROBLAST PROLIFERATION#0.8420;NEURITE#0.8417;PRO-INFLAMMATORY#0.8410;B CELL#0.8404;FIBRINOGEN#0.8404;CERVIX#0.8395;INTERSTITIAL CELL#0.8384;HYALURONATE#0.8367;GLYCERALDEHYDE-3-PHOSPHATE#0.8362;CELL MEMBRANE#0.8324;MONONUCLEAR CELLS#0.8312;HEAT SHOCK PROTEIN#0.8295;BONE MARROW STROMAL CELL#0.8290;COLON CARCINOMA#0.8284;SYNOVIUM#0.8274;72-HOURS#0.8259;VASCULAR ENDOTHELIAL CELL#0.8258;SKELETAL MUSCLE REGENERATION#0.8222;ADIPOSE-DERIVED STEM CELL#0.8181;CORONARY ARTERY#0.8178;HYALURONIDASE#0.8165;ENDOCHONDRAL OSSIFICATION#0.8160;MARROW STROMAL CELLS#0.8150;ASCORBIC ACID#0.8142;RNA INTERFERENCE#0.8124;PHOSPHATE BUFFERED SALINE#0.8103;EOSIN#0.8097;MENSTRUAL CYCLE#0.8093;DIFFERENTIAL GENE EXPRESSION#0.8086;SURFACE PLASMON RESONANCE#0.8075;BIOTIN#0.8063;TROPHOBLAST CELL#0.8046;EARLY GROWTH RESPONSE#0.8023;ALZHEIMER'S DISEASE#0.8021;MECHANISM OF ACTION#0.8016;AORTIC VALVE#0.7976;PARENCHYMA#0.7959;ANNULUS FIBROSUS#0.7959;CELLULAR COMPONENT#0.7954;MEDIAL COLLATERAL LIGAMENT#0.7948;OSTEOARTHRITIC CARTILAGE#0.7947;CHONDROITINASE AC#0.7947;STREPTOZOTOCIN#0.7944;SPINAL CORD INJURY#0.7944;PERIPHERAL NERVE#0.7929;BETA GALACTOSIDASE#0.7927;MALIGNANT GLIOMA#0.7926;TUMOUR NECROSIS FACTOR#0.7919;PROTEOGLYCAN BIOSYNTHESIS#0.7915;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7908;MATRIX PROTEIN 1#0.7896;COMMUNICATING HYDROCEPHALUS#0.7889;PROTEIN KINASE B#0.7887;TYROSINE KINASE INHIBITOR#0.7887;ESTROGEN RECEPTOR#0.7878;BRANCHING MORPHOGENESIS#0.7869;HYPERTENSION#0.7866;MUSCLE FIBER#0.7815;LUNG BRANCHING MORPHOGENESIS#0.7804;GUANIDINE HYDROCHLORIDE#0.7801;FOCAL ADHESION#0.7801;ANNULUS#0.7774;HYPOXIA INDUCIBLE FACTOR#0.7764;BINDING PROTEIN 1#0.7764;EXTRA CELLULAR MATRIX#0.7761;INDUCIBLE NITRIC OXIDE#0.7744;UMBILICAL VEIN#0.7744;MITOPHAGY#0.7730;CELL ADHESION MOLECULE#0.7716;CARDIOMYOCYTE#0.7709;MYOMETRIUM#0.7702;TOOTH DEVELOPMENT#0.7686;HUMAN DERMAL FIBROBLAST#0.7682;AORTIC ANEURYSM#0.7669;SIZE EXCLUSION CHROMATOGRAPHY#0.7662;HUMAN MESENCHYMAL STEM#0.7657;GLUCURONIC ACID#0.7642;LUNG MORPHOGENESIS#0.7641;MESOTHELIAL CELL#0.7637;EXTRACELLULAR MATRIX ORGANIZATION#0.7622;ANAGEN#0.7602;BONE REMODELING#0.7585;HEPATOCELLULAR CARCINOMA#0.7581;MRNA SYNTHESIS#0.7572;LOCALIZED SCLERODERMA#0.7549;ALKALINE PHOSPHATASE ACTIVITY#0.7518;ASIALOGLYCOPROTEIN RECEPTOR#0.7510;MARFAN SYNDROME#0.7492;NEPHRITIS#0.7490;NEURITE OUTGROWTH#0.7489;PHOSPHATASE ACTIVITY#0.7489;MAP KINASE#0.7421;TENDON DEVELOPMENT#0.7412;NASAL MUCOSA#0.7388;NEUTROPHIL#0.7387;GLUCURONATE#0.7383;RETINAL PIGMENT EPITHELIAL#0.7377;SYNOVIAL FLUID#0.7373;GINGIVA#0.7367;DELAYED-TYPE HYPERSENSITIVITY#0.7359;SULPHATION#0.7358;ADIPOGENESIS#0.7356;UTERUS#0.7351;PARATHYROID HORMONE#0.7347;LUNG GROWTH#0.7343;VASCULAR CELL#0.7338;PECTORALIS MAJOR#0.7334;LYMPH NODE METASTASIS#0.7331;INDUCTION OF APOPTOSIS#0.7327;HAIR CYCLE#0.7325;INTERVERTEBRAL DISC DEGENERATION#0.7312;ARGININE#0.7299;NITRIC OXIDE SYNTHASE#0.7297;EMBRYONIC LUNG#0.7294;MYOCARDIUM#0.7274;PLASMA MEMBRANE#0.7255;RECEPTOR ANTAGONIST#0.7254;PERIODONTAL DISEASE#0.7236;OSTEOBLAST DIFFERENTIATION#0.7227;PRE-ECLAMPSIA#0.7219;VASCULAR DISEASE#0.7194;CELL MOTILITY#0.7192;SIGNALLING PATHWAY#0.7173;METASTATIC BREAST CANCER#0.7164;SCLERODERMA#0.7161;REGULATION OF GENE EXPRESSION#0.7153;OBESE#0.7147;MULTIPLE MYELOMA#0.7136;HUMAN UMBILICAL VEIN#0.7135;MUSCLE HYPERTROPHY#0.7098;MYOBLAST MIGRATION#0.7088;GLYCINE#0.7063;CHONDROCYTE DIFFERENTIATION#0.7059;ABDOMINAL AORTIC ANEURYSM#0.7052;DENTIN MATRIX PROTEIN#0.7039;HYDROCEPHALUS#0.7034;RENAL ARTERY#0.7027;SULFATE BINDING#0.7025;INCONTINENCE#0.7022;OSTEOCLAST#0.7017;RHEUMATOID ARTHRITIS#0.7010;SMC PROLIFERATION#0.7008;DUCHENNE MUSCULAR DYSTROPHY#0.6993;ENDOTHELIAL CELL MIGRATION#0.6974;GERM CELL#0.6971;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6970;CELL DIVISION#0.6968;SIGNAL TRANSDUCER#0.6965;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6937;MESENCHYMAL STROMAL CELL#0.6913;FETAL GROWTH RESTRICTION#0.6909;SERUM ALBUMIN#0.6906;STROMELYSIN#0.6894;G1 PHASE#0.6889;PATERNALLY EXPRESSED GENE#0.6858;PARTURITION#0.6828;OSTEOGENESIS IMPERFECTA#0.6823;DORSAL ROOT GANGLION#0.6817;DORSAL AORTA#0.6808;TOPICAL#0.6792;MAMMARY GLAND#0.6789;DENTIN MINERALIZATION#0.6785;ASTROCYTE#0.6777;CELL CYCLE ARREST#0.6757;T LYMPHOCYTE#0.6743;PEPTIDOGLYCAN#0.6727;MRNA TRANSCRIPTION#0.6722;EPITHELIAL MESENCHYMAL TRANSITION#0.6688;MELANOMA CELL LINES#0.6684;GROWTH HORMONE#0.6679;ENDOSOME#0.6676;CELLULAR LOCALIZATION#0.6670;CORNEA PLANA#0.6651;LIPOPROTEIN LIPASE#0.6637;LUNG ADENOCARCINOMA#0.6631;INNER LAYER#0.6614;CARRIE#0.6606;PARATHYROID#0.6599;CLEFT PALATE#0.6591;VIRULENCE#0.6584;QUIESCENCE#0.6538;MYOGENIC REGULATORY FACTOR#0.6536;CEREBRAL CORTEX#0.6525;PECTORALIS MAJOR MUSCLE#0.6483;DRUG RESISTANCE#0.6434;HEPATIC STELLATE CELL#0.6430;D-GLUCURONATE#0.6426;ACTINOMYCIN D#0.6421;SIGNAL PEPTIDE#0.6418;PROTEASOME#0.6412;LUNG DISEASE#0.6407;INFERTILITY#0.6402;FIBROBLAST MIGRATION#0.6369;PERITONEAL MESOTHELIAL CELLS#0.6351;CYTOTOXICITY#0.6333;FIBRONECTIN BINDING#0.6324;BICEPS#0.6312;ESTRADIOL#0.6301;CARBOHYDRATE RECOGNITION DOMAIN#0.6281;VULVA CARCINOMA#0.6261;COLLAGEN METABOLISM#0.6253;PROLYL 4-HYDROXYLASE#0.6251;RECEPTOR BINDING#0.6220;INHIBITION OF CELL PROLIFERATION#0.6215;MAGNETIC RESONANCE IMAGING#0.6212;INTERMEDIATE FILAMENT#0.6207;CARCINOMA IN SITU#0.6202;SEQUESTERING#0.6193;TRANSCRIPTIONAL CONTROL#0.6189;INHIBIN#0.6182;GM-CSF#0.6173;SUBCUTANEOUS ADIPOSE TISSUE#0.6170;SKELETAL TISSUES#0.6158;VEGFR 2 BINDING#0.6149;LASER DESORPTION IONIZATION#0.6143;ISCHEMIA#0.6131;CHORIONIC VILLUS#0.6120;INTERSTITIAL CYSTITIS#0.6113;PODOCYTE#0.6077;ELASTIC FIBRE#0.6060;TROPHOBLAST STEM CELL#0.6058;SPINDLE CELL SARCOMA#0.6047
163589	GERM CELL#0.8793
163590	NUCLEAR ENVELOPE#0.8049;ENDOPLASMIC RETICULUM#0.7748;DYSTONIA#0.7055;ATPASE ACTIVITY#0.6806;PREIMPLANTATION EMBRYO DEVELOPMENT#0.6367;EMBRYO DEVELOPMENT#0.6074
1635	DCMP DEAMINASE#1.0942;DEAMINASE ACTIVITY#1.0938;THYMIDINE#0.9981;CYTIDINE DEAMINASE#0.9658;CYTIDINE#0.9433;DNA SYNTHESIS#0.8827;THYMIDINE KINASE#0.8555;CELL CYCLE#0.8420;THYMIDYLATE#0.8403;DEOXYCYTIDINE KINASE#0.8290;THYMIDYLATE SYNTHASE#0.7469;DIPHOSPHATE#0.7247;2'-DEOXYCYTIDINE#0.7064;DNA REPLICATION#0.6953;GEMCITABINE#0.6539;ENZYME ACTIVITY#0.6455;PRE-ECLAMPSIA#0.6223;5-AZA-2'-DEOXYCYTIDINE#0.6157
1636	KININASE II ACTIVITY#1.1232;PEPTIDYL DIPEPTIDASE A#1.0892;PEPTIDYL DIPEPTIDASE#1.0678;TEMOCAPRIL#1.0533;SPIRAPRIL#1.0509;MIGRAINE#1.0507;TRANDOLAPRIL#1.0492;T- PA#1.0485;OMAPATRILAT#1.0479;CILAZAPRIL#1.0471;SEMINAL PLASMA#1.0451;BENAZEPRIL#1.0450;ALPHA GLUCOSIDASE#1.0448;L-PROLINE#1.0445;GERM CELL#1.0432;FACTOR V LEIDEN#1.0430;DIPEPTIDYL PEPTIDASE IV#1.0422;AMINOPEPTIDASE P#1.0420;CHYMASE ACTIVITY#1.0374;QUINAPRIL#1.0354;NEUTRAL ENDOPEPTIDASE 24.11#1.0346;AT1 RECEPTOR BLOCKER#1.0335;PROSTATE CANCER#1.0323;EPIDIDYMIS#1.0318;FOSINOPRIL#1.0312;LUPUS NEPHRITIS#1.0311;DIPEPTIDYL PEPTIDASE#1.0305;SPIRONOLACTONE#1.0293;C TERMINAL DOMAIN#1.0288;ENDOPEPTIDASE 24.11#1.0286;ANGIOEDEMA#1.0282;INTERLEUKIN 2 RECEPTOR#1.0270;ACE ACTIVITY#1.0268;AORTIC ANEURYSM#1.0260;TELMISARTAN#1.0256;THIAZIDE#1.0256;ANGIOTENSIN RECEPTOR BLOCKER#1.0249;FIBRINOGEN#1.0248;ANGIOTENSIN TYPE 1#1.0240;INDAPAMIDE#1.0239;PERINDOPRIL#1.0227;ANGIOTENSIN RECEPTOR BLOCKADE#1.0220;DIPEPTIDE HYDROLASE#1.0216;RESPONSE SURFACE METHODOLOGY#1.0214;ALPHA AMYLASE#1.0211;ABDOMINAL AORTIC ANEURYSM#1.0201;L-LEUCINE#1.0195;ACE INHIBITOR#1.0189;SILICOSIS#1.0174;RAMIPRIL#1.0169;PHOSPHODIESTERASE#1.0169;SPERMATOZOA#1.0166;PHOSPHORAMIDON#1.0162;COLORECTAL CANCER#1.0161;FACTOR VIII#1.0157;BRUSH BORDER MEMBRANE#1.0152;OF DIABETIC RATS#1.0151;CHYMOSTATIN#1.0147;DIGOXIN#1.0146;ENALAPRILAT#1.0145;CALCIUM CHANNEL#1.0134;BRUSH BORDER#1.0129;NEPHROTIC SYNDROME#1.0126;AMLODIPINE#1.0124;GLYCOSYLATION#1.0123;ANGIOTENSIN CONVERTING ENZYME#1.0123;HYPERTROPHIC CARDIOMYOPATHY#1.0120;LUNG CANCER#1.0119;NEPHRITIS#1.0118;CEREBRAL INFARCTION#1.0113;ENALAPRIL MALEATE#1.0109;ANGIOTENSIN RECEPTOR#1.0108;CANDESARTAN CILEXETIL#1.0108;CANCER CELL#1.0107;CEREBROVASCULAR DISEASE#1.0102;DEXAMETHASONE#1.0097;ENZYME INHIBITOR#1.0096;METAL BINDING#1.0096;CONTROL OF BLOOD PRESSURE#1.0092;ASPIRIN#1.0092;POLYCYSTIC KIDNEY DISEASE#1.0090;ANGII TYPE 1#1.0089;ADRENERGIC RECEPTOR#1.0088;VALSARTAN#1.0084;ALKALINE PHOSPHATASE#1.0070;SLEEP APNEA#1.0069;LISINOPRIL#1.0061;ALKALINE PROTEASE#1.0060;SYNOVIAL FLUID#1.0055;ENDOTHELIAL NITRIC OXIDE#1.0055;LACTIC ACID BACTERIA#1.0053;BREAST CANCER#1.0051;VASCULAR ENDOTHELIAL CELL#1.0049;CORTISOL#1.0039;VASCULAR ENDOTHELIUM#1.0039;STRUCTURE ACTIVITY RELATIONSHIP#1.0039;PNEUMONIA#1.0038;ISCHEMIC HEART DISEASE#1.0037;CANDESARTAN#1.0033;METOPROLOL#1.0032;VESICOURETERAL REFLUX#1.0026;RENOVASCULAR HYPERTENSION#1.0024;DIABETIC RETINOPATHY#1.0022;ATENOLOL#1.0021;REVERSE TRANSCRIPTION#1.0020;RADICAL SCAVENGING ACTIVITY#1.0017;CATALYTIC ACTIVITY#1.0017;NIFEDIPINE#1.0016;DNA METHYLATION#1.0008;THIORPHAN#1.0006;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#1.0004;INCREASED BLOOD PRESSURE#1.0004;ENALAPRIL#1.0001;BLOOD PRESSURE REGULATION#0.9998;REGULATION OF BLOOD PRESSURE#0.9998;COLORECTAL#0.9998;CAPTOPRIL#0.9998;LACTIC ACID#0.9997;TYPE 1 DIABETIC#0.9997;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.9996;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.9995;FRAGMENT LENGTH POLYMORPHISM#0.9993;SARCOIDOSIS#0.9993;MEMBRANE FRACTION#0.9991;ACUTE LUNG INJURY#0.9989;CHOROID PLEXUS#0.9981;QUANTITATIVE REAL TIME#0.9978;BETA-2#0.9977;DNA BINDING#0.9974;PULMONARY HYPERTENSION#0.9974;BRADYKININ RECEPTOR#0.9973;SUBSTANCE P#0.9968;T LYMPHOCYTE#0.9965;TRANSCRIPTION FACTOR#0.9962;POLYMERASE CHAIN REACTION#0.9962;TYPE 2 DIABETIC#0.9962;MILK PROTEIN#0.9961;ENZYME ACTIVITY#0.9960;MONOCYTE#0.9960;ENDOPLASMIC RETICULUM#0.9958;PROTEIN KINASE C#0.9957;LIVER CIRRHOSIS#0.9952;ENDOPEPTIDASE INHIBITOR#0.9949;NEUTROPHIL#0.9947;PULMONARY SARCOIDOSIS#0.9946;LINEAR REGRESSION ANALYSIS#0.9943;ETHANOL#0.9943;TRADITIONAL RISK FACTORS#0.9936;CORONARY ARTERY LIGATION#0.9936;ADIPOSE TISSUE#0.9936;TRANSCRIPTASE#0.9935;RECEPTOR BINDING#0.9935;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9935;CELL SURFACE#0.9933;PLASMA MEMBRANE#0.9931;END STAGE RENAL FAILURE#0.9929;DEMENTIA#0.9928;FERMENTATION#0.9928;RHEUMATOID ARTHRITIS#0.9928;TYPE 1 DIABETES#0.9927;CELL MEMBRANE#0.9927;OBSTRUCTIVE SLEEP APNEA#0.9924;ENDOTHELIAL CELL#0.9923;ISOPROTERENOL#0.9922;NITRIC OXIDE SYNTHASE#0.9921;MAST CELL#0.9919;HEART RATE VARIABILITY#0.9916;VASOCONSTRICTOR#0.9914;BETA ADRENOCEPTOR#0.9911;LUMINAL#0.9911;HUMAN UMBILICAL VEIN#0.9911;ALLERGIC RHINITIS#0.9910;SKELETAL MUSCLE#0.9908;RESONANCE ENERGY TRANSFER#0.9906;RESPIRATORY DISTRESS#0.9906;DOPAMINE#0.9905;PROSTACYCLIN#0.9902;HYPOXIC#0.9900;GLOMERULONEPHRITIS#0.9898;CONNECTIVE TISSUE#0.9897;LEFT VENTRICULAR MASS#0.9897;RESPONSE TO ANGIOTENSIN#0.9896;C REACTIVE PROTEIN#0.9894;BRAIN NATRIURETIC PEPTIDE#0.9893;OBESE#0.9891;TUMOR NECROSIS FACTOR#0.9891;MACROPHAGE#0.9889;UMBILICAL VEIN#0.9889;URIC ACID#0.9888;CORONARY ARTERY BYPASS#0.9885;GROWTH FACTOR RECEPTOR#0.9885;CORONARY HEART DISEASE#0.9885;ARTERIOLE#0.9884;NEPHRON#0.9883;LEUCINE#0.9878;ANTIOXIDANT ACTIVITY#0.9876;ESSENTIAL HYPERTENSION#0.9875;DIGESTION#0.9875;SEMEN#0.9873;WEIGHT GAIN#0.9872;T CELL#0.9872;DIABETIC NEPHROPATHY#0.9872;MYOFIBROBLAST#0.9871;BLOOD PRESSURE HOMEOSTASIS#0.9871;MULTIPLE REGRESSION ANALYSIS#0.9870;LYMPH NODE#0.9870;HYDRALAZINE#0.9869;HEALTHY CONTROL SUBJECTS#0.9868;DILATED CARDIOMYOPATHY#0.9867;TYPE 1 DIABETES MELLITUS#0.9866;IRBESARTAN#0.9866;SUPEROXIDE DISMUTASE#0.9864;ENDOTHELIAL GROWTH FACTOR#0.9864;CARDIOVASCULAR RISK FACTOR#0.9863;PARKINSON'S DISEASE#0.9862;RENAL FIBROSIS#0.9861;TYPE 2 DIABETES MELLITUS#0.9861;2 DIABETES MELLITUS#0.9861;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9858;VASCULAR CELL#0.9857;GESTATION#0.9857;PERIPHERAL BLOOD#0.9856;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9855;CHRONIC HEART FAILURE#0.9853;ALZHEIMER'S DISEASE#0.9851;LUPUS ERYTHEMATOSUS#0.9848;KAWASAKI DISEASE#0.9846;MYOCARDIUM#0.9846;VASOPRESSIN#0.9846;DIABETIC KIDNEY DISEASE#0.9844;CORONARY ARTERY DISEASE#0.9842;MYOCARDIAL INFARCTION#0.9841;DIPEPTIDASE ACTIVITY#0.9840;NEPHROPATHY#0.9838;HEMATOPOIETIC STEM CELL#0.9837;HYDROCHLOROTHIAZIDE#0.9834;GLYCINE#0.9834;MULTIPLE LINEAR REGRESSION#0.9832;HIGH RISK PATIENTS#0.9831;LUNG DISEASE#0.9831;NORADRENALINE#0.9830;ACUTE MYOCARDIAL INFARCTION#0.9827;STEM CELL#0.9826;AMINOPEPTIDASE A#0.9826;FUROSEMIDE#0.9826;ALDOSTERONE#0.9825;URINARY TRACT INFECTION#0.9823;OSTEOARTHRITIS#0.9823;ARTERY DISEASE#0.9822;CONGESTIVE HEART FAILURE#0.9821;GLUTATHIONE#0.9820;VASODILATOR#0.9819;EPITHELIAL CELL#0.9819;HEMORRHAGE#0.9819;MESANGIAL CELL#0.9818;CAROTID ARTERY#0.9818;NADPH OXIDASE#0.9817;HYPERCHOLESTEROLEMIA#0.9815;HYPOXIA#0.9812;AMYLOID PRECURSOR PROTEIN#0.9812;ATRIAL FIBRILLATION#0.9809;CREATINE KINASE#0.9808;FOREARM#0.9806;PULMONARY ARTERY#0.9805;ADRENAL GLAND#0.9805;QUANTITATIVE TRAIT LOCUS#0.9805;HYPOTENSIVE#0.9804;ATHEROSCLEROTIC#0.9803;CARDIOMYOCYTE#0.9802;SERUM ALBUMIN#0.9801;PRE-ECLAMPSIA#0.9800;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9798;VASCULAR DISEASE#0.9796;HEART DISEASE#0.9796;BONE MARROW#0.9793;MECHANISM OF ACTION#0.9793;RECEPTOR ANTAGONIST#0.9790;SMALL INTESTINE#0.9790;AMBULATORY BLOOD PRESSURE#0.9789;FIBRINOLYSIS#0.9789;TRYPTOPHAN#0.9789;THROMBOSIS#0.9788;MAGNETIC RESONANCE IMAGING#0.9787;LOSARTAN#0.9786;PULMONARY FIBROSIS#0.9786;COLLAGEN TYPE I#0.9782;ALISKIREN#0.9781;TRANSFORMING GROWTH FACTOR BETA#0.9778;APOPTOTIC#0.9777;TRANSFORMING GROWTH FACTOR#0.9777;NITRIC OXIDE#0.9776;MYOSIN HEAVY CHAIN#0.9775;LIPID METABOLISM#0.9775;RENAL ARTERY#0.9774;OPIOID PEPTIDE#0.9774;ANEMIA#0.9772;BLOOD VESSEL#0.9771;LOW DENSITY LIPOPROTEIN#0.9769;TYPE 2 DIABETES#0.9769;HARDY WEINBERG EQUILIBRIUM#0.9769;BODY WEIGHT RATIO#0.9768;PSORIASIS#0.9763;INSECTICIDE RESISTANCE#0.9758;ENDOTHELIUM#0.9757;EDEMA#0.9754;PROTEIN KINASE#0.9754;PROPRANOLOL#0.9753;ANGIOGENESIS#0.9752;PULMONARY EDEMA#0.9752;MONONUCLEAR CELLS#0.9749;LEUKOCYTE#0.9746;PEPTIDASE INHIBITOR#0.9746;RECEPTOR AGONIST#0.9745;GENE EXPRESSION#0.9744;CATABOLISM#0.9744;HOE 140#0.9741;IMMUNE RESPONSE#0.9737;CORONARY ARTERY#0.9736;TACHYKININ#0.9736;INFLAMMATORY RESPONSE#0.9735;DIABETES MELLITUS#0.9735;PROTEINURIA#0.9732;JUXTAMEMBRANE#0.9732;CELL GROWTH#0.9730;LECTIN#0.9730;HYPOTENSION#0.9726;CARDIOMYOPATHY#0.9726;RENIN ACTIVITY#0.9725;SMOOTH MUSCLE ACTIN#0.9724;VASODILATION#0.9722;BRAIN RENIN-ANGIOTENSIN SYSTEM#0.9721;MUSCLE CELL#0.9716;VASOCONSTRICTION#0.9714;SMOOTH MUSCLE CELL#0.9714;NEUROPATHY#0.9714;UVEITIS#0.9711;GROWTH FACTOR#0.9711;COAGULATION#0.9711;TOXICITY#0.9710;VERAPAMIL#0.9708;ISCHEMIA#0.9706;TUMOUR NECROSIS FACTOR#0.9705;CELL PROLIFERATION#0.9705;VASCULAR SMOOTH MUSCLE CELL#0.9701;STREPTOZOTOCIN#0.9697;TARGET ORGAN DAMAGE#0.9697;HYPERTENSION#0.9697;URINARY PROTEIN#0.9697;PEROXISOME#0.9695;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.9694;PANIC DISORDER#0.9694;ALANINE#0.9693;CHRONIC KIDNEY DISEASE#0.9693;PRO-INFLAMMATORY#0.9689;HYPERGLYCEMIA#0.9688;MALIGNANT HYPERTENSION#0.9687;VENOUS BLOOD#0.9685;ICATIBANT#0.9683;CARDIOVASCULAR SYSTEM#0.9679;GLUCOSE METABOLISM#0.9678;NITRO-L-ARGININE#0.9677;PEPTIDE METABOLISM#0.9677;NOREPINEPHRINE#0.9677;LYSINE#0.9676;RANDOMIZED CONTROLLED TRIAL#0.9675;CARBOXYPEPTIDASE ACTIVITY#0.9674;CARBOXYPEPTIDASE A#0.9674;MESENTERIC ARTERY#0.9672;ARRHYTHMIA#0.9669;MYOCYTES#0.9665;KIDNEY DISEASE#0.9664;SIGNALING PATHWAY#0.9662;ADENOSINE#0.9662;NATRIURESIS#0.9661;APOPTOSIS#0.9660;ARGININE#0.9653;CONSTRICTION#0.9653;ADIPOCYTE#0.9652;CENTRAL NERVOUS SYSTEM#0.9649;ALVEOLAR MACROPHAGE#0.9648;HIGH DENSITY LIPOPROTEIN#0.9647;ARTERY#0.9647;RNA INTERFERENCE#0.9645;L-ARGININE#0.9644;LASER DESORPTION IONIZATION#0.9643;MYELOID CELL#0.9634;MULTIPLE LOGISTIC REGRESSION#0.9630;OVARIAN#0.9629;ZINC BINDING#0.9627;UMBILICAL CORD#0.9618;CYTOTOXICITY#0.9616;SMOOTH MUSCLE#0.9614;HISTAMINE#0.9610;ERYTHROCYTE#0.9609;CREATINE#0.9607;BENAZEPRIL HYDROCHLORIDE#0.9607;EXTRACELLULAR MATRIX#0.9606;APROTININ#0.9606;ARACHIDONIC ACID#0.9605;MECHANISMS OF ACTION#0.9603;URINARY KALLIKREIN#0.9603;MALARIA#0.9603;FRONTAL#0.9601;INDOMETHACIN#0.9595;EXCRETION#0.9595;NERVOUS SYSTEM#0.9589;GLOMERULAR FILTRATION RATE#0.9582;SIGNAL TRANSDUCTION#0.9581;MITRAL VALVE#0.9579;BONE FORMATION#0.9578;PEPTIDE HORMONE#0.9575;RESPONSE TO EXERCISE#0.9573;GLOMERULAR FILTRATION#0.9571;BLOOD GLUCOSE LEVEL#0.9571;PHYSICAL ACTIVITY LEVEL#0.9570;STRIATUM#0.9568;REACTIVE OXYGEN SPECIES#0.9565;MITOGEN ACTIVATED PROTEIN#0.9564;WEIGHT LOSS#0.9563;PLATELET-DERIVED GROWTH FACTOR#0.9560;GLUCOSE INTOLERANCE#0.9559;ACUTE CORONARY SYNDROME#0.9557;POSITIVE FAMILY HISTORY#0.9551;BLOOD PLASMA#0.9551;VASODILATATION#0.9550;ADJUSTED ODDS RATIO#0.9548;HYDROXYPROLINE#0.9546;INFLAMMATORY CELL#0.9545;DIURESIS#0.9541;ACID PHOSPHATASE#0.9537;SYSTOLIC BLOOD PRESSURE#0.9518;SPINAL CORD#0.9516;ATHEROSCLEROSIS#0.9512;IN STENT RESTENOSIS#0.9512;GLUCOSE TOLERANCE TEST#0.9508;PODOCYTE#0.9504;BESTATIN#0.9496;SODIUM NITROPRUSSIDE#0.9493;GLUCOSE UPTAKE#0.9487;METHIONINE#0.9477;SOLUBLE FRACTION#0.9476;LIVER DISEASE#0.9475;PLATELET AGGREGATION#0.9459;THORACIC AORTA#0.9458;HEPATOCELLULAR CARCINOMA#0.9453;ALDOSTERONE RECEPTOR#0.9451;GLUTAMIC ACID#0.9450;HIGH FAT DIET#0.9445;HIGH CARDIOVASCULAR RISK#0.9444;GROWTH HORMONE#0.9441;SELECTIN#0.9433;CEREBRAL CORTEX#0.9433;EPIDERMAL GROWTH FACTOR#0.9419;PROGENITOR CELL#0.9417;MODE OF ACTION#0.9413;KIDNEY DAMAGE#0.9412;MILD COGNITIVE IMPAIRMENT#0.9411;FASTING PLASMA GLUCOSE#0.9410;INTIMA MEDIA THICKNESS#0.9404;CELL ADHESION#0.9402;MICROVASCULAR ENDOTHELIAL CELL#0.9399;ARGININE VASOPRESSIN#0.9398;BLOOD BRAIN BARRIER#0.9394;OPIOID RECEPTOR#0.9393;COLLAGENASE#0.9392;TACHYCARDIA#0.9388;CYTOPLASM#0.9387;PERCUTANEOUS CORONARY INTERVENTION#0.9383;PROTEIN SYNTHESIS#0.9370;BRONCHITIS#0.9363;VASCULAR RISK FACTORS#0.9361;SODIUM CHANNEL#0.9352;LINES OF EVIDENCE#0.9349;CARBAMATE RESISTANCE#0.9341;AORTIC VALVE#0.9338;HEMORRHAGIC#0.9338;MULTIPLE SCLEROSIS#0.9336;BASEMENT MEMBRANE#0.9336;INTERSTITIAL CELL#0.9335;GENETIC ASSOCIATION STUDIES#0.9334;HEMATOPOIESIS#0.9332;ALDOSTERONE SECRETION#0.9331;GLOMERULUS#0.9331;HYPERACTIVITY#0.9321;PANCREATITIS#0.9321;N-OMEGA-NITRO-L-ARGININE#0.9317;RESPONSE TO TREATMENT#0.9313;OXYGENASE#0.9312;DOXAZOSIN#0.9311;ORAL GLUCOSE TOLERANCE#0.9309;CELL ADHESION MOLECULE#0.9308;CLOPIDOGREL#0.9302;MUTAGENESIS#0.9302;AGE AT ONSET#0.9298;TUBERCULOSIS#0.9295;FASTING BLOOD GLUCOSE#0.9293;CELL DEATH#0.9279;MIGRAINE WITH AURA#0.9277;FORMALIN#0.9276;ACETYLCHOLINE#0.9276;SEPTUM#0.9271;HEALTHY CONTROL GROUP#0.9265;MULTIFACTOR DIMENSIONALITY REDUCTION#0.9256;OLMESARTAN#0.9255;LEFT VENTRICULAR REMODELING#0.9248;CEREBRAL ISCHEMIA#0.9240;ADVENTITIA#0.9211;IMPAIRED GLUCOSE TOLERANCE#0.9205;END ORGAN DAMAGE#0.9196;QUERCETIN#0.9194;SUDDEN CARDIAC DEATH#0.9188;BIPOLAR DISORDER#0.9186;LOCALISATION#0.9179;TRANSEPITHELIAL TRANSPORT#0.9179;TUBULAR EPITHELIAL CELL#0.9178;ACUTE PANCREATITIS#0.9176;CYTOCHROME P450#0.9171;NITROPRUSSIDE#0.9160;DODECYL SULFATE#0.9159;SODIUM DODECYL SULFATE#0.9159;CORONARY ARTERY STENOSIS#0.9155;INSULIN DEGRADING ENZYME#0.9153;PROXIMAL TUBULAR CELL#0.9153;VITAMIN D RECEPTOR#0.9147;NEOPTERIN#0.9141;WOUND HEALING#0.9141;ALBUMIN CREATININE RATIO#0.9139;PROSTAGLANDIN E2#0.9138;GLUTATHIONE PEROXIDASE#0.9137;POLYCYSTIC OVARY SYNDROME#0.9133;PARATHYROID HORMONE#0.9133;SQUAMOUS CELL CARCINOMA#0.9122;CROSS SECTIONAL AREA#0.9119;EPINEPHRINE#0.9111;ENDOTHELIN RECEPTOR#0.9109;CARVEDILOL#0.9094;RHINITIS#0.9094;ECLAMPSIA#0.9094;LIPOPROTEIN LIPASE#0.9088;HYPERSENSITIVITY#0.9085;PHENYLEPHRINE#0.9075;AUTOIMMUNE DISEASE#0.9075;COENZYME A#0.9075;DETOXIFICATION#0.9074;GASTROINTESTINAL TRACT#0.9072;TUBULOGLOMERULAR FEEDBACK#0.9068;SIZE EXCLUSION CHROMATOGRAPHY#0.9065;DIRECT RENIN INHIBITOR#0.9062;MOLECULAR DYNAMICS SIMULATION#0.9058;ESTRADIOL#0.9056;PORTAL HYPERTENSION#0.9052;QUANTITATIVE TRAIT LOCI#0.9045;LYMPH NODE METASTASES#0.9042;INSULIN RECEPTOR#0.9040;PROLIFERATIVE DIABETIC RETINOPATHY#0.9040;CELL ACTIVATION#0.9039;GLUCOCORTICOID RECEPTOR#0.9037;ADENINE#0.9020;ANCHORING#0.9004;FIBRILLAR COLLAGEN#0.8999;ALPHA-2 MACROGLOBULIN#0.8992;FELODIPINE#0.8991;CYCLOSPORINE#0.8988;HEMATOPOIETIC CELL#0.8978;FERTILIZATION#0.8978;BLEOMYCIN#0.8977;ENDOMETRIOSIS#0.8976;ACUTE KIDNEY INJURY#0.8965;PULSE WAVE VELOCITY#0.8960;NG-NITRO-L-ARGININE#0.8956;FIXED DOSE COMBINATION#0.8940;MAP KINASE#0.8930;END DIASTOLIC VOLUME#0.8910;ELITE ENDURANCE ATHLETES#0.8905;INTRACRANIAL ANEURYSM#0.8903;SIGNAL PEPTIDE#0.8895;TOPICAL#0.8891;AT1 RECEPTOR BINDING#0.8891;CARDIAC ARREST#0.8864;RESPIRATORY FAILURE#0.8861;RENAL TRANSPLANT RECIPIENTS#0.8857;PITUITARY GLAND#0.8856;NORMAL CONTROL GROUP#0.8850;EPLERENONE#0.8842;RENAL CELL CARCINOMA#0.8837;HYPERTENSIVE HEART DISEASE#0.8834;ISOLEUCINE#0.8832;UTERUS#0.8820;TRANSMISSION DISEQUILIBRIUM TEST#0.8807;HEPARIN#0.8806;STEM CELL PROLIFERATION#0.8798;SYSTOLIC HEART FAILURE#0.8793;STROMAL CELL#0.8783;TETRAHYDROFOLATE#0.8779;DNA SYNTHESIS#0.8776;LOW BIRTH WEIGHT#0.8775;RECURRENT PREGNANCY LOSS#0.8773;ARTERIOSCLEROSIS#0.8770;SWELLING#0.8769;NEPHROTOXICITY#0.8767;INSULIN-LIKE GROWTH FACTOR#0.8761;IMMUNE SYSTEM#0.8758;TO THE PROGRESSION#0.8755;CILIARY BODY#0.8754;RESPONSE TO ACE INHIBITOR#0.8753;MIGRAINE WITHOUT AURA#0.8749;BLOOD UREA NITROGEN#0.8736;WHITE BLOOD CELL#0.8719;SPERM MOTILITY#0.8716;GASTRIC MUCOSA#0.8700;CROHN'S DISEASE#0.8688;SUBSTANTIA NIGRA#0.8681;VALINE#0.8677;TOTAL PHENOLIC CONTENT#0.8670;PROTEINASE INHIBITOR#0.8665;PHOSPHODIESTERASE INHIBITOR#0.8664;PERIPHERAL BLOOD LEUKOCYTE#0.8663;ATORVASTATIN#0.8661;EOSIN#0.8649;GONAD#0.8649;INTENSIVE CARE UNIT#0.8648;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8641;GENE SILENCING#0.8638;BOSENTAN#0.8632;RESVERATROL#0.8627;COGNITION#0.8620;HOMOLOGOUS RECOMBINATION#0.8617;NUCLEIC ACID#0.8616;CORD BLOOD#0.8609;PEPTIDASE ACTIVITY#0.8606;NEUROTRANSMISSION#0.8605;INDOOR RESIDUAL SPRAYING#0.8605;INSULIN SECRETION#0.8597;PULMONARY ARTERIAL HYPERTENSION#0.8584;FRUCTOSE#0.8584;MAJOR DEPRESSIVE DISORDER#0.8574;TUMOR CELLS#0.8560;SERUM URIC ACID#0.8558;LEFT VENTRICLE HYPERTROPHY#0.8557;ADRENALINE#0.8547;PUROMYCIN#0.8543;SEVERE ACUTE RESPIRATORY SYNDROME#0.8539;PARENCHYMA#0.8534;ADVANCED GLYCATION END#0.8533;PARATHYROID#0.8529;SALIVARY GLAND#0.8518;REGENERATION#0.8505;RANDOMISED CONTROLLED TRIAL#0.8502;COLLAGEN SYNTHESIS#0.8497;VASCULAR DEMENTIA#0.8494;HISTIDINE#0.8482;WORLD HEALTH ORGANIZATION#0.8481;GRANULOCYTE#0.8477;ADENOSINE DEAMINASE#0.8472;URETERAL OBSTRUCTION#0.8469;KINASE INHIBITOR#0.8469;LATE PREGNANCY#0.8467;CYCLIC GUANOSINE MONOPHOSPHATE#0.8462;CELL CYCLE#0.8458;SLEEP APNEA SYNDROME#0.8457;GLUCOSE HOMEOSTASIS#0.8434;PYRETHROID RESISTANCE#0.8434;MUSCLE CONTRACTION#0.8432;ELECTROPHORETIC MOBILITY SHIFT#0.8426;BLAST CELL#0.8423;TISSUE DAMAGE#0.8420;BISOPROLOL#0.8420;X CHROMOSOME#0.8410;WHITE MATTER LESIONS#0.8404;ACROSOME REACTION#0.8400;DIMINAZENE ACETURATE#0.8399;PEPSTATIN#0.8398;AS MYOCARDIAL INFARCTION#0.8380;ASCITES#0.8377;BETA GALACTOSIDASE#0.8369;ASPARTATE#0.8366;FACTOR I#0.8366;DENDRITIC CELL#0.8358;AEROBIC EXERCISE TRAINING#0.8353;ACARBOSE#0.8345;PLASMA PROTEIN#0.8337;SOMATIC TISSUE#0.8328;CELLULAR GROWTH#0.8312;HINDLIMB#0.8289;CELLULAR LOCALIZATION#0.8289;HUMAN SERUM ALBUMIN#0.8279;SPERMATOGENESIS#0.8275;PERICARDIUM#0.8266;JUGULAR VEIN#0.8261;PERIPHERAL LEUKOCYTES#0.8259;INDUCIBLE NITRIC OXIDE#0.8257;PERMETHRIN#0.8248;PURPURA#0.8242;HEAT SHOCK PROTEIN#0.8237;DIPEPTIDYL CARBOXYPEPTIDASE ACTIVITY#0.8232;VESICLE COAT#0.8229;DYSPNEA#0.8227;GUANOSINE#0.8214;FOLATE#0.8208;HEME OXYGENASE 1#0.8206;BETA ADRENERGIC RECEPTOR#0.8187;LEFT ANTERIOR DESCENDING#0.8184;INULIN#0.8183;METFORMIN#0.8170;PLATELET ACTIVATION#0.8164;PROGESTERONE#0.8163;STROMA#0.8155;NITRIC OXIDE SYNTHESIS#0.8150;RAYNAUD’S#0.8148;MUSCLE FIBER#0.8147;DIPEPTIDYL PEPTIDASE 4#0.8128;AGEING#0.8120;PROSTAGLANDIN SYNTHESIS#0.8116;AMNIOTIC FLUID#0.8111;PROTEASE ACTIVITY#0.8106;FAT FREE MASS#0.8105;NEUROHORMONE#0.8090;HYPERGLYCEMIC#0.8082;COMMON CAROTID ARTERY#0.8080;ADRENAL MEDULLA#0.8070;RENNIN#0.8067;ALLERGEN#0.8065;CORONARY RESTENOSIS#0.8055;OVIDUCT#0.8050;BRADYCARDIA#0.8044;URTICARIA#0.8042;ASPARTIC ACID#0.8039;LITHIUM#0.8015;PREDNISOLONE#0.8013;RENNIN ANGIOTENSIN SYSTEM#0.8004;NASAL MUCOSA#0.7997;SUCROSE#0.7994;RENAL REPLACEMENT THERAPY#0.7986;ISCHEMIA REPERFUSION INJURY#0.7986;NALOXONE#0.7981;BRAIN INFARCTION#0.7979;CYCLIC AMP#0.7970;END SYSTOLIC VOLUME#0.7969;TESTOSTERONE#0.7959;COLITIS#0.7955;1,10-PHENANTHROLINE#0.7955;RETINOPATHY OF PREMATURITY#0.7950;NODULAR#0.7949;CARRIE#0.7942;TOTAL ANTIOXIDANT CAPACITY#0.7918;THROMBOPHILIA#0.7917;MULTIPLE MYELOMA#0.7916;PERIPHERAL BLOOD MONOCYTES#0.7895;NEURODEGENERATIVE DISEASE#0.7894;PSORIATIC ARTHRITIS#0.7893;XANTHINE OXIDASE#0.7892;FIBROBLAST GROWTH FACTOR#0.7887;STANDARD OF CARE#0.7886;CYCLOSPORIN#0.7880;PREMATURITY#0.7880;RISK OF DEATH#0.7868;FLUORESCEIN#0.7868;CEREBRAL ARTERY#0.7863;G-CSF#0.7857;BONE MINERAL DENSITY#0.7855;METALLOPROTEASE INHIBITOR#0.7851;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7849;CISPLATIN#0.7846;ASCORBIC ACID#0.7840;ANTI INFLAMMATORY DRUGS#0.7838;IL-1RA#0.7838;INTERVENTRICULAR SEPTUM#0.7834;CHLORIDE BINDING#0.7833;ACROSOME#0.7833;HEMOSTASIS#0.7830;KIDNEY FAILURE#0.7829;CALCITRIOL#0.7825;ENZYME REPLACEMENT THERAPY#0.7824;DUODENUM#0.7820;SOLID PHASE EXTRACTION#0.7815;EMBRYONIC STEM CELL#0.7815;LIPID LOWERING AGENT#0.7812;INFERTILITY#0.7809;MALATHION#0.7803;CANDOXATRIL#0.7797;HEREDITARY ANGIOEDEMA#0.7794;TOLL LIKE RECEPTOR#0.7792;NEPHROSIS#0.7789;TISSUE REMODELING#0.7788;RESPONSE TO COPPER#0.7777;MIDBRAIN#0.7776;ZONA PELLUCIDA#0.7772;LUNG DAMAGE#0.7769;RENAL TUBULAR DYSGENESIS#0.7768;NITRIC-OXIDE SYNTHASE INHIBITOR#0.7752;MOLAR#0.7745;IDIOPATHIC PULMONARY FIBROSIS#0.7740;SCLERODERMA#0.7737;CARDIAC MUSCLE#0.7727;QUANTITATIVE REVERSE TRANSCRIPTION#0.7708;MINI MENTAL STATE#0.7706;CYCLOSPORIN A#0.7704;PROTEIN COMPLEX#0.7697;ASTROCYTE#0.7696;INFERTILE#0.7696;XYLANASE#0.7695;MIDDLE CEREBRAL ARTERY#0.7691;ERYTHROPOIESIS#0.7691;IONOPHORE#0.7684;ALPHA ADRENOCEPTOR#0.7671;OUABAIN#0.7655;L-PHENYLALANINE#0.7644;HEMATOPOIETIC STEM CELL PROLIFERATION#0.7641;ENDOPEPTIDASE ACTIVITY#0.7639;SENSITIZATION#0.7633;CYTOCHROME C#0.7624;END OF TREATMENT#0.7616;PERIODONTITIS#0.7608;TROPHOBLAST#0.7607;NITROGLYCERIN#0.7605;DIZZINESS#0.7598;YOLK PROTEIN#0.7596;OOCYTE#0.7592;ANAPHYLAXIS#0.7587;BASAL GANGLIA#0.7585;REPRODUCTIVE SYSTEM#0.7571;METAL CHELATING#0.7570;ADRIAMYCIN#0.7569;DIURNAL#0.7564;OSTEOBLAST#0.7561;FEMUR#0.7556;EXTRACELLULAR SPACE#0.7551;ENDOCRINE SYSTEM#0.7551;MEMORY IMPAIRMENT#0.7548;PANCREATIC CANCER#0.7541;OESTRADIOL#0.7533;HYPERTENSIVE RETINOPATHY#0.7527;EOSINOPHIL#0.7521;ACETYLCHOLINESTERASE ACTIVITY#0.7518;ADENINE DINUCLEOTIDE PHOSPHATE#0.7516;GLUCOSE TRANSPORT#0.7508;PLATELET ACTIVATING FACTOR#0.7500;POSITRON EMISSION TOMOGRAPHY#0.7495;SPERM CAPACITATION#0.7472;ZUCKER DIABETIC FATTY#0.7467;CELL MIGRATION#0.7457;BREAST CANCER CELL#0.7434;DIMINAZENE#0.7432;ADULT RESPIRATORY DISTRESS SYNDROME#0.7424;CHAGAS DISEASE#0.7424;PENTOBARBITAL#0.7421;ACTION POTENTIAL#0.7405;JEJUNUM#0.7390;CELL BOUND#0.7381;NEPHROSCLEROSIS#0.7377;L-TYROSINE#0.7376;HIGH CHOLESTEROL DIET#0.7364;SIMVASTATIN#0.7362;BLOOD LOSS#0.7356;PEPTIDE DEGRADATION#0.7356;NICARDIPINE#0.7350;BETA GLUCURONIDASE#0.7347;INFLAMMATORY BOWEL DISEASE#0.7342;N-NITRO-L-ARGININE#0.7339;MOEXIPRIL#0.7335;CARBOHYDRATE METABOLISM#0.7334;MITOCHONDRIA#0.7329;ALPHA-TOCOPHEROL#0.7323;MAMMARY GLAND#0.7321;GERM CELL TUMORS#0.7313;PRIMARY PULMONARY HYPERTENSION#0.7308;RENAL HYPERTENSION#0.7291;MITOCHONDRIAL DNA#0.7288;ESTROGEN RECEPTOR#0.7281;LYMPH NODE METASTASIS#0.7262;CELL DIFFERENTIATION#0.7255;COLONY-STIMULATING FACTOR#0.7255;CEREBRAL AMYLOID ANGIOPATHY#0.7249;CONNEXIN#0.7246;UNILATERAL URETERAL OBSTRUCTION#0.7236;EPIDIDYMAL ADIPOSE TISSUE#0.7233;NICOTINE DEPENDENCE#0.7208;BODY SURFACE AREA#0.7205;SENESCENCE#0.7193;NATRIURETIC PEPTIDE RECEPTOR#0.7178;CHLORTHALIDONE#0.7172;AGE AT DIAGNOSIS#0.7171;TIBIA#0.7171;BODY WEIGHT GAIN#0.7170;BRONCHOPULMONARY DYSPLASIA#0.7165;ELECTROLYTE HOMEOSTASIS#0.7162;CELL ASSOCIATED#0.7161;STORAGE PROTEIN#0.7160;ISOTHERMAL TITRATION CALORIMETRY#0.7158;ACETYLSALICYLIC ACID#0.7151;FOREBRAIN#0.7150;LACRIMAL GLAND#0.7148;MICROVILLI#0.7142;INTESTINAL TRACT#0.7138;TARGET BLOOD PRESSURE#0.7134;SIGNALLING PATHWAY#0.7132;BASAL CELL#0.7132;HYPOXIA INDUCIBLE FACTOR#0.7131;CHROMOSOMAL REGION#0.7126;MESENCHYMAL STEM CELL#0.7118;TISSUE GROWTH FACTOR#0.7111;METAL CHELATING ACTIVITY#0.7095;NITRENDIPINE#0.7080;LOOP OF HENLE#0.7079;HYDROCORTISONE#0.7077;BONE MARROW CELLS#0.7073;L-DOPA#0.7063;XANTHINE#0.7059;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7056;PREDNISONE#0.7051;EPILEPSY#0.7026;VITAMIN E#0.7026;CONTACT DERMATITIS#0.7023;THYMIDINE#0.7014;SPONTANEOUS ABORTION#0.7007;APSTATIN#0.7005;PARTIAL LEAST SQUARE#0.6998;CONNECTIVE TISSUE DISEASE#0.6983;PRINCIPAL COMPONENT ANALYSIS#0.6956;LONE ATRIAL FIBRILLATION#0.6955;SERUM AMYLOID A#0.6947;FACTOR S#0.6947;ADRENAL CORTEX#0.6947;ESTROUS CYCLE#0.6946;GUANYLATE CYCLASE#0.6942;72-HOURS#0.6918;SECONDARY HYPERTENSION#0.6915;RECEPTOR LIGAND#0.6907;PROTEIN BINDING#0.6902;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6898;HEPATITIS B#0.6889;CELL FRACTION#0.6887;MALE REPRODUCTIVE SYSTEM#0.6886;MALNUTRITION#0.6877;RETINAL VEIN OCCLUSION#0.6870;DEHYDRATION#0.6865;SARCOPLASMIC RETICULUM#0.6859;ADENOSINE MONOPHOSPHATE#0.6852;NICOTINAMIDE#0.6848;SPERMIOGENESIS#0.6846;PHOSPHOLIPASE C#0.6831;VSMC PROLIFERATION#0.6824;L-TRYPTOPHAN#0.6823;EPROSARTAN#0.6819;LUNG DEVELOPMENT#0.6809;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6804;COLLAGEN FORMATION#0.6787;CIRCADIAN RHYTHM#0.6777;HYPOGLYCEMIA#0.6768;SMALL VESSEL DISEASE#0.6768;WATER RETENTION#0.6758;IMPLANTABLE CARDIOVERTER DEFIBRILLATOR#0.6753;AUTOLYSIS#0.6750;BETA CELL#0.6749;TRANSIENT ISCHEMIC ATTACK#0.6740;GRANULOSA CELL#0.6731;ULCERATIVE COLITIS#0.6729;PERIPHERAL ARTERIAL DISEASE#0.6720;SODIUM TRANSPORT#0.6706;CALCINEURIN#0.6695;DIASTOLIC HEART FAILURE#0.6693;VITAMIN C#0.6688;SPERMATOCYTES#0.6687;SECONDARY METABOLISM#0.6687;Y CHROMOSOME#0.6687;CYSTATIN#0.6678;IGA GLOMERULONEPHRITIS#0.6675;MEDULLA OBLONGATA#0.6674;INSULIN RECEPTOR SUBSTRATE#0.6671;POSITIVE PREDICTIVE VALUE#0.6665;RANDOMIZED CLINICAL TRIAL#0.6665;AMYGDALA#0.6646;PROTON PUMP INHIBITOR#0.6644;MUSCULAR DYSTROPHY#0.6643;NEURONAL CELLS#0.6641;RED BLOOD CELL#0.6629;CHOLINE BINDING#0.6625;LAMINA TERMINALIS#0.6625;PROTON PUMP#0.6621;C FIBER#0.6615;LUNG ENDOTHELIUM#0.6610;DOPAMINE D2 RECEPTOR#0.6606;ERYTHROCYTE SEDIMENTATION RATE#0.6605;ALPHA 1-ANTITRYPSIN#0.6603;SURFACE EPITHELIUM#0.6602;QUALITY OF CARE#0.6597;THYROID GLAND#0.6595;SILDENAFIL#0.6594;BACITRACIN#0.6594;FETAL BRAIN#0.6576;OSTEOPOROSIS#0.6564;DIABETIC NEUROPATHY#0.6561;SODIUM DODECYL SULPHATE#0.6554;CHRONIC ALLOGRAFT NEPHROPATHY#0.6553;DCP1-DCP2 COMPLEX#0.6553;OVARIES#0.6551;RESPIRATION#0.6551;RHEUMATIC HEART DISEASE#0.6519;SCHISTOSOMIASIS#0.6500;ATROPINE#0.6488;TRANSMISSION ELECTRON MICROSCOPY#0.6482;LARGE ARTERIES#0.6480;PERICYTE#0.6476;SIGNALING CASCADE#0.6474;GENERAL LINEAR MODEL#0.6472;RANDOM EFFECT MODEL#0.6459;TRIIODOTHYRONINE#0.6456;GRANULOMA FORMATION#0.6453;ENDOTHELIUM-DERIVED RELAXING FACTOR#0.6452;CALCIUM SIGNALING#0.6447;ENDOTHELIAL CELL ACTIVATION#0.6441;INTERSTITIAL LUNG DISEASE#0.6424;ESSENTIAL AMINO ACID#0.6420;CAUDATE NUCLEUS#0.6414;MIBEFRADIL#0.6413;PULMONARY EMBOLISM#0.6413;TACROLIMUS#0.6411;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6404;AND BODY COMPOSITION#0.6403;GENISTEIN#0.6402;MYOSIN LIGHT-CHAIN KINASE#0.6398;DUCHENNE MUSCULAR DYSTROPHY#0.6396;OPTIC NERVE#0.6385;METHACHOLINE#0.6380;BLOOD COAGULATION#0.6376;BILE DUCT#0.6365;DOPAMINE RECEPTOR#0.6361;COMPLEX I#0.6340;AMILORIDE#0.6324;PRIMARY CARE PHYSICIAN#0.6302;NITROGEN OXIDE#0.6300;OPTICAL COHERENCE TOMOGRAPHY#0.6294;HEMATURIA#0.6290;LIMIT OF DETECTION#0.6281;PRAZOSIN#0.6274;ALLERGIC CONTACT DERMATITIS#0.6271;GERMINAL CELLS#0.6266;CONTROLLED CLINICAL TRIALS#0.6259;QUADRICEPS#0.6254;CLOTTING#0.6253;NEUROTOXIC#0.6249;LIPID OXIDATION#0.6244;SMOOTH MUSCLE CELL PROLIFERATION#0.6240;MUSCLE CELL PROLIFERATION#0.6238;DERMATITIS#0.6235;5'-AMP#0.6229;3,4-DICHLOROISOCOUMARIN#0.6228;DEPRESSIVE SYMPTOMS#0.6222;SECRETORY GRANULE#0.6213;POLYMORPHONUCLEAR LEUKOCYTES#0.6212;HEPATIC STELLATE CELL#0.6208;GASTRIC ULCER#0.6202;KERATINOCYTE#0.6201;NEGATIVE PREDICTIVE VALUE#0.6199;VIRAL HEPATITIS#0.6186;EARLY GROWTH RESPONSE#0.6176;AMERICAN DIABETES ASSOCIATION#0.6166;LOW MOLECULAR WEIGHT HEPARIN#0.6163;DILTIAZEM#0.6163;ALDOSTERONE RENIN RATIO#0.6161;MONOCYTE DERIVED MACROPHAGE#0.6147;MITRAL VALVE DISEASE#0.6144;COPII VESICLE#0.6142;FATTY ACID SYNTHASE#0.6133;INTESTINAL MUCOSA#0.6130;DDT RESISTANCE#0.6127;ANTIGEN PRESENTING CELLS#0.6126;DPP IV ACTIVITY#0.6121;QUANTITATIVE CORONARY ANGIOGRAPHY#0.6117;MESENCHYMAL CELL#0.6115;WAIST HIP RATIO#0.6109;PROTEIN SECRETION#0.6102;COR PULMONALE#0.6100;ACTIVATED PROTEIN C#0.6100;17BETA OESTRADIOL#0.6099;MONOCYTE CHEMOTACTIC PROTEIN#0.6098;L-CYSTEINE#0.6095;ANTIDIURETIC HORMONE#0.6089;PORTAL VEIN#0.6088;MIXED CONNECTIVE TISSUE DISEASE#0.6077;HOMOCYSTEINE METABOLISM#0.6059;ABDOMINAL PAIN#0.6056;SERTOLI CELL#0.6056;BLOOD STASIS SYNDROME#0.6051;SIGNALING MOLECULE#0.6050;BREAST CANCER PATIENTS#0.6049;COLON CANCER#0.6042;ERYTHEMA#0.6035;HYDRONEPHROSIS#0.6034;HYPERTHYROIDISM#0.6027;ANURIA#0.6026;TOCOPHEROL#0.6025;CORONARY FLOW RESERVE#0.6023;SUMMARY ODDS RATIO#0.6018;S PHASE#0.6018;VSMC APOPTOSIS#0.6017;URINE ALBUMIN EXCRETION#0.6000
163702	PERIPHERAL BLOOD#0.9814;SIGNALING PATHWAY#0.8795;MONONUCLEAR CELLS#0.8686;LYMPH NODE#0.8675;HEPATITIS C#0.8415;HEPATITIS C VIRUS#0.8277;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8217;RECEPTOR COMPLEX#0.8060;GENE EXPRESSION#0.7974;T CELL#0.7765;B CELL#0.7405;EPITHELIAL CELL#0.7384;PSORIASIS#0.7198;CYTOKINE RECEPTOR#0.6943;APOPTOSIS#0.6937;SIGNAL TRANSDUCER#0.6931;CANCER CELL#0.6914;IMMUNE RESPONSE#0.6765;VIRAL INFECTION#0.6624;LIVER DISEASE#0.6445;DENDRITIC CELL#0.6326;HEPATITIS B#0.6223;TRANSCRIPTION FACTOR#0.6157;HEPATITIS B VIRUS#0.6068;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6055;LUPUS ERYTHEMATOSUS#0.6052;IMMUNE CELL#0.6022
163720	BREAST CANCER#1.0910;ANGIOGENESIS#0.7757;BREAST CANCER CELL#0.6653;CANCER CELL#0.6606
163732	GENE EXPRESSION#1.0001;BREAST CANCER#0.8068;PROGENITOR CELL#0.6407;CARDIAC PROGENITOR CELL#0.6067
163747	CD8+ T CELL#0.7033;T CELL#0.6928
163778	CORNIFIED ENVELOPE#0.6272
163786	CENTRIOLE ASSEMBLY#1.0712;CENTRIOLE#1.0523;PROCENTRIOLE#1.0493;CENTRIOLE DUPLICATION#1.0492;MOTHER CENTRIOLE#1.0261;MICROTUBULE#1.0017;CENTROSOME#0.9961;DAUGHTER CENTRIOLE#0.9730;BASAL BODY#0.9493;SPINDLE ASSEMBLY#0.9476;CELL CYCLE#0.9253;CENTROSOME DUPLICATION#0.8835;ORGANELLE#0.8618;S PHASE#0.8138;MICROCEPHALY#0.7696;PERICENTRIOLAR MATERIAL#0.7009;FLAGELLUM ASSEMBLY#0.7000;CELL DIVISION#0.6119
1637	CHROMOSOME REGION#1.1300;DOWN SYNDROME#1.1245
163859	UBIQUITIN#0.7961;PRE-MRNA SPLICING#0.6707;MRNA SPLICING#0.6674;TELOMERIC SILENCING#0.6609;REPLICATION FORK#0.6247
1638	DOPACHROME TAUTOMERASE ACTIVITY#1.1291;RELATED PROTEIN 1#1.0395;DOPA OXIDASE#1.0391;MELANOCYTE DIFFERENTIATION#1.0332;REVERSE TRANSCRIPTION#1.0161;MELANIN BIOSYNTHESIS#1.0147;MICROPHTHALMIA#1.0120;CD8+ T CELL#1.0106;MELANOMA CELL LINES#1.0099;IFN-GAMMA#1.0090;CYTOTOXIC T-LYMPHOCYTE#1.0051;POLYMERASE CHAIN REACTION#1.0040;T CELL#0.9995;PERIPHERAL BLOOD#0.9993;TRANSCRIPTION FACTOR#0.9989;MELANOSOME#0.9987;T LYMPHOCYTE#0.9970;CYTOTOXIC T CELL#0.9920;STEM CELL#0.9896;HAIR FOLLICLE#0.9892;MELANOCYTE#0.9877;DENDRITIC CELL#0.9869;NEURAL CREST#0.9866;TUMOR ANTIGEN#0.9866;LYMPH NODE#0.9850;TUMOR CELLS#0.9820;MELANIN SYNTHESIS#0.9818;CD4+ T CELL#0.9818;TYROSINASE ACTIVITY#0.9788;IMMUNE RESPONSE#0.9763;GENE EXPRESSION#0.9756;MELANOCYTE STEM CELL#0.9749;CAMP RESPONSE ELEMENT#0.9711;SIGNALING PATHWAY#0.9694;CYTOTOXICITY#0.9678;PROTEIN KINASE#0.9670;GROWTH FACTOR#0.9666;CAMP RESPONSE ELEMENT BINDING#0.9643;KERATINOCYTE#0.9612;MITOGEN ACTIVATED PROTEIN#0.9577;CELL PROLIFERATION#0.9574;TUMOR ASSOCIATED ANTIGEN#0.9562;MELANIN FORMATION#0.9542;METASTATIC MELANOMA#0.9307;APOPTOSIS#0.9232;NEURAL CREST CELL#0.9231;MACROPHAGE#0.9199;ADENOSINE MONOPHOSPHATE#0.9146;CYCLIC ADENOSINE MONOPHOSPHATE#0.9097;PROTEIN KINASE A#0.9091;QUANTITATIVE REAL TIME#0.9061;ENZYME ACTIVITY#0.8878;REACTIVE OXYGEN SPECIES#0.8863;BONE MARROW#0.8855;RETINAL PIGMENT EPITHELIUM#0.8662;PROTEASOME#0.8517;CELL SURFACE#0.8471;ADENOSINE#0.8427;L-TYROSINE#0.8368;TRANSCRIPTASE#0.8303;OCULOCUTANEOUS ALBINISM#0.8275;CELL GROWTH#0.8226;CELL CYCLE#0.8161;AUTOIMMUNITY#0.8149;GM-CSF#0.8118;IMMUNE SYSTEM#0.8058;MONONUCLEAR CELLS#0.8057;GLYCOSYLATION#0.7974;AMELANOTIC MELANOMA#0.7936;DRUG RESISTANCE#0.7857;SKIN CANCER#0.7792;ANTIGEN PRESENTING CELLS#0.7759;APOPTOTIC#0.7717;CELL DEATH#0.7613;PRECURSOR CELL#0.7609;CYCLIC AMP#0.7594;MELANIN BIOSYNTHETIC#0.7592;TOXICITY#0.7533;ARRHYTHMIA#0.7524;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7464;MECHANISM OF ACTION#0.7448;GLIOBLASTOMA MULTIFORME#0.7437;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7367;B CELL#0.7300;PIGMENT SYNTHESIS#0.7296;QUERCETIN#0.7259;REGULATORY T CELL#0.7106;MALIGNANT GLIOMA#0.7093;3,4-DIHYDROXYPHENYLALANINE#0.7059;MAPK SIGNALING#0.7022;COLONY-STIMULATING FACTOR#0.6978;LYSOSOME#0.6976;CELLULAR IMMUNE RESPONSE#0.6974;FORSKOLIN#0.6963;AKT SIGNALING#0.6949;ROOT SHEATH#0.6896;PERIPHERAL BLOOD LYMPHOCYTES#0.6865;ORGANELLE#0.6844;UBIQUITIN#0.6844;MELANOCORTIN RECEPTOR#0.6805;INDOLE#0.6769;PROGENITOR CELL#0.6737;TOPICAL#0.6679;ANAGEN#0.6666;MECHANISMS OF ACTION#0.6642;STEM CELL FACTOR#0.6615;ETHANOL#0.6589;MUTAGENESIS#0.6542;ASCORBIC ACID#0.6536;GLUTATHIONE#0.6507;ENDOPLASMIC RETICULUM#0.6432;IFN-GAMMA SECRETION#0.6316;CYTOPLASM#0.6300;TOLL LIKE RECEPTOR#0.6257;EXOSOME#0.6226;CELL DEVELOPMENT#0.6169;COPPER BINDING#0.6145;PLASMA MEMBRANE#0.6127;CELL DIFFERENTIATION#0.6107;EPITHELIAL CELL#0.6082;METAL BINDING#0.6077;CIS-DIAMMINEDICHLOROPLATINUM#0.6006
163933	CELL PROLIFERATION#1.1787
1639	PERRY SYNDROME#1.1367;DYNEIN#1.0370;MOTOR NEURON DISEASE#1.0168;AXONAL TRANSPORT#1.0077;AMYOTROPHIC LATERAL SCLEROSIS#0.9990;LATERAL SCLEROSIS#0.9990;DYNACTIN COMPLEX#0.9523;MOTOR NEURON DEGENERATION#0.9351;MICROTUBULE#0.8847;GENE EXPRESSION#0.8814;PROTEIN COMPLEX#0.8589;NEURODEGENERATIVE DISEASE#0.8207;WEIGHT LOSS#0.8089;RETROGRADE AXONAL TRANSPORT#0.8024;FRONTOTEMPORAL DEMENTIA#0.8024;PROGRESSIVE SUPRANUCLEAR PALSY#0.7951;DEMENTIA#0.7871;AUTOPHAGOSOME#0.7690;HEREDITARY MOTOR NEUROPATHY#0.7521;DYNACTIN MOTOR#0.7478;PARKINSON'S DISEASE#0.6857;SUPEROXIDE DISMUTASE#0.6558;GROWTH FACTOR#0.6523;AUTOSOMAL DOMINANT PARKINSONISM#0.6395;NEUROPATHY#0.6224;ANAPLASTIC LYMPHOMA KINASE#0.6224;INFLAMMATORY MYOFIBROBLASTIC TUMOR#0.6199;BASAL CORTEX#0.6166;EARLY GROWTH RESPONSE#0.6128;HERPES SIMPLEX VIRUS#0.6002
163	ADAPTIN#1.1078;ENDOCYTOSIS#0.9315;COATED VESICLE#0.9198;CLATHRIN COATED VESICLE#0.9150;CLATHRIN-MEDIATED ENDOCYTOSIS#0.7105;CLATHRIN HEAVY CHAIN#0.6906;PLASMA MEMBRANE#0.6695;CLATHRIN BINDING#0.6663;AP-1 ADAPTOR COMPLEX#0.6555;BETA-2#0.6306;FIBRILLIN#0.6135
164045	DNA HELICASE#1.1076;MEIOSIS#1.0000;SYNAPSIS#0.8284;DOUBLE STRAND BREAK#0.7775;SYNAPTONEMAL COMPLEX#0.7668;PROPHASE#0.7219;BUDDING#0.7215;PRIMARY OVARIAN INSUFFICIENCY#0.6424
164091	MEMBRANE PROGESTIN RECEPTOR#1.0993;PROGESTIN#1.0582;SPERM MOTILITY#1.0513;PROGESTERONE#1.0457;OOCYTE MATURATION#1.0403;OOCYTE#1.0381;PLASMA MEMBRANE#0.9608;OVARIAN#0.8826;GROWTH FACTOR#0.7793;GENE EXPRESSION#0.7610;EPIDERMAL GROWTH FACTOR#0.7449;GROWTH FACTOR RECEPTOR#0.7253;STEROID BINDING#0.7238;SMOOTH MUSCLE#0.6920;ESTROGEN RECEPTOR#0.6906;OVARIES#0.6708;ESTRADIOL#0.6357;CORPUS LUTEUM#0.6325;PROTEIN KINASE#0.6123;T LYMPHOCYTE#0.6091;ENDOPLASMIC RETICULUM#0.6054
164153	GERM CELL#0.7534
1641	NEUROBLAST DIFFERENTIATION#1.0597;SUBCORTICAL BAND HETEROTOPIA#1.0490;IMMATURE NEURON#1.0447;NEUROBLAST#1.0398;MICROTUBULE ASSOCIATED PROTEIN#1.0386;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0360;CELL ADHESION MOLECULE#1.0356;CELL ADHESION#1.0346;LISSENCEPHALY#1.0343;MICROTUBULE#1.0305;NEURAL CELL#1.0268;MICROTUBULE BINDING#1.0203;STRIATUM#1.0186;2'-DEOXYURIDINE#1.0164;NEURONAL MIGRATION#1.0150;CELL CYCLE#1.0089;ROSTRAL MIGRATORY STREAM#1.0071;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0068;HIPPOCAMPAL DENTATE GYRUS#1.0064;TRANSCRIPTION FACTOR#1.0032;OLFACTORY BULB#1.0001;PRECURSOR CELL#0.9996;CELL MIGRATION#0.9967;ASTROCYTE#0.9965;NEURAL PROGENITOR CELL#0.9964;CEREBRAL CORTEX#0.9960;NEURONAL CELLS#0.9956;INTERNEURON#0.9943;NEURAL STEM CELL#0.9924;CELL PROLIFERATION#0.9913;DENTATE GYRUS#0.9912;LATERAL VENTRICLE#0.9885;BRAIN DEVELOPMENT#0.9876;PROGENITOR CELL#0.9869;OLIGODENDROCYTE#0.9854;NERVOUS SYSTEM#0.9852;EPILEPSY#0.9849;ISCHEMIA#0.9829;MENTAL RETARDATION#0.9828;GROWTH FACTOR#0.9816;CELL DEATH#0.9806;STEM CELL#0.9800;NEUROGENESIS#0.9795;APOPTOSIS#0.9795;GENE EXPRESSION#0.9787;ADULT HIPPOCAMPAL NEUROGENESIS#0.9786;MORRIS WATER MAZE#0.9712;NEURONAL PROGENITOR CELL#0.9694;CENTRAL NERVOUS SYSTEM#0.9644;SIGNALING PATHWAY#0.9625;PYRAMIDAL CELL#0.9606;CEREBRAL ISCHEMIA#0.9600;GLIAL CELL#0.9576;CAMP RESPONSE ELEMENT BINDING#0.9556;CAMP RESPONSE ELEMENT#0.9545;MIDDLE CEREBRAL ARTERY#0.9513;CEREBRAL ARTERY#0.9511;CELL DIFFERENTIATION#0.9480;TELENCEPHALON#0.9465;NEURITE#0.9457;CEREBRAL ARTERY OCCLUSION#0.9426;NEURONAL PRECURSOR CELLS#0.9410;AMYGDALA#0.9403;GROWTH CONE#0.9374;ARTERY#0.9335;APOPTOTIC#0.9301;SPATIAL LEARNING#0.9231;ACTIN FILAMENT#0.9154;TEMPORAL LOBE#0.9109;NERVE GROWTH FACTOR#0.9093;TRAUMATIC BRAIN INJURY#0.9028;FOREBRAIN#0.9007;SPINAL CORD#0.8889;ALZHEIMER'S DISEASE#0.8866;POLYMERASE CHAIN REACTION#0.8848;PROTEIN KINASE#0.8846;FOCAL CEREBRAL ISCHEMIA#0.8797;INTELLECTUAL DISABILITY#0.8787;MAGNETIC RESONANCE IMAGING#0.8709;NEUROPROTECTION#0.8560;PARENCHYMA#0.8504;MEMORY IMPAIRMENT#0.8486;FORCED SWIM TEST#0.8457;NEURODEGENERATIVE DISEASE#0.8415;COGNITION#0.8323;REGENERATION#0.8290;DENDRITIC TREE#0.8203;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8203;ENDOTHELIAL GROWTH FACTOR#0.8202;BRAIN ISCHEMIA#0.8173;FLUORO JADE B#0.8158;BASAL DENDRITE#0.8149;GLUTAMIC ACID#0.7947;CELL DIVISION#0.7932;MELATONIN#0.7902;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7788;FRONTAL#0.7777;S PHASE#0.7777;GROWTH FACTOR RECEPTOR#0.7721;PERIVENTRICULAR NODULAR HETEROTOPIA#0.7717;DEVELOPMENTAL DELAY#0.7709;PROTEIN PHOSPHATASE 1#0.7629;BONE MARROW#0.7572;NEURAL PRECURSOR CELL#0.7563;BASAL GANGLIA#0.7540;TEMPORAL LOBE EPILEPSY#0.7519;ANGIOGENESIS#0.7474;PERIPHERAL BLOOD#0.7469;STEM CELL MARKER#0.7435;IN UTERO ELECTROPORATION#0.7386;THYMIDINE#0.7377;DOPAMINE#0.7363;NEUROBLASTOMA#0.7326;MITOSIS#0.7293;NOVEL OBJECT RECOGNITION#0.7254;HYPOXIC#0.7157;SHORT TERM MEMORY#0.7133;BRAIN DAMAGE#0.7130;MICROTUBULE DYNAMICS#0.7115;FIBROBLAST GROWTH FACTOR#0.7094;CHONDROCYTE#0.7090;DEMENTIA#0.7069;NEUROBLAST MIGRATION#0.7003;MICROTUBULE END#0.6970;HYPOXIA#0.6926;TAMOXIFEN#0.6856;TUMOR CELLS#0.6797;PILOCARPINE#0.6769;GLYCOGEN SYNTHASE KINASE#0.6764;CYCLIN DEPENDENT KINASE#0.6736;BLOOD VESSEL#0.6725;PARKINSON'S DISEASE#0.6724;X CHROMOSOME#0.6723;NEURITE OUTGROWTH#0.6719;ENDOTHELIAL CELL#0.6691;NEURON MIGRATION#0.6680;NESTIN POSITIVE CELLS#0.6659;DENDRITIC SPINE#0.6618;INTRACTABLE EPILEPSY#0.6611;NEURAL STEM PROGENITOR#0.6565;ACTIVATED CASPASE 3#0.6524;NODULAR#0.6473;INFLAMMATORY RESPONSE#0.6424;DYNEIN#0.6385;APICAL DENDRITE#0.6369;ETHANOL#0.6314;GESTATION#0.6312;TESTOSTERONE#0.6307;THYMIDINE KINASE#0.6265;EPIDERMAL GROWTH FACTOR#0.6243;ESTRADIOL#0.6240;RNA INTERFERENCE#0.6239;ADENOSINE MONOPHOSPHATE#0.6239;FORCED SWIMMING TEST#0.6225;HEMORRHAGE#0.6203;MICROGLIAL CELL#0.6200;AXON BRANCHING#0.6148;SIGNAL TRANSDUCTION#0.6129;NOTCH INTRACELLULAR DOMAIN#0.6100;CILIARY NEUROTROPHIC FACTOR#0.6093;HERPES SIMPLEX VIRUS#0.6036;HERPES SIMPLEX#0.6032;NEURAL CREST#0.6031;CORTICOGENESIS#0.6031;STATUS EPILEPTICUS#0.6016;BLOOD BRAIN BARRIER#0.6004
1642	DNA DAMAGE BINDING#1.0826;DAMAGED DNA BINDING#1.0609;UBIQUITIN LIGASE COMPLEX#1.0558;BINDING PROTEIN 1#1.0535;DNA BINDING#1.0396;XERODERMA PIGMENTOSUM GROUP E#1.0244;UBIQUITIN#1.0232;COP9 SIGNALOSOME#1.0155;PROTEIN COMPLEX#1.0150;XERODERMA PIGMENTOSUM#1.0111;HEPATITIS B#1.0107;HEPATITIS B VIRUS#1.0085;S PHASE#1.0079;NUCLEOTIDE EXCISION REPAIR#1.0032;DNA REPLICATION#1.0008;COMPLEX I#1.0000;DNA REPAIR#0.9987;CELL CYCLE#0.9983;PROTEASOME#0.9896;CELL CYCLE ARREST#0.9882;TRANSCRIPTION FACTOR#0.9845;CELL PROLIFERATION#0.9728;APOPTOSIS#0.9710;GENE EXPRESSION#0.9602;SIGNALOSOME#0.9559;CELL GROWTH#0.9458;TUMOR SUPPRESSOR#0.9334;PROTEIN DEGRADATION#0.9196;CELL DEATH#0.9123;LIGASE ACTIVITY#0.9116;VIRAL REPLICATION#0.9049;HUMAN IMMUNODEFICIENCY VIRUS#0.9000;DNA DAMAGE RESPONSE#0.8736;RNA INTERFERENCE#0.8662;RESPONSE TO UV#0.8660;THALIDOMIDE#0.8200;UBIQUITIN LIGASE ACTIVITY#0.8152;SIGNALING PATHWAY#0.8114;CANCER CELL#0.8080;HOST CELL#0.8065;LENALIDOMIDE#0.8027;COCKAYNE SYNDROME#0.7872;MULTIPLE MYELOMA#0.7808;GROWTH FACTOR#0.7739;PHOTOMORPHOGENESIS#0.7713;CRL4 COMPLEX#0.7706;DNA METHYLATION#0.7551;PROTEIN PROTEIN INTERACTION#0.7512;PLASTID#0.7421;LYSINE#0.7371;VIRAL TRANSCRIPTION#0.7255;UBIQUITIN PROTEASOME SYSTEM#0.7219;CISPLATIN#0.7215;CELL DIVISION#0.7095;CELL CYCLE REGULATION#0.7031;VIRAL PROTEIN R#0.7025;STEM CELL#0.7010;DOUBLE STRAND BREAK#0.6918;REVERSE TRANSCRIPTION#0.6876;26S PROTEASOME#0.6870;T CELL#0.6844;HETEROCHROMATIN#0.6829;MITOSIS#0.6683;DNA REPAIR PROTEIN#0.6597;VIRAL INFECTION#0.6500;BASE EXCISION REPAIR#0.6367;GENE SILENCING#0.6339;PROTEIN KINASE#0.6271;LIVER CANCER#0.6195;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6183;ZINC BINDING#0.6155;HEPATOCELLULAR CARCINOMA#0.6152;SIGNAL TRANSDUCTION#0.6143;PROTEASOME PATHWAY#0.6057;HOMOLOGOUS RECOMBINATION#0.6009;M PHASE#0.6007
164312	MESOTHELIOMA CELL#0.8295;MESOTHELIAL CELL#0.8186;LEUCINE RICH REPEAT#0.6810
164380	CYSTATIN#0.6636
1643	DNA DAMAGE BINDING#1.1067;DAMAGED DNA BINDING#1.0644;XERODERMA PIGMENTOSUM GROUP E#1.0480;XERODERMA PIGMENTOSUM#1.0464;CANCER CELL#1.0426;DNA BINDING#1.0377;APOPTOSIS#1.0268;UBIQUITIN#1.0248;NUCLEOTIDE EXCISION REPAIR#1.0110;CELL CYCLE#1.0035;GENE EXPRESSION#0.9959;OVARIAN CANCER#0.9837;COLON CANCER#0.9734;DNA REPAIR#0.9518;LIGASE ACTIVITY#0.9467;UBIQUITIN LIGASE ACTIVITY#0.9265;TRANSCRIPTION FACTOR#0.9238;TUMOR SUPPRESSOR#0.9094;PROTEIN COMPLEX#0.9051;OVARIAN#0.8814;GLOBAL GENOMIC REPAIR#0.8721;DNA DAMAGE RESPONSE#0.8088;BREAST CANCER#0.8065;CELL PROLIFERATION#0.8060;SKIN CANCER#0.7836;POLY ADP RIBOSE#0.7535;PERIPHERAL BLOOD#0.7421;CISPLATIN#0.7403;RESPONSE TO UV#0.7361;CELL GROWTH#0.7335;SQUAMOUS CELL CARCINOMA#0.7306;RIBOSE#0.6970;BINDING PROTEIN 1#0.6601;UBIQUITIN LIGASE COMPLEX#0.6470;CELL CYCLE REGULATION#0.6385;SENESCENCE#0.6351;CELL DEATH#0.6350;COCKAYNE SYNDROME#0.6213;DNA METHYLATION#0.6139;MISMATCH REPAIR#0.6004
1644	DDC ACTIVITY#1.0948;DOPA DECARBOXYLASE ACTIVITY#1.0685;PROSTATE CANCER#1.0467;GTP CYCLOHYDROLASE I#1.0426;PHENYLETHANOLAMINE N METHYLTRANSFERASE#1.0393;DECARBOXYLASE ACTIVITY#1.0390;L-DIHYDROXYPHENYLALANINE#1.0376;N METHYLTRANSFERASE#1.0371;LEVODOPA#1.0361;HISTIDINE DECARBOXYLASE#1.0357;ADRENAL MEDULLA#1.0356;CARBIDOPA#1.0332;GLUTAMIC ACID#1.0295;L-TRYPTOPHAN#1.0235;HISTIDINE#1.0220;METHYLDOPA#1.0219;CORPUS STRIATUM#1.0213;ADENO ASSOCIATED VIRUS#1.0152;TYROSINE HYDROXYLASE ACTIVITY#1.0147;5-HYDROXY-L-TRYPTOPHAN#1.0141;PYRIDOXAL PHOSPHATE#1.0126;L-DOPA#1.0118;SEROTONIN SYNTHESIS#1.0113;CATECHOL O METHYLTRANSFERASE#1.0112;ENTACAPONE#1.0108;L-TYROSINE#1.0103;PHEOCHROMOCYTOMA#1.0091;PYRIDOXAL 5-PHOSPHATE#1.0088;O METHYLTRANSFERASE#1.0087;POLYMERASE CHAIN REACTION#1.0082;MIDBRAIN#1.0074;PYRIDOXAL#1.0042;DOPAMINE METABOLISM#1.0029;CANCER CELL#1.0027;HYDROXYLASE ACTIVITY#1.0027;3,4-DIHYDROXYPHENYLALANINE#1.0027;TRYPTOPHAN#1.0016;CAUDATE NUCLEUS#0.9982;DOPAMINE SYNTHESIS#0.9980;L-PHENYLALANINE#0.9978;SPINAL CORD#0.9969;POSITRON EMISSION TOMOGRAPHY#0.9956;CHOLINE#0.9950;DOPAMINE#0.9927;CATECHOLAMINE SYNTHESIS#0.9921;DOPAMINE RECEPTOR#0.9897;STRIATUM#0.9883;DOPAMINE BIOSYNTHESIS#0.9869;CENTRAL NERVOUS SYSTEM#0.9868;NORADRENALINE#0.9867;LUNG CANCER#0.9835;TRANSCRIPTION FACTOR#0.9830;NEUROBLASTOMA#0.9819;ENZYME ACTIVITY#0.9807;RESERPINE#0.9807;BLOOD BRAIN BARRIER#0.9802;NOREPINEPHRINE#0.9802;NERVOUS SYSTEM#0.9801;GLIAL CELL#0.9791;CATECHOLAMINE METABOLISM#0.9778;CATECHOLAMINE BIOSYNTHESIS#0.9776;GENE EXPRESSION#0.9775;EXCRETION#0.9769;NERVE TERMINAL#0.9752;PARKINSON'S DISEASE#0.9730;DOPAMINERGIC NEURON#0.9727;SUBSTANTIA NIGRA#0.9705;DYSKINESIA#0.9696;HALOPERIDOL#0.9693;APOMORPHINE#0.9689;RECEPTOR ANTAGONIST#0.9673;TASTE BUD#0.9658;RECEPTOR AGONIST#0.9635;BASAL GANGLIA#0.9604;ECLOSION#0.9593;PARGYLINE#0.9580;INNERVATION#0.9569;GROWTH FACTOR#0.9563;ATPASE ACTIVITY#0.9554;FOREBRAIN#0.9545;PYRIDOXINE#0.9536;AUTOIMMUNE POLYENDOCRINE SYNDROME#0.9498;TETRAHYDROBIOPTERIN#0.9495;IMMUNE RESPONSE#0.9490;ADRENAL GLAND#0.9482;NEURONAL CELLS#0.9440;BLOOD VESSEL#0.9438;REVERSE TRANSCRIPTION#0.9436;LOCUS COERULEUS#0.9421;CEREBRAL CORTEX#0.9399;NEUROTRANSMISSION#0.9396;OLFACTORY BULB#0.9358;CYCLIC AMP#0.9358;EPITHELIAL CELL#0.9342;GLUTAMATE DECARBOXYLASE#0.9329;CHROMAFFIN CELL#0.9307;PINEAL GLAND#0.9296;EPINEPHRINE#0.9294;L-THREO-3,4-DIHYDROXYPHENYLSERINE#0.9257;ALANINE#0.9236;NICOTINE DEPENDENCE#0.9229;TOXICITY#0.9148;PROTEIN KINASE#0.9124;ADENOCARCINOMA#0.9117;HYPOTENSION#0.9106;TRYPTOPHAN HYDROXYLASE ACTIVITY#0.9092;SUBSTANCE P#0.9090;LUNG CARCINOMA#0.9089;HYPERTENSION#0.9063;SEROTONERGIC NEURON#0.9054;STEM CELL#0.8972;DYSTONIA#0.8967;NMDA RECEPTOR#0.8954;TRANSCRIPTASE#0.8929;HISTAMINE#0.8910;HYPERACTIVITY#0.8897;MELANIN SYNTHESIS#0.8889;FRONTAL#0.8882;SEROTONIN BIOSYNTHESIS#0.8840;RESPONSE TO L-DOPA#0.8815;AMANTADINE#0.8806;ADRENALINE#0.8754;DEVELOPMENTAL DELAY#0.8737;PANCREATIC ISLET#0.8732;CERVICAL#0.8691;SYNAPTIC VESICLE#0.8603;CATECHOLAMINE BIOSYNTHETIC#0.8590;THALAMUS#0.8579;ASPARTATE#0.8527;RAPHE NUCLEI#0.8470;BROMOCRIPTINE#0.8466;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.8422;CELL DEATH#0.8349;QUANTITATIVE REAL TIME#0.8311;TOLCAPONE#0.8290;NATRIURESIS#0.8273;ENDOCRINE CELL#0.8261;DOPAMINE D2 RECEPTOR#0.8242;SMALL INTESTINE#0.8240;ENZYME INHIBITOR#0.8223;DOPAMINE FORMATION#0.8217;NEURAL CELL#0.8213;MUTAGENESIS#0.8196;GUANOSINE#0.8186;PROTEIN SYNTHESIS#0.8171;TUMOR CELLS#0.8165;NITRIC OXIDE#0.8163;MEDULLA OBLONGATA#0.8139;ASTROCYTE#0.8111;ADDISON'S DISEASE#0.8072;ACETIC ACID#0.8071;CATALYTIC ACTIVITY#0.8047;PEPTIDE HORMONE#0.8044;CYTOTOXICITY#0.8012;MELATONIN#0.8009;NEUROFILAMENT#0.7980;2-PHENYLETHYLAMINE#0.7884;CARBOXY LYASE#0.7867;SULPIRIDE#0.7813;TASTE BUD CELL#0.7767;RENIN ACTIVITY#0.7758;NERVE GROWTH FACTOR#0.7737;NEURODEGENERATIVE DISEASE#0.7725;B CELL#0.7716;AMINE SYNTHESIS#0.7688;VITAMIN B6#0.7674;CIRCADIAN RHYTHM#0.7639;PP CELL#0.7638;METAMORPHOSIS#0.7630;ANDROGEN RECEPTOR#0.7616;NEUROENDOCRINE TUMOR#0.7578;SELEGILINE#0.7571;NEUROLOGICAL DISORDER#0.7571;L-DOPS#0.7571;TYROSINE 3 MONOOXYGENASE#0.7467;ACETYLCHOLINE#0.7452;NEUROTOXIN#0.7417;MICROTUBULE ASSOCIATED PROTEIN#0.7361;APOPTOSIS#0.7318;SYNAPTOSOME#0.7310;DISEASE FREE SURVIVAL#0.7285;PROTEIN KINASE C#0.7280;MITOCHONDRIA#0.7274;NEUROTRANSMITTER SYNTHESIS#0.7201;MECHANISM OF ACTION#0.7188;HYPOTENSIVE#0.7180;VASOPRESSIN#0.7176;SALIVARY GLAND#0.7169;ETHANOL#0.7163;HUMAN IMMUNODEFICIENCY VIRUS#0.7059;ORNITHINE DECARBOXYLASE#0.7041;ZALCITABINE#0.7003;CREATINE KINASE#0.6977;INSULIN SECRETION#0.6964;BETA CELL#0.6959;RECEPTOR BINDING#0.6954;CLONIDINE#0.6948;CELL DIFFERENTIATION#0.6935;GLYCINE#0.6935;HYPOXIA#0.6934;CELL ADHESION#0.6927;PROPRANOLOL#0.6911;MONOAMINE OXIDASE ACTIVITY#0.6897;ADENOSINE#0.6888;SPINAL CORD INJURY#0.6822;ERGIC#0.6800;DOPAMINE D1 RECEPTOR#0.6782;REACTIVE OXYGEN SPECIES#0.6779;ZIDOVUDINE#0.6728;RNA INTERFERENCE#0.6713;AUTOIMMUNE DISEASE#0.6700;CELL ADHESION MOLECULE#0.6686;INDOLE#0.6668;SUBTHALAMIC NUCLEUS#0.6666;PERIPHERAL BLOOD#0.6649;PROGENITOR CELL#0.6624;PLASMA MEMBRANE#0.6614;5-HT RECEPTOR#0.6604;OVARIAN#0.6567;CHORION#0.6504;DIENCEPHALON#0.6487;CONVECTION ENHANCED DELIVERY#0.6477;NEUROENDOCRINE CELL#0.6471;PROLACTIN SECRETION#0.6454;NERVE FIBER#0.6440;BETA GALACTOSIDASE#0.6429;ADENYLATE CYCLASE#0.6415;GLUTAMATE RECEPTOR#0.6409;DIABETES MELLITUS#0.6384;METHIONINE#0.6373;CIRCUMVALLATE PAPILLA#0.6370;LAMIVUDINE#0.6350;ENDOTHELIAL CELL#0.6350;PHOSPHATE BINDING#0.6297;ORNITHINE#0.6258;PYRIDOXAL P#0.6252;NEUROTRANSMITTER BIOSYNTHESIS#0.6247;SEPIAPTERIN REDUCTASE#0.6214;CLOZAPINE#0.6209;SCIATIC NERVE#0.6190;N ACETYLTRANSFERASE#0.6184;BETA ADRENOCEPTOR#0.6173;TEGMENTUM#0.6171;ABNORMAL INVOLUNTARY MOVEMENT#0.6135;ARGININE#0.6117;COLORECTAL#0.6097;NITRIC OXIDE SYNTHASE#0.6092;NEURONAL CELL BODIES#0.6073;CATABOLISM#0.6052;PROXIMAL TUBULE CELL#0.6047;MICROTUBULE#0.6039;OOCYTE#0.6031;HYPERPROLACTINEMIA#0.6020
1645	20ALPHA-HYDROXYSTEROID DEHYDROGENASE#1.0839;CISPLATIN#1.0323;ALDO KETO REDUCTASE#1.0191;OVARIAN#1.0141;PROGESTERONE METABOLISM#1.0127;LUNG CANCER#1.0123;PROGESTERONE#1.0120;CANCER CELL#1.0092;DRUG RESISTANCE#1.0045;BREAST CANCER#0.9823;ENZYME ACTIVITY#0.9812;GENE EXPRESSION#0.9743;POLYMERASE CHAIN REACTION#0.9699;PROGESTIN#0.9585;CHLORDECONE REDUCTASE#0.9426;DIHYDROTESTOSTERONE#0.9311;POLYCYCLIC AROMATIC HYDROCARBON#0.9259;TESTOSTERONE#0.9244;OVARIAN CARCINOMA#0.9232;REACTIVE OXYGEN SPECIES#0.9165;EPITHELIAL CELL#0.9137;APOPTOSIS#0.9075;GRANULOSA CELL#0.9072;GLUTATHIONE#0.9046;SQUAMOUS CELL CARCINOMA#0.8929;MEDROXYPROGESTERONE ACETATE#0.8822;ESTRADIOL#0.8817;PROSTATE CANCER#0.8782;ENDOMETRIAL CANCER#0.8763;DETOXIFICATION#0.8742;REVERSE TRANSCRIPTION#0.8685;ALDEHYDE REDUCTASE#0.8523;ETHACRYNIC ACID#0.8256;ADIPOSE TISSUE#0.8154;BETA-HYDROXYSTEROID DEHYDROGENASE#0.8094;TRANSCRIPTION FACTOR#0.8080;CARCINOGEN#0.8061;QUANTITATIVE REAL TIME#0.7991;CORPUS LUTEUM#0.7940;OVARIES#0.7925;FLUFENAMIC ACID#0.7914;MUTAGENESIS#0.7826;MALIC ENZYME#0.7654;MEDROXYPROGESTERONE#0.7642;5ALPHA DIHYDROTESTOSTERONE#0.7578;CELL PROLIFERATION#0.7574;CERVICAL#0.7521;COLON CANCER#0.7419;PROSTAGLANDIN F SYNTHASE#0.7396;ENDOMETRIOSIS#0.7320;CYTOCHROME P450#0.7233;CYTOTOXICITY#0.7084;ADENOCARCINOMA#0.6990;ENDOMETRIUM#0.6949;BREAST CANCER CELL#0.6906;GAMMA-GLUTAMYLCYSTEINE#0.6899;SALICYLIC ACID#0.6824;4-ANDROSTENE-3,17-DIONE#0.6769;LYMPH NODE#0.6679;PREGNENOLONE#0.6344;3-ALPHA-HSD ACTIVITY#0.6326;ANTIOXIDANT RESPONSE ELEMENT#0.6279;CELL DIFFERENTIATION#0.6212;CATABOLISM#0.6165;XENOBIOTIC METABOLISM#0.6111;ESTRONE#0.6079;METASTATIC LYMPH NODE#0.6058;1,10-PHENANTHROLINE#0.6026;ANDROGEN RECEPTOR#0.6009
164633	INTERCELLULAR BRIDGE#0.6971
164656	IRON DEFICIENCY ANEMIA#1.0567;DEFICIENCY ANEMIA#1.0565;ANAEMIA#1.0457;CELL SURFACE#1.0439;ANEMIA#1.0381;THALASSEMIA#1.0370;IRON HOMEOSTASIS#1.0238;IRON OVERLOAD#1.0216;BONE MORPHOGENETIC PROTEIN#1.0102;ERYTHROPOIESIS#0.9982;MICROCYTIC ANEMIA#0.9970;TRANSFERRIN RECEPTOR#0.9901;HYPOXIA#0.8935;ERYTHROCYTE#0.8784;BREAST CANCER#0.8689;HYPOXIA INDUCIBLE FACTOR#0.8511;PLASMA MEMBRANE#0.8503;CANCER CELL#0.8472;GENE EXPRESSION#0.8142;HYPOCHROMIC MICROCYTIC ANEMIA#0.7528;GROWTH FACTOR#0.7423;RESPONSE TO IRON#0.7287;PROSTATE CANCER#0.7280;RED BLOOD CELL#0.7205;SIGNALING PATHWAY#0.7155;INFLAMMATORY RESPONSE#0.7109;CELL MEMBRANE#0.6943;CELIAC DISEASE#0.6866;ANEMIC#0.6833;MACROPHAGE#0.6711;PARENTERAL#0.6558;ZYMOGEN ACTIVATION#0.6293;SOLUBLE TRANSFERRIN RECEPTOR#0.6182;LOW IRON#0.6099
164668	CYTIDINE DEAMINASE#1.0350;RNA BINDING#1.0291;CYTIDINE#1.0277;DEAMINASE ACTIVITY#1.0034;CYTOSINE DEAMINASE#0.9975;HUMAN IMMUNODEFICIENCY VIRUS#0.9479;VIRION#0.9144;T CELL#0.9038;MUTAGENESIS#0.8763;APOBEC#0.8589;REVERSE TRANSCRIPTION#0.8569;HEPATITIS B#0.7454;MRNA EDITING#0.7077;RETROTRANSPOSITION#0.7017;VIRAL GENOME#0.6991;SIMIAN IMMUNODEFICIENCY VIRUS#0.6725;T LYMPHOCYTE#0.6685;NUCLEIC ACID#0.6658;HEPATITIS B VIRUS#0.6366;LUNG CANCER#0.6047
164684	WW DOMAIN BINDING#1.1466;FERTILIZATION#1.0938;OOCYTE#1.0614;GENE EXPRESSION#0.9794;SPERMATOZOA#0.9793;PHOSPHOLIPASE C#0.9472;BREAST CANCER#0.7698;PERINUCLEAR THECA#0.7605;INFERTILE#0.6988;SEMEN#0.6889;DNA FRAGMENTATION#0.6313
1646	LIVER CANCER#1.0476;BILE ACID BINDING#1.0395;ALDO KETO REDUCTASE#1.0121;CANCER CELL#1.0107;DIHYDROTESTOSTERONE#1.0055;ADIPOSE TISSUE#1.0002;PROGESTERONE#0.9942;PROSTATE CANCER#0.9828;TESTOSTERONE#0.9537;ANDROGEN RECEPTOR#0.9485;BREAST CANCER#0.9437;GENE EXPRESSION#0.9157;CISPLATIN#0.9087;5ALPHA DIHYDROTESTOSTERONE#0.8690;CELL PROLIFERATION#0.8690;20ALPHA-HYDROXYSTEROID DEHYDROGENASE#0.8640;CHLORDECONE REDUCTASE#0.8416;POLYMERASE CHAIN REACTION#0.7644;ANTIOXIDANT RESPONSE ELEMENT#0.7610;PROGESTERONE METABOLISM#0.7544;ALDEHYDE REDUCTASE#0.7193;ENZYME ACTIVITY#0.7142;PREADIPOCYTE#0.7053;POLYCYCLIC AROMATIC HYDROCARBON#0.6899;SIGNALING PATHWAY#0.6762;HORMONE METABOLISM#0.6715;DRUG RESISTANCE#0.6567;OVARIAN#0.6555;PROSTAGLANDIN F SYNTHASE#0.6360;SQUAMOUS CELL CARCINOMA#0.6306;BREAST CANCER CELL#0.6213;ESTRADIOL#0.6209;STEROID METABOLISM#0.6188;REACTIVE OXYGEN SPECIES#0.6019
164781	INTRAFLAGELLAR TRANSPORT#0.9600;DYNEIN#0.9495;MOTILE CILIA#0.7013;CILIARY MOTILITY#0.6896;OUTER DYNEIN ARM#0.6569
1647	DNA DEMETHYLATION#1.0462;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0409;CYCLIN DEPENDENT KINASE INHIBITOR#1.0345;DEMETHYLATION#1.0340;CELL CYCLE CHECKPOINT#1.0287;CELL CYCLE CONTROL#1.0276;P53 BINDING#1.0264;KINASE INHIBITOR#1.0210;NUCLEOTIDE EXCISION REPAIR#1.0189;MITOGEN ACTIVATED PROTEIN#1.0174;CYCLIN DEPENDENT KINASE#1.0155;B CELL#1.0135;DNA REPLICATION#1.0135;DNA DAMAGE RESPONSE#1.0131;KINASE ACTIVITY#1.0114;T CELL#1.0097;KERATINOCYTE#1.0073;SENESCENCE#1.0072;DNA REPAIR#1.0053;GENOTOXIC#1.0011;CELL CYCLE REGULATION#1.0002;MUSCLE ATROPHY#0.9986;DNA METHYLTRANSFERASE#0.9977;BONE MARROW#0.9973;CISPLATIN#0.9954;PROSTATE CANCER#0.9946;PROTEIN KINASE#0.9933;DNA BINDING#0.9933;CELL GROWTH#0.9932;HEAT SHOCK PROTEIN#0.9912;CELL CYCLE ARREST#0.9907;SKELETAL MUSCLE#0.9905;CELL CYCLE#0.9904;M PHASE#0.9896;GROWTH FACTOR#0.9875;BREAST CANCER#0.9875;S PHASE#0.9868;REVERSE TRANSCRIPTION#0.9856;ATAXIA TELANGIECTASIA#0.9854;BASE EXCISION REPAIR#0.9847;OVARIAN#0.9845;QUANTITATIVE REAL TIME#0.9841;HEMATOPOIETIC CELL#0.9840;STEM CELL#0.9834;SIGNAL TRANSDUCTION#0.9832;IMMUNE RESPONSE#0.9825;POLYMERASE CHAIN REACTION#0.9819;SIGNALING PATHWAY#0.9818;OVARIAN CANCER#0.9812;DNA METHYLATION#0.9807;APOPTOTIC#0.9805;CELL MIGRATION#0.9803;MAPK SIGNALING#0.9785;TUMOR SUPPRESSOR#0.9774;APOPTOSIS#0.9765;ENDOTHELIAL CELL#0.9759;EPITHELIAL CELL#0.9756;TRANSCRIPTION FACTOR#0.9749;COLON CANCER#0.9724;INDUCTION OF APOPTOSIS#0.9720;LUNG CANCER#0.9711;CELL PROLIFERATION#0.9698;CELL DEATH#0.9697;TRANSACTIVATION#0.9696;REACTIVE OXYGEN SPECIES#0.9694;CANCER CELL#0.9687;TOXICITY#0.9673;DOUBLE STRAND BREAK#0.9633;APOPTOTIC CELL DEATH#0.9622;PERIPHERAL BLOOD#0.9603;CYTOTOXICITY#0.9600;MAP KINASE#0.9595;P53 SIGNALING PATHWAY#0.9575;CD4+ T CELL#0.9573;TUMOR CELLS#0.9559;TUMOR NECROSIS FACTOR#0.9559;GENE EXPRESSION#0.9549;DNA SYNTHESIS#0.9540;ONCOGENIC#0.9538;DNA FRAGMENTATION#0.9511;GENOTOXICITY#0.9488;BREAST CANCER CELL#0.9469;PANCREATIC CANCER#0.9468;GLUTATHIONE#0.9465;G1 PHASE#0.9408;DNA EXCISION#0.9367;SQUAMOUS CELL CARCINOMA#0.9269;PROTEIN SYNTHESIS#0.9255;REGENERATION#0.9228;MELANOCYTE#0.9219;CENTROSOME#0.9217;ISCHEMIA#0.9216;POLY ADP RIBOSE#0.9196;ENDOPLASMIC RETICULUM#0.9187;SMOOTH MUSCLE#0.9164;HEPATOCELLULAR CARCINOMA#0.9127;CARCINOGEN#0.9121;INFLAMMATORY RESPONSE#0.9070;CELLULAR SENESCENCE#0.9035;CYTOCHROME C#0.9025;TRANSCRIPTASE#0.9009;TOPOISOMERASE#0.8982;MUSCLE FIBER#0.8980;HYPOXIA#0.8964;CENTROSOME DUPLICATION#0.8960;COLON CARCINOMA#0.8949;SUPEROXIDE DISMUTASE#0.8935;ADENOCARCINOMA#0.8916;HISTONE DEACETYLASE#0.8796;MITOSIS#0.8781;RESPONSE TO STRESS#0.8749;MACROPHAGE#0.8732;CDC2 KINASE ACTIVITY#0.8724;RETINOIC ACID#0.8707;HUMAN BREAST CANCER#0.8701;ACTINOMYCIN D#0.8694;AUTOPHAGY#0.8691;MAPK ACTIVATION#0.8657;TOPOISOMERASE II#0.8641;TUMOR TISSUES#0.8625;DIFFERENTIAL GENE EXPRESSION#0.8624;PROGRAMMED CELL DEATH#0.8619;BREAST CARCINOMA#0.8610;HUMAN BRONCHIAL EPITHELIAL#0.8528;COLORECTAL#0.8495;NULL CELL#0.8481;MYELOID LEUKEMIA#0.8468;QUANTITATIVE REVERSE TRANSCRIPTION#0.8445;UBIQUITIN#0.8421;ACTIVATING TRANSCRIPTION FACTOR#0.8418;NEUROBLASTOMA#0.8405;AKT SIGNALING#0.8405;DOXORUBICIN#0.8345;RIBOSE#0.8345;ATAXIA TELANGIECTASIA MUTATED#0.8316;RESPONSE TO OXIDATIVE STRESS#0.8303;GLYCOSYLASE#0.8231;ETOPOSIDE#0.8224;CELL ADHESION#0.8214;MYELOID CELL#0.8185;SKELETAL MUSCLE ATROPHY#0.8141;HOMOLOGOUS RECOMBINATION#0.8120;GENE SILENCING#0.8120;MOUSE EMBRYONIC FIBROBLAST#0.8119;CELL DIFFERENTIATION#0.8047;VP-16#0.7979;TERMINAL DIFFERENTIATION#0.7975;EXTRACELLULAR MATRIX#0.7965;5 FLUOROURACIL#0.7957;HEMATOPOIETIC STEM CELL#0.7956;ENHANCER BINDING#0.7945;PROTEIN PROTEIN INTERACTION#0.7941;SMOOTH MUSCLE CELL#0.7921;PROGENITOR CELL#0.7920;PROTEIN KINASE C#0.7916;MUSCLE CELL#0.7914;OXIDATIVE DNA DAMAGE#0.7886;COLORECTAL CANCER#0.7884;HUMAN PANCREATIC CANCER#0.7881;MITOCHONDRIAL MEMBRANE#0.7823;CELLULAR GROWTH#0.7784;MOUSE EMBRYO FIBROBLASTS#0.7772;NERVOUS SYSTEM#0.7770;RESPONSE TO GENOTOXIC STRESS#0.7747;INSULIN-LIKE GROWTH FACTOR#0.7712;BRONCHIAL EPITHELIAL CELLS#0.7699;INHIBITION OF CELL GROWTH#0.7668;RNA BINDING#0.7661;G2 PHASE#0.7650;NUCLEAR SPECKLE#0.7645;ANGIOGENESIS#0.7644;ESTROGEN RECEPTOR#0.7625;CERVICAL#0.7597;CERVICAL CANCER#0.7591;HEME OXYGENASE 1#0.7577;MECHANISM OF ACTION#0.7556;FIBROBLAST GROWTH FACTOR#0.7537;MITOCHONDRIA#0.7484;REGULATION OF CELL CYCLE#0.7480;PROTEASOME#0.7460;DNA HYPOMETHYLATION#0.7443;CYTOPLASM#0.7415;RNA BINDING PROTEIN#0.7408;ELECTROPHORETIC MOBILITY SHIFT#0.7383;OXYGENASE#0.7365;RNA INTERFERENCE#0.7363;TRANSFORMING GROWTH FACTOR#0.7337;TELOMERE#0.7292;HISTONE DEACETYLASE INHIBITOR#0.7262;FLOW CYTOMETRY ANALYSIS#0.7256;SIGNAL TRANSDUCER#0.7222;ENHANCER BINDING PROTEIN#0.7192;IMMUNE SYSTEM#0.7190;OVARIAN CARCINOMA#0.7182;ONCOGENESIS#0.7181;CELL CYCLE REGULATOR#0.7142;CARCINOGENICITY#0.7039;FLUOROURACIL#0.7036;THYMIDINE#0.7018;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7014;LUPUS ERYTHEMATOSUS#0.7012;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6992;VASCULAR SMOOTH MUSCLE CELL#0.6991;PROTEIN KINASE INHIBITOR#0.6986;ARTERY#0.6985;RETINOBLASTOMA#0.6979;SIGNALLING PATHWAY#0.6973;LUNG CARCINOMA#0.6937;NITRIC OXIDE#0.6936;MECHANISMS OF ACTION#0.6898;ALANINE#0.6888;NEURAL TUBE#0.6870;ESOPHAGEAL CANCER#0.6870;RESPONSE TO UV#0.6857;DNA REPAIR CAPACITY#0.6853;EMBRYONIC STEM CELL#0.6842;CEREBRAL ISCHEMIA#0.6837;DRUG RESISTANCE#0.6810;TELOMERASE ACTIVITY#0.6799;P38 MAPK SIGNALING#0.6783;72-HOURS#0.6777;ADIPOCYTE#0.6768;MRNA TRANSCRIPTION#0.6767;QUERCETIN#0.6751;PEROXISOME#0.6746;DEATH RECEPTOR#0.6708;CYTOCHROME P450#0.6707;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6703;MONONUCLEAR CELLS#0.6693;NB1011#0.6635;THYMINE#0.6575;VITAMIN D RECEPTOR#0.6569;SIGNALING MOLECULE#0.6560;GLUTATHIONE PEROXIDASE#0.6550;DOUBLE-STRAND BREAK REPAIR#0.6512;ARSENIC TRIOXIDE#0.6506;OXIDATIVE STRESS RESPONSE#0.6498;SKIN FIBROBLASTS#0.6479;DOMINANT NEGATIVE MUTANT#0.6475;ENDOPLASMIC RETICULUM STRESS#0.6454;HOST CELL#0.6426;GENISTEIN#0.6341;ARSENITE#0.6333;DETOXIFICATION#0.6310;LEUCINE#0.6286;TROGLITAZONE#0.6279;LUNG ADENOCARCINOMA#0.6271;MUTAGEN#0.6230;XERODERMA PIGMENTOSUM#0.6225;GROWTH FACTOR BINDING#0.6223;BREAST CANCER PATIENTS#0.6219;MULTIPLE MYELOMA#0.6151;INNATE IMMUNE RESPONSE#0.6150;4-HPR#0.6137;CAMPTOTHECIN#0.6132;IFN-GAMMA#0.6113;ENDOTHELIAL GROWTH FACTOR#0.6110;THYMIDYLATE SYNTHASE#0.6071;NEUROTOXICITY#0.6070;LYSINE#0.6051;GRANULOCYTE#0.6043;1α,25-DIHYDROXYVITAMIN D3#0.6039;MELANOMA CELL LINES#0.6037;CELL CELL ADHESION#0.6026
1649	CAAT ENHANCER BINDING#1.0670;IMMUNOGLOBULIN BINDING#1.0548;XBP1 MRNA SPLICING#1.0391;MYXOID LIPOSARCOMA#1.0328;ENHANCER BINDING PROTEIN#1.0299;ENHANCER BINDING#1.0295;PROTEIN KINASE R#1.0273;ARSENITE#1.0266;LIPOSARCOMA#1.0250;MRNA SPLICING#1.0212;ADIPOCYTE DIFFERENTIATION#1.0190;DEATH RECEPTOR 5#1.0187;GLUCOSE REGULATED PROTEIN#1.0181;AMINO ACID RESPONSE#1.0180;PROTEIN DISULFIDE ISOMERASE#1.0172;CHONDROCYTE#1.0169;CELECOXIB#1.0159;MELATONIN#1.0157;SIGNALING MOLECULE#1.0144;BINDING PROTEIN 1#1.0135;TRANSACTIVATION#1.0132;PREADIPOCYTE#1.0127;GENE SILENCING#1.0119;ASPARAGINE#1.0118;ACTIVATING TRANSCRIPTION FACTOR#1.0117;B CELL LYMPHOMA#1.0111;EUKARYOTIC INITIATION FACTOR#1.0106;PODOCYTE#1.0104;TUDCA#1.0101;TRANSLATION INITIATION FACTOR#1.0101;RESPONSE TO ER STRESS#1.0076;TRANSLATION INITIATION#1.0052;VASCULAR SMOOTH MUSCLE CELL#1.0050;CLEAVED CASPASE 3#1.0045;BORTEZOMIB#1.0031;ADIPOGENESIS#1.0029;OSTEOBLAST#1.0028;LEUCINE#1.0027;TRANSCRIPTION FACTOR#1.0026;SMOOTH MUSCLE CELL#1.0012;PALMITATE#1.0010;MOUSE EMBRYONIC FIBROBLAST#1.0006;RESVERATROL#1.0002;LIGHT CHAIN 3#1.0001;ONCOGENIC#0.9993;MICROTUBULE ASSOCIATED PROTEIN#0.9991;DNA BINDING#0.9989;ASTROCYTE#0.9985;RNA INTERFERENCE#0.9977;INTEGRATED STRESS RESPONSE#0.9977;RETINOIC ACID#0.9970;GLUTAMINE#0.9970;B CELL#0.9969;OLIGODENDROCYTE#0.9965;CISPLATIN#0.9960;MUSCLE CELL#0.9960;MAPK SIGNALING#0.9956;QUANTITATIVE REAL TIME#0.9946;REVERSE TRANSCRIPTION#0.9944;OVARIAN CANCER#0.9938;OVARIAN#0.9932;HEAT SHOCK PROTEIN#0.9932;DEATH RECEPTOR#0.9930;POLYMERASE CHAIN REACTION#0.9922;SMOOTH MUSCLE#0.9916;STROMAL CELL#0.9886;HEPATOCYTE APOPTOSIS#0.9882;ENDOTHELIAL GROWTH FACTOR#0.9879;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9879;HEME OXYGENASE 1#0.9876;TUBULAR EPITHELIAL CELL#0.9875;ER STRESS-INDUCED APOPTOSIS#0.9873;RNA BINDING#0.9872;METFORMIN#0.9871;MACROPHAGE APOPTOSIS#0.9867;CYTOCHROME C RELEASE#0.9863;N-ACETYLCYSTEINE#0.9860;MACROPHAGE#0.9859;SIGNALLING PATHWAY#0.9857;MICROTUBULE#0.9855;PALMITIC ACID#0.9852;ACETYLCYSTEINE#0.9851;SENSITIZATION#0.9848;ASPARTATE#0.9847;ADIPOSE TISSUE#0.9846;BONE MARROW#0.9845;ADIPOCYTE#0.9842;SPINAL CORD#0.9842;HEPATOMA CELLS#0.9840;SIGNALING CASCADE#0.9835;CASPASE-3 ACTIVITY#0.9831;ADENOSINE#0.9830;LIVER DAMAGE#0.9829;ER STRESS RESPONSE#0.9826;MYELOID LEUKEMIA#0.9823;POLY ADP RIBOSE#0.9822;RIBOSE#0.9822;TARGET OF RAPAMYCIN#0.9821;ROS GENERATION#0.9821;MYOCARDIUM#0.9812;TAUROURSODEOXYCHOLIC ACID#0.9808;OXYGENASE#0.9801;PROGRAMMED CELL DEATH#0.9793;PROTEIN KINASE#0.9793;NEURONAL CELLS#0.9792;MITOGEN ACTIVATED PROTEIN#0.9792;BETA CELL#0.9791;RAPAMYCIN#0.9791;NEURONAL CELL DEATH#0.9778;ATHEROSCLEROTIC#0.9778;TRANSCRIPTASE#0.9777;AUTOPHAGY#0.9776;NITRIC OXIDE SYNTHASE#0.9776;KINASE INHIBITOR#0.9772;NEUROBLASTOMA#0.9770;T CELL#0.9769;COLON CANCER#0.9766;PEROXISOME#0.9757;APOPTOSIS#0.9752;UBIQUITIN#0.9752;SPINAL CORD INJURY#0.9748;DEPHOSPHORYLATION#0.9748;AKT SIGNALING#0.9743;PROTEIN DEGRADATION#0.9741;SUPEROXIDE DISMUTASE#0.9741;LOW DENSITY LIPOPROTEIN#0.9738;NADPH OXIDASE#0.9738;MONOCYTE#0.9738;HEPATOCELLULAR CARCINOMA CELL#0.9737;CYTOCHROME C#0.9734;CARDIOMYOCYTE#0.9733;HYPOXIA#0.9733;SIGNAL TRANSDUCTION#0.9726;APOPTOTIC SIGNALING PATHWAY#0.9725;L-CYSTEINE#0.9725;PROSTATE CANCER#0.9725;NEUROPROTECTION#0.9721;DNA REPAIR#0.9720;NITRIC OXIDE#0.9720;LIPOMA#0.9719;TOLL LIKE RECEPTOR#0.9717;ETHANOL#0.9717;QUANTITATIVE REVERSE TRANSCRIPTION#0.9715;AUTOPHAGOSOME#0.9715;APOPTOTIC#0.9713;HYPOXIC#0.9713;S PHASE#0.9710;PRO-INFLAMMATORY#0.9705;GENOTOXIC#0.9702;CEREBRAL ISCHEMIA#0.9696;CYTOPLASM#0.9694;CASPASE ACTIVATION#0.9693;SATURATED FATTY ACID#0.9688;PROTEASOME#0.9687;CELL SURFACE#0.9686;LUNG CANCER#0.9684;PERIPHERAL BLOOD#0.9682;DNA FRAGMENTATION#0.9681;GLIAL CELL#0.9679;HISTONE DEACETYLASE#0.9675;CELL DIFFERENTIATION#0.9674;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9672;GLUTATHIONE#0.9670;HIGH FAT DIET#0.9668;DOXORUBICIN#0.9664;INDUCTION OF APOPTOSIS#0.9661;OBESE#0.9657;BREAST CANCER CELL#0.9654;CERVICAL CANCER#0.9650;TUMOR SUPPRESSOR#0.9647;ISCHEMIA REPERFUSION INJURY#0.9644;OF DIABETIC RATS#0.9641;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9639;INSULIN SECRETION#0.9634;GROWTH FACTOR#0.9634;COLORECTAL CANCER#0.9632;ADENOCARCINOMA#0.9632;ENDOTHELIAL CELL#0.9629;MITOCHONDRIAL MEMBRANE#0.9628;PROTEIN SYNTHESIS#0.9626;SMOOTH MUSCLE ACTIN#0.9623;UNFOLDED PROTEIN RESPONSE#0.9623;PROTEIN FOLDING#0.9622;TUMOR NECROSIS FACTOR#0.9621;SKELETAL MUSCLE#0.9620;MULTIPLE MYELOMA#0.9618;STEM CELL#0.9617;CELL DEATH#0.9617;HEPATOCELLULAR CARCINOMA#0.9616;HYPERGLYCEMIA#0.9616;CYCLIN DEPENDENT KINASE#0.9616;SIGNALING PATHWAY#0.9610;GENE EXPRESSION#0.9607;BREAST CANCER#0.9606;EPITHELIAL CELL#0.9603;CELL CYCLE#0.9602;TRANSMISSION ELECTRON MICROSCOPY#0.9602;APOPTOTIC CELL DEATH#0.9597;ER LUMEN#0.9597;ER MEMBRANE#0.9592;HUMAN UMBILICAL VEIN#0.9592;KIDNEY DISEASE#0.9591;CELL CYCLE ARREST#0.9591;UMBILICAL VEIN#0.9590;TUMOR CELLS#0.9589;MITOCHONDRIA#0.9588;3-METHYLADENINE#0.9586;ARTERY#0.9586;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9585;STREPTOZOTOCIN#0.9582;PANCREATIC ISLET#0.9582;ENDOPLASMIC RETICULUM#0.9582;COLORECTAL#0.9582;G1 PHASE#0.9579;PROPIDIUM#0.9576;INFLAMMATORY RESPONSE#0.9575;REACTIVE OXYGEN SPECIES#0.9575;LIPID METABOLISM#0.9574;CYTOTOXICITY#0.9570;FATTY LIVER#0.9562;ISCHEMIA#0.9560;CELL GROWTH#0.9559;FATTY LIVER DISEASE#0.9551;ATHEROSCLEROSIS#0.9550;MECHANISM OF ACTION#0.9542;DIABETES MELLITUS#0.9541;CYTOKINE PRODUCTION#0.9540;PARKINSON'S DISEASE#0.9537;QUERCETIN#0.9531;NEUROTOXICITY#0.9531;ORGANELLE#0.9530;CELL MIGRATION#0.9528;ARSENIC TRIOXIDE#0.9526;CELL PROLIFERATION#0.9526;ENDOPLASMIC RETICULUM STRESS#0.9525;PANCREATIC CANCER#0.9521;CANCER CELL#0.9519;MONONUCLEAR CELLS#0.9518;LIVER DISEASE#0.9517;PROTEIN TRANSLATION#0.9515;OPTIC NERVE#0.9515;INFLAMMATORY CELL#0.9514;TYPE 2 DIABETES#0.9514;MYOCARDIAL INFARCTION#0.9513;METHIONINE#0.9508;MIDDLE CEREBRAL ARTERY#0.9505;CEREBRAL ARTERY#0.9503;EOSIN#0.9500;CASPASE INHIBITOR#0.9495;HUMAN BREAST CANCER#0.9487;M PHASE#0.9486;INSULIN-LIKE GROWTH FACTOR#0.9485;TOXICITY#0.9484;NEURODEGENERATIVE DISEASE#0.9483;ALZHEIMER'S DISEASE#0.9479;APOPTOSIS SIGNALING#0.9472;NERVOUS SYSTEM#0.9469;SQUAMOUS CELL CARCINOMA#0.9463;CERVICAL#0.9459;KERATINOCYTE#0.9456;DIABETIC NEPHROPATHY#0.9448;INTESTINAL EPITHELIAL CELL#0.9421;TRABECTEDIN#0.9418;REGENERATION#0.9408;CEREBRAL ARTERY OCCLUSION#0.9402;BRONCHIAL EPITHELIAL CELLS#0.9398;INDUCIBLE NITRIC OXIDE#0.9397;RESPONSE TO STRESS#0.9374;GRANULOSA CELL#0.9373;PROTEIN KINASE C#0.9373;SOFT TISSUE SARCOMA#0.9369;GLYCOGEN SYNTHASE KINASE#0.9367;ACTIVATION OF APOPTOSIS#0.9358;EXTRACELLULAR MATRIX#0.9351;PLASMA MEMBRANE#0.9350;ALANINE#0.9341;HYPERTENSION#0.9333;TRANSFORMING GROWTH FACTOR#0.9329;TYPE 1 DIABETES#0.9321;GLYCOSYLATION#0.9320;CARDIOMYOPATHY#0.9318;STEROL REGULATORY ELEMENT#0.9316;CHRONIC KIDNEY DISEASE#0.9312;MITOCHONDRIAL DAMAGE#0.9307;CELL COUNTING KIT#0.9304;CENTRAL NERVOUS SYSTEM#0.9298;MESENCHYMAL STEM CELL#0.9294;MAP KINASE#0.9283;FENRETINIDE#0.9281;ALCOHOLIC FATTY LIVER#0.9275;NONALCOHOLIC FATTY LIVER DISEASE#0.9272;ANGIOGENESIS#0.9262;DOMINANT NEGATIVE MUTANT#0.9261;NEUTROPHIL#0.9255;VASCULAR ENDOTHELIAL CELL#0.9248;ACTIVATOR PROTEIN 1#0.9230;HEPATOTOXICITY#0.9218;BONE FORMATION#0.9214;NEPHROPATHY#0.9206;MESANGIAL CELL#0.9190;RETINAL GANGLION CELL#0.9189;LYSOSOME#0.9186;CHOLINE#0.9186;PROTEIN KINASE B#0.9185;ESTROGEN RECEPTOR#0.9182;SIGNAL TRANSDUCER#0.9182;ACUTE KIDNEY INJURY#0.9181;ACTIVATED CASPASE 3#0.9174;ACTIVE CASPASE 3#0.9172;UBIQUITIN PROTEASOME SYSTEM#0.9163;MECHANISMS OF ACTION#0.9158;HEMORRHAGE#0.9157;CORONARY ARTERY#0.9154;GLUTATHIONE PEROXIDASE#0.9140;LEYDIG CELL#0.9131;GROWTH FACTOR RECEPTOR#0.9116;HYPOXIA INDUCIBLE FACTOR#0.9109;ALVEOLAR EPITHELIAL CELL#0.9104;RETINAL DEGENERATION#0.9103;PROXIMAL TUBULAR EPITHELIAL#0.9091;TYPE 2 DIABETES MELLITUS#0.9084;2 DIABETES MELLITUS#0.9084;PULMONARY FIBROSIS#0.9080;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.9071;SMALL INTESTINE#0.9053;ALKALINE PHOSPHATASE#0.9036;ENDOTHELIAL CELL APOPTOSIS#0.9028;LIPID DROPLET#0.9025;NORMAL CONTROL GROUP#0.9019;VACUOLE#0.9017;WHITE ADIPOSE TISSUE#0.9012;TRADITIONAL CHINESE MEDICINE#0.9007;MYELOID CELL#0.9004;FACTOR I#0.8995;PODOCYTE APOPTOSIS#0.8990;PLEOMORPHIC LIPOSARCOMA#0.8985;OVARIAN CARCINOMA#0.8980;INSULIN RECEPTOR#0.8976;PANCREATITIS#0.8974;KINASE ACTIVITY#0.8963;OSTEOARTHRITIS#0.8947;RECEPTOR ANTAGONIST#0.8944;EPITHELIAL CELL APOPTOSIS#0.8903;APOPTOTIC PROCESS#0.8901;PROGENITOR CELL#0.8869;MORRIS WATER MAZE#0.8857;MULTIPLE MYELOMA CELLS#0.8849;IMMUNE RESPONSE#0.8843;FLOW CYTOMETRY ANALYSIS#0.8830;PROXIMAL TUBULAR CELL#0.8827;CHLOROQUINE#0.8823;ACINAR CELL#0.8811;METHIONINE CHOLINE DEFICIENT#0.8801;MYOCYTES#0.8800;DOPAMINE#0.8794;IFN-GAMMA#0.8789;LUCIFERASE ACTIVITY#0.8786;CHONDROCYTE DIFFERENTIATION#0.8756;AUTOPHAGIC CELL DEATH#0.8753;CELLULAR HOMEOSTASIS#0.8749;BLOOD UREA NITROGEN#0.8746;ACUTE MYELOID LEUKEMIA#0.8744;ANTI APOPTOSIS#0.8730;REACTIVE OXYGEN SPECIES GENERATION#0.8724;T LYMPHOCYTE#0.8715;NECROTIC#0.8711;DRUG RESISTANCE#0.8706;CHAPERONE BINDING#0.8695;MAPK ACTIVATION#0.8684;LIVER CANCER#0.8680;PROGESTERONE#0.8679;ETOPOSIDE#0.8678;PLASMA CELL#0.8670;EDEMA#0.8664;ADENOSINE MONOPHOSPHATE#0.8663;RIBOSOMAL PROTEIN#0.8660;FIBROUS HISTIOCYTOMA#0.8660;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8643;DOPAMINERGIC NEURON#0.8643;LIPOGENESIS#0.8626;PHOTORECEPTOR CELL#0.8620;CREATINE KINASE#0.8601;HUMAN BRONCHIAL EPITHELIAL#0.8599;SCHWANN CELL#0.8586;RETINAL PIGMENT EPITHELIAL#0.8586;HEART DISEASE#0.8581;RNA BINDING PROTEIN#0.8577;STRIATUM#0.8574;CAMKII#0.8557;GENISTEIN#0.8554;OXYGEN GLUCOSE DEPRIVATION#0.8549;ACUTE PANCREATITIS#0.8534;NEPHROTOXICITY#0.8527;EWING SARCOMA#0.8517;BLEOMYCIN#0.8509;INFLAMMATORY BOWEL DISEASE#0.8501;APOPTOSIS INDUCING FACTOR#0.8488;MODE OF ACTION#0.8481;COLITIS#0.8474;MAMMARY EPITHELIAL CELL#0.8473;RESPONSE TO AMINO ACID#0.8466;OSTEOBLAST DIFFERENTIATION#0.8458;REPORTER GENE ASSAY#0.8458;SEVOFLURANE#0.8447;FIBROSARCOMA#0.8444;CLEAR CELL SARCOMA#0.8442;THYROID CARCINOMA#0.8440;IMMUNE SYSTEM#0.8430;GLUCOSE METABOLISM#0.8413;INDOMETHACIN#0.8393;RETINOIC ACID RECEPTOR#0.8385;FLOW CYTOMETRY ASSAY#0.8377;NEUROLOGICAL DISORDER#0.8372;OXIDATIVE STRESS RESPONSE#0.8361;STATUS EPILEPTICUS#0.8343;THYROID CANCER#0.8343;BAFILOMYCIN A1#0.8336;MITOCHONDRIAL UNFOLDED PROTEIN RESPONSE#0.8331;ACTINOMYCIN D#0.8324;GANGLION CELLS#0.8316;TYPE 2 DIABETIC#0.8309;ANDROGEN RECEPTOR#0.8308;TESTOSTERONE#0.8306;ATORVASTATIN#0.8303;HOST CELL#0.8292;BLOOD BRAIN BARRIER#0.8289;GLUCOSE INTOLERANCE#0.8267;COLON CARCINOMA#0.8266;IL-6 PRODUCTION#0.8266;ADENINE#0.8231;EPILEPSY#0.8229;PROTEIN QUALITY CONTROL#0.8206;NEONATAL RAT CARDIOMYOCYTES#0.8190;BERBERINE#0.8189;CEREBRAL CORTEX#0.8187;BREAST CARCINOMA#0.8179;DNA DAMAGE RESPONSE#0.8178;CHOLINE DEFICIENT DIET#0.8176;ARGININE#0.8176;CASPASE ACTIVITY#0.8167;PROTEASOME PATHWAY#0.8160;VSMC APOPTOSIS#0.8155;PROPOFOL#0.8154;DNA SYNTHESIS#0.8148;EPIDERMAL GROWTH FACTOR#0.8134;AUTOPHAGOSOME FORMATION#0.8133;ACUTE LIVER FAILURE#0.8130;RESPIRATION#0.8111;ENDOTHELIUM#0.8100;PROTEIN PROTEIN INTERACTION#0.8095;EXTRINSIC APOPTOTIC PATHWAY#0.8085;NEUROLOGICAL DEFICIT SCORE#0.8079;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8076;LEFT ANTERIOR DESCENDING#0.8075;NEUROPATHY#0.8073;HIGH MOBILITY GROUP#0.8067;MACULAR DEGENERATION#0.8061;LUNG ADENOCARCINOMA#0.8054;OLEIC ACID#0.8053;SHAM OPERATION GROUP#0.8042;SARCOPLASMIC RETICULUM#0.8042;FORMALIN#0.8032;TRANSMISSION ELECTRON MICROSCOPE#0.8030;PIGMENT EPITHELIAL CELL#0.8016;CELL MEMBRANE#0.7994;DIFFERENTIAL GENE EXPRESSION#0.7981;ER UNFOLDED PROTEIN RESPONSE#0.7964;TARGET OF RAPAMYCIN COMPLEX#0.7961;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7956;RENAL FIBROSIS#0.7950;INHIBITION OF APOPTOSIS#0.7947;COMPLEX I#0.7934;WOUND HEALING#0.7928;IMMUNE CELL#0.7920;MINERALIZATION#0.7918;PULMONARY ARTERY#0.7917;RETINAL DETACHMENT#0.7904;L-GLUTAMINE#0.7900;EXTRINSIC APOPTOSIS#0.7898;CELL KILLING#0.7895;AMYLOID PRECURSOR PROTEIN#0.7891;PROTEINURIA#0.7888;INSULINOMA#0.7880;MICROVASCULAR ENDOTHELIAL CELL#0.7879;CREATINE#0.7866;ROS FORMATION#0.7860;TROPHOBLAST#0.7854;UBIQUITIN PROTEASOME PATHWAY#0.7850;HEPATITIS C#0.7842;CALPAIN ACTIVITY#0.7829;ACUTE PHASE RESPONSE#0.7798;NULL CELL#0.7795;PROTEIN KINASE A#0.7775;TYROSINE KINASE INHIBITOR#0.7764;EMODIN#0.7764;PROTEIN PHOSPHATASE 1#0.7760;TRANSCRIPTIONAL CONTROL#0.7757;TERMINAL DIFFERENTIATION#0.7752;PROTEIN KINASE INHIBITOR#0.7743;AGE RELATED MACULAR DEGENERATION#0.7741;BILE DUCT#0.7740;ONCOGENESIS#0.7724;LIRAGLUTIDE#0.7716;INTRINSIC APOPTOSIS#0.7705;MITOCHONDRION#0.7689;RENAL ISCHEMIA REPERFUSION#0.7682;DEXAMETHASONE#0.7679;RETINAL PIGMENT EPITHELIAL CELLS#0.7678;HEPATITIS C VIRUS#0.7673;HINDLIMB#0.7672;SWELLING#0.7661;M2 MACROPHAGE#0.7659;MITOCHONDRIAL PERMEABILITY TRANSITION#0.7655;CELL CYCLE REGULATION#0.7621;SYNOVIAL SARCOMA#0.7620;CAMP RESPONSE ELEMENT#0.7619;HISTIOCYTOMA#0.7579;ADENINE DINUCLEOTIDE PHOSPHATE#0.7572;NICOTINAMIDE#0.7561;SENESCENCE#0.7545;LYSINE#0.7531;NEUROTOXIC#0.7530;ELECTROPHORETIC MOBILITY SHIFT#0.7530;IL-8 PRODUCTION#0.7523;HISTONE DEACETYLASE INHIBITOR#0.7521;RECEPTOR AGONIST#0.7502;AUTOPHAGIC VACUOLE#0.7496;TUMOR TISSUES#0.7485;BRAIN WATER CONTENT#0.7480;LYMPH NODE#0.7476;GALECTIN#0.7468;PERMEABILITY TRANSITION PORE#0.7462;HYPERTHERMIA#0.7447;INHIBITION OF CELL PROLIFERATION#0.7444;RETINITIS PIGMENTOSA#0.7443;MALIGNANT GLIOMA#0.7440;EXTRASKELETAL MYXOID CHONDROSARCOMA#0.7436;CHONDROGENESIS#0.7424;EMBRYONIC KIDNEY#0.7422;MYXOID CHONDROSARCOMA#0.7419;TRAUMATIC BRAIN INJURY#0.7418;PHOSPHATIDYLSERINE#0.7416;EPIGALLOCATECHIN#0.7410;METHAMPHETAMINE#0.7409;VIRAL REPLICATION#0.7405;VASCULAR CELL#0.7386;DISEASE FREE SURVIVAL#0.7376;DENDRITIC CELL#0.7364;CELL ADHESION#0.7363;SECRETORY PATHWAY#0.7352;BRAIN DAMAGE#0.7347;DIABETIC RETINOPATHY#0.7342;AP-1 COMPLEX#0.7338;MELANOCYTE#0.7330;TOPOISOMERASE#0.7317;TUMOUR NECROSIS FACTOR#0.7309;TRANSLATIONAL ATTENUATION#0.7300;FIBROBLAST GROWTH FACTOR#0.7294;CAROTID ARTERY#0.7283;TIGHT JUNCTION#0.7281;RIBOSOME#0.7281;PROTEIN GLYCOSYLATION#0.7279;C REACTIVE PROTEIN#0.7272;MACROAUTOPHAGY#0.7267;CHONDROSARCOMA#0.7263;MURINE EMBRYONIC FIBROBLASTS#0.7262;HEPATOCYTE PROLIFERATION#0.7255;HEPATITIS B VIRUS#0.7255;PACLITAXEL#0.7254;BILE DUCT LIGATION#0.7245;RENAL CARCINOMA#0.7241;HEPATITIS B#0.7240;NEURON APOPTOSIS#0.7237;FOCAL CEREBRAL ISCHEMIA#0.7232;INHIBITION OF ADIPOGENESIS#0.7231;COLON ADENOCARCINOMA#0.7229;DIMETHYL SULFOXIDE#0.7229;SUBCUTANEOUS ADIPOSE TISSUE#0.7227;PRIMARY HUMAN HEPATOCYTES#0.7210;CAMP RESPONSE ELEMENT BINDING#0.7206;INSULIN RECEPTOR SUBSTRATE#0.7203;HISTONE ACETYLATION#0.7197;ALL TRANS RETINOIC ACID#0.7194;TRANSIENT RECEPTOR POTENTIAL#0.7192;CARCINOGEN#0.7189;RESPIRATORY CHAIN#0.7189;MYOTUBE#0.7178;GLUCOSE UPTAKE#0.7176;CALCINEURIN#0.7172;HYPERGLYCEMIC#0.7168;CELL CYCLE CONTROL#0.7162;CIGARETTE SMOKE EXTRACT#0.7151;CELLULAR GROWTH#0.7146;SORAFENIB#0.7145;NEUROTOXIN#0.7097;CELL DIVISION#0.7093;OSTEOGENESIS#0.7090;HUMAN PROXIMAL TUBULAR#0.7086;HUMAN IMMUNODEFICIENCY VIRUS#0.7076;INDUCED RENAL INJURY#0.7075;GLOBAL CEREBRAL ISCHEMIA#0.7072;VIRULENCE#0.7063;DEXMEDETOMIDINE#0.7060;CAMP-RESPONSIVE ELEMENT BINDING#0.7049;PROTEIN DEFICIENCY#0.7048;PROTEIN PROCESSING#0.7028;PENICILLAMINE#0.7020;ACUTE LIVER INJURY#0.7015;CEREBRAL INFARCTION#0.6998;REGULATION OF APOPTOSIS#0.6997;OSTEOPOROSIS#0.6996;RHEUMATOID ARTHRITIS#0.6988;NEURON SURVIVAL#0.6971;MESENCHYMAL CELL#0.6969;AIRWAY EPITHELIAL CELL#0.6969;HUMAN EMBRYONIC KIDNEY#0.6965;SERTOLI CELL#0.6962;MICROGLIAL CELL#0.6960;ACUTE LUNG INJURY#0.6958;ENDOTHELIAL NITRIC OXIDE#0.6956;SUBSTANTIA NIGRA#0.6942;LUNG DISEASE#0.6942;GERM CELL#0.6933;AMYOTROPHIC LATERAL SCLEROSIS#0.6930;LATERAL SCLEROSIS#0.6930;BONE MORPHOGENETIC PROTEIN#0.6929;DEOXYCHOLIC ACID#0.6924;TOPOISOMERASE II#0.6907;MYOBLAST#0.6900;EARLY BRAIN INJURY#0.6883;PRECURSOR CELL#0.6872;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6858;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6848;LEUKOCYTE#0.6844;LOCOMOTION#0.6830;GLIOBLASTOMA MULTIFORME#0.6826;REGULATION OF GENE EXPRESSION#0.6818;HEAD AND NECK CANCER#0.6795;NECK CANCER#0.6794;CHRONIC MYELOID LEUKEMIA#0.6791;HODGKIN'S LYMPHOMA#0.6782;FOAM CELL FORMATION#0.6774;JNK SIGNALING PATHWAY#0.6761;NECROTIC CELL DEATH#0.6757;2-DEOXY-D-GLUCOSE#0.6746;2-DEOXYGLUCOSE#0.6737;CHROMOSOMAL REGION#0.6732;PHOSPHATASE INHIBITOR#0.6726;RESPONSE TO TUNICAMYCIN#0.6709;DUAL LUCIFERASE REPORTER#0.6709;HIGH DENSITY LIPOPROTEIN#0.6708;FATTY ACID SYNTHASE#0.6703;LUMINAL#0.6703;MACROPHAGE POLARIZATION#0.6701;CYCLIN DEPENDENT KINASE INHIBITOR#0.6696;CANCER STEM CELL#0.6679;MAMMARY GLAND#0.6675;MYOCARDIAL INFARCT SIZE#0.6666;RECEPTOR TYROSINE KINASE#0.6661;MULTIPLE SCLEROSIS#0.6658;FRUCTOSE#0.6622;SIMVASTATIN#0.6619;MEMORY IMPAIRMENT#0.6606;HEPATIC STELLATE CELL#0.6602;ADENOSINE TRIPHOSPHATE#0.6594;NEURAL CELL#0.6584;GLYCOLYSIS#0.6580;CONSTRICTION#0.6569;HUMAN PANCREATIC CANCER#0.6567;RESPONSE TO THAPSIGARGIN#0.6555;BLOOD VESSEL#0.6552;RYANODINE RECEPTOR#0.6547;DIFFUSE LARGE B-CELL LYMPHOMA#0.6540;MYELOID CELL LEUKEMIA#0.6527;NF-KAPPAB ACTIVATION#0.6526;ENTEROCYTE#0.6523;NUCLEUS PULPOSUS#0.6519;DOUBLE STRAND BREAK#0.6516;ATYPICAL LIPOMATOUS TUMOR#0.6498;FAT CELL#0.6494;TRANSCRIPTION REGULATOR#0.6485;CASPASE-4 ACTIVITY#0.6476;BETA CELL MASS#0.6475;STEAROYL COA DESATURASE#0.6474;SINGLE STRAND BREAK#0.6470;PROXIMAL TUBULE CELL#0.6469;VALSARTAN#0.6464;26S PROTEASOME#0.6449;GINSENG#0.6443;FLUORESCEIN#0.6443;ACTIVATED T-CELLS#0.6435;TO THE PROGRESSION#0.6435;ACTIVATED T CELL#0.6432;CELL CYCLE REGULATOR#0.6432;RETINITIS#0.6426;ENALAPRIL#0.6412;CYCLOSPORIN A#0.6404;72-HOURS#0.6402;ANTI INFLAMMATORY DRUGS#0.6399;PROTEIN COMPLEX#0.6395;AGGRESOME#0.6393;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6371;CYTOCHROME P450#0.6361;RENAL INTERSTITIAL FIBROSIS#0.6322;INTRINSIC APOPTOTIC PATHWAY#0.6308;PHAGOCYTOSIS#0.6305;SKIN CANCER#0.6305;ADVANCED GLYCATION END#0.6293;BLOOD GLUCOSE LEVEL#0.6290;GLUCOSE TOLERANCE TEST#0.6283;MURINE DOUBLE MINUTE#0.6279;VASCULAR DISEASE#0.6276;MIDBRAIN#0.6275;EPITHELIAL MESENCHYMAL TRANSITION#0.6270;CHOLESTEROL METABOLISM#0.6252;SMC APOPTOSIS#0.6251;IRON OVERLOAD#0.6249;BRONCHOPULMONARY DYSPLASIA#0.6236;CHLORAMPHENICOL#0.6227;TROPHOBLAST CELL#0.6217;BONE MINERAL DENSITY#0.6208;FRONTAL#0.6204;BIOTIN#0.6204;RU486#0.6203;UNILATERAL URETERAL OBSTRUCTION#0.6185;ISLET AMYLOID POLYPEPTIDE#0.6185;ATPASE INHIBITOR#0.6182;URETERAL OBSTRUCTION#0.6175;SALIVARY GLAND#0.6175;ENALAPRIL MALEATE#0.6160;SENSITIZER#0.6158;RESPONSE TO LPS#0.6144;NLRP3 INFLAMMASOME ACTIVATION#0.6141;CYCLIC ADENOSINE MONOPHOSPHATE#0.6128;CD4+ T CELL#0.6126;NEURITE#0.6116;ASCORBIC ACID#0.6111;THYMIDINE#0.6108;RETINAL PIGMENT EPITHELIUM#0.6100;FATTY ACID OXIDATION#0.6090;LUNG CARCINOMA#0.6071;CATABOLISM#0.6065;CYSTIC FIBROSIS#0.6062;HYPERPHOSPHORYLATION#0.6057;VIRAL INFECTION#0.6055;ASPIRIN#0.6037;OVARIES#0.6036;HUMAN INTESTINAL EPITHELIAL#0.6035;OCULAR HYPERTENSION#0.6028;MITOTIC CLONAL EXPANSION#0.6022
164	ADAPTIN#1.1213;AP-1 COMPLEX#0.7635;TRANS GOLGI NETWORK#0.7587;ENDOSOME#0.6210;INNER EAR#0.6091
165082	TASTE RECEPTOR#0.6850
1650	OST COMPLEX#1.1280;OLIGOSACCHARYL TRANSFERASE#1.0800;ASPARAGINE#1.0359;GLYCOSYLATION#1.0235;OLIGOSACCHARYLTRANSFERASE COMPLEX#1.0202;PROTEIN COMPLEX#1.0198;ENDOPLASMIC RETICULUM#1.0187;ADVANCED GLYCATION END#1.0024;LYSINE#0.9314;PROTEIN GLYCOSYLATION#0.8418;N GLYCAN#0.8154;ROUGH ENDOPLASMIC RETICULUM#0.8064;COMPLEX I#0.7971;PROTEIN MODIFICATION#0.7860;MACROPHAGE#0.7820;GLCNAC#0.7776;ADVANCED GLYCATION ENDPRODUCT#0.7663;TYPE 1 DIABETES#0.7612;MESANGIAL CELL#0.7610;GENE EXPRESSION#0.7523;KIDNEY DISEASE#0.7509;SCAVENGER RECEPTOR#0.7378;CELL SURFACE#0.7332;LUMINAL#0.7276;ENDOPLASMIC RETICULUM MEMBRANE#0.6957;MONONUCLEAR CELLS#0.6812;PERIPHERAL BLOOD#0.6789;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6784;CONGENITAL DISORDER#0.6683;RIBOSOME#0.6575;LOCALISATION#0.6394;ENZYME COMPLEX#0.6245;ER LUMEN#0.6120;CANCER CELL#0.6077
165140	RECEPTOR ANTAGONIST#1.0262;EOSINOPHIL#1.0059;CANCER CELL#0.9814;PROSTATE CANCER#0.8486;CALCIUM MOBILIZATION#0.7576;INDOLE#0.6900;ARACHIDONIC ACID#0.6855
165215	CELL MIGRATION#0.8014;COLORECTAL CANCER#0.8011;CANCER CELL#0.6838
165257	PATTERN RECOGNITION RECEPTOR#0.7880
1652	D-DOPACHROME TAUTOMERASE ACTIVITY#1.0574;MIGRATION INHIBITORY FACTOR#1.0366;MACROPHAGE MIGRATION#1.0345;MACROPHAGE#1.0238;DOPACHROME TAUTOMERASE ACTIVITY#0.9843;IMMUNE RESPONSE#0.7402;PROTEIN KINASE#0.6862;PREADIPOCYTE#0.6528;ADIPOCYTE#0.6443;GENE EXPRESSION#0.6309;MULTIPLE SCLEROSIS#0.6241;LIPID METABOLISM#0.6065
165324	CANCER CELL#1.1177;COLON CANCER#0.9637;UBIQUITIN#0.7753;APOPTOTIC#0.7220;LIGASE ACTIVITY#0.6682;CELL SURFACE#0.6456
1653	RNA HELICASE#1.0732;NEUROBLASTOMA#1.0669;RNA BINDING#0.9210;RETINOBLASTOMA#0.9197;RNA BINDING PROTEIN#0.8799;GENE COPY NUMBER#0.8694;CYTOPLASM#0.8239;DOUBLE STRAND BREAK#0.8198;BREAST CANCER#0.8092;VIRAL REPLICATION#0.8033;GENE EXPRESSION#0.7966;RNA METABOLISM#0.7468;ORNITHINE DECARBOXYLASE#0.6957;STEM CELL#0.6855;TRANSLATION INITIATION#0.6435;HELICASE ACTIVITY#0.6145;HOMOLOGOUS RECOMBINATION#0.6059;OVARIAN CANCER#0.6021;COLORECTAL CANCER#0.6006
1654	HCV CORE PROTEIN#1.0838;TRANSLATION INITIATION#1.0528;BREAST CANCER#1.0498;CELL CYCLE#1.0495;CANCER CELL#1.0486;COLORECTAL CANCER#1.0435;RNA HELICASE#1.0433;APOPTOSIS#1.0390;HEPATITIS C VIRUS#1.0319;CELL GROWTH#1.0314;STRESS GRANULE#1.0310;HEPATITIS C#1.0300;LUNG CANCER#1.0254;HEPATITIS B#1.0245;NUCLEAR EXPORT#1.0243;HELICASE ACTIVITY#1.0235;RNA METABOLISM#1.0170;VIRAL REPLICATION#1.0167;CYTOPLASM#1.0150;GENE EXPRESSION#1.0145;X CHROMOSOME#1.0047;ONCOGENIC#1.0045;SIGNALING PATHWAY#0.9995;MEDULLOBLASTOMA#0.9927;RNA BINDING#0.9914;ATPASE ACTIVITY#0.9913;VIRAL INFECTION#0.9905;IMMUNE RESPONSE#0.9868;TUMOR SUPPRESSOR#0.9842;INTELLECTUAL DISABILITY#0.9759;COLORECTAL#0.9748;INNATE IMMUNE RESPONSE#0.9747;HEPATOCELLULAR CARCINOMA#0.9732;HEPATITIS B VIRUS#0.9717;BREAST CANCER CELL#0.9701;INNATE IMMUNITY#0.9663;RIBOSOME#0.9649;STEM CELL#0.9384;T CELL#0.9365;TRANSLATION INITIATION FACTOR#0.9119;CELL PROLIFERATION#0.8825;GERM CELL#0.8815;HUMAN IMMUNODEFICIENCY VIRUS#0.8774;RNA REPLICATION#0.8730;NUCLEIC ACID#0.8616;APOPTOTIC#0.8462;CELL CYCLE REGULATION#0.8225;CELL DEATH#0.8141;TRANSACTIVATION#0.8122;TRANSCRIPTION FACTOR#0.8111;ATP HYDROLYSIS#0.8087;SPERMATOGENESIS#0.8067;LIPID DROPLET#0.7979;IFN-BETA#0.7962;PROTEIN KINASE#0.7940;TUMOR CELLS#0.7826;EIF4E BINDING#0.7784;RNA BINDING PROTEIN#0.7749;HOST CELL#0.7617;NEURITE OUTGROWTH#0.7531;ATP BINDING#0.7271;TANK BINDING KINASE#0.7270;DEATH RECEPTOR#0.7145;EUKARYOTIC INITIATION FACTOR#0.7143;B CELL#0.7131;RNA INTERFERENCE#0.7105;RNA PROCESSING#0.7074;RNA SPLICING#0.7013;SQUAMOUS CELL CARCINOMA#0.6980;Y CHROMOSOME#0.6976;MRNA METABOLISM#0.6963;LYMPH NODE#0.6874;CELL CYCLE CONTROL#0.6814;SIGNALLING PATHWAY#0.6760;COLON CANCER#0.6758;DRUG RESISTANCE#0.6756;LYMPH NODE METASTASIS#0.6721;SPINAL CORD#0.6688;PROSTATE CANCER#0.6686;CYTOTOXICITY#0.6655;TOXICITY#0.6654;PROTEIN SYNTHESIS#0.6610;RNA HELICASE ACTIVITY#0.6602;BINDING PROTEIN 1#0.6535;S PHASE#0.6507;SG ASSEMBLY#0.6503;RNA HELICASE A#0.6352;CYTOPLASMIC FOCI#0.6275;HYPOXIA#0.6232;80S RIBOSOME#0.6176;RELAPSE FREE SURVIVAL#0.6150;RIBOSOMAL PROTEIN#0.6106;MACROPHAGE#0.6104;STEM CELL MAINTENANCE#0.6090;DNA REPAIR#0.6056;EWING SARCOMA#0.6052;WEST NILE VIRUS#0.6046;PROGENITOR CELL#0.6041;REVERSE TRANSCRIPTION#0.6034
165530	KUPFFER CELL#1.0779;LECTIN#0.8435;GALACTOSE BINDING#0.6595
165545	RNA DEPENDENT ATPASE#0.9576
1655	RNA HELICASE#1.0450;CELL GROWTH#1.0432;CELL PROLIFERATION#1.0356;CANCER CELL#1.0238;SIGNALING PATHWAY#1.0209;RNA BINDING#1.0197;TRANSCRIPTION FACTOR#1.0196;BREAST CANCER#1.0161;ESTROGEN RECEPTOR#1.0134;CELL CYCLE#1.0111;GROWTH FACTOR#1.0070;GENE EXPRESSION#0.9994;HELICASE ACTIVITY#0.9974;RNA DEPENDENT ATPASE#0.9944;RNA HELICASE A#0.9940;ONCOGENIC#0.9841;MIRNA PROCESSING#0.9711;RNA METABOLISM#0.9689;APOPTOSIS#0.9661;TUMOR SUPPRESSOR#0.9515;BREAST CANCER CELL#0.9463;MRNA SPLICING#0.9354;PRE-MRNA SPLICING#0.9313;RNA PROCESSING#0.9193;PROSTATE CANCER#0.9187;COLON CANCER#0.9182;PROTEIN KINASE#0.9053;TRANSACTIVATION#0.9039;RNA BINDING PROTEIN#0.9016;POLYMERASE CHAIN REACTION#0.8892;CYTOPLASM#0.8762;HISTONE DEACETYLASE#0.8725;ATPASE ACTIVITY#0.8702;RNA HELICASE ACTIVITY#0.8639;EPITHELIAL MESENCHYMAL TRANSITION#0.8634;MRNA PROCESSING#0.8387;PROTEIN PROTEIN INTERACTION#0.8368;ESTROGEN RECEPTOR ALPHA#0.8359;RNA SPLICING#0.8289;DNA HELICASE#0.8284;CELL MIGRATION#0.8223;ANDROGEN RECEPTOR#0.8164;RIBOSOME#0.8158;DNA BINDING#0.8130;COLORECTAL#0.8062;HEPATOCELLULAR CARCINOMA#0.8014;SQUAMOUS CELL CARCINOMA#0.7853;DNA REPLICATION#0.7729;HEPATITIS C#0.7717;MICROPROCESSOR COMPLEX#0.7634;PLATELET-DERIVED GROWTH FACTOR#0.7611;COLORECTAL CANCER#0.7578;CELL NUCLEUS#0.7537;HEPATITIS C VIRUS#0.7528;GERM CELL#0.7465;QUANTITATIVE REAL TIME#0.7446;RIBOSOME BIOGENESIS#0.7415;AKT SIGNALING#0.7316;MIRNA BIOGENESIS#0.7311;TRANSLATION INITIATION#0.7268;LUNG CANCER#0.7211;CELL DEATH#0.7191;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.7189;CELL DIFFERENTIATION#0.7087;STEM CELL#0.7014;T CELL#0.6941;TRANSLATION INITIATION FACTOR#0.6819;APOPTOTIC#0.6495;TUMOR CELLS#0.6483;SPLICEOSOME#0.6428;C TERMINAL DOMAIN#0.6339;SPERMATOGENESIS#0.6323;SIGNALLING PATHWAY#0.6311;TRANSCRIPTIONAL CO-REGULATOR#0.6274;EPITHELIAL CELL#0.6179;CREB BINDING#0.6174;NUCLEOCYTOPLASMIC SHUTTLING#0.6122;EPITHELIAL TO MESENCHYMAL#0.6116;PROGENITOR CELL#0.6043;SKELETAL MUSCLE#0.6036;VIRAL REPLICATION#0.6022;ORGAN DEVELOPMENT#0.6021;NUCLEIC ACID#0.6013;ATP BINDING#0.6012
165631	POLY ADP RIBOSE#0.8054;RIBOSE#0.7863
165679	SERINE PALMITOYLTRANSFERASE#0.7002
1656	P BODY ASSEMBLY#1.0852;P BODY#1.0683;RNA HELICASE#1.0667;STRESS GRANULE#1.0212;HEPATITIS C VIRUS#0.9881;HEPATITIS C#0.9871;RNA BINDING#0.9814;MRNA DEGRADATION#0.9735;CANCER CELL#0.9678;MRNA DECAY#0.9663;GENE EXPRESSION#0.9556;OOCYTE#0.9496;GENE SILENCING#0.9220;RNA BINDING PROTEIN#0.9149;RNA GRANULE#0.8910;CCR4 NOT COMPLEX#0.8876;B CELL#0.8738;TRANSLATION INITIATION#0.8102;B CELL LYMPHOMA#0.7964;RIBOSOME#0.7319;CYTOPLASM#0.7070;APOPTOSIS#0.6934;RNP GRANULE#0.6842;COLORECTAL CANCER#0.6829;PROGENITOR CELL#0.6787;VIRAL REPLICATION#0.6677;STEM CELL#0.6544;HELICASE ACTIVITY#0.6534;POLYSOME#0.6375;OOCYTE GROWTH#0.6279;RNA-INDUCED SILENCING COMPLEX#0.6219;GERM CELL#0.6095;COLORECTAL#0.6030
165721	CANCER STEM-LIKE CELL#0.9906;HEAT SHOCK PROTEIN#0.7655;RENAL CELL CARCINOMA#0.6930;INDUCES CANCER#0.6733;CANCER INITIATING CELLS#0.6182
165904	ACTIN BINDING#1.0911;INTERCALATED DISC#1.0715;SKELETAL MUSCLE#1.0084;CARDIOMYOPATHY#0.9988;CARDIAC MORPHOGENESIS#0.9561;STRIATED MUSCLE#0.9192;MUSCLE CELL#0.8819;ACTIN FILAMENT#0.8248;CARDIAC DEVELOPMENT#0.8046;MORPHOGENESIS#0.7892;MYOFIBRIL#0.7253;SKELETAL MUSCLE CELLS#0.7191;ACTIN BINDING PROTEIN#0.6869;SIGNALING PATHWAY#0.6328;Z DISC#0.6052
165918	RIDDLE SYNDROME#1.1619;UBIQUITIN#1.0468;DNA DAMAGE RESPONSE#1.0058;DNA REPAIR#1.0019;HOMOLOGOUS RECOMBINATION#1.0009;DOUBLE STRAND BREAK#0.9998;CANCER CELL#0.9817;LYSINE#0.9372;BREAST CANCER#0.9368;NUCLEOSOME#0.8727;UBIQUITIN BINDING#0.8371;CELL PROLIFERATION#0.8015;IONIZING RADIATION-INDUCED FOCI#0.7985;LIGASE ACTIVITY#0.7921;DOUBLE-STRAND BREAK REPAIR#0.7825;HISTONE UBIQUITINATION#0.7701;ATAXIA TELANGIECTASIA#0.7450;HISTONE UBIQUITYLATION#0.7392;TELOMERE#0.7175;DEUBIQUITINATING ENZYME#0.6784;CHROMATIN REMODELING#0.6636;TUMOR SUPPRESSOR#0.6569;POLYUBIQUITIN#0.6538;SIGNALING PATHWAY#0.6538;CELL CYCLE#0.6532;UBIQUITIN LIGASE ACTIVITY#0.6489;SIGNALING CASCADE#0.6411;PROTEIN RECRUITMENT#0.6207;POLY ADP RIBOSE#0.6173;INHIBITION OF HR#0.6152
1659	RNA HELICASE#1.0604;SPLICEOSOME#1.0397;PRE-MRNA SPLICING#1.0292;MRNA SPLICING#1.0253;RNA BINDING#0.9003;SPLICEOSOME DISASSEMBLY#0.8519;ATP HYDROLYSIS#0.8478;C TERMINAL DOMAIN#0.8329;RNA DEPENDENT ATPASE#0.7002
165	ENHANCER BINDING PROTEIN#1.0915;ENHANCER BINDING#1.0911;BINDING PROTEIN 1#1.0858;ADIPOCYTE#1.0777;SMOOTH MUSCLE#1.0555;ADIPOGENESIS#1.0340;MACROPHAGE#1.0303;CHOLESTEROL EFFLUX#1.0170;ADIPOSE TISSUE#0.9999;FOAM CELL FORMATION#0.9875;EXTRACELLULAR MATRIX#0.9857;TRANSCRIPTION FACTOR#0.9744;SMOOTH MUSCLE CELL#0.9638;MUSCLE CELL#0.9629;PREADIPOCYTE#0.9507;CELL PROLIFERATION#0.9022;GENE EXPRESSION#0.8593;SIGNALING PATHWAY#0.8502;GROWTH FACTOR#0.8487;VASCULAR SMOOTH MUSCLE CELL#0.8271;DNA BINDING#0.8186;LUNG FIBROBLASTS#0.7881;MYOFIBROBLAST#0.7840;WOUND HEALING#0.7782;APOPTOSIS#0.7754;CHOLESTEROL HOMEOSTASIS#0.7621;TRANSFORMING GROWTH FACTOR#0.7250;PROTEIN PROTEIN INTERACTION#0.7111;CONNECTIVE TISSUE#0.7104;ADIPOCYTE DIFFERENTIATION#0.7027;MAMMARY GLAND#0.6982;HIGH FAT DIET#0.6928;GASTROSCHISIS#0.6859;CELL DIFFERENTIATION#0.6657;GROWTH FACTOR RECEPTOR#0.6406;EPITHELIAL MESENCHYMAL TRANSITION#0.6261;AORTIC SMOOTH MUSCLE CELLS#0.6234;MAMMARY GLAND DEVELOPMENT#0.6223;GLAND DEVELOPMENT#0.6202;MAPK ACTIVATION#0.6200;MAMMARY EPITHELIAL CELL#0.6189;WHITE ADIPOSE TISSUE#0.6189;DIET INDUCED OBESITY#0.6144;C TERMINAL DOMAIN#0.6107;EPITHELIAL CELL#0.6063
1660	DNA HELICASE#1.0818;RNA HELICASE A#1.0687;HELICASE ACTIVITY#1.0556;RNA HELICASE#1.0547;NADH DEHYDROGENASE#1.0491;ELECTRON TRANSPORT#1.0394;COMPLEX I#1.0284;RNA METABOLISM#1.0265;DOUBLE-STRANDED RNA BINDING#1.0210;NUCLEIC ACID#1.0137;RESPIRATORY CHAIN#1.0134;GENE EXPRESSION#1.0128;RNA PROCESSING#1.0120;RNA BINDING#1.0099;CANCER CELL#0.9925;CYTOPLASM#0.9891;NADH OXIDATION#0.9853;ELECTRON TRANSPORT CHAIN#0.9756;PROTEIN KINASE#0.9680;TUMOR SUPPRESSOR#0.9645;TRANSCRIPTION FACTOR#0.9621;TUBERCULOSIS#0.9614;ELECTRON TRANSFER#0.9586;DNA REPLICATION#0.9428;VIRION#0.9281;TRANSACTIVATION#0.9242;CELL CYCLE#0.9232;MITOCHONDRIA#0.9227;VIRAL REPLICATION#0.9211;PROTEIN PROTEIN INTERACTION#0.9176;NUCLEAR TRANSPORT#0.9169;ONCOGENIC#0.9162;NUCLEAR EXPORT#0.9133;EWING SARCOMA#0.9071;DNA BINDING#0.9031;REVERSE TRANSCRIPTION#0.9019;ATPASE ACTIVITY#0.8979;APOPTOSIS#0.8961;RNA SYNTHESIS#0.8912;RESPIRATION#0.8729;NUCLEOPLASM#0.8655;PHENOTHIAZINE#0.8508;T CELL#0.8311;ARGININE#0.8266;INNATE IMMUNITY#0.8171;COMPLEX II#0.8118;BREAST CANCER#0.8104;RNA BINDING PROTEIN#0.8095;NUCLEOLUS#0.8085;HUMAN IMMUNODEFICIENCY VIRUS#0.8038;LUPUS ERYTHEMATOSUS#0.8018;DOSAGE COMPENSATION#0.8002;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7930;TRANSCRIPTIONAL CONTROL#0.7923;OXIDATIVE PHOSPHORYLATION#0.7907;LUNG CANCER#0.7877;CELL DEATH#0.7818;TOPOISOMERASE#0.7747;DSRNA BINDING#0.7643;RIBOSOME#0.7620;STEM CELL#0.7608;DENDRITIC CELL#0.7572;RNA SPLICING#0.7354;CELL PROLIFERATION#0.7248;FLAVIN#0.7224;CREB BINDING#0.7012;RRNA SYNTHESIS#0.6965;EPITHELIAL CELL#0.6860;NUCLEAR IMPORT#0.6852;POLY ADP RIBOSE#0.6779;ACTINOMYCIN D#0.6764;HISTONE DEACETYLASE#0.6763;DNA REPAIR#0.6749;STRUCTURE ACTIVITY RELATIONSHIP#0.6733;QUINONE BINDING#0.6702;LYSINE#0.6589;C TERMINAL DOMAIN#0.6533;RIBOSOMAL RNA#0.6337;HOST CELL#0.6333;UBIQUINONE-1#0.6329;OXIDOREDUCTASE ACTIVITY#0.6323;HEPATITIS C VIRUS#0.6316;HEPATITIS C#0.6306;CATALYTIC ACTIVITY#0.6282;WERNER SYNDROME#0.6278;VIRAL INFECTION#0.6277;SMN COMPLEX#0.6271;MITOCHONDRIAL ELECTRON TRANSPORT CHAIN#0.6228;RNA INTERFERENCE#0.6221;MITOCHONDRIAL ELECTRON TRANSPORT#0.6202;MRNA BINDING#0.6190;DNA UNWINDING#0.6143;FOOT AND MOUTH DISEASE#0.6079;MOUTH DISEASE#0.6074;MITOCHONDRIAL INNER MEMBRANE#0.6056
1661	RNA HELICASE A#1.1049;RNA HELICASE#1.0762;PROSTATE CANCER#0.8011
1662	RNA HELICASE#1.1092;RIBOSOME ASSEMBLY#0.8622;ACUTE MYELOID LEUKEMIA#0.6952;MYELOID LEUKEMIA#0.6941;RIBOSOME#0.6785;CANCER CELL#0.6458
166336	PLANAR CELL POLARITY#1.0393;CELL POLARITY#1.0373;NEURITE#0.7566;NEURITE OUTGROWTH#0.6246;TERMINAL WEB#0.6141
166378	LIMITS OF DETECTION#0.9379;DEVELOPMENTAL DELAY#0.7717;LIMITS OF QUANTIFICATION#0.7580;HEARING LOSS#0.7571;SPERMATOGENESIS#0.7051;HEARING IMPAIRMENT#0.6160;INTELLECTUAL DISABILITY#0.6089
166379	BARDET BIEDL SYNDROME#1.0081;CHAPERONIN#0.9781;POLYDACTYLY#0.7319
1663	WARSAW BREAKAGE SYNDROME#1.1456;SISTER CHROMATID COHESION#1.0794;DNA HELICASE#1.0756;CHROMATID#1.0713;CHROMOSOME SEGREGATION#1.0404;DNA REPLICATION#1.0162;REPLICATION FORK#0.9891;S PHASE#0.9825;DNA REPAIR#0.9405;CELL CYCLE#0.9319;HELICASE ACTIVITY#0.8963;COHESIN COMPLEX#0.8930;DNA BINDING#0.8430;DNA UNWINDING#0.7995;FANCONI ANEMIA#0.7975;ATP BINDING#0.7526;REPLICATION FORK PROTECTION#0.7520;MITOSIS#0.7136;GENETIC DISORDER#0.6960;CENTROMERE#0.6952;CHROMOSOME TRANSMISSION#0.6877;ROBERTS SYNDROME#0.6808;ANEMIA#0.6737;DNA DEPENDENT ATPASE#0.6485;CELL PROLIFERATION#0.6193;VIRAL GENOME#0.6163;INTELLECTUAL DISABILITY#0.6111;HETEROCHROMATIN ORGANIZATION#0.6101
1665	RNA HELICASE#1.0715;SPLICEOSOME#1.0488;SPLICEOSOME DISASSEMBLY#1.0413;MRNA SPLICING#0.9758;PRE-MRNA SPLICING#0.9668;HELICASE ACTIVITY#0.9538;RNA BINDING#0.9203;RIBOSOME#0.8842;ATP HYDROLYSIS#0.8663;RIBOSOME BIOGENESIS#0.8538;C TERMINAL DOMAIN#0.8180;ATPASE ACTIVITY#0.8177;GENE EXPRESSION#0.7962;RRNA PROCESSING#0.7600;RNA DEPENDENT ATPASE#0.7584;SIGNALING PATHWAY#0.7146;DNA BINDING#0.6881;CELL PROLIFERATION#0.6805;U2 SNRNP#0.6466;RNA PROCESSING#0.6403;RIBOSOMAL RNA#0.6159;APOPTOSIS#0.6136;ANDROGEN RECEPTOR#0.6027;PROSTATE CANCER#0.6000
166614	PROTEIN KINASE#0.6412;NERVOUS SYSTEM#0.6344
166647	STEM CELL#0.9947;SPERMATOGONIAL STEM CELL#0.9330;GERM CELL#0.7777
166655	TUMOR NECROSIS FACTOR#0.7102
1666	LIPID METABOLISM#0.6623;ISOCITRATE DEHYDROGENASE ACTIVITY#0.6313;TUMOR CELLS#0.6251
166752	BASEMENT MEMBRANE#1.0092;EXTRACELLULAR MATRIX#0.9765;FRASER SYNDROME#0.8723;MALARIA#0.6503
166785	METHYLMALONIC ACIDEMIA#1.0473;VITAMIN B12#1.0430;METHYLMALONYL COA MUTASE#1.0391;COBALAMIN METABOLISM#0.9241;METHYLMALONIC ACID#0.8058;METHIONINE#0.6906;METHIONINE SYNTHASE#0.6445;GTPASE ACTIVITY#0.6354;PILUS ASSEMBLY#0.6058
1667	HUMAN NEUTROPHIL PEPTIDE#1.0612;NEUTROPHIL#1.0217;EPITHELIAL CELL#0.9902;GENE EXPRESSION#0.9598;HUMAN BETA DEFENSIN#0.9523;IMMUNE SYSTEM#0.9181;RECEPTOR ANTAGONIST#0.9107;IMMUNE RESPONSE#0.9092;IFN-GAMMA#0.8402;GENE COPY NUMBER#0.8203;PANETH CELL#0.8185;MACROPHAGE#0.7991;TUMOR CELLS#0.7720;POLYMERASE CHAIN REACTION#0.7499;ADENOSINE#0.7399;COPY NUMBER VARIATION#0.7365;PERIPHERAL BLOOD#0.7245;INNATE IMMUNE SYSTEM#0.7116;INNATE IMMUNITY#0.6950;T CELL#0.6768;SURFACE PLASMON RESONANCE#0.6584;HEMORRHAGE#0.6522;NITRIC OXIDE#0.6508;PORE FORMATION#0.6491;IB-MECA#0.6391;CYTOTOXICITY#0.6377;SMALL INTESTINE#0.6363;CORTISOL#0.6279;BIOFILM FORMATION#0.6024
166824	APOPTOSIS#1.0649;CELL CYCLE#1.0597;TUMOR SUPPRESSOR#1.0554;HIPPO SIGNALING#0.9837;EPITHELIAL MESENCHYMAL TRANSITION#0.9656;COLORECTAL CANCER#0.9600;CELL PROLIFERATION#0.9101;SIGNALING PATHWAY#0.8403;CELL CYCLE ARREST#0.8367;COLORECTAL#0.7893;CANCER CELL#0.7475;CYTOCHROME C#0.7046;HIPPO SIGNALING PATHWAY#0.6490;DNA METHYLATION#0.6362;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6290;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6284;RENAL CELL CARCINOMA#0.6280;LYMPH NODE#0.6218;MITOCHONDRIAL MEMBRANE#0.6195
1668	HUMAN NEUTROPHIL PEPTIDE#1.0592;NEUTROPHIL#1.0296;INNATE IMMUNITY#0.8600;COPY NUMBER VARIATION#0.7832;GENE EXPRESSION#0.7757;T CELL#0.7300;COPY NUMBER POLYMORPHISM#0.6999;TUMOR NECROSIS FACTOR#0.6159;SALIVARY GLAND#0.6117;ATP EFFLUX#0.6084
166929	SPHINGOMYELIN SYNTHASE#1.0520;PLASMA MEMBRANE#1.0249;ATHEROSCLEROSIS#0.9811;MACROPHAGE#0.9678;HIGH FAT DIET#0.9575;APOPTOSIS#0.9447;GOLGI APPARATUS#0.9013;LIPID RAFT#0.8909;ATHEROSCLEROTIC#0.8790;CELL MEMBRANE#0.8763;SIGNALING PATHWAY#0.8534;PHOSPHOCHOLINE#0.8299;SPHINGOLIPID METABOLISM#0.8170;SPHINGOMYELIN SYNTHESIS#0.7756;PROTEIN KINASE#0.7679;GENE EXPRESSION#0.7631;CELL PROLIFERATION#0.7491;ENDOPLASMIC RETICULUM#0.7122;CELL GROWTH#0.6977;LIPID METABOLISM#0.6919;CERAMIDE SYNTHESIS#0.6879;MECHANISM OF ACTION#0.6856;NEUTRAL SPHINGOMYELINASE#0.6743;MOUSE EMBRYONIC FIBROBLAST#0.6418;BONE MARROW#0.6265;CERAMIDE METABOLISM#0.6235;CHOLESTEROL EFFLUX#0.6069;GLUCOSE METABOLISM#0.6035
166968	CELL PROLIFERATION#0.7181;COLORECTAL CANCER#0.7031;MAMMARY GLAND#0.6805;EPITHELIAL MESENCHYMAL TRANSITION#0.6789;BREAST CANCER#0.6690;COLORECTAL#0.6672
1669	NEUTROPHIL#1.0181;GENE EXPRESSION#0.9562;PERIPHERAL BLOOD#0.8566;IFN-GAMMA#0.8169;INNATE IMMUNITY#0.7861;CORTISOL#0.6998;POLYMERASE CHAIN REACTION#0.6861;PANETH CELL#0.6794;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6651;MONONUCLEAR CELLS#0.6640
166	GENE EXPRESSION#0.9806;TRANSCRIPTION FACTOR#0.9794;CYSTIC FIBROSIS#0.9443;CANCER CELL#0.9164;DNA BINDING#0.8057;ANDROGEN RECEPTOR#0.7629;PROTEIN PROTEIN INTERACTION#0.7358;CELL DEATH#0.7348;DIARRHEA#0.6453;STEM CELL#0.6366;T CELL#0.6244;HISTONE DEACETYLASE#0.6175;APOPTOSIS#0.6167;COLORECTAL CANCER#0.6140
1670	PANETH CELL#1.0497;SMALL INTESTINE#1.0342;HUMAN NEUTROPHIL PEPTIDE#1.0188;NEUTROPHIL#1.0169;EPITHELIAL CELL#1.0152;CROHN'S DISEASE#1.0048;HUMAN BETA DEFENSIN#1.0017;INTESTINAL EPITHELIAL CELL#0.9988;POLYMERASE CHAIN REACTION#0.9954;INNATE IMMUNITY#0.9910;INFLAMMATORY BOWEL DISEASE#0.9594;REVERSE TRANSCRIPTION#0.9381;GENE EXPRESSION#0.9222;IMMUNE RESPONSE#0.9133;IMMUNE SYSTEM#0.9069;COLITIS#0.8923;T CELL#0.8882;ULCERATIVE COLITIS#0.8766;LARGE INTESTINE#0.8174;VIRAL CAPSID#0.8173;TRANSCRIPTION FACTOR#0.7718;ARGININE#0.7700;INNATE IMMUNE SYSTEM#0.7693;HOST CELL#0.7662;CELL SURFACE#0.7494;COLON CANCER#0.7480;GASTROINTESTINAL TRACT#0.7356;QUANTITATIVE REAL TIME#0.7337;CELL DIFFERENTIATION#0.7331;VIRION#0.7023;INTESTINAL CRYPT#0.6803;MECHANISM OF ACTION#0.6549;LEUKOCYTE#0.6395;INNATE IMMUNE RESPONSE#0.6236;CANCER CELL#0.6058;OUTER MEMBRANE#0.6006
167153	RNA BINDING#1.0386;GERM CELL#1.0174;RNA BINDING PROTEIN#1.0124;MEIOTIC ENTRY#1.0114;MEIOSIS#1.0022;OOCYTE#0.9859;RNA EDITING#0.9599;ENTRY INTO MEIOSIS#0.9198;STEM CELL#0.9082;GENE EXPRESSION#0.8884;CELL CYCLE#0.8310;OOGENESIS#0.7782;MITOSIS#0.7068;SPERMATOGENESIS#0.6789;MRNA POLYADENYLATION#0.6563;CYTOPLASM#0.6493;OOCYTE MATURATION#0.6213
1671	PANETH CELL#1.0705;EPITHELIAL CELL#0.9340;CROHN'S DISEASE#0.9136;SMALL INTESTINE#0.8649;COLON CANCER#0.8222;INNATE IMMUNITY#0.8070;GENE EXPRESSION#0.7869;COLORECTAL CANCER#0.7579;POLYMERASE CHAIN REACTION#0.6972;ULCERATIVE COLITIS#0.6871;CANCER CELL#0.6267;REVERSE TRANSCRIPTION#0.6103;COLITIS#0.6061
167227	P BODY#1.0585;DCP1-DCP2 COMPLEX#1.0268;MRNA DEGRADATION#1.0143;MRNA DECAY#1.0109;RNA BINDING#0.9865;GENE EXPRESSION#0.9751;RNA BINDING PROTEIN#0.9562;TRANSLATION INITIATION#0.9235;STRESS GRANULE#0.8882;CYTOPLASMIC FOCI#0.8498;C TERMINAL DOMAIN#0.8282;RNA GRANULE#0.8090;CYTOPLASM#0.7994;GENE SILENCING#0.7989;7-METHYLGUANOSINE#0.7619;OOCYTE#0.7399;EXOSOME#0.7360;AUTOPHAGY#0.7352;PROTEIN COMPLEX#0.6592;NONSENSE-MEDIATED MRNA DECAY#0.6177;MRNA METABOLISM#0.6043
1672	CANCER CELL#1.0467;PERIODONTITIS#1.0393;HUMAN BETA DEFENSIN#1.0271;KERATINOCYTE#1.0261;SALIVARY GLAND#1.0179;REVERSE TRANSCRIPTION#1.0072;POLYMERASE CHAIN REACTION#1.0056;CYSTIC FIBROSIS#1.0042;NEUTROPHIL#0.9973;HUMAN NEUTROPHIL PEPTIDE#0.9940;EPITHELIAL CELL#0.9920;PERIPHERAL BLOOD#0.9915;GENE EXPRESSION#0.9907;INNATE IMMUNE SYSTEM#0.9877;TOLL LIKE RECEPTOR#0.9874;TRANSCRIPTASE#0.9843;MACROPHAGE#0.9830;IMMUNE SYSTEM#0.9821;FRAGMENT LENGTH POLYMORPHISM#0.9815;INNATE IMMUNE RESPONSE#0.9813;INNATE IMMUNITY#0.9781;MONOCYTE#0.9756;MAMMARY GLAND#0.9750;IMMUNE RESPONSE#0.9686;RESPIRATORY TRACT#0.9649;GROWTH FACTOR#0.9648;TONSIL#0.9629;PROSTATE CANCER#0.9620;QUANTITATIVE REAL TIME#0.9606;LEUKOCYTE#0.9576;SQUAMOUS CELL CARCINOMA#0.9572;CROHN'S DISEASE#0.9505;GINGIVAL CREVICULAR FLUID#0.9442;APOPTOSIS#0.9398;PRO-INFLAMMATORY#0.9327;TUMOR NECROSIS FACTOR#0.9307;CATIONIC ANTIMICROBIAL PEPTIDE#0.9270;ORAL CAVITY#0.9239;PERIODONTAL DISEASE#0.9232;TUMOR SUPPRESSOR#0.9213;DENDRITIC CELL#0.9146;IMMUNE CELL#0.9045;ORAL MUCOSA#0.9019;INFLAMMATORY BOWEL DISEASE#0.9012;TUBERCULOSIS#0.9009;GINGIVAL EPITHELIAL CELLS#0.8954;INFLAMMATORY RESPONSE#0.8876;T CELL#0.8824;ORAL SQUAMOUS CELL CARCINOMA#0.8823;INTESTINAL EPITHELIAL CELL#0.8822;HEPARIN BINDING#0.8772;ATOPIC DERMATITIS#0.8766;ULCERATIVE COLITIS#0.8720;CELL WALL#0.8715;TONSILLITIS#0.8704;PANETH CELL#0.8646;AGGRESSIVE PERIODONTITIS#0.8554;WOUND HEALING#0.8514;NASAL MUCOSA#0.8438;TRANSCRIPTION FACTOR#0.8361;DIABETES MELLITUS#0.8291;COLITIS#0.8288;TUMOUR NECROSIS FACTOR#0.8214;GASTROINTESTINAL TRACT#0.8180;SIGNALING PATHWAY#0.8131;ORAL EPITHELIAL CELLS#0.8111;PLEOMORPHIC ADENOMA#0.8103;DERMATITIS#0.7790;SMALL INTESTINE#0.7775;SURFACTANT PROTEINS A#0.7692;GASTRITIS#0.7654;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7590;INFERTILITY#0.7512;EPITHELIAL TISSUES#0.7491;HEPARIN#0.7468;LUNG DISEASE#0.7466;PNEUMONIA#0.7462;RESPIRATORY TRACT INFECTION#0.7449;CYTOPLASM#0.7376;LUNG CANCER#0.7325;PHOSPHOLIPASE A#0.7318;CERVICAL#0.7288;ADAPTIVE IMMUNE RESPONSE#0.7285;COPY NUMBER POLYMORPHISM#0.7246;DEXAMETHASONE#0.7147;RENAL CELL CARCINOMA#0.7056;GINGIVA#0.7031;VIRAL INFECTION#0.7027;MIDDLE EAR#0.6887;TIGHT JUNCTION#0.6878;DNA METHYLATION#0.6854;LYMPH NODE#0.6814;ALVEOLAR MACROPHAGE#0.6810;HAIR FOLLICLE#0.6761;SPERM MOTILITY#0.6749;MALE INFERTILITY#0.6740;HERPES SIMPLEX#0.6732;EXTRACELLULAR MATRIX#0.6722;EPIDERMAL GROWTH FACTOR#0.6720;DUODENUM#0.6715;LINGUAL ANTIMICROBIAL PEPTIDE#0.6667;PSORIASIS#0.6659;AIRWAY EPITHELIAL CELL#0.6639;CORNEAL EPITHELIAL CELL#0.6624;CELL SURFACE#0.6553;URINARY TRACT INFECTION#0.6540;HERPES SIMPLEX VIRUS#0.6488;MUTAGENESIS#0.6485;CHEMOKINE RECEPTOR#0.6478;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6457;MONONUCLEAR CELLS#0.6446;CHORIOAMNIONITIS#0.6361;DENTAL PULP#0.6337;VIRAL REPLICATION#0.6297;MITOGEN ACTIVATED PROTEIN#0.6263;CELL PROLIFERATION#0.6238;BUDDING#0.6237;GINGIVITIS#0.6226;GROWTH FACTOR RECEPTOR#0.6142;HUMAN CORNEAL EPITHELIAL#0.6096;PROTEIN KINASE#0.6091;LUNG EPITHELIAL CELL#0.6079;ADAPTIVE IMMUNE SYSTEM#0.6031
167359	SYSTEMIC ACQUIRED RESISTANCE#1.0825;PROTEIN KINASE#1.0420;SALICYLIC ACID#1.0328;CELL CYCLE#1.0256;MITOSIS#1.0149;DISEASE RESISTANCE#1.0080;GENE EXPRESSION#0.9603;TRANSCRIPTION FACTOR#0.9548;SIGNAL TRANSDUCTION#0.8939;BUDDING#0.7096;KINASE ACTIVITY#0.6669;DEFENSE RESPONSE#0.6562;SALICYLATE#0.6404;THYROID CARCINOMA#0.6089
1673	HUMAN NEUTROPHIL PEPTIDE#1.0528;MIDDLE EAR#1.0520;ORAL EPITHELIAL CELLS#1.0443;ULCERATIVE COLITIS#1.0345;GENE COPY NUMBER#1.0325;COPY NUMBER VARIATION#1.0289;GINGIVAL EPITHELIAL CELLS#1.0282;MITOGEN ACTIVATED PROTEIN#1.0281;COLITIS#1.0276;HUMAN BETA DEFENSIN#1.0229;INTESTINAL EPITHELIAL CELL#1.0220;PROTEIN KINASE#1.0219;CORNEAL EPITHELIAL CELL#1.0187;PERIODONTITIS#1.0145;TUMOR NECROSIS FACTOR#1.0142;IFN-GAMMA#1.0123;CROHN'S DISEASE#1.0120;MAST CELL#1.0117;CELL WALL#1.0116;PERIPHERAL BLOOD#1.0114;TRANSCRIPTION FACTOR#1.0079;AIRWAY EPITHELIAL CELL#1.0078;KERATINOCYTE#1.0050;REVERSE TRANSCRIPTION#1.0041;LEUKOCYTE#1.0028;NEUTROPHIL#1.0015;CANCER CELL#1.0008;QUANTITATIVE REAL TIME#1.0007;PSORIASIS#1.0006;NASAL MUCOSA#1.0005;MACROPHAGE#1.0001;ADAPTIVE IMMUNE RESPONSE#0.9985;WOUND HEALING#0.9985;DENDRITIC CELL#0.9984;CATIONIC ANTIMICROBIAL PEPTIDE#0.9981;MONOCYTE#0.9974;POLYMERASE CHAIN REACTION#0.9966;PRO-INFLAMMATORY#0.9960;GROWTH FACTOR#0.9956;SIGNALING PATHWAY#0.9942;SALIVARY GLAND#0.9940;EPITHELIAL CELL#0.9930;ORAL CAVITY#0.9914;TOLL LIKE RECEPTOR#0.9911;INFLAMMATORY BOWEL DISEASE#0.9892;NF-KAPPAB ACTIVATION#0.9884;HUMAN CORNEAL EPITHELIAL#0.9877;GENE EXPRESSION#0.9876;TRANSCRIPTASE#0.9873;INNATE IMMUNE SYSTEM#0.9838;ATOPIC DERMATITIS#0.9832;T CELL#0.9825;PERIODONTAL DISEASE#0.9806;SQUAMOUS CELL CARCINOMA#0.9802;PNEUMONIA#0.9795;RESPIRATORY TRACT#0.9766;INFLAMMATORY RESPONSE#0.9765;TUMOUR NECROSIS FACTOR#0.9750;DERMATITIS#0.9741;INNATE IMMUNE RESPONSE#0.9740;LUNG EPITHELIAL CELL#0.9715;CELL PROLIFERATION#0.9705;INNATE IMMUNITY#0.9688;IMMUNE SYSTEM#0.9682;IMMUNE RESPONSE#0.9678;BRONCHIAL EPITHELIAL CELLS#0.9657;GASTRITIS#0.9612;IMMUNE CELL#0.9549;MAP KINASE#0.9547;APOPTOSIS#0.9514;DENTAL PULP#0.9484;PATTERN RECOGNITION RECEPTOR#0.9471;EPITHELIAL TISSUES#0.9458;B CELL#0.9448;ENDOTHELIAL CELL#0.9434;VIRULENCE#0.9421;COLONIC EPITHELIAL CELLS#0.9411;TUBERCULOSIS#0.9408;CERVICAL#0.9403;MONONUCLEAR CELLS#0.9365;IMMATURE DENDRITIC CELL#0.9345;ORAL MUCOSA#0.9322;CANDIDIASIS#0.9316;CELL SURFACE#0.9280;PROTEIN SECRETION#0.9246;CYTOPLASM#0.9204;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9157;SKIN DISEASE#0.9149;GINGIVA#0.9139;CHEMOKINE RECEPTOR#0.9130;CYSTIC FIBROSIS#0.9109;TOPICAL#0.9085;CD4+ T CELL#0.9072;TRANSFORMING GROWTH FACTOR#0.9040;LUNG DISEASE#0.9025;DEXAMETHASONE#0.8955;PEPTIDOGLYCAN#0.8946;AIRWAY EPITHELIUM#0.8891;GASTROINTESTINAL TRACT#0.8888;GINGIVITIS#0.8803;HAIR FOLLICLE#0.8800;STEM CELL#0.8798;CYTOKINE PRODUCTION#0.8795;GINGIVAL CREVICULAR FLUID#0.8776;ACTIVATOR PROTEIN 1#0.8758;ORAL SQUAMOUS CELL CARCINOMA#0.8756;HUMAN DENTAL PULP#0.8742;HISTAMINE#0.8675;CHOLESTEATOMA#0.8675;NF-KAPPAB INHIBITOR#0.8668;HOST CELL#0.8613;CELL GROWTH#0.8560;PROTEIN KINASE C#0.8540;ORAL CANDIDIASIS#0.8520;MACROPHAGE INFLAMMATORY PROTEIN#0.8518;AGGRESSIVE PERIODONTITIS#0.8507;INFLAMMATORY CELL#0.8461;DEFENSE RESPONSE#0.8423;NUCLEOTIDE BINDING#0.8403;GM-CSF#0.8401;HEPARIN BINDING#0.8394;PHOSPHOLIPASE C#0.8334;NF KAPPAB BINDING#0.8300;HEPARIN#0.8268;SIGNALLING PATHWAY#0.8233;QUANTITATIVE REVERSE TRANSCRIPTION#0.8209;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8155;CELL MIGRATION#0.8148;LANGERHANS CELL#0.8123;CELL CYCLE#0.8089;BETA-2#0.8077;CORNEAL EPITHELIUM#0.8060;CYTOTOXICITY#0.8054;RESPONSE TO LPS#0.8049;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8047;ENDOTHELIAL GROWTH FACTOR#0.8046;IL-1RA#0.8022;HUMAN AIRWAY EPITHELIAL#0.8020;DENTAL PULP CELL#0.7996;LUNG CANCER#0.7982;CELL ACTIVATION#0.7980;SIGNALING MOLECULE#0.7941;HUMAN INTESTINAL EPITHELIAL#0.7938;LPS BINDING#0.7927;AUTOIMMUNE DISEASE#0.7925;NITRIC OXIDE#0.7907;HUMAN BRONCHIAL EPITHELIAL#0.7882;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7852;AMNION#0.7813;ANGIOGENESIS#0.7784;CHEMOTAXIS#0.7766;TONSIL#0.7761;KERATITIS#0.7671;SMALL INTESTINE#0.7645;GREEN TEA EXTRACT#0.7616;PANETH CELL#0.7569;CELL MEMBRANE#0.7540;SPUTUM#0.7538;VITAMIN D RECEPTOR#0.7468;PERIPHERAL BLOOD CELLS#0.7451;GRANULOCYTE#0.7447;HUMAN EPIDERMAL KERATINOCYTES#0.7437;CELL DIFFERENTIATION#0.7389;TIGHT JUNCTION#0.7388;GROWTH PATTERN#0.7387;T LYMPHOCYTE#0.7374;AMNIOTIC FLUID#0.7365;GROWTH FACTOR RECEPTOR#0.7337;NEUTROPHIL APOPTOSIS#0.7335;CC CHEMOKINE LIGAND#0.7331;TUMOR TISSUES#0.7323;SIGNAL TRANSDUCTION#0.7295;COPY NUMBER POLYMORPHISM#0.7268;GASTRIC MUCOSA#0.7248;ALVEOLAR MACROPHAGE#0.7243;ACUTE LUNG INJURY#0.7226;EPIDERMAL GROWTH FACTOR#0.7187;APOPTOTIC#0.7155;SIGNAL TRANSDUCER#0.7154;LUMINAL#0.7146;COLONY-STIMULATING FACTOR#0.7133;CIGARETTE SMOKE EXTRACT#0.7046;AUTOPHAGY#0.7033;HISTONE DEACETYLASE#0.7013;PERTUSSIS#0.7011;MUTAGENESIS#0.7008;L-ISOLEUCINE#0.7004;VIRAL REPLICATION#0.6997;POLYMORPHONUCLEAR NEUTROPHIL#0.6991;OSTEOBLAST#0.6965;DIABETES MELLITUS#0.6957;CHLAMYDIA#0.6916;1α,25-DIHYDROXYVITAMIN D3#0.6889;LICHEN PLANUS#0.6863;DIARRHEA#0.6855;RESPONSE TO BACTERIAL LIPOPROTEIN#0.6836;BIOFILM FORMATION#0.6834;INTERCELLULAR SPACE#0.6772;DERMIS#0.6686;C REACTIVE PROTEIN#0.6685;DNA BINDING#0.6649;BACTERIAL VAGINOSIS#0.6633;ONCOSTATIN M PRODUCTION#0.6633;INTESTINAL TRACT#0.6626;TH17 CELL#0.6591;ECZEMA#0.6587;MECHANISMS OF ACTION#0.6568;ENTEROCYTE#0.6546;CHANNEL INHIBITOR#0.6526;ADAPTIVE IMMUNE SYSTEM#0.6500;ESOPHAGUS#0.6493;ACTIVATION OF NF-KAPPAB#0.6490;TIGHT JUNCTION PROTEIN#0.6483;PHOSPHATE BUFFERED SALINE#0.6473;CALCIPOTRIOL#0.6454;PROGESTERONE#0.6434;VIRAL INFECTION#0.6430;ADENOCARCINOMA#0.6428;SKIN BARRIER FUNCTION#0.6423;CELL ADHESION#0.6399;LOCALISATION#0.6293;CUTANEOUS TUBERCULOSIS#0.6293;CEFTAROLINE#0.6287;BASAL CELL#0.6272;PROTEINASE INHIBITOR#0.6186;INTESTINAL MUCOSA#0.6182;MESENCHYMAL STEM CELL#0.6180;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6162;TINEA CORPORIS#0.6137;RESPONSE TO BACTERIA#0.6132;TRANSFORMING GROWTH FACTOR BETA#0.6131;TRACHEA#0.6110;RECEPTOR ANTAGONIST#0.6109;ENDOSCOPIC SINUS SURGERY#0.6086;FULL THICKNESS BURN#0.6085;ASCENDING COLON#0.6047;AIRWAY SURFACE LIQUID#0.6026;LACTIC ACID#0.6022
167410	SPINAL CORD#0.7957;SPINAL MUSCULAR ATROPHY#0.6966;MUSCULAR ATROPHY#0.6947
167465	LUCIFERASE ACTIVITY#0.6511;SPINAL CORD INJURY#0.6492;SPINAL CORD#0.6398
1674	SHU COMPLEX#1.1328;TYPE III INTERMEDIATE FILAMENT#1.0420;INTERCALATED DISK#1.0369;SPECTRIN#1.0321;DECIDUAL CELL#1.0321;ITO CELL#1.0290;ANAPLASTIC LYMPHOMA KINASE#1.0270;MYOFIBRILLAR MYOPATHY#1.0239;CONNEXIN#1.0237;GLIAL FILAMENT#1.0235;RESTRICTIVE CARDIOMYOPATHY#1.0234;FACTOR XIIIA#1.0234;CARDIAC TROPONIN I#1.0232;COSTAMERE#1.0216;INTERCALATED DISC#1.0212;Z DISK#1.0208;FACTOR VIII#1.0190;COLLAGEN TYPE IV#1.0183;ALPHA 1-ANTITRYPSIN#1.0180;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0179;CALPAIN ACTIVITY#1.0175;INHIBIN#1.0174;PODOCYTE#1.0172;Z DISC#1.0165;ACETYLCHOLINE RECEPTOR#1.0165;SMOOTH MUSCLE ACTIN#1.0160;THYROID TRANSCRIPTION FACTOR#1.0144;NEUROFILAMENT#1.0137;MESOTHELIAL CELL#1.0128;Z BAND#1.0127;LEUKOCYTE#1.0117;MURAL CELL#1.0104;BIOTIN#1.0088;MYOSIN HEAVY CHAIN#1.0084;VITAMIN A#1.0078;COLLAGEN TYPE I#1.0061;ESTROGEN RECEPTOR#1.0060;Z LINE#1.0060;MYOTENDINOUS JUNCTION#1.0058;SOMITE#1.0053;CELL ADHESION MOLECULE#1.0052;GLOMERULAR EPITHELIAL CELL#1.0047;MESANGIAL CELL#1.0047;SMOOTH MUSCLE#1.0042;PERICYTE#1.0036;ANDROGEN RECEPTOR#1.0007;MYOGENIC CELL#0.9999;PROGESTERONE#0.9998;NEURAL CELL#0.9994;WILMS TUMOR 1#0.9992;INTERMEDIATE FILAMENT#0.9980;STEM CELL MARKER#0.9979;DILATED CARDIOMYOPATHY#0.9977;MYOPATHY#0.9975;MUSCLE CELL DIFFERENTIATION#0.9966;MYOSIN BINDING#0.9965;ACETYLCHOLINE#0.9964;CARDIAC MUSCLE#0.9963;UBIQUITIN#0.9924;CREATINE KINASE#0.9922;NEUROMUSCULAR JUNCTION#0.9917;DECIDUALIZATION#0.9914;LECTIN#0.9909;SERTOLI CELL#0.9908;GLOMUS TUMOR#0.9907;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9903;SARCOLEMMA#0.9897;CARDIOMYOPATHY#0.9895;PANCREATIC STELLATE CELL#0.9891;MUSCLE SATELLITE CELL#0.9881;CELL ADHESION#0.9880;MYOEPITHELIAL CELL#0.9879;SKELETAL MUSCLE CELLS#0.9879;CREATINE#0.9878;SARCOMERE#0.9877;MYOCYTES#0.9876;TUMOR CELLS#0.9872;ALVEOLAR SOFT PART SARCOMA#0.9869;DESMOPLASTIC SMALL ROUND CELL TUMOR#0.9868;MALIGNANT MESOTHELIOMA#0.9868;GROWTH FACTOR RECEPTOR#0.9867;STRIATED MUSCLE#0.9861;SMOOTH MUSCLE CELL DIFFERENTIATION#0.9859;HYPOXIA#0.9857;MYOTUBE#0.9856;PROTEOGLYCAN#0.9855;MYOBLAST#0.9855;MUSCLE FIBRE#0.9855;CARDIOMYOCYTE#0.9852;OVAL CELL#0.9846;GAP JUNCTION#0.9845;ALKALINE PHOSPHATASE#0.9842;INCLUSION BODY#0.9838;I BAND#0.9830;AZACYTIDINE#0.9820;HYPERTROPHIC CARDIOMYOPATHY#0.9820;PROTEIN COMPLEX#0.9818;MYOFIBRIL#0.9813;HEAT SHOCK PROTEIN#0.9813;PLEOMORPHIC RHABDOMYOSARCOMA#0.9813;CYTOPLASMIC INCLUSION#0.9809;GLCNAC#0.9806;EPIDERMAL GROWTH FACTOR#0.9804;MYOBLAST FUSION#0.9802;MUSCLE FIBER#0.9799;HINDLIMB#0.9797;FOOT PROCESS EFFACEMENT#0.9794;SPINDLE CELL LIPOMA#0.9792;VASCULAR SMOOTH MUSCLE CELL#0.9790;SPINDLE CELL SARCOMA#0.9784;GRANULAR CELL TUMOR#0.9784;NEUROBLASTOMA#0.9781;TRANSCRIPTION FACTOR#0.9775;MICROTUBULE#0.9775;MYOGENESIS#0.9772;ENDOMETRIAL STROMAL SARCOMA#0.9772;EOSIN#0.9768;MUSCLE DAMAGE#0.9760;MONONUCLEAR CELLS#0.9758;GRANULOSA CELL#0.9756;FORMALIN#0.9755;AGEING#0.9752;B CELL#0.9751;ALVEOLAR RHABDOMYOSARCOMA#0.9750;PROLYL 4-HYDROXYLASE#0.9750;PLASMA MEMBRANE#0.9747;FIBROBLAST GROWTH FACTOR#0.9747;MUSCLE WEAKNESS#0.9745;SCHWANN CELL#0.9744;MYOFIBROBLAST#0.9740;EMBRYONAL RHABDOMYOSARCOMA#0.9739;PLATELET-DERIVED GROWTH FACTOR#0.9739;PERIVASCULAR EPITHELIOID CELL TUMOR#0.9733;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9732;PROTEASOME#0.9731;ENDOTHELIAL GROWTH FACTOR#0.9731;BILE DUCT#0.9730;STROMAL CELL#0.9730;CHONDROSARCOMA#0.9730;GLIAL CELL#0.9727;ACTIN FILAMENT#0.9725;STROMAL SARCOMA#0.9724;FIBROMA#0.9724;GESTATION#0.9722;INSULIN-LIKE GROWTH FACTOR#0.9721;ASTROCYTE#0.9714;MICROFILAMENT#0.9712;SMOOTH MUSCLE TUMOR#0.9711;CARCINOSARCOMA#0.9709;TRANSFORMING GROWTH FACTOR BETA#0.9702;DEDIFFERENTIATION#0.9701;THYMIDINE#0.9700;PROTEIN SYNTHESIS#0.9698;EXTRACELLULAR MATRIX COMPONENT#0.9698;CELL MEMBRANE#0.9697;MESENCHYMAL CELL#0.9696;RETE TESTIS#0.9696;HEMANGIOPERICYTOMA#0.9695;DIGESTION#0.9695;MUSCLE CELL#0.9691;DIAPHRAGM#0.9689;PERIVASCULAR EPITHELIOID CELL#0.9688;INTERSTITIAL CELL#0.9688;OVARIES#0.9687;MYOMETRIUM#0.9686;HEPATIC STELLATE CELL#0.9684;CELL ACTIVATION#0.9683;SARCOPLASMIC RETICULUM#0.9683;LIPID DROPLET#0.9682;ANGIOMYOLIPOMA#0.9681;PROTEIN KINASE#0.9680;INFLAMMATORY MYOFIBROBLASTIC TUMOR#0.9679;MONOCYTE#0.9677;ATRIOVENTRICULAR BLOCK#0.9671;PROTEIN KINASE C#0.9671;MITOCHONDRIA#0.9669;COLORECTAL#0.9669;GERM CELL#0.9666;EPSTEIN BARR VIRUS#0.9663;SMOOTH MUSCLE CELL#0.9661;ORGANELLE#0.9660;CELL SURFACE#0.9658;T CELL#0.9654;PROTEINURIA#0.9653;SODIUM DODECYL SULFATE#0.9652;DODECYL SULFATE#0.9651;DESMOSOME#0.9651;DENDRITIC CELL#0.9648;FIBRIL#0.9647;MUSCULAR DYSTROPHY#0.9646;RHABDOMYOSARCOMA#0.9645;HEART DISEASE#0.9645;MYOFILAMENT#0.9643;KERATIN FILAMENT#0.9641;LEIOMYOMA#0.9640;MYOCARDIUM#0.9640;SYNOVIAL SARCOMA#0.9640;SOLITARY FIBROUS TUMOR#0.9639;PRECURSOR CELL#0.9639;ENDOTHELIUM#0.9639;ESOPHAGUS#0.9638;NITRIC OXIDE#0.9637;STRESS FIBER#0.9637;MYOCARDIAL INFARCTION#0.9635;CELL CYCLE#0.9634;MACROPHAGE#0.9633;URINARY PROTEIN#0.9633;PARENCHYMA#0.9632;DIABETIC NEPHROPATHY#0.9632;BASAL LAMINA#0.9632;TUMOR NECROSIS FACTOR#0.9632;PROTEIN DEGRADATION#0.9631;TRANSFORMING GROWTH FACTOR#0.9629;LEIOMYOSARCOMA#0.9626;TRANSMISSION ELECTRON MICROSCOPY#0.9625;NECROTIC#0.9625;PROGENITOR CELL#0.9624;MESENCHYME#0.9624;LIPOSARCOMA#0.9622;SKELETAL MUSCLE#0.9619;CELL DIFFERENTIATION#0.9618;MITOSIS#0.9618;DERMATOFIBROSARCOMA PROTUBERANS#0.9616;GENE EXPRESSION#0.9615;VACUOLE#0.9613;LIPOMA#0.9609;NON-MUSCLE MYOSIN#0.9608;TRANSCRIPTASE#0.9606;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.9606;BASEMENT MEMBRANE#0.9606;ISCHEMIA#0.9605;EPITHELIOID SARCOMA#0.9605;ARRHYTHMIA#0.9605;NEUROECTODERMAL TUMOR#0.9604;HAMARTOMA#0.9604;MAST CELL#0.9603;CELL DEATH#0.9603;MESENTERY#0.9600;MUSCLE CONTRACTION#0.9599;PLEURA#0.9599;CORONARY ARTERY#0.9598;BENIGN NEOPLASM#0.9597;MELANOSOME#0.9593;DIED OF DISEASE#0.9592;CROSS SECTIONAL AREA#0.9592;RENAL CELL CARCINOMA#0.9590;NEPHROPATHY#0.9588;OMENTUM#0.9587;ELASTIC FIBER#0.9586;ENDOTHELIAL CELL#0.9583;ARTERIOLE#0.9583;SPINAL CORD#0.9581;PROSTATE SPECIFIC ANTIGEN#0.9579;ENDOMETRIUM#0.9577;CANCER CELL#0.9575;EPITHELIAL CELL#0.9575;ADIPOSE TISSUE#0.9575;MYOFIBROMA#0.9573;EXCRETION#0.9573;SALIVARY GLAND#0.9572;ROUGH ENDOPLASMIC RETICULUM#0.9571;CELLULAR COMPONENT#0.9571;NERVE SHEATH TUMORS#0.9570;URINARY BLADDER#0.9569;KINETOCHORE#0.9568;REVERSE TRANSCRIPTION#0.9562;BILE DUCT LIGATION#0.9561;APOPTOSIS#0.9561;VULVA#0.9559;GROWTH FACTOR#0.9559;ANGIOGENESIS#0.9558;MYOBLAST DIFFERENTIATION#0.9557;REGENERATION#0.9557;SOFT TISSUE SARCOMA#0.9555;ORAL CAVITY#0.9553;SCANNING ELECTRON MICROSCOPY#0.9553;PELVIS#0.9551;PERITUBULAR MYOID CELL#0.9547;SKELETAL MUSCLE REGENERATION#0.9546;FIBROUS HISTIOCYTOMA#0.9545;FIBROSARCOMA#0.9544;CELLULAR LEIOMYOMA#0.9542;NEUROMUSCULAR DISEASE#0.9542;OSTEOCLAST#0.9541;ADIPOCYTE#0.9541;HISTIOCYTOMA#0.9540;ZONULA OCCLUDENS#0.9538;CONNECTIVE TISSUE#0.9537;TUNICA ALBUGINEA#0.9535;SMALL INTESTINE#0.9535;SPINDLE CELL CARCINOMA#0.9533;INFLAMMATORY CELL#0.9533;APOPTOTIC#0.9532;MUSCLE ATROPHY#0.9531;CERVIX#0.9530;POLYMERASE CHAIN REACTION#0.9530;MAMMARY GLAND#0.9530;DUCHENNE MUSCULAR DYSTROPHY#0.9529;AGGRESSIVE BEHAVIOR#0.9528;PLEOMORPHIC ADENOMA#0.9526;HOMOLOGOUS RECOMBINATION#0.9524;ADENOCARCINOMA#0.9524;PLASMA CELL#0.9522;BLOOD VESSEL#0.9520;EXTRACELLULAR MATRIX#0.9517;ARTERY#0.9516;CERVICAL#0.9515;WOUND HEALING#0.9515;SIGNALING PATHWAY#0.9514;SQUAMOUS CELL CARCINOMA#0.9514;PERIPHERAL NERVE#0.9510;ARGININE#0.9510;HISTOGENESIS#0.9510;EWING SARCOMA#0.9507;LUMINAL#0.9506;DERMIS#0.9504;FINE NEEDLE ASPIRATION#0.9504;CELL GROWTH#0.9503;TUBEROUS SCLEROSIS#0.9503;MYOSIN LIGHT-CHAIN KINASE#0.9499;COLLAGENASE#0.9499;OVARIAN#0.9498;HYPERTENSION#0.9497;SWELLING#0.9497;NITRIC OXIDE SYNTHASE#0.9497;CELL MIGRATION#0.9496;CELL PROLIFERATION#0.9493;BASAL CELL#0.9492;ABDOMINAL PAIN#0.9491;AUTOPHAGY#0.9491;FASCIITIS#0.9490;CENTRAL NERVOUS SYSTEM#0.9487;HIGH POWER FIELD#0.9485;HYPOXIC#0.9484;NERVOUS SYSTEM#0.9483;VENA CAVA#0.9481;GASTROINTESTINAL STROMAL TUMOR#0.9481;NODULAR#0.9478;GI TRACT#0.9478;STEM CELL#0.9477;METAPLASIA#0.9477;KIDNEY DISEASE#0.9476;MESENCHYMAL STEM CELL#0.9476;NUCLEAR MEMBRANE#0.9472;HEMORRHAGE#0.9472;ENDOPLASMIC RETICULUM#0.9468;SIGNAL TRANSDUCTION#0.9468;GASTROINTESTINAL TRACT#0.9468;GROWTH PATTERN#0.9466;IMMUNE RESPONSE#0.9463;UTERUS#0.9463;PERITONEUM#0.9461;NEURAL CREST#0.9461;STROMA#0.9460;EMBRYONIC STEM CELL#0.9454;KUPFFER CELL#0.9454;MAGNETIC RESONANCE IMAGING#0.9454;DNA SYNTHESIS#0.9447;RECTUM#0.9444;DOXORUBICIN#0.9443;THICK FILAMENT#0.9443;MANDIBLE#0.9440;BONE MARROW#0.9435;LYMPH NODE#0.9430;KINASE INHIBITOR#0.9424;MEDIASTINUM#0.9422;EDEMA#0.9421;CYTOPLASM#0.9421;NEUROFIBROMA#0.9419;UMBILICAL CORD#0.9417;ENDOMETRIAL STROMAL TUMOR#0.9414;MORPHOGENESIS#0.9406;EPITHELIOID LEIOMYOSARCOMA#0.9400;NERVE GROWTH FACTOR#0.9399;ATHEROSCLEROTIC#0.9393;NERVE FIBER#0.9381;MICROPHTHALMIA#0.9373;TERMINAL DIFFERENTIATION#0.9367;MYOEPITHELIOMA#0.9365;HEPATOCELLULAR CARCINOMA#0.9359;QUANTITATIVE REAL TIME#0.9359;ADENO ASSOCIATED VIRUS#0.9358;ADVENTITIA#0.9357;LOCALISATION#0.9355;ATP SYNTHASE#0.9354;TRANSDIFFERENTIATION#0.9353;ANGIOMATOID FIBROUS HISTIOCYTOMA#0.9345;PAROTID GLAND#0.9344;CONGENITAL MYOPATHY#0.9340;GIANT CELL TUMOR#0.9338;FIBRINOGEN#0.9336;TUMOR TISSUES#0.9333;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY#0.9333;GLUTATHIONE#0.9330;LYMPH NODE METASTASIS#0.9327;PROSTATE CANCER#0.9317;ZONULA OCCLUDENS 1#0.9312;LYSOSOME#0.9305;ADRIAMYCIN#0.9302;CYTOSKELETAL ELEMENT#0.9298;A BAND#0.9297;CARDIAC CONDUCTION#0.9296;WEIGHT LOSS#0.9294;BLADDER SMOOTH MUSCLE#0.9288;THROMBOSIS#0.9284;LIVER DISEASE#0.9283;INTERMEDIATE FILAMENT ASSOCIATED PROTEIN#0.9282;ANGIOSARCOMA#0.9279;EPITHELIAL MESENCHYMAL TRANSITION#0.9277;HEPARIN#0.9275;EPITHELIAL TO MESENCHYMAL#0.9274;NEUTROPHIL#0.9268;GALECTIN#0.9256;INFLAMMATORY RESPONSE#0.9254;MESOTHELIUM#0.9234;MYOGENIC REGULATORY FACTOR#0.9227;WATER HOLDING CAPACITY#0.9219;RETINOIC ACID#0.9215;BETA GALACTOSIDASE#0.9214;CLEAR CELL SARCOMA#0.9212;BINDING PROTEIN 1#0.9210;SCLEROTIC#0.9203;CONGESTIVE HEART FAILURE#0.9200;VASCULAR CELL#0.9191;ERYTHROCYTE#0.9178;AUTOLYSIS#0.9173;DERMAL FIBROBLAST#0.9172;REACTIVE OXYGEN SPECIES#0.9171;SEPTUM#0.9163;TOXICITY#0.9154;S PHASE#0.9145;TERATOMA#0.9142;DIABETES MELLITUS#0.9142;COLLAGEN SYNTHESIS#0.9127;NUCLEIC ACID#0.9112;PULMONARY ARTERY#0.9107;HEMATURIA#0.9103;EMBRYONIC HEART#0.9096;T LYMPHOCYTE#0.9094;SUPEROXIDE DISMUTASE#0.9094;INTERMEDIATE FILAMENT CYTOSKELETON#0.9093;IMATINIB#0.9087;VASCULAR ENDOTHELIAL CELL#0.9087;AORTIC SMOOTH MUSCLE CELLS#0.9076;ADRENAL GLAND#0.9073;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9054;STRUCTURAL ORGANIZATION#0.9052;FACTOR I#0.9047;HEART MUSCLE#0.9044;SMOOTH MUSCLE FIBER#0.9032;OSTEOBLAST#0.9012;COMPLEX I#0.9012;NEMALINE MYOPATHY#0.9005;POSITRON EMISSION TOMOGRAPHY#0.9002;POST-TRANSLATIONAL MODIFICATION#0.8995;HEPATOCYTE GROWTH FACTOR#0.8992;EPIDERMOLYSIS BULLOSA#0.8983;ACID PHOSPHATASE#0.8980;GLOMERULAR FILTRATION#0.8971;TROPHOBLAST#0.8966;HEMORRHAGIC#0.8959;MESENCHYMAL CHONDROSARCOMA#0.8951;LYSINE#0.8949;TUMOR SUPPRESSOR#0.8934;ESTRADIOL#0.8927;DYSPNEA#0.8927;KINASE ACTIVITY#0.8925;LARYNX#0.8922;RETINOBLASTOMA#0.8922;EPIDERMOLYSIS BULLOSA SIMPLEX#0.8918;EFFERENT DUCT#0.8910;BREAST CANCER#0.8903;ATHEROSCLEROSIS#0.8898;CELL JUNCTION#0.8890;RECEPTOR ANTAGONIST#0.8881;AMYLOID PRECURSOR PROTEIN#0.8869;INFANTILE MYOFIBROMATOSIS#0.8864;ACTIN BINDING#0.8850;GLOMERULUS#0.8850;DNA BINDING#0.8850;GLOMUS CELL#0.8841;CAROTID ARTERY#0.8840;ACTIN CYTOSKELETON#0.8839;BREAST CARCINOMA#0.8831;MEIOSIS I#0.8822;INTERCELLULAR JUNCTION#0.8818;ANEMIA#0.8818;MUSCLE-DERIVED CELL#0.8813;LYMPHANGIOLEIOMYOMATOSIS#0.8799;LASER SCANNING MICROSCOPY#0.8791;FINE NEEDLE ASPIRATE#0.8791;PLEOMORPHIC LIPOSARCOMA#0.8790;SUDDEN CARDIAC DEATH#0.8787;REGIONAL LYMPH NODE#0.8781;PUROMYCIN#0.8780;FOLLICULAR DENDRITIC CELL#0.8769;TUBULAR EPITHELIAL CELL#0.8768;MYOSITIS#0.8759;SCALP#0.8751;COLUMNAR#0.8748;DENSE PLAQUE#0.8737;M LINE#0.8733;MELANOCYTE#0.8728;SIGNALING MOLECULE#0.8720;ADENOSINE#0.8718;NEUROPATHY#0.8712;MYOMA#0.8710;BONE MORPHOGENETIC PROTEIN#0.8709;MICROVILLI#0.8705;CHONDROCYTE#0.8704;KERATINOCYTE#0.8690;LEIOMYOMATOSIS#0.8677;AIRWAY SMOOTH MUSCLE#0.8673;MYOCARDITIS#0.8671;2'-DEOXYURIDINE#0.8667;STREPTOZOTOCIN#0.8666;ADENOSARCOMA#0.8664;ENDOMETRIOSIS#0.8659;RESPIRATION#0.8647;PERIPHERAL BLOOD#0.8643;CELL DIVISION#0.8634;HIGH FAT DIET#0.8632;URETHRA#0.8630;CARCINOMA IN SITU#0.8612;SMALL CELL CARCINOMA#0.8608;LEYDIG CELL#0.8599;METASTATIC CARCINOMA#0.8598;COLORECTAL CANCER#0.8597;NEBULIN BINDING#0.8592;MALIGNANT LYMPHOMA#0.8581;WORLD HEALTH ORGANIZATION#0.8577;FOREARM#0.8573;TYPE 2 DIABETES#0.8559;EPIDIDYMIS#0.8551;VENULE#0.8543;CILIARY BODY#0.8539;MOLAR#0.8539;AGE AT DIAGNOSIS#0.8533;RNA BINDING#0.8516;MALIGNANT TRITON TUMOR#0.8511;B LYMPHOCYTE#0.8507;MITRAL VALVE#0.8493;GRANULOSA CELL TUMOR#0.8493;LIMB-GIRDLE MUSCULAR DYSTROPHY#0.8493;MUSCLE STEM CELL#0.8491;LARGE INTESTINE#0.8457;MESENCHYMAL STROMAL CELL#0.8447;LYMPH NODE METASTASES#0.8423;SLIT DIAPHRAGM#0.8412;INNERVATION#0.8410;CELL PERIPHERY#0.8396;GINGIVA#0.8395;ASCITES#0.8390;OSSIFYING FIBROMYXOID TUMOR#0.8388;SERUM ALBUMIN#0.8381;NOT OTHERWISE SPECIFIED#0.8379;BOTRYOID RHABDOMYOSARCOMA#0.8373;MEDULLOBLASTOMA#0.8369;NUCLEAR ENVELOPE#0.8368;FETAL LIVER#0.8341;PORTAL VEIN#0.8333;MUSCULAR ATROPHY#0.8328;CHRONIC KIDNEY DISEASE#0.8326;UBIQUITIN PROTEASOME SYSTEM#0.8325;SYSTOLIC BLOOD PRESSURE#0.8321;JEJUNUM#0.8318;PITUITARY GLAND#0.8312;PARAGANGLIOMA#0.8303;METAPLASTIC CARCINOMA#0.8300;IMMUNE SYSTEM#0.8298;CYCLOPHOSPHAMIDE#0.8295;SKELETON#0.8285;LUNG CARCINOMA#0.8283;STROMAL NEOPLASM#0.8282;COLLAGEN TYPE III#0.8282;INCONTINENCE#0.8279;HEMATOPOIETIC CELL#0.8273;CAVEOLAE#0.8272;FAT CELL#0.8267;ANGIOTENSIN CONVERTING ENZYME#0.8260;HEMANGIOMA#0.8236;UNCERTAIN MALIGNANT POTENTIAL#0.8236;BONE MARROW CELLS#0.8217;TO THE PROGRESSION#0.8212;CELL FUSION#0.8195;72-HOURS#0.8187;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8187;FRONTAL#0.8185;PERINEUM#0.8180;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8179;HEPATOBLAST#0.8169;PANCREATIC CANCER#0.8155;URETER#0.8136;ATRIAL FIBRILLATION#0.8136;HUMAN IMMUNODEFICIENCY VIRUS#0.8133;B CELL LYMPHOMA#0.8130;SCROTUM#0.8124;BETA-2#0.8124;MYOSIN FILAMENT#0.8124;CENTRONUCLEAR MYOPATHY#0.8114;INTERPHASE#0.8112;MUSCLE PRECURSOR CELL#0.8104;METASTATIC MELANOMA#0.8104;GONAD#0.8100;MAXILLA#0.8097;PROTEIN OXIDATION#0.8094;TUBEROUS SCLEROSIS COMPLEX#0.8093;SARCOPLASM#0.8089;HYDROXYPROLINE#0.8086;IMATINIB MESYLATE#0.8079;SURFACE EPITHELIUM#0.8076;MEIOSIS#0.8074;TRANSFORMING GROWTH FACTOR ALPHA#0.8069;DISEASE FREE SURVIVAL#0.8068;RYANODINE RECEPTOR#0.8061;ISCHEMIC HEART DISEASE#0.8060;CLEAVAGE FURROW#0.8048;NUCLEAR LAMINA#0.8046;RAPAMYCIN#0.8042;MYOFIBROBLAST DIFFERENTIATION#0.8039;MYOBLAST PROLIFERATION#0.8031;DIGESTIVE TRACT#0.8029;GOLGI APPARATUS#0.8025;VINCRISTINE#0.8020;CYCLIN DEPENDENT KINASE#0.8011;DECIDUA#0.7985;MUTAGENESIS#0.7985;RECEPTOR TYROSINE KINASE#0.7983;ENZYME ACTIVITY#0.7982;MYXOID CHONDROSARCOMA#0.7981;PROTEIN QUALITY CONTROL#0.7979;INCLUSION BODY MYOSITIS#0.7978;FAMILIAL DILATED CARDIOMYOPATHY#0.7975;BICEPS#0.7975;RESPIRATORY FAILURE#0.7966;TISSUE GROWTH FACTOR#0.7965;ANCHORING#0.7964;SATELLITE CELL ACTIVATION#0.7952;PERIPHERAL NERVOUS SYSTEM#0.7947;NOTOCHORD#0.7946;PULMONARY HYPERTENSION#0.7945;ACUTE MYOCARDIAL INFARCTION#0.7929;TIGHT JUNCTION#0.7927;FIBROCYTE#0.7925;ETHANOL#0.7915;BUDDING#0.7912;GLOMERULONEPHRITIS#0.7911;BONE FORMATION#0.7911;NEUROENDOCRINE CARCINOMA#0.7910;DUCT CELL#0.7899;MUSCLE WASTING#0.7897;DUODENUM#0.7892;THYROID GLAND#0.7887;NOREPINEPHRINE#0.7884;ADENINE#0.7881;ATYPICAL TERATOID RHABDOID TUMOR#0.7870;FOCAL ADHESION#0.7864;SUBSTANCE P#0.7845;LOSARTAN#0.7839;SMOOTH MUSCLE CONTRACTION#0.7829;STEM CELL DIFFERENTIATION#0.7823;MITOGEN ACTIVATED PROTEIN#0.7822;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7820;OBESE#0.7817;CYTOCHROME C#0.7812;LIVER REGENERATION#0.7798;LIVER DEVELOPMENT#0.7780;PROTEIN PHOSPHORYLATION#0.7780;CELLULAR LOCALIZATION#0.7778;CRISPR-CAS SYSTEM#0.7775;SENESCENCE#0.7771;MUSCLE LIM PROTEIN#0.7767;RETINOL#0.7765;PEROXISOME#0.7758;TRANSVERSE COLON#0.7752;CHROMOSOME SEGREGATION#0.7748;COAGULATION#0.7747;CLEAR CELL CARCINOMA#0.7740;EOSINOPHIL#0.7738;BLASTOMA#0.7737;LEFT ANTERIOR DESCENDING#0.7727;SEMINAL VESICLE#0.7723;SPINDLE CELL RHABDOMYOSARCOMA#0.7723;GALLBLADDER#0.7717;GERM CELL TUMORS#0.7716;LIVER CIRRHOSIS#0.7702;EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY#0.7694;PULMONARY FIBROSIS#0.7682;THYROID CARCINOMA#0.7665;SPECIFIC PROTEIN 1#0.7659;FILAMENTOUS ACTIN#0.7658;ADULT STEM CELL#0.7647;GRANULOCYTE#0.7646;PYRUVATE#0.7636;FEMUR#0.7635;NEPHROSIS#0.7629;PERITONEAL CAVITY#0.7617;COLLAGEN TYPE VI#0.7616;LOW DENSITY LIPOPROTEIN#0.7612;SKIN FIBROBLASTS#0.7598;CELL MOTILITY#0.7580;PROTEIN PROTEIN INTERACTION#0.7568;CELL DEVELOPMENT#0.7556;SPINAL MUSCULAR ATROPHY#0.7550;MYOFIBRIL ASSEMBLY#0.7543;CHRONIC HEART FAILURE#0.7542;TISSUE REGENERATION#0.7538;HAIR FOLLICLE#0.7534;LARGE ARTERIES#0.7505;MYOGENIC PRECURSOR CELL#0.7499;NORMAL CONTROL GROUP#0.7479;NUCLEOLUS#0.7470;PODOCYTE FOOT#0.7464;MENINGES#0.7434;ENUCLEATION#0.7433;METASTATIC ADENOCARCINOMA#0.7432;KAPOSI'S SARCOMA#0.7432;RENAL FIBROSIS#0.7426;CUTANEOUS LEIOMYOSARCOMA#0.7415;INFLAMMATORY CELL INFILTRATION#0.7413;CARDIOMYOCYTE DIFFERENTIATION#0.7410;NEPHRITIS#0.7410;VISCERAL ORGAN#0.7409;CELL SURFACE ANTIGEN#0.7408;CARBACHOL#0.7402;NEURAL TUBE#0.7399;ACTINOMYCIN D#0.7389;POSTTRANSLATIONAL MODIFICATION#0.7385;LYMPHOID CELL#0.7383;LYMPHOID TISSUE#0.7378;LYMPH NODE DISSECTION#0.7364;GOLGI COMPLEX#0.7359;HEPATIC ANGIOMYOLIPOMA#0.7358;TIBIA#0.7350;PANCREATITIS#0.7345;HUMAN MESENCHYMAL STEM#0.7343;DENSE MATERIAL#0.7340;GROWTH HORMONE#0.7336;NUCLEAR MATRIX#0.7329;UNDIFFERENTIATED PLEOMORPHIC SARCOMA#0.7304;T TUBULE#0.7301;MUCOUS#0.7293;CREATINE KINASE ACTIVITY#0.7289;PHOSPHATASE ACTIVITY#0.7257;CONTACT INHIBITION#0.7257;GERMINAL CENTER#0.7255;STRESS URINARY INCONTINENCE#0.7254;ADENOID CYSTIC CARCINOMA#0.7242;MONOPOLIN COMPLEX#0.7234;IFOSFAMIDE#0.7227;PEDICLE#0.7221;NEURAL CREST CELL#0.7212;QUADRICEPS#0.7210;LIVER METASTASIS#0.7202;TISSUE REMODELING#0.7196;OVIDUCT#0.7194;OF DIABETIC RATS#0.7190;HEPATIC STELLATE CELL ACTIVATION#0.7184;PERINEURIOMA#0.7182;HISTAMINE#0.7181;TONGUE DEVELOPMENT#0.7176;MITOCHONDRIAL DISTRIBUTION#0.7175;LASER DESORPTION IONIZATION#0.7175;GANGLION CELLS#0.7172;NEURONAL CELLS#0.7160;DNASE#0.7158;CARRIE#0.7152;LUMINAL EPITHELIAL CELL#0.7152;INCLUSION BODY MYOPATHY#0.7149;ACETIC ACID#0.7146;BLOOD BRAIN BARRIER#0.7146;PULMONARY BLASTOMA#0.7144;TESTOSTERONE#0.7120;COMPARATIVE GENOMIC HYBRIDIZATION#0.7111;TENOSYNOVIAL GIANT CELL TUMOR#0.7109;CELL ASSOCIATED#0.7103;CHRONIC LIVER DISEASE#0.7098;NEPHROTIC SYNDROME#0.7092;ACTIN BINDING PROTEIN#0.7073;THYMOCYTE#0.7062;TYROSINE KINASE INHIBITOR#0.7058;EXTRASKELETAL MYXOID CHONDROSARCOMA#0.7052;FLOW CYTOMETRY ANALYSIS#0.7047;MYOEPITHELIAL CARCINOMA#0.7021;INTERCELLULAR SPACE#0.7018;STEROID HORMONE RECEPTOR#0.7011;GLOMERULAR FILTRATION RATE#0.7010;MYXOID LEIOMYOSARCOMA#0.7009;FIBROBLAST ACTIVATION#0.7003;MYXOID LIPOSARCOMA#0.7003;NEURODEGENERATIVE DISEASE#0.7001;COLORECTAL ADENOCARCINOMA#0.7001;MESENCHYMAL HAMARTOMA#0.6988;PULMONARY EMBOLISM#0.6988;RENAL CARCINOMA#0.6982;RETINOL BINDING#0.6971;STRIATED MUSCLE FIBER#0.6970;BASAL CELL CARCINOMA#0.6965;ADHERENS JUNCTION#0.6951;OUTER LAYER#0.6950;LIPOPROTEIN LIPASE#0.6934;HODGKIN'S LYMPHOMA#0.6934;NEVUS#0.6926;PLURIPOTENT STEM CELL#0.6925;ATYPICAL POLYPOID ADENOMYOMA#0.6921;QUANTITATIVE REVERSE TRANSCRIPTION#0.6920;UMBILICAL VEIN#0.6907;NEPHROBLASTOMA#0.6900;GLYCOGEN GRANULE#0.6891;METHIONINE#0.6882;PORTAL HYPERTENSION#0.6881;LYMPHATIC VESSEL#0.6874;MALIGNANT PLEURAL MESOTHELIOMA#0.6867;ASPARTATE#0.6866;INSOLUBLE FRACTION#0.6858;AMNIOTIC FLUID#0.6852;EMBRYONIC MUSCLE#0.6842;TYPE 2 DIABETIC#0.6832;NADPH OXIDASE#0.6825;MIND COMPLEX#0.6816;LANGERHANS CELL#0.6802;MIDLINE#0.6799;BUPIVACAINE#0.6796;BOWMAN'S CAPSULE#0.6790;NEURAL STEM CELL#0.6788;ASTROCYTOMA#0.6786;OVARIAN CARCINOMA#0.6785;ONCOGENIC#0.6777;BINDING PROTEIN 3#0.6771;ELECTROPHORETIC MOBILITY SHIFT#0.6771;TARGET OF RAPAMYCIN#0.6758;AMYOTROPHIC LATERAL SCLEROSIS#0.6758;LATERAL SCLEROSIS#0.6758;INVASIVE GROWTH#0.6747;RIGHT ATRIUM#0.6746;THYMIC EPITHELIAL CELLS#0.6745;LEFT ATRIUM#0.6743;NEOPLASTIC TISSUES#0.6743;NEONATAL RAT CARDIOMYOCYTES#0.6739;TRYPTOPHAN#0.6737;CELL FRACTION#0.6719;MUSCLE CELL PROLIFERATION#0.6709;CONSTRICTION#0.6707;RETE OVARII#0.6703;FURROW#0.6700;HYALURONIC ACID#0.6677;MODAL#0.6673;LOWER LEG#0.6673;PROSOME#0.6672;TACHYCARDIA#0.6663;NEPHRON#0.6663;ATPASE ACTIVITY#0.6659;HISTONE DEACETYLASE#0.6652;HEPATITIS B#0.6650;COLON CANCER#0.6642;HYPOXIA INDUCIBLE FACTOR#0.6641;PYRUVATE KINASE#0.6639;MITOCHONDRIAL MEMBRANE#0.6635;ADVENTITIAL CELL#0.6631;FASCIA ADHERENS#0.6630;CYCLIN DEPENDENT KINASE INHIBITOR#0.6624;CISPLATIN#0.6623;INGUINAL LYMPH NODE#0.6623;AMELOBLASTOMA#0.6603;LUNG METASTASIS#0.6593;AUTOPHAGIC VACUOLE#0.6589;TAMOXIFEN#0.6587;RENAL VEIN#0.6583;ANOREXIA#0.6580;TRANSMISSION ELECTRON MICROSCOPE#0.6568;LIVER DAMAGE#0.6567;DERMOMYOTOME#0.6548;SOFT PALATE#0.6546;THORACIC AORTA#0.6540;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.6532;PLEUROPULMONARY BLASTOMA#0.6530;IMMUNE CELL#0.6526;TISSUE LESIONS#0.6520;INNER LAYER#0.6510;VASCULAR ENDOTHELIUM#0.6509;MICROVASCULAR ENDOTHELIAL CELL#0.6509;GREATER OMENTUM#0.6496;EMBRYOID BODY#0.6495;CALCIUM CHANNEL#0.6488;DNA REPLICATION#0.6483;FLUORESCEIN#0.6482;GUBERNACULUM#0.6482;PULMONARY VEIN#0.6478;KINESIN#0.6478;MYOCYTE ENHANCER FACTOR#0.6474;GLUTATHIONE PEROXIDASE#0.6470;MECHANISM OF ACTION#0.6464;HEMIDESMOSOME#0.6460;SIGNET RING CELL#0.6457;CARDIAC DEVELOPMENT#0.6457;OESOPHAGUS#0.6450;HEART DEVELOPMENT#0.6450;PURKINJE CELL#0.6437;GROWTH FACTOR BINDING#0.6427;PAPILLARY CARCINOMA#0.6424;EMBRYONAL CARCINOMA#0.6421;BLEOMYCIN#0.6421;AMYLOIDOSIS#0.6418;CELL BODY#0.6406;ORGANOGENESIS#0.6405;ASCENDING COLON#0.6401;DEXAMETHASONE#0.6399;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6398;RESPIRATORY CHAIN#0.6397;CORE NEEDLE BIOPSY#0.6387;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6385;PECTORALIS MAJOR#0.6380;ANAPLASTIC CARCINOMA#0.6376;AGGRESOME#0.6372;DISTRIBUTION OF MITOCHONDRIA#0.6369;SHORTNESS OF BREATH#0.6368;ISCHEMIA REPERFUSION INJURY#0.6365;LYSIS#0.6364;G-CSF#0.6362;HUMAN UMBILICAL VEIN#0.6354;DNA REPAIR#0.6345;ARTERY DISEASE#0.6345;SPHEROID BODY MYOPATHY#0.6342;FRAGMENT LENGTH POLYMORPHISM#0.6339;CYST WALL#0.6338;SEMINOMA#0.6331;ALZHEIMER'S DISEASE#0.6325;GLUTAMINE#0.6323;CARDIAC MAGNETIC RESONANCE#0.6307;ALANINE#0.6301;TONSIL#0.6294;BONE MARROW STROMAL#0.6285;MUSCLE HYPERTROPHY#0.6284;EMBOLISM#0.6274;SWEAT GLAND#0.6273;SCIATIC NERVE#0.6267;PODOCYTE APOPTOSIS#0.6258;LIM DOMAIN BINDING#0.6252;RED BLOOD CELL#0.6239;PERITONEAL MESOTHELIOMA#0.6239;GLYCINE#0.6236;CHOROID PLEXUS#0.6236;MESENTERIC ARTERY#0.6228;ADENYLATE#0.6225;SECRETORY GRANULE#0.6222;GENETIC DISORDER#0.6207;MICROTUBULE ASSOCIATED PROTEIN#0.6196;NERVE TERMINAL#0.6190;GLOBOID#0.6190;ADENOMYOMA#0.6185;PROTEIN KINASE A#0.6183;INNER EAR#0.6183;CYTOSKELETON ORGANIZATION#0.6178;L-ARGININE#0.6176;NUCLEAR MORPHOLOGY#0.6173;MATRIX METALLOPROTEINASE 1#0.6172;OOCYTE#0.6162;CANCER ASSOCIATED FIBROBLASTS#0.6159;POTASSIUM CHANNEL#0.6158;UTERINE HORN#0.6152;EYELID#0.6149;OXYTOCIN RECEPTOR#0.6134;MERKEL CELL#0.6131;TRACHEA#0.6123;HEPATOCYTE PROLIFERATION#0.6122;VOMITING#0.6101;MITOCHONDRIAL DNA#0.6079;CORONARY ARTERY BYPASS#0.6077;C TERMINAL DOMAIN#0.6075;ACINAR CELL#0.6071;FACTOR S#0.6069;PODOCYTE FOOT PROCESS#0.6064;PERICARDIUM#0.6040;MONOPOLAR ATTACHMENT#0.6035;ELASTIC FIBRE#0.6018;NUCLEIC ACID BINDING#0.6015;LUNG CANCER#0.6002
1675	FACTOR D#1.0584;LIPOPROTEIN LIPASE#1.0495;ENHANCER BINDING#1.0369;ENHANCER BINDING PROTEIN#1.0356;FATTY ACID BINDING#1.0324;TUMOR NECROSIS FACTOR#1.0287;PEROXISOME#1.0193;GROWTH FACTOR#1.0150;ADIPOCYTE#1.0101;FAT CELL#1.0061;ADIPOCYTE DIFFERENTIATION#1.0044;C REACTIVE PROTEIN#1.0036;OBESE#1.0022;PREADIPOCYTE#1.0016;TRANSCRIPTION FACTOR#0.9986;ADIPOGENESIS#0.9906;GENE EXPRESSION#0.9880;RETINOL BINDING#0.9874;ADIPOSE TISSUE#0.9844;LIPID DROPLET#0.9835;TYPE 2 DIABETES#0.9804;COMPLEMENT ACTIVATION#0.9740;STEM CELL#0.9683;BONE MARROW#0.9453;INSULIN-LIKE GROWTH FACTOR#0.9324;DIABETES MELLITUS#0.9295;LIPID METABOLISM#0.9271;MONOCYTE#0.9145;ALKALINE PHOSPHATASE#0.9131;MACULAR DEGENERATION#0.9124;RETINOL#0.9114;AGE RELATED MACULAR DEGENERATION#0.9059;WHITE ADIPOSE TISSUE#0.8901;POLYMERASE CHAIN REACTION#0.8810;INSULIN SECRETION#0.8792;IMMUNE SYSTEM#0.8724;OSTEOBLAST#0.8713;MESENCHYMAL STEM CELL#0.8710;MACROPHAGE#0.8670;STROMAL CELL#0.8662;SPONTANEOUS ABORTION#0.8544;INSULIN RECEPTOR#0.8469;TYPE 2 DIABETES MELLITUS#0.8433;2 DIABETES MELLITUS#0.8432;T CELL#0.8412;ENDOTHELIAL CELL#0.8376;GROWTH HORMONE#0.8369;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8300;CELL DIFFERENTIATION#0.8179;DEXAMETHASONE#0.8116;IMMUNE RESPONSE#0.7912;FAT PAD#0.7891;TERMINAL DIFFERENTIATION#0.7858;FATTY LIVER#0.7852;SIGNALING PATHWAY#0.7829;BETA-2#0.7792;OSTEOARTHRITIS#0.7784;WEIGHT GAIN#0.7661;NEUTROPHIL#0.7631;HIGH FAT DIET#0.7588;STEROL REGULATORY ELEMENT#0.7481;MIGRATION INHIBITORY FACTOR#0.7471;PRO-INFLAMMATORY#0.7468;NERVE GROWTH FACTOR#0.7385;INFLAMMATORY RESPONSE#0.7384;VASCULAR CELL#0.7288;GLOMERULAR FILTRATION#0.7269;INNATE IMMUNE SYSTEM#0.7265;BREAST CANCER#0.7218;VISCERAL ADIPOSE TISSUE#0.7201;HYPERTENSION#0.7166;APOPTOSIS#0.7091;GLOMERULAR FILTRATION RATE#0.7073;GLUCOSE METABOLISM#0.6893;HORMONE SENSITIVE LIPASE#0.6831;LIVER DISEASE#0.6785;REVERSE TRANSCRIPTION#0.6745;BONE MARROW STROMAL#0.6711;MULTIPLE SCLEROSIS#0.6672;HYPERGLYCEMIA#0.6668;CELL ADHESION MOLECULE#0.6667;CELL ADHESION#0.6642;FATTY LIVER DISEASE#0.6570;CELL PROLIFERATION#0.6561;WEIGHT LOSS#0.6540;COMPLEMENT ALTERNATIVE PATHWAY#0.6525;BINDING PROTEIN 1#0.6505;TUMOUR NECROSIS FACTOR#0.6484;CELL GROWTH#0.6458;LECTIN#0.6442;CELL DEATH#0.6435;PROTEIN KINASE#0.6429;BONE MARROW STROMAL CELL#0.6413;COMPLEMENT CASCADE#0.6413;COMPLEMENT FACTOR H#0.6356;COMPLEMENT ACTIVITY#0.6344;HEPATIC GROWTH FACTOR#0.6313;CAFFEINE#0.6281;EXTRACELLULAR MATRIX#0.6278;TRANSFERRIN RECEPTOR#0.6276;ADRENERGIC RECEPTOR#0.6263;BROWN ADIPOSE TISSUE#0.6242;OSTEOPOROSIS#0.6236;FOR ADIPOCYTE DIFFERENTIATION#0.6144;OSTEOGENESIS#0.6135;NONALCOHOLIC FATTY LIVER DISEASE#0.6095;FASTING PLASMA GLUCOSE#0.6093;MARROW STROMAL CELLS#0.6081;HEPATOCYTE GROWTH FACTOR#0.6069
167681	EMBRYO DEVELOPMENT#0.8876;GENE EXPRESSION#0.8250;CLEFT LIP#0.6901;CORPUS LUTEUM#0.6839;OOCYTE#0.6671;OOCYTE MATURATION#0.6476
167691	LEBER CONGENITAL AMAUROSIS#1.0753;AMAUROSIS#1.0433;RETINITIS PIGMENTOSA#0.7537;RETINAL DEGENERATION#0.7200;RETINITIS#0.6133
1676	DNA FRAGMENTATION FACTOR#1.0511;POLY ADP RIBOSE#1.0426;RIBOSE#1.0364;B CELL#1.0356;NUCLEASE ACTIVITY#1.0323;APOPTOTIC DNA FRAGMENTATION#1.0301;DNA FRAGMENTATION#1.0241;DNASE#1.0229;CYTOCHROME C#1.0111;CELL DEATH#1.0086;LIPID DROPLET#0.9996;CASPASE-3 ACTIVITY#0.9920;APOPTOSIS#0.9920;FAT SPECIFIC PROTEIN#0.9890;APOPTOTIC#0.9862;CANCER CELL#0.9808;DNA DEGRADATION#0.9739;CASPASE ACTIVATION#0.9703;MITOCHONDRIA#0.9578;TUMOR NECROSIS FACTOR#0.9388;DNASE ACTIVITY#0.9376;STAUROSPORINE#0.9129;CASPASE INHIBITOR#0.9040;ADIPOSE TISSUE#0.8976;INDUCTION OF APOPTOSIS#0.8944;ENDOMETRIUM#0.8849;CELL CYCLE#0.8842;APOPTOTIC CELL DEATH#0.8841;THYMOCYTE#0.8808;LIPID HOMEOSTASIS#0.8806;CYTOCHROME C RELEASE#0.8748;DEATH RECEPTOR#0.8591;NEUROBLASTOMA#0.8588;LIPID METABOLISM#0.8581;CHAPERONE ACTIVITY#0.8566;B CELL LYMPHOMA#0.8466;MENSTRUAL CYCLE#0.8464;GENE EXPRESSION#0.8410;MITOCHONDRIAL MEMBRANE#0.8335;T CELL#0.8182;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8043;POLYMERASE CHAIN REACTION#0.7807;SIGNALING PATHWAY#0.7769;APOPTOSIS INDUCING FACTOR#0.7754;REACTIVE OXYGEN SPECIES#0.7701;ADIPOCYTE#0.7671;CAD ACTIVITY#0.7638;BREAST CANCER#0.7484;LIPID STORAGE#0.7412;ACTIVATED CASPASE 3#0.7357;WHITE ADIPOSE TISSUE#0.7350;PROGRAMMED CELL DEATH#0.7188;CYTOPLASM#0.7092;DNASE INHIBITOR#0.6927;DIGESTION#0.6926;MENOPAUSE#0.6874;COLON CANCER#0.6837;CASPASE ACTIVITY#0.6720;PERIPHERAL BLOOD#0.6486;GROWTH FACTOR#0.6465;RECEPTOR INTERACTING PROTEIN#0.6371;TUMOR SUPPRESSOR#0.6293;EPITHELIAL CELL#0.6293;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.6279;ADENOCARCINOMA#0.6251;ENDOPLASMIC RETICULUM#0.6171;PROTEIN KINASE#0.6145;CELL PROLIFERATION#0.6145;SPATIAL LEARNING#0.6005;BREAST CANCER CELL#0.6002
1677	CAD ACTIVITY#1.0836;DNA FRAGMENTATION FACTOR#1.0551;NUCLEASE ACTIVITY#1.0527;DNASE#1.0462;APOPTOTIC DNA FRAGMENTATION#1.0439;DNA DEGRADATION#1.0341;DNASE ACTIVITY#1.0335;POLY ADP RIBOSE#1.0308;RIBOSE#1.0253;DNA FRAGMENTATION#1.0199;DNASE I#1.0046;CYTOCHROME C#1.0017;APOPTOSIS#0.9991;APOPTOTIC#0.9946;INDUCTION OF APOPTOSIS#0.9847;TUMOR NECROSIS FACTOR#0.9807;CASPASE ACTIVATION#0.9797;CELL DEATH#0.9770;APOPTOSIS INDUCING FACTOR#0.9763;B CELL#0.9621;CELL CYCLE#0.9562;CANCER CELL#0.9561;T CELL#0.9512;PROGRAMMED CELL DEATH#0.9510;APOPTOTIC CELL DEATH#0.9504;MITOCHONDRIA#0.9489;TUMOR CELLS#0.9476;ACTIVATED CASPASE 3#0.9476;CASPASE INHIBITOR#0.9426;PROTEIN KINASE#0.9397;STAUROSPORINE#0.9168;ISCHEMIA#0.8923;CASPASE-3 ACTIVITY#0.8889;DIGESTION#0.8726;ACTIVE CASPASE 3#0.8673;DNA REPAIR#0.8649;MITOCHONDRIAL MEMBRANE#0.8562;DNA BINDING#0.8556;THYMOCYTE#0.8469;CYTOPLASM#0.8433;B CELL LYMPHOMA#0.8423;DEATH RECEPTOR#0.8344;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8320;NEUROBLASTOMA#0.8297;GROWTH FACTOR#0.8149;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8035;GENE EXPRESSION#0.7830;CASPASE ACTIVITY#0.7782;TEMPORAL BONE#0.7606;CHAPERONE ACTIVITY#0.7594;HEAT SHOCK PROTEIN#0.7566;CLEAVED CASPASE 3#0.7500;CELL DIFFERENTIATION#0.7461;MITOGEN ACTIVATED PROTEIN#0.7452;SIGNALING PATHWAY#0.7335;SIGNAL TRANSDUCTION#0.7257;NUCLEOSOME#0.7249;POLYMERASE CHAIN REACTION#0.7105;CYTOCHROME C RELEASE#0.7083;DNASE INHIBITOR#0.7069;MACROPHAGE#0.6968;MUTAGENESIS#0.6892;REACTIVE OXYGEN SPECIES#0.6865;CELL CYCLE ARREST#0.6770;GM-CSF#0.6741;NUCLEAR MORPHOLOGY#0.6686;CELL GROWTH#0.6587;FACTOR I#0.6483;NECROTIC#0.6379;CISPLATIN#0.6361;ENDONUCLEASE ACTIVITY#0.6341;PROTEIN PROTEIN INTERACTION#0.6208;ETOPOSIDE#0.6164;NUCLEAR IMPORT#0.6128;MENSTRUAL CYCLE#0.6086;NUCLEAR CHROMATIN#0.6036;DOUBLE STRAND BREAK#0.6001
167826	SPINAL CORD#1.0655;TRANSCRIPTION FACTOR#0.9960;RHEUMATOID ARTHRITIS#0.8921;INTERNEURON#0.8291;PROGENITOR CELL#0.6504;CLIMBING FIBER#0.6433
167838	REGENERATION#0.7327;CARDIAC MUSCLE#0.6716;MUSCLE FIBER#0.6689
1678	DYSTONIA#1.0631;CISPLATIN#1.0386;CYTOTOXICITY#1.0278;CELL PROLIFERATION#1.0178;MITOCHONDRIA#0.9982;X CHROMOSOME#0.9963;MITOCHONDRIAL MEMBRANE#0.9948;CANCER CELL#0.9934;APOPTOSIS#0.9868;MITOCHONDRIAL INTERMEMBRANE SPACE#0.9801;CELL DEATH#0.9695;CELL GROWTH#0.9628;POLYMERASE CHAIN REACTION#0.9555;NUCLEIC ACID#0.9465;GROWTH FACTOR#0.9437;APOPTOTIC#0.9369;MITOCHONDRIAL INNER MEMBRANE#0.9216;CELL CYCLE#0.9194;ENDOTHELIAL CELL#0.8842;LUNG CANCER#0.8835;SIGNALING PATHWAY#0.8771;TOXICITY#0.8643;OUTER MEMBRANE#0.8617;CYTOCHROME C#0.8580;HETEROCHROMATIN#0.8201;POLYTENE CHROMOSOME#0.8135;INNER MITOCHONDRIAL MEMBRANE#0.8109;HEARING LOSS#0.8099;SCANNING ELECTRON MICROSCOPY#0.8097;OVARIAN#0.7973;BREAST CANCER#0.7935;STEM CELL#0.7930;PROTEIN IMPORT#0.7930;REVERSE TRANSCRIPTION#0.7871;CYTOPLASM#0.7857;MICROTUBULE#0.7794;PROPIDIUM#0.7459;PERIPHERAL BLOOD#0.7440;GENE EXPRESSION#0.7375;EPITHELIAL CELL#0.7329;CELL MEMBRANE#0.7148;TUMOR CELLS#0.7012;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7004;BREAST CANCER CELL#0.6975;NUCLEIC ACID BINDING#0.6911;HEARING IMPAIRMENT#0.6885;DRUG RESISTANCE#0.6782;CELL ADHESION#0.6765;TEMPORAL BONE#0.6737;MITOCHONDRION#0.6600;WOUND HEALING#0.6494;PROTEIN KINASE#0.6446;PLASMID MAINTENANCE#0.6432;BLINDNESS#0.6375;THYMIDINE#0.6327;5 FLUOROURACIL#0.6287;SENSORINEURAL HEARING LOSS#0.6248;PERICENTRIC HETEROCHROMATIN#0.6247;NEUROPATHY#0.6233;DOXORUBICIN#0.6231;MITOCHONDRIAL TRANSPORT#0.6189;TRANSMISSION ELECTRON MICROSCOPY#0.6187;CELL MIGRATION#0.6156;DRUG DELIVERY SYSTEM#0.6131;TRANSCRIPTION FACTOR#0.6125;MITOCHONDRIAL PROTEIN IMPORT#0.6113;APOPTOTIC CELL DEATH#0.6060;OVARIAN CANCER#0.6043
167	FERTILIZATION#1.0391;EPIDIDYMIS#1.0239;ACTIN RELATED PROTEIN#0.9623;ZONA PELLUCIDA#0.9556;SPERMATOZOA#0.9554;SALIVARY GLAND#0.9366;SEMINAL PLASMA#0.9063;CAPUT#0.8649;GENE EXPRESSION#0.8633;ACIDIC EPIDIDYMAL GLYCOPROTEIN#0.8601;ACROSOME#0.8242;ACROSOME REACTION#0.8055;SPERM MOTILITY#0.7832;GLUTATHIONE PEROXIDASE#0.7619;ANDROGEN RECEPTOR#0.7578;CAUDA#0.7220;OOCYTE#0.7009;GLUTATHIONE#0.6823;SPERM CAPACITATION#0.6580;LUMINAL#0.6260;WISKOTT ALDRICH SYNDROME#0.6178
168002	CANCER CELL#1.1129;TUMOR SUPPRESSOR#1.0480;BREAST CANCER#1.0175;SIGNALING PATHWAY#0.9685;CELL PROLIFERATION#0.9531;5-AZA-2'-DEOXYCYTIDINE#0.8478;2'-DEOXYCYTIDINE#0.8472;BREAST CANCER CELL#0.8357;ESOPHAGEAL CANCER#0.8033;SQUAMOUS CELL CARCINOMA#0.7733;HEPATOCELLULAR CARCINOMA#0.7037;WNT SIGNALING PATHWAY#0.6821;LUNG CANCER#0.6566;WOUND HEALING#0.6537;LIVER CANCER#0.6314;THYROID CANCER#0.6312;COLON CANCER#0.6266;CELL GROWTH#0.6223;GENE EXPRESSION#0.6181
1680	HEARING LOSS#0.9905;SENSORINEURAL HEARING LOSS#0.6389
168391	SPERM MOTILITY#0.9351;POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE#0.7524;MALE INFERTILITY#0.6894;SPERMATOZOA#0.6196;SPERMATOGENESIS#0.6186
168400	COLORECTAL ADENOCARCINOMA#1.0753;COLON ADENOCARCINOMA#1.0565;LEWIS LUNG CARCINOMA#1.0504;LUNG CARCINOMA#1.0460;CANCER TESTIS ANTIGEN#1.0414;COLON CARCINOMA#1.0337;ADENOCARCINOMA#1.0335;LUNG METASTASIS#1.0296;GM-CSF#1.0213;BREAST CANCER#1.0180;LIVER METASTASIS#1.0140;LUNG CANCER#1.0113;COLON CANCER#1.0103;TUMOR GROWTH INHIBITION#1.0003;GENE EXPRESSION#0.9992;CANCER CELL#0.9960;COLORECTAL#0.9934;COLONY-STIMULATING FACTOR#0.9929;5 FLUOROURACIL#0.9928;CISPLATIN#0.9926;CYTOTOXICITY#0.9896;TUMOR ANTIGEN#0.9890;BETA GALACTOSIDASE#0.9879;PACLITAXEL#0.9878;BONE MARROW#0.9872;ENDOTHELIAL CELL#0.9855;STEM CELL#0.9842;COLORECTAL CANCER#0.9827;CYTOTOXIC T-LYMPHOCYTE#0.9819;TUMOR CELLS#0.9810;APOPTOTIC#0.9809;CELL GROWTH#0.9797;APOPTOSIS#0.9787;IFN-GAMMA#0.9787;MACROPHAGE#0.9767;TUMOR TISSUES#0.9764;CD4+ T CELL#0.9757;CYTOTOXIC T CELL#0.9746;CELL PROLIFERATION#0.9743;REGULATORY T CELL#0.9742;T LYMPHOCYTE#0.9739;COLORECTAL ADENOCARCINOMA CELLS#0.9729;DOXORUBICIN#0.9728;CELL CYCLE#0.9727;FLUOROURACIL#0.9721;CELL DEATH#0.9721;CD8+ T CELL#0.9704;IMMUNE CELL#0.9695;GRANULOCYTE#0.9692;ANGIOGENESIS#0.9677;T CELL#0.9674;EPITHELIAL CELL#0.9661;DENDRITIC CELL#0.9661;TOXICITY#0.9660;GROWTH FACTOR#0.9639;AUTOPHAGY#0.9629;SIGNALING PATHWAY#0.9625;LYMPH NODE#0.9592;IMMUNE SYSTEM#0.9576;IMMUNE RESPONSE#0.9572;TUMOR ASSOCIATED ANTIGEN#0.9571;REACTIVE OXYGEN SPECIES#0.9537;MYELOID-DERIVED SUPPRESSOR CELL#0.9525;TUMOR NECROSIS FACTOR#0.9492;CANCER STEM CELL#0.9478;DRUG RESISTANCE#0.9461;INDUCTION OF APOPTOSIS#0.9454;HERPES SIMPLEX VIRUS#0.9449;HERPES SIMPLEX#0.9446;OXALIPLATIN#0.9442;ENDOTHELIAL GROWTH FACTOR#0.9397;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9397;CELL ACTIVATION#0.9381;POLYMERASE CHAIN REACTION#0.9364;OVARIAN#0.9344;PERIPHERAL BLOOD#0.9316;DRAINING LYMPH NODE#0.9297;PROSTATE CANCER#0.9261;TRANSCRIPTION FACTOR#0.9196;TUMOR SUPPRESSOR#0.9133;TOLL LIKE RECEPTOR#0.9088;BREAST CANCER CELL#0.9067;AMELANOTIC MELANOMA#0.9066;T CELL ACTIVATION#0.9039;CELL ADHESION#0.9011;B CELL#0.8995;PROTEIN KINASE#0.8993;REVERSE TRANSCRIPTION#0.8939;HYPOXIA#0.8898;MAGNETIC RESONANCE IMAGING#0.8800;G-CSF#0.8787;RENAL CELL CARCINOMA#0.8702;OVARIAN CANCER#0.8686;SQUAMOUS CELL CARCINOMA#0.8671;BLOOD VESSEL#0.8600;ASCITES#0.8592;CELL MIGRATION#0.8571;LUNG ADENOCARCINOMA#0.8530;CELL SURFACE#0.8497;PRO-INFLAMMATORY#0.8475;EFFECTOR T CELL#0.8448;THYMIDINE KINASE#0.8352;NKT CELL#0.8171;POSITRON EMISSION TOMOGRAPHY#0.8167;NEUTROPHIL#0.8160;HUMAN BREAST CANCER#0.8083;UBIQUITIN#0.8068;LIVER CANCER#0.8055;DRUG DELIVERY SYSTEM#0.7986;LYSIS#0.7891;MONONUCLEAR CELLS#0.7879;LEUKOCYTE#0.7844;MYELOID CELL#0.7839;HEAT SHOCK PROTEIN#0.7816;WOUND HEALING#0.7755;NATURAL KILLER CELL#0.7740;EPITHELIAL MESENCHYMAL TRANSITION#0.7738;TRANSFORMING GROWTH FACTOR#0.7700;TAXOL#0.7686;RNA INTERFERENCE#0.7640;CELL CYCLE ARREST#0.7632;EXTRACELLULAR MATRIX#0.7611;ANTIGEN PRESENTING CELLS#0.7581;HUMAN UMBILICAL VEIN#0.7580;UMBILICAL VEIN#0.7578;QUERCETIN#0.7543;TUMOR GROWTH DELAY#0.7533;FIBROSARCOMA#0.7518;TUMOR ASSOCIATED MACROPHAGE#0.7513;HYPERTHERMIA#0.7467;CELL MOTILITY#0.7435;CYTOKINE PRODUCTION#0.7434;HEPATOCELLULAR CARCINOMA#0.7418;MONOCYTE#0.7410;NITRIC OXIDE#0.7406;CYCLOPHOSPHAMIDE#0.7387;METASTATIC COLORECTAL CANCER#0.7379;HISTONE DEACETYLASE#0.7374;ONCOGENIC#0.7362;MECHANISM OF ACTION#0.7311;POLY ETHYLENE GLYCOL#0.7292;CELLULAR IMMUNE RESPONSE#0.7256;ADAPTIVE IMMUNE RESPONSE#0.7254;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7227;NECROTIC#0.7219;PANCREATIC CANCER#0.7176;THYMIDINE#0.7148;BREAST CANCER PATIENTS#0.7092;STROMAL CELL#0.7080;QUANTITATIVE REAL TIME#0.7080;MEMORY T CELL#0.7017;ESTROGEN RECEPTOR#0.6986;VACCINIA#0.6979;COLITIS#0.6959;TRYPTOPHAN#0.6935;ANTI HER2#0.6922;BLOOD CIRCULATION#0.6914;TRANSMISSION ELECTRON MICROSCOPY#0.6849;MITOCHONDRIAL MEMBRANE#0.6833;WEIGHT LOSS#0.6833;BIOLUMINESCENCE#0.6821;CPT-11#0.6811;IMMUNE SUPPRESSION#0.6775;BREAST CARCINOMA#0.6726;T CELL PROLIFERATION#0.6631;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6568;BEVACIZUMAB#0.6561;HYPOXIC#0.6535;GROWTH FACTOR RECEPTOR#0.6528;ANCHORAGE INDEPENDENT GROWTH#0.6482;TREG CELL#0.6462;INNATE IMMUNITY#0.6433;SERUM ALBUMIN#0.6396;STEM CELL LIKE#0.6316;EXOSOME#0.6314;HEPATOCYTE GROWTH FACTOR#0.6274;G1 PHASE#0.6266;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6265;BONE MARROW CELLS#0.6262;ENDOPLASMIC RETICULUM#0.6233;GEMCITABINE#0.6112;GLYCOLYSIS#0.6089;MITOGEN ACTIVATED PROTEIN#0.6085;KINASE INHIBITOR#0.6085;PLASMA MEMBRANE#0.6080
168451	CELL DEATH#0.9270;CELL CYCLE#0.7437;DNA BINDING#0.6493
168507	POLYCYSTIN#0.8395;POLYCYSTIC KIDNEY DISEASE#0.7800;KIDNEY DISEASE#0.7706;POLYCYSTIC KIDNEY DISEASE 1#0.6935;MOTILE CILIA#0.6801;GENE EXPRESSION#0.6619
168537	T CELL#0.9519;NUCLEOTIDE BINDING#0.9098;LYMPHOPENIA#0.7014;GTP BINDING#0.6676;GTP HYDROLYSIS#0.6061
168544	ZINC FINGER PROTEIN#1.0352;STEM CELL#0.8727;ADIPOSE-DERIVED STEM CELL#0.8314;ADIPOCYTE#0.6944;NUCLEOCYTOPLASMIC SHUTTLING#0.6500;OSTEOBLAST#0.6346;NUCLEAR IMPORT#0.6308;NUCLEAR EXPORT#0.6279
168620	ACINAR CELL#1.0644;TRANSCRIPTION FACTOR#1.0507;PLASMA CELL#1.0089;GENE EXPRESSION#1.0068;STEM CELL#0.9655;SECRETORY CELL#0.9382;CELL DIFFERENTIATION#0.9137;SALIVARY GLAND#0.8862;PANCREATITIS#0.8781;PANCREATIC CANCER#0.8354;METAPLASIA#0.8066;EXOCYTOSIS#0.8040;CANCER CELL#0.7996;PROGENITOR CELL#0.7636;CELL MATURATION#0.7472;REGULATED EXOCYTOSIS#0.7403;EPITHELIAL CELL#0.7395;PLASMA CELL DIFFERENTIATION#0.7141;TERMINAL DIFFERENTIATION#0.7132;SEMINAL VESICLE#0.7020;SECRETORY GRANULE#0.7006;CELL PROLIFERATION#0.6993;ENDOPLASMIC RETICULUM#0.6882;PANCREATIC DUCTAL ADENOCARCINOMA#0.6677;ADENOCARCINOMA#0.6592;DUCT CELL#0.6437;REGENERATION#0.6339;PANETH CELL#0.6300;BETA CELL#0.6237;MUCOUS#0.6192;SEROUS ACINAR CELL#0.6065
168667	BMP BINDING#1.1181;ENDOTHELIAL CELL#1.0762;BONE MORPHOGENETIC PROTEIN BINDING#1.0519;SIGNALING PATHWAY#1.0323;BONE MORPHOGENETIC PROTEIN#1.0290;GASTRULATION#0.9848;PROTEIN BINDING#0.9699;ANGIOGENESIS#0.9611;CORONARY ARTERY#0.9079;BMP SIGNALING PATHWAY#0.8461;CARDIOMYOCYTE DIFFERENTIATION#0.8429;GROWTH FACTOR#0.8371;BLOOD VESSEL#0.8276;GENE EXPRESSION#0.7947;SMOOTH MUSCLE#0.7601;ARTERY#0.7271;CARDIOMYOCYTE#0.7217;HEPATITIS C#0.6886;TRANSCRIPTION FACTOR#0.6850;CELL MIGRATION#0.6832;PROTEIN KINASE#0.6788;CELL DIFFERENTIATION#0.6671;ENDOTHELIUM#0.6606;OSTEOBLAST#0.6369;HEPATITIS C VIRUS#0.6152;RELATED PROTEIN 1#0.6143;ACTIVATED T-CELLS#0.6082;ACTIVATED T CELL#0.6078;EPITHELIAL MESENCHYMAL TRANSITION#0.6067;NEURAL CREST#0.6058;FIBROBLAST GROWTH FACTOR#0.6032;SMOOTH MUSCLE CELL#0.6024;MUSCLE CELL#0.6015;BONE FORMATION#0.6014
1687	HEARING IMPAIRMENT#1.0825;HEARING LOSS#1.0778;CELL DEATH#0.9987;TUMOR SUPPRESSOR#0.9771;BREAST CANCER#0.9628;SENSORINEURAL HEARING LOSS#0.9571;APOPTOSIS#0.8574;CANCER CELL#0.7780;TUMOR CELLS#0.7509;PROGRAMMED CELL DEATH#0.6807;COLORECTAL#0.6678;COCHLEA#0.6659;INNER EAR#0.6206;HUMAN BREAST CANCER#0.6142;COLORECTAL CANCER#0.6110;ETOPOSIDE#0.6030
1689	HEARING IMPAIRMENT#0.8003
169026	INSULINOMA#1.0530;SECRETORY GRANULE#1.0450;GLUTAMIC ACID#1.0364;T CELL#1.0172;INSULIN SECRETION#1.0121;BETA CELL#1.0080;TYPE 1 DIABETIC#1.0038;PROTEIN TYROSINE PHOSPHATASE#1.0012;TYPE 2 DIABETES MELLITUS#0.9988;2 DIABETES MELLITUS#0.9988;PANCREATIC ISLET#0.9980;TYPE 1 DIABETES#0.9961;TYPE 2 DIABETES#0.9951;DIABETES MELLITUS#0.9859;AUTOIMMUNITY#0.9857;TYPE 2 DIABETIC#0.9854;CD8+ T CELL#0.9812;TYPE 1 DIABETES MELLITUS#0.9747;GLUCOSE METABOLISM#0.9686;ZINC TRANSPORT#0.9631;TRYPTOPHAN#0.9557;GENE EXPRESSION#0.9488;ARGININE#0.9394;ZINC HOMEOSTASIS#0.9378;GLUTAMATE DECARBOXYLASE#0.9263;GLUCOSE HOMEOSTASIS#0.9259;TRANSCRIPTION FACTOR#0.9232;AUTOIMMUNE DISEASE#0.9138;HUMAN LEUKOCYTE ANTIGEN#0.8575;TYPE 1A DIABETES#0.8388;CELL SURFACE#0.8354;GLUCOSE TOLERANCE TEST#0.8299;GESTATIONAL DIABETES#0.8250;PERIPHERAL BLOOD#0.8236;GROWTH FACTOR#0.8217;INSULIN PROCESSING#0.8128;LEUKOCYTE#0.7967;IMPAIRED GLUCOSE TOLERANCE#0.7940;ORAL GLUCOSE TOLERANCE#0.7825;GESTATIONAL DIABETES MELLITUS#0.7771;OBESE#0.7509;C TERMINAL DOMAIN#0.7486;APOPTOSIS#0.7458;POLYMERASE CHAIN REACTION#0.7385;PARATUBERCULOSIS#0.7241;B CELL#0.7236;IMPAIRED GLUCOSE REGULATION#0.7213;AGE AT ONSET#0.6936;GLUTAMINE#0.6911;NORMAL GLUCOSE TOLERANCE#0.6868;REPAGLINIDE#0.6514;CYCLIN DEPENDENT KINASE#0.6493;INSULIN-LIKE GROWTH FACTOR#0.6471;HIGH DENSITY LIPOPROTEIN#0.6464;IMMUNE RESPONSE#0.6455;AGE AT DIAGNOSIS#0.6416;GLUCAGON SECRETION#0.6377;HYPERGLYCEMIA#0.6367;CYCLIN DEPENDENT KINASE INHIBITOR#0.6296;KINASE INHIBITOR#0.6229;ALPHA CELL#0.6158;INSULIN METABOLISM#0.6144;RESPONSE TO GLUCOSE#0.6141;WEIGHT GAIN#0.6062
169044	INTRACRANIAL ANEURYSM#0.6352
1690	INNER EAR#1.0594;EXTRACELLULAR MATRIX#1.0445;HEARING IMPAIRMENT#1.0426;SENSORINEURAL HEARING LOSS#1.0413;HEARING LOSS#1.0274;TEMPORAL BONE#0.9903;COCHLEA#0.9412;COAGULATION#0.8743;MIDDLE EAR#0.8521;VERTIGO#0.8513;INNER EAR DISEASE#0.8348;GENE EXPRESSION#0.8177;LABYRINTH#0.8012;NONSYNDROMIC DEAFNESS#0.7803;TINNITUS#0.7071;MENIERE'S DISEASE#0.6746;AUDITORY BRAINSTEM RESPONSE#0.6733;FIBROCYTE#0.6504;IMMUNE RESPONSE#0.6027;MAGNETIC RESONANCE IMAGING#0.6001
169166	EARLY ENDOSOME#0.7092;ENDOSOME#0.6183
169200	OSTEOCLAST DIFFERENTIATION#0.7294;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7158;PROSTATE CANCER#0.7144;MONONUCLEAR CELLS#0.7137;PERIPHERAL BLOOD#0.7103;CANCER CELL#0.7084;ADIPOCYTE DIFFERENTIATION#0.6350
169355	TRYPTOPHAN#1.0269;T CELL#1.0151;TRYPTOPHAN CATABOLISM#0.9944;INDOLE#0.9807;CANCER CELL#0.9798;CATABOLISM#0.9731;DENDRITIC CELL#0.9598;IMMUNE RESPONSE#0.9438;GENE EXPRESSION#0.9160;B CELL#0.9013;L-TRYPTOPHAN#0.8563;TRYPTOPHAN METABOLISM#0.8440;PERIPHERAL BLOOD#0.8281;RECEPTOR ANTAGONIST#0.8189;PANCREATIC CANCER#0.8093;ACETIC ACID#0.7829;CELL PROLIFERATION#0.7572;LYMPH NODE#0.7474;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7150;MONONUCLEAR CELLS#0.7137;IMMUNE CELL#0.7042;RHEUMATOID ARTHRITIS#0.7041;INFLAMMATORY RESPONSE#0.6940;RECEPTOR AGONIST#0.6803;ALZHEIMER'S DISEASE#0.6749;REGULATORY T CELL#0.6687;ENZYME ACTIVITY#0.6612;BONE MARROW#0.6531;ESSENTIAL AMINO ACID#0.6465;KYNURENINE 3 MONOOXYGENASE#0.6417;GABA A RECEPTOR#0.6408;T CELL PROLIFERATION#0.6149;APOPTOSIS#0.6144;STRUCTURE ACTIVITY RELATIONSHIP#0.6065;AUTOIMMUNE DISEASE#0.6041;CROHN'S DISEASE#0.6008
1694	HEARING LOSS#0.8602
169522	CONE DYSTROPHY#1.1000;POTASSIUM CHANNEL#1.0902;OPTICAL COHERENCE TOMOGRAPHY#0.8801;OCCULT MACULAR DYSTROPHY#0.6624
169714	IFN-GAMMA#0.6477;CELL DEATH#0.6445
169792	CONGENITAL HYPOTHYROIDISM#1.0803;BETA CELL#1.0770;TRANSCRIPTION FACTOR#1.0514;HYPOTHYROIDISM#1.0431;TYPE 2 DIABETES#1.0265;ZINC FINGER PROTEIN#1.0135;GENE EXPRESSION#1.0097;DIABETES MELLITUS#0.9485;KIDNEY DISEASE#0.9434;STEM CELL#0.8461;CELL DEVELOPMENT#0.8186;POLYCYSTIC KIDNEY DISEASE#0.7944;TYPE 1 DIABETES#0.7851;INSULIN SECRETION#0.7284;CELL PROLIFERATION#0.7179;SIGNALING PATHWAY#0.7145;PANCREAS DEVELOPMENT#0.7128;APOPTOSIS#0.7120;PRIMARY CILIUM#0.7084;GLUCOSE METABOLISM#0.6917;DNA BINDING#0.6841;NEONATAL DIABETES MELLITUS#0.6828;PANCREATIC ISLET#0.6728;TRANSACTIVATION#0.6618;HORMONE BIOSYNTHESIS#0.6218;ENDOCRINE CELL#0.6141;EMBRYONIC STEM CELL#0.6082;PROGENITOR CELL#0.6001
169981	MAGIC ANGLE SPINNING#0.8881
16	ALANINE#1.0206;PROTEIN SYNTHESIS#0.9550;TRANSFER RNA#0.9408;GLYCINE#0.9153;CHARCOT MARIE TOOTH#0.9125;CHARCOT-MARIE-TOOTH DISEASE#0.8147;TOOTH DISEASE#0.8146;SYNTHETASE ACTIVITY#0.8025;CARDIOMYOPATHY#0.7759;RIBOSOME#0.7507;RIBOSOMAL PROTEIN#0.7342;LEUKOENCEPHALOPATHY#0.7278;TRNA AMINOACYLATION#0.7231;LYSINE#0.7141;NEUROPATHY#0.6976;OVARIAN#0.6943;MUTAGENESIS#0.6633;TRNA BINDING#0.6545;CTP SYNTHASE#0.6498;WHOLE GENOME DUPLICATION#0.6233;TRNA CHARGING#0.6068
170261	MENTAL RETARDATION#0.9320;GENE EXPRESSION#0.7857;CAJAL-RETZIUS CELL#0.6480;PML NB#0.6472;PAPILLARY THYROID CANCER#0.6263;THYROID CANCER#0.6141
170302	INTERNEURON#1.0617;FOREBRAIN#1.0583;LISSENCEPHALY#1.0565;INTELLECTUAL DISABILITY#1.0509;TRANSCRIPTION FACTOR#1.0452;WEST SYNDROME#1.0434;MENTAL RETARDATION#1.0362;EPILEPSY#1.0177;BRAIN DEVELOPMENT#1.0096;NEURONAL MIGRATION#1.0070;DYSTONIA#1.0062;PROGENITOR CELL#1.0056;X CHROMOSOME#1.0041;NERVOUS SYSTEM#0.9687;GABAERGIC NEURON#0.9681;ENDOCRINE CELL#0.9658;INTERNEURON MIGRATION#0.9447;TELENCEPHALON#0.9251;OLFACTORY BULB#0.8941;ALANINE#0.8939;BETA CELL#0.8903;ALPHA CELL#0.8774;CENTRAL NERVOUS SYSTEM#0.8697;DEVELOPMENTAL DELAY#0.8683;CEREBRAL CORTEX#0.8598;DNA BINDING#0.8408;FLOOR PLATE#0.8169;ENTEROENDOCRINE CELL#0.8141;CYCLIN DEPENDENT KINASE#0.8109;NEUROLOGICAL DISORDER#0.8086;NUCLEAR IMPORT#0.8029;CELL CYCLE#0.7945;CELL DIFFERENTIATION#0.7911;BASAL GANGLIA#0.7819;THALAMUS#0.7662;GENE EXPRESSION#0.7625;INFANTILE EPILEPTIC ENCEPHALOPATHY#0.7535;CORPUS CALLOSUM AGENESIS#0.7346;PANCREAS DEVELOPMENT#0.7340;EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY#0.7337;SYNDROMIC INTELLECTUAL DISABILITY#0.7175;FETAL BRAIN#0.6897;CELL PROLIFERATION#0.6778;CELL DEATH#0.6744;NON-SYNDROMIC INTELLECTUAL DISABILITY#0.6661;CELL DEVELOPMENT#0.6621;MICROCEPHALY#0.6580;STEM CELL#0.6553;CELL MIGRATION#0.6522;DIARRHEA#0.6419;IMPORTIN#0.6410;PANCREATIC ISLET#0.6372;FOREBRAIN DEVELOPMENT#0.6338;TRANSDIFFERENTIATION#0.6324;TELENCEPHALON DEVELOPMENT#0.6234;SUBCORTICAL BAND HETEROTOPIA#0.6148;STRIATUM#0.6012;LEYDIG CELL#0.6006
170370	ACROSOME#0.6892;FERTILIZATION#0.6512
170392	ORGANIC ANION TRANSPORTER#0.7060;ATP BINDING CASSETTE#0.6951;ATP BINDING#0.6929;ZONA PELLUCIDA#0.6879;HEPATOCELLULAR CARCINOMA#0.6320
170482	LECTIN#1.0436;PLASMACYTOID DENDRITIC CELL#1.0033;PERIPHERAL BLOOD#0.9964;DENDRITIC CELL#0.9943;LUPUS ERYTHEMATOSUS#0.9852;MONONUCLEAR CELLS#0.9850;MYELOID DENDRITIC CELL#0.9832;T CELL#0.9830;TOLL LIKE RECEPTOR#0.9666;IMMUNE RESPONSE#0.9658;MONOCYTE#0.9606;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9424;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9394;PRE-ECLAMPSIA#0.9388;MACROPHAGE#0.9386;BONE MARROW#0.9366;LYMPH NODE#0.9332;IMMUNE SYSTEM#0.9193;LANGERHANS CELL#0.9153;B CELL#0.9078;DENDRITIC CELL SUBSETS#0.8587;CORD BLOOD#0.8512;IFN-ALPHA PRODUCTION#0.8316;AUTOIMMUNE DISEASE#0.8097;CARBOHYDRATE RECOGNITION DOMAIN#0.7936;CELL SURFACE#0.7859;DERMIS#0.7733;ECLAMPSIA#0.7720;STEM CELL#0.7702;ANTIGEN PRESENTING CELLS#0.7688;ANTIGEN PRESENTATION#0.7590;LEUKOCYTE#0.7514;IMMUNE CELL#0.7419;CELL ACTIVATION#0.7251;CD4+ T CELL#0.7181;TYPE I IFN PRODUCTION#0.7040;STEM CELL TRANSPLANTATION#0.6881;OVARIAN#0.6837;LUTEAL PHASE#0.6833;CD8+ T CELL#0.6815;T LYMPHOCYTE#0.6795;REGULATORY T CELL#0.6719;NEUTROPHIL#0.6531;HEMATOPOIETIC STEM CELL#0.6353;CYTOKINE PRODUCTION#0.6352;CELL ASSOCIATED#0.6351;PRO-INFLAMMATORY#0.6339;GENE EXPRESSION#0.6297;NATURAL KILLER CELL#0.6263;POLYMERASE CHAIN REACTION#0.6165;CELL PROLIFERATION#0.6164;MANNOSE RECEPTOR#0.6054;ORAL MUCOSA#0.6050;PLASMA CELL#0.6048
170506	RNA HELICASE#1.0960;AU RICH ELEMENT#1.0643;RNA BINDING#0.8327;TELOMERASE RNA#0.8034;GENE EXPRESSION#0.7993;GUANINE#0.7966;NUCLEIC ACID#0.7839;HELICASE ACTIVITY#0.7459;STRESS GRANULE#0.7191;G QUADRUPLEX BINDING#0.6728
170529	RIBOSOMAL PROTEIN#0.6469
170532	OTOSCLEROSIS#0.6880
170534	PARKINSON'S DISEASE#0.9586;AGE AT ONSET#0.9284
170572	SEROTONIN RECEPTOR#0.9594;PRIMARY ANGLE-CLOSURE GLAUCOMA#0.6358;PRIMARY ANGLE CLOSURE#0.6329;ANGLE-CLOSURE GLAUCOMA#0.6256;ION CHANNEL#0.6176
170575	B CELL#0.8045;LYMPHOID CELL#0.6735
170589	ADENYLATE CYCLASE#1.0415;PROTEIN KINASE#1.0060;PROTEIN KINASE A#0.9937;ADENYLATE#0.9846;SIGNALING PATHWAY#0.9734;HETEROTRIMERIC G-PROTEIN#0.9417;CAMP SYNTHESIS#0.8877;GLUCOSE SENSING#0.8853;CAMP SIGNALLING#0.8517;CAMP SIGNALING#0.8495;FILAMENTOUS GROWTH#0.8342;POTATO VIRUS X#0.8295;RESPONSE TO GLUCOSE#0.8238;ADENYLATE CYCLASE ACTIVATION#0.7839;CYCLIC AMP#0.7812;PHEROMONE RESPONSE#0.7799;LEUCINE RICH REPEAT#0.7788;NUCLEOTIDE BINDING#0.7772;SIGNAL TRANSDUCTION#0.7670;GUANINE#0.7259;MAP KINASE#0.7211;DISEASE RESISTANCE#0.7182;MORPHOGENESIS#0.7163;INTRACELLULAR ACIDIFICATION#0.6852;CELL DEATH#0.6773;CELL GROWTH#0.6686;LEUCINE#0.6655;MITOGEN ACTIVATED PROTEIN#0.6580;ALPHA-2 MACROGLOBULIN#0.6228
170593	UBIQUITIN#0.9349;UBIQUITIN BINDING#0.9034;DNA DAMAGE TOLERANCE#0.7848
1705	HEARING LOSS#0.9009
170679	PSORIASIS#0.9749;RHEUMATOID ARTHRITIS#0.6602
170680	PSORIASIS#0.7053
170682	HEMOLYTIC ANEMIA#0.7955;EPOXIDE HYDROLASE#0.7669
170685	ADDISON'S DISEASE#1.0709;AUTOIMMUNE POLYENDOCRINE SYNDROME#1.0535;AUTOIMMUNE POLYGLANDULAR SYNDROME#0.9908;TYPE 1 DIABETES#0.9805;DIABETES MELLITUS#0.8595;AUTOIMMUNE DISEASE#0.7560;AUTOIMMUNITY#0.7364;THYROIDITIS#0.6975;RADICAL SCAVENGING ACTIVITY#0.6304;TYPE 1 DIABETES MELLITUS#0.6145
170689	CANCER CELL#0.9265;BREAST CANCER#0.6633;BREAST CARCINOMA#0.6476;CELL MIGRATION#0.6434;COLORECTAL CANCER#0.6431;MYOBLAST FUSION#0.6099
170690	OVARIAN#0.8917;PREMATURE OVARIAN FAILURE#0.8279;GRANULOSA CELL#0.8080;EXTRACELLULAR MATRIX#0.7933;CANCER CELL#0.7055;OVARIAN CANCER#0.6329
170691	WEILL-MARCHESANI SYNDROME#0.9339;PRIMARY OPEN ANGLE GLAUCOMA#0.8604;OPEN ANGLE GLAUCOMA#0.8588;FIBRILLIN#0.8100;EXTRACELLULAR MATRIX#0.7841;MICROFIBRIL#0.6843
170692	TUMOR SUPPRESSOR#1.0034;CANCER CELL#0.7592;BREAST CANCER#0.7477;TUMOR TISSUES#0.6988;CELL MIGRATION#0.6149;POLYMERASE CHAIN REACTION#0.6045
170825	GAMMA-GLUTAMYLCYSTEINE#1.0525;GLUTATHIONE#1.0487;OLFACTORY BULB#1.0475;TELENCEPHALON#1.0461;TRANSCRIPTION FACTOR#1.0300;GLUTATHIONE BIOSYNTHESIS#1.0280;INTERNEURON#1.0167;PROGENITOR CELL#0.9972;NEUROGENESIS#0.9627;GENE EXPRESSION#0.9412;STEM CELL#0.9016;FOREBRAIN#0.8263;STRIATUM#0.7741;NERVOUS SYSTEM#0.7293;NEURAL STEM CELL#0.6977;MEDIAL GANGLIONIC EMINENCE#0.6546;OLFACTORY BULB DEVELOPMENT#0.6392;DETOXIFICATION#0.6352;PLASTID#0.6168;NEURAL PLATE#0.6158;PRECURSOR CELL#0.6022
170850	POTASSIUM CHANNEL#0.9321;HIRSCHSPRUNG'S DISEASE#0.6378;GLIOBLASTOMA MULTIFORME#0.6225;GENE EXPRESSION#0.6024
170949	SURFACE PLASMON RESONANCE#0.6926;TOPICAL#0.6702
170954	ACTIN FILAMENT#1.0116;PROTEIN PHOSPHATASE 1#0.9629;ACTIN BINDING#0.8184;ACTIN CYTOSKELETON#0.7439;TERMINAL DIFFERENTIATION#0.6092;BONE RESORPTION#0.6040
170959	TRANSCRIPTION FACTOR#0.7784
1709	HEARING LOSS#0.7582
171013	GROWTH FACTOR#0.8704;RECEPTOR TYROSINE KINASE#0.8239;SIGNALING PATHWAY#0.8180;GROWTH FACTOR RECEPTOR#0.8133;EPIDERMAL GROWTH FACTOR#0.7536;SIGNAL TRANSDUCTION#0.7394;PHOSPHOTYROSINE BINDING#0.6776;ENGULFMENT OF APOPTOTIC CELL#0.6212
171017	NUCLEAR MATRIX#1.0959;ZINC FINGER PROTEIN#1.0901;NUCLEOCYTOPLASMIC SHUTTLING#1.0857;TRANSCRIPTION FACTOR#1.0821;OSTEOBLAST#1.0762;B CELL#1.0458;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0438;ACUTE LEUKEMIA#1.0222;BONE FORMATION#0.9700;BONE MARROW#0.9380;GENE EXPRESSION#0.9262;PARATHYROID HORMONE#0.9243;DNA BINDING#0.9082;FOCAL ADHESION#0.8871;PARATHYROID#0.7978;T CELL#0.7626;CHONDROCYTE#0.7047;BONE RESORPTION#0.6997;OSTEOPOROSIS#0.6744;STEM CELL#0.6457;BONE CELLS#0.6357
171019	PREMATURE OVARIAN FAILURE#0.8892;OVARIAN#0.8669;COLORECTAL CANCER#0.6055
171022	CELL PROLIFERATION#0.9224;COLORECTAL CANCER#0.8541;CANCER CELL#0.6694;COLORECTAL#0.6508;EGFR SIGNALING PATHWAY#0.6445;ENDOMETRIAL CARCINOMA#0.6294;ENDOMETRIAL CANCER#0.6255;TUMOR TISSUES#0.6197;SIGNALLING PATHWAY#0.6174;OVARIAN CANCER#0.6163;SIGNALING PATHWAY#0.6086
171023	TUMOR SUPPRESSOR#1.0136;DNA METHYLATION#1.0112;CHRONIC MYELOMONOCYTIC LEUKEMIA#1.0079;MYELOID NEOPLASM#1.0068;HISTONE MODIFICATION#1.0060;HEMATOPOIESIS#0.9973;HEMATOPOIETIC CELL#0.9939;RNA SPLICING#0.9929;GENE EXPRESSION#0.9912;PROGENITOR CELL#0.9890;MYELOFIBROSIS#0.9883;TRANSCRIPTION FACTOR#0.9859;POLYCYTHEMIA VERA#0.9851;HEMATOPOIETIC STEM CELL#0.9807;ANEMIA#0.9797;MYELOID LEUKEMIA#0.9753;STEM CELL TRANSPLANTATION#0.9746;ACUTE MYELOID LEUKEMIA#0.9735;MYELOPROLIFERATIVE NEOPLASM#0.9735;ESSENTIAL THROMBOCYTHEMIA#0.9733;STEM CELL#0.9698;POLYCYTHEMIA#0.9694;MYELODYSPLASTIC SYNDROME#0.9694;BONE MARROW#0.9673;CHRONIC MYELOID LEUKEMIA#0.9644;PERIPHERAL BLOOD#0.9580;MYELOID CELL#0.9506;CYTOPENIA#0.9477;ACUTE LEUKEMIA#0.9461;WORLD HEALTH ORGANIZATION#0.9403;DNA METHYLTRANSFERASE#0.9345;RETINOIC ACID#0.9312;SYSTEMIC MASTOCYTOSIS#0.9249;WHITE BLOOD CELL#0.9211;SIGNALING PATHWAY#0.9088;CELL PROLIFERATION#0.8963;INTERNAL TANDEM DUPLICATION#0.8952;MASTOCYTOSIS#0.8922;DEUBIQUITINASE#0.8908;MONOCYTE#0.8832;APOPTOSIS#0.8818;ONCOGENIC#0.8664;THROMBOCYTOSIS#0.8662;STEM CELL TRANSPLANT#0.8660;POLYMERASE CHAIN REACTION#0.8628;CHRONIC NEUTROPHILIC LEUKEMIA#0.8595;DECITABINE#0.8548;MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM#0.8478;SPLICEOSOME#0.8403;RETINOIC ACID RECEPTOR#0.8400;MEDIAN OVERALL SURVIVAL#0.8372;IMMATURE MYELOID CELL#0.8307;ACUTE MYELOID LEUKAEMIA#0.8263;EVENT FREE SURVIVAL#0.8199;JUVENILE MYELOMONOCYTIC LEUKEMIA#0.8045;LEUKOCYTE#0.8010;CELL DIFFERENTIATION#0.7974;NEUTROPHIL#0.7943;B CELL#0.7757;UBIQUITIN#0.7745;AZACITIDINE#0.7728;POLYCOMB REPRESSIVE COMPLEX#0.7711;THROMBOCYTOPENIA#0.7655;LYSINE#0.7634;T CELL#0.7615;KINASE INHIBITOR#0.7566;LEUKEMIA FREE SURVIVAL#0.7562;APLASTIC ANEMIA#0.7561;MAST CELL#0.7122;COMPARATIVE GENOMIC HYBRIDIZATION#0.7068;DISEASE FREE SURVIVAL#0.7019;COHESIN COMPLEX#0.6897;CELL CYCLE#0.6827;RELAPSE FREE SURVIVAL#0.6818;OVERALL RESPONSE RATE#0.6802;BONE MARROW CELLS#0.6730;CELLULAR SENESCENCE#0.6726;TYROSINE KINASE INHIBITOR#0.6709;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6606;CHROMATIN MODIFICATION#0.6570;METHYLCYTOSINE DIOXYGENASE#0.6509;ANDROGEN RECEPTOR#0.6473;HIGH RISK PATIENTS#0.6387;TACROLIMUS HYDRATE#0.6324;HISTONE DEACETYLASE#0.6293;HYDROXYUREA#0.6273;DEUBIQUITINATION#0.6233;SIGNAL TRANSDUCTION#0.6192;RUXOLITINIB#0.6140;MEGAKARYOCYTE#0.6052;THROMBOSIS#0.6011
171024	PROSTATE CANCER#1.0974;CANCER CELL#1.0916;TUMOR SUPPRESSOR#1.0912;ACTIN BINDING#1.0391;ACTIN BUNDLING#1.0252;Z DISC#0.9936;ACTIN BINDING PROTEIN#0.9831;CELL MIGRATION#0.9359;SMOOTH MUSCLE#0.9183;NUCLEAR IMPORT#0.7822;CYTOPLASM#0.7344;MUSCLE CELL#0.7210;SIGNALING PATHWAY#0.7114;STRESS FIBER#0.7104;BREAST CANCER#0.6965;ACTIN FILAMENT#0.6782;GENE EXPRESSION#0.6385;CELL BODY#0.6329;SKELETAL MUSCLE#0.6304;NUCLEAR EXPORT#0.6244
171157	SPLIT HAND-FOOT MALFORMATION#0.8084
171169	INNER ACROSOMAL MEMBRANE#0.7897;ACROSOMAL MEMBRANE#0.7739;ACROSOME REACTION#0.7135;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.7050
171177	NEURAL CREST#0.9534;P21 ACTIVATED KINASE#0.7927;SIGNALING PATHWAY#0.6416;PROTEIN KINASE#0.6301;LUNG CANCER#0.6222;CANCER CELL#0.6129
171221	BETA CELL#0.8056
171389	VASOPRESSIN RECEPTOR#1.0321;COLITIS#1.0276;NUCLEOTIDE BINDING#0.9869;GOBLET CELL#0.9699;VASOPRESSIN#0.9552;LEUCINE RICH REPEAT#0.9063;EPITHELIAL CELL#0.9009;INNATE IMMUNITY#0.8990;IMMUNE RESPONSE#0.8941;PRO-INFLAMMATORY#0.8411;INFLAMMATORY RESPONSE#0.8350;CELL DEATH#0.8248;APOPTOSIS#0.8088;CANCER CELL#0.8046;SIGNALING PATHWAY#0.8045;LEUCINE#0.7921;PYROPTOSIS#0.7722;NUCLEOTIDE BINDING DOMAIN#0.7656;T CELL#0.7348;GENE EXPRESSION#0.7339;INFLAMMATORY BOWEL DISEASE#0.7274;PATTERN RECOGNITION RECEPTOR#0.7061;INTESTINAL EPITHELIAL CELL#0.6931;CELL PROLIFERATION#0.6811;IMMUNE SYSTEM#0.6707;ARGININE VASOPRESSIN#0.6639;MUCUS SECRETION#0.6245
171392	ZINC FINGER PROTEIN#0.7940
171423	CELL PROLIFERATION#0.9071;APOPTOSIS#0.8665;PROTEIN DISULFIDE ISOMERASE#0.7982;ORAL SQUAMOUS CELL CARCINOMA#0.7200;SQUAMOUS CELL CARCINOMA#0.7113;PENTOSE PHOSPHATE PATHWAY#0.6787;LUNG CANCER#0.6580
171425	GLYOXYLATE BYPASS#1.0564;GLYOXYSOME#1.0437;MALATE DEHYDROGENASE#1.0388;GLYOXYLATE CYCLE#1.0300;COENZYME A#1.0268;GERMINATION#1.0204;TUBERCULOSIS#1.0170;PEROXISOMAL#1.0016;GLYCOLATE OXIDASE#0.9926;TRICARBOXYLIC ACID CYCLE#0.9894;PEROXISOME#0.9881;GENE EXPRESSION#0.9853;PYRUVATE#0.9838;LYASE ACTIVITY#0.9783;SUCROSE#0.9661;ORGANELLE#0.9658;SUCCINATE#0.9547;ETHANOL#0.9379;GLUCONEOGENESIS#0.9322;PHOSPHOENOLPYRUVATE#0.9291;SEED GERMINATION#0.9142;ENZYME ACTIVITY#0.9140;TCA CYCLE#0.9109;VIRULENCE#0.9103;FRUCTOSE#0.9017;ACETATE METABOLISM#0.8910;ENDOPLASMIC RETICULUM#0.8886;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.8858;CITRIC ACID#0.8847;SUCCINATE DEHYDROGENASE#0.8599;KREBS CYCLE#0.8561;PYRUVATE CARBOXYLASE#0.8374;CITRIC ACID CYCLE#0.8279;MITOCHONDRIA#0.8062;ACETYL-COENZYME A SYNTHETASE#0.8035;TRANSCRIPTION FACTOR#0.7782;GLYCINE#0.7722;SUPEROXIDE DISMUTASE#0.7535;PYRUVATE KINASE#0.7485;ACYL COA OXIDASE#0.7367;ALANINE#0.7234;MICROBODY#0.7151;CELL WALL#0.7054;GLUCOSE-6-PHOSPHATE#0.6984;FUMARATE#0.6733;METHIONINE#0.6511;MUTAGENESIS#0.6468;CATABOLISM#0.6369;FUMARATE HYDRATASE#0.6363;CYTOCHROME C#0.6300;MALIC ENZYME#0.6285;GLUTAMATE DEHYDROGENASE#0.6263;HISTAMINE#0.6235;DNA BINDING#0.6174;GLYCOLYSIS#0.6125;LEUCINE#0.6107;HISTAMINE RECEPTOR#0.6043
171484	HEPATOCELLULAR CARCINOMA#0.9016;APOPTOTIC#0.6435
1714	DIGEORGE SYNDROME#0.6907;CLEFT PALATE#0.6243
171546	SERINE PALMITOYLTRANSFERASE#0.9009
171558	THYMOCYTE#1.0432;T CELL#1.0307;CELL DEVELOPMENT#1.0173;T CELL DEVELOPMENT#1.0158;GENE EXPRESSION#0.9586;PRE-TCR COMPLEX#0.9534;TCR COMPLEX#0.9464;CELL PROLIFERATION#0.9253;CELL SURFACE#0.8969;BETA SELECTION#0.8870;CELL DIFFERENTIATION#0.8764;T CELL DIFFERENTIATION#0.8732;TRANSCRIPTION FACTOR#0.7898;B CELL#0.7784;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6916;ESTROGEN RECEPTOR#0.6166;ENDOPLASMIC RETICULUM#0.6018
171559	NODULAR GOITER#1.2190;THYROID LESIONS#1.2189;GOITER#0.8611;NODULAR#0.8564
171568	TRANSFER RNA#0.8435;RNA SYNTHESIS#0.6586;CYTIDINE-5'-MONOPHOSPHATE#0.6325
1716	DGK ACTIVITY#1.1049;THYMIDINE KINASE 2#1.0919;DEOXYGUANOSINE KINASE#1.0710;DIACYLGLYCEROL KINASE#1.0678;THYMIDINE KINASE#1.0600;DEOXYCYTIDINE KINASE#1.0527;THYMIDINE#1.0511;MTDNA DEPLETION SYNDROME#1.0491;DEOXYADENOSINE#1.0406;MTDNA#1.0348;KINASE ACTIVITY#1.0298;MITOCHONDRIA#1.0270;MITOCHONDRIAL DNA#1.0164;THYMIDINE KINASE 1#0.9907;ADENOSINE#0.9753;PURINE NUCLEOSIDE PHOSPHORYLASE#0.9682;MTDNA REPLICATION#0.9626;2'-DEOXYADENOSINE#0.9592;ADENOSINE KINASE#0.9529;NUCLEOSIDE KINASE#0.9213;RESPIRATORY CHAIN#0.8973;MYOPATHY#0.8432;MITOCHONDRIAL MYOPATHY#0.8308;GUANINE#0.8294;T CELL#0.8196;DNA REPLICATION#0.8125;2-CHLORO-2'-DEOXYADENOSINE#0.8059;SKELETAL MUSCLE#0.8031;GENE EXPRESSION#0.7797;MITOCHONDRIAL DNA REPLICATION#0.7796;PLASMA MEMBRANE#0.7753;MTDNA SYNTHESIS#0.7672;PROTEIN KINASE#0.7643;CELL CYCLE#0.7472;CYTOTOXICITY#0.7355;CYTOCHROME C#0.7326;GUANOSINE#0.7288;CANCER CELL#0.7267;2-CHLORODEOXYADENOSINE#0.7152;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6904;LYMPHOCYTIC LEUKEMIA#0.6896;NERVOUS SYSTEM#0.6827;EQUILIBRATIVE NUCLEOSIDE TRANSPORTER#0.6789;MITOCHONDRIAL DISEASE#0.6784;ADENINE#0.6772;2'-DEOXYCYTIDINE#0.6618;CENTRAL NERVOUS SYSTEM#0.6580;PROTEIN KINASE C#0.6537;DNA COPY NUMBER#0.6510;CLADRIBINE#0.6426;THYMIDINE PHOSPHORYLASE#0.6353;CYTOPLASM#0.6347;HYPOXANTHINE#0.6318;CONCENTRATIVE NUCLEOSIDE TRANSPORTER#0.6188;APOPTOSIS#0.6158;MITOCHONDRIAL MATRIX#0.6042;PURKINJE CELL#0.6021;ADENOSINE DEAMINASE#0.6004
1717	7 DEHYDROCHOLESTEROL REDUCTASE#1.0687;SMITH-LEMLI-OPITZ SYNDROME#1.0307;CHOLESTEROL SYNTHESIS#1.0255;CHOLESTEROL BIOSYNTHESIS#1.0241;VITAMIN D BINDING#1.0110;VITAMIN D METABOLISM#1.0009;CYTOCHROME P450#0.9917;MENTAL RETARDATION#0.9887;CHOLESTEROL METABOLISM#0.9755;VITAMIN D DEFICIENCY#0.9692;VITAMIN D SYNTHESIS#0.9589;GENE EXPRESSION#0.9584;CHOLESTEROL BIOSYNTHETIC#0.9515;VITAMIN D RECEPTOR#0.9476;COENZYME A#0.8805;AMNIOTIC FLUID#0.8366;GENE SILENCING#0.7988;TYPE 2 DIABETES#0.7870;POLYMERASE CHAIN REACTION#0.7849;SIMVASTATIN#0.7689;LOW DENSITY LIPOPROTEIN#0.7595;STEROL BIOSYNTHESIS#0.7489;CHOLESTEROL HOMEOSTASIS#0.7470;SYNDACTYLY#0.7443;VITAMIN D3#0.7307;ENZYME ACTIVITY#0.7046;LIPID METABOLISM#0.7044;HOLOPROSENCEPHALY#0.7042;CHOLECALCIFEROL#0.6956;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6949;HEPATITIS C#0.6885;TRANSCRIPTION FACTOR#0.6737;INTELLECTUAL DISABILITY#0.6672;LIVER DISEASE#0.6601;LANOSTEROL#0.6494;ARIPIPRAZOLE#0.6468;NERVOUS SYSTEM#0.6455;CHORIONIC VILLUS#0.6370;GESTATION#0.6293;RHEUMATOID ARTHRITIS#0.6283;STEROL METABOLISM#0.6041
1718	CHOLESTEROL BIOSYNTHESIS#1.0609;APOPTOTIC#1.0496;APOPTOSIS#1.0481;CHOLESTEROL SYNTHESIS#1.0440;ALZHEIMER'S DISEASE#1.0212;GENE EXPRESSION#1.0025;ENDOPLASMIC RETICULUM#0.9990;REACTIVE OXYGEN SPECIES#0.9705;HEPATITIS C#0.9419;LIPID RAFT#0.9327;ADRENAL GLAND#0.9279;CHOLESTEROL BIOSYNTHETIC#0.9227;LIPID METABOLISM#0.9108;TOXICITY#0.9095;NEUROPROTECTION#0.8962;STEM CELL#0.8941;HEPATITIS C VIRUS#0.8858;PROSTATE CANCER#0.8778;NEUROBLASTOMA#0.8765;ANDROGEN RECEPTOR#0.8675;NEURONAL CELLS#0.8632;SIGNALING PATHWAY#0.8485;ESTROGENS#0.8429;CANCER CELL#0.8022;QUANTITATIVE REAL TIME#0.7915;CYTOPLASM#0.7798;CHOLESTEROL METABOLISM#0.7764;HAIR FOLLICLE#0.7645;AKT SIGNALING#0.7557;CELL DEATH#0.7262;7 DEHYDROCHOLESTEROL REDUCTASE#0.7086;RESPONSE TO OXIDATIVE STRESS#0.7073;PLASMA MEMBRANE#0.7017;HYPOXIA#0.6956;INFLAMMATORY RESPONSE#0.6929;AMYLOID PRECURSOR PROTEIN#0.6859;MOUSE EMBRYONIC FIBROBLAST#0.6844;CELL ADHESION#0.6788;CYTOTOXICITY#0.6755;CHOLESTEROL HOMEOSTASIS#0.6754;NEURODEGENERATIVE DISEASE#0.6672;ADENINE#0.6650;ESTROGEN RECEPTOR#0.6603;PROGESTERONE#0.6557;ONCOGENIC#0.6522;POLYMERASE CHAIN REACTION#0.6514;FLAVIN ADENINE DINUCLEOTIDE#0.6468;STEROIDOGENESIS#0.6411;ISCHEMIA#0.6379;DNA METHYLATION#0.6362;NEUROEPITHELIAL CELL#0.6286;MESENCHYMAL STEM CELL#0.6259;HEPATOCELLULAR CARCINOMA#0.6245;GROWTH FACTOR#0.6201;ADRENAL CORTEX#0.6187;TESTOSTERONE#0.6179;GLIAL CELL#0.6118;PROTOPORPHYRIN IX#0.6095;ARTERY#0.6085
1719	AMETHOPTERIN#1.0792;5,6,7,8-TETRAHYDROFOLATE#1.0766;GLYCINAMIDE RIBONUCLEOTIDE#1.0519;PROGUANIL#1.0509;7,8-DIHYDROBIOPTERIN#1.0452;DNA POLYMERASE ALPHA#1.0321;ALIMTA#1.0301;CYTOCHROME B#1.0278;SEPIAPTERIN REDUCTASE#1.0277;DIHYDROFOLATE REDUCTASE#1.0258;L-ORNITHINE#1.0255;DAPSONE#1.0245;THYMIDINE KINASE#1.0232;PEMETREXED#1.0229;TUBERCULOSIS#1.0221;THYMIDYLATE SYNTHASE#1.0208;FOLATE BINDING#1.0207;TETRAHYDROFOLIC ACID#1.0182;ORNITHINE#1.0175;L-GLUTAMIC ACID#1.0169;REDUCED FOLATE CARRIER#1.0167;THYMIDYLATE#1.0165;IMP DEHYDROGENASE#1.0163;AMINOPTERIN#1.0154;ADENINE DINUCLEOTIDE PHOSPHATE#1.0136;METHOTREXATE TRANSPORT#1.0125;TRIMETREXATE#1.0124;NICOTINAMIDE ADENINE DINUCLEOTIDE#1.0114;TETRAHYDROFOLATE#1.0108;LY231514#1.0097;TRYPTOPHAN#1.0082;GENE COPY NUMBER#1.0076;HEMATOPOIETIC CELL#1.0072;TRIMETHOPRIM#1.0071;HEPATOMA CELLS#1.0053;ASPARTATE#1.0053;MOLECULAR DYNAMICS SIMULATION#1.0052;TOPOISOMERASE#1.0045;PYRIMETHAMINE#1.0038;SULFADOXINE#1.0037;FOLATE BIOSYNTHESIS#1.0033;STRUCTURE ACTIVITY RELATIONSHIP#1.0024;BONE MARROW CELLS#1.0018;BIOPTERIN#1.0016;FOLINIC ACID#1.0016;MEMBRANE TRANSPORT#1.0008;SULFONAMIDE#1.0005;TETRAHYDROBIOPTERIN#1.0001;METHIONINE SYNTHASE#0.9991;NEOMYCIN#0.9989;G1 PHASE#0.9986;GLOBIN#0.9975;ENDOTHELIAL CELL#0.9959;PROGENITOR CELL#0.9955;NADPH BINDING#0.9953;LEUCINE#0.9952;GLUCOCORTICOID RECEPTOR#0.9949;CHLORAMPHENICOL#0.9948;HYDROXYUREA#0.9947;DNA AMPLIFICATION#0.9943;METHOTREXATE#0.9942;ONE CARBON METABOLISM#0.9938;ENZYME INHIBITOR#0.9932;HISTIDINE#0.9932;FOLATE TRANSPORT#0.9930;COENZYME BINDING#0.9921;GLUTAMIC ACID#0.9916;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9909;MITOCHONDRIA#0.9906;FOLATE METABOLISM#0.9902;GLUTATHIONE#0.9901;SULFAMETHOXAZOLE#0.9895;ARGININE#0.9893;METHIONINE#0.9892;RIBOSOME#0.9891;FOLATE#0.9888;NUCLEOSIDE KINASE#0.9886;ADENOSINE#0.9882;CATALYTIC ACTIVITY#0.9880;ADENINE#0.9879;COFACTOR BINDING#0.9875;PROTEIN PROTEIN INTERACTION#0.9870;5 FLUOROURACIL#0.9869;CHLOROQUINE#0.9865;FLUOROURACIL#0.9852;ENZYME COMPLEX#0.9850;LYSINE#0.9847;NITRIC OXIDE SYNTHASE#0.9845;DNA SYNTHESIS#0.9843;NICOTINAMIDE#0.9843;DNA REPLICATION#0.9842;MODE OF ACTION#0.9841;FOLIC ACID#0.9838;5-METHYLTETRAHYDROFOLATE#0.9836;DIGESTION#0.9828;STEM CELL#0.9822;NUCLEIC ACID#0.9822;ALANINE#0.9819;DNA REPAIR#0.9814;S PHASE#0.9811;LEUCOVORIN#0.9806;FRAGMENT LENGTH POLYMORPHISM#0.9802;STREPTOMYCIN#0.9801;PNEUMONIA#0.9801;THYMIDINE#0.9800;L-GLUTAMATE#0.9798;MUTAGENESIS#0.9796;PLASMODIUM FALCIPARUM MALARIA#0.9794;T CELL#0.9793;BREAST CANCER CELL#0.9792;CELL GROWTH#0.9790;GLYCINE#0.9790;PRALATREXATE#0.9790;BONE MARROW#0.9786;PROTEIN BINDING#0.9777;CELL CYCLE REGULATION#0.9776;HERPES SIMPLEX VIRUS#0.9771;HOST CELL#0.9771;CELL PROLIFERATION#0.9770;PROTEIN KINASE#0.9769;ENZYME ACTIVITY#0.9768;HERPES SIMPLEX#0.9768;NITRIC OXIDE#0.9767;HUMAN BREAST CANCER#0.9764;DNA BINDING#0.9760;MECHANISM OF ACTION#0.9757;BETA GALACTOSIDASE#0.9752;GROWTH FACTOR#0.9740;L-LYSINE#0.9740;LEUKOCYTE#0.9737;PROTEIN SYNTHESIS#0.9736;RHEUMATOID ARTHRITIS#0.9730;POLYMERASE CHAIN REACTION#0.9721;CELL DEATH#0.9721;CYTOPLASM#0.9721;HYPOXANTHINE#0.9719;CISPLATIN#0.9717;BREAST CANCER#0.9717;ADENOSINE DEAMINASE#0.9708;PERIPHERAL BLOOD#0.9705;COLORECTAL CANCER#0.9702;ENDOTHELIAL NITRIC OXIDE#0.9697;SMALL INTESTINE#0.9696;HEAT SHOCK PROTEIN#0.9685;RNA SYNTHESIS#0.9683;LYMPHOBLAST#0.9678;GENE EXPRESSION#0.9673;CO-TRIMOXAZOLE#0.9671;MALARIA#0.9671;TRANSCRIPTION FACTOR#0.9670;TUMOR CELLS#0.9665;TETRACYCLINE#0.9665;DRUG RESISTANCE#0.9664;CELL CYCLE#0.9663;GUANINE#0.9645;CHAPERONIN#0.9644;APOPTOSIS#0.9627;ESTROGEN RECEPTOR#0.9624;TRANSCRIPTASE#0.9619;COMPLEX I#0.9612;COLORECTAL#0.9611;CYTOTOXICITY#0.9604;CYCLIN DEPENDENT KINASE#0.9604;CANCER CELL#0.9601;2'-DEOXYURIDINE#0.9596;HEMATOPOIETIC PROGENITOR CELL#0.9596;CYTIDINE DEAMINASE#0.9595;SQUAMOUS CELL CARCINOMA#0.9594;PROTEIN FOLDING#0.9586;LUNG CANCER#0.9586;TOXICITY#0.9585;ATOVAQUONE#0.9583;COLON CANCER#0.9578;ASPARAGINE#0.9569;OVARIAN#0.9560;MACROPHAGE#0.9543;SYNTHETASE ACTIVITY#0.9525;REVERSE TRANSCRIPTION#0.9515;MISMATCH REPAIR#0.9492;VALINE#0.9490;ERYTHROCYTE#0.9481;MECHANISMS OF ACTION#0.9479;CELL MEMBRANE#0.9455;GUANIDINE#0.9436;COLONY-STIMULATING FACTOR#0.9434;RETINOBLASTOMA#0.9428;RED BLOOD CELL#0.9409;CARRIE#0.9409;TOXOPLASMOSIS#0.9387;TUMOR SUPPRESSOR#0.9384;HEMATOPOIETIC STEM CELL#0.9384;PLASMA MEMBRANE#0.9380;TRANSLATION INITIATION#0.9379;CHLOROPLAST#0.9370;ADENOCARCINOMA#0.9368;REGENERATION#0.9367;GLUTAMINE#0.9358;XANTHINE#0.9357;TOPOISOMERASE II#0.9349;MITOCHONDRIAL MEMBRANE#0.9346;ASCITES#0.9345;METHYLENETETRAHYDROFOLATE DEHYDROGENASE#0.9344;THYMINE#0.9338;VITAMIN B12#0.9336;METAPHASE#0.9333;CELL DIVISION#0.9333;FLUORESCEIN#0.9323;THYMIDINE PHOSPHORYLASE#0.9315;MOLAR#0.9305;FLUORODEOXYURIDINE#0.9295;OUTER MEMBRANE#0.9292;MINIMUM INHIBITORY CONCENTRATION#0.9284;ISOLEUCINE#0.9278;MULTI DRUG RESISTANCE#0.9268;RESPONSE TO METHOTREXATE#0.9244;T- PA#0.9242;CELL CYCLE ARREST#0.9242;SODIUM DODECYL SULFATE#0.9234;DODECYL SULFATE#0.9233;NUCLEOTIDE BIOSYNTHESIS#0.9232;ANEMIA#0.9212;ORNITHINE DECARBOXYLASE#0.9201;CELL SURFACE#0.9190;ASPARTIC ACID#0.9189;NERVOUS SYSTEM#0.9183;SPECTINOMYCIN#0.9180;KINASE ACTIVITY#0.9179;GROWTH FACTOR RECEPTOR#0.9171;LYMPHOCYTIC LEUKEMIA#0.9166;GUANIDINE HYDROCHLORIDE#0.9143;ENDOPLASMIC RETICULUM#0.9119;NEURAL TUBE DEFECT#0.9115;GRANULOCYTE#0.9103;PROTEASOME#0.9100;SULPHONAMIDE#0.9088;CARCINOGEN#0.9075;NEURAL TUBE#0.9067;PROTEIN COMPLEX#0.9066;NUCLEOTIDE SYNTHESIS#0.9064;KINASE INHIBITOR#0.9055;CENTRAL NERVOUS SYSTEM#0.9045;CONJUGATION#0.9037;METAPHASE CHROMOSOME#0.9032;DNA METHYLATION#0.9028;MITOCHONDRIAL DNA#0.9021;OVARIAN CANCER#0.9018;UBIQUITIN#0.9016;DRUG BINDING#0.9013;RIBOSE#0.9011;AMPICILLIN#0.9009;DEXAMETHASONE#0.9005;PROTEIN DATA BANK#0.8979;RIBOZYME#0.8970;RIBOSOMAL RNA#0.8968;FPGS ACTIVITY#0.8935;B CELL#0.8856;EPITHELIAL CELL#0.8845;COENZYME A#0.8841;ADENINE PHOSPHORIBOSYLTRANSFERASE#0.8836;MEROZOITE SURFACE PROTEIN#0.8819;CYTOCHROME B2#0.8816;ENZYME BINDING#0.8811;HYPERSENSITIVITY#0.8798;AUTOIMMUNE DISEASE#0.8795;MONONUCLEAR CELLS#0.8795;VAN DER WAALS#0.8790;EPIDERMAL GROWTH FACTOR#0.8777;CYTIDINE#0.8762;LUNG CARCINOMA#0.8756;SIGNAL PEPTIDE#0.8749;HEPATITIS B#0.8738;HISTONE DEACETYLASE#0.8734;NUCLEOSIDE TRANSPORT#0.8731;INHIBITION OF GROWTH#0.8721;MITOCHONDRIAL MATRIX#0.8715;SUPEROXIDE DISMUTASE#0.8702;ALKALINE PHOSPHATASE#0.8700;FDURD#0.8680;URACIL#0.8670;BENZIMIDAZOLE#0.8601;ANTIBODY PRODUCTION#0.8589;ACUTE LYMPHOCYTIC LEUKEMIA#0.8561;HEPATITIS B VIRUS#0.8558;CYTOSINE DEAMINASE#0.8540;LEISHMANIASIS#0.8518;PROTEIN IMPORT#0.8505;URIDINE#0.8501;XERODERMA PIGMENTOSUM#0.8493;ISOTHERMAL TITRATION CALORIMETRY#0.8488;CYSTATHIONINE BETA SYNTHASE#0.8468;FOLIC ACID METABOLISM#0.8435;NUCLEOTIDE METABOLISM#0.8432;FACTOR XA#0.8405;RALTITREXED#0.8388;DOXORUBICIN#0.8331;BLAST CELL#0.8321;MUCOSITIS#0.8300;BREAST CARCINOMA#0.8286;AMODIAQUINE#0.8283;RETICULOCYTE#0.8278;HYPERTENSION#0.8274;NEUTROPENIA#0.8246;DNA FRAGMENTATION#0.8230;NATIONAL CANCER INSTITUTE#0.8227;RNA BINDING#0.8218;NITROGEN MUSTARD#0.8216;HUMAN IMMUNODEFICIENCY VIRUS#0.8214;G-CSF#0.8213;DNA BIOSYNTHESIS#0.8184;EXCRETION#0.8172;OTHER ORGANISM#0.8163;NADPH OXIDASE#0.8158;REPLICATION FORK#0.8141;ZD1694#0.8119;CHLOROPLAST ENVELOPE#0.8105;CORD BLOOD#0.8103;DETOXIFICATION#0.8100;EPIGALLOCATECHIN#0.8064;LINES OF EVIDENCE#0.8058;VANCOMYCIN#0.8056;ACTINOMYCIN D#0.8033;GEMCITABINE#0.8017;CYTOCHROME C#0.8015;QUANTITATIVE REAL TIME#0.8015;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8011;HOMOCYSTEINE METABOLISM#0.8001;MEFLOQUINE#0.7999;EFFLUX PUMP#0.7997;SPINA BIFIDA#0.7994;GLUCOSE-6-PHOSPHATE#0.7983;L-ASPARTATE#0.7976;MEGALOBLASTIC ANEMIA#0.7943;T LYMPHOCYTE#0.7940;CHROMOSOME REGION#0.7938;GM-CSF#0.7932;PENICILLIN#0.7930;5 FLUORODEOXYURIDINE#0.7929;ENDOTHELIUM#0.7927;VIRION#0.7908;INOSINE#0.7876;ATP BINDING#0.7873;NUCLEOTIDE EXCISION REPAIR#0.7873;GENE OF INTEREST#0.7867;CLEFT PALATE#0.7866;HOMOLOGOUS RECOMBINATION#0.7857;SUCROSE#0.7853;ANGIOTENSIN CONVERTING ENZYME#0.7851;L-ARGININE#0.7839;DNA METABOLISM#0.7837;MALTOSE BINDING#0.7816;CLEFT LIP#0.7815;VIRULENCE#0.7813;DIPHOSPHATE#0.7808;DNASE I#0.7805;BIOTIN#0.7757;ARA-C#0.7756;FLAVIN#0.7727;TRIAMTERENE#0.7726;MAGNETIC RESONANCE SPECTROSCOPY#0.7721;TOMUDEX#0.7720;INDOLE#0.7715;COLON ADENOCARCINOMA#0.7713;HEAD AND NECK CANCER#0.7701;NECK CANCER#0.7701;GUANOSINE#0.7695;CYTOSINE ARABINOSIDE#0.7690;GROWTH HORMONE#0.7681;ORGANELLE#0.7680;CELL DIFFERENTIATION#0.7673;IMMUNE SYSTEM#0.7664;CHAGAS DISEASE#0.7655;CHORIOCARCINOMA#0.7617;MAXIMUM TOLERATED DOSE#0.7564;DNA TOPOISOMERASE#0.7555;N ACETYLTRANSFERASE#0.7553;DTMP SYNTHESIS#0.7550;TRANSPOSITION#0.7547;GTP CYCLOHYDROLASE I#0.7526;IMMUNE RESPONSE#0.7523;WHITE BLOOD CELL#0.7510;SURFACE PLASMON RESONANCE#0.7503;COLON CARCINOMA#0.7503;CERVICAL#0.7477;SULFADIAZINE#0.7474;REACTIVE OXYGEN SPECIES#0.7466;PSORIASIS#0.7441;FORMATE#0.7399;DIARRHEA#0.7389;LYMPHOID LEUKEMIA#0.7386;CELL KILLING#0.7348;APOPTOTIC#0.7342;CYCLOPHILIN#0.7330;TRYPANOTHIONE#0.7319;NUCLEOTIDE BINDING#0.7315;CELLULAR METABOLISM#0.7312;TERATOGENIC#0.7311;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7304;BREAST CANCER PATIENTS#0.7299;ACUTE LEUKEMIA#0.7295;DNASE#0.7289;OVARIAN CARCINOMA#0.7287;LYMPHOBLASTOID CELLS#0.7241;BENZOIC ACID#0.7238;KAPOSI'S SARCOMA#0.7221;CYCLIC AMP#0.7216;UMBILICAL CORD BLOOD#0.7187;CARDIAC DEVELOPMENT#0.7179;M PHASE#0.7175;INTRACELLULAR RETENTION#0.7170;ONCOGENIC#0.7164;UMBILICAL CORD#0.7159;THROMBOCYTOPENIA#0.7157;THYMIDINE KINASE ACTIVITY#0.7151;GLYCERALDEHYDE-3-PHOSPHATE#0.7149;ROOT MEAN SQUARE#0.7122;ENDOTHELIAL GROWTH FACTOR#0.7118;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7118;BIRTH DEFECT#0.7113;TUMOR NECROSIS FACTOR#0.7103;MUSCLE CELL#0.7097;PEMETREXED DISODIUM#0.7091;CYTOCHROME P450#0.7067;MINIMAL INHIBITORY CONCENTRATION#0.7066;MITOSIS#0.7058;XANTHINE OXIDASE#0.6978;ATP HYDROLYSIS#0.6973;TRANSCRIPTION-COUPLED REPAIR#0.6968;RIBOSOMAL PROTEIN#0.6954;PROTEIN DEGRADATION#0.6944;INDUCTION OF APOPTOSIS#0.6921;PERIPHERAL BLOOD CELLS#0.6916;RNA INTERFERENCE#0.6908;MYELOID LEUKEMIA#0.6901;SIGNAL TRANSDUCTION#0.6889;GUANINE PHOSPHORIBOSYLTRANSFERASE#0.6887;SERUM ALBUMIN#0.6886;RESONANCE ENERGY TRANSFER#0.6886;DTMP BIOSYNTHESIS#0.6878;PARTIAL LEAST SQUARE#0.6861;BENZODIAZEPINE RECEPTOR#0.6858;THYMIDYLATE SYNTHETASE ACTIVITY#0.6827;SULPHAMETHOXAZOLE#0.6794;ATAXIA TELANGIECTASIA#0.6791;DHF BINDING#0.6771;MALIGNANT PLEURAL MESOTHELIOMA#0.6761;DOPAMINE#0.6739;HEMATOPOIESIS#0.6730;TETRAHYDROBIOPTERIN SYNTHESIS#0.6726;NON-SMALL CELL LUNG CARCINOMA#0.6718;FK506 BINDING PROTEIN#0.6715;FK506 BINDING#0.6712;STATIONARY PHASE#0.6709;DRUG METABOLISM#0.6699;ENDOCYTOSIS#0.6696;COLONY-FORMING CELL#0.6680;LYMPHOID CELL#0.6669;C TERMINAL DOMAIN#0.6668;MALTOSE#0.6651;GLYCOSYLATION#0.6638;TRANSFERRIN RECEPTOR#0.6630;CHROMATID#0.6607;DISEASE FREE SURVIVAL#0.6606;MICROTUBULE#0.6577;WHOLE GENOME SEQUENCING#0.6563;NUCLEAR ENVELOPE#0.6545;ARTEMETHER#0.6539;T-CELL LEUKEMIA#0.6538;PUROMYCIN#0.6536;TRANSCRIPTIONAL CONTROL#0.6531;FIBROSARCOMA#0.6526;MUTAGENIC#0.6500;RECEPTOR BINDING#0.6493;FACTOR I#0.6482;KANAMYCIN#0.6477;INTERNAL TRANSCRIBED SPACER#0.6467;DENSITY FUNCTIONAL THEORY#0.6460;SULFAMETHOXAZOLE & TRIMETHOPRIM#0.6459;SKIN FIBROBLASTS#0.6451;MICROSOME#0.6449;SENESCENCE#0.6449;INHIBITION OF CELL GROWTH#0.6447;RNA PROCESSING#0.6436;EVENT FREE SURVIVAL#0.6431;MITOMYCIN C#0.6431;CELL CYCLE CONTROL#0.6410;VINCRISTINE#0.6408;WORLD HEALTH ORGANIZATION#0.6398;RETINOIC ACID#0.6397;NITRO-L-ARGININE#0.6386;PRIMAQUINE#0.6383;CELL WALL#0.6370;BETA-2#0.6367;ACID PHOSPHATASE#0.6366;HYPOXIA#0.6361;TUMOR TISSUES#0.6360;AMINOSALICYLIC ACID#0.6350;THYMIDYLATE KINASE#0.6347;METHIONINE SYNTHASE REDUCTASE#0.6340;PROTEIN OF INTEREST#0.6335;LUMEFANTRINE#0.6325;PLASTOCYANIN#0.6305;TRYPANOSOMIASIS#0.6302;DIHYDROOROTATE DEHYDROGENASE#0.6280;PANCREATIC CANCER#0.6257;URINARY TRACT INFECTION#0.6254;LYSOSOME#0.6243;ADENYLATE#0.6239;CHROMOSOMAL REGION#0.6238;EPSTEIN BARR VIRUS#0.6202;PROTEIN UNFOLDING#0.6197;GRANULOCYTE COLONY STIMULATING FACTOR#0.6197;PENTAMIDINE#0.6191;ABC TRANSPORTER#0.6178;ERYTHROLEUKEMIA#0.6166;BH4 BINDING#0.6164;CELL CYCLE PHASE#0.6164;FOLATE RECEPTOR ALPHA#0.6158;DRUG TRANSPORT#0.6154;DNA METHYLTRANSFERASE#0.6143;UMBILICAL VEIN#0.6143;DEOXYTHYMIDINE#0.6142;MITOCHONDRIAL GENOME#0.6137;TRANSLATION INITIATION FACTOR#0.6125;ARSENITE#0.6083;GERM CELL#0.6079;GUANINE DEAMINASE#0.6077;NUCLEAR PERIPHERY#0.6074;CRYPTOSPORIDIOSIS#0.6041;SATURATION TRANSFER DIFFERENCE#0.6029;CELLULOSE BINDING#0.6015;TRANSACTIVATION#0.6007
1723	TRIAZOLOPYRIMIDINE#1.0799;TERIFLUNOMIDE#1.0769;DIHYDROOROTATE DEHYDROGENASE#1.0479;OROTATE PHOSPHORIBOSYLTRANSFERASE#1.0390;LEFLUNOMIDE#1.0379;OROTIDINE-5'-MONOPHOSPHATE#1.0240;ELECTRON TRANSPORT#1.0234;RESPIRATORY CHAIN#1.0223;STRUCTURE ACTIVITY RELATIONSHIP#1.0203;CANCER CELL#1.0156;ASPARTATE#1.0143;MALARIA#1.0137;FLAVIN#1.0133;ELECTRON TRANSPORT CHAIN#1.0102;APOPTOSIS#1.0063;MITOCHONDRIA#1.0045;RHEUMATOID ARTHRITIS#1.0023;AUTOIMMUNE DISEASE#0.9967;CELL PROLIFERATION#0.9957;URIDINE#0.9955;CELL CYCLE#0.9940;ATOVAQUONE#0.9875;CELL CYCLE ARREST#0.9865;MITOCHONDRIAL ELECTRON TRANSPORT#0.9800;S PHASE#0.9743;URACIL#0.9730;MECHANISM OF ACTION#0.9708;MULTIPLE SCLEROSIS#0.9622;ENZYME ACTIVITY#0.9612;OROTIC ACID#0.9570;MITOCHONDRIAL MEMBRANE#0.9559;FUMARATE#0.9542;SUCCINATE#0.9525;ACUTE MYELOID LEUKEMIA#0.9419;MYELOID LEUKEMIA#0.9417;MITOCHONDRIAL ELECTRON TRANSPORT CHAIN#0.9348;T CELL#0.9231;COMPLEX III#0.9095;CELL DEATH#0.9071;MODE OF ACTION#0.9047;ELECTRON TRANSFER#0.8987;TOXICITY#0.8937;GLUTAMINE#0.8887;NUCLEOTIDE SYNTHESIS#0.8812;ASPARTATE CARBAMOYLTRANSFERASE#0.8701;UMP SYNTHESIS#0.8681;UBIQUINONE BINDING#0.8650;CYTOCHROME C#0.8519;COMPLEX II#0.8492;MUTAGENESIS#0.8360;SUCCINATE DEHYDROGENASE#0.8292;GENE EXPRESSION#0.8261;CELL GROWTH#0.8250;CYTOTOXICITY#0.8131;HISTIDINE#0.7891;DIHYDROFOLATE REDUCTASE#0.7731;INNER MITOCHONDRIAL MEMBRANE#0.7692;PYRIMIDINE NUCLEOTIDE SYNTHESIS#0.7625;DIHYDROOROTIC ACID#0.7546;MECHANISMS OF ACTION#0.7490;PYRIMIDINE METABOLISM#0.7347;COLLAGEN INDUCED ARTHRITIS#0.7331;BREAST CANCER#0.7304;PYRIMIDINE SALVAGE#0.7299;CHAGAS DISEASE#0.7281;CYTIDINE#0.7231;VIRAL REPLICATION#0.7213;ENZYME INHIBITOR#0.7207;REACTIVE OXYGEN SPECIES#0.7180;CYTOCHROME C OXIDASE#0.7106;LYMPHOCYTE PROLIFERATION#0.7104;NUCLEOTIDE BIOSYNTHESIS#0.7068;NUCLEIC ACID#0.7030;TUMOR CELLS#0.6991;MITOCHONDRIAL RESPIRATORY CHAIN#0.6968;DRUG RESISTANCE#0.6925;ADENINE#0.6757;PERIPHERAL BLOOD#0.6715;BREAST CANCER CELL#0.6635;ACROFACIAL DYSOSTOSIS#0.6616;EPITHELIAL CELL#0.6479;COMPLEX I#0.6479;DNA SYNTHESIS#0.6477;IMMUNOSUPPRESSANT#0.6475;B CELL#0.6427;MITOCHONDRIAL INNER MEMBRANE#0.6387;RNA INTERFERENCE#0.6230;DNA REPLICATION#0.6187;IMP DEHYDROGENASE#0.6187;SUCCINATE DEHYDROGENASE ACTIVITY#0.6180;RESPIRATION#0.6161;L-ASPARTATE#0.6142;IMMUNE RESPONSE#0.6102;HYPOXIA#0.6090;PERIPHERAL MEMBRANE PROTEIN#0.6030
1725	DEOXYHYPUSINE SYNTHASE ACTIVITY#1.1372;DEOXYHYPUSINE SYNTHASE#1.0735;SPERMIDINE#1.0413;EUKARYOTIC INITIATION FACTOR#1.0220;LYSINE#1.0204;TRANSLATION INITIATION FACTOR#1.0145;TRANSLATION INITIATION#1.0114;CELL PROLIFERATION#1.0080;CELL GROWTH#0.9990;HYPUSINE FORMATION#0.9830;POSTTRANSLATIONAL MODIFICATION#0.9828;POST-TRANSLATIONAL MODIFICATION#0.9787;HYPUSINE BIOSYNTHESIS#0.9550;MALARIA#0.8709;PUTRESCINE#0.8379;PROTEIN KINASE#0.8134;PROTEIN SYNTHESIS#0.8114;SENESCENCE#0.8042;CELL CYCLE#0.7922;ORNITHINE DECARBOXYLASE#0.7577;APOPTOSIS#0.7543;HYPUSINE SYNTHESIS#0.7287;CELL MIGRATION#0.7150;BUTYLAMINE#0.6880;T CELL#0.6829;ORNITHINE#0.6662;CELL DEATH#0.6590;ENZYME ACTIVITY#0.6559;SPERMINE#0.6494;PRIMARY METABOLISM#0.6375;PRO-INFLAMMATORY#0.6352;LEAF SENESCENCE#0.6266;POLYAMINE BIOSYNTHESIS#0.6210;RIBOSOME#0.6196;TYPE 1 DIABETES#0.6147
1727	NADPH DIAPHORASE ACTIVITY#1.1011;DIAPHORASE ACTIVITY#1.0775;METHEMOGLOBINEMIA#1.0562;VACCINIA#1.0550;CYTOCHROME B5 REDUCTASE#1.0518;NICOTINAMIDE ADENINE DINUCLEOTIDE#1.0477;ADENINE DINUCLEOTIDE PHOSPHATE#1.0445;CYTOCHROME B5#1.0431;CYTOCHROME C#1.0322;ADENINE#1.0301;NICOTINAMIDE#1.0254;CYTOCHROME B#1.0232;ERYTHROCYTE#1.0221;NITRIC OXIDE SYNTHASE#1.0181;FERREDOXIN#1.0065;NITRIC OXIDE#1.0063;FLAVIN#0.9406;ELECTRON TRANSFER#0.9293;SOLUBLE FRACTION#0.9245;SOLUBLE GUANYLYL CYCLASE#0.9008;ENZYME ACTIVITY#0.8872;ENDOPLASMIC RETICULUM#0.8554;SMOOTH MUSCLE#0.8554;MITOCHONDRIA#0.8397;NOS ACTIVITY#0.8113;MENTAL RETARDATION#0.8081;SPINAL CORD#0.7726;SULFONAMIDE#0.7665;EPITHELIAL CELL#0.7598;CYTOCHROME P450#0.7446;CANCER CELL#0.7442;VIRION#0.7425;OXIDOREDUCTASE ACTIVITY#0.7290;PLASMA MEMBRANE#0.7279;SPERMATOZOA#0.7230;ELECTRON TRANSPORT#0.7214;BREAST CANCER#0.7189;GUANYLATE CYCLASE#0.7117;LEUKOCYTE#0.7051;BLOOD VESSEL#0.6905;GLUTATHIONE#0.6887;HYPERSENSITIVITY#0.6843;ASCORBATE#0.6827;OUTER MEMBRANE#0.6786;DETOXIFICATION#0.6766;NADH OXIDATION#0.6730;CELL SURFACE#0.6722;POLYMERASE CHAIN REACTION#0.6711;PERINUCLEAR ER#0.6622;NADPH OXIDASE#0.6531;ENDOTHELIAL CELL#0.6528;ENDOTHELIUM#0.6519;L-ARGININE#0.6507;CARCINOGEN#0.6289;ARGININE#0.6237;GLUCOSE-6-PHOSPHATE#0.6232;NEUTROPHIL#0.6218;SMOOTH MUSCLE CELL#0.6205;MUSCLE CELL#0.6198;SUPEROXIDE DISMUTASE#0.6195;GOLGI VESICLE#0.6185;NERVOUS SYSTEM#0.6148;FLAVIN ADENINE DINUCLEOTIDE#0.6133;DICOUMAROL#0.6016;RED BLOOD CELL#0.6005
1728	NADPH DIAPHORASE ACTIVITY#1.0905;AZOREDUCTASE ACTIVITY#1.0789;BETA GLUCOSIDASE#1.0701;DT-DIAPHORASE ACTIVITY#1.0644;BETA GLUCURONIDASE#1.0565;QUININE#1.0544;GLUTAMATE CYSTEINE LIGASE#1.0533;EPOXIDE HYDROLASE#1.0499;DIAPHORASE ACTIVITY#1.0493;CYTOCHROME B5 REDUCTASE#1.0477;ADENINE DINUCLEOTIDE PHOSPHATE#1.0392;DICOUMAROL#1.0382;GLUTATHIONE TRANSFERASE#1.0379;DICUMAROL#1.0331;XANTHINE OXIDASE#1.0329;CYTOCHROME B5#1.0326;NICOTINAMIDE ADENINE DINUCLEOTIDE#1.0300;HEME OXYGENASE 1#1.0285;QUINONE REDUCTASE ACTIVITY#1.0242;OXYGENASE#1.0242;COLON CARCINOMA#1.0207;VITAMIN K#1.0206;XANTHINE#1.0199;NICOTINAMIDE#1.0172;SR-4233#1.0142;ADENINE#1.0138;MENADIONE#1.0125;REVERSE TRANSCRIPTION#1.0097;NADPH OXIDASE#1.0087;2-METHYL-1,4-NAPHTHOQUINONE#1.0076;FERREDOXIN#1.0074;MITOMYCIN#1.0044;MITOMYCIN C#1.0044;MONONUCLEAR CELLS#1.0041;HYPOXIC#1.0003;RESVERATROL#0.9980;PLASMA MEMBRANE#0.9977;BONE MARROW#0.9955;FLAVIN#0.9954;SQUAMOUS CELL CARCINOMA#0.9946;POLYMERASE CHAIN REACTION#0.9944;CLEAVED CASPASE 3#0.9942;CYTOCHROME P450#0.9936;COLORECTAL#0.9933;LUNG CANCER#0.9918;NADH OXIDATION#0.9917;DNA REPAIR#0.9917;PERIPHERAL BLOOD#0.9915;NITRIC OXIDE SYNTHASE#0.9904;QUANTITATIVE REAL TIME#0.9900;GLUTATHIONE PEROXIDASE#0.9899;ELECTRON TRANSFER#0.9893;DOPAMINE#0.9892;INDUCIBLE NITRIC OXIDE#0.9892;CYTOCHROME C#0.9890;GLUTATHIONE#0.9887;BREAST CANCER#0.9884;CATALYTIC ACTIVITY#0.9879;TUMOR CELLS#0.9872;ENZYME ACTIVITY#0.9860;ANTIOXIDANT RESPONSE ELEMENT#0.9858;TUMOR TISSUES#0.9853;NEUROTOXICITY#0.9849;ADENOCARCINOMA#0.9847;INDOLE#0.9843;BREAST CANCER CELL#0.9839;CISPLATIN#0.9837;QUERCETIN#0.9837;SUPEROXIDE DISMUTASE#0.9836;DETOXIFICATION#0.9835;ANTIOXIDANT RESPONSIVE ELEMENT#0.9835;COLON CANCER#0.9833;XENOBIOTIC METABOLIZING ENZYME#0.9831;HYPOXIA#0.9830;COLORECTAL CANCER#0.9829;MACROPHAGE#0.9815;DOPAMINERGIC NEURON#0.9801;TUMOR NECROSIS FACTOR#0.9801;SUBSTANTIA NIGRA#0.9800;CANCER CELL#0.9787;SMALL INTESTINE#0.9785;PROSTATE CANCER#0.9784;CYTOPLASM#0.9781;POLYCYCLIC AROMATIC HYDROCARBON#0.9780;OXIDATIVE STRESS RESPONSE#0.9776;BREAST CANCER PATIENTS#0.9776;ARYL HYDROCARBON RECEPTOR#0.9768;COMPLEX I#0.9766;ELECTRON TRANSPORT#0.9764;MELATONIN#0.9761;ROS GENERATION#0.9755;NITRIC OXIDE#0.9752;STRUCTURE ACTIVITY RELATIONSHIP#0.9739;ANTIOXIDANT ACTIVITY#0.9738;PHENOBARBITAL#0.9735;CELL CYCLE#0.9728;DNA BINDING#0.9718;CYTOTOXICITY#0.9714;HEPATOCELLULAR CARCINOMA#0.9702;MICROSOME#0.9700;SMOOTH MUSCLE#0.9695;XENOBIOTIC METABOLISM#0.9693;ENDOTHELIAL CELL#0.9692;NEUTROPHIL#0.9688;GENE EXPRESSION#0.9686;PROTEIN KINASE#0.9684;MITOCHONDRIA#0.9664;CELL PROLIFERATION#0.9662;PRO-INFLAMMATORY#0.9660;CARCINOGEN#0.9652;ASTROCYTE#0.9652;MITOCHONDRIAL MEMBRANE#0.9648;STEM CELL#0.9646;ENDOPLASMIC RETICULUM#0.9646;PROTEASOME#0.9633;CELL DEATH#0.9629;CELL GROWTH#0.9618;EPITHELIAL CELL#0.9612;TOXICITY#0.9610;HEPATOTOXICITY#0.9608;SIGNALING PATHWAY#0.9597;APOPTOTIC#0.9590;ISCHEMIA#0.9590;TRANSCRIPTION FACTOR#0.9577;PARKINSON'S DISEASE#0.9575;INFLAMMATORY RESPONSE#0.9574;CATALASE ACTIVITY#0.9574;MECHANISM OF ACTION#0.9570;APOPTOSIS#0.9566;MYELOID LEUKEMIA#0.9564;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9557;GROWTH FACTOR#0.9556;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9554;ASCORBIC ACID#0.9550;ETHANOL#0.9546;NEUROTOXIC#0.9528;CONJUGATION#0.9519;ISCHEMIA REPERFUSION INJURY#0.9517;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9514;DRUG METABOLISM#0.9513;REACTIVE OXYGEN SPECIES#0.9512;FLAVIN ADENINE DINUCLEOTIDE#0.9501;ALANINE#0.9499;BETA-NAPHTHOFLAVONE#0.9499;TOTAL ANTIOXIDANT CAPACITY#0.9496;COLITIS#0.9494;GAMMA-GLUTAMYLCYSTEINE#0.9490;APOPTOTIC CELL DEATH#0.9485;MUTAGENESIS#0.9485;ALKALINE PHOSPHATASE#0.9484;ESTROGEN RECEPTOR#0.9476;B CELL#0.9472;GENOTOXIC#0.9466;DRUG RESISTANCE#0.9461;NEUROPROTECTION#0.9454;NADH DEHYDROGENASE#0.9453;DOXORUBICIN#0.9451;GLUCOSE-6-PHOSPHATE#0.9448;OVARIAN CANCER#0.9447;PEROXISOME#0.9443;ARE BINDING#0.9433;SPINAL CORD#0.9402;OVARIAN#0.9401;HEPATOMA CELLS#0.9395;TOPOISOMERASE#0.9382;MITOGEN ACTIVATED PROTEIN#0.9370;ALPHA-TOCOPHEROL#0.9367;TIGHT JUNCTION#0.9362;IMMUNE RESPONSE#0.9359;QUINONE REDUCTASE 2#0.9352;CEREBRAL ISCHEMIA#0.9339;AUTOPHAGY#0.9330;KERATINOCYTE#0.9323;LUNG CARCINOMA#0.9312;NEPHROTOXICITY#0.9298;OXIDATIVE DNA DAMAGE#0.9297;N-ACETYLCYSTEINE#0.9285;WARFARIN#0.9282;HEAT SHOCK PROTEIN#0.9277;EXCRETION#0.9268;TOPOISOMERASE II#0.9267;NEURODEGENERATIVE DISEASE#0.9260;URIDINE#0.9232;CYTOCHROME B#0.9226;T CELL#0.9224;LIVER DISEASE#0.9222;NEUROBLASTOMA#0.9212;MUTAGENICITY#0.9206;ASPARTATE#0.9206;ACETAMINOPHEN#0.9189;ARTERY#0.9188;HIGH FAT DIET#0.9184;GENOTOXICITY#0.9170;FRAGMENT LENGTH POLYMORPHISM#0.9169;ROS FORMATION#0.9169;SWISS ALBINO MICE#0.9167;AKT SIGNALING#0.9148;CARCINOGENICITY#0.9142;LIVER DAMAGE#0.9136;ACUTE MYELOID LEUKEMIA#0.9114;CELL CYCLE ARREST#0.9101;OXIDOREDUCTASE ACTIVITY#0.9082;TUMOR SUPPRESSOR#0.9079;RESPONSE TO OXIDATIVE STRESS#0.9069;DODECYL SULFATE#0.9052;SODIUM DODECYL SULFATE#0.9052;PEROXIDASE ACTIVITY#0.9042;STRIATUM#0.9026;ADRIAMYCIN#0.8998;MONOCYTE#0.8942;VITAMIN E#0.8939;FAD BINDING#0.8935;TOCOPHEROL#0.8932;GLIAL CELL#0.8917;SIGNALLING PATHWAY#0.8900;LYMPH NODE#0.8871;ALDEHYDE OXIDASE#0.8856;HAEM OXYGENASE 1#0.8837;ACETYLCYSTEINE#0.8837;TRANSFERASE ACTIVITY#0.8828;CYTOCHROME C REDUCTASE ACTIVITY#0.8825;OXIDATION REDUCTION#0.8772;CERVICAL#0.8755;NADPH OXIDATION#0.8751;COLON ADENOCARCINOMA#0.8747;NERVOUS SYSTEM#0.8745;ESOPHAGEAL CANCER#0.8733;ASCORBATE#0.8732;ALZHEIMER'S DISEASE#0.8730;MUSCLE CELL#0.8730;MUTAGENIC#0.8710;NEURONAL CELLS#0.8706;UMBILICAL VEIN#0.8694;B CELL LYMPHOMA#0.8669;LUCIFERASE ACTIVITY#0.8635;CIBACRON BLUE#0.8611;HUMAN UMBILICAL VEIN#0.8600;ARGININE#0.8586;5 FLUOROURACIL#0.8574;FLAVODOXIN#0.8547;BETA-NF#0.8544;DNA METHYLATION#0.8539;EDEMA#0.8531;INFLAMMATORY BOWEL DISEASE#0.8494;ELECTROPHORETIC MOBILITY SHIFT#0.8468;MYELODYSPLASTIC SYNDROME#0.8456;HUMAN BREAST CANCER#0.8455;COLORECTAL ADENOMA#0.8451;BRONCHIAL EPITHELIAL CELLS#0.8423;L-ARGININE#0.8421;LEUKOCYTE#0.8408;DIMETHYL FUMARATE#0.8406;FUMARATE#0.8398;TRANSACTIVATION#0.8395;ACUTE LIVER INJURY#0.8394;ESTRADIOL#0.8383;EOSIN#0.8380;ANTIOXIDANT DEFENSE SYSTEM#0.8379;HUMAN BRONCHIAL EPITHELIAL#0.8359;TISSUE DAMAGE#0.8343;INFLAMMATORY CELL#0.8291;NEPHROPATHY#0.8284;URINARY BLADDER#0.8280;CERVICAL CANCER#0.8277;ELECTRON TRANSPORT CHAIN#0.8242;TOXICANT#0.8238;CARDIOMYOCYTE#0.8233;THIOREDOXIN REDUCTASE 1#0.8232;PROTEIN SYNTHESIS#0.8226;CYCLOPHOSPHAMIDE#0.8222;LIVER CANCER#0.8219;TRANSMISSION ELECTRON MICROSCOPY#0.8208;RESPIRATION#0.8205;DAUNORUBICIN#0.8192;BLOOD BRAIN BARRIER#0.8176;ANGIOGENESIS#0.8159;STREPTOZOTOCIN#0.8153;ANTHRACENE#0.8138;ACUTE LUNG INJURY#0.8129;RESPIRATORY CHAIN#0.8129;SMOOTH MUSCLE CELL#0.8080;ENDOPLASMIC RETICULUM STRESS#0.8078;MACULAR DEGENERATION#0.8072;EXTRACELLULAR MATRIX#0.8071;COLON MUCOSA#0.8070;PANCREATIC CANCER#0.8048;MECHANISMS OF ACTION#0.8044;FLUOROURACIL#0.8034;ALDO KETO REDUCTASE#0.8020;RNA INTERFERENCE#0.8014;CENTRAL NERVOUS SYSTEM#0.8004;CELL MEMBRANE#0.8000;ERYTHROCYTE#0.7997;20S PROTEASOME#0.7994;REGENERATION#0.7994;TRAUMATIC BRAIN INJURY#0.7977;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7956;DNA FRAGMENTATION#0.7955;NADPH:CYTOCHROME C REDUCTASE ACTIVITY#0.7954;TRANSCRIPTASE#0.7950;ADIPOSE TISSUE#0.7926;AGE RELATED MACULAR DEGENERATION#0.7922;ACTINOMYCIN D#0.7918;ARSENITE#0.7914;BETA GALACTOSIDASE#0.7911;L-CYSTEINE#0.7905;ADENOSINE#0.7897;OLFACTORY BULB#0.7894;UBIQUITIN#0.7877;TOLL LIKE RECEPTOR#0.7872;ENZYME INHIBITOR#0.7869;DISEASE FREE SURVIVAL#0.7861;MITOCHONDRIAL DAMAGE#0.7852;DIABETES MELLITUS#0.7852;CELL ADHESION#0.7833;REPORTER GENE ASSAY#0.7823;8-HYDROXY-2'-DEOXYGUANOSINE#0.7814;HYPERGLYCEMIA#0.7782;LUNG ADENOCARCINOMA#0.7782;HISTONE DEACETYLASE#0.7781;LUNG EPITHELIAL CELL#0.7774;CEREBRAL CORTEX#0.7688;SENESCENCE#0.7668;SIGNAL TRANSDUCTION#0.7652;LEUCINE#0.7634;PROTEIN STABILIZATION#0.7631;ADJUSTED ODDS RATIO#0.7627;TESTOSTERONE#0.7580;PROGENITOR CELL#0.7577;SKELETAL MUSCLE#0.7564;SERUM ALBUMIN#0.7559;DEXAMETHASONE#0.7556;DNA METHYLTRANSFERASE#0.7554;PROTEIN DEGRADATION#0.7553;MICROGLIAL CELL#0.7529;NON-SMALL CELL LUNG CARCINOMA#0.7527;MAPK SIGNALING#0.7512;KINASE INHIBITOR#0.7464;BENZENE METABOLISM#0.7443;SUCCINATE#0.7424;MIDDLE CEREBRAL ARTERY#0.7420;CEREBRAL ARTERY#0.7418;THYMIDYLATE SYNTHASE#0.7413;GLUCOSE METABOLISM#0.7394;TIRAPAZAMINE#0.7389;KIDNEY DISEASE#0.7387;RNA SYNTHESIS#0.7379;REACTIVE OXYGEN SPECIES GENERATION#0.7362;LIPOIC ACID#0.7360;ESTROGEN METABOLISM#0.7355;SENSITIZER#0.7322;MESENCHYMAL STEM CELL#0.7313;NADPH BINDING#0.7307;MUTAGEN#0.7301;ULCERATIVE COLITIS#0.7272;NORMAL CONTROL GROUP#0.7224;TYPE 2 DIABETES#0.7221;CEREBRAL ARTERY OCCLUSION#0.7213;N ACETYLTRANSFERASE#0.7194;DIABETIC NEPHROPATHY#0.7194;DNA REPAIR ENZYME#0.7191;POLY ADP RIBOSE#0.7189;VITAMIN K1#0.7172;CORONARY ARTERY#0.7148;NLRP3 INFLAMMASOME ACTIVATION#0.7118;AIRWAY EPITHELIAL CELL#0.7093;MOUSE EMBRYONIC FIBROBLAST#0.7090;GLUCURONIDASE ACTIVITY#0.7082;MAMMARY GLAND#0.7060;G1 PHASE#0.7055;CLOFIBRATE#0.7052;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7043;RADICAL SCAVENGING ACTIVITY#0.7027;GLUTATHIONE S-TRANSFERASE ACTIVITY#0.7024;HYPERTENSION#0.7021;DUROQUINONE#0.6996;VITAMIN C#0.6974;SOLUBLE FRACTION#0.6930;STROMAL CELL#0.6922;PERIPHERAL MONONUCLEAR CELLS#0.6915;XANTHINE DEHYDROGENASE#0.6895;SENSITIZATION#0.6888;MORRIS WATER MAZE#0.6882;GLUTATHIONE PEROXIDASE ACTIVITY#0.6880;FATTY LIVER#0.6857;BLEOMYCIN#0.6844;BRAIN DAMAGE#0.6829;NEUROFILAMENT#0.6826;MYOCARDIUM#0.6813;GASTROINTESTINAL TRACT#0.6798;GLYCOLYSIS#0.6795;THE ANTIOXIDANT CAPACITY#0.6794;ENDOTHELIUM#0.6792;SIGNALING MOLECULE#0.6791;ANILINE#0.6789;DNA SYNTHESIS#0.6786;MULTIPLE SCLEROSIS#0.6786;SINGLE STRAND BREAK#0.6768;DENDRITIC CELL#0.6766;PHOSPHODIESTERASE#0.6736;ACUTE KIDNEY INJURY#0.6704;NOS ACTIVITY#0.6702;ALVEOLAR MACROPHAGE#0.6699;DIMETHYL SULFOXIDE#0.6690;ANAL CANAL CARCINOMA#0.6688;CHRONIC KIDNEY DISEASE#0.6674;HEMATOPOIETIC STEM CELL#0.6673;VITAMIN K3#0.6671;ACETIC ACID#0.6653;ENDOTHELIAL NITRIC OXIDE#0.6639;RIBOSE#0.6616;HEMORRHAGE#0.6613;TRADITIONAL CHINESE MEDICINE#0.6609;THYMIDINE#0.6606;LYMPH NODE METASTASIS#0.6600;BILE DUCT#0.6597;FATTY LIVER DISEASE#0.6594;SUPEROXIDE DISMUTASE ACTIVITY#0.6580;CYTOCHROME C RELEASE#0.6551;TRANSFORMING GROWTH FACTOR#0.6545;DEMETHYLATION#0.6524;THYMIDYLATE#0.6523;AUTOPHAGOSOME#0.6514;VASCULAR SMOOTH MUSCLE CELL#0.6514;CELL MIGRATION#0.6492;ENDOTHELIAL GROWTH FACTOR#0.6483;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6483;ANEMIA#0.6468;CB1954#0.6465;DEXTRAN SULFATE SODIUM#0.6459;MICROTUBULE#0.6453;SALIVARY GLAND#0.6453;TOPICAL#0.6447;SWELLING#0.6444;TIGHT JUNCTION PROTEIN#0.6443;MEMBRANE FRACTION#0.6423;EPOXIDE HYDROLASE ACTIVITY#0.6419;ENDOMETRIAL CANCER#0.6416;HEART DISEASE#0.6412;BREAST CARCINOMA#0.6398;PYRUVATE#0.6392;NADH BINDING#0.6381;MALONALDEHYDE#0.6379;LIPID METABOLISM#0.6376;CYTOKINE PRODUCTION#0.6371;ESTROGENS#0.6369;CELL ACTIVATION#0.6367;ATHEROSCLEROSIS#0.6366;BRAIN EDEMA#0.6341;RETINAL PIGMENT EPITHELIAL#0.6335;OBESE#0.6335;BETA-GLUCURONIDASE ACTIVITY#0.6333;TUBULAR EPITHELIAL CELL#0.6317;DEHYDROGENASE COMPLEX#0.6298;MITOCHONDRIAL DNA#0.6293;LUNG DISEASE#0.6289;WOUND HEALING#0.6266;17β-ESTRADIOL#0.6265;DIGESTION#0.6257;HYDROLASE ACTIVITY#0.6243;NOREPINEPHRINE#0.6214;INDUCTION OF APOPTOSIS#0.6213;CELL ADHESION MOLECULE#0.6202;CELLULAR OXIDATIVE STRESS#0.6188;ONCOGENIC#0.6187;CANCER STEM CELL#0.6185;UREASE ACTIVITY#0.6181;CELL SURFACE#0.6172;QUINONE FORMATION#0.6171;CATECHOL O METHYLTRANSFERASE#0.6152;TUBERCULOSIS#0.6148;O METHYLTRANSFERASE#0.6143;OXYGEN GLUCOSE DEPRIVATION#0.6130;CELLULAR HOMEOSTASIS#0.6128;LYSOSOME#0.6123;NAD SYNTHESIS#0.6104;URINARY SYSTEM CANCER#0.6102;PHYLLOQUINONE#0.6093;TYPE 2 DIABETIC#0.6083;DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE#0.6073;SIGNALING CASCADE#0.6067;RECEPTOR AGONIST#0.6052;BONE MARROW ENDOTHELIAL#0.6043;AMINOPYRINE#0.6038;GUANINE#0.6034;TRYPTOPHAN#0.6032;METHIONINE#0.6021;ANAL CANAL#0.6017
1729	ACTIN POLYMERIZATION#1.0308;MICROTUBULE#1.0296;HEARING LOSS#1.0213;CELL MIGRATION#0.9758;ACTIN FILAMENT#0.9738;SIGNAL TRANSDUCTION#0.9159;ACTIN CYTOSKELETON#0.8694;PLASMA MEMBRANE#0.8619;ADHERENS JUNCTION#0.8605;CANCER CELL#0.8593;ADVANCED GLYCATION END#0.8435;SENSORINEURAL HEARING LOSS#0.7859;HEARING IMPAIRMENT#0.7686;CELL CELL JUNCTION#0.7665;T CELL#0.7614;CELL JUNCTION#0.7613;SIGNALING PATHWAY#0.7078;MICROTUBULE CYTOSKELETON#0.7016;CELL DIVISION#0.6916;CYTOKINESIS#0.6848;ACTIN NUCLEATION#0.6755;GENE EXPRESSION#0.6342;CELL SURFACE#0.6254;EPITHELIAL CELL#0.6248;ADVANCED GLYCATION ENDPRODUCT#0.6230;MICROTUBULE DYNAMICS#0.6151;PERINUCLEAR ER#0.6121;STRESS FIBER#0.6033
172	MITOCHONDRIAL INNER MEMBRANE#0.7517;MITOCHONDRIA#0.7262
1730	ACTIN FILAMENT#0.9021;OVARIAN#0.8880;MICROTUBULE#0.8643;GENE EXPRESSION#0.8346;ACTIN POLYMERIZATION#0.7989;ACTIN CYTOSKELETON#0.7641;X CHROMOSOME#0.7593;PREMATURE OVARIAN FAILURE#0.7289;CANCER CELL#0.6630;CELL JUNCTION#0.6275;CELL CELL JUNCTION#0.6214;CYTOKINESIS#0.6122
1731	INTENTION TO TREAT#0.9415;CYTOKINESIS#0.9041;RANDOMISED CONTROLLED TRIAL#0.8420;CELL DIVISION#0.7192;TRANSCRIPTION FACTOR#0.6529;SERIOUS ADVERSE EVENT#0.6499;CLEAVAGE FURROW#0.6185
1733	THYROXINE 5-DEIODINASE ACTIVITY#1.1155;HARDERIAN GLAND#1.0791;THYROID HORMONE RECEPTOR#1.0346;BROWN ADIPOSE TISSUE#1.0274;GLUTATHIONE PEROXIDASE#1.0252;ADIPOSE TISSUE#1.0201;GLUTATHIONE#1.0166;3,5,3'-TRIIODOTHYRONINE#1.0162;THYROID HORMONE METABOLISM#0.9973;HORMONE METABOLISM#0.9916;PROPYLTHIOURACIL#0.9912;GENE EXPRESSION#0.9904;TRIIODOTHYRONINE#0.9851;PINEAL GLAND#0.9791;ENZYME ACTIVITY#0.9762;THYROID GLAND#0.9746;SELENOCYSTEINE#0.9402;N ACETYLTRANSFERASE#0.9364;HYPOTHYROIDISM#0.9197;OBESE#0.9110;ADRENERGIC RECEPTOR#0.9008;MICROSOME#0.8865;HORMONE SYNTHESIS#0.8695;QUANTITATIVE REAL TIME#0.8679;ISOPROTERENOL#0.8530;MAMMARY GLAND#0.8283;RETINOIC ACID#0.8140;THYROID CARCINOMA#0.8007;NOREPINEPHRINE#0.7957;L-THYROXINE#0.7922;EUTHYROID SICK SYNDROME#0.7915;PROTEIN SYNTHESIS#0.7824;RENAL CANCER CELLS#0.7791;BETA ADRENERGIC RECEPTOR#0.7782;ENDOCRINE SYSTEM#0.7503;GROWTH HORMONE#0.7497;IODINE DEFICIENCY#0.7447;CANCER CELL#0.7360;HYPERTHYROIDISM#0.7318;SKELETAL MUSCLE#0.7264;OOCYTE#0.7240;SULFATION#0.7154;TOXICITY#0.7086;POLYMERASE CHAIN REACTION#0.6742;FERTILIZATION#0.6731;TUMOR NECROSIS FACTOR#0.6705;NAT ACTIVITY#0.6513;PROTEIN KINASE#0.6450;TRANSCRIPTION FACTOR#0.6447;GROWTH FACTOR#0.6435;LACTATION#0.6397;MELATONIN#0.6386;CERVICAL#0.6338;METHIMAZOLE#0.6279;CORTICOTROPHIN RELEASING HORMONE#0.6034;PITUITARY GLAND#0.6023;CEREBRAL CORTEX#0.6008
1734	EPENDYMAL CELL#1.0323;THYROID HORMONE RECEPTOR#1.0234;SKELETAL MUSCLE#1.0091;MELATONIN#1.0091;ADIPOCYTE#1.0044;THYROID HORMONE METABOLISM#1.0040;3,5,3'-TRIIODOTHYRONINE#1.0030;BROWN ADIPOSE TISSUE#1.0001;HORMONE METABOLISM#0.9981;ADIPOSE TISSUE#0.9933;THYROID GLAND#0.9923;POLYMERASE CHAIN REACTION#0.9913;TRANSCRIPTION FACTOR#0.9864;HYPOTHYROIDISM#0.9847;PARS TUBERALIS#0.9819;WHITE ADIPOSE TISSUE#0.9817;TRIIODOTHYRONINE#0.9813;ASTROCYTE#0.9767;GENE EXPRESSION#0.9758;TYPE 2 DIABETES#0.9670;GLUTATHIONE PEROXIDASE#0.9554;ADRENERGIC RECEPTOR#0.9512;OSTEOARTHRITIS#0.9506;PITUITARY GLAND#0.9445;NERVOUS SYSTEM#0.9424;ENZYME ACTIVITY#0.9412;HIGH FAT DIET#0.9321;HYPERTHYROIDISM#0.9282;GLUTATHIONE#0.9191;PEROXISOME#0.9132;N ACETYLTRANSFERASE#0.9079;OBESE#0.9076;SELENOCYSTEINE#0.9048;GLIAL CELL#0.9042;PROTEIN KINASE#0.9020;GROWTH FACTOR#0.9001;METAMORPHOSIS#0.8887;CEREBRAL CORTEX#0.8834;SIGNALING PATHWAY#0.8788;PINEAL GLAND#0.8703;CENTRAL NERVOUS SYSTEM#0.8700;TOXICITY#0.8690;FERTILIZATION#0.8625;ENDOCRINE SYSTEM#0.8567;SIGNAL TRANSDUCTION#0.8491;GRAVES' DISEASE#0.8461;THYROTROPIN RELEASING HORMONE#0.8425;DIABETES MELLITUS#0.8408;QUANTITATIVE REAL TIME#0.8377;GONAD#0.8355;BRAIN DEVELOPMENT#0.8346;DIET INDUCED OBESITY#0.8236;REVERSE TRANSCRIPTION#0.8222;CAMP RESPONSE ELEMENT#0.8015;PROPYLTHIOURACIL#0.8011;GROWTH HORMONE#0.7754;LIPOGENESIS#0.7748;GLUCOSE METABOLISM#0.7575;WEIGHT GAIN#0.7573;ENDOPLASMIC RETICULUM#0.7547;TYPE 2 DIABETES MELLITUS#0.7546;2 DIABETES MELLITUS#0.7546;HARDERIAN GLAND#0.7443;CORTICOTROPIN#0.7381;LEVOTHYROXINE#0.7380;IODINE DEFICIENCY#0.7279;ADAPTIVE THERMOGENESIS#0.7261;CYCLIC AMP#0.7252;SIGNALLING PATHWAY#0.7206;THYROID CANCER#0.7079;ENERGY HOMEOSTASIS#0.7050;CHONDROCYTE#0.7027;NOREPINEPHRINE#0.6988;ADENOSINE#0.6924;CORTICOTROPHIN RELEASING HORMONE#0.6849;H POST FERTILIZATION#0.6817;TETRAIODOTHYRONINE#0.6806;CELL PROLIFERATION#0.6799;SUBCUTANEOUS ADIPOSE TISSUE#0.6783;WEIGHT LOSS#0.6748;HORMONE SYNTHESIS#0.6747;LIPID METABOLISM#0.6745;HATCHING#0.6740;INFLAMMATORY RESPONSE#0.6720;APOPTOSIS#0.6676;GESTATION#0.6675;THYROID CARCINOMA#0.6610;DIURNAL#0.6599;UBIQUITIN#0.6494;RETINOIC ACID#0.6467;LIPOLYSIS#0.6458;PROTEIN SYNTHESIS#0.6444;MAMMARY GLAND#0.6278;ISOPROTERENOL#0.6250;GONADOTROPIN RELEASING HORMONE#0.6198;PROTEIN KINASE A#0.6184;LACTATION#0.6129;CORTICOTROPIN-RELEASING FACTOR#0.6067;METHIMAZOLE#0.6054;ANDROGEN RECEPTOR#0.6025;PROGESTERONE#0.6009
1735	THYROXINE 5-DEIODINASE ACTIVITY#1.1143;HARDERIAN GLAND#1.0774;THYROID HORMONE RECEPTOR#1.0293;BROWN ADIPOSE TISSUE#1.0263;DNA METHYLATION#1.0163;ADIPOSE TISSUE#1.0159;STEM CELL#1.0091;PINEAL GLAND#0.9934;MELATONIN#0.9923;TRIIODOTHYRONINE#0.9893;GENE EXPRESSION#0.9805;THYROID HORMONE METABOLISM#0.9768;DIFFERENTIALLY METHYLATED REGION#0.9710;HORMONE METABOLISM#0.9706;N ACETYLTRANSFERASE#0.9580;SKELETAL MUSCLE#0.9406;PROTEIN CODING GENE#0.9360;CELL PROLIFERATION#0.9352;EMBRYONIC STEM CELL#0.9257;ENZYME ACTIVITY#0.9200;PLURIPOTENT STEM CELL#0.9125;3,5,3'-TRIIODOTHYRONINE#0.9033;THYROID GLAND#0.8988;INDUCED PLURIPOTENT STEM CELL#0.8984;METAMORPHOSIS#0.8844;TRANSCRIPTION FACTOR#0.8835;HYPOTHYROIDISM#0.8797;ADRENERGIC RECEPTOR#0.8692;NERVOUS SYSTEM#0.8613;ISOPROTERENOL#0.8605;GLUTATHIONE PEROXIDASE#0.8462;POLYMERASE CHAIN REACTION#0.8363;GROWTH FACTOR#0.8347;OBESE#0.8252;CELL CYCLE#0.8232;PROTEIN KINASE#0.8184;PARS TUBERALIS#0.8054;B CELL#0.7993;SELENOCYSTEINE#0.7919;PITUITARY GLAND#0.7916;PROPYLTHIOURACIL#0.7800;BETA ADRENERGIC RECEPTOR#0.7768;NOREPINEPHRINE#0.7587;SIGNALING PATHWAY#0.7584;LUNG CANCER#0.7539;CENTRAL NERVOUS SYSTEM#0.7401;IMPRINTING CONTROL REGION#0.7391;GLUTATHIONE#0.7339;BRAIN DEVELOPMENT#0.7314;CARDIOMYOCYTE#0.7311;PATERNALLY EXPRESSED GENE#0.7215;DIURNAL#0.7068;OOCYTE#0.6895;GESTATION#0.6872;PROSTATE CANCER#0.6864;ENDOTHELIAL CELL#0.6760;DNA METHYLTRANSFERASE#0.6522;ADIPOCYTE#0.6504;NAT ACTIVITY#0.6501;CERVICAL#0.6322;EPENDYMAL CELL#0.6317;RETINOIC ACID#0.6308;CEREBRAL CORTEX#0.6295;MAMMARY GLAND#0.6271;ALLELE SPECIFIC EXPRESSION#0.6161;CELL DIFFERENTIATION#0.6148;CARDIOMYOCYTE PROLIFERATION#0.6142;COLD ACCLIMATION#0.6056
1736	PSEUDOURIDINE SYNTHASE#1.0675;TELOMERASE RNA#1.0509;RIBOSOMAL RNA#1.0434;SMALL NUCLEOLAR RNA#1.0406;PSEUDOURIDYLATION#1.0393;SNORNP#1.0310;TELOMERASE REVERSE TRANSCRIPTASE#1.0302;DYSKERATOSIS CONGENITA#1.0294;TRANSCRIPTASE#1.0277;TELOMERASE ACTIVITY#1.0251;RIBOSOME#1.0213;SMALL NUCLEOLAR RIBONUCLEOPROTEIN#1.0206;TELOMERE MAINTENANCE#1.0187;RIBOSOME BIOGENESIS#1.0186;RRNA PROCESSING#1.0176;TELOMERE#1.0110;BONE MARROW FAILURE#0.9964;STEM CELL#0.9956;URIDINE#0.9956;BONE MARROW#0.9868;APLASTIC ANEMIA#0.9653;CELL CYCLE#0.9607;RNA BINDING#0.9586;ANEMIA#0.9456;CELL PROLIFERATION#0.9449;RIBONUCLEOPROTEIN COMPLEX#0.9347;SENESCENCE#0.9283;RNA PROCESSING#0.9255;CANCER CELL#0.9035;PULMONARY FIBROSIS#0.9002;CENTROMERE BINDING#0.8965;X CHROMOSOME#0.8741;NUCLEOLUS#0.8631;GENE EXPRESSION#0.8626;PERIPHERAL BLOOD#0.8534;RNA MODIFICATION#0.8506;HEMATOPOIETIC STEM CELL#0.8506;SMALL NUCLEAR RNA#0.8444;CENTROMERE#0.8412;DNA DAMAGE RESPONSE#0.8158;APOPTOSIS#0.8136;SHELTERIN COMPLEX#0.8097;NUCLEAR LOCALIZATION SIGNAL#0.8097;LUNG CANCER#0.7972;PROSTATE CANCER#0.7851;POLYMERASE CHAIN REACTION#0.7771;RNA BINDING PROTEIN#0.7763;CATALYTIC ACTIVITY#0.7756;TUMOR SUPPRESSOR#0.7659;CAJAL BODY#0.7555;COLORECTAL CANCER#0.7456;HEPATOCELLULAR CARCINOMA#0.7438;MYELODYSPLASTIC SYNDROME#0.7337;REVESZ SYNDROME#0.7245;GENETIC DISEASE#0.7053;BREAST CANCER#0.6860;RNA INTERFERENCE#0.6760;RRNA MODIFICATION#0.6729;BREAST CARCINOMA#0.6728;CELL GROWTH#0.6720;IDIOPATHIC PULMONARY FIBROSIS#0.6705;TELOMERE COMPLEX#0.6604;COLORECTAL#0.6572;RIBOSOMAL PROTEIN#0.6545;B CELL#0.6480;COMPLEX I#0.6274;ANAEMIA#0.6083;PANCYTOPENIA#0.6077;STEM CELL TRANSPLANTATION#0.6071
1737	LIPOIC ACID#1.0477;PRIMARY SCLEROSING CHOLANGITIS#1.0465;SCLEROSING CHOLANGITIS#1.0457;HEPATITIS B#1.0437;CHOLANGITIS#1.0358;B CELL#1.0338;AUTOIMMUNE HEPATITIS#1.0332;PYRUVATE DEHYDROGENASE COMPLEX#1.0281;URSODEOXYCHOLIC ACID#1.0257;DEHYDROGENASE COMPLEX#1.0254;PYRUVATE#1.0211;CHRONIC LIVER DISEASE#1.0193;LIVER CIRRHOSIS#1.0119;CHOLESTASIS#1.0096;BILE DUCT#1.0070;LIVER DISEASE#1.0065;T CELL#1.0064;EPITHELIAL CELL#1.0049;PERIPHERAL BLOOD#1.0039;ALKALINE PHOSPHATASE#1.0032;CD4+ T CELL#0.9977;IMMUNE RESPONSE#0.9968;PRIMARY BILIARY CIRRHOSIS#0.9948;AUTOIMMUNE DISEASE#0.9921;HEPATOCELLULAR CARCINOMA#0.9883;MITOCHONDRIA#0.9823;BEZAFIBRATE#0.9783;APOPTOSIS#0.9776;OSTEOPOROSIS#0.9655;AUTOIMMUNITY#0.9636;FARNESOID X RECEPTOR#0.9618;HEPATITIS C#0.9486;SENESCENCE#0.9397;IMMUNE SYSTEM#0.9389;GENE EXPRESSION#0.9263;OF LIVER TRANSPLANTATION#0.9208;APOPTOTIC#0.9170;LYSINE#0.9058;ASPARTATE#0.8950;ALANINE#0.8919;BILIARY ATRESIA#0.8893;CHRONIC HEPATITIS B#0.8870;CD8+ T CELL#0.8830;OXOGLUTARATE DEHYDROGENASE COMPLEX#0.8802;B LYMPHOCYTE#0.8784;2-OXOGLUTARATE DEHYDROGENASE COMPLEX#0.8736;MONONUCLEAR CELLS#0.8702;CELLULAR SENESCENCE#0.8583;GROWTH FACTOR#0.8467;HEPATITIS B VIRUS#0.8344;INTRAHEPATIC CHOLESTASIS#0.8266;SERUM ALBUMIN#0.8244;T LYMPHOCYTE#0.8239;RISK OF DEATH#0.8168;MACROPHAGE#0.8157;HUMAN LEUKOCYTE ANTIGEN#0.8148;PRO-INFLAMMATORY#0.8108;SIGNALING PATHWAY#0.8077;AUTOPHAGY#0.8076;E2 COMPLEX#0.8013;FENOFIBRATE#0.8012;LEUKOCYTE#0.7975;CELL ACTIVATION#0.7925;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7821;CELL SURFACE#0.7799;SJOGREN'S SYNDROME#0.7724;PLASMABLAST#0.7709;DUCT CELL#0.7673;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7615;LUPUS ERYTHEMATOSUS#0.7613;MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX#0.7607;STRUCTURE ACTIVITY RELATIONSHIP#0.7563;TRANSCRIPTION FACTOR#0.7553;LIVER DAMAGE#0.7435;IMMUNE CELL#0.7427;SIGNALLING PATHWAY#0.7414;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7407;VIRAL HEPATITIS#0.7316;MONOCYTE#0.7302;AGE AT DIAGNOSIS#0.7233;LYMPH NODE#0.7218;FATTY LIVER#0.7198;INFLAMMATORY BOWEL DISEASE#0.7192;LUMINAL#0.7183;STEM CELL#0.7134;FATTY LIVER DISEASE#0.6976;HYPERTENSION#0.6953;CYTOTOXIC T CELL#0.6895;BONE MINERAL DENSITY#0.6869;CHRONIC HEPATITIS C#0.6779;DENDRITIC CELL#0.6727;MAGNETIC RESONANCE IMAGING#0.6701;RED BLOOD CELL#0.6698;HEPATIC STELLATE CELL#0.6631;HEPATITIS C VIRUS#0.6592;STANDARD OF CARE#0.6505;T CELL ACTIVATION#0.6474;APOPTOTIC BLEB#0.6432;ANION EXCHANGER 2#0.6425;TUMOR NECROSIS FACTOR#0.6412;DENOSUMAB#0.6369;KUPFFER CELL#0.6330;BILE DUCT LIGATION#0.6264;INFLAMMATORY RESPONSE#0.6255;RANDOMIZED CONTROLLED TRIAL#0.6231;YEAR SURVIVAL RATE#0.6211;SALIVARY GLAND#0.6196;OR LIVER TRANSPLANTATION#0.6103;POLYMERASE CHAIN REACTION#0.6092;TH17 CELL#0.6047;PORTAL HYPERTENSION#0.6027
1738	DIAPHORASE ACTIVITY#1.0768;NICOTINAMIDE ADENINE DINUCLEOTIDE#1.0521;GLYCINE CLEAVAGE SYSTEM#1.0471;LIPOATE#1.0458;ALPHA KETOACID DEHYDROGENASE#1.0445;DISULFIDE OXIDOREDUCTASE#1.0428;MALATE DEHYDROGENASE#1.0402;ALPHA-KETOGLUTARATE DEHYDROGENASE COMPLEX#1.0288;SKELETAL MUSCLE#1.0267;NICOTINAMIDE#1.0256;ADENINE#1.0216;CORONARY ARTERY#1.0175;GLUTATHIONE#1.0122;NADH DEHYDROGENASE#1.0121;ADENINE DINUCLEOTIDE PHOSPHATE#1.0099;CYTOCHROME C#1.0089;SUCCINATE DEHYDROGENASE#1.0088;GLYCINE#1.0081;ARTERY#1.0054;NITRIC OXIDE#1.0052;LIPOIC ACID#1.0052;DELTA OPIOID RECEPTOR#1.0030;PYRUVATE#1.0029;OPIOID RECEPTOR#1.0019;PYRUVATE DEHYDROGENASE COMPLEX#1.0016;DEHYDROGENASE COMPLEX#0.9993;FLAVIN#0.9975;COMPLEX I#0.9955;TRYPANOTHIONE#0.9934;ELECTRON TRANSFER#0.9916;ENZYME COMPLEX#0.9909;SUCCINATE#0.9904;MITOCHONDRIA#0.9870;GLYCINE DECARBOXYLASE COMPLEX#0.9868;REACTIVE OXYGEN SPECIES#0.9838;ISCHEMIA#0.9834;ENZYME ACTIVITY#0.9776;OXOGLUTARATE DEHYDROGENASE COMPLEX#0.9710;NITRIC OXIDE SYNTHASE#0.9698;TUBERCULOSIS#0.9689;MUTAGENESIS#0.9673;OXIDATION REDUCTION#0.9537;RECEPTOR BINDING#0.9531;2-OXOGLUTARATE DEHYDROGENASE COMPLEX#0.9529;OPIOID PEPTIDE#0.9449;ERYTHROCYTE#0.9406;LACTIC ACIDOSIS#0.9384;FLAVIN ADENINE DINUCLEOTIDE#0.9344;CATALYTIC ACTIVITY#0.9305;SUPEROXIDE DISMUTASE#0.9233;PYRUVATE KINASE#0.9166;ELECTRON TRANSPORT#0.9151;MITOCHONDRIAL MATRIX#0.9107;ARGININE#0.9079;COENZYME A#0.9055;ALANINE#0.9031;FRIEDREICH ATAXIA#0.8987;LYSINE#0.8960;HISTIDINE#0.8941;FAD BINDING#0.8831;GENE EXPRESSION#0.8816;GLUCOSE-6-PHOSPHATE#0.8797;DIHYDROLIPOIC ACID#0.8792;GLUTAMATE DEHYDROGENASE#0.8782;PYRUVATE METABOLISM#0.8715;XANTHINE OXIDASE#0.8580;PYRUVATE DEHYDROGENASE COMPLEX ACTIVITY#0.8529;ATP SYNTHASE#0.8488;ACROSOME REACTION#0.8462;METHIONINE#0.8434;SPERMATOZOA#0.8419;SPINAL CORD#0.8366;MITOCHONDRIAL MEMBRANE#0.8351;TRYPTOPHAN#0.8342;NAD BINDING#0.8308;TOXICITY#0.8300;SKIN FIBROBLASTS#0.8287;FERREDOXIN#0.8285;PLASMA MEMBRANE#0.8282;SPERM CAPACITATION#0.8271;CYTOCHROME C OXIDASE#0.8268;MYOCARDIAL INFARCTION#0.8229;VASOPRESSIN#0.8191;VALINE#0.8168;GLYCERALDEHYDE-3-PHOSPHATE#0.8137;HEAT SHOCK PROTEIN#0.8057;ALZHEIMER'S DISEASE#0.8050;PYRUVATE OXIDATION#0.8045;PRIMARY BILIARY CIRRHOSIS#0.8020;DODECYL SULFATE#0.8011;TCA CYCLE#0.8005;MAPLE SYRUP URINE DISEASE#0.7974;VIRULENCE#0.7889;SODIUM DODECYL SULFATE#0.7842;THIAMINE#0.7828;REGENERATION#0.7824;N-ETHYLMALEIMIDE#0.7820;ALPHA LIPOIC ACID#0.7812;GLYCOLYSIS#0.7770;CREATINE KINASE#0.7759;LEUCINE#0.7738;MYOCARDIUM#0.7690;ELECTRON TRANSPORT CHAIN#0.7651;NADPH DIAPHORASE ACTIVITY#0.7637;ACROSOME#0.7592;TRANSCRIPTION FACTOR#0.7580;NAD TRANSHYDROGENASE#0.7571;CANCER CELL#0.7540;ARSENITE#0.7516;IMMUNE RESPONSE#0.7466;ROS GENERATION#0.7401;XANTHINE#0.7341;OXIDATIVE PHOSPHORYLATION#0.7257;LEYDIG CELL#0.7239;NITROFURAN#0.7217;OUTER MEMBRANE#0.7177;POLYMERASE CHAIN REACTION#0.7171;MU OPIOID RECEPTOR#0.7161;PYRUVATE CARBOXYLASE#0.7122;KREBS CYCLE#0.7103;PROTEIN KINASE#0.7100;DIHYDROLIPOYL DEHYDROGENASE#0.7096;NADH OXIDATION#0.7035;PHENOTHIAZINE#0.7013;ADENOSINE#0.7004;ARGININE VASOPRESSIN#0.7001;CELL DEATH#0.6937;CREATINE#0.6925;RESPIRATION#0.6924;CATABOLISM#0.6919;GUANIDINE HYDROCHLORIDE#0.6868;ETHANOL#0.6858;CHAGAS DISEASE#0.6805;NADPH OXIDASE#0.6681;N-ACETYLCYSTEINE#0.6466;MEMBRANE FRACTION#0.6460;DNA BINDING#0.6459;MICROSOME#0.6435;PROTEIN SYNTHESIS#0.6426;OTHER ORGANISM#0.6336;SPERM MOTILITY#0.6306;DIGESTION#0.6302;L-CYSTEINE#0.6296;LIVER DISEASE#0.6244;FOREBRAIN#0.6176;RIBOSOME#0.6162;TRICARBOXYLIC ACID CYCLE#0.6069;MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX#0.6053
1739	SYNAPSE ASSOCIATED PROTEIN#1.0624;MAGUK#1.0508;TUMOR SUPPRESSOR#1.0313;T CELL#1.0275;PROTEIN KINASE#1.0274;PDZ BINDING MOTIF#1.0263;AMPA RECEPTOR#1.0233;CELL POLARITY#1.0217;GUANYLATE KINASE#1.0203;NMDA RECEPTOR#1.0199;MEMBRANE-ASSOCIATED GUANYLATE KINASE#1.0178;POSTSYNAPTIC DENSITY#1.0173;ADHERENS JUNCTION#1.0166;GLUTAMATE RECEPTOR#1.0124;SCHWANN CELL#1.0114;PLASMA MEMBRANE#1.0110;ION CHANNEL#1.0083;EPITHELIAL CELL#1.0077;CAMKII#1.0074;ANCHORING#1.0061;PDZ DOMAIN BINDING#0.9956;CELL SURFACE#0.9924;CELL JUNCTION#0.9869;POTASSIUM CHANNEL#0.9864;CELL CYCLE#0.9616;MYOCYTES#0.9592;ASPARTATE#0.9564;SIGNALING PATHWAY#0.9545;LOCALISATION#0.9538;SPINDLE ORIENTATION#0.9516;EXCITATORY SYNAPSE#0.9387;CELL ADHESION#0.9339;PROTEIN PROTEIN INTERACTION#0.9321;ONCOGENIC#0.9226;CERVICAL#0.9226;MICROTUBULE#0.9186;GROWTH FACTOR#0.9171;APICAL JUNCTION#0.9156;IMMUNOLOGICAL SYNAPSE#0.9134;GENE EXPRESSION#0.9126;PROTEIN KINASE A#0.9043;ENDOPLASMIC RETICULUM#0.8978;IONOTROPIC GLUTAMATE RECEPTOR#0.8879;ENDOCYTOSIS#0.8801;CELL DIVISION#0.8793;NERVOUS SYSTEM#0.8737;ADRENERGIC RECEPTOR#0.8664;UBIQUITIN#0.8651;CYTOPLASM#0.8648;POSTSYNAPTIC MEMBRANE#0.8624;TIGHT JUNCTION#0.8584;SIGNALING MOLECULE#0.8547;SYNAPTIC JUNCTION#0.8486;APOPTOSIS#0.8454;SYNAPTIC TRANSMISSION#0.8447;MORPHOGENESIS#0.8376;CELL PROLIFERATION#0.8365;CARDIOMYOCYTE#0.8352;B CELL#0.8352;PROTEIN KINASE C#0.8340;PROTEASOME#0.8317;CYTOKINE PRODUCTION#0.8036;MITOTIC SPINDLE#0.7981;POST SYNAPTIC DENSITY#0.7936;ADENOMATOUS POLYPOSIS COLI#0.7815;TRANSCRIPTION FACTOR#0.7790;HYDRONEPHROSIS#0.7744;CELL MIGRATION#0.7691;CELL DIFFERENTIATION#0.7651;NEUROMUSCULAR JUNCTION#0.7633;CELL CELL JUNCTION#0.7546;PURKINJE CELL#0.7526;PEPTIDE BINDING#0.7476;MYELINATION#0.7381;ZONULA OCCLUDENS#0.7339;LONG TERM POTENTIATION#0.7322;KINESIN#0.7292;COMPLEX I#0.7282;CELL MEMBRANE#0.7269;ACTIN CYTOSKELETON#0.7235;PROTEIN COMPLEX#0.7235;CANCER CELL#0.7230;URETER MATURATION#0.7089;CERVICAL CANCER#0.7061;KERATINOCYTE#0.7037;CORTICAL CYTOSKELETON#0.7019;MIDBODY#0.6975;CELL GROWTH#0.6949;SYNAPTIC MEMBRANE#0.6910;PLANAR CELL POLARITY#0.6904;URETER#0.6901;CYTOKINESIS#0.6844;T-CELL LEUKEMIA#0.6832;CELL ACTIVATION#0.6795;SURFACE PLASMON RESONANCE#0.6779;T CELL DEVELOPMENT#0.6776;CELL DEVELOPMENT#0.6758;RECEPTOR ANTAGONIST#0.6701;S PHASE#0.6685;ENDOTHELIAL CELL#0.6684;CD8+ T CELL#0.6670;ALZHEIMER'S DISEASE#0.6592;DENDRITIC SPINE#0.6559;MEMBRANE FRACTION#0.6529;PROTEIN BINDING#0.6512;RNA INTERFERENCE#0.6493;SYNAPSE ASSEMBLY#0.6463;CENTROSOME#0.6297;MENTAL RETARDATION#0.6231;MITOGEN ACTIVATED PROTEIN#0.6180;NITRIC OXIDE#0.6165;RECEPTOR INTERACTING PROTEIN#0.6147;GLUTAMATERGIC SYNAPSE#0.6096;URETERIC BUD#0.6095;INTERCALATED DISC#0.6077;KIDNEY DEVELOPMENT#0.6042;CENTRAL NERVOUS SYSTEM#0.6016
173	VITAMIN E#1.0666;VITAMIN D BINDING#1.0577;OVARIAN CANCER#1.0128;SERUM ALBUMIN#0.9817;HUMAN SERUM ALBUMIN#0.9768;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9765;OVARIAN#0.9515;PLASMA PROTEIN#0.9202;GESTATIONAL DIABETES#0.9179;DIABETES MELLITUS#0.9070;FIBRINOGEN#0.8900;GESTATIONAL DIABETES MELLITUS#0.8849;PLASMA GLYCOPROTEIN#0.8745;PAPILLARY THYROID CARCINOMA#0.8087;THYROID CARCINOMA#0.8023;GLUCOSE METABOLISM#0.7909;PRE-ECLAMPSIA#0.7629;TOCOPHEROL#0.7445;GROWTH FACTOR#0.7204;HORMONE BINDING#0.6798;FIRST TRIMESTER SCREENING#0.6137;MULTIPLE REACTION MONITORING#0.6125;BETA-2#0.6090;BREAST CANCER#0.6026
1740	MAGUK#1.0705;POSTSYNAPTIC DENSITY#1.0258;MEMBRANE-ASSOCIATED GUANYLATE KINASE#1.0232;NMDA RECEPTOR#1.0227;GUANYLATE KINASE#1.0210;GLUTAMATE RECEPTOR#1.0050;AMPA RECEPTOR#1.0004;EXCITATORY SYNAPSE#0.9945;SYNAPSE ASSOCIATED PROTEIN#0.9781;ASPARTATE#0.9649;SYNAPTIC TRANSMISSION#0.9585;LONG TERM POTENTIATION#0.9029;NITRIC OXIDE#0.8503;DENDRITIC SPINE#0.8481;PROTEIN KINASE#0.8471;NITRIC OXIDE SYNTHASE#0.8250;ION CHANNEL#0.8145;ISCHEMIA#0.7310;NEUROTOXICITY#0.7206;SIGNALING PATHWAY#0.7088;POST SYNAPTIC DENSITY#0.7048;PROTEIN PROTEIN INTERACTION#0.6998;CELL SURFACE#0.6966;NERVOUS SYSTEM#0.6953;NEUROPROTECTION#0.6923;GLUTAMATERGIC SYNAPSE#0.6825;IONOTROPIC GLUTAMATE RECEPTOR#0.6400;CENTRAL NERVOUS SYSTEM#0.6379;POSTSYNAPTIC MEMBRANE#0.6231;SYNAPTIC SIGNALING#0.6178;ALZHEIMER'S DISEASE#0.6104;CEREBRAL ISCHEMIA#0.6048;SYNAPSE MATURATION#0.6021
1741	SYNAPSE ASSOCIATED PROTEIN#1.0757;MAGUK#1.0644;MEMBRANE-ASSOCIATED GUANYLATE KINASE#1.0340;GUANYLATE KINASE#1.0326;POSTSYNAPTIC DENSITY#1.0278;EXCITATORY SYNAPSE#1.0213;NMDA RECEPTOR#1.0212;GLUTAMATE RECEPTOR#1.0121;AMPA RECEPTOR#0.9779;ASPARTATE#0.9739;MENTAL RETARDATION#0.9736;TUMOR SUPPRESSOR#0.9535;SYNAPTIC TRANSMISSION#0.9150;BIPOLAR DISORDER#0.8636;SYNAPTOGENESIS#0.8427;SIGNALING PATHWAY#0.8358;DENDRITIC SPINE#0.8180;POSTSYNAPTIC MEMBRANE#0.8138;INTELLECTUAL DISABILITY#0.7957;CELL SURFACE#0.7911;SYNAPSE DEVELOPMENT#0.7900;NEURONAL CELLS#0.7405;PROTEIN PROTEIN INTERACTION#0.7382;PLASMA MEMBRANE#0.7216;CANCER CELL#0.6793;RECEPTOR COMPLEX#0.6699;ANCHORING#0.6574;MRX COMPLEX#0.6541;CELL ADHESION#0.6383;GLUTAMATERGIC SYNAPSE#0.6359;PROTEIN KINASE#0.6248;EPITHELIAL CELL#0.6213;IONOTROPIC GLUTAMATE RECEPTOR#0.6169;GENE EXPRESSION#0.6018
1742	ZONULA OCCLUDENS 1#1.0481;ZONULA OCCLUDENS#1.0454;POST SYNAPTIC DENSITY#1.0439;SYNAPSE ASSOCIATED PROTEIN#1.0437;MAGUK#1.0410;LIPID RAFT#1.0376;NEUROLIGIN#1.0356;POTASSIUM CHANNEL#1.0305;SYNAPSE MATURATION#1.0247;TUMOR SUPPRESSOR#1.0245;GUANYLATE KINASE#1.0220;PDZ BINDING MOTIF#1.0204;CAMKII#1.0172;MEMBRANE-ASSOCIATED GUANYLATE KINASE#1.0171;D-ASPARTIC ACID#1.0161;POSTSYNAPTIC DENSITY#1.0157;KETAMINE#1.0143;SYNAPTIC MATURATION#1.0129;CAMP RESPONSE ELEMENT BINDING#1.0116;BRAIN ISCHEMIA#1.0114;CAMP RESPONSE ELEMENT#1.0106;POLYMERASE CHAIN REACTION#1.0102;ANCHORING#1.0087;ASPARTIC ACID#1.0081;DENDRITIC SHAFT#1.0080;MICROTUBULE ASSOCIATED PROTEIN#1.0060;INHIBITORY SYNAPSE#1.0056;NITRIC OXIDE SYNTHASE#1.0055;SYNAPTOSOME#1.0035;SPINAL CORD#1.0035;CEREBRAL ISCHEMIA#1.0013;PROTEIN COMPLEX#1.0013;AMYGDALA#1.0011;RECEPTOR INTERACTING PROTEIN#1.0007;AMPA RECEPTOR#1.0001;NITRIC OXIDE#0.9995;ENDOCYTOSIS#0.9995;NMDA RECEPTOR#0.9994;SYNAPTIC JUNCTION#0.9988;GLUTAMATERGIC SYNAPSE#0.9987;POSTSYNAPTIC MEMBRANE#0.9985;STRIATUM#0.9979;EXCITATORY SYNAPSE#0.9969;RECEPTOR COMPLEX#0.9967;PROTEIN KINASE A#0.9964;COMPLEX I#0.9960;ISCHEMIA#0.9954;DENDRITIC SPINE DENSITY#0.9952;ION CHANNEL#0.9951;MICROTUBULE#0.9946;FRONTAL#0.9937;SYNAPTIC MEMBRANE#0.9930;IONOTROPIC GLUTAMATE RECEPTOR#0.9926;PRESYNAPTIC TERMINAL#0.9919;SYNAPTIC VESICLE#0.9913;SYNAPSE DEVELOPMENT#0.9902;SIGNALING MOLECULE#0.9891;DOPAMINE#0.9882;PROTEIN KINASE C#0.9860;INTERNEURON#0.9859;DENTATE GYRUS#0.9858;PROTEIN PROTEIN INTERACTION#0.9856;DENDRITIC SPINE#0.9846;NEURONAL CELL DEATH#0.9840;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9839;GLUTAMATE RECEPTOR#0.9837;ETHANOL#0.9835;PLASMA MEMBRANE#0.9826;CEREBRAL CORTEX#0.9826;NEUROPROTECTION#0.9813;FOREBRAIN#0.9812;PROTEIN KINASE#0.9811;NEURITE OUTGROWTH#0.9810;NEUROFILAMENT#0.9808;CELL SURFACE#0.9807;LONG TERM DEPRESSION#0.9806;ASTROCYTE#0.9802;NEUROTRANSMITTER RECEPTOR#0.9796;PYRAMIDAL CELL#0.9794;ASPARTATE#0.9794;TIGHT JUNCTION#0.9794;SYNAPTOGENESIS#0.9789;NEURITE#0.9769;SENSITIZATION#0.9766;PDZ DOMAIN BINDING#0.9761;CELL DEATH#0.9755;SIGNALING CASCADE#0.9753;AUTISM SPECTRUM DISORDER#0.9751;NEURONAL CELLS#0.9735;CELL ADHESION MOLECULE#0.9732;GROWTH FACTOR#0.9729;MIXED LINEAGE KINASE#0.9727;NEUROGENESIS#0.9716;COGNITION#0.9716;SIGNAL TRANSDUCTION#0.9713;MENTAL RETARDATION#0.9711;RECEPTOR CLUSTERING#0.9710;ADRENERGIC RECEPTOR#0.9706;ISOFLURANE#0.9702;SPATIAL LEARNING#0.9700;MEMORY IMPAIRMENT#0.9698;APOPTOTIC#0.9697;CELL ADHESION#0.9697;APOPTOSIS#0.9697;TRANSCRIPTION FACTOR#0.9695;RECEPTOR ANTAGONIST#0.9688;NEUROTRANSMISSION#0.9681;CELL MEMBRANE#0.9681;RAPAMYCIN#0.9679;SYNAPTIC TRANSMISSION#0.9673;GLIAL CELL#0.9668;SYNAPTIC SIGNALING#0.9667;MORPHOGENESIS#0.9665;TOXICITY#0.9657;MITOGEN ACTIVATED PROTEIN#0.9642;CEREBRAL ARTERY#0.9631;BRAIN DEVELOPMENT#0.9630;ACTIN CYTOSKELETON#0.9624;FLUOXETINE#0.9624;NEUROTOXICITY#0.9620;LONG TERM POTENTIATION#0.9618;FOCAL CEREBRAL ISCHEMIA#0.9617;PROTEIN TYROSINE PHOSPHATASE#0.9615;MEDIAL PREFRONTAL CORTEX#0.9606;CLEAVED CASPASE 3#0.9601;SIGNALING PATHWAY#0.9601;MORRIS WATER MAZE#0.9600;CALCIUM CHANNEL#0.9598;FRAGILE X SYNDROME#0.9594;GENE EXPRESSION#0.9594;DEMENTIA#0.9585;AMYLOID PRECURSOR PROTEIN#0.9575;SPINE HEAD#0.9568;NERVE GROWTH FACTOR#0.9567;LEUCINE#0.9566;MEMBRANE FRACTION#0.9560;NOVEL OBJECT RECOGNITION#0.9556;PRO-INFLAMMATORY#0.9555;STEM CELL#0.9550;GABA A RECEPTOR#0.9549;CEREBRAL ARTERY OCCLUSION#0.9549;SCIATIC NERVE#0.9547;LONG TERM MEMORY#0.9543;EPITHELIAL CELL#0.9540;CENTRAL NERVOUS SYSTEM#0.9538;PEPTIDE BINDING#0.9538;PROTEIN TYROSINE KINASE#0.9535;NEURODEGENERATIVE DISEASE#0.9526;ACTIN BINDING#0.9521;SEVOFLURANE#0.9518;PROTEASOME#0.9515;MIDDLE CEREBRAL ARTERY#0.9514;BIPOLAR CELL#0.9513;SUCROSE#0.9510;NERVOUS SYSTEM#0.9509;GANGLION CELLS#0.9508;GLYCOGEN SYNTHASE KINASE#0.9500;PROTEIN SYNTHESIS#0.9497;ESTRADIOL#0.9497;NEUROLOGICAL DISORDER#0.9494;RECEPTOR ACTIVITY#0.9463;ARTERY#0.9445;ALZHEIMER'S DISEASE#0.9444;TRANSMISSION ELECTRON MICROSCOPY#0.9435;ANESTHETIC#0.9434;TRAUMATIC BRAIN INJURY#0.9434;REACTIVE OXYGEN SPECIES#0.9423;ENDOPLASMIC RETICULUM#0.9422;TIGHT JUNCTION PROTEIN#0.9387;CHANNEL ACTIVITY#0.9384;BRAIN DAMAGE#0.9384;RECEPTOR INTERNALIZATION#0.9375;TUMOR NECROSIS FACTOR#0.9370;UBIQUITIN#0.9358;CELL JUNCTION#0.9355;IMMATURE NEURON#0.9345;CYTOPLASM#0.9339;OXYGEN GLUCOSE DEPRIVATION#0.9333;PARKINSON'S DISEASE#0.9308;NEUROTOXIC#0.9306;EPILEPSY#0.9303;GLYCINE#0.9299;BIPOLAR DISORDER#0.9276;CYCLIN DEPENDENT KINASE#0.9273;DENDRITIC SPINE MORPHOGENESIS#0.9268;KINASE ACTIVITY#0.9267;METABOTROPIC GLUTAMATE RECEPTORS#0.9248;OPEN FIELD TEST#0.9247;DORSOLATERAL PREFRONTAL CORTEX#0.9218;ANTERIOR CINGULATE CORTEX#0.9201;DOPAMINE RECEPTOR#0.9199;HYPOXIA#0.9190;ACETYLCHOLINE#0.9180;AKT SIGNALING#0.9177;LEUCINE RICH REPEAT#0.9167;INTELLECTUAL DISABILITY#0.9167;OBJECT RECOGNITION TEST#0.9165;HUMAN EMBRYONIC KIDNEY#0.9159;L-GLUTAMATE#0.9159;GUANINE#0.9157;BLOOD BRAIN BARRIER#0.9155;EMBRYONIC KIDNEY#0.9154;PALMITATE#0.9151;FORCED SWIMMING TEST#0.9145;ACTIN BINDING PROTEIN#0.9125;TARGET OF RAPAMYCIN#0.9119;C TERMINAL DOMAIN#0.9084;ELEVATED PLUS MAZE#0.9076;TAIL SUSPENSION TEST#0.9070;CYTOCHROME C#0.9038;HIPPOCAMPAL REGION#0.9037;GLUTAMIC ACID#0.9033;HUNTINGTON'S DISEASE#0.9019;BOUTON#0.9018;AXON TERMINAL#0.9014;MITOCHONDRIA#0.9002;RECEPTOR AGONIST#0.8985;SRC FAMILY KINASE#0.8974;CELL POLARITY#0.8974;ESTROGEN RECEPTOR#0.8966;RETINAL GANGLION CELL#0.8957;ACTIVATION OF NMDA RECEPTOR#0.8956;SPINAL DORSAL HORN#0.8953;AUTOPHAGY#0.8942;RNA INTERFERENCE#0.8937;INSULIN RECEPTOR#0.8926;PRIMARY CORTICAL NEURON#0.8865;SPINE SYNAPSE#0.8858;NEURAL STEM CELL#0.8846;CYCLIC AMP#0.8842;RECEPTOR TYROSINE KINASE#0.8839;CELL PROLIFERATION#0.8837;BASAL SYNAPTIC TRANSMISSION#0.8766;NEUROTRANSMITTER RELEASE#0.8759;SUCROSE PREFERENCE TEST#0.8747;INFLAMMATORY RESPONSE#0.8733;NUCLEOTIDE EXCHANGE FACTOR#0.8719;SYNAPTIC COMPONENT#0.8719;HYPERPHOSPHORYLATION#0.8695;REVERSE TRANSCRIPTION#0.8692;NEUROMUSCULAR JUNCTION#0.8689;HYPERACTIVITY#0.8642;SUPEROXIDE DISMUTASE#0.8608;MOLECULAR DYNAMICS SIMULATION#0.8602;OLIGODENDROCYTE#0.8588;T CELL#0.8588;GLUTATHIONE#0.8541;SOCIAL BEHAVIOR#0.8537;MEMANTINE#0.8531;MOOD DISORDER#0.8519;SIGNALLING PATHWAY#0.8492;L-DOPA#0.8467;MAP KINASE#0.8456;PROTEIN BINDING#0.8453;MAJOR DEPRESSIVE DISORDER#0.8435;LITHIUM#0.8407;REGENERATION#0.8390;INSOLUBLE FRACTION#0.8380;ACTION POTENTIAL#0.8353;POST-TRANSLATIONAL MODIFICATION#0.8339;SPECTRIN#0.8319;RNA BINDING#0.8319;INSULIN-LIKE GROWTH FACTOR#0.8316;RIBBON SYNAPSE#0.8305;THALAMUS#0.8291;NEUROFIBRILLARY TANGLE#0.8281;ACETYLCHOLINE RECEPTOR#0.8273;PURKINJE CELL#0.8247;APICAL DENDRITE#0.8226;TRANSIENT CEREBRAL ISCHEMIA#0.8209;PERIPHERAL NERVE#0.8192;EXCITATORY SYNAPSE FORMATION#0.8187;HALOPERIDOL#0.8166;FILAMENTOUS ACTIN#0.8161;DOPAMINE D1 RECEPTOR#0.8133;MUTAGENESIS#0.8126;PRESYNAPTIC MEMBRANE#0.8110;OLFACTORY BULB#0.8102;MEDIUM SPINY NEURONS#0.8080;POSTSYNAPSE#0.8059;CYTOSKELETAL ELEMENT#0.8004;SYNAPTIC CLEFT#0.8003;LOW DENSITY LIPOPROTEIN#0.7994;GLUTAMATERGIC NEURON#0.7993;MICROGLIAL CELL#0.7985;RNA BINDING PROTEIN#0.7979;NERVE TERMINAL#0.7939;ADENOSINE MONOPHOSPHATE#0.7928;SCHAFFER COLLATERAL#0.7909;CATALYTIC ACTIVITY#0.7872;DYNEIN#0.7871;SYNAPTIC VESICLE PROTEIN#0.7838;POSTTRANSLATIONAL MODIFICATION#0.7814;ACTIN FILAMENT#0.7804;HAIR CELL#0.7790;FORCED SWIM TEST#0.7784;CHRONIC MILD STRESS#0.7755;POSTNATAL DAY 7#0.7728;DYSKINESIA#0.7718;PROGENITOR CELL#0.7699;SEPTATE JUNCTION#0.7682;OOCYTE#0.7667;KINASE INHIBITOR#0.7666;CELL BODY#0.7664;GESTATION#0.7662;MEMORY LOSS#0.7636;PROTEIN LOCALIZATION#0.7630;ADENOSINE#0.7629;GLUCOCORTICOID RECEPTOR#0.7610;HISTONE DEACETYLASE#0.7605;NEUROBLASTOMA#0.7603;CYCLIC ADENOSINE MONOPHOSPHATE#0.7582;GABAERGIC NEURON#0.7573;MELATONIN#0.7569;PRESYNAPTIC ACTIVE ZONE#0.7567;NEURAL CELL#0.7521;CALCINEURIN#0.7513;DEPHOSPHORYLATION#0.7513;BRAIN DISEASE#0.7500;SIGNAL TRANSMISSION#0.7448;PROTEIN PHOSPHORYLATION#0.7434;HIPPOCAMPAL DENTATE GYRUS#0.7404;ALANINE#0.7381;RESONANCE ENERGY TRANSFER#0.7378;SKELETAL MUSCLE#0.7371;EPHRIN#0.7350;SPINAL NERVE LIGATION#0.7345;EARLY LIFE STRESS#0.7333;STERILE ALPHA MOTIF#0.7319;PROTEIN PALMITOYLATION#0.7308;INTERCELLULAR JUNCTION#0.7284;CONDITIONED PLACE PREFERENCE#0.7277;F-ACTIN BINDING#0.7272;SYNAPSE ELIMINATION#0.7263;RETINAL DEGENERATION#0.7235;NICOTINIC ACETYLCHOLINE RECEPTOR#0.7222;PALMITOYL#0.7221;SPINAL CORD INJURY#0.7216;AUTISTIC#0.7216;SURFACE PLASMON RESONANCE#0.7214;PROTEIN KINASE B#0.7209;ADENOMATOUS POLYPOSIS COLI#0.7200;VASCULAR DEMENTIA#0.7188;RECEPTOR BINDING#0.7180;ISCHEMIA REPERFUSION INJURY#0.7175;MECHANISM OF ACTION#0.7165;SUBSTANTIA NIGRA#0.7127;PHOSPHODIESTERASE#0.7068;HYPERSENSITIVITY#0.7065;NEURITE GROWTH#0.7049;ENDOSOME#0.7001;INSULIN RECEPTOR SUBSTRATE#0.6984;PLURIPOTENT STEM CELL#0.6967;CALCIUM SIGNALING#0.6940;CONTEXTUAL FEAR CONDITIONING#0.6939;SMOOTH MUSCLE#0.6902;ISOTHERMAL TITRATION CALORIMETRY#0.6876;EARLY GROWTH RESPONSE#0.6872;TYROSINE RECEPTOR KINASE#0.6855;PKC ACTIVATION#0.6854;HIGH FAT DIET#0.6853;DOUBLE TRANSGENIC MICE#0.6845;OVARIAN#0.6844;D-SERINE#0.6840;ASCORBIC ACID#0.6805;TROPOMYOSIN RECEPTOR KINASE#0.6803;SERINE HYDROLASE#0.6798;CHOLINE#0.6796;OCULAR DOMINANCE PLASTICITY#0.6777;CONTROLLED CORTICAL IMPACT#0.6772;CAMP-RESPONSIVE ELEMENT BINDING#0.6755;PROTEIN TRANSLATION#0.6751;EXOCYTOSIS#0.6743;17β-ESTRADIOL#0.6736;TRADITIONAL CHINESE MEDICINE#0.6718;PROPOFOL#0.6702;PHOSPHATASE ACTIVITY#0.6695;INDUCIBLE NITRIC OXIDE#0.6682;LIPID MODIFICATION#0.6675;TROPOMYOSIN RELATED KINASE#0.6672;KINESIN#0.6665;SYNAPTIC RIBBON#0.6655;GLUTAMINE#0.6619;MACROMOLECULAR COMPLEX#0.6557;MAPK SIGNALING#0.6543;INHIBITORY SYNAPSE FORMATION#0.6532;SPATIAL WORKING MEMORY#0.6531;QUANTITATIVE REAL TIME#0.6510;MEMBRANE MICRODOMAIN#0.6504;PROTEIN INTERACTION NETWORK#0.6492;AMACRINE CELL#0.6478;SCHWANN CELL#0.6475;CHRONIC UNPREDICTABLE STRESS#0.6469;OBJECT RECOGNITION MEMORY#0.6463;INNERVATION#0.6458;MILD COGNITIVE IMPAIRMENT#0.6446;DNA METHYLATION#0.6436;PAIRED PULSE FACILITATION#0.6426;INDUCED PLURIPOTENT STEM CELL#0.6424;DOPAMINERGIC NEURON#0.6424;APOPTOTIC CELL DEATH#0.6410;BETA-2#0.6381;EXTRACELLULAR MATRIX#0.6363;ARGININE#0.6336;POSTSYNAPTIC SPECIALIZATION#0.6321;MYELINATION#0.6320;BASKET CELL#0.6317;SUPERIOR COLLICULUS#0.6305;NEURON DEATH#0.6300;TWO PHOTON MICROSCOPY#0.6294;MITOCHONDRIAL MEMBRANE#0.6278;INTRACELLULAR SIGNALING PATHWAY#0.6267;ACTIN DEPOLYMERIZATION#0.6267;TESTOSTERONE#0.6253;TRANSCRIPTASE#0.6236;SOMATOSTATIN RECEPTOR#0.6233;NERVE FIBER#0.6229;DENDRITIC TREE#0.6223;SYNAPSE ASSEMBLY#0.6215;HALOTHANE#0.6214;MITOCHONDRIAL FISSION#0.6193;TRKB SIGNALING PATHWAY#0.6182;SEROTONIN RECEPTOR#0.6172;NUCLEAR LAYER#0.6141;SEROTONIN REUPTAKE INHIBITOR#0.6137;BINDING PROTEIN 1#0.6091;TRANSFORMING GROWTH FACTOR#0.6071;MICROTUBULE BUNDLING#0.6068;COGNITIVE DISORDER#0.6067;IMMUNE RESPONSE#0.6028;HIGH FREQUENCY STIMULATION#0.6016;MOLECULARLY IMPRINTED POLYMER#0.6007;RELATED PROTEIN 1#0.6004
1743	DEHYDROGENASE COMPLEX#1.0645;PRIMARY BILIARY CIRRHOSIS#0.9957;2-OXOGLUTARATE DEHYDROGENASE COMPLEX#0.9783;OXOGLUTARATE DEHYDROGENASE COMPLEX#0.9745;PYRUVATE DEHYDROGENASE COMPLEX#0.9695;PYRUVATE#0.9611;ALPHA-KETOGLUTARATE DEHYDROGENASE COMPLEX#0.9155;TCA CYCLE#0.8305;T CELL#0.7458;MITOCHONDRIA#0.6504
1745	INTERNEURON#1.0403;FOREBRAIN#1.0171;TRANSCRIPTION FACTOR#1.0063;TELENCEPHALON#0.9859;GENE EXPRESSION#0.9668;PROSTATE CANCER#0.9661;MEDIAL GANGLIONIC EMINENCE#0.9289;PROGENITOR CELL#0.8842;NERVOUS SYSTEM#0.8818;GABAERGIC NEURON#0.8719;CANCER CELL#0.8429;OLFACTORY BULB#0.8426;GROWTH FACTOR#0.8289;NEUROGENESIS#0.8270;DNA METHYLATION#0.8092;CELL MIGRATION#0.8086;INTERNEURON MIGRATION#0.8064;BRANCHIAL ARCH#0.8037;STEM CELL#0.7816;NEURAL CREST#0.7738;THALAMUS#0.7519;MOLAR#0.7495;MORPHOGENESIS#0.7493;POLYMERASE CHAIN REACTION#0.7459;BRAIN DEVELOPMENT#0.7416;FOREBRAIN DEVELOPMENT#0.7319;CRANIOFACIAL DEVELOPMENT#0.6969;DIENCEPHALON#0.6948;SIGNALLING PATHWAY#0.6828;BASAL GANGLIA#0.6727;CEREBRAL CORTEX#0.6693;CELL DIFFERENTIATION#0.6557;MESENCHYME#0.6553;CENTRAL NERVOUS SYSTEM#0.6410;GLUTAMIC ACID#0.6398;EPILEPSY#0.6397;TERMINAL DIFFERENTIATION#0.6176;LIMB DEVELOPMENT#0.6111;TOOTH DEVELOPMENT#0.6081;AMACRINE CELL#0.6073
1746	NEURAL CREST#1.0430;BRANCHIAL ARCH#1.0287;INTERNEURON#1.0258;TOOTH DEVELOPMENT#1.0136;FOREBRAIN#1.0125;TELENCEPHALON#1.0096;NEUROGENESIS#1.0065;NEURAL CREST CELL#1.0065;TRANSCRIPTION FACTOR#0.9986;GABAERGIC NEURON#0.9928;CRANIAL NEURAL CREST#0.9923;OLFACTORY BULB#0.9882;GENE EXPRESSION#0.9862;PROGENITOR CELL#0.9848;STEM CELL#0.9768;MEDIAL GANGLIONIC EMINENCE#0.9723;MESENCHYME#0.9661;APOPTOSIS#0.9422;MORPHOGENESIS#0.9351;NEURAL STEM CELL#0.9321;NERVOUS SYSTEM#0.9296;MOLAR#0.9283;SIGNALING PATHWAY#0.9237;CELL PROLIFERATION#0.9232;GROWTH FACTOR#0.9175;CEREBRAL CORTEX#0.9116;CRANIOFACIAL DEVELOPMENT#0.8972;PRECURSOR CELL#0.8920;CELL CYCLE#0.8917;OSTEOBLAST#0.8725;NEUROBLAST#0.8701;EPSTEIN BARR VIRUS#0.8387;DNA BINDING#0.8161;CELL MIGRATION#0.8062;DIENCEPHALON#0.8055;OLIGODENDROCYTE#0.7982;CENTRAL NERVOUS SYSTEM#0.7960;BASAL GANGLIA#0.7854;INTERNEURON MIGRATION#0.7806;BONE MORPHOGENETIC PROTEIN#0.7731;CANCER CELL#0.7685;POLYMERASE CHAIN REACTION#0.7677;EPITHELIAL MESENCHYMAL TRANSITION#0.7618;CELL ADHESION#0.7576;MINERALIZATION#0.7565;CELL DIFFERENTIATION#0.7508;FOREBRAIN DEVELOPMENT#0.7508;SKELETON#0.7483;ALKALINE PHOSPHATASE#0.7437;STRIATUM#0.7280;BRAIN DEVELOPMENT#0.7206;TERMINAL DIFFERENTIATION#0.6966;GANGLION CELLS#0.6956;GLUTAMIC ACID#0.6945;BONE FORMATION#0.6921;OSTEOGENESIS#0.6777;NEURAL TUBE#0.6630;FIBROBLAST GROWTH FACTOR#0.6626;THALAMUS#0.6500;CLEFT PALATE#0.6420;HINDBRAIN#0.6296;NEURAL PROGENITOR CELL#0.6251;CHONDROGENESIS#0.6218;DENTAL PAPILLA#0.6162;CELL CYCLE ARREST#0.6061;ASTROCYTE#0.6007
1747	TROPHOBLAST#1.0573;OSTEOBLAST DIFFERENTIATION#1.0496;OSTEOBLAST#1.0307;TRANSCRIPTION FACTOR#1.0281;KERATINOCYTE#1.0212;STEM CELL#1.0164;GENE EXPRESSION#1.0151;NEURAL CREST#1.0148;BONE FORMATION#1.0126;SIGNALING PATHWAY#1.0016;BONE MORPHOGENETIC PROTEIN#0.9849;HAIR FOLLICLE#0.9833;NEURAL PLATE#0.9764;AMELOGENESIS IMPERFECTA#0.9658;AMELOGENESIS#0.9573;ALKALINE PHOSPHATASE#0.9549;PLACENTAL DEVELOPMENT#0.9523;TROPHOBLAST CELL#0.9451;DNA BINDING#0.9367;ECTODERMAL DYSPLASIA#0.9170;MINERALIZATION#0.9051;BONE MARROW#0.8814;OLFACTORY PLACODE#0.8785;DENTAL PULP CELL#0.8658;TOOTH DEVELOPMENT#0.8652;HUMAN DENTAL PULP#0.8640;DENTAL PULP#0.8585;MESENCHYMAL STEM CELL#0.8545;MORPHOGENESIS#0.8427;GROWTH FACTOR#0.8415;BONE DEVELOPMENT#0.7908;DENTAL CARIES#0.7824;POLYMERASE CHAIN REACTION#0.7718;APOPTOSIS#0.7676;NERVOUS SYSTEM#0.7526;INNER EAR#0.7414;OTIC PLACODE#0.7318;PRECURSOR CELL#0.7300;MESENCHYME#0.7153;GASTRULATION#0.7015;TRANSACTIVATION#0.6990;SKELETON#0.6925;CENTRAL NERVOUS SYSTEM#0.6846;ELECTROPHORETIC MOBILITY SHIFT#0.6802;CELL DIFFERENTIATION#0.6788;T CELL#0.6693;CHORIOCARCINOMA#0.6655;ODONTOBLAST DIFFERENTIATION#0.6614;OSTEOGENESIS#0.6444;ALKALINE PHOSPHATASE ACTIVITY#0.6416;MESENCHYMAL CELL#0.6396;PHOSPHATASE ACTIVITY#0.6384;REGENERATION#0.6360;PLACENTAL GROWTH FACTOR#0.6222;TROPHOBLAST GIANT CELLS#0.6210;VILLOUS CYTOTROPHOBLAST#0.6191;ROOT SHEATH#0.6096
1748	BETA PROTEIN 1#1.1385;BREAST CANCER#1.0677;TRANSCRIPTION FACTOR#1.0125;CANCER CELL#0.9909;OVARIAN CANCER#0.9881;GENE EXPRESSION#0.9516;OVARIAN#0.8730;GLOBIN#0.8564;TUMOR CELLS#0.8530;ANGELMAN SYNDROME#0.8354;BREAST CANCER CELL#0.8245;MESENCHYMAL CELL#0.8203;HUMAN BREAST CANCER#0.8082;MYELOID LEUKEMIA#0.7871;NORMAL BREAST TISSUE#0.7847;APOPTOSIS#0.7735;HEPATOCELLULAR CARCINOMA#0.7648;ACUTE MYELOID LEUKEMIA#0.7241;BREAST CANCER PATIENTS#0.6874;LUNG CANCER#0.6868;POLYMERASE CHAIN REACTION#0.6862;STEM CELL#0.6584;ENDOTHELIAL CELL#0.6347;DNA BINDING#0.6310;TRANSCRIPTIONAL CONTROL#0.6130
1749	INTERNEURON#1.0287;NEURAL PLATE#1.0208;OSTEOBLAST DIFFERENTIATION#1.0131;FOREBRAIN#1.0109;TRANSCRIPTION FACTOR#1.0105;UPPER JAW#1.0096;POLYMERASE CHAIN REACTION#1.0068;MESENCHYME#1.0025;NEURAL CREST#1.0004;DNA BINDING#0.9982;OSTEOBLAST#0.9981;INNER EAR#0.9938;SIGNALING PATHWAY#0.9910;ALKALINE PHOSPHATASE#0.9902;CHONDROCYTE#0.9901;OSTEOGENESIS#0.9897;MINERALIZATION#0.9875;BONE MORPHOGENETIC PROTEIN#0.9868;MORPHOGENESIS#0.9831;BONE FORMATION#0.9827;SPLIT HAND-FOOT MALFORMATION#0.9811;COLLAGEN TYPE I#0.9805;BONE MARROW#0.9802;MESENCHYMAL STEM CELL#0.9785;CELL PROLIFERATION#0.9782;GENE EXPRESSION#0.9767;STEM CELL#0.9749;GROWTH FACTOR#0.9740;STROMAL CELL#0.9727;ALKALINE PHOSPHATASE ACTIVITY#0.9604;PROTEIN KINASE#0.9586;PHOSPHATASE ACTIVITY#0.9576;LIMB DEVELOPMENT#0.9566;GABAERGIC NEURON#0.9540;CELL DIFFERENTIATION#0.9487;MESENCHYMAL CELL#0.9473;EXTRACELLULAR MATRIX#0.9440;DNA METHYLATION#0.9435;PROGENITOR CELL#0.9383;OLFACTORY BULB#0.9294;BONE DEVELOPMENT#0.9290;CRANIOFACIAL DEVELOPMENT#0.9261;RETT SYNDROME#0.9258;SKELETON#0.9250;NEURAL CREST CELL#0.9148;ADIPOCYTE#0.9126;OSSIFICATION#0.9091;MANDIBLE#0.9069;REGENERATION#0.8925;BONE MARROW STROMAL#0.8899;OSTEOGENIC CELL#0.8823;CRANIAL NEURAL CREST#0.8822;MARROW STROMAL CELLS#0.8812;NERVOUS SYSTEM#0.8776;BONE MARROW STROMAL CELL#0.8603;ENHANCER BINDING PROTEIN#0.8566;ENDOCHONDRAL OSSIFICATION#0.8562;ENHANCER BINDING#0.8560;HUMAN MESENCHYMAL STEM#0.8493;TELENCEPHALON#0.8402;CANCER CELL#0.8382;CHONDROCYTE DIFFERENTIATION#0.8376;NEURAL TUBE#0.8375;REVERSE TRANSCRIPTION#0.8375;LUNG CANCER#0.8310;APOPTOSIS#0.8282;PRECURSOR CELL#0.8279;SKELETAL DEVELOPMENT#0.8222;OSTEOCLAST#0.8115;OTIC PLACODE#0.8064;T CELL#0.8048;BONE REGENERATION#0.8029;OLFACTORY EPITHELIUM#0.7981;FIBROBLAST GROWTH FACTOR#0.7940;NON-NEURAL ECTODERM#0.7887;SIGNALING MOLECULE#0.7817;EMBRYONIC STEM CELL#0.7786;NEURAL ECTODERM#0.7748;HEARING LOSS#0.7641;CHONDROGENESIS#0.7573;TRANSFORMING GROWTH FACTOR#0.7463;CELL CYCLE#0.7413;CLEFT LIP#0.7374;PROTEIN KINASE A#0.7277;BONE RESORPTION#0.7276;EAR DEVELOPMENT#0.7248;PROTEIN COMPLEX#0.7245;STRIATUM#0.7143;NEURAL FOLD#0.7141;BONE MORPHOGENIC PROTEIN#0.7135;ADIPOCYTE DIFFERENTIATION#0.7128;ALIZARIN RED STAINING#0.7041;CEREBRAL CORTEX#0.7032;INNER EAR DEVELOPMENT#0.7027;SOFT PALATE#0.6969;CHONDROCYTE HYPERTROPHY#0.6959;MAXILLA#0.6953;OSTEOPOROSIS#0.6904;NEURAL PLATE BORDER#0.6883;NODULE FORMATION#0.6869;PROTEIN BINDING#0.6780;QUANTITATIVE REAL TIME#0.6757;OSTEOCYTE#0.6753;CENTRAL NERVOUS SYSTEM#0.6735;TROPHOBLAST#0.6733;EPITHELIAL CELL#0.6723;CLEFT PALATE#0.6690;ENDOLYMPHATIC DUCT#0.6653;ENZYME ACTIVITY#0.6644;ADIPOGENESIS#0.6604;MITOGEN ACTIVATED PROTEIN#0.6582;BRANCHIAL ARCH#0.6482;OVARIAN#0.6447;FOREBRAIN DEVELOPMENT#0.6393;NEUROGENESIS#0.6365;CAMP RESPONSE ELEMENT#0.6339;OTOCYST#0.6334;CHONDROBLAST#0.6322;BONE MINERAL DENSITY#0.6313;ALIZARIN RED S#0.6282;CELL GROWTH#0.6259;PROTEIN COMPLEX FORMATION#0.6258;STEROIDOGENESIS#0.6254;MESENCHYMAL STROMAL CELL#0.6211;ESTROGEN RECEPTOR#0.6172;TOOTH DEVELOPMENT#0.6169;PARIETAL BONE#0.6158;FRONTAL#0.6123;TRANSACTIVATION#0.6120;CELL DEATH#0.6113;GENE SILENCING#0.6051
174	OESTRIOL#1.0624;PLACENTAL GROWTH FACTOR#1.0513;INTERNATIONAL NORMALIZED RATIO#1.0447;ESTRIOL#1.0447;BETA-2#1.0403;PORTAL VEIN INVASION#1.0390;ARACHIDONIC ACID#1.0390;INHIBIN#1.0388;ESTROGENS#1.0386;LOW DETECTION LIMIT#1.0368;GLASSY CARBON ELECTRODE#1.0355;PROSTATE SPECIFIC ANTIGEN#1.0345;HUMAN HEPATOMA CELL LINES#1.0331;ESTROGEN BINDING#1.0319;OVAL CELL#1.0314;VITAMIN D BINDING#1.0298;ALPHA 1-ANTITRYPSIN#1.0277;RISK OF DEATH#1.0253;ESTRADIOL#1.0235;CD8+ T CELL#1.0234;GALLBLADDER CARCINOMA#1.0221;HEPATOID ADENOCARCINOMA#1.0217;CD4+ T CELL#1.0191;LECTIN#1.0190;HEPATOCYTE NUCLEAR FACTOR#1.0186;AMNIOTIC FLUID#1.0185;TUMOR NODE METASTASIS#1.0173;FUCOSYLATION#1.0173;LIMIT OF DETECTION#1.0166;LIVER DEVELOPMENT#1.0162;VITAMIN K#1.0157;C REACTIVE PROTEIN#1.0152;CORD BLOOD#1.0149;ENDODERMAL SINUS TUMOR#1.0146;EARLY GASTRIC CANCER#1.0145;TUMOR NECROSIS FACTOR#1.0141;LEUCINE#1.0139;PLASMA PROTEIN#1.0137;BREAST CANCER#1.0135;DNASE I#1.0134;RENAL CELL CARCINOMA#1.0127;DEXAMETHASONE#1.0127;ANENCEPHALY#1.0127;LIVER REGENERATION#1.0126;PORTAL VEIN THROMBOSIS#1.0122;SPINA BIFIDA#1.0117;SQUAMOUS CELL CARCINOMA#1.0116;NEURAL TUBE DEFECT#1.0111;ASPARTATE#1.0110;INSULIN-LIKE GROWTH FACTOR#1.0107;PANCREATIC CANCER#1.0100;DENDRITIC CELL#1.0098;CYTOCHROME P450#1.0096;GASTRIC ADENOCARCINOMA#1.0095;PROGESTERONE#1.0088;RECEIVER OPERATING CURVE#1.0086;HEPATIC STEM CELL#1.0080;HEPATOMA CELLS#1.0074;HEPATOBLAST#1.0071;FETAL LIVER#1.0059;THYMIDINE KINASE#1.0049;RETINOIC ACID#1.0048;FIBRINOGEN#1.0046;NEURAL TUBE#1.0043;TUMOR ASSOCIATED ANTIGEN#1.0041;ENDOPLASMIC RETICULUM#1.0035;THYMIDINE#1.0031;LUNG CANCER#1.0028;EPIDERMAL GROWTH FACTOR#1.0026;AREA UNDER CURVE#1.0026;LIVER METASTASIS#1.0025;T CELL#1.0024;GLYCOSYLATION#1.0022;ADVERSE PREGNANCY OUTCOME#1.0020;GALLBLADDER#1.0019;ALANINE#1.0016;TRANSCRIPTASE#1.0015;TROPHOBLAST#1.0013;CYTOTOXIC T-LYMPHOCYTE#1.0011;MATERNAL SERUM MARKERS#1.0007;ALKALINE PHOSPHATASE#1.0006;ESTROGEN RECEPTOR#1.0005;CHLORAMPHENICOL#1.0003;CARCINOGEN#0.9997;SERUM ALBUMIN#0.9993;REGENERATION#0.9987;ENDOTHELIAL GROWTH FACTOR#0.9986;MONONUCLEAR CELLS#0.9986;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9986;CELL ADHESION MOLECULE#0.9985;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9976;MONOCYTE#0.9973;TESTOSTERONE#0.9964;DNA SYNTHESIS#0.9962;T LYMPHOCYTE#0.9958;DIABETES MELLITUS#0.9951;IFN-GAMMA#0.9949;IMMUNE RESPONSE#0.9948;RECEIVER OPERATOR CHARACTERISTIC#0.9948;UMBILICAL CORD#0.9947;GASTROINTESTINAL TRACT#0.9947;TRANSCRIPTION FACTOR#0.9945;LIMITS OF DETECTION#0.9943;PERIPHERAL BLOOD#0.9941;MACROPHAGE#0.9928;YOLK SAC#0.9927;CELL ADHESION#0.9924;LIVER CARCINOMA#0.9923;GROWTH FACTOR RECEPTOR#0.9921;MULTIPLES OF MEDIAN#0.9920;HUMAN BREAST CANCER#0.9918;STEM CELL MARKER#0.9917;TRANSFORMING GROWTH FACTOR#0.9916;VIRAL HEPATITIS#0.9916;SIGNAL TRANSDUCTION#0.9915;HEAT SHOCK PROTEIN#0.9910;TESTICULAR CANCER#0.9910;ROUGH ENDOPLASMIC RETICULUM#0.9909;CELL GROWTH#0.9901;NEUTROPHIL#0.9901;OVARIAN CANCER#0.9901;CHORIOCARCINOMA#0.9899;NEGATIVE PREDICTIVE VALUE#0.9898;HEPATOCELLULAR CARCINOMA CELL#0.9897;CYTOTOXICITY#0.9896;ASCITES#0.9896;GLUTATHIONE#0.9896;COLORECTAL CANCER#0.9895;DOWN SYNDROME#0.9895;SMOOTH MUSCLE#0.9890;SEMINOMA#0.9890;BIOTIN#0.9886;LIVER LESIONS#0.9884;LEYDIG CELL#0.9878;REVERSE TRANSCRIPTION#0.9874;LYMPH NODE METASTASIS#0.9868;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9866;TUMOR CELLS#0.9865;COLORECTAL#0.9863;CELL SURFACE#0.9859;THROMBOSIS#0.9857;POSITIVE PREDICTIVE VALUE#0.9854;GROWTH FACTOR BINDING#0.9853;EMBRYONAL CARCINOMA#0.9850;DISEASE CONTROL RATE#0.9847;GERMINOMA#0.9844;TUMOR ANTIGEN#0.9843;PORTAL VEIN#0.9843;CELL CYCLE#0.9840;MATURE TERATOMA#0.9837;RESPONSE TO TREATMENT#0.9830;GENE EXPRESSION#0.9828;ADENOCARCINOMA#0.9821;HEPATOBLASTOMA#0.9820;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9815;LIVER DAMAGE#0.9810;IMMUNOGLOBULIN G#0.9807;CYTOPLASM#0.9807;HIGH RISK PATIENTS#0.9806;GERM CELL TUMORS#0.9804;GROWTH FACTOR#0.9801;GESTATION#0.9796;FALSE POSITIVE RATE#0.9793;CHRONIC LIVER DISEASE#0.9792;PROTEIN SYNTHESIS#0.9791;HEPATOCYTE GROWTH FACTOR#0.9790;ALPHA-2 MACROGLOBULIN#0.9789;BLOOD VESSEL#0.9787;SORAFENIB#0.9784;HEPATIC VEIN#0.9773;NERVOUS SYSTEM#0.9769;ATAXIA TELANGIECTASIA#0.9768;HUMAN SERUM ALBUMIN#0.9767;CANCER CELL#0.9767;APOPTOSIS#0.9765;OVARIAN#0.9764;B CELL#0.9761;NORMAL LIVER TISSUES#0.9761;CELL DIFFERENTIATION#0.9757;POLYMERASE CHAIN REACTION#0.9757;GERM CELL#0.9756;TUMOR TISSUES#0.9755;UTERUS#0.9754;EPITHELIAL CELL#0.9748;PORTAL HYPERTENSION#0.9745;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9745;OVERALL SURVIVAL RATE#0.9732;CELL PROLIFERATION#0.9731;RECURRENCE FREE SURVIVAL#0.9730;ACINAR CELL CARCINOMA#0.9726;POSITRON EMISSION TOMOGRAPHY#0.9726;5 FLUOROURACIL#0.9723;TERATOMA#0.9721;LIVER CIRRHOSIS#0.9719;SIGNALING PATHWAY#0.9719;LIVER DISEASE#0.9719;BILE DUCT#0.9718;CHOLANGIOCARCINOMA#0.9713;LIVER CANCER#0.9711;APOPTOTIC#0.9709;CENTRAL NERVOUS SYSTEM#0.9709;TIME TO RECURRENCE#0.9709;RECURRENT HEPATOCELLULAR CARCINOMA#0.9709;SMOOTH MUSCLE ACTIN#0.9707;BIRTH DEFECT#0.9705;CELL DEATH#0.9703;PRE-ECLAMPSIA#0.9701;LYMPH NODE DISSECTION#0.9700;PROTEIN KINASE#0.9694;BONE MARROW#0.9694;OVARIAN CARCINOMA#0.9692;ORTHOTOPIC LIVER TRANSPLANTATION#0.9691;QUANTITATIVE REAL TIME#0.9691;GRANULOSA CELL#0.9687;PROGENITOR CELL#0.9685;HEPATIC PROGENITOR CELL#0.9680;S PHASE#0.9680;HEPATIC ARTERY#0.9679;HEPATITIS B#0.9676;ACINAR CELL#0.9673;MEDIAN SURVIVAL TIME#0.9669;COLON CANCER#0.9666;CHRONIC HEPATITIS C#0.9665;WHITE BLOOD CELL#0.9659;HYPERTENSION#0.9658;LYMPH NODE#0.9656;LYMPH NODE METASTASES#0.9653;DISEASE FREE SURVIVAL#0.9649;MEDIAN OVERALL SURVIVAL#0.9646;HEPATITIS B VIRUS#0.9643;HERPES SIMPLEX VIRUS#0.9640;FLUOROURACIL#0.9639;GERM CELL CANCER#0.9638;CHRONIC HEPATITIS B#0.9637;HERPES SIMPLEX#0.9636;EXTRACELLULAR MATRIX#0.9636;BLOOD LOSS#0.9635;HEALTHY CONTROL GROUP#0.9635;MOLAR#0.9630;NODULAR#0.9628;CERVICAL#0.9628;PARENCHYMA#0.9625;NEUROENDOCRINE CARCINOMA#0.9623;BLEOMYCIN#0.9623;FIRST TRIMESTER SCREENING#0.9620;ETOPOSIDE#0.9616;ADRIAMYCIN#0.9613;MAGNETIC RESONANCE IMAGING#0.9611;ARTERY#0.9610;HEPATITIS C#0.9604;ANGIOGENESIS#0.9603;ABDOMINAL PAIN#0.9596;HEPATITIS C VIRUS#0.9586;CISPLATIN#0.9575;LEYDIG CELL TUMOR#0.9567;DNA METHYLATION#0.9566;ENDOTHELIAL CELL#0.9565;FIBROBLAST GROWTH FACTOR#0.9563;LEUKOCYTE#0.9561;YEAR SURVIVAL RATE#0.9560;ETHANOL#0.9548;SERTOLI-LEYDIG CELL TUMOR#0.9547;GOLGI APPARATUS#0.9546;FINE NEEDLE ASPIRATION#0.9542;HEPATOCELLULAR CARCINOMA#0.9541;FORMALIN#0.9541;POINT OF CARE#0.9540;EMBRYONIC STEM CELL#0.9532;THROMBOCYTOPENIA#0.9529;TOXICITY#0.9526;HISTOGENESIS#0.9524;STEM CELL#0.9523;ENDOCYTOSIS#0.9521;ELECTRON TRANSFER#0.9520;DOXORUBICIN#0.9519;FACTOR I#0.9515;CANCER STEM CELL#0.9502;AGE AT DIAGNOSIS#0.9501;SUSTAINED VIROLOGICAL RESPONSE#0.9499;BREAST CANCER CELL#0.9498;WEIGHT LOSS#0.9497;HEMORRHAGE#0.9496;MITOMYCIN C#0.9495;MESENCHYMAL STEM CELL#0.9490;DNASE#0.9490;GROWTH PATTERN#0.9487;DYSGERMINOMA#0.9481;N GLYCAN#0.9474;OF LIVER TRANSPLANTATION#0.9473;END OF TREATMENT#0.9463;LUNG ADENOCARCINOMA#0.9446;ACID PHOSPHATASE#0.9445;BINDING PROTEIN 1#0.9440;FETAL DISTRESS#0.9433;ONCOGENIC#0.9427;ENHANCED COMPUTED TOMOGRAPHY#0.9424;CELL MEMBRANE#0.9421;MICROPARTICLE#0.9399;FATTY LIVER#0.9395;LUNG METASTASIS#0.9376;UTERINE ARTERY DOPPLER#0.9372;TUMOR SUPPRESSOR#0.9370;BLOOD UREA NITROGEN#0.9359;RANDOMIZED CONTROLLED TRIAL#0.9348;MITOMYCIN#0.9332;EVENT FREE SURVIVAL#0.9331;CIRCULATING TUMOR CELL#0.9327;RUPTURE OF MEMBRANES#0.9316;QUANTITATIVE REVERSE TRANSCRIPTION#0.9313;RIBAVIRIN#0.9305;ESTRONE#0.9301;CANCER RELATED DEATH#0.9289;CHILD TURCOTTE PUGH#0.9288;NECROTIC#0.9286;MEDIASTINUM#0.9283;LUNG CARCINOMA#0.9279;TRANSMISSION ELECTRON MICROSCOPY#0.9254;MESENCHYMAL CELL#0.9241;ANEMIA#0.9240;RECEPTOR BINDING#0.9239;SUPEROXIDE DISMUTASE#0.9226;HUMAN EMBRYONIC STEM#0.9224;COAGULATION#0.9209;GENE SILENCING#0.9206;AGGRESSIVE BEHAVIOR#0.9203;TERATOCARCINOMA#0.9192;TRANSCRIPTIONAL CONTROL#0.9176;HEMATOPOIETIC STEM CELL#0.9173;DIAGNOSTIC ODDS RATIO#0.9160;DIFFERENTIAL PULSE VOLTAMMETRY#0.9152;GLUCOSE 6 PHOSPHATASE#0.9138;REGIONAL LYMPH NODE#0.9121;PLURIPOTENT STEM CELL#0.9112;GAMMA GLUTAMYLTRANSFERASE#0.9099;SWELLING#0.9092;PACLITAXEL#0.9060;CELLULAR LOCALIZATION#0.9053;WIDE DYNAMIC RANGE#0.9048;FATTY LIVER DISEASE#0.9043;CLEAR CELL CARCINOMA#0.9039;ALPHA L FUCOSIDASE#0.9035;CYTOCHROME C#0.9033;TIME TO PROGRESSION#0.9023;TUBULAR ADENOCARCINOMA#0.9021;BETA GALACTOSIDASE#0.9012;ORGANELLE#0.9005;NITRIC OXIDE#0.8996;ACTINOMYCIN D#0.8993;IMMUNE SYSTEM#0.8991;VOMITING#0.8977;HEMANGIOMA#0.8974;ALL TRANS RETINOIC ACID#0.8973;NEOPLASTIC DISEASE#0.8970;PAPILLARY ADENOCARCINOMA#0.8951;PELVIS#0.8927;ECLAMPSIA#0.8924;GLUTAMINE#0.8917;IFOSFAMIDE#0.8907;GANCICLOVIR#0.8905;LYMPHOID CELL#0.8899;CHORIONIC VILLUS#0.8893;CARBOPLATIN#0.8879;TELOMERASE REVERSE TRANSCRIPTASE#0.8874;TRANSFORMING GROWTH FACTOR BETA#0.8869;OVARIES#0.8852;RESONANCE ENERGY TRANSFER#0.8848;CYSTIC FIBROSIS#0.8811;STOMACH CANCER#0.8800;BASEMENT MEMBRANE#0.8799;DIGESTION#0.8782;HEPATITIS B VIRUS RELATED HEPATOCELLULAR CARCINOMA#0.8755;BREAST CARCINOMA#0.8753;VENA CAVA#0.8745;NATURAL KILLER CELL#0.8743;CHOLINE#0.8731;ADVANCED GASTRIC CANCER#0.8722;HORMONE BINDING#0.8721;VIRAL INFECTION#0.8715;RECEIVER OPERATOR CURVE#0.8707;IMMUNE CELL#0.8701;RELAPSE FREE SURVIVAL#0.8698;FOREGUT#0.8687;ENHANCER BINDING#0.8670;PERINUCLEAR SPACE#0.8663;PHOSPHATE BUFFERED SALINE#0.8661;FATTY ACID BINDING#0.8638;TRYPTOPHAN#0.8637;HEPATOCYTE PROLIFERATION#0.8632;CYCLOPHOSPHAMIDE#0.8622;COMPLETE BLOOD COUNT#0.8622;EPIRUBICIN#0.8612;STROMA#0.8602;AUTOIMMUNE DISEASE#0.8595;ADIPOSE TISSUE#0.8590;OXALIPLATIN#0.8581;ENHANCER BINDING PROTEIN#0.8574;LOW DENSITY LIPOPROTEIN#0.8572;VINBLASTINE#0.8564;OBSTRUCTIVE JAUNDICE#0.8547;ERYTHROCYTE#0.8518;PLATELET-DERIVED GROWTH FACTOR#0.8510;MITOCHONDRIA#0.8504;SIGNAL PEPTIDE#0.8486;PROSTATE CANCER#0.8486;HEMATOPOIETIC CELL#0.8476;OMPHALOCELE#0.8457;CARCINOSARCOMA#0.8454;INTENTION TO TREAT#0.8432;BONE MARROW CELLS#0.8415;METASTATIC CARCINOMA#0.8413;ESTRADIOL BINDING#0.8411;PROTEIN BINDING#0.8406;RED BLOOD CELL#0.8391;TYROSINEMIA#0.8386;SMALL CELL CARCINOMA#0.8379;FETAL KIDNEY#0.8368;BILIARY ATRESIA#0.8347;OVERALL RESPONSE RATE#0.8338;EOSIN#0.8328;VITAMIN K ANTAGONIST#0.8326;CHOLESTASIS#0.8323;VINCRISTINE#0.8321;LOW BIRTH WEIGHT#0.8288;ENDOMETRIAL CARCINOMA#0.8264;PUBERTY#0.8246;DNA BINDING#0.8242;LYMPH NODE INVOLVEMENT#0.8234;CONJUGATION#0.8226;PERIPHERAL BLOOD LYMPHOCYTES#0.8220;HYPOXIA#0.8206;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8205;HEPATIC ENCEPHALOPATHY#0.8198;ENDODERM CELL#0.8187;SURFACE PLASMON RESONANCE#0.8168;AKT SIGNALING#0.8163;CYSTIC TERATOMA#0.8161;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8134;ENDOMETRIUM#0.8119;NEPHROTIC SYNDROME#0.8116;PANCREATIC CARCINOMA#0.8090;METASTATIC LYMPH NODE#0.8085;GONAD#0.8083;CHOROID PLEXUS#0.8081;UMBILICAL CORD BLOOD#0.8067;URINARY BLADDER#0.8060;LIVER STEM CELL#0.8057;INDUCED PLURIPOTENT STEM CELL#0.8040;ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY#0.8024;ADRENAL GLAND#0.7988;OBJECTIVE RESPONSE RATE#0.7982;STROMAL CELL#0.7977;G-CSF#0.7971;SYNCYTIOTROPHOBLAST#0.7971;BILIARY TRACT#0.7953;PRECOCIOUS PUBERTY#0.7946;HUMAN LEUKOCYTE ANTIGEN#0.7945;GASTROSCHISIS#0.7927;MITOGENIC ACTIVITY#0.7914;ENTECAVIR#0.7909;HEPATIC NUCLEAR FACTOR#0.7904;NEPHROSIS#0.7896;RIBOSOME#0.7890;VENOUS BLOOD#0.7886;SALIVARY GLAND#0.7884;ENDOMETRIAL ADENOCARCINOMA#0.7856;RHEUMATOID ARTHRITIS#0.7843;DRUG RESISTANCE#0.7824;ACUTE LIVER INJURY#0.7797;HEPARIN#0.7796;TO TUMOR PROGRESSION#0.7787;PERITONEUM#0.7770;PLACENTAL INSUFFICIENCY#0.7763;CATALYTIC ACTIVITY#0.7753;INDUCTION OF APOPTOSIS#0.7750;OVERALL SURVIVAL TIME#0.7749;SPONTANEOUS ABORTION#0.7742;RETINOIC ACID RECEPTOR#0.7740;CHRONIC LIVER FAILURE#0.7732;CELL ACTIVATION#0.7730;OESTRADIOL#0.7721;PLASMA MEMBRANE#0.7715;COLORECTAL CARCINOMA#0.7711;MULTIPLE LOGISTIC REGRESSION#0.7709;LARGE CELL NEUROENDOCRINE CARCINOMA#0.7703;PLACENTA ACCRETA#0.7699;ONCOGENESIS#0.7697;COLONY-STIMULATING FACTOR#0.7662;MICROVILLI#0.7661;ENZYME ACTIVITY#0.7660;ESOPHAGEAL CARCINOMA#0.7660;HEPATOCYTE DIFFERENTIATION#0.7657;KINASE INHIBITOR#0.7657;TOTAL BILIRUBIN LEVEL#0.7654;DEDIFFERENTIATION#0.7653;OMENTUM#0.7653;TRANSITIONAL CELL CARCINOMA#0.7646;CARRIE#0.7617;FERTILIZATION#0.7613;SERTOLI CELL#0.7597;HUMAN CORD BLOOD#0.7586;AMNION#0.7583;STEM CELL TRANSPLANTATION#0.7580;RECTUM#0.7579;ADENOSINE#0.7571;LOCALISATION#0.7569;RECEPTOR MEDIATED ENDOCYTOSIS#0.7548;MOUSE EMBRYONIC STEM#0.7547;SPECIFIC SURFACE AREA#0.7533;NEGATIVE CONTROL GROUP#0.7523;NEUROPATHY#0.7508;POSITIVE LIKELIHOOD RATIO#0.7504;G1 PHASE#0.7480;LIVER NEOPLASM#0.7464;GROWTH HORMONE#0.7449;CASPASE-3 ACTIVITY#0.7440;DIED OF DISEASE#0.7420;ESOPHAGUS#0.7418;NEUROENDOCRINE TUMOR#0.7406;RELATIVE STANDARD DEVIATION#0.7391;EPITHELIAL MESENCHYMAL TRANSITION#0.7376;PROTEIN PROTEIN INTERACTION#0.7362;DIARRHEA#0.7345;IRINOTECAN#0.7339;STEM CELL FACTOR#0.7330;STANDARD OF CARE#0.7330;GLUCOCORTICOID RECEPTOR#0.7327;HYDROCEPHALUS#0.7324;MULTIPLE REGRESSION ANALYSIS#0.7321;INTERMEDIATE FILAMENT#0.7317;ANTISENSE RNA#0.7316;CONNEXIN#0.7280;HEPATOBILIARY DISEASE#0.7274;TELOMERASE ACTIVITY#0.7270;VP-16#0.7267;EXOSOME#0.7264;FOLATE#0.7255;TREG CELL#0.7254;GD-EOB-DTPA#0.7248;ACUTE LIVER FAILURE#0.7226;LYSINE#0.7224;RETINOID X RECEPTOR#0.7186;GRANULOCYTE#0.7182;WORLD HEALTH ORGANIZATION#0.7174;AT-17#0.7172;HEPATITIS A#0.7171;NASAL BONE#0.7163;SELECTIN#0.7161;DISEASE SPECIFIC SURVIVAL#0.7148;PANCREATOBLASTOMA#0.7143;PYRUVATE KINASE#0.7141;URIC ACID#0.7140;MEDIASTINAL LYMPH NODE#0.7131;DUCTUS VENOSUS#0.7108;FOLLICLE STIMULATING HORMONE#0.7104;ANAPLASTIC SEMINOMA#0.7093;TUMOUR NECROSIS FACTOR#0.7085;HEPATOCELLULAR ADENOMA#0.7071;SIGNAL GENERATION#0.7070;B LYMPHOCYTE#0.7070;NONALCOHOLIC FATTY LIVER DISEASE#0.7064;NORMAL CONTROL GROUP#0.7064;ALCOHOLIC FATTY LIVER#0.7062;EXCRETION#0.7059;HYPOTHYROIDISM#0.7050;SPINAL CORD#0.7046;BONE MORPHOGENETIC PROTEIN#0.7019;CORTISOL#0.7017;RNA INTERFERENCE#0.7013;NEUTROPENIA#0.7002;GOLGI COMPLEX#0.6983;MACROPHAGE MIGRATION#0.6981;STEM CELL LIKE#0.6981;BINDING PROTEIN 3#0.6970;DIGESTIVE TRACT#0.6969;FLUORESCEIN#0.6966;CAPECITABINE#0.6960;RETINOL BINDING#0.6955;ADJACENT NORMAL TISSUE#0.6950;LINEAR REGRESSION ANALYSIS#0.6936;HYDROCORTISONE#0.6931;GM-CSF#0.6900;EMBRYOID BODY#0.6895;TYPE 2 DIABETES#0.6881;CERVIX#0.6868;MULTIPLE REACTION MONITORING#0.6861;INTENT TO TREAT#0.6853;CHEMOKINE RECEPTOR#0.6841;ACTIVATED T LYMPHOCYTES#0.6829;NEGATIVE LIKELIHOOD RATIO#0.6781;POLYHYDRAMNIOS#0.6779;PYRUVATE#0.6769;BLOOD PLASMA#0.6764;REGULATORY T CELL#0.6758;FETAL GROWTH RESTRICTION#0.6754;MECHANISM OF ACTION#0.6746;CHROMATIN ASSEMBLY#0.6742;DIMETHYL SULFOXIDE#0.6703;TAMOXIFEN#0.6700;GALECTIN#0.6692;L-ALANINE#0.6689;ANTIOXIDANT ACTIVITY#0.6682;ENTEROENDOCRINE CELL#0.6670;CIRCULATING CELL FREE#0.6666;FACTOR VIII#0.6664;DNA FRAGMENTATION#0.6663;NEURAL CELL#0.6662;FETAL BRAIN#0.6652;BREAST CANCER PATIENTS#0.6640;HEPATITIS C VIRAL#0.6603;GLUCOSE-6-PHOSPHATE#0.6596;LAMIVUDINE#0.6593;METHIONINE#0.6545;OOCYTE#0.6538;LYSIS#0.6523;PLATELET AGGREGATION#0.6515;ALCOHOLIC HEPATITIS#0.6491;HISTONE DEACETYLASE#0.6485;PERIPHERAL BLOOD CELLS#0.6469;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6464;LUPUS ERYTHEMATOSUS#0.6462;DIAPHRAGM#0.6456;AUTOIMMUNE HEPATITIS#0.6452;PLACENTATION#0.6443;CEREBELLAR ATAXIA#0.6438;HYALURONIC ACID#0.6438;RAPAMYCIN#0.6431;LATE PREGNANCY#0.6421;INTRACRANIAL GERMINOMA#0.6418;ARGININE#0.6411;PHOSPHATASE AND TENSIN HOMOLOG#0.6409;OLIGOHYDRAMNIOS#0.6408;EMBOLISM#0.6406;TESTICULAR GERM CELL CANCER#0.6399;ANOREXIA#0.6396;ENDOMETRIOSIS#0.6386;RETE TESTIS#0.6382;PARATHYROID HORMONE#0.6376;PROTEIN KINASE C#0.6371;CERVICAL CANCER#0.6369;PROGRAMMED CELL DEATH#0.6367;PRO-INFLAMMATORY#0.6364;CONNECTIVE TISSUE#0.6353;KIDNEY DISEASE#0.6348;TOLL LIKE RECEPTOR#0.6344;CELL MIGRATION#0.6334;PREMATURITY#0.6309;RESECTABLE HEPATOCELLULAR CARCINOMA#0.6304;ADENOSQUAMOUS CARCINOMA#0.6294;GEMCITABINE#0.6274;CHENODEOXYCHOLIC ACID#0.6270;COLLAGENASE#0.6258;TRIIODOTHYRONINE#0.6253;ADVANCED LIVER DISEASE#0.6221;MIGRATION INHIBITORY FACTOR#0.6200;SUCROSE#0.6181;NEUROBLASTOMA#0.6174;ASPARTIC ACID#0.6172;GLUTAMATE DEHYDROGENASE#0.6170;COLON CARCINOMA#0.6167;TERMINAL DIFFERENTIATION#0.6140;ADENOSINE TRIPHOSPHATE#0.6138;CEREBRAL CORTEX#0.6131;TYPE 2 DIABETES MELLITUS#0.6128;2 DIABETES MELLITUS#0.6128;INFLAMMATORY RESPONSE#0.6123;MESENCHYMAL HAMARTOMA#0.6120;SKELETAL MUSCLE#0.6095;HEALTHY CONTROL SUBJECTS#0.6094;CYTOTOXIC T CELL#0.6093;THROMBOPLASTIN#0.6090;METHYLATION SPECIFIC PCR#0.6088;DODECYL SULFATE#0.6073;SODIUM DODECYL SULFATE#0.6073;SMALL INTESTINE#0.6064;CLEAR CELL ADENOCARCINOMA#0.6060;ORGANOGENESIS#0.6042;B CELL LYMPHOMA#0.6038;TYROSINE KINASE 1#0.6019;THYMOCYTE#0.6001
1750	TRANSCRIPTION FACTOR#1.0231;FOREBRAIN#0.9778;GENE EXPRESSION#0.9739;NEURAL CREST#0.9362;SPLIT HAND-FOOT MALFORMATION#0.9009;MORPHOGENESIS#0.8745;INTERNEURON#0.8740;ANTISENSE RNA#0.8377;UPPER JAW#0.8218;BRANCHIAL ARCH#0.8002;NEURAL CREST CELL#0.7957;LIMB DEVELOPMENT#0.7459;MESENCHYME#0.7052;CELL PROLIFERATION#0.6831;HEARING LOSS#0.6640;CRANIOFACIAL DEVELOPMENT#0.6557;OSTEOBLAST#0.6419;RAPP-HODGKIN SYNDROME#0.6389;CHONDROCYTE HYPERTROPHY#0.6309;CHONDROCYTE#0.6246;OLFACTORY BULB#0.6225;INNER EAR#0.6163;TELENCEPHALON#0.6133;MESENCHYMAL CELL#0.6027
1755	TERMINAL DIFFERENTIATION#1.0682;MALIGNANT BRAIN TUMOR#1.0626;SURFACTANT PROTEIN D#1.0501;EXTRACELLULAR MATRIX#1.0484;INNATE IMMUNITY#1.0476;TUMOR SUPPRESSOR#1.0471;SCAVENGER RECEPTOR#1.0414;EPSTEIN BARR VIRUS#1.0398;LUNG CANCER#1.0300;EPITHELIAL CELL#1.0281;CANCER CELL#1.0131;T CELL#1.0055;LECTIN#1.0036;BREAST CANCER#1.0014;GALECTIN#0.9986;GENE EXPRESSION#0.9935;SALIVARY GLAND#0.9923;CELL SURFACE#0.9912;ORAL CAVITY#0.9876;POLYMERASE CHAIN REACTION#0.9788;CROHN'S DISEASE#0.9774;MALIGNANT GLIOMA#0.9634;COMPLEMENT ACTIVATION#0.9619;B CELL#0.9568;COLUMNAR#0.9488;IMMUNE RESPONSE#0.9487;REVERSE TRANSCRIPTION#0.9391;GROWTH FACTOR#0.9267;SURFACE PLASMON RESONANCE#0.9259;BILE DUCT#0.9089;VACCINIA#0.9078;DENTAL CARIES#0.8989;COLORECTAL CANCER#0.8885;BIOFILM FORMATION#0.8766;CELL DIFFERENTIATION#0.8740;ACINAR CELL#0.8714;ZONA PELLUCIDA#0.8666;MACROPHAGE#0.8657;MEDULLOBLASTOMA#0.8579;PELLICLE#0.8566;CARBOHYDRATE RECOGNITION DOMAIN#0.8560;COLORECTAL#0.8556;BACTERIAL BINDING#0.8518;IMMUNE SYSTEM#0.8501;SQUAMOUS CELL CARCINOMA#0.8425;TWITCHING MOTILITY#0.8366;COLITIS#0.8343;ASTROCYTOMA#0.8308;METABOLIC ACIDOSIS#0.8302;GLYCOSYLATION#0.8260;VIRULENCE#0.8206;PROSTATE CANCER#0.8056;INFLAMMATORY BOWEL DISEASE#0.8018;SIGNALING PATHWAY#0.7942;AMNIOTIC FLUID#0.7937;COPY NUMBER VARIATION#0.7935;CELL CYCLE#0.7912;ADENOCARCINOMA#0.7867;ENDOTHELIAL CELL#0.7807;INTESTINAL EPITHELIAL CELL#0.7744;SMALL INTESTINE#0.7712;ZYMOGEN GRANULE#0.7658;PATTERN RECOGNITION RECEPTOR#0.7629;APOPTOSIS#0.7592;ULCERATIVE COLITIS#0.7590;BLADDER CARCINOMA#0.7567;LUNG EPITHELIAL CELL#0.7527;GASTRIC MUCOSA#0.7484;DIGESTION#0.7484;CHROMOSOMAL REGION#0.7476;NF-KAPPAB ACTIVATION#0.7465;CELL WALL#0.7390;NASAL MUCOSA#0.7324;ANGIOGENESIS#0.7140;RESPIRATORY TRACT#0.7101;RENAL TUBULAR ACIDOSIS#0.7060;TRANSCRIPTION FACTOR#0.7004;LEUKOCYTE#0.7002;CELL PROLIFERATION#0.6977;BETA CELL#0.6972;SIGNAL TRANSDUCTION#0.6938;STEM CELL#0.6919;CERVICAL#0.6882;CD4+ T CELL#0.6851;PRIMARY SCLEROSING CHOLANGITIS#0.6841;MANNOSE BINDING LECTIN#0.6835;DEXTRAN SULFATE SODIUM#0.6830;SCLEROSING CHOLANGITIS#0.6826;MANNOSE BINDING#0.6821;HUMAN IMMUNODEFICIENCY VIRUS#0.6789;CELL MEMBRANE#0.6781;DIGESTIVE TRACT#0.6770;ENDOCYTOSIS#0.6703;LUNG CARCINOMA#0.6699;LYMPH NODE#0.6690;LIVER DISEASE#0.6651;SUCROSE#0.6576;GLIOBLASTOMA MULTIFORME#0.6537;CELL ADHESION#0.6451;GROWTH FACTOR RECEPTOR#0.6206;AGGLUTINATION#0.6189;TRANS GOLGI NETWORK#0.6117;REGENERATION#0.6102;GASTROINTESTINAL SYSTEM#0.6077;ALVEOLAR MACROPHAGE#0.6062;HEPATITIS B#0.6030;COMPARATIVE GENOMIC HYBRIDIZATION#0.6024;INTRACELLULAR VESICLE#0.6015
1756	X-LINKED RECESSIVE DISEASE#1.0802;DYSTROPHIN-ASSOCIATED GLYCOPROTEIN COMPLEX#1.0696;DYSTROGLYCAN COMPLEX#1.0442;DYSTROPHIN GLYCOPROTEIN COMPLEX#1.0432;PURKINJE CELL#1.0431;INHIBITORY SYNAPSE#1.0428;NON-MUSCLE TISSUE#1.0413;GLYCOPROTEIN COMPLEX#1.0387;COSTAMERE#1.0387;GABA A RECEPTOR#1.0340;PROTEIN COMPLEX#1.0314;SPECTRIN#1.0253;T TUBULE#1.0244;C TERMINAL DOMAIN#1.0236;DYSTROGLYCAN BINDING#1.0209;TRANSVERSE TUBULE#1.0202;PRE-MRNA SPLICING#1.0199;SARCOGLYCAN COMPLEX#1.0195;POSTSYNAPTIC MEMBRANE#1.0154;ACTIN CYTOSKELETON#1.0138;BETA GALACTOSIDASE#1.0135;ACTIN BINDING#1.0124;MUSCULAR DISEASE#1.0118;ACTIN BINDING PROTEIN#1.0118;COMPLEX I#1.0116;MYOTENDINOUS JUNCTION#1.0109;MUSCLE PRECURSOR CELL#1.0105;GLYCEROL KINASE#1.0101;PERIPHERAL MEMBRANE PROTEIN#1.0095;GLIAL CELL#1.0093;MRNA PROCESSING#1.0088;PROTEASOME#1.0087;MRNA SPLICING#1.0076;MUSCLE CONTRACTION#1.0063;SARCOLEMMA#1.0054;LAMININ BINDING#1.0051;HEART MUSCLE#1.0044;BECKER MUSCULAR DYSTROPHY#1.0041;GENTAMICIN#1.0041;FOCAL ADHESION#1.0040;ACTIN FILAMENT#1.0039;MICROTUBULE#1.0023;STRIATED MUSCLE#1.0002;BASAL LAMINA#1.0001;ION CHANNEL#1.0000;CELL MEMBRANE#0.9999;PERIPHERAL NERVE#0.9993;ANCHORING#0.9993;SCHWANN CELL#0.9990;MUSCLE FIBRE#0.9989;AQUAPORIN#0.9988;MAST CELL#0.9987;CARDIAC MUSCLE#0.9974;CELL PENETRATING PEPTIDE#0.9969;SHORT TANDEM REPEAT#0.9969;SMOOTH MUSCLE#0.9961;SIGNALING MOLECULE#0.9958;CARDIOMYOCYTE#0.9955;NITRIC OXIDE SYNTHASE#0.9948;NUCLEIC ACID#0.9947;WATER CHANNEL#0.9945;MYOFIBRIL#0.9935;EXTRACELLULAR MATRIX#0.9935;MUSCLE WASTING#0.9933;PLASMA MEMBRANE#0.9928;INTERMEDIATE FILAMENT#0.9927;SODIUM CHANNEL#0.9926;X CHROMOSOME#0.9924;LAMININ RECEPTOR#0.9923;INDUCED PLURIPOTENT STEM CELL#0.9921;MEMBRANE FRACTION#0.9917;PROTEIN PROTEIN INTERACTION#0.9917;NICOTINIC ACETYLCHOLINE RECEPTOR#0.9916;ISCHEMIA#0.9911;MUSCLE STEM CELL#0.9910;SKELETAL MUSCLE WASTING#0.9908;REVERSE TRANSCRIPTION#0.9905;DILATED CARDIOMYOPATHY#0.9904;OSTEOPOROSIS#0.9904;PERIPHERAL BLOOD#0.9903;Z LINE#0.9903;DUCHENNE MUSCULAR DYSTROPHY#0.9900;MUSCULAR DYSTROPHY#0.9899;BASEMENT MEMBRANE#0.9899;MYOCYTES#0.9898;NEUROMUSCULAR DISEASE#0.9894;MYOCARDIUM#0.9894;ASTROCYTE#0.9892;CENTRAL NERVOUS SYSTEM#0.9891;PLURIPOTENT STEM CELL#0.9888;NITRIC OXIDE#0.9886;PRECURSOR CELL#0.9883;UBIQUITIN#0.9883;SYNAPTIC TRANSMISSION#0.9882;MUSCLE FIBER#0.9876;GENETIC DISEASE#0.9875;SPINAL CORD#0.9875;MYOGENIC CELL#0.9869;SKELETAL MUSCLE CELLS#0.9869;LOCALISATION#0.9867;SMOOTH MUSCLE CELL#0.9866;POLYMERASE CHAIN REACTION#0.9861;CELL SURFACE#0.9856;CEREBRAL CORTEX#0.9855;MYOSIN HEAVY CHAIN#0.9853;ACETYLCHOLINE RECEPTOR#0.9851;CALCIUM CHANNEL#0.9851;BIPOLAR CELL#0.9848;CARDIOMYOPATHY#0.9845;BONE MARROW#0.9842;NEUROMUSCULAR JUNCTION#0.9838;GENETIC DISORDER#0.9837;SIGNAL TRANSDUCTION#0.9835;RESPIRATORY FAILURE#0.9833;MUSCULAR ATROPHY#0.9832;PROGENITOR CELL#0.9831;BLOOD BRAIN BARRIER#0.9829;CREATINE KINASE ACTIVITY#0.9826;QUADRICEPS#0.9823;SKELETON#0.9823;VACUOLE#0.9822;MUSCLE CELL#0.9821;ADENO ASSOCIATED VIRUS#0.9819;MUSCLE ATROPHY#0.9817;MENTAL RETARDATION#0.9809;CELL ADHESION#0.9801;T CELL#0.9800;HEART DISEASE#0.9795;NERVOUS SYSTEM#0.9793;PROTEIN KINASE#0.9789;SKELETAL MUSCLE#0.9786;MUSCLE DAMAGE#0.9784;MYOTUBE#0.9784;MYOBLAST#0.9781;ACETYLCHOLINE#0.9781;MUSCLE SATELLITE CELL#0.9778;TRANSCRIPTASE#0.9767;IMMUNE RESPONSE#0.9766;MUSCLE HYPERTROPHY#0.9766;DIAPHRAGM#0.9763;HINDLIMB#0.9760;MESENCHYMAL STEM CELL#0.9760;CONGENITAL MUSCULAR DYSTROPHY#0.9759;INFLAMMATORY RESPONSE#0.9758;SARCOPLASMIC RETICULUM#0.9758;FEMUR#0.9755;CELL PROLIFERATION#0.9754;SYNAPTIC MEMBRANE#0.9752;GLYCOSYLATION#0.9751;CYTOPLASM#0.9751;SARCOMERE#0.9747;LIMB-GIRDLE MUSCULAR DYSTROPHY#0.9747;CELL DEATH#0.9746;KINASE ACTIVITY#0.9738;APOPTOSIS#0.9735;CHANNEL ACTIVITY#0.9730;MYOPATHY#0.9729;BLOOD VESSEL#0.9729;SPINAL MUSCULAR ATROPHY#0.9728;TOXICITY#0.9725;MITOCHONDRIA#0.9722;EXTRACELLULAR MATRIX COMPONENT#0.9720;COMPARATIVE GENOMIC HYBRIDIZATION#0.9715;SIGNALING PATHWAY#0.9708;CONNECTIVE TISSUE#0.9707;RYANODINE RECEPTOR#0.9692;SKELETAL MUSCLE REGENERATION#0.9690;MYOGENESIS#0.9687;STEM CELL TRANSPLANTATION#0.9678;STEM CELL#0.9676;INFLAMMATORY CELL#0.9676;MUSCLE WEAKNESS#0.9674;NECROTIC#0.9667;MUTAGENESIS#0.9664;CAVEOLAE#0.9660;ADIPOSE TISSUE#0.9659;POTASSIUM CHANNEL#0.9656;PREDNISOLONE#0.9656;REGENERATION#0.9649;ARGININE#0.9648;ENDOTHELIAL CELL#0.9648;ARRHYTHMIA#0.9643;CARRIE#0.9632;MAGNETIC RESONANCE IMAGING#0.9629;CONGENITAL MUSCULAR DYSTROPHIES#0.9628;TRANSCRIPTION FACTOR#0.9623;CROSS SECTIONAL AREA#0.9622;EPILEPSY#0.9604;FRAGMENT LENGTH POLYMORPHISM#0.9595;PREDNISONE#0.9595;REACTIVE OXYGEN SPECIES#0.9592;ISOPROTERENOL#0.9590;BICEPS#0.9588;GENE EXPRESSION#0.9584;MACROPHAGE#0.9582;CELL ADHESION MOLECULE#0.9582;MYOCARDITIS#0.9577;IMMUNE SYSTEM#0.9564;ACTION POTENTIAL#0.9563;PREMATURE TERMINATION CODON#0.9562;APOPTOTIC#0.9561;CREATINE KINASE#0.9553;X CHROMOSOME INACTIVATION#0.9536;CREATINE#0.9535;CHROMOSOME INACTIVATION#0.9533;DIGESTION#0.9522;NEURONAL CELLS#0.9520;GROWTH FACTOR#0.9511;EDEMA#0.9502;AUTOSOMAL RECESSIVE LIMB-GIRDLE MUSCULAR DYSTROPHY#0.9491;Z BAND#0.9483;TRANSFORMING GROWTH FACTOR#0.9476;LEAK CHANNEL#0.9462;HYPOXIA#0.9450;CELL CYCLE#0.9427;POLYMYOSITIS#0.9423;LINES OF EVIDENCE#0.9404;INTERCALATED DISC#0.9403;PROTEIN SYNTHESIS#0.9390;FIBROBLAST GROWTH FACTOR#0.9388;NERVE TERMINAL#0.9381;CARDIOTOXIN#0.9380;CARDIAC ABNORMALITIES#0.9365;TUMOR SUPPRESSOR#0.9350;IMMUNE CELL#0.9339;SCOLIOSIS#0.9320;GESTATION#0.9317;ENDOPLASMIC RETICULUM#0.9302;CERVICAL#0.9281;NEUROTRANSMISSION#0.9265;CONGESTIVE HEART FAILURE#0.9254;EPITHELIAL CELL#0.9250;HEAT SHOCK PROTEIN#0.9249;UMBILICAL CORD#0.9239;ANGIOTENSIN CONVERTING ENZYME#0.9238;MITOGEN ACTIVATED PROTEIN#0.9234;CELL DIFFERENTIATION#0.9224;LEUKOCYTE#0.9219;PROTEIN DEFICIENCY#0.9214;ANGIOGENESIS#0.9210;MYOGENIC REGULATORY FACTOR#0.9209;PRO-INFLAMMATORY#0.9196;DEVELOPMENTAL DELAY#0.9190;CALCIUM SIGNALING#0.9189;L-ARGININE#0.9163;HOMOLOGOUS RECOMBINATION#0.9155;CYTOSKELETAL ELEMENT#0.9151;TUMOR NECROSIS FACTOR#0.9140;PLASMALEMMA#0.9130;GLYCEROL KINASE DEFICIENCY#0.9125;DAP I#0.9115;SIGNALLING PATHWAY#0.9107;ARTERY#0.9103;ENZYME INHIBITOR#0.9101;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9087;ENDOTHELIAL GROWTH FACTOR#0.9086;MAGNETIC RESONANCE SPECTROSCOPY#0.9083;RECEPTOR CLUSTERING#0.9073;PREMATURE STOP CODONS#0.9060;INSULIN-LIKE GROWTH FACTOR#0.9043;FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY#0.9042;SMALL NUCLEAR RNA#0.9042;QUANTITATIVE REAL TIME#0.9041;VASCULAR SMOOTH MUSCLE CELL#0.9010;STRIATED MUSCLE FIBER#0.9003;AUTOPHAGY#0.8994;PROTEIN DEGRADATION#0.8988;STROMAL CELL#0.8975;INNERVATION#0.8972;PERIPHERAL BLOOD LYMPHOCYTES#0.8963;NEUROTRANSMITTER RELEASE#0.8951;M LINE#0.8940;Z DISK#0.8935;POSTSYNAPTIC DENSITY#0.8934;INTELLECTUAL DISABILITY#0.8915;SARCOPLASM#0.8910;ADHERENS JUNCTION#0.8909;BONE FORMATION#0.8903;I BAND#0.8875;PHOSPHODIESTERASE#0.8865;HYPERTROPHIC CARDIOMYOPATHY#0.8849;KYPHOSIS#0.8839;EMBRYONIC STEM CELL#0.8837;ENDOTHELIUM#0.8830;AKT SIGNALING#0.8816;AMYOTROPHIC LATERAL SCLEROSIS#0.8812;Y CHROMOSOME#0.8812;LATERAL SCLEROSIS#0.8811;CYTOTOXICITY#0.8795;NEURAL CELL#0.8792;T LYMPHOCYTE#0.8782;BONE MARROW STEM CELL#0.8765;CALMODULIN BINDING#0.8754;ORGANELLE#0.8748;RHABDOMYOSARCOMA#0.8738;HISTONE DEACETYLASE#0.8720;MYOBLAST FUSION#0.8716;AMYLOID PRECURSOR PROTEIN#0.8714;VIRAL GENOME#0.8699;BETA-2#0.8695;FAMILIAL DILATED CARDIOMYOPATHY#0.8691;CHORIONIC VILLUS#0.8685;COPY NUMBER VARIATION#0.8684;MYOCARDIAL INFARCTION#0.8659;FOREARM#0.8654;PROTEOGLYCAN#0.8652;OXIDATIVE PHOSPHORYLATION#0.8651;TRANSIENT RECEPTOR POTENTIAL#0.8644;METHYLPREDNISOLONE#0.8639;MONONUCLEAR CELLS#0.8637;CYSTIC FIBROSIS#0.8624;EOSIN#0.8620;Z DISC#0.8615;CORD BLOOD#0.8610;PEPTIDE NUCLEIC ACID#0.8591;LIPID RAFT#0.8581;BRAIN DEVELOPMENT#0.8568;SCIATIC NERVE#0.8542;AUTOSOME#0.8531;NERVE GROWTH FACTOR#0.8523;TIBIA#0.8511;CONGENITAL MYOPATHY#0.8502;NEUROPATHY#0.8499;FORELIMB#0.8497;SKELETAL MUSCLE TISSUES#0.8495;TEMPORAL LOBE EPILEPSY#0.8487;RNA SPLICING#0.8481;PYRUVATE KINASE#0.8459;LECTIN#0.8454;EXONIC SPLICING ENHANCER#0.8453;TEMPORAL LOBE#0.8448;CELL DIVISION#0.8402;NEUTROPHIL#0.8379;STANDARD OF CARE#0.8368;SKIN FIBROBLASTS#0.8360;MYOSITIS#0.8349;MICROTUBULE BINDING#0.8342;VENTRICULAR CARDIOMYOCYTE#0.8339;DERMAL FIBROBLAST#0.8329;SMOOTH MUSCLE FIBER#0.8324;MAP KINASE#0.8317;FACTOR I#0.8313;DENTATE GYRUS#0.8312;VIRAL INFECTION#0.8273;PHOTORECEPTOR CELL#0.8271;DERMATOMYOSITIS#0.8258;ALANINE#0.8239;SYNAPTOGENESIS#0.8230;MUSCLE ATTACHMENT#0.8224;NUCLEAR MEMBRANE#0.8208;SYNTROPHIN COMPLEX#0.8196;FOCAL ADHESION COMPLEX#0.8193;NEURITE#0.8185;DOBUTAMINE#0.8172;PROTEIN BINDING#0.8151;MYOBLAST DIFFERENTIATION#0.8126;PARATHYROID HORMONE#0.8118;NEURITE OUTGROWTH#0.8114;SKELETAL MUSCLE MASS#0.8098;MASSETER#0.8067;WALKER-WARBURG SYNDROME#0.8061;LASER SCANNING MICROSCOPY#0.8055;ALKALINE PHOSPHATASE#0.8051;CARDIAC MAGNETIC RESONANCE#0.8049;CYTOTOXIC T CELL#0.8048;OSTEOBLAST#0.8044;STEM CELLS TRANSPLANTATION#0.8003;KINASE INHIBITOR#0.7989;ADENOSINE#0.7985;F-ACTIN BINDING#0.7967;HEARING LOSS#0.7961;POST-SYNAPTIC MEMBRANE#0.7939;PYRUVATE#0.7938;UMBILICAL CORD BLOOD#0.7932;LYMPHOBLASTOID CELLS#0.7932;BRAIN DISEASE#0.7929;CELL POLARITY#0.7926;RETINITIS PIGMENTOSA#0.7919;NEUROFILAMENT#0.7908;CELL MIGRATION#0.7899;CELLULAR IMMUNE RESPONSE#0.7897;RNA PROCESSING#0.7896;OSTEOGENESIS#0.7842;GROWTH HORMONE#0.7841;PROTEIN KINASE C#0.7839;DNA FRAGMENTATION#0.7835;SIGNALING CASCADE#0.7835;EMERY-DREIFUSS MUSCULAR DYSTROPHY#0.7833;MALIGNANT HYPERTHERMIA#0.7829;MARROW STEM CELLS#0.7829;SKELETAL MUSCLE ATROPHY#0.7825;EXOSOME#0.7812;INTERCALATED DISK#0.7807;NUCLEAR ENVELOPE#0.7806;EXTRACELLULAR SPACE#0.7801;ADIPOSE-DERIVED STEM CELL#0.7801;CANCER CELL#0.7800;AIRWAY SMOOTH MUSCLE#0.7796;CAFFEINE#0.7778;PIA MATER#0.7776;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY#0.7769;CELL FUSION#0.7765;GLUTAMATE RECEPTOR#0.7759;LYSOSOME#0.7758;CALCINEURIN#0.7758;RECEPTOR COMPLEX#0.7750;HERPES SIMPLEX VIRUS#0.7741;HERPES SIMPLEX#0.7738;MICROFILAMENT#0.7733;INTEGRIN COMPLEX#0.7732;PREIMPLANTATION GENETIC DIAGNOSIS#0.7724;CELLULAR LOCALIZATION#0.7721;LOCOMOTION#0.7713;END DIASTOLIC VOLUME#0.7688;ADRENERGIC RECEPTOR#0.7672;NEUROTRANSMITTER RECEPTOR#0.7666;EMBRYONIC MUSCLE#0.7665;INCLUSION BODY#0.7662;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7662;DANTROLENE#0.7661;A BAND#0.7651;RESVERATROL#0.7634;TRANSLATION TERMINATION#0.7627;CHOROID PLEXUS#0.7619;GLUTATHIONE#0.7597;BRAIN EDEMA#0.7597;DNA AMPLIFICATION#0.7595;MESENCHYMAL STROMAL CELL#0.7560;MICROSOME#0.7542;SUCCINATE#0.7535;MITOCHONDRIAL DNA#0.7518;ATPASE ACTIVITY#0.7517;BETA-DYSTROGLYCAN BINDING#0.7513;CALCIUM RELEASE CHANNEL#0.7509;BODY WALL MUSCLE#0.7504;CYCLOSPORINE#0.7489;SMOOTH MUSCLE ACTIN#0.7480;MUSCLE-DERIVED CELL#0.7425;SEX DETERMINATION#0.7421;NEURONAL MIGRATION#0.7417;CATION CHANNEL#0.7409;PTC124#0.7397;PROTEIN LOCALIZATION#0.7387;MYOGLOBINURIA#0.7378;INTERSTITIAL CELL#0.7376;FETAL BRAIN#0.7375;SUCROSE#0.7374;ION HOMEOSTASIS#0.7372;HEMATOPOIETIC STEM CELL#0.7365;RNA INTERFERENCE#0.7361;INTRACELLULAR LOCALIZATION#0.7352;PERICYTE#0.7352;VASOCONSTRICTION#0.7347;MYOGENIC PRECURSOR CELL#0.7345;ADVANCED HEART FAILURE#0.7343;CHOLINERGIC SYNAPSE#0.7333;ORTHOGONAL ARRAY#0.7275;OSTEOGENESIS IMPERFECTA#0.7251;ANESTHETIC#0.7241;CENTROMERE#0.7237;TRYPTOPHAN#0.7224;HYPOXIC#0.7216;MYOSIN BINDING#0.7206;POSTSYNAPTIC SPECIALIZATION#0.7201;NUCLEAR MATRIX#0.7186;HYPERTHERMIA#0.7180;PROTEIN PHOSPHORYLATION#0.7180;SYNAPTIC VESICLE#0.7180;POST-TRANSLATIONAL MODIFICATION#0.7167;ACID PHOSPHATASE#0.7152;NERVE FIBER#0.7151;HOST CELL#0.7141;GUANINE#0.7140;MECHANISM OF ACTION#0.7139;WEIGHT LOSS#0.7133;SKELETAL MUSCLE GENE#0.7130;MICROTUBULE ASSOCIATED PROTEIN#0.7111;VASCULAR ENDOTHELIAL CELL#0.7103;MINERALIZATION#0.7097;BODY WEIGHT RATIO#0.7074;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7073;TACHYCARDIA#0.7067;TURNER SYNDROME#0.7046;DISTAL MUSCULAR DYSTROPHY#0.7045;RNA BINDING#0.7027;EXCITATORY SYNAPSE#0.7027;PARATHYROID#0.7014;MYELINATION#0.7004;MYASTHENIA GRAVIS#0.6988;SPATIAL LEARNING#0.6987;CARDIAC ARREST#0.6979;OLFACTORY BULB#0.6943;ENDOTHELIAL NITRIC OXIDE#0.6926;BONE MARROW CELLS#0.6920;LOSARTAN#0.6919;INCREASED MUSCLE MASS#0.6892;ENZYME ACTIVITY#0.6892;HEPARIN#0.6880;AUTOPHAGIC VACUOLE#0.6875;POSITIVE FAMILY HISTORY#0.6846;RETINITIS#0.6807;INTERPHASE#0.6805;HUMAN ARTIFICIAL CHROMOSOME#0.6805;COGNITION#0.6784;BIOTIN#0.6783;LEUCINE#0.6778;MYOFILAMENT#0.6777;RAPAMYCIN#0.6765;CYTOCHROME C#0.6752;MYOFIBRILLAR MYOPATHY#0.6746;RECEPTOR ANTAGONIST#0.6731;VACUOLAR MEMBRANE#0.6722;AGEING#0.6717;TRANSCRIPTIONAL CONTROL#0.6683;NMDA RECEPTOR#0.6652;LATERAL WALL#0.6634;BLOOD LOSS#0.6621;SIGNAL TRANSMISSION#0.6594;CALPAIN ACTIVITY#0.6589;FORMALIN#0.6583;ADIPOCYTE#0.6579;MEMBRANE ORGANIZATION#0.6548;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6547;SILDENAFIL#0.6534;TISSUE REGENERATION#0.6534;AMNIOTIC FLUID#0.6526;FOCAL ADHESION KINASE#0.6519;ACE INHIBITOR#0.6512;ADULT STEM CELL#0.6436;PROTEASOME PATHWAY#0.6432;ATRIAL FIBRILLATION#0.6432;MUSCLE HOMEOSTASIS#0.6428;SOMITE#0.6423;ONCOSIS#0.6423;INFLAMMATORY CELL INFILTRATION#0.6410;COLLAGEN TYPE I#0.6407;TOLL LIKE RECEPTOR#0.6379;DOUBLE STRAND BREAK#0.6378;GLUCOSE UPTAKE#0.6372;BETHLEM MYOPATHY#0.6366;TUMOUR NECROSIS FACTOR#0.6364;MEMBRANE INVAGINATION#0.6364;CELL ACTIVATION#0.6346;ADENYLATE#0.6337;HYPERTENSION#0.6333;CELL GROWTH#0.6324;CTLA4IG#0.6316;VENTRICULAR ASSIST DEVICE#0.6307;LOCKED NUCLEIC ACID#0.6297;CLENBUTEROL#0.6285;PERIPHERAL NERVOUS SYSTEM#0.6280;CELL PERIPHERY#0.6279;HYPERACTIVITY#0.6265;NADPH OXIDASE#0.6260;MICROTUBULE CYTOSKELETON#0.6259;BONE RESORPTION#0.6255;PROTEIN TRANSLATION#0.6251;BONE REMODELING#0.6229;PYRAMIDAL CELL#0.6226;SARCOGLYCAN-SARCOSPAN COMPLEX#0.6223;LOW BONE MASS#0.6197;ANDROGEN RECEPTOR#0.6181;OSTEOCLAST#0.6180;MITOCHONDRIAL MEMBRANE#0.6179;MEMBRANE PROTEIN COMPLEX#0.6168;PHOSPHOLIPASE A2#0.6158;ACTIN POLYMERIZATION#0.6157;MYELIN SHEATH#0.6146;CORONARY ARTERY#0.6140;GERM CELL#0.6139;FORCED VITAL CAPACITY#0.6126;GLYCINE#0.6123;STRESS FIBER#0.6117;TOPOISOMERASE II#0.6114;SKELETAL MUSCLE STEM CELL#0.6108;HUMORAL IMMUNE RESPONSE#0.6107;CACHEXIA#0.6099;DENSE PLAQUE#0.6080;RESPIRATORY CHAIN#0.6076;MUSCLE LIM PROTEIN#0.6031;TELOMERE#0.6024
1757	DIMETHYLGLYCINE DEHYDROGENASE#1.1190;SARCOSINE DEHYDROGENASE#1.0984;DIMETHYLGLYCINE#1.0810;GLYCINE#1.0281;FOLATE#0.9569;SARCOSINE METABOLISM#0.9497;MITOCHONDRIA#0.8975;FOLATE BINDING#0.8325;FLAVIN#0.8174;DEMETHYLATION#0.7673;GLYCINE N METHYLTRANSFERASE#0.7648;N METHYLTRANSFERASE#0.7454;MITOCHONDRIAL MATRIX#0.6957;SARCOSINE OXIDASE#0.6696;TETRAHYDROFOLATE#0.6570;CHOLINE#0.6016
1758	AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS#1.0773;DENTIN MATRIX PROTEIN#1.0465;MATRIX PROTEIN 1#1.0462;BONE MINERALIZATION#1.0362;X CHROMOSOME#1.0361;COLLAGEN TYPE I#1.0285;RICKETS#1.0274;OSTEOCYTE#1.0244;INTEGRIN BINDING#1.0212;NODULE FORMATION#1.0180;DENTIN MINERALIZATION#1.0152;ALKALINE PHOSPHATASE ACTIVITY#1.0147;PHOSPHATASE ACTIVITY#1.0119;BIOMINERALIZATION#1.0106;ODONTOBLAST DIFFERENTIATION#1.0089;CHONDROCYTE#1.0047;DENTAL PAPILLA#1.0047;OSTEOMALACIA#1.0040;ODONTOGENESIS#1.0031;DENTINOGENESIS#1.0012;POLYMERASE CHAIN REACTION#1.0006;TRANSCRIPTION FACTOR#1.0001;REVERSE TRANSCRIPTION#1.0001;HYPOPHOSPHATEMIA#0.9987;ALKALINE PHOSPHATASE#0.9960;OSTEOBLAST#0.9930;FIBROBLAST GROWTH FACTOR#0.9930;OSTEOBLAST DIFFERENTIATION#0.9923;OSTEOGENESIS#0.9921;MINERALIZATION#0.9897;BONE MORPHOGENETIC PROTEIN#0.9896;TOOTH DEVELOPMENT#0.9895;GENE EXPRESSION#0.9892;PERIODONTAL LIGAMENT#0.9890;ALIZARIN RED STAINING#0.9881;QUANTITATIVE REAL TIME#0.9881;MESENCHYMAL CELL#0.9866;PROTEIN KINASE#0.9844;OSTEOCLAST#0.9834;CELL DIFFERENTIATION#0.9805;EXTRACELLULAR MATRIX#0.9804;GROWTH FACTOR#0.9780;BONE FORMATION#0.9780;MOLAR#0.9754;DENTAL PULP STEM CELL#0.9725;CELL PROLIFERATION#0.9711;DENTAL PULP CELL#0.9711;ALIZARIN RED S#0.9709;RECEPTOR ACTIVATOR#0.9709;SIGNALING PATHWAY#0.9676;DENTINOGENESIS IMPERFECTA#0.9673;HUMAN DENTAL PULP#0.9640;MESENCHYMAL STEM CELL#0.9634;SCANNING ELECTRON MICROSCOPY#0.9630;DENTAL PULP#0.9614;BONE MARROW#0.9609;CHONDROGENESIS#0.9597;ENDOTHELIAL GROWTH FACTOR#0.9597;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9597;REGENERATION#0.9539;STEM CELL#0.9525;BONE REMODELING#0.9514;PARATHYROID HORMONE#0.9511;BONE MINERAL DENSITY#0.9483;BONE RESORPTION#0.9447;APOPTOSIS#0.9423;TRABECULAR BONE VOLUME#0.9409;MITOGEN ACTIVATED PROTEIN#0.9406;OSSIFICATION#0.9392;PROTEOGLYCAN#0.9377;BONE FORMATION RATE#0.9373;PARATHYROID#0.9369;FIBRIL#0.9307;SKELETON#0.9271;STROMAL CELL#0.9259;FEMUR#0.9245;BONE CELLS#0.9242;ACID PHOSPHATASE#0.9220;KIDNEY DISEASE#0.9174;CELL SURFACE#0.9145;MINERAL TRIOXIDE AGGREGATE#0.9144;GLYCOSYLATION#0.9138;CHRONIC KIDNEY DISEASE#0.9129;SIGNALING MOLECULE#0.9116;INCISORS#0.9106;HUMAN PERIODONTAL LIGAMENT#0.9075;ENDOTHELIAL CELL#0.9065;TISSUE REGENERATION#0.9033;TRANSFORMING GROWTH FACTOR#0.9025;CELL GROWTH#0.9017;MANDIBLE#0.8946;CELL CYCLE#0.8936;MARROW STROMAL CELLS#0.8869;PROGENITOR CELL#0.8790;CELL ADHESION#0.8787;BONE MARROW STROMAL#0.8776;BLOOD VESSEL#0.8707;BONE DEVELOPMENT#0.8706;TRANSMISSION ELECTRON MICROSCOPY#0.8646;PHOSPHATE METABOLISM#0.8636;BONE MARROW STROMAL CELL#0.8571;ANGIOGENESIS#0.8521;CORE BINDING FACTOR#0.8355;OSTEOPOROSIS#0.8285;CYTOPLASM#0.8181;CELL MIGRATION#0.8143;OSTEOGENIC CELL#0.8069;BONE GROWTH#0.8041;SKELETAL DEVELOPMENT#0.7758;CANCER CELL#0.7738;CELL COUNTING KIT#0.7631;PLASMA MEMBRANE#0.7585;VITAMIN D METABOLISM#0.7574;PHOSPHODIESTERASE#0.7543;TERMINAL DIFFERENTIATION#0.7496;PERIODONTAL LIGAMENT STEM CELL#0.7443;SALIVARY GLAND#0.7411;MATRIX GLA PROTEIN#0.7344;DNA BINDING#0.7305;LUNG CANCER#0.7299;BONE REGENERATION#0.7211;TUMOR NECROSIS FACTOR#0.7192;ENDOPLASMIC RETICULUM#0.7003;ENAMEL ORGAN#0.6983;QUANTITATIVE REVERSE TRANSCRIPTION#0.6965;FOCAL ADHESION#0.6778;TRANSCRIPTASE#0.6761;HYPERPHOSPHATEMIA#0.6728;VITAMIN D RECEPTOR#0.6724;GAP JUNCTION#0.6720;APOPTOTIC#0.6679;CEMENTUM FORMATION#0.6602;MAPK SIGNALING#0.6600;BONE MORPHOGENIC PROTEIN#0.6565;FACTOR I#0.6550;DIGESTION#0.6485;SIGNAL PEPTIDE#0.6477;CONNECTIVE TISSUE#0.6459;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6457;AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS#0.6296;ASCORBIC ACID#0.6154
1759	VESICLE ENDOCYTOSIS#1.0630;SYNAPTIC VESICLE ENDOCYTOSIS#1.0614;MITOCHONDRIAL DIVISION#1.0539;MITOCHONDRIAL FISSION#1.0356;SYNAPTIC VESICLE#1.0267;GTPASE ACTIVITY#1.0266;MITOCHONDRIAL FUSION#1.0242;ENDOCYTOSIS#1.0129;SYNAPTIC VESICLE RECYCLING#1.0075;CLATHRIN-MEDIATED ENDOCYTOSIS#1.0073;MITOCHONDRIA#1.0065;DOMINANT NEGATIVE MUTANT#1.0042;SYNAPTIC TRANSMISSION#0.9967;PLASMA MEMBRANE#0.9836;CELL DEATH#0.9759;COATED PIT#0.9738;MEMBRANE FISSION#0.9715;NERVOUS SYSTEM#0.9596;PEROXISOME#0.9584;MITOCHONDRIAL MEMBRANE#0.9412;ORGANELLE#0.9388;EXOCYTOSIS#0.9382;CLATHRIN-COATED PIT#0.9370;APOPTOSIS#0.9363;PROTEIN KINASE#0.9362;GENE EXPRESSION#0.9281;ALZHEIMER'S DISEASE#0.9194;GUANOSINE#0.9172;CELL SURFACE#0.9063;GTP HYDROLYSIS#0.8972;GROWTH FACTOR#0.8935;NERVE TERMINAL#0.8921;OUTER MEMBRANE#0.8887;ENDOSOME#0.8721;COATED VESICLE#0.8702;CENTRAL NERVOUS SYSTEM#0.8631;EPILEPSY#0.8470;CLATHRIN COATED VESICLE#0.8353;NEUROTRANSMISSION#0.8257;MICROTUBULE#0.8237;RECEPTOR MEDIATED ENDOCYTOSIS#0.8119;CALCINEURIN#0.8000;MEMBRANE SCISSION#0.7999;PEROXISOME FISSION#0.7979;CHROMAFFIN CELL#0.7967;CALYX OF HELD#0.7864;MEMORY IMPAIRMENT#0.7777;OUTER MITOCHONDRIAL MEMBRANE#0.7732;ACTIN CYTOSKELETON#0.7620;RECEPTOR INTERNALIZATION#0.7532;NEURONAL CELLS#0.7505;MITOCHONDRIAL OUTER MEMBRANE#0.7382;DEMENTIA#0.7364;MITOPHAGY#0.7326;BUDDING#0.7293;DEPHOSPHORYLATION#0.7285;CYTOCHROME C#0.7211;ENDOCYTIC VESICLE#0.7180;CANCER CELL#0.7166;CONSTRICTION#0.7125;AUTOPHAGY#0.7083;ATP SYNTHASE#0.7068;ASPARTATE#0.7037;VESICLE FORMATION#0.7030;SIGNALING PATHWAY#0.6995;CEREBRAL CORTEX#0.6995;N-ETHYLMALEIMIDE#0.6961;VESICLE TRAFFICKING#0.6885;ENDOPLASMIC RETICULUM#0.6881;CYTOPLASM#0.6863;EPIDERMAL GROWTH FACTOR#0.6862;GUANINE#0.6725;NEUROTRANSMITTER RELEASE#0.6682;CLATHRIN HEAVY CHAIN#0.6672;MITOCHONDRIAL DNA#0.6647;PEROXISOMAL#0.6633;TOTAL INTERNAL REFLECTION#0.6607;PROTEIN KINASE C#0.6606;VACUOLE#0.6545;MEMBRANE CURVATURE#0.6520;INHIBITION OF ENDOCYTOSIS#0.6484;GROWTH FACTOR RECEPTOR#0.6476;RECYCLING ENDOSOME#0.6428;TEMPORAL LOBE EPILEPSY#0.6392;ADAPTOR PROTEIN 2#0.6352;TEMPORAL LOBE#0.6351;NICOTINE DEPENDENCE#0.6050;LIPID RAFT#0.6034;VESICLE SCISSION#0.6010
175	ASPARAGINE#1.0452;LYSOSOMAL STORAGE DISEASE#1.0419;LYSOSOMAL STORAGE DISORDER#1.0185;ASPARTIC ACID#1.0175;L-ASPARAGINE#1.0130;L-ASPARTIC ACID#0.9846;ENZYME ACTIVITY#0.9807;LYSOSOME#0.9657;GLYCOPROTEIN DEGRADATION#0.9359;MENTAL RETARDATION#0.9212;ENDOPLASMIC RETICULUM#0.9166;LEUKOCYTE#0.8877;CATALYTIC ACTIVITY#0.8258;GLYCOSYLATION#0.7673;CATABOLISM#0.7625;GLCNAC#0.7477;ARGININE#0.7080;ENZYME REPLACEMENT THERAPY#0.6755
1760	MYOTONIC DYSTROPHY 1#1.0806;EXCESSIVE DAYTIME SLEEPINESS#1.0532;HUNTINGTON'S DISEASE#1.0504;SLEEPINESS#1.0376;MUSCLE CELL#1.0352;SUDDEN CARDIAC DEATH#1.0349;PROTEIN KINASE#1.0347;MYOTONIC DYSTROPHY TYPE 1#1.0323;MYOTUBE#1.0308;INSULIN RECEPTOR#1.0299;CARDIAC CONDUCTION#1.0299;MYOBLAST#1.0297;THYMINE#1.0294;MUSCLE WASTING#1.0287;MRNA SPLICING#1.0286;STEM CELL#1.0262;NEUROMUSCULAR DISEASE#1.0226;CARDIAC MUSCLE#1.0219;FRONTAL#1.0219;GUANINE#1.0216;MYOTONIC DYSTROPHY TYPE 2#1.0157;GENETIC DISORDER#1.0140;CENTRAL NERVOUS SYSTEM#1.0135;NERVOUS SYSTEM#1.0128;MUSCULAR DYSTROPHY#1.0124;POLYMERASE CHAIN REACTION#1.0104;MUSCLE WEAKNESS#1.0100;ARRHYTHMIA#1.0096;AGE AT ONSET#1.0092;TOXICITY#1.0077;PRE-MRNA SPLICING#1.0077;MYOPATHY#1.0065;AMYOTROPHIC LATERAL SCLEROSIS#1.0047;LATERAL SCLEROSIS#1.0047;MYOGENESIS#1.0045;AUTOSOMAL DOMINANT DISEASE#1.0045;SKELETAL MUSCLE#1.0018;MUSCLE FIBER#0.9995;DUCHENNE MUSCULAR DYSTROPHY#0.9969;EMBRYONIC STEM CELL#0.9941;PREIMPLANTATION GENETIC DIAGNOSIS#0.9941;SLEEP APNEA#0.9931;RNA BINDING PROTEIN#0.9922;RNA BINDING#0.9899;GENE EXPRESSION#0.9897;MENTAL RETARDATION#0.9891;DIABETES MELLITUS#0.9867;HUMAN EMBRYONIC STEM#0.9864;CHLORIDE CHANNEL#0.9840;TRANSCRIPTION FACTOR#0.9809;CARDIOMYOPATHY#0.9746;ATRIAL FIBRILLATION#0.9738;ZINC FINGER PROTEIN#0.9725;GENETIC DISEASE#0.9703;WHITE MATTER LESIONS#0.9699;NEUROPATHY#0.9686;MAGNETIC RESONANCE IMAGING#0.9684;SMOOTH MUSCLE#0.9637;MUSCLE ATROPHY#0.9508;CARDIOMYOCYTE#0.9507;RNA SPLICING#0.9495;RNA PROCESSING#0.9446;MUSCULAR ATROPHY#0.9436;SIGNALING PATHWAY#0.9381;RNA METABOLISM#0.9379;PERIPHERAL NERVE#0.9378;SARCOPLASMIC RETICULUM#0.9365;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY#0.9333;RESPIRATORY FAILURE#0.9326;GLUCOSE INTOLERANCE#0.9321;MYOCYTES#0.9305;PLURIPOTENT STEM CELL#0.9295;SLEEP DISORDER#0.9270;HYPOGONADISM#0.9234;NUCLEIC ACID#0.9197;SLEEP DISORDERED BREATHING#0.9185;ENDOPLASMIC RETICULUM#0.9157;OOCYTE#0.9022;COGNITION#0.9013;GRAY MATTER VOLUME#0.8964;INTERCALATED DISC#0.8944;ENDOCRINE SYSTEM#0.8887;SPINOCEREBELLAR ATAXIA TYPE 8#0.8884;LEUKOCYTE#0.8840;INDUCED PLURIPOTENT STEM CELL#0.8754;SODIUM CHANNEL#0.8636;CYTOPLASM#0.8622;SPINAL MUSCULAR ATROPHY#0.8597;NEUROMUSCULAR JUNCTION#0.8565;KINASE ACTIVITY#0.8500;HEALTHY CONTROL SUBJECTS#0.8489;SKELETAL MUSCLE CELLS#0.8476;PERIPHERAL BLOOD#0.8422;DEMENTIA#0.8404;CREATINE#0.8390;MYOTONIA CONGENITA#0.8390;ACTION POTENTIAL#0.8390;GROWTH FACTOR#0.8321;EPWORTH SLEEPINESS SCALE#0.8280;ATRIOVENTRICULAR BLOCK#0.8262;MYOBLAST DIFFERENTIATION#0.8236;CARDIAC ABNORMALITIES#0.8085;CREATINE KINASE#0.8081;NON INVASIVE VENTILATION#0.8078;BINDING PROTEIN 1#0.7956;REGENERATION#0.7915;HEARING LOSS#0.7879;CHARCOT MARIE TOOTH#0.7869;OBSTRUCTIVE SLEEP APNEA#0.7868;FRONTOTEMPORAL DEMENTIA#0.7849;OXIDATIVE METABOLISM#0.7840;RYANODINE RECEPTOR#0.7835;BREAST CANCER#0.7753;CELL DEATH#0.7741;FRAGILE X SYNDROME#0.7727;OVARIAN#0.7721;MEDICAL RESEARCH COUNCIL#0.7699;DIAPHRAGM#0.7668;NEUROLOGICAL DISORDER#0.7665;MYOGENIC CELL#0.7625;NARCOLEPSY#0.7586;NEURODEGENERATIVE DISEASE#0.7562;VOXEL BASED MORPHOMETRY#0.7535;PROTEIN TRANSLATION#0.7508;SHORT TANDEM REPEAT#0.7471;ALTERNATIVE SPLICING FACTOR#0.7430;BASAL CELL CARCINOMA#0.7394;SEQUESTERING#0.7382;BASAL CELL#0.7342;IMPLANTABLE CARDIOVERTER DEFIBRILLATOR#0.7323;TUMOR NECROSIS FACTOR#0.7315;LIMB-GIRDLE MUSCULAR DYSTROPHY#0.7290;SOMATIC TISSUE#0.7280;GINGIVITIS#0.7236;SKELETAL MUSCLE WASTING#0.7234;PERIODIC LIMB MOVEMENTS#0.7168;MUSCULAR DISEASE#0.7167;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7146;TRASTUZUMAB#0.7095;MUSCLE FIBRE#0.7091;TOOTH DISEASE#0.7087;PATIENT REPORTED OUTCOME#0.7048;PTOSIS#0.7018;RESTLESS LEGS SYNDROME#0.7015;TRANSCRIPTASE#0.6984;APOPTOSIS#0.6965;MYOSIN HEAVY CHAIN#0.6952;TRASTUZUMAB EMTANSINE#0.6864;TESTOSTERONE#0.6825;MRNA PROCESSING#0.6809;SOMNOLENCE#0.6795;TEMPORAL LOBE#0.6787;SPINAL CORD#0.6786;EPITHELIAL CELL#0.6756;DNA REPAIR#0.6705;MITOCHONDRIA#0.6704;HYPERTROPHIC CARDIOMYOPATHY#0.6701;AGEING#0.6689;ULNAR NERVE#0.6649;BRUGADA SYNDROME#0.6637;CELL GROWTH#0.6610;LOWER LEG#0.6576;TUMOR SUPPRESSOR#0.6557;NUCLEIC ACID BINDING#0.6553;RAPID EYE MOVEMENT#0.6527;TACHYCARDIA#0.6512;AUTOPHAGY#0.6495;PERIODIC LEG MOVEMENTS#0.6447;MYOBLAST FUSION#0.6360;RIBOZYME#0.6292;CHARCOT-MARIE-TOOTH DISEASE#0.6285;TERMINAL DIFFERENTIATION#0.6258;DIFFUSION TENSOR IMAGING#0.6253;INTRACELLULAR LOCALIZATION#0.6247;FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME#0.6202;DILATED CARDIOMYOPATHY#0.6185;NEURAL CELL#0.6161;STANDARDIZED MORTALITY RATIO#0.6152;TYPE 2 DIABETES#0.6152;MICROTUBULE#0.6149;CELL CYCLE#0.6133;SIGNALLING PATHWAY#0.6133;WHITE MATTER ABNORMALITIES#0.6124;AJMALINE#0.6117;APOPTOTIC#0.6102;Z BAND#0.6101
1761	Z CHROMOSOME#1.0444;TESTIS DEVELOPMENT#1.0367;SERTOLI CELL#1.0267;TESTICULAR DEVELOPMENT#1.0261;TRANSCRIPTION FACTOR#1.0230;GONAD DEVELOPMENT#1.0220;GONADAL DYSGENESIS#1.0205;SEX DIFFERENTIATION#1.0161;Y CHROMOSOME#1.0160;MEIOSIS#1.0107;SPERMATOGENESIS#1.0076;DNA BINDING#1.0056;POLYMERASE CHAIN REACTION#1.0041;SEX CHROMOSOME#1.0022;GERM CELL#1.0015;GONAD#1.0008;OVARIES#1.0001;SEX DETERMINATION#0.9967;OVARIAN#0.9874;GENE EXPRESSION#0.9799;W CHROMOSOME#0.9779;ESTRADIOL#0.9762;STEM CELL#0.9686;OOCYTE#0.9663;CYTOCHROME P450#0.9625;HATCHING#0.9605;REVERSE TRANSCRIPTION#0.9473;GRANULOSA CELL#0.9462;PRIMORDIAL GERM CELL#0.9312;MALE SEX DETERMINATION#0.9090;DNA METHYLATION#0.9080;OVARIAN DEVELOPMENT#0.9019;QUANTITATIVE REAL TIME#0.9003;CELL DIFFERENTIATION#0.8986;GERM CELL TUMORS#0.8969;TESTOSTERONE#0.8916;X CHROMOSOME#0.8878;SPERMATOCYTES#0.8825;MITOSIS#0.8794;CELL DEVELOPMENT#0.8764;FERTILIZATION#0.8659;46 XY GONADAL DYSGENESIS#0.8546;MALE SEX DIFFERENTIATION#0.8512;SPERMATOGONIAL STEM CELL#0.8437;GERM CELL DEVELOPMENT#0.8426;LEYDIG CELL#0.8340;APOPTOSIS#0.8333;ESTROGEN RECEPTOR#0.8250;SIGNALING PATHWAY#0.8215;AUTOSOME#0.8055;ANDROGEN RECEPTOR#0.7991;RETINOIC ACID#0.7956;GONADOGENESIS#0.7742;TERATOMA#0.7587;CELL PROLIFERATION#0.7576;GAMETOGENESIS#0.7529;GENETIC SEX DETERMINATION#0.7460;ESTROGENS#0.7440;SEMINOMA#0.7440;OOGENESIS#0.7332;DAYS POST FERTILIZATION#0.7314;OVARY DEVELOPMENT#0.7262;GONADOTROPIN RELEASING HORMONE#0.7255;PROTEIN KINASE#0.7173;PRIMARY SEX DETERMINATION#0.6934;WILMS TUMOR 1#0.6913;COMPARATIVE GENOMIC HYBRIDIZATION#0.6818;STEROIDOGENESIS#0.6725;GROWTH FACTOR#0.6705;GONOCYTE#0.6681;TRANSDIFFERENTIATION#0.6576;INFERTILITY#0.6414;MILLION YEARS AGO#0.6303;QUANTITATIVE REVERSE TRANSCRIPTION#0.6271;17β-ESTRADIOL#0.6210;17-METHYLTESTOSTERONE#0.6187;METHYLTESTOSTERONE#0.6163;BACTERIAL ARTIFICIAL CHROMOSOME#0.6067;MALE INFERTILITY#0.6049
1762	DNA REPLICATION#1.0405;DNA HELICASE#0.9996;DNA SYNTHESIS#0.9863;RIBOSOMAL PROTEIN#0.8869;DNA BINDING#0.8759;SINGLE-STRANDED DNA BINDING#0.7471;LEUCINE RICH REPEAT#0.7133;REPLICATION FORK#0.6831;GENE EXPRESSION#0.6294
1763	NUCLEASE ACTIVITY#1.0601;HELICASE ACTIVITY#1.0521;REPLICATION PROTEIN A#1.0501;FLAP ENDONUCLEASE#1.0496;ENDONUCLEASE ACTIVITY#1.0469;S PHASE#1.0389;DNA HELICASE#1.0345;DNA REPLICATION#1.0170;REPLICATION FORK#1.0146;CELL CYCLE#1.0125;TELOMERE#1.0079;N ACETYLTRANSFERASE#1.0051;NAT ACTIVITY#1.0040;DNA UNWINDING#1.0039;DOUBLE STRAND BREAK#0.9980;DNA SYNTHESIS#0.9960;DNA REPAIR#0.9947;STRAND DISPLACEMENT#0.9944;ARYLAMINE N ACETYLTRANSFERASE#0.9894;HOMOLOGOUS RECOMBINATION#0.9828;MITOCHONDRIAL DNA#0.9617;DNA BINDING#0.9601;CANCER CELL#0.9591;GENE EXPRESSION#0.9447;ARYLAMINE#0.9429;DOUBLE-STRAND BREAK REPAIR#0.8965;MTDNA#0.8731;DNA DAMAGE CHECKPOINT#0.8678;BASE EXCISION REPAIR#0.8631;DNA LIGASE#0.8607;DNA DEPENDENT ATPASE#0.8529;MITOCHONDRIA#0.8346;DNA DAMAGE RESPONSE#0.8327;LOW DETECTION LIMIT#0.7855;BUDDING#0.7721;DNA HELICASE ACTIVITY#0.7710;MTDNA REPLICATION#0.7671;MYOPATHY#0.7598;ADENOSINE#0.7575;SINGLE STRAND ANNEALING#0.7567;S-PHASE CHECKPOINT#0.7432;SINGLE-STRANDED DNA BINDING#0.7340;MRX COMPLEX#0.7152;SSDNA BINDING#0.7103;BIOTIN#0.6805;N-ACETYLTRANSFERASE ACTIVITY#0.6732;TELOMERE MAINTENANCE#0.6626;ACETYLTRANSFERASE ACTIVITY#0.6590;WERNER SYNDROME#0.6397;HOMOLOGY-DIRECTED REPAIR#0.6303;CELL CYCLE ARREST#0.6213;DNA METABOLISM#0.6049;DNA POLYMERASE ALPHA#0.6021;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6016;CELL DIVISION#0.6008
1767	CILIARY AXONEME#1.0567;PRIMARY CILIARY DYSKINESIA#1.0490;DYSKINESIA#1.0420;OUTER DYNEIN ARM#1.0406;MOTILE CILIA#1.0355;DYNEIN#1.0353;AXONEME#1.0306;RESPIRATORY TRACT#1.0092;GENETIC DISORDER#0.9776;INFERTILITY#0.9694;BRONCHIECTASIS#0.9549;SITUS INVERSUS#0.9143;EPITHELIAL CELL#0.8931;INNER DYNEIN ARM#0.8928;OTITIS MEDIA#0.8878;TRANSMISSION ELECTRON MICROSCOPY#0.8827;MALE INFERTILITY#0.8776;CILIARY MOTILITY#0.8538;CYSTIC FIBROSIS#0.8284;NASAL NITRIC OXIDE#0.8153;MICROTUBULE#0.8099;NITRIC OXIDE#0.7700;RADIAL SPOKE#0.7661;LUNG DISEASE#0.7576;HYDROCEPHALUS#0.7082;KARTAGENER SYNDROME#0.7014;RESPIRATORY TRACT INFECTION#0.6687;CILIATED CELL#0.6384;RESPIRATORY DISTRESS#0.6351;SLEEP DISORDERED BREATHING#0.6295;RADIAL SPOKE HEAD#0.6294;ENDOSCOPIC SINUS SURGERY#0.6206;NASAL MUCOSA#0.6151
1768	DYNEIN#0.6729;SPERM HEAD#0.6695;CYSTIC FIBROSIS#0.6454;GENE EXPRESSION#0.6323
1769	PROSTATE CANCER#0.6487
176	HYALURONAN SYNTHASE#1.0427;HYALURONAN BINDING#1.0423;HYALURONIC ACID BINDING#1.0402;COLLAGEN TYPE II#1.0240;MATRIX METALLOPROTEINASE 1#1.0239;STROMELYSIN#1.0228;VITAMIN D RECEPTOR#1.0122;LECTIN#1.0113;PERINEURONAL NET#1.0107;COLLAGEN DEGRADATION#1.0099;MATRIX METALLOPROTEINASE 13#1.0090;CHONDROITIN 6 SULFOTRANSFERASE#1.0085;QUANTITATIVE REVERSE TRANSCRIPTION#1.0056;RETINOIC ACID#1.0049;COLLAGEN TYPE I#1.0047;HIGH MOBILITY GROUP#1.0046;CELL ASSOCIATED#1.0043;T CELL#1.0012;INDUCIBLE NITRIC OXIDE#1.0012;CHONDROITIN SULFATE PROTEOGLYCAN#0.9979;HYALURONAN#0.9979;COLLAGEN BREAKDOWN#0.9973;GROWTH CONE#0.9971;CD4+ T CELL#0.9961;NITRIC OXIDE SYNTHASE#0.9960;CHONDROSARCOMA#0.9932;LUMBAR DISC HERNIATION#0.9930;ENDOTHELIAL GROWTH FACTOR#0.9928;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9928;LEUCINE#0.9923;NEURITE#0.9913;CATABOLISM#0.9910;COLLAGEN SYNTHESIS#0.9903;SYNOVIAL FLUID#0.9898;EXTRACELLULAR MATRIX COMPONENT#0.9895;PROTEOGLYCAN DEGRADATION#0.9895;SULFATION#0.9894;HYALURONIDASE#0.9883;COLLAGEN NETWORK#0.9875;PROTEOGLYCAN#0.9870;SPINAL CORD#0.9861;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9860;PROTEIN SYNTHESIS#0.9855;PROTEOGLYCAN SYNTHESIS#0.9852;CHONDROCYTE HYPERTROPHY#0.9852;REVERSE TRANSCRIPTION#0.9839;OSTEOARTHRITIC CARTILAGE#0.9835;EPIDERMAL GROWTH FACTOR#0.9830;CHONDROGENIC CELL#0.9828;SPONDYLITIS#0.9824;QUANTITATIVE REAL TIME#0.9822;NITRIC OXIDE#0.9813;HUMAN NUCLEUS PULPOSUS#0.9812;ALKALINE PHOSPHATASE#0.9808;CARTILAGE DEVELOPMENT#0.9803;DEGENERATIVE DISC DISEASE#0.9800;GENE EXPRESSION#0.9797;RELATIVE GENE EXPRESSION#0.9796;GLUCOSAMINE#0.9793;CELL MIGRATION#0.9791;FACTOR I#0.9784;CHONDROCYTE DIFFERENTIATION#0.9783;MENISCUS#0.9782;SMOOTH MUSCLE#0.9778;TRANSCRIPTASE#0.9777;SKELETAL DEVELOPMENT#0.9775;FIBRIL#0.9774;HYDROXYPROLINE#0.9771;HYPOXIA#0.9770;AUTOLOGOUS CHONDROCYTE IMPLANTATION#0.9769;COLLAGENASE#0.9769;CELL ADHESION#0.9768;TUMOUR NECROSIS FACTOR#0.9767;POLYMERASE CHAIN REACTION#0.9766;SENESCENCE#0.9764;HYALURONIC ACID#0.9760;HYPOXIA INDUCIBLE FACTOR#0.9755;RHEUMATOID ARTHRITIS#0.9747;MESENCHYME#0.9746;OSTEOGENESIS#0.9739;CHONDROCYTE PROLIFERATION#0.9737;DIGESTION#0.9728;NOTOCHORD#0.9713;CELL CYCLE#0.9712;B CELL#0.9711;DEXAMETHASONE#0.9709;HEPARIN#0.9703;ALKALINE PHOSPHATASE ACTIVITY#0.9703;CHONDROCYTE#0.9701;TRANSCRIPTION FACTOR#0.9701;ANNULUS#0.9700;IDIOPATHIC SHORT STATURE#0.9695;ENDOCHONDRAL OSSIFICATION#0.9693;ANNULUS FIBROSUS#0.9691;MACROPHAGE#0.9687;INSULIN-LIKE GROWTH FACTOR#0.9687;CARTILAGE HOMEOSTASIS#0.9686;CHONDROITIN SULPHATE PROTEOGLYCAN#0.9686;PHOSPHATASE ACTIVITY#0.9680;CELL GROWTH#0.9678;SWELLING#0.9672;PROSTAGLANDIN E2#0.9668;DEDIFFERENTIATION#0.9664;OSTEOBLAST#0.9663;TUMOR NECROSIS FACTOR#0.9660;HUMAN ARTICULAR CHONDROCYTES#0.9659;PRO-INFLAMMATORY#0.9656;EOSIN#0.9655;NEURITE OUTGROWTH#0.9655;MINERALIZATION#0.9649;CELL DEATH#0.9646;CARTILAGE FORMATION#0.9641;IMMUNE RESPONSE#0.9639;CRUCIATE LIGAMENT#0.9639;ANTERIOR CRUCIATE LIGAMENT#0.9637;KNEE JOINT#0.9633;TISSUE GROWTH FACTOR#0.9631;NUCLEUS PULPOSUS CELL#0.9630;CENTRAL NERVOUS SYSTEM#0.9628;REACTIVE OXYGEN SPECIES#0.9623;LOW BACK PAIN#0.9622;NERVOUS SYSTEM#0.9621;SYNOVIUM#0.9621;BONE MORPHOGENETIC PROTEIN#0.9612;MARROW STROMAL CELLS#0.9609;CHONDROGENESIS#0.9607;APOPTOSIS#0.9607;FIBROBLAST GROWTH FACTOR#0.9602;PERIPHERAL BLOOD#0.9601;BONE MARROW STROMAL CELL#0.9601;MESENCHYMAL CELL#0.9600;HYPOXIC#0.9598;ENDOPLASMIC RETICULUM#0.9597;NUCLEUS PULPOSUS#0.9597;CONNECTIVE TISSUE#0.9594;BONE MARROW STROMAL#0.9594;TRANSFORMING GROWTH FACTOR BETA#0.9592;OSSIFICATION#0.9591;GROWTH FACTOR RECEPTOR#0.9590;SUPERFICIAL ZONE PROTEIN#0.9578;EXTRACELLULAR MATRIX#0.9576;GLYCOSAMINOGLYCAN SYNTHESIS#0.9570;CELL SURFACE#0.9568;APOPTOTIC#0.9567;PARATHYROID HORMONE#0.9566;AUTOPHAGY#0.9565;MESENCHYMAL STROMAL CELL#0.9564;MITOGEN ACTIVATED PROTEIN#0.9562;BONE FORMATION#0.9561;POLY ETHYLENE GLYCOL#0.9560;MAGNETIC RESONANCE IMAGING#0.9559;ADIPOSE-DERIVED STEM CELL#0.9551;INFLAMMATORY RESPONSE#0.9550;ANABOLISM#0.9547;INTERVERTEBRAL DISC DEGENERATION#0.9544;HYALURONATE#0.9543;CELL DIFFERENTIATION#0.9540;HUMAN MESENCHYMAL STEM#0.9540;PROGENITOR CELL#0.9539;TISSUE REGENERATION#0.9537;CELL PROLIFERATION#0.9537;ADIPOCYTE#0.9536;GLYCERALDEHYDE-3-PHOSPHATE#0.9533;SCANNING ELECTRON MICROSCOPY#0.9521;INTERVERTEBRAL DISC#0.9519;SIGNALING PATHWAY#0.9518;ANGIOGENESIS#0.9514;BONE GROWTH#0.9507;RECEPTOR ANTAGONIST#0.9503;BLOOD VESSEL#0.9503;ADIPOSE TISSUE#0.9503;PROTEIN KINASE#0.9499;SYNOVITIS#0.9497;TRANSFORMING GROWTH FACTOR#0.9493;OSTEOARTHRITIS#0.9493;FEMUR#0.9488;STEM CELL DIFFERENTIATION#0.9488;GROWTH FACTOR#0.9485;CYTOTOXICITY#0.9483;STROMAL CELL#0.9464;UMBILICAL CORD#0.9455;SIGNALING MOLECULE#0.9452;SKELETON#0.9441;TELOMERASE ACTIVITY#0.9436;ENDOTHELIAL CELL#0.9435;SIGNAL TRANSDUCTION#0.9403;BONE MARROW#0.9396;SODIUM DODECYL SULFATE#0.9391;DODECYL SULFATE#0.9390;MESENCHYMAL STEM CELL#0.9384;REGENERATION#0.9376;TERMINAL DIFFERENTIATION#0.9374;STEM CELL#0.9360;NEOCARTILAGE#0.9356;BONE DEVELOPMENT#0.9349;ANKYLOSING SPONDYLITIS#0.9337;NEURAL CREST#0.9325;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9317;PEROXISOME#0.9285;TIBIA#0.9284;TRANSMISSION ELECTRON MICROSCOPY#0.9275;ADULT STEM CELL#0.9267;FOCAL ADHESION#0.9261;CLEAVED CASPASE 3#0.9257;C TERMINAL DOMAIN#0.9244;ADVANCED GLYCATION END#0.9240;LACTIC ACID#0.9229;JOINT DAMAGE#0.9228;PARATHYROID#0.9223;TISSUE DEVELOPMENT#0.9194;PLASMA MEMBRANE#0.9194;ENZYME ACTIVITY#0.9177;ADIPOGENESIS#0.9175;PENTOSAN POLYSULFATE#0.9153;EMBRYONIC STEM CELL#0.9151;GLYCOSYLATION#0.9148;IL-1RA#0.9142;METALLOPROTEINASE ACTIVITY#0.9109;MORPHOGENESIS#0.9107;SIGNALLING PATHWAY#0.9087;CELL COUNTING KIT#0.9084;ASTROCYTE#0.9063;VERTEBRAE#0.9051;CEREBRAL CORTEX#0.9049;SULPHATION#0.9037;OSTEOCLAST#0.9028;METALLOPROTEINASE INHIBITOR#0.9012;IDIOPATHIC SCOLIOSIS#0.9004;LEUKOCYTE#0.8981;CELL EXPANSION#0.8979;GROWTH DIFFERENTIATION FACTOR#0.8976;EPITHELIAL CELL#0.8968;PERIOSTEUM#0.8968;SURFACE PLASMON RESONANCE#0.8949;MUSCLE CELL#0.8942;CELL MEMBRANE#0.8942;GLIAL CELL#0.8936;MESENCHYMAL PROGENITOR CELL#0.8885;MOLAR#0.8881;SMOOTH MUSCLE CELL#0.8873;BASEMENT MEMBRANE#0.8868;PROTEIN KINASE C#0.8867;PLEOMORPHIC ADENOMA#0.8865;DORSAL ROOT GANGLION#0.8864;SUPEROXIDE DISMUTASE#0.8863;NEURAL CREST CELL#0.8851;CERVICAL#0.8822;GUANIDINE#0.8790;GROWTH HORMONE#0.8790;AXON GROWTH#0.8784;CYTOPLASM#0.8733;INFLAMMATORY CELL#0.8730;MAP KINASE#0.8727;OPTIC NERVE#0.8702;JUVENILE IDIOPATHIC ARTHRITIS#0.8699;WOUND HEALING#0.8698;PHOSPHATE BUFFERED SALINE#0.8695;HISTONE DEACETYLASE#0.8686;ALANINE#0.8678;INTERNEURON#0.8673;ASCORBIC ACID#0.8668;BLANK CONTROL GROUP#0.8660;DNA SYNTHESIS#0.8627;STROMA#0.8614;BRAIN DEVELOPMENT#0.8614;NEUTROPHIL#0.8613;MECHANISM OF ACTION#0.8601;TOTAL KNEE REPLACEMENT#0.8588;LEUCINE RICH REPEAT#0.8579;MONONUCLEAR CELLS#0.8552;RAT BONE MARROW#0.8547;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8546;MELATONIN#0.8526;SCOLIOSIS#0.8515;TOTAL KNEE ARTHROPLASTY#0.8496;PLURIPOTENT STEM CELL#0.8478;PRECURSOR CELL#0.8472;EXTRACELLULAR SPACE#0.8462;MARROW STEM CELLS#0.8461;BONE MARROW STEM CELL#0.8453;CASPASE-3 ACTIVITY#0.8448;FIBRILLAR COLLAGEN#0.8435;CELL RECOGNITION#0.8417;CELL AGGREGATION#0.8398;CYTOKINE PRODUCTION#0.8398;ARGININE#0.8391;MONOCYTE#0.8389;SPINAL CORD INJURY#0.8385;DERMAL FIBROBLAST#0.8356;TOLL LIKE RECEPTOR#0.8340;ASPARTIC ACID#0.8338;FOCAL ADHESION KINASE#0.8335;ENHANCER BINDING#0.8321;DNA BINDING#0.8319;COLLAGEN CATABOLISM#0.8319;NERVE GROWTH FACTOR#0.8295;CELLULAR SENESCENCE#0.8280;C REACTIVE PROTEIN#0.8277;IFN-GAMMA#0.8275;BONE REMODELING#0.8259;HUMAN ADIPOSE TISSUE#0.8247;AKT SIGNALING#0.8222;ELECTROPHORETIC MOBILITY SHIFT#0.8195;BONE MORPHOGENIC PROTEIN#0.8193;ANKLE JOINT#0.8192;SMOOTH MUSCLE ACTIN#0.8186;RESVERATROL#0.8174;ESTRADIOL#0.8155;THYMIDINE#0.8127;ADIPOSE STEM CELLS#0.8123;GLYCINE#0.8115;TUMOR CELLS#0.8105;STRESS FIBER#0.8086;FAT PAD#0.8086;BIOTIN#0.8077;PROTEINASE INHIBITOR#0.8077;KINASE INHIBITOR#0.8060;LARYNGEAL CARTILAGE#0.8056;TISSUE DAMAGE#0.8017;MEMBRANE TYPE 1#0.8005;COLLAGEN TYPE III#0.7996;NODULE FORMATION#0.7986;PROTEOGLYCAN METABOLISM#0.7983;DUAL LUCIFERASE REPORTER#0.7979;TOXICITY#0.7962;CYCLIC TENSILE STRAIN#0.7960;EXTRA CELLULAR MATRIX#0.7920;HIP JOINT#0.7910;LOCALISATION#0.7899;STEM CELL MARKER#0.7886;ENHANCER BINDING PROTEIN#0.7881;CHONDROITIN SULFATE SYNTHESIS#0.7867;VESICULAR TRANSPORT#0.7858;POST-TRANSLATIONAL MODIFICATION#0.7855;AGEING#0.7809;MESENCHYMAL STEM CELL DIFFERENTIATION#0.7805;MAPK SIGNALING#0.7788;RNA INTERFERENCE#0.7764;SIMVASTATIN#0.7734;SERUM ALBUMIN#0.7733;SPONDYLOEPIMETAPHYSEAL DYSPLASIA#0.7721;CORD BLOOD#0.7707;LIPOPROTEIN LIPASE#0.7690;ADIPOSE-DERIVED STROMAL CELL#0.7654;72-HOURS#0.7609;OSTEOCYTE#0.7595;SUBSTANCE P#0.7564;SIZE EXCLUSION CHROMATOGRAPHY#0.7549;ASCORBATE#0.7529;ATHEROSCLEROSIS#0.7524;RHEUMATIC DISEASE#0.7522;REPORTER GENE ASSAY#0.7517;CELL ACTIVATION#0.7507;G1 PHASE#0.7497;AUTOIMMUNE DISEASE#0.7497;SIGNALING CASCADE#0.7477;ENDOCYTOSIS#0.7467;COLLAGEN METABOLISM#0.7460;RESPONSE TO IL-1#0.7459;NASAL SEPTUM#0.7458;TAMOXIFEN#0.7420;CYTOCHROME C#0.7408;CARTILAGE DISEASE#0.7394;ENDOTHELIAL CELL MIGRATION#0.7374;CELL ADHESION MOLECULE#0.7367;INDUCED PLURIPOTENT STEM CELL#0.7338;A DISC#0.7329;COLLAGEN INDUCED ARTHRITIS#0.7326;PROTEIN COMPLEX#0.7315;MECHANISMS OF ACTION#0.7313;INTERLEUKIN 1 RECEPTOR#0.7302;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7270;JOINT PAIN#0.7268;MITOCHONDRIAL MEMBRANE#0.7257;CORE BINDING FACTOR#0.7246;ELASTIC FIBER#0.7238;TRANSACTIVATION#0.7236;LOW DENSITY LIPOPROTEIN#0.7226;WNT SIGNALING PATHWAY#0.7204;ANTI INFLAMMATORY DRUGS#0.7191;BONE MATURATION#0.7160;SALIVARY GLAND#0.7160;ADENOSINE#0.7149;HEAT SHOCK PROTEIN#0.7141;GROWTH FACTOR BINDING#0.7139;ESTROGEN RECEPTOR#0.7134;TISSUE CULTURE POLYSTYRENE#0.7113;CD8+ T CELL#0.7083;PLATELET-DERIVED GROWTH FACTOR#0.7083;FLUORESCEIN#0.7057;ALIZARIN RED S#0.7055;RIBOSE#0.7046;ALIZARIN RED STAINING#0.7029;GUANIDINE HYDROCHLORIDE#0.7025;SCANNING ELECTRON MICROSCOPE#0.7024;MULTIPLE EPIPHYSEAL DYSPLASIA#0.7015;OSTEOPOROSIS#0.7004;MATRIX GLA PROTEIN#0.6992;STROMAL STEM CELL#0.6979;FLOW CYTOMETRY ANALYSIS#0.6952;BETA GALACTOSIDASE#0.6949;SEPTUM#0.6933;VASCULAR SMOOTH MUSCLE CELL#0.6916;AUTOIMMUNITY#0.6905;ALZHEIMER'S DISEASE#0.6884;UMBILICAL CORD BLOOD#0.6877;FORMALIN#0.6877;GLUCURONIC ACID#0.6875;MANDIBLE#0.6854;ACTIN CYTOSKELETON#0.6845;SKELETAL TISSUES#0.6841;PROPIDIUM#0.6834;CHONDROBLAST#0.6820;COLLAGENASE ACTIVITY#0.6805;MRNA SPLICING#0.6799;EMBRYOID BODY#0.6789;CELL DIVISION#0.6779;LIMB DEVELOPMENT#0.6773;RAPAMYCIN#0.6763;T CELL ACTIVATION#0.6739;HYALURONAN SYNTHESIS#0.6713;MEDIAL COLLATERAL LIGAMENT#0.6704;LIPID DROPLET#0.6695;REGULATION OF GENE EXPRESSION#0.6694;IL-6 SECRETION#0.6692;DYNAMIC LIGHT SCATTERING#0.6687;GESTATION#0.6663;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6656;PROTEOGLYCAN BREAKDOWN#0.6632;RESPONSE TO INTERLEUKIN-1#0.6629;TISSUE HOMEOSTASIS#0.6611;VACUOLE#0.6610;ENERGY DISSIPATION#0.6586;DERMIS#0.6554;HEPARIN BINDING#0.6534;NEURITE GROWTH#0.6533;ACID PHOSPHATASE#0.6510;GENES OF INTEREST#0.6495;AORTIC VALVE#0.6486;COLONY-STIMULATING FACTOR#0.6479;LYSIS#0.6470;DENTAL PULP#0.6431;CELECOXIB#0.6425;RELATED PROTEIN 1#0.6422;FATTY ACID BINDING#0.6414;MAPK ACTIVATION#0.6411;LYSINE#0.6411;MUTAGENESIS#0.6410;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6404;SIGNAL TRANSDUCER#0.6369;ETHANOL#0.6346;FIBRINOGEN#0.6334;ROUGH ENDOPLASMIC RETICULUM#0.6328;ADULT BONE MARROW#0.6304;DAYS OF DIFFERENTIATION#0.6294;PROLYL 4-HYDROXYLASE#0.6278;ION CHANNEL#0.6263;OSTEOCHONDROSIS#0.6258;LYME DISEASE#0.6255;DIFFERENTIAL GENE EXPRESSION#0.6249;HYDROCORTISONE#0.6245;MRNA TRANSCRIPTION#0.6242;MICROTUBULE#0.6242;PROTEASE ACTIVITY#0.6240;NEURITE EXTENSION#0.6235;INTERMEDIATE FILAMENT#0.6221;LUMINAL#0.6196;CELL CYCLE ARREST#0.6185;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6179;CAMKII#0.6156;GLUCOCORTICOID RECEPTOR#0.6154;AXON REGENERATION#0.6153;LIGHT CHAIN 3#0.6152;BICUSPID AORTIC VALVE#0.6133;AQUAPORIN#0.6130;PERIODONTAL LIGAMENT#0.6107;17β-ESTRADIOL#0.6102;TISSUE REMODELING#0.6099;HUMAN EMBRYONIC STEM#0.6099;ALL TRANS RETINOIC ACID#0.6082;BONE MARROW CELLS#0.6066;MYOEPITHELIAL CELL#0.6005
1770	DYNEIN#0.9891;OUTER DYNEIN ARM#0.7401;AXONEME#0.7285;MOTILE CILIA#0.7214;PRIMARY CILIARY DYSKINESIA#0.6914;NODAL SIGNALING PATHWAY#0.6140;CILIARY AXONEME#0.6115;SIGNALING PATHWAY#0.6096
1773	DNA METABOLIC#1.0853;PULMOZYME#1.0837;PANCREATIC DEOXYRIBONUCLEASE#1.0766;RHDNASE#1.0672;DORNASE ALFA#1.0634;DEOXYRIBONUCLEASE I#1.0417;SPUTUM#1.0366;MYOCARDIAL INFARCTION#1.0290;HYPERSENSITIVITY#1.0273;DNASE#1.0236;TOBRAMYCIN#1.0221;DNASE I#1.0203;HUMAN IMMUNODEFICIENCY VIRUS#1.0202;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0192;LUPUS ERYTHEMATOSUS#1.0181;DIGESTION#1.0052;CYSTIC FIBROSIS#1.0032;DNA DEGRADATION#0.9999;LUNG DISEASE#0.9978;ACUTE MYOCARDIAL INFARCTION#0.9956;NUCLEOSOME#0.9897;APOPTOSIS#0.9838;TRANSCRIPTASE#0.9812;ACTIN BINDING#0.9797;ELECTROPHORETIC MOBILITY SHIFT#0.9778;ENZYME ACTIVITY#0.9754;DNA BINDING#0.9753;NEUTROPHIL#0.9709;MANNITOL#0.9700;POLYMERASE CHAIN REACTION#0.9692;CANCER CELL#0.9688;TRANSCRIPTION FACTOR#0.9682;CELL DEATH#0.9673;FORCED EXPIRATORY VOLUME#0.9664;ACTIN FILAMENT#0.9661;GENE EXPRESSION#0.9647;NUCLEIC ACID#0.9634;PHOSPHODIESTERASE#0.9628;PROTEIN BINDING#0.9621;LUPUS NEPHRITIS#0.9601;ALKALINE PHOSPHATASE#0.9579;FILAMENTOUS ACTIN#0.9576;APOPTOTIC#0.9510;PAROTID GLAND#0.9464;T CELL#0.9444;EPITHELIAL CELL#0.9414;DNASE ACTIVITY#0.9387;SKELETAL MUSCLE#0.9381;NEPHRITIS#0.9379;AUTOIMMUNITY#0.9376;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9354;ACTIN BINDING PROTEIN#0.9340;DNA POLYMERASE I#0.9324;CELL CYCLE#0.9248;FORCED VITAL CAPACITY#0.9221;MUTAGENESIS#0.9186;CYTOPLASM#0.9072;GROWTH FACTOR#0.9029;DNA FRAGMENTATION#0.8937;RHEUMATOID ARTHRITIS#0.8538;GLOBIN#0.8532;DEOXYRIBONUCLEASE II#0.8526;ENDOTHELIAL CELL#0.8488;TRANSCRIPTION FACTOR BINDING#0.8408;HEPARIN#0.8394;NUCLEASE ACTIVITY#0.8385;RESPIRATORY TRACT#0.8270;SODIUM DODECYL SULFATE#0.8254;DODECYL SULFATE#0.8253;AUTOIMMUNE DISEASE#0.8198;SEMEN#0.8189;ADENOSINE#0.8126;MACROPHAGE#0.8125;SUCROSE#0.8062;COLLAGENASE#0.8019;ERYTHROCYTE#0.7982;NUCLEAR ENVELOPE#0.7963;RANDOMIZED CONTROLLED TRIAL#0.7960;TOPOISOMERASE#0.7948;MIDDLE EAR#0.7903;ACTIN POLYMERIZATION#0.7873;FLUORESCEIN#0.7861;BREAST CANCER#0.7776;ATPASE ACTIVITY#0.7756;RNA SYNTHESIS#0.7718;THYMIDINE#0.7697;NUCLEAR MATRIX#0.7695;MICROFILAMENT#0.7676;Z LINE#0.7605;HYPOXIA#0.7535;TF BINDING#0.7523;GROWTH HORMONE#0.7490;CELL PROLIFERATION#0.7483;DNA REPAIR#0.7433;MECHANISM OF ACTION#0.7422;INFLAMMATORY RESPONSE#0.7402;LIVER DISEASE#0.7287;LYSINE#0.7261;DNA POLYMERASE ALPHA#0.7237;COMPLEX I#0.7221;LYSIS#0.7207;PROTEIN SYNTHESIS#0.7206;CELL MEMBRANE#0.7201;TOLL LIKE RECEPTOR#0.7200;BREAST CANCER CELL#0.7197;ESTROGEN RECEPTOR#0.7196;INSULIN-LIKE GROWTH FACTOR#0.7193;CYTOTOXICITY#0.7170;NECROTIC#0.7163;POLY ADP RIBOSE#0.7159;DNA TOPOISOMERASE#0.7138;CHLORAMPHENICOL#0.7132;ENDONUCLEASE ACTIVITY#0.7112;IMP DEHYDROGENASE#0.7085;TUMOR CELLS#0.7050;METAPHASE CHROMOSOME#0.7048;HEPATOCYTE NUCLEAR FACTOR#0.7048;PROTEIN COMPLEX#0.6991;B CELL#0.6941;ACID PHOSPHATASE#0.6834;BIOFILM FORMATION#0.6792;OVIDUCT#0.6732;RANDOMIZED CLINICAL TRIAL#0.6706;KERATINOCYTE#0.6705;METAPHASE#0.6683;CELL SURFACE#0.6678;PERIPHERAL BLOOD#0.6673;TOPICAL#0.6661;PANCREATIC CANCER#0.6659;RED BLOOD CELL#0.6652;BLEOMYCIN#0.6651;T LYMPHOCYTE#0.6615;BIOFILM MATRIX#0.6597;PLASMA MEMBRANE#0.6586;FACTOR I#0.6546;VITAMIN D BINDING#0.6533;RANDOMISED CONTROLLED TRIAL#0.6494;HIGH MOBILITY GROUP#0.6452;GLUCOCORTICOID RECEPTOR#0.6444;SMALL INTESTINE#0.6439;PHOSPHOLIPASE C#0.6433;CELL GROWTH#0.6392;ISCHEMIA#0.6368;N-ACETYLCYSTEINE#0.6289;IVACAFTOR#0.6282;SALIVARY GLAND#0.6263;ETHANOL#0.6245;RIBOSE#0.6164;ACTIN CYTOSKELETON#0.6119;ACETYLCYSTEINE#0.6095;RESPIRATORY SYNCYTIAL VIRUS#0.6053;PITUITARY GLAND#0.6014
1774	DNASE#1.1173;DNASE I#1.0832;DEOXYRIBONUCLEASE I#0.8606;CELL SURFACE#0.8474;APOPTOSIS#0.7207;HOST CELL#0.6722;SKELETAL MUSCLE#0.6441;MUSCLE CELL#0.6387;ENDOCYTOSIS#0.6212
1775	TERMINAL DIFFERENTIATION#1.0512;KERATINOCYTE#1.0373;DNASE I#1.0261;DNASE#1.0068;DEOXYRIBONUCLEASE I#0.9351;DNA DEGRADATION#0.6528;BIOFILM FORMATION#0.6176
1776	DNASE I#1.0894;APOPTOTIC DNA FRAGMENTATION#1.0825;DNA FRAGMENTATION#1.0767;DNASE#1.0684;APOPTOSIS#1.0416;APOPTOTIC#1.0396;POLY ADP RIBOSE#0.8984;DEOXYRIBONUCLEASE I#0.8900;THYMOCYTE#0.8761;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8664;LUPUS ERYTHEMATOSUS#0.8661;AUTOIMMUNE DISEASE#0.8647;B CELL#0.8498;DNASE ACTIVITY#0.8111;LIVER CIRRHOSIS#0.8085;ENDONUCLEASE ACTIVITY#0.7888;VP-16#0.7883;PORTAL HYPERTENSION#0.7785;MACROPHAGE#0.7579;RIBOSE#0.7535;DNA FRAGMENTATION FACTOR#0.7468;CELL DEATH#0.7159;DNA DEGRADATION#0.6557;GENE EXPRESSION#0.6549;NUCLEASE ACTIVITY#0.6180;ENDOPLASMIC RETICULUM#0.6147;CANCER CELL#0.6109
1777	DNASE ACTIVITY#1.0849;DNASE#1.0619;BETA GLUCURONIDASE#1.0336;DNASE I#1.0174;ACID PHOSPHATASE#0.9557;DNA DEGRADATION#0.9482;LYSOSOME#0.8672;BETA GALACTOSIDASE#0.8193;ENZYME ACTIVITY#0.7992;CANCER CELL#0.7954;APOPTOSIS#0.7793;CELL DEATH#0.7782;APOPTOTIC#0.7332;RHEUMATOID ARTHRITIS#0.7020;MACROPHAGE#0.6954;NUCLEIC ACID#0.6742;DNA FRAGMENTATION#0.6333;GENE EXPRESSION#0.6319;DEOXYRIBONUCLEASE II#0.6194;SUBMANDIBULAR GLAND#0.6167
1778	CYTOPLASMIC DYNEIN HEAVY CHAIN#1.1015;SPINAL MUSCULAR ATROPHY#1.0846;MUSCULAR ATROPHY#1.0824;DYNEIN#1.0659;NADPH OXIDASE#1.0323;MICROTUBULE#1.0112;CHARCOT MARIE TOOTH#0.9881;CYTOCHROME B#0.9578;NADPH OXIDASE COMPLEX#0.9423;NEURONAL MIGRATION#0.9344;ANTIOXIDANT ACTIVITY#0.9061;PROTEIN KINASE#0.8991;PROTEIN KINASE C#0.8785;REACTIVE OXYGEN SPECIES#0.8597;NEUTROPHIL#0.8591;DYNEIN COMPLEX#0.8584;AXONAL TRANSPORT#0.8440;MOTOR NEURON DISEASE#0.8305;KINESIN#0.8148;INTELLECTUAL DISABILITY#0.8006;CHARCOT-MARIE-TOOTH DISEASE#0.7977;TOOTH DISEASE#0.7976;MICROTUBULE BINDING#0.7663;HEPATITIS B VIRUS#0.7651;HEPATITIS B#0.7632;NEUROPATHY#0.7598;PLASMA MEMBRANE#0.7472;MICROTUBULE MOTOR#0.7456;ENDOPLASMIC RETICULUM#0.7132;CENTROSOME#0.7003;GENE EXPRESSION#0.6786;RETROGRADE AXONAL TRANSPORT#0.6757;SPINDLE POLE#0.6365;MENTAL RETARDATION#0.6353;NUCLEAR MOVEMENT#0.6317
177	TRANSMEMBRANE RECEPTOR#1.0579;RELATED PROTEIN 1#1.0461;OF DIABETIC RATS#1.0447;SURFACTANT PROTEIN D#1.0433;MYOBLAST#1.0416;CHONDROCYTE#1.0370;NEURITE OUTGROWTH#1.0362;DIABETIC NEUROPATHY#1.0336;MAP KINASE#1.0334;PULMONARY FIBROSIS#1.0320;ROS GENERATION#1.0306;NEURITE#1.0304;MESANGIAL CELL#1.0278;PANCREATIC CANCER#1.0268;PROSTATE CANCER#1.0250;SQUAMOUS CELL CARCINOMA#1.0246;HEPATOCELLULAR CARCINOMA#1.0243;ADVANCED GLYCATION END#1.0233;SIGNALLING PATHWAY#1.0233;NADPH OXIDASE#1.0232;TOLL LIKE RECEPTOR#1.0231;SCAVENGER RECEPTOR#1.0229;PODOCYTE#1.0227;GLYCOSYLATION#1.0223;MULTIPLE SCLEROSIS#1.0222;ACTIVATION OF NF-KAPPAB#1.0222;MAPK SIGNALING#1.0221;ADIPOSE TISSUE#1.0219;PATTERN RECOGNITION RECEPTOR#1.0204;CELL MEMBRANE#1.0203;INDUCIBLE NITRIC OXIDE#1.0202;CELL SURFACE#1.0194;PERIPHERAL NERVE#1.0192;SIGNAL TRANSDUCTION#1.0179;QUANTITATIVE REAL TIME#1.0168;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0162;PIOGLITAZONE#1.0155;BREAST CANCER#1.0155;VASCULAR DISEASE#1.0154;UMBILICAL VEIN ENDOTHELIAL CELLS#1.0152;CELL ADHESION MOLECULE#1.0144;OVARIAN#1.0143;SPINAL CORD#1.0130;ALVEOLAR EPITHELIAL CELL#1.0129;HYPOXIA#1.0125;COLORECTAL CANCER#1.0122;ADIPOCYTE#1.0110;CORONARY ARTERY DISEASE#1.0105;CELL ADHESION#1.0103;TYPE 1 DIABETIC#1.0099;TRANSFORMING GROWTH FACTOR#1.0098;AUTOPHAGY#1.0098;MICROGLIAL CELL#1.0093;ARTERY DISEASE#1.0092;HUMAN UMBILICAL VEIN#1.0090;UMBILICAL VEIN#1.0088;ISCHEMIA REPERFUSION INJURY#1.0085;CANCER CELL#1.0080;LUNG CANCER#1.0079;SIGNALING CASCADE#1.0076;VASCULAR ENDOTHELIAL CELL#1.0073;DIABETIC RETINOPATHY#1.0072;PNEUMONIA#1.0071;NEUROPATHY#1.0070;NITRIC OXIDE SYNTHASE#1.0070;REVERSE TRANSCRIPTION#1.0069;VASCULAR CELL#1.0060;AMYLOID PRECURSOR PROTEIN#1.0058;TUMOR CELLS#1.0057;SMOOTH MUSCLE ACTIN#1.0052;CELL ACTIVATION#1.0051;LOW DENSITY LIPOPROTEIN#1.0047;PERIPHERAL BLOOD MONONUCLEAR CELLS#1.0038;VASCULAR SMOOTH MUSCLE CELL#1.0038;OBESE#1.0034;PERIODONTITIS#1.0033;CELL MIGRATION#1.0033;WOUND HEALING#1.0032;LIGAND BINDING DOMAIN#1.0031;LYSINE#1.0029;PEROXISOME#1.0027;MONONUCLEAR CELLS#1.0025;TYPE 2 DIABETES MELLITUS#1.0023;REGENERATION#1.0020;SIGNALING PATHWAY#1.0017;2 DIABETES MELLITUS#1.0013;COLORECTAL#1.0012;MITOGEN ACTIVATED PROTEIN#0.9998;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9995;TYPE 1 DIABETES#0.9993;INFLAMMATORY CELL#0.9992;RESPIRATORY DISTRESS#0.9989;GLIAL CELL#0.9988;PROGENITOR CELL#0.9988;MICROVASCULAR ENDOTHELIAL CELL#0.9986;ENDOTHELIAL GROWTH FACTOR#0.9977;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9977;ENDOPLASMIC RETICULUM#0.9976;ACUTE LUNG INJURY#0.9976;B CELL#0.9974;CELL GROWTH#0.9972;RHEUMATOID ARTHRITIS#0.9972;GENE SILENCING#0.9972;CYTOKINE PRODUCTION#0.9972;CARDIOMYOCYTE#0.9968;ANGIOGENESIS#0.9967;STEM CELL#0.9964;POLYMERASE CHAIN REACTION#0.9962;LUPUS NEPHRITIS#0.9962;CELL PROLIFERATION#0.9960;SMOOTH MUSCLE CELL#0.9959;IMMUNE CELL#0.9959;KERATINOCYTE#0.9955;CORONARY ARTERY#0.9951;ADVANCED GLYCATION ENDPRODUCT#0.9946;PROTEIN KINASE#0.9944;MUSCLE CELL#0.9943;DIABETIC NEPHROPATHY#0.9943;NF-KAPPAB ACTIVATION#0.9942;MONOCYTE#0.9941;MYOFIBROBLAST#0.9939;SKELETAL MUSCLE#0.9939;ISCHEMIA#0.9939;NEUROTOXICITY#0.9938;TIGHT JUNCTION#0.9937;NITRIC OXIDE#0.9936;TRANSCRIPTION FACTOR#0.9933;SMOOTH MUSCLE#0.9933;LYMPH NODE#0.9932;CYTOTOXICITY#0.9928;IDIOPATHIC PULMONARY FIBROSIS#0.9924;ENDOTHELIAL CELL#0.9916;GROWTH FACTOR#0.9911;KIDNEY DISEASE#0.9910;NEPHROPATHY#0.9910;TYPE 2 DIABETIC#0.9908;PRO-INFLAMMATORY#0.9908;PERIPHERAL BLOOD#0.9907;CHRONIC KIDNEY DISEASE#0.9905;GENE EXPRESSION#0.9904;NEUTROPHIL#0.9903;ALVEOLAR FLUID CLEARANCE#0.9903;CEREBRAL ISCHEMIA#0.9901;MYELOID CELL#0.9900;T CELL#0.9898;DENDRITIC CELL#0.9898;PYRUVATE#0.9897;ENDOTHELIUM#0.9897;ATHEROSCLEROTIC#0.9897;HEPATIC STELLATE CELL#0.9894;ATHEROSCLEROSIS#0.9893;MYOCARDIAL INFARCTION#0.9893;BREAST CANCER CELL#0.9892;FRUCTOSE#0.9891;LUNG DISEASE#0.9889;MACROPHAGE#0.9888;METFORMIN#0.9886;EPITHELIAL CELL#0.9883;INFLAMMATORY RESPONSE#0.9880;GLUTATHIONE#0.9879;ASTROCYTE#0.9877;PROTEIN KINASE C#0.9871;BONE MARROW#0.9870;SCHWANN CELL#0.9869;PLASMA MEMBRANE#0.9869;CELL CYCLE#0.9866;APOPTOSIS#0.9865;EPITHELIAL MESENCHYMAL TRANSITION#0.9854;SUPEROXIDE DISMUTASE#0.9853;TUMOR NECROSIS FACTOR#0.9852;C REACTIVE PROTEIN#0.9849;OSTEOARTHRITIS#0.9846;TYPE 2 DIABETES#0.9844;INNATE IMMUNE RESPONSE#0.9840;MESENCHYMAL STEM CELL#0.9838;HIGH MOBILITY GROUP#0.9832;SERUM ALBUMIN#0.9825;REACTIVE OXYGEN SPECIES#0.9821;EXTRACELLULAR MATRIX#0.9819;NEURODEGENERATIVE DISEASE#0.9811;T LYMPHOCYTE#0.9811;BLOOD BRAIN BARRIER#0.9809;TISSUE DAMAGE#0.9809;ADENOCARCINOMA#0.9807;APOPTOTIC#0.9805;HYPERGLYCEMIA#0.9804;BLOOD VESSEL#0.9803;MYOCARDIUM#0.9801;CERVICAL#0.9800;LEUKOCYTE#0.9799;ADENINE DINUCLEOTIDE PHOSPHATE#0.9798;COLITIS#0.9790;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9790;CELL DEATH#0.9784;IMMUNE RESPONSE#0.9783;ARTERY#0.9783;FIBRIL#0.9771;HIGH FAT DIET#0.9771;CYTOPLASM#0.9769;LIVER DISEASE#0.9764;TOXICITY#0.9759;AUTOIMMUNE DISEASE#0.9744;FRAGMENT LENGTH POLYMORPHISM#0.9743;EARLY GROWTH RESPONSE#0.9741;NERVOUS SYSTEM#0.9739;ALZHEIMER'S DISEASE#0.9735;EDEMA#0.9730;ALVEOLAR MACROPHAGE#0.9726;HEMORRHAGE#0.9726;STREPTOZOTOCIN#0.9723;HYPERTENSION#0.9722;ENDOPLASMIC RETICULUM STRESS#0.9720;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9718;CHEMOTAXIS#0.9716;LUNG CARCINOMA#0.9715;NECROTIC#0.9712;DNA BINDING#0.9706;DIABETES MELLITUS#0.9702;ACUTE PANCREATITIS#0.9697;NEURONAL CELLS#0.9686;STROMAL CELL#0.9682;HYPERGLYCEMIC#0.9672;ALKALINE PHOSPHATASE#0.9670;HEART DISEASE#0.9664;SCIATIC NERVE#0.9664;SELECTIN#0.9659;IMMUNE SYSTEM#0.9653;COLON CANCER#0.9644;HYPOXIC#0.9636;CENTRAL NERVOUS SYSTEM#0.9627;INSULIN DEGRADING ENZYME#0.9614;ENDOTHELIAL NITRIC OXIDE#0.9610;ATORVASTATIN#0.9588;ALVEOLAR TYPE I#0.9586;INTENSIVE CARE UNIT#0.9578;EXTRACELLULAR SPACE#0.9573;BRAIN DAMAGE#0.9571;INNATE IMMUNITY#0.9566;NUCLEIC ACID#0.9564;FIBROBLAST GROWTH FACTOR#0.9563;MAST CELL#0.9557;HYPOXIA INDUCIBLE FACTOR#0.9540;RNA INTERFERENCE#0.9529;GLUTATHIONE PEROXIDASE#0.9526;ONCOGENIC#0.9520;MONOCYTE CHEMOTACTIC PROTEIN#0.9515;LUNG EPITHELIAL CELL#0.9513;OSTEOBLAST#0.9507;DEMENTIA#0.9499;HEME OXYGENASE 1#0.9493;PLATELET ACTIVATION#0.9483;SPINAL CORD INJURY#0.9481;LUNG METASTASIS#0.9477;MEMORY IMPAIRMENT#0.9466;MILD COGNITIVE IMPAIRMENT#0.9465;PERICYTE#0.9458;CORD BLOOD#0.9439;N-ACETYLCYSTEINE#0.9435;RETINOIC ACID#0.9416;NEPHRITIS#0.9396;REACTIVE OXYGEN SPECIES GENERATION#0.9385;HEPARIN#0.9366;OXYGENASE#0.9361;SURFACE PLASMON RESONANCE#0.9359;PULMONARY HYPERTENSION#0.9345;ENDOCYTOSIS#0.9337;RESVERATROL#0.9334;ADAPTIVE IMMUNE RESPONSE#0.9332;PARKINSON'S DISEASE#0.9332;GALECTIN#0.9326;SIGNALING MOLECULE#0.9323;BASEMENT MEMBRANE#0.9297;GLUCOSE METABOLISM#0.9291;CONNECTIVE TISSUE#0.9290;TRANSFORMING GROWTH FACTOR BETA#0.9278;PLASMA PROTEIN#0.9275;NICOTINAMIDE#0.9266;CELL MOTILITY#0.9217;ADENINE#0.9207;SERUM AMYLOID A#0.9205;GLOMERULAR FILTRATION#0.9201;NEUROPROTECTION#0.9198;PULMONARY EDEMA#0.9197;INNATE IMMUNE SYSTEM#0.9190;CIGARETTE SMOKE EXTRACT#0.9178;PERIODONTAL DISEASE#0.9156;LUNG ADENOCARCINOMA#0.9153;KUPFFER CELL#0.9150;PULMONARY ARTERY#0.9137;MACROPHAGE ACTIVATION#0.9131;CHOLESTEROL EFFLUX#0.9104;SMOOTH MUSCLE CELL PROLIFERATION#0.9079;MUSCLE CELL PROLIFERATION#0.9076;TO THE PROGRESSION#0.9064;INFLAMMATORY BOWEL DISEASE#0.9058;TRANSCRIPTASE#0.9048;CERVICAL CANCER#0.9031;AMYLOIDOSIS#0.9030;INTIMA MEDIA THICKNESS#0.9029;TISSUE GROWTH FACTOR#0.9024;NUCLEUS PULPOSUS#0.9007;NEURONAL CELL DEATH#0.9005;AQUAPORIN#0.8987;WEIGHT LOSS#0.8982;SIGNAL TRANSDUCER#0.8972;MECHANISM OF ACTION#0.8971;CAROTID ARTERY#0.8966;AGEING#0.8965;MORRIS WATER MAZE#0.8960;ENDOTHELIAL PROGENITOR CELL#0.8956;STRIATUM#0.8954;ORAL SQUAMOUS CELL CARCINOMA#0.8953;INSULIN-LIKE GROWTH FACTOR#0.8946;OSTEOCLAST#0.8943;BLOOD GLUCOSE LEVEL#0.8937;CLARA CELL#0.8900;ATRIAL FIBRILLATION#0.8888;PULMONARY ARTERIAL HYPERTENSION#0.8873;LECTIN#0.8864;RECEPTOR ANTAGONIST#0.8858;APOPTOTIC CELL DEATH#0.8852;FATTY LIVER#0.8845;GRANULOCYTE#0.8840;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8827;LUPUS ERYTHEMATOSUS#0.8825;N GLYCAN#0.8807;MITOCHONDRIA#0.8806;AMYLOID PROTEIN#0.8801;NEUROTOXIC#0.8795;SYSTEMIC INFLAMMATORY RESPONSE#0.8788;EXCRETION#0.8768;CORONARY HEART DISEASE#0.8750;HUNTINGTON'S DISEASE#0.8741;INTERVERTEBRAL DISC#0.8736;GLOMERULAR FILTRATION RATE#0.8723;SPUTUM#0.8709;MACROPHAGE INFLAMMATORY PROTEIN#0.8709;CROHN'S DISEASE#0.8707;ACETYLCHOLINE#0.8687;HEMATOPOIETIC CELL#0.8686;HEMORRHAGIC#0.8686;NERVE FIBER#0.8683;AMNIOTIC FLUID#0.8681;BONE MINERAL DENSITY#0.8678;LUNG DAMAGE#0.8674;G1 PHASE#0.8663;PANCREATITIS#0.8658;BRAIN ENDOTHELIAL CELL#0.8654;TUMOUR NECROSIS FACTOR#0.8650;SYNOVIAL FLUID#0.8646;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8644;CELL DIFFERENTIATION#0.8643;ESTROGEN RECEPTOR#0.8642;P38 MAPK SIGNALING#0.8638;AORTIC VALVE#0.8625;ANGIOTENSIN RECEPTOR#0.8599;TIGHT JUNCTION PROTEIN#0.8595;LEUKOCYTE ADHESION#0.8577;GRANULOSA CELL#0.8573;EPITHELIAL TO MESENCHYMAL#0.8573;CHEMOKINE RECEPTOR#0.8572;UMBILICAL CORD#0.8570;FATTY LIVER DISEASE#0.8567;ACETYLCYSTEINE#0.8541;SYSTOLIC BLOOD PRESSURE#0.8536;ANGIOTENSIN CONVERTING ENZYME#0.8535;ENZYME ACTIVITY#0.8524;BLEOMYCIN#0.8523;BRAIN NATRIURETIC PEPTIDE#0.8506;CARDIOVASCULAR RISK FACTOR#0.8505;ESTRADIOL#0.8504;CARDIOMYOPATHY#0.8492;LYSOSOME#0.8485;TRAUMATIC BRAIN INJURY#0.8461;HIGH DENSITY LIPOPROTEIN#0.8461;ROSIGLITAZONE#0.8447;ELECTROPHORETIC MOBILITY SHIFT#0.8445;PROXIMAL TUBULAR CELL#0.8440;PULSE WAVE VELOCITY#0.8432;TARGET OF RAPAMYCIN#0.8426;NIFEDIPINE#0.8417;COLORECTAL CARCINOMA#0.8366;TRANSCYTOSIS#0.8351;MUSCULAR DYSTROPHY#0.8350;FASTING BLOOD GLUCOSE#0.8340;SENESCENCE#0.8339;CYTOKINE SECRETION#0.8333;HYPERSENSITIVITY#0.8330;OSTEOPOROSIS#0.8330;RESPONSE TO STRESS#0.8327;CYSTIC FIBROSIS#0.8325;MIDDLE CEREBRAL ARTERY#0.8323;CEREBRAL ARTERY#0.8320;LOW MOLECULAR WEIGHT HEPARIN#0.8318;HEAT SHOCK PROTEIN#0.8318;HUMAN SERUM ALBUMIN#0.8311;TUMOR TISSUES#0.8308;INSULIN RECEPTOR#0.8304;GROWTH FACTOR RECEPTOR#0.8297;PERIODONTAL LIGAMENT#0.8287;NUCLEOSOME#0.8284;SIMVASTATIN#0.8249;CELL BOUND#0.8249;ASPARTATE#0.8222;RECEPTOR AGONIST#0.8217;COLONY-STIMULATING FACTOR#0.8210;ANGIOTENSIN RECEPTOR BLOCKER#0.8203;CEREBRAL ARTERY OCCLUSION#0.8203;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8201;ACETYLCHOLINE RECEPTOR#0.8188;MACROPHAGE POLARIZATION#0.8144;ULCERATIVE COLITIS#0.8141;MYOCYTES#0.8113;PLASMACYTOID DENDRITIC CELL#0.8093;NEUROBLASTOMA#0.8078;INTRACELLULAR SIGNALING PATHWAY#0.8071;URIC ACID#0.8070;CYTOCHROME C#0.8038;GLUCOSE UPTAKE#0.8035;CIRCULATING ENDOTHELIAL CELL#0.8025;RIBOSE#0.8025;KAWASAKI DISEASE#0.8022;PLATELET-DERIVED GROWTH FACTOR#0.8022;INTRACELLULAR SIGNAL TRANSDUCTION#0.8021;TYPE 1 DIABETES MELLITUS#0.8000;LINEAR REGRESSION ANALYSIS#0.7985;CD8+ T CELL#0.7983;RAPAMYCIN#0.7960;PYROPTOSIS#0.7924;PSORIASIS#0.7923;KINASE INHIBITOR#0.7923;PHAGOCYTOSIS#0.7912;MULTIPLE REGRESSION ANALYSIS#0.7899;EOSINOPHIL#0.7879;MITOCHONDRIAL FISSION#0.7870;IFN-GAMMA#0.7863;M1 MACROPHAGE#0.7856;PLACENTAL GROWTH FACTOR#0.7845;TUBERCULOSIS#0.7843;TELMISARTAN#0.7833;M2 MACROPHAGE#0.7827;MULTIPLE LINEAR REGRESSION#0.7823;LUNG DEVELOPMENT#0.7822;AUTOIMMUNITY#0.7813;PERIAPICAL GRANULOMA#0.7810;MYASTHENIA GRAVIS#0.7805;TUBE FORMATION#0.7787;POLYCYSTIC OVARY SYNDROME#0.7758;CELLULAR LOCALIZATION#0.7752;BETA-2#0.7744;MATRIX METALLOPROTEINASE 13#0.7739;UREMIA#0.7713;AMINOGUANIDINE#0.7708;TROPHOBLAST#0.7702;CAVEOLAE#0.7700;FIBRINOGEN#0.7693;BRAIN ISCHEMIA#0.7690;NEUROINFLAMMATORY RESPONSE#0.7685;COAGULATION#0.7685;QUERCETIN#0.7669;HMGB1 BINDING#0.7658;PROTEOGLYCAN#0.7645;MARKERS OF INFLAMMATION#0.7645;DORSAL ROOT GANGLION#0.7639;BRAIN EDEMA#0.7630;LYMPH NODE METASTASIS#0.7595;T CELL ACTIVATION#0.7594;PAPAVERINE#0.7585;VITAMIN E#0.7575;ADENOSINE#0.7544;TUBULAR EPITHELIAL CELL#0.7538;OSTEOCYTE#0.7516;IL-6 PRODUCTION#0.7503;MESOTHELIAL CELL#0.7500;CHONDROCYTE HYPERTROPHY#0.7497;UBIQUITIN#0.7497;SEROTONIN RELEASE#0.7495;EPIDERMAL GROWTH FACTOR#0.7492;HUMAN PULMONARY ARTERY#0.7490;KETAMINE#0.7482;VASCULITIS#0.7446;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7445;PROLIFERATIVE DIABETIC RETINOPATHY#0.7434;HEALTHY CONTROL SUBJECTS#0.7425;72-HOURS#0.7424;HYPERACTIVITY#0.7423;CLEAVED CASPASE 3#0.7423;GASTRIC EPITHELIAL CELLS#0.7419;MYOBLAST DIFFERENTIATION#0.7417;MECHANISMS OF ACTION#0.7401;MYELOID-DERIVED SUPPRESSOR CELL#0.7398;GM-CSF#0.7391;NON-SMALL CELL LUNG CARCINOMA#0.7363;ADJUSTED ODDS RATIO#0.7360;LIVER DAMAGE#0.7352;EOSIN#0.7343;ARTERIOSCLEROSIS#0.7339;BREAST CANCER PATIENTS#0.7322;ETHANOL#0.7317;NEUROFIBRILLARY TANGLE#0.7317;DOPAMINERGIC NEURON#0.7281;STROMA#0.7280;CANCER STEM CELL#0.7268;PERIPHERAL ARTERIAL DISEASE#0.7265;OLIGODENDROCYTE#0.7264;OOCYTE#0.7241;OXYGEN GLUCOSE DEPRIVATION#0.7239;RETINAL PIGMENT EPITHELIAL#0.7234;THROMBOSIS#0.7228;ALCOHOLIC FATTY LIVER#0.7221;TRADITIONAL CHINESE MEDICINE#0.7218;MACULAR DEGENERATION#0.7210;LIPID RAFT#0.7207;INTESTINAL EPITHELIAL CELL#0.7201;VILDAGLIPTIN#0.7201;ESSENTIAL HYPERTENSION#0.7187;ACTIVATED B CELL#0.7187;DNA FRAGMENTATION#0.7178;HYPERCHOLESTEROLEMIA#0.7173;HEPATOCELLULAR CARCINOMA CELL#0.7171;HUMAN BRONCHIAL EPITHELIAL#0.7166;LUNG FIBROBLASTS#0.7166;INFLAMMATORY CELL INFILTRATION#0.7163;WEIGHT GAIN#0.7157;17β-ESTRADIOL#0.7146;MYOBLAST PROLIFERATION#0.7145;GLUCOSE TOLERANCE TEST#0.7124;VALSARTAN#0.7123;AKT SIGNALING#0.7115;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7104;HIGH FAT FEEDING#0.7097;ALLERGEN#0.7091;IRBESARTAN#0.7084;BLOOD UREA NITROGEN#0.7082;PARENCHYMA#0.7075;RENAL CELL CARCINOMA#0.7065;FIBROBLAST PROLIFERATION#0.7049;ACUTE ISCHEMIC STROKE#0.7031;CHOROID PLEXUS#0.7028;BONE REMODELING#0.7010;TRANSDIFFERENTIATION#0.7001;RESPIRATORY FAILURE#0.6998;PERITONITIS#0.6989;GANGLION CELLS#0.6986;BILE DUCT#0.6983;AIRWAY EPITHELIAL CELL#0.6982;UMBILICAL CORD BLOOD#0.6981;LUCIFERASE ACTIVITY#0.6978;AGE RELATED MACULAR DEGENERATION#0.6975;GROWTH FACTOR BINDING#0.6971;DIPEPTIDYL PEPTIDASE#0.6970;ROS FORMATION#0.6966;AUTOPHAGOSOME#0.6949;RANDOMIZED CONTROLLED TRIAL#0.6940;DRUG RESISTANCE#0.6927;LIPID METABOLISM#0.6925;CELL CYCLE ARREST#0.6922;PERIPHERAL NERVOUS SYSTEM#0.6906;ORAL GLUCOSE TOLERANCE#0.6902;POLY ADP RIBOSE#0.6880;ALBUMIN CREATININE RATIO#0.6852;ARGININE#0.6844;DENTAL PULP#0.6842;PHOSPHATIDYLSERINE#0.6824;IMPAIRED GLUCOSE TOLERANCE#0.6821;NEURAL STEM CELL#0.6800;AMYOTROPHIC LATERAL SCLEROSIS#0.6794;LATERAL SCLEROSIS#0.6794;MITOCHONDRIAL MEMBRANE#0.6787;NUCLEUS PULPOSUS CELL#0.6785;LYMPHOID CELL#0.6783;PROTEIN COMPLEX#0.6777;CHONDROCYTE DIFFERENTIATION#0.6752;FORCED EXPIRATORY VOLUME#0.6742;DIGESTION#0.6741;GLOBAL CEREBRAL ISCHEMIA#0.6727;ASCORBATE#0.6727;PANCREATIC DUCTAL ADENOCARCINOMA#0.6719;EXTRACELLULAR REGION#0.6717;ALLERGIC AIRWAY INFLAMMATION#0.6716;PERIPHERAL NERVE INJURY#0.6715;LDL RECEPTOR#0.6702;ACUTE CORONARY SYNDROME#0.6701;NEURON DEATH#0.6689;HUMAN PANCREATIC CANCER#0.6687;PRE-ECLAMPSIA#0.6687;EPITHELIAL SODIUM CHANNEL#0.6682;TISSUE HOMEOSTASIS#0.6673;RED BLOOD CELL#0.6669;CHRONIC HEART FAILURE#0.6667;CD4+ T CELL#0.6666;BLOOD PLASMA#0.6663;DIABETIC ANGIOPATHY#0.6662;FACTOR I#0.6661;GLUCOSE HOMEOSTASIS#0.6650;SODIUM CHANNEL#0.6642;COMPLEX I#0.6622;PROTEINURIA#0.6617;IMPAIRED GLUCOSE METABOLISM#0.6616;MULTIPLE ORGAN DYSFUNCTION#0.6614;FORMYL PEPTIDE RECEPTOR#0.6572;ACUTE MYOCARDIAL INFARCTION#0.6531;POLYNEUROPATHY#0.6522;GESTATIONAL DIABETES#0.6507;MTDNA#0.6501;COLLAGEN SYNTHESIS#0.6490;PRIMARY GRAFT DYSFUNCTION#0.6469;AORTIC SMOOTH MUSCLE CELLS#0.6461;RENAL FIBROSIS#0.6457;TROPHOBLAST CELL#0.6437;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6435;ACTIN POLYMERIZATION#0.6428;DERMATITIS#0.6427;L-CYSTEINE#0.6425;INTERLEUKIN 1 RECEPTOR#0.6420;PANCREATIC ISLET#0.6413;MICROTUBULE ASSOCIATED PROTEIN#0.6413;QUANTITATIVE REVERSE TRANSCRIPTION#0.6403;RECEPTOR BINDING#0.6393;PROTEIN BINDING#0.6393;DNA SYNTHESIS#0.6389;NMDA RECEPTOR#0.6386;MICROTUBULE#0.6343;CORONARY ARTERY ENDOTHELIAL CELLS#0.6337;PULMONARY VASCULAR REMODELING#0.6334;EFFEROCYTOSIS#0.6332;CANDESARTAN#0.6325;VASCULAR RISK FACTORS#0.6319;LINAGLIPTIN#0.6316;HUMAN PERIODONTAL LIGAMENT#0.6313;SARCOIDOSIS#0.6293;ACETAMINOPHEN#0.6284;MAST CELL ACTIVATION#0.6281;PERITONEUM#0.6275;EXTRACELLULAR REGULATED KINASE#0.6268;EPILEPSY#0.6265;PERITONEAL CAVITY#0.6263;NORMAL CONTROL GROUP#0.6260;MUTAGENESIS#0.6256;PHOSPHATE BUFFERED SALINE#0.6253;PULMONARY TUBERCULOSIS#0.6247;ALANINE#0.6247;CASPASE-3 ACTIVITY#0.6239;COLLAGENASE#0.6230;ANTIGEN PRESENTING CELLS#0.6222;NEURAL CELL#0.6218;LIRAGLUTIDE#0.6217;PROTEASOME#0.6205;TH17 CELL#0.6202;AORTIC VALVE CALCIFICATION#0.6198;ABETA PRECURSOR PROTEIN#0.6191;KIDNEY DAMAGE#0.6178;CREATINE#0.6130;MONOCYTE CHEMOTAXIS#0.6129;RECEPTOR LIGAND#0.6115;CREATINE KINASE#0.6112;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6107;MITOPHAGY#0.6105;KINASE ACTIVITY#0.6081;TRANSVERSE AORTIC CONSTRICTION#0.6070;METALLOPROTEINASE INHIBITOR#0.6059;DNA REPAIR#0.6056;FEMORAL ARTERY LIGATION#0.6036;LEWIS LUNG CARCINOMA#0.6031;NEUTROPHIL MIGRATION#0.6025;RETINAL PIGMENT EPITHELIAL CELLS#0.6025;SENSITIZATION#0.6020;AIRWAY EPITHELIUM#0.6019;PIGMENT EPITHELIAL CELL#0.6012;ABSENT IN MELANOMA#0.6002;LENGTH OF STAY#0.6001
1780	DYNEIN#0.8922;CANCER CELL#0.6397;MULTIPLE SYSTEM ATROPHY#0.6140;INTELLECTUAL DISABILITY#0.6023
1781	DYNEIN#1.0629;CELL MIGRATION#0.8246;GROWTH PATTERN#0.6621
1783	LIGHT INTERMEDIATE CHAIN#1.0736;DYNEIN#1.0678;SPINDLE ORIENTATION#0.6447;SPINDLE POLE#0.6273
1784	CYTOPLASMIC MEMBRANE#0.7524;PLASMA MEMBRANE#0.6893
1785	CENTRONUCLEAR MYOPATHY#1.0522;MEMBRANE FISSION#1.0374;PROTEIN BINDING#1.0337;DOMINANT NEGATIVE MUTANT#1.0305;CHARCOT MARIE TOOTH#1.0287;MYOPATHY#1.0279;PROTEIN DEGRADATION#1.0254;PROTEIN PHOSPHORYLATION#1.0205;GTPASE ACTIVITY#1.0193;CHARCOT-MARIE-TOOTH DISEASE#1.0128;TOOTH DISEASE#1.0128;SPECTRIN#1.0127;NEUROPATHY#1.0120;VESICLE FORMATION#1.0117;PROTEIN COMPLEX#1.0111;DUCHENNE MUSCULAR DYSTROPHY#1.0085;INTEGRIN ACTIVATION#1.0076;CELL MOTILITY#1.0074;FOCAL ADHESION#1.0058;CLATHRIN-COATED PIT#1.0035;COATED PIT#1.0035;PROTEIN SYNTHESIS#1.0033;CAVEOLAE#1.0026;ENDOCYTIC VESICLE#1.0020;ERYTHROCYTE#1.0012;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0009;LIPID RAFT#0.9996;PROTEIN PROTEIN INTERACTION#0.9976;MUSCULAR DYSTROPHY#0.9973;MICROTUBULE ASSOCIATED PROTEIN#0.9972;CYTOKINESIS#0.9954;SARCOLEMMA#0.9948;MUSCLE FIBER#0.9939;ENDOCYTOSIS#0.9936;SMOOTH MUSCLE ACTIN#0.9933;CELL DIVISION#0.9921;CLATHRIN-MEDIATED ENDOCYTOSIS#0.9916;ACTIN POLYMERIZATION#0.9903;GTP BINDING#0.9879;BRUSH BORDER#0.9869;MICROFILAMENT#0.9861;PROTEIN KINASE C#0.9850;ASTROCYTE#0.9845;SPINAL CORD#0.9837;ACTIN BINDING PROTEIN#0.9835;MORPHOGENESIS#0.9828;GLUTATHIONE#0.9817;SMOOTH MUSCLE#0.9803;ENDOSOME#0.9802;FOCAL ADHESION KINASE#0.9801;SMOOTH MUSCLE CELL#0.9799;RED BLOOD CELL#0.9789;ISCHEMIA#0.9789;ACTIN BINDING#0.9789;CELL GROWTH#0.9787;CELL ADHESION MOLECULE#0.9786;NEUROFILAMENT#0.9782;EXOCYTOSIS#0.9781;STEM CELL#0.9780;MEMBRANE SCISSION#0.9780;CELL MIGRATION#0.9779;TRANSCRIPTION FACTOR#0.9775;CLATHRIN HEAVY CHAIN#0.9770;ACTIN FILAMENT#0.9763;CELL ADHESION#0.9752;MUSCLE CELL#0.9751;MICROTUBULE#0.9750;HOST CELL#0.9748;RNA INTERFERENCE#0.9744;NITRIC OXIDE#0.9744;EXTRACELLULAR MATRIX#0.9743;CELL CYCLE#0.9742;RECEPTOR MEDIATED ENDOCYTOSIS#0.9741;MICROVILLI#0.9734;TUMOR CELLS#0.9732;CELL MEMBRANE#0.9731;INTERMEDIATE FILAMENT#0.9724;PERIPHERAL NERVE#0.9723;T CELL#0.9715;SKELETAL MUSCLE#0.9712;VESICLE SCISSION#0.9712;CELL PROLIFERATION#0.9712;SCIATIC NERVE#0.9710;MACROPHAGE#0.9709;ACTIN CYTOSKELETON#0.9707;SIGNAL TRANSDUCTION#0.9705;PROTEIN KINASE#0.9702;SIGNALING PATHWAY#0.9702;APOPTOTIC#0.9694;GOLGI APPARATUS#0.9691;STRESS FIBER#0.9690;CENTRAL NERVOUS SYSTEM#0.9688;ENDOTHELIAL CELL#0.9688;DYNEIN#0.9687;CELL DIFFERENTIATION#0.9683;EPIDERMAL GROWTH FACTOR#0.9683;TRAUMATIC BRAIN INJURY#0.9673;NEUROMUSCULAR JUNCTION#0.9670;EPITHELIAL CELL#0.9665;B CELL#0.9662;NITRIC OXIDE SYNTHASE#0.9661;GROWTH FACTOR#0.9660;ALZHEIMER'S DISEASE#0.9653;APOPTOSIS#0.9652;CANCER CELL#0.9648;PLASMA MEMBRANE#0.9648;SYNAPTIC VESICLE#0.9647;CARDIOMYOPATHY#0.9641;NERVOUS SYSTEM#0.9633;CELL SURFACE#0.9632;NEURODEGENERATIVE DISEASE#0.9626;ORGANELLE#0.9626;CYTOPLASM#0.9624;GROWTH FACTOR RECEPTOR#0.9617;COATED VESICLE#0.9601;MITOCHONDRIA#0.9600;CELL DEATH#0.9592;MUSCLE WEAKNESS#0.9589;REGENERATION#0.9588;NEURITE#0.9584;GENE EXPRESSION#0.9583;GLUTAMATE RECEPTOR#0.9559;VASCULAR SMOOTH MUSCLE CELL#0.9554;SCHWANN CELL#0.9548;ADHERENS JUNCTION#0.9544;POLYMERASE CHAIN REACTION#0.9543;AUTOPHAGY#0.9541;BECKER MUSCULAR DYSTROPHY#0.9539;CYTOSKELETAL ELEMENT#0.9535;CARDIAC MUSCLE#0.9528;ANGIOGENESIS#0.9525;MACROPINOCYTOSIS#0.9501;CARDIOMYOCYTE#0.9493;SERTOLI CELL#0.9491;WOUND HEALING#0.9490;HYPERTENSION#0.9490;UBIQUITIN#0.9480;GLIAL CELL#0.9447;BUDDING#0.9442;DILATED CARDIOMYOPATHY#0.9438;T LYMPHOCYTE#0.9433;BREAST CANCER#0.9429;FILAMENTOUS ACTIN#0.9420;MYOFIBROBLAST#0.9419;C TERMINAL DOMAIN#0.9415;KINASE ACTIVITY#0.9390;ION CHANNEL#0.9387;DODECYL SULFATE#0.9385;ARTERY#0.9384;TUMOR SUPPRESSOR#0.9363;MUSCLE FIBRE#0.9360;NEURONAL CELLS#0.9357;SODIUM DODECYL SULFATE#0.9353;TRANSFORMING GROWTH FACTOR#0.9344;CONGENITAL MYOPATHY#0.9329;HEAT SHOCK PROTEIN#0.9329;PHAGOCYTOSIS#0.9308;TRANSMEMBRANE RECEPTOR#0.9297;IMMUNE RESPONSE#0.9294;DENDRITIC SPINE#0.9288;TRANS GOLGI NETWORK#0.9273;CEREBRAL CORTEX#0.9260;ENDOPLASMIC RETICULUM#0.9228;TRANSMISSION ELECTRON MICROSCOPY#0.9223;SIGNALING MOLECULE#0.9223;MYOSIN HEAVY CHAIN#0.9203;MYOCYTES#0.9199;TOXICITY#0.9188;INTRACELLULAR MEMBRANE#0.9158;HYPOXIA#0.9148;ACETYLCHOLINE RECEPTOR#0.9146;CAVEOLAE-MEDIATED ENDOCYTOSIS#0.9138;LEUKOCYTE#0.9114;MUSCLE WASTING#0.9091;AXONAL TRANSPORT#0.9069;ENDOTHELIAL NITRIC OXIDE#0.9068;CLATHRIN COATED VESICLE#0.9058;GAP JUNCTION#0.9057;ADHESION PLAQUE#0.9057;OOCYTE#0.9038;NEURITE OUTGROWTH#0.9025;STRIATED MUSCLE#0.9007;CELL BODY#0.8995;ATPASE ACTIVITY#0.8983;ACETYLCHOLINE#0.8973;REACTIVE OXYGEN SPECIES#0.8971;ACTOMYOSIN#0.8959;ANCHORING#0.8956;DEPHOSPHORYLATION#0.8944;HAIR CELL#0.8943;OPIOID RECEPTOR#0.8943;NMDA RECEPTOR#0.8930;MITOGEN ACTIVATED PROTEIN#0.8893;MYOBLAST#0.8885;CENTROSOME#0.8876;MESENCHYMAL CELL#0.8868;PLATELET-DERIVED GROWTH FACTOR#0.8844;RUFFLE#0.8840;KERATINOCYTE#0.8834;GROWTH CONE#0.8817;PANCREATIC CANCER#0.8810;SODIUM CHANNEL#0.8800;CELL MOVEMENT#0.8769;CYCLIN DEPENDENT KINASE#0.8768;RECEPTOR TYROSINE KINASE#0.8765;SIGNALLING PATHWAY#0.8758;CELL ACTIVATION#0.8732;DOPAMINE#0.8724;NEUTROPHIL#0.8720;LYMPH NODE#0.8716;CONSTRICTION#0.8701;CALCIUM CHANNEL#0.8684;MITOSIS#0.8683;PROTEIN TYROSINE PHOSPHATASE#0.8682;COMPLEX I#0.8672;PROTEIN TYROSINE KINASE#0.8667;VINCULIN BINDING#0.8663;MOLECULAR FUNCTION#0.8647;BONE MARROW#0.8638;DNASE I#0.8621;PROTEIN OXIDATION#0.8612;REVERSE TRANSCRIPTION#0.8611;FOCAL CONTACT#0.8596;TOTAL INTERNAL REFLECTION#0.8587;GTP HYDROLYSIS#0.8566;MUTAGENESIS#0.8560;BLOOD VESSEL#0.8559;PERIPHERAL BLOOD#0.8558;SQUAMOUS CELL CARCINOMA#0.8538;MITOCHONDRIAL FISSION#0.8531;TUMOR NECROSIS FACTOR#0.8526;MU OPIOID RECEPTOR#0.8510;SARCOMERE#0.8509;ENDOTHELIUM#0.8499;CYTOTOXICITY#0.8488;SIGNALING CASCADE#0.8464;ARGININE#0.8458;KINASE INHIBITOR#0.8455;OUTER MEMBRANE#0.8450;NEUROTOXICITY#0.8448;CERVICAL#0.8431;LATE ENDOSOME#0.8414;RECEPTOR INTERNALIZATION#0.8399;CELL CELL ADHESION#0.8388;ADENOCARCINOMA#0.8384;LYSOSOME#0.8361;BASAL CELL#0.8359;PROSTATE CANCER#0.8339;GERM CELL#0.8330;PODOCYTE#0.8310;PROTEIN BREAKDOWN#0.8288;INSOLUBLE FRACTION#0.8285;DIGESTION#0.8275;PHOSPHATASE ACTIVITY#0.8267;POST-TRANSLATIONAL MODIFICATION#0.8267;TIGHT JUNCTION#0.8267;GUANOSINE#0.8264;EARLY ENDOSOME#0.8247;CALPAIN ACTIVITY#0.8234;F-ACTIN BINDING#0.8207;TRANSFERRIN RECEPTOR#0.8203;NERVE GROWTH FACTOR#0.8172;METHIONINE#0.8155;ETORPHINE#0.8134;DENTATE GYRUS#0.8129;INTEGRIN BINDING#0.8127;BASEMENT MEMBRANE#0.8116;DNASE#0.8116;Z LINE#0.8110;CHROMAFFIN CELL#0.8100;ERYTHROCYTE MEMBRANES#0.8073;CEREBRAL ISCHEMIA#0.8043;ALKALINE PHOSPHATASE#0.8034;NERVE FIBER#0.7982;MEMBRANE FUSION#0.7965;OSTEOBLAST#0.7963;MYOTUBE#0.7961;NEUROBLASTOMA#0.7932;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7923;PHOSPHATIDYLSERINE#0.7903;SARCOPLASMIC RETICULUM#0.7903;MEMBRANE FRACTION#0.7899;SIGNAL TRANSDUCER#0.7867;ONCOGENIC#0.7834;RETINOIC ACID#0.7834;BRAIN DEVELOPMENT#0.7818;INTESTINAL EPITHELIAL CELL#0.7817;NON-MUSCLE MYOSIN#0.7808;NUCLEOTIDE EXCHANGE FACTOR#0.7807;BREAST CANCER CELL#0.7771;ION BINDING#0.7725;GUANINE#0.7719;DYNAMIN GTPASE ACTIVITY#0.7694;CONNECTIVE TISSUE#0.7691;DYNEIN LIGHT CHAIN#0.7690;MICROTUBULE BINDING#0.7690;TRANSFORMING GROWTH FACTOR BETA#0.7681;MYOCARDIUM#0.7673;ESTRADIOL#0.7665;MYOFIBRIL#0.7636;TALIN BINDING#0.7629;T CELL ACTIVATION#0.7603;MESENCHYMAL STEM CELL#0.7600;MECHANISM OF ACTION#0.7594;RELATED PROTEIN 1#0.7594;CLATHRIN-DEPENDENT ENDOCYTOSIS#0.7583;PKC ACTIVATION#0.7566;CELL POLARITY#0.7549;RYANODINE RECEPTOR#0.7544;ADENOSINE#0.7541;STROMAL CELL#0.7540;B LYMPHOCYTE#0.7535;ETHANOL#0.7533;PERIPHERAL NERVOUS SYSTEM#0.7532;EPITHELIAL MESENCHYMAL TRANSITION#0.7520;PROGENITOR CELL#0.7510;ENZYME ACTIVITY#0.7490;ALANINE#0.7476;GOLGI MEMBRANE#0.7442;NERVE TERMINAL#0.7439;PROTEIN LOCALIZATION#0.7425;POSTSYNAPTIC DENSITY#0.7411;VIRION#0.7389;CHAPERONIN#0.7373;PROTEASOME#0.7335;BRAIN DAMAGE#0.7324;ESSENTIAL HYPERTENSION#0.7312;SYNAPTIC TRANSMISSION#0.7310;POSTSYNAPTIC MEMBRANE#0.7305;HEREDITARY SPHEROCYTOSIS#0.7304;CELL WALL#0.7302;GLYCOPROTEIN COMPLEX#0.7299;DOPAMINE RECEPTOR#0.7297;LATERAL SCLEROSIS#0.7288;AMYOTROPHIC LATERAL SCLEROSIS#0.7288;CYCLIC AMP#0.7287;NEUROMUSCULAR DISEASE#0.7286;CALCIUM ION BINDING#0.7270;SKELETON#0.7268;SYNAPTIC VESICLE RECYCLING#0.7265;LUNG CANCER#0.7254;BIOTIN#0.7253;PROTEIN TRANSPORT#0.7235;SPINAL CORD INJURY#0.7208;PULMONARY ARTERY#0.7207;ULCERATIVE COLITIS#0.7200;DNA FRAGMENTATION#0.7187;GLYCERALDEHYDE-3-PHOSPHATE#0.7182;MYOSIN LIGHT-CHAIN KINASE#0.7179;INFLAMMATORY CELL#0.7170;DNA REPAIR#0.7168;FIBRINOGEN#0.7160;COLCHICINE#0.7151;MONOCYTE#0.7135;COLLECTING DUCTS#0.7125;CREATINE KINASE#0.7118;HYPERPHOSPHORYLATION#0.7111;ADIPOCYTE#0.7079;NECROTIC#0.7076;VIRULENCE#0.7063;IONOPHORE#0.7044;QUANTITATIVE REAL TIME#0.7041;PUMP ACTIVITY#0.7030;COSTAMERE#0.7010;CELL JUNCTION#0.7007;FLUORESCEIN#0.7002;GENETIC DISEASE#0.6984;NEUROFIBRILLARY TANGLE#0.6978;SCANNING ELECTRON MICROSCOPY#0.6967;MODE OF ACTION#0.6959;NUCLEAR PORE#0.6959;LIPID BINDING#0.6957;INHIBITION OF ENDOCYTOSIS#0.6953;MEGAKARYOCYTE#0.6934;PARATHYROID HORMONE#0.6928;TROPHOBLAST#0.6916;IFN-GAMMA#0.6915;LOW DENSITY LIPOPROTEIN#0.6903;BLEBBING#0.6889;LONG TERM POTENTIATION#0.6889;DEMENTIA#0.6867;ENTEROCYTE#0.6845;DORSAL ROOT GANGLION#0.6836;STRIATUM#0.6826;INFLAMMATORY RESPONSE#0.6822;CLATHRIN ADAPTOR#0.6813;COLORECTAL#0.6806;AXONAL NEUROPATHY#0.6801;PYRUVATE#0.6793;LEUCINE#0.6788;CYTOCHROME C#0.6787;FIBROBLAST GROWTH FACTOR#0.6782;TRANSPORT VESICLE#0.6781;ESTROGEN RECEPTOR#0.6779;VESICULAR TRANSPORT#0.6779;BASAL LAMINA#0.6753;SERUM RESPONSE FACTOR#0.6733;SPERMATOZOA#0.6727;SYNAPTOGENESIS#0.6724;CALCINEURIN#0.6719;MENTAL RETARDATION#0.6704;CELL-MATRIX JUNCTION#0.6699;PLATELET AGGREGATION#0.6697;AMYLOID PRECURSOR PROTEIN#0.6694;PHOSPHOLIPASE C#0.6690;PROTEIN KINASE A#0.6687;BLOOD BRAIN BARRIER#0.6681;URINARY BLADDER#0.6677;FOREBRAIN#0.6675;LUMINAL#0.6665;COLORECTAL CANCER#0.6660;MYELINATION#0.6659;DENDRITIC CELL#0.6658;CHONDROCYTE#0.6619;PODOSOME#0.6614;PROGESTERONE#0.6576;DEXAMETHASONE#0.6574;NUCLEAR ENVELOPE#0.6573;SKIN FIBROBLASTS#0.6560;MICROVASCULAR ENDOTHELIAL CELL#0.6551;PLATELET ACTIVATION#0.6546;ACTIN BUNDLING#0.6543;VESICLE TRANSPORT#0.6526;MAP KINASE#0.6524;BETA-2#0.6518;CONTROLLED CORTICAL IMPACT#0.6513;COLITIS#0.6506;TAXOL#0.6502;ENDOTHELIAL GROWTH FACTOR#0.6491;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6491;MEMBRANE MICRODOMAIN#0.6487;CYTOPLASMIC MEMBRANE#0.6482;ATHEROSCLEROSIS#0.6482;PROTEIN METABOLISM#0.6475;ZONULA OCCLUDENS#0.6474;MITOTIC SPINDLE#0.6458;NEUROTRANSMITTER RELEASE#0.6458;CELLULAR COMPONENT#0.6454;NADPH OXIDASE#0.6453;MUSCLE CONTRACTION#0.6442;ADENO ASSOCIATED VIRUS#0.6427;NUCLEIC ACID#0.6407;NEUTROPENIA#0.6401;POTASSIUM CHANNEL#0.6387;PRO-INFLAMMATORY#0.6366;T TUBULE#0.6365;MEMBRANE RUFFLING#0.6347;RECYCLING ENDOSOME#0.6319;MYOGENESIS#0.6319;LASER DESORPTION IONIZATION#0.6318;CHOLERA#0.6313;PHOSPHOINOSITIDE BINDING#0.6312;PROTEIN MODIFICATION#0.6291;UMBILICAL VEIN#0.6284;AMPA RECEPTOR#0.6261;RESONANCE ENERGY TRANSFER#0.6255;DIAPHRAGM#0.6253;EPITHELIAL TO MESENCHYMAL#0.6247;HYPERACTIVITY#0.6243;LOCALISATION#0.6238;MITOCHONDRIAL MEMBRANE#0.6213;SPECTRIN BINDING#0.6209;ROS GENERATION#0.6203;MITOCHONDRIAL DIVISION#0.6200;HYALURONAN#0.6193;NEUROTRANSMISSION#0.6168;ACTIN CROSSLINKING#0.6163;LYSIS#0.6162;CHROMOSOME SEGREGATION#0.6158;SPERMATOGENESIS#0.6148;STEM CELL MARKER#0.6145;PTOSIS#0.6130;CREATINE#0.6123;LECTIN#0.6113;RNA BINDING#0.6112;CAROTID ARTERY#0.6088;APOPTOTIC CELL DEATH#0.6081;HEPATOCELLULAR CARCINOMA#0.6080;DYSTROPHIN GLYCOPROTEIN COMPLEX#0.6044;RECEPTOR ANTAGONIST#0.6042;MOTOR ACTIVITY#0.6016
1786	ZEBULARINE#1.0457;MAINTENANCE OF DNA METHYLATION#1.0385;AZACITIDINE#1.0358;AUTONOMIC NEUROPATHY#1.0296;GABAERGIC NEURON#1.0269;CERVICAL CANCER#1.0267;NARCOLEPSY#1.0247;CEREBELLAR ATAXIA#1.0226;DECITABINE#1.0212;DNA METHYLTRANSFERASE#1.0208;CD4+ T CELL#1.0190;ENZYME ACTIVITY#1.0186;METHYL CPG BINDING#1.0182;CERVICAL#1.0165;OVARIAN CANCER#1.0159;NEUROPATHY#1.0140;DNA REPLICATION#1.0112;CELL DIVISION#1.0108;METHYLTRANSFERASE ACTIVITY#1.0105;SENESCENCE#1.0105;HEARING LOSS#1.0102;FOLATE#1.0089;UBIQUITIN#1.0079;DNA METHYLTRANSFERASE ACTIVITY#1.0064;HISTONE METHYLTRANSFERASE#1.0058;AUTOSOMAL DOMINANT CEREBELLAR ATAXIA#1.0049;REGULATION OF DNA METHYLATION#1.0045;CYTOSINE METHYLATION#1.0038;OOCYTE#1.0035;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0035;EPITHELIAL MESENCHYMAL TRANSITION#1.0010;S PHASE#1.0007;AZACYTIDINE#0.9991;PANCREATIC CANCER#0.9989;CYTOPLASM#0.9989;FOLIC ACID#0.9988;EMBRYO DEVELOPMENT#0.9986;PROGENITOR CELL#0.9985;RNA INTERFERENCE#0.9981;HISTONE DEACETYLASE#0.9977;T CELL#0.9974;MOUSE EMBRYONIC STEM#0.9971;PROTEIN KINASE#0.9968;OVARIAN#0.9967;MONONUCLEAR CELLS#0.9967;CATALYTIC ACTIVITY#0.9961;B CELL#0.9957;SQUAMOUS CELL CARCINOMA#0.9951;DNA HYPOMETHYLATION#0.9942;PROSTATE CANCER#0.9924;COLON CANCER#0.9922;COLORECTAL CANCER#0.9922;HISTONE DEACETYLASE INHIBITOR#0.9921;LUNG CANCER#0.9917;METHIONINE#0.9915;5-AZA-2'-DEOXYCYTIDINE#0.9914;CPG ISLAND METHYLATION#0.9900;2'-DEOXYCYTIDINE#0.9899;DNA HYPERMETHYLATION#0.9891;MISMATCH REPAIR#0.9890;REVERSE TRANSCRIPTION#0.9889;PERIPHERAL BLOOD#0.9884;S-ADENOSYLMETHIONINE#0.9883;ONCOGENIC#0.9879;CHROMATIN REMODELING#0.9879;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9875;GENE SILENCING#0.9866;COLORECTAL#0.9855;DNA REPAIR#0.9851;MYELODYSPLASTIC SYNDROME#0.9848;DNA DEMETHYLATION#0.9845;BREAST CANCER#0.9838;GROWTH FACTOR#0.9836;TUMOR TISSUES#0.9831;EMBRYONIC STEM CELL#0.9828;CHANGES IN DNA METHYLATION#0.9827;HYPOXIA#0.9820;QUANTITATIVE REAL TIME#0.9817;BREAST CANCER CELL#0.9808;HETEROCHROMATIN#0.9804;ENDOTHELIAL CELL#0.9799;GLUTAMIC ACID#0.9794;LYSINE#0.9793;CYCLIN DEPENDENT KINASE#0.9793;POLY ADP RIBOSE#0.9786;DNA BINDING#0.9783;EPITHELIAL CELL#0.9783;DEMETHYLATION#0.9771;TUMOR CELLS#0.9756;CYTOTOXICITY#0.9754;GERM CELL#0.9753;N METHYLTRANSFERASE#0.9749;ACUTE MYELOID LEUKEMIA#0.9741;SIGNALING PATHWAY#0.9740;HEPATOCELLULAR CARCINOMA#0.9734;CELL DEATH#0.9732;HISTONE ACETYLATION#0.9731;CELL MIGRATION#0.9731;CYTIDINE#0.9727;STEM CELL#0.9723;DNA METHYLATION#0.9721;CANCER CELL#0.9716;CELL GROWTH#0.9713;MYELOID LEUKEMIA#0.9712;CELL DIFFERENTIATION#0.9708;KINASE INHIBITOR#0.9703;METHYLCYTOSINE DIOXYGENASE#0.9695;CELL PROLIFERATION#0.9693;POLYMERASE CHAIN REACTION#0.9691;APOPTOTIC#0.9688;CELL CYCLE#0.9688;CELL CYCLE ARREST#0.9686;APOPTOSIS#0.9685;HISTONE METHYLATION#0.9676;ESTROGEN RECEPTOR#0.9673;TUMOR SUPPRESSOR#0.9672;INTERNEURON#0.9666;MTDNA#0.9664;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9662;LUPUS ERYTHEMATOSUS#0.9660;HISTONE MODIFICATION#0.9653;FERTILIZATION#0.9651;B CELL LYMPHOMA#0.9645;DIFFERENTIALLY METHYLATED REGION#0.9643;TRANSCRIPTION FACTOR#0.9641;METHYLATION SPECIFIC PCR#0.9625;REACTIVE OXYGEN SPECIES#0.9617;RIBOSE#0.9617;HUMAN BREAST CANCER#0.9608;TOXICITY#0.9605;CANCER STEM CELL#0.9592;ADENOCARCINOMA#0.9587;GENE EXPRESSION#0.9580;MECHANISM OF ACTION#0.9577;SIGNAL TRANSDUCER#0.9570;CISPLATIN#0.9565;REGULATION OF GENE EXPRESSION#0.9545;NERVOUS SYSTEM#0.9532;RETINOIC ACID#0.9499;MITOCHONDRIA#0.9487;AMYGDALA#0.9485;HEMATOPOIETIC STEM CELL#0.9479;TRANSFORMING GROWTH FACTOR#0.9475;BONE MARROW#0.9458;METHYLASE#0.9440;PROCAINAMIDE#0.9436;LYMPH NODE#0.9435;ATHEROSCLEROSIS#0.9427;GLUTATHIONE#0.9427;DRUG RESISTANCE#0.9418;TERMINAL DIFFERENTIATION#0.9382;CYCLIN DEPENDENT KINASE INHIBITOR#0.9382;MACROPHAGE#0.9352;ASTROCYTE#0.9340;CARCINOGEN#0.9335;G1 PHASE#0.9327;SMOOTH MUSCLE#0.9295;GUANINE#0.9293;MITOCHONDRIAL DNA#0.9281;VALPROIC ACID#0.9277;RETINOBLASTOMA#0.9268;METHYLATION SPECIFIC POLYMERASE#0.9266;IMMUNE RESPONSE#0.9242;ETHANOL#0.9234;L-METHIONINE#0.9216;MESENCHYMAL STEM CELL#0.9216;DOXORUBICIN#0.9209;IN VITRO MATURATION#0.9204;X CHROMOSOME#0.9197;TRANSCRIPTASE#0.9183;CD8+ T CELL#0.9176;CELL CYCLE REGULATOR#0.9151;POLYCOMB REPRESSIVE COMPLEX#0.9129;LYMPH NODE METASTASIS#0.9128;LYSINE SPECIFIC DEMETHYLASE#0.9079;TUMOR NECROSIS FACTOR#0.9078;EPIGALLOCATECHIN#0.9072;HISTONE DEACETYLATION#0.9067;HYDRALAZINE#0.9059;INDUCTION OF APOPTOSIS#0.9052;REPLICATION FOCUS#0.9028;PROTEASOMAL PATHWAY#0.9028;GESTATION#0.9009;RENAL CELL CARCINOMA#0.8970;INHIBITION OF DNA METHYLATION#0.8959;PROTEASOME#0.8947;NULL CELL#0.8935;HEPATITIS B#0.8923;ESOPHAGEAL CANCER#0.8916;HISTONE ACETYLTRANSFERASE#0.8906;MUSCLE CELL#0.8901;C TERMINAL DOMAIN#0.8874;RETINOIC ACID RECEPTOR#0.8861;REGENERATION#0.8852;PROTEIN COMPLEX#0.8842;DNA DAMAGE RESPONSE#0.8778;DNA SYNTHESIS#0.8765;GERMINAL VESICLE#0.8763;TELOMERE#0.8762;CHROMATIN MODIFICATION#0.8739;LIVER CANCER#0.8692;SMOOTH MUSCLE CELL#0.8680;CERVIX#0.8665;WOUND HEALING#0.8640;SKIN FIBROBLASTS#0.8621;NITRIC OXIDE#0.8615;SPECIFICITY PROTEIN 1#0.8589;ANGIOGENESIS#0.8586;HEPATITIS B VIRUS#0.8569;CEREBRAL ISCHEMIA#0.8566;AUTOIMMUNITY#0.8534;PROTEIN KINASE C#0.8531;EPITHELIAL TO MESENCHYMAL#0.8530;GROWTH FACTOR RECEPTOR#0.8514;DE NOVO DNA METHYLATION#0.8503;METAPHASE#0.8497;ONCOGENESIS#0.8494;RESVERATROL#0.8484;RNA BINDING#0.8481;PRO-INFLAMMATORY#0.8473;SIGNAL TRANSDUCTION#0.8468;PROTEIN PROTEIN INTERACTION#0.8458;S-ADENOSYL-L-METHIONINE#0.8444;NUCLEOSOME#0.8443;BIPOLAR DISORDER#0.8394;GLYCOSYLASE#0.8358;QUANTITATIVE REVERSE TRANSCRIPTION#0.8338;BREAST CARCINOMA#0.8319;CELLULAR SENESCENCE#0.8307;MONOCYTE#0.8301;ADIPOCYTE#0.8294;ESTRADIOL#0.8280;DNA METHYLASE#0.8271;BLASTOCYST FORMATION#0.8246;DEMENTIA#0.8235;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8209;CARDIOMYOCYTE#0.8206;VIRAL INFECTION#0.8204;NEURODEGENERATIVE DISEASE#0.8197;HISTONE H3 ACETYLATION#0.8187;INSULIN-LIKE GROWTH FACTOR#0.8178;ARGININE#0.8172;OOCYTE MATURATION#0.8164;ALZHEIMER'S DISEASE#0.8147;HEMATOPOIESIS#0.8134;AUTOPHAGY#0.8128;METHYL BINDING DOMAIN#0.8103;STROMAL CELL#0.8100;OOCYTE DIFFERENTIATION#0.8089;BREAST CANCER PATIENTS#0.8059;TROPHOBLAST#0.8054;IN VITRO FERTILIZED#0.8016;WNT SIGNALING PATHWAY#0.7958;COLORECTAL CARCINOMA#0.7943;MOUSE EMBRYONIC FIBROBLAST#0.7935;MITOGEN ACTIVATED PROTEIN#0.7932;ENDOMETRIUM#0.7930;SUPEROXIDE DISMUTASE#0.7926;CENTRAL NERVOUS SYSTEM#0.7925;HOMOLOGOUS RECOMBINATION#0.7918;X CHROMOSOME INACTIVATION#0.7881;CHROMOSOME INACTIVATION#0.7878;ADENOID CYSTIC CARCINOMA#0.7858;HYPERMETHYLATION OF CPG ISLAND#0.7844;ISCHEMIA#0.7821;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7802;MULTIPLE MYELOMA#0.7799;72-HOURS#0.7795;MAMMARY GLAND#0.7793;EXOSOME#0.7787;CELL ADHESION#0.7766;DIFFUSE LARGE B-CELL LYMPHOMA#0.7766;CELL CYCLE REGULATION#0.7765;AKT SIGNALING#0.7756;ZINC FINGER PROTEIN#0.7750;SOMATIC TISSUE#0.7731;ARTERY#0.7709;EARLY EMBRYO DEVELOPMENT#0.7708;ENDOTHELIAL GROWTH FACTOR#0.7707;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7707;PRIMORDIAL GERM CELL#0.7705;INTESTINAL DEVELOPMENT#0.7700;SUBEROYLANILIDE HYDROXAMIC ACID#0.7674;LEUKOCYTE#0.7673;HUMAN BRONCHIAL EPITHELIAL#0.7665;FOREBRAIN#0.7652;MECHANISMS OF ACTION#0.7618;REPLICATION FORK#0.7597;ADIPOSE TISSUE#0.7588;IMMUNE SYSTEM#0.7583;EXTRACELLULAR MATRIX#0.7580;IMPRINTING CONTROL REGION#0.7570;THYMINE#0.7568;THYMINE DNA GLYCOSYLASE#0.7565;SENSITIZATION#0.7565;RNA BINDING PROTEIN#0.7540;CEREBRAL CORTEX#0.7539;SIGNALLING PATHWAY#0.7530;VORINOSTAT#0.7528;TOPOISOMERASE II#0.7516;CELL DEVELOPMENT#0.7485;TELOMERASE REVERSE TRANSCRIPTASE#0.7457;DNA MODIFICATION#0.7452;CELL COUNTING KIT#0.7452;GLOBIN#0.7449;CHOLINE#0.7434;CLEAR CELL RENAL CELL CARCINOMA#0.7423;TOPOISOMERASE#0.7419;EPSTEIN BARR VIRUS#0.7414;ENDOMETRIAL CANCER#0.7410;NEURAL STEM CELL#0.7404;LUNG FIBROBLASTS#0.7395;THYROID CANCER#0.7393;MITOSIS#0.7330;GLIAL CELL#0.7329;SCHWANN CELL#0.7311;DEACETYLASE ACTIVITY#0.7301;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7287;PROGESTERONE#0.7268;HYPERHOMOCYSTEINEMIA#0.7263;CYTIDINE DEAMINASE#0.7256;HISTONE DEMETHYLASE#0.7220;5 FLUOROURACIL#0.7200;GLUCOCORTICOID RECEPTOR#0.7188;HEPATITIS C#0.7174;HISTONE DEACETYLASE ACTIVITY#0.7170;TRANSFORMING GROWTH FACTOR BETA#0.7170;CYTOSINE PHOSPHATE GUANINE#0.7170;ENDOPLASMIC RETICULUM#0.7166;CELL ACTIVATION#0.7163;PROTEIN SYNTHESIS#0.7161;LINES OF EVIDENCE#0.7143;PROCAINE#0.7140;ACINAR CELL#0.7136;SKELETAL MUSCLE#0.7133;LACTATION#0.7131;ARSENIC TRIOXIDE#0.7128;HEAT SHOCK PROTEIN#0.7116;PANCREATIC DUCTAL ADENOCARCINOMA#0.7101;HEPATOCELLULAR CARCINOMA CELL#0.7099;FRONTAL#0.7089;NITRIC OXIDE SYNTHASE#0.7086;M PHASE#0.7071;POST-TRANSLATIONAL MODIFICATION#0.7069;ANDROGEN RECEPTOR#0.7052;GASTRULATION#0.7046;ADIPOCYTE DIFFERENTIATION#0.7024;DUAL LUCIFERASE REPORTER#0.7022;RENAL FIBROSIS#0.7018;RAPAMYCIN#0.6987;VALPROATE#0.6987;PLATELET-DERIVED GROWTH FACTOR#0.6968;LUNG CARCINOMA#0.6960;PRECURSOR CELL#0.6956;TARGET OF RAPAMYCIN#0.6950;ONE CARBON METABOLISM#0.6946;HIGH FAT DIET#0.6946;OVARIES#0.6940;NUCLEAR LOCALIZATION SIGNAL#0.6939;KIDNEY DISEASE#0.6936;AUTOIMMUNE DISEASE#0.6935;COLITIS#0.6921;COLON CARCINOMA#0.6914;LOSS OF METHYLATION#0.6903;PERICENTRIC HETEROCHROMATIN#0.6886;MUTAGENESIS#0.6883;GLYCINE#0.6877;PLURIPOTENT STEM CELL#0.6876;ACUTE LEUKEMIA#0.6818;NUCLEIC ACID#0.6808;HYPERACTIVITY#0.6807;TAMOXIFEN#0.6775;METFORMIN#0.6727;SPERMATOZOA#0.6710;ERYTHROID CELL#0.6694;NEUROGENESIS#0.6679;TREG CELL#0.6673;T LYMPHOCYTE#0.6665;CANCER TESTIS ANTIGEN#0.6648;DNA TOPOISOMERASE#0.6620;MELATONIN#0.6588;PHOSPHATASE AND TENSIN HOMOLOG#0.6584;AZADC#0.6573;ESTROGEN RECEPTOR ALPHA#0.6564;RETINAL ENDOTHELIAL CELLS#0.6546;LUNG ADENOCARCINOMA#0.6538;HEPATITIS C VIRUS#0.6524;SPERMATOGENESIS#0.6511;NON HODGKIN LYMPHOMA#0.6505;OOGENESIS#0.6504;LONG TERM POTENTIATION#0.6483;SPINAL CORD#0.6479;TYPE 2 DIABETES#0.6472;ENDOTHELIUM#0.6428;REGULATORY T CELL#0.6390;RHEUMATOID ARTHRITIS#0.6376;INFLAMMATORY RESPONSE#0.6360;GLYCINE N METHYLTRANSFERASE#0.6350;GENISTEIN#0.6306;BASE EXCISION REPAIR#0.6276;ANCHORAGE INDEPENDENT GROWTH#0.6270;EPITHELIAL OVARIAN CANCER#0.6265;POSTTRANSLATIONAL MODIFICATION#0.6255;CELL EXPANSION#0.6233;NEUROENDOCRINE TUMOR#0.6229;HEMATOPOIETIC CELL#0.6228;WNT INHIBITORY FACTOR#0.6209;HYPOXIC#0.6204;ULCERATIVE COLITIS#0.6200;EPIDERMAL GROWTH FACTOR#0.6189;GENOTOXIC#0.6179;B LYMPHOCYTE#0.6177;INHIBITORY FACTOR 1#0.6174;TRANSCRIPTIONAL CONTROL#0.6143;L-OHP#0.6140;HYPERTENSION#0.6123;STRUCTURE ACTIVITY RELATIONSHIP#0.6115;DOUBLE STRAND BREAK#0.6087;MITOCHONDRIAL MEMBRANE#0.6069;FIBROBLAST ACTIVATION#0.6054;PACLITAXEL#0.6054;GAMETOGENESIS#0.6049;FLUOROURACIL#0.6046
1787	TRNA METHYLATION#1.1218;RNA METHYLTRANSFERASE#1.0963;RNA METHYLATION#1.0438;DNA METHYLTRANSFERASE#1.0276;METHYLTRANSFERASE ACTIVITY#1.0212;DNA METHYLATION#0.9994;CYTOSINE METHYLATION#0.9645;GENE EXPRESSION#0.9634;TRANSFER RNA#0.9162;ASPARTIC ACID#0.8661;CATALYTIC ACTIVITY#0.8472;STRESS GRANULE#0.8290;METHYL CPG BINDING#0.8208;STEM CELL#0.8178;CELL PROLIFERATION#0.7443;CELL CYCLE#0.6940;DNA METHYLTRANSFERASE ACTIVITY#0.6600;RNA MODIFICATION#0.6385;CANCER CELL#0.6346;RNA PROCESSING#0.6059
1788	DE NOVO DNA METHYLATION#1.0368;METHYL CPG BINDING#1.0266;OVARIAN CANCER#1.0264;METHYLTRANSFERASE ACTIVITY#1.0217;MOUSE EMBRYONIC STEM#1.0169;WHITE BLOOD CELL#1.0154;INTERNAL TANDEM DUPLICATION#1.0107;OVARIAN#1.0096;CYTOSINE METHYLATION#1.0075;C TERMINAL DOMAIN#1.0066;DNA BINDING#1.0056;DNA METHYLTRANSFERASE#1.0038;CATALYTIC ACTIVITY#1.0033;DNA DEMETHYLATION#1.0024;SPINAL CORD#1.0011;BREAST CANCER CELL#0.9994;EMBRYONIC STEM CELL#0.9993;COLORECTAL CANCER#0.9990;PROGENITOR CELL#0.9979;LUNG CANCER#0.9974;DNA METHYLTRANSFERASE ACTIVITY#0.9962;DNA HYPERMETHYLATION#0.9962;BREAST CANCER#0.9954;QUANTITATIVE REAL TIME#0.9927;GERM CELL#0.9916;DECITABINE#0.9906;HEMATOPOIETIC STEM CELL#0.9903;ACUTE MYELOID LEUKAEMIA#0.9898;OOCYTE#0.9892;HEMATOPOIESIS#0.9887;T CELL#0.9878;DNA HYPOMETHYLATION#0.9871;POLYMERASE CHAIN REACTION#0.9859;STEM CELL TRANSPLANTATION#0.9852;B CELL#0.9840;5-AZA-2'-DEOXYCYTIDINE#0.9838;HISTONE DEACETYLASE#0.9836;REVERSE TRANSCRIPTION#0.9832;MYELOPROLIFERATIVE NEOPLASM#0.9825;HISTONE MODIFICATION#0.9824;CELL PROLIFERATION#0.9820;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9818;2'-DEOXYCYTIDINE#0.9814;HEMATOPOIETIC CELL#0.9813;CELL DIFFERENTIATION#0.9811;COLORECTAL#0.9802;DEMETHYLATION#0.9793;ACUTE MYELOID LEUKEMIA#0.9787;CELL CYCLE#0.9778;MYELOID LEUKEMIA#0.9773;CANCER CELL#0.9769;GROWTH FACTOR#0.9768;LYSINE#0.9762;GENE SILENCING#0.9748;TRANSCRIPTION FACTOR#0.9747;SIGNALING PATHWAY#0.9743;METHYLATION SPECIFIC PCR#0.9733;STEM CELL#0.9732;TUMOR SUPPRESSOR#0.9722;ONCOGENIC#0.9721;DNA METHYLATION#0.9720;APOPTOSIS#0.9712;RELAPSE FREE SURVIVAL#0.9711;PERIPHERAL BLOOD#0.9700;BONE MARROW#0.9694;CELL DEVELOPMENT#0.9664;MYELODYSPLASTIC SYNDROME#0.9662;HETEROCHROMATIN#0.9629;EVENT FREE SURVIVAL#0.9628;DENTATE GYRUS#0.9616;EMBRYO DEVELOPMENT#0.9613;APOPTOTIC#0.9608;GENE EXPRESSION#0.9603;HISTONE ACETYLATION#0.9600;DISEASE FREE SURVIVAL#0.9594;MINIMAL RESIDUAL DISEASE#0.9590;CHANGES IN DNA METHYLATION#0.9549;HEPATOCELLULAR CARCINOMA#0.9538;CELL GROWTH#0.9521;DIFFERENTIALLY METHYLATED REGION#0.9506;PROSTATE CANCER#0.9485;HIGH RESOLUTION MELTING#0.9475;EPITHELIAL CELL#0.9417;ACUTE LEUKEMIA#0.9364;CHROMATIN REMODELING#0.9363;NERVOUS SYSTEM#0.9296;S PHASE#0.9268;CELL DEATH#0.9204;HISTONE METHYLATION#0.9178;MYELOID NEOPLASM#0.9176;TUMOR CELLS#0.9150;CD4+ T CELL#0.9089;METHIONINE#0.9055;CHRONIC MYELOMONOCYTIC LEUKEMIA#0.9013;NUCLEOSOME#0.9009;REGULATION OF GENE EXPRESSION#0.8947;HISTONE METHYLTRANSFERASE#0.8944;DNA REPLICATION#0.8868;MONONUCLEAR CELLS#0.8846;REGULATION OF DNA METHYLATION#0.8836;DUAL LUCIFERASE REPORTER#0.8826;PERIPHERAL T-CELL LYMPHOMA#0.8815;CYTOTOXICITY#0.8710;METHYLASE#0.8703;BONE MARROW CELLS#0.8686;PROTEIN KINASE#0.8643;SKELETAL MUSCLE#0.8598;X CHROMOSOME#0.8547;INTELLECTUAL DISABILITY#0.8504;IN VITRO FERTILIZED#0.8458;ENZYME ACTIVITY#0.8437;AZACYTIDINE#0.8408;DNA REPAIR#0.8392;AZACITIDINE#0.8305;MYELOFIBROSIS#0.8288;PRECURSOR CELL#0.8285;ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA#0.8272;PRIMORDIAL GERM CELL#0.8234;INSULIN-LIKE GROWTH FACTOR#0.8173;FOLATE#0.8158;ENDOMETRIUM#0.8130;B CELL LYMPHOMA#0.8121;FERTILIZATION#0.8111;MACROPHAGE#0.8110;ANEMIA#0.8087;IMMUNE RESPONSE#0.8084;MAINTENANCE OF DNA METHYLATION#0.8070;GESTATION#0.8057;HISTONE DEACETYLASE INHIBITOR#0.8018;METHYLCYTOSINE DIOXYGENASE#0.7998;LYMPH NODE#0.7996;OVARIAN CARCINOMA#0.7968;CYTOPLASM#0.7966;ESTROGEN RECEPTOR#0.7959;LYMPH NODE METASTASIS#0.7947;TOXICITY#0.7945;ADIPOCYTE#0.7920;RNA INTERFERENCE#0.7918;GLUTATHIONE#0.7905;CERVICAL CANCER#0.7903;POLYCYTHEMIA VERA#0.7896;S-ADENOSYLMETHIONINE#0.7877;LIVER CANCER#0.7812;L-METHIONINE#0.7810;DNA DAMAGE RESPONSE#0.7785;TRANSFORMING GROWTH FACTOR#0.7777;TUMOR TISSUES#0.7766;CENTRAL NERVOUS SYSTEM#0.7762;QUANTITATIVE REVERSE TRANSCRIPTION#0.7744;SOCIAL DEFEAT STRESS#0.7722;STEM CELL DIFFERENTIATION#0.7703;CPG ISLAND METHYLATION#0.7701;ASTROCYTE#0.7692;PRO-INFLAMMATORY#0.7687;NEUROGENESIS#0.7685;S-ADENOSYL-L-METHIONINE#0.7672;DNA MODIFICATION#0.7669;CERVICAL#0.7639;TRANSCRIPTASE#0.7638;HYPOXIA#0.7633;ADENOCARCINOMA#0.7631;FRAGMENT LENGTH POLYMORPHISM#0.7622;SPERMATOGENESIS#0.7617;MEDIAN OVERALL SURVIVAL#0.7563;ADIPOSE TISSUE#0.7554;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7540;IN VITRO MATURATION#0.7523;TELOMERE#0.7523;CELL CYCLE ARREST#0.7510;SPERMATOCYTES#0.7495;ARGININE#0.7495;INNATE IMMUNITY#0.7488;AMYGDALA#0.7444;NEURAL STEM CELL#0.7426;EPITHELIAL MESENCHYMAL TRANSITION#0.7359;DNA METHYLASE#0.7349;HEARING LOSS#0.7343;HISTONE DEACETYLATION#0.7315;SENSITIZATION#0.7295;CELL DIVISION#0.7205;CYTARABINE#0.7193;MESENCHYMAL STEM CELL#0.7193;BREAST CANCER PATIENTS#0.7189;ZINC FINGER PROTEIN#0.7185;KINASE INHIBITOR#0.7174;PROGESTERONE#0.7158;REGENERATION#0.7091;CHRONIC SOCIAL DEFEAT#0.7087;GLYCOSYLASE#0.7065;SQUAMOUS CELL CARCINOMA#0.7051;FOREBRAIN#0.7039;HISTONE ACETYLTRANSFERASE#0.6964;GERM CELL DEVELOPMENT#0.6939;CARDIOMYOCYTE#0.6935;LYMPHOCYTIC LEUKEMIA#0.6819;LEUKEMIC STEM CELL#0.6813;POLYCYTHEMIA#0.6803;INNER CELL MASS#0.6802;UBIQUITIN#0.6794;SIGNAL TRANSDUCTION#0.6789;BLAST CELL#0.6729;ESTRADIOL#0.6722;PLURIPOTENT STEM CELL#0.6722;POST-TRANSLATIONAL MODIFICATION#0.6716;OOCYTE GROWTH#0.6710;MONOCYTE#0.6707;RETINOIC ACID#0.6695;OBESE#0.6695;STROMAL CELL#0.6688;X CHROMOSOME INACTIVATION#0.6686;CHROMOSOME INACTIVATION#0.6684;MTDNA#0.6677;CHRONIC MYELOID LEUKEMIA#0.6579;ADOMET#0.6578;REACTIVE OXYGEN SPECIES#0.6569;PERIPHERAL NERVE INJURY#0.6559;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6540;G1 PHASE#0.6533;HIGH FAT DIET#0.6520;ALZHEIMER'S DISEASE#0.6512;ENDOTHELIAL CELL#0.6497;RNA SPLICING#0.6494;PERIPHERAL NERVE#0.6482;PERICENTRIC HETEROCHROMATIN#0.6476;EARLY EMBRYO DEVELOPMENT#0.6400;IN VITRO PRODUCED#0.6387;HISTONE H3 ACETYLATION#0.6383;STEM CELL TRANSPLANT#0.6322;GAMETOGENESIS#0.6320;TYROSINE KINASE DOMAIN#0.6266;MYELOID CELL#0.6250;EPIBLAST#0.6250;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6230;LUPUS ERYTHEMATOSUS#0.6228;SPLICEOSOME#0.6225;CELL MIGRATION#0.6219;COMPLEX I#0.6196;HEMATOPOIETIC PROGENITOR CELL#0.6174;COLON CANCER#0.6117;HIPPOCAMPAL DENTATE GYRUS#0.6092;MECHANISM OF ACTION#0.6079;TROPHECTODERM#0.6065;SENESCENCE#0.6062;CHONDROCYTE#0.6054;NEURAL PROGENITOR CELL#0.6031;MITOCHONDRIA#0.6024;NOT OTHERWISE SPECIFIED#0.6019;HEMATOPOIETIC CELL TRANSPLANTATION#0.6013
1789	DE NOVO DNA METHYLATION#1.0316;FRAGMENT LENGTH POLYMORPHISM#1.0289;RNA INTERFERENCE#1.0186;COLON CANCER#1.0177;METHYLTRANSFERASE ACTIVITY#1.0172;METHYL CPG BINDING#1.0146;PROSTATE CANCER#1.0120;OOCYTE#1.0096;CPG ISLAND METHYLATION#1.0077;OVARIAN CANCER#1.0065;LUNG CANCER#1.0037;COLORECTAL#1.0026;MOUSE EMBRYONIC STEM#1.0025;COLORECTAL CANCER#1.0006;PANCREATIC CANCER#0.9999;DNA METHYLTRANSFERASE#0.9990;QUANTITATIVE REAL TIME#0.9952;B CELL#0.9950;T CELL#0.9948;DNA HYPERMETHYLATION#0.9932;REVERSE TRANSCRIPTION#0.9928;BREAST CANCER#0.9918;DNA DEMETHYLATION#0.9915;POLYMERASE CHAIN REACTION#0.9913;BREAST CANCER CELL#0.9901;HETEROCHROMATIN#0.9896;HEPATOCELLULAR CARCINOMA#0.9881;HISTONE METHYLTRANSFERASE#0.9875;HISTONE DEACETYLASE#0.9859;CHROMATIN REMODELING#0.9853;DNA HYPOMETHYLATION#0.9850;SQUAMOUS CELL CARCINOMA#0.9848;DEMETHYLATION#0.9848;DNA METHYLTRANSFERASE ACTIVITY#0.9839;MAINTENANCE OF DNA METHYLATION#0.9839;TUMOR CELLS#0.9825;CENTROMERE#0.9821;GENE SILENCING#0.9821;5-AZA-2'-DEOXYCYTIDINE#0.9815;2'-DEOXYCYTIDINE#0.9811;CANCER CELL#0.9806;OVARIAN#0.9803;PLURIPOTENT STEM CELL#0.9796;X CHROMOSOME#0.9795;GERM CELL#0.9795;PROGENITOR CELL#0.9792;CATALYTIC ACTIVITY#0.9784;EPITHELIAL CELL#0.9769;CELL DIFFERENTIATION#0.9755;EMBRYONIC STEM CELL#0.9755;DNA BINDING#0.9750;DNA METHYLATION#0.9735;APOPTOSIS#0.9734;HISTONE MODIFICATION#0.9732;SIGNALING PATHWAY#0.9729;METHYLATION SPECIFIC PCR#0.9727;CELL PROLIFERATION#0.9721;MYELOID LEUKEMIA#0.9713;CELL GROWTH#0.9710;CHANGES IN DNA METHYLATION#0.9710;TRANSCRIPTION FACTOR#0.9704;ACUTE MYELOID LEUKEMIA#0.9703;HUMAN EMBRYONIC STEM#0.9694;STEM CELL#0.9688;CYTOSINE METHYLATION#0.9676;PERIPHERAL BLOOD#0.9673;CELL CYCLE#0.9666;TUMOR SUPPRESSOR#0.9647;LYSINE#0.9644;ONCOGENIC#0.9615;BONE MARROW#0.9615;CELL DEVELOPMENT#0.9603;CERVICAL#0.9579;GENE EXPRESSION#0.9577;FOLATE#0.9572;GROWTH FACTOR#0.9531;CERVICAL CANCER#0.9501;AZACYTIDINE#0.9497;TUMOR TISSUES#0.9476;DNA REPLICATION#0.9476;METHIONINE#0.9429;DNA REPAIR#0.9374;ESTROGEN RECEPTOR#0.9364;HISTONE ACETYLATION#0.9354;HISTONE METHYLATION#0.9305;NEURAL CREST#0.9277;ENDOMETRIAL CANCER#0.9265;LYMPH NODE#0.9243;CD4+ T CELL#0.9192;ENZYME ACTIVITY#0.9158;PROTEIN KINASE#0.9156;NERVOUS SYSTEM#0.9133;RETINOIC ACID#0.9128;ADENOCARCINOMA#0.9095;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9092;BREAST CANCER PATIENTS#0.9080;MONONUCLEAR CELLS#0.9080;INDUCED PLURIPOTENT STEM CELL#0.9058;PRIMORDIAL GERM CELL#0.9054;REGULATION OF DNA METHYLATION#0.9040;DECITABINE#0.9038;TELOMERE#0.8975;CHROMATIN MODIFICATION#0.8970;DIFFERENTIALLY METHYLATED REGION#0.8949;HEPATOCELLULAR CARCINOMA CELL#0.8947;EMBRYO DEVELOPMENT#0.8936;TRANSCRIPTASE#0.8906;APOPTOTIC#0.8883;S PHASE#0.8861;HYPOXIA#0.8841;CELL DEATH#0.8831;CYTOTOXICITY#0.8753;DUAL LUCIFERASE REPORTER#0.8729;SOMATIC TISSUE#0.8724;HEAD AND NECK CANCER#0.8717;NECK CANCER#0.8716;REGULATION OF GENE EXPRESSION#0.8704;ENDOMETRIUM#0.8687;CHONDROCYTE#0.8657;SPINAL CORD#0.8645;HUMAN BREAST CANCER#0.8593;HUMAN BRONCHIAL EPITHELIAL#0.8566;FERTILIZATION#0.8520;C TERMINAL DOMAIN#0.8480;HISTONE DEACETYLATION#0.8457;PERICENTRIC HETEROCHROMATIN#0.8445;IMMUNE RESPONSE#0.8438;HEMATOPOIETIC STEM CELL#0.8367;SENESCENCE#0.8326;INFLAMMATORY RESPONSE#0.8323;LOSS OF METHYLATION#0.8310;ESTRADIOL#0.8304;HISTONE ACETYLTRANSFERASE#0.8272;ONE CARBON METABOLISM#0.8239;GAMETOGENESIS#0.8153;METAPHASE#0.8147;BRONCHIAL EPITHELIAL CELLS#0.8142;QUANTITATIVE REVERSE TRANSCRIPTION#0.8092;MYELODYSPLASTIC SYNDROME#0.8088;CELL MIGRATION#0.8060;CYTOPLASM#0.8026;GERM CELL DEVELOPMENT#0.8015;TOXICITY#0.7984;DNA DAMAGE RESPONSE#0.7957;HISTONE DEACETYLASE INHIBITOR#0.7955;REACTIVE OXYGEN SPECIES#0.7946;METHYLASE#0.7936;COLORECTAL ADENOMA#0.7922;X CHROMOSOME INACTIVATION#0.7904;CHROMOSOME INACTIVATION#0.7902;CISPLATIN#0.7866;S-ADENOSYLMETHIONINE#0.7819;SPERMATOGENESIS#0.7816;STROMAL CELL#0.7800;STEM CELL DIFFERENTIATION#0.7794;EPIBLAST#0.7765;CARCINOGEN#0.7755;LYMPH NODE METASTASIS#0.7751;L-METHIONINE#0.7714;ANGIOGENESIS#0.7699;DOWN SYNDROME#0.7691;METHYLATION SPECIFIC POLYMERASE#0.7663;PHOSPHATASE AND TENSIN HOMOLOG#0.7655;CELL DIVISION#0.7636;NEUROGENESIS#0.7582;HIPPO SIGNALING PATHWAY#0.7575;GLYCOSYLASE#0.7558;S-ADENOSYL-L-METHIONINE#0.7552;INNER CELL MASS#0.7533;HIPPO SIGNALING#0.7517;ALKALINE PHOSPHATASE#0.7516;MESENCHYMAL STEM CELL#0.7516;G1 PHASE#0.7405;HEMATOPOIETIC PROGENITOR CELL#0.7393;NUCLEOSOME#0.7391;MISMATCH REPAIR#0.7390;B CELL LYMPHOMA#0.7359;POLYCOMB REPRESSIVE COMPLEX#0.7313;TUMOR NECROSIS FACTOR#0.7308;HEPATITIS B#0.7287;EMBRYONAL CARCINOMA#0.7282;ENDOMETRIAL CARCINOMA#0.7243;PROGESTERONE#0.7242;MACROPHAGE#0.7231;CELL CYCLE ARREST#0.7203;ALZHEIMER'S DISEASE#0.7174;CANCER STEM CELL#0.7143;HIGH RESOLUTION MELTING#0.7115;AUTOIMMUNE DISEASE#0.7114;CENTROMERIC HETEROCHROMATIN#0.7095;NEUROBLASTOMA#0.7013;UBIQUITIN#0.6993;ENDOMETRIOSIS#0.6989;EPITHELIAL MESENCHYMAL TRANSITION#0.6972;DISEASE FREE SURVIVAL#0.6970;DRUG RESISTANCE#0.6960;NEURAL TUBE#0.6950;IN VITRO MATURATION#0.6905;PURPURA#0.6886;NEURAL CREST CELL#0.6885;CELLULAR SENESCENCE#0.6875;ESOPHAGEAL CANCER#0.6854;OVARIES#0.6848;RENAL CELL CARCINOMA#0.6807;MOUSE EMBRYONIC FIBROBLAST#0.6779;ACUTE LEUKEMIA#0.6770;GERMINAL VESICLE#0.6767;DNA METHYLASE#0.6765;PRIMARY BREAST CANCER#0.6714;INSULIN-LIKE GROWTH FACTOR#0.6683;SKELETAL MUSCLE#0.6679;BONE MARROW CELLS#0.6678;TAMOXIFEN#0.6655;INFERTILITY#0.6651;THYMINE DNA GLYCOSYLASE#0.6650;LIVER CANCER#0.6629;GUANINE#0.6611;MENTAL RETARDATION#0.6569;PRECURSOR CELL#0.6561;POST-TRANSLATIONAL MODIFICATION#0.6560;SEMINOMA#0.6548;MUSCLE CELL#0.6518;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6511;CARDIOMYOCYTE#0.6507;CELL SURFACE#0.6507;LUMINAL#0.6496;STEM CELL MARKER#0.6469;IN VITRO FERTILIZED#0.6458;RESVERATROL#0.6449;GLUTATHIONE#0.6435;EPSTEIN BARR VIRUS#0.6427;METHYL BINDING DOMAIN#0.6327;HYPERMETHYLATION OF CPG ISLAND#0.6315;MTDNA#0.6314;SPONTANEOUS ABORTION#0.6309;CELL ADHESION#0.6281;LEUKOCYTE#0.6268;CHROMATIN REMODELLING#0.6258;FOLATE METABOLISM#0.6248;ADIPOCYTE#0.6231;HYPOXIC#0.6225;HEPATOBLAST DIFFERENTIATION#0.6197;CENTRAL NERVOUS SYSTEM#0.6195;BASE EXCISION REPAIR#0.6150;THYMINE#0.6115;HEPATITIS B VIRUS#0.6110;MULTIPLE MYELOMA#0.6105;SMOOTH MUSCLE#0.6061;TERATOMA#0.6038;NEURAL PROGENITOR CELL#0.6036
178	GLYCOGEN DEBRANCHING ENZYME#1.0724;DEBRANCHING ENZYME#1.0673;GLYCOGEN PHOSPHORYLASE#1.0590;GLYCOGEN STORAGE DISEASE#1.0564;GLYCOGEN METABOLISM#1.0279;SKELETAL MUSCLE#0.9830;AUTOSOMAL RECESSIVE DISEASE#0.9794;ALPHA GLUCOSIDASE#0.9606;ENZYME ACTIVITY#0.9542;GLYCOGEN DEGRADATION#0.9485;GLYCOGENOLYSIS#0.9185;CANCER CELL#0.9090;HYPOGLYCEMIA#0.9063;GLUCOSIDASE ACTIVITY#0.8915;CARDIOMYOPATHY#0.8653;MYOPATHY#0.8634;ALPHA AMYLASE#0.8461;TRANSFERASE ACTIVITY#0.7534;GLYCOGEN BREAKDOWN#0.7309;GLYCOLYSIS#0.6969;CREATINE#0.6881;CREATINE KINASE#0.6868;1-DEOXYNOJIRIMYCIN#0.6408;GAMMA GLUTAMYLTRANSFERASE#0.6231;LONGISSIMUS DORSI MUSCLE#0.6206;HYALURONIC ACID#0.6180;GLUCOSE METABOLISM#0.6140;MALTOSE#0.6123
1791	BIOTIN#1.0449;BLAST CELL#1.0336;V-D-J RECOMBINATION#1.0284;THYMOCYTE#1.0262;DNA FRAGMENTATION#1.0260;DEOXYURIDINE-5'-TRIPHOSPHATE#1.0180;PROPIDIUM#1.0138;SPINAL CORD#1.0123;DNA POLYMERASE BETA#0.9994;APOPTOSIS#0.9974;APOPTOTIC CELL DEATH#0.9920;CELL CYCLE#0.9895;B CELL#0.9888;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9886;BONE MARROW#0.9859;ACUTE LEUKEMIA#0.9856;POLY ADP RIBOSE#0.9852;MACROPHAGE#0.9830;APOPTOTIC#0.9825;POLYMERASE CHAIN REACTION#0.9825;2'-DEOXYURIDINE#0.9814;CASPASE-3 ACTIVITY#0.9795;CELL PROLIFERATION#0.9790;T CELL#0.9785;INDUCTION OF APOPTOSIS#0.9767;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9737;PERIPHERAL BLOOD#0.9719;EPITHELIAL CELL#0.9717;RIBOSE#0.9713;CELL DEATH#0.9684;TUMOR CELLS#0.9680;TUMOR NECROSIS FACTOR#0.9669;ENDOTHELIAL CELL#0.9662;CANCER CELL#0.9660;ISCHEMIA#0.9638;CLEAVED CASPASE 3#0.9627;GROWTH FACTOR#0.9625;GENE EXPRESSION#0.9615;EOSIN#0.9606;PROTEIN KINASE#0.9590;PROGRAMMED CELL DEATH#0.9581;REACTIVE OXYGEN SPECIES#0.9554;CELL GROWTH#0.9539;LYMPHOID CELL#0.9517;TRANSCRIPTION FACTOR#0.9515;CASPASE ACTIVATION#0.9490;SIGNALING PATHWAY#0.9471;CYTOCHROME C#0.9468;NEUTROPHIL#0.9466;STEM CELL#0.9465;CYTOTOXICITY#0.9460;CARDIOMYOCYTE#0.9442;NITRIC OXIDE#0.9371;T LYMPHOCYTE#0.9362;ARTERY#0.9352;FLUORESCEIN#0.9331;TERMINAL TRANSFERASE ACTIVITY#0.9329;DNA SYNTHESIS#0.9259;MITOCHONDRIA#0.9255;MITOCHONDRIAL MEMBRANE#0.9220;DNA BINDING#0.9153;TRANSCRIPTASE#0.9107;LEUKOCYTE#0.9100;MITOGEN ACTIVATED PROTEIN#0.9054;B CELL LYMPHOMA#0.9044;NERVOUS SYSTEM#0.9039;TRANSFERASE ACTIVITY#0.9039;MONOCYTE#0.9016;CYTOPLASM#0.8958;BONE MARROW CELLS#0.8888;LYMPH NODE#0.8868;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8837;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8829;MYOCYTES#0.8712;MONONUCLEAR CELLS#0.8700;ISCHEMIA REPERFUSION INJURY#0.8643;CASPASE INHIBITOR#0.8633;CELL DEVELOPMENT#0.8623;CELL CYCLE ARREST#0.8616;DNA REPAIR#0.8600;ACTIVE CASPASE 3#0.8571;REVERSE TRANSCRIPTION#0.8521;SMOOTH MUSCLE#0.8476;TRANSFORMING GROWTH FACTOR#0.8388;CENTRAL NERVOUS SYSTEM#0.8387;MYELOID LEUKEMIA#0.8383;CELL DIFFERENTIATION#0.8373;LYMPHOBLAST#0.8361;MIDDLE CEREBRAL ARTERY#0.8315;CEREBRAL ARTERY#0.8313;MYELOPEROXIDASE ACTIVITY#0.8287;TOXICITY#0.8195;APOPTOTIC PROCESS#0.8192;CEREBRAL ISCHEMIA#0.8110;DNA POLYMERASE I#0.8110;HEAT SHOCK PROTEIN#0.8098;ADENOSINE#0.8059;PROGENITOR CELL#0.8058;LYMPHOBLASTIC LYMPHOMA#0.8053;CASPASE ACTIVITY#0.8029;SUPEROXIDE DISMUTASE#0.7975;INFLAMMATORY RESPONSE#0.7973;CELL SURFACE#0.7969;TRANSMISSION ELECTRON MICROSCOPY#0.7964;HYPOXIA#0.7863;IMMUNE RESPONSE#0.7793;NITRIC OXIDE SYNTHASE#0.7752;SPINAL CORD INJURY#0.7685;PRECURSOR CELL#0.7670;ACTIVATED CASPASE 3#0.7665;PHOSPHATIDYLSERINE#0.7654;DODECYL SULFATE#0.7532;SODIUM DODECYL SULFATE#0.7532;ENDOPLASMIC RETICULUM#0.7434;CD4+ T CELL#0.7431;GLUTATHIONE#0.7421;PLASMA MEMBRANE#0.7420;ADENOSINE DEAMINASE#0.7408;EDEMA#0.7378;MUTAGENESIS#0.7369;ANGIOGENESIS#0.7344;URIDINE#0.7264;LYMPHOID TISSUE#0.7255;HOST CELL#0.7237;MUSCLE CELL#0.7211;GERM CELL#0.7171;INDUCIBLE NITRIC OXIDE#0.7167;NEURONAL CELL DEATH#0.7150;ACUTE MYELOID LEUKAEMIA#0.7098;MECHANISM OF ACTION#0.7090;INHIBITION OF APOPTOSIS#0.7061;CEREBRAL ARTERY OCCLUSION#0.7029;LYMPHOCYTIC LEUKEMIA#0.7012;ACUTE MYELOID LEUKEMIA#0.6994;NECROTIC#0.6983;MYOCARDIAL INFARCTION#0.6977;CYTOCHROME C RELEASE#0.6889;CEREBRAL CORTEX#0.6853;OVARIAN#0.6847;MYELOID CELL#0.6741;S PHASE#0.6725;TRANSFORMING GROWTH FACTOR BETA#0.6720;CD8+ T CELL#0.6715;SMOOTH MUSCLE CELL#0.6710;IMMUNE SYSTEM#0.6705;LUNG CANCER#0.6700;MYOCARDIUM#0.6630;KINASE INHIBITOR#0.6606;TUMOR SUPPRESSOR#0.6603;SIGNAL TRANSDUCTION#0.6601;HERPES SIMPLEX VIRUS#0.6595;HERPES SIMPLEX#0.6592;CAROTID ARTERY#0.6588;NEURONAL CELLS#0.6586;TISSUE DAMAGE#0.6584;CELL MEMBRANE#0.6557;ESTROGEN RECEPTOR#0.6534;ALKALINE PHOSPHATASE#0.6531;PROTEIN COMPLEX#0.6515;DEATH RECEPTOR#0.6469;NUCLEIC ACID#0.6446;VIRAL INFECTION#0.6441;STROMAL CELL#0.6428;BREAST CANCER#0.6395;NUCLEAR MORPHOLOGY#0.6326;T CELL DEVELOPMENT#0.6302;INTESTINAL MUCOSA#0.6281;HEMATOPOIETIC CELL#0.6276;ENZYME ACTIVITY#0.6248;ASTROCYTE#0.6239;ASPARTATE#0.6158;PROSTATE CANCER#0.6099;KLENOW FRAGMENT#0.6079;THYMOCYTE DIFFERENTIATION#0.6064;ADENOCARCINOMA#0.6050;DNA POLYMERASE GAMMA#0.6009
1793	CYTOKINESIS#1.0553;MYOBLAST#1.0513;CANCER CELL#1.0394;NUCLEOTIDE EXCHANGE FACTOR#1.0377;GUANINE#1.0336;PHAGOCYTOSIS#1.0268;FOCAL ADHESION#1.0229;CELL MOTILITY#1.0226;CELL MIGRATION#1.0166;APOPTOTIC#1.0139;BREAST CANCER#1.0138;SIGNALING PATHWAY#1.0103;ACTIN CYTOSKELETON#0.9941;MYOBLAST FUSION#0.9786;EPITHELIAL CELL#0.9560;PLASMA MEMBRANE#0.9387;CELL PROLIFERATION#0.9109;GROWTH FACTOR#0.9093;ENGULFMENT OF APOPTOTIC CELL#0.8889;CELL DEATH#0.8664;ENDOTHELIAL CELL#0.8649;PROTEIN COMPLEX#0.8441;CELL ADHESION#0.8339;SIGNALING CASCADE#0.8234;PROTEIN KINASE#0.8026;APOPTOSIS#0.7991;OVARIAN CANCER#0.7953;BREAST CANCER CELL#0.7942;COMPLEX I#0.7770;OVARIAN#0.7598;FOCAL ADHESION KINASE#0.7590;PROGRAMMED CELL DEATH#0.7562;CELL SURFACE#0.7475;MEMBRANE RUFFLE#0.7144;RUFFLE#0.7114;RNA INTERFERENCE#0.7092;SIGNAL TRANSDUCTION#0.7081;GUANINE EXCHANGE FACTOR#0.7005;SIGNALING MOLECULE#0.6959;SIGNALLING PATHWAY#0.6951;GROWTH FACTOR RECEPTOR#0.6902;SURFACE PLASMON RESONANCE#0.6811;SCHWANN CELL#0.6808;SRC FAMILY KINASE#0.6425;NEURITE#0.6405;PHOSPHATIDYLSERINE#0.6325;CELL MEMBRANE#0.6241;ANGIOGENESIS#0.6019
1794	LYMPHOCYTE MIGRATION#1.0676;CYTOKINESIS#1.0640;HEMATOPOIETIC CELL#1.0581;B CELL#1.0511;T CELL#1.0507;NUCLEOTIDE EXCHANGE FACTOR#1.0472;GUANINE#1.0386;CHEMOTAXIS#1.0243;DENDRITIC CELL#0.9606;ACTIN POLYMERIZATION#0.9523;ACTIN CYTOSKELETON#0.9504;T LYMPHOCYTE#0.9244;CELL MIGRATION#0.9180;NEUTROPHIL#0.9151;CELL PROLIFERATION#0.8986;IMMUNE RESPONSE#0.8408;GUANINE EXCHANGE FACTOR#0.8388;CELL MOTILITY#0.8047;CD4+ T CELL#0.8039;BONE MARROW#0.7846;NEUTROPHIL CHEMOTAXIS#0.7638;IMMUNE CELL#0.6875;PROGENITOR CELL#0.6861;SMOOTH MUSCLE#0.6840;IMMUNOLOGICAL SYNAPSE#0.6548;PLASMACYTOID DENDRITIC CELL#0.6489;CELL ACTIVATION#0.6331;SIGNALING PATHWAY#0.6294;MARGINAL ZONE B CELL#0.6277;MARGINAL ZONE B#0.6272;INTEGRIN ACTIVATION#0.6249;LEUKOCYTE#0.6239;MYOBLAST#0.6064;VIRAL INFECTION#0.6036;CELL DIFFERENTIATION#0.6020;PLASMA MEMBRANE#0.6003
1795	CELL ADHESION#1.0638;NUCLEOTIDE EXCHANGE FACTOR#1.0161;OPTIC NERVE#0.9843;GUANINE#0.9511;CYTOKINESIS#0.9220;ALZHEIMER'S DISEASE#0.8998;RETINAL DEGENERATION#0.7980;DEVELOPMENTAL DELAY#0.7964;NEURITE OUTGROWTH#0.7635;REGENERATION#0.7526;OPTIC NERVE INJURY#0.7285;PLASMA MEMBRANE#0.6996;CELL DEATH#0.6978;CENTRAL NERVOUS SYSTEM#0.6703;NERVOUS SYSTEM#0.6693;NEURITE#0.6609;MICROTUBULE ASSEMBLY#0.6397;SOLUBLE FRACTION#0.6381;AXON REGENERATION#0.6300;CELL CELL ADHESION#0.6292;NMDA RECEPTOR#0.6232;ACTIN POLYMERIZATION#0.6218;CELL DIVISION#0.6160;WAVE COMPLEX#0.6055
1796	DOCKING PROTEIN#1.0855;T CELL#1.0361;TUMOR SUPPRESSOR#1.0165;CELL PROLIFERATION#1.0118;PROTEIN TYROSINE KINASE#1.0078;AFRICAN SWINE FEVER#0.9999;PHOSPHOTYROSINE BINDING#0.9950;GROWTH FACTOR#0.9791;PROTEIN KINASE#0.9668;B CELL#0.9653;SIGNALING PATHWAY#0.9620;MITOGEN ACTIVATED PROTEIN#0.9344;MAP KINASE#0.9322;CELL MIGRATION#0.9296;KINASE ACTIVITY#0.9111;HEMATOPOIETIC CELL#0.9004;GENE EXPRESSION#0.8913;INTEGRIN ACTIVATION#0.8794;MAST CELL#0.8579;TYROSINE KINASE 1#0.8401;APOPTOSIS#0.8183;EPITHELIAL CELL#0.8087;MACROPHAGE#0.7685;PLASMA MEMBRANE#0.7555;MYELOID CELL#0.7550;INSULIN RECEPTOR#0.7355;CELL GROWTH#0.7327;SIGNALING MOLECULE#0.7168;RECEPTOR TYROSINE KINASE#0.7163;IMMUNE RESPONSE#0.7036;CELL MOTILITY#0.6897;BONE MARROW#0.6873;SIGNALLING PATHWAY#0.6860;RETINOIC ACID#0.6857;CANCER CELL#0.6795;CELL ADHESION#0.6569;SIGNAL TRANSDUCTION#0.6434;INSULIN RECEPTOR SUBSTRATE#0.6409;CELL ACTIVATION#0.6393;CELL CYCLE#0.6352;GLIAL CELL#0.6160;CELL DEVELOPMENT#0.6037
1797	EXORIBONUCLEASE ACTIVITY#0.8484
1798	GLCNAC#1.0626;CONGENITAL MYASTHENIC SYNDROME#1.0521;GLYCOSYLATION#1.0233;CONGENITAL DISORDER#1.0183;CONGENITAL DISORDER OF GLYCOSYLATION#1.0166;ENDOPLASMIC RETICULUM#1.0121;CELL CYCLE#0.9387;ASPARAGINE#0.9207;PROTEIN GLYCOSYLATION#0.9155;MICROSOME#0.9031;N GLYCAN#0.8946;CELL CYCLE ARREST#0.8524;TRANSFERASE ACTIVITY#0.8185;SIGNALING PATHWAY#0.7756;ENZYME ACTIVITY#0.7656;GLUCOSAMINE#0.6840;EARLY GROWTH RESPONSE#0.6665;GENE EXPRESSION#0.6636;ACETYLCHOLINE RECEPTOR#0.6408;MAMMARY GLAND#0.6299;ER MEMBRANE#0.6240;ORAL SQUAMOUS CELL CARCINOMA#0.6182;SQUAMOUS CELL CARCINOMA#0.6112;NEUROMUSCULAR JUNCTION#0.6109
17	CERVICAL CANCER#1.0409;HEMOPHILIA B#1.0327;DNA REPLICATION#1.0275;DNA SYNTHESIS#1.0240;HERPES SIMPLEX VIRUS#1.0237;CERVICAL#1.0235;HERPES SIMPLEX#1.0191;BETA GALACTOSIDASE#1.0185;ADENO ASSOCIATED VIRUS#1.0169;VIRION#1.0158;HOST CELL#1.0150;HEMOPHILIA#1.0144;TROPISM#1.0135;DNA AMPLIFICATION#1.0095;RETINAL DISEASE#1.0087;DNA INTEGRATION#1.0086;ENDOTHELIAL CELL#1.0077;CYSTIC FIBROSIS#1.0070;VIRAL GENOME#1.0061;VIRAL CAPSID#1.0051;VIRAL DNA REPLICATION#1.0046;CD8+ T CELL#1.0024;HOMOLOGOUS RECOMBINATION#1.0023;DNA BINDING#1.0003;RETINAL DEGENERATION#0.9989;VIRAL REPLICATION#0.9986;ANGIOGENESIS#0.9984;DENDRITIC CELL#0.9977;BLOOD BRAIN BARRIER#0.9963;INDUCED PLURIPOTENT STEM CELL#0.9954;TRANSCRIPTION ACTIVATOR#0.9952;T CELL#0.9948;CARDIOMYOCYTE#0.9942;HEMATOPOIETIC CELL#0.9936;MUSCLE CELL#0.9934;GLOBIN#0.9931;CANCER CELL#0.9918;NEOMYCIN#0.9915;PARKINSON'S DISEASE#0.9915;DNA REPAIR#0.9912;SPINAL CORD#0.9909;AMAUROSIS#0.9906;IMMUNE RESPONSE#0.9893;COCHLEA#0.9888;NEURODEGENERATIVE DISEASE#0.9877;PLURIPOTENT STEM CELL#0.9874;POLYMERASE CHAIN REACTION#0.9872;SUBSTANTIA NIGRA#0.9869;DUCHENNE MUSCULAR DYSTROPHY#0.9865;EPITHELIAL CELL#0.9858;DNA DAMAGE RESPONSE#0.9841;CELL DEATH#0.9835;CELL SURFACE#0.9832;CENTRAL NERVOUS SYSTEM#0.9828;GANGLION CELLS#0.9828;NERVOUS SYSTEM#0.9826;MUSCULAR DYSTROPHY#0.9823;APOPTOSIS#0.9819;MACROPHAGE#0.9814;TUMOR CELLS#0.9813;TOXICITY#0.9811;RETINAL PIGMENT EPITHELIUM#0.9811;HEPARIN#0.9806;ASTROCYTE#0.9803;MUTAGENESIS#0.9802;GLIAL CELL#0.9800;SKELETAL MUSCLE#0.9785;GENE EXPRESSION#0.9781;HYPERTENSION#0.9780;GROWTH FACTOR#0.9779;STRIATUM#0.9777;RETINITIS PIGMENTOSA#0.9765;BONE MARROW#0.9759;STEM CELL#0.9750;INFLAMMATORY RESPONSE#0.9749;TRANSCRIPTION FACTOR#0.9737;HEMATOPOIETIC STEM CELL#0.9734;BONE RESORPTION#0.9734;HEPATOCELLULAR CARCINOMA#0.9705;HAIR CELL#0.9700;RETINAL GANGLION CELL#0.9692;T LYMPHOCYTE#0.9689;CELL CYCLE#0.9666;RNA INTERFERENCE#0.9660;PHOTORECEPTOR CELL#0.9658;DNASE I#0.9652;ENDOTHELIAL GROWTH FACTOR#0.9632;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9632;PROGENITOR CELL#0.9624;PROTEOGLYCAN#0.9620;SMOOTH MUSCLE#0.9615;FACTOR VIII#0.9609;LEBER CONGENITAL AMAUROSIS#0.9606;ALKALINE PHOSPHATASE#0.9596;ALZHEIMER'S DISEASE#0.9565;DNASE#0.9563;DOPAMINE#0.9542;PERIPHERAL BLOOD#0.9537;GENETIC DISEASE#0.9529;EMBRYONIC STEM CELL#0.9501;ISCHEMIA#0.9488;REGENERATION#0.9468;MESENCHYMAL STEM CELL#0.9465;HEPARIN BINDING#0.9462;DIGESTION#0.9457;APOPTOTIC#0.9444;ARTERY#0.9436;PROTEASOME#0.9435;CYTOTOXICITY#0.9418;HINDLIMB#0.9418;RETINITIS#0.9415;EPSTEIN BARR VIRUS#0.9388;OSTEOCLAST#0.9382;BLINDNESS#0.9339;GREEN FLUORESCENCE PROTEIN#0.9329;MUSCLE FIBER#0.9299;TUMOR NECROSIS FACTOR#0.9292;MYOCARDIAL INFARCTION#0.9287;MYOCARDIUM#0.9259;IMMUNE SYSTEM#0.9256;CYTOTOXIC T-LYMPHOCYTE#0.9219;SIGNALING PATHWAY#0.9210;LIVER DISEASE#0.9200;GENETIC DISORDER#0.9189;HUMAN EMBRYONIC STEM#0.9185;VIRAL INFECTION#0.9184;GROWTH FACTOR RECEPTOR#0.9182;SEMEN#0.9164;SPINAL CORD INJURY#0.9137;OPTIC NERVE#0.9114;BIPOLAR CELL#0.9048;CARDIOMYOPATHY#0.9022;NUCLEIC ACID#0.9011;RECEPTOR BINDING#0.9010;COAGULATION#0.9010;HELICASE ACTIVITY#0.8994;HUMAN IMMUNODEFICIENCY VIRUS#0.8980;HUMORAL IMMUNE RESPONSE#0.8976;THYMIDINE KINASE#0.8974;CELL PROLIFERATION#0.8953;SMOOTH MUSCLE CELL#0.8910;PROTEIN KINASE#0.8898;DOPAMINERGIC NEURON#0.8876;DNA HELICASE#0.8861;DENTATE GYRUS#0.8840;HOMOLOGY-DIRECTED REPAIR#0.8782;ELECTROPHORETIC MOBILITY SHIFT#0.8778;COAGULATION FACTOR IX#0.8769;BREAST CANCER#0.8747;HEPATITIS B#0.8711;AUTOPHAGY#0.8709;CELLULAR IMMUNE RESPONSE#0.8703;REPLICATION COMPARTMENT#0.8695;NEUROLOGICAL DISORDER#0.8693;INNER EAR#0.8681;HYPOXIA#0.8659;AMYOTROPHIC LATERAL SCLEROSIS#0.8652;LATERAL SCLEROSIS#0.8652;INSULIN-LIKE GROWTH FACTOR#0.8640;B CELL#0.8619;HYDROXYUREA#0.8606;EPISOME#0.8600;ERYTHROID CELL#0.8597;SUPEROXIDE DISMUTASE#0.8550;HEART DISEASE#0.8549;GENOTOXIC#0.8528;CLOTTING#0.8519;ONCOGENIC#0.8470;DOUBLE STRAND BREAK#0.8462;ATHEROSCLEROSIS#0.8429;CONVECTION ENHANCED DELIVERY#0.8428;TRANSFORMING GROWTH FACTOR#0.8414;THYMIDINE#0.8359;NEURONAL CELLS#0.8351;IMMUNE CELL#0.8348;ENDONUCLEASE ACTIVITY#0.8336;BLOOD VESSEL#0.8335;MACULAR DEGENERATION#0.8301;PROTEIN SYNTHESIS#0.8300;PRO-INFLAMMATORY#0.8293;ENDOPLASMIC RETICULUM#0.8238;LYSOSOMAL STORAGE DISEASE#0.8225;MONONUCLEAR CELLS#0.8187;HIGH FAT DIET#0.8184;RHEUMATOID ARTHRITIS#0.8165;AGE RELATED MACULAR DEGENERATION#0.8164;HEPATITIS B VIRUS#0.8130;REGULATORY T CELL#0.8119;AXONAL TRANSPORT#0.8116;SYNAPTIC TRANSMISSION#0.8095;AMYLOID PRECURSOR PROTEIN#0.8062;FIBROBLAST GROWTH FACTOR#0.8050;NITRIC OXIDE#0.8023;CARDIAC MUSCLE#0.8009;CISPLATIN#0.7993;L-DOPA#0.7979;PERIPHERAL NERVOUS SYSTEM#0.7913;CARCINOGEN#0.7886;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7883;DOXYCYCLINE#0.7877;ENZYME ACTIVITY#0.7857;STRIATED MUSCLE#0.7848;LIVER CANCER#0.7774;STROMAL CELL#0.7753;TETRACYCLINE#0.7745;VIRION ASSEMBLY#0.7738;GLUTAMIC ACID#0.7725;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7717;VACCINIA#0.7706;EPIDERMAL GROWTH FACTOR#0.7699;CELL GROWTH#0.7696;EXOSOME#0.7689;CANAVAN DISEASE#0.7671;DEPHOSPHORYLATION#0.7664;VIRAL GENE EXPRESSION#0.7639;CHICKEN BETA ACTIN#0.7619;GM-CSF#0.7612;MIDBRAIN#0.7609;CHONDROCYTE#0.7558;CELL ACTIVATION#0.7546;KNEE JOINT#0.7545;NITRIC OXIDE SYNTHASE#0.7538;THALAMUS#0.7528;CORONARY ARTERY#0.7522;OPSIN#0.7518;AIRWAY EPITHELIUM#0.7460;MITOCHONDRIA#0.7434;CREATINE KINASE#0.7427;CILIARY NEUROTROPHIC FACTOR#0.7426;LIVER DAMAGE#0.7407;POST-TRANSLATIONAL MODIFICATION#0.7392;VASCULAR CELL#0.7358;SUBTHALAMIC NUCLEUS#0.7333;DIAPHRAGM#0.7316;PERIPHERAL NERVE#0.7312;CD4+ T CELL#0.7310;INFLAMMATORY CELL#0.7287;MYOCYTES#0.7284;QUANTITATIVE REAL TIME#0.7284;ENDOCYTOSIS#0.7283;MYOBLAST#0.7271;NUCLEAR LAYER#0.7268;PARENCHYMA#0.7267;ENDOTHELIUM#0.7261;STRAND DISPLACEMENT#0.7184;WEIGHT GAIN#0.7177;PORTAL VEIN#0.7161;IFN-GAMMA#0.7158;PLASMA MEMBRANE#0.7139;PROGRAMMED CELL DEATH#0.7127;OPTICAL COHERENCE TOMOGRAPHY#0.7127;ADIPOSE TISSUE#0.7115;TRANSCRIPTASE#0.7107;YELLOW FLUORESCENT PROTEIN#0.7104;INNATE IMMUNE RESPONSE#0.7096;VIRAL LIFE CYCLE#0.7095;REVERSE TRANSCRIPTION#0.7085;REACTIVE OXYGEN SPECIES#0.7079;QUADRICEPS#0.7078;VIRUS ASSEMBLY#0.7070;IODIXANOL#0.7046;PERIODONTITIS#0.7023;CREATINE#0.7003;MYELOID CELL#0.6987;OVARIAN#0.6969;BREAST CANCER CELL#0.6951;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6951;NEURAL RETINA#0.6914;VASCULAR ENDOTHELIAL CELL#0.6901;NUCLEAR TRANSPORT#0.6897;BONE MORPHOGENETIC PROTEIN#0.6892;ION CHANNEL#0.6890;COLONY-STIMULATING FACTOR#0.6868;SARCOPLASMIC RETICULUM#0.6843;SCIATIC NERVE#0.6835;MUCOPOLYSACCHARIDOSIS#0.6822;SENSITIZATION#0.6817;MAGNETIC RESONANCE IMAGING#0.6801;LYSINE#0.6787;UBIQUITIN#0.6783;EXTRACELLULAR MATRIX#0.6779;TOLERANCE INDUCTION#0.6769;BASAL GANGLIA#0.6753;BIOLUMINESCENCE#0.6737;BETA THALASSEMIA#0.6729;VESICULAR STOMATITIS VIRUS#0.6721;PROVIRUS#0.6712;NADPH OXIDASE#0.6702;TRANSMISSION ELECTRON MICROSCOPY#0.6702;HEMATOPOIETIC PROGENITOR CELL#0.6697;CELL KILLING#0.6693;CHLORAMPHENICOL#0.6667;PLATELET-DERIVED GROWTH FACTOR#0.6647;ACUTE MYOCARDIAL INFARCTION#0.6644;PERIODONTAL DISEASE#0.6636;GERM CELL#0.6630;RAPAMYCIN#0.6618;ENZYME REPLACEMENT THERAPY#0.6616;MICROTUBULE#0.6580;CYTOPLASM#0.6566;DIABETIC RETINOPATHY#0.6564;MIDDLE CEREBRAL ARTERY#0.6552;COLLAGEN TYPE II#0.6552;CEREBRAL ARTERY#0.6549;EYE DISEASE#0.6544;CHRONIC GRANULOMATOUS DISEASE#0.6514;MALTOSE BINDING#0.6507;CARRIE#0.6505;NEUROGENESIS#0.6494;NEUTROPHIL#0.6483;HEARING LOSS#0.6482;MONOCYTE#0.6462;GRANULOCYTE#0.6462;T CELL ACTIVATION#0.6451;BONE FORMATION#0.6449;DORSAL ROOT GANGLION#0.6448;MICROTUBULE ASSOCIATED PROTEIN#0.6430;TISSUE DAMAGE#0.6423;RIBOSOME#0.6383;LEUKOCYTE#0.6340;PUROMYCIN#0.6308;CAMKII#0.6289;THALASSEMIA#0.6275;HUMAN EMBRYONIC KIDNEY#0.6265;EMBRYONIC KIDNEY#0.6262;CEREBRAL ARTERY OCCLUSION#0.6261;ADAPTIVE IMMUNE RESPONSE#0.6256;IMMUNE SUPPRESSION#0.6255;HEPATOCYTE GROWTH FACTOR#0.6245;GLYCOSYLATION#0.6215;PHOSPHATE BUFFERED SALINE#0.6202;RETINAL PIGMENT EPITHELIAL#0.6179;CELL-MEDIATED IMMUNE RESPONSE#0.6167;CELL DIVISION#0.6116;SIGNALING CASCADE#0.6115;VASCULAR SMOOTH MUSCLE CELL#0.6114;ARGININE#0.6113;STOMATITIS#0.6098;CELL ADHESION#0.6085;CONSTRICTION#0.6065;HYPERCHOLESTEROLEMIA#0.6059;LYSOSOMAL STORAGE DISORDER#0.6043;DNA HELICASE ACTIVITY#0.6042;KERATINOCYTE#0.6027;LIMB-GIRDLE MUSCULAR DYSTROPHY#0.6002;OUTER HAIR CELL#0.6001
1800	CILASTATIN#1.0688;IMIPENEM#1.0508;PHOSPHOLIPASE C#1.0382;MEROPENEM#1.0036;COLORECTAL CANCER#0.9509;COLORECTAL#0.9276;BRUSH BORDER#0.9046;GLUTATHIONE#0.8597;GENE EXPRESSION#0.8157;CELL PROLIFERATION#0.8137;CANCER CELL#0.7932;COLON CANCER#0.7523;MEMBRANE FRACTION#0.7377;BETA-LACTAMASE ACTIVITY#0.7173;NEPHROTOXICITY#0.6995;CISPLATIN#0.6965;APOPTOSIS#0.6871;BONE DISEASE#0.6861;ENZYME INHIBITOR#0.6777;EPITHELIAL CELL#0.6745;EXCRETION#0.6477;MICROVILLI#0.6370;PENICILLIN#0.6212
1801	DIPHTHAMIDE#1.1276;TUMOR SUPPRESSOR#1.0692;OVARIAN#1.0436;OVARIAN CANCER#1.0157;CANCER CELL#0.9235;CELL PROLIFERATION#0.8252;TRANSLATION ELONGATION FACTOR#0.8237;TRANSLATION ELONGATION#0.8223;DIPHTHERIA#0.7758;OVARIAN CARCINOMA#0.7369;INTELLECTUAL DISABILITY#0.7049;UBIQUITIN#0.6783;SENSENBRENNER SYNDROME#0.6547;HISTIDINE#0.6478;DEVELOPMENTAL DELAY#0.6347
1802	DIPHTHAMIDE#1.1346;DIPHTHERIA#0.6436;TRANSLATION ELONGATION FACTOR#0.6204;TRANSLATION ELONGATION#0.6192;DOMINANT NEGATIVE MUTANT#0.6027
1803	DEAMINASE BINDING#1.0894;DIPEPTIDYL-AMINOPEPTIDASE IV#1.0786;SITAGLIPTIN PHOSPHATE#1.0686;DIPEPTIDYL-PEPTIDASE IV ACTIVITY#1.0627;T CELL COSTIMULATION#1.0591;OVARIAN CARCINOMA#1.0578;GAMMA GLUTAMYLTRANSFERASE#1.0551;AMINOPEPTIDASE A#1.0504;BULLOUS PEMPHIGOID#1.0502;PROTEIN TYROSINE PHOSPHATASE#1.0489;DIPEPTIDYL-PEPTIDASE ACTIVITY#1.0448;AMINOPEPTIDASE P#1.0411;JANUVIA#1.0374;XANTHINE#1.0332;DIPEPTIDYL PEPTIDASE 8#1.0322;ENDOPEPTIDASE 24.11#1.0314;VOGLIBOSE#1.0309;DIPEPTIDYL PEPTIDASE IV#1.0297;CORD BLOOD#1.0282;DIPEPTIDYL PEPTIDASE 4#1.0280;HEART FAILURE HOSPITALIZATION#1.0273;ANGIOEDEMA#1.0259;ADENOSINE DEAMINASE#1.0255;DIPEPTIDYL PEPTIDASE#1.0244;FIBROBLAST ACTIVATION PROTEIN#1.0232;SEMINAL PLASMA#1.0232;DPP IV ACTIVITY#1.0228;LINAGLIPTIN#1.0221;ALOGLIPTIN#1.0218;LAF237#1.0206;THYMOCYTE#1.0203;MEMORY T CELL#1.0202;ALPHA GLUCOSIDASE#1.0182;FIBROBLAST ACTIVATION#1.0176;VALINE#1.0174;INSULIN GLARGINE#1.0173;ALKALINE PHOSPHATASE#1.0171;SAXAGLIPTIN#1.0171;T CELL ACTIVATION#1.0169;ACE INHIBITOR#1.0168;VILDAGLIPTIN#1.0160;ACID PHOSPHATASE#1.0152;ISCHEMIA REPERFUSION INJURY#1.0152;CATALYTIC ACTIVITY#1.0151;NEUTRAL PROTAMINE HAGEDORN#1.0145;SQUAMOUS CELL CARCINOMA#1.0137;RHEUMATOID ARTHRITIS#1.0135;TYPE 1 DIABETIC#1.0132;LACTASE-PHLORIZIN HYDROLASE#1.0130;PEPTIDASE ACTIVITY#1.0119;SIGNAL TRANSDUCTION#1.0117;SUBSTANCE P#1.0117;G-CSF#1.0116;PSORIASIS#1.0113;CELL ACTIVATION#1.0108;CHRONIC HEPATITIS C#1.0106;THYROID CARCINOMA#1.0106;WOUND HEALING#1.0102;HYPOXIA#1.0100;COLONY-STIMULATING FACTOR#1.0097;SITAGLIPTIN#1.0094;RECEPTOR AGONIST#1.0093;MILK PROTEIN#1.0093;PERIPHERAL BLOOD LYMPHOCYTES#1.0089;STROMAL DERIVED FACTOR#1.0086;ADENOSINE#1.0080;ANGIOTENSIN CONVERTING ENZYME#1.0076;LIPID RAFT#1.0075;HUMAN IMMUNODEFICIENCY VIRUS#1.0067;CONTINUOUS GLUCOSE MONITORING#1.0067;DIABETIC KIDNEY DISEASE#1.0065;ACUTE KIDNEY INJURY#1.0063;LUPUS ERYTHEMATOSUS#1.0060;PROSTATE CANCER#1.0051;LEUCINE#1.0041;EATING DISORDER#1.0037;GLIMEPIRIDE#1.0035;CHEMOTAXIS#1.0034;NEUTRAL ENDOPEPTIDASE 24.11#1.0034;MALIGNANT MESOTHELIOMA#1.0034;BRUSH BORDER MEMBRANE#1.0033;CANCER STEM CELL#1.0032;ACUTE PANCREATITIS#1.0030;PEROXISOME#1.0029;ENDOTHELIAL PROGENITOR CELL#1.0027;NON OBESE DIABETIC#1.0020;T CELL PROLIFERATION#1.0019;RENAL FIBROSIS#1.0019;LYMPHOCYTE ACTIVATION#1.0018;CD4+ T CELL#1.0017;PRAMLINTIDE#1.0013;TYPE 1 DIABETES MELLITUS#1.0010;ENZYME INHIBITOR#1.0008;T CELL#1.0008;OVARIAN#1.0005;AUTOIMMUNE DISEASE#0.9999;ACARBOSE#0.9997;HEPATITIS C#0.9994;REGULATION OF DNA SYNTHESIS#0.9993;ADJUSTED HAZARD RATIO#0.9993;PAPILLARY CARCINOMA#0.9992;GLICLAZIDE#0.9990;MESOTHELIOMA CELL#0.9989;CANAGLIFLOZIN#0.9987;BRUSH BORDER#0.9986;CD8+ T CELL#0.9985;FIXED DOSE COMBINATION#0.9983;ADVANCED GLYCATION END#0.9983;DIABETIC RETINOPATHY#0.9980;RECEPTOR BINDING#0.9979;T LYMPHOCYTE#0.9973;CELL SURFACE#0.9973;COLORECTAL#0.9970;GRANULOCYTE COLONY STIMULATING FACTOR#0.9970;BREAST CANCER#0.9967;INFLAMMATORY BOWEL DISEASE#0.9965;ACUTE CORONARY SYNDROME#0.9961;MILD COGNITIVE IMPAIRMENT#0.9959;STROMAL CELL#0.9959;ZUCKER DIABETIC FATTY#0.9956;EXENATIDE#0.9954;CYTOKINE PRODUCTION#0.9954;GRANULOCYTE#0.9952;ACTIVATED T CELL#0.9952;GROWTH HORMONE#0.9951;JEJUNUM#0.9949;THYROID CANCER#0.9947;RANDOMISED CONTROLLED TRIAL#0.9940;COLORECTAL CANCER#0.9931;NATURAL KILLER CELL#0.9930;COLON CANCER#0.9929;ALPHA CELL#0.9928;PANCREATIC CANCER#0.9927;C REACTIVE PROTEIN#0.9927;MULTIPLE SCLEROSIS#0.9924;PLASMA MEMBRANE#0.9919;RANDOMIZED CLINICAL TRIAL#0.9919;DIET INDUCED OBESITY#0.9919;PANCREATITIS#0.9917;ADIPOCYTE#0.9913;DIABETIC NEPHROPATHY#0.9913;TUMOR CELLS#0.9912;ACTIVATED T-CELLS#0.9912;HYPERGLYCEMIC#0.9912;ACUTE MYOCARDIAL INFARCTION#0.9909;CELL MEMBRANE#0.9908;B CELL#0.9907;WEIGHTED MEAN DIFFERENCE#0.9905;INSULIN RECEPTOR#0.9904;ISCHEMIA#0.9903;PROTEIN BINDING#0.9903;IFN-GAMMA#0.9902;ATHEROSCLEROTIC#0.9897;LIRAGLUTIDE#0.9894;SKELETAL MUSCLE#0.9893;CELL ADHESION#0.9891;PEPTIDE HORMONE#0.9891;ENZYME ACTIVITY#0.9890;STRUCTURE ACTIVITY RELATIONSHIP#0.9890;ALANINE#0.9887;CELL MIGRATION#0.9886;ATHEROSCLEROSIS#0.9882;URIC ACID#0.9879;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9878;GLUCOSE UPTAKE#0.9878;GLIBENCLAMIDE#0.9876;COLITIS#0.9873;HOST CELL#0.9872;LIPID METABOLISM#0.9868;CELL DIFFERENTIATION#0.9867;KERATINOCYTE#0.9866;HEMATOPOIETIC STEM CELL#0.9864;GLYCOSYLATION#0.9862;ANGIOGENESIS#0.9860;CHEMOKINE RECEPTOR#0.9860;CARDIOVASCULAR SYSTEM#0.9858;PRO-INFLAMMATORY#0.9857;CELL GROWTH#0.9856;PIOGLITAZONE#0.9856;POLYCYSTIC OVARY SYNDROME#0.9855;CELL SURFACE ANTIGEN#0.9853;ALCOHOLIC FATTY LIVER#0.9853;DNA SYNTHESIS#0.9846;METFORMIN#0.9843;L-PROLINE#0.9842;DERMAL FIBROBLAST#0.9837;RECEPTOR ANTAGONIST#0.9836;PROGENITOR CELL#0.9835;ENTEROCYTE#0.9834;MEAL TOLERANCE TEST#0.9834;RESPIRATORY TRACT#0.9832;IMMUNE CELL#0.9830;CORONARY ARTERY DISEASE#0.9830;CELL DEATH#0.9826;TYPE 2 DIABETIC#0.9825;CANCER CELL#0.9824;NEPHROPATHY#0.9823;MONONUCLEAR CELLS#0.9823;ADIPOSE TISSUE#0.9823;MYCOSIS FUNGOIDES#0.9822;IMPAIRED GLUCOSE TOLERANCE#0.9821;ARTERY DISEASE#0.9821;IMMUNE SYSTEM#0.9821;NATIONAL HEALTH INSURANCE#0.9817;PYY 3-36#0.9811;CYTOTOXICITY#0.9809;CARDIOMYOCYTE#0.9808;HEMATOPOIETIC CELL#0.9806;STIMULATION OF INSULIN SECRETION#0.9805;FATTY LIVER DISEASE#0.9804;STREPTOZOTOCIN#0.9803;LUNG CANCER#0.9803;BETA CELL MASS#0.9801;KIDNEY DISEASE#0.9800;LUMINAL#0.9798;TYPE 1 DIABETES#0.9797;ADENOCARCINOMA#0.9796;PERIPHERAL BLOOD#0.9795;REGULATORY T CELL#0.9793;CEREBRAL ISCHEMIA#0.9793;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9791;GLUCOSE METABOLISM#0.9790;CELL CYCLE#0.9790;REGENERATION#0.9788;SIGNALING PATHWAY#0.9788;LOW DENSITY LIPOPROTEIN#0.9787;MICROVILLUS#0.9786;SYNOVIAL FLUID#0.9784;PANCREATIC ISLET#0.9782;HEPATOCELLULAR CARCINOMA#0.9779;CHRONIC KIDNEY DISEASE#0.9779;TYPE 2 DIABETES#0.9778;HEMATOPOIESIS#0.9777;SMOOTH MUSCLE CELL#0.9775;MECHANISM OF ACTION#0.9775;RANDOMIZED CONTROLLED TRIAL#0.9774;ATOPIC DERMATITIS#0.9774;SMOOTH MUSCLE#0.9773;INHIBITION OF GLUCAGON SECRETION#0.9773;FATTY LIVER#0.9773;GOLGI APPARATUS#0.9770;EXTRACELLULAR MATRIX#0.9769;REVERSE TRANSCRIPTION#0.9768;HEART DISEASE#0.9767;MUSCLE CELL#0.9766;BONE MARROW#0.9766;BLOOD VESSEL#0.9765;ENDOTHELIAL GROWTH FACTOR#0.9765;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9765;NEUTROPHIL#0.9762;MECHANISMS OF ACTION#0.9761;CONTROLLED CLINICAL TRIALS#0.9761;ENDOPLASMIC RETICULUM#0.9761;LYMPHOID CELL#0.9755;ENDOTHELIAL CELL#0.9755;LEUKOCYTE#0.9754;EPITHELIAL CELL#0.9752;GLUCOSE INTOLERANCE#0.9752;MONOCYTE#0.9750;SKIN DISEASE#0.9749;MACROPHAGE#0.9748;STEM CELL#0.9748;PEPTIDASE INHIBITOR#0.9748;APOPTOTIC#0.9744;MITOGEN ACTIVATED PROTEIN#0.9744;OBESE#0.9743;INFLAMMATORY CELL#0.9743;CYTOCHROME P450#0.9742;AMERICAN DIABETES ASSOCIATION#0.9742;ENDOTHELIUM#0.9742;CONNECTIVE TISSUE#0.9739;CELL ADHESION MOLECULE#0.9739;CORONARY ARTERY#0.9734;ALZHEIMER'S DISEASE#0.9732;DENDRITIC CELL#0.9732;HIGH FAT DIET#0.9732;TRANSFORMING GROWTH FACTOR#0.9729;TYPE 2 DIABETES MELLITUS#0.9725;2 DIABETES MELLITUS#0.9725;POSTPRANDIAL PLASMA GLUCOSE#0.9723;IMMUNE RESPONSE#0.9722;EXCRETION#0.9722;NITRIC OXIDE#0.9721;PROTEINURIA#0.9719;SERUM ALBUMIN#0.9718;LYMPH NODE#0.9717;FASTING BLOOD GLUCOSE#0.9710;HIGH DENSITY LIPOPROTEIN#0.9709;GLYBURIDE#0.9703;POLYMERASE CHAIN REACTION#0.9701;DIGESTION#0.9701;PROTEASE ACTIVITY#0.9700;EXOPEPTIDASE ACTIVITY#0.9699;TRANSCRIPTION FACTOR#0.9697;NITRIC OXIDE SYNTHASE#0.9693;CHRONIC LIVER DISEASE#0.9693;TUMOR NECROSIS FACTOR#0.9690;INFLAMMATORY RESPONSE#0.9689;LIVER DISEASE#0.9689;GROWTH FACTOR#0.9688;DIABETES MELLITUS#0.9687;PROTEIN KINASE#0.9680;REACTIVE OXYGEN SPECIES#0.9680;MYOCARDIAL INFARCTION#0.9679;INTESTINAL EPITHELIAL CELL#0.9677;GLOMERULAR FILTRATION#0.9677;GLOMERULAR FILTRATION RATE#0.9673;SMALL INTESTINE#0.9672;RESPIRATORY TRACT INFECTION#0.9667;GLUCOSE HOMEOSTASIS#0.9662;CENTRAL NERVOUS SYSTEM#0.9661;ENDOPEPTIDASE ACTIVITY#0.9661;ROSIGLITAZONE#0.9660;GLUCAGON SECRETION#0.9659;GLUCAGON RECEPTOR#0.9657;ORAL GLUCOSE TOLERANCE#0.9657;CELL PROLIFERATION#0.9655;SENSITIZER#0.9655;MYOCARDIUM#0.9652;VASCULAR DISEASE#0.9646;GENE EXPRESSION#0.9643;BLOOD GLUCOSE LEVEL#0.9642;WEIGHT LOSS#0.9640;ACTIVATED T LYMPHOCYTES#0.9640;SERIOUS ADVERSE EVENT#0.9640;HYPOGLYCEMIA#0.9639;GM-CSF#0.9638;APOPTOSIS#0.9635;STANDARD OF CARE#0.9631;ANTIOXIDANT ACTIVITY#0.9629;ARTERY#0.9628;WEIGHT GAIN#0.9624;HUMAN UMBILICAL VEIN#0.9624;GLUCOSE TOLERANCE TEST#0.9622;UMBILICAL VEIN#0.9622;NERVOUS SYSTEM#0.9620;BETA CELL#0.9619;LINEAR REGRESSION ANALYSIS#0.9619;INSULIN-LIKE GROWTH FACTOR#0.9616;SUCROSE#0.9615;TOXICITY#0.9614;STROMA#0.9612;PROXIMAL TUBULAR CELL#0.9612;HYPERTENSION#0.9607;FOLLICULAR ADENOMA#0.9605;SYSTOLIC BLOOD PRESSURE#0.9603;INSULIN SECRETION#0.9602;CUTANEOUS T CELL LYMPHOMA#0.9601;GLIPIZIDE#0.9598;CARDIOVASCULAR RISK FACTOR#0.9596;GASTROINTESTINAL TRACT#0.9596;HYPERGLYCEMIA#0.9595;INTIMA MEDIA THICKNESS#0.9594;BRAIN NATRIURETIC PEPTIDE#0.9588;MITIGLINIDE#0.9588;MIGLITOL#0.9583;CARDIOMYOPATHY#0.9582;UMBILICAL CORD#0.9579;LECTIN#0.9578;FIBROBLAST GROWTH FACTOR#0.9574;EDEMA#0.9568;CHANGE FROM BASELINE#0.9568;WHITE BLOOD CELL#0.9562;GASTRIC EMPTYING#0.9561;PERIODONTITIS#0.9545;GALECTIN#0.9544;T-CELL LEUKEMIA#0.9540;MODE OF ACTION#0.9540;B LYMPHOCYTE#0.9530;NPH INSULIN#0.9529;PARENCHYMA#0.9528;BODY WEIGHT GAIN#0.9524;COLORECTAL CARCINOMA#0.9523;EOSINOPHIL#0.9523;RESPONSE TO NUTRIENT#0.9513;LYMPHOCYTE PROLIFERATION#0.9511;PERIPHERAL BLOOD T-CELLS#0.9509;FRUCTOSE#0.9502;DEMENTIA#0.9499;FASTING PLASMA GLUCOSE#0.9498;GEOMETRIC MEAN RATIO#0.9492;PODOCYTE#0.9483;CORONARY HEART DISEASE#0.9477;HEPATOCYTE NUCLEAR FACTOR#0.9466;GLUTAMIC ACID#0.9461;HEPATITIS C VIRUS#0.9458;PARKINSON'S DISEASE#0.9458;ANGIOTENSIN RECEPTOR#0.9451;IL-2 PRODUCTION#0.9450;TOLL LIKE RECEPTOR#0.9445;ADJUSTED ODDS RATIO#0.9444;URINARY TRACT INFECTION#0.9438;TUMOR SUPPRESSOR#0.9434;ARGININE#0.9431;GLUTATHIONE#0.9422;BREAST CANCER CELL#0.9419;BONE MINERAL DENSITY#0.9416;STEM CELL MARKER#0.9414;NATEGLINIDE#0.9412;LYMPHOCYTIC LEUKEMIA#0.9407;PROTEIN KINASE C#0.9405;AUTOIMMUNITY#0.9403;LAF 237#0.9401;MYELOID LEUKEMIA#0.9394;MICROVILLI#0.9390;BILE DUCT#0.9389;NICOTINAMIDE#0.9388;MAST CELL#0.9383;BONE MARROW CELLS#0.9372;ASPARTATE#0.9369;EPIDERMAL GROWTH FACTOR#0.9368;ADENOSINE MONOPHOSPHATE#0.9366;HORMONE SECRETION#0.9362;CROHN'S DISEASE#0.9361;T LYMPHOCYTE ACTIVATION#0.9358;GROWTH FACTOR RECEPTOR#0.9355;MESOTHELIAL CELL#0.9348;PNEUMONIA#0.9343;OSTEOPOROSIS#0.9335;LYSOSOME#0.9322;TROPISM#0.9319;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9317;NEUROPATHY#0.9313;GRAFT VERSUS HOST#0.9307;ADENYLATE CYCLASE#0.9307;EXTRACELLULAR REGION#0.9299;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9297;NEURODEGENERATIVE DISEASE#0.9287;ANGIOTENSIN RECEPTOR BLOCKER#0.9286;PHOSPHODIESTERASE#0.9286;PHOSPHATASE ACTIVITY#0.9284;ENDOCRINE CELL#0.9284;MULTIPLE LINEAR REGRESSION#0.9282;TUMOUR NECROSIS FACTOR#0.9279;VISCERAL ADIPOSE TISSUE#0.9263;BLOOD BRAIN BARRIER#0.9261;L-ALANINE#0.9259;MESENCHYMAL STEM CELL#0.9256;ELECTRONIC MEDICAL RECORD#0.9250;XANTHINE OXIDASE#0.9240;SHORT BOWEL SYNDROME#0.9239;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9236;VASCULAR ENDOTHELIUM#0.9219;INTESTINAL MUCOSA#0.9209;C-LEVEL#0.9205;ENTEROENDOCRINE CELL#0.9201;VASCULAR CELL#0.9198;PLASMA PROTEIN#0.9194;ENDMT#0.9192;TIGHT JUNCTION#0.9188;ATRIAL FIBRILLATION#0.9187;PROTEIN KINASE A#0.9186;DERMATITIS#0.9182;HODGKIN'S LYMPHOMA#0.9181;METHIONINE#0.9171;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9168;UMBILICAL CORD BLOOD#0.9159;PIPERAZINE#0.9151;TROPHOBLAST#0.9150;SUPEROXIDE DISMUTASE#0.9142;VASCULAR SMOOTH MUSCLE CELL#0.9141;MEMBRANE FRACTION#0.9132;GLYCOGEN SYNTHASE KINASE#0.9128;CHONDROCYTE#0.9110;CONGESTIVE HEART FAILURE#0.9109;ALLERGEN#0.9099;ENDOTHELIAL NITRIC OXIDE#0.9098;MICROVASCULAR ENDOTHELIAL CELL#0.9095;SMOOTH MUSCLE ACTIN#0.9090;REPAGLINIDE#0.9085;GLYCINE#0.9074;AORTIC ANEURYSM#0.9074;ANTIGEN PRESENTING CELLS#0.9072;ABDOMINAL AORTIC ANEURYSM#0.9070;NASOPHARYNGITIS#0.9063;COLON CARCINOMA#0.9051;VIRULENCE#0.9050;HYPOXIC#0.9038;THYROID GLAND#0.9028;JOINT PAIN#0.9020;SIGNALLING PATHWAY#0.9012;KINASE INHIBITOR#0.9009;ADVERSE DRUG REACTION#0.8995;TH2 CELL#0.8993;RESPONSE TO GLUCOSE#0.8975;OPIOID PEPTIDE#0.8972;NEW ONSET DIABETES#0.8963;GESTATIONAL DIABETES#0.8954;SENESCENCE#0.8952;NORMAL GLUCOSE TOLERANCE#0.8950;TH17 CELL#0.8948;INSULIN RECEPTOR SUBSTRATE#0.8940;CHRONIC MYELOID LEUKEMIA#0.8934;NONALCOHOLIC FATTY LIVER DISEASE#0.8923;HIGH RISK PATIENTS#0.8918;CAROTID ARTERY#0.8915;INTERLEUKIN 2 RECEPTOR#0.8912;DOPAMINE#0.8884;ISCHEMIC HEART DISEASE#0.8872;STRIATUM#0.8867;TRANSFORMING GROWTH FACTOR BETA#0.8865;AMD3100#0.8854;FOAM CELL FORMATION#0.8851;MUTAGENESIS#0.8845;CATABOLISM#0.8843;ENDOSOME#0.8842;THYROID LESIONS#0.8833;PROTON PUMP#0.8825;INTENSIVE INSULIN THERAPY#0.8819;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8816;OPIOID RECEPTOR#0.8810;MOLECULAR DYNAMICS SIMULATION#0.8810;GLUCAGON RECEPTOR ANTAGONIST#0.8808;RESPONSE TO TREATMENT#0.8806;NATRIURESIS#0.8803;RENAL CELL CARCINOMA#0.8802;SEVERE COMBINED IMMUNODEFICIENCY#0.8796;VIRAL INFECTION#0.8796;GESTATIONAL DIABETES MELLITUS#0.8793;CALCIUM CHANNEL#0.8786;CIRCULATING ENDOTHELIAL PROGENITOR#0.8776;ADENYLATE#0.8771;T HELPER CELL#0.8763;BESTATIN#0.8756;TRANSFERRIN RECEPTOR#0.8753;GLUCOSE 6 PHOSPHATASE#0.8752;BASEMENT MEMBRANE#0.8750;ANOREXIA NERVOSA#0.8749;CELL CYCLE ARREST#0.8747;CELL ASSOCIATED#0.8745;VASODILATION#0.8723;VASCULAR ENDOTHELIAL CELL#0.8719;PHOSPHOLIPASE C#0.8715;RENAL CARCINOMA#0.8713;FORSKOLIN#0.8697;LUNG METASTASIS#0.8678;DUODENUM#0.8678;PAPILLARY THYROID CARCINOMA#0.8670;FLOW CYTOMETRY ANALYSIS#0.8669;EXOSOME#0.8669;CYCLOSPORINE#0.8667;HEMATOPOIETIC PROGENITOR CELL#0.8664;COAGULATION#0.8664;WHITE ADIPOSE TISSUE#0.8659;MYOFIBROBLAST#0.8658;IL-1RA#0.8655;5 FLUOROURACIL#0.8653;BLOOD PLASMA#0.8650;MESENCHYMAL CELL#0.8639;DECIDUAL CELL#0.8636;ALBUMIN CREATININE RATIO#0.8636;DIARRHEA#0.8631;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8616;CYCLIC AMP#0.8613;PROXIMAL TUBULE CELL#0.8605;CAPTOPRIL#0.8593;LEUKEMIC STEM CELL#0.8586;DNA METHYLATION#0.8585;ALKALINE PHOSPHATASE ACTIVITY#0.8573;NASAL MUCOSA#0.8572;HIGH CARDIOVASCULAR RISK#0.8570;NEPHRITIS#0.8558;SUBMANDIBULAR GLAND#0.8554;TREG CELL#0.8550;LYMPHOID TISSUE#0.8550;MEAN FLUORESCENCE INTENSITY#0.8537;LYMPHOBLAST#0.8537;BONE RESORPTION#0.8525;PRIMARY BILIARY CIRRHOSIS#0.8517;DOXORUBICIN#0.8515;MALIGNANT MESOTHELIOMA CELL#0.8510;COLLAGENASE#0.8508;KINASE ACTIVITY#0.8508;CELL BOUND#0.8504;INHALED INSULIN#0.8501;BETA-2#0.8498;DIFFERENTIATED THYROID CARCINOMA#0.8497;MALIGNANT PLEURAL MESOTHELIOMA#0.8493;OF DIABETIC RATS#0.8485;ENERGY HOMEOSTASIS#0.8453;DODECYL SULFATE#0.8450;VOMITING#0.8449;PROTON PUMP INHIBITOR#0.8449;ANGIOTENSINASE A#0.8447;ALDOSTERONE#0.8442;AUTOPHAGY#0.8436;SPINAL CORD#0.8435;BROMOCRIPTINE#0.8427;HEALTHY CONTROL SUBJECTS#0.8425;PIPERAZIN#0.8424;RESPONSE TO FOOD#0.8423;COMPLEX I#0.8416;SCHWANN CELL#0.8409;QUERCETIN#0.8404;PAPILLARY THYROID CANCER#0.8400;L-ARGININE#0.8396;PEPTIDYL DIPEPTIDASE A#0.8394;AMINOPEPTIDASE N ACTIVITY#0.8393;NEUROPROTECTION#0.8383;ZUCKER FATTY RATS#0.8382;M2 MACROPHAGE#0.8370;MULTIPLE LOGISTIC REGRESSION#0.8368;NADPH OXIDASE#0.8350;DEXAMETHASONE#0.8346;MESANGIAL CELL#0.8346;CYTOPLASM#0.8345;HEPATIC STELLATE CELL#0.8331;NOREPINEPHRINE#0.8315;FETAL LIVER#0.8313;ANAPLASTIC LARGE CELL LYMPHOMA#0.8308;MULTIPLE REGRESSION ANALYSIS#0.8306;MACROPHAGE MIGRATION#0.8276;PEPTIDYL DIPEPTIDASE#0.8262;OSTEOBLAST#0.8249;PORTAL VEIN#0.8248;TONSILLITIS#0.8245;FLUID RETENTION#0.8236;CISPLATIN#0.8223;AMINOPEPTIDASE ACTIVITY#0.8223;MULTIPLE MYELOMA#0.8221;ACINAR CELL#0.8219;SODIUM DODECYL SULFATE#0.8212;PRIMARY CARE PHYSICIAN#0.8209;THALASSEMIA#0.8205;TESTOSTERONE#0.8196;CYCLIN DEPENDENT KINASE#0.8188;LEFT ANTERIOR DESCENDING#0.8183;EFFECTOR T CELL#0.8172;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8171;OVAL CELL#0.8161;SUBCUTANEOUS ADIPOSE TISSUE#0.8154;EPITHELIAL MESENCHYMAL TRANSITION#0.8153;HYPOXIA INDUCIBLE FACTOR#0.8135;APICAL PLASMA MEMBRANE#0.8135;MELANOCYTE#0.8133;ASIALOGLYCOPROTEIN RECEPTOR#0.8131;VASOCONSTRICTION#0.8117;LIPOPROTEIN METABOLISM#0.8115;PREADIPOCYTE#0.8107;BODY WEIGHT REDUCTION#0.8102;GESTATION#0.8102;WORLD HEALTH ORGANIZATION#0.8100;VIRAL REPLICATION#0.8085;T-LYMPHOBLAST#0.8083;COLON ADENOCARCINOMA#0.8060;RETINOL BINDING#0.8043;HEPATOMA CELLS#0.8041;DECIDUA#0.8038;CC CHEMOKINE RECEPTOR#0.8036;SALIVARY GLAND#0.8030;APD668#0.8020;VASODILATOR#0.8006;N GLYCAN#0.7997;OSTEOARTHRITIS#0.7996;STEM CELL TRANSPLANTATION#0.7992;T CELL MIGRATION#0.7985;ADVERSE DRUG EVENT#0.7982;HYPERSENSITIVITY#0.7981;MACROPHAGE POLARIZATION#0.7971;LEUKOCYTE DIFFERENTIATION#0.7965;ESTRADIOL#0.7964;CYCLIC ADENOSINE MONOPHOSPHATE#0.7959;MITOCHONDRIA#0.7958;RETINOL#0.7948;KUPFFER CELL#0.7947;CEREBROVASCULAR DISEASE#0.7922;OBSTRUCTIVE SLEEP APNEA#0.7901;QUANTITATIVE REAL TIME#0.7901;SELECTIN#0.7886;LIVER DAMAGE#0.7886;SLEEP APNEA#0.7885;ALVEOLAR MACROPHAGE#0.7885;CYTOKINE SECRETION#0.7884;SURFACE PLASMON RESONANCE#0.7879;TISSUE REMODELING#0.7877;FASTING GLUCOSE LEVELS#0.7876;ALLERGIC ASTHMA#0.7869;PARENTERAL#0.7867;HUMAN SERUM ALBUMIN#0.7863;CELLULAR LOCALIZATION#0.7857;HUMAN INTESTINAL EPITHELIAL#0.7850;BENZOIC ACID#0.7846;LUNG DISEASE#0.7837;FERMENTATION#0.7836;EPITHELIAL OVARIAN CARCINOMA#0.7834;DIABETIC KETOACIDOSIS#0.7820;ADENOSINE DEAMINASE ACTIVITY#0.7818;END OF TREATMENT#0.7807;NEPHROTOXICITY#0.7800;ENALAPRIL#0.7796;URINARY PROTEIN#0.7794;PERIPHERAL BLOOD CELLS#0.7784;TOPOISOMERASE II#0.7780;BETA GLUCURONIDASE#0.7769;BLISTERING#0.7749;BONE FORMATION#0.7727;DIURESIS#0.7724;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.7722;TH1 CELL#0.7721;SIGNAL PEPTIDE#0.7718;ANOREXIA#0.7712;DEAMINASE ACTIVITY#0.7709;ISOLEUCINE#0.7698;HYPOTENSION#0.7695;MACROPHAGE INFLAMMATORY PROTEIN#0.7689;COGNITION#0.7680;INSULIN BIOSYNTHESIS#0.7669;SUCCINATE#0.7663;ALPHA AMYLASE#0.7661;TRIPEPTIDYL PEPTIDASE#0.7653;INTRACELLULAR TRANSPORT#0.7635;VIRAL RECEPTOR#0.7635;HEAT SHOCK PROTEIN#0.7634;SUCCINATE DEHYDROGENASE#0.7618;OSTEOCLAST#0.7616;RESPONSE SURFACE METHODOLOGY#0.7616;GLUCOKINASE ACTIVATOR#0.7601;PUROMYCIN#0.7594;ULCERATIVE COLITIS#0.7579;PALMITATE#0.7564;MYELOPEROXIDASE ACTIVITY#0.7561;DEXTRAN SULFATE SODIUM#0.7554;FATALITY#0.7551;FOLLICULAR THYROID CARCINOMA#0.7549;HEPATOTOXICITY#0.7548;MICROSOME#0.7536;VENOUS BLOOD#0.7515;BULIMIA NERVOSA#0.7509;PERCUTANEOUS CORONARY INTERVENTION#0.7502;SIGNALING MOLECULE#0.7490;CLINICAL PRACTICE GUIDELINE#0.7488;IMPAIRED FASTING GLUCOSE#0.7474;GLOMERULONEPHRITIS#0.7465;TCR COMPLEX#0.7465;ETHANOL#0.7452;TRYPTOPHAN#0.7450;UROKINASE#0.7444;LIVER CANCER#0.7432;VALSARTAN#0.7427;PERIPHERAL NERVE#0.7421;PERICYTE#0.7418;TOPOISOMERASE#0.7409;KIDNEY TRANSPLANT RECIPIENTS#0.7406;CYSTATIN#0.7404;ADIPOCYTE DIFFERENTIATION#0.7401;FRONTAL#0.7393;ISOPROTERENOL#0.7385;GLYCOGEN PHOSPHORYLASE#0.7384;COLLAGEN BINDING#0.7384;LIVER CIRRHOSIS#0.7374;HUMAN DERMAL FIBROBLAST#0.7373;ACE ACTIVITY#0.7373;GLUCONEOGENESIS#0.7372;RANDOM EFFECT MODEL#0.7367;CYTOTOXIC T-LYMPHOCYTE#0.7363;POTASSIUM CHANNEL#0.7359;CHOROID PLEXUS#0.7353;LIPOPROTEIN PARTICLE#0.7343;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.7341;CONDITIONAL LOGISTIC REGRESSION#0.7339;REGULATION OF GLUCOSE HOMEOSTASIS#0.7338;FACTOR XA#0.7314;BIOFILM FORMATION#0.7311;METHOTREXATE#0.7309;INSULINOMA#0.7307;DIABETIC FOOT ULCER#0.7306;ADULT T-CELL LEUKEMIA#0.7306;PHOSPHORAMIDON#0.7306;DEFINED DAILY DOSE#0.7298;PKC ACTIVITY#0.7295;CORTISOL#0.7292;MITOCHONDRIAL MEMBRANE#0.7283;BYETTA#0.7272;FLUOROURACIL#0.7261;FORMALIN#0.7248;HISTONE DEACETYLASE INHIBITOR#0.7248;HISTIDINE#0.7233;PEPTIDE TRANSPORTER#0.7221;GLOBIN#0.7218;ORLISTAT#0.7211;GRANULOSA CELL#0.7210;HISTONE DEACETYLASE#0.7200;CARBOHYDRATE METABOLISM#0.7194;INOSINE#0.7190;MICROVILLUS MEMBRANE#0.7188;LARYNGEAL CARCINOMA#0.7187;ALX-0600#0.7183;TACROLIMUS#0.7171;TISSUE DAMAGE#0.7159;EZETIMIBE#0.7156;POST-TRANSLATIONAL MODIFICATION#0.7150;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7148;PLATELET AGGREGATION#0.7133;LYSIS#0.7130;VITAMIN D3#0.7128;PERIODONTAL DISEASE#0.7120;MAP KINASE#0.7118;GLUCOSE TRANSPORT#0.7116;BETA GALACTOSIDASE#0.7112;TIGHT GLYCEMIC CONTROL#0.7094;ENCEPHALOMYELITIS#0.7092;GAP JUNCTION#0.7089;C TERMINAL DOMAIN#0.7084;INTESTINAL ABSORPTION#0.7083;LEPROSY#0.7059;ARRHYTHMIA#0.7059;RENAL ISCHEMIA REPERFUSION#0.7029;ORGANELLE#0.7024;PERIPHERAL ARTERIAL DISEASE#0.7002;EICOSAPENTAENOIC ACID#0.6986;TUBERCULOSIS#0.6972;ENDOMETRIUM#0.6966;INSULIN DETEMIR#0.6961;LIVER REGENERATION#0.6956;CONNEXIN#0.6946;HUMAN CORD BLOOD#0.6944;LACTIC ACID#0.6939;THROMBOSIS#0.6939;PEPTIDE METABOLISM#0.6938;URSODEOXYCHOLIC ACID#0.6936;LUNG ADENOCARCINOMA#0.6916;ELECTRONIC HEALTH RECORD#0.6908;LASER SCANNING MICROSCOPY#0.6899;B CELL LYMPHOMA#0.6899;T CELL DIFFERENTIATION#0.6895;GLIAL CELL#0.6894;MAGNETIC RESONANCE IMAGING#0.6888;ADIPOGENESIS#0.6886;BODY WEIGHT LOSS#0.6886;BLOOD RETINAL BARRIER#0.6882;CANNABINOID RECEPTOR#0.6881;ERYTHROCYTE#0.6865;HUMAN LEUKOCYTE ANTIGEN#0.6862;TH1 IMMUNE RESPONSE#0.6859;COLESEVELAM#0.6835;SYNCYTIOTROPHOBLAST#0.6835;MULTIDRUG RESISTANCE PROTEIN#0.6832;BERBERINE#0.6830;COMMON CAROTID ARTERY#0.6828;SURFACE EPITHELIUM#0.6828;LARGE INTESTINE#0.6828;INTESTINAL TRACT#0.6813;SEMINAL VESICLE#0.6809;PHOSPHODIESTERASE I#0.6805;DRUG METABOLISM#0.6805;CELIAC DISEASE#0.6800;ADHERENS JUNCTION#0.6784;GRAVES' DISEASE#0.6783;PROTEIN KINASE B#0.6778;LASER DESORPTION IONIZATION#0.6772;HEPATITIS B#0.6758;GINGIVA#0.6755;PARATHYROID HORMONE#0.6742;PROTEIN SYNTHESIS#0.6740;8-HYDROXY-2'-DEOXYGUANOSINE#0.6733;POST MARKETING SURVEILLANCE#0.6732;GLUCOSE REABSORPTION#0.6719;URACIL#0.6711;CASE FATALITY RATE#0.6709;INTENTION TO TREAT#0.6703;CORONARY ARTERY LIGATION#0.6700;SKIN FIBROBLASTS#0.6695;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6690;MONOCYTE CHEMOTACTIC PROTEIN#0.6686;TUBULAR EPITHELIAL CELL#0.6684;HIGH MOBILITY GROUP#0.6683;RAPAMYCIN#0.6678;CELL MOTILITY#0.6676;FATTY ACID BINDING#0.6675;URETERAL OBSTRUCTION#0.6673;ADENOSINE TRIPHOSPHATE#0.6673;72-HOURS#0.6671;LYSINE#0.6671;ANTIGEN PRESENTATION#0.6667;DUCT CELL#0.6666;IMMUNOGLOBULIN G#0.6662;HUMAN BREAST CANCER#0.6653;TOPICAL#0.6650;CHEMOKINE ACTIVITY#0.6645;PYY3-36#0.6644;LUPUS NEPHRITIS#0.6637;PROTEASE ACTIVATED RECEPTOR#0.6632;DEPRESSIVE SYMPTOMS#0.6626;PROSTATE SPECIFIC ANTIGEN#0.6622;CHRONIC HEART FAILURE#0.6621;BRONCHIAL EPITHELIAL CELLS#0.6619;LUNG DEVELOPMENT#0.6608;ORAL SQUAMOUS CELL CARCINOMA#0.6598;PULMONARY FIBROSIS#0.6598;ACID SECRETION#0.6585;ANCHORING#0.6579;HYPERCHOLESTEROLEMIA#0.6556;SWELLING#0.6555;PLATELET ACTIVATING FACTOR#0.6545;AND VISCERAL FAT#0.6536;HEME OXYGENASE 1#0.6500;LEISHMANIASIS#0.6486;INDUCED RENAL INJURY#0.6484;ROS GENERATION#0.6481;PHOSPHOENOLPYRUVATE#0.6474;HEMATOPOIETIC CELL TRANSPLANTATION#0.6466;C CHEMOKINE RECEPTOR#0.6463;MYOCARDIAL INFARCT SIZE#0.6458;GINGIVAL CREVICULAR FLUID#0.6456;TRANSCRIPTASE#0.6455;ADENINE#0.6450;RIMONABANT#0.6449;HUMAN ADIPOSE TISSUE#0.6447;IL-6 PRODUCTION#0.6444;ACETAMINOPHEN#0.6432;ACUTE LUNG INJURY#0.6427;KIDNEY DAMAGE#0.6427;TRANSCYTOSIS#0.6417;NEURAL CELL#0.6416;STEROL REGULATORY ELEMENT#0.6409;SIZE EXCLUSION CHROMATOGRAPHY#0.6405;TETRAHYDROPYRAN#0.6404;ALLERGIC REACTION#0.6401;BREAST CARCINOMA#0.6398;CYTOTOXIC T CELL#0.6387;CYCLIN DEPENDENT KINASE INHIBITOR#0.6377;HISTAMINE#0.6375;HEPATOCYTE GROWTH FACTOR#0.6368;QUANTITATIVE REVERSE TRANSCRIPTION#0.6364;TRANSMISSION ELECTRON MICROSCOPY#0.6362;REGULATION OF GLUCOSE METABOLISM#0.6362;MANNOSIDASE I#0.6361;LIPOGENESIS#0.6359;CELL DIVISION#0.6355;PROGRAMMED CELL DEATH#0.6345;DIISOPROPYL FLUOROPHOSPHATE#0.6333;GASTRIC BYPASS SURGERY#0.6329;TEDUGLUTIDE#0.6320;ACETYLCHOLINE#0.6312;LIVER DEVELOPMENT#0.6305;CD4+ MEMORY T CELL#0.6305;EUGLYCEMIC HYPERINSULINEMIC CLAMP#0.6302;SUCRASE ACTIVITY#0.6293;CYTOTROPHOBLAST#0.6292;HEALTH CARE SYSTEM#0.6287;FAMILIAL PARTIAL LIPODYSTROPHY TYPE 2#0.6277;ARTERIOLE#0.6271;GALLBLADDER#0.6270;ACUTE LIVER INJURY#0.6269;HYDROXYPROLINE#0.6268;IMMUNOGLOBULIN PRODUCTION#0.6267;SKELETON#0.6255;CONSTRICTION#0.6254;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6251;PULSE WAVE VELOCITY#0.6247;BIOTIN#0.6241;DIAZEPAN#0.6233;COLLAGEN SYNTHESIS#0.6227;PARATHYROID#0.6224;IMMUNOSUPPRESSANT#0.6221;CYTOPLASMIC REGION#0.6214;RANDOMIZED CONTROL TRIAL#0.6212;PROTEIN DATA BANK#0.6201;INTENSIVE CARE UNIT#0.6195;COENZYME A#0.6192;BONE TURNOVER MARKER#0.6189;NUCLEIC ACID#0.6184;BENZIMIDAZOLE#0.6182;PERIPHERAL ARTERY DISEASE#0.6180;TARGET OF RAPAMYCIN#0.6179;CONSTIPATION#0.6178;NEURONAL CELLS#0.6172;INSULIN RESISTANCE INDEX#0.6166;FACTOR I#0.6166;ASTROCYTE#0.6159;PURINE METABOLISM#0.6158;CELL PHYSIOLOGY#0.6153;SEVERE ACUTE RESPIRATORY SYNDROME#0.6152;LUNG CARCINOMA#0.6146;CHYLOMICRON#0.6133;FLOW MEDIATED DILATION#0.6133;WARFARIN#0.6131;DISEASE ACTIVITY SCORE#0.6130;RENAL TRANSPLANT RECIPIENTS#0.6127;SIMVASTATIN#0.6126;NAIVE T CELL#0.6124;ENDOCYTOSIS#0.6119;HYPERTHERMIA#0.6118;CARRIE#0.6112;BROWN ADIPOSE TISSUE#0.6106;GENISTEIN#0.6106;HUMAN EMBRYONIC KIDNEY#0.6098;EMBRYONIC KIDNEY#0.6094;GLUTAMINE#0.6091;RETINOIC ACID#0.6089;ACETIC ACID#0.6087;ALPHA 1-ANTITRYPSIN#0.6084;CORD BLOOD TRANSPLANTATION#0.6080;URINE ALBUMIN EXCRETION#0.6074;MYELOID CELL#0.6070;BRAIN DAMAGE#0.6069;FIBRONECTIN BINDING#0.6069;TO FIRST TREATMENT#0.6065;TRANSIENT CEREBRAL ISCHEMIA#0.6059;GLOMERULAR EPITHELIAL CELL#0.6050;HORMONE METABOLISM#0.6049;INTESTINAL DISEASE#0.6037;SYNAPTIC MEMBRANE#0.6036;TYROSINE KINASE INHIBITOR#0.6030;HEPATIC FAT CONTENT#0.6018;MYOPATHY#0.6016;LACTIC ACIDOSIS#0.6012
1804	DIPEPTIDYL PEPTIDASE#1.0512;POTASSIUM CHANNEL#1.0406;AMYOTROPHIC LATERAL SCLEROSIS#0.9747;LATERAL SCLEROSIS#0.9747;NERVOUS SYSTEM#0.9148;FIBROBLAST ACTIVATION PROTEIN#0.8565;FIBROBLAST ACTIVATION#0.8488;DIPEPTIDYL PEPTIDASE IV#0.8213;CELL SURFACE#0.8072;AUTOSOMAL DOMINANT MICROCEPHALY#0.8003;ACTION POTENTIAL#0.7750;CELL DEATH#0.7606;CENTRAL NERVOUS SYSTEM#0.7499;MAP KINASE#0.7378;GERM CELL#0.7200;GLYCINE RECEPTOR#0.7146;GLUTAMIC ACID#0.7022;GLUTAMATE RECEPTOR#0.7011;OOCYTE#0.7008;GENE EXPRESSION#0.6927;STIFF PERSON SYNDROME#0.6403;CELL ADHESION#0.6326;LONG QT SYNDROME#0.6137;DIARRHEA#0.6068
1805	TRAMP COMPLEX#1.1277;EXOSOME#1.0582;GROWTH FACTOR#1.0293;EXTRACELLULAR MATRIX#1.0286;RNA SURVEILLANCE#1.0279;TRANSFORMING GROWTH FACTOR#1.0223;GENE EXPRESSION#0.9864;RNA BINDING#0.9478;RNA HELICASE#0.9460;PROSTATE CANCER#0.9439;RNA DEGRADATION#0.9211;NUCLEAR RNA SURVEILLANCE#0.9086;CELL ADHESION#0.8865;PROTEOGLYCAN#0.8662;WOUND HEALING#0.8466;FIBRIL#0.8260;RNA PROCESSING#0.7997;CELL PROLIFERATION#0.7897;EXTRACELLULAR MATRIX COMPONENT#0.7795;TRANSFORMING GROWTH FACTOR BETA#0.7570;DERMIS#0.7252;RNA BINDING PROTEIN#0.7226;LEIOMYOMA#0.7203;CANCER CELL#0.7027;MYOCARDIAL INFARCTION#0.6799;BUDDING#0.6680;EXOSOME MEDIATED#0.6573;SNORNA PROCESSING#0.6517;KERATINOCYTE#0.6354;STROMA#0.6350;COMPLEX I#0.6298;DNA METHYLATION#0.6158;IMMUNE RESPONSE#0.6102;SKIN FIBROBLASTS#0.6079;POLYMERASE CHAIN REACTION#0.6029
1806	PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE#1.0890;BETA UREIDOPROPIONASE#1.0797;DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY#1.0677;OROTATE PHOSPHORIBOSYLTRANSFERASE#1.0571;URIDINE PHOSPHORYLASE#1.0400;THYMIDINE PHOSPHORYLASE#1.0359;PYRIMIDINE METABOLISM#1.0358;ESOPHAGEAL CANCER#1.0318;GLUTATHIONE#1.0317;THYMIDYLATE SYNTHASE#1.0290;THYMIDYLATE#1.0277;CATABOLISM#1.0275;TUMOR TISSUES#1.0272;BETA-ALANINE#1.0261;EPIDERMAL GROWTH FACTOR#1.0255;THYMIDINE#1.0251;QUANTITATIVE REAL TIME#1.0239;5-FLUOROURIDINE#1.0235;REVERSE TRANSCRIPTION#1.0234;URIDINE#1.0230;OPRT ACTIVITY#1.0230;GROWTH FACTOR RECEPTOR#1.0227;THYMIDINE KINASE#1.0224;RESPONSE TO 5-FLUOROURACIL#1.0223;LUNG CANCER#1.0180;THYMINE#1.0167;POLYMERASE CHAIN REACTION#1.0164;CIRCADIAN RHYTHM#1.0158;CYTOCHROME P450#1.0153;ENZYME ACTIVITY#1.0147;COLORECTAL CARCINOMA#1.0144;GROWTH FACTOR#1.0125;LIVER METASTASIS#1.0110;ADVANCED COLORECTAL CANCER#1.0100;DISEASE FREE SURVIVAL#1.0063;PANCREATIC CANCER#1.0059;HEPATOCELLULAR CARCINOMA#1.0044;ADVANCED GASTRIC CANCER#1.0041;OXONATE#1.0039;PERIPHERAL BLOOD MONONUCLEAR CELLS#1.0037;QUANTITATIVE REVERSE TRANSCRIPTION#1.0032;CAPECITABINE#1.0026;ORAL SQUAMOUS CELL CARCINOMA#1.0023;DNA REPAIR#1.0018;TUMOR CELLS#1.0012;ALANINE#1.0012;GASTROINTESTINAL TRACT#1.0010;MONONUCLEAR CELLS#1.0008;SQUAMOUS CELL CARCINOMA#1.0005;LYMPH NODE METASTASIS#1.0001;URACIL#0.9998;METASTATIC COLORECTAL CANCER#0.9993;PERIPHERAL BLOOD#0.9976;HEAD AND NECK CANCER#0.9961;NECK CANCER#0.9961;GENE EXPRESSION#0.9957;2'-DEOXYURIDINE#0.9937;FLUOROURACIL#0.9936;TOXICITY#0.9936;THIOPURINE S METHYLTRANSFERASE#0.9934;5 FLUOROURACIL#0.9934;IRINOTECAN#0.9925;LEUCOVORIN#0.9924;S METHYLTRANSFERASE#0.9906;COLON CANCER#0.9905;OXALIPLATIN#0.9893;ADJACENT NORMAL TISSUE#0.9889;LYMPH NODE#0.9887;CYTOTOXICITY#0.9886;COLORECTAL CANCER#0.9883;BREAST CANCER#0.9883;COLORECTAL#0.9878;CELL CYCLE#0.9870;ENDOTHELIAL GROWTH FACTOR#0.9869;BREAST CANCER PATIENTS#0.9867;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9864;HAND FOOT SYNDROME#0.9862;ADENOCARCINOMA#0.9854;FORMALIN#0.9841;CANCER CELL#0.9825;CELL PROLIFERATION#0.9815;TRANSCRIPTASE#0.9814;MUCOSITIS#0.9800;CISPLATIN#0.9773;DIPHOSPHATE#0.9735;COLON CARCINOMA#0.9728;NEUTROPENIA#0.9703;DIARRHEA#0.9690;LASER CAPTURE MICRODISSECTION#0.9689;APOPTOSIS#0.9674;BONE MARROW#0.9672;OVARIAN CANCER#0.9669;PACLITAXEL#0.9639;RECURRENCE FREE SURVIVAL#0.9638;VOMITING#0.9625;CYTIDINE#0.9529;GEMCITABINE#0.9499;CPT-11#0.9489;CYTIDINE DEAMINASE#0.9479;DRUG RESISTANCE#0.9431;FOLINIC ACID#0.9392;STOMATITIS#0.9383;EQUILIBRATIVE NUCLEOSIDE TRANSPORTER#0.9377;CERVICAL#0.9372;GLYCERALDEHYDE-3-PHOSPHATE#0.9364;MAXIMUM TOLERATED DOSE#0.9307;CELL GROWTH#0.9209;NEUROTOXICITY#0.9185;MEDIAN SURVIVAL TIME#0.9149;PROSTATE CANCER#0.9143;FOLATE#0.9055;OVARIAN#0.9031;DNA SYNTHESIS#0.9017;DRUG METABOLISM#0.8925;TOPOISOMERASE#0.8876;EPITHELIAL OVARIAN CANCER#0.8834;MOLAR#0.8824;METASTATIC BREAST CANCER#0.8737;TIME TO PROGRESSION#0.8548;XELODA#0.8536;DOCETAXEL#0.8536;NUCLEIC ACID#0.8511;OVERALL RESPONSE RATE#0.8501;FDURD#0.8468;DIHYDROFOLATE REDUCTASE#0.8426;OBJECTIVE RESPONSE RATE#0.8404;ADVERSE DRUG REACTION#0.8361;RENAL CELL CARCINOMA#0.8307;ANABOLISM#0.8302;PERIPHERAL MONONUCLEAR CELLS#0.8205;STANDARD OF CARE#0.8204;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8200;BILIARY TRACT#0.8160;LYMPH NODE METASTASES#0.8128;RALTITREXED#0.8096;APOPTOTIC#0.8095;PYRIMIDINE SALVAGE#0.8082;THROMBOCYTOPENIA#0.8080;MERCAPTOPURINE#0.8078;ADVANCED PANCREATIC CANCER#0.8047;MRNA SPLICING#0.8012;HIGH RESOLUTION MELTING#0.7983;BEVACIZUMAB#0.7975;CETUXIMAB#0.7946;FLAVIN#0.7921;S PHASE#0.7915;LEUKOPENIA#0.7889;OXONIC ACID#0.7843;QUANTITATIVE REVERSE TRANSCRIPTASE#0.7832;LUNG ADENOCARCINOMA#0.7803;BREAST CARCINOMA#0.7792;YEAR SURVIVAL RATE#0.7786;STROMAL CELL#0.7747;URACIL CATABOLISM#0.7738;ANOREXIA#0.7728;COMPLEMENTATION GROUP 1#0.7723;N ACETYLTRANSFERASE#0.7571;SEVERE ADVERSE EVENTS#0.7561;BILIARY TRACT CANCER#0.7530;EXCRETION#0.7451;GASTROINTESTINAL CARCINOMA#0.7438;LIVER DAMAGE#0.7395;5-IODOURACIL#0.7372;GALLBLADDER#0.7370;MEDIAN OVERALL SURVIVAL#0.7352;FRAGMENT LENGTH POLYMORPHISM#0.7351;VARICELLA ZOSTER VIRUS#0.7324;TRANSCRIPTION FACTOR#0.7298;DOSE LIMITING TOXICITIES#0.7291;INTRAHEPATIC CHOLANGIOCARCINOMA#0.7288;NUCLEOTIDE METABOLISM#0.7284;DEVELOPMENTAL DELAY#0.7247;METASTATIC GASTRIC CANCER#0.7215;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7174;BODY SURFACE AREA#0.7145;ANEMIA#0.7121;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7075;MECHANISM OF ACTION#0.7062;6-MERCAPTOPURINE#0.7039;ESOPHAGUS#0.6982;CATALYTIC ACTIVITY#0.6975;AUTOSOMAL RECESSIVE DISEASE#0.6903;RESPONSE TO FLUOROURACIL#0.6884;HERPES ZOSTER#0.6852;CYCLOPHOSPHAMIDE#0.6841;PANCREATIC ADENOCARCINOMA#0.6796;ADVANCED BREAST CANCER#0.6763;CERVICAL CANCER#0.6661;CYTOSINE DEAMINASE#0.6657;TETRAHYDROFOLATE#0.6564;PANCREATIC CARCINOMA#0.6495;GASTRIC ADENOCARCINOMA#0.6488;XANTHINE#0.6481;ELECTRON TRANSFER#0.6450;HUMAN BREAST CANCER#0.6426;DOUBLE STRAND BREAK#0.6425;TAMOXIFEN#0.6397;THERAPEUTIC DRUG MONITORING#0.6362;GALLBLADDER CANCER#0.6350;METHOTREXATE#0.6311;TOPICAL#0.6301;MITOMYCIN C#0.6299;ADENINE#0.6283;5-FLUORO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE#0.6265;WHITE BLOOD CELL#0.6247;CYTOPLASM#0.6245;SYNCHRONOUS LIVER METASTASES#0.6223;BONE MARROW CELLS#0.6222;HEPATIC ARTERY#0.6186;FLUORODEOXYURIDINE#0.6166;OVARIES#0.6161;ANGIOGENESIS#0.6121;URIDINE KINASE#0.6054;CHOLANGIOCARCINOMA#0.6037;FINE NEEDLE ASPIRATION#0.6026;ALDEHYDE OXIDASE#0.6025;PYRIMIDINE BINDING#0.6009
1807	BETA UREIDOPROPIONASE#1.1314;BETA-ALANINE#1.0498;HYDANTOIN#1.0447;CREATINE KINASE#1.0303;5 FLUOROURACIL#1.0038;ALANINE#1.0012;HEAT SHOCK PROTEIN#1.0011;CREATINE#0.9841;ENZYME ACTIVITY#0.9822;URACIL#0.9759;TOXICITY#0.9735;ICRF-187#0.9605;FLUOROURACIL#0.9522;DEXRAZOXANE#0.9398;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8988;NERVOUS SYSTEM#0.8537;CATABOLISM#0.8305;ALZHEIMER'S DISEASE#0.8220;GLYCERALDEHYDE-3-PHOSPHATE#0.8098;ATP SYNTHASE#0.7742;MALATE DEHYDROGENASE#0.7697;LYSINE#0.7659;URACIL CATABOLISM#0.7519;THYMINE#0.7361;GUANINE#0.7281;PYRUVATE#0.7259;GLUTAMATE DEHYDROGENASE#0.7170;UBIQUITIN#0.7081;RELATED PROTEIN 1#0.7004;FRUCTOSE BISPHOSPHATE ALDOLASE#0.6781;NUCLEOTIDE BINDING#0.6773;PYRIMIDINE METABOLISM#0.6561;DIHYDROOROTIC ACID#0.6402;PYRUVATE KINASE#0.6349;CATALYTIC ACTIVITY#0.6246;PROTEIN KINASE#0.6238;GENE EXPRESSION#0.6142;COENZYME A#0.6116;SUPEROXIDE DISMUTASE#0.6063
1808	MICROTUBULE ASSEMBLY#1.0882;LACOSAMIDE#1.0864;SUMOYLATION#1.0547;GROWTH CONE COLLAPSE#1.0497;DENDRITIC SPINE#1.0440;MICROTUBULE#1.0385;GROWTH CONE#1.0355;PROTEIN KINASE#1.0333;NEURITE OUTGROWTH#1.0321;NEURITE#1.0302;CALCIUM CHANNEL#1.0301;KINESIN#1.0299;AXON GUIDANCE#1.0253;OPTIC NERVE#1.0253;GLYCOGEN SYNTHASE KINASE#1.0245;AXON GROWTH#1.0222;REGENERATION#1.0198;SPINAL CORD#1.0187;SODIUM CHANNEL#1.0177;CYCLIN DEPENDENT KINASE#1.0175;MICROTUBULE DYNAMICS#1.0167;SIGNALING PATHWAY#1.0116;ALZHEIMER'S DISEASE#1.0112;T LYMPHOCYTE#1.0091;NEUROFIBRILLARY TANGLE#1.0080;NEURITE GROWTH#1.0048;DORSAL ROOT GANGLION#0.9977;MICROTUBULE ASSOCIATED PROTEIN#0.9966;POST-TRANSLATIONAL MODIFICATION#0.9961;NERVOUS SYSTEM#0.9750;HYPERPHOSPHORYLATION#0.9723;ISCHEMIA#0.9634;CENTRAL NERVOUS SYSTEM#0.9593;GROWTH FACTOR#0.9566;NEURONAL CELLS#0.9497;UBIQUITIN#0.9490;ION CHANNEL#0.9436;AXON REGENERATION#0.9407;CELL MIGRATION#0.9241;HEAT SHOCK PROTEIN#0.9221;NEURODEGENERATIVE DISEASE#0.9214;CEREBRAL ISCHEMIA#0.9191;GENE EXPRESSION#0.9076;BRAIN DEVELOPMENT#0.8980;MIDDLE CEREBRAL ARTERY#0.8973;CEREBRAL ARTERY#0.8970;APOPTOSIS#0.8969;CEREBRAL CORTEX#0.8966;OPTIC NERVE INJURY#0.8958;DEPHOSPHORYLATION#0.8776;CEREBRAL ARTERY OCCLUSION#0.8696;SEVOFLURANE#0.8660;MICROTUBULE BINDING#0.8652;NEUROTRANSMITTER RELEASE#0.8650;LYMPHOCYTE MIGRATION#0.8640;ARTERY#0.8501;PROTEIN KINASE B#0.8500;NEUROBLASTOMA#0.8456;AMYLOID PRECURSOR PROTEIN#0.8436;NEUROPROTECTION#0.8420;TRAUMATIC BRAIN INJURY#0.8401;OLIGODENDROCYTE#0.8336;T CELL#0.8324;NEUROGENESIS#0.8310;CELL PROLIFERATION#0.8282;SIGNAL TRANSDUCTION#0.8279;BINDING PROTEIN 1#0.8278;MICROTUBULE POLYMERIZATION#0.8255;AXONAL TRANSPORT#0.8232;NEURITE FORMATION#0.8222;LITHIUM#0.8031;PROTEIN PROTEIN INTERACTION#0.7981;NEURONAL MIGRATION#0.7975;NMDA RECEPTOR#0.7890;MICROTUBULE FORMATION#0.7880;SPINAL CORD INJURY#0.7862;NEUROPATHY#0.7788;NEUROLOGICAL DISORDER#0.7699;RETINAL GANGLION CELL#0.7670;EPILEPSY#0.7661;CELL DEATH#0.7661;BRAIN DAMAGE#0.7632;MITOGEN ACTIVATED PROTEIN#0.7550;HYPERSENSITIVITY#0.7531;BIPOLAR DISORDER#0.7485;SYNAPTIC TRANSMISSION#0.7464;MODE OF ACTION#0.7458;CONDITIONED PLACE PREFERENCE#0.7409;ASPARTATE#0.7344;ENDOCYTOSIS#0.7191;NEUROTOXICITY#0.7167;T LYMPHOCYTE MIGRATION#0.7118;MORPHOGENESIS#0.7095;CYTOPLASM#0.7023;DEMENTIA#0.6911;NEURAL CELL#0.6908;STEM CELL#0.6905;RETINOIC ACID#0.6887;NEURITE EXTENSION#0.6884;MULTIPLE SCLEROSIS#0.6879;NERVE GROWTH FACTOR#0.6813;HYPOXIC#0.6810;CELL ADHESION#0.6785;KINASE ACTIVITY#0.6770;REPULSIVE GUIDANCE MOLECULE#0.6766;POSTTRANSLATIONAL MODIFICATION#0.6745;CANCER CELL#0.6683;STRIATUM#0.6667;NEUROTRANSMISSION#0.6533;DENDRITIC SPINE DEVELOPMENT#0.6399;VESICLE TRAFFICKING#0.6361;RAPAMYCIN#0.6361;PROPOFOL#0.6348;DYNEIN#0.6315;PLASMA MEMBRANE#0.6287;LUNG CANCER#0.6257;INHIBITION OF GSK#0.6239;POLYMERASE CHAIN REACTION#0.6202;MECHANISM OF ACTION#0.6191;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6068;GAP ACTIVITY#0.6050;CELL ADHESION MOLECULE#0.6037;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6031
1809	PROSTATE CANCER#1.0353;GROWTH CONE#1.0155;CANCER CELL#1.0019;NEURITE#0.9760;NERVOUS SYSTEM#0.9757;CELL ADHESION#0.9651;SPINAL CORD#0.9595;NEURITE OUTGROWTH#0.9419;APICAL DENDRITE#0.9379;GENE EXPRESSION#0.8998;MICROTUBULE#0.8817;REGENERATION#0.8482;PRIMARY CORTICAL NEURON#0.8329;CELL PROLIFERATION#0.8214;IMMATURE NEURON#0.8122;SPINAL CORD INJURY#0.8065;ACTIN CYTOSKELETON#0.8043;SIGNALING PATHWAY#0.8036;PANCREATIC CANCER#0.8024;INFLAMMATORY RESPONSE#0.7501;DENTATE GYRUS#0.7351;NEUROGENESIS#0.7313;CEREBRAL CORTEX#0.7218;GROWTH CONE COLLAPSE#0.7055;GLYCOGEN SYNTHASE KINASE#0.7031;LYMPH NODE#0.6985;SCIATIC NERVE#0.6918;CENTRAL NERVOUS SYSTEM#0.6746;AXON GROWTH#0.6717;CELL ADHESION MOLECULE#0.6602;CELL MIGRATION#0.6588;CELL DEATH#0.6562;AXON GUIDANCE#0.6504;PROGENITOR CELL#0.6394;STRIATUM#0.6380;ACTIN BUNDLING#0.6253;NEUROBLASTOMA#0.6240;ISCHEMIA#0.6211;LUNG CANCER#0.6138;LIVER METASTASIS#0.6128;DORSAL ROOT GANGLION#0.6040;FOCAL ADHESION#0.6016
1810	TBP BINDING#1.0356;TRANSCRIPTION FACTOR#1.0080;T CELL#0.9914;PREINITIATION COMPLEX#0.9869;RHEUMATOID ARTHRITIS#0.9856;GENE EXPRESSION#0.8783;DNA BINDING#0.8263;C TERMINAL DOMAIN#0.6860;CELL PROLIFERATION#0.6071
1811	INTESTINAL EPITHELIAL CELL#1.0539;EPITHELIAL CELL#1.0256;DIARRHEA#1.0254;CYSTIC FIBROSIS#1.0179;LUMINAL#0.9853;GENE EXPRESSION#0.9809;COLITIS#0.9534;ANION TRANSPORT#0.9532;PLASMA MEMBRANE#0.9335;BRUSH BORDER#0.9195;ULCERATIVE COLITIS#0.9193;SMALL INTESTINE#0.8936;ENTEROCYTE#0.8691;OOCYTE#0.8633;BRUSH BORDER MEMBRANE#0.8286;GOBLET CELL#0.8254;PENDRED SYNDROME#0.8176;ION TRANSPORT#0.8117;OXALATE TRANSPORT#0.8045;CELL SURFACE#0.8037;DIASTROPHIC DYSPLASIA#0.7678;SULFATE TRANSPORT#0.7663;SPERM CAPACITATION#0.7565;INFLAMMATORY BOWEL DISEASE#0.7337;EPIDIDYMIS#0.7236;DUODENUM#0.6982;DEHYDRATION#0.6968;POLYMERASE CHAIN REACTION#0.6780;ADENOCARCINOMA#0.6585;SECRETORY DIARRHEA#0.6470;LARGE INTESTINE#0.6433;CONSTIPATION#0.6376;GLYCOSYLATION#0.6301;CANCER CELL#0.6284;PROTEIN KINASE#0.6200;ENAMEL ORGAN#0.6176;PDZ BINDING MOTIF#0.6156;ANION CHANNEL#0.6110;SEMINAL VESICLE#0.6019
1812	DOPAMINE RECEPTOR D1#1.0621;DOPAMINE D1 RECEPTOR#1.0348;FENOLDOPAM#1.0345;DOPAMINE#1.0255;MEDIUM SPINY NEURONS#1.0135;RECEPTOR BINDING#1.0108;CLOZAPINE#1.0106;RNA-DIRECTED DNA METHYLATION#1.0094;RECEPTOR LIGAND#1.0085;RECEPTOR ANTAGONIST#1.0083;ADENOSINE#1.0078;SUBSTANCE P#1.0072;SULPIRIDE#1.0067;BIPOLAR DISORDER#1.0041;DOPAMINE D2 RECEPTOR#1.0036;RECEPTOR AGONIST#1.0034;METHAMPHETAMINE#1.0009;CYCLIC AMP#0.9998;ADENYLATE CYCLASE#0.9991;PROTEIN KINASE A#0.9983;AMYGDALA#0.9976;L-DOPA#0.9972;CYCLASE ACTIVITY#0.9962;DNA METHYLATION#0.9961;AMPA RECEPTOR#0.9955;ETHANOL#0.9951;HALOPERIDOL#0.9939;OPIOID RECEPTOR#0.9925;POSITRON EMISSION TOMOGRAPHY#0.9923;HYPERTENSION#0.9921;ADENYLATE#0.9921;ACETYLCHOLINE#0.9920;DYSKINESIA#0.9919;SIGNAL TRANSDUCTION#0.9912;ADENYLYL CYCLASE ACTIVITY#0.9912;MEDIAL PREFRONTAL CORTEX#0.9909;APOMORPHINE#0.9898;MOTOR ACTIVITY#0.9893;NMDA RECEPTOR#0.9882;SENSITIZATION#0.9881;ASPARTATE#0.9872;POLYMERASE CHAIN REACTION#0.9859;SUBSTANTIA NIGRA#0.9817;CONDITIONED PLACE PREFERENCE#0.9812;SCOPOLAMINE#0.9811;RECEPTOR ACTIVITY#0.9809;CAUDATE NUCLEUS#0.9809;DOPAMINE RECEPTOR#0.9784;FORSKOLIN#0.9779;GENE EXPRESSION#0.9774;PROTEIN KINASE#0.9768;BASAL GANGLIA#0.9764;SIGNALING PATHWAY#0.9736;HYPERACTIVITY#0.9725;STRIATUM#0.9719;TRANSCRIPTION FACTOR#0.9715;GLUTAMATE RECEPTOR#0.9715;MU OPIOID RECEPTOR#0.9706;LOCOMOTION#0.9704;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9697;PROTEIN KINASE C#0.9685;RESERPINE#0.9684;NEUROTRANSMISSION#0.9670;FRONTAL#0.9667;ADRENERGIC RECEPTOR#0.9659;CEREBRAL CORTEX#0.9629;HEROIN#0.9628;PARKINSON'S DISEASE#0.9623;ACETYLCHOLINE RECEPTOR#0.9593;FOREBRAIN#0.9567;DOPAMINERGIC NEURON#0.9552;NERVOUS SYSTEM#0.9547;COGNITION#0.9539;CENTRAL NERVOUS SYSTEM#0.9509;DOPAMINE D3 RECEPTOR#0.9492;NOREPINEPHRINE#0.9488;PRAZOSIN#0.9479;RESPONSE TO DOPAMINE#0.9448;SEROTONIN RECEPTOR#0.9418;CYCLIC ADENOSINE MONOPHOSPHATE#0.9393;CHROMATIN REMODELING#0.9377;ADENOSINE MONOPHOSPHATE#0.9373;EXCRETION#0.9373;D-AMPHETAMINE#0.9336;LONG TERM POTENTIATION#0.9332;MIDBRAIN#0.9298;NALOXONE#0.9278;SYNAPTIC TRANSMISSION#0.9254;O METHYLTRANSFERASE#0.9248;HISTAMINE#0.9247;INTERNEURON#0.9242;3,4-DIHYDROXYPHENYLALANINE#0.9192;ALPHA2 ADRENOCEPTOR#0.9165;CAMP RESPONSE ELEMENT#0.9112;CRAVING#0.9088;CATECHOL O METHYLTRANSFERASE#0.8986;CAMP RESPONSE ELEMENT BINDING#0.8984;MEMORY IMPAIRMENT#0.8979;RISPERIDONE#0.8958;BROMOCRIPTINE#0.8951;PLASMA MEMBRANE#0.8939;PERIPHERAL BLOOD#0.8894;NOVEL OBJECT RECOGNITION#0.8892;CELL SURFACE#0.8871;PHOSPHOLIPASE C#0.8866;INNERVATION#0.8836;MOTOR BEHAVIOR#0.8797;POSITIVE ALLOSTERIC MODULATOR#0.8775;PHENCYCLIDINE#0.8772;CAFFEINE#0.8759;CANNABINOID RECEPTOR#0.8721;PHOSPHODIESTERASE#0.8711;NERVE TERMINAL#0.8709;LITHIUM#0.8698;LEVODOPA#0.8692;SUCROSE#0.8661;METHYLPHENIDATE#0.8616;CAMP SIGNALING#0.8580;QUANTITATIVE REAL TIME#0.8554;MECHANISM OF ACTION#0.8498;ARTERY#0.8490;NITRIC OXIDE#0.8470;ACTION POTENTIAL#0.8457;YOHIMBINE#0.8408;NORADRENALINE#0.8367;SPINAL CORD#0.8348;ESTRADIOL#0.8331;DOPAMINE RECEPTOR BINDING#0.8313;POSTSYNAPTIC DENSITY#0.8298;DOPAMINE D5 RECEPTOR#0.8259;HUNTINGTON'S DISEASE#0.8168;ALZHEIMER'S DISEASE#0.8160;BACTERIAL ARTIFICIAL CHROMOSOME#0.8158;FRAGMENT LENGTH POLYMORPHISM#0.8145;AMNESIA#0.8142;DOMPERIDONE#0.8128;FEAR RESPONSE#0.8109;CHOLERA#0.8105;KINASE INHIBITOR#0.8100;CHEWING#0.8094;NICOTINIC ACETYLCHOLINE RECEPTOR#0.8085;ABNORMAL INVOLUNTARY MOVEMENT#0.8072;GROWTH FACTOR#0.8059;GROWTH HORMONE#0.8053;CALCIUM CHANNEL#0.8051;NEUROTOXICITY#0.8048;SPATIAL LEARNING#0.8018;DENDRITIC SPINE#0.7936;NUCLEUS ACCUMBENS CORE#0.7919;ALPHA ADRENOCEPTOR#0.7915;ATPASE ACTIVITY#0.7903;ALCOHOL DEPENDENCE#0.7889;SMOOTH MUSCLE#0.7841;DOPAMINE UPTAKE#0.7833;CYTOSINE METHYLATION#0.7793;MECAMYLAMINE#0.7769;OBJECT RECOGNITION MEMORY#0.7720;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.7718;CAMP FORMATION#0.7697;GABAERGIC NEURON#0.7693;RECEPTOR INTERNALIZATION#0.7637;SOCIAL BEHAVIOR#0.7631;SOCIAL DEFEAT STRESS#0.7603;HEROIN DEPENDENCE#0.7568;TOXICITY#0.7537;PREPULSE INHIBITION#0.7535;OLANZAPINE#0.7522;BIPOLAR CELL#0.7485;NLRP3 INFLAMMASOME ACTIVATION#0.7470;NUCLEUS ACCUMBENS SHELL#0.7461;HUMAN EMBRYONIC KIDNEY#0.7451;EMBRYONIC KIDNEY#0.7447;LINES OF EVIDENCE#0.7445;WEIGHT GAIN#0.7416;DYSTONIA#0.7404;MITOGEN ACTIVATED PROTEIN#0.7396;OBESE#0.7396;ARGININE#0.7393;FORCED SWIM TEST#0.7391;CELL DEATH#0.7368;DENTATE GYRUS#0.7364;NEUROGENESIS#0.7360;STARTLE RESPONSE#0.7343;DORSOLATERAL PREFRONTAL CORTEX#0.7324;HYPERACTIVE#0.7317;PROPRANOLOL#0.7281;IMIPRAMINE#0.7272;MUTAGENESIS#0.7226;ATROPINE#0.7212;NEUROTRANSMITTER RECEPTOR#0.7209;PERGOLIDE#0.7190;OPEN FIELD TEST#0.7145;DELTA OPIOID RECEPTOR#0.7142;SEROTONIN SYNTHESIS#0.7136;GLUCOCORTICOID RECEPTOR#0.7133;L-ARGININE#0.7125;TURNING BEHAVIOR#0.7104;REVERSE TRANSCRIPTION#0.7095;RESPONSE TO COCAINE#0.7035;ADENYLATE CYCLASE ACTIVITY#0.7034;ESSENTIAL HYPERTENSION#0.7011;MORRIS WATER MAZE#0.6997;GLIAL CELL#0.6952;NITRIC OXIDE SYNTHASE#0.6937;ELEVATED PLUS MAZE#0.6925;NEUROTOXIN#0.6924;GABA A RECEPTOR#0.6878;MOOD DISORDER#0.6862;RECEPTOR COMPLEX#0.6844;TURNING BEHAVIOUR#0.6821;SEPTUM#0.6766;GLUTAMIC ACID#0.6713;GENE SILENCING#0.6712;SIGNALING MOLECULE#0.6696;ESTROGEN RECEPTOR#0.6693;EXTRACELLULAR REGULATED KINASE#0.6692;ADRENAL GLAND#0.6603;PERIPHERAL BLOOD LYMPHOCYTES#0.6600;NUCLEAR LAYER#0.6594;LUNG CANCER#0.6586;OLFACTORY BULB#0.6574;NICOTINE DEPENDENCE#0.6557;HYPERTHERMIA#0.6548;THALAMUS#0.6545;QUINOLINIC ACID#0.6536;GUANOSINE#0.6535;BETA-2#0.6532;GLYCINE#0.6518;MODAFINIL#0.6498;NEUROBLASTOMA#0.6486;PROLACTIN SECRETION#0.6457;SIGNALING CASCADE#0.6418;TARGET OF RAPAMYCIN#0.6401;PERTUSSIS#0.6396;CORTICOTROPIN#0.6385;EXPLORATORY BEHAVIOR#0.6373;PHENOXYBENZAMINE#0.6369;CONTEXTUAL FEAR CONDITIONING#0.6358;OBSESSIVE COMPULSIVE DISORDER#0.6348;KETAMINE#0.6338;FLUPHENAZINE#0.6315;GALANTAMINE#0.6306;GLUTAMATE DECARBOXYLASE#0.6303;BETA ADRENOCEPTOR#0.6287;NATRIURESIS#0.6278;PYRAMIDAL CELL#0.6275;MELATONIN#0.6271;DRUG DEPENDENCE#0.6252;TRANSMISSION DISEQUILIBRIUM TEST#0.6222;CHOLINERGIC NEURON#0.6170;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6158;DEMENTIA#0.6123;CIRCADIAN RHYTHM#0.6114;SIGNALLING PATHWAY#0.6111;EPITHELIAL CELL#0.6110;BLOOD BRAIN BARRIER#0.6086;MAGNETIC RESONANCE IMAGING#0.6079;AMP FORMATION#0.6065;DOPAMINE D4 RECEPTOR#0.6039;SUBSTANCE ABUSE#0.6021;CARBACHOL#0.6002
1813	HEROIN DEPENDENCE#1.0903;DOPAMINE RECEPTOR D1#1.0610;REMOXIPRIDE#1.0562;RESPONSE TO RISPERIDONE#1.0425;CATECHOL O METHYLTRANSFERASE#1.0374;O METHYLTRANSFERASE#1.0370;HEROIN#1.0343;CABERGOLINE#1.0316;ROPINIROLE#1.0309;DOPAMINE D4 RECEPTOR#1.0301;PRAMIPEXOLE#1.0299;MIGRAINE#1.0289;DOPAMINE D2 RECEPTOR#1.0260;DOMPERIDONE#1.0251;RECEPTOR-RECEPTOR INTERACTION#1.0245;PROLACTINOMA#1.0242;MOTOR LEARNING#1.0221;RECEPTOR ACTIVITY#1.0218;METHADONE#1.0196;SUBSTANCE DEPENDENCE#1.0188;MU OPIOID RECEPTOR#1.0178;SOMATOSTATIN RECEPTOR#1.0173;ARIPIPRAZOLE#1.0164;DEPRESSIVE SYMPTOMS#1.0162;DOPAMINE#1.0151;BREAST CANCER#1.0151;BROMOCRIPTINE#1.0143;ALCOHOL DEPENDENCE#1.0136;GABA A RECEPTOR#1.0133;COCAINE DEPENDENCE#1.0132;CYTOCHROME P450#1.0128;FRAGMENT LENGTH POLYMORPHISM#1.0112;SEROTONIN RECEPTOR#1.0104;NICOTINE DEPENDENCE#1.0103;DNA METHYLATION#1.0100;BUPROPION#1.0092;MEDIUM SPINY NEURONS#1.0091;SULPIRIDE#1.0091;ALCOHOL USE DISORDER#1.0065;OBESE#1.0062;RECEPTOR ANTAGONIST#1.0062;QUETIAPINE#1.0059;CANCER CELL#1.0057;METOCLOPRAMIDE#1.0057;DOPAMINE D1 RECEPTOR#1.0057;INSULIN SECRETION#1.0054;GLUCOSE METABOLISM#1.0051;CRAVING#1.0038;DRUG DEPENDENCE#1.0032;RECEPTOR LIGAND#1.0029;SUBSTANCE ABUSE#1.0025;MOOD DISORDER#1.0021;HYPERPROLACTINEMIA#1.0016;LEVODOPA#1.0013;ADENOSINE#1.0011;OPIOID RECEPTOR#1.0007;AMISULPRIDE#1.0004;EMISSION COMPUTED TOMOGRAPHY#1.0003;SUBSTANCE P#1.0002;ETHANOL#0.9996;DOPAMINE UPTAKE#0.9994;SUBSTANCE USE DISORDER#0.9992;RISPERIDONE#0.9985;CAFFEINE#0.9981;D-AMPHETAMINE#0.9981;RECEPTOR AGONIST#0.9980;DOPAMINE D3 RECEPTOR#0.9978;CAROTID BODY#0.9975;RECEPTOR BINDING#0.9974;BIPOLAR DISORDER#0.9969;CELL SURFACE#0.9968;NUCLEUS ACCUMBENS CORE#0.9967;DOPAMINE SYNTHESIS#0.9959;ANXIETY DISORDER#0.9956;DYSTONIA#0.9951;PROTEIN KINASE C#0.9951;L-DOPA#0.9941;RESPONSE TO DOPAMINE#0.9941;PLASMA MEMBRANE#0.9937;REVERSE TRANSCRIPTION#0.9936;PITUITARY GLAND#0.9936;CHLORPROMAZINE#0.9935;PSYCHOTIC DISORDER#0.9928;PITUITARY ADENOMA#0.9921;GROWTH HORMONE#0.9921;RETINOIC ACID#0.9918;EATING DISORDER#0.9915;OLANZAPINE#0.9914;RESONANCE ENERGY TRANSFER#0.9904;HALOPERIDOL#0.9902;APOMORPHINE#0.9900;CELL PROLIFERATION#0.9893;APOPTOSIS#0.9892;WEIGHT GAIN#0.9881;CLOZAPINE#0.9876;SUCROSE#0.9874;ACETYLCHOLINE RECEPTOR#0.9872;MIDBRAIN#0.9871;PROLACTIN SECRETION#0.9864;PHENCYCLIDINE#0.9863;ADRENERGIC RECEPTOR#0.9859;MAJOR DEPRESSIVE DISORDER#0.9858;METHAMPHETAMINE#0.9858;DYSKINESIA#0.9855;TUMOR CELLS#0.9854;AMYGDALA#0.9854;DOPAMINE RECEPTOR#0.9852;ADENYLATE CYCLASE#0.9852;DOPAMINE BINDING#0.9851;POLYMERASE CHAIN REACTION#0.9848;GROWTH FACTOR#0.9846;POSITRON EMISSION TOMOGRAPHY#0.9845;NICOTINIC ACETYLCHOLINE RECEPTOR#0.9845;BLOOD BRAIN BARRIER#0.9838;THIORIDAZINE#0.9837;MENTAL DISORDER#0.9831;GLUTAMATE RECEPTOR#0.9828;INTERNEURON#0.9826;LITHIUM#0.9817;PROTEIN KINASE A#0.9816;FIRST EPISODE PSYCHOSIS#0.9816;NEUROTOXICITY#0.9812;CAUDATE NUCLEUS#0.9811;NMDA RECEPTOR#0.9808;SCOPOLAMINE#0.9804;PERIPHERAL BLOOD#0.9803;MOTOR BEHAVIOR#0.9799;RESERPINE#0.9798;MEDIAL PREFRONTAL CORTEX#0.9797;SENSITIZATION#0.9795;CONDITIONED PLACE PREFERENCE#0.9789;SYNAPTIC TRANSMISSION#0.9784;PROTEIN KINASE#0.9775;CALCIUM CHANNEL#0.9770;REGIONS OF INTEREST#0.9767;PRAZOSIN#0.9765;TRANSCRIPTION FACTOR#0.9764;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9764;POTASSIUM CHANNEL#0.9761;COGNITION#0.9760;GRAY MATTER VOLUME#0.9751;PIMOZIDE#0.9751;MOTOR ACTIVITY#0.9750;ACETYLCHOLINE#0.9747;DOPAMINERGIC NEURON#0.9746;FORSKOLIN#0.9742;SIGNAL TRANSDUCTION#0.9742;STRIATUM#0.9742;PREPULSE INHIBITION#0.9742;NOREPINEPHRINE#0.9742;LOCOMOTION#0.9739;SIGNALING PATHWAY#0.9736;ASPARTATE#0.9728;COCAINE ABUSE#0.9716;CONDUCT DISORDER#0.9713;HISTAMINE#0.9701;ACTION POTENTIAL#0.9700;PHOSPHOLIPASE C#0.9697;BASAL GANGLIA#0.9695;CYCLASE ACTIVITY#0.9691;CELL DEATH#0.9681;THALAMUS#0.9681;GENE EXPRESSION#0.9679;ADENYLATE#0.9678;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9677;FOREBRAIN#0.9676;DOPAMINE RECEPTOR BINDING#0.9674;ANTERIOR CINGULATE CORTEX#0.9669;SUBSTANTIA NIGRA#0.9667;HYPERACTIVITY#0.9659;PARKINSON'S DISEASE#0.9658;TOXICITY#0.9656;PERGOLIDE#0.9649;MECHANISM OF ACTION#0.9645;NORADRENALINE#0.9644;ESTRADIOL#0.9642;NITRIC OXIDE#0.9642;DENDRITIC SPINE#0.9639;FRONTAL#0.9638;HUNTINGTON'S DISEASE#0.9635;CENTRAL NERVOUS SYSTEM#0.9633;MAGNETIC RESONANCE IMAGING#0.9633;OBSESSIVE COMPULSIVE DISORDER#0.9620;NEUROTRANSMISSION#0.9618;RESPONSE TO TREATMENT#0.9608;NERVOUS SYSTEM#0.9606;YOHIMBINE#0.9600;METHYLPHENIDATE#0.9594;5-HT RECEPTOR#0.9583;CYCLIC AMP#0.9579;ZIPRASIDONE#0.9576;CELL ADHESION#0.9570;MOLECULAR DYNAMICS SIMULATION#0.9570;STRUCTURE ACTIVITY RELATIONSHIP#0.9568;CAMKII#0.9562;LUNG CANCER#0.9560;HYPERTENSION#0.9550;PERSONALITY DISORDER#0.9542;OPEN FIELD TEST#0.9541;SEROTONIN REUPTAKE INHIBITOR#0.9529;SERTINDOLE#0.9526;QUANTITATIVE REAL TIME#0.9526;NEUROTRANSMITTER RECEPTOR#0.9522;CANNABINOID RECEPTOR#0.9513;SIGNALLING PATHWAY#0.9500;TRANSMISSION DISEQUILIBRIUM TEST#0.9498;TYPE 2 DIABETES#0.9497;OVARIAN#0.9479;CORPUS STRIATUM#0.9470;CAMP RESPONSE ELEMENT#0.9460;NEURODEGENERATIVE DISEASE#0.9457;NUCLEUS ACCUMBENS SHELL#0.9453;ELEVATED PLUS MAZE#0.9436;HALLUCINATIONS#0.9428;VASOPRESSIN#0.9426;CHRONIC SCHIZOPHRENIA#0.9421;INNERVATION#0.9406;ASTROCYTE#0.9399;NEUROBLASTOMA#0.9398;LINES OF EVIDENCE#0.9389;AXON TERMINAL#0.9385;CEREBRAL CORTEX#0.9383;ADENYLYL CYCLASE ACTIVITY#0.9375;PERTUSSIS#0.9367;AGE AT ONSET#0.9363;3,4-DIHYDROXYPHENYLALANINE#0.9353;NERVE TERMINAL#0.9346;HEALTHY CONTROL SUBJECTS#0.9346;VOMITING#0.9338;SOCIAL BEHAVIOR#0.9330;NALOXONE#0.9328;DOPAMINE METABOLISM#0.9320;ABNORMAL INVOLUNTARY MOVEMENT#0.9319;HIGH FAT DIET#0.9319;ARGININE#0.9313;KETAMINE#0.9311;CELL GROWTH#0.9290;CELL MEMBRANE#0.9287;SECOND GENERATION ANTIPSYCHOTICS#0.9280;NEUROLOGICAL DISORDER#0.9276;LISURIDE#0.9270;BETA ADRENOCEPTOR#0.9262;NICOTINE REPLACEMENT THERAPY#0.9251;REGION OF INTEREST#0.9246;SCHIZOAFFECTIVE DISORDER#0.9245;NITRIC OXIDE SYNTHASE#0.9245;BUSPIRONE#0.9238;CHOLINERGIC NEURON#0.9233;SHORT TANDEM REPEAT#0.9218;RECEPTOR INTERNALIZATION#0.9203;CAMP RESPONSE ELEMENT BINDING#0.9196;PROTEIN PROTEIN INTERACTION#0.9179;GUANINE#0.9177;ADENOSINE MONOPHOSPHATE#0.9176;SPINAL CORD#0.9176;SIGNALING CASCADE#0.9175;PALIPERIDONE#0.9154;STEM CELL#0.9148;PATHOLOGICAL GAMBLING#0.9146;REACTIVE OXYGEN SPECIES#0.9141;HYPERSENSITIVITY#0.9140;POST-TRAUMATIC STRESS DISORDER#0.9133;NEURONAL CELLS#0.9131;ANOREXIA NERVOSA#0.9124;TRAUMATIC BRAIN INJURY#0.9124;EXPLORATORY BEHAVIOR#0.9120;GABAERGIC NEURON#0.9100;GLYCOGEN SYNTHASE KINASE#0.9079;DETOXIFICATION#0.9047;EPIDERMAL GROWTH FACTOR#0.9022;ANOREXIA#0.9011;AUTISM SPECTRUM DISORDER#0.9007;OLFACTORY BULB#0.9005;MULTIPLE SYSTEM ATROPHY#0.9004;LONG TERM DEPRESSION#0.9003;CHRONIC MILD STRESS#0.9000;ESTROGEN RECEPTOR#0.8996;PROXIMAL TUBULE CELL#0.8972;MIGRAINE WITH AURA#0.8969;WEIGHT LOSS#0.8964;ALZHEIMER'S DISEASE#0.8960;HYPOXIA#0.8957;NEURONAL CALCIUM SENSOR#0.8955;MUTAGENESIS#0.8951;FLUPHENAZINE#0.8950;FORCED SWIM TEST#0.8905;CYCLIC ADENOSINE MONOPHOSPHATE#0.8876;GLUTAMIC ACID#0.8875;MECHANISMS OF ACTION#0.8868;CORTISOL#0.8857;DENTATE GYRUS#0.8840;AKT SIGNALING#0.8831;FLUOXETINE#0.8830;PIPERAZINE#0.8811;DEMENTIA#0.8810;LIPOIC ACID#0.8805;LONG TERM POTENTIATION#0.8796;IMIPRAMINE#0.8790;RECEPTOR COMPLEX#0.8772;APOPTOTIC#0.8769;NEURAL CELL#0.8763;BETA CELL#0.8760;ANTISOCIAL PERSONALITY DISORDER#0.8734;PERIPHERAL BLOOD LYMPHOCYTES#0.8726;KAPPA OPIOID RECEPTOR#0.8716;OCTREOTIDE#0.8696;ARTERY#0.8693;EATING BEHAVIOR#0.8683;TRANSFORMING GROWTH FACTOR#0.8655;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.8626;GLIAL CELL#0.8624;CITALOPRAM#0.8623;ATROPINE#0.8618;DIABETES MELLITUS#0.8614;INFLAMMATORY RESPONSE#0.8605;TRYPTOPHAN#0.8605;SUBTHALAMIC NUCLEUS#0.8604;GLYCINE#0.8581;INDOLE#0.8576;BRAIN DEVELOPMENT#0.8575;OPC-14597#0.8546;ALPHA1 ADRENOCEPTOR#0.8537;ARGININE VASOPRESSIN#0.8536;OXYTOCIN RECEPTOR#0.8521;GUANOSINE#0.8509;NEURITE#0.8503;GESTATION#0.8496;GASTRIC EMPTYING#0.8494;BIOLUMINESCENCE#0.8491;NEUROPROTECTION#0.8477;GENETIC ASSOCIATION STUDIES#0.8444;GILLES DE LA TOURETTE SYNDROME#0.8433;MRNA SPLICING#0.8428;GLUCOCORTICOID RECEPTOR#0.8409;NEURON DEVELOPMENT#0.8407;MITOGEN ACTIVATED PROTEIN#0.8405;PRO-INFLAMMATORY#0.8404;CLONIDINE#0.8395;EMESIS#0.8386;HYPERTHERMIA#0.8384;BACTERIAL ARTIFICIAL CHROMOSOME#0.8381;HORMONE SECRETION#0.8376;SPATIAL WORKING MEMORY#0.8375;ENDOTHELIAL CELL#0.8364;HUMAN EMBRYONIC KIDNEY#0.8322;FORCED SWIMMING TEST#0.8320;EMBRYONIC KIDNEY#0.8317;ANGIOGENESIS#0.8299;STUTTERING#0.8296;STARTLE RESPONSE#0.8285;AGGRESSIVE BEHAVIOR#0.8282;SUPEROXIDE DISMUTASE#0.8242;BETA ADRENERGIC RECEPTOR#0.8239;DIET INDUCED OBESITY#0.8195;AMPA RECEPTOR#0.8191;ISCHEMIA#0.8180;HYPERACTIVE#0.8179;CIRCADIAN RHYTHM#0.8175;SEDATION#0.8125;HYPOXIC#0.8122;MEMORY IMPAIRMENT#0.8114;CELL ADHESION MOLECULE#0.8089;ENDOMETRIOSIS#0.8080;GLUCOSE INTOLERANCE#0.8073;LEUKOCYTE#0.8044;NEUROTOXIC#0.8043;PROPRANOLOL#0.8042;ALPHA ADRENOCEPTOR#0.8040;MELATONIN#0.8025;RESTLESS#0.8015;DELUSIONAL DISORDER#0.7999;IMMUNE RESPONSE#0.7973;FEEDING BEHAVIOR#0.7943;ENDOCYTOSIS#0.7943;PYRAMIDAL CELL#0.7920;CHEWING#0.7918;NEUROTOXIN#0.7909;HARDY WEINBERG EQUILIBRIUM#0.7902;IMMUNE SYSTEM#0.7900;CORTICOTROPIN-RELEASING FACTOR#0.7897;L-ARGININE#0.7867;RESTLESS LEGS SYNDROME#0.7865;NUCLEOTIDE BINDING#0.7862;HYPOTENSION#0.7845;LACTATION#0.7842;GROWTH FACTOR RECEPTOR#0.7837;CHOLINE#0.7827;BINGE EATING DISORDER#0.7822;PHOSPHODIESTERASE#0.7819;NEUROTRANSMITTER RELEASE#0.7818;GLUTAMATE DECARBOXYLASE#0.7817;OOCYTE#0.7808;LOCUS COERULEUS#0.7808;PINDOLOL#0.7804;TEMPORAL LOBE#0.7802;FUNCTIONING PITUITARY ADENOMA#0.7794;LONG TERM MEMORY#0.7779;PROSTATE APOPTOSIS RESPONSE#0.7763;REPORTER GENE ASSAY#0.7758;MAPK SIGNALING#0.7749;RESPONSE TO COCAINE#0.7742;COLORECTAL#0.7739;TURNING BEHAVIOUR#0.7736;EARLY LIFE STRESS#0.7724;NF-KAPPAB ACTIVATION#0.7698;ACTIVE TRANSPORTER#0.7697;QUANTITATIVE REVERSE TRANSCRIPTION#0.7690;ENZYME ACTIVITY#0.7688;PROGENITOR CELL#0.7686;PROGESTERONE#0.7657;CLASS A GPCR#0.7645;GLUTATHIONE#0.7644;NEUROLEPTIC MALIGNANT SYNDROME#0.7641;LINKED POLYMORPHIC REGION#0.7636;TAIL SUSPENSION TEST#0.7617;NOCICEPTION#0.7597;PROTEIN COMPLEX#0.7585;DESIPRAMINE#0.7568;MIGRAINE WITHOUT AURA#0.7568;SEPTUM#0.7567;CORTICOTROPIN#0.7559;GONADOTROPIN RELEASING HORMONE#0.7547;GENE X ENVIRONMENT#0.7531;NITRO-L-ARGININE#0.7529;TUMOR NECROSIS FACTOR#0.7527;RNA INTERFERENCE#0.7520;BINDING PROTEIN 1#0.7503;RESPONSE TO HALOPERIDOL#0.7484;EPITHELIAL CELL#0.7471;DELTA OPIOID RECEPTOR#0.7466;SEROTONIN SYNTHESIS#0.7464;9-HYDROXYRISPERIDONE#0.7463;MODAFINIL#0.7459;CAMP SIGNALING#0.7452;TRANSIENT RECEPTOR POTENTIAL#0.7448;TACHYCARDIA#0.7432;PROGRESSIVE SUPRANUCLEAR PALSY#0.7405;MODE OF ACTION#0.7399;BODY WEIGHT GAIN#0.7381;GLOMUS CELL#0.7351;PROTEIN KINASE B#0.7322;PROCHLORPERAZINE#0.7309;T CELL#0.7308;GTP BINDING#0.7294;CYTOPLASM#0.7288;SCHIZOPHRENIA 1#0.7287;RIMONABANT#0.7285;TRANSCRIPTASE#0.7284;DORSOLATERAL PREFRONTAL CORTEX#0.7283;ENDOPLASMIC RETICULUM#0.7274;ALPHA2 ADRENOCEPTOR#0.7273;METHADONE MAINTENANCE TREATMENT#0.7235;RESPONSE TO NICOTINE#0.7224;ACOUSTIC STARTLE RESPONSE#0.7211;QUINOLINIC ACID#0.7206;COLORECTAL CANCER#0.7188;DRINKING BEHAVIOR#0.7169;ION CHANNEL#0.7153;MELANOCYTE#0.7147;LIMBIC SYSTEM#0.7129;FLUPENTHIXOL#0.7111;BREAST CANCER CELL#0.7076;BRUXISM#0.7067;ASSOCIATIVE LEARNING#0.7065;DOPAMINE TRANSPORT#0.7050;ENDOTHELIAL GROWTH FACTOR#0.7048;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7048;THYMIDINE#0.7034;NOXIOUS#0.7033;NERVE ENDING#0.7009;PROTEIN SYNTHESIS#0.7008;PAROXETINE#0.7004;SPATIAL LEARNING#0.6977;CISPLATIN#0.6958;PANCREATIC ISLET#0.6952;NOMIFENSINE#0.6937;MORPHINE DEPENDENCE#0.6930;MIANSERIN#0.6923;DENDRITIC SPINE DENSITY#0.6919;BETA-2#0.6916;RECEPTOR ANTAGONIST ACTIVITY#0.6904;TRANSACTIVATION#0.6903;EPILEPSY#0.6901;LIPID METABOLISM#0.6900;PERPHENAZINE#0.6900;TRANSCRANIAL MAGNETIC STIMULATION#0.6884;SHORT TERM MEMORY#0.6880;NALTREXONE#0.6876;CIGARETTES PER DAY#0.6839;GRADIENT GEL ELECTROPHORESIS#0.6837;SYNAPTOSOME#0.6820;5-HYDROXYTRYPTAMINE RECEPTOR#0.6793;RESPONSE TO DRUG#0.6789;NEUROGENESIS#0.6777;BIFEPRUNOX#0.6769;PILOCARPINE#0.6753;NOVEL OBJECT RECOGNITION#0.6752;CALCIUM SIGNALING#0.6711;CHANNEL ACTIVITY#0.6710;ALCOHOLIC PSYCHOSIS#0.6708;CLINICAL GLOBAL IMPRESSION#0.6695;MULTIPLE REGRESSION ANALYSIS#0.6689;ADRENAL GLAND#0.6675;TYPE 2 DIABETES MELLITUS#0.6651;2 DIABETES MELLITUS#0.6650;FACTOR I#0.6639;CALCINEURIN#0.6608;FLUPENTIXOL#0.6587;AMNESIA#0.6585;ESTROUS CYCLE#0.6581;POSITIVE FAMILY HISTORY#0.6576;AUTOPHAGY#0.6572;TIC DISORDER#0.6548;DIAZEPAM#0.6541;LATERAL VENTRICLE#0.6536;T LYMPHOCYTE#0.6531;PROLACTIN RECEPTOR#0.6515;ARACHIDONIC ACID#0.6496;DOPAMINE DEGRADATION#0.6484;ADIPOSE TISSUE#0.6472;RETINOIC ACID RECEPTOR#0.6457;ANESTHETIC#0.6454;BETA GLUCURONIDASE#0.6426;CHROMOSOMAL REGION#0.6421;NEUROENDOCRINE TUMOR#0.6417;TETRODOTOXIN#0.6414;FATTY ACID BINDING#0.6410;HUMAN BREAST CANCER#0.6409;MORRIS WATER MAZE#0.6400;FOLLICLE STIMULATING HORMONE#0.6389;SOCIAL DEFEAT STRESS#0.6378;ANGIOTENSIN CONVERTING ENZYME#0.6348;TRIFLUOPERAZINE#0.6338;RESPONSE TO ANTIPSYCHOTIC DRUG#0.6315;ACROMEGALY#0.6297;PANIC DISORDER#0.6289;IODOPHENYL#0.6283;HABITUATION#0.6282;DEPRESSANT#0.6274;NOREPINEPHRINE REUPTAKE INHIBITOR#0.6268;QUANTITATIVE TRAIT LOCI#0.6254;NOREPINEPHRINE REUPTAKE#0.6246;MULTIPLE LOGISTIC REGRESSION#0.6242;ALANINE#0.6228;HYPOTHALAMIC PITUITARY ADRENAL#0.6224;VASOPRESSIN RECEPTOR#0.6222;NEURAL PROGENITOR CELL#0.6221;ACETIC ACID#0.6218;ATAXIA TELANGIECTASIA#0.6197;MACROPHAGE#0.6184;RISK OF RELAPSE#0.6163;EPINEPHRINE#0.6152;COMT I#0.6128;ADVERSE DRUG REACTION#0.6123;HISTONE ACETYLATION#0.6122;MULTIPLE LINEAR REGRESSION#0.6115;STRESSFUL LIFE EVENTS#0.6105;HERPES SIMPLEX#0.6094;DIGESTION#0.6092;CONSTRICTION#0.6073;STATISTICAL PARAMETRIC MAPPING#0.6064;HYPOTENSIVE#0.6055;SIGNALING MOLECULE#0.6047;KINASE INHIBITOR#0.6047;NERVE GROWTH FACTOR#0.6045;OVARIAN CORTEX#0.6042;BLOOD VESSEL#0.6034;RECEPTOR SYNTHESIS#0.6031;PAIRED PULSE FACILITATION#0.6012
1814	O METHYLTRANSFERASE#1.0473;ESSENTIAL TREMOR#1.0465;DOPAMINE D3 RECEPTOR#1.0439;CATECHOL O METHYLTRANSFERASE#1.0361;SEROTONIN RECEPTOR#1.0326;DYSKINESIA#1.0272;GLYCINE#1.0251;DOPAMINE RECEPTOR#1.0248;BIPOLAR DISORDER#1.0230;DOPAMINE#1.0224;RISPERIDONE#1.0191;PARKINSON'S DISEASE#1.0161;POLYMERASE CHAIN REACTION#1.0091;FRAGMENT LENGTH POLYMORPHISM#0.9974;STRIATUM#0.9781;GENE EXPRESSION#0.9723;PERIPHERAL BLOOD#0.9598;ALCOHOL DEPENDENCE#0.9498;CLOZAPINE#0.9425;NEUROTRANSMISSION#0.9410;AGE AT ONSET#0.9305;DOPAMINE D2 RECEPTOR#0.9210;LIMBIC SYSTEM#0.8887;T CELL#0.8830;MIGRAINE#0.8799;NICOTINE DEPENDENCE#0.8662;TRANSMISSION DISEQUILIBRIUM TEST#0.8381;COCAINE DEPENDENCE#0.8304;DRUG DEPENDENCE#0.8213;NERVOUS SYSTEM#0.8152;AUTISM SPECTRUM DISORDER#0.7923;HYPERACTIVITY#0.7880;PRAMIPEXOLE#0.7872;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.7869;HEROIN#0.7865;ABNORMAL INVOLUNTARY MOVEMENT#0.7828;PERIPHERAL BLOOD LYMPHOCYTES#0.7815;RESPONSE TO RISPERIDONE#0.7780;MOOD DISORDER#0.7761;OLANZAPINE#0.7735;L-DOPA#0.7524;CENTRAL NERVOUS SYSTEM#0.7463;CYTOCHROME P450#0.7408;LITHIUM#0.7307;GENETIC ASSOCIATION STUDIES#0.7246;ALZHEIMER'S DISEASE#0.7242;DEVELOPMENTAL DELAY#0.7125;SCHIZOAFFECTIVE DISORDER#0.7074;AUTOPHAGY#0.7068;SIGNALING PATHWAY#0.7066;ARIPIPRAZOLE#0.7059;LEVODOPA#0.7031;MAGNETIC RESONANCE IMAGING#0.7022;DNA METHYLATION#0.6796;CILIARY NEUROTROPHIC FACTOR#0.6792;GLIAL CELL#0.6722;T LYMPHOCYTE#0.6684;AMYGDALA#0.6583;RECEPTOR ANTAGONIST#0.6576;PERSONALITY DISORDER#0.6437;HALLUCINATIONS#0.6434;OBSESSIVE COMPULSIVE DISORDER#0.6419;HARDY WEINBERG EQUILIBRIUM#0.6365;RECENT POSITIVE SELECTION#0.6348;GONAD#0.6259;WEIGHT GAIN#0.6156;NOREPINEPHRINE#0.6122;MENTAL DISORDER#0.6046;PSYCHOTIC DISORDER#0.6022;DOPAMINE SYNTHESIS#0.6015
1815	RESPONSE TO CLOZAPINE#1.0609;CRAVING#1.0513;CATECHOL O METHYLTRANSFERASE#1.0431;DOPAMINE D4 RECEPTOR#1.0429;O METHYLTRANSFERASE#1.0425;HEROIN#1.0391;EXPLORATORY BEHAVIOUR#1.0387;RECEPTOR LIGAND#1.0374;SEROTONIN RECEPTOR#1.0360;LINKED POLYMORPHIC REGION#1.0299;CONTINUOUS PERFORMANCE TEST#1.0255;MOOD DISORDER#1.0252;DOPAMINE#1.0243;RECEPTOR ANTAGONIST#1.0205;DOPAMINE RECEPTOR#1.0188;SEASON OF BIRTH#1.0188;RECEPTOR AGONIST#1.0183;SUBSTANCE ABUSE#1.0171;ALCOHOL DEPENDENCE#1.0169;DNA METHYLATION#1.0169;AGGRESSIVE BEHAVIOR#1.0154;DOPAMINE D2 RECEPTOR#1.0146;CLOZAPINE#1.0063;DOPAMINE D3 RECEPTOR#1.0057;FRONTAL#1.0042;RECEPTOR BINDING#1.0021;POLYMERASE CHAIN REACTION#1.0017;TRANSMISSION DISEQUILIBRIUM TEST#1.0014;METHYLPHENIDATE#0.9979;PIPERAZIN#0.9956;BIPOLAR DISORDER#0.9896;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9859;WEIGHT GAIN#0.9817;GENE EXPRESSION#0.9814;HYPERACTIVITY#0.9811;PARKINSON'S DISEASE#0.9808;STRIATUM#0.9770;CONDUCT DISORDER#0.9759;PERIPHERAL BLOOD#0.9711;NEUROTRANSMISSION#0.9690;MENTAL DISORDER#0.9661;HALOPERIDOL#0.9654;COGNITION#0.9606;OPIOID RECEPTOR#0.9515;OBSESSIVE COMPULSIVE DISORDER#0.9502;HYPERACTIVE#0.9486;NOREPINEPHRINE#0.9464;NERVOUS SYSTEM#0.9461;CENTRAL NERVOUS SYSTEM#0.9296;MAGNETIC RESONANCE IMAGING#0.9275;L-DOPA#0.9133;FRAGMENT LENGTH POLYMORPHISM#0.9064;HEROIN DEPENDENCE#0.9033;TRANSCRIPTION FACTOR#0.9001;ADRENERGIC RECEPTOR#0.8986;TRYPTOPHAN#0.8966;PENILE ERECTION#0.8965;PSYCHOTIC DISORDER#0.8864;APOMORPHINE#0.8849;SULPIRIDE#0.8831;TIC DISORDER#0.8787;DEPRESSIVE SYMPTOMS#0.8745;PERSONALITY DISORDER#0.8735;GROWTH FACTOR#0.8728;PROTEIN KINASE#0.8726;EXPLORATORY BEHAVIOR#0.8690;DYSKINESIA#0.8605;GENETIC ASSOCIATION STUDIES#0.8563;RESPONSE TO MPH#0.8474;NMDA RECEPTOR#0.8366;SIGNALING PATHWAY#0.8356;AUTISM SPECTRUM DISORDER#0.8317;PERIPHERAL BLOOD LYMPHOCYTES#0.8301;CEREBRAL CORTEX#0.8279;OLANZAPINE#0.8269;OPPOSITIONAL DEFIANT DISORDER#0.8269;METHAMPHETAMINE#0.8175;RESPONSE TO METHYLPHENIDATE#0.8140;DELUSIONAL DISORDER#0.8070;ANOREXIA NERVOSA#0.8048;CORTISOL#0.7948;SUBSTANCE USE DISORDER#0.7879;PATHOLOGICAL GAMBLING#0.7835;OBESE#0.7818;NICOTINE DEPENDENCE#0.7774;DOPAMINE D5 RECEPTOR#0.7740;SEASONAL AFFECTIVE DISORDER#0.7734;AMYGDALA#0.7722;SELF REPORT QUESTIONNAIRE#0.7719;BULIMIA NERVOSA#0.7713;SUBSTANCE DEPENDENCE#0.7675;HARDY WEINBERG EQUILIBRIUM#0.7658;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7629;MIGRAINE WITHOUT AURA#0.7573;NALTREXONE#0.7543;SCHIZOAFFECTIVE DISORDER#0.7525;STEM CELL#0.7389;MAJOR DEPRESSIVE DISORDER#0.7366;REVERSE TRANSCRIPTION#0.7322;MEDIAL PREFRONTAL CORTEX#0.7292;DOPAMINE D1 RECEPTOR#0.7232;RISPERIDONE#0.7196;GABA A RECEPTOR#0.6977;RESPONSE TO TREATMENT#0.6935;MIDBRAIN#0.6929;MU OPIOID RECEPTOR#0.6886;ANOREXIA#0.6872;GRAY MATTER VOLUME#0.6829;ANDROGEN RECEPTOR#0.6800;POSITRON EMISSION TOMOGRAPHY#0.6723;AUTISTIC#0.6709;HYPOXIA#0.6657;NORADRENALINE#0.6623;PIPERAZINE#0.6600;CHROMOSOMAL REGION#0.6597;BASAL GANGLIA#0.6586;BUPROPION#0.6579;ADHD RATING SCALE#0.6570;STRUCTURE ACTIVITY RELATIONSHIP#0.6560;NICOTINE REPLACEMENT THERAPY#0.6554;LINEAR MIXED MODEL#0.6533;NEUROTRANSMITTER RECEPTOR#0.6510;MIGRAINE#0.6469;HEALTHY CONTROL SUBJECTS#0.6449;SIGNAL TRANSDUCTION#0.6436;ANTERIOR CINGULATE CORTEX#0.6351;EATING DISORDER#0.6349;RESPONSE TO ALCOHOL#0.6238;ION CHANNEL#0.6236;ACETYLCHOLINE#0.6234;ACTIVE TRANSPORTER#0.6228;ALZHEIMER'S DISEASE#0.6216;ANXIETY DISORDER#0.6165;NEUROBLASTOMA#0.6154;CATATONIC SCHIZOPHRENIA#0.6141;GROWTH FACTOR RECEPTOR#0.6140;CYCLIC AMP#0.6132;PANIC DISORDER#0.6110;RISK OF RELAPSE#0.6064;ASPARTATE#0.6038
1816	DOPAMINE D5 RECEPTOR#1.0927;DOPAMINE#1.0336;DOPAMINE RECEPTOR#1.0258;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9977;HYPERACTIVITY#0.9884;PERIPHERAL BLOOD#0.9785;GENE EXPRESSION#0.9477;PERIPHERAL BLOOD LYMPHOCYTES#0.9289;POLYMERASE CHAIN REACTION#0.8767;BIPOLAR DISORDER#0.8766;NEUROTRANSMISSION#0.8556;SEROTONIN RECEPTOR#0.8109;T CELL#0.7980;DOPAMINE D1 RECEPTOR#0.7789;DOPAMINE D4 RECEPTOR#0.7280;RECEPTOR AGONIST#0.7261;NERVOUS SYSTEM#0.7165;STRIATUM#0.6799;PARKINSON'S DISEASE#0.6661;DYSTONIA#0.6433;MIGRAINE#0.6359;CENTRAL NERVOUS SYSTEM#0.6338;QUANTITATIVE REAL TIME#0.6247;ACETYLCHOLINE#0.6173;NICOTINE DEPENDENCE#0.6170;CATECHOL O METHYLTRANSFERASE#0.6006
1819	GTP BINDING#1.0969;APOPTOSIS#0.9140;CELL GROWTH#0.9109;LUNG CANCER#0.7986;CELL CYCLE#0.7661;CYCLIN B1-CDK1 COMPLEX#0.6622;MICROTUBULE DYNAMICS#0.6496;M PHASE#0.6295;MICROTUBULE#0.6118;MICROTUBULE STABILIZATION#0.6030
181	AGOUTI SIGNALING PROTEIN#1.0492;ADRENAL GLAND#1.0373;MELANIN CONCENTRATING HORMONE#1.0364;RECEPTOR ANTAGONIST#1.0174;MELANOCORTIN RECEPTOR#1.0151;ANOREXIA NERVOSA#1.0109;MELANOCYTE#1.0106;RECEPTOR AGONIST#1.0059;ETHANOL#1.0054;FEEDING BEHAVIOR#1.0035;GROWTH HORMONE#0.9998;CORTICOTROPIN#0.9976;ANORECTIC#0.9955;LACTATION#0.9951;ANOREXIA#0.9903;GENE EXPRESSION#0.9891;SIGNALING PATHWAY#0.9882;REGULATION OF ENERGY HOMEOSTASIS#0.9863;TRANSCRIPTION FACTOR#0.9843;NEGATIVE ENERGY BALANCE#0.9837;WEIGHT GAIN#0.9832;DOPAMINE#0.9825;WEIGHT LOSS#0.9824;HIGH FAT DIET#0.9818;DIET INDUCED OBESITY#0.9812;OBESE#0.9793;ADIPOSE TISSUE#0.9788;GLUCOSE HOMEOSTASIS#0.9778;ENERGY HOMEOSTASIS#0.9773;BROWN ADIPOSE TISSUE#0.9730;CENTRAL NERVOUS SYSTEM#0.9721;CORTISOL#0.9712;NERVOUS SYSTEM#0.9667;PROTEIN KINASE#0.9633;BODY WEIGHT GAIN#0.9609;STRUCTURE ACTIVITY RELATIONSHIP#0.9590;INSULIN RECEPTOR#0.9527;C TERMINAL DOMAIN#0.9503;RECEPTOR BINDING#0.9303;GROWTH HORMONE SECRETAGOGUE#0.9291;ADIPOCYTE#0.9260;FEEDING BEHAVIOUR#0.9223;EATING DISORDER#0.9222;LATERAL HYPOTHALAMIC AREA#0.9119;SIGNALING MOLECULE#0.9033;WHITE ADIPOSE TISSUE#0.9018;INTEGRIN BINDING#0.8904;THYROTROPIN RELEASING HORMONE#0.8863;SUCROSE#0.8849;POLYMERASE CHAIN REACTION#0.8769;BLOOD BRAIN BARRIER#0.8714;TYPE 2 DIABETES#0.8611;GLUCOSE SENSING#0.8586;GROWTH FACTOR#0.8533;ADRENOCORTICOTROPIC HORMONE#0.8394;REGULATION OF FEEDING BEHAVIOR#0.8392;GLUCOSE METABOLISM#0.8364;ESTRADIOL#0.8339;ANOREXIC#0.8222;SKELETAL MUSCLE#0.8200;OPIOID RECEPTOR#0.8133;HYPERGLYCEMIA#0.8078;GLUCOSE INTOLERANCE#0.8056;SPINAL CORD#0.8012;SIGNAL TRANSDUCER#0.7962;HIGH FAT FEEDING#0.7960;CELL SURFACE#0.7917;RESPONSE TO LEPTIN#0.7822;CORTICOTROPIN-RELEASING FACTOR#0.7815;FATTY LIVER#0.7807;SIGNALLING PATHWAY#0.7773;EATING BEHAVIOR#0.7733;MUSCLE WASTING#0.7696;GLUCOCORTICOID RECEPTOR#0.7674;PARACRINE SIGNALING#0.7670;LIPID METABOLISM#0.7648;INNERVATION#0.7641;PEPTIDE HORMONE#0.7633;CACHEXIA#0.7632;2-DEOXY-D-GLUCOSE#0.7629;HYPOTHALAMIC PITUITARY ADRENAL#0.7625;FATTY ACID SYNTHASE#0.7592;POSITIVE ENERGY BALANCE#0.7533;HINDBRAIN#0.7498;NERVE FIBER#0.7428;DOPAMINERGIC NEURON#0.7394;CUSHING'S SYNDROME#0.7273;RECEPTOR ACTIVITY#0.7233;AMYGDALA#0.7233;ESTROGEN RECEPTOR#0.7213;VASOPRESSIN#0.7204;LOW FAT DIET#0.7191;STEROIDOGENESIS#0.7176;TARGET OF RAPAMYCIN#0.7107;QUANTITATIVE REAL TIME#0.7093;GESTATION#0.7059;PROTEIN TYROSINE PHOSPHATASE#0.7054;CORTICOTROPHIN#0.7009;RELATED PROTEIN 1#0.6905;TUMOR NECROSIS FACTOR#0.6884;RECEPTOR LIGAND#0.6871;INSULIN SECRETION#0.6832;SIGNAL TRANSDUCTION#0.6820;APPETITE SUPPRESSION#0.6789;ADRENAL CORTEX#0.6747;NERVE TERMINAL#0.6720;SERUM LEPTIN LEVEL#0.6647;RAPAMYCIN#0.6625;PEROXISOME#0.6621;MECHANISM OF ACTION#0.6558;FATTY ACID OXIDATION#0.6482;ARGININE VASOPRESSIN#0.6460;CONDITIONED TASTE AVERSION#0.6445;INSULIN-LIKE GROWTH FACTOR#0.6416;OLANZAPINE#0.6398;PRADER WILLI SYNDROME#0.6388;OREXIN RECEPTOR#0.6351;NOREPINEPHRINE#0.6305;ADENOSINE#0.6297;FATTY LIVER DISEASE#0.6282;LIVER DISEASE#0.6241;BODY FAT MASS#0.6211;HORMONE SECRETION#0.6144;GONADOTROPIN RELEASING HORMONE#0.6141;GASTROINTESTINAL TRACT#0.6128;PHOSPHODIESTERASE#0.6085;AND BODY COMPOSITION#0.6062;CAMP RESPONSE ELEMENT BINDING#0.6056;DIURNAL#0.6055;CAMP RESPONSE ELEMENT#0.6045
1820	B CELL#1.0847;TRANSCRIPTION FACTOR#1.0604;DNA BINDING#1.0479;B LYMPHOCYTE#1.0202;GENE EXPRESSION#1.0048;STEM CELL#0.8756;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8089;LUPUS ERYTHEMATOSUS#0.8087;CELL CYCLE#0.7969;PML NB#0.7867;HEMATOPOIESIS#0.7574;CELL DEVELOPMENT#0.7475;HEMATOPOIETIC STEM CELL#0.7140;SENESCENCE#0.7036;CELL GROWTH#0.6951;B CELL DEVELOPMENT#0.6545;BONE MARROW#0.6232;PERIPHERAL BLOOD#0.6229;COLON CANCER#0.6161;TUMOR SUPPRESSOR#0.6128;APOPTOSIS#0.6002
1821	SCHWANN CELL#0.9996;DYSTROGLYCAN COMPLEX#0.7629
1822	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY#1.0613;NEURODEGENERATIVE DISEASE#1.0016;HUNTINGTON'S DISEASE#0.9847;GLUTAMINE#0.9810;CEREBELLAR ATAXIA#0.9695;MACHADO-JOSEPH DISEASE#0.9203;ANDROGEN RECEPTOR#0.9001;NERVOUS SYSTEM#0.8705;DEMENTIA#0.8447;AGE AT ONSET#0.8218;CENTRAL NERVOUS SYSTEM#0.8054;GENE EXPRESSION#0.7877;CELL DEATH#0.7493;AUTOSOMAL DOMINANT CEREBELLAR ATAXIA#0.7415;NEURONAL INTRANUCLEAR INCLUSIONS#0.7332;EPILEPSY#0.7257;TOXICITY#0.7228;T CELL#0.6548;ADULT T-CELL LEUKEMIA#0.6452;T-CELL LEUKEMIA#0.6413;CYTOPLASM#0.6277
1823	PEMPHIGUS#1.0343;KERATINOCYTE#0.9930;SUBCORNEAL PUSTULAR DERMATOSIS#0.9711;DESMOSOME#0.9141;CELL SURFACE#0.7177;GENE EXPRESSION#0.7161;PEMPHIGUS VULGARIS#0.6603
1824	DESMOSOME#1.0113;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY#1.0112;EPITHELIAL CELL#1.0034;CELL ADHESION#0.9997;CARDIOMYOPATHY#0.9947;SQUAMOUS CELL CARCINOMA#0.9637;CANCER CELL#0.9602;PLASMA MEMBRANE#0.9529;ADHERENS JUNCTION#0.9472;CELL CELL ADHESION#0.9463;KERATINOCYTE#0.9253;CELL PROLIFERATION#0.8950;GENE EXPRESSION#0.8874;CELL JUNCTION#0.8549;LYMPH NODE#0.8522;COLORECTAL CANCER#0.8476;CELL ADHESION MOLECULE#0.8341;GROWTH FACTOR#0.8296;ARRHYTHMIA#0.8222;COLORECTAL#0.8102;LUNG CANCER#0.7918;CELL SURFACE#0.7916;TIGHT JUNCTION#0.7900;INTERCELLULAR JUNCTION#0.7876;SUDDEN CARDIAC DEATH#0.7773;GAP JUNCTION#0.7741;HEART MUSCLE#0.7662;TASK FORCE CRITERIA#0.7329;DILATED CARDIOMYOPATHY#0.7270;POLYMERASE CHAIN REACTION#0.7241;TRANSFORMING GROWTH FACTOR#0.7104;MYOCARDIUM#0.6983;DESMOSOME ASSEMBLY#0.6953;ZONULA OCCLUDENS#0.6913;INTERMEDIATE FILAMENT#0.6604;BASAL CELL#0.6601;PEMPHIGUS#0.6505;INTERCALATED DISK#0.6252;ADENOCARCINOMA#0.6175;INTESTINAL EPITHELIAL CELL#0.6173;ZONULA OCCLUDENS 1#0.6139;TRANSFORMING GROWTH FACTOR BETA#0.6128;CARDIOMYOCYTE#0.6097;DNA HYPERMETHYLATION#0.6093
1825	PEMPHIGUS#1.0375;KERATINOCYTE#1.0140;CELL ADHESION#1.0125;DESMOSOME#1.0102;SQUAMOUS CELL CARCINOMA#1.0097;PEMPHIGUS VULGARIS#0.9933;CELL SURFACE#0.9862;BLISTERING#0.9828;TRANSCRIPTION FACTOR#0.9767;LUNG CANCER#0.9428;THYROID TRANSCRIPTION FACTOR#0.9398;EPITHELIAL CELL#0.9209;CELL CELL ADHESION#0.9108;ADENOCARCINOMA#0.8604;CELL PROLIFERATION#0.8142;CELL ADHESION MOLECULE#0.8055;SUBCORNEAL PUSTULAR DERMATOSIS#0.8048;GENE EXPRESSION#0.8025;LUNG CARCINOMA#0.7401;IMMUNOGLOBULIN G#0.7363;BREAST CANCER#0.7125;CANCER CELL#0.7115;SKIN DISEASE#0.7016;LYMPH NODE#0.6865;PLASMA MEMBRANE#0.6795;SIGNALING PATHWAY#0.6779;ADHERENS JUNCTION#0.6642;SREBP CLEAVAGE#0.6365;BASEMENT MEMBRANE#0.6292;HAIR FOLLICLE#0.6107;AUTOIMMUNE BLISTERING DISEASE#0.6084;DESMOSOME ASSEMBLY#0.6060;ORAL SQUAMOUS CELL CARCINOMA#0.6051
1826	AXON GUIDANCE#1.0649;DOWN SYNDROME#1.0532;CELL ADHESION MOLECULE#1.0520;CELL ADHESION#1.0501;CELL SURFACE#1.0401;NERVOUS SYSTEM#1.0265;NEURITE#1.0124;IMMUNE SYSTEM#1.0001;SELF RECOGNITION#0.9643;DENDRITE ARBORIZATION#0.9510;INNATE IMMUNITY#0.9226;IMMUNE RESPONSE#0.9133;SPINAL CORD#0.9023;RETINAL GANGLION CELL#0.8991;NETRIN RECEPTOR#0.8925;CENTRAL NERVOUS SYSTEM#0.8910;HEMOCYTE#0.8884;CELL DEATH#0.8821;GROWTH CONE#0.8792;MORPHOGENESIS#0.8780;MENTAL RETARDATION#0.8568;AXON GROWTH#0.8326;AMACRINE CELL#0.8318;COLORECTAL CANCER#0.8198;GANGLION CELLS#0.8068;NEURITE OUTGROWTH#0.8017;CELL RECOGNITION#0.8012;GENE EXPRESSION#0.7886;SIGNALING PATHWAY#0.7835;CEREBRAL CORTEX#0.7540;SYNAPTOGENESIS#0.7503;AXON GUIDANCE RECEPTOR#0.7340;COLORECTAL#0.7308;BIPOLAR CELL#0.7262;EXTRACELLULAR REGION#0.7193;INTERNEURON#0.7138;PHAGOCYTOSIS#0.6969;DENDRITE SELF-AVOIDANCE#0.6949;SYSTEM DEVELOPMENT#0.6881;RNA INTERFERENCE#0.6371;AXON BRANCHING#0.6364;RESPIRATION#0.6340;PATTERN RECOGNITION RECEPTOR#0.6313;NERVOUS SYSTEM DEVELOPMENT#0.6042;NEURAL CREST#0.6013
1827	CRITICAL REGION 1#1.0890;CALCINEURIN ACTIVITY#1.0632;ANGIOGENESIS#1.0492;CALCINEURIN SIGNALING#1.0480;STATIONARY PHASE#1.0436;CALCINEURIN#1.0412;DOWN SYNDROME#1.0332;APOPTOSIS#1.0299;ALZHEIMER'S DISEASE#1.0280;ACTIVATED T-CELLS#1.0241;ACTIVATED T CELL#1.0221;ENDOTHELIAL CELL#1.0207;SIGNALING PATHWAY#1.0153;GROWTH FACTOR#1.0147;T CELL#1.0126;PROTEIN KINASE#1.0124;TRANSCRIPTION FACTOR#1.0021;CELL DEATH#1.0016;SKELETAL MUSCLE#1.0010;PHOSPHATASE ACTIVITY#1.0000;POLYMERASE CHAIN REACTION#0.9934;CYCLOSPORIN A#0.9905;GENE EXPRESSION#0.9897;CALCINEURIN ACTIVATION#0.9770;ENDOTHELIAL GROWTH FACTOR#0.9685;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9685;CELL ACTIVATION#0.9667;UBIQUITIN#0.9604;CYCLOSPORIN#0.9547;CELL PROLIFERATION#0.9414;COMPETENCE STIMULATING PEPTIDE#0.9397;PROTEIN SYNTHESIS#0.9372;MUSCLE CELL#0.9322;CELL MIGRATION#0.9279;SIGNAL TRANSDUCTION#0.9194;REACTIVE OXYGEN SPECIES#0.9118;CARDIOMYOCYTE#0.9046;CAMP RESPONSE ELEMENT#0.8877;MENTAL RETARDATION#0.8789;NEUROFIBRILLARY TANGLE#0.8772;APOPTOTIC#0.8746;IMMUNE RESPONSE#0.8608;CALCINEURIN-NFAT SIGNALING PATHWAY#0.8592;BONE MARROW#0.8583;PROTEASOME#0.8571;EXOCYTOSIS#0.8473;MAST CELL#0.8402;NEURONAL CELLS#0.8375;INFLAMMATORY RESPONSE#0.8202;FETAL BRAIN#0.8136;NEUROGENESIS#0.8058;PROTEIN KINASE A#0.8052;ENDOPLASMIC RETICULUM#0.7993;CELL GROWTH#0.7980;SMOOTH MUSCLE#0.7957;HYPERPHOSPHORYLATION#0.7887;GLYCOGEN SYNTHASE KINASE#0.7882;CYCLOSPORINE#0.7834;VESICLE EXOCYTOSIS#0.7749;ADULT HIPPOCAMPAL NEUROGENESIS#0.7710;MACROPHAGE#0.7691;SMOOTH MUSCLE CELL#0.7682;NERVOUS SYSTEM#0.7658;AUTOPHAGY#0.7615;DNA BINDING#0.7591;MYOCYTES#0.7513;CANCER CELL#0.7506;MESANGIAL CELL#0.7498;AMYLOID PRECURSOR PROTEIN#0.7471;DEPHOSPHORYLATION#0.7430;CYTOKINE PRODUCTION#0.7370;VIRULENCE#0.7358;HUMAN UMBILICAL VEIN#0.7282;UMBILICAL VEIN#0.7280;T CELL ACTIVATION#0.7279;HEART DISEASE#0.7261;VASCULAR SMOOTH MUSCLE CELL#0.7240;CONGENITAL HEART DISEASE#0.7163;PRO-INFLAMMATORY#0.7022;ENDOTHELIAL CELL MIGRATION#0.7000;REVERSE TRANSCRIPTION#0.6949;CAMP RESPONSE ELEMENT BINDING#0.6944;ARTERY#0.6930;SECRETORY VESICLE#0.6901;MAP KINASE#0.6892;SPINAL CORD#0.6862;MITOCHONDRIAL FISSION#0.6811;TOXICITY#0.6798;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6787;PROTEASOME PATHWAY#0.6781;HYPERGLYCEMIA#0.6779;MYOSIN HEAVY CHAIN#0.6773;TUMOR NECROSIS FACTOR#0.6687;CYTOCHROME C#0.6668;QUORUM SENSING#0.6594;INHIBITION OF CALCINEURIN ACTIVITY#0.6586;CALCIUM SIGNALING#0.6558;LEUCINE#0.6555;TRANSCRIPTASE#0.6510;STEM CELL#0.6449;MYOCARDIUM#0.6316;ASTROCYTE#0.6299;CALCIUM CHANNEL#0.6299;TUBE FORMATION#0.6287;PLASMA MEMBRANE#0.6250;HYPOXIC#0.6227;TRANSCRIPTION REPRESSOR#0.6227;SUPEROXIDE DISMUTASE#0.6216;LYMPH NODE#0.6212;HYPERTENSION#0.6211;SIGNALING CASCADE#0.6203;ISCHEMIA#0.6193;SUBLINGUAL GLAND#0.6169;CHROMAFFIN CELL#0.6131;MITOCHONDRIA#0.6090;RNA BINDING#0.6052;HISTONE DEACETYLASE#0.6043;MAST CELL ACTIVATION#0.6017
1828	KERATINOCYTE DIFFERENTIATION#1.0298;AUTOIMMUNE BLISTERING DISEASE#1.0167;PEMPHIGUS#1.0110;CELL-CELL ADHESION MOLECULE#1.0109;CELL ADHESION MOLECULE#1.0068;MUCOUS#1.0043;SQUAMOUS CELL CARCINOMA#1.0043;BLISTERS#1.0025;IMPETIGO#1.0007;CELL CELL ADHESION#1.0007;T CELL#0.9990;BULLOUS PEMPHIGOID#0.9988;LICHEN PLANUS#0.9977;PEMPHIGUS VULGARIS#0.9974;B CELL#0.9972;SKIN DISEASE#0.9967;BLISTERING#0.9967;CELL SURFACE#0.9940;DESMOSOME#0.9933;EPITHELIAL CELL#0.9926;TIGHT JUNCTION#0.9917;AUTOIMMUNE DISEASE#0.9910;DERMATITIS#0.9893;CELL ADHESION#0.9888;KERATINOCYTE#0.9875;BASEMENT MEMBRANE#0.9847;ADHERENS JUNCTION#0.9804;GENE EXPRESSION#0.9772;PLASMA MEMBRANE#0.9691;ORAL MUCOSA#0.9683;AUTOIMMUNITY#0.9601;BASAL CELL#0.9536;IMMUNE RESPONSE#0.9486;LYMPH NODE#0.9415;CELL JUNCTION#0.9289;ESOPHAGUS#0.9241;APOPTOSIS#0.9233;SIGNALING PATHWAY#0.9233;GROWTH FACTOR#0.9192;IMMUNOGLOBULIN G#0.9151;POLYMERASE CHAIN REACTION#0.9134;GAP JUNCTION#0.9093;RITUXIMAB#0.9038;INTERMEDIATE FILAMENT#0.9024;INTRAVENOUS IMMUNOGLOBULIN#0.8879;ORAL LICHEN PLANUS#0.8868;KERATIN FILAMENT#0.8838;DESMOSOME ASSEMBLY#0.8784;PROTEIN KINASE#0.8772;NETHERTON SYNDROME#0.8700;INTERCELLULAR SPACE#0.8696;HAIR FOLLICLE#0.8543;HUMAN EPIDERMAL KERATINOCYTES#0.8365;PROTEASE ACTIVITY#0.8285;T LYMPHOCYTE#0.8223;ATOPIC DERMATITIS#0.8118;CELL MEMBRANE#0.8101;TOPICAL#0.8072;APOPTOTIC#0.8053;BULLOUS SKIN DISEASE#0.8000;PSORIASIS#0.7990;AUTOIMMUNE BULLOUS DISEASES#0.7936;EOSINOPHILIC ESOPHAGITIS#0.7842;EPIDERMOLYSIS BULLOSA#0.7559;TRANSCRIPTION FACTOR#0.7537;CHAGAS DISEASE#0.7512;INTERCELLULAR JUNCTION#0.7479;PREDNISOLONE#0.7457;TIGHT JUNCTION PROTEIN#0.7443;EPITHELIAL TISSUES#0.7320;OESOPHAGUS#0.7304;ACETYLCHOLINE RECEPTOR#0.7258;ANCHORING#0.7258;EPIDERMAL GROWTH FACTOR#0.7204;GROWTH FACTOR RECEPTOR#0.7204;CYTOPLASM#0.7196;LECTIN#0.7137;PERIPHERAL BLOOD#0.7065;SUBCORNEAL PUSTULAR DERMATOSIS#0.7059;CELL CELL JUNCTION#0.6955;STEM CELL#0.6948;LYMPH NODE METASTASES#0.6888;ESOPHAGITIS#0.6759;CONNECTIVE TISSUE#0.6737;SERINE PROTEASE ACTIVITY#0.6637;CANCER CELL#0.6634;ACETYLCHOLINE#0.6623;TERMINAL DIFFERENTIATION#0.6611;MITOGEN ACTIVATED PROTEIN#0.6551;ANAL REGION#0.6522;RESPONSE TO TREATMENT#0.6485;DERMATITIS HERPETIFORMIS#0.6463;LUPUS ERYTHEMATOSUS#0.6448;HEAT SHOCK PROTEIN#0.6431;AZATHIOPRINE#0.6262;ENDOTHELIAL CELL#0.6214;MELANOCYTE#0.6201;ORAL SQUAMOUS CELL CARCINOMA#0.6194;IGG ANTIBODY#0.6081;EOSINOPHIL#0.6002
1829	BASAL CELL#1.0307;KERATINOCYTE#1.0290;INTERCALATED DISC#1.0247;CANCER CELL#1.0188;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY#1.0187;CELL SURFACE#1.0081;EPITHELIAL CELL#1.0066;TIGHT JUNCTION#1.0064;DESMOSOME#1.0052;GROWTH FACTOR#1.0046;CELL CELL ADHESION#1.0036;INTERCELLULAR JUNCTION#1.0011;CELL ADHESION#1.0001;ADHERENS JUNCTION#0.9991;CARDIOMYOPATHY#0.9963;SQUAMOUS CELL CARCINOMA#0.9873;CELL JUNCTION#0.9795;CELL PROLIFERATION#0.9786;PEMPHIGUS#0.9718;PLASMA MEMBRANE#0.9693;ARRHYTHMIA#0.9671;CARDIOMYOCYTE#0.9643;PEMPHIGUS VULGARIS#0.9381;APOPTOSIS#0.9375;SIGNALING PATHWAY#0.9310;CELL ADHESION MOLECULE#0.9302;INTESTINAL EPITHELIAL CELL#0.9267;GENE EXPRESSION#0.9264;GROWTH FACTOR RECEPTOR#0.9252;STEM CELL#0.9047;EPIDERMAL GROWTH FACTOR#0.8915;MYOCARDIUM#0.8813;SUDDEN CARDIAC DEATH#0.8739;GAP JUNCTION#0.8467;ZONULA OCCLUDENS#0.8139;DILATED CARDIOMYOPATHY#0.8076;LIPID RAFT#0.8054;CELL CELL JUNCTION#0.7918;PANCREATIC CANCER#0.7895;DESMOSOME ASSEMBLY#0.7854;EPITHELIAL TISSUES#0.7811;HEART MUSCLE#0.7611;TRANSCRIPTION FACTOR#0.7608;ZONULA OCCLUDENS 1#0.7571;INTERMEDIATE FILAMENT#0.7554;TASK FORCE CRITERIA#0.7537;BASAL CELL CARCINOMA#0.7517;POLYMERASE CHAIN REACTION#0.7475;PROSTATE CANCER#0.7392;CONNEXIN#0.7264;ENDOTHELIAL CELL#0.7235;PROTEIN KINASE#0.7187;HEART DISEASE#0.7161;CADHERIN BINDING#0.7125;OVARIAN#0.7080;CELL MIGRATION#0.7061;ENTEROCYTE#0.6890;SWEAT GLAND#0.6866;TACHYCARDIA#0.6811;BONE MARROW#0.6716;SKIN DISEASE#0.6679;OVARIAN CANCER#0.6568;PROGENITOR CELL#0.6555;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6553;EPITHELIAL TO MESENCHYMAL#0.6551;TRANSFORMING GROWTH FACTOR#0.6484;LUNG CANCER#0.6282;BREAST CANCER#0.6265;BLISTERING#0.6217;MYOCYTES#0.6145;BREAST CANCER CELL#0.6050;COLONIC EPITHELIAL CELLS#0.6023;WOUND HEALING#0.6006
182	ALAGILLE SYNDROME#1.0374;TETRALOGY OF FALLOT#1.0365;NOTCH LIGAND#1.0234;OVARIAN CANCER#1.0219;INNER EAR#1.0139;PROSTATE CANCER#1.0128;ASTROCYTE#1.0092;TREG CELL#1.0086;OVARIAN#1.0069;NOTCH INTRACELLULAR DOMAIN#1.0059;COLORECTAL CANCER#1.0032;CD4+ T CELL#1.0025;RECEPTOR LIGAND#1.0025;ENDOTHELIAL PROGENITOR CELL#1.0016;COLON CANCER#1.0011;OSTEOBLAST#1.0010;KERATINOCYTE#1.0004;NOTCH SIGNALLING PATHWAY#0.9985;ENDOTHELIUM#0.9976;COLORECTAL#0.9975;CELL SURFACE#0.9973;S PHASE#0.9973;REVERSE TRANSCRIPTION#0.9963;MACROPHAGE#0.9962;B CELL#0.9949;BREAST CANCER CELL#0.9948;BILE DUCT#0.9947;VASCULAR SMOOTH MUSCLE CELL#0.9939;BREAST CANCER#0.9937;TUMOR CELLS#0.9932;CELL MIGRATION#0.9927;TONGUE CANCER#0.9912;CERVICAL#0.9906;CANCER CELL#0.9905;NEURAL CREST#0.9904;NOTCH RECEPTOR#0.9903;HEPATOCELLULAR CARCINOMA#0.9901;QUANTITATIVE REAL TIME#0.9898;STROMAL CELL#0.9897;T CELL#0.9891;MUSCLE CELL#0.9877;SMOOTH MUSCLE CELL#0.9874;SIGNALING MOLECULE#0.9870;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9865;ENDOTHELIAL GROWTH FACTOR#0.9858;CENTRAL NERVOUS SYSTEM#0.9856;SMOOTH MUSCLE#0.9847;DENDRITIC CELL#0.9846;SIGNALING CASCADE#0.9843;REGULATORY T CELL#0.9840;CD8+ T CELL#0.9839;SMOOTH MUSCLE ACTIN#0.9835;MYOFIBROBLAST#0.9835;EPITHELIAL CELL#0.9833;ENDOTHELIAL CELL#0.9824;EPIDERMAL GROWTH FACTOR#0.9822;HYPOXIA#0.9818;LYMPH NODE#0.9812;TUMOR TISSUES#0.9810;CELL GROWTH#0.9808;HEPATIC STELLATE CELL#0.9808;HEMATOPOIETIC STEM CELL#0.9806;CELL ADHESION#0.9803;HEMATOPOIESIS#0.9803;BLOOD VESSEL#0.9802;SIGNALLING PATHWAY#0.9798;APOPTOTIC#0.9795;IMMUNE RESPONSE#0.9791;CHOLESTASIS#0.9789;MESENCHYMAL STEM CELL#0.9789;NERVOUS SYSTEM#0.9781;MORPHOGENESIS#0.9777;STROMA#0.9776;CANCER STEM CELL#0.9775;HEMATOPOIETIC CELL#0.9768;ANGIOGENESIS#0.9764;TRANSFORMING GROWTH FACTOR#0.9764;HAIR CELL#0.9763;POLYMERASE CHAIN REACTION#0.9755;EXTRACELLULAR MATRIX#0.9740;CELL ACTIVATION#0.9739;OSTEOBLAST DIFFERENTIATION#0.9737;BONE MARROW#0.9734;REGENERATION#0.9732;CELL DIFFERENTIATION#0.9731;ADENOCARCINOMA#0.9727;NOTCH SIGNALING PATHWAY#0.9727;GROWTH FACTOR RECEPTOR#0.9724;PROGENITOR CELL#0.9723;ARTERY#0.9722;GENE EXPRESSION#0.9713;GROWTH FACTOR#0.9713;LUNG CANCER#0.9713;CELL CYCLE#0.9702;PROTEIN KINASE#0.9700;NEURAL STEM CELL#0.9700;SIGNAL TRANSDUCTION#0.9699;MINERALIZATION#0.9694;WOUND HEALING#0.9689;TRANSCRIPTION FACTOR#0.9687;LYMPH NODE METASTASIS#0.9679;EPITHELIAL MESENCHYMAL TRANSITION#0.9677;MESENCHYME#0.9674;CELL CYCLE ARREST#0.9670;ONCOGENIC#0.9668;APOPTOSIS#0.9667;DISEASE FREE SURVIVAL#0.9664;T CELL PROLIFERATION#0.9657;LATERAL INHIBITION#0.9650;STEM CELL#0.9647;NEUROGENESIS#0.9640;ALKALINE PHOSPHATASE#0.9632;SIGNALING PATHWAY#0.9632;CELL PROLIFERATION#0.9630;CELL DEVELOPMENT#0.9623;CELL DEATH#0.9616;TUMOR SUPPRESSOR#0.9605;PERIODONTAL LIGAMENT#0.9602;HUMAN PERIODONTAL LIGAMENT#0.9601;BILIARY ATRESIA#0.9591;SKELETON#0.9582;SQUAMOUS CELL CARCINOMA#0.9579;OSTEOCLAST#0.9565;EPITHELIAL TO MESENCHYMAL#0.9564;CARDIOMYOCYTE#0.9563;STEM CELL MARKER#0.9560;SPINAL CORD#0.9533;CELL FATE DETERMINATION#0.9509;PERIPHERAL BLOOD#0.9507;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9491;PRECURSOR CELL#0.9470;MESENCHYMAL CELL#0.9457;LIVER DISEASE#0.9437;CORD BLOOD#0.9367;IHBD DEVELOPMENT#0.9361;PERICYTE#0.9355;CYTOTOXICITY#0.9346;RNA INTERFERENCE#0.9341;MULTIPLE MYELOMA#0.9322;TUBE FORMATION#0.9321;BILE DUCT DEVELOPMENT#0.9312;ISCHEMIA#0.9281;MONOCYTE#0.9274;PLATELET-DERIVED GROWTH FACTOR#0.9269;PODOCYTE#0.9265;DRUG RESISTANCE#0.9264;OLIGODENDROCYTE#0.9242;FIBROBLAST GROWTH FACTOR#0.9227;MYELOID LEUKEMIA#0.9210;HEART DISEASE#0.9208;PORTAL VEIN#0.9193;ALLERGIC AIRWAY INFLAMMATION#0.9190;EAR DEVELOPMENT#0.9187;IFN-GAMMA#0.9166;PULMONARY FIBROSIS#0.9157;G1 PHASE#0.9149;T LYMPHOCYTE#0.9130;OVARIAN CARCINOMA#0.9113;THYMOCYTE#0.9074;CHONDROCYTE#0.9026;NEPHROPATHY#0.9021;ACUTE MYELOID LEUKEMIA#0.9015;SIGNAL TRANSDUCER#0.9011;BREAST CARCINOMA#0.8991;QUANTITATIVE REVERSE TRANSCRIPTION#0.8978;BONE MARROW STROMAL#0.8978;CYTOPLASM#0.8973;GRANULOSA CELL#0.8967;T CELL ACTIVATION#0.8928;CELL ADHESION MOLECULE#0.8927;LUMINAL#0.8913;KINASE INHIBITOR#0.8908;OOCYTE#0.8897;CERVICAL CANCER#0.8891;HYPOXIA INDUCIBLE FACTOR#0.8868;DNA METHYLATION#0.8851;DIABETIC NEPHROPATHY#0.8851;BONE MINERAL DENSITY#0.8848;AUTOIMMUNE DISEASE#0.8847;TRANSFORMING GROWTH FACTOR BETA#0.8842;BONE MARROW STROMAL CELL#0.8819;CONGENITAL HEART DISEASE#0.8813;PANCREATIC CANCER#0.8770;BONE FORMATION#0.8762;ALLERGEN#0.8750;SERTOLI CELL#0.8748;BONE MORPHOGENETIC PROTEIN#0.8747;OSTEOCLAST DIFFERENTIATION#0.8739;T CELL DIFFERENTIATION#0.8735;INFLAMMATORY RESPONSE#0.8730;DNA BINDING#0.8718;MYOCARDIUM#0.8703;HUMAN MESENCHYMAL STEM#0.8694;HAIR FOLLICLE#0.8675;PRO-INFLAMMATORY#0.8660;LIVER REGENERATION#0.8626;TRANSCRIPTASE#0.8613;MAMMARY GLAND#0.8604;INNER EAR DEVELOPMENT#0.8591;HUMAN BREAST CANCER#0.8589;CONGENITAL HEART DEFECTS#0.8588;CELL FATE SPECIFICATION#0.8582;ENDOCYTOSIS#0.8549;TUMOR NECROSIS FACTOR#0.8538;IMMUNE CELL#0.8456;MESENCHYMAL STROMAL CELL#0.8455;DENTAL PULP#0.8442;DENTAL PULP CELL#0.8437;SKELETAL MUSCLE#0.8425;MARROW STROMAL CELLS#0.8404;DUAL LUCIFERASE REPORTER#0.8401;GESTATION#0.8393;HYPERTENSION#0.8367;BREAST CANCER PATIENTS#0.8345;CAROTID ARTERY#0.8341;PITUITARY ADENOMA#0.8339;INTRAHEPATIC CHOLESTASIS#0.8335;TH17 CELL#0.8326;ESTROGEN RECEPTOR#0.8300;IMMUNE SYSTEM#0.8293;ADJACENT NORMAL TISSUE#0.8269;COCHLEA#0.8268;CYTOKINE PRODUCTION#0.8252;INDUCTION OF APOPTOSIS#0.8210;MECHANISM OF ACTION#0.8173;MYOCARDIAL INFARCTION#0.8168;METASTATIC PROSTATE CANCER#0.8149;NITRIC OXIDE#0.8142;GLIAL CELL#0.8121;MULTIPLE SCLEROSIS#0.8119;TROPHOBLAST#0.8119;CELL COMMUNICATION#0.8109;MURAL CELL#0.8104;OSTEOPOROSIS#0.8103;CISPLATIN#0.8097;SPROUTING ANGIOGENESIS#0.8090;BONE MARROW CELLS#0.8088;ANTIGEN PRESENTING CELLS#0.8082;HEPATIC PROGENITOR CELL#0.8081;COLONY-STIMULATING FACTOR#0.8051;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8051;INSULIN-LIKE GROWTH FACTOR#0.8047;VERTEBRAE#0.8045;ORGAN OF CORTI#0.8028;CARDIAC DEVELOPMENT#0.8015;OUTFLOW TRACT#0.7996;VASCULAR ENDOTHELIAL CELL#0.7982;REPORTER GENE ASSAY#0.7974;HEMATOPOIETIC PROGENITOR CELL#0.7972;STEM CELL FACTOR#0.7969;FETAL LIVER#0.7959;RENAL CELL CARCINOMA#0.7922;HUMAN DENTAL PULP#0.7921;STEM CELL MAINTENANCE#0.7919;MONONUCLEAR CELLS#0.7882;CORONARY ARTERY#0.7859;HYPOXIC#0.7855;UMBILICAL CORD#0.7825;BASAL CELL#0.7825;EMBRYONIC STEM CELL#0.7807;OSTEOARTHRITIS#0.7800;TOLL LIKE RECEPTOR#0.7786;BONE RESORPTION#0.7779;ATHEROSCLEROSIS#0.7773;TRANSMEMBRANE RECEPTOR#0.7763;RECEPTOR ACTIVATOR#0.7740;BONE MARROW MICROENVIRONMENT#0.7729;SENESCENCE#0.7721;GLYCOSYLATION#0.7715;UBIQUITIN#0.7711;CELL COUNTING KIT#0.7662;EPIDERMAL STEM CELL#0.7656;LIVER CANCER#0.7647;GASTRIC MUCOSA#0.7646;NEUROBLASTOMA#0.7642;PULMONARY ARTERY#0.7634;5 FLUOROURACIL#0.7634;GASTRIC EPITHELIAL CELLS#0.7632;GERM CELL#0.7624;BASEMENT MEMBRANE#0.7624;KIDNEY DISEASE#0.7602;CONNECTIVE TISSUE#0.7546;VASCULAR CELL#0.7540;SENSITIZATION#0.7533;CELL MEMBRANE#0.7531;EPITHELIAL OVARIAN CARCINOMA#0.7517;REACTIVE OXYGEN SPECIES#0.7511;NEURAL PROGENITOR CELL#0.7481;5-AZA-2'-DEOXYCYTIDINE#0.7478;T CELL DEVELOPMENT#0.7475;2'-DEOXYCYTIDINE#0.7474;ENDOMETRIUM#0.7456;OVARIES#0.7436;TUBULAR EPITHELIAL CELL#0.7432;TRANSDIFFERENTIATION#0.7413;OSTEOGENESIS#0.7400;CHONDROGENESIS#0.7378;KNEE JOINT#0.7357;VASCULOGENESIS#0.7346;RECEPTOR BINDING#0.7343;UMBILICAL VEIN#0.7342;PDZ BINDING MOTIF#0.7341;PLASMA MEMBRANE#0.7341;TRANSACTIVATION#0.7339;EPITHELIAL CELL PROLIFERATION#0.7274;THYMIC EPITHELIAL CELLS#0.7264;GAMMA SECRETASE INHIBITORS#0.7259;ADIPOCYTE#0.7256;WNT SIGNALING PATHWAY#0.7241;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7220;LYMPHOCYTIC LEUKEMIA#0.7213;ALLERGIC RHINITIS#0.7211;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7204;LIVER DEVELOPMENT#0.7196;PARATHYROID HORMONE#0.7174;ADIPOSE TISSUE#0.7169;STEM CELL LIKE#0.7145;OLIGODENDROCYTE DIFFERENTIATION#0.7122;VSMC PROLIFERATION#0.7093;M PHASE#0.7081;ARTERIOVENOUS MALFORMATION#0.7078;MITOGEN ACTIVATED PROTEIN#0.7039;ALLERGIC ASTHMA#0.7020;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7019;TISSUE REGENERATION#0.7014;FLUOROURACIL#0.7012;NEURITE#0.7009;GRANULOCYTE#0.7004;HUMAN CORD BLOOD#0.7003;HEPATITIS B VIRUS#0.6976;PLASMA CELL#0.6976;HEPATITIS B#0.6960;CRANIOFACIAL DEVELOPMENT#0.6958;HUMAN GASTRIC CARCINOMA#0.6932;MACROPHAGE DIFFERENTIATION#0.6905;NOTCH BINDING#0.6904;INHIBITION OF CELL GROWTH#0.6893;QUIESCENCE#0.6888;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6874;HUMAN UMBILICAL VEIN#0.6870;EXOSOME#0.6856;GENETIC DISORDER#0.6842;CRANIAL NEURAL CREST#0.6825;SECRETORY CELL#0.6810;TRASTUZUMAB#0.6785;GASTRIC TISSUE#0.6784;STEM CELL DIFFERENTIATION#0.6770;YEAR SURVIVAL RATE#0.6753;MYELODYSPLASTIC SYNDROME#0.6750;MYELINATION#0.6737;GOBLET CELL#0.6737;NORMAL BREAST TISSUE#0.6733;IL-4 PRODUCTION#0.6726;NAIVE T CELL#0.6709;VASCULAR DISEASE#0.6706;MYELOID CELL#0.6703;BILIARY TRACT#0.6696;LUNG CARCINOMA#0.6665;LENS DEVELOPMENT#0.6657;LEUKOCYTE#0.6592;KERATINOCYTE DIFFERENTIATION#0.6568;EXTRACELLULAR REGION#0.6504;YOLK SAC#0.6478;HEPATOCYTE GROWTH FACTOR#0.6473;VASCULAR MORPHOGENESIS#0.6450;GALECTIN#0.6438;MICROVASCULAR ENDOTHELIAL CELL#0.6431;SENSORY ORGAN#0.6358;SMOOTH MUSCLE CELL DIFFERENTIATION#0.6337;KIDNEY DEVELOPMENT#0.6334;CANCER STEM-LIKE CELL#0.6331;BENIGN PROSTATIC TISSUE#0.6304;LUNG DEVELOPMENT#0.6288;CARDIOVASCULAR SYSTEM#0.6262;MUSCLE CELL DIFFERENTIATION#0.6259;METAPLASIA#0.6253;CYTOKINE SECRETION#0.6246;ISCHEMIA REPERFUSION INJURY#0.6238;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6236;MICROTUBULE#0.6217;ADENO ASSOCIATED VIRUS#0.6202;AMELOBLASTOMA#0.6196;HEMANGIOMA#0.6192;DIABETES MELLITUS#0.6183;TOXICITY#0.6182;TISSUE GROWTH FACTOR#0.6168;DERMIS#0.6166;ESTRADIOL#0.6165;CHOLANGIOCYTE PROLIFERATION#0.6162;EFFECTOR T CELL#0.6155;PARATHYROID#0.6153;MYOSIN HEAVY CHAIN#0.6149;COLON CARCINOMA#0.6148;GROWTH FACTOR BINDING#0.6148;INTESTINAL EPITHELIAL CELL#0.6143;MUSCULAR DYSTROPHY#0.6131;LYMPHOID ORGANS#0.6128;THYMUS DEVELOPMENT#0.6122;B CELL LYMPHOMA#0.6117;CELL MOTILITY#0.6104;B LYMPHOCYTE#0.6085;CYCLIN DEPENDENT KINASE#0.6082;ADRENOCORTICAL CARCINOMA#0.6077;MYOBLAST#0.6073;MIDDLE EAR#0.6053;FORMALIN#0.6045;PROTEINURIA#0.6042;EOSINOPHIL#0.6037;ETHANOL#0.6029;HETEROTRIMERIC G-PROTEIN#0.6022;BONE CELLS#0.6017
1830	LYMPH NODE#1.0332;CD4+ T CELL#1.0299;AUTOIMMUNE BLISTERING DISEASE#1.0236;TH2 CELL#1.0203;B CELL#1.0202;T CELL#1.0172;PEMPHIGUS#1.0126;CELL RECOGNITION#1.0120;CELL ADHESION MOLECULE#1.0116;PEMPHIGUS VULGARIS#1.0110;CELL CELL ADHESION#1.0092;SQUAMOUS CELL CARCINOMA#1.0087;KERATIN FILAMENT#1.0077;ADHERENS JUNCTION#1.0068;BLISTERS#1.0039;BLISTERING#1.0017;ORAL MUCOSA#1.0011;CELL SURFACE#1.0004;SKIN DISEASE#1.0003;EPITHELIAL CELL#1.0002;MUCOUS#0.9993;DESMOSOME#0.9987;KERATINOCYTE#0.9972;CELL ADHESION#0.9968;BULLOUS PEMPHIGOID#0.9908;IGG BINDING#0.9883;AUTOIMMUNE DISEASE#0.9879;AUTOIMMUNITY#0.9815;IMMUNOGLOBULIN G#0.9807;SIGNALING PATHWAY#0.9800;PERIPHERAL BLOOD#0.9784;LUNG CANCER#0.9728;PROTEIN KINASE#0.9694;PLASMA MEMBRANE#0.9688;BASAL CELL#0.9673;GROWTH FACTOR#0.9669;ENDOCYTOSIS#0.9615;ESOPHAGUS#0.9588;POLYMERASE CHAIN REACTION#0.9540;GENE EXPRESSION#0.9537;LICHEN PLANUS#0.9512;ANTIBODY PRODUCTION#0.9507;INTRAVENOUS IMMUNOGLOBULIN#0.9480;DESMOSOME ASSEMBLY#0.9453;STEM CELL#0.9443;TRANSCRIPTION FACTOR#0.9442;CELL PROLIFERATION#0.9415;BULLOUS SKIN DISEASE#0.9410;PLAKOGLOBIN BINDING#0.9391;RITUXIMAB#0.9259;APOPTOSIS#0.9154;IMMUNE RESPONSE#0.9116;LYMPH NODE METASTASIS#0.9104;BASEMENT MEMBRANE#0.9081;CELL MEMBRANE#0.9062;T LYMPHOCYTE#0.9003;ADENOCARCINOMA#0.8990;DERMATITIS#0.8856;AUTOIMMUNE BULLOUS DISEASES#0.8618;INTERCELLULAR SPACE#0.8487;INTERMEDIATE FILAMENT#0.8470;PROTEIN KINASE C#0.8368;HAIR FOLLICLE#0.8315;APOPTOTIC#0.8261;CANCER CELL#0.8247;REVERSE TRANSCRIPTION#0.8238;HAIR LOSS#0.8097;GROWTH FACTOR RECEPTOR#0.8088;ORAL SQUAMOUS CELL CARCINOMA#0.8019;PREDNISOLONE#0.8011;ORAL LICHEN PLANUS#0.8010;WOUND HEALING#0.7960;TH1 CELL#0.7942;MITOGEN ACTIVATED PROTEIN#0.7934;EPIDERMAL GROWTH FACTOR#0.7934;HUMAN EPIDERMAL KERATINOCYTES#0.7883;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7809;MONONUCLEAR CELLS#0.7796;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7625;ETHYLENEDIAMINETETRAACETIC ACID#0.7574;CELL JUNCTION#0.7532;CELL-CELL ADHESION MOLECULE#0.7393;TOPICAL#0.7332;TIGHT JUNCTION#0.7253;IGG ANTIBODY#0.7242;DERMATITIS HERPETIFORMIS#0.7200;LUPUS ERYTHEMATOSUS#0.7163;SIGNAL TRANSDUCTION#0.6997;INFLAMMATORY RESPONSE#0.6975;MEMORY B CELL#0.6937;SUBCORNEAL PUSTULAR DERMATOSIS#0.6913;REGULATORY T CELL#0.6841;CYTOPLASM#0.6835;TERMINAL DIFFERENTIATION#0.6807;ACETYLCHOLINE RECEPTOR#0.6758;CELL SURFACE ANTIGEN#0.6753;MAPK ACTIVATION#0.6747;CELL DIFFERENTIATION#0.6678;KERATINOCYTE DIFFERENTIATION#0.6624;ROOT SHEATH#0.6582;AZATHIOPRINE#0.6507;CELL MIGRATION#0.6484;ACTIN CYTOSKELETON#0.6465;CERVICAL#0.6461;EPIDERMOLYSIS BULLOSA#0.6427;EXTRACELLULAR REGION#0.6310;TELOGEN#0.6272;INTERCELLULAR JUNCTION#0.6223;EPIDERMAL STEM CELL#0.6206;EPITHELIAL TISSUES#0.6204;ENDOSOME#0.6105;CERVICAL LYMPH NODE#0.6096;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6011
1831	MACROPHAGE#1.0534;T LYMPHOCYTE#1.0512;DENDRITIC CELL#1.0501;LEUCINE#1.0487;T CELL#1.0392;CELL DEATH#1.0328;DEXAMETHASONE#1.0210;SIGNALING PATHWAY#1.0177;PRO-INFLAMMATORY#1.0175;APOPTOSIS#1.0167;EPITHELIAL CELL#1.0140;STEM CELL#1.0108;INFLAMMATORY RESPONSE#1.0055;TRANSCRIPTION FACTOR#1.0003;ALDOSTERONE#0.9915;BONE MARROW#0.9897;DNA BINDING#0.9849;GLUCOCORTICOID RECEPTOR#0.9847;GROWTH FACTOR#0.9812;GENE EXPRESSION#0.9805;CELL PROLIFERATION#0.9745;CELL ACTIVATION#0.9711;TRANSACTIVATION#0.9702;MESENCHYMAL STEM CELL#0.9692;ADIPOSE TISSUE#0.9684;CANCER CELL#0.9651;IMMUNE CELL#0.9615;IMMUNE RESPONSE#0.9554;NEUTROPHIL#0.9522;PROTEIN KINASE#0.9485;THYMOCYTE#0.9466;HUMAN AIRWAY EPITHELIAL#0.9385;APOPTOTIC#0.9294;T CELL ACTIVATION#0.9220;MONOCYTE#0.9089;TUMOR NECROSIS FACTOR#0.9079;PERIPHERAL BLOOD#0.9050;B CELL#0.9005;TH17 CELL#0.8993;AIRWAY EPITHELIAL CELL#0.8960;MITOGEN ACTIVATED PROTEIN#0.8935;IMMUNE SYSTEM#0.8854;POLYMERASE CHAIN REACTION#0.8850;LEUKOCYTE#0.8829;CORTISOL#0.8706;ENDOTHELIAL CELL#0.8701;OSTEOBLAST#0.8611;SODIUM TRANSPORT#0.8585;MUSCLE CELL#0.8465;FK506 BINDING PROTEIN#0.8406;FK506 BINDING#0.8403;TRANSFORMING GROWTH FACTOR#0.8299;EPITHELIAL SODIUM CHANNEL#0.8296;TOLL LIKE RECEPTOR#0.8256;SODIUM CHANNEL#0.8209;SPERMATOGENESIS#0.8192;MONONUCLEAR CELLS#0.8130;SMOOTH MUSCLE#0.7969;SIGNAL TRANSDUCTION#0.7966;TISSUE DAMAGE#0.7909;REGULATORY T CELL#0.7880;CELL CYCLE#0.7848;RHEUMATOID ARTHRITIS#0.7809;THYMOCYTE APOPTOSIS#0.7698;QUANTITATIVE REAL TIME#0.7635;RETINAL DEGENERATION#0.7589;HYPOXIA#0.7569;GERM CELL#0.7497;AUTOIMMUNE DISEASE#0.7491;HYPOTHALAMIC PITUITARY ADRENAL#0.7340;ESTROGEN RECEPTOR#0.7286;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7224;SMOOTH MUSCLE CELL#0.7084;EXCRETION#0.7044;ADIPOCYTE#0.7036;CD4+ T CELL#0.6985;PREDNISOLONE#0.6888;REPORTER GENE ASSAY#0.6849;COLITIS#0.6842;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6816;IL-10 PRODUCTION#0.6791;NERVOUS SYSTEM#0.6790;ADIPOGENESIS#0.6781;CYTOKINE SECRETION#0.6764;SPINAL CORD#0.6742;BUDESONIDE#0.6637;IFN-GAMMA#0.6548;OVARIAN#0.6310;PSORIASIS#0.6285;ALLERGEN#0.6278;INFECTIOUS BURSAL DISEASE#0.6175;GLUCOCORTICOID-INDUCED OSTEOPOROSIS#0.6149;ADIPOCYTE DIFFERENTIATION#0.6133;CELL POLARIZATION#0.6054;AIRWAY EPITHELIUM#0.6020;ENCEPHALOMYELITIS#0.6012
1832	BULLOUS PEMPHIGOID#1.0483;ERYTHEMA MULTIFORME#1.0443;CONNEXIN#1.0309;DESMOSOME ASSEMBLY#1.0287;INTERCALATED DISK#1.0151;INTERMEDIATE FILAMENT#1.0075;KERATIN FILAMENT#1.0070;GAP JUNCTION#1.0068;INTERCALATED DISC#1.0060;ADHERENS JUNCTION#1.0034;ENDOTHELIAL CELL#1.0027;DESMOSOME#0.9962;TIGHT JUNCTION#0.9946;CELL JUNCTION#0.9941;CARDIOMYOCYTE#0.9926;PLASMA MEMBRANE#0.9895;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY#0.9894;INTERCELLULAR JUNCTION#0.9873;GROWTH FACTOR#0.9865;KERATINOCYTE#0.9817;DILATED CARDIOMYOPATHY#0.9813;CELL SURFACE#0.9808;PEMPHIGUS#0.9787;CELL ADHESION#0.9770;CARDIOMYOPATHY#0.9765;CELL CELL ADHESION#0.9750;EPITHELIAL CELL#0.9734;LYMPHATIC VESSEL#0.9733;CYTOPLASM#0.9732;BASEMENT MEMBRANE#0.9719;CELL CELL JUNCTION#0.9713;PEMPHIGUS VULGARIS#0.9709;ZONULA OCCLUDENS#0.9660;CELL ADHESION MOLECULE#0.9640;ARRHYTHMIA#0.9636;CONTACT SITE#0.9634;MYOCARDIUM#0.9630;GENE EXPRESSION#0.9616;SQUAMOUS CELL CARCINOMA#0.9585;SUDDEN CARDIAC DEATH#0.9549;ERYTHEMA#0.9539;LYMPH NODE#0.9539;EPIDERMOLYSIS BULLOSA#0.9533;MICROTUBULE#0.9493;BLISTERING#0.9416;EPIDERMAL GROWTH FACTOR#0.9399;HEART MUSCLE#0.9396;CANCER CELL#0.9362;STEM CELL#0.9305;POLYMERASE CHAIN REACTION#0.9261;CORNIFIED ENVELOPE#0.9255;PROTEIN KINASE#0.9228;TIGHT JUNCTION PROTEIN#0.9199;APOPTOSIS#0.9163;BASAL CELL#0.9074;ANCHORING#0.9055;MORPHOGENESIS#0.9052;TRANSFORMING GROWTH FACTOR#0.9043;INTERMEDIATE FILAMENT BINDING#0.8996;TACHYCARDIA#0.8936;SIGNALING PATHWAY#0.8928;EPITHELIAL TISSUES#0.8817;CELL MEMBRANE#0.8797;HEART DISEASE#0.8773;ZONULA OCCLUDENS 1#0.8768;INTERMEDIATE FILAMENT CYTOSKELETON#0.8682;TRANSCRIPTION FACTOR#0.8668;SPECTRIN#0.8646;SKIN DISEASE#0.8479;TRANSMISSION ELECTRON MICROSCOPY#0.8452;HEMIDESMOSOME#0.8449;MYOCYTES#0.8439;CELL DIFFERENTIATION#0.8421;DENSE PLAQUE#0.8335;CELL PROLIFERATION#0.8315;C TERMINAL DOMAIN#0.8280;EXTRACELLULAR MATRIX#0.8270;NEUROFILAMENT#0.8167;TROPHOBLAST#0.8043;TUMOR CELLS#0.7974;ALOPECIA#0.7932;PROTEIN KINASE C#0.7906;MICROFILAMENT#0.7858;ACTIN FILAMENT#0.7802;EPITHELIAL MESENCHYMAL TRANSITION#0.7757;GROWTH FACTOR RECEPTOR#0.7750;BLOOD VESSEL#0.7648;AUTOIMMUNE DISEASE#0.7451;TASK FORCE CRITERIA#0.7353;MUSCLE CELL#0.7316;SIGNAL TRANSDUCTION#0.7313;CELL PERIPHERY#0.7276;WOUND HEALING#0.7236;NADPH OXIDASE#0.7208;SMOOTH MUSCLE#0.7201;ACTIN CYTOSKELETON#0.7125;BREAST CANCER#0.7122;CYTOTROPHOBLAST#0.6844;MYOSIN BINDING#0.6810;MYOSIN HEAVY CHAIN#0.6774;IDIOPATHIC PULMONARY FIBROSIS#0.6774;MESENCHYMAL CELL#0.6761;PULMONARY FIBROSIS#0.6730;SKELETAL MUSCLE#0.6710;CELL CYCLE#0.6693;STROMA#0.6635;TROPHOBLAST CELL#0.6633;ECTODERMAL DYSPLASIA#0.6585;LASER SCANNING MICROSCOPY#0.6523;HAIR FOLLICLE#0.6504;LUNG CANCER#0.6469;DENDRITIC CELL#0.6434;PROGENITOR CELL#0.6425;T CELL#0.6397;INTERCELLULAR SPACE#0.6389;INTERMEDIATE FILAMENT ASSOCIATED PROTEIN#0.6379;TERMINAL DIFFERENTIATION#0.6367;AUTOIMMUNE BLISTERING DISEASE#0.6321;ADIPOCYTE#0.6312;BLISTERS#0.6273;UMBILICAL VEIN#0.6245;OVARIAN#0.6231;CARDIAC MUSCLE#0.6164;PLAKOGLOBIN BINDING#0.6157;FOCAL ADHESION#0.6138;CYTOSKELETAL ELEMENT#0.6119;DERMATITIS#0.6112;CELL GROWTH#0.6094;OUTFLOW TRACT#0.6048;CORNEAL EPITHELIAL CELL#0.6031;CELL FUSION#0.6006
1833	PROTEOGLYCAN#1.0856;LEUCINE#1.0188;LEUCINE RICH REPEAT#1.0088;CHONDROCYTE#0.7990;EXTRACELLULAR MATRIX#0.7700;CARTILAGE DEVELOPMENT#0.7313;CORNEA PLANA#0.6708;GENE EXPRESSION#0.6144
1834	COLLAGEN TYPE I#1.0456;MATRIX PROTEIN 1#1.0448;DENTIN MATRIX PROTEIN#1.0387;DENTINOGENESIS IMPERFECTA#1.0316;DENTIN MINERALIZATION#1.0291;INTEGRIN BINDING#1.0214;NODULE FORMATION#1.0170;QUANTITATIVE REAL TIME#1.0156;BIOMINERALIZATION#1.0101;ALKALINE PHOSPHATASE ACTIVITY#1.0094;PHOSPHATASE ACTIVITY#1.0072;DENTAL PAPILLA#1.0024;ODONTOBLAST DIFFERENTIATION#1.0001;ENDOTHELIAL GROWTH FACTOR#0.9990;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9990;DENTINOGENESIS#0.9982;ODONTOGENESIS#0.9979;ALKALINE PHOSPHATASE#0.9977;INCISORS#0.9975;POLYMERASE CHAIN REACTION#0.9943;SQUAMOUS CELL CARCINOMA#0.9943;ASPARTIC ACID#0.9942;MESENCHYMAL CELL#0.9912;PROTEOGLYCAN#0.9901;TOOTH DEVELOPMENT#0.9901;SALIVARY GLAND#0.9899;REVERSE TRANSCRIPTION#0.9887;BONE MORPHOGENETIC PROTEIN#0.9884;TRANSCRIPTION FACTOR#0.9883;MINERALIZATION#0.9869;GENE EXPRESSION#0.9854;ALIZARIN RED STAINING#0.9830;ALIZARIN RED S#0.9801;PROTEIN KINASE#0.9790;OSTEOBLAST#0.9777;MINERAL TRIOXIDE AGGREGATE#0.9739;EXTRACELLULAR MATRIX#0.9727;CELL DIFFERENTIATION#0.9722;SCANNING ELECTRON MICROSCOPY#0.9722;OSTEOGENESIS#0.9718;MOLAR#0.9684;DENTAL PULP CELL#0.9684;SIGNALING PATHWAY#0.9681;CELL ADHESION#0.9665;CELL PROLIFERATION#0.9665;PROGENITOR CELL#0.9657;TISSUE REGENERATION#0.9650;GROWTH FACTOR#0.9642;PERIODONTAL LIGAMENT#0.9641;MESENCHYMAL STEM CELL#0.9619;DENTAL PULP STEM CELL#0.9614;TRANSFORMING GROWTH FACTOR#0.9610;DENTAL PULP#0.9589;HUMAN DENTAL PULP#0.9585;APOPTOSIS#0.9516;REGENERATION#0.9508;ORAL SQUAMOUS CELL CARCINOMA#0.9503;BONE MARROW#0.9493;MESENCHYME#0.9492;STEM CELL#0.9463;BONE FORMATION#0.9237;CELL MIGRATION#0.9228;AMELOGENESIS#0.9222;MITOGEN ACTIVATED PROTEIN#0.9206;CELL CYCLE#0.9175;ENDOPLASMIC RETICULUM#0.9136;CANCER CELL#0.9067;FACTOR I#0.9043;CELL SURFACE#0.9023;DIGESTION#0.8953;TRANSCRIPTASE#0.8912;GINGIVAL CREVICULAR FLUID#0.8884;MAPK SIGNALING#0.8817;ENAMEL FORMATION#0.8810;NEURAL CREST#0.8810;GENETIC DISEASE#0.8767;FIBRIL#0.8734;MORPHOGENESIS#0.8682;CELL COUNTING KIT#0.8674;FIBROBLAST GROWTH FACTOR#0.8636;TRANSMISSION ELECTRON MICROSCOPY#0.8635;CELL GROWTH#0.8617;OSTEOBLAST DIFFERENTIATION#0.8523;CYTOPLASM#0.8483;TRANSFORMING GROWTH FACTOR BETA#0.8476;CONNECTIVE TISSUE#0.8429;ROOT RESORPTION#0.8389;PROSTATE CANCER#0.8264;OSTEOCYTE#0.8255;CORE BINDING FACTOR#0.8234;TERMINAL DIFFERENTIATION#0.8197;DEXAMETHASONE#0.8149;DODECYL SULFATE#0.8102;SODIUM DODECYL SULFATE#0.8102;STEM CELL DIFFERENTIATION#0.8079;ORAL CANCER CELL#0.8065;STROMAL CELL#0.7935;SIGNALING MOLECULE#0.7917;STEM CELL MARKER#0.7878;CYTOTOXICITY#0.7854;FOCAL ADHESION#0.7828;ROOT DEVELOPMENT#0.7731;BONE REGENERATION#0.7705;HEME OXYGENASE 1#0.7685;URETERIC BUD#0.7614;GLYCOSYLATION#0.7575;HEARING LOSS#0.7549;TOOTH MINERALIZATION#0.7538;CERVICAL#0.7459;P38 MAPK SIGNALING#0.7449;BLOOD VESSEL#0.7436;ENAMEL ORGAN#0.7427;GENE SILENCING#0.7414;SIGNAL PEPTIDE#0.7409;ENDOTHELIAL CELL#0.7402;EOSIN#0.7340;INFLAMMATORY RESPONSE#0.7300;QUANTITATIVE REVERSE TRANSCRIPTION#0.7253;ENHANCER BINDING#0.7241;WOUND HEALING#0.7226;SIGNAL TRANSDUCTION#0.7197;EPITHELIAL CELL#0.7190;POST-TRANSLATIONAL MODIFICATION#0.7176;MANDIBLE#0.7171;ROOT SHEATH#0.7107;ANGIOGENESIS#0.7078;HEAT SHOCK PROTEIN#0.6981;TOOTH MORPHOGENESIS#0.6946;BASEMENT MEMBRANE#0.6933;MACROPHAGE#0.6915;SIGNALLING PATHWAY#0.6895;PLURIPOTENT STEM CELL#0.6849;CORONAL#0.6775;ASCORBIC ACID#0.6755;OSTEOCLAST#0.6747;UNFOLDED PROTEIN RESPONSE#0.6723;CELL DIVISION#0.6622;OXYGENASE#0.6469;CELL ADHESION MOLECULE#0.6441;AMELOBLAST DIFFERENTIATION#0.6395;BONE MORPHOGENIC PROTEIN#0.6366;ENAMEL MINERALIZATION#0.6359;ROUGH ENDOPLASMIC RETICULUM#0.6319;BONE MINERALIZATION#0.6306;PERIODONTAL DISEASE#0.6292;WNT SIGNALING PATHWAY#0.6288;DIPEPTIDYL PEPTIDASE#0.6228;C TERMINAL DOMAIN#0.6217;MESENCHYMAL CELL DIFFERENTIATION#0.6181;GUANIDINE#0.6144;PRO-INFLAMMATORY#0.6124;OSTEOGENESIS IMPERFECTA#0.6094;BONE CELLS#0.6005
1836	DIASTROPHIC DYSPLASIA#1.0892;ACHONDROGENESIS#1.0867;ATELOSTEOGENESIS#1.0815;MULTIPLE EPIPHYSEAL DYSPLASIA#1.0599;SULFATE TRANSPORT#1.0352;CHONDROCYTE#0.9720;SULFATION#0.9539;PROTEOGLYCAN#0.9281;PENDRED SYNDROME#0.8247;DIARRHEA#0.7648;PATELLA#0.7428;PLASMA MEMBRANE#0.7374;DESBUQUOIS DYSPLASIA#0.6848;OOCYTE#0.6813;CELL MEMBRANE#0.6407;OSTEOCHONDRODYSPLASIA#0.6384
1837	LEFT VENTRICULAR NONCOMPACTION#0.6788;APOPTOSIS#0.6655;CARDIOMYOPATHY#0.6385;SKELETAL MUSCLE#0.6358
1838	PROTEIN COMPLEX#0.9357;NON-MUSCLE TISSUE#0.7587;SARCOLEMMA#0.6923;KINESIN#0.6666;MUSCULAR DYSTROPHY#0.6333
1839	ALPHA-HEPARIN#1.0794;DIPHTHERIA TOXIN RECEPTOR#1.0527;OVARIAN CANCER#1.0390;DIPHTHERIA#1.0375;FACTOR I#1.0352;HEPARIN BINDING#1.0348;HEPARIN#1.0323;HEPATOCYTE GROWTH FACTOR#1.0276;LEUKEMIA INHIBITORY FACTOR#1.0264;GROWTH FACTOR#1.0262;TRANSFORMING GROWTH FACTOR ALPHA#1.0230;PLATELET-DERIVED GROWTH FACTOR#1.0217;TROPHOBLAST#1.0198;FIBROBLAST GROWTH FACTOR#1.0191;EPIDERMAL GROWTH FACTOR#1.0190;NECROTIZING#1.0177;INSULIN-LIKE GROWTH FACTOR#1.0153;ISCHEMIA#1.0147;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0141;ENDOTHELIAL GROWTH FACTOR#1.0132;OVARIAN#1.0131;INTERSTITIAL CYSTITIS#1.0125;RECEPTOR BINDING#1.0113;INTESTINAL EPITHELIAL CELL#1.0101;TRANSFORMING GROWTH FACTOR#1.0055;HYPOXIA#1.0010;RECEPTOR LIGAND#1.0005;ISCHEMIA REPERFUSION INJURY#1.0003;EGF RECEPTOR LIGAND#0.9992;LOW MOLECULAR WEIGHT HEPARIN#0.9975;KERATINOCYTE#0.9972;TUMOR NECROSIS FACTOR#0.9952;ENDOMETRIUM#0.9943;BREAST CANCER#0.9942;VASCULAR SMOOTH MUSCLE CELL#0.9933;MONOCYTE#0.9930;SMOOTH MUSCLE CELL#0.9929;RECEPTOR TYROSINE KINASE#0.9922;STROMAL CELL#0.9918;MUSCLE CELL#0.9912;TRANSACTIVATION#0.9911;DNA SYNTHESIS#0.9910;SMOOTH MUSCLE#0.9909;MACROPHAGE#0.9893;MITOGENIC ACTIVITY#0.9893;BONE MARROW#0.9882;COLONY-STIMULATING FACTOR#0.9841;STEM CELL#0.9835;WOUND HEALING#0.9829;CYSTITIS#0.9816;CANCER CELL#0.9760;NITRIC OXIDE#0.9759;ANGIOGENESIS#0.9754;ATHEROSCLEROSIS#0.9753;MITOGEN ACTIVATED PROTEIN#0.9751;TRANSCRIPTION FACTOR#0.9748;MESANGIAL CELL#0.9744;REGULATORY T CELL#0.9742;CELL MIGRATION#0.9742;T LYMPHOCYTE#0.9739;EPITHELIAL CELL#0.9714;CELL ADHESION#0.9713;TROPHOBLAST CELL#0.9712;REGENERATION#0.9707;CELL GROWTH#0.9705;CELL SURFACE#0.9704;KINASE INHIBITOR#0.9704;APOPTOSIS#0.9696;CD8+ T CELL#0.9694;GROWTH FACTOR RECEPTOR#0.9693;DENDRITIC CELL#0.9692;T CELL#0.9689;PROTEIN KINASE C#0.9687;TRANSFORMING GROWTH FACTOR BETA#0.9685;ENDOTHELIAL CELL#0.9679;PROTEOGLYCAN#0.9678;GROWTH FACTOR BINDING#0.9676;CELL CYCLE#0.9669;CELL DEATH#0.9664;EXTRACELLULAR MATRIX#0.9656;CELL PROLIFERATION#0.9654;PROTEIN KINASE#0.9649;SIGNAL TRANSDUCTION#0.9646;POLYMERASE CHAIN REACTION#0.9606;NEUTROPHIL#0.9602;NERVOUS SYSTEM#0.9587;REVERSE TRANSCRIPTION#0.9586;INFLAMMATORY RESPONSE#0.9585;PROTEIN SYNTHESIS#0.9581;IMMUNE RESPONSE#0.9572;GENE EXPRESSION#0.9568;TUMOR CELLS#0.9553;BREAST CANCER CELL#0.9549;PROGESTERONE#0.9544;REACTIVE OXYGEN SPECIES#0.9537;ASTROCYTE#0.9532;SIGNALING PATHWAY#0.9524;LYMPH NODE#0.9519;TREG CELL#0.9512;TOXIN BINDING#0.9507;PLASMA MEMBRANE#0.9499;UTERUS#0.9495;ATHEROSCLEROTIC#0.9454;METALLOPROTEINASE INHIBITOR#0.9426;APOPTOTIC#0.9418;B CELL#0.9406;KERATINOCYTE PROLIFERATION#0.9370;AORTIC SMOOTH MUSCLE CELLS#0.9350;ADIPOCYTE#0.9340;RECEPTOR TRANSACTIVATION#0.9338;GRANULOSA CELL#0.9263;EMBRYO IMPLANTATION#0.9238;TYROSINE KINASE INHIBITOR#0.9236;CENTRAL NERVOUS SYSTEM#0.9235;PANCREATIC CANCER#0.9231;IMMUNE CELL#0.9223;TOXIN RECEPTOR BINDING#0.9221;THYMIDINE#0.9218;BLASTOCYST IMPLANTATION#0.9203;CELL MEMBRANE#0.9137;PLACENTAL GROWTH FACTOR#0.9125;ESTROGEN RECEPTOR#0.9051;NITRIC OXIDE SYNTHASE#0.9031;INFLAMMATORY CELL#0.9005;ARTERY#0.8994;LUNG CANCER#0.8991;CELL ADHESION MOLECULE#0.8940;RETINOIC ACID#0.8939;PODOCYTE#0.8925;PROSTATE CANCER#0.8916;LANGERHANS CELL#0.8915;PROGENITOR CELL#0.8870;MYELOID CELL#0.8804;LEUKOCYTE#0.8773;QUANTITATIVE REAL TIME#0.8766;TRANSCRIPTASE#0.8761;GROWTH FACTOR ACTIVITY#0.8759;KINASE ACTIVITY#0.8741;LUMINAL#0.8737;TOXICITY#0.8731;ALKALINE PHOSPHATASE#0.8703;VASCULAR ENDOTHELIAL CELL#0.8696;VASCULAR CELL#0.8694;ADIPOSE TISSUE#0.8642;PERIPHERAL BLOOD#0.8636;CONNECTIVE TISSUE#0.8581;GRANULOCYTE#0.8579;GASTRIC EPITHELIAL CELLS#0.8565;ADENOCARCINOMA#0.8556;COLORECTAL CANCER#0.8500;TUMOUR NECROSIS FACTOR#0.8496;VASCULAR DISEASE#0.8474;CHEMOKINE RECEPTOR#0.8465;PRO-INFLAMMATORY#0.8460;SKELETAL MUSCLE#0.8457;RECEPTOR ANTAGONIST#0.8422;GESTATION#0.8406;STROMA#0.8402;HYPOXIA INDUCIBLE FACTOR#0.8392;ACUTE LUNG INJURY#0.8387;PLACENTATION#0.8376;ONCOGENIC#0.8345;CD4+ T CELL#0.8312;PSORIASIS#0.8289;EGF BINDING#0.8274;KERATINOCYTE MIGRATION#0.8260;BLADDER SMOOTH MUSCLE#0.8255;EPITHELIAL MESENCHYMAL TRANSITION#0.8237;TOPICAL#0.8232;LOW DENSITY LIPOPROTEIN#0.8193;HUMAN CORNEAL EPITHELIAL#0.8189;IMMUNE SYSTEM#0.8173;NEUROGENESIS#0.8153;EMBRYO DEVELOPMENT#0.8150;MAP KINASE#0.8139;LIVER REGENERATION#0.8138;UMBILICAL VEIN#0.8133;MYOCARDIAL INFARCTION#0.8131;CLODRONATE#0.8088;CHEMOTAXIS#0.8034;CYTOTROPHOBLAST#0.8024;CORNEAL EPITHELIAL CELL#0.8018;CELL MOTILITY#0.8005;COLORECTAL#0.7997;HAIR CELL#0.7994;HUMAN UMBILICAL VEIN#0.7984;ESTRADIOL#0.7972;PRE-ECLAMPSIA#0.7925;GLIAL CELL#0.7921;CELL ACTIVATION#0.7897;GM6001#0.7886;HYPOXIC#0.7865;STEM CELL FACTOR#0.7833;ANTIGEN PRESENTING CELLS#0.7825;BREAST CARCINOMA#0.7770;SIGNALING CASCADE#0.7753;ENDOCYTOSIS#0.7741;BASEMENT MEMBRANE#0.7721;CYTOTOXICITY#0.7709;SMOOTH MUSCLE CELL PROLIFERATION#0.7704;MUSCLE CELL PROLIFERATION#0.7701;TISSUE GROWTH FACTOR#0.7697;HEMORRHAGIC#0.7687;MESENCHYMAL CELL#0.7654;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7641;SQUAMOUS CELL CARCINOMA#0.7603;ALVEOLAR MACROPHAGE#0.7588;ANTI EGFR#0.7572;PHOSPHOLIPASE C#0.7531;CARDIOMYOCYTE#0.7518;PACLITAXEL#0.7510;IFN-GAMMA#0.7495;MORPHOGENESIS#0.7475;CELL ASSOCIATED#0.7468;BLOOD BRAIN BARRIER#0.7425;BETA CELL#0.7421;BLOOD VESSEL#0.7419;COLON CANCER#0.7413;CYTOKINE PRODUCTION#0.7413;CETUXIMAB#0.7411;DRAINING LYMPH NODE#0.7398;SIGNALING MOLECULE#0.7353;HUMAN BRONCHIAL EPITHELIAL#0.7349;NERVE GROWTH FACTOR#0.7349;KIDNEY DISEASE#0.7340;BRONCHIAL EPITHELIAL CELLS#0.7339;PERICYTE#0.7314;RECEPTOR AGONIST#0.7298;EPITHELIAL CELL PROLIFERATION#0.7287;ARGININE#0.7284;BINDING PROTEIN 3#0.7209;M2 MACROPHAGE#0.7207;MESENCHYMAL STEM CELL#0.7196;CELL DIFFERENTIATION#0.7194;FOCAL ADHESION#0.7090;VISCERAL FAT ACCUMULATION#0.7015;MAST CELL#0.6986;GM-CSF#0.6963;DNA BINDING#0.6939;HEMORRHAGE#0.6918;MATRIX METALLOPROTEINASE 1#0.6885;CEREBRAL ISCHEMIA#0.6820;HYPERTENSION#0.6818;GLOMERULAR EPITHELIAL CELL#0.6817;RECEPTOR MEDIATED ENDOCYTOSIS#0.6807;MESENCHYME#0.6759;PROTEINURIA#0.6745;CYCLIC GUANOSINE MONOPHOSPHATE#0.6745;ALL TRANS RETINOIC ACID#0.6738;GLOMERULONEPHRITIS#0.6726;TISSUE REMODELING#0.6597;VIRAL INFECTION#0.6546;LUNG FIBROBLASTS#0.6536;INDUCIBLE NITRIC OXIDE#0.6469;AIRWAY EPITHELIAL CELL#0.6460;OVARIAN CARCINOMA#0.6455;MICROVASCULAR ENDOTHELIAL CELL#0.6443;DOPAMINERGIC NEURON#0.6436;AKT SIGNALING#0.6426;HIGH FAT DIET#0.6412;TYPE 2 DIABETES#0.6396;DECIDUALIZATION#0.6390;HUMAN EPIDERMAL KERATINOCYTES#0.6351;EFFECTOR T CELL#0.6342;AIRWAY SMOOTH MUSCLE#0.6306;ENDOTHELIAL CELL PROLIFERATION#0.6304;MUTAGENESIS#0.6284;GASTRIC MUCOSA#0.6272;GUANOSINE#0.6261;PLASMA CELL#0.6257;SMOOTH MUSCLE ACTIN#0.6249;MAMMARY EPITHELIAL CELL#0.6248;MYOCYTES#0.6236;ECLAMPSIA#0.6223;HUMAN PANCREATIC CANCER#0.6194;SUPEROXIDE DISMUTASE#0.6166;ENDOTHELIUM#0.6159;BINDING PROTEIN 1#0.6147;PRECURSOR CELL#0.6142;ACTIVATOR PROTEIN 1#0.6138;MAPK ACTIVATION#0.6137;HEMATOPOIETIC CELL#0.6135;MENSTRUAL CYCLE#0.6125;RESPONSE TO WOUNDING#0.6121;HATCHING#0.6120;QUANTITATIVE REVERSE TRANSCRIPTION#0.6118;FACTOR D#0.6116;HEPATOCELLULAR CARCINOMA#0.6105;ERBB SIGNALING#0.6076;ETHANOL#0.6053;EOSINOPHIL#0.6050;SMC PROLIFERATION#0.6031;FOCAL CEREBRAL ISCHEMIA#0.6031;PLACENTAL DEVELOPMENT#0.6006;ADAPTIVE IMMUNE RESPONSE#0.6000
183	AZILSARTAN#1.0383;ARGININE VASOTOCIN#1.0283;DOUBLE TRANSGENIC MICE#1.0277;DRINKING BEHAVIOUR#1.0259;ADULT RAT CARDIOMYOCYTES#1.0250;RESPONSE TO ANGIOTENSIN#1.0247;LOSARTAN POTASSIUM#1.0247;SERPIN#1.0243;HEPATOMA CELLS#1.0241;SKELETAL MUSCLE WASTING#1.0209;PEPTIDYL DIPEPTIDASE#1.0198;SMALL MESENTERIC ARTERIES#1.0195;MEDULLARY CELL#1.0189;TEMOCAPRIL#1.0186;DIASTOLIC HEART FAILURE#1.0183;LOW DOSE ASPIRIN#1.0182;CHRONIC LOW DOSE#1.0166;PANCREATIC CANCER#1.0161;ALPHA 1-ANTITRYPSIN#1.0161;PODOCYTE APOPTOSIS#1.0161;OLMESARTAN MEDOXOMIL#1.0159;MYOMETRIUM#1.0159;THYROTROPIN RELEASING HORMONE#1.0149;BENZIMIDAZOLE#1.0148;HUMAN CARDIAC FIBROBLASTS#1.0148;ISOLEUCINE#1.0147;HUMAN ADIPOSE TISSUE#1.0146;ENDOTHELIN TYPE A#1.0144;RAT NEONATAL CARDIOMYOCYTES#1.0141;VASOTOCIN#1.0140;INOSITOL PHOSPHATE FORMATION#1.0138;ACUTE PHASE RESPONSE#1.0136;CAROTID BODY#1.0136;NEBIVOLOL#1.0129;RECEPTOR TRANSACTIVATION#1.0121;HUMAN PROXIMAL TUBULAR#1.0117;EPROSARTAN#1.0114;ASCENDING AORTIC ANEURYSM#1.0104;LONG TERM POTENTIATION#1.0102;CORD BLOOD#1.0102;ENALAPRIL MALEATE#1.0102;BREAST CANCER CELL#1.0091;FLUID TRANSPORT#1.0091;ALPHA1 ADRENOCEPTOR#1.0087;ANGII TYPE 1#1.0087;CORTICOSTEROID SECRETION#1.0086;OMAPATRILAT#1.0086;GLUCONEOGENESIS#1.0078;RESVERATROL#1.0076;METHOXAMINE#1.0075;ALPHA2 ADRENOCEPTOR#1.0074;RESPONSE TO VASOPRESSIN#1.0073;MELATONIN#1.0073;FRUSEMIDE#1.0069;SMOOTH MUSCLE CELL MIGRATION#1.0069;VALINE#1.0069;MUSCLE CELL MIGRATION#1.0067;SENESCENCE#1.0064;CARVEDILOL#1.0062;CORTICOTROPIN-RELEASING FACTOR#1.0062;DIABETES INSIPIDUS#1.0060;PREADIPOCYTE#1.0055;ALVEOLAR EPITHELIAL CELL#1.0054;RESPONSE TO ENDOTHELIN#1.0054;RENNIN ANGIOTENSIN SYSTEM#1.0053;CILAZAPRIL#1.0047;ENDOTHELIN-1 SECRETION#1.0046;LIPOXYGENASE PATHWAY#1.0045;INTESTINAL EPITHELIAL CELL#1.0045;PROTEOLYSIS INDUCING FACTOR#1.0044;CORONARY ARTERY ENDOTHELIAL CELLS#1.0043;SOLUBLE EPOXIDE HYDROLASE#1.0042;TYROSINE KINASE 1#1.0036;ADRENOCORTICOTROPIC HORMONE#1.0032;MEDULLA OBLONGATA#1.0031;FELODIPINE#1.0030;HYPOALDOSTERONISM#1.0030;PROLACTIN SECRETION#1.0029;ATORVASTATIN#1.0029;SUBMANDIBULAR GLAND#1.0029;PROSTAGLANDIN E1#1.0026;HYDROCORTISONE#1.0024;SKIN FIBROBLASTS#1.0024;ENDOTHELIN A RECEPTOR#1.0023;RESPONSE TO NOREPINEPHRINE#1.0021;ENDOTHELIAL PROGENITOR CELL#1.0020;POTASSIUM CHLORIDE#1.0018;BETA-ESTRADIOL#1.0018;ALPHA-2 MACROGLOBULIN#1.0016;HISTAMINE#1.0013;RENNIN#1.0011;CHRONIC INTERMITTENT HYPOXIA#1.0007;OBSTRUCTIVE NEPHROPATHY#1.0005;PROSTATE CANCER#1.0005;NEUTRAL ENDOPEPTIDASE 24.11#1.0005;ISOPRENALINE#1.0004;MENSTRUAL CYCLE#1.0001;HYPERTROPHIC CARDIOMYOPATHY#1.0000;NOMEGA-NITRO-L-ARGININE#0.9999;PROSTAGLANDIN I2#0.9996;REGULATION OF ALDOSTERONE SECRETION#0.9996;METHACHOLINE#0.9995;EPOXIDE HYDROLASE#0.9995;QUERCETIN#0.9994;NEUROBLASTOMA#0.9994;PIOGLITAZONE#0.9993;BLOOD PLASMA#0.9992;SUBSTANCE P#0.9989;ANTIDIURETIC HORMONE#0.9989;ENDOPEPTIDASE 24.11#0.9989;UMBILICAL ARTERY#0.9988;ACINAR CELL#0.9988;CARDIOMYOCYTE GROWTH#0.9987;HORMONE BINDING#0.9985;CORTICAL CELL#0.9984;DOXAZOSIN#0.9983;FATTY ACID BINDING#0.9983;VASOPRESSIN SECRETION#0.9983;CEREBRAL ISCHEMIA#0.9982;PROTEIN KINASE C ACTIVITY#0.9981;TACHYKININ#0.9980;BENAZEPRIL#0.9980;INDUCED RENAL INJURY#0.9979;ANTIDIURESIS#0.9977;RNA SYNTHESIS#0.9977;MUSCLE WASTING#0.9975;AMINOPEPTIDASE P#0.9973;CANDESARTAN CILEXETIL#0.9971;PHOSPHOLIPASE D#0.9969;T- PA#0.9968;GAP JUNCTION#0.9968;VENTRICULAR CARDIOMYOCYTE#0.9966;METABOLIC ACIDOSIS#0.9965;SUBCUTANEOUS ADIPOSE TISSUE#0.9964;MELANOCYTE#0.9964;CARBACHOL#0.9963;CORTICOTROPIN#0.9963;PROXIMAL TUBULAR EPITHELIAL#0.9962;GONADOTROPIN RELEASING HORMONE#0.9962;ACTH SECRETION#0.9960;ROSIGLITAZONE#0.9958;BLOOD PRESSURE HOMEOSTASIS#0.9958;THORACIC AORTIC ANEURYSM#0.9957;PHOSPHOLIPASE C ACTIVATION#0.9957;ASPARTIC ACID#0.9957;NICARDIPINE#0.9955;PROTEIN KINASE D#0.9954;HEPATOCYTE GROWTH FACTOR#0.9952;PENTOBARBITAL SODIUM#0.9950;MALIGNANT HYPERTENSION#0.9949;VASOPRESSIN#0.9947;CATECHOLAMINE SECRETION#0.9946;DRINKING BEHAVIOR#0.9946;PLATELET ACTIVATING FACTOR#0.9945;NORADRENALINE#0.9945;INCREASE BLOOD PRESSURE#0.9945;PROTEINASE INHIBITOR#0.9945;TRANSMEMBRANE RECEPTOR#0.9943;SIMVASTATIN#0.9942;PROXIMAL TUBULE CELL#0.9942;ARGININE VASOPRESSIN#0.9942;MAP KINASE ACTIVITY#0.9940;PODOCYTE#0.9938;MESOTHELIAL CELL#0.9938;AMINOPEPTIDASE A#0.9937;FOSINOPRIL#0.9935;OVARIES#0.9934;SMOOTH MUSCLE CELL PROLIFERATION#0.9933;REACTIVE OXYGEN SPECIES GENERATION#0.9932;UMBILICAL CORD#0.9932;L-NNA#0.9932;MUSCLE CELL PROLIFERATION#0.9931;PANCREATIC ISLET#0.9929;FIBROBLAST PROLIFERATION#0.9929;NITRIC OXIDE SYNTHESIS#0.9929;LIPOPROTEIN LIPASE#0.9924;CHLORIDE CHANNEL#0.9924;OPIOID RECEPTOR#0.9923;RENAL TRANSPLANT RECIPIENTS#0.9923;AUTOPHAGY#0.9922;CACHEXIA#0.9922;PERICYTE#0.9922;ADRENALINE#0.9921;ADRIAMYCIN#0.9920;ENDOTHELIAL CELL APOPTOSIS#0.9920;PRE-ECLAMPSIA#0.9920;GLYCERYL TRINITRATE#0.9919;SODIUM TRANSPORT#0.9919;SCIATIC NERVE#0.9919;ALDOSTERONE RECEPTOR#0.9918;CAROTID SINUS#0.9917;RENAL ISCHEMIA REPERFUSION#0.9915;FRUCTOSE#0.9915;SUPERIOR COLLICULUS#0.9914;ARACHIDONIC ACID METABOLISM#0.9914;VASCULAR ENDOTHELIAL DYSFUNCTION#0.9913;ETHANOL#0.9911;NATRIURETIC PEPTIDE RECEPTOR#0.9910;METOCLOPRAMIDE#0.9910;OSTEOBLAST#0.9909;NEPHROGENESIS#0.9909;TELMISARTAN#0.9908;CAMKII#0.9908;BREAST CANCER#0.9908;HEPATIC STELLATE CELL#0.9907;NITRENDIPINE#0.9906;OVULATION#0.9906;PEPTIDE HORMONE#0.9905;TRANSDIFFERENTIATION#0.9905;PROXIMAL TUBULAR CELL#0.9904;AMNIOTIC FLUID#0.9903;KIDNEY DEVELOPMENT#0.9900;ISOFLURANE#0.9900;GLUCOSE TRANSPORT#0.9899;HEPATIC ARTERY#0.9899;QUINAPRIL#0.9898;METHIONINE#0.9898;LOCUS COERULEUS#0.9898;AORTIC VALVE#0.9897;ASTROCYTE#0.9897;HEPATOCELLULAR CARCINOMA#0.9896;OLMESARTAN#0.9895;CACL2#0.9895;EICOSAPENTAENOIC ACID#0.9893;STRESS FIBER#0.9893;MESANGIAL CELL#0.9893;ALISKIREN#0.9893;ASYMMETRIC DIMETHYLARGININE#0.9892;KIDNEY TRANSPLANT RECIPIENTS#0.9892;PERIVASCULAR ADIPOSE TISSUE#0.9892;OUABAIN#0.9892;EPIDIDYMIS#0.9891;GLOMERULAR EPITHELIAL CELL#0.9889;CARBOXYPEPTIDASE A#0.9889;NEONATAL RAT CARDIOMYOCYTES#0.9887;CHROMAFFIN CELL#0.9886;CELLULAR LOCALIZATION#0.9886;CAFFEINE#0.9886;RECEPTOR ACTIVATOR#0.9886;DIACYLGLYCEROL FORMATION#0.9885;ALDOSTERONE SECRETION#0.9884;PLATELET-DERIVED GROWTH FACTOR#0.9883;OVARIAN FOLLICLE#0.9881;COLLAGEN SYNTHESIS#0.9881;MARFAN SYNDROME#0.9881;PORTAL HYPERTENSION#0.9880;PORTAL VEIN#0.9880;PARA-AMINOHIPPURATE#0.9878;MECLOFENAMATE#0.9877;ALDOSTERONE#0.9875;MULTIPLE SCLEROSIS#0.9875;SECONDARY HYPERTENSION#0.9874;RENAL HYPERTENSION#0.9874;SPHINGOSINE#0.9874;DIET INDUCED OBESITY#0.9874;ENDOPEPTIDASE INHIBITOR#0.9874;VASOPRESSIN RECEPTOR#0.9873;SKELETAL MUSCLE ATROPHY#0.9872;GRANULOSA CELL#0.9872;BRAIN ISCHEMIA#0.9871;ECLAMPSIA#0.9871;NOREPINEPHRINE#0.9871;CHYMASE ACTIVITY#0.9870;PANCREATITIS#0.9870;NEUROTRANSMISSION#0.9869;BROWN ADIPOSE TISSUE#0.9869;FOREARM#0.9869;PROTEIN DEGRADATION#0.9868;MUSCLE ATROPHY#0.9868;HEME OXYGENASE 1#0.9867;PRESSURE NATRIURESIS#0.9866;EPITHELIAL MESENCHYMAL TRANSITION#0.9866;PERINDOPRIL#0.9865;MYO-INOSITOL#0.9864;GLYCOGENOLYSIS#0.9864;AT1 RECEPTOR BINDING#0.9864;PLATELET ACTIVATION#0.9863;CHYMOSTATIN#0.9863;VISCERAL ADIPOSE TISSUE#0.9863;WHITE ADIPOSE TISSUE#0.9862;METFORMIN#0.9860;TRIIODOTHYRONINE#0.9860;LDL RECEPTOR#0.9858;PROTEIN KINASE ACTIVATION#0.9857;PEPSTATIN#0.9857;L-LEUCINE#0.9857;OOCYTE#0.9856;DOPAMINERGIC NEURON#0.9856;OESTRADIOL#0.9855;CALCIUM MOBILIZATION#0.9854;ASCITES#0.9853;LEUKOCYTE ADHESION#0.9852;MIDBRAIN#0.9850;PULMONARY FIBROSIS#0.9849;EPINEPHRINE#0.9849;RESPONSE TO POTASSIUM#0.9849;VITAMIN C#0.9848;NEURITE#0.9847;CIRCADIAN RHYTHM#0.9846;PENTOLINIUM#0.9846;HEALTHY CONTROL SUBJECTS#0.9846;BOSENTAN#0.9846;MICROVASCULAR ENDOTHELIAL CELL#0.9846;LIVER METASTASIS#0.9846;COR PULMONALE#0.9845;BETA CELL#0.9845;NEURITE OUTGROWTH#0.9845;IN STENT RESTENOSIS#0.9845;CONNEXIN#0.9844;INTRACELLULAR SIGNAL TRANSDUCTION#0.9844;ACUTE LUNG INJURY#0.9844;ELECTROLYTE HOMEOSTASIS#0.9844;LIVER CIRRHOSIS#0.9844;TRANSVERSE AORTIC CONSTRICTION#0.9844;DILTIAZEM#0.9844;17β-ESTRADIOL#0.9843;NALOXONE#0.9843;ENHANCER BINDING PROTEIN#0.9843;PHOSPHOINOSITIDE METABOLISM#0.9843;CORTISOL SECRETION#0.9842;GLIAL CELL#0.9842;T-TYPE CALCIUM CHANNEL#0.9842;THEOPHYLLINE#0.9841;L-PROLINE#0.9841;MESENTERY#0.9841;LUNG FIBROBLASTS#0.9841;PHENYLEPHRINE#0.9840;BASILAR ARTERY#0.9840;EXTRACELLULAR REGULATED KINASE#0.9840;FACTOR I#0.9840;GLYCOSYLATION#0.9839;DOBUTAMINE#0.9839;LINES OF EVIDENCE#0.9839;RESPONSE TO HYPOXIA#0.9838;NERVE TERMINAL#0.9838;IRBESARTAN#0.9838;PITUITARY GLAND#0.9838;L-TYPE CALCIUM CHANNEL#0.9837;NEPHROSCLEROSIS#0.9836;ION TRANSPORT#0.9836;MESENCHYMAL STEM CELL#0.9836;OPIOID PEPTIDE#0.9835;PRAVASTATIN#0.9834;TRANDOLAPRIL#0.9834;HEPARIN BINDING#0.9834;RENAL VEIN#0.9834;MITRAL VALVE#0.9833;NEURONAL CELLS#0.9832;DUCT CELL#0.9832;TOLL LIKE RECEPTOR#0.9832;CHOROID PLEXUS#0.9832;FETAL BRAIN#0.9832;TYPE 1 DIABETES MELLITUS#0.9831;WATER HOMEOSTASIS#0.9831;DENDRITIC CELL#0.9831;TOPICAL#0.9829;CAVEOLAE#0.9828;CLONIDINE#0.9828;ENHANCER BINDING#0.9827;PROTEIN TYROSINE PHOSPHATASE#0.9827;ADVANCED GLYCATION END#0.9826;INSULIN-LIKE GROWTH FACTOR#0.9826;PROTEIN KINASE C ACTIVATION#0.9826;APOPTOTIC CELL DEATH#0.9824;AORTIC ANEURYSM#0.9824;CYCLIC ADENOSINE MONOPHOSPHATE#0.9822;GUANETHIDINE#0.9822;CYCLOSPORIN A#0.9821;ADENOSINE TRIPHOSPHATE#0.9820;COLORECTAL#0.9820;URINARY KALLIKREIN#0.9820;URINARY BLADDER#0.9819;PROTEIN KINASE ACTIVITY#0.9819;COLLAGEN VOLUME FRACTION#0.9819;CYCLOSPORIN#0.9818;NITROGLYCERIN#0.9817;DIABETIC RETINOPATHY#0.9817;INSULIN SECRETION#0.9816;PEPTIDASE INHIBITOR#0.9815;ABDOMINAL AORTIC ANEURYSM#0.9814;CATABOLISM#0.9814;AMLODIPINE#0.9814;AMINOHIPPURATE#0.9813;NERVE ENDING#0.9813;FIBRINOGEN#0.9813;TUBULOGLOMERULAR FEEDBACK#0.9812;METOPROLOL#0.9812;ENDOPLASMIC RETICULUM STRESS#0.9810;CALCIUM SIGNALING#0.9809;ENALAPRILAT#0.9808;PULMONARY EDEMA#0.9808;RENAL INTERSTITIAL FIBROSIS#0.9807;ACTIVATION OF NF-KAPPAB#0.9807;LAMINA TERMINALIS#0.9807;ILOPROST#0.9807;CAMP FORMATION#0.9805;ROSUVASTATIN#0.9805;PUROMYCIN#0.9804;STROMAL CELL#0.9804;LATERAL VENTRICLE#0.9804;TESTOSTERONE#0.9803;RECEPTOR LIGAND#0.9803;BLEOMYCIN#0.9803;AQUAPORIN#0.9803;ADRENOCORTICAL CARCINOMA#0.9802;FIBROBLAST ACTIVATION#0.9801;MYOCARDITIS#0.9801;SPERMATOZOA#0.9801;NEUROHORMONE#0.9800;BETA-2#0.9800;AT1 RECEPTOR BLOCKER#0.9800;SPHINGOSINE 1 PHOSPHATE#0.9800;DIURNAL#0.9798;HALOTHANE#0.9798;UTERUS#0.9798;CYSTATIN#0.9797;PROTEIN PHOSPHORYLATION#0.9797;DEXAMETHASONE#0.9797;PROPOFOL#0.9797;URETERAL OBSTRUCTION#0.9796;EARLY GROWTH RESPONSE#0.9796;CYCLIC AMP#0.9796;BRADYKININ RECEPTOR#0.9796;REGULATORY T CELL#0.9795;HYPERTENSIVE HEART DISEASE#0.9794;THIAZIDE#0.9794;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9794;ATPASE ACTIVITY#0.9793;ADIPOCYTE#0.9793;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9793;HISTIDINE#0.9793;ISOPROTERENOL#0.9792;DIPEPTIDYL PEPTIDASE#0.9792;FIBROBLAST GROWTH FACTOR#0.9792;LOOP OF HENLE#0.9791;FOCAL ADHESION KINASE#0.9791;LARGE ARTERIES#0.9790;HINDLIMB#0.9789;DIRECT RENIN INHIBITOR#0.9788;EPITHELIAL SODIUM CHANNEL#0.9788;TISSUE REMODELING#0.9788;CYCLOSPORINE#0.9786;NEPHRITIS#0.9786;RESPIRATORY DISTRESS#0.9786;HYPOTHALAMIC PITUITARY ADRENAL#0.9785;HIGH CHOLESTEROL DIET#0.9785;PROGENITOR CELL#0.9785;EXPLORATORY BEHAVIOR#0.9785;DOPAMINE#0.9785;ERYTHROPOIESIS#0.9785;VASOCONSTRICTOR#0.9785;POLYCYSTIC KIDNEY DISEASE#0.9784;BRAIN DAMAGE#0.9784;VSMC PROLIFERATION#0.9783;NEPHROSIS#0.9783;RESERPINE#0.9782;RECEPTOR INTERNALIZATION#0.9781;ACETIC ACID#0.9780;CANDESARTAN#0.9778;NMDA RECEPTOR#0.9778;ADENYLATE CYCLASE ACTIVITY#0.9778;UNILATERAL URETERAL OBSTRUCTION#0.9777;DOXORUBICIN#0.9776;LATE PREGNANCY#0.9776;EPLERENONE#0.9776;SENSITIZATION#0.9776;ENDOCYTOSIS#0.9776;VENOUS BLOOD#0.9775;BROMOCRIPTINE#0.9775;TRANSACTIVATION#0.9775;L-GLUTAMATE#0.9775;PROSTAGLANDIN SYNTHESIS#0.9775;VALSARTAN#0.9774;MUSCLE CELL APOPTOSIS#0.9773;ACTION POTENTIAL DURATION#0.9773;HEMORRHAGE#0.9773;DOPAMINE RECEPTOR#0.9772;NEUROPATHY#0.9772;BRUSH BORDER MEMBRANE#0.9772;ASPIRIN#0.9771;MESENTERIC ARTERY#0.9771;CHORION#0.9770;PHENOXYBENZAMINE#0.9770;ENDOCRINE SYSTEM#0.9770;NISOLDIPINE#0.9769;HORMONE SECRETION#0.9769;PARATHYROID#0.9769;RECEPTOR COMPLEX#0.9768;CAMP RESPONSE ELEMENT#0.9768;DIGOXIN#0.9768;PROSTAGLANDIN E2#0.9767;CARDIAC ARREST#0.9767;STRUCTURE ACTIVITY RELATIONSHIP#0.9767;CARDIOMYOCYTE#0.9766;ESTROGEN RECEPTOR#0.9766;TRANSFORMING GROWTH FACTOR BETA#0.9766;ANGIOEDEMA#0.9766;GROWTH HORMONE#0.9766;AORTIC SMOOTH MUSCLE CELLS#0.9765;MOLAR#0.9765;ICATIBANT#0.9765;CHEMOKINE RECEPTOR#0.9765;SERUM URIC ACID#0.9764;BETA ADRENERGIC RECEPTOR#0.9763;BILE DUCT LIGATION#0.9763;PRIMARY HYPERALDOSTERONISM#0.9763;HETEROTRIMERIC G-PROTEIN#0.9763;MACROPHAGE MIGRATION#0.9763;PKC ACTIVITY#0.9762;PHOSPHOLIPASE A#0.9762;AMYGDALA#0.9762;CORTICOTROPHIN#0.9762;CORTISOL#0.9762;MYOCARDIAL INFARCT SIZE#0.9762;SPERM MOTILITY#0.9761;RENAL SODIUM EXCRETION#0.9761;BINDING PROTEIN 1#0.9761;C REACTIVE PROTEIN#0.9761;HYPERGLYCEMIC#0.9761;BRAIN NATRIURETIC PEPTIDE#0.9761;ADRENAL MEDULLA#0.9761;MAST CELL#0.9760;ACTIVATION OF MAP KINASE#0.9758;REGULATION OF BLOOD PRESSURE#0.9758;PARATHYROID HORMONE#0.9758;TROPHOBLAST#0.9756;ALPHA ADRENOCEPTOR#0.9756;RECEPTOR INTERACTING PROTEIN#0.9756;ANEMIA#0.9756;FAT CELL#0.9755;CERVICAL#0.9755;ATPASE INHIBITOR#0.9755;TYPE 1 DIABETIC#0.9755;GTP BINDING#0.9755;ADIPOSE TISSUE#0.9755;CHRONIC ALLOGRAFT NEPHROPATHY#0.9754;STRIATUM#0.9754;ADENOSINE MONOPHOSPHATE#0.9753;SELECTIN#0.9752;WATER TRANSPORT#0.9752;REGULATION OF CELLULAR#0.9751;FLUID RETENTION#0.9751;POSITIVE FAMILY HISTORY#0.9750;MYELOID CELL#0.9750;NF-KAPPAB ACTIVATION#0.9750;HEART RATE VARIABILITY#0.9750;ENDOTHELIUM-DERIVED RELAXING FACTOR#0.9750;ANESTHETIC#0.9749;CAMP RESPONSE ELEMENT BINDING#0.9749;RO 42-5892#0.9748;HYPOXIA#0.9748;LUNG DISEASE#0.9748;TISSUE DAMAGE#0.9747;HYDROXYLASE ACTIVITY#0.9747;ESTROGENS#0.9746;RESPONSE TO SALT#0.9746;ACETYLSALICYLIC ACID#0.9746;BETA ADRENOCEPTOR#0.9746;DEHYDRATION#0.9746;NEPHROTOXICITY#0.9745;URETHANE#0.9745;WATER RETENTION#0.9745;TYPE 2 DIABETIC#0.9744;TUMOUR NECROSIS FACTOR#0.9744;HYPERSENSITIVITY#0.9744;SMALL INTESTINE#0.9744;VASCULAR SMOOTH MUSCLE CELL#0.9744;TUMOR CELLS#0.9743;FEMORAL VEIN#0.9743;TARGET ORGAN DAMAGE#0.9742;SMOOTH MUSCLE CONTRACTION#0.9742;ADRENERGIC RECEPTOR#0.9742;RECEPTOR ACTIVITY#0.9742;RENIN ACTIVITY#0.9742;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9742;HISTONE DEACETYLASE#0.9742;TISSUE GROWTH FACTOR#0.9741;POLY ADP RIBOSE#0.9741;HEMORRHAGIC#0.9740;CANCER CELL#0.9739;TUBULAR EPITHELIAL CELL#0.9739;HYPOXIA INDUCIBLE FACTOR#0.9738;VITAMIN D RECEPTOR#0.9738;VENA CAVA#0.9738;LEFT VENTRICULAR REMODELING#0.9737;ATENOLOL#0.9734;ISCHEMIA REPERFUSION INJURY#0.9734;BRAIN RENIN-ANGIOTENSIN SYSTEM#0.9734;EPITHELIAL TO MESENCHYMAL#0.9734;MUSCLE CONTRACTION#0.9734;END ORGAN DAMAGE#0.9734;OVARIAN#0.9733;D-ARGININE#0.9733;CELLULAR GROWTH#0.9733;MAP KINASE#0.9733;ENDOTHELIUM DEPENDENT VASODILATATION#0.9733;THALAMUS#0.9733;INTRACELLULAR ALKALINIZATION#0.9732;CYCLIC GUANOSINE MONOPHOSPHATE#0.9732;STEROIDOGENESIS#0.9732;RIGHT ATRIUM#0.9731;KIDNEY FAILURE#0.9731;PROSTACYCLIN#0.9731;KIDNEY INJURY MOLECULE#0.9731;ESTRADIOL#0.9730;PAPAVERINE#0.9730;JUGULAR VEIN#0.9729;SPIRONOLACTONE#0.9729;ADENYLYL CYCLASE ACTIVITY#0.9729;MYOCYTES#0.9728;ARTERIOSCLEROSIS#0.9728;CUSHING'S SYNDROME#0.9728;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9727;COMMON CAROTID ARTERY#0.9727;SCAVENGER RECEPTOR#0.9727;ANGIOTENSIN RECEPTOR BLOCKADE#0.9726;PREGNENOLONE#0.9726;PROSTAGLANDIN FORMATION#0.9725;PLATELET AGGREGATION#0.9724;NEUTROPHIL#0.9724;INTRACELLULAR SIGNALING PATHWAY#0.9724;SIGNAL TRANSDUCER#0.9724;PHEOCHROMOCYTOMA#0.9724;ISCHEMIC HEART DISEASE#0.9724;FIBRINOLYSIS#0.9724;ADRENAL GLAND#0.9724;ADENOSINE#0.9724;72-HOURS#0.9723;PHOSPHOLIPASE A2#0.9723;PENTOBARBITAL#0.9722;CYCLASE ACTIVITY#0.9722;OOCYTE MATURATION#0.9722;HYPERCHOLESTEROLEMIA#0.9722;BESTATIN#0.9721;VASOCONSTRICTION#0.9721;GUANINE#0.9721;COENZYME A#0.9721;COLORECTAL LIVER METASTASES#0.9721;LEFT ATRIUM#0.9720;RANDOMIZED CLINICAL TRIAL#0.9720;COLORECTAL CANCER#0.9719;BLOOD CIRCULATION#0.9719;HUMAN UMBILICAL VEIN#0.9719;GLIBENCLAMIDE#0.9719;PLASMA PROTEIN#0.9719;YOHIMBINE#0.9718;VASCULAR SMOOTH MUSCLE CONTRACTION#0.9718;RETINOIC ACID#0.9717;MYOFIBROBLAST DIFFERENTIATION#0.9717;VENULE#0.9717;ANGIOTENSIN CONVERTING ENZYME#0.9716;COLITIS#0.9715;1,2,4-TRIAZOLE#0.9715;MESANGIUM#0.9714;ENDOTHELIN RECEPTOR#0.9713;ADIPOGENESIS#0.9713;NEW ONSET DIABETES#0.9713;8-HYDROXY-2'-DEOXYGUANOSINE#0.9713;ADENOSINE 5'-TRIPHOSPHATE#0.9713;PULMONARY VASCULAR REMODELING#0.9713;ANGIOTENSIN TYPE 1#0.9713;ENDOTHELIAL CELL PROLIFERATION#0.9712;ATRIAL FIBRILLATION#0.9712;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9712;PULSE WAVE VELOCITY#0.9711;FOCAL ADHESION#0.9711;FOREBRAIN#0.9711;ADDISON'S DISEASE#0.9711;EPIDERMAL GROWTH FACTOR#0.9711;UMBILICAL VEIN#0.9711;OXYGENASE#0.9710;RENAL FIBROSIS#0.9710;VERAPAMIL#0.9710;MOTOR ACTIVITY#0.9709;TO THE PROGRESSION#0.9709;PULMONARY ARTERY#0.9709;GLUTAMATE RECEPTOR#0.9709;ENDOTHELIAL GROWTH FACTOR#0.9709;CORONARY ARTERY BYPASS#0.9708;CARDIAC MUSCLE#0.9708;VASCULAR ENDOTHELIAL CELL#0.9708;ADENYLATE CYCLASE#0.9708;HUMAN EMBRYONIC KIDNEY#0.9707;GUANOSINE-3',5'-MONOPHOSPHATE#0.9707;NUCLEOTIDE BINDING#0.9707;CREATINE KINASE#0.9707;PHENTOLAMINE#0.9707;MONOCYTE CHEMOTACTIC PROTEIN#0.9707;SMC PROLIFERATION#0.9707;MUSCLE HYPERTROPHY#0.9707;HIGH FAT DIET#0.9707;SUBSTANTIA NIGRA#0.9706;CALCINEURIN#0.9706;NEPHROTIC SYNDROME#0.9706;DIABETIC KIDNEY DISEASE#0.9706;APROTININ#0.9706;ADRENAL CORTEX#0.9706;CYCLIN DEPENDENT KINASE#0.9705;SODIUM CHANNEL#0.9704;RECEPTOR ANTAGONIST#0.9704;RAMIPRIL#0.9703;BLOOD GLUCOSE LEVEL#0.9703;NG-NITRO-L-ARGININE#0.9703;GLUTATHIONE PEROXIDASE#0.9703;BILE DUCT#0.9702;CISPLATIN#0.9702;SMOOTH MUSCLE CELL#0.9702;GENE SILENCING#0.9702;ROS FORMATION#0.9702;SECRETORY GRANULE#0.9701;ADENYLATE#0.9701;GLOMERULONEPHRITIS#0.9700;RECEPTOR BINDING#0.9700;MYOTUBE#0.9700;KIDNEY DAMAGE#0.9700;INTERSTITIAL CELL#0.9699;FATTY LIVER#0.9699;SUDDEN CARDIAC DEATH#0.9699;4-AMINOPYRIDINE#0.9699;MODE OF ACTION#0.9699;NITRIC-OXIDE SYNTHASE INHIBITOR#0.9699;N-NITRO-L-ARGININE#0.9698;CAPTOPRIL#0.9698;COGNITION#0.9697;FETAL KIDNEY#0.9697;CYTOKINE PRODUCTION#0.9697;MUSCLE CELL#0.9696;HEPARIN#0.9696;LISINOPRIL#0.9696;HYPOKALEMIA#0.9696;HOE 140#0.9695;PYRUVATE#0.9694;ALANINE#0.9694;APOMORPHINE#0.9694;PHOSPHATASE ACTIVITY#0.9693;WOUND HEALING#0.9693;MEMBRANE DEPOLARIZATION#0.9693;PROTEOGLYCAN#0.9692;PROLIFERATIVE DIABETIC RETINOPATHY#0.9692;ACTIN CYTOSKELETON#0.9691;COLLAGENASE#0.9691;ADENINE DINUCLEOTIDE PHOSPHATE#0.9691;HYDRONEPHROSIS#0.9691;COLLAGEN TYPE I#0.9691;RECEPTOR MEDIATED ENDOCYTOSIS#0.9690;PROTEIN TYROSINE KINASE#0.9689;PULMONARY ARTERIAL HYPERTENSION#0.9688;CONSTITUTIVELY ACTIVE MUTANT#0.9688;CALCIUM CHANNEL#0.9688;CEREBRAL CORTEX#0.9688;ALBUMIN CREATININE RATIO#0.9687;FUROSEMIDE#0.9687;ENDOTHELIAL NITRIC OXIDE#0.9686;INDUCIBLE NITRIC OXIDE#0.9686;URIC ACID#0.9686;LIVER DISEASE#0.9686;INSULIN RECEPTOR SUBSTRATE#0.9685;ANGIOGENESIS#0.9685;ARTERIOLE#0.9685;FIBRILLAR COLLAGEN#0.9684;CIRCULATORY SYSTEM#0.9683;EMBRYONIC KIDNEY#0.9683;QUANTITATIVE REVERSE TRANSCRIPTION#0.9683;RIBOSE#0.9683;ENALAPRIL#0.9683;B CELL#0.9681;ADIPOCYTE DIFFERENTIATION#0.9681;PRAZOSIN#0.9681;CEREBRAL INFARCTION#0.9681;CATION CHANNEL#0.9681;NITROARGININE#0.9680;PRO-INFLAMMATORY#0.9680;ACUTE KIDNEY INJURY#0.9680;GLUCOCORTICOID RECEPTOR#0.9680;URETER#0.9679;POSITRON EMISSION TOMOGRAPHY#0.9679;ACE INHIBITOR#0.9679;CHOLINE#0.9679;AMBULATORY BLOOD PRESSURE#0.9678;RESONANCE ENERGY TRANSFER#0.9678;LITHIUM#0.9678;DILATED CARDIOMYOPATHY#0.9678;SPINAL CORD#0.9678;CORPUS LUTEUM#0.9677;ACE ACTIVITY#0.9677;RESPONSE TO STRESS#0.9676;PROGESTERONE#0.9676;CEREBRAL ARTERY#0.9675;MAPK ACTIVATION#0.9674;PROSTAGLANDIN BIOSYNTHESIS#0.9674;ASPARTATE#0.9674;TUMOR NECROSIS FACTOR#0.9674;CATALYTIC ACTIVITY#0.9674;LUMINAL#0.9673;ACUTE MYOCARDIAL INFARCTION#0.9673;PROTEASOME#0.9673;PHOSPHOLIPASE C#0.9672;HYPOXIC#0.9672;ACTINOMYCIN D#0.9672;GENISTEIN#0.9672;INSULIN SIGNALING PATHWAY#0.9671;BIOTIN#0.9671;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.9670;GANGLION CELLS#0.9670;FATTY LIVER DISEASE#0.9670;SMOOTH MUSCLE CELL APOPTOSIS#0.9670;NERVE GROWTH FACTOR#0.9670;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9669;GROWTH FACTOR#0.9669;CELLULAR SENESCENCE#0.9669;PUMP ACTIVITY#0.9668;XANTHINE OXIDASE#0.9668;ACIDIFICATION#0.9668;LEUCINE#0.9668;INNERVATION#0.9668;ARGININE#0.9668;COLLECTING DUCTS#0.9667;ADENOCARCINOMA#0.9667;SLIT DIAPHRAGM#0.9667;NADPH OXIDASE#0.9666;OF DIABETIC RATS#0.9665;DNA SYNTHESIS#0.9664;RENOVASCULAR HYPERTENSION#0.9664;SKELETAL MUSCLE#0.9664;PROTEIN KINASE INHIBITOR#0.9664;HARDY WEINBERG EQUILIBRIUM#0.9664;HIGH GLUCOSE LEVEL#0.9663;HYDRALAZINE#0.9663;CREATINE#0.9663;T LYMPHOCYTE#0.9663;LOW DENSITY LIPOPROTEIN#0.9662;HEAT SHOCK PROTEIN#0.9662;SERUM ALBUMIN#0.9662;RENAL REPLACEMENT THERAPY#0.9662;PULMONARY VEIN#0.9661;TUBE FORMATION#0.9661;TRANSFORMING GROWTH FACTOR#0.9661;BLOOD BRAIN BARRIER#0.9661;LECTIN#0.9661;NICOTINAMIDE#0.9661;ACTIVATOR PROTEIN 1#0.9660;GLUCOSE METABOLISM#0.9660;COLLAGEN METABOLISM#0.9660;PROGRAMMED CELL DEATH#0.9659;MAPK SIGNALING#0.9659;CONTROL OF BLOOD PRESSURE#0.9658;END STAGE RENAL FAILURE#0.9658;LOSARTAN#0.9657;HYPERGLYCEMIA#0.9657;ANTIOXIDANT ACTIVITY#0.9657;RYANODINE RECEPTOR#0.9656;OLEIC ACID#0.9656;ESSENTIAL HYPERTENSION#0.9656;BILE DUCT LIGATED#0.9656;UBIQUITIN#0.9656;GASTROINTESTINAL TRACT#0.9656;NITRIC OXIDE SYNTHASE ACTIVITY#0.9655;ACETYLCHOLINE#0.9655;RNA INTERFERENCE#0.9654;MYOFIBROBLAST#0.9654;PROTEIN KINASE B#0.9654;XANTHINE#0.9653;SMOOTH MUSCLE#0.9652;GLUCOSE UPTAKE#0.9652;PULMONARY HYPERTENSION#0.9652;OSTEOPOROSIS#0.9652;SARCOIDOSIS#0.9652;STEM CELL#0.9650;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9650;LIPOLYSIS#0.9650;ATROPINE#0.9650;MIDDLE CEREBRAL ARTERY#0.9650;AMILORIDE#0.9650;RESPIRATION#0.9650;ACTIVATED T-CELLS#0.9649;ENZYME INHIBITOR#0.9649;BLOOD PRESSURE REGULATION#0.9649;LIMIT OF DETECTION#0.9649;ARACHIDONIC ACID#0.9649;ADENINE#0.9648;NIFEDIPINE#0.9648;THROMBOSIS#0.9648;RENAL ARTERY#0.9648;RHEUMATOID ARTHRITIS#0.9648;RETINOL BINDING#0.9647;ADVENTITIA#0.9647;BETA1 ADRENERGIC RECEPTOR#0.9647;FRAGMENT LENGTH POLYMORPHISM#0.9647;CONSTRICTION#0.9647;FIXED DOSE COMBINATION#0.9646;DIABETIC NEPHROPATHY#0.9645;OBESE#0.9644;RENAL WATER EXCRETION#0.9644;GROWTH FACTOR RECEPTOR#0.9644;KINASE ACTIVITY#0.9644;AGEING#0.9643;HYDROCHLOROTHIAZIDE#0.9643;INSULIN RECEPTOR#0.9642;VASOMOTION#0.9642;PHOSPHODIESTERASE INHIBITOR#0.9642;PEROXISOME#0.9642;PKC ACTIVATION#0.9641;TYPE 1 DIABETES#0.9640;CELL ADHESION MOLECULE#0.9640;APOPTOSIS#0.9639;HYPOGLYCEMIA#0.9638;CORONARY HEART DISEASE#0.9638;INCREASED BLOOD PRESSURE#0.9637;CEREBROVASCULAR DISEASE#0.9637;BICARBONATE TRANSPORT#0.9637;OSTEOCLAST#0.9636;MANNITOL#0.9636;POTASSIUM CHANNEL#0.9636;CENTRAL NERVOUS SYSTEM#0.9635;NITRIC OXIDE#0.9635;TETRODOTOXIN#0.9635;ACTIVATED T CELL#0.9634;TARGET OF RAPAMYCIN#0.9633;NOS ACTIVITY#0.9633;KETAMINE#0.9633;SODIUM DODECYL SULFATE#0.9633;ACTION POTENTIAL#0.9633;GUANYLATE CYCLASE#0.9633;ACUTE CORONARY SYNDROME#0.9632;DODECYL SULFATE#0.9632;BRUSH BORDER#0.9632;TRANSIENT RECEPTOR POTENTIAL#0.9631;IONOPHORE#0.9631;COMPLEX I#0.9631;OSMOREGULATION#0.9630;MONONUCLEAR CELLS#0.9630;CIS-DIAMMINEDICHLOROPLATINUM#0.9630;CELL GROWTH#0.9629;MINERALOCORTICOID RECEPTOR BLOCKER#0.9629;PERTUSSIS#0.9629;CYTOCHROME P450#0.9628;DNA METHYLATION#0.9628;INTEGRIN LINKED KINASE#0.9627;PROTEIN SECRETION#0.9627;DIPHOSPHATE#0.9627;NEPHROPATHY#0.9627;CASPASE-3 ACTIVITY#0.9626;SODIUM NITROPRUSSIDE#0.9626;SLEEP APNEA#0.9624;SUPEROXIDE ANION GENERATION#0.9624;NITROPRUSSIDE#0.9624;POLYURIA#0.9624;LUNG CANCER#0.9624;N-OMEGA-NITRO-L-ARGININE#0.9623;CONNECTIVE TISSUE#0.9623;SUCROSE#0.9622;LEFT VENTRICULAR MASS#0.9621;CHANNEL ACTIVITY#0.9621;FORSKOLIN#0.9620;PARKINSON'S DISEASE#0.9620;TACHYCARDIC#0.9620;END DIASTOLIC VOLUME#0.9619;INTIMA MEDIA THICKNESS#0.9619;ISCHEMIA#0.9619;RESPONSE TO ACETYLCHOLINE#0.9618;GESTATION#0.9618;RECEPTOR AGONIST#0.9617;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9616;NATRIURESIS#0.9615;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.9615;LYSINE#0.9615;HIGH DENSITY LIPOPROTEIN#0.9615;LEUKOCYTE#0.9614;THORACIC AORTA#0.9614;CHRONIC HEART FAILURE#0.9614;BLOOD UREA NITROGEN#0.9613;MYOFILAMENT#0.9613;EXTRACELLULAR SPACE#0.9610;CYTOCHROME C#0.9610;AKT SIGNALING#0.9610;LIPID METABOLISM#0.9609;HYPERTENSION#0.9609;GLOMERULUS#0.9609;REGENERATION#0.9609;CHRONIC LIVER DISEASE#0.9609;MECHANISMS OF ACTION#0.9608;EPITHELIAL CELL#0.9608;T CELL#0.9608;RAPAMYCIN#0.9608;HYPOTENSIVE#0.9607;GLYCINE#0.9607;CELL MIGRATION#0.9607;PROTEIN BINDING#0.9607;PROPRANOLOL#0.9606;DIAPHRAGM#0.9606;ADENO ASSOCIATED VIRUS#0.9605;INULIN#0.9605;CELL COMMUNICATION#0.9605;SARCOPLASMIC RETICULUM#0.9605;ION CHANNEL#0.9605;SEX CHROMOSOME#0.9604;PHOSPHODIESTERASE#0.9603;COAGULATION#0.9603;SOLUBLE GUANYLYL CYCLASE#0.9603;OVARIAN HYPERSTIMULATION SYNDROME#0.9602;N-ACETYLCYSTEINE#0.9602;L-ARG#0.9602;URETERIC BUD#0.9602;INFLAMMATORY CELL INFILTRATION#0.9601;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9601;MIGRATION INHIBITORY FACTOR#0.9599;SIGNALING MOLECULE#0.9599;ENZYME ACTIVITY#0.9599;MEMBRANE FRACTION#0.9599;CAROTID ARTERY#0.9599;MULTIPLE REGRESSION ANALYSIS#0.9598;TRANSCRIPTASE#0.9598;OVARIAN CANCER#0.9598;GLUCOSE HOMEOSTASIS#0.9597;ENDOTHELIAL CELL#0.9597;ANGIOTENSIN RECEPTOR BLOCKER#0.9596;SIGNALLING PATHWAY#0.9596;THROMBOXANE A2 RECEPTOR#0.9595;ACETYLCYSTEINE#0.9595;SIGNALING CASCADE#0.9595;DNA BINDING#0.9594;TYPE 2 DIABETES MELLITUS#0.9594;DEPHOSPHORYLATION#0.9594;CORONARY ARTERY LIGATION#0.9594;MAGNETIC RESONANCE IMAGING#0.9594;RENAL SYSTEM#0.9593;IMMUNE CELL#0.9593;REACTIVE OXYGEN SPECIES#0.9593;PROTEIN SYNTHESIS#0.9592;CELL ADHESION#0.9592;FACTOR S#0.9592;NITRIC OXIDE SYNTHASE#0.9591;TRADITIONAL CHINESE MEDICINE#0.9591;2 DIABETES MELLITUS#0.9591;ERYTHROCYTE#0.9591;HYDROXYPROLINE#0.9590;BONE MARROW#0.9590;CARDIOMYOPATHY#0.9589;CEREBRAL ARTERY OCCLUSION#0.9589;BODY WEIGHT GAIN#0.9588;RECEPTOR TYROSINE KINASE#0.9585;CELL DEATH#0.9585;CYTOTOXICITY#0.9584;SUPEROXIDE DISMUTASE ACTIVITY#0.9584;LASER DESORPTION IONIZATION#0.9584;ROS GENERATION#0.9584;VASCULAR CELL#0.9584;CHOLERA#0.9584;ENDOPLASMIC RETICULUM#0.9583;SIGNAL TRANSDUCTION#0.9583;FOCAL CEREBRAL ISCHEMIA#0.9583;MICROTUBULE#0.9582;MYOSIN PHOSPHATASE#0.9582;ANTI INFLAMMATORY DRUGS#0.9581;WEIGHT GAIN#0.9581;GLUCOSE TOLERANCE TEST#0.9581;CHEMOTAXIS#0.9581;HYPERACTIVITY#0.9580;GLYCOGEN SYNTHASE KINASE#0.9580;MITOGEN ACTIVATED PROTEIN#0.9579;VASODILATOR#0.9579;MYOCARDIUM#0.9579;TUMOR SUPPRESSOR#0.9578;EXOCYTOSIS#0.9578;SWELLING#0.9578;PHOSPHATASE INHIBITOR#0.9578;SEMINAL PLASMA#0.9577;HIGH RISK PATIENTS#0.9577;PROTEIN KINASE C#0.9577;TACHYCARDIA#0.9576;EXTRACELLULAR MATRIX COMPONENT#0.9576;RANDOMIZED CONTROLLED TRIAL#0.9576;NEUROPROTECTION#0.9575;FLUDROCORTISONE#0.9575;VASCULAR ENDOTHELIUM#0.9575;GENE EXPRESSION#0.9574;BRADYCARDIA#0.9574;NEPHRON#0.9574;GUANOSINE#0.9573;LATERAL HYPOTHALAMIC AREA#0.9573;STAUROSPORINE#0.9573;CARDIOVASCULAR SYSTEM#0.9573;MORPHOGENESIS#0.9572;INDOMETHACIN#0.9572;IMMUNE SYSTEM#0.9572;GLOMERULAR FILTRATION BARRIER#0.9571;HALOPERIDOL#0.9571;CELL MEMBRANE#0.9571;HYPERTHYROIDISM#0.9570;THYMIDINE#0.9570;SEPTUM#0.9570;ANGIOTENSIN RECEPTOR#0.9569;CHLORAMPHENICOL#0.9569;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9568;NOS INHIBITOR#0.9568;NERVOUS SYSTEM#0.9568;BLADDER OUTLET OBSTRUCTION#0.9568;MECHANISM OF ACTION#0.9568;ATHEROSCLEROSIS#0.9567;ANDROGEN RECEPTOR#0.9567;CELL SURFACE#0.9566;GLUTATHIONE#0.9566;VITAMIN E#0.9565;S PHASE#0.9565;CELL ACTIVATION#0.9564;K+ CONDUCTANCE#0.9564;MYOCARDIAL INFARCTION#0.9563;GLYCERALDEHYDE-3-PHOSPHATE#0.9563;PROTEIN KINASE A#0.9562;MITOCHONDRIAL MEMBRANE#0.9562;MUTAGENESIS#0.9562;ARRHYTHMIA#0.9560;PERIPHERAL BLOOD#0.9559;WEIGHT LOSS#0.9559;CHRONIC KIDNEY DISEASE#0.9559;CELL PROLIFERATION#0.9559;TETRAHYDROBIOPTERIN#0.9558;PARENCHYMA#0.9557;MONOCYTE#0.9557;CARDIOVASCULAR RISK FACTOR#0.9556;EDEMA#0.9556;PROTEIN KINASE G#0.9555;TIGHT JUNCTION#0.9555;DNA FRAGMENTATION#0.9554;VASODILATATION#0.9554;LYMPH NODE#0.9553;DIURESIS#0.9553;QUANTITATIVE REAL TIME#0.9553;TROGLITAZONE#0.9551;CELL DIFFERENTIATION#0.9549;BLOOD COAGULATION#0.9549;TETRAETHYLAMMONIUM#0.9548;SPLENIC ARTERY#0.9548;PROTEIN KINASE CASCADE#0.9548;TYROSINE KINASE 2#0.9547;DEMENTIA#0.9546;L-PHENYLALANINE#0.9546;CORONARY ARTERY DISEASE#0.9544;PHOSPHORAMIDON#0.9544;ILIAC ARTERY#0.9544;MYOSIN HEAVY CHAIN#0.9543;HUMAN PULMONARY ARTERY#0.9543;INDOLE#0.9543;HUMAN ADRENOCORTICAL CARCINOMA#0.9543;HEPATOCYTE NUCLEAR FACTOR#0.9543;ESTROUS CYCLE#0.9543;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9543;ALZHEIMER'S DISEASE#0.9542;END SYSTOLIC VOLUME#0.9542;STREPTOZOTOCIN#0.9542;RESPONSE TO TREATMENT#0.9542;BLOOD VESSEL#0.9542;RED BLOOD CELL#0.9541;FLUORESCEIN#0.9540;TYROSINE KINASE INHIBITOR#0.9540;MITOCHONDRIA#0.9539;PROTEIN KINASE#0.9539;COLLAGEN DEGRADATION#0.9539;CONGESTIVE HEART FAILURE#0.9537;INFLAMMATORY RESPONSE#0.9536;FERTILIZATION#0.9536;ARTERY DISEASE#0.9536;LYSOSOME#0.9535;LEFT ANTERIOR DESCENDING#0.9534;MITOMYCIN C#0.9534;KIDNEY DISEASE#0.9533;ZUCKER DIABETIC FATTY#0.9529;FLOW MEDIATED DILATION#0.9529;TYPE 2 DIABETES#0.9529;MYELOPEROXIDASE ACTIVITY#0.9528;HYPOTENSION#0.9528;ANTIBODY MEDIATED REJECTION#0.9528;ATHEROSCLEROTIC#0.9528;NITRO-L-ARGININE#0.9526;G1 PHASE#0.9526;BETA-HYDROXYSTEROID DEHYDROGENASE#0.9526;BODY WEIGHT RATIO#0.9525;VASODILATION#0.9525;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9525;ASCORBIC ACID#0.9524;L-ARGININE#0.9523;MACROPHAGE#0.9521;DIABETES MELLITUS#0.9521;PINEAL GLAND#0.9521;INDUCTION OF APOPTOSIS#0.9520;ELASTIN DEGRADATION#0.9519;PLASMA MEMBRANE#0.9518;MESENCHYMAL CELL#0.9517;ENDOTHELIUM#0.9517;CELL CYCLE#0.9516;URINARY PROTEIN#0.9516;CROSS SECTIONAL AREA#0.9514;PENTOBARBITONE#0.9513;TARGET BLOOD PRESSURE#0.9512;BIOLUMINESCENCE#0.9511;IMMUNE RESPONSE#0.9511;SUPEROXIDE DISMUTASE#0.9511;ARTERY#0.9510;HEART DISEASE#0.9510;MYOSIN LIGHT-CHAIN KINASE#0.9508;GLUCOSE INTOLERANCE#0.9508;PROTEINURIA#0.9507;DENTATE GYRUS#0.9506;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.9506;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.9505;APOPTOTIC#0.9504;DIGESTION#0.9504;ALKALINE PHOSPHATASE#0.9502;CARRIE#0.9502;URIDINE#0.9501;DOMINANT NEGATIVE MUTANT#0.9501;EXCRETION#0.9500;ORAL GLUCOSE TOLERANCE#0.9499;SMOOTH MUSCLE ACTIN#0.9498;VASCULAR DISEASE#0.9498;LYMPHATIC VESSEL#0.9497;ETHINYL ESTRADIOL#0.9497;NORMAL CONTROL GROUP#0.9495;MAGNESIUM SULFATE#0.9494;LUTEAL PHASE#0.9494;BASEMENT MEMBRANE#0.9492;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9491;SIGNALING PATHWAY#0.9490;ADRENAL ADENOMA#0.9487;NERVE FIBER#0.9487;L-LYSINE#0.9486;BUMETANIDE#0.9486;LINEAR REGRESSION ANALYSIS#0.9485;BONE RESORPTION#0.9484;ELECTROPHORETIC MOBILITY SHIFT#0.9484;ADRENAL HYPERPLASIA#0.9483;COLCHICINE#0.9482;EXTRACELLULAR MATRIX#0.9482;CORONARY ARTERY#0.9480;CLEAVED CASPASE 3#0.9480;TRANSCRIPTION FACTOR#0.9479;CYTOPLASM#0.9479;TRANSCRIPTIONAL CONTROL#0.9478;VITAMIN D DEFICIENCY#0.9476;KINASE INHIBITOR#0.9476;TRIFLUOPERAZINE#0.9474;DECIDUA#0.9472;AND AORTIC ANEURYSM#0.9472;POLYMERASE CHAIN REACTION#0.9470;EOSIN#0.9469;INFLAMMATORY CELL#0.9469;GLOMERULAR FILTRATION#0.9468;LUPUS ERYTHEMATOSUS#0.9468;TOXICITY#0.9466;VERTEBRAL ARTERY#0.9465;REGULATION OF GLOMERULAR FILTRATION#0.9462;PERCUTANEOUS CORONARY INTERVENTION#0.9462;REVERSE TRANSCRIPTION#0.9462;NEUROHYPOPHYSIS#0.9461;L-DOPA#0.9461;LUCIFERASE ACTIVITY#0.9460;COLONY-STIMULATING FACTOR#0.9459;GLOMERULAR FILTRATION RATE#0.9459;2'-DEOXYURIDINE#0.9458;SMOOTH MUSCLE HYPERTROPHY#0.9458;LACTATION#0.9457;ASPARAGINE#0.9457;LABETALOL#0.9456;FATTY ACID SYNTHASE#0.9455;CD4+ T CELL#0.9455;LIPID RAFT#0.9454;REACTIVE OXYGEN SPECIES FORMATION#0.9453;NOCICEPTION#0.9452;T CELL ACTIVATION#0.9451;LEYDIG CELL#0.9449;ACUTE PANCREATITIS#0.9447;FOLLICLE STIMULATING HORMONE#0.9446;EMBRYONIC STEM CELL#0.9444;MYOBLAST#0.9444;MOUSE MESANGIAL CELLS#0.9438;TRANSMISSION ELECTRON MICROSCOPY#0.9436;IDIOPATHIC PULMONARY FIBROSIS#0.9436;AUTOIMMUNE DISEASE#0.9431;IMPAIRED GLUCOSE TOLERANCE#0.9425;MULTIPLE LOGISTIC REGRESSION#0.9419;CILIARY BODY#0.9416;IFN-GAMMA#0.9415;INTERVENTRICULAR SEPTUM#0.9413;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.9409;CYCLIN DEPENDENT KINASE INHIBITOR#0.9408;MENOPAUSE#0.9407;SYSTOLIC BLOOD PRESSURE#0.9407;FASTING BLOOD GLUCOSE#0.9403;DECOMPENSATED HEART FAILURE#0.9403;TRYPTOPHAN#0.9402;UROKINASE#0.9399;TOCOPHEROL#0.9399;INDAPAMIDE#0.9396;CORTICOSTERONE SECRETION#0.9394;SMALL VESSEL DISEASE#0.9393;SODIUM PUMP#0.9392;GALECTIN#0.9391;ANAPHYLAXIS#0.9384;L-CYSTEINE#0.9380;HEMATOPOIETIC STEM CELL#0.9379;CELL CYCLE ARREST#0.9378;ELEVATED PLUS MAZE#0.9376;HEPATITIS C#0.9375;OBSTRUCTIVE SLEEP APNEA#0.9373;JEJUNUM#0.9373;DIAZOXIDE#0.9373;END OF TREATMENT#0.9370;CYTOCHROME C RELEASE#0.9368;RETINAL GANGLION CELL#0.9367;BONE MORPHOGENETIC PROTEIN#0.9365;ALLOPURINOL#0.9363;STROMA#0.9363;SARCOMERE#0.9361;ENDOMETRIUM#0.9356;CALCINEURIN ACTIVITY#0.9356;NO SYNTHASE ACTIVITY#0.9354;DIAZEPAM#0.9351;HINDBRAIN#0.9348;MARKERS OF INFLAMMATION#0.9348;MAP KINASE KINASE#0.9347;CALCIUM CHLORIDE#0.9347;ACUTE AORTIC DISSECTION#0.9346;GLUTAMINE#0.9346;REDUCED HEART RATE#0.9345;ANDROSTENEDIONE#0.9345;NLRP3 INFLAMMASOME ACTIVATION#0.9345;CHANGE FROM BASELINE#0.9344;SEVOFLURANE#0.9343;ISRADIPINE#0.9343;BRAIN INFARCTION#0.9341;BLADDER SMOOTH MUSCLE#0.9341;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9340;LEUKEMIA INHIBITORY FACTOR#0.9339;ACTIN FILAMENT#0.9339;BENZOIC ACID#0.9338;DIENCEPHALON#0.9333;THIORPHAN#0.9330;REGULATION OF CELL PROLIFERATION#0.9328;GLOMUS CELL#0.9327;M2 MACROPHAGE#0.9326;HYPOTHYROIDISM#0.9323;CIMETIDINE#0.9320;FLUVASTATIN#0.9319;MUSCULAR DYSTROPHY#0.9318;GABA A RECEPTOR#0.9316;PROTEIN PROTEIN INTERACTION#0.9315;PERIPHERAL NERVOUS SYSTEM#0.9312;ADRENALIN#0.9311;COLLAGENASE ACTIVITY#0.9308;LOCALISATION#0.9308;BETA2 ADRENERGIC RECEPTOR#0.9308;INTENSIVE CARE UNIT#0.9307;SIGNAL PEPTIDE#0.9307;CELECOXIB#0.9305;ACETYLCHOLINE RECEPTOR#0.9305;PROTEIN COMPLEX#0.9304;DNA REPLICATION#0.9303;ALPHA1 ADRENERGIC RECEPTOR#0.9303;WATER CHANNEL#0.9302;RESPONSE TO EXERCISE#0.9300;TYROSINE KINASE RECEPTOR#0.9297;SOLITARY TRACT NUCLEUS#0.9297;L-NORADRENALINE#0.9295;NEURODEGENERATIVE DISEASE#0.9292;GLYCOGEN PHOSPHORYLASE#0.9290;SIGNALLING CASCADE#0.9286;SQUAMOUS CELL CARCINOMA#0.9285;OLFACTORY BULB#0.9284;ENDOSOME#0.9284;COLLAGEN FORMATION#0.9283;VITAMIN D3#0.9282;SOLUBLE FRACTION#0.9281;CARBOHYDRATE METABOLISM#0.9277;HOMOLOGOUS RECOMBINATION#0.9276;AMINOPEPTIDASE ACTIVITY#0.9276;CALCITRIOL#0.9275;UMBILICAL CORD BLOOD#0.9273;NEPHROTOXIC#0.9271;SRC FAMILY KINASE#0.9270;DEHYDROEPIANDROSTERONE#0.9269;POST-TRANSLATIONAL MODIFICATION#0.9267;UBIQUITIN PROTEASOME SYSTEM#0.9266;MITOGENIC ACTIVITY#0.9265;IMMUNOGLOBULIN G#0.9265;RESPIRATORY FAILURE#0.9261;HEART MUSCLE#0.9258;DANTROLENE#0.9257;NOREPINEPHRINE UPTAKE#0.9254;METHYSERGIDE#0.9254;IL-6 PRODUCTION#0.9254;IBUPROFEN#0.9251;CROHN'S DISEASE#0.9248;ISOSORBIDE DINITRATE#0.9246;RETINOPATHY OF PREMATURITY#0.9243;TIBIA#0.9241;SOLID PHASE EXTRACTION#0.9240;ALVEOLAR MACROPHAGE#0.9238;NF-KAPPAB INHIBITOR#0.9235;EPIGALLOCATECHIN#0.9233;RENAL TUBULAR DYSGENESIS#0.9232;FETAL LIVER#0.9229;BONE MARROW CELLS#0.9223;ORGANELLE#0.9223;PROTEASE ACTIVITY#0.9222;STEROID SYNTHESIS#0.9221;MICROGLIAL CELL#0.9220;GASTRIC MUCOSA#0.9219;PREMATURITY#0.9219;LIPID LOWERING AGENT#0.9214;MIGRAINE#0.9213;BLOOD LOSS#0.9212;INFLAMMATORY BOWEL DISEASE#0.9211;LATERAL PREOPTIC AREA#0.9208;ENDOTHELIAL CELL DYSFUNCTION#0.9208;SCLEROTIC#0.9207;CATECHOLAMINE SYNTHESIS#0.9207;BASAL CELL#0.9205;CELL COUNTING KIT#0.9201;SYNAPTIC TRANSMISSION#0.9200;SALBUTAMOL#0.9196;AMINOHIPPURIC ACID#0.9195;MYCOPHENOLATE MOFETIL#0.9191;COLON CANCER#0.9189;AT2 RECEPTOR BINDING#0.9187;3-ISOBUTYL-1-METHYLXANTHINE#0.9186;DIZZINESS#0.9184;NUCLEIC ACID#0.9183;COLLAGEN TYPE IV#0.9180;PEPTIDE BINDING#0.9179;SYNAPTOSOME#0.9176;ERYTHROID PROGENITOR#0.9176;PLACENTAL GROWTH FACTOR#0.9170;KALLIKREIN I#0.9168;TAMOXIFEN#0.9168;RANDOMISED CONTROLLED TRIAL#0.9165;PERIPHERAL NERVE#0.9152;URATE#0.9151;BETA GALACTOSIDASE#0.9150;PKCALPHA#0.9149;MINOXIDIL#0.9148;ESTRADIOL BENZOATE#0.9143;TGF-BETA PRODUCTION#0.9143;PRIMARY HYPERPARATHYROIDISM#0.9142;SERUM AMYLOID A#0.9140;AS MYOCARDIAL INFARCTION#0.9138;ACTIVATING TRANSCRIPTION FACTOR#0.9138;HANDLE REGION PEPTIDE#0.9136;PERITONEAL MESOTHELIAL CELLS#0.9136;GRANULOCYTE#0.9133;CONTROLLED CLINICAL TRIALS#0.9127;SECRETORY PATHWAY#0.9126;LOVASTATIN#0.9123;FATTY ACID OXIDATION#0.9116;FENOFIBRATE#0.9114;URETHAN#0.9109;ETHANE#0.9104;GLUTAMIC ACID#0.9102;METALLOPROTEINASE ACTIVITY#0.9100;FOAM CELL FORMATION#0.9100;CALCIUM SIGNALLING#0.9093;CLOTTING#0.9093;HEMATOPOIETIC CELL#0.9089;PHOSPHATASE 2A#0.9085;SYSTOLIC HEART FAILURE#0.9084;CELL DIVISION#0.9082;SODIUM:HYDROGEN EXCHANGER#0.9079;HYPERTHERMIA#0.9071;ADJUSTED ODDS RATIO#0.9070;PHOSPHOLIPASE C ACTIVITY#0.9069;AMYLOID PRECURSOR PROTEIN#0.9067;POLYCYSTIC OVARY SYNDROME#0.9064;SCANNING ELECTRON MICROSCOPY#0.9061;DOXYCYCLINE#0.9060;PROTEASE ACTIVATED RECEPTOR#0.9060;CHANNEL INHIBITOR#0.9051;CELL ASSOCIATED#0.9048;ANTISENSE RNA#0.9040;PHOSPHOLIPID METABOLISM#0.9039;STEROL REGULATORY ELEMENT#0.9039;CARDIAC DEVELOPMENT#0.9038;LUPUS NEPHRITIS#0.9033;MEMBRANE TYPE 1#0.9030;HEMOSTASIS#0.9030;B CELL LYMPHOMA#0.9029;TROPHOBLAST CELL#0.9029;ACUTE HEART FAILURE#0.9028;PEPTIDE SYNTHESIS#0.9024;POLYMORPHONUCLEAR LEUKOCYTES#0.9016;MEMORY IMPAIRMENT#0.9013;NEUROTOXIN#0.9012;UREMIA#0.9010;MICROSOME#0.9010;SKELETAL MUSCLE CELLS#0.9004;LIPOGENESIS#0.9004;MIBEFRADIL#0.9003;CONN'S SYNDROME#0.9003;COMPLEMENT ACTIVATION#0.9002;SERUM RESPONSE FACTOR#0.9000;GUANYLATE CYCLASE INHIBITOR#0.9000;CARBOXYPEPTIDASE ACTIVITY#0.8990;AUTOPHAGOSOME#0.8984;MITOMYCIN#0.8984;HUMAN PANCREATIC CANCER#0.8980;FENOLDOPAM#0.8974;MATRIX METALLOPROTEINASE 1#0.8974;KERATINOCYTE#0.8974;FAT PAD#0.8974;NUCLEAR EXPORT#0.8971;DIHYDROFOLATE REDUCTASE#0.8968;SMOOTH MUSCLE RELAXATION#0.8967;NEUROTRANSMITTER RELEASE#0.8963;MULTIPLE LINEAR REGRESSION#0.8957;SODIUM BICARBONATE#0.8955;NUCLEOTIDE EXCHANGE FACTOR#0.8947;METALLOPROTEINASE INHIBITOR#0.8947;LIPID DROPLET#0.8945;FASTING PLASMA GLUCOSE#0.8945;ACROSOME REACTION#0.8941;NECROTIC#0.8939;PITAVASTATIN#0.8937;ALL TRANS RETINOIC ACID#0.8936;PROTEASOME PATHWAY#0.8935;INOSITOL TRISPHOSPHATE FORMATION#0.8932;CARNITINE#0.8932;HUMAN LEUKOCYTE ANTIGEN#0.8931;MAGNESIUM DEFICIENCY#0.8929;SILDENAFIL#0.8927;ESTROGEN RECEPTOR ALPHA#0.8925;CEREBRAL MALARIA#0.8925;CGRP RECEPTOR#0.8922;ASCENDING COLON#0.8920;ELASTIC FIBER#0.8919;LIMITS OF DETECTION#0.8917;BONE MINERAL DENSITY#0.8915;LOW BIRTH WEIGHT#0.8904;C-LEVEL#0.8904;FOLLICULAR PHASE#0.8899;SEROTONIN RECEPTOR#0.8898;NORDIHYDROGUAIARETIC ACID#0.8893;RETINOL#0.8892;VENTRICULAR ASSIST DEVICE#0.8886;TISSUE HOMEOSTASIS#0.8885;CATALASE ACTIVITY#0.8881;INTERRENAL GLAND#0.8878;ANGIOTENSINASE A#0.8877;PKCEPSILON#0.8877;HYPERPARATHYROIDISM#0.8873;ELECTRON TRANSPORT#0.8870;COMMON CAROTID ARTERIES#0.8870;ALCOHOLIC FATTY LIVER#0.8869;DIPEPTIDYL PEPTIDASE IV#0.8866;CORONARY FLOW RESERVE#0.8859;INNATE IMMUNE RESPONSE#0.8859;KUPFFER CELL#0.8858;ANTIPORT#0.8858;MITRAL VALVE PROLAPSE#0.8858;PLACENTAL DEVELOPMENT#0.8856;CARDIOTOXIC#0.8850;SPINAL CORD INJURY#0.8849;ENDOPEPTIDASE ACTIVITY#0.8849;5-HT RECEPTOR#0.8847;ALDOSTERONE RENIN RATIO#0.8846;COATED PIT#0.8845;ATP BINDING#0.8841;FRONTAL#0.8838;KIDNEY TRANSPLANT PATIENTS#0.8835;2-DEOXYGLUCOSE#0.8825;MITOCHONDRIAL DAMAGE#0.8821;PHOSPHATE BUFFERED SALINE#0.8820;RESPIRATORY CHAIN#0.8818;WHITE BLOOD CELL#0.8805;SUCCINATE#0.8801;PLACENTATION#0.8800;SIGNAL GENERATION#0.8798;TIGHT JUNCTION PROTEIN#0.8794;PENICILLAMINE#0.8783;SMC APOPTOSIS#0.8777;PERIPHERAL VASCULAR DISEASE#0.8774;BASAL GANGLIA#0.8771;TUMOR TISSUES#0.8766;MAMMARY GLAND#0.8765;ENALKIREN#0.8764;BLOOD PLATELETS#0.8758;ANTIPORTER ACTIVITY#0.8753;HIGH CARDIOVASCULAR RISK#0.8753;CHLORTHALIDONE#0.8751;KIDNEY PROXIMAL TUBULE#0.8749;EOSINOPHIL#0.8747;COLLAGEN TYPE III#0.8738;PROTEIN TYROSINE KINASE ACTIVITY#0.8736;TACROLIMUS#0.8735;MACROPHAGE INFLAMMATORY PROTEIN#0.8735;RESPONSE TO ACE INHIBITOR#0.8734;CILOSTAZOL#0.8733;INFERTILITY#0.8730;LIVER X RECEPTOR#0.8729;RETINOBLASTOMA#0.8721;TRACHEA#0.8718;AMINOGUANIDINE#0.8717;FOLIC ACID#0.8708;SPIRAPRIL#0.8704;MOLECULAR DYNAMICS SIMULATION#0.8700;CALCIUM TRANSPORT#0.8699;IGF BINDING#0.8695;HYPERACTIVE#0.8695;CELL CYCLE REGULATION#0.8693;RETICULAR FORMATION#0.8692;PURINOCEPTOR#0.8691;GUANYLATE CYCLASE ACTIVITY#0.8691;BRAIN DEVELOPMENT#0.8690;CELLULAR ADHESION MOLECULE#0.8680;EVERY OTHER DAY#0.8680;5 FLUOROURACIL#0.8678;HYPERINSULINEMIC EUGLYCEMIC CLAMP#0.8676;AIRWAY SMOOTH MUSCLE#0.8665;VEGF PRODUCTION#0.8664;SITAGLIPTIN#0.8651;MACROPHAGE POLARIZATION#0.8650;MALARIA#0.8645;GASTRIC ULCER#0.8641;DUCTUS ARTERIOSUS#0.8624;TELOMERE#0.8623;D-ALDOSTERONE#0.8618;PENTOXIFYLLINE#0.8615;MEPACRINE#0.8613;CARBAMYLCHOLINE#0.8604;MITOSIS#0.8602;DORSAL ROOT GANGLION#0.8601;POSTTRANSLATIONAL MODIFICATION#0.8600;REGULATION OF ANGIOGENESIS#0.8599;ORGANOGENESIS#0.8594;HISTAMINE RECEPTOR#0.8590;VITAMIN D BINDING#0.8589;ORNITHINE#0.8588;CELL NUCLEUS#0.8584;VASCULAR DEMENTIA#0.8583;ASCORBATE#0.8581;HYPERURICEMIA#0.8573;BRANCHING MORPHOGENESIS#0.8566;JANUS ACTIVATED KINASE#0.8563;UBIQUITIN PROTEASOME PATHWAY#0.8562;PODOCYTE FOOT#0.8559;LASER SCANNING MICROSCOPY#0.8557;N-TYPE CALCIUM CHANNEL#0.8556;LACRIMAL GLAND#0.8556;NITRIC OXIDE FORMATION#0.8551;ACID SECRETION#0.8551;CELLULAR COMPONENT#0.8547;INNATE IMMUNITY#0.8546;L-NOREPINEPHRINE#0.8545;LONG TERM MEMORY#0.8544;N-ETHYLMALEIMIDE#0.8543;DIAMMINEDICHLOROPLATINUM#0.8542;X CHROMOSOME#0.8539;AXON TERMINAL#0.8539;DIFFERENTIAL GENE EXPRESSION#0.8537;PERITONEAL CAVITY#0.8535;CHLORIDE TRANSPORT#0.8531;TRIFLUOROETHANOL#0.8528;CAMP SYNTHESIS#0.8524;FATTY ACID METABOLISM#0.8521;DIMETHYL SULFOXIDE#0.8521;CARDIAC TROPONIN I#0.8521;CITRULLINE#0.8521;DRUG DELIVERY SYSTEM#0.8519;FETAL GROWTH RESTRICTION#0.8519;FIBROBLAST MIGRATION#0.8515;PAROXYSMAL ATRIAL FIBRILLATION#0.8515;HYPERCALCEMIA#0.8509;TRANSCRIPTION FACTOR BINDING#0.8504;CANNABINOID RECEPTOR#0.8500;DERMAL FIBROBLAST#0.8500;MAPK CASCADE#0.8494;OPTIC NERVE#0.8489;MORRIS WATER MAZE#0.8487;PARTURITION#0.8487;RESPONSE TO INSULIN#0.8481;PKCDELTA#0.8480;CYSTIC FIBROSIS#0.8479;AMNION#0.8479;LIVER CANCER#0.8476;UREMIC TOXIN#0.8475;REGULATION OF GROWTH#0.8469;DEDIFFERENTIATION#0.8469;PERIODONTITIS#0.8468;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.8467;DIHYDROTESTOSTERONE#0.8467;ACROSOME#0.8463;CERVICAL CANCER#0.8462;MAP KINASE PHOSPHATASE#0.8460;ALPHA-TOCOPHEROL#0.8459;SODIUM PENTOBARBITAL#0.8453;CGMP SYNTHESIS#0.8453;C CHEMOKINE RECEPTOR#0.8451;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8450;TRADITIONAL RISK FACTORS#0.8446;ALDOSTERONE RECEPTOR ANTAGONISTS#0.8446;5'-AMP#0.8445;OXYTOCIN RECEPTOR#0.8445;MICROPARTICLE#0.8444;GINKGO BILOBA#0.8439;GESTATIONAL DIABETES#0.8439;CYCLOOXYGENASE PATHWAY#0.8434;ISORENIN#0.8431;BIBR 277#0.8429;TORASEMIDE#0.8425;IRON OVERLOAD#0.8422;ARGININE TRANSPORT#0.8422;PROTEIN PHOSPHATASE 2A#0.8420;OXYTOCIN SECRETION#0.8420;ACTIN POLYMERIZATION#0.8417;PSORIASIS#0.8413;3BETA-HYDROXYSTEROID DEHYDROGENASE#0.8412;RESPONSE TO ISOLATION STRESS#0.8402;PARA-AMINOHIPPURIC ACID#0.8402;PANCREATIC STELLATE CELL#0.8402;NEUROGENESIS#0.8400;METALLOPROTEASE INHIBITOR#0.8399;HYALURONIC ACID#0.8397;AT-17#0.8387;POTASSIUM DEFICIENCY#0.8384;SENSITIZER#0.8382;REGULATION OF GENE EXPRESSION#0.8378;RESPONSE TO SEROTONIN#0.8377;EPITHELIAL CELL APOPTOSIS#0.8372;M PHASE#0.8372;HOME BLOOD PRESSURE#0.8370;CAUDATE NUCLEUS#0.8370;EPIDIDYMAL ADIPOSE TISSUE#0.8368;VASCULAR ENDOTHELIAL FUNCTION#0.8367;CEREBRAL HEMORRHAGE#0.8366;INHIBITION OF BINDING#0.8362;FORMALIN#0.8361;PHAGOCYTOSIS#0.8360;PROSTAGLANDIN E SYNTHASE#0.8356;ADVANCED GLYCATION ENDPRODUCT#0.8356;PEPTIDASE ACTIVITY#0.8355;CAMP SIGNALING#0.8354;CD8+ T CELL#0.8350;MYOCYTE ENHANCER FACTOR#0.8345;LEUCINE UPTAKE#0.8344;B LYMPHOCYTE#0.8341;HYPERHOMOCYSTEINEMIA#0.8340;CYTOKINE RECEPTOR#0.8333;DDAVP#0.8327;GUANABENZ#0.8322;TISSUE DEVELOPMENT#0.8321;FLOW CYTOMETRY ANALYSIS#0.8315;MRNA SYNTHESIS#0.8313;ENERGY HOMEOSTASIS#0.8312;SALICYLIC ACID#0.8311;GLYCOLYSIS#0.8308;MUSCLE FIBER#0.8304;PROESTRUS#0.8303;ADIPOSE TISSUE DEVELOPMENT#0.8302;NADPH OXIDASE COMPLEX#0.8301;BACITRACIN#0.8301;CATECHOL O METHYLTRANSFERASE#0.8298;DICLOFENAC#0.8289;O METHYLTRANSFERASE#0.8288;BONE FORMATION#0.8287;OXIDATIVE STRESS RESPONSE#0.8285;ENDOCRINE CELL#0.8282;7-NITROINDAZOLE#0.8280;LIVER REGENERATION#0.8280;CYCLOPHILIN#0.8277;RIBOSOMAL S6 KINASE#0.8276;RAYNAUD’S#0.8271;ENDOTHELIN B RECEPTOR#0.8270;MITOCHONDRIAL DNA#0.8266;P38 MAPK SIGNALING#0.8257;MULTIFACTOR DIMENSIONALITY REDUCTION#0.8255;NEOMYCIN#0.8246;TRANSLATION INITIATION#0.8245;VIRAL INFECTION#0.8245;LIDOCAINE#0.8240;TRANSPORTER ACTIVITY#0.8228;PROSTANOID SYNTHESIS#0.8228;PHOSPHATASE AND TENSIN HOMOLOG#0.8224;PERMEABILITY TRANSITION PORE#0.8224;1,10-PHENANTHROLINE#0.8218;FEEDING BEHAVIOR#0.8218;RELATED PROTEIN 1#0.8218;DEFEROXAMINE#0.8215;MITOCHONDRIAL PERMEABILITY TRANSITION#0.8215;JNK SIGNALING PATHWAY#0.8214;PARENTERAL#0.8203;DUAL LUCIFERASE REPORTER#0.8202;AUTONOMIC NEUROPATHY#0.8202;CALCINEURIN SIGNALING#0.8201;MEDROXYPROGESTERONE ACETATE#0.8200;ISCHEMIC HEART FAILURE#0.8197;LIPOIC ACID#0.8196;FOOT PROCESS EFFACEMENT#0.8193;LYMPHOCYTE ACTIVATION#0.8190;ADAPTIVE IMMUNE RESPONSE#0.8189;NF KAPPAB BINDING#0.8187;FACTOR VIII#0.8184;TNF PRODUCTION#0.8183;M1 MACROPHAGE#0.8175;MICROFILAMENT#0.8173;AORTIC ATHEROSCLEROSIS#0.8162;RESPONSE TO HISTAMINE#0.8155;NOXIOUS#0.8155;PALMITATE#0.8150;IMMUNOSUPPRESSANT#0.8145;EXOSOME#0.8144;FIBRILLIN#0.8142;CLATHRIN-COATED PIT#0.8142;DIPEPTIDE HYDROLASE#0.8141;LUTEOLYSIS#0.8137;SERIOUS ADVERSE EVENT#0.8135;GINSENG#0.8124;TRANSFERRIN RECEPTOR#0.8121;AUTOIMMUNITY#0.8115;TIMOLOL#0.8113;RETINAL DISEASE#0.8108;ANAPHYLACTIC#0.8108;ANGIOTENSIN RECEPTOR BLOCKING#0.8107;POTASSIUM TRANSPORT#0.8105;CLOPIDOGREL#0.8104;MRNA TRANSCRIPTION#0.8103;CAROTID ARTERY OCCLUSION#0.8101;CORTICOTROPHIN RELEASING HORMONE#0.8097;HEPATITIS B#0.8077;PERIPHERAL BLOOD MONOCYTES#0.8077;SULFONAMIDE#0.8076;EUKARYOTIC INITIATION FACTOR#0.8076;NEUROTOXICITY#0.8075;LIGAND BINDING POCKET#0.8067;EMODIN#0.8067;AMIODARONE#0.8061;ARYL HYDROCARBON RECEPTOR#0.8060;PRESERVED SYSTOLIC FUNCTION#0.8054;IL-6 SECRETION#0.8052;DESIPRAMINE#0.8050;BACLOFEN#0.8046;REGULATION OF CELL GROWTH#0.8045;DESCENDING COLON#0.8041;SALIVARY GLAND#0.8040;ATP BINDING CASSETTE#0.8039;LUNG CARCINOMA#0.8038;VIRUS LIKE PARTICLE#0.8035;AORTIC DISEASE#0.8034;P21 ACTIVATED KINASE#0.8032;ACID PHOSPHATASE#0.8032;ANTIGEN PRESENTING CELLS#0.8030;PUBERTY#0.8029;ATRIAL CELL#0.8023;VOMITING#0.8020;INTENTION TO TREAT#0.8019;LIRAGLUTIDE#0.8010;ELECTRON TRANSPORT CHAIN#0.8006;FLOW MEDIATED VASODILATION#0.8005;SKIN CHYMOTRYPTIC PROTEINASE#0.8005;HISTONE MODIFICATION#0.8005;INHIBITION OF APOPTOSIS#0.8000;TREG CELL#0.7992;CYCLIC MECHANICAL STRETCH#0.7990;2-METHOXYESTRADIOL#0.7989;ANURIA#0.7989;CELL MOTILITY#0.7986;NONALCOHOLIC FATTY LIVER DISEASE#0.7981;TNF-ALPHA PRODUCTION#0.7981;INTRACELLULAR SIGNALING CASCADE#0.7977;ENDOMETRIAL CANCER#0.7969;INNATE IMMUNE SYSTEM#0.7967;HUMAN SERUM ALBUMIN#0.7966;COLLISION INDUCED DISSOCIATION#0.7966;SEMEN#0.7954;FLUOROURACIL#0.7953;BENZODIAZEPINE RECEPTOR#0.7951;ERK CASCADE#0.7944;INOSITOL 1,3,4,5-TETRAKISPHOSPHATE#0.7937;HEART ATTACK#0.7936;GLUCOSE REGULATED PROTEIN#0.7936;CHLOROQUINE#0.7928;BODY WEIGHT LOSS#0.7926;RIBOSOME#0.7922;GESTATIONAL DIABETES MELLITUS#0.7912;L-CARNITINE#0.7912;GAP JUNCTION REMODELING#0.7912;VENTRICULAR SEPTAL DEFECT#0.7909;MAP KINASE CASCADE#0.7908;EXPERIMENTAL AUTOIMMUNE MYOCARDITIS#0.7903;AMYOTROPHIC LATERAL SCLEROSIS#0.7902;LATERAL SCLEROSIS#0.7902;COATED VESICLE#0.7901;RELATIVE STANDARD DEVIATION#0.7901;PEPTIDE METABOLISM#0.7896;CAMP-RESPONSIVE ELEMENT BINDING#0.7891;AMINOPHYLLINE#0.7891;SOTALOL#0.7890;BETA1 ADRENOCEPTOR#0.7884;NIMODIPINE#0.7879;URINARY TRACT INFECTION#0.7876;RNA BINDING#0.7876;TISSUE DOPPLER IMAGING#0.7870;AMPHOTERICIN B#0.7865;RHOGEF#0.7858;3-METHYLADENINE#0.7856;VITAMIN K#0.7856;BOWMAN'S CAPSULE#0.7855;DNA REPAIR#0.7853;HEMATOPOIESIS#0.7852;BODY SURFACE AREA#0.7847;INTRACELLULAR ACIDIFICATION#0.7846;RECEPTOR RECYCLING#0.7839;LUTEIN#0.7839;REMIKIREN#0.7833;LEFT ATRIAL DIAMETER#0.7831;CYTOTROPHOBLAST#0.7828;LACIDIPINE#0.7807;PROTEIN KINASE C SIGNALING#0.7806;CORONARY ARTERY STENOSIS#0.7805;CALCITONIN RECEPTOR#0.7802;MEMBRANE MICRODOMAIN#0.7799;CHONDROCYTE#0.7798;CHRONIC HEPATITIS C#0.7796;NORADRENALINE UPTAKE#0.7794;COMPOSITE END POINT#0.7790;METYRAPONE#0.7788;QUANTITATIVE TRAIT LOCUS#0.7788;GENTAMICIN#0.7787;FARNESYL#0.7780;ZUCKER FATTY RATS#0.7779;VACUOLE#0.7776;MEDROXYPROGESTERONE#0.7772;ACTIVE CASPASE 3#0.7771;NITROGEN OXIDE#0.7769;PEPTIDE DEGRADATION#0.7769;STEM CELL PROLIFERATION#0.7769;TERBUTALINE#0.7765;VSMC APOPTOSIS#0.7760;INHIBITION OF CELL PROLIFERATION#0.7760;CELLULAR MEMBRANE#0.7758;INTRACELLULAR SIGNAL TRANSDUCTION PATHWAY#0.7752;NEPHROPATHIC#0.7748;CERIVASTATIN#0.7741;STEROID BIOSYNTHESIS#0.7739;MACROPHAGE ACTIVATION#0.7738;TH17 CELL#0.7731;GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM#0.7728;FATTY ACID SYNTHESIS#0.7727;BONE CELLS#0.7727;INSULIN BINDING#0.7724;LIVER DAMAGE#0.7723;OVIDUCT#0.7721;DEPRESSANT#0.7719;MICROTUBULE ASSOCIATED PROTEIN#0.7715;EPILEPSY#0.7709;MINERALOCORTICOID BIOSYNTHESIS#0.7705;ION CYCLOTRON RESONANCE#0.7705;OXIDATIVE DNA DAMAGE#0.7702;FIBROCYTE#0.7700;MESTRANOL#0.7698;SYNCYTIOTROPHOBLAST#0.7698;DORSAL AORTA#0.7696;PHOSPHOLIPASE A2 INHIBITOR#0.7694;INHIBITION OF GROWTH#0.7691;RESPONSE TO WATER#0.7684;MICROVILLI#0.7681;EMBOLISM#0.7677;PEPTIDYL DIPEPTIDASE A#0.7675;BRAIN EDEMA#0.7674;NUCLEAR MEMBRANE#0.7670;REGULATION OF PKC#0.7670;REPRODUCTIVE SYSTEM#0.7667;MATRIX METALLOPROTEINASE 2 ACTIVITY#0.7661;DIPYRIDAMOLE#0.7661;MCP-1 PRODUCTION#0.7657;SPERMINE#0.7656;CHOLESTEROL METABOLISM#0.7656;MOUSE EMBRYONIC STEM#0.7654;LUNG ADENOCARCINOMA#0.7650;CORONARY STENT IMPLANTATION#0.7649;INTRACRANIAL ANEURYSM#0.7649;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.7642;GOLGI APPARATUS#0.7641;LEFT VENTRICLE HYPERTROPHY#0.7637;L-PHENYLEPHRINE#0.7635;HUMAN BREAST CANCER#0.7635;PYRAZOLE#0.7633;CHRONIC ALLOGRAFT INJURY#0.7633;GAP JUNCTION CHANNEL#0.7632;STEROIDOGENIC FACTOR 1#0.7625;L-THIOCITRULLINE#0.7623;VASCULAR RISK FACTORS#0.7623;PHENOTYPIC SWITCHING#0.7623;IOTHALAMATE#0.7622;C TERMINAL DOMAIN#0.7618;LIMBIC SYSTEM#0.7617;MRNA BINDING#0.7612;PSEUDOHYPOALDOSTERONISM#0.7610;YES ASSOCIATED PROTEIN#0.7608;ENDOTHELIAL CELL MIGRATION#0.7602;ANCHORING#0.7602;MICROSOMAL MEMBRANE#0.7599;CHEMOATTRACTANT ACTIVITY#0.7597;ADVANCED HEART FAILURE#0.7596;MAST CELL DEGRANULATION#0.7596;MYOFIBRIL#0.7594;ADAPTIVE IMMUNE SYSTEM#0.7587;SALVIANOLIC ACID B#0.7584;KINASE INHIBITOR P27#0.7580;ENDOCYTIC VESICLE#0.7574;RANITIDINE#0.7573;PHOSPHATIDYLCHOLINE BIOSYNTHESIS#0.7573;SOMATOSTATIN RECEPTOR#0.7560;REGULATION OF MRNA#0.7552;NODULAR#0.7549;MEPYRAMINE#0.7549;KININOGENASE#0.7548;THORACIC DUCT#0.7544;NICOTINIC ACID#0.7543;RNA BINDING PROTEIN#0.7542;MECAMYLAMINE#0.7537;PHOSPHOENOLPYRUVATE#0.7529;CGMP FORMATION#0.7528;OPEN FIELD TEST#0.7522;MACROPHAGE DIFFERENTIATION#0.7520;RETINAL ENDOTHELIAL CELLS#0.7518;TERLIPRESSIN#0.7518;RENAL FILTRATION#0.7513;ADIPOSE TISSUE MASS#0.7512;ICI 182,780#0.7503;BETA-ALANINE#0.7502;PNEUMONIA#0.7496;PERITONEUM#0.7494;INNER MITOCHONDRIAL MEMBRANE#0.7490;MITOCHONDRIAL RESPIRATORY CHAIN#0.7488;AMPK ACTIVITY#0.7488;CHINESE HERBAL MEDICINE#0.7482;TYROSINE KINASE INHIBITION#0.7480;CAROTID ARTERY LIGATION#0.7479;BETAMETHASONE#0.7473;HISTONE DEACETYLASE INHIBITOR#0.7459;PERICARDIUM#0.7455;ACTIVATED CASPASE 3#0.7453;ALVEOLAR FLUID CLEARANCE#0.7452;DIACYLGLYCEROL KINASE#0.7446;INTERSTITIAL FLUID PRESSURE#0.7440;RECEPTOR DEGRADATION#0.7436;SUPEROXIDE RELEASE#0.7433;ASTROCYTOMA#0.7432;URETERIC BUD BRANCHING#0.7428;MUSCLE WEAKNESS#0.7428;APICAL PLASMA MEMBRANE#0.7421;CONTROL GROUP 1#0.7420;ALPHA-1 PROTEASE INHIBITOR#0.7416;DICARBOXYLIC ACID#0.7415;RENAL CELL CARCINOMA#0.7414;METANEPHROS#0.7413;BRAIN CORTEX#0.7413;SPIRONOLACTONE A#0.7410;INHIBITION OF ANGIOGENESIS#0.7409;PHOSPHORYLASE ACTIVITY#0.7404;EARLY TIME POINT#0.7403;MULTIVARIATE LINEAR REGRESSION#0.7403;ADRENOCEPTOR ACTIVITY#0.7399;PHOSPHOCHOLINE#0.7397;GENETICALLY ENGINEERED MICE#0.7392;LERCANIDIPINE#0.7383;RESPONSE TO NITRIC OXIDE#0.7379;RETINOID X RECEPTOR#0.7375;ORNITHINE DECARBOXYLASE#0.7369;HEPATIC VEIN#0.7368;GLYCERO-3-PHOSPHOCHOLINE#0.7364;GONAD#0.7364;RETINAL PIGMENT EPITHELIUM#0.7357;WORLD HEALTH ORGANIZATION#0.7355;CHOLINERGIC NEURON#0.7351;MACULAR DEGENERATION#0.7346;URINARY TRACT OBSTRUCTION#0.7344;CORONARY ENDOTHELIAL DYSFUNCTION#0.7344;MINOCYCLINE#0.7341;CATECHOLAMINE BIOSYNTHETIC#0.7340;TRAUMATIC BRAIN INJURY#0.7339;DIMINAZENE ACETURATE#0.7335;PRECURSOR CELL#0.7334;YOLK SAC#0.7333;DOPAMINE D1 RECEPTOR#0.7325;PERITONITIS#0.7323;INTERSTITIAL MATRIX#0.7319;SCLERODERMA#0.7317;ETOPOSIDE#0.7315;HEPATITIS C VIRUS#0.7308;MALNUTRITION#0.7308;P2X RECEPTOR#0.7305;PRIMARY PULMONARY HYPERTENSION#0.7304;ACTIVATED B CELL#0.7295;GREEN FLUORESCENCE PROTEIN#0.7293;ANOREXIA#0.7292;PROPIDIUM#0.7287;ROFECOXIB#0.7284;ULCERATIVE COLITIS#0.7283;APOPTOSIS OF ENDOTHELIAL CELLS#0.7281;FACTOR V LEIDEN#0.7280;ESTRADIOL VALERATE#0.7276;DNA DEMETHYLATION#0.7269;N METHYLTRANSFERASE#0.7268;URINE ALBUMIN EXCRETION#0.7262;ENDMT#0.7261;ALCOHOLIC CARDIOMYOPATHY#0.7249;MESENTERIC VEIN#0.7248;HYDROLASE INHIBITOR#0.7246;TELOMERASE ACTIVITY#0.7246;ANAESTHETIC#0.7238;RESPONSE TO DRUG#0.7237;CALCIUM PUMP#0.7235;RESPONSE TO WATER DEPRIVATION#0.7231;CALYCULIN A#0.7225;HYALURONAN#0.7225;CLATHRIN COATED VESICLE#0.7217;PELVIS#0.7217;PERIPHERAL ARTERY DISEASE#0.7216;DYSPNEA#0.7210;EPHEDRINE#0.7209;GRAMICIDIN D#0.7203;FEAR RESPONSE#0.7202;PARTIAL LEAST SQUARE#0.7199;LEUKOCYTE ACTIVATION#0.7199;INSULIN TOLERANCE TEST#0.7197;2-DEOXY-D-GLUCOSE#0.7175;ENDOMETRIOSIS#0.7174;L-ALANINE#0.7166;DIFFERENTIAL SCANNING CALORIMETRY#0.7160;RESPONSE TO LPS#0.7159;B NATRIURETIC PEPTIDE#0.7156;DIPEPTIDYL PEPTIDASE 4#0.7153;PROTEIN BREAKDOWN#0.7153;SN-GLYCERO-3-PHOSPHOCHOLINE#0.7150;HUMAN DERMAL FIBROBLAST#0.7148;TERAZOSIN#0.7148;DUCHENNE MUSCULAR DYSTROPHY#0.7146;LACTIC ACID#0.7141;NEURAL STEM CELL#0.7138;AGE RELATED MACULAR DEGENERATION#0.7129;CHOLESTEROL EFFLUX#0.7127;NEUROLOGICAL DISORDER#0.7124;VERY-LOW-DENSITY LIPOPROTEIN#0.7117;EXTRA CELLULAR MATRIX#0.7116;RECEPTOR-LIGAND COMPLEX#0.7116;WARFARIN#0.7115;MINERALOCORTICOID SECRETION#0.7114;GINGIVAL OVERGROWTH#0.7103;PINDOLOL#0.7101;PARACRINE SIGNALING#0.7081;CDK INHIBITOR#0.7073;IRON DEXTRAN#0.7073;GENETIC ASSOCIATION STUDIES#0.7068;NIMESULIDE#0.7061;FEMUR#0.7060;PARICALCITOL#0.7060;NO BINDING#0.7056;CHRONIC ALLOGRAFT DYSFUNCTION#0.7054;BLANK CONTROL GROUP#0.7049;GROWTH FACTOR BINDING#0.7049;OXIDATIVE PHOSPHORYLATION#0.7049;CARDIAC CONTRACTION#0.7048;GENETIC DISORDER#0.7047;OSTEOARTHRITIS#0.7040;ESTRUS#0.7038;POSITIVE FEEDBACK MECHANISM#0.7035;VESICOURETERAL REFLUX#0.7030;VALVULAR HEART DISEASE#0.7027;PROTON PUMP#0.7024;NEPHROGENIC DIABETES INSIPIDUS#0.7024;AEROBIC EXERCISE TRAINING#0.7023;DIURETIC HORMONE#0.7020;GLUCOSE-6-PHOSPHATE#0.7019;MONOCYTE DERIVED MACROPHAGE#0.7018;PHOSPHATIDIC ACID FORMATION#0.7016;VASCULITIS#0.7014;TUMOR GROWTH FACTOR#0.7013;ADENOHYPOPHYSIS#0.7011;CORONAL#0.7011;THERMOREGULATION#0.7010;LIDDLE SYNDROME#0.7010;SLEEP APNEA SYNDROME#0.7003;SYNAPTIC VESICLE#0.7000;RETINAL DAMAGE#0.6994;TNF-ALPHA SECRETION#0.6990;CARDIAC MAGNETIC RESONANCE#0.6989;NEURAL CELL#0.6986;PLURIPOTENT STEM CELL#0.6984;SURAMIN#0.6981;CATHEPSIN D ACTIVITY#0.6981;HIGH FAT FEEDING#0.6978;PROGESTIN#0.6977;COGNITIVE DISORDER#0.6977;CEREBRAL AMYLOID ANGIOPATHY#0.6973;MITOCHONDRIAL FISSION#0.6960;DECIDUAL CELL#0.6958;L-TYROSINE#0.6957;GMP FORMATION#0.6957;P2Y RECEPTOR#0.6956;CLOFIBRATE#0.6956;RESPONSE TO GLUCAGON#0.6952;ADIPOSE-DERIVED STEM CELL#0.6948;CELL PHYSIOLOGY#0.6948;GLYBENCLAMIDE#0.6946;2,3-DIMERCAPTOPROPANOL#0.6943;BRACHIAL ARTERY DIAMETER#0.6941;IKAPPAB KINASE#0.6936;FENTANYL#0.6931;BASAL CELL CARCINOMA#0.6928;PROTEIN TRANSLATION#0.6926;INHIBITION OF LTP#0.6926;PI3K SIGNALING#0.6925;ERGIC#0.6924;DIARRHEA#0.6920;MOOD DISORDER#0.6916;OLIGOHYDRAMNIOS#0.6913;HEMATOPOIETIC PROGENITOR CELL#0.6913;FAMILIAL HYPERCHOLESTEROLEMIA#0.6912;TRANSFORMING GROWTH FACTOR ALPHA#0.6912;PROGESTERONE SECRETION#0.6910;PERIPHERAL BLOOD LEUKOCYTE#0.6909;SPATIAL LEARNING#0.6904;FLUTAMIDE#0.6904;STREPTOZOCIN#0.6904;LIGAND BINDING DOMAIN#0.6903;MAMMARY EPITHELIAL CELL#0.6899;HEART GROWTH#0.6894;GLUCOSAMINE#0.6888;COLORECTAL CARCINOMA#0.6887;MINERALOCORTICOID SYNTHESIS#0.6887;AORTIC VALVE DISEASE#0.6883;URATE EXCRETION#0.6882;NEUROPEPTIDE Y RECEPTOR#0.6876;OUTER MEMBRANE#0.6867;METHYLPREDNISOLONE#0.6864;MICTURITION#0.6862;MITRAL VALVE DISEASE#0.6860;CLINICAL RESEARCH CENTER#0.6859;5'-ADENOSINE MONOPHOSPHATE#0.6854;IODIXANOL#0.6854;DESMOPRESSIN#0.6851;PEPTIDE SECRETION#0.6850;ACETAZOLAMIDE#0.6849;MALE INFERTILITY#0.6847;1α,25-DIHYDROXYVITAMIN D3#0.6841;HYPERPHOSPHORYLATION#0.6836;PHYSIOLOGICAL PROCESS#0.6832;TETRAHYDROFOLATE#0.6832;RESPONSE TO EPINEPHRINE#0.6824;TERMINAL DIFFERENTIATION#0.6818;LOWER URINARY TRACT#0.6814;DONOR SPECIFIC ANTIBODIES#0.6801;SHORT TERM MEMORY#0.6797;SECRETORY CELL#0.6795;INTERNAL CAROTID ARTERY#0.6794;ADVERSE DRUG REACTION#0.6792;A BAND#0.6792;EPITHELIAL CELL PROLIFERATION#0.6790;DEHYDROEPIANDROSTERONE SULFATE#0.6788;PERIPHERAL BENZODIAZEPINE RECEPTOR#0.6788;LEUKOTRIENE SYNTHESIS#0.6788;RESPONSE TO DOPAMINE#0.6787;GTPASE ACTIVITY#0.6786;APOPTOTIC PROCESS#0.6785;PROTEIN KINASE CALPHA#0.6784;ANTI APOPTOSIS#0.6781;BENIGN ESSENTIAL HYPERTENSION#0.6773;L-VALINE#0.6771;WASTING SYNDROME#0.6770;CATION TRANSPORT#0.6770;CONJUGATION#0.6765;NUCLEAR ENVELOPE#0.6763;ATP BINDING CASSETTE TRANSPORTER#0.6762;CATECHOLAMINE BIOSYNTHESIS#0.6762;FLUID-PHASE ENDOCYTOSIS#0.6760;STANDARD OF CARE#0.6750;SARCOLEMMA#0.6748;OBSTRUCTIVE JAUNDICE#0.6739;METARAMINOL#0.6729;POSITIVE AIRWAY PRESSURE#0.6727;PHOSPHOLIPASE A2 ACTIVITY#0.6727;CAAT ENHANCER BINDING#0.6726;ALPHA LIPOIC ACID#0.6719;INTEGRIN ACTIVATION#0.6715;WHITE MATTER LESIONS#0.6713;TETRAETHYLAMMONIUM CHLORIDE#0.6709;HEPATIC ENCEPHALOPATHY#0.6708;PODOCYTE FOOT PROCESS#0.6706;DIABETIC NEUROPATHY#0.6701;ACROMEGALY#0.6700;NO-CGMP SIGNALING PATHWAY#0.6699;TRANSMISSION DISEQUILIBRIUM TEST#0.6694;INSOLUBLE FRACTION#0.6694;RESPONSE TO PNS#0.6692;EXTERNAL JUGULAR VEIN#0.6689;GALACTOSIDASE ACTIVITY#0.6687;PHOSPHATIDYLETHANOLAMINE#0.6684;EMETIC#0.6683;PROSTAGLANDIN SECRETION#0.6681;MITOCHONDRIAL MATRIX#0.6677;AND BODY COMPOSITION#0.6675;PREDNISOLONE#0.6675;CYCLIC NUCLEOTIDE PHOSPHODIESTERASE#0.6672;LEAN BODY MASS#0.6670;PROTEIN PHOSPHATASE 1#0.6669;PURPURA#0.6659;VASCULOGENESIS#0.6657;DETOXIFICATION#0.6656;ATP HYDROLYSIS#0.6656;PYRUVATE KINASE#0.6653;OXYPURINOL#0.6649;PANCREATIC DUCTAL ADENOCARCINOMA#0.6649;CELL BODY#0.6648;DIISOPROPYL FLUOROPHOSPHATE#0.6646;ADENOSINE DEAMINASE#0.6645;ZINC FINGER PROTEIN#0.6638;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6635;NADOLOL#0.6630;CYTOKINE SECRETION#0.6629;INTRACELLULAR STORAGE#0.6619;EMBRYONIC LUNG#0.6618;GLUCOCORTICOID SECRETION#0.6616;SKELETON#0.6612;NIFLUMIC ACID#0.6610;CORTISOL BIOSYNTHESIS#0.6607;PLACENTAL INSUFFICIENCY#0.6600;MITOCHONDRIAL ELECTRON TRANSPORT#0.6598;AMP FORMATION#0.6597;CYCLOPHOSPHAMIDE#0.6596;QUININE#0.6596;SUMOYLATION#0.6593;QUINIDINE#0.6588;PERIPHERAL ARTERIAL DISEASE#0.6583;RESPONSE TO COLD#0.6583;INTRAHEPATIC CHOLANGIOCARCINOMA#0.6582;L-ADRENALINE#0.6575;VITAMIN K ANTAGONIST#0.6575;OXYGEN INDUCED RETINOPATHY#0.6572;SEDATION#0.6571;AMPHOTERICIN#0.6570;PROTEIN OXIDATION#0.6569;RECEPTOR-RECEPTOR INTERACTION#0.6563;ENTEROCYTE#0.6563;ETHYLENEDIAMINETETRAACETIC ACID#0.6557;PROLIFERATIVE GLOMERULONEPHRITIS#0.6555;DESMETHYLIMIPRAMINE#0.6554;THYROID GLAND#0.6544;ACTIVATION OF CREB#0.6540;MOUSE EMBRYONIC FIBROBLAST#0.6540;DIMINAZENE#0.6540;UNFOLDED PROTEIN RESPONSE#0.6534;PIRFENIDONE#0.6522;METHYLDOPA#0.6520;LOW FAT DIET#0.6517;THIOPENTAL#0.6514;ARTERIAL SYSTEM#0.6511;PDGF B-CHAIN#0.6511;LIPASE ACTIVITY#0.6496;PALMITIC ACID#0.6491;DOPAMINE SYNTHESIS#0.6489;KINASE ACTIVATOR#0.6488;ALDACTONE#0.6482;GABA B RECEPTOR#0.6476;CASPASE INHIBITOR#0.6473;CHORIOCARCINOMA#0.6473;EXCITATORY POSTSYNAPTIC POTENTIAL#0.6466;AMINO ACID TRANSPORT#0.6460;CRISTAE#0.6458;ISCHEMIC REPERFUSION INJURY#0.6458;ESTRONE#0.6457;THROMBOPHILIA#0.6452;ALKALINE PHOSPHATASE ACTIVITY#0.6448;NEUROTOXIC#0.6445;ER STRESS RESPONSE#0.6444;ELASTIN FIBER#0.6443;BLOOD RETINAL BARRIER#0.6443;INFERTILE#0.6442;REGULATORY LIGHT CHAIN#0.6440;CHROMAFFIN GRANULE#0.6438;CRE BINDING#0.6434;DIETHYLSTILBESTROL#0.6424;CHOLESTEROL BIOSYNTHESIS#0.6424;HYPOPHYSIS#0.6423;PENTAGASTRIN#0.6422;PROTEIN BIOSYNTHESIS#0.6419;SIGNAL TRANSMISSION#0.6410;PULMONARY EMBOLISM#0.6410;GASTRIC ACID SECRETION#0.6409;P2 RECEPTOR#0.6408;BETA CELL MASS#0.6408;PROTEIN TRANSPORT#0.6404;MESENCHYME#0.6400;DUODENUM#0.6392;PHOSPHATIDYLSERINE#0.6391;SODIUM DODECYL SULPHATE#0.6387;DISTAL CONVOLUTED TUBULE CELL#0.6386;ZINC BINDING#0.6385;THIAMINE#0.6385;PROTOPORPHYRIN IX#0.6384;ETANERCEPT#0.6383;RESPONSE TO OXIDATIVE STRESS#0.6383;METHYLTYROSINE#0.6378;FALSE DISCOVERY RATE#0.6374;GUANIDINE#0.6365;IRON HOMEOSTASIS#0.6363;L-ARGININE TRANSPORT#0.6362;TOTAL ANTIOXIDANT CAPACITY#0.6362;BEVACIZUMAB#0.6362;MICONAZOLE#0.6358;DOPAMINE D2 RECEPTOR#0.6358;CELLULAR METABOLISM#0.6358;HUNTINGTON'S DISEASE#0.6357;BONE REMODELING#0.6356;L-ISOPROTERENOL#0.6351;SCHISTOSOMIASIS#0.6351;EFFECTOR T CELL#0.6349;TRIPHENYL TETRAZOLIUM CHLORIDE#0.6347;AMRINONE#0.6344;INTESTINAL MUCOSA#0.6343;GRANULOCYTE COLONY STIMULATING FACTOR#0.6343;DEOXYURIDINE-5'-TRIPHOSPHATE#0.6342;HEPATORENAL SYNDROME#0.6338;SURFACE PLASMON RESONANCE#0.6337;REGULATION OF STEROIDOGENESIS#0.6335;MTDNA#0.6332;ENDOTOXIN INDUCED UVEITIS#0.6328;MEGAKARYOCYTE#0.6328;L-CITRULLINE#0.6322;BISOPROLOL#0.6316;ERGOMETRINE#0.6312;PKB SIGNAL TRANSDUCTION#0.6312;LINAGLIPTIN#0.6311;INDOMETACIN#0.6310;VARICOSE VEINS#0.6309;PEPTIDE FORMATION#0.6305;LEVONORGESTREL#0.6297;METHOTREXATE#0.6295;ION CHANNEL ACTIVITY#0.6293;SHAM OPERATION GROUP#0.6293;HABITUATION#0.6290;CONGENITAL ADRENAL HYPERPLASIA#0.6285;NITRIC OXIDE METABOLISM#0.6278;KW-3902#0.6278;CHRONIC ALCOHOL CONSUMPTION#0.6277;NARINGENIN#0.6273;HYALURONIDASE#0.6264;DISCOIDIN DOMAIN RECEPTOR#0.6260;CHLOROTHIAZIDE#0.6258;BERBERINE#0.6258;UTERINE HORN#0.6256;AMINOGLUTETHIMIDE#0.6255;ENFLURANE#0.6254;FARNESYL PYROPHOSPHATE SYNTHASE#0.6253;L-EPINEPHRINE#0.6253;INTRACELLULAR LOCALIZATION#0.6252;RISK OF DEATH#0.6246;L-THYROXINE#0.6244;PHOSPHODIESTERASE ACTIVITY#0.6244;RETINAL ISCHEMIA#0.6242;PHENYLETHANOLAMINE N METHYLTRANSFERASE#0.6241;ANGIOGENIC GROWTH FACTORS#0.6240;NEURONAL CELL BODIES#0.6227;HIGH MOBILITY GROUP#0.6225;REACTIVE OXIDATIVE SPECIES#0.6225;DNASE#0.6223;MYOCARDIAL STUNNING#0.6221;CALCINEURIN-NFAT SIGNALING PATHWAY#0.6221;THROMBIN RECEPTOR#0.6221;PLASMINOGEN ACTIVATION#0.6220;CC CHEMOKINE RECEPTOR#0.6220;PROCATEROL#0.6213;GROWTH DIFFERENTIATION FACTOR#0.6211;PROTON PUMP INHIBITOR#0.6207;SUBSTANCE P RECEPTOR#0.6202;ADENYLATE CYCLASE ACTIVATION#0.6200;LARGE INTESTINE#0.6200;EPITHELIAL GROWTH FACTOR#0.6194;T LYMPHOCYTE ACTIVATION#0.6193;POLYCYTHEMIA#0.6190;LEFT ATRIAL APPENDAGE#0.6190;ACETYL COA CARBOXYLASE#0.6189;MAGNETIC RESONANCE SPECTROSCOPY#0.6182;RECTUM#0.6181;AXONAL TRANSPORT#0.6181;HIGH SUCROSE DIET#0.6180;MARROW STROMAL CELLS#0.6180;SALMON CALCITONIN#0.6176;INHIBITION OF PHOSPHORYLATION#0.6175;ENHANCED GENE EXPRESSION#0.6170;CASPASE ACTIVATION#0.6166;INDUCED PLURIPOTENT STEM CELL#0.6164;VENOUS SYSTEM#0.6161;NITRIC OXIDE SIGNALING#0.6156;CENTRAL GRAY#0.6156;AORTIC VALVE STENOSIS#0.6153;LOCKED NUCLEIC ACID#0.6153;AGT ACTIVITY#0.6150;CORONARY ARTERY CALCIFICATION#0.6148;HEPATIC LIPASE#0.6147;OTOSCLEROSIS#0.6143;SALT WASTING SYNDROME#0.6140;SPHINGOSINE KINASE 1#0.6138;ATRIOVENTRICULAR BLOCK#0.6137;KIDNEY HYPERTROPHY#0.6134;SULPIRIDE#0.6123;SPECIFICITY PROTEIN 1#0.6121;MITOPHAGY#0.6116;EGF BINDING#0.6114;INFLAMMATORY MONOCYTE#0.6110;HEAT SHOCK FACTOR#0.6110;GENERAL LINEAR MODEL#0.6103;INHIBIN#0.6097;BAFILOMYCIN A1#0.6094;PYRAMIDAL CELL#0.6093;CLINICALLY IMPORTANT DIFFERENCE#0.6088;SICKLE CELL DISEASE#0.6083;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.6080;BLAST CELL#0.6080;INVASIVE CARCINOMA#0.6078;THYROXIN#0.6069;PROTEIN METABOLISM#0.6067;GUANFACINE#0.6066;INTESTINAL ABSORPTION#0.6055;REGULATION OF APOPTOSIS#0.6055;CONGENITAL HEART DISEASE#0.6054;PURKINJE CELL#0.6052;VITAMIN A#0.6051;CELL JUNCTION#0.6050;ADJUSTED HAZARD RATIO#0.6050;ADENYLATE CYCLASE INHIBITOR#0.6050;MOEXIPRIL#0.6049;Y CHROMOSOME#0.6043;GONADORELIN#0.6041;PEROXIDASE ACTIVITY#0.6036;ONCOGENIC#0.6033;TISSUE REGENERATION#0.6033;ACTOMYOSIN#0.6028;CHLORPROMAZINE#0.6028;CYTOCHROME C OXIDASE#0.6025;T CELL PROLIFERATION#0.6024;PULMONARY ARTERY HYPERTENSION#0.6022;COUGHING#0.6017;G-CSF#0.6016;INTERNEURON#0.6014;STRUCTURAL HEART DISEASE#0.6013;RESPIRATORY TRACT#0.6013;MAPKK#0.6013;FK-506#0.6010;HYPOKALEMIC PERIODIC PARALYSIS#0.6002;VOLTAGE-SENSITIVE CALCIUM CHANNEL#0.6002;ACRYLIC ACID#0.6002;DOMPERIDONE#0.6001
1840	T CELL#1.0169;THYMOCYTE#0.9744;SIGNALING PATHWAY#0.9732;TOXICITY#0.9595;GENE EXPRESSION#0.9541;B CELL#0.9344;NOTCH SIGNALING PATHWAY#0.9337;STEM CELL#0.8951;CELL DEVELOPMENT#0.8939;TRANSCRIPTION FACTOR#0.8861;APOPTOSIS#0.8812;T CELL ANERGY#0.8734;CELL PROLIFERATION#0.8663;T CELL DEVELOPMENT#0.8562;NOTCH RECEPTOR#0.8471;CELL DIFFERENTIATION#0.8323;CANCER CELL#0.8176;CELL ACTIVATION#0.7952;T CELL ACTIVATION#0.7943;UBIQUITIN#0.7550;MESENCHYMAL STEM CELL#0.7535;PROGENITOR CELL#0.7283;SOLID PHASE EXTRACTION#0.7031;PALMITOYL#0.6243;PROTEIN PHOSPHATASE 2A#0.6098;PHOSPHATASE 2A#0.6096;NEURAL PROGENITOR CELL#0.6064
1841	THYMIDYLATE KINASE#1.0607;TUBERCULOSIS#1.0571;THYMIDYLATE#1.0498;KINASE ACTIVITY#1.0382;DNA SYNTHESIS#1.0287;THYMIDINE KINASE#1.0282;DIPHOSPHATE#1.0269;DNA REPLICATION#1.0246;HERPES SIMPLEX VIRUS#1.0228;THYMIDINE#1.0225;DEOXYTHYMIDINE#1.0223;HERPES SIMPLEX#1.0209;CELL CYCLE#1.0110;THYMIDYLATE SYNTHASE#0.9697;S PHASE#0.9302;CELL DIVISION#0.9278;THYMIDINE MONOPHOSPHATE#0.9195;MITOCHONDRIAL DNA#0.9164;VACCINIA#0.9014;ACTIN FILAMENT#0.8987;AZIDOTHYMIDINE#0.8908;NUCLEOSIDE DIPHOSPHATE KINASE#0.8860;2'-DEOXYURIDINE#0.8757;CELL DIVISION CYCLE#0.8665;CANCER CELL#0.8435;DEOXYCYTIDINE KINASE#0.8315;THYMIDINE KINASE ACTIVITY#0.8302;CONTRACTILE RING#0.8273;DNA REPAIR#0.8237;ADENOSINE#0.8177;KINASE INHIBITOR#0.8149;ENZYME ACTIVITY#0.8055;MUTAGENESIS#0.8004;CELL KILLING#0.7959;MITOCHONDRIAL DNA REPLICATION#0.7927;T CELL#0.7828;HUMAN IMMUNODEFICIENCY VIRUS#0.7718;CATALYTIC ACTIVITY#0.7273;NUCLEOTIDE METABOLISM#0.7157;STRUCTURE ACTIVITY RELATIONSHIP#0.7075;HOST CELL#0.7063;ACTIN CABLE#0.7018;THYMIDINE KINASE 1#0.6968;GENE EXPRESSION#0.6858;CYTOKINESIS#0.6770;SMALLPOX#0.6746;ZIDOVUDINE#0.6680;PREMEIOTIC DNA SYNTHESIS#0.6649;DNA LIGASE#0.6628;DNA BIOSYNTHESIS#0.6595;MITOSIS#0.6590;THYMINE#0.6572;DCMP DEAMINASE#0.6305;VARICELLA ZOSTER VIRUS#0.6296;TUMOR CELLS#0.6290;MITOCHONDRIA#0.6129;DNA POLYMERASE I#0.6057;L-THYMIDINE#0.6031
1842	EXTRACELLULAR MATRIX#0.9514;SKELETAL MUSCLE#0.6008
1843	DUAL-SPECIFICITY PROTEIN PHOSPHATASE#1.0441;MAP KINASE PHOSPHATASE#1.0414;PROTEIN PHOSPHATASE 1#1.0302;MAP KINASE ACTIVITY#1.0277;DUAL SPECIFICITY PHOSPHATASE#1.0272;CISPLATIN#1.0254;BREAST CANCER CELL#1.0249;MAP KINASE#1.0248;HYPOXIA#1.0243;PROTEASOME#1.0206;INNATE IMMUNE RESPONSE#1.0188;MESANGIAL CELL#1.0137;LUNG CANCER#1.0124;DEPHOSPHORYLATION#1.0109;MAPK ACTIVATION#1.0108;MITOGEN ACTIVATED PROTEIN#1.0085;SIGNALING CASCADE#1.0068;BREAST CANCER#1.0062;DEXAMETHASONE#1.0059;PROTEIN KINASE#1.0053;PROTEIN TYROSINE PHOSPHATASE#1.0050;PROTEIN KINASE C#1.0043;PROSTATE CANCER#1.0029;KINASE ACTIVITY#1.0020;CYTOKINE PRODUCTION#1.0012;ACTIVATION OF MAP KINASE#1.0006;MONOCYTE#0.9993;ENDOTHELIAL CELL#0.9988;CELL DEATH#0.9987;VASCULAR SMOOTH MUSCLE CELL#0.9978;SMOOTH MUSCLE#0.9975;PHOSPHATASE ACTIVITY#0.9969;REVERSE TRANSCRIPTION#0.9962;CARDIOMYOCYTE#0.9960;SMOOTH MUSCLE CELL#0.9957;CANCER CELL#0.9946;MAPK SIGNALING#0.9946;MACROPHAGE#0.9937;MUSCLE CELL#0.9935;POLYMERASE CHAIN REACTION#0.9917;INNATE IMMUNITY#0.9908;EPIDERMAL GROWTH FACTOR#0.9903;BONE MARROW#0.9902;APOPTOSIS#0.9895;REACTIVE OXYGEN SPECIES#0.9887;NITRIC OXIDE#0.9883;T CELL#0.9883;KINASE INHIBITOR#0.9881;STEM CELL#0.9876;PHOSPHATASE INHIBITOR#0.9875;HEPATOMA CELLS#0.9866;PRO-INFLAMMATORY#0.9866;INFLAMMATORY RESPONSE#0.9856;IMMUNE RESPONSE#0.9854;EPITHELIAL CELL#0.9854;GLUCOCORTICOID RECEPTOR#0.9848;APOPTOTIC#0.9846;TUMOR NECROSIS FACTOR#0.9835;MAP KINASE CASCADE#0.9829;CELL GROWTH#0.9809;CELL CYCLE#0.9787;B CELL#0.9779;OSTEOBLAST#0.9779;AIRWAY SMOOTH MUSCLE#0.9765;TRANSCRIPTION FACTOR#0.9755;GROWTH FACTOR#0.9748;TOLL LIKE RECEPTOR#0.9730;CELL PROLIFERATION#0.9722;SIGNALLING PATHWAY#0.9707;GENE EXPRESSION#0.9702;MAPK CASCADE#0.9697;SIGNALING PATHWAY#0.9697;SIGNAL TRANSDUCTION#0.9695;ISCHEMIA#0.9693;OVARIAN#0.9646;QUANTITATIVE REAL TIME#0.9616;OVARIAN CANCER#0.9601;CYTOTOXICITY#0.9573;PROTEIN SYNTHESIS#0.9552;PANCREATIC CANCER#0.9537;SIGNALING MOLECULE#0.9516;SPINAL CORD#0.9503;DRUG RESISTANCE#0.9489;UBIQUITIN#0.9486;ACTINOMYCIN D#0.9481;SKELETAL MUSCLE#0.9471;DNA SYNTHESIS#0.9447;HEPATOCELLULAR CARCINOMA#0.9447;TUMOR CELLS#0.9413;NITRIC OXIDE SYNTHASE#0.9393;DNA BINDING#0.9388;PROTEIN KINASE A#0.9361;PERIPHERAL BLOOD#0.9335;CYTOPLASM#0.9328;SIGNAL TRANSDUCER#0.9294;CYCLIC AMP#0.9245;CAMP RESPONSE ELEMENT#0.9204;DOMINANT NEGATIVE MUTANT#0.9187;CALCINEURIN#0.9172;ANGIOGENESIS#0.9157;MACROPHAGE MIGRATION#0.9139;INDUCIBLE NITRIC OXIDE#0.9138;ARTERY#0.9137;GROWTH FACTOR RECEPTOR#0.9132;ATHEROSCLEROSIS#0.9130;GLUTATHIONE#0.9129;TRANSFORMING GROWTH FACTOR#0.9110;THYROTROPIN RELEASING HORMONE#0.9110;ENDOTHELIAL GROWTH FACTOR#0.9098;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9098;ACTIVATOR PROTEIN 1#0.9079;MONONUCLEAR CELLS#0.9076;TRANSACTIVATION#0.9075;CYTOKINE SECRETION#0.9016;HYPERTENSION#0.9008;NERVOUS SYSTEM#0.8956;ADENOCARCINOMA#0.8944;MYOCYTES#0.8910;PROTEIN PHOSPHATASE 2A#0.8874;PHOSPHATASE 2A#0.8871;S PHASE#0.8870;MECHANISM OF ACTION#0.8865;MYOCARDIUM#0.8828;SQUAMOUS CELL CARCINOMA#0.8766;RECEPTOR ANTAGONIST#0.8758;RNA BINDING#0.8752;POLY ADP RIBOSE#0.8752;OSTEOCLAST#0.8732;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8680;IMMUNE SYSTEM#0.8674;TUMOR SUPPRESSOR#0.8666;ADRENERGIC RECEPTOR#0.8634;HYPOXIA INDUCIBLE FACTOR#0.8622;MACROPHAGE ACTIVATION#0.8616;HYPOXIC#0.8584;ADIPOCYTE#0.8563;IMMUNE CELL#0.8560;ERK CASCADE#0.8560;GENE SILENCING#0.8542;HISTONE DEACETYLASE#0.8538;RECEPTOR TYROSINE KINASE#0.8498;CELL ACTIVATION#0.8491;RNA INTERFERENCE#0.8471;HEAT SHOCK PROTEIN#0.8462;RNA BINDING PROTEIN#0.8412;ANISOMYCIN#0.8410;INDUCTION OF APOPTOSIS#0.8380;MAP KINASE KINASE#0.8357;MITOCHONDRIAL MEMBRANE#0.8345;TUMOR TISSUES#0.8292;RESPONSE TO LPS#0.8280;HUMAN BRONCHIAL EPITHELIAL#0.8278;STRIATUM#0.8274;INSULIN RECEPTOR#0.8270;HUMAN BREAST CANCER#0.8174;CHONDROCYTE#0.8146;ATHEROSCLEROTIC#0.8133;CYTOKINE BIOSYNTHESIS#0.8122;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8120;FORMOTEROL#0.8107;CATALYTIC ACTIVITY#0.8106;PROTEIN PROTEIN INTERACTION#0.8100;PROTEIN KINASE B#0.8089;CELL MIGRATION#0.8075;PINEAL GLAND#0.8056;CELL CYCLE ARREST#0.8055;MAST CELL#0.8055;PHOSPHATASE I#0.8051;REGENERATION#0.8046;PROTEIN KINASE ACTIVATION#0.8043;FIBROBLAST GROWTH FACTOR#0.7978;TRANSFORMING GROWTH FACTOR BETA#0.7970;MOUSE EMBRYONIC FIBROBLAST#0.7970;HIGH FAT DIET#0.7934;SUPEROXIDE DISMUTASE#0.7915;MAPK SIGNALLING#0.7908;NERVE GROWTH FACTOR#0.7905;DOXORUBICIN#0.7899;HEPARIN#0.7888;ONCOGENIC#0.7862;LUCIFERASE ACTIVITY#0.7847;MICROGLIAL CELL#0.7843;RESPONSE TO UV-B#0.7843;RIBOSE#0.7831;FORSKOLIN#0.7825;MEK ACTIVITY#0.7813;GASTRIC MUCOSA#0.7808;OVARIAN CARCINOMA#0.7806;RECEPTOR AGONIST#0.7801;RESPONSE TO LIPOPOLYSACCHARIDE#0.7775;DENDRITIC CELL#0.7749;EXTRACELLULAR MATRIX#0.7727;NOREPINEPHRINE#0.7714;GONADOTROPIN RELEASING HORMONE#0.7673;THALAMUS#0.7668;DENTATE GYRUS#0.7659;G1 PHASE#0.7651;TYROSINE KINASE INHIBITOR#0.7637;EXTRACELLULAR REGULATED KINASE#0.7622;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7591;CAMP RESPONSE ELEMENT BINDING#0.7582;QUANTITATIVE REVERSE TRANSCRIPTION#0.7581;HEME OXYGENASE 1#0.7576;HYPERSENSITIVITY#0.7560;LOW DENSITY LIPOPROTEIN#0.7536;SENSITIZATION#0.7528;RESPONSE TO UV#0.7511;PULMONARY ARTERY#0.7500;NEUTROPHIL#0.7492;RESPONSE TO OXIDATIVE STRESS#0.7484;TOXICITY#0.7478;TAMOXIFEN#0.7467;ESTRADIOL#0.7444;TNF-ALPHA PRODUCTION#0.7442;PROTEIN KINASE ACTIVITY#0.7442;CYCLIN DEPENDENT KINASE#0.7437;RHEUMATOID ARTHRITIS#0.7414;COLON CANCER#0.7399;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7378;ALVEOLAR MACROPHAGE#0.7342;CENTRAL NERVOUS SYSTEM#0.7335;CAMKII#0.7316;N ACETYLTRANSFERASE#0.7286;P38 MAPK SIGNALING#0.7278;BRONCHIAL EPITHELIAL CELLS#0.7274;STREPTOZOTOCIN#0.7272;LEUCINE#0.7267;NEURONAL CELL DEATH#0.7263;DNA FRAGMENTATION#0.7225;AKT SIGNALING#0.7223;HEARING LOSS#0.7216;MIGRATION INHIBITORY FACTOR#0.7215;DOPAMINERGIC NEURON#0.7210;L-ARGININE#0.7208;ORAL EPITHELIAL CELLS#0.7193;PACLITAXEL#0.7136;AUTOIMMUNE DISEASE#0.7136;ADENOSINE#0.7124;PHOSPHODIESTERASE#0.7101;PLATELET-DERIVED GROWTH FACTOR#0.7094;LUNG EPITHELIAL CELL#0.7076;OXYGENASE#0.7024;OOCYTE#0.7018;FLUTICASONE PROPIONATE#0.6995;GM-CSF#0.6986;HUMAN UMBILICAL VEIN#0.6982;UMBILICAL VEIN#0.6980;COLITIS#0.6975;RETINOIC ACID#0.6970;RAPAMYCIN#0.6967;ENDOPLASMIC RETICULUM#0.6961;PARATHYROID HORMONE#0.6900;TRANSCRIPTASE#0.6899;ORAL SQUAMOUS CELL CARCINOMA#0.6869;CARDIOMYOPATHY#0.6849;RESPONSE TO CISPLATIN#0.6831;FOREBRAIN#0.6830;DEFENSE RESPONSE#0.6825;JNK SIGNALING PATHWAY#0.6789;PULMONARY HYPERTENSION#0.6777;ADAPTIVE IMMUNE RESPONSE#0.6773;AIRWAY EPITHELIAL CELL#0.6767;NADPH OXIDASE#0.6755;SALICYLIC ACID#0.6746;MITOCHONDRIA#0.6730;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6727;IL-10 PRODUCTION#0.6724;PROGESTERONE#0.6694;T LYMPHOCYTE#0.6686;SENESCENCE#0.6655;CONSTITUTIVELY ACTIVE MUTANT#0.6623;MINERALIZATION#0.6623;THYMIDINE#0.6615;CELL SURFACE#0.6580;CELL DIFFERENTIATION#0.6540;KERATINOCYTE#0.6531;PARKINSON'S DISEASE#0.6527;INTESTINAL EPITHELIAL CELL#0.6514;ACETYLCHOLINE RECEPTOR#0.6505;CELL DIVISION#0.6486;GENOTOXIC#0.6480;REPORTER GENE ASSAY#0.6472;PEROXISOME#0.6443;BREAST CARCINOMA#0.6432;GLUTAMINE#0.6427;CELL ADHESION#0.6411;ESTROGEN RECEPTOR#0.6408;OSTEOBLAST PROLIFERATION#0.6323;AUTOPHAGY#0.6291;ANTI INFLAMMATORY DRUGS#0.6281;ARGININE#0.6278;PREADIPOCYTE#0.6266;ARSENITE#0.6249;RESPONSE TO STRESS#0.6241;LUNG DISEASE#0.6237;DIABETIC NEPHROPATHY#0.6235;ROSIGLITAZONE#0.6231;PEPTIDOGLYCAN#0.6231;PLASMA MEMBRANE#0.6224;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6152;CALYCULIN A#0.6133;VACCINIA#0.6114;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.6088;FRONTAL#0.6080;ASTROCYTE#0.6049;INHIBITION OF APOPTOSIS#0.6049;CHRONIC NEUROPATHIC PAIN#0.6040;HISTONE H4 ACETYLATION#0.6029;DIET INDUCED OBESITY#0.6026;ANTI-INFLAMMATORY RESPONSE#0.6018;MUSCLE FIBER#0.6016;DEATH RECEPTOR#0.6006;HISTONE H3 ACETYLATION#0.6003
1844	SELECTIN#1.0652;DUAL SPECIFICITY PHOSPHATASE#1.0471;T CELL#1.0380;MAP KINASE#1.0364;FIBRINOGEN#1.0329;MITOGEN ACTIVATED PROTEIN#1.0142;PROTEIN KINASE#1.0093;PLATELET AGGREGATION#1.0017;HYPOXIA#0.9953;CANCER CELL#0.9950;PLATELET ACTIVATION#0.9917;APOPTOSIS#0.9645;GENE EXPRESSION#0.9562;ENDOTHELIAL CELL#0.9056;INFLAMMATORY RESPONSE#0.8850;ADENOSINE#0.8790;DEPHOSPHORYLATION#0.8787;TRANSCRIPTION FACTOR#0.8667;IMMUNE CELL#0.8533;MAP KINASE PHOSPHATASE#0.8410;LEUKOCYTE#0.8371;DIPHOSPHATE#0.8316;IMMUNE RESPONSE#0.8297;COLORECTAL CANCER#0.8190;COLON CANCER#0.8121;GROWTH FACTOR#0.8056;CELL CYCLE#0.8023;STROMAL CELL#0.7967;SIGNALING PATHWAY#0.7900;SIGNAL TRANSDUCTION#0.7737;OVARIAN CARCINOMA#0.7618;THROMBIN RECEPTOR#0.7609;COAGULATION#0.7575;FIBRINOGEN BINDING#0.7510;CELL PROLIFERATION#0.7493;MONOCYTE#0.7358;BREAST CANCER#0.7301;MAPK SIGNALING#0.7237;OVARIAN#0.7195;B CELL#0.7108;ANGIOGENESIS#0.7079;APOPTOTIC#0.7069;POLYMERASE CHAIN REACTION#0.7055;ASPIRIN#0.6885;ACTIVATED T-CELLS#0.6803;ACTIVATED T CELL#0.6799;COLORECTAL#0.6761;KINASE ACTIVITY#0.6545;MEAN PLATELET VOLUME#0.6469;CELL ACTIVATION#0.6345;BREAST CANCER CELL#0.6344;MACROPHAGE#0.6228;B CELL LYMPHOMA#0.6124;TUBE FORMATION#0.6020
1845	VACCINIA#1.0753;DUAL SPECIFICITY PHOSPHATASE#1.0501;CELL CYCLE#1.0316;MITOGEN ACTIVATED PROTEIN#1.0265;PROTEIN TYROSINE PHOSPHATASE#1.0262;CANCER CELL#1.0240;PROTEIN KINASE#1.0213;PHOSPHATASE ACTIVITY#1.0087;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.9848;MAP KINASE#0.9748;DEPHOSPHORYLATION#0.9136;SENESCENCE#0.8765;SIGNALING PATHWAY#0.8382;T CELL#0.8217;MACROPHAGE#0.8041;PHOSPHATASE INHIBITOR#0.8026;PROSTATE CANCER#0.8007;ANGIOGENESIS#0.7820;CATALYTIC ACTIVITY#0.7628;RNA INTERFERENCE#0.7036;MUTAGENESIS#0.7016;BREAST CANCER CELL#0.6928;BREAST CANCER#0.6897;CELL CYCLE ARREST#0.6888;PHOSPHATASE I#0.6743;CELL GROWTH#0.6351;PLATELET ACTIVATION#0.6225;DNA DAMAGE RESPONSE#0.6223;THROMBOSIS#0.6083;CERVICAL#0.6075;DNA REPAIR#0.6044;CERVICAL CANCER#0.6039
1846	BREAST CANCER#1.0629;MAP KINASE PHOSPHATASE#1.0621;T CELL#1.0426;MAP KINASE#1.0412;DUAL SPECIFICITY PHOSPHATASE#1.0393;CANCER CELL#1.0276;APOPTOSIS#1.0209;PROTEIN KINASE#1.0042;MITOGEN ACTIVATED PROTEIN#1.0033;CELL PROLIFERATION#1.0017;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.9929;GENE EXPRESSION#0.9918;GROWTH FACTOR#0.9742;SIGNALING PATHWAY#0.9729;ENDOTHELIAL CELL#0.9697;MACROPHAGE#0.9587;TRANSCRIPTION FACTOR#0.9490;PHOSPHATASE ACTIVITY#0.9478;MAPK SIGNALING#0.9475;CELL DEATH#0.9436;BREAST CANCER CELL#0.9231;B CELL#0.9167;CELL CYCLE#0.9167;COLORECTAL CANCER#0.9143;TUMOR SUPPRESSOR#0.9100;COLORECTAL#0.8869;DEPHOSPHORYLATION#0.8866;LUNG CANCER#0.8847;CD4+ T CELL#0.8752;PROTEIN PHOSPHATASE 4#0.8691;STEM CELL#0.8587;CELL GROWTH#0.8560;INFLAMMATORY RESPONSE#0.8244;APOPTOTIC#0.8228;KINASE ACTIVITY#0.8214;IMMUNE RESPONSE#0.7832;RENAL FIBROSIS#0.7659;EPITHELIAL CELL#0.7646;CARDIOMYOPATHY#0.7604;MAPK ACTIVATION#0.7537;MAPK CASCADE#0.7523;CYTOKINE PRODUCTION#0.7451;SIGNAL TRANSDUCTION#0.7172;NEUTROPHIL#0.7172;ONCOGENIC#0.7045;SENESCENCE#0.6977;LUNG ADENOCARCINOMA#0.6976;ADENOCARCINOMA#0.6940;PROTEIN KINASE C#0.6846;BONE MARROW#0.6821;EPITHELIAL MESENCHYMAL TRANSITION#0.6816;B CELL LYMPHOMA#0.6767;HYPOXIA#0.6750;CELL DIFFERENTIATION#0.6591;CELL MIGRATION#0.6525;DOXORUBICIN#0.6300;MAP KINASE ACTIVITY#0.6268;LYMPH NODE#0.6220;EARLY GROWTH RESPONSE#0.6207;CANCER STEM CELL#0.6135;T CELL DEVELOPMENT#0.6039;EXTRACELLULAR REGULATED KINASE#0.6031
1847	DUAL SPECIFICITY PHOSPHATASE#1.0422;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#1.0167;CELL PROLIFERATION#1.0111;GROWTH FACTOR#1.0068;PROTEIN KINASE#0.9968;MAP KINASE#0.9965;MITOGEN ACTIVATED PROTEIN#0.9949;GENE EXPRESSION#0.9903;SIGNALING PATHWAY#0.9857;CANCER CELL#0.9766;APOPTOSIS#0.9685;T CELL#0.9567;TRANSCRIPTION FACTOR#0.9479;MAPK SIGNALING#0.9225;ENDOTHELIAL CELL#0.9122;CELL CYCLE#0.8977;TUMOR SUPPRESSOR#0.8654;BREAST CANCER#0.8375;COLORECTAL CANCER#0.8229;MAP KINASE PHOSPHATASE#0.8120;PROTEIN PHOSPHATASE 5#0.7902;APOPTOTIC#0.7756;STEM CELL#0.7727;DEPHOSPHORYLATION#0.7460;POLYMERASE CHAIN REACTION#0.7313;MACROPHAGE#0.7286;EARLY GROWTH RESPONSE#0.7232;EPIDERMAL GROWTH FACTOR#0.7083;COLORECTAL#0.6951;PHOSPHATASE ACTIVITY#0.6911;B CELL#0.6814;CELL MIGRATION#0.6796;TUMOR NECROSIS FACTOR#0.6646;EPITHELIAL CELL#0.6637;ARTERIOLE#0.6386;QUANTITATIVE REAL TIME#0.6375;REVERSE TRANSCRIPTION#0.6344;ISCHEMIA#0.6324;CATALYTIC ACTIVITY#0.6147;BIOFILM FORMATION#0.6106;PROSTATE CANCER#0.6106;FIBROBLAST PROLIFERATION#0.6105;BREAST CANCER CELL#0.6049;CELL GROWTH#0.6022;IMMUNE RESPONSE#0.6010
1848	PANCREATIC CANCER#1.0621;MAP KINASE PHOSPHATASE#1.0471;DUAL SPECIFICITY PHOSPHATASE#1.0376;DEPHOSPHORYLATION#1.0303;TUMOR SUPPRESSOR#1.0272;MAP KINASE#1.0233;MAPK SIGNALING#1.0148;T CELL#1.0091;LUNG CANCER#1.0050;BREAST CANCER#1.0030;APOPTOSIS#0.9961;CANCER CELL#0.9956;CELL PROLIFERATION#0.9927;CELL GROWTH#0.9911;FIBROBLAST GROWTH FACTOR#0.9900;MITOGEN ACTIVATED PROTEIN#0.9897;PROTEIN KINASE#0.9891;ONCOGENIC#0.9885;GROWTH FACTOR#0.9867;TRANSCRIPTION FACTOR#0.9864;ENDOTHELIAL CELL#0.9847;CELL DEATH#0.9842;SIGNALING PATHWAY#0.9839;PHOSPHATASE ACTIVITY#0.9828;POLYMERASE CHAIN REACTION#0.9793;CELL CYCLE#0.9763;BREAST CANCER CELL#0.9737;GENE EXPRESSION#0.9714;OVARIAN CANCER#0.9601;SIGNAL TRANSDUCTION#0.9585;EPITHELIAL CELL#0.9565;STEM CELL#0.9540;EPIDERMAL GROWTH FACTOR#0.9510;PROTEIN TYROSINE PHOSPHATASE#0.9423;ADENOCARCINOMA#0.9353;SQUAMOUS CELL CARCINOMA#0.9191;MACROPHAGE#0.9128;OBESE#0.9066;CD4+ T CELL#0.9025;CELL DIFFERENTIATION#0.9011;SIGNALING CASCADE#0.8965;CELL MIGRATION#0.8755;GROWTH FACTOR RECEPTOR#0.8722;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.8676;OVARIAN#0.8547;EXTRACELLULAR REGULATED KINASE#0.8528;REGENERATION#0.8442;KINASE INHIBITOR#0.8276;KINASE ACTIVITY#0.8260;INFLAMMATORY RESPONSE#0.8199;BIPOLAR DISORDER#0.8098;REVERSE TRANSCRIPTION#0.8096;HEPATOMA CELLS#0.8026;IMMUNE RESPONSE#0.8004;GLUCONEOGENESIS#0.7996;RESONANCE ENERGY TRANSFER#0.7995;NITRIC OXIDE#0.7971;REACTIVE OXYGEN SPECIES#0.7930;DRUG RESISTANCE#0.7879;CYTOTOXICITY#0.7836;CISPLATIN#0.7782;ANCHORAGE INDEPENDENT GROWTH#0.7780;CYTOPLASM#0.7780;MELTING CURVE ANALYSIS#0.7711;CATALYTIC ACTIVITY#0.7623;APOPTOTIC#0.7540;MAPK CASCADE#0.7522;QUANTITATIVE REAL TIME#0.7417;HIGH FAT DIET#0.7385;ENDOMETRIAL CANCER#0.7320;NUCLEAR EXPORT#0.7300;RETINOIC ACID#0.7268;MAPK ACTIVATION#0.7258;SENESCENCE#0.7185;ADIPOSE TISSUE#0.7183;SIGNALLING PATHWAY#0.7141;TUMOR CELLS#0.7107;THYROID CANCER#0.7076;SKELETAL MUSCLE#0.7041;PROTEIN PROTEIN INTERACTION#0.7038;CELL CYCLE ARREST#0.6882;ENDOMETRIAL ADENOCARCINOMA#0.6841;TOPOISOMERASE II#0.6795;HUMAN PANCREATIC CANCER#0.6776;DOPAMINE#0.6775;ASTROCYTE#0.6754;SIGNAL TRANSDUCER#0.6735;MESENCHYME#0.6735;QUANTITATIVE REVERSE TRANSCRIPTION#0.6512;RECEPTOR TYROSINE KINASE#0.6478;COLORECTAL#0.6455;PERIPHERAL BLOOD#0.6437;TETRACYCLINE#0.6280;HEPATOCELLULAR CARCINOMA#0.6260;PROSTATE CANCER#0.6258;HINDBRAIN#0.6188;MONOCYTE#0.6183;PROTEIN KINASE C#0.6177;THYROID CARCINOMA#0.6176;INSULIN-LIKE GROWTH FACTOR#0.6175;CELL ADHESION#0.6171;EARLY GROWTH RESPONSE#0.6142;CHRONIC NEUROPATHIC PAIN#0.6126;DIET INDUCED OBESITY#0.6106
1849	DUAL SPECIFICITY PHOSPHATASE#1.0045;BREAST CANCER#0.9924;MAP KINASE#0.9831;MAP KINASE PHOSPHATASE#0.8865;MITOGEN ACTIVATED PROTEIN#0.7817;PROTEIN KINASE#0.7175
1850	DUAL SPECIFICITY PHOSPHATASE#1.0631;PROTEIN KINASE#0.9530;MITOGEN ACTIVATED PROTEIN#0.9514;GENE EXPRESSION#0.9311;EPSTEIN BARR VIRUS#0.7845;MAP KINASE#0.7051;APOPTOSIS#0.6881;MAPK SIGNALING#0.6771;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.6594;SIGNAL TRANSDUCTION#0.6479;B LYMPHOCYTE#0.6443;B CELL#0.6399;SIGNALING PATHWAY#0.6388
1852	DUAL SPECIFICITY PHOSPHATASE#1.0825;MAP KINASE#1.0400;PROTEIN KINASE#1.0156;MITOGEN ACTIVATED PROTEIN#1.0093;TYPE 2 DIABETES#0.9453;MAP KINASE PHOSPHATASE#0.9164;GLUCOSE UPTAKE#0.8446;GESTATIONAL DIABETES MELLITUS#0.8042;GESTATIONAL DIABETES#0.8002;DIABETES MELLITUS#0.7544;STEM CELL#0.7443;SIGNALING PATHWAY#0.7401;ADIPOCYTE#0.6949;GENE EXPRESSION#0.6781;CELL CYCLE#0.6387
1854	DUTPASE ACTIVITY#1.0958;THYMIDINE KINASE#1.0405;THYMIDYLATE#1.0333;URACIL#1.0327;GLYCOSYLASE#1.0327;THYMIDYLATE SYNTHASE#1.0313;HERPES SIMPLEX#1.0304;HERPES SIMPLEX VIRUS#1.0279;THYMIDINE#1.0166;EQUINE INFECTIOUS ANEMIA#1.0115;VIRAL REPLICATION#1.0087;DNA REPLICATION#1.0040;5 FLUOROURACIL#0.9959;CANCER CELL#0.9925;DNA REPAIR#0.9873;CELL CYCLE#0.9860;DNA SYNTHESIS#0.9664;MACROPHAGE#0.9652;GENE EXPRESSION#0.9650;TUBERCULOSIS#0.9585;NUCLEAR LOCALIZATION SIGNAL#0.9580;HOST CELL#0.9450;CELL DEATH#0.9410;APOPTOSIS#0.9332;VIRION#0.9271;FLUOROURACIL#0.9263;VIRULENCE#0.9249;EPSTEIN BARR VIRUS#0.9115;ANEMIA#0.8970;CYTOTOXICITY#0.8873;NUCLEOTIDE METABOLISM#0.8831;CATALYTIC ACTIVITY#0.8714;AFRICAN SWINE FEVER#0.8704;VACCINIA#0.8679;DIHYDROFOLATE REDUCTASE#0.8633;VIRAL GENOME#0.8618;PROTEIN KINASE#0.8533;THYMINE#0.8521;VISNA#0.8499;COLON CANCER#0.8377;T CELL#0.8299;TRANSCRIPTASE#0.8294;COLORECTAL#0.8192;ENZYME ACTIVITY#0.8151;REVERSE TRANSCRIPTION#0.8113;NUCLEOCAPSID#0.8108;DCMP DEAMINASE#0.8099;COLORECTAL CANCER#0.8084;MUTAGENESIS#0.8064;NUCLEOTIDE BINDING#0.8063;IMMUNE RESPONSE#0.7829;CYTOPLASM#0.7761;2'-DEOXYURIDINE#0.7569;NUCLEAR IMPORT#0.7558;POLYMERASE CHAIN REACTION#0.7234;APOPTOTIC#0.7056;TRIPHOSPHATASE ACTIVITY#0.7029;BASE EXCISION REPAIR#0.6963;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6938;TOXICITY#0.6812;MUTAGENIC#0.6753;TRANSCRIPTION FACTOR#0.6736;CELL CYCLE ARREST#0.6553;THYMIDYLATE KINASE#0.6499;BREAST CANCER#0.6464;TUMOR CELLS#0.6459;NERVOUS SYSTEM#0.6457;VARICELLA ZOSTER VIRUS#0.6441;DIPHOSPHATE#0.6246;PERIPHERAL BLOOD#0.6167;NEOPLASTIC TISSUES#0.6052
1855	DEMENTIA RATING SCALE#1.0908;DEMENTIA#1.0586;SIGNALLING PATHWAY#1.0326;PCP PATHWAY#1.0293;GLYCOGEN SYNTHASE KINASE#1.0286;PLASMA MEMBRANE#1.0165;WNT RECEPTOR#1.0130;WNT SIGNALING PATHWAY#1.0100;PLANAR CELL POLARITY#1.0082;SIGNAL TRANSDUCTION#0.9997;LUNG CANCER#0.9996;T CELL#0.9988;ADENOMATOUS POLYPOSIS COLI#0.9985;CASEIN KINASE 1#0.9962;CELL POLARITY#0.9958;SIGNALING PATHWAY#0.9929;CANCER CELL#0.9911;TRANSCRIPTION FACTOR#0.9866;T CELL FACTOR#0.9838;BREAST CANCER#0.9785;CELL PROLIFERATION#0.9762;GENE EXPRESSION#0.9753;CYTOPLASM#0.9697;FLIPPASE#0.9672;CONVERGENT EXTENSION#0.9661;SIGNALING MOLECULE#0.9644;NEURITE#0.9636;SIGNALING CASCADE#0.9574;APOPTOSIS#0.9479;EPITHELIAL CELL#0.9425;MICROTUBULE#0.9422;NEURITE OUTGROWTH#0.9408;MORPHOGENESIS#0.9143;LOW DENSITY LIPOPROTEIN#0.9116;MINI MENTAL STATE#0.9088;STEM CELL#0.9075;TUMOR SUPPRESSOR#0.9062;NEURAL TUBE#0.8920;CELL GROWTH#0.8902;HYPERPHOSPHORYLATION#0.8848;CELL MIGRATION#0.8844;PROTEIN KINASE#0.8799;ROBINOW SYNDROME#0.8628;CANONICAL WNT SIGNALING PATHWAY#0.8592;ENDOCYTOSIS#0.8514;COLON CANCER#0.8407;GASTRULATION#0.8325;CELL MEMBRANE#0.8148;COLORECTAL CANCER#0.8134;RNA INTERFERENCE#0.8127;NEUROTRANSMITTER RELEASE#0.8030;GROWTH FACTOR#0.7985;CELL CYCLE#0.7950;PROTEIN PROTEIN INTERACTION#0.7846;HETEROTRIMERIC G-PROTEIN#0.7804;GROWTH CONE#0.7794;COLORECTAL#0.7770;MESOTHELIOMA CELL#0.7681;BASAL BODY#0.7635;OSTEOBLAST#0.7495;ALZHEIMER'S DISEASE#0.7467;UBIQUITIN#0.7413;DEPHOSPHORYLATION#0.7380;BREAST CANCER CELL#0.7341;COGNITION#0.7168;RECEPTOR COMPLEX#0.7114;CELL SURFACE#0.7109;PHOSPHATIDYLSERINE#0.7101;TISSUE HOMEOSTASIS#0.7092;PLANAR CELL POLARITY PATHWAY#0.7078;OVARIAN#0.7053;QUANTITATIVE REAL TIME#0.7037;AUTOPHAGY#0.7024;CAMKII#0.6979;KINASE ACTIVITY#0.6964;OSTEOBLAST DIFFERENTIATION#0.6944;NERVOUS SYSTEM#0.6852;TRANS GOLGI NETWORK#0.6841;MILD COGNITIVE IMPAIRMENT#0.6828;ACTIN CYTOSKELETON#0.6751;ONCOGENIC#0.6736;CELLULAR LOCALIZATION#0.6532;PARKINSON'S DISEASE#0.6470;CELL ADHESION#0.6286;PROSTATE CANCER#0.6260;SKELETAL MUSCLE#0.6253;PRIMARY GROWTH#0.6246;OSTEOPOROSIS#0.6230;NEURITE EXTENSION#0.6174;BUDDING#0.6137;40S RIBOSOMAL SUBUNIT#0.6119;ADIPOSE TISSUE#0.6012
1856	PCP PATHWAY#1.0285;PLASMA MEMBRANE#1.0278;GLYCOGEN SYNTHASE KINASE#1.0222;AUTOPHAGY#1.0125;CANCER CELL#1.0023;PLANAR CELL POLARITY#0.9969;WNT SIGNALING PATHWAY#0.9961;CELL POLARITY#0.9886;SIGNALING PATHWAY#0.9878;CELL PROLIFERATION#0.9861;BREAST CANCER#0.9753;CELL MIGRATION#0.9600;COLORECTAL CANCER#0.9478;STEM CELL#0.9455;TRANSCRIPTION FACTOR#0.9422;GENE EXPRESSION#0.9401;NEURAL TUBE#0.9362;APOPTOSIS#0.9196;CONVERGENT EXTENSION#0.9178;CELL GROWTH#0.9104;LOW DENSITY LIPOPROTEIN#0.8682;COLORECTAL#0.8670;POLYMERASE CHAIN REACTION#0.8637;PROTEIN KINASE#0.8578;BREAST CANCER CELL#0.8487;ENDOTHELIAL CELL#0.8457;CELL CYCLE#0.8425;NICLOSAMIDE#0.8417;T CELL#0.8277;WNT RECEPTOR#0.8177;BASAL BODY#0.8115;NEURAL TUBE CLOSURE#0.8061;TUBE CLOSURE#0.8059;CYTOPLASM#0.8001;RHEUMATOID ARTHRITIS#0.7962;LUNG CANCER#0.7881;RNA INTERFERENCE#0.7835;UBIQUITIN#0.7827;RECEPTOR COMPLEX#0.7799;SIGNAL TRANSDUCTION#0.7705;COLON CANCER#0.7696;CASEIN KINASE 1#0.7639;OUTFLOW TRACT#0.7589;NEURITE OUTGROWTH#0.7477;SIGNALLING PATHWAY#0.7307;SIGNALING MOLECULE#0.7250;SIGNALING CASCADE#0.7230;ENDOCYTOSIS#0.7222;CELL MOTILITY#0.7040;OSTEOBLAST#0.6927;PLANAR CELL POLARITY PATHWAY#0.6835;SQUAMOUS CELL CARCINOMA#0.6820;PROSTATE CANCER#0.6750;NEURAL TUBE DEFECT#0.6694;MESENCHYMAL STEM CELL#0.6631;HEPATOCELLULAR CARCINOMA#0.6628;ONCOGENIC#0.6608;TUMOR SUPPRESSOR#0.6317;LAFORA DISEASE#0.6305;FIBROBLAST LIKE SYNOVIOCYTES#0.6078;CELL MEMBRANE#0.6075;MORPHOGENESIS#0.6068;SKELETAL MUSCLE#0.6047;BONE MARROW#0.6029;OVARIAN CANCER#0.6011;NEURITE#0.6002
1857	LUNG CANCER#1.0150;SIGNALING PATHWAY#0.9998;CANCER CELL#0.9913;WNT SIGNALING PATHWAY#0.9659;CELL POLARITY#0.9356;CELL GROWTH#0.9338;PLANAR CELL POLARITY#0.9250;ROBINOW SYNDROME#0.9071;GENE EXPRESSION#0.8980;GLYCOGEN SYNTHASE KINASE#0.8664;CASEIN KINASE 1#0.8661;NEURAL TUBE#0.8387;LOW DENSITY LIPOPROTEIN#0.8063;CELL PROLIFERATION#0.7741;PCP PATHWAY#0.7589;NEURITE OUTGROWTH#0.7556;SIGNAL TRANSDUCTION#0.7099;STEM CELL#0.7080;CELL CYCLE#0.6939;SQUAMOUS CELL CARCINOMA#0.6675;TRANSCRIPTION FACTOR#0.6529;GROWTH FACTOR#0.6524;APOPTOSIS#0.6433;HALOPERIDOL#0.6270;MESOTHELIOMA CELL#0.6204;WNT RECEPTOR#0.6137;HEPATOCELLULAR CARCINOMA#0.6125;POST-TRANSLATIONAL MODIFICATION#0.6029
1859	DUAL-SPECIFICITY PROTEIN KINASE#1.0563;NEUROGENESIS#1.0406;BRAIN DEVELOPMENT#1.0395;TYROSINE AUTOPHOSPHORYLATION#1.0392;MICROCEPHALY#1.0370;PROGENITOR CELL#1.0317;PROTEIN KINASE#1.0262;KINASE ACTIVITY#1.0240;T CELL#1.0238;CELL PROLIFERATION#1.0227;NEURODEGENERATIVE DISEASE#1.0203;DOWN SYNDROME#1.0193;EPIGALLOCATECHIN#1.0191;MENTAL RETARDATION#1.0169;MITOGEN ACTIVATED PROTEIN#1.0131;CELL DEATH#1.0123;ALZHEIMER'S DISEASE#1.0114;CALCINEURIN#1.0105;NERVOUS SYSTEM#1.0077;SIGNALING PATHWAY#1.0050;TRANSCRIPTION FACTOR#1.0033;CELL CYCLE#1.0014;INTELLECTUAL DISABILITY#0.9993;CENTRAL NERVOUS SYSTEM#0.9972;CELL GROWTH#0.9970;APOPTOSIS#0.9949;STEM CELL#0.9938;GROWTH FACTOR#0.9936;KINASE INHIBITOR#0.9915;GENE EXPRESSION#0.9898;CYTOPLASM#0.9838;NEUROFIBRILLARY TANGLE#0.9830;CANCER CELL#0.9812;BETA CELL#0.9770;PROTEIN KINASE ACTIVITY#0.9751;ACTIVATED T CELL#0.9711;APOPTOTIC#0.9674;STRUCTURE ACTIVITY RELATIONSHIP#0.9632;HYPERHOMOCYSTEINEMIA#0.9549;ACTIVATED T-CELLS#0.9542;HYPERPHOSPHORYLATION#0.9504;AMYLOID PRECURSOR PROTEIN#0.9501;MAP KINASE#0.9488;MICROTUBULE#0.9463;CYCLIN DEPENDENT KINASE#0.9407;SYNAPTIC VESICLE#0.9390;PROTEIN KINASE C#0.9384;GLYCOGEN SYNTHASE KINASE#0.9335;NEURAL PROGENITOR CELL#0.9283;DEVELOPMENTAL DELAY#0.9252;CARDIOMYOCYTE#0.9185;SIGNAL TRANSDUCTION#0.9104;CELL DIVISION#0.8856;ALTERNATIVE SPLICING FACTOR#0.8813;TUMOR SUPPRESSOR#0.8694;OOCYTE#0.8689;CATALYTIC ACTIVITY#0.8653;AUTISM SPECTRUM DISORDER#0.8570;ATP BINDING#0.8539;INDOLE#0.8482;DEMENTIA#0.8477;CAMKII#0.8375;PRE-MRNA SPLICING#0.8307;MRNA SPLICING#0.8276;ONCOGENIC#0.8147;MICROTUBULE ASSOCIATED PROTEIN#0.8142;PROTEIN KINASE B#0.7999;NEURAL STEM CELL#0.7997;SPINAL CORD#0.7986;PARKINSON'S DISEASE#0.7933;ARGININE#0.7893;PLURIPOTENT STEM CELL#0.7718;CLATHRIN COATED VESICLE#0.7639;TARGET OF RAPAMYCIN#0.7596;COATED VESICLE#0.7572;ACTIN CYTOSKELETON#0.7565;MITOSIS#0.7506;CEREBRAL CORTEX#0.7409;MORPHOGENESIS#0.7399;CELL CYCLE ARREST#0.7398;CELL DIFFERENTIATION#0.7389;FETAL BRAIN#0.7294;ASTROCYTE#0.7269;C TERMINAL DOMAIN#0.7234;CELL NUCLEUS#0.7108;CELL CYCLE REGULATION#0.7097;SYNDROMIC INTELLECTUAL DISABILITY#0.7090;CELL CYCLE CONTROL#0.7082;APOPTOTIC CELL DEATH#0.7063;GREEN TEA EXTRACT#0.7050;SENESCENCE#0.7019;UBIQUITIN#0.7004;CYCLIN DEPENDENT KINASE INHIBITOR#0.6994;VESICLE ENDOCYTOSIS#0.6991;EPIDERMAL GROWTH FACTOR#0.6982;GENE COPY NUMBER#0.6950;PROTEIN KINASE INHIBITOR#0.6935;MEMORY IMPAIRMENT#0.6918;NEURONAL CELLS#0.6881;S PHASE#0.6853;CASEIN KINASE 1#0.6639;CYSTATHIONINE BETA SYNTHASE#0.6593;SPATIAL LEARNING#0.6589;ENDOCYTOSIS#0.6552;COGNITION#0.6507;FIBROBLAST GROWTH FACTOR#0.6505;MACROPHAGE#0.6409;QUIESCENCE#0.6398;GENETIC DISORDER#0.6379;DEPHOSPHORYLATION#0.6352;HYPERACTIVITY#0.6350;MORRIS WATER MAZE#0.6327;RAPAMYCIN#0.6322;SKELETAL MUSCLE#0.6263;NEURONAL PROGENITOR CELL#0.6225;VIRAL REPLICATION#0.6194;NMDA RECEPTOR#0.6187;SYNAPTIC VESICLE ENDOCYTOSIS#0.6164;PROTEIN SYNTHESIS#0.6125;TYPE 2 DIABETES#0.6115;CYTOTOXICITY#0.6070;NUCLEAR SPECKLE#0.6036
185	ANGII TYPE 1#1.0612;AT1 RECEPTOR BLOCKER#1.0502;OLMESARTAN#1.0393;IRBESARTAN#1.0289;TELMISARTAN#1.0268;ANGIOTENSIN TYPE 1#1.0256;ARTERIOLE#1.0256;ANTIBODY MEDIATED REJECTION#1.0240;CANDESARTAN#1.0216;PROSTATE CANCER#1.0206;ENDOTHELIN RECEPTOR#1.0205;RESONANCE ENERGY TRANSFER#1.0199;PODOCYTE#1.0186;ENALAPRIL#1.0181;CORONARY HEART DISEASE#1.0174;ADRENAL CORTEX#1.0168;DOPAMINE#1.0154;VALSARTAN#1.0145;BREAST CANCER#1.0136;FRAGMENT LENGTH POLYMORPHISM#1.0131;ADRENERGIC RECEPTOR#1.0119;ADRENAL GLAND#1.0110;ACE INHIBITOR#1.0107;MYOCYTES#1.0101;LOSARTAN#1.0068;TRANSCRIPTASE#1.0065;RECEPTOR BINDING#1.0059;PROTEIN SYNTHESIS#1.0053;ENDOTHELIAL NITRIC OXIDE#1.0046;NADPH OXIDASE#1.0044;CELL SURFACE#1.0043;HYPOXIA#1.0037;LUMINAL#1.0031;QUANTITATIVE REAL TIME#1.0030;PROXIMAL TUBULE CELL#1.0028;THORACIC AORTA#1.0025;CAPTOPRIL#1.0016;VASOCONSTRICTION#1.0015;ATRIAL FIBRILLATION#1.0013;HUMAN EMBRYONIC KIDNEY#1.0011;EMBRYONIC KIDNEY#1.0007;MESANGIAL CELL#1.0005;RECEPTOR AGONIST#1.0004;TRANSACTIVATION#0.9999;ACE ACTIVITY#0.9998;BONE MARROW#0.9997;TYPE 2 DIABETIC#0.9994;CALCIUM CHANNEL#0.9993;PLASMA MEMBRANE#0.9990;REVERSE TRANSCRIPTION#0.9989;CARDIOMYOCYTE#0.9982;VASOPRESSIN#0.9981;AORTIC ANEURYSM#0.9977;CELL MEMBRANE#0.9977;MAP KINASE#0.9973;CANCER CELL#0.9959;VASCULAR CELL#0.9959;ESSENTIAL HYPERTENSION#0.9958;MARFAN SYNDROME#0.9954;CELL MIGRATION#0.9954;EPROSARTAN#0.9954;CANDESARTAN CILEXETIL#0.9949;GROWTH FACTOR RECEPTOR#0.9948;INTERSTITIAL CELL#0.9946;ANGIOTENSIN RECEPTOR#0.9941;MYOCARDIUM#0.9937;VASODILATION#0.9932;ANGIOTENSIN CONVERTING ENZYME#0.9932;SIGNALLING PATHWAY#0.9926;INFLAMMATORY RESPONSE#0.9923;POLYMERASE CHAIN REACTION#0.9923;T CELL#0.9923;RESPONSE TO ANGIOTENSIN#0.9922;ENDOCYTOSIS#0.9922;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9921;LIVER DISEASE#0.9920;PHOSPHOLIPASE C#0.9919;ADENINE DINUCLEOTIDE PHOSPHATE#0.9917;PRO-INFLAMMATORY#0.9913;MONOCYTE#0.9913;ENDOTHELIAL GROWTH FACTOR#0.9911;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9911;HEART DISEASE#0.9906;ANGIOGENESIS#0.9903;ENZYME INHIBITOR#0.9900;BLOOD VESSEL#0.9899;CELL GROWTH#0.9897;EPIDERMAL GROWTH FACTOR#0.9891;NATRIURESIS#0.9890;NITRIC OXIDE SYNTHASE#0.9890;RECEPTOR ANTAGONIST#0.9887;OBESE#0.9884;LEUKOCYTE#0.9882;SUPEROXIDE DISMUTASE#0.9882;REGULATION OF BLOOD PRESSURE#0.9880;PEROXISOME#0.9880;VASOCONSTRICTOR#0.9875;TYPE 2 DIABETES#0.9873;FATTY LIVER#0.9872;BLOOD PRESSURE REGULATION#0.9869;MYOCARDIAL INFARCTION#0.9867;EPITHELIAL CELL#0.9861;ADENINE#0.9860;TRANSMISSION ELECTRON MICROSCOPY#0.9858;APOPTOTIC#0.9855;SIGNAL TRANSDUCTION#0.9855;CHRONIC HEART FAILURE#0.9855;CENTRAL NERVOUS SYSTEM#0.9851;SKELETAL MUSCLE#0.9851;GESTATION#0.9850;PROTEIN KINASE C#0.9847;ISCHEMIA#0.9846;ASTROCYTE#0.9846;LEFT VENTRICULAR MASS#0.9845;MESENTERIC ARTERY#0.9842;MITOGEN ACTIVATED PROTEIN#0.9841;SIGNALING PATHWAY#0.9838;ALDOSTERONE#0.9833;ADENO ASSOCIATED VIRUS#0.9832;TUMOR NECROSIS FACTOR#0.9830;ANGIOTENSIN RECEPTOR BLOCKER#0.9828;ADIPOCYTE#0.9828;TRANSFORMING GROWTH FACTOR BETA#0.9825;VASCULAR SMOOTH MUSCLE CELL#0.9823;TYPE 2 DIABETES MELLITUS#0.9820;2 DIABETES MELLITUS#0.9820;MACROPHAGE#0.9817;UMBILICAL VEIN#0.9817;TUBULAR EPITHELIAL CELL#0.9817;APOPTOSIS#0.9816;MUTAGENESIS#0.9816;AT1 RECEPTOR BINDING#0.9814;ADIPOSE TISSUE#0.9814;ARTERY DISEASE#0.9812;ENDOPLASMIC RETICULUM#0.9811;DIABETIC NEPHROPATHY#0.9811;VASODILATOR#0.9810;CARDIOVASCULAR SYSTEM#0.9808;SMOOTH MUSCLE CELL#0.9800;TOXICITY#0.9797;INSULIN SECRETION#0.9797;KINASE INHIBITOR#0.9797;SMOOTH MUSCLE#0.9795;DIABETES MELLITUS#0.9795;CORONARY ARTERY DISEASE#0.9794;MUSCLE CELL#0.9789;FATTY LIVER DISEASE#0.9787;GLIAL CELL#0.9787;RENIN ACTIVITY#0.9782;EXTRACELLULAR MATRIX#0.9782;NEPHROPATHY#0.9781;ATHEROSCLEROSIS#0.9779;RENAL FIBROSIS#0.9779;CONNECTIVE TISSUE#0.9776;PROTEIN KINASE#0.9776;CELL PROLIFERATION#0.9774;TRANSCRIPTION FACTOR#0.9773;ATHEROSCLEROTIC#0.9770;ENDOTHELIAL CELL#0.9770;DNA METHYLATION#0.9767;ACUTE MYOCARDIAL INFARCTION#0.9767;PERIPHERAL BLOOD#0.9762;BREAST CANCER CELL#0.9762;GENE EXPRESSION#0.9760;TRANSFORMING GROWTH FACTOR#0.9759;ENDOTHELIUM#0.9756;IMMUNE CELL#0.9754;HYPERTENSION#0.9752;NERVOUS SYSTEM#0.9742;FRUCTOSE#0.9742;NICOTINAMIDE#0.9739;GLOMERULAR FILTRATION#0.9738;REACTIVE OXYGEN SPECIES#0.9738;RECEPTOR LIGAND#0.9737;SPINAL CORD#0.9736;NITRIC OXIDE#0.9733;HUMAN UMBILICAL VEIN#0.9732;PROTEINURIA#0.9730;CELL DEATH#0.9729;CONGESTIVE HEART FAILURE#0.9728;CHRONIC KIDNEY DISEASE#0.9719;INFLAMMATORY CELL#0.9710;GROWTH FACTOR#0.9707;HETEROTRIMERIC G-PROTEIN#0.9706;ARTERY#0.9700;ARRHYTHMIA#0.9700;RNA INTERFERENCE#0.9697;CARDIOMYOPATHY#0.9696;L-ARGININE#0.9692;STEM CELL#0.9688;RENAL ARTERY#0.9687;HIGH FAT DIET#0.9687;MYOFIBROBLAST#0.9685;EXCRETION#0.9682;TROPHOBLAST#0.9680;ARGININE#0.9678;GLOMERULAR FILTRATION RATE#0.9676;NEPHRON#0.9676;CORONARY ARTERY#0.9669;SYSTOLIC BLOOD PRESSURE#0.9650;PITUITARY GLAND#0.9649;STREPTOZOTOCIN#0.9646;NORADRENALINE#0.9646;LOW DENSITY LIPOPROTEIN#0.9635;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9634;KIDNEY DISEASE#0.9630;NOREPINEPHRINE#0.9624;CORTISOL#0.9622;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9622;URINARY PROTEIN#0.9615;OOCYTE#0.9585;DIGESTION#0.9574;IMMUNE RESPONSE#0.9568;INCREASED BLOOD PRESSURE#0.9556;TISSUE GROWTH FACTOR#0.9553;LIPID METABOLISM#0.9544;HYPOTENSIVE#0.9544;CYTOPLASM#0.9536;CEREBRAL ARTERY#0.9531;ALISKIREN#0.9526;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9523;VASCULAR DISEASE#0.9512;ALZHEIMER'S DISEASE#0.9504;CONTROL OF BLOOD PRESSURE#0.9501;ROS GENERATION#0.9501;ACETYLCHOLINE#0.9486;BRAIN RENIN-ANGIOTENSIN SYSTEM#0.9476;COLLAGEN SYNTHESIS#0.9474;VASODILATATION#0.9469;BODY WEIGHT RATIO#0.9464;SMOOTH MUSCLE ACTIN#0.9455;NITRO-L-ARGININE#0.9441;HYPOTENSION#0.9437;DEXAMETHASONE#0.9437;SIGNALING MOLECULE#0.9428;SCANNING ELECTRON MICROSCOPY#0.9425;DIABETIC RETINOPATHY#0.9420;PRE-ECLAMPSIA#0.9419;OVARIAN#0.9410;ENDOTHELIN TYPE A#0.9410;LYMPH NODE#0.9410;SIGNAL TRANSDUCER#0.9394;ALDOSTERONE SECRETION#0.9383;RENOVASCULAR HYPERTENSION#0.9383;OVARIAN CANCER#0.9381;ISCHEMIA REPERFUSION INJURY#0.9370;GLUTATHIONE#0.9366;VASCULAR ENDOTHELIAL CELL#0.9349;HYPERGLYCEMIA#0.9340;RESVERATROL#0.9331;RECEPTOR INTERNALIZATION#0.9327;PARKINSON'S DISEASE#0.9310;PEPTIDE HORMONE#0.9308;CELL ADHESION#0.9299;CELL CYCLE#0.9295;CAROTID ARTERY#0.9280;CONSTRICTION#0.9271;LIPID RAFT#0.9261;HYDRALAZINE#0.9230;CARDIOMYOCYTE GROWTH#0.9217;SMALL INTESTINE#0.9213;ALPHA1 ADRENERGIC RECEPTOR#0.9195;RAMIPRIL#0.9194;SENESCENCE#0.9194;MALIGNANT HYPERTENSION#0.9190;PULMONARY HYPERTENSION#0.9180;AMLODIPINE#0.9176;CELLULAR LOCALIZATION#0.9171;MAPK ACTIVATION#0.9122;INDUCIBLE NITRIC OXIDE#0.9111;CROSS SECTIONAL AREA#0.9102;GLUCOSE HOMEOSTASIS#0.9096;BRAIN NATRIURETIC PEPTIDE#0.9089;PERINDOPRIL#0.9076;KINASE ACTIVITY#0.9059;GLUCOCORTICOID RECEPTOR#0.9047;BIOLUMINESCENCE#0.9040;WOUND HEALING#0.9037;ADENOSINE#0.9022;PULMONARY FIBROSIS#0.9009;MITOCHONDRIA#0.9001;PHENYLEPHRINE#0.8985;BLOOD BRAIN BARRIER#0.8979;AORTIC SMOOTH MUSCLE CELLS#0.8976;BASEMENT MEMBRANE#0.8965;DILATED CARDIOMYOPATHY#0.8959;ESTRADIOL#0.8957;DOPAMINERGIC NEURON#0.8932;TYPE 1 DIABETES#0.8912;LEUCINE#0.8908;STROMAL CELL#0.8906;ELECTROLYTE HOMEOSTASIS#0.8905;HARDY WEINBERG EQUILIBRIUM#0.8898;NF-KAPPAB ACTIVATION#0.8895;ISOPROTERENOL#0.8883;NEONATAL RAT CARDIOMYOCYTES#0.8882;ACTION POTENTIAL#0.8882;EPLERENONE#0.8879;HEPATOCELLULAR CARCINOMA#0.8877;LACRIMAL GLAND#0.8864;COLLAGEN VOLUME FRACTION#0.8857;VASCULAR ENDOTHELIUM#0.8855;VSMC PROLIFERATION#0.8853;QUANTITATIVE REVERSE TRANSCRIPTION#0.8848;MIDDLE CEREBRAL ARTERY#0.8845;CEREBRAL ISCHEMIA#0.8840;VEGF PRODUCTION#0.8839;RECEPTOR TYROSINE KINASE#0.8837;ENZYME ACTIVITY#0.8801;B CELL#0.8793;INSULIN-LIKE GROWTH FACTOR#0.8793;CELLULAR GROWTH#0.8790;MONONUCLEAR CELLS#0.8789;MONOCYTE CHEMOTACTIC PROTEIN#0.8785;BRUSH BORDER#0.8756;ARACHIDONIC ACID#0.8737;INSULIN RECEPTOR#0.8736;GUANOSINE#0.8729;FIBROBLAST GROWTH FACTOR#0.8718;QUANTITATIVE REVERSE TRANSCRIPTASE#0.8718;SENSITIZATION#0.8716;ENDOTHELIN A RECEPTOR#0.8713;MULTIFACTOR DIMENSIONALITY REDUCTION#0.8712;ESTROGEN RECEPTOR#0.8711;TUMOR CELLS#0.8707;PANCREATIC CANCER#0.8705;WEIGHT LOSS#0.8700;TRANSIENT RECEPTOR POTENTIAL#0.8682;CEREBRAL ARTERY OCCLUSION#0.8672;CARDIAC MUSCLE#0.8668;CEREBRAL CORTEX#0.8659;GLUCOSE METABOLISM#0.8642;OLMESARTAN MEDOXOMIL#0.8638;NEPHRITIS#0.8637;ECLAMPSIA#0.8636;HYPERACTIVITY#0.8622;BENAZEPRIL#0.8622;PROXIMAL TUBULAR CELL#0.8613;AMINOPEPTIDASE A#0.8589;COLLAGEN TYPE I#0.8583;KIDNEY TRANSPLANT RECIPIENTS#0.8549;ION CHANNEL#0.8539;CARDIOVASCULAR RISK FACTOR#0.8536;DIURESIS#0.8526;CAVEOLAE#0.8525;CELL ADHESION MOLECULE#0.8525;BETA CELL#0.8506;HIGH DENSITY LIPOPROTEIN#0.8497;ISCHEMIC HEART DISEASE#0.8467;ALCOHOLIC FATTY LIVER#0.8464;POTASSIUM CHANNEL#0.8451;PANCREATIC ISLET#0.8444;PULMONARY ARTERY#0.8443;SUBSTANTIA NIGRA#0.8441;GLOMERULONEPHRITIS#0.8408;HEPATIC STELLATE CELL#0.8405;ROSIGLITAZONE#0.8397;FOREBRAIN#0.8388;HYPOXIC#0.8383;RECEPTOR ACTIVITY#0.8382;TO THE PROGRESSION#0.8365;MYOSIN HEAVY CHAIN#0.8357;MOLECULAR DYNAMICS SIMULATION#0.8348;ELECTROPHORETIC MOBILITY SHIFT#0.8337;MECHANISMS OF ACTION#0.8329;HYDROCHLOROTHIAZIDE#0.8326;STRUCTURE ACTIVITY RELATIONSHIP#0.8326;SPIRONOLACTONE#0.8306;ALDOSTERONE RECEPTOR#0.8290;LIVER CIRRHOSIS#0.8278;LEFT ANTERIOR DESCENDING#0.8277;MAPK SIGNALING#0.8273;CALCINEURIN#0.8244;THORACIC AORTIC ANEURYSM#0.8222;OSTEOBLAST#0.8222;HEART RATE VARIABILITY#0.8214;END ORGAN DAMAGE#0.8213;ARGININE VASOPRESSIN#0.8205;BRUSH BORDER MEMBRANE#0.8194;PROGENITOR CELL#0.8193;PROTEIN PROTEIN INTERACTION#0.8189;FORSKOLIN#0.8163;VITAMIN D RECEPTOR#0.8136;REGENERATION#0.8115;AMBULATORY BLOOD PRESSURE#0.8113;RENNIN#0.8112;URIC ACID#0.8097;N-ACETYLCYSTEINE#0.8078;TOLL LIKE RECEPTOR#0.8077;T LYMPHOCYTE#0.8065;HYPERCHOLESTEROLEMIA#0.8043;TARGET ORGAN DAMAGE#0.8025;LEFT VENTRICULAR REMODELING#0.8012;ENDOMETRIUM#0.8011;CORONARY ARTERY STENOSIS#0.8001;HYDROXYPROLINE#0.7999;AUTOPHAGY#0.7972;WHITE ADIPOSE TISSUE#0.7964;URETERAL OBSTRUCTION#0.7942;SQUAMOUS CELL CARCINOMA#0.7919;RESPIRATORY DISTRESS#0.7915;ACTIN CYTOSKELETON#0.7899;PROTEIN KINASE A#0.7897;GLUCOSE UPTAKE#0.7896;IMMUNE SYSTEM#0.7894;ENDOMETRIOSIS#0.7885;ADENYLATE CYCLASE#0.7883;PLATELET-DERIVED GROWTH FACTOR#0.7883;LISINOPRIL#0.7866;SIGNALING CASCADE#0.7854;HYPOXIA INDUCIBLE FACTOR#0.7853;ABDOMINAL AORTIC ANEURYSM#0.7845;MITRAL VALVE#0.7841;CYTOKINE PRODUCTION#0.7834;TRANSMEMBRANE RECEPTOR#0.7831;COLORECTAL CANCER#0.7828;LATE PREGNANCY#0.7823;ADRENAL MEDULLA#0.7812;ADENOCARCINOMA#0.7798;HYPERTROPHIC CARDIOMYOPATHY#0.7797;THIAZIDE#0.7791;BRAIN DAMAGE#0.7785;ENDOMETRIAL CANCER#0.7781;PLATELET AGGREGATION#0.7773;GLOMERULUS#0.7766;WEIGHT GAIN#0.7757;ALANINE#0.7749;DNA BINDING#0.7744;ATPASE ACTIVITY#0.7737;BRADYKININ RECEPTOR#0.7725;FACTOR I#0.7722;NERVE TERMINAL#0.7711;PROPRANOLOL#0.7701;PLACENTAL DEVELOPMENT#0.7684;GLOMERULAR FILTRATION BARRIER#0.7672;DNA SYNTHESIS#0.7670;HYPERTHYROIDISM#0.7670;CYTOCHROME C#0.7662;GROWTH HORMONE#0.7655;NONALCOHOLIC FATTY LIVER DISEASE#0.7641;INTRACELLULAR SIGNALING PATHWAY#0.7635;ANGIOTENSIN RECEPTOR BLOCKADE#0.7624;ADVANCED GLYCATION END#0.7617;GLUCOSE INTOLERANCE#0.7617;INTESTINAL EPITHELIAL CELL#0.7615;LECTIN#0.7611;GLOMUS CELL#0.7609;COLORECTAL#0.7609;ACUTE CORONARY SYNDROME#0.7602;CALCIUM SIGNALING#0.7578;BETA-2#0.7570;PERTUSSIS#0.7566;CYTOTOXICITY#0.7557;DEHYDRATION#0.7555;EDEMA#0.7551;C REACTIVE PROTEIN#0.7549;MICROVASCULAR ENDOTHELIAL CELL#0.7548;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7546;FIBROBLAST PROLIFERATION#0.7532;LDL RECEPTOR#0.7525;NUCLEOTIDE BINDING#0.7518;INVASIVE CARCINOMA#0.7516;KIDNEY DEVELOPMENT#0.7495;CORONARY ARTERY LIGATION#0.7493;NOS ACTIVITY#0.7488;MINERALOCORTICOID RECEPTOR BLOCKER#0.7485;GASTRIC MUCOSA#0.7471;TISSUE REMODELING#0.7436;LYMPH NODE METASTASIS#0.7434;CHONDROCYTE#0.7432;NIFEDIPINE#0.7429;SODIUM NITROPRUSSIDE#0.7427;INTIMA MEDIA THICKNESS#0.7425;MORRIS WATER MAZE#0.7421;DEPHOSPHORYLATION#0.7411;L-ARG#0.7408;INTRACELLULAR SIGNAL TRANSDUCTION#0.7403;TISSUE TRANSGLUTAMINASE#0.7403;GUANINE#0.7393;PULSE WAVE VELOCITY#0.7387;UNILATERAL URETERAL OBSTRUCTION#0.7370;MULTIPLE LOGISTIC REGRESSION#0.7367;EOSIN#0.7365;VESICOURETERAL REFLUX#0.7355;MICROGLIAL CELL#0.7347;HORMONE SECRETION#0.7330;ACUTE CELLULAR REJECTION#0.7323;PROTEIN BINDING#0.7320;NORMAL CONTROL GROUP#0.7319;CORONARY ARTERY ENDOTHELIAL CELLS#0.7319;HEMORRHAGE#0.7315;RENAL SYSTEM#0.7313;ETHANOL#0.7307;EPITHELIAL OVARIAN CANCER#0.7304;DEMENTIA#0.7303;LYSINE#0.7302;ENDOCRINE CELL#0.7296;SERUM ALBUMIN#0.7276;ALPHA ADRENOCEPTOR#0.7255;MECHANISM OF ACTION#0.7254;RENNIN ANGIOTENSIN SYSTEM#0.7237;GLUTAMATE RECEPTOR#0.7232;NEPHROTOXICITY#0.7223;UBIQUITIN#0.7223;ASPARTATE#0.7221;LUNG FIBROBLASTS#0.7214;MEMORY IMPAIRMENT#0.7198;ENDOPLASMIC RETICULUM STRESS#0.7190;NEUROTRANSMISSION#0.7164;INDOMETHACIN#0.7162;CHANNEL ACTIVITY#0.7152;AUTOIMMUNE DISEASE#0.7148;HUMAN BREAST CANCER#0.7147;OVARIAN CARCINOMA#0.7139;LUCIFERASE ACTIVITY#0.7133;COLLECTING DUCTS#0.7127;SODIUM CHANNEL#0.7126;CD4+ T CELL#0.7119;DRINKING BEHAVIOR#0.7115;LYMPH NODE METASTASES#0.7101;ANDROGEN RECEPTOR#0.7089;BLOOD UREA NITROGEN#0.7072;FETAL KIDNEY#0.7069;SARCOIDOSIS#0.7069;ENDOSOME#0.7062;PROSTAGLANDIN E2#0.7045;PROXIMAL TUBULAR EPITHELIAL#0.7043;BILE DUCT#0.7036;BREAST CANCER PATIENTS#0.7036;INFLAMMATORY CELL INFILTRATION#0.7009;PORTAL HYPERTENSION#0.7006;ACETYLCYSTEINE#0.7005;LUNG CANCER#0.7004;PKC ACTIVATION#0.6991;BETA ADRENERGIC RECEPTOR#0.6984;ACUTE LUNG INJURY#0.6962;SURFACE PLASMON RESONANCE#0.6956;HUMAN LEUKOCYTE ANTIGEN#0.6950;CYCLIC GUANOSINE MONOPHOSPHATE#0.6943;AKT SIGNALING#0.6934;RENAL TRANSPLANT RECIPIENTS#0.6930;CHEMOKINE RECEPTOR#0.6927;MAST CELL#0.6922;KIDNEY DAMAGE#0.6915;GLYCOSYLATION#0.6910;L-CYSTEINE#0.6906;LOCALISATION#0.6893;OXYGENASE#0.6864;SUCROSE#0.6863;MESENCHYMAL STEM CELL#0.6850;GLUTATHIONE PEROXIDASE#0.6849;NITROPRUSSIDE#0.6844;LARGE ARTERIES#0.6811;PHOSPHOLIPASE A2#0.6804;KIDNEY PROXIMAL TUBULE#0.6784;QUANTITATIVE TRAIT LOCUS#0.6782;NITRIC OXIDE SYNTHESIS#0.6781;AT2 RECEPTOR BINDING#0.6780;SIMVASTATIN#0.6764;LITHIUM#0.6763;LOCUS COERULEUS#0.6747;SUDDEN CARDIAC DEATH#0.6738;ROSUVASTATIN#0.6738;ADIPOCYTE DIFFERENTIATION#0.6735;PROTEIN PHOSPHORYLATION#0.6721;GUANYLATE CYCLASE#0.6717;MRNA BINDING#0.6717;PROSTACYCLIN#0.6704;PLACENTATION#0.6684;NEURONAL CELLS#0.6677;FOCAL ADHESION#0.6674;SPONTANEOUS ABORTION#0.6650;UMBILICAL CORD#0.6619;ADENYLATE#0.6609;TESTOSTERONE#0.6580;POSTTRANSLATIONAL MODIFICATION#0.6575;OBSTRUCTIVE NEPHROPATHY#0.6561;LIVER CANCER#0.6559;PRAZOSIN#0.6552;DIET INDUCED OBESITY#0.6551;FIBRILLIN#0.6544;NEPHROTIC SYNDROME#0.6536;NEPHROGENESIS#0.6506;EPITHELIAL SODIUM CHANNEL#0.6485;BRADYCARDIA#0.6469;PROTEASOME#0.6466;OUABAIN#0.6458;PREADIPOCYTE#0.6450;OF DIABETIC RATS#0.6449;ADIPOGENESIS#0.6431;GLYCERALDEHYDE-3-PHOSPHATE#0.6430;CAMP RESPONSE ELEMENT BINDING#0.6415;CAMP RESPONSE ELEMENT#0.6405;SARCOPLASMIC RETICULUM#0.6403;HEME OXYGENASE 1#0.6387;PODOCYTE APOPTOSIS#0.6386;MULTIPLE SCLEROSIS#0.6378;NEURODEGENERATIVE DISEASE#0.6373;COLITIS#0.6365;CELL ACTIVATION#0.6365;FLUORESCEIN#0.6362;NEUROPROTECTION#0.6358;KERATINOCYTE#0.6354;ENDOCYTIC VESICLE#0.6305;GENISTEIN#0.6293;TIBIA#0.6292;DECIDUA#0.6282;CREATINE KINASE#0.6281;SMOOTH MUSCLE CELL PROLIFERATION#0.6274;SENSITIZER#0.6272;MUSCLE CELL PROLIFERATION#0.6271;NF-KAPPAB INHIBITOR#0.6267;MOLAR#0.6264;DDAVP#0.6237;CEREBRAL INFARCTION#0.6232;PROTEIN KINASE B#0.6222;WATER RETENTION#0.6215;TISSUE DAMAGE#0.6214;CLATHRIN-COATED PIT#0.6213;SELECTIN#0.6208;POLYMORPHONUCLEAR LEUKOCYTES#0.6207;GUANETHIDINE#0.6205;TARGET OF RAPAMYCIN#0.6203;G1 PHASE#0.6194;MICROTUBULE#0.6191;COATED PIT#0.6182;MUSCLE FIBER#0.6154;CEREBROVASCULAR DISEASE#0.6146;17β-ESTRADIOL#0.6142;OESTRADIOL#0.6141;EPINEPHRINE#0.6134;COLLAGENASE#0.6130;TYPE 1 DIABETIC#0.6115;CLEAVED CASPASE 3#0.6114;PSORIASIS#0.6109;THROMBOSIS#0.6105;CYTOCHROME P450#0.6072;SLIT DIAPHRAGM#0.6070;REGULATION OF ANGIOGENESIS#0.6060;TYROSINE KINASE INHIBITOR#0.6053;APICAL PLASMA MEMBRANE#0.6043;ER TO GOLGI TRANSPORT#0.6039;UTERUS#0.6031;VSMC APOPTOSIS#0.6026;CORTICOTROPIN#0.6025
1861	A-GLUTAMIC ACID#1.0575;EARLY ONSET DYSTONIA#1.0567;GLUTAMIC ACID#1.0334;GENERALIZED DYSTONIA#1.0310;DYSTONIA#1.0293;SEGMENTAL DYSTONIA#1.0292;DOPAMINE RECEPTOR#1.0258;GLOBUS PALLIDUS INTERNUS#1.0235;CERVICAL DYSTONIA#1.0194;FOCAL DYSTONIA#1.0190;DOPAMINE#1.0138;TRANSCRIPTION FACTOR#1.0128;NUCLEAR ENVELOPE#1.0078;ENDOPLASMIC RETICULUM#1.0033;STRIATUM#1.0030;CERVICAL#0.9987;BASAL GANGLIA#0.9918;DEEP BRAIN STIMULATION#0.9893;MUSCLE CONTRACTION#0.9878;INTERNEURON#0.9842;AGE AT ONSET#0.9745;SUBSTANTIA NIGRA#0.9361;HYPERKINETIC#0.9320;ANTHER DEVELOPMENT#0.9296;PURKINJE CELL#0.8886;POLYMERASE CHAIN REACTION#0.8777;NEUROLOGICAL DISORDER#0.8768;POSITRON EMISSION TOMOGRAPHY#0.8673;NERVOUS SYSTEM#0.8605;SYNAPTIC VESICLE#0.8605;DOPAMINERGIC NEURON#0.8423;POSITIVE FAMILY HISTORY#0.8195;GENE EXPRESSION#0.8195;CEREBRAL PALSY#0.8136;MAGNETIC RESONANCE IMAGING#0.8119;DOPAMINE D2 RECEPTOR#0.8035;PARKINSON'S DISEASE#0.8023;FOCAL HAND DYSTONIA#0.8003;CEREBRAL CORTEX#0.7997;CENTRAL NERVOUS SYSTEM#0.7957;CELIAC DISEASE#0.7934;NEUROTRANSMISSION#0.7918;HEALTHY CONTROL SUBJECTS#0.7871;GTP CYCLOHYDROLASE I#0.7870;POLLEN DEVELOPMENT#0.7733;BLEPHAROSPASM#0.7682;LONG TERM POTENTIATION#0.7454;MYOCLONIC DYSTONIA#0.7357;L-DOPA#0.7315;DYSKINESIA#0.7243;MOTOR BEHAVIOR#0.7202;ACETYLCHOLINE#0.7128;MYOCLONUS DYSTONIA SYNDROME#0.7040;NUCLEAR MEMBRANE#0.6947;THALAMUS#0.6926;MEDIUM SPINY NEURONS#0.6893;UBIQUITIN#0.6849;SECRETORY PATHWAY#0.6841;LEVODOPA#0.6804;POLLEN WALL FORMATION#0.6774;PERIPHERAL BLOOD#0.6672;CHROMOSOMAL REGION#0.6526;HUMAN LEUKOCYTE ANTIGEN#0.6511;ATP BINDING#0.6488;POLLEN WALL#0.6418;DIFFUSION TENSOR IMAGING#0.6407;DEVELOPMENTAL DELAY#0.6324;APOPTOSIS#0.6287;RECEPTOR BINDING#0.6270;EARLY ONSET PARKINSONISM#0.6198;FOREBRAIN#0.6121;SYNAPTIC VESICLE RECYCLING#0.6114
1862	DYSTONIA#1.0639
1866	DYSTONIA#1.0026;FOCAL DYSTONIA#0.8588;CERVICAL DYSTONIA#0.7770;CERVICAL#0.6582
1867	DYSLEXIA#0.7509
1869	PROMOTER BINDING#1.0322;FACTOR I#1.0254;AUTOPHAGY#1.0217;ELECTROPHORETIC MOBILITY SHIFT#1.0187;ETOPOSIDE#1.0174;DIHYDROFOLATE REDUCTASE#1.0159;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0157;THYMIDYLATE SYNTHASE#1.0128;THYMIDYLATE#1.0124;HYPERPHOSPHORYLATION#1.0123;TRANSACTIVATION#1.0101;HYPOXIA#1.0088;LUNG CARCINOMA#1.0085;THYMIDINE KINASE#1.0067;TELOMERASE ACTIVITY#1.0066;PANCREATIC CANCER#1.0048;LYMPH NODE#1.0023;NEUROBLASTOMA#1.0017;LUCIFERASE ACTIVITY#1.0014;TRANSCRIPTIONAL CONTROL#1.0007;CISPLATIN#1.0002;T CELL#0.9998;MYOCYTES#0.9997;LIVER CANCER#0.9986;KERATINOCYTE#0.9979;CERVICAL CANCER#0.9979;BONE MARROW#0.9976;TRANSCRIPTION FACTOR BINDING#0.9975;DUAL LUCIFERASE REPORTER#0.9973;ANDROGEN RECEPTOR#0.9972;BETA CELL#0.9965;CELL CYCLE PATHWAY#0.9960;DNA BINDING#0.9956;DNA DAMAGE RESPONSE#0.9951;TRANSCRIPTION FACTOR#0.9946;VIRAL REPLICATION#0.9945;TERMINAL DIFFERENTIATION#0.9943;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9927;S-PHASE CHECKPOINT#0.9926;ENDOTHELIAL GROWTH FACTOR#0.9926;THYMIDINE#0.9924;CELL CYCLE REGULATOR#0.9923;TOPOISOMERASE#0.9921;PROTEASOME#0.9920;B CELL#0.9916;CARDIOMYOCYTE#0.9914;DOXORUBICIN#0.9911;SALIVARY GLAND#0.9910;COLON CANCER#0.9897;PROGENITOR CELL#0.9896;MITOGEN ACTIVATED PROTEIN#0.9895;PROTEIN BINDING#0.9894;CELL CYCLE CHECKPOINT#0.9893;POLY ADP RIBOSE#0.9891;LUNG ADENOCARCINOMA#0.9885;COLORECTAL CANCER#0.9884;RNA INTERFERENCE#0.9882;S PHASE#0.9882;5 FLUOROURACIL#0.9881;B CELL LYMPHOMA#0.9879;CELL CYCLE CONTROL#0.9878;DRUG RESISTANCE#0.9871;ADENOCARCINOMA#0.9871;BREAST CANCER CELL#0.9863;DNA REPAIR#0.9862;COLORECTAL#0.9861;CERVICAL#0.9858;REVERSE TRANSCRIPTION#0.9857;UBIQUITIN#0.9851;TOPOISOMERASE II#0.9850;CYTOPLASM#0.9849;CELLULAR SENESCENCE#0.9848;FLUOROURACIL#0.9847;INSULIN SECRETION#0.9844;CELLULAR TRANSCRIPTION#0.9843;APOPTOSIS#0.9842;PROTEIN SYNTHESIS#0.9841;SMOOTH MUSCLE CELL#0.9838;DOUBLE STRAND BREAK#0.9837;INDUCTION OF APOPTOSIS#0.9836;SIGNAL TRANSDUCTION#0.9836;TELOMERASE REVERSE TRANSCRIPTASE#0.9835;MUSCLE CELL#0.9833;ENDOTHELIAL CELL#0.9833;DNA REPLICATION#0.9832;SIGNALING CASCADE#0.9831;GROWTH FACTOR RECEPTOR#0.9829;LYSINE#0.9828;SENESCENCE#0.9826;APOPTOTIC#0.9824;DNA SYNTHESIS#0.9823;MITOSIS#0.9823;RETINOBLASTOMA#0.9821;COMPLEX I#0.9821;REGULATION OF CELL CYCLE#0.9819;ATAXIA TELANGIECTASIA#0.9816;SMOOTH MUSCLE#0.9816;APOPTOTIC CELL DEATH#0.9815;QUANTITATIVE REAL TIME#0.9814;PROSTATE CANCER#0.9812;CELL CYCLE PHASE#0.9812;CDK INHIBITOR#0.9811;M PHASE#0.9810;MACROPHAGE#0.9809;SQUAMOUS CELL CARCINOMA#0.9809;OVARIAN#0.9808;GENOTOXIC#0.9806;RIBOSE#0.9805;LUNG FIBROBLASTS#0.9803;RETINOIC ACID#0.9801;PROTEIN COMPLEX#0.9795;CELL MIGRATION#0.9791;CYCLIN DEPENDENT KINASE INHIBITOR#0.9790;BREAST CARCINOMA#0.9788;PROGRAMMED CELL DEATH#0.9787;EPSTEIN BARR VIRUS#0.9786;TRANSCRIPTASE#0.9786;BREAST CANCER#0.9786;HEPATITIS B#0.9780;HISTONE DEACETYLASE#0.9780;CELL CYCLE#0.9779;CELL CYCLE REGULATION#0.9779;POLYMERASE CHAIN REACTION#0.9779;G1 PHASE#0.9770;BREAST CANCER PATIENTS#0.9770;ANGIOGENESIS#0.9768;RENAL CELL CARCINOMA#0.9767;BETA GALACTOSIDASE#0.9765;PROTEIN PROTEIN INTERACTION#0.9764;ONCOGENIC#0.9764;LUNG CANCER#0.9763;OVARIAN CANCER#0.9762;CELL DIVISION#0.9762;MOUSE EMBRYONIC FIBROBLAST#0.9756;KINASE ACTIVITY#0.9756;CELL DEATH#0.9755;OXIDATIVE METABOLISM#0.9753;HUMAN BREAST CANCER#0.9751;ESTROGEN RECEPTOR#0.9748;CELL CYCLE ARREST#0.9744;PROTEIN KINASE#0.9736;COLON ADENOCARCINOMA#0.9728;TUMOR CELLS#0.9726;EPITHELIAL CELL#0.9717;SIGNALING PATHWAY#0.9717;MITOCHONDRIA#0.9716;WOUND HEALING#0.9716;CELL DIFFERENTIATION#0.9714;EPITHELIAL MESENCHYMAL TRANSITION#0.9708;MYELOID LEUKEMIA#0.9704;CANCER CELL#0.9696;HEPATOCELLULAR CARCINOMA#0.9691;KINASE INHIBITOR#0.9678;HEPATOCELLULAR CARCINOMA CELL#0.9677;EPIDERMAL GROWTH FACTOR#0.9677;REACTIVE OXYGEN SPECIES#0.9676;CELL PROLIFERATION#0.9676;VASCULAR SMOOTH MUSCLE CELL#0.9676;INSULIN-LIKE GROWTH FACTOR#0.9671;G0 PHASE#0.9671;STEM CELL#0.9669;TOXICITY#0.9668;HISTONE ACETYLATION#0.9666;TUMOR SUPPRESSOR#0.9665;CYCLIN DEPENDENT KINASE#0.9664;TRANSFORMING GROWTH FACTOR#0.9660;CYTOTOXICITY#0.9656;TUMOR TISSUES#0.9652;DNA METHYLATION#0.9650;GROWTH FACTOR#0.9646;CELL GROWTH#0.9639;DNA FRAGMENTATION#0.9639;CYTOCHROME C#0.9638;ESTRADIOL#0.9637;GENE EXPRESSION#0.9636;DISEASE FREE SURVIVAL#0.9635;TRANSCRIPTION FACTOR ACTIVITY#0.9630;T LYMPHOCYTE#0.9615;ONCOGENESIS#0.9612;PERIPHERAL BLOOD#0.9607;FLAVOPIRIDOL#0.9606;DEPHOSPHORYLATION#0.9604;TUMOR NECROSIS FACTOR#0.9597;SKELETAL MUSCLE#0.9590;AKT SIGNALING#0.9588;LYMPH NODE METASTASIS#0.9580;MYELOID CELL#0.9567;CHROMATIN REMODELING#0.9556;CELL DIVISION CYCLE#0.9534;DNA METHYLTRANSFERASE#0.9532;REPORTER GENE ASSAY#0.9520;MITOCHONDRIAL MEMBRANE#0.9518;ARGININE#0.9517;CELL ADHESION#0.9515;RAPAMYCIN#0.9481;HEPATITIS B VIRUS#0.9453;NON-SMALL CELL LUNG CARCINOMA#0.9444;ATAXIA TELANGIECTASIA MUTATED#0.9440;ENHANCER BINDING#0.9439;REGENERATION#0.9433;ISCHEMIA#0.9425;MAPK SIGNALING#0.9413;ENHANCER BINDING PROTEIN#0.9409;C TERMINAL DOMAIN#0.9408;ADIPOCYTE#0.9405;MYOBLAST#0.9403;SIGNALLING PATHWAY#0.9376;CELL KILLING#0.9371;GENE SILENCING#0.9362;MESANGIAL CELL#0.9349;HISTONE MODIFICATION#0.9338;MONONUCLEAR CELLS#0.9332;GEMCITABINE#0.9303;TAMOXIFEN#0.9296;INHIBITION OF CELL PROLIFERATION#0.9287;GLIAL CELL#0.9278;ESOPHAGEAL CANCER#0.9258;DNA POLYMERASE ALPHA#0.9256;POST-TRANSLATIONAL MODIFICATION#0.9256;MELANOCYTE#0.9247;REGULATION OF CELL PROLIFERATION#0.9246;GLYCOLYSIS#0.9245;TARGET OF RAPAMYCIN#0.9243;DOMINANT NEGATIVE MUTANT#0.9238;HEPATOMA CELLS#0.9235;QUIESCENCE#0.9214;MULTIPLE MYELOMA#0.9205;CLEAVED CASPASE 3#0.9197;MAP KINASE#0.9188;ENDOPLASMIC RETICULUM#0.9184;HOST CELL#0.9161;NERVOUS SYSTEM#0.9160;DIFFUSE LARGE B-CELL LYMPHOMA#0.9141;ADIPOSE TISSUE#0.9140;HISTONE DEACETYLASE INHIBITOR#0.9133;CEREBELLAR GRANULE NEURON#0.9116;HOMOLOGOUS RECOMBINATION#0.9116;PROTEIN KINASE C#0.9111;APOPTOTIC PROCESS#0.9107;PITUITARY ADENOMA#0.9092;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9079;GLUTATHIONE#0.9070;ADENOSINE#0.9066;G2 PHASE#0.9065;RNA BINDING#0.9064;MECHANISM OF ACTION#0.9058;HISTONE ACETYLTRANSFERASE#0.9049;GLUCOSE HOMEOSTASIS#0.9044;P53 BINDING#0.9031;MOUSE EMBRYO FIBROBLASTS#0.9030;CYCLIN-DEPENDENT KINASE ACTIVITY#0.9017;MELANOMA CELL LINES#0.9012;HUMAN IMMUNODEFICIENCY VIRUS#0.9007;EMBRYONIC STEM CELL#0.8992;NUCLEOTIDE EXCISION REPAIR#0.8983;DRY MOUTH#0.8981;NULL CELL#0.8979;HYPOXIA INDUCIBLE FACTOR#0.8973;PROTEASOME PATHWAY#0.8952;INFLAMMATORY RESPONSE#0.8938;ACUTE MYELOID LEUKEMIA#0.8919;HISTONE METHYLTRANSFERASE#0.8884;MUTAGENESIS#0.8855;SIGNAL TRANSDUCER#0.8847;TRANSCRIPTION ACTIVATOR#0.8844;NEURONAL CELL DEATH#0.8790;PROTEIN DEGRADATION#0.8770;LEUCINE#0.8769;QUANTITATIVE REVERSE TRANSCRIPTION#0.8767;NUCLEAR LOCALIZATION SIGNAL#0.8703;MESENCHYMAL STEM CELL#0.8672;THYROID HORMONE RECEPTOR#0.8670;COPY NUMBER VARIATION#0.8668;ACTIVATING TRANSCRIPTION FACTOR#0.8635;SPINAL CORD#0.8635;MAMMARY EPITHELIAL CELL#0.8631;IMMUNE RESPONSE#0.8621;REGULATION OF GENE EXPRESSION#0.8611;MYOGENESIS#0.8596;NEURAL CELL#0.8586;CAMPTOTHECIN#0.8579;PRECURSOR CELL#0.8559;NEURODEGENERATIVE DISEASE#0.8552;HEMATOPOIETIC CELL#0.8551;UBIQUITIN PROTEASOME PATHWAY#0.8549;CLEAR CELL RENAL CELL CARCINOMA#0.8548;GLIOBLASTOMA MULTIFORME#0.8483;CELL MOTILITY#0.8480;OVARIAN CARCINOMA#0.8474;ALL TRANS RETINOIC ACID#0.8470;DEMETHYLATION#0.8468;KINASE INHIBITOR P27#0.8465;TRANSFORMING GROWTH FACTOR BETA#0.8459;ASTROCYTE#0.8453;MURINE DOUBLE MINUTE#0.8450;ADRIAMYCIN#0.8446;MIRNA BINDING#0.8441;IFN-GAMMA#0.8422;EXTRACELLULAR MATRIX#0.8418;APOPTOTIC PROGRAM#0.8412;TETRACYCLINE#0.8379;NUCLEAR EXPORT#0.8369;MAMMARY GLAND#0.8368;TELOMERE#0.8360;COLONY FORMATION ASSAY#0.8354;CASPASE INHIBITOR#0.8342;SENSITIZATION#0.8326;DAMAGED DNA BINDING#0.8316;FIBROBLAST GROWTH FACTOR#0.8310;REPLICATIVE SENESCENCE#0.8305;CELLULAR GROWTH#0.8296;TRANSCRIPTION REGULATOR#0.8290;DNA DAMAGE CHECKPOINT#0.8288;HYPOXIC#0.8283;MALIGNANT GLIOMA#0.8280;PEROXISOME#0.8279;MONOCYTE#0.8251;HETEROCHROMATIN#0.8238;ADIPOCYTE DIFFERENTIATION#0.8219;PROTEIN PHOSPHORYLATION#0.8201;NUCLEAR IMPORT#0.8193;GLYCOGEN SYNTHASE KINASE#0.8190;CELL CYCLE TRANSITION#0.8187;THYMOCYTE#0.8166;KERATINOCYTE DIFFERENTIATION#0.8159;COMPARATIVE GENOMIC HYBRIDIZATION#0.8153;NF-KAPPAB ACTIVATION#0.8141;ALZHEIMER'S DISEASE#0.8134;SKIN CANCER#0.8131;ADIPOGENESIS#0.8111;LUNG EPITHELIAL CELL#0.8108;MECHANISMS OF ACTION#0.8104;INTERFERON REGULATORY FACTOR#0.8103;CASPASE ACTIVATION#0.8085;COLON CARCINOMA#0.8081;BRONCHIAL EPITHELIAL CELLS#0.8068;BINDING PROTEIN 1#0.8067;NEUROTOXICITY#0.8065;ARYL HYDROCARBON RECEPTOR#0.8054;RIBOSOMAL PROTEIN#0.8038;RNA BINDING PROTEIN#0.8038;GERM CELL#0.8020;PROTEIN PHOSPHATASE 2A#0.8008;HUMAN GASTRIC CARCINOMA#0.8005;PHOSPHATASE 2A#0.8005;COLORECTAL CARCINOMA#0.7994;GRANULOSA CELL#0.7986;LIVER REGENERATION#0.7986;FLOW CYTOMETRY ANALYSIS#0.7983;DEACETYLASE ACTIVITY#0.7972;ANTISENSE RNA#0.7964;NEURONAL CELLS#0.7946;TYROSINE KINASE INHIBITOR#0.7942;GRANULOCYTE#0.7938;VIRAL INFECTION#0.7931;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7929;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7926;EPITHELIAL TO MESENCHYMAL#0.7924;INTESTINAL EPITHELIAL CELL#0.7922;PHOSPHATASE AND TENSIN HOMOLOG#0.7922;ANCHORAGE INDEPENDENT GROWTH#0.7909;POSTTRANSLATIONAL MODIFICATION#0.7893;MYOCARDIAL INFARCTION#0.7873;DEUBIQUITINATING ENZYME#0.7847;ESTROGEN RECEPTOR ALPHA#0.7820;RECURRENCE FREE SURVIVAL#0.7817;NEUROGENESIS#0.7808;CARCINOMA IN SITU#0.7805;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7787;MICROTUBULE#0.7781;NEURITE OUTGROWTH#0.7775;EPITHELIAL OVARIAN CANCER#0.7775;HEMATOPOIETIC PROGENITOR CELL#0.7763;CEREBRAL ISCHEMIA#0.7763;VITAMIN C#0.7751;REGULATION OF CELLULAR#0.7749;MITOTIC SPINDLE#0.7745;NERVE GROWTH FACTOR#0.7742;CENTROSOME#0.7717;MYOTUBE#0.7699;RECEPTOR TYROSINE KINASE#0.7679;CARCINOGEN#0.7676;NEURITE#0.7672;REGULATION OF APOPTOSIS#0.7665;LIVER DISEASE#0.7665;5-AZA-2'-DEOXYCYTIDINE#0.7660;2'-DEOXYCYTIDINE#0.7656;CENTRAL NERVOUS SYSTEM#0.7648;CELECOXIB#0.7646;CHONDROCYTE#0.7641;PROGESTERONE#0.7619;PROSTATE CARCINOMA#0.7610;THYROID CANCER#0.7605;RIBOSOME#0.7605;RELAPSE FREE SURVIVAL#0.7587;OXALIPLATIN#0.7566;THYMIDINE PHOSPHORYLASE#0.7555;CREB BINDING#0.7541;BORTEZOMIB#0.7538;GASTRIC ADENOCARCINOMA#0.7520;THYROID CARCINOMA#0.7504;NEUROPROTECTION#0.7502;FEED FORWARD LOOP#0.7495;ATP BINDING#0.7466;CELL SURFACE#0.7448;DIFFERENTIAL GENE EXPRESSION#0.7446;ARTERY#0.7440;OBESE#0.7395;DEATH RECEPTOR#0.7388;IMMUNE SYSTEM#0.7370;TYPE 2 DIABETES#0.7369;CANCER RELATED DEATH#0.7367;INHIBITION OF CELL GROWTH#0.7363;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7348;CELL DEVELOPMENT#0.7322;PLATELET-DERIVED GROWTH FACTOR#0.7322;TISSUE HOMEOSTASIS#0.7307;CANCER STEM CELL#0.7292;4-HYDROXYTAMOXIFEN#0.7268;BURKITT LYMPHOMA#0.7268;NEUROEPITHELIAL CELL#0.7265;DNA REPAIR PROTEIN#0.7236;OLIGODENDROCYTE#0.7229;SERUM RESPONSE FACTOR#0.7222;VSMC PROLIFERATION#0.7201;NEURAL STEM CELL#0.7201;MESENCHYMAL CELL#0.7182;SIGNALING MOLECULE#0.7178;GENE EXPRESSION OMNIBUS#0.7156;HEAT SHOCK PROTEIN#0.7155;OVERALL SURVIVAL RATE#0.7154;PANCREATIC DUCTAL ADENOCARCINOMA#0.7148;ACTIVATOR PROTEIN 1#0.7147;STROMAL CELL#0.7137;BIOTIN#0.7124;CHROMATIN REMODELLING#0.7103;OOCYTE#0.7090;RETINOIC ACID RECEPTOR#0.7086;CROHN'S DISEASE#0.7076;HIGH MOBILITY GROUP#0.7071;HEPATOCYTE GROWTH FACTOR#0.7060;LIPID SYNTHESIS#0.7045;PROPIDIUM#0.7040;PROTEIN INTERACTION NETWORK#0.7023;EMBRYONAL CARCINOMA#0.7018;NUCLEOSOME#0.7013;MEDULLOBLASTOMA#0.7001;HUMAN EPIDERMAL KERATINOCYTES#0.6985;KERATINOCYTE PROLIFERATION#0.6980;NUCLEOLUS#0.6976;BRAIN DEVELOPMENT#0.6959;HISTONE DEACETYLASE ACTIVITY#0.6956;PROTEIN KINASE B#0.6950;HUMAN UMBILICAL VEIN#0.6940;UMBILICAL VEIN#0.6938;METASTATIC MELANOMA#0.6904;MORPHOGENESIS#0.6888;RIBOSOME BIOGENESIS#0.6878;URSODEOXYCHOLIC ACID#0.6877;CEREBRAL CORTEX#0.6868;DUCTAL CARCINOMA IN SITU#0.6858;GENE COPY NUMBER#0.6844;ATHEROSCLEROSIS#0.6838;SUMOYLATION#0.6837;MYOBLAST DIFFERENTIATION#0.6823;RRNA TRANSCRIPTION#0.6820;GLUCOSE INTOLERANCE#0.6810;LYMPH NODE METASTASES#0.6803;SERTOLI CELL#0.6797;P53 SIGNALING PATHWAY#0.6796;SUBMANDIBULAR GLAND#0.6769;GLUCOCORTICOID RECEPTOR#0.6763;HUMAN MESENCHYMAL STEM#0.6753;HAIR FOLLICLE#0.6736;HEAD AND NECK CANCER#0.6730;NECK CANCER#0.6729;ACUTE LEUKEMIA#0.6729;PAPILLOMA#0.6704;MRNA TRANSCRIPTION#0.6702;APOPTOSIS INDUCING FACTOR#0.6697;SIMIAN IMMUNODEFICIENCY VIRUS#0.6692;GERMINAL CENTER#0.6662;PARKINSON'S DISEASE#0.6659;T CELL PROLIFERATION#0.6613;MDM2 BINDING#0.6611;TOLL LIKE RECEPTOR#0.6603;LUPUS ERYTHEMATOSUS#0.6599;PACLITAXEL#0.6586;EPITHELIAL CELL PROLIFERATION#0.6575;MANTLE CELL LYMPHOMA#0.6566;STEROID RECEPTOR COACTIVATOR#0.6563;CHRONIC MYELOID LEUKEMIA#0.6548;MITOTIC CELL CYCLE#0.6548;PROSTATE SPECIFIC ANTIGEN#0.6542;SMALL MOLECULE METABOLISM#0.6539;ACETYLCHOLINE RECEPTOR#0.6530;CHROMATIN BINDING#0.6518;GROWTH OF CELL#0.6506;SEQUENCE SPECIFIC DNA BINDING#0.6504;COLONY-STIMULATING FACTOR#0.6492;ARSENIC TRIOXIDE#0.6464;MUSCLE CELL PROLIFERATION#0.6462;EARLY GROWTH RESPONSE#0.6459;DNA TOPOISOMERASE#0.6439;ORAL SQUAMOUS CELL CARCINOMA#0.6423;GEFITINIB#0.6421;ENDOPLASMIC RETICULUM STRESS#0.6417;LIPOGENESIS#0.6416;BASAL CELL#0.6414;PREADIPOCYTE#0.6398;REGULATION OF CELL GROWTH#0.6371;GENE REGULATORY NETWORK#0.6362;CDK ACTIVITY#0.6362;NEURAL PRECURSOR CELL#0.6282;ANAPHASE PROMOTING COMPLEX#0.6278;HOST CELL FACTOR#0.6273;PYRUVATE DEHYDROGENASE KINASE#0.6270;17β-ESTRADIOL#0.6263;MOUSE EMBRYONIC STEM#0.6260;ADJACENT NORMAL TISSUE#0.6256;LUNG METASTASIS#0.6250;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6248;CAFFEINE#0.6246;HERPES SIMPLEX VIRUS#0.6231;RIBOZYME#0.6230;HERPES SIMPLEX#0.6228;LYMPHOCYTIC LEUKEMIA#0.6227;RESPONSE TO STRESS#0.6220;VITAMIN D3#0.6217;NEUROTROPHIN RECEPTOR#0.6209;BLOOD VESSEL#0.6195;BILE DUCT#0.6190;SMOOTH MUSCLE CELL PROLIFERATION#0.6167;HYPERGLYCEMIA#0.6163;HISTONE DEMETHYLASE#0.6157;INFLAMMATORY CELL#0.6151;XERODERMA PIGMENTOSUM#0.6139;OSTEOBLAST#0.6138;DOPAMINE#0.6133;UNFOLDED PROTEIN RESPONSE#0.6130;4-OHT#0.6129;MITOTIC CATASTROPHE#0.6078;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6070;ASTROCYTOMA#0.6064;RESVERATROL#0.6058;INTERPHASE#0.6057;HEPATITIS C#0.6056;NECROTIC CELL DEATH#0.6025;RESPONSE TO UV#0.6024;NITRIC OXIDE#0.6024
186	AT2 RECEPTOR BINDING#1.0833;VALSARTAN#1.0227;RECEPTOR LIGAND#1.0162;NEURITE OUTGROWTH#1.0130;ANGIOTENSIN TYPE 1#1.0123;MYOCARDIAL INFARCTION#1.0101;AT1 RECEPTOR BLOCKER#1.0082;MENTAL RETARDATION#1.0078;ADRENAL GLAND#1.0059;RECEPTOR AGONIST#1.0054;ISCHEMIA#1.0049;ANGIOGENESIS#1.0046;CANDESARTAN#1.0040;THORACIC AORTA#1.0037;RECEPTOR BINDING#1.0029;NITRIC OXIDE SYNTHASE#1.0007;LOSARTAN#1.0001;VASODILATION#0.9994;CELL GROWTH#0.9991;NADPH OXIDASE#0.9984;ANGIOTENSIN RECEPTOR#0.9969;GESTATION#0.9962;RECEPTOR ANTAGONIST#0.9961;ENDOTHELIAL CELL#0.9955;APOPTOSIS#0.9952;RESPONSE TO ANGIOTENSIN#0.9951;TRANSFORMING GROWTH FACTOR#0.9948;CELL PROLIFERATION#0.9933;CORONARY ARTERY#0.9932;CENTRAL NERVOUS SYSTEM#0.9930;NERVOUS SYSTEM#0.9929;CARDIOMYOCYTE#0.9928;OVARIAN#0.9914;REVERSE TRANSCRIPTION#0.9912;X CHROMOSOME#0.9911;MITOGEN ACTIVATED PROTEIN#0.9905;VASOCONSTRICTION#0.9896;VASCULAR SMOOTH MUSCLE CELL#0.9881;EPITHELIAL CELL#0.9877;NITRIC OXIDE#0.9866;MACROPHAGE#0.9862;ALDOSTERONE#0.9862;BLOOD PRESSURE REGULATION#0.9858;PROTEIN KINASE C#0.9857;ACE INHIBITOR#0.9854;POLYMERASE CHAIN REACTION#0.9848;BLOOD VESSEL#0.9846;LOCUS COERULEUS#0.9841;NEURITE#0.9838;ENZYME INHIBITOR#0.9833;ANGIOTENSIN CONVERTING ENZYME#0.9823;NEPHROPATHY#0.9821;ENDOTHELIUM#0.9820;NITRO-L-ARGININE#0.9814;ALDOSTERONE SECRETION#0.9809;SMOOTH MUSCLE CELL#0.9807;MUSCLE CELL#0.9800;ARTERY#0.9796;PROTEIN KINASE#0.9792;ARGININE#0.9792;SMOOTH MUSCLE#0.9791;GROWTH FACTOR#0.9791;MYOCARDIUM#0.9790;MESANGIAL CELL#0.9789;GENE EXPRESSION#0.9772;ATHEROSCLEROSIS#0.9770;VASOCONSTRICTOR#0.9764;L-ARGININE#0.9762;SIGNAL TRANSDUCTION#0.9759;PROTEIN TYROSINE PHOSPHATASE#0.9733;TUMOR NECROSIS FACTOR#0.9725;HYPERTENSION#0.9717;CELL SURFACE#0.9702;SIGNALING PATHWAY#0.9686;ARACHIDONIC ACID#0.9683;SYSTOLIC BLOOD PRESSURE#0.9678;CELL DIFFERENTIATION#0.9670;APOPTOTIC#0.9649;BREAST CANCER#0.9644;VASOPRESSIN#0.9643;CEREBRAL ARTERY#0.9642;CARDIOVASCULAR SYSTEM#0.9631;VASODILATOR#0.9590;MONOCYTE#0.9585;FIBROBLAST GROWTH FACTOR#0.9576;CANCER CELL#0.9568;ADIPOSE TISSUE#0.9563;CELL DEATH#0.9552;DIABETIC NEPHROPATHY#0.9520;EXCRETION#0.9508;NATRIURESIS#0.9507;REGULATION OF BLOOD PRESSURE#0.9492;REGENERATION#0.9482;MYOCYTES#0.9423;EXTRACELLULAR MATRIX#0.9417;DNA SYNTHESIS#0.9406;PHEOCHROMOCYTOMA#0.9381;PERTUSSIS#0.9381;GRANULOSA CELL#0.9371;PHOSPHOLIPASE C#0.9362;HYPOTENSIVE#0.9362;CAPTOPRIL#0.9337;STREPTOZOTOCIN#0.9331;DOPAMINE#0.9329;KIDNEY DISEASE#0.9328;STEM CELL#0.9316;TELMISARTAN#0.9314;MIDDLE CEREBRAL ARTERY#0.9259;TRANSCRIPTASE#0.9247;OBESE#0.9247;RENIN ACTIVITY#0.9234;ENDOTHELIAL GROWTH FACTOR#0.9228;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9228;TRANSCRIPTION FACTOR#0.9223;ANGIOTENSIN RECEPTOR BLOCKER#0.9209;CAROTID ARTERY#0.9207;ESSENTIAL HYPERTENSION#0.9206;PLASMA MEMBRANE#0.9194;ENDOTHELIAL NITRIC OXIDE#0.9186;ACE ACTIVITY#0.9186;ADRENAL CORTEX#0.9181;CORONARY ARTERY DISEASE#0.9176;ARTERY DISEASE#0.9174;CELL MEMBRANE#0.9154;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9112;REACTIVE OXYGEN SPECIES#0.9107;VASODILATATION#0.9083;ARTERIOLE#0.9069;GLOMERULAR FILTRATION#0.9027;DIABETES MELLITUS#0.8982;RENAL ARTERY#0.8976;GUANOSINE#0.8945;EPIDERMAL GROWTH FACTOR#0.8930;ISCHEMIA REPERFUSION INJURY#0.8901;QUANTITATIVE REAL TIME#0.8872;SIGNALLING PATHWAY#0.8870;INFLAMMATORY RESPONSE#0.8826;OOCYTE#0.8804;AORTIC ANEURYSM#0.8793;IRBESARTAN#0.8792;INDOMETHACIN#0.8787;CEREBRAL ISCHEMIA#0.8774;TUBULAR EPITHELIAL CELL#0.8736;NOREPINEPHRINE#0.8713;PRO-INFLAMMATORY#0.8681;ENALAPRIL#0.8665;SKELETAL MUSCLE#0.8653;LUMINAL#0.8639;GUANOSINE-3',5'-MONOPHOSPHATE#0.8598;STROMAL CELL#0.8587;MYOMETRIUM#0.8585;CHRONIC KIDNEY DISEASE#0.8583;ADRENAL MEDULLA#0.8569;RECEPTOR INTERACTING PROTEIN#0.8532;PHOSPHOLIPASE A2#0.8522;ADIPOCYTE#0.8494;MAP KINASE#0.8483;PROSTATE CANCER#0.8469;PROTEINURIA#0.8406;FETAL KIDNEY#0.8356;CARDIOMYOPATHY#0.8337;TYPE 2 DIABETES#0.8305;ARGININE VASOPRESSIN#0.8292;CROSS SECTIONAL AREA#0.8287;ATHEROSCLEROTIC#0.8276;GLOMERULAR FILTRATION RATE#0.8267;CONSTRICTION#0.8248;INFLAMMATORY CELL#0.8212;NERVE GROWTH FACTOR#0.8203;KINASE INHIBITOR#0.8174;BONE MARROW#0.8173;BODY WEIGHT RATIO#0.8133;PROSTAGLANDIN E2#0.8094;DORSAL ROOT GANGLION#0.8092;HIGH FAT DIET#0.8081;WOUND HEALING#0.8074;KINASE ACTIVITY#0.8069;PROTEIN SYNTHESIS#0.8065;INDUCIBLE NITRIC OXIDE#0.8054;PODOCYTE#0.8033;GROWTH FACTOR RECEPTOR#0.8027;THYMIDINE#0.7995;OLMESARTAN#0.7985;HYPOTENSION#0.7978;NEPHROGENESIS#0.7952;ACETYLCHOLINE#0.7943;VASCULAR CELL#0.7907;PROXIMAL TUBULE CELL#0.7903;NITRIC-OXIDE SYNTHASE INHIBITOR#0.7894;N-NITRO-L-ARGININE#0.7860;LEFT VENTRICULAR MASS#0.7825;PULMONARY FIBROSIS#0.7801;NEUROBLASTOMA#0.7796;HYPOXIA#0.7787;SUPERIOR COLLICULUS#0.7754;CEREBRAL ARTERY OCCLUSION#0.7751;NEUROPROTECTION#0.7696;ALZHEIMER'S DISEASE#0.7686;PROXIMAL TUBULAR CELL#0.7672;SIGNALING CASCADE#0.7631;CYTOCHROME P450#0.7615;MESENTERIC ARTERY#0.7615;CAMP SYNTHESIS#0.7607;HUMAN UMBILICAL VEIN#0.7565;NUCLEOTIDE BINDING#0.7564;UMBILICAL VEIN#0.7562;HOE 140#0.7529;BRAIN DEVELOPMENT#0.7523;PROXIMAL TUBULAR EPITHELIAL#0.7513;NEPHRON#0.7510;VASCULAR ENDOTHELIAL CELL#0.7501;SUPEROXIDE DISMUTASE#0.7491;GUANYLATE CYCLASE#0.7455;ENDOMETRIUM#0.7450;CALCIUM CHANNEL#0.7435;PRESSURE NATRIURESIS#0.7425;HEART DISEASE#0.7417;INHIBITION OF CELL PROLIFERATION#0.7380;GUANINE#0.7367;MESENCHYMAL STEM CELL#0.7348;DOPAMINERGIC NEURON#0.7320;INCREASED BLOOD PRESSURE#0.7307;PHENYLEPHRINE#0.7296;CORTICAL CELL#0.7295;CORTISOL#0.7287;OVARIAN CANCER#0.7274;PERIPHERAL NERVE#0.7213;DNA FRAGMENTATION#0.7212;VESICOURETERAL REFLUX#0.7208;ADENINE#0.7185;DNA BINDING#0.7177;SEPTUM#0.7173;N-OMEGA-NITRO-L-ARGININE#0.7165;BRAIN RENIN-ANGIOTENSIN SYSTEM#0.7151;NERVE FIBER#0.7145;PEROXISOME#0.7124;T LYMPHOCYTE#0.7111;HYPERSENSITIVITY#0.7106;TYPE 2 DIABETIC#0.7098;LEFT VENTRICULAR REMODELING#0.7038;PITUITARY GLAND#0.7022;STRUCTURE ACTIVITY RELATIONSHIP#0.7005;CONGESTIVE HEART FAILURE#0.7002;ADENOCARCINOMA#0.7000;GLUCOCORTICOID RECEPTOR#0.6977;PROGENITOR CELL#0.6965;MAGNETIC RESONANCE IMAGING#0.6963;MIDBRAIN#0.6959;DEXAMETHASONE#0.6910;PHOSPHATASE INHIBITOR#0.6887;TISSUE REMODELING#0.6864;CELLULAR LOCALIZATION#0.6857;THORACIC AORTIC ANEURYSM#0.6853;ACINAR CELL#0.6851;ADRENERGIC RECEPTOR#0.6838;FRUCTOSE#0.6827;CORONARY ARTERY ENDOTHELIAL CELLS#0.6815;GLIAL CELL#0.6799;COLLAGEN METABOLISM#0.6793;DIURESIS#0.6780;BRAIN DAMAGE#0.6744;MESENCHYMAL CELL#0.6731;LACRIMAL GLAND#0.6729;AMYGDALA#0.6717;SIGNAL TRANSDUCER#0.6706;BLOOD BRAIN BARRIER#0.6705;THALAMUS#0.6668;INSULIN RECEPTOR#0.6646;ICATIBANT#0.6616;SCIATIC NERVE#0.6498;ESTRADIOL#0.6493;PHOSPHATASE 2A#0.6484;INTERFERON REGULATORY FACTOR#0.6480;ENZYME ACTIVITY#0.6444;TRANSACTIVATION#0.6444;MECHANISMS OF ACTION#0.6434;PROSTACYCLIN#0.6424;CELL MIGRATION#0.6404;INSULIN-LIKE GROWTH FACTOR#0.6402;HYPOXIC#0.6378;CAKUT#0.6345;NEUROTRANSMISSION#0.6306;COLLAGEN SYNTHESIS#0.6292;MORRIS WATER MAZE#0.6279;STRIATUM#0.6278;CANDESARTAN CILEXETIL#0.6278;LEUKOCYTE#0.6259;HIGH CHOLESTEROL DIET#0.6259;VASCULAR DISEASE#0.6255;MODE OF ACTION#0.6226;BREAST CANCER CELL#0.6208;ACUTE LUNG INJURY#0.6207;ORGANOGENESIS#0.6198;RECEPTOR ACTIVITY#0.6168;ASTROCYTE#0.6165;HEMORRHAGIC#0.6162;ADENOSINE#0.6158;ACUTE MYOCARDIAL INFARCTION#0.6144;ANGII TYPE 1#0.6144;SUBSTANTIA NIGRA#0.6142;PHOSPHATASE ACTIVITY#0.6142;PROGRAMMED CELL DEATH#0.6133;PTPASE ACTIVITY#0.6130;CYCLIC AMP#0.6096;PROPRANOLOL#0.6089;PROTEIN KINASE G#0.6085;PANCREATIC PROGENITOR CELL#0.6062;CGMP SYNTHESIS#0.6052;FETAL BRAIN#0.6039;ALANINE#0.6029;KIDNEY DEVELOPMENT#0.6016
1870	T CELL#1.0188;S PHASE#1.0022;CANCER CELL#0.9955;DNA BINDING#0.9951;DNA REPLICATION#0.9930;BREAST CANCER#0.9890;CELL CYCLE#0.9858;TRANSCRIPTION FACTOR#0.9852;RETINOBLASTOMA#0.9850;CELL PROLIFERATION#0.9845;APOPTOSIS#0.9844;GENE EXPRESSION#0.9833;TUMOR SUPPRESSOR#0.9829;CELL GROWTH#0.9828;OVARIAN#0.9815;CELL DEATH#0.9750;T LYMPHOCYTE#0.9741;OVARIAN CANCER#0.9735;CELL CYCLE REGULATOR#0.9689;CYCLIN DEPENDENT KINASE#0.9665;APOPTOTIC#0.9614;EPITHELIAL CELL#0.9600;STEM CELL#0.9575;GROWTH FACTOR#0.9569;ENDOTHELIAL CELL#0.9560;CELL CYCLE ARREST#0.9407;CELL CYCLE REGULATION#0.9368;DNA SYNTHESIS#0.9363;SIGNALING PATHWAY#0.9275;ONCOGENIC#0.9255;LUNG CANCER#0.9203;POLYMERASE CHAIN REACTION#0.9192;CELL CYCLE CONTROL#0.9094;CELL DIVISION#0.9094;TUMOR CELLS#0.8917;PROGENITOR CELL#0.8804;SQUAMOUS CELL CARCINOMA#0.8717;BONE MARROW#0.8693;BREAST CANCER CELL#0.8664;MOUSE EMBRYONIC FIBROBLAST#0.8432;HEPATOCELLULAR CARCINOMA#0.8346;CARDIOMYOCYTE#0.8173;CORNEAL ENDOTHELIAL CELL#0.8068;REGENERATION#0.7955;SENESCENCE#0.7890;DUAL LUCIFERASE REPORTER#0.7785;TERMINAL DIFFERENTIATION#0.7754;DNA DAMAGE RESPONSE#0.7740;G1 PHASE#0.7602;REVERSE TRANSCRIPTION#0.7486;LIVER REGENERATION#0.7480;TRANSACTIVATION#0.7348;DNA REPAIR#0.7291;LIVER CANCER#0.7289;CELL DIFFERENTIATION#0.7276;QUANTITATIVE REAL TIME#0.7218;PROTEIN PROTEIN INTERACTION#0.7169;DISEASE FREE SURVIVAL#0.7104;HEMATOPOIETIC PROGENITOR CELL#0.6780;RHEUMATOID ARTHRITIS#0.6683;PROSTATE CANCER#0.6596;ERYTHROPOIESIS#0.6558;B CELL#0.6473;LYMPH NODE#0.6468;PROTEIN KINASE#0.6449;COLORECTAL#0.6351;COLON CANCER#0.6299;HISTONE DEACETYLASE#0.6180;HUMAN BREAST CANCER#0.6180;ANGIOGENESIS#0.6117;MAMMARY GLAND#0.6079;RELAPSE FREE SURVIVAL#0.6057
1871	S PHASE#1.0070;PROSTATE CANCER#1.0048;BREAST CANCER#1.0038;LUNG CANCER#0.9989;DNA BINDING#0.9956;CANCER CELL#0.9948;HEPATOCELLULAR CARCINOMA#0.9924;CELL GROWTH#0.9906;TRANSCRIPTION FACTOR#0.9844;EPITHELIAL CELL#0.9842;CELL CYCLE#0.9833;APOPTOSIS#0.9822;GROWTH FACTOR#0.9821;BREAST CANCER CELL#0.9820;TUMOR SUPPRESSOR#0.9812;CELL PROLIFERATION#0.9810;RETINOBLASTOMA#0.9806;SIGNALING PATHWAY#0.9791;ONCOGENIC#0.9790;POLYMERASE CHAIN REACTION#0.9756;TUMOR CELLS#0.9749;GENE EXPRESSION#0.9708;CELL CYCLE ARREST#0.9542;DUAL LUCIFERASE REPORTER#0.9499;CELL MIGRATION#0.9448;OVARIAN CANCER#0.9394;CELL CYCLE CONTROL#0.9353;CYCLIN DEPENDENT KINASE#0.9279;CELL CYCLE REGULATION#0.9254;STEM CELL#0.9250;QUANTITATIVE REAL TIME#0.9213;LUNG ADENOCARCINOMA#0.9122;OVARIAN#0.9121;DNA REPLICATION#0.9095;CELL DEATH#0.9067;G1 PHASE#0.8783;ADENOCARCINOMA#0.8779;B CELL#0.8757;HYPOXIA#0.8749;APOPTOTIC#0.8657;MAMMARY GLAND#0.8566;SENESCENCE#0.8340;REVERSE TRANSCRIPTION#0.8242;COLORECTAL#0.8037;LYMPH NODE#0.7928;MOUSE EMBRYONIC FIBROBLAST#0.7903;RENAL CELL CARCINOMA#0.7897;MITOSIS#0.7806;ANGIOGENESIS#0.7716;CISPLATIN#0.7517;DNA REPAIR#0.7485;CARDIOMYOCYTE#0.7432;INDUCTION OF APOPTOSIS#0.7431;PROTEIN KINASE#0.7328;CELL CYCLE REGULATOR#0.7328;LUCIFERASE ACTIVITY#0.7280;TERMINAL DIFFERENTIATION#0.7248;CENTROSOME#0.7071;CELL DIVISION#0.7041;LYMPH NODE METASTASIS#0.7039;COLORECTAL CANCER#0.7013;QUIESCENCE#0.6960;TRANSACTIVATION#0.6880;KINASE ACTIVITY#0.6790;PROGENITOR CELL#0.6780;SERTOLI CELL#0.6778;RNA INTERFERENCE#0.6774;DNA SYNTHESIS#0.6772;DNA DAMAGE RESPONSE#0.6520;EPITHELIAL MESENCHYMAL TRANSITION#0.6503;DRUG RESISTANCE#0.6491;T CELL#0.6477;CELL DIFFERENTIATION#0.6463;NERVOUS SYSTEM#0.6454;TRANSFORMING GROWTH FACTOR#0.6451;CELL COUNTING KIT#0.6352;CERVICAL CANCER#0.6304;PRECURSOR CELL#0.6303;PANCREATIC CANCER#0.6288;MYOBLAST#0.6256;HYPOXIA INDUCIBLE FACTOR#0.6203;HISTONE DEACETYLASE#0.6163;DNA METHYLATION#0.6158;CLEAR CELL RENAL CELL CARCINOMA#0.6124
1872	HEPATOCELLULAR CARCINOMA#0.9080
1874	COLORECTAL CANCER#1.0132;COLORECTAL#1.0086;BREAST CANCER#1.0086;DNA BINDING#1.0084;EPITHELIAL CELL#1.0082;TRANSFORMING GROWTH FACTOR#1.0040;GROWTH FACTOR#1.0034;G1 PHASE#1.0030;TRANSFORMING GROWTH FACTOR BETA#1.0012;STEM CELL#0.9956;CELL CYCLE ARREST#0.9905;S PHASE#0.9877;CELL DEATH#0.9830;CELL CYCLE#0.9828;TRANSCRIPTION FACTOR#0.9811;CANCER CELL#0.9804;CYCLIN DEPENDENT KINASE#0.9801;APOPTOSIS#0.9798;COLON CANCER#0.9790;GENE EXPRESSION#0.9781;CELL GROWTH#0.9771;HISTONE DEACETYLASE#0.9742;TUMOR SUPPRESSOR#0.9726;CELL PROLIFERATION#0.9706;RETINOBLASTOMA#0.9692;KINASE ACTIVITY#0.9642;DNA SYNTHESIS#0.9615;CELL CYCLE REGULATOR#0.9552;APOPTOTIC#0.9540;SIGNALING PATHWAY#0.9512;TRANSACTIVATION#0.9479;CELL CYCLE CONTROL#0.9399;CELL DIFFERENTIATION#0.9372;HUMAN INTESTINAL EPITHELIAL#0.9353;QUIESCENCE#0.9342;TUMOR CELLS#0.9340;T CELL#0.9309;TERMINAL DIFFERENTIATION#0.9284;DEPHOSPHORYLATION#0.9233;ONCOGENIC#0.9206;DNA REPAIR#0.9191;ELECTROPHORETIC MOBILITY SHIFT#0.9160;CDK INHIBITOR#0.9069;MISMATCH REPAIR#0.9041;KINASE INHIBITOR#0.8900;DNA REPLICATION#0.8858;CYTOPLASM#0.8857;INTESTINAL EPITHELIAL CELL#0.8818;OVARIAN CANCER#0.8741;CARDIOMYOCYTE#0.8720;B CELL#0.8699;KERATINOCYTE#0.8606;NUCLEAR LOCALIZATION SIGNAL#0.8584;NUCLEAR EXPORT#0.8425;CELL CYCLE REGULATION#0.8377;PROGENITOR CELL#0.8352;HEPATOCELLULAR CARCINOMA#0.8267;ADIPOCYTE#0.8244;CYCLIN DEPENDENT KINASE INHIBITOR#0.8223;INSULIN-LIKE GROWTH FACTOR#0.8206;MUSCLE CELL#0.8194;OVARIAN#0.8190;BREAST CANCER CELL#0.8178;LYMPH NODE#0.8112;LUNG FIBROBLASTS#0.8063;COMPLEX I#0.8040;M PHASE#0.7975;BREAST CARCINOMA#0.7882;MITOSIS#0.7843;SKELETAL MUSCLE#0.7823;ESTROGEN RECEPTOR#0.7791;POLYMERASE CHAIN REACTION#0.7759;PROTEIN PROTEIN INTERACTION#0.7693;MYOTUBE#0.7593;PROTEIN KINASE#0.7530;TRANSCRIPTION FACTOR BINDING#0.7477;MESENCHYMAL STEM CELL#0.7428;ADENOCARCINOMA#0.7378;CENTRIOLE AMPLIFICATION#0.7338;NERVE GROWTH FACTOR#0.7200;TRANSCRIPTION REPRESSOR#0.7056;PROTEIN COMPLEX#0.7056;POLY ADP RIBOSE#0.6892;GENOTOXIC#0.6734;CENTRIOLE#0.6684;GROWTH FACTOR RECEPTOR#0.6677;REGULATION OF CELL CYCLE#0.6590;MYOBLAST#0.6588;PROSTATE CANCER#0.6581;CELL DIVISION#0.6474;REGENERATION#0.6450;G0 PHASE#0.6344;PROSTATE CARCINOMA#0.6343;DNA METHYLATION#0.6297;HYPOXIA#0.6277;ERYTHROPOIESIS#0.6257;BONE MARROW#0.6247;QUANTITATIVE REAL TIME#0.6224;HYPERPHOSPHORYLATION#0.6163;KERATINOCYTE DIFFERENTIATION#0.6148;LUNG CANCER#0.6121;CISPLATIN#0.6114;ADIPOCYTE DIFFERENTIATION#0.6095;INTESTINAL CRYPT#0.6035;SIGNALLING PATHWAY#0.6018;HISTONE ACETYLATION#0.6016;CERVICAL#0.6013;CHROMATIN REMODELING#0.6005;FIBROBLAST GROWTH FACTOR#0.6004
1875	CANCER CELL#1.0353;BREAST CANCER#1.0215;CELL PROLIFERATION#1.0062;TRANSCRIPTION FACTOR#1.0060;CELL CYCLE#0.9993;TUMOR SUPPRESSOR#0.9939;S PHASE#0.9725;GENE EXPRESSION#0.9711;DNA BINDING#0.9707;RETINOBLASTOMA#0.9680;APOPTOSIS#0.9556;CYCLIN DEPENDENT KINASE#0.9033;PROSTATE CANCER#0.8995;CELL GROWTH#0.8915;GROWTH FACTOR#0.8815;CELL CYCLE ARREST#0.8731;OVARIAN CANCER#0.8663;OVARIAN#0.8289;EPITHELIAL CELL#0.8094;G1 PHASE#0.7923;KERATINOCYTE#0.7913;BREAST CANCER CELL#0.7656;CHOROID PLEXUS#0.7252;ONCOGENIC#0.7217;CELL MIGRATION#0.7123;QUANTITATIVE REAL TIME#0.7110;HEPATOCELLULAR CARCINOMA#0.6965;NUCLEAR LOCALIZATION SIGNAL#0.6918;CELL CYCLE REGULATOR#0.6880;CYTOPLASM#0.6821;PROTEIN KINASE#0.6729;DUAL LUCIFERASE REPORTER#0.6631;SQUAMOUS CELL CARCINOMA#0.6559;TUMOR CELLS#0.6542;CELL DEATH#0.6518;NUCLEAR IMPORT#0.6095
1876	TRANSCRIPTION FACTOR#1.0151;CELL CYCLE#1.0139;APOPTOSIS#1.0109;S PHASE#1.0032;CELL PROLIFERATION#0.9877;GENE EXPRESSION#0.9779;CANCER CELL#0.9558;DNA BINDING#0.9316;CELL GROWTH#0.8396;GENE SILENCING#0.8311;BREAST CANCER#0.8247;PROSTATE CANCER#0.8172;TUMOR SUPPRESSOR#0.8058;CELL CYCLE REGULATION#0.7915;RETINOBLASTOMA#0.7864;DILATED CARDIOMYOPATHY#0.7625;MYOCARDIUM#0.7223;AXIAL SKELETON#0.7084;DNA METHYLATION#0.6942;CARDIOMYOCYTE#0.6470;STEM CELL#0.6383;HYPOXIA#0.6346;SOMATIC TISSUE#0.6243;PROTEIN COMPLEX#0.6207;OVARIAN CANCER#0.6175;TRANSACTIVATION#0.6090;MEIOSIS#0.6021
1877	TRANSCRIPTION FACTOR#1.0654;CELL CYCLE#1.0639;DNA BINDING#1.0438;CELLULAR TRANSCRIPTION#0.9806;CELL CYCLE ARREST#0.9136;STEM CELL#0.8483;CELL DEATH#0.8251;CELL GROWTH#0.8167;EPIDERMAL STEM CELL#0.7968;KINASE ACTIVITY#0.7874;APOPTOSIS#0.7531;TUMOR SUPPRESSOR#0.7049;HEMATOPOIETIC CELL#0.6250;MYELOID LEUKEMIA#0.6161;CELL PROLIFERATION#0.6160;PYRUVATE#0.6030
1878	SIMIAN IMMUNODEFICIENCY VIRUS#0.9898
1879	ADIPOCYTE#1.0347;B CELL#1.0258;DNA BINDING#1.0188;TRANSCRIPTION FACTOR#1.0153;B CELL DEVELOPMENT#1.0138;LYMPHOCYTE DEVELOPMENT#1.0122;CELL DEVELOPMENT#1.0081;B LYMPHOCYTE#1.0073;B CELL DIFFERENTIATION#1.0011;COMMON LYMPHOID PROGENITOR#0.9996;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9936;PROGENITOR CELL#0.9917;SIGNALING PATHWAY#0.9913;CELL DIFFERENTIATION#0.9896;GENE EXPRESSION#0.9806;BONE MARROW#0.9804;B CELL RECEPTOR#0.9801;T CELL#0.9740;STEM CELL#0.9709;ZINC FINGER PROTEIN#0.9673;ADIPOSE TISSUE#0.9574;OLFACTORY EPITHELIUM#0.9378;NERVOUS SYSTEM#0.9366;HEMATOPOIETIC STEM CELL#0.9358;CELL PROLIFERATION#0.9203;FACTOR I#0.9149;CELL CYCLE#0.8987;ADIPOGENESIS#0.8986;LYMPHOCYTE DIFFERENTIATION#0.8848;OSTEOBLAST#0.8799;ADIPOCYTE DIFFERENTIATION#0.8790;B LYMPHOCYTE DIFFERENTIATION#0.8653;DNA METHYLATION#0.8540;TRANSCRIPTIONAL CONTROL#0.8463;APOPTOSIS#0.8282;EPSTEIN BARR VIRUS#0.8226;B CELL LYMPHOMA#0.8166;BONE FORMATION#0.8138;SIGNAL TRANSDUCTION#0.8130;COPY NUMBER ALTERATION#0.8098;B CELL LINEAGE COMMITMENT#0.8062;ELECTROPHORETIC MOBILITY SHIFT#0.8044;TRANSCRIPTION FACTOR BINDING#0.8034;LYMPHOID CELL#0.7909;PROTEIN KINASE#0.7822;KINASE INHIBITOR#0.7776;HEMATOPOIETIC PROGENITOR CELL#0.7678;CENTRAL NERVOUS SYSTEM#0.7632;WHITE ADIPOSE TISSUE#0.7627;HEMATOPOIESIS#0.7395;CELL MATURATION#0.7296;CYTOKINE RECEPTOR#0.7262;NEUROGENESIS#0.7059;CELL SURFACE#0.7001;CELL FATE SPECIFICATION#0.6969;ETHYLENE SIGNALING PATHWAY#0.6858;MYELOID CELL#0.6793;STROMAL CELL#0.6765;OLFACTORY RECEPTOR#0.6617;DEMETHYLATION#0.6545;DNA REPAIR#0.6542;MACROPHAGE#0.6535;PLASMA CELL#0.6517;UBIQUITIN#0.6510;GLOMERULAR DEVELOPMENT#0.6342;ENHANCER BINDING#0.6292;IMMUNE RESPONSE#0.6269;SIGNAL TRANSDUCER#0.6205;PROTEASOME#0.6125;OLFACTORY SENSORY NEURON#0.6053
187	ANGIOTENSIN RECEPTOR#1.0621;RECEPTOR AGONIST#1.0525;RECEPTOR INTERNALIZATION#1.0467;RECEPTOR ANTAGONIST#1.0367;POLYMERASE CHAIN REACTION#1.0276;NERVOUS SYSTEM#1.0240;CENTRAL NERVOUS SYSTEM#1.0238;ADIPOSE TISSUE#1.0166;CARDIOVASCULAR SYSTEM#1.0143;SIGNALING PATHWAY#1.0119;SMOOTH MUSCLE CELL#1.0116;MUSCLE CELL#1.0110;SMOOTH MUSCLE#1.0105;BLOOD VESSEL#1.0094;NITRIC OXIDE#1.0089;ENDOTHELIAL CELL#1.0087;ENDOTHELIAL NITRIC OXIDE#1.0086;HYPOXIA#1.0084;CORONARY ARTERY DISEASE#1.0067;GENE EXPRESSION#1.0066;ARTERY DISEASE#1.0065;CORONARY ARTERY#1.0062;CARDIOMYOCYTE#1.0040;HYPERTENSION#1.0028;STEM CELL#1.0023;NITRIC OXIDE SYNTHASE#1.0023;ANGIOGENESIS#1.0006;SKELETAL MUSCLE#0.9990;HUMAN IMMUNODEFICIENCY VIRUS#0.9969;ISCHEMIA#0.9953;CELL PROLIFERATION#0.9931;REVERSE TRANSCRIPTION#0.9930;PROTEIN KINASE#0.9896;VASOPRESSIN#0.9874;APOPTOSIS#0.9853;ARTERY#0.9852;VASCULAR SMOOTH MUSCLE CELL#0.9831;ATHEROSCLEROSIS#0.9770;GROWTH FACTOR#0.9747;OBESE#0.9740;SIGNAL TRANSDUCTION#0.9703;MYOCARDIUM#0.9696;SPINAL CORD#0.9606;ADIPOCYTE#0.9542;HEART DEVELOPMENT#0.9539;ENDOTHELIUM#0.9490;OPIOID RECEPTOR#0.9485;PEPTIDE HORMONE#0.9338;HYPOXIC#0.9323;PULMONARY ARTERIAL HYPERTENSION#0.9248;ENDOTHELIAL GROWTH FACTOR#0.9198;ISCHEMIA REPERFUSION INJURY#0.9186;RECEPTOR BINDING#0.9176;HIGH FAT DIET#0.9173;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9147;VASCULAR ENDOTHELIAL CELL#0.9127;MYOCARDIAL INFARCTION#0.9114;HYPOXIA INDUCIBLE FACTOR#0.9098;HEART DISEASE#0.9076;AKT SIGNALING#0.9029;LIVER DISEASE#0.8995;APOPTOTIC#0.8932;MACROPHAGE#0.8922;PULMONARY HYPERTENSION#0.8904;EMBRYONIC STEM CELL#0.8857;OVARIAN#0.8714;TUMOR NECROSIS FACTOR#0.8686;CARDIAC DEVELOPMENT#0.8665;CELL MIGRATION#0.8633;TRANSMEMBRANE RECEPTOR#0.8574;GASTROINTESTINAL TRACT#0.8521;TYPE 2 DIABETES#0.8508;PROGENITOR CELL#0.8488;DIABETIC RETINOPATHY#0.8469;DIABETES MELLITUS#0.8357;ARGININE#0.8343;MONOCYTE#0.8297;KIDNEY DISEASE#0.8263;HUMAN UMBILICAL VEIN#0.8263;UMBILICAL VEIN#0.8260;PROTEIN KINASE C#0.8260;CYTOPLASM#0.8197;CELL DEATH#0.8088;RENAL FIBROSIS#0.8036;HUMAN EMBRYONIC STEM#0.8003;CHEMOKINE RECEPTOR#0.7990;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7983;AUTOPHAGY#0.7952;CELL ADHESION#0.7947;T CELL#0.7910;HEPATOCELLULAR CARCINOMA#0.7859;INSULIN SECRETION#0.7859;ESSENTIAL HYPERTENSION#0.7855;QUANTITATIVE REAL TIME#0.7761;REGULATION OF BLOOD PRESSURE#0.7725;ANGIOTENSIN TYPE 1#0.7720;CANCER CELL#0.7714;ANGIOTENSIN CONVERTING ENZYME#0.7673;RECEPTOR LIGAND#0.7616;STRUCTURE ACTIVITY RELATIONSHIP#0.7606;GRANULOSA CELL#0.7574;REGENERATION#0.7522;NALOXONE#0.7513;EXTRACELLULAR MATRIX#0.7444;ARGININE VASOPRESSIN#0.7426;ASTROCYTE#0.7395;HYPOTENSIVE#0.7381;VASODILATOR#0.7326;LUTEAL PHASE#0.7266;PANCREATIC ISLET#0.7257;TROPHOBLAST#0.7230;CELL SURFACE#0.7214;LYMPH NODE#0.7209;CARDIOMYOPATHY#0.7165;GLUCOSE HOMEOSTASIS#0.7149;SIMIAN IMMUNODEFICIENCY VIRUS#0.7110;ENDOCYTOSIS#0.7108;CHRONIC HEART FAILURE#0.7010;SIGNALLING PATHWAY#0.6866;TRANSCRIPTION FACTOR#0.6818;LIVER REGENERATION#0.6726;REACTIVE OXYGEN SPECIES#0.6718;VASODILATATION#0.6693;ARTERIOLE#0.6680;CARDIOVASCULAR SYSTEM DEVELOPMENT#0.6597;VASOCONSTRICTION#0.6578;MAMMARY GLAND#0.6540;CLASS A GPCR#0.6524;MESENCHYMAL STEM CELL#0.6514;RESONANCE ENERGY TRANSFER#0.6504;WHITE ADIPOSE TISSUE#0.6504;ATRIAL FIBRILLATION#0.6496;GESTATION#0.6450;TRANSCRIPTASE#0.6425;EPITHELIAL CELL#0.6417;CORECEPTOR ACTIVITY#0.6409;DRINKING BEHAVIOUR#0.6361;HEPATIC STELLATE CELL#0.6309;PRE-ECLAMPSIA#0.6298;DIABETIC NEPHROPATHY#0.6277;VASCULAR DISEASE#0.6276;ENDOPLASMIC RETICULUM#0.6255;VASODILATION#0.6216;OSTEOBLAST#0.6192;CHRONIC KIDNEY DISEASE#0.6177;OVARIAN CANCER#0.6165;VASCULAR CELL#0.6153;PROLIFERATIVE DIABETIC RETINOPATHY#0.6142;GI TRACT#0.6115;FORSKOLIN#0.6106;TUMOR TISSUES#0.6035;DRINKING BEHAVIOR#0.6010
1880	EPSTEIN BARR VIRUS#1.0743;B CELL#1.0602;CELL MIGRATION#1.0571;T CELL#1.0504;IMMUNE RESPONSE#1.0436;IMMUNE CELL#1.0429;DENDRITIC CELL#1.0035;LYMPHOID TISSUE#0.9988;ACTIVATED B CELL#0.9602;GERMINAL CENTER#0.8673;IMMUNE SYSTEM#0.8639;MACROPHAGE#0.8488;ADAPTIVE IMMUNE RESPONSE#0.8392;CHEMOKINE RECEPTOR#0.7920;AUTOIMMUNE DISEASE#0.7849;MULTIPLE SCLEROSIS#0.7789;CELL LOCALIZATION#0.7780;ASTROCYTE#0.7768;CD4+ T CELL#0.7228;MONOCYTE#0.7023;SIGNALLING PATHWAY#0.6926;LYMPHOID CELL#0.6695;PLASMA CELL#0.6694;PERIPHERAL BLOOD#0.6332;TRANSCRIPTION FACTOR#0.6323;HUMORAL IMMUNE RESPONSE#0.6299;TRANSMEMBRANE RECEPTOR#0.6224;PRO-INFLAMMATORY#0.6222;LYMPHOID ORGANS#0.6113;GENE EXPRESSION#0.6091;B LYMPHOCYTE#0.6066
1889	ECE-1 ACTIVITY#1.0979;NEUTRAL ENDOPEPTIDASE 24.11#1.0466;NITRIC OXIDE SYNTHASE#1.0416;ENDOSOME#1.0407;ENDOPEPTIDASE 24.11#1.0402;ANGIOTENSIN CONVERTING ENZYME#1.0390;PHOSPHORAMIDON#1.0351;HUMAN UMBILICAL VEIN#1.0238;UMBILICAL VEIN#1.0236;NITRIC OXIDE#1.0224;UMBILICAL VEIN ENDOTHELIAL CELLS#1.0204;PLASMA MEMBRANE#1.0186;POLYMERASE CHAIN REACTION#1.0153;REVERSE TRANSCRIPTION#1.0146;EPITHELIAL CELL#1.0132;CANCER CELL#1.0124;MEMBRANE FRACTION#1.0076;SMOOTH MUSCLE CELL#1.0068;ENDOTHELIN RECEPTOR#1.0052;PROTEIN KINASE#1.0049;CELL SURFACE#1.0048;ENDOTHELIAL CELL#1.0047;MUSCLE CELL#1.0039;MACROPHAGE#1.0032;ATHEROSCLEROSIS#1.0021;CORONARY ARTERY#1.0009;MYOCARDIUM#1.0007;THIORPHAN#0.9956;INSULIN DEGRADING ENZYME#0.9948;SMOOTH MUSCLE#0.9934;ARTERY#0.9932;GENE EXPRESSION#0.9902;GROWTH FACTOR#0.9892;ENDOTHELIUM#0.9872;VASOCONSTRICTOR#0.9854;PROTEIN KINASE C#0.9838;RECEPTOR ANTAGONIST#0.9832;ALZHEIMER'S DISEASE#0.9831;VASOCONSTRICTION#0.9823;HYPERTENSION#0.9814;TRANSCRIPTION FACTOR#0.9741;BIOFILM FORMATION#0.9720;HYPOXIA#0.9707;PROSTATE CANCER#0.9698;QUANTITATIVE REAL TIME#0.9674;SIGNALING PATHWAY#0.9663;METALLOPROTEASE INHIBITOR#0.9603;APOPTOSIS#0.9574;PULMONARY HYPERTENSION#0.9417;ENDOTHELIAL NITRIC OXIDE#0.9378;NEURAL CREST#0.9363;ENDOTHELIN B RECEPTOR#0.9358;ENZYME INHIBITOR#0.9327;VASCULAR ENDOTHELIAL CELL#0.9318;EDN1 SECRETION#0.9302;INFLAMMATORY CELL#0.9302;CELL PROLIFERATION#0.9293;ENZYME ACTIVITY#0.9250;SUBSTANCE P#0.9242;VASCULAR SMOOTH MUSCLE CELL#0.9217;EARLY ENDOSOME#0.9213;ENDOTHELIN A RECEPTOR#0.9171;ATHEROSCLEROTIC#0.9101;STROMAL CELL#0.9094;PRO-INFLAMMATORY#0.9076;INDUCIBLE NITRIC OXIDE#0.8991;ENDOTHELIAL GROWTH FACTOR#0.8967;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8967;BLOOD VESSEL#0.8897;VIRULENCE#0.8841;MYOCYTES#0.8683;ISCHEMIA#0.8553;CORPUS LUTEUM#0.8465;INDOMETHACIN#0.8461;INFLAMMATORY RESPONSE#0.8378;CORONARY ARTERY DISEASE#0.8354;ARTERY DISEASE#0.8352;KERATINOCYTE#0.8335;TRANSFORMING GROWTH FACTOR#0.8216;ACE INHIBITOR#0.8213;OVARIAN#0.8150;BOSENTAN#0.8084;GRANULOSA CELL#0.8033;PULMONARY ARTERY#0.8007;CARDIOVASCULAR SYSTEM#0.7889;LUTEAL PHASE#0.7876;TRANSCRIPTASE#0.7868;MYOCARDIAL INFARCTION#0.7836;INTRACELLULAR LOCALIZATION#0.7830;REACTIVE OXYGEN SPECIES#0.7820;CONGESTIVE HEART FAILURE#0.7791;MITOGEN ACTIVATED PROTEIN#0.7766;HYPOXIC#0.7709;CARDIOMYOCYTE#0.7639;CAROTID ARTERY#0.7605;CELL ELONGATION#0.7604;RECEPTOR RECYCLING#0.7559;MICROVASCULAR ENDOTHELIAL CELL#0.7543;SECRETORY PATHWAY#0.7514;SYSTOLIC BLOOD PRESSURE#0.7471;ANGIOGENESIS#0.7439;MONOCYTE#0.7436;NERVOUS SYSTEM#0.7432;HYPHAL GROWTH#0.7416;NEPHRON#0.7415;CARDIOMYOPATHY#0.7404;SPINAL CORD#0.7387;CONSTRICTION#0.7348;PROSTACYCLIN#0.7343;HEART DISEASE#0.7337;HEMORRHAGE#0.7319;ADRENAL GLAND#0.7271;PULMONARY FIBROSIS#0.7229;LOW DENSITY LIPOPROTEIN#0.7166;TOXICITY#0.7118;TUMOR NECROSIS FACTOR#0.7074;ARTERIOLE#0.7053;CELL WALL#0.6966;MUTAGENESIS#0.6925;ENDOPLASMIC RETICULUM#0.6922;BRANCHIAL ARCH#0.6904;WOUND HEALING#0.6764;VASODILATOR#0.6759;PEPTIDE HORMONE#0.6748;RECEPTOR BINDING#0.6748;CELLULAR LOCALIZATION#0.6741;ACIDIFICATION#0.6729;MONOCYTE CHEMOTACTIC PROTEIN#0.6711;GLIAL CELL#0.6701;SUPEROXIDE DISMUTASE#0.6670;ENDOPEPTIDASE INHIBITOR#0.6645;AMYLOID PRECURSOR PROTEIN#0.6599;LUTEOLYSIS#0.6597;CATALYTIC ACTIVITY#0.6592;THORACIC AORTA#0.6588;NEUROBLASTOMA#0.6552;GESTATION#0.6524;DEMENTIA#0.6478;ENDOTHELIN TYPE A#0.6411;BLOOD PRESSURE REGULATION#0.6358;LOCALISATION#0.6352;SIGNALOSOME#0.6346;CHRONIC HEART FAILURE#0.6333;AIRWAY SMOOTH MUSCLE#0.6330;SCANNING ELECTRON MICROSCOPY#0.6309;VASCULAR ENDOTHELIUM#0.6306;GLYCOSYLATION#0.6300;PKC ACTIVATION#0.6293;PROTEIN KINASE A#0.6226;MORPHOGENESIS#0.6215;BREAST CANCER#0.6197;CARDIAC NEURAL CREST#0.6192;ARGININE#0.6164;CELL ADHESION#0.6143;CELL GROWTH#0.6134;DIPEPTIDYL PEPTIDASE#0.6052;EPITHELIAL CELL APOPTOSIS#0.6026
1890	TRIFLURIDINE#1.0761;THYMIDINE PHOSPHORYLASE ACTIVITY#1.0736;OROTATE PHOSPHORIBOSYLTRANSFERASE#1.0610;NUCLEOSIDE METABOLISM#1.0570;PHOSPHORYLASE ACTIVITY#1.0563;HEPATOCELLULAR CARCINOMA#1.0472;FACTOR I#1.0444;URIDINE PHOSPHORYLASE#1.0443;PURINE NUCLEOSIDE PHOSPHORYLASE#1.0417;OVARIAN CANCER#1.0367;THYMIDINE PHOSPHORYLASE#1.0363;ADENOSINE DEAMINASE#1.0347;THYMIDINE#1.0312;FIBROBLAST GROWTH FACTOR#1.0297;RENAL CELL CARCINOMA#1.0290;OVARIAN#1.0280;CYTIDINE DEAMINASE#1.0273;URIDINE#1.0268;CERVICAL#1.0266;THYMIDYLATE SYNTHASE#1.0229;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0223;COLORECTAL CARCINOMA#1.0219;THYMIDYLATE#1.0207;ENDOTHELIAL GROWTH FACTOR#1.0199;CELL GROWTH#1.0185;THYMIDINE KINASE#1.0154;GROWTH FACTOR#1.0148;CAPECITABINE#1.0131;CYTIDINE#1.0128;ENDOTHELIAL CELL#1.0114;5-FLUOROURIDINE#1.0106;ADENOSINE#1.0059;DOCETAXEL#1.0032;RIBOSE-1-PHOSPHATE#1.0021;THYMINE#1.0018;ADVANCED GASTRIC CANCER#1.0018;ENDOMETRIAL CANCER#1.0013;BREAST CARCINOMA#1.0009;PYRIMIDINE SALVAGE#1.0000;SQUAMOUS CELL CARCINOMA#0.9990;RIBOSE#0.9987;MTDNA#0.9982;PERIPHERAL BLOOD#0.9980;PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE#0.9976;LUNG CANCER#0.9960;MACROPHAGE#0.9956;TUMOR TISSUES#0.9952;GROWTH FACTOR RECEPTOR#0.9943;DNA SYNTHESIS#0.9938;ENZYME INHIBITOR#0.9912;REVERSE TRANSCRIPTION#0.9912;URACIL#0.9907;OXALIPLATIN#0.9903;2'-DEOXYURIDINE#0.9879;HYPOXIA#0.9874;ERYTHROCYTE#0.9870;PANCREATIC CANCER#0.9864;ANGIOGENESIS#0.9850;AUTOSOMAL RECESSIVE DISEASE#0.9834;XELODA#0.9833;STEM CELL TRANSPLANTATION#0.9830;FLUOROURACIL#0.9828;5 FLUOROURACIL#0.9828;COLORECTAL#0.9827;MITOMYCIN C#0.9824;HUMAN GASTRIC CARCINOMA#0.9822;APOPTOSIS#0.9817;ENZYME ACTIVITY#0.9816;STEM CELL#0.9808;COLORECTAL CANCER#0.9805;BREAST CANCER#0.9805;FDURD#0.9804;MITOCHONDRIAL DNA#0.9800;METASTATIC COLORECTAL CANCER#0.9794;COLON CANCER#0.9790;COLON CARCINOMA#0.9782;EPIDERMAL GROWTH FACTOR#0.9777;CANCER CELL#0.9771;GENE EXPRESSION#0.9771;POLYMERASE CHAIN REACTION#0.9769;CATABOLISM#0.9754;CISPLATIN#0.9751;STROMAL CELL#0.9742;METASTATIC BREAST CANCER#0.9731;ADENOCARCINOMA#0.9729;STROMA#0.9725;CELL MIGRATION#0.9725;CELL PROLIFERATION#0.9716;HYPOXIA INDUCIBLE FACTOR#0.9711;BREAST CANCER PATIENTS#0.9711;TUMOR CELLS#0.9690;NEUROPATHY#0.9684;CYTOTOXICITY#0.9678;FACTOR VIII#0.9655;CERVICAL CANCER#0.9650;IRINOTECAN#0.9643;LEUKOENCEPHALOPATHY#0.9630;LYMPH NODE#0.9618;TUMOR NECROSIS FACTOR#0.9609;APOPTOTIC#0.9587;PACLITAXEL#0.9556;TOXICITY#0.9553;OPHTHALMOPLEGIA#0.9545;CELL CYCLE#0.9506;ENDOTHELIAL CELL MIGRATION#0.9469;HAND FOOT SYNDROME#0.9454;DISEASE FREE SURVIVAL#0.9435;RHEUMATOID ARTHRITIS#0.9410;LYMPH NODE METASTASIS#0.9408;EPITHELIAL OVARIAN CANCER#0.9405;PYRIMIDINE METABOLISM#0.9402;MONOCYTE#0.9396;ADJACENT NORMAL TISSUE#0.9379;FORMALIN#0.9369;NUCLEIC ACID#0.9365;THYMIDINE KINASE 1#0.9343;TRANSCRIPTASE#0.9329;DIHYDROFOLATE REDUCTASE#0.9313;HUMAN BREAST CANCER#0.9284;LIVER METASTASIS#0.9269;ADVANCED COLORECTAL CANCER#0.9259;LUNG CARCINOMA#0.9170;CACHEXIA#0.9155;MITOMYCIN#0.9142;BLOOD VESSEL#0.9132;DIARRHEA#0.9128;CYCLOPHOSPHAMIDE#0.9100;MTDNA REPLICATION#0.9099;MITOCHONDRIA#0.9084;T CELL#0.9067;CYTOPLASM#0.9022;PEAK SYSTOLIC VELOCITY#0.9016;SMOOTH MUSCLE#0.9001;URIDINE KINASE#0.8968;STRUCTURE ACTIVITY RELATIONSHIP#0.8959;ENZYME REPLACEMENT THERAPY#0.8939;MOLAR#0.8933;PTOSIS#0.8879;HEMATOPOIETIC STEM CELL#0.8870;HEAD AND NECK CANCER#0.8855;NECK CANCER#0.8855;PROSTATE CANCER#0.8844;CELL DEATH#0.8821;TRANSCRIPTION FACTOR#0.8811;DRUG RESISTANCE#0.8809;LASER CAPTURE MICRODISSECTION#0.8799;INFLAMMATORY CELL#0.8766;QUANTITATIVE REAL TIME#0.8766;NEUTROPENIA#0.8763;BREAST CANCER CELL#0.8759;DNA POLYMERASE GAMMA#0.8713;MECHANISM OF ACTION#0.8712;TIME TO PROGRESSION#0.8696;BLOOD BRAIN BARRIER#0.8638;ENDOMETRIUM#0.8634;OVERALL RESPONSE RATE#0.8608;LEUCOVORIN#0.8587;TOPOISOMERASE#0.8548;NERVOUS SYSTEM#0.8538;FIBROBLAST LIKE SYNOVIOCYTES#0.8526;MITOCHONDRIAL DISEASE#0.8447;MUSCLE CELL#0.8430;SIGNALING PATHWAY#0.8403;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8401;QUANTITATIVE REVERSE TRANSCRIPTION#0.8364;CATALYTIC ACTIVITY#0.8344;RESPIRATORY CHAIN#0.8242;VASCULAR ENDOTHELIAL CELL#0.8238;DNA REPLICATION#0.8236;ADENINE#0.8229;ESTROGEN RECEPTOR#0.8182;CARCINOMA IN SITU#0.8145;RELAPSE FREE SURVIVAL#0.8117;NUCLEOSIDE SALVAGE#0.8115;ENDOTHELIUM#0.8031;SMOOTH MUSCLE CELL#0.8030;GASTRIC ADENOCARCINOMA#0.8013;GALLBLADDER#0.8011;MYOPATHY#0.7974;ADVANCED BREAST CANCER#0.7953;TUMOR ASSOCIATED MACROPHAGE#0.7879;SKELETAL MUSCLE#0.7866;HERPES SIMPLEX VIRUS#0.7838;HERPES SIMPLEX#0.7835;METHOTREXATE#0.7829;CERVICAL SQUAMOUS CELL CARCINOMA#0.7803;CYTOCHROME C#0.7803;PRIMARY BREAST CANCER#0.7782;INTESTINAL PSEUDO-OBSTRUCTION#0.7778;GEMCITABINE#0.7777;MTDNA DEPLETION SYNDROME#0.7734;PROGESTERONE#0.7709;VOMITING#0.7689;BLOOD PLATELETS#0.7625;MEDIAN OVERALL SURVIVAL#0.7600;TRANSFORMING GROWTH FACTOR#0.7588;DEOXYTHYMIDINE#0.7578;CENTRAL NERVOUS SYSTEM#0.7547;TRIMETHOPRIM#0.7531;NUCLEOTIDE METABOLISM#0.7506;XANTHINE OXIDASE#0.7417;NEUTROPHIL#0.7417;ENDOMETRIAL CARCINOMA#0.7417;LEUKOCYTE#0.7397;B CELL#0.7346;CELL ADHESION MOLECULE#0.7342;MONONUCLEAR CELLS#0.7329;CELL ADHESION#0.7322;ESOPHAGEAL CARCINOMA#0.7303;KERATINOCYTE#0.7283;MAXIMUM TOLERATED DOSE#0.7272;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7240;MAGNETIC RESONANCE IMAGING#0.7206;ENDOTHELIAL CELL PROLIFERATION#0.7205;ORAL SQUAMOUS CELL CARCINOMA#0.7196;KINASE ACTIVITY#0.7191;EXTRACELLULAR MATRIX#0.7173;EPITHELIAL CELL#0.7169;ESOPHAGUS#0.7168;BILIARY TRACT#0.7104;MAST CELL#0.7101;INVASIVE BREAST CARCINOMA#0.7088;INVASIVE CARCINOMA#0.7049;INOSINE#0.7040;MITOCHONDRIAL GENOME#0.7032;DIPHOSPHATE#0.7029;OVARIAN CARCINOMA#0.7029;TAMOXIFEN#0.7024;CERVIX#0.7009;DEOXYCYTIDINE KINASE#0.6957;THYMIDINE KINASE ACTIVITY#0.6947;YEAR SURVIVAL RATE#0.6913;CHEMOTAXIS#0.6912;TRANSITIONAL CELL CARCINOMA#0.6895;COMPLEMENTATION GROUP 1#0.6892;HEPATOCELLULAR CARCINOMA CELL#0.6856;LUNG ADENOCARCINOMA#0.6840;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6822;DNA REPAIR#0.6814;BONE MARROW#0.6782;MEDIAN SURVIVAL TIME#0.6767;FOLATE#0.6764;5-IODOURACIL#0.6748;POSITRON EMISSION TOMOGRAPHY#0.6721;METASTATIC GASTRIC CANCER#0.6683;XANTHINE#0.6676;NON-SMALL CELL LUNG CARCINOMA#0.6612;SMALL INTESTINE#0.6607;BONE RESORPTION#0.6594;EQUILIBRATIVE NUCLEOSIDE TRANSPORTER#0.6579;IFN-GAMMA#0.6519;ERLOTINIB#0.6502;FLUORODEOXYURIDINE#0.6496;CHOLANGIOCARCINOMA#0.6473;MITOCHONDRIAL DNA REPLICATION#0.6469;GLUTATHIONE#0.6463;LIVER CANCER#0.6439;RESPONSE TO 5-FLUOROURACIL#0.6421;HUMAN IMMUNODEFICIENCY VIRUS#0.6418;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6410;HEPARIN#0.6400;TUMOR SUPPRESSOR#0.6397;ASTROCYTE#0.6395;GASTRO#0.6348;THROMBOSIS#0.6285;UMBILICAL VEIN#0.6246;REACTIVE OXYGEN SPECIES#0.6210;TUMOUR NECROSIS FACTOR#0.6205;5 FLUORODEOXYURIDINE#0.6170;OBJECTIVE RESPONSE RATE#0.6156;POLYNEUROPATHY#0.6105;DUCTAL CARCINOMA IN SITU#0.6055;IMMUNE RESPONSE#0.6052;OESOPHAGEAL SQUAMOUS CELL#0.6041;BILIARY TRACT CANCER#0.6023;NEOPLASTIC TISSUES#0.6018
1891	ENOYL COA HYDRATASE#1.1085;COENZYME A#0.9276;PEROXISOMAL#0.8884;GENE EXPRESSION#0.8000;FATTY ACID OXIDATION#0.7802;ADIPOSE TISSUE#0.6978;CELL PROLIFERATION#0.6256;PEROXISOME#0.6040
1892	ENOYL COA HYDRATASE#1.1093;FATTY ACID OXIDATION#1.0309;VALINE#0.9973;COENZYME A#0.9659;CELL PROLIFERATION#0.9604;HEPATOCELLULAR CARCINOMA#0.8675;LIPID METABOLISM#0.8156;FATTY ACID BETA-OXIDATION#0.8105;VALINE METABOLISM#0.8093;CANCER CELL#0.8036;FATTY ACID METABOLISM#0.7889;APOPTOSIS#0.7457;BREAST CANCER#0.7432;MITOCHONDRIA#0.7365;GENE EXPRESSION#0.6939;LACTIC ACIDOSIS#0.6799;CATABOLISM#0.6706;MITOCHONDRIAL MATRIX#0.6541;CUTIS LAXA#0.6470;RESPIRATORY CHAIN#0.6223;LEIGH DISEASE#0.6170;RENAL CELL CARCINOMA#0.6147;COLORECTAL CANCER#0.6056
1893	LIPOID PROTEINOSIS#1.0822;EPIDERMAL GROWTH FACTOR#1.0732;MATRIX PROTEIN 1#1.0654;BREAST CANCER#1.0521;GROWTH FACTOR#1.0517;ANGIOGENESIS#1.0468;EXTRACELLULAR MATRIX#1.0456;LARYNGEAL CARCINOMA#1.0095;CANCER CELL#0.9971;GENE EXPRESSION#0.9946;POLYMERASE CHAIN REACTION#0.9682;CELL PROLIFERATION#0.9614;BASEMENT MEMBRANE#0.9434;HEPATOCELLULAR CARCINOMA#0.9203;BREAST CANCER CELL#0.8856;ULCERATIVE COLITIS#0.8777;BLOOD VESSEL#0.8610;LYMPH NODE#0.8501;CELL ADHESION#0.8341;IMMUNE RESPONSE#0.8181;CONNECTIVE TISSUE#0.8122;BONE FORMATION#0.8120;DERMIS#0.7961;BREAST CARCINOMA#0.7952;WOUND HEALING#0.7640;COLITIS#0.7586;PROTEIN PROTEIN INTERACTION#0.7540;CELL DIFFERENTIATION#0.7515;ENDOTHELIAL CELL#0.7447;THYROID CANCER#0.7377;AUTOSOMAL RECESSIVE DISEASE#0.7367;SIGNALING PATHWAY#0.7287;CELL MIGRATION#0.7283;THYROID CARCINOMA#0.7172;ADOMET#0.7050;STROMAL CELL#0.7031;TUMOR SUPPRESSOR#0.7014;CROHN'S DISEASE#0.6971;KERATINOCYTE#0.6952;METHYLTRANSFERASE ACTIVITY#0.6906;EYELID#0.6830;GROWTH FACTOR RECEPTOR#0.6773;INFLAMMATORY BOWEL DISEASE#0.6544;EPIDERMAL DIFFERENTIATION COMPLEX#0.6392;T CELL#0.6200;KERATINOCYTE DIFFERENTIATION#0.6114;ENDOTHELIAL GROWTH FACTOR#0.6077;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6077;THYROID NODULE#0.6040;HUMORAL IMMUNE RESPONSE#0.6023
1894	RHOGEF#1.0884;CENTRAL SPINDLE#1.0768;NUCLEOTIDE EXCHANGE FACTOR#1.0570;EPITHELIAL CELL#1.0569;CONTRACTILE RING#1.0499;GUANINE#1.0493;LUNG ADENOCARCINOMA#1.0452;CLEAVAGE FURROW#1.0371;BREAST CANCER#1.0291;CYTOKINESIS#1.0265;CENTRALSPINDLIN COMPLEX#1.0259;FURROW#1.0227;CELL CYCLE#1.0179;CANCER CELL#1.0166;CELL PROLIFERATION#1.0064;LUNG CANCER#0.9915;CELL DIVISION#0.9857;CLEAVAGE FURROW FORMATION#0.9839;GENE EXPRESSION#0.9804;MITOSIS#0.9794;M PHASE#0.9762;ONCOGENIC#0.9743;SPINDLE MIDZONE#0.9578;LYMPH NODE METASTASIS#0.9571;ACTOMYOSIN#0.9534;ADENOCARCINOMA#0.9529;LYMPH NODE#0.9526;ANAPHASE#0.9486;SIGNALING PATHWAY#0.9395;MICROTUBULE#0.9337;MIDBODY#0.9098;POLYMERASE CHAIN REACTION#0.9055;RNA INTERFERENCE#0.8990;CELL MIGRATION#0.8827;SQUAMOUS CELL CARCINOMA#0.8798;APOPTOSIS#0.8669;CYTOPLASM#0.8664;CELL POLARITY#0.8602;PANCREATIC CANCER#0.8508;ACTOMYOSIN RING#0.8206;CELL CYCLE REGULATOR#0.8189;PROTEIN KINASE#0.8139;GROWTH FACTOR#0.8016;DISEASE FREE SURVIVAL#0.7799;S PHASE#0.7786;REVERSE TRANSCRIPTION#0.7655;HEPATOCELLULAR CARCINOMA#0.7521;TUMOR TISSUES#0.7506;COLORECTAL CANCER#0.7283;CELL CORTEX#0.7245;INTERPHASE#0.7150;COLORECTAL#0.7138;ASTRAL MICROTUBULE#0.7114;KINESIN#0.6873;RECURRENCE FREE SURVIVAL#0.6843;QUANTITATIVE REAL TIME#0.6789;CENTROSOME#0.6771;TRANSCRIPTION FACTOR#0.6744;CHROMOSOME SEGREGATION#0.6729;SPINDLE LOCALIZATION#0.6715;SPINDLE ASSEMBLY#0.6706;ABSCISSION#0.6470;LUNG SQUAMOUS CELL CARCINOMA#0.6388;ACTIN CYTOSKELETON#0.6385;GTP BINDING#0.6358;LEAF FORMATION#0.6318;CYCLIN DEPENDENT KINASE#0.6316;STEM CELL#0.6302;PROTEIN KINASE C#0.6241;RRNA SYNTHESIS#0.6224;STRESS GRANULE#0.6139;RIBOSOME BIOGENESIS#0.6100;BREAST CANCER CELL#0.6091;SPINDLE MICROTUBULE#0.6084;LIVER REGENERATION#0.6040;PLASMA MEMBRANE#0.6010;MITOTIC SPINDLE#0.6007
1896	APPENDAGE DEVELOPMENT#1.0399;MACROPHAGE#1.0371;HYPOHIDROTIC ECTODERMAL DYSPLASIA#1.0358;ECTODERMAL DYSPLASIA#1.0306;TOOTH AGENESIS#1.0304;MONOCYTE#1.0274;SIGNALING PATHWAY#1.0256;X CHROMOSOME#1.0211;MORPHOGENESIS#1.0183;SWEAT GLAND#1.0125;HAIR FOLLICLE#1.0098;TOOTH DEVELOPMENT#1.0037;TUMOR NECROSIS FACTOR#0.9941;MOLAR#0.9820;GROWTH FACTOR#0.9812;POLYMERASE CHAIN REACTION#0.9808;TRANSCRIPTION FACTOR#0.9805;SALIVARY GLAND#0.9784;MAMMARY GLAND#0.9704;EPITHELIAL CELL#0.9634;T CELL#0.9617;TUMOUR NECROSIS FACTOR#0.9605;APOPTOSIS#0.9560;HYPOHIDROSIS#0.9465;STEM CELL#0.9451;RECEPTOR BINDING#0.9266;GLAND DEVELOPMENT#0.9184;NITRIC OXIDE#0.9111;INCISORS#0.9103;DENDRITIC CELL#0.9101;HYPOTRICHOSIS#0.9031;NEUTROPHIL#0.8978;APOPTOTIC#0.8972;GENETIC DISORDER#0.8962;SIGNALING MOLECULE#0.8922;T LYMPHOCYTE#0.8862;INFLAMMATORY RESPONSE#0.8839;TOOTH MORPHOGENESIS#0.8809;SEBACEOUS GLAND#0.8800;CELL DEATH#0.8794;INFLAMMATORY CELL#0.8762;NITRIC OXIDE SYNTHASE#0.8719;TRANSFORMING GROWTH FACTOR#0.8713;MONONUCLEAR CELLS#0.8625;GENE EXPRESSION#0.8597;CELL PROLIFERATION#0.8506;SMOOTH MUSCLE#0.8485;BRANCHING MORPHOGENESIS#0.8473;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8456;INDUCIBLE NITRIC OXIDE#0.8403;WOUND HEALING#0.8377;REGENERATION#0.8359;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8350;SIGNALLING PATHWAY#0.8336;HAIR GROWTH#0.8028;PERIPHERAL BLOOD#0.7998;NECROTIC#0.7908;KUPFFER CELL#0.7893;MICROGLIAL CELL#0.7830;SMOOTH MUSCLE ACTIN#0.7795;MEIOSIS#0.7778;FIBROBLAST GROWTH FACTOR#0.7769;SPINAL CORD#0.7755;REVERSE TRANSCRIPTION#0.7574;IFN-GAMMA#0.7231;ASTROCYTE#0.7224;BONE MORPHOGENETIC PROTEIN#0.7205;SKELETAL MUSCLE#0.7157;ANHIDROSIS#0.7116;ISCHEMIA#0.7113;NERVOUS SYSTEM#0.7096;TRANSFORMING GROWTH FACTOR BETA#0.7014;ENAMEL ORGAN#0.6974;LEUKOCYTE#0.6924;ORGAN DEVELOPMENT#0.6838;KERATINOCYTE#0.6492;HYPERTHERMIA#0.6395;ARGININE#0.6304;CENTRAL NERVOUS SYSTEM#0.6269;SWEAT GLAND DEVELOPMENT#0.6242;GENETIC DISEASE#0.6233;MUCOUS GLAND#0.6219;DENTAL PULP#0.6213;CELL ADHESION#0.6161;IKK COMPLEX#0.6071;PATTERN FORMATION#0.6024
189	AGT ACTIVITY#1.1032;GLYOXYLATE METABOLISM#1.0741;AMINOTRANSFERASE ACTIVITY#1.0646;CATALYTIC ACTIVITY#1.0598;AUTOSOMAL RECESSIVE DISEASE#1.0577;L-SERINE#1.0493;L-ALANINE#1.0478;PEROXISOMAL#1.0432;PYRUVATE#1.0421;PRIMARY HYPEROXALURIA#1.0394;MITOCHONDRIA#1.0357;ALANINE#1.0342;PYRIDOXAL 5-PHOSPHATE#1.0310;GLYCINE#1.0309;PYRIDOXAL#1.0298;PEROXISOME#1.0281;END STAGE RENAL FAILURE#1.0221;MITOCHONDRION#1.0188;PYRIDOXINE#1.0126;PYRIDOXAL PHOSPHATE#1.0084;NEPHROCALCINOSIS#1.0074;ENZYME ACTIVITY#1.0038;HYDROXYPYRUVATE REDUCTASE#1.0000;KIDNEY DISEASE#0.9971;EXCRETION#0.9864;DETOXIFICATION#0.9799;PROTEIN IMPORT#0.9777;GLYCOLATE OXIDASE#0.9767;VITAMIN B6#0.9706;ORGANELLE#0.9610;NEPHROLITHIASIS#0.9609;STEM CELL#0.9236;ASPARTATE#0.9233;INDUCED PLURIPOTENT STEM CELL#0.9087;GENE EXPRESSION#0.9081;OXALATE SYNTHESIS#0.9070;PLURIPOTENT STEM CELL#0.9065;POLYCYSTIC KIDNEY DISEASE#0.9028;MITOCHONDRIAL PROTEIN IMPORT#0.8643;GLOMERULAR FILTRATION#0.8572;TRANSLATION INITIATION#0.8479;GENETIC DISEASE#0.8442;KIDNEY FAILURE#0.8356;PROTEIN KINASE#0.8271;GLOMERULAR FILTRATION RATE#0.8252;CHRONIC KIDNEY DISEASE#0.8191;GLYCERATE DEHYDROGENASE#0.8160;GENETIC DISORDER#0.8158;POLYMERASE CHAIN REACTION#0.8065;SUCROSE#0.8050;AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE#0.7811;AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY#0.7809;HYDROXYPROLINE#0.7782;PEROXISOMAL MATRIX#0.7624;HISTIDINE#0.7556;HEPATOCELLULAR CARCINOMA#0.7400;ADENOSINE#0.7263;GROWTH FACTOR#0.7177;DIGESTION#0.7046;FETAL LIVER#0.6921;PROTEIN FOLDING#0.6913;BONE DISEASE#0.6833;OPTICAL COHERENCE TOMOGRAPHY#0.6794;ASPARAGINE#0.6786;ACYL COA OXIDASE#0.6592;ORTHOTOPIC LIVER TRANSPLANTATION#0.6570;ZELLWEGER SYNDROME#0.6488;ARGININE#0.6406;BILE DUCT#0.6293;COENZYME BINDING#0.6282;GLUCONEOGENESIS#0.6236;ENZYME REPLACEMENT THERAPY#0.6130;OXALATE SECRETION#0.6116;URINARY TRACT INFECTION#0.6080;RENAL REPLACEMENT THERAPY#0.6040;PROTEIN KINASE A#0.6024
18	GABA TRANSAMINASE ACTIVITY#1.0971;TRANSAMINASE ACTIVITY#1.0688;SUCCINATE SEMIALDEHYDE DEHYDROGENASE#1.0646;GAMMA-VINYL GABA#1.0600;ETHANOLAMINE#1.0501;VIGABATRIN#1.0478;GABA REUPTAKE#1.0419;BETA-ALANINE#1.0357;GABA SHUNT#1.0301;SUCCINATE#1.0278;GLUTAMATE DEHYDROGENASE#1.0240;GLUTAMATE DECARBOXYLASE#1.0226;ALANINE#1.0151;GABA CATABOLISM#1.0123;RECEPTOR AGONIST#1.0113;GLUTAMIC ACID#1.0100;PYRIDOXAL#1.0062;VALPROATE#1.0057;PYRIDOXAL 5-PHOSPHATE#1.0039;ASPARTATE#0.9995;GABACULINE#0.9993;GABA B RECEPTOR#0.9979;GABA METABOLISM#0.9977;VALPROIC ACID#0.9971;BACLOFEN#0.9872;CATABOLISM#0.9840;EPILEPSY#0.9829;GABA A RECEPTOR#0.9795;GLUTAMINE#0.9767;NERVOUS SYSTEM#0.9720;TIAGABINE#0.9704;CENTRAL NERVOUS SYSTEM#0.9693;NEUROTRANSMISSION#0.9648;CONVULSION#0.9645;DOPAMINE#0.9586;MITOCHONDRIA#0.9467;ORNITHINE#0.9456;CATALYTIC ACTIVITY#0.9418;AMINOTRANSFERASE ACTIVITY#0.9364;GABA BINDING#0.9339;RECEPTOR ANTAGONIST#0.9321;ENZYME ACTIVITY#0.9309;STRIATUM#0.9258;GENE EXPRESSION#0.9247;GABA AMINOTRANSFERASE ACTIVITY#0.9218;SUBSTANTIA NIGRA#0.9158;L-GLUTAMATE#0.9150;GABAERGIC NEURON#0.8878;DIAZEPAM#0.8864;MECHANISM OF ACTION#0.8848;CEREBRAL CORTEX#0.8834;ETHANOL#0.8403;PYRIDOXAL PHOSPHATE#0.8373;NEUROLOGICAL DISORDER#0.8353;SYNAPTOSOME#0.8276;BREAST CANCER#0.8267;PICROTOXIN#0.8236;LYSINE#0.8217;ERGIC#0.8170;PYRUVATE#0.7923;DECARBOXYLASE ACTIVITY#0.7874;NERVE TERMINAL#0.7647;BLOOD BRAIN BARRIER#0.7612;MECHANISMS OF ACTION#0.7581;MYELODYSPLASTIC SYNDROME#0.7455;SPINAL CORD#0.7454;GABAPENTIN#0.7369;TOXICITY#0.7316;RECEPTOR BINDING#0.7255;TRICARBOXYLIC ACID CYCLE#0.7213;GLUTAMATE DECARBOXYLASE ACTIVITY#0.7209;TCA CYCLE#0.7047;L-GLUTAMIC ACID#0.6904;BENZODIAZEPINE RECEPTOR#0.6846;PUTRESCINE#0.6836;NERVOUS TISSUE#0.6771;ARGININE#0.6743;BASAL GANGLIA#0.6631;POLYMERASE CHAIN REACTION#0.6544;GLYCINE#0.6509;SODIUM CHANNEL#0.6491;NUCLEOSIDE SALVAGE#0.6466;AMYGDALA#0.6355;HALOPERIDOL#0.6239;GLIAL CELL#0.6017
1901	BREAST CANCER#1.0262;ASTROCYTE#1.0248;SECONDARY LYMPHOID ORGANS#1.0227;RECEPTOR INTERNALIZATION#1.0223;LYMPHOID ORGANS#1.0211;CARDIOMYOCYTE#1.0142;PLASMA MEMBRANE#1.0134;CD4+ T CELL#1.0114;LYMPHOID TISSUE#1.0094;FINGOLIMOD#1.0063;SPHINGOSINE KINASE 1#1.0053;MACROPHAGE#1.0032;B CELL#1.0023;SMOOTH MUSCLE CELL#1.0021;CELL SURFACE#1.0016;CHEMOTAXIS#1.0008;RECEPTOR AGONIST#0.9989;CANCER CELL#0.9987;MUSCLE CELL#0.9984;CD8+ T CELL#0.9980;SMOOTH MUSCLE#0.9962;AUTOIMMUNE DISEASE#0.9958;T CELL#0.9954;SPHINGOSINE#0.9954;VASCULAR SMOOTH MUSCLE CELL#0.9952;SPHINGOSINE 1 PHOSPHATE#0.9948;LYMPH NODE#0.9947;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9946;SPINAL CORD#0.9920;CELL MIGRATION#0.9911;POLYMERASE CHAIN REACTION#0.9910;BLOOD VESSEL#0.9909;IMMUNE RESPONSE#0.9886;MITOGEN ACTIVATED PROTEIN#0.9878;ENDOTHELIAL CELL#0.9876;PROTEIN KINASE C#0.9876;GENE EXPRESSION#0.9875;THYMOCYTE#0.9866;IMMUNE SYSTEM#0.9860;PROTEIN KINASE#0.9858;BONE MARROW#0.9853;LYMPHOPENIA#0.9843;TUMOR CELLS#0.9838;ANGIOGENESIS#0.9830;PLATELET-DERIVED GROWTH FACTOR#0.9827;CELL PROLIFERATION#0.9822;SIGNAL TRANSDUCER#0.9814;IMMUNE CELL#0.9813;MULTIPLE SCLEROSIS#0.9812;PERTUSSIS#0.9802;CENTRAL NERVOUS SYSTEM#0.9795;PERIPHERAL BLOOD#0.9795;NERVOUS SYSTEM#0.9795;DENDRITIC CELL#0.9794;NITRIC OXIDE#0.9789;ISCHEMIA#0.9789;RECEPTOR ANTAGONIST#0.9789;SIGNALING PATHWAY#0.9788;APOPTOSIS#0.9776;ENDOTHELIUM#0.9775;TRANSCRIPTION FACTOR#0.9772;HUMAN UMBILICAL VEIN#0.9756;INFLAMMATORY RESPONSE#0.9754;UMBILICAL VEIN#0.9754;T LYMPHOCYTE#0.9751;CELL ADHESION#0.9750;BLOOD BRAIN BARRIER#0.9729;T CELL MIGRATION#0.9728;KINASE INHIBITOR#0.9723;VASCULAR ENDOTHELIAL CELL#0.9708;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9702;GROWTH FACTOR#0.9699;REGULATORY T CELL#0.9697;ENCEPHALOMYELITIS#0.9691;CELL MOTILITY#0.9680;SIGNAL TRANSDUCTION#0.9678;ARTERY#0.9661;APOPTOTIC#0.9630;SIGNALLING PATHWAY#0.9628;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.9621;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9619;ENDOTHELIAL GROWTH FACTOR#0.9618;B CELL LYMPHOMA#0.9597;MONOCYTE#0.9567;CELL GROWTH#0.9504;STEM CELL#0.9491;TUMOR NECROSIS FACTOR#0.9491;TREG CELL#0.9448;PROGENITOR CELL#0.9436;STRUCTURE ACTIVITY RELATIONSHIP#0.9433;CHEMOKINE RECEPTOR#0.9427;LEUKOCYTE#0.9423;EPITHELIAL CELL#0.9387;PRO-INFLAMMATORY#0.9323;MAP KINASE#0.9265;ENDOTHELIAL CELL MIGRATION#0.9242;SIGNALING MOLECULE#0.9218;PHOSPHOLIPASE C#0.9217;COLITIS#0.9149;RAPAMYCIN#0.9144;HIGH DENSITY LIPOPROTEIN#0.9133;TRANSACTIVATION#0.9123;CELL CHEMOTAXIS#0.9116;CELL DEATH#0.9058;STROMAL CELL#0.9029;KINASE ACTIVITY#0.9028;GROWTH FACTOR RECEPTOR#0.9025;HETEROTRIMERIC G-PROTEIN#0.8981;CELL ACTIVATION#0.8966;CELL ADHESION MOLECULE#0.8966;AUTOIMMUNITY#0.8951;TUBE FORMATION#0.8920;QUANTITATIVE REAL TIME#0.8892;BREAST CANCER CELL#0.8889;RHEUMATOID ARTHRITIS#0.8888;MECHANISM OF ACTION#0.8871;OLIGODENDROCYTE#0.8768;SPHINGOLIPID METABOLISM#0.8766;HYPOXIA#0.8755;ENDOPLASMIC RETICULUM#0.8748;MORPHOGENESIS#0.8735;MYELOID CELL#0.8733;DIFFUSE LARGE B-CELL LYMPHOMA#0.8699;NITRIC OXIDE SYNTHASE#0.8694;REVERSE TRANSCRIPTION#0.8672;ISCHEMIA REPERFUSION INJURY#0.8604;MEMORY T CELL#0.8564;INFLAMMATORY BOWEL DISEASE#0.8547;CELL DIFFERENTIATION#0.8487;BRADYCARDIA#0.8481;DRAINING LYMPH NODE#0.8434;S1P SIGNALING PATHWAY#0.8409;TOXICITY#0.8402;CYTOKINE PRODUCTION#0.8396;TH17 CELL#0.8391;OVARIAN#0.8376;B LYMPHOCYTE#0.8358;RNA INTERFERENCE#0.8354;WOUND HEALING#0.8343;MESANGIAL CELL#0.8339;ADHERENS JUNCTION#0.8286;RECEPTOR TYROSINE KINASE#0.8270;AKT SIGNALING#0.8257;IMMUNOSUPPRESSANT#0.8225;HEPATOCELLULAR CARCINOMA#0.8218;IMMUNE CELL TRAFFICKING#0.8170;ATHEROSCLEROSIS#0.8155;ACTIVATED PROTEIN C#0.8126;NUCLEOTIDE BINDING#0.8095;ADRENERGIC RECEPTOR#0.8087;ADENYLATE CYCLASE#0.8082;CELL MEMBRANE#0.8067;MAST CELL#0.8021;EMBRYONIC KIDNEY#0.7978;SELECTIN#0.7950;LIVER METASTASIS#0.7943;EFFECTOR T CELL#0.7829;GLIAL CELL#0.7739;EPIDERMAL GROWTH FACTOR#0.7734;LYMPHATIC ENDOTHELIAL CELL#0.7684;ACUTE LUNG INJURY#0.7640;REACTIVE OXYGEN SPECIES#0.7610;MURAL CELL#0.7609;ULCERATIVE COLITIS#0.7601;VENULE#0.7580;MICROVASCULAR ENDOTHELIAL CELL#0.7572;VASCULAR CELL#0.7554;BREAST CANCER PATIENTS#0.7508;PROTEASE ACTIVATED RECEPTOR#0.7505;OVARIAN CANCER#0.7494;ENDOTHELIAL NITRIC OXIDE#0.7459;GUANINE#0.7454;ALZHEIMER'S DISEASE#0.7420;ACTIVATED T-CELLS#0.7392;PRECURSOR CELL#0.7391;ACTIVATED T CELL#0.7389;TARGET OF RAPAMYCIN#0.7320;TRANSFORMING GROWTH FACTOR#0.7298;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7246;PLASMA CELL#0.7242;LYMPHOCYTIC LEUKEMIA#0.7238;CELL DEVELOPMENT#0.7234;RECEPTOR ACTIVATOR#0.7227;HUMAN EMBRYONIC KIDNEY#0.7221;PSORIASIS#0.7196;VASCULAR ENDOTHELIUM#0.7188;NEUTROPHIL#0.7176;ENDOCYTOSIS#0.7156;ADENOSINE#0.7140;LYMPHOCYTE MIGRATION#0.7127;EDEMA#0.7096;MESENCHYMAL STEM CELL#0.7088;SKELETAL MUSCLE#0.7068;NATURAL KILLER T#0.7068;GLYCOPROTEIN TRANSPORT#0.7030;FOCAL ADHESION#0.7007;HYPERTENSION#0.6995;SIGNALING CASCADE#0.6987;REGENERATION#0.6976;CELL CYCLE#0.6944;LYMPHANGIOGENESIS#0.6936;HYPERSENSITIVITY#0.6850;CAROTID ARTERY#0.6843;LIGAND BINDING POCKET#0.6835;INFLAMMATORY CELL#0.6833;TRANSCRIPTASE#0.6831;HISTONE DEACETYLASE#0.6830;BONE REMODELING#0.6800;SURAMIN#0.6799;STRESS FIBER#0.6775;TOPICAL#0.6759;LYMPHATIC VESSEL#0.6748;COLORECTAL CANCER#0.6722;FIBROBLAST GROWTH FACTOR#0.6707;ADENYLATE#0.6672;OSTEOCLAST#0.6660;ENERGY HOMEOSTASIS#0.6657;CARDIOVASCULAR SYSTEM#0.6652;ATHEROSCLEROTIC#0.6647;CYTOPLASM#0.6487;SMOOTH MUSCLE ACTIN#0.6451;TIGHT JUNCTION#0.6446;PACLITAXEL#0.6424;AUTOPHAGY#0.6417;PARENCHYMA#0.6331;CYCLOSPORINE#0.6302;TROPHOBLAST CELL#0.6291;BONE RESORPTION#0.6255;HEMORRHAGE#0.6244;INSULIN-LIKE GROWTH FACTOR#0.6238;PERIODONTITIS#0.6205;ENDOTHELIAL CELL CHEMOTAXIS#0.6194;COLORECTAL#0.6190;RECEPTOR DEGRADATION#0.6161;GLYCOSYLATION#0.6161;PERICYTE#0.6132;SQUAMOUS CELL CARCINOMA#0.6122;ERYTHROCYTE#0.6049;MACROPHAGE MIGRATION#0.6041;COLITIS ASSOCIATED CANCER#0.6040;OPTIC NERVE#0.6019;MEMBRANE RUFFLING#0.6010;GRANULOSA CELL#0.6001
1902	BREAST CANCER#1.0300;RECEPTOR ANTAGONIST#1.0245;PULMONARY FIBROSIS#1.0158;RESPONSE TO LPA#1.0118;OVARIAN CANCER#1.0077;CELL MOTILITY#1.0070;CELL SURFACE#1.0025;CELL MIGRATION#1.0018;EPITHELIAL CELL#1.0014;OVARIAN#0.9986;CANCER CELL#0.9972;ENDOTHELIAL CELL#0.9960;APOPTOSIS#0.9948;SPHINGOSINE#0.9927;SPHINGOSINE 1 PHOSPHATE#0.9925;CELL PROLIFERATION#0.9872;GENE EXPRESSION#0.9866;PANCREATIC CANCER#0.9819;SIGNALING PATHWAY#0.9796;PROTEIN KINASE#0.9756;GROWTH FACTOR#0.9697;PERTUSSIS#0.9669;SMOOTH MUSCLE#0.9605;POLYMERASE CHAIN REACTION#0.9597;T CELL#0.9546;STEM CELL#0.9535;MITOGEN ACTIVATED PROTEIN#0.9514;BREAST CANCER CELL#0.9480;STROMAL CELL#0.9476;PHOSPHOLIPASE C#0.9434;NERVOUS SYSTEM#0.9313;PROSTATE CANCER#0.9311;MYELINATION#0.9295;TRANSMEMBRANE RECEPTOR#0.9100;CEREBRAL CORTEX#0.9099;SIGNALING MOLECULE#0.9026;NEUROGENESIS#0.8943;SCHWANN CELL#0.8868;IDIOPATHIC PULMONARY FIBROSIS#0.8850;ANGIOGENESIS#0.8836;WOUND HEALING#0.8757;TUMOR CELLS#0.8750;QUANTITATIVE REAL TIME#0.8737;ENDOTHELIAL GROWTH FACTOR#0.8641;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8641;REVERSE TRANSCRIPTION#0.8635;PROTEIN KINASE C#0.8567;EXTRACELLULAR MATRIX#0.8557;EPIDERMAL GROWTH FACTOR#0.8555;OLIGODENDROCYTE#0.8521;PLASMA MEMBRANE#0.8508;TRANSCRIPTION FACTOR#0.8498;ENDOMETRIUM#0.8424;CHEMOTAXIS#0.8419;GROWTH FACTOR RECEPTOR#0.8371;AKT SIGNALING#0.8224;BONE CANCER#0.8171;SIGNALING CASCADE#0.8154;CELL GROWTH#0.8008;MACROPHAGE#0.8007;ADENOCARCINOMA#0.7953;PROGENITOR CELL#0.7793;STRESS FIBER#0.7744;PERIPHERAL NERVE#0.7718;TRANSFORMING GROWTH FACTOR#0.7673;SMOOTH MUSCLE CELL#0.7671;MUSCLE CELL#0.7665;SPINAL CORD#0.7632;FIBROBLAST PROLIFERATION#0.7571;BRAIN DEVELOPMENT#0.7502;SMOOTH MUSCLE ACTIN#0.7498;SCIATIC NERVE#0.7498;OSTEOBLAST#0.7488;SIGNAL TRANSDUCTION#0.7459;BONE MARROW#0.7447;BLEOMYCIN#0.7411;LYMPH NODE#0.7399;CELL CYCLE#0.7375;MYO-INOSITOL#0.7297;MAP KINASE#0.7273;CELL ADHESION#0.7243;TISSUE GROWTH FACTOR#0.7029;COLON CANCER#0.7023;REPORTER GENE ASSAY#0.7018;KINASE INHIBITOR#0.7004;BREAST CARCINOMA#0.6979;CONNECTIVE TISSUE#0.6971;DORSAL ROOT GANGLION#0.6926;SPINAL CORD INJURY#0.6915;HUMAN UMBILICAL VEIN#0.6891;UMBILICAL VEIN#0.6889;ASTROCYTE#0.6878;DNA METHYLATION#0.6876;ASCITES#0.6861;UTERUS#0.6846;HEPATOMA CELLS#0.6766;MESENCHYMAL STEM CELL#0.6759;MUTAGENESIS#0.6749;HEPATOCELLULAR CARCINOMA#0.6705;TUMOR NECROSIS FACTOR#0.6679;PERIPHERAL BLOOD#0.6667;TRANSFORMING GROWTH FACTOR BETA#0.6658;HETEROTRIMERIC G-PROTEIN#0.6561;OSTEOARTHRITIS#0.6528;RECEPTOR TYROSINE KINASE#0.6489;GLIAL CELL#0.6478;RHEUMATOID ARTHRITIS#0.6472;NEUTROPHIL#0.6470;COLORECTAL#0.6453;TRANSACTIVATION#0.6356;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6313;MONOCYTE#0.6271;LIPID PHOSPHATE PHOSPHATASE#0.6247;PERIPHERAL NERVE INJURY#0.6140;NEUROBLASTOMA#0.6120;LUNG FIBROBLASTS#0.6104;IL-6 PRODUCTION#0.6087;ARTERY#0.6073;CALCIUM MOBILIZATION#0.6037;OLIGODENDROCYTE DIFFERENTIATION#0.6033
1903	SPHINGOSINE KINASE 1#1.0039;CELL MIGRATION#0.9982;BREAST CANCER#0.9975;ENDOTHELIAL CELL#0.9951;RECEPTOR AGONIST#0.9863;SIGNALING PATHWAY#0.9852;CANCER CELL#0.9839;SURAMIN#0.9835;BONE MARROW#0.9816;SPHINGOSINE#0.9807;ANGIOGENESIS#0.9806;SPHINGOSINE 1 PHOSPHATE#0.9800;PERTUSSIS#0.9796;GROWTH FACTOR#0.9792;SMOOTH MUSCLE#0.9786;APOPTOSIS#0.9774;EPITHELIAL CELL#0.9766;MACROPHAGE#0.9729;PROTEIN KINASE#0.9719;CELL PROLIFERATION#0.9710;FINGOLIMOD#0.9633;MUSCLE CELL#0.9541;PHOSPHOLIPASE C#0.9498;SMOOTH MUSCLE CELL#0.9497;MULTIPLE SCLEROSIS#0.9446;NITRIC OXIDE#0.9407;CELL SURFACE#0.9386;BREAST CANCER CELL#0.9379;MONOCYTE#0.9366;GENE EXPRESSION#0.9318;CHEMOTAXIS#0.9241;DENDRITIC CELL#0.9240;KINASE INHIBITOR#0.9196;INFLAMMATORY RESPONSE#0.9183;POLYMERASE CHAIN REACTION#0.9139;STEM CELL#0.9055;T CELL#0.9037;B CELL#0.9001;HIGH DENSITY LIPOPROTEIN#0.8928;MITOGEN ACTIVATED PROTEIN#0.8866;CELL GROWTH#0.8824;ASTROCYTE#0.8680;SIGNALLING PATHWAY#0.8674;ISCHEMIA#0.8646;APOPTOTIC#0.8303;PROGENITOR CELL#0.8289;TUBE FORMATION#0.8269;ISCHEMIA REPERFUSION INJURY#0.8263;HUMAN UMBILICAL VEIN#0.8222;UMBILICAL VEIN#0.8220;VASCULAR SMOOTH MUSCLE CELL#0.8134;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7903;SIGNAL TRANSDUCTION#0.7862;ARTERY#0.7849;NERVOUS SYSTEM#0.7753;IMMUNE RESPONSE#0.7747;NITRIC OXIDE SYNTHASE#0.7683;TUMOR NECROSIS FACTOR#0.7662;ACUTE LUNG INJURY#0.7593;CELL DIFFERENTIATION#0.7561;TRANSFORMING GROWTH FACTOR#0.7474;PRO-INFLAMMATORY#0.7412;GROWTH FACTOR RECEPTOR#0.7405;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7359;ENDOTHELIAL GROWTH FACTOR#0.7358;RECEPTOR ANTAGONIST#0.7252;LYMPH NODE#0.7249;ENDOTHELIUM#0.7186;ATHEROSCLEROSIS#0.7085;CARDIOMYOCYTE#0.7078;VASCULAR ENDOTHELIAL CELL#0.7058;REVERSE TRANSCRIPTION#0.6957;BLOOD BRAIN BARRIER#0.6952;MYOFIBROBLAST#0.6936;GLIAL CELL#0.6894;TRANSCRIPTION FACTOR#0.6848;CELL CYCLE#0.6836;WOUND HEALING#0.6614;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6522;CELL MOTILITY#0.6510;CELL DEATH#0.6446;AUTOIMMUNE DISEASE#0.6306;EPIDERMAL GROWTH FACTOR#0.6287;PERIPHERAL BLOOD#0.6275;RNA INTERFERENCE#0.6256;SMOOTH MUSCLE ACTIN#0.6175;MAP KINASE#0.6171;MORPHOGENESIS#0.6136;RESPIRATORY DISTRESS#0.6090;BACTERIAL SEPSIS#0.6077;ENDOTHELIAL CELL MIGRATION#0.6075;MEMBRANE RUFFLING#0.6054;MYOGENIC CELL#0.6031;SKELETAL MUSCLE#0.6020;CENTRAL NERVOUS SYSTEM#0.6016;NOTCH SIGNALING PATHWAY#0.6003
1906	EDN1 SECRETION#1.1543;ENDOTHELIN-1 SECRETION#1.0656;GASTRIC ULCER#1.0442;NEOPTERIN#1.0399;CIRCULATING ENDOTHELIAL CELL#1.0398;AMNIOTIC FLUID#1.0397;OVARIAN CARCINOMA#1.0369;RESPONSE TO ENDOTHELIN#1.0345;POLYMORPHONUCLEAR LEUKOCYTES#1.0318;MALIGNANT HYPERTENSION#1.0316;NORMAL TENSION GLAUCOMA#1.0314;ASYMMETRIC DIMETHYLARGININE#1.0270;UMBILICAL ARTERY#1.0244;OPHTHALMIC ARTERY#1.0232;BRONCHIAL EPITHELIAL CELLS#1.0231;ALDOSTERONE SECRETION#1.0219;STEM CELL FACTOR#1.0202;CELLULAR ADHESION MOLECULE#1.0188;FOCAL CEREBRAL ISCHEMIA#1.0188;MYOMETRIUM#1.0184;HUMAN PULMONARY ARTERY#1.0177;PERSISTENT PULMONARY HYPERTENSION#1.0173;PROSTAGLANDIN I2#1.0172;MITOGENIC ACTIVITY#1.0171;PRIMARY PULMONARY HYPERTENSION#1.0164;TISSUE GROWTH FACTOR#1.0160;CAROTID BODY#1.0155;PRIMARY OPEN ANGLE GLAUCOMA#1.0152;HEPATOCYTE GROWTH FACTOR#1.0151;MACROPHAGE INFLAMMATORY PROTEIN#1.0146;GLYCERYL TRINITRATE#1.0139;ADRENALINE#1.0136;MONOCYTE CHEMOTACTIC PROTEIN#1.0135;METHACHOLINE#1.0131;HEPATOPULMONARY SYNDROME#1.0122;CARDIAC ARREST#1.0120;FLOW MEDIATED VASODILATION#1.0119;GRANULOSA CELL#1.0119;POTASSIUM CHLORIDE#1.0118;METHOXAMINE#1.0117;BONE MORPHOGENETIC PROTEIN#1.0115;CORD BLOOD#1.0113;ENDOTHELIN TYPE B#1.0112;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0106;PROLIFERATIVE DIABETIC RETINOPATHY#1.0102;SELECTIN#1.0097;OPEN ANGLE GLAUCOMA#1.0093;FIBRINOGEN#1.0084;AIRWAY EPITHELIAL CELL#1.0084;PHOSPHOLIPASE D#1.0083;BREAST CANCER#1.0081;BLOOD PLASMA#1.0078;DUCTUS ARTERIOSUS#1.0077;CORTISOL#1.0077;RESPONSE TO NOREPINEPHRINE#1.0076;ADVANCED GLYCATION END#1.0075;NEONATAL RAT CARDIOMYOCYTES#1.0075;CEREBRAL ARTERY OCCLUSION#1.0072;RESPONSE TO ANGIOTENSIN#1.0068;TYROSINE KINASE 1#1.0066;SICKLE CELL DISEASE#1.0064;CONGENITAL HEART DISEASE#1.0064;PRE-ECLAMPSIA#1.0054;BETA-ESTRADIOL#1.0052;ISOPRENALINE#1.0046;MAST CELL#1.0046;CARBACHOL#1.0045;RESPIRATORY DISTRESS#1.0043;CHRONIC INTERMITTENT HYPOXIA#1.0039;PANCREATITIS#1.0038;DUCT CELL#1.0037;CARVEDILOL#1.0036;CARDIAC TROPONIN I#1.0034;FLOW MEDIATED DILATATION#1.0033;PODOCYTE#1.0032;URINARY BLADDER#1.0031;PULMONARY ARTERY HYPERTENSION#1.0028;VENTRICULAR CARDIOMYOCYTE#1.0028;AORTIC SMOOTH MUSCLE CELLS#1.0027;TRACHEA#1.0027;HUMAN BRONCHIAL EPITHELIAL#1.0027;T- PA#1.0026;TUMOUR NECROSIS FACTOR#1.0025;CELL ADHESION MOLECULE#1.0025;SMALL MESENTERIC ARTERIES#1.0024;UMBILICAL CORD#1.0020;ARGININE VASOPRESSIN#1.0019;PLATELET ACTIVATING FACTOR#1.0016;PULMONARY VEIN#1.0014;CHROMAFFIN CELL#1.0014;ECLAMPSIA#1.0012;BETA-2#1.0010;C REACTIVE PROTEIN#1.0008;MESANGIAL CELL#1.0008;HEME OXYGENASE 1#1.0006;CATION CHANNEL#1.0003;EPINEPHRINE#1.0002;LUTEOLYSIS#1.0001;BRAIN NATRIURETIC PEPTIDE#1.0000;PROSTATE CANCER#1.0000;SUBSTANCE P#1.0000;RAYNAUD’S#1.0000;GLUCOSE UPTAKE#0.9999;GASTRIC MUCOSA#0.9999;PHENYLEPHRINE#0.9998;ADRENOCORTICAL CARCINOMA#0.9998;GM-CSF#0.9995;NORADRENALINE#0.9995;BILE DUCT LIGATED#0.9995;ADIPOCYTE#0.9995;MELANOCYTE#0.9994;PROSTACYCLIN#0.9992;FIBROBLAST GROWTH FACTOR#0.9992;NERVE GROWTH FACTOR#0.9992;URIC ACID#0.9992;COLLAGEN SYNTHESIS#0.9989;ALDOSTERONE#0.9988;NORLEUCINE#0.9981;JUGULAR VEIN#0.9980;ACUTE ISCHEMIC STROKE#0.9978;KERATINOCYTE#0.9976;GRANULOCYTE#0.9976;GLUCOSE TRANSPORT#0.9973;SIMVASTATIN#0.9972;OBSTRUCTIVE SLEEP APNEA#0.9971;MIDDLE CEREBRAL ARTERY#0.9971;VASOPRESSIN#0.9971;PLATELET-DERIVED GROWTH FACTOR#0.9970;COLONY-STIMULATING FACTOR#0.9969;SILDENAFIL#0.9964;INDUCIBLE NITRIC OXIDE#0.9964;PARATHYROID HORMONE#0.9964;NOREPINEPHRINE#0.9962;CYCLIC GUANOSINE MONOPHOSPHATE#0.9961;INTERSTITIAL LUNG DISEASE#0.9961;DIABETIC RETINOPATHY#0.9961;COLORECTAL#0.9959;CREATINE KINASE#0.9957;PERICYTE#0.9957;COLORECTAL CANCER#0.9956;OPTIC NERVE HEAD#0.9956;PARATHYROID#0.9953;HISTAMINE#0.9953;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9951;SUPERIOR COLLICULUS#0.9950;MECLOFENAMATE#0.9950;ENDOTHELIAL GROWTH FACTOR#0.9950;OSTEOBLAST#0.9948;TROPHOBLAST#0.9946;FLOW MEDIATED DILATION#0.9946;VASOCONSTRICTOR#0.9945;ILOPROST#0.9943;INTIMA MEDIA THICKNESS#0.9942;CYCLIC ADENOSINE MONOPHOSPHATE#0.9941;CEREBRAL ARTERY#0.9940;RENIN ACTIVITY#0.9939;LOCALISATION#0.9937;ENDOTHELIN TYPE A#0.9934;METALLOPROTEINASE INHIBITOR#0.9933;PULMONARY FIBROSIS#0.9933;VASCULAR CELL#0.9933;GAP JUNCTION#0.9932;CORTICOTROPIN#0.9931;NOCICEPTION#0.9930;ENDOPEPTIDASE 24.11#0.9930;NEUTRAL ENDOPEPTIDASE 24.11#0.9928;TRANSFORMING GROWTH FACTOR BETA#0.9920;AMNION#0.9919;ASTROCYTE#0.9918;PHOSPHOLIPASE A2#0.9916;OVARIAN CANCER#0.9915;CEREBRAL ISCHEMIA#0.9914;CORPUS LUTEUM#0.9912;BASILAR ARTERY#0.9911;STRIATUM#0.9910;ATRIAL FIBRILLATION#0.9906;CELL ADHESION#0.9905;OPTIC NERVE#0.9905;ADENOSINE MONOPHOSPHATE#0.9904;ALPHA1 ADRENOCEPTOR#0.9903;AIRWAY SMOOTH MUSCLE#0.9902;TRANSACTIVATION#0.9902;MAP KINASE#0.9901;PROTEIN KINASE C ACTIVATION#0.9900;L-NNA#0.9896;ETHANOL#0.9896;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9893;DILATED CARDIOMYOPATHY#0.9893;TRAUMATIC BRAIN INJURY#0.9892;PLATELET AGGREGATION#0.9891;ENDOMETRIUM#0.9891;TRANSFORMING GROWTH FACTOR#0.9891;CYCLOSPORINE#0.9890;ACUTE PANCREATITIS#0.9890;RENOVASCULAR HYPERTENSION#0.9889;NIMODIPINE#0.9888;TOPICAL#0.9888;SLEEP APNEA#0.9887;NITRIC OXIDE SYNTHESIS#0.9885;OVARIAN#0.9882;SMALL INTESTINE#0.9881;LUNG FIBROBLASTS#0.9880;TUBULAR EPITHELIAL CELL#0.9880;CARDIOMYOCYTE#0.9874;MEMBRANE DEPOLARIZATION#0.9874;PROSTAGLANDIN E2#0.9873;PKC ACTIVITY#0.9873;CHRONIC HEART FAILURE#0.9873;HUMAN ADRENOCORTICAL CARCINOMA#0.9872;MULTIPLE SCLEROSIS#0.9871;ISCHEMIC HEART DISEASE#0.9870;PULSE WAVE VELOCITY#0.9867;ACUTE MYOCARDIAL INFARCTION#0.9866;LUNG DISEASE#0.9865;ENDOTHELIAL NITRIC OXIDE#0.9861;HEMORRHAGIC#0.9861;CYCLIC AMP#0.9860;BONE FORMATION#0.9860;ENDOTHELIAL PROGENITOR CELL#0.9859;URINARY PROTEIN#0.9857;LEFT VENTRICULAR MASS#0.9856;TYPE 2 DIABETIC#0.9854;ENDOTHELIN B RECEPTOR#0.9853;ASCITES#0.9852;PULMONARY EDEMA#0.9852;CARDIAC MUSCLE#0.9850;GLOMERULONEPHRITIS#0.9848;ARTERIOSCLEROSIS#0.9847;ISOPROTERENOL#0.9845;LIVER CIRRHOSIS#0.9844;FIBROBLAST PROLIFERATION#0.9844;RESPONSE TO HYPOXIA#0.9843;DOPAMINE#0.9843;CALCIUM MOBILIZATION#0.9842;HYPERCHOLESTEROLEMIA#0.9842;NICARDIPINE#0.9842;ALANINE#0.9841;ENDOTHELIN A RECEPTOR#0.9841;VASCULAR ENDOTHELIAL CELL#0.9841;TOLL LIKE RECEPTOR#0.9840;NITRIC OXIDE SYNTHASE ACTIVITY#0.9839;MYOCYTES#0.9838;HEPATIC STELLATE CELL#0.9837;HYPOXIA INDUCIBLE FACTOR#0.9836;DEXAMETHASONE#0.9834;NITRIC OXIDE#0.9833;SPHINGOSINE 1 PHOSPHATE#0.9833;ADRENAL CORTEX#0.9833;CEREBRAL CORTEX#0.9833;IFN-GAMMA#0.9832;TUMOR NECROSIS FACTOR#0.9832;LEUKOCYTE ADHESION#0.9831;KUPFFER CELL#0.9831;GUANOSINE#0.9830;FORELIMB#0.9830;NITROGLYCERIN#0.9829;CYTOCHROME P450#0.9828;INSULIN-LIKE GROWTH FACTOR#0.9828;MONOCYTE#0.9828;MIGRAINE#0.9828;SPINAL CORD#0.9828;ENDOTHELIUM-DERIVED RELAXING FACTOR#0.9826;CREATINE#0.9825;ALPHA ADRENOCEPTOR#0.9824;PEROXISOME#0.9824;ESTRADIOL#0.9823;OXYGENASE#0.9823;RETINAL GANGLION CELL#0.9823;DILTIAZEM#0.9823;CONGESTIVE HEART FAILURE#0.9819;HEART RATE VARIABILITY#0.9819;COLLAGEN TYPE I#0.9819;CYCLOSPORIN#0.9815;ASPARTATE#0.9815;PEPTIDE HORMONE#0.9814;INCREASED BLOOD PRESSURE#0.9814;BRAIN DAMAGE#0.9814;L-TYPE CALCIUM CHANNEL#0.9813;NOS ACTIVITY#0.9813;ADRENERGIC RECEPTOR#0.9812;SCLERODERMA#0.9812;SMOOTH MUSCLE CELL PROLIFERATION#0.9810;GROWTH FACTOR#0.9809;LUNG CANCER#0.9809;MESENTERY#0.9809;MITRAL VALVE#0.9808;MUSCLE CELL PROLIFERATION#0.9808;ALVEOLAR MACROPHAGE#0.9808;BILE DUCT LIGATION#0.9806;NEURAL CREST#0.9806;ADRENAL GLAND#0.9806;CRANIOFACIAL DEVELOPMENT#0.9805;CYCLOSPORIN A#0.9805;STROMAL CELL#0.9804;BILE DUCT#0.9802;BRAIN ISCHEMIA#0.9802;MEMBRANE FRACTION#0.9802;HEPARIN#0.9802;WOUND HEALING#0.9802;MESENTERIC ARTERY#0.9802;PROTEIN TYROSINE KINASE#0.9801;PROXIMAL TUBULAR CELL#0.9800;ACUTE LUNG INJURY#0.9798;PROGENITOR CELL#0.9798;NITROGEN OXIDE#0.9797;MOLAR#0.9796;GLIAL CELL#0.9796;RECEPTOR TRANSACTIVATION#0.9795;PULMONARY VASCULAR REMODELING#0.9795;NMDA RECEPTOR#0.9795;NITRIC OXIDE SYNTHASE#0.9794;ARACHIDONIC ACID#0.9794;HYPERSENSITIVITY#0.9792;PORTAL HYPERTENSION#0.9791;EPIDERMAL GROWTH FACTOR#0.9789;TYPE 2 DIABETES MELLITUS#0.9788;ENDOTHELIUM DEPENDENT VASODILATATION#0.9788;ACE ACTIVITY#0.9788;TESTOSTERONE#0.9787;BRAIN EDEMA#0.9787;ALKALINE PHOSPHATASE#0.9786;HYPOXIA#0.9786;UTERUS#0.9785;SPHINGOSINE#0.9785;BETA ADRENOCEPTOR#0.9784;MICROVASCULAR ENDOTHELIAL CELL#0.9784;2 DIABETES MELLITUS#0.9783;ESSENTIAL HYPERTENSION#0.9782;RETINAL DETACHMENT#0.9781;BLOOD PRESSURE REGULATION#0.9780;ENDOPLASMIC RETICULUM STRESS#0.9779;TO THE PROGRESSION#0.9779;RESVERATROL#0.9778;QUERCETIN#0.9778;SMOOTH MUSCLE CONTRACTION#0.9776;CONNECTIVE TISSUE#0.9776;BLOOD BRAIN BARRIER#0.9775;PRO-INFLAMMATORY#0.9773;DERMAL FIBROBLAST#0.9773;BONE MARROW#0.9772;CAPTOPRIL#0.9771;THIORPHAN#0.9769;4-AMINOPYRIDINE#0.9769;ANGIOTENSIN TYPE 1#0.9769;BREAST CARCINOMA#0.9768;NADPH OXIDASE#0.9768;RENAL ARTERY#0.9768;NATRIURESIS#0.9767;SQUAMOUS CELL CARCINOMA#0.9767;NEUROHORMONE#0.9766;HIGH DENSITY LIPOPROTEIN#0.9765;EPITHELIAL CELL#0.9765;VENOUS BLOOD#0.9764;CORONARY FLOW RESERVE#0.9764;MAPK ACTIVATION#0.9763;T CELL#0.9763;GLUTATHIONE PEROXIDASE#0.9761;OUABAIN#0.9761;ENALAPRIL#0.9761;GTP BINDING#0.9760;CAROTID ARTERY#0.9759;PLATELET ACTIVATION#0.9758;PHOSPHORAMIDON#0.9758;BLOOD UREA NITROGEN#0.9757;SMALL PULMONARY ARTERIES#0.9757;HEMORRHAGE#0.9757;NEUTROPHIL#0.9756;HYALURONIC ACID#0.9756;REGULATION OF BLOOD PRESSURE#0.9756;RHEUMATOID ARTHRITIS#0.9756;RESPIRATORY TRACT#0.9755;GENISTEIN#0.9755;COAGULATION#0.9754;ENDOPEPTIDASE INHIBITOR#0.9753;PORTAL VEIN#0.9752;RESPONSE TO ACETYLCHOLINE#0.9751;CALCINEURIN#0.9750;FOREARM#0.9750;RECEPTOR LIGAND#0.9750;STEM CELL#0.9749;ACTIVATOR PROTEIN 1#0.9749;ION CHANNEL#0.9749;HEALTHY CONTROL SUBJECTS#0.9748;MUSCLE CONTRACTION#0.9748;RENAL FIBROSIS#0.9747;CANCER CELL#0.9747;MECONIUM#0.9747;HUMAN UMBILICAL VEIN#0.9747;NEPHROTIC SYNDROME#0.9745;MYOFILAMENT#0.9745;VASCULAR SMOOTH MUSCLE CELL#0.9745;CELLULAR LOCALIZATION#0.9743;ADENINE DINUCLEOTIDE PHOSPHATE#0.9743;ARTERIOLE#0.9742;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9740;TRANSIENT RECEPTOR POTENTIAL#0.9740;NITRIC-OXIDE SYNTHASE INHIBITOR#0.9740;ACUTE CORONARY SYNDROME#0.9739;FOCAL ADHESION KINASE#0.9739;DOMINANT NEGATIVE MUTANT#0.9739;TETRODOTOXIN#0.9739;ENDOTHELIAL CELL#0.9739;GROWTH HORMONE#0.9739;ADENINE#0.9738;CORONARY ARTERY BYPASS#0.9737;XANTHINE OXIDASE#0.9737;HEAT SHOCK PROTEIN#0.9737;VERAPAMIL#0.9737;ADENYLATE CYCLASE#0.9737;NEPHRON#0.9736;PITUITARY GLAND#0.9736;PROSTAGLANDIN SYNTHESIS#0.9735;MYOFIBROBLAST#0.9734;UMBILICAL VEIN#0.9733;ARRHYTHMIA#0.9732;DEMENTIA#0.9731;CARDIOMYOPATHY#0.9731;B CELL#0.9730;TYPE 1 DIABETES#0.9730;ERYTHROCYTE#0.9730;MYOSIN HEAVY CHAIN#0.9729;LOW DENSITY LIPOPROTEIN#0.9729;ITO CELL#0.9728;CORONARY HEART DISEASE#0.9728;STEROIDOGENESIS#0.9727;VSMC PROLIFERATION#0.9727;EMBOLISM#0.9727;NOMEGA-NITRO-L-ARGININE#0.9727;PROGESTERONE#0.9727;NEPHROTOXICITY#0.9726;VENA CAVA#0.9725;72-HOURS#0.9724;NEURAL CREST CELL#0.9724;PULMONARY HYPERTENSION#0.9724;RED BLOOD CELL#0.9722;THORACIC AORTA#0.9721;CONSTRICTION#0.9721;ISCHEMIA REPERFUSION INJURY#0.9720;NOS INHIBITOR#0.9718;ISCHEMIA#0.9718;IONOPHORE#0.9716;EXCRETION#0.9715;CELL MEMBRANE#0.9715;DIURESIS#0.9715;PLACENTAL GROWTH FACTOR#0.9714;DNA SYNTHESIS#0.9713;LUPUS ERYTHEMATOSUS#0.9712;LOSARTAN#0.9711;PERIPHERAL BLOOD#0.9710;TISSUE DAMAGE#0.9710;FIBRINOLYSIS#0.9710;GROWTH FACTOR RECEPTOR#0.9710;LEFT ATRIUM#0.9709;ECE-1 ACTIVITY#0.9709;HYPOXIC#0.9708;ACTION POTENTIAL#0.9707;PROSTAGLANDIN E1#0.9704;MENSTRUAL CYCLE#0.9703;PARENCHYMA#0.9703;DIABETIC NEPHROPATHY#0.9703;RECEPTOR AGONIST#0.9702;ATORVASTATIN#0.9702;INOSITOL PHOSPHATE FORMATION#0.9702;OF DIABETIC RATS#0.9701;BOSENTAN#0.9701;OBESE#0.9697;BREAST CANCER CELL#0.9694;GALLBLADDER#0.9694;VASOCONSTRICTION#0.9693;NEUROPATHY#0.9693;QUANTITATIVE REAL TIME#0.9692;CONNEXIN#0.9688;LEUKOCYTE#0.9688;SENSITIZATION#0.9688;CORONARY ARTERY DISEASE#0.9688;ARTERY DISEASE#0.9688;NG-NITRO-L-ARGININE#0.9688;ADIPOSE TISSUE#0.9688;TYPE 2 DIABETES#0.9687;MECHANISMS OF ACTION#0.9686;HYPOTENSIVE#0.9685;N-NITRO-L-ARGININE#0.9685;COR PULMONALE#0.9684;VASCULAR ENDOTHELIAL FUNCTION#0.9684;CHANNEL INHIBITOR#0.9683;MONONUCLEAR CELLS#0.9683;INTERNAL CAPSULE#0.9682;SIGNALING MOLECULE#0.9682;VASCULAR ENDOTHELIAL DYSFUNCTION#0.9681;CALCIUM CHANNEL#0.9681;THROMBIN RECEPTOR#0.9681;STREPTOZOTOCIN#0.9680;URETHANE#0.9680;COLLECTING DUCTS#0.9679;ENDOPLASMIC RETICULUM#0.9679;CHRONIC KIDNEY DISEASE#0.9678;FACTOR I#0.9678;QUANTITATIVE REVERSE TRANSCRIPTION#0.9677;CALCIUM SIGNALING#0.9676;POTASSIUM CHANNEL#0.9674;VASCULAR ENDOTHELIUM#0.9673;THROMBOXANE A2 RECEPTOR#0.9672;AMILORIDE#0.9672;THROMBOSIS#0.9670;MARKERS OF INFLAMMATION#0.9670;HYPERGLYCEMIA#0.9669;ROS GENERATION#0.9669;SMOOTH MUSCLE CELL#0.9668;LEUCINE#0.9666;ASPIRIN#0.9666;CELL MIGRATION#0.9665;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9664;PRAZOSIN#0.9664;ENDOTHELIN RECEPTOR#0.9663;CELL GROWTH#0.9663;RECEPTOR BINDING#0.9662;ALZHEIMER'S DISEASE#0.9661;MUSCLE CELL#0.9661;VENULE#0.9661;GLUCOSE METABOLISM#0.9660;POSITIVE AIRWAY PRESSURE#0.9660;ACTINOMYCIN D#0.9660;HEPATOCELLULAR CARCINOMA#0.9659;ATROPINE#0.9659;NEPHROPATHY#0.9659;TUMOR CELLS#0.9658;CHOROID PLEXUS#0.9658;ADENOSINE#0.9658;SUPEROXIDE DISMUTASE#0.9657;SIGNALING CASCADE#0.9656;ENDOTHELIAL CELL DYSFUNCTION#0.9655;ANGIOTENSIN CONVERTING ENZYME#0.9654;CELL ACTIVATION#0.9653;EOSINOPHIL#0.9653;N-OMEGA-NITRO-L-ARGININE#0.9652;CARDIOVASCULAR RISK FACTOR#0.9652;HETEROTRIMERIC G-PROTEIN#0.9652;EDEMA#0.9651;GLUTATHIONE#0.9651;PULMONARY ARTERIAL HYPERTENSION#0.9650;GANGLION CELLS#0.9649;DNA BINDING#0.9649;MYOCARDIUM#0.9649;STRESS FIBER#0.9648;SMOOTH MUSCLE#0.9647;PHOSPHODIESTERASE#0.9647;PROPRANOLOL#0.9646;REACTIVE OXYGEN SPECIES#0.9646;PULMONARY ARTERY#0.9645;GLIBENCLAMIDE#0.9645;MYOCARDIAL INFARCTION#0.9644;FACTOR S#0.9644;NEUROTRANSMISSION#0.9643;PENTOBARBITAL#0.9643;VASODILATATION#0.9643;KINASE ACTIVITY#0.9643;NIFEDIPINE#0.9642;SMOOTH MUSCLE ACTIN#0.9641;ENDOTHELIUM#0.9641;FOCAL ADHESION#0.9641;ACETYLCHOLINE#0.9640;SIGNALLING PATHWAY#0.9639;MECHANISM OF ACTION#0.9639;MACROPHAGE#0.9638;PROTEIN KINASE A#0.9638;HYDROXYPROLINE#0.9638;BRADYCARDIA#0.9638;HYPOTENSION#0.9637;LEFT ANTERIOR DESCENDING#0.9637;TUBE FORMATION#0.9636;PROTEINURIA#0.9635;KIDNEY DISEASE#0.9634;TACHYCARDIA#0.9634;SKELETAL MUSCLE#0.9633;THYMIDINE#0.9633;POLYCYSTIC KIDNEY DISEASE#0.9633;MITOGEN ACTIVATED PROTEIN#0.9632;VASODILATOR#0.9632;CHANNEL ACTIVITY#0.9631;ENDOTHELIAL CELL ACTIVATION#0.9631;COLLAGENASE#0.9631;VASOMOTION#0.9630;BASEMENT MEMBRANE#0.9629;PKC ACTIVATION#0.9629;ANGIOTENSIN RECEPTOR#0.9628;GENE EXPRESSION#0.9628;HEART DISEASE#0.9628;PHOSPHOLIPASE C#0.9627;STAUROSPORINE#0.9626;ESTROGEN RECEPTOR#0.9625;DIABETES MELLITUS#0.9625;SARCOPLASMIC RETICULUM#0.9625;PRAVASTATIN#0.9624;CELL CYCLE#0.9622;ADENYLATE#0.9622;ANGIOGENESIS#0.9621;CARDIOVASCULAR SYSTEM#0.9619;IDIOPATHIC PULMONARY FIBROSIS#0.9619;SERUM ALBUMIN#0.9618;CEREBRAL INFARCTION#0.9618;ATHEROSCLEROTIC#0.9617;CAFFEINE#0.9616;SODIUM NITROPRUSSIDE#0.9616;CENTRAL NERVOUS SYSTEM#0.9613;ENZYME ACTIVITY#0.9612;PROTEIN KINASE C#0.9612;MAGNESIUM SULFATE#0.9611;HYPERTENSION#0.9611;CELL PROLIFERATION#0.9611;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9611;LIVER DISEASE#0.9611;CORONARY ARTERY#0.9610;BRANCHIAL ARCH#0.9609;PROTEIN SYNTHESIS#0.9608;REGENERATION#0.9607;INDUCED RENAL INJURY#0.9604;XANTHINE#0.9603;ARTERY#0.9601;GESTATION#0.9601;ADENOSINE TRIPHOSPHATE#0.9600;TRANSCRIPTASE#0.9598;MULTIPLE REGRESSION ANALYSIS#0.9597;PHOSPHODIESTERASE INHIBITOR#0.9597;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9597;PERTUSSIS#0.9597;MAGNETIC RESONANCE IMAGING#0.9597;NITROPRUSSIDE#0.9595;RECEPTOR TYROSINE KINASE#0.9594;METABOLIC ACIDOSIS#0.9593;VASODILATION#0.9593;ESTROUS CYCLE#0.9592;OPIOID RECEPTOR#0.9591;IMMUNE RESPONSE#0.9589;GUANYLATE CYCLASE#0.9589;RETINAL VEIN OCCLUSION#0.9589;AMBULATORY BLOOD PRESSURE#0.9587;FORSKOLIN#0.9586;APOPTOSIS#0.9586;ACE INHIBITOR#0.9586;TYROSINE KINASE INHIBITOR#0.9586;IMPAIRED GLUCOSE TOLERANCE#0.9584;NICOTINAMIDE#0.9584;ACTIVATED T CELL#0.9583;INSULIN RECEPTOR#0.9581;BLOOD VESSEL#0.9581;NERVOUS SYSTEM#0.9580;PROTEIN KINASE B#0.9580;PLASMA MEMBRANE#0.9578;CERVICAL#0.9577;CARDIAC SYNDROME X#0.9575;CONNECTIVE TISSUE DISEASE#0.9572;ARGININE#0.9572;ATPASE ACTIVITY#0.9571;TETRAETHYLAMMONIUM#0.9571;REVERSE TRANSCRIPTION#0.9570;ACUTE KIDNEY INJURY#0.9570;RIGHT ATRIUM#0.9569;MESENCHYMAL STEM CELL#0.9567;ATHEROSCLEROSIS#0.9566;GLOMERULAR FILTRATION RATE#0.9566;HIGH FAT DIET#0.9566;PROTEIN KINASE#0.9565;CROSS SECTIONAL AREA#0.9564;INFLAMMATORY CELL#0.9564;LUMINAL#0.9564;MYELOPEROXIDASE ACTIVITY#0.9562;BRAIN ENDOTHELIAL CELL#0.9562;AORTIC VALVE#0.9562;EARLY GROWTH RESPONSE#0.9561;APOPTOTIC#0.9558;METALLOPROTEASE INHIBITOR#0.9558;DEPHOSPHORYLATION#0.9558;MODE OF ACTION#0.9557;MORPHOGENESIS#0.9556;GLOMERULAR FILTRATION#0.9554;WHITE BLOOD CELL#0.9553;NITROGEN MONOXIDE#0.9550;ENZYME INHIBITOR#0.9549;INDOMETHACIN#0.9548;RANDOMIZED CONTROLLED TRIAL#0.9548;CEREBROVASCULAR DISEASE#0.9546;VASCULAR DISEASE#0.9545;RYANODINE RECEPTOR#0.9543;SIGNALING PATHWAY#0.9543;SIGNAL TRANSDUCTION#0.9540;NEBIVOLOL#0.9539;IMMUNE CELL#0.9539;INSULIN RECEPTOR SUBSTRATE#0.9538;L-ARGININE#0.9538;NEUROBLASTOMA#0.9535;TOXICITY#0.9534;ACUTE HEART FAILURE#0.9532;POLYMERASE CHAIN REACTION#0.9531;ADENOCARCINOMA#0.9529;MYOSIN LIGHT-CHAIN KINASE#0.9528;KINASE INHIBITOR#0.9528;CORONARY ARTERY ENDOTHELIAL CELLS#0.9527;EXTRACELLULAR MATRIX#0.9524;NEUROPROTECTION#0.9523;NITRO-L-ARGININE#0.9523;LIPID METABOLISM#0.9520;TRANSCRIPTION FACTOR#0.9520;CYTOPLASM#0.9520;FRUCTOSE#0.9518;PHENTOLAMINE#0.9515;PROTEASOME#0.9515;INFLAMMATORY RESPONSE#0.9513;CELL SURFACE#0.9510;VASCULAR SMOOTH MUSCLE CONTRACTION#0.9508;CLONIDINE#0.9507;PEPTIDE SECRETION#0.9507;ESTROGENS#0.9506;STRUCTURE ACTIVITY RELATIONSHIP#0.9499;SODIUM CHANNEL#0.9497;ACTIVATED T-CELLS#0.9495;SPIRONOLACTONE#0.9494;LECTIN#0.9490;SYSTOLIC BLOOD PRESSURE#0.9488;OOCYTE#0.9487;RECEPTOR ANTAGONIST#0.9483;UROKINASE#0.9481;INTRACELLULAR SIGNALING PATHWAY#0.9480;CELL DEATH#0.9476;T LYMPHOCYTE#0.9469;CELL DIFFERENTIATION#0.9461;SKELETON#0.9459;RETINITIS PIGMENTOSA#0.9450;ION TRANSPORT#0.9445;OVIDUCT#0.9442;MITOCHONDRIA#0.9442;HEPATIC SINUSOIDS#0.9442;FLUID SHEAR STRESS#0.9436;STROMA#0.9436;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9436;PERCUTANEOUS CORONARY INTERVENTION#0.9432;ISOFLURANE#0.9432;WEIGHT LOSS#0.9431;INTENSIVE CARE UNIT#0.9429;N-ACETYLCYSTEINE#0.9427;NF-KAPPAB ACTIVATION#0.9426;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9423;CYTOTOXICITY#0.9420;RENAL ISCHEMIA REPERFUSION#0.9417;OLEIC ACID#0.9410;SOLUBLE GUANYLYL CYCLASE#0.9407;PAPAVERINE#0.9403;GALECTIN#0.9398;ELECTROPHORETIC MOBILITY SHIFT#0.9396;RECEPTOR COMPLEX#0.9395;CHONDROCYTE#0.9394;MELATONIN#0.9389;UMBILICAL CORD BLOOD#0.9386;RECEPTOR ACTIVATOR#0.9378;BODY WEIGHT RATIO#0.9376;DIPHOSPHATE#0.9375;DOXORUBICIN#0.9372;GASTROINTESTINAL TRACT#0.9367;GRANULOCYTE COLONY STIMULATING FACTOR#0.9366;NORMAL CONTROL GROUP#0.9363;S PHASE#0.9362;EOSIN#0.9361;BLEOMYCIN#0.9359;MACROPHAGE CHEMOATTRACTANT PROTEIN#0.9357;LOWER URINARY TRACT#0.9351;COLON CANCER#0.9350;LUTEAL PHASE#0.9345;GUANINE#0.9343;PROTEIN KINASE INHIBITOR#0.9343;MULTIPLE LINEAR REGRESSION#0.9341;AIRWAY EPITHELIUM#0.9339;ERYTHROCYTE SEDIMENTATION RATE#0.9333;SIGNAL TRANSDUCER#0.9330;HISTONE DEACETYLASE#0.9329;PHOSPHATASE ACTIVITY#0.9327;AMLODIPINE#0.9327;BRONCHOPULMONARY DYSPLASIA#0.9322;PROTEIN PROTEIN INTERACTION#0.9318;PSORIASIS#0.9315;ACIDIFICATION#0.9315;ANEMIA#0.9314;FETAL GROWTH RESTRICTION#0.9313;PROTEIN KINASE C ACTIVITY#0.9312;TRADITIONAL CHINESE MEDICINE#0.9304;HEPATORENAL SYNDROME#0.9303;FASTING PLASMA GLUCOSE#0.9303;PROPOFOL#0.9297;SMOOTH MUSCLE RELAXATION#0.9294;GUANOSINE-3',5'-MONOPHOSPHATE#0.9292;SERTOLI CELL#0.9287;HINDLIMB#0.9286;ASPHYXIA#0.9286;RIBOSE#0.9283;NECROTIC#0.9280;HUMAN TRABECULAR MESHWORK#0.9274;HEPATIC ISCHEMIA REPERFUSION#0.9274;SMC PROLIFERATION#0.9273;RECEPTOR ACTIVITY#0.9272;TRABECULAR MESHWORK CELLS#0.9272;ACTIN CYTOSKELETON#0.9272;FASTING BLOOD GLUCOSE#0.9270;HEMOSTASIS#0.9263;SCIATIC NERVE#0.9262;PROTEOGLYCAN#0.9250;CHEMOTAXIS#0.9249;SPUTUM#0.9242;CHAGAS DISEASE#0.9239;TACROLIMUS#0.9235;PERITUBULAR MYOID CELL#0.9235;RALOXIFENE#0.9232;POLYCYSTIC OVARY SYNDROME#0.9231;FACTOR VIII#0.9226;RIGHT VENTRICULAR PRESSURE#0.9226;GLYCOGEN SYNTHASE KINASE#0.9226;ROSIGLITAZONE#0.9225;ADVENTITIA#0.9221;FLUORESCEIN#0.9216;DIGESTION#0.9216;PROTEIN KINASE G#0.9212;CYSTATIN#0.9207;PRECURSOR CELL#0.9205;CHRONIC LIVER DISEASE#0.9202;HORMONE SECRETION#0.9193;MYOMETRIAL CONTRACTION#0.9193;EMBRYONIC STEM CELL#0.9192;AORTIC ANEURYSM#0.9190;NEPHRITIS#0.9185;TIGHT JUNCTION#0.9184;BIOTIN#0.9181;FEMORAL VEIN#0.9178;PKCDELTA#0.9176;TYPE 1 DIABETIC#0.9173;RNA SYNTHESIS#0.9171;PHOSPHOLIPASE A#0.9170;CORONARY ARTERY LIGATION#0.9169;EPITHELIAL OVARIAN CANCER#0.9166;TAMOXIFEN#0.9163;INNERVATION#0.9155;HYPERTROPHIC CARDIOMYOPATHY#0.9153;FENOFIBRATE#0.9147;ACTION POTENTIAL DURATION#0.9145;LAMINAR SHEAR STRESS#0.9144;EXHALED BREATH CONDENSATE#0.9136;LARGE ARTERIES#0.9132;RETINOIC ACID#0.9129;LATERAL VENTRICLE#0.9125;TARGET ORGAN DAMAGE#0.9124;IMMUNE SYSTEM#0.9123;ENDOTHELIAL CELL PROLIFERATION#0.9119;SYNCOPE#0.9115;THYROID GLAND#0.9114;INSULIN SECRETION#0.9113;OVARIES#0.9112;GLOBAL CEREBRAL ISCHEMIA#0.9112;NITRIC OXIDE FORMATION#0.9110;DECIDUA#0.9106;TISSUE REMODELING#0.9106;SEPTUM#0.9105;INTERSTITIAL CELL#0.9102;NEUTROPHIL ACTIVATION#0.9095;CATECHOLAMINE SECRETION#0.9092;BLOOD COAGULATION#0.9091;END ORGAN DAMAGE#0.9091;METHIONINE#0.9089;VIRAL INFECTION#0.9084;EPITHELIAL MESENCHYMAL TRANSITION#0.9084;CAMKII#0.9083;OESTRADIOL#0.9082;HUMAN BREAST CANCER#0.9076;LEYDIG CELL#0.9067;WATER RETENTION#0.9066;RNA INTERFERENCE#0.9060;HYDRALAZINE#0.9057;LYMPH NODE#0.9054;EICOSAPENTAENOIC ACID#0.9048;PHOSPHATASE INHIBITOR#0.9047;OVULATION#0.9047;OSTEOGENESIS#0.9043;CONGENITAL DIAPHRAGMATIC HERNIA#0.9035;D-ARGININE#0.9033;AGEING#0.9029;MAPK SIGNALING#0.9024;ACETYLCYSTEINE#0.9024;RELATED PROTEIN 1#0.9022;CANDESARTAN#0.9019;MESENTERIC VEIN#0.9013;CYTOKINE PRODUCTION#0.9009;GLUCOSE TOLERANCE TEST#0.9005;PHEOCHROMOCYTOMA#0.9004;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.8999;VASCULITIS#0.8998;RESPONSE TO POTASSIUM#0.8998;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.8998;ATRIAL CELL#0.8992;MITOCHONDRIAL MEMBRANE#0.8991;BETA ADRENERGIC RECEPTOR#0.8991;OBSTRUCTIVE SLEEP APNOEA#0.8986;CHLORIDE CHANNEL#0.8986;PULMONARY EMBOLISM#0.8980;HYPERHOMOCYSTEINEMIA#0.8978;AUTOIMMUNE DISEASE#0.8969;RIGHT HEART FAILURE#0.8965;ACETIC ACID#0.8961;SCANNING ELECTRON MICROSCOPY#0.8960;OLIGODENDROCYTE#0.8958;BLOOD GLUCOSE LEVEL#0.8956;ATENOLOL#0.8947;SUCROSE#0.8946;NEURONAL CELLS#0.8945;MESOTHELIAL CELL#0.8941;COLITIS#0.8934;ANGIOTENSIN RECEPTOR BLOCKER#0.8929;LINEAR REGRESSION ANALYSIS#0.8927;NASAL MUCOSA#0.8917;METASTATIC PROSTATE CANCER#0.8910;ANTIOXIDANT ACTIVITY#0.8901;HEPARIN BINDING#0.8894;NECROTIZING#0.8892;LIVER DAMAGE#0.8891;CORTICOTROPIN-RELEASING FACTOR#0.8884;LACTIC ACID#0.8880;SODIUM:HYDROGEN EXCHANGER#0.8877;PLURIPOTENT STEM CELL#0.8876;WEIGHT GAIN#0.8871;VASCULAR DEMENTIA#0.8865;PROTEIN KINASE ACTIVATION#0.8862;MAP KINASE ACTIVITY#0.8860;AKT SIGNALING#0.8859;FRAGMENT LENGTH POLYMORPHISM#0.8857;NALOXONE#0.8848;PHOSPHATE BUFFERED SALINE#0.8847;PIOGLITAZONE#0.8846;OMAPATRILAT#0.8846;SALVIANOLIC ACID B#0.8844;RENAL HYPERTENSION#0.8841;PROTEASE ACTIVATED RECEPTOR#0.8837;L-ARG#0.8821;PIGMENT EPITHELIAL CELL#0.8817;PERIODONTITIS#0.8805;CISPLATIN#0.8804;CAMP FORMATION#0.8802;SWELLING#0.8801;FIBROBLAST ACTIVATION#0.8798;CYCLASE ACTIVITY#0.8798;RAPAMYCIN#0.8797;MICROPARTICLE#0.8790;CHOLINE#0.8786;DELAYED CEREBRAL ISCHEMIA#0.8785;TRYPTOPHAN#0.8784;TACHYKININ#0.8770;RETINAL ISCHEMIA#0.8769;SPINAL CORD INJURY#0.8767;VITAMIN C#0.8767;LACIDIPINE#0.8765;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.8757;TROPHOBLAST CELL#0.8756;WATER HOMEOSTASIS#0.8756;SARCOMERE#0.8755;CAMP RESPONSE ELEMENT#0.8726;CLEAVED CASPASE 3#0.8719;PULMONARY VASCULAR REMODELLING#0.8708;PKCALPHA#0.8707;HEPATIC VEIN#0.8702;PERIPHERAL VASCULAR DISEASE#0.8701;VALSARTAN#0.8698;RESPIRATION#0.8698;HALOTHANE#0.8693;LYSINE#0.8680;SYSTEMIC INFLAMMATORY RESPONSE#0.8678;REACTIVE OXYGEN SPECIES GENERATION#0.8677;ULCERATIVE COLITIS#0.8677;HIGH CHOLESTEROL DIET#0.8674;FERTILIZATION#0.8658;PROGESTIN#0.8655;LUCIFERASE ACTIVITY#0.8653;NUCLEOTIDE BINDING#0.8636;METFORMIN#0.8635;MYOSIN PHOSPHATASE#0.8617;RESPONSE TO INSULIN#0.8614;NERVE DAMAGE#0.8613;PROTEIN BINDING#0.8612;RETINAL PIGMENT EPITHELIAL#0.8609;BLADDER OUTLET OBSTRUCTION#0.8606;CACL2#0.8605;RAT NEONATAL CARDIOMYOCYTES#0.8603;ACTIVATION OF NF-KAPPAB#0.8601;NERVE FIBER#0.8600;FOREBRAIN#0.8597;NEPHROTOXIC#0.8589;END STAGE RENAL FAILURE#0.8585;MAST CELL DEGRANULATION#0.8581;HYPERACTIVITY#0.8571;ISRADIPINE#0.8566;LEFT VENTRICULAR REMODELING#0.8543;LEIOMYOMA#0.8538;NUCLEAR EXPORT#0.8538;FUROSEMIDE#0.8536;MESENCHYME#0.8525;MELANOCYTE PROLIFERATION#0.8521;PENICILLAMINE#0.8519;OSTEOARTHRITIS#0.8513;PROTEIN TYROSINE PHOSPHATASE#0.8510;FORMALIN#0.8508;DECIDUAL CELL#0.8505;TETRAHYDROBIOPTERIN#0.8498;GLUCOCORTICOID RECEPTOR#0.8492;COENZYME A#0.8491;LISINOPRIL#0.8483;IL-6 PRODUCTION#0.8480;EPITHELIAL SODIUM CHANNEL#0.8476;DENDRITIC CELL#0.8471;ORAL GLUCOSE TOLERANCE#0.8464;GUANYLATE CYCLASE INHIBITOR#0.8464;RETINAL PIGMENT EPITHELIAL CELLS#0.8460;MESENCHYMAL CELL#0.8459;OCTREOTIDE#0.8459;OPTIC DISC#0.8459;DICLOFENAC#0.8453;CELLULAR GROWTH#0.8451;TYPE 1 DIABETES MELLITUS#0.8441;LASER SCANNING MICROSCOPY#0.8435;INDUCED PLURIPOTENT STEM CELL#0.8431;PHOSPHOLIPASE C ACTIVATION#0.8429;LEUKEMIA INHIBITORY FACTOR#0.8427;NITRENDIPINE#0.8427;HIGH MOBILITY GROUP#0.8426;UTERINE HORN#0.8425;OSTEOCLAST#0.8423;MENOPAUSE#0.8417;PHOSPHOLIPASE C ACTIVITY#0.8417;ANESTHETIC#0.8416;HEPATIC ARTERY#0.8403;ORTHOTOPIC LIVER TRANSPLANTATION#0.8394;BLOOD CIRCULATION#0.8394;BETA GALACTOSIDASE#0.8393;RETINITIS#0.8393;FOLLICLE STIMULATING HORMONE#0.8391;SICKLE CELL ANEMIA#0.8383;PERIPHERAL NERVE#0.8380;COMMON CAROTID ARTERY#0.8376;ATPASE INHIBITOR#0.8374;CROHN'S DISEASE#0.8364;DNA METHYLATION#0.8359;OUTFLOW TRACT#0.8357;HEALTHY CONTROL GROUP#0.8349;ARACHIDONIC ACID METABOLISM#0.8348;NOXIOUS#0.8341;RETINAL PIGMENT EPITHELIUM#0.8339;PARTURITION#0.8338;QUANTITATIVE REVERSE TRANSCRIPTASE#0.8330;RENAL TRANSPLANT RECIPIENTS#0.8327;COCHLEA#0.8325;END DIASTOLIC VOLUME#0.8315;LYMPHATIC VESSEL#0.8309;COMMON CAROTID ARTERIES#0.8309;SYNOVIAL FLUID#0.8306;NITROARGININE#0.8304;MYOCARDIAL INFARCT SIZE#0.8300;BRUSH BORDER#0.8299;PLACENTA GROWTH FACTOR#0.8292;HUMAN DENTAL PULP#0.8289;ADULT RESPIRATORY DISTRESS SYNDROME#0.8286;NO SYNTHASE ACTIVITY#0.8285;GLUTAMATE RECEPTOR#0.8281;EPITHELIAL TO MESENCHYMAL#0.8275;VERY-LOW-DENSITY LIPOPROTEIN#0.8271;DENTAL PULP#0.8270;INFLAMMATORY BOWEL DISEASE#0.8269;DECOMPENSATED HEART FAILURE#0.8266;ACTIVATION OF MAP KINASE#0.8263;LUNG CARCINOMA#0.8262;NITRIC OXIDE METABOLISM#0.8261;BLOOD CLOT#0.8259;GINKGO BILOBA#0.8258;CAVEOLAE#0.8257;LARGE INTESTINE#0.8250;BONE MINERAL DENSITY#0.8248;INFLAMMATORY CELL INFILTRATION#0.8245;VASOPRESSIN RECEPTOR#0.8241;WATER TRANSPORT#0.8240;HEMOLYSIS#0.8239;MYOFIBROBLAST DIFFERENTIATION#0.8238;LIPOLYSIS#0.8230;SKIN FIBROBLASTS#0.8227;TOTAL NITRIC OXIDE#0.8226;CHOLERA#0.8224;GESTATIONAL DIABETES#0.8223;FLUID PERCUSSION INJURY#0.8221;NISOLDIPINE#0.8219;RHINITIS#0.8219;DYSPNEA#0.8212;AQUAPORIN#0.8211;CELL MOTILITY#0.8210;RESPONSE TO EXERCISE#0.8208;GLOMERULAR EPITHELIAL CELL#0.8201;ADULT RAT CARDIOMYOCYTES#0.8185;FORCED EXPIRATORY VOLUME#0.8180;GINKGO BILOBA EXTRACT#0.8175;QUINAPRIL#0.8170;EPOPROSTENOL#0.8166;UREMIA#0.8163;CRANIAL NEURAL CREST#0.8156;VEGF PRODUCTION#0.8145;ACTIN FILAMENT#0.8139;ANTI INFLAMMATORY DRUGS#0.8138;VENTRICULAR ASSIST DEVICE#0.8137;BETA CELL#0.8132;CYSTIC FIBROSIS#0.8131;MUTAGENESIS#0.8122;KETAMINE#0.8121;EXTRACELLULAR SPACE#0.8092;GLOMERULUS#0.8092;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8088;TUMOR SUPPRESSOR#0.8082;RANDOMIZED CLINICAL TRIAL#0.8081;TYROSINASE ACTIVITY#0.8080;MYOFIBROBLAST CONTRACTION#0.8069;DORSAL ROOT GANGLION#0.8067;URIDINE#0.8063;FLUVASTATIN#0.8062;CYCLOOXYGENASE PATHWAY#0.8055;RENAL CELL CARCINOMA#0.8052;LUNG ENDOTHELIAL CELLS#0.8051;PKCEPSILON#0.8051;PROXIMAL TUBULE CELL#0.8051;INDUCTION OF APOPTOSIS#0.8049;PROTEIN KINASE D#0.8046;BENZOIC ACID#0.8042;CYCLIN DEPENDENT KINASE#0.8042;PEPSTATIN#0.8038;IRBESARTAN#0.8032;ALLERGEN#0.8030;STABLE ANGINA PECTORIS#0.8026;MATRIX METALLOPROTEINASE 1#0.8020;NORDIHYDROGUAIARETIC ACID#0.8015;METOPROLOL#0.8009;CANNABINOID RECEPTOR#0.8007;PEAK SYSTOLIC VELOCITY#0.8003;BRONCHIOLITIS#0.8001;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8000;POLY ADP RIBOSE#0.7998;LEUKOTRIENE RECEPTOR#0.7998;FATTY ACID BINDING#0.7997;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7991;LIMB ISCHEMIA#0.7989;ADENOSINE 5'-TRIPHOSPHATE#0.7987;PANCREATIC ISLET#0.7979;SUDDEN CARDIAC DEATH#0.7968;LATE PREGNANCY#0.7966;R/AMP#0.7963;PERIPHERAL BLOOD MONOCYTES#0.7962;CELL COMMUNICATION#0.7961;MANNITOL#0.7961;ADRENAL MEDULLA#0.7957;ISCHEMIC REPERFUSION INJURY#0.7957;PARACRINE SIGNALING#0.7956;SALBUTAMOL#0.7936;FLUID RETENTION#0.7929;ENDOTHELIAL CELL MIGRATION#0.7925;DUODENUM#0.7924;ACINAR CELL#0.7918;BRACHIAL ARTERY DIAMETER#0.7916;MYOCARDITIS#0.7915;LYSOSOME#0.7910;GENE SILENCING#0.7910;NESIRITIDE#0.7909;HYDROCORTISONE#0.7895;ROS FORMATION#0.7895;MELANIN SYNTHESIS#0.7893;INTRACELLULAR SIGNAL TRANSDUCTION#0.7892;NEOMYCIN#0.7890;NEURODEGENERATIVE DISEASE#0.7884;YOHIMBINE#0.7883;ALKALINE PHOSPHATASE ACTIVITY#0.7883;EPIDIDYMIS#0.7883;SITAXSENTAN#0.7882;HISTONE ACETYLATION#0.7881;BILIARY ATRESIA#0.7879;CYTOCHROME C#0.7879;GLUCOSE INTOLERANCE#0.7877;DEHYDRATION#0.7869;MICROPHTHALMIA#0.7868;ORAL SQUAMOUS CELL CARCINOMA#0.7866;ARYL HYDROCARBON RECEPTOR#0.7860;LEFT ATRIAL DIAMETER#0.7860;BASAL CELL#0.7859;APNEA HYPOPNEA INDEX#0.7857;GLOMUS CELL#0.7849;DENTAL PULP CELL#0.7849;CIRCULATORY SYSTEM#0.7847;MICROTUBULE#0.7847;PROTEIN PHOSPHORYLATION#0.7841;PROSTAGLANDIN ENDOPEROXIDE SYNTHASE#0.7840;LINES OF EVIDENCE#0.7834;RESPIRATORY SYSTEM#0.7825;G-CSF#0.7823;8-HYDROXY-2'-DEOXYGUANOSINE#0.7819;SLEEP APNEA SYNDROME#0.7805;DIPYRIDAMOLE#0.7800;TYROSINE KINASE 2#0.7795;HYPERGLYCEMIC#0.7787;BONE DEVELOPMENT#0.7785;GLYCINE#0.7782;DIABETIC ANGIOPATHY#0.7747;MINERALIZATION#0.7744;ISOSORBIDE DINITRATE#0.7739;FRONTAL#0.7735;TRANSVERSE AORTIC CONSTRICTION#0.7734;WHITE MATTER DAMAGE#0.7721;MRNA SYNTHESIS#0.7721;MEDIAL PREFRONTAL CORTEX#0.7707;GLYCERALDEHYDE-3-PHOSPHATE#0.7705;CHORION#0.7705;ATRIAL SEPTAL DEFECT#0.7700;POSITRON EMISSION TOMOGRAPHY#0.7698;GIANT CELL ARTERITIS#0.7696;END SYSTOLIC VOLUME#0.7695;ATOPIC DERMATITIS#0.7690;RESPONSE TO SEROTONIN#0.7689;END OF TREATMENT#0.7688;SYNAPTIC TRANSMISSION#0.7682;DERMIS#0.7677;MEMBRANE HYPERPOLARIZATION#0.7677;SUBARACHNOID SPACE#0.7673;ALLOPURINOL#0.7673;TRANSMISSION ELECTRON MICROSCOPY#0.7670;CHOLESTASIS#0.7660;IMMUNOSUPPRESSANT#0.7656;RIBOSOMAL S6 KINASE#0.7653;RIGHT VENTRICULAR DYSFUNCTION#0.7651;TADALAFIL#0.7646;CAROTID ARTERY STENTING#0.7645;CHRONIC RHINITIS#0.7635;METHYLPREDNISOLONE#0.7631;TARGET OF RAPAMYCIN#0.7630;RECEPTOR INTERNALIZATION#0.7622;HUMAN DERMAL FIBROBLAST#0.7616;SEROTONIN RECEPTOR#0.7607;INTERNAL CAROTID ARTERY#0.7606;OPTICAL COHERENCE TOMOGRAPHY#0.7603;SEMINAL VESICLE#0.7598;CILAZAPRIL#0.7597;PROTEIN KINASE ACTIVITY#0.7597;PROTEIN KINASE CASCADE#0.7595;ETHANE#0.7590;DARUSENTAN#0.7590;CONGENITAL HEART DEFECTS#0.7586;ANGIOGENIC GROWTH FACTORS#0.7586;ARTERIOSCLEROSIS OBLITERANS#0.7585;SECRETORY PATHWAY#0.7583;TRANSFORMING GROWTH FACTOR ALPHA#0.7583;PENILE ERECTION#0.7582;CAMP RESPONSE ELEMENT BINDING#0.7573;CHINESE HERBAL MEDICINE#0.7573;NOREPINEPHRINE UPTAKE#0.7569;CARDIAC MAGNETIC RESONANCE#0.7569;MICROFILAMENT#0.7561;SURFACE PLASMON RESONANCE#0.7559;CHLOROQUINE#0.7559;C-LEVEL#0.7557;RETINAL DAMAGE#0.7555;BRADYKININ RECEPTOR#0.7553;HOE 140#0.7552;PLASMA PROTEIN#0.7546;THYROID CARCINOMA#0.7545;RESPIRATORY FAILURE#0.7544;CHEMOKINE RECEPTOR#0.7542;MOTOR ACTIVITY#0.7534;MALARIA#0.7527;MYCOPHENOLIC ACID#0.7526;MAPK CASCADE#0.7522;SRC FAMILY KINASE#0.7510;CALCIUM CHLORIDE#0.7510;EXTRACELLULAR MATRIX COMPONENT#0.7509;TOTAL ANTIOXIDANT CAPACITY#0.7508;ENHANCER BINDING PROTEIN#0.7507;EXHALED NITRIC OXIDE#0.7505;ENHANCER BINDING#0.7503;BLADDER SMOOTH MUSCLE#0.7503;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7499;AEROBIC EXERCISE TRAINING#0.7498;MAPK SIGNALLING#0.7485;B LYMPHOCYTE#0.7484;NEUROTOXIC#0.7480;NUCLEOTIDE EXCHANGE FACTOR#0.7477;SMALL VESSEL DISEASE#0.7475;ERK CASCADE#0.7471;PANCREATIC STELLATE CELL#0.7468;VENTRICULAR SEPTAL DEFECT#0.7468;CARDIOMYOCYTE GROWTH#0.7464;SENESCENCE#0.7462;PROGESTERONE SECRETION#0.7459;CONTROL GROUP 1#0.7453;3-ISOBUTYL-1-METHYLXANTHINE#0.7452;OBSTRUCTIVE JAUNDICE#0.7436;IL-6 SECRETION#0.7424;PERIVASCULAR ADIPOSE TISSUE#0.7423;GASTRIC TISSUE#0.7422;HEART MUSCLE#0.7419;KNEE JOINT#0.7414;NERVE ENDING#0.7411;FOLLICULAR PHASE#0.7406;EMBRYONIC HEART#0.7404;MELANOMA CELL LINES#0.7392;GASTRITIS#0.7388;SECRETORY GRANULE#0.7382;BUMETANIDE#0.7382;BLOOD LOSS#0.7381;ENDOCRINE CELL#0.7380;CGRP RECEPTOR#0.7367;TESTICULAR CANCER#0.7367;NEUROGENESIS#0.7362;SERUM RESPONSE FACTOR#0.7361;SALIVARY GLAND#0.7359;LARYNGEAL CARCINOMA#0.7351;SODIUM DODECYL SULFATE#0.7346;DODECYL SULFATE#0.7345;ACID SECRETION#0.7343;AXONAL TRANSPORT#0.7338;CARRIE#0.7337;ADENYLYL CYCLASE ACTIVITY#0.7336;ANTECUBITAL VEIN#0.7334;PEPTIDE SYNTHESIS#0.7331;DISSEMINATED INTRAVASCULAR COAGULATION#0.7330;HEARING LOSS#0.7323;CARBENOXOLONE#0.7323;PALMITATE#0.7320;FORCED VITAL CAPACITY#0.7315;INTESTINAL MUCOSA#0.7304;SODIUM PUMP#0.7302;PACLITAXEL#0.7295;VESICOURETERAL REFLUX#0.7290;NEUROLOGICAL DEFICIT SCORE#0.7287;PNEUMONIA#0.7280;ADRENOCORTICOTROPIC HORMONE#0.7279;MUCOUS#0.7274;RESPONSE TO COLD#0.7271;BRUSH BORDER MEMBRANE#0.7268;REGULATION OF GENE EXPRESSION#0.7261;CORONARY STENOSIS#0.7259;PROSTATE SPECIFIC ANTIGEN#0.7255;CIRCADIAN RHYTHM#0.7252;HELLP SYNDROME#0.7249;EPIGALLOCATECHIN#0.7238;SUNITINIB#0.7232;SHAM OPERATION GROUP#0.7226;CARDIAC DEVELOPMENT#0.7222;AUTOCRINE SIGNALING#0.7219;CILIARY BODY#0.7219;LUNG TRANSPLANT RECIPIENTS#0.7219;CARNITINE#0.7212;TELMISARTAN#0.7210;CITRULLINE#0.7205;PHAGOCYTOSIS#0.7201;LUNG DEVELOPMENT#0.7201;COLLAGEN BINDING#0.7193;ORGANELLE#0.7184;POLYMORPHONUCLEAR NEUTROPHIL#0.7183;MALONALDEHYDE#0.7175;UPPER JAW#0.7172;ACTIN POLYMERIZATION#0.7172;17β-ESTRADIOL#0.7172;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.7170;TYROSINE KINASE RECEPTOR#0.7170;MU OPIOID RECEPTOR#0.7168;TIGHT JUNCTION PROTEIN#0.7166;SCAVENGER RECEPTOR#0.7163;RESPONSE TO NITRIC OXIDE#0.7161;KIDNEY INJURY MOLECULE#0.7160;MONOCYTE DERIVED MACROPHAGE#0.7154;RESONANCE ENERGY TRANSFER#0.7153;UNFOLDED PROTEIN RESPONSE#0.7151;PHOSPHOLIPASE D ACTIVITY#0.7144;DENTATE GYRUS#0.7143;MAPK ERK KINASE#0.7141;DOBUTAMINE#0.7136;ICI 182,780#0.7132;SARCOIDOSIS#0.7132;CATALYTIC ACTIVITY#0.7132;AMYLOID PRECURSOR PROTEIN#0.7127;ISCHEMIC HEART FAILURE#0.7117;SEVERE ACUTE PANCREATITIS#0.7098;NIFLUMIC ACID#0.7077;ENALAPRILAT#0.7075;CLEFT PALATE#0.7074;LDL RECEPTOR#0.7073;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.7072;GASTRIC DAMAGE#0.7065;VITAMIN E#0.7065;VARICOSE VEINS#0.7062;PERITONITIS#0.7062;THYROID CANCER#0.7062;URETHRA#0.7057;MULTIPLE MYELOMA#0.7052;EXTRA CELLULAR MATRIX#0.7046;SITAXENTAN#0.7027;COLLAGEN DEGRADATION#0.7016;LIPOXYGENASE PATHWAY#0.7013;OVARIAN HYPERSTIMULATION SYNDROME#0.7007;CEREBRAL MALARIA#0.7006;NATRIURETIC PEPTIDE RECEPTOR#0.6996;INNATE IMMUNITY#0.6996;ANTIPHOSPHOLIPID SYNDROME#0.6994;VASCULAR RISK FACTORS#0.6992;INTEGRIN LINKED KINASE#0.6989;ANDROGEN RECEPTOR#0.6988;GROWTH DIFFERENTIATION FACTOR#0.6985;PENTOBARBITONE#0.6984;NORETHISTERONE#0.6983;HYPOXANTHINE#0.6982;LUNG DAMAGE#0.6977;CYTOTROPHOBLAST#0.6971;DIABETIC NEUROPATHY#0.6969;ADVANCED PROSTATE CANCER#0.6968;URETERAL OBSTRUCTION#0.6968;ACETYLSALICYLIC ACID#0.6967;CAUDATE NUCLEUS#0.6962;FEMUR#0.6958;SOLID PHASE EXTRACTION#0.6955;EXOCYTOSIS#0.6949;ABDOMINAL AORTIC ANEURYSM#0.6949;ALLERGIC RHINITIS#0.6945;CELLULAR COMPONENT#0.6936;MAGNETIC RESONANCE SPECTROSCOPY#0.6929;RENAL SODIUM EXCRETION#0.6928;HIGH RISK PATIENTS#0.6924;REPORTER GENE ASSAY#0.6919;AUTOPHAGY#0.6915;ADIPONECTIN SECRETION#0.6913;POSTERIOR CEREBRAL ARTERY#0.6913;CASPASE-3 ACTIVITY#0.6912;CAROTID SINUS#0.6912;INSULIN SIGNALING PATHWAY#0.6906;LUNG ADENOCARCINOMA#0.6904;MAMMARY GLAND#0.6892;SUPEROXIDE DISMUTASE ACTIVITY#0.6882;DRUG RESISTANCE#0.6880;ACTIVATING TRANSCRIPTION FACTOR#0.6873;COMPLEX I#0.6872;EUGLYCEMIC HYPERINSULINEMIC CLAMP#0.6863;DIFFERENTIAL GENE EXPRESSION#0.6847;INULIN#0.6844;BETA1 ADRENOCEPTOR#0.6832;COMPLEX REGIONAL PAIN SYNDROME#0.6827;ACUTE CEREBRAL ISCHEMIA#0.6826;PEDICLE#0.6826;MYO-INOSITOL#0.6822;ENDOCYTOSIS#0.6816;PROLIFERATIVE VITREORETINOPATHY#0.6790;GUANETHIDINE#0.6789;HYPERURICEMIA#0.6782;ACUTE PULMONARY EMBOLISM#0.6780;ESOPHAGUS#0.6780;TYPE II PNEUMOCYTE#0.6774;CELL ASSOCIATED#0.6773;CELLULAR LOCALISATION#0.6768;PERIODONTAL LIGAMENT#0.6766;CEREBRAL AMYLOID ANGIOPATHY#0.6766;PSEUDOXANTHOMA ELASTICUM#0.6757;DIACYLGLYCEROL KINASE#0.6753;STEM CELL TRANSPLANTATION#0.6747;BONE RESORPTION#0.6743;CATALASE ACTIVITY#0.6740;CONSTITUTIVELY ACTIVE MUTANT#0.6738;CHONDROSARCOMA#0.6729;L-PHENYLEPHRINE#0.6726;RENAL VEIN#0.6723;NALOXONE HYDROCHLORIDE#0.6710;BIRTH DEFECT#0.6705;TRADITIONAL RISK FACTORS#0.6700;LIPOIC ACID#0.6699;DAZOXIBEN#0.6698;PERIPHERAL ARTERY DISEASE#0.6692;SIGNALLING CASCADE#0.6688;BETAMETHASONE#0.6686;OPTIC NEURITIS#0.6681;LUPUS NEPHRITIS#0.6680;MELANOCYTE ADHESION#0.6678;LYMPHATIC ENDOTHELIAL CELL#0.6671;VENOUS INSUFFICIENCY#0.6660;ONCOGENIC#0.6650;WALL SHEAR STRESS#0.6649;CHYMOSTATIN#0.6649;ADVANCED GLYCATION ENDPRODUCT#0.6646;MUSCLE FIBER#0.6646;BETA-ESCIN#0.6643;PROTEOGLYCAN SYNTHESIS#0.6638;LIPOPROTEIN LIPASE#0.6635;PHOSPHOLIPASE A2 INHIBITOR#0.6633;PROTEIN COMPLEX#0.6629;SENSORINEURAL HEARING LOSS#0.6628;COGNITION#0.6623;RETINAL DEGENERATION#0.6623;HUMAN EMBRYONIC STEM#0.6621;DETRUSOR SMOOTH MUSCLE#0.6619;ACTIVATED PROTEIN C#0.6617;LIVER X RECEPTOR#0.6617;KIDNEY DAMAGE#0.6599;PAPILLARY THYROID CARCINOMA#0.6597;CARDIAC ALLOGRAFT VASCULOPATHY#0.6596;LEUCINE UPTAKE#0.6588;MYCOPHENOLATE MOFETIL#0.6588;CIRCULATING ENDOTHELIAL PROGENITOR#0.6588;EVERY OTHER DAY#0.6588;MIDLINE#0.6572;BETA2 ADRENOCEPTOR#0.6570;AMP FORMATION#0.6559;MORRIS WATER MAZE#0.6558;MITOSIS#0.6557;HEART DEVELOPMENT#0.6550;AMYGDALA#0.6549;DERMATITIS#0.6541;PHOSPHOINOSITIDE METABOLISM#0.6540;NUCLEAR LAYER#0.6531;PROGRAMMED CELL DEATH#0.6529;FENOTEROL#0.6527;INCREASE BLOOD PRESSURE#0.6526;RELATIVE GENE EXPRESSION#0.6525;HEMOLYTIC UREMIC SYNDROME#0.6524;ELASTIC FIBER#0.6520;VITAMIN D DEFICIENCY#0.6509;POSTNATAL DAY 7#0.6509;END DIASTOLIC VELOCITY#0.6502;NERVE TERMINAL#0.6491;GROWTH FACTOR BINDING#0.6491;THROMBOPLASTIN#0.6489;THEOPHYLLINE#0.6487;IMMUNOGLOBULIN G#0.6483;BEVACIZUMAB#0.6481;BRONCHIOLITIS OBLITERANS#0.6480;INOSINE#0.6475;MENINGITIS#0.6473;SIGNAL PEPTIDE#0.6461;HYPERTHYROIDISM#0.6459;BRIMONIDINE#0.6453;CLOTTING#0.6452;ANTI APOPTOSIS#0.6448;COLLAGEN TYPE IV#0.6439;TYROSINE HYDROXYLASE ACTIVITY#0.6438;MUSCLE HYPERTROPHY#0.6436;1,10-PHENANTHROLINE#0.6431;PERIPHERAL ARTERIAL DISEASE#0.6429;MEDULLA OBLONGATA#0.6427;AREA UNDER CURVE#0.6427;OVARIAN VEIN#0.6425;MAGNESIUM SULPHATE#0.6413;GLYCOLYSIS#0.6401;IBUPROFEN#0.6400;CHANGE FROM BASELINE#0.6400;TRANSMEMBRANE RECEPTOR#0.6396;OLMESARTAN#0.6391;TRANSCRIPTION FACTOR BINDING#0.6391;ACETYLCHOLINE RECEPTOR#0.6389;NITRIC OXIDE HOMEOSTASIS#0.6389;ADIPOGENESIS#0.6385;IOHEXOL#0.6384;SPATIAL LEARNING#0.6384;M PHASE#0.6384;RESPONSE TO STRESS#0.6378;BONE REMODELING#0.6375;ALLERGIC ASTHMA#0.6374;LITHIUM#0.6369;HEPATITIS B#0.6367;BINDING PROTEIN 3#0.6365;HYDROXYLASE ACTIVITY#0.6361;ENDOMETRIOSIS#0.6359;ASCORBIC ACID#0.6358;MELANOCYTE MIGRATION#0.6354;NEUROTOXICITY#0.6349;G1 PHASE#0.6346;CORONARY MICROVASCULAR DYSFUNCTION#0.6339;ENCEPHALOMYELITIS#0.6339;ASTROCYTOMA#0.6339;DORSAL AORTA#0.6333;HUMAN IMMUNODEFICIENCY VIRUS#0.6323;WHITE MATTER INJURY#0.6318;CARTILAGE MORPHOGENESIS#0.6313;SLEEP DISORDERED BREATHING#0.6312;ALDOSTERONE RECEPTOR#0.6304;MECONIUM ASPIRATION SYNDROME#0.6294;ADENINE NUCLEOSIDE#0.6293;MIGRAINE WITH AURA#0.6293;ILIAC ARTERY#0.6292;OMEPRAZOLE#0.6285;MAP KINASE CASCADE#0.6282;OCULAR HYPERTENSION#0.6281;SUBCLAVIAN ARTERY#0.6280;SODIUM TRANSPORT#0.6274;ESTRADIOL-17BETA#0.6269;CONVULSION#0.6267;PRIMARY MOTOR CORTEX#0.6266;PROTEINASE ACTIVATED RECEPTOR#0.6258;DIABETIC KIDNEY DISEASE#0.6256;UNILATERAL URETERAL OBSTRUCTION#0.6255;FK-506#0.6253;SMOOTH MUSCLE HYPERTROPHY#0.6249;CORNEAL ENDOTHELIAL CELL#0.6249;GINGIVA#0.6248;NORMAL GLUCOSE TOLERANCE#0.6236;DNA FRAGMENTATION#0.6231;OXYTOCIN RECEPTOR#0.6230;LIPID OXIDATION#0.6217;SENSITIZER#0.6214;SOLUBLE FRACTION#0.6213;VEGF SIGNALING#0.6207;OPIOID PEPTIDE#0.6207;INNER EAR#0.6206;HUMAN PROXIMAL TUBULAR#0.6203;LATANOPROST#0.6201;HAIR FOLLICLE#0.6199;LOW TENSION GLAUCOMA#0.6199;MECLOFENAMIC ACID#0.6199;AMITRIPTYLINE#0.6193;CALCINEURIN-NFAT SIGNALING PATHWAY#0.6193;COLLAGEN METABOLISM#0.6187;HUMAN ADIPOSE TISSUE#0.6172;ELECTROLYTE HOMEOSTASIS#0.6164;TUMOR TISSUES#0.6163;SYNCYTIOTROPHOBLAST#0.6163;TRANSDIFFERENTIATION#0.6160;HEMATOPOIETIC STEM CELL#0.6159;HIGH GLUCOSE LEVEL#0.6158;GRAVES' DISEASE#0.6156;OSTEOPOROSIS#0.6155;URETER#0.6153;CELECOXIB#0.6152;CRIMEAN-CONGO HEMORRHAGIC FEVER#0.6141;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6140;REGULATORY LIGHT CHAIN#0.6134;ACUTE LIVER INJURY#0.6133;HISTAMINE RECEPTOR#0.6121;CORONARY ATHEROSCLEROTIC PLAQUE#0.6121;KIDNEY TRANSPLANT RECIPIENTS#0.6117;HYPERINSULINEMIC EUGLYCEMIC CLAMP#0.6114;HYDROXYFASUDIL#0.6112;CATABOLISM#0.6111;OVARIAN FOLLICLE#0.6100;NO BINDING#0.6100;DIATRIZOATE#0.6096;MOUSE EMBRYONIC STEM#0.6092;FOLATE#0.6091;RETINOL BINDING#0.6089;HYPOXIA INDUCED FACTOR#0.6089;UBIQUITIN#0.6087;BODY SURFACE AREA#0.6078;CD4+ T CELL#0.6074;THYROTROPIN RELEASING HORMONE#0.6069;2'-DEOXYURIDINE#0.6065;PYRUVATE#0.6065;PROTEIN SECRETION#0.6061;HERPES SIMPLEX#0.6058;RENNIN#0.6056;URETEROPELVIC JUNCTION OBSTRUCTION#0.6054;CEREBRAL BLOOD VOLUME#0.6046;ATP BINDING#0.6043;CHONDROGENESIS#0.6037;SEVERE PRE-ECLAMPSIA#0.6029;HYPERTENSIVE HEART DISEASE#0.6027;POST-TRANSLATIONAL MODIFICATION#0.6026;COLLAGEN VOLUME FRACTION#0.6026;ACUTE CHEST SYNDROME#0.6025;BRAIN INFARCTION#0.6021;ADVANCED HEART FAILURE#0.6017;B NATRIURETIC PEPTIDE#0.6007;RESPONSE TO HISTAMINE#0.6005
1907	GRANULOSA CELL#1.0368;OVULATION#1.0266;PHOSPHORAMIDON#1.0212;HYPOXIA#1.0163;POLYMERASE CHAIN REACTION#1.0025;ARTERY#0.9978;EPITHELIAL CELL#0.9966;GROWTH FACTOR#0.9963;GASTROINTESTINAL TRACT#0.9923;VASOCONSTRICTION#0.9902;GENE EXPRESSION#0.9891;PULMONARY ARTERY#0.9869;RECEPTOR AGONIST#0.9867;VASOCONSTRICTOR#0.9861;SMOOTH MUSCLE CELL#0.9826;OVARIAN#0.9825;MUSCLE CELL#0.9810;SMOOTH MUSCLE#0.9770;NITRIC OXIDE#0.9769;ENDOTHELIUM#0.9761;ENDOTHELIN RECEPTOR#0.9733;SIGNALING PATHWAY#0.9715;ENDOTHELIAL CELL#0.9677;RECEPTOR ANTAGONIST#0.9670;HYPERTENSION#0.9634;INDOMETHACIN#0.9606;CELL PROLIFERATION#0.9599;PROTEIN KINASE#0.9570;THIORPHAN#0.9559;VASODILATOR#0.9554;VASCULAR SMOOTH MUSCLE CELL#0.9458;PROTEIN KINASE C#0.9359;VASCULAR ENDOTHELIAL CELL#0.9327;FORSKOLIN#0.9306;ENDOTHELIAL GROWTH FACTOR#0.9275;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9275;BLOOD VESSEL#0.9225;CARDIOVASCULAR SYSTEM#0.9164;ADENOCARCINOMA#0.9160;NERVOUS SYSTEM#0.9034;ANGIOGENESIS#0.8879;BOSENTAN#0.8813;REVERSE TRANSCRIPTION#0.8796;TRANSCRIPTASE#0.8761;SIGNAL TRANSDUCTION#0.8740;PHOSPHOLIPASE C#0.8718;HYPOXIA INDUCIBLE FACTOR#0.8699;RECEPTOR BINDING#0.8675;VASCULAR ENDOTHELIUM#0.8658;OOCYTE#0.8625;CORONARY ARTERY#0.8498;PROGESTERONE#0.8493;MACROPHAGE#0.8447;UMBILICAL VEIN#0.8442;OVARIES#0.8425;HYPOXIC#0.8380;GLIAL CELL#0.8321;REACTIVE OXYGEN SPECIES#0.8315;TUMOR CELLS#0.8309;CENTRAL NERVOUS SYSTEM#0.8291;VASODILATION#0.8288;PULMONARY HYPERTENSION#0.8131;FIBROBLAST GROWTH FACTOR#0.8096;CONSTRICTION#0.8061;APOPTOSIS#0.7982;MUSCLE CONTRACTION#0.7980;ESSENTIAL HYPERTENSION#0.7943;CORPUS LUTEUM#0.7905;PROSTACYCLIN#0.7895;SPINAL CORD#0.7823;HUMAN UMBILICAL VEIN#0.7776;CANCER CELL#0.7774;NITRIC OXIDE SYNTHASE#0.7737;SMALL INTESTINE#0.7689;RESPONSE TO ENDOTHELIN#0.7662;ARACHIDONIC ACID#0.7610;ADENYLATE CYCLASE#0.7602;UTERUS#0.7575;ENDOTHELIN A RECEPTOR#0.7535;ARTERIOLE#0.7526;DNA SYNTHESIS#0.7467;MYOCARDIAL INFARCTION#0.7457;MAST CELL#0.7241;STROMAL CELL#0.7159;ISCHEMIA#0.7099;PLATELET-DERIVED GROWTH FACTOR#0.7025;TUMOR NECROSIS FACTOR#0.6964;HISTAMINE#0.6963;L-ARGININE#0.6920;CAPTOPRIL#0.6892;CELL SURFACE#0.6829;PERTUSSIS#0.6748;ACUTE PANCREATITIS#0.6700;TRACHEA#0.6694;NEURITE OUTGROWTH#0.6685;GROWTH FACTOR RECEPTOR#0.6673;ARGININE#0.6658;NEUTROPHIL#0.6648;VERAPAMIL#0.6538;NICARDIPINE#0.6529;ACETYLCHOLINE#0.6495;EPIDERMAL GROWTH FACTOR#0.6482;NOREPINEPHRINE#0.6424;ASTROCYTE#0.6410;ATHEROSCLEROSIS#0.6395;THYMIDINE#0.6334;ADENYLATE#0.6331;DEXAMETHASONE#0.6326;ENDOMETRIUM#0.6306;NIFEDIPINE#0.6305;MENSTRUAL CYCLE#0.6294;CYCLIC AMP#0.6287;ALDOSTERONE#0.6219;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6182;SIGNALLING PATHWAY#0.6167;MEMBRANE FRACTION#0.6166;CALCIUM CHANNEL#0.6146;MULLER CELL#0.6131;STEM CELL#0.6124;TRYPSINOGEN ACTIVATION#0.6113;CHEMOTAXIS#0.6111;NITRO-L-ARGININE#0.6036;HEDGEHOG SIGNALING PATHWAY#0.6026;CEREBRAL CORTEX#0.6011;VASOPRESSIN#0.6010
1908	STEM CELL FACTOR#1.0296;MELANOCYTE#1.0277;ASTROCYTE#1.0233;RESPONSE TO ENDOTHELIN#1.0216;NOREPINEPHRINE#1.0143;ENDOTHELIN B RECEPTOR#1.0101;STEM CELL#1.0080;VASODILATOR#1.0078;GLIAL CELL#1.0062;HIRSCHSPRUNG'S DISEASE#1.0027;ENTERIC NERVOUS SYSTEM#1.0026;NEURAL CREST CELL#1.0024;RECEPTOR AGONIST#1.0022;PULMONARY ARTERY#1.0022;PHOSPHORAMIDON#0.9993;EPITHELIAL CELL#0.9987;GROWTH FACTOR#0.9982;VASODILATION#0.9957;NEURAL CREST#0.9951;PHOSPHOLIPASE C#0.9939;INDOMETHACIN#0.9925;BOSENTAN#0.9904;ENDOTHELIUM#0.9896;SIGNALING PATHWAY#0.9895;L-ARGININE#0.9888;ACETYLCHOLINE#0.9888;NITRO-L-ARGININE#0.9875;VASOCONSTRICTION#0.9873;CONSTRICTION#0.9854;ARTERY#0.9851;NERVOUS SYSTEM#0.9841;ARGININE#0.9837;NG-NITRO-L-ARGININE#0.9834;CELL PROLIFERATION#0.9823;SIGNAL TRANSDUCTION#0.9816;VASODILATATION#0.9815;NITRIC OXIDE#0.9813;CORONARY ARTERY#0.9801;POLYMERASE CHAIN REACTION#0.9799;VASOPRESSIN#0.9798;PROTEIN KINASE C#0.9792;VASCULAR SMOOTH MUSCLE CELL#0.9789;SPINAL CORD#0.9783;MEMBRANE FRACTION#0.9772;TRANSCRIPTION FACTOR#0.9772;NITRIC OXIDE SYNTHASE#0.9772;GENE EXPRESSION#0.9769;EXCRETION#0.9768;MESENTERIC ARTERY#0.9760;PROTEIN KINASE#0.9758;REVERSE TRANSCRIPTION#0.9757;HYPOXIA#0.9750;GUANYLATE CYCLASE#0.9746;VASOCONSTRICTOR#0.9727;SMOOTH MUSCLE CELL#0.9716;RECEPTOR BINDING#0.9716;RECEPTOR ANTAGONIST#0.9714;ENDOTHELIAL CELL#0.9714;MUSCLE CELL#0.9712;CYCLIC AMP#0.9710;ENDOTHELIN A RECEPTOR#0.9698;PERTUSSIS#0.9698;ENDOTHELIN RECEPTOR#0.9680;SIGNALLING PATHWAY#0.9662;HYPERTENSION#0.9652;SMOOTH MUSCLE#0.9642;TRACHEA#0.9631;BLOOD VESSEL#0.9576;GLOMERULAR FILTRATION#0.9574;DNA SYNTHESIS#0.9571;GLOMERULAR FILTRATION RATE#0.9552;CENTRAL NERVOUS SYSTEM#0.9541;ENDOTHELIUM-DERIVED RELAXING FACTOR#0.9528;NIFEDIPINE#0.9496;PHENYLEPHRINE#0.9452;MUSCLE CONTRACTION#0.9389;CALCIUM CHANNEL#0.9384;VASCULAR ENDOTHELIAL CELL#0.9362;ARTERIOLE#0.9345;DOPAMINE#0.9274;FIBROBLAST GROWTH FACTOR#0.9256;CELL GROWTH#0.9229;RENAL ARTERY#0.9188;ARACHIDONIC ACID#0.9161;PULMONARY HYPERTENSION#0.9134;MEGACOLON#0.9063;ENZYME ACTIVITY#0.9062;GANGLION CELLS#0.8987;PROSTAGLANDIN E2#0.8970;CARBACHOL#0.8964;PLASMA MEMBRANE#0.8920;SMALL INTESTINE#0.8885;SCHWANN CELL#0.8873;MESANGIAL CELL#0.8836;PITUITARY GLAND#0.8827;UMBILICAL VEIN#0.8806;PLATELET-DERIVED GROWTH FACTOR#0.8766;PROSTACYCLIN#0.8764;NORADRENALINE#0.8758;ISCHEMIA#0.8755;RECEPTOR LIGAND#0.8709;MELANOCYTE DIFFERENTIATION#0.8626;MITOGEN ACTIVATED PROTEIN#0.8608;ISOPROTERENOL#0.8605;HYPOXIC#0.8594;HEPATOCYTE GROWTH FACTOR#0.8561;THORACIC AORTA#0.8549;GAP JUNCTION#0.8539;THYMIDINE#0.8490;RECEPTOR TYROSINE KINASE#0.8467;HUMAN UMBILICAL VEIN#0.8347;PROGESTERONE#0.8345;TRANSCRIPTASE#0.8315;OVARIAN#0.8313;MESENCHYMAL CELL#0.8309;STEROIDOGENESIS#0.8274;MYOCARDIUM#0.8232;SMOOTH MUSCLE CONTRACTION#0.8229;TETRODOTOXIN#0.8161;VASCULAR ENDOTHELIUM#0.8161;GUANOSINE#0.8137;FOREARM#0.8100;NEPHRON#0.8092;FORSKOLIN#0.8070;CEREBRAL CORTEX#0.8062;TUMOR NECROSIS FACTOR#0.8042;CELL MIGRATION#0.8036;PRECURSOR CELL#0.7953;ADENOSINE#0.7926;MAP KINASE#0.7898;CELL SURFACE#0.7892;ENDOTHELIAL GROWTH FACTOR#0.7890;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7890;NITRIC OXIDE SYNTHESIS#0.7880;CERVICAL#0.7861;VERAPAMIL#0.7852;ARGININE VASOPRESSIN#0.7837;APOPTOSIS#0.7807;MENSTRUAL CYCLE#0.7799;HYPOTENSIVE#0.7777;NITROPRUSSIDE#0.7772;NOREPINEPHRINE UPTAKE#0.7750;UTERUS#0.7744;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7738;HISTAMINE#0.7738;NOS ACTIVITY#0.7729;CANCER CELL#0.7707;ENDOTHELIN TYPE B#0.7693;METASTATIC MELANOMA#0.7668;GRANULOSA CELL#0.7666;ENDOTHELIN SIGNALING PATHWAY#0.7642;ATROPINE#0.7634;HEMORRHAGE#0.7604;EPIDERMAL GROWTH FACTOR#0.7601;COLLECTING DUCTS#0.7575;PROGENITOR CELL#0.7564;GASTROINTESTINAL TRACT#0.7512;GROWTH HORMONE#0.7469;CELL MEMBRANE#0.7423;ADRENAL GLAND#0.7387;HYPOTENSION#0.7386;MECHANISM OF ACTION#0.7383;CELL DEATH#0.7377;STREPTOZOTOCIN#0.7367;ADENYLATE CYCLASE#0.7304;AORTIC SMOOTH MUSCLE CELLS#0.7280;HEARING LOSS#0.7245;MACROPHAGE#0.7236;ACETIC ACID#0.7233;CERVICAL CANCER#0.7219;ANGIOGENESIS#0.7193;MOLAR#0.7193;DIABETES MELLITUS#0.7165;AIRWAY SMOOTH MUSCLE#0.7149;RED BLOOD CELL#0.7139;TRANSFORMING GROWTH FACTOR#0.7110;CAMP FORMATION#0.7103;POTASSIUM CHANNEL#0.7086;CGMP FORMATION#0.7075;NEUROTRANSMISSION#0.7063;NICARDIPINE#0.7051;PORTAL VEIN#0.7045;MICROPHTHALMIA#0.6986;HINDGUT#0.6970;CELL DIFFERENTIATION#0.6960;GROWTH FACTOR RECEPTOR#0.6875;GALLBLADDER#0.6821;BREAST CARCINOMA#0.6815;NATRIURESIS#0.6811;NERVOUS SYSTEM DEVELOPMENT#0.6802;MYOMETRIUM#0.6800;N-NITRO-L-ARGININE#0.6787;SYSTEM DEVELOPMENT#0.6784;ENTERIC NERVOUS SYSTEM DEVELOPMENT#0.6782;MYOCYTES#0.6756;GUANINE#0.6753;MESENTERY#0.6746;FACTOR I#0.6721;PROLACTIN SECRETION#0.6718;TYROSINE KINASE RECEPTOR#0.6714;INSULIN-LIKE GROWTH FACTOR#0.6708;CONGENITAL DISORDER#0.6700;MOTOR ACTIVITY#0.6682;ATHEROSCLEROSIS#0.6669;STRESS FIBER#0.6664;NORLEUCINE#0.6653;CHOLERA#0.6649;STAUROSPORINE#0.6647;STROMAL CELL#0.6633;NITRIC OXIDE FORMATION#0.6611;BASILAR ARTERY#0.6609;THIORPHAN#0.6599;METHOXAMINE#0.6583;ENZYME INHIBITOR#0.6562;TYROSINE HYDROXYLASE ACTIVITY#0.6540;PROTEIN KINASE C ACTIVATION#0.6535;SKELETAL MUSCLE#0.6503;STRIATUM#0.6501;ENDOMETRIUM#0.6464;HYDROXYLASE ACTIVITY#0.6464;CAROTID ARTERY#0.6436;METASTATIC MELANOMA CELLS#0.6423;MAST CELL#0.6412;UMBILICAL ARTERY#0.6358;CARDIOVASCULAR SYSTEM#0.6340;DIURESIS#0.6331;PHOSPHOLIPASE A2#0.6270;TESTOSTERONE#0.6242;VENULE#0.6226;RENIN ACTIVITY#0.6218;CORTICOSTEROID SECRETION#0.6190;GUANYLATE CYCLASE INHIBITOR#0.6162;SODIUM NITROPRUSSIDE#0.6136;URETHANE#0.6133;INTESTINAL OBSTRUCTION#0.6112;ADENYLATE#0.6109;IONOPHORE#0.6078;PHOSPHOINOSITIDE METABOLISM#0.6075;SENSORINEURAL HEARING LOSS#0.6050;ATRIAL CELL#0.6042;ALANINE#0.6034
1909	ENDOTHELIN TYPE A#1.0503;AIRWAY SMOOTH MUSCLE#1.0369;BOSENTAN#1.0302;ADRENAL CORTEX#1.0202;PHOSPHOLIPASE C#1.0157;BREAST CANCER#1.0157;CAROTID ARTERY#1.0127;RENAL ARTERY#1.0116;MUSCLE CONTRACTION#1.0104;NEURAL CREST#1.0098;ENDOTHELIN A RECEPTOR#1.0092;RECEPTOR BINDING#1.0088;CELL SURFACE#1.0084;TRANSCRIPTASE#1.0070;RECEPTOR ANTAGONIST#1.0062;OVARIAN#1.0055;VASODILATION#1.0050;BLOOD VESSEL#1.0046;CONSTRICTION#1.0046;RESPONSE TO ENDOTHELIN#1.0025;CANCER CELL#1.0003;HYPOXIC#0.9993;REVERSE TRANSCRIPTION#0.9987;POLYMERASE CHAIN REACTION#0.9978;ISCHEMIA#0.9965;OVARIAN CANCER#0.9964;SMOOTH MUSCLE CONTRACTION#0.9961;HYPOXIA#0.9949;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9946;VASOCONSTRICTION#0.9942;ENDOTHELIN TYPE B#0.9942;NEURAL CREST CELL#0.9939;ENDOTHELIAL GROWTH FACTOR#0.9935;ANGIOGENESIS#0.9931;PROSTATE CANCER#0.9931;MYOCARDIUM#0.9930;VASCULAR SMOOTH MUSCLE CELL#0.9922;SIGNAL TRANSDUCTION#0.9917;ALDOSTERONE#0.9912;SPINAL CORD#0.9911;LOSARTAN#0.9905;EPITHELIAL CELL#0.9899;CARDIOMYOCYTE#0.9898;ASTROCYTE#0.9886;VASODILATOR#0.9882;SMOOTH MUSCLE#0.9881;APOPTOSIS#0.9871;ENZYME INHIBITOR#0.9868;ENDOTHELIN RECEPTOR#0.9867;CONGESTIVE HEART FAILURE#0.9866;RECEPTOR AGONIST#0.9864;TRANSFORMING GROWTH FACTOR#0.9861;PULMONARY ARTERY#0.9858;CELL PROLIFERATION#0.9852;SIGNALING PATHWAY#0.9852;NITRIC OXIDE SYNTHASE#0.9848;SMOOTH MUSCLE CELL#0.9844;MESANGIAL CELL#0.9843;MUSCLE CELL#0.9832;VASODILATATION#0.9832;PROTEIN KINASE C#0.9827;CELL GROWTH#0.9817;PULMONARY ARTERIAL HYPERTENSION#0.9816;NADPH OXIDASE#0.9816;CORONARY ARTERY#0.9815;NITRO-L-ARGININE#0.9803;MITOGEN ACTIVATED PROTEIN#0.9798;FOREARM#0.9795;L-ARGININE#0.9790;PROTEIN KINASE#0.9783;CARDIOVASCULAR SYSTEM#0.9781;ARTERY#0.9781;ARTERIOLE#0.9778;INDOMETHACIN#0.9763;ENDOTHELIUM#0.9763;ADRENAL GLAND#0.9761;GENE EXPRESSION#0.9754;TUMOR CELLS#0.9753;ARGININE#0.9752;ENDOTHELIN B RECEPTOR#0.9745;ENDOTHELIAL CELL#0.9743;PULMONARY HYPERTENSION#0.9738;ANGIOTENSIN CONVERTING ENZYME#0.9735;VASCULAR ENDOTHELIAL CELL#0.9731;GROWTH FACTOR#0.9720;PROSTACYCLIN#0.9706;TRACHEA#0.9703;PLASMA MEMBRANE#0.9699;MACROPHAGE#0.9698;ACE INHIBITOR#0.9691;VASOCONSTRICTOR#0.9690;T CELL#0.9686;NITRIC OXIDE#0.9684;QUANTITATIVE REAL TIME#0.9682;HYPERTENSION#0.9678;TRANSCRIPTION FACTOR#0.9670;MYOCYTES#0.9669;DNA SYNTHESIS#0.9664;STRUCTURE ACTIVITY RELATIONSHIP#0.9642;ATHEROSCLEROSIS#0.9635;EXCRETION#0.9623;VASOPRESSIN#0.9612;MYOMETRIUM#0.9595;LUNG FIBROBLASTS#0.9589;MYOCARDIAL INFARCTION#0.9576;ENDOMETRIUM#0.9561;NERVOUS SYSTEM#0.9542;ENDOTHELIAL NITRIC OXIDE#0.9535;HEMORRHAGE#0.9497;GLOMERULAR FILTRATION#0.9453;ACETYLCHOLINE#0.9435;SIGNALLING PATHWAY#0.9425;TRANSFORMING GROWTH FACTOR BETA#0.9419;STREPTOZOTOCIN#0.9374;TUMOR NECROSIS FACTOR#0.9345;ARACHIDONIC ACID#0.9332;NOS INHIBITOR#0.9329;MIGRAINE#0.9325;PROTEINURIA#0.9319;CELL MIGRATION#0.9291;GLOMERULAR FILTRATION RATE#0.9258;KIDNEY DISEASE#0.9254;ADIPOCYTE#0.9236;GESTATION#0.9235;NEPHROPATHY#0.9229;PERIPHERAL BLOOD#0.9218;MESENTERIC ARTERY#0.9213;PORTAL VEIN#0.9170;EXTRACELLULAR MATRIX#0.9152;KINASE INHIBITOR#0.9103;SUPEROXIDE DISMUTASE#0.9097;CEREBRAL ISCHEMIA#0.9087;RECEPTOR LIGAND#0.9070;GROWTH FACTOR RECEPTOR#0.9063;CONNECTIVE TISSUE#0.9046;THYMIDINE#0.9035;SYSTOLIC BLOOD PRESSURE#0.9024;LEUKOCYTE#0.9016;THORACIC AORTA#0.9013;PHOSPHORAMIDON#0.8997;BREAST CARCINOMA#0.8951;ADRENERGIC RECEPTOR#0.8938;NOREPINEPHRINE#0.8930;PHENYLEPHRINE#0.8914;OSTEOBLAST#0.8903;CARDIOMYOPATHY#0.8896;VASCULAR ENDOTHELIUM#0.8889;DIABETIC NEPHROPATHY#0.8872;OVARIAN CARCINOMA#0.8851;REACTIVE OXYGEN SPECIES#0.8836;NEUTROPHIL#0.8824;INFLAMMATORY RESPONSE#0.8820;BASILAR ARTERY#0.8799;INDUCIBLE NITRIC OXIDE#0.8769;SITAXSENTAN#0.8766;DIABETES MELLITUS#0.8735;CHRONIC HEART FAILURE#0.8719;TYPE 2 DIABETES#0.8709;HEART DISEASE#0.8708;VIRAL INFECTION#0.8707;VASCULAR CELL#0.8686;BREAST CANCER CELL#0.8680;PERTUSSIS#0.8680;UTERUS#0.8658;ADENYLATE CYCLASE#0.8604;GRANULOSA CELL#0.8601;CAMP FORMATION#0.8586;ARTERY DISEASE#0.8573;MAST CELL#0.8567;SODIUM NITROPRUSSIDE#0.8550;SMOOTH MUSCLE ACTIN#0.8520;PROGESTERONE#0.8510;DILATED CARDIOMYOPATHY#0.8502;STROMA#0.8494;CORONARY ARTERY DISEASE#0.8465;INTRACRANIAL ANEURYSM#0.8449;STROMAL CELL#0.8446;COLLAGEN SYNTHESIS#0.8419;CENTRAL NERVOUS SYSTEM#0.8413;CALCIUM CHANNEL#0.8405;SULFONAMIDE#0.8397;RESPIRATORY TRACT#0.8394;MELANOCYTE#0.8338;VASCULAR DISEASE#0.8337;PODOCYTE#0.8331;APOPTOTIC#0.8323;KUPFFER CELL#0.8318;ESSENTIAL HYPERTENSION#0.8294;MAP KINASE#0.8254;ADENOSINE#0.8253;ATHEROSCLEROTIC#0.8249;EPIDERMAL GROWTH FACTOR#0.8186;NG-NITRO-L-ARGININE#0.8163;HEPATIC STELLATE CELL#0.8116;NITROPRUSSIDE#0.8086;CYCLIC AMP#0.8075;TOXICITY#0.8061;OOCYTE#0.8051;MENSTRUAL CYCLE#0.8032;STEM CELL#0.8020;CARDIAC MUSCLE#0.7926;RECEPTOR ACTIVITY#0.7925;IMMUNE CELL#0.7850;MONOCYTE#0.7820;SERTOLI CELL#0.7814;NORADRENALINE#0.7800;SKELETAL MUSCLE#0.7760;CELL DEATH#0.7756;EDEMA#0.7752;CEREBRAL CORTEX#0.7742;OXYGENASE#0.7723;CELL ADHESION#0.7711;BRANCHIAL ARCH#0.7703;CAVEOLAE#0.7622;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7615;THYMOCYTE PROLIFERATION#0.7592;ARGININE VASOPRESSIN#0.7592;RETINOIC ACID#0.7563;TRANSACTIVATION#0.7561;MYOFIBROBLAST#0.7523;PROSTAGLANDIN E2#0.7521;CELL MEMBRANE#0.7498;PANCREATITIS#0.7482;ADENYLATE#0.7452;RNA SPLICING#0.7431;SIGNALING CASCADE#0.7418;PLATELET-DERIVED GROWTH FACTOR#0.7418;UMBILICAL VEIN#0.7417;GASTROINTESTINAL TRACT#0.7417;TROPHOBLAST#0.7413;SUBSTANCE P#0.7408;IMPETIGO#0.7400;ALANINE#0.7393;ISCHEMIA REPERFUSION INJURY#0.7391;LIVER METASTASIS#0.7389;PRO-INFLAMMATORY#0.7381;PORTAL HYPERTENSION#0.7372;CELL CYCLE#0.7368;CELL ADHESION MOLECULE#0.7337;SKIN FIBROBLASTS#0.7328;ARRHYTHMIA#0.7288;AORTIC SMOOTH MUSCLE CELLS#0.7263;SCLERODERMA#0.7255;MELANOMA CELL LINES#0.7224;CHRONIC KIDNEY DISEASE#0.7203;CALCIUM SIGNALING#0.7189;PROTEIN SYNTHESIS#0.7177;ENDOPLASMIC RETICULUM#0.7170;QUANTITATIVE REVERSE TRANSCRIPTION#0.7152;BONE MARROW#0.7147;OBESE#0.7058;ALDOSTERONE SECRETION#0.7050;HYPOTENSIVE#0.7041;PARENCHYMA#0.7018;RENIN ACTIVITY#0.6988;CEREBRAL ARTERY#0.6974;LUNG DISEASE#0.6971;NEUROBLASTOMA#0.6961;EPITHELIAL OVARIAN CANCER#0.6942;ETHANOL#0.6938;CISPLATIN#0.6936;ANGIOTENSIN TYPE 1#0.6929;VASCULAR SMOOTH MUSCLE CONTRACTION#0.6906;LEIOMYOMA#0.6902;LEFT ANTERIOR DESCENDING#0.6864;END ORGAN DAMAGE#0.6859;URINARY BLADDER#0.6838;HUMAN PULMONARY ARTERY#0.6834;HUMAN UMBILICAL VEIN#0.6818;DUCTUS ARTERIOSUS#0.6793;NEPHRON#0.6771;CORPUS LUTEUM#0.6751;MICROVASCULAR ENDOTHELIAL CELL#0.6726;HORMONE SECRETION#0.6719;UPPER JAW#0.6717;MIDDLE CEREBRAL ARTERY#0.6716;LIPOLYSIS#0.6715;ACUTE MYOCARDIAL INFARCTION#0.6712;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6708;INTIMA MEDIA THICKNESS#0.6684;SCIATIC NERVE#0.6677;CRANIOFACIAL DEVELOPMENT#0.6673;CARBACHOL#0.6669;BASAL CELL#0.6661;CYCLOSPORINE#0.6649;VIRULENCE#0.6629;ISOPROTERENOL#0.6620;ISCHEMIC HEART DISEASE#0.6565;CARDIOVASCULAR RISK FACTOR#0.6531;IMMUNE SYSTEM#0.6509;COLLECTING DUCTS#0.6508;EXTRACELLULAR REGION#0.6497;OUABAIN#0.6491;N-OMEGA-NITRO-L-ARGININE#0.6488;CARDIAC NEURAL CREST#0.6477;LYSINE#0.6473;CELECOXIB#0.6467;HEMORRHAGIC#0.6461;GLUTATHIONE#0.6453;CELLULAR LOCALIZATION#0.6450;NIFEDIPINE#0.6446;ENDOCYTOSIS#0.6432;TYPE 1 DIABETES#0.6423;NORLEUCINE#0.6423;WOUND HEALING#0.6406;LOW DENSITY LIPOPROTEIN#0.6361;ATROPINE#0.6361;PHOSPHOLIPASE C ACTIVATION#0.6351;VENTRICULAR CARDIOMYOCYTE#0.6347;L-NNA#0.6342;MANDIBLE#0.6326;NOCICEPTION#0.6319;DARUSENTAN#0.6280;MESENCHYME#0.6272;STRESS FIBER#0.6252;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6241;HYPERSENSITIVITY#0.6234;TRAUMATIC BRAIN INJURY#0.6228;PERICYTE#0.6222;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6216;N-NITRO-L-ARGININE#0.6184;ANGIOTENSIN RECEPTOR#0.6162;CEREBRAL ARTERY OCCLUSION#0.6152;THYMOCYTE#0.6146;ENDOTHELIUM DEPENDENT VASODILATATION#0.6143;NUCLEOTIDE BINDING#0.6139;BLOOD UREA NITROGEN#0.6119;SITAXENTAN#0.6091;GLIAL CELL#0.6084;LUNG CANCER#0.6084;ASTROCYTOMA#0.6081;DETRUSOR SMOOTH MUSCLE#0.6079;D-TRYPTOPHAN#0.6065;CONGENITAL DIAPHRAGMATIC HERNIA#0.6059;CERVICAL#0.6037;TISSUE GROWTH FACTOR#0.6021;SLEEP APNEA#0.6017
190	NUCLEAR HORMONE RECEPTOR BINDING#1.1430;HORMONE RECEPTOR BINDING#1.0745;X-LINKED ADRENAL HYPOPLASIA CONGENITA#1.0634;COLITIS#1.0419;GLYCEROL KINASE#1.0399;X CHROMOSOME#1.0387;NUCLEAR HORMONE RECEPTOR#1.0377;RECEPTOR BINDING#1.0254;HYPOGONADOTROPIC HYPOGONADISM#1.0254;FARNESOID X RECEPTOR#1.0253;NUCLEAR RECEPTOR SUPERFAMILY#1.0245;LIVER X RECEPTOR#1.0230;SEX DIFFERENTIATION#1.0214;SERTOLI CELL#1.0213;PRECOCIOUS PUBERTY#1.0207;HYPOGONADISM#1.0182;SPERMATOGENESIS#1.0172;PEROXISOME#1.0171;STEROIDOGENIC FACTOR 1#1.0162;GRANULOSA CELL#1.0124;RECEPTOR ACTIVITY#1.0121;ADRENAL CORTEX#1.0067;ADIPOCYTE#1.0065;LEYDIG CELL#1.0058;GONADAL DYSGENESIS#1.0056;ANDROGEN RECEPTOR#1.0035;TESTIS DEVELOPMENT#1.0018;STEROIDOGENESIS#1.0017;EMBRYONIC STEM CELL#1.0009;ADRENAL GLAND#1.0003;SEX DETERMINATION#0.9993;ADIPOGENESIS#0.9986;BREAST CANCER#0.9971;MUSCULAR DYSTROPHY#0.9965;ADIPOCYTE DIFFERENTIATION#0.9958;TRANSACTIVATION#0.9950;RECEPTOR LIGAND#0.9939;LIPID METABOLISM#0.9938;CYTOCHROME P450#0.9936;GERM CELL#0.9932;CELL DIFFERENTIATION#0.9909;RETINOID X RECEPTOR#0.9907;GONAD#0.9906;OVARIAN#0.9903;LIGAND BINDING DOMAIN#0.9891;SMALL HETERODIMER PARTNER#0.9885;RELATED ORPHAN RECEPTOR#0.9885;DNA BINDING#0.9882;PUBERTY#0.9870;RETINOIC ACID RECEPTOR#0.9861;POLYMERASE CHAIN REACTION#0.9859;HEPATOCYTE NUCLEAR FACTOR#0.9853;ESTROGEN RECEPTOR#0.9847;RETINOIC ACID#0.9844;STEM CELL#0.9823;THYROID HORMONE RECEPTOR#0.9812;TRANSCRIPTION FACTOR#0.9800;MOUSE EMBRYONIC STEM#0.9792;TESTICULAR DEVELOPMENT#0.9790;PROGESTERONE#0.9787;VITAMIN D RECEPTOR#0.9771;SIGNALING PATHWAY#0.9770;CELL PROLIFERATION#0.9753;PROSTATE CANCER#0.9751;COLON CANCER#0.9739;TUMOR CELLS#0.9734;REVERSE TRANSCRIPTION#0.9731;GLYCEROL KINASE DEFICIENCY#0.9718;GLUCOCORTICOID RECEPTOR#0.9713;CANCER CELL#0.9693;GROWTH FACTOR#0.9693;GENE EXPRESSION#0.9677;NERVOUS SYSTEM#0.9674;QUANTITATIVE REAL TIME#0.9669;TESTOSTERONE#0.9665;CELL CYCLE#0.9664;OVARIES#0.9660;STEROID RECEPTOR COACTIVATOR#0.9653;EPITHELIAL CELL#0.9651;APOPTOSIS#0.9646;PROTEIN KINASE#0.9638;Y CHROMOSOME#0.9634;BREAST CANCER CELL#0.9601;CELL GROWTH#0.9592;GLUCOSE HOMEOSTASIS#0.9529;TYPE 2 DIABETES#0.9510;PITUITARY GLAND#0.9500;CORTISOL#0.9478;ESTRADIOL#0.9455;IMMUNE RESPONSE#0.9453;HYPOTHALAMIC PITUITARY ADRENAL#0.9449;TUMOR SUPPRESSOR#0.9446;DUCHENNE MUSCULAR DYSTROPHY#0.9406;MACROPHAGE#0.9390;ADIPOSE TISSUE#0.9378;CYTOPLASM#0.9377;CENTRAL NERVOUS SYSTEM#0.9355;OVARIAN DEVELOPMENT#0.9296;T CELL#0.9295;GLUCOSE METABOLISM#0.9283;HISTONE DEACETYLASE#0.9282;TRANSFORMING GROWTH FACTOR#0.9274;LIVER RECEPTOR HOMOLOG#0.9224;SKELETAL MUSCLE#0.9176;INFERTILITY#0.9138;FATTY ACID METABOLISM#0.9108;CELL DEATH#0.9099;REGULATION OF STEROIDOGENESIS#0.9097;STEROID BIOSYNTHESIS#0.9089;ALDOSTERONE#0.9076;SIGNAL TRANSDUCTION#0.9054;ADRENOCORTICAL CARCINOMA#0.9035;PROTEIN PROTEIN INTERACTION#0.9026;MENTAL RETARDATION#0.9017;OVARIAN FOLLICLE#0.9014;PRO-INFLAMMATORY#0.8997;ATHEROSCLEROSIS#0.8986;SIGNALLING PATHWAY#0.8944;ESTROGEN RECEPTOR ALPHA#0.8857;ONCOGENIC#0.8834;HUMAN BREAST CANCER#0.8830;PERIPHERAL BLOOD#0.8820;GONADOGENESIS#0.8803;PEROXISOME PROLIFERATION#0.8755;ESTROGENS#0.8747;MUTAGENESIS#0.8738;RECEPTOR COMPLEX#0.8724;ADRENOCORTICOTROPIC HORMONE#0.8709;RNA INTERFERENCE#0.8699;PREGNANE X RECEPTOR#0.8669;ELECTROPHORETIC MOBILITY SHIFT#0.8645;LUNG ADENOCARCINOMA#0.8642;ADENOCARCINOMA#0.8600;HIGH FAT DIET#0.8580;HYPERTENSION#0.8554;LYMPH NODE#0.8544;GONAD DEVELOPMENT#0.8537;FATTY ACID OXIDATION#0.8527;KALLMANN SYNDROME#0.8483;PEROXISOMAL#0.8437;UBIQUITIN#0.8415;ROSIGLITAZONE#0.8394;MECHANISM OF ACTION#0.8392;AZOOSPERMIA#0.8384;TOXICITY#0.8380;CONSTITUTIVE ANDROSTANE RECEPTOR#0.8327;MITOGEN ACTIVATED PROTEIN#0.8308;DIABETES MELLITUS#0.8307;INFLAMMATORY RESPONSE#0.8300;ADRENAL HYPERPLASIA#0.8276;REPRODUCTIVE SYSTEM#0.8237;PROGENITOR CELL#0.8204;MUSCLE CELL#0.8198;INFLAMMATORY BOWEL DISEASE#0.8137;ORGANOGENESIS#0.8127;COPY NUMBER VARIATION#0.8119;FOLLICLE STIMULATING HORMONE#0.8102;OOCYTE#0.8020;CELL SURFACE#0.8020;STEROID HORMONE RECEPTOR#0.7978;COLORECTAL#0.7918;DETOXIFICATION#0.7891;LIPID HOMEOSTASIS#0.7891;ESTROGEN RELATED RECEPTOR#0.7880;RECEPTOR INTERACTING PROTEIN#0.7877;GONADOTROPIN RELEASING HORMONE#0.7825;SIGNALING MOLECULE#0.7815;PITUITARY ADENOMA#0.7808;DEXAMETHASONE#0.7805;COLORECTAL CANCER#0.7790;EPIDERMAL GROWTH FACTOR#0.7767;DIAPAUSE#0.7742;AUTOIMMUNE DISEASE#0.7736;SMOOTH MUSCLE#0.7711;PROTEASOME#0.7657;ONCOGENESIS#0.7630;CONGENITAL ADRENAL HYPERPLASIA#0.7617;ENDOPLASMIC RETICULUM#0.7604;TH17 CELL#0.7594;GLUTATHIONE#0.7592;EWING SARCOMA#0.7575;TRANSFORMING GROWTH FACTOR BETA#0.7549;IMMUNE SYSTEM#0.7532;NITRIC OXIDE#0.7482;KERATINOCYTE#0.7420;FACTOR I#0.7414;FSH-BETA#0.7401;TRANSCRIPTASE#0.7335;9-CIS-RETINOIC ACID#0.7332;PROTEIN KINASE A#0.7318;EPITHELIAL OVARIAN CARCINOMA#0.7313;FORSKOLIN#0.7312;GLAND DEVELOPMENT#0.7300;LEUCINE#0.7273;ULCERATIVE COLITIS#0.7226;METAMORPHOSIS#0.7194;IMMUNE CELL#0.7188;LUNG CANCER#0.7181;GROWTH FACTOR RECEPTOR#0.7170;OVARIAN CARCINOMA#0.7155;PROTEIN COMPLEX#0.7152;LEUKOCYTE#0.7150;46 XY GONADAL DYSGENESIS#0.7123;REPORTER GENE ASSAY#0.7122;COMPLEX I#0.7076;RECEPTOR AGONIST#0.7066;PERIPHERAL BLOOD LEUKOCYTE#0.7040;AUTOPHAGY#0.7003;CAMP RESPONSE ELEMENT#0.7003;ENERGY HOMEOSTASIS#0.7000;HYPOXIA#0.6985;WOUND HEALING#0.6956;VITAMIN D3#0.6954;HIGH DENSITY LIPOPROTEIN#0.6936;LYMPHOID CELL#0.6924;HEPATITIS B VIRUS#0.6920;HEPATITIS B#0.6905;RETE TESTIS#0.6880;DELAYED PUBERTY#0.6864;PROGESTERONE SYNTHESIS#0.6859;ESTROGEN RESPONSE ELEMENT#0.6852;STEROID SYNTHESIS#0.6846;PROTEIN BINDING#0.6839;INSULIN RECEPTOR#0.6806;GROWTH HORMONE#0.6806;EXTRACELLULAR MATRIX#0.6770;CHOLESTEROL EFFLUX#0.6765;CAMP RESPONSE ELEMENT BINDING#0.6752;BREAST CARCINOMA#0.6735;CELL DEVELOPMENT#0.6716;MONOCYTE#0.6711;VITAMIN A#0.6703;DENDRITIC CELL#0.6699;APOPTOTIC#0.6605;TYPE 2 DIABETES MELLITUS#0.6605;2 DIABETES MELLITUS#0.6605;SUMOYLATION#0.6577;REACTIVE OXYGEN SPECIES#0.6573;C TERMINAL DOMAIN#0.6563;SENSITIZER#0.6562;PRECURSOR CELL#0.6561;UBIQUITIN PROTEASOME PATHWAY#0.6561;INHIBIN#0.6548;PROTEASOME PATHWAY#0.6546;INFLAMMATORY CELL#0.6538;MAMMARY GLAND#0.6486;AKT SIGNALING#0.6482;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6470;STROMAL CELL#0.6454;TRANSCRIPTIONAL CONTROL#0.6452;CHROMATIN REMODELING#0.6450;HYDROCORTISONE#0.6423;MAP KINASE#0.6418;SIGNALING CASCADE#0.6418;LYSINE#0.6407;PROTEIN SYNTHESIS#0.6399;TUMOR NECROSIS FACTOR#0.6372;CHOLESTEROL METABOLISM#0.6296;STEROL REGULATORY ELEMENT#0.6284;ADENOSINE#0.6278;ARGININE#0.6256;SMOOTH MUSCLE CELL#0.6222;RNA BINDING#0.6216;TROGLITAZONE#0.6139;RHABDOMYOSARCOMA#0.6115;ATP BINDING CASSETTE#0.6115;ATP BINDING#0.6101;PREADIPOCYTE#0.6097;RECEPTOR ANTAGONIST#0.6095;INSULIN-LIKE GROWTH FACTOR#0.6075;NUCLEAR BODY#0.6072;SEX CHROMOSOME#0.6069;UTERUS#0.6061;BONE MARROW#0.6056;SYSTEM DEVELOPMENT#0.6055;SERTOLI CELL-ONLY SYNDROME#0.6051;RETINAL DEGENERATION#0.6019;XENOBIOTIC METABOLISM#0.6013;GAMETOGENESIS#0.6003
1910	ENDOTHELIN TYPE B#1.0860;RECEPTOR AGONIST#1.0378;ASTROCYTE#1.0362;BOSENTAN#1.0293;VASODILATION#1.0243;MELANOCYTE#1.0241;ENDOTHELIN TYPE A#1.0237;AIRWAY SMOOTH MUSCLE#1.0235;RECEPTOR TYROSINE KINASE#1.0181;MEGACOLON#1.0176;TRANSCRIPTION FACTOR#1.0165;PROSTATE CANCER#1.0156;ADRENAL CORTEX#1.0145;ENDOTHELIN B RECEPTOR#1.0143;BLOOD VESSEL#1.0139;RECEPTOR BINDING#1.0112;CONSTRICTION#1.0090;PULMONARY ARTERY#1.0078;NITRIC OXIDE SYNTHASE#1.0070;ISCHEMIA#1.0068;REVERSE TRANSCRIPTION#1.0067;POLYMERASE CHAIN REACTION#1.0065;VASCULAR SMOOTH MUSCLE CELL#1.0055;TRACHEA#1.0052;VASODILATATION#1.0047;CANCER CELL#1.0040;GLIAL CELL#1.0040;HYPOXIA#1.0030;ENDOTHELIN A RECEPTOR#1.0022;ENDOTHELIN RECEPTOR#1.0011;HIRSCHSPRUNG'S DISEASE#1.0003;VASODILATOR#0.9996;NEURAL CREST CELL#0.9975;EPITHELIAL CELL#0.9966;TRANSCRIPTASE#0.9961;MUSCLE CELL#0.9959;ENDOTHELIAL CELL#0.9959;ENDOTHELIUM#0.9956;SMOOTH MUSCLE#0.9954;SMOOTH MUSCLE CELL#0.9953;ARGININE#0.9949;VASOCONSTRICTION#0.9947;L-ARGININE#0.9944;APOPTOSIS#0.9940;ENTERIC NERVOUS SYSTEM#0.9934;SIGNALING PATHWAY#0.9929;RECEPTOR ANTAGONIST#0.9926;QUANTITATIVE REAL TIME#0.9916;NITRIC OXIDE#0.9907;NEURAL CREST#0.9900;ALDOSTERONE#0.9894;ANGIOGENESIS#0.9888;CORONARY ARTERY#0.9877;ARTERY#0.9873;RESPONSE TO ENDOTHELIN#0.9850;PULMONARY HYPERTENSION#0.9845;PROTEIN KINASE#0.9842;CELL PROLIFERATION#0.9831;SIGNAL TRANSDUCTION#0.9822;NITRO-L-ARGININE#0.9816;VASOCONSTRICTOR#0.9807;GENE EXPRESSION#0.9793;MITOGEN ACTIVATED PROTEIN#0.9792;PHOSPHOLIPASE C#0.9776;NERVOUS SYSTEM#0.9744;GROWTH FACTOR#0.9732;CELL SURFACE#0.9731;HYPERTENSION#0.9728;STEM CELL#0.9722;HYPOXIC#0.9715;BREAST CANCER#0.9715;PROTEIN KINASE C#0.9701;EXCRETION#0.9695;ADRENAL GLAND#0.9644;INDOMETHACIN#0.9633;ENDOTHELIAL GROWTH FACTOR#0.9596;SQUAMOUS CELL CARCINOMA#0.9596;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9582;PULMONARY ARTERIAL HYPERTENSION#0.9553;GANGLION CELLS#0.9526;CELL DEATH#0.9510;SIGNALLING PATHWAY#0.9497;CEREBRAL ISCHEMIA#0.9455;ATHEROSCLEROSIS#0.9444;CELL GROWTH#0.9438;APOPTOTIC#0.9391;METHYLATION SPECIFIC POLYMERASE#0.9389;VASCULAR ENDOTHELIAL CELL#0.9342;T CELL#0.9313;HEARING LOSS#0.9297;PROSTACYCLIN#0.9290;ENDOTHELIAL NITRIC OXIDE#0.9276;RENAL ARTERY#0.9252;CARDIOVASCULAR SYSTEM#0.9243;DNA METHYLATION#0.9231;CARDIOMYOCYTE#0.9208;MUSCLE CONTRACTION#0.9189;GRANULOSA CELL#0.9184;MESANGIAL CELL#0.9177;SMOOTH MUSCLE CONTRACTION#0.9171;SPINAL CORD#0.9152;ARTERIOLE#0.9145;THORACIC AORTA#0.9137;DNA SYNTHESIS#0.9133;MACROPHAGE#0.9119;PLATELET AGGREGATION#0.9087;TUMOR CELLS#0.9050;CONGESTIVE HEART FAILURE#0.9040;MYOMETRIUM#0.9024;RECEPTOR LIGAND#0.9023;VIRAL INFECTION#0.8952;TUMOR SUPPRESSOR#0.8935;ENDOMETRIUM#0.8928;PLASMA MEMBRANE#0.8917;5-AZA-2'-DEOXYCYTIDINE#0.8909;2'-DEOXYCYTIDINE#0.8904;CELL CYCLE#0.8893;BRAIN EDEMA#0.8887;EDEMA#0.8806;MESENTERIC ARTERY#0.8779;OVARIAN#0.8771;CAMP FORMATION#0.8763;MICROPHTHALMIA#0.8747;INDUCIBLE NITRIC OXIDE#0.8705;STRUCTURE ACTIVITY RELATIONSHIP#0.8697;GASTROINTESTINAL TRACT#0.8650;EXTRACELLULAR MATRIX#0.8634;COLORECTAL#0.8601;RESPIRATORY TRACT#0.8584;INTESTINAL OBSTRUCTION#0.8583;UMBILICAL VEIN#0.8581;TRANSFORMING GROWTH FACTOR#0.8567;PERIPHERAL BLOOD#0.8531;CELL DIFFERENTIATION#0.8524;CAROTID ARTERY#0.8517;QUANTITATIVE METHYLATION SPECIFIC#0.8515;HINDGUT#0.8513;PERTUSSIS#0.8511;VASCULAR ENDOTHELIUM#0.8496;THYMIDINE#0.8485;COLORECTAL CANCER#0.8476;VASCULAR CELL#0.8475;HUMAN UMBILICAL VEIN#0.8468;PROGENITOR CELL#0.8455;ACETYLCHOLINE#0.8453;KINASE INHIBITOR#0.8432;MICROVASCULAR ENDOTHELIAL CELL#0.8421;BASILAR ARTERY#0.8413;METHYLATION SPECIFIC PCR#0.8398;GESTATION#0.8350;MENSTRUAL CYCLE#0.8346;MELANOMA CELL LINES#0.8338;HEMORRHAGE#0.8328;OPTIC NERVE#0.8318;CELL MIGRATION#0.8313;DOPAMINE#0.8292;GLOMERULAR FILTRATION#0.8275;CEREBRAL CORTEX#0.8269;NEURAL TUBE#0.8209;ENDOTHELIN SIGNALING PATHWAY#0.8206;GROWTH FACTOR RECEPTOR#0.8168;RETINOIC ACID#0.8147;BREAST CARCINOMA#0.8136;MYOCARDIAL INFARCTION#0.8117;DIABETIC NEPHROPATHY#0.8103;MAP KINASE#0.8089;SYSTOLIC BLOOD PRESSURE#0.8088;CHRONIC HEART FAILURE#0.8071;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8060;NATRIURESIS#0.8032;CENTRAL NERVOUS SYSTEM#0.8022;MONOCYTE#0.8019;COLLECTING DUCTS#0.8011;NG-NITRO-L-ARGININE#0.7987;GLOMERULAR FILTRATION RATE#0.7982;BASAL CELL#0.7982;ANGIOTENSIN CONVERTING ENZYME#0.7978;TUMOR NECROSIS FACTOR#0.7936;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7934;CAVEOLAE#0.7925;NADPH OXIDASE#0.7904;TROPHOBLAST#0.7862;NEPHROPATHY#0.7857;CONGENITAL DISORDER#0.7837;PITUITARY GLAND#0.7826;SCHWANN CELL#0.7823;CALCIUM SIGNALING#0.7787;STREPTOZOTOCIN#0.7744;B CELL#0.7731;LYSINE#0.7730;AORTIC SMOOTH MUSCLE CELLS#0.7715;NEUTROPHIL#0.7704;NEUROBLASTOMA#0.7703;REGENERATION#0.7680;SENSORINEURAL HEARING LOSS#0.7633;MYOCARDIUM#0.7585;CELL DEVELOPMENT#0.7552;CALCIUM CHANNEL#0.7533;VASOPRESSIN#0.7519;MYOCYTES#0.7514;NEURAL STEM CELL#0.7431;HEART DISEASE#0.7418;ETHANOL#0.7418;PROGESTERONE#0.7408;CYCLIC AMP#0.7394;HEPATOCELLULAR CARCINOMA#0.7333;EPIDERMAL GROWTH FACTOR#0.7322;NOREPINEPHRINE#0.7308;BONE MORPHOGENETIC PROTEIN#0.7300;INTERSTITIAL CELL#0.7249;MELANOCYTE DIFFERENTIATION#0.7230;HYPOTENSIVE#0.7227;SMOOTH MUSCLE ACTIN#0.7219;NORADRENALINE#0.7198;SPIRAL GANGLION NEURONS#0.7182;RECEPTOR ACTIVITY#0.7179;KERATINOCYTE#0.7174;HYPOXIA INDUCIBLE FACTOR#0.7143;VASCULAR DISEASE#0.7092;ENZYME INHIBITOR#0.7090;ADENOCARCINOMA#0.7079;SUBSTANCE P#0.7072;LYMPHOPENIA#0.7050;SODIUM NITROPRUSSIDE#0.7003;CELLULAR LOCALIZATION#0.7000;GENETIC DISORDER#0.6998;QUANTITATIVE REVERSE TRANSCRIPTION#0.6990;TYPE 2 DIABETES#0.6958;PHENYLEPHRINE#0.6933;ATHEROSCLEROTIC#0.6911;INNER EAR#0.6856;ESSENTIAL HYPERTENSION#0.6850;TRANSFORMING GROWTH FACTOR BETA#0.6813;STROMAL CELL#0.6811;CORONARY ARTERY DISEASE#0.6798;ARTERY DISEASE#0.6796;MAST CELL#0.6794;REACTIVE OXYGEN SPECIES#0.6790;SULFONAMIDE#0.6788;NITRIC-OXIDE SYNTHASE INHIBITOR#0.6787;CARBACHOL#0.6781;EPITHELIAL SODIUM CHANNEL#0.6775;N-NITRO-L-ARGININE#0.6773;STROMA#0.6768;NUCLEAR MEMBRANE#0.6733;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6725;PARENCHYMA#0.6722;NOS INHIBITOR#0.6718;MAPK CASCADE#0.6708;PROXIMAL TUBULE CELL#0.6708;SODIUM CHANNEL#0.6684;UTERUS#0.6652;B LYMPHOCYTE#0.6644;NITROPRUSSIDE#0.6637;CELL ADHESION#0.6632;INFLAMMATORY RESPONSE#0.6623;LYMPH NODE#0.6622;CORPUS LUTEUM#0.6600;ADENOSINE#0.6585;MESENTERY#0.6525;LIVER CIRRHOSIS#0.6497;TOXICITY#0.6491;PORTAL HYPERTENSION#0.6482;ALANINE#0.6473;OVULATION#0.6437;CEREBRAL ARTERY#0.6432;LUNG CANCER#0.6431;CELL MEMBRANE#0.6395;DIABETES MELLITUS#0.6395;SUPEROXIDE DISMUTASE#0.6394;NERVOUS SYSTEM DEVELOPMENT#0.6330;ISOPROTERENOL#0.6318;SYSTEM DEVELOPMENT#0.6313;FLUID RETENTION#0.6309;CARRIE#0.6304;PROTEINURIA#0.6300;PERICYTE#0.6299;LUMINAL#0.6291;DIABETIC RETINOPATHY#0.6276;ABC TRANSPORTER#0.6274;PROTEIN KINASE A#0.6250;MELANOCYTE STEM CELL#0.6245;ENTERIC NERVOUS SYSTEM DEVELOPMENT#0.6245;FOCAL ADHESION#0.6218;ITO CELL#0.6215;TUMOR TISSUES#0.6180;LYSOSOME#0.6146;PRECURSOR CELL#0.6143;ADENYLATE CYCLASE#0.6139;HEPATIC STELLATE CELL#0.6134;LEUKOCYTE#0.6120;ASPARTATE#0.6119;END ORGAN DAMAGE#0.6108;PLATELET-DERIVED GROWTH FACTOR#0.6099;KIDNEY DISEASE#0.6085;IMMUNE RESPONSE#0.6079;TRYPTOPHAN#0.6055;ADIPOCYTE#0.6050;RELATED PROTEIN 1#0.6037;MICROGLIAL CELL#0.6001
1911	DISEASE RESISTANCE#1.0604;CELL DEATH#1.0210;PROTEIN KINASE#0.9698;DEFENSE RESPONSE#0.9467;STEM CELL#0.9041;SENESCENCE#0.8627;TRANSCRIPTION FACTOR#0.8151;CARDIAC MORPHOGENESIS#0.8117;MAP KINASE#0.8085;STRUCTURAL ORGANIZATION#0.7876;CELL CYCLE#0.7809;SALICYLIC ACID#0.7664;GLUCOCORTICOID RECEPTOR#0.7612;GENE EXPRESSION#0.7591;FETAL LIVER#0.6966;HEMATOPOIETIC STEM CELL#0.6937;MORPHOGENESIS#0.6440;PROGRAMMED CELL DEATH#0.6233;B CELL#0.6175;NEURAL CREST#0.6147;DNA BINDING#0.6123
1912	TREATMENT PLANNING SYSTEM#1.0057;DISEASE RESISTANCE#0.9434;CELL DEATH#0.8886;DISTANCE TO AGREEMENT#0.8570;MONTE CARLO SIMULATION#0.8518;SALICYLIC ACID#0.7052;DEFENSE RESPONSE#0.6709;POLYCOMB REPRESSIVE COMPLEX#0.6372
1913	CLEFT LIP#0.9781;ECTODERMAL DYSPLASIA#0.9440;EEC SYNDROME#0.9208;ADULT SYNDROME#0.8228;CLEFT PALATE#0.6666;TUMOR TISSUES#0.6074
191585	DOWN SYNDROME#0.8635;PERIPHERAL BLOOD#0.7884
1915	PROTEIN SYNTHESIS ELONGATION#1.0904;AMINOACYL-TRNA BINDING#1.0766;NUCLEOTIDE EXCHANGE FACTOR#1.0519;TRANSLATIONAL ELONGATION#1.0495;ATP SYNTHASE#1.0400;EUKARYOTIC ELONGATION FACTOR#1.0395;TRANSLATION ELONGATION FACTOR#1.0386;TRANSLATION ELONGATION#1.0354;TRANSFER RNA#1.0347;CHLOROPLAST#1.0330;GUANOSINE-5'-TRIPHOSPHATE#1.0304;GLYCERALDEHYDE-3-PHOSPHATE#1.0269;ACTIN BUNDLING#1.0264;HEAT SHOCK PROTEIN#1.0250;HISTIDINE#1.0241;TRNA BINDING#1.0237;ELONGATION FACTOR 1ALPHA#1.0236;GTP BINDING#1.0204;PROTEIN TRANSLATION#1.0201;GTP HYDROLYSIS#1.0196;MUTAGENESIS#1.0188;PROTEIN BIOSYNTHESIS#1.0183;DIPHOSPHATE#1.0180;RIBOSOMAL PROTEIN#1.0151;GUANOSINE#1.0149;RIBOSOMAL SUBUNIT#1.0141;GUANINE#1.0131;CANCER CELL#1.0127;70S RIBOSOME#1.0114;LYSINE#1.0103;GDP BINDING#1.0100;ACTIN CYTOSKELETON#1.0055;CELL GROWTH#1.0052;RIBOSOME#1.0050;GTPASE ACTIVITY#1.0040;NUCLEOTIDE BINDING#1.0039;REVERSE TRANSCRIPTION#1.0009;CELL DEATH#0.9989;CELL PROLIFERATION#0.9980;PROTEIN KINASE#0.9969;RIBOSOMAL RNA#0.9958;TRANSLATION INITIATION#0.9940;PROSTATE CANCER#0.9935;SKELETAL MUSCLE#0.9933;PROTEIN SYNTHESIS#0.9928;APOPTOSIS#0.9922;COMPLEX I#0.9908;SIGNALING PATHWAY#0.9905;MITOCHONDRIA#0.9885;CYTOPLASM#0.9841;PYRUVATE#0.9798;NUCLEIC ACID#0.9738;NUCLEAR EXPORT#0.9733;ACTIN BINDING#0.9711;SIGNAL TRANSDUCTION#0.9694;OUTER MEMBRANE#0.9671;CELL CYCLE#0.9649;DIGESTION#0.9639;ALANINE#0.9635;GENE EXPRESSION#0.9626;IMMUNE RESPONSE#0.9602;RNA BINDING#0.9592;UBIQUITIN#0.9586;POLYMERASE CHAIN REACTION#0.9559;TRANSCRIPTION FACTOR#0.9541;PLASTID#0.9525;C TERMINAL DOMAIN#0.9519;HEPATOCELLULAR CARCINOMA#0.9497;VIRAL REPLICATION#0.9481;MITOCHONDRIAL TRNA#0.9466;PROSTATE CARCINOMA#0.9433;TRANSLATION INITIATION FACTOR#0.9413;ONCOGENIC#0.9394;VIRULENCE#0.9371;LASER DESORPTION IONIZATION#0.9319;POST-TRANSLATIONAL MODIFICATION#0.9297;FACTOR I#0.9266;MOLECULAR DYNAMICS SIMULATION#0.9231;TETRACYCLINE#0.9215;MACROPHAGE#0.9134;QUANTITATIVE REAL TIME#0.9129;GLUTATHIONE#0.9123;HOST CELL#0.9088;EPITHELIAL CELL#0.9070;GROWTH FACTOR#0.9019;COLON CANCER#0.9009;PROTEASOME#0.9009;EUKARYOTIC INITIATION FACTOR#0.8994;CHAPERONIN#0.8974;MITOCHONDRIAL TRANSLATION#0.8891;ENDOPLASMIC RETICULUM#0.8840;CELL WALL#0.8814;COLORECTAL CANCER#0.8809;MECHANISM OF ACTION#0.8763;METHIONINE#0.8760;ACTIN FILAMENT#0.8754;PROTEIN PROTEIN INTERACTION#0.8727;MALATE DEHYDROGENASE#0.8654;NUCLEOTIDE BINDING DOMAIN#0.8646;RNA SYNTHESIS#0.8619;PHOSPHOGLYCERATE KINASE#0.8613;GUANOSINE-5'-DIPHOSPHATE#0.8606;GLYCINE#0.8572;PATTERN RECOGNITION RECEPTOR#0.8536;RENATURATION#0.8521;INNATE IMMUNITY#0.8492;CELL SURFACE#0.8481;REACTIVE OXYGEN SPECIES#0.8440;PLASMA MEMBRANE#0.8428;TRANSCRIPTASE#0.8427;POSTTRANSLATIONAL MODIFICATION#0.8427;POLYSOME#0.8409;BINDING PROTEIN 1#0.8406;CYTOCHROME C#0.8369;LEUCINE#0.8352;ENDOTHELIAL CELL#0.8308;RNA BINDING PROTEIN#0.8300;OOCYTE#0.8253;COLORECTAL#0.8235;80S RIBOSOME#0.8197;MITOCHONDRIAL PROTEIN SYNTHESIS#0.8154;RETICULOCYTE#0.8148;BREAST CANCER#0.8148;SELENOCYSTEINE#0.8098;KINASE ACTIVITY#0.8066;STATIONARY PHASE#0.8040;RNA REPLICATION#0.8018;ADENYLATE#0.7970;RIBOSOME BINDING#0.7948;GERM CELL#0.7943;ACTIN BUNDLING ACTIVITY#0.7919;CERVICAL#0.7865;DEFENSE RESPONSE#0.7845;TUBERCULOSIS#0.7797;ISCHEMIA#0.7763;OVARIAN#0.7707;RICIN#0.7638;MEMBRANE FRACTION#0.7591;ACTIN BINDING PROTEIN#0.7569;CATALYTIC ACTIVITY#0.7565;ETHANOLAMINE#0.7549;RAPAMYCIN#0.7543;NUCLEOSIDE DIPHOSPHATE KINASE#0.7531;ONCOGENESIS#0.7514;FUSIDIC ACID#0.7511;ARGININE#0.7497;T CELL#0.7494;BETA-2#0.7488;ADENOSINE#0.7451;FLUORESCEIN#0.7449;BRAIN ISCHEMIA#0.7446;PROTEIN FOLDING#0.7437;N-ETHYLMALEIMIDE#0.7407;CERVICAL CANCER#0.7380;TRANS-DIAMMINEDICHLOROPLATINUM#0.7372;LUNG CANCER#0.7320;CHAPERONE ACTIVITY#0.7303;ADENYLATE KINASE#0.7287;FRUCTOSE BISPHOSPHATE ALDOLASE#0.7231;PROTEIN MODIFICATION#0.7215;PYRUVATE KINASE#0.7211;RESONANCE ENERGY TRANSFER#0.7175;SUPEROXIDE DISMUTASE#0.7171;DISEASE FREE SURVIVAL#0.7162;STEM CELL#0.7153;NEURITE OUTGROWTH#0.7147;MICROTUBULE#0.7141;TRNA AMINOACYLATION#0.7090;POLY-A BINDING#0.6954;OVARIAN CANCER#0.6952;CELL DIVISION#0.6906;GLUTAMINE#0.6899;CELL DIFFERENTIATION#0.6882;RNASE P#0.6800;VALINE#0.6736;FILAMENTOUS ACTIN#0.6720;LEUCINE RICH REPEAT#0.6707;PROTEIN DISULFIDE ISOMERASE#0.6699;G1 PHASE#0.6653;MITOGEN ACTIVATED PROTEIN#0.6630;LARGE RIBOSOMAL SUBUNIT#0.6630;EXTRACELLULAR MATRIX#0.6625;TUMOR CELLS#0.6615;STREPTOMYCIN#0.6587;PEPTIDYL TRANSFERASE CENTER#0.6535;DISEASE RESISTANCE#0.6507;AMINO ACID BINDING#0.6486;MAMMARY GLAND#0.6483;SQUAMOUS CELL CARCINOMA#0.6400;MODE OF ACTION#0.6321;GLYCOLYSIS#0.6308;SUCROSE#0.6283;TRANSLATION TERMINATION#0.6267;APOPTOTIC#0.6249;PEPTIDE FORMATION#0.6204;TARGET OF RAPAMYCIN#0.6127;CYTOSKELETON ORGANIZATION#0.6095;30S RIBOSOMAL SUBUNIT#0.6078;SENESCENCE#0.6064;ADENINE#0.6062;ERYTHROLEUKEMIA#0.6055;MOLAR#0.6054;ASPARTATE#0.6042;CELLULAR LOCALIZATION#0.6009
1917	OVARIAN CANCER#1.0605;SKELETAL MUSCLE#1.0505;EUKARYOTIC ELONGATION FACTOR#1.0484;OVARIAN#1.0446;TRANSLATION ELONGATION FACTOR#1.0424;TRANSLATION ELONGATION#1.0412;BREAST CANCER#1.0394;CANCER CELL#1.0191;PROTEIN SYNTHESIS#0.9940;APOPTOSIS#0.9903;GENE EXPRESSION#0.9488;INTELLECTUAL DISABILITY#0.9310;CELL GROWTH#0.9185;CELL PROLIFERATION#0.9182;PANCREATIC CANCER#0.9176;EPILEPSY#0.8669;ONCOGENIC#0.8504;MYOCARDIAL INFARCTION#0.8489;LUNG CANCER#0.8290;HEPATOCELLULAR CARCINOMA#0.8222;CELL DEATH#0.8166;CELL MIGRATION#0.8054;APOPTOTIC#0.7783;ACUTE CORONARY SYNDROME#0.7738;CELL CYCLE#0.7725;ACUTE MYOCARDIAL INFARCTION#0.7684;LYMPH NODE#0.7499;PROSTATE CANCER#0.7457;TUMOR SUPPRESSOR#0.7448;SIGNALING PATHWAY#0.7398;COLORECTAL CANCER#0.7297;ADENOCARCINOMA#0.7086;BREAST CANCER CELL#0.6952;PROTEIN TRANSLATION#0.6639;OVARIAN CARCINOMA#0.6596;REVERSE TRANSCRIPTION#0.6540;MYOTUBE#0.6370;PROTEIN KINASE#0.6325;EPITHELIAL CELL#0.6316;SPINAL CORD#0.6304;ELONGATION FACTOR 1ALPHA#0.6277;RIBOSOME#0.6187;ACTIN BINDING#0.6177;LIPID KINASE#0.6163;CLEAR CELL CARCINOMA#0.6065;CHOLESTEROL BIOSYNTHESIS#0.6037
191	METHIONINE ADENOSYLTRANSFERASE#1.0597;HYDROLASE INHIBITOR#1.0543;S-ADENOSYL-L-HOMOCYSTEINE#1.0535;HYDROLASE ACTIVITY#1.0286;DNA METHYLATION#1.0212;ADENOSINE KINASE#1.0177;2'-DEOXYADENOSINE#1.0154;DEOXYADENOSINE#1.0101;ADOMET#1.0071;S-ADENOSYL-L-METHIONINE#1.0061;ADENOSINE#1.0055;L-METHIONINE#1.0032;ADENOSINE DEAMINASE#1.0030;ERYTHROCYTE#1.0020;METHIONINE#0.9984;9-BETA-D-ARABINOFURANOSYLADENINE#0.9929;S-ADENOSYLMETHIONINE#0.9916;ADENINE#0.9914;ENZYME ACTIVITY#0.9798;N METHYLTRANSFERASE#0.9746;VACCINIA#0.9733;GENE EXPRESSION#0.9722;PURINE NUCLEOSIDE PHOSPHORYLASE#0.9678;CELL PROLIFERATION#0.9678;CANCER CELL#0.9666;T CELL#0.9614;TOXICITY#0.9554;APOPTOSIS#0.9546;CELL CYCLE#0.9475;ARA-A#0.9451;CYTOTOXICITY#0.9258;METHIONINE METABOLISM#0.9180;LYMPHOBLAST#0.9173;INOSINE#0.9061;CYSTATHIONINE BETA SYNTHASE#0.8969;CELL DEATH#0.8775;HYPOXANTHINE#0.8719;GLYCINE N METHYLTRANSFERASE#0.8713;HYPERHOMOCYSTEINEMIA#0.8614;NEUROBLASTOMA#0.8596;DNA METHYLTRANSFERASE#0.8577;MALARIA#0.8512;GLYCINE#0.8510;MECHANISM OF ACTION#0.8491;GLUTATHIONE#0.8438;RED BLOOD CELL#0.8429;GUANINE#0.8409;DEOXYCOFORMYCIN#0.8407;VESICULAR STOMATITIS VIRUS#0.8349;METHYLTRANSFERASE ACTIVITY#0.8346;POLYMERASE CHAIN REACTION#0.8268;LYSINE#0.8190;PROTEIN KINASE#0.8189;CELL CYCLE ARREST#0.8167;CELL GROWTH#0.8128;TUBERCULOSIS#0.8118;GUANINE PHOSPHORIBOSYLTRANSFERASE#0.8116;METHIONINE SYNTHASE#0.8097;STOMATITIS#0.8083;2'-DEOXYCOFORMYCIN#0.8077;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8007;COPPER BINDING#0.7996;SIGNAL TRANSDUCTION#0.7993;ENDOTHELIAL CELL#0.7978;MUTAGENESIS#0.7970;NAD BINDING#0.7872;PURINE METABOLISM#0.7847;NICOTINAMIDE#0.7801;T-LYMPHOBLAST#0.7750;CAMP BINDING#0.7651;CATABOLISM#0.7632;FOLATE#0.7531;ADENOSINE DEAMINASE DEFICIENCY#0.7529;O METHYLTRANSFERASE#0.7451;ARGININE#0.7441;LYMPHOID CELL#0.7417;STEM CELL#0.7412;RIBOSE#0.7405;B CELL#0.7356;HOST CELL#0.7351;HOMOCYSTEINE METABOLISM#0.7344;REVERSE TRANSCRIPTION#0.7323;TRANSSULFURATION#0.6949;5-METHYLTETRAHYDROFOLATE#0.6914;IMMUNE RESPONSE#0.6896;ERYTHRO#0.6880;PROTEIN SYNTHESIS#0.6847;HEPATOCELLULAR CARCINOMA#0.6824;MACROPHAGE#0.6820;GROWTH FACTOR#0.6799;LYMPHOBLASTOID CELLS#0.6776;CATALYTIC ACTIVITY#0.6750;B-LYMPHOBLAST#0.6734;TUMOR CELLS#0.6707;ORNITHINE#0.6706;HISTONE DEACETYLASE#0.6706;SIGNALING PATHWAY#0.6534;ADENOSINE FORMATION#0.6477;NUCLEIC ACID#0.6475;T CELL ACTIVATION#0.6468;IMP DEHYDROGENASE#0.6467;CELL ACTIVATION#0.6450;APOPTOTIC#0.6382;RIBAVIRIN#0.6376;ATHEROSCLEROSIS#0.6310;GENE SILENCING#0.6300;ADENINE ARABINOSIDE#0.6278;CELL DIFFERENTIATION#0.6265;REGENERATION#0.6262;ATP SYNTHASE#0.6242;PERIPHERAL BLOOD#0.6239;ALKALINE PHOSPHATASE#0.6225;HUMAN IMMUNODEFICIENCY VIRUS#0.6160;NORMAL MODE ANALYSIS#0.6122;BREAST CANCER#0.6122;URIDINE#0.6121;LIVER DISEASE#0.6119;COFACTOR BINDING#0.6118;TRANSCRIPTASE#0.6086;CYTOPLASM#0.6075;GLYCERALDEHYDE-3-PHOSPHATE#0.6072;HISTONE METHYLATION#0.6042;SEVERE COMBINED IMMUNODEFICIENCY#0.6021
192111	PHOSPHOGLYCERATE MUTASE#1.1055;MITOPHAGY#1.0780;NECROPTOSIS#1.0717;MITOCHONDRIA#1.0249;PHOSPHATASE ACTIVITY#1.0185;CELL DEATH#1.0084;MITOCHONDRIAL MEMBRANE#1.0068;APOPTOSIS#1.0066;DEPHOSPHORYLATION#0.9359;MITOCHONDRIAL FISSION#0.8897;PROTEIN KINASE#0.8552;ISCHEMIA REPERFUSION INJURY#0.8290;RELATED PROTEIN 1#0.8270;REACTIVE OXYGEN SPECIES#0.8036;ISCHEMIA#0.7952;GENE EXPRESSION#0.7610;AUTOPHAGY#0.7380;SIGNALING PATHWAY#0.7349;APOPTOTIC#0.7334;HYPOXIA#0.7204;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7125;MACROPHAGE#0.7059;LIPID METABOLISM#0.6932;UBIQUITIN#0.6872;RECEPTOR INTERACTING PROTEIN#0.6867;T CELL#0.6855;MIXED LINEAGE KINASE#0.6528;OUTER MEMBRANE#0.6472;MITOCHONDRIAL DAMAGE#0.6349;IL-1 SECRETION#0.6319;OUTER MITOCHONDRIAL MEMBRANE#0.6281;HEPATOCELLULAR CARCINOMA#0.6062;TNF-INDUCED NECROPTOSIS#0.6055;PROTEASOME#0.6042
192115	CANCER CELL#0.7848;LAMININ RECEPTOR PRECURSOR#0.6642;LAMININ RECEPTOR#0.6128;HEARING IMPAIRMENT#0.6064
192134	O GLYCAN#0.8695;CANCER CELL#0.8492;HUMAN PANCREATIC CANCER#0.6764;PANCREATIC CANCER#0.6644;COLON CANCER#0.6627
192142	RESTLESS#1.0111;RESTLESS LEGS SYNDROME#1.0072;DOPAMINE#0.9548;SLEEP DISORDER#0.9363;INSOMNIA#0.9260;ROPINIROLE#0.8550;PARKINSON'S DISEASE#0.8100;LEVODOPA#0.7560;PERIODIC LIMB MOVEMENTS#0.7537;SPINAL CORD#0.7536;HYPERTENSION#0.6675;SLEEPINESS#0.6593;ANEMIA#0.6473;L-DOPA#0.6262;IRON DEFICIENCY ANEMIA#0.6210;DEFICIENCY ANEMIA#0.6206;HYPERACTIVITY#0.6123;SUBSTANTIA NIGRA#0.6044
192286	CELL CYCLE#0.6221
192644	HEARING IMPAIRMENT#0.6540
192666	KERATINOCYTE#0.7097;KERATINOCYTE DIFFERENTIATION#0.6481
192668	GLUTAMINE#0.9390;KIDNEY DISEASE#0.8070;PROTEIN SPLICING#0.7888;MUTAGENESIS#0.7579;GLUTATHIONE#0.7438;POLYCYSTIC KIDNEY DISEASE#0.7393;VASOPRESSIN#0.6655;PROTEIN KINASE#0.6545;ASPARAGINE#0.6270;INTEIN#0.6236;LYSINE#0.6080
192669	NUAGE#1.0478;GERM CELL#0.9595;RNA INTERFERENCE#0.9436;GENE EXPRESSION#0.8528;GENE SILENCING#0.8204;OVARIES#0.7909;OVARIAN#0.6652;RNA-INDUCED SILENCING COMPLEX#0.6584;ADENINE#0.6097
192670	RNA-DIRECTED DNA METHYLATION#1.0445;DNA METHYLATION#1.0293;GENE SILENCING#1.0071;TRANSCRIPTIONAL GENE SILENCING#1.0062;DNA METHYLTRANSFERASE#0.9732;GENE EXPRESSION#0.9573;CHROMATIN MODIFICATION#0.9297;RNA-INDUCED SILENCING COMPLEX#0.8566;RNA BINDING#0.8557;RNA INTERFERENCE#0.8152;CYTOSINE METHYLATION#0.7892;DE NOVO DNA METHYLATION#0.6862;RNA BINDING PROTEIN#0.6624;CUCUMBER MOSAIC VIRUS#0.6553;NUCLEOLUS#0.6342;VIRAL GENOME#0.6063
192683	SYNAPTIC VESICLE#0.8969;PLASMA MEMBRANE#0.6568;ENDOCYTOSIS#0.6277;NEUROTRANSMITTER RELEASE#0.6245;GOLGI APPARATUS#0.6213;CYTOKINE SECRETION#0.6193;SIGNAL PEPTIDE#0.6189;ENDOPLASMIC RETICULUM#0.6094
1933	GUANINE#1.0639;TRANSLATION ELONGATION FACTOR#1.0620;NUCLEOTIDE EXCHANGE FACTOR#1.0606;TRANSLATION ELONGATION#1.0596;RIBOSOME#1.0038;PROTEIN SYNTHESIS#0.9874;EUKARYOTIC ELONGATION FACTOR#0.9324;C TERMINAL DOMAIN#0.7900;CELL GROWTH#0.7522;PROTEIN KINASE#0.6576;OOCYTE#0.6557;TRNA BINDING#0.6310;TRANSLATIONAL ELONGATION#0.6304;KINASE ACTIVITY#0.6184;PROTEIN BINDING#0.6087
1934	TRANSLATION ELONGATION#0.8972;TRANSLATION ELONGATION FACTOR#0.8396;NUCLEOTIDE EXCHANGE FACTOR#0.6938
1936	TRANSLATION ELONGATION FACTOR#1.0598;TRANSLATION ELONGATION#1.0563;PROTEIN KINASE#1.0141;PROTEIN SYNTHESIS#0.9820;GUANINE#0.8543;HERPES SIMPLEX VIRUS#0.7869;HERPES SIMPLEX#0.7865;EUKARYOTIC ELONGATION FACTOR#0.7825;LEUCINE#0.7791;ENDOPLASMIC RETICULUM#0.7520;CELL CYCLE#0.7471;GENE EXPRESSION#0.7452;HYPERPHOSPHORYLATION#0.7108;EPSTEIN BARR VIRUS#0.7001;TRANSLATIONAL ELONGATION#0.6499;C TERMINAL DOMAIN#0.6313;CELL PROLIFERATION#0.6234;KINASE ACTIVITY#0.6109;SIGNALING PATHWAY#0.6107;EPITHELIAL CELL#0.6068
1937	TRANSLATION ELONGATION FACTOR#1.0106;TRANSLATION ELONGATION#1.0099;EUKARYOTIC ELONGATION FACTOR#0.9196;PROTEIN SYNTHESIS#0.8365;GLUTATHIONE#0.7712;COLORECTAL#0.7034;COLORECTAL CANCER#0.6986;RIBOSOME#0.6794
1938	EEF-2 KINASE ACTIVITY#1.1641;DIPHTHAMIDE#1.0684;PROTEIN SYNTHESIS ELONGATION#1.0668;80S RIBOSOME#1.0551;GTP BINDING#1.0473;DEPHOSPHORYLATION#1.0437;TRANSLATION ELONGATION FACTOR#1.0433;TRANSLATIONAL ELONGATION#1.0427;HISTIDINE#1.0401;GTPASE ACTIVITY#1.0384;EUKARYOTIC ELONGATION FACTOR#1.0371;RICIN#1.0356;TRANSLATION ELONGATION#1.0331;RIBOSE#1.0311;GTP HYDROLYSIS#1.0282;KINASE ACTIVITY#1.0255;DIPHTHERIA#1.0228;PHOSPHATASE 2A#1.0223;TRANSLATION INITIATION FACTOR#1.0200;EUKARYOTIC INITIATION FACTOR#1.0198;PROTEIN TRANSLATION#1.0180;PROTEIN PHOSPHATASE 2A#1.0168;RETICULOCYTE#1.0151;RIBOSOME#1.0139;BINDING PROTEIN 1#1.0131;CELL CYCLE#1.0128;CELL DEATH#1.0052;RIBOSOMAL PROTEIN#1.0045;RAPAMYCIN#0.9970;KETAMINE#0.9966;PROTEIN KINASE#0.9960;APOPTOSIS#0.9954;CANCER CELL#0.9948;RIBOSOMAL SUBUNIT#0.9938;CELL GROWTH#0.9918;TRANSLATION INITIATION#0.9913;PROTEIN SYNTHESIS#0.9911;AUTOPHAGY#0.9908;CARDIOMYOCYTE#0.9902;TARGET OF RAPAMYCIN#0.9889;RIBOSOMAL RNA#0.9863;GROWTH FACTOR#0.9850;SIGNALING PATHWAY#0.9828;PROTEIN BIOSYNTHESIS#0.9802;KINASE INHIBITOR#0.9799;SKELETAL MUSCLE#0.9774;MUSCLE PROTEIN SYNTHESIS#0.9723;GUANINE#0.9699;POLYRIBOSOME#0.9693;ADENOSINE#0.9666;LEUCINE#0.9618;NMDA RECEPTOR#0.9573;GENE EXPRESSION#0.9569;POST-TRANSLATIONAL MODIFICATION#0.9512;NICOTINAMIDE#0.9429;GUANOSINE#0.9426;SIGNALLING PATHWAY#0.9388;NUCLEOTIDE BINDING#0.9367;RIBOSOMAL S6 KINASE#0.9362;BREAST CANCER#0.9286;HEAT SHOCK PROTEIN#0.9272;CELL PROLIFERATION#0.9272;TUMOR CELLS#0.9271;POLYSOME#0.9270;AGEING#0.9201;MUTAGENESIS#0.9094;HYPOXIA#0.9065;CYTOTOXICITY#0.9039;PROTEIN KINASE B#0.9016;FUSIDIC ACID#0.8942;NAD BINDING#0.8938;POLYMERASE CHAIN REACTION#0.8938;ISCHEMIA#0.8810;MITOGEN ACTIVATED PROTEIN#0.8777;CYTOPLASM#0.8714;MECHANISM OF ACTION#0.8610;PROTEIN KINASE C#0.8607;TRNA BINDING#0.8605;UBIQUITIN#0.8523;RNA BINDING#0.8500;AMPK ACTIVITY#0.8499;REGULATION OF PROTEIN SYNTHESIS#0.8446;EPITHELIAL CELL#0.8410;PUROMYCIN#0.8399;ALANINE#0.8361;HYPERPHOSPHORYLATION#0.8294;T CELL#0.8228;TARGET OF RAPAMYCIN COMPLEX#0.8194;SIGNAL TRANSDUCTION#0.8194;IMMUNE RESPONSE#0.8113;GLYCOGEN SYNTHASE KINASE#0.8108;MILK PROTEIN#0.8079;LUNG CANCER#0.8036;POSTTRANSLATIONAL MODIFICATION#0.8010;PROTEASOME#0.8010;ETHANOL#0.8010;LARGE RIBOSOMAL SUBUNIT#0.7990;METHIONINE#0.7964;GROWTH CONE#0.7873;DIGESTION#0.7845;APOPTOTIC#0.7822;C TERMINAL DOMAIN#0.7794;PROTEIN COMPLEX#0.7791;TRANSCRIPTION FACTOR#0.7784;PROSTATE CANCER#0.7745;S-ADENOSYLMETHIONINE#0.7600;ASPARTATE#0.7590;SIGNALING CASCADE#0.7571;GLUTAMATE RECEPTOR#0.7557;PROTEIN PHOSPHORYLATION#0.7488;MOUSE EMBRYO FIBROBLASTS#0.7483;ADENINE#0.7481;ATPASE ACTIVITY#0.7471;LONG TERM POTENTIATION#0.7464;MUSCLE CELL#0.7422;ALZHEIMER'S DISEASE#0.7420;GDP BINDING#0.7419;DODECYL SULFATE#0.7390;SODIUM DODECYL SULFATE#0.7390;COLON CANCER#0.7384;ENDOPLASMIC RETICULUM#0.7353;T LYMPHOCYTE#0.7284;ESSENTIAL AMINO ACID#0.7228;ELONGATION FACTOR 1ALPHA#0.7195;REGULATION OF TRANSLATION#0.7180;PROTEIN PROTEIN INTERACTION#0.7166;TOXICITY#0.7118;OVARIAN#0.7098;DIPHOSPHATE#0.7033;HYPOXIC#0.7026;ARGININE#0.7013;CATALYTIC ACTIVITY#0.6996;U5 SNRNP#0.6970;ASCITES#0.6855;RECEPTOR ANTAGONIST#0.6816;RNA BINDING PROTEIN#0.6711;ONCOGENIC#0.6711;BREAST CANCER CELL#0.6711;DENTATE GYRUS#0.6698;NAD GLYCOHYDROLASE ACTIVITY#0.6679;GROWTH FACTOR RECEPTOR#0.6651;CYTOTOXIC T-LYMPHOCYTE#0.6628;NEURITE#0.6621;MITOSIS#0.6618;TRYPTOPHAN#0.6616;EIF4E BINDING#0.6588;TRANSFER RNA#0.6557;ADP-RIBOSYLTRANSFERASE ACTIVITY#0.6500;CEREBRAL CORTEX#0.6500;S PHASE#0.6489;MACROPHAGE#0.6471;PROTEIN KINASE A#0.6445;MAP KINASE#0.6441;CALMODULIN BINDING#0.6351;SMALL RIBOSOMAL SUBUNIT#0.6344;GLYCINE#0.6304;ADENOSINE MONOPHOSPHATE#0.6286;PROTEIN PHOSPHATASE-2A ACTIVITY#0.6276;OOCYTE#0.6272;MICROFILAMENT#0.6252;CYCLIN DEPENDENT KINASE#0.6231;MELATONIN#0.6206;MYOCYTES#0.6180;ENDOTHELIAL CELL#0.6179;PHOSPHATASE ACTIVITY#0.6168;INSULIN RECEPTOR#0.6156;MODE OF ACTION#0.6137;2-DEOXYGLUCOSE#0.6075;TIME TO DEATH#0.6056;MAMMARY GLAND#0.6001
1939	TRANSLATION INITIATION#0.9011;RIBOSOME#0.8329;TRANSLATION INITIATION FACTOR#0.7200;RIBOSOME RECYCLING#0.6355;C TERMINAL DOMAIN#0.6059
1942	EPHRIN#1.0521;CELL PROLIFERATION#1.0391;EPITHELIAL CELL#1.0388;T CELL#1.0346;ENDOTHELIAL CELL#1.0346;GROWTH FACTOR#1.0293;CANCER CELL#1.0239;ANGIOGENESIS#1.0136;CELL MIGRATION#1.0099;BREAST CANCER#0.9912;GENE EXPRESSION#0.9855;TUMOR CELLS#0.9841;RECEPTOR TYROSINE KINASE#0.9839;CELL ADHESION#0.9833;CELL SURFACE#0.9785;SIGNALING PATHWAY#0.9783;PROTEIN TYROSINE KINASE#0.9622;POLYMERASE CHAIN REACTION#0.9588;ENDOMETRIAL EPITHELIAL CELLS#0.9371;LUNG METASTASIS#0.9334;COLORECTAL CANCER#0.9263;PROTEIN KINASE#0.9089;REVERSE TRANSCRIPTION#0.8885;TUMOR SUPPRESSOR#0.8812;MONOCYTE#0.8805;ADENOCARCINOMA#0.8699;LUNG CANCER#0.8698;PROSTATE CANCER#0.8509;RECEPTOR LIGAND#0.8499;COLORECTAL#0.8479;HEPATOCELLULAR CARCINOMA#0.8285;ENDOTHELIAL CELL MIGRATION#0.8181;CELL DEATH#0.8110;EMBRYO IMPLANTATION#0.8101;ENDOTHELIAL GROWTH FACTOR#0.8051;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8051;KINASE ACTIVITY#0.8016;TUMOR NECROSIS FACTOR#0.8002;CELL CYCLE#0.7981;RECEPTOR BINDING#0.7938;T LYMPHOCYTE#0.7925;HUMAN UMBILICAL VEIN#0.7866;UMBILICAL VEIN#0.7863;HYPOXIA#0.7862;LYMPH NODE#0.7745;MITOGEN ACTIVATED PROTEIN#0.7743;APOPTOSIS#0.7726;CORNEAL EPITHELIAL CELL#0.7712;STEM CELL#0.7708;NERVOUS SYSTEM#0.7608;GROWTH CONE#0.7546;PROGENITOR CELL#0.7317;EPHRIN RECEPTOR#0.7312;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7281;TRANSFORMING GROWTH FACTOR#0.7266;BREAST CANCER CELL#0.7252;MACROPHAGE#0.7113;TRANSCRIPTION FACTOR#0.6896;SIGNAL TRANSDUCTION#0.6835;ONCOGENIC#0.6707;VASCULAR ENDOTHELIAL CELL#0.6568;OVARIAN#0.6537;OVARIAN CANCER#0.6536;MORPHOGENESIS#0.6502;ENDOCYTOSIS#0.6373;TUBE FORMATION#0.6349;CHEMOTAXIS#0.6312;FIBROBLAST GROWTH FACTOR#0.6294;KERATINOCYTE#0.6285;EPIDERMAL GROWTH FACTOR#0.6276;MELANOMA CELL LINES#0.6176;OSTEOSARCOMA CELL LINES#0.6131;CD4+ T CELL#0.6092;LUMINAL#0.6017;CORNEAL EPITHELIAL CELL MIGRATION#0.6014;CELL COMMUNICATION#0.6013
1943	OPTIC NERVE#1.0818;EPHRIN#1.0631;REGENERATION#1.0126;RECEPTOR TYROSINE KINASE#0.9935;TECTUM#0.9930;SUPERIOR COLLICULUS#0.9677;RETINAL GANGLION CELL#0.9307;GANGLION CELLS#0.9301;AXON GUIDANCE#0.9200;GROWTH CONE#0.9130;HAIR CELL#0.8953;NERVOUS SYSTEM#0.8765;GENE EXPRESSION#0.8603;GROWTH FACTOR#0.7662;INNERVATION#0.7544;CELL SURFACE#0.7501;TRANSCRIPTION FACTOR#0.7267;GROWTH CONE COLLAPSE#0.7114;PROGENITOR CELL#0.6843;CENTRAL NERVOUS SYSTEM#0.6571;NEURITE#0.6427;STEM CELL#0.6312;CARTILAGE MORPHOGENESIS#0.6212;INNER EAR#0.6056;NEURAL CREST#0.6032
1944	EPHRIN#1.0703;HYPOXIA#1.0024;ANGIOGENESIS#0.9286;RECEPTOR TYROSINE KINASE#0.9195;GENE EXPRESSION#0.9189;APOPTOSIS#0.8912;GROWTH FACTOR#0.8891;ENDOTHELIAL CELL#0.8302;DENTATE GYRUS#0.7779;TUBE FORMATION#0.7314;SIGNALING PATHWAY#0.7150;DENDRITIC SPINE#0.7018;RESPONSE TO HYPOXIA#0.6983;POLYMERASE CHAIN REACTION#0.6892;STEM CELL#0.6612;ASTROCYTE#0.6407;ENDOTHELIAL GROWTH FACTOR#0.6334;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6334;HAIR FOLLICLE#0.6182;CELL SURFACE#0.6120;HEPATOCELLULAR CARCINOMA#0.6083;BREAST CANCER#0.6004
1945	EPHRIN#1.0837;B CELL#0.9556;ENDOTHELIAL CELL#0.8295;RECEPTOR TYROSINE KINASE#0.7254
1946	GROWTH CONE COLLAPSE#1.0635;EPHRIN#1.0526;GROWTH CONE#1.0514;AXON GUIDANCE#0.9982;CELL ADHESION#0.9959;TRANSACTIVATION#0.9881;RECEPTOR TYROSINE KINASE#0.9876;GENE EXPRESSION#0.9808;TECTUM#0.9797;SPINAL CORD#0.9774;SIGNALING PATHWAY#0.9735;NEURITE#0.9724;RETINAL GANGLION CELL#0.9674;TYROSINE KINASE RECEPTOR#0.9603;NERVOUS SYSTEM#0.9577;EPITHELIAL CELL#0.9543;CAROTENOID#0.9517;TRANSCRIPTION FACTOR#0.9515;CELL MIGRATION#0.9391;LIPOIC ACID#0.9137;APOPTOSIS#0.8967;PROTEIN KINASE#0.8901;GROWTH FACTOR#0.8809;CANCER CELL#0.8626;LIGAND BINDING DOMAIN#0.8614;GANGLION CELLS#0.8418;CELL PROLIFERATION#0.8406;RECEPTOR LIGAND#0.8392;INNERVATION#0.8153;BREAST CANCER#0.7994;MIDBRAIN#0.7807;CELL SURFACE#0.7684;THALAMUS#0.7676;NEURITE OUTGROWTH#0.7674;POLYMERASE CHAIN REACTION#0.7589;COLITIS#0.7588;CELL WALL#0.7539;SRC FAMILY KINASE#0.7510;PROSTATE CANCER#0.7475;AXON GROWTH#0.7417;HINDLIMB#0.7392;GRANULOSA CELL#0.7294;BREAST CANCER CELL#0.7283;DNA BINDING#0.7276;CELL DEATH#0.7252;PROGENITOR CELL#0.7213;CELL CYCLE#0.7212;BRAIN DEVELOPMENT#0.7112;CAROTENOID BIOSYNTHESIS#0.7088;ESTROGEN RECEPTOR#0.6983;NEURAL TUBE#0.6807;PEPTIDOGLYCAN#0.6803;SIGNAL TRANSDUCTION#0.6725;CEREBRAL CORTEX#0.6641;CAROTENOID BIOSYNTHETIC#0.6619;REGENERATION#0.6592;OLFACTORY BULB#0.6561;INTERNEURON#0.6518;REVERSE TRANSCRIPTION#0.6482;NEUROGENESIS#0.6352;REACTIVE OXYGEN SPECIES#0.6237;RECEPTOR CLUSTERING#0.6142;ASTROCYTE#0.6133;LENS DEVELOPMENT#0.6116;GENE SILENCING#0.6089;CELL ADHESION MOLECULE#0.6058;PATTERN FORMATION#0.6032;SUPERIOR COLLICULUS#0.6023
1947	T CELL#1.0604;EPHRIN#1.0486;NEURAL CREST#1.0222;CANCER CELL#1.0092;GROWTH FACTOR#0.9983;ENDOTHELIAL CELL#0.9948;SLIT DIAPHRAGM#0.9872;RECEPTOR TYROSINE KINASE#0.9866;GENE EXPRESSION#0.9760;CELL MIGRATION#0.9741;CELL ADHESION#0.9695;DIAPHRAGM#0.9689;STEM CELL#0.9680;NEURAL CREST CELL#0.9581;NERVOUS SYSTEM#0.9433;CELL SURFACE#0.9413;PROGENITOR CELL#0.9361;BONE MARROW#0.9336;POLYMERASE CHAIN REACTION#0.9318;SIGNALING PATHWAY#0.9146;AXON GUIDANCE#0.8780;BONE FORMATION#0.8751;GROWTH CONE#0.8671;THYMOCYTE#0.8572;T CELL DEVELOPMENT#0.8552;EPITHELIAL CELL#0.8549;CELL DIFFERENTIATION#0.8546;PROTEIN KINASE#0.8525;SPINAL CORD#0.8483;CELL DEVELOPMENT#0.8461;MORPHOGENESIS#0.8352;RECEPTOR LIGAND#0.8335;CELL PROLIFERATION#0.8283;STROMAL CELL#0.8161;GROWTH FACTOR RECEPTOR#0.8151;OSTEOBLAST#0.8150;ANGIOGENESIS#0.8132;CORONAL#0.8046;NEURAL PROGENITOR CELL#0.8005;TRANSCRIPTION FACTOR#0.7978;B CELL#0.7972;MONOCYTE#0.7936;REVERSE TRANSCRIPTION#0.7830;CONGENITAL DIAPHRAGMATIC HERNIA#0.7820;NEUROEPITHELIAL CELL#0.7756;FIBROBLAST GROWTH FACTOR#0.7740;T LYMPHOCYTE#0.7710;X CHROMOSOME#0.7686;DOMINANT NEGATIVE MUTANT#0.7676;PODOCYTE#0.7659;KINASE ACTIVITY#0.7599;CELL CELL ADHESION#0.7591;ASTROCYTE#0.7590;NEURITE#0.7564;TYROSINE KINASE RECEPTOR#0.7460;MIDLINE#0.7419;BONE MARROW STROMAL#0.7351;EPHRIN RECEPTOR#0.7304;MITOGEN ACTIVATED PROTEIN#0.7286;CHEMOTAXIS#0.7159;SOMITE#0.7003;GROWTH CONE COLLAPSE#0.6970;CELL CHEMOTAXIS#0.6930;COLORECTAL CANCER#0.6820;INFLAMMATORY RESPONSE#0.6735;SAETHRE-CHOTZEN SYNDROME#0.6670;MESENCHYMAL CELL#0.6552;SIGNAL TRANSDUCTION#0.6491;TUMOR NECROSIS FACTOR#0.6475;NEUROGENESIS#0.6406;CAUDAL HALF#0.6404;OSTEOCLAST#0.6378;DENTAL PULP STEM CELL#0.6235;MESENCHYME#0.6194;CELL CYCLE#0.6187;DENTAL PULP#0.6162;COLORECTAL#0.6137;PROTEIN TYROSINE KINASE#0.6094;RECEPTOR BINDING#0.6023
1948	EPHRIN#1.0433;T CELL#1.0286;ENDOTHELIAL GROWTH FACTOR#1.0215;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0215;CELL PROLIFERATION#1.0173;PROGENITOR CELL#1.0160;CELL SURFACE#1.0154;SMOOTH MUSCLE#1.0131;GROWTH FACTOR#1.0093;ANGIOGENESIS#1.0070;POLYMERASE CHAIN REACTION#1.0055;ENDOTHELIAL CELL#1.0053;SIGNALING PATHWAY#1.0015;STEM CELL#0.9957;BONE MARROW#0.9936;ENDOTHELIUM#0.9878;BLOOD VESSEL#0.9872;GENE EXPRESSION#0.9870;CELL MIGRATION#0.9862;NEURAL CREST#0.9861;ARTERY#0.9860;RECEPTOR BINDING#0.9803;RECEPTOR TYROSINE KINASE#0.9789;EPHRIN RECEPTOR#0.9767;SPINAL CORD#0.9745;STROMAL CELL#0.9716;CANCER CELL#0.9707;ASTROCYTE#0.9606;EPITHELIAL CELL#0.9583;MORPHOGENESIS#0.9549;OSTEOBLAST#0.9453;CELL ADHESION#0.9378;GROWTH FACTOR RECEPTOR#0.9359;SIGNALING MOLECULE#0.9339;TRANSCRIPTION FACTOR#0.9325;REVERSE TRANSCRIPTION#0.9308;NEURAL CREST CELL#0.9251;SIGNAL TRANSDUCTION#0.9249;ISCHEMIA#0.9249;APOPTOSIS#0.9239;NERVOUS SYSTEM#0.9176;HOST CELL#0.9139;PERIPHERAL BLOOD#0.9088;MAMMARY GLAND#0.9057;OSTEOCLAST#0.8999;SQUAMOUS CELL CARCINOMA#0.8999;GROWTH CONE#0.8998;ENDOCYTOSIS#0.8933;UMBILICAL VEIN#0.8922;SMOOTH MUSCLE CELL#0.8897;MUSCLE CELL#0.8889;HUMAN UMBILICAL VEIN#0.8869;TUBE FORMATION#0.8853;MESENCHYMAL CELL#0.8853;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8830;AXON GUIDANCE#0.8775;CELL GROWTH#0.8770;CELL MEMBRANE#0.8766;MIDLINE#0.8697;THYMOCYTE#0.8652;SIGNALLING PATHWAY#0.8649;BONE FORMATION#0.8470;MONONUCLEAR CELLS#0.8365;PROTEIN KINASE#0.8359;NEURAL STEM CELL#0.8342;CELL DIFFERENTIATION#0.8337;REGENERATION#0.8316;COLORECTAL CANCER#0.8141;TROPHOBLAST#0.8041;CEREBRAL ISCHEMIA#0.8007;EPIDERMAL GROWTH FACTOR#0.8002;VASCULAR ENDOTHELIAL CELL#0.7859;COLORECTAL#0.7778;VASCULOGENESIS#0.7753;RETINAL GANGLION CELL#0.7744;AXON PATHFINDING#0.7725;ENDOTHELIAL PROGENITOR CELL#0.7686;BONE REMODELING#0.7672;INFERIOR COLLICULUS#0.7637;LIGAND BINDING DOMAIN#0.7634;CELL DEVELOPMENT#0.7590;BREAST CANCER#0.7569;FOCAL CEREBRAL ISCHEMIA#0.7561;TYROSINE KINASE RECEPTOR#0.7481;MESENCHYMAL STEM CELL#0.7468;LYMPH NODE METASTASIS#0.7438;PERICYTE#0.7426;QUANTITATIVE REAL TIME#0.7420;RECEPTOR LIGAND#0.7403;NEUROBLASTOMA#0.7369;MACROPHAGE#0.7282;NEURITE#0.7217;ARTERIOGENESIS#0.7182;PLASMA MEMBRANE#0.7180;LYMPH NODE#0.7167;CHONDROCYTE#0.7103;GANGLION CELLS#0.7067;SOMITE#0.6971;ARTERIOVENOUS MALFORMATION#0.6949;MESENCHYME#0.6941;MONOCYTE#0.6866;PLACENTAL DEVELOPMENT#0.6864;MEMBRANE FUSION#0.6836;T CELL DEVELOPMENT#0.6812;COLON CANCER#0.6801;INNER EAR#0.6792;FOCAL ADHESION#0.6750;T CELL PROLIFERATION#0.6707;PANCREATIC CANCER#0.6690;CELL CYCLE#0.6555;PROSTATE CANCER#0.6525;GROWTH CONE COLLAPSE#0.6506;PLATELET-DERIVED GROWTH FACTOR#0.6493;EXTRACELLULAR MATRIX#0.6454;HYPOXIA#0.6337;BONE RESORPTION#0.6314;MARROW STROMAL CELLS#0.6308;BONE MARROW STROMAL CELL#0.6308;BONE MARROW STROMAL#0.6304;TUMOR CELLS#0.6275;MURAL CELL#0.6248;SMOOTH MUSCLE ACTIN#0.6208;FIBROBLAST GROWTH FACTOR#0.6184;TRANSFORMING GROWTH FACTOR#0.6170;LUMINAL#0.6131;ENDOCHONDRAL OSSIFICATION#0.6018;BONE DEVELOPMENT#0.6003
1949	EPHRIN#1.0660;MIDLINE#1.0338;SPINAL CORD#1.0329;CELL SURFACE#0.8970;RECEPTOR TYROSINE KINASE#0.7849;APOPTOSIS#0.7757;NEUROBLASTOMA#0.7577;NERVOUS SYSTEM#0.7491;TYROSINE KINASE RECEPTOR#0.7277;CELL DEATH#0.7021;NEURITE#0.6999;HEPARIN#0.6955;SIGNALING PATHWAY#0.6595;HYPERTENSION#0.6385;TUMOR CELLS#0.6374;VASCULAR SMOOTH MUSCLE CELL#0.6101;SMOOTH MUSCLE CELL#0.6065;MUSCLE CELL#0.6056;SMOOTH MUSCLE#0.6042
1950	RECEPTOR TRANSACTIVATION#1.0749;EGF BINDING#1.0628;HEPARIN BINDING#1.0509;GM-CSF#1.0393;TRANSACTIVATION#1.0300;G-CSF#1.0273;HEPARIN#1.0252;CETUXIMAB#1.0203;GEFITINIB#1.0149;PHOSPHOLIPASE C#1.0143;DNA SYNTHESIS#1.0106;MAMMARY EPITHELIAL CELL#1.0101;ENDOSOME#1.0041;OVARIAN CANCER#1.0021;ENDOCYTOSIS#1.0021;MAPK SIGNALING#1.0005;CELL MOTILITY#0.9992;OOCYTE#0.9980;KERATINOCYTE#0.9970;KINASE ACTIVITY#0.9970;SIGNALLING PATHWAY#0.9968;RETINOIC ACID#0.9967;FOCAL ADHESION#0.9923;ANCHORAGE INDEPENDENT GROWTH#0.9915;DNA BINDING#0.9904;LATE ENDOSOME#0.9895;MAP KINASE#0.9893;OVARIAN#0.9879;PROTEIN TYROSINE KINASE#0.9876;PROTEIN KINASE C#0.9876;EPITHELIAL MESENCHYMAL TRANSITION#0.9866;IL-1RA#0.9862;TYROSINE KINASE INHIBITOR#0.9857;AKT SIGNALING#0.9856;SIGNALING MOLECULE#0.9850;EPIDERMAL GROWTH FACTOR#0.9840;CELL CYCLE ARREST#0.9832;REGENERATION#0.9832;NEURAL STEM CELL#0.9827;EPITHELIAL TO MESENCHYMAL#0.9826;COLORECTAL CANCER#0.9823;PROSTATE CANCER#0.9820;CELL MEMBRANE#0.9820;MAPK ACTIVATION#0.9812;HUMAN BREAST CANCER#0.9811;BREAST CANCER CELL#0.9810;ERLOTINIB#0.9810;KINASE INHIBITOR#0.9801;PROGESTERONE#0.9796;GROWTH FACTOR#0.9794;CELL MIGRATION#0.9794;COLON CANCER#0.9790;EARLY ENDOSOME#0.9788;CYTOPLASM#0.9782;PLASMA MEMBRANE#0.9781;CELL DIFFERENTIATION#0.9779;RECEPTOR BINDING#0.9779;TRANSFORMING GROWTH FACTOR#0.9777;GROWTH FACTOR RECEPTOR#0.9774;COLORECTAL#0.9772;ONCOGENIC#0.9769;SIGNALING CASCADE#0.9768;MACROPHAGE#0.9767;BREAST CANCER#0.9764;ADENOCARCINOMA#0.9763;WOUND HEALING#0.9757;CELL ADHESION#0.9756;TUMOR CELLS#0.9751;STROMAL CELL#0.9751;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9742;RECEPTOR TYROSINE KINASE#0.9741;ANTI EGFR#0.9732;SIGNAL TRANSDUCTION#0.9731;CELL CYCLE#0.9729;CELL SURFACE#0.9728;LUNG CANCER#0.9719;INSULIN-LIKE GROWTH FACTOR#0.9716;CELL GROWTH#0.9711;S PHASE#0.9707;BREAST CARCINOMA#0.9706;UBIQUITIN#0.9704;PANCREATIC CANCER#0.9701;SMOOTH MUSCLE#0.9701;SIGNALING PATHWAY#0.9693;CELL PROLIFERATION#0.9690;MAMMARY GLAND#0.9684;CANCER CELL#0.9681;APOPTOTIC#0.9680;THYMIDINE#0.9677;PROGENITOR CELL#0.9676;APOPTOSIS#0.9674;SMOOTH MUSCLE CELL#0.9673;PROTEIN KINASE#0.9673;MUSCLE CELL#0.9670;TUMOR SUPPRESSOR#0.9668;ANGIOGENESIS#0.9666;SQUAMOUS CELL CARCINOMA#0.9664;TRANSCRIPTION FACTOR#0.9663;CELL DEATH#0.9660;MITOGEN ACTIVATED PROTEIN#0.9657;RECEPTOR INTERNALIZATION#0.9656;EPITHELIAL CELL#0.9656;EXTRACELLULAR MATRIX#0.9642;ESTROGEN RECEPTOR#0.9637;MESENCHYMAL STEM CELL#0.9623;ENDOTHELIAL CELL#0.9621;GASTRIC MUCOSA#0.9607;STEM CELL#0.9604;GENE EXPRESSION#0.9598;TIGHT JUNCTION#0.9575;SIGNAL TRANSDUCER#0.9559;ACTIVATION OF MAP KINASE#0.9549;TYROSINE KINASE RECEPTOR#0.9549;HYPOXIA#0.9544;HEPATOCELLULAR CARCINOMA#0.9535;ANDROGEN RECEPTOR#0.9531;DEPHOSPHORYLATION#0.9530;COATED PIT#0.9526;TRASTUZUMAB#0.9517;MORPHOGENESIS#0.9503;BONE MARROW#0.9492;FIBROBLAST GROWTH FACTOR#0.9484;IFN-GAMMA#0.9483;PRECURSOR CELL#0.9470;RECEPTOR LIGAND#0.9441;PROTEIN SYNTHESIS#0.9436;GENISTEIN#0.9378;SRC FAMILY KINASE#0.9356;TRANSFORMING GROWTH FACTOR ALPHA#0.9346;PROTEIN TYROSINE PHOSPHATASE#0.9334;MEMBRANE RUFFLE#0.9333;ASTROCYTE#0.9330;ESTRADIOL#0.9319;BEVACIZUMAB#0.9299;CYTOTOXICITY#0.9295;LYSOSOME#0.9294;TROPHOBLAST#0.9294;STEM CELL MARKER#0.9281;PROTEASOME#0.9269;PRO-INFLAMMATORY#0.9260;MESENCHYMAL CELL#0.9255;CLATHRIN-COATED PIT#0.9207;TOXICITY#0.9200;NERVOUS SYSTEM#0.9175;INSULIN RECEPTOR#0.9162;CHEMOTAXIS#0.9142;BREAST CANCER PATIENTS#0.9133;DRUG RESISTANCE#0.9124;POLYMERASE CHAIN REACTION#0.9123;METASTATIC COLORECTAL CANCER#0.9120;ACTIN CYTOSKELETON#0.9085;G1 PHASE#0.9074;FACTOR I#0.9053;LUMINAL#0.9040;EPITHELIAL CELL PROLIFERATION#0.9032;RUFFLE#0.9031;LUNG ADENOCARCINOMA#0.9022;BASEMENT MEMBRANE#0.9003;LAPATINIB#0.8992;PKG II#0.8986;RESPONSE TO GROWTH FACTOR#0.8984;PROTEIN PHOSPHORYLATION#0.8973;FOCAL ADHESION KINASE#0.8970;RECEPTOR ANTAGONIST#0.8969;T CELL#0.8966;EMBRYONIC STEM CELL#0.8926;REACTIVE OXYGEN SPECIES#0.8926;CAVEOLAE#0.8925;CYTOTROPHOBLAST#0.8886;PROTEIN PROTEIN INTERACTION#0.8875;GLAND DEVELOPMENT#0.8874;VASCULAR SMOOTH MUSCLE CELL#0.8858;PLATELET-DERIVED GROWTH FACTOR#0.8849;RNA INTERFERENCE#0.8844;CARBACHOL#0.8837;MOUSE EMBRYONIC FIBROBLAST#0.8820;CYCLIN DEPENDENT KINASE#0.8771;IMMUNE RESPONSE#0.8770;CANCER STEM CELL#0.8752;LIPID RAFT#0.8727;EGFR SIGNALING PATHWAY#0.8718;INTESTINAL EPITHELIAL CELL#0.8717;NEURAL CREST#0.8714;PHOSPHATASE ACTIVITY#0.8678;GOBLET CELL#0.8653;DOCKING PROTEIN#0.8626;KERATINOCYTE MIGRATION#0.8622;CELLULAR GROWTH#0.8613;TUMOR TISSUES#0.8598;RAPAMYCIN#0.8597;QUANTITATIVE REAL TIME#0.8596;ADHERENS JUNCTION#0.8590;NUCLEOTIDE EXCHANGE FACTOR#0.8587;DEXAMETHASONE#0.8585;MAMMARY GLAND DEVELOPMENT#0.8570;STRESS FIBER#0.8519;INTRACELLULAR SIGNALING PATHWAY#0.8517;THYROID CANCER#0.8500;PROTEIN KINASE ACTIVITY#0.8496;DOMINANT NEGATIVE MUTANT#0.8490;OVARIAN CARCINOMA#0.8482;GRANULOSA CELL#0.8465;RECEPTOR AGONIST#0.8453;NADPH OXIDASE#0.8446;ADIPOCYTE#0.8427;MYOFIBROBLAST#0.8425;EXOSOME#0.8412;EGF RECEPTOR LIGAND#0.8372;LIVER REGENERATION#0.8372;HEPATOCYTE GROWTH FACTOR#0.8362;M PHASE#0.8360;CISPLATIN#0.8342;NEUROGENESIS#0.8335;ENDOMETRIAL CANCER#0.8326;INFLAMMATORY RESPONSE#0.8308;GUANINE#0.8266;NERVE GROWTH FACTOR#0.8256;5 FLUOROURACIL#0.8229;MAP KINASE ACTIVITY#0.8213;TRANSFORMING GROWTH FACTOR BETA#0.8198;MICROTUBULE#0.8158;MACROPINOSOME#0.8147;LYMPH NODE#0.8145;LACRIMAL GLAND#0.8111;LUNG CARCINOMA#0.8082;TUBE FORMATION#0.8067;CELL DIVISION#0.8067;PROTEIN KINASE A#0.8038;NEURITE#0.8037;CORNEAL EPITHELIAL CELL#0.8007;ESOPHAGEAL CANCER#0.7980;ACTIN FILAMENT#0.7976;PROTEOGLYCAN#0.7968;STROMA#0.7968;CERVICAL#0.7950;ARACHIDONIC ACID#0.7897;HUMAN MAMMARY EPITHELIAL#0.7882;CENTRAL NERVOUS SYSTEM#0.7863;NEURITE OUTGROWTH#0.7820;MACROPINOCYTOSIS#0.7812;RECEPTOR MEDIATED ENDOCYTOSIS#0.7804;ENDOMETRIUM#0.7797;NEURAL STEM PROGENITOR#0.7762;MESENCHYME#0.7758;HYDROCORTISONE#0.7746;TUMOR NECROSIS FACTOR#0.7746;RECEPTOR ACTIVITY#0.7743;VEGF PRODUCTION#0.7726;EGFR:ERBB2 HETERODIMER#0.7722;IRINOTECAN#0.7688;ADIPOSE TISSUE#0.7674;ACID SECRETION#0.7663;CUMULUS OOCYTE COMPLEXES#0.7655;FORSKOLIN#0.7648;CHONDROCYTE#0.7647;PI3K SIGNALING#0.7620;FERTILIZATION#0.7619;OSTEOBLAST#0.7618;ARGININE#0.7609;MITOGENIC ACTIVITY#0.7608;MONOCYTE#0.7600;ENDOPLASMIC RETICULUM#0.7589;CELL ACTIVATION#0.7586;HEPATOCYTE PROLIFERATION#0.7581;B CELL#0.7564;PSORIASIS#0.7542;GASTRIC ACID SECRETION#0.7540;SENESCENCE#0.7535;OVARIES#0.7521;FLUOROURACIL#0.7520;GROWTH HORMONE#0.7519;MUTAGENESIS#0.7491;BLOOD VESSEL#0.7490;STAUROSPORINE#0.7472;AIRWAY SMOOTH MUSCLE#0.7470;HYALURONAN#0.7466;MESENCHYMAL STROMAL CELL#0.7465;OXALIPLATIN#0.7462;PERIPHERAL BLOOD#0.7458;TISSUE REGENERATION#0.7454;LEUKOCYTE#0.7423;AUTOPHAGY#0.7412;PANCREATIC CARCINOMA#0.7409;PROGRAMMED CELL DEATH#0.7405;MECHANISM OF ACTION#0.7398;COAGULATION#0.7392;TOPICAL#0.7377;SPINAL CORD#0.7345;WNT SIGNALING PATHWAY#0.7339;BRANCHING MORPHOGENESIS#0.7302;MAP KINASE KINASE#0.7295;CELL PERIPHERY#0.7285;PANITUMUMAB#0.7277;ADULT STEM CELL#0.7273;MEMBRANE RUFFLING#0.7271;GASTRIC ULCER#0.7259;NITRIC OXIDE#0.7249;CYSTATIN#0.7242;MAPK SIGNALLING#0.7239;MITOCHONDRIA#0.7234;CELL CELL ADHESION#0.7232;FGF-7#0.7231;UMBILICAL CORD#0.7216;LIVER CANCER#0.7211;EXCRETION#0.7176;DIGESTION#0.7166;REVERSE TRANSCRIPTION#0.7165;TESTOSTERONE#0.7155;PLURIPOTENT STEM CELL#0.7127;UTERUS#0.7096;ANISOMYCIN#0.7081;MECHANISMS OF ACTION#0.7066;LEUCINE#0.7060;CLATHRIN-MEDIATED ENDOCYTOSIS#0.7042;CATALYTIC ACTIVITY#0.7039;VULVAL DEVELOPMENT#0.7035;DENDRITIC CELL#0.7033;TYROSINE AUTOPHOSPHORYLATION#0.7030;CELL MOVEMENT#0.7029;ROS GENERATION#0.6997;LIGAND BINDING DOMAIN#0.6991;GTP BINDING#0.6981;SALIVARY GLAND#0.6971;SMOOTH MUSCLE ACTIN#0.6958;TARGET OF RAPAMYCIN#0.6946;PACLITAXEL#0.6941;CETRORELIX#0.6938;MESOTHELIOMA CELL#0.6936;HUMAN EPIDERMAL KERATINOCYTES#0.6914;VANDETANIB#0.6909;GLYCOSYLATION#0.6898;MAPK CASCADE#0.6889;SUBMANDIBULAR GLAND#0.6876;MAPK SIGNAL TRANSDUCTION#0.6850;QUERCETIN#0.6848;FLOW CYTOMETRY ANALYSIS#0.6840;ORAL SQUAMOUS CELL CARCINOMA#0.6837;CLEFT PALATE#0.6799;DOXORUBICIN#0.6798;ENZYME ACTIVITY#0.6783;REGULATION OF CELL PROLIFERATION#0.6775;5S RRNA TRANSCRIPTION#0.6770;ONCOGENESIS#0.6752;HUMAN PANCREATIC CANCER#0.6749;IL-11#0.6734;CHOLERA#0.6724;SEMINAL PLASMA#0.6713;IL-8 PRODUCTION#0.6713;MAST CELL#0.6699;GASTRIC ADENOCARCINOMA#0.6698;OVIDUCT#0.6690;RENAL CELL CARCINOMA#0.6690;ACTIN POLYMERIZATION#0.6689;GLIOBLASTOMA MULTIFORME#0.6688;EPITHELIAL OVARIAN CANCER#0.6687;BETA CELL#0.6686;CYCLIC AMP#0.6685;HOST CELL#0.6683;JUXTAMEMBRANE#0.6673;MESOTHELIAL CELL#0.6656;OLIGODENDROCYTE#0.6636;HUMAN CORNEAL EPITHELIAL#0.6589;TRANSMEMBRANE RECEPTOR#0.6584;SKIN CANCER#0.6569;COLLAGENASE#0.6568;FACTOR S#0.6564;FUCOSYLATION#0.6548;APOPTOTIC CELL DEATH#0.6535;CELL ADHESION MOLECULE#0.6518;ACTIVATION OF NF-KAPPAB#0.6500;NOTCH RECEPTOR#0.6496;TYROSINE KINASE DOMAIN#0.6495;NEUROBLASTOMA#0.6493;NOCODAZOLE#0.6487;EGF RECEPTOR ACTIVITY#0.6479;SIGNALLING CASCADE#0.6476;INHIBITION OF CELL PROLIFERATION#0.6469;MALIGNANT GLIOMA#0.6459;LUNG EPITHELIAL CELL#0.6451;HUMAN MESENCHYMAL STEM#0.6451;LUNG METASTASIS#0.6448;RECEPTOR COMPLEX#0.6436;HEAD AND NECK CANCER#0.6432;NECK CANCER#0.6431;NEURAL CELL#0.6416;GERM CELL#0.6411;CORD BLOOD#0.6406;SMALL INTESTINE#0.6406;PANCREATIC DUCTAL ADENOCARCINOMA#0.6329;SORAFENIB#0.6323;NEURAL PRECURSOR CELL#0.6322;GESTATION#0.6312;NEURAL PROGENITOR CELL#0.6289;LUNG DEVELOPMENT#0.6279;CLEAVED CASPASE 3#0.6252;ADENOSINE#0.6251;TRANSIENT RECEPTOR POTENTIAL#0.6246;PKCALPHA#0.6240;STEM CELL MEDIUM#0.6230;OMMATIDIAL ROTATION#0.6227;INDUCTION OF APOPTOSIS#0.6225;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.6210;NF-KAPPAB ACTIVATION#0.6208;VILLOUS CYTOTROPHOBLAST#0.6162;INVASIVE BREAST CANCER#0.6162;CELL CYCLE REGULATOR#0.6158;ETHANOL#0.6153;HERCEPTIN#0.6135;EMBRYO DEVELOPMENT#0.6130;UBIQUITIN INTERACTING MOTIF#0.6129;MESENCHYMAL CELL PROLIFERATION#0.6128;ENDOTHELIUM#0.6114;NEPHRON#0.6114;HISTONE DEACETYLASE#0.6109;BETA-2#0.6103;DNA FRAGMENTATION#0.6084;LOCOMOTION#0.6083;HUMAN UMBILICAL VEIN#0.6081;UMBILICAL VEIN#0.6079;KIDNEY DISEASE#0.6065;BIOTIN#0.6056;IMMUNE SYSTEM#0.6051;INDOMETHACIN#0.6043;SENSITIZATION#0.6043;CONTACT INHIBITION#0.6005
1951	PLANAR CELL POLARITY#1.0425;CELL POLARITY#1.0419;FOREBRAIN#0.9663;AXON GUIDANCE#0.8672;NEURITE GROWTH#0.8449;NERVOUS SYSTEM#0.8322;INTERNAL CAPSULE#0.7762;NEURITE#0.7335;PCP PATHWAY#0.6916;AMACRINE CELL#0.6309;SIGNALING MOLECULE#0.6089;INTERNEURON MIGRATION#0.6045
1952	PLANAR CELL POLARITY#0.9723;CELL POLARITY#0.9646;LOW DENSITY LIPOPROTEIN#0.9312;CORONARY ARTERY#0.8707;ARTERY DISEASE#0.8603;CORONARY ARTERY DISEASE#0.8475;SERTOLI CELL#0.8288;GENE EXPRESSION#0.8136;ARTERY#0.7853;HIGH DENSITY LIPOPROTEIN#0.7740;MYOCARDIAL INFARCTION#0.6307;GERM CELL#0.6090;BREAST CANCER#0.6020
1953	EPITHELIAL TO MESENCHYMAL TRANSITION#0.6420;EPITHELIAL TO MESENCHYMAL#0.6417;CELL MIGRATION#0.6321;CELL PROLIFERATION#0.6264;SIGNALING PATHWAY#0.6029
1954	CARPENTER SYNDROME#0.7387;BINDING PROTEIN 1#0.6775
1955	TUMOR SUPPRESSOR#0.6586;NERVOUS SYSTEM#0.6562;BREAST CANCER#0.6553
1956	ERBB SIGNALLING PATHWAY#1.1106;PKG II#1.0790;ZD-1839#1.0652;ERBB SIGNALING PATHWAY#1.0606;MATUZUMAB#1.0568;GW572016#1.0558;BIBW 2992#1.0543;CI-1033#1.0504;GROWTH FACTOR RECEPTOR BINDING#1.0468;HER2 SIGNALING PATHWAY#1.0455;COPY NUMBER INCREASE#1.0439;EGFR BINDING#1.0425;ERBB SIGNALING#1.0412;IGG1 ANTIBODY#1.0406;COMPLEMENTATION GROUP 1#1.0354;FACTOR RECEPTOR SUBSTRATE#1.0347;CHOLESTEATOMA#1.0336;HUMAN EPIDERMAL RECEPTOR#1.0324;OSI-774#1.0322;KERATINOCYTE MIGRATION#1.0306;OUABAIN#1.0296;EGFR SIGNALING PATHWAY#1.0293;THYMIC CARCINOMA#1.0292;INSULIN GROWTH FACTOR#1.0284;URINARY BLADDER CANCER#1.0282;PLEOMORPHIC CARCINOMA#1.0274;CYSTATIN#1.0272;EGFR:ERBB2 HETERODIMER#1.0263;ZD1839#1.0263;MET SIGNALING PATHWAY#1.0250;GALLBLADDER CARCINOMA#1.0243;INCREASED COPY NUMBER#1.0238;MIDDLE EAR#1.0235;NUCLEAR TRANSPORT#1.0233;PROSTATE-SPECIFIC MEMBRANE ANTIGEN#1.0230;AMELOBLASTOMA#1.0225;SALIVARY GLAND CARCINOMA#1.0223;METASTATIC COLORECTAL CARCINOMA#1.0220;BERBERINE#1.0217;RECEPTOR TRANSACTIVATION#1.0204;VANDETANIB#1.0194;LARYNGEAL CARCINOMA#1.0191;HAS ACTIVITY#1.0191;ERBITUX#1.0180;LEPTOMENINGEAL METASTASES#1.0177;EARLY GROWTH RESPONSE#1.0176;N GLYCAN#1.0171;UVEAL MELANOMA#1.0169;TUMOR GROWTH FACTOR#1.0166;VECTIBIX#1.0166;VEGF SIGNALING#1.0164;NOTCH SIGNALING PATHWAY#1.0163;INHIBITION OF PHOSPHORYLATION#1.0162;LIQUID BASED CYTOLOGY#1.0161;GROWTH FACTOR RECEPTOR#1.0161;MAPK ERK KINASE#1.0160;RECEPTOR DEGRADATION#1.0159;TARCEVA#1.0159;EPIDERMAL GROWTH FACTOR#1.0159;METALLOPROTEASE INHIBITOR#1.0158;EPHRIN#1.0150;TYROSINE KINASE 2#1.0143;ORAL CANCER CELL#1.0142;GASTRIC TISSUE#1.0140;MELTING CURVE ANALYSIS#1.0138;MAPK SIGNALLING#1.0137;GM6001#1.0137;MESOTHELIOMA CELL#1.0136;HYPERACTIVE#1.0135;CERVICAL INTRAEPITHELIAL NEOPLASIA#1.0131;GROWTH FACTOR#1.0131;HEAD AND NECK CARCINOMA#1.0128;CERVICAL SQUAMOUS CELL CARCINOMA#1.0127;MESENCHYMAL EPITHELIAL TRANSITION#1.0126;BARRETT'S ESOPHAGUS#1.0126;IRESSA#1.0121;CERVICAL ADENOCARCINOMA#1.0114;IL-8 PRODUCTION#1.0111;PROGESTIN#1.0110;ANTI EGFR#1.0108;LOCKED NUCLEIC ACID#1.0106;TOPOISOMERASE II#1.0106;VORINOSTAT#1.0105;TO THE PROGRESSION#1.0104;TYROSINE KINASE INHIBITION#1.0104;TYROSINE AUTOPHOSPHORYLATION#1.0104;SINGLE PARTICLE TRACKING#1.0101;LARYNGEAL SQUAMOUS CELL CARCINOMA#1.0100;MUCOEPIDERMOID CARCINOMA#1.0097;AFATINIB#1.0097;LAPATINIB#1.0095;PERITONEAL MESOTHELIOMA#1.0095;GALECTIN#1.0090;CORNEAL EPITHELIAL CELL#1.0088;TELOMERASE REVERSE TRANSCRIPTASE#1.0087;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#1.0087;TYROSINE KINASE DOMAIN#1.0087;IMMUNOTOXIN#1.0086;ENDOMETRIOSIS#1.0085;VULVA#1.0084;ANAPLASTIC THYROID CANCER#1.0083;HUMAN CORNEAL EPITHELIAL#1.0082;SPINAL CORD INJURY#1.0080;MYELINATION#1.0079;PEPTIDE NUCLEIC ACID#1.0077;AUTOCRINE SIGNALING#1.0076;DNA TOPOISOMERASE#1.0075;EGF RECEPTOR LIGAND#1.0073;FOLATE#1.0072;EPIDERMAL GROWTH FACTOR BINDING#1.0070;ALBUMIN CREATININE RATIO#1.0068;RETINOIC ACID RECEPTOR#1.0066;ANAPLASTIC LYMPHOMA KINASE#1.0066;PANITUMUMAB#1.0064;RENAL FIBROSIS#1.0064;PROTEIN KINASE ACTIVATION#1.0064;VEGF PRODUCTION#1.0062;LIPID RAFT#1.0060;JUXTAMEMBRANE#1.0058;TRANSACTIVATION#1.0058;RECEPTOR CLUSTERING#1.0055;TROPHOBLAST CELL#1.0053;TYKERB#1.0052;OOGENESIS#1.0051;METFORMIN#1.0050;CONSTITUTIVELY ACTIVE MUTANT#1.0050;TUMOR NODE METASTASIS#1.0047;TYROSINE KINASE INHIBITOR#1.0047;TRIPLE NEGATIVE PHENOTYPE#1.0045;SURAMIN#1.0044;MULTIVESICULAR BODY#1.0043;ANTI APOPTOSIS#1.0043;PARACRINE SIGNALING#1.0042;EARLY TO LATE#1.0041;MENSTRUAL CYCLE#1.0040;TEMSIROLIMUS#1.0040;TRAMETINIB#1.0040;RECEPTOR ACTIVITY#1.0038;CNS METASTASES#1.0038;SOMATOSTATIN RECEPTOR#1.0037;THYMIDYLATE SYNTHASE#1.0035;EGF RECEPTOR BINDING#1.0034;SIALYLATION#1.0033;PHOSPHOLIPASE D#1.0032;METALLOPROTEINASE INHIBITOR#1.0029;QUERCETIN#1.0028;EXTRACELLULAR REGION#1.0028;NEOPLASTIC TISSUES#1.0028;GASTRIC ULCER#1.0027;MATRIX METALLOPROTEINASE 1#1.0027;CPT-11#1.0027;LARGE CELL NEUROENDOCRINE CARCINOMA#1.0027;ENDOMETRIAL ADENOCARCINOMA#1.0027;CLATHRIN-MEDIATED ENDOCYTOSIS#1.0026;ALDOSTERONE#1.0024;GENE COPY NUMBER#1.0023;BLADDER CARCINOMA#1.0023;COPY NUMBER GAIN#1.0023;ALVEOLAR EPITHELIAL CELL#1.0022;RAD001#1.0022;ACTIVATION OF MAP KINASE#1.0021;EYELID#1.0021;FULVESTRANT#1.0021;CLATHRIN-COATED PIT#1.0020;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#1.0019;GASTRIC EPITHELIAL CELLS#1.0017;PHOSPHATASE AND TENSIN HOMOLOG#1.0017;CAMP RESPONSE ELEMENT BINDING#1.0016;ANOIKIS#1.0016;CELECOXIB#1.0015;THYMIDYLATE#1.0015;GLOMERULAR FILTRATION#1.0014;URIC ACID#1.0013;TRANSFERASE INHIBITOR#1.0012;GLOMERULAR FILTRATION RATE#1.0012;ACTIN POLYMERIZATION#1.0011;PAPILLARY THYROID CARCINOMA#1.0009;DASATINIB#1.0008;TRANSMEMBRANE RECEPTOR#1.0008;GALLBLADDER#1.0007;MAPK CASCADE#1.0006;CIRCULATING CELL FREE#1.0005;NF-KAPPAB ACTIVATION#1.0004;EYE DEVELOPMENT#1.0004;SYNOVIAL SARCOMA#1.0003;AXON REGENERATION#1.0002;ESOPHAGEAL CARCINOMA#1.0001;KINASE INHIBITOR#1.0000;STEROID HORMONE RECEPTOR#0.9999;SMALL MOLECULAR INHIBITOR#0.9998;PROSTATE EPITHELIAL CELL#0.9997;VEMURAFENIB#0.9996;TRANSFERRIN RECEPTOR#0.9995;MAST CELL#0.9995;RESVERATROL#0.9994;AXON GROWTH#0.9993;ERK CASCADE#0.9993;GEFITINIB#0.9993;INFLAMMATORY BREAST CANCER#0.9993;REGULATION OF CELLULAR#0.9992;URINARY BLADDER#0.9991;COLON ADENOCARCINOMA#0.9991;CETUXIMAB#0.9990;HEPATIC STELLATE CELL#0.9990;SCHWANN CELL#0.9989;GOBLET CELL HYPERPLASIA#0.9989;EUROPEAN RESPIRATORY SOCIETY#0.9987;SIGNALLING CASCADE#0.9987;HIGH RESOLUTION MELTING#0.9987;OPTIC NERVE#0.9985;NORMAL ORAL MUCOSA#0.9984;MEDIATED DRUG RESISTANCE#0.9984;EPITHELIAL CARCINOMA#0.9983;TONGUE SQUAMOUS CELL CARCINOMA#0.9981;FINE NEEDLE ASPIRATE#0.9981;BILIARY TRACT CANCER#0.9980;LATE ENDOSOME#0.9980;PULMONARY FIBROSIS#0.9980;REGORAFENIB#0.9980;COLORECTAL ADENOMA#0.9979;BETA-2#0.9978;MOLECULAR DYNAMICS SIMULATION#0.9977;RIBOSOMAL PROTEIN#0.9976;EXTRACELLULAR REGULATED KINASE#0.9975;ENDOMETRIAL CARCINOMA#0.9974;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9974;ADENOID CYSTIC CARCINOMA#0.9973;MALIGNANT PLEURAL MESOTHELIOMA#0.9972;MESANGIAL CELL#0.9972;CHIMERIC ANTIGEN RECEPTOR#0.9971;CELLULAR LOCALIZATION#0.9970;RECEPTOR LIGAND#0.9970;EXOSOME#0.9970;DNA METHYLTRANSFERASE#0.9969;BINDING PROTEIN 3#0.9969;CAVEOLAE#0.9969;ORAL MUCOSA#0.9969;PROTEASE ACTIVATED RECEPTOR#0.9968;AVIAN LEUKOSIS#0.9967;PLEOMORPHIC ADENOMA#0.9967;YES ASSOCIATED PROTEIN#0.9966;LIGAND BINDING DOMAIN#0.9965;CAMP RESPONSE ELEMENT#0.9964;AXON GUIDANCE#0.9964;INTESTINAL STEM CELL#0.9962;SOMITE#0.9962;HUMAN MAMMARY EPITHELIAL#0.9959;HYALURONAN#0.9958;LIVER REGENERATION#0.9958;MOUSE EMBRYONIC FIBROBLAST#0.9957;STEM CELL FACTOR#0.9956;NEUROENDOCRINE CARCINOMA#0.9956;ERLOTINIB#0.9956;CHONDROCYTE#0.9954;HEPATOCYTE PROLIFERATION#0.9954;PITUITARY ADENOMA#0.9952;THYMIDINE PHOSPHORYLASE#0.9951;AMERICAN THORACIC SOCIETY#0.9951;ORAL SQUAMOUS CARCINOMA#0.9951;KERATINOCYTE DIFFERENTIATION#0.9950;HYALURONIC ACID#0.9949;HIPPO SIGNALING#0.9949;EARLY ENDOSOME#0.9949;RESPONSE TO RADIATION#0.9949;TOPOISOMERASE#0.9948;LUNG FIBROBLASTS#0.9948;GM-CSF#0.9947;LUNG LESIONS#0.9946;CYTOTROPHOBLAST#0.9946;RECEPTOR TYROSINE KINASE#0.9945;MALIGNANT PLEURAL EFFUSION#0.9945;PI3K SIGNALING#0.9944;TROPHOBLAST#0.9944;INTERLEUKIN 6 RECEPTOR#0.9943;RECYCLING ENDOSOME#0.9942;CHEMOKINE RECEPTOR#0.9942;UROKINASE PLASMINOGEN ACTIVATOR#0.9941;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9941;MYOEPITHELIAL CELL#0.9940;GALLBLADDER CANCER#0.9940;OPIOID RECEPTOR#0.9939;TELOMERASE ACTIVITY#0.9939;MEMBRANE MICRODOMAIN#0.9939;NEURITE OUTGROWTH#0.9938;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9938;GASTRIC MUCOSA#0.9938;ENDOTHELIAL GROWTH FACTOR#0.9937;TISSUE GROWTH FACTOR#0.9936;METASTATIC ADENOCARCINOMA#0.9936;SALIVARY GLAND CANCER#0.9935;BORTEZOMIB#0.9935;HUMAN AIRWAY EPITHELIAL#0.9934;MITOGENIC ACTIVITY#0.9933;COATED PIT#0.9932;BREAST CANCER MODEL#0.9932;UROKINASE#0.9930;CELL CYCLE PATHWAY#0.9929;SYSTOLIC BLOOD PRESSURE#0.9929;PKCALPHA#0.9928;BRAIN CANCER#0.9928;EPIGALLOCATECHIN#0.9926;CANCER STEM-LIKE CELL#0.9926;PERTUZUMAB#0.9926;PLATELET-DERIVED GROWTH FACTOR#0.9926;TYROSINE KINASE RECEPTOR#0.9924;KERATINOCYTE PROLIFERATION#0.9924;ADENOSQUAMOUS CARCINOMA#0.9924;HUMAN GASTRIC CARCINOMA#0.9923;MALIGNANT MESOTHELIOMA#0.9923;METASTATIC PROSTATE CANCER#0.9923;ACINAR CELL#0.9920;HEART DEVELOPMENT#0.9918;WNT SIGNALING PATHWAY#0.9918;SERTOLI CELL#0.9917;ENTEROCYTE#0.9916;LUNG EPITHELIAL CELL#0.9915;ADENOSINE TRIPHOSPHATE#0.9915;SRC FAMILY KINASE#0.9915;INVERTED PAPILLOMA#0.9913;TRANSFORMING GROWTH FACTOR ALPHA#0.9913;SMOOTH MUSCLE ACTIN#0.9912;FATTY ACID SYNTHASE#0.9912;MAPK ACTIVATION#0.9911;C TERMINAL DOMAIN#0.9910;BETA CELL#0.9909;GENISTEIN#0.9909;BODY SURFACE AREA#0.9908;INHIBITION OF APOPTOSIS#0.9907;METASTATIC LYMPH NODE#0.9906;GRANULOSA CELL#0.9905;OVARIAN FOLLICLE#0.9904;INSULIN RECEPTOR#0.9904;FATTY LIVER#0.9904;SIMPLE SEQUENCE REPEAT#0.9904;OSTEOSARCOMA CELL LINES#0.9903;CALCIUM SIGNALING#0.9903;OESOPHAGEAL SQUAMOUS CELL#0.9902;EVEROLIMUS#0.9901;OOCYTE MATURATION#0.9901;PKCDELTA#0.9900;HEPATOMA CELLS#0.9900;GROUND GLASS OPACITY#0.9900;CORNEAL EPITHELIUM#0.9900;ADHERENS JUNCTION#0.9900;COLORECTAL ADENOCARCINOMA#0.9899;OOCYTE#0.9898;DOCKING PROTEIN#0.9897;CELL NUCLEUS#0.9897;RENAL CARCINOMA#0.9896;TUMOR INITIATING CELL#0.9896;INVASIVE GROWTH#0.9894;GASTRIC ADENOCARCINOMA#0.9893;DRUG BINDING#0.9892;CABOZANTINIB#0.9891;FOLINIC ACID#0.9891;CARDIOMYOCYTE#0.9890;LARYNX#0.9890;FARNESYL#0.9890;LUNG SQUAMOUS CELL CARCINOMA#0.9890;OSTEOBLAST#0.9889;LUNG ADENOCARCINOMA#0.9888;PERIPHERAL NERVE#0.9886;PANCREATIC CARCINOMA#0.9886;RESONANCE ENERGY TRANSFER#0.9886;GLUTAMINE#0.9886;B CELL LYMPHOMA#0.9885;OXYGENASE#0.9885;PROSTATE CARCINOMA#0.9885;MAPK SIGNALING#0.9884;CENTROMERE#0.9884;ADVANCED COLORECTAL CANCER#0.9884;ANILINE#0.9883;FOLIC ACID#0.9883;TUMOR ANTIGEN#0.9882;LEUCINE RICH REPEAT#0.9881;CLEAR CELL RENAL CELL CARCINOMA#0.9881;ORNITHINE DECARBOXYLASE#0.9881;REGULATION OF CELL PROLIFERATION#0.9880;COLORECTAL CARCINOMA#0.9879;TISSUE REMODELING#0.9879;PROTEIN KINASE A#0.9878;PARATHYROID#0.9877;INSULIN-LIKE GROWTH FACTOR#0.9877;PHOSPHOTYROSINE BINDING#0.9876;CARBACHOL#0.9876;ESOPHAGEAL CANCER#0.9876;INTESTINAL EPITHELIAL CELL#0.9875;HEPATOCYTE GROWTH FACTOR#0.9874;PROTEIN KINASE B#0.9874;PROGESTERONE#0.9874;PANCREATITIS#0.9874;TRANSITIONAL CELL CARCINOMA#0.9873;ADRENERGIC RECEPTOR#0.9873;SPINAL CORD#0.9873;GENETICALLY ENGINEERED MOUSE#0.9872;METASTATIC COLORECTAL CANCER#0.9871;NON-SMALL CELL LUNG CARCINOMA#0.9871;THYROID TRANSCRIPTION FACTOR#0.9870;INTRACELLULAR SIGNALING CASCADE#0.9870;HEPARIN BINDING#0.9870;LYMPHATIC VESSEL#0.9869;PROTEIN KINASE INHIBITOR#0.9869;METASTATIC SQUAMOUS CELL CARCINOMA#0.9869;NERVE GROWTH FACTOR#0.9869;AKT SIGNALING#0.9869;ORAL SQUAMOUS CELL CARCINOMA#0.9868;DNA AMPLIFICATION#0.9868;COPY NUMBER CHANGE#0.9868;DISCOIDIN DOMAIN RECEPTOR#0.9868;RESPONSE TO IONIZING RADIATION#0.9868;LOCALISATION#0.9867;COLON CARCINOMA#0.9866;MICROTUBULE ASSOCIATED PROTEIN#0.9866;ADVANCED PANCREATIC CANCER#0.9866;PROTEIN COMPLEX#0.9866;QUIESCENCE#0.9865;INDOLE#0.9865;SPHINGOSINE#0.9865;EPITHELIAL TISSUES#0.9865;SALIVARY DUCT CARCINOMA#0.9865;RECEPTOR INTERNALIZATION#0.9863;AIRWAY EPITHELIUM#0.9863;HUMAN PANCREATIC CANCER#0.9863;PROTEIN KINASE CASCADE#0.9863;PAPILLOMA#0.9862;LECTIN#0.9861;TRANSFORMING GROWTH FACTOR BETA#0.9860;PROTEIN DEGRADATION#0.9860;MYOCARDIUM#0.9860;SQUAMOUS CELL CANCER#0.9859;CELL POLARITY#0.9859;CERVIX#0.9858;ADENOCARCINOMA IN SITU#0.9858;ACETYLCHOLINE RECEPTOR#0.9858;IMMUNOGLOBULIN G#0.9857;C REACTIVE PROTEIN#0.9857;PROTEIN TYROSINE KINASE ACTIVITY#0.9856;TUMOR ASSOCIATED MACROPHAGE#0.9856;ANDROGEN RECEPTOR#0.9856;TIGHT JUNCTION#0.9856;MELANOMA CELL LINES#0.9856;HISTAMINE#0.9856;FRAGMENT LENGTH POLYMORPHISM#0.9856;NADPH OXIDASE#0.9855;BREAST CARCINOMA CELL LINES#0.9855;CERVICAL CANCER#0.9854;LIPID METABOLISM#0.9853;INSULIN RECEPTOR SUBSTRATE#0.9852;CELL JUNCTION#0.9852;TUMOUR NECROSIS FACTOR#0.9852;HUMAN PAPILLOMA VIRUS#0.9852;ADJUSTED ODDS RATIO#0.9851;KARNOFSKY PERFORMANCE STATUS#0.9850;ABC TRANSPORTER#0.9850;AIRWAY EPITHELIAL CELL#0.9850;TUMOR ASSOCIATED ANTIGEN#0.9849;CHORIOCARCINOMA#0.9849;MESOTHELIAL CELL#0.9849;ERYTHROBLAST#0.9849;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9849;CORE NEEDLE BIOPSY#0.9849;CHOLANGIOCARCINOMA#0.9848;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9848;VON HIPPEL LINDAU#0.9848;PKC ACTIVITY#0.9848;COLONIC EPITHELIAL CELLS#0.9848;NOT OTHERWISE SPECIFIED#0.9848;SPHINGOSINE 1 PHOSPHATE#0.9848;PAZOPANIB#0.9847;TARGET OF RAPAMYCIN#0.9847;SEBACEOUS GLAND#0.9846;LETROZOLE#0.9845;ROS GENERATION#0.9845;NEUROBLASTOMA#0.9845;MAMMARY GLAND DEVELOPMENT#0.9844;BILIARY TRACT#0.9844;TO BACKGROUND RATIO#0.9844;G-CSF#0.9844;NEURITE#0.9844;EPITHELIAL GROWTH FACTOR#0.9844;COLLAGENASE#0.9843;ENDOMETRIAL CANCER#0.9843;IDIOPATHIC PULMONARY FIBROSIS#0.9843;MENINGITIS#0.9842;COLONY-STIMULATING FACTOR#0.9842;MUCOUS#0.9841;CELL CYCLE CONTROL#0.9841;METAPLASTIC CARCINOMA#0.9841;PHOSPHOLIPASE A2#0.9841;LUNG CANCER#0.9841;ENDOCYTOSIS#0.9841;PODOCYTE#0.9840;CYCLIN DEPENDENT KINASE INHIBITOR#0.9840;DEATH RECEPTOR#0.9839;AUTOPHAGY#0.9839;HUMAN EPIDERMAL KERATINOCYTES#0.9839;VASCULAR ENDOTHELIUM#0.9839;ION CHANNEL#0.9839;CYTOKINE PRODUCTION#0.9839;SALIVARY GLAND#0.9838;ANTIGEN BINDING#0.9837;TRANSFORMING GROWTH FACTOR#0.9837;EMBRYONAL CARCINOMA#0.9836;HEMATOPOIETIC CELL#0.9836;NERVE SHEATH TUMORS#0.9836;EPITHELIAL OVARIAN CANCER#0.9836;GELDANAMYCIN#0.9835;ESTROGEN RECEPTOR ALPHA#0.9835;CASPASE-3 ACTIVITY#0.9834;POLY ETHYLENE GLYCOL#0.9834;CARDIOMYOPATHY#0.9834;NEURAL CELL#0.9834;GLYCOSYLATION#0.9833;MIDLINE#0.9832;CELL DEVELOPMENT#0.9831;LACK OF EFFICACY#0.9831;UTERUS#0.9831;DOXYCYCLINE#0.9830;DISEASE SPECIFIC SURVIVAL#0.9830;GLUCOSE UPTAKE#0.9830;PYRUVATE KINASE#0.9828;COPY NUMBER VARIATION#0.9828;ENDOPLASMIC RETICULUM STRESS#0.9828;INDUCIBLE NITRIC OXIDE#0.9828;GERM CELL#0.9828;STEM CELL LIKE#0.9828;SIGNALLING PATHWAY#0.9827;ACUTE MYELOID LEUKEMIA#0.9827;PARONYCHIA#0.9827;ATP BINDING#0.9827;GLUCOCORTICOID RECEPTOR#0.9827;PROTEIN INTERACTION NETWORK#0.9826;HAIR FOLLICLE#0.9825;DOMINANT NEGATIVE MUTANT#0.9825;HUMAN EMBRYONIC KIDNEY#0.9824;ENDOSOME#0.9824;GOBLET CELL#0.9823;HEPATOTOXICITY#0.9823;BINDING PROTEIN 1#0.9822;GLAND DEVELOPMENT#0.9822;PANCREATIC CANCER#0.9821;DEOXYCHOLIC ACID#0.9820;MYOCYTES#0.9819;LINES OF EVIDENCE#0.9819;SIGNALING CASCADE#0.9819;ENDOMETRIUM#0.9818;FOCAL ADHESION KINASE#0.9818;CASPASE ACTIVATION#0.9818;CATENIN COMPLEX#0.9817;GONADOTROPIN RELEASING HORMONE#0.9817;PROTEIN TYROSINE KINASE#0.9817;MEDULLOBLASTOMA#0.9817;HIGH GRADE DYSPLASIA#0.9817;LOW GRADE GLIOMAS#0.9816;IL-8 SECRETION#0.9816;COLITIS#0.9815;EPITHELIAL CELL PROLIFERATION#0.9815;TRANSCRIPTIONAL CONTROL#0.9815;RAPAMYCIN#0.9815;PERTUSSIS#0.9815;SOFT TISSUE SARCOMA#0.9814;SUNITINIB#0.9813;DEPHOSPHORYLATION#0.9812;MOLECULAR TARGETED THERAPY#0.9812;ANAPLASTIC OLIGODENDROGLIOMA#0.9810;ACTIVATION OF NF-KAPPAB#0.9810;TISSUE HOMEOSTASIS#0.9809;HEPARIN#0.9808;DYNAMIC CONTRAST ENHANCED#0.9808;MITOSIS#0.9808;INHIBITION OF CELL GROWTH#0.9807;MELANOCYTE#0.9807;HYPOXIA INDUCIBLE FACTOR#0.9806;VITAMIN D RECEPTOR#0.9806;ORAL CAVITY#0.9805;GROWTH FACTOR BINDING#0.9805;CELL CYCLE REGULATOR#0.9805;MYOFIBROBLAST#0.9804;OLIGODENDROCYTE#0.9804;PEMETREXED#0.9804;N-ACETYLCYSTEINE#0.9804;TOLL LIKE RECEPTOR#0.9803;KERATINOCYTE#0.9803;COLORECTAL#0.9803;SIGNAL TRANSDUCER#0.9802;ADVANCED GASTRIC CANCER#0.9802;THYROID CANCER#0.9802;MUCINOUS ADENOCARCINOMA#0.9801;PHOSPHATASE INHIBITOR#0.9801;LASER CAPTURE MICRODISSECTION#0.9801;BILE DUCT#0.9800;TIME TO TREATMENT#0.9800;MAP KINASE#0.9800;CELL ADHESION MOLECULE#0.9800;HISTONE DEACETYLASE INHIBITOR#0.9800;DOPAMINE#0.9799;FIBROBLAST GROWTH FACTOR#0.9799;EOSINOPHIL#0.9798;PRECURSOR CELL#0.9798;GENE SILENCING#0.9798;HIGH FAT DIET#0.9798;MAMMARY EPITHELIAL CELL#0.9797;MISMATCH REPAIR#0.9797;COLORECTAL CANCER#0.9797;IMATINIB#0.9797;TERMINAL DIFFERENTIATION#0.9797;PROTEIN KINASE ACTIVITY#0.9797;PLASMA CELL#0.9797;DUAL LUCIFERASE REPORTER#0.9796;PHOSPHATASE ACTIVITY#0.9796;CYTOTOXIC T-LYMPHOCYTE#0.9796;NEURAL PROGENITOR CELL#0.9796;DEDIFFERENTIATION#0.9795;RECEPTOR MEDIATED ENDOCYTOSIS#0.9795;NEUROBLAST#0.9794;PROTEASOME#0.9794;AVASTIN#0.9794;PARATHYROID HORMONE#0.9794;PRIMARY BREAST CANCER#0.9793;OSTEOCLAST#0.9792;CLEAR CELL CARCINOMA#0.9792;HUMAN BRONCHIAL EPITHELIAL#0.9792;STANDARDIZED UPTAKE VALUE#0.9791;GASTROINTESTINAL STROMAL TUMOR#0.9791;LUNG CARCINOMA#0.9791;PHOSPHOLIPASE C#0.9789;ESTROGEN RECEPTOR#0.9789;EMBRYONIC KIDNEY#0.9789;OVARIAN CARCINOMA#0.9789;PEROXISOME#0.9789;HERCEPTIN#0.9788;SORAFENIB#0.9788;FACTOR I#0.9788;SERUM ALBUMIN#0.9787;INTRACELLULAR SIGNALING PATHWAY#0.9787;CELL CELL JUNCTION#0.9787;HEPATOCELLULAR CARCINOMA CELL#0.9786;FOCAL ADHESION#0.9786;BRONCHIAL EPITHELIAL CELLS#0.9785;PROTEINURIA#0.9784;LOW DENSITY LIPOPROTEIN#0.9784;HEAD AND NECK CANCER#0.9784;NITRIC OXIDE SYNTHASE#0.9784;OVARIAN CANCER#0.9784;IMATINIB MESYLATE#0.9783;NECK CANCER#0.9783;PROTEASOME PATHWAY#0.9783;INVASIVE BREAST CARCINOMA#0.9782;PSORIASIS#0.9781;IFN-GAMMA#0.9781;RHEUMATOID ARTHRITIS#0.9781;P53 SIGNALING PATHWAY#0.9781;ACETYLCHOLINE#0.9781;DABRAFENIB#0.9780;ANAL CARCINOMA#0.9780;MICROVASCULAR ENDOTHELIAL CELL#0.9780;ANAPLASTIC THYROID CARCINOMA#0.9779;ASTROCYTE#0.9779;GLUTAMIC ACID#0.9779;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9779;ARYL HYDROCARBON RECEPTOR#0.9778;CYTOKINE RECEPTOR#0.9778;MEMBRANE FRACTION#0.9777;MACROPINOCYTOSIS#0.9777;SMALL CELL CARCINOMA#0.9777;ADENOSINE MONOPHOSPHATE#0.9777;ACTIVATION OF GROWTH#0.9777;CERVICAL#0.9776;DERMAL FIBROBLAST#0.9776;TAXOL#0.9775;CELL COMMUNICATION#0.9775;GROWTH OF CELL#0.9775;RECEPTOR BINDING#0.9775;MICROTUBULE#0.9774;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9774;GLYCOGEN SYNTHASE KINASE#0.9774;LUNG DEVELOPMENT#0.9774;CYCLIC AMP#0.9773;GAP JUNCTION#0.9773;THYROID CARCINOMA#0.9773;ANTISENSE RNA#0.9772;NUCLEOTIDE BINDING#0.9772;CELL KILLING#0.9772;TRANSIENT RECEPTOR POTENTIAL#0.9772;DNA DAMAGE RESPONSE#0.9772;REGIONAL LYMPH NODE#0.9772;PROTEINASE ACTIVATED RECEPTOR#0.9770;ADVANCED PROSTATE CANCER#0.9770;SIGNALING MOLECULE#0.9770;MALIGNANT GLIOMA#0.9770;L-CYSTEINE#0.9770;P38 MAPK SIGNALING#0.9770;SUBMANDIBULAR GLAND#0.9770;DOUBLE STRAND BREAK#0.9769;HERPES SIMPLEX#0.9768;BEXAROTENE#0.9767;RECEPTOR COMPLEX#0.9767;CLEAVED CASPASE 3#0.9767;RECEPTOR SYNTHESIS#0.9767;LUCIFERASE ACTIVITY#0.9767;PERIPHERAL NERVOUS SYSTEM#0.9766;ADENOSINE#0.9766;LASER SCANNING MICROSCOPY#0.9765;LARGE CELL CARCINOMA#0.9765;VINORELBINE#0.9765;BRANCHING MORPHOGENESIS#0.9764;CHROMOSOMAL REGION#0.9764;INNATE IMMUNE RESPONSE#0.9764;ACETYLCYSTEINE#0.9764;TIME TO RECURRENCE#0.9763;RENAL CELL CARCINOMA#0.9763;HYPOXIA#0.9763;INHIBITION OF GROWTH#0.9763;KINASE ACTIVITY#0.9763;STEM CELL MARKER#0.9762;MYELOID CELL#0.9762;PROSTATE CANCER#0.9762;METAPLASIA#0.9762;PROTEIN PHOSPHATASE 2A#0.9761;17β-ESTRADIOL#0.9761;IMMUNE EVASION#0.9761;RESPONSE TO WOUNDING#0.9761;TOPOTECAN#0.9761;MULTIPLE MYELOMA#0.9760;CELL ACTIVATION#0.9760;RANDOMISED CONTROLLED TRIAL#0.9760;PRIMARY BREAST TUMORS#0.9759;GLUCOSE METABOLISM#0.9759;PANCREATIC ADENOCARCINOMA#0.9759;FOLLICULITIS#0.9758;PHOSPHATASE 2A#0.9758;PROTEIN TYROSINE PHOSPHATASE#0.9758;RETINOIC ACID#0.9757;COPY NUMBER ALTERATION#0.9757;INTRACELLULAR SIGNAL TRANSDUCTION#0.9756;EPSTEIN BARR VIRUS#0.9756;RETINOBLASTOMA#0.9756;CELLULAR MEMBRANE#0.9756;NUCLEOTIDE EXCHANGE FACTOR#0.9755;ADVERSE DRUG REACTION#0.9755;BASAL CELL CARCINOMA#0.9755;TRASTUZUMAB#0.9755;GROWTH HORMONE#0.9755;PKC ACTIVATION#0.9755;STAUROSPORINE#0.9754;LYSIS#0.9754;SIGNALING PATHWAY#0.9754;SURFACE PLASMON RESONANCE#0.9753;TO TUMOR PROGRESSION#0.9753;INHIBITION OF ANGIOGENESIS#0.9753;OVARIAN#0.9752;VASCULAR SMOOTH MUSCLE CELL#0.9752;HEPATITIS C VIRUS#0.9751;COMPLEX I#0.9751;ERYTHROPOIETIN RECEPTOR#0.9750;LYMPH NODE INVOLVEMENT#0.9750;RISK OF DEATH#0.9750;LIMIT OF DETECTION#0.9750;COLON CANCER#0.9749;NORMAL BREAST TISSUE#0.9749;PHOSPHOLIPASE A#0.9748;NITRIC OXIDE#0.9748;ADENOCARCINOMA#0.9748;AIRWAY SMOOTH MUSCLE#0.9747;ETHANOL#0.9747;METHIONINE#0.9746;BIOTIN#0.9746;TRASTUZUMAB EMTANSINE#0.9746;SENSITIZATION#0.9745;FIBROSARCOMA#0.9745;SPUTUM#0.9743;CONNECTIVE TISSUE#0.9743;GLYCOLYSIS#0.9743;URINARY PROTEIN#0.9743;CHEMOTAXIS#0.9743;LASER DESORPTION IONIZATION#0.9743;INHIBITION OF CELL PROLIFERATION#0.9743;ISOPROTERENOL#0.9742;ASPIRIN#0.9742;ADJACENT NORMAL TISSUE#0.9742;ESTROUS CYCLE#0.9741;UBIQUITIN#0.9741;ADENYLATE CYCLASE#0.9741;BASAL CELL#0.9741;ADENOMATOUS POLYPOSIS COLI#0.9740;CELLULAR GROWTH#0.9740;LUTEAL PHASE#0.9740;EMISSION COMPUTED TOMOGRAPHY#0.9739;72-HOURS#0.9738;RHABDOMYOSARCOMA#0.9738;PATHOLOGIC COMPLETE RESPONSE#0.9738;PRIMARY BRAIN TUMORS#0.9738;HEPATITIS C#0.9737;TAMOXIFEN#0.9737;DUAL SPECIFICITY PHOSPHATASE#0.9736;VEGF SIGNALING PATHWAY#0.9736;ATP BINDING CASSETTE#0.9736;ACTIVATOR PROTEIN 1#0.9735;UBIQUITIN BINDING#0.9735;FLOW CYTOMETRY ANALYSIS#0.9735;GRANULOCYTE#0.9735;CYSTIC FIBROSIS#0.9734;ASCITES#0.9734;LYMPH NODE METASTASES#0.9734;GOBLET CELL METAPLASIA#0.9734;ADENINE#0.9733;TUMOR NECROSIS FACTOR#0.9733;RECEPTOR ACTIVATOR#0.9732;METASTASIS FREE SURVIVAL#0.9732;RECEPTOR AGONIST#0.9731;INVASIVE DUCTAL CARCINOMA#0.9730;TRADITIONAL CHINESE MEDICINE#0.9730;ADJUSTED HAZARD RATIO#0.9730;BEVACIZUMAB#0.9730;ONCOGENESIS#0.9730;MYELOID LEUKEMIA#0.9729;AGE AT DIAGNOSIS#0.9729;CATALYTIC ACTIVITY#0.9729;EXTRACELLULAR VESICLE#0.9728;LYSOSOME#0.9727;OLIGODENDROGLIOMA#0.9727;T- PA#0.9726;CELL FRACTION#0.9726;MORPHOGENESIS#0.9726;NUCLEIC ACID#0.9726;RECEPTOR ANTAGONIST#0.9726;MAMMARY GLAND#0.9725;TETRACYCLINE#0.9725;MOLAR#0.9724;SENSITIZER#0.9724;PROTEOGLYCAN#0.9723;REGENERATION#0.9723;EARLY BREAST CANCER#0.9723;ESOPHAGUS#0.9723;OXIDATIVE PHOSPHORYLATION#0.9723;REGULATION OF CELL GROWTH#0.9722;TISSUE MICROARRAY ANALYSIS#0.9722;PROSTAGLANDIN E2#0.9721;MITOGEN ACTIVATED PROTEIN#0.9720;MUCUS PRODUCTION#0.9720;FACTOR VIII#0.9720;FIBROBLAST PROLIFERATION#0.9720;POLYCYSTIC KIDNEY DISEASE#0.9720;PROSTATE SPECIFIC ANTIGEN#0.9719;OVARIES#0.9719;LIVER METASTASIS#0.9719;AGGRESSIVE BEHAVIOR#0.9718;ALL TRANS RETINOIC ACID#0.9718;DIABETIC NEPHROPATHY#0.9718;GROWTH PATTERN#0.9717;NODULAR#0.9717;CELL ASSOCIATED#0.9717;DNA REPAIR#0.9716;SIGNET RING CELL#0.9716;ARGININE#0.9716;MITOMYCIN C#0.9714;INFILTRATING DUCTAL CARCINOMA#0.9713;PERICARDIAL EFFUSION#0.9713;BREAST CANCER#0.9713;LIVER CANCER#0.9712;ASTROCYTOMA#0.9712;CALCIUM CHANNEL#0.9712;MEDIASTINAL LYMPH NODE#0.9711;METASTATIC GASTRIC CANCER#0.9711;MURINE DOUBLE MINUTE#0.9711;RESPONSE TO LAPATINIB#0.9711;DNA REPAIR PROTEIN#0.9710;CELLULAR HOMEOSTASIS#0.9710;HOMOLOGOUS RECOMBINATION#0.9709;TRANSCRIPTASE#0.9709;WHITE BLOOD CELL#0.9709;VASCULAR ENDOTHELIAL CELL#0.9708;BONE MORPHOGENETIC PROTEIN#0.9707;TESTOSTERONE#0.9707;SMOOTH MUSCLE CELL#0.9706;CELL MEMBRANE#0.9705;MUSCLE CELL#0.9704;CHRONIC MYELOID LEUKEMIA#0.9704;MESENCHYMAL CELL#0.9704;BREAST CANCER CELL#0.9704;CYCLIN DEPENDENT KINASE#0.9704;FINE NEEDLE ASPIRATION#0.9703;ADRIAMYCIN#0.9702;DUCTAL CARCINOMA IN SITU#0.9702;TUMOR STEM CELL#0.9702;VIRAL INFECTION#0.9702;GASTRITIS#0.9702;METASTATIC BREAST CANCER#0.9700;STRUCTURE ACTIVITY RELATIONSHIP#0.9700;RESPONSE TO TREATMENT#0.9699;RENAL CELL CANCER#0.9699;SUPEROXIDE DISMUTASE#0.9698;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9697;NEUROGENESIS#0.9696;T LYMPHOCYTE#0.9696;SMOOTH MUSCLE#0.9696;EPIRUBICIN#0.9696;XL647#0.9695;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.9695;IRINOTECAN#0.9695;GLIOBLASTOMA MULTIFORME#0.9695;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.9695;EPITHELIAL TO MESENCHYMAL#0.9694;LUMINAL CELL#0.9694;PYRUVATE#0.9693;RANDOMIZED CLINICAL TRIAL#0.9693;BETA-ESTRADIOL#0.9693;ARSENITE#0.9691;TRANSLATION INITIATION#0.9691;PROTEIN KINASE#0.9691;PAPILLARY ADENOCARCINOMA#0.9691;POINT OF CARE#0.9691;ACTIN CYTOSKELETON#0.9691;VITAMIN A#0.9691;DRUG DELIVERY SYSTEM#0.9690;RNA INTERFERENCE#0.9690;TELOMERE#0.9690;AQUAPORIN#0.9690;RELAPSE FREE SURVIVAL#0.9690;CONJUGATION#0.9688;B CELL#0.9688;BIOLUMINESCENCE#0.9688;HEPATITIS B#0.9688;CARCINOSARCOMA#0.9688;PULMONARY TOXICITY#0.9688;PANCREATIC DUCTAL ADENOCARCINOMA#0.9688;PROTEIN KINASE C#0.9688;POLY ADP RIBOSE#0.9687;DNA METHYLATION#0.9687;ETOPOSIDE#0.9687;EXCRETION#0.9686;ARACHIDONIC ACID#0.9686;LIVER DISEASE#0.9686;TUBULAR EPITHELIAL CELL#0.9686;INVASIVE CARCINOMA#0.9685;LEUCINE#0.9685;CELL CELL ADHESION#0.9685;RIBOSE#0.9685;HEPATOCELLULAR CARCINOMA#0.9684;CDK INHIBITOR#0.9684;TUMOR TISSUES#0.9684;NEUROENDOCRINE TUMOR#0.9684;GLIAL CELL#0.9684;MODE OF ACTION#0.9684;CANCER ASSOCIATED FIBROBLASTS#0.9683;CIRCULATING TUMOR CELL#0.9683;EMBRYONIC STEM CELL#0.9683;PARENCHYMA#0.9683;FLUORESCEIN#0.9683;GLYCINE#0.9682;PLASMA MEMBRANE#0.9682;VASCULAR CELL#0.9682;BREAST ADENOCARCINOMA#0.9681;CANCER CELL#0.9680;SKELETAL MUSCLE#0.9680;PRO-INFLAMMATORY#0.9679;CD8+ T CELL#0.9679;DEXAMETHASONE#0.9678;SQUAMOUS CELL CARCINOMA#0.9678;COAGULATION#0.9678;CD4+ T CELL#0.9677;CYTOCHROME P450#0.9675;CLATHRIN ADAPTOR#0.9674;CAPECITABINE#0.9673;DNA COPY NUMBER#0.9673;EPITHELIAL MESENCHYMAL TRANSITION#0.9673;HISTONE DEACETYLASE#0.9671;ANGIOGENESIS#0.9669;HYPOXIC#0.9669;QUANTITATIVE REAL TIME#0.9669;LIGASE ACTIVITY#0.9668;CANCER SPECIFIC SURVIVAL#0.9668;GUANINE#0.9668;ENDOSOMAL MEMBRANE#0.9668;SYNCYTIOTROPHOBLAST#0.9668;RANDOMIZED CONTROLLED TRIAL#0.9668;PROTEIN BINDING#0.9668;ADENO ASSOCIATED VIRUS#0.9667;ANCHORAGE INDEPENDENT GROWTH#0.9667;LEUCOVORIN#0.9667;ONCOGENIC#0.9666;INTERSTITIAL LUNG DISEASE#0.9666;PROGRAMMED CELL DEATH#0.9665;PILOCYTIC ASTROCYTOMA#0.9665;ANGIOTENSIN CONVERTING ENZYME#0.9665;GEMCITABINE#0.9665;METHOTREXATE#0.9665;SKIN DISEASE#0.9664;ANTI HER2#0.9663;ACTIN FILAMENT#0.9662;BLEOMYCIN#0.9662;RNA BINDING#0.9661;CYCLIC ADENOSINE MONOPHOSPHATE#0.9661;RECURRENCE FREE SURVIVAL#0.9660;CARRIE#0.9660;TIGHT JUNCTION PROTEIN#0.9660;GERM CELL TUMORS#0.9659;HOST CELL#0.9659;BREAST CARCINOMA#0.9658;APOPTOTIC CELL DEATH#0.9658;CELL MOTILITY#0.9658;ISCHEMIA#0.9658;LYMPH NODE METASTASIS#0.9658;ALKALINE PHOSPHATASE#0.9657;INVASIVE BREAST CANCER#0.9657;DOXORUBICIN#0.9655;INTRACELLULAR VESICLE#0.9655;CALCINEURIN#0.9654;INTENT TO TREAT#0.9654;TYPE 2 DIABETIC#0.9654;GLUTATHIONE#0.9654;HUMAN BREAST CANCER#0.9654;TUMOR GROWTH INHIBITION#0.9653;AUTOPHAGOSOME#0.9653;SKIN CANCER#0.9653;LUMINAL#0.9653;SENESCENCE#0.9653;DNA SYNTHESIS#0.9652;NEGATIVE PREDICTIVE VALUE#0.9652;RECTUM#0.9652;TONGUE CANCER#0.9651;ACUTE KIDNEY INJURY#0.9651;MUTAGENESIS#0.9651;HERPES SIMPLEX VIRUS#0.9650;PATHOLOGICAL COMPLETE RESPONSE#0.9650;ENDOTHELIN A RECEPTOR#0.9650;BASEMENT MEMBRANE#0.9650;HUMAN IMMUNODEFICIENCY VIRUS#0.9649;RIBOZYME#0.9649;CARCINOMA IN SITU#0.9649;CHINESE HERBAL MEDICINE#0.9649;DRUG RESISTANCE#0.9648;LUNG METASTASIS#0.9648;OXALIPLATIN#0.9648;HEART DISEASE#0.9648;TUBE FORMATION#0.9647;P21 ACTIVATED KINASE#0.9647;CYCLOSPORINE#0.9646;SOMITOGENESIS#0.9646;CELL CYCLE REGULATION#0.9645;ORNITHINE#0.9645;POSITRON EMISSION TOMOGRAPHY#0.9644;BEST SUPPORTIVE CARE#0.9644;LOVASTATIN#0.9644;CARDIAC DEVELOPMENT#0.9644;EXTRACELLULAR MATRIX COMPONENT#0.9643;CLINICAL BENEFIT RATE#0.9643;CERVICAL LYMPH NODE#0.9642;ADVANCED BREAST CANCER#0.9642;STRESS FIBER#0.9642;MACROPHAGE#0.9641;LEIOMYOMA#0.9640;EPITHELIAL CELL#0.9640;ALOPECIA#0.9640;CELL SURFACE#0.9639;TOTAL INTERNAL REFLECTION#0.9639;CELL ADHESION#0.9638;SUPPORT VECTOR MACHINE#0.9638;NEURAL STEM CELL#0.9637;HEAT SHOCK PROTEIN#0.9636;QUANTITATIVE REVERSE TRANSCRIPTION#0.9636;STIMULATION OF CELL PROLIFERATION#0.9635;AUTOPHAGIC CELL DEATH#0.9635;INTERPHASE#0.9635;FLUORESCENCE LIFETIME IMAGING#0.9635;INFLAMMATORY BOWEL DISEASE#0.9635;ENDOTHELIUM#0.9634;MOLECULAR FUNCTION#0.9634;DOCETAXEL#0.9634;MALIGNANT BRAIN TUMOR#0.9633;T CELL#0.9633;INFLAMMATORY CELL#0.9632;HYPERSENSITIVITY#0.9632;GTP BINDING#0.9632;ORGANELLE#0.9631;LEUKOCYTE#0.9630;STROMAL CELL#0.9630;SIROLIMUS#0.9629;CARBOPLATIN#0.9627;DNA REPLICATION#0.9627;OVERALL SURVIVAL TIME#0.9626;CELL DIFFERENTIATION#0.9626;POST-TRANSLATIONAL MODIFICATION#0.9626;PACLITAXEL#0.9625;COMPARATIVE GENOMIC HYBRIDIZATION#0.9625;ACTINOMYCIN D#0.9625;INSTITUTIONAL REVIEW BOARD#0.9625;GLCNAC#0.9625;RIBOSOME#0.9625;PYRAZOLE#0.9624;COMMON TERMINOLOGY CRITERIA#0.9624;FOLLICLE STIMULATING HORMONE#0.9624;CELL MIGRATION#0.9624;1α,25-DIHYDROXYVITAMIN D3#0.9623;CORONARY ARTERY#0.9623;ERLOTINIB HYDROCHLORIDE#0.9623;MONOCYTE#0.9623;TUMOR SUPPRESSOR#0.9622;OVULATION#0.9622;CELLULAR SENESCENCE#0.9622;PERICYTE#0.9622;NEURONAL CELLS#0.9621;NOTCH LIGAND#0.9621;CHROMATIN REMODELING#0.9621;NEUTROPHIL#0.9620;FORMALIN#0.9620;PAPILLARY CARCINOMA#0.9619;ZACTIMA#0.9619;REPORTER GENE ASSAY#0.9619;DIPHTHERIA#0.9619;FORSKOLIN#0.9618;ENZYME ACTIVITY#0.9618;ENDOPLASMIC RETICULUM#0.9618;SIGNAL TRANSDUCTION#0.9618;EGF RECEPTOR ACTIVITY#0.9618;VACCINIA#0.9617;S PHASE#0.9617;CELL DIVISION#0.9617;DENDRITIC CELL#0.9617;INDUCTION OF APOPTOSIS#0.9616;CISPLATIN#0.9616;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9616;EDEMA#0.9616;SEVERE ADVERSE EVENTS#0.9616;POLYMERASE CHAIN REACTION#0.9616;STROMA#0.9616;DIPHOSPHATE#0.9616;COLONY FORMATION ASSAY#0.9616;BONE FORMATION#0.9616;NATURAL KILLER CELL#0.9615;FRONTAL#0.9615;TEMOZOLOMIDE#0.9615;DIFFUSE ASTROCYTOMA#0.9614;ESTROGENS#0.9614;PERIODONTAL LIGAMENT#0.9614;WHOLE GENOME SEQUENCING#0.9614;PROGENITOR CELL#0.9613;INTENTION TO TREAT#0.9613;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9612;NEUROPATHY#0.9612;SIGNAL TRANSMISSION#0.9612;SKIN RASH#0.9612;CELL MOVEMENT#0.9611;PARATHYROID GLAND#0.9610;SUBSTANCE P#0.9610;HEPATITIS B VIRUS#0.9608;IMMUNE CELL#0.9608;PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING#0.9608;MESENCHYMAL STEM CELL#0.9608;MITOCHONDRIA#0.9607;LYSINE#0.9607;LEYDIG CELL#0.9607;PROTEIN PHOSPHORYLATION#0.9607;NECROTIC#0.9606;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9606;SYSTEM DEVELOPMENT#0.9606;CANCER STEM CELL#0.9605;EOSIN#0.9604;PROXIMAL TUBULE CELL#0.9604;ACTIN BINDING#0.9603;DEUBIQUITINATING ENZYME#0.9603;DNA FRAGMENTATION#0.9601;ALPHA-HEPARIN#0.9601;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9601;INFLAMMATORY RESPONSE#0.9600;MIDBRAIN#0.9600;RECURSIVE PARTITIONING ANALYSIS#0.9600;EGF BINDING#0.9599;NATIONAL CANCER INSTITUTE#0.9599;CELL PROLIFERATION#0.9599;PERIPHERAL BLOOD#0.9598;LINEAR REGRESSION ANALYSIS#0.9598;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.9597;TUMOR GROWTH DELAY#0.9597;GENOTOXIC#0.9596;GASTROINTESTINAL TRACT#0.9596;CONNEXIN#0.9595;METASTATIC MELANOMA#0.9595;TOPICAL#0.9595;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.9595;BLOOD PLASMA#0.9594;CELL GROWTH#0.9592;NEURODEGENERATIVE DISEASE#0.9590;ESTRADIOL#0.9590;POSITIVE PREDICTIVE VALUE#0.9590;CYTOCHROME C#0.9589;TUMOR CELLS#0.9588;MULTIPLE REGRESSION ANALYSIS#0.9588;TUBERCULOSIS#0.9587;IGF BINDING#0.9586;ACIDIFICATION#0.9586;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9586;STANDARD OF CARE#0.9586;CYTOTOXICITY#0.9585;HIGH RISK PATIENTS#0.9584;TREG CELL#0.9583;WORLD HEALTH ORGANIZATION#0.9583;ADENYLATE#0.9583;PROTEIN SYNTHESIS#0.9582;BREAST CANCER PATIENTS#0.9582;LUNG DISEASE#0.9581;STEM CELL PROLIFERATION#0.9581;MECHANISMS OF ACTION#0.9580;REACTIVE OXYGEN SPECIES#0.9580;CALCIUM MOBILIZATION#0.9580;LYMPH NODE#0.9580;OMMATIDIAL ROTATION#0.9580;THYMIDINE#0.9579;CHLOROQUINE#0.9579;MAP KINASE KINASE#0.9578;WOUND HEALING#0.9578;DISEASE FREE SURVIVAL#0.9577;HUMAN UMBILICAL VEIN#0.9577;ENDOTHELIAL CELL#0.9577;APOPTOSIS#0.9576;BLOOD BRAIN BARRIER#0.9575;MONONUCLEAR CELLS#0.9575;NUCLEAR MATRIX#0.9575;MIDGUT#0.9574;MAMMARY EPITHELIUM#0.9574;RETINOID X RECEPTOR#0.9574;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9573;PRINCIPAL COMPONENT ANALYSIS#0.9573;CELL COUNTING KIT#0.9573;CYTOPLASM#0.9573;VASOCONSTRICTION#0.9572;DESMOSOME#0.9572;DERMATITIS#0.9570;5 FLUOROURACIL#0.9570;NEPHROPATHY#0.9570;ADIPOSE TISSUE#0.9569;2'-DEOXYURIDINE#0.9568;KINASE BINDING#0.9567;PROPIDIUM#0.9567;ELECTROPHORETIC MOBILITY SHIFT#0.9566;EPITHELIAL OVARIAN CARCINOMA#0.9566;UMBILICAL VEIN#0.9566;CYCLOPHOSPHAMIDE#0.9565;OBESE#0.9565;GESTATION#0.9564;HYPERGLYCEMIA#0.9563;REVERSE TRANSCRIPTION#0.9563;MECHANISM OF ACTION#0.9563;GOLGI APPARATUS#0.9562;INNATE IMMUNITY#0.9561;MYOCARDIAL INFARCTION#0.9558;MAXIMUM TOLERATED DOSE#0.9557;CASPASE INHIBITOR#0.9557;DNA BINDING#0.9557;STEM CELL#0.9556;FLUOROURACIL#0.9556;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9556;THROMBOSIS#0.9555;VEGF-AS#0.9555;BLOOD VESSEL#0.9554;MITOMYCIN#0.9553;JNK SIGNALING PATHWAY#0.9552;ASPARTATE#0.9552;ENDOCYTIC VESICLE#0.9551;OLFACTORY BULB#0.9551;FATTY ACID BINDING#0.9551;ENHANCER BINDING#0.9550;TIME TO PROGRESSION#0.9550;MUSCLE CELL PROLIFERATION#0.9549;MESENCHYME#0.9549;APOPTOTIC#0.9548;STREPTOZOTOCIN#0.9548;CELL CYCLE ARREST#0.9548;WEIGHT LOSS#0.9548;GUANOSINE#0.9547;CELL DEATH#0.9546;MALE BREAST CANCER#0.9546;KERATOSIS#0.9546;CARDIOVASCULAR SYSTEM#0.9545;CENTRAL NERVOUS SYSTEM#0.9543;MITOCHONDRIAL MEMBRANE#0.9543;GENE EXPRESSION OMNIBUS#0.9542;TRANSCRIPTION FACTOR#0.9542;ARTERY#0.9542;SERUM URIC ACID#0.9541;NICOTINIC ACETYLCHOLINE RECEPTOR#0.9541;HYPERTENSION#0.9540;OVERALL SURVIVAL RATE#0.9540;PROTEIN PROTEIN INTERACTION#0.9539;TYPE 2 DIABETES#0.9539;ADVANCED OVARIAN CANCER#0.9537;ICI 182,780#0.9536;NULL CELL#0.9534;TRANSMISSION ELECTRON MICROSCOPY#0.9534;DIABETES MELLITUS#0.9534;KIDNEY TRANSPLANT RECIPIENTS#0.9533;LYMPHOCYTE ANTIGEN#0.9533;TRANSDIFFERENTIATION#0.9533;ACTIVE CASPASE 3#0.9532;CELL CYCLE#0.9532;SMOOTH MUSCLE CELL PROLIFERATION#0.9532;INTERLEUKIN 1 RECEPTOR#0.9532;NERVOUS SYSTEM#0.9531;ALZHEIMER'S DISEASE#0.9530;INDOMETHACIN#0.9529;CUMULUS OOCYTE COMPLEXES#0.9528;CIRCULATING TUMOUR CELLS#0.9528;ARTERY DISEASE#0.9528;DIFFERENTIAL GENE EXPRESSION#0.9528;METHYLATION SPECIFIC PCR#0.9527;MAGNETIC RESONANCE IMAGING#0.9527;ATAXIA TELANGIECTASIA#0.9526;ASTHENIA#0.9526;NUCLEAR MEMBRANE#0.9526;CARCINOGEN#0.9526;COLUMNAR#0.9526;ENZYME INHIBITOR#0.9526;CEREBRAL CORTEX#0.9526;DOPAMINERGIC NEURON#0.9525;DUCTAL CELL#0.9525;MEDIAN SURVIVAL TIME#0.9525;ANTHRACENE#0.9525;UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR#0.9523;STOMATITIS#0.9523;REGULATION OF GROWTH#0.9522;IMMUNE SYSTEM#0.9522;YELLOW FLUORESCENT PROTEIN#0.9522;ORGANOGENESIS#0.9521;SERIOUS ADVERSE EVENT#0.9521;SMALL INTESTINE#0.9521;BONE MARROW#0.9520;REGULATION OF GENE EXPRESSION#0.9519;LIPID KINASE#0.9519;IMMUNE RESPONSE#0.9518;CHARLSON COMORBIDITY INDEX#0.9517;DYSPNEA#0.9514;NICOTINAMIDE#0.9514;RESPONSE TO GROWTH FACTOR#0.9514;SELECTIN#0.9513;PNEUMONIA#0.9513;SKIN DEVELOPMENT#0.9511;BRAIN DEVELOPMENT#0.9510;OLEIC ACID#0.9506;EGF RECEPTOR SIGNALING PATHWAY#0.9505;HIGH DENSITY LIPOPROTEIN#0.9504;ION TRANSPORT#0.9503;ALLERGEN#0.9501;MUCOSITIS#0.9501;CELL PENETRATING PEPTIDE#0.9500;M PHASE#0.9499;IN SITU CARCINOMA#0.9498;EPITHELIAL CELL MIGRATION#0.9497;LYMPHOEPITHELIOMA-LIKE CARCINOMA#0.9497;ANEMIA#0.9496;ACTIVATING TRANSCRIPTION FACTOR#0.9496;OBJECTIVE RESPONSE RATE#0.9494;GENE EXPRESSION#0.9493;TYPE 1 DIABETES#0.9492;ALANINE#0.9492;TYPE 2 DIABETES MELLITUS#0.9492;2 DIABETES MELLITUS#0.9492;ERYTHROID PROGENITOR#0.9490;GLUCOSE TRANSPORT#0.9489;LEUKOPENIA#0.9489;DOSE LIMITING TOXICITIES#0.9489;DISEASE CONTROL RATE#0.9488;OVERALL RESPONSE RATE#0.9487;G1 PHASE#0.9486;GLEEVEC#0.9485;REGULATORY T CELL#0.9483;HEMORRHAGE#0.9482;PROTEIN TRANSLATION#0.9481;VASOPRESSIN#0.9481;PLATELET ACTIVATING FACTOR#0.9480;HAIR CELL#0.9479;SPIRONOLACTONE#0.9478;GENE EXPRESSION SIGNATURES#0.9478;GRB2 ASSOCIATED BINDER#0.9477;HETEROTRIMERIC G-PROTEIN#0.9477;ATHEROSCLEROSIS#0.9476;KIDNEY DISEASE#0.9476;T CELL ACTIVATION#0.9475;TISSUE DAMAGE#0.9473;YEAR SURVIVAL RATE#0.9473;ACTIVATED T-CELLS#0.9472;ANOREXIA#0.9470;DIGESTION#0.9470;ACTIVATED T CELL#0.9469;EXTRACELLULAR MATRIX#0.9468;SWELLING#0.9466;RNA BINDING PROTEIN#0.9465;VACUOLE#0.9465;BRAIN GLIOMA#0.9464;LYMPH NODE DISSECTION#0.9463;COMPOUND 18#0.9463;PEPTIDE BINDING#0.9462;CHRONIC KIDNEY DISEASE#0.9461;PENILE CANCER#0.9458;ADIPOCYTE#0.9458;INTEGRIN ACTIVATION#0.9456;BASAL EPITHELIAL CELL#0.9456;SKELETON#0.9456;ANGIOTENSIN RECEPTOR#0.9455;CONTACT INHIBITION#0.9455;ENDOTHELIAL CELL PROLIFERATION#0.9454;MEDULLARY THYROID CANCER#0.9454;ACETIC ACID#0.9453;VASCULAR DISEASE#0.9450;SIMVASTATIN#0.9450;FERTILIZATION#0.9449;HEPATOCYTE APOPTOSIS#0.9446;THROMBOCYTOPENIA#0.9444;SEOUL NATIONAL UNIVERSITY#0.9442;IONOPHORE#0.9442;ARSENIC TRIOXIDE#0.9441;ACUTE LUNG INJURY#0.9440;FAT PAD#0.9440;AFLIBERCEPT#0.9437;INGENUITY PATHWAY ANALYSIS#0.9437;MULTIDRUG RESISTANCE PROTEIN#0.9434;BETA GALACTOSIDASE#0.9433;INTEGRIN LINKED KINASE#0.9432;KIDNEY FAILURE#0.9430;TOXICITY#0.9428;VOMITING#0.9426;RISK OF RELAPSE#0.9426;DODECYL SULFATE#0.9423;BIOLOGICAL PROCESS#0.9422;SURFACE EPITHELIUM#0.9421;FALSE DISCOVERY RATE#0.9420;KIDNEY CANCER#0.9420;PTPASE ACTIVITY#0.9420;RESPIRATORY TRACT#0.9418;SODIUM DODECYL SULFATE#0.9417;ADRENOCORTICAL CARCINOMA#0.9416;CELL CYCLE CHECKPOINT#0.9415;ATHEROSCLEROTIC#0.9415;TRYPTOPHAN#0.9414;AMERICAN CANCER SOCIETY#0.9413;MEDIAN OVERALL SURVIVAL#0.9412;TISSUE DEVELOPMENT#0.9407;SPINAL CHORDOMA#0.9407;ALLERGIC REACTION#0.9402;PHAGOCYTOSIS#0.9401;VALINE#0.9395;CELL FATE SPECIFICATION#0.9394;BLOOD LOSS#0.9393;AUTOIMMUNE DISEASE#0.9392;CANCER RELATED DEATH#0.9389;RESPIRATORY FAILURE#0.9389;TISSUE MICRO ARRAY#0.9389;CALCITRIOL#0.9385;HUMAN CERVICAL CARCINOMA#0.9382;PLEURA#0.9377;HISTOGENESIS#0.9377;ANASTROZOLE#0.9376;BILE DUCT CARCINOMA#0.9376;MULTIPLE LOGISTIC REGRESSION#0.9375;ATPASE ACTIVITY#0.9374;DEMETHYLATION#0.9374;RETINAL PIGMENT EPITHELIAL#0.9373;MERKEL CELL#0.9371;MESENCHYMAL TO EPITHELIAL TRANSITION#0.9370;METASTATIC CARCINOMA#0.9370;BICALUTAMIDE#0.9369;ULCERATIVE COLITIS#0.9368;FATTY ACID METABOLISM#0.9366;STANDARD UPTAKE VALUE#0.9365;CORONARY ARTERY DISEASE#0.9360;17-DMAG#0.9358;TROPISM#0.9357;PHOSPHODIESTERASE#0.9357;NEURAL CREST#0.9356;NEUTROPENIA#0.9356;MEMBRANE RAFT#0.9353;POSTTRANSLATIONAL MODIFICATION#0.9349;CYTOKINE SECRETION#0.9348;VIRAL REPLICATION#0.9348;ANCHORING#0.9348;COMPLEMENT DEPENDENT CYTOTOXICITY#0.9347;OVIDUCT#0.9343;RITUXIMAB#0.9342;TISSUE REGENERATION#0.9340;STEROIDOGENESIS#0.9338;DIARRHEA#0.9337;DUCTAL BREAST CANCER#0.9335;AKT SIGNALING CASCADE#0.9333;ASIALOGLYCOPROTEIN RECEPTOR#0.9333;PERCUTANEOUS CORONARY INTERVENTION#0.9332;GROWTH DIFFERENTIATION FACTOR#0.9332;ENDOTHELIAL NITRIC OXIDE#0.9331;ATP BINDING CASSETTE TRANSPORTER#0.9330;LACTATION#0.9329;SCHWANN CELL PROLIFERATION#0.9329;AMYLOID PRECURSOR PROTEIN#0.9326;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9324;INTESTINAL MUCOSA#0.9323;INTERNEURON#0.9321;CYTOPLASMIC MEMBRANE#0.9317;DOUBLE-STRAND BREAK REPAIR#0.9317;NEPHRON#0.9317;ATAXIA TELANGIECTASIA MUTATED#0.9315;SINGLE NUCLEOTIDE VARIANTS#0.9315;PULMONARY HYPERTENSION#0.9315;FIBROBLAST ACTIVATION#0.9314;NATIONAL UNIVERSITY HOSPITAL#0.9312;CHOLINE#0.9310;NEUROMUSCULAR JUNCTION#0.9307;RELATED PROTEIN 1#0.9306;TUMOR REGRESSION GRADE#0.9305;HISTONE ACETYLATION#0.9304;CELL CYCLE PHASE#0.9304;LEWIS LUNG CARCINOMA#0.9303;HISTIDINE#0.9302;CHONDROITIN SULFATE PROTEOGLYCAN#0.9298;SIGNALOSOME#0.9298;PATTERN FORMATION#0.9296;INTRACELLULAR SIGNAL TRANSDUCTION PATHWAY#0.9294;PROXIMAL TUBULAR CELL#0.9292;MULTIPLE LINEAR REGRESSION#0.9290;PUBERTY#0.9290;TACROLIMUS#0.9289;POTASSIUM CHANNEL#0.9289;CHLORIDE CHANNEL#0.9288;ENHANCER BINDING PROTEIN#0.9287;NEGATIVE CONTROL GROUP#0.9285;L-ARGININE#0.9281;INHIBITION OF CELL MIGRATION#0.9281;GRANULOCYTE COLONY STIMULATING FACTOR#0.9281;DIGESTIVE TRACT#0.9275;MAP KINASE ACTIVITY#0.9274;4-HYDROXYTAMOXIFEN#0.9273;VINCRISTINE#0.9267;EMBRYO DEVELOPMENT#0.9264;RED BLOOD CELL#0.9263;ACETAMIDE#0.9259;FAMILIAL ADENOMATOUS POLYPOSIS#0.9259;NEUROFIBROMA#0.9259;PHOSPHATIDYLSERINE#0.9257;CLINICAL PRACTICE GUIDELINE#0.9255;FACTOR S#0.9254;ERYTHEMA#0.9252;MULTI DRUG RESISTANCE#0.9252;INHIBIN#0.9252;THYROID HORMONE RECEPTOR#0.9251;INTERSTITIAL CELL#0.9248;UNFOLDED PROTEIN RESPONSE#0.9244;CELLULAR COMPONENT#0.9244;PARKINSON'S DISEASE#0.9243;EGFR-HER2 SIGNALING PATHWAY#0.9238;CILIATED CELL#0.9237;LONG TERM POTENTIATION#0.9236;UBIQUITIN SPECIFIC PROTEASE#0.9232;KARNOFSKY PERFORMANCE SCORE#0.9232;SCANNING ELECTRON MICROSCOPY#0.9231;FIBROUS HISTIOCYTOMA#0.9231;VIRULENCE#0.9231;RECEPTOR RECYCLING#0.9227;VITAMIN D DEFICIENCY#0.9223;CONVECTION ENHANCED DELIVERY#0.9223;NUCLEAR IMPORT#0.9222;DECIDUALIZATION#0.9222;CAROTID ARTERY#0.9221;UBIQUITIN PROTEASOME PATHWAY#0.9218;PARATHYROID ADENOMA#0.9216;HUMAN DERMAL FIBROBLAST#0.9207;PAROTID GLAND#0.9204;CRYSTAL VIOLET#0.9203;EPITHELIAL STEM CELL#0.9202;ABT-263#0.9202;REGULATION OF APOPTOSIS#0.9201;CERVICAL CANCER CELL LINES#0.9198;DIABETIC KIDNEY DISEASE#0.9194;RUFFLE#0.9194;PROTEIN KINASE C ACTIVITY#0.9192;MEMBRANE TYPE 1#0.9191;EUKARYOTIC INITIATION FACTOR#0.9191;ABDOMINAL PAIN#0.9190;CYTOCHROME C RELEASE#0.9190;LOCALIZED PROSTATE CANCER#0.9189;INTERMEDIATE FILAMENT#0.9188;OSTEOARTHRITIS#0.9188;ACID PHOSPHATASE#0.9186;COMMON TOXICITY CRITERIA#0.9185;EPIDIDYMIS#0.9185;UBIQUITIN LIGASE ACTIVITY#0.9181;FIBRINOGEN#0.9180;CELL SURFACE ANTIGEN#0.9175;BUDDING#0.9173;LACRIMAL GLAND#0.9173;VITAMIN D3#0.9173;SENTINEL LYMPH NODE#0.9170;METALLOPROTEASE ACTIVITY#0.9170;LUPUS ERYTHEMATOSUS#0.9170;DEUBIQUITINATION#0.9169;COLON EPITHELIAL CELL#0.9168;KIDNEY DAMAGE#0.9168;LYNCH SYNDROME#0.9165;JANUS ACTIVATED KINASE#0.9156;SPERMATOZOA#0.9156;VALPROIC ACID#0.9150;GLUTAMATE RECEPTOR#0.9148;TRANS GOLGI NETWORK#0.9147;INTRACELLULAR LOCALIZATION#0.9147;EARLY TIME POINT#0.9146;PERITONEUM#0.9144;MENADIONE#0.9142;DIACYLGLYCEROL KINASE#0.9142;VAN DER WAALS#0.9141;MELATONIN#0.9135;COATED VESICLE#0.9129;OESOPHAGUS#0.9128;ANDROGEN DEPRIVATION THERAPY#0.9127;MYOMETRIUM#0.9123;NEUROTOXICITY#0.9121;OLFACTORY EPITHELIUM#0.9118;PHENYLEPHRINE#0.9117;AREA UNDER CURVE#0.9117;BETA2 ADRENERGIC RECEPTOR#0.9116;IN VITRO MATURATION#0.9115;ANAEMIA#0.9114;HISTONE MODIFICATION#0.9112;PANCREATIC ISLET#0.9109;RESPONSE TO CISPLATIN#0.9109;CHROMOSOME REGION#0.9109;GLIOSARCOMA#0.9108;ACTIVATED CASPASE 3#0.9106;RENAL REPLACEMENT THERAPY#0.9105;RESPONSE TO HYPOXIA#0.9101;CASPASE ACTIVITY#0.9100;AORTIC SMOOTH MUSCLE CELLS#0.9098;INNER EAR#0.9091;CONTRAST INDUCED NEPHROPATHY#0.9087;PROSTATE ADENOCARCINOMA#0.9086;LIPID RAFT LOCALIZATION#0.9085;PATIENT REPORTED OUTCOME#0.9085;SUCROSE#0.9084;ROOT SHEATH#0.9079;BREAST DUCTAL CARCINOMA#0.9072;CYTOTOXIN#0.9071;MIDDLE LOBE#0.9069;CYTOLYSIS#0.9068;PHOSPHATE BUFFERED SALINE#0.9067;PEPTIDE HORMONE#0.9066;METAPHASE#0.9066;CORPUS LUTEUM#0.9065;M2 MACROPHAGE#0.9065;CHOLERA#0.9063;NERVOUS SYSTEM DEVELOPMENT#0.9062;HIGH MOBILITY GROUP#0.9061;LIVER DAMAGE#0.9056;GTPASE ACTIVITY#0.9049;PROTON PUMP#0.9049;ORAL CAVITY CANCER#0.9048;FOREBRAIN#0.9048;WILLINGNESS TO PAY#0.9046;EPITHELIAL CELL DIFFERENTIATION#0.9043;CYTOSKELETON ORGANIZATION#0.9042;INTERLEUKIN 2 RECEPTOR#0.9040;GROWTH REGULATOR#0.9039;ADIPOGENESIS#0.9036;CAMPTOTHECIN#0.9035;ASTROCYTE ACTIVATION#0.9016;CEREBRAL ARTERY#0.9013;OVARIAN SURFACE EPITHELIAL#0.9007;DORMANCY#0.9006;RECEPTOR-RECEPTOR INTERACTION#0.9006;LYMPHANGIOGENESIS#0.9004;ESOPHAGEAL EPITHELIAL CELLS#0.9004;NOTCH RECEPTOR#0.9000;BREAST CELL LINES#0.8996;HYPERACTIVITY#0.8995;UBIQUITIN PROTEIN LIGASE#0.8994;PERITONEAL CAVITY#0.8992;CARDIOTOXIC#0.8991;CYSTITIS#0.8988;DIHYDROTESTOSTERONE#0.8986;MAMMARY FAT PAD#0.8984;CARDIOVASCULAR RISK FACTOR#0.8983;EXEMESTANE#0.8981;MEIOSIS#0.8979;LUMINAL EPITHELIAL CELL#0.8977;NEUROENDOCRINE CELL#0.8976;MINIMAL RESIDUAL DISEASE#0.8976;ESOPHAGITIS#0.8975;BRAIN ENDOTHELIAL CELL#0.8974;EFFLUX PUMP#0.8973;EVERY OTHER DAY#0.8971;AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE#0.8968;LYMPHOPENIA#0.8967;AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY#0.8966;PROTEASE ACTIVITY#0.8964;DERMIS#0.8963;PULMONARY EMBOLISM#0.8963;HYPERPARATHYROIDISM#0.8962;METALLOPROTEINASE ACTIVITY#0.8960;BENZIMIDAZOLE#0.8956;CYTOPLASMIC REGION#0.8953;SCALP#0.8949;C-LEVEL#0.8949;ACID SECRETION#0.8948;CONGESTIVE HEART FAILURE#0.8946;VASOCONSTRICTOR#0.8943;NASAL MUCOSA#0.8938;INTERCELLULAR JUNCTION#0.8937;CHANNEL ACTIVITY#0.8937;NEPHROTOXICITY#0.8935;GASTRO#0.8934;NATIONAL CANCER CENTER#0.8932;MRNA BINDING#0.8931;CONSTRICTION#0.8927;NATIONAL HEALTH INSURANCE#0.8926;MEDROXYPROGESTERONE ACETATE#0.8924;FLOW CYTOMETRY ASSAY#0.8922;TONSIL#0.8921;IMPORTIN#0.8920;RESPONSE TO DRUG#0.8917;HIGH POWER FIELD#0.8917;BLOOD GROUP ANTIGEN#0.8912;GLOMERULONEPHRITIS#0.8909;HYPOKALEMIA#0.8909;PENTOSE PHOSPHATE PATHWAY#0.8908;PELVIS#0.8907;CELL RECOGNITION#0.8905;URIDINE#0.8902;LIGHT CHAIN 3#0.8901;SPERMATOGENESIS#0.8901;SQUAMOUS INTRAEPITHELIAL LESION#0.8899;DUCT CELL#0.8896;MYOBLAST#0.8893;ENDOCYTIC RECYCLING#0.8893;B LYMPHOCYTE#0.8889;BREAST CONSERVING SURGERY#0.8888;ZOLEDRONIC ACID#0.8886;ERYTHROCYTE#0.8886;PITUITARY GLAND#0.8885;ELECTRONIC MEDICAL RECORD#0.8885;ADENINE DINUCLEOTIDE PHOSPHATE#0.8883;RENAL ARTERY#0.8882;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.8882;THYMIDINE KINASE#0.8880;ZINC FINGER PROTEIN#0.8880;VIRION#0.8879;TRANSLATION INITIATION FACTOR#0.8879;LUNG SQUAMOUS CARCINOMA#0.8876;CELL MATRIX ADHESION#0.8876;HIPPO SIGNALING PATHWAY#0.8869;SKIN FIBROBLASTS#0.8866;INDIVIDUAL PATIENT DATA#0.8864;PROLACTIN RECEPTOR#0.8862;LINEAR MIXED MODEL#0.8862;MULTIPLE REACTION MONITORING#0.8861;APOPTOSIS SIGNALING#0.8858;HYPERPHOSPHORYLATION#0.8855;SCIATIC NERVE#0.8855;HEDGEHOG SIGNALING PATHWAY#0.8853;ATROPHIC GASTRITIS#0.8848;PULSE WAVE VELOCITY#0.8847;HEME OXYGENASE 1#0.8846;BONE MARROW CELLS#0.8844;INTERFERON REGULATORY FACTOR#0.8843;STRIATUM#0.8836;ISCHEMIA REPERFUSION INJURY#0.8835;MEASLES#0.8835;INFLUENZA A VIRUS#0.8832;JUN PHOSPHORYLATION#0.8830;INSULIN SECRETION#0.8826;DRUG METABOLISM#0.8824;NEUROFILAMENT#0.8822;FATTY ACID SYNTHESIS#0.8820;COMPLEMENT ACTIVATION#0.8818;MEMBRANE RUFFLE#0.8815;TOTAL KIDNEY VOLUME#0.8814;RIBOSOMAL S6 KINASE#0.8810;MUCOUS CELLS#0.8809;ACROSOME REACTION#0.8802;EXTRACELLULAR SPACE#0.8797;RU486#0.8797;ASPARTIC ACID#0.8796;DEXTRAN SODIUM SULFATE#0.8795;MOUSE EMBRYONIC STEM#0.8795;CIGARETTE SMOKE EXTRACT#0.8794;OSTEOBLAST DIFFERENTIATION#0.8791;PLASMA PROTEIN#0.8785;ACTIVATION OF APOPTOSIS#0.8781;MICROSOME#0.8779;PEMPHIGUS#0.8778;ANAL CANAL#0.8778;ATOPIC DERMATITIS#0.8778;BRUSH BORDER#0.8775;ASCORBIC ACID#0.8773;BODY WEIGHT LOSS#0.8772;MTOR COMPLEX#0.8771;INDUCES CANCER#0.8770;FATTY LIVER DISEASE#0.8768;CELL FATE DETERMINATION#0.8765;COLITIS ASSOCIATED CANCER#0.8764;PHEOCHROMOCYTOMA#0.8758;WEIGHT GAIN#0.8756;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8756;AIRWAY MUCUS HYPERSECRETION#0.8753;TENOFOVIR#0.8752;ANTI INFLAMMATORY DRUGS#0.8749;LIVER CIRRHOSIS#0.8747;IL-6 SECRETION#0.8746;LIDOCAINE#0.8743;DEMENTIA#0.8742;ENVIRONMENTAL TOBACCO SMOKE#0.8737;2-DEOXYGLUCOSE#0.8733;SEROUS CYSTADENOCARCINOMA#0.8729;RESPIRATORY DISTRESS#0.8729;PHENOBARBITAL#0.8728;NEPHRITIS#0.8725;BATIMASTAT#0.8725;BETA ADRENERGIC RECEPTOR#0.8721;MONOCYTE CHEMOTACTIC PROTEIN#0.8721;MALIGNANT PERITONEAL MESOTHELIOMA#0.8720;GROSS TOTAL RESECTION#0.8718;ZONULA OCCLUDENS#0.8715;MEDULLARY CARCINOMA#0.8714;ERYTHROID CELL#0.8710;SPECIFICITY PROTEIN 1#0.8708;DEHYDRATION#0.8708;CELL EXPANSION#0.8707;RENAL TRANSPLANT RECIPIENTS#0.8705;BREAST DISEASE#0.8703;TYROSINE KINASE BINDING#0.8701;GASTROINTESTINAL CARCINOMA#0.8698;SINONASAL PAPILLOMA#0.8694;CHRONIC LIVER DISEASE#0.8692;COLLAGEN BINDING#0.8688;RETINAL GANGLION CELL#0.8687;TO DISTANT METASTASIS#0.8683;VULVAL DEVELOPMENT#0.8683;SECRETORY PATHWAY#0.8683;HUMAN SERUM ALBUMIN#0.8680;FUCOSYLATION#0.8678;METAPLASTIC BREAST CARCINOMAS#0.8675;PHOSPHOLIPID BINDING#0.8675;ATORVASTATIN#0.8674;CLARA CELL#0.8672;L-LYSINE#0.8669;NEURAL PRECURSOR CELL#0.8668;MEMBRANE FUSION#0.8664;LUNG CARCINOMA CELL LINES#0.8664;INTEGRIN BINDING#0.8663;EMBOLISM#0.8663;VSMC PROLIFERATION#0.8662;RALOXIFENE#0.8659;KINASE INSERT DOMAIN#0.8657;CYSTADENOCARCINOMA#0.8654;TRACHEA#0.8646;2'-DEOXYCYTIDINE#0.8642;FILOPODIA FORMATION#0.8642;PROSTAGLANDIN ENDOPEROXIDE SYNTHASE#0.8640;MUCUS SECRETION#0.8639;LIPOGENESIS#0.8639;CYTOTOXIC T CELL#0.8638;STOMACH CANCER#0.8635;NEUROTROPHIN RECEPTOR#0.8634;SMOOTH MUSCLE CELL MIGRATION#0.8634;CAMKII#0.8634;ITCHING#0.8633;MUSCLE CELL MIGRATION#0.8632;HUMAN WHOLE BLOOD#0.8629;COLLAGEN SYNTHESIS#0.8626;BLOOD CIRCULATION#0.8625;FOLLICLE STEM CELL#0.8622;HUMAN MESENCHYMAL STEM#0.8620;GINSENG#0.8620;JUN KINASE#0.8616;CENTROSOME#0.8614;LEWIS LUNG CANCER#0.8607;CHONDROSARCOMA#0.8604;VITAMIN C#0.8600;MIDDLE CEREBRAL ARTERY#0.8591;PEMPHIGUS VULGARIS#0.8590;AURANOFIN#0.8590;MICROFILAMENT#0.8588;LOSARTAN#0.8588;PEDIATRIC BRAIN TUMORS#0.8587;REGULATION OF CELL CYCLE#0.8584;THROMBIN RECEPTOR#0.8575;MITOTIC CATASTROPHE#0.8573;DECIDUA#0.8571;CARCINOMA OF UNKNOWN PRIMARY#0.8571;FILAMENTOUS ACTIN#0.8569;RESECTED GASTRIC CANCER#0.8564;CHRONIC HEART FAILURE#0.8562;DEATH RECEPTOR LIGAND#0.8562;MRNA TRANSCRIPTION#0.8561;MITOXANTRONE#0.8561;URETERAL OBSTRUCTION#0.8554;GLUTATHIONE PEROXIDASE#0.8550;PLATIN#0.8550;NEUROECTODERMAL TUMOR#0.8548;COLORECTAL LIVER METASTASES#0.8544;DELAYED GRAFT FUNCTION#0.8543;INVASIVE CERVICAL CANCER#0.8541;CORTISOL#0.8534;LICHEN PLANUS#0.8533;ERYTHROLEUKEMIA#0.8515;CYCLOSPORIN A#0.8512;PROTEIN CODING GENE#0.8509;RESPONSE TO ESTROGEN#0.8509;BRAIN LESIONS#0.8508;LAMININ RECEPTOR#0.8506;GENE REGULATORY NETWORK#0.8504;BONE MARROW STROMAL#0.8504;MARROW STROMAL CELLS#0.8502;RESPONSE TO UV#0.8499;PROTEIN STABILIZATION#0.8493;2-DEOXY-D-GLUCOSE#0.8492;NK CELL ACTIVATION#0.8487;MERKEL CELL CARCINOMA#0.8487;TYROSINE KINASE 1#0.8483;MICROVESICLE#0.8480;LINEAR MIXED EFFECTS#0.8479;LDL RECEPTOR#0.8478;PROTEIN KINASE C ACTIVATION#0.8472;T CELL PROLIFERATION#0.8468;SPORADIC BREAST CANCER#0.8468;LATERAL VENTRICLE#0.8467;FOLLICULAR DENDRITIC CELL#0.8464;NMDA RECEPTOR#0.8464;LARYNX CANCER#0.8463;SULINDAC#0.8458;MOUSE EMBRYO FIBROBLASTS#0.8457;SKELETAL RELATED EVENTS#0.8456;GRB2-SOS COMPLEX#0.8453;PLACENTAL DEVELOPMENT#0.8449;EMODIN#0.8448;GROUND GLASS OPACITIES#0.8443;KERATOACANTHOMA#0.8443;5-AZA-2'-DEOXYCYTIDINE#0.8432;MIGRATION INHIBITORY FACTOR#0.8431;GROWTH INHIBITION RATE#0.8431;ANTIGEN PROCESSING#0.8423;NEOPLASTIC DISEASE#0.8422;KINASE INHIBITOR PROTEIN#0.8419;PROTON PUMP INHIBITOR#0.8418;RETINAL PIGMENT EPITHELIUM#0.8418;BONE MINERAL DENSITY#0.8413;PROTEIN MODIFICATION#0.8413;SELECTED REACTION MONITORING#0.8409;GASTRIC ACID SECRETION#0.8406;IGG ANTIBODY#0.8406;EPITHELIAL CELL APOPTOSIS#0.8405;ORAL LICHEN PLANUS#0.8404;ENDOTHELIAL CELL MIGRATION#0.8403;IL-6 PRODUCTION#0.8403;FLAVOPIRIDOL#0.8399;IRINOTECAN, CPT-11#0.8397;SIGNALING PROCESS#0.8397;CAM BINDING#0.8396;NUCLEAR EXPORT#0.8388;LOCOMOTION#0.8388;CLOZAPINE#0.8385;MICROGLIAL CELL#0.8385;VITAMIN K#0.8381;BLOOD UREA NITROGEN#0.8380;SEQUESTERING#0.8380;THYROID GLAND#0.8378;HISTIOCYTOMA#0.8377;MEMBRANE TRANSPORT#0.8374;NEPHROTIC SYNDROME#0.8369;ADVERSE CLINICAL OUTCOME#0.8361;METASTATIC RENAL CELL CARCINOMA#0.8361;HORMONE BINDING#0.8361;OSTEOPOROSIS#0.8361;ENDOMETRIAL EPITHELIAL CELLS#0.8360;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8359;CALMODULIN BINDING#0.8350;ARECOLINE#0.8349;MYCOPHENOLATE MOFETIL#0.8346;SIZE EXCLUSION CHROMATOGRAPHY#0.8345;ENDOCHONDRAL OSSIFICATION#0.8344;METHYLATION SPECIFIC POLYMERASE#0.8343;PALMITATE#0.8343;RESPONSE TO STRESS#0.8338;ROS FORMATION#0.8337;EVENT FREE SURVIVAL#0.8336;PARENTERAL#0.8334;DNASE#0.8334;GONAD#0.8332;IFOSFAMIDE#0.8331;DIMETHYL SULFOXIDE#0.8331;ACTIVATION OF SIGNAL TRANSDUCTION#0.8329;HUMAN AIRWAY EPITHELIUM#0.8327;PARTIAL LEAST SQUARE#0.8326;SPERM CAPACITATION#0.8325;CELL AGGREGATION#0.8325;PROLACTINOMA#0.8323;LH RECEPTOR#0.8323;FOLATE RECEPTOR ALPHA#0.8322;POSITIVE SURGICAL MARGIN#0.8320;SMALL AIRWAY EPITHELIAL#0.8320;HIERARCHICAL CLUSTERING ANALYSIS#0.8319;HH SIGNALING PATHWAY#0.8318;ENDOTHELIN RECEPTOR#0.8311;CHOLANGITIS#0.8309;HIERARCHICAL CLUSTER ANALYSIS#0.8309;UBIQUITIN PROTEASOME SYSTEM#0.8306;YOLK SAC#0.8305;BONE DEVELOPMENT#0.8304;PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY#0.8299;LEUKEMIA INHIBITORY FACTOR#0.8296;LEIOMYOSARCOMA#0.8294;SHORTNESS OF BREATH#0.8288;SOLUBLE FRACTION#0.8285;OSTEOCLAST DIFFERENTIATION#0.8284;DIHYDROFOLATE REDUCTASE#0.8280;PAPILLARY THYROID CANCER#0.8280;HUMORAL IMMUNE RESPONSE#0.8277;GLYCERALDEHYDE-3-PHOSPHATE#0.8272;HEARING LOSS#0.8272;NUCLEAR LOCALIZATION SIGNAL#0.8272;ESTROGEN RESPONSE ELEMENT#0.8271;ACTIVATED B CELL#0.8271;ADRENOCORTICOTROPIC HORMONE#0.8268;LIMIT OF QUANTIFICATION#0.8267;BONE MARROW STROMAL CELL#0.8266;CANNABINOID RECEPTOR#0.8262;FORESKIN#0.8261;PROPRANOLOL#0.8259;VESICLE TRAFFICKING#0.8254;OLIGODENDROCYTE PROGENITOR CELL#0.8249;MEK ACTIVITY#0.8245;SPHINGOSINE KINASE 1#0.8240;ADRENAL GLAND#0.8240;3-METHYLADENINE#0.8238;CONTACT SITE#0.8237;TISSUE INVASION#0.8235;VASCULOGENESIS#0.8234;PROTEIN TARGETING#0.8234;LYMPHOCYTIC LEUKEMIA#0.8233;PIOGLITAZONE#0.8232;SPINDLE CELL CARCINOMA#0.8230;APOPTOSIS INDUCING FACTOR#0.8230;XERODERMA PIGMENTOSUM#0.8230;SECRETORY CELL#0.8229;RNA PROCESSING#0.8224;HIGH GRADE LESION#0.8223;NEUROPROTECTION#0.8220;INFLAMMATORY CELL INFILTRATION#0.8216;RESPIRATORY SYNCYTIAL VIRUS#0.8216;NUCLEAR HORMONE RECEPTOR#0.8215;PHOTOTOXICITY#0.8211;METHYL THIAZOLYL TETRAZOLIUM#0.8210;CELL MATURATION#0.8207;TNF PRODUCTION#0.8203;TERATOMA#0.8196;COLLECTING DUCTS#0.8193;HYPOTENSION#0.8192;CLEFT PALATE#0.8192;HAIR GROWTH#0.8192;GENETIC DISORDER#0.8191;STIMULATION OF GROWTH#0.8191;VITAMIN E#0.8183;TARGET OF RAPAMYCIN COMPLEX#0.8180;GASTRULATION#0.8180;PULMONARY ARTERY#0.8179;LI-FRAUMENI SYNDROME#0.8178;PROTEIN TYROSINE PHOSPHATASE ACTIVITY#0.8176;ACUTE PANCREATITIS#0.8175;RESPONSE TO PLATINUM#0.8173;MYOSIN LIGHT-CHAIN KINASE#0.8171;ADENOSQUAMOUS LUNG CARCINOMA#0.8169;HEMATOPOIETIC STEM CELL#0.8160;HYPERTHERMIA#0.8152;DNASE I#0.8151;UTERINE CERVICAL CANCER#0.8149;TENOFOVIR DISOPROXIL FUMARATE#0.8148;PORTAL VEIN#0.8148;EXOSOME PRODUCTION#0.8147;TENOFOVIR DISOPROXIL#0.8146;CHRONIC HEPATITIS C#0.8136;BASOLATERAL PLASMA MEMBRANE#0.8136;EPITHELIAL BARRIER FUNCTION#0.8131;CYCLASE ACTIVITY#0.8131;MYELODYSPLASTIC SYNDROME#0.8127;MINERALIZATION#0.8125;DUCTAL EPITHELIAL CELLS#0.8124;AMILORIDE#0.8123;VITAMIN K3#0.8123;NASAL EPITHELIUM#0.8120;PELVIC LYMPH NODE#0.8119;CAUSE SPECIFIC SURVIVAL#0.8113;EMBRYO IMPLANTATION#0.8112;CELL PERIPHERY#0.8112;DEATH-INDUCING SIGNALING COMPLEX#0.8108;PLX4032#0.8108;ANGIOSARCOMA#0.8106;NOTTINGHAM PROGNOSTIC INDEX#0.8101;SUBEROYLANILIDE HYDROXAMIC ACID#0.8100;TYPE II PNEUMOCYTE#0.8098;CLATHRIN COATED VESICLE#0.8095;COLON MUCOSA#0.8093;MICROVILLI#0.8087;MEDROXYPROGESTERONE#0.8082;ACTIN BINDING PROTEIN#0.8082;TIME TO RESPONSE#0.8075;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8074;NORMAL COLORECTAL MUCOSA#0.8073;APOPTOTIC SIGNALING PATHWAY#0.8070;CBDCA#0.8070;CPG ISLAND METHYLATION#0.8069;DETOXIFICATION#0.8066;EWING SARCOMA#0.8063;NO BINDING#0.8059;BRAIN STEM GLIOMA#0.8057;CELL DIVISION CYCLE#0.8055;EXTERNAL BEAM RADIOTHERAPY#0.8050;LATERAL INHIBITION#0.8050;ATRIAL FIBRILLATION#0.8048;WHOLE TISSUE SECTIONS#0.8045;RNA SPLICING#0.8045;REGULATION OF SIGNALING#0.8043;CD3+ T CELL#0.8035;CELL PROLIFERATION INDEX#0.8035;COENZYME A#0.8032;CYCLOSPORIN#0.8027;AKT SIGNAL TRANSDUCTION#0.8027;FASLODEX#0.8023;B CELL RECEPTOR#0.8019;PIGMENT EPITHELIAL CELL#0.8014;PANCREATIC ENDOCRINE TUMORS#0.8014;NORMAL SQUAMOUS EPITHELIUM#0.8012;MACROPHAGE MIGRATION#0.8012;ANAPLASTIC OLIGOASTROCYTOMA#0.8003;WILCOXON RANK SUM#0.7992;ROSIGLITAZONE#0.7991;GABAERGIC NEURON#0.7990;ERBB4 HOMODIMER#0.7989;HEMORRHAGIC#0.7980;HEALTH CARE SYSTEM#0.7979;CEREBRAL ISCHEMIA#0.7974;VERAPAMIL#0.7972;MEPRIN#0.7971;MYOTUBE#0.7968;ACTINIC KERATOSIS#0.7966;CELL CHEMOTAXIS#0.7964;ANAPLASTIC CARCINOMA#0.7963;STIMULATION OF CELL GROWTH#0.7963;MICROPARTICLE#0.7959;RECEIVER OPERATOR CHARACTERISTIC#0.7958;R115777#0.7956;1,2,4-TRIAZOLE#0.7954;PTERYGIUM#0.7953;LITHIUM#0.7947;DEXTRAN SULFATE SODIUM#0.7945;SKIN PAPILLOMA#0.7945;PKCEPSILON#0.7944;GLUTAMATERGIC SYNAPSE#0.7943;PROMOTER BINDING#0.7933;GLAND MORPHOGENESIS#0.7928;ANGIOTENSIN TYPE 1#0.7927;GREEN TEA POLYPHENOL#0.7923;DISC FORMATION#0.7923;OESTRADIOL#0.7921;RANDOM EFFECT MODEL#0.7920;ZONULA OCCLUDENS 1#0.7920;ORAL SUBMUCOUS FIBROSIS#0.7917;TUMOUR GROWTH FACTOR#0.7917;TRAF SIGNALING#0.7913;HEMANGIOBLASTOMA#0.7909;T CELL FACTOR#0.7907;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.7907;BONE DISEASE#0.7906;NEONATAL RAT CARDIOMYOCYTES#0.7903;COMPOUND 9#0.7902;PROTEIN SECRETION#0.7899;TUBULAR ADENOCARCINOMA#0.7897;OVARIAN SEROUS CARCINOMA#0.7896;URSODEOXYCHOLIC ACID#0.7896;REGIONS OF INTEREST#0.7894;GI TRACT#0.7894;GELONIN#0.7889;ACROSOME#0.7888;ANTIOXIDANT ACTIVITY#0.7887;HYDROXYUREA#0.7885;PHOSPHATASE I#0.7885;EPILEPSY#0.7883;FUMARATE#0.7882;RESPONSE TO INSULIN#0.7882;CLATHRIN-DEPENDENT ENDOCYTOSIS#0.7877;SCLEROSING CHOLANGITIS#0.7873;MULTIVARIATE LINEAR REGRESSION#0.7867;MEMBRANE DEPOLARIZATION#0.7867;MONOCLONAL ANTIBODY 2C4#0.7865;REACTIVE OXYGEN SPECIES GENERATION#0.7861;LUNG GROWTH#0.7859;THYROID LESIONS#0.7857;SECONDARY HYPERPARATHYROIDISM#0.7854;TISSUE MORPHOGENESIS#0.7848;G ASSOCIATED KINASE#0.7847;PKCZETA#0.7844;INTRACELLULAR RETENTION#0.7843;PROSTAGLANDIN SYNTHESIS#0.7843;CELLULAR IMMUNE RESPONSE#0.7838;ORDINARY DIFFERENTIAL EQUATION#0.7837;SIGNAL GENERATION#0.7834;VASCULITIS#0.7824;HYDRONEPHROSIS#0.7824;ANGIOGENIC GROWTH FACTORS#0.7808;SCAVENGER RECEPTOR#0.7807;OVAL CELL#0.7806;RECURRENT OVARIAN CANCER#0.7805;SIGNAL PEPTIDE#0.7803;ALLERGIC ASTHMA#0.7803;CEREBRAL ARTERY OCCLUSION#0.7803;PREPULSE INHIBITION#0.7800;OCTREOTIDE#0.7799;NORMAL HUMAN UROTHELIAL#0.7796;LIVER CARCINOMA#0.7793;APOPTOTIC PROCESS#0.7771;CHANGE FROM BASELINE#0.7771;ABERRANT CRYPT FOCI#0.7771;O GLYCAN#0.7770;BETA CELL MASS#0.7768;HUMAN BETA DEFENSIN#0.7767;WHOLE GENOME AMPLIFICATION#0.7766;DNA REPAIR CAPACITY#0.7765;PREADIPOCYTE#0.7764;EICOSAPENTAENOIC ACID#0.7757;SMC PROLIFERATION#0.7755;PHOTORECEPTOR CELL#0.7755;CELL BODY#0.7754;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.7753;MYELOID CELL LEUKEMIA#0.7752;PERIPHERAL BLOOD MONOCYTES#0.7751;HUMAN PERIODONTAL LIGAMENT#0.7749;SPECTRIN#0.7747;ACTH SECRETION#0.7744;NEGATIVE LIKELIHOOD RATIO#0.7743;MUSCLE CONTRACTION#0.7740;MUCINOUS CYSTADENOCARCINOMA#0.7737;TEMPORAL LOBE#0.7737;SPERM MOTILITY#0.7729;AORTIC VALVE#0.7724;SORTING ENDOSOME#0.7723;MAMMARY GLAND MORPHOGENESIS#0.7723;OSSIFICATION#0.7722;HAIR LOSS#0.7721;FIBRIL#0.7721;SYNAPTIC TRANSMISSION#0.7719;STEROID RECEPTOR COACTIVATOR#0.7718;PNEUMOTHORAX#0.7715;FRUCTOSE#0.7706;LYMPH NODE INVASION#0.7705;GRADE III ASTROCYTOMA#0.7701;CANCER INITIATING CELLS#0.7701;EXHALED BREATH CONDENSATE#0.7700;OXYGEN GLUCOSE DEPRIVATION#0.7700;DENTATE GYRUS#0.7694;BRONCHITIS#0.7694;THALIDOMIDE#0.7694;NUCLEAR ENVELOPE#0.7691;PROTEIN PHOSPHATASE ACTIVITY#0.7690;HEPATOBLASTOMA#0.7687;METASTATIC LUNG CARCINOMA#0.7684;PLACENTAL GROWTH FACTOR#0.7683;GYNECOLOGIC ONCOLOGY GROUP#0.7681;STEROL REGULATORY ELEMENT#0.7679;SILDENAFIL#0.7678;MRNA SPLICING#0.7678;CATION CHANNEL#0.7674;OXIDATIVE STRESS RESPONSE#0.7666;TRAUMATIC BRAIN INJURY#0.7665;CYTOKINESIS#0.7664;CELL-CELL ADHESION MOLECULE#0.7660;ORAL EPITHELIAL CELLS#0.7659;MEMBRANE RUFFLING#0.7658;AXITINIB#0.7658;SENSORY ORGAN#0.7658;CARBONIC ANHYDRASE 9#0.7658;GLUTAMINE METABOLISM#0.7657;ECZEMA#0.7657;CELLULAR METABOLISM#0.7655;OSTEOGENESIS#0.7652;TAXOTERE#0.7652;RESPIRATION#0.7644;APPARENT DIFFUSION COEFFICIENT#0.7640;GANGLION CELLS#0.7627;LASER CAPTURE MICRODISSECTED#0.7623;EPENDYMAL CELL#0.7622;MITOCHONDRION#0.7618;ORGAN DEVELOPMENT#0.7617;HEMATURIA#0.7613;DYNEIN#0.7611;PROTEIN FOLDING#0.7610;BASALOID SQUAMOUS CELL CARCINOMA#0.7608;LIPOSARCOMA#0.7608;INVASIVE LOBULAR CARCINOMA#0.7604;CELL PHYSIOLOGY#0.7603;UNILATERAL URETERAL OBSTRUCTION#0.7602;TYROSINE RECEPTOR KINASE#0.7602;EPIDERMAL STEM CELL#0.7601;BODY WEIGHT RATIO#0.7595;SINONASAL INVERTED PAPILLOMA#0.7594;PHARYNX#0.7593;DYNAMIC LIGHT SCATTERING#0.7591;HYALURONAN SYNTHASE#0.7591;SEVERE COMBINED IMMUNODEFICIENCY#0.7587;ANAPLASTIC LARGE CELL LYMPHOMA#0.7582;DIED OF DISEASE#0.7575;MITOTIC SPINDLE#0.7574;MUCINOUS LUNG ADENOCARCINOMA#0.7574;CORE NEEDLE BIOPSIES#0.7573;BASAL LAMINA#0.7573;MONTE CARLO SIMULATION#0.7567;HUMAN PROXIMAL TUBULE#0.7557;CHRONIC HEPATITIS B#0.7556;BOSUTINIB#0.7554;KIDNEY INJURY MOLECULE#0.7553;GLOMERULUS#0.7552;LIPID PHOSPHATASE#0.7551;LIPID DROPLET#0.7547;ADAPTIVE IMMUNE RESPONSE#0.7546;CARDIAC MUSCLE#0.7539;ACUTE CORONARY SYNDROME#0.7536;PLATELET ACTIVATION#0.7534;PYRUVATE DEHYDROGENASE KINASE#0.7531;PERIPHERAL BLOOD LYMPHOCYTES#0.7530;ACTION POTENTIAL#0.7530;DEVELOPMENTAL PROCESS#0.7522;MYELOID-DERIVED SUPPRESSOR CELL#0.7512;GRANULOSA CELL TUMOR#0.7512;HUMAN EMBRYONIC STEM#0.7510;GERMINAL VESICLE#0.7506;CORD BLOOD#0.7504;END OF TREATMENT#0.7503;VILLOUS CYTOTROPHOBLAST#0.7501;HIGH CONTENT SCREENING#0.7497;HEMATOPOIESIS#0.7496;STEVENS-JOHNSON SYNDROME#0.7492;INTESTINAL CANCER#0.7492;UTERINE CANCER#0.7488;CHLORAMPHENICOL#0.7482;REFUSAL#0.7474;EPHRIN RECEPTOR#0.7473;REPRODUCTIVE SYSTEM#0.7472;SODIUM CHANNEL#0.7470;LUPUS NEPHRITIS#0.7470;TUMOR ENDOTHELIAL CELL#0.7466;INTRACELLULAR MEMBRANE#0.7465;VISMODEGIB#0.7464;MUSCLE FIBER#0.7464;VACUOLAR PROTEIN SORTING#0.7462;HEMIDESMOSOME#0.7462;PROTEIN KINASE D#0.7460;AMPA RECEPTOR#0.7460;CYTOPLASMIC VESICLE#0.7459;NASOPHARYNX#0.7450;INHIBITION OF BINDING#0.7448;GASTRIC EPITHELIUM#0.7447;RECEIVER OPERATING CURVE#0.7444;FLUORESCENCE CORRELATION SPECTROSCOPY#0.7442;OPTIC NERVE HEAD#0.7442;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7440;DIABETIC RETINOPATHY#0.7440;METABOLIC PROCESS#0.7440;MAP KINASE CASCADE#0.7438;CANCER TESTIS ANTIGEN#0.7437;IMC-A12#0.7436;VESICLE FORMATION#0.7435;THYMOCYTE#0.7428;TESTIS DEVELOPMENT#0.7423;MAPK SIGNAL TRANSDUCTION#0.7422;NORMAL CERVICAL TISSUE#0.7418;DEACETYLASE ACTIVITY#0.7417;GOOD MANUFACTURING PRACTICE#0.7412;COLLAGEN TYPE IV#0.7410;SIGNALING ADAPTOR#0.7409;CONTROLLED CLINICAL TRIALS#0.7402;GROWTH FACTOR ACTIVITY#0.7401;THYROID NODULE#0.7398;PAPILLARY RENAL CELL CARCINOMA#0.7396;VIRAL ENVELOPE#0.7395;BLOOD PRESSURE REGULATION#0.7391;STRIATED MUSCLE#0.7383;TOXICANT#0.7383;SEMINAL VESICLE#0.7382;HEALTHY CONTROL GROUP#0.7381;MRNA STABILIZATION#0.7378;GLUCOSE REGULATED PROTEIN#0.7377;LIVER LESIONS#0.7370;DIAGNOSTIC ODDS RATIO#0.7368;ARTERIOLE#0.7367;CLATHRIN HEAVY CHAIN#0.7353;SCHWANN CELL DEVELOPMENT#0.7352;MULTIVESICULAR ENDOSOME#0.7351;EARLY GASTRIC CANCER#0.7351;FK506 BINDING PROTEIN#0.7344;TH2 CELL#0.7343;LEAVE ONE OUT#0.7342;FK506 BINDING#0.7341;ADVANCED GLYCATION END#0.7338;DOPAMINE RECEPTOR#0.7337;OUTER MEMBRANE#0.7337;SKIN SQUAMOUS CELL CARCINOMA#0.7336;HUMAN LEUKOCYTE ANTIGEN#0.7334;NERVE FIBER#0.7330;RETINAL PIGMENT EPITHELIAL CELLS#0.7329;HOMOLOGOUS RECOMBINATION REPAIR#0.7326;SESSILE SERRATED ADENOMA#0.7324;ALVEOLAR MACROPHAGE#0.7321;ADULT STEM CELL#0.7320;LIPID SYNTHESIS#0.7317;PLACENTAL MEMBRANES#0.7312;HIGH THROUGHPUT SCREEN#0.7311;ISCHEMIC HEART DISEASE#0.7310;ENZALUTAMIDE#0.7310;DILATED CARDIOMYOPATHY#0.7310;G2 PHASE#0.7309;MACROPHAGE ACTIVATION#0.7306;FAILURE FREE SURVIVAL#0.7298;IMMUNE SUPPRESSION#0.7297;EPITHELIOID SARCOMA#0.7297;CELLULAR RETENTION#0.7286;C-SIS#0.7278;IL-1RA#0.7275;CYAN FLUORESCENT PROTEIN#0.7273;NEU SIGNALING#0.7272;MEMORY T CELL#0.7271;LIVER X RECEPTOR#0.7264;APLIDIN#0.7263;VASODILATOR#0.7261;PERIPHERAL BLOOD CELLS#0.7259;CYTOKINE INDUCED KILLER CELL#0.7257;HYPERCHOLESTEROLEMIA#0.7256;MODAL#0.7252;BONE RESORPTION#0.7247;KINESIN#0.7247;PNGASE F#0.7246;GRAFT VERSUS HOST#0.7244;GREEN TEA EXTRACT#0.7243;RANDOMIZED CONTROL TRIAL#0.7239;ORAL PREMALIGNANT LESIONS#0.7239;ASBESTOSIS#0.7234;FOLLICULAR THYROID CARCINOMA#0.7233;GASTRIC GLAND#0.7231;INSULINOMA#0.7230;NODAL SIGNALING#0.7229;GALL BLADDER#0.7223;WARM ISCHEMIA TIME#0.7222;NEUROLOGICAL DISORDER#0.7218;CORNEAL ENDOTHELIAL CELL#0.7215;FGFR SIGNALING PATHWAY#0.7212;MITOTIC CHECKPOINT#0.7210;MOTHERS AGAINST DECAPENTAPLEGIC#0.7208;COLLAGEN TYPE I#0.7208;PEPTIDE SYNTHESIS#0.7204;TRANSCRIPTION REGULATOR#0.7201;FORMIC ACID#0.7201;MITOCHONDRIAL LOCALIZATION#0.7201;PROXIMAL TUBULAR EPITHELIAL#0.7200;PROTEIN PROCESSING#0.7192;MULTIPLE SCLEROSIS#0.7189;INFLAMMATORY AIRWAY DISEASE#0.7186;NUCLEOSOME#0.7184;DIFFUSE ALVEOLAR DAMAGE#0.7184;MYOSIN PHOSPHATASE#0.7184;P53 BINDING#0.7182;SINGLE NUCLEOTIDE VARIATIONS#0.7181;NEPHROTOXIC#0.7181;PROTEIN TRANSPORT#0.7181;MEMBRANE ESTROGEN RECEPTOR#0.7180;NEVUS#0.7179;DIFFERENTIATED THYROID CANCER#0.7174;DNA REPAIR ENZYME#0.7171;CREATINE#0.7167;SURFACTANT PROTEIN D#0.7162;TONSIL CANCER#0.7162;HUMAN UROTHELIAL CELLS#0.7159;MUCOUS CELL METAPLASIA#0.7158;MESENCHYMAL STROMAL CELL#0.7157;FOLLICULAR PHASE#0.7156;MACROPHAGE POLARIZATION#0.7154;ECTODOMAIN CLEAVAGE#0.7151;REGULATION OF ANGIOGENESIS#0.7151;CYSTADENOMA#0.7147;GENETIC DISEASE#0.7141;CHROMATIN REMODELING COMPLEX#0.7135;GOITER#0.7135;HUNTINGTON'S DISEASE#0.7134;SEBORRHEIC KERATOSIS#0.7130;WISKOTT ALDRICH SYNDROME#0.7130;EFFECTOR T CELL#0.7126;COLLAGENASE TYPE IV#0.7126;BOMBESIN RECEPTOR#0.7125;GERMLINE STEM CELL#0.7125;RHINITIS#0.7122;PLURIPOTENT STEM CELL#0.7119;SH2 DOMAIN BINDING#0.7118;ANTIGEN PRESENTATION#0.7115;BLOOD GLUCOSE LEVEL#0.7114;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.7112;FEMALE BREAST CANCER#0.7110;NEURONAL CELL DEATH#0.7110;INSULIN SIGNALING PATHWAY#0.7109;ALLERGIC AIRWAY INFLAMMATION#0.7106;CROHN'S DISEASE#0.7102;ACUTE LEUKEMIA#0.7101;PHOTOSENSITIVITY#0.7100;COCHLEA#0.7097;CYCLIC GUANOSINE MONOPHOSPHATE#0.7096;ANGII TYPE 1#0.7090;CELL CYCLE TRANSITION#0.7089;MALARIA#0.7089;RNA HELICASE#0.7086;CACHEXIA#0.7086;INTRACELLULAR TRANSPORT#0.7085;PRIMARY EPITHELIAL CELLS#0.7076;HYPOPHOSPHATEMIA#0.7065;PROSTAGLANDIN RECEPTOR#0.7060;ALKALINE PHOSPHATASE ACTIVITY#0.7057;BRAIN NATRIURETIC PEPTIDE#0.7055;SUCCINATE#0.7054;OVARIAN SURFACE EPITHELIAL CELL#0.7053;PERIPHERAL NERVE INJURY#0.7045;MEMBRANE ORGANIZATION#0.7044;INSULIN BINDING#0.7042;METASTATIC ANAL CANCER#0.7042;INTERLEUKIN 4 RECEPTOR#0.7042;HIGH GLUCOSE LEVEL#0.7039;ESTIMATED BLOOD LOSS#0.7036;BLURRED VISION#0.7036;VESICULAR STOMATITIS VIRUS#0.7034;ANGIOTENSIN RECEPTOR BLOCKER#0.7032;ADO-TRASTUZUMAB EMTANSINE#0.7032;RAB COUPLING PROTEIN#0.7030;NEURAL CREST CELL#0.7030;VEGFR SIGNALING PATHWAY#0.7029;STROMAL SARCOMA#0.7019;MUTAGENIC#0.7017;STRESS FIBRE#0.7016;TRANSCRIPTION FACTOR BINDING#0.7016;PREDNISONE#0.7015;GLOBIN#0.7012;BLISTERING#0.7011;ENHANCED COMPUTED TOMOGRAPHY#0.7009;DUODENUM#0.7004;DIGITAL IMAGE ANALYSIS#0.6998;REGULATION OF AUTOPHAGY#0.6994;CIRCADIAN RHYTHM#0.6991;RUXOLITINIB#0.6990;PEARSON CORRELATION COEFFICIENT#0.6984;MUCINOUS NEOPLASM#0.6980;MENOPAUSE#0.6980;CALPAIN ACTIVITY#0.6977;NEOMYCIN#0.6973;COPY NUMBER VARIANTS#0.6972;BRADYKININ RECEPTOR#0.6966;RESPONSE TO ALDOSTERONE#0.6963;CANINE MAMMARY TUMORS#0.6963;INTERLEUKIN 8 PRODUCTION#0.6958;FURROW#0.6957;CRANIOPHARYNGIOMA#0.6957;INFERTILITY#0.6955;MEAN FLUORESCENCE INTENSITY#0.6951;INSOLUBLE FRACTION#0.6951;KERATINIZATION#0.6950;SOCIAL BEHAVIOR#0.6944;INNER NUCLEAR MEMBRANE#0.6937;BRONCHIOLE#0.6932;DUODENAL ULCER#0.6931;INTESTINAL TRACT#0.6930;CAMP SIGNALING#0.6929;PROVIRUS#0.
1957	IDIOPATHIC GENERALIZED EPILEPSY#0.7382;EPILEPSY#0.6353
195814	RETINOL DEHYDROGENASE#1.1104;RETINOL#0.9993;RETINOIC ACID#0.7766;HAIR GROWTH#0.6096
195827	CANCER CELL#0.7420
1958	STEROIDOGENIC FACTOR 1#1.0734;PROSTATE CARCINOMA#1.0566;MACROPHAGE DIFFERENTIATION#1.0527;SPECIFICITY PROTEIN 1#1.0487;PRIMARY RESPONSE GENE#1.0411;GM-CSF#1.0407;RESVERATROL#1.0345;ACTIVATOR PROTEIN 1#1.0316;DOMINANT NEGATIVE MUTANT#1.0308;EARLY GROWTH RESPONSE#1.0292;ETHANOL#1.0240;CAFFEINE#1.0237;ZINC FINGER PROTEIN#1.0229;DUAL SPECIFICITY PHOSPHATASE#1.0228;BETA CELL#1.0216;INTRACELLULAR SIGNALING CASCADE#1.0205;ACTIVATING TRANSCRIPTION FACTOR#1.0205;FIBROSARCOMA#1.0186;RNA INTERFERENCE#1.0185;MACROPHAGE INFLAMMATORY PROTEIN#1.0159;HISTONE ACETYLATION#1.0158;HYPOXIA INDUCIBLE FACTOR#1.0153;FORSKOLIN#1.0153;HALOPERIDOL#1.0152;THYMOCYTE#1.0146;REPORTER GENE ASSAY#1.0140;TRANSACTIVATION#1.0122;MESANGIAL CELL#1.0122;CAMP RESPONSE ELEMENT BINDING#1.0117;CARDIOMYOCYTE#1.0109;SMC PROLIFERATION#1.0109;HYPOXIA#1.0102;OLFACTORY BULB#1.0097;STROMAL CELL#1.0095;LUCIFERASE ACTIVITY#1.0091;PROSTATE CANCER#1.0084;B LYMPHOCYTE#1.0082;ADIPOCYTE#1.0081;SPINAL CORD#1.0071;CAMP RESPONSE ELEMENT#1.0068;KERATINOCYTE#1.0067;MUTAGENESIS#1.0065;FACTOR I#1.0064;NEUROBLASTOMA#1.0062;BREAST CANCER CELL#1.0058;COLONY-STIMULATING FACTOR#1.0050;ELECTROPHORETIC MOBILITY SHIFT#1.0050;EMBRYONAL CARCINOMA#1.0049;SERUM RESPONSE FACTOR#1.0044;SIGNAL TRANSDUCER#1.0042;MICROVASCULAR ENDOTHELIAL CELL#1.0039;TRANSCRIPTION FACTOR#1.0029;HYPOXIC#1.0028;VASCULAR DISEASE#1.0026;MAPK SIGNALING#1.0024;CELLULAR GROWTH#1.0018;CALCINEURIN#1.0015;PHENYLETHANOLAMINE N METHYLTRANSFERASE#1.0013;GRANULOSA CELL#1.0010;INSULIN RECEPTOR#1.0004;GRANULOCYTE#1.0000;ASTROCYTE#0.9998;SQUAMOUS CELL CARCINOMA#0.9997;GLUCOCORTICOID RECEPTOR#0.9996;COLORECTAL CANCER#0.9995;LONG TERM POTENTIATION#0.9994;STRIATUM#0.9994;FRONTAL#0.9994;GASTRIC MUCOSA#0.9991;TRANSCRIPTIONAL CONTROL#0.9989;VASCULAR SMOOTH MUSCLE CELL#0.9988;VIRAL REPLICATION#0.9985;DENTATE GYRUS#0.9984;ENDOTHELIAL GROWTH FACTOR#0.9982;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9982;ACTIVATED T-CELLS#0.9978;TRANSFORMING GROWTH FACTOR BETA#0.9978;THALAMUS#0.9975;TRANSCRIPTION FACTOR BINDING#0.9974;B CELL#0.9973;AUTOPHAGY#0.9973;ACETYLCHOLINE RECEPTOR#0.9972;N METHYLTRANSFERASE#0.9970;ACTIVATED T CELL#0.9968;TRANSCRIPTASE#0.9957;OXYGENASE#0.9956;S PHASE#0.9953;ISCHEMIA REPERFUSION INJURY#0.9952;INSULIN-LIKE GROWTH FACTOR#0.9945;HEME OXYGENASE 1#0.9945;CHLORAMPHENICOL#0.9943;BREAST CARCINOMA#0.9942;PROTEASOME#0.9942;NMDA RECEPTOR#0.9939;CELL MIGRATION#0.9934;GLIAL CELL#0.9931;AMYGDALA#0.9931;DNA METHYLATION#0.9931;GENE SILENCING#0.9931;RETINOIC ACID#0.9930;ISCHEMIA#0.9930;MYELOID LEUKEMIA#0.9926;HEPATOCELLULAR CARCINOMA#0.9926;OSTEOBLAST#0.9924;DNA BINDING#0.9923;SIGNALING CASCADE#0.9920;MACROPHAGE#0.9917;MAP KINASE#0.9917;CEREBRAL CORTEX#0.9917;SMOOTH MUSCLE CELL#0.9912;COLON CANCER#0.9912;WOUND HEALING#0.9910;CONTEXTUAL FEAR CONDITIONING#0.9909;EPIDERMAL GROWTH FACTOR#0.9909;ANDROGEN RECEPTOR#0.9908;FOREBRAIN#0.9900;ESOPHAGEAL CARCINOMA#0.9900;LUNG CANCER#0.9899;HISTONE DEACETYLASE#0.9898;TUMOR NECROSIS FACTOR#0.9897;TUMOR SUPPRESSOR#0.9891;PROGENITOR CELL#0.9891;SCHWANN CELL#0.9890;VSMC PROLIFERATION#0.9890;CYCLIC AMP#0.9888;SMOOTH MUSCLE#0.9886;PROTEIN KINASE A#0.9885;NERVE GROWTH FACTOR#0.9885;KINASE INHIBITOR#0.9885;PROTEIN KINASE C#0.9884;PROTEIN BINDING#0.9883;MITOGEN ACTIVATED PROTEIN#0.9882;QUANTITATIVE REAL TIME#0.9878;NEUTROPHIL#0.9875;PRO-INFLAMMATORY#0.9873;COLORECTAL#0.9873;BREAST CANCER#0.9871;PLATELET-DERIVED GROWTH FACTOR#0.9866;MONOCYTE#0.9862;HEAT SHOCK PROTEIN#0.9860;TERMINAL DIFFERENTIATION#0.9860;FIBROBLAST GROWTH FACTOR#0.9855;KINASE ACTIVITY#0.9853;CELL DEATH#0.9849;CYCLIN DEPENDENT KINASE#0.9849;MUSCLE CELL#0.9848;COLLAGEN SYNTHESIS#0.9848;LONG TERM MEMORY#0.9846;MEDIAL PREFRONTAL CORTEX#0.9846;VASCULAR CELL#0.9846;TRANSFORMING GROWTH FACTOR#0.9845;AKT SIGNALING#0.9845;CELL ACTIVATION#0.9844;ENHANCER BINDING#0.9842;ENHANCER BINDING PROTEIN#0.9841;MYELOID CELL#0.9840;SKELETAL MUSCLE#0.9840;CELL DIFFERENTIATION#0.9838;REVERSE TRANSCRIPTION#0.9837;NITRIC OXIDE#0.9830;ACETYLCHOLINE#0.9830;ADENOSINE#0.9830;GROWTH FACTOR RECEPTOR#0.9828;CELL GROWTH#0.9825;NEURITE OUTGROWTH#0.9821;PROTEIN SYNTHESIS#0.9820;ADENOCARCINOMA#0.9820;PROTEIN KINASE#0.9818;THYMIDINE KINASE#0.9816;ASPARTATE#0.9815;PEROXISOME#0.9813;ATHEROSCLEROSIS#0.9811;ANGIOGENESIS#0.9810;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9808;MOUSE EMBRYONIC FIBROBLAST#0.9808;CYCLOSPORIN A#0.9806;OVARIAN#0.9804;TELENCEPHALON#0.9803;CANCER CELL#0.9802;ATHEROSCLEROTIC#0.9802;IFN-GAMMA#0.9801;POLYMERASE CHAIN REACTION#0.9798;ARTERY#0.9792;ROS GENERATION#0.9792;NITRIC OXIDE SYNTHASE#0.9790;SMOOTH MUSCLE CELL PROLIFERATION#0.9790;LIVER REGENERATION#0.9790;THYMIDINE#0.9788;MUSCLE CELL PROLIFERATION#0.9787;REACTIVE OXYGEN SPECIES#0.9784;BONE MARROW#0.9782;RENAL FIBROSIS#0.9779;T CELL#0.9779;CELL ADHESION#0.9776;RESPONSE TO STRESS#0.9769;GONADOTROPIN RELEASING HORMONE#0.9767;APOPTOSIS#0.9767;T LYMPHOCYTE#0.9764;CELL CYCLE ARREST#0.9763;GROWTH FACTOR#0.9763;DOPAMINE#0.9762;VASOPRESSIN#0.9762;NEURITE#0.9759;INFLAMMATORY RESPONSE#0.9751;ESTROGEN RECEPTOR#0.9750;ONCOGENIC#0.9749;APOPTOTIC#0.9748;RHEUMATOID ARTHRITIS#0.9747;ENDOTHELIAL CELL#0.9744;TUMOR CELLS#0.9743;CHONDROCYTE#0.9742;EPITHELIAL CELL#0.9741;SUPEROXIDE DISMUTASE#0.9736;SIGNALING MOLECULE#0.9735;CELL DEVELOPMENT#0.9733;DOXORUBICIN#0.9733;CYTOPLASM#0.9732;ESTRADIOL#0.9730;CELL PROLIFERATION#0.9730;SIGNALING PATHWAY#0.9729;QUANTITATIVE REVERSE TRANSCRIPTION#0.9723;GLUTAMATE RECEPTOR#0.9722;DIFFERENTIAL GENE EXPRESSION#0.9721;HEPATOCELLULAR CARCINOMA CELL#0.9719;FATTY LIVER#0.9715;MESENCHYMAL STEM CELL#0.9714;STEM CELL#0.9713;CISPLATIN#0.9711;EXTRACELLULAR MATRIX#0.9708;BLOOD VESSEL#0.9707;RECEPTOR AGONIST#0.9705;DNA SYNTHESIS#0.9703;CELL SURFACE#0.9703;CELL CYCLE#0.9701;HISTONE DEACETYLASE INHIBITOR#0.9693;SIGNALLING PATHWAY#0.9691;CELL CYCLE REGULATOR#0.9690;PROSTAGLANDIN E2#0.9679;NEURONAL CELLS#0.9678;VASCULAR ENDOTHELIAL CELL#0.9678;CAMKII#0.9676;PROTEIN PROTEIN INTERACTION#0.9675;FACTOR S#0.9675;PERIPHERAL BLOOD#0.9674;REGENERATION#0.9674;OVARIAN CANCER#0.9669;PHOSPHOLIPASE C#0.9666;ACUTE MYELOID LEUKEMIA#0.9666;RECEPTOR ANTAGONIST#0.9664;HYPERTENSION#0.9656;CONNECTIVE TISSUE#0.9649;IMMUNE RESPONSE#0.9642;UMBILICAL VEIN#0.9638;DIABETIC NEPHROPATHY#0.9637;CELL DIVISION#0.9636;CENTRAL NERVOUS SYSTEM#0.9634;ENDOPLASMIC RETICULUM#0.9634;SIGNAL TRANSDUCTION#0.9634;GLUTATHIONE#0.9634;TOLL LIKE RECEPTOR#0.9633;SCIATIC NERVE#0.9625;SKIN FIBROBLASTS#0.9623;AORTIC SMOOTH MUSCLE CELLS#0.9620;CYTOTOXICITY#0.9618;HUMAN UMBILICAL VEIN#0.9618;ALZHEIMER'S DISEASE#0.9616;HERPES SIMPLEX#0.9612;CREB BINDING#0.9611;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9607;LYMPH NODE#0.9601;ORNITHINE DECARBOXYLASE#0.9599;ADRENAL MEDULLA#0.9598;HERPES SIMPLEX VIRUS#0.9597;ENDOTHELIUM#0.9590;DEXAMETHASONE#0.9588;LOW DENSITY LIPOPROTEIN#0.9585;PROTEIN PHOSPHORYLATION#0.9584;TENDON FORMATION#0.9582;PROGESTERONE#0.9578;GENE EXPRESSION#0.9574;INTRACELLULAR SIGNALING PATHWAY#0.9573;UTERUS#0.9569;G-CSF#0.9567;MYOCARDIUM#0.9565;COAGULATION#0.9565;SENESCENCE#0.9554;NERVOUS SYSTEM#0.9552;T CELL ACTIVATION#0.9547;TOXICITY#0.9534;GENISTEIN#0.9518;MECHANISM OF ACTION#0.9517;HISTONE MODIFICATION#0.9510;MIDDLE CEREBRAL ARTERY#0.9506;CEREBRAL ARTERY#0.9504;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.9489;EXTRACELLULAR REGULATED KINASE#0.9480;ACUTE PANCREATITIS#0.9480;RESPONSE TO IONIZING RADIATION#0.9479;DNASE I#0.9473;REGULATION OF GENE EXPRESSION#0.9473;MONONUCLEAR CELLS#0.9472;PERTUSSIS#0.9469;PHOSPHATASE AND TENSIN HOMOLOG#0.9468;PULMONARY HYPERTENSION#0.9468;LEUKOCYTE#0.9464;NOXIOUS#0.9461;HEMATOPOIETIC CELL#0.9457;SENSITIZATION#0.9455;FIBROSARCOMA CELLS#0.9447;ARACHIDONIC ACID#0.9443;MYOCYTES#0.9434;DUAL LUCIFERASE REPORTER#0.9433;BONE MARROW CELLS#0.9430;MIDBRAIN#0.9423;HEPATOMA CELLS#0.9421;MALIGNANT GLIOMA#0.9416;MYOFIBROBLAST#0.9415;LYSINE#0.9414;INDUCTION OF APOPTOSIS#0.9413;HEPATOCYTE GROWTH FACTOR#0.9413;HEMATOPOIETIC STEM CELL#0.9393;MYOSIN HEAVY CHAIN#0.9389;LIPID METABOLISM#0.9387;COMPLEX I#0.9387;B CELL LYMPHOMA#0.9382;PULMONARY FIBROSIS#0.9379;G1 PHASE#0.9374;BINDING PROTEIN 1#0.9373;NEPHROPATHY#0.9350;REGULATION OF CELL GROWTH#0.9348;SPATIAL LEARNING#0.9344;GENE EXPRESSION OMNIBUS#0.9343;MAST CELL#0.9340;OVULATION#0.9338;GROWTH HORMONE#0.9331;RECEPTOR TYROSINE KINASE#0.9328;LUNG FIBROBLASTS#0.9322;MICROTUBULE#0.9321;ARGININE#0.9317;PROGRAMMED CELL DEATH#0.9314;CYCLOSPORIN#0.9312;UBIQUITIN#0.9310;CD4+ T CELL#0.9306;TUMOR TISSUES#0.9300;CARBACHOL#0.9293;PROTEIN TYROSINE KINASE#0.9291;SMOOTH MUSCLE ACTIN#0.9283;PANCREATITIS#0.9263;INDUCIBLE NITRIC OXIDE#0.9261;LOCUS COERULEUS#0.9257;ADIPOSE TISSUE#0.9255;CELL ADHESION MOLECULE#0.9253;TYPE 2 DIABETES#0.9248;CELLULAR TRANSCRIPTION#0.9246;ADRENAL GLAND#0.9236;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9229;INTESTINAL EPITHELIAL CELL#0.9228;PULMONARY ARTERY#0.9220;GRANULOCYTE COLONY STIMULATING FACTOR#0.9215;LUNG ADENOCARCINOMA#0.9202;ERK CASCADE#0.9186;CD8+ T CELL#0.9165;BRAIN DEVELOPMENT#0.9164;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9164;ADVANCED GLYCATION END#0.9160;TYROSINE KINASE INHIBITOR#0.9159;TUBE FORMATION#0.9158;CORONARY ARTERY#0.9157;EPSTEIN BARR VIRUS#0.9153;AMACRINE CELL#0.9151;DRUG RESISTANCE#0.9146;DNA REPAIR#0.9142;HUMAN BREAST CANCER#0.9142;RESPONSE TO OXIDATIVE STRESS#0.9139;DUODENAL ULCER#0.9134;QUERCETIN#0.9119;SKELETAL MUSCLE CELLS#0.9116;MYELODYSPLASTIC SYNDROME#0.9115;KIDNEY DISEASE#0.9110;NEUROGENESIS#0.9108;NOREPINEPHRINE#0.9092;INFLAMMATORY CELL#0.9089;CEREBRAL ARTERY OCCLUSION#0.9080;IMMUNE SYSTEM#0.9054;TISSUE GROWTH FACTOR#0.9049;PROSTAGLANDIN E SYNTHASE#0.9042;APOPTOTIC CELL DEATH#0.9039;DNASE#0.9035;MAPK ACTIVATION#0.9023;PLASMA MEMBRANE#0.9014;ACTINOMYCIN D#0.9011;CAROTID ARTERY#0.9010;EMBRYO IMPLANTATION#0.9000;FLUID SHEAR STRESS#0.8993;PHEOCHROMOCYTOMA#0.8990;CIGARETTE SMOKE EXTRACT#0.8965;DERMAL FIBROBLAST#0.8960;CANNABINOID RECEPTOR#0.8957;NEUROTOXICITY#0.8957;INFERIOR COLLICULUS#0.8945;DIABETES MELLITUS#0.8944;COGNITION#0.8927;RAPAMYCIN#0.8924;LEYDIG CELL#0.8923;HEMATOPOIESIS#0.8917;PANCREATIC CANCER#0.8911;EPITHELIAL MESENCHYMAL TRANSITION#0.8908;HOST CELL#0.8892;HEART DISEASE#0.8888;PROTEIN COMPLEX#0.8880;SUBSTANCE P#0.8874;BILE DUCT#0.8864;MONOCYTE CHEMOTACTIC PROTEIN#0.8856;NUCLEAR LOCALIZATION SIGNAL#0.8840;VIRAL INFECTION#0.8827;ANISOMYCIN#0.8817;LDL RECEPTOR#0.8811;CYTOCHROME P450#0.8801;BASAL GANGLIA#0.8784;GROWTH FACTOR BINDING#0.8784;MEMORY IMPAIRMENT#0.8778;CYSTEAMINE#0.8776;EMBRYONIC KIDNEY#0.8768;LUNG CARCINOMA#0.8748;ACINAR CELL#0.8721;ESOPHAGEAL CANCER#0.8716;HEPARIN#0.8706;PROTEIN KINASE INHIBITOR#0.8703;CYCLIN DEPENDENT KINASE INHIBITOR#0.8692;HYPOTHALAMIC PITUITARY ADRENAL#0.8671;PERIPHERAL NERVE#0.8670;IONOPHORE#0.8670;TROGLITAZONE#0.8654;SYNOVIAL SARCOMA#0.8648;RNA BINDING#0.8642;ORNITHINE#0.8637;CYTOCHROME C#0.8618;FLUOROURACIL#0.8599;THROMBOSIS#0.8581;CHROMATIN REMODELING#0.8580;PROTEIN TYROSINE PHOSPHATASE#0.8578;NICOTINIC ACETYLCHOLINE RECEPTOR#0.8574;GENOTOXIC#0.8573;LIVER CANCER#0.8563;CALCIUM CHANNEL#0.8560;ADRENERGIC RECEPTOR#0.8546;SUMOYLATION#0.8533;SEPTUM#0.8531;MAP KINASE KINASE#0.8529;HYPOXIA RESPONSE ELEMENT#0.8508;KUPFFER CELL#0.8506;IMMUNE CELL#0.8502;GASTRIC EPITHELIAL CELLS#0.8500;B CELL RECEPTOR#0.8496;DNA FRAGMENTATION#0.8484;BONE MARROW STROMAL#0.8483;PITUITARY GLAND#0.8449;MORRIS WATER MAZE#0.8447;PLASMA CELL#0.8447;5 FLUOROURACIL#0.8434;DECIDUALIZATION#0.8432;ASTROCYTOMA#0.8429;NADPH OXIDASE#0.8424;INGENUITY PATHWAY ANALYSIS#0.8415;HEPATOCYTE NUCLEAR FACTOR#0.8414;ERYTHROLEUKEMIA#0.8409;ISOFLURANE#0.8405;CYTOKINE PRODUCTION#0.8397;DENDRITIC CELL#0.8366;LUNG EPITHELIAL CELL#0.8365;HUMAN EMBRYONIC KIDNEY#0.8358;ARSENITE#0.8354;PROTEASE ACTIVATED RECEPTOR#0.8353;PROTEIN KINASE ACTIVATION#0.8340;OSTEOARTHRITIS#0.8335;SCLERODERMA#0.8331;BETA-2#0.8328;MITOCHONDRIA#0.8309;PRECURSOR CELL#0.8305;MYOCARDIAL INFARCTION#0.8297;HYPERGLYCEMIA#0.8295;TRANSCRIPTION REGULATOR#0.8280;ROSIGLITAZONE#0.8280;ANCHORAGE INDEPENDENT GROWTH#0.8278;NUCLEIC ACID#0.8270;PIOGLITAZONE#0.8262;BETA GALACTOSIDASE#0.8249;M PHASE#0.8248;CYCLOPHOSPHAMIDE#0.8242;DNA REPLICATION#0.8236;TNF-ALPHA PRODUCTION#0.8227;DOPAMINE RECEPTOR#0.8216;LIVER DISEASE#0.8215;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8214;EPITHELIAL TO MESENCHYMAL#0.8211;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8196;NEURAL CELL#0.8196;INSULINOMA#0.8195;SELECTIN#0.8183;HIGH MOBILITY GROUP#0.8182;GANGLION CELLS#0.8181;MECHANISMS OF ACTION#0.8172;CEREBRAL ISCHEMIA#0.8171;LEUCINE#0.8170;IL-8 PRODUCTION#0.8165;CERVICAL#0.8160;TUMOUR NECROSIS FACTOR#0.8154;EPILEPSY#0.8137;OLIGODENDROCYTE#0.8134;MEGAKARYOCYTE#0.8133;CYTOKINE RECEPTOR#0.8129;CIRCADIAN RHYTHM#0.8115;UROKINASE#0.8113;MORPHOGENESIS#0.8097;CYSTITIS#0.8094;CHEMOKINE PRODUCTION#0.8090;CELL CYCLE CONTROL#0.8087;HEPATIC STELLATE CELL#0.8079;QUANTITATIVE REVERSE TRANSCRIPTASE#0.8076;PKCBETA#0.8072;TISSUE REMODELING#0.8060;GESTATION#0.8059;RECEPTOR LIGAND#0.8058;LUTEINIZING HORMONE BETA SUBUNIT#0.8058;SUBSTANTIA NIGRA#0.8052;ADENYLATE CYCLASE#0.8048;INTERNEURON#0.8015;TESTOSTERONE#0.8006;INTERSTITIAL CELL#0.8006;BONE FORMATION#0.8002;ALANINE#0.7997;MEMBRANE TYPE 1#0.7988;N-ACETYLCYSTEINE#0.7974;THYROID HORMONE RECEPTOR#0.7972;SULINDAC#0.7960;CHROMAFFIN CELL#0.7948;LEUKEMIA INHIBITORY FACTOR#0.7945;FATTY ACID SYNTHASE#0.7945;QUIESCENCE#0.7941;AMPA RECEPTOR#0.7937;OPTIC NERVE#0.7928;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7920;MYOTUBE#0.7917;COLLAGENASE#0.7912;ADENOSINE MONOPHOSPHATE#0.7906;PROTEIN KINASE B#0.7903;MICROTUBULE ASSOCIATED PROTEIN#0.7889;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7883;SYNAPTIC TRANSMISSION#0.7873;ANGIOTENSIN CONVERTING ENZYME#0.7871;OSTEOCLAST#0.7870;METFORMIN#0.7862;POST-TRANSLATIONAL MODIFICATION#0.7859;MAP KINASE PHOSPHATASE#0.7857;EMBRYONIC STEM CELL#0.7850;MEDULLARY CELL#0.7839;REGULATION OF GROWTH#0.7830;PI3K SIGNALING#0.7823;HUMAN MESENCHYMAL STEM#0.7796;NEUROPROTECTION#0.7795;ANGIOGENIC GROWTH FACTORS#0.7795;EPINEPHRINE#0.7792;ARTERIOGENESIS#0.7791;MITOCHONDRIAL MEMBRANE#0.7765;CERVICAL CANCER#0.7751;L-DOPA#0.7749;SOCIAL BEHAVIOR#0.7749;CYCLIC ADENOSINE MONOPHOSPHATE#0.7749;SILICOSIS#0.7744;WHITE BLOOD CELL#0.7708;TRANSCRIPTIONAL REGULATORY NETWORK#0.7702;MAST CELL ACTIVATION#0.7696;MATERNAL BEHAVIOR#0.7695;OBESE#0.7674;P53 SIGNALING PATHWAY#0.7674;B CELL DEVELOPMENT#0.7659;MELATONIN#0.7652;PACLITAXEL#0.7642;MYOBLAST#0.7641;OOCYTE#0.7622;STREPTOZOTOCIN#0.7622;RESPONSE TO GM-CSF#0.7620;CELLULAR LOCALIZATION#0.7619;SERTOLI CELL#0.7618;LINES OF EVIDENCE#0.7611;GLYCOGEN SYNTHASE KINASE#0.7608;FOCAL ADHESION#0.7600;CRE BINDING#0.7595;INHIBITION OF CELL PROLIFERATION#0.7579;PARKINSON'S DISEASE#0.7569;HEMATOPOIETIC PROGENITOR CELL#0.7565;NEURITE EXTENSION#0.7563;TRANSCRIPTION ACTIVATOR#0.7559;STROMA#0.7554;CHOLESTASIS#0.7554;DEPHOSPHORYLATION#0.7553;AMYLOID PRECURSOR PROTEIN#0.7546;GLOMERULONEPHRITIS#0.7523;PROPOFOL#0.7520;INDOMETHACIN#0.7512;SPHINGOSINE#0.7506;OVARIES#0.7487;ION CHANNEL#0.7481;CALYCULIN A#0.7469;KETAMINE#0.7460;RESPONSE TO HYPOXIA#0.7448;NECROTIC#0.7445;VIRAL GENE EXPRESSION#0.7439;BONE MARROW STROMAL CELL#0.7426;WNT SIGNALING PATHWAY#0.7424;ENDOTHELIAL CELL PROLIFERATION#0.7414;SRC FAMILY KINASE#0.7412;ANTI INFLAMMATORY DRUGS#0.7407;MRNA TRANSCRIPTION#0.7391;GUANINE#0.7390;CHEMOKINE RECEPTOR#0.7384;HIGH FAT DIET#0.7376;MESENCHYMAL CELL#0.7370;L-CYSTEINE#0.7355;ROS FORMATION#0.7355;INSULIN RECEPTOR SUBSTRATE#0.7354;BINDING PROTEIN 3#0.7351;NUCLEOSOME#0.7346;COLON CARCINOMA#0.7343;DNA METHYLTRANSFERASE#0.7337;EARLY LIFE STRESS#0.7320;ARGININE VASOPRESSIN#0.7320;GEFITINIB#0.7319;T-CELL LEUKEMIA#0.7312;PROTEIN TYROSINE KINASE ACTIVITY#0.7294;MULTIPLE MYELOMA#0.7275;ANTERIOR CINGULATE CORTEX#0.7275;BONE MORPHOGENETIC PROTEIN#0.7270;MONOCYTIC LEUKEMIA#0.7253;PROTEIN INTERACTION NETWORK#0.7251;EARLY TIME POINT#0.7250;DOPAMINE D1 RECEPTOR#0.7250;BILE DUCT LIGATION#0.7244;FALSE DISCOVERY RATE#0.7238;B CELL ACTIVATION#0.7219;INHIBITION OF CELL GROWTH#0.7206;PERIPHERAL NERVOUS SYSTEM#0.7201;RETINAL GANGLION CELL#0.7200;MITHRAMYCIN#0.7194;POSTSYNAPTIC DENSITY#0.7192;PURKINJE CELL#0.7189;ENDOPLASMIC RETICULUM STRESS#0.7187;WHITE ADIPOSE TISSUE#0.7185;RIBOSOMAL PROTEIN#0.7181;ONCOGENESIS#0.7178;ATROPINE#0.7170;NEUROTRANSMISSION#0.7167;WAKEFULNESS#0.7160;ILEUS#0.7157;AUTOIMMUNE DISEASE#0.7155;CHOLINE#0.7155;CORONARY HEART DISEASE#0.7148;BETA SELECTION#0.7135;DORSAL ROOT GANGLION#0.7128;HINDBRAIN#0.7124;MYELINATION#0.7089;MOTOR BEHAVIOR#0.7080;MRNA STABILIZATION#0.7077;HYPERACTIVITY#0.7067;SALIVARY GLAND#0.7067;PROSTAGLANDIN ENDOPEROXIDE SYNTHASE#0.7015;ALKALINE PHOSPHATASE#0.7011;HISTONE ACETYLTRANSFERASE#0.7010;MEGAKARYOCYTE DIFFERENTIATION#0.7008;ISOPROTERENOL#0.6997;AIRWAY SMOOTH MUSCLE#0.6997;LEIOMYOMA#0.6997;TUBULAR EPITHELIAL CELL#0.6994;MEDIUM SPINY NEURONS#0.6992;DEMETHYLATION#0.6992;VIRAL GENOME#0.6986;HUMAN BRONCHIAL EPITHELIAL#0.6985;ACUTE PHASE RESPONSE#0.6984;ADENYLATE#0.6975;NF KAPPAB BINDING#0.6964;TYROSINE KINASE RECEPTOR#0.6964;HEPATOCYTE PROLIFERATION#0.6958;CELL CYCLE REGULATION#0.6957;HEPARIN BINDING#0.6957;MAPK CASCADE#0.6948;TIGHT JUNCTION#0.6940;ACETYLCYSTEINE#0.6939;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6935;PKC ACTIVATION#0.6928;ENDOCYTOSIS#0.6926;AMITRIPTYLINE#0.6925;NEURODEGENERATIVE DISEASE#0.6918;REPRESSOR ELEMENT 1#0.6918;1α,25-DIHYDROXYVITAMIN D3#0.6916;PKB SIGNALING#0.6892;NF-KAPPAB ACTIVATION#0.6881;UMBILICAL CORD#0.6881;PREGNENOLONE#0.6861;ACUTE LIVER INJURY#0.6860;IMPORTIN#0.6859;PROTEOGLYCAN#0.6855;PULMONARY ARTERIAL HYPERTENSION#0.6840;ANTISENSE RNA#0.6836;GANCICLOVIR#0.6836;SEROTONIN RECEPTOR#0.6828;FEMORAL ARTERY LIGATION#0.6823;BETA ADRENOCEPTOR#0.6812;72-HOURS#0.6809;LOSARTAN#0.6805;EMODIN#0.6795;ACTIN CYTOSKELETON#0.6793;TISSUE DAMAGE#0.6791;POLY ADP RIBOSE#0.6789;SUCROSE#0.6789;SMALL HETERODIMER PARTNER#0.6760;RAPID EYE MOVEMENT#0.6754;PHOTORECEPTOR CELL#0.6744;SYSTEM DEVELOPMENT#0.6732;SUPERIOR COLLICULUS#0.6729;MOUSE EMBRYO FIBROBLASTS#0.6729;NEONATAL RAT CARDIOMYOCYTES#0.6723;GLUCONEOGENESIS#0.6722;LH RECEPTOR#0.6720;TRIGLYCERIDE LIPASE#0.6714;NEUROFILAMENT#0.6704;MELANOCYTE#0.6694;INSULIN BINDING#0.6688;RESPONSE TO TREATMENT#0.6686;DOPAMINERGIC NEURON#0.6683;UROKINASE PLASMINOGEN ACTIVATOR#0.6680;HOMOLOGOUS RECOMBINATION#0.6677;RELATED PROTEIN 1#0.6671;NUCLEAR IMPORT#0.6669;PHOSPHOLIPASE D#0.6663;ACTIVATION OF NF-KAPPAB#0.6663;TARGET OF RAPAMYCIN#0.6660;NEURONAL CELL DEATH#0.6643;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6641;BLEOMYCIN#0.6641;CARCINOGEN#0.6616;HISTIDINE#0.6607;EPIGALLOCATECHIN#0.6606;NATURAL KILLER CELL#0.6594;ADIPOCYTE DIFFERENTIATION#0.6589;PODOCYTE#0.6580;LITHIUM#0.6580;INNERVATION#0.6577;ALVEOLAR EPITHELIAL CELL#0.6563;RESPONSE TO LPS#0.6561;T CELL DEVELOPMENT#0.6557;SPHINGOSINE 1 PHOSPHATE#0.6548;SENSORY PROCESSING#0.6544;TENDON DEVELOPMENT#0.6532;TRANSIENT RECEPTOR POTENTIAL#0.6524;UNFOLDED PROTEIN RESPONSE#0.6520;PROMOTER BINDING#0.6501;BLOOD BRAIN BARRIER#0.6501;GABAERGIC NEURON#0.6500;PROTEIN KINASE C ACTIVITY#0.6497;PERIODONTAL LIGAMENT#0.6486;CELL MEMBRANE#0.6486;SEQUENCE SPECIFIC DNA BINDING#0.6485;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.6476;CELLULAR SENESCENCE#0.6475;MITOSIS#0.6472;LOCOMOTION#0.6466;GENE REGULATORY NETWORK#0.6465;CORTICOTROPIN#0.6465;MRNA SYNTHESIS#0.6462;FIBROBLAST PROLIFERATION#0.6460;NEUROTOXIC#0.6447;CHEMOTAXIS#0.6438;CANCER STEM CELL#0.6436;PHENYLEPHRINE#0.6431;PYRAMIDAL CELL#0.6424;VACCINIA#0.6414;CYTOCHROME C OXIDASE#0.6405;RNA BINDING PROTEIN#0.6403;GONAD#0.6402;HISTAMINE#0.6397;MODE OF ACTION#0.6390;GERANYLGERANYL DIPHOSPHATE#0.6362;ADULT RAT CARDIOMYOCYTES#0.6338;RESPONSE TO GNRH#0.6319;BUSERELIN#0.6305;G0 TO G1 TRANSITION#0.6284;TOOTH DEVELOPMENT#0.6284;MELATONIN RECEPTOR#0.6282;PSORIASIS#0.6267;RESPONSE TO PMA#0.6263;MULTIPLE SCLEROSIS#0.6259;ENDOTHELIAL CELL MIGRATION#0.6256;ESTROUS CYCLE#0.6236;IL-11#0.6221;PHOSPHATASE ACTIVITY#0.6213;TAMOXIFEN#0.6213;MARROW STROMAL CELLS#0.6209;SHORT TERM MEMORY#0.6194;FIBROBLAST ACTIVATION#0.6189;OVARIAN CARCINOMA#0.6185;TELOMERASE REVERSE TRANSCRIPTASE#0.6182;L-ARGININE#0.6180;GLUCOSE UPTAKE#0.6169;AIRWAY EPITHELIUM#0.6155;GABA A RECEPTOR#0.6148;HYPERGLYCEMIC#0.6145;OESTRADIOL#0.6139;ATORVASTATIN#0.6137;STEROL REGULATORY ELEMENT#0.6133;TELOMERE#0.6129;ASPIRIN#0.6127;VALPROIC ACID#0.6119;FORMALIN#0.6115;CLEAVED CASPASE 3#0.6111;VOCAL LEARNING#0.6109;CENTROMERE#0.6108;2'-DEOXYURIDINE#0.6106;LYMPHOID CELL#0.6100;INFLAMMATORY BOWEL DISEASE#0.6087;3,4-METHYLENEDIOXYMETHAMPHETAMINE#0.6078;RHABDOMYOSARCOMA#0.6077;FOLLICLE STIMULATING HORMONE#0.6069;GABA B RECEPTOR#0.6047;ANEMIA#0.6043;HIPPOCAMPAL DENTATE GYRUS#0.6041;ENZYME ACTIVITY#0.6034;HUMAN INTESTINAL EPITHELIAL#0.6034;MYELOID NEOPLASM#0.6021;C FIBER#0.6018;ERYTHROPOIETIN RECEPTOR#0.6011;MYELOID CELL DIFFERENTIATION#0.6001
1959	HINDBRAIN DEVELOPMENT#1.0602;SCHWANN CELL DEVELOPMENT#1.0464;MYELIN PROTEIN ZERO#1.0385;EARLY GROWTH RESPONSE#1.0324;RHOMBOMERE#1.0288;ZINC FINGER PROTEIN#1.0272;T CELL ANERGY#1.0268;SCHWANN CELL DIFFERENTIATION#1.0258;MYELINATION#1.0227;HINDBRAIN#1.0193;CELL DEVELOPMENT#1.0158;NKT CELL#1.0136;MACROPHAGE#1.0079;CD4+ T CELL#1.0072;SCHWANN CELL#1.0065;TRANSCRIPTION FACTOR#1.0035;T CELL#1.0013;CHARCOT MARIE TOOTH#1.0006;NEUROPATHY#1.0004;CHARCOT-MARIE-TOOTH DISEASE#1.0003;TOOTH DISEASE#1.0002;DNA BINDING#0.9988;CELL DIFFERENTIATION#0.9978;CELL CYCLE#0.9950;SCIATIC NERVE#0.9939;PERIPHERAL NERVE#0.9926;NEURAL CREST CELL#0.9921;B CELL#0.9912;GROWTH FACTOR#0.9891;RETINOIC ACID#0.9890;POLYMERASE CHAIN REACTION#0.9876;NEURAL CREST#0.9870;SIGNALING PATHWAY#0.9861;CELL PROLIFERATION#0.9860;NEURAL TUBE#0.9852;PERIPHERAL NERVOUS SYSTEM#0.9844;IMMUNE RESPONSE#0.9843;CELL ACTIVATION#0.9818;PROTEIN KINASE#0.9779;APOPTOSIS#0.9774;CENTRAL NERVOUS SYSTEM#0.9730;NERVOUS SYSTEM#0.9712;T CELL ACTIVATION#0.9690;STEM CELL#0.9670;GENE EXPRESSION#0.9611;AUTOIMMUNE DISEASE#0.9599;TRANSFORMING GROWTH FACTOR#0.9518;REGULATORY T CELL#0.9516;REGENERATION#0.9499;SIGNAL TRANSDUCTION#0.9492;TUMOR SUPPRESSOR#0.9458;ADIPOGENESIS#0.9458;MYELIN SHEATH#0.9411;STRIATUM#0.9402;CELL DEATH#0.9232;CHARCOT-MARIE-TOOTH DISEASE TYPE 1#0.9221;FOREBRAIN#0.9170;TRANSCRIPTIONAL CONTROL#0.9161;APOPTOTIC#0.9155;GLIAL CELL#0.9094;BONE FORMATION#0.9091;MYELIN FORMATION#0.9065;FACTOR I#0.9054;EXTRACELLULAR MATRIX#0.8958;PERIPHERAL BLOOD#0.8919;MONOCYTE#0.8914;MIDBRAIN#0.8907;OSTEOBLAST#0.8864;SMOOTH MUSCLE#0.8812;FRONTAL#0.8792;CONNEXIN#0.8780;ADIPOCYTE#0.8728;AORTIC VALVE#0.8726;TRANSACTIVATION#0.8724;BONE MARROW#0.8670;OLIGODENDROCYTE#0.8625;RECEPTOR TYROSINE KINASE#0.8601;LYMPHOCYTE ACTIVATION#0.8566;MEDIAL PREFRONTAL CORTEX#0.8503;SIGNALLING PATHWAY#0.8492;LONG TERM POTENTIATION#0.8442;CD8+ T CELL#0.8393;PROTEIN KINASE C#0.8373;FIBROBLAST GROWTH FACTOR#0.8372;SCHWANN CELL PROLIFERATION#0.8370;CELL ADHESION#0.8362;CELL MIGRATION#0.8362;CELL GROWTH#0.8352;REVERSE TRANSCRIPTION#0.8332;MAPK SIGNALING#0.8326;NITRIC OXIDE#0.8243;IMMUNE SYSTEM#0.8224;PRO-INFLAMMATORY#0.8220;SPINAL CORD#0.8203;CANCER CELL#0.8186;ISCHEMIA#0.8158;SOMITE#0.8138;EFFECTOR T CELL#0.8033;SIGNALING MOLECULE#0.8008;CEREBRAL CORTEX#0.7969;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7952;M2 MACROPHAGE#0.7878;INSULIN-LIKE GROWTH FACTOR#0.7787;IFN-GAMMA#0.7783;THYMOCYTE#0.7777;MITOGEN ACTIVATED PROTEIN#0.7760;ASTROCYTE#0.7747;NERVE GROWTH FACTOR#0.7746;T LYMPHOCYTE#0.7741;UBIQUITIN#0.7720;ADENOSINE#0.7703;AUTOIMMUNITY#0.7575;NEURAL PLATE#0.7567;EPIDERMAL GROWTH FACTOR#0.7551;RECEPTOR ANTAGONIST#0.7514;OSTEOCLAST#0.7512;T CELL DIFFERENTIATION#0.7488;ACTIVATED T-CELLS#0.7466;ACTIVATED T CELL#0.7463;MORPHOGENESIS#0.7454;IL-10 PRODUCTION#0.7454;CYTOKINE PRODUCTION#0.7437;STROMAL CELL#0.7432;BIPOLAR DISORDER#0.7427;EPITHELIAL CELL#0.7396;PROGENITOR CELL#0.7353;SERUM RESPONSE FACTOR#0.7324;ADIPOCYTE DIFFERENTIATION#0.7280;CEREBRAL ISCHEMIA#0.7249;ALVEOLAR MACROPHAGE#0.7231;PROTEIN SYNTHESIS#0.7218;RETINOIC ACID RECEPTOR#0.7208;DENDRITIC CELL#0.7203;TRANSFORMING GROWTH FACTOR BETA#0.7150;DEDIFFERENTIATION#0.7088;PERIPHERAL NERVE INJURY#0.7074;B CELL RECEPTOR#0.7048;CALCINEURIN#0.7019;MUSCLE CELL#0.6987;CYCLIC ADENOSINE MONOPHOSPHATE#0.6977;ADENOSINE MONOPHOSPHATE#0.6959;PATTERN FORMATION#0.6948;HAIR FOLLICLE#0.6884;AMYGDALA#0.6870;CELL ADHESION MOLECULE#0.6839;MACROPHAGE DIFFERENTIATION#0.6789;DORSAL ROOT GANGLION#0.6767;TERMINAL DIFFERENTIATION#0.6761;EWING SARCOMA#0.6755;MULTIPLE SCLEROSIS#0.6748;AORTIC VALVE DEVELOPMENT#0.6742;DOPAMINE#0.6741;MUTAGENESIS#0.6711;COLONY-STIMULATING FACTOR#0.6710;CELL SURFACE#0.6690;SMOOTH MUSCLE CELL#0.6644;BRAIN DEVELOPMENT#0.6598;CELL DIVISION#0.6572;ADIPOSE TISSUE#0.6547;TH2 CELL#0.6537;GENE REGULATORY NETWORK#0.6530;LYSINE#0.6521;PROGESTERONE#0.6514;T CELL DEVELOPMENT#0.6508;ENDOTHELIAL CELL#0.6503;NEUROGENESIS#0.6499;CYCLOSPORIN A#0.6473;MYELOID CELL#0.6461;COMPLEX I#0.6447;BRANCHIAL ARCH#0.6444;TRANSCRIPTIONAL REGULATORY NETWORK#0.6442;CELL CYCLE ARREST#0.6439;HYPOXIA#0.6439;QUANTITATIVE REAL TIME#0.6437;MESENCHYMAL STEM CELL#0.6430;LIPID BIOSYNTHETIC#0.6343;DEXAMETHASONE#0.6306;CAMP RESPONSE ELEMENT#0.6301;INHERITED NEUROPATHY#0.6238;ENHANCER BINDING PROTEIN#0.6190;ENHANCER BINDING#0.6186;DIFFERENTIAL GENE EXPRESSION#0.6170;NERVE DEVELOPMENT#0.6163;NERVE FIBER#0.6140;GROWTH FACTOR RECEPTOR#0.6118;ACTION POTENTIAL#0.6008
196047	PAPILLARY THYROID CANCER#0.7117;THYROID CANCER#0.6996
196051	PHOSPHATIDATE PHOSPHATASE#0.7028;LUNG CARCINOMA#0.6472
1960	TINNITUS#1.0543;CHRONIC HEPATITIS C#1.0464;ATOPIC DERMATITIS#1.0413;FIBROMYALGIA#1.0400;MIGRAINE#1.0361;KIDNEY TRANSPLANT RECIPIENTS#1.0359;CEREBRAL PALSY#1.0342;GESTATIONAL DIABETES#1.0326;MESENCHYMAL STEM CELL#1.0324;DERMATITIS#1.0311;IRRITABLE BOWEL SYNDROME#1.0309;OBSESSIVE COMPULSIVE DISORDER#1.0258;CRITICAL LIMB ISCHEMIA#1.0256;ACUTE ISCHEMIC STROKE#1.0252;BREAST CANCER SURVIVORS#1.0250;MULTIPLE SCLEROSIS#1.0245;MYELOID LEUKEMIA#1.0240;SLEEP APNEA#1.0240;TACROLIMUS#1.0235;OVARIAN CANCER#1.0234;OBSTRUCTIVE SLEEP APNEA#1.0229;PACLITAXEL#1.0224;PULMONARY HYPERTENSION#1.0221;HYALURONIC ACID#1.0219;CENTRAL SEROUS CHORIORETINOPATHY#1.0215;SICKLE CELL DISEASE#1.0213;TYPE 1 DIABETES#1.0210;RENAL CELL CARCINOMA#1.0206;RIBAVIRIN#1.0204;FERMENTATION#1.0203;TRANSCRANIAL MAGNETIC STIMULATION#1.0198;CYSTIC FIBROSIS#1.0197;METASTATIC BREAST CANCER#1.0196;CROHN'S DISEASE#1.0195;RANDOMIZED CONTROL TRIAL#1.0193;ATRIAL FIBRILLATION#1.0193;METFORMIN#1.0192;METHADONE#1.0191;HEPATITIS C#1.0189;BUPRENORPHINE#1.0186;SPINAL CORD INJURY#1.0183;DYNAMIC CONTRAST ENHANCED#1.0182;CHRONIC HEPATITIS B#1.0178;EARLY GROWTH RESPONSE#1.0172;METHAMPHETAMINE#1.0164;WASTEWATER TREATMENT PLANT#1.0163;ACUTE MYOCARDIAL INFARCTION#1.0159;RHEUMATOID ARTHRITIS#1.0159;LOW BACK PAIN#1.0158;COGNITIVE BEHAVIOURAL THERAPY#1.0157;LIMB ISCHEMIA#1.0152;HEPATITIS B#1.0148;CHLAMYDIA#1.0145;CLEFT LIP#1.0142;MUSCULAR DYSTROPHY#1.0140;HEPATOCELLULAR CARCINOMA#1.0136;PSORIASIS#1.0134;CARBOPLATIN#1.0131;PARKINSON'S DISEASE#1.0128;AUTISM SPECTRUM DISORDER#1.0126;ANOREXIA NERVOSA#1.0124;LONG TERM CARE#1.0123;HEAD AND NECK CANCER#1.0112;NECK CANCER#1.0111;RANDOMISED CONTROLLED TRIAL#1.0107;DNA METHYLATION#1.0101;SUBSTANCE USE DISORDER#1.0099;KETAMINE#1.0099;STEM CELL TRANSPLANTATION#1.0097;OPEN ANGLE GLAUCOMA#1.0094;SHARED DECISION MAKING#1.0094;ACUTE KIDNEY INJURY#1.0088;RETINOIC ACID#1.0087;LUNG CANCER#1.0085;EATING DISORDER#1.0077;ULCERATIVE COLITIS#1.0077;PROSTATE CANCER#1.0077;AORTIC VALVE#1.0071;ALCOHOL USE DISORDER#1.0070;INSOMNIA#1.0068;MILD COGNITIVE IMPAIRMENT#1.0065;DOCETAXEL#1.0064;PROPOFOL#1.0062;COGNITIVE BEHAVIORAL THERAPY#1.0060;5 FLUOROURACIL#1.0060;CISPLATIN#1.0056;TRAUMATIC BRAIN INJURY#1.0055;ALCOHOL DEPENDENCE#1.0053;PANCREATIC CANCER#1.0051;PERIODONTITIS#1.0045;DEXAMETHASONE#1.0045;FLUOROURACIL#1.0041;CORONARY ARTERY BYPASS#1.0038;POSITIVE AIRWAY PRESSURE#1.0036;POLYCYSTIC OVARY SYNDROME#1.0030;DIGESTION#1.0026;OSTEOARTHRITIS#1.0019;MOOD DISORDER#1.0015;ATTENTION DEFICIT HYPERACTIVITY DISORDER#1.0014;CERVICAL CANCER#1.0013;ACUTE MYELOID LEUKEMIA#1.0012;ETOPOSIDE#1.0012;GEMCITABINE#1.0011;CONTINUOUS GLUCOSE MONITORING#1.0010;CARDIAC ARREST#1.0005;PERCUTANEOUS CORONARY INTERVENTION#1.0004;BREAST CANCER#0.9995;ACUTE CORONARY SYNDROME#0.9994;TOTAL KNEE ARTHROPLASTY#0.9993;DEEP BRAIN STIMULATION#0.9993;BIPOLAR DISORDER#0.9988;FATTY LIVER DISEASE#0.9988;ANOREXIA#0.9986;INCONTINENCE#0.9979;BEVACIZUMAB#0.9978;RESPIRATORY DISTRESS#0.9977;BREAST CANCER PATIENTS#0.9967;PERSONALITY DISORDER#0.9965;DOXORUBICIN#0.9962;RANDOMIZED CONTROLLED TRIAL#0.9962;ELECTRONIC HEALTH RECORD#0.9961;DIABETIC RETINOPATHY#0.9959;HEMATOPOIETIC STEM CELL#0.9952;SPINAL CORD#0.9951;PRIMARY CARE PROVIDER#0.9949;SEXUAL DYSFUNCTION#0.9949;TUBERCULOSIS#0.9949;TYPE 2 DIABETES#0.9948;RANDOMIZED CLINICAL TRIAL#0.9947;FATTY LIVER#0.9944;MITRAL VALVE#0.9942;GENERALIZED ANXIETY DISORDER#0.9940;SCOLIOSIS#0.9935;COLITIS#0.9933;URINARY TRACT INFECTION#0.9932;STEM CELL#0.9932;POINT OF CARE#0.9932;INTIMATE PARTNER VIOLENCE#0.9932;EPILEPSY#0.9931;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9930;INFLAMMATORY BOWEL DISEASE#0.9930;WHOLE BODY VIBRATION#0.9919;PRIMARY HEALTH CARE#0.9914;COLORECTAL#0.9913;COLORECTAL CANCER#0.9910;DEMENTIA#0.9908;ANXIETY DISORDER#0.9908;ALZHEIMER'S DISEASE#0.9907;TRANSCRIPTION FACTOR#0.9907;MALARIA#0.9907;ETHANOL#0.9904;CHRONIC KIDNEY DISEASE#0.9903;SOCIAL ANXIETY DISORDER#0.9900;LIVER DISEASE#0.9900;TYPE 2 DIABETIC#0.9899;ARRHYTHMIA#0.9899;CERVICAL CANCER SCREENING#0.9897;DENDRITIC CELL#0.9894;ADOLESCENT IDIOPATHIC SCOLIOSIS#0.9892;HEPATITIS C VIRUS#0.9890;SENTINEL LYMPH NODE#0.9889;HIGH RISK PATIENTS#0.9886;BREAST CARCINOMA#0.9884;HYPERACTIVITY#0.9882;B CELL#0.9881;MAJOR DEPRESSIVE DISORDER#0.9880;VOLATILE ORGANIC COMPOUND#0.9878;KIDNEY DISEASE#0.9873;STIGMA#0.9873;CONGENITAL HEART DISEASE#0.9871;TYPE 2 DIABETES MELLITUS#0.9870;2 DIABETES MELLITUS#0.9870;ASPIRIN#0.9870;CERVICAL#0.9868;SEDATION#0.9868;AGE RELATED MACULAR DEGENERATION#0.9865;OVARIAN#0.9863;OPTICAL COHERENCE TOMOGRAPHY#0.9862;MACULAR DEGENERATION#0.9861;COAGULATION#0.9859;SQUAMOUS CELL CARCINOMA#0.9858;CONSTIPATION#0.9855;POST-TRAUMATIC STRESS DISORDER#0.9854;LUPUS ERYTHEMATOSUS#0.9851;CORD BLOOD#0.9851;TOPICAL#0.9850;HEARING LOSS#0.9849;OBESE#0.9847;CEREBRAL ARTERY#0.9846;IDIOPATHIC SCOLIOSIS#0.9846;AMYOTROPHIC LATERAL SCLEROSIS#0.9845;LATERAL SCLEROSIS#0.9845;MYOCARDIAL INFARCTION#0.9839;CRAVING#0.9839;DYSPNEA#0.9837;HEART RATE VARIABILITY#0.9836;COLONY-STIMULATING FACTOR#0.9833;ISCHEMIA#0.9829;PATIENT REPORTED OUTCOME#0.9827;HUMAN IMMUNODEFICIENCY VIRUS#0.9824;GRANULOCYTE COLONY STIMULATING FACTOR#0.9823;G-CSF#0.9822;ACADEMIC MEDICAL CENTER#0.9822;PHYSICAL ACTIVITY LEVEL#0.9819;PARENTERAL#0.9817;NEUROPATHY#0.9813;CYCLOPHOSPHAMIDE#0.9812;CORONARY HEART DISEASE#0.9808;NITRIC OXIDE#0.9807;NATIONAL CANCER INSTITUTE#0.9806;CYCLOSPORINE#0.9802;REGENERATION#0.9795;RENAL REPLACEMENT THERAPY#0.9793;LOWER URINARY TRACT#0.9789;CELL ACTIVATION#0.9788;PRIMARY CARE PHYSICIAN#0.9787;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9787;POSITRON EMISSION TOMOGRAPHY#0.9785;QUALITY OF CARE#0.9779;LUNG DISEASE#0.9779;CARPAL TUNNEL SYNDROME#0.9775;VITAMIN C#0.9774;CHRONIC HEART FAILURE#0.9774;HEMORRHAGE#0.9773;SUBSTANCE ABUSE#0.9773;DIABETIC FOOT ULCER#0.9772;ANESTHETIC#0.9769;METHOTREXATE#0.9768;ARTERY DISEASE#0.9763;GRANULOCYTE#0.9762;CORONARY ARTERY DISEASE#0.9760;BONE MINERAL DENSITY#0.9759;MYCOPHENOLATE MOFETIL#0.9758;ADIPOSE TISSUE#0.9757;GLUCOSE METABOLISM#0.9755;CARDIOMYOPATHY#0.9753;DNA BINDING#0.9751;LYMPH NODE#0.9751;SKELETAL MUSCLE#0.9748;TESTOSTERONE#0.9746;WOUND HEALING#0.9746;CARDIOVASCULAR RISK FACTOR#0.9744;HYPOXIA#0.9744;CORTISOL#0.9744;PNEUMONIA#0.9743;HEPARIN#0.9742;BONE MARROW#0.9742;HYPERTENSION#0.9731;DIFFUSION TENSOR IMAGING#0.9728;DIABETES MELLITUS#0.9723;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9722;CORONARY ARTERY#0.9721;ANGIOGENESIS#0.9720;INSTITUTIONAL REVIEW BOARD#0.9720;ELECTRONIC MEDICAL RECORD#0.9720;WEIGHT GAIN#0.9719;GLASGOW COMA SCALE#0.9718;T CELL ACTIVATION#0.9716;WEIGHT LOSS#0.9711;MENTAL HEALTH SERVICES#0.9709;CONGESTIVE HEART FAILURE#0.9709;CELL PROLIFERATION#0.9704;INNERVATION#0.9702;EPITHELIAL CELL#0.9701;MENTAL HEALTH PROBLEMS#0.9700;EPIDERMAL GROWTH FACTOR#0.9699;ATHEROSCLEROSIS#0.9698;MENTAL DISORDER#0.9697;ENDOTHELIAL CELL#0.9697;ADENOCARCINOMA#0.9692;HEART DISEASE#0.9690;TREATMENT RESISTANT DEPRESSION#0.9688;INTENSIVE CARE UNIT#0.9686;MONOCYTE#0.9686;GROWTH FACTOR RECEPTOR#0.9684;IFOSFAMIDE#0.9683;HEALTH CARE PROVIDER#0.9683;HEALTH CARE SYSTEM#0.9683;CRUCIATE LIGAMENT#0.9681;FENTANYL#0.9681;ANGIOTENSIN CONVERTING ENZYME#0.9680;DOPAMINE#0.9679;MOLAR#0.9675;B CELL LYMPHOMA#0.9672;HYPOGLYCEMIA#0.9672;INFLAMMATORY RESPONSE#0.9670;KNEE JOINT#0.9670;COLON CANCER#0.9668;T CELL#0.9667;UMBILICAL CORD#0.9666;DEPRESSIVE SYMPTOMS#0.9662;ESTROGEN RECEPTOR#0.9661;GLOMERULAR FILTRATION RATE#0.9661;WORLD HEALTH ORGANIZATION#0.9658;RANGE OF MOTION#0.9656;GESTATION#0.9655;AGITATION#0.9654;LEUKOCYTE#0.9653;GRAFT VERSUS HOST#0.9653;EDEMA#0.9652;GLOMERULAR FILTRATION#0.9651;BONE FORMATION#0.9651;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9651;MALNUTRITION#0.9648;ENDOTHELIAL GROWTH FACTOR#0.9643;MAST CELL#0.9639;NEPHROPATHY#0.9639;HYPOXIC#0.9637;SIGNALING PATHWAY#0.9637;ARTERY#0.9634;VITAMIN D DEFICIENCY#0.9632;DORSOLATERAL PREFRONTAL CORTEX#0.9632;SORAFENIB#0.9629;RESPONSE TO TREATMENT#0.9627;COGNITION#0.9626;CENTRAL NERVOUS SYSTEM#0.9624;BLOOD LOSS#0.9623;PATIENT HEALTH QUESTIONNAIRE#0.9623;APOPTOSIS#0.9622;NEUROBLASTOMA#0.9621;ALOPECIA#0.9620;DIARRHEA#0.9618;LIDOCAINE#0.9613;MAGNETIC RESONANCE IMAGING#0.9612;MACROPHAGE#0.9610;VAGUS NERVE STIMULATION#0.9610;GROWTH FACTOR#0.9606;ANEMIA#0.9604;LYMPHEDEMA#0.9601;TUMOR CELLS#0.9600;IMMUNE RESPONSE#0.9600;NEUROLOGICAL DISORDER#0.9599;RED BLOOD CELL#0.9598;NERVOUS SYSTEM#0.9595;PERIPHERAL NERVE#0.9594;SLEEP DISORDER#0.9591;RECEPTOR ANTAGONIST#0.9591;CHRONIC MYELOID LEUKEMIA#0.9590;AGEING#0.9589;INTENT TO TREAT#0.9589;THROMBOSIS#0.9587;SLEEPINESS#0.9584;EATING BEHAVIOR#0.9581;72-HOURS#0.9580;STANDARD OF CARE#0.9578;PROGESTERONE#0.9575;INTRACLASS CORRELATION COEFFICIENT#0.9574;ESOPHAGEAL CANCER#0.9574;MEDICAL RESEARCH COUNCIL#0.9572;LENGTH OF STAY#0.9570;HYPERTHERMIA#0.9569;FIBROBLAST GROWTH FACTOR#0.9568;DEPRESSION RATING SCALE#0.9568;SEXUALLY TRANSMITTED INFECTION#0.9566;GENE EXPRESSION#0.9565;VOMITING#0.9565;EXCRETION#0.9562;MELATONIN#0.9562;NEUTROPHIL#0.9561;ABDOMINAL PAIN#0.9560;LOW BIRTH WEIGHT#0.9560;FRONTAL#0.9560;HEMORRHAGIC#0.9558;RETINOPATHY OF PREMATURITY#0.9558;BONE REGENERATION#0.9556;CYSTITIS#0.9555;METASTATIC COLORECTAL CANCER#0.9554;MINISTRY OF HEALTH#0.9553;CAROTID ARTERY#0.9552;BECK DEPRESSION INVENTORY#0.9550;CHEWING#0.9546;IMMUNE SYSTEM#0.9545;EYE DISEASE#0.9545;PROGENITOR CELL#0.9543;MONONUCLEAR CELLS#0.9543;OVERALL RESPONSE RATE#0.9540;PANCREATITIS#0.9539;RISPERIDONE#0.9537;RECEPTOR AGONIST#0.9536;PERIPHERAL BLOOD#0.9535;ADENOSINE#0.9535;VENA CAVA#0.9533;OSTEOPOROSIS#0.9533;VISUAL ANALOGUE SCALE#0.9532;INTENTION TO TREAT#0.9528;MULTIPLE MYELOMA#0.9526;HIGH DENSITY LIPOPROTEIN#0.9526;HYPOTHYROIDISM#0.9523;CHANGE FROM BASELINE#0.9522;END OF TREATMENT#0.9520;PROSTATE SPECIFIC ANTIGEN#0.9518;VIGOROUS PHYSICAL ACTIVITY#0.9517;HEARING IMPAIRMENT#0.9517;CYCLOSPORIN A#0.9515;CLINICAL GLOBAL IMPRESSION#0.9513;MINI MENTAL STATE#0.9512;ENDOMETRIAL CANCER#0.9510;HYPERSENSITIVITY#0.9509;ESTRADIOL#0.9506;ATORVASTATIN#0.9506;LINEAR MIXED MODEL#0.9505;VITAMIN K#0.9504;LOW DENSITY LIPOPROTEIN#0.9502;PROTON PUMP#0.9500;CD4+ T CELL#0.9499;PROTEIN KINASE#0.9498;NEUTROPENIA#0.9498;VISUAL ANALOG SCALE#0.9498;CANCER CELL#0.9497;MIDDLE CEREBRAL ARTERY#0.9496;ATHEROSCLEROTIC#0.9496;LIPID METABOLISM#0.9495;TUMOR NECROSIS FACTOR#0.9492;MAGNETIC RESONANCE SPECTROSCOPY#0.9491;CREATINE#0.9490;PANIC DISORDER#0.9490;SERIOUS ADVERSE EVENT#0.9490;SYSTOLIC BLOOD PRESSURE#0.9485;ENDOMETRIOSIS#0.9485;C REACTIVE PROTEIN#0.9481;STROMAL CELL#0.9478;NEGATIVE PREDICTIVE VALUE#0.9477;POSITIVE PREDICTIVE VALUE#0.9476;THROMBOCYTOPENIA#0.9476;KINASE INHIBITOR#0.9472;FLOCCULATION#0.9470;DEXMEDETOMIDINE#0.9470;REGIONS OF INTEREST#0.9468;NEURODEGENERATIVE DISEASE#0.9468;CORRECTED VISUAL ACUITY#0.9467;PERIPHERAL ARTERIAL DISEASE#0.9465;GABAPENTIN#0.9459;POLYMERASE CHAIN REACTION#0.9458;ANTERIOR CRUCIATE LIGAMENT#0.9458;TOXICITY#0.9455;PRO-INFLAMMATORY#0.9452;SKIN CANCER#0.9452;IRINOTECAN#0.9443;MUCOSITIS#0.9442;SIMVASTATIN#0.9440;PEOPLE WITH DEMENTIA#0.9439;VIRAL INFECTION#0.9437;OOCYTE#0.9435;HEPATITIS B VIRUS#0.9430;PERCEIVED STRESS SCALE#0.9430;HYPOTENSION#0.9428;CELL DEATH#0.9424;PREMATURITY#0.9423;METASTATIC MELANOMA#0.9421;FOOD FREQUENCY QUESTIONNAIRE#0.9419;CIRCULATING TUMOR CELL#0.9406;PULMONARY ARTERY#0.9403;VITAMIN A#0.9394;CELL ADHESION#0.9391;PRIMARY CARE SETTINGS#0.9389;URIC ACID#0.9383;MENSTRUAL CYCLE#0.9380;MANDIBLE#0.9380;T LYMPHOCYTE#0.9378;MUSCLE FIBER#0.9378;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9377;CHEMICAL OXYGEN DEMAND#0.9375;MECHANISM OF ACTION#0.9375;ERYTHEMA#0.9374;EVIDENCE BASED PRACTICE#0.9373;RESPIRATORY FAILURE#0.9372;SELF REPORT QUESTIONNAIRE#0.9366;PRIMARY OPEN ANGLE GLAUCOMA#0.9363;FOLIC ACID#0.9362;VENTRICULAR ASSIST DEVICE#0.9361;SWELLING#0.9358;PROTON PUMP INHIBITOR#0.9355;GLUTATHIONE#0.9346;INSULIN-LIKE GROWTH FACTOR#0.9343;PULMONARY EMBOLISM#0.9340;ALANINE#0.9336;APHASIA#0.9314;CONGENITAL HYPOTHYROIDISM#0.9311;ERYTHROCYTE#0.9305;MARKERS OF INFLAMMATION#0.9304;ADVERSE DRUG REACTION#0.9301;TRANSFORMING GROWTH FACTOR#0.9295;TYPE 1 DIABETES MELLITUS#0.9292;WHITE BLOOD CELL#0.9283;MEDIAN OVERALL SURVIVAL#0.9279;DENTAL CARIES#0.9276;FIBRINOGEN#0.9276;AND BODY COMPOSITION#0.9274;FOREARM#0.9268;AORTIC ANEURYSM#0.9268;NONALCOHOLIC FATTY LIVER DISEASE#0.9264;BLOOD VESSEL#0.9264;SKIN DISEASE#0.9260;SMOOTH MUSCLE#0.9259;VANCOMYCIN#0.9257;ALKALINE PHOSPHATASE#0.9255;CELL GROWTH#0.9252;AUTOIMMUNE DISEASE#0.9252;CELL CYCLE#0.9250;INFERTILITY#0.9241;RENAL TRANSPLANT RECIPIENTS#0.9240;CHILDHOOD CANCER SURVIVORS#0.9237;PULMONARY ARTERIAL HYPERTENSION#0.9226;PARATHYROID#0.9218;CAFFEINE#0.9218;DISEASE FREE SURVIVAL#0.9216;INFERTILE#0.9208;ALLERGEN#0.9203;GESTATIONAL DIABETES MELLITUS#0.9199;TEMPORAL LOBE#0.9192;MEDROXYPROGESTERONE ACETATE#0.9189;SEROTONIN REUPTAKE INHIBITOR#0.9186;CARDIAC RESYNCHRONIZATION THERAPY#0.9184;VITAMIN E#0.9180;GENERALIZED ESTIMATING EQUATION#0.9179;AORTIC VALVE REPLACEMENT#0.9176;ARGININE#0.9174;MODIFIED RANKIN SCALE#0.9169;BOTULINUM TOXIN A#0.9167;LAMIVUDINE#0.9166;DIFFUSION WEIGHTED IMAGING#0.9163;MUSCLE CELL#0.9159;NERVE GROWTH FACTOR#0.9159;CONNECTIVE TISSUE#0.9149;DRIED BLOOD SPOT#0.9144;N-ACETYLCYSTEINE#0.9142;QUANTITATIVE REAL TIME#0.9135;STRESS URINARY INCONTINENCE#0.9133;VENOUS BLOOD#0.9132;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9132;CHRONIC LIVER DISEASE#0.9130;PEDICLE#0.9128;GRADUATE MEDICAL EDUCATION#0.9124;ENDOSCOPIC SUBMUCOSAL DISSECTION#0.9124;NATIONAL HEALTH SERVICE#0.9122;APPARENT DIFFUSION COEFFICIENT#0.9120;LOCALIZED PROSTATE CANCER#0.9119;CELL SURFACE#0.9110;CLOZAPINE#0.9109;WARFARIN#0.9109;PIOGLITAZONE#0.9107;MUSCULAR ATROPHY#0.9103;WILCOXON RANK SUM#0.9101;GLASGOW OUTCOME SCALE#0.9100;ASPARTATE#0.9100;TYROSINE KINASE INHIBITOR#0.9100;THYROID CANCER#0.9099;PELVIS#0.9087;MITOMYCIN C#0.9087;ORAL GLUCOSE TOLERANCE#0.9084;GLUCOSE TOLERANCE TEST#0.9079;EVENT FREE SURVIVAL#0.9076;PRIMARY BILIARY CIRRHOSIS#0.9074;QUADRICEPS#0.9068;EMBOLISM#0.9067;DOXYCYCLINE#0.9064;ENZYME INHIBITOR#0.9063;CANCER RELATED FATIGUE#0.9049;HEALTH CARE WORKERS#0.9045;CELIAC DISEASE#0.9032;ESOPHAGUS#0.9032;REVERSE TRANSCRIPTION#0.9031;PREGABALIN#0.9031;CENTRAL VENOUS CATHETER#0.9031;DIABETIC MACULAR EDEMA#0.9022;TRAIL MAKING TEST#0.9022;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9018;HEMOSTASIS#0.9013;VARENICLINE#0.9007;HEPATIC ENCEPHALOPATHY#0.9007;STEM CELL TRANSPLANT#0.9001;SERUM ALBUMIN#0.9001;INTIMA MEDIA THICKNESS#0.9001;PLATELET AGGREGATION#0.8998;DECISION SUPPORT SYSTEM#0.8996;THYMOCYTE#0.8991;BORDERLINE PERSONALITY DISORDER#0.8984;SEVERE PAIN#0.8981;FINE NEEDLE ASPIRATION#0.8978;CD8+ T CELL#0.8978;JOINT PAIN#0.8977;MECHANISMS OF ACTION#0.8974;FORCED EXPIRATORY VOLUME#0.8974;GLUTEN FREE DIET#0.8973;VENLAFAXINE#0.8957;ANDROGEN DEPRIVATION THERAPY#0.8954;MYOCARDIUM#0.8954;PAROXETINE#0.8945;ACETIC ACID#0.8945;FOLATE#0.8943;PROSTATIC ADENOMA#0.8931;NOREPINEPHRINE#0.8928;FLUSHING#0.8925;CYCLOSPORIN#0.8907;ORAL CAVITY#0.8907;RESPIRATION#0.8907;LINEAR MIXED EFFECTS#0.8903;BLOOD GLUCOSE LEVEL#0.8902;MEDIAN NERVE#0.8901;AFRICAN AMERICAN MEN#0.8895;AUTOIMMUNITY#0.8892;OPTIC NERVE#0.8891;DUCHENNE MUSCULAR DYSTROPHY#0.8884;VINCRISTINE#0.8882;NALTREXONE#0.8881;DOWN SYNDROME#0.8879;PLATELET RICH FIBRIN#0.8878;BASAL CELL#0.8874;RHEUMATIC FEVER#0.8873;THALAMUS#0.8866;OXALIPLATIN#0.8864;TIME TO PROGRESSION#0.8864;COLORECTAL CARCINOMA#0.8860;GASTROINTESTINAL TRACT#0.8859;APNEA HYPOPNEA INDEX#0.8857;ENDOTHELIUM#0.8854;BASAL CELL CARCINOMA#0.8854;ADVANCED BREAST CANCER#0.8849;CONTACT DERMATITIS#0.8847;CROSS SECTIONAL AREA#0.8838;AMYGDALA#0.8836;MALIGNANT GLIOMA#0.8833;TRIAMCINOLONE ACETONIDE#0.8833;IMIQUIMOD#0.8813;CAMP RESPONSE ELEMENT#0.8812;ANTI INFLAMMATORY DRUGS#0.8811;GROWTH HORMONE#0.8807;IBUPROFEN#0.8803;PEYRONIE'S DISEASE#0.8800;COMPUTED TOMOGRAPHY ANGIOGRAPHY#0.8798;MITOMYCIN#0.8797;ADJUSTED ODDS RATIO#0.8788;AMERICAN CANCER SOCIETY#0.8787;OSWESTRY DISABILITY INDEX#0.8786;SPINAL MUSCULAR ATROPHY#0.8783;LACTATION#0.8781;URSODEOXYCHOLIC ACID#0.8776;MENOPAUSE#0.8774;CAMP RESPONSE ELEMENT BINDING#0.8774;THALIDOMIDE#0.8774;EICOSAPENTAENOIC ACID#0.8763;TOTAL SLEEP TIME#0.8759;CELL ADHESION MOLECULE#0.8756;NALOXONE#0.8748;TUMOR SUPPRESSOR#0.8742;CHLORHEXIDINE#0.8742;MULTIPLE LINEAR REGRESSION#0.8738;BOTULINUM TOXIN TYPE A#0.8727;PRINCIPAL COMPONENT ANALYSIS#0.8726;ALBUTEROL#0.8724;SENSITIZATION#0.8721;GASTRIC EMPTYING#0.8718;PRIMARY MOTOR CORTEX#0.8713;PREMOLAR#0.8702;HEMATOPOIETIC CELL#0.8688;GERM CELL#0.8686;DIZZINESS#0.8684;GENERAL LINEAR MODEL#0.8683;PENTOXIFYLLINE#0.8678;GM-CSF#0.8669;CACHEXIA#0.8669;HYPERCHOLESTEROLEMIA#0.8655;VITAMIN D3#0.8654;PANCREATIC DUCTAL ADENOCARCINOMA#0.8653;FRONTOTEMPORAL DEMENTIA#0.8648;TRADITIONAL CHINESE MEDICINE#0.8645;MUSCLE CONTRACTION#0.8644;SCANNING ELECTRON MICROSCOPY#0.8639;RESPIRATORY TRACT#0.8634;MEDIAN SURVIVAL TIME#0.8626;LUMINAL#0.8617;DRY EYE DISEASE#0.8616;SCALP#0.8615;ACE INHIBITOR#0.8615;TOTAL HIP ARTHROPLASTY#0.8614;ESSENTIAL TREMOR#0.8611;DYSPEPSIA#0.8610;BRIEF PAIN INVENTORY#0.8603;FLUORESCEIN#0.8603;ENDOMETRIUM#0.8601;FACTOR I#0.8601;CEREBRAL CORTEX#0.8600;IMMUNE CELL#0.8596;PELVIC ORGAN PROLAPSE#0.8590;MIDAZOLAM#0.8589;REGULATORY T CELL#0.8585;THYROID NODULE#0.8584;PULSE WAVE VELOCITY#0.8578;DIAPHRAGM#0.8576;POSTPARTUM DEPRESSION#0.8572;LOW INCOME COUNTRIES#0.8566;HEROIN#0.8561;LYMPH NODE METASTASIS#0.8561;ANGIOTENSIN RECEPTOR BLOCKER#0.8552;INTELLECTUAL DISABILITY#0.8547;CLOPIDOGREL#0.8542;EXPLORATORY FACTOR ANALYSIS#0.8541;DISEASE ACTIVITY INDEX#0.8532;MISOPROSTOL#0.8531;ENVIRONMENTAL PROTECTION AGENCY#0.8528;GALLBLADDER#0.8528;ANGIOTENSIN RECEPTOR#0.8523;PARATHYROID HORMONE#0.8521;MYELODYSPLASTIC SYNDROME#0.8519;THYROID CARCINOMA#0.8516;AMPHOTERICIN B#0.8514;TAMOXIFEN#0.8510;STANDARDIZED UPTAKE VALUE#0.8509;CORONAL#0.8505;FEMUR#0.8499;CEREBRAL ISCHEMIA#0.8499;TOTAL KNEE REPLACEMENT#0.8499;APOPTOTIC#0.8497;LUNG CARCINOMA#0.8495;CHRONIC PELVIC PAIN#0.8494;MODIFIED ASHWORTH SCALE#0.8490;RITUXIMAB#0.8490;APPENDICITIS#0.8484;LIMITS OF AGREEMENT#0.8483;INTERSTITIAL LUNG DISEASE#0.8478;OVER THE COUNTER#0.8473;IMPLANTABLE CARDIOVERTER DEFIBRILLATOR#0.8473;TRIAMCINOLONE#0.8467;LIQUID BASED CYTOLOGY#0.8461;ROOT MEAN SQUARE#0.8458;SYSTEM DEVELOPMENT#0.8458;AUTISTIC#0.8458;ANDROID#0.8452;GLIOBLASTOMA MULTIFORME#0.8445;CHRONIC FATIGUE SYNDROME#0.8445;SLEEP APNEA SYNDROME#0.8443;SIGNAL TRANSDUCTION#0.8443;RETINAL DETACHMENT#0.8442;PERIODONTAL DISEASE#0.8437;VOCAL FOLD#0.8430;NEPHROTIC SYNDROME#0.8429;GLUTAMINE#0.8427;LEPROSY#0.8427;HYPERGLYCEMIA#0.8423;SURGICAL SITE INFECTION#0.8422;RHINITIS#0.8421;ACETYLCYSTEINE#0.8418;AZITHROMYCIN#0.8414;HYPERPARATHYROIDISM#0.8414;DEPARTMENT OF ENERGY#0.8409;LYMPH NODE METASTASES#0.8407;INTERSTITIAL CYSTITIS#0.8407;MULTIPLE REGRESSION ANALYSIS#0.8400;FASTING BLOOD GLUCOSE#0.8400;VASODILATOR#0.8397;SALIVARY GLAND#0.8393;BLOOD BRAIN BARRIER#0.8392;TRANSCRIPTASE#0.8391;BLEEDING ON PROBING#0.8388;PULMONARY VEIN#0.8386;RETURN TO WORK#0.8386;BODY SURFACE AREA#0.8384;CARDIAC MAGNETIC RESONANCE#0.8384;HISTAMINE#0.8378;VASCULAR DISEASE#0.8377;ALDOSTERONE#0.8375;NATURAL KILLER CELL#0.8375;TRASTUZUMAB#0.8370;CONTROLLED CLINICAL TRIALS#0.8368;ABDOMINAL AORTIC ANEURYSM#0.8365;NEW SOUTH WALES#0.8350;FASTING PLASMA GLUCOSE#0.8341;IFN-GAMMA#0.8340;LYSIS#0.8333;EARLY BREAST CANCER#0.8333;STRIATUM#0.8329;REACTIVE OXYGEN SPECIES#0.8328;INTRAVENOUS IMMUNOGLOBULIN#0.8327;CALCIUM CHANNEL#0.8323;METHYLPHENIDATE#0.8306;SPUTUM#0.8298;OVERALL SURVIVAL RATE#0.8298;BARRETT'S ESOPHAGUS#0.8296;CAPECITABINE#0.8283;HODGKIN'S LYMPHOMA#0.8283;CIRCADIAN RHYTHM#0.8282;SYPHILIS#0.8281;SEVOFLURANE#0.8279;INTERNATIONAL NORMALIZED RATIO#0.8276;AMIODARONE#0.8274;CHOLANGITIS#0.8271;OMEPRAZOLE#0.8261;CITALOPRAM#0.8260;FOLLICLE STIMULATING HORMONE#0.8259;SIROLIMUS#0.8254;PRIMARY SCLEROSING CHOLANGITIS#0.8253;INTERNAL CAROTID ARTERY#0.8247;SECONDARY HYPERPARATHYROIDISM#0.8245;PARENCHYMA#0.8243;SCLEROSING CHOLANGITIS#0.8241;BINGE EATING DISORDER#0.8238;ACUTE HEART FAILURE#0.8237;ISCHEMIC HEART DISEASE#0.8232;PROPRIOCEPTION#0.8232;CLOTTING#0.8220;CERVIX#0.8217;HEALTHY CONTROL SUBJECTS#0.8217;EVIDENCE BASED MEDICINE#0.8214;ADVANCED GASTRIC CANCER#0.8212;VERTEBRAE#0.8211;LIRAGLUTIDE#0.8200;EPWORTH SLEEPINESS SCALE#0.8174;ORAL MUCOSA#0.8173;IRRITATION#0.8171;MAXIMUM TOLERATED DOSE#0.8170;TACHYCARDIA#0.8163;MOTOR LEARNING#0.8160;HUNTINGTON'S DISEASE#0.8156;TEMPORAL BONE#0.8150;FERTILIZATION#0.8150;BILE DUCT#0.8134;NERVOUS SYSTEM DEVELOPMENT#0.8126;TENSION TYPE HEADACHE#0.8117;PROSTATE CARCINOMA#0.8116;CYTOKINE PRODUCTION#0.8115;MINIMAL RESIDUAL DISEASE#0.8107;FIRST EPISODE PSYCHOSIS#0.8105;PENICILLIN#0.8103;HEALTHY CONTROL GROUP#0.8103;GINGIVITIS#0.8089;EOSIN#0.8080;CHOLECALCIFEROL#0.8080;LOSARTAN#0.8079;INNER EAR#0.8079;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.8077;LINEAR REGRESSION ANALYSIS#0.8075;ONDANSETRON#0.8071;EMISSION COMPUTED TOMOGRAPHY#0.8068;CYTOTOXICITY#0.8067;DIURNAL#0.8067;PORTAL HYPERTENSION#0.8062;RAPAMYCIN#0.8062;JUVENILE IDIOPATHIC ARTHRITIS#0.8056;LEIOMYOMA#0.8055;FALSE DISCOVERY RATE#0.8050;CALCINEURIN#0.8044;METASTATIC PROSTATE CANCER#0.8044;MEMORY IMPAIRMENT#0.8036;SYNOVIAL FLUID#0.8030;MUNICIPAL SOLID WASTE#0.8026;CELL DIFFERENTIATION#0.8025;SUCROSE#0.8024;EXHALED BREATH CONDENSATE#0.8024;LEUKOPENIA#0.8023;FORMALIN#0.8023;PREDNISOLONE#0.8018;POLYCYCLIC AROMATIC HYDROCARBON#0.8017;ALLERGIC RHINITIS#0.8017;ASCORBIC ACID#0.8012;LUTEAL PHASE#0.8008;MINOCYCLINE#0.7994;SCHIZOAFFECTIVE DISORDER#0.7992;MAJOR ADVERSE EVENT#0.7990;EXHALED NITRIC OXIDE#0.7986;ONCHOCERCIASIS#0.7986;DECOMPENSATED HEART FAILURE#0.7983;MEDROXYPROGESTERONE#0.7981;RESVERATROL#0.7980;ZOLEDRONIC ACID#0.7979;DRUG RESISTANCE#0.7975;ALL TRANS RETINOIC ACID#0.7974;MIFEPRISTONE#0.7967;NECROTIZING#0.7962;OBSESSIVE COMPULSIVE SCALE#0.7952;PEARSON CORRELATION COEFFICIENT#0.7948;EPITHELIAL OVARIAN CANCER#0.7946;EWING SARCOMA#0.7945;PREDNISONE#0.7942;MELPHALAN#0.7934;PERIPHERAL ARTERY DISEASE#0.7923;FORCED VITAL CAPACITY#0.7916;SOFT TISSUE SARCOMA#0.7914;HEMATOPOIETIC CELL TRANSPLANTATION#0.7910;PANCREATIC ADENOCARCINOMA#0.7905;AMOXICILLIN#0.7897;FEMALE SEXUAL DYSFUNCTION#0.7896;NEPHROTOXICITY#0.7895;MAXILLA#0.7895;ARACHIDONIC ACID#0.7893;MYOTUBE#0.7885;LEAN BODY MASS#0.7880;INVASIVE BREAST CANCER#0.7876;LACTIC ACID#0.7872;SMOOTH MUSCLE CELL#0.7869;PULMONARY TUBERCULOSIS#0.7868;VINORELBINE#0.7866;SEMEN#0.7865;OBJECTIVE RESPONSE RATE#0.7865;GLYCINE#0.7856;CEREBRAL ARTERY OCCLUSION#0.7853;UMBILICAL CORD BLOOD#0.7846;BRAIN COMPUTER INTERFACE#0.7841;ANTERIOR CINGULATE CORTEX#0.7832;ADRIAMYCIN#0.7827;C-LEVEL#0.7822;ADVANCED OVARIAN CANCER#0.7819;CYTOCHROME P450#0.7815;CARDIOVASCULAR MAGNETIC RESONANCE#0.7803;CAROTENOID#0.7800;REFUSAL#0.7796;HYPOXIC ISCHEMIC ENCEPHALOPATHY#0.7795;APREPITANT#0.7787;COLCHICINE#0.7785;AND NEW ZEALAND#0.7785;DEHYDROEPIANDROSTERONE#0.7774;ACID MINE DRAINAGE#0.7763;TELOMERE#0.7760;FRUCTOSE#0.7760;LARYNX#0.7754;SCLERODERMA#0.7751;NERVE FIBER#0.7749;ANAEMIA#0.7741;FLUOXETINE#0.7738;SUPPORT VECTOR MACHINE#0.7736;DETOXIFICATION#0.7728;IMPAIRED GLUCOSE TOLERANCE#0.7717;PAROTID GLAND#0.7714;ERECTOR SPINAE#0.7702;INTERVERTEBRAL DISC#0.7698;ERLOTINIB#0.7696;EXTRACELLULAR MATRIX#0.7695;YEAR SURVIVAL RATE#0.7691;CELL DEVELOPMENT#0.7689;BREAST CANCER CELL#0.7682;ALLERGIC REACTION#0.7679;ENALAPRIL#0.7678;DONEPEZIL#0.7676;VASCULAR CELL#0.7675;ADVANCED HEART FAILURE#0.7663;EPINEPHRINE#0.7662;BULIMIA NERVOSA#0.7652;REGION OF INTEREST#0.7647;DENTATE GYRUS#0.7641;SPINAL STENOSIS#0.7640;MENINGITIS#0.7638;BUPROPION#0.7630;ANKLE JOINT#0.7625;METHYLPREDNISOLONE#0.7622;MYELOMENINGOCELE#0.7621;LIGHT EMITTING DIODE#0.7617;PROTEINURIA#0.7615;RUMINATION#0.7615;GEFITINIB#0.7612;FRAGILE X SYNDROME#0.7607;SEVERE ADVERSE EVENTS#0.7599;BRONCHOPULMONARY DYSPLASIA#0.7597;ETANERCEPT#0.7582;DEHISCENCE#0.7574;DERMIS#0.7571;LACTOSE#0.7563;ZIDOVUDINE#0.7562;LIVER CIRRHOSIS#0.7560;MULTIPLE SYSTEM ATROPHY#0.7557;CITRIC ACID#0.7551;DYSTONIA#0.7548;DEFAULT MODE NETWORK#0.7547;TRANSIENT ISCHEMIC ATTACK#0.7543;FLOW MEDIATED DILATION#0.7540;RESPIRATORY TRACT INFECTION#0.7539;BLEOMYCIN#0.7539;PEGYLATED LIPOSOMAL DOXORUBICIN#0.7533;ENOXAPARIN#0.7530;BISMUTH#0.7525;BODY DYSMORPHIC DISORDER#0.7522;MULTIPLE LOGISTIC REGRESSION#0.7520;LEUCOVORIN#0.7512;BACTERIAL VAGINOSIS#0.7507;BURDEN OF DISEASE#0.7506;ERYTHROCYTE SEDIMENTATION RATE#0.7495;VERTIGO#0.7494;DIPEPTIDYL PEPTIDASE#0.7494;LITHIUM#0.7490;VP-16#0.7487;SKIN BARRIER FUNCTION#0.7486;ACUTE PANCREATITIS#0.7480;SYSTEMIC INFLAMMATORY RESPONSE#0.7474;SIGNALLING PATHWAY#0.7473;BRAIN NATRIURETIC PEPTIDE#0.7472;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7471;INSULIN GLARGINE#0.7468;MAGNESIUM SULFATE#0.7463;FIXED DOSE COMBINATION#0.7457;TOCOPHEROL#0.7455;RECTUM#0.7444;VITAMIN K ANTAGONIST#0.7444;BONE RESORPTION#0.7439;NITRIC OXIDE SYNTHASE#0.7438;SLEEP DISORDERED BREATHING#0.7436;BRACHIAL PLEXUS#0.7430;SERUM URIC ACID#0.7420;BRAIN CANCER#0.7419;CONFUSION ASSESSMENT METHOD#0.7414;BIOFILM FORMATION#0.7414;FLECAINIDE#0.7413;THALASSEMIA#0.7410;RIFAXIMIN#0.7401;BORTEZOMIB#0.7396;CPT-11#0.7391;HYDROCORTISONE#0.7390;BUPIVACAINE#0.7383;L-CITRULLINE#0.7379;DILATED CARDIOMYOPATHY#0.7379;ALCOHOLIC HEPATITIS#0.7359;NICOTINE DEPENDENCE#0.7359;TISSUE DAMAGE#0.7355;DISEASE CONTROL RATE#0.7354;ANAESTHETIC#0.7353;NUCLEIC ACID#0.7350;MICROTUBULE#0.7347;GONADOTROPIN RELEASING HORMONE#0.7344;GASTROESOPHAGEAL REFLUX DISEASE#0.7344;CLINICAL PRACTICE GUIDELINE#0.7344;COMPLETE BLOOD COUNT#0.7339;MEDULLOBLASTOMA#0.7323;UVEITIS#0.7322;BETA-2#0.7317;SUPEROXIDE DISMUTASE#0.7312;HIGH DOSE RATE#0.7311;ESTIMATED BLOOD LOSS#0.7305;ALCOHOLIC FATTY LIVER#0.7302;LYMPH NODE DISSECTION#0.7301;AMPHOTERICIN#0.7301;HEPATIC ARTERY#0.7294;DIFFUSE LARGE B-CELL LYMPHOMA#0.7293;ORAL SQUAMOUS CELL CARCINOMA#0.7287;PEELING#0.7287;LIVER CANCER#0.7286;CEREBRAL INFARCTION#0.7286;CONVERSION DISORDER#0.7286;OVARIAN CARCINOMA#0.7280;NEURITE OUTGROWTH#0.7279;LIVER METASTASIS#0.7278;EVEROLIMUS#0.7274;CELECOXIB#0.7259;LOSS OF CONTROL#0.7259;BASAL GANGLIA#0.7258;BLOOD PLASMA#0.7255;THEORY OF MIND#0.7251;OMALIZUMAB#0.7248;GLUCOSE HOMEOSTASIS#0.7243;PARTIAL LEAST SQUARE#0.7230;FILARIASIS#0.7229;GERIATRIC DEPRESSION SCALE#0.7222;TRANEXAMIC ACID#0.7205;TOLL LIKE RECEPTOR#0.7204;ACTIVATED T CELL#0.7204;BIRTH DEFECT#0.7203;OVULATION#0.7198;BLOOD CLOT#0.7194;SPASTIC CEREBRAL PALSY#0.7190;DEVELOPMENTAL DELAY#0.7169;UBIQUITIN#0.7160;L-CARNITINE#0.7159;GINSENG#0.7157;OLANZAPINE#0.7151;PRIMARY BREAST CANCER#0.7151;HYPOTHALAMIC PITUITARY ADRENAL#0.7146;FRAGMENT LENGTH POLYMORPHISM#0.7126;DIABETIC NEPHROPATHY#0.7126;SCHWANN CELL#0.7123;HYPERTROPHIC CARDIOMYOPATHY#0.7116;CELLULAR GROWTH#0.7115;HIP JOINT#0.7114;THETA BURST STIMULATION#0.7112;TRYPTOPHAN#0.7110;ADVERSE DRUG EVENT#0.7108;DRUG DELIVERY SYSTEM#0.7104;LUMBAR DISC HERNIATION#0.7102;MOTOR ACTIVITY#0.7100;METHIONINE#0.7100;MODAL#0.7099;URETHRAL STRICTURE#0.7095;ESOPHAGITIS#0.7093;CARNITINE#0.7089;RISK OF DEATH#0.7089;RESPONSE TO EXERCISE#0.7082;ENCEPHALOMYELITIS#0.7078;CARDIOVASCULAR SYSTEM#0.7071;DEPOT-MEDROXYPROGESTERONE ACETATE#0.7070;RESIDUAL RENAL FUNCTION#0.7064;MITOCHONDRIAL DNA#0.7062;UTERUS#0.7060;RETINOL#0.7050;INTRACRANIAL ANEURYSM#0.7047;BLINDNESS#0.7044;SMALL INTESTINE#0.7041;SOCIAL BEHAVIOR#0.7040;PERICARDIAL EFFUSION#0.7029;IRRITABILITY#0.7016;PROSTATE CANCER SCREENING#0.7008;ANKLE BRACHIAL INDEX#0.7005;TRANSMISSION ELECTRON MICROSCOPY#0.7000;HAIR LOSS#0.6996;DRUG ELUTING STENT#0.6991;DIABETIC POLYNEUROPATHY#0.6989;SUBSTANCE DEPENDENCE#0.6987;RIVAROXABAN#0.6982;HEAT SHOCK PROTEIN#0.6975;DECITABINE#0.6974;RITONAVIR#0.6973;CYSTIC ECHINOCOCCOSIS#0.6969;AMBLYOPIA#0.6969;CIGARETTES PER DAY#0.6966;GABA A RECEPTOR#0.6962;ACETYLCHOLINE#0.6954;ENDOMETRIAL CARCINOMA#0.6953;VISCERAL ADIPOSE TISSUE#0.6952;SYNCOPE#0.6948;INCIDENCE RATE RATIO#0.6946;WHOLE GENOME SEQUENCING#0.6945;FAT PAD#0.6942;HIDRADENITIS SUPPURATIVA#0.6941;NON-SMALL CELL LUNG CARCINOMA#0.6941;SODIUM BICARBONATE#0.6938;MESENCHYMAL STROMAL CELL#0.6935;CHOLANGIOCARCINOMA#0.6934;TISSUE REGENERATION#0.6930;DIPEPTIDYL PEPTIDASE 4#0.6927;INFLIXIMAB#0.6922;ITCHING#0.6917;BODY FAT PERCENTAGE#0.6912;MALIGNANT BRAIN TUMOR#0.6911;ENCAINIDE#0.6910;HEPATITIS A#0.6909;MEATUS#0.6909;NICOTINE REPLACEMENT THERAPY#0.6900;ARA-C#0.6898;EPIRUBICIN#0.6896;LYMPHOCYTIC LEUKEMIA#0.6892;QUETIAPINE#0.6891;HIGH RISK NEUROBLASTOMA#0.6890;ACIDIFICATION#0.6889;AMANTADINE#0.6889;SEBORRHEIC DERMATITIS#0.6886;EARLY GASTRIC CANCER#0.6883;ISCHEMIA REPERFUSION INJURY#0.6881;UTERINE FIBROID#0.6879;HYDROXYUREA#0.6875;SIGNALING MOLECULE#0.6873;CARDIOMYOCYTE#0.6872;RECEPTOR TYROSINE KINASE#0.6870;ANTIBODY MEDIATED REJECTION#0.6868;TRAPEZIUS#0.6866;ALPHA-TOCOPHEROL#0.6862;MITOGEN ACTIVATED PROTEIN#0.6857;CALCIUM CARBONATE#0.6852;FIBRINOLYSIS#0.6839;ATENOLOL#0.6834;PHENYLKETONURIA#0.6822;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.6821;MUTAGENESIS#0.6817;BONE MARROW ASPIRATE#0.6810;CREATINE KINASE#0.6808;HYPERURICEMIA#0.6803;RIFAMPIN#0.6793;PAPILLOMA#0.6792;DYSKINESIA#0.6789;PNEUMOTHORAX#0.6787;TIBIA#0.6785;INFLAMMATORY CELL#0.6784;ADHD RATING SCALE#0.6783;ENVIRONMENTAL TOBACCO SMOKE#0.6783;HYDROXYCHLOROQUINE#0.6780;ENDOSCOPIC SINUS SURGERY#0.6776;ACUTE LEUKEMIA#0.6771;INTERFERON BETA-1B#0.6770;OSTEOGENESIS#0.6766;EXOSOME#0.6766;DESMOPRESSIN#0.6763;CANCER STEM CELL#0.6751;SHORTNESS OF BREATH#0.6750;PLASMA CELL#0.6748;EPSTEIN BARR VIRUS#0.6746;TRACHEA#0.6746;BONE MORPHOGENETIC PROTEIN#0.6738;BETA CELL#0.6735;ABACAVIR#0.6733;TETRAHYDROCANNABINOL#0.6731;TH2 CELL#0.6731;MENTAL RETARDATION#0.6730;ACTINIC KERATOSIS#0.6729;PULMONARY FIBROSIS#0.6728;NARCOTIC#0.6724;SHORT TERM MEMORY#0.6724;CONTROL GROUP 1#0.6723;NEUROMUSCULAR DISEASE#0.6718;ALPHA 1-ANTITRYPSIN#0.6717;RADICULOPATHY#0.6709;BONE MARROW CELLS#0.6707;INVASIVE DUCTAL CARCINOMA#0.6705;CARDIAC TROPONIN I#0.6699;RIO DE JANEIRO#0.6685;TETRACYCLINE#0.6677;KERATOSIS#0.6671;AGGRESSIVE PERIODONTITIS#0.6669;DRY MOUTH#0.6667;CHOLINE#0.6666;THYROIDITIS#0.6665;VASOPRESSIN#0.6664;UVEAL MELANOMA#0.6656;BLOOD UREA NITROGEN#0.6652;NIACIN#0.6651;PORTAL VEIN#0.6651;DISABILITY STATUS SCALE#0.6638;FACTOR VIII#0.6636;FLUDARABINE#0.6636;ACUTE MYELOID LEUKAEMIA#0.6633;HALOPERIDOL#0.6633;CYTARABINE#0.6627;ANKYLOSING SPONDYLITIS#0.6624;SEWAGE TREATMENT PLANT#0.6620;FAT FREE MASS#0.6609;INTERNAL LIMITING MEMBRANE#0.6606;NKT CELL#0.6605;THROMBOPLASTIN#0.6602;PARATHYROID GLAND#0.6598;MYOSIN HEAVY CHAIN#0.6598;DRINKING BEHAVIOR#0.6598;COLON CARCINOMA#0.6597;HEALTHY EATING INDEX#0.6597;BONE MARROW FAILURE#0.6592;HEMATURIA#0.6592;BINDING PROTEIN 1#0.6582;NODULAR#0.6580;NEUROTRANSMISSION#0.6576;TH1 CELL#0.6575;ACUTE LIVER FAILURE#0.6575;LUCIFERASE ACTIVITY#0.6573;INSTITUTE OF MEDICINE#0.6563;PAROXYSMAL ATRIAL FIBRILLATION#0.6560;IDARUBICIN#0.6560;ESTRAMUSTINE#0.6559;CARRIE#0.6550;SENTINEL NODE BIOPSY#0.6548;ASCITES#0.6542;SUSTAINED VIROLOGICAL RESPONSE#0.6541;PEROXISOME#0.6541;FETAL ALCOHOL SPECTRUM DISORDER#0.6539;FETAL ALCOHOL SPECTRUM#0.6538;AUTOPHAGY#0.6535;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.6533;DABIGATRAN#0.6528;TENOFOVIR#0.6525;PLATELET-DERIVED GROWTH FACTOR#0.6524;EXTERNAL BEAM RADIOTHERAPY#0.6519;FOLLICULAR PHASE#0.6504;BRONCHITIS#0.6502;MOTOR EVOKED POTENTIAL#0.6499;AUTONOMIC NEUROPATHY#0.6497;NEURALGIA#0.6495;SILDENAFIL#0.6491;PERITONITIS#0.6490;LOCOMOTION#0.6486;BURNING MOUTH SYNDROME#0.6485;T CELL ANERGY#0.6480;RETINAL VEIN OCCLUSION#0.6465;INNATE IMMUNITY#0.6462;ATROPINE#0.6456;PARACETAMOL#0.6452;MYOPATHY#0.6442;CONFIRMATORY FACTOR ANALYSIS#0.6434;ADVANCED COLORECTAL CANCER#0.6433;ORTHOTOPIC LIVER TRANSPLANTATION#0.6424;MINIMAL HEPATIC ENCEPHALOPATHY#0.6423;SLOW TRANSIT CONSTIPATION#0.6420;NEURITE#0.6417;GLUTEUS MEDIUS#0.6416;DUODENUM#0.6413;DISEASE ASSESSMENT SCALE#0.6409;CETUXIMAB#0.6402;SENSORINEURAL HEARING LOSS#0.6402;GASTRIC ADENOCARCINOMA#0.6397;MOHS MICROGRAPHIC SURGERY#0.6388;HERPES SIMPLEX#0.6387;VASCULITIS#0.6386;BTX-A#0.6383;PROPRANOLOL#0.6381;NEUROENDOCRINE TUMOR#0.6379;AMNIOTIC FLUID#0.6374;IMMUNOSUPPRESSANT#0.6373;DULOXETINE#0.6373;DEHYDRATION#0.6372;INSULIN RECEPTOR#0.6367;MAP KINASE#0.6366;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6359;DIURESIS#0.6357;ZONISAMIDE#0.6343;MAMMARY GLAND#0.6343;MYOBLAST#0.6337;TUMOR TISSUES#0.6335;SODIUM HYALURONATE#0.6334;L-ARGININE#0.6332;PERCENT BODY FAT#0.6331;TIREDNESS#0.6330;METHADONE MAINTENANCE TREATMENT#0.6326;PROSTATITIS#0.6325;METRONIDAZOLE#0.6324;CLARITHROMYCIN#0.6320;EMESIS#0.6316;CENTRAL NERVOUS SYSTEM CANCER#0.6309;GROUND REACTION FORCE#0.6302;CLAVULANIC ACID#0.6298;PSYCHOTIC DISORDER#0.6291;AMIFOSTINE#0.6288;NODULAR BASAL CELL CARCINOMA#0.6285;HYALURONATE#0.6277;COLORECTAL LIVER METASTASES#0.6276;HYDROCEPHALUS#0.6271;LIMIT OF DETECTION#0.6268;MUSCLE WEAKNESS#0.6266;DIAZEPAM#0.6259;TOLUENE#0.6254;GERM CELL TUMORS#0.6243;HEPATOTOXICITY#0.6240;GI TRACT#0.6236;SPIRONOLACTONE#0.6235;PLACENTAL GROWTH FACTOR#0.6234;SICKLE CELL ANEMIA#0.6234;SPINA BIFIDA#0.6233;EFAVIRENZ#0.6227;MYELOFIBROSIS#0.6224;ALLERGIC CONTACT DERMATITIS#0.6219;IMATINIB#0.6215;INGUINAL HERNIA#0.6214;TRICHOTILLOMANIA#0.6214;SUSTAINED VIRAL RESPONSE#0.6212;VITAMIN B12#0.6211;NERVOUS SYSTEM CANCER#0.6208;POSTERIOR CEREBRAL ARTERY#0.6204;ONCOGENIC#0.6203;SPINDLE FORMATION#0.6202;PROGESTERONE-RECEPTOR POSITIVE BREAST CANCER#0.6193;HYPOTENSIVE#0.6190;LICHEN PLANUS#0.6188;HALLUCINATIONS#0.6182;ADVANCED PANCREATIC CANCER#0.6180;DOBUTAMINE#0.6178;BREATHLESSNESS#0.6177;KIDNEY TRANSPLANT PATIENTS#0.6174;DIABETIC NEUROPATHY#0.6173;OOCYTE MATURATION#0.6169;ASTIGMATISM#0.6166;T CELL DEVELOPMENT#0.6164;LIPOIC ACID#0.6162;DIDANOSINE#0.6159;GYNECOLOGIC ONCOLOGY GROUP#0.6147;DNA REPAIR#0.6144;NEURON SURVIVAL#0.6144;ONYCHOMYCOSIS#0.6143;MEMORY LOSS#0.6143;GLIDE#0.6142;URETER#0.6136;ALPHA AMYLASE#0.6135;PROTEIN KINASE C#0.6134;LACTULOSE#0.6130;RESTING ENERGY EXPENDITURE#0.6130;OTITIS MEDIA#0.6128;HEMIPLEGIA#0.6128;LEVETIRACETAM#0.6126;MOTOR VEHICLE CRASH#0.6124;NEWBORN HEARING SCREENING#0.6120;TOPOTECAN#0.6119;CARCINOGEN#0.6112;STATUS EPILEPTICUS#0.6110;FALSE POSITIVE RATE#0.6100;FAMILIAL HYPERCHOLESTEROLEMIA#0.6096;INFERIOR FRONTAL GYRUS#0.6093;ANAL CANAL#0.6089;GRAVES' DISEASE#0.6084;HAMSTRING#0.6078;LEFT VENTRICULAR MASS#0.6078;TAMSULOSIN#0.6073;VERTEBRA#0.6072;METOPROLOL#0.6070;OPPOSITIONAL DEFIANT DISORDER#0.6067;TOTAL ANTIOXIDANT CAPACITY#0.6066;ADAPTIVE IMMUNE RESPONSE#0.6064;ORAL PREMALIGNANT LESIONS#0.6063;ASPHYXIA#0.6063;ESSENTIAL HYPERTENSION#0.6061;LEFT ANTERIOR DESCENDING#0.6058;RHEUMATIC HEART DISEASE#0.6056;IL-1RA#0.6049;NMDA RECEPTOR#0.6044;GENETIC DISORDER#0.6040;SCHISTOSOMIASIS#0.6039;NEUROGENIC BLADDER#0.6037;POLYNEUROPATHY#0.6032;PAIN DISORDER#0.6025;CHRONIC LIVER FAILURE#0.6019;MASTICATION#0.6013;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6012;INSULIN SECRETION#0.6012;ANTITHYMOCYTE GLOBULIN#0.6011;STABLE ANGINA PECTORIS#0.6001
1961	EARLY GROWTH RESPONSE#1.0527;TRANSCRIPTION FACTOR#1.0335;GENE EXPRESSION#0.9815;GROWTH FACTOR#0.9593;DNA BINDING#0.8906;ZINC FINGER PROTEIN#0.8676;GERM CELL#0.8654;CELL GROWTH#0.7031;NERVOUS SYSTEM#0.6721;SIGNALING PATHWAY#0.6710;NERVE GROWTH FACTOR#0.6462;T CELL#0.6391;CELLULAR GROWTH#0.6284;IMMATURE NEURON#0.6277;LEYDIG CELL#0.6154;INFERTILITY#0.6132
196264	MYELIN PROTEIN ZERO#0.9143;HAIR LOSS#0.6880
196294	MITOCHONDRIAL INNER MEMBRANE#0.8156;PEPTIDASE COMPLEX#0.7049
1962	ENOYL COA HYDRATASE#1.0661;ACYL COA OXIDASE#1.0508;PEROXISOMAL#1.0439;FATTY ACID OXIDATION#1.0184;PEROXISOME#1.0006;COENZYME A#1.0002;PEROXISOME PROLIFERATION#0.9724;MITOCHONDRIA#0.9424;FATTY ACID BETA-OXIDATION#0.9424;CARNITINE#0.9348;FATTY ACID METABOLISM#0.9203;GENE EXPRESSION#0.9043;ACYL COA DEHYDROGENASE#0.8871;SKIN FIBROBLASTS#0.8231;DENSITY FUNCTIONAL THEORY#0.7955;PALMITOYL#0.7356;LIPID METABOLISM#0.7326;PROTEIN PROTEIN INTERACTION#0.6836;SIGNALING PATHWAY#0.6779;ENZYME ACTIVITY#0.6514;TRANSCRIPTION FACTOR#0.6498;RETINOIC ACID RECEPTOR#0.6358;RETINOIC ACID#0.6302;TRIFUNCTIONAL ENZYME#0.6280;BILE ACID BIOSYNTHESIS#0.6262
196383	CILIARY MEMBRANE#0.6459;PRIMARY CILIUM#0.6186;MOTOR ACTIVITY#0.6060
196394	CELL CYCLE#0.7375
196441	ZINC FINGER PROTEIN#0.8424;EXOSOME#0.7754
196463	OUTER MEMBRANE#0.6985;PROTEIN KINASE#0.6941;MEMBRANE FRACTION#0.6518;PROTEIN KINASE C#0.6081
196475	RHABDOMYOSARCOMA#0.7010;TRANSCRIPTION FACTOR#0.6977;MICROGLIAL CELL#0.6603;DNA METHYLATION#0.6524
1964	TRANSLATION INITIATION FACTOR#1.0466;PREINITIATION COMPLEX#1.0439;UVEAL MELANOMA#1.0409;EUKARYOTIC INITIATION FACTOR#1.0338;RIBOSOMAL SUBUNIT#1.0266;40S RIBOSOMAL SUBUNIT#1.0246;RIBOSOME#1.0199;TRANSLATION INITIATION#1.0195;PROTEIN SYNTHESIS#1.0045;THYROID CANCER#0.9662;GTP HYDROLYSIS#0.9224;GENE EXPRESSION#0.9055;THYROID CARCINOMA#0.8429;FOLLICULAR ADENOMA#0.8206;C TERMINAL DOMAIN#0.8005;80S RIBOSOME#0.7768;BASE PAIRING#0.7659;CELL PROLIFERATION#0.7291;MRNA BINDING#0.7187;REVERSE TRANSCRIPTION#0.6779;RNA BINDING#0.6306;PROTEIN TRANSLATION#0.6117;CILIARY BODY#0.6112;DNA REPLICATION#0.6019
196500	PLASMA MEMBRANE#0.6873;IMMUNE RESPONSE#0.6271
196513	P BODY#1.0600;DCP1-DCP2 COMPLEX#1.0334;MRNA DECAY#1.0121;MRNA DEGRADATION#1.0104;STRESS GRANULE#0.8451;RNA BINDING#0.8304;CYTOPLASMIC FOCI#0.7658;CYTOPLASM#0.7167;GENE EXPRESSION#0.6838;RNA BINDING PROTEIN#0.6652;TRANSLATION INITIATION#0.6358;RNA GRANULE#0.6244
196527	SCOTT SYNDROME#1.1205;PHOSPHOLIPID SCRAMBLING#1.0862;PHOSPHOLIPID SCRAMBLASE#1.0777;SCRAMBLASE#1.0756;PHOSPHATIDYLSERINE#1.0417;ION CHANNEL#1.0402;PLASMA MEMBRANE#1.0283;CHLORIDE CHANNEL#1.0253;CELL DEATH#0.9878;APOPTOSIS#0.9795;CATION CHANNEL#0.9735;EPITHELIAL CELL#0.9685;CHANNEL ACTIVITY#0.9022;ANION CHANNEL#0.8885;APOPTOTIC#0.8852;BLOOD COAGULATION#0.8751;SIGNALING PATHWAY#0.8508;COAGULATION#0.8283;CELL MIGRATION#0.8111;CELL MEMBRANE#0.8080;ION TRANSPORT#0.7796;CELL PROLIFERATION#0.7738;OSTEOBLAST#0.7441;SWELLING#0.7364;CELL SURFACE#0.7294;CYSTIC FIBROSIS#0.7016;PHOSPHOLIPASE A2#0.6882;IONOPHORE#0.6849;MACROPHAGE#0.6562;BLEBBING#0.6542;PLATELET ACTIVATION#0.6406;BONE MINERALIZATION#0.6303;MINERALIZATION#0.6265;PRIMARY CILIUM#0.6243;SMOOTH MUSCLE#0.6235;MEMBRANE BLEBBING#0.6146;AKT SIGNALING#0.6062
196528	HEPATOCELLULAR CARCINOMA#1.0252;FRONTAL#1.0128;CELL PROLIFERATION#1.0091;CHROMATIN REMODELING#1.0052;TUMOR SUPPRESSOR#0.9780;BLISTERING#0.9571;CONGENITAL HEART BLOCK#0.9411;CELL CYCLE#0.9352;GOLGI MEMBRANE#0.9168;GENE EXPRESSION#0.8837;EXTRACELLULAR MATRIX#0.8543;BULLOUS PEMPHIGOID#0.8424;SWI-SNF COMPLEX#0.8346;CHROMATIN REMODELING COMPLEX#0.8324;BASEMENT MEMBRANE#0.8302;INTELLECTUAL DISABILITY#0.8100;PBAF COMPLEX#0.7825;NEUROFILAMENT#0.7790;SCHWANN CELL#0.7575;HEPATOMA CELLS#0.7574;SIGNALING PATHWAY#0.7464;DIGESTION#0.7351;MUCOUS MEMBRANE PEMPHIGOID#0.7186;HEPATOCELLULAR CARCINOMA CELL#0.6809;HEPATITIS B#0.6542;CYTOPLASM#0.6528;LIVER CANCER#0.6378;PROTEOGLYCAN#0.6284;HEPARIN#0.6267;OCCIPITAL REGION#0.6203;CELL GROWTH#0.6062;GOLGI COMPLEX#0.6048
196541	HEAT SHOCK PROTEIN#0.6964;PROTEIN BREAKDOWN#0.6681
1965	HEME REGULATED INHIBITOR#1.0697;GTP HYDROLYSIS#1.0506;40S RIBOSOMAL SUBUNIT#1.0486;INTEGRATED STRESS RESPONSE#1.0463;PROTEIN SYNTHESIS INITIATION#1.0379;PREINITIATION COMPLEX#1.0321;PROTEIN PHOSPHATASE 1#1.0305;REGULATION OF PROTEIN SYNTHESIS#1.0270;NUCLEOTIDE EXCHANGE FACTOR#1.0269;PHOSPHATASE ACTIVITY#1.0258;PROTEIN TRANSLATION#1.0254;GUANINE#1.0232;TRANSLATION INITIATION FACTOR#1.0228;STRESS GRANULE#1.0221;ACTIVATING TRANSCRIPTION FACTOR#1.0212;DEPHOSPHORYLATION#1.0196;TRANSLATIONAL INITIATION#1.0189;PROTEIN KINASE R#1.0174;RIBOSOMAL SUBUNIT#1.0160;RETICULOCYTE#1.0148;EUKARYOTIC INITIATION FACTOR#1.0144;TRANSLATION INITIATION#1.0132;HERPES SIMPLEX VIRUS#1.0105;HERPES SIMPLEX#1.0102;PROTEIN P1#1.0086;KINASE ACTIVITY#1.0034;PROTEIN SYNTHESIS#0.9991;VIRAL INFECTION#0.9967;HEAT SHOCK PROTEIN#0.9965;RIBOSOME#0.9927;CELL GROWTH#0.9924;PROTEIN KINASE#0.9914;ISCHEMIA#0.9889;TRANSCRIPTION FACTOR#0.9878;POLYSOME#0.9877;COMPLEX I#0.9872;RNA BINDING#0.9870;RIBOSOMAL PROTEIN#0.9856;ER STRESS RESPONSE#0.9856;HEPATITIS C#0.9851;UNFOLDED PROTEIN RESPONSE#0.9845;SIGNALING PATHWAY#0.9840;CANCER CELL#0.9837;GLOBIN#0.9812;HEPATITIS C VIRUS#0.9795;CELL CYCLE#0.9790;CELL DEATH#0.9771;GENE EXPRESSION#0.9759;ENDOPLASMIC RETICULUM#0.9755;ENDOPLASMIC RETICULUM STRESS#0.9750;APOPTOSIS#0.9713;RAPAMYCIN#0.9700;EIF4E BINDING#0.9666;VIRAL REPLICATION#0.9657;APOPTOTIC#0.9629;VIRAL PROTEIN SYNTHESIS#0.9624;HOST CELL#0.9615;TUMOR CELLS#0.9599;GROWTH FACTOR#0.9599;SKELETAL MUSCLE#0.9584;GLUCOSE REGULATED PROTEIN#0.9572;BINDING PROTEIN 1#0.9561;TARGET OF RAPAMYCIN#0.9558;MEHMO SYNDROME#0.9550;VACCINIA#0.9529;T CELL#0.9517;REGULATION OF TRANSLATION#0.9486;METHIONINE#0.9485;RNA BINDING PROTEIN#0.9480;CELL PROLIFERATION#0.9465;AUTOPHAGY#0.9331;PROTEIN KINASE ACTIVITY#0.9322;CYCLIC AMP#0.9294;N-ETHYLMALEIMIDE#0.9254;HYPERPHOSPHORYLATION#0.9240;EPITHELIAL CELL#0.9198;RESPONSE TO AMINO ACID#0.9189;SODIUM DODECYL SULFATE#0.9139;SIGNAL TRANSDUCTION#0.9138;DODECYL SULFATE#0.9138;80S RIBOSOME#0.9083;ANTIVIRAL RESPONSE#0.9034;EUKARYOTIC ELONGATION FACTOR#0.8977;DSRNA BINDING#0.8880;RESPONSE TO STRESS#0.8850;IFN-GAMMA#0.8825;ENHANCER BINDING#0.8736;ARSENITE#0.8731;LEUCINE#0.8674;BASE PAIRING#0.8646;TRANSLATION INITIATION COMPLEX#0.8615;TOXICITY#0.8597;TUMOR NECROSIS FACTOR#0.8494;CYTOPLASM#0.8478;ENHANCER BINDING PROTEIN#0.8397;INDUCTION OF APOPTOSIS#0.8381;HYPOXIA#0.8331;SMALL RIBOSOMAL SUBUNIT#0.8296;ERYTHROID CELL#0.8285;C TERMINAL DOMAIN#0.8238;VESICULAR STOMATITIS VIRUS#0.8229;ALANINE#0.8217;PROTEASOME#0.8186;GLUTATHIONE#0.8158;ETHANOL#0.8147;BETA CELL#0.8106;MRNA BINDING#0.8061;REACTIVE OXYGEN SPECIES#0.8036;MOUSE EMBRYONIC FIBROBLAST#0.7990;TRNA BINDING#0.7986;GLUCOSE-6-PHOSPHATE#0.7978;TRANSFER RNA#0.7909;TRANSLATION ELONGATION#0.7891;MACROPHAGE#0.7778;PROTEIN FOLDING#0.7773;POLYRIBOSOME#0.7770;PROTEIN PROCESSING#0.7768;DOUBLE-STRANDED RNA BINDING#0.7709;INTELLECTUAL DISABILITY#0.7707;SPECTRIN#0.7669;PUROMYCIN#0.7668;PHOSPHATASE INHIBITOR#0.7647;LYSINE#0.7602;ARGININE#0.7589;MUTAGENESIS#0.7585;KINASE INHIBITOR#0.7551;ALZHEIMER'S DISEASE#0.7510;STEM CELL#0.7505;MOUSE EMBRYO FIBROBLASTS#0.7493;RESPONSE TO ER STRESS#0.7419;GTP BINDING#0.7410;SUCROSE#0.7382;APOPTOTIC CELL DEATH#0.7337;NITRIC OXIDE#0.7330;FACTOR I#0.7317;PROTEIN PHOSPHORYLATION#0.7264;HISTIDINE#0.7212;STOMATITIS#0.7199;60S RIBOSOMAL SUBUNIT#0.7175;BREAST CANCER#0.7159;NEUROBLASTOMA#0.7154;TRANSLATIONAL ATTENUATION#0.7078;ASPARAGINE#0.7073;DOMINANT NEGATIVE MUTANT#0.7068;RNA INTERFERENCE#0.6980;CUGBP1-EIF2 COMPLEX#0.6976;LUNG CANCER#0.6974;GLYCOGEN SYNTHASE KINASE#0.6950;UBIQUITIN#0.6893;TRANSCRIPTIONAL CONTROL#0.6879;MODE OF ACTION#0.6859;PROTEIN PROTEIN INTERACTION#0.6843;ESSENTIAL AMINO ACID#0.6801;TRANSLATION REINITIATION#0.6757;MECHANISM OF ACTION#0.6708;BONE MARROW#0.6698;RIBOSOME BINDING#0.6697;MITOGEN ACTIVATED PROTEIN#0.6696;DIHYDROFOLATE REDUCTASE#0.6658;BRAIN ISCHEMIA#0.6578;TRANSCRIPTION ACTIVATOR#0.6537;IMMUNE SYSTEM#0.6516;RESPONSE TO HEAT#0.6380;TUMOR SUPPRESSOR#0.6294;REGULATION OF MRNA#0.6254;POST-TRANSLATIONAL MODIFICATION#0.6240;GERMINATION#0.6230;VANISHING WHITE MATTER#0.6203;TARGET OF RAPAMYCIN COMPLEX#0.6186;ADENOSINE#0.6146;PROTEIN DEGRADATION#0.6137;ENDOTHELIAL CELL#0.6098;RESPONSE TO OXIDATIVE STRESS#0.6073;DIGESTION#0.6067;TRANSLATION ELONGATION FACTOR#0.6056
196743	POLYAMINE OXIDASE ACTIVITY#1.0875;POLYAMINE OXIDASE#1.0528;DIAMINE OXIDASE#1.0471;POLYAMINE CATABOLISM#1.0240;PEROXISOMAL#1.0039;FLAVIN#1.0005;ORNITHINE DECARBOXYLASE#0.9986;CATABOLISM#0.9973;SPERMIDINE#0.9967;SPERMINE#0.9963;PUTRESCINE#0.9959;ORNITHINE#0.9958;POLYAMINE METABOLISM#0.9862;POLYAMINE BIOSYNTHESIS#0.9808;CELL DEATH#0.9722;REACTIVE OXYGEN SPECIES#0.9610;APOPTOSIS#0.9551;ADENOSYLMETHIONINE DECARBOXYLASE#0.9488;ALPHA-DIFLUOROMETHYLORNITHINE#0.9481;S-ADENOSYLMETHIONINE#0.9351;CANCER CELL#0.9297;NADPH OXIDASE#0.9259;ENZYME ACTIVITY#0.9206;PEROXISOME#0.9195;CYTOTOXICITY#0.9129;CELL PROLIFERATION#0.9062;ACETYLTRANSFERASE ACTIVITY#0.9028;CELL WALL#0.8996;CELL GROWTH#0.8942;GENE EXPRESSION#0.8622;TOXICITY#0.8176;GASTROINTESTINAL TRACT#0.8167;OXIDATIVE BURST#0.8165;AMINOGUANIDINE#0.8005;PROGRAMMED CELL DEATH#0.7865;TUMOR CELLS#0.7850;POLYAMINE HOMEOSTASIS#0.7822;FLAVIN ADENINE DINUCLEOTIDE#0.7777;ARGININE#0.7726;N ACETYLTRANSFERASE#0.7674;EXCRETION#0.7485;DECARBOXYLASE ACTIVITY#0.7484;ISCHEMIA#0.7460;SPERMIDINE SYNTHASE#0.7437;POLYAMINE DEGRADATION#0.7376;SUPEROXIDE DISMUTASE#0.7363;COLON CARCINOMA#0.7134;LUNG CARCINOMA#0.7013;APOPTOTIC#0.6982;MACROPHAGE#0.6843;ARGININE DECARBOXYLASE#0.6778;MDL72527#0.6628;SPERMINE SYNTHASE#0.6566;POLYAMINE BIOSYNTHETIC#0.6537;ORNITHINE DECARBOXYLASE ACTIVITY#0.6491;POLYAMINE SYNTHESIS#0.6471;NITRIC OXIDE#0.6455;ADENINE#0.6362;PUTRESCINE FORMATION#0.6281;EDEMA#0.6243;DEXAMETHASONE#0.6239;POLYAMINE METABOLIC#0.6221;SMALL INTESTINE#0.6214;ADENOCARCINOMA#0.6201
1967	TRANSLATION INITIATION#1.0192;VANISHING WHITE MATTER#0.9960;TRANSLATION INITIATION FACTOR#0.9888;EUKARYOTIC INITIATION FACTOR#0.9529;PROTEIN SYNTHESIS#0.8889;LEUKOENCEPHALOPATHY#0.8351;NUCLEOTIDE EXCHANGE FACTOR#0.8155;GUANINE#0.8001;LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER#0.6478;INTEGRATED STRESS RESPONSE#0.6044
196883	GENE EXPRESSION#0.9141;PROTEIN KINASE#0.7579;GENE SILENCING#0.7523;SIGNALING PATHWAY#0.7440;ADENYLATE CYCLASE#0.7128;PROTEIN KINASE A#0.6949;POLYMERASE CHAIN REACTION#0.6753;POSTTRANSCRIPTIONAL GENE SILENCING#0.6584;CAMP SIGNALING#0.6062
1968	MEHMO SYNDROME#1.2371;TRANSLATION INITIATION#1.0800;TRANSLATION INITIATION FACTOR#1.0766;PROTEIN SYNTHESIS#1.0083;INTELLECTUAL DISABILITY#0.9288;RIBOSOMAL SUBUNIT#0.9049;GUANINE#0.8899;EUKARYOTIC INITIATION FACTOR#0.8864;NUCLEOTIDE EXCHANGE FACTOR#0.8806;RIBOSOME#0.7914;GTP BINDING#0.7828;HETEROTRIMERIC G-PROTEIN#0.6416;40S RIBOSOMAL SUBUNIT#0.6309
196996	EPITHELIAL CELL#0.7969
1969	LYMPH NODE METASTASIS#1.0626;PANCREATIC CANCER#1.0579;DASATINIB#1.0549;LYMPH NODE#1.0475;PROTEIN TYROSINE KINASE#1.0438;TYROSINE KINASE RECEPTOR#1.0401;OVARIAN CANCER#1.0384;PROSTATE CANCER#1.0365;EPHRIN RECEPTOR#1.0352;OVARIAN#1.0346;FOCAL ADHESION#1.0330;RENAL CELL CARCINOMA#1.0324;SQUAMOUS CELL CARCINOMA#1.0323;KINASE ACTIVITY#1.0316;CELL GROWTH#1.0310;COLORECTAL CANCER#1.0283;ADENOCARCINOMA#1.0282;BREAST CANCER CELL#1.0252;CELL MOTILITY#1.0240;EPHRIN#1.0226;FOCAL ADHESION KINASE#1.0207;TUMOR SUPPRESSOR#1.0200;COLORECTAL#1.0194;EPITHELIAL CELL#1.0186;LUNG CANCER#1.0177;PROTEIN KINASE#1.0176;BREAST CANCER#1.0169;HEPATOCELLULAR CARCINOMA#1.0161;GROWTH FACTOR RECEPTOR#1.0156;ONCOGENIC#1.0143;SIGNALING PATHWAY#1.0134;T CELL#1.0134;ANGIOGENESIS#1.0132;STEM CELL#1.0123;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0123;POLYMERASE CHAIN REACTION#1.0119;ENDOTHELIAL GROWTH FACTOR#1.0112;KINASE INHIBITOR#1.0106;CELL MIGRATION#1.0106;CANCER CELL#1.0103;EPIDERMAL GROWTH FACTOR#1.0099;CELL PROLIFERATION#1.0098;CELL SURFACE#1.0080;RECEPTOR TYROSINE KINASE#1.0077;CELL ADHESION#1.0069;GROWTH FACTOR#1.0065;ENDOTHELIAL CELL#1.0064;EPITHELIAL MESENCHYMAL TRANSITION#1.0062;OVARIAN CARCINOMA#1.0052;MITOGEN ACTIVATED PROTEIN#1.0051;APOPTOSIS#1.0044;CELL CYCLE#1.0037;INFLAMMATORY RESPONSE#1.0013;ENDOCYTOSIS#1.0011;TUMOR CELLS#0.9996;MONOCYTE#0.9993;SIGNALLING PATHWAY#0.9965;CD8+ T CELL#0.9963;DEPHOSPHORYLATION#0.9886;PLASMA MEMBRANE#0.9861;GLIOBLASTOMA MULTIFORME#0.9860;RECEPTOR LIGAND#0.9856;GENE EXPRESSION#0.9839;KAPOSI'S SARCOMA#0.9825;HYPOXIA#0.9791;LIGAND BINDING DOMAIN#0.9786;TRANSCRIPTION FACTOR#0.9786;VASCULAR ENDOTHELIAL CELL#0.9774;PACLITAXEL#0.9728;HUMAN BREAST CANCER#0.9674;EXTRACELLULAR MATRIX#0.9667;REVERSE TRANSCRIPTION#0.9626;COLON CANCER#0.9611;FIBROBLAST GROWTH FACTOR#0.9541;CYTOTOXICITY#0.9538;GENE SILENCING#0.9527;CELL CELL ADHESION#0.9509;TYROSINE KINASE INHIBITOR#0.9504;ENDOTHELIUM#0.9451;RNA INTERFERENCE#0.9430;AKT SIGNALING#0.9406;MACROPHAGE#0.9367;DENDRITIC CELL#0.9364;CELL MEMBRANE#0.9332;CELL DEATH#0.9315;MALIGNANT MESOTHELIOMA#0.9272;LEUKOCYTE#0.9243;BLOOD VESSEL#0.9101;SIGNAL TRANSDUCTION#0.9096;ENDOMETRIAL CANCER#0.9066;WOUND HEALING#0.9051;APOPTOTIC#0.9023;MALIGNANT GLIOMA#0.9017;ADENOID CYSTIC CARCINOMA#0.9004;BRAIN ENDOTHELIAL CELL#0.8998;MELANOMA CELL LINES#0.8995;PROTEIN TYROSINE PHOSPHATASE#0.8920;TRANSMEMBRANE RECEPTOR#0.8881;PANCREATIC ADENOCARCINOMA#0.8862;PROSTATE CARCINOMA#0.8829;B CELL#0.8801;STERILE ALPHA MOTIF#0.8760;GASTRIC ADENOCARCINOMA#0.8757;SURFACE PLASMON RESONANCE#0.8753;MICROVASCULAR ENDOTHELIAL CELL#0.8752;LIPID PHOSPHATASE#0.8732;HUMAN UMBILICAL VEIN#0.8723;UMBILICAL VEIN#0.8721;STRUCTURE ACTIVITY RELATIONSHIP#0.8642;BONE MARROW#0.8593;PERIPHERAL BLOOD#0.8591;KERATINOCYTE#0.8577;LIPID RAFT#0.8558;ANOIKIS#0.8543;TUBE FORMATION#0.8536;DOXAZOSIN#0.8481;TIGHT JUNCTION#0.8438;CELL CYCLE ARREST#0.8380;NEURAL CREST#0.8363;RECEPTOR ANTAGONIST#0.8305;DOCETAXEL#0.8289;CELL COMMUNICATION#0.8180;CETUXIMAB#0.8141;MEMBRANE TYPE 1#0.8135;OSTEOCLAST#0.8083;ANCHORAGE INDEPENDENT GROWTH#0.8063;TOXICITY#0.8057;DOXORUBICIN#0.8002;CANCER ASSOCIATED FIBROBLASTS#0.7981;METASTATIC MELANOMA#0.7971;MORPHOGENESIS#0.7956;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7941;SAM COMPLEX#0.7938;ONCOGENESIS#0.7906;NERVOUS SYSTEM#0.7886;SRC FAMILY KINASE#0.7881;NUCLEOTIDE EXCHANGE FACTOR#0.7859;17-DMAG#0.7835;OSTEOBLAST#0.7824;TUMOR TISSUES#0.7794;QUANTITATIVE REAL TIME#0.7774;CERVICAL#0.7768;CELL ADHESION MOLECULE#0.7751;MAMMARY EPITHELIAL CELL#0.7722;IMMUNE RESPONSE#0.7704;MAPK SIGNALING#0.7702;BLOOD BRAIN BARRIER#0.7675;ATHEROSCLEROSIS#0.7672;HOST CELL#0.7656;PROTEASOME#0.7653;PATTERN FORMATION#0.7583;SIGNALING CASCADE#0.7583;MAMMARY EPITHELIUM#0.7582;BLEOMYCIN#0.7571;MECHANISM OF ACTION#0.7563;INTEGRIN LIGAND#0.7550;BENZOIC ACID#0.7520;ATHEROSCLEROTIC#0.7464;HEPATOCELLULAR CARCINOMA CELL#0.7439;VASCULAR CELL#0.7404;ESTROGEN RECEPTOR#0.7368;PROGENITOR CELL#0.7365;CONJUGATION#0.7350;DRUG RESISTANCE#0.7340;CELL DIFFERENTIATION#0.7327;AXON GUIDANCE#0.7315;CORNEAL EPITHELIAL CELL#0.7307;TUMOR ASSOCIATED ANTIGEN#0.7306;ENDOTHELIAL CELL MIGRATION#0.7298;CELL KILLING#0.7289;MONONUCLEAR CELLS#0.7204;MESENCHYMAL STEM CELL#0.7197;RECEPTOR BINDING#0.7197;ASTROCYTOMA#0.7186;CD4+ T CELL#0.7128;HINDBRAIN#0.7072;COLORECTAL CARCINOMA#0.7068;LENS DEVELOPMENT#0.7056;HUMAN LENS EPITHELIAL#0.7042;TYROSINE KINASE DOMAIN#0.7036;ERLOTINIB#0.7033;RECEPTOR INTERNALIZATION#0.7030;GUANINE#0.7027;LUNG METASTASIS#0.7001;ACTIN CYTOSKELETON#0.6956;DUAL LUCIFERASE REPORTER#0.6904;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6890;BREAST CARCINOMA#0.6851;EXOSOME#0.6779;JUXTAMEMBRANE#0.6772;HYPOXIA INDUCIBLE FACTOR#0.6703;MELANOCYTE#0.6699;HYPOXIC#0.6668;CHIMERIC ANTIGEN RECEPTOR#0.6549;TUMOR ANTIGEN#0.6505;LUNG CARCINOMA#0.6469;DISEASE FREE SURVIVAL#0.6454;TUMOR NECROSIS FACTOR#0.6400;MACROPINOCYTOSIS#0.6339;TUMOR NODE METASTASIS#0.6308;IMMUNOTOXIN#0.6302;NEUROBLASTOMA#0.6279;STEM CELL MARKER#0.6257;LYMPH NODE METASTASES#0.6254;NEUTROPHIL#0.6243;HEPATOCYTE GROWTH FACTOR#0.6230;SPINAL CORD#0.6220;INVASIVE BREAST CANCER#0.6218;MALARIA#0.6204;EPSTEIN BARR VIRUS#0.6176;CORNEAL EPITHELIUM#0.6104;PI3K SIGNALING#0.6089;CELL RECOGNITION#0.6088;NEURAL CREST CELL#0.6079;ADHERENS JUNCTION#0.6063;BONE REMODELING#0.6053;ERBB SIGNALING#0.6028;GLUTAMINE METABOLISM#0.6022;CRANIAL NEURAL CREST#0.6005
196	ARYL HYDROCARBON RECEPTOR ACTIVITY#1.1169;AHR COMPLEX#1.0644;RECEPTOR AGONIST ACTIVITY#1.0539;IL-22 PRODUCTION#1.0517;BETA-NF#1.0491;RESPONSE TO DIOXIN#1.0482;THYROID HORMONE RECEPTOR#1.0473;RECEPTOR ACTIVITY#1.0402;HEMATOPOIETIC CELL#1.0401;CELL CYCLE CONTROL#1.0390;TREG CELL#1.0365;HEPATITIS B#1.0364;HEPATITIS B VIRUS#1.0355;LIVER PROGENITOR CELL#1.0348;GRANULOSA CELL#1.0339;RESVERATROL#1.0332;MAST CELL#1.0318;RECEPTOR LIGAND#1.0318;COMPLEX I#1.0318;FACTOR I#1.0317;RECEPTOR AGONIST#1.0315;CELL CYCLE REGULATION#1.0308;CONSTITUTIVE ANDROSTANE RECEPTOR#1.0302;CIGARETTE SMOKE CONDENSATE#1.0294;A-GEL#1.0283;NUCLEAR EXPORT#1.0281;TRYPTOPHAN METABOLISM#1.0280;BONE MARROW STROMAL#1.0278;CONTACT INHIBITION#1.0276;RECEPTOR COMPLEX#1.0263;ARYL HYDROCARBON RECEPTOR#1.0261;SIGNALLING PATHWAY#1.0259;OMEPRAZOLE#1.0253;UREMIC TOXIN#1.0246;LIGAND BINDING DOMAIN#1.0244;RECEPTOR ANTAGONIST#1.0238;T CELL DIFFERENTIATION#1.0218;BONE MARROW STROMAL CELL#1.0214;PREGNANE X RECEPTOR#1.0213;OVARIAN FOLLICLE#1.0210;L-TRYPTOPHAN#1.0209;TRANSFORMING GROWTH FACTOR BETA#1.0207;HEAT SHOCK PROTEIN#1.0200;RESPONSE TO TCDD#1.0199;CELL DEVELOPMENT#1.0197;RNA INTERFERENCE#1.0196;SIGNALING CASCADE#1.0194;FURAN#1.0187;NADPH OXIDASE#1.0182;HYPOXIA INDUCIBLE FACTOR#1.0179;INTESTINAL EPITHELIAL CELL#1.0174;STROMAL CELL#1.0173;PRIMARY HUMAN HEPATOCYTES#1.0172;MALE INFERTILITY#1.0167;ADIPOCYTE DIFFERENTIATION#1.0164;LUNG ADENOCARCINOMA#1.0161;PROTEASOME#1.0152;PANCREATIC CANCER#1.0148;MAMMARY EPITHELIAL CELL#1.0146;RECEPTOR BINDING#1.0146;LIVER CANCER#1.0138;ROS GENERATION#1.0137;SMOOTH MUSCLE CELL#1.0130;ELECTROPHORETIC MOBILITY SHIFT#1.0130;QUERCETIN#1.0129;PROSTATE DEVELOPMENT#1.0127;COLITIS#1.0121;ADAPTIVE IMMUNE RESPONSE#1.0116;ARYL HYDROCARBON HYDROXYLASE ACTIVITY#1.0114;DNA BINDING#1.0107;MUSCLE CELL#1.0105;DIESEL EXHAUST PARTICLE#1.0104;OXIDATIVE STRESS RESPONSE#1.0103;B CELL DIFFERENTIATION#1.0102;HYPOXIA#1.0102;CELL MIGRATION#1.0099;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#1.0094;XENOBIOTIC METABOLISM#1.0092;POLY ADP RIBOSE#1.0091;ANDROGEN RECEPTOR#1.0089;TRANSCRIPTION FACTOR#1.0087;LEFLUNOMIDE#1.0087;ESTROGEN RECEPTOR ALPHA#1.0082;TRANSACTIVATION#1.0082;NUCLEOCYTOPLASMIC SHUTTLING#1.0082;GLUCOCORTICOID RECEPTOR#1.0081;STEROID HORMONE RECEPTOR#1.0080;CD8+ T CELL#1.0079;PEROXISOME#1.0078;CARDIOMYOCYTE#1.0072;XENOBIOTIC METABOLIZING ENZYME#1.0070;REPORTER GENE ASSAY#1.0070;LUNG FIBROBLASTS#1.0069;CELL DIFFERENTIATION#1.0068;IMMUNE SUPPRESSION#1.0067;RETINOIC ACID RECEPTOR#1.0065;OXIDATIVE DNA DAMAGE#1.0060;UBIQUITIN#1.0055;SIGNAL TRANSDUCTION#1.0053;FATTY LIVER#1.0053;PROSTATE CANCER#1.0051;SUCROSE#1.0051;WOUND HEALING#1.0049;CELL ACTIVATION#1.0045;LIVER DEVELOPMENT#1.0045;BETA-NAPHTHOFLAVONE#1.0045;TRYPTOPHAN#1.0037;CROHN'S DISEASE#1.0034;CYTOPLASM#1.0034;INDOLE#1.0032;B CELL#1.0030;MARROW STROMAL CELLS#1.0030;KINASE ACTIVITY#1.0030;GERM CELL#1.0028;PSORIASIS#1.0027;HEMATOPOIETIC STEM CELL#1.0024;RETINOIC ACID#1.0023;ENCEPHALOMYELITIS#1.0022;DENDRITIC CELL#1.0017;TH17 CELL#1.0017;SENESCENCE#1.0015;IMMUNOTOXICITY#1.0013;COLON CARCINOMA#1.0008;RHEUMATOID ARTHRITIS#1.0008;LUCIFERASE ACTIVITY#1.0007;CELL CYCLE ARREST#1.0005;GASTROINTESTINAL TRACT#0.9999;SQUAMOUS CELL CARCINOMA#0.9995;CYTOKINE PRODUCTION#0.9995;EMBRYONIC STEM CELL#0.9993;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9990;ADIPOCYTE#0.9989;MICROVASCULAR ENDOTHELIAL CELL#0.9989;CLEFT PALATE#0.9985;SIGNALING PATHWAY#0.9985;KINASE INHIBITOR#0.9983;MAMMARY GLAND#0.9981;VITAMIN A#0.9979;RELATED ORPHAN RECEPTOR#0.9976;PHENANTHRENE#0.9974;BONE MARROW CELLS#0.9973;PROTEIN BINDING#0.9972;KERATINOCYTE#0.9969;MONONUCLEAR CELLS#0.9969;ETHANOL#0.9969;BREAST CARCINOMA#0.9968;GENISTEIN#0.9967;ESTROGEN RECEPTOR#0.9966;NEUROTOXICITY#0.9965;SMALL INTESTINE#0.9965;MUTAGENICITY#0.9963;PROTEIN COMPLEX#0.9963;STRUCTURE ACTIVITY RELATIONSHIP#0.9963;PROGENITOR CELL#0.9962;RETINOBLASTOMA#0.9960;NEUROGENESIS#0.9959;B LYMPHOCYTE#0.9959;CIRCADIAN RHYTHM#0.9958;OSTEOBLAST#0.9958;ENDOTHELIAL CELL#0.9958;TOLL LIKE RECEPTOR#0.9957;LYMPHOID CELL#0.9956;CARCINOGENICITY#0.9954;TERMINAL DIFFERENTIATION#0.9952;MONOCYTE#0.9951;BONE MARROW#0.9951;17β-ESTRADIOL#0.9950;COLON CANCER#0.9949;TUMOR SUPPRESSOR#0.9947;DERMATITIS#0.9947;ATOPIC DERMATITIS#0.9947;NUCLEAR LOCALIZATION SIGNAL#0.9945;SKIN DISEASE#0.9944;REGULATORY T CELL#0.9942;CELL ADHESION#0.9941;REGENERATION#0.9940;SMOOTH MUSCLE#0.9939;ENDOCRINE DISRUPTING CHEMICAL#0.9937;THYMOCYTE#0.9937;BREAST CANCER CELL#0.9937;STEM CELL#0.9936;STEROIDOGENESIS#0.9935;HEPATOMA CELLS#0.9934;VASCULAR ENDOTHELIAL CELL#0.9933;MODE OF ACTION#0.9932;MACROPHAGE#0.9931;NUCLEAR HORMONE RECEPTOR#0.9931;MITOGEN ACTIVATED PROTEIN#0.9930;ANGIOGENESIS#0.9929;ADIPOGENESIS#0.9929;ARACHIDONIC ACID#0.9926;T LYMPHOCYTE#0.9925;TRANSFORMING GROWTH FACTOR#0.9922;SIGNALING MOLECULE#0.9920;26S PROTEASOME#0.9915;SIGNAL TRANSDUCER#0.9915;UMBILICAL VEIN#0.9912;BRONCHIAL EPITHELIAL CELLS#0.9912;OVARIAN#0.9911;UTERUS#0.9911;LUNG CANCER#0.9905;INFLAMMATORY RESPONSE#0.9904;HEMATOPOIESIS#0.9904;IMMUNE CELL#0.9903;WASTING SYNDROME#0.9903;CYCLIN DEPENDENT KINASE#0.9902;HUMAN BREAST CANCER#0.9901;HEPATOTOXICITY#0.9900;CELL GROWTH#0.9898;KERATINOCYTE DIFFERENTIATION#0.9898;HYDRONEPHROSIS#0.9898;CELL CYCLE#0.9897;GENOTOXICITY#0.9894;SUPEROXIDE DISMUTASE#0.9893;LIPID METABOLISM#0.9890;CARDIOVASCULAR SYSTEM#0.9890;REVERSE TRANSCRIPTION#0.9890;AUTOIMMUNE DISEASE#0.9888;HYDROXYLASE ACTIVITY#0.9887;DRUG METABOLISM#0.9887;PROTEIN KINASE C#0.9885;DNA SYNTHESIS#0.9883;IMMUNOTOXIC#0.9882;HIGH FAT DIET#0.9882;CD4+ T CELL#0.9881;CANCER CELL#0.9879;OVARIAN CANCER#0.9877;BREAST CANCER#0.9875;CENTRAL NERVOUS SYSTEM#0.9874;SENSITIZATION#0.9873;EARLY LIFE STAGES#0.9871;HISTONE ACETYLATION#0.9869;RIBOSE#0.9869;CELLULAR HOMEOSTASIS#0.9866;MECHANISM OF ACTION#0.9866;T HELPER CELL#0.9864;TOXICANT#0.9864;PROTEIN SYNTHESIS#0.9862;PROTEIN PROTEIN INTERACTION#0.9861;ADENOCARCINOMA#0.9861;T CELL#0.9860;COLORECTAL#0.9859;ENDOMETRIAL CANCER#0.9858;NERVOUS SYSTEM#0.9855;COLLAGEN INDUCED ARTHRITIS#0.9853;HUMAN UMBILICAL VEIN#0.9848;MUTAGENESIS#0.9847;TUMOR CELLS#0.9843;DETOXIFICATION#0.9842;GROWTH FACTOR RECEPTOR#0.9842;PRO-INFLAMMATORY#0.9837;CELL SURFACE#0.9835;NEUTROPHIL#0.9834;MORPHOGENESIS#0.9834;KIDNEY DISEASE#0.9832;HEPATOCELLULAR CARCINOMA#0.9829;EXTRACELLULAR MATRIX#0.9827;CELL DEATH#0.9823;IMMUNE RESPONSE#0.9820;CYTOCHROME P450#0.9818;RIFAMPICIN#0.9818;PHENOBARBITAL#0.9817;ENDOTHELIAL GROWTH FACTOR#0.9817;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9817;IFN-GAMMA#0.9815;DEXAMETHASONE#0.9815;CELL PROLIFERATION#0.9813;HISTONE DEACETYLASE#0.9812;ASTROCYTE#0.9812;TRANSCRIPTASE#0.9811;PROGESTERONE#0.9811;MITOCHONDRIA#0.9810;RECEPTOR INTERACTING PROTEIN#0.9810;IMMUNE SYSTEM#0.9808;HEME OXYGENASE 1#0.9808;NITRIC OXIDE#0.9804;CHRONIC KIDNEY DISEASE#0.9802;ESTROGENS#0.9801;TOXICITY#0.9800;TERATOGENIC#0.9799;AUTOIMMUNITY#0.9799;DNA METHYLATION#0.9798;EPITHELIAL CELL#0.9798;GENE EXPRESSION#0.9792;CANCER STEM CELL#0.9790;INFERTILITY#0.9789;RETINOID X RECEPTOR#0.9789;QUANTITATIVE REAL TIME#0.9788;MUTAGENIC#0.9783;LYMPHOID TISSUE#0.9780;COLORECTAL CANCER#0.9779;TRANSCRIPTIONAL CONTROL#0.9777;GENOTOXIC#0.9775;LYMPH NODE#0.9774;LIVER DISEASE#0.9773;ANTHRACENE#0.9772;PROTEIN KINASE#0.9771;HUMAN BRONCHIAL EPITHELIAL#0.9770;PERSISTENT ORGANIC POLLUTANT#0.9770;S PHASE#0.9767;TUMOR NECROSIS FACTOR#0.9767;PERIPHERAL BLOOD#0.9766;ATHEROSCLEROSIS#0.9764;APOPTOTIC#0.9762;ENHANCER BINDING#0.9757;LEUKOCYTE#0.9756;APOPTOSIS#0.9755;GLUTATHIONE PEROXIDASE#0.9753;EPIDERMAL GROWTH FACTOR#0.9750;ADIPOSE TISSUE#0.9749;CATABOLISM#0.9747;INFLAMMATORY BOWEL DISEASE#0.9746;TRANSCRIPTION FACTOR BINDING#0.9745;HYPOXIC#0.9741;MELANOCYTE#0.9741;POLYMERASE CHAIN REACTION#0.9740;POLYCYCLIC AROMATIC HYDROCARBON#0.9734;GESTATION#0.9734;OXYGENASE#0.9733;G1 PHASE#0.9733;GROWTH FACTOR#0.9725;HYPERTENSION#0.9720;CATALYTIC ACTIVITY#0.9718;CARCINOGEN#0.9716;MECHANISMS OF ACTION#0.9714;CYTOTOXICITY#0.9712;OVARIES#0.9710;INSULIN-LIKE GROWTH FACTOR#0.9703;IL-10 PRODUCTION#0.9703;CELL POLARIZATION#0.9698;ALKALINE PHOSPHATASE#0.9696;LIVER DAMAGE#0.9695;ESTRADIOL#0.9689;CAFFEINE#0.9689;REPRODUCTIVE SYSTEM#0.9686;GLUTATHIONE#0.9686;REACTIVE OXYGEN SPECIES#0.9679;BETA-ESTRADIOL#0.9679;NUCLEAR IMPORT#0.9678;LUNG EPITHELIAL CELL#0.9673;ACTINOMYCIN D#0.9668;HUMAN EPIDERMAL KERATINOCYTES#0.9667;DNA REPAIR#0.9665;ANTIOXIDANT RESPONSE ELEMENT#0.9665;FIBROBLAST GROWTH FACTOR#0.9661;EDEMA#0.9660;ENHANCER BINDING PROTEIN#0.9658;DIFFERENTIAL GENE EXPRESSION#0.9653;ENZYME ACTIVITY#0.9648;MESENCHYMAL STEM CELL#0.9643;TESTOSTERONE#0.9632;MOUSE EMBRYONIC FIBROBLAST#0.9625;VASCULAR SMOOTH MUSCLE CELL#0.9625;OSTEOCLAST#0.9620;ENDOTHELIUM#0.9615;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9604;DNA DAMAGE RESPONSE#0.9603;IL-22 SECRETION#0.9598;EPOXIDE HYDROLASE#0.9597;FATTY LIVER DISEASE#0.9597;EXCRETION#0.9597;MULTIPLE SCLEROSIS#0.9593;SKIN CANCER#0.9590;LINES OF EVIDENCE#0.9586;FERTILIZATION#0.9584;QUANTITATIVE REVERSE TRANSCRIPTION#0.9579;LIVER X RECEPTOR#0.9577;DEXTRAN SODIUM SULFATE#0.9565;MAP KINASE#0.9563;RECEPTOR TRANSACTIVATION#0.9555;OOCYTE#0.9554;ESTROGEN METABOLISM#0.9553;LEYDIG CELL#0.9547;LIPID SYNTHESIS#0.9546;MICROSOME#0.9540;ESTROGEN SYNTHESIS#0.9532;MOLAR#0.9531;TISSUE HOMEOSTASIS#0.9531;PROTEIN DEGRADATION#0.9529;FARNESOID X RECEPTOR#0.9529;CHROMATIN REMODELING#0.9510;BREAST CANCER PATIENTS#0.9499;IMMUNOPHILIN#0.9495;NAIVE T CELL#0.9486;TYROSINE KINASE INHIBITOR#0.9485;EFFECTOR T CELL#0.9481;BENZIMIDAZOLE#0.9478;VITAMIN D RECEPTOR#0.9459;CORD BLOOD#0.9452;INFLUENZA A VIRUS#0.9443;T CELL ACTIVATION#0.9431;MITOCHONDRIAL MEMBRANE#0.9428;ARTERY#0.9426;ENDOPLASMIC RETICULUM#0.9425;ALANINE#0.9422;ABC TRANSPORTER#0.9413;ALLERGEN#0.9408;MUTAGEN#0.9408;CYTOCHROME C#0.9406;ATP BINDING#0.9393;REGULATION OF GENE EXPRESSION#0.9385;TOPICAL#0.9376;RECEPTOR ACTIVATOR#0.9368;INNATE IMMUNITY#0.9368;BLOOD VESSEL#0.9362;TAMOXIFEN#0.9362;GELDANAMYCIN#0.9360;LIVER REGENERATION#0.9348;PITUITARY ADENOMA#0.9346;LANGERHANS CELL#0.9341;INDUCTION OF APOPTOSIS#0.9338;PROTEIN TYROSINE KINASE#0.9333;CELL NUCLEUS#0.9323;GLUTAMINE#0.9322;CHLORAMPHENICOL#0.9317;ISCHEMIA#0.9315;CELL PHYSIOLOGY#0.9311;CELLULAR GROWTH#0.9303;ENDOMETRIOSIS#0.9293;FACTOR S#0.9287;NITRIC OXIDE SYNTHASE#0.9279;WEIGHT LOSS#0.9274;WEIGHT GAIN#0.9270;HEPATOCYTE NUCLEAR FACTOR#0.9269;DUCTUS VENOSUS#0.9260;VITAMIN E#0.9247;BONE RESORPTION#0.9236;BINDING PROTEIN 1#0.9221;ANTIOXIDANT ACTIVITY#0.9201;PROGRAMMED CELL DEATH#0.9198;ALDO KETO REDUCTASE#0.9192;GLYCOLYSIS#0.9178;GENE SILENCING#0.9177;ATP BINDING CASSETTE#0.9158;REPRODUCTIVE TOXICITY#0.9154;T CELL PROLIFERATION#0.9153;AUTOPHAGY#0.9152;HOMOLOGOUS RECOMBINATION#0.9139;NEURONAL CELLS#0.9122;MAST CELL ACTIVATION#0.9122;IN UTERO EXPOSURE#0.9108;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9102;INFLAMMATORY CELL#0.9098;ENDOCRINE SYSTEM#0.9096;HSP90 BINDING#0.9083;CELL MOTILITY#0.9082;CALCIUM SIGNALING#0.9079;IL-17 PRODUCTION#0.9073;N-ACETYLCYSTEINE#0.9061;LUNG DISEASE#0.9061;INGENUITY PATHWAY ANALYSIS#0.9056;YOLK SAC#0.9023;ACETIC ACID#0.9022;LUMINAL#0.9011;T CELL POLARIZATION#0.9005;GROWTH HORMONE#0.8994;BENZOTHIAZOLE#0.8980;NATURAL KILLER CELL#0.8969;CELLULAR LOCALIZATION#0.8960;MYELOID LEUKEMIA#0.8951;LOW DENSITY LIPOPROTEIN#0.8922;CIGARETTE SMOKE EXTRACT#0.8920;CAMP RESPONSE ELEMENT#0.8909;LACTATION#0.8905;HISTONE MODIFICATION#0.8896;ANTIGEN PRESENTING CELLS#0.8896;CHEMOKINE RECEPTOR#0.8891;AROMATASE ACTIVITY#0.8890;PROTON PUMP#0.8887;INNATE IMMUNE RESPONSE#0.8886;SEBACEOUS GLAND#0.8871;KETOCONAZOLE#0.8856;GINKGO BILOBA#0.8846;ESTROGEN RESPONSE ELEMENT#0.8833;NEUROTOXIC#0.8832;MELATONIN#0.8832;MRNA TRANSCRIPTION#0.8822;SIMVASTATIN#0.8822;PROTON PUMP INHIBITOR#0.8818;NEUROBLASTOMA#0.8818;PREADIPOCYTE#0.8814;GLUCOSE METABOLISM#0.8814;VIRAL INFECTION#0.8811;PROTEIN PHOSPHORYLATION#0.8810;DNA FRAGMENTATION#0.8807;GOBLET CELL#0.8807;ALLERGIC AIRWAY INFLAMMATION#0.8805;HEMATOPOIETIC PROGENITOR CELL#0.8797;ACTIVATED B CELL#0.8796;PAROTID GLAND#0.8795;PLASMA MEMBRANE#0.8783;GRAFT VERSUS HOST#0.8762;ICI 182,780#0.8761;HUMAN MAMMARY EPITHELIAL#0.8746;VEGF PRODUCTION#0.8746;CARDIOTOXIC#0.8740;EPITHELIAL TO MESENCHYMAL#0.8735;LYSINE#0.8730;BONE FORMATION#0.8729;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8727;RETICULOCYTE#0.8713;PLURIPOTENT STEM CELL#0.8709;THYMIDINE#0.8704;FLAVIN CONTAINING MONOOXYGENASE#0.8700;ORAL EPITHELIAL CELLS#0.8687;AGE RELATED MACULAR DEGENERATION#0.8680;QUANTITATIVE REVERSE TRANSCRIPTASE#0.8676;FATTY ACID OXIDATION#0.8675;MACULAR DEGENERATION#0.8675;TH1 CELL#0.8663;HUMORAL IMMUNE RESPONSE#0.8660;GLUCOSE HOMEOSTASIS#0.8658;ONCOGENIC#0.8657;OSTEOBLAST DIFFERENTIATION#0.8653;ARSENITE#0.8645;ENDOMETRIUM#0.8638;M PHASE#0.8636;DIGESTION#0.8626;RED BLOOD CELL#0.8623;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8617;PLASMA CELL#0.8615;PREGNENOLONE#0.8614;SKELETAL MUSCLE#0.8610;WORLD HEALTH ORGANIZATION#0.8605;DIMETHYL SULFOXIDE#0.8601;ENDOCRINE DISRUPTING COMPOUNDS#0.8590;OBESE#0.8583;HYPERSENSITIVITY#0.8581;EMBRYONIC KIDNEY#0.8573;PROXIMAL TUBULAR CELL#0.8569;MOUSE EMBRYO FIBROBLASTS#0.8555;C TERMINAL DOMAIN#0.8553;EPIGALLOCATECHIN#0.8544;BETA GALACTOSIDASE#0.8539;ASPARTATE#0.8534;ACETYLCYSTEINE#0.8531;OXIDATIVE METABOLISM#0.8517;GLUTATHIONE TRANSFERASE#0.8515;OSTEOGENESIS#0.8502;TRYPTOPHAN CATABOLISM#0.8501;NMDA RECEPTOR#0.8492;CELL MATURATION#0.8482;ERYTHROCYTE#0.8474;INTESTINAL MUCOSA#0.8473;MONOOXYGENASE ACTIVITY#0.8469;GINKGO BILOBA EXTRACT#0.8465;INHIBITION OF APOPTOSIS#0.8465;HEPATOCELLULAR CARCINOMA CELL#0.8463;CELL CYCLE REGULATOR#0.8450;LUNG CARCINOMA#0.8448;YELLOW FLUORESCENT PROTEIN#0.8441;QUIESCENCE#0.8436;CYTOTOXIC T-LYMPHOCYTE#0.8435;COMPOUND S#0.8425;CAMP RESPONSE ELEMENT BINDING#0.8416;IL-6 PRODUCTION#0.8416;SODIUM DODECYL SULFATE#0.8411;TROPHOBLAST#0.8410;DODECYL SULFATE#0.8410;EMBRYO DEVELOPMENT#0.8403;EPITHELIAL MESENCHYMAL TRANSITION#0.8401;MIDBRAIN#0.8387;ARGININE#0.8381;BRANCHING MORPHOGENESIS#0.8368;CONJUGATION#0.8362;ESTROUS CYCLE#0.8361;IMMUNE DYSFUNCTION#0.8360;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8353;URIDINE#0.8351;ORAL TOLERANCE#0.8337;NUCLEAR EXPORT SIGNAL#0.8336;DRUG RESISTANCE#0.8328;WASTEWATER TREATMENT PLANT#0.8327;BILE DUCT#0.8321;ACTIVATED T CELL#0.8313;MESENCHYMAL CELL#0.8298;GONAD#0.8297;STROMA#0.8293;WHITE BLOOD CELL#0.8291;CELL EXPANSION#0.8285;SIGNALLING CASCADE#0.8279;CELL DIVISION#0.8277;TERATOGEN#0.8261;DIET INDUCED OBESITY#0.8257;ALL TRANS RETINOIC ACID#0.8251;HEPATIC STELLATE CELL#0.8248;GLYCOGEN SYNTHASE KINASE#0.8233;OVULATION#0.8226;FLUTAMIDE#0.8217;GROWTH FACTOR BINDING#0.8217;ADENOSINE#0.8203;ACTIVATED T-CELLS#0.8197;DNA METHYLTRANSFERASE#0.8193;4-HYDROXYTAMOXIFEN#0.8170;PROTEIN KINASE A#0.8162;STAUROSPORINE#0.8162;FOLLICLE STIMULATING HORMONE#0.8156;INTRACELLULAR LOCALIZATION#0.8152;ACUTE PHASE RESPONSE#0.8149;CERVICAL#0.8146;EGF BINDING#0.8139;TRIIODOTHYRONINE#0.8138;INDUCIBLE NITRIC OXIDE#0.8138;MICROTUBULE#0.8137;TYPE 2 DIABETES#0.8131;DIHYDROTESTOSTERONE#0.8118;DOXORUBICIN#0.8115;LIMIT OF DETECTION#0.8112;BODY WEIGHT GAIN#0.8104;ULCERATIVE COLITIS#0.8096;CARDIAC DEVELOPMENT#0.8095;TOCOPHEROL#0.8090;CYTOCHROME P450 ACTIVITY#0.8085;SPERMATOGENESIS#0.8077;SYSTEM DEVELOPMENT#0.8065;DERMAL FIBROBLAST#0.8062;CELL MEMBRANE#0.8060;TH2 CELL#0.8059;INFERTILE#0.8054;RNA SYNTHESIS#0.8053;RETINAL PIGMENT EPITHELIAL#0.8052;B CELL ACTIVATION#0.8045;PYRUVIC ACID#0.8044;PRECURSOR CELL#0.8032;PORPHYRIA#0.8025;ACUTE MYELOID LEUKEMIA#0.8023;ENDOPLASMIC RETICULUM STRESS#0.8018;HUMAN INTESTINAL EPITHELIAL#0.8018;TIGHT JUNCTION#0.8004;PYRUVATE#0.7995;GLUCOSE UPTAKE#0.7990;GRANULOCYTE#0.7989;PERIODONTITIS#0.7985;LEUCINE#0.7983;NUCLEAR RECEPTOR SUPERFAMILY#0.7942;REPRODUCTIVE SENESCENCE#0.7904;OXIDATIVE PHOSPHORYLATION#0.7896;DEMETHYLATION#0.7896;CELL-MEDIATED IMMUNE RESPONSE#0.7887;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7884;CIGARETTE SMOKE EXPOSURE#0.7879;ACTIVATOR PROTEIN 1#0.7877;L-CYSTEINE#0.7876;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7873;CORTISOL#0.7867;PARTIAL LEAST SQUARE#0.7864;VASCULAR ENDOTHELIUM#0.7864;HEART DISEASE#0.7847;ROS FORMATION#0.7844;MACROPHAGE POLARIZATION#0.7823;PARKINSON'S DISEASE#0.7814;BLOOD BRAIN BARRIER#0.7806;DRAINING LYMPH NODE#0.7801;SEMINAL VESICLE#0.7798;ORGANIC ANION TRANSPORTER#0.7783;LUNG METASTASIS#0.7781;PKC ACTIVITY#0.7779;WHITE ADIPOSE TISSUE#0.7777;PRIMAQUINE#0.7775;DAYS POST FERTILIZATION#0.7749;TRANSCRIPTION FACTOR COMPLEX#0.7733;HEXANE#0.7726;MESENTERIC LYMPH NODE#0.7718;GAP JUNCTION#0.7710;FUNCTIONAL DIFFERENTIATION#0.7705;CYCLIN DEPENDENT KINASE INHIBITOR#0.7695;GLIAL CELL#0.7692;LUPUS ERYTHEMATOSUS#0.7690;HOST CELL#0.7685;PHOSPHOLIPASE A2#0.7681;REGULATION OF CELL PROLIFERATION#0.7668;MYOCYTES#0.7649;H POST FERTILIZATION#0.7643;EPITHELIAL CELL PROLIFERATION#0.7642;NULL CELL#0.7641;LYMPHOID TISSUE INDUCER#0.7625;ALLERGIC ASTHMA#0.7613;ALLERGIC RHINITIS#0.7612;HISTONE H3 ACETYLATION#0.7599;UMBILICAL CORD#0.7592;HATCHING#0.7588;LIGAND BINDING POCKET#0.7578;COLON ADENOCARCINOMA#0.7575;AKT SIGNALING#0.7574;TRANSFORMING GROWTH FACTOR ALPHA#0.7554;CANCER STEM-LIKE CELL#0.7541;STEROL REGULATORY ELEMENT#0.7530;WNT SIGNALING PATHWAY#0.7527;ANTIBODY PRODUCTION#0.7522;MONOCYTE DERIVED DENDRITIC CELL#0.7509;CALCIUM CHANNEL#0.7507;BASAL CELL#0.7501;OVAL CELL#0.7501;MAPK SIGNALING#0.7498;GM-CSF#0.7495;RETINOL#0.7488;NICOTINAMIDE#0.7488;PROTEIN DNA COMPLEX#0.7469;ASCORBIC ACID#0.7465;AUTOIMMUNE UVEITIS#0.7428;FOCAL ADHESION#0.7425;FATTY ACID SYNTHESIS#0.7400;NF-KAPPAB ACTIVATION#0.7389;TISSUE REGENERATION#0.7380;CONSTITUTIVELY ACTIVE MUTANT#0.7380;URINARY BLADDER#0.7371;NARINGENIN#0.7370;DNA REPLICATION#0.7368;B CELL LYMPHOMA#0.7358;BROMINATED FLAME RETARDANT#0.7351;MYOCARDIUM#0.7339;TUBE FORMATION#0.7328;CELL ASSOCIATED#0.7325;MYOSIN HEAVY CHAIN#0.7322;MENADIONE#0.7301;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7298;OSTEOPOROSIS#0.7293;IMIQUIMOD#0.7291;FRAGMENT LENGTH POLYMORPHISM#0.7286;FLAVIN#0.7284;SULINDAC#0.7275;VITAMIN D3#0.7271;GLUCONEOGENESIS#0.7264;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7262;PROSTAGLANDIN E2#0.7259;SMOOTH MUSCLE ACTIN#0.7258;PHAGOCYTOSIS#0.7228;DEXTRAN SULFATE SODIUM#0.7225;NLRP3 INFLAMMASOME ACTIVATION#0.7207;B CELL DEVELOPMENT#0.7202;TISSUE REMODELING#0.7197;NUCLEAR TRANSPORT#0.7195;HISTONE DEACETYLASE INHIBITOR#0.7187;TERMINAL END BUD#0.7184;ENERGY HOMEOSTASIS#0.7177;CHOLESTEROL BIOSYNTHESIS#0.7156;ANEMIA#0.7125;PACLITAXEL#0.7124;ATPASE ACTIVITY#0.7112;DOPAMINE#0.7112;MONOCYTE DERIVED MACROPHAGE#0.7098;RESPIRATION#0.7093;CHOLINE#0.7081;ORGANOGENESIS#0.7080;PEROXIDASE ACTIVITY#0.7069;AIRWAY EPITHELIAL CELL#0.7067;LIPOGENESIS#0.7067;CELL ADHESION MOLECULE#0.7064;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7055;THROMBOSIS#0.7047;HEPATOCYTE PROLIFERATION#0.7036;ACETAMINOPHEN#0.7034;SEQUENCE SPECIFIC DNA BINDING#0.7031;APOPTOTIC CELL DEATH#0.7028;NF KAPPAB BINDING#0.7008;BUDDING#0.6995;DIPHOSPHATE#0.6973;72-HOURS#0.6941;OVARIAN CARCINOMA#0.6940;GLAND DEVELOPMENT#0.6939;LANSOPRAZOLE#0.6933;METFORMIN#0.6921;LARGE INTESTINE#0.6916;RENAL CELL CARCINOMA#0.6914;COMPENDIUM#0.6908;EMBRYOTOXIC#0.6900;ADENINE#0.6894;INTERLEUKIN-22 PRODUCTION#0.6894;CYTOKINE RECEPTOR#0.6886;STEROIDOGENIC FACTOR 1#0.6868;MOLECULAR DYNAMICS SIMULATION#0.6866;EPITHELIAL BARRIER FUNCTION#0.6863;UROGENITAL SINUS#0.6859;B CELL APOPTOSIS#0.6854;BIRTH DEFECT#0.6852;RESPONSE TO OXIDATIVE STRESS#0.6845;CEREBRAL CORTEX#0.6843;BODY WEIGHT LOSS#0.6839;RECEPTOR-LIGAND COMPLEX#0.6829;PIGMENT EPITHELIAL CELL#0.6826;PRINCIPAL COMPONENT ANALYSIS#0.6825;APOPTOTIC PROCESS#0.6819;CHOLESTASIS#0.6819;ATP SYNTHASE#0.6814;CATECHOL O METHYLTRANSFERASE#0.6797;SPERMATOZOA#0.6794;CASPASE-3 ACTIVITY#0.6792;REGULATION OF INFLAMMATORY RESPONSE#0.6791;GUANINE#0.6791;PITUITARY GLAND#0.6790;O METHYLTRANSFERASE#0.6785;DEPHOSPHORYLATION#0.6782;HISTIDINE#0.6775;BERBERINE#0.6761;THYROID CANCER#0.6754;ARACHIDONIC ACID METABOLISM#0.6745;INFLAMMATORY BREAST CANCER#0.6729;EARLY GROWTH RESPONSE#0.6726;BEHCET'S DISEASE#0.6724;CELLULAR RESPIRATION#0.6723;REGULATION OF CELL GROWTH#0.6711;HEPATOCELLULAR ADENOMA#0.6706;CARDIAC ABNORMALITIES#0.6700;ANTIOXIDANT RESPONSIVE ELEMENT#0.6698;CYTOKINE SECRETION#0.6692;UVEITIS#0.6690;TISSUE DEVELOPMENT#0.6690;RETINAL PIGMENT EPITHELIAL CELLS#0.6683;OSTEOBLAST PROLIFERATION#0.6675;METAPLASIA#0.6670;STEM CELL LIKE#0.6669;SOY PROTEIN ISOLATE#0.6663;IL-8 PRODUCTION#0.6661;VASCULAR DISEASE#0.6658;OSTEOCLAST DIFFERENTIATION#0.6656;ATHEROSCLEROTIC#0.6655;CHORIOCARCINOMA#0.6653;CHOLESTEROL SYNTHESIS#0.6641;RUTIN#0.6639;HEPATITIS C#0.6637;COLLAGEN SYNTHESIS#0.6631;LUTEAL PHASE#0.6629;ENDOCRINE SIGNALING#0.6627;SPHINGOSINE 1 PHOSPHATE#0.6626;RESPONSE TO TREATMENT#0.6623;GLUCOSE INTOLERANCE#0.6621;AGEING#0.6610;POST-TRANSLATIONAL MODIFICATION#0.6610;EPSTEIN BARR VIRUS#0.6608;TUMOR TISSUES#0.6602;THYMOCYTE DIFFERENTIATION#0.6598;HUMAN HEPATOMA CELL LINES#0.6591;CLOFIBRATE#0.6562;FERMENTATION#0.6557;RESPONSE TO HYPOXIA#0.6553;OPTIC NERVE#0.6550;MULTIPLE LINEAR REGRESSION#0.6527;NEPHROGENESIS#0.6526;MICRONUCLEUS#0.6500;TISSUE DAMAGE#0.6499;CRANIOFACIAL DEVELOPMENT#0.6498;LYMPHOCYTE DIFFERENTIATION#0.6497;DETOXIFICATION RESPONSE#0.6474;TOOTH DEVELOPMENT#0.6470;GENE REGULATORY NETWORK#0.6465;1α,25-DIHYDROXYVITAMIN D3#0.6465;T CELL DEVELOPMENT#0.6465;MAST CELL HOMEOSTASIS#0.6463;GALACTOSIDASE ACTIVITY#0.6462;ORGAN DEVELOPMENT#0.6461;HEART DEVELOPMENT#0.6459;PHOTOLYSIS#0.6452;BODY WEIGHT RATIO#0.6445;PEROXISOMAL#0.6438;HUMAN DENDRITIC CELL#0.6437;RHINITIS#0.6436;NEURAL CREST#0.6436;SOLID PHASE EXTRACTION#0.6432;MULTIDRUG RESISTANCE PROTEIN#0.6430;INHIBITION OF CELL PROLIFERATION#0.6429;PERIPHERAL BLOOD LYMPHOCYTES#0.6424;LIPOPROTEIN LIPASE#0.6422;MOUSE EMBRYONIC STEM#0.6419;AMBIENT PARTICULATE MATTER#0.6416;MYELOID CELL#0.6411;DOMINANT NEGATIVE MUTANT#0.6411;PROTEIN FOLDING#0.6405;PHOSPHODIESTERASE#0.6401;NEUROLOGICAL DISORDER#0.6389;CISPLATIN#0.6376;FIN REGENERATION#0.6353;ION CHANNEL#0.6349;MYOCARDIAL INFARCTION#0.6345;LISTERIOSIS#0.6319;ESTRONE#0.6296;VITAMIN D RECEPTOR ACTIVITY#0.6292;EPIDIDYMIS#0.6290;TRYPTOPHAN DEGRADATION#0.6277;PYRAZOLE#0.6269;MINERALIZATION#0.6263;MESENCHYME#0.6262;LIPID HOMEOSTASIS#0.6258;SUMOYLATION#0.6250;ORAL MUCOSA#0.6248;ENVIRONMENTAL PROTECTION AGENCY#0.6236;UMBILICAL CORD BLOOD#0.6231;RENAL CARCINOMA#0.6227;1,10-PHENANTHROLINE#0.6223;LYMPHOCYTE PROLIFERATION#0.6221;GLUCOSE TRANSPORT#0.6216;DEATH RECEPTOR#0.6215;OESTRADIOL#0.6215;CELL COMMUNICATION#0.6213;PROSTATE CARCINOMA#0.6203;PHOSPHOLIPASE A#0.6202;VEMURAFENIB#0.6197;MALIGNANT GLIOMA#0.6195;HISTAMINE#0.6183;GERMINAL CENTER#0.6178;MULTIPLE MYELOMA#0.6175;FIBROBLAST LIKE SYNOVIOCYTES#0.6170;IRON OVERLOAD#0.6162;NONALCOHOLIC FATTY LIVER DISEASE#0.6161;EARLY TIME POINT#0.6161;ACETYLSALICYLIC ACID#0.6159;MITOCHONDRIAL DNA#0.6158;MANDIBLE#0.6156;MACROPHAGE ACTIVATION#0.6152;BRONCHOPULMONARY DYSPLASIA#0.6136;FAT PAD#0.6135;PERIPHERAL BLOOD CELLS#0.6133;SRC FAMILY KINASE#0.6129;BETA-2#0.6129;MESENCHYMAL STROMAL CELL#0.6128;MYELINATION#0.6126;CELLULAR METABOLISM#0.6123;DIURNAL#0.6120;MAPK ACTIVATION#0.6112;ISOQUINOLINE#0.6109;THIABENDAZOLE#0.6103;LINEAR REGRESSION ANALYSIS#0.6102;FRUCTOSE#0.6088;PANCREATITIS#0.6086;FEMALE REPRODUCTIVE SYSTEM#0.6084;POSTTRANSLATIONAL MODIFICATION#0.6074;TUBERCULOSIS#0.6067;SEMEN#0.6046;INTESTINAL STEM CELL#0.6033;REGULATION OF IMMUNE RESPONSE#0.6033;CAMP-RESPONSIVE ELEMENT BINDING#0.6033;CARRIE#0.6028;HIGH DENSITY LIPOPROTEIN#0.6013;TF BINDING#0.6010;CHEMOTAXIS#0.6010
197131	UBIQUITIN#1.0453;UBIQUITIN PROTEIN LIGASE#1.0259;PROTEASOME#0.9503;PROTEIN DEGRADATION#0.9441;EXOCRINE PANCREATIC INSUFFICIENCY#0.8809;DNA REPAIR#0.7161;PROTEIN KINASE#0.7142;MENTAL RETARDATION#0.6936;PROTEIN QUALITY CONTROL#0.6854;TRANSCRIPTION FACTOR#0.6387;UBIQUITIN PROTEASOME SYSTEM#0.6341
197135	OOCYTE MATURATION#1.0775;OOCYTE#1.0598;INFERTILITY#0.7950;GERMINAL VESICLE#0.7587;GONAD#0.6264
197257	LACTATE DEHYDROGENASE ACTIVITY#1.0840;L LACTATE DEHYDROGENASE#1.0600;D-LACTIC ACID#1.0371;SUCCINATE DEHYDROGENASE#1.0290;LACTIC ACID#1.0137;PYRUVATE#1.0062;SUCCINATE#0.9991;FERMENTATION#0.9855;FLAVIN#0.9753;ADENINE#0.9486;FORMATE#0.9474;LACTATE OXIDATION#0.9378;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9358;ELECTRON TRANSFER#0.9016;MITOCHONDRIA#0.8844;ENZYME ACTIVITY#0.8780;MEMBRANE FRACTION#0.8643;NICOTINAMIDE#0.8595;CYTOPLASMIC MEMBRANE#0.8534;NADH DEHYDROGENASE#0.8128;ETHANOL#0.8076;LACTATE METABOLISM#0.7968;MALATE DEHYDROGENASE#0.7892;ELECTRON TRANSPORT#0.7872;CYTOCHROME C#0.7816;MUTAGENESIS#0.7662;RESPIRATORY CHAIN#0.7346;GLYCOLATE OXIDASE#0.7299;LACTIC ACID BACTERIUM#0.7262;BUTYRYL COA DEHYDROGENASE#0.7252;FRUCTOSE#0.7118;TRYPTOPHAN#0.7074;ALANINE#0.6989;PYRUVATE KINASE#0.6983;GENE EXPRESSION#0.6840;FAD BINDING#0.6718;FLAVIN ADENINE DINUCLEOTIDE#0.6658;LACTIC ACID BACTERIA#0.6599;RESPIRATION#0.6567;COENZYME BINDING#0.6452;RIBOSOMAL PROTEIN#0.6305;AMINO ACID TRANSPORT#0.6074;FUMARATE#0.6055;METASTATIC LYMPH NODE#0.6052;BIOFILM FORMATION#0.6030
197258	FUCOSYLATION#0.7600
197259	NECROPTOSIS SIGNALING#1.0578;MIXED LINEAGE KINASE#1.0514;TNF-INDUCED NECROPTOSIS#1.0486;NECROSOME#1.0447;PLASMA MEMBRANE#1.0294;REGULATED NECROSIS#1.0224;CELL MEMBRANE#1.0223;NECROPTOSIS#1.0218;PROGRAMMED NECROSIS#1.0187;RECEPTOR INTERACTING PROTEIN#1.0185;NEUTROPHIL#1.0125;PROTEIN KINASE#1.0104;NECROTIC CELL DEATH#1.0044;INDUCTION OF NECROPTOSIS#1.0044;ACTIVATION OF NECROPTOSIS#1.0002;PYROPTOSIS#0.9976;KINASE ACTIVITY#0.9966;SIGNALING PATHWAY#0.9949;NECROTIC#0.9944;DEATH RECEPTOR#0.9925;MACROPHAGE#0.9886;AUTOPHAGY#0.9876;TUMOR NECROSIS FACTOR#0.9872;ISCHEMIA#0.9868;CANCER CELL#0.9854;CELL DEATH#0.9833;PROGRAMMED CELL DEATH#0.9827;PRO-INFLAMMATORY#0.9804;CLEAVED CASPASE 3#0.9799;INFLAMMATORY RESPONSE#0.9779;REACTIVE OXYGEN SPECIES#0.9773;EPITHELIAL CELL#0.9771;APOPTOSIS#0.9735;TOLL LIKE RECEPTOR#0.9717;APOPTOTIC#0.9642;REGULATED CELL DEATH#0.9620;CASPASE INHIBITOR#0.9574;ROS GENERATION#0.9562;ISCHEMIA REPERFUSION INJURY#0.9476;IMMUNE RESPONSE#0.9373;MITOCHONDRIA#0.9341;GENE EXPRESSION#0.9205;KINASE INHIBITOR#0.9058;TUMOR CELLS#0.9043;LUNG CANCER#0.8970;RELATED PROTEIN 1#0.8904;CYTOTOXICITY#0.8893;T CELL#0.8874;SIGNALING CASCADE#0.8866;IMMUNE CELL#0.8743;COLITIS#0.8730;LYSIS#0.8702;NLRP3 INFLAMMASOME ACTIVATION#0.8696;HIGH MOBILITY GROUP#0.8669;SIGNAL TRANSDUCTION#0.8514;BONE MARROW#0.8480;CISPLATIN#0.8413;TISSUE DAMAGE#0.8404;LIVER DISEASE#0.8354;APOPTOTIC CELL DEATH#0.8335;ACUTE KIDNEY INJURY#0.8327;TUMOUR NECROSIS FACTOR#0.8292;FERROPTOSIS#0.8264;MONOCYTE#0.8093;INFLAMMATORY CELL#0.7976;TOXICITY#0.7958;NEURODEGENERATIVE DISEASE#0.7943;INTESTINAL EPITHELIAL CELL#0.7902;CYTOPLASM#0.7902;CAMKII#0.7883;CARDIOMYOCYTE#0.7869;PLASMA MEMBRANE INTEGRITY#0.7813;RESPONSE TO TNF#0.7772;CELLULAR MEMBRANE#0.7761;ENDOTHELIAL CELL#0.7729;PROGRAMMED NECROTIC CELL DEATH#0.7704;HOST CELL#0.7649;HEAT SHOCK PROTEIN#0.7635;PHOSPHOGLYCERATE MUTASE#0.7613;MITOCHONDRIAL MEMBRANE#0.7576;HYPOXIA#0.7573;CATION CHANNEL#0.7495;NUCLEOTIDE BINDING#0.7485;PROPIDIUM#0.7445;PHOSPHATIDYLSERINE#0.7386;CASPASE-8 ACTIVITY#0.7372;CYTOKINE PRODUCTION#0.7357;OVARIAN CANCER#0.7353;NERVOUS SYSTEM#0.7221;POLY ADP RIBOSE#0.7209;COLON CANCER#0.7054;DNA BINDING#0.7032;PNEUMONIA#0.7017;CASPASE-INDEPENDENT CELL DEATH#0.6932;CELL KILLING#0.6845;EXTRACELLULAR VESICLE#0.6811;SIGNALING MOLECULE#0.6765;CELL SURFACE#0.6679;MITOCHONDRIAL PERMEABILITY TRANSITION#0.6672;OVARIAN#0.6651;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6611;DENDRITIC CELL#0.6578;CENTRAL NERVOUS SYSTEM#0.6571;PROTEASOME#0.6494;PROTEIN COMPLEX#0.6490;IDN-6556#0.6473;MYOCARDIAL INFARCTION#0.6451;VIRAL INFECTION#0.6359;TUBULAR EPITHELIAL CELL#0.6345;RIPOPTOSOME#0.6344;CASPASE ACTIVATION#0.6335;ADENOCARCINOMA#0.6321;MITOCHONDRIA-ASSOCIATED MEMBRANE#0.6286;OXYGEN GLUCOSE DEPRIVATION#0.6216;CERVICAL#0.6194;GROWTH FACTOR#0.6089
197322	MALONATE#1.0354;MALONIC ACID#0.7584;COENZYME A#0.7070;MALONYL COA DECARBOXYLASE#0.7052
197335	CASPASE-1 ACTIVITY#0.7835
197342	REPLICATION FORK#0.6269
197358	T CELL#1.0463;NUCLEOTIDE BINDING#0.9983;IMMUNE RESPONSE#0.9498;SIGNALING PATHWAY#0.8912;LEUCINE RICH REPEAT#0.8823;NUCLEOTIDE OLIGOMERIZATION DOMAIN#0.8514;INFLAMMATORY RESPONSE#0.8352;EPITHELIAL CELL#0.8227;GENE EXPRESSION#0.8020;LEUCINE#0.7850;TOLL LIKE RECEPTOR#0.7829;APOPTOSIS#0.7804;MACROPHAGE#0.7511;NALP3 INFLAMMASOME COMPLEX#0.7253;COLORECTAL CANCER#0.6992;T LYMPHOCYTE#0.6980;NUCLEOTIDE BINDING DOMAIN#0.6910;PATTERN RECOGNITION RECEPTOR#0.6877;QUANTITATIVE REAL TIME#0.6712;COLORECTAL#0.6462;T CELL ACTIVATION#0.6201;CELL ACTIVATION#0.6174;CELL PROLIFERATION#0.6072
197370	SMC5-SMC6 COMPLEX#1.0259;DNA REPAIR#0.8983;UBIQUITIN#0.6503
1973	RNA HELICASE ACTIVITY#1.0754;HELICASE ACTIVITY#1.0583;ATPASE ACTIVITY#1.0396;RNA HELICASE#1.0342;TRANSLATION INITIATION COMPLEX#1.0341;POLY-A BINDING#1.0334;CAP BINDING COMPLEX#1.0293;ATP HYDROLYSIS#1.0242;TRANSLATION INITIATION FACTOR#1.0154;RIBOSOME BINDING#1.0135;EIF4E BINDING#1.0114;PROTEIN SYNTHESIS INITIATION#1.0110;PROGRAMMED CELL DEATH#1.0090;TUMOR SUPPRESSOR#1.0088;RIBOSOMAL SUBUNIT#1.0084;TRANSLATION INITIATION#1.0062;EUKARYOTIC INITIATION FACTOR#1.0014;CELL DEATH#1.0007;ATP BINDING#0.9985;RIBOSOME#0.9949;RNA BINDING#0.9946;RETICULOCYTE#0.9894;PROTEIN COMPLEX#0.9893;CANCER CELL#0.9863;RNA DEPENDENT ATPASE#0.9741;PROTEIN SYNTHESIS#0.9732;MRNA CAP BINDING#0.9730;TRANSLATIONAL INITIATION#0.9705;GENE EXPRESSION#0.9700;RIBOSOMAL PROTEIN#0.9691;40S RIBOSOMAL SUBUNIT#0.9647;STRESS GRANULE#0.9604;CELL GROWTH#0.9547;PREINITIATION COMPLEX#0.9494;APOPTOSIS#0.9424;PROTEIN KINASE#0.9276;CELL CYCLE#0.9260;C TERMINAL DOMAIN#0.9239;BREAST CANCER#0.9162;CELL PROLIFERATION#0.9108;TARGET OF RAPAMYCIN#0.8948;RAPAMYCIN#0.8943;GLOBIN#0.8786;RNA BINDING PROTEIN#0.8721;PROTEIN TRANSLATION#0.8662;MRNA BINDING#0.8539;SIGNALING PATHWAY#0.8538;ONCOGENIC#0.8338;COMPLEX I#0.8204;GROWTH FACTOR#0.8203;BINDING PROTEIN 1#0.7988;HEPATITIS C#0.7876;HEPATITIS C VIRUS#0.7699;BREAST CANCER CELL#0.7639;COLORECTAL CANCER#0.7635;POLYSOME#0.7612;HOST CELL#0.7497;SMALL RIBOSOMAL SUBUNIT#0.7409;TUMOR CELLS#0.7339;DNA HELICASE#0.7339;CERVICAL CANCER#0.7242;EIF4G BINDING#0.7200;NUCLEIC ACID#0.6984;PROTEIN PROTEIN INTERACTION#0.6979;REGULATION OF TRANSLATION#0.6954;CYTOPLASM#0.6929;FOOT AND MOUTH DISEASE#0.6892;MOUTH DISEASE#0.6889;COLORECTAL#0.6680;RNA-DEPENDENT ATPASE ACTIVITY#0.6671;MUTAGENESIS#0.6653;RNA METABOLISM#0.6596;KINASE INHIBITOR#0.6283;B CELL#0.6257;TRANSCRIPTION FACTOR#0.6256
1974	HELICASE ACTIVITY#1.0747;RNA HELICASE#1.0654;TRANSLATION INITIATION FACTOR#1.0602;TRANSLATION INITIATION#1.0394;EUKARYOTIC INITIATION FACTOR#1.0382;RIBOSOME#0.9955;PROTEIN SYNTHESIS#0.9786;POLY-A BINDING#0.9563;CAP BINDING COMPLEX#0.9487;ATP HYDROLYSIS#0.9164;GENE EXPRESSION#0.9107;TRANSLATION INITIATION COMPLEX#0.9059;RNA HELICASE ACTIVITY#0.8608;RIBOSOMAL SUBUNIT#0.8377;PROTEIN SYNTHESIS INITIATION#0.8021;TRANSCRIPTION FACTOR#0.7816;CANCER CELL#0.7780;RNA BINDING#0.7582;BREAST CANCER#0.6990;CELL CYCLE#0.6649;RIBOSOME BINDING#0.6372;NERVE SHEATH TUMORS#0.6275;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.6267;ATPASE ACTIVITY#0.6226;PERIPHERAL NERVE#0.6047;ATP BINDING#0.6033
1975	POLY-A BINDING#1.0661;HELICASE ACTIVITY#1.0562;RNA HELICASE#1.0455;RNA HELICASE ACTIVITY#1.0303;RIBOSOMAL PROTEIN#1.0267;TRANSLATION INITIATION FACTOR#1.0258;ATP HYDROLYSIS#1.0248;RNA BINDING#1.0163;TRANSLATION INITIATION#1.0134;RIBOSOMAL SUBUNIT#1.0128;EUKARYOTIC INITIATION FACTOR#1.0116;PROTEIN TRANSLATION#1.0011;RIBOSOME#0.9941;APOPTOSIS#0.9883;PROTEIN KINASE#0.9757;PROTEIN SYNTHESIS#0.9745;RETICULOCYTE#0.9739;PROTEIN SYNTHESIS INITIATION#0.9630;SIGNALING PATHWAY#0.9608;RAPAMYCIN#0.9565;CANCER CELL#0.9556;TARGET OF RAPAMYCIN#0.9435;RNA RECOGNITION MOTIF#0.9343;RIBOSOME BINDING#0.8878;40S RIBOSOMAL SUBUNIT#0.8877;GENE EXPRESSION#0.8776;SMALL RIBOSOMAL SUBUNIT#0.8514;EIF4E BINDING#0.8477;PROTEIN COMPLEX#0.8466;GLOBIN#0.8448;RNA BINDING PROTEIN#0.8362;BREAST CANCER#0.8286;POLYPYRIMIDINE TRACT BINDING#0.8240;FOOT AND MOUTH DISEASE#0.8174;MOUTH DISEASE#0.8170;MRNA BINDING#0.8113;GROWTH FACTOR#0.7963;RNA DEPENDENT ATPASE#0.7962;CAP BINDING COMPLEX#0.7913;ATPASE ACTIVITY#0.7856;ASSOCIATIVE LEARNING#0.7800;RIBOSOMAL S6 KINASE#0.7757;PROTEIN PROCESSING#0.7744;TRANSLATIONAL INITIATION#0.7678;AMYLOID PRECURSOR PROTEIN#0.7634;CELL DEATH#0.7604;ALZHEIMER'S DISEASE#0.7582;STRESS GRANULE#0.7371;DEPHOSPHORYLATION#0.7254;ONCOGENIC#0.7189;BINDING PROTEIN 1#0.7110;CELL PROLIFERATION#0.7017;RNA INTERFERENCE#0.7011;CELL CYCLE#0.6880;POLYSOME#0.6811;CELL GROWTH#0.6770;KINASE INHIBITOR#0.6556;TOBACCO ETCH VIRUS#0.6402
1977	EIF4F ASSEMBLY#1.1231;EIF4G BINDING#1.0688;MRNA CAP BINDING#1.0578;TRANSLATION REPRESSOR#1.0533;RIBAVIRIN#1.0508;CREB BINDING#1.0506;EIF4E BINDING#1.0452;CAP BINDING COMPLEX#1.0412;TRANSLATION INITIATION COMPLEX#1.0398;TOBACCO ETCH VIRUS#1.0387;HISTONE ACETYLTRANSFERASE#1.0348;40S RIBOSOMAL SUBUNIT#1.0315;7-METHYLGUANOSINE#1.0311;PROTEIN SYNTHESIS INITIATION#1.0299;MRNA BINDING#1.0268;SMALL RIBOSOMAL SUBUNIT#1.0255;BREAST CARCINOMA#1.0236;MRNA TRANSPORT#1.0209;TRANSLATIONAL INITIATION#1.0205;RIBOSOMAL S6 KINASE#1.0194;CERVICAL#1.0192;TRANSLATION INITIATION FACTOR#1.0190;POLY-A BINDING#1.0188;BINDING PROTEIN 1#1.0177;HEAD AND NECK CANCER#1.0169;NECK CANCER#1.0168;RNA HELICASE#1.0164;LYMPH NODE#1.0158;GUANOSINE#1.0152;SQUAMOUS CELL CARCINOMA#1.0146;CISPLATIN#1.0128;DEPHOSPHORYLATION#1.0123;CERVICAL CANCER#1.0121;PROTEIN COMPLEX#1.0115;RIBOSOME BINDING#1.0108;COMPLEX I#1.0102;MRNA CAP BINDING COMPLEX#1.0099;TRANSLATION INITIATION#1.0096;REGULATION OF TRANSLATION#1.0096;ACUTE MYELOID LEUKEMIA#1.0096;PROSTATE CANCER#1.0096;EUKARYOTIC INITIATION FACTOR#1.0085;COLORECTAL CANCER#1.0083;NUCLEAR EXPORT#1.0080;RETICULOCYTE#1.0061;MYELOID LEUKEMIA#1.0057;ONCOGENIC#1.0055;MAP KINASE#1.0049;COLORECTAL#1.0046;ESOPHAGEAL CANCER#1.0033;OOCYTE#1.0029;PREINITIATION COMPLEX#1.0029;PROTEIN KINASE C#1.0028;RIBOSOMAL SUBUNIT#1.0018;HISTONE ACETYLATION#1.0016;ADENOCARCINOMA#1.0009;ANTISENSE RNA#1.0008;HEAD AND NECK SQUAMOUS CELL CARCINOMA#1.0005;TRANSACTIVATION#0.9992;POLYSOME#0.9981;LYMPH NODE METASTASIS#0.9977;HUMAN MAMMARY EPITHELIAL#0.9973;MULTIPLE MYELOMA#0.9970;LUNG CANCER#0.9961;PROTEIN TRANSLATION#0.9957;MAMMARY EPITHELIAL CELL#0.9956;PROTEIN PROTEIN INTERACTION#0.9954;ENDOTHELIAL GROWTH FACTOR#0.9951;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9951;HYPERPHOSPHORYLATION#0.9948;RIBOSOMAL PROTEIN#0.9945;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.9945;STRESS GRANULE#0.9935;REGULATION OF PROTEIN SYNTHESIS#0.9932;TARGET OF RAPAMYCIN COMPLEX#0.9924;AUTOPHAGY#0.9919;LUNG ADENOCARCINOMA#0.9919;LYSINE#0.9918;MUSCLE CELL#0.9914;REVERSE TRANSCRIPTION#0.9914;P BODY#0.9905;PROTEIN BINDING#0.9903;CYTOTOXICITY#0.9901;MRNA DECAY#0.9899;SIGNALLING PATHWAY#0.9894;SMOOTH MUSCLE#0.9892;LEUCINE#0.9889;HYPOXIA#0.9880;BREAST CANCER#0.9874;CELL MIGRATION#0.9874;BREAST CANCER CELL#0.9873;HISTONE DEACETYLASE#0.9871;PROTEIN KINASE B#0.9870;MITOGEN ACTIVATED PROTEIN#0.9864;MUTAGENESIS#0.9862;POLYMERASE CHAIN REACTION#0.9857;B CELL#0.9848;TRANSFORMING GROWTH FACTOR#0.9843;CELL CYCLE ARREST#0.9839;RNA INTERFERENCE#0.9836;CYTOPLASM#0.9835;AKT SIGNALING#0.9833;DRUG RESISTANCE#0.9830;KINASE ACTIVITY#0.9826;RIBOSOME#0.9826;EPITHELIAL CELL#0.9822;HELICASE ACTIVITY#0.9820;PROTEASOME#0.9818;HYPOXIC#0.9813;T CELL#0.9813;MUSCLE PROTEIN SYNTHESIS#0.9808;RAPAMYCIN#0.9805;VIRAL GENOME#0.9801;VIRAL REPLICATION#0.9800;BREAST CANCER PATIENTS#0.9798;CELL GROWTH#0.9795;STEM CELL#0.9795;HYPOXIA INDUCIBLE FACTOR#0.9793;ANGIOGENESIS#0.9791;PRO-INFLAMMATORY#0.9781;SIGNALING CASCADE#0.9781;PROTEIN SYNTHESIS#0.9779;TUMOR TISSUES#0.9771;EUKARYOTIC ELONGATION FACTOR#0.9766;CELL PROLIFERATION#0.9765;KINASE INHIBITOR#0.9764;FERTILIZATION#0.9757;CANCER RELATED DEATH#0.9751;RNA BINDING#0.9750;UBIQUITIN#0.9749;SMOOTH MUSCLE CELL#0.9748;PROTEIN KINASE#0.9746;TRYPTOPHAN#0.9746;TUMOR SUPPRESSOR#0.9745;DNA BINDING#0.9745;TARGET OF RAPAMYCIN#0.9744;RNA BINDING PROTEIN#0.9740;SIGNAL TRANSDUCTION#0.9740;APOPTOTIC#0.9739;MRNA DEGRADATION#0.9739;APOPTOSIS#0.9732;CELL CYCLE#0.9731;VIRAL INFECTION#0.9729;ESTROGEN RECEPTOR#0.9725;CANCER CELL#0.9722;HEPATOCELLULAR CARCINOMA#0.9717;COLON CANCER#0.9712;POST-TRANSLATIONAL MODIFICATION#0.9712;ISCHEMIA#0.9709;MTOR COMPLEX#0.9709;INSULIN-LIKE GROWTH FACTOR#0.9706;GROWTH FACTOR#0.9706;TUMOR NECROSIS FACTOR#0.9705;ORNITHINE DECARBOXYLASE#0.9704;HOST CELL#0.9699;DNA REPLICATION#0.9693;CELL DEATH#0.9689;OVARIAN CANCER#0.9680;TUMOR CELLS#0.9678;EPIDERMAL GROWTH FACTOR#0.9678;FACTOR I#0.9676;SKELETAL MUSCLE#0.9674;SIGNALING PATHWAY#0.9661;NERVOUS SYSTEM#0.9656;S PHASE#0.9651;INSULIN RECEPTOR#0.9650;GLOBIN#0.9650;TRANSCRIPTION FACTOR#0.9648;MACROPHAGE#0.9647;ACETYLTRANSFERASE ACTIVITY#0.9645;G1 PHASE#0.9629;TOXICITY#0.9624;PROTEIN DEGRADATION#0.9619;OVARIAN#0.9613;GUANINE#0.9612;PHOSPHATASE 2A#0.9598;REACTIVE OXYGEN SPECIES#0.9580;GENE EXPRESSION#0.9574;ONCOGENESIS#0.9569;PANCREATIC CANCER#0.9562;B CELL LYMPHOMA#0.9547;CELLULAR GROWTH#0.9524;BONE MARROW#0.9515;EVEROLIMUS#0.9508;GROWTH FACTOR RECEPTOR#0.9502;C TERMINAL DOMAIN#0.9486;UNFERTILIZED EGG#0.9469;HEAT SHOCK PROTEIN#0.9455;FIBROBLAST GROWTH FACTOR#0.9448;RAD001#0.9440;80S RIBOSOME#0.9410;HEPATITIS C#0.9399;MAMMARY GLAND#0.9398;ENDOTHELIAL CELL#0.9384;ENDOPLASMIC RETICULUM#0.9372;HISTONE MODIFICATION#0.9367;PROTEIN PHOSPHATASE 2A#0.9323;OOCYTE MATURATION#0.9320;MECHANISM OF ACTION#0.9320;ASPARTIC ACID#0.9317;SURFACE PLASMON RESONANCE#0.9310;MITOSIS#0.9302;RENAL CELL CARCINOMA#0.9299;COLON ADENOCARCINOMA#0.9291;IMMUNE RESPONSE#0.9274;GERM CELL#0.9253;MRNA SPLICING#0.9244;ANDROGEN RECEPTOR#0.9162;REGULATION OF GENE EXPRESSION#0.9159;DISEASE FREE SURVIVAL#0.9143;FOOT AND MOUTH DISEASE#0.9111;MOUTH DISEASE#0.9107;ORNITHINE#0.9106;CELL DIFFERENTIATION#0.9100;HEPATITIS C VIRUS#0.9096;NUCLEAR CAP BINDING COMPLEX#0.9069;MYOBLAST#0.9063;SIGNAL TRANSDUCER#0.9052;CELL MOTILITY#0.9046;VIRAL PROTEIN SYNTHESIS#0.9040;REGULATION OF MRNA#0.9039;NONSENSE-MEDIATED MRNA DECAY#0.9038;METHIONINE#0.9026;MAPK SIGNALING#0.9015;EPITHELIAL MESENCHYMAL TRANSITION#0.9012;RIBOSOME BIOGENESIS#0.9007;ADIPOCYTE#0.8996;GENE SILENCING#0.8980;INSULIN RECEPTOR SUBSTRATE#0.8977;ARGININE#0.8971;ENHANCER BINDING PROTEIN#0.8959;ENHANCER BINDING#0.8954;INFLAMMATORY RESPONSE#0.8953;VACCINIA#0.8937;GEMCITABINE#0.8936;TUBEROUS SCLEROSIS#0.8931;CYCLIN DEPENDENT KINASE#0.8918;CELL DIVISION#0.8918;NUCLEOCYTOPLASMIC SHUTTLING#0.8910;ALANINE#0.8899;SEQUESTERING#0.8876;HUMAN BREAST CANCER#0.8842;PROTEIN PHOSPHORYLATION#0.8841;MYELOID CELL#0.8827;SUCROSE#0.8776;YEAR SURVIVAL RATE#0.8772;INDUCTION OF APOPTOSIS#0.8747;THYROID CANCER#0.8743;ERYTHROCYTE#0.8716;SG ASSEMBLY#0.8713;CHROMATIN REMODELING#0.8704;ENDOMETRIAL CANCER#0.8693;PROGRAMMED CELL DEATH#0.8655;SIGNALING MOLECULE#0.8649;CYTOCHROME C#0.8649;CYTOPLASMIC POLYADENYLATION ELEMENT#0.8647;PROGENITOR CELL#0.8623;ACID PHOSPHATASE#0.8552;RNA CAP BINDING#0.8535;THYMIDINE KINASE#0.8519;PROTEIN KINASE ACTIVITY#0.8511;SENESCENCE#0.8511;PROTEIN KINASE A#0.8497;PERIPHERAL BLOOD#0.8495;GLUTAMIC ACID#0.8485;ETHANOL#0.8475;SQUAMOUS CELL CANCER#0.8469;MICROTUBULE#0.8461;TRANSLATION ELONGATION#0.8452;MOLECULAR DYNAMICS SIMULATION#0.8451;PLATELET-DERIVED GROWTH FACTOR#0.8438;DENTATE GYRUS#0.8436;NECROTIC#0.8431;DOXORUBICIN#0.8402;NUCLEOCYTOPLASMIC TRANSPORT#0.8398;RNA HELICASE ACTIVITY#0.8384;LONG TERM POTENTIATION#0.8363;IN VITRO MATURATION#0.8357;GLUTAMATE RECEPTOR#0.8339;PACLITAXEL#0.8335;ADJACENT NORMAL TISSUE#0.8325;PROGESTERONE#0.8275;ENDOMETRIUM#0.8264;TUBEROUS SCLEROSIS COMPLEX#0.8262;FRAGILE X SYNDROME#0.8248;MOUSE EMBRYONIC FIBROBLAST#0.8244;HISTONE ACETYLTRANSFERASE ACTIVITY#0.8233;DNA METHYLATION#0.8233;NERVE GROWTH FACTOR#0.8230;ARSENITE#0.8220;RETINOIC ACID#0.8219;HYPERACTIVE#0.8199;RECEPTOR TYROSINE KINASE#0.8194;EXTRACELLULAR MATRIX#0.8194;TRANSCRIPTASE#0.8193;CYTOPLASMIC FOCI#0.8193;HERPES SIMPLEX VIRUS#0.8191;HERPES SIMPLEX#0.8187;QUANTITATIVE REAL TIME#0.8184;RNA RECOGNITION MOTIF#0.8146;ANISOMYCIN#0.8141;PRE-MRNA SPLICING#0.8127;MRNA METABOLISM#0.8123;CEREBRAL CORTEX#0.8119;STEROID RECEPTOR COACTIVATOR#0.8116;LARYNGEAL CARCINOMA#0.8114;INNATE IMMUNE RESPONSE#0.8096;DOMINANT NEGATIVE MUTANT#0.8067;TRANSCRIPTIONAL CONTROL#0.8060;VASCULAR SMOOTH MUSCLE CELL#0.8051;FOCAL ADHESION#0.8030;TYPE 2 DIABETES#0.8017;CARDIOMYOCYTE#0.8013;DNA SYNTHESIS#0.8012;OOGENESIS#0.7992;MENTAL RETARDATION#0.7973;HEPATITIS A#0.7972;NUCLEAR IMPORT#0.7967;TOR SIGNALING#0.7966;GLUCOCORTICOID RECEPTOR#0.7956;AUTISM SPECTRUM DISORDER#0.7911;MESOTHELIOMA CELL#0.7898;POLYRIBOSOME#0.7897;RNA METABOLISM#0.7881;STRUCTURE ACTIVITY RELATIONSHIP#0.7869;GLUTATHIONE#0.7859;THYMIDINE#0.7835;PROTEIN BIOSYNTHESIS#0.7829;ISOTHERMAL TITRATION CALORIMETRY#0.7821;IMMUNOSUPPRESSANT#0.7779;ANCHORAGE INDEPENDENT GROWTH#0.7769;PROTEIN METABOLISM#0.7768;LIVER CANCER#0.7754;MITOCHONDRIA#0.7711;GLYCOGEN SYNTHASE KINASE#0.7710;MYOTUBE#0.7702;STROMAL CELL#0.7701;CELL ADHESION#0.7657;AMYGDALA#0.7647;5 FLUOROURACIL#0.7615;IMPORTIN#0.7613;VIRAL TRANSLATION#0.7613;NUCLEOTIDE EXCHANGE FACTOR#0.7570;LUNG CARCINOMA#0.7567;GLUCOSE UPTAKE#0.7564;HISTIDINE#0.7556;FORMALIN#0.7554;RESPONSE TO AMINO ACID#0.7547;RESPONSE TO INSULIN#0.7472;GLIOBLASTOMA MULTIFORME#0.7435;T-CELL LEUKEMIA#0.7435;DEXAMETHASONE#0.7434;DIFFUSE LARGE B-CELL LYMPHOMA#0.7432;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7424;EPITHELIAL TO MESENCHYMAL#0.7422;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7404;CARDIAC MUSCLE#0.7402;M PHASE#0.7402;MITOGENIC ACTIVITY#0.7390;SPERMATOGENESIS#0.7389;RETINOBLASTOMA#0.7348;INVASIVE DUCTAL CARCINOMA#0.7347;EXON JUNCTION COMPLEX#0.7340;ESTROGEN RECEPTOR ALPHA#0.7296;UNFOLDED PROTEIN RESPONSE#0.7293;SUMOYLATION#0.7265;CHRONIC ALCOHOL CONSUMPTION#0.7262;KERATINOCYTE#0.7240;CHRONIC MYELOID LEUKEMIA#0.7200;ADVANCED PROSTATE CANCER#0.7193;LYMPHOCYTIC LEUKEMIA#0.7191;SORAFENIB#0.7178;INTERFERON REGULATORY FACTOR#0.7159;METFORMIN#0.7148;ELECTROPHORETIC MOBILITY SHIFT#0.7118;DNA REPAIR#0.7085;VIRULENCE#0.7075;MAP KINASE KINASE#0.7042;ADIPOSE TISSUE#0.7024;EXTRACELLULAR REGULATED KINASE#0.7020;NON HODGKIN LYMPHOMA#0.7019;CYTARABINE#0.7008;MANTLE CELL LYMPHOMA#0.7005;ATP HYDROLYSIS#0.6985;NMDA RECEPTOR#0.6947;NUCLEIC ACID#0.6946;TRANSFORMING GROWTH FACTOR BETA#0.6920;RNA GRANULE#0.6897;ADENOSINE#0.6895;HISTONE DEACETYLASE INHIBITOR#0.6887;MUSCLE ATROPHY#0.6849;ERLOTINIB#0.6845;NON-SMALL CELL LUNG CARCINOMA#0.6841;METAPHASE#0.6831;TERMINAL LOOP#0.6827;MUSCLE HYPERTROPHY#0.6816;MOLAR#0.6803;CELL DEVELOPMENT#0.6801;CELLULAR LOCALIZATION#0.6801;COLORECTAL CARCINOMA#0.6793;RIBOSE#0.6786;RIBONUCLEOPROTEIN COMPLEX#0.6782;CYTOKINE PRODUCTION#0.6779;LUMINAL#0.6771;LUNG EPITHELIAL CELL#0.6754;MELANOMA CELL LINES#0.6753;MAPK SIGNALLING#0.6749;MULTIPLE MYELOMA CELLS#0.6740;DENDRITIC SPINE#0.6726;REPORTER GENE ASSAY#0.6716;LACTATION#0.6710;GENE COPY NUMBER#0.6692;TIGHT JUNCTION#0.6687;RIBAVIRIN TRIPHOSPHATE#0.6669;PEROXISOME#0.6649;NUCLEOTIDE BINDING#0.6647;PERIPHERAL NERVE#0.6620;VASCULAR CELL#0.6616;ASTROCYTOMA#0.6593;VESICULAR STOMATITIS VIRUS#0.6584;PROTOPLAST#0.6574;POSTTRANSLATIONAL MODIFICATION#0.6549;MYELOID CELL LEUKEMIA#0.6540;RESPONSE TO RAPAMYCIN#0.6532;ARA-C#0.6528;MOUSE EMBRYO FIBROBLASTS#0.6506;AUTISTIC#0.6500;IL-11#0.6473;MONOCYTE#0.6466;COLORECTAL ADENOCARCINOMA#0.6457;ANTIVIRAL RESPONSE#0.6455;DOCETAXEL#0.6445;HEMATOPOIETIC CELL#0.6439;ETOPOSIDE#0.6437;COLON CARCINOMA#0.6426;BINDING PROTEIN 3#0.6425;LINES OF EVIDENCE#0.6422;ACTINOMYCIN D#0.6415;RHABDOMYOSARCOMA#0.6409;NEUROGENESIS#0.6395;CENTRAL NERVOUS SYSTEM#0.6393;MECHANISMS OF ACTION#0.6391;TUMOUR NECROSIS FACTOR#0.6376;HYPERSENSITIVITY#0.6376;GROWTH HORMONE#0.6366;MONONUCLEAR CELLS#0.6365;HISTONE ACETYL TRANSFERASE#0.6358;LYSOSOME#0.6357;SENSITIZATION#0.6356;CELLULAR TRANSCRIPTION#0.6319;CANCER STEM CELL#0.6291;APOPTOTIC CELL DEATH#0.6283;KAPOSI'S SARCOMA#0.6277;NEURODEGENERATIVE DISEASE#0.6267;CLEAR CELL RENAL CELL CARCINOMA#0.6248;EMBRYONIC KIDNEY#0.6244;FACTOR INHIBITING HIF#0.6240;HINDLIMB#0.6238;LUNG FIBROBLASTS#0.6235;NUCLEAR LOCALIZATION SIGNAL#0.6231;FLUOROURACIL#0.6226;CHOLANGIOCARCINOMA#0.6221;HUMAN UMBILICAL VEIN#0.6215;UMBILICAL VEIN#0.6213;TYROSINE KINASE INHIBITOR#0.6207;REGULATION OF CELL GROWTH#0.6204;MESENCHYMAL STEM CELL#0.6203;LYMPHOMA CELL LINES#0.6187;PLASMA CELL#0.6182;TAMOXIFEN#0.6181;CAROTENOID#0.6177;WOUND HEALING#0.6154;THYROID CARCINOMA#0.6154;MRNA PROCESSING#0.6150;CARRIE#0.6143;60S RIBOSOMAL SUBUNIT#0.6121;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6106;HEPATOMA CELLS#0.6093;TOLL LIKE RECEPTOR#0.6078;EPSTEIN BARR VIRUS#0.6076;MAP KINASE ACTIVITY#0.6073;INNATE IMMUNITY#0.6070;RNA DEPENDENT ATPASE#0.6065;AGEING#0.6051;FLUORESCENCE POLARIZATION ASSAY#0.6051;CHITIN BINDING#0.6034;DIGESTION#0.6019;NUCLEAR PORE#0.6006
1978	TRANSLATION REPRESSOR#1.0744;2-HYDROXY-4-METHOXYBENZOPHENONE#1.0703;EIF4G BINDING#1.0551;HYPERPHOSPHORYLATION#1.0445;EIF4E BINDING#1.0378;MRNA CAP BINDING#1.0359;BENZOPHENONE#1.0337;BINDING PROTEIN 1#1.0324;RIBOSOMAL S6 KINASE#1.0313;DEPHOSPHORYLATION#1.0227;RIBOSOMAL PROTEIN#1.0198;L-LEUCINE#1.0198;ADIPOSE TISSUE#1.0195;EUKARYOTIC INITIATION FACTOR#1.0182;TRANSLATION INITIATION FACTOR#1.0182;INHIBITION OF PHOSPHORYLATION#1.0139;EUKARYOTIC ELONGATION FACTOR#1.0107;ADIPOCYTE#1.0095;GLYCOGEN SYNTHASE KINASE#1.0046;INSULIN RECEPTOR#1.0001;MAP KINASE#0.9991;PROTEIN TRANSLATION#0.9990;TRANSLATION INITIATION#0.9987;B CELL#0.9985;MTOR COMPLEX#0.9975;KINASE ACTIVITY#0.9965;BONE MARROW#0.9951;RESPONSE TO INSULIN#0.9944;LEUCINE#0.9939;HYPOXIA#0.9937;AMINOPEPTIDASE A#0.9936;REGULATION OF PROTEIN SYNTHESIS#0.9936;RAD001#0.9907;REGULATION OF TRANSLATION#0.9897;PROTEIN KINASE B#0.9893;SIGNALING MOLECULE#0.9881;BETA CELL#0.9877;AKT SIGNALING#0.9860;TARGET OF RAPAMYCIN COMPLEX#0.9845;RAPAMYCIN#0.9828;TUBEROUS SCLEROSIS COMPLEX#0.9819;TUBEROUS SCLEROSIS#0.9812;T CELL#0.9812;LUNG CANCER#0.9811;TOR SIGNALING#0.9807;CELL SURFACE#0.9803;MITOGEN ACTIVATED PROTEIN#0.9798;CELL CYCLE ARREST#0.9791;ONCOGENIC#0.9789;SIGNALLING PATHWAY#0.9785;SMOOTH MUSCLE CELL#0.9781;PROTEIN KINASE#0.9778;PANCREATIC CANCER#0.9775;TRANSLATION INITIATION COMPLEX#0.9774;GROWTH FACTOR RECEPTOR#0.9773;MOUSE EMBRYONIC FIBROBLAST#0.9770;SMOOTH MUSCLE#0.9765;SIGNALING CASCADE#0.9762;MACROPHAGE#0.9757;PROTEIN SYNTHESIS#0.9757;BREAST CANCER CELL#0.9754;AUTOPHAGY#0.9749;EPITHELIAL CELL#0.9748;UBIQUITIN#0.9748;REACTIVE OXYGEN SPECIES#0.9745;MUSCLE CELL#0.9743;MUSCLE PROTEIN SYNTHESIS#0.9740;TUMOR CELLS#0.9734;PROSTATE CANCER#0.9734;TRANSLATIONAL INITIATION#0.9734;PROTEIN DEGRADATION#0.9732;EPIDERMAL GROWTH FACTOR#0.9730;BREAST CANCER#0.9728;EIF4F ASSEMBLY#0.9723;TARGET OF RAPAMYCIN#0.9722;PROTEIN KINASE C#0.9717;MUSCLE ATROPHY#0.9716;POLYMERASE CHAIN REACTION#0.9713;TRANSCRIPTION FACTOR#0.9707;HYPOXIA INDUCIBLE FACTOR#0.9702;EVEROLIMUS#0.9696;INSULIN-LIKE GROWTH FACTOR#0.9695;FACTOR I#0.9691;TUMOR SUPPRESSOR#0.9683;SIGNAL TRANSDUCTION#0.9676;BONE MARROW CELLS#0.9674;PROTEASOME#0.9674;PHOSPHATASE 2A#0.9667;RIBOSOME#0.9664;PROTEIN PHOSPHATASE 2A#0.9656;ANGIOGENESIS#0.9654;CELL MIGRATION#0.9653;STROMAL CELL#0.9652;CYCLIN DEPENDENT KINASE#0.9652;CELL CYCLE#0.9650;KINASE INHIBITOR#0.9648;CELL GROWTH#0.9645;INSULIN RECEPTOR SUBSTRATE#0.9645;APOPTOTIC#0.9643;CELL DEATH#0.9641;COLORECTAL CANCER#0.9638;CANCER CELL#0.9635;CELL MOTILITY#0.9624;CELL DIFFERENTIATION#0.9620;ADENOCARCINOMA#0.9618;GROWTH FACTOR#0.9612;G1 PHASE#0.9608;CELL PROLIFERATION#0.9606;ENDOTHELIAL CELL#0.9592;HYPOXIC#0.9591;GENE EXPRESSION#0.9589;STEM CELL#0.9584;SQUAMOUS CELL CARCINOMA#0.9581;APOPTOSIS#0.9579;OVARIAN#0.9578;SKELETAL MUSCLE#0.9577;S PHASE#0.9574;SIGNALING PATHWAY#0.9573;ENDOTHELIAL GROWTH FACTOR#0.9571;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9571;OVARIAN CANCER#0.9569;POLYSOME#0.9551;SPINAL CORD#0.9532;HEPATOCELLULAR CARCINOMA#0.9528;IGF BINDING#0.9496;DEXAMETHASONE#0.9490;MYOTUBE#0.9479;PROTEIN PHOSPHORYLATION#0.9464;METFORMIN#0.9422;PROTEIN METABOLISM#0.9422;CYTOTOXICITY#0.9384;ENDOPLASMIC RETICULUM#0.9379;MITOSIS#0.9376;GLUTATHIONE#0.9366;OOCYTE#0.9357;TOXICITY#0.9347;ARGININE#0.9342;TUMOR NECROSIS FACTOR#0.9327;LYMPH NODE#0.9318;COLON CANCER#0.9304;PROTEIN KINASE ACTIVITY#0.9265;TUMOR TISSUES#0.9261;MUSCLE HYPERTROPHY#0.9240;COMPLEX I#0.9230;INDUCTION OF APOPTOSIS#0.9225;B CELL LYMPHOMA#0.9222;ESSENTIAL AMINO ACID#0.9219;COLORECTAL#0.9179;DRUG RESISTANCE#0.9169;MYOBLAST#0.9160;SKELETAL MUSCLE MASS#0.9142;VASCULAR SMOOTH MUSCLE CELL#0.9078;MECHANISM OF ACTION#0.9069;EXTRACELLULAR MATRIX#0.9043;PRO-INFLAMMATORY#0.9033;LIGHT CHAIN 3#0.9013;HYPERGLYCEMIA#0.8995;ESTROGEN RECEPTOR#0.8988;PROTEIN COMPLEX#0.8955;CELL DEVELOPMENT#0.8951;RIBOSOMAL SUBUNIT#0.8938;RNA INTERFERENCE#0.8932;CAP BINDING COMPLEX#0.8920;MULTIPLE MYELOMA#0.8908;CALYCULIN A#0.8885;MICROTUBULE#0.8817;GROWTH FACTOR BINDING#0.8816;HOST CELL#0.8780;PLATELET-DERIVED GROWTH FACTOR#0.8766;PI3K SIGNALING#0.8749;GLUTAMINE#0.8739;IMMUNOSUPPRESSANT#0.8737;MICROTUBULE ASSOCIATED PROTEIN#0.8706;MUSCLE FIBER#0.8703;ISCHEMIA#0.8692;ADENOSINE#0.8643;T LYMPHOCYTE#0.8634;TYPE 2 DIABETES#0.8522;HINDLIMB#0.8513;TRANSLATION ELONGATION#0.8511;METHIONINE#0.8500;FOCAL ADHESION#0.8494;HEPATOMA CELLS#0.8480;BROWN ADIPOSE TISSUE#0.8475;CYTOPLASM#0.8465;PEROXISOME#0.8441;DIET INDUCED OBESITY#0.8417;RENAL CELL CARCINOMA#0.8398;APOPTOTIC CELL DEATH#0.8360;C TERMINAL DOMAIN#0.8340;KERATINOCYTE#0.8338;GLUCOSE UPTAKE#0.8335;PROTEIN PROTEIN INTERACTION#0.8325;REVERSE TRANSCRIPTION#0.8320;CROSS SECTIONAL AREA#0.8319;PROTEIN BREAKDOWN#0.8317;ESOPHAGEAL CANCER#0.8307;WHITE ADIPOSE TISSUE#0.8299;GLYCOLYSIS#0.8280;ANABOLISM#0.8260;B CELL DEVELOPMENT#0.8257;CELLULAR GROWTH#0.8248;MYELOID LEUKEMIA#0.8245;B LYMPHOCYTE#0.8207;CARDIOMYOCYTE#0.8200;OBESE#0.8186;REGENERATION#0.8173;INHIBITION OF CELL PROLIFERATION#0.8141;ETHANOL#0.8140;IMMUNE RESPONSE#0.8111;INSULIN SECRETION#0.8108;MESANGIAL CELL#0.8108;INTESTINAL EPITHELIAL CELL#0.8098;CISPLATIN#0.8092;ALANINE#0.8072;DNA SYNTHESIS#0.8036;TESTOSTERONE#0.8023;RESPONSE TO NUTRIENT#0.8015;MYOSIN HEAVY CHAIN#0.8003;AMPK ACTIVITY#0.7985;TRANSFORMING GROWTH FACTOR#0.7936;BREAST CARCINOMA#0.7922;RETINOIC ACID#0.7912;PROTEIN SYNTHESIS INITIATION#0.7878;MILK PROTEIN#0.7877;SORAFENIB#0.7863;PHOSPHATASE AND TENSIN HOMOLOG#0.7862;ACETYL COA CARBOXYLASE#0.7860;GROWTH HORMONE#0.7860;CERVICAL#0.7841;PHOTOSYSTEM II#0.7838;NITRIC OXIDE#0.7838;MUTAGENESIS#0.7837;MUSCLE WASTING#0.7800;TUBULAR EPITHELIAL CELL#0.7800;MAP KINASE ACTIVITY#0.7776;RESPONSE TO AMINO ACID#0.7767;PERSONAL CARE PRODUCTS#0.7765;L-ARGININE#0.7746;CATALYTIC ACTIVITY#0.7741;MAMMARY EPITHELIAL CELL#0.7740;CELL ADHESION#0.7738;SIGNAL TRANSDUCER#0.7736;CYTOCHROME C#0.7722;PROXIMAL TUBULAR EPITHELIAL#0.7717;CELL DIVISION#0.7706;RECEPTOR TYROSINE KINASE#0.7701;HEAT SHOCK PROTEIN#0.7689;CONSTITUTIVELY ACTIVE MUTANT#0.7660;PERIPHERAL BLOOD#0.7658;FETAL LIVER#0.7653;MAPK SIGNALING#0.7636;ACUTE MYELOID LEUKEMIA#0.7621;HIGH FAT DIET#0.7611;DNA REPLICATION#0.7572;DISEASE FREE SURVIVAL#0.7572;RHABDOMYOSARCOMA#0.7560;ENDOMETRIUM#0.7548;INTRINSICALLY DISORDERED PROTEIN#0.7518;DOUBLE TRANSGENIC MICE#0.7516;FIBROBLAST GROWTH FACTOR#0.7506;3-METHYLADENINE#0.7495;5'-AMP#0.7445;ENDOPLASMIC RETICULUM STRESS#0.7440;ORNITHINE DECARBOXYLASE#0.7435;INFLAMMATORY RESPONSE#0.7385;FAT CELL#0.7361;MYELOID CELL#0.7352;MUSCLE CONTRACTION#0.7338;PHOTOSYSTEM#0.7327;ORNITHINE#0.7309;LYSOSOME#0.7299;MOLAR#0.7288;ESTRADIOL#0.7278;SPINDLE FORMATION#0.7275;SENESCENCE#0.7273;SKELETAL MUSCLE ATROPHY#0.7239;HUMAN BREAST CANCER#0.7200;WEIGHT GAIN#0.7199;NEURONAL CELLS#0.7194;STREPTOZOTOCIN#0.7183;GEMCITABINE#0.7161;GENE SILENCING#0.7140;GM-CSF#0.7134;40S RIBOSOMAL SUBUNIT#0.7120;AUTOPHAGOSOME#0.7104;FK506 BINDING PROTEIN#0.7058;FK506 BINDING#0.7056;HUMAN PANCREATIC CANCER#0.7018;ACTIVATING TRANSCRIPTION FACTOR#0.7012;REGULATION OF CELL GROWTH#0.7004;NERVOUS SYSTEM#0.6995;UNFOLDED PROTEIN RESPONSE#0.6994;M PHASE#0.6972;TYROSINE KINASE INHIBITOR#0.6954;4-HYDROXYTAMOXIFEN#0.6949;QUANTITATIVE REAL TIME#0.6938;DNA BINDING#0.6925;B CELL PROLIFERATION#0.6884;RETICULOCYTE#0.6853;HEAD AND NECK CANCER#0.6847;NECK CANCER#0.6847;CLEAVED CASPASE 3#0.6839;GESTATION#0.6829;MAMMARY GLAND#0.6824;POLY-A BINDING#0.6820;CATABOLISM#0.6814;QUADRICEPS#0.6810;CELL ACTIVATION#0.6793;SKELETAL MUSCLE HYPERTROPHY#0.6784;RIBOSOME BIOGENESIS#0.6779;ENDOMETRIAL CANCER#0.6729;ADENOSINE MONOPHOSPHATE#0.6719;HISTONE DEACETYLASE#0.6694;ANDROGEN RECEPTOR#0.6688;WEIGHT LOSS#0.6686;SUBTILISIN E#0.6670;PACLITAXEL#0.6640;TEMSIROLIMUS#0.6618;NEUROTOXICITY#0.6618;TUMOR GROWTH INHIBITION#0.6612;ISOLEUCINE#0.6561;PHOSPHATASE ACTIVITY#0.6546;BREAST CANCER PATIENTS#0.6531;MITOCHONDRIAL MEMBRANE#0.6527;MAP KINASE KINASE#0.6522;CELL MEMBRANE#0.6517;RECEPTOR ANTAGONIST#0.6500;MYOPATHY#0.6483;ATP SYNTHASE#0.6473;ACTIN CYTOSKELETON#0.6468;BONE MARROW STROMAL CELL#0.6462;BONE MARROW STROMAL#0.6459;CASPASE INHIBITOR#0.6453;ENHANCER BINDING PROTEIN#0.6450;FOCAL ADHESION KINASE#0.6446;ENHANCER BINDING#0.6446;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6433;SURFACE PLASMON RESONANCE#0.6432;CHRONIC ALCOHOL CONSUMPTION#0.6430;CD4+ T CELL#0.6427;ATP BINDING#0.6416;MRNA CAP BINDING COMPLEX#0.6404;WOUND HEALING#0.6402;METAPHASE#0.6310;PHOSPHOLIPASE D#0.6289;HYPERGLYCEMIC#0.6277;ATAXIA TELANGIECTASIA#0.6275;OF DIABETIC RATS#0.6264;DIABETES MELLITUS#0.6264;LYMPHOID CELL#0.6247;ADIPOCYTE DIFFERENTIATION#0.6245;POST-TRANSLATIONAL MODIFICATION#0.6243;ENDOCRINE DISRUPTING CHEMICAL#0.6236;MOUSE EMBRYO FIBROBLASTS#0.6226;RESVERATROL#0.6219;MYOGENESIS#0.6217;CORD BLOOD#0.6200;MULTIPLE MYELOMA CELLS#0.6183;CENTRAL NERVOUS SYSTEM#0.6179;INHIBITION OF CELL GROWTH#0.6165;RESPONSE TO RAPAMYCIN#0.6165;DOMINANT NEGATIVE MUTANT#0.6160;SKELETAL MUSCLE CELLS#0.6145;UBIQUITIN PROTEASOME SYSTEM#0.6139;ACID PHOSPHATASE#0.6125;VIRAL REPLICATION#0.6098;GENISTEIN#0.6084;PARKINSON'S DISEASE#0.6071;MYOFIBRILLAR PROTEIN SYNTHESIS#0.6068;CHONDROCYTE#0.6043;GUANINE#0.6043;HYPERACTIVE#0.6023
1979	EIF4E BINDING#1.0491;TRANSLATION INITIATION#1.0330;EUKARYOTIC INITIATION FACTOR#1.0312;TRANSLATION INITIATION FACTOR#1.0259;TARGET OF RAPAMYCIN#1.0098;PROTEIN SYNTHESIS#1.0059;RAPAMYCIN#0.9988;PROTEIN KINASE#0.9767;TRANSLATION REPRESSOR#0.9591;GENE EXPRESSION#0.9135;SIGNALING PATHWAY#0.8791;RIBOSOMAL PROTEIN#0.8548;PRO-INFLAMMATORY#0.8491;BINDING PROTEIN 1#0.8463;GROWTH FACTOR#0.8368;MITOGEN ACTIVATED PROTEIN#0.8095;APOPTOSIS#0.7857;DIET INDUCED OBESITY#0.7796;MOUSE EMBRYONIC FIBROBLAST#0.7698;INFLAMMATORY RESPONSE#0.7417;MYELOID CELL#0.7409;SKELETAL MUSCLE#0.6845;AUTISTIC#0.6527;ACID PHOSPHATASE#0.6461;TARGET OF RAPAMYCIN COMPLEX#0.6368;B CELL#0.6360;MACROPHAGE#0.6337;RELATIVE GENE EXPRESSION#0.6292;SYNAPTIC TRANSMISSION#0.6242;MYOSIN LIGHT-CHAIN KINASE#0.6096;CELL GROWTH#0.6084;ADIPOSE TISSUE#0.6049;ASPARAGINE#0.6045
197	MATRIX GLA PROTEIN#1.0544;POLYCYSTIC OVARY SYNDROME#1.0498;RETINOL BINDING#1.0497;ALPHA 1-ANTITRYPSIN#1.0472;VITAMIN D BINDING#1.0470;FIBROBLAST GROWTH FACTOR#1.0438;GESTATIONAL DIABETES MELLITUS#1.0405;CYSTATIN#1.0395;PERIPHERAL ARTERIAL DISEASE#1.0394;GESTATIONAL DIABETES#1.0366;INSULIN RECEPTOR#1.0353;RETINOL#1.0349;LINEAR REGRESSION ANALYSIS#1.0347;TRANSFORMING GROWTH FACTOR#1.0345;HEART DISEASE#1.0334;FIBRINOGEN#1.0333;SERUM ALBUMIN#1.0323;BONE MORPHOGENETIC PROTEIN#1.0321;HIGH DENSITY LIPOPROTEIN#1.0317;ALKALINE PHOSPHATASE#1.0285;MULTIPLE REGRESSION ANALYSIS#1.0277;TUMOR NECROSIS FACTOR#1.0277;TYPE 2 DIABETES MELLITUS#1.0276;2 DIABETES MELLITUS#1.0275;NONALCOHOLIC FATTY LIVER DISEASE#1.0249;CORONARY ARTERY CALCIFICATION#1.0240;GROWTH FACTOR#1.0240;CORONARY ARTERY DISEASE#1.0230;PARATHYROID HORMONE#1.0227;ARTERY DISEASE#1.0205;MYOCARDIAL INFARCTION#1.0202;PARATHYROID#1.0193;C REACTIVE PROTEIN#1.0190;INTIMA MEDIA THICKNESS#1.0170;MINERALIZATION#1.0159;FATTY LIVER DISEASE#1.0151;LOW DENSITY LIPOPROTEIN#1.0143;RECEPTOR TYROSINE KINASE#1.0118;FATTY LIVER#1.0113;LIVER DISEASE#1.0111;GLOMERULAR FILTRATION#1.0108;PRO-INFLAMMATORY#1.0108;VASCULAR DISEASE#1.0096;MACROPHAGE#1.0092;OBESE#1.0090;GLOMERULAR FILTRATION RATE#1.0088;DIABETES MELLITUS#1.0080;CARDIOVASCULAR RISK FACTOR#1.0078;ALPHA-2 MACROGLOBULIN#1.0072;TYPE 2 DIABETES#1.0071;PLASMA PROTEIN#1.0061;CORONARY ARTERY#1.0050;PULSE WAVE VELOCITY#1.0049;ADIPOSE TISSUE#1.0038;VASCULAR SMOOTH MUSCLE CELL#1.0013;ATHEROSCLEROSIS#1.0008;TUMOR CELLS#0.9986;ARTERY#0.9966;AORTIC VALVE#0.9965;ADIPOCYTE#0.9962;SMOOTH MUSCLE CELL#0.9955;MUSCLE CELL#0.9951;SMOOTH MUSCLE#0.9934;MALNUTRITION#0.9911;BONE MINERAL DENSITY#0.9907;WEIGHT LOSS#0.9896;ATHEROSCLEROTIC#0.9884;GENE EXPRESSION#0.9859;CORONARY HEART DISEASE#0.9838;ALANINE#0.9772;HIGH FAT DIET#0.9755;CAROTID ARTERY#0.9753;SYSTOLIC BLOOD PRESSURE#0.9741;HYPERTENSION#0.9738;KIDNEY DISEASE#0.9701;INFLAMMATORY RESPONSE#0.9692;PALMITATE#0.9691;CHRONIC KIDNEY DISEASE#0.9683;FATTY ACID BINDING#0.9644;RENAL TRANSPLANT RECIPIENTS#0.9588;LIPID METABOLISM#0.9583;EXTRACELLULAR MATRIX#0.9578;MONOCYTE#0.9544;MULTIPLE LINEAR REGRESSION#0.9538;INSULIN-LIKE GROWTH FACTOR#0.9485;SERUM AMYLOID A#0.9471;ALCOHOLIC FATTY LIVER#0.9455;OSTEOBLAST#0.9429;APOPTOSIS#0.9353;BONE FORMATION#0.9343;NEPHROTIC SYNDROME#0.9331;PIOGLITAZONE#0.9314;EXOSOME#0.9308;URIC ACID#0.9270;PROTEIN KINASE#0.9261;NORMAL GLUCOSE TOLERANCE#0.9140;MARKERS OF INFLAMMATION#0.9136;SIGNALING PATHWAY#0.9131;SKELETAL MUSCLE#0.9064;RHEUMATOID ARTHRITIS#0.9058;VASCULAR CELL#0.9033;EXCRETION#0.8913;PSORIASIS#0.8838;PLASMA GLYCOPROTEIN#0.8837;TRADITIONAL RISK FACTORS#0.8788;AORTIC VALVE CALCIFICATION#0.8786;LIVER DAMAGE#0.8779;POLYMERASE CHAIN REACTION#0.8759;ACUTE PHASE RESPONSE#0.8754;BONE MINERALIZATION#0.8731;ENDOMETRIOSIS#0.8727;TYPE 2 DIABETIC#0.8713;KINASE ACTIVITY#0.8704;GLUCOSE HOMEOSTASIS#0.8684;FASTING BLOOD GLUCOSE#0.8651;ERYTHROCYTE#0.8651;OSTEOPOROSIS#0.8651;TRANSCRIPTION FACTOR#0.8642;LECTIN#0.8641;METFORMIN#0.8639;TUMOUR NECROSIS FACTOR#0.8604;PROTEINASE INHIBITOR#0.8577;IMMUNE RESPONSE#0.8564;HYPERPHOSPHATEMIA#0.8524;RANDOMIZED CONTROLLED TRIAL#0.8511;COLORECTAL CANCER#0.8494;SEVELAMER#0.8454;ISCHEMIA#0.8407;DIABETIC NEPHROPATHY#0.8405;BETA-2#0.8399;GLYCOSYLATION#0.8397;HYPERPARATHYROIDISM#0.8374;MITRAL VALVE#0.8366;LEUKOCYTE#0.8341;HEPATOCELLULAR CARCINOMA#0.8331;UREMIA#0.8310;BONE MORPHOGENIC PROTEIN#0.8304;LIVER FAT CONTENT#0.8298;CELL GROWTH#0.8265;NEPHROPATHY#0.8252;MULTIVARIATE LINEAR REGRESSION#0.8187;MITRAL ANNULAR CALCIFICATION#0.8163;IMPAIRED GLUCOSE TOLERANCE#0.8160;ADJUSTED ODDS RATIO#0.8115;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8079;PLASMA MEMBRANE#0.8065;CELL SURFACE#0.8056;TYPE 1 DIABETES#0.8033;EPIDERMAL GROWTH FACTOR#0.8023;AORTIC VALVE STENOSIS#0.8016;MEPRIN#0.8014;SURFACE PLASMON RESONANCE#0.8013;BONE RESORPTION#0.7964;PROTEINURIA#0.7957;HYPERTHYROIDISM#0.7930;OSTEOGENESIS#0.7914;CELL ADHESION#0.7905;TYPE 1 DIABETIC#0.7860;ANKYLOSING SPONDYLITIS#0.7853;ACUTE CORONARY SYNDROME#0.7850;HEPATOCYTE GROWTH FACTOR#0.7825;ENDOPLASMIC RETICULUM#0.7777;MITRAL VALVE DISEASE#0.7774;INFLAMMATORY BOWEL DISEASE#0.7773;WHITE BLOOD CELL#0.7745;HISTIDINE#0.7734;TOLL LIKE RECEPTOR#0.7716;LASER DESORPTION IONIZATION#0.7578;WEIGHT GAIN#0.7506;DIGESTION#0.7476;BONE CELLS#0.7467;ADJUSTED HAZARD RATIO#0.7441;OSTEOARTHRITIS#0.7431;KIDNEY TRANSPLANT RECIPIENTS#0.7423;VITAMIN K#0.7420;NEUTROPHIL#0.7410;HORMONE BINDING#0.7392;BETA CELL#0.7382;ACID PHOSPHATASE#0.7381;OSTEOCYTE#0.7373;ALZHEIMER'S DISEASE#0.7340;PERIPHERAL BLOOD#0.7325;APOPTOTIC#0.7321;GESTATION#0.7301;TRANSFORMING GROWTH FACTOR BETA#0.7299;PSORIATIC ARTHRITIS#0.7258;MULTIPLE SCLEROSIS#0.7215;ASPARTATE#0.7179;CARDIOVASCULAR HEALTH STUDY#0.7176;INSULIN SECRETION#0.7154;COLORECTAL#0.7144;HYPERCALCEMIA#0.7138;RECEPTOR ACTIVATOR#0.7022;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7017;LUPUS ERYTHEMATOSUS#0.7014;GLUCOSE TOLERANCE TEST#0.7005;SUBCUTANEOUS ADIPOSE TISSUE#0.6990;BREAST CANCER#0.6932;CORONARY ARTERY CALCIUM#0.6924;OSSIFICATION#0.6871;ERYTHROCYTE SEDIMENTATION RATE#0.6855;CALCIPHYLAXIS#0.6834;BIOMINERALIZATION#0.6787;DIET INDUCED OBESITY#0.6770;CELL PROLIFERATION#0.6754;ORAL GLUCOSE TOLERANCE#0.6749;ACUTE ISCHEMIC STROKE#0.6746;MACROPHAGE MIGRATION#0.6733;VITAMIN D3#0.6726;GLUCOSE METABOLISM#0.6724;HEPATOMA CELLS#0.6708;DIABETIC RETINOPATHY#0.6654;CALCIUM CARBONATE#0.6623;TESTOSTERONE#0.6586;OVARIAN#0.6569;IMPAIRED FASTING GLUCOSE#0.6558;FASTING PLASMA GLUCOSE#0.6470;VENOUS BLOOD#0.6466;PERIODONTITIS#0.6463;GROWTH FACTOR BINDING#0.6463;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6395;ENDOTHELIAL GROWTH FACTOR#0.6394;FRAMINGHAM HEART STUDY#0.6393;ENDOTHELIAL CELL#0.6378;PHOSPHATE METABOLISM#0.6371;ACUTE KIDNEY INJURY#0.6288;CARDIOVASCULAR SYSTEM#0.6280;IL-1RA#0.6269;MYELODYSPLASTIC SYNDROME#0.6261;HYPERGLYCEMIA#0.6260;SPONDYLITIS#0.6231;SUPEROXIDE DISMUTASE#0.6154;INSULIN RESISTANCE INDEX#0.6101;FAT CELL#0.6066;EXTRACELLULAR VESICLE#0.6058;UMBILICAL CORD#0.6001;MULTIPLE MYELOMA#0.6000
1980	TRANSLATION INITIATION FACTOR#1.1980;TRANSLATION INITIATION#1.1934
1981	EIF4G BINDING#1.0952;CAP BINDING COMPLEX#1.0431;TRANSLATION INITIATION COMPLEX#1.0393;MRNA BINDING#1.0250;RNA HELICASE#1.0242;MRNA CAP BINDING#1.0236;EIF4F ASSEMBLY#1.0226;TRANSLATIONAL INITIATION#1.0218;LEUCINE#1.0217;40S RIBOSOMAL SUBUNIT#1.0216;PROTEIN COMPLEX#1.0215;PARKINSON'S DISEASE#1.0211;PREINITIATION COMPLEX#1.0189;EIF4E BINDING#1.0175;POLY-A BINDING#1.0150;BINDING PROTEIN 1#1.0132;PROTEIN SYNTHESIS INITIATION#1.0114;C TERMINAL DOMAIN#1.0103;FOOT AND MOUTH DISEASE#1.0102;RETICULOCYTE#1.0099;MOUTH DISEASE#1.0091;TRANSLATION REPRESSOR#1.0081;HELICASE ACTIVITY#1.0081;COMPLEX I#1.0068;TRANSLATION INITIATION FACTOR#1.0053;STRESS GRANULE#1.0021;RIBOSOMAL SUBUNIT#0.9989;DEPHOSPHORYLATION#0.9970;BREAST CANCER#0.9967;SMALL RIBOSOMAL SUBUNIT#0.9965;TRANSLATION INITIATION#0.9964;EUKARYOTIC INITIATION FACTOR#0.9962;CELL PROLIFERATION#0.9948;RIBOSOMAL PROTEIN#0.9943;PROTEIN TRANSLATION#0.9933;RNA BINDING PROTEIN#0.9919;REGULATION OF TRANSLATION#0.9897;RNA BINDING#0.9892;POLYSOME#0.9884;APOPTOSIS#0.9873;RIBOSOME#0.9863;MUSCLE PROTEIN SYNTHESIS#0.9859;APOPTOTIC#0.9847;VIRAL PROTEIN SYNTHESIS#0.9841;CANCER CELL#0.9834;SIGNALING PATHWAY#0.9819;RAPAMYCIN#0.9818;HOST CELL#0.9801;CELL DEATH#0.9790;PROTEIN SYNTHESIS#0.9782;CELL CYCLE#0.9764;CELL GROWTH#0.9759;TARGET OF RAPAMYCIN#0.9746;PROTEASOME#0.9728;SKELETAL MUSCLE#0.9719;PROTEIN KINASE#0.9690;PROTEIN PROTEIN INTERACTION#0.9671;GROWTH FACTOR#0.9671;CYTOPLASM#0.9622;GENE EXPRESSION#0.9605;MRNA DECAY#0.9563;OOCYTE#0.9559;MITOGEN ACTIVATED PROTEIN#0.9534;HEAT SHOCK PROTEIN#0.9473;SIGNAL TRANSDUCTION#0.9470;VIRAL REPLICATION#0.9401;ONCOGENIC#0.9370;TRANSCRIPTION FACTOR#0.9344;RIBOSOME BINDING#0.9314;PROTEIN KINASE C#0.9297;HEPATITIS C#0.9267;HEPATITIS C VIRUS#0.9225;MUTAGENESIS#0.9215;VACCINIA#0.9209;PROGRAMMED CELL DEATH#0.9192;RNA RECOGNITION MOTIF#0.9184;T CELL#0.9128;VIRAL INFECTION#0.9112;OOCYTE MATURATION#0.9069;HEPATITIS A#0.8940;RNA HELICASE ACTIVITY#0.8890;GERM CELL#0.8797;KINASE INHIBITOR#0.8767;PROTEIN KINASE B#0.8737;VACUOLAR PROTEIN SORTING#0.8737;MITOSIS#0.8703;HYPERPHOSPHORYLATION#0.8682;MAP KINASE#0.8630;RNA INTERFERENCE#0.8611;TUMOR CELLS#0.8572;TUMOR SUPPRESSOR#0.8558;INDUCTION OF APOPTOSIS#0.8498;BREAST CANCER CELL#0.8475;ISCHEMIA#0.8415;LUNG CANCER#0.8364;REGULATION OF MRNA#0.8322;HYPOXIA#0.8319;ATPASE ACTIVITY#0.8312;CASPASE INHIBITOR#0.8260;EPITHELIAL CELL#0.8246;VIRAL TRANSLATION#0.8228;ARGININE#0.8222;MRNA DEGRADATION#0.8195;INSULIN-LIKE GROWTH FACTOR#0.8123;SURFACE PLASMON RESONANCE#0.8118;TRANSLATION TERMINATION#0.7911;FACTOR I#0.7896;KINASE ACTIVITY#0.7893;ISOTHERMAL TITRATION CALORIMETRY#0.7875;SIGNALLING PATHWAY#0.7822;TARGET OF RAPAMYCIN COMPLEX#0.7724;ENDOPLASMIC RETICULUM#0.7707;AUTOPHAGY#0.7683;80S RIBOSOME#0.7667;UBIQUITIN#0.7622;MRNA CAP BINDING COMPLEX#0.7553;MTOR COMPLEX#0.7552;B CELL#0.7496;GENE SILENCING#0.7489;STEM CELL#0.7488;ARSENITE#0.7446;UNFERTILIZED EGG#0.7405;REGULATION OF PROTEIN SYNTHESIS#0.7401;MRNA METABOLISM#0.7394;POLYMERASE CHAIN REACTION#0.7388;SQUAMOUS CELL CARCINOMA#0.7382;REGULATION OF GENE EXPRESSION#0.7363;TUMOR NECROSIS FACTOR#0.7323;GUANIDINE#0.7045;GUANOSINE#0.7039;ATP HYDROLYSIS#0.7033;PROSTATE CANCER#0.6981;EUKARYOTIC ELONGATION FACTOR#0.6857;HUMAN IMMUNODEFICIENCY VIRUS#0.6711;MULTIPLE MYELOMA#0.6685;ETHANOL#0.6643;CERVICAL CANCER#0.6626;VESICULAR STOMATITIS VIRUS#0.6619;FERTILIZATION#0.6617;RNA DEPENDENT ATPASE#0.6495;7-METHYLGUANOSINE#0.6466;PROTEIN DEGRADATION#0.6453;MECHANISM OF ACTION#0.6414;CHRONIC ALCOHOL CONSUMPTION#0.6403;BONE MARROW#0.6380;NONSENSE-MEDIATED MRNA DECAY#0.6374;VIRAL GENOME#0.6372;CARDIAC MUSCLE#0.6296;PROTEIN BINDING#0.6157;DNA REPLICATION#0.6146;PLASMA MEMBRANE#0.6109;REACTIVE OXYGEN SPECIES#0.6106;MYOTUBE#0.6100;GLOBIN#0.6092;GUANINE#0.6068;IMMUNE RESPONSE#0.6064;PROGESTERONE#0.6044
1982	TRANSLATION INITIATION FACTOR#1.0547;TRANSLATION INITIATION#1.0389;APOPTOSIS#1.0261;RIBOSOME#1.0049;PROTEIN SYNTHESIS#0.9890;GENE EXPRESSION#0.9626;CELL DEATH#0.9540;APOPTOTIC#0.9008;EUKARYOTIC INITIATION FACTOR#0.8965;CELL CYCLE#0.8514;STEM CELL#0.8495;POLYSOME#0.7870;PROTEASOME#0.7730;APOBEC#0.7580;TRANSCRIPTION FACTOR#0.7518;PROTEIN TRANSLATION#0.7430;CELL PROLIFERATION#0.7383;SIGNALING PATHWAY#0.7374;UBIQUITIN#0.7166;TRANSLATIONAL INITIATION#0.7102;PROGRAMMED CELL DEATH#0.7064;RIBOSOMAL PROTEIN#0.6905;EMBRYONIC STEM CELL#0.6885;EIF4E BINDING#0.6807;RNA INTERFERENCE#0.6633;CELL DIFFERENTIATION#0.6615;RETINOIC ACID#0.6196;TRANSITIONAL CELL CARCINOMA#0.6189;M PHASE#0.6098;GERM CELL#0.6083
1983	GTP HYDROLYSIS#1.0802;PREINITIATION COMPLEX#1.0597;RIBOSOMAL SUBUNIT#1.0323;TRANSLATION INITIATION FACTOR#1.0309;RIBOSOME#1.0293;C TERMINAL DOMAIN#1.0282;TRANSLATION INITIATION#1.0254;EUKARYOTIC INITIATION FACTOR#1.0234;PROTEIN SYNTHESIS#0.9909;40S RIBOSOMAL SUBUNIT#0.9576;RETICULOCYTE#0.9571;GTPASE ACTIVITY#0.8746;CELL GROWTH#0.8665;GUANINE#0.8094;PROTEIN SYNTHESIS INITIATION#0.7757;80S RIBOSOME#0.7592;CELL CYCLE#0.7332;MRNA BINDING#0.7267;RIBOSOMAL PROTEIN#0.7154;60S RIBOSOMAL SUBUNIT#0.7045;RIBOSOME BINDING#0.6983;PROTEIN KINASE#0.6933;NUCLEOTIDE EXCHANGE FACTOR#0.6915;GENE EXPRESSION#0.6645;COMPLEX I#0.6399;GDP DISSOCIATION INHIBITOR#0.6339;ARGININE#0.6307;LYSINE#0.6041;TRANSCRIPTION FACTOR#0.6019
1984	HYPUSINE FORMATION#1.0886;TRANSLATION ELONGATION#1.0700;POSTTRANSLATIONAL MODIFICATION#1.0555;EUKARYOTIC INITIATION FACTOR#1.0495;TRANSLATION INITIATION FACTOR#1.0485;TRANSLATION INITIATION#1.0445;RIBOSOME#1.0401;PUROMYCIN#1.0379;DEOXYHYPUSINE SYNTHASE#1.0379;PROTEIN SYNTHESIS INITIATION#1.0370;LYSINE#1.0365;POST-TRANSLATIONAL MODIFICATION#1.0363;NUCLEAR EXPORT#1.0356;SPERMIDINE#1.0347;CELL GROWTH#1.0289;PROTEIN SYNTHESIS#1.0288;CELL DEATH#1.0237;CELL PROLIFERATION#1.0168;CANCER CELL#1.0140;APOPTOSIS#1.0063;HUMAN IMMUNODEFICIENCY VIRUS#1.0020;CELL CYCLE#0.9924;PUTRESCINE#0.9918;HYPUSINE SYNTHESIS#0.9895;GENE EXPRESSION#0.9889;T CELL#0.9828;HYPUSINE BIOSYNTHESIS#0.9803;CYTOPLASM#0.9585;POLYSOME#0.9537;AUTOPHAGY#0.9495;SPERMINE#0.9472;APOPTOTIC#0.9384;PROTEIN KINASE#0.9381;SIGNALING PATHWAY#0.9145;TRANSCRIPTION FACTOR#0.9081;TRANSLATION ELONGATION FACTOR#0.9009;B CELL#0.8931;RIBOSOMAL SUBUNIT#0.8849;SKELETAL MUSCLE#0.8835;RNA INTERFERENCE#0.8783;MALARIA#0.8783;80S RIBOSOME#0.8764;BUTYLAMINE#0.8717;SENESCENCE#0.8676;CELL DIFFERENTIATION#0.8616;ORNITHINE DECARBOXYLASE#0.8495;CICLOPIROX#0.8286;RIBOSOMAL PROTEIN#0.8274;ORNITHINE#0.8086;GROWTH FACTOR#0.8073;NUCLEIC ACID#0.7981;MRNA DECAY#0.7940;NUCLEOCYTOPLASMIC TRANSPORT#0.7893;CELL DIVISION#0.7859;RNA BINDING#0.7857;STEM CELL#0.7825;INDUCTION OF APOPTOSIS#0.7726;HYPOXIA#0.7719;CELL MIGRATION#0.7697;ENDOPLASMIC RETICULUM#0.7693;TROPHOBLAST#0.7588;PANCREATIC CANCER#0.7585;INHIBITION OF CELL GROWTH#0.7573;POLYAMINE BIOSYNTHESIS#0.7567;NUCLEAR PORE#0.7495;GLUCOSE INTOLERANCE#0.7296;DEFERIPRONE#0.7295;SPINAL CORD#0.7191;TRANSLATIONAL ELONGATION#0.7089;TUMOR SUPPRESSOR#0.7046;FACTOR I#0.7029;COLORECTAL#0.7020;POLYAMINE METABOLISM#0.6920;PROGRAMMED CELL DEATH#0.6899;PROTEIN PROTEIN INTERACTION#0.6895;HEAT SHOCK PROTEIN#0.6877;REGULATION OF CELL PROLIFERATION#0.6855;T-CELL LEUKEMIA#0.6800;HEPATOCELLULAR CARCINOMA#0.6710;ARGININE#0.6647;DEOXYHYPUSINE SYNTHASE ACTIVITY#0.6638;POLYMERASE CHAIN REACTION#0.6569;RETICULOCYTE#0.6552;OVARIAN CANCER#0.6479;ONCOGENIC#0.6335;OVARIAN#0.6320;BETA CELL#0.6292;LUNG CANCER#0.6253;HISTIDINE#0.6253;ALPHA-DIFLUOROMETHYLORNITHINE#0.6134;POLYAMINE SYNTHESIS#0.6130;TANDEM AFFINITY PURIFICATION#0.6123;ACTINOMYCIN D#0.6083;STRESS GRANULE#0.6051;AUTOPHAGOSOME FORMATION#0.6012;SPONTANEOUS ABORTION#0.6008;A-GEL#0.6002
1990	ACINAR CELL#0.8029;EXOCRINE PANCREATIC INSUFFICIENCY#0.7983;GENE EXPRESSION#0.7431;PANCREATIC CARCINOMA#0.7086;EXTRACELLULAR MATRIX#0.6451;CELLULOSE BIOSYNTHESIS#0.6231;STEATORRHEA#0.6210;ANGIOGENESIS#0.6048
1991	ONO-6818#1.0998;NEOPTERIN#1.0503;SECRETORY CELL#1.0489;NEUTROPHIL ELASTASE INHIBITOR#1.0461;1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE#1.0296;METAPLASIA#1.0296;NERVE GROWTH FACTOR#1.0293;AZUROPHIL GRANULE#1.0282;ALPHA-1 PROTEASE INHIBITOR#1.0264;MATRIX METALLOPROTEINASE-8#1.0239;TUMOUR NECROSIS FACTOR#1.0230;ELASTIN DEGRADATION#1.0224;PULMONARY FIBROSIS#1.0215;NEUTROPHIL#1.0206;FACTOR XA#1.0199;NEUTROPHIL SERINE PROTEASE#1.0162;PRIMARY GRANULE#1.0149;SEVERE CONGENITAL NEUTROPENIA#1.0147;OLEIC ACID#1.0137;HUMAN AIRWAY EPITHELIAL#1.0125;ADULT RESPIRATORY DISTRESS SYNDROME#1.0090;LEUKOCYTE#1.0087;VALINE#1.0087;ISCHEMIA REPERFUSION INJURY#1.0086;HUMAN BRONCHIAL EPITHELIAL#1.0085;ELASTASE ACTIVITY#1.0080;AMNIOTIC FLUID#1.0077;UROKINASE#1.0076;NEUTROPENIA#1.0059;MAST CELL#1.0054;XANTHINE OXIDASE#1.0049;LUNG CANCER#1.0045;BREAST CANCER#1.0045;EOSINOPHIL#1.0044;BRONCHIECTASIS#1.0041;ELASTIC FIBER#1.0036;SEMINAL PLASMA#1.0034;UNFOLDED PROTEIN RESPONSE#1.0034;SELECTIN#1.0033;COLLAGENASE#1.0022;G-CSF#1.0017;MYELOPEROXIDASE ACTIVITY#1.0015;C REACTIVE PROTEIN#1.0012;ALPHA-1-PROTEINASE INHIBITOR#1.0012;DISSEMINATED INTRAVASCULAR COAGULATION#1.0008;SPUTUM#1.0008;DNASE#0.9998;CORTISOL#0.9991;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.9989;STRUCTURE ACTIVITY RELATIONSHIP#0.9988;TRANSFORMING GROWTH FACTOR#0.9983;AIRWAY EPITHELIAL CELL#0.9976;HEMORRHAGE#0.9974;PULMONARY EMPHYSEMA#0.9971;ACUTE LUNG INJURY#0.9967;PANCREATITIS#0.9959;BRONCHIAL EPITHELIAL CELLS#0.9953;ERYTHROCYTE#0.9945;DIGESTION#0.9945;APROTININ#0.9943;FIBRINOGEN#0.9940;GINGIVAL CREVICULAR FLUID#0.9940;SYNOVIAL FLUID#0.9939;ACUTE PANCREATITIS#0.9935;MYELOID CELL#0.9933;FIBRINOLYSIS#0.9928;NEUTROPHIL DEGRANULATION#0.9923;PROTEIN KINASE C#0.9920;SERPIN#0.9919;LUNG DAMAGE#0.9919;NATURAL KILLER CELL#0.9911;POLYMORPHONUCLEAR NEUTROPHIL#0.9909;ALPHA-2 MACROGLOBULIN#0.9907;MUCOUS#0.9901;WHITE BLOOD CELL#0.9901;COLITIS#0.9900;T- PA#0.9896;ISCHEMIA#0.9895;BONE MARROW CELLS#0.9892;PSORIASIS#0.9892;SUPEROXIDE DISMUTASE#0.9891;GOBLET CELL#0.9889;BETA GLUCURONIDASE#0.9877;COMPLEMENT ACTIVATION#0.9877;CELL ADHESION#0.9871;LUNG EPITHELIAL CELL#0.9870;PROTEINASE INHIBITOR#0.9866;ACTIVATED PROTEIN C#0.9865;BASEMENT MEMBRANE#0.9865;MOLAR#0.9864;TUMOR NECROSIS FACTOR#0.9860;VENOUS BLOOD#0.9859;ALVEOLAR MACROPHAGE#0.9859;CONNECTIVE TISSUE#0.9858;PERIODONTITIS#0.9855;HEPARIN#0.9853;T LYMPHOCYTE#0.9851;RESPIRATORY TRACT#0.9846;MYELOID LEUKEMIA#0.9845;NITRIC OXIDE SYNTHASE#0.9840;REVERSE TRANSCRIPTION#0.9832;NEUTROPHIL CHEMOTAXIS#0.9832;ENZYME ACTIVITY#0.9831;RHEUMATOID ARTHRITIS#0.9831;ELASTIC FIBRE#0.9831;PROTEOGLYCAN#0.9826;SEMEN#0.9824;ALPHA 1-ANTITRYPSIN#0.9822;RESPIRATORY FAILURE#0.9817;POLYMERASE CHAIN REACTION#0.9817;PLASMA PROTEIN#0.9815;PLATELET ACTIVATION#0.9814;LYSIS#0.9813;RECEPTOR ANTAGONIST#0.9813;PHAGOCYTOSIS#0.9810;ALANINE#0.9805;GROWTH FACTOR#0.9800;RESPIRATORY DISTRESS#0.9799;PROTEIN KINASE#0.9797;SYSTEMIC INFLAMMATORY RESPONSE#0.9795;PNEUMONIA#0.9795;ULCERATIVE COLITIS#0.9789;NEUTROPHIL ACTIVATION#0.9787;PERIODONTAL DISEASE#0.9783;TISSUE DAMAGE#0.9777;SERUM ALBUMIN#0.9774;CELL SURFACE#0.9772;GINGIVITIS#0.9771;INNATE IMMUNITY#0.9768;AORTIC ANEURYSM#0.9767;BLOOD COAGULATION#0.9758;AIRWAY EPITHELIUM#0.9755;HYPERTENSION#0.9753;ESOPHAGEAL CANCER#0.9753;MONOCYTE#0.9751;PRO-INFLAMMATORY#0.9750;CHEMOTAXIS#0.9750;SMOOTH MUSCLE#0.9747;CELL ACTIVATION#0.9746;EDEMA#0.9741;NITRIC OXIDE#0.9741;REACTIVE OXYGEN SPECIES#0.9741;WOUND HEALING#0.9741;KERATINOCYTE#0.9735;COAGULATION#0.9735;VASCULITIS#0.9734;TOXICITY#0.9731;TRANSCRIPTION FACTOR#0.9730;MYOCARDIAL INFARCTION#0.9727;ACUTE MYELOID LEUKEMIA#0.9727;PROGENITOR CELL#0.9727;MARKERS OF INFLAMMATION#0.9727;CYSTATIN#0.9725;TRACHEA#0.9724;GROWTH FACTOR RECEPTOR#0.9724;LEUKOCYTE ACTIVATION#0.9723;ENZYME INHIBITOR#0.9721;LYSINE#0.9721;GRANULOCYTE#0.9721;GRANULOCYTE COLONY STIMULATING FACTOR#0.9720;ALPHA 1-ANTITRYPSIN DEFICIENCY#0.9719;DODECYL SULFATE#0.9718;PLATELET ACTIVATING FACTOR#0.9714;EXTRACELLULAR MATRIX#0.9711;EPITHELIAL CELL#0.9710;COMPLEX I#0.9710;CELL PROLIFERATION#0.9710;PROTEASE ACTIVITY#0.9707;COLONY-STIMULATING FACTOR#0.9704;GM-CSF#0.9703;ALPHA-1-ANTIPROTEINASE#0.9702;BRONCHITIS#0.9701;APOPTOTIC#0.9700;SODIUM DODECYL SULFATE#0.9699;CANCER CELL#0.9697;NEUTROPHIL GRANULOCYTES#0.9696;LUNG DISEASE#0.9694;APOPTOSIS#0.9693;ENDOTHELIAL CELL#0.9693;PLASMA MEMBRANE#0.9690;EPIDERMAL GROWTH FACTOR#0.9690;NADPH OXIDASE#0.9689;CLOTTING#0.9686;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.9685;CYSTIC FIBROSIS#0.9684;CELL DEATH#0.9683;MACROPHAGE#0.9681;STEM CELL#0.9681;ACUTE MYOCARDIAL INFARCTION#0.9681;CORONARY ARTERY#0.9680;DIPEPTIDYL PEPTIDASE#0.9679;ARGININE#0.9679;CYTOTOXICITY#0.9678;ABDOMINAL AORTIC ANEURYSM#0.9677;POLYMORPHONUCLEAR LEUKOCYTES#0.9663;INTENSIVE CARE UNIT#0.9659;TUMOR CELLS#0.9658;ATHEROSCLEROSIS#0.9657;CORONARY ARTERY BYPASS#0.9654;B CELL#0.9654;T CELL#0.9654;SIGNALING PATHWAY#0.9648;FORCED EXPIRATORY VOLUME#0.9646;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9638;BONE MARROW#0.9632;PERIPHERAL BLOOD#0.9629;ADENOSINE#0.9627;INFLAMMATORY CELL#0.9626;SECRETORY GRANULE#0.9624;MONONUCLEAR CELLS#0.9624;IMMUNE SYSTEM#0.9621;DENDRITIC CELL#0.9616;TOLL LIKE RECEPTOR#0.9611;IMMUNE CELL#0.9608;ENDOTHELIUM#0.9606;ARTERY#0.9606;METHIONINE#0.9605;GENE EXPRESSION#0.9604;MECHANISM OF ACTION#0.9602;INFLAMMATORY BOWEL DISEASE#0.9599;INTERSTITIAL LUNG DISEASE#0.9590;PHOSPHOLIPASE A2#0.9585;RETINOIC ACID#0.9580;SMOOTH MUSCLE CELL#0.9578;SIGNAL TRANSDUCTION#0.9572;MUSCLE CELL#0.9571;PLATELET AGGREGATION#0.9570;MEAN LINEAR INTERCEPT#0.9570;LIVER DISEASE#0.9569;PULMONARY EDEMA#0.9563;ENDOPLASMIC RETICULUM#0.9561;CYTOKINE PRODUCTION#0.9557;INFLAMMATORY RESPONSE#0.9556;AUTOIMMUNE DISEASE#0.9541;OXIDATIVE BURST#0.9529;IMMUNE RESPONSE#0.9509;GLUTATHIONE#0.9500;DIABETES MELLITUS#0.9485;BLEOMYCIN#0.9482;LEUCINE#0.9477;THROMBOSIS#0.9475;XANTHINE#0.9461;VIRULENCE#0.9452;HYPOXIA#0.9449;HEART DISEASE#0.9443;VASCULAR CELL#0.9436;PARENCHYMA#0.9424;CYTOPLASM#0.9423;HEPARIN BINDING#0.9423;ENDOTHELIAL GROWTH FACTOR#0.9417;PANCREATIC ELASTASE 2#0.9415;NEUTROPHIL MIGRATION#0.9392;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9387;CELL DIFFERENTIATION#0.9385;ANGIOGENESIS#0.9383;INNATE IMMUNE RESPONSE#0.9369;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9359;EXTRACELLULAR SPACE#0.9337;BLOOD LOSS#0.9337;CELL ADHESION MOLECULE#0.9335;MULTIPLE SCLEROSIS#0.9332;PEPTIDASE INHIBITOR#0.9327;HYALURONIC ACID#0.9326;HEMATOPOIESIS#0.9326;STEM CELL TRANSPLANTATION#0.9325;ATHEROSCLEROTIC#0.9311;INNATE IMMUNE SYSTEM#0.9307;CREATINE KINASE#0.9286;CARDIAC ARREST#0.9278;HEMORRHAGIC#0.9277;PROTEASE ACTIVATED RECEPTOR#0.9267;PROMYELOCYTE#0.9263;GLYCOSYLATION#0.9257;STROMELYSIN#0.9243;PROTEINASE ACTIVITY#0.9240;PULMONARY HYPERTENSION#0.9237;CATALYTIC ACTIVITY#0.9233;IONOPHORE#0.9224;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9223;SCANNING ELECTRON MICROSCOPY#0.9221;BLOOD VESSEL#0.9218;RANDOMIZED CONTROLLED TRIAL#0.9191;BULLOUS PEMPHIGOID#0.9180;MITOGEN ACTIVATED PROTEIN#0.9179;GENETIC DISORDER#0.9178;IL-8 PRODUCTION#0.9176;KINASE INHIBITOR#0.9168;FIBRIL#0.9164;CLARA CELL#0.9162;INDUCIBLE NITRIC OXIDE#0.9156;ERYTHROCYTE SEDIMENTATION RATE#0.9115;ADENOCARCINOMA#0.9113;TISSUE REMODELING#0.9090;SPINAL CORD#0.9082;PROSTAGLANDIN E2#0.9073;TRANSFORMING GROWTH FACTOR BETA#0.9073;CELL MIGRATION#0.9070;72-HOURS#0.9069;PULMONARY ARTERY#0.9065;SPECIFIC GRANULE#0.9055;ALLERGEN#0.9026;CREATINE#0.9022;GOBLET CELL METAPLASIA#0.9022;EXOCYTOSIS#0.9017;CERVICAL#0.9014;L-PHENYLALANINE#0.9011;DNA BINDING#0.9001;LYMPH NODE#0.9000;BETA-2#0.8996;CYTOTOXIC T-LYMPHOCYTE#0.8991;CELL CYCLE#0.8984;TYPE 2 DIABETES#0.8979;TOPICAL#0.8977;SUPEROXIDE ANION GENERATION#0.8975;ALKALINE PHOSPHATASE#0.8974;LECTIN#0.8939;LYSOSOME#0.8931;L-LYSINE#0.8926;UMBILICAL VEIN#0.8915;CROHN'S DISEASE#0.8904;ARTERY DISEASE#0.8897;STROMAL CELL#0.8872;MATRIX METALLOPROTEINASE 1#0.8872;PERITONITIS#0.8870;KNEE JOINT#0.8869;ACUTE PROMYELOCYTIC LEUKEMIA#0.8859;BLOOD PLASMA#0.8850;LUMINAL#0.8846;HEALTHY CONTROL SUBJECTS#0.8845;HUMAN UMBILICAL VEIN#0.8845;GINGIVAL OVERGROWTH#0.8837;MULTIPLE ORGAN DYSFUNCTION#0.8831;HEMATOPOIETIC CELL#0.8831;CORONARY ARTERY DISEASE#0.8830;RESPIRATORY BURST#0.8805;BREAST CANCER CELL#0.8798;SPINAL CORD INJURY#0.8796;NEUTROPHIL GRANULE PROTEIN#0.8791;HIGH MOBILITY GROUP#0.8789;LUNG FIBROBLASTS#0.8787;NUCLEAR LOCALIZATION SIGNAL#0.8775;GESTATION#0.8767;ACETIC ACID#0.8764;VASCULAR ENDOTHELIUM#0.8759;GLOMERULONEPHRITIS#0.8757;PHOSPHOLIPASE C#0.8743;VASCULAR DISEASE#0.8739;BRONCHIOLITIS#0.8717;DERMATITIS#0.8712;SKIN DISEASE#0.8711;LOW DENSITY LIPOPROTEIN#0.8703;OBESE#0.8702;ALVEOLAR EPITHELIAL CELL#0.8695;CYCLIC HEMATOPOIESIS#0.8691;NEUTROPHIL APOPTOSIS#0.8690;IFN-GAMMA#0.8690;GLYCINE#0.8689;COLLAGEN DEGRADATION#0.8686;CHRONIC MYELOID LEUKEMIA#0.8675;N-ACETYLCYSTEINE#0.8667;MUTAGENESIS#0.8640;SERUM AMYLOID A#0.8608;HEMATOPOIETIC STEM CELL#0.8578;DNASE I#0.8576;VASCULAR ENDOTHELIAL CELL#0.8558;BRONCHOPULMONARY DYSPLASIA#0.8556;EOSIN#0.8548;HUMAN LEUKOCYTE ANTIGEN#0.8548;C TERMINAL DOMAIN#0.8541;ARACHIDONIC ACID#0.8525;MACROPHAGE INFLAMMATORY PROTEIN#0.8508;CELL MEMBRANE#0.8497;ELASTIN FIBER#0.8496;DEXAMETHASONE#0.8495;NERVOUS SYSTEM#0.8470;RED BLOOD CELL#0.8466;CHORIOAMNIONITIS#0.8459;TUBERCULOSIS#0.8454;HOST CELL#0.8453;EXHALED BREATH CONDENSATE#0.8430;LUNG CARCINOMA#0.8427;PLASMINOGEN ACTIVATION#0.8396;FIBROBLAST GROWTH FACTOR#0.8384;HISTAMINE#0.8379;IMMUNOGLOBULIN G#0.8378;PROTEASE S#0.8359;MUCUS SECRETION#0.8354;EXCRETION#0.8352;METHYLPREDNISOLONE#0.8327;CELL WALL#0.8321;THYMIDINE#0.8318;CORD BLOOD#0.8305;ERYTHROMYCIN#0.8294;LUPUS ERYTHEMATOSUS#0.8284;INFLAMMATORY AIRWAY DISEASE#0.8268;CYTOCHROME C#0.8268;CELL GROWTH#0.8264;MYELODYSPLASTIC SYNDROME#0.8249;THROMBIN ACTIVITY#0.8248;LEUKOCYTE ADHESION#0.8235;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8233;INFERTILITY#0.8233;RETINOIC ACID RECEPTOR#0.8221;OUTER MEMBRANE#0.8211;EXTRACELLULAR MATRIX COMPONENT#0.8209;NECROTIZING#0.8183;BOVINE PANCREATIC TRYPSIN INHIBITOR#0.8170;HEPATOCYTE GROWTH FACTOR#0.8165;QUANTITATIVE REAL TIME#0.8163;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8153;CD8+ T CELL#0.8152;SQUAMOUS CELL CARCINOMA#0.8145;KAWASAKI DISEASE#0.8143;SKELETAL MUSCLE#0.8140;INDOMETHACIN#0.8136;RESPIRATORY SYSTEM#0.8105;AIRWAY SURFACE LIQUID#0.8103;THROMBOPLASTIN#0.8103;GLUTAMIC ACID#0.8102;BONE MARROW FAILURE#0.8099;CEREBRAL ISCHEMIA#0.8082;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8081;FLUORESCEIN#0.8077;ENDOCYTOSIS#0.8060;INFLAMMATORY CELL INFILTRATION#0.8058;ANTICOAGULANT ACTIVITY#0.8023;LASER INDUCED FLUORESCENCE#0.8023;PROTEINASE ACTIVATED RECEPTOR#0.8012;DERMIS#0.8004;SIGNALLING PATHWAY#0.7990;BACTERIAL PNEUMONIA#0.7977;SERINE ELASTASE#0.7975;AIRWAY SMOOTH MUSCLE#0.7954;METALLOPROTEINASE INHIBITOR#0.7954;L-VALINE#0.7920;CELL ASSOCIATED#0.7908;ATOPIC DERMATITIS#0.7908;INTERLEUKIN 1 RECEPTOR#0.7905;ANTI INFLAMMATORY DRUGS#0.7897;SPERMATOZOA#0.7893;PROSTATITIS#0.7876;HYALURONIDASE#0.7866;HIGH FAT DIET#0.7866;NECROTIC#0.7865;LARGE GRANULAR LYMPHOCYTE#0.7865;SARCOIDOSIS#0.7860;IDIOPATHIC PULMONARY FIBROSIS#0.7829;3,4-DICHLOROISOCOUMARIN#0.7816;NUCLEOSOME#0.7812;GENETIC DISEASE#0.7805;AMINOACETIC ACID#0.7801;RESONANCE ENERGY TRANSFER#0.7798;TERMINAL COMPLEMENT COMPLEX#0.7781;COLLAGEN INDUCED ARTHRITIS#0.7760;ROS GENERATION#0.7753;FACTOR I#0.7748;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7738;MOLECULAR DYNAMICS SIMULATION#0.7720;FACTOR D#0.7720;IL-1RA#0.7709;FORCED VITAL CAPACITY#0.7672;CITRIC ACID#0.7653;HISTIDINE#0.7651;ACETYLCYSTEINE#0.7648;NEUROTOXIN#0.7622;HEMOSTASIS#0.7611;ACUTE INFLAMMATORY RESPONSE#0.7608;SINUSITIS#0.7605;LIVER DAMAGE#0.7603;PENTOXIFYLLINE#0.7592;SURFACTANT PROTEIN D#0.7591;BLOOD BRAIN BARRIER#0.7574;TRANSCRIPTASE#0.7564;PROTEIN SYNTHESIS#0.7556;ACUTE LEUKEMIA#0.7545;PHOSPHODIESTERASE#0.7542;LUNG ADENOCARCINOMA#0.7542;SURFACE PLASMON RESONANCE#0.7541;RESPIRATORY TRACT INFECTION#0.7541;ADAPTIVE IMMUNE RESPONSE#0.7535;ETHANOL#0.7525;REGENERATION#0.7517;CHEMOKINE RECEPTOR#0.7511;ASPARTATE#0.7495;HEAT SHOCK PROTEIN#0.7491;SQUALENE SYNTHASE#0.7486;VENTILATOR FREE DAYS#0.7472;SERINE PROTEASE ACTIVITY#0.7471;ENZYME COMPLEX#0.7457;NASAL MUCOSA#0.7445;END OF TREATMENT#0.7429;PROSTACYCLIN#0.7422;L-ALANINE#0.7398;LYMPHOID CELL#0.7391;CHEMOKINE PRODUCTION#0.7386;TRYPTOPHAN#0.7385;VIRAL INFECTION#0.7382;ACTIVATION OF COAGULATION#0.7375;SEVERE ACUTE PANCREATITIS#0.7367;PERIPHERAL BLOOD LEUKOCYTE#0.7365;GRANULOCYTE ACTIVATION#0.7361;PLURIPOTENT STEM CELL#0.7357;SWELLING#0.7354;TNF-ALPHA PRODUCTION#0.7353;CENTRAL NERVOUS SYSTEM#0.7349;TAUROCHOLATE#0.7347;PELVIC ORGAN PROLAPSE#0.7340;ANGIOTENSIN CONVERTING ENZYME#0.7327;S PHASE#0.7325;IDIOPATHIC INTERSTITIAL PNEUMONIA#0.7322;FACTOR VIII#0.7319;PRIMARY BREAST CANCER#0.7296;ENHANCER BINDING#0.7293;LIVER CIRRHOSIS#0.7284;TRANSACTIVATION#0.7247;ALZHEIMER'S DISEASE#0.7229;OSTEOARTHRITIS#0.7228;ADENINE#0.7201;NEGATIVE PREDICTIVE VALUE#0.7192;HYALURONAN#0.7184;MYELOID CELL DIFFERENTIATION#0.7175;INDUCED PLURIPOTENT STEM CELL#0.7173;TRANSMISSION ELECTRON MICROSCOPY#0.7163;AUTOIMMUNITY#0.7148;HUMAN NEUTROPHIL PEPTIDE#0.7142;PERIODONTAL LIGAMENT#0.7121;CATHEPSIN G ACTIVITY#0.7105;CIGARETTE SMOKE EXTRACT#0.7072;DERMAL FIBROBLAST#0.7067;OTITIS MEDIA#0.7018;HYPERSENSITIVITY#0.7000;LUNG INJURY SCORE#0.6996;ALPHA GLUCOSIDASE#0.6996;SPERM MOTILITY#0.6993;MONOCYTE CHEMOTACTIC PROTEIN#0.6961;PHOSPHATE BUFFERED SALINE#0.6961;HYPERTHYROIDISM#0.6956;URIC ACID#0.6951;GUANIDINE#0.6929;FRUCTOSE#0.6925;PLATELET-DERIVED GROWTH FACTOR#0.6919;METHACHOLINE#0.6918;HEPATOCELLULAR CARCINOMA#0.6899;ZYMOGEN ACTIVATION#0.6876;EPITHELIAL SODIUM CHANNEL#0.6872;SULFONAMIDE#0.6859;HISTONE CITRULLINATION#0.6850;PANCREATIC KALLIKREIN#0.6832;CORTISOL BINDING#0.6825;ADIPOSE TISSUE#0.6824;SODIUM CHANNEL#0.6803;IMMATURE MYELOID CELL#0.6791;PULMONARY SARCOIDOSIS#0.6790;TIGHT JUNCTION#0.6787;MENSTRUAL CYCLE#0.6780;RUPTURE OF MEMBRANES#0.6771;MUCOUS CELLS#0.6756;VENULE#0.6750;HYDROXYPROLINE#0.6735;MUCUS PRODUCTION#0.6733;SUBSTANCE P#0.6726;KERATINOCYTE PROLIFERATION#0.6714;PERIPHERAL BLOOD MONOCYTES#0.6709;LIGAMENTUM NUCHAE#0.6696;ALL TRANS RETINOIC ACID#0.6688;UMBILICAL CORD#0.6677;APOPTOSIS INDUCING FACTOR#0.6676;MITOCHONDRIA#0.6672;MODE OF ACTION#0.6671;HUMAN BREAST CANCER#0.6670;RECEPTOR MEDIATED ENDOCYTOSIS#0.6667;PNEUMOCOCCAL PNEUMONIA#0.6665;EPIGALLOCATECHIN#0.6656;PHOSPHATIDYLSERINE#0.6620;COLON CARCINOMA#0.6617;CHLAMYDIA#0.6614;ALKALINE PROTEASE#0.6584;SIGNAL PEPTIDE#0.6582;AGGRESSIVE PERIODONTITIS#0.6581;LITHIUM#0.6572;ALLERGIC RHINITIS#0.6543;LUNG TRANSPLANT RECIPIENTS#0.6542;COLLAGEN TYPE I#0.6537;CASPASE-INDEPENDENT CELL DEATH#0.6532;MIDDLE EAR#0.6517;PRECURSOR CELL#0.6509;SIGNALING CASCADE#0.6498;CELL RECOGNITION#0.6495;HEPATIC ISCHEMIA REPERFUSION#0.6475;AUTOPHAGY#0.6469;ALPHA-TOCOPHEROL#0.6467;LEUKOCYTE MIGRATION#0.6457;IL-1 PRODUCTION#0.6455;COMPLEMENT RECEPTOR#0.6440;POINT OF CARE#0.6435;PROTEINURIA#0.6423;HEMATOPOIETIC PROGENITOR CELL#0.6412;HEMOLYSIS#0.6404;TH17 CELL#0.6404;CYTOTOXIC T CELL#0.6403;SKIN FIBROBLASTS#0.6402;NEPHRITIS#0.6390;DNA FRAGMENTATION#0.6380;B LYMPHOCYTE#0.6373;MITOCHONDRIAL MEMBRANE#0.6367;SIGNAL TRANSDUCER#0.6366;TYROSINE KINASE INHIBITOR#0.6362;OBSTRUCTIVE LUNG DISEASE#0.6326;LEUKOPENIA#0.6312;SHWACHMAN DIAMOND SYNDROME#0.6294;COMMUNITY ACQUIRED PNEUMONIA#0.6292;SODIUM DODECYL SULPHATE#0.6275;PULMONARY DAMAGE#0.6273;GINGIVA#0.6265;MALARIA#0.6257;LEUKOTRIENE FORMATION#0.6250;ENHANCER BINDING PROTEIN#0.6229;PROTEASE INHIBITOR COMPLEX#0.6226;POLY ETHYLENE GLYCOL#0.6222;MICROVASCULAR ENDOTHELIAL CELL#0.6222;FATTY LIVER#0.6203;MAPK SIGNALING#0.6196;PANCREATIC CANCER#0.6194;CATABOLISM#0.6194;WEIGHT GAIN#0.6193;STEROID BINDING#0.6178;METHIONINE SULFOXIDE#0.6172;INSULIN-LIKE GROWTH FACTOR#0.6170;MYELOID PROGENITOR CELL#0.6161;OVARIAN#0.6157;MYOCARDIUM#0.6133;VERAPAMIL#0.6122;CHRONIC RESPIRATORY DISEASE#0.6121;PROTEIN ARGININE DEIMINASE#0.6117;MACROPHAGE ACTIVATION#0.6117;CYCLOPHOSPHAMIDE#0.6114;PROTEIN FOLDING#0.6114;RESPIRATORY SYNCYTIAL VIRUS#0.6113;ACUTE LUNG INFLAMMATION#0.6112;PROTEIN SECRETION#0.6095;CATHEPSIN B ACTIVITY#0.6086;L-PROLINE#0.6054;NUCLEIC ACID#0.6054;DNA SYNTHESIS#0.6043;RHINITIS#0.6042;ASCITES#0.6033;ENDOMETRIUM#0.6028;HYPOTENSION#0.6026;CHONDROCYTE#0.6017;DIISOPROPYL FLUOROPHOSPHATE#0.6017;CONTACT DERMATITIS#0.6014;KU70 BINDING#0.6011;NASAL EPITHELIUM#0.6006;STROMA#0.6006;BLEEDING ON PROBING#0.6003
199221	CILIARY TRANSITION ZONE#0.7237
1992	NEUTROPHIL ELASTASE INHIBITOR#1.0788;ELASTASE ACTIVITY#1.0621;PILUS#1.0600;COLLAGENASE#1.0454;SERPIN#1.0346;MONOCYTE#1.0092;PROTEINASE INHIBITOR#1.0068;NEUTROPHIL#1.0051;ALPHA 1-ANTITRYPSIN#0.9998;HYALURONIDASE#0.9539;ALPHA-1-PROTEINASE INHIBITOR#0.9384;NEUTROPHIL SERINE PROTEASE#0.9324;LEUKOCYTE#0.9195;CELL PROLIFERATION#0.8997;CANCER CELL#0.8862;APOPTOSIS#0.8704;BONE MARROW#0.8549;EPITHELIAL CELL#0.8396;T CELL#0.8379;INFLAMMATORY RESPONSE#0.8158;RESPIRATORY TRACT#0.8087;MACROPHAGE#0.8044;GENE EXPRESSION#0.8022;CELL DEATH#0.7772;ALPHA-2 MACROGLOBULIN#0.7576;TH17 CELL#0.7548;CYSTIC FIBROSIS#0.7419;LUNG DISEASE#0.7323;PROTEASE ACTIVITY#0.7292;HYALURONIDASE ACTIVITY#0.7115;CELL MIGRATION#0.6898;SURFACTANT PROTEIN D#0.6897;ANTIOXIDANT ACTIVITY#0.6867;ALPHA-1 PROTEASE INHIBITOR#0.6716;GRANULOCYTE#0.6676;MYELOID CELL#0.6595;TISSUE DAMAGE#0.6540;BREAST CANCER#0.6528;GROWTH FACTOR#0.6460;PSORIASIS#0.6407;IMMUNE RESPONSE#0.6293;SIGNALING PATHWAY#0.6279;VIRULENCE#0.6274;HOST CELL#0.6073;PULMONARY EMPHYSEMA#0.6049
1993	PROTEIN INTERACTION NETWORK#1.0253;RNA BINDING#1.0168;RNA BINDING PROTEIN#1.0157;PROTEIN PROTEIN INTERACTION#0.9986;SIGNALING PATHWAY#0.9904;CELL CYCLE#0.9828;TRANSCRIPTION FACTOR#0.9781;ALZHEIMER'S DISEASE#0.9724;CENTRAL NERVOUS SYSTEM#0.9670;NERVOUS SYSTEM#0.9617;GENE EXPRESSION#0.9574;STEM CELL#0.9490;IMMUNE RESPONSE#0.9455;GENE EXPRESSION OMNIBUS#0.9443;PROTEIN KINASE#0.9378;APOPTOSIS#0.8992;GROWTH FACTOR#0.8863;NEUROGENESIS#0.8647;LUNG CANCER#0.8621;CYTOPLASM#0.8539;NEURODEGENERATIVE DISEASE#0.8460;MAPK SIGNALING#0.8138;ASTROCYTE#0.8035;CELL GROWTH#0.8009;GERM CELL#0.7928;SPLICEOSOME#0.7903;SYNAPTIC TRANSMISSION#0.7902;THALAMUS#0.7882;FRONTAL#0.7875;INTERNEURON#0.7810;POLYMERASE CHAIN REACTION#0.7799;COGNITION#0.7745;CELL PROLIFERATION#0.7642;CANCER CELL#0.7626;IMMUNE SYSTEM#0.7597;DEFAULT MODE NETWORK#0.7580;INFERIOR COLLICULUS#0.7570;CELL ADHESION#0.7462;MAGNETIC RESONANCE IMAGING#0.7404;PARKINSON'S DISEASE#0.7399;RNA RECOGNITION MOTIF#0.7176;EXTRACELLULAR MATRIX#0.7156;ION CHANNEL#0.7142;NERVOUS SYSTEM DEVELOPMENT#0.7120;SYSTEM DEVELOPMENT#0.7101;FALSE DISCOVERY RATE#0.7099;REGENERATION#0.7045;PROTEIN BINDING#0.7044;FOREBRAIN#0.7011;PROGENITOR CELL#0.7008;SIGNAL TRANSDUCTION#0.6996;DOPAMINE#0.6977;EPILEPSY#0.6952;NEURONAL CELLS#0.6949;LUNG CARCINOMA#0.6899;MEDULLOBLASTOMA#0.6876;ENCEPHALOMYELITIS#0.6857;NUCLEOPLASM#0.6828;NEUROLOGICAL DISORDER#0.6792;CELL DEATH#0.6722;PERIPHERAL BLOOD#0.6721;BRAIN DEVELOPMENT#0.6690;OLIGODENDROCYTE#0.6584;BREAST CANCER#0.6560;MOLECULAR FUNCTION#0.6420;ANTERIOR CINGULATE CORTEX#0.6404;FOCAL ADHESION#0.6372;GLIAL CELL#0.6359;NEURITE#0.6312;GAP JUNCTION#0.6303;MRNA BINDING#0.6291;TARGET OF RAPAMYCIN#0.6241;AMYGDALA#0.6220;PERIPHERAL NERVOUS SYSTEM#0.6185;CEREBRAL CORTEX#0.6156;ETHANOL#0.6112;AU RICH ELEMENT#0.6100;NEURAL STEM CELL#0.6004
1994	NUCLEOCYTOPLASMIC SHUTTLING#1.0663;AU-RICH ELEMENT BINDING#1.0546;PANCREATIC CANCER#1.0540;RNA RECOGNITION MOTIF#1.0516;OVARIAN CANCER#1.0505;ARE BINDING#1.0462;NUCLEAR EXPORT#1.0455;RNA STABILIZATION#1.0450;MRNA BINDING#1.0415;BINDING PROTEIN 1#1.0371;COLON CANCER#1.0361;BREAST CANCER CELL#1.0357;CYTOPLASM#1.0326;T CELL#1.0321;RNA INTERFERENCE#1.0299;MRNA STABILIZATION#1.0284;OVARIAN#1.0275;LUNG CANCER#1.0274;APOPTOTIC#1.0236;HYPOXIA#1.0227;POLYSOME#1.0207;MRNA DECAY#1.0187;GEMCITABINE#1.0182;EPITHELIAL CELL#1.0176;RNA BINDING PROTEIN#1.0168;RNA BINDING#1.0153;BREAST CANCER#1.0150;AU RICH ELEMENT#1.0131;SQUAMOUS CELL CARCINOMA#1.0090;PROTEIN KINASE#1.0087;CANCER CELL#1.0068;COLORECTAL CANCER#1.0051;ADENYLATE#1.0051;COLORECTAL#1.0034;CELL MIGRATION#1.0011;CELL ACTIVATION#1.0004;CELL DEATH#1.0001;MACROPHAGE#0.9988;SIGNALING PATHWAY#0.9982;CELL GROWTH#0.9976;CELL CYCLE#0.9966;STRESS GRANULE#0.9963;MRNA DEGRADATION#0.9961;GROWTH FACTOR#0.9930;TRANSCRIPTION FACTOR#0.9897;ONCOGENIC#0.9889;APOPTOSIS#0.9887;ADENOCARCINOMA#0.9885;CELL PROLIFERATION#0.9879;MITOGEN ACTIVATED PROTEIN#0.9874;ENDOTHELIAL GROWTH FACTOR#0.9872;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9871;NUCLEAR IMPORT#0.9869;INFLAMMATORY RESPONSE#0.9867;ANGIOGENESIS#0.9864;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.9852;TUMOR NECROSIS FACTOR#0.9852;TUMOR SUPPRESSOR#0.9843;INTESTINAL EPITHELIAL CELL#0.9817;T CELL ACTIVATION#0.9816;LYMPH NODE#0.9814;GENE EXPRESSION#0.9765;MUSCLE CELL#0.9742;PROSTATE CANCER#0.9740;ELECTROPHORETIC MOBILITY SHIFT#0.9695;URIDINE#0.9670;REGULATION OF MRNA#0.9647;PANCREATIC DUCTAL ADENOCARCINOMA#0.9613;ADENINE#0.9604;PROTEIN KINASE C#0.9599;LUCIFERASE ACTIVITY#0.9597;ORAL CANCER CELL#0.9596;PRO-INFLAMMATORY#0.9571;HEPATOCELLULAR CARCINOMA#0.9543;MRNA PROCESSING#0.9427;SMOOTH MUSCLE#0.9387;TRANSCRIPTIONAL CONTROL#0.9387;ENDOTHELIAL CELL#0.9368;SENESCENCE#0.9366;TRANSLATION INITIATION#0.9245;REVERSE TRANSCRIPTION#0.9239;LYMPH NODE METASTASIS#0.9216;DEOXYCYTIDINE KINASE#0.9080;IMMUNE RESPONSE#0.9075;TUMOR CELLS#0.9051;COLON CARCINOMA#0.9020;STEM CELL#0.9009;REGULATION OF GENE EXPRESSION#0.8964;HYPOXIC#0.8929;DRUG RESISTANCE#0.8920;EPITHELIAL BARRIER FUNCTION#0.8916;TH17 CELL#0.8870;UBIQUITIN#0.8817;TUMOR TISSUES#0.8802;POLYMERASE CHAIN REACTION#0.8775;BREAST CARCINOMA#0.8774;MYOGENESIS#0.8764;RIBOSOME#0.8760;AUTOPHAGY#0.8742;CELL CYCLE ARREST#0.8729;ACTINOMYCIN D#0.8648;MUSCLE FIBER#0.8633;GM-CSF#0.8623;MAP KINASE#0.8622;MYOBLAST#0.8615;ESTROGEN RECEPTOR#0.8601;PROTEIN SYNTHESIS#0.8594;CERVICAL#0.8581;TRANSPORTIN#0.8543;MESANGIAL CELL#0.8520;REPLICATIVE SENESCENCE#0.8469;RHEUMATOID ARTHRITIS#0.8453;AMYOTROPHIC LATERAL SCLEROSIS#0.8428;LATERAL SCLEROSIS#0.8428;KERATINOCYTE#0.8380;NADPH OXIDASE#0.8364;CELL DIFFERENTIATION#0.8353;SMOOTH MUSCLE CELL#0.8348;PROTEIN PROTEIN INTERACTION#0.8264;KINASE INHIBITOR#0.8238;GROWTH FACTOR RECEPTOR#0.8231;SKELETAL MUSCLE#0.8228;B CELL#0.8212;PROTEIN BINDING#0.8140;ENHANCER BINDING PROTEIN#0.8135;ENHANCER BINDING#0.8130;BIOTIN#0.8121;PROTEIN COMPLEX#0.8117;CYTOKINE PRODUCTION#0.8088;ORAL SQUAMOUS CELL CARCINOMA#0.7977;GENE SILENCING#0.7976;NITRIC OXIDE#0.7974;CYCLIN DEPENDENT KINASE#0.7845;DIABETIC RETINOPATHY#0.7844;MITOCHONDRIA#0.7837;MRNA DESTABILIZATION#0.7836;RENAL CELL CARCINOMA#0.7832;TRANSLATION INITIATION FACTOR#0.7814;SPINAL CORD#0.7800;DNA DAMAGE RESPONSE#0.7784;CELLULAR GROWTH#0.7738;POLYPYRIMIDINE TRACT BINDING#0.7720;BREAST CANCER PATIENTS#0.7672;INTESTINAL MUCOSA#0.7666;EPIDERMAL GROWTH FACTOR#0.7628;MIRNA BINDING#0.7609;TRANSFORMING GROWTH FACTOR#0.7585;ASTROCYTE#0.7582;5 FLUOROURACIL#0.7550;SKIN CANCER#0.7482;ADENOSINE#0.7482;DOXORUBICIN#0.7478;TO THE PROGRESSION#0.7414;ANCHORAGE INDEPENDENT GROWTH#0.7410;RNA PROCESSING#0.7407;HUMAN BREAST CANCER#0.7393;NERVOUS SYSTEM#0.7302;MRNA SPLICING#0.7288;RNA-INDUCED SILENCING COMPLEX#0.7215;ENDOPLASMIC RETICULUM#0.7214;POST-TRANSLATIONAL MODIFICATION#0.7187;RNA METABOLISM#0.7101;POSTTRANSLATIONAL MODIFICATION#0.7075;COLORECTAL CARCINOMA#0.7066;CELLULAR LOCALIZATION#0.7033;COMPLEX I#0.7029;RETINOIC ACID#0.7023;PERIPHERAL BLOOD#0.6978;ISCHEMIA#0.6903;QUANTITATIVE REAL TIME#0.6844;REACTIVE OXYGEN SPECIES#0.6822;CD4+ T CELL#0.6814;FOLATE#0.6790;DISEASE FREE SURVIVAL#0.6769;INVASIVE BREAST CANCER#0.6756;NEURODEGENERATIVE DISEASE#0.6754;DNA REPAIR#0.6752;MOUSE EMBRYONIC FIBROBLAST#0.6744;HEAT SHOCK PROTEIN#0.6725;RNA METHYLTRANSFERASE#0.6680;MICROVASCULAR ENDOTHELIAL CELL#0.6674;THYROID CARCINOMA#0.6654;GLOBIN#0.6653;LIVER CANCER#0.6602;T LYMPHOCYTE#0.6585;RESPONSE TO GEMCITABINE#0.6533;S-ADENOSYLMETHIONINE#0.6526;EXOSOME#0.6512;INTRACELLULAR LOCALIZATION#0.6509;INFLAMMATORY CELL#0.6496;MAPK SIGNALING#0.6481;APOPTOTIC CELL DEATH#0.6457;INFLAMMATORY BOWEL DISEASE#0.6452;ANDROGEN RECEPTOR#0.6444;WOUND HEALING#0.6437;BONE MARROW#0.6400;PRE-MRNA SPLICING#0.6346;ACTIVATING TRANSCRIPTION FACTOR#0.6313;PROTEASOME#0.6306;NEUROGENESIS#0.6290;LYMPH NODE METASTASES#0.6288;PROTEIN TRANSLATION#0.6284;CYTOTOXICITY#0.6282;LYMPHANGIOGENESIS#0.6275;DNA METHYLATION#0.6261;MUTAGENESIS#0.6261;INSULIN-LIKE GROWTH FACTOR#0.6253;CARBOPLATIN#0.6251;HEPATITIS C VIRUS#0.6244;HEPATITIS C#0.6234;VON HIPPEL LINDAU#0.6233;STROMAL CELL#0.6227;MONONUCLEAR CELLS#0.6211;TAMOXIFEN#0.6204;ARSENITE#0.6166;FLUOROURACIL#0.6103;MONOCYTE#0.6058;LUNG CARCINOMA#0.6015;PERIAMPULLARY ADENOCARCINOMA#0.6014
1995	RNA BINDING#1.0302;RNA BINDING PROTEIN#1.0273;NERVOUS SYSTEM#0.9803;NEUROGENESIS#0.9714;GLIAL CELL#0.9287;CENTRAL NERVOUS SYSTEM#0.8670;GENE EXPRESSION#0.8245;NEURONAL CELLS#0.8144;STEM CELL#0.8114;NITRIC OXIDE SYNTHASE#0.8092;NITRIC OXIDE#0.8073;TRANSCRIPTION FACTOR#0.7840;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7743;PURKINJE CELL#0.7716;CELL CYCLE#0.7654;LUNG CANCER#0.7365;SPINAL CORD#0.7364;PROGENITOR CELL#0.7231;CELL PROLIFERATION#0.7203;ENCEPHALOMYELITIS#0.7177;CELL DIFFERENTIATION#0.6701;ENTERIC NERVOUS SYSTEM#0.6542;IMMATURE NEURON#0.6499;NEUROTOXICITY#0.6134;TELENCEPHALON#0.6127
199675	MAST CELL#0.9850;APOPTOSIS#0.7373;T LYMPHOCYTE APOPTOSIS#0.7290;LYMPHOCYTE APOPTOSIS#0.7018;T LYMPHOCYTE#0.6718
199692	MYOCARDIAL INFARCTION#0.9648;ZINC FINGER PROTEIN#0.6078
199699	DNA BINDING#1.0366;TRANSCRIPTION FACTOR#1.0240;LUNG CANCER#0.9987;GENE EXPRESSION#0.9814;SIGNALING PATHWAY#0.9573;CANCER CELL#0.9421;GROWTH FACTOR#0.9417;APOPTOSIS#0.9064;ELECTROPHORETIC MOBILITY SHIFT#0.9059;RETINOIC ACID#0.9024;BONE MORPHOGENETIC PROTEIN#0.8801;BREAST CANCER#0.8753;NODAL SIGNALING#0.8468;TRANSFORMING GROWTH FACTOR#0.7932;ESTROGEN RECEPTOR#0.7865;CELL GROWTH#0.7839;PROTEIN KINASE#0.7769;ZINC FINGER PROTEIN#0.7687;TRANSACTIVATION#0.7672;FATTY ACID ELONGATION#0.7381;POLYMERASE CHAIN REACTION#0.7330;HEART DISEASE#0.7261;LATERAL PLATE MESODERM#0.7207;MONOCYTE#0.7153;TRANSFORMING GROWTH FACTOR BETA#0.7136;ACTIVATOR PROTEIN 1#0.7102;SPECIFICITY PROTEIN 1#0.7056;BREAST CANCER CELL#0.7054;ARTERY#0.6949;STEM CELL#0.6926;TRANSCRIPTION FACTOR BINDING#0.6793;CORONARY ARTERY#0.6782;MUTAGENESIS#0.6754;EXTRACELLULAR MATRIX#0.6743;T CELL#0.6714;NARCOLEPSY#0.6381;MAGNETIC RESONANCE IMAGING#0.6303;HYPOXIA#0.6246;RECEPTOR ANTAGONIST#0.6131;ENDOTHELIAL CELL#0.6118;MACROPHAGE#0.6113;CONGENITAL HEART DISEASE#0.6049
1996	T CELL#1.0598;NEUROBLASTOMA#1.0300;RNA BINDING#1.0293;RNA BINDING PROTEIN#1.0286;PARANEOPLASTIC NEUROLOGICAL SYNDROME#1.0279;ENCEPHALOMYELITIS#1.0271;LUNG CANCER#1.0244;NERVOUS SYSTEM#1.0060;AU RICH ELEMENT#0.9801;CD8+ T CELL#0.9791;GENE EXPRESSION#0.9647;NEURITE#0.9605;NEURITE OUTGROWTH#0.9585;NEURONAL CELLS#0.9569;IMMUNE RESPONSE#0.9511;MRNA BINDING#0.9450;CENTRAL NERVOUS SYSTEM#0.9010;RNA RECOGNITION MOTIF#0.8256;CANCER CELL#0.8076;LUNG CARCINOMA#0.7955;STEM CELL#0.7879;NEUROPATHY#0.7658;PERIPHERAL BLOOD#0.7501;CELL CYCLE#0.7469;REVERSE TRANSCRIPTION#0.7141;BONE MARROW#0.7124;CELL DEATH#0.6847;CYTOPLASM#0.6841;MONONUCLEAR CELLS#0.6806;ALZHEIMER'S DISEASE#0.6801;TRANSCRIPTIONAL CONTROL#0.6687;GROWTH CONE#0.6455;NERVOUS SYSTEM DEVELOPMENT#0.6438;SYSTEM DEVELOPMENT#0.6419;MICROTUBULE#0.6414;POLYMERASE CHAIN REACTION#0.6231;POLY-A BINDING#0.6125;AUTOIMMUNITY#0.6076;MRNA DEGRADATION#0.6062
199713	MOLAR#1.0404;OOCYTE#0.9601;DNA METHYLATION#0.9290;SPONTANEOUS ABORTION#0.9208;NUCLEOTIDE BINDING#0.9202;LEUCINE RICH REPEAT#0.8496;LEUCINE#0.8160;TROPHOBLAST#0.7795;APOPTOSIS#0.7453;INNATE IMMUNITY#0.6650;RECURRENT PREGNANCY LOSS#0.6565;GENE EXPRESSION#0.6392;MACROPHAGE#0.6357;MICROTUBULE ORGANIZING CENTER#0.6312;ENDOMETRIAL CANCER#0.6145
199720	GERM CELL#0.8733;SPERMATOCYTES#0.6983;SPERMATOGENESIS#0.6390;DNA REPAIR#0.6165
199731	CELL ADHESION MOLECULE#1.0584;SCHWANN CELL#1.0570;CELL ADHESION#1.0569;TUMOR SUPPRESSOR#1.0328;MYELINATION#0.9402;BREAST CANCER#0.9297;NERVOUS SYSTEM#0.8941;CANCER CELL#0.7976;PERIPHERAL NERVOUS SYSTEM#0.7764;ADENOCARCINOMA#0.7503;INTERNODE#0.7183;PROSTATE CANCER#0.7053;PERIPHERAL NERVE#0.6873;DISEASE FREE SURVIVAL#0.6278;PARANODAL JUNCTION#0.6273
199746	TRANSCRIPTION FACTOR#0.7178
199786	B CELL#1.0753;COPY NUMBER CHANGE#0.6855;SIGNALLING PATHWAY#0.6630;MITOGEN ACTIVATED PROTEIN#0.6591;PROTEIN KINASE#0.6543
1997	T CELL#1.0275;TRANSCRIPTION FACTOR#1.0254;DNA BINDING#1.0114;B CELL#1.0079;GENE EXPRESSION#1.0061;ELECTROPHORETIC MOBILITY SHIFT#0.9657;CANCER CELL#0.9616;ENDOTHELIAL CELL#0.9602;HEMATOPOIETIC CELL#0.8895;GM-CSF#0.8671;BREAST CANCER#0.8657;TRANSACTIVATION#0.8579;EPITHELIAL CELL#0.8438;PROTEIN BINDING#0.8306;MYELOID CELL#0.8284;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8149;LUPUS ERYTHEMATOSUS#0.8146;MACROPHAGE#0.7839;CELL DEVELOPMENT#0.7805;GLCNAC#0.7777;LUNG CANCER#0.7588;ONCOGENIC#0.7293;ANGIOGENESIS#0.7277;PROSTATE CANCER#0.7155;GROWTH FACTOR#0.7086;STEM CELL#0.6957;T CELL ACTIVATION#0.6936;CELL ACTIVATION#0.6915;HUMAN IMMUNODEFICIENCY VIRUS#0.6884;BREAST CANCER CELL#0.6657;FACTOR I#0.6599;COLONY-STIMULATING FACTOR#0.6591;TRANSCRIPTION FACTOR BINDING#0.6318;GREEN TEA POLYPHENOL#0.6260;GRANULOCYTE#0.6051
199800	DORSAL AORTA#0.8771;BLOOD VESSEL#0.6003
199857	ER MEMBRANE#0.8756;GLYCOSYLATION#0.8174;ENDOPLASMIC RETICULUM#0.8043;GLCNAC#0.7113;CONGENITAL MYASTHENIC SYNDROME#0.7105;INTELLECTUAL DISABILITY#0.6109
1998	TRANSCRIPTION FACTOR#1.0513;PROTEIN KINASE#0.9860;PROTEIN SYNTHESIS#0.9747;GENE EXPRESSION#0.8273;B CELL#0.8242;EUKARYOTIC INITIATION FACTOR#0.8141;TRANSLATION INITIATION#0.7990;ENDOTHELIAL CELL#0.7762;T CELL#0.7628;TRANSLATION INITIATION FACTOR#0.7058;CELL PROLIFERATION#0.6969;PROTEIN SYNTHESIS INITIATION#0.6517;VALOSIN CONTAINING PROTEIN#0.6454;CANCER CELL#0.6404;APOPTOSIS#0.6017
199920	INTEGRIN ACTIVATION#1.2079;SIGNALING PATHWAY#1.1785;T CELL#1.1769
199953	INNER NUCLEAR MEMBRANE#1.0832;NUCLEAR MEMBRANE#1.0731;SENESCENCE ACCELERATED MOUSE#1.0602;SENESCENCE#1.0487;SENESCENCE ACCELERATED MICE#1.0351;NUCLEAR ENVELOPE#1.0251;T CELL#1.0134;STROMAL CELL#0.9069;AMYLOIDOSIS#0.8847;UBIQUITIN#0.8794;GENE EXPRESSION#0.8740;GANGLION CELLS#0.8592;LINC COMPLEX#0.7979;NUCLEAR MOVEMENT#0.7940;HEARING LOSS#0.7889;SPERMATOGENIC CELLS#0.7712;B CELL#0.7566;CD4+ T CELL#0.7516;TAN LINE#0.7230;NUCLEAR PERIPHERY#0.7217;SPIRAL GANGLION CELL#0.7143;MITOTIC SPINDLE#0.7098;GROWTH FACTOR#0.6944;MUSCLE CELL#0.6843;CELL PROLIFERATION#0.6769;SPERMATOGENESIS#0.6651;BONE MARROW#0.6562;NUCLEOSKELETON#0.6242;SKELETAL MUSCLE#0.6140;MOCO BIOSYNTHESIS#0.6113;ILEITIS#0.6106;5 FLUOROURACIL#0.6064;STEM CELL#0.6053;MUSCULAR DYSTROPHY#0.6018
199974	BREAST CANCER#1.1099;CYTOCHROME P450#1.0111;BREAST CANCER CELL#0.9745;CANCER CELL#0.9692;ANGIOGENESIS#0.7767;MYRISTIC ACID#0.6731;HUMAN BREAST CANCER#0.6497
199990	UBIQUITIN BINDING#1.1365;FA CORE COMPLEX#1.1200;FANCONI ANEMIA#1.0771;UBIQUITIN#1.0510;ANEMIA#0.9773;DNA REPAIR#0.7343;PROGENITOR CELL#0.6097
1999	FLOWERING#1.0484;BREAST CANCER CELL#1.0462;BREAST CANCER#1.0356;DNA BINDING#1.0292;GROWTH FACTOR#1.0270;EPITHELIAL CELL#1.0256;TRANSCRIPTION FACTOR#1.0252;CANCER CELL#1.0248;TERMINAL DIFFERENTIATION#1.0209;TRANSACTIVATION#1.0141;CIRCADIAN RHYTHM#1.0065;CELL PROLIFERATION#0.9967;CHONDROCYTE#0.9949;TUMOR SUPPRESSOR#0.9911;COLORECTAL CANCER#0.9908;GENE EXPRESSION#0.9871;SIGNALING PATHWAY#0.9865;CELL DIFFERENTIATION#0.9570;ELECTROPHORETIC MOBILITY SHIFT#0.9374;TRANSFORMING GROWTH FACTOR#0.9259;CELL GROWTH#0.9217;HUMAN BREAST CANCER#0.9203;APOPTOSIS#0.9150;T CELL#0.9108;ONCOGENIC#0.9013;TRANSFORMING GROWTH FACTOR BETA#0.8865;LUNG CANCER#0.8756;EPITHELIAL CELL DIFFERENTIATION#0.8662;MAMMARY GLAND#0.8635;COLORECTAL#0.8604;SYNOVIAL SARCOMA#0.8564;MAMMARY EPITHELIAL CELL#0.8560;KERATINOCYTE#0.8543;EPIDERMAL GROWTH FACTOR#0.8467;GROWTH FACTOR RECEPTOR#0.8467;PRO-INFLAMMATORY#0.8419;SQUAMOUS CELL CARCINOMA#0.8229;PROTEIN KINASE#0.8142;POLYMERASE CHAIN REACTION#0.8110;INTESTINAL EPITHELIAL CELL#0.8064;SHADE AVOIDANCE#0.7933;ENTEROCYTE#0.7830;PHYTOCHROME INTERACTING FACTOR#0.7769;ACTIVE CASPASE 3#0.7638;ADENOCARCINOMA#0.7588;COLON CANCER#0.7574;INFLAMMATORY RESPONSE#0.7573;GOBLET CELL#0.7499;NITRIC OXIDE SYNTHASE#0.7403;MACROPHAGE#0.7380;NITRIC OXIDE#0.7379;PROSTATE CANCER#0.7289;SIGNAL TRANSDUCTION#0.7279;UBIQUITIN#0.7125;LUMINAL#0.7075;STEM CELL#0.7021;SMALL INTESTINE#0.6930;RETINOIC ACID#0.6803;DIURNAL#0.6772;ENDOTHELIAL CELL#0.6721;TUMOR NECROSIS FACTOR#0.6718;HISTONE DEACETYLASE#0.6526;CELL ADHESION#0.6504;MORPHOGENESIS#0.6394;ANCHORAGE INDEPENDENT GROWTH#0.6342;PSEUDO RESPONSE REGULATOR#0.6296;EPITHELIAL MESENCHYMAL TRANSITION#0.6293;LYMPH NODE#0.6284;MONOCYTE#0.6223;ASPARTIC ACID#0.6133;LEAF SENESCENCE#0.6133;KERATINOCYTE DIFFERENTIATION#0.6070;ALLERGIC AIRWAY INFLAMMATION#0.6052;MUSCLE CELL#0.6044;SMOOTH MUSCLE#0.6033;HUMAN MAMMARY EPITHELIAL#0.6026;OSTEOARTHRITIS#0.6006;NUCLEAR LOCALIZATION SIGNAL#0.6003
199	ALLOGRAFT INFLAMMATORY FACTOR#1.0586;VASCULAR SMOOTH MUSCLE CELL#1.0458;SMOOTH MUSCLE CELL#1.0404;IFN-GAMMA#1.0402;MUSCLE CELL#1.0400;RHEUMATOID ARTHRITIS#1.0346;SMOOTH MUSCLE#1.0294;MACROPHAGE ACTIVATION#1.0266;CLEAVED CASPASE 3#1.0214;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0213;SPINAL DORSAL HORN#1.0153;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0125;ACTIVATED MICROGLIAL CELLS#1.0116;T LYMPHOCYTE#1.0108;NEUROFILAMENT#1.0087;MEMBRANE RUFFLING#1.0073;ASTROCYTE ACTIVATION#1.0072;EOSIN#1.0065;MACROPHAGE#1.0027;LEUKOCYTE#1.0004;T CELL#0.9993;OLIGODENDROCYTE#0.9978;APOPTOSIS INDUCING FACTOR#0.9975;INDUCIBLE NITRIC OXIDE#0.9973;ASTROCYTE#0.9967;DENTATE GYRUS#0.9952;CELL MIGRATION#0.9946;FLUORO JADE B#0.9935;OPTIC NERVE#0.9926;MINOCYCLINE#0.9925;PERIPHERAL BLOOD#0.9910;TRANSLATION INITIATION#0.9908;MYELOID CELL#0.9906;INFLAMMATORY CELL#0.9901;FRONTAL#0.9895;MICROGLIAL CELL#0.9890;NITRIC OXIDE SYNTHASE#0.9887;AMYGDALA#0.9879;MONOCYTE#0.9879;CEREBRAL CORTEX#0.9869;REVERSE TRANSCRIPTION#0.9867;NEUTROPHIL#0.9865;B CELL#0.9861;ENDOTHELIAL CELL#0.9857;CYTOPLASM#0.9846;PHAGOCYTOSIS#0.9840;SPINAL CORD#0.9837;STRIATUM#0.9832;BLOOD VESSEL#0.9828;TUMOR NECROSIS FACTOR#0.9828;SUBSTANTIA NIGRA#0.9827;MONONUCLEAR CELLS#0.9822;DENDRITIC CELL#0.9819;NITRIC OXIDE#0.9818;TRANSCRIPTION FACTOR#0.9794;CELL ACTIVATION#0.9779;CELL PROLIFERATION#0.9773;TOLL LIKE RECEPTOR#0.9769;POLYMERASE CHAIN REACTION#0.9763;GALECTIN#0.9758;MITOGEN ACTIVATED PROTEIN#0.9753;PROGENITOR CELL#0.9719;NEUROINFLAMMATORY RESPONSE#0.9718;LECTIN#0.9710;SCIATIC NERVE#0.9708;CANCER CELL#0.9703;NEUROGENESIS#0.9702;COLONY-STIMULATING FACTOR#0.9699;PROTEIN KINASE#0.9696;AMYLOID PRECURSOR PROTEIN#0.9686;GROWTH FACTOR#0.9685;BLOOD BRAIN BARRIER#0.9683;DOPAMINE#0.9679;PRECURSOR CELL#0.9673;APOPTOTIC#0.9663;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9656;GENE EXPRESSION#0.9654;GLIAL CELL#0.9651;PRO-INFLAMMATORY#0.9651;DOPAMINERGIC NEURON#0.9649;EDEMA#0.9646;PARENCHYMA#0.9646;CELL CYCLE#0.9645;APOPTOSIS#0.9645;BONE MARROW#0.9645;CELL ADHESION#0.9643;SUPEROXIDE DISMUTASE#0.9643;GLIAL CELL ACTIVATION#0.9643;MICROTUBULE ASSOCIATED PROTEIN#0.9638;RETINAL GANGLION CELL#0.9634;GLUTATHIONE#0.9634;TUMOR CELLS#0.9631;IMMUNE CELL#0.9630;CELL DEATH#0.9630;BRAIN DAMAGE#0.9626;ISCHEMIA#0.9620;FORMALIN#0.9618;CEREBRAL ARTERY OCCLUSION#0.9617;IMMUNE SYSTEM#0.9614;PERIPHERAL NERVE#0.9607;QUANTITATIVE REAL TIME#0.9599;HIGH FAT DIET#0.9596;IMMUNE RESPONSE#0.9592;CHRONIC CONSTRICTION INJURY#0.9591;THALAMUS#0.9589;SPINAL CORD INJURY#0.9588;MEMORY IMPAIRMENT#0.9585;ENCEPHALOMYELITIS#0.9580;INFLAMMATORY RESPONSE#0.9572;REACTIVE OXYGEN SPECIES#0.9572;MORRIS WATER MAZE#0.9568;MIDDLE CEREBRAL ARTERY#0.9568;PERIPHERAL NERVE INJURY#0.9567;CEREBRAL ARTERY#0.9567;MULTIPLE SCLEROSIS#0.9565;CELL BODY#0.9562;HYPOXIA#0.9554;ENDOTHELIAL GROWTH FACTOR#0.9547;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9547;CHOROID PLEXUS#0.9542;CEREBRAL ISCHEMIA#0.9542;STEM CELL#0.9541;OPEN FIELD TEST#0.9541;ADAPTOR PROTEIN 1#0.9541;CYTOCHROME C#0.9540;HIPPOCAMPAL REGION#0.9532;MITOCHONDRIA#0.9531;NEUROPROTECTION#0.9524;SIGNALING PATHWAY#0.9521;TRAUMATIC BRAIN INJURY#0.9520;FOCAL CEREBRAL ISCHEMIA#0.9520;AMYOTROPHIC LATERAL SCLEROSIS#0.9519;TRANSFORMING GROWTH FACTOR#0.9519;LATERAL SCLEROSIS#0.9519;NEUROTOXICITY#0.9513;OLFACTORY BULB#0.9506;HIPPOCAMPAL DENTATE GYRUS#0.9505;ARTERY#0.9501;RECEPTOR ANTAGONIST#0.9498;BRAIN EDEMA#0.9497;SPATIAL LEARNING#0.9494;HYPERSENSITIVITY#0.9482;PARKINSON'S DISEASE#0.9482;SENSITIZATION#0.9481;NEURODEGENERATIVE DISEASE#0.9479;HEME OXYGENASE 1#0.9475;CERVICAL#0.9469;CENTRAL NERVOUS SYSTEM#0.9466;HEAT SHOCK PROTEIN#0.9462;TOXICITY#0.9462;OXYGENASE#0.9454;GANGLION CELLS#0.9453;ALZHEIMER'S DISEASE#0.9451;NEUROPATHY#0.9447;NERVOUS SYSTEM#0.9445;CELL ADHESION MOLECULE#0.9439;DEMENTIA#0.9433;GLUTATHIONE PEROXIDASE#0.9415;CD3+ T CELL#0.9407;NEURONAL CELLS#0.9391;INNATE IMMUNE RESPONSE#0.9390;DORSAL ROOT GANGLION#0.9381;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9378;HEMORRHAGE#0.9374;CONTROLLED CORTICAL IMPACT#0.9369;MAGNETIC RESONANCE IMAGING#0.9359;RETINAL DEGENERATION#0.9352;NEUROLOGICAL DISORDER#0.9324;PERICYTE#0.9306;MONOCYTE CHEMOTACTIC PROTEIN#0.9300;NEURONAL CELL DEATH#0.9298;SIGNAL TRANSDUCTION#0.9269;MIDBRAIN#0.9264;REGENERATION#0.9263;NERVE FIBER#0.9261;BRAIN WATER CONTENT#0.9239;NEUROTOXIC#0.9238;CONSTRICTION#0.9233;CEREBRAL INFARCTION#0.9228;ETHANOL#0.9225;TIGHT JUNCTION#0.9219;AUTOPHAGY#0.9205;MESENCHYMAL STEM CELL#0.9205;HYPOXIC#0.9198;NUCLEAR LAYER#0.9188;SMOOTH MUSCLE ACTIN#0.9186;EPILEPSY#0.9184;NADPH OXIDASE#0.9183;TISSUE DAMAGE#0.9182;CHEMOKINE RECEPTOR#0.9175;FOREBRAIN#0.9164;CYTOKINE PRODUCTION#0.9163;NEURAL STEM CELL#0.9153;NEURAL CELL#0.9152;GRANULOCYTE#0.9133;TRANSMISSION ELECTRON MICROSCOPY#0.9131;ANGIOGENESIS#0.9118;POSITRON EMISSION TOMOGRAPHY#0.9089;BRAIN ISCHEMIA#0.9079;ISCHEMIA REPERFUSION INJURY#0.9075;NMDA RECEPTOR#0.9070;ADENOSINE#0.9066;MICROGLIAL CELL ACTIVATION#0.9035;NOVEL OBJECT RECOGNITION#0.9031;COGNITION#0.9017;STREPTOZOTOCIN#0.9013;PLATELET-DERIVED GROWTH FACTOR#0.9005;MICROTUBULE#0.8998;DENDRITIC SPINE#0.8984;HYPERTENSION#0.8965;SUCROSE#0.8940;UBIQUITIN#0.8935;BREAST CANCER#0.8934;MEMBRANE RUFFLE#0.8904;OBESE#0.8882;PROTEOGLYCAN#0.8862;CAROTID ARTERY#0.8858;RECEPTOR AGONIST#0.8855;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.8851;TYPE 2 DIABETES#0.8839;BRAIN DEVELOPMENT#0.8825;ADIPOSE TISSUE#0.8807;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8775;ELEVATED PLUS MAZE#0.8738;TRANSIENT CEREBRAL ISCHEMIA#0.8737;GLOBAL CEREBRAL ISCHEMIA#0.8716;WHITE MATTER INJURY#0.8713;DIABETES MELLITUS#0.8702;HUMAN LEUKOCYTE ANTIGEN#0.8692;HIGH MOBILITY GROUP#0.8690;APOPTOTIC CELL DEATH#0.8686;GESTATION#0.8678;MACULAR DEGENERATION#0.8666;DIABETIC RETINOPATHY#0.8663;ATHEROSCLEROSIS#0.8642;PHAGOCYTIC CUP#0.8642;ASPARTATE#0.8628;PURKINJE CELL#0.8618;CELL SURFACE#0.8617;DAYS POST INJURY#0.8614;STATUS EPILEPTICUS#0.8607;ASTROCYTOMA#0.8604;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8583;OUTER NUCLEAR LAYER#0.8576;AGE RELATED MACULAR DEGENERATION#0.8575;LATERAL VENTRICLE#0.8562;SPARED NERVE INJURY#0.8560;TEMPORAL LOBE#0.8525;G-CSF#0.8524;MYELIN SHEATH#0.8523;GLUTAMINE#0.8512;UMBILICAL CORD#0.8507;ADVANCED GLYCATION END#0.8506;MAST CELL#0.8464;MYELINATION#0.8444;PHOTORECEPTOR CELL#0.8444;GM-CSF#0.8443;ENDOPLASMIC RETICULUM#0.8438;SUBSTANCE P#0.8427;BRAIN LESIONS#0.8422;COMPLEX II#0.8405;EXTRACELLULAR MATRIX#0.8401;WEIGHT LOSS#0.8365;PHOSPHODIESTERASE#0.8354;GLUCOCORTICOID RECEPTOR#0.8349;TUMOUR NECROSIS FACTOR#0.8341;INNATE IMMUNE SYSTEM#0.8339;CONNEXIN#0.8267;2'-DEOXYURIDINE#0.8265;SWELLING#0.8256;ACTIVATED CASPASE 3#0.8254;NOCICEPTION#0.8248;CELL DIFFERENTIATION#0.8187;OLIGODENDROCYTE PROGENITOR CELL#0.8174;OCULAR HYPERTENSION#0.8167;NEURITE#0.8147;GROWTH FACTOR RECEPTOR#0.8144;TIGHT JUNCTION PROTEIN#0.8113;M2 MACROPHAGE#0.8099;OPTICAL COHERENCE TOMOGRAPHY#0.8096;CASPASE-3 ACTIVITY#0.8089;AUTOIMMUNE DISEASE#0.8045;CHEMOTAXIS#0.8027;OLIGODENDROCYTE PRECURSOR CELL#0.8010;LYMPH NODE#0.7995;ISOFLURANE#0.7993;72-HOURS#0.7990;NECROTIC#0.7987;INNATE IMMUNITY#0.7963;ACETYLCHOLINE#0.7953;DNA BINDING#0.7933;BASEMENT MEMBRANE#0.7897;FIBROBLAST GROWTH FACTOR#0.7886;RESPONSE TO LPS#0.7852;LYMPHOCYTE ACTIVATION#0.7824;NEUROBLAST#0.7776;NEUROLOGICAL DEFICIT SCORE#0.7769;MANNOSE RECEPTOR#0.7715;ATHEROSCLEROTIC#0.7707;SIGNALING CASCADE#0.7697;NEURITIS#0.7672;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7519;PLASMA MEMBRANE#0.7502;MEDIAL PREFRONTAL CORTEX#0.7479;AQUAPORIN#0.7455;MENINGES#0.7448;PIOGLITAZONE#0.7445;TRANSFORMING GROWTH FACTOR BETA#0.7442;SPINAL NERVE LIGATION#0.7438;ESTRADIOL#0.7433;MEMORY LOSS#0.7432;8-HYDROXY-2'-DEOXYGUANOSINE#0.7430;NERVE GROWTH FACTOR#0.7400;CYTOTOXICITY#0.7380;PERIVENTRICULAR WHITE MATTER#0.7372;CHOLINE#0.7347;OBJECT RECOGNITION TEST#0.7325;ACTIN BINDING#0.7320;METHAMPHETAMINE#0.7305;RUFFLE#0.7301;OPIOID RECEPTOR#0.7278;INSULIN-LIKE GROWTH FACTOR#0.7265;T LYMPHOCYTE ACTIVATION#0.7242;NEUROTOXIN#0.7237;PYRAMIDAL CELL#0.7232;PHOSPHATE BUFFERED SALINE#0.7231;SUCROSE PREFERENCE TEST#0.7219;REGIONS OF INTEREST#0.7215;ACETYLCHOLINE RECEPTOR#0.7209;PILOCARPINE#0.7191;B LYMPHOCYTE#0.7191;HEMORRHAGIC#0.7189;STROMAL CELL#0.7177;MARKERS OF INFLAMMATION#0.7164;SKELETAL MUSCLE#0.7148;EPITHELIAL CELL#0.7145;MACROPHAGE POLARIZATION#0.7138;FETAL BRAIN#0.7126;CLODRONATE#0.7106;VON FREY HAIR#0.7072;UVEITIS#0.7055;COMPLEX I#0.7053;HYPERACTIVITY#0.7047;CHONDROITIN SULFATE PROTEOGLYCAN#0.7046;FACTOR I#0.7044;KINASE INHIBITOR#0.7029;PAW WITHDRAWAL THRESHOLD#0.7026;INTERNEURON#0.7010;M1 MACROPHAGE#0.6975;TRANSCRIPTASE#0.6974;ANTIGEN PRESENTATION#0.6972;TAIL SUSPENSION TEST#0.6965;ACTIVE CASPASE 3#0.6958;COMMON CAROTID ARTERY#0.6924;OXYGEN GLUCOSE DEPRIVATION#0.6922;DEXAMETHASONE#0.6888;CYCLIN DEPENDENT KINASE#0.6877;RAPAMYCIN#0.6868;PEROXISOME#0.6864;ENDOTHELIUM#0.6855;NEUROLOGICAL SEVERITY SCORE#0.6851;EVANS BLUE EXTRAVASATION#0.6851;MECHANISM OF ACTION#0.6843;MIDLINE#0.6839;MACROPHAGE MIGRATION#0.6838;SCAVENGER RECEPTOR#0.6818;HEMATOPOIETIC CELL#0.6808;COLITIS#0.6801;HEMOCYTE#0.6793;TUMOR ASSOCIATED MACROPHAGE#0.6781;HEPATOCELLULAR CARCINOMA#0.6744;CD4+ T CELL#0.6744;ACTIVATING TRANSCRIPTION FACTOR#0.6743;CHRONIC NEUROPATHIC PAIN#0.6743;HYDROCEPHALUS#0.6738;SATELLITE GLIAL CELLS#0.6737;RETINITIS PIGMENTOSA#0.6737;MONOCYTE DERIVED MACROPHAGE#0.6735;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6723;IL-1RA#0.6722;NEUROFIBRILLARY TANGLE#0.6720;PERIPHERAL NERVOUS SYSTEM#0.6716;LIGHT CHAIN 3#0.6713;TRANSIENT RECEPTOR POTENTIAL#0.6706;B CELL LYMPHOMA#0.6704;ACTIN CYTOSKELETON#0.6696;WEIGHT GAIN#0.6684;NEURON DEATH#0.6682;FLUOXETINE#0.6678;ESTROGEN RECEPTOR#0.6664;TEMPORAL LOBE EPILEPSY#0.6655;VASCULAR CELL#0.6648;FIBRINOGEN#0.6613;SYNOVIAL FLUID#0.6606;AMYLOID PROTEIN#0.6592;BREAST CANCER CELL#0.6587;TARGET OF RAPAMYCIN#0.6585;NERVE FIBER LAYER#0.6553;BLOOD GLUCOSE LEVEL#0.6550;GAP JUNCTION#0.6545;ANTIGEN PRESENTING CELLS#0.6533;RETINAL ISCHEMIA#0.6532;GRANULOCYTE COLONY STIMULATING FACTOR#0.6530;KUPFFER CELL#0.6495;LOCOMOTION#0.6436;CELLULAR LOCALIZATION#0.6425;LYMPHOID TISSUE#0.6410;CAROTID ARTERY OCCLUSION#0.6405;MITOCHONDRIAL MEMBRANE#0.6388;T CELL ACTIVATION#0.6387;INTERNAL CAPSULE#0.6362;SMALL RIBOSOMAL SUBUNIT#0.6354;DEMYELINATING DISEASE#0.6348;IMMATURE NEURON#0.6336;LONG TERM POTENTIATION#0.6318;CORD BLOOD#0.6294;ACETIC ACID#0.6247;OPTIC NERVE HEAD#0.6243;RIBOSOMAL SUBUNIT#0.6228;HERPES SIMPLEX#0.6226;COLLAGENASE#0.6226;SHORT TERM MEMORY#0.6177;QUANTITATIVE REVERSE TRANSCRIPTION#0.6173;INNERVATION#0.6169;NLRP3 INFLAMMASOME ACTIVATION#0.6161;PARALYSIS#0.6155;MELATONIN#0.6152;FLUID PERCUSSION INJURY#0.6140;GLYCOGEN SYNTHASE KINASE#0.6130;MAGNETIC RESONANCE SPECTROSCOPY#0.6124;PATTERN RECOGNITION RECEPTOR#0.6119;POLY ADP RIBOSE#0.6114;TYPE 1 DIABETES#0.6111;CONNECTIVE TISSUE#0.6103;RETINAL DAMAGE#0.6084;MAP KINASE#0.6077;HEMATOPOIETIC STEM CELL#0.6076;AGEING#0.6059;FORCED SWIMMING TEST#0.6050;OSTEOARTHRITIS#0.6042;FORCED SWIM TEST#0.6036;RETINAL DISEASE#0.6033;CARDIAC ALLOGRAFT VASCULOPATHY#0.6030;NEURAL PROGENITOR CELL#0.6016;MOTOR ACTIVITY#0.6011;WHITE MATTER LESIONS#0.6010
19	HDL ASSEMBLY#1.0881;CHOLESTEROL EXPORT#1.0704;CALPAIN ACTIVITY#1.0667;PROBUCOL#1.0632;PROTEIN DEGRADATION#1.0584;NASCENT HDL#1.0555;PHOSPHOLIPID EFFLUX#1.0546;LIPID TRANSPORTER#1.0512;GLYBURIDE#1.0489;ADENOSINE TRIPHOSPHATE#1.0424;TANGIER DISEASE#1.0421;HEPATIC LIPASE#1.0411;HIGH-DENSITY LIPOPROTEIN PARTICLE#1.0396;9-CIS-RETINOIC ACID#1.0386;BETA CELL#1.0385;CHOLESTEROL TRANSPORTER#1.0368;INSULIN SECRETION#1.0317;ATP BINDING CASSETTE TRANSPORTER#1.0305;ADENOSINE#1.0262;ATP BINDING CASSETTE#1.0255;DNA METHYLATION#1.0252;ATP BINDING#1.0248;REVERSE TRANSCRIPTION#1.0220;PROTEIN KINASE A#1.0216;REGULATION OF CHOLESTEROL EFFLUX#1.0212;RNA INTERFERENCE#1.0208;CELL MEMBRANE#1.0188;ASTROCYTE#1.0172;RETINOIC ACID#1.0153;ATORVASTATIN#1.0151;LEUKOCYTE#1.0143;ABC TRANSPORTER#1.0141;LIPOPROTEIN LIPASE#1.0140;LIPID RAFT#1.0130;RETINOID X RECEPTOR#1.0120;CHOLESTEROL EFFLUX#1.0104;SCAVENGER RECEPTOR#1.0101;LATE ENDOSOME#1.0097;LIPOPROTEIN PARTICLE#1.0097;TOLL LIKE RECEPTOR#1.0091;LIPID TRANSPORT#1.0090;COENZYME A#1.0082;PHOSPHATIDYLSERINE#1.0082;PLASMA MEMBRANE#1.0080;ENDOCYTOSIS#1.0076;QUANTITATIVE REAL TIME#1.0073;SMALL INTESTINE#1.0064;CELL SURFACE#1.0062;VITAMIN E#1.0038;ENDOSOME#1.0025;TOCOPHEROL#1.0008;HDL PARTICLE#0.9999;MACROPHAGE#0.9997;CENTRAL NERVOUS SYSTEM#0.9994;POLYMERASE CHAIN REACTION#0.9982;SIGNAL TRANSDUCTION#0.9981;CHOLESTEROL UPTAKE#0.9980;OBESE#0.9975;HEPATOMA CELLS#0.9966;ROSIGLITAZONE#0.9966;PROTEIN KINASE C#0.9960;LDL RECEPTOR#0.9954;FRAGMENT LENGTH POLYMORPHISM#0.9947;LIPOPROTEIN FORMATION#0.9946;NERVOUS SYSTEM#0.9940;CHOLESTEROL ESTERIFICATION#0.9937;SIMVASTATIN#0.9936;ADIPOCYTE#0.9932;APOPTOTIC#0.9929;PROSTATE CANCER#0.9927;LIPID BINDING#0.9926;CORONARY HEART DISEASE#0.9918;T CELL#0.9916;MONONUCLEAR CELLS#0.9915;STEROL REGULATORY ELEMENT#0.9914;INTESTINAL CHOLESTEROL ABSORPTION#0.9914;ALVEOLAR MACROPHAGE#0.9913;PROTEIN KINASE#0.9901;BINDING PROTEIN 1#0.9897;HEART DISEASE#0.9897;SKIN FIBROBLASTS#0.9896;CORONARY ARTERY DISEASE#0.9886;EPITHELIAL CELL#0.9883;PEROXISOME#0.9883;PERIPHERAL BLOOD#0.9881;ARTERY DISEASE#0.9881;ENTEROCYTE#0.9881;FOAM CELL FORMATION#0.9880;MONOCYTE DERIVED MACROPHAGE#0.9880;SIGNALING PATHWAY#0.9871;C-LEVEL#0.9869;LIVER X RECEPTOR#0.9866;SECRETORY PATHWAY#0.9859;CHOLESTEROL TRANSPORT#0.9859;QUERCETIN#0.9858;NUCLEAR HORMONE RECEPTOR#0.9858;GROWTH FACTOR#0.9858;ENDOPLASMIC RETICULUM#0.9857;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9856;REVERSE CHOLESTEROL TRANSPORT#0.9853;DIABETES MELLITUS#0.9853;CANCER CELL#0.9852;NIACIN#0.9847;LYSOSOME#0.9844;LIPID DROPLET#0.9843;CORONARY ARTERY#0.9843;CHOLESTEROL SYNTHESIS#0.9841;BONE MARROW#0.9841;RECEPTOR AGONIST#0.9823;LIPID HOMEOSTASIS#0.9820;EFFLUX PUMP#0.9814;ADIPOSE TISSUE#0.9807;ALZHEIMER'S DISEASE#0.9802;LIPOPROTEIN METABOLISM#0.9798;MITOGEN ACTIVATED PROTEIN#0.9788;TYPE 2 DIABETES MELLITUS#0.9788;HIGH CHOLESTEROL DIET#0.9788;2 DIABETES MELLITUS#0.9788;CELLULAR LOCALIZATION#0.9784;CHOLESTEROL HOMEOSTASIS#0.9784;IFN-GAMMA#0.9781;TUMOR NECROSIS FACTOR#0.9781;MYOCARDIAL INFARCTION#0.9780;CATABOLISM#0.9780;BLOOD BRAIN BARRIER#0.9767;MATURE HDL#0.9767;GENE EXPRESSION#0.9758;ARTERY#0.9758;CELL PROLIFERATION#0.9758;ENDOTHELIAL CELL#0.9758;HIGH DENSITY LIPOPROTEIN#0.9756;MONOCYTE#0.9756;SMOOTH MUSCLE CELL#0.9755;CHOLESTEROL BIOSYNTHESIS#0.9755;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9750;PRO-INFLAMMATORY#0.9747;SMOOTH MUSCLE#0.9745;STEM CELL#0.9739;AGE RELATED MACULAR DEGENERATION#0.9738;LIPOGENESIS#0.9735;HYPERTENSION#0.9734;MUSCLE CELL#0.9731;MACULAR DEGENERATION#0.9731;FATTY ACID SYNTHASE#0.9722;REACTIVE OXYGEN SPECIES#0.9719;DISCOIDAL HDL#0.9712;TYPE 2 DIABETES#0.9711;HYPERCHOLESTEROLEMIA#0.9700;VERY-LOW-DENSITY LIPOPROTEIN#0.9695;PRAVASTATIN#0.9689;ISCHEMIC HEART DISEASE#0.9689;GLUCOSE HOMEOSTASIS#0.9688;APOPTOSIS#0.9682;CHOLESTEROL METABOLISM#0.9680;TRANSCRIPTION FACTOR#0.9676;VASCULAR ENDOTHELIAL CELL#0.9668;NUCLEOTIDE BINDING#0.9653;INFLAMMATORY RESPONSE#0.9652;EXCRETION#0.9651;PHAGOCYTOSIS#0.9650;PITAVASTATIN#0.9644;LOW DENSITY LIPOPROTEIN#0.9636;ATHEROSCLEROSIS#0.9635;LIPID METABOLISM#0.9630;ATHEROSCLEROTIC#0.9629;BREAST CANCER#0.9622;NITRIC OXIDE#0.9620;AMYLOID PRECURSOR PROTEIN#0.9613;HIGH FAT DIET#0.9604;TYPE 2 DIABETIC#0.9602;VASCULAR SMOOTH MUSCLE CELL#0.9598;MEMBRANE MICRODOMAIN#0.9575;GENETIC DISORDER#0.9536;TRANSACTIVATION#0.9534;CELL DEATH#0.9525;C REACTIVE PROTEIN#0.9508;VASCULAR DISEASE#0.9496;PROTEASOME#0.9496;PANCREATIC ISLET#0.9470;ATPASE ACTIVITY#0.9450;FATTY LIVER#0.9446;IMMUNE RESPONSE#0.9422;AUTOPHAGY#0.9417;HYPOXIA#0.9410;MICROPARTICLE#0.9392;FARNESOID X RECEPTOR#0.9383;STEAROYL COA DESATURASE#0.9376;INTESTINAL ABSORPTION#0.9372;ADVANCED GLYCATION END#0.9369;PIOGLITAZONE#0.9369;GLUCOSE METABOLISM#0.9360;RETINOIC ACID RECEPTOR#0.9359;PROGESTERONE#0.9357;WESTERN TYPE DIET#0.9355;MUTAGENESIS#0.9338;LIVER DISEASE#0.9324;CHOLINE#0.9317;LECTIN#0.9314;SIGNALING MOLECULE#0.9292;CYCLIC AMP#0.9275;CELL ADHESION#0.9266;KINASE INHIBITOR#0.9246;STEROL RESPONSE ELEMENT BINDING#0.9242;CYCLOSPORIN A#0.9235;CELLULAR MEMBRANE#0.9232;BEXAROTENE#0.9226;STEROL RESPONSE ELEMENT#0.9220;CELL CYCLE#0.9202;ENDOPLASMIC RETICULUM STRESS#0.9198;OLEIC ACID#0.9194;REPORTER GENE ASSAY#0.9184;ROSUVASTATIN#0.9175;RELATED PROTEIN 1#0.9171;METHIONINE#0.9167;STEROL TRANSPORTER#0.9166;EXTRACELLULAR MATRIX#0.9162;EICOSAPENTAENOIC ACID#0.9155;SKELETAL MUSCLE#0.9136;MESANGIAL CELL#0.9133;CEREBRAL INFARCTION#0.9120;RESPONSE TO CHOLESTEROL#0.9099;INTIMA MEDIA THICKNESS#0.9093;SCAVENGER RECEPTOR A#0.9072;FENOFIBRATE#0.9038;LYSINE#0.9037;MYELOID CELL#0.9031;SATURATED FATTY ACID#0.9030;FATTY LIVER DISEASE#0.9004;VASCULAR CELL#0.9004;NUCLEOTIDE BINDING DOMAIN#0.8987;FAMILIAL HYPERCHOLESTEROLEMIA#0.8976;C TERMINAL DOMAIN#0.8974;MAP KINASE#0.8971;BILE ACID SYNTHESIS#0.8970;FATTY ACID OXIDATION#0.8956;NEUTROPHIL#0.8939;CELL ADHESION MOLECULE#0.8907;DNA BINDING#0.8905;EMBRYONIC KIDNEY#0.8889;SIGNALING CASCADE#0.8883;QUANTITATIVE REVERSE TRANSCRIPTION#0.8823;HUMAN EMBRYONIC KIDNEY#0.8806;B CELL#0.8799;CELL GROWTH#0.8797;ENDOTHELIUM#0.8794;KIDNEY DISEASE#0.8770;HORMONE SENSITIVE LIPASE#0.8770;BACTERIAL ARTIFICIAL CHROMOSOME#0.8761;ARACHIDONIC ACID#0.8747;SPHINGOSINE 1 PHOSPHATE#0.8718;TRANSFORMING GROWTH FACTOR#0.8711;IMPAIRED GLUCOSE TOLERANCE#0.8693;AORTIC ATHEROSCLEROSIS#0.8676;GLUCOSE UPTAKE#0.8668;CHYLOMICRON#0.8661;CYTOTOXICITY#0.8635;CELL MIGRATION#0.8624;M2 MACROPHAGE#0.8615;INTRACELLULAR CHOLESTEROL TRANSPORT#0.8612;TOXICITY#0.8603;NEURODEGENERATIVE DISEASE#0.8588;REGULATION OF CHOLESTEROL HOMEOSTASIS#0.8584;OXYGENASE#0.8565;LIPOLYSIS#0.8553;SPHERICAL HDL#0.8536;LIPID STORAGE#0.8534;DIGESTION#0.8531;SERUM AMYLOID A#0.8514;ETHANOL#0.8510;HDL RECEPTOR#0.8504;PALMITIC ACID#0.8491;CHOLESTEROL 24 HYDROXYLASE#0.8488;VISCERAL ADIPOSE TISSUE#0.8486;ALPHA-TOCOPHEROL#0.8483;RETINAL PIGMENT EPITHELIUM#0.8479;EZETIMIBE#0.8439;SIGNAL TRANSDUCER#0.8427;GLIAL CELL#0.8427;MECHANISM OF ACTION#0.8409;DENDRITIC CELL#0.8409;PROTEIN SYNTHESIS#0.8406;UBIQUITIN#0.8399;ANGIOGENESIS#0.8398;TRADITIONAL CHINESE MEDICINE#0.8397;HEME OXYGENASE 1#0.8373;SPHINGOSINE#0.8372;AKT SIGNALING#0.8363;NITRIC OXIDE SYNTHASE#0.8350;LUCIFERASE ACTIVITY#0.8345;DEMENTIA#0.8330;PROTEIN PROTEIN INTERACTION#0.8319;CHOLIC ACID#0.8316;CYTOKINE PRODUCTION#0.8312;PALMITATE#0.8308;COLONY-STIMULATING FACTOR#0.8284;PRIMARY OPEN ANGLE GLAUCOMA#0.8283;OPEN ANGLE GLAUCOMA#0.8270;PODOCYTE#0.8249;FATTY ACID METABOLISM#0.8231;MITOCHONDRIA#0.8211;NEURONAL CELLS#0.8203;INNATE IMMUNITY#0.8193;LOVASTATIN#0.8187;CYTOCHROME P450#0.8185;REGULATION OF LIPID METABOLISM#0.8177;IMMUNE CELL#0.8152;TRANSCRIPTASE#0.8146;ALCOHOLIC FATTY LIVER#0.8140;SUPEROXIDE DISMUTASE#0.8133;PHOSPHATASE 2B#0.8121;ACAT ACTIVITY#0.8120;UMBILICAL VEIN#0.8107;NADPH OXIDASE#0.8102;VESICULAR TRANSPORT#0.8090;HYPERGLYCEMIA#0.8082;ACUTE CORONARY SYNDROME#0.8081;APOLIPOPROTEIN A-I BINDING#0.8057;DRUG RESISTANCE#0.8046;LCAT ACTIVITY#0.8041;HDL BINDING#0.7998;RECEPTOR LIGAND#0.7971;CYCLOSPORIN#0.7954;CAROTID ARTERY#0.7954;GALLBLADDER#0.7952;TESTOSTERONE#0.7948;DOMINANT NEGATIVE MUTANT#0.7935;TROPHOBLAST#0.7926;PRE-MRNA SPLICING#0.7886;MRNA SPLICING#0.7844;ALANINE#0.7811;CAROTENOID#0.7757;LUNG CANCER#0.7748;CARNITINE#0.7743;INSULIN-LIKE GROWTH FACTOR#0.7713;NEPHROPATHY#0.7702;AORTIC SINUS#0.7699;CHLAMYDIA#0.7698;MECHANISMS OF ACTION#0.7694;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7694;SERUM ALBUMIN#0.7690;HUMAN UMBILICAL VEIN#0.7690;OVARIAN#0.7676;COGNITION#0.7640;DIET INDUCED OBESITY#0.7637;CHOLESTEROL STORAGE#0.7625;ARGININE#0.7598;CYCLOSPORINE#0.7591;GLUTATHIONE#0.7589;PHOSPHOLIPID TRANSPORT#0.7569;APOE RECYCLING#0.7567;NEUROPATHY#0.7561;RECEPTOR ANTAGONIST#0.7549;CYTOPLASM#0.7542;FATTY ACID SYNTHESIS#0.7535;RAPAMYCIN#0.7530;HEMATOPOIETIC STEM CELL#0.7508;CHOLESTEROL BINDING#0.7493;ENDOCYTIC VESICLE#0.7488;LUNG EPITHELIAL CELL#0.7482;SPECIFICITY PROTEIN 1#0.7475;NEURITE#0.7447;CARDIOVASCULAR RISK FACTOR#0.7415;MALARIA#0.7414;SIGNALLING PATHWAY#0.7388;TUMOUR NECROSIS FACTOR#0.7386;STEROIDOGENESIS#0.7361;JEJUNUM#0.7354;INTESTINAL EPITHELIAL CELL#0.7353;STREPTOZOTOCIN#0.7338;PHOSPHODIESTERASE#0.7332;GESTATION#0.7315;LUNG CARCINOMA#0.7271;LINES OF EVIDENCE#0.7203;PLASMODIUM BERGHEI ANKA#0.7202;EXOSOME#0.7198;SCHWANN CELL#0.7193;GENE SILENCING#0.7178;INDUCIBLE NITRIC OXIDE#0.7174;PRE-ECLAMPSIA#0.7163;PROTEINURIA#0.7162;PROGENITOR CELL#0.7150;GLUCOSE INTOLERANCE#0.7150;MILD COGNITIVE IMPAIRMENT#0.7148;INFLAMMATORY CELL#0.7147;VITAMIN A#0.7146;ADENOSINE MONOPHOSPHATE#0.7133;PALMITOYL#0.7108;SPERMATOZOA#0.7102;CEREBRAL MALARIA#0.7096;CONJUGATED LINOLEIC ACID#0.7046;RECEPTOR MEDIATED ENDOCYTOSIS#0.7041;MAMMARY GLAND#0.7037;ZINC FINGER PROTEIN#0.7014;TUBULAR EPITHELIAL CELL#0.7011;REGULATION OF CELLULAR#0.7003;STEROL TRANSPORT#0.6971;THIOL PROTEASE INHIBITOR#0.6964;O ACYLTRANSFERASE#0.6946;WEIGHT GAIN#0.6941;DNA REPAIR#0.6922;ADENOCARCINOMA#0.6911;ACYLTRANSFERASE ACTIVITY#0.6909;ACTINOMYCIN D#0.6905;OXYSTEROL BINDING#0.6896;PHOSPHOLIPASE C#0.6879;INSULIN RECEPTOR#0.6874;ACTIVE TRANSPORTER#0.6854;CHOLESTEROL BIOSYNTHETIC#0.6854;STEROL RESPONSIVE ELEMENT#0.6838;IMMUNE SYSTEM#0.6823;WEIGHT LOSS#0.6788;NEUROBLASTOMA#0.6773;ISCHEMIA#0.6771;LYMPH NODE#0.6758;PROTEIN STABILIZATION#0.6748;MONOCYTIC LEUKEMIA#0.6745;AMYLOID PROTEIN#0.6743;GENISTEIN#0.6732;CAVEOLAE#0.6729;TO THE PROGRESSION#0.6728;LINEAR REGRESSION ANALYSIS#0.6708;TYPE 1 DIABETES#0.6700;COLON CANCER#0.6684;THORACIC AORTA#0.6684;CHRONIC KIDNEY DISEASE#0.6676;GOLGI APPARATUS#0.6669;HUMAN IMMUNODEFICIENCY VIRUS#0.6664;NIEMANN-PICK DISEASE#0.6648;LUNG ADENOCARCINOMA#0.6643;APOLIPOPROTEIN BINDING#0.6639;TUMOR CELLS#0.6638;LIPID METABOLIC#0.6635;PLURIPOTENT STEM CELL#0.6628;CHOROID PLEXUS#0.6626;PHOSPHATIDYLETHANOLAMINE#0.6621;TROGLITAZONE#0.6571;FATTY ACID TRANSPORTER#0.6564;SUBCUTANEOUS ADIPOSE TISSUE#0.6508;BREAST CANCER CELL#0.6496;CALCINEURIN#0.6489;CELL ASSOCIATED#0.6474;SERTOLI CELL#0.6471;ACTIVATOR PROTEIN 1#0.6440;ATP HYDROLYSIS#0.6434;FATTY ACID BINDING#0.6432;OLIGODENDROCYTE#0.6423;OVARIAN CANCER#0.6419;TRANSCRIPTIONAL CONTROL#0.6419;GLIBENCLAMIDE#0.6415;TARGET OF RAPAMYCIN#0.6395;HEMORRHAGE#0.6385;EOSIN#0.6362;MICROPARTICLE RELEASE#0.6359;O-ACYLTRANSFERASE ACTIVITY#0.6345;CYTOTROPHOBLAST#0.6309;GLYBENCLAMIDE#0.6306;DUODENUM#0.6279;CEREBRAL AMYLOID ANGIOPATHY#0.6273;ACETYL COA CARBOXYLASE#0.6270;ABDOMINAL AORTIC ANEURYSM#0.6253;THYROID HORMONE RECEPTOR#0.6240;TRANSCYTOSIS#0.6236;AORTIC ANEURYSM#0.6230;BERBERINE#0.6219;STEROL HOMEOSTASIS#0.6207;CORD BLOOD#0.6207;PROPOFOL#0.6203;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6199;M1 MACROPHAGE#0.6187;RESPONSE TO LPS#0.6157;NIFEDIPINE#0.6155;ORGANELLE#0.6151;COLORECTAL CANCER#0.6140;MACROPHAGE ACTIVATION#0.6139;IMMUNOFLUORESCENCE CONFOCAL MICROSCOPY#0.6137;MAMMARY EPITHELIAL CELL#0.6134;ALL TRANS RETINOIC ACID#0.6130;MEMBRANE FRACTION#0.6127;LUMINAL#0.6122;ARTERIOSCLEROSIS#0.6106;ENHANCER BINDING PROTEIN#0.6102;CEREBRAL CORTEX#0.6099;DETERGENT RESISTANT MEMBRANE#0.6098;ENHANCER BINDING#0.6098;DEXAMETHASONE#0.6093;GROWTH FACTOR RECEPTOR#0.6063;ENGULFMENT OF APOPTOTIC CELL#0.6060;HAEM OXYGENASE 1#0.6055;LACTATION#0.6052;PRIMARY CORTICAL NEURON#0.6044;NUCLEAR RECEPTOR SUPERFAMILY#0.6041;DOXORUBICIN#0.6035;RESPONSE TO STATIN#0.6025;KERATINOCYTE#0.6023;LIPID BIOSYNTHESIS#0.6007;LUTEIN#0.6007
1	PANCREATIC CANCER#0.7824;PLASMA PROTEIN#0.7517;VITAMIN D BINDING#0.7400
200010	FRUCTOSE#0.6184;SUGAR TRANSPORTER#0.6004
200014	FEAR-INDUCED AGGRESSION#0.8056
200081	B CELL#0.8712;GROWTH FACTOR#0.8023;CELL GROWTH#0.7545;TUMOR NECROSIS FACTOR#0.6440
2000	FLOWERING#1.0563;TRANSCRIPTION FACTOR#1.0496;T CELL#1.0473;EPITHELIAL CELL#1.0467;CELL CYCLE#1.0222;TRANSACTIVATION#1.0000;CELL PROLIFERATION#0.9671;GENE EXPRESSION#0.9587;BONE MARROW#0.9451;OSTEOBLAST#0.9357;CD8+ T CELL#0.9232;STEM CELL#0.9156;DNA BINDING#0.8718;CIRCADIAN RHYTHM#0.8442;CANCER CELL#0.8246;OSTEOBLAST DIFFERENTIATION#0.8220;ENDOTHELIAL CELL#0.8066;CELL DEVELOPMENT#0.7817;MYELOID LEUKEMIA#0.7719;TUMOR SUPPRESSOR#0.7694;HEMATOPOIETIC CELL#0.7576;HUMAN BETA DEFENSIN#0.7179;ACUTE MYELOID LEUKEMIA#0.7045;APOPTOSIS#0.6191;QUIESCENCE#0.6153;INNATE IMMUNITY#0.6106;ANTIVIRAL RESPONSE#0.6096;BONE MARROW CELLS#0.6082;CYCLIN DEPENDENT KINASE#0.6054;BONE FORMATION#0.6054;DIURNAL#0.6047
200162	CENTRAL PAIR#0.8983;AXONEME#0.8212;MICROTUBULE#0.7890;MOTILE CILIA#0.7458;HOST CELL#0.6311;SKELETAL MALFORMATION#0.6102
200185	KERATINOCYTE#0.8839;GLYCOSYLATION#0.7377;ALPHA AMYLASE#0.6418;AMYLOID PRECURSOR PROTEIN#0.6260
200186	TORC2 COMPLEX#1.1261;TORC2 SIGNALING#1.1127;TOR COMPLEX 1#1.0724;TRANSCRIPTION COACTIVATOR#1.0716;TOR COMPLEX 2#1.0646;TOR COMPLEX#1.0522;CALCINEURIN#1.0436;TARGET OF RAPAMYCIN COMPLEX#1.0366;DEPHOSPHORYLATION#1.0363;GLUCOSE HOMEOSTASIS#1.0311;CAMP RESPONSE ELEMENT BINDING#1.0303;ACTIN CYTOSKELETON#1.0279;GLUCONEOGENESIS#1.0275;PLASMA MEMBRANE#1.0271;CAMP RESPONSE ELEMENT#1.0250;RAPAMYCIN#1.0075;GENE EXPRESSION#0.9976;PROTEIN KINASE#0.9969;KINASE ACTIVITY#0.9947;TARGET OF RAPAMYCIN#0.9940;GROWTH FACTOR#0.9908;TRANSCRIPTION FACTOR#0.9902;SIGNALING PATHWAY#0.9897;TOR SIGNALING#0.9884;AUTOPHAGY#0.9880;CELL GROWTH#0.9851;CELL CYCLE#0.9841;BUDDING#0.9825;CHEMOTAXIS#0.9820;CREB BINDING#0.9672;ADIPOCYTE#0.9650;GLUCOSE METABOLISM#0.9586;CANCER CELL#0.9561;CELL WALL#0.9544;TYPE 2 DIABETES#0.9530;CELL MIGRATION#0.9498;PROTEIN KINASE A#0.9495;CELL PROLIFERATION#0.9439;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.9417;LUNG CANCER#0.9291;PROSTATE CANCER#0.9290;SIGNALING CASCADE#0.9265;SALT INDUCIBLE KINASE#0.9238;MTOR COMPLEX#0.9238;KINASE INHIBITOR#0.9233;LIPID METABOLISM#0.9195;CYTOPLASM#0.9166;AKT SIGNALING#0.9161;PROTEIN SYNTHESIS#0.9071;SIGNAL TRANSDUCTION#0.9002;TUMOR SUPPRESSOR#0.8989;APOPTOSIS#0.8878;BETA CELL#0.8821;CYCLIC AMP#0.8761;MITOGEN ACTIVATED PROTEIN#0.8635;T CELL#0.8616;PHOSPHOENOLPYRUVATE#0.8399;EISOSOME#0.8368;SIGNALLING PATHWAY#0.8239;CELL WALL INTEGRITY#0.8206;HYPERGLYCEMIA#0.8185;FORSKOLIN#0.8145;METFORMIN#0.8134;HIGH FAT DIET#0.8125;ACTIN POLYMERIZATION#0.8056;PEROXISOME#0.8026;ENDOCYTOSIS#0.8016;GLUCOSE 6 PHOSPHATASE#0.7930;UBIQUITIN#0.7926;GRANULOSA CELL#0.7887;STROMAL CELL#0.7876;RESPONSE TO NUTRIENT#0.7842;PROTEIN PHOSPHATASE 2A#0.7654;BLOOD GLUCOSE LEVEL#0.7652;PHOSPHATASE 2A#0.7650;RIBOSOME#0.7637;MULTIPLE MYELOMA#0.7469;DNA REPLICATION#0.7462;RESPONSE TO GLUCAGON#0.7422;PROTEIN KINASE C#0.7412;BREAST CANCER#0.7384;ENDOPLASMIC RETICULUM#0.7360;CELLULAR GROWTH#0.7335;B CELL#0.7332;TRANSCRIPTIONAL CONTROL#0.7321;TUBEROUS SCLEROSIS#0.7290;ADENOSINE#0.7188;OVARIAN#0.7151;SKELETAL MUSCLE#0.7123;PROTEIN KINASE B#0.7062;SPHINGOLIPID SYNTHESIS#0.6998;CAMP SIGNALING#0.6977;CELL DIFFERENTIATION#0.6962;GENE SILENCING#0.6913;ADIPOGENESIS#0.6879;GLUCOSE SENSING#0.6878;DYNEIN#0.6862;TUMOR CELLS#0.6841;STEM CELL#0.6755;CELL DEATH#0.6732;ADIPOSE TISSUE#0.6653;NUTRIENT SENSING#0.6633;CAMP-RESPONSIVE ELEMENT BINDING#0.6614;PROTEIN COMPLEX#0.6506;INSULIN RECEPTOR#0.6494;CELL POLARITY#0.6308;INSULIN RECEPTOR SUBSTRATE#0.6300;TORC1 SIGNALING#0.6286;EPITHELIAL CELL#0.6236;ADENOSINE MONOPHOSPHATE#0.6231;FATTY LIVER#0.6214;ABT-263#0.6208;RNA INTERFERENCE#0.6200;COMPLEX I#0.6199;ACTIVATION OF CREB#0.6182;CYTOKINESIS#0.6177;OBESE#0.6098;MITOCHONDRIA#0.6091;TOR SIGNALING PATHWAY#0.6056
2001	LUMINAL#1.0431;TRANSCRIPTION FACTOR#1.0346;TROPHOBLAST#1.0268;MAMMARY GLAND#1.0259;EPITHELIAL CELL#1.0164;BREAST CANCER#1.0137;STEM CELL#1.0069;GENE EXPRESSION#0.9860;CANCER CELL#0.9822;MAMMARY EPITHELIAL CELL#0.9775;LUMINAL PROGENITOR#0.9758;PROGENITOR CELL#0.9757;SIGNALING PATHWAY#0.9676;MAMMARY GLAND DEVELOPMENT#0.9441;GLAND DEVELOPMENT#0.9422;EPITHELIAL MESENCHYMAL TRANSITION#0.9407;TROPHOBLAST STEM CELL#0.9200;LACTATION#0.9076;OVARIAN CANCER#0.9042;BREAST CANCER CELL#0.9015;DNA BINDING#0.8953;MILK PROTEIN#0.8781;ESTROGEN RECEPTOR#0.8517;LUMINAL CELL#0.8389;CELL DIFFERENTIATION#0.8360;TROPHOBLAST CELL#0.8317;GROWTH FACTOR#0.8309;ALVEOLOGENESIS#0.8246;MAMMARY EPITHELIUM#0.8120;DNA METHYLATION#0.8113;PROSTATE CANCER#0.8080;TROPHECTODERM#0.7929;OVARIAN#0.7644;LYMPH NODE METASTASIS#0.7618;LUMINAL PROGENITOR CELL#0.7584;MORPHOGENESIS#0.7582;LYMPH NODE#0.7317;KERATINOCYTE#0.7008;TUMOR SUPPRESSOR#0.6970;SALIVARY GLAND#0.6849;CELL PROLIFERATION#0.6822;POLYMERASE CHAIN REACTION#0.6543;PROLACTIN RECEPTOR#0.6459;PROGESTERONE#0.6314;LUNG EPITHELIAL CELL#0.6051;CELL CYCLE#0.6029
200205	IRON SULFUR CLUSTER#0.9103;LIPOIC ACID#0.8280;IRON-SULFUR CLUSTER ASSEMBLY#0.7584;COMPLEX I#0.7190;PROTEIN MATURATION#0.6860
2002	TRANSACTIVATION#1.0458;RECEPTOR TYROSINE KINASE#1.0252;SERUM RESPONSE FACTOR#1.0135;TRANSCRIPTION FACTOR#1.0111;CELL MIGRATION#1.0093;BREAST CANCER#1.0074;DOMINANT NEGATIVE MUTANT#1.0031;DNA BINDING#0.9991;MAP KINASE#0.9969;SMOOTH MUSCLE#0.9961;PROTEIN KINASE C#0.9931;BREAST CANCER CELL#0.9900;SIGNALING CASCADE#0.9863;KINASE ACTIVITY#0.9860;EPIDERMAL GROWTH FACTOR#0.9859;CANCER CELL#0.9853;PROSTATE CANCER#0.9845;MUSCLE CELL#0.9837;ELECTROPHORETIC MOBILITY SHIFT#0.9817;CELL PROLIFERATION#0.9816;MAPK CASCADE#0.9805;MITOGEN ACTIVATED PROTEIN#0.9791;PROTEIN KINASE#0.9785;SIGNALING PATHWAY#0.9760;GENE EXPRESSION#0.9750;APOPTOSIS#0.9743;SIGNAL TRANSDUCTION#0.9726;HEPATOCELLULAR CARCINOMA#0.9721;CELL CYCLE#0.9717;GROWTH FACTOR#0.9706;KINASE INHIBITOR#0.9705;EARLY GROWTH RESPONSE#0.9692;CELL GROWTH#0.9649;MAPK SIGNALING#0.9545;SMOOTH MUSCLE CELL#0.9521;GROWTH FACTOR RECEPTOR#0.9492;PROTEIN PROTEIN INTERACTION#0.9423;EPITHELIAL CELL#0.9390;CELL DEATH#0.9242;APOPTOTIC#0.9202;T CELL#0.9160;CYTOPLASM#0.9036;ONCOGENIC#0.8953;RIBOSOMAL S6 KINASE#0.8883;SILODOSIN#0.8842;ERK CASCADE#0.8808;HYPOXIA#0.8785;CAMP RESPONSE ELEMENT#0.8771;ANDROGEN RECEPTOR#0.8751;SKELETAL MUSCLE#0.8660;LUCIFERASE ACTIVITY#0.8597;MAPK ACTIVATION#0.8575;FACTOR I#0.8500;REPORTER GENE ASSAY#0.8305;ACTIVATION OF MAP KINASE#0.8270;STEM CELL#0.8261;MYELOID LEUKEMIA#0.8242;CAMP RESPONSE ELEMENT BINDING#0.8169;TUMOR SUPPRESSOR#0.8072;MUTAGENESIS#0.7995;CELL DIFFERENTIATION#0.7972;INTRACELLULAR SIGNALING CASCADE#0.7966;FIBROBLAST GROWTH FACTOR#0.7926;ANISOMYCIN#0.7864;SIGNALLING PATHWAY#0.7856;VASCULAR SMOOTH MUSCLE CELL#0.7854;HISTONE DEACETYLASE#0.7845;RNA INTERFERENCE#0.7771;MAP KINASE CASCADE#0.7747;SUMOYLATION#0.7699;MACROPHAGE#0.7669;UBIQUITIN#0.7629;ESTROGEN RECEPTOR#0.7615;PLATELET-DERIVED GROWTH FACTOR#0.7606;DEATH RECEPTOR#0.7584;NEURONAL CELLS#0.7563;EXTRACELLULAR MATRIX#0.7540;CERVICAL#0.7518;NEUROBLASTOMA#0.7490;MAP KINASE KINASE#0.7466;HISTONE ACETYLATION#0.7425;ESTRADIOL#0.7283;ACTIVATING TRANSCRIPTION FACTOR#0.7279;PROTEIN BINDING#0.7274;CERVICAL CANCER#0.7250;DEATH RECEPTOR 5#0.7224;ADENOCARCINOMA#0.7210;ALANINE#0.7203;HUMAN BREAST CANCER#0.7189;TYROSINE KINASE INHIBITOR#0.7168;EXTRACELLULAR REGULATED KINASE#0.7154;TUMOR CELLS#0.7133;ENDOTHELIAL CELL#0.7080;TUMOR NECROSIS FACTOR#0.7080;CHRONIC MYELOID LEUKEMIA#0.6994;MICROTUBULE#0.6967;POLYMERASE CHAIN REACTION#0.6962;MYELOID ZINC FINGER#0.6824;ACTIVATOR PROTEIN 1#0.6794;SKELETAL MUSCLE CELLS#0.6792;T LYMPHOCYTE#0.6606;PROMOTER BINDING#0.6592;THYMIDINE#0.6567;DEPHOSPHORYLATION#0.6501;CYCLIC AMP#0.6474;CYCLIN DEPENDENT KINASE#0.6472;NERVE GROWTH FACTOR#0.6472;COMPLEX I#0.6471;SIGNALING MOLECULE#0.6460;PERTUSSIS#0.6448;TRANSCRIPTION FACTOR BINDING#0.6342;ASTROCYTE#0.6322;PHOSPHATASE ACTIVITY#0.6303;COLORECTAL CANCER#0.6255;THYMIDINE KINASE#0.6228;POST-TRANSLATIONAL MODIFICATION#0.6190;SIGNAL TRANSDUCER#0.6177;PROTEIN KINASE A#0.6146;PKCALPHA#0.6138;DNA SYNTHESIS#0.6136;B CELL#0.6133;LUNG CANCER#0.6110;HYPOXIC#0.6099;MONOCYTE#0.6061;NUCLEOTIDE EXCHANGE FACTOR#0.6056;ACETYLCHOLINE RECEPTOR#0.6034
200315	DEAMINASE ACTIVITY#1.0505;MRNA EDITING#1.0240;CYTIDINE DEAMINASE#1.0197;APOBEC#1.0188;CYTOSINE DEAMINASE#1.0187;CYTIDINE#1.0179;BREAST CANCER#1.0171;CANCER CELL#0.9911;RNA EDITING#0.9871;MUTAGENESIS#0.9722;MONOCYTE#0.9662;URACIL#0.9575;HEPATITIS B#0.9330;CYTIDINE DEAMINATION#0.9295;HUMAN IMMUNODEFICIENCY VIRUS#0.9166;GENE EXPRESSION#0.9155;RETROTRANSPOSITION#0.9143;IMMUNE RESPONSE#0.9037;DNA REPLICATION#0.8909;CELL CYCLE#0.8861;HEPATITIS B VIRUS#0.8841;T CELL#0.8468;MACROPHAGE#0.8410;REVERSE TRANSCRIPTION#0.8387;KERATINOCYTE#0.8333;CELL CYCLE ARREST#0.8061;VIRION#0.7960;NUCLEIC ACID#0.7923;INNATE IMMUNE RESPONSE#0.7901;ADENO ASSOCIATED VIRUS#0.7831;REPLICATION FORK#0.7728;MYELOID CELL#0.7552;SSDNA BINDING#0.7307;CERVICAL#0.7133;NUCLEIC ACID BINDING#0.6947;CD4+ T CELL#0.6855;ACTIN POLYMERIZATION#0.6843;MUTAGENIC#0.6685;CATALYTIC ACTIVITY#0.6569;HERPES SIMPLEX VIRUS#0.6391;HERPES SIMPLEX#0.6387;VIRAL INFECTION#0.6375;APOPTOSIS#0.6318;DNA BINDING#0.6293;PRO-INFLAMMATORY#0.6096;EPITHELIAL CELL#0.6062;INNATE IMMUNITY#0.6049
200316	T CELL ACTIVATION#1.0805;CELL ACTIVATION#1.0785;MRNA EDITING#1.0434;VIRION INFECTIVITY FACTOR#1.0315;CYTOSINE DEAMINASE#1.0298;T CELL#1.0256;DEAMINASE ACTIVITY#1.0247;CYTIDINE DEAMINASE#1.0236;VIRION#1.0219;CYTIDINE#1.0196;APOBEC#1.0111;HUMAN IMMUNODEFICIENCY VIRUS#1.0083;CD4+ T CELL#1.0077;VIRAL INFECTIVITY FACTOR#1.0020;REVERSE TRANSCRIPTION#1.0000;C TERMINAL DOMAIN#0.9752;VIRAL REPLICATION#0.9695;UBIQUITIN#0.9607;HEPATITIS B#0.9330;T LYMPHOCYTE#0.9301;MACROPHAGE#0.9230;GENE EXPRESSION#0.9214;CYTIDINE DEAMINATION#0.9138;RNA BINDING#0.9115;PERIPHERAL BLOOD#0.9029;MONONUCLEAR CELLS#0.8967;HEPATITIS B VIRUS#0.8944;SIMIAN IMMUNODEFICIENCY VIRUS#0.8922;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8794;RETROTRANSPOSITION#0.8740;PROTEASOME#0.8672;VIRAL GENOME#0.8655;MUTAGENESIS#0.8645;DENDRITIC CELL#0.8608;IMMUNE RESPONSE#0.8480;NUCLEIC ACID#0.8368;HOST CELL#0.8199;URACIL#0.8032;CYTIDINE DEAMINASE ACTIVITY#0.8012;CATALYTIC ACTIVITY#0.7937;TUMOR TISSUES#0.7935;DNA BINDING#0.7692;MONOCYTE#0.7682;SIGNALING PATHWAY#0.7280;TRANSCRIPTION FACTOR#0.7273;INNATE IMMUNITY#0.7203;NUCLEOCAPSID#0.6696;UBIQUITIN LIGASE COMPLEX#0.6666;MRNA PROCESSING#0.6406;DNA INTEGRATION#0.6230;VIRAL INFECTION#0.6209;MONOCYTE DERIVED DENDRITIC CELL#0.6017
200350	TRANSCRIPTION FACTOR#1.0735;NEURAL PLATE#1.0079;NEURAL ECTODERM#0.7866;STEM CELL#0.6007
200373	PRIMARY CILIARY DYSKINESIA#0.9937;DYSKINESIA#0.8369;CENTRAL PAIR#0.7435;CILIARY MOTILITY#0.7128;EPITHELIAL CELL#0.6672
200403	INTELLECTUAL DISABILITY#0.8135
200424	METHYLCYTOSINE DIOXYGENASE#1.0605;DNA METHYLTRANSFERASE#1.0241;OOCYTE#1.0132;DEMETHYLATION#1.0029;DNA DEMETHYLATION#1.0024;STEM CELL#0.9950;DNA METHYLATION#0.9816;GENE EXPRESSION#0.9803;EMBRYONIC STEM CELL#0.9426;CANCER CELL#0.9344;THYMINE DNA GLYCOSYLASE#0.9170;TRANSCRIPTION FACTOR#0.9080;FERTILIZATION#0.9051;PRONUCLEUS#0.9038;PROGENITOR CELL#0.8834;T CELL#0.8649;B CELL#0.8526;BASE EXCISION REPAIR#0.8256;POLYMERASE CHAIN REACTION#0.8149;HYPOXIA#0.8141;NEURAL PROGENITOR CELL#0.8046;TUMOR SUPPRESSOR#0.8036;GLYCOSYLASE#0.8035;HISTONE MODIFICATION#0.7968;THYMINE#0.7920;LYSINE#0.7897;CELL PROLIFERATION#0.7835;DNA REPLICATION#0.7717;OVARIAN CANCER#0.7491;EMBRYO DEVELOPMENT#0.7379;DNA HYPERMETHYLATION#0.7369;DNA REPAIR#0.7314;CELL DIFFERENTIATION#0.7172;CATALYTIC ACTIVITY#0.7086;NEUROGENESIS#0.7018;CELL CYCLE#0.6890;MOUSE EMBRYONIC STEM#0.6875;ASCORBATE#0.6873;APOPTOSIS#0.6860;COLORECTAL CANCER#0.6829;CYTOPLASM#0.6724;MALE PRONUCLEUS#0.6662;O-GLCNAC TRANSFERASE#0.6464;VITAMIN C#0.6393;BREAST CANCER#0.6307;GERM CELL#0.6206;BRAIN DEVELOPMENT#0.6051;METHYL CPG BINDING#0.6021
2004	EXCRETION#1.0280;TRANSCRIPTION FACTOR#1.0103;SERUM ALBUMIN#0.9327;SERUM RESPONSE FACTOR#0.9146;DNA BINDING#0.9108;CANCER CELL#0.9009;GENE EXPRESSION#0.8907;GROWTH FACTOR#0.8901;CELL MIGRATION#0.8896;BREAST CANCER#0.8314;NEUTROPHIL#0.8148;B CELL#0.8078;KIDNEY DISEASE#0.8015;CHOLESTEROL EFFLUX#0.7981;ANGIOGENESIS#0.7914;MACROPHAGE#0.7825;GLOMERULAR FILTRATION RATE#0.7729;GLOMERULAR FILTRATION#0.7726;PANCREATITIS#0.7664;SIGNALING PATHWAY#0.7591;LYMPH NODE#0.7269;BREAST CANCER CELL#0.7088;ARTERY#0.7007;CHRONIC KIDNEY DISEASE#0.6922;NOREPINEPHRINE#0.6921;MAP KINASE#0.6842;MUSCLE CELL#0.6734;C REACTIVE PROTEIN#0.6608;INFLAMMATORY RESPONSE#0.6280;STEM CELL#0.6013
200504	CANCER CELL#1.0829;EPITHELIAL CELL#0.9971;GASTRIC MUCOSA#0.9788;TUMOR SUPPRESSOR#0.8457;TRANSCRIPTION FACTOR#0.8324;APOPTOSIS#0.8109;SIGNALING PATHWAY#0.8002;GASTRIC EPITHELIAL CELLS#0.7951;GENE EXPRESSION#0.6724;GASTROINTESTINAL TRACT#0.6310;GASTRIC ADENOCARCINOMA#0.6309;EPITHELIAL MESENCHYMAL TRANSITION#0.6309
200539	SKELETAL MUSCLE#0.9798;ANKYRIN REPEAT DOMAIN#0.6997;CARDIAC DEVELOPMENT#0.6775;REGULATION OF GLUCOSE HOMEOSTASIS#0.6365;MYOBLAST DIFFERENTIATION#0.6221;MYOBLAST#0.6210;AMPK ACTIVITY#0.6192;PROTEIN CODING GENE#0.6111;GLUCOSE HOMEOSTASIS#0.6039;GENE SILENCING#0.6029;GLUCOSE UPTAKE#0.6026
200558	DNA REPAIR#0.9922;HISTONE CHAPERONE#0.9849;DNA LIGASE#0.9792;DOUBLE STRAND BREAK#0.9772;POLY ADP RIBOSE#0.9677;RIBOSE#0.8194;DOUBLE-STRAND BREAK REPAIR#0.7325;TANDEM ZINC FINGER#0.6365;SINGLE STRAND BREAK#0.6048
200576	ROOT HAIR#1.0901;ADIPOCYTE#1.0605;LIPID KINASE#1.0603;KINASE ACTIVITY#1.0461;PROTEIN KINASE#1.0408;OOCYTE#1.0293;CORNEAL DYSTROPHY#1.0245;LATE ENDOSOME#1.0237;ENDOSOME#1.0229;LYSOSOME#1.0202;VACUOLE#1.0177;EARLY ENDOSOME#1.0031;PLASMA MEMBRANE#0.9995;AUTOPHAGY#0.9960;GROWTH FACTOR#0.9874;LIPID KINASE ACTIVITY#0.9870;ACTIN BINDING PROTEIN#0.9781;ACTIN BINDING#0.9753;CELL MEMBRANE#0.9594;GLUCOSE UPTAKE#0.9531;PHAGOSOME#0.9418;CANCER CELL#0.9401;PHAGOSOME MATURATION#0.9336;MACROPHAGE#0.9334;SIGNALING PATHWAY#0.9242;ENDOCYTOSIS#0.9227;CELL SURFACE#0.9219;MULTIVESICULAR BODY#0.9202;PROTEIN COMPLEX#0.9118;ORGANELLE#0.8819;B CELL#0.8778;EPIDERMAL GROWTH FACTOR#0.8662;TRANS GOLGI NETWORK#0.8658;FAB 2#0.8488;PAS COMPLEX#0.8456;PROTEIN KINASE B#0.8399;ACTIN CYTOSKELETON#0.8334;T CELL#0.8185;SIGNAL TRANSDUCTION#0.8140;CELL PROLIFERATION#0.8122;CELL MIGRATION#0.8087;GENE EXPRESSION#0.8077;PROTEIN KINASE ACTIVITY#0.8073;MICROTUBULE#0.8042;ACIDIFICATION#0.7862;FATTY ACID BIOSYNTHESIS#0.7761;NON HODGKIN LYMPHOMA#0.7566;AMYLOID PRECURSOR PROTEIN#0.7489;PHOSPHOLIPASE C#0.7404;CHARCOT MARIE TOOTH#0.7367;AUTOPHAGOSOME#0.7298;BREAST CANCER#0.7213;ERYTHROCYTE#0.7012;CELL DEATH#0.7005;COMPLEX I#0.6991;GLUCOSE TRANSPORT#0.6965;GROWTH FACTOR RECEPTOR#0.6959;ENDOLYSOSOME#0.6940;ALZHEIMER'S DISEASE#0.6868;ACYL CARRIER PROTEIN#0.6856;EXOCYTOSIS#0.6855;ACYL CARRIER#0.6855;ACTIN POLYMERIZATION#0.6802;HOST CELL#0.6791;EPITHELIAL CELL#0.6745;TRANSCRIPTION FACTOR#0.6737;TOLL LIKE RECEPTOR#0.6733;LIPID PHOSPHATASE#0.6661;ROOT HAIR ELONGATION#0.6595;ALANINE#0.6512;KAS II#0.6510;APOPTOSIS#0.6438;MELANOSOME#0.6385;PHAGOCYTOSIS#0.6365;ENDOSOMAL MEMBRANE#0.6357;PODOCYTE#0.6293;PHAGOSOME-LYSOSOME FUSION#0.6269;CREATINE TRANSPORTER#0.6209;BUDDING#0.6167;TYPE I IFN PRODUCTION#0.6160;RESPONSE TO INSULIN#0.6146;RHOPTRY#0.6116;CHANNEL ACTIVITY#0.6102;GLUCOSE HOMEOSTASIS#0.6084;CELL MOTILITY#0.6083;CATALYTIC ACTIVITY#0.6075;SKELETAL MUSCLE#0.6021;BAFILOMYCIN A1#0.6019
2005	PROSTATE CANCER#1.0464;SERUM RESPONSE FACTOR#1.0452;TRANSCRIPTION FACTOR#1.0336;DNA BINDING#1.0228;CANCER CELL#1.0130;GENE EXPRESSION#0.9349;T CELL#0.9160;GROWTH FACTOR#0.9030;CELL PROLIFERATION#0.8260;MAP KINASE#0.7863;THYMOCYTE#0.6527;CELL GROWTH#0.6378
200634	DNA METHYLATION#0.7517
2006	ELASTIN FIBER ASSEMBLY#1.0989;ELASTIN BREAKDOWN#1.0806;LAMININ RECEPTOR#1.0646;RECEPTOR COMPLEX#1.0577;LIGAMENTUM NUCHAE#1.0495;ELASTIN DEGRADATION#1.0443;ELASTIN FIBER#1.0398;VARICOSE VEINS#1.0321;LACTOSE#1.0243;SUPRAVALVULAR AORTIC STENOSIS#1.0226;PROTEIN KINASE C#1.0226;BETA GALACTOSIDASE#1.0224;INTRACRANIAL ANEURYSM#1.0224;FIBRONECTIN BINDING#1.0223;OPTIC NERVE HEAD#1.0216;ELASTIC FIBER ASSEMBLY#1.0209;MICROFIBRIL#1.0205;CUTIS LAXA#1.0198;SMC PROLIFERATION#1.0195;SERINE ELASTASE#1.0185;PENICILLAMINE#1.0180;FIBRILLIN#1.0177;SECOND HARMONIC GENERATION#1.0177;ALVEOLAR DUCT#1.0165;D-PENICILLAMINE#1.0164;FIBRILLAR COLLAGEN#1.0150;COLLAGEN TYPE III#1.0148;VALINE#1.0137;MATRIX METALLOPROTEINASE 1#1.0136;ASCORBATE#1.0128;ASPARTIC ACID#1.0125;COLLAGEN NETWORK#1.0124;LAMININ BINDING#1.0120;EXTRACELLULAR SPACE#1.0119;OXALIC ACID#1.0115;COLLAGEN TYPE IV#1.0105;LUNG FIBROBLASTS#1.0089;ALPHA-1-PROTEINASE INHIBITOR#1.0084;WILLIAMS BEUREN SYNDROME#1.0083;METALLOPROTEINASE ACTIVITY#1.0075;VOCAL FOLD#1.0074;CHEMOTAXIS#1.0073;INTERVERTEBRAL DISC#1.0070;COLLAGEN TYPE I#1.0068;TRYPTOPHAN#1.0061;HYALURONAN#1.0060;COLLAGEN DEGRADATION#1.0059;DIFFERENTIAL SCANNING CALORIMETRY#1.0058;OPTIC NERVE#1.0058;COLLAGEN TYPE VI#1.0055;ELASTIC FIBRE#1.0051;FIBRINOGEN#1.0045;PROTEOGLYCAN#1.0042;SPUTUM#1.0042;ALVEOLARIZATION#1.0039;COLLAGEN TYPE II#1.0039;PSEUDOXANTHOMA ELASTICUM#1.0036;ELASTICA VAN GIESON#1.0032;COSTELLO SYNDROME#1.0027;CHLORAMPHENICOL#1.0022;PERIODONTAL LIGAMENT#1.0009;LYSINE#0.9991;GLYCINE#0.9988;ASCORBIC ACID#0.9986;LARGE ARTERIES#0.9978;HYALURONIC ACID#0.9978;VASCULAR TISSUE ENGINEERING#0.9975;RETINOIC ACID#0.9974;LYSYL OXIDASE ACTIVITY#0.9966;PRIMARY OPEN ANGLE GLAUCOMA#0.9966;HYDROXYPROLINE#0.9965;PLEURA#0.9964;SKIN FIBROBLASTS#0.9963;FORMIC ACID#0.9958;MYOSIN HEAVY CHAIN#0.9955;LUNG CANCER#0.9955;MEAN LINEAR INTERCEPT#0.9953;PERICARDIUM#0.9953;HEPARIN#0.9947;MUSCLE CELL PROLIFERATION#0.9946;UTERUS#0.9944;BLEOMYCIN#0.9943;DUCTUS ARTERIOSUS#0.9940;ARTERIOSCLEROSIS#0.9939;MYOFIBROBLAST#0.9937;PELVIC ORGAN PROLAPSE#0.9935;SMOOTH MUSCLE CELL PROLIFERATION#0.9935;ARTERIOLE#0.9935;SMOOTH MUSCLE ACTIN#0.9933;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9932;BASAL LAMINA#0.9929;OUTER LAYER#0.9926;AORTIC SMOOTH MUSCLE CELLS#0.9924;PROTEINASE INHIBITOR#0.9923;TISSUE GROWTH FACTOR#0.9919;PULMONARY EMPHYSEMA#0.9919;EXCRETION#0.9916;ASTROCYTE#0.9915;OPEN ANGLE GLAUCOMA#0.9914;GLUTAMIC ACID#0.9914;DEXAMETHASONE#0.9912;LUNG GROWTH#0.9911;EOSIN#0.9910;AORTIC DISEASE#0.9909;SEPTATION#0.9905;MOLECULAR DYNAMICS SIMULATION#0.9905;MINERALIZATION#0.9895;SERUM ALBUMIN#0.9894;ELASTASE ACTIVITY#0.9891;MOLAR#0.9888;MAST CELL#0.9886;MUSCLE FIBER#0.9886;COLLAGEN METABOLISM#0.9877;DOXYCYCLINE#0.9876;INSULIN-LIKE GROWTH FACTOR#0.9876;MESOTHELIAL CELL#0.9876;ALANINE#0.9875;MACULAR DEGENERATION#0.9875;VITAMIN K#0.9874;FACTOR I#0.9868;CHONDROCYTE#0.9865;PULMONARY FIBROSIS#0.9864;CELL ADHESION MOLECULE#0.9864;PROTEASE ACTIVITY#0.9860;ELASTIC FIBER#0.9858;DERMIS#0.9856;PROTEIN SYNTHESIS#0.9850;ETHANOL#0.9850;DRUG DELIVERY SYSTEM#0.9849;DIGESTION#0.9847;PNEUMONIA#0.9845;CONNECTIVE TISSUE DISEASE#0.9841;TRANSFORMING GROWTH FACTOR BETA#0.9832;PARENCHYMA#0.9832;INNER LAYER#0.9830;STROMA#0.9830;FIBRIL#0.9830;ADVANCED GLYCATION END#0.9829;ADVENTITIA#0.9829;BREAST CANCER#0.9827;HYPOXIC#0.9826;ASCENDING AORTIC ANEURYSM#0.9826;ARGININE#0.9824;ALVEOLAR MACROPHAGE#0.9822;EXTRACELLULAR MATRIX COMPONENT#0.9821;PLASMA MEMBRANE#0.9821;ALKALINE PHOSPHATASE#0.9819;CROSS SECTIONAL AREA#0.9818;SIGNAL TRANSDUCTION#0.9818;ALPHA-2 MACROGLOBULIN#0.9817;AGEING#0.9811;ENDOTHELIAL GROWTH FACTOR#0.9810;TRANSCRIPTASE#0.9809;HYPOXIA#0.9809;CELL MEMBRANE#0.9808;NEUTROPHIL#0.9805;REVERSE TRANSCRIPTION#0.9804;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9804;HYALURONIDASE#0.9803;VASCULAR CELL#0.9803;L-ALANINE#0.9802;PERIPHERAL BLOOD#0.9801;MESENCHYMAL CELL#0.9801;LECTIN#0.9800;POLY ETHYLENE GLYCOL#0.9798;HUMAN DERMAL FIBROBLAST#0.9796;ELASTIC FIBRE ASSEMBLY#0.9795;T LYMPHOCYTE#0.9791;INTERSTITIAL CELL#0.9791;SMOOTH MUSCLE#0.9787;CELLULAR COMPONENT#0.9787;POLYMORPHONUCLEAR LEUKOCYTES#0.9786;CELL PENETRATING PEPTIDE#0.9785;FIBROBLAST GROWTH FACTOR#0.9784;SUPEROXIDE DISMUTASE#0.9783;COLLAGEN SYNTHESIS#0.9782;AGE RELATED MACULAR DEGENERATION#0.9780;DODECYL SULFATE#0.9777;HAIR FOLLICLE#0.9776;LEUCINE#0.9776;THORACIC AORTIC ANEURYSM#0.9774;GENETIC DISORDER#0.9773;STROMELYSIN#0.9772;TUMOR CELLS#0.9771;SODIUM DODECYL SULFATE#0.9771;DERMAL FIBROBLAST#0.9770;CELL SURFACE#0.9769;NICOTINAMIDE#0.9769;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9768;ALPHA 1-ANTITRYPSIN#0.9766;SWELLING#0.9766;LEUKOCYTE#0.9765;LOW DENSITY LIPOPROTEIN#0.9765;COLLAGEN FORMATION#0.9761;VASCULAR SMOOTH MUSCLE CELL#0.9761;FORMALIN#0.9757;PROTEIN KINASE#0.9756;MESENCHYME#0.9756;MARFAN SYNDROME#0.9756;PLATELET AGGREGATION#0.9755;SMOOTH MUSCLE CELL#0.9755;GROWTH FACTOR RECEPTOR#0.9755;CELL MIGRATION#0.9755;CELL CYCLE#0.9750;CONJUGATION#0.9749;MITRAL VALVE#0.9748;MUSCLE CELL#0.9748;FIBROBLAST PROLIFERATION#0.9748;ADIPOCYTE#0.9747;GENE EXPRESSION#0.9745;BASEMENT MEMBRANE#0.9745;QUANTITATIVE REAL TIME#0.9745;PLATELET-DERIVED GROWTH FACTOR#0.9744;ENZYME INHIBITOR#0.9743;INFLAMMATORY CELL INFILTRATION#0.9742;COLLAGENASE#0.9742;EPIDERMAL GROWTH FACTOR#0.9740;ADIPOSE TISSUE#0.9739;IMMUNE CELL#0.9737;T CELL#0.9737;TRANSFORMING GROWTH FACTOR#0.9735;APOPTOTIC#0.9734;ANCHORING#0.9734;MACROPHAGE#0.9732;TISSUE DAMAGE#0.9732;LUNG DEVELOPMENT#0.9731;LOSARTAN#0.9729;BLOOD VESSEL#0.9729;CELL DIFFERENTIATION#0.9728;RESPIRATORY DISTRESS#0.9728;ENDOPLASMIC RETICULUM#0.9726;MICROFILAMENT#0.9724;CYSTIC FIBROSIS#0.9724;MONOCYTE#0.9724;L-LYSINE#0.9722;THORACIC AORTA#0.9720;INFLAMMATORY CELL#0.9720;INTEGRIN BINDING#0.9719;GINGIVA#0.9718;CELL ADHESION#0.9716;PULMONARY HYPERTENSION#0.9715;PULMONARY ARTERY#0.9713;MONONUCLEAR CELLS#0.9713;STROMAL CELL#0.9711;GESTATION#0.9707;STRESS URINARY INCONTINENCE#0.9699;SKELETAL MUSCLE#0.9692;LACTIC ACID#0.9690;PROGENITOR CELL#0.9688;POLYMERASE CHAIN REACTION#0.9687;CONNECTIVE TISSUE#0.9686;LYSIS#0.9686;COMMON CAROTID ARTERIES#0.9686;RECEPTOR BINDING#0.9685;MYOCARDIUM#0.9685;CELL PROLIFERATION#0.9685;CATABOLISM#0.9684;ANGIOGENESIS#0.9683;AORTIC VALVE#0.9682;TISSUE REGENERATION#0.9682;UMBILICAL CORD#0.9681;NITRIC OXIDE SYNTHASE#0.9680;PULSE WAVE VELOCITY#0.9679;ENZYME ACTIVITY#0.9674;KERATINOCYTE#0.9674;CANCER CELL#0.9673;APOPTOSIS#0.9670;PRO-INFLAMMATORY#0.9670;TRANSMISSION ELECTRON MICROSCOPY#0.9668;CELL DEATH#0.9667;ANGIOTENSIN CONVERTING ENZYME#0.9667;TISSUE REMODELING#0.9666;EXTRACELLULAR MATRIX#0.9665;SCANNING ELECTRON MICROSCOPY#0.9663;MORPHOGENESIS#0.9663;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9657;TUMOR NECROSIS FACTOR#0.9653;EDEMA#0.9651;URINARY BLADDER#0.9650;IMMUNE RESPONSE#0.9646;TRANSCRIPTION FACTOR#0.9646;ENDOTHELIUM#0.9646;LUMINAL#0.9646;ATHEROSCLEROTIC#0.9646;ADIPOSE-DERIVED STEM CELL#0.9645;ALVEOLAR EPITHELIAL CELL#0.9641;DIABETES MELLITUS#0.9640;GROWTH FACTOR#0.9639;CARDIOVASCULAR SYSTEM#0.9638;ALPHA 1-ANTITRYPSIN DEFICIENCY#0.9637;LINKING COLLAGEN#0.9637;EPITHELIAL CELL#0.9636;BRONCHOPULMONARY DYSPLASIA#0.9635;SENESCENCE#0.9633;SYSTOLIC BLOOD PRESSURE#0.9632;NITRIC OXIDE#0.9630;INFLAMMATORY RESPONSE#0.9626;REACTIVE OXYGEN SPECIES#0.9626;CELL GROWTH#0.9625;MENTAL RETARDATION#0.9625;MONOCYTE CHEMOTAXIS#0.9624;TOPICAL#0.9624;FLUORESCEIN#0.9624;HOST CELL#0.9622;LUNG DISEASE#0.9622;ATHEROSCLEROSIS#0.9621;UMBILICAL VEIN#0.9619;REGENERATION#0.9617;VASCULAR DISEASE#0.9616;MYOCARDIAL INFARCTION#0.9615;VIRULENCE#0.9614;ANNULUS#0.9613;MUSCLE FIBRE#0.9611;FACTOR VIII#0.9609;POLYPOIDAL CHOROIDAL VASCULOPATHY#0.9606;ENDOTHELIAL CELL#0.9606;MAGNETIC RESONANCE IMAGING#0.9599;ABDOMINAL AORTIC ANEURYSM#0.9598;URETHRA#0.9595;BONE MORPHOGENETIC PROTEIN#0.9592;HEMORRHAGE#0.9592;SIGNALING PATHWAY#0.9590;COMMON CAROTID ARTERY#0.9589;AORTIC ANEURYSM#0.9589;CATALYTIC ACTIVITY#0.9587;CAROTID ARTERY#0.9587;MEDIAL COLLATERAL LIGAMENT#0.9585;HYPERTHERMIA#0.9584;HIGH FAT DIET#0.9583;GRANULOCYTE#0.9582;CELL WALL#0.9580;INTIMA MEDIA THICKNESS#0.9580;HEART DISEASE#0.9580;MODULUS OF ELASTICITY#0.9578;BICUSPID AORTIC VALVE#0.9576;INCONTINENCE#0.9571;ADENINE#0.9570;TOXICITY#0.9564;HYPERTENSION#0.9559;NECROTIC#0.9558;ENERGY LOSS#0.9556;L-ARGININE#0.9556;CORONARY ARTERY#0.9552;HUMAN UMBILICAL VEIN#0.9546;ESTRADIOL#0.9545;SMOOTH MUSCLE CELL MIGRATION#0.9543;MUSCLE CELL MIGRATION#0.9540;WOUND HEALING#0.9538;POST-TRANSLATIONAL MODIFICATION#0.9535;MINOXIDIL#0.9534;ARTERY#0.9534;BONE MARROW#0.9534;MESENCHYMAL STEM CELL#0.9534;THROMBOSIS#0.9532;STEM CELL#0.9528;OUTFLOW TRACT#0.9528;ISCHEMIA#0.9524;CERVICAL#0.9522;CYTOPLASM#0.9520;CYTOTOXICITY#0.9515;HUMAN TRABECULAR MESHWORK#0.9507;OSTEOBLAST#0.9507;MECHANISM OF ACTION#0.9498;RETINAL PIGMENT EPITHELIAL#0.9496;MESENTERIC ARTERY#0.9496;CRUCIATE LIGAMENT#0.9495;KIDNEY DISEASE#0.9494;JUGULAR VEIN#0.9485;SIGNAL PEPTIDE#0.9479;ORGANELLE#0.9475;VENA CAVA#0.9473;RESPIRATORY SYSTEM#0.9471;VITAMIN A#0.9466;ARTERY DISEASE#0.9451;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9449;RECEPTOR ANTAGONIST#0.9449;CACL2#0.9448;TRACHEA#0.9446;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9442;ACETYLCHOLINE#0.9435;CARDIOMYOCYTE#0.9434;CHRONIC KIDNEY DISEASE#0.9433;CILIARY BODY#0.9431;INCREASED BLOOD PRESSURE#0.9431;SALIVARY GLAND#0.9425;PEROXISOME#0.9424;ASPARTATE#0.9420;BREAST CARCINOMA#0.9415;TYPE III PROCOLLAGEN#0.9405;OVARIAN#0.9401;VITAMIN C#0.9379;HEAT SHOCK PROTEIN#0.9375;END OF TREATMENT#0.9373;SKIN DISEASE#0.9366;ACUTE AORTIC DISSECTION#0.9366;PHOSPHATE BUFFERED SALINE#0.9366;COMPLEX I#0.9358;CERVIX#0.9357;ALDOSTERONE#0.9344;TISSUE DEVELOPMENT#0.9343;EXTRA CELLULAR MATRIX#0.9338;EHLERS-DANLOS SYNDROME#0.9333;CORONARY ARTERY DISEASE#0.9324;COAGULATION#0.9324;VASODILATION#0.9320;PULMONARY TRUNK#0.9317;SECRETORY PATHWAY#0.9315;PERIPHERAL NERVE#0.9314;THYMIDINE#0.9313;CD4+ T CELL#0.9307;TWO PHOTON MICROSCOPY#0.9304;LYSOSOME#0.9295;ESTROGEN RECEPTOR#0.9287;RESPIRATORY TRACT#0.9281;AIRWAY SMOOTH MUSCLE#0.9271;LIPID DROPLET#0.9269;PHAGOCYTOSIS#0.9263;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9258;C REACTIVE PROTEIN#0.9253;GENETIC DISEASE#0.9245;NERVOUS SYSTEM#0.9243;BETA-2#0.9237;DYNAMIC LIGHT SCATTERING#0.9232;LASER SCANNING MICROSCOPY#0.9226;MITOGEN ACTIVATED PROTEIN#0.9219;RHEUMATOID ARTHRITIS#0.9184;COLLAGEN BREAKDOWN#0.9179;DOXORUBICIN#0.9167;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.9167;MESENCHYMAL STROMAL CELL#0.9162;SEPTUM#0.9162;METHIONINE#0.9149;MATRIX GLA PROTEIN#0.9149;LIVER DISEASE#0.9141;SMOOTH MUSCLE CELL APOPTOSIS#0.9140;ACE INHIBITOR#0.9137;ENDOTHELIAL NITRIC OXIDE#0.9135;MITOCHONDRIA#0.9127;ERYTHEMA#0.9127;DNA SYNTHESIS#0.9125;LUNG CARCINOMA#0.9124;MUSCLE CELL APOPTOSIS#0.9123;UROKINASE#0.9123;TISSUE HOMEOSTASIS#0.9121;HISTIDINE#0.9120;RAPAMYCIN#0.9116;GLUTATHIONE#0.9110;ESSENTIAL HYPERTENSION#0.9093;IFN-GAMMA#0.9089;TUMOR SUPPRESSOR#0.9088;LYMPH NODE#0.9085;PROTEIN BINDING#0.9085;FOREARM#0.9084;HYPERCHOLESTEROLEMIA#0.9079;B CELL#0.9078;NADPH OXIDASE#0.9077;RENAL ARTERY#0.9061;RETINAL PIGMENT EPITHELIUM#0.9057;ION BINDING#0.9039;CALCIUM CHLORIDE#0.9038;TUNICA ALBUGINEA#0.9029;STRUCTURAL ORGANIZATION#0.9026;GALECTIN#0.9022;OSTEOGENESIS#0.9012;IN SITU ZYMOGRAPHY#0.9012;HIGH DENSITY LIPOPROTEIN#0.9010;IDIOPATHIC PULMONARY FIBROSIS#0.9010;COLLAGEN TYPE V#0.8994;FLAVIN#0.8990;GOBLET CELL#0.8989;CYSTATIN#0.8988;GLYCOSYLATION#0.8985;ACTIVATOR PROTEIN 1#0.8981;RETINOL#0.8981;MYOBLAST#0.8981;PULMONARY VALVE#0.8980;COLLAGENASE ACTIVITY#0.8963;SOLUBLE FRACTION#0.8946;BREAST CANCER CELL#0.8937;BRONCHIOLE#0.8935;EYELID#0.8935;OBESE#0.8934;PHOSPHOLIPASE C#0.8930;TOLL LIKE RECEPTOR#0.8923;KINASE INHIBITOR#0.8915;BASAL CELL#0.8913;MACROPHAGE CHEMOTAXIS#0.8911;CORONARY ARTERY BYPASS#0.8906;ANTERIOR CRUCIATE LIGAMENT#0.8905;INTEIN#0.8894;CRIBRIFORM PLATE#0.8890;CARDIOVASCULAR RISK FACTOR#0.8889;LARYNGES#0.8888;GUANIDINE#0.8869;ALVEOLOGENESIS#0.8868;GROWTH FACTOR BINDING#0.8865;NUCLEUS PULPOSUS#0.8852;TUBERCULOSIS#0.8842;HUMAN BREAST CANCER#0.8829;ADENOCARCINOMA#0.8823;WALL SHEAR STRESS#0.8821;COLLAGEN BINDING#0.8817;VASCULAR ENDOTHELIAL CELL#0.8811;NUCLEIC ACID#0.8806;SMALL INTESTINAL SUBMUCOSA#0.8804;C TERMINAL DOMAIN#0.8804;PLASMA PROTEIN#0.8795;VACUOLE#0.8795;GM-CSF#0.8792;ROUGH ENDOPLASMIC RETICULUM#0.8791;CHEMOKINE RECEPTOR#0.8791;CONGENITAL HEART DISEASE#0.8786;AUTOIMMUNE DISEASE#0.8776;ENALAPRIL#0.8770;CARDIOMYOPATHY#0.8767;LYMPHATIC VESSEL#0.8764;PIGMENT EPITHELIAL CELL#0.8760;TYPE 2 DIABETES#0.8755;PROTEINASE ACTIVITY#0.8744;CEREBRAL ARTERY#0.8720;MYOCYTES#0.8717;SCANNING ELECTRON MICROSCOPE#0.8713;HYPOXIA INDUCIBLE FACTOR#0.8700;CALCIUM CHANNEL#0.8688;HEART MUSCLE#0.8677;BONE FORMATION#0.8677;DENDRITIC CELL#0.8674;CAPTOPRIL#0.8655;IMMUNE SYSTEM#0.8652;PLURIPOTENT STEM CELL#0.8641;DEHYDRATION#0.8632;IMMUNOGLOBULIN G#0.8628;VASCULITIS#0.8622;INTERSTITIAL MATRIX#0.8622;SKELETON#0.8620;ILIAC ARTERY#0.8618;METALLOPROTEINASE INHIBITOR#0.8611;EXFOLIATION SYNDROME#0.8601;FOCAL ADHESION#0.8600;COLONY-STIMULATING FACTOR#0.8588;AMINE OXIDASE ACTIVITY#0.8585;1,10-PHENANTHROLINE#0.8585;EMBRYONIC STEM CELL#0.8584;TO THE PROGRESSION#0.8575;PROSTATE CANCER#0.8575;ANNULUS FIBROSUS#0.8575;MYOFIBROBLAST DIFFERENTIATION#0.8551;COLORECTAL#0.8548;CHONDROGENESIS#0.8547;CELL ASSOCIATED#0.8536;LIPID METABOLISM#0.8512;TRICUSPID VALVE#0.8496;CHONDROBLAST#0.8489;RED BLOOD CELL#0.8487;MOYAMOYA DISEASE#0.8487;STRIATED MUSCLE#0.8485;AND AORTIC ANEURYSM#0.8485;VSMC PROLIFERATION#0.8482;MONOCYTE CHEMOTACTIC PROTEIN#0.8478;SELECTIN#0.8473;HYDRALAZINE#0.8469;SODIUM DODECYL SULPHATE#0.8464;STRESS FIBER#0.8460;BLADDER OUTLET OBSTRUCTION#0.8448;MACROPHAGE MIGRATION#0.8447;SIGNALING MOLECULE#0.8446;NOREPINEPHRINE#0.8430;PARTURITION#0.8428;ADULT RESPIRATORY DISTRESS SYNDROME#0.8424;LARYNX#0.8419;MICROPARTICLE#0.8403;SUCROSE#0.8396;HUMAN MESENCHYMAL STEM#0.8388;ARTERIAL SYSTEM#0.8377;CHONDROITIN SULFATE PROTEOGLYCAN#0.8366;CONGENITAL DIAPHRAGMATIC HERNIA#0.8364;DEVELOPMENTAL DELAY#0.8362;NEURAL CREST#0.8361;SPINAL CORD#0.8356;HYPERGLYCEMIA#0.8352;VASOCONSTRICTION#0.8349;SCLEROTIC#0.8345;HYDROCORTISONE#0.8332;LEWIS LUNG CARCINOMA#0.8328;NODULAR#0.8323;MITRAL VALVE PROLAPSE#0.8323;STATIONARY PHASE#0.8317;MENOPAUSE#0.8316;CONFOCAL FLUORESCENCE MICROSCOPY#0.8298;LUNG DAMAGE#0.8296;SQUAMOUS CELL CARCINOMA#0.8294;ACTINOMYCIN D#0.8288;CENTRAL NERVOUS SYSTEM#0.8285;HUMAN PERIODONTAL LIGAMENT#0.8285;PROGESTERONE#0.8271;NERVE GROWTH FACTOR#0.8250;SCLERODERMA#0.8240;MUSCLE CONTRACTION#0.8233;KAWASAKI DISEASE#0.8229;ORAL MUCOSA#0.8219;MELANOCYTE#0.8209;INGUINAL HERNIA#0.8199;FORCED EXPIRATORY VOLUME#0.8192;HEPATIC STELLATE CELL#0.8189;SURFACE PLASMON RESONANCE#0.8185;BILE DUCT#0.8171;SCAVENGER RECEPTOR#0.8171;GOLGI APPARATUS#0.8163;LUPUS ERYTHEMATOSUS#0.8160;POSTTRANSLATIONAL MODIFICATION#0.8159;PEYRONIE'S DISEASE#0.8158;MICROVASCULAR ENDOTHELIAL CELL#0.8154;EOSINOPHIL#0.8148;URETER#0.8142;BIOTIN#0.8129;PROGERIA#0.8126;ENDOTHELIAL PROGENITOR CELL#0.8106;HYPERHOMOCYSTEINEMIA#0.8105;ACUTE LUNG INJURY#0.8091;HYALURONATE#0.8090;MUCOUS#0.8085;MATRIX METALLOPROTEINASE 2 ACTIVITY#0.8085;ROFECOXIB#0.8077;INTERMEDIATE FILAMENT#0.8069;DENSE MATERIAL#0.8060;BODY WEIGHT RATIO#0.8056;CYTOKINE PRODUCTION#0.8046;DNA BINDING#0.8033;ACETIC ACID#0.8032;VITAMIN E#0.8023;TISSUE CULTURE POLYSTYRENE#0.8021;INDUCED PLURIPOTENT STEM CELL#0.8016;COLORECTAL CANCER#0.8015;BLOOD PLASMA#0.8013;LASER INDUCED FLUORESCENCE#0.8010;AUTOIMMUNITY#0.8008;HEMORRHAGIC#0.8007;HYALURONAN SYNTHASE#0.7997;HYPERCALCEMIA#0.7987;HIGH CHOLESTEROL DIET#0.7985;SMALL INTESTINE#0.7979;MUTAGENESIS#0.7977;WHITE BLOOD CELL#0.7976;OPTICAL COHERENCE TOMOGRAPHY#0.7970;EMBRYONIC LUNG#0.7962;PHOTOLYSIS#0.7958;PULMONARY ARTERIAL HYPERTENSION#0.7953;LUNG EPITHELIAL CELL#0.7947;DERMATITIS#0.7942;SODIUM NITROPRUSSIDE#0.7941;STREPTOZOTOCIN#0.7920;TETRACYCLINE#0.7905;VITAMIN D3#0.7903;A-GEL#0.7901;TRANSCRIPTIONAL CONTROL#0.7894;L-PROLINE#0.7862;NEUTROPHIL ELASTASE INHIBITOR#0.7855;PROTEIN DEFICIENCY#0.7826;CONSTRICTION#0.7818;AORTIC VALVE DISEASE#0.7816;ACTIVATED T CELL#0.7801;NEURITE#0.7800;PERINDOPRIL#0.7799;GROWTH PATTERN#0.7788;CIGARETTE SMOKE EXPOSURE#0.7788;PULMONARY VASCULAR REMODELING#0.7770;VASCULAR ENDOTHELIUM#0.7766;CIRCULATORY SYSTEM#0.7761;INTERCELLULAR SPACE#0.7758;CORTISOL#0.7743;VASOCONSTRICTOR#0.7721;SCHWANN CELL#0.7711;ALKALINE PROTEASE#0.7703;CELLULAR SENESCENCE#0.7691;OBSTRUCTIVE LUNG DISEASE#0.7690;INDOMETHACIN#0.7665;PERIOSTEUM#0.7641;INDUCIBLE NITRIC OXIDE#0.7641;COLLAGEN BIOSYNTHESIS#0.7633;DNASE#0.7631;GIANT CELL ARTERITIS#0.7628;CELL ACTIVATION#0.7622;DIGITAL IMAGE ANALYSIS#0.7620;M2 MACROPHAGE#0.7617;FIBROCYTE#0.7603;LEFT ANTERIOR DESCENDING#0.7602;METAPLASIA#0.7592;L-PHENYLALANINE#0.7578;ACTIN FILAMENT#0.7577;METAL BINDING#0.7577;A BAND#0.7567;ADVENTITIAL CELL#0.7561;BONE REGENERATION#0.7559;TUMOUR NECROSIS FACTOR#0.7549;NITROPRUSSIDE#0.7546;WEIGHT LOSS#0.7545;LOCALISATION#0.7543;HEPATOCELLULAR CARCINOMA#0.7527;SKIN CANCER#0.7526;FIBROSARCOMA#0.7519;BRONCHITIS#0.7518;RESPIRATORY FAILURE#0.7500;IL-1RA#0.7500;MYOFILAMENT#0.7493;GROWTH HORMONE#0.7474;HYALURONIC ACID SYNTHASE#0.7459;PLEOMORPHIC ADENOMA#0.7447;SMOOTH MUSCLE CONTRACTION#0.7439;PHENYLEPHRINE#0.7435;METAL CHELATING#0.7428;SMC APOPTOSIS#0.7421;SURFACTANT PROTEIN C#0.7417;FLAVIN ADENINE DINUCLEOTIDE#0.7410;MONOCYTE DERIVED MACROPHAGE#0.7403;TROPHOBLAST#0.7396;PERITONEAL CAVITY#0.7395;TISSUE TRANSGLUTAMINASE#0.7390;PORTAL VEIN#0.7386;ERYTHROCYTE#0.7383;ADENO ASSOCIATED VIRUS#0.7380;VASODILATOR#0.7377;FINITE ELEMENT MODEL#0.7377;HOE 140#0.7376;BAFILOMYCIN A1#0.7367;SODIUM HYALURONATE#0.7366;UROKINASE PLASMINOGEN ACTIVATOR#0.7354;SIGNALING CASCADE#0.7350;CELL NUCLEUS#0.7344;RECTUM#0.7321;AMYLOIDOSIS#0.7321;FLUORESCENCE LIFETIME IMAGING#0.7312;CLEFT PALATE#0.7294;HYPERSENSITIVITY#0.7293;ASPERGILLOSIS#0.7291;GLUCOSAMINE#0.7286;ESOPHAGUS#0.7273;AMNIOTIC MEMBRANE#0.7262;RETICULOCYTE#0.7261;1α,25-DIHYDROXYVITAMIN D3#0.7259;URETHANE#0.7259;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7258;ACUTE MYOCARDIAL INFARCTION#0.7251;PROTEIN BODY#0.7240;NORADRENALINE#0.7236;NEOCARTILAGE#0.7219;ADENOSINE#0.7218;MIDDLE EAR#0.7215;TESTOSTERONE#0.7203;PRINCIPAL COMPONENT ANALYSIS#0.7189;RESPONSE TO ACETYLCHOLINE#0.7172;ALL TRANS RETINOIC ACID#0.7158;72-HOURS#0.7157;TRIFLUOROETHANOL#0.7145;MIDDLE CEREBRAL ARTERY#0.7144;SIALIDASE ACTIVITY#0.7139;WEIGHT GAIN#0.7138;OSTEOARTHRITIS#0.7138;CYCLIN DEPENDENT KINASE#0.7102;LIVER CIRRHOSIS#0.7099;TRANSMISSION ELECTRON MICROSCOPE#0.7093;SOLAR SIMULATED RADIATION#0.7091;IRRITATION#0.7090;ANTIOXIDANT ACTIVITY#0.7076;CELL JUNCTION#0.7068;ADVANCED GLYCATION ENDPRODUCT#0.7059;POTASSIUM CHANNEL#0.7058;B LYMPHOCYTE#0.7056;MESENCHYMAL PROGENITOR CELL#0.7055;PERTUSSIS#0.7055;LANGERHANS CELL#0.7048;ANGIOTENSIN RECEPTOR#0.7045;AMNIOTIC FLUID#0.7042;HEALTHY CONTROL SUBJECTS#0.7033;NERVE FIBER#0.7026;TERMINAL DIFFERENTIATION#0.7010;NECROTIZING#0.6991;INTERSTITIAL LUNG DISEASE#0.6972;SPINAL STENOSIS#0.6971;ENDOCARDIAL FIBROELASTOSIS#0.6963;BASAL CELL CARCINOMA#0.6956;BASILAR ARTERY#0.6946;MUSCLE HYPERTROPHY#0.6940;MRNA SYNTHESIS#0.6920;BLADDER SMOOTH MUSCLE#0.6909;STEM CELL DIFFERENTIATION#0.6903;MENISCUS#0.6884;BRONCHIECTASIS#0.6863;NEURITE OUTGROWTH#0.6850;CANDESARTAN#0.6847;NEUTROPHIL CHEMOTAXIS#0.6844;PSORIASIS#0.6843;NEUROPATHY#0.6830;TRETINOIN#0.6810;NONSENSE MEDIATED DECAY#0.6799;INNERVATION#0.6796;CARDIAC MUSCLE#0.6788;ALZHEIMER'S DISEASE#0.6777;MALIGNANT HYPERTENSION#0.6775;PROTEIN DEGRADATION#0.6774;MYOFIBRIL#0.6772;PERIODONTITIS#0.6771;FIBRINOLYSIS#0.6767;PLASMA CELL#0.6762;LEUCINE RICH REPEAT#0.6761;RETINOIC ACID RECEPTOR#0.6758;PROSTAGLANDIN E2#0.6756;MIDLINE#0.6756;SCOLIOSIS#0.6755;ETHYLENEDIAMINETETRAACETIC ACID#0.6753;MYOMETRIUM#0.6746;SIGNALLING PATHWAY#0.6742;FOREIGN BODY RESPONSE#0.6726;PERICYTE#0.6724;SARCOMERE#0.6717;FOAM CELL FORMATION#0.6715;HATCHING#0.6691;SIZE EXCLUSION CHROMATOGRAPHY#0.6685;ADENINE DINUCLEOTIDE PHOSPHATE#0.6683;CELL PHYSIOLOGY#0.6676;BACTERIAL PNEUMONIA#0.6668;TUBE FORMATION#0.6664;SPINAL CORD INJURY#0.6659;RESPONSE TO TREATMENT#0.6654;FAT CELL#0.6649;CELL MOTILITY#0.6649;DIMETHYL SULFOXIDE#0.6643;ACID PHOSPHATASE#0.6639;TARGET OF RAPAMYCIN#0.6628;L-TRYPTOPHAN#0.6611;ATORVASTATIN#0.6609;ADIPOSE STEM CELLS#0.6602;QUARTZ CRYSTAL MICROBALANCE#0.6601;PROPRANOLOL#0.6596;ADRENERGIC RECEPTOR#0.6593;PEPTIDOGLYCAN#0.6586;CELL DIVISION#0.6581;SEBACEOUS GLAND#0.6580;UMBILICAL ARTERY#0.6578;ENDOCYTOSIS#0.6577;BLOOD PLATELETS#0.6576;NIFEDIPINE#0.6574;VITAMIN D2#0.6567;CYTOCHROME C#0.6564;CIGARETTE SMOKE CONDENSATE#0.6561;BLOOD CIRCULATION#0.6546;TGF-BETA BINDING#0.6538;CHROMOSOMAL REGION#0.6519;PROTEIN FOLDING#0.6509;BLOOD COAGULATION#0.6506;TRANSDIFFERENTIATION#0.6505;CORONAL#0.6495;NITRO-L-ARGININE#0.6493;HEMOSTASIS#0.6492;VASODILATATION#0.6485;CLOTTING#0.6483;CARRIE#0.6481;DENSE PLAQUE#0.6473;ARTERIOVENOUS MALFORMATION#0.6473;TEMPORAL ARTERITIS#0.6453;CONGENITAL HEART DEFECTS#0.6449;INTERNAL CAROTID ARTERY#0.6444;MEMBRANE TYPE 1#0.6442;BLINDNESS#0.6439;FORESKIN#0.6435;HUMAN ADIPOSE TISSUE#0.6426;PORTAL HYPERTENSION#0.6420;ARACHIDONIC ACID#0.6382;SYNOVIAL FLUID#0.6379;MULTIPLE REGRESSION ANALYSIS#0.6378;CLEAVED CASPASE 3#0.6377;GLYCOSAMINOGLYCAN SYNTHESIS#0.6370;PROTEIN PROTEIN INTERACTION#0.6344;CALCINOSIS#0.6343;AUTOPHAGY#0.6331;PROLYL 4-HYDROXYLASE#0.6309;ARTERIAL TORTUOSITY SYNDROME#0.6302;LAYER BY LAYER#0.6302;HAMARTOMA#0.6297;FIBRINOGEN BINDING#0.6294;SMALL PULMONARY ARTERIES#0.6276;MATRIX METALLOPROTEINASE 9 ACTIVITY#0.6271;SMOOTH MUSCLE CELL DIFFERENTIATION#0.6271;FEMUR#0.6259;RENOVASCULAR HYPERTENSION#0.6258;COGNITION#0.6243;NEURITE EXTENSION#0.6239;POLYMORPHONUCLEAR NEUTROPHIL#0.6233;DIAPHRAGM#0.6209;HEPARIN BINDING#0.6204;C CHEMOKINE RECEPTOR#0.6202;FOREIGN BODY REACTION#0.6201;MUSCLE CELL DIFFERENTIATION#0.6194;FERMENTATION#0.6191;QUANTITATIVE TRAIT LOCI#0.6190;VERY-LOW-DENSITY LIPOPROTEIN#0.6185;REACTIVE OXYGEN SPECIES GENERATION#0.6181;GLUTAMINE#0.6164;PROTEIN BIOSYNTHESIS#0.6160;FACTOR XIIIA#0.6160;GLUTATHIONE PEROXIDASE#0.6159;GRANULOCYTE COLONY STIMULATING FACTOR#0.6154;CD8+ T CELL#0.6152;TH17 CELL#0.6149;TYPE II PNEUMOCYTE#0.6145;GLIAL CELL#0.6144;NO BINDING#0.6144;RETINAL PIGMENT EPITHELIAL CELLS#0.6142;MAPK SIGNALING#0.6139;RIGHT VENTRICULAR PRESSURE#0.6137;INTENSIVE CARE UNIT#0.6135;LYMPHOID CELL#0.6135;CONTROLLED DRUG DELIVERY#0.6132;BIOFILM FORMATION#0.6130;COLCHICINE#0.6122;G-CSF#0.6120;OSTEOPOROSIS#0.6113;BETAMETHASONE#0.6103;GUANOSINE#0.6098;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6094;PERSISTENT PULMONARY HYPERTENSION#0.6091;ISCHEMIC HEART DISEASE#0.6067;THYROID CARCINOMA#0.6066;CAROTENOID#0.6047;HEPATOCYTE GROWTH FACTOR#0.6040;POSITRON EMISSION TOMOGRAPHY#0.6038;LUNG MORPHOGENESIS#0.6035;MAP KINASE#0.6027;BIOMINERALIZATION#0.6024;RESVERATROL#0.6019;LITHIUM#0.6013;KINASE ACTIVITY#0.6011
200728	CANCER CELL#0.9856;BREAST CANCER CELL#0.7487;LUNG CANCER#0.7463;BREAST CANCER#0.7435
200734	GROWTH FACTOR#1.0237;MAPK SIGNALING#0.8563;SIGNALING PATHWAY#0.8161;KUPFFER CELL#0.7961;CELL PROLIFERATION#0.7619;MAP KINASE#0.7593;MACROPHAGE#0.7410;PROTEIN KINASE#0.7217;APOPTOSIS#0.6650;MITOGEN ACTIVATED PROTEIN#0.6508;FIBROBLAST GROWTH FACTOR#0.6414;EPITHELIAL CELL#0.6385;CHRONIC MYELOID LEUKEMIA#0.6272;P85 BINDING#0.6224;MYELOID LEUKEMIA#0.6201;HIGH FAT DIET#0.6148;IMATINIB#0.6049
200765	CELL CYCLE#0.6867
200879	AUTOSOMAL RECESSIVE HYPOTRICHOSIS#1.0835;HYPOTRICHOSIS#1.0704;OUTER MEMBRANE#1.0412;PHOSPHOLIPASE A#1.0398;TRIGLYCERIDE LIPASE#1.0188;PLATELET ACTIVATING FACTOR#1.0172;PHOSPHOLIPASE D#1.0149;PHOSPHOLIPASE C#1.0146;PROTEIN KINASE C#1.0049;LIPASE ACTIVITY#1.0043;ARACHIDONIC ACID#0.9953;MACROPHAGE#0.9932;ENDOTHELIAL CELL#0.9914;PHOSPHOLIPASE A1#0.9908;PROTEIN KINASE#0.9906;LOW DENSITY LIPOPROTEIN#0.9862;MITOGEN ACTIVATED PROTEIN#0.9826;PHOSPHATIDYLETHANOLAMINE#0.9812;PLASMA MEMBRANE#0.9780;ACUTE PANCREATITIS#0.9778;NITRIC OXIDE#0.9670;ACID PHOSPHATASE#0.9651;PANCREATITIS#0.9650;ENZYME ACTIVITY#0.9629;SIGNALING PATHWAY#0.9541;PHOSPHOLIPASE A2#0.9511;GROWTH FACTOR#0.9492;HAIR GROWTH#0.9435;CELL MEMBRANE#0.9406;MITOCHONDRIA#0.9380;SIGNAL TRANSDUCTION#0.9360;INDOMETHACIN#0.9259;PHOSPHATIDYLSERINE#0.9239;SMOOTH MUSCLE#0.9208;CELL DEATH#0.9200;NITRIC OXIDE SYNTHASE#0.9134;ATHEROSCLEROSIS#0.9104;RECEPTOR ANTAGONIST#0.9101;C REACTIVE PROTEIN#0.9060;GENE EXPRESSION#0.8997;NEUTROPHIL#0.8979;EPITHELIAL CELL#0.8957;MUSCLE CELL#0.8894;LIPASE INHIBITOR#0.8827;ARTERY#0.8809;INHIBITION OF PHOSPHOLIPASE A#0.8774;LIPID METABOLISM#0.8717;LYSOPHOSPHOLIPASE ACTIVITY#0.8696;QUINACRINE#0.8657;CORONARY ARTERY#0.8656;APOPTOSIS#0.8567;CANCER CELL#0.8546;HIGH DENSITY LIPOPROTEIN#0.8488;MICROSOME#0.8480;SMOOTH MUSCLE CELL#0.8476;DIGESTION#0.8449;HEPARIN#0.8448;INFLAMMATORY RESPONSE#0.8367;HAIR LOSS#0.8261;BIPOLAR DISORDER#0.8169;MEPACRINE#0.8077;ACETYLCHOLINE#0.8055;CELL SURFACE#0.7980;ATHEROSCLEROTIC#0.7956;LITHIUM#0.7931;CHOLINE#0.7852;OLEIC ACID#0.7797;ALKALINE PHOSPHATASE#0.7786;LIPOLYSIS#0.7664;INFLAMMATORY CELL#0.7657;HAIR FOLLICLE#0.7646;PHOSPHOLIPASE ACTIVITY#0.7646;IONOPHORE#0.7640;CARDIOLIPIN#0.7627;LIPOPROTEIN LIPASE#0.7603;KINASE INHIBITOR#0.7568;INDUCIBLE NITRIC OXIDE#0.7533;TOXICITY#0.7468;ENDOTHELIUM#0.7460;CELL ASSOCIATED#0.7457;ISCHEMIA#0.7438;ELECTRON TRANSPORT#0.7268;CATALYTIC ACTIVITY#0.7253;PERTUSSIS#0.7248;MAP KINASE#0.7245;MAST CELL#0.7238;MONOCYTE#0.7191;TRANSCRIPTION FACTOR#0.7187;HOST CELL#0.7175;OVARIAN CANCER#0.7164;PHOSPHOLIPID METABOLISM#0.7146;ERYTHROCYTE#0.7120;PHOSPHOCHOLINE#0.7118;EPIDERMAL GROWTH FACTOR#0.7082;CYTOCHROME C#0.7001;LYSOSOME#0.6981;TUMOR NECROSIS FACTOR#0.6956;VASCULAR SMOOTH MUSCLE CELL#0.6944;ENDOPLASMIC RETICULUM#0.6836;CARBAMAZEPINE#0.6812;N-ETHYLMALEIMIDE#0.6793;BREAST CANCER#0.6787;MEMBRANE FRACTION#0.6770;SCALP#0.6737;CELL MIGRATION#0.6721;SERUM ALBUMIN#0.6708;SN-GLYCERO-3-PHOSPHOCHOLINE#0.6707;GLYCERO-3-PHOSPHOCHOLINE#0.6701;PHOSPHODIESTERASE#0.6680;VIRULENCE#0.6675;KERATINOCYTE#0.6616;SURFACE PLASMON RESONANCE#0.6614;SIGNALLING PATHWAY#0.6576;LDL PARTICLE#0.6526;CORONARY ARTERY DISEASE#0.6506;ARTERY DISEASE#0.6504;PHOSPHOLIPASE A2 ACTIVITY#0.6464;PROPRANOLOL#0.6445;CELL PROLIFERATION#0.6401;ARGININE#0.6393;NEUROTOXICITY#0.6335;ADENYLYLCYCLASE ACTIVITY#0.6332;SURAMIN BINDING#0.6332;PEROXISOME#0.6321;ADENOSINE#0.6310;APOPTOTIC#0.6291;SODIUM DODECYL SULFATE#0.6289;DODECYL SULFATE#0.6288;SOLUBLE FRACTION#0.6277;ATPASE ACTIVITY#0.6185;PLATELET AGGREGATION#0.6181;NADPH OXIDASE#0.6177;OVARIAN#0.6155;PHOSPHOLIPASE A1 ACTIVITY#0.6153;PHOSPHATASE ACTIVITY#0.6144;ETHANOLAMINE#0.6050;FACTOR S#0.6045;CORONARY ARTERY ENDOTHELIAL CELLS#0.6036;PROSTAGLANDIN SYNTHESIS#0.6018;LYSIS#0.6012
200894	JOUBERT SYNDROME#1.0640;CILIARY MEMBRANE#1.0330;CILIUM#1.0260;CILIOGENESIS#0.9894;PRIMARY CILIUM#0.9562;CILIOPATHY#0.9413;AXONEME#0.9367;CELL MIGRATION#0.8621;NUCLEOTIDE EXCHANGE FACTOR#0.8301;RETINAL DEGENERATION#0.8169;INTRAFLAGELLAR TRANSPORT#0.7897;GUANINE#0.7807;MOTILE CILIA#0.7492;NEURAL TUBE#0.7137;PHOTORECEPTOR OUTER SEGMENT#0.7113;CANCER CELL#0.6827;MICROTUBULE#0.6800;ORGANELLE#0.6613;SIGNALING PATHWAY#0.6579;PHOTORECEPTOR DEVELOPMENT#0.6478;BASAL BODY#0.6437;ACTIN CYTOSKELETON#0.6075;NEURAL TUBE PATTERNING#0.6055
200895	DIHYDROFOLATE REDUCTASE#0.9640;DHF BINDING#0.8539
200909	SEROTONIN RECEPTOR#0.7163;PRIMARY ANGLE-CLOSURE GLAUCOMA#0.6655;PRIMARY ANGLE CLOSURE#0.6627;ANGLE-CLOSURE GLAUCOMA#0.6553
200916	RIBOSOMAL PROTEIN#0.8995;OVARIAN CANCER#0.6849;5 FLUOROURACIL#0.6394
200931	ORGANIC SOLUTE TRANSPORTER#1.1076;FARNESOID X RECEPTOR#1.0192;TAUROCHOLATE#0.9337;CHOLESTASIS#0.9208;ENTEROCYTE#0.8868;PLASMA MEMBRANE#0.8845;BILE ACID TRANSPORT#0.8481;EPITHELIAL CELL#0.8399;BILE DUCT#0.8106;ESTRONE#0.7436;OOCYTE#0.7048;EXCRETION#0.6934;GROWTH FACTOR#0.6886;GENE EXPRESSION#0.6723;FIBROBLAST GROWTH FACTOR#0.6656;HEXANE#0.6574;ADRENAL GLAND#0.6399;SMALL INTESTINE#0.6149
200933	UBIQUITIN#1.0524;UBIQUITIN LIGASE COMPLEX#0.9509;CANCER CELL#0.7476;PROTEASOME#0.6497;APOPTOSIS#0.6300
200942	LYMPH NODE#0.6673
200958	GENE EXPRESSION#0.8283;EPITHELIAL CELL#0.7319;NEPHROPATHY#0.6656;REVERSE TRANSCRIPTION#0.6532;ENDOMETRIAL CANCER#0.6357;HEPATOCYTE GROWTH FACTOR#0.6326;CELL ADHESION#0.6191;GROWTH FACTOR#0.6139
2009	MICROTUBULE ASSOCIATED PROTEIN#1.1145;MICROTUBULE#1.1025;MICROTUBULE BINDING#0.7934;MITOTIC SPINDLE#0.7802;GENE EXPRESSION#0.7156;MICROTUBULE DYNAMICS#0.6339;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6180
2010	INNER NUCLEAR MEMBRANE#1.0392;NUCLEAR MEMBRANE#1.0287;LINC COMPLEX#1.0198;EMERY-DREIFUSS MUSCULAR DYSTROPHY#1.0195;NUCLEAR LAMINA#1.0138;LAMIN BINDING#1.0137;NUCLEAR ENVELOPE#1.0107;SKELETAL MUSCLE#1.0084;MUSCULAR DYSTROPHY#1.0079;MYOBLAST#1.0069;NUCLEAR PERIPHERY#1.0052;CELL CYCLE#0.9993;GENE EXPRESSION#0.9973;TRANSCRIPTION FACTOR#0.9903;MUSCLE CELL#0.9891;NULL CELL#0.9800;CARDIOMYOPATHY#0.9790;MITOSIS#0.9745;CARDIAC MUSCLE#0.9741;CYTOPLASM#0.9713;DILATED CARDIOMYOPATHY#0.9639;CARDIAC CONDUCTION#0.9626;MUSCLE WASTING#0.9590;NUCLEOSKELETON#0.9479;REGENERATION#0.9451;LIPODYSTROPHY#0.9433;LIMB-GIRDLE MUSCULAR DYSTROPHY#0.9410;NUCLEAR PORE#0.9394;OUTER NUCLEAR MEMBRANE#0.9365;MUSCLE WEAKNESS#0.9269;HETEROCHROMATIN#0.9188;INTERPHASE#0.9166;SIGNALING PATHWAY#0.9144;ENDOPLASMIC RETICULUM#0.9070;CHROMATIN ORGANIZATION#0.9067;NUCLEAR MATRIX#0.8946;PROTEIN KINASE#0.8901;PARTIAL LIPODYSTROPHY#0.8866;CELL DIFFERENTIATION#0.8859;NUCLEOPLASM#0.8823;CENTROSOME#0.8715;CARDIOMYOCYTE#0.8671;SPECTRIN#0.8601;FAMILIAL PARTIAL LIPODYSTROPHY#0.8566;MYOPATHY#0.8532;PAPILLARY THYROID CARCINOMA#0.8480;CELL DIVISION#0.8439;THYROID CARCINOMA#0.8427;NUCLEAR MORPHOLOGY#0.8255;INTERMEDIATE FILAMENT#0.8230;NUCLEAR ORGANIZATION#0.8183;DNA BINDING#0.8105;INTERCALATED DISC#0.8104;PLASMA MEMBRANE#0.7939;GERM CELL#0.7881;HUMAN IMMUNODEFICIENCY VIRUS#0.7841;PROGERIA#0.7752;HISTONE DEACETYLASE#0.7714;NUCLEAR INNER MEMBRANE#0.7676;MYOTUBE#0.7613;MYOGENESIS#0.7580;ACTIN BINDING#0.7544;SKIN FIBROBLASTS#0.7541;MUSCLE FIBER#0.7508;X CHROMOSOME#0.7463;APOPTOSIS#0.7456;C TERMINAL DOMAIN#0.7453;EXTRACELLULAR MATRIX#0.7399;SMOOTH MUSCLE#0.7395;STEM CELL#0.7237;NUCLEAR EGRESS#0.7207;MITOTIC SPINDLE#0.7150;NUCLEAR MOVEMENT#0.7111;NUCLEAR PORE COMPLEXES#0.7098;CHROMATIN REMODELING#0.7096;TAN LINE#0.7067;CHROMATIN BINDING#0.7042;EPITHELIAL CELL#0.7006;LOCALISATION#0.6952;ATRIAL FIBRILLATION#0.6912;MOUSE EMBRYO FIBROBLASTS#0.6885;TELOPHASE#0.6868;STRIATED MUSCLE#0.6849;SKELETAL MUSCLE WASTING#0.6698;MUSCLE FIBRE#0.6573;ARRHYTHMIA#0.6547;ACTIN POLYMERIZATION#0.6543;HYPERPHOSPHORYLATION#0.6525;ACTIN CYTOSKELETON#0.6515;PROTEIN COMPLEX#0.6515;CELL DEATH#0.6501;PROTEASOME#0.6479;VACUOLE#0.6384;MYOBLAST DIFFERENTIATION#0.6325;ACTIN FILAMENT#0.6322;HERPES SIMPLEX VIRUS#0.6318;HERPES SIMPLEX#0.6315;FOCAL ADHESION#0.6305;THYROID LESIONS#0.6243;GENE SILENCING#0.6220;PROTEIN PROTEIN INTERACTION#0.6205;GENETIC DISORDER#0.6194;MICROTUBULE#0.6151;CANCER CELL#0.6146;DERMAL FIBROBLAST#0.6093;VESICULAR TRANSPORT#0.6021
201140	SARCOPLASMIC RETICULUM#0.7018
201161	MITOTIC CHROMOSOME#0.6888
201163	KIDNEY CANCER#1.0500;PROTEIN KINASE#1.0487;TUMOR SUPPRESSOR#1.0463;RAPAMYCIN#1.0216;TARGET OF RAPAMYCIN#1.0179;RENAL CARCINOMA#1.0032;CANCER CELL#1.0014;PNEUMOTHORAX#0.9993;RENAL CELL CARCINOMA#0.9961;LYSOSOME#0.9936;SIGNALING PATHWAY#0.9929;AUTOPHAGY#0.9767;TRANSCRIPTION FACTOR#0.9691;HAIR FOLLICLE#0.9528;PROGESTERONE#0.9512;5'-AMP#0.9456;LUNG DISEASE#0.9386;CHROMOPHOBE RENAL CELL CARCINOMA#0.9347;RENAL CANCER CELLS#0.9343;NULL CELL#0.9279;CELL CYCLE#0.9278;HAMARTOMA#0.9179;APOPTOSIS#0.8927;EPITHELIAL CELL#0.8868;CELL ADHESION#0.8768;GAP ACTIVITY#0.8648;CELL CELL ADHESION#0.8498;RENAL CELL CANCER#0.8416;AUTOSOMAL DOMINANT DISEASE#0.8410;TUBEROUS SCLEROSIS#0.8290;TESTOSTERONE#0.8091;RENAL ONCOCYTOMA#0.7941;B CELL#0.7797;TUBEROUS SCLEROSIS COMPLEX#0.7695;UTERUS#0.7541;MENSTRUAL CYCLE#0.7473;CELL DEVELOPMENT#0.7416;ENERGY HOMEOSTASIS#0.7256;GENE EXPRESSION#0.7213;CELL DEATH#0.7032;OXIDATIVE METABOLISM#0.6964;OXIDATIVE PHOSPHORYLATION#0.6939;NUTRIENT SENSING#0.6884;CLEAR CELL CARCINOMA#0.6842;B CELL DEVELOPMENT#0.6790;M PHASE#0.6717;CELL PROLIFERATION#0.6677;LYSOSOME LOCALIZATION#0.6672;FUMARATE HYDRATASE#0.6670;ESTROGENS#0.6584;PROTEIN COMPLEX#0.6274;CYTOPLASM#0.6196;GUANINE#0.6190;OVARIAN#0.6104;REGULATION OF AUTOPHAGY#0.6058
201164	PHOSPHOLIPASE A2#1.0764;PHOSPHOLIPASE A#1.0756;PHOSPHOLIPASE D#1.0608;MITOCHONDRIA#0.9989;PHOSPHOLIPASE A2 ACTIVITY#0.9398;MITOCHONDRIAL MEMBRANE#0.9013;MITOCHONDRIAL FUSION#0.8996;CARDIOLIPIN#0.8759;NUAGE#0.7968;B CELL#0.7393;APOPTOSIS#0.7279;GERM CELL#0.7225;PHOSPHATIDYLETHANOLAMINE#0.7059;OUTER MEMBRANE#0.6917;PHOSPHOLIPASE A2 ACTIVATION#0.6528;SPERMATOGENESIS#0.6506;B CELL RECEPTOR#0.6181
201181	OSSIFICATION#0.8586;CHONDROCYTE#0.8528
2011	THROMBIN RECEPTOR#1.0765;PROTEASE ACTIVATED RECEPTOR#1.0534;OOCYTE#1.0384;CELL POLARITY#1.0334;MICROTUBULE#1.0262;MICROTUBULE ASSOCIATED PROTEIN#1.0200;KINASE ACTIVITY#1.0185;EPITHELIAL CELL#1.0076;MICROTUBULE CYTOSKELETON#1.0060;SIGNALING PATHWAY#1.0050;PROTEIN KINASE#0.9977;GROWTH FACTOR#0.9829;ENDOTHELIAL CELL#0.9811;MICROTUBULE DYNAMICS#0.9708;CELL CYCLE#0.9667;GLYCOGEN SYNTHASE KINASE#0.9599;CELL DIVISION#0.9472;CELL MIGRATION#0.9467;PROTEIN KINASE C#0.9301;GASTRIC EPITHELIAL CELLS#0.8981;NEURITE OUTGROWTH#0.8891;APOPTOSIS#0.8805;NEURITE#0.8755;PLASMA MEMBRANE#0.8745;CELL ADHESION#0.8664;ALZHEIMER'S DISEASE#0.8661;PLATELET AGGREGATION#0.8620;TRANSCRIPTION FACTOR#0.8399;LOCALISATION#0.8359;OOGENESIS#0.8329;SIGNAL TRANSDUCTION#0.8326;STEM CELL#0.8270;GENE EXPRESSION#0.8260;TUMOR SUPPRESSOR#0.8155;UBIQUITIN#0.7963;MITOTIC SPINDLE#0.7962;LUNG CANCER#0.7912;CENTROSOME#0.7830;EXTRACELLULAR MATRIX#0.7787;ASYMMETRIC CELL DIVISION#0.7785;TIGHT JUNCTION#0.7672;CANCER CELL#0.7657;CELL SURFACE#0.7614;CELL CELL ADHESION#0.7541;ONCOGENIC#0.7333;CELL GROWTH#0.7266;T CELL#0.7228;MAP KINASE#0.7104;TOXICITY#0.7014;CELL DEATH#0.7011;CELL PROLIFERATION#0.7008;MICROTUBULE PLUS END#0.6979;STRESS FIBER#0.6972;BREAST CANCER#0.6950;PROTEIN KINASE A#0.6921;BETA CELL#0.6914;PROTEINASE ACTIVATED RECEPTOR#0.6901;DENDRITIC SPINE#0.6830;ACTIN CYTOSKELETON#0.6812;EPIDERMAL GROWTH FACTOR#0.6764;MITOSIS#0.6689;MICROTUBULE BINDING#0.6609;KINESIN#0.6567;WNT SIGNALING PATHWAY#0.6561;PLATELET ACTIVATION#0.6543;CYTOPLASM#0.6521;RECEPTOR AGONIST#0.6495;DENDRITIC MICROTUBULE#0.6473;CELL POLARIZATION#0.6423;ADHERENS JUNCTION#0.6384;CATALYTIC ACTIVITY#0.6336;BASEMENT MEMBRANE#0.6315;TUMOR CELLS#0.6263;FOCAL ADHESION#0.6231;KINASE INHIBITOR#0.6193;LUNG GIANT CELL CARCINOMA#0.6189;HYPERPHOSPHORYLATION#0.6096;LAMININ RECEPTOR#0.6042
201232	GASTROINTESTINAL TRACT#0.6878
201254	CENTROMERE#1.0106;FANCONI ANEMIA#0.7778;KINETOCHORE#0.7636;DNA BINDING#0.7091;DNA REPAIR#0.6849;ANEMIA#0.6566
201255	CENTRIOLE#0.7125;CENTROSOME#0.6458
201288	NITRIC OXIDE#0.7951;NITRIC OXIDE SYNTHASE#0.6610;ORAL CAVITY#0.6523
201292	LUNG CANCER#0.8477;UBIQUITIN#0.7798;ONCOGENIC#0.7322;CANCER CELL#0.7239;CELL PROLIFERATION#0.6684;CELL GROWTH#0.6489;APOPTOSIS#0.6034
201294	MAST CELL#1.0431;EXOCYTOSIS#1.0356;FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS#1.0323;PLASMA MEMBRANE#1.0271;NEUTROPHIL#1.0226;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS#1.0139;T CELL#0.9950;CYTOTOXICITY#0.9853;MEMBRANE FUSION#0.9841;HEMATOPOIETIC CELL#0.9778;FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS#0.9669;STEM CELL#0.9619;T LYMPHOCYTE#0.9496;SECRETORY GRANULE#0.9463;STEM CELL TRANSPLANTATION#0.9353;HEMATOPOIETIC STEM CELL#0.9298;LYSOSOME#0.9084;CYTOTOXIC T-LYMPHOCYTE#0.8957;NATURAL KILLER CELL#0.8631;NERVOUS SYSTEM#0.8619;EPSTEIN BARR VIRUS#0.8442;GRISCELLI SYNDROME#0.8387;CD8+ T CELL#0.8222;BONE MARROW#0.8000;MACROPHAGE#0.7967;MACROPHAGE ACTIVATION#0.7801;CENTRAL NERVOUS SYSTEM#0.7746;CYTOPENIA#0.7643;MAST CELL DEGRANULATION#0.7498;NK CELL DEGRANULATION#0.7411;GRISCELLI SYNDROME TYPE 2#0.7366;IMMUNE CELL#0.7151;ORGANELLE#0.6983;MACROPHAGE ACTIVATION SYNDROME#0.6635;HEMOSTASIS#0.6468;JUVENILE IDIOPATHIC ARTHRITIS#0.6446;TOTAL INTERNAL REFLECTION#0.6402;CELL ACTIVATION#0.6358;VESICLE EXOCYTOSIS#0.6335;REGULATED EXOCYTOSIS#0.6228;CYTOTOXIC T CELL#0.6085;LATE ENDOSOME#0.6049;PERIPHERAL BLOOD#0.6013
201299	DNA METHYLATION#1.0121;CELL PROLIFERATION#0.9930;RNA-DIRECTED DNA METHYLATION#0.9377;CISPLATIN#0.8596;CANCER CELL#0.7812;DOUBLE STRAND BREAK#0.7553;RNA RECOGNITION MOTIF#0.7456;CELL CYCLE#0.7229;APOPTOSIS#0.6865;DOUBLE-STRAND BREAK REPAIR#0.6805;NUCLEIC ACID BINDING#0.6691;NUCLEIC ACID#0.6520;TUMOR SUPPRESSOR#0.6465;LUNG CANCER#0.6460
2012	LYMPH NODE#1.0130;MOLECULAR DYNAMICS SIMULATION#1.0095;CELL PROLIFERATION#1.0070;CANCER CELL#1.0014;LYMPH NODE METASTASIS#0.9949;APOPTOSIS#0.9823;GENE EXPRESSION#0.9766;DENSITY FUNCTIONAL THEORY#0.9643;POLYMERASE CHAIN REACTION#0.9563;EPITHELIAL CELL#0.9534;SIGNALING PATHWAY#0.9478;MOLAR#0.8826;ERYTHROCYTE#0.8382;TOXICITY#0.8345;LARYNGEAL CARCINOMA#0.8228;PROSTATE CANCER#0.7901;STEM CELL#0.7852;REVERSE TRANSCRIPTION#0.7741;TIGHT JUNCTION#0.7547;BREAST CANCER#0.7486;ESOPHAGEAL CANCER#0.7407;CELL GROWTH#0.7262;NUCLEUS PULPOSUS#0.6927;SQUAMOUS CELL CARCINOMA#0.6913;INTERVERTEBRAL DISC#0.6901;MALARIA#0.6656;CELL CYCLE#0.6626;2,4,6-TRINITROTOLUENE#0.6506;GROWTH FACTOR#0.6489;QUANTITATIVE REAL TIME#0.6245;ELECTRON TRANSFER#0.6160
2013	ENDOMETRIAL CANCER#1.1037;CANCER CELL#0.9945;TUMOR SUPPRESSOR#0.9367;CELL DEATH#0.9237;BREAST CANCER#0.8728;ANGIOGENESIS#0.8492;LIPID RAFT#0.8342;CELL SURFACE#0.8021;PROLIFERATIVE VITREORETINOPATHY#0.7476;RIBOZYME#0.7331;RETINAL PIGMENT EPITHELIUM#0.7321;FOCAL ADHESION#0.7135;PLASMA MEMBRANE#0.6656;EPITHELIAL CELL#0.6453;APOPTOSIS#0.6253;CELL MEMBRANE#0.6247;STEM CELL#0.6208;OVARIAN CANCER#0.6133;CELL PROLIFERATION#0.6023
201456	UBIQUITIN#0.6947;GENE EXPRESSION#0.6867;STEM CELL#0.6712;UBIQUITIN PROTEASOME PATHWAY#0.6248;PROTEASOME PATHWAY#0.6223
201475	AUTOPHAGY#0.9627;LYSOSOME#0.8067;NUCLEOTIDE EXCHANGE FACTOR#0.8060;RECYCLING ENDOSOME#0.8018;TRANSFERRIN RECEPTOR#0.7524;GTP BINDING#0.7361;GUANINE#0.6483;MOUSE EMBRYONIC FIBROBLAST#0.6457;PLASMA MEMBRANE#0.6324;ENDOSOME#0.6243;DYNEIN COMPLEX#0.6237;PLASMA MEMBRANE INVAGINATION#0.6217;MEMBRANE INVAGINATION#0.6053
2014	TUMOR SUPPRESSOR#1.0561;CANCER CELL#0.9996;CELL PROLIFERATION#0.9490;BREAST CARCINOMA#0.8344;NEUROBLASTOMA#0.8165;GENE EXPRESSION#0.7962;POLYMERASE CHAIN REACTION#0.6949;DNA METHYLATION#0.6562;SQUAMOUS CELL CARCINOMA#0.6190;CELL GROWTH#0.6172
201501	ENDOSOME#0.8936;AP-1 COMPLEX#0.8800;AUXIN TRANSPORT#0.8643;TRANSCRIPTION FACTOR#0.8538;VACUOLE FUSION#0.7744;ADAPTOR PROTEIN 1#0.7685;VACUOLE#0.6870;PLASMA MEMBRANE#0.6561;GLUCOSE 6 PHOSPHATASE#0.6037
201516	TELOMERE#1.1007;STEM CELL#1.0446;EMBRYONIC STEM CELL#1.0434;MOUSE EMBRYONIC STEM#1.0261;TELOMERE MAINTENANCE#0.8399;PLURIPOTENT STEM CELL#0.8262;CANCER CELL#0.8141;GENE EXPRESSION#0.7961;TRANSCRIPTION FACTOR#0.7418;INDUCED PLURIPOTENT STEM CELL#0.7280;ZYGOTIC GENOME ACTIVATION#0.7065;DNA METHYLATION#0.6575;CELL CYCLE#0.6524;DNA DEMETHYLATION#0.6466;RETINOIC ACID#0.6167
201562	ENDOPLASMIC RETICULUM MEMBRANE#0.6999;ENDOPLASMIC RETICULUM#0.6732
201595	GLYCOSYLATION#1.0778;ENDOPLASMIC RETICULUM#0.8478;OST COMPLEX#0.7803;CONGENITAL DISORDER#0.6295;ASPARAGINE#0.6263
2015	MACROPHAGE#1.0355;GENE EXPRESSION#1.0179;ADIPOSE TISSUE#1.0091;MONOCYTE#0.9925;GROWTH FACTOR#0.9913;EPIDERMAL GROWTH FACTOR#0.9897;TUMOR NECROSIS FACTOR#0.9345;PRO-INFLAMMATORY#0.8669;EOSINOPHIL#0.8473;BONE MARROW#0.7993;HIGH FAT DIET#0.7177;TOLL LIKE RECEPTOR#0.7117;ADIPOCYTE#0.7033;INFLAMMATORY RESPONSE#0.6880;M2 MACROPHAGE#0.6717;NUCLEAR ENVELOPE#0.6521;LEUKOCYTE#0.6458;IMMUNE CELL#0.6436;EXTRACELLULAR REGION#0.6125;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6053;OBESE#0.6034
201625	LYSIS#0.8070;DYNEIN#0.7314;BIOFILM FORMATION#0.7287;RRNA BINDING#0.6317
201626	PHOSPHODIESTERASE#0.9583
201633	CD8+ T CELL#1.0394;T CELL ACTIVATION#1.0383;T LYMPHOCYTE#1.0363;CD4+ T CELL#1.0308;DENDRITIC CELL#1.0277;T CELL#1.0245;CELL ACTIVATION#1.0231;CELL PROLIFERATION#1.0201;PERIPHERAL BLOOD#1.0102;REGULATORY T CELL#1.0092;CELL DEATH#1.0068;PROGRAMMED CELL DEATH#1.0065;TUMOR CELLS#1.0031;CYTOTOXICITY#0.9986;IMMUNE CELL#0.9934;IMMUNE RESPONSE#0.9912;CYTOKINE PRODUCTION#0.9898;NATURAL KILLER CELL#0.9719;CYTOTOXIC T-LYMPHOCYTE#0.9683;AUTOIMMUNE DISEASE#0.9677;TREG CELL#0.9566;IMMUNE SYSTEM#0.9451;EFFECTOR T CELL#0.9400;MEMORY T CELL#0.9399;TRANSCRIPTION FACTOR#0.9152;CANCER CELL#0.9101;LYMPHOCYTE ACTIVATION#0.9081;MACROPHAGE#0.8930;GENE EXPRESSION#0.8864;LYMPH NODE#0.8544;ACTIVATED T CELL#0.8530;CELL SURFACE#0.8416;B CELL#0.8305;LUNG CANCER#0.8286;AUTOIMMUNITY#0.8172;ACTIVATED T-CELLS#0.8065;MONONUCLEAR CELLS#0.8013;STEM CELL#0.7990;TH2 CELL#0.7967;T CELL PROLIFERATION#0.7859;CELL ADHESION#0.7737;ACUTE MYELOID LEUKEMIA#0.7629;MYELOID LEUKEMIA#0.7615;HEPATOCELLULAR CARCINOMA#0.7497;COLORECTAL#0.7383;DNA METHYLATION#0.7322;BONE MARROW#0.7282;EFFECTOR MEMORY T CELL#0.7280;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7239;CYTOKINE SECRETION#0.7054;BREAST CANCER#0.7046;APOPTOSIS#0.7023;NK CELL ACTIVATION#0.6977;B LYMPHOCYTE#0.6939;STEM CELL TRANSPLANTATION#0.6792;EXHAUSTED T CELL#0.6577;VIRAL INFECTION#0.6540;COLORECTAL CANCER#0.6516;TUMOR NECROSIS FACTOR#0.6483;MYELOID-DERIVED SUPPRESSOR CELL#0.6419;TH17 CELL#0.6382;PRO-INFLAMMATORY#0.6321
2016	CEREBRAL CORTEX#1.0440;FOREBRAIN#1.0379;TELENCEPHALON#1.0364;TRANSCRIPTION FACTOR#1.0347;GENE EXPRESSION#0.9911;STEM CELL#0.9668;BRAIN DEVELOPMENT#0.9227;NEUROGENESIS#0.9185;NEURAL STEM CELL#0.8525;INTERNEURON#0.8454;PROGENITOR CELL#0.8369;OLFACTORY BULB#0.8153;NEURAL TUBE#0.8050;STRIATUM#0.7866;GROWTH FACTOR#0.7327;CAJAL-RETZIUS CELL#0.7277;DENTATE GYRUS#0.6737;NERVOUS SYSTEM#0.6732;FOREBRAIN DEVELOPMENT#0.6510;GABAERGIC NEURON#0.6501;CAMKII#0.6433;MIDLINE#0.6223;ANTERIOR CINGULATE CORTEX#0.6196;GLUTAMATERGIC NEURON#0.6121;CENTRAL NERVOUS SYSTEM#0.6106
201725	ADJACENT NORMAL TISSUE#1.1976
201780	SYNAPTIC VESICLE#1.0135;CHOLINERGIC NEURON#0.9232;MAST CELL#0.7347;NERVOUS SYSTEM#0.7294;TAUROCHOLATE#0.7293;ACETYLCHOLINE#0.6787;SYNAPTIC VESICLE PROTEIN#0.6778;PLASMA MEMBRANE#0.6734;MAST CELL DEGRANULATION#0.6117;PERIPHERAL NERVOUS SYSTEM#0.6005
201799	TYPE 2 DIABETES#0.7379;PNEUMONIA#0.6220;BETA CELL#0.6029
2017	F-ACTIN BINDING#1.0633;ACTIN NUCLEATION#1.0563;MEMBRANE RUFFLE#1.0540;COLORECTAL CANCER#1.0540;INVADOPODIUM#1.0513;CELL PERIPHERY#1.0512;GROWTH CONE#1.0485;ACTIN RELATED PROTEIN#1.0437;PODOSOME#1.0432;RUFFLE#1.0419;FILAMENTOUS ACTIN#1.0415;ACTIN BINDING PROTEIN#1.0406;ACTIN BINDING#1.0383;COLORECTAL#1.0360;LYMPH NODE METASTASIS#1.0256;DENDRITIC SPINE#1.0249;MYOSIN LIGHT-CHAIN KINASE#1.0232;ENDOSOME#1.0219;CELL MOVEMENT#1.0205;WISKOTT ALDRICH SYNDROME#1.0184;FOCAL ADHESION KINASE#1.0183;RNA INTERFERENCE#1.0181;ADENOCARCINOMA#1.0164;LYMPH NODE#1.0146;ACTIN POLYMERIZATION#1.0136;SRC FAMILY KINASE#1.0121;HEAD AND NECK SQUAMOUS CELL CARCINOMA#1.0102;ACTIN FILAMENT#1.0098;EPIDERMAL GROWTH FACTOR#1.0085;GROWTH FACTOR RECEPTOR#1.0085;ENDOCYTOSIS#1.0074;BREAST CANCER CELL#1.0046;FOCAL ADHESION#1.0037;STRESS FIBER#1.0030;CELL MIGRATION#1.0026;CELL MOTILITY#1.0015;BREAST CANCER#0.9994;CYTOPLASM#0.9986;CELL ADHESION#0.9979;PROTEIN KINASE#0.9979;KINASE ACTIVITY#0.9978;MUSCLE CELL#0.9954;EPITHELIAL CELL#0.9949;GROWTH FACTOR#0.9943;PLASMA MEMBRANE#0.9936;SMOOTH MUSCLE#0.9935;SQUAMOUS CELL CARCINOMA#0.9909;ACTIN CYTOSKELETON#0.9889;HOST CELL#0.9883;CANCER CELL#0.9877;SMOOTH MUSCLE CELL#0.9875;PROTEIN TYROSINE KINASE#0.9865;DEPHOSPHORYLATION#0.9860;TUMOR CELLS#0.9857;HISTONE DEACETYLASE#0.9840;ENDOTHELIAL CELL#0.9822;HEPATOCELLULAR CARCINOMA#0.9813;KINASE INHIBITOR#0.9812;CELL PROLIFERATION#0.9812;ORAL SQUAMOUS CELL CARCINOMA#0.9808;OSTEOCLAST#0.9801;CELL CORTEX#0.9801;CELL CYCLE#0.9792;LARYNGEAL CARCINOMA#0.9783;COLON CANCER#0.9777;MICROTUBULE#0.9770;SIGNALING PATHWAY#0.9768;CELL SURFACE#0.9759;SPHINGOSINE 1 PHOSPHATE#0.9750;INVADOPODIUM FORMATION#0.9741;OVARIAN#0.9681;ADHERENS JUNCTION#0.9681;LEUKOCYTE#0.9679;EXTRACELLULAR MATRIX#0.9664;SIGNAL TRANSDUCTION#0.9633;GENE EXPRESSION#0.9599;RECEPTOR TYROSINE KINASE#0.9596;ENDOTHELIUM#0.9580;CELL MEMBRANE#0.9559;BREAST CARCINOMA#0.9556;SERTOLI CELL#0.9555;FIBROBLAST GROWTH FACTOR#0.9507;OVARIAN CANCER#0.9502;DNA AMPLIFICATION#0.9467;B CELL#0.9452;MORPHOGENESIS#0.9448;APOPTOSIS#0.9447;ACTIN BUNDLING#0.9374;LYSOSOME#0.9311;POSTSYNAPTIC DENSITY#0.9288;MEMBRANE TYPE 1#0.9267;SIGNALLING PATHWAY#0.9266;PLATELET-DERIVED GROWTH FACTOR#0.9260;PROSTATE CANCER#0.9259;CELL JUNCTION#0.9248;HUMAN BREAST CANCER#0.9227;COMPLEX I#0.9163;MEMBRANE RUFFLING#0.9160;NERVOUS SYSTEM#0.9113;PODOCYTE#0.9101;NUCLEOTIDE EXCHANGE FACTOR#0.9075;SPHINGOSINE#0.9072;CORTICAL ACTIN CYTOSKELETON#0.9061;PROTEIN COMPLEX#0.9004;ACTIN FILAMENT BINDING#0.8987;FILOPODIA FORMATION#0.8982;ONCOGENIC#0.8945;ANGIOGENESIS#0.8944;BONE RESORPTION#0.8869;DISEASE FREE SURVIVAL#0.8800;KERATINOCYTE#0.8777;CELL GROWTH#0.8685;CONTACT SITE#0.8684;CELL CELL ADHESION#0.8680;BONE MARROW#0.8656;ACTOMYOSIN#0.8625;VASCULAR SMOOTH MUSCLE CELL#0.8622;GUANINE#0.8614;PROTEIN KINASE C#0.8602;BREAST CANCER PATIENTS#0.8572;INVASIVE BREAST CANCER#0.8556;WOUND HEALING#0.8554;ACTIN DEPOLYMERIZATION#0.8554;HEAD AND NECK CANCER#0.8525;NECK CANCER#0.8524;ESOPHAGEAL CANCER#0.8517;POST-TRANSLATIONAL MODIFICATION#0.8511;APICAL ES#0.8495;INSOLUBLE FRACTION#0.8492;REACTIVE OXYGEN SPECIES#0.8448;MYASTHENIA GRAVIS#0.8385;MACROPHAGE#0.8353;CELL DIFFERENTIATION#0.8340;TUMOR TISSUES#0.8339;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8332;P21 ACTIVATED KINASE#0.8327;LYMPHOCYTIC LEUKEMIA#0.8323;APOPTOTIC#0.8307;NMDA RECEPTOR#0.8307;TRANSCRIPTION FACTOR#0.8302;NEURITE#0.8292;TUMOR SUPPRESSOR#0.8269;EARLY ENDOSOME#0.8269;SIGNALING MOLECULE#0.8253;CENTRAL NERVOUS SYSTEM#0.8249;AUTOPHAGOSOME-LYSOSOME FUSION#0.8245;COATED VESICLE#0.8176;NADPH OXIDASE#0.8169;PROTEIN TYROSINE PHOSPHATASE#0.8098;CELL LEADING EDGE#0.8056;RECEPTOR MEDIATED ENDOCYTOSIS#0.8046;LAMELLIPODIUM#0.8044;PANCREATIC CANCER#0.8033;CHEMOTAXIS#0.8033;CLATHRIN-COATED PIT#0.7998;PLATELET ACTIVATION#0.7992;COLORECTAL ADENOCARCINOMA#0.7977;PLATELET AGGREGATION#0.7971;HEPATOCYTE GROWTH FACTOR#0.7964;COATED PIT#0.7955;IMMUNE RESPONSE#0.7954;PODOSOME ASSEMBLY#0.7931;REGULATION OF ACTIN POLYMERIZATION#0.7924;LUNG CANCER#0.7923;EPITHELIAL MESENCHYMAL TRANSITION#0.7831;COMPARATIVE GENOMIC HYBRIDIZATION#0.7814;PULMONARY ARTERY#0.7800;BINDING PROTEIN 1#0.7766;SPECIFIC PROTEIN 1#0.7757;PROTEIN PROTEIN INTERACTION#0.7740;NEURITE OUTGROWTH#0.7690;SH3 DOMAIN BINDING#0.7646;ARTERY#0.7636;CORTICAL CYTOSKELETON#0.7620;LYSINE#0.7606;DISEASE SPECIFIC SURVIVAL#0.7605;MAP KINASE#0.7585;AUTOPHAGY#0.7559;HUMAN PULMONARY ARTERY#0.7544;CLATHRIN COATED VESICLE#0.7514;UBIQUITIN#0.7476;ZONULA OCCLUDENS#0.7466;OVARIAN CARCINOMA#0.7451;AIRWAY EPITHELIAL CELL#0.7429;T CELL#0.7392;POTASSIUM CHANNEL#0.7391;ORGANELLE#0.7378;MAMMARY GLAND#0.7365;HEAT SHOCK PROTEIN#0.7359;GTPASE ACTIVITY#0.7309;HUMAN AIRWAY EPITHELIAL#0.7305;SPERMATOGENESIS#0.7300;ACETYLCHOLINE#0.7288;CLATHRIN-MEDIATED ENDOCYTOSIS#0.7261;EPITHELIAL TO MESENCHYMAL#0.7257;TIGHT JUNCTION#0.7246;CELL ADHESION MOLECULE#0.7217;AUTOPHAGOSOME#0.7216;CYCLIN DEPENDENT KINASE#0.7185;POLYMERASE CHAIN REACTION#0.7174;GLUTATHIONE#0.7167;RENAL CELL CARCINOMA#0.7149;CHROMOSOMAL REGION#0.7147;MEGAKARYOCYTE#0.7126;ENDOTHELIAL GROWTH FACTOR#0.7126;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7126;LYMPH NODE METASTASES#0.7064;HUMAN UMBILICAL VEIN#0.7002;UMBILICAL VEIN#0.6999;ZONULA ADHERENS#0.6991;ASTROCYTE#0.6977;DOMINANT NEGATIVE MUTANT#0.6975;DENDRITIC CELL#0.6969;NEURONAL CELLS#0.6941;HEMATOPOIETIC CELL#0.6934;PRIMARY BREAST CANCER#0.6893;NON-MUSCLE MYOSIN#0.6890;WASP INTERACTING PROTEIN#0.6865;ROS GENERATION#0.6859;SIGNALING CASCADE#0.6847;CLEAR CELL CARCINOMA#0.6789;FIBRINOGEN#0.6782;EXOSOME#0.6760;LATE ENDOSOME#0.6759;PHOSPHOLIPASE C#0.6735;CERVICAL#0.6730;LIVER CANCER#0.6709;PKC ACTIVATION#0.6709;ACTIN CROSS-LINKING ACTIVITY#0.6633;ENDOTHELIAL CELL MIGRATION#0.6594;NEUTROPHIL#0.6571;BASEMENT MEMBRANE#0.6570;AMPULLA OF VATER ADENOCARCINOMA#0.6567;HYPERPHOSPHORYLATION#0.6466;C TERMINAL DOMAIN#0.6464;ACETYLCHOLINE RECEPTOR#0.6453;TYROSINE KINASE INHIBITOR#0.6431;PROTEIN KINASE D#0.6406;GASTRIC EPITHELIAL CELLS#0.6341;MITOSIS#0.6315;ANOIKIS#0.6290;HYPOXIA#0.6287;COPY NUMBER GAIN#0.6276;CELL CELL JUNCTION#0.6251;ZONULA OCCLUDENS 1#0.6251;GERM CELL#0.6235;LUNG ENDOTHELIAL CELLS#0.6204;PHOSPHOTYROSINE BINDING#0.6157;SEROUS CYSTADENOCARCINOMA#0.6147;ACUTE LUNG INJURY#0.6145;MUCINOUS CYSTADENOCARCINOMA#0.6134;HYALURONAN#0.6124;MITOGEN ACTIVATED PROTEIN#0.6090;SMOOTH MUSCLE CONTRACTION#0.6080;GASTRIC ADENOCARCINOMA#0.6055;MITOCHONDRIA#0.6045;NEURONAL MIGRATION#0.6042;INTERCELLULAR JUNCTION#0.6030;MUSCLE CONTRACTION#0.6028;FLUTAMIDE#0.6011
2018	FOREBRAIN#1.0340;TELENCEPHALON#1.0291;TRANSCRIPTION FACTOR#1.0210;CEREBRAL CORTEX#1.0201;GENE EXPRESSION#0.9947;DENTATE GYRUS#0.9930;STEM CELL#0.9843;CELL PROLIFERATION#0.9632;GROWTH FACTOR#0.9245;ENDOMETRIUM#0.9113;NERVOUS SYSTEM#0.9104;NEURAL STEM CELL#0.8878;CANCER CELL#0.8792;PROGENITOR CELL#0.8791;CENTRAL NERVOUS SYSTEM#0.8780;REGIONALIZATION#0.8775;GONAD#0.8761;NEURAL TUBE#0.8658;FOREBRAIN DEVELOPMENT#0.8651;CAJAL-RETZIUS CELL#0.8465;SCAPULA#0.8305;MORPHOGENESIS#0.8171;ENDOMETRIAL CANCER#0.8088;DIENCEPHALON#0.8053;CELL MIGRATION#0.7909;OLFACTORY BULB#0.7901;HAIR CELL#0.7843;CELL CYCLE#0.7728;BRAIN DEVELOPMENT#0.7723;SPINAL CORD#0.7701;NEUROGENESIS#0.7638;MUSCLE FIBER#0.7585;PRECURSOR CELL#0.7554;FIBROBLAST GROWTH FACTOR#0.7536;SIGNALING PATHWAY#0.7430;UTERUS#0.7274;SOMITE#0.7170;EPITHELIAL CELL#0.7087;THALAMUS#0.6983;RETINOIC ACID#0.6939;INNER EAR#0.6871;MIDBRAIN#0.6867;CELL POLARITY#0.6832;CELL DIFFERENTIATION#0.6640;EMBRYO IMPLANTATION#0.6218;GERM CELL#0.6112;NEURAL PRECURSOR CELL#0.6104;URETERIC BUD#0.6085;CORTICAL CELL#0.6037;ANTISENSE RNA#0.6019;MYOSIN HEAVY CHAIN#0.6001
201931	LYSOSOMAL MEMBRANE#1.0698;AUTOPHAGY#0.7167;HEPATOMA CELLS#0.7104;LYSOSOME#0.6187
201965	CELL PROLIFERATION#1.1787
201973	REPLICATION FORK#1.0796;DNA PRIMASE#1.0758;DNA REPLICATION#1.0558;MITOCHONDRIAL DNA#1.0505;TRANSLESION SYNTHESIS#1.0038;DNA SYNTHESIS#0.9988;DNA DAMAGE TOLERANCE#0.9729;MITOCHONDRIAL DNA REPLICATION#0.9472;MITOCHONDRIA#0.7677;MTDNA#0.7593;S PHASE#0.7506;DNA POLYMERASE ACTIVITY#0.7221;DNA BINDING#0.7216;DNA POLYMERASE ALPHA#0.6608;MUTAGENIC#0.6021
2019	TRANSCRIPTION FACTOR#1.0310;MIDBRAIN#1.0305;HINDBRAIN#1.0158;GENE EXPRESSION#1.0003;DOPAMINERGIC NEURON#0.9910;DOPAMINE#0.9475;PARKINSON'S DISEASE#0.9131;STEM CELL#0.8736;GROWTH FACTOR#0.8482;CANCER CELL#0.8201;NEURON DEVELOPMENT#0.8180;BREAST CANCER#0.8070;INTERNEURON#0.7908;SUBSTANTIA NIGRA#0.7624;FIBROBLAST GROWTH FACTOR#0.7591;SPINAL CORD#0.7181;TECTUM#0.7155;FOREBRAIN#0.7009;CEREBELLUM DEVELOPMENT#0.6571;NERVOUS SYSTEM#0.6430;SALIVARY GLAND#0.6196
201	AMELOGENESIS IMPERFECTA#0.6110
202051	SPERMIOGENESIS#0.8676;CYTOPLASM#0.8484
202052	GERM CELL#1.1894
2020	PROSTATE CANCER#1.0900;AUTISM SPECTRUM DISORDER#1.0553;TRANSCRIPTION FACTOR#1.0260;HINDBRAIN#1.0259;PURKINJE CELL#1.0178;MIDBRAIN#1.0118;GENE EXPRESSION#0.9948;RENAL CELL CARCINOMA#0.9177;DOPAMINERGIC NEURON#0.9114;FOREBRAIN#0.9083;NERVOUS SYSTEM#0.8975;CLEAR CELL RENAL CELL CARCINOMA#0.8927;CELL CYCLE#0.8853;DNA BINDING#0.8479;CANCER CELL#0.8257;PARKINSON'S DISEASE#0.8224;APOPTOSIS#0.8219;METENCEPHALON#0.8196;GROWTH FACTOR#0.8011;CENTRAL NERVOUS SYSTEM#0.7999;BRAIN DEVELOPMENT#0.7985;TECTUM#0.7840;NEURAL TUBE#0.7815;SIGNALING PATHWAY#0.7680;CELL PROLIFERATION#0.7635;SPATIAL LEARNING#0.7615;INTERNEURON#0.7614;FLOOR PLATE#0.7568;CEREBRAL CORTEX#0.7360;STEM CELL#0.7304;GANGLION CELLS#0.6818;REGIONALIZATION#0.6500;AUTISTIC#0.6483;NOTOCHORD#0.6294;O CELL#0.6238;SOCIAL BEHAVIOR#0.6217;GABAERGIC NEURON#0.6212;FACTOR I#0.6116;FORCED SWIM TEST#0.6108;EPITHELIAL CELL#0.6065;MORPHOGENESIS#0.6031;CELL DEATH#0.6003
202151	MESENCHYMAL STEM CELL DIFFERENTIATION#0.7935;STEM CELL DIFFERENTIATION#0.7709;NUCLEAR EXPORT#0.7670;CELL DIFFERENTIATION#0.7565;MESENCHYMAL STEM CELL#0.7341;STEM CELL#0.7287
2021	DNA DEGRADATION#1.0604;DNASE I#1.0598;CASPASE-INDEPENDENT APOPTOSIS#1.0539;APOPTOSIS INDUCING FACTOR#1.0508;DNASE#1.0423;TELOMERASE ACTIVITY#1.0416;CASPASE-INDEPENDENT CELL DEATH#1.0333;MTDNA#1.0321;NUCLEASE ACTIVITY#1.0274;CYTOCHROME C#1.0253;CYTOPLASM#1.0177;APOPTOSIS#1.0107;MITOCHONDRIA#1.0095;DNA FRAGMENTATION#1.0030;POLY ADP RIBOSE#1.0029;T CELL#0.9982;MITOCHONDRIAL DNA#0.9976;RIBOSE#0.9935;CYTOCHROME C RELEASE#0.9927;CASPASE ACTIVATION#0.9904;APOPTOTIC#0.9862;MITOCHONDRIAL INTERMEMBRANE SPACE#0.9851;CELL DEATH#0.9832;APOPTOTIC CELL DEATH#0.9824;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9777;MITOCHONDRIAL MEMBRANE#0.9776;PROGRAMMED CELL DEATH#0.9770;CASPASE INHIBITOR#0.9760;CELL CYCLE#0.9713;SIGNALING PATHWAY#0.9692;CANCER CELL#0.9674;REACTIVE OXYGEN SPECIES#0.9674;INDUCTION OF APOPTOSIS#0.9646;B CELL#0.9631;ISCHEMIA#0.9629;CELL CYCLE ARREST#0.9578;CYTOTOXICITY#0.9545;MITOCHONDRION#0.9506;MITOCHONDRIAL PERMEABILITY TRANSITION#0.9439;CISPLATIN#0.9407;DNA REPLICATION#0.9338;GENE EXPRESSION#0.9271;CLEAVED CASPASE 3#0.9208;CELL PROLIFERATION#0.9166;CARDIOMYOCYTE#0.9102;MTDNA REPLICATION#0.9083;ENDOPLASMIC RETICULUM#0.9079;ENDONUCLEASE ACTIVITY#0.9078;CEREBRAL ISCHEMIA#0.9060;AUTOPHAGY#0.8997;G1 PHASE#0.8920;OUTER MITOCHONDRIAL MEMBRANE#0.8858;PERMEABILITY TRANSITION PORE#0.8858;TUMOR CELLS#0.8817;PROTEIN KINASE#0.8815;BREAST CANCER#0.8713;DEATH RECEPTOR#0.8669;EPITHELIAL CELL#0.8619;CASPASE ACTIVITY#0.8619;SQUAMOUS CELL CARCINOMA#0.8609;ROS GENERATION#0.8585;ENDOTHELIAL CELL#0.8581;CELL GROWTH#0.8561;PROSTATE CANCER#0.8534;OUTER MEMBRANE#0.8501;BREAST CANCER CELL#0.8418;TOXICITY#0.8352;HYPOXIA#0.8297;M PHASE#0.8295;B CELL LYMPHOMA#0.8289;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.8231;MACROPHAGE#0.8221;MITOCHONDRIAL TRANSCRIPTION#0.8120;T LYMPHOCYTE#0.8097;N-ACETYLCYSTEINE#0.8095;ENDOPLASMIC RETICULUM STRESS#0.8080;FOCAL CEREBRAL ISCHEMIA#0.8047;DNA FRAGMENTATION FACTOR#0.7979;MITOCHONDRIAL DAMAGE#0.7958;TRANSCRIPTION FACTOR#0.7952;HAIR CELL#0.7931;TUBULAR EPITHELIAL CELL#0.7924;EXONUCLEASE ACTIVITY#0.7888;APOPTOTIC PROCESS#0.7885;COLON CANCER#0.7881;RNA INTERFERENCE#0.7619;S PHASE#0.7590;DNA BINDING#0.7250;ASTROCYTE#0.7217;MIDDLE CEREBRAL ARTERY#0.7106;CEREBRAL ARTERY#0.7103;STAUROSPORINE#0.7087;CERVICAL#0.7072;ANION CHANNEL#0.7068;ACETYLCYSTEINE#0.7046;NECROTIC#0.6972;ORGANELLE#0.6959;MITOCHONDRIAL LOCALIZATION#0.6899;HUMAN BREAST CANCER#0.6898;SKELETAL MUSCLE#0.6868;MITOCHONDRIAL GENOME#0.6844;ACTIVE CASPASE 3#0.6835;HEAT SHOCK PROTEIN#0.6766;ARTERY#0.6754;DNASE ACTIVITY#0.6715;SUPEROXIDE DISMUTASE#0.6586;L-CYSTEINE#0.6526;SENESCENCE#0.6518;MITOCHONDRIAL MEMBRANE PERMEABILITY#0.6491;DNA REPAIR#0.6489;TUMOR NECROSIS FACTOR#0.6454;5'-3' EXONUCLEASE ACTIVITY#0.6408;CASPASE-3 ACTIVITY#0.6397;ORAL SQUAMOUS CELL CARCINOMA#0.6290;NEURONAL CELL DEATH#0.6248;MACROPHAGE APOPTOSIS#0.6226;MITOCHONDRIAL DNA REPLICATION#0.6223;GLUTATHIONE#0.6208;NITRIC OXIDE#0.6125;MITOCHONDRIAL MEMBRANE PERMEABILIZATION#0.6103;MUSCLE ATROPHY#0.6052;PROPIDIUM#0.6004;PHOSPHATIDYLSERINE#0.6003
202243	CELL MOTILITY#0.9098
2022	TGF-BETA RECEPTOR COMPLEX#1.0799;SOLUBLE VASCULAR ENDOTHELIAL#1.0692;TGF-BETA BINDING#1.0542;FACTOR VIII#1.0483;TYROSINE KINASE 1#1.0417;RECEPTOR COMPLEX#1.0401;HUMAN LEUKOCYTE ANTIGEN#1.0379;RENAL FIBROSIS#1.0374;ACTIVIN RECEPTOR#1.0372;ACTIVATED MONOCYTES#1.0371;ATORVASTATIN#1.0369;PLACENTAL GROWTH FACTOR#1.0329;SELECTIN#1.0272;ATHEROSCLEROTIC#1.0271;INTRACRANIAL ANEURYSM#1.0260;ORAL SUBMUCOUS FIBROSIS#1.0236;HEREDITARY HAEMORRHAGIC TELANGIECTASIA#1.0232;BREAST CARCINOMA#1.0217;ENDOTHELIAL NITRIC OXIDE#1.0211;LARYNGEAL CARCINOMA#1.0189;FLOW CYTOMETRY ANALYSIS#1.0181;NITRIC OXIDE SYNTHASE#1.0170;SYNCYTIOTROPHOBLAST#1.0162;LARYNGEAL SQUAMOUS CELL CARCINOMA#1.0159;HYPOXIA INDUCIBLE FACTOR#1.0140;OVARIAN CANCER#1.0119;IMMUNOTOXIN#1.0108;PROSTATE CANCER#1.0100;CELL MEMBRANE#1.0099;GROWTH FACTOR RECEPTOR#1.0095;BREAST CANCER PATIENTS#1.0086;TROPHOBLAST CELL#1.0084;NIGRIN B#1.0078;HEREDITARY HEMORRHAGIC TELANGIECTASIA#1.0073;ENDOTHELIAL CELL PROLIFERATION#1.0073;STEM CELL MARKER#1.0069;CERVICAL#1.0069;VASCULAR ENDOTHELIAL CELL#1.0063;VASCULAR ENDOTHELIUM#1.0059;ORAL MUCOSA#1.0046;ENDOMETRIUM#1.0042;POSITRON EMISSION TOMOGRAPHY#1.0041;RENAL CELL CARCINOMA#1.0038;LYMPHATIC VESSEL#1.0033;TRANSFORMING GROWTH FACTOR BETA#1.0022;OVARIAN#1.0020;VASCULAR CELL#1.0010;PERICYTE#1.0009;DISEASE FREE SURVIVAL#1.0006;NITRIC OXIDE#1.0003;CELL ADHESION MOLECULE#1.0001;MONOCYTE#0.9996;PLASMA PROTEIN#0.9993;TYROSINE KINASE RECEPTOR#0.9990;PRE-ECLAMPSIA#0.9990;TUMOR TISSUES#0.9989;HEPATOCELLULAR CARCINOMA#0.9983;HEMATOPOIETIC CELL#0.9982;TROPHOBLAST#0.9978;HEMORRHAGIC#0.9967;CANCER STEM CELL#0.9965;LEUKOCYTE#0.9960;TRANSFORMING GROWTH FACTOR#0.9958;COLORECTAL#0.9955;ECLAMPSIA#0.9952;LYMPH NODE METASTASIS#0.9947;CELL FRACTION#0.9946;COLORECTAL CANCER#0.9941;SQUAMOUS CELL CARCINOMA#0.9941;ADENOCARCINOMA#0.9934;SMOOTH MUSCLE ACTIN#0.9932;SIGNALLING PATHWAY#0.9931;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9931;ENDOTHELIAL GROWTH FACTOR#0.9928;COLORECTAL CARCINOMA#0.9927;BONE MORPHOGENETIC PROTEIN#0.9921;PLATELET-DERIVED GROWTH FACTOR#0.9915;CELL ADHESION#0.9909;PANCREATIC CANCER#0.9904;CELL SURFACE ANTIGEN#0.9903;LOW DENSITY LIPOPROTEIN#0.9903;MICROPARTICLE#0.9902;SIGNAL TRANSDUCTION#0.9900;BREAST CANCER#0.9896;ENDOTHELIUM#0.9892;NORMAL ORAL MUCOSA#0.9885;VASCULAR SMOOTH MUSCLE CELL#0.9880;MESENCHYMAL CELL#0.9878;ENDOTHELIAL CELL#0.9876;MESENCHYMAL PROGENITOR CELL#0.9874;MACROPHAGE#0.9872;HYPOXIA#0.9871;ORAL SQUAMOUS CELL CARCINOMA#0.9869;CELL SURFACE#0.9860;INHIBIN#0.9859;C REACTIVE PROTEIN#0.9858;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9858;GROWTH FACTOR#0.9856;VASCULAR DISEASE#0.9853;PULMONARY ARTERIAL HYPERTENSION#0.9850;INSULIN-LIKE GROWTH FACTOR#0.9846;LYMPH NODE#0.9842;ATHEROSCLEROSIS#0.9837;CELL MIGRATION#0.9829;HUMAN UMBILICAL VEIN#0.9827;HEMATOPOIETIC STEM CELL#0.9825;UMBILICAL VEIN#0.9825;MYOBLAST#0.9823;SIGNALING PATHWAY#0.9822;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9821;BLOOD VESSEL#0.9813;AMNIOTIC FLUID#0.9813;LUNG CANCER#0.9801;ENDOTHELIAL PROGENITOR CELL#0.9800;TUMOR NECROSIS FACTOR#0.9796;BONE MARROW STROMAL CELL#0.9795;SMOOTH MUSCLE#0.9794;CELL MOTILITY#0.9791;MICROVASCULAR ENDOTHELIAL CELL#0.9790;EPIDERMAL GROWTH FACTOR#0.9788;BONE MARROW STROMAL#0.9783;SMOOTH MUSCLE CELL#0.9778;TUBE FORMATION#0.9777;T LYMPHOCYTE#0.9777;HEMATOPOIESIS#0.9776;STEM CELL LIKE#0.9776;QUANTITATIVE REAL TIME#0.9774;ARTERIOVENOUS MALFORMATION#0.9768;CANCER CELL#0.9763;MICRO VESSEL DENSITY#0.9760;PLACENTA GROWTH FACTOR#0.9757;ANGIOGENESIS#0.9754;WOUND HEALING#0.9751;LUNG CARCINOMA#0.9750;HYPOXIC#0.9743;MYOCARDIAL INFARCTION#0.9741;PRO-INFLAMMATORY#0.9739;ENDOTHELIAL CELL MIGRATION#0.9737;METASTATIC BREAST CANCER#0.9737;YOLK SAC#0.9736;B CELL#0.9731;FOCAL ADHESION#0.9731;FIBROBLAST GROWTH FACTOR#0.9729;MARROW STROMAL CELLS#0.9729;PROTEIN KINASE#0.9728;MUSCLE CELL#0.9725;SENESCENCE#0.9721;TUMOR CELLS#0.9720;OSTEOCYTE#0.9718;DERMAL FIBROBLAST#0.9714;HEPATOCYTE GROWTH FACTOR#0.9713;FORMALIN#0.9713;ARTERY#0.9710;CONNECTIVE TISSUE#0.9701;TUMOR SUPPRESSOR#0.9699;CORONARY ARTERY#0.9699;TRANSCRIPTION FACTOR#0.9696;HEPATIC STELLATE CELL#0.9695;DENTAL PULP#0.9692;PULMONARY HYPERTENSION#0.9691;CERVICAL CANCER#0.9690;CELL ACTIVATION#0.9683;STROMA#0.9680;REVERSE TRANSCRIPTION#0.9678;PERIODONTAL LIGAMENT#0.9674;HEME OXYGENASE 1#0.9665;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9665;IMMUNE RESPONSE#0.9661;EMBRYONIC STEM CELL#0.9656;DIABETES MELLITUS#0.9654;GESTATION#0.9653;CHONDROGENESIS#0.9652;FETAL GROWTH RESTRICTION#0.9646;ADIPOGENESIS#0.9643;ADIPOSE-DERIVED STEM CELL#0.9637;ALIZARIN RED STAINING#0.9637;DENTAL PULP STEM CELL#0.9636;APOPTOTIC#0.9635;STROMAL VASCULAR FRACTION#0.9635;HYPERTENSION#0.9633;UMBILICAL CORD BLOOD#0.9631;PROTEINURIA#0.9628;ADULT STEM CELL#0.9626;INFLAMMATORY RESPONSE#0.9623;ISCHEMIA#0.9617;OSTEOGENESIS#0.9616;CELL GROWTH#0.9614;PLURIPOTENT STEM CELL#0.9613;PERIPHERAL BLOOD#0.9612;CHONDROCYTE#0.9611;COLLAGEN TYPE I#0.9611;VASCULOGENESIS#0.9610;TRANSCRIPTASE#0.9609;EPITHELIAL CELL#0.9609;T CELL#0.9609;BONE FORMATION#0.9609;COLONY-STIMULATING FACTOR#0.9606;APOPTOSIS#0.9598;HYPERCHOLESTEROLEMIA#0.9595;CORD BLOOD#0.9591;OSTEOARTHRITIS#0.9588;POLYMERASE CHAIN REACTION#0.9579;MONONUCLEAR CELLS#0.9579;BREAST CANCER CELL#0.9577;GRANULOCYTE#0.9575;CELL PROLIFERATION#0.9575;HEMORRHAGE#0.9572;ALKALINE PHOSPHATASE#0.9571;ALKALINE PHOSPHATASE ACTIVITY#0.9571;HUMAN MESENCHYMAL STEM#0.9570;MESENCHYMAL STROMAL CELL#0.9569;OSTEOBLAST#0.9569;ADIPOCYTE#0.9567;MULTIPOTENT STEM CELL#0.9567;AMNIOTIC MEMBRANE#0.9564;EXTRACELLULAR MATRIX#0.9564;PHOSPHATASE ACTIVITY#0.9564;CELL CYCLE#0.9560;AMNION#0.9560;STEM CELL#0.9556;HUMAN ADIPOSE TISSUE#0.9552;STROMAL CELL#0.9551;URETERAL OBSTRUCTION#0.9549;COLLAGENASE#0.9548;PROGENITOR CELL#0.9543;GENE EXPRESSION#0.9541;COLLAGEN TYPE II#0.9539;DIGESTION#0.9539;TISSUE REGENERATION#0.9536;CELL DIFFERENTIATION#0.9534;G-CSF#0.9533;BEVACIZUMAB#0.9530;STROMAL STEM CELL#0.9529;PRECURSOR CELL#0.9523;MESENCHYMAL STEM CELL#0.9520;LECTIN#0.9518;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9516;UMBILICAL CORD#0.9507;PLASMA MEMBRANE#0.9503;BONE MARROW#0.9497;MINERALIZATION#0.9492;ADIPOSE TISSUE#0.9489;COLONY-FORMING CELL#0.9486;ENDOMETRIAL CANCER#0.9471;CIRCULATING ENDOTHELIAL CELL#0.9470;CHEMOKINE RECEPTOR#0.9470;LYMPH NODE METASTASES#0.9457;CYTOTROPHOBLAST#0.9448;LIPID DROPLET#0.9432;MITOGEN ACTIVATED PROTEIN#0.9430;MAGNETIC RESONANCE IMAGING#0.9430;REGENERATION#0.9426;HUMAN EMBRYONIC STEM#0.9425;SALIVARY GLAND#0.9424;NEURAL CELL#0.9416;CELL DEATH#0.9412;HUMAN DENTAL PULP#0.9412;IMMUNE CELL#0.9405;EOSIN#0.9396;TOXICITY#0.9396;TRANSMISSION ELECTRON MICROSCOPY#0.9396;BETA-2#0.9375;CARDIOMYOCYTE#0.9373;TISSUE GROWTH FACTOR#0.9367;MESANGIAL CELL#0.9367;PROTEOGLYCAN#0.9355;CYTOPLASM#0.9351;ANGIOGENIC GROWTH FACTORS#0.9351;TUMOR ENDOTHELIAL CELL#0.9349;COLON CARCINOMA#0.9344;MAST CELL#0.9327;T CELL PROLIFERATION#0.9314;ARTERY DISEASE#0.9314;INDUCED PLURIPOTENT STEM CELL#0.9288;REACTIVE OXYGEN SPECIES#0.9286;DENDRITIC CELL#0.9286;SYNOVIUM#0.9283;MYOFIBROBLAST#0.9273;CYTOTOXICITY#0.9270;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9264;EPITHELIAL OVARIAN CANCER#0.9264;NERVOUS SYSTEM#0.9263;PLACENTATION#0.9263;LIVER DISEASE#0.9260;BONE REGENERATION#0.9245;GENETIC DISORDER#0.9245;OXYGENASE#0.9238;ADULT BONE MARROW#0.9225;HELLP SYNDROME#0.9209;STEM CELL ANTIGEN#0.9200;OVARIAN CARCINOMA#0.9200;KIDNEY DISEASE#0.9172;MYOCARDIUM#0.9150;INFLAMMATORY CELL#0.9140;RENAL CARCINOMA#0.9138;SCANNING ELECTRON MICROSCOPY#0.9130;CHONDROBLAST#0.9130;DEXAMETHASONE#0.9127;CELL EXPANSION#0.9119;BONE MARROW CELLS#0.9114;ADIPOGENIC CELL#0.9101;AUTOSOMAL DOMINANT DISEASE#0.9099;STEM CELL FACTOR#0.9086;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9074;NEURAL CREST#0.9065;SUBCUTANEOUS ADIPOSE TISSUE#0.9063;SCLERODERMA#0.9049;GRANULOCYTE COLONY STIMULATING FACTOR#0.9046;STEM CELL TRANSPLANTATION#0.9045;DERMIS#0.9036;OSTEOBLAST DIFFERENTIATION#0.9028;IMMUNE SYSTEM#0.9027;MYELOID CELL#0.8989;ENDOMETRIAL CARCINOMA#0.8985;ENDOTHELIAL MICROPARTICLE#0.8959;ALIZARIN RED S#0.8954;OBESE#0.8954;BONE MARROW ASPIRATE#0.8949;TYPE 1 DIABETES#0.8947;SKELETAL MUSCLE#0.8944;FALSE POSITIVE RATE#0.8929;TELOMERASE ACTIVITY#0.8918;EPITHELIAL MESENCHYMAL TRANSITION#0.8913;HUMAN BREAST CANCER#0.8910;GALECTIN#0.8908;ENDOTHELIAL CELL ACTIVATION#0.8907;CORONARY ARTERY DISEASE#0.8902;CENTRAL NERVOUS SYSTEM#0.8882;DIABETIC NEPHROPATHY#0.8877;NEPHROPATHY#0.8855;CELL DIVISION#0.8835;ASCORBIC ACID#0.8822;PULMONARY ARTERY#0.8820;MOLAR#0.8814;MEGAKARYOCYTE#0.8810;COAGULATION#0.8807;KINASE INHIBITOR#0.8794;SYNOVIAL FLUID#0.8777;QUANTITATIVE REVERSE TRANSCRIPTION#0.8772;SPINAL CORD#0.8772;HEPARIN#0.8767;S PHASE#0.8762;GROWTH FACTOR BINDING#0.8757;CHRONIC KIDNEY DISEASE#0.8743;FAT PAD#0.8724;ZONA PELLUCIDA#0.8719;RHEUMATOID ARTHRITIS#0.8711;FETAL LIVER#0.8702;AUTOPHAGY#0.8692;BASEMENT MEMBRANE#0.8686;PLACENTAL DEVELOPMENT#0.8682;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8676;RECEPTOR LIGAND#0.8673;NEURAL STEM CELL#0.8671;PROGESTERONE#0.8666;MURAL CELL#0.8642;ENDOPLASMIC RETICULUM#0.8617;KERATINOCYTE#0.8614;PITUITARY ADENOMA#0.8613;MORPHOGENESIS#0.8593;CELL ASSOCIATED#0.8593;ANEMIA#0.8589;ACUTE MYOCARDIAL INFARCTION#0.8570;LYMPHOCYTE PROLIFERATION#0.8558;COLON CANCER#0.8543;HIGH FAT DIET#0.8531;DRUG RESISTANCE#0.8521;CYTOTOXIC T-LYMPHOCYTE#0.8499;ADIPOSE STEM CELLS#0.8484;ORAL CAVITY#0.8481;PRAVASTATIN#0.8467;DECIDUA#0.8455;OSTEOGENIC CELL#0.8453;ERYTHROCYTE#0.8452;ADIPOSE-DERIVED STROMAL CELL#0.8434;HEAT SHOCK PROTEIN#0.8430;HUMAN PERIODONTAL LIGAMENT#0.8395;ESOPHAGEAL CANCER#0.8370;ARTERIOLE#0.8364;GM-CSF#0.8359;UNILATERAL URETERAL OBSTRUCTION#0.8347;CLEAR CELL RENAL CELL CARCINOMA#0.8338;HEART DISEASE#0.8334;EXTRACELLULAR REGION#0.8325;HEMANGIOMA#0.8319;MECHANISM OF ACTION#0.8295;PEROXISOME#0.8291;VENULE#0.8285;UTERINE ARTERY DOPPLER#0.8282;AUTOIMMUNE DISEASE#0.8275;BRAIN NATRIURETIC PEPTIDE#0.8266;UROKINASE#0.8257;LIVER CIRRHOSIS#0.8248;COLLAGEN SYNTHESIS#0.8236;UTERUS#0.8236;G1 PHASE#0.8234;PSORIASIS#0.8209;URIC ACID#0.8193;PROSTATE SPECIFIC ANTIGEN#0.8190;VEGF SIGNALING#0.8187;MULTIPLE MYELOMA#0.8182;MICROVESICLE#0.8160;BONE MARROW STEM CELL#0.8153;HEART DEVELOPMENT#0.8119;SIGNAL TRANSDUCER#0.8103;NEUTROPHIL#0.8101;HEMANGIOBLAST#0.8097;MATURE ENDOTHELIAL CELL#0.8095;MYELOID LEUKEMIA#0.8065;GOOD MANUFACTURING PRACTICE#0.8036;NUCLEUS PULPOSUS#0.8017;LOCALIZED PROSTATE CANCER#0.8005;GROWTH DIFFERENTIATION FACTOR#0.7999;SEVERE PRE-ECLAMPSIA#0.7982;AMELOBLASTOMA#0.7981;MSC PROLIFERATION#0.7975;LYMPHANGIOGENESIS#0.7972;TERATOMA#0.7969;EWING SARCOMA#0.7958;EXTRACELLULAR VESICLE#0.7952;ERYTHROID PROGENITOR#0.7950;EXOSOME#0.7932;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.7927;DIABETIC RETINOPATHY#0.7926;LIVER X RECEPTOR#0.7921;UMBILICAL ARTERY#0.7882;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7865;NEURONAL CELLS#0.7863;TIGHT JUNCTION#0.7861;TRANSDIFFERENTIATION#0.7852;FLUORESCEIN#0.7839;THROMBOSIS#0.7815;TUMOR INITIATING CELL#0.7800;PANCREATIC DUCTAL ADENOCARCINOMA#0.7792;EMBRYOID BODY#0.7789;EARLY BREAST CANCER#0.7788;TRANSMEMBRANE RECEPTOR#0.7787;LEWIS LUNG CARCINOMA#0.7779;HIGH POWER FIELD#0.7770;INTERVERTEBRAL DISC#0.7768;HAIR FOLLICLE#0.7762;MULTIPOTENT STROMAL CELLS#0.7760;FACTOR I#0.7756;PERIOSTEUM#0.7734;OSSIFICATION#0.7732;COLITIS#0.7720;TISSUE DAMAGE#0.7716;CONJUGATION#0.7686;PERIODONTAL LIGAMENT STEM CELL#0.7686;CD8+ T CELL#0.7685;SORAFENIB#0.7684;EDEMA#0.7682;HINDLIMB#0.7671;RECEPTOR ANTAGONIST#0.7668;NEUROFILAMENT#0.7657;MYOEPITHELIAL CELL#0.7639;BONE MORPHOGENIC PROTEIN#0.7623;MYELODYSPLASTIC SYNDROME#0.7622;HYALURONIC ACID#0.7612;TELOMERE#0.7604;ARGININE#0.7592;CHORIOCARCINOMA#0.7585;PLACENTAL ABRUPTION#0.7575;ACUTE MYELOID LEUKEMIA#0.7573;LIVER CANCER#0.7561;TYPE 2 DIABETES#0.7561;CD4+ T CELL#0.7552;CISPLATIN#0.7550;ENDOMETRIOSIS#0.7542;VENOUS BLOOD#0.7539;DEDIFFERENTIATION#0.7532;CELL COUNTING KIT#0.7522;CEREBRAL ARTERY#0.7512;GLIAL CELL#0.7488;MOTHERS AGAINST DECAPENTAPLEGIC#0.7482;SUPEROXIDE DISMUTASE#0.7480;ANTIPHOSPHOLIPID SYNDROME#0.7471;FIBROBLAST ACTIVATION PROTEIN#0.7468;VASCULAR ENDOTHELIAL CADHERIN#0.7452;CHONDROGENIC CELL#0.7447;MESENCHYME#0.7439;LEUKOCYTE ADHESION#0.7438;GROWTH PATTERN#0.7434;VASODILATATION#0.7432;INTERSTITIAL CELL#0.7428;PARENCHYMA#0.7408;LUNG DISEASE#0.7404;RIBOSOME#0.7396;CANCER SPECIFIC SURVIVAL#0.7394;EXTRAVILLOUS TROPHOBLAST CELL#0.7389;STEM CELL DIFFERENTIATION#0.7383;FIBROBLAST ACTIVATION#0.7379;SPINAL CORD INJURY#0.7337;PHOSPHATIDYLSERINE#0.7334;HEMATOPOIETIC PROGENITOR CELL#0.7316;CETUXIMAB#0.7305;FEMUR#0.7300;GRAFT VERSUS HOST#0.7294;REGULATION OF ANGIOGENESIS#0.7293;ESTROGEN RECEPTOR#0.7288;PLEOMORPHIC ADENOMA#0.7287;IFN-GAMMA#0.7279;GASTROINTESTINAL TRACT#0.7274;QUIESCENCE#0.7272;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7272;LUPUS ERYTHEMATOSUS#0.7269;LUMINAL#0.7268;BRONCHOPULMONARY DYSPLASIA#0.7263;TESTOSTERONE#0.7250;SIGNALING MOLECULE#0.7240;GINGIVA#0.7210;ERYTHROID CELL#0.7207;MACULAR DEGENERATION#0.7205;CHEMOTAXIS#0.7187;CONNEXIN#0.7173;RAT BONE MARROW#0.7171;WHITE BLOOD CELL#0.7166;MARROW STEM CELLS#0.7151;TOLL LIKE RECEPTOR#0.7143;MIDDLE CEREBRAL ARTERY#0.7112;HUMAN DERMAL FIBROBLAST#0.7110;COMPLEX I#0.7104;M PHASE#0.7099;ENDOTHELIAL CELL DYSFUNCTION#0.7052;ADVERSE PREGNANCY OUTCOME#0.7050;NON-SMALL CELL LUNG CARCINOMA#0.7019;PROTEIN KINASE C#0.7014;MESOTHELIAL CELL#0.7004;URINARY PROTEIN#0.6998;AGE RELATED MACULAR DEGENERATION#0.6968;NERVE GROWTH FACTOR#0.6918;R/AMP#0.6904;ONCOGENIC#0.6882;POSITIVE PREDICTIVE VALUE#0.6868;RNA INTERFERENCE#0.6854;MULTIPOTENT PROGENITOR CELL#0.6844;INVASIVE BREAST CANCER#0.6812;VASODILATION#0.6811;LOCALISATION#0.6804;MICROTUBULE#0.6801;MACROPHAGE INFLAMMATORY PROTEIN#0.6798;CARDIOVASCULAR RISK FACTOR#0.6794;MITOCHONDRIA#0.6775;ASTROCYTE#0.6765;LIVER METASTASIS#0.6743;LATE PREGNANCY#0.6734;SOMATIC STEM CELL#0.6730;KNEE JOINT#0.6723;ALZHEIMER'S DISEASE#0.6722;ACUTE LEUKEMIA#0.6720;CELLULAR SENESCENCE#0.6712;LEUKOCYTE TRAFFICKING#0.6705;MICROVILLI#0.6704;METFORMIN#0.6702;CARDIOVASCULAR SYSTEM#0.6693;TRANSLATION INITIATION#0.6687;PROTON PUMP INHIBITOR#0.6687;PEMPHIGUS VULGARIS#0.6686;ERYTHROBLAST#0.6685;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6673;ADJACENT NORMAL TISSUE#0.6665;PARATHYROID#0.6664;PROTON PUMP#0.6664;BIOTIN#0.6662;NEURODEGENERATIVE DISEASE#0.6654;DENTAL PULP CELL#0.6630;FAT CELL#0.6626;INDUCIBLE NITRIC OXIDE#0.6613;GREEN FLUORESCENCE PROTEIN#0.6597;FETAL LIVER KINASE#0.6594;LIMB ISCHEMIA#0.6581;EXTRACELLULAR MATRIX COMPONENT#0.6561;MALARIA#0.6556;ADIPOCYTE DIFFERENTIATION#0.6550;INTIMA MEDIA THICKNESS#0.6543;MYOSIN HEAVY CHAIN#0.6536;NEGATIVE PREDICTIVE VALUE#0.6533;CELL REPLACEMENT THERAPY#0.6527;PROGENITOR STEM CELL#0.6525;5-FUR#0.6521;WORLD HEALTH ORGANIZATION#0.6518;VEGF-AS#0.6508;EPITHELIAL STEM CELL#0.6503;WEIGHT LOSS#0.6498;CELLULAR ADHESION MOLECULE#0.6497;SCANNING ELECTRON MICROSCOPE#0.6472;ADENOID CYSTIC CARCINOMA#0.6471;LEYDIG CELL#0.6461;X CHROMOSOME#0.6448;ASPIRIN#0.6444;5 FLUOROURACIL#0.6438;HUMAN AMNIOTIC EPITHELIAL#0.6433;PORTAL VEIN#0.6419;FOCAL ADHESION KINASE#0.6415;SCHWANN CELL#0.6412;HEPATITIS C#0.6409;FATTY ACID BINDING#0.6408;CERVIX#0.6407;AKT SIGNALING#0.6392;ANGIODYSPLASIA#0.6386;LYMPHATIC VESSEL DENSITY#0.6380;NEUROBLASTOMA#0.6362;ANGIOTENSIN CONVERTING ENZYME#0.6358;RESPONSE TO BMP#0.6345;FIBRINOGEN#0.6338;LYMPHATIC ENDOTHELIAL CELL#0.6296;EPITHELIAL TO MESENCHYMAL#0.6292;UVEAL MELANOMA#0.6291;MICROTUBULE ASSOCIATED PROTEIN#0.6283;HEALTHY CONTROL GROUP#0.6271;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6254;METASTASIS FREE SURVIVAL#0.6236;RETINAL VASCULAR PERMEABILITY#0.6233;RESPONSE TO HYPOXIA#0.6231;72-HOURS#0.6229;HEMOLYSIS#0.6227;ADVENTITIA#0.6221;MENSTRUAL CYCLE#0.6215;ZONULA OCCLUDENS#0.6215;COLORECTAL ADENOCARCINOMA#0.6206;PEMPHIGUS#0.6203;GANGLION CELLS#0.6183;ANGIOTENSIN RECEPTOR#0.6171;ANAEMIA#0.6165;HEPARIN BINDING#0.6164;SIDE-POPULATION CELL#0.6124;VACUOLE#0.6117;ANGIOSARCOMA#0.6112;PERIODONTAL DISEASE#0.6103;TISSUE REMODELING#0.6103;TISSUE ENGINEERED BONE#0.6099;HUMAN CARDIAC FIBROBLASTS#0.6096;ADJUSTED ODDS RATIO#0.6092;NATURAL KILLER CELL#0.6091;EXCRETION#0.6090;T CELL ACTIVATION#0.6083;PRIMITIVE HEMATOPOIESIS#0.6068;OUTGROWTH ENDOTHELIAL CELLS#0.6068;CIRCULATING ENDOTHELIAL PROGENITOR#0.6054;HOST CELL#0.6053;HUMAN LEUCOCYTE ANTIGEN#0.6042;ERYTHROPOIESIS#0.6038;PACLITAXEL#0.6034;THROMBIN RECEPTOR#0.6028;FORESKIN#0.6020;ECTOPIC BONE FORMATION#0.6009;SUNITINIB#0.6006
202309	B CELL#0.8979
202333	CARDIOMYOPATHY#1.0017;STRIATED MUSCLE#0.9678;PROTEIN KINASE A#0.9390;PROTEIN KINASE#0.9301;SKELETAL MUSCLE#0.8489;MUSCULAR DYSTROPHY#0.7927;Z DISC#0.6583;DUCHENNE MUSCULAR DYSTROPHY#0.6527;M BAND#0.6227;CALCINEURIN SIGNALING#0.6160
2023	PROMOTER BINDING#1.0669;PHOSPHOGLYCERATE MUTASE#1.0653;ATP SYNTHASE#1.0620;GLYCERALDEHYDE-3-PHOSPHATE#1.0578;BINDING PROTEIN 1#1.0547;PROTEIN DISULFIDE ISOMERASE#1.0532;PYRUVATE KINASE#1.0499;ENOLASE ACTIVITY#1.0491;PHOSPHOGLYCERATE KINASE#1.0466;CREATINE KINASE#1.0443;TRIOSE PHOSPHATE ISOMERASE#1.0437;HEAT SHOCK PROTEIN#1.0403;PYRUVATE#1.0375;GLUTATHIONE#1.0293;CELL GROWTH#1.0264;SUPEROXIDE DISMUTASE#1.0252;LUNG CANCER#1.0249;GLUCOSE-6-PHOSPHATE#1.0192;CELL MIGRATION#1.0152;PHOSPHOGLYCERATE MUTASE 1#1.0130;CREATINE#1.0113;DNA BINDING#1.0100;T CELL#1.0089;CELL SURFACE#1.0079;GROWTH FACTOR#1.0052;CELL CYCLE#1.0040;HYPOXIA#1.0023;SIGNALING PATHWAY#0.9985;RHEUMATOID ARTHRITIS#0.9983;PLASMINOGEN ACTIVATION#0.9982;GLYCOLYSIS#0.9973;BREAST CARCINOMA#0.9966;ADENOCARCINOMA#0.9959;EPITHELIAL CELL#0.9943;RIBOSOMAL PROTEIN#0.9942;BREAST CANCER#0.9932;TRANSCRIPTION FACTOR#0.9931;CELL PROLIFERATION#0.9925;PANCREATIC CANCER#0.9904;CELL DEATH#0.9902;BREAST CANCER CELL#0.9885;CANCER CELL#0.9883;APOPTOSIS#0.9870;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.9866;PROTEIN KINASE#0.9834;MONOCYTE#0.9830;IMMUNE RESPONSE#0.9821;AUTOIMMUNE DISEASE#0.9820;FRUCTOSE#0.9806;ENDOTHELIAL CELL#0.9803;HYPOXIA INDUCIBLE FACTOR#0.9801;SQUAMOUS CELL CARCINOMA#0.9776;GENE EXPRESSION#0.9768;PHOSPHOENOLPYRUVATE#0.9756;HEPATOCELLULAR CARCINOMA#0.9746;MALATE DEHYDROGENASE#0.9725;ENDOTHELIAL GROWTH FACTOR#0.9719;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9719;GLUCOSE METABOLISM#0.9702;PERIPHERAL BLOOD#0.9676;EXTRACELLULAR MATRIX#0.9664;LYSINE#0.9651;LASER DESORPTION IONIZATION#0.9638;UBIQUITIN#0.9595;TUMOR SUPPRESSOR#0.9582;B CELL#0.9561;MACROPHAGE#0.9493;PROSTATE CANCER#0.9452;CYTOPLASM#0.9430;BASAL CELL#0.9399;FIBRINOGEN#0.9364;CYTOCHROME C#0.9359;FATTY ACID BINDING#0.9211;TRANSLATION INITIATION#0.9199;TUMOR CELLS#0.9176;POLYMERASE CHAIN REACTION#0.9165;POST-TRANSLATIONAL MODIFICATION#0.9157;ALZHEIMER'S DISEASE#0.9131;VIRULENCE#0.9009;LUNG ADENOCARCINOMA#0.8996;CELL WALL#0.8982;PLASMA MEMBRANE#0.8982;ADENYLATE KINASE#0.8980;HYPOXIC#0.8935;LYMPH NODE#0.8896;PANCREATIC DUCTAL ADENOCARCINOMA#0.8885;CARBOHYDRATE METABOLISM#0.8875;GLUCOSE UPTAKE#0.8849;APOPTOTIC#0.8805;NUCLEOSIDE DIPHOSPHATE KINASE#0.8785;DIGESTION#0.8758;EPITHELIAL MESENCHYMAL TRANSITION#0.8716;PRO-INFLAMMATORY#0.8715;PROTEASOME#0.8704;INFLAMMATORY RESPONSE#0.8682;SIGNAL TRANSDUCTION#0.8651;NEUTROPHIL#0.8647;ANION CHANNEL#0.8609;TRANSLATION ELONGATION FACTOR#0.8588;PROTEIN SYNTHESIS#0.8578;TRANSLATION ELONGATION#0.8570;REVERSE TRANSCRIPTION#0.8563;FRUCTOSE BISPHOSPHATE ALDOLASE#0.8563;UROKINASE#0.8545;TUMOR TISSUES#0.8525;NERVOUS SYSTEM#0.8498;GLUTAMINE#0.8492;GLUCOSE REGULATED PROTEIN#0.8487;MONONUCLEAR CELLS#0.8450;CYCLOPHILIN#0.8438;IGG ANTIBODY#0.8369;COLORECTAL#0.8362;QUANTITATIVE REAL TIME#0.8343;CERVICAL#0.8330;GUANIDINE#0.8287;DRUG RESISTANCE#0.8266;ARGININE#0.8255;CELL MEMBRANE#0.8225;REACTIVE OXYGEN SPECIES#0.8213;MITOCHONDRIA#0.8212;GLUTAMATE DEHYDROGENASE#0.8155;CENTRAL NERVOUS SYSTEM#0.8122;NUCLEOTIDE BINDING#0.8111;LUPUS ERYTHEMATOSUS#0.8106;PROTEIN PROTEIN INTERACTION#0.8075;STEM CELL#0.8023;NEUROBLASTOMA#0.8013;TRANSLATION INITIATION FACTOR#0.7997;COLORECTAL CANCER#0.7977;GDP DISSOCIATION INHIBITOR#0.7975;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7948;RESPONSE TO HYPOXIA#0.7888;GRANULOSA CELL#0.7846;AKT SIGNALING#0.7821;SURFACE PLASMON RESONANCE#0.7778;ENDOPLASMIC RETICULUM#0.7743;MITOGEN ACTIVATED PROTEIN#0.7712;SMOOTH MUSCLE#0.7700;GLIAL CELL#0.7651;HOST CELL#0.7649;DIPHOSPHATE#0.7622;PROTEIN OXIDATION#0.7617;CONNECTIVE TISSUE#0.7603;OVARIAN#0.7585;CELL ADHESION#0.7574;CYTOTOXICITY#0.7570;AUTOIMMUNITY#0.7536;ADENYLATE#0.7523;LYMPH NODE METASTASIS#0.7509;GALECTIN#0.7507;LUNG CARCINOMA#0.7495;SYNOVIAL FLUID#0.7436;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7377;CYTOCHROME B#0.7360;SPERMATOZOA#0.7350;GLUCONEOGENESIS#0.7320;LECTIN#0.7312;S PHASE#0.7207;ENZYME ACTIVITY#0.7202;PLASTIN#0.7169;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7139;ANGIOGENESIS#0.7121;CATALYTIC ACTIVITY#0.7021;HYPOXIA RESPONSE ELEMENT#0.7011;ESTROGEN RECEPTOR#0.6990;LIVER DISEASE#0.6976;SYSTEMIC AUTOIMMUNE DISEASE#0.6965;MUSCLE CELL#0.6954;TRANSFORMING GROWTH FACTOR#0.6951;CELL DIVISION#0.6926;ASPARTATE#0.6899;VALOSIN CONTAINING PROTEIN#0.6873;TOXICITY#0.6872;DETOXIFICATION#0.6861;HUMAN BREAST CANCER#0.6843;DNA REPLICATION#0.6827;ADENOSINE#0.6822;CORNEAL EPITHELIUM#0.6814;TUBE FORMATION#0.6784;AMINOCAPROIC ACID#0.6765;COLON CANCER#0.6739;UMBILICAL VEIN#0.6725;HEAD AND NECK CANCER#0.6715;NECK CANCER#0.6715;MEMBRANE FRACTION#0.6712;EPIDERMAL GROWTH FACTOR#0.6690;CYCLIC CITRULLINATED PEPTIDE#0.6689;ANCHORAGE INDEPENDENT GROWTH#0.6682;HISTONE DEACETYLASE#0.6668;BREAST CANCER PATIENTS#0.6665;TUMOR ASSOCIATED ANTIGEN#0.6625;RETINAL DEGENERATION#0.6499;INFLAMMATORY BOWEL DISEASE#0.6494;OXIDATIVE PHOSPHORYLATION#0.6477;MYOSIN HEAVY CHAIN#0.6468;BETA GALACTOSIDASE#0.6460;CISPLATIN#0.6454;HUMAN UMBILICAL VEIN#0.6435;KERATINOCYTE#0.6424;GLUTATHIONE PEROXIDASE#0.6421;HUMAN CERVICAL CARCINOMA#0.6347;METHIONINE#0.6296;GUANINE#0.6295;HISTIDINE#0.6294;SELENIUM BINDING#0.6290;PLASMIN ACTIVITY#0.6284;PEPTIDE MASS FINGERPRINTING#0.6250;LUNG DISEASE#0.6243;TCA CYCLE#0.6232;AUTOIMMUNE PANCREATITIS#0.6231;PHOSPHOGLYCERATE DEHYDROGENASE#0.6213;ACID PHOSPHATASE#0.6158;ETHANOL#0.6158;RNA BINDING#0.6155;CANDIDIASIS#0.6137;CERVICAL CANCER#0.6127;NEURODEGENERATIVE DISEASE#0.6104;NITRIC OXIDE#0.6104;GRANULOCYTE#0.6048;L LACTATE DEHYDROGENASE#0.6032;CELL MOTILITY#0.6018
202559	ACTIN CYTOSKELETON#0.9766;RNA BINDING#0.9041;PLASMA MEMBRANE#0.8525;RNA BINDING PROTEIN#0.8283;CALCINEURIN#0.7688;TARGET OF RAPAMYCIN#0.7009;CELL GROWTH#0.6768;ACTIN CYTOSKELETON ORGANIZATION#0.6523;CYTOSKELETON ORGANIZATION#0.6444;RAPAMYCIN#0.6413;TORC2 SIGNALING#0.6270;CYTOSKELETON POLARIZATION#0.6072;TOR COMPLEX#0.6057
2026	BETA-2#1.0557;ENOLASE ACTIVITY#1.0493;TASTE BUD#1.0378;MALIGNANT PLEURAL EFFUSION#1.0342;C REACTIVE PROTEIN#1.0339;ALPHA 1-ANTITRYPSIN#1.0338;CREATINE KINASE#1.0333;INHIBIN#1.0330;CREATINE#1.0305;THYROID TRANSCRIPTION FACTOR#1.0297;THYMIDINE KINASE#1.0292;MICROTUBULE ASSOCIATED PROTEIN#1.0288;HEMOLYSIS#1.0268;FACTOR VIII#1.0242;ACUTE ISCHEMIC STROKE#1.0185;UBIQUITIN#1.0181;GLYCERALDEHYDE-3-PHOSPHATE#1.0177;ACID PHOSPHATASE#1.0172;HEAT SHOCK PROTEIN#1.0171;NEUROFILAMENT#1.0166;CELL ADHESION MOLECULE#1.0145;FACTOR XIIIA#1.0142;STATUS EPILEPTICUS#1.0135;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0129;HYPOXIC ISCHEMIC ENCEPHALOPATHY#1.0116;72-HOURS#1.0113;NEUROLOGICAL DISORDER#1.0107;ESTROGEN RECEPTOR#1.0103;CEREBRAL INFARCTION#1.0101;SMOOTH MUSCLE ACTIN#1.0100;ADRENOCORTICOTROPIC HORMONE#1.0095;SCIATIC NERVE#1.0082;VENOUS BLOOD#1.0080;ALKALINE PHOSPHATASE#1.0076;HIRSCHSPRUNG'S DISEASE#1.0073;TUMOR NECROSIS FACTOR#1.0072;PROGESTERONE#1.0068;CHOLINE#1.0066;AMNIOTIC FLUID#1.0057;SEMINOMA#1.0056;CELL ADHESION#1.0054;FALSE POSITIVE RATE#1.0052;LEUKOCYTE#1.0043;CORONARY ARTERY BYPASS#1.0019;MICROTUBULE#1.0003;SUBSTANCE P#1.0000;SALIVARY GLAND#0.9999;PROSTATE SPECIFIC ANTIGEN#0.9997;MYOEPITHELIAL CELL#0.9996;GLUTAMIC ACID#0.9993;MENINGITIS#0.9992;BIOTIN#0.9991;THYMIDINE#0.9965;GLYCOLYSIS#0.9960;NERVOUS TISSUE#0.9957;RETINOBLASTOMA#0.9951;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9948;TISSUE DAMAGE#0.9945;GLASGOW COMA SCALE#0.9944;PLATELET-DERIVED GROWTH FACTOR#0.9936;LARGE CELL CARCINOMA#0.9929;SMOOTH MUSCLE#0.9929;NEURONAL CELL DEATH#0.9926;CORONARY ARTERY#0.9921;ENDOTHELIAL GROWTH FACTOR#0.9921;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9921;BRAIN DAMAGE#0.9920;NITRIC OXIDE SYNTHASE#0.9914;LUNG CANCER#0.9913;LUNG DISEASE#0.9912;GERM CELL#0.9902;GROWTH FACTOR RECEPTOR#0.9900;OLIGODENDROCYTE#0.9897;COMATOSE#0.9889;GLUTATHIONE#0.9889;NEUROENDOCRINE CELL#0.9888;SPINAL CORD INJURY#0.9885;NEURAL CELL#0.9876;SQUAMOUS CELL CARCINOMA#0.9871;SUPEROXIDE DISMUTASE#0.9870;CARDIAC ARREST#0.9866;ASPARTATE#0.9866;ENDOCRINE CELL#0.9866;CREUTZFELDT JAKOB DISEASE#0.9865;NERVE FIBER#0.9864;PERIPHERAL BLOOD#0.9863;BREAST CARCINOMA#0.9862;DENTATE GYRUS#0.9850;TUMOR CELLS#0.9841;HYPOXIA#0.9838;TRANSCRIPTION FACTOR#0.9836;RENAL CELL CARCINOMA#0.9836;DOPAMINE#0.9836;NITRIC OXIDE#0.9835;GANGLION CELLS#0.9830;LUNG CARCINOMA#0.9829;BASAL CELL#0.9822;ASPHYXIA#0.9822;TUMOR TISSUES#0.9820;RESPONSE TO TREATMENT#0.9819;NERVE ENDING#0.9813;HYPOXIC#0.9811;STEM CELL MARKER#0.9805;CORD BLOOD#0.9802;GLASGOW OUTCOME SCALE#0.9800;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9800;GANGLIONEUROMA#0.9799;ASTROCYTE#0.9799;BREAST CANCER#0.9787;NEGATIVE PREDICTIVE VALUE#0.9786;EPILEPSY#0.9786;MEDULLOBLASTOMA#0.9782;NEURONAL CELLS#0.9781;CAROTID ARTERY#0.9780;POSITIVE PREDICTIVE VALUE#0.9777;GROWTH HORMONE#0.9773;TRAUMATIC BRAIN INJURY#0.9771;GESTATION#0.9769;PITUITARY ADENOMA#0.9768;PHEOCHROMOCYTOMA#0.9768;LUNG ADENOCARCINOMA#0.9763;NERVE GROWTH FACTOR#0.9763;GLUTAMINE#0.9760;THYROID CARCINOMA#0.9760;MACROPHAGE#0.9758;ENTERIC NERVOUS SYSTEM#0.9755;NEURITE#0.9753;STRIATUM#0.9748;NEUROBLAST#0.9747;DEMENTIA#0.9746;MERKEL CELL#0.9745;GRANULAR CELL TUMOR#0.9744;STROMAL CELL#0.9742;DENSE CORE GRANULE#0.9742;GLIAL CELL#0.9739;FORMALIN#0.9739;PEPTIDE HORMONE#0.9736;REVERSE TRANSCRIPTION#0.9732;NEURAL STEM CELL#0.9725;EOSIN#0.9723;GERM CELL TUMORS#0.9723;BRAIN ISCHEMIA#0.9722;BLOOD BRAIN BARRIER#0.9720;B CELL#0.9715;ASTROCYTOMA#0.9714;T CELL#0.9714;CELL CYCLE#0.9713;INTENSIVE CARE UNIT#0.9705;PROTEIN KINASE#0.9703;HYPERTENSION#0.9702;MALIGNANT LYMPHOMA#0.9702;NEUROENDOCRINE TUMOR#0.9701;UMBILICAL CORD#0.9701;MULTIPLE SCLEROSIS#0.9696;INNERVATION#0.9696;EPIDERMAL GROWTH FACTOR#0.9694;PARAGANGLIOMA#0.9693;HEMORRHAGE#0.9693;NEURITE OUTGROWTH#0.9690;RHABDOMYOSARCOMA#0.9689;SPINAL CORD#0.9685;CEREBRAL CORTEX#0.9685;SMALL CELL CARCINOMA#0.9683;NEUROBLASTOMA#0.9681;APOPTOTIC#0.9680;ANDROGEN RECEPTOR#0.9678;RETINOIC ACID#0.9677;INTERMEDIATE FILAMENT#0.9677;SCHWANN CELL#0.9676;ISCHEMIA#0.9676;CEREBRAL ISCHEMIA#0.9671;MERKEL CELL CARCINOMA#0.9669;LYMPH NODE METASTASES#0.9666;OVARIAN#0.9663;BACTERIAL MENINGITIS#0.9661;MIDDLE CEREBRAL ARTERY#0.9661;CEREBRAL ARTERY#0.9659;PROGENITOR CELL#0.9658;CONNECTIVE TISSUE#0.9656;ENDOTHELIAL CELL#0.9653;GASTROINTESTINAL TRACT#0.9651;EDEMA#0.9648;EPITHELIAL CELL#0.9648;LATERAL VENTRICLE#0.9648;THYROID GLAND#0.9648;TERATOMA#0.9646;HEMORRHAGIC#0.9645;CELL DEATH#0.9645;SERTOLI CELL#0.9644;GENE EXPRESSION#0.9643;MUSCLE CELL#0.9641;ISLET CELL TUMOR#0.9639;ARTERY#0.9635;SIGNALING PATHWAY#0.9634;ESOPHAGUS#0.9629;CORTISOL#0.9628;B CELL LYMPHOMA#0.9627;CERVICAL#0.9624;INFLAMMATORY RESPONSE#0.9623;PERIPHERAL NERVE#0.9623;DOPAMINERGIC NEURON#0.9622;SECRETORY GRANULE#0.9621;NEUROPATHY#0.9620;CELL SURFACE#0.9620;CENTRAL NEUROCYTOMA#0.9618;YEAR SURVIVAL RATE#0.9613;GROWTH PATTERN#0.9611;PANCREATIC ISLET#0.9610;SMALL INTESTINE#0.9610;GANGLIONEUROBLASTOMA#0.9609;NEUROTOXICITY#0.9607;ADRENAL GLAND#0.9606;MULTIPLE MYELOMA#0.9605;CELL GROWTH#0.9605;PROSTATE CANCER#0.9604;PITUITARY GLAND#0.9598;CANCER CELL#0.9597;GROWTH FACTOR#0.9597;NON-SMALL CELL LUNG CARCINOMA#0.9596;MAGNETIC RESONANCE IMAGING#0.9596;INTERSTITIAL CELL#0.9592;NEURAL CREST#0.9592;NECROTIC#0.9591;REGENERATION#0.9588;KINASE INHIBITOR#0.9582;TOXICITY#0.9581;PYRUVATE KINASE#0.9579;OLFACTORY RECEPTOR#0.9578;FIBROBLAST GROWTH FACTOR#0.9577;CELL PROLIFERATION#0.9577;APOPTOSIS#0.9576;ADENOCARCINOMA#0.9576;ALZHEIMER'S DISEASE#0.9574;ADENOSINE#0.9572;TRANSMISSION ELECTRON MICROSCOPY#0.9571;URINARY BLADDER#0.9570;CELL DIFFERENTIATION#0.9569;POLYMERASE CHAIN REACTION#0.9569;MELANOCYTE#0.9569;PYRUVATE#0.9568;MESENCHYMAL CELL#0.9568;BLOOD VESSEL#0.9568;PARENCHYMA#0.9566;LYMPH NODE METASTASIS#0.9566;LEIOMYOSARCOMA#0.9560;NERVOUS SYSTEM#0.9556;FRONTAL#0.9555;MEDULLARY CARCINOMA#0.9554;LACTIC ACID#0.9550;CENTRAL NERVOUS SYSTEM#0.9550;NEURODEGENERATIVE DISEASE#0.9547;SMOOTH MUSCLE CELL#0.9545;TEMPORAL LOBE#0.9544;CERVIX#0.9542;NEUROECTODERMAL TUMOR#0.9541;CISPLATIN#0.9540;PINEAL GLAND#0.9539;HISTOGENESIS#0.9536;PARKINSON'S DISEASE#0.9535;NEUROENDOCRINE CARCINOMA#0.9528;CYCLIC AMP#0.9528;REGIONAL LYMPH NODE#0.9524;FINE NEEDLE ASPIRATION#0.9523;NEUROGENESIS#0.9521;BONE MARROW#0.9520;PURKINJE CELL#0.9519;HEMANGIOBLASTOMA#0.9519;ETOPOSIDE#0.9519;PERIPHERAL NERVOUS SYSTEM#0.9518;SERUM ALBUMIN#0.9516;LEYDIG CELL#0.9515;SWELLING#0.9514;ABDOMINAL PAIN#0.9513;BILE DUCT#0.9512;SUBSTANTIA NIGRA#0.9503;EXTRACELLULAR MATRIX#0.9499;COLORECTAL#0.9495;DERMIS#0.9488;STROMA#0.9487;PRECURSOR CELL#0.9486;OPTIC NERVE#0.9485;MELANOSOME#0.9482;OLFACTORY NEUROBLASTOMA#0.9480;MESENCHYMAL STEM CELL#0.9479;TRANSFORMING GROWTH FACTOR#0.9473;MEDIAN SURVIVAL TIME#0.9472;ADRENAL MEDULLA#0.9467;NEUROPROTECTION#0.9463;TRANSCRIPTASE#0.9461;LARGE CELL NEUROENDOCRINE CARCINOMA#0.9461;NODULAR#0.9459;GASTROINTESTINAL STROMAL TUMOR#0.9458;CYTOPLASM#0.9455;STEM CELL#0.9452;MAST CELL#0.9450;LYMPH NODE#0.9450;PARATHYROID#0.9448;TUBERCULOSIS#0.9445;MITOCHONDRIA#0.9442;WEIGHT LOSS#0.9440;MINI MENTAL STATE#0.9431;CELL MEMBRANE#0.9423;DESMOSOME#0.9389;OLIGODENDROGLIOMA#0.9384;ENDOPLASMIC RETICULUM#0.9383;BASEMENT MEMBRANE#0.9381;SYNAPTIC VESICLE#0.9379;CEREBRAL ARTERY OCCLUSION#0.9360;BASAL LAMINA#0.9340;EWING SARCOMA#0.9338;ADIPOCYTE#0.9333;LECTIN#0.9323;NEURONAL CELL BODIES#0.9318;COLUMNAR#0.9317;LANGERHANS CELL#0.9315;GLUTAMATE RECEPTOR#0.9309;ALL TRANS RETINOIC ACID#0.9295;TYROSINE KINASE INHIBITOR#0.9295;RECEIVER OPERATOR CHARACTERISTIC#0.9292;HIGH POWER FIELD#0.9291;FOREBRAIN#0.9277;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9273;GLASGOW OUTCOME SCORE#0.9270;PARATHYROID HORMONE#0.9270;QUANTITATIVE REAL TIME#0.9270;ACINAR CELL#0.9261;DESMOPLASTIC SMALL ROUND CELL TUMOR#0.9250;NEURONAL CELL ADHESION#0.9246;NERVE PLEXUS#0.9241;ISCHEMIA REPERFUSION INJURY#0.9237;DUODENUM#0.9230;RANDOMIZED CONTROLLED TRIAL#0.9218;ACETYLCHOLINE#0.9217;HAIR CELL#0.9211;S PHASE#0.9208;AREA UNDER CURVE#0.9207;REACTIVE OXYGEN SPECIES#0.9205;CHOROID PLEXUS#0.9197;CEREBRUM#0.9194;TRANSITIONAL CELL CARCINOMA#0.9192;MARROW STROMAL CELLS#0.9183;MALIGNANT PHEOCHROMOCYTOMA#0.9181;NEUTROPHIL#0.9180;WORLD HEALTH ORGANIZATION#0.9171;VASCULAR DEMENTIA#0.9168;ANAPLASTIC CARCINOMA#0.9165;INSULIN-LIKE GROWTH FACTOR#0.9165;L-DOPA#0.9157;PLASMA MEMBRANE#0.9139;LIVER METASTASIS#0.9139;TUMOUR NECROSIS FACTOR#0.9133;CARCINOID SYNDROME#0.9127;OVAL CELL#0.9122;ADIPOSE TISSUE#0.9114;HODGKIN'S LYMPHOMA#0.9102;TASTE BUD CELL#0.9097;GLASGOW COMA SCORE#0.9096;INSULINOMA#0.9076;HEART DISEASE#0.9068;AGGRESSIVE BEHAVIOR#0.9053;RESPIRATORY TRACT#0.9051;NOREPINEPHRINE#0.9050;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.9045;NEUROFIBROMA#0.9040;TUBEROUS SCLEROSIS#0.9038;PROSTATE CARCINOMA#0.9027;ADENO ASSOCIATED VIRUS#0.9015;CARCINOMA IN SITU#0.9010;NEURAL TUBE#0.9004;HEMATURIA#0.8996;SKELETAL MUSCLE#0.8993;ENDOTHELIUM#0.8985;BONE MARROW STROMAL#0.8981;SEDATION#0.8980;LUMINAL#0.8977;ANGIOGENESIS#0.8970;LOCALISATION#0.8970;CYTOCHROME C#0.8970;VOMITING#0.8952;DENTAL PULP#0.8945;DENDRITIC CELL#0.8933;PHOSPHOGLYCERATE KINASE#0.8932;MULTIPLE ENDOCRINE NEOPLASIA#0.8929;MITOGEN ACTIVATED PROTEIN#0.8927;PHOSPHODIESTERASE#0.8927;CAROTID BODY#0.8922;CHONDROSARCOMA#0.8914;CARBOPLATIN#0.8904;PANCREATIC ENDOCRINE TUMORS#0.8903;METHIONINE#0.8902;RECTUM#0.8897;NEURITE EXTENSION#0.8888;FETAL BRAIN#0.8885;PHOTORECEPTOR CELL#0.8864;N METHYLTRANSFERASE#0.8863;MONONUCLEAR CELLS#0.8862;THALAMUS#0.8854;BONE MARROW STROMAL CELL#0.8851;CUSHING'S SYNDROME#0.8850;TRANSDIFFERENTIATION#0.8838;MODIFIED RANKIN SCALE#0.8832;VON HIPPEL LINDAU#0.8826;POSITRON EMISSION TOMOGRAPHY#0.8817;RAT BONE MARROW#0.8814;NORADRENALINE#0.8807;SOFT TISSUE SARCOMA#0.8794;LARYNX#0.8787;PYRAMIDAL CELL#0.8773;DIABETES MELLITUS#0.8773;SERTOLI CELL TUMOR#0.8736;MONOCYTE#0.8734;DIGESTION#0.8733;EMBRYONIC STEM CELL#0.8730;PROPOFOL#0.8717;ETHANOL#0.8713;BRAIN EDEMA#0.8695;DEXMEDETOMIDINE#0.8688;SOMATOSTATIN RECEPTOR#0.8687;COLORECTAL CANCER#0.8684;HYDROCEPHALUS#0.8683;UTERUS#0.8677;CLEAVED CASPASE 3#0.8673;ROUGH ENDOPLASMIC RETICULUM#0.8664;HYPOXANTHINE#0.8661;ENDOMETRIUM#0.8649;LYMPH NODE INVOLVEMENT#0.8646;HEPATOCELLULAR CARCINOMA#0.8640;UBIQUITIN C-TERMINAL HYDROLASE#0.8635;NEUROTOXIC#0.8633;AMYLOID PRECURSOR PROTEIN#0.8630;CELL BODY#0.8626;MEDIASTINUM#0.8622;JEJUNUM#0.8617;EXCRETION#0.8612;AGE AT DIAGNOSIS#0.8610;SPUTUM#0.8610;VACUOLE#0.8603;ENZYME ACTIVITY#0.8590;CAROTID ARTERY STENTING#0.8589;PAPILLARY CARCINOMA#0.8580;METAPLASIA#0.8576;NEURAL PROGENITOR CELL#0.8570;IMMUNE RESPONSE#0.8554;GLOBAL CEREBRAL ISCHEMIA#0.8548;BENIGN NEOPLASM#0.8544;NERVOUS SYSTEM DISEASE#0.8540;MICROVILLI#0.8540;WHITE BLOOD CELL#0.8537;TUMOR SUPPRESSOR#0.8536;ERYTHROCYTE#0.8529;GLUTATHIONE PEROXIDASE#0.8521;MYOCARDIAL INFARCTION#0.8513;MITOSIS#0.8513;AUTOPHAGY#0.8509;RETINAL DETACHMENT#0.8508;PELVIS#0.8491;RETINAL GANGLION CELL#0.8470;ANEMIA#0.8470;NEUROLOGICAL DAMAGE#0.8468;CEREBROVASCULAR DISEASE#0.8468;RECEPTOR ANTAGONIST#0.8464;CELL SURFACE ANTIGEN#0.8448;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8448;GASTRINOMA#0.8446;LIMIT OF DETECTION#0.8446;PHENYLETHANOLAMINE N METHYLTRANSFERASE#0.8444;CYSTATIN#0.8441;PLEOMORPHIC ADENOMA#0.8420;LYMPH NODE DISSECTION#0.8410;PANCREATIC CANCER#0.8403;STEM CELL TRANSPLANTATION#0.8403;BONE MORPHOGENETIC PROTEIN#0.8400;CELLULAR COMPONENT#0.8396;RED BLOOD CELL#0.8392;MULTIPLE LINEAR REGRESSION#0.8360;PAPILLOMA#0.8359;BRAIN INFARCTION#0.8351;OSTEOBLAST#0.8350;INTRACRANIAL HYPERTENSION#0.8343;DIFFUSE LARGE B-CELL LYMPHOMA#0.8340;HYPERGLYCEMIA#0.8322;ORAL CAVITY#0.8319;SWEAT GLAND#0.8315;SPECTRIN#0.8303;DISEASE FREE SURVIVAL#0.8303;FOCAL CEREBRAL ISCHEMIA#0.8264;INTERLEUKIN 2 RECEPTOR#0.8256;HYPOGLYCEMIA#0.8255;SPINAL CORD ISCHEMIA#0.8223;ALVEOLAR SOFT PART SARCOMA#0.8222;URIC ACID#0.8220;PRION DISEASE#0.8215;OPSIN#0.8210;NERVE TERMINAL#0.8195;NERVE TRUNK#0.8190;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8188;PROSTATE ADENOCARCINOMA#0.8174;CERVICAL CANCER#0.8168;BRAIN DEVELOPMENT#0.8167;ORGANELLE#0.8151;DIED OF DISEASE#0.8138;DORSAL ROOT GANGLION#0.8111;CORTICOTROPIN#0.8109;SIGNAL TRANSDUCTION#0.8106;T LYMPHOCYTE#0.8105;MENTAL RETARDATION#0.8097;OLFACTORY EPITHELIUM#0.8091;PULMONARY TUBERCULOSIS#0.8090;MELANOTIC NEUROECTODERMAL TUMOR#0.8083;FORSKOLIN#0.8063;ATP SYNTHASE#0.8055;LEUCINE#0.8045;HYPERCALCEMIA#0.8041;PLEURISY#0.8040;UMBILICAL CORD BLOOD#0.8039;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8037;FATTY ACID BINDING#0.8035;ENUCLEATION#0.8032;TRANSCRIPTIONAL CONTROL#0.8014;ADIPOSE-DERIVED STEM CELL#0.7998;LIVER DISEASE#0.7998;CLEAR CELL SARCOMA#0.7997;MESENTERY#0.7989;SHAM OPERATION GROUP#0.7984;GALLBLADDER#0.7969;WHITE MATTER LESIONS#0.7968;OLFACTORY BULB#0.7958;PANCREATIC ADENOCARCINOMA#0.7938;CILIARY BODY#0.7933;TIME TO PROGRESSION#0.7932;AQUAPORIN#0.7926;HYPOXIA INDUCIBLE FACTOR#0.7923;TESTICULAR CANCER#0.7919;LEIOMYOMA#0.7910;FIBRIL#0.7910;HEALTHY CONTROL GROUP#0.7904;CIRCULATING TUMOR CELL#0.7901;PHOSPHOGLYCERATE MUTASE#0.7900;COGNITION#0.7898;FINE NEEDLE ASPIRATE#0.7897;NERVE SHEATH TUMORS#0.7885;PANCREATIC NEUROENDOCRINE TUMOR#0.7881;LASER DESORPTION IONIZATION#0.7869;ALANINE#0.7864;METASTATIC MELANOMA#0.7864;PLEURA#0.7862;NMDA RECEPTOR#0.7862;BRAIN LESIONS#0.7853;HUMAN DENTAL PULP#0.7848;DIABETIC RETINOPATHY#0.7848;MANDIBLE#0.7838;LYSINE#0.7828;NEURAL CREST CELL#0.7820;DIFFUSE AXONAL INJURY#0.7813;DUCTAL CELL#0.7799;HAIR FOLLICLE#0.7793;BRAIN WATER CONTENT#0.7784;TEMPORAL LOBE EPILEPSY#0.7779;HAMARTOMA#0.7756;CYCLOPHOSPHAMIDE#0.7755;AMYGDALA#0.7754;COLORECTAL CARCINOMA#0.7744;GANGLIOGLIOMA#0.7734;CHOLINERGIC NEURON#0.7706;MYXOID CHONDROSARCOMA#0.7698;NESTIN POSITIVE CELLS#0.7688;EYELID#0.7685;MIDGUT#0.7681;IFN-GAMMA#0.7660;NUCLEAR LAYER#0.7645;COLLAGEN TYPE IV#0.7627;MAJOR DEPRESSIVE DISORDER#0.7619;DIMETHYL SULFOXIDE#0.7617;GOBLET CELL#0.7599;INTERCELLULAR JUNCTION#0.7593;MIDDLE EAR#0.7588;CYTOTOXICITY#0.7584;SOLID PSEUDOPAPILLARY TUMOR#0.7580;INFLAMMATORY CELL#0.7562;MELATONIN#0.7561;NORMAL CONTROL GROUP#0.7547;MIGRAINE#0.7544;ADENOID CYSTIC CARCINOMA#0.7537;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7532;LYSOSOME#0.7530;LYSIS#0.7529;SCALP#0.7524;BASAL CELL CARCINOMA#0.7522;DYSGERMINOMA#0.7516;MILIARY TUBERCULOSIS#0.7515;GTP BINDING#0.7511;GIANT CELL TUMOR#0.7502;PHOSPHOENOLPYRUVATE#0.7487;RECEPTOR AGONIST#0.7484;NEVUS#0.7484;DIARRHEA#0.7472;HEPARIN#0.7472;CHONDROCYTE#0.7470;ADENINE#0.7448;CARCINOSARCOMA#0.7446;DUCT CELL#0.7436;PANCREATIC CARCINOMA#0.7432;CELLULAR LOCALIZATION#0.7404;MICROFILAMENT#0.7396;VINCRISTINE#0.7375;SEPTUM#0.7369;KINASE ACTIVITY#0.7346;HYALURONIC ACID#0.7330;EVEROLIMUS#0.7320;ADENOSINE MONOPHOSPHATE#0.7319;CHROMAFFIN CELL#0.7316;OBESE#0.7312;HERPES SIMPLEX#0.7311;LYMPHOID CELL#0.7309;CONVULSION#0.7308;MACHADO-JOSEPH DISEASE#0.7284;LYMPHOBLASTIC LYMPHOMA#0.7282;POSITIVE LIKELIHOOD RATIO#0.7245;TRANSFORMING GROWTH FACTOR BETA#0.7237;PROTEIN SYNTHESIS#0.7230;MOUTH DISEASE#0.7229;PROTEIN KINASE C#0.7227;PRO-INFLAMMATORY#0.7222;INTESTINAL TRACT#0.7220;PNEUMONIA#0.7216;JUGULAR VEIN#0.7213;ENDOCRINE SYSTEM#0.7213;DOWN SYNDROME#0.7209;MIDBRAIN#0.7194;EMBRYONAL RHABDOMYOSARCOMA#0.7185;CELL ASSOCIATED#0.7176;OUTER HAIR CELL#0.7176;ANOREXIA#0.7172;GALECTIN#0.7169;NEUROTROPHIN RECEPTOR#0.7165;SLEEP APNEA#0.7158;CROHN'S DISEASE#0.7154;EXTRASKELETAL MYXOID CHONDROSARCOMA#0.7154;ACETIC ACID#0.7152;FOLATE#0.7151;ADULT STEM CELL#0.7145;FACTOR I#0.7140;IMMUNE SYSTEM#0.7124;SPINAL CORD COMPRESSION#0.7121;ANESTHETIC#0.7111;LARGE INTESTINE#0.7086;IRINOTECAN#0.7078;ADRENAL CORTEX#0.7068;NICOTINAMIDE#0.7047;14-3-2-PROTEIN#0.7045;TRANSIENT ISCHEMIC ATTACK#0.7028;NEURAL TUBE DEFECT#0.7026;HEROIN#0.7023;INDUCIBLE NITRIC OXIDE#0.7017;METASTATIC CARCINOMA#0.7016;PERITONEUM#0.7013;HYPOTENSION#0.7010;LOSS OF CONSCIOUSNESS#0.7008;VON HIPPEL-LINDAU DISEASE#0.6999;SUBEPENDYMAL GIANT CELL ASTROCYTOMA#0.6996;XANTHINE#0.6994;NEUROTOXIN#0.6989;OBSTRUCTIVE SLEEP APNEA#0.6983;VALPROIC ACID#0.6981;CELL JUNCTION#0.6974;PARATHYROID GLAND#0.6968;TETRACYCLINE#0.6953;LINEAR REGRESSION ANALYSIS#0.6935;GM-CSF#0.6914;CATALYTIC ACTIVITY#0.6910;OSSIFICATION#0.6905;BETA-MERCAPTOETHANOL#0.6901;LUNG LESIONS#0.6899;HISTIDINE#0.6892;DIABETIC KETOACIDOSIS#0.6888;ACINAR CELL CARCINOMA#0.6885;DENSE CORE VESICLE#0.6885;FIBROUS HISTIOCYTOMA#0.6874;TYPE 2 DIABETES#0.6872;POSITIVE CONTROL GROUP#0.6872;CYTOPLASMIC INCLUSION#0.6864;FLUORESCEIN#0.6853;DEDIFFERENTIATION#0.6851;MIDLINE#0.6838;OPEN ANGLE GLAUCOMA#0.6833;MUCOUS#0.6831;STRIATED MUSCLE#0.6827;GROWTH CONE#0.6822;SPIRAL GANGLION CELL#0.6821;GOBLET CELL CARCINOID#0.6813;HYPERGLYCEMIC#0.6809;AMYLOID PROTEIN#0.6809;DOCETAXEL#0.6794;HEALTHY CONTROL SUBJECTS#0.6792;MEDIAN NERVE#0.6789;EMBRYONIC BRAIN#0.6786;ACETYLCHOLINE RECEPTOR#0.6781;CORNEAL ENDOTHELIAL CELL#0.6770;ADRENOCORTICAL CARCINOMA#0.6755;SIGNET RING CELL#0.6754;PLATELET ACTIVATION#0.6753;CELL NUCLEUS#0.6736;NEUROBLASTIC TUMOR#0.6733;GASTRIC ADENOCARCINOMA#0.6727;ANAPLASTIC LYMPHOMA KINASE#0.6723;GINGIVA#0.6714;NUCLEOSOME#0.6689;MICROPARTICLE#0.6689;BRAIN DISEASE#0.6686;BETA GALACTOSIDASE#0.6668;HERPES SIMPLEX VIRUS#0.6665;OMENTUM#0.6657;CELL MATURATION#0.6643;SYNOVIAL SARCOMA#0.6640;RHEUMATOID ARTHRITIS#0.6635;MORPHOGENESIS#0.6634;MULTIPLE REGRESSION ANALYSIS#0.6632;CHOROID PLEXUS PAPILLOMA#0.6632;PAROTID GLAND#0.6625;SOLID PSEUDOPAPILLARY NEOPLASM#0.6625;ADENOSQUAMOUS CARCINOMA#0.6622;ADJUSTED ODDS RATIO#0.6612;EPINEPHRINE#0.6608;SCRAPIE#0.6607;MYOSIN HEAVY CHAIN#0.6604;HUMAN MESENCHYMAL STEM#0.6601;DNA FRAGMENTATION#0.6600;GUANINE#0.6583;FOREGUT#0.6578;NEOPLASTIC DISEASE#0.6566;PLURIPOTENT STEM CELL#0.6566;CORNEAL ENDOTHELIUM#0.6561;CENTRAL NERVOUS SYSTEM DISEASE#0.6556;DOXORUBICIN#0.6555;OBJECTIVE RESPONSE RATE#0.6546;TAMOXIFEN#0.6535;BASAL GANGLIA#0.6521;KARNOFSKY PERFORMANCE STATUS#0.6508;HEPATIC ENCEPHALOPATHY#0.6508;BIPOLAR DISORDER#0.6506;GRANULOSA CELL#0.6505;DEXAMETHASONE#0.6503;NEGATIVE LIKELIHOOD RATIO#0.6498;GALL BLADDER#0.6491;PROTEIN KINASE A#0.6491;GLUCOSE METABOLISM#0.6487;BRAIN CORTEX#0.6467;RAPAMYCIN#0.6466;SPONDYLOSIS#0.6464;RISK OF DEATH#0.6454;LIMITS OF DETECTION#0.6453;GUANOSINE#0.6450;MEMORY IMPAIRMENT#0.6448;CORTICAL CELL#0.6444;CLEAR CELL CARCINOMA#0.6442;SUBMANDIBULAR GLAND#0.6436;MAXILLA#0.6434;VULVA#0.6429;EMBRYONAL CARCINOMA#0.6426;GLUTAMATE DECARBOXYLASE#0.6421;CAUDA#0.6416;EPULIS#0.6415;ADRIAMYCIN#0.6404;RETINAL PIGMENT EPITHELIUM#0.6401;LUPUS ERYTHEMATOSUS#0.6399;NEPHROBLASTOMA#0.6389;TUBULAR ADENOCARCINOMA#0.6385;THROMBOSIS#0.6370;OLIGODENDROGLIAL CELLS#0.6368;DNA SYNTHESIS#0.6351;INTERNEURON#0.6347;OVARIAN CANCER#0.6344;ORAL MUCOSA#0.6307;RETINALDEHYDE BINDING#0.6306;SYNAPTOGENESIS#0.6300;DIAGNOSTIC ODDS RATIO#0.6294;EPIDIDYMIS#0.6293;CIRCUMVALLATE PAPILLA#0.6290;FIBROSARCOMA#0.6287;MEDIAN OVERALL SURVIVAL#0.6287;LIPID DROPLET#0.6282;DENTATE NUCLEUS#0.6282;CONTROLLED CORTICAL IMPACT#0.6281;HISTIOCYTOMA#0.6271;OESOPHAGUS#0.6267;RETICULOCYTE#0.6266;LOW DETECTION LIMIT#0.6249;DIGESTIVE TRACT#0.6247;POINT OF CARE#0.6240;ADENYLATE#0.6239;ENDOMETRIAL CARCINOMA#0.6238;2'-DEOXYURIDINE#0.6236;NEUROLOGICAL DEFICIT SCORE#0.6228;FOLLICLE STIMULATING HORMONE#0.6198;SYNAPTIC VESICLE PROTEIN#0.6196;INNER EAR#0.6189;CHRONIC PULMONARY HEART DISEASE#0.6188;HUNTINGTON'S DISEASE#0.6185;PERCUTANEOUS CORONARY INTERVENTION#0.6183;SOLITARY FIBROUS TUMOR#0.6160;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6135;GLOMERULAR FILTRATION#0.6125;LOCUS COERULEUS#0.6124;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6120;CEFTRIAXONE#0.6115;HEROIN DEPENDENCE#0.6115;CAUDATE NUCLEUS#0.6111;HINDGUT#0.6110;TICK-BORNE ENCEPHALITIS#0.6108;MARKERS OF INFLAMMATION#0.6083;VASCULAR CELL#0.6076;HEMATOPOIETIC CELL#0.6071;METAIODOBENZYLGUANIDINE#0.6069;B LYMPHOCYTE#0.6064;EPITHELIOID LEIOMYOSARCOMA#0.6055;ABIRATERONE#0.6054;PLASMA CELL#0.6051;LACTATE DEHYDROGENASE ACTIVITY#0.6047;SUBARACHNOID SPACE#0.6038;ASEPTIC MENINGITIS#0.6024;PROPIDIUM#0.6022
202781	SMOOTH MUSCLE CELL#0.8013;MUSCLE CELL#0.8001;SMOOTH MUSCLE#0.7984;TRANSCRIPTION FACTOR#0.7954
2027	CREATINE KINASE#1.0603;CREATINE#1.0402;SKELETAL MUSCLE#1.0104;GENE EXPRESSION#0.9862;GLYCOLYSIS#0.9184;MUSCLE CELL#0.8616;PYRUVATE KINASE#0.8302;MYOBLAST#0.8188;PHOSPHOGLYCERATE MUTASE#0.8152;SCIATIC NERVE#0.8121;GLYCERALDEHYDE-3-PHOSPHATE#0.7861;TRANSCRIPTION FACTOR#0.7651;MUSCLE FIBER#0.7490;FRUCTOSE#0.7378;MYOSIN HEAVY CHAIN#0.7338;PYRUVATE#0.7325;STRIATED MUSCLE#0.7191;ENOLASE ACTIVITY#0.7187;HEAT SHOCK PROTEIN#0.7054;MYOTUBE#0.6901;HYPOXIA#0.6780;SIGNALING PATHWAY#0.6768;PHOSPHOGLYCERATE KINASE#0.6457;FRUCTOSE BISPHOSPHATE ALDOLASE#0.6408;TRIOSE PHOSPHATE ISOMERASE#0.6309;POLYMERASE CHAIN REACTION#0.6233;GLUCOSE-6-PHOSPHATE#0.6153;NEUROMUSCULAR DISEASE#0.6151
2028	ANGIOTENSINASE A#1.1330;DIPEPTIDYL PEPTIDASE IV#1.0540;DIPEPTIDYL PEPTIDASE#1.0479;AMINOPEPTIDASE A#1.0472;BRUSH BORDER#1.0348;AMINOPEPTIDASE ACTIVITY#1.0204;LEUCINE#1.0193;ENDOPLASMIC RETICULUM#1.0163;VACCINIA#1.0151;ANGIOTENSIN CONVERTING ENZYME#1.0116;SYNCYTIUM FORMATION#1.0083;HYPERTENSION#1.0077;GLOMERULAR EPITHELIAL CELL#1.0054;CELL FUSION#1.0049;BRAIN RENIN-ANGIOTENSIN SYSTEM#1.0044;GROWTH FACTOR#1.0041;MEMBRANE FUSION#1.0029;HUMORAL IMMUNE RESPONSE#0.9971;PLASMA MEMBRANE#0.9961;APOPTOSIS#0.9959;VIRAL ENVELOPE#0.9947;ENZYME ACTIVITY#0.9941;EPITHELIAL CELL#0.9940;CELL SURFACE#0.9929;MESANGIAL CELL#0.9926;VIRION#0.9915;ASPARTATE#0.9913;GLYCOSYLATION#0.9912;IFN-GAMMA#0.9894;B CELL#0.9893;ALKALINE PHOSPHATASE#0.9889;CELLULAR IMMUNE RESPONSE#0.9888;HOST CELL#0.9872;CELL MEMBRANE#0.9868;SIMIAN IMMUNODEFICIENCY VIRUS#0.9853;CD4+ T CELL#0.9849;VIRUS LIKE PARTICLE#0.9844;GAMMA GLUTAMYLTRANSFERASE#0.9825;MUTAGENESIS#0.9817;CALMODULIN BINDING#0.9816;CELL PROLIFERATION#0.9803;MONOCYTE#0.9797;CYTOTOXIC T-LYMPHOCYTE#0.9788;B LYMPHOCYTE#0.9779;MACROPHAGE#0.9777;ENDOTHELIAL CELL#0.9764;POLYMERASE CHAIN REACTION#0.9758;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9750;HUMAN IMMUNODEFICIENCY VIRUS#0.9740;INTRACELLULAR TRANSPORT#0.9739;GENE EXPRESSION#0.9732;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9730;T CELL#0.9721;CD8+ T CELL#0.9721;IMMUNE RESPONSE#0.9712;PERIPHERAL BLOOD#0.9710;T LYMPHOCYTE#0.9708;MONONUCLEAR CELLS#0.9705;ARGININE#0.9692;AMINOPEPTIDASE P#0.9669;CYTOTOXIC T CELL#0.9667;BESTATIN#0.9656;CYTOTOXICITY#0.9629;VIRAL INFECTION#0.9568;CELL ASSOCIATED#0.9559;IMMUNE SYSTEM#0.9507;CELL-MEDIATED IMMUNE RESPONSE#0.9486;RECEPTOR ANTAGONIST#0.9485;TRANSCRIPTASE#0.9482;SMALL INTESTINE#0.9466;VASOPRESSIN#0.9462;ALANINE#0.9459;CELL DEATH#0.9450;PODOCYTE#0.9376;CELL ACTIVATION#0.9376;LYSIS#0.9371;VIRAL REPLICATION#0.9350;BLOOD BRAIN BARRIER#0.9350;DENDRITIC CELL#0.9336;BETA GALACTOSIDASE#0.9286;GOLGI COMPLEX#0.9258;HEPATITIS B#0.9253;CELL DIFFERENTIATION#0.9232;CONTROL OF BLOOD PRESSURE#0.9209;CATALYTIC ACTIVITY#0.9190;LYMPH NODE#0.9102;PUROMYCIN#0.9045;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9043;CYTOPLASM#0.9011;CHOROID PLEXUS#0.9003;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.8965;VIRULENCE#0.8947;N GLYCAN#0.8902;NERVOUS SYSTEM#0.8897;PROTEIN KINASE#0.8890;GOLGI APPARATUS#0.8869;VIRAL GLYCOPROTEIN#0.8817;LECTIN#0.8779;NEWCASTLE DISEASE#0.8773;STROMAL CELL#0.8757;TUMOR CELLS#0.8727;TROPHOBLAST#0.8699;ANTIBODY PRODUCTION#0.8650;TROPISM#0.8642;DIGESTION#0.8637;LEUKOCYTE#0.8599;LYMPHOID CELL#0.8587;CELLULAR MEMBRANE#0.8542;CENTRAL NERVOUS SYSTEM#0.8537;TOXICITY#0.8537;METHIONINE#0.8526;T CELL ACTIVATION#0.8481;BLOOD VESSEL#0.8474;C TERMINAL DOMAIN#0.8470;CHEMOKINE RECEPTOR#0.8453;REVERSE TRANSCRIPTION#0.8421;TUMOR NECROSIS FACTOR#0.8402;T HELPER CELL#0.8395;REGULATION OF BLOOD PRESSURE#0.8393;PERIPHERAL BLOOD LYMPHOCYTES#0.8376;BONE MARROW#0.8356;MUCOSAL IMMUNE RESPONSE#0.8342;STEM CELL#0.8320;BUDDING#0.8315;ZINC BINDING#0.8311;PROTEIN SYNTHESIS#0.8310;CORD BLOOD#0.8308;VESICULAR STOMATITIS VIRUS#0.8271;T CELL PROLIFERATION#0.8236;SODIUM DODECYL SULFATE#0.8235;DODECYL SULFATE#0.8234;KINASE ACTIVITY#0.8234;LYSOSOME#0.8233;ENDOTHELIUM#0.8194;CELL-MEDIATED IMMUNITY#0.8177;CELL KILLING#0.8130;SIGNAL PEPTIDE#0.8071;BREAST CANCER#0.8060;COMPLEMENT ACTIVATION#0.7983;B CELL DIFFERENTIATION#0.7977;CELL GROWTH#0.7939;TRANSCRIPTION FACTOR#0.7921;GLUTAMIC ACID#0.7905;COLONY-STIMULATING FACTOR#0.7902;ANTIGEN PRESENTING CELLS#0.7897;TUBULAR EPITHELIAL CELL#0.7882;RECEPTOR BINDING#0.7806;SIGNALING PATHWAY#0.7806;ALDOSTERONE#0.7791;SKELETAL MUSCLE#0.7764;CAPTOPRIL#0.7763;GLYCINE#0.7732;PERICYTE#0.7724;ENDOPEPTIDASE 24.11#0.7692;PEPTIDE HORMONE#0.7663;L-LEUCINE#0.7655;CELL RECOGNITION#0.7633;TRANS GOLGI NETWORK#0.7628;LOSARTAN#0.7626;ANGIOTENSIN RECEPTOR#0.7600;SECRETORY PATHWAY#0.7600;PROTEIN KINASE C#0.7599;ADIPOCYTE#0.7580;SEMINAL VESICLE#0.7571;CHORIOCARCINOMA#0.7550;SUCROSE#0.7520;CYTOKINE PRODUCTION#0.7504;GESTATION#0.7497;GLOMERULUS#0.7496;ALPHA MANNOSIDASE#0.7468;HYPERACTIVITY#0.7462;ROUGH ENDOPLASMIC RETICULUM#0.7450;PROGESTERONE#0.7399;ACID PHOSPHATASE#0.7357;APOPTOTIC#0.7317;CERVICAL#0.7294;GLUCOSE TRANSPORT#0.7242;LYSINE#0.7173;ASPARTIC ACID#0.7170;STOMATITIS#0.7132;TRANSFORMING GROWTH FACTOR#0.7115;LYMPHOCYTE PROLIFERATION#0.7109;NITRIC OXIDE#0.7086;B LYMPHOCYTE DIFFERENTIATION#0.7082;ENDOTHELIAL GROWTH FACTOR#0.7047;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7047;AMINOPEPTIDASE B ACTIVITY#0.7034;MEMBRANE FRACTION#0.6989;GM-CSF#0.6964;LYMPHOCYTE DIFFERENTIATION#0.6962;SMOOTH MUSCLE#0.6920;EXCRETION#0.6919;CANCER CELL#0.6902;CELL CELL FUSION#0.6853;IMMUNOGLOBULIN G#0.6841;ESSENTIAL HYPERTENSION#0.6824;NUCLEIC ACID#0.6824;CELL PENETRATING PEPTIDE#0.6781;MICROSOME#0.6764;HISTIDINE#0.6764;MEMORY T CELL#0.6761;AIDS RELATED COMPLEX#0.6743;TRANSCRIPTIONAL CONTROL#0.6738;ZIDOVUDINE#0.6732;EPSTEIN BARR VIRUS#0.6711;ADRENAL GLAND#0.6678;HYPOXIA#0.6672;PROGENITOR CELL#0.6628;BLOOD PRESSURE REGULATION#0.6627;VIRAL TRANSMISSION#0.6616;DOPAMINE#0.6609;B CELL ACTIVATION#0.6597;MUSCLE CELL#0.6511;MONOCYTE DERIVED MACROPHAGE#0.6460;CELL ADHESION#0.6430;RENAL CELL CARCINOMA#0.6425;DAP I#0.6291;BRUSH BORDER MEMBRANE#0.6282;ANGIOGENESIS#0.6255;FACTOR S#0.6242;ETHANOL#0.6227;GRANULOCYTE#0.6205;ALPHA 1-ANTITRYPSIN#0.6192;RABIES#0.6171;EPIDERMAL GROWTH FACTOR#0.6158;LUNG CANCER#0.6158;CYTOKINE SECRETION#0.6150;IMMUNOTOXIN#0.6149;MYOCARDIAL INFARCTION#0.6143;HYPOXIC#0.6123;ERAD PATHWAY#0.6102;PHOSPHODIESTERASE I#0.6057;FRONTAL#0.6051;BETA GLUCURONIDASE#0.6040;PRE-ECLAMPSIA#0.6025;ESTRADIOL#0.6024;OVARIAN#0.6013;ENTEROCYTE#0.6003
202915	HEPARIN#1.0092;VASCULAR CELL#0.7077;SERTOLI CELL#0.7035;GERM CELL#0.6993;VASCULAR SMOOTH MUSCLE CELL#0.6823;SMOOTH MUSCLE CELL#0.6792;MUSCLE CELL#0.6784;SMOOTH MUSCLE#0.6772;SECRETORY GRANULE#0.6525
2029	MITOSIS#0.9432;MITOTIC ENTRY#0.8825;CELL CYCLE#0.8808;DEPHOSPHORYLATION#0.7730;M PHASE#0.7190;S PHASE#0.6279;MITOTIC EXIT#0.6160
202	ABSENT IN MELANOMA#1.1085;PROSTATE CANCER#0.9393;ACTIN BINDING PROTEIN#0.7191;ACTIN BINDING#0.7161;TUMOR SUPPRESSOR#0.6540;T CELL#0.6323;EPITHELIAL CELL#0.6177
203068	MICROTUBULE#1.0091;HEAT SHOCK PROTEIN#0.9926;PACLITAXEL#0.9839;BREAST CANCER#0.7945;GENE EXPRESSION#0.7936;CYTOCHROME B#0.7703;PROTEIN DISULFIDE ISOMERASE#0.7660;CANCER CELL#0.7649;GLYCERALDEHYDE-3-PHOSPHATE#0.7414;MEGAKARYOCYTE#0.7393;POLYMERASE CHAIN REACTION#0.6674;PYRUVATE KINASE#0.6661;MICROTUBULE ASSOCIATED PROTEIN#0.6630;ATP SYNTHASE#0.6450;NERVOUS SYSTEM#0.6367;LASER DESORPTION IONIZATION#0.6301;PYRUVATE#0.6232
2030	ETHANOL#1.0598;DEOXYCYTIDINE KINASE#1.0528;ADENOSINE TRANSPORT#1.0489;ARA-C#1.0446;RIBAVIRIN#1.0437;DIPYRIDAMOLE#1.0390;EQUILIBRATIVE NUCLEOSIDE TRANSPORTER#1.0358;RESPONSE TO GEMCITABINE#1.0342;CONCENTRATIVE NUCLEOSIDE TRANSPORTER#1.0327;CYTIDINE DEAMINASE#1.0324;GEMCITABINE#1.0300;PANCREATIC ADENOCARCINOMA#1.0294;OOCYTE#1.0276;CYTIDINE#1.0252;ERYTHROCYTE#1.0247;DISEASE FREE SURVIVAL#1.0221;URIDINE#1.0218;THYMIDINE#1.0184;ADENOSINE#1.0161;POLYMERASE CHAIN REACTION#1.0154;PROTEIN KINASE#1.0143;PANCREATIC CANCER#1.0123;NUCLEOSIDE TRANSPORT#1.0123;CYTARABINE#1.0103;PLASMA MEMBRANE#1.0100;ENDOTHELIAL CELL#1.0088;ADENOCARCINOMA#1.0050;PANCREATIC DUCTAL ADENOCARCINOMA#1.0046;THYMIDINE KINASE#1.0018;CYTOTOXICITY#1.0014;5 FLUOROURACIL#1.0001;LUNG CANCER#0.9962;GENE EXPRESSION#0.9934;TOXICITY#0.9930;CANCER CELL#0.9927;LYMPH NODE#0.9918;NITRIC OXIDE#0.9893;HUMAN UMBILICAL VEIN#0.9875;UMBILICAL VEIN#0.9873;CELL SURFACE#0.9821;URIDINE TRANSPORT#0.9815;QUANTITATIVE REAL TIME#0.9786;FLUOROURACIL#0.9754;APOPTOSIS#0.9729;STRIATUM#0.9718;HEPATITIS C#0.9699;GESTATIONAL DIABETES#0.9666;REVERSE TRANSCRIPTION#0.9663;DECITABINE#0.9653;TUMOR CELLS#0.9648;CELL MEMBRANE#0.9577;HYPOXANTHINE#0.9544;TRANSCRIPTION FACTOR#0.9485;HYPOXIA#0.9459;ADENOSINE DEAMINASE#0.9435;CELL CYCLE#0.9432;THYMIDYLATE SYNTHASE#0.9343;MYELOID LEUKEMIA#0.9278;CELL PROLIFERATION#0.9231;HEPATITIS C VIRUS#0.9205;INOSINE#0.9199;ADENOSINE KINASE#0.9195;BREAST CANCER#0.9132;ACUTE MYELOID LEUKEMIA#0.9131;THYMIDINE KINASE 1#0.9128;SIGNALING PATHWAY#0.9114;ADENINE#0.9086;CELL DEATH#0.9084;RECEPTOR ANTAGONIST#0.9029;FLUDARABINE#0.8905;ENDOCYTOSIS#0.8742;ARGININE#0.8735;ISCHEMIA#0.8711;THYMIDYLATE#0.8664;DRUG RESISTANCE#0.8498;EPITHELIAL CELL#0.8483;ENDOTHELIUM#0.8482;ASTROCYTE#0.8400;L-ARGININE#0.8258;NUCLEOBASE TRANSPORT#0.8212;HUMAN PANCREATIC CANCER#0.8204;POSITRON EMISSION TOMOGRAPHY#0.8151;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8150;NEUROTRANSMISSION#0.8096;PROTEIN KINASE C#0.8083;ORGANIC CATION TRANSPORTER#0.8081;BILIARY TRACT#0.8072;MEMBRANE TRANSPORT#0.8038;PROXIMAL TUBULE CELL#0.7982;BONE MARROW#0.7925;INTERVERTEBRAL DISC#0.7921;GLYCOSYLATION#0.7902;GUANOSINE#0.7899;MICROVASCULAR ENDOTHELIAL CELL#0.7881;CISPLATIN#0.7842;B CELL#0.7799;TRANSCRIPTASE#0.7748;MITOCHONDRIAL TOXICITY#0.7744;MEDIAN OVERALL SURVIVAL#0.7744;ANNULUS FIBROSUS#0.7714;CHRONIC HEPATITIS C#0.7700;ACAMPROSATE#0.7651;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7625;PERIPHERAL BLOOD#0.7623;T CELL#0.7617;ADVANCED PANCREATIC CANCER#0.7614;MONONUCLEAR CELLS#0.7608;DRUG TRANSPORT#0.7600;BILIARY TRACT CANCER#0.7590;ACTIN CYTOSKELETON#0.7564;TICAGRELOR#0.7526;GROWTH FACTOR#0.7521;HYPOXIC#0.7494;SERTOLI CELL#0.7454;CHOLANGIOCARCINOMA#0.7390;CYTOSINE ARABINOSIDE#0.7297;NITRO-L-ARGININE#0.7238;SKELETAL MUSCLE#0.7218;RECEPTOR AGONIST#0.7113;D-PENICILLAMINE#0.7040;MUTAGENESIS#0.7040;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7010;PEMETREXED#0.7006;DIABETES MELLITUS#0.6983;MITOGEN ACTIVATED PROTEIN#0.6927;PANCREATIC CARCINOMA#0.6860;TRANSPORTER ACTIVITY#0.6835;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6811;LYMPHOCYTIC LEUKEMIA#0.6804;2'-DEOXYCYTIDINE#0.6776;MINERALIZATION#0.6774;LUNG CARCINOMA#0.6729;2'-DEOXYADENOSINE#0.6726;PROTEIN KINASE A#0.6714;EPITHELIAL MESENCHYMAL TRANSITION#0.6714;COLORECTAL#0.6625;KINASE INHIBITOR#0.6568;ORGANIC ANION TRANSPORTER#0.6568;CENTRAL NERVOUS SYSTEM#0.6561;NERVOUS SYSTEM#0.6552;LYMPH NODE METASTASIS#0.6525;HERPES SIMPLEX#0.6486;TUMOR TISSUES#0.6482;CEREBRAL CORTEX#0.6467;DEOXYADENOSINE#0.6449;NEUTROPENIA#0.6340;VASODILATOR#0.6311;APOPTOTIC#0.6297;COLORECTAL CANCER#0.6268;HERPES SIMPLEX VIRUS#0.6251;DEMETHYLATION#0.6242;GLYCINE#0.6200;NITRIC OXIDE SYNTHASE#0.6198;AUTOPHAGY#0.6184;DNA METHYLATION#0.6174;5-FLUOROURIDINE#0.6167;FLUORESCEIN#0.6120;DRINKING BEHAVIOR#0.6053;PERIAMPULLARY ADENOCARCINOMA#0.6042;NUCLEOTIDE METABOLISM#0.6006
203100	ENDOTHELIAL CELL#0.9813;TROPHOBLAST#0.8740;PRE-ECLAMPSIA#0.8080;CELL MIGRATION#0.6462;ECLAMPSIA#0.6459;CELL DEATH#0.6335;CELL CELL FUSION#0.6117
203190	ADIPOSE TISSUE#1.0882;LEUCINE#1.0526;KERATINOCYTE#0.9064;LEUCINE RICH REPEAT#0.8702;ASTROCYTE#0.7717;PREADIPOCYTE#0.6826;ENDOCYTOSIS#0.6759;MELANIN SYNTHESIS#0.6649;PRO-INFLAMMATORY#0.6471;PLASMA MEMBRANE#0.6418;LUNG CANCER#0.6417;ADIPOGENESIS#0.6317
203197	CANCER CELL#0.8953
203228	MICROTUBULE ASSOCIATED PROTEIN#1.0328;INDUCED PLURIPOTENT STEM CELL#1.0326;SUPEROXIDE DISMUTASE#1.0318;PLURIPOTENT STEM CELL#1.0300;MICROTUBULE#1.0235;NUCLEOCYTOPLASMIC TRANSPORT#1.0207;AUTOPHAGY#1.0187;PARKINSON'S DISEASE#1.0152;POLYMERASE CHAIN REACTION#1.0147;STRESS GRANULE#1.0138;STEM CELL#1.0131;FRONTOTEMPORAL DEMENTIA#1.0100;DEMENTIA#1.0046;LYSOSOME#1.0030;CENTRAL NERVOUS SYSTEM#1.0021;AGE AT ONSET#1.0016;AGE AT DEATH#0.9994;LATERAL SCLEROSIS#0.9980;AMYOTROPHIC LATERAL SCLEROSIS#0.9979;MOTOR NEURON DISEASE#0.9975;DNA METHYLATION#0.9960;PRIMARY PROGRESSIVE APHASIA#0.9959;RNA METABOLISM#0.9934;GENE EXPRESSION#0.9932;APHASIA#0.9929;NERVOUS SYSTEM#0.9922;CYTOPLASMIC INCLUSION#0.9916;ARGININE#0.9916;RNA BINDING PROTEIN#0.9910;RNA BINDING#0.9908;TOXICITY#0.9907;MOTOR NEURON DEGENERATION#0.9902;RNA PROCESSING#0.9900;FRONTAL#0.9885;ALZHEIMER'S DISEASE#0.9872;NEUROLOGICAL DISORDER#0.9861;DNA BINDING#0.9860;LOWER MOTOR NEURON#0.9850;SPINAL CORD#0.9827;NEURODEGENERATIVE DISEASE#0.9776;PROGRESSIVE SUPRANUCLEAR PALSY#0.9734;NEURONAL CYTOPLASMIC INCLUSION#0.9718;UBIQUITIN#0.9700;MULTIPLE SYSTEM ATROPHY#0.9691;TEMPORAL LOBE#0.9660;MAGNETIC RESONANCE IMAGING#0.9629;ASTROCYTE#0.9577;MYELOID CELL#0.9517;CELL DEATH#0.9477;HUNTINGTON'S DISEASE#0.9400;MUSCULAR ATROPHY#0.9321;MYOTONIC DYSTROPHY TYPE 1#0.9195;THALAMUS#0.9169;CYTOPLASM#0.9166;ANTISENSE RNA#0.9024;GUANINE#0.8946;POSITIVE FAMILY HISTORY#0.8890;NEUROTOXICITY#0.8863;GLYCINE#0.8807;MULTIPLE SCLEROSIS#0.8687;VALOSIN CONTAINING PROTEIN#0.8652;FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME#0.8520;NUCLEOTIDE EXCHANGE FACTOR#0.8514;NEURONAL CELLS#0.8400;PROTEIN COMPLEX#0.8349;GLUTAMATE RECEPTOR#0.8340;PARALYSIS#0.8269;NEURITE#0.8250;AUTOIMMUNITY#0.8231;PROTEASOME#0.8188;VOXEL BASED MORPHOMETRY#0.8086;COGNITION#0.8018;UPPER MOTOR NEURON#0.7993;CEREBELLAR ATAXIA#0.7900;HALLUCINATIONS#0.7883;BIPOLAR DISORDER#0.7862;NUCLEIC ACID#0.7777;PROTEIN TRANSLATION#0.7740;POSITRON EMISSION TOMOGRAPHY#0.7656;PROTEIN DEGRADATION#0.7591;AUTOPHAGY-INITIATION COMPLEX#0.7578;CEREBRAL CORTEX#0.7564;NEUROTOXIC#0.7511;ESSENTIAL TREMOR#0.7421;BASAL GANGLIA#0.7417;ENDOPLASMIC RETICULUM#0.7415;SPINOCEREBELLAR ATAXIA TYPE 8#0.7324;AUTOIMMUNE DISEASE#0.7301;VESICLE TRAFFICKING#0.7289;NUCLEAR PORE#0.7239;AMPA RECEPTOR#0.7209;LIPID METABOLISM#0.7126;STRESS GRANULE ASSEMBLY#0.7111;WHOLE GENOME SEQUENCING#0.7102;AUTOPHAGOSOME#0.7090;NUCLEAR IMPORT#0.7052;LEWY BODY#0.7021;MACROAUTOPHAGY#0.6927;NUCLEAR EXPORT#0.6887;PERIPHERAL BLOOD#0.6876;SPINAL MUSCULAR ATROPHY#0.6836;PRIMARY LATERAL SCLEROSIS#0.6811;TRANSCRANIAL MAGNETIC STIMULATION#0.6796;NEUROFILAMENT#0.6746;PROGRESSIVE MUSCULAR ATROPHY#0.6743;INTELLECTUAL DISABILITY#0.6724;NEUROFIBRILLARY TANGLE#0.6717;INCLUSION BODY#0.6653;NUCLEAR TRANSPORT#0.6540;NEUROMUSCULAR JUNCTION#0.6479;APRAXIA#0.6460;ULK1 COMPLEX#0.6456;IMMUNE RESPONSE#0.6396;LINEAR MIXED EFFECTS#0.6389;ALANINE#0.6378;PARAPLEGIA#0.6371;PURKINJE CELL#0.6301;DENTATE GYRUS#0.6278;DIFFUSION TENSOR IMAGING#0.6261;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.6242;CYTOTOXICITY#0.6230;QUANTITATIVE REAL TIME#0.6212;RNA EDITING#0.6089;NUCLEOCYTOPLASMIC SHUTTLING#0.6005
203245	APOPTOSIS INDUCING FACTOR#1.1041;CELL PROLIFERATION#1.0684;CANCER CELL#1.0283;APOPTOSIS#1.0273;CELL CYCLE#0.7608;CELL CYCLE ARREST#0.6906;ESOPHAGEAL CARCINOMA#0.6537;S PHASE#0.6348;PROSTATE CANCER#0.6318;LUNG CANCER#0.6301
203286	POLYCYSTIC KIDNEY DISEASE#1.0982;KIDNEY DISEASE#1.0647;STERILE ALPHA MOTIF#0.9967;NEPHRONOPHTHISIS#0.8716;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.6666;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.6666;CYSTIC KIDNEY DISEASE#0.6326
203328	BREAST CANCER#1.0831;NORMAL BREAST TISSUE#0.7105;FACTOR I#0.6931;BREAST CANCER CELL#0.6917;INSULIN-LIKE GROWTH FACTOR#0.6910;CANCER CELL#0.6849;GROWTH FACTOR#0.6830
2033	ACETYLASE ACTIVITY#1.0586;ENHANCEOSOME#1.0470;HISTONE ACETYL TRANSFERASE#1.0449;TRANSCRIPTION COACTIVATOR#1.0406;CAMP-RESPONSIVE ELEMENT BINDING#1.0389;FACTOR INHIBITING HIF#1.0312;GLUTAMIC ACID#1.0302;DEMENTIA#1.0277;CREB BINDING#1.0277;HISTONE H4 ACETYLATION#1.0274;HISTONE ACETYLTRANSFERASE ACTIVITY#1.0273;HABITUATION#1.0262;ASPARTIC ACID#1.0256;CAMP RESPONSE ELEMENT BINDING#1.0240;RUBINSTEIN TAYBI SYNDROME#1.0234;HISTONE H3 ACETYLATION#1.0230;TRANSCRIPTION COFACTOR#1.0209;TRANSFERASE ACTIVITY#1.0207;ACETYLTRANSFERASE ACTIVITY#1.0204;HISTIDINE#1.0185;BETA CELL#1.0182;PROTEIN BINDING#1.0175;MELATONIN#1.0164;BRAIN COMPUTER INTERFACE#1.0159;SCALP#1.0150;HISTONE ACETYLTRANSFERASE#1.0138;CAMP RESPONSE ELEMENT#1.0133;MEDIATOR COMPLEX#1.0122;CELLULAR TRANSCRIPTION#1.0120;PROTEIN COMPLEX#1.0116;DNA SYNTHESIS#1.0115;STEROID RECEPTOR COACTIVATOR#1.0108;C TERMINAL DOMAIN#1.0096;GRAY MATTER VOLUME#1.0090;TEMPORAL LOBE#1.0086;IFN-GAMMA#1.0077;MYOCYTES#1.0075;COENZYME A#1.0062;EARLY GROWTH RESPONSE#1.0059;AUTOPHAGY#1.0044;MYOBLAST#1.0038;RETINOBLASTOMA#1.0029;CYCLIC AMP#1.0011;ASTROCYTE#1.0008;COMPLEX I#1.0002;HISTONE METHYLTRANSFERASE#1.0002;B CELL LYMPHOMA#0.9988;PROTEIN ACETYLATION#0.9986;S PHASE#0.9985;RESVERATROL#0.9983;RNA BINDING#0.9983;DIFFUSE LARGE B-CELL LYMPHOMA#0.9981;MESANGIAL CELL#0.9971;DEACETYLASE ACTIVITY#0.9961;P53 BINDING#0.9960;FRONTAL#0.9957;ADENOSINE MONOPHOSPHATE#0.9956;INTERFERON REGULATORY FACTOR#0.9949;NUCLEOSOME#0.9947;PROTEIN KINASE C#0.9947;DNA DAMAGE RESPONSE#0.9941;AMYOTROPHIC LATERAL SCLEROSIS#0.9939;MYOCYTE ENHANCER FACTOR#0.9938;LATERAL SCLEROSIS#0.9930;SENESCENCE#0.9928;RETINOIC ACID RECEPTOR#0.9926;CYCLIC ADENOSINE MONOPHOSPHATE#0.9924;TRANSACTIVATION#0.9922;CARDIOMYOCYTE#0.9920;SEQUENCE SPECIFIC DNA BINDING#0.9920;GLUCOCORTICOID RECEPTOR#0.9920;ENHANCER BINDING PROTEIN#0.9917;ALZHEIMER'S DISEASE#0.9911;SQUAMOUS CELL CARCINOMA#0.9903;TRANSCRIPTION FACTOR BINDING#0.9902;PARKINSON'S DISEASE#0.9902;ARGININE#0.9896;DOXORUBICIN#0.9894;ENHANCER BINDING#0.9894;ACUTE MYELOID LEUKEMIA#0.9892;THYROID HORMONE RECEPTOR#0.9891;EPIDERMAL GROWTH FACTOR#0.9888;GLUTATHIONE#0.9882;SUMOYLATION#0.9879;MYELOID LEUKEMIA#0.9877;SIGNALLING PATHWAY#0.9873;HISTONE ACETYLATION#0.9863;SPINAL CORD#0.9859;COLON CANCER#0.9850;LYSINE#0.9848;PROTEASOME#0.9841;CHROMATIN REMODELING#0.9833;EPITHELIAL MESENCHYMAL TRANSITION#0.9828;DEXAMETHASONE#0.9826;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9819;COLORECTAL CANCER#0.9816;KERATINOCYTE#0.9815;ANDROGEN RECEPTOR#0.9814;NUCLEAR EXPORT#0.9813;RETINOID X RECEPTOR#0.9812;MUTAGENESIS#0.9811;ZINC FINGER PROTEIN#0.9810;DOMINANT NEGATIVE MUTANT#0.9809;SMOOTH MUSCLE CELL#0.9808;TRANSCRIPTIONAL CONTROL#0.9808;RECEPTOR INTERACTING PROTEIN#0.9804;COLORECTAL#0.9804;CHROMATIN REMODELLING#0.9803;MUSCLE CELL#0.9802;CYCLIN DEPENDENT KINASE#0.9802;B CELL#0.9800;RETINOIC ACID#0.9794;CELL DIFFERENTIATION#0.9793;MONOCYTE#0.9792;CD4+ T CELL#0.9790;MIDLINE#0.9785;LINEAR DISCRIMINANT ANALYSIS#0.9781;DNA REPLICATION#0.9780;DNA REPAIR#0.9777;REVERSE TRANSCRIPTION#0.9777;HYPOXIA#0.9777;LUNG CANCER#0.9777;SMOOTH MUSCLE#0.9773;SKELETAL MUSCLE#0.9770;T-CELL LEUKEMIA#0.9770;ESTROGEN RECEPTOR ALPHA#0.9769;HISTONE ACETYLASE ACTIVITY#0.9767;TRANSCRIPTION REGULATOR#0.9765;NUCLEAR HORMONE RECEPTOR#0.9760;HUMAN IMMUNODEFICIENCY VIRUS#0.9759;PROTEIN PROTEIN INTERACTION#0.9759;TRANSCRIPTION ACTIVATOR#0.9755;SIGNAL TRANSDUCER#0.9754;REGULATION OF GENE EXPRESSION#0.9750;SIGNALING CASCADE#0.9745;EMBRYONIC STEM CELL#0.9744;RNA INTERFERENCE#0.9742;PREINITIATION COMPLEX#0.9736;SIGNAL TRANSDUCTION#0.9736;CHROMATIN MODIFICATION#0.9736;POLYMERASE CHAIN REACTION#0.9736;PROTEIN KINASE A#0.9735;MACROPHAGE#0.9731;HYPOXIC#0.9730;ADENOSINE#0.9730;ADIPOCYTE#0.9729;NF-KAPPAB ACTIVATION#0.9724;PROSTATE CANCER#0.9723;HYPOXIA INDUCIBLE FACTOR#0.9722;DNA METHYLATION#0.9716;PROTEASOME PATHWAY#0.9712;CHONDROCYTE#0.9708;CDK INHIBITOR#0.9700;RNA HELICASE#0.9698;PEROXISOME#0.9696;ACTIVATING TRANSCRIPTION FACTOR#0.9695;ACTIVATOR PROTEIN 1#0.9692;NF KAPPAB BINDING#0.9691;DNA BINDING#0.9690;ESTROGEN RECEPTOR#0.9688;REACTIVE OXYGEN SPECIES#0.9688;KINASE ACTIVITY#0.9686;MITOGEN ACTIVATED PROTEIN#0.9682;CYTOTOXICITY#0.9682;NITRIC OXIDE#0.9681;CELL ADHESION#0.9680;CYTOPLASM#0.9679;HISTONE DEACETYLASE INHIBITOR#0.9679;VIRAL REPLICATION#0.9677;CELL CYCLE ARREST#0.9677;ONCOGENIC#0.9677;UBIQUITIN#0.9677;MINI MENTAL STATE#0.9673;RESPONSE TO HYPOXIA#0.9668;HOST CELL#0.9666;T CELL FACTOR#0.9663;HISTONE DEACETYLASE#0.9660;HISTONE MODIFICATION#0.9657;MYELOID CELL#0.9653;BREAST CANCER CELL#0.9652;HEPATOCELLULAR CARCINOMA#0.9650;TUMOR NECROSIS FACTOR#0.9650;PROTEIN KINASE#0.9649;T LYMPHOCYTE#0.9647;T CELL#0.9646;GROWTH FACTOR RECEPTOR#0.9644;CELL MIGRATION#0.9644;POSTTRANSLATIONAL MODIFICATION#0.9643;LYMPH NODE#0.9643;PROGENITOR CELL#0.9642;ACTIVATED T CELL#0.9641;ENDOTHELIAL GROWTH FACTOR#0.9640;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9640;CELL CYCLE#0.9639;TUMOR CELLS#0.9636;ACTIVATED T-CELLS#0.9635;OSTEOBLAST#0.9635;CELL DEVELOPMENT#0.9633;HISTONE DEACETYLATION#0.9632;TRANSFORMING GROWTH FACTOR BETA#0.9629;EPITHELIAL CELL#0.9628;VIRAL TRANSCRIPTION#0.9627;MAP KINASE#0.9627;BREAST CANCER#0.9627;ANGIOGENESIS#0.9626;TUMOR SUPPRESSOR#0.9625;APOPTOSIS#0.9623;COGNITION#0.9620;MOUSE EMBRYONIC FIBROBLAST#0.9620;KINASE INHIBITOR#0.9615;APOPTOTIC#0.9613;GENOTOXIC#0.9612;FACTOR I#0.9612;NADPH OXIDASE#0.9607;ENDOTHELIAL CELL#0.9605;CELL GROWTH#0.9603;TRANSCRIPTION FACTOR#0.9600;CANCER CELL#0.9599;EXTRACELLULAR MATRIX#0.9596;POST-TRANSLATIONAL MODIFICATION#0.9596;AKT SIGNALING#0.9595;STEM CELL#0.9593;TRANSFORMING GROWTH FACTOR#0.9593;ESTRADIOL#0.9587;HEMATOPOIESIS#0.9579;INFLAMMATORY RESPONSE#0.9575;CELL PROLIFERATION#0.9575;CELL CYCLE CONTROL#0.9570;COLLAGEN SYNTHESIS#0.9570;SUPPORT VECTOR MACHINE#0.9569;CELL DEATH#0.9561;TYPE 2 DIABETES#0.9560;SIGNALING PATHWAY#0.9559;IMMUNE RESPONSE#0.9555;NERVOUS SYSTEM#0.9549;OVARIAN CANCER#0.9548;INDUCTION OF APOPTOSIS#0.9547;GENE EXPRESSION#0.9546;PRO-INFLAMMATORY#0.9546;VIRAL INFECTION#0.9545;ELECTROPHORETIC MOBILITY SHIFT#0.9540;TERMINAL DIFFERENTIATION#0.9539;CATALYTIC ACTIVITY#0.9539;LEUCINE#0.9538;CELL ACTIVATION#0.9537;PROTEIN DEGRADATION#0.9537;ADIPOCYTE DIFFERENTIATION#0.9534;GROWTH FACTOR#0.9530;PERIPHERAL BLOOD#0.9528;CENTRAL NERVOUS SYSTEM#0.9509;LUCIFERASE ACTIVITY#0.9507;HUMAN BREAST CANCER#0.9505;CERVICAL#0.9496;CHROMATIN ASSEMBLY#0.9494;SLEEPINESS#0.9493;NITRIC OXIDE SYNTHASE#0.9493;HEMATOPOIETIC STEM CELL#0.9487;OVARIAN#0.9486;MECHANISM OF ACTION#0.9482;MIXED LINEAGE LEUKEMIA#0.9473;ASPARAGINE#0.9450;NEURAL TUBE#0.9443;METHYLTRANSFERASE ACTIVITY#0.9438;LIGAND BINDING DOMAIN#0.9434;TRANSCRIPTION FACTOR COMPLEX#0.9426;BONE MARROW#0.9420;ADULT T-CELL LEUKEMIA#0.9410;CYCLIN DEPENDENT KINASE INHIBITOR#0.9408;QUANTITATIVE REAL TIME#0.9407;BONE MORPHOGENETIC PROTEIN#0.9404;PROGESTERONE#0.9397;ADENOCARCINOMA#0.9396;CISPLATIN#0.9393;ENDOPLASMIC RETICULUM#0.9388;HEPATOCYTE NUCLEAR FACTOR#0.9382;HISTONE CHAPERONE#0.9381;VIRAL GENE EXPRESSION#0.9377;INTELLECTUAL DISABILITY#0.9376;MAPK SIGNALING#0.9369;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9359;MAMMARY EPITHELIAL CELL#0.9349;ZINC BINDING#0.9344;LIGASE ACTIVITY#0.9335;REGENERATION#0.9334;DOUBLE STRAND BREAK#0.9322;GLUCOSE METABOLISM#0.9322;ADIPOGENESIS#0.9319;DEMETHYLATION#0.9312;PANCREATIC CANCER#0.9311;TOXICITY#0.9311;ONCOGENESIS#0.9310;SMAD BINDING#0.9305;LIPID METABOLISM#0.9304;MAGNETIC RESONANCE IMAGING#0.9300;CYTOCHROME C#0.9293;REGULATION OF HISTONE ACETYLATION#0.9289;EPSTEIN BARR VIRUS#0.9281;SWI-SNF COMPLEX#0.9276;PROVIRUS#0.9275;TUMOR TISSUES#0.9271;REPORTER GENE ASSAY#0.9263;PHENYLEPHRINE#0.9246;OSTEOBLAST DIFFERENTIATION#0.9244;GENE SILENCING#0.9244;DNASE#0.9227;T CELL ACTIVATION#0.9217;PROTEIN SYNTHESIS#0.9217;PROMOTER BINDING#0.9213;PRINCIPAL COMPONENT ANALYSIS#0.9212;VON HIPPEL LINDAU#0.9207;ALANINE#0.9206;G1 PHASE#0.9200;HYPOXIA RESPONSE ELEMENT#0.9191;ARYL HYDROCARBON RECEPTOR#0.9175;COLON CARCINOMA#0.9165;INSULIN-LIKE GROWTH FACTOR#0.9162;POLY ADP RIBOSE#0.9161;HEMATOPOIETIC CELL#0.9145;ENDOMETRIAL CARCINOMA#0.9140;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9128;EPITHELIAL TO MESENCHYMAL#0.9126;NEURODEGENERATIVE DISEASE#0.9110;SUPERIOR TEMPORAL GYRUS#0.9096;RIBOZYME#0.9091;NUCLEAR LOCALIZATION SIGNAL#0.9085;MOUSE EMBRYONIC STEM#0.9082;HIGH MOBILITY GROUP#0.9079;ACTIVATION OF NF-KAPPAB#0.9077;ERYTHROID CELL#0.9076;OBESE#0.9062;HYPERACTIVITY#0.9062;HYPERGLYCEMIA#0.9057;HISTONE METHYLATION#0.9056;IFN-BETA#0.9050;VALPROIC ACID#0.9045;CHROMATIN BINDING#0.9043;CRE BINDING#0.9034;RECEPTOR TYROSINE KINASE#0.9029;ALCOHOL DEPENDENCE#0.9029;MYOGENESIS#0.9028;DNASE I#0.9021;LYSINE ACETYLTRANSFERASE ACTIVITY#0.9021;NULL CELL#0.9020;VASCULAR SMOOTH MUSCLE CELL#0.9015;CELLULAR SENESCENCE#0.9014;CALCINEURIN#0.9012;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9000;FOLLICULAR LYMPHOMA#0.8998;NUCLEOTIDE EXCISION REPAIR#0.8992;MESENCHYMAL STEM CELL#0.8979;BINDING PROTEIN 1#0.8976;ISCHEMIA#0.8971;MORPHOGENESIS#0.8965;MYOTUBE#0.8952;ARTERY#0.8952;NEUROGENESIS#0.8937;MONONUCLEAR CELLS#0.8936;CELL CYCLE REGULATION#0.8935;SUBSTANCE USE DISORDER#0.8902;DISEASE FREE SURVIVAL#0.8892;LUNG EPITHELIAL CELL#0.8888;NERVE GROWTH FACTOR#0.8888;ADIPOSE TISSUE#0.8887;THYMOCYTE#0.8883;HERPES SIMPLEX#0.8874;DOPAMINE#0.8874;DIABETIC NEPHROPATHY#0.8868;MELANOCYTE#0.8859;ETHANOL#0.8854;EPILEPSY#0.8838;HEART DEVELOPMENT#0.8833;IMMUNE SYSTEM#0.8830;HETEROCHROMATIN#0.8828;NEPHROPATHY#0.8818;INDUCIBLE NITRIC OXIDE#0.8810;CANCER STEM CELL#0.8774;MAJOR DEPRESSIVE DISORDER#0.8762;CELL SURFACE#0.8760;LONG TERM MEMORY#0.8755;RNA BINDING PROTEIN#0.8754;BREAST CARCINOMA#0.8742;PROTEIN KINASE B#0.8740;MODE OF ACTION#0.8740;MULTIPLE MYELOMA#0.8739;SEQUESTERING#0.8731;GLOBIN#0.8727;ATHEROSCLEROSIS#0.8724;SERUM RESPONSE FACTOR#0.8720;STEROID HORMONE RECEPTOR#0.8713;NUCLEOSOME ASSEMBLY#0.8710;ALL TRANS RETINOIC ACID#0.8677;DNA METHYLTRANSFERASE#0.8671;GLYCOSYLASE#0.8665;SENSITIZATION#0.8661;IKAPPAB KINASE#0.8660;PHOSPHOLIPASE A2#0.8647;TRANSCRIPTASE#0.8638;DRUG RESISTANCE#0.8637;26S PROTEASOME#0.8630;MYOBLAST DIFFERENTIATION#0.8628;STEM CELL DIFFERENTIATION#0.8605;BIPOLAR DISORDER#0.8588;BONE FORMATION#0.8583;RIBOSE#0.8582;CELLULAR GROWTH#0.8575;MAMMARY GLAND#0.8569;MYOSIN HEAVY CHAIN#0.8558;SLEEP APNEA#0.8556;FIBROBLAST GROWTH FACTOR#0.8555;NEURONAL CELLS#0.8553;UBIQUITIN PROTEASOME PATHWAY#0.8548;GLUTAMINE#0.8546;HOMOLOGOUS RECOMBINATION#0.8537;UBIQUITIN LIGASE ACTIVITY#0.8535;MENTAL RETARDATION#0.8532;CHROMATIN REMODELING COMPLEX#0.8524;ESTROGEN RESPONSE ELEMENT#0.8509;DERMAL FIBROBLAST#0.8508;IFN REGULATORY FACTOR#0.8506;DIABETES MELLITUS#0.8497;SUPEROXIDE DISMUTASE#0.8485;TAMOXIFEN#0.8469;PERSONALITY DISORDER#0.8464;OLANZAPINE#0.8461;HERPES SIMPLEX VIRUS#0.8459;GERMINAL CENTER#0.8452;SIGNALING MOLECULE#0.8451;ENZYME ACTIVITY#0.8445;CELL MOTILITY#0.8427;SCHWANN CELL#0.8423;HEARING LOSS#0.8419;THYMINE#0.8407;CELL DIVISION#0.8402;CARDIAC DEVELOPMENT#0.8400;MYOCARDIAL INFARCTION#0.8398;NICOTINAMIDE#0.8386;PROSTATE SPECIFIC ANTIGEN#0.8382;MAPK ACTIVATION#0.8372;ANTIVIRAL RESPONSE#0.8343;TH17 CELL#0.8332;LUNG ADENOCARCINOMA#0.8322;HEPATIC STELLATE CELL#0.8321;B LYMPHOCYTE#0.8287;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8286;CELL CYCLE REGULATOR#0.8272;GLUCONEOGENESIS#0.8251;ACUTE LEUKEMIA#0.8243;HEPATOMA CELLS#0.8242;MUSCLE WASTING#0.8240;SALICYLATE#0.8237;COLORECTAL CARCINOMA#0.8216;PLURIPOTENT STEM CELL#0.8189;NEUTROPHIL#0.8180;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8180;DEPHOSPHORYLATION#0.8179;CORTISOL#0.8166;BETA-2#0.8163;PREADIPOCYTE#0.8158;GROWTH HORMONE#0.8152;HEPATITIS C#0.8150;STREPTOZOTOCIN#0.8131;HEART DISEASE#0.8129;WNT SIGNALING PATHWAY#0.8123;OOCYTE#0.8115;EMBRYONIC KIDNEY#0.8115;INDEPENDENT COMPONENT ANALYSIS#0.8114;THYMINE DNA GLYCOSYLASE#0.8108;KIDNEY DISEASE#0.8105;NEUROLOGICAL DISORDER#0.8104;STRUCTURE ACTIVITY RELATIONSHIP#0.8100;CERVICAL CANCER#0.8079;CELL ADHESION MOLECULE#0.8067;MITOSIS#0.8063;NUCLEAR IMPORT#0.8063;LAMINAR SHEAR STRESS#0.8050;MITOCHONDRIA#0.8025;GESTATION#0.8003;AMYGDALA#0.7990;STROMAL CELL#0.7985;STEROIDOGENIC FACTOR 1#0.7983;LIVER DISEASE#0.7981;CARDIOMYOPATHY#0.7936;ACTIVATION OF CREB#0.7932;VASCULAR DEMENTIA#0.7929;CONNECTIVE TISSUE#0.7924;HUNTINGTON'S DISEASE#0.7921;IMMUNE CELL#0.7908;HYPERTENSION#0.7907;B CELL DEVELOPMENT#0.7904;CEREBRAL INFARCTION#0.7901;CONTINUOUS PERFORMANCE TEST#0.7896;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7848;TOLL LIKE RECEPTOR#0.7844;HYPERPHOSPHORYLATION#0.7832;WOUND HEALING#0.7828;AUTOIMMUNE DISEASE#0.7823;IL-6 PRODUCTION#0.7797;BRAIN DEVELOPMENT#0.7786;PULMONARY FIBROSIS#0.7777;LUNG CARCINOMA#0.7774;EMBRYONAL CARCINOMA#0.7770;PROGRAMMED CELL DEATH#0.7765;PLATELET-DERIVED GROWTH FACTOR#0.7759;RECEPTOR BINDING#0.7756;BASE EXCISION REPAIR#0.7751;HISTONE DEACETYLASE ACTIVITY#0.7744;TRAUMATIC BRAIN INJURY#0.7734;RECEPTOR ACTIVITY#0.7732;MYOFIBROBLAST#0.7712;ASPIRIN#0.7702;MECHANISMS OF ACTION#0.7698;GLUCOSE HOMEOSTASIS#0.7683;PSYCHOTIC DISORDER#0.7680;HUMAN MAMMARY EPITHELIAL#0.7667;NEURITE#0.7651;BORDERLINE PERSONALITY DISORDER#0.7642;RHEUMATOID ARTHRITIS#0.7642;RENAL CELL CARCINOMA#0.7639;CHROMATIN LOOPING#0.7613;NEURAL STEM CELL#0.7609;HISTONE DEMETHYLASE#0.7608;NUCLEAR RECEPTOR SUPERFAMILY#0.7604;VITAMIN D RECEPTOR#0.7597;CAMP SIGNALING#0.7587;M PHASE#0.7586;SUBEROYLANILIDE HYDROXAMIC ACID#0.7577;ANTERIOR CINGULATE CORTEX#0.7576;HUMAN UMBILICAL VEIN#0.7574;UMBILICAL VEIN#0.7572;CYTOKINE PRODUCTION#0.7565;MINI MENTAL STATUS#0.7562;ALKALINE PHOSPHATASE#0.7547;HEALTHY CONTROL SUBJECTS#0.7534;MICROTUBULE#0.7531;GLYCOLYSIS#0.7502;LYMPH NODE METASTASIS#0.7502;T CELL DEVELOPMENT#0.7499;G0 PHASE#0.7485;LEUKOCYTE#0.7469;TRANSCRANIAL MAGNETIC STIMULATION#0.7458;HEAT SHOCK PROTEIN#0.7454;CELL FATE DETERMINATION#0.7448;C-TERMINAL BINDING#0.7432;RESONANCE ENERGY TRANSFER#0.7400;ENERGY HOMEOSTASIS#0.7396;MESENCHYME#0.7383;ATP BINDING#0.7373;CONSTRICTION#0.7372;SMAD BINDING ELEMENT#0.7370;TRAIL MAKING TEST#0.7367;HDAC3 COMPLEX#0.7365;N ACETYLTRANSFERASE#0.7361;SMALL INTESTINE#0.7360;FOAM CELL FORMATION#0.7354;TISSUE HOMEOSTASIS#0.7352;OXYGENASE#0.7315;MURINE DOUBLE MINUTE#0.7294;HUMAN EMBRYONIC KIDNEY#0.7293;PKCALPHA#0.7282;PARATHYROID HORMONE#0.7280;EMBRYONIC HEART#0.7271;VASCULAR CELL#0.7268;VASCULAR ENDOTHELIAL CELL#0.7267;BREAST CANCER PATIENTS#0.7254;ENDOMETRIUM#0.7243;BLOOD VESSEL#0.7242;NOTCH SIGNALING PATHWAY#0.7230;NEUROBLASTOMA#0.7213;ALCOHOL USE DISORDER#0.7210;CAFFEINE#0.7208;THYROID TRANSCRIPTION FACTOR#0.7199;CHRONIC CONSTRICTION INJURY#0.7198;MELANOMA CELL LINES#0.7193;TUMOR ANTIGEN#0.7178;APOPTOTIC CELL DEATH#0.7166;OCCIPITAL REGION#0.7162;SPINAL CORD INJURY#0.7161;TELOMERE#0.7157;CATABOLISM#0.7150;REGULATORY T CELL#0.7141;ACTIVATED B CELL#0.7139;TRANSCRIPTIONAL CO-REGULATOR#0.7102;HALLUCINATIONS#0.7092;VIRAL GENOME#0.7081;HEMATOPOIETIC PROGENITOR CELL#0.7072;WHOLE GENOME SEQUENCING#0.7071;NEUROEPITHELIAL CELL#0.7061;MONOCYTIC LEUKEMIA#0.7058;PANCREATIC ISLET#0.7042;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7031;ADVANCED PROSTATE CANCER#0.7028;HIGH FAT DIET#0.7020;NEURAL TUBE DEFECT#0.7013;ROSIGLITAZONE#0.7008;HEAT SHOCK FACTOR#0.7008;CELL MEMBRANE#0.7007;NEPHRITIS#0.7006;COPY NUMBER ALTERATION#0.7003;LIPOGENESIS#0.6999;COGNITIVE DISORDER#0.6979;OLIGODENDROCYTE#0.6973;TISSUE GROWTH FACTOR#0.6968;MYOGENIC CELL#0.6950;ORAL SQUAMOUS CELL CARCINOMA#0.6949;ACTINOMYCIN D#0.6948;TOPOISOMERASE#0.6927;TF BINDING#0.6926;INSULIN RECEPTOR#0.6915;PROTEIN DEACETYLASE#0.6909;STARTLE RESPONSE#0.6901;SILENT INFORMATION REGULATOR#0.6897;LYSOSOME#0.6868;FORSKOLIN#0.6856;DNA REPAIR SYNTHESIS#0.6847;OSTEOGENESIS#0.6816;DETOXIFICATION#0.6806;BLOOD GLUCOSE LEVEL#0.6796;VIRION#0.6787;ENDOPLASMIC RETICULUM STRESS#0.6772;PYRUVATE#0.6765;JUN DIMERIZATION PROTEIN#0.6764;REGULATION OF CELL CYCLE#0.6753;NF-KAPPAB INHIBITOR#0.6743;ORGANOGENESIS#0.6740;MULTIPLE SCLEROSIS#0.6737;GENISTEIN#0.6703;P38 MAPK SIGNALING#0.6701;LYMPHOMA CELL LINES#0.6697;GLYCERALDEHYDE-3-PHOSPHATE#0.6695;REGULATION OF CELL PROLIFERATION#0.6695;MRNA TRANSCRIPTION#0.6687;INHIBITION OF HISTONE ACETYLATION#0.6683;INTESTINAL EPITHELIAL CELL#0.6679;MESENCHYMAL CELL#0.6674;THYROID CANCER#0.6671;ARACHIDONIC ACID#0.6666;TYPE 2 DIABETES MELLITUS#0.6663;2 DIABETES MELLITUS#0.6663;ETOPOSIDE#0.6663;SMOOTH MUSCLE ACTIN#0.6658;TUBERCULOSIS#0.6655;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6654;HEPATITIS C VIRUS#0.6649;CAMKII#0.6643;RECURRENCE FREE SURVIVAL#0.6633;NEURITE OUTGROWTH#0.6628;GENE EXPRESSION OMNIBUS#0.6615;COLLAGENASE#0.6602;RESPONSE TO STRESS#0.6599;PACLITAXEL#0.6598;LUPUS NEPHRITIS#0.6594;LIVER CANCER#0.6576;TOPOISOMERASE II#0.6571;INNATE IMMUNE RESPONSE#0.6561;CELLULAR HOMEOSTASIS#0.6557;GLOMERULONEPHRITIS#0.6552;METHIONINE#0.6552;FACTOR S#0.6529;REPLICATIVE SENESCENCE#0.6526;TRANSCRIPTION REPRESSOR#0.6506;PROSTAGLANDIN E2#0.6499;CARDIOGENESIS#0.6495;INSULIN SECRETION#0.6492;HEPATITIS B#0.6491;OBSTRUCTIVE SLEEP APNEA#0.6489;HYPERSENSITIVITY#0.6479;ISCHEMIA REPERFUSION INJURY#0.6476;CHROMATIN ORGANIZATION#0.6473;MOUSE EMBRYO FIBROBLASTS#0.6467;DNA REPAIR PROTEIN#0.6460;FIBROSARCOMA#0.6450;PLASMA MEMBRANE#0.6433;MILD COGNITIVE IMPAIRMENT#0.6426;KAPOSI'S SARCOMA#0.6426;ENDOMETRIAL CANCER#0.6407;HEME OXYGENASE 1#0.6389;MUSCULAR DYSTROPHY#0.6385;PRECURSOR CELL#0.6375;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6366;LUPUS ERYTHEMATOSUS#0.6364;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6363;TRAP COMPLEX#0.6311;SHORT TERM MEMORY#0.6295;NUCLEAR EXPORT SIGNAL#0.6291;RECEPTOR TRANSACTIVATION#0.6284;DIHYDROTESTOSTERONE#0.6283;CONGENITAL DISORDER#0.6281;REGULATION OF AUTOPHAGY#0.6276;HUMAN DENTAL PULP#0.6262;SPERMIDINE#0.6261;ATP-DEPENDENT CHROMATIN REMODELING#0.6253;CARBOXYL-TERMINAL BINDING#0.6252;TYROSINE KINASE INHIBITOR#0.6250;CELL PHYSIOLOGY#0.6246;CELLULAR RESPONSE TO HYPOXIA#0.6245;CYTOCHROME P450#0.6242;STEROL REGULATORY ELEMENT#0.6237;CORONARY ARTERY#0.6234;PODOCYTE#0.6226;DENTAL PULP#0.6215;MOLECULAR DYNAMICS SIMULATION#0.6212;DENTATE GYRUS#0.6205;CREATINE KINASE#0.6204;HEPATITIS B VIRUS#0.6202;INVASIVE BREAST CANCER#0.6201;CHONDROGENESIS#0.6186;VASCULAR DISEASE#0.6183;PRC2 COMPLEX#0.6182;RESPONSE TO DOXORUBICIN#0.6167;AFRICAN SWINE FEVER#0.6135;PHOSPHATASE AND TENSIN HOMOLOG#0.6133;UBIQUITIN PROTEASOME SYSTEM#0.6131;MUSCLE ATROPHY#0.6130;HUMAN DERMAL FIBROBLAST#0.6115;HEPATOCELLULAR CARCINOMA CELL#0.6115;CEREBRAL CORTEX#0.6113;CARDIAC MUSCLE#0.6112;REGULATION OF CELLULAR#0.6107;RENAL FIBROSIS#0.6102;HODGKIN'S LYMPHOMA#0.6101;CHRONIC SCHIZOPHRENIA#0.6095;TELOMERASE REVERSE TRANSCRIPTASE#0.6094;TRANSCRIPTIONALLY ACTIVE CHROMATIN#0.6090;PARATHYROID#0.6086;SKIN CANCER#0.6084;PHOSPHOLIPASE C#0.6079;NEURAL CREST#0.6073;DNA FRAGMENTATION#0.6050;DENTAL PULP CELL#0.6043;NATRIURETIC PEPTIDE RECEPTOR#0.6025;CONJUGATION#0.6017;SELECTIN#0.6015;MOUSE MESANGIAL CELLS#0.6013;SALT INDUCIBLE KINASE#0.6009
203413	LUNG CANCER#1.0854;CANCER TESTIS ANTIGEN#1.0759;BREAST CANCER#0.8908;T CELL#0.8384;GENE EXPRESSION#0.7821;PYLORIC GLAND#0.6814
203427	BREAST CANCER#1.0569;CELL CYCLE#0.8758;S PHASE#0.7724;BREAST CANCER CELL#0.6955;CANCER CELL#0.6900;BASAL CELL CARCINOMA#0.6554;BASAL CELL#0.6484
203430	MACROPHAGE#0.6721;YOLK SAC#0.6444
203447	PLACENTAL DEVELOPMENT#0.7811;X CHROMOSOME#0.7712;GERMINAL CENTER#0.6979;SKELETAL MUSCLE#0.6878;STEM CELL#0.6847;MAMMARY GLAND#0.6388
2034	NEUROBLASTOMA#1.0390;DNA BINDING#1.0246;PARAGANGLIOMA#1.0222;POLYCYTHEMIA#1.0219;CARBONIC ANHYDRASE 9#1.0178;LUNG CANCER#1.0167;TRANSACTIVATION#1.0164;PULMONARY HYPERTENSION#1.0129;RENAL CARCINOMA#1.0118;ADENOCARCINOMA#1.0098;HYPOXIA RESPONSE ELEMENT#1.0097;ENDOTHELIAL CELL#1.0035;CHONDROCYTE#1.0007;RNA INTERFERENCE#1.0002;VASCULAR ENDOTHELIAL CELL#1.0000;STEM CELL#0.9998;PHEOCHROMOCYTOMA#0.9998;HYPOXIA#0.9971;BREAST CANCER#0.9968;MACROPHAGE#0.9959;POLYMERASE CHAIN REACTION#0.9933;CLEAR CELL RENAL CELL CARCINOMA#0.9908;RESPONSE TO HYPOXIA#0.9900;TUMOR CELLS#0.9896;ERYTHROPOIESIS#0.9875;CELL DEATH#0.9868;ENDOTHELIAL GROWTH FACTOR#0.9866;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9866;HYPOXIA INDUCIBLE FACTOR#0.9865;HYPERTENSION#0.9862;ISCHEMIA#0.9861;CANCER CELL#0.9852;CELL PROLIFERATION#0.9849;VON HIPPEL LINDAU#0.9848;EPITHELIAL CELL#0.9847;HYPOXIC#0.9846;TRANSCRIPTION FACTOR#0.9820;RENAL CELL CARCINOMA#0.9808;GROWTH FACTOR#0.9802;ANGIOGENESIS#0.9791;APOPTOSIS#0.9771;COLORECTAL#0.9767;GENE EXPRESSION#0.9765;CELL CYCLE#0.9739;HEPATOCELLULAR CARCINOMA#0.9738;REACTIVE OXYGEN SPECIES#0.9738;COLORECTAL CANCER#0.9732;SIGNALING PATHWAY#0.9731;TUMOR SUPPRESSOR#0.9725;ONCOGENIC#0.9711;HYPOXIA RESPONSIVE ELEMENT#0.9590;GLYCOLYSIS#0.9581;PROLYL HYDROXYLASE DOMAIN#0.9557;LUNG ADENOCARCINOMA#0.9540;NERVOUS SYSTEM#0.9535;CELL DIFFERENTIATION#0.9531;ENDOTHELIUM#0.9528;CELL GROWTH#0.9499;REVERSE TRANSCRIPTION#0.9465;HEPATOCELLULAR CARCINOMA CELL#0.9452;UBIQUITIN#0.9402;TUMOR TISSUES#0.9373;DNA METHYLATION#0.9370;GROWTH FACTOR RECEPTOR#0.9318;EXTRACELLULAR MATRIX#0.9302;SOMATOSTATINOMA#0.9299;ARYL HYDROCARBON RECEPTOR#0.9291;SMOOTH MUSCLE#0.9268;PROSTATE CANCER#0.9262;BLOOD VESSEL#0.9257;STROMAL CELL#0.9103;THYMIDINE PHOSPHORYLASE#0.9034;BREAST CANCER CELL#0.9034;CELL MIGRATION#0.9026;EMBRYONIC STEM CELL#0.8986;SKELETAL MUSCLE#0.8955;CYTOPLASM#0.8952;ARTERY#0.8940;ANEMIA#0.8910;CELLULAR RESPONSE TO HYPOXIA#0.8903;PROTEIN KINASE#0.8864;NEURAL CREST#0.8792;QUANTITATIVE REAL TIME#0.8791;PROLYL 4-HYDROXYLASE#0.8789;BONE MARROW#0.8770;OXYGEN DEPENDENT DEGRADATION#0.8760;ADIPOGENESIS#0.8756;RAPAMYCIN#0.8754;OXYGEN HOMEOSTASIS#0.8752;LYMPH NODE#0.8740;KINASE INHIBITOR#0.8697;TUMOR NECROSIS FACTOR#0.8675;PROTEASOME#0.8633;HEPATOMA CELLS#0.8543;CHROMAFFIN CELL#0.8494;COLON CANCER#0.8477;INFLAMMATORY RESPONSE#0.8468;FIBROBLAST GROWTH FACTOR#0.8467;HEART DISEASE#0.8467;EPIDERMAL GROWTH FACTOR#0.8397;RECEPTOR TYROSINE KINASE#0.8375;INSULIN-LIKE GROWTH FACTOR#0.8360;PROGENITOR CELL#0.8352;SORAFENIB#0.8318;PULMONARY ARTERY#0.8254;NECK CANCER#0.8235;HIF PROLYL HYDROXYLASE#0.8231;STROMA#0.8217;ERYTHROPOIETIN RECEPTOR#0.8192;NITRIC OXIDE#0.8182;RENAL CANCER CELLS#0.8146;OSTEOARTHRITIS#0.8146;TRANSFORMING GROWTH FACTOR#0.8075;TUMOR ASSOCIATED MACROPHAGE#0.8073;THYMIDINE#0.8060;GLUCOSE METABOLISM#0.8009;CANCER STEM CELL#0.7985;CONGENITAL HEART DISEASE#0.7972;HEAD AND NECK CANCER#0.7840;TARGET OF RAPAMYCIN#0.7838;ISCHEMIA REPERFUSION INJURY#0.7824;MUSCLE CELL#0.7808;NEUROENDOCRINE TUMOR#0.7785;APOPTOTIC#0.7780;PLATELET-DERIVED GROWTH FACTOR#0.7777;NITRIC OXIDE SYNTHASE#0.7715;TRANSCRIPTASE#0.7663;VON HIPPEL-LINDAU DISEASE#0.7645;PROTEIN PROTEIN INTERACTION#0.7587;CYTOTROPHOBLAST#0.7437;SMOOTH MUSCLE CELL#0.7426;PANCREATIC CANCER#0.7393;DOMINANT NEGATIVE MUTANT#0.7389;PROTEIN STABILIZATION#0.7349;CHEMOKINE RECEPTOR#0.7227;REGENERATION#0.7191;PULMONARY VASCULAR REMODELING#0.7176;HEMANGIOBLASTOMA#0.7159;CELL CYCLE ARREST#0.7091;SUCCINATE DEHYDROGENASE#0.6987;MYOCYTES#0.6977;ADIPOCYTE#0.6957;ELECTROPHORETIC MOBILITY SHIFT#0.6944;SUNITINIB#0.6932;COLORECTAL ADENOCARCINOMA#0.6922;LYMPH NODE METASTASIS#0.6830;ANDROGEN RECEPTOR#0.6825;IRON REGULATORY PROTEIN#0.6823;CELL ADHESION#0.6820;KIDNEY DEVELOPMENT#0.6812;ENDOCHONDRAL OSSIFICATION#0.6799;EDEMA#0.6785;HUMAN BREAST CANCER#0.6755;UBIQUITIN LIGASE COMPLEX#0.6733;SQUAMOUS CELL CARCINOMA#0.6705;PROGESTERONE#0.6704;PERIPHERAL BLOOD#0.6684;KIDNEY CANCER#0.6666;OSSIFICATION#0.6575;TYROSINE KINASE INHIBITOR#0.6565;LUNG DEVELOPMENT#0.6535;PROLYL HYDROXYLASE INHIBITOR#0.6519;LUCIFERASE ACTIVITY#0.6488;VASCULOGENESIS#0.6478;UTERUS#0.6475;NOREPINEPHRINE#0.6463;DRUG RESISTANCE#0.6443;RED BLOOD CELL#0.6433;CYTOCHROME C#0.6423;SUPEROXIDE DISMUTASE#0.6417;VEGF PRODUCTION#0.6359;DUODENAL SOMATOSTATINOMA#0.6331;ADRENAL MEDULLA#0.6322;OSTEOARTHRITIC CARTILAGE#0.6311;ALANINE#0.6289;BREAST CANCER PATIENTS#0.6230;CELL SURFACE#0.6227;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6195;HUMAN HEPATOMA CELL LINES#0.6188;RESPIRATORY DISTRESS#0.6185;MICROVASCULAR ENDOTHELIAL CELL#0.6182;NODULAR MALIGNANT MELANOMA#0.6177;QUANTITATIVE REVERSE TRANSCRIPTION#0.6175;MYOCARDIUM#0.6172;AKT SIGNALING#0.6163;TUBE FORMATION#0.6148;GLIAL CELL#0.6148;MESENCHYMAL STEM CELL#0.6143;FACTOR I#0.6139;ENDOMETRIAL ADENOCARCINOMA#0.6116;FACTOR INHIBITING HIF#0.6110;GLOMUS CELL#0.6106;TROPHOBLAST#0.6090;MITOCHONDRIA#0.6047;PLACENTAL DEVELOPMENT#0.6028
203547	MYOPATHY#1.1030;AUTOPHAGY#1.0964;DANON DISEASE#0.8965;AUTOPHAGIC VACUOLE#0.8439;VACUOLE#0.8178;SKELETAL MUSCLE#0.8103;LYSOSOME#0.6728;PROTON PUMP#0.6655;ACIDIFICATION#0.6015
203562	METASTATIC MELANOMA#0.9124
2035	SPECTRIN#1.0393;PROTEIN TYROSINE PHOSPHATASE#1.0343;PROTEIN KINASE#1.0220;PLASMA MEMBRANE#1.0067;ERYTHROCYTE#1.0010;HEREDITARY ELLIPTOCYTOSIS#0.9953;ACTIN FILAMENT#0.9925;PROTEIN KINASE C#0.9915;RED BLOOD CELL#0.9891;SKELETON#0.9878;ERYTHROCYTE MEMBRANES#0.9833;CELL MEMBRANE#0.9820;TUMOR SUPPRESSOR#0.9409;SPECTRIN BINDING#0.8954;FOCAL ADHESION#0.8901;ACTIN BINDING#0.8817;CELL ADHESION#0.8673;SIGNAL TRANSDUCTION#0.8439;ANEMIA#0.8362;ERYTHROID CELL#0.8224;DODECYL SULFATE#0.8203;SODIUM DODECYL SULFATE#0.8044;ACTIN CYTOSKELETON#0.7874;HEREDITARY SPHEROCYTOSIS#0.7832;FOCAL ADHESION KINASE#0.7769;GENE EXPRESSION#0.7605;DIGESTION#0.7594;ACTIN POLYMERIZATION#0.7580;GLOBIN#0.6953;PROTEIN PROTEIN INTERACTION#0.6813;CELL PROLIFERATION#0.6758;A BAND#0.6614;EXTRACELLULAR MATRIX#0.6484;CELL SURFACE#0.6475;ENDOTHELIAL CELL#0.6469;HEMOLYTIC ANEMIA#0.6454;C TERMINAL DOMAIN#0.6359;CYTOPLASM#0.6165
203859	MYOPATHY#1.0785;LIMB-GIRDLE MUSCULAR DYSTROPHY#1.0718;MUSCULAR DYSTROPHY#1.0629;CHLORIDE CHANNEL#1.0363;SKELETAL MUSCLE#1.0277;PLASMA MEMBRANE#0.7931;CREATINE KINASE#0.7856;PHOSPHOLIPID SCRAMBLING#0.7065;MUSCLE WEAKNESS#0.6982;OSTEOBLAST#0.6958;CREATINE#0.6515;SPERM MOTILITY#0.6204
2038	ERYTHROCYTE#1.0491;HEREDITARY SPHEROCYTOSIS#1.0298;RED BLOOD CELL#0.8622;CELL MEMBRANE#0.8522;HEMOLYTIC ANEMIA#0.8493;ANEMIA#0.8151;RETICULOCYTE#0.7917;SPECTRIN#0.7858;ERYTHROID PROGENITOR#0.7105;ERYTHROID CELL#0.7100;DNA BINDING#0.6967;POLYMERASE CHAIN REACTION#0.6954
2039	CORTICAL CYTOSKELETON#0.8478
203	CREATINE KINASE#1.0425;CREATINE#1.0392;ADENYLATE KINASE#1.0370;PYRUVATE KINASE#1.0367;ADENYLATE#1.0286;PYRUVATE#1.0203;ADENOSINE#1.0201;SKELETAL MUSCLE#1.0034;ACID PHOSPHATASE#0.9854;KINASE ACTIVITY#0.9616;ADENINE#0.9574;GLYCERALDEHYDE-3-PHOSPHATE#0.9343;ATP SYNTHASE#0.9282;ADENOSINE TRIPHOSPHATE#0.9247;ERYTHROCYTE#0.9247;ADENOSINE DEAMINASE#0.9104;ENZYME ACTIVITY#0.9096;MITOCHONDRIA#0.8986;DIPHOSPHATE#0.8832;ADENYLATE KINASE ACTIVITY#0.8217;MUSCLE FIBRE#0.7926;ADENOSINE-5'-PENTAPHOSPHATE#0.7776;ATP SYNTHESIS#0.7555;AMP DEAMINASE#0.7435;PHOSPHOGLYCERATE KINASE#0.7117;OUTER DENSE FIBER#0.7110;ADENOSINE KINASE#0.7061;REGENERATION#0.6898;MUSCLE FIBER#0.6864;MALATE DEHYDROGENASE#0.6842;CREATINE KINASE ACTIVITY#0.6748;GLYCOLYSIS#0.6704;PROTEIN KINASE#0.6588;ADENOSINE MONOPHOSPHATE#0.6545;GLUCOSE-6-PHOSPHATE#0.6520;MYOBLAST#0.6393;HEMOLYTIC ANEMIA#0.6386;ATP REGENERATION#0.6252;TRIOSE PHOSPHATE ISOMERASE#0.6242;PATELLA#0.6152;NUCLEOSIDE DIPHOSPHATE KINASE#0.6045;OXIDATIVE PHOSPHORYLATION#0.6038;GLYCOGEN PHOSPHORYLASE#0.6012
204010	PITUITARY ADENOMA#0.9693;RNA BINDING PROTEIN#0.7628;RNA BINDING#0.7608;CELL CYCLE#0.7523
2040	ION CHANNEL#1.0517;LIPID RAFT#1.0453;ERYTHROCYTE#1.0434;PLASMA MEMBRANE#1.0251;DETERGENT RESISTANT MEMBRANE#0.9683;CELL MEMBRANE#0.9523;EPITHELIAL CELL#0.9490;RED BLOOD CELL#0.9345;GLUCOSE TRANSPORT#0.9177;LUNG CANCER#0.9076;HEMOLYTIC ANEMIA#0.8914;SQUAMOUS CELL CARCINOMA#0.8885;ANESTHETIC#0.8728;T CELL#0.8549;ERYTHROCYTE MEMBRANES#0.7992;MEMBRANE RAFT#0.7852;ANEMIA#0.7704;NERVOUS SYSTEM#0.7600;MITOCHONDRIA#0.7106;T CELL ACTIVATION#0.6966;MITOCHONDRIAL MEMBRANE#0.6950;CELL ACTIVATION#0.6944;MITOCHONDRIAL INNER MEMBRANE#0.6910;LYMPH NODE#0.6799;CERVICAL CANCER#0.6795;APOPTOSIS#0.6705;CANCER CELL#0.6318;HYPOXIA#0.6282;CELL GROWTH#0.6227;CELL PROLIFERATION#0.6172;CEREBRAL CORTEX#0.6119;CELL FUSION#0.6058;BREAST CANCER#0.6057
2041	TYROSINE KINASE RECEPTOR#1.0566;EPHRIN#1.0368;CELL COMMUNICATION#1.0344;AXON GUIDANCE#1.0220;RECEPTOR TYROSINE KINASE#1.0198;CELL CELL ADHESION#1.0189;GROWTH CONE#1.0141;ANGIOGENESIS#1.0140;SIGNALING PATHWAY#1.0127;MORPHOGENESIS#1.0123;CELL MIGRATION#1.0110;CELL ADHESION#1.0102;EPITHELIAL CELL#1.0099;CELL SURFACE#1.0097;CANCER CELL#1.0079;KINASE ACTIVITY#1.0077;NERVOUS SYSTEM#1.0023;SIGNAL TRANSDUCTION#1.0011;CELL PROLIFERATION#0.9997;T CELL#0.9991;ENDOTHELIAL CELL#0.9977;ALZHEIMER'S DISEASE#0.9973;STEM CELL#0.9959;CENTRAL NERVOUS SYSTEM#0.9935;GROWTH CONE COLLAPSE#0.9918;GROWTH FACTOR#0.9817;COLORECTAL CANCER#0.9806;GENE EXPRESSION#0.9803;ENDOCYTOSIS#0.9763;ONCOGENIC#0.9716;RECEPTOR LIGAND#0.9706;PROTEIN TYROSINE KINASE#0.9705;COLORECTAL#0.9692;BREAST CANCER#0.9680;SPINAL CORD#0.9584;REGENERATION#0.9581;SIGNALING MOLECULE#0.9559;INNERVATION#0.9524;NEURITE#0.9496;APOPTOSIS#0.9478;AXON PATHFINDING#0.9441;B CELL#0.9352;PROTEIN KINASE#0.9325;LYMPH NODE#0.9322;EMBRYO IMPLANTATION#0.9304;SIGNALLING PATHWAY#0.9251;ENDOMETRIAL EPITHELIAL CELLS#0.9248;PROGENITOR CELL#0.9217;HINDBRAIN#0.9191;CELL MEMBRANE#0.9186;TUMOR CELLS#0.9051;CELL DIFFERENTIATION#0.9050;LYMPH NODE METASTASIS#0.9035;MOTOR AXON GUIDANCE#0.9017;ACTIN CYTOSKELETON#0.8846;CELL DEATH#0.8842;POLYMERASE CHAIN REACTION#0.8754;BLOOD VESSEL#0.8722;AXON GROWTH#0.8668;NEURAL CREST#0.8664;HEPATOCELLULAR CARCINOMA#0.8634;TECTUM#0.8605;OVARIAN CANCER#0.8600;PROSTATE CANCER#0.8501;COCHLEA#0.8429;CELL MOVEMENT#0.8429;EXTRACELLULAR MATRIX#0.8408;ASTROCYTE#0.8396;PLASMA MEMBRANE#0.8383;RETINAL GANGLION CELL#0.8370;EPHRIN RECEPTOR#0.8352;SYSTEM DEVELOPMENT#0.8305;CELL DEVELOPMENT#0.8117;PROTEIN PROTEIN INTERACTION#0.8109;THYMOCYTE#0.8097;RHOMBOMERE#0.8067;TRANSCRIPTION FACTOR#0.7978;MIDLINE#0.7968;SQUAMOUS CELL CARCINOMA#0.7968;RENAL CELL CARCINOMA#0.7907;OVARIAN#0.7901;BONE REMODELING#0.7901;NEURITE OUTGROWTH#0.7805;APOPTOTIC#0.7803;MITOGEN ACTIVATED PROTEIN#0.7789;TUMOR SUPPRESSOR#0.7786;INNER EAR#0.7755;COLON CANCER#0.7684;SOMITE#0.7682;TISSUE HOMEOSTASIS#0.7656;NEUROEPITHELIAL CELL#0.7649;GANGLION CELLS#0.7600;SIGNALING CASCADE#0.7598;QUANTITATIVE REAL TIME#0.7581;ADENOCARCINOMA#0.7535;DENDRITIC SPINE#0.7512;PROTEIN TYROSINE PHOSPHATASE#0.7477;NEURODEGENERATIVE DISEASE#0.7465;STROMAL CELL#0.7461;CELL MOTILITY#0.7432;CARDIOVASCULAR SYSTEM#0.7407;SUPERIOR COLLICULUS#0.7382;IMMUNE SYSTEM#0.7375;NEURAL CREST CELL#0.7325;OPTIC NERVE#0.7293;PURKINJE CELL#0.7253;FIBROBLAST GROWTH FACTOR#0.7171;TISSUE DEVELOPMENT#0.7128;REVERSE TRANSCRIPTION#0.7099;SMOOTH MUSCLE#0.7090;PATTERN FORMATION#0.7077;ONCOGENESIS#0.7066;LEUKOCYTE#0.6914;NERVE FIBER#0.6891;CONTACT INHIBITION#0.6836;BONE MARROW#0.6830;TRANSMEMBRANE RECEPTOR#0.6776;TRANSCRIPTASE#0.6756;RECEPTOR BINDING#0.6756;SCHWANN CELL#0.6747;GROWTH FACTOR RECEPTOR#0.6722;CELL CYCLE#0.6709;LIGAND BINDING DOMAIN#0.6639;VASCULOGENESIS#0.6581;THALAMUS#0.6520;VASCULAR ENDOTHELIAL CELL#0.6489;CELL DIVISION#0.6480;CEREBRAL CORTEX#0.6464;CELL BOUND#0.6341;MONOCYTE#0.6304;THYMIC EPITHELIAL CELLS#0.6287;SCHWANN CELL MIGRATION#0.6285;NEURONAL MIGRATION#0.6285;RHOMBOMERE BOUNDARY FORMATION#0.6276;ENDOMETRIUM#0.6228;ACTOMYOSIN#0.6186;FOCAL ADHESION#0.6153;ENDOTHELIAL CELL MIGRATION#0.6123;FOREBRAIN#0.6120;ENDOTHELIAL GROWTH FACTOR#0.6113;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6113;EPITHELIAL TISSUES#0.6111;OSTEOBLAST#0.6087;NEURAL STEM CELL#0.6052;MESENCHYME#0.6051
204219	KERATINOCYTE#0.8212;ICHTHYOSIS#0.8198;AUTOSOMAL RECESSIVE CONGENITAL ICHTHYOSIS#0.7385;CERAMIDE SYNTHESIS#0.6997;GENE EXPRESSION#0.6580;GERM CELL#0.6268
2042	EPHRIN#1.0356;CANCER CELL#1.0137;RECEPTOR TYROSINE KINASE#1.0106;SIGNALING PATHWAY#0.9786;TUMOR SUPPRESSOR#0.9776;EPHRIN RECEPTOR#0.9687;TRANSCRIPTION FACTOR#0.9570;SUPERIOR COLLICULUS#0.9545;GENE EXPRESSION#0.9522;HEPATOCELLULAR CARCINOMA#0.9517;GROWTH FACTOR#0.9492;CELL MIGRATION#0.9434;TUMOR CELLS#0.9305;LUNG CANCER#0.9194;COLORECTAL CANCER#0.9171;AXON GROWTH#0.9144;RETINAL GANGLION CELL#0.9141;APOPTOSIS#0.9080;COLORECTAL#0.9027;CELL ADHESION#0.8987;CELL SURFACE#0.8854;EPITHELIAL CELL#0.8854;PROSTATE CANCER#0.8745;ANGIOGENESIS#0.8305;TECTUM#0.8231;T CELL#0.8217;GROWTH CONE COLLAPSE#0.8208;GROWTH CONE#0.8119;PROTEIN KINASE#0.8113;POLYMERASE CHAIN REACTION#0.7987;AXON GUIDANCE#0.7854;TYROSINE KINASE RECEPTOR#0.7725;PLASMA MEMBRANE#0.7674;COPY NUMBER VARIATION#0.7592;ANDROGEN RECEPTOR#0.7505;COLON CANCER#0.7496;STROMAL CELL#0.7489;KINASE ACTIVITY#0.7459;STEM CELL#0.7140;BONE MARROW#0.6977;CELL CYCLE#0.6973;JUXTAMEMBRANE#0.6924;ENDOSOME#0.6821;LYMPH NODE METASTASIS#0.6789;CELL PROLIFERATION#0.6766;MULTIPLE MYELOMA#0.6755;LYMPH NODE#0.6741;GANGLION CELLS#0.6626;EPIDERMAL GROWTH FACTOR#0.6558;ADENOCARCINOMA#0.6524;ONCOGENIC#0.6381;INTERNEURON#0.6320;SPINAL CORD#0.6309;REVERSE TRANSCRIPTION#0.6263;MORPHOGENESIS#0.6253;CELL GROWTH#0.6204;ENDOTHELIAL CELL#0.6194;RECEPTOR CLUSTERING#0.6110;DNA METHYLATION#0.6085;SIGNAL TRANSDUCTION#0.6047
2043	DENDRITIC SPINE#1.0598;LIGAND BINDING DOMAIN#1.0591;ASTROCYTE#1.0534;SPINAL CORD INJURY#1.0512;TYROSINE KINASE RECEPTOR#1.0423;EPHRIN RECEPTOR#1.0408;AXON GUIDANCE#1.0323;SPINAL CORD#1.0286;GROWTH CONE#1.0278;NEURAL CREST#1.0258;REGENERATION#1.0255;CANCER CELL#1.0254;MIDLINE#1.0253;EPHRIN#1.0229;CELL ADHESION#1.0169;HINDLIMB#1.0152;INTERNEURON#1.0097;SIGNALING PATHWAY#1.0079;CENTRAL NERVOUS SYSTEM#1.0035;GROWTH CONE COLLAPSE#1.0014;RECEPTOR TYROSINE KINASE#1.0000;ENDOTHELIAL CELL#0.9998;NERVOUS SYSTEM#0.9995;GENE EXPRESSION#0.9912;CELL MIGRATION#0.9873;KINASE ACTIVITY#0.9833;ISCHEMIA#0.9651;ALZHEIMER'S DISEASE#0.9621;PRECURSOR CELL#0.9620;APOPTOSIS#0.9596;T CELL#0.9587;TRANSCRIPTION FACTOR#0.9577;CELL PROLIFERATION#0.9569;CELL SURFACE#0.9532;HINDBRAIN#0.9511;FOREBRAIN#0.9508;GROWTH FACTOR#0.9414;CELL DEATH#0.9381;BREAST CANCER#0.9370;AMYOTROPHIC LATERAL SCLEROSIS#0.9342;LATERAL SCLEROSIS#0.9342;NEURAL CREST CELL#0.9277;STEM CELL#0.9264;SOMITE#0.9127;D-SERINE#0.9125;ACTIN CYTOSKELETON#0.9125;PROGENITOR CELL#0.9121;PURKINJE CELL#0.9035;RETINAL GANGLION CELL#0.8973;CEREBRAL CORTEX#0.8928;NEURITE#0.8847;RHOMBOMERE#0.8754;MONOCYTE#0.8742;PROTEIN KINASE#0.8599;PLASMA MEMBRANE#0.8489;BLOOD VESSEL#0.8453;PROTEIN TYROSINE KINASE#0.8449;NEURITE OUTGROWTH#0.8442;INNER EAR#0.8365;LYMPH NODE#0.8321;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8259;CELL ADHESION MOLECULE#0.8237;FIBROBLAST GROWTH FACTOR#0.8226;NEUROGENESIS#0.8134;REVERSE TRANSCRIPTION#0.8102;SYSTEM DEVELOPMENT#0.8084;GANGLION CELLS#0.8057;LONG TERM POTENTIATION#0.8044;NERVOUS SYSTEM DEVELOPMENT#0.8021;KINASE INHIBITOR#0.8013;BONE RESORPTION#0.7951;POLYMERASE CHAIN REACTION#0.7949;LYMPH NODE METASTASIS#0.7942;MESENCHYME#0.7918;NEUROMUSCULAR JUNCTION#0.7912;SCHWANN CELL#0.7901;COLORECTAL#0.7892;SMOOTH MUSCLE#0.7877;ANGIOGENESIS#0.7842;B CELL#0.7836;INNERVATION#0.7740;SIGNALLING PATHWAY#0.7716;COLORECTAL CANCER#0.7695;RHOMBOMERE BOUNDARY FORMATION#0.7651;GROWTH FACTOR RECEPTOR#0.7586;OSTEOCLAST#0.7563;CHLORIDE CHANNEL#0.7541;JUXTAMEMBRANE#0.7521;EPITHELIAL CELL#0.7460;OPTIC NERVE#0.7440;LOCOMOTION#0.7417;APOPTOTIC#0.7324;SIGNAL TRANSDUCTION#0.7249;THALAMUS#0.7242;AXON GROWTH#0.7199;SOMITOGENESIS#0.7132;MORPHOGENESIS#0.7080;NEURODEGENERATIVE DISEASE#0.7031;NEURONAL CELLS#0.6910;STRIATUM#0.6879;BREAST CANCER CELL#0.6868;ORGAN OF CORTI#0.6848;AXON REGENERATION#0.6846;BENZOIC ACID#0.6812;DISEASE SPECIFIC SURVIVAL#0.6795;GLIAL CELL#0.6778;EXTRACELLULAR MATRIX#0.6776;CATALYTIC ACTIVITY#0.6747;PANCREATIC CANCER#0.6742;TUMOR CELLS#0.6740;SCIATIC NERVE#0.6727;SUBSTANTIA NIGRA#0.6710;ONCOGENIC#0.6658;OLIGODENDROCYTE#0.6592;TUMOR SUPPRESSOR#0.6590;MOTOR AXON GUIDANCE#0.6576;MACROPHAGE#0.6517;SIGNALING CASCADE#0.6495;CELL CYCLE#0.6454;CELL GROWTH#0.6453;TYROSINE KINASE DOMAIN#0.6352;ADENOCARCINOMA#0.6336;SRC FAMILY KINASE#0.6322;SCHWANN CELL MIGRATION#0.6322;NEURAL CELL#0.6225;ASTROCYTE PRECURSOR CELL#0.6160;MIDBRAIN#0.6140;NEURAL STEM PROGENITOR#0.6065;NEURON SURVIVAL#0.6037;INFERIOR COLLICULUS#0.6030;RAPID EYE MOVEMENT#0.6019
204474	PROTEIN DISULFIDE ISOMERASE#1.0532;CHAPERONE ACTIVITY#0.8032;ENDOPLASMIC RETICULUM#0.6933
2044	EPHRIN#1.0542;RECEPTOR TYROSINE KINASE#0.9998;CANCER CELL#0.9944;NERVOUS SYSTEM#0.9760;AXON GUIDANCE#0.9747;GENE EXPRESSION#0.9653;BREAST CANCER#0.9503;TYROSINE KINASE RECEPTOR#0.9384;OPTIC NERVE#0.8662;EPHRIN RECEPTOR#0.8651;CONGENITAL HYPOTHYROIDISM#0.8332;LYMPH NODE METASTASIS#0.8123;LYMPH NODE#0.8061;PROTEIN KINASE#0.8034;DNA METHYLATION#0.7787;NEURITE#0.7778;NEURITE OUTGROWTH#0.7633;GROWTH FACTOR#0.7260;LUNG CANCER#0.7140;PROTEIN TYROSINE KINASE#0.7060;SYNAPTOGENESIS#0.7000;SPINAL CORD#0.6999;RETINAL GANGLION CELL#0.6897;BREAST CANCER CELL#0.6855;SUPERIOR COLLICULUS#0.6802;TRANSCRIPTION FACTOR#0.6796;SIGNALING PATHWAY#0.6556;HYPOGLYCEMIA#0.6415;HYPOTHYROIDISM#0.6394;BRAIN DEVELOPMENT#0.6342;GLUCOSE SENSING#0.6238;CENTRAL NERVOUS SYSTEM#0.6070;DENTATE GYRUS#0.6062;POLYMERASE CHAIN REACTION#0.6039
2045	EPHRIN#1.0384;TUMOR SUPPRESSOR#1.0368;RECEPTOR TYROSINE KINASE#1.0035;CANCER CELL#0.9832;GENE EXPRESSION#0.9668;APOPTOSIS#0.9621;B CELL#0.9423;COLORECTAL CANCER#0.9320;NERVOUS SYSTEM#0.9267;POLYMERASE CHAIN REACTION#0.8735;EPHRIN RECEPTOR#0.8650;LUNG CANCER#0.8558;CELL PROLIFERATION#0.8532;SQUAMOUS CELL CARCINOMA#0.8338;COLORECTAL#0.8198;GALLBLADDER ADENOCARCINOMA#0.8179;INNERVATION#0.8144;LYMPH NODE#0.8077;SIGNALING PATHWAY#0.7686;CELL GROWTH#0.7657;REVERSE TRANSCRIPTION#0.7510;PROSTATE CANCER#0.7500;PROGENITOR CELL#0.7370;NEURAL TUBE#0.7251;MIDLINE#0.7207;CELL SURFACE#0.7152;CELL MIGRATION#0.7119;SUPERIOR COLLICULUS#0.7012;AXON GUIDANCE#0.6953;APOPTOTIC#0.6904;FOLLICULAR LYMPHOMA#0.6738;THALAMUS#0.6643;CELL DEATH#0.6613;STRIATUM#0.6448;ADENOCARCINOMA#0.6420;QUANTITATIVE REAL TIME#0.6290;ENDOTHELIAL CELL#0.6256;GROWTH FACTOR#0.6235;TRANSCRIPTION FACTOR#0.6206;PRONEPHROS DEVELOPMENT#0.6085;CELL ADHESION#0.6054;OVARIAN CANCER#0.6004
2046	EPHRIN#1.0417;KINASE ACTIVITY#1.0250;CELL MIGRATION#0.9437;RECEPTOR TYROSINE KINASE#0.8966;CELL ADHESION#0.8049;SIGNALING PATHWAY#0.7690;PROTEIN KINASE#0.7373;JUXTAMEMBRANE#0.7281;PHOSPHOTYROSINE BINDING#0.6532;NUCLEOTIDE EXCHANGE FACTOR#0.6382;MAP KINASE#0.6322;ENDOCYTOSIS#0.6104
2047	EPHRIN#1.0223;TRANSCRIPTION FACTOR#1.0155;RECEPTOR TYROSINE KINASE#0.9879;SPINAL CORD#0.9828;GROWTH FACTOR#0.9826;SIGNALING PATHWAY#0.9771;CELL MIGRATION#0.9637;RETINAL GANGLION CELL#0.9451;PHOTOSYNTHESIS#0.9411;AXON GUIDANCE#0.9336;ENDOTHELIAL CELL#0.9332;NERVOUS SYSTEM#0.9192;GENE EXPRESSION#0.9184;BONE CANCER#0.8999;COLORECTAL CANCER#0.8874;CANCER CELL#0.8831;CELL ADHESION#0.8660;KINASE ACTIVITY#0.8660;ASTROCYTE#0.8508;PROTEIN KINASE#0.8285;MICROGLIAL CELL#0.7959;LYMPH NODE#0.7887;POLYMERASE CHAIN REACTION#0.7806;COLORECTAL#0.7758;ANGIOGENESIS#0.7652;CELL SURFACE#0.7628;EPHRIN RECEPTOR#0.7544;SYSTEM DEVELOPMENT#0.7537;PROGENITOR CELL#0.7487;TUMOR SUPPRESSOR#0.7479;AXON PATHFINDING#0.7131;MIDLINE#0.7105;GROWTH CONE#0.6913;RUBISCO ACTIVITY#0.6531;REVERSE TRANSCRIPTION#0.6502;GANGLION CELLS#0.6370;STRIATUM#0.6370;CELL ADHESION MOLECULE#0.6336;MICROVASCULAR ENDOTHELIAL CELL#0.6320;COLON CANCER#0.6318;EPIDERMAL GROWTH FACTOR#0.6288;CELL GROWTH#0.6284;ROOF PLATE#0.6277;TUMOR NECROSIS FACTOR#0.6187;STEM CELL#0.6183;RESPIRATION#0.6110;CALCIUM TRANSPORT#0.6090;NERVOUS SYSTEM DEVELOPMENT#0.6054;NEURAL CREST CELL#0.6022
204801	SIGNALING PATHWAY#0.6480
204851	PROTEIN KINASE#1.0720;TRANSCRIPTION FACTOR#0.8751;BREAST CANCER#0.8163;APOPTOSIS#0.7840;CELL PROLIFERATION#0.7465;CANCER CELL#0.7190;MOUSE EMBRYONIC FIBROBLAST#0.7126;DESUMOYLATION#0.6390;CELL DEATH#0.6211
2048	EPHRIN RECEPTOR#1.0519;L-CYSTEINE#1.0489;GROWTH CONE#1.0322;MAP KINASE#1.0321;TYROSINE KINASE RECEPTOR#1.0218;NMDA RECEPTOR#1.0202;KINASE ACTIVITY#1.0197;EPHRIN#1.0192;MESANGIAL CELL#1.0158;PROSTATE CANCER#1.0128;TUMOR SUPPRESSOR#1.0125;COLORECTAL#1.0093;CELL ADHESION#1.0081;PROTEIN KINASE#1.0078;COLORECTAL CANCER#1.0046;SIGNALLING PATHWAY#1.0036;SIGNALING CASCADE#1.0032;ERK CASCADE#1.0028;CELL GROWTH#1.0016;SIGNALING PATHWAY#1.0015;ENDOTHELIAL CELL#1.0013;AKT SIGNALING#0.9988;T CELL#0.9951;CANCER CELL#0.9948;CELL SURFACE#0.9946;SPINAL CORD#0.9941;PROGENITOR CELL#0.9933;APOPTOTIC#0.9931;CELL PROLIFERATION#0.9921;CELL MIGRATION#0.9905;GLUTAMATE RECEPTOR#0.9903;EPIDERMAL GROWTH FACTOR#0.9886;EPITHELIAL CELL#0.9866;STEM CELL#0.9864;SIGNAL TRANSDUCTION#0.9863;TRANSCRIPTION FACTOR#0.9862;COLON CANCER#0.9834;AXON GUIDANCE#0.9832;RECEPTOR TYROSINE KINASE#0.9823;APOPTOSIS#0.9820;GROWTH FACTOR RECEPTOR#0.9811;GENE EXPRESSION#0.9807;BREAST CANCER#0.9805;CELL DEATH#0.9797;JUXTAMEMBRANE#0.9773;CELL CYCLE#0.9759;POLYMERASE CHAIN REACTION#0.9753;SCHWANN CELL#0.9740;KINASE INHIBITOR#0.9737;RENAL CELL CARCINOMA#0.9736;MITOGEN ACTIVATED PROTEIN#0.9732;GROWTH FACTOR#0.9727;DENDRITIC SPINE#0.9708;TUBULAR EPITHELIAL CELL#0.9696;ALZHEIMER'S DISEASE#0.9685;NERVOUS SYSTEM#0.9685;RENAL FIBROSIS#0.9609;B CELL#0.9599;ANGIOGENESIS#0.9565;TUMOR CELLS#0.9562;PROTEIN KINASE C#0.9536;AUTOPHAGY#0.9515;KIDNEY DISEASE#0.9514;NEURITE#0.9512;MACROPHAGE#0.9473;PANCREATIC CANCER#0.9454;MORPHOGENESIS#0.9435;ASPARTATE#0.9404;ISCHEMIA#0.9385;PROTEIN TYROSINE KINASE#0.9347;ENDOCYTOSIS#0.9329;FOCAL ADHESION#0.9314;GROWTH CONE COLLAPSE#0.9308;LONG TERM POTENTIATION#0.9300;TRANSFORMING GROWTH FACTOR#0.9276;EPITHELIAL MESENCHYMAL TRANSITION#0.9256;HEPARIN#0.9234;ADENOCARCINOMA#0.9224;MAPK SIGNALING#0.9190;NEUROGENESIS#0.9112;ENDOTHELIAL GROWTH FACTOR#0.9071;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9071;TOXICITY#0.9066;EXTRACELLULAR REGULATED KINASE#0.9058;ASTROCYTE#0.9033;FOCAL ADHESION KINASE#0.9011;RNA INTERFERENCE#0.8991;ONCOGENIC#0.8985;EXTRACELLULAR MATRIX#0.8935;REGENERATION#0.8905;CENTRAL NERVOUS SYSTEM#0.8806;MONOCYTE#0.8802;MIDLINE#0.8775;CELL DIFFERENTIATION#0.8707;WOUND HEALING#0.8620;TRANSACTIVATION#0.8608;DENTATE GYRUS#0.8600;POLYCYSTIC KIDNEY DISEASE#0.8595;NEPHROPATHY#0.8505;HYPERTENSION#0.8495;DIABETIC NEPHROPATHY#0.8431;PROTEIN KINASE A#0.8414;REVERSE TRANSCRIPTION#0.8402;THYMOCYTE#0.8398;ISCHEMIA REPERFUSION INJURY#0.8396;SIGNALING MOLECULE#0.8392;DEPHOSPHORYLATION#0.8387;NEUROBLASTOMA#0.8382;MUSCLE CELL#0.8367;CAMKII#0.8367;TUMOR NECROSIS FACTOR#0.8362;NEURONAL CELLS#0.8356;NEURAL CREST#0.8291;AMYGDALA#0.8289;RETINAL GANGLION CELL#0.8266;CELL ACTIVATION#0.8260;GLUTATHIONE#0.8259;RENAL ISCHEMIA REPERFUSION#0.8222;NITRIC OXIDE#0.8214;HYPOXIA#0.8161;NEURAL STEM CELL#0.8153;CELL ADHESION MOLECULE#0.8102;INTESTINAL STEM CELL#0.8091;LIGAND BINDING DOMAIN#0.8042;NEPHROTOXICITY#0.8021;PROTEIN KINASE B#0.8010;PLASMA MEMBRANE#0.7976;REACTIVE OXYGEN SPECIES#0.7970;CLEFT PALATE#0.7945;SMOOTH MUSCLE#0.7917;PROTEINURIA#0.7911;MUTAGENESIS#0.7874;CYCLIC AMP#0.7817;CHEMOTAXIS#0.7789;CHRONIC KIDNEY DISEASE#0.7769;LUNG CANCER#0.7742;OVARIAN#0.7724;GUANINE#0.7701;RECEPTOR LIGAND#0.7674;CYTOPLASM#0.7671;TYROSINE KINASE DOMAIN#0.7666;CANCER STEM CELL#0.7665;AMPA RECEPTOR#0.7662;TRANSMEMBRANE RECEPTOR#0.7650;INTESTINAL EPITHELIAL CELL#0.7644;SRC FAMILY KINASE#0.7636;FIBROBLAST GROWTH FACTOR#0.7636;RECEPTOR ANTAGONIST#0.7620;CLEAR CELL RENAL CELL CARCINOMA#0.7619;STEM CELL MARKER#0.7614;NUCLEOTIDE EXCHANGE FACTOR#0.7590;MITOCHONDRIA#0.7565;DOPAMINE#0.7559;MIDDLE CEREBRAL ARTERY#0.7544;CEREBRAL ARTERY#0.7541;PROXIMAL TUBULE CELL#0.7541;EXCRETION#0.7525;BONE MARROW#0.7505;CEREBRAL INFARCTION#0.7472;EPITHELIAL CELL PROLIFERATION#0.7468;TRANSFORMING GROWTH FACTOR BETA#0.7440;MESENCHYMAL STEM CELL#0.7439;OVARIAN CANCER#0.7408;SQUAMOUS CELL CARCINOMA#0.7395;TUMOR TISSUES#0.7390;RAPAMYCIN#0.7367;GLYCOGEN SYNTHASE KINASE#0.7364;DNA BINDING#0.7356;THYMIC EPITHELIAL CELLS#0.7350;CELL CYCLE ARREST#0.7326;QUANTITATIVE REAL TIME#0.7324;CELL COMMUNICATION#0.7302;DOMINANT NEGATIVE MUTANT#0.7278;MEMORY IMPAIRMENT#0.7277;CYTOTOXICITY#0.7256;OLFACTORY BULB#0.7210;CAMP RESPONSE ELEMENT#0.7202;CEREBRAL CORTEX#0.7198;CATALYTIC ACTIVITY#0.7192;LYMPH NODE#0.7182;STRIATUM#0.7179;ARTERY#0.7177;OSTEOBLAST#0.7153;DENDRITIC SPINE DEVELOPMENT#0.7109;PROXIMAL TUBULAR EPITHELIAL#0.7097;PRECURSOR CELL#0.7040;G1 PHASE#0.7010;CAMP RESPONSE ELEMENT BINDING#0.6979;PROTEIN SYNTHESIS#0.6973;NADPH OXIDASE#0.6943;PRO-INFLAMMATORY#0.6902;GLIAL CELL#0.6826;SMOOTH MUSCLE CELL#0.6803;AXON PATHFINDING#0.6772;PROTEIN PROTEIN INTERACTION#0.6759;NEURITE OUTGROWTH#0.6758;CELL MOTILITY#0.6753;S PHASE#0.6748;HYPOXIA INDUCIBLE FACTOR#0.6736;DNA SYNTHESIS#0.6726;COLORECTAL CARCINOMA#0.6716;NF-KAPPAB ACTIVATION#0.6707;CERVICAL CANCER#0.6696;LEUKOCYTE#0.6694;TARGET OF RAPAMYCIN#0.6688;ACUTE KIDNEY INJURY#0.6658;PERIPHERAL BLOOD#0.6587;STROMAL CELL#0.6558;OPTIC NERVE#0.6539;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.6530;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.6529;ADRENERGIC RECEPTOR#0.6514;PROXIMAL TUBULAR CELL#0.6512;ASPARTIC ACID#0.6489;SYNAPTIC TRANSMISSION#0.6476;HEPATOCYTE GROWTH FACTOR#0.6469;SMALL INTESTINE#0.6452;SYNAPTOGENESIS#0.6366;BLOOD UREA NITROGEN#0.6360;FRONTAL AFFINITY CHROMATOGRAPHY#0.6350;MEDULLOBLASTOMA#0.6258;INNER EAR#0.6255;PROTEASOME#0.6246;T CELL ACTIVATION#0.6234;AXON GROWTH#0.6210;SERUM RESPONSE FACTOR#0.6206;SH2 DOMAIN BINDING#0.6204;INTRACELLULAR SIGNALING PATHWAY#0.6203;PALATE DEVELOPMENT#0.6186;FRONTAL#0.6179;OOCYTE#0.6160;OUABAIN#0.6139;ESTROGEN RECEPTOR#0.6133;ACTIN CYTOSKELETON#0.6132;INSULIN-LIKE GROWTH FACTOR#0.6130;NITRIC OXIDE SYNTHASE#0.6128;AFRICAN AMERICAN MEN#0.6115;NEUROTOXICITY#0.6094;SOCIAL DEFEAT STRESS#0.6089;KERATINOCYTE#0.6075;ENDOTHELIUM#0.6056;LIVER METASTASIS#0.6054;CELL CELL ADHESION#0.6042;FOREBRAIN#0.6018;RENAL CANCER CELLS#0.6012;CELL CHEMOTAXIS#0.6009
204962	MELANOMA CELL LINES#0.6634
2049	EPHRIN#1.0335;COLORECTAL CANCER#1.0155;RECEPTOR TYROSINE KINASE#1.0148;PROGENITOR CELL#1.0124;EPITHELIAL CELL#1.0012;COLORECTAL#0.9768;CELL MIGRATION#0.9685;TUMOR SUPPRESSOR#0.9662;GROWTH FACTOR#0.9438;CELL DEATH#0.9101;ENDOTHELIAL CELL#0.9041;CELL GROWTH#0.8940;STEM CELL#0.8928;CELL ADHESION#0.8921;SPINAL CORD#0.8777;NERVOUS SYSTEM#0.8688;LYMPH NODE#0.8483;CANCER CELL#0.8459;SIGNALING PATHWAY#0.8352;D-SERINE#0.8306;CLEFT PALATE#0.8238;TRAUMATIC BRAIN INJURY#0.8152;PANETH CELL#0.8106;GENE EXPRESSION#0.8015;LYMPH NODE METASTASIS#0.7996;THYMIC EPITHELIAL CELLS#0.7967;LUNG CANCER#0.7945;TRANSCRIPTION FACTOR#0.7868;COLORECTAL CARCINOMA#0.7615;TYROSINE KINASE RECEPTOR#0.7586;POLYMERASE CHAIN REACTION#0.7324;CELL PROLIFERATION#0.7322;APOPTOSIS#0.7283;AXON GUIDANCE#0.7207;NEURAL CREST#0.7197;MORPHOGENESIS#0.7182;CELL CYCLE#0.6949;PROTEIN TYROSINE KINASE#0.6903;INTESTINAL EPITHELIAL CELL#0.6860;THYMOCYTE#0.6819;EPHRIN RECEPTOR#0.6528;PALATE DEVELOPMENT#0.6400;KINASE ACTIVITY#0.6383;TUMOR CELLS#0.6352;T CELL#0.6344;MESENCHYME#0.6260;COLON CARCINOMA#0.6020;SPINAL CORD INJURY#0.6014
204	RETICULAR DYSGENESIS#1.1185;ADENYLATE KINASE#1.0417;ADENYLATE#1.0329;CYTOCHROME C#0.9686;APOPTOSIS#0.9303;ADENINE#0.9068;MITOCHONDRIA#0.8953;SEVERE COMBINED IMMUNODEFICIENCY#0.8359;MITOCHONDRIAL INTERMEMBRANE SPACE#0.7968;MITOCHONDRIAL MATRIX#0.7706;CANCER CELL#0.7598;SKELETAL MUSCLE#0.7540;ADENOSINE#0.7441;CELL PROLIFERATION#0.7392;CELL GROWTH#0.7391;GENE EXPRESSION#0.7227;STEM CELL#0.6872;B CELL#0.6826;NEUTROPHIL#0.6583;NEUTROPHIL DIFFERENTIATION#0.6447;ORAL CANCER CELL#0.6272;CREATINE KINASE#0.6133;RED BLOOD CELL#0.6027;PROGENITOR CELL#0.6008
2050	OVARIAN CANCER#1.0600;OSTEOBLAST#1.0553;BREAST CANCER#1.0509;OSTEOCLAST#1.0419;CELL GROWTH#1.0418;SQUAMOUS CELL CARCINOMA#1.0404;BREAST CANCER CELL#1.0398;PROSTATE CANCER#1.0397;TUMOR CELLS#1.0339;CANCER CELL#1.0331;TYROSINE KINASE RECEPTOR#1.0311;EPHRIN RECEPTOR#1.0299;OVARIAN#1.0294;EPHRIN#1.0229;ARTERIOVENOUS MALFORMATION#1.0215;PROGENITOR CELL#1.0208;CELL MIGRATION#1.0206;MAMMARY GLAND#1.0179;POLYMERASE CHAIN REACTION#1.0176;KINASE ACTIVITY#1.0139;COLORECTAL CANCER#1.0134;LUNG CANCER#1.0128;SIGNALING PATHWAY#1.0123;BLOOD VESSEL#1.0118;BONE FORMATION#1.0113;STROMAL CELL#1.0111;LYMPH NODE#1.0098;RECEPTOR TYROSINE KINASE#1.0090;APOPTOSIS#1.0048;ENDOTHELIAL CELL#1.0042;ANGIOGENESIS#1.0026;EPITHELIAL CELL#1.0024;TROPHOBLAST#1.0023;BONE MARROW#1.0018;STEM CELL#0.9982;GROWTH FACTOR#0.9975;ENDOTHELIAL GROWTH FACTOR#0.9971;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9971;COLORECTAL#0.9939;GENE EXPRESSION#0.9934;KINASE INHIBITOR#0.9922;CELL PROLIFERATION#0.9891;MYELOID LEUKEMIA#0.9829;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9820;OSTEOBLAST DIFFERENTIATION#0.9817;ENDOTHELIUM#0.9539;MORPHOGENESIS#0.9512;CELL ADHESION#0.9500;HEMATOPOIETIC CELL#0.9459;GROWTH FACTOR RECEPTOR#0.9449;BONE REMODELING#0.9441;LYMPH NODE METASTASIS#0.9439;TROPHOBLAST CELL#0.9407;PROTEIN TYROSINE KINASE#0.9349;HEPATOCELLULAR CARCINOMA#0.9335;BONE RESORPTION#0.9209;SMOOTH MUSCLE#0.9187;COLON CANCER#0.9147;ARTERY#0.9113;CHRONIC MYELOID LEUKEMIA#0.9087;HYPOXIA#0.8981;TRANSCRIPTION FACTOR#0.8885;REVERSE TRANSCRIPTION#0.8726;AUTISM SPECTRUM DISORDER#0.8707;SIGNALLING PATHWAY#0.8665;SPROUTING ANGIOGENESIS#0.8652;T CELL#0.8492;TUMOR SUPPRESSOR#0.8488;ENDOMETRIUM#0.8476;MESENCHYMAL STEM CELL#0.8422;MACROPHAGE#0.8375;PROTEIN KINASE#0.8357;CARDIOMYOCYTE#0.8279;ATP BINDING#0.8253;CELL DEATH#0.8187;VASCULAR MORPHOGENESIS#0.8137;CELL SURFACE#0.8085;REGENERATION#0.8080;TUBE FORMATION#0.8006;CELL DIFFERENTIATION#0.7999;EXTRACELLULAR MATRIX#0.7985;TUMOR TISSUES#0.7859;ALKALINE PHOSPHATASE#0.7800;UMBILICAL VEIN#0.7596;PERIPHERAL BLOOD#0.7587;ERYTHROID CELL#0.7538;NEURAL STEM CELL#0.7494;ERYTHROID PROGENITOR#0.7491;VASCULAR ENDOTHELIAL CELL#0.7489;RECEPTOR LIGAND#0.7452;VENULE#0.7418;ENDOMETRIAL CARCINOMA#0.7314;PAPILLARY THYROID CARCINOMA#0.7308;SMOOTH MUSCLE ACTIN#0.7284;QUANTITATIVE REAL TIME#0.7263;THYROID CARCINOMA#0.7247;CELL COMMUNICATION#0.7215;APOPTOTIC#0.7185;MAMMARY EPITHELIUM#0.7181;VASCULOGENESIS#0.7179;HUMAN UMBILICAL VEIN#0.7152;SMOOTH MUSCLE CELL#0.7028;MUSCLE CELL#0.7021;PERICYTE#0.7017;CELL MEMBRANE#0.6962;MARROW STROMAL CELLS#0.6948;BONE MARROW STROMAL CELL#0.6948;IMATINIB#0.6945;BONE MARROW STROMAL#0.6944;ACTIN CYTOSKELETON#0.6905;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6902;TYROSINE KINASE INHIBITOR#0.6890;ONCOGENIC#0.6885;MESOTHELIOMA CELL#0.6868;PLACENTAL DEVELOPMENT#0.6861;ENDOTHELIAL CELL MIGRATION#0.6852;SERUM ALBUMIN#0.6849;EARLY TIME POINT#0.6817;HEMATOPOIETIC PROGENITOR CELL#0.6800;HEAD AND NECK CANCER#0.6784;NECK CANCER#0.6784;EPIDERMAL GROWTH FACTOR#0.6770;BEVACIZUMAB#0.6745;SIGNALING CASCADE#0.6738;RNA INTERFERENCE#0.6733;HEMATOPOIESIS#0.6728;OVARIAN CARCINOMA#0.6726;CORD BLOOD#0.6699;TUMOR NECROSIS FACTOR#0.6686;ADENOCARCINOMA#0.6681;PERIODONTAL LIGAMENT#0.6619;LYMPHATIC VESSEL#0.6557;OSTEOCLAST DIFFERENTIATION#0.6549;CHEMOTAXIS#0.6350;OXYGEN INDUCED RETINOPATHY#0.6344;MICROVASCULAR ENDOTHELIAL CELL#0.6323;SIGNAL TRANSDUCTION#0.6281;HYDROPS FETALIS#0.6176;LUNG DEVELOPMENT#0.6142;PERIODONTAL LIGAMENT STEM CELL#0.6138;NOTCH SIGNALING PATHWAY#0.6138;ALIZARIN RED S#0.6134;MINERALIZATION#0.6131;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.6127;ADJACENT NORMAL TISSUE#0.6109;ISCHEMIA#0.6094;ENDOMETRIAL CANCER#0.6085;HUMAN SERUM ALBUMIN#0.6061;POSITRON EMISSION TOMOGRAPHY#0.6057;BONE REMODELLING#0.6056;DASATINIB#0.6055;ORTHODONTIC TOOTH MOVEMENT#0.6051;HUMAN BREAST CANCER#0.6041;PARATHYROID HORMONE#0.6019
2051	BREAST CARCINOMA#1.0622;T CELL#1.0371;EPHRIN#1.0229;CANCER CELL#1.0228;RECEPTOR TYROSINE KINASE#1.0206;BREAST CANCER#0.9793;NEUROBLASTOMA#0.9291;CELL PROLIFERATION#0.9043;SIGNALING PATHWAY#0.9042;LYMPH NODE#0.9040;APOPTOSIS#0.9016;GENE EXPRESSION#0.8848;COLORECTAL CANCER#0.8818;LUNG CANCER#0.8668;HEPATOCELLULAR CARCINOMA#0.8278;CELL ADHESION#0.8115;KINASE ACTIVITY#0.7979;PROTEIN KINASE#0.7958;CHROMAFFIN CELL#0.7804;ADRENAL GLAND#0.7718;INVASIVE BREAST CARCINOMA#0.7705;COLORECTAL#0.7425;BREAST CANCER CELL#0.7205;EPITHELIAL CELL#0.7141;LIVER CANCER#0.7075;MACROPHAGE#0.6993;METASTATIC MELANOMA#0.6946;DRUG RESISTANCE#0.6891;MAP KINASE#0.6866;T LYMPHOCYTE#0.6857;THYMOCYTE#0.6419;BREAST CARCINOMA CELL LINES#0.6380;SIGNAL TRANSDUCTION#0.6295;LUNG ADENOCARCINOMA#0.6081
2052	EPOXIDE HYDRATASE ACTIVITY#1.1396;ESOPHAGEAL CANCER#1.0789;DOUBLE-STRANDED RNA BINDING#1.0681;RNA BINDING#1.0582;RNA BINDING PROTEIN#1.0580;WARFARIN#1.0482;EPOXIDE HYDROLASE#1.0388;COLORECTAL#1.0319;MIRNA BIOGENESIS#1.0300;ENZYME ACTIVITY#1.0287;CARBAMAZEPINE#1.0257;OVARIAN#1.0251;FRAGMENT LENGTH POLYMORPHISM#1.0251;LUNG CANCER#1.0201;BREAST CANCER#1.0176;POLYMERASE CHAIN REACTION#1.0164;GLUTATHIONE#1.0163;DNA REPAIR#1.0160;CYTOCHROME P450#1.0157;MIRNA PROCESSING#1.0141;COLORECTAL CANCER#1.0119;DETOXIFICATION#1.0106;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#1.0079;MICROSOME#1.0073;SOLUBLE EPOXIDE HYDROLASE#1.0071;XENOBIOTIC METABOLIZING ENZYME#1.0055;XENOBIOTIC METABOLISM#1.0051;POLYCYCLIC AROMATIC HYDROCARBON#1.0010;GENOTOXIC#0.9935;CARCINOGEN#0.9924;DSRNA BINDING#0.9888;GENE EXPRESSION#0.9832;HEPATOCELLULAR CARCINOMA#0.9831;TOXICITY#0.9830;PERIPHERAL BLOOD#0.9827;TRANSCRIPTION FACTOR#0.9777;SIGNALING PATHWAY#0.9705;BILE ACID TRANSPORT#0.9692;ENDOPLASMIC RETICULUM#0.9678;GENOTOXICITY#0.9572;OVARIAN CANCER#0.9523;PHENOBARBITAL#0.9425;N ACETYLTRANSFERASE#0.9376;PERIPHERAL BLOOD LYMPHOCYTES#0.9348;SQUAMOUS CELL CARCINOMA#0.9342;PROTEIN KINASE#0.9131;MUTAGENICITY#0.9121;EPILEPSY#0.9068;PHENYTOIN#0.8998;PROSTATE CANCER#0.8845;ANTHRACENE#0.8839;COLORECTAL ADENOMA#0.8829;HYDROLASE ACTIVITY#0.8827;CONJUGATION#0.8819;REACTIVE OXYGEN SPECIES#0.8758;MUTAGENIC#0.8732;ASTROCYTE#0.8709;EPOXIDE HYDROLASE ACTIVITY#0.8539;SUPEROXIDE DISMUTASE#0.8343;GLUTATHIONE TRANSFERASE#0.8343;MICRORNA BIOGENESIS#0.8339;PLASMA MEMBRANE#0.8306;TOXICANT#0.8263;GROWTH FACTOR#0.8240;OXYGENASE#0.8221;EPITHELIAL CELL#0.8193;VITAMIN K#0.8181;DRUG METABOLISM#0.8180;ADJUSTED ODDS RATIO#0.8133;HEPATOTOXICITY#0.8108;CLOTRIMAZOLE#0.8098;CHROMATID#0.8089;OVARIES#0.8088;APOPTOSIS#0.7971;MYELOID LEUKEMIA#0.7831;ACUTE MYELOID LEUKEMIA#0.7803;MUTAGEN#0.7778;CYTOCHROME C#0.7750;MICRORNA PROCESSING#0.7681;HYDROXYLASE ACTIVITY#0.7676;CELL CYCLE#0.7552;LEUKOCYTE#0.7509;MULTIPLE LINEAR REGRESSION#0.7507;HEAD AND NECK CANCER#0.7481;NECK CANCER#0.7480;INTESTINAL MUCOSA#0.7462;PI3K SIGNALING#0.7451;HARDY WEINBERG EQUILIBRIUM#0.7411;BREAST CARCINOMA#0.7382;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7357;OXIDATIVE METABOLISM#0.7234;DNA BINDING#0.7218;MITOGEN ACTIVATED PROTEIN#0.7170;GLUTATHIONE PEROXIDASE#0.7167;EXCRETION#0.7147;HEPATITIS C#0.7029;HISTIDINE#0.7029;OBESE#0.7025;ER MEMBRANE#0.6947;REVERSE TRANSCRIPTION#0.6913;PROTEIN KINASE B#0.6875;PRI-MIRNA PROCESSING#0.6831;VALPROIC ACID#0.6783;MICROSOMAL EPOXIDE HYDROLASE ACTIVITY#0.6752;ECLAMPSIA#0.6750;PRE-ECLAMPSIA#0.6731;CYTOTOXICITY#0.6727;TRANSCRIPTASE#0.6664;ENDOTHELIAL CELL#0.6632;MULTIFACTOR DIMENSIONALITY REDUCTION#0.6606;LIVER DISEASE#0.6550;OVARIAN FOLLICLE#0.6519;CATALYTIC ACTIVITY#0.6470;INTERNATIONAL NORMALIZED RATIO#0.6366;CYTOCHROME B5#0.6364;TAUROCHOLATE#0.6291;ARACHIDONIC ACID#0.6282;DEXAMETHASONE#0.6272;HEME OXYGENASE 1#0.6236;TAMOXIFEN#0.6207;MUTAGENESIS#0.6171;URIDINE#0.6132;B CELL#0.6124;MICRONUCLEUS#0.6092;MULTIPLE REGRESSION ANALYSIS#0.6045
2053	BENZOIC ACID#1.0617;PHOSPHATASE ACTIVITY#1.0565;SOLUBLE EPOXIDE HYDROLASE#1.0396;EPOXIDE HYDROLASE#1.0357;ATHEROSCLEROSIS#1.0293;PEROXISOME#1.0233;ENZYME ACTIVITY#1.0223;ENDOTHELIAL CELL#1.0184;INFLAMMATORY RESPONSE#1.0178;CELL PROLIFERATION#1.0177;HYDROLASE ACTIVITY#1.0174;MACROPHAGE#1.0173;STRUCTURE ACTIVITY RELATIONSHIP#1.0170;GROWTH FACTOR#1.0168;HYPERTENSION#1.0159;NITRIC OXIDE#1.0138;ISCHEMIA#1.0133;ARTERY#1.0042;MIDDLE CEREBRAL ARTERY#1.0006;CEREBRAL ARTERY#1.0003;SIGNALING PATHWAY#0.9973;SMOOTH MUSCLE#0.9961;EPOXIDE HYDRATASE ACTIVITY#0.9949;GENE EXPRESSION#0.9902;EPOXIDE HYDROLASE ACTIVITY#0.9901;APOPTOSIS#0.9900;PRO-INFLAMMATORY#0.9877;ASTROCYTE#0.9872;ENDOTHELIUM#0.9858;MONOCYTE#0.9824;CYTOCHROME P450#0.9822;GLUTATHIONE#0.9814;ANGIOGENESIS#0.9803;ARACHIDONIC ACID#0.9794;ISCHEMIA REPERFUSION INJURY#0.9775;CEREBRAL ARTERY OCCLUSION#0.9764;ARACHIDONIC ACID METABOLISM#0.9758;CEREBRAL ISCHEMIA#0.9725;VASODILATOR#0.9723;TYPE 2 DIABETES#0.9704;CELL DEATH#0.9696;HYDROLASE INHIBITOR#0.9684;KIDNEY DISEASE#0.9670;TOXICITY#0.9639;VASODILATION#0.9595;CORONARY ARTERY#0.9545;EXCRETION#0.9536;SMOOTH MUSCLE CELL#0.9494;MUSCLE CELL#0.9487;ATHEROSCLEROTIC#0.9406;HIGH FAT DIET#0.9354;SIGNALING MOLECULE#0.9321;MICROSOME#0.9319;CLOFIBRATE#0.9316;PEROXISOMAL#0.9312;NEUTROPHIL#0.9294;ADIPOCYTE#0.9249;NEPHROPATHY#0.9180;ENDOPLASMIC RETICULUM#0.9159;HYPOXIA#0.9117;C TERMINAL DOMAIN#0.9067;STREPTOZOTOCIN#0.8966;CARDIOMYOCYTE#0.8961;NITRIC OXIDE SYNTHASE#0.8948;ARGININE#0.8937;PROTEIN KINASE#0.8933;PARKINSON'S DISEASE#0.8923;ADIPOSE TISSUE#0.8911;CHRONIC KIDNEY DISEASE#0.8898;ACETYLCHOLINE#0.8889;PULMONARY HYPERTENSION#0.8816;TYPE 2 DIABETIC#0.8802;RECEPTOR ANTAGONIST#0.8707;MYOCARDIAL INFARCTION#0.8693;LIPID PHOSPHATASE#0.8636;INFLAMMATORY CELL#0.8616;EPITHELIAL CELL#0.8595;CHOLESTEROL METABOLISM#0.8555;BRAIN DAMAGE#0.8534;PROTEINURIA#0.8410;SYSTOLIC BLOOD PRESSURE#0.8408;CISPLATIN#0.8406;ACUTE KIDNEY INJURY#0.8399;VASOCONSTRICTION#0.8331;NEPHROTOXICITY#0.8301;REACTIVE OXYGEN SPECIES#0.8234;CARDIOVASCULAR SYSTEM#0.8210;NERVOUS SYSTEM#0.8197;TUMOR NECROSIS FACTOR#0.8194;FATTY ACID METABOLISM#0.8177;ETHANOL#0.8064;POLYMERASE CHAIN REACTION#0.8040;PULMONARY ARTERY#0.8035;GLUCOSE HOMEOSTASIS#0.8030;CHOLESTEROL EFFLUX#0.7978;ADENOSINE#0.7960;XENOBIOTIC METABOLIZING ENZYME#0.7908;CENTRAL NERVOUS SYSTEM#0.7900;HYPERGLYCEMIA#0.7893;DIABETIC NEPHROPATHY#0.7865;BLOOD PRESSURE REGULATION#0.7862;CONSTRICTION#0.7822;TRANSFORMING GROWTH FACTOR#0.7795;LIPID METABOLISM#0.7671;VASOCONSTRICTOR#0.7664;ENDOPLASMIC RETICULUM STRESS#0.7631;ADAMANTANE#0.7445;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7417;DIABETIC RETINOPATHY#0.7394;EDEMA#0.7389;HEART DISEASE#0.7377;COLITIS#0.7365;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7365;NEUROINFLAMMATORY RESPONSE#0.7364;ENDOTHELIAL GROWTH FACTOR#0.7364;OXYGENASE#0.7303;ESSENTIAL HYPERTENSION#0.7252;VASCULAR SMOOTH MUSCLE CELL#0.7246;ANGIOTENSIN CONVERTING ENZYME#0.7173;NEUROPROTECTION#0.7135;REGULATION OF BLOOD PRESSURE#0.7060;BLOOD VESSEL#0.7002;CELL GROWTH#0.6978;HEME OXYGENASE 1#0.6966;EICOSAPENTAENOIC ACID#0.6923;HYPOTENSION#0.6898;ARTERIOLE#0.6885;EPILEPSY#0.6877;CAROTID ARTERY#0.6869;APOPTOTIC#0.6809;MACROPHAGE POLARIZATION#0.6802;FATTY LIVER#0.6783;STRIATUM#0.6766;L-ARGININE#0.6744;NEURODEGENERATIVE DISEASE#0.6735;ULCERATIVE COLITIS#0.6719;SIGNALING CASCADE#0.6704;INFLAMMATORY BOWEL DISEASE#0.6699;WOUND HEALING#0.6681;INSULIN SECRETION#0.6640;BONE MARROW#0.6637;GLIBENCLAMIDE#0.6585;DIABETES MELLITUS#0.6554;DETOXIFICATION#0.6515;NITRO-L-ARGININE#0.6488;CATALYTIC ACTIVITY#0.6471;AUTOPHAGY#0.6439;ALZHEIMER'S DISEASE#0.6434;SUPEROXIDE DISMUTASE#0.6432;LOW DENSITY LIPOPROTEIN#0.6428;CONTROL OF BLOOD PRESSURE#0.6353;LIPID PHOSPHATASE ACTIVITY#0.6313;NEUROTOXICITY#0.6308;ENDOTHELIAL NITRIC OXIDE#0.6231;INDUCIBLE NITRIC OXIDE#0.6216;KINASE INHIBITOR#0.6186;NADPH OXIDASE#0.6179;UNILATERAL URETERAL OBSTRUCTION#0.6131;URETERAL OBSTRUCTION#0.6120;PRESSURE NATRIURESIS#0.6118;TRANSCRIPTION FACTOR#0.6112;CARDIOMYOPATHY#0.6102;HYPOXIC#0.6091;MUTAGENESIS#0.6076
205428	STEM CELL#0.8092;SECRETORY PATHWAY#0.7634;MENTAL RETARDATION#0.6744;CARDIOMYOCYTE#0.6470;PERIODONTAL LIGAMENT#0.6212;DNA SYNTHESIS#0.6090;MYOCARDIAL INFARCTION#0.6061
2054	MORPHOGENESIS#1.0458;MESENCHYMAL CELL#1.0382;BRANCHING MORPHOGENESIS#1.0276;TUBULAR EPITHELIAL CELL#1.0265;APOPTOSIS#1.0257;MITOMYCIN C#1.0163;SIGNALING PATHWAY#1.0150;TOXICITY#1.0132;CELL SURFACE#1.0067;CYTOTOXICITY#1.0027;EPITHELIAL CELL#1.0013;MAMMARY GLAND#0.9980;MICROVASCULAR ENDOTHELIAL CELL#0.9962;ENDOTHELIAL CELL#0.9962;FIMBRIAE#0.9945;RECEPTOR BINDING#0.9941;GENE EXPRESSION#0.9917;N-ETHYLMALEIMIDE#0.9911;POLYMERASE CHAIN REACTION#0.9906;EXOCYTOSIS#0.9898;PLASMA MEMBRANE#0.9898;MACROPHAGE#0.9896;NEUTROPHIL#0.9889;MITOMYCIN#0.9887;HAEMOLYTIC URAEMIC SYNDROME#0.9882;PROTEIN SYNTHESIS#0.9880;CIPROFLOXACIN#0.9869;VIRULENCE#0.9839;GROWTH FACTOR#0.9826;RIBOSOME#0.9792;INTESTINAL EPITHELIAL CELL#0.9756;AGGLUTINATION#0.9745;PROPHAGE INDUCTION#0.9721;IMMUNE RESPONSE#0.9714;MEMBRANE FUSION#0.9685;COLITIS#0.9647;HEMOLYTIC UREMIC SYNDROME#0.9643;HEMORRHAGIC#0.9633;DIARRHEA#0.9625;MYOFIBROBLAST#0.9573;CELL DEATH#0.9525;TETRACYCLINE#0.9473;DIARRHEAGENIC ESCHERICHIA COLI#0.9460;ENTEROCYTE#0.9442;STREPTOMYCIN#0.9419;LEUKOCYTE#0.9417;HOST CELL#0.9382;INFLAMMATORY RESPONSE#0.9311;AMPICILLIN#0.9283;OUTER MEMBRANE#0.9228;REVERSE TRANSCRIPTION#0.9195;ENDOSOME#0.9177;FRAGMENT LENGTH POLYMORPHISM#0.9154;CELL PROLIFERATION#0.9153;HAEMOLYTIC UREMIC SYNDROME#0.9150;SOS RESPONSE#0.9140;THROMBOCYTOPENIA#0.9125;TUMOR NECROSIS FACTOR#0.9121;APOPTOTIC#0.9111;PROTEIN KINASE#0.9084;ENDOPLASMIC RETICULUM#0.8997;CYTOTOXIN#0.8988;HAIR FOLLICLE#0.8985;RICIN#0.8960;COMPLEMENT ACTIVATION#0.8951;NERVOUS SYSTEM#0.8902;LYSIS#0.8871;QUANTITATIVE REAL TIME#0.8853;APICAL PLASMA MEMBRANE#0.8805;VASCULAR ENDOTHELIAL CELL#0.8768;CENTRAL NERVOUS SYSTEM#0.8744;CYTOLETHAL DISTENDING TOXIN#0.8744;LIMIT OF DETECTION#0.8735;ACROSOME#0.8726;PRO-INFLAMMATORY#0.8722;HEMOLYTIC ANEMIA#0.8665;ACINAR CELL#0.8648;WHOLE GENOME SEQUENCING#0.8635;ANEMIA#0.8584;WEIGHT LOSS#0.8490;EDEMA#0.8457;ACROSOME REACTION#0.8436;THROMBOSIS#0.8408;GENTAMICIN#0.8377;EARLY ENDOSOME#0.8366;TRIMETHOPRIM#0.8365;MAMMARY EPITHELIAL CELL#0.8354;KERATINOCYTE#0.8341;ZYMOGEN GRANULE#0.8333;CEFIXIME#0.8308;BLOOD BRAIN BARRIER#0.8269;SYNTAXIN BINDING#0.8215;HEPATIC STELLATE CELL#0.8210;GASTROINTESTINAL TRACT#0.8206;GASTROENTERITIS#0.8144;CHLORAMPHENICOL#0.8101;HORIZONTAL GENE TRANSFER#0.8085;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8054;UMBILICAL VEIN#0.8046;KIDNEY FAILURE#0.8045;LIPID RAFT#0.7968;ENDOCYTOSIS#0.7937;REGENERATION#0.7927;T CELL#0.7923;PULMONARY FIBROSIS#0.7869;BRAIN DAMAGE#0.7825;MODE OF ACTION#0.7790;LASER DESORPTION IONIZATION#0.7763;STEM CELL#0.7719;ENDOTHELIUM#0.7719;MONOCYTE#0.7701;MITOGEN ACTIVATED PROTEIN#0.7691;GLYCOSIDASE ACTIVITY#0.7665;VESICLE FUSION#0.7528;HUMAN UMBILICAL VEIN#0.7489;NALIDIXIC ACID#0.7487;IL-6 SECRETION#0.7462;SPERMATOGENESIS#0.7457;BETA GLUCURONIDASE#0.7426;CELL ASSOCIATED#0.7407;LIVER REGENERATION#0.7394;BIOFILM FORMATION#0.7389;GLIAL CELL#0.7356;FERMENTATION#0.7338;RIBOSOME BINDING#0.7326;CARRIE#0.7324;ASTROCYTE#0.7300;BETA-2#0.7288;PLATELET EXOCYTOSIS#0.7274;KANAMYCIN#0.7244;NITRIC OXIDE#0.7161;SULFAMETHOXAZOLE#0.7120;VESICLE DOCKING#0.7096;NORFLOXACIN#0.7045;GESTATION#0.7017;ADENINE#0.6973;INTESTINAL DISEASE#0.6956;SNARE COMPLEX#0.6935;SPERMATOZOA#0.6862;B CELL#0.6858;DEPURINATION#0.6822;CEPHALOTHIN#0.6812;PROXIMAL TUBULAR EPITHELIAL#0.6770;MESENCHYME#0.6738;DEXTRAN SODIUM SULFATE#0.6722;ACUTE LIVER INJURY#0.6715;DNA FRAGMENTATION#0.6711;PHOSPHATE BUFFERED SALINE#0.6703;HUMORAL IMMUNE RESPONSE#0.6702;GOLGI APPARATUS#0.6701;PERIPHERAL BLOOD#0.6675;ACUTE DIARRHEA#0.6649;GLOMERULAR FILTRATION#0.6576;CANCER CELL#0.6503;CHOLERA#0.6483;BETA CELL#0.6468;ADENOCARCINOMA#0.6467;PENICILLIN#0.6428;DIGESTION#0.6407;CYTOKINESIS#0.6306;PODOCYTE#0.6298;LYSOSOME#0.6201;MINIMUM INHIBITORY CONCENTRATION#0.6186;INTESTINAL MUCOSA#0.6166;RECEPTOR ANTAGONIST#0.6163;HAIR FOLLICLE MORPHOGENESIS#0.6158;CYTOPLASM#0.6125;NUCLEIC ACID#0.6101;DRUG RESISTANCE#0.6089;ITO CELL#0.6083;CELL MEMBRANE#0.6080;CURLI#0.6070;DETERGENT RESISTANT MEMBRANE#0.6057;AZITHROMYCIN#0.6055;INTRACELLULAR TRANSPORT#0.6041;TRANSCRIPTASE#0.6036;VESICULAR TRANSPORT#0.6006
205564	SUMO SPECIFIC PROTEASE#1.0086;SUMOYLATION#0.8846;ORAL SQUAMOUS CELL CARCINOMA#0.7985;SQUAMOUS CELL CARCINOMA#0.7906;APOPTOSIS#0.7521;MITOCHONDRIA#0.7332;CELL DIVISION#0.7251;CELL CYCLE#0.7200;CELL GROWTH#0.6412;BREAST CANCER#0.6395;CELL PROLIFERATION#0.6388;UBIQUITIN#0.6306;NEUTROPHIL DIFFERENTIATION#0.6249
2055	NEURONAL CEROID LIPOFUSCINOSIS#1.0306;EPILEPSY#1.0305;MENTAL RETARDATION#0.9901;ENDOPLASMIC RETICULUM#0.9381;MOTOR NEURON DEGENERATION#0.9340;LYSOSOME#0.8094;APOPTOSIS#0.7141;NEURODEGENERATIVE DISEASE#0.7082;NERVOUS SYSTEM#0.6589;LYSOSOMAL STORAGE DISEASE#0.6560;CENTRAL NERVOUS SYSTEM#0.6277
2056	PEGINESATIDE#1.0640;OPTIC NEURITIS#1.0500;ERYTHROPOIETIN STIMULATING AGENT#1.0471;RESPONSE TO ERYTHROPOIETIN#1.0461;MELATONIN#1.0446;BLOOD CELL FORMATION#1.0445;AMIFOSTINE#1.0364;ANABOLIC ANDROGENIC STEROID#1.0355;CEREBRAL MALARIA#1.0348;EPOETIN ALFA#1.0347;ANEMIA OF PREMATURITY#1.0343;METASTATIC BREAST CANCER#1.0337;STATUS EPILEPTICUS#1.0336;URETERAL OBSTRUCTION#1.0322;LIVER REGENERATION#1.0316;IRON RESTRICTED ERYTHROPOIESIS#1.0294;EPREX#1.0290;NEURITIS#1.0282;AMNIOTIC FLUID#1.0273;TRANEXAMIC ACID#1.0251;N-ACETYLCYSTEINE#1.0250;LIMB ISCHEMIA#1.0247;RENAL CARCINOMA#1.0246;DARBEPOETIN ALFA#1.0243;LEUKEMIA INHIBITORY FACTOR#1.0243;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#1.0235;HEMANGIOBLASTOMA#1.0226;MESENCHYMAL STROMAL CELL#1.0204;ENALAPRIL#1.0204;BEVACIZUMAB#1.0203;NEURAL PROGENITOR CELL#1.0193;MECONIUM#1.0192;HEAD AND NECK CANCER#1.0191;CARDIAC ARREST#1.0187;CALCITRIOL#1.0187;L-CARNITINE#1.0180;EPHRIN#1.0177;DIMETHYL SULFOXIDE#1.0177;GENTAMICIN#1.0170;HYPOXIA RESPONSIVE ELEMENT#1.0168;NECK CANCER#1.0166;MYOBLAST#1.0160;PERIPHERAL NERVE#1.0159;SCHWANN CELL#1.0157;RNA SYNTHESIS#1.0155;THEOPHYLLINE#1.0152;RETINAL GANGLION CELL#1.0151;VASCULAR SMOOTH MUSCLE CELL#1.0151;NANDROLONE DECANOATE#1.0148;TRAUMATIC BRAIN INJURY#1.0148;SPINAL CORD ISCHEMIA#1.0146;UMBILICAL ARTERY#1.0143;PROLIFERATIVE DIABETIC RETINOPATHY#1.0143;CAROTID BODY#1.0134;HYPOXIC ISCHEMIC ENCEPHALOPATHY#1.0132;ENCEPHALOMYELITIS#1.0128;IL-11#1.0122;CARNITINE#1.0118;HEPATOCELLULAR CARCINOMA CELL#1.0117;RITUXIMAB#1.0117;BLOOD PLASMA#1.0115;APROTININ#1.0115;TOPICAL#1.0107;ESSENTIAL HYPERTENSION#1.0107;ACETYLCYSTEINE#1.0106;CERVICAL CANCER#1.0105;ASCORBIC ACID#1.0104;NEUROBLASTOMA#1.0102;FRIEDREICH ATAXIA#1.0099;ADENYLATE CYCLASE#1.0098;RECEPTOR ACTIVATOR#1.0089;METHYLPREDNISOLONE#1.0087;CIRCADIAN RHYTHM#1.0084;PURE RED-CELL APLASIA#1.0083;MINOCYCLINE#1.0081;LOW BIRTH WEIGHT#1.0078;INTERSTITIAL CELL#1.0078;HEMATOPOIETIC TISSUES#1.0077;ZIDOVUDINE#1.0076;SIMVASTATIN#1.0073;NANDROLONE#1.0072;ASPHYXIA#1.0066;HEME OXYGENASE 1#1.0065;TOTAL HIP ARTHROPLASTY#1.0063;NEUROTOXICITY#1.0063;GROWTH HORMONE#1.0063;SLEEP APNEA#1.0061;MESENCHYMAL STEM CELL#1.0058;HEME SYNTHESIS#1.0056;G-CSF#1.0056;RECEPTOR TYROSINE KINASE#1.0046;BREAST CANCER PATIENTS#1.0046;HEPATOCELLULAR CARCINOMA#1.0045;GRANULOCYTE COLONY STIMULATING FACTOR#1.0045;HEPATOCYTE GROWTH FACTOR#1.0044;AUTONOMIC NEUROPATHY#1.0042;NEPHROTIC SYNDROME#1.0041;SOLUBLE TRANSFERRIN RECEPTOR#1.0041;LENALIDOMIDE#1.0038;KIDNEY FAILURE#1.0038;DIABETIC RETINOPATHY#1.0038;HUMAN SERUM ALBUMIN#1.0036;STEM CELL FACTOR#1.0035;INHIBITION OF APOPTOSIS#1.0030;NEURAL CELL#1.0029;INDUCIBLE NITRIC OXIDE#1.0029;SMOOTH MUSCLE CELL#1.0028;ASYMMETRIC DIMETHYLARGININE#1.0027;BRONCHOPULMONARY DYSPLASIA#1.0027;GANGLION CELLS#1.0027;NORMOBLAST#1.0027;BRAIN ISCHEMIA#1.0026;ISCHEMIA REPERFUSION INJURY#1.0026;ESTRADIOL#1.0025;RENAL ISCHEMIA REPERFUSION#1.0025;CHRONIC LYMPHOCYTIC LEUKEMIA#1.0025;FIBROBLAST GROWTH FACTOR#1.0023;NEPHROTOXICITY#1.0022;PERIPHERAL NERVE INJURY#1.0021;ACUTE MYOCARDIAL INFARCTION#1.0021;SPINAL CORD INJURY#1.0020;RAT BONE MARROW#1.0018;HYPOXIA RESPONSE ELEMENT#1.0017;FOCAL CEREBRAL ISCHEMIA#1.0009;DIURNAL#1.0008;AMYOTROPHIC LATERAL SCLEROSIS#1.0007;LATERAL SCLEROSIS#1.0007;MESANGIAL CELL#1.0007;CISPLATIN#1.0006;FERROUS SULFATE#1.0006;MYELOID METAPLASIA#1.0003;ERYTHROPOIETIN RECEPTOR#1.0000;UNILATERAL URETERAL OBSTRUCTION#1.0000;TYPE 2 DIABETIC#1.0000;CYCLIC AMP#1.0000;VITAMIN D3#1.0000;ADENO ASSOCIATED VIRUS#0.9999;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.9998;MULTIPLE SCLEROSIS#0.9998;PERCUTANEOUS CORONARY INTERVENTION#0.9995;NEUROGENESIS#0.9994;ADENYLATE#0.9990;SQUAMOUS CELL CARCINOMA#0.9990;HEMOSTASIS#0.9988;CALCIUM CHANNEL#0.9988;MALARIA#0.9988;RESIDUAL RENAL FUNCTION#0.9987;NEURONAL CELLS#0.9986;ADIPOSE TISSUE#0.9983;CERVICAL#0.9982;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9982;GM-CSF#0.9981;DOXORUBICIN#0.9980;ENDOTHELIAL GROWTH FACTOR#0.9980;CYCLOSPORIN A#0.9979;LYMPHOCYTIC LEUKEMIA#0.9978;NEURAL STEM CELL#0.9977;PROERYTHROBLAST#0.9975;PREMATURITY#0.9975;ACUTE ISCHEMIC STROKE#0.9972;PERIPHERAL NERVOUS SYSTEM#0.9971;MAP KINASE#0.9971;COLON CANCER#0.9969;PEPTIDE HORMONE#0.9969;DIABETIC NEUROPATHY#0.9968;SPINAL CORD#0.9968;OPTIC NERVE#0.9966;COLONY-STIMULATING FACTOR#0.9965;DEFINITIVE ERYTHROPOIESIS#0.9963;RHEUMATOID ARTHRITIS#0.9962;MULTIPLE MYELOMA#0.9961;VITAMIN C#0.9961;DEFEROXAMINE#0.9960;VITAMIN A#0.9960;HYPERSENSITIVITY#0.9959;OXYGENASE#0.9958;SIALYLATION#0.9954;NORMOCYTIC ANEMIA#0.9953;ENDOTHELIAL NITRIC OXIDE#0.9951;HEME BIOSYNTHESIS#0.9951;DESFERRIOXAMINE#0.9949;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.9949;DEXAMETHASONE#0.9949;FERRIC CARBOXYMALTOSE#0.9946;TOTAL KNEE ARTHROPLASTY#0.9944;OXYGEN SENSOR#0.9944;RETINOIC ACID#0.9943;PEGFILGRASTIM#0.9942;BRAIN EDEMA#0.9941;ADRENERGIC RECEPTOR#0.9939;NATIONAL KIDNEY FOUNDATION#0.9938;BREAST CANCER CELL#0.9937;EPIDERMAL GROWTH FACTOR#0.9936;CYCLOSPORIN#0.9935;CARDIOMYOPATHY#0.9935;GROWTH DIFFERENTIATION FACTOR#0.9934;INSULIN-LIKE GROWTH FACTOR#0.9932;ANAEMIA#0.9932;URIC ACID#0.9932;RENIN ACTIVITY#0.9930;SALIVARY GLAND#0.9929;MUSCLE CELL#0.9928;RENAL FIBROSIS#0.9928;FIBRINOLYSIS#0.9928;WOUND HEALING#0.9928;SICKLE CELL DISEASE#0.9926;PROTEIN KINASE B#0.9925;HODGKIN'S LYMPHOMA#0.9925;PROLYL HYDROXYLASE INHIBITOR#0.9922;OVARIAN CANCER#0.9921;PROTEIN CATABOLIC#0.9919;RENAL CELL CARCINOMA#0.9919;OBSTRUCTIVE SLEEP APNEA#0.9918;LIVER CIRRHOSIS#0.9918;PACLITAXEL#0.9916;CLINICAL PRACTICE GUIDELINE#0.9915;ENDOTHELIAL PROGENITOR CELL#0.9914;CORONARY ARTERY BYPASS#0.9912;MAGNESIUM SULFATE#0.9912;THALIDOMIDE#0.9912;HUMAN CORD BLOOD#0.9911;INDOMETHACIN#0.9908;CEREBRAL ISCHEMIA#0.9908;ALDOSTERONE#0.9907;EVERY OTHER WEEK#0.9906;PROGESTERONE#0.9906;SIGNALING CASCADE#0.9906;END STAGE RENAL FAILURE#0.9905;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9904;BREAST CANCER#0.9904;SECONDARY HYPERPARATHYROIDISM#0.9903;GASTROINTESTINAL TRACT#0.9903;OXYGEN TRANSPORT#0.9902;LUNG DISEASE#0.9902;TESTOSTERONE#0.9901;CIRCULATING ENDOTHELIAL PROGENITOR#0.9901;INTERLEUKIN 2 RECEPTOR#0.9900;DOPAMINERGIC NEURON#0.9899;IMATINIB#0.9898;ACUTE CORONARY SYNDROME#0.9897;VASOPRESSIN#0.9894;PLATELET-DERIVED GROWTH FACTOR#0.9894;RESPONSE TO HYPOXIA#0.9892;FOLIC ACID#0.9892;RESPONSE TO TREATMENT#0.9891;OLIGODENDROCYTE#0.9890;CELL MIGRATION#0.9890;RETINAL DETACHMENT#0.9890;EVERY OTHER DAY#0.9890;HEMOGLOBIN SYNTHESIS#0.9888;FACTOR I#0.9888;HEPATOMA CELLS#0.9887;BONE FORMATION#0.9886;GRANULOCYTE#0.9885;YOLK SAC#0.9883;STANDARD OF CARE#0.9883;BETA THALASSEMIA#0.9882;N GLYCAN#0.9882;SPATIAL LEARNING#0.9878;BRAIN DEVELOPMENT#0.9878;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9877;CARBOPLATIN#0.9876;VITAMIN E#0.9876;PARKINSON'S DISEASE#0.9876;POLYCYSTIC KIDNEY DISEASE#0.9875;AKT SIGNALING#0.9875;ANGIOTENSIN RECEPTOR#0.9874;OXYGEN HOMEOSTASIS#0.9873;ADENINE#0.9872;RENAL ARTERY#0.9872;NEUROLOGICAL DISORDER#0.9871;LACTIC ACID#0.9870;RETINOPATHY OF PREMATURITY#0.9870;BONE MARROW STROMAL CELL#0.9870;L-ARGININE#0.9868;HYDROXYUREA#0.9868;NITRIC OXIDE SYNTHASE#0.9867;CARDIOVASCULAR SYSTEM#0.9867;UREMIC TOXIN#0.9866;CELL DEVELOPMENT#0.9865;ENDOPLASMIC RETICULUM STRESS#0.9865;LUNG CANCER#0.9865;DNA SYNTHESIS#0.9864;CELL MATURATION#0.9864;TUMOUR NECROSIS FACTOR#0.9864;NEURONAL CELL DEATH#0.9862;GLUCOSE METABOLISM#0.9861;RECEPTOR AGONIST#0.9861;TERMINAL DIFFERENTIATION#0.9861;ACTINOMYCIN D#0.9860;ACE INHIBITOR#0.9860;ALL TRANS RETINOIC ACID#0.9860;ADENOSINE#0.9860;SICKLE CELL ANEMIA#0.9860;SIGNALLING PATHWAY#0.9859;FACTOR VIII#0.9858;VITAMIN B12#0.9858;BONE MARROW STROMAL#0.9858;APLASTIC ANEMIA#0.9857;RECEPTOR COMPLEX#0.9855;ANEMIA#0.9855;ACUTE KIDNEY INJURY#0.9855;KIDNEY TRANSPLANT PATIENTS#0.9854;LUPUS ERYTHEMATOSUS#0.9854;TUBULAR EPITHELIAL CELL#0.9854;RANDOMISED CONTROLLED TRIAL#0.9853;RIBAVIRIN#0.9852;ANGIOTENSIN RECEPTOR BLOCKER#0.9852;DELAYED GRAFT FUNCTION#0.9851;PREDNISOLONE#0.9851;KIDNEY TRANSPLANT RECIPIENTS#0.9850;ERYTHROID PROGENITOR#0.9848;PROLYL HYDROXYLASE DOMAIN#0.9847;HIF PROLYL HYDROXYLASE#0.9846;GLYCOGEN SYNTHASE KINASE#0.9846;TYPE 1 DIABETES#0.9845;AUTOPHAGY#0.9845;ENDOPLASMIC RETICULUM#0.9844;BETA-2#0.9844;NEUROPROTECTION#0.9843;MYOCARDIAL INFARCTION#0.9843;HUMAN UMBILICAL VEIN#0.9843;CORTISOL#0.9842;PROSTATE CANCER#0.9841;HYPOXIA#0.9841;ISCHEMIA#0.9837;THALASSEMIA#0.9837;ANEMIC#0.9836;CHRONIC HEART FAILURE#0.9836;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9835;RENAL TRANSPLANT RECIPIENTS#0.9832;PHOSPHOLIPASE C#0.9831;TRANSFERRIN RECEPTOR#0.9830;NERVOUS SYSTEM#0.9830;CYTOCHROME C#0.9829;OXYGEN GLUCOSE DEPRIVATION#0.9829;NERVE GROWTH FACTOR#0.9827;CREATINE#0.9826;NEUROPATHY#0.9826;PULMONARY HYPERTENSION#0.9825;BRAIN DAMAGE#0.9823;TACROLIMUS#0.9822;PULMONARY ARTERY#0.9822;BONE MORPHOGENETIC PROTEIN#0.9821;OVARIAN#0.9821;HEREDITARY SPHEROCYTOSIS#0.9821;IRON DEXTRAN#0.9821;CYTOKINE PRODUCTION#0.9821;LYMPHOID CELL#0.9820;COGNITION#0.9820;ACUTE PHASE RESPONSE#0.9819;LECTIN#0.9819;MARROW STROMAL CELLS#0.9819;TRANSFORMING GROWTH FACTOR BETA#0.9818;IFN-GAMMA#0.9818;ASPIRIN#0.9818;RANDOMIZED CLINICAL TRIAL#0.9818;FETAL LIVER#0.9817;BLOOD PROGENITOR CELL#0.9817;SUCROSE#0.9817;FACTOR S#0.9817;SCIATIC NERVE#0.9815;CENTRAL NERVOUS SYSTEM#0.9814;POLYCYTHEMIA#0.9814;LEIOMYOMA#0.9814;ERYTHROLEUKEMIA#0.9814;BONE DISEASE#0.9814;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9813;COLORECTAL CANCER#0.9813;PHLEBOTOMY#0.9813;MYOCARDIUM#0.9813;SIGNALING MOLECULE#0.9812;ENZYME INHIBITOR#0.9812;VASCULAR ENDOTHELIAL CELL#0.9812;PROTEIN KINASE C#0.9812;SKELETAL MUSCLE#0.9811;LITHIUM#0.9811;BRAIN DISEASE#0.9808;PLATELET AGGREGATION#0.9806;HYPOTHYROIDISM#0.9806;ADENOCARCINOMA#0.9803;ADULT BONE MARROW#0.9802;HYPERGLYCEMIA#0.9801;LIVER DISEASE#0.9801;ERYTHROBLAST#0.9800;UREMIA#0.9799;STREPTOZOTOCIN#0.9798;HEMOPOIESIS#0.9798;MYELODYSPLASTIC SYNDROME#0.9797;NITRIC OXIDE#0.9797;CACHEXIA#0.9795;PLASMA MEMBRANE#0.9795;REGENERATION#0.9794;FOLATE#0.9793;GLYCOSYLATION#0.9793;SMOOTH MUSCLE#0.9793;ANGIOTENSIN CONVERTING ENZYME#0.9792;VENOUS BLOOD#0.9791;CYTOKINE RECEPTOR#0.9791;UMBILICAL CORD#0.9790;INCREASED BLOOD PRESSURE#0.9789;PENTOXIFYLLINE#0.9788;TUMOR CELLS#0.9787;AZATHIOPRINE#0.9787;HEMORRHAGIC#0.9787;RANDOMIZED CONTROLLED TRIAL#0.9786;ERYTHROID PRECURSOR#0.9785;CEREBRAL PALSY#0.9785;ALZHEIMER'S DISEASE#0.9784;PROGRAMMED CELL DEATH#0.9783;ARGININE#0.9783;ASTROCYTE#0.9783;NEURODEGENERATIVE DISEASE#0.9782;MECHANISMS OF ACTION#0.9782;VASOCONSTRICTION#0.9782;CORD BLOOD#0.9782;UMBILICAL VEIN#0.9782;NECROTIZING#0.9781;NEPHROGENIC SYSTEMIC FIBROSIS#0.9781;CYCLOSPORINE#0.9778;MULTIPLE LINEAR REGRESSION#0.9778;BLAST CELL#0.9776;COLITIS#0.9775;UMBILICAL CORD BLOOD#0.9775;MAST CELL#0.9775;PARENTERAL#0.9774;EMBRYONIC KIDNEY#0.9773;PRO-INFLAMMATORY#0.9772;VINCRISTINE#0.9772;MITOGEN ACTIVATED PROTEIN#0.9771;HYPOTENSION#0.9771;TYPE 1 DIABETIC#0.9771;INTESTINAL ABSORPTION#0.9768;RED BLOOD CELL DEVELOPMENT#0.9767;DOPAMINE#0.9767;MARKERS OF INFLAMMATION#0.9767;72-HOURS#0.9766;COMPLETE BLOOD COUNT#0.9766;DNA FRAGMENTATION#0.9765;PREDNISONE#0.9765;5 FLUOROURACIL#0.9764;MITOCHONDRIAL MEMBRANE#0.9762;ERYTHROID CELL#0.9761;PROTEIN TYROSINE KINASE#0.9761;ANESTHETIC#0.9760;PROTEIN TYROSINE PHOSPHATASE#0.9760;MECHANISM OF ACTION#0.9760;GROWTH FACTOR#0.9759;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9759;CARDIOMYOCYTE#0.9758;KINASE ACTIVITY#0.9758;FLUOROURACIL#0.9756;AMPHOTERICIN B#0.9756;HEPATITIS B#0.9755;UTERUS#0.9753;RESPONSE TO IRON#0.9752;DESMOPRESSIN#0.9752;VASCULAR DISEASE#0.9751;PRECURSOR CELL#0.9750;SILDENAFIL#0.9750;MACROPHAGE#0.9749;CANCER CELL#0.9749;PORPHYRIA#0.9749;GLIAL CELL#0.9749;DEFICIENCY ANEMIA#0.9749;HEMOGLOBINURIA#0.9748;IRON DEFICIENCY ANEMIA#0.9748;HYPOXIA INDUCIBLE FACTOR#0.9747;BIPOLAR DISORDER#0.9747;PERIPHERAL BLOOD CELLS#0.9747;HYPERPARATHYROIDISM#0.9746;MICROVASCULAR ENDOTHELIAL CELL#0.9746;TYROSINE KINASE DOMAIN#0.9745;SIGNAL TRANSDUCER#0.9744;EMBRYONIC STEM CELL#0.9744;NUCLEIC ACID#0.9744;IN VIVO ELECTROPORATION#0.9741;LEFT VENTRICULAR MASS#0.9741;CYCLOPHOSPHAMIDE#0.9740;HOST CELL#0.9740;SELECTIN#0.9739;STROMAL CELL#0.9739;LYSINE#0.9738;LINEAR REGRESSION ANALYSIS#0.9737;ENZYME ACTIVITY#0.9736;BONE MARROW FAILURE#0.9736;METAPLASIA#0.9736;IRON BINDING#0.9734;AMINOLEVULINIC ACID#0.9733;ANGIOGENESIS#0.9732;OVARIAN CARCINOMA#0.9732;RAPAMYCIN#0.9732;URINARY PROTEIN#0.9731;CHRONIC LIVER DISEASE#0.9731;BONE MARROW CELLS#0.9730;SODIUM DODECYL SULFATE#0.9730;DODECYL SULFATE#0.9729;HEPARIN#0.9728;SUSTAINED VIROLOGICAL RESPONSE#0.9728;RECEPTOR BINDING#0.9727;PYRUVATE#0.9726;EXCRETION#0.9725;GLOBIN#0.9725;COLORECTAL#0.9724;CROHN'S DISEASE#0.9723;TRANSFORMING GROWTH FACTOR#0.9722;MODE OF ACTION#0.9722;TARGET OF RAPAMYCIN#0.9721;GENE SILENCING#0.9721;BLOOD BRAIN BARRIER#0.9720;THROMBOCYTOSIS#0.9720;HUMAN IMMUNODEFICIENCY VIRUS#0.9717;SERUM ALBUMIN#0.9717;POLYCYTHEMIA VERA#0.9714;HYPOXIC#0.9713;CELL DIVISION#0.9709;WEIGHT LOSS#0.9707;DNA BINDING#0.9707;NEURITE OUTGROWTH#0.9706;ACUTE LEUKEMIA#0.9706;RED BLOOD CELL#0.9704;GLOMERULONEPHRITIS#0.9704;RECEPTOR LIGAND#0.9704;ERYTHROCYTE#0.9704;SIGNAL TRANSDUCTION#0.9703;ASPARTATE#0.9703;EPITHELIAL CELL#0.9702;HEMOLYTIC UREMIC SYNDROME#0.9700;ERYTHROPOIESIS#0.9700;PANCYTOPENIA#0.9699;END OF TREATMENT#0.9698;PROTEIN KINASE#0.9698;BREAST CARCINOMA#0.9697;VON HIPPEL LINDAU#0.9697;B CELL#0.9696;TISSUE DAMAGE#0.9695;MYELOID PROGENITOR CELL#0.9694;STEM CELL#0.9693;HEMORRHAGE#0.9693;CELL ACTIVATION#0.9692;RECEPTOR ANTAGONIST#0.9692;MALNUTRITION#0.9691;LOW DENSITY LIPOPROTEIN#0.9690;ALKALINE PHOSPHATASE#0.9689;EDEMA#0.9689;PLASMA CELL#0.9689;STEM CELL TRANSPLANTATION#0.9688;AMBULATORY BLOOD PRESSURE#0.9687;ISCHEMIC HEART DISEASE#0.9687;COLONY-FORMING CELL#0.9687;DRUG DELIVERY SYSTEM#0.9686;CELL ADHESION#0.9686;PARATHYROID#0.9686;PROTEIN SYNTHESIS#0.9685;PLURIPOTENT STEM CELL#0.9685;INFLAMMATORY BOWEL DISEASE#0.9685;CHRONIC KIDNEY DISEASE#0.9684;ALANINE#0.9683;CELL SURFACE#0.9683;GLUTATHIONE PEROXIDASE#0.9683;COAGULATION#0.9683;RISK OF DEATH#0.9682;CONGENITAL HEART DISEASE#0.9682;HEMOLYTIC ANEMIA#0.9681;GENE EXPRESSION#0.9680;DIABETIC NEPHROPATHY#0.9680;PARATHYROID HORMONE#0.9680;CONGESTIVE HEART FAILURE#0.9679;NEPHROPATHY#0.9678;BIOTIN#0.9678;KIDNEY DISEASE#0.9677;HISTONE DEACETYLASE#0.9677;PERITONITIS#0.9676;SUSTAINED VIROLOGIC RESPONSE#0.9674;TYPE 2 DIABETES#0.9674;KINASE INHIBITOR#0.9673;INTENSIVE CARE UNIT#0.9672;CEREBRAL ARTERY OCCLUSION#0.9672;CHRONIC HEPATITIS C#0.9671;MAMMARY GLAND#0.9670;PROGENITOR CELL#0.9670;ACETYLCHOLINE#0.9670;CASPASE-3 ACTIVITY#0.9669;S PHASE#0.9669;PROTEASOME#0.9668;ENDOTHELIAL CELL#0.9667;CELL EXPANSION#0.9666;GESTATION#0.9666;CELL DIFFERENTIATION#0.9665;CELL FRACTION#0.9664;SIGNALING PATHWAY#0.9664;TUMOR NECROSIS FACTOR#0.9663;IMMUNOSUPPRESSANT#0.9662;B LYMPHOCYTE#0.9662;RETICULOCYTE#0.9661;CORONARY ARTERY DISEASE#0.9661;ARTERY DISEASE#0.9661;C REACTIVE PROTEIN#0.9660;ANTI APOPTOSIS#0.9660;BONE MARROW ASPIRATE#0.9659;LEUKOCYTE#0.9658;MALIGNANT LYMPHOMA#0.9658;APOPTOSIS#0.9658;SERIOUS ADVERSE EVENT#0.9658;ETHANOL#0.9658;IRON OVERLOAD#0.9657;GROWTH FACTOR RECEPTOR#0.9657;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9657;HIGH DENSITY LIPOPROTEIN#0.9655;WEIGHT GAIN#0.9653;THYMIDINE#0.9653;HEART DISEASE#0.9653;IMMUNE RESPONSE#0.9652;MULTIPLE REGRESSION ANALYSIS#0.9651;IRON HOMEOSTASIS#0.9651;EPILEPSY#0.9651;RENAL REPLACEMENT THERAPY#0.9651;CIRCULATING PROGENITOR CELL#0.9650;PROTEINURIA#0.9649;HEMOLYSIS#0.9649;NEURITE#0.9648;VASCULAR CELL#0.9646;PHOSPHOGLYCERATE KINASE#0.9645;STROMA#0.9645;MONONUCLEAR CELLS#0.9645;STEM CELL PROLIFERATION#0.9645;SMALL INTESTINE#0.9644;MEGAKARYOCYTE#0.9643;MYELOFIBROSIS#0.9643;INFLAMMATORY CELL#0.9642;CELL GROWTH#0.9640;APOPTOTIC CELL DEATH#0.9640;PERIVENTRICULAR LEUKOMALACIA#0.9640;ENDOTHELIUM#0.9640;SYSTOLIC BLOOD PRESSURE#0.9640;QUANTITATIVE REAL TIME#0.9639;IMMUNE SYSTEM#0.9638;UBIQUITIN#0.9637;INTRAVENOUS IMMUNOGLOBULIN#0.9636;IRON TRANSPORT#0.9634;ERYTHROPOIESIS STIMULATING AGENT#0.9634;T LYMPHOCYTE#0.9633;PHEOCHROMOCYTOMA#0.9632;PHOSPHATIDYLSERINE#0.9632;BLOOD VESSEL#0.9632;BONE MARROW#0.9632;HEAT SHOCK PROTEIN#0.9630;NEUTROPENIA#0.9629;DENTATE GYRUS#0.9626;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9626;LIPID METABOLISM#0.9625;HEMATOPOIETIC PROGENITOR CELL#0.9625;DENDRITIC CELL#0.9625;AMYLOIDOSIS#0.9624;MIDDLE CEREBRAL ARTERY#0.9624;ACUTE MYELOID LEUKEMIA#0.9624;ESSENTIAL THROMBOCYTHEMIA#0.9623;HEMATOPOIETIC CELL#0.9622;PHAGOCYTOSIS#0.9621;BLOOD UREA NITROGEN#0.9621;TRASTUZUMAB#0.9621;CYTOTOXICITY#0.9620;CLOTTING#0.9620;METABOLIC ACIDOSIS#0.9619;HYPERTENSION#0.9619;INTENT TO TREAT#0.9619;EOSINOPHIL#0.9616;FIBRINOGEN#0.9615;CAROTID ARTERY#0.9615;DIABETES MELLITUS#0.9614;CEREBRAL ARTERY#0.9612;DIGESTION#0.9612;MAGNETIC RESONANCE IMAGING#0.9612;SUPEROXIDE DISMUTASE#0.9611;TRANSCRIPTASE#0.9610;HEPATITIS C#0.9610;GLUCOSE UPTAKE#0.9610;CERVIX#0.9609;TRANSCRIPTION FACTOR#0.9607;CORONARY ARTERY#0.9606;WORLD HEALTH ORGANIZATION#0.9605;ATHEROSCLEROSIS#0.9604;DOXYCYCLINE#0.9604;THROMBOSIS#0.9604;EXTRACELLULAR MATRIX#0.9604;DIABETIC MACULAR EDEMA#0.9603;INTENTION TO TREAT#0.9603;ELECTROPHORETIC MOBILITY SHIFT#0.9602;LASER DESORPTION IONIZATION#0.9602;TYROSINE KINASE RECEPTOR#0.9602;CELL MEMBRANE#0.9601;APOPTOTIC#0.9598;INFLAMMATORY RESPONSE#0.9597;CELL CYCLE#0.9596;CHRONIC MYELOID LEUKEMIA#0.9596;GLUTATHIONE#0.9596;MYELOPROLIFERATIVE NEOPLASM#0.9595;CELL PROLIFERATION#0.9595;MUTAGENESIS#0.9595;TRANSACTIVATION#0.9594;HEPATITIS C VIRUS#0.9594;LEUKOPENIA#0.9592;ETOPOSIDE#0.9592;NOREPINEPHRINE#0.9590;BLOOD LOSS#0.9589;CYTOPENIA#0.9589;MYCOPHENOLATE MOFETIL#0.9589;LENGTH OF STAY#0.9588;T CELL#0.9588;LYMPH NODE#0.9588;MONOCYTE#0.9587;VASODILATION#0.9585;ADIPOCYTE#0.9585;ENUCLEATION#0.9582;CELL DEATH#0.9582;VASCULAR ENDOTHELIUM#0.9582;MENSTRUAL CYCLE#0.9581;REACTIVE OXYGEN SPECIES#0.9581;AUTOIMMUNE DISEASE#0.9576;OSTEOBLAST#0.9576;TRANSIENT RECEPTOR POTENTIAL#0.9574;SPINAL CORD COMPRESSION#0.9572;PROSTAGLANDIN E2#0.9570;OBESE#0.9570;MYELOID LEUKEMIA#0.9569;LOW IRON#0.9569;CELL CYCLE ARREST#0.9569;REVERSE TRANSCRIPTION#0.9568;VIRAL HEPATITIS#0.9568;PERIPHERAL BLOOD#0.9566;MYELOID CELL#0.9563;VIRAL INFECTION#0.9563;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9561;MORRIS WATER MAZE#0.9558;GLOMERULAR FILTRATION RATE#0.9558;PERICYTE#0.9555;NITRO-L-ARGININE#0.9554;WHITE BLOOD CELL#0.9554;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9553;TUBE FORMATION#0.9551;GLOMERULAR FILTRATION#0.9549;FUMARATE#0.9548;HEMATOPOIESIS#0.9548;ARTERY#0.9543;CYTOPLASM#0.9542;CEREBRAL CORTEX#0.9542;INDUCED RENAL INJURY#0.9541;DEMENTIA#0.9541;REGULATION OF HEMATOPOIESIS#0.9539;MOOD DISORDER#0.9538;MUSCLE WEAKNESS#0.9537;METHOTREXATE#0.9536;MITOMYCIN C#0.9534;KERATINOCYTE#0.9534;THROMBOCYTOPENIA#0.9532;HEMATIDE#0.9532;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9530;2 DIABETES MELLITUS#0.9528;RENAL VEIN#0.9525;HIGH RISK PATIENTS#0.9524;CONTROLLED CORTICAL IMPACT#0.9524;TUMOR SUPPRESSOR#0.9522;HEMATOPOIETIC STEM CELL#0.9522;NEUTROPHIL#0.9522;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.9522;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.9522;TOXICITY#0.9517;STRIATUM#0.9517;TOCOPHEROL#0.9516;POST-TRANSLATIONAL MODIFICATION#0.9516;PEGINTERFERON ALFA-2B#0.9514;IMATINIB MESYLATE#0.9513;PROTEIN PHOSPHORYLATION#0.9513;SUBMANDIBULAR GLAND#0.9511;HYPERTENSIVE ENCEPHALOPATHY#0.9510;MYOFIBROBLAST#0.9509;TYPE 2 DIABETES MELLITUS#0.9508;MITOCHONDRIA#0.9505;NECROTIC#0.9499;WHITE MATTER DAMAGE#0.9498;TETRACYCLINE#0.9498;LUNG CARCINOMA#0.9497;CHANGE FROM BASELINE#0.9497;PLASMODIUM FALCIPARUM MALARIA#0.9494;CELL ADHESION MOLECULE#0.9494;PROLYL 4-HYDROXYLASE#0.9492;CREATINE KINASE#0.9491;CONTROLLED CLINICAL TRIALS#0.9489;MYOCYTES#0.9489;BOCEPREVIR#0.9487;CARDIOVASCULAR RISK FACTOR#0.9484;RNA INTERFERENCE#0.9483;GRAFT VERSUS HOST#0.9483;ACUTE LUNG INJURY#0.9481;POLYMERASE CHAIN REACTION#0.9475;IMMUNE CELL#0.9473;NORMAL CONTROL GROUP#0.9468;BORTEZOMIB#0.9466;ONCOGENIC#0.9465;PHOSPHODIESTERASE#0.9463;LOSARTAN#0.9462;NEPHRON#0.9462;MESENCHYMAL CELL#0.9458;DIAMOND BLACKFAN ANEMIA#0.9453;ESTROGEN RECEPTOR#0.9443;SODIUM NITROPRUSSIDE#0.9438;KUPFFER CELL#0.9437;PLATELET ACTIVATION#0.9437;PLASMA PROTEIN#0.9433;POSTNATAL DAY 7#0.9431;INSULIN RECEPTOR#0.9429;PHOSPHATE BUFFERED SALINE#0.9417;TELAPREVIR#0.9412;MYOMA#0.9410;GLYCINE#0.9408;MICROCYTIC ANEMIA#0.9405;CATABOLISM#0.9403;ADENOSINE MONOPHOSPHATE#0.9399;POLYMORPHONUCLEAR LEUKOCYTES#0.9398;RETINAL DEGENERATION#0.9394;RETINAL DISEASE#0.9393;PRIMARY POLYCYTHEMIA#0.9393;ENDOCYTOSIS#0.9392;ADJUSTED ODDS RATIO#0.9388;HAEMOPOIESIS#0.9388;KIDNEY DAMAGE#0.9387;SPECTRIN#0.9384;NADPH OXIDASE#0.9379;CENTRAL VENOUS CATHETER#0.9378;FLUORESCEIN#0.9376;HEPATITIS B VIRUS#0.9372;TYROSINE KINASE INHIBITOR#0.9372;CLEAR CELL RENAL CELL CARCINOMA#0.9364;NEPHROTOXIC#0.9359;PULMONARY EMBOLISM#0.9352;ARACHIDONIC ACID#0.9350;OXYGEN INDUCED RETINOPATHY#0.9348;SCOLIOSIS#0.9347;LEUCINE#0.9347;HYPOXIA INDUCED FACTOR#0.9344;FETAL DISTRESS#0.9341;NERVE FIBER#0.9332;VITAMIN B12 DEFICIENCY#0.9329;CELL-MEDIATED IMMUNITY#0.9329;GLUTAMINE#0.9328;HYPOTENSIVE#0.9327;HERPES SIMPLEX#0.9321;ANTITHYMOCYTE GLOBULIN#0.9320;CAFFEINE#0.9316;BINDING PROTEIN 3#0.9312;ERYTHROCYTE SEDIMENTATION RATE#0.9309;CALCINEURIN#0.9305;CANCER RELATED FATIGUE#0.9295;AQUAPORIN#0.9295;CARRIE#0.9289;ACTIVE VITAMIN D#0.9287;DOCETAXEL#0.9284;SENESCENCE#0.9284;CONSTRICTION#0.9277;ARRHYTHMIA#0.9275;FEMUR#0.9273;EOSIN#0.9263;LYSIS#0.9262;ATHEROSCLEROTIC#0.9258;DELTA-AMINOLEVULINIC ACID#0.9253;SOMATROPIN#0.9250;DIARRHEA#0.9246;SENSITIZATION#0.9246;TRIIODOTHYRONINE#0.9244;HUMAN EMBRYONIC KIDNEY#0.9243;FULL BLOOD COUNT#0.9242;LYSOSOME#0.9240;MITOSIS#0.9237;POLYNEUROPATHY#0.9237;HEALTHY CONTROL SUBJECTS#0.9235;GUANOSINE#0.9228;LIMIT OF DETECTION#0.9224;OVERALL RESPONSE RATE#0.9222;SUCCINATE#0.9218;NICOTINAMIDE#0.9217;CALCIUM CARBONATE#0.9216;ERYTHRO#0.9216;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9214;BUDD-CHIARI SYNDROME#0.9213;TO THE PROGRESSION#0.9212;PROPOFOL#0.9206;CELLULAR METABOLISM#0.9202;G1 PHASE#0.9200;METASTATIC RENAL CELL CARCINOMA#0.9198;GROWTH FACTOR BINDING#0.9188;EPINEPHRINE#0.9181;ANTI INFLAMMATORY DRUGS#0.9179;EPIRUBICIN#0.9176;CYSTATIN#0.9171;BETA ADRENERGIC RECEPTOR#0.9170;BUSULFAN#0.9167;CLEAVED CASPASE 3#0.9167;NULL CELL#0.9166;MACROPHAGE INFLAMMATORY PROTEIN#0.9161;AORTIC VALVE#0.9158;SERUM AMYLOID A#0.9156;OCULAR HYPERTENSION#0.9152;AZACITIDINE#0.9152;END DIASTOLIC VOLUME#0.9151;ULCERATIVE COLITIS#0.9150;INDUCTION OF APOPTOSIS#0.9148;PODOCYTE#0.9141;TOLL LIKE RECEPTOR#0.9132;PROTEIN-ENERGY MALNUTRITION#0.9131;PERIPHERAL VASCULAR DISEASE#0.9124;PYRIDOXINE#0.9122;BETA GALACTOSIDASE#0.9120;HAEMOPOIETIC STEM CELLS#0.9117;MITOMYCIN#0.9117;DIURESIS#0.9113;LASER INDUCED FLUORESCENCE#0.9109;ATORVASTATIN#0.9103;ENDOTHELIAL CELL PROLIFERATION#0.9103;SURFACE PLASMON RESONANCE#0.9099;HEALTH CARE SYSTEM#0.9098;HERPES SIMPLEX VIRUS#0.9096;HYALURONIC ACID#0.9096;BRAIN NATRIURETIC PEPTIDE#0.9090;TISSUE REGENERATION#0.9086;ALPHA-TOCOPHEROL#0.9081;LEYDIG CELL#0.9080;DIVALENT METAL TRANSPORTER#0.9078;ASCITES#0.9077;EMBOLISM#0.9075;MAPK ACTIVATION#0.9073;L-LYSINE#0.9073;NEOPLASTIC DISEASE#0.9069;AMPHOTERICIN#0.9068;NORADRENALINE#0.9068;ADVERSE DRUG REACTION#0.9067;VASODILATATION#0.9066;STEM CELL DIFFERENTIATION#0.9061;HAIR FOLLICLE#0.9058;PROPRANOLOL#0.9058;HEALTH CARE PROVIDER#0.9056;ANAKINRA#0.9056;CATION CHANNEL#0.9055;HEARING LOSS#0.9053;NEOPTERIN#0.9051;GLUCOSE HOMEOSTASIS#0.9047;QUALITY OF CARE#0.9043;VITAMIN B6#0.9042;CONNECTIVE TISSUE#0.9041;MOUSE EMBRYONIC STEM#0.9039;VITAMIN DEFICIENCY#0.9036;CAPTOPRIL#0.9031;PRIMITIVE ERYTHROPOIESIS#0.9031;PRE-ECLAMPSIA#0.9019;VOMITING#0.9018;BINDING PROTEIN 1#0.9006;MUSCLE FIBER#0.8998;MULTIPLE LOGISTIC REGRESSION#0.8995;SIDEROBLASTIC ANEMIA#0.8995;NITROPRUSSIDE#0.8995;BODY SURFACE AREA#0.8992;LOW MOLECULAR WEIGHT HEPARIN#0.8990;B CELL LYMPHOMA#0.8989;INTERNATIONAL WORKING GROUP#0.8985;PORPHYRIA CUTANEA TARDA#0.8985;HEPARIN BINDING#0.8985;LEFT ANTERIOR DESCENDING#0.8982;CYCLIN DEPENDENT KINASE#0.8980;NEPHRITIS#0.8974;BONE MARROW MICROENVIRONMENT#0.8970;SUSTAINED VIRAL RESPONSE#0.8966;PEGINTERFERON ALFA-2A#0.8965;SMOOTH MUSCLE ACTIN#0.8963;NON HODGKIN LYMPHOMA#0.8956;BLOOD COAGULATION#0.8956;PERIPHERAL BLOOD LYMPHOCYTES#0.8955;ARTERIOLE#0.8949;GUANINE#0.8948;PROTEIN METABOLISM#0.8948;AZACYTIDINE#0.8946;GLYCOLYSIS#0.8944;SWELLING#0.8942;ALLOPURINOL#0.8941;ASPARAGINE#0.8937;COMMON CAROTID ARTERY#0.8931;TAMOXIFEN#0.8928;CYCLIC ADENOSINE MONOPHOSPHATE#0.8926;TACHYCARDIA#0.8925;ERYTHROCYTE PRECURSORS#0.8919;TYROSINE KINASE 2#0.8919;WEIGHTED MEAN DIFFERENCE#0.8919;SIZE EXCLUSION CHROMATOGRAPHY#0.8907;PNEUMONIA#0.8892;PEROXISOME#0.8879;BLOOD CIRCULATION#0.8870;STAUROSPORINE#0.8867;ALLERGIC REACTION#0.8866;HYDRONEPHROSIS#0.8864;AMINOCAPROIC ACID#0.8857;VASOCONSTRICTOR#0.8857;GLUCOSE-6-PHOSPHATE#0.8856;DNA BREAKDOWN#0.8856;DISEASE FREE SURVIVAL#0.8855;EPITHELIAL TO MESENCHYMAL#0.8851;ION CHANNEL#0.8837;CHRONIC MYELOPROLIFERATIVE DISORDERS#0.8835;CINACALCET#0.8833;MICRONUCLEUS#0.8830;LEFT VENTRICULAR REMODELING#0.8826;GEMCITABINE#0.8824;PROTEASE ACTIVITY#0.8822;PERITONEAL CAVITY#0.8818;BONE MARROW ENDOTHELIAL#0.8814;WHITE ADIPOSE TISSUE#0.8812;HEMOSIDEROSIS#0.8811;GENISTEIN#0.8811;MACULAR DEGENERATION#0.8807;TRANSMEMBRANE RECEPTOR#0.8805;URETER#0.8801;HEPATOCYTE NUCLEAR FACTOR#0.8801;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8795;FRONTAL#0.8793;FLUDROCORTISONE#0.8792;BETA CELL#0.8776;RETINAL VEIN OCCLUSION#0.8774;MEMORY IMPAIRMENT#0.8773;RH ISOIMMUNIZATION#0.8764;FETAL BRAIN#0.8759;ACTIVE CASPASE 3#0.8754;HYDROCORTISONE#0.8754;THYMOCYTE#0.8751;RETINAL ISCHEMIA#0.8749;PROSTACYCLIN#0.8746;ORTHOTOPIC LIVER TRANSPLANTATION#0.8745;ADJUSTED HAZARD RATIO#0.8743;ANTIBODY PRODUCTION#0.8734;CYTOSINE ARABINOSIDE#0.8727;LINES OF EVIDENCE#0.8720;XANTHINE#0.8718;ANOREXIA#0.8718;ARYL HYDROCARBON RECEPTOR#0.8713;CASPASE ACTIVATION#0.8712;HUMAN MESENCHYMAL STEM#0.8705;O GLYCAN#0.8704;METHIONINE#0.8700;PROLACTIN RECEPTOR#0.8696;VASCULOGENESIS#0.8696;MODAFINIL#0.8689;INSULIN GROWTH FACTOR#0.8685;HUMAN BREAST CANCER#0.8681;COLLECTING DUCTS#0.8674;ALBUTEROL#0.8671;RESPIRATION#0.8660;VASODILATOR#0.8658;PROGENITOR STEM CELL#0.8642;R/AMP#0.8634;HEMATOPOIETIC ORGANS#0.8631;MAMMARY EPITHELIAL CELL#0.8629;TIME TO RESPONSE#0.8628;COMPLEX I#0.8622;HISTONE DEACETYLASE INHIBITOR#0.8622;PARENCHYMA#0.8619;XANTHINE OXIDASE#0.8618;PLASMODIUM BERGHEI ANKA#0.8615;TRANSMISSION ELECTRON MICROSCOPY#0.8615;CYTOCHROME C RELEASE#0.8614;HYPERTHYROIDISM#0.8613;BONE MARROW STEM CELL#0.8609;GLUCOCORTICOID RECEPTOR#0.8604;SUNITINIB#0.8594;HYPERPHOSPHATEMIA#0.8594;MYELINATION#0.8590;CD8+ T CELL#0.8579;GENOTOXICITY#0.8575;HIGH FAT DIET#0.8575;CYTOCHROME P450#0.8572;TOTAL KNEE REPLACEMENT#0.8571;SIGNALLING CASCADE#0.8568;NEURON APOPTOSIS#0.8565;OPTIC NERVE CRUSH#0.8560;DEPHOSPHORYLATION#0.8554;BONE REGENERATION#0.8552;PLATELET ACTIVATING FACTOR#0.8549;ISCHEMIC REPERFUSION INJURY#0.8549;MICROPARTICLE#0.8547;PHOSPHODIESTERASE INHIBITOR#0.8543;HYPOGONADISM#0.8542;TIGHT JUNCTION#0.8542;REGULATION OF GENE EXPRESSION#0.8535;BASEMENT MEMBRANE#0.8532;ENTEROCYTE#0.8529;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8528;OXYGEN DEPENDENT DEGRADATION#0.8526;ASCORBATE#0.8524;MEGAKARYOCYTE PROGENITOR CELL#0.8521;MYCOPHENOLIC ACID#0.8519;AGE RELATED MACULAR DEGENERATION#0.8517;DEATH RECEPTOR#0.8505;FOLIC ACID DEFICIENCY#0.8502;TUMOR TISSUES#0.8502;AMINOLEVULINATE#0.8500;SODIUM BICARBONATE#0.8497;PURPURA#0.8495;INNATE IMMUNE RESPONSE#0.8481;POLY ADP RIBOSE#0.8476;CRITICAL LIMB ISCHEMIA#0.8452;PHOTORECEPTOR CELL#0.8450;CD4+ T CELL#0.8447;SHORTNESS OF BREATH#0.8444;HYPOGLYCEMIA#0.8442;INNER EAR#0.8441;PROXIMAL TUBULAR CELL#0.8439;HAIR CELL#0.8438;BODY GROWTH#0.8438;HYPERSPLENISM#0.8436;OSTEOGENESIS#0.8431;CHEMOTAXIS#0.8431;VENA CAVA#0.8430;SERUM LEPTIN LEVEL#0.8425;DIZZINESS#0.8425;ACUTE RENAL INJURY#0.8422;KETAMINE#0.8420;HINDLIMB#0.8417;RESPIRATORY FAILURE#0.8413;ERGOCALCIFEROL#0.8412;IMMUNOGLOBULIN G#0.8408;INTRACELLULAR SIGNALING PATHWAY#0.8408;ANAPHYLACTIC#0.8406;ERYTHROCYTE DIFFERENTIATION#0.8400;GASTRIC ANTRAL VASCULAR ECTASIA#0.8399;RECURRENT HEPATITIS C#0.8399;NEURAL CREST#0.8395;SIROLIMUS#0.8395;RECOMBINANT HUMAN GM-CSF#0.8392;BLOOD GLUCOSE LEVEL#0.8391;NEUROTOXIC#0.8390;CHEMOKINE RECEPTOR#0.8388;AMLODIPINE#0.8385;ANAPHYLAXIS#0.8382;SEXUAL DYSFUNCTION#0.8381;DRUG RESISTANCE#0.8377;GLUTAMIC ACID#0.8375;POSITRON EMISSION TOMOGRAPHY#0.8372;DIABETIC AUTONOMIC NEUROPATHY#0.8371;MEAN PLATELET VOLUME#0.8370;NATURAL KILLER CELL#0.8363;PLACENTAL GROWTH FACTOR#0.8363;RENAL OSTEODYSTROPHY#0.8362;POTASSIUM CHANNEL#0.8362;VON HIPPEL-LINDAU DISEASE#0.8359;VITAMIN D DEFICIENCY#0.8356;ATPASE ACTIVITY#0.8352;DIFFUSION TENSOR IMAGING#0.8350;ANGIOGENIC GROWTH FACTORS#0.8350;STEM CELL TRANSPLANT#0.8343;CYTOPLASMIC REGION#0.8343;SIGNAL PEPTIDE#0.8331;LIPOIC ACID#0.8331;HUMAN EMBRYONIC STEM#0.8330;ACETYLSALICYLIC ACID#0.8325;CHRONIC MYELOMONOCYTIC LEUKEMIA#0.8318;REFUSAL#0.8312;ESTROGENS#0.8311;PI3K SIGNALING#0.8309;IRON REGULATORY PROTEIN#0.8308;MITOCHONDRIAL PERMEABILITY TRANSITION#0.8306;PORPHOBILINOGEN#0.8299;ADRENOCORTICOTROPIC HORMONE#0.8296;MANNITOL#0.8296;QUERCETIN#0.8288;INCREASE BLOOD PRESSURE#0.8286;HEPATIC ISCHEMIA REPERFUSION#0.8284;REPORTER GENE ASSAY#0.8276;PROTEIN BINDING#0.8276;TRADITIONAL CHINESE MEDICINE#0.8275;PANCREATIC ISLET#0.8272;MEMANTINE#0.8270;SORAFENIB#0.8269;EPITHELIAL MESENCHYMAL TRANSITION#0.8267;NITRIC OXIDE SYNTHESIS#0.8259;FG-4592#0.8256;NEOVASCULAR GLAUCOMA#0.8254;ARGININE VASOPRESSIN#0.8245;PROTEIN KINASE A#0.8237;RBC AGGREGATION#0.8235;HEPATIC VEIN#0.8229;MELPHALAN#0.8226;DNA METHYLATION#0.8222;DEHYDRATION#0.8218;LUCIFERASE ACTIVITY#0.8207;MUCOSITIS#0.8202;NEUROTRANSMITTER RELEASE#0.8200;FUROSEMIDE#0.8189;VALSARTAN#0.8182;AORTIC VALVE REPLACEMENT#0.8178;MAGNESIUM SULPHATE#0.8167;2'-DEOXYURIDINE#0.8156;ALLOIMMUNIZATION#0.8153;GEFITINIB#0.8145;PANCREATITIS#0.8144;CORONARY ARTERY LIGATION#0.8142;HAEMATOPOIETIC STEM CELL#0.8137;ROS GENERATION#0.8135;WHITE MATTER INJURY#0.8130;ENHANCER BINDING#0.8129;BLINDNESS#0.8129;PHOSPHATASE ACTIVITY#0.8114;FLUID RETENTION#0.8112;FOLLICLE STIMULATING HORMONE#0.8111;PARAGANGLIOMA#0.8106;URIDINE#0.8103;THYMIDINE KINASE#0.8087;GASTRIC ADENOCARCINOMA#0.8081;INTERLEUKIN 3 RECEPTOR#0.8080;METHYLPHENIDATE#0.8077;SEPTUM#0.8076;ENERGY HOMEOSTASIS#0.8069;TRYPTOPHAN#0.8068;RECEPTOR INTERNALIZATION#0.8064;ACETIC ACID#0.8062;CASPASE ACTIVITY#0.8056;SUBSTANTIA NIGRA#0.8049;MIDODRINE#0.8045;RIBOSOMAL PROTEIN#0.8038;DNA REPLICATION#0.8038;PROPIDIUM#0.8037;ECLAMPSIA#0.8033;END SYSTOLIC VOLUME#0.8031;INULIN#0.8029;NEURONAL PROGENITOR CELL#0.8023;SYSTEMIC INFLAMMATORY RESPONSE#0.8022;MICROGLIAL CELL#0.8013;METAPHASE#0.8010;ELTROMBOPAG#0.8005;BILE DUCT#0.8004;TOPOTECAN#0.7999;RNA BINDING PROTEIN#0.7994;RENOVASCULAR HYPERTENSION#0.7994;FLOW CYTOMETRY ANALYSIS#0.7990;AGEING#0.7985;ALPHA THALASSEMIA#0.7980;RNA BINDING#0.7979;GONADOTROPIN RELEASING HORMONE#0.7974;HISTIDINE#0.7973;DECITABINE#0.7960;LEAN BODY MASS#0.7958;OSTEOCLAST#0.7955;CYSTIC FIBROSIS#0.7953;PERITONEUM#0.7953;TUBERCULOSIS#0.7951;FOREARM#0.7950;DIPHOSPHATE#0.7949;PREGABALIN#0.7943;HALOPERIDOL#0.7941;PROTEIN SECRETION#0.7932;RESPONSE TO EXERCISE#0.7924;LACTATION#0.7919;EXTRACELLULAR REGULATED KINASE#0.7915;RESPIRATORY DISTRESS#0.7914;GENETIC DISORDER#0.7912;MARROW STEM CELLS#0.7911;FORSKOLIN#0.7909;DULOXETINE HYDROCHLORIDE#0.7908;MYELOBLAST#0.7890;LUNG GROWTH#0.7889;MICROTUBULE#0.7882;RETINOL#0.7872;INSULIN RECEPTOR SUBSTRATE#0.7870;HYPOCHROMIC ANEMIA#0.7867;DORSAL ROOT GANGLION#0.7861;ROSUVASTATIN CALCIUM#0.7860;MEGALOBLASTIC ANEMIA#0.7858;TADALAFIL#0.7858;OXIDATIVE PHOSPHORYLATION#0.7855;HISTAMINE#0.7853;PORTAL VEIN#0.7853;OSTEONECROSIS#0.7848;LIVER DAMAGE#0.7847;CYTARABINE#0.7847;CELLULAR COMPONENT#0.7845;CARDIAC MAGNETIC RESONANCE#0.7839;HAEM BIOSYNTHESIS#0.7838;CAROTID ARTERY OCCLUSION#0.7835;ARTERIOGENESIS#0.7833;T- PA#0.7830;OUABAIN#0.7830;CASPASE INHIBITOR#0.7828;PATIENT REPORTED OUTCOME#0.7828;ADVANCED GLYCATION END#0.7825;INSULIN SECRETION#0.7819;FORMALIN#0.7811;TIOTROPIUM BROMIDE#0.7809;ARA-C#0.7800;ACUTE MYELOID LEUKAEMIA#0.7799;ERLOTINIB#0.7798;AMINOCAPROIC#0.7794;HEMATOPOIETIC CELL TRANSPLANTATION#0.7794;THYROTROPIN RELEASING HORMONE#0.7793;RILUZOLE#0.7787;TIME TO PROGRESSION#0.7779;RANDOMIZED CONTROL TRIAL#0.7777;RIBOSE#0.7776;DANAZOL#0.7768;MAGNETIC RESONANCE SPECTROSCOPY#0.7765;MACROCYTIC ANEMIA#0.7762;ADVANCED OVARIAN CANCER#0.7758;RESPONSE TO GROWTH FACTOR#0.7749;NERVOUS SYSTEM DISEASE#0.7741;PERMEABILITY TRANSITION PORE#0.7728;RESPONSE TO IL-3#0.7727;OPEN ANGLE GLAUCOMA#0.7726;CYCLASE ACTIVITY#0.7723;PULMONARY EDEMA#0.7722;CORONARY HEART DISEASE#0.7722;NMDA RECEPTOR#0.7719;ADRENAL GLAND#0.7719;PROTEIN ENERGY WASTING#0.7715;IGF BINDING#0.7711;NEUROLOGICAL SEVERITY SCORE#0.7706;SPIRAL GANGLION NEURONS#0.7701;CELLULAR GROWTH#0.7700;CONGENITAL HYPOPLASTIC ANEMIA#0.7700;ERYTHROCYTE MATURATION#0.7697;PANCREATIC CANCER#0.7695;CORD BLOOD TRANSPLANTATION#0.7691;STIMULATION OF ANGIOGENESIS#0.7689;VALPROIC ACID#0.7688;LATERAL VENTRICLE#0.7678;ISOPROTERENOL#0.7665;FLUOXYMESTERONE#0.7664;HEMANGIOMA#0.7659;ISOFLURANE#0.7659;PILOCARPINE#0.7658;CONTROL OF BLOOD PRESSURE#0.7653;MULTIPLE SYSTEM ATROPHY#0.7640;SPINAL CORD INJURIES#0.7634;DYSPNEA#0.7625;ENOXAPARIN#0.7625;BOSENTAN#0.7624;CELL PHYSIOLOGY#0.7620;HEMOPHILIA#0.7614;CHRONIC ALLOGRAFT NEPHROPATHY#0.7613;DNA REPAIR#0.7606;FIMBRIA#0.7601;CEREBROVASCULAR DISEASE#0.7587;BLOOD PLATELET AGGREGATION#0.7576;ERYTHROCYTE DEVELOPMENT#0.7575;MYELOPEROXIDASE ACTIVITY#0.7573;MYOCARDIAL INFARCT SIZE#0.7571;RETINOIC ACID RECEPTOR#0.7569;PROTEIN DEFICIENCY#0.7568;ADRIAMYCIN#0.7546;INTRACELLULAR SIGNAL TRANSDUCTION#0.7546;TISSUE HOMEOSTASIS#0.7532;ENDOCRINE SYSTEM#0.7528;VALINE#0.7527;HEMATOPOIETIC PRECURSOR CELL#0.7523;MODAL#0.7518;ZOLEDRONIC ACID#0.7510;MITOGENIC ACTIVITY#0.7504;PROTEIN KINASE ACTIVITY#0.7504;VISUAL ANALOGUE SCALE#0.7503;GERM CELL#0.7496;ENHANCER BINDING PROTEIN#0.7495;EVIDENCE BASED MEDICINE#0.7492;MRNA BINDING#0.7484;AUTOIMMUNE HEMOLYTIC ANEMIA#0.7483;GANCICLOVIR#0.7477;EXPERIMENTAL CEREBRAL MALARIA#0.7476;MYOTUBE#0.7476;PARICALCITOL#0.7476;GROWTH PATTERN#0.7475;DUCTAL BREAST CANCER#0.7463;WARFARIN#0.7452;HUMAN HEPATOMA CELL LINES#0.7448;NERVE FIBER LAYER#0.7448;SKELETON#0.7445;RETINAL PIGMENT EPITHELIUM#0.7444;POSITIVE AIRWAY PRESSURE#0.7435;HEPATOBLASTOMA#0.7433;PATENT DUCTUS ARTERIOSUS#0.7432;SEVOFLURANE#0.7431;BONE RESORPTION#0.7429;SHAM OPERATION GROUP#0.7428;PULMONARY VASCULAR REMODELING#0.7427;GLCNAC#0.7421;ACUTE HEART FAILURE#0.7416;DNASE#0.7410;MALNUTRITION INFLAMMATION SCORE#0.7409;IONOPHORE#0.7403;HEAD AND NECK CARCINOMA#0.7402;FETAL KIDNEY#0.7402;DULOXETINE#0.7394;DUCTUS ARTERIOSUS#0.7392;IGG ANTIBODY#0.7387;SRC FAMILY KINASE#0.7385;DECIDUA#0.7385;CEREBRAL INFARCTION#0.7383;INFLAMMATORY CELL INFILTRATION#0.7380;OXPENTIFYLLINE#0.7380;EMBRYONIC BRAIN#0.7380;STROMAL DERIVED FACTOR#0.7380;THROMBOPLASTIN#0.7379;BEST SUPPORTIVE CARE#0.7376;NIFEDIPINE#0.7373;HYPERACTIVITY#0.7371;HYPOXANTHINE#0.7370;LIGAND BINDING DOMAIN#0.7369;SECRETORY PATHWAY#0.7368;RECEPTOR ACTIVITY#0.7363;MICROTUBULE ASSOCIATED PROTEIN#0.7353;AMYLOID PRECURSOR PROTEIN#0.7347;ENDOTHELIAL CELL MIGRATION#0.7347;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7346;OBSTRUCTIVE JAUNDICE#0.7345;LYMPHOPROLIFERATIVE DISEASE#0.7345;1α,25-DIHYDROXYVITAMIN D3#0.7343;GLUCOSE TOLERANCE TEST#0.7343;VIRAL ENVELOPE#0.7342;LYMPH NODE METASTASIS#0.7335;PITAVASTATIN CALCIUM#0.7330;GASTRO#0.7329;HEALTHY CONTROL GROUP#0.7327;PORTAL HYPERTENSION#0.7325;ANDROGEN RECEPTOR#0.7320;PULMONARY ARTERIAL HYPERTENSION#0.7315;INFLIXIMAB#0.7307;RESTLESS#0.7305;PROTEIN COMPLEX#0.7293;LONG TERM POTENTIATION#0.7288;FACTOR INHIBITING HIF#0.7285;INTERLEUKIN 1 RECEPTOR#0.7282;CLINICAL PERFORMANCE MEASURES#0.7281;STEM CELL DEVELOPMENT#0.7278;BOTULINUM TOXIN TYPE B#0.7242;AORTIC ANEURYSM#0.7237;QUANTITATIVE REVERSE TRANSCRIPTION#0.7235;HYPERHOMOCYSTEINEMIA#0.7235;ADRENALINE#0.7232;BLOOD RETINAL BARRIER#0.7232;BONE MINERAL DENSITY#0.7220;ATAZANAVIR#0.7217;NEURON SURVIVAL#0.7212;ESOPHAGEAL CANCER#0.7211;NEUROFILAMENT#0.7210;PROXIMAL TUBULAR EPITHELIAL#0.7209;ESTIMATED BLOOD LOSS#0.7208;ERLOTINIB HYDROCHLORIDE#0.7206;OXYGEN BINDING#0.7204;MENINGITIS#0.7197;CRYSTALLOID#0.7197;PEMETREXED DISODIUM#0.7197;MULTIPLE ORGAN DYSFUNCTION#0.7195;HEMOGLOBINOPATHY#0.7192;ADALIMUMAB#0.7186;EZETIMIBE#0.7182;ERYTHEMA#0.7177;THORACIC AORTA#0.7176;SERUM URIC ACID#0.7176;CYSTIC KIDNEY DISEASE#0.7175;OSTEOPOROSIS#0.7175;DNA DEGRADATION#0.7174;RESPONSE TO CYTOKINE#0.7167;ADENYLATE CYCLASE ACTIVITY#0.7167;PHOSPHATE METABOLISM#0.7164;MEDIAN OVERALL SURVIVAL#0.7156;YEAR SURVIVAL RATE#0.7150;DILATED CARDIOMYOPATHY#0.7149;POSITIVE PREDICTIVE VALUE#0.7148;RUXOLITINIB#0.7147;MACROPHAGE ACTIVATION#0.7145;ORGANELLE#0.7137;CHLORAMPHENICOL#0.7137;FATTY ACID OXIDATION#0.7136;ELECTRONIC MEDICAL RECORD#0.7134;BLEOMYCIN#0.7132;TUMOR INITIATING CELL#0.7131;BONE REMODELING#0.7131;RECEPTOR INTERACTING PROTEIN#0.7129;VEGF SIGNALING#0.7127;GROWTH HORMONE RECEPTOR#0.7120;ACTIVATED T-CELLS#0.7119;ACUTE PANCREATITIS#0.7119;HYDRALAZINE#0.7118;MULTIPOTENT STEM CELL#0.7118;ACTIVATED T CELL#0.7116;MEDICAL OUTCOMES STUDY#0.7109;PRIMARY OPEN ANGLE GLAUCOMA#0.7109;EVEROLIMUS#0.7108;ASTHENIA#0.7106;ENDOMETRIUM#0.7102;LYMPHOBLASTOID CELLS#0.7097;ANAGRELIDE#0.7090;FETAL GROWTH RESTRICTION#0.7089;PARAPLEGIA#0.7088;FIBROSARCOMA#0.7087;SLEEP DISORDER#0.7082;ANAESTHETIC#0.7074;GENETIC DISEASE#0.7073;FERMENTATION#0.7072;VERAPAMIL#0.7071;DUODENUM#0.7069;JANUS ACTIVATED KINASE#0.7064;ELITE ENDURANCE ATHLETES#0.7064;PEDICLE#0.7044;FOCAL ADHESION#0.7043;ATP BINDING#0.7035;MINERALIZATION#0.7035;OXIDATIVE METABOLISM#0.7032;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7031;INTERVENTRICULAR SEPTUM#0.7025;INTESTINAL MUCOSA#0.7017;DEAMINASE ACTIVITY#0.7017;TIPIFARNIB#0.7017;RETINAL DEVELOPMENT#0.7015;POSTTRANSLATIONAL MODIFICATION#0.7014;LOW DOSE ASPIRIN#0.7006;DIGOXIN#0.7006;ORGAN OF CORTI#0.7006;PHOSPHOLIPASE A2#0.7001;FORELIMB#0.7000;SOLID ORGAN TRANSPLANTATION#0.6995;BASOPHIL#0.6994;PIOGLITAZONE#0.6991;HYALURONATE#0.6989;ACTIVE PHARMACEUTICAL INGREDIENT#0.6988;SUNITINIB MALATE#0.6988;PHOSPHATE BINDING#0.6988;IN VITRO MATURATION#0.6987;ROMIPLOSTIM#0.6979;NOVEL OBJECT RECOGNITION#0.6976;ANTIOXIDANT ACTIVITY#0.6974;PRIMITIVE ERYTHROID CELL#0.6970;QUADRICEPS#0.6968;STABLE GRAFT FUNCTION#0.6955;IFOSFAMIDE#0.6950;TO TUMOR PROGRESSION#0.6949;PAROTID GLAND#0.6948;CHRONIC IDIOPATHIC MYELOFIBROSIS#0.6948;ETANERCEPT#0.6945;PLASMACYTOMA#0.6942;ADVANCED BREAST CANCER#0.6942;CETUXIMAB#0.6939;CHORIOAMNIONITIS#0.6938;GESTATIONAL DIABETES#0.6937;POINT OF CARE#0.6937;METFORMIN#0.6936;RESTING ENERGY EXPENDITURE#0.6933;CELLULAR MEMBRANE#0.6929;EICOSAPENTAENOIC ACID#0.6925;WILLINGNESS TO PAY#0.6919;CHOLINE#0.6916;INOSINE#0.6914;TRANSCRIPTIONAL CONTROL#0.6911;DIABETIC KIDNEY DISEASE#0.6906;INTIMA MEDIA THICKNESS#0.6905;FASTING BLOOD GLUCOSE#0.6901;CAMP RESPONSE ELEMENT#0.6899;PHENOBARBITAL#0.6895;MITOCHONDRIAL DNA#0.6894;ALPHA 1-ANTITRYPSIN#0.6887;NEUTROPHIL DIFFERENTIATION#0.6885;CYCLIC GUANOSINE MONOPHOSPHATE#0.6880;GLYCERYL TRINITRATE#0.6865;RESPONSE TO HYPOXIC STRESS#0.6862;PIMECROLIMUS#0.6859;NATIVE CHEMICAL LIGATION#0.6859;NUCLEAR LAYER#0.6852;RETINAL ENDOTHELIAL CELLS#0.6851;PYRUVATE KINASE#0.6849;OSTEITIS FIBROSA#0.6849;HYPERCALCEMIA#0.6839;PYELONEPHRITIS#0.6838;LISINOPRIL#0.6823;NUCLEOTIDE BINDING#0.6819;MULTIVARIATE LINEAR REGRESSION#0.6817;POTASSIUM CHLORIDE#0.6816;OXYGEN METABOLISM#0.6811;CHONDROCYTE#0.6809;METOPROLOL#0.6805;HYDROCEPHALUS#0.6804;BLADDER CARCINOMA#0.6801;FLUDARABINE#0.6800;CARBONIC ANHYDRASE 9#0.6792;PI3-KINASE ACTIVITY#0.6791;CLOPIDOGREL#0.6790;CONVULSION#0.6788;GLIBENCLAMIDE#0.6788;FRAGMENT LENGTH POLYMORPHISM#0.6786;REGULATORY T CELL#0.6781;DIFFERENTIAL GENE EXPRESSION#0.6780;MRNA TRANSCRIPTION#0.6776;SOLID ORGAN TRANSPLANT#0.6775;CARDIAC MUSCLE#0.6765;RESPIRATORY CHAIN#0.6764;OESTRADIOL#0.6761;LOCALIZED PROSTATE CANCER#0.6758;PERIVENTRICULAR WHITE MATTER#0.6756;ADVANCED HEART FAILURE#0.6753;HIP JOINT#0.6752;BASILAR ARTERY#0.6746;MALIGNANT HYPERTENSION#0.6744;TROPHOBLAST#0.6743;ASTROCYTOMA#0.6741;TERIPARATIDE#0.6731;PLACENTA GROWTH FACTOR#0.6731;COLORECTAL CARCINOMA#0.6725;BRAIN WATER CONTENT#0.6724;ABACAVIR SULFATE#0.6722;BRAIN ENDOTHELIAL CELL#0.6701;PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY#0.6700;AND BODY COMPOSITION#0.6692;VASCULITIS#0.6686;NOS INHIBITOR#0.6675;ADVERSE DRUG EVENT#0.6674;HIGH RISK NEUROBLASTOMA#0.6673;ENDOTHELIAL CELL APOPTOSIS#0.6670;GLASGOW OUTCOME SCALE#0.6668;INHIBITION OF CELL PROLIFERATION#0.6667;HYDROXYPROLINE#0.6666;MYOBLAST PROLIFERATION#0.6666;IRINOTECAN#0.6660;SKIN FIBROBLASTS#0.6658;MACROPHAGE MIGRATION#0.6658;HYPERGLYCEMIC#0.6653;CAMP RESPONSE ELEMENT BINDING#0.6650;UNFOLDED PROTEIN RESPONSE#0.6647;SEVERE ADVERSE EVENTS#0.6636;CYTOCHROME B#0.6634;MUSCULAR DYSTROPHY#0.6632;PERTUSSIS#0.6632;COLON ADENOCARCINOMA#0.6631;NON-SMALL CELL LUNG CARCINOMA#0.6623;RETINAL PIGMENT EPITHELIAL#0.6622;ACTION POTENTIAL#0.6622;OBSTRUCTIVE SLEEP APNOEA#0.6618;COENZYME A#0.6618;CONTROL GROUP 1#0.6614;PROTEIN PROTEIN INTERACTION#0.6612;TRANSFORMING GROWTH FACTOR ALPHA#0.6610;CELECOXIB#0.6602;RITONAVIR#0.6598;GLUCOSAMINE#0.6590;NEUROREGENERATION#0.6586;CLENBUTEROL#0.6582;MELANOCYTE#0.6555;INSTITUTIONAL REVIEW BOARD#0.6550;ADJUSTED RELATIVE RISK#0.6549;EXTRACELLULAR REGION#0.6535;OOCYTE#0.6533;HORMONE BINDING#0.6532;HYPAQUE#0.6528;AIDS RELATED COMPLEX#0.6528;MEGAKARYOCYTE DIFFERENTIATION#0.6520;PARALYSIS#0.6519;RENAL INTERSTITIAL FIBROSIS#0.6518;OF DIABETIC RATS#0.6511;TOTAL NUCLEATED CELL#0.6506;TOTAL ANTIOXIDANT CAPACITY#0.6506;EVENT FREE SURVIVAL#0.6505;HEPATIC NUCLEAR FACTOR#0.6497;GLUCOSE TRANSPORT#0.6494;ENDOTHELIAL STEM CELL#0.6479;FK-506#0.6478;CAROTID ARTERY LIGATION#0.6478;NEURON DEATH#0.6475;INTERSTITIAL NEPHRITIS#0.6472;OSTEOMALACIA#0.6466;MINISTRY OF HEALTH#0.6454;MURINE EMBRYONIC STEM#0.6444;LETROZOLE#0.6437;ENDOMETRIOSIS#0.6435;TETRAHYDROBIOPTERIN#0.6433;PRIMARY CORTICAL NEURON#0.6431;PROTEIN GLYCOSYLATION#0.6431;AMYGDALA#0.6431;VANCOMYCIN#0.6431;OVARIES#0.6418;ADENOSINE DEAMINASE#0.6417;ACTIVIN RECEPTOR#0.6415;NEUROBLAST#0.6414;CELLULAR RESPONSE TO HYPOXIA#0.6411;TELOMERASE ACTIVITY#0.6410;ESCITALOPRAM OXALATE#0.6410;HEART DEVELOPMENT#0.6407;MYOPATHY#0.6407;EARLY GROWTH RESPONSE#0.6405;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.6405;COCHLEA#0.6402;GENOTOXIC#0.6401;SEVERE MALARIAL ANEMIA#0.6401;AZIDOTHYMIDINE#0.6400;PROSTAGLANDIN SYNTHESIS#0.6396;MITRAL VALVE#0.6394;PKC ACTIVITY#0.6393;COMPLEMENT RECEPTOR#0.6391;LUPUS NEPHRITIS#0.6388;5 AMINOLEVULINATE SYNTHASE#0.6379;MALIGNANT GLIOMA#0.6377;GLYCERALDEHYDE-3-PHOSPHATE#0.6371;PEROXIDASE ACTIVITY#0.6368;CHLOROQUINE#0.6367;NUCLEOTIDE EXCHANGE FACTOR#0.6366;SEVELAMER#0.6365;DNASE I#0.6363;BODY WEIGHT GAIN#0.6361;MYOSIN HEAVY CHAIN#0.6358;OVIDUCT#0.6356;HAEM OXYGENASE 1#0.6351;GLUCOSE INTOLERANCE#0.6350;LIVER CANCER#0.6349;MIDBRAIN#0.6347;RIBOSOME#0.6343;ACT D#0.6341;MAPK SIGNALING#0.6340;MOLAR#0.6336;OUTER NUCLEAR LAYER#0.6315;ADEFOVIR DIPIVOXIL#0.6313;SILDENAFIL CITRATE#0.6306;TUMOR GROWTH FACTOR#0.6303;EARLY BRAIN INJURY#0.6301;PNGASE F#0.6294;JUXTAMEMBRANE#0.6291;DAYS POST INJURY#0.6286;STANDARDIZED MEAN DIFFERENCE#0.6281;FENOTEROL#0.6281;ADVERSE CLINICAL OUTCOME#0.6280;PEMETREXED#0.6279;DOBUTAMINE#0.6277;TIOTROPIUM#0.6276;HYDRAZIDE#0.6276;FELODIPINE#0.6271;TRANSPOSITION#0.6269;REGULATION OF PKC#0.6266;ASIALOGLYCOPROTEIN RECEPTOR#0.6266;GROWTH OF CELL#0.6265;GUANIDINE#0.6263;ADULT HIPPOCAMPAL NEUROGENESIS#0.6254;ACADEMIC MEDICAL CENTER#0.6254;DYSKERATOSIS CONGENITA#0.6253;VITAMIN A DEFICIENCY#0.6251;VEGF PRODUCTION#0.6239;SCANNING ELECTRON MICROSCOPY#0.6237;APOPTOSIS OF NEURONS#0.6230;RESPIRATORY SYSTEM#0.6228;MENSTRUATION#0.6226;INDIVIDUAL PATIENT DATA#0.6226;HAIRY CELL LEUKEMIA#0.6215;PULSE WAVE VELOCITY#0.6214;REGULATION OF CELLULAR#0.6211;HEMATURIA#0.6207;LYMPHOPENIA#0.6201;MESENTERIC ARTERY#0.6194;LETHARGY#0.6189;L-CYSTEINE#0.6188;GABAPENTIN#0.6188;RETINITIS PIGMENTOSA#0.6181;LUNG METASTASIS#0.6181;CYCLIN DEPENDENT KINASE INHIBITOR#0.6180;PRIMARY HYPERPARATHYROIDISM#0.6176;HUMAN LEUKOCYTE ANTIGEN#0.6172;ACUTE PORPHYRIA#0.6171;MRNA SYNTHESIS#0.6163;HOMOLOGOUS RECOMBINATION#0.6162;SKELETAL MUSCLE ADAPTATION#0.6161;EPSTEIN BARR VIRUS#0.6157;ACID PHOSPHATASE#0.6157;ADENOSINE TRIPHOSPHATE#0.6156;BRADYCARDIA#0.6152;CATALYTIC ACTIVITY#0.6151;SUBJECTIVE GLOBAL ASSESSMENT#0.6148;L-THYROXINE#0.6144;DRUG ELUTING STENT#0.6144;HEMATOPOIETIC STEM CELL PROLIFERATION#0.6141;GUANIDINE HYDROCHLORIDE#0.6135;HYDROPHILIC INTERACTION CHROMATOGRAPHY#0.6131;AXITINIB#0.6130;NEURAL PRECURSOR CELL#0.6129;PLASMA ANTIOXIDANT CAPACITY#0.6128;RESPONSE TO GM-CSF#0.6127;PERIPHERAL NERVE INJURIES#0.6127;HYPOCHROMIC MICROCYTIC ANEMIA#0.6126;THALAMUS#0.6117;PROSTAGLANDIN E1#0.6116;VITREOUS HUMOUR#0.6113;VITAMIN K#0.6111;ITO CELL#0.6101;RECEPTOR MEDIATED ENDOCYTOSIS#0.6098;OLMESARTAN#0.6096;SPINAL CORD CONTUSION#0.6094;VORINOSTAT#0.6092;ROSUVASTATIN#0.6092;NIMODIPINE#0.6084;ACETAZOLAMIDE#0.6083;MUSCLE ADAPTATION#0.6080;CHOLINERGIC NEURON#0.6078;HALLUCINATIONS#0.6078;GLUCOSE REGULATED PROTEIN#0.6067;DIAZOXIDE#0.6060;PANEL REACTIVE ANTIBODIES#0.6059;TENOFOVIR DISOPROXIL FUMARATE#0.6056;CYTOTOXIC T CELL#0.6056;INTERFERON GAMMA RECEPTOR#0.6054;TENOFOVIR DISOPROXIL#0.6053;RED BLOOD CELL DIFFERENTIATION#0.6051;SYNAPTIC TRANSMISSION#0.6050;DOMINANT NEGATIVE MUTANT#0.6045;IL-6 PRODUCTION#0.6045;URIDINE METABOLISM#0.6039;FATTY LIVER#0.6037;RESPONSE TO TESTOSTERONE#0.6036;HEMOGLOBIN FORMATION#0.6035;RESPIRATORY TRACT#0.6027;PORPHYRIN METABOLISM#0.6022;C-LEVEL#0.6020;SUBSTANCE P#0.6019;M PHASE#0.6017;PALPITATION#0.6015;ACTIN CYTOSKELETON#0.6015;TROPISM#0.6012;CYTOTOXIC T-LYMPHOCYTE#0.6008
205717	THYROID CANCER#0.6996
2057	CYTOPLASMIC REGION#1.0581;RECEPTOR ACTIVATOR#1.0454;SKELETAL MUSCLE#1.0407;LUNG CANCER#1.0391;ERYTHROPOIETIN RECEPTOR#1.0348;BREAST CANCER#1.0257;BREAST CANCER CELL#1.0237;RECEPTOR COMPLEX#1.0235;INTERLEUKIN 2 RECEPTOR#1.0222;TUMOR CELLS#1.0179;REVERSE TRANSCRIPTION#1.0177;DARBEPOETIN ALFA#1.0162;EPIDERMAL GROWTH FACTOR#1.0161;ASTROCYTE#1.0154;CANCER CELL#1.0122;SIGNALING CASCADE#1.0099;GLOBIN#1.0091;SQUAMOUS CELL CARCINOMA#1.0084;POLYMERASE CHAIN REACTION#1.0068;ERYTHROLEUKEMIA#1.0067;EPITHELIAL CELL#1.0062;FETAL LIVER#1.0061;HEMATOPOIETIC TISSUES#1.0051;COLONY-STIMULATING FACTOR#1.0044;HYPOXIA INDUCIBLE FACTOR#1.0037;RECEPTOR AGONIST#1.0033;EXTRACELLULAR REGION#1.0025;GRANULOCYTE COLONY STIMULATING FACTOR#1.0010;BONE MARROW CELLS#1.0006;MITOGEN ACTIVATED PROTEIN#1.0003;ENDOTHELIAL CELL#0.9995;CENTRAL NERVOUS SYSTEM#0.9987;NERVOUS SYSTEM#0.9978;RECEPTOR TYROSINE KINASE#0.9974;ENDOTHELIAL GROWTH FACTOR#0.9973;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9973;ERYTHROBLAST#0.9971;GRANULOCYTE#0.9971;ENDOPLASMIC RETICULUM#0.9960;POLYCYTHEMIA#0.9956;RESPONSE TO ERYTHROPOIETIN#0.9954;GM-CSF#0.9941;STEM CELL FACTOR#0.9939;ERYTHROPOIESIS STIMULATING AGENT#0.9928;RECEPTOR BINDING#0.9927;GROWTH FACTOR RECEPTOR#0.9926;ERYTHROID CELL#0.9924;ERYTHROID PROGENITOR#0.9922;KINASE ACTIVITY#0.9921;MACROPHAGE#0.9916;CYTOKINE RECEPTOR#0.9909;SPINAL CORD#0.9907;HYPOXIA#0.9904;SIGNALING MOLECULE#0.9896;CELL GROWTH#0.9891;CORD BLOOD#0.9891;TRANSFERRIN RECEPTOR#0.9890;ERYTHROID PRECURSOR#0.9882;SIGNAL TRANSDUCER#0.9882;CELL SURFACE#0.9880;PROTEIN KINASE#0.9877;ANGIOGENESIS#0.9875;HYPOXIC#0.9875;NEUROPROTECTION#0.9874;CHRONIC KIDNEY DISEASE#0.9871;T CELL#0.9869;ADENOCARCINOMA#0.9869;NITRIC OXIDE#0.9867;GENE EXPRESSION#0.9865;SIGNAL TRANSDUCTION#0.9862;SIGNALING PATHWAY#0.9861;HEMATOPOIETIC CELL#0.9858;KIDNEY DISEASE#0.9848;ISCHEMIA#0.9836;PROTEIN TYROSINE PHOSPHATASE#0.9834;B CELL#0.9829;HYPERSENSITIVITY#0.9827;TRANSCRIPTION FACTOR#0.9812;BONE MARROW#0.9809;PROGENITOR CELL#0.9804;ANAEMIA#0.9799;CELL CYCLE#0.9791;CELL DIFFERENTIATION#0.9791;ANEMIC#0.9790;PERIPHERAL BLOOD#0.9789;POLYCYTHEMIA VERA#0.9788;ERYTHROPOIESIS#0.9787;G-CSF#0.9787;CELL MEMBRANE#0.9784;APOPTOSIS#0.9772;PRECURSOR CELL#0.9766;PEGINESATIDE#0.9749;CELL PROLIFERATION#0.9747;ERYTHROCYTE#0.9736;HEMATOPOIETIC STEM CELL#0.9734;GROWTH FACTOR#0.9730;PROTEIN TYROSINE KINASE#0.9726;HEMATOPOIESIS#0.9721;PLASMA MEMBRANE#0.9720;ANEMIA#0.9718;CELL DEATH#0.9714;RED BLOOD CELL#0.9710;APOPTOTIC#0.9709;STEM CELL#0.9708;OVARIAN#0.9700;DNA BINDING#0.9699;MAP KINASE#0.9698;MYELOID CELL#0.9695;PROLACTIN RECEPTOR#0.9694;PROSTATE CANCER#0.9641;TYROSINE KINASE DOMAIN#0.9640;CELL DEVELOPMENT#0.9638;AKT SIGNALING#0.9625;MYELODYSPLASTIC SYNDROME#0.9603;HEMATOPOIETIC PROGENITOR CELL#0.9603;CARDIOMYOCYTE#0.9571;TERMINAL DIFFERENTIATION#0.9506;MEGAKARYOCYTE#0.9501;LUNG CARCINOMA#0.9491;OVARIAN CANCER#0.9455;TRANSCRIPTASE#0.9452;TUMOR NECROSIS FACTOR#0.9448;MONONUCLEAR CELLS#0.9366;EPOETIN ALFA#0.9350;NEURONAL CELLS#0.9334;ENDOCYTOSIS#0.9326;ENDOTHELIUM#0.9323;MUSCLE CELL#0.9311;ISCHEMIA REPERFUSION INJURY#0.9306;SIGNALLING PATHWAY#0.9296;STROMAL CELL#0.9279;MUTAGENESIS#0.9271;GROWTH HORMONE#0.9252;GLYCOSYLATION#0.9232;PRIMARY POLYCYTHEMIA#0.9230;LYMPH NODE#0.9181;ONCOGENIC#0.9151;NITRIC OXIDE SYNTHASE#0.9146;JUXTAMEMBRANE#0.9138;INHIBITION OF APOPTOSIS#0.9105;RETICULOCYTE#0.9098;DEFINITIVE ERYTHROPOIESIS#0.9094;PROTEIN KINASE B#0.9056;QUANTITATIVE REAL TIME#0.9056;NON-SMALL CELL LUNG CARCINOMA#0.9009;SMOOTH MUSCLE#0.9008;HEAD AND NECK CANCER#0.8993;NECK CANCER#0.8993;YOLK SAC#0.8961;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8947;REACTIVE OXYGEN SPECIES#0.8920;CERVICAL#0.8898;RBC DEVELOPMENT#0.8854;GESTATION#0.8847;VON HIPPEL LINDAU#0.8846;DIABETIC RETINOPATHY#0.8841;OLIGODENDROCYTE#0.8795;ESTROGEN RECEPTOR#0.8792;INTERLEUKIN 3 RECEPTOR#0.8772;MYOCARDIAL INFARCTION#0.8749;CELL ADHESION#0.8741;HEPATOCELLULAR CARCINOMA#0.8729;RECEPTOR ACTIVITY#0.8725;HYPERTENSION#0.8701;NEURAL CELL#0.8688;ENDOTHELIAL PROGENITOR CELL#0.8685;RENAL CELL CARCINOMA#0.8583;NEURODEGENERATIVE DISEASE#0.8582;HEMOGLOBIN SYNTHESIS#0.8535;MYELOPROLIFERATIVE NEOPLASM#0.8521;GLIAL CELL#0.8485;FLUORESCEIN#0.8483;COLORECTAL#0.8466;BREAST CARCINOMA#0.8455;PRO-INFLAMMATORY#0.8427;NEUTROPHIL#0.8390;CYTOTOXICITY#0.8344;PHOSPHOLIPASE C#0.8339;COLORECTAL CANCER#0.8331;SMOOTH MUSCLE CELL#0.8304;ARTERY#0.8298;GROWTH HORMONE RECEPTOR#0.8291;MONOCYTE#0.8242;MAST CELL#0.8236;LYSOSOME#0.8186;BRAIN DEVELOPMENT#0.8184;APOPTOTIC CELL DEATH#0.8139;KINASE INHIBITOR#0.8098;CARDIOVASCULAR SYSTEM#0.8092;ENDOTHELIAL NITRIC OXIDE#0.8061;CELL MIGRATION#0.8054;EMBRYONIC STEM CELL#0.8051;INSULIN RECEPTOR#0.8048;MYELOID LEUKEMIA#0.8038;PROTEASOME#0.8022;EMBRYONIC BRAIN#0.7997;LUNG GROWTH#0.7990;MUSCLE FIBER#0.7974;NEURAL PROGENITOR CELL#0.7974;DEPHOSPHORYLATION#0.7968;TRAUMATIC BRAIN INJURY#0.7965;CELL EXPANSION#0.7964;ACUTE KIDNEY INJURY#0.7958;PROERYTHROBLAST#0.7944;ADIPOCYTE#0.7935;PROTEIN KINASE C#0.7899;CERVICAL CANCER#0.7898;CYTOPLASM#0.7892;IMMUNE CELL#0.7866;MYOCARDIUM#0.7865;LIPID RAFT#0.7840;ACUTE LEUKEMIA#0.7823;PROGRAMMED CELL DEATH#0.7800;LENALIDOMIDE#0.7784;ADIPOSE TISSUE#0.7719;UBIQUITIN#0.7714;AUTOPHAGY#0.7643;DUCTAL BREAST CANCER#0.7642;REGENERATION#0.7633;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7618;VIRAL ENVELOPE#0.7591;MEMBRANE RAFT#0.7586;LIGAND BINDING DOMAIN#0.7582;KIDNEY TRANSPLANT RECIPIENTS#0.7575;DISEASE SPECIFIC SURVIVAL#0.7570;TUMOR SUPPRESSOR#0.7522;NEUROGENESIS#0.7520;PHLEBOTOMY#0.7518;ALANINE#0.7443;GASTRIC ADENOCARCINOMA#0.7434;RNA INTERFERENCE#0.7416;GANGLION CELLS#0.7416;PROTEIN SYNTHESIS#0.7400;INVASIVE BREAST CANCER#0.7387;LYMPHOID CELL#0.7368;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7352;HUMAN UMBILICAL VEIN#0.7347;UMBILICAL VEIN#0.7345;CEREBRAL ISCHEMIA#0.7296;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7288;PODOCYTE#0.7218;RECEPTOR LIGAND#0.7218;THALASSEMIA#0.7202;MULTIPLE MYELOMA#0.7196;INTERLEUKIN 4 RECEPTOR#0.7174;TAMOXIFEN#0.7165;MYOBLAST#0.7154;NEUROBLASTOMA#0.7138;PLATELET-DERIVED GROWTH FACTOR#0.7132;CYTOKINE PRODUCTION#0.7116;TRANSFORMING GROWTH FACTOR#0.7096;ACUTE MYELOID LEUKEMIA#0.7073;MARROW STROMAL CELLS#0.7044;BONE MARROW STROMAL CELL#0.7044;TOXICITY#0.7041;BONE MARROW STROMAL#0.7040;RETINAL GANGLION CELL#0.7032;RESPONSE TO HYPOXIA#0.7029;TRANSMEMBRANE RECEPTOR#0.7018;LEUCINE#0.6995;UMBILICAL CORD#0.6982;FIBROBLAST GROWTH FACTOR#0.6940;NEUTROPHIL DIFFERENTIATION#0.6916;BLOOD BRAIN BARRIER#0.6871;PROTEIN PROTEIN INTERACTION#0.6819;TYPE 2 DIABETIC#0.6815;BIOTIN#0.6814;INSULIN-LIKE GROWTH FACTOR#0.6794;BREAST CANCER PATIENTS#0.6790;INTRACELLULAR SIGNAL TRANSDUCTION#0.6745;DOXORUBICIN#0.6718;5 FLUOROURACIL#0.6716;RETINAL DETACHMENT#0.6712;CISPLATIN#0.6710;FORMALIN#0.6701;TYROSINE KINASE RECEPTOR#0.6700;DNASE I#0.6693;CELL CYCLE ARREST#0.6687;ESSENTIAL THROMBOCYTHEMIA#0.6687;INFLAMMATORY RESPONSE#0.6666;MYELOFIBROSIS#0.6662;HEMATIDE#0.6598;PURE RED-CELL APLASIA#0.6590;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6566;VASCULAR ENDOTHELIAL CELL#0.6551;RECEPTOR INTERNALIZATION#0.6493;INDUCIBLE NITRIC OXIDE#0.6461;REPORTER GENE ASSAY#0.6450;MICROVASCULAR ENDOTHELIAL CELL#0.6436;TUMOR TISSUES#0.6425;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6425;HUMAN BREAST CANCER#0.6420;BLOOD VESSEL#0.6405;WOUND HEALING#0.6393;T LYMPHOCYTE#0.6386;ALZHEIMER'S DISEASE#0.6379;THROMBOCYTOSIS#0.6379;RECEPTOR DEGRADATION#0.6332;UMBILICAL CORD BLOOD#0.6282;ARGININE#0.6267;GLUTATHIONE#0.6241;DECIDUA#0.6218;COLONY-FORMING CELL#0.6204;CELL ACTIVATION#0.6175;GLUCOCORTICOID RECEPTOR#0.6171;BRAIN DAMAGE#0.6159;BLOOD LOSS#0.6131;METASTASIS TO LYMPH NODE#0.6120;SPINAL CORD INJURY#0.6116;DIABETIC NEPHROPATHY#0.6102;TYROSINE KINASE INHIBITOR#0.6086;S PHASE#0.6083;IMMUNE RESPONSE#0.6044;OXYGEN HOMEOSTASIS#0.6013
205860	G1 PHASE#0.6971;CELL CYCLE ARREST#0.6099;CELL CYCLE#0.6051
2058	GAIT COMPLEX#1.1417;PARS PLANA VITRECTOMY#1.0980;PROLINE TRNA#1.0040;MULTISYNTHETASE COMPLEX#1.0025;HALOFUGINONE#0.9901;POLY ADP RIBOSE#0.9574;SYNTHETASE ACTIVITY#0.9518;PROTEIN SYNTHESIS#0.9490;DIABETIC RETINOPATHY#0.9268;INTERNAL LIMITING MEMBRANE#0.9224;RIBOSOMAL PROTEIN#0.8935;OTITIS MEDIA#0.8814;RIBOSE#0.8714;PARS PLANITIS#0.8576;GENE EXPRESSION#0.8569;PEELING#0.8388;OTITIS MEDIA WITH EFFUSION#0.8220;CHOLESTEATOMA#0.8132;TRANSFER RNA#0.8085;RETINAL DETACHMENT#0.7928;GLUTAMINE#0.7850;IFN-GAMMA#0.7850;RNA BINDING#0.7786;MITOCHONDRIA#0.7322;ORGANELLE#0.7248;AMINOACYL-TRNA SYNTHETASE COMPLEX#0.7189;GLYCERALDEHYDE-3-PHOSPHATE#0.7080;INFLAMMATORY RESPONSE#0.7010;GLUTAMIC ACID#0.6975;EPITHELIAL CELL#0.6969;PETAL DEVELOPMENT#0.6704;ADENYLATE#0.6690;AMINO ACID ACTIVATION#0.6602;PROLIFERATIVE DIABETIC RETINOPATHY#0.6343;GLUTATHIONE#0.6286;CELL PROLIFERATION#0.6240;CYSTOID MACULAR EDEMA#0.6228;TRANSLATION INITIATION#0.6045;CYCLIN DEPENDENT KINASE#0.6026
2059	ACTIN BUNDLING#1.0765;EPIDERMAL GROWTH FACTOR#1.0513;GROWTH FACTOR RECEPTOR#1.0501;CANCER CELL#1.0486;GROWTH FACTOR#1.0392;CELL PROLIFERATION#1.0294;ACTIN FILAMENT#1.0217;CELL MIGRATION#1.0150;RECEPTOR TYROSINE KINASE#1.0066;ACTIN BINDING#1.0050;HAIR CELL#1.0005;ACTIN RELATED PROTEIN#0.9882;BREAST CANCER#0.9866;ACTIN CYTOSKELETON#0.9797;CELL GROWTH#0.9716;NUCLEOTIDE EXCHANGE FACTOR#0.9716;SERTOLI CELL#0.9666;SIGNALING PATHWAY#0.9540;SQUAMOUS CELL CARCINOMA#0.9506;ACTIN BINDING PROTEIN#0.9483;APICAL ES#0.9385;CELL MOTILITY#0.9368;COMPLEX I#0.9342;GUANINE#0.9327;APOPTOSIS#0.9110;OVARIAN CANCER#0.9000;GENE EXPRESSION#0.8867;ACTIN POLYMERIZATION#0.8836;MEMBRANE RUFFLE#0.8693;MORPHOGENESIS#0.8604;CERVICAL CANCER#0.8549;PANCREATIC CANCER#0.8527;BREAST CANCER CELL#0.8494;COLON CANCER#0.8465;BLOOD TESTIS BARRIER#0.8448;CELL CORTEX#0.8296;DENDRITIC SPINE#0.8294;RUFFLE#0.8184;CELLULAR GROWTH#0.8160;CELL CYCLE#0.8159;LUNG CANCER#0.7948;T CELL#0.7907;FOCAL ADHESION#0.7893;GERM CELL#0.7850;EPITHELIAL CELL#0.7830;CYTOTOXIC T-LYMPHOCYTE#0.7801;T LYMPHOCYTE#0.7756;SIGNALING ADAPTOR#0.7608;NMDA RECEPTOR#0.7590;ACTIN FILAMENT BUNDLE#0.7458;TRANSCRIPTION FACTOR#0.7451;MYELOID LEUKEMIA#0.7354;ACUTE MYELOID LEUKEMIA#0.7342;ENDOCYTOSIS#0.7334;KINASE ACTIVITY#0.7304;TUMOR CELLS#0.7248;ACTIN NUCLEATION#0.7228;OVARIAN#0.7204;FILOPODIA FORMATION#0.7192;CELL ADHESION#0.7105;POLYMERASE CHAIN REACTION#0.7105;ACTIN CAPPING ACTIVITY#0.7033;SIGNAL TRANSDUCTION#0.6935;FOCAL ADHESION KINASE#0.6851;CERVICAL#0.6849;ORAL SQUAMOUS CELL CARCINOMA#0.6836;PLASMA MEMBRANE#0.6820;PROTEIN KINASE#0.6758;APICAL ECTOPLASMIC SPECIALIZATION#0.6683;MITHRAMYCIN#0.6544;TIGHT JUNCTION#0.6397;SIGNALLING PATHWAY#0.6325;LYMPH NODE#0.6292;SPERMATOGENESIS#0.6117;BONE MARROW#0.6087
205	ADENYLATE KINASE#1.0952;ADENYLATE#1.0839;CELL PROLIFERATION#0.9139;LUNG CANCER#0.8323;HYPOXIA#0.7865;CELL DEATH#0.7571;MITOCHONDRIAL MATRIX#0.7299;GENE EXPRESSION#0.7194;LUNG ADENOCARCINOMA#0.7080;ADENOSINE#0.6755;GTP:AMP PHOSPHOTRANSFERASE#0.6474;ADENOSINE TRIPHOSPHATE#0.6389;DRUG RESISTANCE#0.6258;TRANSCRIPTION FACTOR#0.6185;CANCER CELL#0.6124
2060	EPS15 HOMOLOGY DOMAIN#1.1014;DOMINANT NEGATIVE MUTANT#1.0625;ADAPTIN#1.0578;UBIQUITIN INTERACTING MOTIF#1.0491;CLATHRIN ADAPTOR#1.0458;CLATHRIN-COATED PIT#1.0357;CLATHRIN COAT#1.0330;COATED PIT#1.0305;COATED VESICLE#1.0282;GROWTH FACTOR RECEPTOR#1.0264;SYNAPTIC VESICLE#1.0260;UBIQUITIN#1.0256;EPIDERMAL GROWTH FACTOR#1.0213;GROWTH FACTOR#1.0116;CLATHRIN-MEDIATED ENDOCYTOSIS#1.0106;CLATHRIN HEAVY CHAIN#1.0084;RECEPTOR MEDIATED ENDOCYTOSIS#1.0077;ENDOCYTOSIS#1.0048;PLASMA MEMBRANE#0.9966;ENDOSOME#0.9951;PROTEIN PROTEIN INTERACTION#0.9938;CLATHRIN COATED VESICLE#0.9915;CLATHRIN-DEPENDENT ENDOCYTOSIS#0.9892;EARLY ENDOSOME#0.9821;CELL SURFACE#0.9692;ADAPTOR PROTEIN 2#0.9550;RNA INTERFERENCE#0.9319;RECEPTOR TYROSINE KINASE#0.9298;SYNAPTIC VESICLE RECYCLING#0.9240;RECEPTOR INTERNALIZATION#0.9136;CHLORPROMAZINE#0.9051;PROTEIN COMPLEX#0.8907;TRANSFERRIN RECEPTOR#0.8827;LIPID RAFT#0.8716;VESICLE FORMATION#0.8618;CAVEOLAE#0.8497;SIGNAL TRANSDUCTION#0.8421;UBIQUITIN BINDING#0.8304;LYSOSOME#0.8239;NERVE TERMINAL#0.7954;FACTOR RECEPTOR SUBSTRATE#0.7929;PROTEIN KINASE#0.7773;HOST CELL#0.7737;CANCER CELL#0.7598;UBIQUITIN LIGASE ACTIVITY#0.7470;CELL PROLIFERATION#0.7416;LIGASE ACTIVITY#0.7412;LATE ENDOSOME#0.7387;GENE EXPRESSION#0.7252;MYELOID LEUKEMIA#0.7242;SIGNALING PATHWAY#0.7024;EPITHELIAL CELL#0.6970;PROTEIN BINDING#0.6792;KINASE ACTIVITY#0.6760;ACTIN CYTOSKELETON#0.6718;GLUTATHIONE#0.6524;CYTOPLASM#0.6368;COATED PIT ASSEMBLY#0.6364;BREAST CANCER#0.6275;ENDOSOMAL MEMBRANE#0.6068
206338	TROPHOBLAST#0.9524;CELL SURFACE#0.9104;CELL MEMBRANE#0.8726;TROPHOBLAST CELL#0.8470;PLACENTATION#0.7835;CYTOPLASM#0.6840;TROPHOBLAST CELL MIGRATION#0.6639;GENE SILENCING#0.6001
206358	OOCYTE#1.0153;BRUSH BORDER#1.0138;LYSOSOME#1.0032;BRUSH BORDER MEMBRANE#0.9901;PLASMA MEMBRANE#0.9771;GABOXADOL#0.9761;SMALL INTESTINE#0.9630;VIGABATRIN#0.9588;L-TRYPTOPHAN#0.9432;INTESTINAL ABSORPTION#0.9431;GLYCINE#0.9426;LUMINAL#0.9214;ALANINE#0.9083;L-PROLINE#0.8663;TRYPTOPHAN#0.8554;TARGET OF RAPAMYCIN#0.7898;AMINOLEVULINIC ACID#0.7891;AMINO ACID TRANSPORT#0.7865;5-HYDROXY-L-TRYPTOPHAN#0.7294;RAPAMYCIN#0.7103;ENTEROCYTE#0.7048;LYSOSOMAL MEMBRANE#0.6998;EPITHELIAL CELL#0.6842;GENE EXPRESSION#0.6546;TRANSEPITHELIAL TRANSPORT#0.6374;JEJUNUM#0.6346;METAL ION TRANSPORT#0.6050;SYMPORT#0.6023
2063	T CELL#1.0786;TRANSCRIPTION FACTOR#0.9858;GENE EXPRESSION#0.9391;DNA BINDING#0.8941;CANCER CELL#0.8358;BONE MARROW#0.8144;CD4+ T CELL#0.8096;LOCUS COERULEUS#0.7867;OVARIAN CANCER#0.7731;RETINOIC ACID#0.7200;RNASE A ACTIVITY#0.7099;STEM CELL#0.6898;APOPTOSIS#0.6232;COLON CANCER#0.6111
2064	EGFR:ERBB2 HETERODIMER#1.1427;ERBB2 SIGNALING PATHWAY#1.1107;NEU SIGNALING#1.0932;BIBW 2992#1.0793;HER2 SIGNALING PATHWAY#1.0747;GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA#1.0636;EMODIN#1.0614;TYROSINE KINASE 2#1.0570;GW572016#1.0544;UTERINE SEROUS CARCINOMA#1.0491;ADO-TRASTUZUMAB EMTANSINE#1.0472;TYKERB#1.0438;HUMAN EPIDERMAL RECEPTOR#1.0431;RESPONSE TO LAPATINIB#1.0424;RIBOZYME#1.0377;EPITHELIAL GROWTH FACTOR#1.0331;FEMALE BREAST CARCINOMA#1.0326;PEGYLATED LIPOSOMAL DOXORUBICIN#1.0312;DILATED CARDIOMYOPATHY#1.0301;BAYER#1.0291;MELATONIN#1.0289;SYNOVIAL SARCOMA#1.0282;TRASTUZUMAB EMTANSINE#1.0279;ANTI HER2#1.0274;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0266;CI-1033#1.0257;LEPTOMENINGEAL METASTASES#1.0255;UTERINE CARCINOSARCOMA#1.0253;INCREASED COPY NUMBER#1.0250;LIPID RAFT#1.0248;FINE NEEDLE ASPIRATE#1.0247;RESPONSE TO DOXORUBICIN#1.0245;GALLBLADDER CARCINOMA#1.0244;LUMINAL EPITHELIAL CELL#1.0241;FACTOR 2 RECEPTOR#1.0240;PERTUZUMAB#1.0226;NF-KAPPAB ACTIVATION#1.0223;17-DMAG#1.0220;BARRETT'S ESOPHAGUS#1.0215;METASTATIC GASTRIC CANCER#1.0209;IMMUNOTOXIN#1.0205;EXTRACELLULAR REGION#1.0193;EXTRAMAMMARY PAGET'S DISEASE#1.0190;INVASIVE UROTHELIAL CARCINOMA#1.0187;AFATINIB#1.0186;GALLBLADDER CANCER#1.0186;BREAST CARCINOMA CELL LINES#1.0176;N GLYCAN#1.0173;METFORMIN#1.0166;COPY NUMBER INCREASE#1.0166;TYROSINE KINASE INHIBITION#1.0165;METASTATIC ADENOCARCINOMA#1.0163;CENTROMERE#1.0162;DASATINIB#1.0161;THYMIDYLATE SYNTHASE#1.0155;CALIFORNIA CANCER REGISTRY#1.0152;TIME TO RELAPSE#1.0151;ERIBULIN#1.0148;WHOLE TISSUE SECTIONS#1.0146;DIGITAL IMAGE ANALYSIS#1.0146;DNA AMPLIFICATION#1.0143;HUMORAL IMMUNE RESPONSE#1.0142;HUMAN LEUKOCYTE ANTIGEN#1.0137;IXABEPILONE#1.0133;LAPATINIB#1.0131;UROKINASE PLASMINOGEN ACTIVATOR#1.0129;GALLBLADDER#1.0127;COLORECTAL ADENOCARCINOMA#1.0124;RECEPTOR COMPLEX#1.0118;TRASTUZUMAB#1.0115;EXOSOME#1.0115;SURFACE PLASMON RESONANCE#1.0109;TRANSFERRIN RECEPTOR#1.0106;HUMAN PANCREATIC CANCER#1.0106;URINARY BLADDER CANCER#1.0104;TRANSMEMBRANE RECEPTOR#1.0103;GENISTEIN#1.0103;CORE NEEDLE BIOPSIES#1.0101;SALIVARY GLAND CARCINOMA#1.0097;PANCREATIC CARCINOMA#1.0096;METASTATIC PROSTATE CANCER#1.0095;CNS METASTASES#1.0089;ESOPHAGEAL CARCINOMA#1.0086;PLEOMORPHIC ADENOMA#1.0084;EPIDERMAL GROWTH FACTOR#1.0081;GROWTH FACTOR RECEPTOR#1.0081;TOPOISOMERASE II#1.0079;DNA TOPOISOMERASE#1.0076;RESECTED GASTRIC CANCER#1.0075;FATTY ACID SYNTHASE#1.0074;RESPONSE TO PACLITAXEL#1.0073;BREAST ADENOCARCINOMA#1.0073;ADVANCED OVARIAN CANCER#1.0071;HERCEPTIN#1.0069;MYOCYTES#1.0067;HUMAN MAMMARY EPITHELIAL#1.0063;ZOLEDRONIC ACID#1.0063;INSULIN RECEPTOR#1.0062;PROSTATE CARCINOMA#1.0062;THYMIDYLATE#1.0059;PROGESTERONE#1.0058;TRANSITIONAL CELL CARCINOMA#1.0055;BLADDER CARCINOMA#1.0054;GASTRO#1.0053;TOPOISOMERASE#1.0053;THYROID TRANSCRIPTION FACTOR#1.0052;ZD1839#1.0052;CARCINOSARCOMA#1.0052;NEUROENDOCRINE TUMOR#1.0051;AUTOCRINE SIGNALING#1.0046;ADENOSQUAMOUS CARCINOMA#1.0045;SRC FAMILY KINASE#1.0041;PAZOPANIB#1.0040;GROWTH OF CELL#1.0040;BREAST CELL LINES#1.0039;BILIARY TRACT CANCER#1.0037;GLUCOSE UPTAKE#1.0037;LUMINAL#1.0035;TYROSINE KINASE RECEPTOR#1.0032;JUXTAMEMBRANE#1.0030;HEPATOCYTE GROWTH FACTOR#1.0030;GASTRIC ADENOCARCINOMA#1.0029;TRANSACTIVATION#1.0027;CELLULAR IMMUNE RESPONSE#1.0027;EVEROLIMUS#1.0026;HERPES SIMPLEX#1.0026;GROWTH FACTOR#1.0026;TISSUE MICRO ARRAY#1.0022;CELL CYCLE REGULATOR#1.0020;EPITHELIAL OVARIAN CARCINOMA#1.0019;ADVANCED GASTRIC CANCER#1.0019;TYROSINE KINASE DOMAIN#1.0019;STEROID HORMONE RECEPTOR#1.0016;COPY NUMBER GAIN#1.0016;PLATELET-DERIVED GROWTH FACTOR#1.0016;INVASIVE DUCTAL CANCER#1.0015;FOCAL ADHESION KINASE#1.0007;THYROID CANCER#1.0006;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#1.0005;RAD001#1.0003;MESENCHYMAL EPITHELIAL TRANSITION#1.0002;CARDIOMYOCYTE#1.0001;GENE COPY NUMBER#1.0001;ANTIGEN PROCESSING#1.0001;MAPK SIGNALING#1.0001;TUMOR NODE METASTASIS#0.9999;VALINE#0.9998;ORAL SQUAMOUS CELL CARCINOMA#0.9996;DOMINANT NEGATIVE MUTANT#0.9994;CELECOXIB#0.9991;POLY ETHYLENE GLYCOL#0.9990;GERM CELL TUMORS#0.9988;URINARY BLADDER#0.9987;UROKINASE#0.9987;PROTEIN DEGRADATION#0.9987;EMISSION COMPUTED TOMOGRAPHY#0.9986;TRANSFORMING GROWTH FACTOR BETA#0.9986;TRANSCRIPTIONAL CONTROL#0.9985;THYROID CARCINOMA#0.9984;TUMOR INITIATING CELL#0.9982;GELDANAMYCIN#0.9980;RESPONSE TO HORMONE#0.9977;TAXOTERE#0.9977;CERVIX#0.9976;SCHWANN CELL#0.9975;SALIVARY GLAND CANCER#0.9972;PATHOLOGICAL COMPLETE REMISSION#0.9972;RECEPTOR MEDIATED ENDOCYTOSIS#0.9969;MAMMARY EPITHELIUM#0.9969;SALIVARY DUCT CARCINOMA#0.9969;MUCOEPIDERMOID CARCINOMA#0.9967;COLON CARCINOMA#0.9967;RIBOSOMAL PROTEIN#0.9964;ACTIVATED T-CELLS#0.9964;IRESSA#0.9964;CLINICAL PRACTICE GUIDELINE#0.9964;MEDULLOBLASTOMA#0.9963;GENETICALLY ENGINEERED MOUSE#0.9962;BREAST CANCER MODEL#0.9962;KERATINOCYTE#0.9961;ADVANCED COLORECTAL CANCER#0.9961;INHIBITION OF CELL PROLIFERATION#0.9961;CHIMERIC ANTIGEN RECEPTOR#0.9960;TRIPLE NEGATIVE PHENOTYPE#0.9960;SORAFENIB#0.9960;ESTROGEN RECEPTOR#0.9959;PHOSPHATASE AND TENSIN HOMOLOG#0.9957;INTERPHASE#0.9955;RETINOIC ACID#0.9954;BETA-2#0.9953;PANCREATIC ADENOCARCINOMA#0.9952;ENDOCYTOSIS#0.9950;PROTEIN KINASE B#0.9949;VINORELBINE#0.9949;PHOSPHOLIPASE C#0.9948;GERM CELL#0.9946;HYALURONAN#0.9945;ADJUVANT BREAST CANCER#0.9941;ACTIVATED T CELL#0.9941;CARDIOTOXIC#0.9941;ETHANOL#0.9939;TELOMERASE REVERSE TRANSCRIPTASE#0.9938;INVASIVE GROWTH#0.9937;MOLECULAR DYNAMICS SIMULATION#0.9935;PROTEIN COMPLEX#0.9935;PROTEIN TYROSINE KINASE#0.9933;AGE AT MENARCHE#0.9930;CELLULAR LOCALIZATION#0.9929;ATYPICAL DUCTAL HYPERPLASIA#0.9928;DISSEMINATED TUMOR CELLS#0.9926;BILIARY TRACT#0.9925;GLYCINE#0.9925;HERPES SIMPLEX VIRUS#0.9924;CHOLANGIOCARCINOMA#0.9923;RETINOIC ACID RECEPTOR#0.9923;OVARIAN CARCINOMA#0.9923;PANITUMUMAB#0.9921;RECEPTOR ACTIVITY#0.9921;METASTATIC LYMPH NODE#0.9921;LACRIMAL GLAND#0.9920;CORE NEEDLE BIOPSY#0.9920;DEPHOSPHORYLATION#0.9918;INVASIVE MICROPAPILLARY CARCINOMA#0.9918;CANCER STEM-LIKE CELL#0.9917;MOLECULAR TARGETED THERAPY#0.9916;FULVESTRANT#0.9914;CARDIOMYOCYTE PROLIFERATION#0.9913;LOBULAR BREAST CANCER#0.9913;ENDOMETRIAL CARCINOMA#0.9911;MAP KINASE#0.9911;PANCREATIC DUCTAL ADENOCARCINOMA#0.9911;EPSTEIN BARR VIRUS#0.9908;HYALURONIC ACID#0.9908;CARDIOMYOPATHY#0.9908;LIMIT OF DETECTION#0.9906;METASTATIC BREAST CANCER#0.9906;SUNITINIB#0.9906;COMPLEX I#0.9905;DRUG DELIVERY SYSTEM#0.9904;PRIMARY BREAST TUMORS#0.9904;SMOOTH MUSCLE ACTIN#0.9904;ANAPLASTIC LYMPHOMA KINASE#0.9904;CERVICAL CANCER#0.9902;TUMOR ASSOCIATED ANTIGEN#0.9901;NOTTINGHAM PROGNOSTIC INDEX#0.9899;EPITHELIAL OVARIAN CANCER#0.9899;LYSIS#0.9897;CAPECITABINE#0.9896;DIFFERENTIAL GENE EXPRESSION#0.9894;ESOPHAGEAL CANCER#0.9894;SENSITIZATION#0.9893;IMATINIB#0.9892;METASTATIC CARCINOMA#0.9892;LETROZOLE#0.9891;TAXOL#0.9890;EPITHELIAL CELL PROLIFERATION#0.9890;IMMUNOGLOBULIN G#0.9890;NATIONAL CANCER CENTER#0.9890;SIGNALING CASCADE#0.9890;HAS ACTIVITY#0.9889;BASAL CELL#0.9889;BEVACIZUMAB#0.9888;NO SPECIAL TYPE#0.9887;PROSTATE SPECIFIC ANTIGEN#0.9887;RITUXIMAB#0.9886;HEPARIN BINDING#0.9885;FOCAL ADHESION#0.9883;ADENOID CYSTIC CARCINOMA#0.9882;ESTROGEN RECEPTOR ALPHA#0.9882;STOMACH CANCER#0.9882;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9882;MAPK ACTIVATION#0.9881;PATIENT REPORTED OUTCOME#0.9881;TISSUE MICROARRAY ANALYSIS#0.9881;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9880;DUCTAL CELL#0.9880;CANCER SPECIFIC MORTALITY#0.9879;SERUM ALBUMIN#0.9879;OVARIES#0.9879;GM-CSF#0.9879;ADJUVANT HORMONAL THERAPY#0.9879;HUMAN SERUM ALBUMIN#0.9876;GLIOBLASTOMA MULTIFORME#0.9876;CD8+ T CELL#0.9876;PROGESTIN#0.9875;LYSOSOME#0.9874;ANSAMYCIN#0.9874;CYTOTOXIC T-LYMPHOCYTE#0.9874;MAMMARY EPITHELIAL CELL#0.9873;SOFT TISSUE SARCOMA#0.9873;COLORECTAL CARCINOMA#0.9872;FOLATE#0.9869;PROTEIN KINASE A#0.9868;AKT SIGNALING#0.9868;LUMINAL CELL#0.9867;GLIAL CELL#0.9866;ANTIGEN BINDING#0.9865;MICROTUBULE ASSOCIATED PROTEIN#0.9865;TIGHT JUNCTION#0.9863;TRANSFORMING GROWTH FACTOR ALPHA#0.9863;BREAST CONSERVATION THERAPY#0.9862;LIGAND BINDING DOMAIN#0.9862;BIOTIN#0.9862;ENDOSOME#0.9860;CANCER ASSOCIATED FIBROBLASTS#0.9859;HYPOXIA INDUCIBLE FACTOR#0.9859;ESOPHAGUS#0.9859;ENDOMETRIAL CANCER#0.9857;ALKALINE PHOSPHATASE#0.9856;PROTEIN TYROSINE PHOSPHATASE#0.9856;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9856;MYOCARDIUM#0.9855;RENAL CELL CARCINOMA#0.9854;KINASE ACTIVITY#0.9854;ESTROGEN-RECEPTOR NEGATIVE BREAST CANCER#0.9853;MENARCHE#0.9852;RESONANCE ENERGY TRANSFER#0.9852;MONOCLONAL ANTIBODY 2C4#0.9852;COPY NUMBER CHANGE#0.9852;GROWTH FACTOR BINDING#0.9851;NON-SMALL CELL LUNG CARCINOMA#0.9851;OVARIAN#0.9849;ENDOPLASMIC RETICULUM#0.9849;STANDARD OF CARE#0.9848;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9848;CD4+ T CELL#0.9847;GASTRIC MUCOSA#0.9847;ANCHORAGE INDEPENDENT GROWTH#0.9846;BREAST CANCER#0.9846;RECEPTOR INTERNALIZATION#0.9845;APOPTOTIC CELL DEATH#0.9845;CETUXIMAB#0.9845;NATURAL KILLER CELL#0.9844;OVARIAN CANCER#0.9844;NEUROBLASTOMA#0.9844;CELL ADHESION MOLECULE#0.9844;PI3K SIGNALING#0.9842;RECEPTOR TYROSINE KINASE#0.9842;GALL BLADDER#0.9842;MAMMARY FAT PAD#0.9842;IN SITU CARCINOMA#0.9842;ENDOTHELIAL GROWTH FACTOR#0.9842;BREAST CANCER CELL#0.9841;NOT OTHERWISE SPECIFIED#0.9840;INHIBITION OF CELL GROWTH#0.9838;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9838;RANDOMISED CONTROLLED TRIAL#0.9837;OXALIPLATIN#0.9836;HISTONE DEACETYLASE INHIBITOR#0.9836;CYTOTOXIC T CELL#0.9835;T CELL PROLIFERATION#0.9834;STEM CELL LIKE#0.9834;DUCTAL BREAST CANCER#0.9833;MISMATCH REPAIR#0.9833;EXEMESTANE#0.9833;FIBROBLAST GROWTH FACTOR#0.9833;BREAST DUCTAL CARCINOMA#0.9833;PROTEIN SYNTHESIS#0.9832;CATALYTIC ACTIVITY#0.9832;SMOOTH MUSCLE#0.9831;RISK OF DEATH#0.9831;BILATERAL BREAST CANCER#0.9831;PAPILLARY CARCINOMA#0.9830;ACID PHOSPHATASE#0.9830;PERIPHERAL NERVE#0.9829;PROTEIN PHOSPHORYLATION#0.9829;CELL NUCLEUS#0.9828;INFLAMMATORY BREAST CANCER#0.9828;PROTEIN KINASE C#0.9828;TUMOR GROWTH INHIBITION#0.9827;FAMILIAL BREAST CANCER#0.9827;ANDROGEN RECEPTOR#0.9827;PROSTATE CANCER#0.9827;METASTATIC COLORECTAL CANCER#0.9826;MAMMARY GLAND DEVELOPMENT#0.9822;LYMPH NODE INVOLVEMENT#0.9822;MORPHOGENESIS#0.9822;ANTI EGFR#0.9822;CARBOPLATIN#0.9821;HEPARIN#0.9821;PROTEASOME#0.9821;METAPLASTIC CARCINOMA#0.9820;CELL MEMBRANE#0.9820;AUTOPHAGY#0.9817;HIERARCHICAL CLUSTER ANALYSIS#0.9817;TYROSINE KINASE INHIBITOR#0.9816;ORAL MUCOSA#0.9815;LIVER METASTASIS#0.9815;T CELL#0.9814;TETRACYCLINE#0.9812;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9810;INSULIN-LIKE GROWTH FACTOR#0.9810;CIRCULATING TUMOUR CELLS#0.9810;SIGNET RING CELL#0.9809;LUNG ADENOCARCINOMA#0.9808;ENDOMETRIUM#0.9807;NEUROENDOCRINE CARCINOMA#0.9806;INVASIVE BREAST CARCINOMA#0.9806;CYCLIN DEPENDENT KINASE INHIBITOR#0.9806;ADVANCED BREAST CANCER#0.9805;IFN-GAMMA#0.9804;PANCREATIC CANCER#0.9803;B CELL LYMPHOMA#0.9803;GLAND DEVELOPMENT#0.9803;REGENERATION#0.9802;CERVICAL#0.9802;GEFITINIB#0.9802;RAPAMYCIN#0.9802;CLINICAL COMPLETE RESPONSE#0.9801;INFILTRATING DUCTAL CARCINOMA#0.9801;RANDOMIZED CONTROLLED TRIAL#0.9801;TUMOR ANTIGEN#0.9800;MUSCLE CELL#0.9799;TELOMERE#0.9799;DISEASE SPECIFIC SURVIVAL#0.9799;PLASMA MEMBRANE#0.9799;GRANULOCYTE COLONY STIMULATING FACTOR#0.9797;MUTAGENESIS#0.9797;EVENT FREE SURVIVAL#0.9796;TO THE PROGRESSION#0.9796;ASTROCYTE#0.9796;ALL TRANS RETINOIC ACID#0.9796;INTRACELLULAR SIGNALING PATHWAY#0.9794;SIGNAL TRANSDUCER#0.9794;BINDING PROTEIN 1#0.9793;RECEPTOR BINDING#0.9793;ENDOMETRIAL ADENOCARCINOMA#0.9793;SIGNALING MOLECULE#0.9792;CELL KILLING#0.9792;TARGET OF RAPAMYCIN#0.9791;CELL MOTILITY#0.9791;CHEMOKINE RECEPTOR#0.9791;GENE EXPRESSION SIGNATURES#0.9789;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9789;RANDOMIZED CLINICAL TRIAL#0.9789;COPY NUMBER VARIATION#0.9787;SENTINEL NODE BIOPSY#0.9786;SENESCENCE#0.9785;CDK INHIBITOR#0.9784;CELL SURFACE#0.9784;NUCLEAR TRANSPORT#0.9784;LUNG CARCINOMA#0.9784;KINASE INHIBITOR#0.9784;OVERALL SURVIVAL TIME#0.9783;TO TUMOR PROGRESSION#0.9782;CANINE MAMMARY TUMORS#0.9782;GLUCOSE METABOLISM#0.9781;MICROTUBULE#0.9780;GLUTATHIONE#0.9778;EARLY BREAST CANCER#0.9778;DOCETAXEL#0.9778;METAPLASIA#0.9778;QUANTITATIVE REVERSE TRANSCRIPTION#0.9777;G-CSF#0.9776;STRUCTURE ACTIVITY RELATIONSHIP#0.9776;CHROMOSOMAL REGION#0.9775;CAUSE SPECIFIC SURVIVAL#0.9774;DNA METHYLTRANSFERASE#0.9774;DNA COPY NUMBER#0.9774;DENDRITIC CELL#0.9774;ANOIKIS#0.9774;DNA SYNTHESIS#0.9773;PACLITAXEL#0.9773;HUMAN BREAST CANCER#0.9772;RNA INTERFERENCE#0.9771;BREAST CONSERVING THERAPY#0.9769;EGFR SIGNALING PATHWAY#0.9769;AGGRESSIVE BEHAVIOR#0.9768;LYMPHATIC VESSEL#0.9767;GEMCITABINE#0.9767;HEAT SHOCK FACTOR#0.9766;TRANSFORMING GROWTH FACTOR#0.9766;ADENOCARCINOMA#0.9766;FRAGMENT LENGTH POLYMORPHISM#0.9766;CELLULAR GROWTH#0.9764;MONOCYTE#0.9764;GENE SILENCING#0.9764;THYMIDINE#0.9763;HYPOXIC#0.9762;TRANSCRIPTASE#0.9762;PAROTID GLAND#0.9761;ASCITES#0.9761;CANCER CELL#0.9761;T LYMPHOCYTE#0.9760;MITOGEN ACTIVATED PROTEIN#0.9754;B CELL#0.9754;FAT PAD#0.9754;RISK OF RELAPSE#0.9754;COLON CANCER#0.9753;MONONUCLEAR CELLS#0.9753;TIME TO RECURRENCE#0.9752;LUNG METASTASIS#0.9752;SALIVARY GLAND#0.9750;TUMOR NECROSIS FACTOR#0.9750;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9749;ONCOGENIC#0.9747;MYELINATION#0.9746;OBESE#0.9746;ADJUSTED HAZARD RATIO#0.9745;ESTROGENS#0.9744;CYTOKINE PRODUCTION#0.9744;RETINOBLASTOMA#0.9743;S PHASE#0.9743;CELL DIVISION#0.9743;PERIPHERAL NERVOUS SYSTEM#0.9742;ONCOGENESIS#0.9742;FLOW CYTOMETRY ANALYSIS#0.9741;REGIONAL LYMPH NODE#0.9741;COPY NUMBER ALTERATION#0.9740;SIGNALLING PATHWAY#0.9740;LEUKOCYTE#0.9739;GLYCOSYLATION#0.9738;COLONY-STIMULATING FACTOR#0.9737;RIBOSOME#0.9737;MENOPAUSE#0.9736;GROWTH HORMONE#0.9736;COLORECTAL CANCER#0.9735;CYTOTOXICITY#0.9734;CELL CYCLE REGULATION#0.9734;LYMPH NODE METASTASES#0.9734;BILE DUCT#0.9733;MITOCHONDRIA#0.9733;HEPATOCELLULAR CARCINOMA#0.9733;BREAST CARCINOMA#0.9732;ADRIAMYCIN#0.9732;HUMAN GASTRIC CARCINOMA#0.9732;LYMPH NODE METASTASIS#0.9732;ACETYLCHOLINE RECEPTOR#0.9731;TUBULAR ADENOCARCINOMA#0.9730;INVASIVE LOBULAR CARCINOMA#0.9729;BORTEZOMIB#0.9729;ATP BINDING#0.9729;TIME TO TREATMENT#0.9727;FACTOR I#0.9727;MECHANISM OF ACTION#0.9727;COLORECTAL#0.9726;ETOPOSIDE#0.9726;MYOEPITHELIAL CELL#0.9725;GRANULOCYTE#0.9725;ORAL CAVITY#0.9724;EGF BINDING#0.9723;LASER CAPTURE MICRODISSECTION#0.9723;TELOMERASE ACTIVITY#0.9722;IRINOTECAN#0.9721;PROGRAMMED CELL DEATH#0.9720;SKELETAL MUSCLE#0.9720;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9720;GASTROINTESTINAL TRACT#0.9719;HYPOXIA#0.9718;GLUTAMIC ACID#0.9718;CYCLIN DEPENDENT KINASE#0.9718;MODE OF ACTION#0.9717;ERBB SIGNALING#0.9716;BINDING PROTEIN 3#0.9714;VIRUS LIKE PARTICLE#0.9714;MYELOID-DERIVED SUPPRESSOR CELL#0.9714;BREAST DISEASE#0.9713;GLYCOLYSIS#0.9712;CISPLATIN#0.9711;LYSINE#0.9711;MINIMAL RESIDUAL DISEASE#0.9711;EPITHELIAL TO MESENCHYMAL#0.9710;ERLOTINIB#0.9709;HEPATITIS B#0.9709;REGULATORY T CELL#0.9708;WORLD HEALTH ORGANIZATION#0.9707;DYNAMIC CONTRAST ENHANCED#0.9707;HYPERSENSITIVITY#0.9707;FLUORESCEIN#0.9706;HEAD AND NECK CANCER#0.9705;CIRCULATING TUMOR CELL#0.9705;NECK CANCER#0.9705;APPARENT DIFFUSION COEFFICIENT#0.9705;SPINAL CORD#0.9705;PROTEIN KINASE#0.9704;HEAT SHOCK PROTEIN#0.9701;GASTROINTESTINAL STROMAL TUMOR#0.9700;CONTRALATERAL BREAST CANCER#0.9700;MYELOID LEUKEMIA#0.9699;MOLAR#0.9699;INDUCTION OF APOPTOSIS#0.9698;DOXORUBICIN#0.9696;MEDULLARY CARCINOMA#0.9696;SMALL CELL CARCINOMA#0.9695;INSTITUTIONAL REVIEW BOARD#0.9695;ANASTROZOLE#0.9695;RESVERATROL#0.9694;MUCINOUS ADENOCARCINOMA#0.9694;DEDIFFERENTIATION#0.9694;MAPK CASCADE#0.9694;MAMMARY GLAND#0.9694;CONJUGATION#0.9693;BRAIN LESIONS#0.9693;ERBB SIGNALING PATHWAY#0.9693;INTENT TO TREAT#0.9693;MALE BREAST CANCER#0.9693;QUANTITATIVE REAL TIME#0.9693;CLEAR CELL CARCINOMA#0.9691;PATHOLOGICAL COMPLETE RESPONSE#0.9691;NEUTROPHIL#0.9689;TEMSIROLIMUS#0.9689;AXILLARY METASTASIS#0.9689;HISTONE DEACETYLASE#0.9689;METASTASIS FREE SURVIVAL#0.9689;STEM CELL MARKER#0.9688;NEGATIVE PREDICTIVE VALUE#0.9688;HIGH RISK PATIENTS#0.9688;INVASIVE CARCINOMA#0.9686;RESPONSE TO TREATMENT#0.9686;PATHOLOGIC COMPLETE RESPONSE#0.9686;PAPILLARY THYROID CARCINOMA#0.9685;POSITIVE PREDICTIVE VALUE#0.9685;EARLY GASTRIC CANCER#0.9685;ADJACENT NORMAL TISSUE#0.9685;EPIRUBICIN#0.9684;EPITHELIAL CELL#0.9684;COATED PIT#0.9683;FORMALIN#0.9683;ESTRADIOL#0.9681;ADIPOSE TISSUE#0.9681;RECEPTOR LIGAND#0.9680;CELL ADHESION#0.9679;TUMOR TISSUES#0.9679;PRIMARY BREAST CANCER#0.9679;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9678;FINE NEEDLE ASPIRATION#0.9676;TROPISM#0.9675;BLOOD BRAIN BARRIER#0.9674;ANTIGEN PRESENTING CELLS#0.9673;LINES OF EVIDENCE#0.9672;PEROXISOME#0.9672;MECHANISMS OF ACTION#0.9669;ADJUSTED ODDS RATIO#0.9669;CELL DIFFERENTIATION#0.9668;IMMUNE RESPONSE#0.9667;CARRIE#0.9666;CYTOCHROME C#0.9665;METHOTREXATE#0.9664;INVASIVE BREAST CANCER#0.9664;CLEAVED CASPASE 3#0.9663;TAMOXIFEN#0.9663;CELL ACTIVATION#0.9659;PROGENITOR CELL#0.9659;M PHASE#0.9659;FEMALE BREAST CANCER#0.9658;DOUBLE STRAND BREAK#0.9657;LIPID METABOLISM#0.9657;UBIQUITIN#0.9657;SIGNALING PATHWAY#0.9657;MACROPHAGE#0.9655;BREAST CANCER PATIENTS#0.9655;DISEASE CONTROL RATE#0.9654;SPORADIC BREAST CANCER#0.9654;SQUAMOUS CELL CARCINOMA#0.9654;CENTRAL NERVOUS SYSTEM#0.9653;MEDIAN SURVIVAL TIME#0.9653;DUCTAL CARCINOMA IN SITU#0.9652;LYMPH NODE#0.9652;MITOSIS#0.9651;TUMOR CELLS#0.9650;STROMAL CELL#0.9650;RHABDOMYOSARCOMA#0.9650;REVERSE TRANSCRIPTION#0.9650;LUNG CANCER#0.9650;BASEMENT MEMBRANE#0.9648;ARGININE#0.9647;VULVA#0.9645;MICROGLANDULAR ADENOSIS#0.9645;AGE AT DIAGNOSIS#0.9644;RECEPTOR ANTAGONIST#0.9644;INVASIVE DUCTAL CARCINOMA#0.9642;PRO-INFLAMMATORY#0.9642;DNA FRAGMENTATION#0.9641;5 FLUOROURACIL#0.9641;CYCLOPHOSPHAMIDE#0.9640;DELAYED-TYPE HYPERSENSITIVITY#0.9640;ENDOTHELIUM#0.9640;EXTRACELLULAR REGULATED KINASE#0.9639;STANDARDIZED UPTAKE VALUE#0.9638;RELAPSE FREE SURVIVAL#0.9638;SIGNAL TRANSDUCTION#0.9636;PHAGOCYTOSIS#0.9636;INFLAMMATORY RESPONSE#0.9635;CANCER SPECIFIC SURVIVAL#0.9633;POLYMERASE CHAIN REACTION#0.9633;HEREDITARY BREAST CANCER#0.9632;BLOOD VESSEL#0.9630;BIOLUMINESCENCE#0.9629;CARCINOMA IN SITU#0.9629;HIGH GRADE DYSPLASIA#0.9629;EPITHELIAL MESENCHYMAL TRANSITION#0.9629;PERIPHERAL BLOOD#0.9627;G1 PHASE#0.9626;RNA BINDING#0.9623;SMOOTH MUSCLE CELL#0.9621;FALSE POSITIVE RATE#0.9621;LOCALISATION#0.9621;POSITRON EMISSION TOMOGRAPHY#0.9619;FLUOROURACIL#0.9619;LACTATION#0.9619;DNA DAMAGE RESPONSE#0.9619;CELL MIGRATION#0.9619;CELL GROWTH#0.9618;PROTEIN PROTEIN INTERACTION#0.9618;CANCER STEM CELL#0.9618;APOPTOSIS#0.9617;NERVOUS SYSTEM#0.9616;LYMPH NODE INVASION#0.9616;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.9616;DNA REPLICATION#0.9614;CHROMATIN REMODELING#0.9614;ANGIOGENESIS#0.9613;OVERALL SURVIVAL RATE#0.9613;GROWTH PATTERN#0.9612;DRUG RESISTANCE#0.9612;PERIPHERAL BLOOD LYMPHOCYTES#0.9612;RECURRENCE FREE SURVIVAL#0.9611;ANTIBODY PRODUCTION#0.9611;OLIGODENDROCYTE#0.9609;MULTINOMIAL LOGISTIC REGRESSION#0.9609;DNA REPAIR#0.9607;BONE MARROW#0.9607;MAXIMUM TOLERATED DOSE#0.9606;HOMOLOGOUS RECOMBINATION#0.9606;CELL DEATH#0.9606;CELL CYCLE ARREST#0.9604;COMPARATIVE GENOMIC HYBRIDIZATION#0.9604;EPIGALLOCATECHIN#0.9603;DNA METHYLATION#0.9603;YEAR SURVIVAL RATE#0.9601;PEPTIDE NUCLEIC ACID#0.9601;NUCLEIC ACID#0.9601;RESPONSE TO DOCETAXEL#0.9600;ACTIN CYTOSKELETON#0.9600;KARNOFSKY PERFORMANCE STATUS#0.9599;ENDOTHELIAL CELL#0.9598;APOPTOTIC#0.9597;TUMOR SUPPRESSOR#0.9595;TRANSCRIPTION FACTOR#0.9595;EOSIN#0.9594;STANDARD REFERENCE MATERIAL#0.9594;IMMUNE CELL#0.9593;DNA BINDING#0.9593;CELL PROLIFERATION#0.9593;POLY ADP RIBOSE#0.9592;PROSTATE ADENOCARCINOMA#0.9590;TH1 CELL#0.9590;ALANINE#0.9589;CARDIAC DEVELOPMENT#0.9589;NORMAL BREAST TISSUE#0.9588;LUCIFERASE ACTIVITY#0.9585;PAPILLOMA#0.9584;REACTIVE OXYGEN SPECIES#0.9583;EPITHELIAL CARCINOMA#0.9580;ADENOSINE#0.9580;COLONY FORMATION ASSAY#0.9579;MYELOID CELL#0.9578;DIFFUSION WEIGHTED IMAGING#0.9577;STROMA#0.9577;DIGESTION#0.9577;TIME TO PROGRESSION#0.9576;THYMIDINE PHOSPHORYLASE#0.9575;PEMETREXED#0.9575;SOMATOSTATIN RECEPTOR#0.9573;NATIONAL CANCER INSTITUTE#0.9573;WOUND HEALING#0.9573;NEEDLE CORE BIOPSY#0.9570;COMPLEMENT DEPENDENT CYTOTOXICITY#0.9568;RIBOSE#0.9568;CHEMOTAXIS#0.9567;IMMUNE SYSTEM#0.9565;OESOPHAGUS#0.9563;PHOSPHATASE ACTIVITY#0.9560;CELL CYCLE CONTROL#0.9557;CARCINOGEN#0.9557;HYPERTHERMIA#0.9556;THYMIDINE KINASE#0.9554;BARRETT'S ADENOCARCINOMA#0.9554;GENE EXPRESSION#0.9552;UTERUS#0.9552;WHOLE GENOME SEQUENCING#0.9552;STEM CELL#0.9551;SQUAMOUS CELL CANCER#0.9551;CYTOKINE RECEPTOR#0.9549;WEIGHT LOSS#0.9547;CYTOPLASM#0.9545;DOSE LIMITING TOXICITIES#0.9539;INHIBITION OF GROWTH#0.9535;CELL-MEDIATED IMMUNE RESPONSE#0.9533;VITAMIN D RECEPTOR#0.9533;STOMATITIS#0.9533;T CELL ACTIVATION#0.9532;CELL CYCLE#0.9532;72-HOURS#0.9532;CELL CELL ADHESION#0.9531;GENE EXPRESSION OMNIBUS#0.9530;HAND FOOT SYNDROME#0.9530;TRAMETINIB#0.9530;CLINICAL BENEFIT RATE#0.9529;INTENTION TO TREAT#0.9529;4-HYDROXYTAMOXIFEN#0.9528;BREAST CONSERVING SURGERY#0.9528;LYMPHANGIOGENESIS#0.9521;SENTINEL LYMPH NODE#0.9518;MAGNETIC RESONANCE SPECTROSCOPY#0.9517;DISEASE FREE SURVIVAL#0.9515;EXTRACELLULAR MATRIX#0.9514;DOUBLE TRANSGENIC MICE#0.9513;PEPTIDE BINDING#0.9513;ISCHEMIA#0.9513;ASTHENIA#0.9511;ALOPECIA#0.9511;MAGNETIC RESONANCE IMAGING#0.9511;RNA BINDING PROTEIN#0.9507;AUTOIMMUNITY#0.9505;CENTROSOME#0.9504;CELL POLARITY#0.9501;MUCOSITIS#0.9500;INTRACELLULAR LOCALIZATION#0.9498;CONGESTIVE HEART FAILURE#0.9497;PEPTIDE SYNTHESIS#0.9496;TRANSLATION INITIATION#0.9494;OBJECTIVE RESPONSE RATE#0.9493;RHUMAB-2C4#0.9491;MEDIAN OVERALL SURVIVAL#0.9491;ANDROGEN DEPRIVATION THERAPY#0.9490;LYMPH NODE DISSECTION#0.9489;INFLAMMATORY BREAST CARCINOMA#0.9488;AMERICAN CANCER SOCIETY#0.9487;ACETYLCHOLINE#0.9481;GLUTAMINE#0.9475;FACTOR VIII#0.9468;VEMURAFENIB#0.9467;SKIN RASH#0.9467;HEART DISEASE#0.9467;LEUKOPENIA#0.9466;SERIOUS ADVERSE EVENT#0.9465;ELECTRONIC MEDICAL RECORD#0.9462;TRANSMISSION ELECTRON MICROSCOPY#0.9460;GASTRIC TISSUE#0.9457;SUPPORT VECTOR MACHINE#0.9455;CANCER RELATED DEATH#0.9455;NITRIC OXIDE#0.9451;LYMPH NODE RATIO#0.9447;ANOREXIA#0.9446;HEART DEVELOPMENT#0.9444;DYSPNEA#0.9443;ADVANCED PROSTATE CANCER#0.9442;TOXICITY#0.9442;PRECURSOR CELL#0.9442;OVERALL RESPONSE RATE#0.9438;SIGNALLING CASCADE#0.9436;UROTHELIAL BLADDER CANCER#0.9434;VASCULAR ENDOTHELIAL CELL#0.9431;ANTHRACENE#0.9429;CELLULAR MEMBRANE#0.9423;TOLL LIKE RECEPTOR#0.9422;HEALTH CARE SYSTEM#0.9422;LARGE CELL CARCINOMA#0.9420;ADAPTIVE IMMUNE RESPONSE#0.9418;MULTIPLE LOGISTIC REGRESSION#0.9418;TUMOR ASSOCIATED MACROPHAGE#0.9417;NEUROPATHY#0.9414;HYPERTENSION#0.9414;HYPERGLYCEMIA#0.9413;THROMBOCYTOPENIA#0.9413;METAPLASTIC BREAST CARCINOMAS#0.9411;DEXAMETHASONE#0.9411;EPITHELIAL TISSUES#0.9411;CELL EXPANSION#0.9410;METHYLATION SPECIFIC PCR#0.9408;ABDOMINAL PAIN#0.9408;CELLULAR SENESCENCE#0.9408;POST-TRANSLATIONAL MODIFICATION#0.9407;ANEMIA#0.9404;ORGANELLE#0.9401;LOCAL RECURRENCE FREE#0.9401;NECROTIC#0.9399;POSITIVE SURGICAL MARGIN#0.9398;CELL JUNCTION#0.9397;DEATH RECEPTOR#0.9393;VOMITING#0.9392;HOST CELL#0.9388;LUNG SQUAMOUS CELL CARCINOMA#0.9384;CELLULAR METABOLISM#0.9382;ATP BINDING CASSETTE#0.9381;QUERCETIN#0.9375;LOCAL RECURRENCE RATE#0.9374;DIARRHEA#0.9373;ENZYME ACTIVITY#0.9371;TYPE 2 DIABETES#0.9371;CHRONIC MYELOID LEUKEMIA#0.9364;PAPILLARY ADENOCARCINOMA#0.9364;TROPHOBLAST#0.9357;WEIGHT GAIN#0.9356;PROTEOGLYCAN#0.9351;VITAMIN E#0.9348;HISTIDINE#0.9345;LIVER CANCER#0.9344;LINEAR REGRESSION ANALYSIS#0.9342;WNT SIGNALING PATHWAY#0.9341;LEUCINE#0.9340;STEROID RECEPTOR COACTIVATOR#0.9336;DOXYCYCLINE#0.9336;CELL DEVELOPMENT#0.9335;UNILATERAL BREAST CANCER#0.9335;SUCCINATE#0.9334;REGULATION OF CELL PROLIFERATION#0.9334;PRINCIPAL COMPONENT ANALYSIS#0.9328;MESENCHYMAL STEM CELL#0.9326;EFFLUX PUMP#0.9325;PATHOLOGIC COMPLETE REMISSION#0.9324;GUANINE#0.9320;NEUTROPENIA#0.9319;MULTIPLE MYELOMA#0.9317;OLEIC ACID#0.9316;CELL FRACTION#0.9315;BREAST CARCINOMA IN SITU#0.9312;SWELLING#0.9306;GALLBLADDER ADENOCARCINOMA#0.9302;WHITE BLOOD CELL#0.9301;CPT-11#0.9293;CHROMOSOME REGION#0.9290;PROTEIN KINASE INHIBITOR#0.9286;CELL CYCLE CHECKPOINT#0.9285;SCIATIC NERVE#0.9278;CASPASE ACTIVATION#0.9273;PLEURA#0.9271;INGENUITY PATHWAY ANALYSIS#0.9266;ACTIVE CASPASE 3#0.9263;MESENCHYMAL CELL#0.9261;LASER SCANNING MICROSCOPY#0.9260;PARENCHYMA#0.9253;DIABETES MELLITUS#0.9248;CELL SURFACE ANTIGEN#0.9247;EGFR-HER2 SIGNALING PATHWAY#0.9247;ANTIGEN PRESENTATION#0.9243;MITOCHONDRIAL MEMBRANE#0.9242;PROTEIN BINDING#0.9242;INSULIN RECEPTOR SUBSTRATE#0.9239;TESTOSTERONE#0.9237;FIBROSARCOMA#0.9231;TREG CELL#0.9228;CYTOKINE SECRETION#0.9223;MALIGNANT GLIOMA#0.9222;ADIPOCYTE#0.9222;ANGIOTENSIN CONVERTING ENZYME#0.9217;SEVERE ADVERSE EVENTS#0.9216;WILLINGNESS TO PAY#0.9216;HIGH POWER FIELD#0.9216;POSITIVE FAMILY HISTORY#0.9215;EXTRACELLULAR VESICLE#0.9215;SKIN CANCER#0.9213;SCHWANN CELL PROLIFERATION#0.9211;MULTIPLE LINEAR REGRESSION#0.9208;N-ACETYLCYSTEINE#0.9203;REGULATION OF CELL GROWTH#0.9202;LEUCOVORIN#0.9200;FALSE DISCOVERY RATE#0.9198;HISTOGENESIS#0.9190;INFLAMMATORY CELL#0.9189;HEPATITIS B VIRUS#0.9180;NORMAL ADJACENT TISSUE#0.9178;CANCER TESTIS ANTIGEN#0.9173;PHOSPHATE BUFFERED SALINE#0.9157;LUNG EPITHELIAL CELL#0.9154;TRADITIONAL CHINESE MEDICINE#0.9152;BEST SUPPORTIVE CARE#0.9152;ISOLATED TUMOR CELLS#0.9147;END OF TREATMENT#0.9144;PANCREATITIS#0.9139;NEUROMUSCULAR JUNCTION#0.9137;EXCRETION#0.9126;ADENOSINE TRIPHOSPHATE#0.9121;HISTONE MODIFICATION#0.9120;SPHINGOSINE 1 PHOSPHATE#0.9120;CELL RECOGNITION#0.9118;ARTERY#0.9116;PROPIDIUM#0.9109;ASTROCYTOMA#0.9108;ELECTROPHORETIC MOBILITY SHIFT#0.9106;TERMINAL DIFFERENTIATION#0.9106;AREOLA#0.9104;MEMORY T CELL#0.9101;LOVASTATIN#0.9100;STEM CELL TRANSPLANTATION#0.9096;MYOCARDIAL INFARCTION#0.9095;EMBRYONIC STEM CELL#0.9090;COLON ADENOCARCINOMA#0.9082;RECEPTOR AGONIST#0.9082;COMPOUND 18#0.9079;ASPIRIN#0.9079;IMATINIB MESYLATE#0.9077;HEMATOPOIETIC STEM CELL#0.9077;C REACTIVE PROTEIN#0.9075;BREAST CANCER SURVIVORS#0.9073;LASER DESORPTION IONIZATION#0.9072;INTEGRIN LINKED KINASE#0.9063;ERBITUX#0.9063;NUCLEAR LOCALIZATION SIGNAL#0.9063;GESTATION#0.9061;FIBROBLAST ACTIVATION#0.9057;MAMMARY GLAND TUMORS#0.9051;WILCOXON RANK SUM#0.9048;CHLOROQUINE#0.9048;FATTY ACID SYNTHESIS#0.9046;HEPATOTOXICITY#0.9044;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9041;HODGKIN'S LYMPHOMA#0.9034;17β-ESTRADIOL#0.9030;COLUMNAR#0.9026;TRABECULATION#0.9026;HEMATOPOIETIC CELL#0.9024;BETA-ESTRADIOL#0.9019;AROMATASE ACTIVITY#0.9015;SCHWANN CELL MIGRATION#0.9014;ACTIVATION OF NF-KAPPAB#0.9012;CELL ASSOCIATED#0.9010;MULTIDRUG RESISTANCE PROTEIN#0.9004;PLASMA CELL#0.8996;OVARIAN SEROUS CARCINOMA#0.8987;MALIGNANT PLEURAL EFFUSION#0.8977;SINGLE NUCLEOTIDE VARIANTS#0.8971;GOSERELIN#0.8970;ASPARTATE#0.8966;CATENIN COMPLEX#0.8962;NEURAL CELL#0.8960;EDEMA#0.8959;CYTOPLASMIC MEMBRANE#0.8957;ANAEMIA#0.8954;METHIONINE#0.8950;GLUTAMINE METABOLISM#0.8948;PELVIS#0.8942;GALECTIN#0.8941;BICALUTAMIDE#0.8937;GLYCOGEN SYNTHASE KINASE#0.8936;CHAPERONE COMPLEX#0.8926;RECEPTOR DEGRADATION#0.8921;INHIBITION OF APOPTOSIS#0.8920;GYNECOLOGIC ONCOLOGY GROUP#0.8916;DIED OF DISEASE#0.8915;LIPOGENESIS#0.8911;ADJUVANT RADIATION THERAPY#0.8900;LOCALIZED PROSTATE CANCER#0.8898;SPINDLE CELL CARCINOMA#0.8894;NODULAR#0.8886;HUMAN DENDRITIC CELL#0.8886;RADICICOL#0.8885;UNCONDITIONAL LOGISTIC REGRESSION#0.8883;NERVE GROWTH FACTOR#0.8883;ADHERENS JUNCTION#0.8883;UNFOLDED PROTEIN RESPONSE#0.8877;CONDITIONAL LOGISTIC REGRESSION#0.8877;ATPASE ACTIVITY#0.8876;AREA UNDER CURVE#0.8874;EMBRYONIC KIDNEY#0.8870;CELL PENETRATING PEPTIDE#0.8867;NEURAL CREST#0.8867;TOREMIFENE#0.8865;OESOPHAGEAL SQUAMOUS CELL#0.8855;MITOXANTRONE#0.8850;ACTIN POLYMERIZATION#0.8844;BLOOD VESSEL INVASION#0.8841;MYOFIBROBLAST#0.8832;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.8824;CHOLINE#0.8824;PROGESTERONE RECEPTOR A#0.8821;ENZYME INHIBITOR#0.8816;GRANULOSA CELL#0.8815;INDIVIDUAL PATIENT DATA#0.8815;FALLOPIAN TUBE CARCINOMA#0.8811;HEMATOPOIETIC PROGENITOR CELL#0.8810;SARCOSINE METABOLISM#0.8808;COAGULATION#0.8808;NEUROTOXICITY#0.8807;MAPK SIGNALLING#0.8805;BONE MARROW ASPIRATE#0.8804;TOPOTECAN#0.8797;SPHINGOSINE#0.8793;GAP JUNCTION#0.8792;BRENTUXIMAB VEDOTIN#0.8782;HIGH MOBILITY GROUP#0.8781;NITROGEN MUSTARD#0.8778;FLAVOPIRIDOL#0.8777;NEURAL STEM CELL#0.8771;PROTEINURIA#0.8766;CARDIAC TRABECULATION#0.8765;CYTOLYSIS#0.8764;COMMON TERMINOLOGY CRITERIA#0.8762;PEDIATRIC OSTEOSARCOMA#0.8757;LUMINAL PROGENITOR#0.8755;B LYMPHOCYTE#0.8752;SEBACEOUS CARCINOMA#0.8751;MITOGENIC ACTIVITY#0.8750;IGG1 ANTIBODY#0.8748;T- PA#0.8746;RECURRENT OVARIAN CANCER#0.8746;CONNECTIVE TISSUE#0.8744;ENDOMETRIOSIS#0.8744;FATTY ACID METABOLISM#0.8738;MELANOMA CELL LINES#0.8738;DRAINING LYMPH NODE#0.8730;OVARIAN SURFACE EPITHELIAL#0.8728;NUCLEOTIDE EXCHANGE FACTOR#0.8724;CELL MOVEMENT#0.8724;PERIPHERAL BLOOD LEUKOCYTE#0.8713;CROSS PRESENTATION#0.8708;RECTUM#0.8704;TH1 IMMUNE RESPONSE#0.8702;HSP90 BINDING#0.8698;LECTIN#0.8692;CYTOCHROME P450#0.8691;CASPASE-3 ACTIVITY#0.8690;SUBMANDIBULAR GLAND#0.8689;NUCLEOTIDE BINDING#0.8687;ADIPOGENESIS#0.8677;HIGH RESOLUTION MELTING#0.8675;PROSTAGLANDIN E2#0.8673;MENINGITIS#0.8673;CHORIOCARCINOMA#0.8665;PERITONEUM#0.8661;SEVERE COMBINED IMMUNODEFICIENCY#0.8660;PROTEASOME PATHWAY#0.8657;TYROSINE AUTOPHOSPHORYLATION#0.8650;BRONCHIAL EPITHELIAL CELLS#0.8633;ESTROGEN RESPONSE ELEMENT#0.8631;DYNAMIC LIGHT SCATTERING#0.8630;TUBE FORMATION#0.8629;ELECTRONIC HEALTH RECORD#0.8624;PEARSON CORRELATION COEFFICIENT#0.8616;MENSTRUATION#0.8609;PROTEIN FOLDING#0.8607;MENSTRUAL CYCLE#0.8599;MAMMARY PAGET'S DISEASE#0.8599;DECALCIFICATION#0.8596;MTDNA#0.8587;DIPHOSPHATE#0.8580;2'-DEOXYCYTIDINE#0.8579;INTESTINAL CANCER#0.8579;C TERMINAL DOMAIN#0.8578;PERITONEAL CAVITY#0.8572;P21 ACTIVATED KINASE#0.8560;CD3+ T CELL#0.8558;SUPEROXIDE DISMUTASE#0.8555;PERIPHERAL SENSORY NEUROPATHY#0.8553;HYPERACTIVE#0.8552;CORD BLOOD#0.8551;UTERINE CANCER#0.8550;INTRADUCTAL PAPILLOMA#0.8548;L-LYSINE#0.8547;FARNESYL#0.8545;METASTATIC OSTEOSARCOMA#0.8543;TUBEROUS SCLEROSIS#0.8538;PTEN ACTIVITY#0.8534;RELATIVE GENE EXPRESSION#0.8531;PROTEIN KINASE ACTIVITY#0.8530;VACCINIA#0.8528;VINCRISTINE#0.8524;ERBB3 SIGNALING PATHWAY#0.8523;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8515;AGE AT ONSET#0.8515;LI-FRAUMENI SYNDROME#0.8514;PUBERTY#0.8513;MUCINOUS NEOPLASM#0.8512;ENDOPLASMIC RETICULUM STRESS#0.8508;HUMAN EMBRYONIC KIDNEY#0.8503;MODAL#0.8501;BIOLOGICAL PROCESS#0.8497;PROGESTERONE-RECEPTOR POSITIVE BREAST CANCER#0.8487;SIGNAL PEPTIDE#0.8485;GONADOTROPIN RELEASING HORMONE#0.8484;LEPROSY#0.8483;PROTEIN KINASE ACTIVATION#0.8482;MYOEPITHELIAL CARCINOMA#0.8481;VORINOSTAT#0.8479;INTRACLASS CORRELATION COEFFICIENT#0.8478;RHEUMATOID ARTHRITIS#0.8467;TEMOZOLOMIDE#0.8467;SMALL INTESTINE#0.8463;ARYL HYDROCARBON RECEPTOR#0.8456;MALIGNANT MESOTHELIOMA#0.8449;NOTCH RECEPTOR#0.8448;4-HPR#0.8448;ACETYLCYSTEINE#0.8447;IMMEDIATE BREAST RECONSTRUCTION#0.8442;PROSTATE-SPECIFIC MEMBRANE ANTIGEN#0.8440;INTRACELLULAR SIGNAL TRANSDUCTION#0.8439;COMPARATIVE GENOMIC HYBRIDISATION#0.8436;DUCT CELL#0.8432;LUNG DISEASE#0.8428;NATIONAL HEALTH SERVICE#0.8427;AKT SIGNAL TRANSDUCTION#0.8426;TO BACKGROUND RATIO#0.8426;GLEEVEC#0.8423;GREEN TEA POLYPHENOL#0.8419;ANTI APOPTOSIS#0.8419;PROTEIN TRANSLATION#0.8416;PEGFILGRASTIM#0.8414;NON HODGKIN LYMPHOMA#0.8411;PRIMARY MAMMARY EPITHELIAL#0.8408;CARDIOVASCULAR SYSTEM#0.8407;ABC TRANSPORTER#0.8407;MEMBRANE FRACTION#0.8406;IMMUNE EVASION#0.8405;NEURITE#0.8399;ZINC FINGER PROTEIN#0.8394;TARCEVA#0.8393;T TUBULE#0.8380;STEM CELL PROLIFERATION#0.8377;PROLACTIN RECEPTOR#0.8368;LYMPHOCYTIC LEUKEMIA#0.8367;5-AZA-2'-DEOXYCYTIDINE#0.8360;MOLECULAR FUNCTION#0.8360;HEMORRHAGE#0.8351;CYCLIC AMP#0.8350;CHONDROSARCOMA#0.8343;MITOCHONDRIAL DNA#0.8342;DORMANCY#0.8341;NEOPLASTIC DISEASE#0.8338;SELECTED REACTION MONITORING#0.8335;NEOPLASTIC TISSUES#0.8335;LIVER DISEASE#0.8331;HIGH GRADE LESION#0.8326;ISOLEUCINE#0.8319;ARRHYTHMIA#0.8318;TUMOR STEM CELL#0.8317;2-DEOXY-D-GLUCOSE#0.8311;OOCYTE#0.8310;LOW DENSITY LIPOPROTEIN#0.8309;RECURSIVE PARTITIONING ANALYSIS#0.8303;TIGHT JUNCTION PROTEIN#0.8286;OXYGENASE#0.8271;MOUSE EMBRYONIC FIBROBLAST#0.8269;SODIUM DODECYL SULFATE#0.8262;DODECYL SULFATE#0.8261;PROTEIN INTERACTION NETWORK#0.8258;PNEUMONIA#0.8257;GENOTOXIC#0.8244;LOBULAR NEOPLASIA#0.8239;MALIGNANT BRAIN TUMOR#0.8237;ERYTHEMA#0.8233;ADRENERGIC RECEPTOR#0.8232;BREAST INTERNATIONAL GROUP#0.8231;QUALITY OF CARE#0.8221;ICI 182,780#0.8216;BACTERIAL ARTIFICIAL CHROMOSOME#0.8214;METASTATIC MELANOMA#0.8203;STAUROSPORINE#0.8201;DNA HYPERMETHYLATION#0.8197;SCHWANN CELL DEVELOPMENT#0.8184;RETINOID X RECEPTOR#0.8171;TRANSLATION INITIATION FACTOR#0.8170;PREADIPOCYTE#0.8168;FOLIC ACID#0.8154;TRANSCRIPTION FACTOR BINDING#0.8142;CANCER INITIATING CELLS#0.8139;IFOSFAMIDE#0.8133;CASPASE INHIBITOR#0.8132;SUCROSE#0.8132;EPHRIN#0.8128;MULTIPLE REGRESSION ANALYSIS#0.8124;HEAD AND NECK CARCINOMA#0.8123;CELL CYCLE PATHWAY#0.8123;CERVICAL LYMPH NODE#0.8109;HYPERACTIVITY#0.8097;KINASE INHIBITOR P27#0.8096;CHANGE FROM BASELINE#0.8095;RALOXIFENE#0.8093;ENDOMETRIOID ENDOMETRIAL CANCER#0.8092;MYELOID ZINC FINGER#0.8083;LACK OF EFFICACY#0.8076;INTERCELLULAR JUNCTION#0.8075;TRYPTOPHAN#0.8074;RENAL CELL CANCER#0.8073;BRAIN DISEASE#0.8071;CONTROLLED CLINICAL TRIALS#0.8068;RECEIVER OPERATOR CHARACTERISTIC#0.8067;BRAIN NATRIURETIC PEPTIDE#0.8066;VEGF SIGNALING#0.8065;ERBB2-ERBB3 SIGNALING PATHWAY#0.8059;OVARIAN CLEAR CELL CARCINOMA#0.8058;HEPATOID ADENOCARCINOMA#0.8057;HISTONE ACETYLATION#0.8056;METALLOPROTEINASE INHIBITOR#0.8052;CYTOKINE INDUCED KILLER CELL#0.8051;CELL CELL JUNCTION#0.8043;FIBROBLAST ACTIVATION PROTEIN#0.8030;CERVICAL ADENOCARCINOMA#0.8030;TUBEROUS SCLEROSIS COMPLEX#0.8026;PALMITATE#0.8021;CHRONIC HEART FAILURE#0.8021;ADENINE#0.8010;REGULATION OF GENE EXPRESSION#0.8010;AUTOIMMUNE DISEASE#0.8010;ANCHORING#0.8010;T HELPER CELL#0.8007;TERMINAL END BUD#0.8003;RECEPTOR ACTIVATOR#0.8000;LARGE CELL NEUROENDOCRINE CARCINOMA#0.7997;ROS GENERATION#0.7995;XELODA#0.7989;TIME TO DEATH#0.7988;BASAL EPITHELIAL CELL#0.7978;INHIBITION OF PHOSPHORYLATION#0.7978;LEIOMYOSARCOMA#0.7969;DNASE I#0.7965;VIRGIN OLIVE OIL#0.7964;SURFACE EPITHELIUM#0.7963;PHOSPHOTYROSINE BINDING#0.7958;CLATHRIN-COATED PIT#0.7949;SPHINGOSINE KINASE 1#0.7949;POINT OF CARE#0.7945;THIOTEPA#0.7941;LAMININ RECEPTOR#0.7936;APOCRINE GLAND#0.7934;NORMAL ORAL MUCOSA#0.7927;CORONARY ARTERY#0.7923;INSULIN GROWTH FACTOR#0.7922;HAIR FOLLICLE#0.7919;VIRION#0.7917;BREAST FIBROADENOMA#0.7913;ACINAR CELL#0.7913;POSTTRANSLATIONAL MODIFICATION#0.7907;LIPID SYNTHESIS#0.7903;DNA TOPOISOMERASE II#0.7902;GOBLET CELL#0.7899;ADAPTIVE IMMUNE SYSTEM#0.7893;CARDIOVASCULAR RISK FACTOR#0.7886;HEALTHY CONTROL SUBJECTS#0.7885;REGULATION OF CELLULAR#0.7880;MUSCLE FIBER#0.7879;ADRENAL GLAND#0.7877;VESICULAR STOMATITIS VIRUS#0.7876;HUMAN UMBILICAL VEIN#0.7875;UMBILICAL VEIN#0.7873;DERMATITIS#0.7872;RELATED PROTEIN 1#0.7871;AIRWAY EPITHELIAL CELL#0.7866;CIRCULATING ENDOTHELIAL CELL#0.7861;LEAVE ONE OUT#0.7852;DNASE#0.7851;IMMUNE SUPPRESSION#0.7843;SMALL MOLECULAR INHIBITOR#0.7837;ALLERGIC REACTION#0.7837;ACTIVATION OF GROWTH#0.7815;INNATE IMMUNITY#0.7815;PARTIAL LEAST SQUARE#0.7813;SCANNING ELECTRON MICROSCOPY#0.7810;ACETIC ACID#0.7804;HIERARCHICAL CLUSTERING ANALYSIS#0.7802;INTRACELLULAR RETENTION#0.7789;NICOTINAMIDE#0.7785;OSI-774#0.7783;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7781;VACUOLE#0.7781;ADVERSE CLINICAL OUTCOME#0.7780;MEMBRANE MICRODOMAIN#0.7779;FORSKOLIN#0.7776;NORDIHYDROGUAIARETIC ACID#0.7775;VASCULAR SMOOTH MUSCLE CELL#0.7775;CELL COMMUNICATION#0.7774;BODY SURFACE AREA#0.7772;MAST CELL#0.7769;AMENORRHEA#0.7763;PLASMA PROTEIN#0.7763;DIFFERENTIATED THYROID CANCER#0.7760;SIMVASTATIN#0.7759;CELLULAR COMPONENT#0.7759;RANDOM EFFECT MODEL#0.7758;PHEOCHROMOCYTOMA#0.7757;BRAIN CANCER#0.7754;OSTEOBLAST#0.7753;ACADEMIC MEDICAL CENTER#0.7752;DUAL LUCIFERASE REPORTER#0.7750;BILE DUCT CANCER#0.7750;RESPONSE TO DRUG#0.7749;DRUG BINDING#0.7749;GASTRITIS#0.7749;URACIL#0.7748;PARATHYROID#0.7746;EFFECTOR T CELL#0.7742;DERMIS#0.7741;CYTOCHROME C RELEASE#0.7741;OSTEOSARCOMA CELL LINES#0.7730;SUBSTANCE P#0.7730;AVASTIN#0.7728;CELLULAR RETENTION#0.7717;DETOXIFICATION#0.7710;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7710;INNATE IMMUNE RESPONSE#0.7710;EARLY ENDOSOME#0.7709;ENZALUTAMIDE#0.7704;IGG ANTIBODY#0.7701;ADENO ASSOCIATED VIRUS#0.7694;CAVEOLAE#0.7689;BONE DISEASE#0.7679;TOPICAL#0.7676;MEASLES#0.7676;MAMMOGRAPHIC BREAST DENSITY#0.7675;M2 MACROPHAGE#0.7673;MESENCHYME#0.7672;BASAL CELL CARCINOMA#0.7670;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7662;CANNABINOID RECEPTOR#0.7653;HEALTH CARE PROVIDER#0.7638;EYELID#0.7637;POTASSIUM CHANNEL#0.7637;GLCNAC#0.7635;CONSTIPATION#0.7630;MEMBRANE RUFFLE#0.7628;INHIBITION OF ANGIOGENESIS#0.7617;CIRCULATING CELL FREE#0.7601;VISCERA#0.7598;MONOCYTE DERIVED DENDRITIC CELL#0.7594;ANTISENSE RNA#0.7592;CERVICAL SQUAMOUS CELL CARCINOMA#0.7591;EMBOLISM#0.7590;BOSUTINIB#0.7584;ATAXIA TELANGIECTASIA#0.7564;IGF BINDING#0.7562;MULTI DRUG RESISTANCE#0.7561;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.7560;REGION OF INTEREST#0.7554;CELLULAR ADHESION MOLECULE#0.7547;INTRAEPITHELIAL NEOPLASM#0.7544;MALIGNANT PHEOCHROMOCYTOMA#0.7542;CRYSTAL VIOLET#0.7540;MONTE CARLO SIMULATION#0.7537;ACTIVATION OF APOPTOSIS#0.7533;ALPHA-HEPARIN#0.7532;IFN-GAMMA SECRETION#0.7529;PARANEOPLASTIC NEUROLOGICAL SYNDROME#0.7526;DEMETHYLATION#0.7520;DESFERRIOXAMINE#0.7518;CERVICAL CANCER CELL LINES#0.7515;AFINITOR#0.7513;LIQUID BASED CYTOLOGY#0.7504;INTESTINAL EPITHELIAL CELL#0.7491;ASPARTIC ACID#0.7485;SIZE EXCLUSION CHROMATOGRAPHY#0.7471;RICIN#0.7468;RUFFLE#0.7464;STATISTICALLY SIGNIFICANTLY DIFFERENT#0.7462;CEREBRAL CORTEX#0.7462;DABRAFENIB#0.7461;ACTINOMYCIN D#0.7456;EPITHELIAL CELL DIFFERENTIATION#0.7452;NERVE SHEATH TUMORS#0.7448;CELL MATRIX ADHESION#0.7443;COMPLEMENTATION GROUP 1#0.7441;CREATINE#0.7439;FASLODEX#0.7435;PARATHYROID HORMONE#0.7428;HUMAN PAPILLOMA VIRUS#0.7417;CELL CYCLE PHASE#0.7413;METHYLATION SPECIFIC POLYMERASE#0.7412;BERBERINE#0.7410;COLD ISCHEMIA TIME#0.7409;VINBLASTINE#0.7407;FLOW CYTOMETRY ASSAY#0.7402;CARDIAC RISK FACTORS#0.7400;RECURRENT ENDOMETRIAL CANCER#0.7400;NUCLEAR MORPHOLOGY#0.7397;CYSTADENOCARCINOMA#0.7396;LYMPHOPENIA#0.7392;BLOOD CIRCULATION#0.7392;HYPERPHOSPHORYLATION#0.7390;PROTEIN TARGETING#0.7389;MENOPAUSAL HORMONE THERAPY#0.7387;TRABECTEDIN#0.7385;ERK CASCADE#0.7383;MICROPARTICLE#0.7379;TO DISTANT METASTASIS#0.7376;LUTEAL PHASE#0.7371;INTRACELLULAR SIGNALING CASCADE#0.7365;GROWTH REGULATOR#0.7363;METAPHASE#0.7361;VENTRICULAR CARDIOMYOCYTE#0.7359;MRNA SPLICING#0.7354;ACIDIFICATION#0.7351;REGULATION OF APOPTOSIS#0.7349;LIMITS OF DETECTION#0.7348;HER3 SIGNALING PATHWAY#0.7345;MEBENDAZOLE#0.7343;PERITONEAL CARCINOMA#0.7342;ERYTHROPOIETIN RECEPTOR#0.7339;OSTEOCLAST#0.7334;KARNOFSKY PERFORMANCE SCORE#0.7330;ROLLING CIRCLE AMPLIFICATION#0.7329;IKAPPAB KINASE#0.7326;LARYNX#0.7326;PARACRINE SIGNALING#0.7320;IL-6 PRODUCTION#0.7320;GLUCOCORTICOID RECEPTOR#0.7320;CLEAR CELL ADENOCARCINOMA#0.7320;CONTACT INHIBITION#0.7317;GASTROINTESTINAL CARCINOMA#0.7311;BENZIMIDAZOLE#0.7308;ADENOCARCINOMA IN SITU#0.7306;REGULATION OF CELL CYCLE#0.7304;METASTATIC SQUAMOUS CELL CARCINOMA#0.7303;NEURITE OUTGROWTH#0.7297;MEDROXYPROGESTERONE ACETATE#0.7291;THYMIC CARCINOMA#0.7287;REPORTER GENE ASSAY#0.7286;LIPID DROPLET#0.7281;BORDERLINE OVARIAN TUMOR#0.7272;CERULENIN#0.7270;CALCITRIOL#0.7268;EXTRINSIC APOPTOSIS#0.7261;UMBILICAL CORD#0.7250;JANUS ACTIVATED KINASE#0.7249;ACTIN BINDING#0.7244;ARIMIDEX#0.7243;X CHROMOSOME#0.7229;SUBEROYLANILIDE HYDROXAMIC ACID#0.7229;CATABOLISM#0.7219;TESTICULAR CANCER#0.7213;THROMBOSIS#0.7202;LYNCH SYNDROME#0.7198;SEOUL NATIONAL UNIVERSITY#0.7196;REGULATION OF GROWTH#0.7193;MYOTUBE#0.7190;DNA REPAIR DEFICIENCY#0.7190;BLEOMYCIN#0.7187;UVEAL MELANOMA#0.7185;CHONDROITIN SULFATE PROTEOGLYCAN#0.7184;PYRUVATE#0.7179;GENETICALLY ENGINEERED MICE#0.7179;HUMAN IMMUNE SYSTEM#0.7179;PROTEIN STABILIZATION#0.7176;EGFR BINDING#0.7172;ISOPROTERENOL#0.7164;SYSTEM DEVELOPMENT#0.7164;IGG3 ANTIBODY#0.7164;MILK PROTEIN#0.7156;HUMAN BRONCHIAL EPITHELIAL#0.7150;VIRAL GENOME#0.7150;MATRIX METALLOPROTEINASE 1#0.7146;METHYL CPG BINDING#0.7134;TISSUE GROWTH FACTOR#0.7128;APOBEC#0.7127;OXIDATIVE PHOSPHORYLATION#0.7127;INNER EAR#0.7125;SH2 DOMAIN BINDING#0.7123;DIHYDROTESTOSTERONE#0.7122;CYTOTOXIN#0.7117;GLAND MORPHOGENESIS#0.7115;COLITIS#0.7114;CD8+ CYTOTOXIC T CELL#0.7112;SURGICAL MARGIN STATUS#0.7109;LIFE YEAR GAINED#0.7107;MUCINOUS CYSTADENOCARCINOMA#0.7103;VISCERAL ORGAN#0.7096;STREPTOZOTOCIN#0.7095;CYSTITIS#0.7092;PULMONARY EMBOLISM#0.7084;ANDROGEN ABLATION THERAPY#0.7080;DUAL SPECIFICITY PHOSPHATASE#0.7078;ALZHEIMER'S DISEASE#0.7077;ATP BINDING CASSETTE TRANSPORTER#0.7076;GLUCOSE TRANSPORT#0.7071;EPITHELIAL STEM CELL#0.7067;REGIONS OF INTEREST#0.7066;INDUCES CANCER#0.7057;RECEPTOR CLUSTERING#0.7049;TISSUE INVASION#0.7043;TYPE 1 DIABETES#0.7028;STROMAL SARCOMA#0.7026;CARBONIC ANHYDRASE 9#0.7026;MICROTUBULE CAPTURE#0.7025;LIFE YEARS GAINED#0.7018;LEUCINE RICH REPEAT#0.7015;ACTIVATOR PROTEIN 1#0.7015;EPOTHILONE B#0.7015;TRANSFERASE INHIBITOR#0.7008;NAVELBINE#0.7006;VASCULAR ENDOTHELIUM#0.7000;MICROVASCULAR ENDOTHELIAL CELL#0.7000;HORMONE BINDING#0.6991;CAMPTOTHECIN#0.6989;R/AMP#0.6984;FATTY ACID BIOSYNTHESIS#0.6980;MEDIASTINAL LYMPH NODE#0.6979;TIME TO RESPONSE#0.6978;METASTASIS TO LYMPH NODE#0.6968;KERATINOCYTE PROLIFERATION#0.6963;FOLATE BINDING#0.6962;GROWTH DIFFERENTIATION FACTOR#0.6960;DISSEMINATED TUMOUR CELLS#0.6957;OSTEOPOROSIS#0.6951;RESPIRATION#0.6949;MAMMARY GLAND MORPHOGENESIS#0.6949;SIALYLATION#0.6945;CELL DIVISION CYCLE#0.6945;PREDNISONE#0.6944;DR BINDING#0.6934;LASER CAPTURE MICRODISSECTED#0.6930;VALPROIC ACID#0.6924;NEURAL CREST CELL#0.6923;MITOTIC SPINDLE#0.6920;PHOSPHATASE INHIBITOR#0.6919;NKT CELL#0.6917;TO TUMOR RECURRENCE#0.6917;NUCLEOTIDE EXCISION REPAIR#0.6912;COLLAGEN TYPE I#0.6912;PYRUVATE KINASE#0.6907;ACUTE PANCREATITIS#0.6905;FIELD OF VIEW#0.6904;GLYCINE METABOLISM#0.6901;PULMONARY FIBROSIS#0.6901;PHOTOTOXIC#0.6900;CAMP RESPONSE ELEMENT BINDING#0.6900;ANTI INFLAMMATORY DRUGS#0.6891;INVASIVE CERVICAL CANCER#0.6891;DERMAL FIBROBLAST#0.6891;CAMP RESPONSE ELEMENT#0.6890;HYALURONIDASE#0.6889;PROTEIN LOCALIZATION#0.6883;GOOD MANUFACTURING PRACTICE#0.6883;ACE INHIBITOR#0.6880;DEXRAZOXANE#0.6872;ARACHIDONIC ACID#0.6867;AMYLOID PRECURSOR PROTEIN#0.6866;COLON EPITHELIAL CELL#0.6841;DOXORUBICIN HYDROCHLORIDE#0.6837;GLYCERALDEHYDE-3-PHOSPHATE#0.6836;AUTOPHAGIC CELL DEATH#0.6828;GTP BINDING#0.6825;SYBR GREEN I#0.6823;EOSINOPHIL#0.6813;RESPONSE TO AROMATASE INHIBITOR#0.6804;SOLID PHASE EXTRACTION#0.6793;APOPTOSIS INDUCING FACTOR#0.6793;SEQUESTERING#0.6792;METASTATIC COLORECTAL CARCINOMA#0.6781;HOSPITAL BASED STUDY#0.6781;ESTROGEN RELATED RECEPTOR#0.6766;SCREEN PRINTED ELECTRODE#0.6765;PRIMARY BRAIN TUMORS#0.6761;DEHYDRATION#0.6761;CELL-MEDIATED IMMUNITY#0.6761;PKC ACTIVATION#0.6748;INTRACELLULAR SIGNAL TRANSDUCTION PATHWAY#0.6747;TUMOR GROWTH DELAY#0.6746;ANTIGEN PROCESSING AND PRESENTATION#0.6743;ADVANCED PANCREATIC CANCER#0.6739;EPITHELIAL-MYOEPITHELIAL CARCINOMA#0.6736;FLUORESCENCE LIFETIME IMAGING#0.6735;CROHN'S DISEASE#0.6732;ARSENITE#0.6730;MELATONIN RECEPTOR#0.6730;XL647#0.6728;PROTEIN SECRETION#0.6728;HAIR CELL#0.6723;ACUTE MYELOID LEUKEMIA#0.6718;PROTEIN KINASE CASCADE#0.6717;TUMOUR NECROSIS FACTOR#0.6716;ENDOCYTIC RECYCLING#0.6714;ORAL SQUAMOUS CARCINOMA#0.6710;KIDNEY DISEASE#0.6704;COMPLEMENT ACTIVATION#0.6703;MITOMYCIN#0.6697;T CELL FACTOR#0.6692;EARLY TUMOR RECURRENCE#0.6690;METASTATIC PANCREATIC ADENOCARCINOMA#0.6690;COMMON TOXICITY CRITERIA#0.6689;RECEIVER OPERATING CURVE#0.6688;DNA REPAIR PROTEIN#0.6687;NEUROTROPHIN RECEPTOR#0.6682;MESOTHELIOMA CELL#0.6681;AGE OF MENARCHE#0.6680;RENAL CARCINOMA#0.6675;NUCLEAR HORMONE RECEPTOR#0.6671;LYMPHOCYTE ANTIGEN#0.6670;ACTIVATED CASPASE 3#0.6667;G2 PHASE#0.6666;ATAXIA TELANGIECTASIA MUTATED#0.6663;THYROID HORMONE RECEPTOR#0.6661;NUCLEOSOME#0.6649;VEGF PRODUCTION#0.6646;SKELETON#0.6645;ADOPTIVE CELL THERAPY#0.6631;RANDOMISED CLINICAL TRIALS#0.6631;KERATINOCYTE DIFFERENTIATION#0.6630;RESPONSE TO GROWTH FACTOR#0.6626;SELECTIN#0.6623;5-FLUOROURIDINE#0.6623;LYMPHOID TISSUE#0.6622;EMBRYO IMPLANTATION#0.6620;NEUROENDOCRINE CELL#0.6618;ZD-1839#0.6614;ENTERIC NERVOUS SYSTEM#0.6606;BETA CELL#0.6605;TYPE 2 DIABETES MELLITUS#0.6601;2 DIABETES MELLITUS#0.6601;NEURODEGENERATIVE DISEASE#0.6592;DOCKING PROTEIN#0.6587;UMBILICAL CORD BLOOD#0.6561;COPY NUMBER VARIANTS#0.6560;CARBAMAZEPINE#0.6559;SCROTUM#0.6559;MYOBLAST#0.6554;INHIBITION OF DNA REPAIR#0.6548;AUTOPHAGOSOME#0.6538;TO TUMOUR PROGRESSION#0.6536;FOLLICULAR PHASE#0.6526;PROLYL 4-HYDROXYLASE#0.6509;METAL CHELATING#0.6508;NULL CELL#0.6504;LYMPHATIC VESSEL DENSITY#0.6503;ADIPOCYTE DIFFERENTIATION#0.6498;GASTRIC ADENOSQUAMOUS CARCINOMA#0.6493;MEGESTROL ACETATE#0.6491;PHOTOTOXIN#0.6490;ONCOGENE INDUCED SENESCENCE#0.6489;METALLOPROTEASE INHIBITOR#0.6480;FATTY ACID BINDING#0.6475;RECEPTOR TRANSACTIVATION#0.6475;LIKELIHOOD RATIO TEST#0.6473;MAPK ERK KINASE#0.6469;DIFFERENTIATED THYROID CARCINOMA#0.6455;COENZYME A#0.6453;INJECTION SITE REACTIONS#0.6447;MELANOCYTE#0.6445;VEGF-AS#0.6442;LOPERAMIDE#0.6439;CORONARY ARTERY DISEASE#0.6435;INTRACELLULAR CYTOKINE STAINING#0.6435;ARTERY DISEASE#0.6433;CONNEXIN#0.6432;CHARCOT MARIE TOOTH#0.6427;LATE ENDOSOME#0.6425;RNA HELICASE#0.6422;ACETYL COA CARBOXYLASE#0.6411;PROSTATE EPITHELIAL CELL#0.6409;MEAN FLUORESCENCE INTENSITY#0.6405;GROWTH HORMONE RECEPTOR#0.6401;MICROTUBULE DYNAMICS#0.6400;PARKINSON'S DISEASE#0.6397;PAPILLARY THYROID CANCER#0.6395;2-DEOXYGLUCOSE#0.6391;ANAPLASTIC LARGE CELL LYMPHOMA#0.6388;INHIBIN#0.6387;UBIQUITIN PROTEASOME PATHWAY#0.6387;ACUTE LEUKEMIA#0.6386;RNA PROCESSING#0.6379;PROTEIN PHOSPHATASE 2A#0.6368;PHOSPHATASE 2A#0.6365;TOCOPHEROL#0.6349;DOPAMINE#0.6347;MONOCYTE CHEMOTACTIC PROTEIN#0.6345;ESTROGEN SYNTHESIS#0.6333;PERIAMPULLARY ADENOCARCINOMA#0.6333;BONE MARROW CELLS#0.6331;FOLLICLE STIMULATING HORMONE#0.6331;TISSUE DAMAGE#0.6323;CELL PROLIFERATION INDEX#0.6323;FERTILIZATION#0.6316;SUBEPENDYMAL GIANT CELL ASTROCYTOMA#0.6313;BONE FORMATION#0.6313;VIRAL INFECTION#0.6312;HISTONE DEACETYLATION#0.6307;GLUTATHIONE PEROXIDASE#0.6305;OLIGODENDROCYTE DEVELOPMENT#0.6300;CHARLSON COMORBIDITY INDEX#0.6296;OVARIAN SURFACE EPITHELIAL CELL#0.6296;ASBESTOSIS#0.6294;ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY#0.6291;PROTEASOME DEGRADATION#0.6275;EVERY OTHER DAY#0.6269;ANILINE#0.6267;LYMPHATIC SYSTEM#0.6264;PAPILLARY RENAL CELL CARCINOMA#0.6257;DOXIL#0.6249;MALIGNANT PLEURAL MESOTHELIOMA#0.6246;CELL COUNTING KIT#0.6245;PKCALPHA#0.6244;EXTRA-ADRENAL PHEOCHROMOCYTOMA#0.6217;ISOTHERMAL TITRATION CALORIMETRY#0.6212;MEDROXYPROGESTERONE#0.6210;METASTATIC RENAL CELL CARCINOMA#0.6207;WILMS TUMOR 1#0.6207;CONJUGATED LINOLEIC ACID#0.6206;CELLULAR HOMEOSTASIS#0.6202;ERBB SIGNALLING PATHWAY#0.6201;ENDOMETRIAL STROMAL SARCOMA#0.6201;LICHEN PLANUS#0.6199;ENDOTHELIAL CELL PROLIFERATION#0.6198;MITOMYCIN C#0.6194;NUCLEAR MEMBRANE#0.6185;REFUSAL#0.6183;MEDIATED DRUG RESISTANCE#0.6180;STANDARD UPTAKE VALUE#0.6179;KINESIN#0.6178;FALLOPIAN TUBES#0.6168;STEM CELL ANTIGEN#0.6158;PLURIPOTENT STEM CELL#0.6157;OUTER MEMBRANE#0.6156;LYMPHOID CELL#0.6154;MESENCHYMAL TO EPITHELIAL TRANSITION#0.6153;MATUZUMAB#0.6150;UTERINE CORPUS CANCER#0.6148;VP-16#0.6139;CHILDHOOD MEDULLOBLASTOMA#0.6136;INSOMNIA#0.6130;BODY WEIGHT GAIN#0.6126;OVARIAN CLEAR CELL ADENOCARCINOMA#0.6126;SCANNING ELECTRON MICROSCOPE#0.6123;CELL BOUND#0.6122;HOMOLOGOUS RECOMBINATION REPAIR#0.6117;NITRIC OXIDE SYNTHASE#0.6113;PROLACTINOMA#0.6111;EARLY TIME POINT#0.6111;IL-6 SECRETION#0.6105;ADENOMATOUS POLYPOSIS COLI#0.6101;PRIMARY PERITONEAL CARCINOMA#0.6100;TARGET OF RAPAMYCIN COMPLEX#0.6098;TRAIL RECEPTOR 2#0.6098;APOPTOTIC PROCESS#0.6093;PKC ACTIVITY#0.6086;MIGRATION INHIBITORY FACTOR#0.6078;SATURATED FATTY ACID#0.6075;EUKARYOTIC INITIATION FACTOR#0.6073;GI TRACT#0.6072;HIGH FAT DIET#0.6072;MACROPHAGE MIGRATION#0.6072;SPINDLE ASSEMBLY#0.6064;HISTONE METHYLTRANSFERASE#0.6064;CASPASE ACTIVITY#0.6062;LACTIC ACID#0.6059;FACTOR S#0.6056;POLYCYSTIC KIDNEY DISEASE#0.6055;TH2 CELL#0.6053;MYOSIN HEAVY CHAIN#0.6051;NUCLEIC ACID AMPLIFICATION#0.6050;TISSUE HOMEOSTASIS#0.6046;CREATINE KINASE#0.6033;PROTEIN TRANSDUCTION DOMAIN#0.6033;LYMPHOCYTE PROLIFERATION#0.6029;ENDOCYTIC RECYCLING COMPARTMENT#0.6028;CYTOSINE DEAMINASE#0.6022;RADIAL GLIAL CELL#0.6014;CELL CORTEX#0.6008
2065	ERBB3 SIGNALING PATHWAY#1.1144;BINDING PROTEIN 1#1.0352;AKT SIGNALING#1.0289;COLON CANCER#1.0209;TRANSACTIVATION#1.0190;PERTUZUMAB#1.0186;TRANSMEMBRANE RECEPTOR#1.0183;INSULIN RECEPTOR#1.0176;LYMPH NODE METASTASES#1.0174;AFATINIB#1.0159;FULVESTRANT#1.0159;UBIQUITIN#1.0133;PROSTATE CANCER#1.0128;MAMMARY EPITHELIAL CELL#1.0104;LUNG ADENOCARCINOMA#1.0096;PANCREATIC CANCER#1.0088;PROTEIN TYROSINE KINASE#1.0086;PLASMA MEMBRANE#1.0068;CERVICAL#1.0063;LUMINAL#1.0054;TYPE 1 DIABETES#1.0052;EXTRACELLULAR REGION#1.0048;INSULIN-LIKE GROWTH FACTOR#1.0046;RECEPTOR COMPLEX#1.0045;OVARIAN CARCINOMA#1.0042;SCHWANN CELL#1.0024;ANTI EGFR#1.0024;PROTEIN KINASE B#1.0020;MYELINATION#1.0017;NEURAL CREST#1.0010;HEPARIN BINDING#1.0000;OVARIAN CANCER#0.9999;PACLITAXEL#0.9994;TYROSINE KINASE DOMAIN#0.9992;CETUXIMAB#0.9991;ANDROGEN RECEPTOR#0.9991;MAMMARY GLAND#0.9990;PI3K SIGNALING#0.9987;TYROSINE KINASE RECEPTOR#0.9976;T CELL#0.9974;LYMPH NODE#0.9971;MAPK SIGNALING#0.9965;OVARIAN#0.9963;TRANSFORMING GROWTH FACTOR ALPHA#0.9962;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9957;LAPATINIB#0.9948;GEFITINIB#0.9938;KINASE ACTIVITY#0.9935;TAMOXIFEN#0.9924;TRANSFORMING GROWTH FACTOR#0.9917;CELL MIGRATION#0.9911;RECEPTOR DEGRADATION#0.9909;DRUG RESISTANCE#0.9902;LYMPH NODE METASTASIS#0.9891;SIGNALLING PATHWAY#0.9890;BASAL CELL#0.9884;CERVICAL CANCER#0.9882;CELL SURFACE#0.9879;SIGNALING MOLECULE#0.9874;ANTI HER2#0.9871;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9868;ONCOGENIC#0.9867;GROWTH FACTOR RECEPTOR#0.9867;BREAST CARCINOMA#0.9865;CYTOTOXICITY#0.9863;ENDOTHELIAL GROWTH FACTOR#0.9862;COLORECTAL#0.9858;ERLOTINIB#0.9857;COLORECTAL CANCER#0.9846;BREAST CANCER CELL#0.9845;TUMOR TISSUES#0.9843;RECEPTOR TYROSINE KINASE#0.9838;TRANSCRIPTION FACTOR#0.9837;FORMALIN#0.9835;MITOGEN ACTIVATED PROTEIN#0.9833;HEPARIN#0.9832;DISEASE FREE SURVIVAL#0.9832;EPIDERMAL GROWTH FACTOR#0.9830;HERCEPTIN#0.9828;CATALYTIC ACTIVITY#0.9824;TUMOR SUPPRESSOR#0.9823;PROTEIN KINASE#0.9817;CELL MEMBRANE#0.9815;GROWTH FACTOR#0.9814;REVERSE TRANSCRIPTION#0.9811;TRASTUZUMAB#0.9810;CELL DEATH#0.9805;SQUAMOUS CELL CARCINOMA#0.9805;EPITHELIAL CELL#0.9799;ADENOCARCINOMA#0.9799;MAP KINASE#0.9798;PROGESTERONE#0.9798;ERBB SIGNALING#0.9797;PLATELET-DERIVED GROWTH FACTOR#0.9797;CANCER CELL#0.9789;METASTATIC BREAST CANCER#0.9788;CYTOPLASM#0.9784;HUMAN BREAST CANCER#0.9760;ESTROGEN RECEPTOR#0.9756;LUNG CANCER#0.9754;TUMOR CELLS#0.9746;CELL GROWTH#0.9745;HEAD AND NECK CANCER#0.9744;NECK CANCER#0.9743;POLYMERASE CHAIN REACTION#0.9740;BREAST CANCER#0.9739;BREAST CANCER PATIENTS#0.9737;APOPTOSIS#0.9732;KERATINOCYTE#0.9732;CELL MOTILITY#0.9727;CELL PROLIFERATION#0.9727;SIGNALING PATHWAY#0.9727;STEM CELL#0.9723;TYROSINE KINASE INHIBITOR#0.9720;SIGNALING CASCADE#0.9707;APOPTOTIC#0.9706;CELL CYCLE ARREST#0.9704;DNA SYNTHESIS#0.9697;SIGNAL TRANSDUCTION#0.9695;ANGIOGENESIS#0.9687;OLIGODENDROCYTE#0.9685;QUANTITATIVE REAL TIME#0.9685;FIBROBLAST GROWTH FACTOR#0.9676;KINASE INHIBITOR#0.9676;NERVOUS SYSTEM#0.9675;CELL CYCLE#0.9673;GENE COPY NUMBER#0.9665;FOCAL ADHESION#0.9651;NEURAL CREST CELL#0.9643;GENE EXPRESSION#0.9636;HEPATOCELLULAR CARCINOMA#0.9615;ENDOCYTOSIS#0.9615;AUTOCRINE SIGNALING#0.9608;ONCOGENESIS#0.9592;HEPATOCYTE GROWTH FACTOR#0.9588;MUSCLE CELL#0.9587;LUNG CARCINOMA#0.9571;SKELETAL MUSCLE#0.9564;RECEPTOR BINDING#0.9553;MECHANISM OF ACTION#0.9547;TOXICITY#0.9543;ENDOTHELIAL CELL#0.9542;PERIPHERAL NERVOUS SYSTEM#0.9541;REGENERATION#0.9536;ACETYLCHOLINE RECEPTOR#0.9527;RNA INTERFERENCE#0.9505;MELANOMA CELL LINES#0.9466;CISPLATIN#0.9437;CELL DIFFERENTIATION#0.9437;FACTOR I#0.9427;CELL ADHESION#0.9423;PROTEIN PROTEIN INTERACTION#0.9420;HUMAN MAMMARY EPITHELIAL#0.9393;GEMCITABINE#0.9331;PERIPHERAL NERVE#0.9324;N GLYCAN#0.9319;CELL DEVELOPMENT#0.9312;GLIAL CELL#0.9306;PRIMARY BREAST CANCER#0.9279;HYPOXIA#0.9277;CANCER STEM CELL#0.9275;EPITHELIAL MESENCHYMAL TRANSITION#0.9262;RAPAMYCIN#0.9261;PROGENITOR CELL#0.9259;TARGET OF RAPAMYCIN#0.9237;CENTRAL NERVOUS SYSTEM#0.9227;FOCAL ADHESION KINASE#0.9217;TRANSCRIPTASE#0.9185;SCHWANN CELL DEVELOPMENT#0.9184;GENE SILENCING#0.9184;PERIPHERAL BLOOD#0.9160;COMPLEX I#0.9118;PROTEIN KINASE C#0.9105;MORPHOGENESIS#0.9103;METASTATIC COLORECTAL CANCER#0.9046;SPINAL CORD#0.9042;HISTONE DEACETYLASE#0.9035;ESTRADIOL#0.9012;ANCHORAGE INDEPENDENT GROWTH#0.8982;RESONANCE ENERGY TRANSFER#0.8933;ASTROCYTE#0.8931;BONE MARROW#0.8915;ACETYLCHOLINE#0.8894;HER3 SIGNALING PATHWAY#0.8880;ERBB2-ERBB3 SIGNALING PATHWAY#0.8880;DIARRHEA#0.8850;SIGNAL TRANSDUCER#0.8844;TIME TO PROGRESSION#0.8839;NON-SMALL CELL LUNG CARCINOMA#0.8825;RECEPTOR LIGAND#0.8811;INDUCTION OF APOPTOSIS#0.8793;SALIVARY GLAND#0.8789;BREAST CARCINOMA CELL LINES#0.8763;ESOPHAGEAL CANCER#0.8747;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8710;EPITHELIAL TO MESENCHYMAL#0.8708;JUXTAMEMBRANE#0.8699;SMOOTH MUSCLE#0.8665;CELL ADHESION MOLECULE#0.8632;CARCINOMA IN SITU#0.8614;OSTEOBLAST#0.8613;INTRACELLULAR SIGNALING PATHWAY#0.8606;INVASIVE BREAST CANCER#0.8596;HEAT SHOCK PROTEIN#0.8592;ORAL SQUAMOUS CELL CARCINOMA#0.8589;COLORECTAL CARCINOMA#0.8583;EXTRACELLULAR MATRIX#0.8556;ATP BINDING#0.8555;ADVANCED BREAST CANCER#0.8501;MECHANISMS OF ACTION#0.8472;WOUND HEALING#0.8459;BREAST CANCER MODEL#0.8450;INVASIVE DUCTAL CARCINOMA#0.8407;DEPHOSPHORYLATION#0.8384;MUTAGENESIS#0.8380;PANCREATIC DUCTAL ADENOCARCINOMA#0.8378;PROTEIN KINASE A#0.8367;S PHASE#0.8358;DENTATE GYRUS#0.8293;TUMOR NECROSIS FACTOR#0.8285;MELANOCYTE#0.8262;NEUROGENESIS#0.8261;GASTRIC ADENOCARCINOMA#0.8249;SURFACE PLASMON RESONANCE#0.8234;MESENCHYMAL STEM CELL#0.8234;DOXORUBICIN#0.8201;IRESSA#0.8187;DNA REPAIR#0.8164;C TERMINAL DOMAIN#0.8149;STROMA#0.8142;CELLULAR GROWTH#0.8085;ENDOMETRIAL CANCER#0.8081;PROTEASOME#0.8042;CELL MOVEMENT#0.8029;MAPK ACTIVATION#0.8005;MACROPHAGE#0.7996;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.7991;ENDOSOME#0.7947;ORAL MUCOSA#0.7944;SCHWANN CELL PROLIFERATION#0.7941;RETINOIC ACID#0.7902;HUMAN EPIDERMAL RECEPTOR#0.7892;ERBB SIGNALING PATHWAY#0.7889;NORMAL BREAST TISSUE#0.7874;ZD1839#0.7851;ALPHA-HEPARIN#0.7842;BILIARY TRACT#0.7841;NEUROMUSCULAR JUNCTION#0.7840;OLFACTORY BULB#0.7812;EPITHELIAL OVARIAN CANCER#0.7789;CYCLIN DEPENDENT KINASE#0.7788;DOCETAXEL#0.7780;STROMAL CELL#0.7776;BETA-2#0.7752;STANDARD OF CARE#0.7734;TRANSFORMING GROWTH FACTOR BETA#0.7724;ENDOPLASMIC RETICULUM#0.7709;NERVE GROWTH FACTOR#0.7695;TRASTUZUMAB EMTANSINE#0.7686;EPITHELIAL GROWTH FACTOR#0.7679;OBJECTIVE RESPONSE RATE#0.7672;RELAPSE FREE SURVIVAL#0.7667;QUANTITATIVE REVERSE TRANSCRIPTASE#0.7662;CAPECITABINE#0.7652;IMMUNE RESPONSE#0.7645;TRANSITIONAL CELL CARCINOMA#0.7643;SCIATIC NERVE#0.7632;PHOSPHATASE AND TENSIN HOMOLOG#0.7602;DORSAL ROOT GANGLION#0.7576;CARBOPLATIN#0.7574;CERVIX#0.7565;INSULIN RECEPTOR SUBSTRATE#0.7562;MOLECULAR DYNAMICS SIMULATION#0.7562;LUNG METASTASIS#0.7527;SMOOTH MUSCLE CELL#0.7478;UVEAL MELANOMA#0.7448;RECEPTOR INTERNALIZATION#0.7419;ESTROGEN RECEPTOR ALPHA#0.7370;MESENCHYMAL CELL#0.7358;POSITRON EMISSION TOMOGRAPHY#0.7348;NUCLEIC ACID#0.7339;LYSOSOME#0.7338;TROPHOBLAST#0.7317;MYOTUBE#0.7310;DUCTAL CARCINOMA IN SITU#0.7271;COLORECTAL ADENOCARCINOMA#0.7256;NEURAL PLATE#0.7254;LIVER METASTASIS#0.7235;CANCER ASSOCIATED FIBROBLASTS#0.7230;INHIBITION OF CELL GROWTH#0.7206;MEDIAN SURVIVAL TIME#0.7203;MODE OF ACTION#0.7201;PHOSPHOLIPASE C#0.7189;HYPOXIA INDUCIBLE FACTOR#0.7186;DOSE LIMITING TOXICITIES#0.7186;CELL DIVISION#0.7185;NEURITE#0.7173;MAXIMUM TOLERATED DOSE#0.7115;RETINOBLASTOMA#0.7086;EGFR SIGNALING PATHWAY#0.7084;MITOGENIC ACTIVITY#0.7039;ANTIGEN BINDING#0.7014;NEURITE OUTGROWTH#0.6978;COLON CARCINOMA#0.6975;RESPONSE TO TREATMENT#0.6974;QUANTITATIVE REVERSE TRANSCRIPTION#0.6966;RECURRENCE FREE SURVIVAL#0.6932;DNA BINDING#0.6924;GROWTH HORMONE#0.6922;ADENOID CYSTIC CARCINOMA#0.6895;VEMURAFENIB#0.6889;TUMOR GROWTH INHIBITION#0.6881;OLIGODENDROCYTE DEVELOPMENT#0.6863;DIFFERENTIAL GENE EXPRESSION#0.6856;OSTEOBLAST DIFFERENTIATION#0.6827;TOPOISOMERASE#0.6795;LEUKOCYTE#0.6774;CANCER SPECIFIC SURVIVAL#0.6767;MEDULLOBLASTOMA#0.6761;MAMMARY EPITHELIUM#0.6757;REACTIVE OXYGEN SPECIES#0.6740;MESENCHYME#0.6737;RECEPTOR ACTIVITY#0.6721;THYROID CARCINOMA#0.6720;IRINOTECAN#0.6678;ESOPHAGUS#0.6659;HEPATITIS B#0.6635;BONE FORMATION#0.6610;GLYCOGEN SYNTHASE KINASE#0.6548;ASTROCYTOMA#0.6541;HUMAN PANCREATIC CANCER#0.6517;ENDOMETRIUM#0.6506;PEMETREXED#0.6504;INVASIVE CARCINOMA#0.6470;SIGNALLING CASCADE#0.6462;LIGAND BINDING DOMAIN#0.6448;TERMINAL END BUD#0.6435;GROWTH FACTOR BINDING#0.6424;TRAMETINIB#0.6385;T LYMPHOCYTE#0.6352;CLEAVED CASPASE 3#0.6311;IGG1 ANTIBODY#0.6311;PROTEIN TYROSINE PHOSPHATASE#0.6305;GELDANAMYCIN#0.6282;VORINOSTAT#0.6277;PI3K COMPLEX#0.6238;ORAL CAVITY#0.6230;PATHOLOGIC COMPLETE RESPONSE#0.6226;FLOW CYTOMETRY ANALYSIS#0.6220;REGULATION OF CELL PROLIFERATION#0.6194;TO TUMOR PROGRESSION#0.6190;HER2 SIGNALING PATHWAY#0.6181;EARLY BREAST CANCER#0.6180;BETA CELL#0.6178;PANCREATIC ADENOCARCINOMA#0.6168;SRC FAMILY KINASE#0.6166;ACIDIFICATION#0.6160;COLONY FORMATION ASSAY#0.6160;THYMIDINE#0.6155;EPITHELIAL CELL PROLIFERATION#0.6150;PROTEIN TYROSINE KINASE ACTIVITY#0.6128;DASATINIB#0.6128;THYROID CANCER#0.6128;PROTEIN COMPLEX#0.6118;MONOCYTE#0.6069;AUTOIMMUNE DISEASE#0.6062;LACTATION#0.6060;OLFACTORY EPITHELIUM#0.6046;RETROPERITONEAL LEIOMYOSARCOMA#0.6041;SENSITIZATION#0.6041;POSITIVE SURGICAL MARGIN#0.6030
2066	ERBB4 SIGNALING PATHWAY#1.1305;EXCITATORY SYNAPSE#1.0550;ERBB4 HOMODIMER#1.0463;AFATINIB#1.0400;INTERNEURON#1.0379;NMDA RECEPTOR#1.0250;TYROSINE KINASE RECEPTOR#1.0213;TRANSMEMBRANE RECEPTOR#1.0175;MAMMARY EPITHELIAL CELL#1.0165;JUXTAMEMBRANE#1.0129;PROSTATE CANCER#1.0121;MAMMARY GLAND#1.0115;TUMOR NECROSIS FACTOR#1.0108;PROGENITOR CELL#1.0072;HEPARIN BINDING#1.0042;TUMOR SUPPRESSOR#1.0031;ASTROCYTE#1.0026;HEPARIN#1.0019;CARDIOMYOCYTE#0.9993;ESTROGEN RECEPTOR#0.9984;RECEPTOR TYROSINE KINASE#0.9977;TRANSCRIPTION FACTOR#0.9960;AMYLOID PRECURSOR PROTEIN#0.9955;CELL MIGRATION#0.9948;OVARIAN CANCER#0.9946;KINASE ACTIVITY#0.9943;DENDRITIC SPINE#0.9930;TRANSACTIVATION#0.9928;HUMAN BREAST CANCER#0.9928;DOPAMINERGIC NEURON#0.9918;MYOCYTES#0.9911;CELL DIFFERENTIATION#0.9899;GROWTH FACTOR RECEPTOR#0.9899;BREAST CANCER CELL#0.9895;ONCOGENIC#0.9892;BREAST CARCINOMA#0.9891;COLORECTAL#0.9887;REVERSE TRANSCRIPTION#0.9879;COLORECTAL CANCER#0.9878;SQUAMOUS CELL CARCINOMA#0.9874;LYMPH NODE#0.9872;TRANSFORMING GROWTH FACTOR#0.9870;OVARIAN#0.9861;TRANSFORMING GROWTH FACTOR ALPHA#0.9857;EPITHELIAL CELL#0.9855;BREAST CANCER PATIENTS#0.9853;EPIDERMAL GROWTH FACTOR#0.9837;LAPATINIB#0.9835;APOPTOSIS#0.9835;CENTRAL NERVOUS SYSTEM#0.9829;CELL SURFACE#0.9826;CYTOPLASM#0.9825;LONG TERM POTENTIATION#0.9824;CELL CYCLE#0.9822;MITOGEN ACTIVATED PROTEIN#0.9820;ERBB SIGNALING#0.9812;PROTEIN KINASE#0.9811;GROWTH FACTOR#0.9807;POLYMERASE CHAIN REACTION#0.9800;SIGNALLING PATHWAY#0.9798;CANCER CELL#0.9796;SCHWANN CELL#0.9794;CEREBRAL CORTEX#0.9792;OLIGODENDROCYTE#0.9787;SIGNAL TRANSDUCTION#0.9786;TUMOR CELLS#0.9784;CELL ADHESION#0.9781;AKT SIGNALING#0.9770;CELL PROLIFERATION#0.9769;SIGNALING CASCADE#0.9762;GENE EXPRESSION#0.9758;NERVOUS SYSTEM#0.9756;CELL DEATH#0.9753;LUMINAL#0.9751;ENDOTHELIAL CELL#0.9751;TYROSINE KINASE INHIBITOR#0.9748;BREAST CANCER#0.9741;DOPAMINE#0.9734;DISEASE FREE SURVIVAL#0.9732;LUNG CANCER#0.9732;GLUTAMATERGIC SYNAPSE#0.9730;STEM CELL#0.9726;TRASTUZUMAB#0.9725;ADENOCARCINOMA#0.9725;UBIQUITIN#0.9720;PYRAMIDAL CELL#0.9719;CELL GROWTH#0.9707;SIGNALING PATHWAY#0.9698;KINASE INHIBITOR#0.9684;SUBSTANTIA NIGRA#0.9683;PROGESTERONE#0.9666;RECEPTOR COMPLEX#0.9660;DNA SYNTHESIS#0.9646;ALZHEIMER'S DISEASE#0.9631;OLFACTORY BULB#0.9630;SPINAL CORD#0.9585;NEURITE#0.9570;APOPTOTIC#0.9567;MUSCLE CELL#0.9566;SMOOTH MUSCLE#0.9555;ERLOTINIB#0.9538;ANGIOGENESIS#0.9526;GEFITINIB#0.9511;MIDBRAIN#0.9503;LYMPH NODE METASTASIS#0.9492;LACTATION#0.9434;PLASMA MEMBRANE#0.9423;FORMALIN#0.9394;ANTI HER2#0.9348;TAMOXIFEN#0.9338;T CELL#0.9315;BRAIN DEVELOPMENT#0.9310;PROTEIN KINASE C#0.9300;MORPHOGENESIS#0.9294;ENDOTHELIAL GROWTH FACTOR#0.9289;BASKET CELL#0.9287;SIGNALING MOLECULE#0.9278;CETUXIMAB#0.9277;BIPOLAR DISORDER#0.9265;PROTEIN TYROSINE KINASE#0.9252;INSOLUBLE FRACTION#0.9228;BASAL CELL#0.9227;SKELETAL MUSCLE#0.9192;GLIAL CELL#0.9186;ENDOCYTOSIS#0.9186;TROPHOBLAST#0.9184;NEUROTRANSMISSION#0.9168;MYOCARDIUM#0.9136;LUNG ADENOCARCINOMA#0.9103;YES ASSOCIATED PROTEIN#0.9092;HEART DEVELOPMENT#0.9089;NEUROGENESIS#0.9087;HERCEPTIN#0.9062;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9054;LUNG DEVELOPMENT#0.9053;MAMMARY EPITHELIUM#0.9017;POSTSYNAPTIC DENSITY#0.9013;QUANTITATIVE REAL TIME#0.9001;MEDULLOBLASTOMA#0.8999;MAP KINASE#0.8944;ANTI EGFR#0.8934;REGENERATION#0.8933;PLATELET-DERIVED GROWTH FACTOR#0.8930;BETA-2#0.8927;NEURONAL MIGRATION#0.8893;TOXICITY#0.8848;HYPOXIA#0.8843;CELL MOTILITY#0.8816;MEDIAL PREFRONTAL CORTEX#0.8810;RECEPTOR LIGAND#0.8808;FRONTAL#0.8802;EXTRACELLULAR REGION#0.8796;SIGNAL TRANSDUCER#0.8793;SMOOTH MUSCLE CELL#0.8786;NEURITE OUTGROWTH#0.8781;FOREBRAIN#0.8735;BLOOD BRAIN BARRIER#0.8697;DRUG RESISTANCE#0.8692;ACETYLCHOLINE RECEPTOR#0.8679;COLITIS#0.8672;CELL MEMBRANE#0.8662;CERVICAL#0.8606;DOXORUBICIN#0.8586;TYROSINE KINASE DOMAIN#0.8574;ERBB SIGNALING PATHWAY#0.8564;ISCHEMIA#0.8526;HINDBRAIN#0.8517;HEPATOCELLULAR CARCINOMA#0.8513;COLON CANCER#0.8511;PHOSPHOLIPID SYNTHESIS#0.8506;CEREBELLAR GRANULE NEURON#0.8505;STRIATUM#0.8466;MACROPHAGE#0.8441;CARDIAC DEVELOPMENT#0.8438;CHILDHOOD MEDULLOBLASTOMA#0.8409;PROTEIN PROTEIN INTERACTION#0.8404;ASPARTATE#0.8396;NEURAL CREST#0.8382;AMYGDALA#0.8374;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8372;TUMOR TISSUES#0.8366;PREPULSE INHIBITION#0.8347;RECEPTOR ANTAGONIST#0.8341;GLUCOSE UPTAKE#0.8314;INVASIVE BREAST CANCER#0.8282;ANCHORAGE INDEPENDENT GROWTH#0.8279;ESTRADIOL#0.8276;PRIMARY BREAST CANCER#0.8250;ENDOMETRIUM#0.8228;EPILEPSY#0.8214;CLOZAPINE#0.8212;ROSTRAL MIGRATORY STREAM#0.8181;GENE COPY NUMBER#0.8153;PI3K SIGNALING#0.8144;METASTATIC BREAST CANCER#0.8111;STROMAL CELL#0.8065;GLUTAMIC ACID#0.8061;INHIBITORY SYNAPSE#0.8058;CONTEXTUAL FEAR CONDITIONING#0.8045;MAMMARY GLAND DEVELOPMENT#0.8033;GLAND DEVELOPMENT#0.8016;EWING SARCOMA#0.7969;DNA REPAIR#0.7966;ESTROGEN RECEPTOR ALPHA#0.7963;COLON EPITHELIAL CELL#0.7951;EXTRACELLULAR MATRIX#0.7946;KERATINOCYTE#0.7940;STROMA#0.7910;CHOLESTEROL METABOLISM#0.7897;CYCLIN DEPENDENT KINASE#0.7886;NEURAL PROGENITOR CELL#0.7879;FACTOR I#0.7877;ALPHA-HEPARIN#0.7861;MAPK ACTIVATION#0.7854;ACETYLCHOLINE#0.7846;PERIPHERAL NERVOUS SYSTEM#0.7843;DNA DAMAGE RESPONSE#0.7816;ORAL SQUAMOUS CELL CARCINOMA#0.7780;REGULATED INTRAMEMBRANE PROTEOLYSIS#0.7771;PANCREATIC CANCER#0.7759;CELL ADHESION MOLECULE#0.7735;INSULIN-LIKE GROWTH FACTOR#0.7720;CHEMOTAXIS#0.7671;MECHANISM OF ACTION#0.7671;CARDIOMYOPATHY#0.7663;NEURAL CREST CELL#0.7656;RECEPTOR BINDING#0.7623;AMYOTROPHIC LATERAL SCLEROSIS#0.7580;LATERAL SCLEROSIS#0.7580;MAPK SIGNALING#0.7578;MYOCARDIAL INFARCTION#0.7555;GLUTAMATE RECEPTOR#0.7544;FIBROBLAST GROWTH FACTOR#0.7537;PERIPHERAL NERVE#0.7534;MYELINATION#0.7487;DORSOLATERAL PREFRONTAL CORTEX#0.7486;CONNECTIVE TISSUE#0.7478;PERIPHERAL BLOOD#0.7446;MAJOR DEPRESSIVE DISORDER#0.7423;CISPLATIN#0.7419;CELL MATURATION#0.7416;RENAL FIBROSIS#0.7407;HALOPERIDOL#0.7371;HYPOXIA INDUCIBLE FACTOR#0.7361;NEUROMUSCULAR JUNCTION#0.7355;MESENCHYMAL CELL#0.7316;GABAERGIC NEURON#0.7275;MENTAL DISORDER#0.7275;CYTOTOXICITY#0.7259;LUTEAL PHASE#0.7223;NEURONAL CELLS#0.7214;RENAL CELL CARCINOMA#0.7205;CATALYTIC ACTIVITY#0.7205;PUBERTY#0.7204;BETA CELL#0.7189;TRANSCRIPTASE#0.7174;SYNAPTIC TRANSMISSION#0.7158;MESENCHYME#0.7142;KETAMINE#0.7134;TYROSINE KINASE 2#0.7115;HEAD AND NECK CANCER#0.7090;NECK CANCER#0.7089;SYNAPSE DEVELOPMENT#0.7011;PLURIPOTENT STEM CELL#0.6992;PROTEIN TYROSINE PHOSPHATASE#0.6984;FAST SPIKING INTERNEURONS#0.6974;FOCAL ADHESION#0.6972;CELL DEVELOPMENT#0.6970;CELL DIVISION#0.6963;OLIGODENDROCYTE DEVELOPMENT#0.6937;MOLECULAR DYNAMICS SIMULATION#0.6924;HYPERACTIVITY#0.6918;PROTEASOME#0.6909;OXYGEN GLUCOSE DEPRIVATION#0.6881;NEURONAL CELL DEATH#0.6850;PROTEIN KINASE B#0.6840;CHRONIC CEREBRAL HYPOPERFUSION#0.6837;CRANIAL NEURAL CREST#0.6835;NEUROBLASTOMA#0.6822;DIARRHEA#0.6820;DILATED CARDIOMYOPATHY#0.6773;IRESSA#0.6769;TELENCEPHALON#0.6765;NITRIC OXIDE SYNTHASE#0.6763;REACTIVE OXYGEN SPECIES#0.6759;ADJACENT NORMAL TISSUE#0.6751;NITRIC OXIDE#0.6742;PROLACTIN RECEPTOR#0.6710;KIDNEY DISEASE#0.6707;PHOSPHATASE INHIBITOR#0.6668;LOCUS COERULEUS#0.6661;NERVE GROWTH FACTOR#0.6653;PERTUZUMAB#0.6647;PRIMARY BREAST TUMORS#0.6623;CELLULAR GROWTH#0.6593;LYMPH NODE METASTASES#0.6579;SOCIAL BEHAVIOR#0.6550;EARLY BREAST CANCER#0.6548;NEUROBLAST#0.6510;ENDOTHELIUM#0.6505;NEUROLOGICAL DISORDER#0.6433;PRO-INFLAMMATORY#0.6432;TYPE 2 DIABETES#0.6429;LUNG CARCINOMA#0.6427;INTERNEURON MIGRATION#0.6336;CELL COMMUNICATION#0.6304;RECEPTOR ACTIVITY#0.6276;LYSINE#0.6273;MICROVASCULAR ENDOTHELIAL CELL#0.6267;NEURAL CELL#0.6259;ANOIKIS#0.6258;VASCULAR SMOOTH MUSCLE CELL#0.6239;SYNAPSE MATURATION#0.6235;PHOSPHOLIPASE C#0.6233;PARKINSON'S DISEASE#0.6225;GRANULOSA CELL#0.6223;CANCER SPECIFIC SURVIVAL#0.6207;INFLAMMATORY BOWEL DISEASE#0.6204;CARCINOMA IN SITU#0.6174;CARDIOMYOCYTE PROLIFERATION#0.6162;ECTODOMAIN CLEAVAGE#0.6145;INSULIN RECEPTOR#0.6125;COMPLEX I#0.6120;OVARIAN CARCINOMA#0.6118;METALLOPROTEASE ACTIVITY#0.6113;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6079;MEMBRANE MICRODOMAIN#0.6071;ENDOPLASMIC RETICULUM#0.6068;METASTATIC SQUAMOUS CELL CARCINOMA#0.6059;VIRAL RECEPTOR#0.6032;CELL KILLING#0.6002;BLASTOCYST IMPLANTATION#0.6000
2067	XPF-ERCC1 COMPLEX#1.1577;RAD1-RAD10 COMPLEX#1.1197;DNA EXCISION#1.0666;XERODERMA PIGMENTOSUM GROUP F#1.0648;XERODERMA PIGMENTOSUM GROUP D#1.0615;ICL REPAIR#1.0546;MITOTIC RECOMBINATION#1.0532;COMPLEMENTATION GROUP 1#1.0503;THYMIDINE PHOSPHORYLASE#1.0495;EPITHELIAL OVARIAN CANCER#1.0435;RESPONSE TO CISPLATIN#1.0434;ENDONUCLEASE ACTIVITY#1.0425;RESPONSE TO PLATINUM#1.0424;SINGLE STRAND ANNEALING#1.0424;CERVICAL CANCER#1.0421;THYMIDYLATE SYNTHASE#1.0373;ADJUSTED HAZARD RATIO#1.0355;THYMIDYLATE#1.0355;FRAGMENT LENGTH POLYMORPHISM#1.0342;COMPLEX I#1.0322;PROSTATE CANCER#1.0282;CERVICAL#1.0272;DNA REPAIR PROTEIN#1.0264;TRANSCRIPTASE#1.0253;TUMOR TISSUES#1.0245;REPLICATION PROTEIN A#1.0245;PANCREATIC CANCER#1.0237;PROTEIN COMPLEX#1.0232;ESOPHAGEAL CANCER#1.0227;ENDONUCLEASE COMPLEX#1.0227;THYMIDINE#1.0226;REVERSE TRANSCRIPTION#1.0221;ADVANCED COLORECTAL CANCER#1.0217;OVARIAN CARCINOMA#1.0205;LUNG ADENOCARCINOMA#1.0197;PERIPHERAL BLOOD LYMPHOCYTES#1.0189;HEAD AND NECK CANCER#1.0164;PEMETREXED#1.0159;MITOMYCIN C#1.0153;ADVANCED GASTRIC CANCER#1.0151;NECK CANCER#1.0148;DNA REPAIR ENZYME#1.0147;VINORELBINE#1.0136;HEAD AND NECK SQUAMOUS CELL CARCINOMA#1.0127;QUANTITATIVE REAL TIME#1.0127;METASTATIC COLORECTAL CANCER#1.0119;OVARIAN CANCER#1.0118;OXALIPLATIN#1.0117;DNA BINDING#1.0116;HEPATOCELLULAR CARCINOMA#1.0112;BREAST CANCER#1.0112;RISK OF DEATH#1.0108;TOPOISOMERASE#1.0103;GEMCITABINE#1.0091;XERODERMA PIGMENTOSUM#1.0090;OVARIAN#1.0088;MISMATCH REPAIR#1.0083;MEDIAN SURVIVAL TIME#1.0077;GLUTATHIONE#1.0070;LUNG CARCINOMA#1.0065;POLYMERASE CHAIN REACTION#1.0065;HOMOLOGOUS RECOMBINATION#1.0063;DOUBLE-STRAND BREAK REPAIR#1.0051;MITOMYCIN#1.0042;PACLITAXEL#1.0030;BILIARY TRACT#1.0018;DOCETAXEL#1.0016;CISPLATIN#1.0012;EPIDERMAL GROWTH FACTOR#1.0006;DNA REPAIR CAPACITY#1.0005;EMODIN#1.0000;COLON CANCER#0.9998;BASE EXCISION REPAIR#0.9996;TELOMERE#0.9996;GENE COPY NUMBER#0.9996;NUCLEOTIDE EXCISION REPAIR#0.9994;CAPECITABINE#0.9991;GROWTH FACTOR RECEPTOR#0.9979;REPLICATION FORK#0.9976;COLORECTAL#0.9975;DRUG RESISTANCE#0.9969;LYMPH NODE METASTASIS#0.9960;FANCONI ANEMIA#0.9960;GROWTH FACTOR#0.9958;DNA SYNTHESIS#0.9949;YEAR SURVIVAL RATE#0.9948;COLORECTAL CANCER#0.9947;RESPONSE TO TREATMENT#0.9947;PERIPHERAL BLOOD#0.9934;TUMOR CELLS#0.9926;LUNG CANCER#0.9923;PROTEIN KINASE#0.9917;CARBOPLATIN#0.9915;TIME TO PROGRESSION#0.9913;POLY ADP RIBOSE#0.9912;BREAST CANCER PATIENTS#0.9912;GERM CELL#0.9908;DNA DAMAGE RESPONSE#0.9905;SQUAMOUS CELL CARCINOMA#0.9902;TRANSCRIPTION FACTOR#0.9901;IRINOTECAN#0.9900;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9900;ADENOCARCINOMA#0.9895;LYMPH NODE#0.9883;APOPTOTIC#0.9882;DNA REPAIR#0.9882;HOMOLOGOUS RECOMBINATION REPAIR#0.9876;FORMALIN#0.9875;DISEASE FREE SURVIVAL#0.9874;5 FLUOROURACIL#0.9861;APOPTOSIS#0.9852;FLUOROURACIL#0.9845;CANCER CELL#0.9844;DOUBLE STRAND BREAK#0.9836;MEDIAN OVERALL SURVIVAL#0.9832;GENE EXPRESSION#0.9826;SIGNALING PATHWAY#0.9809;CYTOTOXICITY#0.9793;MALIGNANT PLEURAL MESOTHELIOMA#0.9792;ENDOTHELIAL GROWTH FACTOR#0.9786;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9778;CELL CYCLE#0.9777;CELL DEATH#0.9768;ANEMIA#0.9754;STEM CELL#0.9752;OBJECTIVE RESPONSE RATE#0.9746;TOXICITY#0.9740;CELL PROLIFERATION#0.9712;DNA REPLICATION#0.9691;NON-SMALL CELL LUNG CARCINOMA#0.9652;LIVER METASTASIS#0.9624;TOPOISOMERASE II#0.9617;NEUTROPENIA#0.9611;BONE MARROW#0.9611;SENESCENCE#0.9606;GENE CONVERSION#0.9604;OVERALL RESPONSE RATE#0.9595;TUMOR SUPPRESSOR#0.9591;B CELL#0.9580;ESTROGEN RECEPTOR#0.9555;RIBOSE#0.9539;ETOPOSIDE#0.9503;PROTEIN PROTEIN INTERACTION#0.9449;XERODERMA PIGMENTOSUM GROUP A#0.9434;MULTIDRUG RESISTANCE PROTEIN#0.9421;NUCLEASE ACTIVITY#0.9395;DNA METHYLATION#0.9387;INTERSTRAND CROSS-LINK REPAIR#0.9370;KINASE INHIBITOR#0.9313;SKIN CANCER#0.9310;GENOTOXIC#0.9290;RECOMBINATIONAL REPAIR#0.9212;OXIDATIVE DNA DAMAGE#0.9184;CELLULAR SENESCENCE#0.9175;CELL CYCLE ARREST#0.9173;BILIARY TRACT CANCER#0.9154;CPT-11#0.9137;HYPERSENSITIVITY#0.9080;CARCINOGEN#0.9039;DISEASE CONTROL RATE#0.9027;GYNECOLOGIC ONCOLOGY GROUP#0.9021;CELL GROWTH#0.8966;ADJUSTED ODDS RATIO#0.8960;CETUXIMAB#0.8937;QUANTITATIVE REVERSE TRANSCRIPTION#0.8930;COCKAYNE SYNDROME#0.8845;ERLOTINIB#0.8839;C TERMINAL DOMAIN#0.8834;CELL KILLING#0.8811;MECHANISM OF ACTION#0.8808;ANTISENSE RNA#0.8802;WEIGHT LOSS#0.8800;S PHASE#0.8791;XFE PROGEROID SYNDROME#0.8789;COLORECTAL CARCINOMA#0.8783;TYROSINE KINASE INHIBITOR#0.8736;RNA INTERFERENCE#0.8683;MUTAGENESIS#0.8678;G1 PHASE#0.8663;MITOGEN ACTIVATED PROTEIN#0.8637;T CELL#0.8613;ANGIOGENESIS#0.8609;TRABECTEDIN#0.8570;NITROGEN MUSTARD#0.8553;GLYCOSYLASE#0.8553;OVERALL SURVIVAL TIME#0.8548;CIRCULATING TUMOR CELL#0.8547;REACTIVE OXYGEN SPECIES#0.8535;B CELL LYMPHOMA#0.8487;CANCER SPECIFIC SURVIVAL#0.8466;BREAST CANCER CELL#0.8456;METASTATIC LYMPH NODE#0.8410;ENDOMETRIAL CANCER#0.8401;ADENINE#0.8372;RESPONSE TO GEMCITABINE#0.8354;PLATIN#0.8351;DNA METHYLTRANSFERASE#0.8349;DIHYDROFOLATE REDUCTASE#0.8295;NEUROENDOCRINE TUMOR#0.8255;EVENT FREE SURVIVAL#0.8247;BEVACIZUMAB#0.8183;EPITHELIAL CELL#0.8152;FAILURE FREE SURVIVAL#0.8150;HYPOXIA#0.8140;RELAPSE FREE SURVIVAL#0.8102;GEFITINIB#0.8101;STANDARD OF CARE#0.8092;CIS-DIAMMINEDICHLOROPLATINUM#0.8078;BREAST CARCINOMA#0.8073;PROGESTERONE#0.7925;MUTAGENIC#0.7922;KERATINOCYTE#0.7888;SQUAMOUS CELL CANCER#0.7864;CONDITIONAL LOGISTIC REGRESSION#0.7862;MONONUCLEAR CELLS#0.7846;METASTATIC GASTRIC CANCER#0.7841;CHROMATID#0.7833;PHOSPHODIESTERASE#0.7830;FLAP ENDONUCLEASE#0.7815;EQUILIBRATIVE NUCLEOSIDE TRANSPORTER#0.7782;DOXORUBICIN#0.7756;MULTI DRUG RESISTANCE#0.7747;DNA POLYMERASE BETA#0.7729;ADVANCED OVARIAN CANCER#0.7718;TRANSCRIPTION-COUPLED REPAIR#0.7708;PROTEASOME#0.7690;DIARRHEA#0.7689;NUCLEOTIDE-EXCISION REPAIR COMPLEX#0.7633;DIPHOSPHATE#0.7605;CYTIDINE DEAMINASE#0.7603;OVERALL SURVIVAL RATE#0.7599;RECURRENCE FREE SURVIVAL#0.7596;CERVICAL ADENOCARCINOMA#0.7585;MELPHALAN#0.7580;MITOSIS#0.7578;G2 PHASE#0.7555;HOST CELL#0.7522;DNA HELICASE#0.7504;HYPOXIC#0.7468;DRUG METABOLISM#0.7458;METASTATIC BREAST CANCER#0.7434;MUTAGEN#0.7416;CYCLOPHOSPHAMIDE#0.7359;BUDDING#0.7359;GUANINE#0.7353;PATHOLOGIC COMPLETE RESPONSE#0.7311;SIGNALLING PATHWAY#0.7255;FIBROBLAST GROWTH FACTOR#0.7234;LYMPH NODE METASTASES#0.7161;ORAL CAVITY#0.7155;NEPHROTOXICITY#0.7132;ADENINE PHOSPHORIBOSYLTRANSFERASE#0.7112;UBIQUITIN#0.7103;DISEASE SPECIFIC SURVIVAL#0.7063;SITE OF DNA DAMAGE#0.7052;GASTRIC ADENOCARCINOMA#0.7049;PATHOLOGICAL COMPLETE RESPONSE#0.7015;OROTATE PHOSPHORIBOSYLTRANSFERASE#0.7011;CYTOPLASM#0.6972;VOMITING#0.6954;DEOXYCYTIDINE KINASE#0.6935;ADJACENT NORMAL TISSUE#0.6842;EPITHELIAL MESENCHYMAL TRANSITION#0.6814;GENE SILENCING#0.6802;EPITHELIAL OVARIAN CARCINOMA#0.6789;ATP BINDING#0.6786;RESPONSE TO UV#0.6775;EPIRUBICIN#0.6769;TELOMERE MAINTENANCE#0.6754;DNA REPAIR COMPLEX#0.6753;XERODERMA PIGMENTOSUM GROUP G#0.6748;GERM CELL TUMORS#0.6741;DIAMMINEDICHLOROPLATINUM#0.6739;HIGH THROUGHPUT SCREEN#0.6728;FOLATE#0.6727;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6702;ASTROCYTOMA#0.6661;BILE DUCT#0.6653;RECEPTOR TYROSINE KINASE#0.6640;FINE NEEDLE ASPIRATION#0.6629;SINGLE STRAND BREAK#0.6627;LEUCOVORIN#0.6609;CYTIDINE#0.6530;UNCONDITIONAL LOGISTIC REGRESSION#0.6527;DNA LIGASE#0.6513;RESPONSE TO 5-FLUOROURACIL#0.6507;NEUROPATHY#0.6502;PANCREATIC ADENOCARCINOMA#0.6473;METHYLATION SPECIFIC PCR#0.6466;ENDOTHELIAL CELL#0.6461;EMBRYONIC STEM CELL#0.6456;MOUSE EMBRYONIC FIBROBLAST#0.6443;MYELOID LEUKEMIA#0.6439;TEMOZOLOMIDE#0.6423;HUMAN BRONCHIAL EPITHELIA#0.6372;SENSITIZATION#0.6371;NERVOUS SYSTEM#0.6360;MICROTUBULE#0.6358;NATIONAL CANCER INSTITUTE#0.6305;MATING TYPE SWITCHING#0.6285;PTK/ZK#0.6266;SINGLE-STRANDED DNA BINDING#0.6261;RAPAMYCIN#0.6252;LEUKOCYTE#0.6235;DETOXIFICATION#0.6231;AUTOPHAGY#0.6213;LASER CAPTURE MICRODISSECTION#0.6198;ANAPLASTIC LYMPHOMA KINASE#0.6172;CHROMOSOMAL REGION#0.6161;TARGET OF RAPAMYCIN#0.6156;M PHASE#0.6127;CERVICAL SQUAMOUS CELL CARCINOMA#0.6102;CYTOCHROME P450#0.6099;PROGERIA#0.6092;SPORADIC BREAST CANCER#0.6092;AGEING#0.6077;DNA DAMAGE CHECKPOINT#0.6043;BILE DUCT CANCER#0.6022;POLYCYCLIC AROMATIC HYDROCARBON#0.6013;ESOPHAGUS#0.6003
2068	COMPLEMENTATION GROUP 1#1.0611;PANCREATIC CANCER#1.0537;XERODERMA PIGMENTOSUM GROUP D#1.0524;THYMIDYLATE SYNTHASE#1.0489;DNA LIGASE#1.0374;NECK CANCER#1.0355;CAK COMPLEX#1.0347;HEAD AND NECK CANCER#1.0344;COCKAYNE SYNDROME#1.0339;DNA HELICASE#1.0294;RESPONSE TO PLATINUM#1.0294;NEURITE OUTGROWTH#1.0285;NEURITE#1.0279;HELICASE ACTIVITY#1.0274;PROSTATE CANCER#1.0261;METASTATIC COLORECTAL CANCER#1.0257;SINGLE STRAND BREAK#1.0216;PROMOTER ESCAPE#1.0193;XERODERMA PIGMENTOSUM#1.0192;ESOPHAGEAL CANCER#1.0183;PHOTOSENSITIVITY#1.0178;TRANSCRIPTION-COUPLED REPAIR#1.0178;THYMIDYLATE#1.0177;ICHTHYOSIS#1.0172;OVARIAN CANCER#1.0171;GENETIC DISORDER#1.0162;CHROMATID#1.0157;HEPATOCELLULAR CARCINOMA#1.0150;OLIGODENDROCYTE#1.0149;GLUTATHIONE#1.0124;SCHWANN CELL#1.0122;OVARIAN#1.0103;GEMCITABINE#1.0103;TRANSCRIPTION FACTOR#1.0101;OXALIPLATIN#1.0095;LUNG CANCER#1.0068;DNA REPAIR ENZYME#1.0067;SKIN CANCER#1.0067;GLYCOSYLASE#1.0056;DNA REPAIR PROTEIN#1.0044;HYPERSENSITIVITY#1.0040;FRAGMENT LENGTH POLYMORPHISM#1.0032;SCIATIC NERVE#1.0032;COLORECTAL#1.0016;POLYMERASE CHAIN REACTION#1.0014;NEUROPATHY#1.0012;BASAL CELL CARCINOMA#1.0005;APOPTOSIS#0.9991;BREAST CANCER#0.9991;REGENERATION#0.9987;COLORECTAL CANCER#0.9980;DNA BINDING#0.9978;CISPLATIN#0.9977;SPINAL CORD#0.9968;BASAL CELL#0.9964;DOUBLE STRAND BREAK#0.9954;RISK OF DEATH#0.9941;BREAST CANCER PATIENTS#0.9937;BASE EXCISION REPAIR#0.9930;SQUAMOUS CELL CARCINOMA#0.9921;CYTOTOXICITY#0.9914;T CELL#0.9914;PERIPHERAL BLOOD LYMPHOCYTES#0.9910;NUCLEOTIDE EXCISION REPAIR#0.9903;APOPTOTIC#0.9902;HOMOLOGOUS RECOMBINATION#0.9902;REVERSE TRANSCRIPTION#0.9902;5 FLUOROURACIL#0.9899;CELL CYCLE#0.9896;DNA REPAIR CAPACITY#0.9894;ADJUSTED ODDS RATIO#0.9891;DNA REPAIR#0.9876;PERIPHERAL NERVE#0.9872;ADENOCARCINOMA#0.9871;MYELOID LEUKEMIA#0.9857;CELL DEATH#0.9855;GROWTH FACTOR#0.9854;KINASE ACTIVITY#0.9852;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9849;PERIPHERAL BLOOD#0.9846;CENTRAL NERVOUS SYSTEM#0.9843;CYCLIN DEPENDENT KINASE#0.9833;CELL SURFACE#0.9826;B CELL#0.9819;STEM CELL#0.9813;RESPONSE TO CISPLATIN#0.9792;ACUTE MYELOID LEUKEMIA#0.9782;GENE EXPRESSION#0.9774;CANCER CELL#0.9772;NERVOUS SYSTEM#0.9767;HOST CELL#0.9763;XERODERMA PIGMENTOSUM GROUP A#0.9755;FLUOROURACIL#0.9749;CELL PROLIFERATION#0.9749;OXIDATIVE DNA DAMAGE#0.9747;MONONUCLEAR CELLS#0.9744;TOXICITY#0.9741;PROTEIN KINASE#0.9725;MUTAGENESIS#0.9712;DNA SYNTHESIS#0.9704;CARCINOGEN#0.9702;SIGNALING PATHWAY#0.9643;DOUBLE-STRAND BREAK REPAIR#0.9583;DNA EXCISION#0.9582;COMPLEX I#0.9553;TUMOR SUPPRESSOR#0.9552;DRUG RESISTANCE#0.9550;MENTAL RETARDATION#0.9548;GENOTOXIC#0.9489;ATPASE ACTIVITY#0.9485;TOPOISOMERASE#0.9484;COLON CANCER#0.9479;CELL CYCLE CONTROL#0.9474;NEUTROPENIA#0.9440;EVENT FREE SURVIVAL#0.9406;C TERMINAL DOMAIN#0.9357;DORSAL ROOT GANGLION#0.9351;HEPATITIS B#0.9290;DNA REPLICATION#0.9272;TRANSACTIVATION#0.9258;AXON GROWTH#0.9245;MISMATCH REPAIR#0.9228;DNA UNWINDING#0.9221;PERIPHERAL NERVOUS SYSTEM#0.9219;PROTEIN COMPLEX#0.9207;NEURITE GROWTH#0.9197;CELL MIGRATION#0.9131;B CELL LYMPHOMA#0.9117;ADVANCED COLORECTAL CANCER#0.9112;MYELIN SHEATH#0.9112;DNA METHYLATION#0.9070;POLYCYCLIC AROMATIC HYDROCARBON#0.9067;DETOXIFICATION#0.9043;DNA HELICASE ACTIVITY#0.9022;TIME TO PROGRESSION#0.9000;UNCONDITIONAL LOGISTIC REGRESSION#0.8996;OPTIC NERVE#0.8996;RNA SYNTHESIS#0.8994;HEPATITIS B VIRUS#0.8991;HEPATOMA CELLS#0.8977;IRINOTECAN#0.8939;MULTIFACTOR DIMENSIONALITY REDUCTION#0.8911;BONE MARROW#0.8897;GROWTH CONE#0.8893;AXON REGENERATION#0.8893;MICRONUCLEUS#0.8890;NEUROTROPHIN RECEPTOR#0.8877;OVERALL RESPONSE RATE#0.8852;COLORECTAL CARCINOMA#0.8845;REACTIVE OXYGEN SPECIES#0.8817;CELL ADHESION#0.8807;ENDOMETRIAL CANCER#0.8800;CAPECITABINE#0.8796;AUTOSOMAL RECESSIVE DISEASE#0.8757;CELL CYCLE REGULATION#0.8731;SIGNAL TRANSDUCTION#0.8730;CERVICAL#0.8723;FOLATE#0.8701;LUNG ADENOCARCINOMA#0.8698;DNA DEPENDENT ATPASE#0.8659;EXTRACELLULAR MATRIX#0.8636;DNA REPAIR DEFICIENCY#0.8636;CYTOPLASM#0.8622;CELL KILLING#0.8619;XENOBIOTIC METABOLISM#0.8602;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8601;CARBOPLATIN#0.8580;LYMPH NODE#0.8546;MUTAGENIC#0.8544;LYSINE#0.8529;TELOMERE#0.8526;FOLATE METABOLISM#0.8510;POLY ADP RIBOSE#0.8476;MITOSIS#0.8440;PROGENITOR CELL#0.8425;REPLICATION FORK#0.8423;MEDIAN SURVIVAL TIME#0.8417;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.8411;MULTIPLE SCLEROSIS#0.8388;GENETIC DISEASE#0.8371;CHROMOSOME SEGREGATION#0.8359;DNA REPAIR SYNTHESIS#0.8348;GLIAL CELL#0.8348;HOMOLOGOUS RECOMBINATION REPAIR#0.8338;TRANSCRIPTION INITIATION FACTOR#0.8331;GLIAL FIBRILLARY ACIDIC PROTEIN#0.8329;THYROID CANCER#0.8312;MUTAGEN#0.8281;DOCETAXEL#0.8267;ANEMIA#0.8256;CERVICAL CANCER#0.8254;CELL ADHESION MOLECULE#0.8247;IMMUNE RESPONSE#0.8215;CELL CYCLE ARREST#0.8196;MYELINATION#0.8178;QUANTITATIVE REAL TIME#0.8176;TUMOR CELLS#0.8175;FANCONI ANEMIA#0.8166;CONDITIONAL LOGISTIC REGRESSION#0.8142;AGEING#0.8098;GLUTAMINE#0.8034;IRON SULFUR CLUSTER#0.8029;DIFFUSE LARGE B-CELL LYMPHOMA#0.7984;DRUG METABOLISM#0.7931;DIGESTIVE TRACT#0.7907;DNA DAMAGE RESPONSE#0.7904;HARDY WEINBERG EQUILIBRIUM#0.7863;LIGASE ACTIVITY#0.7846;UV RESISTANCE#0.7803;SINGLE STRAND BREAK REPAIR#0.7798;TRANSCRIPTION FACTOR COMPLEX#0.7788;ACUTE LEUKEMIA#0.7779;EPIDERMAL GROWTH FACTOR#0.7701;OLIGODENDROGLIOMA#0.7664;NERVE FIBER#0.7646;NATURAL KILLER CELL#0.7627;AGE AT DIAGNOSIS#0.7619;LYMPH NODE METASTASIS#0.7618;GANGLION CELLS#0.7599;MEDIAN OVERALL SURVIVAL#0.7586;RECOMBINATIONAL REPAIR#0.7573;MITOMYCIN C#0.7570;IMMUNE SYSTEM#0.7537;GENOTOXICITY#0.7517;GROWTH FACTOR RECEPTOR#0.7512;ORAL SQUAMOUS CELL CARCINOMA#0.7511;HEALTHY CONTROL SUBJECTS#0.7508;OVARIAN CARCINOMA#0.7506;OLIGODENDROCYTE DIFFERENTIATION#0.7496;PROGERIA#0.7480;LEUKOCYTE#0.7479;ATP BINDING#0.7475;LYMPHOBLASTOID CELLS#0.7467;REPLICATION PROTEIN A#0.7466;RIBOSE#0.7435;ALLERGEN#0.7421;ATAXIA TELANGIECTASIA#0.7392;TOPOISOMERASE II#0.7392;PRECURSOR CELL#0.7358;MULTIPLE MYELOMA#0.7289;PHOSPHODIESTERASE#0.7283;CYTIDINE DEAMINASE#0.7225;PEMETREXED#0.7216;MITOCHONDRIAL DNA#0.7203;DIARRHEA#0.7191;CELL GROWTH#0.7155;AZOOSPERMIA#0.7138;NEUROTOXICITY#0.7129;MACROPHAGE#0.7127;WERNER SYNDROME#0.7126;BLOOM SYNDROME#0.7116;RESPONSE TO UV#0.7050;NON HODGKIN LYMPHOMA#0.7043;KINASE INHIBITOR#0.7039;CHROMOSOMAL REGION#0.7036;NATIONAL CANCER INSTITUTE#0.7035;BASAL LAMINA#0.7028;RECURRENCE FREE SURVIVAL#0.7015;SKIN FIBROBLASTS#0.7000;DEVELOPMENTAL DELAY#0.6999;THYMIDINE#0.6994;SPINAL CORD INJURY#0.6986;DISEASE FREE SURVIVAL#0.6962;INFERTILITY#0.6962;WHITE BLOOD CELL#0.6958;INFLAMMATORY RESPONSE#0.6935;NEUROBLASTOMA#0.6931;NEURAL CELL#0.6913;TUMOR NECROSIS FACTOR#0.6902;COLORECTAL ADENOMA#0.6899;NERVE GROWTH FACTOR#0.6888;PROTEOGLYCAN#0.6822;IL-1RN#0.6810;KERATINOCYTE#0.6808;CELL DIFFERENTIATION#0.6792;ADJUSTED HAZARD RATIO#0.6787;HUMAN IMMUNODEFICIENCY VIRUS#0.6772;GLOBAL GENOME NER#0.6768;GUANINE#0.6736;LASER DESORPTION IONIZATION#0.6732;CEREBELLAR GRANULE NEURON#0.6715;HYPERTENSION#0.6697;CYTOCHROME P450#0.6679;URINARY BLADDER#0.6678;DNA METHYLTRANSFERASE#0.6675;DIGESTION#0.6582;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6517;EPITHELIAL OVARIAN CANCER#0.6506;MITOMYCIN#0.6506;S PHASE#0.6506;HODGKIN'S LYMPHOMA#0.6488;CHEWING#0.6365;SPORADIC BREAST CANCER#0.6341;CHONDROITIN SULFATE PROTEOGLYCAN#0.6256;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6241;ASTROCYTE#0.6204;CAMPTOTHECIN#0.6197;RENAL CELL CARCINOMA#0.6195;SCHWANN CELL MIGRATION#0.6190;MITOTIC SPINDLE#0.6172;METASTATIC COLORECTAL CARCINOMA#0.6172;METAPHASE#0.6169;VINORELBINE#0.6161;HOMOLOGOUS RECOMBINATIONAL REPAIR#0.6158;MUSCLE CELL#0.6155;LUNG CARCINOMA#0.6133;FACTOR I#0.6103;CYTIDINE#0.6097;UV-SENSITIVE SYNDROME#0.6089;INVASIVE UROTHELIAL CARCINOMA#0.6087;CYTOKINESIS#0.6080;ANCHORING#0.6079;CPT-11#0.6076;PREINITIATION COMPLEX#0.6036
2069	TRANSFORMING GROWTH FACTOR ALPHA#1.0530;HEPARIN BINDING#1.0487;HEPARIN#1.0431;CETUXIMAB#1.0371;TRANSFORMING GROWTH FACTOR#1.0296;ANTI EGFR#1.0249;KERATINOCYTE#1.0197;GRANULOSA CELL#1.0162;METASTATIC COLORECTAL CANCER#1.0140;GROWTH FACTOR#1.0118;COLORECTAL CANCER#1.0072;COLORECTAL#1.0038;CANCER CELL#1.0025;EPITHELIAL CELL#1.0010;OOCYTE#1.0001;EPIDERMAL GROWTH FACTOR#1.0001;OOCYTE MATURATION#1.0000;RECEPTOR LIGAND#0.9998;PROGESTERONE#0.9912;OVULATION#0.9910;CELL PROLIFERATION#0.9898;GROWTH FACTOR RECEPTOR#0.9879;GENE EXPRESSION#0.9867;OVARIAN#0.9826;SIGNALING PATHWAY#0.9810;CELL GROWTH#0.9799;SMOOTH MUSCLE#0.9710;WOUND HEALING#0.9571;FIBROBLAST GROWTH FACTOR#0.9565;SMOOTH MUSCLE CELL#0.9556;MUSCLE CELL#0.9549;CUMULUS OOCYTE COMPLEXES#0.9538;STEM CELL#0.9515;POLYMERASE CHAIN REACTION#0.9505;BREAST CANCER#0.9456;ENDOTHELIAL GROWTH FACTOR#0.9340;TRANSCRIPTION FACTOR#0.9312;COLON CANCER#0.9302;OVARIAN FOLLICLE#0.9277;APOPTOSIS#0.9272;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9259;PROTEIN KINASE#0.9243;TUMOR NECROSIS FACTOR#0.9214;LUNG CANCER#0.9037;REGENERATION#0.9013;MACROPHAGE#0.8962;SIGNALLING PATHWAY#0.8890;CELL CYCLE#0.8788;ALPHA-HEPARIN#0.8718;SQUAMOUS CELL CARCINOMA#0.8717;SIGNAL TRANSDUCTION#0.8707;RECEPTOR TYROSINE KINASE#0.8654;REVERSE TRANSCRIPTION#0.8626;TUMOR CELLS#0.8615;KINASE INHIBITOR#0.8553;FOLLICLE STIMULATING HORMONE#0.8440;DNA SYNTHESIS#0.8332;PROSTAGLANDIN ENDOPEROXIDE SYNTHASE#0.8296;CELL DEATH#0.8234;MITOGEN ACTIVATED PROTEIN#0.8167;PLATELET-DERIVED GROWTH FACTOR#0.8130;VASCULAR SMOOTH MUSCLE CELL#0.7984;QUANTITATIVE REAL TIME#0.7969;NITRIC OXIDE#0.7946;OVARIES#0.7791;BREAST CANCER CELL#0.7788;INFLAMMATORY RESPONSE#0.7738;IRINOTECAN#0.7661;SKIN RASH#0.7596;LUNG METASTASIS#0.7521;IN VITRO MATURATION#0.7497;COMPLEX I#0.7479;PANITUMUMAB#0.7473;CELL SURFACE#0.7411;ANGIOGENESIS#0.7385;CELL ADHESION#0.7383;EGFR SIGNALING PATHWAY#0.7344;DEMETHYLATION#0.7283;FORSKOLIN#0.7259;ADENOCARCINOMA#0.7243;STROMAL CELL#0.7182;ADVANCED COLORECTAL CANCER#0.7082;MESENCHYMAL STEM CELL#0.7027;EXTRACELLULAR MATRIX#0.6990;HEPATOCYTE GROWTH FACTOR#0.6981;PROSTAGLANDIN E2#0.6971;FERTILIZATION#0.6955;ELECTRON TRANSFER#0.6915;ENDOTHELIAL CELL#0.6833;LIVER REGENERATION#0.6783;FORMALIN#0.6780;TYROSINE KINASE INHIBITOR#0.6755;CELL MIGRATION#0.6740;EPITHELIAL MESENCHYMAL TRANSITION#0.6723;BONE MARROW#0.6718;L-ARGININE#0.6661;COLITIS#0.6473;TUBERCULOSIS#0.6471;EGF RECEPTOR LIGAND#0.6462;PERIPHERAL BLOOD#0.6436;IMMUNE RESPONSE#0.6433;OXYGENASE#0.6336;ONCOGENIC#0.6330;ENHANCER BINDING PROTEIN#0.6275;PROSTATE CANCER#0.6274;ENHANCER BINDING#0.6270;EPITHELIAL GROWTH FACTOR#0.6189;GROWTH REGULATOR#0.6167;CELL DIFFERENTIATION#0.6165;ERBB4 HOMODIMER#0.6102;ESTRADIOL#0.6006
2070	HEARING LOSS#1.0657;HEARING IMPAIRMENT#1.0482;SENSORINEURAL HEARING LOSS#1.0250;TUMOR SUPPRESSOR#0.9857;CELL PROLIFERATION#0.9068;HEPATOCELLULAR CARCINOMA#0.9035;TRANSCRIPTION FACTOR#0.8807;COLORECTAL CANCER#0.8636;GENE EXPRESSION#0.8546;COLORECTAL#0.8535;CARDIOMYOPATHY#0.8462;DILATED CARDIOMYOPATHY#0.8398;HAIR CELL#0.8171;DNA METHYLATION#0.7754;CANCER CELL#0.7639;POLYMERASE CHAIN REACTION#0.7555;APOPTOSIS#0.6614;REVERSE TRANSCRIPTION#0.6398;OTITIS MEDIA#0.6352;ULCERATIVE COLITIS#0.6264;HISTONE DEACETYLASE#0.6119
207107	TUMOR SUPPRESSOR#0.6812;SQUAMOUS CELL CARCINOMA#0.6532;LUNG SQUAMOUS CELL CARCINOMA#0.6368;CELL PROLIFERATION#0.6198;LUNG CANCER#0.6012
2071	XERODERMA PIGMENTOSUM GROUP B#1.1269;HELICASE ACTIVITY#1.0476;DNA HELICASE#1.0444;ATPASE ACTIVITY#1.0294;PROMOTER ESCAPE#1.0273;XERODERMA PIGMENTOSUM#1.0251;COCKAYNE SYNDROME#1.0180;TRANSCRIPTION FACTOR#1.0099;DNA REPAIR#0.9958;NUCLEOTIDE EXCISION REPAIR#0.9928;CISPLATIN#0.9906;CELL CYCLE#0.9812;APOPTOSIS#0.9799;GENE EXPRESSION#0.9747;LUNG CANCER#0.9546;POLYMERASE CHAIN REACTION#0.9496;DNA HELICASE ACTIVITY#0.9483;DNA BINDING#0.9468;SKIN CANCER#0.9468;DNA DEPENDENT ATPASE#0.9459;GENETIC DISORDER#0.9392;KINASE ACTIVITY#0.9325;TRANSCRIPTION-COUPLED REPAIR#0.9267;DNA EXCISION#0.9258;DNA REPAIR PROTEIN#0.9124;DNA UNWINDING#0.9110;DNA REPAIR CAPACITY#0.9004;OVARIAN CANCER#0.8864;RNA SYNTHESIS#0.8756;CELL DEATH#0.8731;CANCER CELL#0.8721;DRUG RESISTANCE#0.8671;APOPTOTIC#0.8621;OVARIAN#0.8427;BASE EXCISION REPAIR#0.8414;PROTEIN KINASE#0.8362;DNA REPLICATION#0.8218;CELL CYCLE REGULATION#0.8215;C TERMINAL DOMAIN#0.8169;PROMOTER MELTING#0.8145;REVERSE TRANSCRIPTION#0.7944;PREINITIATION COMPLEX#0.7849;CYCLIN DEPENDENT KINASE#0.7827;DNA SYNTHESIS#0.7825;BREAST CANCER#0.7795;CYTOTOXICITY#0.7557;DNA DAMAGE RESPONSE#0.7507;TRANSCRIPTION FACTOR COMPLEX#0.7414;NUCLEIC ACID#0.7289;CAK COMPLEX#0.7248;TUMOR SUPPRESSOR#0.7170;MUTAGENESIS#0.7164;NUCLEOTIDE-EXCISION REPAIR COMPLEX#0.7137;FRAGMENT LENGTH POLYMORPHISM#0.7058;PROTEASOME#0.7043;SPIRONOLACTONE#0.7010;PROTEIN COMPLEX#0.6999;DNA TRANSLOCASE#0.6838;DNA DEPENDENT ATPASE ACTIVITY#0.6810;T CELL#0.6743;DOUBLE STRAND BREAK#0.6688;OXIDATIVE DNA DAMAGE#0.6574;HOST CELL#0.6501;B CELL#0.6460;TUMOR CELLS#0.6450;ATP HYDROLYSIS#0.6354;PHOTOSENSITIVITY#0.6073;ENDONUCLEASE ACTIVITY#0.6032
2072	XPF-ERCC1 COMPLEX#1.1638;RAD1-RAD10 COMPLEX#1.1180;XERODERMA PIGMENTOSUM GROUP F#1.0956;ICL REPAIR#1.0599;SINGLE STRAND ANNEALING#1.0536;DNA REPAIR PROTEIN#1.0369;ENDONUCLEASE ACTIVITY#1.0366;COMPLEX I#1.0347;TELOMERE#1.0332;MITOTIC RECOMBINATION#1.0318;BREAST CANCER#1.0244;FLAP ENDONUCLEASE#1.0239;RECOMBINATIONAL REPAIR#1.0226;XERODERMA PIGMENTOSUM#1.0200;PROTEIN COMPLEX#1.0140;ENDONUCLEASE COMPLEX#1.0108;REPLICATION PROTEIN A#1.0104;DOUBLE-STRAND BREAK REPAIR#1.0092;DNA BINDING#1.0089;FANCONI ANEMIA#1.0087;POLYMERASE CHAIN REACTION#1.0086;GENE CONVERSION#1.0081;SQUAMOUS CELL CARCINOMA#1.0075;LUNG CANCER#1.0041;NUCLEASE ACTIVITY#1.0035;MISMATCH REPAIR#1.0019;OVARIAN CANCER#0.9989;REPLICATION FORK#0.9984;CISPLATIN#0.9983;ANEMIA#0.9981;HOMOLOGOUS RECOMBINATION#0.9977;NUCLEOTIDE EXCISION REPAIR#0.9951;BASE EXCISION REPAIR#0.9941;TRANSCRIPTION FACTOR#0.9940;DNA DAMAGE RESPONSE#0.9925;CANCER CELL#0.9918;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9896;OVARIAN#0.9882;DNA REPAIR#0.9866;DNA SYNTHESIS#0.9862;GENE EXPRESSION#0.9846;MITOMYCIN C#0.9845;CELL CYCLE#0.9822;DOUBLE STRAND BREAK#0.9816;DNA REPLICATION#0.9798;COCKAYNE SYNDROME#0.9770;S PHASE#0.9716;COLORECTAL CANCER#0.9699;COMPLEMENTATION GROUP 1#0.9682;DNA REPAIR CAPACITY#0.9655;SLIDING CLAMP#0.9650;FRAGMENT LENGTH POLYMORPHISM#0.9630;DNA EXCISION#0.9547;CHROMATID#0.9512;APOPTOSIS#0.9505;HYPERSENSITIVITY#0.9503;MUTAGENESIS#0.9502;DNA DAMAGE CHECKPOINT#0.9414;XFE PROGEROID SYNDROME#0.9401;MITOMYCIN#0.9397;PROTEIN PROTEIN INTERACTION#0.9391;CYTOTOXICITY#0.9329;C TERMINAL DOMAIN#0.9328;TOXICITY#0.9313;COLORECTAL#0.9312;INTERSTRAND CROSS-LINK REPAIR#0.9187;GLYCOSYLASE#0.9067;MEIOSIS#0.9023;HOST CELL#0.8992;TRANSLESION SYNTHESIS#0.8983;HOMOLOGOUS RECOMBINATION REPAIR#0.8979;GENOTOXIC#0.8939;CELL DEATH#0.8938;DNA HELICASE#0.8911;SINGLE-STRANDED DNA BINDING#0.8846;TUMOR SUPPRESSOR#0.8686;OXALIPLATIN#0.8673;TELOMERE MAINTENANCE#0.8627;TRANSCRIPTION-COUPLED REPAIR#0.8606;CARCINOGEN#0.8560;TOPOISOMERASE#0.8548;DNA LIGASE#0.8543;CELL CYCLE ARREST#0.8475;SKIN CANCER#0.8466;MUTAGENIC#0.8408;BUDDING#0.8377;DRUG RESISTANCE#0.8251;OXIDATIVE DNA DAMAGE#0.8230;ADENOCARCINOMA#0.8227;STEM CELL#0.8202;UV RESISTANCE#0.8071;SINGLE STRAND BREAK#0.7946;MUTAGEN#0.7865;GERM CELL#0.7841;PERIPHERAL BLOOD#0.7747;PANCREATIC CANCER#0.7672;PROGERIA#0.7636;POLY ADP RIBOSE#0.7585;DNA REPAIR ENZYME#0.7543;CAMPTOTHECIN#0.7533;BONE MARROW#0.7511;HEAD AND NECK CANCER#0.7429;NECK CANCER#0.7428;REACTIVE OXYGEN SPECIES#0.7388;TUMOR CELLS#0.7346;COLON CANCER#0.7232;HUMAN BRONCHIAL EPITHELIA#0.7224;PROSTATE CANCER#0.7212;CELL PROLIFERATION#0.7183;CELL GROWTH#0.7073;PROTEIN KINASE#0.7057;PHOSPHODIESTERASE#0.7043;DNA REPAIR SYNTHESIS#0.6983;RIBOSE#0.6860;DNA DEMETHYLATION#0.6815;EPITHELIAL CELL#0.6809;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6804;NITROGEN MUSTARD#0.6739;SENESCENCE#0.6718;ADJUSTED ODDS RATIO#0.6603;SIGNALING PATHWAY#0.6524;CHROMOSOME SEGREGATION#0.6495;DNA METABOLISM#0.6405;GROWTH FACTOR#0.6390;MATING TYPE SWITCHING#0.6343;CELL CYCLE CHECKPOINT#0.6334;GEMCITABINE#0.6333;DNA REPAIR COMPLEX#0.6182;REVERSE TRANSCRIPTION#0.6129;TELOMERE BINDING#0.6119;POLYCYCLIC AROMATIC HYDROCARBON#0.6055;ESOPHAGEAL CANCER#0.6043
2073	XERODERMA PIGMENTOSUM#1.0650;BREAST CANCER#1.0332;COLORECTAL CANCER#1.0218;LUNG CANCER#1.0213;POLYMERASE CHAIN REACTION#1.0157;FRAGMENT LENGTH POLYMORPHISM#1.0127;BASE EXCISION REPAIR#1.0057;DNA EXCISION#1.0051;COCKAYNE SYNDROME#1.0027;COLORECTAL#0.9994;DNA REPAIR#0.9894;NUCLEOTIDE EXCISION REPAIR#0.9892;GENE EXPRESSION#0.9842;OXALIPLATIN#0.9788;PROSTATE CANCER#0.9558;DOUBLE STRAND BREAK#0.9493;TRANSCRIPTION FACTOR#0.9490;TRABECTEDIN#0.9414;DNA BINDING#0.9378;SQUAMOUS CELL CARCINOMA#0.9345;OVARIAN CANCER#0.9280;PERIPHERAL BLOOD#0.9240;CELL CYCLE#0.9228;RESPONSE TO PLATINUM#0.9219;CANCER CELL#0.9202;MISMATCH REPAIR#0.9136;APOPTOSIS#0.9024;OVARIAN#0.8972;HOMOLOGOUS RECOMBINATION#0.8967;CISPLATIN#0.8925;TOXICITY#0.8732;HEPATOCELLULAR CARCINOMA#0.8644;TRANSCRIPTION-COUPLED REPAIR#0.8538;ADVANCED COLORECTAL CANCER#0.8538;EPITHELIAL CELL#0.8531;XERODERMA PIGMENTOSUM GROUP G#0.8395;ENDONUCLEASE ACTIVITY#0.8316;DNA REPAIR CAPACITY#0.8101;DNA REPAIR ENZYME#0.8091;BRONCHIAL EPITHELIAL CELLS#0.7935;OXIDATIVE DNA DAMAGE#0.7927;SINGLE STRAND BREAK#0.7912;DNA REPAIR PROTEIN#0.7903;DNA REPLICATION#0.7894;CARCINOGEN#0.7810;ADJUSTED ODDS RATIO#0.7683;FLAP ENDONUCLEASE#0.7624;REPLICATION PROTEIN A#0.7615;DRUG RESISTANCE#0.7539;GENOTOXIC#0.7355;TUMOR TISSUES#0.7277;PERIPHERAL BLOOD LYMPHOCYTES#0.7240;UV RESISTANCE#0.7195;COMPLEMENTATION GROUP 1#0.7118;DOUBLE-STRAND BREAK REPAIR#0.7069;NUCLEASE ACTIVITY#0.7063;DNA SYNTHESIS#0.7037;HOST CELL#0.6811;ENDOMETRIAL CANCER#0.6790;THYMINE#0.6785;BREAST CANCER PATIENTS#0.6740;UNCONDITIONAL LOGISTIC REGRESSION#0.6619;XENOBIOTIC METABOLISM#0.6607;DNA DAMAGE RESPONSE#0.6526;GUANINE#0.6521;DISEASE FREE SURVIVAL#0.6506;CELL DEATH#0.6443;GLYCOSYLASE#0.6186;TIME TO PROGRESSION#0.6124;ALLELE SPECIFIC EXPRESSION#0.6097;POLYCYCLIC AROMATIC HYDROCARBON#0.6095
2074	COCKAYNE SYNDROME B#1.0805;CHROMATIN REMODELING#1.0353;COCKAYNE SYNDROME#1.0307;GENE EXPRESSION#1.0232;UBIQUITIN#1.0194;TRANSCRIPTION-COUPLED REPAIR#1.0167;CELL CYCLE#1.0041;BASE EXCISION REPAIR#0.9988;XERODERMA PIGMENTOSUM#0.9978;DNA REPAIR#0.9947;OXIDATIVE DNA DAMAGE#0.9903;DNA DEPENDENT ATPASE#0.9873;NUCLEOTIDE EXCISION REPAIR#0.9837;S PHASE#0.9792;NUCLEOSOME#0.9767;APOPTOSIS#0.9764;GLYCOSYLASE#0.9708;TELOMERE#0.9665;DNA REPLICATION#0.9655;PHOTOSENSITIVITY#0.9584;TRANSCRIPTION FACTOR#0.9454;LUNG CANCER#0.9443;DNA DAMAGE RESPONSE#0.9396;DOUBLE STRAND BREAK#0.9293;DNA REPAIR PROTEIN#0.9253;TRANSCRIPTION-COUPLED NER#0.9230;REACTIVE OXYGEN SPECIES#0.9127;RNA SYNTHESIS#0.9078;HOMOLOGOUS RECOMBINATION#0.9035;ATPASE ACTIVITY#0.8940;UV-SENSITIVE SYNDROME#0.8914;GENOTOXIC#0.8807;GENETIC DISORDER#0.8803;HYPERSENSITIVITY#0.8733;CELL PROLIFERATION#0.8721;CELL DEATH#0.8707;CANCER CELL#0.8616;STEM CELL#0.8519;CISPLATIN#0.8497;MITOCHONDRIAL DNA#0.8434;HEARING LOSS#0.8198;DNA DAMAGE CHECKPOINT#0.8124;SINGLE STRAND BREAK#0.8116;HISTONE ACETYLATION#0.8009;PROSTATE CANCER#0.7889;COLORECTAL CANCER#0.7835;MICROCEPHALY#0.7798;SKIN CANCER#0.7743;ATP HYDROLYSIS#0.7721;ATROPHIC GASTRITIS#0.7635;RRNA SYNTHESIS#0.7618;PROTEIN KINASE#0.7539;MUTAGENESIS#0.7478;TUMOR NECROSIS FACTOR#0.7390;DNA EXCISION#0.7306;CELL CYCLE ARREST#0.7269;SQUAMOUS CELL CARCINOMA#0.7246;POLY ADP RIBOSE#0.7245;MISMATCH REPAIR#0.7242;B CELL#0.7231;BREAST CANCER#0.7218;IMMUNE RESPONSE#0.7217;MTDNA#0.7217;DNA BINDING#0.7182;UBIQUITIN LIGASE COMPLEX#0.7179;TUMOR SUPPRESSOR#0.7178;AUTOSOMAL RECESSIVE DISEASE#0.7119;MOUSE EMBRYONIC FIBROBLAST#0.7100;PERIPHERAL BLOOD#0.6999;MITOCHONDRIA#0.6937;DNA MODIFICATION#0.6910;UBIQUITIN BINDING#0.6893;LYSINE#0.6862;GLOBAL GENOME NER#0.6848;PROTEASOME#0.6833;RESPONSE TO UV#0.6718;ATP-DEPENDENT CHROMATIN REMODELING#0.6678;COLORECTAL#0.6666;DNA REPAIR CAPACITY#0.6603;DNA HELICASE#0.6589;POLYMERASE CHAIN REACTION#0.6563;COMPLEX I#0.6542;GENETIC DISEASE#0.6539;MITOSIS#0.6449;MENTAL RETARDATION#0.6389;RESPONSE TO OXIDATIVE STRESS#0.6379;CARCINOGEN#0.6301;ISCHEMIA#0.6298;DNA SYNTHESIS#0.6297;AGEING#0.6240;HISTONE CHAPERONE#0.6207;MOUSE EMBRYO FIBROBLASTS#0.6177;APOPTOTIC#0.6173;RIBOSE#0.6127;HYPOXIA#0.6095;CEREBRAL ISCHEMIA#0.6055;ORGAN OF CORTI#0.6033
2077	FERMENTATION#1.0387;ETHANOL#1.0385;TRANSCRIPTION FACTOR#1.0225;GENE EXPRESSION#0.9695;GROWTH FACTOR#0.9023;CELL CYCLE#0.8566;DNA BINDING#0.8540;SIGNALING PATHWAY#0.8203;TRANSCRIPTIONAL REPRESSOR ACTIVITY#0.7998;PROTEIN KINASE#0.7053;ETHANOL FERMENTATION#0.6956;MITOGEN ACTIVATED PROTEIN#0.6837;STEM CELL#0.6829;ONCOGENIC#0.6457;SUCROSE#0.6404;FACTOR I#0.6371;DOPAMINE#0.6358;EMBRYONIC STEM CELL#0.6060;PROSTATE CANCER#0.6016
2078	PROSTATE CANCER ANTIGEN#1.0678;ERYTHROBLAST#1.0307;LOCALIZED PROSTATE CANCER#1.0267;PROSTATE EPITHELIAL CELL#1.0259;ACUTE LEUKEMIA#1.0241;PROSTATE CARCINOMA#1.0185;PROSTATIC INTRAEPITHELIAL NEOPLASIA#1.0172;LYMPH NODE METASTASES#1.0170;PHOSPHATASE AND TENSIN HOMOLOG#1.0139;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0118;CELL MIGRATION#1.0106;PROSTATE ADENOCARCINOMA#1.0093;EWING SARCOMA#1.0079;ANDROGEN RECEPTOR#1.0077;TRANSCRIPTASE#1.0066;TRANSCRIPTION FACTOR#1.0061;REVERSE TRANSCRIPTION#1.0041;ONCOGENIC#1.0034;PROSTATE CANCER#1.0031;QUANTITATIVE REVERSE TRANSCRIPTION#1.0029;ANGIOGENESIS#1.0026;HEMATOPOIETIC STEM CELL#1.0023;MYELOID LEUKEMIA#1.0014;METASTATIC PROSTATE CANCER#1.0011;ACUTE MYELOID LEUKEMIA#1.0009;ADENOCARCINOMA#1.0001;DNA REPAIR#0.9992;SMALL CELL CARCINOMA#0.9989;DOWN SYNDROME#0.9965;ENDOTHELIAL CELL#0.9964;NEUROECTODERMAL TUMOR#0.9961;DNA METHYLATION#0.9957;CANCER CELL#0.9953;EPITHELIAL CELL#0.9952;DNA BINDING#0.9948;ANDROGEN DEPRIVATION THERAPY#0.9946;DOCETAXEL#0.9942;EPITHELIOID SARCOMA#0.9941;B CELL#0.9939;POLYMERASE CHAIN REACTION#0.9939;PROGENITOR CELL#0.9928;TUMOR SUPPRESSOR#0.9923;T CELL#0.9921;FORMALIN#0.9917;CELL GROWTH#0.9913;APOPTOSIS#0.9906;TUMOR CELLS#0.9902;ANGIOSARCOMA#0.9900;BONE MARROW#0.9867;CELL PROLIFERATION#0.9859;ADVANCED PROSTATE CANCER#0.9846;HEMATOPOIESIS#0.9842;TRANSACTIVATION#0.9834;PROSTATE SPECIFIC ANTIGEN#0.9833;SIGNALING PATHWAY#0.9828;CELL CYCLE#0.9820;LYMPH NODE#0.9814;GROWTH FACTOR#0.9797;GENE EXPRESSION#0.9777;ENDOTHELIUM#0.9769;HEMATOPOIETIC CELL#0.9746;FACTOR VIII#0.9744;STEM CELL#0.9733;COPY NUMBER ALTERATION#0.9701;BREAST CANCER#0.9689;CELL DIFFERENTIATION#0.9671;GROWTH FACTOR RECEPTOR#0.9640;PERIPHERAL BLOOD#0.9627;RECURRENCE FREE SURVIVAL#0.9619;PROSTATE EPITHELIUM#0.9590;SMOOTH MUSCLE#0.9589;CHONDROCYTE#0.9570;ONCOGENESIS#0.9557;ABIRATERONE#0.9534;SIGNAL TRANSDUCTION#0.9490;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9464;EPITHELIAL TO MESENCHYMAL#0.9462;COMPARATIVE GENOMIC HYBRIDIZATION#0.9446;CIRCULATING TUMOR CELL#0.9420;PROTEIN KINASE#0.9416;FACTOR I#0.9337;HISTONE DEACETYLASE#0.9320;RNA BINDING#0.9312;CELL DEATH#0.9253;SQUAMOUS CELL CARCINOMA#0.9225;INTERNAL TANDEM DUPLICATION#0.9211;BASAL CELL#0.9189;CELL DEVELOPMENT#0.9179;ENDOTHELIAL GROWTH FACTOR#0.9130;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9130;LUMINAL#0.9063;BLOOD VESSEL#0.9055;DESMOPLASTIC SMALL ROUND CELL TUMOR#0.9030;ELECTROPHORETIC MOBILITY SHIFT#0.9027;EWING FAMILY TUMORS#0.9022;LYMPH NODE METASTASIS#0.9020;RELAPSE FREE SURVIVAL#0.9006;POTASSIUM CHANNEL#0.9002;INSULIN-LIKE GROWTH FACTOR#0.8955;SEMINAL VESICLE#0.8952;CELL ADHESION#0.8951;INTERPHASE#0.8931;QUANTITATIVE REAL TIME#0.8910;EVENT FREE SURVIVAL#0.8855;STROMA#0.8842;FETAL LIVER#0.8800;ENVIRONMENTAL TOBACCO SMOKE#0.8797;GENE EXPRESSION SIGNATURES#0.8731;MEGAKARYOCYTE#0.8703;SMOOTH MUSCLE ACTIN#0.8702;SURGICAL MARGIN STATUS#0.8653;MYXOID LIPOSARCOMA#0.8615;TESTOSTERONE#0.8603;EMBRYONIC STEM CELL#0.8588;MUTAGENESIS#0.8569;MACROPHAGE#0.8527;SEMINAL VESICLE INVASION#0.8524;ERYTHROLEUKEMIA#0.8505;STEM CELL TRANSPLANTATION#0.8484;MINIMAL RESIDUAL DISEASE#0.8462;TRANSCRIPTION FACTOR BINDING#0.8440;LIPOSARCOMA#0.8365;APOPTOTIC#0.8333;SYNOVIAL SARCOMA#0.8329;LUNG CANCER#0.8307;AFRICAN AMERICAN MEN#0.8295;COPY NUMBER GAIN#0.8276;CYTOPLASM#0.8276;CYCLIN DEPENDENT KINASE#0.8260;UBIQUITIN#0.8243;EARLY PROSTATE CANCER#0.8189;DARK ADAPTATION#0.8127;DOUBLE STRAND BREAK#0.8091;LUMINAL CELL#0.8072;HUMAN UMBILICAL VEIN#0.8049;UMBILICAL VEIN#0.8047;TRANSFORMING GROWTH FACTOR#0.8043;CANCER RELATED DEATH#0.8016;DNA COPY NUMBER#0.7986;ACTION POTENTIAL#0.7930;DRUG RESISTANCE#0.7916;CERVICAL#0.7915;ENZALUTAMIDE#0.7861;EXTRACELLULAR MATRIX#0.7760;DISEASE FREE SURVIVAL#0.7714;CONE DYSTROPHY#0.7690;CORE NEEDLE BIOPSY#0.7675;CHROMATIN REMODELING#0.7668;CHONDROSARCOMA#0.7645;DIFFERENTIAL GENE EXPRESSION#0.7611;EXOSOME#0.7600;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7562;DEFINITIVE HEMATOPOIESIS#0.7555;STROMAL CELL#0.7539;COLONY-STIMULATING FACTOR#0.7511;MITOGEN ACTIVATED PROTEIN#0.7489;COLORECTAL CANCER#0.7447;RHABDOMYOSARCOMA#0.7413;POSITIVE SURGICAL MARGIN#0.7399;CANCER SPECIFIC MORTALITY#0.7391;KINASE INHIBITOR#0.7384;RETINOIC ACID#0.7375;RNA BINDING PROTEIN#0.7372;NERVOUS SYSTEM#0.7366;BREAST CANCER CELL#0.7328;MUSCLE CELL#0.7318;PROSTATE-SPECIFIC MEMBRANE ANTIGEN#0.7292;EXTRASKELETAL MYXOID CHONDROSARCOMA#0.7289;BIPOLAR CELL#0.7278;MYXOID CHONDROSARCOMA#0.7270;TRANSCRIPTIONAL CONTROL#0.7237;HOMOLOGOUS RECOMBINATION#0.7215;OVARIAN#0.7212;GENE COPY NUMBER#0.7209;CELL CYCLE ARREST#0.7173;TOPOISOMERASE#0.7142;SOFT TISSUE SARCOMA#0.7141;EPITHELIAL MESENCHYMAL TRANSITION#0.7136;GROWTH PATTERN#0.7122;FALSE DISCOVERY RATE#0.7031;PROTEIN PROTEIN INTERACTION#0.6960;SIGNALING CASCADE#0.6960;COPY NUMBER INCREASE#0.6941;NEUTROPHIL#0.6928;MAGNETIC RESONANCE IMAGING#0.6864;TERMINAL DIFFERENTIATION#0.6831;PROTEIN BINDING#0.6831;VITAMIN D RECEPTOR#0.6823;LYSINE#0.6823;CARTILAGE FORMATION#0.6814;CANCER SPECIFIC SURVIVAL#0.6813;SERUM RESPONSE FACTOR#0.6792;AGGRESSIVE BEHAVIOR#0.6789;INVASIVE CARCINOMA#0.6766;URINARY BLADDER#0.6765;MEGAKARYOCYTIC LEUKEMIA#0.6759;HEMATOPOIETIC PROGENITOR CELL#0.6748;HISTONE MODIFICATION#0.6739;NEUROBLASTOMA#0.6737;TUMOR NECROSIS FACTOR#0.6734;PI3K SIGNALING#0.6732;DISEASE SPECIFIC SURVIVAL#0.6730;NUCLEIC ACID#0.6726;HUMAN BREAST CANCER#0.6654;OVARIAN CARCINOMA#0.6615;COLORECTAL#0.6608;RETINITIS PIGMENTOSA#0.6579;MAST CELL#0.6566;ADVERSE CLINICAL OUTCOME#0.6553;TUMOR TISSUES#0.6545;MYELODYSPLASTIC SYNDROME#0.6498;NEGATIVE PREDICTIVE VALUE#0.6495;DUTASTERIDE#0.6484;GENE SILENCING#0.6479;PHOTORECEPTOR CELL#0.6468;DNA DAMAGE RESPONSE#0.6442;CELL MOTILITY#0.6440;TOXICITY#0.6424;TIME TO RECURRENCE#0.6307;LEUKOCYTE#0.6303;B CELL DEVELOPMENT#0.6274;PROGESTERONE#0.6253;RESPONSE TO TREATMENT#0.6226;CERVICAL CANCER#0.6213;ERYTHROID PROGENITOR#0.6193;OPTICAL COHERENCE TOMOGRAPHY#0.6185;PRECURSOR CELL#0.6135;GRANULOCYTE#0.6124;MAP KINASE#0.6122;CYTARABINE#0.6122;PEPTIDASE INHIBITOR#0.6092;AR BINDING#0.6076;IMMUNE RESPONSE#0.6071;CAUSE SPECIFIC SURVIVAL#0.6055;NUCLEIC ACID AMPLIFICATION#0.6042;CLEAR CELL CHONDROSARCOMA#0.6026
2079	CELL CYCLE#1.0470;CANCER CELL#1.0262;MRNA SPLICING#0.8789;DNA REPLICATION#0.8713;GENE EXPRESSION#0.7380;OVARIAN CANCER#0.6543;CELL GROWTH#0.6407;KINETOCHORE-MICROTUBULE ATTACHMENT#0.6315;OVARIAN#0.6291;NUCLEAR SPECKLE#0.6255;KINETOCHORE MICROTUBULE#0.6229;MITOTIC CHROMOSOME#0.6180;NORMAL BREAST TISSUE#0.6095;RNA PROCESSING#0.6037
207	RAC GTPASE ACTIVATION#1.1167;AKT SIGNALLING CASCADE#1.1050;AKT BINDING#1.0894;PKB SIGNALING CASCADE#1.0611;AKT SIGNAL TRANSDUCTION#1.0530;LAMELLIPODIUM FORMATION#1.0527;AKT SIGNALING CASCADE#1.0525;PKB SIGNALING#1.0522;CILOSTAZOL#1.0521;PROTEUS SYNDROME#1.0510;TOR SIGNALLING PATHWAY#1.0480;TSC1 TSC2 COMPLEX#1.0441;PRIMORDIAL FOLLICLE ACTIVATION#1.0441;EMODIN#1.0424;CDC42 SIGNALING#1.0412;TOR SIGNALING PATHWAY#1.0398;EARLY BRAIN INJURY#1.0379;TELMISARTAN#1.0378;GINSENOSIDE RB1#1.0366;PROPOFOL#1.0349;LIRAGLUTIDE#1.0340;MYRICETIN#1.0335;ALPHA LIPOIC ACID#1.0330;IB-MECA#1.0328;GINSENOSIDE RG1#1.0326;JNK CASCADE#1.0314;ISOFLURANE#1.0314;NELFINAVIR#1.0300;SEVOFLURANE#1.0295;PROTEIN DIGESTION#1.0294;NARINGENIN#1.0287;CALYCULIN A#1.0285;OUABAIN#1.0285;HYDROGEN PEROXIDE-INDUCED APOPTOSIS#1.0279;PODOCYTE APOPTOSIS#1.0273;ACTIVATION OF GSK#1.0272;DEXMEDETOMIDINE#1.0271;GINKGOLIDE-B#1.0262;PKCEPSILON#1.0256;PKCALPHA#1.0251;PKCZETA#1.0248;MELATONIN#1.0246;P85 BINDING#1.0244;GLIMEPIRIDE#1.0242;TOR SIGNALING#1.0228;17-DMAG#1.0225;LOVASTATIN#1.0225;LAMELLIPODIUM#1.0216;P53 SIGNALING PATHWAY#1.0211;AKT SIGNALING#1.0210;ARSENITE#1.0204;PROTEIN KINASE B#1.0203;PIP3 BINDING#1.0203;RENAL CANCER CELLS#1.0201;PI3K CASCADE#1.0198;INHIBITION OF PHOSPHORYLATION#1.0198;RAC GAP ACTIVITY#1.0195;ENDMT#1.0194;PROTEIN PHOSPHATASE 2#1.0194;HAIR CELL#1.0193;NUCLEUS PULPOSUS CELL#1.0188;AFATINIB#1.0184;METHAMPHETAMINE#1.0184;EXTRACELLULAR REGULATED KINASE#1.0183;P38 MAPK SIGNALING#1.0181;CLOZAPINE#1.0180;MITOCHONDRIAL TRANSLOCATION#1.0171;P38 MAPK SIGNALLING#1.0171;RESPIRATORY-BURST OXIDASE#1.0165;G-CSF#1.0164;CHONDROSARCOMA#1.0162;PKCDELTA#1.0160;FIBROBLAST MIGRATION#1.0159;VANDETANIB#1.0158;TUDCA#1.0157;KETAMINE#1.0151;ADENOSINE 5'-MONOPHOSPHATE#1.0150;VEGF SIGNALING PATHWAY#1.0149;MURINE DOUBLE MINUTE#1.0148;PTEN ACTIVITY#1.0148;FLUVASTATIN#1.0148;PI3K COMPLEX#1.0144;AUTOPHAGIC DEATH#1.0143;ACTIN CYTOSKELETON REORGANIZATION#1.0141;HIPPO SIGNALING PATHWAY#1.0137;LIPID PHOSPHATASE ACTIVITY#1.0137;ALPHA-TOCOPHEROL#1.0134;FENOFIBRATE#1.0128;PROTEIN KINASE B ACTIVATION#1.0127;PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY#1.0126;MYOGENIC CELL#1.0124;PI3-KINASE ACTIVITY#1.0124;PHOSPHOINOSITIDE BINDING#1.0118;NADPH OXIDASE COMPLEX#1.0117;CYTOCHROME B#1.0114;VORINOSTAT#1.0114;CHONDROCYTE PROLIFERATION#1.0113;MAPK SIGNALLING#1.0112;JNK SIGNALING PATHWAY#1.0112;ACTIVATION OF CREB#1.0111;CAMKII#1.0108;ATORVASTATIN#1.0105;HIV PROTEASE INHIBITOR#1.0100;AXON GROWTH#1.0099;JUN PHOSPHORYLATION#1.0096;CONSTITUTIVELY ACTIVE MUTANT#1.0095;HUMAN LENS EPITHELIAL#1.0095;LEIOMYOMA#1.0093;DECIDUALIZATION#1.0093;ERK CASCADE#1.0092;LEYDIG CELL#1.0092;PEMETREXED#1.0091;GALLBLADDER CANCER#1.0090;VSMC APOPTOSIS#1.0088;HEPATOCYTE APOPTOSIS#1.0088;GUANINE EXCHANGE FACTOR#1.0082;MEMBRANE RUFFLING#1.0080;LIPOIC ACID#1.0080;ER STRESS-INDUCED APOPTOSIS#1.0078;BERBERINE#1.0076;HESPERETIN#1.0072;MAPK ERK KINASE#1.0071;LIPID KINASE ACTIVITY#1.0070;P2 RECEPTOR#1.0069;SERTOLI CELL#1.0068;HYPERTHERMIA#1.0064;NEURITE FORMATION#1.0064;PSYCHOTIC DISORDER#1.0062;ACTIVATION OF GROWTH#1.0062;PHOSPHOINOSITIDE 3-KINASE ACTIVITY#1.0061;SIMVASTATIN#1.0061;SUMOYLATION#1.0061;HIPPO SIGNALING#1.0060;RIBOSOMAL S6 KINASE#1.0059;4-HYDROXYTAMOXIFEN#1.0057;LARYNGEAL CARCINOMA#1.0057;AUTOCRINE SIGNALING#1.0056;MYOBLAST DIFFERENTIATION#1.0055;CAMP-RESPONSIVE ELEMENT BINDING#1.0055;UVEAL MELANOMA#1.0053;HUMAN GASTRIC CARCINOMA#1.0051;GLYCOGEN SYNTHASE KINASE#1.0051;CAFFEINE#1.0050;GLYCOGEN SYNTHASE ACTIVITY#1.0048;MYOBLAST PROLIFERATION#1.0046;KERATINOCYTE PROLIFERATION#1.0045;FLAVOCYTOCHROME B558#1.0044;TOCOPHEROL#1.0043;TRAMETINIB#1.0043;JANUS ACTIVATED KINASE#1.0042;STI-571#1.0036;GAP ACTIVITY#1.0036;RESPONSE TO GROWTH FACTOR#1.0035;HEMANGIOMA#1.0032;ACTIVATION OF MAP KINASE#1.0031;ENDOMETRIOSIS#1.0031;TYROSINE KINASE 2#1.0030;PROTEIN KINASE B SIGNALING#1.0029;RENAL INTERSTITIAL FIBROSIS#1.0029;O CELL#1.0029;ZD1839#1.0028;CASPASE-9 ACTIVITY#1.0027;HESPERIDIN#1.0026;MIXED LINEAGE KINASE#1.0025;CAMP SIGNALING#1.0025;NEUROBLAST#1.0025;FORMOTEROL#1.0025;NUCLEAR IMPORT#1.0025;IL-8 PRODUCTION#1.0024;HIGH GLUCOSE LEVEL#1.0022;ENDOMETRIAL ADENOCARCINOMA#1.0019;CHONDROGENESIS#1.0018;CHOLESTEROL EFFLUX#1.0018;NUCLEUS PULPOSUS#1.0018;TANK BINDING KINASE#1.0018;ASPIRIN#1.0018;TUBEROUS SCLEROSIS 2#1.0016;NUTRIENT SENSING#1.0014;KERATINOCYTE DIFFERENTIATION#1.0012;PODOCYTE#1.0011;ACTIN CYTOSKELETON REMODELING#1.0010;NEURITE EXTENSION#1.0010;OESTRADIOL#1.0006;QUERCETIN#1.0005;WISKOTT ALDRICH SYNDROME#1.0005;MACROPINOCYTOSIS#1.0002;SULINDAC#1.0002;INHIBITION OF CELL MIGRATION#1.0001;PHAGOSOME#0.9998;MYOBLAST FUSION#0.9995;INSULIN GROWTH FACTOR#0.9995;DONEPEZIL#0.9994;CI-1033#0.9993;OLIGODENDROCYTE DIFFERENTIATION#0.9990;OCTREOTIDE#0.9988;FILOPODIA FORMATION#0.9988;RESPONSE TO RADIATION#0.9987;PI3K BINDING#0.9986;TELOMERASE ACTIVITY#0.9985;PKCBETA#0.9984;SALIVARY GLAND#0.9983;PICEATANNOL#0.9982;CELECOXIB#0.9980;5'-AMP#0.9980;NEURON APOPTOSIS#0.9979;MAPK SIGNALING#0.9978;PRAVASTATIN#0.9977;STRESS FIBRE#0.9975;FIBROBLAST APOPTOSIS#0.9975;MACROPHAGE PROLIFERATION#0.9975;STEROID RECEPTOR COACTIVATOR#0.9974;AMPA RECEPTOR#0.9974;ACUTE PANCREATITIS#0.9974;EPITHELIAL GROWTH FACTOR#0.9973;JUN KINASE#0.9972;TNF-ALPHA PRODUCTION#0.9970;RESVERATROL#0.9969;RAD001#0.9969;ORAL CANCER CELL#0.9969;ABT-263#0.9969;IL-11#0.9968;REGULATION OF PHOSPHORYLATION#0.9968;NEUTROPHIL CHEMOTAXIS#0.9967;HUMAN PULMONARY ARTERY#0.9966;RIBOSOMAL PROTEIN#0.9965;MAPK CASCADE#0.9963;INHIBITION OF GSK#0.9962;PROTEIN STABILIZATION#0.9962;EPHRIN#0.9962;RALOXIFENE#0.9962;MELANIN SYNTHESIS#0.9961;OLANZAPINE#0.9961;TROPOMYOSIN RELATED KINASE#0.9961;CAMP RESPONSE ELEMENT BINDING#0.9961;OSTEOBLAST PROLIFERATION#0.9961;EXTRINSIC APOPTOSIS#0.9959;VEMURAFENIB#0.9958;MTDNA#0.9958;INTRACELLULAR SIGNALING CASCADE#0.9956;PROTEIN KINASE#0.9955;ACINAR CELL#0.9953;PROGESTIN#0.9952;DASATINIB#0.9952;PROTEIN KINASE ACTIVATION#0.9951;COLLAGEN SYNTHESIS#0.9951;DEPHOSPHORYLATION#0.9950;NOTCH SIGNALING PATHWAY#0.9950;MAP KINASE KINASE#0.9948;CONTACT INHIBITION#0.9948;MACROPHAGE APOPTOSIS#0.9947;GLUCOSAMINE#0.9945;ERBB SIGNALING#0.9944;HUMAN DERMAL FIBROBLAST#0.9943;MEDIATED DRUG RESISTANCE#0.9943;GLUCOSE METABOLIC#0.9943;RECEPTOR TRANSACTIVATION#0.9942;SYNOVIAL SARCOMA#0.9941;ELLAGIC ACID#0.9940;CORNEAL EPITHELIAL CELL#0.9940;TROPOMYOSIN RECEPTOR KINASE#0.9940;REGORAFENIB#0.9940;5'-ADENOSINE MONOPHOSPHATE#0.9939;REGULATION OF SIGNALING#0.9939;PITUITARY ADENOMA#0.9938;GENISTEIN#0.9938;LEUCINE RICH REPEAT#0.9936;CAMP RESPONSE ELEMENT#0.9936;MINOCYCLINE#0.9936;MITOPHAGY#0.9936;WNT SIGNALING PATHWAY#0.9935;VEGF PRODUCTION#0.9935;TONGUE SQUAMOUS CELL CARCINOMA#0.9935;IKAPPAB KINASE#0.9934;STEM CELL PROLIFERATION#0.9934;PIOGLITAZONE#0.9933;FOLIC ACID#0.9932;HIBERNATION#0.9931;EPINEPHRINE#0.9931;TREG CELL#0.9929;PROPRANOLOL#0.9929;CELL DIVISION CYCLE#0.9929;PROTEIN KINASE G#0.9927;PROTEASE ACTIVITY#0.9926;LIPID BINDING#0.9926;PHOSPHOLIPASE A#0.9925;EPITHELIAL OVARIAN CARCINOMA#0.9925;ANOIKIS#0.9924;NEUTROPHIL APOPTOSIS#0.9923;T CELL DIFFERENTIATION#0.9923;NUCLEAR EXPORT#0.9922;SKELETAL MUSCLE HYPERTROPHY#0.9922;MEMBRANE RAFT#0.9920;MYOFIBROBLAST DIFFERENTIATION#0.9920;ZOLEDRONIC ACID#0.9920;DOPAMINE D2 RECEPTOR#0.9919;HSP90 BINDING#0.9917;CHORIOCARCINOMA#0.9917;LAPATINIB#0.9917;PHOSPHATASE AND TENSIN HOMOLOG#0.9917;PROTEIN PHOSPHATASE 1#0.9916;SPERMATOGONIAL STEM CELL#0.9915;EIF4E BINDING#0.9915;NF-KAPPAB ACTIVATION#0.9915;VITAMIN C#0.9914;ANISOMYCIN#0.9914;MYELOID CELL LEUKEMIA#0.9913;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.9913;APOPTOSIS SIGNALING#0.9912;CELL POLARIZATION#0.9911;INVASIVE GROWTH#0.9910;P21 ACTIVATED KINASE#0.9909;KINASE BINDING#0.9909;MESOTHELIOMA CELL#0.9908;INHIBITION OF APOPTOSIS#0.9907;APOPTOTIC SIGNALING PATHWAY#0.9906;LUNG EPITHELIAL CELL#0.9906;LIPID PHOSPHATASE#0.9906;NEURITE GROWTH#0.9906;CALCIUM SIGNALING#0.9906;TUBEROUS SCLEROSIS COMPLEX#0.9905;SORAFENIB#0.9905;ERYTHROBLAST#0.9904;TROPHOBLAST CELL#0.9903;CASEIN KINASE 2#0.9902;ENDOTHELIAL NITRIC OXIDE#0.9902;GROWTH CONE#0.9902;MOTHERS AGAINST DECAPENTAPLEGIC#0.9902;NUCLEOTIDE EXCHANGE FACTOR#0.9900;DOMINANT NEGATIVE MUTANT#0.9900;AXON REGENERATION#0.9900;HEAT SHOCK FACTOR#0.9899;GLYCOGEN SYNTHESIS#0.9899;DIAPHRAGM#0.9899;RESPIRATORY BURST#0.9898;MYELINATION#0.9898;CALPAIN ACTIVITY#0.9898;BUPIVACAINE#0.9897;RUFFLE#0.9896;HUMAN NUCLEUS PULPOSUS#0.9895;MAP KINASE#0.9895;MYOSIN LIGHT-CHAIN KINASE#0.9894;THYMOCYTE#0.9894;HYPERPHOSPHORYLATION#0.9894;MESANGIAL CELL#0.9894;TUBULOGENESIS#0.9892;GRB2 ASSOCIATED BINDER#0.9892;HUMAN AIRWAY EPITHELIAL#0.9892;ATAXIA TELANGIECTASIA MUTATED#0.9891;MUSCLE CELL DIFFERENTIATION#0.9891;FLUOXETINE#0.9891;CALCINEURIN#0.9890;FLUVOXAMINE#0.9890;NOS ACTIVITY#0.9890;MULTIPLE MYELOMA CELLS#0.9890;CORONARY ARTERY ENDOTHELIAL CELLS#0.9890;MEMBRANE RUFFLE#0.9889;GUANYLATE CYCLASE#0.9888;GALLBLADDER#0.9888;BLANK CONTROL GROUP#0.9887;BONE CANCER#0.9887;PHOSPHATASE INHIBITOR#0.9887;PKC ACTIVITY#0.9886;GALECTIN#0.9885;ISCHEMIC REPERFUSION INJURY#0.9885;METFORMIN#0.9884;PROTEIN KINASE CASCADE#0.9884;PULMONARY VASCULAR REMODELING#0.9884;URIC ACID#0.9884;ACTIVATION OF NF-KAPPAB#0.9884;NILOTINIB#0.9883;ACTIVATION OF APOPTOSIS#0.9883;TARGET OF RAPAMYCIN#0.9882;PROTEIN PHOSPHATASE 2A#0.9881;DENTAL PULP#0.9881;TARGET OF RAPAMYCIN COMPLEX#0.9880;RENAL CARCINOMA#0.9879;FLUID SHEAR STRESS#0.9879;DE NOVO LIPOGENESIS#0.9879;GEFITINIB#0.9879;ASTROCYTE ELEVATED GENE#0.9879;EPITHELIAL CELL APOPTOSIS#0.9877;PROTEIN UBIQUITINATION#0.9877;CALCIUM MOBILIZATION#0.9877;GDP DISSOCIATION INHIBITOR#0.9877;PHOTORECEPTOR CELL#0.9877;MICROTUBULE DYNAMICS#0.9877;PYRUVATE DEHYDROGENASE KINASE#0.9876;INVASIVE CARCINOMA#0.9876;INTRINSIC APOPTOSIS#0.9876;MULTI DRUG RESISTANCE#0.9876;PHOSPHATASE 2A#0.9875;HERPES SIMPLEX#0.9875;SIGNALLING CASCADE#0.9875;GLYCOGEN PHOSPHORYLASE#0.9875;MEDULLOBLASTOMA#0.9875;KAPOSI'S SARCOMA#0.9874;EARLY ENDOSOME#0.9874;RECEPTOR INTERNALIZATION#0.9873;LIPID BIOSYNTHESIS#0.9873;HYPERACTIVE#0.9873;TROPHOBLAST#0.9872;IKAPPAB PHOSPHORYLATION#0.9872;ACTIVATED B CELL#0.9872;HERPES SIMPLEX VIRUS#0.9871;FOCAL ADHESION KINASE#0.9871;SMOOTH MUSCLE CELL MIGRATION#0.9871;EUKARYOTIC ELONGATION FACTOR#0.9870;NOCODAZOLE#0.9870;REGULATION OF CELL PROLIFERATION#0.9870;RAPAMYCIN#0.9870;ERYTHROID CELL#0.9869;HALOPERIDOL#0.9869;ANAPLASTIC THYROID CARCINOMA#0.9869;INTEGRIN ACTIVATION#0.9869;CEREBRAL INFARCTION#0.9868;SIGNAL TRANSDUCER#0.9868;REGULATION OF CELL GROWTH#0.9868;SEVERE ACUTE PANCREATITIS#0.9867;HAIR FOLLICLE#0.9866;LIGASE ACTIVITY#0.9866;INTEGRIN LINKED KINASE#0.9866;IFN-GAMMA#0.9866;GENE COPY NUMBER#0.9865;IL-10 PRODUCTION#0.9865;TRANSLATION INITIATION FACTOR#0.9865;ESOPHAGEAL CARCINOMA#0.9865;MITOGEN ACTIVATED PROTEIN#0.9864;CYCLIC GUANOSINE MONOPHOSPHATE#0.9864;FIBROBLAST PROLIFERATION#0.9864;NEURON SURVIVAL#0.9864;FULVESTRANT#0.9864;MITOCHONDRION#0.9863;GTP HYDROLYSIS#0.9863;CHROMAFFIN CELL#0.9862;SUNITINIB#0.9862;CELL CYCLE CHECKPOINT#0.9861;KIDNEY CANCER#0.9861;REGULATION OF PROTEIN SYNTHESIS#0.9861;NITRIC OXIDE SYNTHASE ACTIVITY#0.9859;MEMBRANE MICRODOMAIN#0.9859;SIGNALLING PATHWAY#0.9859;PROXIMAL TUBULAR CELL#0.9859;INSULIN RECEPTOR SUBSTRATE#0.9858;FIBROBLAST ACTIVATION#0.9858;CARBACHOL#0.9858;CIGARETTE SMOKE EXTRACT#0.9858;MUSCLE CELL MIGRATION#0.9857;CYCLIC ADENOSINE MONOPHOSPHATE#0.9857;PROSTATE INTRAEPITHELIAL NEOPLASIA#0.9856;PIGMENT EPITHELIAL CELL#0.9856;CHANNEL ACTIVITY#0.9855;PPAR SIGNALING PATHWAY#0.9854;PALMITATE#0.9854;ACETYL COA CARBOXYLASE#0.9854;SIGNALING PATHWAY#0.9854;RETINAL PIGMENT EPITHELIAL CELLS#0.9853;AUTOPHAGY#0.9853;MELATONIN RECEPTOR#0.9853;NEURAL PROGENITOR CELL#0.9853;PRENYLATION#0.9853;GASTRIC ADENOCARCINOMA#0.9852;GENTAMICIN#0.9852;HERCEPTIN#0.9850;SMC PROLIFERATION#0.9850;CHOLANGIOCARCINOMA#0.9849;OXIDATIVE STRESS RESPONSE#0.9849;EXOSOME#0.9849;MURINE EMBRYONIC FIBROBLASTS#0.9849;RHOGEF#0.9848;INFLUENZA A VIRUS#0.9848;FRONTAL#0.9848;CHONDROCYTE#0.9847;DEATH-INDUCING SIGNALING COMPLEX#0.9846;PROTEOGLYCAN SYNTHESIS#0.9846;BLADDER CARCINOMA#0.9846;MACROPHAGE POLARIZATION#0.9846;MUSCLE HYPERTROPHY#0.9846;PHOSPHOTYROSINE BINDING#0.9845;PROXIMAL TUBULE CELL#0.9845;MOUSE EMBRYONIC STEM#0.9844;ADENOID CYSTIC CARCINOMA#0.9843;EPITHELIAL CELL PROLIFERATION#0.9843;GTPASE ACTIVITY#0.9843;NEURONAL MIGRATION#0.9843;RUTIN#0.9843;P2Y RECEPTOR#0.9842;TOPOISOMERASE II#0.9842;TAXOL#0.9841;CENTROSOME#0.9841;LIPID RAFT#0.9841;MYO-INOSITOL#0.9841;FOAM CELL FORMATION#0.9840;INTERLEUKIN 1 RECEPTOR#0.9840;FK506 BINDING#0.9839;MTOR COMPLEX#0.9839;SOLUBLE GUANYLYL CYCLASE#0.9839;TELOMERASE REVERSE TRANSCRIPTASE#0.9838;GUANINE#0.9838;FOCAL CEREBRAL ISCHEMIA#0.9838;TUBEROUS SCLEROSIS#0.9837;VEGF SIGNALING#0.9837;POTASSIUM CHANNEL#0.9837;ENGULFMENT OF APOPTOTIC CELL#0.9836;PROTEIN KINASE ACTIVITY#0.9836;EMBRYO DEVELOPMENT#0.9835;M1 MACROPHAGE#0.9835;CETUXIMAB#0.9835;OPIOID RECEPTOR#0.9834;ADENOSINE MONOPHOSPHATE#0.9834;ICI 182,780#0.9833;T CELL FACTOR#0.9833;VITAMIN E#0.9833;ENDOMETRIAL CANCER#0.9833;CELLULAR METABOLISM#0.9832;LYMPHOBLAST#0.9831;GRANULOSA CELL#0.9830;DOXYCYCLINE#0.9830;HEPATOCYTE PROLIFERATION#0.9829;GENETICALLY ENGINEERED MOUSE#0.9829;HEPATIC ISCHEMIA REPERFUSION#0.9829;ARSENIC TRIOXIDE#0.9828;RESPONSE TO INSULIN#0.9828;GLOBAL CEREBRAL ISCHEMIA#0.9827;KINASE INHIBITOR P27#0.9827;B CELL DEVELOPMENT#0.9827;REGULATION OF AUTOPHAGY#0.9827;T CELL DEVELOPMENT#0.9827;GUANOSINE#0.9825;CASPASE-INDEPENDENT CELL DEATH#0.9825;CYTOKINE RECEPTOR#0.9825;NUCLEAR LOCALIZATION SIGNAL#0.9825;FIBRINOGEN BINDING#0.9824;STEM CELL LIKE#0.9824;RESPONSE TO OXIDATIVE STRESS#0.9823;AMYGDALA#0.9822;PERICYTE#0.9822;BONE DEVELOPMENT#0.9821;AUTOPHAGIC CELL DEATH#0.9821;ACUTE MYELOID LEUKAEMIA#0.9821;ROSIGLITAZONE#0.9821;HISTONE ACETYLATION#0.9821;ENDOTHELIAL CELL MIGRATION#0.9821;NEONATAL RAT CARDIOMYOCYTES#0.9821;CONNEXIN#0.9820;OF DIABETIC RATS#0.9818;DUAL SPECIFICITY PHOSPHATASE#0.9818;REGULATION OF CELL CYCLE#0.9818;FOCAL ADHESION#0.9818;GROWTH OF CELL#0.9818;ESTROUS CYCLE#0.9818;PENTOSE PHOSPHATE PATHWAY#0.9818;GTP BINDING#0.9818;SCIATIC NERVE#0.9818;CDK INHIBITOR#0.9817;MEIOSIS#0.9817;MULTIDRUG RESISTANCE PROTEIN#0.9816;PHOSPHOLIPASE D#0.9816;DECIDUAL CELL#0.9816;MITOCHONDRIAL MEMBRANE DEPOLARIZATION#0.9816;CELL NUCLEUS#0.9816;MOUSE EMBRYO FIBROBLASTS#0.9816;CERVICAL CANCER#0.9816;TROGLITAZONE#0.9815;GAP JUNCTION#0.9815;CHOLESTEROL BIOSYNTHESIS#0.9815;RETINAL PIGMENT EPITHELIUM#0.9815;ANTI APOPTOSIS#0.9815;YES ASSOCIATED PROTEIN#0.9814;TRASTUZUMAB#0.9814;VEGF-AS#0.9814;GINKGO BILOBA#0.9813;ALDOSTERONE#0.9813;MEGAKARYOCYTE#0.9813;ACTIVATING TRANSCRIPTION FACTOR#0.9813;LOSARTAN#0.9812;NF-KAPPAB INHIBITOR#0.9812;INTERVERTEBRAL DISC#0.9812;SUCCINATE#0.9811;SERUM RESPONSE FACTOR#0.9810;SURAMIN#0.9810;ACETAMINOPHEN#0.9810;ANAPLASTIC THYROID CANCER#0.9810;PERIODONTAL LIGAMENT#0.9808;SPHINGOSINE KINASE 1#0.9808;LITHIUM#0.9808;CELL CHEMOTAXIS#0.9807;INSULIN RECEPTOR#0.9807;FIBROBLAST LIKE SYNOVIOCYTES#0.9807;PROTEIN PHOSPHATASE INHIBITOR#0.9807;LIPID SYNTHESIS#0.9807;PANCREATIC CARCINOMA#0.9806;GM-CSF#0.9806;LAMINAR SHEAR STRESS#0.9806;TH17 CELL#0.9806;AMELOBLASTOMA#0.9805;MATRIX METALLOPROTEINASE 1#0.9805;SIGNALOSOME#0.9805;MALIGNANT PLEURAL MESOTHELIOMA#0.9804;BORTEZOMIB#0.9804;INHIBITION OF GROWTH#0.9804;PRIMARY CORTICAL NEURON#0.9803;LOW DOSE RADIATION#0.9803;ACTIN BINDING PROTEIN#0.9803;PLACENTAL DEVELOPMENT#0.9803;REGULATION OF CELLULAR#0.9803;B CELL PROLIFERATION#0.9803;LUMINAL EPITHELIAL CELL#0.9803;CARDIOMYOCYTE PROLIFERATION#0.9803;LYMPHOMA CELL LINES#0.9803;SYNAPTIC TRANSMISSION#0.9803;RHABDOMYOSARCOMA#0.9802;MYOSIN PHOSPHATASE#0.9802;VSMC DIFFERENTIATION#0.9801;ERYTHROPOIETIN RECEPTOR#0.9801;CYTOKINESIS#0.9801;CELL CYCLE TRANSITION#0.9801;ROSUVASTATIN#0.9801;LUNG FIBROBLASTS#0.9801;PROXIMAL TUBULAR EPITHELIAL#0.9800;OSTEOBLAST DIFFERENTIATION#0.9800;MESOTHELIAL CELL#0.9800;EUKARYOTIC INITIATION FACTOR#0.9800;REGULATION OF GROWTH#0.9799;PLATELET ACTIVATION#0.9799;SCHWANN CELL#0.9798;ATAXIA TELANGIECTASIA#0.9798;FAT CELL#0.9798;GASTRIC EPITHELIAL CELLS#0.9798;WAVE COMPLEX#0.9798;SUBSTANCE P#0.9798;HEMORRHAGE#0.9798;PYRUVATE KINASE#0.9797;ERLOTINIB#0.9797;IL-6 PRODUCTION#0.9797;PHOSPHOLIPASE C#0.9796;OLEIC ACID#0.9796;HOMOLOGOUS RECOMBINATION#0.9796;ENDOMETRIAL CARCINOMA#0.9796;RESPONSE TO ISCHEMIA#0.9796;COLONIC EPITHELIAL CELLS#0.9796;VITAMIN D3#0.9796;NULL CELL#0.9795;THORACIC AORTA#0.9795;MEMBRANE FRACTION#0.9795;RENAL ISCHEMIA REPERFUSION#0.9795;MICROGLIAL CELL#0.9795;DOCKING PROTEIN#0.9795;INVASIVE BREAST CARCINOMA#0.9794;TYPE 1 DIABETIC#0.9794;PANCREATITIS#0.9794;PROTEIN BREAKDOWN#0.9793;CELL CYCLE PHASE#0.9793;ACTIVE CASPASE 3#0.9792;BRAIN ISCHEMIA#0.9791;LIPID KINASE#0.9791;OOCYTE#0.9790;CAVEOLAE#0.9790;BETA CELL#0.9789;HORMONE SENSITIVE LIPASE#0.9789;HISTONE ACETYLTRANSFERASE#0.9789;T-CELL LEUKEMIA#0.9789;M2 MACROPHAGE#0.9789;RIBOSOME BIOGENESIS#0.9789;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9789;RESPONSE TO NUTRIENT#0.9788;PAPILLARY THYROID CARCINOMA#0.9788;ACTIN BINDING#0.9787;BETA ADRENERGIC RECEPTOR#0.9787;ENDOTHELIAL CELL APOPTOSIS#0.9787;EOSINOPHIL#0.9787;ACTIVATOR PROTEIN 1#0.9786;GLCNAC#0.9786;MAMMARY EPITHELIUM#0.9786;VASCULAR ENDOTHELIAL CADHERIN#0.9786;ERYTHROID PROGENITOR#0.9785;IL-1RA#0.9785;OLIGODENDROCYTE#0.9784;TRAUMATIC BRAIN INJURY#0.9784;LOCALISATION#0.9784;ROS FORMATION#0.9784;CHOLINE#0.9784;EARLY TIME POINT#0.9783;CYTOCHROME C OXIDASE#0.9782;ACTOMYOSIN#0.9781;MIGRATION INHIBITORY FACTOR#0.9781;NECROTIZING#0.9781;BETA-2#0.9781;MITOCHONDRIAL FISSION#0.9781;TUBULAR EPITHELIAL CELL#0.9781;GLYCOGEN METABOLISM#0.9780;SILENT INFORMATION REGULATOR#0.9780;PROTOPORPHYRIN IX#0.9780;HYALURONAN#0.9780;TELOMERE#0.9779;HISTAMINE#0.9779;EXTRACELLULARLY REGULATED KINASE#0.9778;CANCER STEM-LIKE CELL#0.9778;GELDANAMYCIN#0.9778;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9778;PROTEIN TRANSLATION#0.9777;PKB SIGNAL TRANSDUCTION#0.9777;2-DEOXY-D-GLUCOSE#0.9777;NEGATIVE CONTROL GROUP#0.9777;AXON GUIDANCE#0.9777;NMDA RECEPTOR#0.9777;CHRONIC CEREBRAL HYPOPERFUSION#0.9776;CORPUS LUTEUM#0.9776;INTERFERON REGULATORY FACTOR#0.9776;L-CARNITINE#0.9776;RETINOIC ACID RECEPTOR#0.9776;ACUTE LEUKEMIA#0.9776;UBIQUITIN PROTEASOME PATHWAY#0.9776;DEDIFFERENTIATION#0.9775;TUMOR INITIATING CELL#0.9775;AIRWAY EPITHELIAL CELL#0.9775;BRAIN ENDOTHELIAL CELL#0.9774;NEURITE OUTGROWTH#0.9774;LYMPHANGIOGENESIS#0.9774;AMPK ACTIVITY#0.9774;OOCYTE MATURATION#0.9774;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.9774;SIGNALING CASCADE#0.9774;URINARY BLADDER#0.9773;RESONANCE ENERGY TRANSFER#0.9773;GLUCONEOGENESIS#0.9773;DOPAMINE RECEPTOR#0.9772;TESTOSTERONE#0.9772;COPY NUMBER GAIN#0.9772;IL-2 PRODUCTION#0.9772;SMALL MOLECULAR INHIBITOR#0.9771;RENAL FIBROSIS#0.9771;DERMAL FIBROBLAST#0.9771;GASTRIC MUCOSA#0.9771;RETINOL#0.9770;ASPARTIC ACID#0.9770;THYROID CANCER#0.9770;HISTONE METHYLTRANSFERASE#0.9770;MYOTUBE#0.9769;FOCAL CONTACT#0.9769;GEMCITABINE#0.9769;MAPK ACTIVATION#0.9768;REGULATION OF APOPTOSIS#0.9768;MOLECULAR DYNAMICS SIMULATION#0.9768;SODIUM CHANNEL#0.9767;GLUTAMATE CYSTEINE LIGASE#0.9767;SIGNAL TRANSMISSION#0.9767;ACTIN POLYMERIZATION#0.9767;MICROFILAMENT#0.9766;TRANSLATION INITIATION#0.9766;VALPROIC ACID#0.9766;PKG II#0.9766;MYOBLAST#0.9766;MAPK SIGNAL TRANSDUCTION#0.9764;EXOCYTOSIS#0.9764;ATP SYNTHASE#0.9763;GLYCERALDEHYDE-3-PHOSPHATE#0.9762;DNA METHYLTRANSFERASE#0.9762;VENTRICULAR CARDIOMYOCYTE#0.9762;PERTUSSIS#0.9762;MITOCHONDRIAL DEPOLARIZATION#0.9761;CEREBELLAR GRANULE NEURON#0.9761;VSMC PROLIFERATION#0.9761;LYMPHATIC ENDOTHELIAL CELL#0.9761;VINCRISTINE#0.9761;NEUTROPHIL ACTIVATION#0.9760;RITUXIMAB#0.9760;DUCT CELL#0.9759;APOPTOTIC PROCESS#0.9759;CARBOPLATIN#0.9759;KUPFFER CELL#0.9759;DIABETIC KIDNEY DISEASE#0.9759;TAMOXIFEN#0.9759;PROTEIN KINASE A#0.9758;DIACYLGLYCEROL KINASE#0.9758;AMD3100#0.9758;ETHANOL#0.9758;RESPONSE TO HYPOXIA#0.9757;FORSKOLIN#0.9756;NADPH OXIDASE#0.9756;RESPONSE TO LPS#0.9756;ADENINE DINUCLEOTIDE PHOSPHATE#0.9756;PROTEIN KINASE C#0.9756;ADRIAMYCIN#0.9755;FK506 BINDING PROTEIN#0.9755;ER STRESS RESPONSE#0.9755;GLUCOSE TRANSPORT#0.9755;REACTIVE OXYGEN SPECIES GENERATION#0.9755;NEURITE#0.9755;SOFT TISSUE SARCOMA#0.9755;NEPHROTOXICITY#0.9754;CELLULAR LOCALIZATION#0.9754;EARLY GROWTH RESPONSE#0.9754;NEURON DEATH#0.9754;GROWTH ARREST SPECIFIC#0.9753;MAMMARY GLAND DEVELOPMENT#0.9753;CELL EXPANSION#0.9753;OXIDATIVE BURST#0.9753;CLEAR CELL RENAL CELL CARCINOMA#0.9753;CELL PERIPHERY#0.9753;OSTEOCLAST DIFFERENTIATION#0.9752;EGFR SIGNALING PATHWAY#0.9752;PERMEABILITY TRANSITION PORE#0.9752;RIBOSOME#0.9752;BINDING PROTEIN 1#0.9751;ASTROCYTOMA#0.9751;MESENCHYMAL EPITHELIAL TRANSITION#0.9751;BETA-ESTRADIOL#0.9751;CANCER ASSOCIATED FIBROBLASTS#0.9750;IMATINIB MESYLATE#0.9750;FRUCTOSE#0.9750;ATP BINDING CASSETTE TRANSPORTER#0.9750;NORMAL CONTROL GROUP#0.9750;C TERMINAL DOMAIN#0.9750;CYTOSKELETON ORGANIZATION#0.9749;CELL CYCLE REGULATOR#0.9749;NEUROLOGICAL DEFICIT SCORE#0.9748;NUCLEAR TRANSPORT#0.9748;HYPERACTIVITY#0.9748;17β-ESTRADIOL#0.9748;PAPILLOMA#0.9748;MUSCLE PROTEIN SYNTHESIS#0.9748;AIRWAY SMOOTH MUSCLE#0.9747;PROTEASOME PATHWAY#0.9747;IL-6 SECRETION#0.9747;CLEAVED CASPASE 3#0.9747;SIGNALING MOLECULE#0.9746;OXALIPLATIN#0.9746;ADENYLATE#0.9746;THALIDOMIDE#0.9746;BONE MARROW STEM CELL#0.9745;CELLULAR MEMBRANE#0.9745;DENDRITIC SPINE#0.9745;PALMITIC ACID#0.9744;DEHYDROEPIANDROSTERONE#0.9744;PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING#0.9744;GLUTAMINE#0.9744;SPECIFICITY PROTEIN 1#0.9743;NF KAPPAB BINDING#0.9743;CELL CELL JUNCTION#0.9743;RESPONSE TO TNF#0.9742;IMATINIB#0.9742;OSTEOBLAST#0.9742;ACTIVATED CASPASE 3#0.9742;MEMBRANE DEPOLARIZATION#0.9742;ESOPHAGEAL CANCER#0.9742;HUMAN INTESTINAL EPITHELIAL#0.9741;AORTIC ANEURYSM#0.9741;LIVER REGENERATION#0.9741;SYNAPTOGENESIS#0.9741;INTRINSIC APOPTOTIC PATHWAY#0.9740;INNER EAR#0.9740;LENALIDOMIDE#0.9739;MITOCHONDRIAL RESPIRATORY CHAIN#0.9739;INSULIN SIGNALING PATHWAY#0.9738;ANABOLISM#0.9738;MYOGENESIS#0.9738;FATTY ACID METABOLISM#0.9738;ADIPOGENESIS#0.9738;SRC FAMILY KINASE#0.9738;CERVICAL#0.9738;NITRIC OXIDE SYNTHASE#0.9738;BURKITT LYMPHOMA#0.9738;INVASIVE DUCTAL CARCINOMA#0.9738;PODOSOME#0.9738;PKC ACTIVATION#0.9738;INTRACELLULAR SIGNAL TRANSDUCTION PATHWAY#0.9738;RETINAL PIGMENT EPITHELIAL#0.9737;PHOSPHOLIPASE A2#0.9737;STEROL REGULATORY ELEMENT#0.9737;TRANSFORMING GROWTH FACTOR ALPHA#0.9737;HUMAN EMBRYONIC KIDNEY#0.9736;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.9736;ETOPOSIDE#0.9736;BRONCHIAL EPITHELIAL CELLS#0.9736;MARROW STEM CELLS#0.9736;PHAGOCYTOSIS#0.9735;INHIBITION OF CELL GROWTH#0.9734;26S PROTEASOME#0.9734;CELL MOVEMENT#0.9734;GLYCOLYSIS#0.9734;NITRIC OXIDE SYNTHESIS#0.9734;COLLAGEN TYPE I#0.9734;REGULATION OF GLUCOSE TRANSPORT#0.9733;RESPIRATORY CHAIN#0.9733;GLAND DEVELOPMENT#0.9733;GLUCOSE UPTAKE#0.9733;ISOPROTERENOL#0.9732;PANCREATIC CANCER#0.9732;NEUROPROTECTION#0.9732;INSULINOMA#0.9732;INDOLE#0.9732;TRANSACTIVATION#0.9732;PROSTATE CARCINOMA#0.9732;GLUCOSE REGULATED PROTEIN#0.9732;B CELL RECEPTOR#0.9732;ARTERIOLE#0.9732;ACTIVATION OF SIGNAL TRANSDUCTION#0.9731;LIVER METASTASIS#0.9731;ADENYLATE CYCLASE#0.9731;RETINAL ENDOTHELIAL CELLS#0.9730;FLUDARABINE#0.9730;TEMSIROLIMUS#0.9730;ALVEOLAR MACROPHAGE#0.9730;ACTIN NUCLEATION#0.9730;MISMATCH REPAIR#0.9729;CARDIOMYOCYTE GROWTH#0.9729;SEQUESTERING#0.9729;CD8+ T CELL#0.9728;OSTEOCYTE#0.9728;ADVANCED PROSTATE CANCER#0.9727;B CELL LYMPHOMA#0.9727;NIFEDIPINE#0.9727;SODIUM NITROPRUSSIDE#0.9727;BRAIN DAMAGE#0.9727;CARDIAC STEM CELLS#0.9727;CELLULAR GROWTH#0.9726;MANTLE CELL LYMPHOMA#0.9726;BLEOMYCIN#0.9726;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9726;TIGHT JUNCTION PROTEIN#0.9726;EMBRYONIC KIDNEY#0.9725;CYCLIC AMP#0.9725;PROTEIN COMPLEX#0.9725;BETA GALACTOSIDASE#0.9724;ACTIVATED T CELL#0.9724;CISPLATIN#0.9723;ADIPOCYTE DIFFERENTIATION#0.9723;PRIMARY BREAST CANCER#0.9723;KERATINOCYTE#0.9723;DNA DAMAGE RESPONSE#0.9723;SPINAL CORD#0.9723;CEREBRAL CORTEX#0.9723;ACTIN BUNDLING#0.9722;OSTEOCLAST#0.9722;LEUKEMIA INHIBITORY FACTOR#0.9722;ALVEOLAR EPITHELIAL CELL#0.9722;HUMAN BRONCHIAL EPITHELIAL#0.9722;KINASE ACTIVITY#0.9722;ACTIVATED T-CELLS#0.9721;UMBILICAL CORD BLOOD#0.9721;QUIESCENCE#0.9721;MAST CELL#0.9721;INTERSTITIAL CELL#0.9721;UROKINASE PLASMINOGEN ACTIVATOR#0.9721;NECROPTOSIS#0.9720;ATPASE ACTIVITY#0.9720;CEREBRAL ISCHEMIA#0.9720;BETA CELL MASS#0.9720;VITAMIN A#0.9720;ARYL HYDROCARBON RECEPTOR#0.9719;GERM CELL#0.9719;AUTOPHAGIC VACUOLE#0.9719;IBUPROFEN#0.9718;FIBROSARCOMA CELLS#0.9718;INDUCES CANCER#0.9718;PHOSPHOENOLPYRUVATE#0.9718;LIPID HOMEOSTASIS#0.9718;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9718;MACROPHAGE ACTIVATION#0.9718;ASCORBIC ACID#0.9718;NEUROTRANSMISSION#0.9717;MOUSE EMBRYONIC FIBROBLAST#0.9717;QUADRICEPS#0.9717;DIFFUSE LARGE B-CELL LYMPHOMA#0.9717;LYMPHOID CELL#0.9716;MUSCLE CONTRACTION#0.9716;SKIN FIBROBLASTS#0.9716;ABC TRANSPORTER#0.9716;THYROID HORMONE RECEPTOR#0.9716;TNF PRODUCTION#0.9715;HEPATOCELLULAR CARCINOMA CELL#0.9715;G2 PHASE#0.9715;RECEPTOR ACTIVITY#0.9715;OVARIAN CANCER#0.9715;FOLLICLE STIMULATING HORMONE#0.9715;MINERALIZATION#0.9715;SIROLIMUS#0.9715;EVEROLIMUS#0.9714;PULMONARY ARTERY#0.9714;MYOCYTE ENHANCER FACTOR#0.9714;HETEROTRIMERIC G-PROTEIN#0.9714;COPY NUMBER ALTERATION#0.9713;T CELL APOPTOSIS#0.9713;CELLULAR METABOLIC#0.9713;INTESTINAL MUCOSA#0.9713;SARCOPLASMIC RETICULUM#0.9713;STROMAL DERIVED FACTOR#0.9712;HUMAN EMBRYONIC STEM#0.9712;COCHLEA#0.9711;SPINAL CORD INJURY#0.9711;EWING SARCOMA#0.9711;CHRONIC HEART FAILURE#0.9711;TOPOISOMERASE#0.9711;GLIBENCLAMIDE#0.9711;TRANSDIFFERENTIATION#0.9711;HAIR GROWTH#0.9711;VIRAL REPLICATION#0.9710;CELL CELL ADHESION#0.9710;MITOCHONDRIAL PERMEABILITY TRANSITION#0.9710;ADHERENS JUNCTION#0.9710;SCAVENGER RECEPTOR#0.9710;VITAMIN D RECEPTOR#0.9709;AORTIC VALVE#0.9709;CAMPTOTHECIN#0.9709;HEMATOPOIETIC PROGENITOR CELL#0.9708;MITOMYCIN C#0.9708;SENESCENCE#0.9708;PHENOTYPIC SWITCHING#0.9708;EXTRACELLULAR VESICLE#0.9707;ESTROGEN RECEPTOR ALPHA#0.9707;RETINOBLASTOMA#0.9707;MICROPHTHALMIA#0.9707;PROTEIN PHOSPHATASE ACTIVITY#0.9707;FETAL LIVER#0.9706;CELL COMMUNICATION#0.9706;HUMAN PANCREATIC CANCER#0.9706;HEPATOTOXICITY#0.9706;OXIDATIVE PHOSPHORYLATION#0.9706;OSTEOGENESIS#0.9705;BONE REGENERATION#0.9705;ENDOSOME#0.9705;OVARIES#0.9705;CELL MATURATION#0.9705;INHIBITION OF CELL PROLIFERATION#0.9705;ADIPOSE-DERIVED STEM CELL#0.9704;STAUROSPORINE#0.9703;RAT BONE MARROW#0.9703;HEME OXYGENASE 1#0.9703;MITOCHONDRIAL DAMAGE#0.9702;MITOCHONDRIAL LOCALIZATION#0.9702;STEM CELL DIFFERENTIATION#0.9702;PROTEASOME DEGRADATION#0.9702;MRNA TRANSCRIPTION#0.9701;FIBRINOGEN#0.9701;NEURAL CREST#0.9701;NITROPRUSSIDE#0.9701;AQUAPORIN#0.9701;ACUTE LUNG INJURY#0.9700;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9700;INTESTINAL EPITHELIAL CELL#0.9699;SKELETAL MUSCLE ATROPHY#0.9699;GLUCOSE-6-PHOSPHATE#0.9699;CYTOTOXIN#0.9699;MACROPHAGE MIGRATION#0.9699;SPATIAL LEARNING#0.9698;GTPASE BINDING#0.9698;INHIBITION OF ANGIOGENESIS#0.9698;APOPTOTIC PROGRAM#0.9697;URETERAL OBSTRUCTION#0.9697;PREADIPOCYTE#0.9697;PDZ BINDING MOTIF#0.9697;CALCIUM CHANNEL#0.9697;DILATED CARDIOMYOPATHY#0.9697;UBIQUITIN PROTEASOME SYSTEM#0.9697;SPERMATOZOA#0.9697;MAXIMUM TOLERATED DOSE#0.9696;MACROAUTOPHAGY#0.9696;BEVACIZUMAB#0.9696;COLON ADENOCARCINOMA#0.9695;PACLITAXEL#0.9695;GLUCOSE 6 PHOSPHATASE#0.9695;IRINOTECAN#0.9695;ENTEROCYTE#0.9695;BRAIN EDEMA#0.9695;MALIGNANT MESOTHELIOMA#0.9695;2-DEOXYGLUCOSE#0.9695;AGEING#0.9694;ORAL CAVITY#0.9694;GLUCOCORTICOID RECEPTOR#0.9694;BASAL CELL#0.9694;REGULATION OF CELL MIGRATION#0.9694;CARDIOMYOCYTE#0.9693;PHENYLEPHRINE#0.9693;SKELETAL MUSCLE MASS#0.9693;INTERVERTEBRAL DISC DEGENERATION#0.9693;PROTEIN KINASE INHIBITOR#0.9693;ANTIOXIDANT RESPONSE ELEMENT#0.9693;DOPAMINE#0.9693;CELLULAR SENESCENCE#0.9693;ANCHORING#0.9693;METASTATIC PROSTATE CANCER#0.9693;CYSTIC FIBROSIS#0.9692;NON-SMALL CELL LUNG CARCINOMA#0.9692;HYPOXIA#0.9692;THYROID CARCINOMA#0.9692;INTERNAL TANDEM DUPLICATION#0.9691;ENDOMETRIUM#0.9691;DNA REPLICATION#0.9691;ENDOTHELIAL CELL PROLIFERATION#0.9691;TUBERCULOSIS#0.9691;LOCOMOTION#0.9691;PHOSPHATASE ACTIVITY#0.9690;NEUROENDOCRINE TUMOR#0.9689;ANDROGEN RECEPTOR#0.9689;CELL DEVELOPMENT#0.9688;CELL CYCLE CONTROL#0.9688;ORAL SQUAMOUS CELL CARCINOMA#0.9688;T CELL PROLIFERATION#0.9688;CARDIAC MUSCLE#0.9688;OUTER MEMBRANE#0.9688;PROTEASE ACTIVATED RECEPTOR#0.9687;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.9687;OXYGEN GLUCOSE DEPRIVATION#0.9687;RECEPTOR INTERACTING PROTEIN#0.9686;HEPATITIS B#0.9686;BREAST ADENOCARCINOMA#0.9686;ACTIN CYTOSKELETON#0.9686;DENTATE GYRUS#0.9685;GLYCINE#0.9685;SMOOTH MUSCLE CELL PROLIFERATION#0.9685;IONOPHORE#0.9685;ESTRADIOL#0.9684;EPILEPSY#0.9684;STEROIDOGENESIS#0.9684;TERMINAL DIFFERENTIATION#0.9684;RESPONSE TO STRESS#0.9684;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9684;PROSTATE EPITHELIAL CELL#0.9684;GENOTOXIC#0.9684;PSORIASIS#0.9683;TRANSCRIPTIONAL CONTROL#0.9683;DIMETHYL SULFOXIDE#0.9683;HEMATOPOIETIC CELL#0.9682;PRAZOSIN#0.9682;STEM CELL FACTOR#0.9682;STRIATUM#0.9682;PROSTATE CANCER#0.9682;INTRACELLULAR LOCALIZATION#0.9682;PSEUDOPOD#0.9682;RELATED PROTEIN 1#0.9682;LIPOGENESIS#0.9682;BINDING PROTEIN 3#0.9681;DEXAMETHASONE#0.9681;AGGRESSIVE BEHAVIOR#0.9680;BIPOLAR DISORDER#0.9680;PROSTATE SPECIFIC ANTIGEN#0.9680;INDUCED RENAL INJURY#0.9680;VASODILATION#0.9680;NICOTINIC ACETYLCHOLINE RECEPTOR#0.9680;HUNTINGTON'S DISEASE#0.9679;NORMAL PROSTATE EPITHELIAL#0.9679;C CHEMOKINE RECEPTOR#0.9679;PROTEIN BINDING#0.9679;ENDOTHELIAL PROGENITOR CELL#0.9679;CELL JUNCTION#0.9678;ENDOPLASMIC RETICULUM STRESS#0.9678;EFFECTOR T CELL#0.9678;PERTUZUMAB#0.9678;MOLECULAR TARGETED THERAPY#0.9678;DORMANCY#0.9677;FATTY ACID SYNTHESIS#0.9677;HEARING LOSS#0.9677;ALL TRANS RETINOIC ACID#0.9677;PROTEIN METABOLISM#0.9677;NOTCH RECEPTOR#0.9676;LEUCINE#0.9676;MYELIN SHEATH#0.9676;TEMOZOLOMIDE#0.9676;B CELL#0.9675;EPIGALLOCATECHIN#0.9675;CELL POLARITY#0.9675;MUSCLE CELL PROLIFERATION#0.9675;HYPOXIC#0.9674;FILAMENTOUS ACTIN#0.9674;MELANOCYTE#0.9674;CASPASE ACTIVITY#0.9674;REGULATION OF ANGIOGENESIS#0.9674;CHLORIDE CHANNEL#0.9674;DELTA OPIOID RECEPTOR#0.9673;CLEAR CELL CARCINOMA#0.9673;PROTEIN DEGRADATION#0.9673;HIGH FAT FEEDING#0.9673;LIPOPROTEIN LIPASE#0.9672;VEGFR2 SIGNALING PATHWAY#0.9672;PAPILLARY THYROID CANCER#0.9672;LACTATION#0.9671;ACETYLCYSTEINE#0.9671;ANTI HER2#0.9670;HISTONE MODIFICATION#0.9670;CHANNEL INHIBITOR#0.9670;BONE MARROW MICROENVIRONMENT#0.9670;VASODILATATION#0.9670;N-ACETYLCYSTEINE#0.9669;MUSCLE FIBER#0.9669;DEMETHYLATION#0.9669;CYCLOPHOSPHAMIDE#0.9668;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9668;HUMAN IMMUNODEFICIENCY VIRUS#0.9668;ARE BINDING#0.9668;ADIPOCYTE#0.9668;LUCIFERASE ACTIVITY#0.9668;FARNESYL#0.9668;BIOLOGICAL PROCESS#0.9667;PYRUVATE#0.9667;FATTY ACID SYNTHASE#0.9667;TIGHT JUNCTION#0.9667;FIBROSARCOMA#0.9667;APOPTOSIS INDUCING FACTOR#0.9667;DOCETAXEL#0.9667;EXTRACELLULAR MATRIX ORGANIZATION#0.9667;OVARIAN FOLLICLE#0.9666;LIPOLYSIS#0.9666;PROSTATE ADENOCARCINOMA#0.9666;THYMIDYLATE SYNTHASE#0.9666;ACTIN FILAMENT#0.9666;ATP BINDING CASSETTE#0.9666;NEUTROPHIL MIGRATION#0.9665;FOCAL ADHESION FORMATION#0.9665;VON HIPPEL LINDAU#0.9665;HEPATITIS B VIRUS#0.9665;HEPATOBLASTOMA#0.9665;DEATH RECEPTOR 5#0.9665;MACROPHAGE INFLAMMATORY PROTEIN#0.9665;PHOSPHODIESTERASE#0.9665;PALMITOYL#0.9665;MUSCLE ATROPHY#0.9665;FOLATE#0.9664;AUTOPHAGOSOME FORMATION#0.9663;NEUTROPHIL#0.9663;TH2 CELL#0.9663;FOREBRAIN#0.9663;STRESS FIBER#0.9663;NEURONAL CELL DEATH#0.9663;EPITHELIAL MESENCHYMAL TRANSITION#0.9663;SELECTIN#0.9662;LONG TERM POTENTIATION#0.9662;CHEMOTAXIS#0.9661;INGENUITY PATHWAY ANALYSIS#0.9661;LINES OF EVIDENCE#0.9661;REGULATION OF CELL MOTILITY#0.9660;PROTEIN SYNTHESIS#0.9660;CELL MOTILITY#0.9660;EMBRYO IMPLANTATION#0.9660;DORSAL ROOT GANGLION#0.9660;OVARIAN CARCINOMA#0.9660;NOS INHIBITOR#0.9659;OVARIAN#0.9659;OXYGENASE#0.9659;CELL CYCLE REGULATION#0.9659;EMBRYONIC STEM CELL#0.9659;ASTROCYTE#0.9659;UTERUS#0.9659;ORAL MUCOSA#0.9659;ANAPLASTIC LARGE CELL LYMPHOMA#0.9659;CASPASE ACTIVATION#0.9659;HYPOXIA INDUCIBLE FACTOR#0.9658;SQUAMOUS CELL CANCER#0.9658;HUMAN MAMMARY EPITHELIAL#0.9658;IL-8 SECRETION#0.9658;GREEN TEA POLYPHENOL#0.9657;DOUBLE STRAND BREAK#0.9657;DEATH RECEPTOR#0.9657;SOMATOSTATIN RECEPTOR#0.9657;GLYCOSYLATION#0.9657;NITRIC OXIDE#0.9657;EPITHELIAL OVARIAN CANCER#0.9657;MITOCHONDRIAL DNA#0.9657;CYCLIN DEPENDENT KINASE INHIBITOR#0.9657;SURFACE PLASMON RESONANCE#0.9656;T CELL ACTIVATION#0.9656;MYELODYSPLASTIC SYNDROME#0.9656;GOBLET CELL#0.9656;ACETYLCHOLINE RECEPTOR#0.9656;ZONULA OCCLUDENS#0.9656;RNA BINDING PROTEIN#0.9655;COLON CANCER#0.9655;ASCITES#0.9655;ELECTRON TRANSPORT#0.9655;INDOMETHACIN#0.9655;EUGLYCEMIC HYPERINSULINEMIC CLAMP#0.9655;PANCREATIC ISLET#0.9654;SUBEROYLANILIDE HYDROXAMIC ACID#0.9654;CARDIAC PROGENITOR CELL#0.9654;GRANULOCYTE COLONY STIMULATING FACTOR#0.9654;COLLAGEN INDUCED ARTHRITIS#0.9653;TRANSVERSE AORTIC CONSTRICTION#0.9653;ENZYME ACTIVITY#0.9652;ADRENERGIC RECEPTOR#0.9652;RENAL CELL CARCINOMA#0.9652;BONE MARROW STROMAL CELL#0.9652;RECEPTOR COMPLEX#0.9651;APOPTOSIS#0.9651;MAMMARY GLAND#0.9651;ADENOSINE#0.9651;DOXORUBICIN#0.9650;COLORECTAL CARCINOMA#0.9650;COLON CARCINOMA#0.9650;MYOCYTES#0.9650;HUMAN MESENCHYMAL STEM#0.9650;ERYTHROPOIESIS#0.9650;STEM CELL MARKER#0.9649;ALKALINE PHOSPHATASE ACTIVITY#0.9649;IRESSA#0.9649;SENSITIZATION#0.9649;ISCHEMIA REPERFUSION INJURY#0.9649;HODGKIN'S LYMPHOMA#0.9649;CELL KILLING#0.9649;MYOCARDIAL INFARCT SIZE#0.9649;NICOTINAMIDE#0.9649;INVASIVE BREAST CANCER#0.9649;PLATELET AGGREGATION#0.9648;DOPAMINERGIC NEURON#0.9648;REGULATORY T CELL#0.9648;UMBILICAL CORD#0.9648;CHOLESTEROL SYNTHESIS#0.9648;HUMAN CORNEAL EPITHELIAL#0.9648;MYOCARDITIS#0.9648;NEURAL CELL#0.9648;CREB BINDING#0.9648;NEUROGENESIS#0.9647;ULCERATIVE COLITIS#0.9647;MONOCYTE CHEMOTACTIC PROTEIN#0.9647;NEPHRITIS#0.9647;PULMONARY HYPERTENSION#0.9647;BREAST CANCER MODEL#0.9647;L-CYSTEINE#0.9646;HEMORRHAGIC#0.9646;NEURAL STEM CELL#0.9646;IGF BINDING#0.9645;PROGESTERONE#0.9645;MARROW STROMAL CELLS#0.9645;CATABOLISM#0.9645;HEPATOMA CELLS#0.9644;JEJUNUM#0.9644;CARBOHYDRATE METABOLISM#0.9644;LYMPH NODE METASTASES#0.9644;DIPHOSPHATE#0.9644;GERMINAL CENTER#0.9644;NEUROTOXICITY#0.9644;CYCLOSPORIN A#0.9644;AORTIC SMOOTH MUSCLE CELLS#0.9643;NEUROPATHY#0.9643;ANTI EGFR#0.9643;POSTTRANSLATIONAL MODIFICATION#0.9643;HUMAN PERIODONTAL LIGAMENT#0.9643;CELL MATRIX ADHESION#0.9643;MYOFIBROBLAST#0.9642;BREAST CANCER CELL#0.9642;T CELL#0.9642;LIPOSARCOMA#0.9642;ROS GENERATION#0.9642;CYTOKINE SECRETION#0.9641;TUMOR ASSOCIATED MACROPHAGE#0.9641;PYRAMIDAL CELL#0.9641;KINESIN#0.9641;BONE CELLS#0.9641;DIABETIC NEPHROPATHY#0.9641;TUMOR GROWTH INHIBITION#0.9640;CD4+ T CELL#0.9640;MAST CELL ACTIVATION#0.9640;LUPUS ERYTHEMATOSUS#0.9640;MYOCARDIUM#0.9640;ANTI-INFLAMMATORY RESPONSE#0.9640;BREAST CARCINOMA#0.9639;LIVER CANCER#0.9639;GLUTAMATE RECEPTOR#0.9639;CARRIE#0.9639;ENDOCYTOSIS#0.9639;VESICLE TRAFFICKING#0.9638;GESTATIONAL DIABETES#0.9638;ADVANCED GLYCATION END#0.9638;DNA REPAIR#0.9638;CARNITINE#0.9638;MEMORY IMPAIRMENT#0.9638;SPHINGOSINE#0.9638;NEUROFILAMENT#0.9638;CHINESE HERBAL MEDICINE#0.9638;EPSTEIN BARR VIRUS#0.9637;GOLGI APPARATUS#0.9637;LUPUS NEPHRITIS#0.9637;PHOSPHATE BUFFERED SALINE#0.9637;NEUROTROPHIN RECEPTOR#0.9636;HYALURONIC ACID#0.9636;HYPERGLYCEMIC#0.9636;ATP BINDING#0.9636;PULMONARY FIBROSIS#0.9636;GENE SILENCING#0.9636;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9636;NEUROBLASTOMA#0.9636;TISSUE GROWTH FACTOR#0.9635;RECURRENCE FREE SURVIVAL#0.9635;MUSCULAR DYSTROPHY#0.9635;POLYCYSTIC OVARY SYNDROME#0.9635;BRAIN WATER CONTENT#0.9635;PROTEIN PHOSPHORYLATION#0.9635;GASTROINTESTINAL STROMAL TUMOR#0.9634;CLATHRIN-MEDIATED ENDOCYTOSIS#0.9634;METASTATIC MELANOMA#0.9633;METHYL THIAZOLYL TETRAZOLIUM#0.9633;SILDENAFIL#0.9633;PHEOCHROMOCYTOMA#0.9633;VASODILATOR#0.9632;LIVER DAMAGE#0.9631;BAFILOMYCIN A1#0.9631;OPTIC NERVE#0.9631;NUCLEOTIDE BINDING#0.9629;HUMAN PROSTATE EPITHELIAL#0.9629;REGULATION OF GENE EXPRESSION#0.9629;LIGHT CHAIN 3#0.9629;ACIDIFICATION#0.9629;BRAIN DEVELOPMENT#0.9629;PROTEIN MODIFICATION#0.9629;PERIPHERAL NERVE INJURY#0.9628;CIRCADIAN RHYTHM#0.9628;PANCREATIC ADENOCARCINOMA#0.9628;BONE MARROW STROMAL#0.9628;NEURAL STEM PROGENITOR#0.9628;NEURONAL CELLS#0.9627;VASOCONSTRICTION#0.9627;CANNABINOID RECEPTOR#0.9627;TO THE PROGRESSION#0.9627;NECK CANCER#0.9627;COGNITION#0.9627;CAROTENOID#0.9627;HEPATIC STELLATE CELL#0.9626;AMYLOID PRECURSOR PROTEIN#0.9626;PHOSPHATIDYLSERINE#0.9626;CYTARABINE#0.9626;DIGESTION#0.9626;CELLULAR PROCESS#0.9625;MILK PROTEIN#0.9625;MAST CELL DEGRANULATION#0.9625;PROSTACYCLIN#0.9625;MOLECULAR FUNCTION#0.9625;BRAIN CANCER#0.9625;ONCOGENESIS#0.9625;CELL DIVISION#0.9625;BREAST CANCER#0.9625;NONALCOHOLIC FATTY LIVER DISEASE#0.9624;COLORECTAL ADENOCARCINOMA#0.9624;PRIMARY EFFUSION LYMPHOMA#0.9624;JUXTAMEMBRANE#0.9624;CAM BINDING#0.9624;OSTEOSARCOMA CELL LINES#0.9623;RESPONSE TO TREATMENT#0.9623;RISPERIDONE#0.9623;MELANOMA CELL LINES#0.9623;CYTOTOXIC T-LYMPHOCYTE#0.9623;METASTATIC MELANOMA CELLS#0.9623;MENTAL RETARDATION#0.9623;PROTEOGLYCAN#0.9622;INTRACELLULAR SIGNAL TRANSDUCTION#0.9622;HIGH MOBILITY GROUP#0.9622;SATURATED FATTY ACID#0.9621;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.9621;ANAPLASTIC LYMPHOMA KINASE#0.9621;IMPAIRED GLUCOSE TOLERANCE#0.9620;METASTATIC BREAST CANCER#0.9620;LONG TERM DEPRESSION#0.9620;IFN-BETA#0.9620;PULMONARY ARTERIAL HYPERTENSION#0.9619;RETINOIC ACID#0.9619;HEAD AND NECK CANCER#0.9619;LEUKOCYTE ADHESION#0.9619;FATTY ACID BINDING#0.9619;LIPID DROPLET#0.9618;GANGLION CELLS#0.9618;MESENCHYMAL CELL#0.9618;AGMATINE#0.9618;NORMAL HUMAN ASTROCYTES#0.9618;BILIVERDIN REDUCTASE#0.9618;DETOXIFICATION#0.9617;PROTEIN TYROSINE KINASE#0.9617;VASCULOGENESIS#0.9616;MIDBRAIN#0.9616;GRANULOSA CELL APOPTOSIS#0.9616;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9616;PITAVASTATIN#0.9616;PARATHYROID HORMONE#0.9616;EICOSAPENTAENOIC ACID#0.9615;RECEPTOR BINDING#0.9615;CYTOCHROME C RELEASE#0.9615;MEMORY T CELL#0.9615;CORTISOL#0.9615;NUCLEAR RESPIRATORY FACTOR#0.9614;ADENOSINE TRIPHOSPHATE#0.9614;EPITHELIAL TO MESENCHYMAL#0.9614;ADULT T-CELL LEUKEMIA#0.9614;GLUTAMIC ACID#0.9614;ORNITHINE DECARBOXYLASE#0.9614;STIMULATION OF CELL PROLIFERATION#0.9613;UROKINASE#0.9613;72-HOURS#0.9613;INTEGRIN BINDING#0.9613;LYSINE#0.9613;FALSE DISCOVERY RATE#0.9612;ADENO ASSOCIATED VIRUS#0.9612;CERAMIDE SYNTHESIS#0.9612;RESPONSE TO GLUCOSE#0.9612;MULTIPLE MYELOMA#0.9611;FOLLICULAR THYROID CANCER#0.9611;ANESTHETIC#0.9611;BRAIN NATRIURETIC PEPTIDE#0.9611;ION CHANNEL#0.9611;POSTSYNAPTIC DENSITY#0.9610;TONGUE CANCER#0.9610;TOPICAL#0.9610;LIVER CIRRHOSIS#0.9610;KERATINOCYTE MIGRATION#0.9610;CELLULAR COMPONENT#0.9610;RETINAL GANGLION CELL#0.9609;MITOSIS#0.9609;LUNG ADENOCARCINOMA#0.9609;HEMATOPOIESIS#0.9609;PORTAL VEIN#0.9609;TO TUMOR PROGRESSION#0.9608;SPHINGOSINE 1 PHOSPHATE#0.9608;CHRONIC MYELOID LEUKEMIA#0.9606;TOLL LIKE RECEPTOR#0.9606;L-LYSINE#0.9606;CYCLIN DEPENDENT KINASE#0.9606;HEPATITIS C VIRUS#0.9606;VASCULAR ENDOTHELIUM#0.9606;BROWN ADIPOSE TISSUE#0.9605;SPERMATOGENESIS#0.9605;CHROMATIN REMODELING#0.9605;NUCLEIC ACID#0.9605;COMPLEX I#0.9605;MICROTUBULE ASSOCIATED PROTEIN#0.9605;RNA BINDING#0.9604;HEAT SHOCK PROTEIN#0.9604;UNFOLDED PROTEIN RESPONSE#0.9604;STEM CELL TRANSPLANTATION#0.9604;MYELOPROLIFERATIVE NEOPLASM#0.9604;TRANSCRIPTION FACTOR ACTIVITY#0.9604;SKELETAL MUSCLE CELLS#0.9603;TIME TO PROGRESSION#0.9603;MACROPHAGE#0.9602;MESENCHYMAL STROMAL CELL#0.9602;CORD BLOOD#0.9602;CATALYTIC ACTIVITY#0.9602;COLITIS#0.9601;HEPATOCYTE GROWTH FACTOR#0.9601;NEUROTOXIN#0.9601;NERVE GROWTH FACTOR#0.9601;HEPARIN BINDING#0.9601;SKIN DISEASE#0.9600;PROTEINURIA#0.9600;REGULATION OF METABOLISM#0.9600;CASPASE-3 ACTIVITY#0.9599;NON HODGKIN LYMPHOMA#0.9599;CYCLOSPORINE#0.9599;ENZYME INHIBITOR#0.9599;PORTAL HYPERTENSION#0.9599;ANCHORAGE INDEPENDENT GROWTH#0.9599;UBIQUITIN#0.9599;THROMBIN RECEPTOR#0.9599;ARRHYTHMIA#0.9599;CELL PHYSIOLOGY#0.9598;HISTONE DEACETYLASE INHIBITOR#0.9598;MYOSIN HEAVY CHAIN#0.9597;DNA SYNTHESIS#0.9597;LUNG CARCINOMA#0.9597;NEPHROPATHY#0.9597;CARDIAC ARREST#0.9596;INSULIN-LIKE GROWTH FACTOR#0.9596;DNA BINDING#0.9596;NEUROTOXIC#0.9595;SKELETAL MUSCLE#0.9595;MICROTUBULE#0.9595;PLASMA MEMBRANE#0.9595;ANGIOTENSIN CONVERTING ENZYME#0.9594;SENSITIZER#0.9594;VIRAL INFECTION#0.9594;PHOSPHOCHOLINE#0.9593;OSSIFICATION#0.9593;LIMB ISCHEMIA#0.9592;UNILATERAL URETERAL OBSTRUCTION#0.9592;LIPID METABOLIC#0.9592;PROTEASOME#0.9592;HEPATITIS C#0.9591;TYPE 2 DIABETIC#0.9591;TUMOR GROWTH DELAY#0.9591;TETRACYCLINE#0.9591;WHITE ADIPOSE TISSUE#0.9591;MAMMARY EPITHELIAL CELL#0.9590;CRYSTAL VIOLET#0.9590;COPY NUMBER VARIATION#0.9590;TACHYKININ#0.9590;CATION CHANNEL#0.9590;GROWTH FACTOR BINDING#0.9590;TRANSIENT RECEPTOR POTENTIAL#0.9590;IDIOPATHIC PULMONARY FIBROSIS#0.9590;LUMINAL#0.9589;TYROSINE KINASE RECEPTOR#0.9589;CACHEXIA#0.9588;GINSENG#0.9588;INSULIN TOLERANCE TEST#0.9587;INDUCTION OF APOPTOSIS#0.9586;SUBSTANTIA NIGRA#0.9586;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.9586;HYPERSENSITIVITY#0.9586;SMALL INTESTINE#0.9586;MICROVASCULAR ENDOTHELIAL CELL#0.9586;METHIONINE#0.9585;MORPHOGENESIS#0.9585;ARACHIDONIC ACID#0.9585;PLATELET-DERIVED GROWTH FACTOR#0.9585;ADENINE#0.9584;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9584;B CELL ACTIVATION#0.9584;INTERMEDIATE FILAMENT#0.9584;PROTEIN INTERACTION NETWORK#0.9583;BONE MORPHOGENETIC PROTEIN#0.9582;AMYOTROPHIC LATERAL SCLEROSIS#0.9582;ONCOGENIC#0.9582;ION TRANSPORT#0.9582;TISSUE REGENERATION#0.9582;ACTINOMYCIN D#0.9582;IMMUNE SUPPRESSION#0.9582;LATERAL SCLEROSIS#0.9582;BIOTIN#0.9582;INTRACELLULAR SIGNALING PATHWAY#0.9581;CANCER CELL#0.9581;PROTEIN SECRETION#0.9581;FACTOR I#0.9581;ENHANCER BINDING PROTEIN#0.9581;RESPIRATION#0.9581;PI3K SIGNALING#0.9580;APOPTOTIC#0.9580;PERIPHERAL NERVE#0.9580;ANTI INFLAMMATORY DRUGS#0.9580;CELL WALL#0.9580;FOCAL CORTICAL DYSPLASIA#0.9580;CORONARY ARTERY LIGATION#0.9580;METABOLIC PROCESS#0.9580;MUTAGENESIS#0.9579;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9579;VISCERAL ADIPOSE TISSUE#0.9579;DAUNORUBICIN#0.9578;TRANSFORMING GROWTH FACTOR BETA#0.9578;MUSCLE WASTING#0.9578;OVAL CELL#0.9578;HINDLIMB#0.9577;L-DOPA#0.9577;VASCULAR ENDOTHELIAL CELL#0.9577;RELAPSE FREE SURVIVAL#0.9577;AMILORIDE#0.9576;CYTOPLASM#0.9576;ADAPTIVE IMMUNE RESPONSE#0.9575;SKELETAL MUSCLE WASTING#0.9575;NECROTIC#0.9575;INDUCIBLE NITRIC OXIDE#0.9575;PLASMA CELL#0.9575;PRECURSOR CELL#0.9574;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9574;NATURAL KILLER CELL#0.9573;TOR COMPLEX#0.9573;ENHANCER BINDING#0.9573;INSULIN SECRETION#0.9573;ISCHEMIA#0.9573;ORNITHINE#0.9573;PEPTIDOGLYCAN#0.9573;STANDARD OF CARE#0.9573;LUNG CANCER#0.9573;BONE MARROW CELLS#0.9572;VASCULAR DEMENTIA#0.9572;TRANSMEMBRANE RECEPTOR#0.9572;CELLULAR HOMEOSTASIS#0.9572;CATALASE ACTIVITY#0.9572;RETINOID X RECEPTOR#0.9572;MYOGENIC REGULATORY FACTOR#0.9571;CORTICAL CELL#0.9570;CELL MEMBRANE#0.9570;LDL RECEPTOR#0.9570;ACUTE PROMYELOCYTIC LEUKEMIA#0.9570;SWELLING#0.9569;PARENCHYMA#0.9569;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9569;VASCULAR SMOOTH MUSCLE CELL#0.9569;PRIMORDIAL GERM CELL#0.9568;ENDOTHELIAL CELL#0.9568;MALIGNANT GLIOMA#0.9567;CROSS SECTIONAL AREA#0.9567;LECTIN#0.9567;PLURIPOTENT STEM CELL#0.9567;NOREPINEPHRINE#0.9567;BILE DUCT#0.9566;PLATELET ACTIVATING FACTOR#0.9566;TROPHECTODERM#0.9566;COMPARATIVE GENOMIC HYBRIDIZATION#0.9566;TYROSINE KINASE INHIBITION#0.9566;TRACHEA#0.9566;ENDOPLASMIC RETICULUM#0.9565;B LYMPHOCYTE#0.9565;MAGNETIC RESONANCE IMAGING#0.9565;BUDDING#0.9564;FLAVOPIRIDOL#0.9564;HYPERINSULINEMIC EUGLYCEMIC CLAMP#0.9564;TISSUE REMODELING#0.9564;CYCLOSPORIN#0.9563;INDUCED PLURIPOTENT STEM CELL#0.9563;CELL DIFFERENTIATION#0.9563;TH1 CELL#0.9563;GASTRULATION#0.9563;PHOSPHOLIPID BINDING#0.9563;TYROSINE KINASE DOMAIN#0.9563;LACTIC ACID#0.9562;BIOLUMINESCENCE#0.9562;NITRO-L-ARGININE#0.9562;QUANTITATIVE REVERSE TRANSCRIPTION#0.9562;DERMAL PAPILLA CELL#0.9562;REPORTER GENE ASSAY#0.9562;MESENCHYMAL STEM CELL#0.9562;CELL MIGRATION#0.9562;SKELETON#0.9562;ETHANE#0.9561;BONE DISEASE#0.9561;DIET INDUCED OBESITY#0.9561;MITOTIC SPINDLE#0.9560;SMOOTH MUSCLE CELL#0.9560;ERYTHROCYTE#0.9560;ACUTE KIDNEY INJURY#0.9560;COLORECTAL CANCER#0.9559;VACCINIA#0.9559;HUMAN DENTAL PULP#0.9559;FORMALIN#0.9558;APOPTOTIC CELL DEATH#0.9557;ANTIGEN PRESENTING CELLS#0.9557;DNA METHYLATION#0.9557;CARCINOMA IN SITU#0.9557;CONSTRICTION#0.9557;NITRIC-OXIDE SYNTHASE INHIBITOR#0.9557;PROGRAMMED CELL DEATH#0.9556;ALANINE#0.9556;BILE DUCT LIGATION#0.9556;L-ARGININE#0.9556;POLY ADP RIBOSE#0.9556;AGE RELATED MACULAR DEGENERATION#0.9556;TYROSINASE ACTIVITY#0.9555;HISTIDINE#0.9555;TRANSFERRIN RECEPTOR#0.9554;HEPARIN#0.9554;LYMPHOCYTIC LEUKEMIA#0.9554;GLIAL CELL#0.9554;EPIDIDYMAL ADIPOSE TISSUE#0.9553;CYTOCHROME P450#0.9553;HEPATOCELLULAR CARCINOMA#0.9553;NEURAL PRECURSOR CELL#0.9553;EPITHELIAL CELL MIGRATION#0.9553;GLUCOSE METABOLISM#0.9553;CYTOCHROME C#0.9553;ADJACENT NORMAL TISSUE#0.9553;ORGAN OF CORTI#0.9553;SIGNAL TRANSDUCTION#0.9552;COLONY-STIMULATING FACTOR#0.9552;ESTROGEN RECEPTOR#0.9551;MYELOID CELL#0.9551;CELL PROLIFERATION#0.9551;ANGIOGENESIS#0.9550;T LYMPHOCYTE#0.9550;REGULATION OF AMPK#0.9550;C REACTIVE PROTEIN#0.9550;HUMAN BREAST CANCER#0.9550;RIBOSE#0.9550;RNA INTERFERENCE#0.9549;CREATINE#0.9549;COLORECTAL#0.9549;VASOPRESSIN#0.9549;DIHYDROTESTOSTERONE#0.9549;OSTEOARTHRITIS#0.9549;2'-DEOXYURIDINE#0.9548;NECROTIC CELL DEATH#0.9548;TUBE FORMATION#0.9548;EXTRACELLULAR MATRIX COMPONENT#0.9548;MODE OF ACTION#0.9548;BONE RESORPTION#0.9547;TRANSCRIPTASE#0.9547;PROTEIN TYROSINE PHOSPHATASE#0.9547;SUCROSE#0.9547;LYSOSOME#0.9546;ANTISENSE RNA#0.9546;TRANSCRIPTION FACTOR#0.9546;HUMAN EPIDERMAL KERATINOCYTES#0.9546;HYPOGLYCEMIA#0.9546;MACULAR DEGENERATION#0.9546;FATTY ACID OXIDATION#0.9545;ADVANCED BREAST CANCER#0.9545;DEXTRAN SULFATE SODIUM#0.9544;GASTRIC TISSUE#0.9544;MICROVESICLE#0.9544;RECEPTOR LIGAND#0.9544;ACETYLCHOLINE#0.9544;PLACENTAL GROWTH FACTOR#0.9543;CARDIOMYOPATHY#0.9543;GRANULOSA CELL TUMOR#0.9543;METHOTREXATE#0.9543;INNATE IMMUNE SYSTEM#0.9541;ACUTE MYELOID LEUKEMIA#0.9541;OVERALL SURVIVAL RATE#0.9541;METASTATIC COLORECTAL CANCER#0.9540;HISTONE DEACETYLASE#0.9540;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9540;LYMPHATIC VESSEL#0.9539;MITOCHONDRIA#0.9539;TUMOR SUPPRESSOR#0.9539;MALIGNANT BRAIN TUMOR#0.9539;UBIQUITIN SPECIFIC PROTEASE#0.9539;DIABETIC RETINOPATHY#0.9539;DOSE LIMITING TOXICITIES#0.9538;ENDOTHELIAL GROWTH FACTOR#0.9538;DIFFERENTIAL GENE EXPRESSION#0.9537;POST-TRANSLATIONAL MODIFICATION#0.9537;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9536;RECEPTOR AGONIST#0.9536;DIAZOXIDE#0.9536;MESENCHYME#0.9536;GRANULOCYTE#0.9536;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9535;VALSARTAN#0.9535;LIPID METABOLISM#0.9535;PARACRINE SIGNALING#0.9535;COAGULATION#0.9535;MEMBRANE TYPE 1#0.9534;CANCER STEM CELL#0.9534;AUTOIMMUNITY#0.9534;ESSENTIAL AMINO ACID#0.9534;MUSCLE CELL#0.9533;INFLAMMATORY CELL INFILTRATION#0.9533;PROGENITOR CELL#0.9533;TRYPTOPHAN#0.9533;SQUAMOUS CELL CARCINOMA#0.9533;STRUCTURE ACTIVITY RELATIONSHIP#0.9533;ARGININE#0.9532;EPIDERMAL GROWTH FACTOR#0.9532;CELL GROWTH#0.9531;BODY WEIGHT GAIN#0.9531;MONOCYTE#0.9531;VACUOLE#0.9531;CYTOKINE PRODUCTION#0.9531;HOST CELL#0.9530;CELL ACTIVATION#0.9530;FAT PAD#0.9530;ALCOHOLIC FATTY LIVER#0.9530;GLUCOSE INTOLERANCE#0.9530;PHAGOCYTIC CUP#0.9530;CORONARY HEART DISEASE#0.9530;CONJUGATION#0.9529;STIMULATION OF APOPTOSIS#0.9529;SYSTOLIC BLOOD PRESSURE#0.9529;GROWTH HORMONE#0.9529;BASEMENT MEMBRANE#0.9529;ESTROGENS#0.9528;GROWTH FACTOR RECEPTOR#0.9528;NEUROFIBRILLARY TANGLE#0.9528;POSITRON EMISSION TOMOGRAPHY#0.9527;HYPERGLYCEMIA#0.9527;AEROBIC EXERCISE TRAINING#0.9527;MYELOID LEUKEMIA#0.9526;SMOOTH MUSCLE ACTIN#0.9526;MATRIX METALLOPROTEINASE 13#0.9526;EPITHELIAL CELL#0.9526;SMOOTH MUSCLE#0.9525;TISSUE HOMEOSTASIS#0.9525;BONE REMODELING#0.9525;CREATINE KINASE#0.9524;CHONDROCYTE DIFFERENTIATION#0.9524;OXYGEN INDUCED RETINOPATHY#0.9524;OBESE#0.9524;PERIPHERAL NERVOUS SYSTEM#0.9523;HEMATOPOIETIC STEM CELL#0.9523;ENDOTHELIUM#0.9523;YEAR SURVIVAL RATE#0.9523;GROWTH DIFFERENTIATION FACTOR#0.9523;RECEPTOR ANTAGONIST#0.9523;RECEPTOR ACTIVATOR#0.9523;LEWIS LUNG CARCINOMA#0.9523;PROSTAGLANDIN E2#0.9522;INTEGRIN LIGAND#0.9522;REGULATION OF GLUCOSE UPTAKE#0.9522;BLOOD BRAIN BARRIER#0.9522;GROWTH FACTOR#0.9522;CELL CYCLE#0.9521;DRUG RESISTANCE#0.9521;CELL DEATH#0.9521;TUMOUR NECROSIS FACTOR#0.9521;PEROXISOME#0.9520;CELL ADHESION#0.9519;SERUM ALBUMIN#0.9519;RHEUMATOID ARTHRITIS#0.9519;ANTHRACENE#0.9519;MONOCYTIC LEUKEMIA#0.9518;KINASE INHIBITOR#0.9518;SPERM MOTILITY#0.9517;RED BLOOD CELL#0.9517;GLIOBLASTOMA MULTIFORME#0.9517;ALLERGIC AIRWAY INFLAMMATION#0.9517;VIRULENCE#0.9517;COENZYME A#0.9516;FIBROBLAST GROWTH FACTOR#0.9516;MYOPATHY#0.9515;BLOOD UREA NITROGEN#0.9515;MONONUCLEAR CELLS#0.9515;INNATE IMMUNITY#0.9515;COMMON CAROTID ARTERY#0.9514;CHLOROQUINE#0.9514;EXCRETION#0.9513;2-METHOXYESTRADIOL#0.9513;ATRIAL FIBRILLATION#0.9513;IMMUNE EVASION#0.9513;BODY WEIGHT RATIO#0.9512;PARATHYROID#0.9512;VASCULAR CELL#0.9512;HORMONE SECRETION#0.9511;FIBROCYTE#0.9511;LIVER X RECEPTOR#0.9511;PANCREATIC DUCTAL ADENOCARCINOMA#0.9511;CELL CYCLE ARREST#0.9510;5 FLUOROURACIL#0.9510;CHEMOKINE RECEPTOR#0.9510;S PHASE#0.9510;FLUORESCEIN#0.9510;ELECTRON TRANSPORT CHAIN#0.9509;TRANSFORMING GROWTH FACTOR#0.9509;STROMA#0.9509;SKIN CANCER#0.9509;DENDRITIC CELL#0.9509;CELL ADHESION MOLECULE#0.9508;OXIDATIVE METABOLISM#0.9507;ANTIOXIDANT ACTIVITY#0.9507;MICROTUBULE CYTOSKELETON#0.9506;GESTATION#0.9506;INFLAMMATORY RESPONSE#0.9505;HEPATOCYTE NUCLEAR FACTOR#0.9505;SUPEROXIDE DISMUTASE#0.9504;CANONICAL WNT SIGNALING PATHWAY#0.9504;ACUTE MYOCARDIAL INFARCTION#0.9504;ANDROGEN DEPRIVATION THERAPY#0.9504;GLUTATHIONE#0.9502;ADIPOSE TISSUE#0.9502;STEM CELL#0.9501;STROMAL CELL#0.9501;ACUTE LIVER INJURY#0.9501;TISSUE DAMAGE#0.9501;TACROLIMUS#0.9500;TYPE 1 DIABETES#0.9500;3-METHYLADENINE#0.9500;RECEPTOR TYROSINE KINASE#0.9499;CARCINOGEN#0.9499;ACID PHOSPHATASE#0.9499;GLUTATHIONE PEROXIDASE#0.9499;INNATE IMMUNE RESPONSE#0.9499;HYPERCHOLESTEROLEMIA#0.9499;GLUCOSE HOMEOSTASIS#0.9498;CILIARY NEUROTROPHIC FACTOR#0.9498;BONE FORMATION#0.9498;LATE ENDOSOME#0.9497;FLUOROURACIL#0.9497;CHRONIC LIVER DISEASE#0.9497;ORAL GLUCOSE TOLERANCE#0.9496;FASTING BLOOD GLUCOSE#0.9495;TUMOR TISSUES#0.9495;GALLBLADDER CARCINOMA#0.9495;ASPARTATE#0.9495;FATTY LIVER DISEASE#0.9495;LUNG METASTASIS#0.9495;ESOPHAGUS#0.9495;DEMENTIA#0.9494;PROTEIN FOLDING#0.9493;URIDINE#0.9493;THYMIDINE#0.9493;BREAST CANCER PATIENTS#0.9493;CONNECTIVE TISSUE#0.9492;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9492;CASPASE INHIBITOR#0.9491;SYSTEM DEVELOPMENT#0.9491;ERBB SIGNALING PATHWAY#0.9490;MITOMYCIN#0.9490;GASTRITIS#0.9490;ISCHEMIC HEART DISEASE#0.9489;AUTOPHAGOSOME#0.9489;THROMBOSIS#0.9488;ENERGY HOMEOSTASIS#0.9488;RU486#0.9488;PEPTIDE HORMONE#0.9487;DUAL LUCIFERASE REPORTER#0.9487;REGENERATION#0.9486;FERTILIZATION#0.9485;HIGH DENSITY LIPOPROTEIN#0.9485;ADENOCARCINOMA#0.9485;FATTY LIVER#0.9484;G1 PHASE#0.9483;CHRONIC KIDNEY DISEASE#0.9483;M PHASE#0.9483;LEUKOCYTE#0.9482;HUMAN UMBILICAL VEIN#0.9482;SCHWANN CELL PROLIFERATION#0.9482;SUPEROXIDE DISMUTASE ACTIVITY#0.9481;GM6001#0.9481;INSULIN BINDING#0.9479;PROLIFERATIVE VITREORETINOPATHY#0.9479;UMBILICAL VEIN#0.9479;TUMOR CELLS#0.9478;CONJUGATED LINOLEIC ACID#0.9478;CHOLESTASIS#0.9478;ATHEROSCLEROTIC#0.9477;MYELOPEROXIDASE ACTIVITY#0.9476;FLOW CYTOMETRY ASSAY#0.9476;INFLAMMATORY BOWEL DISEASE#0.9475;INFERTILITY#0.9475;LUNG DISEASE#0.9475;MONOCYTE DERIVED MACROPHAGE#0.9475;NEUROLOGICAL DISORDER#0.9474;CATENIN COMPLEX#0.9474;CARDIAC TROPONIN I#0.9474;PROTEIN KINASE D#0.9473;PRO-INFLAMMATORY#0.9473;BONE MINERAL DENSITY#0.9472;STATUS EPILEPTICUS#0.9472;CAROTID ARTERY#0.9472;KIDNEY DISEASE#0.9471;EDEMA#0.9471;WEIGHT GAIN#0.9471;ELECTROPHORETIC MOBILITY SHIFT#0.9471;TEMPORAL LOBE#0.9471;INFLAMMATORY CELL#0.9470;INHIBITION OF GLYCOLYSIS#0.9470;CEREBRAL ARTERY OCCLUSION#0.9470;ANEMIA#0.9469;WEIGHT LOSS#0.9468;CORONARY ARTERY DISEASE#0.9468;BICALUTAMIDE#0.9468;OSTEOPOROSIS#0.9468;GENETIC DISORDER#0.9466;PREMATURE OVARIAN FAILURE#0.9465;CYTOTOXICITY#0.9464;PUBERTY#0.9464;NICLOSAMIDE#0.9464;EVERY OTHER DAY#0.9464;PARKINSON'S DISEASE#0.9463;ALKALINE PHOSPHATASE#0.9462;MULTIPLE SCLEROSIS#0.9462;REACTIVE OXYGEN SPECIES#0.9462;PROTEIN PROTEIN INTERACTION#0.9461;MITOCHONDRIA MEMBRANE POTENTIAL#0.9461;POLYCYSTIC KIDNEY DISEASE#0.9461;CARDIOVASCULAR SYSTEM#0.9460;COLONY-FORMING CELL#0.9459;MITOCHONDRIAL OUTER MEMBRANE#0.9457;UBIQUITIN PROTEIN LIGASE#0.9457;ENCEPHALOMYELITIS#0.9456;MIDDLE CEREBRAL ARTERY#0.9456;DOUBLE-STRAND BREAK REPAIR#0.9456;ZONULA OCCLUDENS 1#0.9456;GENE EXPRESSION OMNIBUS#0.9455;LEFT ANTERIOR DESCENDING#0.9455;TIBIA#0.9454;METAPHASE#0.9454;HYPOXIA INDUCED FACTOR#0.9454;SIGNALING PROCESS#0.9454;TRADITIONAL CHINESE MEDICINAL#0.9454;SYNOVIUM#0.9454;RITONAVIR#0.9453;XANTHINE#0.9452;CEREBRAL ARTERY#0.9452;DISEASE FREE SURVIVAL#0.9452;LYMPH NODE METASTASIS#0.9452;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.9452;PATTERN RECOGNITION RECEPTOR#0.9451;CELL SURFACE#0.9451;ARTERY DISEASE#0.9451;COLLAGENASE#0.9451;DNA FRAGMENTATION#0.9450;DIARRHEA#0.9450;BLOOD GLUCOSE LEVEL#0.9450;GENE EXPRESSION#0.9450;REVERSE TRANSCRIPTION#0.9449;LEFT VENTRICULAR REMODELING#0.9449;ACUTE LIVER FAILURE#0.9449;PROTEIN KINASE C ACTIVATION#0.9449;LOW DENSITY LIPOPROTEIN#0.9447;PERIPHERAL BLOOD#0.9447;CEREBROVASCULAR DISEASE#0.9447;ZINC FINGER PROTEIN#0.9446;AUTOIMMUNE DISEASE#0.9446;BLOOD VESSEL#0.9446;INTERCELLULAR JUNCTION#0.9444;GLUCOSE TOLERANCE TEST#0.9444;OLFACTORY BULB#0.9443;ESTROGEN RESPONSE ELEMENT#0.9442;L-TYPE CALCIUM CHANNEL#0.9442;VASCULAR DISEASE#0.9442;DENTAL PULP CELL#0.9442;MORRIS WATER MAZE#0.9441;FLOW CYTOMETRY ANALYSIS#0.9441;GASTROINTESTINAL TRACT#0.9441;FOLLICULAR LYMPHOMA#0.9440;CROHN'S DISEASE#0.9438;NORADRENALINE#0.9438;RETINAL DEGENERATION#0.9438;MITOGENIC ACTIVITY#0.9437;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9437;LYMPHOID ORGANS#0.9437;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9436;PERIODONTITIS#0.9436;PNEUMONIA#0.9436;TUMOR NECROSIS FACTOR#0.9436;ACTIVATION-INDUCED CELL DEATH#0.9435;RESPONSE TO IONIZING RADIATION#0.9434;MITOCHONDRIAL MEMBRANE#0.9433;FOLLICULAR THYROID CARCINOMA#0.9431;IMMUNOSUPPRESSANT#0.9430;POLYMERASE CHAIN REACTION#0.9430;ADULT RAT CARDIOMYOCYTES#0.9430;DISEASE SPECIFIC SURVIVAL#0.9430;QUANTITATIVE REAL TIME#0.9430;JNK SIGNALLING PATHWAY#0.9429;N-NITRO-L-ARGININE#0.9429;ORGANELLE#0.9428;EOSIN#0.9427;LOW FAT DIET#0.9427;LIVER DISEASE#0.9425;MYOCARDIAL INFARCTION#0.9424;ALLERGIC ASTHMA#0.9423;MEDIAN OVERALL SURVIVAL#0.9423;LATE PREGNANCY#0.9422;MITOTIC CATASTROPHE#0.9421;LYSIS#0.9421;STREPTOZOTOCIN#0.9420;RESPIRATORY DISTRESS#0.9418;PROPIDIUM#0.9418;STEAROYL COA DESATURASE#0.9417;TCA CYCLE#0.9417;BONE MARROW#0.9417;EXTRACELLULAR MATRIX#0.9416;TYROSINE KINASE INHIBITOR#0.9416;MAP KINASE CASCADE#0.9416;FLUTAMIDE#0.9415;TOPOTECAN#0.9415;MAP KINASE ACTIVITY#0.9414;TYPE 2 DIABETES MELLITUS#0.9413;REACTIVE OXYGEN SPECIES FORMATION#0.9413;2 DIABETES MELLITUS#0.9412;CHOLESTEATOMA#0.9412;HIGH FAT DIET#0.9412;TOXICITY#0.9411;TRANSMISSION ELECTRON MICROSCOPY#0.9411;EXTRINSIC APOPTOTIC PATHWAY#0.9411;REPRODUCTIVE SYSTEM#0.9410;HYPERTENSION#0.9409;TLR4 SIGNALING PATHWAY#0.9407;TRANSMISSION ELECTRON MICROSCOPE#0.9407;ATHEROSCLEROSIS#0.9406;XANTHINE OXIDASE#0.9406;IMMUNE SYSTEM#0.9406;FACTOR S#0.9406;CANDESARTAN#0.9405;DNA REPAIR PROTEIN#0.9405;MALARIA#0.9405;IMMUNE CELL#0.9404;RNA SYNTHESIS#0.9404;L-LEUCINE#0.9403;ARACHIDONIC ACID METABOLISM#0.9402;COLONY FORMATION ASSAY#0.9402;SODIUM PUMP#0.9401;HUMAN CORD BLOOD#0.9399;GONADOTROPIN RELEASING HORMONE#0.9398;BRANCHING MORPHOGENESIS#0.9397;CERVICAL CANCER CELL LINES#0.9397;MECHANISMS OF ACTION#0.9397;LONG TERM MEMORY#0.9397;TUMOR NODE METASTASIS#0.9397;MECHANISM OF ACTION#0.9397;LYMPH NODE#0.9396;TRADITIONAL CHINESE MEDICINE#0.9394;ENDOMETRIAL EPITHELIAL CELLS#0.9393;HEART DISEASE#0.9393;METASTASIS FREE SURVIVAL#0.9392;ALZHEIMER'S DISEASE#0.9391;IKK COMPLEX#0.9391;PERIODONTAL DISEASE#0.9391;DIPEPTIDYL PEPTIDASE#0.9390;INTELLECTUAL DISABILITY#0.9389;IMMUNE RESPONSE#0.9389;CELL BODY#0.9388;PROSTATE EPITHELIUM#0.9388;LYMPHOCYTE MIGRATION#0.9386;CANCER RELATED DEATH#0.9386;CORONARY ARTERY#0.9386;LYMPHOID TISSUE#0.9385;SALVIANOLIC ACID B#0.9385;G0 PHASE#0.9384;MINOXIDIL#0.9382;PROTEINASE ACTIVATED RECEPTOR#0.9380;METHYLATION SPECIFIC PCR#0.9380;CELL FATE DETERMINATION#0.9380;ADIPONECTIN SECRETION#0.9378;WOUND HEALING#0.9378;CELLULAR OXIDATIVE STRESS#0.9376;TRANSFERASE INHIBITOR#0.9375;CERVIX#0.9374;MUSCLE SATELLITE CELL#0.9373;ARTERY#0.9373;AMINO ACID UPTAKE#0.9371;AXONAL TRANSPORT#0.9371;SF1126#0.9370;CELL ASSOCIATED#0.9370;EPIRUBICIN#0.9370;LETROZOLE#0.9369;NEURODEGENERATIVE DISEASE#0.9368;PHOSPHATASE I#0.9368;ACUTE CORONARY SYNDROME#0.9367;GROWTH HORMONE SECRETAGOGUE#0.9367;TAUROURSODEOXYCHOLIC ACID#0.9366;ARA-C#0.9365;DIABETES MELLITUS#0.9365;HER2 SIGNALING PATHWAY#0.9364;ACTIVIN RECEPTOR#0.9363;PERIPHERAL BLOOD LYMPHOCYTES#0.9363;MOLAR#0.9362;HAMARTOMA#0.9359;MITOCHONDRIAL FUSION#0.9358;T CELL MIGRATION#0.9358;MANNITOL#0.9358;AUTISM SPECTRUM DISORDER#0.9354;CELL COUNTING KIT#0.9354;ENDOCRINE CELL#0.9354;ANAPHYLAXIS#0.9353;TYPE 2 DIABETES#0.9353;X CHROMOSOME#0.9351;ACTIN DEPOLYMERIZATION#0.9351;PILOCARPINE#0.9350;DEUBIQUITINATING ENZYME#0.9349;EPITHELIAL CARCINOMA#0.9349;IRON OVERLOAD#0.9347;ENZALUTAMIDE#0.9346;CENTRAL NERVOUS SYSTEM#0.9345;IMMUNOLOGICAL SYNAPSE#0.9344;E BOX BINDING#0.9344;ENZYME COMPLEX#0.9343;HIND LIMB ISCHEMIA#0.9342;ISOQUINOLINE#0.9342;METAPLASIA#0.9340;NODULE FORMATION#0.9339;LYMPHOCYTE ACTIVATION#0.9338;FEED FORWARD LOOP#0.9336;ACTIVATION OF PHOSPHORYLATION#0.9336;OPEN FIELD TEST#0.9335;RRNA SYNTHESIS#0.9335;OESOPHAGEAL SQUAMOUS CELL#0.9334;AMYLOID PROTEIN#0.9333;VERY-LOW-DENSITY LIPOPROTEIN#0.9331;BONE GROWTH#0.9330;TOXICANT#0.9330;MOOD DISORDER#0.9330;MENADIONE#0.9329;NERVOUS SYSTEM#0.9328;ABDOMINAL AORTIC ANEURYSM#0.9326;SIGNALING ADAPTOR#0.9325;VASOCONSTRICTOR#0.9323;NEUTROPENIA#0.9321;THYMIDYLATE#0.9321;HEXANE#0.9320;HEMOSTASIS#0.9319;FILOPODIUM FORMATION#0.9318;GESTATIONAL DIABETES MELLITUS#0.9317;TRANSENDOTHELIAL ELECTRICAL RESISTANCE#0.9315;EPITHELIAL TISSUES#0.9314;HIGH CHOLESTEROL DIET#0.9313;OLIGODENDROCYTE PROGENITOR CELL#0.9313;BLOOD CIRCULATION#0.9312;MRNA SPLICING#0.9312;DUCHENNE MUSCULAR DYSTROPHY#0.9311;NERVOUS SYSTEM DEVELOPMENT#0.9311;MUSCLE CELL APOPTOSIS#0.9310;CELL AGGREGATION#0.9307;SUCCINATE DEHYDROGENASE#0.9307;PANITUMUMAB#0.9306;ACTION POTENTIAL#0.9306;ACETIC ACID#0.9304;GLOMERULAR FILTRATION#0.9304;TAIL SUSPENSION TEST#0.9304;FOCAL ADHESION COMPLEXES#0.9303;MICROSPIKE#0.9303;ISOQUINOLINE ALKALOID#0.9303;OXIDATIVE DNA DAMAGE#0.9302;DISCOIDIN DOMAIN RECEPTOR#0.9302;PLACENTATION#0.9302;TNF SECRETION#0.9299;CHOLESTEROL METABOLISM#0.9298;MITOCHONDRIAL MEMBRANE PERMEABILITY#0.9298;FEMUR#0.9297;TROPISM#0.9295;SCOPOLAMINE#0.9295;HYDROXYPROLINE#0.9294;MEK ACTIVITY#0.9294;CONGESTIVE HEART FAILURE#0.9293;ATP SYNTHESIS#0.9293;DNA DAMAGE CHECKPOINT#0.9292;BLAST CELL#0.9291;INTERNEURON#0.9290;TROPHECTODERM CELL#0.9289;LYMPHOCYTE PROLIFERATION#0.9288;CASPASE-8 ACTIVITY#0.9287;LUTEIN#0.9286;PURKINJE CELL#0.9285;SMOOTH MUSCLE CONTRACTION#0.9284;2'-DEOXYCYTIDINE#0.9282;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9279;REGULATION OF GLUCOSE METABOLISM#0.9278;CELL FUSION#0.9277;THIORIDAZINE#0.9277;NOVEL OBJECT RECOGNITION#0.9277;COLCHICINE#0.9275;NEURONAL CELL APOPTOSIS#0.9274;INTEGRATED STRESS RESPONSE#0.9271;NEUTRAL SPHINGOMYELINASE#0.9271;NORMAL BREAST TISSUE#0.9271;AIRWAY EPITHELIUM#0.9270;BLINDNESS#0.9270;GROWTH FACTOR RECEPTOR BINDING#0.9269;LYMPH NODE INVOLVEMENT#0.9267;INTRACELLULAR MEMBRANE#0.9266;C-LEVEL#0.9264;PROLACTIN RECEPTOR#0.9262;FINGOLIMOD#0.9261;WHITE BLOOD CELL#0.9260;IN VITRO MATURATION#0.9259;ATROPINE#0.9257;ASTROCYTE ACTIVATION#0.9256;BETA ADRENOCEPTOR#0.9254;LUNG DEVELOPMENT#0.9251;GRANULOSA CELL PROLIFERATION#0.9250;GERMINAL CENTER B#0.9248;THROMBOCYTOPENIA#0.9246;MACROGLOBULINEMIA#0.9246;CHRONIC HEPATITIS B#0.9246;ANTIOXIDANT DEFENSE SYSTEM#0.9246;PI3K SIGNAL TRANSDUCTION#0.9244;STOMATITIS#0.9243;DOUBLE TRANSGENIC MICE#0.9240;MEVASTATIN#0.9239;HYPERHOMOCYSTEINEMIA#0.9239;REGULATION OF PKC#0.9237;PROTEIN PROCESSING#0.9237;DUCTAL CARCINOMA IN SITU#0.9236;OVULATION#0.9236;LASER SCANNING MICROSCOPY#0.9230;DOXAZOSIN#0.9229;RESPONSE TO LPA#0.9228;CABOZANTINIB#0.9224;MICROSOME#0.9222;ACTIVATED MICROGLIAL CELLS#0.9222;PHOSPHATIDYLETHANOLAMINE#0.9222;METALLOPROTEINASE INHIBITOR#0.9221;SALVIA MILTIORRHIZA BUNGE#0.9220;NALOXONE#0.9219;SKELETAL MUSCLE REGENERATION#0.9218;COMPOUND 6#0.9218;SECRETORY PATHWAY#0.9217;REGULATION OF CELL DEATH#0.9215;APOPTOSIS OF ENDOTHELIAL CELLS#0.9212;REGIONAL LYMPH NODE#0.9212;GERMINAL CENTER B CELL#0.9211;ACTIN CYTOSKELETON ORGANIZATION#0.9210;EPLERENONE#0.9210;ADVANCED GASTRIC CANCER#0.9210;MAPKK#0.9209;OVERALL SURVIVAL TIME#0.9208;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.9207;GROWTH PATTERN#0.9206;CHRONIC HEPATITIS C#0.9206;AXITINIB#0.9206;DNA COPY NUMBER#0.9205;DNA TOPOISOMERASE#0.9201;CYSTITIS#0.9200;SYNOVIAL FLUID#0.9199;MENSTRUAL CYCLE#0.9199;DEACETYLASE ACTIVITY#0.9199;INHIBITION OF TELOMERASE ACTIVITY#0.9193;CHEMOKINE PRODUCTION#0.9193;1α,25-DIHYDROXYVITAMIN D3#0.9191;DIFFERENTIATED THYROID CANCER#0.9191;MICROPARTICLE#0.9190;INTESTINAL CRYPT#0.9189;BODY WEIGHT LOSS#0.9188;NEOPLASTIC DISEASE#0.9186;MIDGUT#0.9184;INNERVATION#0.9181;5-HT RECEPTOR#0.9180;VASCULAR ENDOTHELIAL DYSFUNCTION#0.9180;NEURAL CREST CELL#0.9180;NAIVE T CELL#0.9178;MITOCHONDRIAL ELECTRON TRANSPORT#0.9178;LEUKEMIC STEM CELL#0.9176;SIDE-POPULATION CELL#0.9174;ANTIGEN PRESENTATION#0.9174;PLX4032#0.9172;CELL-CELL ADHESION MOLECULE#0.9172;MITOTIC CLONAL EXPANSION#0.9170;FATTY ACID BIOSYNTHESIS#0.9166;FORCED SWIM TEST#0.9165;DERMATITIS#0.9164;TRANSPORTER ACTIVITY#0.9162;ALVEOLAR RHABDOMYOSARCOMA#0.9162;COLON EPITHELIAL CELL#0.9161;DABRAFENIB#0.9161;GLEEVEC#0.9160;CYCLOPHILIN#0.9157;CELL ELONGATION#0.9157;CHLAMYDIA#0.9157;GERMINAL VESICLE#0.9155;MEDIAL PREFRONTAL CORTEX#0.9155;POLYCYTHEMIA VERA#0.9154;MIFEPRISTONE#0.9154;LASER DESORPTION IONIZATION#0.9154;CARDIOMYOCYTE DIFFERENTIATION#0.9150;ILOPROST#0.9148;CELL DEDIFFERENTIATION#0.9147;ISOPRENALINE#0.9146;OOGENESIS#0.9143;ALLERGEN#0.9141;RECEPTOR MEDIATED ENDOCYTOSIS#0.9141;LUNG DAMAGE#0.9140;N GLYCAN#0.9136;5-AZA-2'-DEOXYCYTIDINE#0.9135;PTK/ZK#0.9134;MYOMETRIUM#0.9134;VIRAL GENOME#0.9133;PLASMA PROTEIN#0.9132;CELL FRACTION#0.9131;RESPONSE TO CISPLATIN#0.9131;EPITHELIAL SODIUM CHANNEL#0.9129;REGULATION OF MRNA#0.9128;NUCLEAR LAYER#0.9125;HEPATIC STELLATE CELL ACTIVATION#0.9125;CUTANEOUS T CELL LYMPHOMA#0.9124;MUTAGENIC#0.9124;EPOXIDE HYDROLASE#0.9123;SHAM OPERATION GROUP#0.9121;AMINO ACID TRANSPORT#0.9120;DORSAL CLOSURE#0.9119;CARVEDILOL#0.9118;PROTEIN LOCALIZATION#0.9118;GERM CELL TUMORS#0.9117;LIGAND BINDING DOMAIN#0.9116;STEARIC ACID#0.9116;RECEPTOR DEGRADATION#0.9114;TISSUE DEVELOPMENT#0.9113;CARDIAC DEVELOPMENT#0.9104;ERYTHROLEUKEMIA#0.9101;OLIGODENDROCYTE PRECURSOR CELL#0.9100;MEMBRANE ESTROGEN RECEPTOR#0.9099;MALIGNANT MESOTHELIOMA CELL#0.9090;MU OPIOID RECEPTOR#0.9090;BLEBBING#0.9089;TYPE 1 DIABETES MELLITUS#0.9087;CAROTID ARTERY LIGATION#0.9085;MEDULLARY THYROID CANCER#0.9084;CLONIDINE#0.9083;EMBRYONAL CARCINOMA#0.9081;PHOSPHOINOSITIDE METABOLISM#0.9079;PYRAZOLE#0.9078;ACID SECRETION#0.9076;FERMENTATION#0.9075;PANCREATIC STELLATE CELL#0.9071;MITOCHONDRIAL SIGNALING PATHWAY#0.9071;MITOXANTRONE#0.9070;POLYSOME#0.9069;PERIPHERAL T-CELL LYMPHOMA#0.9068;INSULIN RESISTANCE INDEX#0.9067;ADULT STEM CELL#0.9067;EARLY BREAST CANCER#0.9067;STEROID HORMONE RECEPTOR#0.9066;RYANODINE RECEPTOR#0.9065;CIRCULATING ENDOTHELIAL PROGENITOR#0.9062;POLYCYSTIC OVARIAN SYNDROME#0.9061;RESPONSE TO DRUG#0.9059;VIRAL GENE EXPRESSION#0.9057;AXON PATHFINDING#0.9055;TRIIODOTHYRONINE#0.9053;HISTONE METHYLATION#0.9053;ARIPIPRAZOLE#0.9050;MACROPHAGE DIFFERENTIATION#0.9049;ANION CHANNEL#0.9048;CYTOPLASMIC MEMBRANE#0.9046;ADULT HIPPOCAMPAL NEUROGENESIS#0.9045;MELPHALAN#0.9044;LEIOMYOSARCOMA#0.9034;NUCLEAR MEMBRANE#0.9034;HYPERTROPHIC CARDIOMYOPATHY#0.9033;MSC PROLIFERATION#0.9033;MUSCLE FIBRE#0.9032;MEDIAN SURVIVAL TIME#0.9030;ENDOCHONDRAL OSSIFICATION#0.9028;BASAL CELL CARCINOMA#0.9025;PROTEIN BIOSYNTHESIS#0.9024;SCLERODERMA#0.9023;SPROUTING ANGIOGENESIS#0.9021;METASTATIC RENAL CELL CARCINOMA#0.9020;MYELOID-DERIVED SUPPRESSOR CELL#0.9020;NEOMYCIN#0.9015;TAUROCHOLATE#0.9014;L-OHP#0.9013;IGE RECEPTOR#0.9012;PRIMARY HUMAN HEPATOCYTES#0.9008;HYPOTENSION#0.9000;CARDIOVASCULAR RISK FACTOR#0.9000;TRANSCRIPTION ACTIVATOR#0.8998;LIPID OXIDATION#0.8997;WAVE REGULATORY COMPLEX#0.8997;PROTEIN OXIDATION#0.8996;20S PROTEASOME#0.8995;NEUROMUSCULAR JUNCTION#0.8995;SITAGLIPTIN#0.8993;ASCORBATE#0.8990;CAROTID ARTERY OCCLUSION#0.8988;HUMAN PROXIMAL TUBULAR#0.8988;MESENTERIC ARTERY#0.8987;TETRAHYDROBIOPTERIN#0.8986;IMPAIRED GLUCOSE METABOLISM#0.8985;TUMOR STEM CELL#0.8985;HIGH RISK NEUROBLASTOMA#0.8984;IMMUNOGLOBULIN G#0.8983;VALPROATE#0.8978;REPLICATIVE SENESCENCE#0.8976;IL-1 PRODUCTION#0.8975;MUSCLE DAMAGE#0.8975;OREXIN RECEPTOR#0.8974;PROTEIN KINASE C SIGNALING#0.8974;PRIMARY BRAIN TUMORS#0.8970;ANTIVIRAL RESPONSE#0.8969;CORTICOTROPIN#0.8967;AMLODIPINE#0.8966;CORNEAL ENDOTHELIAL CELL#0.8965;HEXOKINASE ACTIVITY#0.8964;CELL LOCOMOTION#0.8962;TOR COMPLEX 2#0.8962;CALCITRIOL#0.8960;D-ASPARTIC ACID#0.8959;CIRCULATING TUMOR CELL#0.8955;TUMOR ANTIGEN#0.8951;DEUBIQUITINASE#0.8951;LUNG MICROVASCULAR ENDOTHELIAL#0.8950;RETINOL BINDING#0.8949;HIPPOCAMPAL DENTATE GYRUS#0.8947;CONTROLLED CORTICAL IMPACT#0.8946;MAGNETIC RESONANCE SPECTROSCOPY#0.8946;ORAL SQUAMOUS CARCINOMA#0.8945;LASER CAPTURE MICRODISSECTION#0.8943;ACID SPHINGOMYELINASE#0.8942;CHROMOSOMAL REGION#0.8942;DNA HYPOMETHYLATION#0.8942;BENZIMIDAZOLE#0.8942;IL-17 PRODUCTION#0.8942;GLOMERULONEPHRITIS#0.8940;CITRATE SYNTHASE ACTIVITY#0.8940;ATPASE INHIBITOR#0.8939;THYROID GLAND#0.8939;OVARIAN CLEAR CELL CARCINOMA#0.8938;HIGH SUCROSE DIET#0.8937;MAMMARY FAT PAD#0.8936;REGULATION OF GSK#0.8935;REGULATION OF TELOMERASE ACTIVITY#0.8935;DIABETIC NEUROPATHY#0.8934;CELL CYCLE PATHWAY#0.8934;CC CHEMOKINE RECEPTOR#0.8934;CYTOTOXIC T CELL#0.8928;CALCINEURIN ACTIVITY#0.8923;SCANNING ELECTRON MICROSCOPY#0.8921;OBJECTIVE RESPONSE RATE#0.8921;REGULATION OF SIGNALING PATHWAY#0.8920;CHONDROITIN SULFATE PROTEOGLYCAN#0.8919;TOTAL ANTIOXIDANT CAPACITY#0.8917;SKELETAL DEVELOPMENT#0.8917;RETINAL ISCHEMIA#0.8917;PERIPHERAL BLOOD MONOCYTES#0.8914;MUSCLE WEAKNESS#0.8906;DERMIS#0.8905;SUBCUTANEOUS ADIPOSE TIS
2081	ENDORIBONUCLEASE ACTIVITY#1.0898;XBP1 MRNA SPLICING#1.0751;RNASE ACTIVITY#1.0716;PROTEIN KINASE R#1.0555;TRANSMEMBRANE RECEPTOR#1.0531;ACTIVATING TRANSCRIPTION FACTOR#1.0358;KINASE ACTIVITY#1.0288;MRNA SPLICING#1.0283;EUKARYOTIC INITIATION FACTOR#1.0243;LUMINAL#1.0209;BINDING PROTEIN 1#1.0197;HYPOXIC#1.0193;RESPONSE TO ER STRESS#1.0184;PROTEIN KINASE#1.0154;TRANSLATION INITIATION FACTOR#1.0133;ER LUMEN#1.0118;ER MEMBRANE#1.0117;BETA CELL#1.0103;ER STRESS-INDUCED APOPTOSIS#1.0096;GLUCOSE REGULATED PROTEIN#1.0069;ENHANCER BINDING PROTEIN#1.0057;ENHANCER BINDING#1.0053;TRANSCRIPTION FACTOR#1.0051;TRANSLATION INITIATION#1.0050;PROTEIN DISULFIDE ISOMERASE#1.0042;MRNA DECAY#1.0029;SIGNALLING PATHWAY#1.0022;GROWTH FACTOR#1.0000;B CELL#0.9992;AUTOPHAGY#0.9959;HYPOXIA#0.9959;ENDOTHELIAL CELL#0.9951;KINASE INHIBITOR#0.9936;RIBONUCLEASE ACTIVITY#0.9935;PLASMA CELL#0.9896;CELL PROLIFERATION#0.9892;ENDONUCLEASE ACTIVITY#0.9887;MACROPHAGE#0.9886;ER STRESS RESPONSE#0.9885;TUMOR NECROSIS FACTOR#0.9848;SIGNALING PATHWAY#0.9845;CLEAVED CASPASE 3#0.9844;POLYMERASE CHAIN REACTION#0.9835;SIGNAL TRANSDUCTION#0.9825;PROTEASOME#0.9794;SIGNALING CASCADE#0.9778;BREAST CANCER#0.9769;CYTOCHROME C#0.9765;ISCHEMIA#0.9763;REACTIVE OXYGEN SPECIES#0.9760;UNFOLDED PROTEIN RESPONSE#0.9744;GENE EXPRESSION#0.9729;REVERSE TRANSCRIPTION#0.9697;MRNA DEGRADATION#0.9696;APOPTOSIS#0.9689;PROTEIN SYNTHESIS#0.9681;INFLAMMATORY RESPONSE#0.9676;CELL CYCLE#0.9673;PROTEIN FOLDING#0.9670;CANCER CELL#0.9666;ENDOPLASMIC RETICULUM#0.9663;RNA SPLICING#0.9663;CYTOPLASM#0.9660;MITOCHONDRIA#0.9650;APOPTOTIC#0.9648;ENDOPLASMIC RETICULUM STRESS#0.9632;CYTOTOXICITY#0.9627;SIGNAL TRANSDUCER#0.9621;SECRETORY PATHWAY#0.9608;EPITHELIAL CELL#0.9607;CELL DEATH#0.9602;VIRAL REPLICATION#0.9575;UBIQUITIN#0.9572;TUMOR CELLS#0.9571;RAPAMYCIN#0.9551;PALMITATE#0.9528;APOPTOTIC CELL DEATH#0.9523;TOXICITY#0.9522;PROTEIN DEGRADATION#0.9501;LIGHT CHAIN 3#0.9484;ALZHEIMER'S DISEASE#0.9480;ANGIOGENESIS#0.9449;MITOGEN ACTIVATED PROTEIN#0.9447;GLUTAMINE#0.9419;ORGANELLE#0.9398;CELL GROWTH#0.9380;PROTEIN TRANSLATION#0.9378;SIGNALING MOLECULE#0.9262;TARGET OF RAPAMYCIN#0.9231;TYPE 2 DIABETES#0.9210;MITOCHONDRIAL MEMBRANE#0.9196;IMMUNE RESPONSE#0.9191;BREAST CANCER CELL#0.9188;HEAT SHOCK PROTEIN#0.9159;CELLULAR HOMEOSTASIS#0.9151;HIGH FAT DIET#0.9124;NEURODEGENERATIVE DISEASE#0.9109;NUCLEASE ACTIVITY#0.9091;INSULIN SECRETION#0.9084;CELL DIFFERENTIATION#0.9068;MOUSE EMBRYONIC FIBROBLAST#0.9068;INSULIN-LIKE GROWTH FACTOR#0.9038;NITRIC OXIDE#0.9024;PROSTATE CANCER#0.9010;CHONDROCYTE#0.8984;CELL CYCLE ARREST#0.8973;MULTIPLE MYELOMA#0.8968;VIRAL INFECTION#0.8968;HOST CELL#0.8967;LIVER DISEASE#0.8967;INNATE IMMUNITY#0.8957;INSULIN RECEPTOR#0.8922;DIABETES MELLITUS#0.8919;SUPEROXIDE DISMUTASE#0.8918;MICROTUBULE ASSOCIATED PROTEIN#0.8909;NERVOUS SYSTEM#0.8899;HEPATOCELLULAR CARCINOMA#0.8893;LIPID METABOLISM#0.8872;RIBOSOME#0.8828;LEUCINE#0.8796;COLON CANCER#0.8787;RNA INTERFERENCE#0.8780;MUSCLE CELL#0.8766;SKELETAL MUSCLE#0.8749;PLASMA MEMBRANE#0.8748;PARKINSON'S DISEASE#0.8723;MECHANISM OF ACTION#0.8713;PRO-INFLAMMATORY#0.8676;NODULATION#0.8663;SECRETORY CELL#0.8653;RESPONSE TO STRESS#0.8653;TAUROURSODEOXYCHOLIC ACID#0.8640;NEURONAL CELLS#0.8621;ISCHEMIA REPERFUSION INJURY#0.8614;CARDIOMYOCYTE#0.8596;SMOOTH MUSCLE#0.8594;STEM CELL#0.8582;ENDOTHELIAL GROWTH FACTOR#0.8551;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8551;ADIPOCYTE#0.8509;ATP BINDING#0.8504;ROS GENERATION#0.8501;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8498;IMMUNOGLOBULIN BINDING#0.8488;GLYCOSYLATION#0.8469;BONE MARROW#0.8436;FATTY LIVER#0.8406;DRUG RESISTANCE#0.8403;MELATONIN#0.8394;ROOT HAIR#0.8367;INDUCTION OF APOPTOSIS#0.8338;ADIPOSE TISSUE#0.8338;BAX INHIBITOR 1#0.8323;AUTOPHAGOSOME#0.8316;CELL SURFACE#0.8296;AUTOPHAGIC CELL DEATH#0.8274;CYTOCHROME C RELEASE#0.8270;B CELL LYMPHOMA#0.8236;ARTERY#0.8219;MICROTUBULE#0.8214;ER DEGRADATION#0.8170;CEREBRAL ISCHEMIA#0.8156;FATTY LIVER DISEASE#0.8155;PROGRAMMED CELL DEATH#0.8145;HAC1 MRNA SPLICING#0.8140;NEUROBLASTOMA#0.8112;GLUCOSE METABOLISM#0.8091;ATHEROSCLEROSIS#0.8079;BUDDING#0.8025;INSULIN BIOSYNTHESIS#0.8007;TRANSLATIONAL ATTENUATION#0.7958;INSULIN RECEPTOR SUBSTRATE#0.7942;BORTEZOMIB#0.7933;HUMAN UMBILICAL VEIN#0.7931;UMBILICAL VEIN#0.7928;PROTEIN QUALITY CONTROL#0.7855;QUERCETIN#0.7839;LIPOGENESIS#0.7834;TOLL LIKE RECEPTOR#0.7799;PROTEIN COMPLEX#0.7740;VASCULAR ENDOTHELIAL CELL#0.7732;LOW DENSITY LIPOPROTEIN#0.7712;GLUCOSE INTOLERANCE#0.7675;POLY ADP RIBOSE#0.7644;RIBOSE#0.7630;JNK SIGNALING PATHWAY#0.7614;LUNG CANCER#0.7603;GLUTATHIONE#0.7594;LIPID HOMEOSTASIS#0.7483;T CELL#0.7475;TRANSMISSION ELECTRON MICROSCOPY#0.7446;ETHANOL#0.7445;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7437;ANTIBODY PRODUCTION#0.7420;DOMINANT NEGATIVE MUTANT#0.7404;CELL WALL#0.7376;TUDCA#0.7289;CENTRAL NERVOUS SYSTEM#0.7254;DEPHOSPHORYLATION#0.7206;ASTROCYTE#0.7179;GLUCOCORTICOID RECEPTOR#0.7171;RESVERATROL#0.7154;SPINAL CORD#0.7059;3-METHYLADENINE#0.7048;UBIQUITIN PROTEASOME SYSTEM#0.7031;INTRACELLULAR SIGNALING PATHWAY#0.7020;CELL DEVELOPMENT#0.7007;DEATH RECEPTOR#0.7003;SORAFENIB#0.6990;B LYMPHOCYTE#0.6978;NEUROPROTECTION#0.6914;INTEGRATED STRESS RESPONSE#0.6899;HYPERGLYCEMIA#0.6897;CYTOKINE PRODUCTION#0.6893;PLASMA CELL DIFFERENTIATION#0.6871;NUCLEOTIDE EXCHANGE FACTOR#0.6855;VIRULENCE#0.6830;KINASE ACTIVATION LOOP#0.6762;OSTEOBLAST#0.6759;PROTEIN SECRETION#0.6757;CASPASE-3 ACTIVITY#0.6736;NADPH OXIDASE#0.6720;MAP KINASE#0.6710;ADIPOCYTE DIFFERENTIATION#0.6709;QUANTITATIVE REAL TIME#0.6696;NEURAL CELL#0.6686;OBESE#0.6671;NF-KAPPAB ACTIVATION#0.6498;RETINITIS PIGMENTOSA#0.6485;ADENOCARCINOMA#0.6472;HEPATITIS B#0.6471;TRANSACTIVATION#0.6459;CASPASE ACTIVATION#0.6451;NEUROTOXICITY#0.6427;G1 PHASE#0.6426;ACTIVATION OF APOPTOSIS#0.6361;TRANSCRIPTION ACTIVATOR#0.6341;MIDDLE CEREBRAL ARTERY#0.6326;CEREBRAL ARTERY#0.6324;DNA FRAGMENTATION#0.6314;HEART DISEASE#0.6293;ADIPOGENESIS#0.6278;ALPHA MANNOSIDASE#0.6266;SENESCENCE#0.6249;CYTOCHROME P450#0.6192;REGULATION OF METABOLIC#0.6164;PROTEIN KINASE B#0.6151;ADENOSINE#0.6132;OVARIAN#0.6124;INSULINOMA#0.6110;JNK CASCADE#0.6106;COLORECTAL CANCER#0.6077;NUCLEAR MEMBRANE#0.6053;GOLGI APPARATUS#0.6013;GROWTH FACTOR BINDING#0.6012
2086	PROVIRUS#0.9622;ADRENAL GLAND#0.9172;CHORIOCARCINOMA#0.8852;SEBACEOUS GLAND#0.7821;ADRENAL CORTEX#0.7699;RHEUMATOID ARTHRITIS#0.7600;TROPHOBLAST#0.7535;POLYMERASE CHAIN REACTION#0.7499;AUTOIMMUNE DISEASE#0.7264;EPITHELIAL CELL#0.7110;SYNCYTIOTROPHOBLAST#0.7098;GENE EXPRESSION#0.6886;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6418;MONONUCLEAR CELLS#0.6406;PERIPHERAL BLOOD#0.6386;VASCULAR DISEASE#0.6143
208	CARDIOMYOCYTE#1.0296;PANCREATIC CANCER#1.0287;POTASSIUM CHANNEL#1.0152;OVARIAN CARCINOMA#1.0144;INSULIN RECEPTOR SUBSTRATE#1.0138;CISPLATIN#1.0114;MACROPHAGE#1.0108;GLUCOSE TRANSPORT#1.0086;AUTOPHAGY#1.0083;MYOBLAST#1.0067;RESPONSE TO INSULIN#1.0065;INSULIN RECEPTOR#1.0057;OVARIAN CANCER#1.0038;OVARIAN#1.0020;ADIPOCYTE#1.0001;HEPATOCELLULAR CARCINOMA#1.0000;CELL MIGRATION#0.9988;GLYCOGEN SYNTHASE KINASE#0.9973;KINASE ACTIVITY#0.9963;COLON CANCER#0.9950;GLUCOSE HOMEOSTASIS#0.9948;GLUCOSE METABOLISM#0.9934;MITOGEN ACTIVATED PROTEIN#0.9931;KINASE INHIBITOR#0.9929;MUSCLE CELL#0.9925;PROSTATE CANCER#0.9923;OBESE#0.9921;BREAST CANCER CELL#0.9909;T CELL#0.9907;INSULIN SIGNALING PATHWAY#0.9906;SKELETAL MUSCLE#0.9892;LUNG CANCER#0.9888;REVERSE TRANSCRIPTION#0.9885;SMOOTH MUSCLE CELL#0.9882;GLUCOSE UPTAKE#0.9876;STEM CELL#0.9875;SMOOTH MUSCLE#0.9864;BREAST CANCER#0.9863;SIGNALING MOLECULE#0.9860;ADENOCARCINOMA#0.9858;EPITHELIAL MESENCHYMAL TRANSITION#0.9858;EPIDERMAL GROWTH FACTOR#0.9853;EPITHELIAL CELL#0.9851;MITOCHONDRIA#0.9849;COLORECTAL#0.9845;COLORECTAL CANCER#0.9841;PROTEIN KINASE B#0.9841;B CELL#0.9838;ADIPOSE TISSUE#0.9831;PLASMA MEMBRANE#0.9827;APOPTOTIC#0.9820;TUMOR SUPPRESSOR#0.9818;RAPAMYCIN#0.9810;ONCOGENIC#0.9809;SIGNAL TRANSDUCTION#0.9805;RNA INTERFERENCE#0.9798;CANCER CELL#0.9797;DIABETES MELLITUS#0.9791;CELL DEATH#0.9783;PROTEIN KINASE#0.9783;GROWTH FACTOR RECEPTOR#0.9782;CELL GROWTH#0.9780;TARGET OF RAPAMYCIN#0.9777;CELL SURFACE#0.9777;LIPOGENESIS#0.9776;TUMOR CELLS#0.9775;ENDOTHELIAL CELL#0.9774;HUMAN BREAST CANCER#0.9762;POLYMERASE CHAIN REACTION#0.9758;APOPTOSIS#0.9752;GENE EXPRESSION#0.9734;BONE MARROW#0.9734;CELL PROLIFERATION#0.9729;TRANSCRIPTION FACTOR#0.9726;SQUAMOUS CELL CARCINOMA#0.9725;CELL CYCLE#0.9715;LIPID METABOLISM#0.9715;LUNG ADENOCARCINOMA#0.9710;HIGH FAT DIET#0.9694;INFLAMMATORY RESPONSE#0.9689;INSULIN-LIKE GROWTH FACTOR#0.9684;TYPE 2 DIABETES#0.9681;SIGNALING PATHWAY#0.9676;SIGNALING CASCADE#0.9674;OSTEOBLAST DIFFERENTIATION#0.9634;QUANTITATIVE REAL TIME#0.9621;CELL DIFFERENTIATION#0.9620;CYTOPLASM#0.9619;PROTEIN KINASE C#0.9612;GROWTH FACTOR#0.9606;AKT SIGNALING#0.9595;TUMOR NECROSIS FACTOR#0.9568;CELL CYCLE ARREST#0.9561;PROTEIN SYNTHESIS#0.9560;NITRIC OXIDE#0.9538;SIGNALLING PATHWAY#0.9536;ANGIOGENESIS#0.9533;OOCYTE#0.9524;DEPHOSPHORYLATION#0.9523;PI3K SIGNALING#0.9487;REACTIVE OXYGEN SPECIES#0.9466;PACLITAXEL#0.9433;PEROXISOME#0.9395;MALIGNANT GLIOMA#0.9345;TARGET OF RAPAMYCIN COMPLEX#0.9344;NEUTROPHIL#0.9315;MYOTUBE#0.9313;GLYCOGEN SYNTHESIS#0.9282;LYMPH NODE#0.9271;2-DEOXYGLUCOSE#0.9269;ENDOMETRIAL CANCER#0.9266;BREAST CARCINOMA#0.9259;BETA CELL#0.9232;VASCULAR SMOOTH MUSCLE CELL#0.9231;MYOCYTES#0.9209;GENE SILENCING#0.9202;ESTROGEN RECEPTOR#0.9161;NITRIC OXIDE SYNTHASE#0.9147;NUCLEOTIDE EXCHANGE FACTOR#0.9132;CELL MOTILITY#0.9116;TUMOR TISSUES#0.9100;OSTEOBLAST#0.9061;LUCIFERASE ACTIVITY#0.9048;HYPERGLYCEMIA#0.9034;PLATELET-DERIVED GROWTH FACTOR#0.8972;PROTEIN PHOSPHORYLATION#0.8960;ISCHEMIA#0.8952;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8914;EPITHELIAL TO MESENCHYMAL#0.8912;HYPOGLYCEMIA#0.8845;CELL ADHESION#0.8841;EXTRACELLULAR MATRIX#0.8837;ANCHORAGE INDEPENDENT GROWTH#0.8835;DUAL LUCIFERASE REPORTER#0.8814;PROTEIN PROTEIN INTERACTION#0.8760;PANCREATIC DUCTAL ADENOCARCINOMA#0.8755;CERVICAL CANCER#0.8743;HEPATOCELLULAR CARCINOMA CELL#0.8726;RECEPTOR TYROSINE KINASE#0.8700;HYPOXIA#0.8691;TYPE 2 DIABETIC#0.8635;ADIPOGENESIS#0.8623;CASPASE-3 ACTIVITY#0.8621;GLUCOSE TOLERANCE TEST#0.8587;TOXICITY#0.8553;TRANSFORMING GROWTH FACTOR#0.8493;THYROID CARCINOMA#0.8480;BLOOD GLUCOSE LEVEL#0.8437;PANCREATIC CARCINOMA#0.8401;INDUCTION OF APOPTOSIS#0.8364;ATHEROSCLEROSIS#0.8314;DRUG RESISTANCE#0.8264;ADIPOCYTE DIFFERENTIATION#0.8261;MECHANISM OF ACTION#0.8255;PODOCYTE#0.8237;DENDRITIC CELL#0.8230;MUSCLE CELL DIFFERENTIATION#0.8228;CELL DEVELOPMENT#0.8214;BREAST CANCER PATIENTS#0.8202;FACTOR I#0.8191;TAMOXIFEN#0.8180;MYOCARDIUM#0.8129;LUNG METASTASIS#0.8118;SUPEROXIDE DISMUTASE#0.8090;MONOCYTE#0.8077;PHOSPHATASE AND TENSIN HOMOLOG#0.8048;FATTY LIVER#0.8044;GLUCOSE INTOLERANCE#0.8029;NEUROBLASTOMA#0.8024;LIVER DISEASE#0.8015;MACROPHAGE POLARIZATION#0.8007;LUNG CARCINOMA#0.7961;PROGENITOR CELL#0.7947;ORAL CANCER CELL#0.7934;ONCOGENESIS#0.7929;LYMPH NODE METASTASIS#0.7927;HYPERINSULINEMIC EUGLYCEMIC CLAMP#0.7923;HEAT SHOCK PROTEIN#0.7880;GLYCOLYSIS#0.7830;PAPILLARY THYROID CARCINOMA#0.7827;FAT CELL#0.7823;STROMAL CELL#0.7773;CYTOTOXICITY#0.7770;LEUCINE#0.7723;INSULIN SECRETION#0.7720;MITOCHONDRIAL MEMBRANE#0.7713;MOUSE EMBRYONIC FIBROBLAST#0.7690;REPORTER GENE ASSAY#0.7687;OSTEOCLAST#0.7679;CERVICAL#0.7659;ADENOSINE#0.7653;TYPE 2 DIABETES MELLITUS#0.7629;2 DIABETES MELLITUS#0.7629;GUANINE#0.7625;S PHASE#0.7623;ARTERY#0.7590;B CELL LYMPHOMA#0.7545;FOCAL ADHESION#0.7537;NERVOUS SYSTEM#0.7518;WOUND HEALING#0.7491;FATTY ACID TRANSPORT#0.7478;MYOCARDIAL INFARCTION#0.7463;GLUCONEOGENESIS#0.7428;REGENERATION#0.7424;CYTOCHROME C#0.7415;M PHASE#0.7413;GLUTATHIONE#0.7396;BINDING PROTEIN 1#0.7378;THYROID CANCER#0.7336;OVARIES#0.7304;POST-TRANSLATIONAL MODIFICATION#0.7303;STREPTOZOTOCIN#0.7286;DE NOVO LIPOGENESIS#0.7265;WHITE ADIPOSE TISSUE#0.7250;RIBOSOMAL PROTEIN#0.7229;CYCLIN DEPENDENT KINASE#0.7205;ACETYL COA CARBOXYLASE#0.7202;KERATINOCYTE#0.7129;DNA BINDING#0.7112;ATHEROSCLEROTIC#0.7110;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7088;FIBROBLAST GROWTH FACTOR#0.7063;OSTEOCLAST DIFFERENTIATION#0.7040;PREADIPOCYTE#0.7026;MYOGENESIS#0.7003;ORAL GLUCOSE TOLERANCE#0.7001;METASTATIC BREAST CANCER#0.7000;STEROL REGULATORY ELEMENT#0.6959;MYELOID LEUKEMIA#0.6958;TESTOSTERONE#0.6932;IMMUNE RESPONSE#0.6926;CELLULAR GROWTH#0.6878;DIET INDUCED OBESITY#0.6873;DOCETAXEL#0.6872;MACROPHAGE ACTIVATION#0.6854;RECEPTOR ANTAGONIST#0.6849;CHEMOTAXIS#0.6844;SUCROSE#0.6836;SIGNAL TRANSDUCER#0.6827;PLATELET AGGREGATION#0.6821;DASATINIB#0.6805;MITOPHAGY#0.6786;PRO-INFLAMMATORY#0.6776;SKELETAL MUSCLE CELLS#0.6775;LEYDIG CELL#0.6773;TUBE FORMATION#0.6766;M1 MACROPHAGE#0.6763;BONE DEVELOPMENT#0.6759;LIPODYSTROPHY#0.6732;APOPTOTIC CELL DEATH#0.6716;PROTEIN KINASE A#0.6714;CELL MEMBRANE#0.6691;ALKALINE PHOSPHATASE#0.6685;PANCREATIC ISLET#0.6683;DNA REPAIR#0.6650;CYTOCHROME P450#0.6648;HYPOXIC#0.6634;G1 PHASE#0.6616;HYPERTENSION#0.6602;DEXAMETHASONE#0.6598;LIPID PHOSPHATASE#0.6575;CANCER STEM CELL#0.6564;PHOSPHATASE ACTIVITY#0.6562;OF DIABETIC RATS#0.6545;ESOPHAGEAL CANCER#0.6519;CIRCULATING TUMOR CELL#0.6483;ACTIN POLYMERIZATION#0.6476;UBIQUITIN#0.6453;LINES OF EVIDENCE#0.6445;METFORMIN#0.6442;ENDOTHELIAL NITRIC OXIDE#0.6442;NADPH OXIDASE#0.6440;LACTATION#0.6439;QUANTITATIVE REVERSE TRANSCRIPTION#0.6439;PARTIAL LIPODYSTROPHY#0.6427;ETHANOL#0.6403;ENDOTHELIAL GROWTH FACTOR#0.6387;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6387;LOW DENSITY LIPOPROTEIN#0.6382;GLYCOGEN SYNTHASE ACTIVITY#0.6344;GEMCITABINE#0.6283;ENDOTHELIUM#0.6281;ENDOMETRIAL CARCINOMA#0.6274;HYPERSENSITIVITY#0.6258;ATP BINDING#0.6249;PROGRAMMED CELL DEATH#0.6237;HEMATOPOIETIC CELL#0.6215;MTOR COMPLEX#0.6199;LOCALISATION#0.6186;THYMOCYTE#0.6161;ANOIKIS#0.6158;EPITHELIAL OVARIAN CANCER#0.6140;MAPK SIGNALING#0.6118;TRASTUZUMAB#0.6090;DOXORUBICIN#0.6067;ASTROCYTE#0.6048;MACROPHAGE MIGRATION#0.6021
2090	ACID PHOSPHATASE#0.7511
2091	SNORNP#1.0541;DENSE FIBRILLAR COMPONENT#1.0313;TOPOISOMERASE#1.0290;SCLERODERMA#1.0234;RRNA PROCESSING#1.0225;FIBRILLAR CENTER#1.0200;GLYCINE#1.0198;RNA PROCESSING#1.0176;SMALL NUCLEOLAR RNA#1.0146;SMALL NUCLEOLAR RIBONUCLEOPROTEIN#1.0122;NUCLEOPLASM#1.0099;RRNA TRANSCRIPTION#1.0086;ARGININE#1.0074;RIBOSOMAL PROTEIN#1.0041;INTERPHASE#1.0017;OOCYTE#1.0013;SMALL NUCLEAR RNA#1.0007;RRNA SYNTHESIS#1.0000;RIBOSOMAL RNA#0.9992;ACTINOMYCIN D#0.9975;MITOSIS#0.9970;NUCLEOLUS#0.9955;RNA BINDING#0.9920;RIBOSOME BIOGENESIS#0.9913;RIBOSOME#0.9885;CELL CYCLE#0.9866;TELOPHASE#0.9819;TRANSCRIPTION FACTOR#0.9805;CYTOPLASM#0.9749;CAJAL BODY#0.9683;AUTOIMMUNITY#0.9674;RRNA METHYLATION#0.9660;GRANULAR COMPONENT#0.9636;T CELL#0.9542;COILED BODY#0.9415;GENE EXPRESSION#0.9371;RIBOSE#0.9342;APOPTOSIS#0.9292;CENTROMERE#0.9223;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.9165;DNA TOPOISOMERASE#0.9130;NUCLEAR MATRIX#0.9126;B CELL#0.9104;ORGANELLE#0.9035;METAPHASE#0.8947;MRNA SPLICING#0.8904;RIBOSOME ASSEMBLY#0.8831;CANCER CELL#0.8784;METHYLTRANSFERASE ACTIVITY#0.8775;AUTOIMMUNE DISEASE#0.8773;RNA BINDING PROTEIN#0.8770;SURVIVAL MOTOR NEURON#0.8670;LASER SCANNING MICROSCOPY#0.8595;NUCLEAR ENVELOPE#0.8568;NUCLEOLOGENESIS#0.8557;CELL PROLIFERATION#0.8415;L-METHIONINE#0.8333;S-ADENOSYL-L-METHIONINE#0.8276;IMMUNE RESPONSE#0.8098;TRANSMISSION ELECTRON MICROSCOPY#0.7971;METHIONINE#0.7890;PRE-MRNA SPLICING#0.7851;STEM CELL#0.7825;NUCLEOLUS ORGANIZER REGION#0.7810;PROTEIN COMPLEX#0.7803;APOPTOTIC#0.7616;CELL DEATH#0.7600;GERMINAL VESICLE#0.7595;PROTEIN SYNTHESIS#0.7566;FIBRIL#0.7411;RNA HELICASE#0.7275;SYSTEMIC SCLERODERMA#0.7205;RNA SYNTHESIS#0.7196;MUTAGENESIS#0.7182;IMMUNE SYSTEM#0.7171;NUCLEIC ACID#0.7145;SPINAL MUSCULAR ATROPHY#0.7103;MUSCULAR ATROPHY#0.7087;ANAPHASE#0.7045;LOCALISATION#0.6936;FIBRILLAR CENTRE#0.6843;B CELL ACTIVATION#0.6827;OOGENESIS#0.6784;CELL ACTIVATION#0.6748;CELL GROWTH#0.6729;RNA METHYLTRANSFERASE#0.6709;SMN COMPLEX#0.6621;HETEROCHROMATIN#0.6602;FERTILIZATION#0.6531;PROTEIN PROTEIN INTERACTION#0.6479;EPITHELIAL CELL#0.6440;RIBOSOMAL SUBUNIT#0.6428;OOCYTE GROWTH#0.6367;NUCLEAR IMPORT#0.6365;RIBONUCLEOPROTEIN COMPLEX#0.6337;UBIQUITIN#0.6333;O METHYLTRANSFERASE#0.6291;SPLICEOSOME#0.6282;CELL SURFACE#0.6228;PROTEASOME#0.6114;CELLULAR GROWTH#0.6091;COFACTOR BINDING#0.6081;LYSINE#0.6015
2098	S FORMYLGLUTATHIONE HYDROLASE#1.1164;ADENYLATE KINASE#1.0775;ADENOSINE DEAMINASE#1.0691;ADENYLATE#1.0582;ADENOSINE#1.0558;ACID PHOSPHATASE#1.0540;RED BLOOD CELL#1.0460;ERYTHROCYTE#1.0445;RETINOBLASTOMA#1.0391;PYRUVATE#0.9135;GLUTATHIONE#0.9020;PLASMA PROTEIN#0.8944;WILSON DISEASE#0.8836;SUPEROXIDE DISMUTASE#0.8732;GLUCOSE-6-PHOSPHATE#0.8696;FORMALDEHYDE DEHYDROGENASE#0.8690;PEPTIDASE B#0.8504;MALATE DEHYDROGENASE#0.8422;ALKALINE PHOSPHATASE#0.7551;PULMONARY TUBERCULOSIS#0.7486;DETOXIFICATION#0.7226;ENZYME ACTIVITY#0.7127;CHROMOSOMAL REGION#0.6948;ADENOSINE KINASE#0.6846;HARDY WEINBERG EQUILIBRIUM#0.6832;TUBERCULOSIS#0.6807;SIGNAL TRANSDUCTION#0.6693;FRAGMENT LENGTH POLYMORPHISM#0.6499;SERINE HYDROLASE#0.6481;CHROMOSOME REGION#0.6292
2099	ALPHA MANNOSIDASE#1.0794;PROPYL PYRAZOLE TRIOL#1.0652;ESTROGEN RECEPTOR 2#1.0560;4-OHT#1.0521;MIGRAINE#1.0464;ERE BINDING#1.0454;MELATONIN#1.0410;EFFERENT DUCT#1.0409;FIBRINOGEN#1.0372;PYRAZOLE#1.0352;PREMATURE OVARIAN FAILURE#1.0279;BETA-2#1.0262;LEIOMYOMA#1.0246;VITAMIN D RECEPTOR#1.0238;SEX DIFFERENTIATION#1.0237;PROTEASOME#1.0218;RECEPTOR INTERACTING PROTEIN#1.0180;PYRAMIDAL CELL#1.0176;C REACTIVE PROTEIN#1.0142;EPITHELIAL CELL PROLIFERATION#1.0138;OVIDUCT#1.0129;RESPONSE TO ESTRADIOL#1.0129;PROGESTERONE RECEPTOR A#1.0120;PROLACTIN RECEPTOR#1.0117;METHYLATION SPECIFIC PCR#1.0113;CAPUT#1.0102;EPIDIDYMIS#1.0099;CHONDROCYTE#1.0094;LUMINAL CELL#1.0094;MAMMARY EPITHELIUM#1.0085;RETINOIC ACID RECEPTOR#1.0081;PRIMARY BREAST TUMORS#1.0077;FOLLICULAR PHASE#1.0071;THYROID HORMONE RECEPTOR#1.0070;LIGAND BINDING DOMAIN#1.0068;DIESTRUS#1.0062;LEYDIG CELL#1.0062;EARLY BREAST CANCER#1.0062;ENDOMETRIAL ADENOCARCINOMA#1.0062;PROTEASOME PATHWAY#1.0059;17BETA OESTRADIOL#1.0059;GLUCOCORTICOID RECEPTOR#1.0059;OXYTOCIN RECEPTOR#1.0058;FRAGMENT LENGTH POLYMORPHISM#1.0051;SURFACE EPITHELIUM#1.0048;MAMMARY GLAND DEVELOPMENT#1.0044;RESONANCE ENERGY TRANSFER#1.0043;ESTROGEN BINDING#1.0033;QUANTITATIVE REVERSE TRANSCRIPTION#1.0030;AMYGDALA#1.0030;DISEASE ACTIVITY INDEX#1.0029;ENDOMETRIOSIS#1.0029;THECAL CELL#1.0025;SEMINAL VESICLE#1.0023;HORMONE BINDING#1.0023;ASTROCYTE#1.0019;ESTROGEN RELATED RECEPTOR#1.0019;MAP KINASE#1.0013;UBIQUITIN#1.0013;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0009;RESVERATROL#1.0007;CHROMATIN REMODELING#1.0005;RNA INTERFERENCE#1.0003;ESTROGEN RECEPTOR ALPHA#1.0001;STEROID RECEPTOR COACTIVATOR#0.9995;FULVESTRANT#0.9992;RECEPTOR DEGRADATION#0.9983;LUTEAL PHASE#0.9982;STEROID BINDING#0.9980;HYPOXIA#0.9979;GLAND DEVELOPMENT#0.9978;RETINOIC ACID#0.9977;FOREBRAIN#0.9977;SERTOLI CELL#0.9977;SKELETAL MUSCLE#0.9974;URIC ACID#0.9973;GRANULOSA CELL#0.9971;MYOMETRIUM#0.9971;DEMETHYLATION#0.9971;4-HYDROXYTAMOXIFEN#0.9969;MAPK SIGNALING#0.9969;BETA CELL#0.9967;SIGNAL TRANSDUCER#0.9967;RESPONSE TO HORMONE#0.9966;CELLULAR LOCALIZATION#0.9960;NUCLEAR RECEPTOR SUPERFAMILY#0.9959;PRIMARY BREAST CANCER#0.9958;LYSINE#0.9954;TRANSACTIVATION#0.9954;HIGH DENSITY LIPOPROTEIN#0.9953;CERVICAL CANCER#0.9953;ESTROGEN METABOLISM#0.9952;NEUROPROTECTION#0.9951;ELECTRON TRANSFER#0.9951;CERVICAL#0.9946;RESPONSE TO ESTROGEN#0.9944;CERVIX#0.9941;CORONARY ARTERY DISEASE#0.9941;MOLAR#0.9938;MAMMARY EPITHELIAL CELL#0.9937;CAVEOLAE#0.9937;DNA BINDING#0.9937;DISEASE ACTIVITY SCORE#0.9934;METASTATIC BREAST CANCER#0.9932;ARTERY DISEASE#0.9928;ELECTROPHORETIC MOBILITY SHIFT#0.9926;DNA METHYLTRANSFERASE#0.9924;ESTROUS CYCLE#0.9920;CORPUS LUTEUM#0.9919;RECEPTOR COMPLEX#0.9919;PROTEIN COMPLEX#0.9919;MEMBRANE ESTROGEN RECEPTOR#0.9918;GROWTH HORMONE#0.9918;REPORTER GENE ASSAY#0.9917;LUCIFERASE ACTIVITY#0.9916;RALOXIFENE#0.9916;LETROZOLE#0.9914;HYPOXIA INDUCIBLE FACTOR#0.9913;GERM CELL#0.9911;PROESTRUS#0.9909;HYPOXIC#0.9906;ANDROGEN RECEPTOR#0.9905;INFERTILE#0.9905;GENISTEIN#0.9903;TRANSCRIPTASE#0.9900;STEARIC ACID#0.9900;OSTEOBLAST#0.9897;HISTONE DEACETYLASE#0.9897;MIDBRAIN#0.9893;ENDOTHELIAL CELL#0.9893;PITUITARY GLAND#0.9893;REPRODUCTIVE BEHAVIOR#0.9892;ACTIVATOR PROTEIN 1#0.9891;CORONARY ARTERY#0.9891;STROMAL CELL#0.9890;PLASMA MEMBRANE#0.9890;ESTROGEN RESPONSE ELEMENT#0.9888;CATECHOL O METHYLTRANSFERASE#0.9884;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9883;STRUCTURE ACTIVITY RELATIONSHIP#0.9883;CYTOCHROME P450#0.9882;NEUTROPHIL#0.9882;ESTRADIOL BINDING#0.9882;PEROXISOME#0.9882;BASAL CELL#0.9881;CELL MEMBRANE#0.9879;OSTEOCLAST#0.9875;O METHYLTRANSFERASE#0.9874;GONAD#0.9872;TUMOR TISSUES#0.9871;DOPAMINE#0.9870;OVARIAN CARCINOMA#0.9870;STROMA#0.9868;ADVANCED BREAST CANCER#0.9868;MENARCHE#0.9866;HEPATITIS B#0.9865;TYPE 2 DIABETES#0.9865;IDIOPATHIC SCOLIOSIS#0.9865;SPINAL CORD#0.9865;CEREBRAL CORTEX#0.9865;LIGAND BINDING POCKET#0.9864;HEAT SHOCK PROTEIN#0.9862;ALPHA CELL#0.9862;GLIAL CELL#0.9861;NORMAL BREAST TISSUE#0.9861;LUMINAL#0.9860;ADIPOCYTE#0.9859;FOLLICLE STIMULATING HORMONE#0.9858;DENDRITIC SPINE#0.9858;FOLATE#0.9857;ESTROGEN RECEPTOR#0.9856;NEURITE#0.9856;MORPHOGENESIS#0.9855;MITOCHONDRIA#0.9854;OVARIAN CANCER#0.9854;BONE CELLS#0.9854;OESTRADIOL#0.9847;IMMUNE SYSTEM#0.9846;ATHEROSCLEROTIC#0.9844;TRANSCRIPTION FACTOR BINDING#0.9844;OBESE#0.9843;CYCLIN DEPENDENT KINASE#0.9843;NUCLEAR MATRIX#0.9842;DNA SYNTHESIS#0.9839;ANEMIA#0.9839;OVARIES#0.9836;ARGININE#0.9835;SERUM ALBUMIN#0.9834;ENDOMETRIAL CANCER#0.9834;CYTOCHROME C#0.9833;ARYL HYDROCARBON RECEPTOR#0.9832;GLUTATHIONE#0.9831;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.9830;ENDOMETRIUM#0.9827;RECEPTOR BINDING#0.9827;ETHANOL#0.9827;MYOCARDIAL INFARCTION#0.9825;ESTRUS#0.9824;GROWTH FACTOR RECEPTOR#0.9824;COLORECTAL#0.9824;SPORADIC BREAST CANCER#0.9823;DIGESTION#0.9822;INVASIVE DUCTAL CARCINOMA#0.9821;PROTEIN KINASE A#0.9820;ESTRADIOL BENZOATE#0.9819;PROSTATE CANCER#0.9819;ESTRADIOL-17BETA#0.9819;ADIPOSE TISSUE#0.9819;BREAST CANCER CELL#0.9816;RELAPSE FREE SURVIVAL#0.9816;SIGNALING CASCADE#0.9813;SIGNALLING PATHWAY#0.9811;SYNOVITIS#0.9809;PROTEIN DEGRADATION#0.9809;COLON CANCER#0.9808;MAMMARY GLAND#0.9808;PROGESTERONE#0.9808;ENDOTHELIAL NITRIC OXIDE#0.9807;ENDOMETRIAL CARCINOMA#0.9806;ENDOTHELIUM#0.9805;CYTOPLASM#0.9805;ENDOTHELIAL GROWTH FACTOR#0.9805;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9805;TRANSFORMING GROWTH FACTOR BETA#0.9803;VASCULAR CELL#0.9803;DNA METHYLATION#0.9802;REVERSE TRANSCRIPTION#0.9801;DIETHYLSTILBESTROL#0.9799;MENSTRUAL CYCLE#0.9796;AGE AT MENARCHE#0.9796;BREAST CANCER#0.9795;AKT SIGNALING#0.9795;MITOGEN ACTIVATED PROTEIN#0.9793;MUTAGENESIS#0.9793;ESTRADIOL#0.9791;DNA REPAIR#0.9789;NUCLEAR HORMONE RECEPTOR#0.9789;RECEPTOR TYROSINE KINASE#0.9788;MACROPHAGE#0.9787;HISTONE ACETYLATION#0.9787;INFERTILITY#0.9786;RECEPTOR ACTIVITY#0.9785;HISTONE DEACETYLASE INHIBITOR#0.9785;ATHEROSCLEROSIS#0.9784;INSULIN-LIKE GROWTH FACTOR#0.9783;POLYMERASE CHAIN REACTION#0.9782;PROGESTIN#0.9780;BETA GALACTOSIDASE#0.9779;ADENOCARCINOMA#0.9778;BONE MARROW#0.9777;BREAST CARCINOMA#0.9775;DUCTAL CARCINOMA IN SITU#0.9774;FIBROBLAST GROWTH FACTOR#0.9774;QUANTITATIVE REAL TIME#0.9774;ENZYME ACTIVITY#0.9773;CELL CYCLE ARREST#0.9773;THYROID CANCER#0.9772;BETA-ESTRADIOL#0.9772;TRANSFORMING GROWTH FACTOR#0.9771;TAMOXIFEN#0.9771;S PHASE#0.9770;UTERUS#0.9770;MAPK ACTIVATION#0.9768;RECEPTOR LIGAND#0.9767;SKELETON#0.9767;ICI 182,780#0.9766;HYPERSENSITIVITY#0.9765;BLOOD VESSEL#0.9764;INTERSTITIAL CELL#0.9763;MONONUCLEAR CELLS#0.9763;OVARIAN FOLLICLE#0.9762;LUNG CANCER#0.9762;OSTEOCYTE#0.9762;CANCER CELL#0.9761;OSTEOARTHRITIS#0.9760;MUSCLE CELL#0.9759;EPIDERMAL GROWTH FACTOR#0.9758;GENE SILENCING#0.9757;MANNOSIDASE I#0.9756;CARCINOMA IN SITU#0.9756;B CELL#0.9754;LACTATION#0.9754;NITRIC OXIDE SYNTHASE#0.9754;HEMORRHAGE#0.9753;PROTEIN SYNTHESIS#0.9751;FACTOR I#0.9751;GESTATION#0.9749;INVASIVE BREAST CANCER#0.9749;BINDING PROTEIN 1#0.9747;CELL MIGRATION#0.9747;ESTRONE#0.9745;HEART DISEASE#0.9745;OOCYTE#0.9743;RESPONSE TO TREATMENT#0.9741;COLORECTAL CANCER#0.9740;SIGNAL TRANSDUCTION#0.9739;ALKALINE PHOSPHATASE#0.9738;HEPATOCELLULAR CARCINOMA#0.9738;SPERMATOGENESIS#0.9737;TRASTUZUMAB#0.9737;QUERCETIN#0.9736;OSTEOBLAST DIFFERENTIATION#0.9735;BONE MINERAL DENSITY#0.9735;T CELL#0.9735;SUCROSE#0.9734;PROTEIN PROTEIN INTERACTION#0.9731;SMOOTH MUSCLE CELL#0.9730;ANKYLOSING SPONDYLITIS#0.9729;ONCOGENIC#0.9729;SMOOTH MUSCLE#0.9729;WEIGHT GAIN#0.9727;TUMOR NECROSIS FACTOR#0.9727;17β-ESTRADIOL#0.9725;KINASE INHIBITOR#0.9725;LYMPH NODE#0.9722;SEPTUM#0.9722;KINASE ACTIVITY#0.9722;LEUKOCYTE#0.9721;BONE FORMATION#0.9721;CELL DIFFERENTIATION#0.9720;ASCORBATE#0.9718;EPITHELIAL CELL#0.9716;RECEPTOR ANTAGONIST#0.9716;ENDOCRINE DISRUPTING CHEMICAL#0.9715;ALZHEIMER'S DISEASE#0.9712;CAUDA#0.9710;LYMPH NODE METASTASIS#0.9708;STEROIDOGENESIS#0.9707;BREAST CANCER PATIENTS#0.9706;HUMAN BREAST CANCER#0.9706;PUBERTY#0.9702;LOW DENSITY LIPOPROTEIN#0.9701;FERTILIZATION#0.9701;CELL DIVISION#0.9701;ARTERY#0.9700;THYMIDINE#0.9699;EXEMESTANE#0.9697;TRANSCRIPTION FACTOR#0.9696;STEROID HORMONE RECEPTOR#0.9696;BONE GROWTH#0.9694;OVARIAN#0.9693;LIPID METABOLISM#0.9693;ETHINYLESTRADIOL#0.9692;FORMALIN#0.9691;OVULATION#0.9686;GONADOTROPIN RELEASING HORMONE#0.9685;ISCHEMIA#0.9685;INVASIVE CARCINOMA#0.9684;PROTEIN KINASE#0.9684;GROWTH FACTOR#0.9682;CYTOTOXICITY#0.9670;REPRODUCTIVE SYSTEM#0.9669;HYPERTENSION#0.9668;ESTROGEN SYNTHESIS#0.9666;DIABETES MELLITUS#0.9665;STEM CELL#0.9664;ANGIOGENESIS#0.9663;CARDIOVASCULAR SYSTEM#0.9663;VISUAL ANALOGUE SCALE#0.9663;MENOPAUSE#0.9662;REGULATION OF GENE EXPRESSION#0.9662;PERIPHERAL BLOOD#0.9660;EPITHELIAL OVARIAN CANCER#0.9660;IMMUNE RESPONSE#0.9655;OSTEOPOROSIS#0.9655;UBIQUITIN PROTEASOME PATHWAY#0.9653;TUMOR SUPPRESSOR#0.9649;WHITE BLOOD CELL#0.9647;DIHYDROTESTOSTERONE#0.9647;RECEPTOR AGONIST#0.9646;PROTEINURIA#0.9645;CELL ADHESION#0.9645;CELL CYCLE#0.9645;TERMINAL END BUD#0.9645;SIGNALING PATHWAY#0.9645;DISEASE FREE SURVIVAL#0.9644;APOPTOTIC#0.9643;CAMP RESPONSE ELEMENT#0.9642;CELL PROLIFERATION#0.9642;NITRIC OXIDE#0.9641;MECHANISM OF ACTION#0.9641;SPERMATOCYTES#0.9640;CPG ISLAND METHYLATION#0.9640;CELL GROWTH#0.9638;VASCULAR SMOOTH MUSCLE CELL#0.9638;CONNECTIVE TISSUE#0.9636;AROMATASE ACTIVITY#0.9634;APOPTOSIS#0.9630;CELL SURFACE#0.9629;INFLAMMATORY RESPONSE#0.9627;PROTEIN KINASE C#0.9627;ESTROGENS#0.9623;COMPLEX I#0.9623;SPERMATOZOA#0.9623;DNA HYPERMETHYLATION#0.9622;INSULIN RECEPTOR#0.9622;MONOCYTE#0.9621;SIGNALING MOLECULE#0.9619;GENE EXPRESSION#0.9619;MULTIPLE SCLEROSIS#0.9616;LEUCINE#0.9616;TESTOSTERONE#0.9607;EXTRACELLULAR MATRIX#0.9607;TUMOR CELLS#0.9604;ENDOPLASMIC RETICULUM#0.9596;PROGENITOR CELL#0.9593;T LYMPHOCYTE#0.9592;LATE PREGNANCY#0.9590;MATERNAL BEHAVIOR#0.9587;CENTRAL NERVOUS SYSTEM#0.9587;CELL DEATH#0.9586;INHIBIN#0.9581;SWELLING#0.9570;IMMUNE CELL#0.9569;OVARIAN DEVELOPMENT#0.9568;NERVOUS SYSTEM#0.9567;STEROIDOGENIC FACTOR 1#0.9567;DECIDUALIZATION#0.9567;PARTURITION#0.9566;EMBRYO IMPLANTATION#0.9565;BREAST ADENOCARCINOMA#0.9565;SQUAMOUS CELL CARCINOMA#0.9563;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9557;LUPUS ERYTHEMATOSUS#0.9554;MECHANISMS OF ACTION#0.9551;SPONDYLITIS#0.9551;REACTIVE OXYGEN SPECIES#0.9546;BONE MORPHOGENETIC PROTEIN#0.9526;INDUCTION OF APOPTOSIS#0.9525;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9525;TOXICITY#0.9522;GLUTAMATE RECEPTOR#0.9522;BONE RESORPTION#0.9521;MEMBRANE FRACTION#0.9518;OLFACTORY BULB#0.9514;SUPEROXIDE DISMUTASE#0.9510;WEIGHT LOSS#0.9509;AUTOIMMUNE DISEASE#0.9506;ADENOSINE#0.9506;PROTEIN BINDING#0.9506;SOCIAL BEHAVIOR#0.9504;PROSTATE CARCINOMA#0.9500;INVASIVE BREAST CARCINOMA#0.9495;IFN-GAMMA#0.9494;KNEE JOINT#0.9494;FEMUR#0.9491;CARCINOGEN#0.9490;NEURONAL CELLS#0.9489;ALANINE#0.9484;GLUCOSE HOMEOSTASIS#0.9481;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9481;MEDROXYPROGESTERONE ACETATE#0.9480;FASLODEX#0.9474;INFLAMMATORY CELL#0.9468;TELOMERASE ACTIVITY#0.9460;CORONARY HEART DISEASE#0.9459;NUCLEAR EXPORT#0.9452;OESTRUS#0.9446;DEXAMETHASONE#0.9444;5ALPHA DIHYDROTESTOSTERONE#0.9435;AGGRESSIVE BEHAVIOR#0.9430;RETE TESTIS#0.9429;RHEUMATOID ARTHRITIS#0.9428;LIVER DISEASE#0.9421;ACTINOMYCIN D#0.9419;PROTEIN KINASE B#0.9415;GENE COPY NUMBER#0.9414;CELL DEVELOPMENT#0.9404;LUMINAL EPITHELIAL CELL#0.9401;ESTROGEN BIOSYNTHESIS#0.9400;MODE OF ACTION#0.9400;GENE EXPRESSION OMNIBUS#0.9398;LYMPH NODE INVOLVEMENT#0.9390;TENDER JOINT COUNT#0.9385;STRIATUM#0.9380;INTERNEURON#0.9380;LASER CAPTURE MICRODISSECTION#0.9380;CYTOKINE PRODUCTION#0.9378;ADRENAL GLAND#0.9370;SWOLLEN JOINT COUNT#0.9365;CELL NUCLEUS#0.9364;RNA BINDING#0.9356;DEMENTIA#0.9356;GROWTH FACTOR BINDING#0.9354;BRANCHING MORPHOGENESIS#0.9345;PROTEIN INTERACTION NETWORK#0.9342;VASOPRESSIN#0.9340;CAMP RESPONSE ELEMENT BINDING#0.9338;ESTRIOL#0.9336;HISTONE MODIFICATION#0.9334;NARINGENIN#0.9330;SENESCENCE#0.9329;DRUG RESISTANCE#0.9320;LOCALISATION#0.9320;PARKINSON'S DISEASE#0.9319;FRONTAL#0.9318;ACETYLCHOLINE#0.9313;TROPHOBLAST#0.9311;HEPATOMA CELLS#0.9308;HEALTH ASSESSMENT QUESTIONNAIRE#0.9307;CRYPTORCHIDISM#0.9301;ETHINYL ESTRADIOL#0.9292;BREAST CANCER MODEL#0.9272;MAGNETIC RESONANCE IMAGING#0.9272;CARDIOMYOCYTE#0.9270;ENDOCRINE SYSTEM#0.9264;THYROID GLAND#0.9260;ESTROGEN RECEPTOR ACTIVITY#0.9250;MALE INFERTILITY#0.9221;GLUTAMIC ACID#0.9219;FLUORESCEIN#0.9215;MEDROXYPROGESTERONE#0.9208;CELL ADHESION MOLECULE#0.9208;NEUROBLASTOMA#0.9181;STEM CELL MARKER#0.9178;HORMONE METABOLISM#0.9173;PLASMA CELL#0.9173;LINES OF EVIDENCE#0.9162;NUCLEOSOME#0.9161;TUBERCULOSIS#0.9160;VITELLOGENESIS#0.9158;ATP BINDING#0.9154;MICROSOME#0.9152;ANDROSTENEDIONE#0.9148;MIFEPRISTONE#0.9145;FAT PAD#0.9143;ALPHA GLUCOSIDASE#0.9143;BONE MARROW CELLS#0.9140;TIBIA#0.9139;ADOLESCENT IDIOPATHIC SCOLIOSIS#0.9134;TRANSCRIPTIONAL CONTROL#0.9133;METHYLATION SPECIFIC POLYMERASE#0.9132;CIRCULATING TUMOR CELL#0.9132;DNA FRAGMENTATION#0.9119;PACLITAXEL#0.9113;CREB BINDING#0.9098;MRNA TRANSCRIPTION#0.9096;COGNITION#0.9095;BONE MARROW STROMAL#0.9094;DIFFERENTIAL GENE EXPRESSION#0.9088;EPITHELIAL MESENCHYMAL TRANSITION#0.9075;SALIVARY GLAND#0.9074;ER DEGRADATION#0.9074;LUNG ADENOCARCINOMA#0.9068;L-ARGININE#0.9067;CELL MOTILITY#0.9063;CYCLIC AMP#0.9061;SCOLIOSIS#0.9059;NERVE GROWTH FACTOR#0.9059;REGENERATION#0.9056;CARDIOVASCULAR RISK FACTOR#0.9054;BINDING PROTEIN 3#0.9054;MULTIPLE LINEAR REGRESSION#0.9051;HUMAN MAMMARY EPITHELIAL#0.9050;ANTIOXIDANT ACTIVITY#0.9038;TRADITIONAL CHINESE MEDICINE#0.9038;CHOLINERGIC NEURON#0.9034;METHOTREXATE#0.9028;CISPLATIN#0.9013;THYROID CARCINOMA#0.9011;BIPOLAR DISORDER#0.9006;PREGNANE X RECEPTOR#0.9001;NEURAL CELL#0.8999;AGE AT ONSET#0.8998;ESTROGEN RECEPTOR BINDING#0.8996;VASODILATION#0.8994;ENERGY HOMEOSTASIS#0.8977;M PHASE#0.8962;POST-TRANSLATIONAL MODIFICATION#0.8960;NMDA RECEPTOR#0.8954;MESENCHYME#0.8946;HATCHING#0.8942;HARDY WEINBERG EQUILIBRIUM#0.8940;5-AZA-2'-DEOXYCYTIDINE#0.8935;2'-DEOXYCYTIDINE#0.8931;PRO-INFLAMMATORY#0.8930;SEX DETERMINATION#0.8928;CYCLIN DEPENDENT KINASE INHIBITOR#0.8923;MARKERS OF INFLAMMATION#0.8921;CALCITONIN RECEPTOR#0.8915;LYMPH NODE METASTASES#0.8915;BREAST DISEASE#0.8914;RETINOID X RECEPTOR#0.8911;INITIAL SEGMENT#0.8911;ERYTHROCYTE#0.8910;PHOSPHATASE ACTIVITY#0.8905;COPY NUMBER CHANGE#0.8903;BRAIN DEVELOPMENT#0.8900;RAPAMYCIN#0.8900;MESENCHYMAL CELL#0.8896;MICROTUBULE#0.8883;CREATINE KINASE#0.8879;BREAST CELL LINES#0.8879;BETA-HYDROXYSTEROID DEHYDROGENASE#0.8876;PITUITARY ADENOMA#0.8875;TARGET OF RAPAMYCIN#0.8871;TYROSINE KINASE INHIBITOR#0.8865;ANASTROZOLE#0.8855;HISTONE ACETYLTRANSFERASE#0.8851;HORMONE SECRETION#0.8842;EDEMA#0.8841;NEURODEGENERATIVE DISEASE#0.8829;GENETIC ASSOCIATION STUDIES#0.8824;PROSTATE SPECIFIC ANTIGEN#0.8822;RECEPTOR ACTIVATOR#0.8815;EPIGALLOCATECHIN#0.8809;FLUTAMIDE#0.8801;MALE REPRODUCTIVE SYSTEM#0.8798;BONE MARROW STROMAL CELL#0.8795;MAST CELL#0.8791;INDUCIBLE NITRIC OXIDE#0.8790;TRYPTOPHAN#0.8785;LUPUS NEPHRITIS#0.8781;CHRONIC HEPATITIS B#0.8780;RU486#0.8780;DNASE I#0.8775;SPERM MOTILITY#0.8772;DEHYDROEPIANDROSTERONE#0.8771;TRANSFORMING GROWTH FACTOR ALPHA#0.8771;METAPLASIA#0.8768;ETHYNYLESTRADIOL#0.8759;ADENINE#0.8758;BONE REMODELING#0.8752;HEMORRHAGIC#0.8749;DOPAMINERGIC NEURON#0.8747;COLON MUCOSA#0.8731;VASCULAR ENDOTHELIAL CELL#0.8722;CEREBRAL ARTERY#0.8717;GONADOTROPIN SECRETION#0.8704;RNA BINDING PROTEIN#0.8698;INNER EAR#0.8686;COAGULATION#0.8680;ADJUSTED ODDS RATIO#0.8673;HYPOSPADIAS#0.8670;ENHANCER BINDING PROTEIN#0.8659;ENDOMETRIAL EPITHELIAL CELLS#0.8658;ENHANCER BINDING#0.8654;BODY WEIGHT GAIN#0.8650;VASCULITIS#0.8648;COPY NUMBER GAIN#0.8647;POSTTRANSLATIONAL MODIFICATION#0.8638;VASCULAR ENDOTHELIUM#0.8632;FORSKOLIN#0.8614;CD4+ T CELL#0.8608;COPY NUMBER ALTERATION#0.8599;BIOTIN#0.8596;URINARY BLADDER#0.8595;NEPHRITIS#0.8593;PARATHYROID HORMONE#0.8587;VSMC PROLIFERATION#0.8574;SUBSTANCE P#0.8571;CAROTID ARTERY#0.8570;OVARIAN SURFACE EPITHELIUM#0.8569;ANOREXIA NERVOSA#0.8566;RECURRENCE FREE SURVIVAL#0.8557;ADJACENT NORMAL TISSUE#0.8551;DENTATE GYRUS#0.8539;CIRCADIAN RHYTHM#0.8532;X CHROMOSOME#0.8527;GLUCOSE METABOLISM#0.8525;MARROW STROMAL CELLS#0.8515;URETHRA#0.8513;GROWTH HORMONE RECEPTOR#0.8508;LH RECEPTOR#0.8505;INDOLE#0.8498;MOOD DISORDER#0.8487;PARATHYROID#0.8484;ABDOMINAL PAIN#0.8481;BONE TURNOVER MARKER#0.8480;CORTISOL#0.8471;ANTHRACENE#0.8467;ONCOGENESIS#0.8465;PSORIATIC ARTHRITIS#0.8455;INSULIN RECEPTOR SUBSTRATE#0.8454;EMBRYONIC KIDNEY#0.8450;TUMOUR NECROSIS FACTOR#0.8447;NEUROGENESIS#0.8446;SURFACE PLASMON RESONANCE#0.8444;LOBULAR BREAST CANCER#0.8439;NITRO-L-ARGININE#0.8433;ANCHORAGE INDEPENDENT GROWTH#0.8431;ADIPOGENESIS#0.8423;MIDDLE CEREBRAL ARTERY#0.8422;SEBACEOUS GLAND#0.8421;LEYDIG CELL TUMOR#0.8419;EPITHELIAL TO MESENCHYMAL#0.8415;TESTICULAR DEVELOPMENT#0.8406;GLYCOGEN SYNTHASE KINASE#0.8406;PREDNISONE#0.8400;COMPLETE BLOOD COUNT#0.8388;DNASE#0.8388;HUMAN UMBILICAL VEIN#0.8387;UMBILICAL VEIN#0.8385;BREAST CARCINOMA CELL LINES#0.8378;PAPILLARY CARCINOMA#0.8376;ENDOCRINE DISRUPTING COMPOUNDS#0.8366;PROSTAGLANDIN ENDOPEROXIDE SYNTHASE#0.8361;COLLAGEN TYPE I#0.8348;RETINOBLASTOMA#0.8344;OSTEOCLAST DIFFERENTIATION#0.8340;ISTHMUS#0.8336;HEPARIN#0.8333;ASPARTATE#0.8330;MINERALIZATION#0.8314;GUANINE#0.8313;ALPHA-TOCOPHEROL#0.8311;ALKALINE PHOSPHATASE ACTIVITY#0.8300;THROMBOSIS#0.8300;KERATINOCYTE#0.8285;SYSTOLIC BLOOD PRESSURE#0.8281;MAMMARY GLAND TUMORS#0.8279;ATP BINDING CASSETTE#0.8278;EVEROLIMUS#0.8274;MULTIPLE MYELOMA#0.8268;INFLAMMATORY BOWEL DISEASE#0.8268;NUCLEIC ACID#0.8265;HYPERGAMMAGLOBULINEMIA#0.8263;EOSIN#0.8262;PHOTOLYSIS#0.8259;CREATINE#0.8259;CELLULAR GROWTH#0.8256;INTRACELLULAR SIGNALING PATHWAY#0.8252;GABAERGIC NEURON#0.8249;RETINOL BINDING#0.8245;EXTRACELLULAR REGULATED KINASE#0.8243;HIGH FAT DIET#0.8229;PEROXIDASE ACTIVITY#0.8202;NEOPLASTIC TISSUES#0.8196;STEROID METABOLISM#0.8195;ADIPOCYTE DIFFERENTIATION#0.8193;CIRCULATING CELL FREE#0.8190;BASEMENT MEMBRANE#0.8187;CYCLOPHOSPHAMIDE#0.8184;DECIDUA#0.8181;ZINC FINGER PROTEIN#0.8173;TRANSCRIPTIONAL CO-REGULATOR#0.8168;HEPATITIS B VIRUS#0.8167;CORTICOTROPIN#0.8163;METESTRUS#0.8159;B CELL LYMPHOMA#0.8155;EOSINOPHIL#0.8150;MOLECULAR DYNAMICS SIMULATION#0.8146;QUANTITATIVE METHYLATION SPECIFIC#0.8146;NULL CELL#0.8145;ATYPICAL DUCTAL HYPERPLASIA#0.8140;B LYMPHOCYTE#0.8138;GENES OF INTEREST#0.8132;PLASMA PROTEIN#0.8130;DEACETYLASE ACTIVITY#0.8108;MYOEPITHELIAL CELL#0.8105;DEPHOSPHORYLATION#0.8103;DENDRITIC CELL#0.8100;ADRENAL CORTEX#0.8100;CHOLINE#0.8090;AORTIC SMOOTH MUSCLE CELLS#0.8077;26S PROTEASOME#0.8070;PARENCHYMA#0.8061;PROLACTINOMA#0.8059;MESENCHYMAL STEM CELL#0.8052;VITAMIN C#0.8046;SENSITIZATION#0.8040;CEREBRAL ARTERY OCCLUSION#0.8040;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8039;THYMIDINE KINASE#0.8038;RETINOL#0.8038;SEX GLANDS#0.8034;PHOSPHODIESTERASE#0.8034;UTERINE CANCER#0.8033;HUMAN EMBRYONIC KIDNEY#0.8023;TOPOISOMERASE#0.8008;GALLBLADDER#0.8002;REGULATION OF CELL PROLIFERATION#0.7997;RIBOSE#0.7996;HOMOLOGOUS RECOMBINATION#0.7991;ANOREXIA#0.7990;THYMOCYTE#0.7989;DECIDUAL CELL#0.7977;FOREARM#0.7970;WOUND HEALING#0.7970;SECRETORY CELL#0.7951;UTERINE HORN#0.7947;POLYCYSTIC OVARY SYNDROME#0.7946;CANCER SPECIFIC SURVIVAL#0.7933;GERMINAL EPITHELIUM#0.7923;ANTI INFLAMMATORY DRUGS#0.7917;POLY ADP RIBOSE#0.7916;LOCUS COERULEUS#0.7908;PREDNISOLONE#0.7908;HEALTHY CONTROL SUBJECTS#0.7878;EMBRYO DEVELOPMENT#0.7875;DOXORUBICIN#0.7875;LEUKEMIA INHIBITORY FACTOR#0.7875;INTRACELLULAR LOCALIZATION#0.7873;FOLLICULAR ADENOMA#0.7864;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7854;VASCULAR DISEASE#0.7831;ACID PHOSPHATASE#0.7830;FEMALE REPRODUCTIVE SYSTEM#0.7810;SPONTANEOUS ABORTION#0.7810;ALPHA-MANNOSIDASE ACTIVITY#0.7795;AUTOPHAGY#0.7783;HAIR FOLLICLE#0.7781;BLOOD PLASMA#0.7773;HORMONE SYNTHESIS#0.7772;COLORECTAL CARCINOMA#0.7765;1-DEOXYMANNOJIRIMYCIN#0.7763;LIVER CANCER#0.7762;DEPRESSIVE SYMPTOMS#0.7762;HISTONE DEACETYLATION#0.7761;SELECTIN#0.7757;DOMINANT NEGATIVE MUTANT#0.7751;NUCLEAR LOCALIZATION SIGNAL#0.7747;HISTIDINE#0.7746;VASODILATOR#0.7740;SARCOPLASMIC RETICULUM#0.7738;INGENUITY PATHWAY ANALYSIS#0.7735;FOLIC ACID#0.7735;ELEVATED PLUS MAZE#0.7734;POLYCYCLIC AROMATIC HYDROCARBON#0.7732;GLAND MORPHOGENESIS#0.7730;GLUTATHIONE PEROXIDASE#0.7727;ERYTHEMA#0.7724;SYNOVIUM#0.7723;TYPE 2 DIABETES MELLITUS#0.7720;2 DIABETES MELLITUS#0.7720;AGE AT DIAGNOSIS#0.7714;FEMALE BREAST CANCER#0.7704;DOXYCYCLINE#0.7699;CD II#0.7682;SYNOVIAL FLUID#0.7681;WHITE ADIPOSE TISSUE#0.7681;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7677;RED BLOOD CELL#0.7675;CEREBRAL ISCHEMIA#0.7658;MANNOSIDASE ACTIVITY#0.7650;PROSTATE EPITHELIAL CELL#0.7646;MAMMARY FAT PAD#0.7637;ADENOMATOUS POLYPOSIS COLI#0.7634;FALSE DISCOVERY RATE#0.7625;TETRACYCLINE#0.7625;TOCOPHEROL#0.7619;TRIIODOTHYRONINE#0.7614;ENCEPHALOMYELITIS#0.7611;SUBCUTANEOUS ADIPOSE TISSUE#0.7609;PAPILLARY THYROID CARCINOMA#0.7607;MITOSIS#0.7592;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.7592;TRANSMISSION DISEQUILIBRIUM TEST#0.7591;CELL CYCLE REGULATION#0.7590;DORSAL ROOT GANGLION#0.7589;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7587;LINEAR REGRESSION ANALYSIS#0.7586;MICROVASCULAR ENDOTHELIAL CELL#0.7578;CROHN'S DISEASE#0.7575;NEURITE OUTGROWTH#0.7573;DERMATOMYOSITIS#0.7571;PHOSPHOLIPASE C#0.7560;CORNIFICATION#0.7555;ANAEMIA#0.7538;GRANULOSA CELL TUMOR#0.7520;GLUCOSE UPTAKE#0.7516;MRNA SPLICING#0.7511;COPY NUMBER VARIATION#0.7509;FULL BLOOD COUNT#0.7506;RIBOSOMAL PROTEIN#0.7505;PANCREATIC CANCER#0.7500;VASODILATATION#0.7499;CANCER STEM CELL#0.7499;IN UTERO EXPOSURE#0.7496;PSORIASIS#0.7486;ALL TRANS RETINOIC ACID#0.7482;ASCORBIC ACID#0.7477;PROTEIN ACETYLATION#0.7471;ULCERATIVE COLITIS#0.7468;PNEUMONIA#0.7463;TOREMIFENE#0.7452;HEPATITIS C#0.7441;LDL RECEPTOR#0.7438;GINSENOSIDE RG1#0.7420;REPRODUCTIVE TOXICITY#0.7407;PROTEIN SECRETION#0.7402;CELL ACTIVATION#0.7401;DNA HYPOMETHYLATION#0.7400;SEMEN#0.7398;MELATONIN RECEPTOR#0.7395;NODULAR#0.7391;LASER DESORPTION IONIZATION#0.7389;P21 ACTIVATED KINASE#0.7378;NOREPINEPHRINE#0.7361;G1 PHASE#0.7359;GLYCINE#0.7356;INSULIN SECRETION#0.7350;UBIQUITIN LIGASE COMPLEX#0.7348;PULMONARY TUBERCULOSIS#0.7346;GASTROINTESTINAL TRACT#0.7346;DIMETHYL SULFOXIDE#0.7342;SKELETAL MUSCLE CELLS#0.7342;GRANULOCYTE#0.7337;COMPARATIVE GENOMIC HYBRIDIZATION#0.7330;BLASTOCYST IMPLANTATION#0.7329;LYSOSOME#0.7325;CARRIE#0.7317;C TERMINAL DOMAIN#0.7295;FOCAL ADHESION#0.7292;RECEPTOR TRANSACTIVATION#0.7289;GOLGI APPARATUS#0.7276;ADENOSINE MONOPHOSPHATE#0.7264;HAIR CELL#0.7252;COLITIS#0.7241;ETHANE#0.7235;SUBSTANTIA NIGRA#0.7223;TYROSINE KINASE 2#0.7221;GENOTOXIC#0.7219;MALNUTRITION#0.7208;VALPROIC ACID#0.7188;TROPHOBLAST CELL#0.7185;PATIENT GLOBAL ASSESSMENT#0.7182;CILIATED EPITHELIAL CELL#0.7169;MULTIPLE REGRESSION ANALYSIS#0.7167;DNA DEMETHYLATION#0.7165;BRAIN DAMAGE#0.7165;PROTEIN PHOSPHORYLATION#0.7163;SODIUM NITROPRUSSIDE#0.7163;2-METHOXYESTRADIOL#0.7161;IL-6 PRODUCTION#0.7160;TH17 CELL#0.7157;NO BINDING#0.7156;TISSUE DEVELOPMENT#0.7151;LEVONORGESTREL#0.7150;SUMOYLATION#0.7147;PLATELET-DERIVED GROWTH FACTOR#0.7142;CHOLESTEROL METABOLISM#0.7134;PKCALPHA#0.7133;FAMILIAL BREAST CANCER#0.7132;COLUMNAR#0.7128;COLONY-STIMULATING FACTOR#0.7109;ERBB SIGNALING#0.7106;BUDDING#0.7105;GERMINAL CENTER#0.7104;PERIODONTITIS#0.7092;ARGININE VASOPRESSIN#0.7076;INFLIXIMAB#0.7070;RITUXIMAB#0.7064;UTERINE GLAND DEVELOPMENT#0.7063;2'-DEOXYURIDINE#0.7059;GLUTAMATERGIC NEURON#0.7051;INFILTRATING DUCTAL CARCINOMA#0.7050;VITAMIN D3#0.7050;TREG CELL#0.7039;HODGKIN'S LYMPHOMA#0.7034;LUTEINIZATION#0.7029;APOPTOTIC CELL DEATH#0.7013;HAIR GROWTH#0.7011;MEDULLA OBLONGATA#0.7010;EMBRYONIC STEM CELL#0.7009;CHOLANGIOCARCINOMA#0.7001;CHROMATIN MODIFICATION#0.6988;NECROTIC#0.6980;SPECIFICITY PROTEIN 1#0.6976;PROTEASOME DEGRADATION#0.6976;LUTEINIZING HORMONE RECEPTOR#0.6975;POLYMYALGIA RHEUMATICA#0.6971;HEALTHY CONTROL GROUP#0.6969;AXON TERMINAL#0.6962;FSH SECRETION#0.6961;PRINCIPAL COMPONENT ANALYSIS#0.6958;PEPTIDE BINDING#0.6951;FASTING PLASMA GLUCOSE#0.6949;HYPERPHOSPHORYLATION#0.6947;CELL CYCLE REGULATOR#0.6947;CANINE MAMMARY TUMORS#0.6946;EXCRETION#0.6944;EARLY RHEUMATOID ARTHRITIS#0.6938;NEPHROPATHY#0.6935;GLUCOSE INTOLERANCE#0.6933;ADENO ASSOCIATED VIRUS#0.6929;FACTOR S#0.6928;IL-1RN#0.6921;CHOLESTASIS#0.6916;DNA REPLICATION#0.6902;CALCIUM CHANNEL#0.6898;THYMINE#0.6897;CATALYTIC ACTIVITY#0.6894;CONJUGATION#0.6893;ANAPLASTIC CARCINOMA#0.6888;GM-CSF#0.6888;RAYNAUD’S#0.6880;CRE BINDING#0.6876;RHEUMATIC DISEASE#0.6875;FATTY ACID SYNTHASE#0.6868;MELANOCYTE#0.6863;MENSTRUATION#0.6863;REGULATION OF GROWTH#0.6846;STEROID 5 ALPHA REDUCTASE#0.6845;HYPOTHALAMIC PITUITARY ADRENAL#0.6839;MIGRAINE WITH AURA#0.6828;MALE BREAST CANCER#0.6817;CAMP SIGNALING#0.6808;ESTRADIOL VALERATE#0.6805;LEFT VENTRICULAR MASS#0.6796;ENDOTHELIAL CELL PROLIFERATION#0.6786;DUCTAL BREAST CANCER#0.6780;GLOMERULONEPHRITIS#0.6772;GAP JUNCTION#0.6772;HYPERACTIVITY#0.6767;EATING DISORDER#0.6762;FSH-BETA#0.6762;DODECYL SULFATE#0.6760;SODIUM DODECYL SULFATE#0.6760;GOITER#0.6759;GALLSTONE FORMATION#0.6758;COLORECTAL ADENOMA#0.6748;JUVENILE IDIOPATHIC ARTHRITIS#0.6729;NUCLEAR RECEPTOR COREGULATOR#0.6720;DENSITY FUNCTIONAL THEORY#0.6718;SPUTUM#0.6716;MITOGENIC ACTIVITY#0.6712;CHROMATIN REMODELLING#0.6711;END OF TREATMENT#0.6710;COFACTOR BINDING#0.6692;CDK INHIBITOR#0.6689;LACRIMAL GLAND#0.6678;PEPTIDE HORMONE#0.6673;LIGASE ACTIVITY#0.6667;IGF BINDING#0.6667;SKELETAL DEVELOPMENT#0.6666;GIANT CELL ARTERITIS#0.6666;72-HOURS#0.6660;METABOTROPIC GLUTAMATE RECEPTORS#0.6657;AND BODY COMPOSITION#0.6653;UROKINASE#0.6653;PROGRAMMED CELL DEATH#0.6649;OPIOID RECEPTOR#0.6644;PROTEIN PHOSPHATASE 2A#0.6644;UBIQUITIN PROTEASOME SYSTEM#0.6644;SOLUBLE FRACTION#0.6642;PHOSPHATASE 2A#0.6641;HEPATITIS C VIRUS#0.6635;MYOCARDIUM#0.6634;POTASSIUM CHANNEL#0.6631;METASTASIS FREE SURVIVAL#0.6631;N ACETYLTRANSFERASE#0.6630;INCONTINENCE#0.6625;METHIONINE#0.6620;TESTIS DEVELOPMENT#0.6612;WINDOW OF IMPLANTATION#0.6609;HSC70 INTERACTING PROTEIN#0.6606;IMMUNOGLOBULIN G#0.6605;RYANODINE RECEPTOR#0.6604;CYCLIC NUCLEOTIDE PHOSPHODIESTERASE#0.6591;SMOOTH MUSCLE ACTIN#0.6586;FALLOPIAN TUBES#0.6553;HERCEPTIN#0.6551;GINSENG#0.6526;COLLAGEN SYNTHESIS#0.6522;IN SITU CARCINOMA#0.6520;CYCLIC ADENOSINE MONOPHOSPHATE#0.6516;STIMULATION OF CELL PROLIFERATION#0.6514;FLOW CYTOMETRY ANALYSIS#0.6508;ECLAMPSIA#0.6500;BENIGN PROSTATE HYPERPLASIA#0.6499;RECTUM#0.6497;VITAMIN E#0.6496;RELATIVE GENE EXPRESSION#0.6490;THALAMUS#0.6487;ERK CASCADE#0.6476;TESTOSTERONE PROPIONATE#0.6467;MYELOID LEUKEMIA#0.6463;BENZOPHENONE#0.6463;FATTY LIVER#0.6459;LECTIN#0.6458;GENE EXPRESSION SIGNATURES#0.6458;PRE-ECLAMPSIA#0.6457;RIBOSOME#0.6453;HIGH RESOLUTION MELTING#0.6439;BONE MARROW ASPIRATE#0.6438;MAPK CASCADE#0.6424;FETAL BRAIN#0.6422;FARNESOID X RECEPTOR#0.6420;LUTEOLYSIS#0.6419;ACUTE PHASE RESPONSE#0.6405;TENOSYNOVITIS#0.6400;BORTEZOMIB#0.6395;HEMATOPOIETIC CELL#0.6391;FINE NEEDLE ASPIRATION#0.6389;ADRIAMYCIN#0.6387;IMPAIRED GLUCOSE TOLERANCE#0.6384;IL-1RA#0.6374;FGF-7#0.6373;RESPIRATORY TRACT#0.6369;DETOXIFICATION#0.6368;PLATELET AGGREGATION#0.6365;TOPICAL#0.6363;LOW DISEASE ACTIVITY#0.6349;ION CHANNEL#0.6346;UNCONDITIONAL LOGISTIC REGRESSION#0.6342;JOINT PAIN#0.6338;RENAL CELL CARCINOMA#0.6336;SEPTIC ARTHRITIS#0.6329;CATABOLISM#0.6326;ANGIOTENSIN CONVERTING ENZYME#0.6325;OVARIAN SURFACE EPITHELIAL#0.6322;CONNECTIVE TISSUE DISEASE#0.6314;HIP JOINT#0.6312;AP1 COMPLEX#0.6297;CILIATED CELL#0.6289;QUIESCENCE#0.6278;RANDOMIZED CLINICAL TRIAL#0.6271;GENE REGULATORY NETWORK#0.6265;CLEAR CELL CARCINOMA#0.6259;PHENYLEPHRINE#0.6254;LUNG DISEASE#0.6251;RIGHT ATRIUM#0.6246;NEUROTRANSMISSION#0.6244;HISTONE METHYLTRANSFERASE#0.6243;SMOOTH MUSCLE CELL PROLIFERATION#0.6242;VASOCONSTRICTION#0.6239;MUSCLE CELL PROLIFERATION#0.6239;EPITHELIAL GROWTH FACTOR#0.6239;XANTHINE#0.6238;ARACHIDONIC ACID#0.6238;OXYGENASE#0.6235;LEAN BODY MASS#0.6232;OLIGODENDROCYTE#0.6232;INDOMETHACIN#0.6229;CELL CYCLE CONTROL#0.6217;SERUM URIC ACID#0.6216;INTIMA MEDIA THICKNESS#0.6211;LIPID DROPLET#0.6207;SERUM RESPONSE FACTOR#0.6192;RNA SYNTHESIS#0.6185;PERTUSSIS#0.6185;PRECURSOR CELL#0.6184;ISCHEMIA REPERFUSION INJURY#0.6178;FUNCTIONAL DIFFERENTIATION#0.6172;SMALL INTESTINE#0.6171;AUTOIMMUNITY#0.6169;RNA HELICASE#0.6166;DIFFERENTIALLY METHYLATED REGION#0.6165;INVASIVE GROWTH#0.6165;PORTAL VEIN#0.6160;LASER SCANNING MICROSCOPY#0.6158;MEMBRANE PROGESTIN RECEPTOR#0.6155;TELENCEPHALON#0.6147;NITROPRUSSIDE#0.6142;CHLORAMPHENICOL#0.6120;NEUROPATHY#0.6116;ORGANELLE#0.6114;LIGAND BINDING CAVITY#0.6111;AREA UNDER CURVE#0.6110;CARBOHYDRATE METABOLISM#0.6108;RISK OF RELAPSE#0.6108;AQUAPORIN#0.6107;GLYCERALDEHYDE-3-PHOSPHATE#0.6099;FETAL LIVER#0.6098;JEJUNUM#0.6096;ASPARAGINE#0.6096;LIPID RAFT#0.6095;THROMBOCYTOPENIA#0.6094;CEREBROVASCULAR DISEASE#0.6082;BLOOD GLUCOSE LEVEL#0.6080;PARAFORMALDEHYDE#0.6075;LIPOPROTEIN LIPASE#0.6071;MUSCLE WEAKNESS#0.6071;OVARY DEVELOPMENT#0.6069;YEAR SURVIVAL RATE#0.6060;MYOSIN HEAVY CHAIN#0.6058;GERM CELL PROLIFERATION#0.6051;MUSCLE FIBER#0.6050;MAMMARY GLAND MORPHOGENESIS#0.6049;CELECOXIB#0.6047;POSITRON EMISSION TOMOGRAPHY#0.6040;MULTIFACTOR DIMENSIONALITY REDUCTION#0.6033;REACTION CENTER#0.6030;PROSTATE DEVELOPMENT#0.6022;DOCETAXEL#0.6018;BODY FAT PERCENTAGE#0.6016;METFORMIN#0.6014;RHEUMATISM#0.6014;CALCINEURIN#0.6012;MALAISE#0.6006;PRECOCIOUS PUBERTY#0.6003
20	ATP BINDING CASSETTE TRANSPORTER#1.0579;ALZHEIMER'S DISEASE#1.0414;ATP BINDING#1.0235;ATP BINDING CASSETTE#1.0216;ABC TRANSPORTER#1.0196;DRUG RESISTANCE#0.9964;OLIGODENDROCYTE#0.9964;GENE EXPRESSION#0.9575;MACROPHAGE#0.9455;NERVOUS SYSTEM#0.8925;SCHWANN CELL#0.8546;LOW DENSITY LIPOPROTEIN#0.8476;ESTRAMUSTINE#0.8349;POLYMERASE CHAIN REACTION#0.8185;PERIPHERAL NERVE#0.8041;CHOLESTEROL HOMEOSTASIS#0.7922;DEVELOPMENTAL COORDINATION DISORDER#0.7806;SPHINGOLIPID METABOLISM#0.7717;ADVANCED BREAST CANCER#0.7599;BREAST CANCER#0.7511;LYSOSOME#0.7425;AMYLOID PRECURSOR PROTEIN#0.7388;CANCER CELL#0.7314;TRANSCRIPTION FACTOR#0.7122;NEUROBLASTOMA#0.7109;CENTRAL NERVOUS SYSTEM#0.6798;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6668;PLASMA MEMBRANE#0.6617;STEM CELL#0.6534;ATHEROSCLEROSIS#0.6380;BONE MARROW#0.6344;LIPID METABOLISM#0.6284;MITOXANTRONE#0.6145;SPINAL CORD#0.6124;MYELINATION#0.6107;ATPASE ACTIVITY#0.6036
2100	ESTROGEN RECEPTOR 2#1.0805;PROPYL PYRAZOLE TRIOL#1.0524;BETA-2#1.0447;LEIOMYOMA#1.0389;MITOCHONDRIA#1.0293;PYRAZOLE#1.0268;COLON CANCER#1.0229;GRANULOSA CELL#1.0175;AMYGDALA#1.0166;SERTOLI CELL#1.0166;ERE BINDING#1.0164;CEREBRAL CORTEX#1.0162;4-OHT#1.0151;GLUCOCORTICOID RECEPTOR#1.0149;MYOMETRIUM#1.0140;EPIDIDYMIS#1.0122;SPERMATOCYTES#1.0101;ESTROGEN BINDING#1.0099;MAMMARY EPITHELIAL CELL#1.0095;MIDBRAIN#1.0093;LUCIFERASE ACTIVITY#1.0093;ESTRADIOL BENZOATE#1.0090;ENDOMETRIOSIS#1.0081;HORMONE BINDING#1.0072;OVARIAN CANCER#1.0068;DNA METHYLATION#1.0059;LEYDIG CELL#1.0059;TRANSCRIPTASE#1.0043;COLORECTAL#1.0042;BASAL CELL#1.0042;VASOPRESSIN#1.0041;LYMPH NODE#1.0039;ESTROUS CYCLE#1.0026;LUTEAL PHASE#1.0025;FRAGMENT LENGTH POLYMORPHISM#1.0020;SKELETAL MUSCLE#1.0012;COLORECTAL CANCER#1.0010;STEROID RECEPTOR COACTIVATOR#1.0009;17BETA OESTRADIOL#1.0008;BETA CELL#1.0006;RESPONSE TO ESTROGEN#1.0001;LUNG CANCER#1.0001;ANDROGEN RECEPTOR#0.9995;ASTROCYTE#0.9994;ENDOTHELIAL CELL#0.9994;GENISTEIN#0.9992;GERM CELL#0.9989;REVERSE TRANSCRIPTION#0.9983;LIGAND BINDING DOMAIN#0.9981;STROMAL CELL#0.9971;RESVERATROL#0.9969;OSTEOBLAST#0.9967;ADIPOSE TISSUE#0.9962;CYTOPLASM#0.9957;OVARIES#0.9955;ENDOMETRIUM#0.9951;TUMOR SUPPRESSOR#0.9950;MAMMARY GLAND#0.9946;MENSTRUAL CYCLE#0.9944;THYROID HORMONE RECEPTOR#0.9941;4-HYDROXYTAMOXIFEN#0.9939;INSULIN-LIKE GROWTH FACTOR#0.9939;REPORTER GENE ASSAY#0.9938;DISEASE FREE SURVIVAL#0.9936;CYTOCHROME P450#0.9934;HEMORRHAGE#0.9934;PRIMARY BREAST CANCER#0.9933;BLOOD VESSEL#0.9933;TRANSACTIVATION#0.9930;LUMINAL#0.9928;STRUCTURE ACTIVITY RELATIONSHIP#0.9928;ADENOCARCINOMA#0.9927;NUCLEAR RECEPTOR SUPERFAMILY#0.9927;QUANTITATIVE REAL TIME#0.9925;OESTRADIOL#0.9924;T CELL#0.9917;ESTROGEN RESPONSE ELEMENT#0.9916;STROMA#0.9915;IMMUNE SYSTEM#0.9915;CARCINOMA IN SITU#0.9914;OOCYTE#0.9912;GONAD#0.9911;RALOXIFENE#0.9910;TUMOR CELLS#0.9909;MACROPHAGE#0.9903;ENDOMETRIAL CANCER#0.9903;POLYMERASE CHAIN REACTION#0.9901;OSTEOCLAST#0.9899;FOLLICLE STIMULATING HORMONE#0.9896;NEUROPROTECTION#0.9895;PROSTATE CANCER#0.9895;ESTRUS#0.9894;FOREBRAIN#0.9894;NITRIC OXIDE SYNTHASE#0.9893;ENDOMETRIAL CARCINOMA#0.9892;BREAST CARCINOMA#0.9890;PROGESTIN#0.9889;OVARIAN FOLLICLE#0.9889;SPERMATOGENESIS#0.9888;PROESTRUS#0.9884;BONE FORMATION#0.9879;PLASMA MEMBRANE#0.9873;S PHASE#0.9873;BONE MARROW#0.9873;ESTROGEN RECEPTOR#0.9865;ESTRADIOL-17BETA#0.9861;BONE MINERAL DENSITY#0.9856;CELLULAR LOCALIZATION#0.9855;ISCHEMIA#0.9850;APOPTOTIC#0.9846;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9846;ENDOTHELIAL GROWTH FACTOR#0.9845;RECEPTOR BINDING#0.9844;OVULATION#0.9844;DNA BINDING#0.9843;CENTRAL NERVOUS SYSTEM#0.9833;SPINAL CORD#0.9832;GROWTH FACTOR RECEPTOR#0.9831;ENDOTHELIUM#0.9830;DIETHYLSTILBESTROL#0.9829;CORPUS LUTEUM#0.9828;REPRODUCTIVE SYSTEM#0.9828;GESTATION#0.9827;SMOOTH MUSCLE#0.9826;SMOOTH MUSCLE CELL#0.9823;DOPAMINE#0.9823;GONADOTROPIN RELEASING HORMONE#0.9822;STEROID HORMONE RECEPTOR#0.9821;SIGNAL TRANSDUCTION#0.9820;PROGESTERONE#0.9813;PURKINJE CELL#0.9810;MUSCLE CELL#0.9807;BETA-ESTRADIOL#0.9807;OVIDUCT#0.9805;EPITHELIAL CELL#0.9804;UTERUS#0.9804;CELL CYCLE#0.9799;ESTROGEN RECEPTOR ALPHA#0.9798;OVARIAN CARCINOMA#0.9798;OVARIAN#0.9793;STEROIDOGENIC FACTOR 1#0.9791;EPIDERMAL GROWTH FACTOR#0.9788;INFERTILITY#0.9785;ALKALINE PHOSPHATASE#0.9784;FORMALIN#0.9784;BREAST CANCER PATIENTS#0.9774;BREAST CANCER#0.9771;MITOGEN ACTIVATED PROTEIN#0.9769;BREAST CANCER CELL#0.9765;PERIPHERAL BLOOD#0.9763;FULVESTRANT#0.9763;ICI 182,780#0.9762;TAMOXIFEN#0.9762;NUCLEAR HORMONE RECEPTOR#0.9756;NITRIC OXIDE#0.9755;MECHANISM OF ACTION#0.9754;RECEPTOR LIGAND#0.9753;NORMAL BREAST TISSUE#0.9753;CANCER CELL#0.9750;QUANTITATIVE REVERSE TRANSCRIPTION#0.9750;VASCULAR SMOOTH MUSCLE CELL#0.9750;DIHYDROTESTOSTERONE#0.9750;NERVOUS SYSTEM#0.9748;HUMAN BREAST CANCER#0.9741;TRANSCRIPTION FACTOR#0.9738;CARDIOVASCULAR SYSTEM#0.9737;ATHEROSCLEROSIS#0.9735;TUMOR NECROSIS FACTOR#0.9735;INVASIVE BREAST CANCER#0.9731;MEMBRANE ESTROGEN RECEPTOR#0.9724;CELL GROWTH#0.9715;APOPTOSIS#0.9710;TRANSFORMING GROWTH FACTOR#0.9705;SKELETON#0.9705;ARTERY#0.9702;FACTOR I#0.9700;SIGNALLING PATHWAY#0.9690;PUBERTY#0.9689;CELL MEMBRANE#0.9688;ESTRADIOL#0.9686;MAP KINASE#0.9684;KINASE INHIBITOR#0.9683;OLFACTORY BULB#0.9676;ENDOMETRIAL ADENOCARCINOMA#0.9675;MENOPAUSE#0.9673;ESTROGENS#0.9672;GENE EXPRESSION#0.9669;PROSTATE CARCINOMA#0.9667;CELL DEATH#0.9665;CELL PROLIFERATION#0.9664;SIGNALING PATHWAY#0.9660;TESTOSTERONE#0.9658;GROWTH FACTOR#0.9657;LIGAND BINDING POCKET#0.9649;OSTEOPOROSIS#0.9647;PROTEIN KINASE#0.9645;CELL DIFFERENTIATION#0.9633;CHONDROCYTE#0.9626;EXTRACELLULAR MATRIX#0.9622;PROTEASOME#0.9618;ELECTROPHORETIC MOBILITY SHIFT#0.9614;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9611;5ALPHA DIHYDROTESTOSTERONE#0.9611;ESTRONE#0.9608;ANGIOGENESIS#0.9603;ARYL HYDROCARBON RECEPTOR#0.9602;BONE CELLS#0.9602;SPERMATOZOA#0.9602;QUERCETIN#0.9579;ACTIVATOR PROTEIN 1#0.9573;TOXICITY#0.9568;RECEPTOR AGONIST#0.9563;LACTATION#0.9560;GLUTATHIONE#0.9560;GLIAL CELL#0.9549;RECEPTOR ANTAGONIST#0.9544;LUNG ADENOCARCINOMA#0.9533;ENDOCRINE DISRUPTING CHEMICAL#0.9532;ALZHEIMER'S DISEASE#0.9529;17β-ESTRADIOL#0.9527;STEM CELL#0.9487;MECHANISMS OF ACTION#0.9457;VASCULAR CELL#0.9442;EPITHELIAL CELL PROLIFERATION#0.9437;SIGNALING CASCADE#0.9433;CYTOKINE PRODUCTION#0.9422;RETINOIC ACID#0.9409;RECEPTOR INTERACTING PROTEIN#0.9407;ARGININE#0.9398;CORONARY ARTERY#0.9397;PITUITARY GLAND#0.9390;DNA SYNTHESIS#0.9384;INDUCIBLE NITRIC OXIDE#0.9384;PROTEIN PROTEIN INTERACTION#0.9366;ENDOTHELIAL NITRIC OXIDE#0.9357;HYPOXIA#0.9339;INTERSTITIAL CELL#0.9331;BONE GROWTH#0.9323;PARKINSON'S DISEASE#0.9321;ESTROGEN RELATED RECEPTOR#0.9315;HISTONE DEACETYLASE#0.9307;CELL MIGRATION#0.9302;IMMUNE RESPONSE#0.9298;STEROIDOGENESIS#0.9269;LEUKOCYTE#0.9263;INHIBIN#0.9252;HYPERTENSION#0.9232;DUCTAL CARCINOMA IN SITU#0.9224;RESPONSE TO ESTRADIOL#0.9222;BRAIN DEVELOPMENT#0.9216;PROGESTERONE RECEPTOR A#0.9202;ADIPOCYTE#0.9194;PROSTATE SPECIFIC ANTIGEN#0.9193;COGNITION#0.9192;HEAT SHOCK PROTEIN#0.9144;FLUTAMIDE#0.9142;MAPK SIGNALING#0.9131;INFERTILE#0.9123;INFLAMMATORY RESPONSE#0.9122;OXYTOCIN RECEPTOR#0.9113;STRIATUM#0.9111;GROWTH HORMONE#0.9107;ESTROGEN METABOLISM#0.9096;NEUTROPHIL#0.9095;SUBSTANTIA NIGRA#0.9093;SEMINAL VESICLE#0.9077;LH RECEPTOR#0.9076;CELL ADHESION#0.9074;INTERNEURON#0.9065;ADRENAL GLAND#0.9059;BONE RESORPTION#0.9041;ESTRADIOL BINDING#0.9039;PROTEIN SYNTHESIS#0.9025;CAMP RESPONSE ELEMENT#0.9018;CAPUT#0.8998;HAIR FOLLICLE#0.8992;TUMOR TISSUES#0.8989;LOCALISATION#0.8988;HUMAN UMBILICAL VEIN#0.8984;UMBILICAL VEIN#0.8982;OVARIAN DEVELOPMENT#0.8971;DIESTRUS#0.8961;PROGENITOR CELL#0.8958;HEART DISEASE#0.8953;PEROXISOME#0.8948;CYTOCHROME C#0.8929;CYTOTOXICITY#0.8927;REPRODUCTIVE BEHAVIOR#0.8920;AROMATASE ACTIVITY#0.8908;CELL CYCLE ARREST#0.8895;VITAMIN D RECEPTOR#0.8869;ESTROGEN SYNTHESIS#0.8853;NEURONAL CELLS#0.8847;PROLACTIN RECEPTOR#0.8837;SURFACE EPITHELIUM#0.8831;FOLLICULAR PHASE#0.8824;NEURODEGENERATIVE DISEASE#0.8814;MONONUCLEAR CELLS#0.8810;RNA INTERFERENCE#0.8803;MAPK ACTIVATION#0.8801;MALE REPRODUCTIVE SYSTEM#0.8800;LYMPH NODE METASTASIS#0.8790;LUMINAL CELL#0.8767;PROTEASOME PATHWAY#0.8753;THYROID CANCER#0.8734;CERVICAL#0.8729;RHEUMATOID ARTHRITIS#0.8719;MONOCYTE#0.8708;QUANTITATIVE REVERSE TRANSCRIPTASE#0.8704;GONOCYTE#0.8682;DENTATE GYRUS#0.8658;VASCULAR ENDOTHELIUM#0.8657;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8649;WEIGHT GAIN#0.8647;LETROZOLE#0.8630;ELEVATED PLUS MAZE#0.8618;IFN-GAMMA#0.8608;OBESE#0.8569;PROTEIN BINDING#0.8546;VIRULENCE#0.8532;RECEPTOR TYROSINE KINASE#0.8528;SQUAMOUS CELL CARCINOMA#0.8511;LASER CAPTURE MICRODISSECTION#0.8509;TIBIA#0.8505;REACTIVE OXYGEN SPECIES#0.8498;CELL SURFACE#0.8492;CAUDA#0.8490;ENDOCRINE SYSTEM#0.8484;GLUCOSE HOMEOSTASIS#0.8475;FORSKOLIN#0.8474;TELOMERASE ACTIVITY#0.8468;THALAMUS#0.8463;REGULATION OF GENE EXPRESSION#0.8460;FEMUR#0.8451;INDUCTION OF APOPTOSIS#0.8447;IMMUNE CELL#0.8427;COLON ADENOCARCINOMA#0.8425;UBIQUITIN#0.8410;OSTEOBLAST DIFFERENTIATION#0.8391;CAMP RESPONSE ELEMENT BINDING#0.8370;MEDROXYPROGESTERONE ACETATE#0.8360;HEMORRHAGIC#0.8355;DEDIFFERENTIATION#0.8344;MELATONIN#0.8343;MULTIPLE SCLEROSIS#0.8341;THYMIDINE#0.8301;GLAND DEVELOPMENT#0.8285;KERATINOCYTE#0.8277;MYOCARDIAL INFARCTION#0.8269;SOCIAL BEHAVIOR#0.8268;CARCINOGEN#0.8243;VASCULAR ENDOTHELIAL CELL#0.8237;CORTICOTROPIN#0.8234;LIPID METABOLISM#0.8228;TRANSFORMING GROWTH FACTOR BETA#0.8224;COLORECTAL CARCINOMA#0.8214;RETINOIC ACID RECEPTOR#0.8207;ETHINYLESTRADIOL#0.8199;BIOTIN#0.8199;DNA FRAGMENTATION#0.8191;ARGININE VASOPRESSIN#0.8178;THYROID CARCINOMA#0.8177;LEUCINE#0.8172;L-ARGININE#0.8159;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8139;CERVIX#0.8132;LATE PREGNANCY#0.8121;TROPHOBLAST#0.8117;SEX GLANDS#0.8085;AUTOIMMUNE DISEASE#0.8081;ESTRIOL#0.8071;EPITHELIAL OVARIAN CANCER#0.8058;PROSTATE EPITHELIUM#0.8047;ACTINOMYCIN D#0.8046;LYMPH NODE METASTASES#0.8042;HORMONE METABOLISM#0.8025;INSULIN RECEPTOR#0.8021;GLUTAMATE RECEPTOR#0.8017;NERVE GROWTH FACTOR#0.8007;MAMMARY GLAND DEVELOPMENT#0.8005;B CELL#0.7997;SEPTUM#0.7986;MEDROXYPROGESTERONE#0.7956;TROPHOBLAST CELL#0.7956;MALE INFERTILITY#0.7954;CREB BINDING#0.7935;OSTEOARTHRITIS#0.7909;INFLAMMATORY BOWEL DISEASE#0.7896;GLUCOSE METABOLISM#0.7888;ETHINYL ESTRADIOL#0.7876;NITRO-L-ARGININE#0.7875;REGENERATION#0.7847;SEX DIFFERENTIATION#0.7847;PROSTATE ADENOCARCINOMA#0.7842;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.7835;INNER EAR#0.7830;RECEPTOR ACTIVITY#0.7813;INVASIVE BREAST CARCINOMA#0.7813;PERIODONTAL LIGAMENT#0.7810;PROSTATE EPITHELIAL CELL#0.7804;TRYPTOPHAN#0.7791;MODE OF ACTION#0.7790;PHOSPHATASE ACTIVITY#0.7786;IDIOPATHIC SCOLIOSIS#0.7782;NARINGENIN#0.7777;GLUTAMIC ACID#0.7776;SIGNAL TRANSDUCER#0.7772;DEHYDROEPIANDROSTERONE#0.7765;VASOCONSTRICTION#0.7746;MESENCHYMAL CELL#0.7745;MUTAGENESIS#0.7745;INITIAL SEGMENT#0.7738;PARTURITION#0.7732;OVARY DEVELOPMENT#0.7731;AKT SIGNALING#0.7730;NMDA RECEPTOR#0.7716;SALIVARY GLAND#0.7710;CYCLIN DEPENDENT KINASE#0.7704;MYOEPITHELIAL CELL#0.7695;UTERINE CANCER#0.7692;LOW DENSITY LIPOPROTEIN#0.7668;INFLAMMATORY CELL#0.7667;STEROID BINDING#0.7653;RU486#0.7650;PRIMARY BREAST TUMORS#0.7649;RESPIRATORY CHAIN#0.7631;ADRENAL CORTEX#0.7630;FRONTAL#0.7620;RESPONSE TO TREATMENT#0.7603;FERTILIZATION#0.7600;PROTEIN KINASE A#0.7599;ISCHEMIA REPERFUSION INJURY#0.7592;HYPOXIA INDUCIBLE FACTOR#0.7588;MITOCHONDRIAL LOCALIZATION#0.7588;ENDOPLASMIC RETICULUM#0.7568;EMBRYONIC KIDNEY#0.7553;ALPHA CELL#0.7547;GASTROINTESTINAL TRACT#0.7544;URETHRA#0.7522;NEURITE#0.7480;PACHYTENE#0.7464;T LYMPHOCYTE#0.7460;TRANSCRIPTION FACTOR BINDING#0.7439;INTRACELLULAR SIGNALING PATHWAY#0.7434;TRILOSTANE#0.7433;DNA REPAIR#0.7420;RELAPSE FREE SURVIVAL#0.7416;ACID PHOSPHATASE#0.7404;LOCUS COERULEUS#0.7375;ONCOGENIC#0.7374;WOUND HEALING#0.7365;SERUM ALBUMIN#0.7349;UBIQUITIN PROTEASOME PATHWAY#0.7348;MICROVASCULAR ENDOTHELIAL CELL#0.7347;CELL MOTILITY#0.7329;POLY ADP RIBOSE#0.7323;OSTEOCYTE#0.7322;CAVEOLAE#0.7316;THECAL CELL#0.7315;HYPOTHALAMIC PITUITARY ADRENAL#0.7303;DIGESTION#0.7297;ETHYNYLESTRADIOL#0.7289;MAMMARY EPITHELIUM#0.7279;CARDIOMYOCYTE#0.7242;AORTIC SMOOTH MUSCLE CELLS#0.7234;AGGRESSIVE BEHAVIOR#0.7229;DORSAL ROOT GANGLION#0.7201;PITUITARY ADENOMA#0.7192;PYRAMIDAL CELL#0.7160;PROTEIN KINASE C#0.7152;MORPHOGENESIS#0.7145;HEPATOMA CELLS#0.7125;SMOOTH MUSCLE ACTIN#0.7118;FASLODEX#0.7097;EFFERENT DUCT#0.7094;MENARCHE#0.7085;ESTROGEN BIOSYNTHESIS#0.7069;BODY WEIGHT GAIN#0.7057;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7035;GONADOTROPIN SECRETION#0.7020;LUMINAL EPITHELIAL CELL#0.7012;GERMINAL EPITHELIUM#0.7002;ATHEROSCLEROTIC#0.7000;MINERALIZATION#0.6995;DENDRITIC SPINE#0.6977;ALKALINE PHOSPHATASE ACTIVITY#0.6966;HUMAN EMBRYONIC KIDNEY#0.6962;HYPOSPADIAS#0.6944;GENE SILENCING#0.6941;CELL NUCLEUS#0.6935;ION CHANNEL#0.6926;HYPOXIC#0.6923;LIVER DISEASE#0.6910;HEPATOCELLULAR CARCINOMA#0.6901;MYOSIN HEAVY CHAIN#0.6896;RAPHE NUCLEI#0.6886;CONNECTIVE TISSUE#0.6839;FETAL BRAIN#0.6837;OXIDATIVE DNA DAMAGE#0.6836;GALLBLADDER#0.6831;GRANULOSA CELL PROLIFERATION#0.6828;HISTONE DEACETYLASE INHIBITOR#0.6824;TESTICULAR DEVELOPMENT#0.6805;BREAST ADENOCARCINOMA#0.6801;ORGANELLE#0.6790;ANDROSTENEDIONE#0.6783;DEXAMETHASONE#0.6767;HIGH DENSITY LIPOPROTEIN#0.6754;COLON MUCOSA#0.6752;FLUORESCEIN#0.6722;BONE REMODELING#0.6711;MITOCHONDRIAL RESPIRATORY CHAIN#0.6701;PERIPHERAL NERVE#0.6699;DNA METHYLTRANSFERASE#0.6691;HYPERSENSITIVITY#0.6683;CEREBRAL ISCHEMIA#0.6680;OLIGODENDROCYTE#0.6676;METHYLATION SPECIFIC PCR#0.6675;CELL DEVELOPMENT#0.6673;FEMALE REPRODUCTIVE SYSTEM#0.6669;CATECHOL O METHYLTRANSFERASE#0.6662;THYROID GLAND#0.6659;DRUG RESISTANCE#0.6658;TRANSCRIPTIONAL CONTROL#0.6657;O METHYLTRANSFERASE#0.6651;NEURAL CELL#0.6639;ESTROGEN RECEPTOR BINDING#0.6598;CISPLATIN#0.6593;CREATINE KINASE#0.6582;ETOPOSIDE#0.6573;RESPONSE TO HORMONE#0.6554;LINES OF EVIDENCE#0.6534;SPORADIC BREAST CANCER#0.6516;SMALL INTESTINE#0.6507;GABAERGIC NEURON#0.6505;HAIR GROWTH#0.6494;MENOPAUSAL HORMONE THERAPY#0.6493;SEBACEOUS GLAND#0.6488;HORMONE SYNTHESIS#0.6474;MRNA TRANSCRIPTION#0.6455;INVASIVE CARCINOMA#0.6452;CILIATED EPITHELIAL CELL#0.6448;TRANSFORMING GROWTH FACTOR ALPHA#0.6439;INTRACELLULAR LOCALIZATION#0.6428;CHROMATIN REMODELING#0.6421;CYCLIN DEPENDENT KINASE INHIBITOR#0.6420;TOPOISOMERASE#0.6412;KINASE ACTIVITY#0.6404;SCHWANN CELL#0.6400;MIDDLE CEREBRAL ARTERY#0.6396;CEREBRAL ARTERY#0.6393;CORONARY HEART DISEASE#0.6381;CORONARY ARTERY DISEASE#0.6372;TYROSINE KINASE INHIBITOR#0.6372;ARTERY DISEASE#0.6370;3BETA-HYDROXYSTEROID DEHYDROGENASE#0.6335;SCOLIOSIS#0.6292;SENESCENCE#0.6264;ETHANOL#0.6253;PAPILLARY CARCINOMA#0.6247;DECIDUAL CELL#0.6246;RESONANCE ENERGY TRANSFER#0.6239;ADENINE#0.6236;ENERGY HOMEOSTASIS#0.6236;GASTRIC TISSUE#0.6226;SPATIAL LEARNING#0.6221;CAROTID ARTERY#0.6219;METABOTROPIC GLUTAMATE RECEPTORS#0.6207;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6207;LUPUS ERYTHEMATOSUS#0.6205;CYCLIC AMP#0.6203;LASER SCANNING MICROSCOPY#0.6196;FORCED SWIM TEST#0.6178;DIABETES MELLITUS#0.6173;DIMETHYL SULFOXIDE#0.6148;HOMOLOGOUS RECOMBINATION#0.6146;CELLULAR GROWTH#0.6140;ADJACENT NORMAL TISSUE#0.6136;ACETYLCHOLINE#0.6131;URINARY BLADDER#0.6127;SEMINOMA#0.6125;SURFACE PLASMON RESONANCE#0.6119;FOLATE#0.6119;RIBOSE#0.6117;NORADRENALINE#0.6111;DIABETIC PERIPHERAL NEUROPATHY#0.6107;ENDOCRINE DISRUPTING COMPOUNDS#0.6105;MAMMARY GLAND TUMORS#0.6093;EMBRYONIC STEM CELL#0.6091;STEROID 5 ALPHA REDUCTASE#0.6090;CEREBRAL ARTERY OCCLUSION#0.6089;EPITHELIAL OVARIAN CARCINOMA#0.6071;VASODILATION#0.6037;VASODILATOR#0.6032;TYPE 2 DIABETES#0.6031;MYOCARDIUM#0.6023;BENIGN PROSTATE HYPERPLASIA#0.6016;NEUROBLASTOMA#0.6016;DECIDUA#0.6007
2101	ESTROGEN RELATED RECEPTOR#1.0515;ENDOMETRIAL CARCINOMA#1.0286;BREAST CANCER CELL#1.0278;OVARIAN CANCER#1.0258;BREAST CANCER#1.0228;ENDOMETRIAL CANCER#1.0222;NUCLEAR RECEPTOR SUPERFAMILY#1.0218;LIGAND BINDING DOMAIN#1.0217;TRANSCRIPTION FACTOR#1.0172;CANCER CELL#1.0170;OVARIAN#1.0157;PEROXISOME#1.0150;ESTROGEN RECEPTOR ALPHA#1.0137;ESTROGEN RECEPTOR#1.0095;SKELETAL MUSCLE#1.0090;ESTRADIOL#0.9987;DNA BINDING#0.9986;SIGNALING PATHWAY#0.9972;ADIPOCYTE#0.9969;GENE EXPRESSION#0.9957;ESTROGEN RESPONSE ELEMENT#0.9915;ADIPOSE TISSUE#0.9859;CELL PROLIFERATION#0.9817;ENERGY HOMEOSTASIS#0.9767;PROTEIN KINASE#0.9755;NUCLEAR RESPIRATORY FACTOR#0.9658;COENZYME A#0.9645;OXIDATIVE PHOSPHORYLATION#0.9621;GROWTH FACTOR#0.9441;FATTY ACID OXIDATION#0.9386;STEROID RECEPTOR COACTIVATOR#0.9374;OSTEOBLAST#0.9297;TRANSACTIVATION#0.9148;THYROID HORMONE RECEPTOR#0.9041;REACTIVE OXYGEN SPECIES#0.8934;BONE FORMATION#0.8853;ESTROGENS#0.8586;PROSTATE CANCER#0.8533;CELL GROWTH#0.8462;EPITHELIAL CELL#0.8447;TRANSCRIPTIONAL CONTROL#0.8359;PYRUVATE DEHYDROGENASE KINASE#0.8295;MITOCHONDRIA#0.8243;STROMAL CELL#0.8117;NUCLEAR HORMONE RECEPTOR#0.8080;PYRUVATE#0.7972;OXIDATIVE METABOLISM#0.7970;BONE MARROW#0.7968;ATP SYNTHASE#0.7967;BREAST CARCINOMA#0.7939;RESPIRATORY CHAIN#0.7803;RESPIRATION#0.7766;CYTOCHROME C#0.7727;MITOCHONDRIAL GENE EXPRESSION#0.7723;MYOTUBE#0.7638;POLYMERASE CHAIN REACTION#0.7612;ADIPOCYTE DIFFERENTIATION#0.7582;OSTEOBLAST DIFFERENTIATION#0.7494;CELL CYCLE#0.7480;PROTEIN KINASE A#0.7441;ACYL COA DEHYDROGENASE#0.7396;STEM CELL#0.7363;LUCIFERASE ACTIVITY#0.7359;OSTEOCLAST#0.7351;MAMMARY GLAND#0.7328;TYPE 2 DIABETES#0.7284;APOPTOSIS#0.7157;UTERUS#0.7144;ADIPOGENESIS#0.7107;SQUAMOUS CELL CARCINOMA#0.7057;REVERSE TRANSCRIPTION#0.7037;AUTOPHAGY#0.6926;RECEPTOR INTERACTING PROTEIN#0.6883;MITOCHONDRIAL TRANSCRIPTION#0.6882;HUMAN BREAST CANCER#0.6808;CELL DEATH#0.6788;ENDOTHELIAL CELL#0.6787;ELECTROPHORETIC MOBILITY SHIFT#0.6783;EPIDERMAL GROWTH FACTOR#0.6730;LUNG CANCER#0.6730;PROGESTERONE#0.6715;MESENCHYMAL STEM CELL#0.6714;MITOCHONDRIAL MEMBRANE#0.6627;ANDROGEN RECEPTOR#0.6524;SIGNALLING PATHWAY#0.6513;RETINOIC ACID#0.6510;OSTEOPOROSIS#0.6371;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6345;SUPEROXIDE DISMUTASE#0.6308;MUTAGENESIS#0.6226;QUANTITATIVE REAL TIME#0.6216;ORAL SQUAMOUS CELL CARCINOMA#0.6123;DIETHYLSTILBESTROL#0.6082;ATP SYNTHESIS#0.6044;CELL NUCLEUS#0.6019;GLUCOCORTICOID RECEPTOR#0.6016
2103	LIVER RECEPTOR HOMOLOG#1.0625;PREGNANE X RECEPTOR#1.0567;SMALL HETERODIMER PARTNER#1.0561;ESTROGEN RELATED RECEPTOR#1.0430;HEPATOCYTE NUCLEAR FACTOR#1.0332;STEROIDOGENIC FACTOR 1#1.0320;RETINOIC ACID RECEPTOR#1.0314;PROSTATE CANCER#1.0250;GERM CELL#1.0250;TH17 CELL#1.0157;RETINOIC ACID#1.0126;NUCLEAR RECEPTOR SUPERFAMILY#1.0030;X CHROMOSOME#1.0029;SKELETAL MUSCLE#1.0007;TROPHOBLAST#0.9985;GONAD#0.9953;RELATED ORPHAN RECEPTOR#0.9942;DOPAMINERGIC NEURON#0.9937;STEROIDOGENESIS#0.9892;ESTROGEN RECEPTOR#0.9891;CELL DIFFERENTIATION#0.9870;BREAST CANCER#0.9862;LEYDIG CELL#0.9859;NERVOUS SYSTEM#0.9838;PLURIPOTENT STEM CELL#0.9807;TRANSCRIPTION FACTOR#0.9802;POLYMERASE CHAIN REACTION#0.9801;T CELL#0.9799;STEM CELL#0.9796;CANCER CELL#0.9793;APOPTOSIS#0.9792;TRANSFORMING GROWTH FACTOR#0.9790;EMBRYONIC STEM CELL#0.9790;ADRENAL GLAND#0.9789;GROWTH FACTOR#0.9783;RETINOID X RECEPTOR#0.9780;OVARIAN#0.9778;LIGAND BINDING DOMAIN#0.9752;CYTOCHROME P450#0.9738;MOUSE EMBRYONIC STEM#0.9728;CELL PROLIFERATION#0.9725;TRANSACTIVATION#0.9715;PEROXISOME#0.9708;NUCLEAR HORMONE RECEPTOR#0.9690;DNA BINDING#0.9665;CIRCADIAN RHYTHM#0.9659;PERIPHERAL BLOOD#0.9653;THYROID HORMONE RECEPTOR#0.9647;CELL CYCLE#0.9644;GENE EXPRESSION#0.9621;LIGAND BINDING POCKET#0.9614;SIGNALING PATHWAY#0.9604;FACTOR I#0.9595;BREAST CANCER CELL#0.9593;PROTEIN KINASE#0.9577;CELL DEVELOPMENT#0.9551;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9540;GRANULOSA CELL#0.9538;NERVE GROWTH FACTOR#0.9533;INDUCED PLURIPOTENT STEM CELL#0.9519;CELL DEATH#0.9517;ADIPOSE TISSUE#0.9511;EPITHELIAL CELL#0.9507;MUSCLE CELL#0.9463;FARNESOID X RECEPTOR#0.9463;CELL GROWTH#0.9414;MACROPHAGE#0.9407;TROPHOBLAST STEM CELL#0.9391;ADRENAL CORTEX#0.9353;LIPID METABOLISM#0.9352;CENTRAL NERVOUS SYSTEM#0.9335;CD4+ T CELL#0.9311;REVERSE TRANSCRIPTION#0.9304;MIDBRAIN#0.9271;ELECTROPHORETIC MOBILITY SHIFT#0.9263;ENERGY HOMEOSTASIS#0.9254;NEURAL STEM CELL#0.9253;HISTONE DEACETYLASE#0.9251;ESTROGEN RESPONSE ELEMENT#0.9220;ADIPOCYTE#0.9215;TREG CELL#0.9142;GLUCONEOGENESIS#0.9139;STEROID HYDROXYLASE#0.9120;TUMOR NECROSIS FACTOR#0.9111;OXIDATIVE METABOLISM#0.9038;HYPOGONADOTROPIC HYPOGONADISM#0.8985;DOPAMINE#0.8964;RECEPTOR BINDING#0.8899;AUTOIMMUNE DISEASE#0.8892;APOPTOTIC#0.8868;TUMOR SUPPRESSOR#0.8849;PROGESTERONE#0.8833;LIVER X RECEPTOR#0.8769;ENDOTHELIAL CELL#0.8741;HYPOXIA#0.8725;MUTAGENESIS#0.8721;PROGENITOR CELL#0.8690;CHOLESTEROL HOMEOSTASIS#0.8670;TRANSCRIPTIONAL CONTROL#0.8631;NUCLEAR RECEPTOR BINDING#0.8615;SIGNAL TRANSDUCER#0.8592;STEROID RECEPTOR COACTIVATOR#0.8586;QUANTITATIVE REAL TIME#0.8578;SEX DETERMINATION#0.8467;HYPOGONADISM#0.8433;METAMORPHOSIS#0.8398;TYPE 2 DIABETES#0.8390;FOREBRAIN#0.8385;IMMUNE CELL#0.8360;RNA INTERFERENCE#0.8344;IMMUNE RESPONSE#0.8327;PROTEIN KINASE A#0.8287;MONONUCLEAR CELLS#0.8263;REPORTER GENE ASSAY#0.8194;NEUROGENESIS#0.8188;PRO-INFLAMMATORY#0.8187;BONE MARROW#0.8170;ADIPOCYTE DIFFERENTIATION#0.8134;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8133;TUMOR CELLS#0.8104;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.8064;HEARING IMPAIRMENT#0.8026;OSTEOBLAST#0.8000;EPIBLAST#0.7961;GLUCOCORTICOID RECEPTOR#0.7944;EPIDERMAL GROWTH FACTOR#0.7903;OVARIES#0.7889;HYPOXIA INDUCIBLE FACTOR#0.7831;PANCREATIC CANCER#0.7810;SIGNAL TRANSDUCTION#0.7796;INFLAMMATORY RESPONSE#0.7793;ALKALINE PHOSPHATASE#0.7790;DRUG METABOLISM#0.7788;GLUCOSE HOMEOSTASIS#0.7787;BETA CELL#0.7785;ESTRADIOL#0.7760;RHEUMATOID ARTHRITIS#0.7739;ORGANOGENESIS#0.7717;PARKINSON'S DISEASE#0.7717;ANGIOGENESIS#0.7711;TRANSCRIPTION FACTOR BINDING#0.7697;PRECURSOR CELL#0.7656;FIBROBLAST GROWTH FACTOR#0.7623;PURKINJE CELL#0.7617;CAMP RESPONSE ELEMENT#0.7604;OVARIAN CANCER#0.7584;DNA METHYLATION#0.7570;TRANSFORMING GROWTH FACTOR BETA#0.7562;CELL CYCLE ARREST#0.7560;ENDOPLASMIC RETICULUM#0.7548;X-LINKED ADRENAL HYPOPLASIA CONGENITA#0.7488;FATTY ACID OXIDATION#0.7481;ESTROGENS#0.7455;PHOTORECEPTOR CELL#0.7432;STROMAL CELL#0.7425;BILE ACID SYNTHESIS#0.7335;GROWTH FACTOR RECEPTOR#0.7335;GLUCOSE METABOLISM#0.7227;SIGNALING MOLECULE#0.7218;HEPATITIS B#0.7218;ANDROGEN RECEPTOR#0.7215;S PHASE#0.7211;COLON CANCER#0.7210;EXTRASKELETAL MYXOID CHONDROSARCOMA#0.7187;T LYMPHOCYTE#0.7185;PHOSPHOENOLPYRUVATE#0.7185;MYXOID CHONDROSARCOMA#0.7171;THYMOCYTE#0.7164;UBIQUITIN#0.7081;PLACENTAL DEVELOPMENT#0.7076;ATHEROSCLEROSIS#0.7072;MITOCHONDRIA#0.7071;INNER EAR#0.7068;HEPATITIS B VIRUS#0.6992;SKELETAL MUSCLE CELLS#0.6899;LEUCINE#0.6897;MITOGEN ACTIVATED PROTEIN#0.6865;ENDOTHELIAL GROWTH FACTOR#0.6861;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6861;ENDOMETRIUM#0.6860;TESTOSTERONE#0.6848;ONCOGENIC#0.6810;GLUTATHIONE#0.6796;LIPID HOMEOSTASIS#0.6789;COLORECTAL CANCER#0.6787;PRIMORDIAL GERM CELL#0.6779;CHOLESTEROL TRANSPORT#0.6775;HEARING LOSS#0.6772;OSTEOBLAST DIFFERENTIATION#0.6764;ESTROGEN RECEPTOR ALPHA#0.6758;CHOLESTEROL METABOLISM#0.6731;INSULIN SECRETION#0.6719;HIGH FAT DIET#0.6715;STEM CELL MARKER#0.6713;SEX DIFFERENTIATION#0.6688;NUCLEAR EXPORT#0.6608;BROWN ADIPOSE TISSUE#0.6603;MECHANISM OF ACTION#0.6603;CHONDROSARCOMA#0.6594;CYTOPLASM#0.6593;NEURON DEVELOPMENT#0.6588;GLYCOGEN SYNTHASE KINASE#0.6583;CELL FATE DETERMINATION#0.6544;REVERSE CHOLESTEROL TRANSPORT#0.6514;OVARIAN FOLLICLE#0.6485;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6459;AUTOIMMUNITY#0.6433;KINASE INHIBITOR#0.6402;NEURON DIFFERENTIATION#0.6364;IL-17 PRODUCTION#0.6358;HORMONE SYNTHESIS#0.6356;BILE ACID BIOSYNTHESIS#0.6349;PROTEIN BINDING#0.6330;PROTEIN PROTEIN INTERACTION#0.6319;STEROID BIOSYNTHESIS#0.6280;4-HYDROXYTAMOXIFEN#0.6232;MONOCYTE#0.6209;PHENOBARBITAL#0.6201;NUCLEOSOME#0.6198;ENDOPLASMIC RETICULUM STRESS#0.6168;CELL ACTIVATION#0.6091;NUCLEOSOME POSITIONING#0.6077;HYPOXIC#0.6057;COLORECTAL#0.6037;DIETHYLSTILBESTROL#0.6033;CAMP RESPONSE ELEMENT BINDING#0.6028
2104	4-OHT#1.1101;4-HYDROXYTAMOXIFEN#1.0794;ESTROGEN RELATED RECEPTOR#1.0559;LIGAND BINDING DOMAIN#1.0336;ESTROGEN RECEPTOR#1.0095;GENE EXPRESSION#1.0025;TRANSCRIPTION FACTOR#0.9969;BREAST CANCER#0.9827;CANCER CELL#0.9637;DNA BINDING#0.9607;TRANSACTIVATION#0.9512;EPITHELIAL CELL#0.9485;SKELETAL MUSCLE#0.9319;PEROXISOME#0.8840;LIGAND BINDING POCKET#0.8711;ESTROGEN RECEPTOR ALPHA#0.8616;ESTROGEN RESPONSE ELEMENT#0.8498;ESTRADIOL#0.8472;OXIDATIVE METABOLISM#0.8409;DIETHYLSTILBESTROL#0.8216;NUCLEAR RECEPTOR SUPERFAMILY#0.8003;PROSTATE CANCER#0.7938;TAMOXIFEN#0.7893;RECEPTOR INTERACTING PROTEIN#0.7772;SIGNALING PATHWAY#0.7527;SMALL HETERODIMER PARTNER#0.7141;ADIPOSE TISSUE#0.7119;BREAST CANCER CELL#0.7101;MAMMARY EPITHELIAL CELL#0.6854;OVARIAN CANCER#0.6827;TUMOR SUPPRESSOR#0.6804;STEROID RECEPTOR COACTIVATOR#0.6705;RECEPTOR BINDING#0.6577;NERVOUS SYSTEM#0.6531;POLYMERASE CHAIN REACTION#0.6342;CELL PROLIFERATION#0.6341;ANAPLASTIC THYROID CANCER#0.6226;ENDOMETRIAL CARCINOMA#0.6211;OVARIAN#0.6176;ENERGY HOMEOSTASIS#0.6093;RESONANCE ENERGY TRANSFER#0.6049;THYROID CANCER#0.6027
2107	TRANSLATION TERMINATION FACTOR#1.0668;GTP BINDING#1.0296;TRANSLATION TERMINATION#1.0271;RIBOSOMAL SUBUNIT#1.0231;RIBOSOME#1.0207;RIBOSOME RECYCLING#1.0139;C TERMINAL DOMAIN#1.0079;GTP HYDROLYSIS#1.0078;PROTEIN SYNTHESIS#1.0001;GTPASE ACTIVITY#0.9949;80S RIBOSOME#0.9878;TRANSLATIONAL TERMINATION#0.9786;MUTAGENESIS#0.9749;GLUTAMINE#0.9723;PEPTIDYL TRANSFERASE CENTER#0.9491;MRNA DECAY#0.9380;GUANINE#0.9305;GENE EXPRESSION#0.9251;NONSENSE-MEDIATED MRNA DECAY#0.9236;CYTOPLASM#0.9212;TRANSCRIPTION FACTOR#0.9065;70S RIBOSOME#0.8797;TRANSFER RNA#0.8772;RIBOSOMAL PROTEIN#0.8587;B CELL#0.8089;PREMATURE TERMINATION CODON#0.8003;40S RIBOSOMAL SUBUNIT#0.7909;COMPLEX I#0.7433;RIBOSOME BINDING#0.7399;RIBOSOMAL RNA#0.7340;EXON JUNCTION COMPLEX#0.7012;TRANSLATION INITIATION#0.6926;NUCLEOTIDE BINDING#0.6771;TRANSLATION ELONGATION#0.6735;HOST CELL#0.6691;POLY-A BINDING#0.6607;POLYSOME#0.6603;FACTOR I#0.6492;LARGE RIBOSOMAL SUBUNIT#0.6481;STERILITY#0.6369;TRANSLATIONAL READTHROUGH#0.6330;HISTIDINE#0.6240;PEPTIDE CHAIN RELEASE FACTOR#0.6170;PTDINS-3-P BINDING#0.6027;MIDDLE EAR#0.6021
2108	ELECTRON TRANSFER FLAVOPROTEIN#1.0692;ELECTRON TRANSFER#1.0511;TUMOR CELLS#1.0051;ACYL COA DEHYDROGENASE#1.0002;MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY#0.9587;ATP SYNTHASE#0.8742;SMOOTH MUSCLE#0.8064;FATTY ACID OXIDATION#0.7776;ACYLCARNITINE#0.7471;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7167;INTERMEDIATE FILAMENT#0.6889;SMOOTH MUSCLE ACTIN#0.6845;CYTOPLASM#0.6349;SCHWANN CELL#0.6102;BUTYRYL COA DEHYDROGENASE#0.6046
2109	ELECTRON TRANSFER FLAVOPROTEIN#1.0692;ELECTRON TRANSFER#1.0534;ACYL COA DEHYDROGENASE#0.9638;MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY#0.9396;MITOCHONDRIA#0.7272;MITOCHONDRIAL MATRIX#0.6451;COENZYME A#0.6236;BUTYRYL COA DEHYDROGENASE#0.6208;FLAVIN#0.6187
210	DELTA-AMINOLEVULINIC ACID#1.0685;AMINOLEVULINATE DEHYDRATASE ACTIVITY#1.0626;AMINOLEVULINATE#1.0623;PORPHYRIA#1.0609;PORPHOBILINOGEN#1.0590;5-AMINOLEVULINIC ACID#1.0514;ERYTHROCYTE#1.0469;AMINOLEVULINIC ACID#1.0452;TETRAPYRROLE BIOSYNTHESIS#1.0450;HEME BIOSYNTHESIS#1.0251;ENZYME ACTIVITY#0.9912;HEME SYNTHESIS#0.9564;HEME BIOSYNTHETIC#0.8892;TOXICITY#0.8740;EXCRETION#0.8421;RED BLOOD CELL#0.8190;LYSINE#0.7908;CATALYTIC ACTIVITY#0.7725;ACUTE INTERMITTENT PORPHYRIA#0.7474;PLASTID#0.7368;METAL BINDING#0.7338;POLYMERASE CHAIN REACTION#0.7234;ANEMIA#0.7040;UROPORPHYRINOGEN DECARBOXYLASE#0.6484;GLUTATHIONE#0.6458;UROPORPHYRINOGEN III SYNTHASE#0.6421;PORPHYRIN BIOSYNTHESIS#0.6343;LYMPHOBLASTOID CELLS#0.6213;VARIEGATE PORPHYRIA#0.6189;PORPHYRIN METABOLISM#0.6131;OXYGENASE#0.6015
2110	ELECTRON TRANSFER FLAVOPROTEIN#1.0705;MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY#1.0618;ELECTRON TRANSFER#1.0559;ACYL COA DEHYDROGENASE#1.0350;LIPID STORAGE#1.0199;MYOPATHY#1.0056;ELECTRON TRANSPORT#1.0006;RESPIRATORY CHAIN#0.9912;FATTY ACID OXIDATION#0.9777;CARNITINE#0.9550;FLAVIN#0.9493;MITOCHONDRIAL MEMBRANE#0.9396;MITOCHONDRIA#0.9346;MUSCLE WEAKNESS#0.9304;ACYLCARNITINE#0.9135;COENZYME A#0.8879;INNER MITOCHONDRIAL MEMBRANE#0.8369;MITOCHONDRIAL MATRIX#0.8000;IRON SULFUR CLUSTER#0.7473;L-CARNITINE#0.7466;ELECTRON TRANSPORT CHAIN#0.7388;FATTY ACID METABOLISM#0.7086;MITOCHONDRIAL RESPIRATORY CHAIN#0.6678;FLAVIN ADENINE DINUCLEOTIDE#0.6534;CHOLINE#0.6443;HIGH RESOLUTION MELTING#0.6170;ELECTRON CARRIER#0.6161;REACTIVE OXYGEN SPECIES#0.6042
2112	ESSENTIAL TREMOR#1.0339
2113	UROKINASE-TYPE PLASMINOGEN ACTIVATOR#1.0549;UROKINASE#1.0426;STROMELYSIN#1.0384;LYMPH NODE METASTASIS#1.0380;NEURAL CREST#1.0369;T CELL ACTIVATION#1.0307;VASCULAR SMOOTH MUSCLE CELL#1.0288;CELL ACTIVATION#1.0271;MATRIX METALLOPROTEINASE 1#1.0263;HYPOXIA#1.0226;GM-CSF#1.0224;COLLAGENASE#1.0223;PROSTATE CANCER#1.0221;THYMOCYTE#1.0218;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0214;LUPUS ERYTHEMATOSUS#1.0212;FACTOR I#1.0195;TRANSACTIVATION#1.0182;OVARIAN CANCER#1.0176;HYPOXIA INDUCIBLE FACTOR#1.0171;COLORECTAL CANCER#1.0144;OVARIAN#1.0143;AFRICAN SWINE FEVER#1.0142;STROMAL CELL#1.0133;HEPATOCYTE GROWTH FACTOR#1.0123;PROTEIN BINDING#1.0123;PANCREATIC CANCER#1.0122;LYMPHOID CELL#1.0118;BREAST CARCINOMA#1.0113;MESANGIAL CELL#1.0106;SMOOTH MUSCLE CELL#1.0103;SMOOTH MUSCLE#1.0096;REVERSE TRANSCRIPTION#1.0085;MAPK SIGNALING#1.0080;COLORECTAL#1.0078;ADENOCARCINOMA#1.0078;RNA INTERFERENCE#1.0076;MUSCLE CELL#1.0070;ENDOTHELIAL GROWTH FACTOR#1.0067;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0067;BREAST CANCER CELL#1.0060;BLOOD VESSEL#1.0054;B CELL DIFFERENTIATION#1.0052;VASCULAR ENDOTHELIAL CELL#1.0051;RHEUMATOID ARTHRITIS#1.0050;ELECTROPHORETIC MOBILITY SHIFT#1.0049;CELL DIFFERENTIATION#1.0048;TRANSFORMING GROWTH FACTOR#1.0041;ANGIOGENESIS#1.0034;RETINOIC ACID#1.0015;MAP KINASE#0.9999;LYMPH NODE#0.9997;FIBROBLAST GROWTH FACTOR#0.9993;DNA BINDING#0.9992;DOMINANT NEGATIVE MUTANT#0.9992;TRANSCRIPTION FACTOR#0.9991;ENDOTHELIAL CELL#0.9982;PLATELET-DERIVED GROWTH FACTOR#0.9968;MORPHOGENESIS#0.9962;HUMAN BREAST CANCER#0.9961;APOPTOTIC#0.9955;HEPATOCELLULAR CARCINOMA#0.9955;BREAST CANCER#0.9950;CD8+ T CELL#0.9948;SQUAMOUS CELL CARCINOMA#0.9948;B CELL#0.9941;CANCER CELL#0.9936;COLON CANCER#0.9935;CELL MIGRATION#0.9928;CELL DEVELOPMENT#0.9925;T CELL#0.9924;EXTRACELLULAR MATRIX#0.9920;POLYMERASE CHAIN REACTION#0.9914;EPITHELIAL MESENCHYMAL TRANSITION#0.9907;HYPOXIC#0.9901;MUTAGENESIS#0.9897;GROWTH FACTOR RECEPTOR#0.9890;CELL ADHESION#0.9883;CYTOPLASM#0.9869;TRANSCRIPTION FACTOR BINDING#0.9868;STROMA#0.9862;HUMAN UMBILICAL VEIN#0.9862;UMBILICAL VEIN#0.9860;TUMOR CELLS#0.9857;MACROPHAGE#0.9852;GROWTH FACTOR#0.9851;EPITHELIAL CELL#0.9846;AUTOIMMUNE DISEASE#0.9843;P BODY#0.9839;ONCOGENIC#0.9834;CELL PROLIFERATION#0.9828;CELL GROWTH#0.9823;CELL CYCLE#0.9808;APOPTOSIS#0.9806;MITOGEN ACTIVATED PROTEIN#0.9801;SIGNALING PATHWAY#0.9786;PROTEIN KINASE C#0.9784;TUMOR SUPPRESSOR#0.9783;PROTEIN KINASE#0.9775;LUNG CANCER#0.9768;LUCIFERASE ACTIVITY#0.9764;OSTEOBLAST#0.9749;CELL MOTILITY#0.9745;CREB BINDING#0.9742;PERIPHERAL BLOOD#0.9734;INVASIVE CARCINOMA#0.9733;B LYMPHOCYTE#0.9733;ENHANCER BINDING#0.9709;STEM CELL#0.9707;DISEASE FREE SURVIVAL#0.9690;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9688;GENE EXPRESSION#0.9682;PLASMA CELL#0.9674;DNASE I#0.9670;MYELOID LEUKEMIA#0.9664;BONE MARROW#0.9664;TRANSFORMING GROWTH FACTOR BETA#0.9651;SEQUENCE SPECIFIC DNA BINDING#0.9635;CELL DEATH#0.9624;SIGNAL TRANSDUCTION#0.9622;TUMOR NECROSIS FACTOR#0.9620;PROTEIN PROTEIN INTERACTION#0.9617;PROGENITOR CELL#0.9611;TH17 CELL#0.9601;IMMUNE RESPONSE#0.9573;IMMUNE CELL#0.9563;MESENCHYMAL CELL#0.9559;HEMATOPOIETIC CELL#0.9546;REPORTER GENE ASSAY#0.9545;DRUG RESISTANCE#0.9514;OVARIAN CARCINOMA#0.9503;ACUTE LEUKEMIA#0.9496;HEMATOPOIESIS#0.9469;T LYMPHOCYTE#0.9456;EPIDERMAL GROWTH FACTOR#0.9456;REACTIVE OXYGEN SPECIES#0.9445;PRO-INFLAMMATORY#0.9386;LYSINE#0.9382;SIGNALING CASCADE#0.9375;MEGAKARYOCYTE#0.9328;PARATHYROID HORMONE#0.9327;MESENCHYME#0.9324;MONOCYTE#0.9296;KINASE INHIBITOR#0.9294;INVASIVE BREAST CANCER#0.9293;DERMAL FIBROBLAST#0.9291;CYCLIC AMP#0.9256;QUANTITATIVE REAL TIME#0.9254;HISTONE ACETYLTRANSFERASE#0.9252;UBIQUITIN#0.9238;CERVICAL#0.9219;MELANOCYTE#0.9219;GENE REGULATORY NETWORK#0.9173;EPITHELIAL TO MESENCHYMAL#0.9163;DNASE#0.9151;FRAGMENT LENGTH POLYMORPHISM#0.9108;CELL SURFACE#0.9092;ONCOGENESIS#0.9090;SENESCENCE#0.9086;CD4+ T CELL#0.9080;DNA METHYLATION#0.9076;TRANSCRIPTIONAL CONTROL#0.9050;ACUTE MYELOID LEUKEMIA#0.9013;MYELOID CELL#0.9012;TRANSCRIPTASE#0.9008;MICROVASCULAR ENDOTHELIAL CELL#0.8976;INFLAMMATORY RESPONSE#0.8953;UROKINASE PLASMINOGEN ACTIVATOR#0.8925;COLONY-STIMULATING FACTOR#0.8917;RNA HELICASE#0.8907;KERATINOCYTE#0.8902;EPSTEIN BARR VIRUS#0.8878;HUMAN IMMUNODEFICIENCY VIRUS#0.8846;CELL ADHESION MOLECULE#0.8846;MONONUCLEAR CELLS#0.8843;ANGIOGENIC GROWTH FACTORS#0.8838;ENDOTHELIUM#0.8836;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8814;CRANIAL NEURAL CREST#0.8811;NATURAL KILLER CELL#0.8790;LUNG ADENOCARCINOMA#0.8763;ESTROGEN RECEPTOR#0.8757;PROTEIN SYNTHESIS#0.8747;T-CELL LEUKEMIA#0.8740;T CELL DIFFERENTIATION#0.8727;S PHASE#0.8703;HISTONE DEACETYLASE#0.8674;CISPLATIN#0.8633;CORE BINDING FACTOR#0.8632;HEPATOCELLULAR CARCINOMA CELL#0.8625;TROPHOBLAST#0.8602;ORAL SQUAMOUS CELL CARCINOMA#0.8599;PROGESTERONE#0.8593;EMBRYONIC STEM CELL#0.8576;WOUND HEALING#0.8544;NITRIC OXIDE#0.8541;PARATHYROID#0.8529;INSULIN SECRETION#0.8525;ISCHEMIA#0.8510;TUBE FORMATION#0.8509;PROTEASOME#0.8485;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8430;COLORECTAL CARCINOMA#0.8410;NEURAL CREST CELL#0.8399;NKT CELL#0.8377;NEURAL TUBE#0.8371;POLY ADP RIBOSE#0.8369;COMPLEX I#0.8369;GRANULOCYTE#0.8350;DNA REPAIR#0.8342;B CELL LYMPHOMA#0.8341;ACTIVATED T CELL#0.8339;METASTATIC MELANOMA#0.8301;CELLULAR GROWTH#0.8274;TUMOR TISSUES#0.8257;CHROMATIN REMODELING#0.8256;NK CELL DIFFERENTIATION#0.8240;ACTIVATED T-CELLS#0.8206;POST-TRANSLATIONAL MODIFICATION#0.8203;SIGNALLING PATHWAY#0.8182;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8160;CHLORAMPHENICOL#0.8138;LUNG CARCINOMA#0.8136;ANCHORAGE INDEPENDENT GROWTH#0.8130;ACTIVATOR PROTEIN 1#0.8089;PROTEIN COMPLEX#0.8055;HISTONE ACETYLATION#0.7970;CYCLIN DEPENDENT KINASE#0.7969;COLON CARCINOMA#0.7963;HEPATOMA CELLS#0.7943;VASCULOGENESIS#0.7940;GENE SILENCING#0.7937;DIGESTION#0.7931;SELECTIN#0.7910;KINASE ACTIVITY#0.7901;ALANINE#0.7890;HEAT SHOCK PROTEIN#0.7890;KIDNEY DEVELOPMENT#0.7887;GLUTATHIONE#0.7884;HYPERTENSION#0.7882;CONNECTIVE TISSUE#0.7879;EWING SARCOMA#0.7859;HEART DEVELOPMENT#0.7854;ARTERY#0.7824;BASEMENT MEMBRANE#0.7806;HEPATIC STELLATE CELL#0.7796;CERVICAL CANCER#0.7796;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7794;CELL CYCLE ARREST#0.7791;BREAST CANCER PATIENTS#0.7789;ENDOPLASMIC RETICULUM#0.7776;VASCULAR CELL#0.7751;CARDIAC NEURAL CREST#0.7739;MELANOMA CELL LINES#0.7686;B CELL ACTIVATION#0.7680;OSTEOBLAST DIFFERENTIATION#0.7674;TERMINAL DIFFERENTIATION#0.7661;LEUCINE#0.7655;HUMAN DERMAL FIBROBLAST#0.7629;SUMOYLATION#0.7628;MONOCYTIC LEUKEMIA#0.7610;VITAMIN D RECEPTOR#0.7600;INVASIVE GROWTH#0.7579;FETAL LIVER#0.7578;GLOMERULONEPHRITIS#0.7566;MOLECULAR DYNAMICS SIMULATION#0.7554;ENDOMETRIAL CARCINOMA#0.7544;CYTOKINE PRODUCTION#0.7535;RECEPTOR TYROSINE KINASE#0.7509;DYNEIN#0.7500;LEUKOCYTE#0.7481;NERVOUS SYSTEM#0.7469;ZINC FINGER PROTEIN#0.7464;REGULATION OF GENE EXPRESSION#0.7453;THROMBOCYTOPENIA#0.7430;FOCAL ADHESION#0.7426;AKT SIGNALING#0.7426;T CELL DEVELOPMENT#0.7404;THYMIDINE KINASE#0.7396;CHONDROCYTE#0.7351;ENDOMETRIAL CANCER#0.7347;TREG CELL#0.7343;REGULATION OF ANGIOGENESIS#0.7291;LARYNGEAL CARCINOMA#0.7276;REGENERATION#0.7249;MAPK ACTIVATION#0.7239;BONE CELLS#0.7236;HISTONE MODIFICATION#0.7231;DNA REPAIR ENZYME#0.7223;ASTROCYTOMA#0.7212;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7206;TISSUE GROWTH FACTOR#0.7204;MICROTUBULE#0.7199;MECHANISM OF ACTION#0.7178;DENDRITIC CELL#0.7167;GENE EXPRESSION OMNIBUS#0.7133;SIGNALING MOLECULE#0.7125;ATHEROSCLEROSIS#0.7099;INHIBITION OF ANGIOGENESIS#0.7098;RIBOSE#0.7096;PROMOTER BINDING#0.7093;IMMUNE SYSTEM#0.7039;ATAXIA TELANGIECTASIA#0.7014;SPHINGOSINE#0.6997;SERUM RESPONSE FACTOR#0.6990;ESTRADIOL#0.6984;INFLAMMATORY BOWEL DISEASE#0.6984;DNA REPLICATION#0.6965;HEART DISEASE#0.6960;HEPATITIS C VIRUS#0.6958;VIRAL INFECTION#0.6954;HEPATITIS C#0.6948;INFLAMMATORY CELL#0.6944;CELL MATURATION#0.6942;ENHANCER BINDING PROTEIN#0.6932;NATRIURETIC PEPTIDE RECEPTOR#0.6929;DIABETES MELLITUS#0.6927;NEUTROPHIL#0.6874;HEMATOPOIETIC STEM CELL#0.6869;CELLULAR SENESCENCE#0.6863;B CELL RECEPTOR#0.6856;FACTOR S#0.6851;MOUSE EMBRYONIC FIBROBLAST#0.6842;CHRONIC MYELOID LEUKEMIA#0.6832;TRANSCRIPTION FACTOR ACTIVITY#0.6823;GROWTH HORMONE#0.6794;LUMINAL#0.6793;VENTRICULAR SEPTAL DEFECT#0.6755;ERYTHROID CELL#0.6747;TISSUE REMODELING#0.6746;KAPOSI'S SARCOMA#0.6720;BONE MORPHOGENETIC PROTEIN#0.6719;CONGENITAL HEART DISEASE#0.6719;DUAL LUCIFERASE REPORTER#0.6699;TH2 CELL#0.6686;TH1 CELL#0.6680;ALL TRANS RETINOIC ACID#0.6671;HODGKIN'S LYMPHOMA#0.6667;NUCLEOSOME#0.6660;ENDOMETRIUM#0.6644;LYMPHOID ORGANS#0.6634;AUTOIMMUNITY#0.6634;CARDIOMYOCYTE#0.6621;ERYTHROLEUKEMIA#0.6581;ACUTE MONOCYTIC LEUKEMIA#0.6578;NEPHROPATHY#0.6567;TRANSLATION INITIATION#0.6561;NEURAL PLATE#0.6530;PROTEIN PHOSPHATASE 2A#0.6524;PHOSPHATASE 2A#0.6520;NITRIC OXIDE SYNTHASE#0.6510;THYMIDINE#0.6482;ACTIVATING TRANSCRIPTION FACTOR#0.6475;CAMP RESPONSE ELEMENT#0.6451;DIABETIC RETINOPATHY#0.6436;ADIPOCYTE#0.6417;ASTROCYTE#0.6414;NEUROBLASTOMA#0.6404;IFN-GAMMA#0.6385;CYTOTOXICITY#0.6380;ARGININE#0.6349;CAMP-RESPONSIVE ELEMENT BINDING#0.6323;METAPHASE#0.6301;N GLYCAN#0.6283;OOCYTE#0.6271;TRANSCRIPTION ACTIVATOR#0.6268;TROPHOBLAST CELL#0.6256;HEMATOPOIETIC PROGENITOR CELL#0.6248;GLYCOLYSIS#0.6245;RNA BINDING#0.6241;ACETYLTRANSFERASE ACTIVITY#0.6236;UMBILICAL CORD#0.6219;NF KAPPAB BINDING#0.6219;CAROTID ARTERY#0.6210;DIABETIC NEPHROPATHY#0.6207;ADIPOSE TISSUE#0.6193;LYMPHOID TISSUE#0.6184;INSULIN-LIKE GROWTH FACTOR#0.6163;COLLAGEN TYPE I#0.6159;ANDROGEN RECEPTOR#0.6156;ANAPLASTIC MENINGIOMA#0.6156;PROVIRUS#0.6136;VIRAL REPLICATION#0.6132;SKELETON#0.6112;TOLL LIKE RECEPTOR#0.6099;GASTRULATION#0.6097;BILE DUCT CARCINOMA#0.6078;PROTEIN DNA COMPLEX#0.6062;PAPILLARY CARCINOMA#0.6048;COLON ADENOMA#0.6036;HUMAN PANCREATIC CANCER#0.6019
2114	TRANSACTIVATION#1.0327;PROSTATE CANCER#1.0260;MAP KINASE#1.0245;MACROPHAGE#1.0229;DOWN SYNDROME#1.0186;EPITHELIAL CELL#1.0186;TROPHOBLAST#1.0131;APOPTOSIS#1.0099;MITOGEN ACTIVATED PROTEIN#1.0097;BREAST CANCER#1.0078;PROTEIN KINASE#1.0057;T CELL#1.0015;TRANSCRIPTION FACTOR#0.9999;SIGNALING PATHWAY#0.9992;DNA BINDING#0.9959;CANCER CELL#0.9940;STEM CELL#0.9927;ENDOTHELIAL CELL#0.9915;GROWTH FACTOR#0.9867;CELL PROLIFERATION#0.9820;ELECTROPHORETIC MOBILITY SHIFT#0.9782;GENE EXPRESSION#0.9773;CELL CYCLE#0.9760;BREAST CANCER CELL#0.9757;COLONY-STIMULATING FACTOR#0.9742;TUMOR SUPPRESSOR#0.9718;ONCOGENIC#0.9711;SUPEROXIDE DISMUTASE#0.9530;LUNG CANCER#0.9517;ANGIOGENESIS#0.9509;FACTOR I#0.9479;TUMOR CELLS#0.9344;POLYMERASE CHAIN REACTION#0.9295;HEPATOCELLULAR CARCINOMA#0.9258;TRANSCRIPTION FACTOR BINDING#0.9197;SIGNAL TRANSDUCTION#0.9134;ADENOCARCINOMA#0.9094;PROTEIN KINASE C#0.8981;SQUAMOUS CELL CARCINOMA#0.8977;UROKINASE#0.8951;PROTEIN PROTEIN INTERACTION#0.8744;CELL DEATH#0.8584;CHORIOCARCINOMA#0.8557;CELL DIFFERENTIATION#0.8512;MYELOID LEUKEMIA#0.8511;TRANSFORMING GROWTH FACTOR#0.8485;B CELL#0.8476;STROMAL CELL#0.8435;UROKINASE PLASMINOGEN ACTIVATOR#0.8427;ANCHORAGE INDEPENDENT GROWTH#0.8419;MYELOID CELL#0.8297;SENESCENCE#0.8240;EPIDERMAL GROWTH FACTOR#0.8224;CELL GROWTH#0.8221;EMBRYONIC STEM CELL#0.8153;CELL MIGRATION#0.8123;INFLAMMATORY RESPONSE#0.8107;BONE MARROW#0.8096;MONOCYTE#0.8074;TRANSCRIPTASE#0.8037;STROMELYSIN#0.8033;PROGENITOR CELL#0.7966;DOMINANT NEGATIVE MUTANT#0.7885;PROTEIN BINDING#0.7869;IMMUNE RESPONSE#0.7723;CELL DEVELOPMENT#0.7694;HEMATOPOIETIC CELL#0.7693;CYCLIN DEPENDENT KINASE#0.7682;PRIMITIVE STREAK#0.7670;ACUTE MYELOID LEUKEMIA#0.7620;REVERSE TRANSCRIPTION#0.7588;APOPTOTIC#0.7563;BREAST CARCINOMA#0.7562;TELOMERASE REVERSE TRANSCRIPTASE#0.7539;TRANSCRIPTIONAL CONTROL#0.7521;STROMA#0.7493;RHEUMATOID ARTHRITIS#0.7463;TROPHECTODERM#0.7457;CAMP-RESPONSIVE ELEMENT BINDING#0.7377;EXTRACELLULAR MATRIX#0.7334;GROWTH FACTOR RECEPTOR#0.7229;MACROPHAGE DIFFERENTIATION#0.7175;KINASE INHIBITOR#0.7167;THYMOCYTE#0.7092;AMYLOID PRECURSOR PROTEIN#0.7073;TELOMERASE ACTIVITY#0.7072;MAPK SIGNALING#0.7043;EPITHELIAL MESENCHYMAL TRANSITION#0.7040;TROPHOBLAST CELL#0.7022;TISSUE ENGINEERED BONE#0.6974;MOUSE EMBRYONIC FIBROBLAST#0.6924;CAMP RESPONSE ELEMENT#0.6913;EPIBLAST#0.6900;PROTEIN KINASE A#0.6876;COLON CANCER#0.6859;ALZHEIMER'S DISEASE#0.6847;MUTAGENESIS#0.6779;MUSCLE CELL#0.6756;ENHANCER BINDING#0.6754;NUCLEAR EXPORT#0.6733;HEMATOPOIETIC STEM CELL#0.6720;MAMMARY EPITHELIAL CELL#0.6714;TUMOR NECROSIS FACTOR#0.6669;ACUTE LEUKEMIA#0.6625;CREB BINDING#0.6563;KINASE ACTIVITY#0.6514;CELL ACTIVATION#0.6510;OSTEOBLAST#0.6462;LYMPH NODE#0.6445;OVARIAN#0.6437;RECEPTOR TYROSINE KINASE#0.6293;T CELL ACTIVATION#0.6268;ACTIVATOR PROTEIN 1#0.6229;ENHANCER BINDING PROTEIN#0.6222;DISEASE FREE SURVIVAL#0.6187;HUMAN BREAST CANCER#0.6185;SMOOTH MUSCLE#0.6145;DNA METHYLATION#0.6144;NEURAL TUBE#0.6083;TELOMERE#0.6041
2115	PROTEIN KINASE#1.0640;GASTROINTESTINAL STROMAL TUMOR#1.0418;ONCOGENIC#1.0262;PROSTATE CANCER#1.0224;CANCER CELL#1.0205;DNA BINDING#1.0146;TRANSCRIPTION FACTOR#1.0143;MAP KINASE#1.0081;BREAST CANCER#1.0065;OLFACTORY BULB#1.0016;MITOGEN ACTIVATED PROTEIN#1.0007;SIGNALING PATHWAY#0.9927;GENE EXPRESSION#0.9922;ANDROGEN RECEPTOR#0.9919;TUMOR SUPPRESSOR#0.9850;SPINAL CORD#0.9845;CELL PROLIFERATION#0.9779;EWING SARCOMA#0.9744;TRANSACTIVATION#0.9524;ADENOCARCINOMA#0.9478;INTERNEURON#0.9399;POLYMERASE CHAIN REACTION#0.9254;GROWTH FACTOR#0.9182;ANCHORAGE INDEPENDENT GROWTH#0.9117;APOPTOSIS#0.8649;STEM CELL#0.8646;CELL CYCLE#0.8629;PROSTATE CARCINOMA#0.8375;RECEPTOR TYROSINE KINASE#0.8191;REVERSE TRANSCRIPTION#0.8153;SIGNALING CASCADE#0.8131;INTERSTITIAL CELL#0.8046;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.8007;CELL GROWTH#0.7986;ONCOGENESIS#0.7928;BREAST CANCER CELL#0.7623;PROGENITOR CELL#0.7362;EPITHELIAL CELL#0.7255;TUMOR CELLS#0.7132;MELANOMA CELL LINES#0.6797;BONE MARROW#0.6785;IMATINIB#0.6777;NEUROGENESIS#0.6395;MYOCYTES#0.6275;KINASE INHIBITOR#0.6197;RIBOSOMAL S6 KINASE#0.6075;MAMMARY GLAND#0.6027;CREB BINDING#0.6026
2116	TRANSCRIPTION FACTOR#1.0436;EMBRYONIC STEM CELL#1.0392;ENDOTHELIAL CELL#1.0311;GENE EXPRESSION#1.0261;STEM CELL#1.0255;VASCULOGENESIS#1.0254;ANGIOGENESIS#1.0251;HEMATOPOIESIS#0.9902;PROGENITOR CELL#0.9604;REGENERATION#0.9557;HEMATOPOIETIC CELL#0.9098;MOUSE EMBRYONIC STEM#0.8467;VEGF SIGNALING#0.8333;YOLK SAC#0.8315;BLOOD VESSEL#0.8272;VASCULAR ENDOTHELIAL CELL#0.8141;ENDOTHELIAL PROGENITOR CELL#0.8099;ENDOTHELIUM#0.7795;HINDLIMB#0.7655;PLURIPOTENT STEM CELL#0.7446;HEMATOPOIETIC STEM CELL#0.7071;ENDOTHELIAL CELL DEVELOPMENT#0.6973;DERMAL FIBROBLAST#0.6949;SKELETAL MUSCLE#0.6850;CELL DEVELOPMENT#0.6656;CELL DIFFERENTIATION#0.6626;EMBRYOID BODY#0.6560;VASCULAR MORPHOGENESIS#0.6425;ISCHEMIA#0.6394;HYPOXIA#0.6372;HEMANGIOBLAST#0.6242;MATRIX METALLOPROTEINASE 1#0.6191;MUSCLE CELL#0.6182;ENDOTHELIAL GROWTH FACTOR#0.6179;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6179;CELL PROLIFERATION#0.6158;GROWTH FACTOR#0.6135;SIGNALING CASCADE#0.6092;SIGNALING PATHWAY#0.6070;MYOCARDIAL INFARCTION#0.6016
2117	MACROPHAGE#0.9705;TRANSCRIPTION FACTOR#0.8442;GENE EXPRESSION#0.7734;CELL CYCLE#0.7620;SCANNING ELECTRON MICROSCOPY#0.7139;CELL CYCLE CONTROL#0.6300;DNA BINDING#0.6276
2118	SQUAMOUS CELL CARCINOMA#1.0309;EWING SARCOMA#1.0204;BREAST CANCER CELL#1.0187;TRANSCRIPTION FACTOR#1.0179;LUNG CANCER#1.0177;PROSTATE CANCER#1.0149;BREAST CANCER#1.0137;LYMPH NODE#1.0082;CELL CYCLE#1.0076;HUMAN BREAST CANCER#1.0064;TRANSACTIVATION#1.0062;CANCER CELL#1.0050;DNA BINDING#1.0049;COLORECTAL CANCER#1.0046;TRANSCRIPTION FACTOR BINDING#1.0033;CELL PROLIFERATION#1.0018;ELECTROPHORETIC MOBILITY SHIFT#1.0007;ONCOGENIC#1.0000;COLLAGENASE#0.9995;EPITHELIAL CELL#0.9947;MAMMARY GLAND#0.9933;URETERIC BUD#0.9925;UROKINASE#0.9906;COLORECTAL#0.9880;SIGNALING PATHWAY#0.9872;TUMOR CELLS#0.9828;PROTEIN KINASE#0.9810;GROWTH FACTOR#0.9803;GENE EXPRESSION#0.9791;BRANCHING MORPHOGENESIS#0.9755;DISEASE FREE SURVIVAL#0.9754;ENHANCER BINDING PROTEIN#0.9736;ENHANCER BINDING#0.9730;MITOGEN ACTIVATED PROTEIN#0.9649;ORAL SQUAMOUS CELL CARCINOMA#0.9645;OVARIAN#0.9644;POLYMERASE CHAIN REACTION#0.9639;ANCHORAGE INDEPENDENT GROWTH#0.9627;FIBROBLAST GROWTH FACTOR#0.9612;ONCOGENESIS#0.9596;APOPTOSIS#0.9568;MAMMARY EPITHELIAL CELL#0.9520;FACTOR I#0.9402;INITIAL SEGMENT#0.9390;ADENOCARCINOMA#0.9326;EXTRACELLULAR MATRIX#0.9305;MORPHOGENESIS#0.9295;STEM CELL#0.9285;RECEPTOR TYROSINE KINASE#0.9283;EPIDERMAL GROWTH FACTOR#0.9227;ACTIVATOR PROTEIN 1#0.9204;OVARIAN CANCER#0.9138;MAP KINASE#0.9138;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.9136;REVERSE TRANSCRIPTION#0.9111;CELL GROWTH#0.9098;SPINAL CORD#0.9026;MESENCHYME#0.8933;CELL MIGRATION#0.8813;CHLORAMPHENICOL#0.8799;OVARIAN CARCINOMA#0.8717;GLAND DEVELOPMENT#0.8529;PROGENITOR CELL#0.8497;STROMELYSIN#0.8434;TUMOR SUPPRESSOR#0.8303;SUMOYLATION#0.8279;EPITHELIAL MESENCHYMAL TRANSITION#0.8272;GROWTH FACTOR RECEPTOR#0.8253;TRANSFORMING GROWTH FACTOR#0.8108;CELL DEATH#0.8095;MAMMARY GLAND DEVELOPMENT#0.8089;TRANSCRIPTIONAL CONTROL#0.7994;CYCLIC AMP#0.7965;UBIQUITIN#0.7954;KIDNEY DEVELOPMENT#0.7945;CELL MOTILITY#0.7877;MAPK SIGNALING#0.7877;EPIDIDYMIS#0.7875;PANCREATIC CANCER#0.7869;LYMPH NODE METASTASIS#0.7852;T CELL#0.7709;MATRIX METALLOPROTEINASE 1#0.7640;ENDOTHELIAL CELL#0.7636;RNA INTERFERENCE#0.7597;RETINOIC ACID#0.7569;UROKINASE PLASMINOGEN ACTIVATOR#0.7493;TUMOR TISSUES#0.7463;NEURAL CREST#0.7413;COLON CANCER#0.7187;EMBRYONAL CARCINOMA#0.7118;PROTEIN BINDING#0.7035;SIGNALING CASCADE#0.7023;TERMINAL END BUD#0.7000;BINDING PROTEIN 3#0.6924;ANGIOGENESIS#0.6913;LUNG DEVELOPMENT#0.6884;TRANSCRIPTASE#0.6850;SIGNAL TRANSDUCTION#0.6846;APOPTOTIC#0.6841;NERVOUS SYSTEM#0.6835;NEURITE#0.6796;BREAST CARCINOMA#0.6795;TRANSFORMING GROWTH FACTOR BETA#0.6749;PROTEIN KINASE C#0.6737;SMOOTH MUSCLE#0.6722;NEURITE OUTGROWTH#0.6699;DNA REPLICATION#0.6534;MUTAGENESIS#0.6532;STROMAL CELL#0.6515;CAMP RESPONSE ELEMENT#0.6509;HEPATOCYTE GROWTH FACTOR#0.6489;ESTROGEN RECEPTOR#0.6460;LYSINE#0.6456;ORGANOGENESIS#0.6377;DOMINANT NEGATIVE MUTANT#0.6321;SEQUENCE SPECIFIC DNA BINDING#0.6297;INNERVATION#0.6225;TISSUE REMODELING#0.6195;DNASE I#0.6189;EMBRYONIC LUNG#0.6119;MACROPHAGE#0.6054;DNASE#0.6049;PROSTATE CARCINOMA#0.6023
2119	SERTOLI CELL#1.0815;T CELL#1.0383;SPERMATOGONIAL STEM CELL#1.0305;DNA BINDING#1.0289;TRANSCRIPTION FACTOR#1.0238;PROSTATE CANCER#1.0180;CANCER CELL#1.0053;STEM CELL#1.0044;GERM CELL#1.0008;GENE EXPRESSION#0.9942;GROWTH FACTOR#0.9888;CELL PROLIFERATION#0.9813;SIGNALING PATHWAY#0.9609;EPITHELIAL CELL#0.9571;TRANSACTIVATION#0.9548;URETERIC BUD#0.9410;GLIAL CELL#0.9366;ONCOGENIC#0.9304;ENDOMETRIAL CANCER#0.9236;BREAST CANCER#0.9152;SPERMATOGENESIS#0.9110;FIBROBLAST GROWTH FACTOR#0.9039;OVARIAN#0.8484;ENDOMETRIAL CARCINOMA#0.8352;MORPHOGENESIS#0.8321;CELL CYCLE#0.8193;POLYMERASE CHAIN REACTION#0.8189;CELL ADHESION#0.8170;KIDNEY DEVELOPMENT#0.7999;CELL DEVELOPMENT#0.7947;NEURAL CREST#0.7944;EPITHELIAL TO MESENCHYMAL#0.7943;BRANCHING MORPHOGENESIS#0.7913;B CELL#0.7787;TUMOR SUPPRESSOR#0.7665;ESTRADIOL#0.7583;PROGESTERONE#0.7492;PROGENITOR CELL#0.7484;UBIQUITIN#0.7382;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7351;THYROID CANCER#0.7338;CELL DIFFERENTIATION#0.7291;OVARIAN CANCER#0.7288;MESENCHYME#0.7279;CELL MIGRATION#0.7222;GROWTH FACTOR RECEPTOR#0.7209;LYMPH NODE#0.7143;INFERTILE#0.7121;APOPTOSIS#0.7074;FACTOR I#0.6999;PROTEIN KINASE#0.6956;RECEPTOR TYROSINE KINASE#0.6800;NEURITE OUTGROWTH#0.6766;EXTRACELLULAR MATRIX#0.6615;TUMOR CELLS#0.6606;SIGNALLING PATHWAY#0.6577;TRANSCRIPTIONAL CONTROL#0.6563;REVERSE TRANSCRIPTION#0.6313;CELL ADHESION MOLECULE#0.6313;ENDOTHELIAL CELL#0.6269;PAPILLARY THYROID CANCER#0.6184;INITIAL SEGMENT#0.6074;INFERTILITY#0.6038
211	ALAS ACTIVITY#1.1142;DELTA-AMINOLEVULINIC ACID#1.0593;AMINOLEVULINATE#1.0568;PYRIDOXAL 5-PHOSPHATE#1.0546;5 AMINOLEVULINATE SYNTHASE#1.0488;SIDEROBLASTIC ANEMIA#1.0476;HEME BIOSYNTHESIS#1.0447;5-AMINOLEVULINIC ACID#1.0402;HEME SYNTHESIS#1.0402;PYRIDOXAL#1.0400;AMINOLEVULINIC ACID#1.0375;HEME BIOSYNTHETIC#1.0363;GLYCINE#1.0315;MITOCHONDRIA#1.0107;CYTOCHROME P450#1.0091;PORPHYRIA#1.0061;GENE EXPRESSION#1.0003;ERYTHROID CELL#0.9994;BONE MARROW#0.9970;ANEMIA#0.9848;OXYGENASE#0.9766;PORPHOBILINOGEN#0.9684;PROTOPORPHYRIN IX#0.9308;ACUTE INTERMITTENT PORPHYRIA#0.9263;ENZYME ACTIVITY#0.8950;PHENOBARBITAL#0.8936;HEME METABOLISM#0.8933;BONE MARROW CELLS#0.8507;HEME OXYGENASE 1#0.8507;MITOCHONDRIAL MATRIX#0.8405;ACUTE PORPHYRIA#0.8403;COPROPORPHYRINOGEN OXIDASE#0.8329;SUCCINYL-COENZYME A#0.8244;POLYMERASE CHAIN REACTION#0.8121;ERYTHROPOIESIS#0.7983;HARDERIAN GLAND#0.7913;COENZYME A#0.7866;TRANSCRIPTION FACTOR#0.7780;PEROXISOME#0.7678;UROPORPHYRINOGEN DECARBOXYLASE#0.7436;NEUROTOXIC#0.7305;SKELETAL MUSCLE#0.7303;CYTOCHROME C#0.7248;PROTEIN SYNTHESIS#0.7112;PROTEIN KINASE#0.7044;CATABOLISM#0.6615;PERIPHERAL BLOOD#0.6550;HYDROXYMETHYLBILANE SYNTHASE#0.6508;ALANINE#0.6233;REVERSE TRANSCRIPTION#0.6054;QUANTITATIVE REAL TIME#0.6014
2120	CONGENITAL FIBROSARCOMA#1.0747;MESOBLASTIC NEPHROMA#1.0473;CHRONIC MYELOMONOCYTIC LEUKEMIA#1.0445;CONGENITAL MESOBLASTIC NEPHROMA#1.0385;CORD BLOOD#1.0380;PROTEIN TYROSINE KINASE#1.0322;PLATELET-DERIVED GROWTH FACTOR#1.0291;FIBROSARCOMA#1.0207;KINASE ACTIVITY#1.0205;INTERPHASE#1.0195;DNA BINDING#1.0190;PROGENITOR CELL#1.0171;TRANSCRIPTASE#1.0169;HISTONE DEACETYLASE#1.0167;MYELOPROLIFERATIVE NEOPLASM#1.0147;CELL DIFFERENTIATION#1.0129;IMATINIB#1.0107;GROWTH FACTOR RECEPTOR#1.0102;BREAST CARCINOMA#1.0079;SALIVARY GLAND#1.0064;PERIPHERAL BLOOD#1.0048;CHILDHOOD LEUKEMIA#1.0033;COMPARATIVE GENOMIC HYBRIDIZATION#1.0031;WHITE BLOOD CELL#1.0030;GROWTH FACTOR#1.0025;MYELOID NEOPLASM#1.0014;TUMOR SUPPRESSOR#1.0001;TRANSCRIPTION FACTOR#1.0001;CHRONIC MYELOID LEUKEMIA#0.9998;T CELL#0.9962;HEMATOPOIETIC CELL#0.9953;HEMATOPOIESIS#0.9953;COPY NUMBER ALTERATION#0.9943;CELL GROWTH#0.9937;POLYMERASE CHAIN REACTION#0.9935;REVERSE TRANSCRIPTION#0.9919;CELL PROLIFERATION#0.9914;SIGNALING PATHWAY#0.9910;RECEPTOR TYROSINE KINASE#0.9904;ONCOGENIC#0.9902;MYELODYSPLASTIC SYNDROME#0.9896;HEMATOPOIETIC STEM CELL#0.9895;MINIMAL RESIDUAL DISEASE#0.9894;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9879;BONE MARROW CELLS#0.9877;B CELL#0.9876;ACUTE MYELOID LEUKEMIA#0.9869;SIGNAL TRANSDUCER#0.9864;TYROSINE KINASE INHIBITOR#0.9862;CELL CYCLE#0.9853;MYELOID LEUKEMIA#0.9847;APOPTOSIS#0.9842;ACUTE LEUKEMIA#0.9841;KINASE INHIBITOR#0.9840;SIGNAL TRANSDUCTION#0.9831;STEM CELL#0.9825;LYMPHOCYTIC LEUKEMIA#0.9810;BREAST CANCER#0.9805;EVENT FREE SURVIVAL#0.9800;GENE EXPRESSION#0.9790;ACUTE LYMPHOCYTIC LEUKEMIA#0.9775;PROTEIN KINASE#0.9756;BONE MARROW#0.9739;MYELOID CELL#0.9720;B CELL DIFFERENTIATION#0.9714;STEM CELL TRANSPLANTATION#0.9695;DRUG RESISTANCE#0.9674;DOWN SYNDROME#0.9654;BLAST CELL#0.9601;IMATINIB MESYLATE#0.9569;TUMOR CELLS#0.9563;LYMPHOID LEUKEMIA#0.9542;TRANSACTIVATION#0.9516;CELL DEVELOPMENT#0.9510;ADENOCARCINOMA#0.9492;CYTOPLASM#0.9478;METAPHASE#0.9471;TYROSINE KINASE RECEPTOR#0.9443;THROMBOCYTOPENIA#0.9397;LYMPHOID CELL#0.9333;APOPTOTIC#0.9316;TYROSINE KINASE DOMAIN#0.9306;T-CELL LEUKEMIA#0.9296;DISEASE FREE SURVIVAL#0.9149;CYCLIN DEPENDENT KINASE#0.9146;MYELOFIBROSIS#0.9134;THYROID CARCINOMA#0.9095;MUCOEPIDERMOID CARCINOMA#0.9085;NERVOUS SYSTEM#0.9042;LYMPH NODE#0.8963;DENDRITIC CELL#0.8925;CENTRAL NERVOUS SYSTEM#0.8913;B CELL DEVELOPMENT#0.8862;RELAPSE FREE SURVIVAL#0.8861;FUSION TYROSINE KINASE#0.8841;MITOGEN ACTIVATED PROTEIN#0.8839;PAROTID GLAND#0.8749;CELL DEATH#0.8729;CYCLIN DEPENDENT KINASE INHIBITOR#0.8729;PAPILLARY THYROID CARCINOMA#0.8648;CANCER CELL#0.8648;MONONUCLEAR CELLS#0.8638;RETINOIC ACID#0.8593;ACUTE MYELOID LEUKAEMIA#0.8575;IDARUBICIN#0.8557;PLEOMORPHIC ADENOMA#0.8528;EOSINOPHIL#0.8503;LEUKOCYTE#0.8453;THYROID CANCER#0.8378;B CELL LYMPHOMA#0.8355;IMMUNE RESPONSE#0.8329;COPY NUMBER VARIATION#0.8326;ADENOID CYSTIC CARCINOMA#0.8308;ACUTE PROMYELOCYTIC LEUKEMIA#0.8243;NOT OTHERWISE SPECIFIED#0.8242;CYTOKINE RECEPTOR#0.8181;ANEMIA#0.8151;LYMPHOBLAST#0.8132;B LYMPHOCYTE#0.8129;CONVENTIONAL CYTOGENETIC ANALYSIS#0.8123;RISK OF RELAPSE#0.8073;PREDNISOLONE#0.8033;ENDOTHELIAL CELL#0.8031;REPORTER GENE ASSAY#0.8006;DNA REPAIR#0.7919;PROSTATE CANCER#0.7911;FETAL LIVER#0.7688;HISTONE DEACETYLASE INHIBITOR#0.7684;AGE AT DIAGNOSIS#0.7673;COPY NUMBER CHANGE#0.7667;MEGAKARYOCYTE#0.7640;VINCRISTINE#0.7623;POLYCYTHEMIA VERA#0.7608;EPITHELIAL CELL#0.7581;BREAST SECRETORY CARCINOMA#0.7579;PLASMACYTOID DENDRITIC CELL#0.7574;MUTAGENESIS#0.7567;ONCOGENESIS#0.7457;PERIPHERAL T-CELL LYMPHOMA#0.7439;LYMPHOPROLIFERATIVE DISEASE#0.7419;CYSTADENOCARCINOMA#0.7329;GRANULOCYTE#0.7328;EPIDERMAL GROWTH FACTOR#0.7318;CELL SURFACE#0.7314;DNA METHYLATION#0.7308;MAP KINASE#0.7293;TOXICITY#0.7226;FIBROBLAST GROWTH FACTOR#0.7174;FINE NEEDLE ASPIRATION#0.7172;CHROMOSOME REGION#0.7169;WORLD HEALTH ORGANIZATION#0.7160;ZYMOGEN GRANULE#0.7157;INSULIN-LIKE GROWTH FACTOR#0.7113;ANGIOGENESIS#0.7105;SUMOYLATION#0.7048;EMBRYONIC STEM CELL#0.6999;CHROMOSOMAL REGION#0.6956;HODGKIN'S LYMPHOMA#0.6936;FACTOR I#0.6892;COLONY-STIMULATING FACTOR#0.6884;TELOMERE#0.6828;G-CSF#0.6807;TRANSCRIPTION REPRESSOR#0.6801;NATIONAL CANCER INSTITUTE#0.6787;MACROPHAGE#0.6778;WHOLE GENOME SEQUENCING#0.6778;PREDNISONE#0.6759;RESPONSE TO TREATMENT#0.6732;YOLK SAC#0.6726;SALIVARY DUCT CARCINOMA#0.6712;UMBILICAL CORD BLOOD#0.6711;UMBILICAL CORD#0.6686;INTERNAL TANDEM DUPLICATION#0.6656;IFN-GAMMA#0.6543;POLYCYTHEMIA#0.6528;BACTERIAL ARTIFICIAL CHROMOSOME#0.6521;QUANTITATIVE REAL TIME#0.6413;CORE BINDING FACTOR#0.6367;GROWTH PATTERN#0.6353;DEFINITIVE HEMATOPOIESIS#0.6327;X CHROMOSOME#0.6269;DOUBLE STRAND BREAK#0.6256;SPECIFIC TRANSCRIPTIONAL REPRESSOR#0.6255;HEMATOPOIETIC PROGENITOR CELL#0.6227;DNA COPY NUMBER#0.6222;SIGNALING MOLECULE#0.6173;RESPONSE TO IL-3#0.6153;JUXTAMEMBRANE#0.6087;HYPEREOSINOPHILIC SYNDROME#0.6081;LYSINE#0.6049
2121	ELLIS-VAN CREVELD SYNDROME#0.8500;GENE EXPRESSION#0.7328;TRANSCRIPTION FACTOR#0.7209;T CELL#0.6184
2122	CANCER CELL#1.0751;ONCOGENIC#1.0477;HEMATOPOIETIC CELL#1.0369;TRANSCRIPTION FACTOR#1.0280;DNA BINDING#1.0265;APOPTOSIS#1.0255;OVARIAN CANCER#1.0255;COLON CANCER#1.0251;MYELODYSPLASTIC SYNDROME#1.0242;MYELOID LEUKEMIA#1.0240;B CELL#1.0233;ACUTE MYELOID LEUKEMIA#1.0229;OVARIAN#1.0218;GENE EXPRESSION#1.0128;CELL PROLIFERATION#1.0127;STEM CELL#1.0103;HEMATOPOIETIC STEM CELL#1.0098;BONE MARROW#1.0070;PROGENITOR CELL#1.0043;ZINC FINGER PROTEIN#0.9977;HISTONE DEACETYLASE#0.9971;POLYMERASE CHAIN REACTION#0.9966;HEMATOPOIESIS#0.9950;MYELOID CELL#0.9905;GROWTH FACTOR#0.9826;CHRONIC MYELOID LEUKEMIA#0.9725;CELL DIFFERENTIATION#0.9623;ARSENIC TRIOXIDE#0.9617;CELL CYCLE#0.9582;RETINOIC ACID#0.9418;TRANSFORMING GROWTH FACTOR#0.9354;TUMOR SUPPRESSOR#0.9307;ACUTE MYELOID LEUKAEMIA#0.9162;HISTONE METHYLTRANSFERASE#0.8940;CELL DEATH#0.8836;MIXED LINEAGE LEUKEMIA#0.8719;MYELOID NEOPLASM#0.8624;TRANSFORMING GROWTH FACTOR BETA#0.8300;PROTEIN KINASE#0.8185;RADIOULNAR SYNOSTOSIS#0.8164;BREAST CANCER#0.8142;SIGNALING PATHWAY#0.8100;ALL TRANS RETINOIC ACID#0.8065;OVARIAN CARCINOMA#0.8058;CHROMATIN REMODELING#0.7979;THROMBOCYTOPENIA#0.7961;PERIPHERAL BLOOD#0.7946;GRANULOCYTE#0.7908;KINASE INHIBITOR#0.7719;TRANSCRIPTION REPRESSOR#0.7689;REVERSE TRANSCRIPTION#0.7633;BONE MARROW FAILURE#0.7567;GLYCOGEN SYNTHASE KINASE#0.7522;CATALYTIC ACTIVITY#0.7494;BONE MARROW CELLS#0.7478;CELL GROWTH#0.7268;APOPTOTIC#0.7214;MYELOPROLIFERATIVE NEOPLASM#0.7198;INTERPHASE#0.7182;PRECURSOR CELL#0.7098;MACROPHAGE#0.7081;EPITHELIAL CELL#0.7055;ONCOGENESIS#0.6960;HAEMATOPOIETIC STEM CELL#0.6865;ACUTE LEUKEMIA#0.6843;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6786;REPORTER GENE ASSAY#0.6783;MINIMAL RESIDUAL DISEASE#0.6587;NEURAL CREST#0.6551;TRANSACTIVATION#0.6541;DRUG RESISTANCE#0.6519;T CELL#0.6462;QUIESCENCE#0.6437;MEGAKARYOCYTE#0.6424;TYROSINE KINASE INHIBITOR#0.6314;HEMATOPOIETIC PRECURSOR CELL#0.6306;COLORECTAL CANCER#0.6291;CELL ADHESION#0.6287;SYNOSTOSIS#0.6195;NUCLEAR SPECKLE#0.6163;EVENT FREE SURVIVAL#0.6144;CRANIOFACIAL DEVELOPMENT#0.6121;DNA HYPERMETHYLATION#0.6069;LYMPH NODE#0.6028;EPITHELIAL MESENCHYMAL TRANSITION#0.6022
2123	TUMOR SUPPRESSOR#0.6574;MYELOID LEUKEMIA#0.6268
2125	CORNIFIED ENVELOPE#1.0756;BULLOUS PEMPHIGOID#1.0621;INTERMEDIATE FILAMENT#1.0225;PEMPHIGUS#1.0212;DESMOSOME#0.9999;KERATINOCYTE#0.9699;PLASMA MEMBRANE#0.8526;PEMPHIGUS VULGARIS#0.8169;BLISTERING#0.7849;BRONCHIOLITIS OBLITERANS#0.6653;CELL SURFACE#0.6607;LICHEN PLANUS#0.6288
2128	SPINAL CORD#0.9755;TRANSCRIPTION FACTOR#0.9239;INTERNEURON#0.8813;PRIMITIVE STREAK#0.7909;CENTRAL NERVOUS SYSTEM#0.7717;NERVOUS SYSTEM#0.7704;NEURAL TUBE#0.7410;FIN DEVELOPMENT#0.6810;GASTRULATION#0.6615;PROSTATE CANCER#0.6535;CANCER CELL#0.6255
212	5 AMINOLEVULINATE SYNTHASE#1.0746;SIDEROBLASTIC ANEMIA#1.0599;5-AMINOLEVULINIC ACID#1.0584;HEME SYNTHESIS#1.0571;AMINOLEVULINATE#1.0539;AMINOLEVULINIC ACID#1.0512;PYRIDOXINE#1.0504;HEME BIOSYNTHESIS#1.0402;ERYTHROID CELL#1.0335;GLOBIN#1.0303;ANEMIA#1.0300;X CHROMOSOME#1.0291;IRON OVERLOAD#1.0127;GENE EXPRESSION#0.9866;ANAEMIA#0.9823;PORPHYRIA#0.9812;HEME BIOSYNTHETIC#0.9775;ERYTHROPOIESIS#0.9770;BONE MARROW#0.9742;TRANSCRIPTION FACTOR#0.9701;PROTOPORPHYRIN IX#0.9587;HYPOXIA#0.9564;ERYTHROPOIETIC PROTOPORPHYRIA#0.9410;DELTA-AMINOLEVULINIC ACID#0.9174;PERIPHERAL BLOOD#0.9172;ERYTHROBLAST#0.9164;MITOCHONDRIA#0.8789;ERYTHROCYTE#0.8759;STEM CELL#0.8524;ERYTHROLEUKEMIA#0.8483;HEMOGLOBIN SYNTHESIS#0.8365;MICROCYTIC ANEMIA#0.8213;RED BLOOD CELL#0.8205;CELL DIFFERENTIATION#0.8029;ENZYME ACTIVITY#0.7903;ERYTHROID PRECURSOR#0.7807;IRON REGULATORY PROTEIN#0.7771;PYRIDOXAL#0.7692;PYRIDOXAL 5-PHOSPHATE#0.7636;POLYMERASE CHAIN REACTION#0.7274;HYPOXIC#0.7228;TRANSFERRIN RECEPTOR#0.6967;ERYTHROID PROGENITOR#0.6899;RETICULOCYTE#0.6870;MYELODYSPLASTIC SYNDROME#0.6851;CENTROMERE#0.6816;GLYCINE#0.6813;PHOTOSENSITIVITY#0.6667;PROGENITOR CELL#0.6523;IRON HOMEOSTASIS#0.6426;OXYGENASE#0.6261;HEMATOPOIESIS#0.6172;CELL DEATH#0.6042
2130	EWING FAMILY TUMORS#1.0719;ANGIOMATOID FIBROUS HISTIOCYTOMA#1.0459;TRANSACTIVATION#1.0412;RNA INTERFERENCE#1.0332;RNA BINDING PROTEIN#1.0327;RNA HELICASE#1.0302;CLEAR CELL CARCINOMA#1.0296;RNA BINDING#1.0288;BINDING PROTEIN 1#1.0281;EXTRASKELETAL MYXOID CHONDROSARCOMA#1.0263;MYOEPITHELIAL CARCINOMA#1.0258;MYXOID CHONDROSARCOMA#1.0253;MYXOID LIPOSARCOMA#1.0232;MYOEPITHELIOMA#1.0210;ACTIVATING TRANSCRIPTION FACTOR#1.0208;EWING SARCOMA#1.0191;DESMOPLASTIC SMALL ROUND CELL TUMOR#1.0174;ONCOGENESIS#1.0171;FIBROUS HISTIOCYTOMA#1.0164;DNA BINDING#1.0160;HISTIOCYTOMA#1.0156;T CELL#1.0133;ONCOGENIC#1.0129;LIPOSARCOMA#1.0121;TRANSCRIPTION FACTOR#1.0112;TRANSCRIPTASE#1.0109;MESENCHYMAL STEM CELL#1.0108;REVERSE TRANSCRIPTION#1.0088;CLEAR CELL SARCOMA#1.0082;CHONDROSARCOMA#1.0076;RNA HELICASE A#1.0067;ALVEOLAR RHABDOMYOSARCOMA#1.0019;TUMOR SUPPRESSOR#1.0012;GENE EXPRESSION#1.0011;POLYMERASE CHAIN REACTION#1.0004;ARGININE#0.9988;RHABDOMYOSARCOMA#0.9984;STEM CELL#0.9973;FORMALIN#0.9973;CELL CYCLE#0.9970;CELL DEATH#0.9957;CELL PROLIFERATION#0.9943;NEUROBLASTOMA#0.9924;SYNOVIAL SARCOMA#0.9922;INTERPHASE#0.9921;INSULIN-LIKE GROWTH FACTOR#0.9921;SALIVARY GLAND#0.9921;FIBROSARCOMA#0.9918;BONE MARROW#0.9918;PROGENITOR CELL#0.9913;CELL GROWTH#0.9909;APOPTOSIS#0.9909;NEUROECTODERMAL TUMOR#0.9903;SIGNALING PATHWAY#0.9881;GROWTH FACTOR#0.9870;CELL SURFACE#0.9858;LATERAL SCLEROSIS#0.9843;AMYOTROPHIC LATERAL SCLEROSIS#0.9815;ANCHORAGE INDEPENDENT GROWTH#0.9800;PERIPHERAL BLOOD#0.9798;PROTEIN PROTEIN INTERACTION#0.9797;B CELL#0.9758;SOFT TISSUE SARCOMA#0.9734;APOPTOTIC#0.9715;GASTROINTESTINAL TRACT#0.9715;RNA PROCESSING#0.9633;TUMOR CELLS#0.9619;STROMA#0.9602;CYTOPLASM#0.9586;SMOOTH MUSCLE#0.9574;SMOOTH MUSCLE ACTIN#0.9544;HISTONE DEACETYLASE#0.9525;LYMPH NODE#0.9520;CELL CYCLE ARREST#0.9504;SENESCENCE#0.9502;NERVOUS SYSTEM#0.9496;MESENCHYMAL PROGENITOR CELL#0.9485;TOXICITY#0.9475;BINDING PROTEIN 3#0.9423;DOXORUBICIN#0.9407;CHROMATIN REMODELING#0.9391;CANCER CELL#0.9359;CENTRAL NERVOUS SYSTEM#0.9348;VINCRISTINE#0.9343;TRABECTEDIN#0.9269;GROWTH PATTERN#0.9243;RNA SPLICING#0.9228;NEURAL CREST#0.9171;COMPARATIVE GENOMIC HYBRIDIZATION#0.9161;OVARIAN#0.9125;BONE CANCER#0.9123;MYELOID LEUKEMIA#0.9109;GROWTH FACTOR RECEPTOR#0.9108;EVENT FREE SURVIVAL#0.9097;NEURODEGENERATIVE DISEASE#0.9096;MESENCHYMAL CELL#0.9086;ENDOTHELIAL CELL#0.9022;KINASE INHIBITOR#0.8989;ETOPOSIDE#0.8962;C TERMINAL DOMAIN#0.8956;PROTEIN KINASE#0.8894;MAGNETIC RESONANCE IMAGING#0.8882;IFOSFAMIDE#0.8868;CELL MIGRATION#0.8850;HISTOGENESIS#0.8835;FINE NEEDLE ASPIRATION#0.8831;MUCOEPIDERMOID CARCINOMA#0.8730;CYTOTOXICITY#0.8727;FOCAL ADHESION#0.8707;CYCLOPHOSPHAMIDE#0.8679;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.8644;DNA DAMAGE RESPONSE#0.8597;POLY ADP RIBOSE#0.8590;RAPAMYCIN#0.8580;TRANSFORMING GROWTH FACTOR#0.8504;DNA METHYLATION#0.8490;CAMP RESPONSE ELEMENT#0.8477;DENDRITIC CELL#0.8464;FACTOR I#0.8444;MRNA SPLICING#0.8440;CELL CYCLE REGULATOR#0.8435;NUCLEAR IMPORT#0.8406;ACUTE MYELOID LEUKEMIA#0.8385;PLATELET-DERIVED GROWTH FACTOR#0.8352;NODULAR#0.8306;RENAL CELL CARCINOMA#0.8225;HUMAN MESENCHYMAL STEM#0.8224;CELLULAR TRANSCRIPTION#0.8219;FEMUR#0.8171;MTDNA#0.8147;NUCLEAR LOCALIZATION SIGNAL#0.8112;SMALL CELL CARCINOMA#0.8059;MITHRAMYCIN#0.8057;CYCLIN DEPENDENT KINASE#0.8048;MINIMAL RESIDUAL DISEASE#0.8043;FIBROBLAST GROWTH FACTOR#0.8042;IMMUNE RESPONSE#0.8030;SIGNAL TRANSDUCTION#0.8016;ADENOCARCINOMA#0.8003;CELL ADHESION#0.7966;TRANSPORTIN#0.7957;FRONTOTEMPORAL DEMENTIA#0.7953;GLYCINE#0.7939;GLYCOSYLATION#0.7837;AGGRESSIVE BEHAVIOR#0.7776;DIED OF DISEASE#0.7762;STRESS GRANULE#0.7743;ADAMANTINOMA#0.7739;PRECURSOR CELL#0.7735;CELL DIFFERENTIATION#0.7727;TUMOR TISSUES#0.7726;PAROTID GLAND#0.7711;DERMIS#0.7576;RNA METABOLISM#0.7525;RIBOSE#0.7515;CREB BINDING#0.7462;GENOTOXIC#0.7454;MOLECULAR FUNCTION#0.7441;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7435;ENHANCER BINDING PROTEIN#0.7434;ENHANCER BINDING#0.7429;AUTOPHAGY#0.7408;NEUROFILAMENT#0.7386;EMBRYONIC STEM CELL#0.7359;GROWTH FACTOR BINDING#0.7335;PELVIS#0.7321;MESENCHYMAL CHONDROSARCOMA#0.7279;ABDOMINAL PAIN#0.7242;SALIVARY GLAND CARCINOMA#0.7224;POSITRON EMISSION TOMOGRAPHY#0.7217;LEIOMYOSARCOMA#0.7209;DNA REPAIR#0.7199;STROMAL CELL#0.7188;NOT OTHERWISE SPECIFIED#0.7187;HISTONE DEACETYLASE INHIBITOR#0.7178;APOPTOTIC CELL DEATH#0.7164;MEDULLOBLASTOMA#0.7144;TRANSFORMING GROWTH FACTOR BETA#0.7137;ACTIN CYTOSKELETON#0.7125;CELL MEMBRANE#0.7117;CAMP RESPONSE ELEMENT BINDING#0.7019;MICROTUBULE#0.6993;LYMPHOBLASTIC LYMPHOMA#0.6962;SPINAL CORD#0.6947;DEMENTIA#0.6892;PRE-MRNA SPLICING#0.6888;SMALL INTESTINE#0.6877;TELOMERASE ACTIVITY#0.6862;ADIPOGENESIS#0.6861;METAPHASE#0.6841;CERVICAL#0.6835;SCLEROTIC#0.6831;URINARY BLADDER#0.6770;ACTINOMYCIN D#0.6761;AGE AT DIAGNOSIS#0.6745;CAMP-RESPONSIVE ELEMENT BINDING#0.6741;GLCNAC#0.6738;MOUSE EMBRYONIC FIBROBLAST#0.6705;CELLULAR SENESCENCE#0.6705;RECEPTOR TYROSINE KINASE#0.6700;PROSTATE CANCER#0.6678;HEPATOCYTE NUCLEAR FACTOR#0.6677;ELECTROPHORETIC MOBILITY SHIFT#0.6673;CONNECTIVE TISSUE#0.6655;ET-743#0.6622;GASTROINTESTINAL STROMAL TUMOR#0.6599;WILMS TUMOR 1#0.6561;PERIPHERAL NERVE#0.6558;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6549;LYMPH NODE METASTASIS#0.6525;REGULATION OF GENE EXPRESSION#0.6462;CANCER STEM CELL#0.6440;EPITHELIOID SARCOMA#0.6434;GLYCOLYSIS#0.6423;HYPOXIA#0.6412;TYROSINE KINASE INHIBITOR#0.6409;PROTEASOME#0.6273;ADENOID CYSTIC CARCINOMA#0.6225;SKELETAL MUSCLE#0.6212;EXTRACELLULAR MATRIX#0.6210;CYCLIN DEPENDENT KINASE INHIBITOR#0.6208;BREAST CANCER#0.6194;EXOSOME#0.6184;OSTEOCLAST#0.6177;TOPOISOMERASE#0.6159;QUANTITATIVE REAL TIME#0.6155;GIANT CELL TUMOR#0.6117;SPINDLE CELL SARCOMA#0.6115;TEMOZOLOMIDE#0.6112;DISEASE FREE SURVIVAL#0.6097;OLFACTORY NEUROBLASTOMA#0.6096;GLYCINE BIOSYNTHESIS#0.6013
2131	EXOSTOSIS#1.0496;TUMOR SUPPRESSOR#1.0450;HEREDITARY MULTIPLE EXOSTOSES#1.0356;CHONDROCYTE#1.0205;POLYMERASE CHAIN REACTION#1.0200;CHONDROSARCOMA#1.0071;GENE EXPRESSION#1.0059;GROWTH FACTOR#0.9903;PROTEOGLYCAN#0.9867;CELL SURFACE#0.9738;HEPARIN#0.9659;EXTRACELLULAR MATRIX#0.9595;SIGNALING PATHWAY#0.9587;CANCER CELL#0.9239;COMPARATIVE GENOMIC HYBRIDIZATION#0.9088;STEM CELL#0.9047;B CELL#0.8755;CHONDROCYTE PROLIFERATION#0.8464;BONE GROWTH#0.8376;FIBROBLAST GROWTH FACTOR#0.8273;CELL CYCLE#0.8203;SULFATION#0.8111;ENDOTHELIAL CELL#0.8054;GENETIC DISORDER#0.8019;ENDOPLASMIC RETICULUM#0.7839;PROGENITOR CELL#0.7708;GLCNAC#0.7680;HEPARIN SULFATE#0.7668;BONE MARROW#0.7538;GLYCOSYLTRANSFERASE ACTIVITY#0.7503;CHROMOSOMAL REGION#0.7497;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7427;GASTRULATION#0.7414;GOLGI APPARATUS#0.7338;MORPHOGENESIS#0.7272;CELL PROLIFERATION#0.7241;PARATHYROID HORMONE#0.7209;GLYCOSYLATION#0.6915;BONE DEVELOPMENT#0.6880;BREAST CANCER#0.6743;T CELL#0.6672;CHONDROCYTE DIFFERENTIATION#0.6629;CHONDROGENESIS#0.6567;PARATHYROID#0.6560;APOPTOSIS#0.6437;ENDOCHONDRAL OSSIFICATION#0.6418;CHROMOSOME REGION#0.6366;OSSIFICATION#0.6344;SEMEN#0.6298;MESENCHYMAL CELL#0.6239;REVERSE TRANSCRIPTION#0.6184;BONE FORMATION#0.6173;ENCHONDROMATOSIS#0.6145;BRAIN DEVELOPMENT#0.6092;MENTAL RETARDATION#0.6085;SPINAL CORD#0.6029
2132	TYPE 2 DIABETES#1.0595;EXOSTOSIS#1.0479;TUMOR SUPPRESSOR#1.0300;HEREDITARY MULTIPLE EXOSTOSES#1.0222;CHONDROCYTE#0.9960;CHONDROSARCOMA#0.9944;PROTEOGLYCAN#0.9862;POLYMERASE CHAIN REACTION#0.9838;GROWTH FACTOR#0.8343;SIGNALING PATHWAY#0.8004;EXTRACELLULAR MATRIX#0.7854;CELL SURFACE#0.7613;GOLGI APPARATUS#0.7404;BONE FORMATION#0.7344;HEPARIN#0.6941;GENETIC DISORDER#0.6833;TYPE 2 DIABETES MELLITUS#0.6767;2 DIABETES MELLITUS#0.6767;GLYCOSYLTRANSFERASE ACTIVITY#0.6755;ENDOTHELIAL CELL#0.6752;BONE GROWTH#0.6749;DIABETES MELLITUS#0.6725;HEPARIN SULFATE#0.6536;CHONDROCYTE PROLIFERATION#0.6492;GLCNAC#0.6459;LIMB DEVELOPMENT#0.6138;SULFATION#0.6019
2133	HEREDITARY MULTIPLE EXOSTOSES#0.9423;TUMOR SUPPRESSOR#0.6932
2134	TUMOR SUPPRESSOR#0.6543;NEUROBLASTOMA#0.6248;B CELL#0.6020
2135	TUMOR SUPPRESSOR#0.8654;GLCNAC#0.7797;HEREDITARY MULTIPLE EXOSTOSES#0.7683;HEPATOCYTE PROLIFERATION#0.6564;VASCULAR SMOOTH MUSCLE CELL#0.6421;SMOOTH MUSCLE CELL#0.6385;SMOOTH MUSCLE#0.6362;MUSCLE CELL#0.6292;REGENERATION#0.6167
2137	BETA CELL#0.9886;TUMOR SUPPRESSOR#0.8309;CANCER CELL#0.7846;COLORECTAL CANCER#0.7453;GROWTH FACTOR#0.7087;PROTEOGLYCAN#0.6676;GENE EXPRESSION#0.6581;REGENERATION#0.6499;SIGNALING PATHWAY#0.6315;HEREDITARY MULTIPLE EXOSTOSES#0.6212;BREAST CANCER#0.6186
2138	EAR DEVELOPMENT#1.0531;MESENCHYME#1.0391;MORPHOGENESIS#1.0359;INNER EAR#1.0337;METANEPHRIC MESENCHYME#1.0133;INNER EAR DEVELOPMENT#1.0129;TRANSCRIPTION FACTOR#1.0110;CELL PROLIFERATION#1.0018;KIDNEY DEVELOPMENT#1.0016;GENE EXPRESSION#0.9991;HEARING LOSS#0.9888;HAIR CELL#0.9700;BREAST CANCER#0.9449;SENSORY ORGAN#0.9386;EPITHELIAL CELL#0.9271;URETERIC BUD#0.9081;BRANCHIAL ARCH#0.9003;APOPTOSIS#0.8979;CELL DIFFERENTIATION#0.8952;PANCREATIC CANCER#0.8921;NEURAL CREST#0.8867;PROGENITOR CELL#0.8780;CANCER CELL#0.8741;EMBRYONIC LUNG#0.8698;NEUROGENESIS#0.8674;STEM CELL#0.8590;NEPHRON#0.8500;NEURAL PLATE#0.8480;ORGANOGENESIS#0.8461;POLYMERASE CHAIN REACTION#0.8407;MESENCHYMAL CELL#0.7954;CELL DEATH#0.7841;OTOCYST#0.7719;SKELETAL MUSCLE#0.7635;SIGNALING PATHWAY#0.7608;CELL POLARITY#0.7577;CELL CYCLE#0.7075;GROWTH FACTOR#0.7015;SPINDLE ORIENTATION#0.7013;DNA BINDING#0.6999;CERVICAL#0.6992;MIDDLE EAR#0.6963;PARATHYROID#0.6941;HEARING IMPAIRMENT#0.6796;QUANTITATIVE REAL TIME#0.6770;ORGAN DEVELOPMENT#0.6721;EAR MORPHOGENESIS#0.6597;CELL DEVELOPMENT#0.6552;SOMITE#0.6468;BRANCHIOOTIC SYNDROME#0.6431;HAIR CELL DIFFERENTIATION#0.6377;OROFACIAL CLEFT#0.6260;LUNG DEVELOPMENT#0.6198;NEPHROGENESIS#0.6171;RENAL AGENESIS#0.6054
2139	CANCER CELL#1.0516;BREAST CANCER#1.0355;TRANSCRIPTION FACTOR#1.0066;CELL PROLIFERATION#0.9912;GENE EXPRESSION#0.9567;LUNG ADENOCARCINOMA#0.9505;MYOGENESIS#0.9196;BREAST CANCER CELL#0.9063;ADENOCARCINOMA#0.8714;LUNG CANCER#0.8595;PHOSPHATASE ACTIVITY#0.8155;STEM CELL#0.8148;APOPTOSIS#0.7889;CELL CYCLE#0.7621;EPITHELIAL CELL#0.7620;PHOSPHATASE INHIBITOR#0.7024;BREAST CANCER PATIENTS#0.6930;CELL GROWTH#0.6637;PROGENITOR CELL#0.6464;LIMB DEVELOPMENT#0.6313;GROWTH FACTOR#0.6308;CANCER STEM CELL#0.6156;CELL MIGRATION#0.6098;NEURAL CREST#0.6094;EPITHELIAL MESENCHYMAL TRANSITION#0.6087;TUMOR SUPPRESSOR#0.6085
213	ALBUMIN-INTERFERON ALPHA#1.1174;SERUM ALBUMIN PRECURSOR#1.0993;GLOBULIN G#1.0895;ADENINE ARABINOSIDE#1.0686;COBALT BINDING#1.0601;OPTISON#1.0592;PERFLUOROPROPANE#1.0590;INSULIN DETEMIR#1.0579;MIDODRINE#1.0432;TOLMETIN#1.0412;DAPTOMYCIN#1.0411;GLUCURONIDASE ACTIVITY#1.0410;URINE ALBUMIN EXCRETION#1.0393;ISCHEMIA MODIFIED ALBUMIN#1.0386;PROMOTER BINDING#1.0375;RETINAL BINDING#1.0369;CYTOCHROME P450 ACTIVITY#1.0358;MECONIUM#1.0339;L LACTATE DEHYDROGENASE#1.0331;CREATININE CLEARANCE RATE#1.0330;CYANOCOBALAMIN#1.0324;RBC AGGREGATION#1.0323;UNINTENTIONAL WEIGHT LOSS#1.0318;GLASGOW COMA SCORE#1.0314;TOTAL OXIDANT STATUS#1.0314;HYPERTHYROXINEMIA#1.0314;MALIC ENZYME#1.0309;GD-BOPTA#1.0304;CAERULOPLASMIN#1.0302;GLICLAZIDE#1.0301;TERLIPRESSIN#1.0297;POLYACRYLIC ACID#1.0296;PHENPROCOUMON#1.0289;HEPATIC NUCLEAR FACTOR#1.0289;RHODAMINE 6G#1.0286;COAGULATION FACTOR IX#1.0285;PANCREATIC RIBONUCLEASE#1.0281;D-LYSINE#1.0275;ALBUMIN CREATININE RATIO#1.0275;INTERNATIONAL STAGING SYSTEM#1.0272;ACUTE PHYSIOLOGY SCORE#1.0269;BROMOPHENOL#1.0266;SULODEXIDE#1.0260;FULL BLOOD COUNT#1.0257;SODIUM HYALURONATE#1.0249;HUMAN PROXIMAL TUBULAR#1.0223;DIFLUNISAL#1.0220;TEICOPLANIN#1.0217;ALPHA-1 PROTEASE INHIBITOR#1.0217;ETHACRYNIC ACID#1.0216;PORTAL VEIN INVASION#1.0215;PHENOTHIAZINE#1.0212;CAPRYLIC ACID#1.0209;POLYRIBOSOME#1.0204;AURANOFIN#1.0197;HUMAN SERUM ALBUMIN#1.0196;CSF FLOW#1.0195;WHEY PROTEIN ISOLATE#1.0195;DIAZEPAM BINDING#1.0193;SURAMIN#1.0185;NAG ACTIVITY#1.0176;SERUM TOTAL BILIRUBIN#1.0172;ADENYLATE KINASE#1.0169;L-ASPARTATE#1.0169;TRANSAMINASE ACTIVITY#1.0168;POLYSOME#1.0167;IMMUNE GLOBULIN#1.0167;SERUM ALBUMIN#1.0157;KIDNEY HYPERTROPHY#1.0156;OXIDATIVE STRESS INDEX#1.0152;FLUID-PHASE ENDOCYTOSIS#1.0151;NEOPTERIN#1.0144;PYRIDOXAL PHOSPHATE#1.0143;CAVEOLAE-MEDIATED ENDOCYTOSIS#1.0142;MALEIC ACID#1.0130;DELAYED HYPERSENSITIVITY RESPONSE#1.0127;POTASSIUM CHLORIDE#1.0127;ANION BINDING#1.0126;CHOLINESTERASE ACTIVITY#1.0124;ERYTHROCYTE AGGREGATION#1.0122;COPPER BINDING#1.0122;THIOPENTAL#1.0120;CORTISOL BINDING#1.0119;P-CRESOL#1.0117;GLYCOGEN SYNTHESIS#1.0117;PACLITAXEL#1.0114;TRANSENDOTHELIAL ELECTRICAL RESISTANCE#1.0114;25-HYDROXYCHOLECALCIFEROL#1.0110;BERBERINE#1.0109;AST ACTIVITY#1.0108;KARNOFSKY PERFORMANCE STATUS#1.0106;INTERNATIONAL NORMALIZED RATIO#1.0106;SECRETORY VESICLE#1.0106;ETHANESULFONIC ACID#1.0104;OCTANOATE#1.0101;FASTING BLOOD SUGAR#1.0101;TOTAL BILIRUBIN LEVEL#1.0099;C1-INH#1.0094;MALATE DEHYDROGENASE#1.0092;BIOMINERALIZATION#1.0089;RESONANCE LIGHT SCATTERING#1.0087;THYMIDINE KINASE#1.0084;NICARDIPINE#1.0083;CIS-DIAMMINEDICHLOROPLATINUM#1.0083;FUNCTIONAL INDEPENDENCE MEASURE#1.0081;THYROXIN#1.0080;DIGITOXIN#1.0080;DICLOFENAC SODIUM#1.0079;PENICILLIN G#1.0077;GEFITINIB#1.0074;HUMAN PROXIMAL TUBULE#1.0072;FLURBIPROFEN#1.0072;TOTAL ANTIOXIDANT STATUS#1.0071;ARTHUS REACTION#1.0070;FELODIPINE#1.0069;ELASTASE ACTIVITY#1.0068;OCTANOIC ACID#1.0068;GD-DTPA#1.0068;LISINOPRIL#1.0065;SCRUB TYPHUS#1.0065;GLUTAMATE DEHYDROGENASE#1.0063;FLUORESCENCE CORRELATION SPECTROSCOPY#1.0061;BENZYLPENICILLIN#1.0059;ESTRADIOL BINDING#1.0057;CIBACRON BLUE#1.0056;EXTRACELLULAR FLUIDS#1.0051;LUNG INJURY SCORE#1.0050;ATP SYNTHASE#1.0048;PROTEIN CATABOLIC#1.0048;RETINOL BINDING#1.0047;FEMORAL NECK FRACTURE#1.0047;MYRISTIC ACID#1.0046;GERIATRIC DEPRESSION SCALE#1.0046;NAPROXEN#1.0045;GLIPIZIDE#1.0044;BRAIN WATER CONTENT#1.0044;ALPHA-2 MACROGLOBULIN#1.0044;BUPIVACAINE#1.0043;TOTAL INTERNAL REFLECTION#1.0043;SALIVARY FLOW RATE#1.0042;HYALURONATE#1.0042;COLLAGEN TYPE IV#1.0042;FDH I#1.0040;AMINOSALICYLIC ACID#1.0040;LEVOFLOXACIN#1.0039;OFLOXACIN#1.0039;ALISKIREN#1.0039;OLMESARTAN#1.0038;PHOSPHATE BUFFER SALINE#1.0038;CEFTRIAXONE#1.0037;CANDESARTAN#1.0036;LIGHT ABSORPTION#1.0035;BAYER#1.0034;8-HYDROXY-2'-DEOXYGUANOSINE#1.0034;GD-EOB-DTPA#1.0032;IRON BINDING#1.0032;INHIBIN#1.0032;PYRUVATE KINASE#1.0031;ALPHA-1-PROTEINASE INHIBITOR#1.0031;NUTRITIONAL RISK INDEX#1.0030;DIMERCAPTOSUCCINIC ACID#1.0029;THORACIC DUCT#1.0025;MITOXANTRONE#1.0024;ESTRADIOL-17BETA#1.0024;RAMIPRIL#1.0023;CASPOFUNGIN#1.0023;THYROXINE BINDING#1.0023;RETINOL#1.0021;ASPARTATE AMINOTRANSFERASE ACTIVITY#1.0020;ALPHA 1-ANTITRYPSIN#1.0016;DIATRIZOATE#1.0015;3,5,3'-TRIIODOTHYRONINE#1.0014;ZINC BINDING#1.0011;LACTATE DEHYDROGENASE ACTIVITY#1.0011;PODOCYTE APOPTOSIS#1.0010;OCTREOTIDE#1.0009;ALANINE AMINOTRANSFERASE ACTIVITY#1.0009;ESTRIOL#1.0008;BLOOD UREA NITROGEN#1.0008;EXCRETION#1.0008;HALOPERIDOL#1.0005;MEAN CELL HEMOGLOBIN#1.0005;LATERAL VENTRICLE#1.0005;CARDIAC TROPONIN I#1.0005;ROSUVASTATIN#1.0005;L-GLUTAMIC ACID#1.0004;RETINAL DETACHMENT#1.0004;CEFAZOLIN#1.0003;ESTIMATED BLOOD LOSS#1.0002;ALPHA AMYLASE#1.0001;SATURATION TRANSFER DIFFERENCE#0.9999;L-PROLINE#0.9997;SIMULATED BODY FLUID#0.9996;CHLORHEXIDINE#0.9996;GAMMA GLUTAMYLTRANSFERASE#0.9995;6-MERCAPTOPURINE#0.9995;LUNG MICROVASCULAR ENDOTHELIAL#0.9993;HARVEY BRADSHAW INDEX#0.9992;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.9991;NEONATAL JAUNDICE#0.9990;DIPHTHERIA#0.9990;YOLK SAC#0.9989;ANTIPYRINE#0.9988;SUM FREQUENCY GENERATION#0.9988;PHOSPHATE BUFFER SOLUTION#0.9987;FRUSEMIDE#0.9986;TRICEPS#0.9986;BODY FAT PERCENTAGE#0.9985;DEHYDROEPIANDROSTERONE SULFATE#0.9984;ALVEOLAR FLUID CLEARANCE#0.9984;ERYTHROCYTE SEDIMENTATION RATE#0.9984;TRANSCYTOSIS#0.9984;LASER FLASH PHOTOLYSIS#0.9984;SODIUM BICARBONATE#0.9983;FIBRINOGEN#0.9983;DOXORUBICIN HYDROCHLORIDE#0.9983;STEARATE#0.9981;KIDNEY INJURY MOLECULE#0.9981;WEIGHT FOR AGE#0.9981;CHARLSON COMORBIDITY INDEX#0.9980;PALMITATE#0.9979;VITAMIN B12#0.9979;INTERSTITIAL FLUID PRESSURE#0.9979;PORTAL VEIN EMBOLIZATION#0.9979;EMODIN#0.9979;PAPAVERINE#0.9978;HEMOPHILIA B#0.9975;POSTPRANDIAL PLASMA GLUCOSE#0.9974;IL-11#0.9972;CHILD TURCOTTE PUGH#0.9971;SALBUTAMOL#0.9971;CONTINUOUS GLUCOSE MONITORING#0.9970;IOHEXOL#0.9969;TRANSFERASE ACTIVITY#0.9969;PROTEINASE ACTIVITY#0.9968;VALPROATE#0.9967;ACUTE ISCHAEMIC STROKE#0.9966;OXAPROZIN#0.9966;ESTERASE ACTIVITY#0.9965;OBSTRUCTIVE SLEEP APNEA#0.9965;CLATHRIN-MEDIATED ENDOCYTOSIS#0.9964;PREKALLIKREIN ACTIVATOR#0.9963;IFN-BETA#0.9963;INSULIN GROWTH FACTOR#0.9962;GLOBIN#0.9962;ICODEXTRIN#0.9961;IMATINIB#0.9961;KEYHOLE LIMPET HEMOCYANIN#0.9961;BICEPS#0.9960;KETOPROFEN#0.9959;METOPROLOL#0.9959;METHADONE#0.9959;LAPATINIB#0.9959;ROUGH MICROSOME#0.9959;AMLODIPINE#0.9959;PHENYTOIN#0.9958;PERCENT BODY FAT#0.9958;BENZOIC ACID#0.9958;UPPER GASTROINTESTINAL BLEEDING#0.9957;MEFENAMIC ACID#0.9957;DIGOXIN#0.9956;CHLORPROMAZINE#0.9954;HEMOCYANIN#0.9953;FOLATE#0.9951;EPIRUBICIN#0.9951;GLUCOSE-6-PHOSPHATASE ACTIVITY#0.9951;TRASTUZUMAB#0.9951;TRANSCRIPTIONAL CONTROL#0.9949;VITAMIN D BINDING#0.9949;MIDDLE EAR#0.9948;PHENOBARBITONE#0.9948;HEME BINDING PROTEIN#0.9948;IMMUNOGLOBULIN G#0.9947;GLYCOGEN PHOSPHORYLASE#0.9946;IOTHALAMATE#0.9946;CALCIUM CHLORIDE#0.9945;STORAGE PROTEIN#0.9945;L-GLUTAMATE#0.9945;PYRIDOXAL 5-PHOSPHATE#0.9945;MALNUTRITION INFLAMMATION SCORE#0.9945;CYSTEAMINE#0.9944;ALUMINUM HYDROXIDE#0.9944;SERUM AMYLOID A#0.9943;SOMATIC CELL COUNT#0.9943;GLUCOSE 6 PHOSPHATASE#0.9941;DOBUTAMINE#0.9941;FENOFIBRATE#0.9941;CEFOTAXIME#0.9939;PROXIMAL TUBULE CELL#0.9939;5.ALPHA.-DIHYDROTESTOSTERONE#0.9939;SIROLIMUS#0.9939;CAROTENOID#0.9938;EPIGALLOCATECHIN#0.9937;GLASSY CARBON ELECTRODE#0.9936;PIROXICAM#0.9936;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9936;DICARBOXYLIC ACID#0.9935;MACROPINOCYTOSIS#0.9934;L-TYROSINE#0.9934;PERICARDIAL EFFUSION#0.9934;LEYDIG CELL#0.9933;URIC ACID#0.9933;SEVOFLURANE#0.9932;HEME BINDING#0.9932;SITAGLIPTIN#0.9932;CYSTATIN#0.9931;COATED MEMBRANE#0.9931;METHAMPHETAMINE#0.9931;2,4-DINITROPHENOL#0.9930;RETINOID BINDING#0.9930;TOLBUTAMIDE#0.9930;MELATONIN#0.9930;STREPTOKINASE#0.9929;ATTENUATED TOTAL REFLECTANCE#0.9929;ALPHA LINOLENIC ACID#0.9928;POST OPERATIVE DAY#0.9927;HEPATOCYTE NUCLEAR FACTOR#0.9924;GLYCERALDEHYDE-3-PHOSPHATE#0.9923;UVEITIS#0.9923;TUMOR NODE METASTASIS#0.9923;IMMUNE-COMPLEX GLOMERULONEPHRITIS#0.9923;L-TRYPTOPHAN#0.9922;CRYSTALLOID#0.9922;THYROID HORMONE BINDING#0.9921;ROSIGLITAZONE#0.9920;DIAMMINEDICHLOROPLATINUM#0.9920;CYTOCHROME C#0.9920;KWASHIORKOR#0.9919;URATE#0.9919;IL-1RA#0.9919;SARCOIDOSIS#0.9919;MYELOPEROXIDASE ACTIVITY#0.9918;T- PA#0.9918;OVARIAN HYPERSTIMULATION SYNDROME#0.9917;COMPLETE BLOOD COUNT#0.9917;LEFT ATRIUM#0.9916;MAJOR URINARY PROTEIN#0.9916;PYRIDOXAL#0.9916;BETA-2#0.9915;VITAMIN B6#0.9914;25-HYDROXYVITAMIN D3#0.9914;ADJUSTED RELATIVE RISK#0.9913;ASPARTATE#0.9913;MEASLES#0.9913;TELMISARTAN#0.9912;D-PENICILLAMINE#0.9911;ASIALOGLYCOPROTEIN RECEPTOR#0.9911;MERCAPTOPURINE#0.9910;KERNICTERUS#0.9910;PROXIMAL TUBULAR EPITHELIAL#0.9909;CIPROFLOXACIN#0.9909;INCONTINENCE#0.9909;CONNEXIN#0.9907;PIOGLITAZONE#0.9907;RESVERATROL#0.9905;QUINIDINE#0.9905;MINI NUTRITIONAL ASSESSMENT#0.9905;L-ALANINE#0.9904;AMIODARONE#0.9904;DNASE I#0.9903;C REACTIVE PROTEIN#0.9903;SPERMIDINE#0.9903;DYNAMIC CONTRAST ENHANCED#0.9903;DAUNORUBICIN#0.9902;LINEAR DISCRIMINANT ANALYSIS#0.9900;CREATINE KINASE#0.9900;OVAL CELL#0.9900;PENTOXIFYLLINE#0.9899;GESTATIONAL DIABETES MELLITUS#0.9899;L-PHENYLALANINE#0.9899;FLUORESCEIN#0.9899;CAMPTOTHECIN#0.9898;PERCUTANEOUS CORONARY INTERVENTION#0.9898;CAVEOLAE#0.9898;OESTRONE#0.9898;HALOTHANE#0.9898;NUCLEAR LOCALIZATION SIGNAL#0.9898;ALKALINE PHOSPHATASE#0.9896;PERINDOPRIL#0.9896;L-THYROXINE#0.9896;MICROTUBULE ASSOCIATED PROTEIN#0.9896;PROTON PUMP INHIBITOR#0.9895;CHOLESTEROL EFFLUX#0.9894;NIFLUMIC ACID#0.9894;NARCOTIC#0.9893;MIDAZOLAM#0.9893;SODIUM DODECYLSULFATE#0.9892;GLASGOW COMA SCALE#0.9892;CELLOBIOSE#0.9892;SIGNAL PEPTIDE#0.9891;SOLID LIPID NANOPARTICLES#0.9891;L-LEUCINE#0.9891;LIRAGLUTIDE#0.9891;NICOTINIC ACID#0.9891;AMPHOTERICIN#0.9890;GEMCITABINE#0.9890;MICROGLIAL CELL#0.9889;AMPHOTERICIN B#0.9888;L-HISTIDINE#0.9887;VALSARTAN#0.9887;NITRENDIPINE#0.9887;PROXIMAL TUBULAR CELL#0.9887;CARDIOLIPIN#0.9887;HUMAN HEPATOMA CELL LINES#0.9886;RUTIN#0.9885;PROPOFOL#0.9885;AMYLOID PROTEIN#0.9885;CREATINE#0.9884;TOLVAPTAN#0.9884;UBIQUITIN#0.9884;NEWCASTLE DISEASE#0.9884;ARSENIC TRIOXIDE#0.9883;DILTIAZEM#0.9883;EXOSOME#0.9883;CARBAMAZEPINE#0.9882;STREPTOMYCIN#0.9882;AMYLASE ACTIVITY#0.9882;MARASMUS#0.9882;INTRAMOLECULAR CHARGE TRANSFER#0.9881;FLOCCULATION#0.9880;SALICYLIC ACID#0.9880;FOLIC ACID#0.9880;ANDROSTENEDIONE#0.9879;SEMINAL PLASMA#0.9879;KIDNEY PROXIMAL TUBULE#0.9879;SV40 T-ANTIGEN#0.9879;PINOCYTOSIS#0.9878;ALANINE#0.9878;LIPOPOLYSACCHARIDE BINDING#0.9878;ETHYLENEDIAMINETETRAACETIC ACID#0.9878;AMOXICILLIN#0.9878;ALPHA GLUCOSIDASE#0.9878;SULFONAMIDE#0.9877;PYROGEN#0.9877;SALICYLATE#0.9877;FUROSEMIDE#0.9877;LEPROSY#0.9877;PELLICLE#0.9877;OXAZEPAM#0.9876;HORMONE BINDING#0.9876;ORAL SQUAMOUS CELL CARCINOMA#0.9875;PRAZOSIN#0.9874;CIRCULATORY SYSTEM#0.9874;MEGAKARYOCYTE#0.9874;CARBOPLATIN#0.9873;BEVACIZUMAB#0.9873;MEAN PLATELET VOLUME#0.9872;FRUCTOSE#0.9872;PHOSPHOENOLPYRUVATE#0.9872;NORFLOXACIN#0.9872;CITRULLINE#0.9872;PIPERAZINE#0.9871;STEROID BINDING#0.9871;ISOFLURANE#0.9871;CUMULUS OOCYTE COMPLEXES#0.9870;HEPATIC LIPASE#0.9870;MEDIUM MOLECULAR WEIGHT#0.9870;CALCULATED FREE TESTOSTERONE#0.9870;LDL PARTICLE#0.9870;ACE ACTIVITY#0.9870;BISMUTH#0.9869;CACHECTIC#0.9869;PHENYLBUTAZONE#0.9869;ERLOTINIB#0.9869;DECOMPENSATED HEART FAILURE#0.9869;TAXOL#0.9868;LIPID BINDING#0.9868;MYO-INOSITOL#0.9868;PERIPHERAL BLOOD LEUKOCYTE#0.9868;LIDOCAINE#0.9867;CLENBUTEROL#0.9866;VALPROIC ACID#0.9866;WHITE BLOOD CELL#0.9865;FAT PAD#0.9865;HYDRONEPHROSIS#0.9865;TAUROCHOLATE#0.9865;RABIES#0.9865;BLOOD CLOT#0.9865;CACL2#0.9864;PROTEIN DISULFIDE ISOMERASE#0.9864;17β-ESTRADIOL#0.9864;RUBELLA#0.9863;THORACIC AORTA#0.9863;ALPHA-TOCOPHEROL#0.9863;WAIST HIP RATIO#0.9863;CARPROFEN#0.9862;DURA MATER#0.9862;ALPHA LIPOIC ACID#0.9862;TOTAL ANTIOXIDANT ACTIVITY#0.9862;SUBJECTIVE GLOBAL ASSESSMENT#0.9861;CONTRAST INDUCED NEPHROPATHY#0.9861;CAPTOPRIL#0.9861;HUMAN WHOLE BLOOD#0.9860;PRAVASTATIN#0.9860;HYALURONAN#0.9860;LIVER METASTASIS#0.9860;INJURY SEVERITY SCORE#0.9859;ATTENUATED TOTAL REFLECTION#0.9859;SN-GLYCERO-3-PHOSPHOCHOLINE#0.9859;LIVER SYSTEM#0.9859;THERAPEUTIC PLASMA EXCHANGE#0.9858;ISOTHERMAL TITRATION CALORIMETRY#0.9858;HEPATOBILIARY DISEASE#0.9858;MOLECULARLY IMPRINTED POLYMER#0.9858;SPERMINE#0.9857;L-CARNITINE#0.9857;ATENOLOL#0.9856;ISOPRENALINE#0.9856;GINGIVAL CREVICULAR FLUID#0.9856;PORTAL VEIN THROMBOSIS#0.9856;KNEE JOINT#0.9856;ITRACONAZOLE#0.9856;FREE LIGHT CHAIN#0.9856;GM-CSF#0.9855;CYCLOHEXANE#0.9854;DOXYCYCLINE#0.9853;THIAMINE#0.9853;BRAIN NATRIURETIC PEPTIDE#0.9853;AMINOHIPPURIC ACID#0.9853;SLEEP APNEA#0.9852;NEUTROPHIL MIGRATION#0.9852;AMINOTRANSFERASE ACTIVITY#0.9852;DRUG BINDING#0.9852;INTERNATIONAL PROGNOSTIC INDEX#0.9851;EVANS BLUE EXTRAVASATION#0.9851;INSULIN GLARGINE#0.9850;HYALURONIC ACID#0.9850;FATTY ACID BINDING#0.9849;L-GLUTAMINE#0.9849;STEARIC ACID#0.9849;BODY FAT MASS#0.9849;BODY WEIGHT RATIO#0.9848;HYALURONIDASE#0.9848;HYPOXANTHINE#0.9848;MULTINOMIAL LOGISTIC REGRESSION#0.9848;BROWN ADIPOSE TISSUE#0.9848;MITOMYCIN C#0.9848;UREA CYCLE#0.9847;SIMULATED GASTRIC FLUID#0.9847;ATORVASTATIN#0.9846;POSITIVE CONTROL GROUP#0.9845;GUANIDINE HYDROCHLORIDE#0.9844;ANKLE BRACHIAL INDEX#0.9843;ACTIVE VITAMIN D#0.9843;CLARA CELL#0.9842;ADENOSINE DEAMINASE#0.9842;EPOETIN ALFA#0.9842;ALL TRANS RETINOIC ACID#0.9842;INTRACELLULAR TRANSPORT#0.9841;IMIPRAMINE#0.9841;1-ANILINO-8-NAPHTHALENE SULFONATE#0.9840;NEGATIVE CONTROL GROUP#0.9840;HEPATOBLAST#0.9839;MALTOSE#0.9839;LYSOZYME ACTIVITY#0.9838;GLUCOSE-6-PHOSPHATE#0.9838;FLOW MEDIATED DILATION#0.9838;TELOMERE#0.9837;SPUTUM#0.9837;MUSCLE FIBER#0.9837;OVIDUCT#0.9836;FASTING SERUM GLUCOSE#0.9836;HINDLIMB#0.9836;TYPE III PROCOLLAGEN#0.9836;FORMATE#0.9836;FUSIDIC ACID#0.9836;COMPREHENSIVE GERIATRIC ASSESSMENT#0.9836;LEUKOCYTE MIGRATION#0.9836;GLCNAC#0.9836;TETRACYCLINE#0.9836;RIBOSOMAL PROTEIN#0.9835;FASTING BLOOD GLUCOSE#0.9835;GLOMERULAR EPITHELIAL CELL#0.9835;ATOMIC FORCE MICROSCOPE#0.9835;DIAZEPAM#0.9835;CETUXIMAB#0.9834;ASPIRATION PNEUMONIA#0.9834;ESTRONE#0.9834;SCAVENGER RECEPTOR LIGAND#0.9834;PYRIDOXINE#0.9833;PHYSICAL COMPONENT SUMMARY#0.9832;FOCAL CEREBRAL ISCHEMIA#0.9831;ADVANCED BREAST CANCER#0.9830;NEPHROSIS#0.9830;MEDROXYPROGESTERONE ACETATE#0.9829;VESICULAR TRANSPORT#0.9829;SPERM CAPACITATION#0.9829;SNEEZING#0.9829;LASER INDUCED FLUORESCENCE#0.9829;LYMPHEDEMA#0.9828;WEIGHTED MEAN DIFFERENCE#0.9828;DICLOFENAC#0.9828;POLY ETHYLENE OXIDE#0.9828;BETAMETHASONE#0.9828;MELOXICAM#0.9828;SUBARACHNOID SPACE#0.9827;HYDRALAZINE#0.9827;OLEIC ACID#0.9827;SERUM URIC ACID#0.9827;AMNIOTIC FLUID#0.9827;OXALIPLATIN#0.9826;IRBESARTAN#0.9826;CLOFIBRATE#0.9826;SPERMATOZOA#0.9826;BETA GLUCURONIDASE#0.9825;IGG BINDING#0.9825;COLORECTAL LIVER METASTASES#0.9825;DOXAZOSIN#0.9823;POLYCYSTIC OVARY SYNDROME#0.9823;PROTOPORPHYRIN IX#0.9823;TOCOPHEROL#0.9823;ASPHYXIA#0.9823;GLUTATHIONE PEROXIDASE ACTIVITY#0.9823;TESTOSTERONE#0.9822;LACTULOSE#0.9822;BETA N ACETYLGLUCOSAMINIDASE#0.9821;ALKALINE PHOSPHATASE ACTIVITY#0.9821;TUBERCULOUS PERITONITIS#0.9821;BOWMAN'S CAPSULE#0.9821;CAPECITABINE#0.9820;PIPERACILLIN#0.9820;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.9820;METAL BINDING#0.9820;SYNOVIAL FLUID#0.9819;PROTEINASE INHIBITOR#0.9819;FACTOR VIII#0.9818;CORTISOL#0.9818;FENTANYL#0.9818;VANCOMYCIN#0.9818;DUCT CELL#0.9817;PROBUCOL#0.9817;EMISSION COMPUTED TOMOGRAPHY#0.9816;IRINOTECAN#0.9816;DEOXYCHOLIC ACID#0.9816;ARTIFICIAL NEURAL NETWORK#0.9815;MICROPARTICLE#0.9815;MAGNESIUM SULFATE#0.9814;PROSTATE SPECIFIC ANTIGEN#0.9814;MAST CELL DEGRANULATION#0.9814;NORADRENALINE#0.9814;GESTATIONAL DIABETES#0.9813;ENALAPRIL#0.9813;DELAYED GASTRIC EMPTYING#0.9812;IMMUNOTOXIN#0.9812;THROMBOCYTOSIS#0.9812;PARAFORMALDEHYDE#0.9811;BETA-ESTRADIOL#0.9811;RIGHT ATRIUM#0.9810;GLYCERO-3-PHOSPHOCHOLINE#0.9810;PYRUVATE#0.9810;IGE ANTIBODY#0.9810;PHYSICAL ACTIVITY LEVEL#0.9810;INTRACELLULAR LOCALIZATION#0.9810;MITOMYCIN#0.9810;GLUCURONIC ACID#0.9809;LIPOIC ACID#0.9809;MACROPHAGE INFLAMMATORY PROTEIN#0.9809;THIAZIDE#0.9809;VASCULAR RISK FACTORS#0.9809;AMPICILLIN#0.9809;ACUTE ISCHEMIC STROKE#0.9808;MESENTERY#0.9808;ION BINDING#0.9807;METRONIDAZOLE#0.9807;AGITATED#0.9807;TRANSIENT ISCHEMIC ATTACK#0.9807;SERPIN#0.9806;PALMITIC ACID#0.9806;INULIN#0.9806;FASTING GLUCOSE LEVELS#0.9806;OESTRADIOL#0.9806;MUSCLE PROTEIN SYNTHESIS#0.9806;PHOSPHATE BUFFERED SALINE#0.9806;LEUCOVORIN#0.9805;DOCETAXEL#0.9805;SCAVENGER RECEPTOR#0.9805;NEUROFILAMENT#0.9805;QUERCETIN#0.9803;PENICILLIN#0.9803;AORTIC VALVE REPLACEMENT#0.9802;FAT FREE MASS#0.9802;PARATHYROID HORMONE#0.9802;VITAMIN C#0.9801;CARNITINE#0.9801;DIPYRIDAMOLE#0.9801;HEPATOPULMONARY SYNDROME#0.9801;DIMETHYLFORMAMIDE#0.9800;RESPONSE SURFACE METHODOLOGY#0.9800;THEOPHYLLINE#0.9800;MANNITOL#0.9800;DISEASE ACTIVITY INDEX#0.9800;BLOOD PLATELETS#0.9800;CAFFEINE#0.9799;HYDRAZIDE#0.9799;CAPILLARY LEAK SYNDROME#0.9799;IFOSFAMIDE#0.9798;COLD ISCHEMIA TIME#0.9798;2'-DEOXYURIDINE#0.9798;STATIONARY PHASE#0.9798;CHOLIC ACID#0.9798;VENULE#0.9797;HEPATOBLASTOMA#0.9796;METASTATIC BREAST CANCER#0.9796;AT-17#0.9795;TOTAL ANTIOXIDANT CAPACITY#0.9795;LOMEFLOXACIN#0.9795;GENTAMICIN#0.9795;SPONTANEOUS BACTERIAL PERITONITIS#0.9795;DEHYDROEPIANDROSTERONE#0.9794;GLYCOCALYX#0.9794;FORCED VITAL CAPACITY#0.9793;BETA GALACTOSIDASE#0.9793;APROTININ#0.9793;CHLOROPLAST#0.9792;PHOSPHOLIPASE A#0.9792;NUCLEAR IMPORT#0.9792;DOXORUBICIN#0.9791;OMEPRAZOLE#0.9791;RICIN#0.9790;SIMULATED INTESTINAL FLUID#0.9790;SIMVASTATIN#0.9790;VINBLASTINE#0.9789;PROTEIN UPTAKE#0.9789;LIGHT CHAIN 3#0.9788;CALCITRIOL#0.9788;SICKLE CELL ANEMIA#0.9788;ACYLTRANSFERASE ACTIVITY#0.9787;ADALIMUMAB#0.9787;HOME BLOOD PRESSURE#0.9787;PARATHYROID#0.9787;CEREBRAL ARTERY OCCLUSION#0.9787;PROTEIN DEFICIENCY#0.9787;WARFARIN#0.9787;NEPHROPATHIC#0.9786;DIETHYLSTILBESTROL#0.9786;AMINOGUANIDINE#0.9786;ETHANOLAMINE#0.9785;ZINC UPTAKE#0.9785;PHOTOLYSIS#0.9784;RETICULOCYTE#0.9784;THE ANTIOXIDANT CAPACITY#0.9784;PROTON PUMP#0.9784;ENHANCER BINDING PROTEIN#0.9784;EARLY ENTERAL NUTRITION#0.9783;PULSE WAVE VELOCITY#0.9783;CONFOCAL FLUORESCENCE MICROSCOPY#0.9782;ADRENALINE#0.9782;LEFT VENTRICULAR MASS#0.9782;SORAFENIB#0.9782;CHLORAMPHENICOL#0.9782;LEAN BODY MASS#0.9781;IGA ANTIBODY#0.9780;ALCOHOLIC LIVER CIRRHOSIS#0.9780;ENHANCER BINDING#0.9780;THALAMUS#0.9780;RIBOSE#0.9780;RETINOIC ACID#0.9779;URINARY PROTEIN#0.9779;SELF ASSEMBLED MONOLAYERS#0.9779;BETA ADRENOCEPTOR#0.9779;CENTRAL VENOUS CATHETER#0.9778;THROMBOPLASTIN#0.9777;G-CSF#0.9777;MEMBRANOUS GLOMERULONEPHRITIS#0.9776;CHYLOMICRON#0.9776;CLONIDINE#0.9776;HIGH CHOLESTEROL DIET#0.9776;FIBROSARCOMA#0.9776;ATRIAL FIBRILLATION#0.9776;LOWER LEG#0.9776;DEPRESSIVE SYMPTOMS#0.9775;PARACETAMOL#0.9775;ADVANCED PANCREATIC CANCER#0.9775;NUCLEOSOME#0.9774;SKIN PRICK TEST#0.9774;LYMPH NODE METASTASES#0.9774;PULMONARY SARCOIDOSIS#0.9774;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9774;GALECTIN#0.9773;MIGRATION INHIBITORY FACTOR#0.9773;ATHEROSCLEROTIC RISK FACTORS#0.9773;DIFFERENTIAL PULSE VOLTAMMETRY#0.9773;ANAESTHETIC#0.9772;MESOTHELIAL CELL#0.9772;HYDROLASE ACTIVITY#0.9772;VITAMIN B1#0.9772;OXYGEN TRANSPORT#0.9772;RENAL VEIN#0.9772;DRUG TRANSPORT#0.9771;NEOMYCIN#0.9771;ANURIA#0.9771;L-METHIONINE#0.9770;DIABETIC NEUROPATHY#0.9770;SPERM HEAD#0.9770;HYDROCORTISONE#0.9770;INDOLE#0.9770;QUARTZ CRYSTAL MICROBALANCE#0.9769;NIFEDIPINE#0.9769;POLYCYCLIC AROMATIC HYDROCARBON#0.9768;CALCIUM CARBONATE#0.9768;PYROGENIC#0.9768;LUNG METASTASIS#0.9768;BRONCHIAL EPITHELIAL CELLS#0.9768;AMITRIPTYLINE#0.9767;ANAPHYLACTIC#0.9767;AMINOPHYLLINE#0.9767;HEPATOMA CELLS#0.9766;LEUKOCYTE ADHESION#0.9766;BUDESONIDE#0.9765;MOLECULAR DYNAMICS SIMULATION#0.9765;LIMITS OF AGREEMENT#0.9765;AMINOLEVULINIC ACID#0.9765;DESFERRIOXAMINE#0.9764;CLINICAL PERFORMANCE MEASURES#0.9764;FEMORAL VEIN#0.9764;SECRETORY GRANULE#0.9764;LYMPH NODE METASTASIS#0.9764;PUTRESCINE#0.9764;N GLYCAN#0.9764;LACTOSE#0.9764;BRAIN DEVELOPMENT#0.9763;PERIPHERAL VASCULAR DISEASE#0.9762;METHACHOLINE#0.9762;POSITIVE AIRWAY PRESSURE#0.9762;DIPHENHYDRAMINE#0.9762;DISEASE SPECIFIC SURVIVAL#0.9762;CONDITIONAL LOGISTIC REGRESSION#0.9762;NEONATAL DIABETES MELLITUS#0.9761;PHOTOTOXICITY#0.9761;MESENTERIC VEIN#0.9760;BLOOD PLASMA#0.9760;BETA-MERCAPTOETHANOL#0.9760;INTERNAL CAROTID ARTERY#0.9760;PERICARDITIS#0.9760;ACID SECRETION#0.9760;BLOOD CIRCULATION#0.9760;PERTUSSIS#0.9760;ADRENOCORTICOTROPIC HORMONE#0.9759;KETOCONAZOLE#0.9759;NITRIC-OXIDE SYNTHASE INHIBITOR#0.9759;COLLAGEN TYPE I#0.9759;NORETHISTERONE#0.9758;CRITICAL LIMB ISCHEMIA#0.9758;GOLGI APPARATUS#0.9758;ETOPOSIDE#0.9758;ASCITES#0.9757;TERBUTALINE#0.9757;URACIL#0.9757;INCREASED BLOOD PRESSURE#0.9757;RESTING ENERGY EXPENDITURE#0.9757;SCHWANN CELL#0.9756;ZIDOVUDINE#0.9756;MASTITIS#0.9756;ACUTE INFLAMMATORY RESPONSE#0.9756;PEPTIDOGLYCAN#0.9756;PENTOBARBITAL SODIUM#0.9756;AUTONOMIC NEUROPATHY#0.9756;CYTOCHROME C OXIDASE#0.9756;CELL BOUND#0.9756;COMMON CAROTID ARTERY#0.9755;SELECTIN#0.9755;AMERICAN DIABETES ASSOCIATION#0.9755;VITAMIN D3#0.9755;INDAPAMIDE#0.9754;APPENDICITIS#0.9753;PREGNENOLONE#0.9753;FOOT PROCESS EFFACEMENT#0.9753;LIPOPROTEIN PARTICLE#0.9753;TAMOXIFEN#0.9753;INTESTINAL OBSTRUCTION#0.9753;PRE-ECLAMPSIA#0.9753;GRANULOSA CELL#0.9752;ALCOHOLIC HEPATITIS#0.9752;FACTOR D#0.9752;CHOLESTERYL LINOLEATE#0.9752;ALLOPURINOL#0.9751;ISCHEMIC HEART DISEASE#0.9751;VASOCONSTRICTOR#0.9751;CREATINE KINASE ACTIVITY#0.9751;LOVASTATIN#0.9750;CATALASE ACTIVITY#0.9750;LOSS OF APPETITE#0.9749;BINDING PROTEIN 3#0.9749;FUMARATE#0.9749;SEVERE COMBINED IMMUNODEFICIENCY#0.9749;NATIONAL KIDNEY FOUNDATION#0.9749;LYMPHATIC SYSTEM#0.9749;IGM ANTIBODY#0.9749;OPTIC NERVE#0.9749;ASEPTIC MENINGITIS#0.9749;NOS INHIBITOR#0.9748;RIBOSOMAL RNA#0.9748;THYMOCYTE#0.9748;NF-KAPPAB ACTIVATION#0.9748;FULL THICKNESS BURN#0.9748;GANCICLOVIR#0.9748;MODAL#0.9748;DNASE#0.9748;CHOLERA#0.9748;LOW MOLECULAR WEIGHT HEPARIN#0.9747;RENAL FILTRATION#0.9747;LAYER BY LAYER#0.9747;PALMITOYL#0.9747;TOTAL BODY FAT#0.9746;HEPATORENAL SYNDROME#0.9746;VITAMIN K#0.9746;AMINOPYRINE#0.9746;L-LYSINE#0.9746;ERYTHROMYCIN#0.9746;VITAMIN A#0.9746;SCIATIC NERVE#0.9746;ACUTE CORONARY SYNDROME#0.9745;GONADOTROPIN RELEASING HORMONE#0.9745;PNEUMONIA SEVERITY INDEX#0.9745;Y CHROMOSOME#0.9745;MINI MENTAL STATE#0.9744;PKC ACTIVITY#0.9744;SPECIFIC GROWTH RATE#0.9744;SUPEROXIDE DISMUTASE ACTIVITY#0.9744;ISCHEMIA#0.9744;FLUSHING#0.9744;GLIBENCLAMIDE#0.9744;ASCORBIC ACID#0.9744;HEPATIC VEIN#0.9743;PUROMYCIN#0.9743;SUPPRESSOR T CELL#0.9743;HEMATURIA#0.9743;ENDOTHELIAL CELL DYSFUNCTION#0.9743;GENISTEIN#0.9743;HYPERSENSITIVITY RESPONSE#0.9742;FORMIC ACID#0.9742;CELL PENETRATING PEPTIDE#0.9742;NG-NITRO-L-ARGININE#0.9742;PROSTAGLANDIN E1#0.9742;EXTRACELLULAR SPACE#0.9741;ESTRONE SULFATE#0.9741;IN VITRO PRODUCED#0.9741;BRUSH BORDER MEMBRANE#0.9741;PENICILLAMINE#0.9741;METHOTREXATE#0.9741;PROTEIN-LOSING ENTEROPATHY#0.9740;PYELONEPHRITIS#0.9740;PODOCYTE FOOT#0.9740;DISOPYRAMIDE#0.9740;1α,25-DIHYDROXYVITAMIN D3#0.9739;OTITIS MEDIA#0.9739;HEPATIC STEM CELL#0.9739;CHANGE FROM BASELINE#0.9739;RECEPTOR MEDIATED ENDOCYTOSIS#0.9739;GUANYLATE CYCLASE#0.9739;COMPLEMENT ACTIVITY#0.9739;CEREBROVASCULAR DISEASE#0.9739;MANNOSE RECEPTOR#0.9738;BECK DEPRESSION INVENTORY#0.9738;ERYTHROPOIESIS STIMULATING AGENT#0.9737;LCAT ACTIVITY#0.9736;BINDING PROTEIN 1#0.9736;LYMPH NODE INVOLVEMENT#0.9736;SKELETAL MUSCLE MASS#0.9736;PARTIAL LEAST SQUARE#0.9736;INFLIXIMAB#0.9735;ACETYLSALICYLIC ACID#0.9735;LITHIUM#0.9735;RESIDUAL RENAL FUNCTION#0.9734;CYTOCHROME P450#0.9734;ESTRADIOL#0.9734;SENTINEL LYMPH NODE#0.9734;BIOTIN BINDING#0.9734;TRACHEA#0.9734;AMBULATORY BLOOD PRESSURE#0.9733;FOLLICLE STIMULATING HORMONE#0.9733;BODY WEIGHT LOSS#0.9732;INHIBITION OF BINDING#0.9732;ACRYLIC ACID#0.9732;OUTER LAYER#0.9732;MONOCYTE DERIVED MACROPHAGE#0.9732;CITRIC ACID#0.9731;IBUPROFEN#0.9731;ANOREXIA NERVOSA#0.9731;SEVERE PRE-ECLAMPSIA#0.9731;NO BINDING#0.9731;3-ISOBUTYL-1-METHYLXANTHINE#0.9731;FAT CELL#0.9730;ISONIAZID#0.9730;ESTROGEN BINDING#0.9730;ROOT MEAN SQUARE#0.9729;SULFAMETHOXAZOLE#0.9729;BACTERIAL MENINGITIS#0.9728;ERYTHROCYTE MEMBRANES#0.9728;POSTTRANSLATIONAL MODIFICATION#0.9727;BUMETANIDE#0.9727;TUBULAR EPITHELIAL CELL#0.9727;DIMETHYL SULPHOXIDE#0.9726;CILIARY BODY#0.9726;HIGH DENSITY LIPOPROTEIN#0.9726;GLOMERULAR FILTRATION BARRIER#0.9725;COLCHICINE#0.9725;ENTECAVIR#0.9725;PROTEIN KINASE B#0.9725;ORNITHINE#0.9725;BRONCHOPULMONARY DYSPLASIA#0.9724;EICOSAPENTAENOIC ACID#0.9724;MULTIPLE REACTION MONITORING#0.9724;END DIASTOLIC VOLUME#0.9724;DELAYED-TYPE HYPERSENSITIVITY#0.9724;FATTY ACID TRANSPORT#0.9724;EPITHELIAL OVARIAN CANCER#0.9724;SUCROSE#0.9724;INNER EAR#0.9724;HYPERGAMMAGLOBULINEMIA#0.9723;FOREARM#0.9722;ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY#0.9722;SHAKING#0.9722;IN VITRO MATURED#0.9722;SOFT TISSUE SARCOMA#0.9722;DIPEPTIDYL PEPTIDASE IV#0.9721;COATED VESICLE#0.9721;N-ACETYL-D-GLUCOSAMINE#0.9721;PERICYTE#0.9721;HERPES SIMPLEX VIRUS#0.9720;QUANTITATIVE REVERSE TRANSCRIPTION#0.9720;PERIPHERAL ARTERIAL DISEASE#0.9720;SPIRONOLACTONE#0.9720;P-NITROPHENOL#0.9720;BONE TURNOVER MARKER#0.9719;STANDARDIZED MEAN DIFFERENCE#0.9719;PHOSPHATASE ACTIVITY#0.9719;CEFOPERAZONE#0.9719;SPECTRIN#0.9718;RITONAVIR#0.9718;TISSUE TRANSGLUTAMINASE#0.9718;FORCED EXPIRATORY VOLUME#0.9718;PROBENECID#0.9718;TOLUENE#0.9718;PEPTIDE MASS FINGERPRINTING#0.9718;NEPHROSCLEROSIS#0.9717;ALLERGEN#0.9717;BOWEL OBSTRUCTION#0.9717;FOSINOPRIL#0.9717;ASYMMETRIC DIMETHYLARGININE#0.9716;INTERCELLULAR SPACE#0.9716;PERIPHERAL ARTERY DISEASE#0.9716;BIOFILM FORMATION#0.9716;HERPES SIMPLEX#0.9716;GUANIDINE#0.9716;MESENTERIC ARTERY#0.9716;BLOOD CLOTTING#0.9715;DIABETIC KETOACIDOSIS#0.9715;NEUROPROTECTION#0.9714;PHENYLEPHRINE#0.9714;BASOPHIL#0.9714;ASCORBATE#0.9714;RENIN ACTIVITY#0.9714;BLEOMYCIN#0.9714;MUSCLE WASTING#0.9714;ARGININE VASOPRESSIN#0.9714;LEUKOCYTE ACTIVATION#0.9714;ECLAMPSIA#0.9712;INTERSTITIAL MATRIX#0.9712;LIPID SYNTHESIS#0.9712;INTERLEUKIN 1 RECEPTOR#0.9712;MULTIVARIATE LINEAR REGRESSION#0.9711;MANNOSE BINDING#0.9711;BLOOD RETINAL BARRIER#0.9711;TIME TO DEATH#0.9711;HEPATOCYTE DIFFERENTIATION#0.9710;PROPRANOLOL#0.9710;CEREBRAL ARTERY#0.9710;RECEIVER OPERATING CURVE#0.9710;NEURITE#0.9710;FATALITY#0.9709;SERUM LEPTIN LEVEL#0.9709;IMPAIRED FASTING GLUCOSE#0.9709;EARLY ENDOSOME#0.9709;EPIDIDYMAL ADIPOSE TISSUE#0.9708;DEDIFFERENTIATION#0.9708;GOLGI COMPLEX#0.9708;PROTEIN UNFOLDING#0.9708;ERYTHROCYTE#0.9708;RENAL ARTERY#0.9708;CIRCADIAN RHYTHM#0.9707;ENDOPLASMIC RETICULUM STRESS#0.9707;EOSINOPHIL#0.9707;HIGH POWER FIELD#0.9707;PROTEIN SECRETION#0.9706;ZONA PELLUCIDA#0.9706;ACUTE HEART FAILURE#0.9706;VIRION#0.9706;LUNG DAMAGE#0.9705;MIDDLE CEREBRAL ARTERY#0.9705;ENDOMETRIAL CANCER#0.9705;CHENODEOXYCHOLIC ACID#0.9705;LACTIC ACID#0.9704;PANCREATIC ADENOCARCINOMA#0.9704;INTRAHEPATIC CHOLESTASIS#0.9704;HYPOKALEMIA#0.9704;CELL JUNCTION#0.9703;PEARSON CORRELATION COEFFICIENT#0.9703;SEQUESTERING#0.9703;BACITRACIN#0.9703;PROTEIN BREAKDOWN#0.9703;QUININE#0.9703;ACROSOME REACTION#0.9702;ANION TRANSPORT#0.9702;FASTING PLASMA GLUCOSE#0.9702;LIVER PROGENITOR CELL#0.9702;KETAMINE#0.9702;FLUOXETINE#0.9702;LIMB ISCHEMIA#0.9701;BIOELECTRICAL IMPEDANCE ANALYSIS#0.9701;METFORMIN#0.9701;MICROSOMAL MEMBRANE#0.9701;NEUTROPHIL ACTIVATION#0.9701;CLINICAL PRACTICE GUIDELINE#0.9701;MONTE CARLO SIMULATION#0.9701;STATUS EPILEPTICUS#0.9701;FORSKOLIN#0.9700;PODOCYTE#0.9700;PARALYSIS#0.9700;SLIT DIAPHRAGM#0.9700;BODY CONDITION SCORE#0.9700;TRIIODOTHYRONINE#0.9699;PENTOBARBITAL#0.9699;ETODOLAC#0.9699;CEREBRAL ISCHEMIA#0.9699;VITAMIN E#0.9699;COLLISION INDUCED DISSOCIATION#0.9699;PROTEIN CATABOLISM#0.9698;ADRIAMYCIN#0.9698;SALIVARY GLAND#0.9698;SURGICAL SITE INFECTION#0.9698;ANILINE#0.9697;TOTAL KNEE ARTHROPLASTY#0.9697;LOSARTAN#0.9697;FLOW MEDIATED DILATATION#0.9697;CHOROID PLEXUS#0.9697;HUMAN ADIPOSE TISSUE#0.9697;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9697;GENE SILENCING#0.9697;HEPATIC ARTERY#0.9697;DIMETHYL SULFOXIDE#0.9696;CHLOROQUINE#0.9696;ENDOCYTOSIS#0.9695;FLUID RETENTION#0.9695;DIURESIS#0.9695;CONJUNCTIVITIS#0.9694;OBSTRUCTIVE LUNG DISEASE#0.9694;IGF BINDING#0.9694;ACID PHOSPHATASE#0.9694;CHOLESTEROL ESTERIFICATION#0.9694;SODIUM TRANSPORT#0.9694;PREMATURITY#0.9694;L-ASCORBIC ACID#0.9693;HIGH MOBILITY GROUP#0.9693;INTERSTITIAL LUNG DISEASE#0.9693;PROSTACYCLIN#0.9693;SUCCINATE DEHYDROGENASE#0.9693;POLYNEUROPATHY#0.9693;IN VITRO MATURATION#0.9692;POPULATION PHARMACOKINETIC MODEL#0.9692;L-CYSTEINE#0.9692;LOCALIZED SURFACE PLASMON#0.9692;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.9692;HYDROCEPHALUS#0.9692;BRAIN EDEMA#0.9692;LOCOMOTION#0.9692;BRUSH BORDER#0.9691;5 FLUOROURACIL#0.9691;HIGH CARDIOVASCULAR RISK#0.9691;OR LIVER TRANSPLANTATION#0.9690;MYCOPHENOLIC ACID#0.9690;DEFEROXAMINE#0.9690;BRONCHIECTASIS#0.9690;PLEURA#0.9690;AGGLUTINATION#0.9689;HUMAN LEUKOCYTE ANTIGEN#0.9689;PEPSTATIN#0.9689;FURAN#0.9689;INTIMA MEDIA THICKNESS#0.9689;STATISTICALLY SIGNIFICANTLY DIFFERENT#0.9689;EPIDIDYMIS#0.9689;ZONULA OCCLUDENS#0.9689;CARDIAC ARREST#0.9688;STREPTOZOCIN#0.9688;ACETIC ACID#0.9687;CHOLECALCIFEROL#0.9687;LIVER STEM CELL#0.9687;PEROXIDASE ACTIVITY#0.9687;PHOSPHOCHOLINE#0.9686;AGITATION#0.9686;PANCREATIC DUCTAL ADENOCARCINOMA#0.9686;RED BLOOD CELL#0.9685;CELL FUSION#0.9685;PANCYTOPENIA#0.9685;BLOOD LOSS#0.9685;CONTROL OF BLOOD PRESSURE#0.9685;CELECOXIB#0.9685;FRONTAL#0.9685;POLYMORPHONUCLEAR NEUTROPHIL#0.9685;RIFAMPICIN#0.9685;CARDIOMYOCYTE#0.9684;MAXIMUM ADSORPTION CAPACITY#0.9684;UREMIC TOXIN#0.9684;HISTAMINE#0.9684;SODIUM NITROPRUSSIDE#0.9684;ILEUS#0.9684;INSEMINATION#0.9684;TACROLIMUS#0.9683;OOCYTE#0.9683;HEPARIN#0.9683;CELL ASSOCIATED#0.9683;MOLAR#0.9683;FORMALIN#0.9683;DERMAL FIBROBLAST#0.9683;MACROPHAGE MIGRATION#0.9683;IGE BINDING#0.9682;BIOTIN#0.9682;SUBSTANCE P#0.9682;PSORIASIS#0.9681;HEART MUSCLE#0.9681;UROKINASE#0.9681;INNER LAYER#0.9681;CAUDA#0.9681;CONTROLLED DRUG DELIVERY#0.9681;END ORGAN DAMAGE#0.9681;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9680;PROTHROMBIN COMPLEX CONCENTRATE#0.9680;CORTICOTROPIN#0.9680;NERVE GROWTH FACTOR#0.9680;GERM CELL#0.9680;ADENINE DINUCLEOTIDE PHOSPHATE#0.9680;CLOSTRIDIUM DIFFICILE INFECTION#0.9679;EPINEPHRINE#0.9679;ANTHRACENE#0.9679;SEMEN#0.9678;PERITONEAL CAVITY#0.9678;FLUCONAZOLE#0.9678;BORTEZOMIB#0.9678;FLUOROURACIL#0.9677;HEMOPHILIA#0.9677;RESPIRATORY SYSTEM#0.9677;TRYPTOPHAN#0.9677;SODIUM DODECYL SULPHATE#0.9676;PROTEIN GLYCOSYLATION#0.9676;MONOCYTE CHEMOTACTIC PROTEIN#0.9676;BENAZEPRIL#0.9676;DILATED CARDIOMYOPATHY#0.9676;NATRIURESIS#0.9675;TENOFOVIR#0.9675;ESTROUS CYCLE#0.9675;CHRONIC LIVER FAILURE#0.9675;METAMORPHOSIS#0.9675;PROTEASOME#0.9675;LEFT ATRIAL DIAMETER#0.9675;INTERCELLULAR JUNCTION#0.9674;CHOLERA TOXIN B#0.9674;LIPID OXIDATION#0.9674;MUCOSITIS#0.9674;DIURNAL#0.9673;MILK PROTEIN#0.9673;ACTINOMYCIN D#0.9673;NITROPRUSSIDE#0.9673;HEAT SHOCK PROTEIN#0.9672;ADVANCED GASTRIC CANCER#0.9672;TIGHT JUNCTION PROTEIN#0.9672;DIHYDROTESTOSTERONE#0.9672;CATABOLISM#0.9672;DEHISCENCE#0.9671;AMYLOID FIBRIL FORMATION#0.9671;COMPLEMENT RECEPTOR#0.9671;PERIODONTITIS#0.9671;SICKLE CELL DISEASE#0.9671;AMILORIDE#0.9671;PROSTAGLANDIN SYNTHESIS#0.9671;TIME TO PROGRESSION#0.9671;LEFT ANTERIOR DESCENDING#0.9670;AMINOHIPPURATE#0.9670;ATOMIC ABSORPTION SPECTROMETRY#0.9670;BREAST CANCER PATIENTS#0.9670;ABDOMINAL AORTIC ANEURYSM#0.9670;HDL PARTICLE#0.9669;GASTRIC EMPTYING#0.9669;MEPYRAMINE#0.9669;AORTIC VALVE#0.9669;XANTHINE#0.9669;GRAFT VERSUS HOST#0.9669;HEPARIN BINDING#0.9669;EVERY OTHER DAY#0.9669;AGE AT ONSET#0.9668;CROSS SECTIONAL AREA#0.9668;DIFFERENTIAL SCANNING CALORIMETRY#0.9668;HYDROCHLOROTHIAZIDE#0.9668;CARDIAC MUSCLE#0.9668;ULTRASOUND CONTRAST AGENTS#0.9668;RESPIRATORY BURST#0.9667;ACETAZOLAMIDE#0.9667;PURKINJE CELL#0.9667;RAT BONE MARROW#0.9667;GLUTAMIC ACID#0.9667;UROKINASE PLASMINOGEN ACTIVATOR#0.9667;MEDROXYPROGESTERONE#0.9666;CHONDROCYTE#0.9666;ATROPINE#0.9666;COLON CARCINOMA#0.9666;LOW BIRTH WEIGHT#0.9666;VENTRICULAR ASSIST DEVICE#0.9666;PERIPHERAL BLOOD MONOCYTES#0.9666;GROWTH FACTOR BINDING#0.9666;ACTION POTENTIAL#0.9666;GLUCONEOGENESIS#0.9666;PROTEASE ACTIVITY#0.9665;LATE PREGNANCY#0.9665;EPOXIDE HYDROLASE#0.9665;SEMINAL VESICLE#0.9665;LEUKOPENIA#0.9665;GUANINE#0.9665;KUPFFER CELL#0.9665;CARDIOVASCULAR HEALTH STUDY#0.9665;LIPOGENESIS#0.9665;STANDARD DEVIATION SCORE#0.9664;CORONARY ARTERY CALCIFICATION#0.9664;GLUCOSE TRANSPORT#0.9664;CELL SURFACE BINDING#0.9664;OVARIAN CARCINOMA#0.9664;HEXANE#0.9664;AGE AT DIAGNOSIS#0.9663;MULTIPLE ORGAN DYSFUNCTION#0.9663;HEPATIC COMA#0.9663;C-LEVEL#0.9663;HEART RATE VARIABILITY#0.9662;LIMIT OF QUANTIFICATION#0.9662;COLLAGEN INDUCED ARTHRITIS#0.9662;INTESTINAL TRACT#0.9662;GRANULOCYTE COLONY STIMULATING FACTOR#0.9662;REGIONAL LYMPH NODE#0.9662;PROTEIN TRANSPORT#0.9662;TRANSFERRIN RECEPTOR#0.9661;LIVER DEVELOPMENT#0.9661;MAST CELL ACTIVATION#0.9661;MAP KINASE#0.9661;SCREEN PRINTED ELECTRODE#0.9661;FLUID TRANSPORT#0.9661;LOW DETECTION LIMIT#0.9661;CORD BLOOD#0.9661;ASPIRIN#0.9661;CHOLINE#0.9661;PERIPHERAL NERVE#0.9660;GLUCOSAMINE#0.9660;HYDROXYPROLINE#0.9660;RECEPTOR ACTIVITY#0.9660;SUCCINATE#0.9660;IMMUNOGLOBULIN PRODUCTION#0.9660;ATOPIC DERMATITIS#0.9660;AMINOCAPROIC ACID#0.9659;VISCERAL LEISHMANIASIS#0.9659;FEED CONVERSION RATIO#0.9659;GLUTEN FREE DIET#0.9659;HEPATITIS E#0.9659;SPHINGOSINE 1 PHOSPHATE#0.9659;MELPHALAN#0.9659;TRIGLYCERIDE LIPASE#0.9659;BLASTOCYST DEVELOPMENT#0.9658;XANTHINE OXIDASE#0.9658;PERITONEUM#0.9658;GLOMERULAR FILTRATION RATE#0.9658;HISTIDINE#0.9658;INTESTINAL ABSORPTION#0.9657;HUMAN DERMAL FIBROBLAST#0.9657;BILE DUCT LIGATION#0.9657;CEREBRAL INFARCTION#0.9657;ADULT RESPIRATORY DISTRESS SYNDROME#0.9657;ACIDIFICATION#0.9657;GLUTATHIONE PEROXIDASE#0.9657;ACUTE LEUKEMIA#0.9657;PROTEIN FOLDING#0.9656;ADVANCED GLYCATION ENDPRODUCT#0.9656;BETA THALASSEMIA#0.9656;LIPID BINDING PROTEIN#0.9656;THYROID CANCER#0.9656;CIMETIDINE#0.9656;MUSCLE DAMAGE#0.9655;COATED PIT#0.9655;INTENSIVE INSULIN THERAPY#0.9655;NORMAL GLUCOSE TOLERANCE#0.9655;N-ETHYLMALEIMIDE#0.9655;PROLIFERATIVE DIABETIC RETINOPATHY#0.9655;AMIKACIN#0.9655;PROTEIN ENERGY WASTING#0.9654;LIPOLYSIS#0.9654;INDIUM TIN OXIDE#0.9654;ANESTHETIC#0.9654;IRON DEXTRAN#0.9654;ASPARAGINE#0.9654;ACETAMINOPHEN#0.9654;MINIMUM INHIBITORY CONCENTRATION#0.9654;DIPEPTIDYL PEPTIDASE 4#0.9653;URETER#0.9653;CONGESTIVE HEART FAILURE#0.9653;ADJUSTED ODDS RATIO#0.9653;ADENYLATE#0.9653;GLUCOSE INTOLERANCE#0.9653;MORBID OBESITY#0.9653;ETHYL ALCOHOL#0.9652;RECEPTOR COMPLEX#0.9652;ACETYLCYSTEINE#0.9652;RETINAL PIGMENT EPITHELIUM#0.9652;MULTIPLE REGRESSION ANALYSIS#0.9651;GALACTOSIDASE ACTIVITY#0.9651;CYTOLYSIS#0.9651;ADVANCED LIVER DISEASE#0.9651;SUBSTANTIA NIGRA#0.9651;FIBRINOGEN GAMMA CHAIN#0.9651;FOOD ALLERGY#0.9651;SYSTOLIC BLOOD PRESSURE#0.9651;CONGENITAL HEART DISEASE#0.9651;LAMIVUDINE#0.9651;CANDESARTAN CILEXETIL#0.9651;ANTICOAGULANT ACTIVITY#0.9651;LEUKOCYTE#0.9650;ASTROCYTE#0.9650;VASCULAR CELL#0.9650;SEVERE ACUTE PANCREATITIS#0.9650;OLFACTORY BULB#0.9649;SPINAL CORD INJURY#0.9649;VERAPAMIL#0.9649;ROUGH ENDOPLASMIC RETICULUM#0.9649;FASTING SERUM INSULIN#0.9649;5'-AMP#0.9649;INTRAVENOUS IMMUNOGLOBULIN#0.9648;ALVEOLAR EPITHELIAL CELL#0.9648;CHOLANGIOCARCINOMA#0.9647;PROTEIN DENATURATION#0.9647;PULMONARY ARTERY#0.9647;FATTY ACID SYNTHESIS#0.9647;ALPHA-AMINOISOBUTYRIC ACID#0.9647;FOREBRAIN#0.9647;VERY-LOW-DENSITY LIPOPROTEIN#0.9647;INFERTILE#0.9647;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9646;ANTI INFLAMMATORY DRUGS#0.9646;GLOMERULAR FILTRATION#0.9646;LYMPH NODE DISSECTION#0.9646;MYOCYTES#0.9646;SKIN FIBROBLASTS#0.9646;PROGESTERONE#0.9646;ACETYLCHOLINE RECEPTOR#0.9646;MAXIMUM CLOT FIRMNESS#0.9646;CONJUGATION#0.9645;D-ARGININE#0.9645;NEUTROPHIL#0.9645;PHOSPHOLIPASE A2#0.9645;DIPHOSPHATE#0.9645;PROTEIN CARBONYL CONTENT#0.9645;DOPAMINE#0.9645;PLASMA PROTEIN#0.9645;LYMPHOPENIA#0.9644;MESENTERIC LYMPH NODE#0.9644;CERVICAL CANCER#0.9644;MAMMARY EPITHELIAL CELL#0.9643;VASODILATATION#0.9643;PITAVASTATIN#0.9643;MALARIA#0.9643;CYTIDINE#0.9642;LOW DENSITY LIPOPROTEIN#0.9642;LIPOPROTEIN LIPASE#0.9642;FLUFENAMIC ACID#0.9642;WATER TRANSPORT#0.9642;N-ACETYLCYSTEINE#0.9642;SPECIFIC SURFACE AREA#0.9642;CYTOTOXIN#0.9642;STROMA#0.9641;MAMMARY GLAND#0.9641;BILE DUCT LIGATED#0.9641;POINT OF CARE#0.9641;DEHYDRATION#0.9641;RECEIVER OPERATOR CHARACTERISTIC#0.9641;MICROVASCULAR ENDOTHELIAL CELL#0.9641;BLASTOCYST FORMATION#0.9641;TRIMETHOPRIM#0.9640;COMMUNITY ACQUIRED PNEUMONIA#0.9640;PEPTIDE BINDING#0.9640;PERITONITIS#0.9640;SPHINGOSINE#0.9640;ANEMIC#0.9639;GLYCINE#0.9639;SERTOLI CELL#0.9639;GUANOSINE#0.9638;DYSPNEA#0.9638;ACUTE LIVER INJURY#0.9638;FETAL LIVER#0.9638;RNA SYNTHESIS#0.9638;MESANGIUM#0.9638;MYASTHENIA GRAVIS#0.9638;ANAPHYLAXIS#0.9638;WATER RETENTION#0.9638;OXIDATIVE PHOSPHORYLATION#0.9638;LYMPHATIC VESSEL#0.9637;MAXIMUM TOLERATED DOSE#0.9637;RISK OF DEATH#0.9637;GENERAL LINEAR MODEL#0.9637;DIAPHRAGM#0.9637;URETHANE#0.9637;LIVER CARCINOMA#0.9637;CORONAL#0.9637;MEROPENEM#0.9637;NEUROBLASTOMA#0.9637;CHLORIDE CHANNEL#0.9637;GLUCOCORTICOID RECEPTOR#0.9637;INDUCED RENAL INJURY#0.9636;VASOPRESSIN#0.9636;GALL BLADDER#0.9635;IMPAIRED GLUCOSE TOLERANCE#0.9635;WEIGHT LOSS#0.9635;SOLUBLE FRACTION#0.9635;RAPAMYCIN#0.9635;TOXICANT#0.9635;PLATELET AGGREGATION#0.9634;CELL FRACTION#0.9634;BRONCHITIS#0.9634;HUMAN UMBILICAL VEIN#0.9634;NEPHRON#0.9634;PITUITARY GLAND#0.9634;GLYBURIDE#0.9633;RHEUMATIC DISEASE#0.9633;METASTATIC COLORECTAL CANCER#0.9633;HYPERCALCEMIA#0.9633;MAGNETIC RESONANCE SPECTROSCOPY#0.9633;CAROTID ARTERY#0.9633;N-OMEGA-NITRO-L-ARGININE#0.9632;MINIMAL CHANGE DISEASE#0.9632;ACYCLOVIR#0.9632;DIPHENYLHYDANTOIN#0.9632;MEAN SQUARE ERROR#0.9632;CONTROL GROUP 1#0.9632;THYROID GLAND#0.9632;RESPIRATION#0.9632;LIPASE ACTIVITY#0.9631;INTERSTITIAL NEPHRITIS#0.9631;CELL AGGREGATION#0.9631;HEARING IMPAIRMENT#0.9631;HEARING LOSS#0.9631;EPIDERMAL GROWTH FACTOR#0.9631;ACROSOME#0.9631;CELL ADHESION MOLECULE#0.9631;LIMITS OF DETECTION#0.9630;HYPOXIA INDUCIBLE FACTOR#0.9630;METABOLIC ACIDOSIS#0.9630;CHEWING#0.9630;ORAL CAVITY#0.9630;GASTRO#0.9630;TROPHOBLAST#0.9630;A-GEL#0.9630;HEPATOCELLULAR CARCINOMA CELL#0.9630;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9630;ADJUSTED HAZARD RATIO#0.9630;VASCULAR SMOOTH MUSCLE CELL#0.9630;GASTRITIS#0.9630;FLUCLOXACILLIN#0.9629;LUTEAL PHASE#0.9629;EMBRYO DEVELOPMENT#0.9628;GROWTH PATTERN#0.9628;ETHINYL ESTRADIOL#0.9628;TO BACKGROUND RATIO#0.9628;POLYURIA#0.9628;DEMETHYLATION#0.9628;THALASSEMIA#0.9628;CLINDAMYCIN#0.9627;NEURONAL CELLS#0.9627;COLORECTAL CARCINOMA#0.9627;URSODEOXYCHOLIC ACID#0.9627;INSULIN-LIKE GROWTH FACTOR#0.9627;MICROSOME#0.9627;CERVICAL LYMPH NODE#0.9627;LYSINE#0.9627;LEUCINE#0.9627;LOCALISATION#0.9627;RESPIRATORY SYNCYTIAL VIRUS#0.9627;MITOCHONDRIAL DNA#0.9627;CELL-MEDIATED IMMUNE RESPONSE#0.9626;CANCER SPECIFIC SURVIVAL#0.9626;HYPERTHERMIA#0.9626;PHOSPHODIESTERASE INHIBITOR#0.9626;CHLORPROPAMIDE#0.9626;IRON DEFICIENCY ANEMIA#0.9626;TUMOUR NECROSIS FACTOR#0.9626;BENZIMIDAZOLE#0.9626;ORAL MUCOSA#0.9626;ALDOSTERONE#0.9625;TOPOISOMERASE#0.9625;SEROTONIN RELEASE#0.9625;TRANSDIFFERENTIATION#0.9625;SUCCINIC ACID#0.9625;ACINAR CELL#0.9625;MAST CELL#0.9624;PHENOBARBITAL#0.9624;HEPATIC PROGENITOR CELL#0.9624;PHOSPHOLIPASE A2 ACTIVITY#0.9624;CORONARY ARTERY BYPASS#0.9623;PRIMARY HEALTH CARE#0.9623;TUMOR TISSUES#0.9623;END OF TREATMENT#0.9623;RETINAL PIGMENT EPITHELIAL#0.9623;TRAUMATIC BRAIN INJURY#0.9623;GLUTAMINE#0.9623;STOMATITIS#0.9623;FIBRIL#0.9623;COLONY-FORMING CELL#0.9623;MENINGOENCEPHALITIS#0.9623;HUMAN EMBRYONIC KIDNEY#0.9622;RETINAL ENDOTHELIAL CELLS#0.9622;HIBERNATION#0.9622;LECTIN#0.9622;ENTEROCYTE#0.9622;LUTEIN#0.9622;SHORT BOWEL SYNDROME#0.9622;KERATINOCYTE#0.9622;DIFFUSE LARGE B-CELL LYMPHOMA#0.9622;VISUAL ANALOG SCALE#0.9622;PULMONARY EDEMA#0.9622;ESSENTIAL AMINO ACID#0.9622;CUSHING'S SYNDROME#0.9622;SCHISTOSOMIASIS#0.9621;AXONAL TRANSPORT#0.9621;PROTEIN DIGESTION#0.9621;PROTEIN OXIDATION#0.9620;ADVERSE CLINICAL OUTCOME#0.9620;AMINO ACID TRANSPORT#0.9620;PULMONARY EMBOLISM#0.9620;ACUTE MYOCARDIAL INFARCTION#0.9620;VINCRISTINE#0.9620;GLUTATHIONE#0.9620;AORTIC ANEURYSM#0.9620;BETA-GLUCURONIDASE ACTIVITY#0.9619;CELIAC DISEASE#0.9619;ASPARTIC ACID#0.9619;CELL KILLING#0.9619;OUABAIN#0.9619;SKIN DISEASE#0.9618;BILE DUCT CELL#0.9618;TACHYCARDIA#0.9618;URIDINE#0.9618;ESSENTIAL HYPERTENSION#0.9618;CEREBRAL CORTEX#0.9618;PLATELET-DERIVED GROWTH FACTOR#0.9618;EMBRYONIC KIDNEY#0.9617;SECRETORY PATHWAY#0.9617;ETHANOL#0.9617;LASER SCANNING MICROSCOPY#0.9616;UMBILICAL CORD BLOOD#0.9616;DEFICIENCY ANEMIA#0.9616;MUTAGENESIS#0.9616;RIBOSOME#0.9616;SPERM MOTILITY#0.9615;CYTOCHROME B5#0.9615;PLASMA GLYCOPROTEIN#0.9615;LINEAR REGRESSION ANALYSIS#0.9615;SCLEROTIC#0.9615;HEMOLYSIS#0.9615;PANCREATIC CANCER#0.9614;FATTY ACID METABOLISM#0.9614;BLOOD GLUCOSE LEVEL#0.9614;BLOOD COAGULATION#0.9614;CHOLECYSTITIS#0.9614;EMBOLISM#0.9614;LACTIC ACIDOSIS#0.9614;PROTEINURIA#0.9613;AND BODY COMPOSITION#0.9613;DENSITY FUNCTIONAL THEORY#0.9613;RITUXIMAB#0.9613;NEUROTOXIN#0.9612;GLIAL CELL#0.9612;CORONARY ARTERY DISEASE#0.9612;PROPIDIUM#0.9612;QUALITY OF CARE#0.9611;DETOXIFICATION#0.9611;BLOOD BRAIN BARRIER#0.9611;IONOPHORE#0.9611;HEALTHY CONTROL GROUP#0.9611;UMBILICAL VEIN#0.9611;GROWTH HORMONE#0.9611;PORTAL VEIN#0.9611;MEMBRANE TRANSPORT#0.9610;RECEPTOR LIGAND#0.9610;FOOD FREQUENCY QUESTIONNAIRE#0.9610;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9610;CONSTRICTION#0.9610;EPITHELIAL MESENCHYMAL TRANSITION#0.9610;CYCLOSPORIN A#0.9610;CHRONIC HEART FAILURE#0.9609;OBSTRUCTIVE JAUNDICE#0.9609;SENSITIZATION#0.9609;RADICAL SCAVENGING ACTIVITY#0.9609;INTERMEDIATE FILAMENT#0.9609;GI TRACT#0.9609;ACTIN CYTOSKELETON#0.9609;ION CYCLOTRON RESONANCE#0.9609;72-HOURS#0.9608;NEOPLASTIC DISEASE#0.9608;AUTOPHAGY#0.9608;LENGTH OF STAY#0.9608;ARTERIOSCLEROSIS#0.9608;ACADEMIC MEDICAL CENTER#0.9608;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9608;PARTICLE SIZE DISTRIBUTION#0.9607;OXIDATIVE BURST#0.9607;GLOMERULUS#0.9607;MENINGITIS#0.9607;LEISHMANIASIS#0.9607;ISOPROTERENOL#0.9606;SEDATION#0.9606;VACUOLE#0.9606;HYPOTHYROIDISM#0.9605;ADENINE#0.9605;LEUKEMIA INHIBITORY FACTOR#0.9605;L-ARGININE#0.9605;INSTITUTIONAL REVIEW BOARD#0.9605;IGG ANTIBODY#0.9605;PRIMARY HUMAN HEPATOCYTES#0.9605;VORICONAZOLE#0.9605;LYMPHOCYTE PROLIFERATION#0.9604;SYNOVITIS#0.9604;LUNG EPITHELIAL CELL#0.9604;LIPOPROTEIN METABOLISM#0.9604;VALINE#0.9604;VENTILATOR ASSOCIATED PNEUMONIA#0.9604;ANDROGEN BINDING#0.9604;OSTEOARTHRITIS#0.9604;PREDNISOLONE#0.9604;BONE MORPHOGENETIC PROTEIN#0.9603;INFLAMMATORY CELL INFILTRATION#0.9603;BODY SURFACE AREA#0.9603;CARBOHYDRATE METABOLISM#0.9603;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9603;HEMOLYTIC ANEMIA#0.9603;NERVE FIBER#0.9603;MENOPAUSE#0.9602;ATPASE ACTIVITY#0.9602;TYPHUS#0.9602;NASAL MUCOSA#0.9602;LDL RECEPTOR#0.9602;METHIONINE#0.9601;STRIATUM#0.9601;ANGIOTENSIN RECEPTOR BLOCKER#0.9601;TYPE 1 DIABETIC#0.9601;ACUTE PHASE RESPONSE#0.9600;DRUG DELIVERY SYSTEM#0.9600;BONE MARROW CELLS#0.9600;DNA SYNTHESIS#0.9600;BONE REGENERATION#0.9600;MULTIPLE LINEAR REGRESSION#0.9600;STEM CELL FACTOR#0.9600;DRUG METABOLISM#0.9600;CYCLIC AMP#0.9600;DIGESTIVE TRACT#0.9600;COLLAGEN SYNTHESIS#0.9600;2-DEOXYGLUCOSE#0.9600;PLATELET ACTIVATING FACTOR#0.9599;VENOUS BLOOD#0.9599;INTERLEUKIN 2 RECEPTOR#0.9599;ANTIBODY PRODUCTION#0.9599;ISOLEUCINE#0.9599;PORTAL HYPERTENSION#0.9599;LONG TERM CARE#0.9599;ANCHORING#0.9599;SPINAL CORD#0.9599;DERMIS#0.9598;ENCEPHALOMYELITIS#0.9598;FACTOR XA#0.9598;ENDOSOME#0.9598;GLYCOSYLATION#0.9598;GROWTH FACTOR RECEPTOR#0.9598;SUDDEN CARDIAC DEATH#0.9598;ORGANIC ANION TRANSPORTER#0.9598;INOSINE#0.9598;TARGET OF RAPAMYCIN#0.9597;ESTROGENS#0.9597;TARGET ORGAN DAMAGE#0.9597;EXTRACELLULAR MATRIX COMPONENT#0.9597;CHEMICAL VAPOR DEPOSITION#0.9597;AREA UNDER CURVE#0.9597;FOLLICULAR PHASE#0.9596;PARTURITION#0.9595;AVERAGE DAILY GAIN#0.9595;NUCLEOTIDE BINDING#0.9595;PROTEIN OF INTEREST#0.9595;CYCLASE ACTIVITY#0.9595;PLATELET ACTIVATION#0.9595;ANTIGEN PRESENTATION#0.9595;CELLULAR MEMBRANE#0.9595;SYPHILIS#0.9595;CORONARY HEART DISEASE#0.9595;HISTAMINE RECEPTOR#0.9594;SEVERE ADVERSE EVENTS#0.9594;OPSONIZATION#0.9594;PROTEIN KINASE INHIBITOR#0.9594;PHOSPHATIDYLSERINE#0.9594;BREAST CANCER#0.9594;SMOOTH MUSCLE ACTIN#0.9593;MALIGNANT GLIOMA#0.9593;POLY ETHYLENE GLYCOL#0.9592;CILOSTAZOL#0.9592;SUPEROXIDE DISMUTASE#0.9592;DRAINING LYMPH NODE#0.9592;MACROPHAGE ACTIVATION#0.9592;OF DIABETIC RATS#0.9591;CYSTIC FIBROSIS#0.9591;IRRITANT#0.9591;OXIDATIVE METABOLISM#0.9591;A BAND#0.9591;DIPEPTIDYL PEPTIDASE#0.9591;ATP BINDING#0.9591;HEME OXYGENASE 1#0.9591;PENICILLIN BINDING#0.9591;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9590;TENOFOVIR DISOPROXIL FUMARATE#0.9590;GERMINATION#0.9590;DISSEMINATED INTRAVASCULAR COAGULATION#0.9590;TOLERANCE INDUCTION#0.9590;HEPATITIS A#0.9589;VENA CAVA#0.9589;PROTEIN-ENERGY MALNUTRITION#0.9589;LYMPHOID CELL#0.9589;DRY MATTER INTAKE#0.9589;ANTIGEN BINDING#0.9588;FLAVIN#0.9588;SIGNAL TRANSDUCER#0.9588;ADIPOCYTE#0.9588;ACUTE PANCREATITIS#0.9588;PERIPHERAL BLOOD LYMPHOCYTES#0.9588;ZONULA OCCLUDENS 1#0.9588;NICOTINAMIDE#0.9588;POSITRON EMISSION TOMOGRAPHY#0.9587;NADPH OXIDASE#0.9587;PELVIS#0.9587;NITRIC OXIDE SYNTHESIS#0.9587;METHYLPREDNISOLONE#0.9587;MARKERS OF INFLAMMATION#0.9587;CLOTTING#0.9587;REGION OF INTEREST#0.9587;RANDOMISED CONTROLLED TRIAL#0.9587;TENOFOVIR DISOPROXIL#0.9587;SQUAMOUS CELL CARCINOMA#0.9587;CELLULAR COMPONENT#0.9587;BREAST CARCINOMA#0.9586;LIPID DROPLET#0.9586;MULTIPLE LOGISTIC REGRESSION#0.9586;PUBERTY#0.9586;METASTATIC RENAL CELL CARCINOMA#0.9586;MEGESTROL ACETATE#0.9586;PERIODONTAL DISEASE#0.9586;NOREPINEPHRINE#0.9586;MUCOUS#0.9585;PRINCIPAL COMPONENT ANALYSIS#0.9585;ARTERY DISEASE#0.9585;OOCYTE MATURATION#0.9585;SENTINEL NODE BIOPSY#0.9585;RESPIRATORY TRACT INFECTION#0.9584;HEPATIC ENCEPHALOPATHY#0.9584;ROSETTING#0.9583;HYPOTENSIVE#0.9583;ARACHIDONIC ACID METABOLISM#0.9583;ANAEMIA#0.9583;MINERALIZATION#0.9583;ELECTRONIC MEDICAL RECORD#0.9583;SATURATED FATTY ACID#0.9582;SIZE EXCLUSION CHROMATOGRAPHY#0.9582;HYPOGLYCEMIA#0.9582;ARACHIDONIC ACID#0.9582;PHOSPHATIDYLETHANOLAMINE#0.9582;BILIARY ATRESIA#0.9581;ADENOSINE MONOPHOSPHATE#0.9581;CACHEXIA#0.9581;DEXAMETHASONE#0.9581;POLYMORPHONUCLEAR LEUKOCYTES#0.9581;IMMUNE DYSFUNCTION#0.9580;DEMENTIA#0.9580;RESPONSE TO PROTEIN#0.9580;HYPERGLYCEMIC#0.9580;5-AMINOSALICYLIC ACID#0.9579;ADENOSINE TRIPHOSPHATE#0.9579;JUGULAR VEIN#0.9579;POST-TRANSLATIONAL MODIFICATION#0.9579;HYPERPHOSPHATEMIA#0.9579;CISPLATIN#0.9578;ELECTRON TRANSPORT#0.9578;LIPOPROTEIN LIPASE ACTIVITY#0.9577;T CELL PROLIFERATION#0.9577;ORAL GLUCOSE TOLERANCE#0.9577;OXYGENASE#0.9577;TRADITIONAL RISK FACTORS#0.9577;ANDROGEN RECEPTOR#0.9577;RELAPSE FREE SURVIVAL#0.9577;AGEING#0.9576;CERVIX#0.9576;OF LIVER TRANSPLANTATION#0.9576;VASCULAR DEMENTIA#0.9576;FRAMINGHAM RISK SCORE#0.9576;PROLIFERATIVE GLOMERULONEPHRITIS#0.9576;SENSITIZER#0.9576;ADENYLATE CYCLASE#0.9576;SURFACE PLASMON RESONANCE#0.9575;CONNECTIVE TISSUE DISEASE#0.9575;VIRAL REPLICATION#0.9575;MODIFIED RANKIN SCALE#0.9575;ANGIOTENSIN RECEPTOR#0.9575;ANTIGEN PRESENTING CELLS#0.9575;CARBOHYDRATE BINDING#0.9575;ACTIN FILAMENT#0.9575;SIGNALING CASCADE#0.9575;LYSOSOME#0.9574;ENDOCYTIC VESICLE#0.9574;HEMATOPOIETIC CELL#0.9574;SUGAR BINDING#0.9574;MYELOID CELL#0.9574;PRECURSOR CELL#0.9574;PERIPHERAL BLOOD CELLS#0.9574;HYPERURICEMIA#0.9574;LIVER LESIONS#0.9574;5-ASA#0.9574;SENESCENCE#0.9574;URINARY TRACT INFECTION#0.9573;LYMPHOCYTIC LEUKEMIA#0.9573;RENAL CELL CARCINOMA#0.9573;MITOSIS#0.9573;IDIOPATHIC MEMBRANOUS NEPHROPATHY#0.9573;AKAIKE INFORMATION CRITERION#0.9573;PROTEIN SECONDARY STRUCTURE#0.9572;PRIMARY SCLEROSING CHOLANGITIS#0.9572;CROMOGLYCATE#0.9572;EPSTEIN BARR VIRUS#0.9572;RECTUM#0.9572;PEPTIDE HORMONE#0.9572;BILIARY TRACT#0.9572;HEMOSTASIS#0.9572;GAP JUNCTION#0.9572;CELL MOTILITY#0.9571;EXOCYTOSIS#0.9571;INVASIVE MECHANICAL VENTILATION#0.9571;TISSUE GROWTH FACTOR#0.9570;MITOGENIC ACTIVITY#0.9570;RENAL TRANSPLANT RECIPIENTS#0.9570;ADRENERGIC RECEPTOR#0.9570;JEJUNUM#0.9570;GROWTH OF CELL#0.9570;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.9570;TRANSMISSION ELECTRON MICROSCOPE#0.9570;CHOLESTEROL TRANSPORT#0.9570;SELECTED REACTION MONITORING#0.9569;CYCLOSPORIN#0.9569;STEM CELL MARKER#0.9569;CALCINEURIN#0.9569;INSULIN SECRETION#0.9569;OVULATION#0.9569;LARGE INTESTINE#0.9569;LINES OF EVIDENCE#0.9569;ANTIDIURETIC HORMONE#0.9569;CELLULAR METABOLISM#0.9569;WATER CONTACT ANGLE#0.9568;EVENT FREE SURVIVAL#0.9568;INDOMETHACIN#0.9568;ALVEOLAR MACROPHAGE#0.9568;COMMON TERMINOLOGY CRITERIA#0.9568;MESANGIAL CELL#0.9568;CANDIDIASIS#0.9568;CELLULAR IMMUNE RESPONSE#0.9568;ADIPOSE-DERIVED STEM CELL#0.9567;PHAGOCYTOSIS#0.9567;DISEASE ACTIVITY SCORE#0.9567;FOCAL ADHESION#0.9567;LUMINAL#0.9567;T HELPER CELL#0.9567;FEMUR#0.9566;LUNG CARCINOMA#0.9566;TOPICAL#0.9566;CHOLANGITIS#0.9566;PULMONARY TUBERCULOSIS#0.9565;PROSTAGLANDIN E2#0.9565;MEMBRANE FRACTION#0.9565;OPEN ANGLE GLAUCOMA#0.9565;INSULIN RECEPTOR#0.9565;COLONY-STIMULATING FACTOR#0.9565;MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS#0.9565;NEURAL CELL#0.9565;MUSCLE WEAKNESS#0.9565;METAL CHELATING#0.9565;DIGESTION#0.9564;STRUCTURE ACTIVITY RELATIONSHIP#0.9564;GRANULOMA FORMATION#0.9563;PROTEIN BIOSYNTHESIS#0.9563;AUTOIMMUNE HEPATITIS#0.9563;CHEMOTAXIS#0.9563;HUMAN MESENCHYMAL STEM#0.9563;IMMUNE SUPPRESSION#0.9563;GENOTOXIC#0.9563;ROS GENERATION#0.9563;COMMON CAROTID ARTERIES#0.9563;PROTEIN COMPLEX#0.9563;T CELL ACTIVATION#0.9562;HUMORAL IMMUNE RESPONSE#0.9562;SCLEROSING CHOLANGITIS#0.9562;APOPTOTIC CELL DEATH#0.9561;OSTEOBLAST#0.9561;IFN-GAMMA#0.9561;PLASMA CELL#0.9561;MYELOID LEUKEMIA#0.9560;GLUCOSE TOLERANCE TEST#0.9560;STOMACH CANCER#0.9560;IDIOPATHIC PULMONARY FIBROSIS#0.9560;ESTROGEN RECEPTOR#0.9559;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9559;KAWASAKI DISEASE#0.9559;OVARIAN FOLLICLE#0.9559;OVERALL SURVIVAL TIME#0.9559;LINEAR MIXED MODEL#0.9559;EPILEPSY#0.9559;REACTIVE OXYGEN SPECIES GENERATION#0.9559;MICROTUBULE#0.9559;PODOCYTE FOOT PROCESS#0.9559;THYMIDINE#0.9559;CD8+ T CELL#0.9559;NORTRIPTYLINE#0.9559;ALLERGIC RHINITIS#0.9559;PLASMINOGEN ACTIVATION#0.9558;CD4+ T CELL#0.9558;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.9558;ACUTE MYELOID LEUKEMIA#0.9558;GASTROENTERITIS#0.9558;HYPERSENSITIVITY#0.9558;AQUAPORIN#0.9558;KIDNEY DAMAGE#0.9558;FRAGMENT LENGTH POLYMORPHISM#0.9558;THALIDOMIDE#0.9558;HATCHING#0.9557;EDEMA#0.9557;VITAMIN D METABOLISM#0.9557;CERVICAL#0.9557;PULMONARY TOXICITY#0.9557;C REACTION PROTEIN#0.9557;PROTEIN METABOLISM#0.9557;LUNG FIBROBLASTS#0.9557;UREMIA#0.9556;MALAISE#0.9556;ADRENAL GLAND#0.9556;PREDNISONE#0.9556;TONSIL#0.9555;GLUCOSE HOMEOSTASIS#0.9555;MESENCHYMAL STROMAL CELL#0.9555;CARCINOGEN#0.9555;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.9555;CHLORTETRACYCLINE#0.9555;MOUSE EMBRYONIC STEM#0.9555;FIELD EFFECT TRANSISTOR#0.9555;HEART DISEASE#0.9555;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.9555;PROGRAMMED CELL DEATH#0.9554;PANCREATIC ISLET#0.9554;SYSTEMIC INFLAMMATORY RESPONSE#0.9554;STAUROSPORINE#0.9554;GLYCOLYSIS#0.9554;BREAST CANCER CELL#0.9554;BODY WEIGHT GAIN#0.9554;HUMAN BREAST CANCER#0.9554;TYROSINE KINASE INHIBITOR#0.9554;ION CHANNEL#0.9554;DITHIOERYTHRITOL#0.9553;CHLORPHENIRAMINE#0.9553;UMBILICAL CORD#0.9553;TAUROCHOLIC ACID#0.9553;ANTIOXIDANT ACTIVITY#0.9552;PULMONARY HYPERTENSION#0.9552;SERUM ADIPONECTIN LEVELS#0.9552;PROTEOGLYCAN#0.9551;MENSTRUAL CYCLE#0.9551;VISUAL ANALOGUE SCALE#0.9551;COLLAGENASE#0.9551;APPARENT DIFFUSION COEFFICIENT#0.9551;CYCLIC ADENOSINE MONOPHOSPHATE#0.9551;TISSUE CULTURE POLYSTYRENE#0.9551;NODULAR#0.9550;CYTOTOXIC T-LYMPHOCYTE#0.9550;OUTER MEMBRANE#0.9550;ACETYLCHOLINE#0.9550;ESOPHAGUS#0.9550;GESTATION#0.9550;ARTERIOLE#0.9550;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9549;CHOLESTASIS#0.9549;SOLUBLE TRANSFERRIN RECEPTOR#0.9549;PULMONARY FIBROSIS#0.9549;VASODILATION#0.9549;FACTOR I#0.9549;MODE OF ACTION#0.9549;LUNG DISEASE#0.9549;NITRO-L-ARGININE#0.9548;HEMORRHAGIC#0.9548;NYSTATIN#0.9548;GOBLET CELL#0.9548;FIBROBLAST GROWTH FACTOR#0.9548;GALLBLADDER#0.9548;CELL MIGRATION#0.9548;VASCULAR DISEASE#0.9547;B LYMPHOCYTE#0.9547;STANDARD OF CARE#0.9547;TYPE 1 DIABETES MELLITUS#0.9547;POLYCYSTIC KIDNEY DISEASE#0.9547;ESOPHAGITIS#0.9547;PULMONARY ARTERIAL HYPERTENSION#0.9546;B CELL LYMPHOMA#0.9546;DNA FRAGMENTATION#0.9546;ENDOTHELIAL NITRIC OXIDE#0.9546;TETRAHYDROCANNABINOL#0.9546;WEIGHT GAIN#0.9546;NECK CANCER#0.9546;LATERAL SCLEROSIS#0.9546;PARKINSON'S DISEASE#0.9546;CHLORAMBUCIL#0.9545;DYNAMIC LIGHT SCATTERING#0.9545;RENAL FIBROSIS#0.9545;WORLD HEALTH ORGANIZATION#0.9545;PARAOXONASE ACTIVITY#0.9545;IRON OVERLOAD#0.9545;OVARIAN CANCER#0.9545;CONVULSION#0.9545;IL-6 PRODUCTION#0.9545;ERYTHROPOIETIN STIMULATING AGENT#0.9544;IMMUNOSUPPRESSANT#0.9544;OVARIES#0.9544;MACROGLOBULINEMIA#0.9544;ACUTE LIVER FAILURE#0.9544;RESPONSE TO INSULIN#0.9544;INDUCTIVELY COUPLED PLASMA#0.9544;MICROFILAMENT#0.9543;DODECYL SULFATE#0.9543;FIBRINOLYSIS#0.9543;PNEUMOTHORAX#0.9543;1,10-PHENANTHROLINE#0.9542;TOTAL ENERGY INTAKE#0.9542;HEAD AND NECK CANCER#0.9542;ADVERSE DRUG REACTION#0.9542;AMYOTROPHIC LATERAL SCLEROSIS#0.9542;FATTY ACID OXIDATION#0.9542;HEALTHY CONTROL SUBJECTS#0.9542;STRESS FIBER#0.9542;BLOOD VESSEL#0.9542;HYPERHOMOCYSTEINEMIA#0.9542;DUODENUM#0.9542;INSULIN BINDING#0.9541;RECEPTOR AGONIST#0.9541;NECROTIZING#0.9541;VASCULITIS#0.9541;EARLY TIME POINT#0.9541;CORONARY ARTERY#0.9541;ELECTROPHORETIC MOBILITY SHIFT#0.9541;DNA METHYLATION#0.9541;AZATHIOPRINE#0.9540;GASTRIC ULCER#0.9540;HEPATOCYTE PROLIFERATION#0.9540;LACTATION#0.9540;DERMATITIS#0.9540;IRRITATION#0.9540;ACE INHIBITOR#0.9540;PROTEIN MODIFICATION#0.9540;SODIUM DODECYL SULFATE#0.9540;PANCREATITIS#0.9540;MIDGUT#0.9539;RECURRENCE FREE SURVIVAL#0.9539;ESTRUS#0.9539;FERTILIZATION#0.9539;COENZYME A#0.9539;ARGININE#0.9539;MONOCYTE#0.9539;COLLAGEN BINDING#0.9539;KINASE ACTIVITY#0.9539;SOLID PHASE EXTRACTION#0.9538;KIDNEY TRANSPLANT RECIPIENTS#0.9538;CEFTAZIDIME#0.9538;BONE DISEASE#0.9538;PROTEIN BINDING#0.9538;HUMAN EMBRYONIC STEM#0.9538;BONE MARROW STEM CELL#0.9537;MITOCHONDRIA#0.9537;PROTEIN KINASE A#0.9537;TIGHT JUNCTION#0.9537;NEUROTOXICITY#0.9537;UTERUS#0.9537;INDUCIBLE NITRIC OXIDE#0.9537;GRADIENT GEL ELECTROPHORESIS#0.9537;CATALYTIC ACTIVITY#0.9537;HYPOXIC#0.9536;GRAVES' DISEASE#0.9536;TRANSFORMING GROWTH FACTOR BETA#0.9536;LYSIS#0.9536;VASCULAR ENDOTHELIAL CELL#0.9536;GLUCOSE UPTAKE#0.9536;ARRHYTHMIA#0.9536;HYPOTENSION#0.9535;ERYTHEMA#0.9535;TUMOR ASSOCIATED ANTIGEN#0.9535;NEUTROPHIL CHEMOTAXIS#0.9535;REGIONS OF INTEREST#0.9534;URINARY BLADDER#0.9534;NEUROPATHY#0.9534;NEPHROTIC SYNDROME#0.9534;GRANULOCYTE#0.9534;CASPASE-3 ACTIVITY#0.9533;LYMPHOID ORGANS#0.9533;MUCOSAL IMMUNE RESPONSE#0.9533;FACTOR S#0.9533;OVARIAN#0.9532;VASODILATOR#0.9532;MALIGNANT LYMPHOMA#0.9532;MUSCLE CONTRACTION#0.9532;CYCLOSPORINE#0.9531;VIRAL HEPATITIS#0.9531;ADENOSINE#0.9531;COAGULATION#0.9531;TIAPROFENIC ACID#0.9531;SODIUM CHANNEL#0.9530;PROTEIN SYNTHESIS#0.9530;COLON CANCER#0.9530;PARENCHYMA#0.9530;PHOSPHODIESTERASE#0.9530;URTICARIA#0.9530;HELLP SYNDROME#0.9529;CELL WALL#0.9529;SYNAPTOSOME#0.9529;INTRACRANIAL HYPERTENSION#0.9529;BRAIN DAMAGE#0.9529;ESOPHAGEAL CANCER#0.9529;ANTIOXIDANT DEFENSE SYSTEM#0.9529;DISEASE CONTROL RATE#0.9528;RESPONSE TO TREATMENT#0.9528;INNATE IMMUNE RESPONSE#0.9528;HYPOXIA#0.9528;LYMPH NODE#0.9528;LIVER REGENERATION#0.9528;ADIPOSE TISSUE#0.9528;MYOSIN HEAVY CHAIN#0.9527;SKELETAL MUSCLE#0.9527;GLUCOSE REGULATED PROTEIN#0.9527;DELAYED GRAFT FUNCTION#0.9526;NEUROLOGICAL DISORDER#0.9526;MESENCHYMAL CELL#0.9526;REVERSE TRANSCRIPTION#0.9526;MOUSE EMBRYONIC FIBROBLAST#0.9526;IGG1 ANTIBODY#0.9526;CALCIUM CHANNEL#0.9526;SMALL INTESTINE#0.9526;NATURAL KILLER CELL#0.9525;RHINITIS#0.9525;TRANSCRIPTASE#0.9525;INTESTINAL MUCOSA#0.9525;NEPHRITIS#0.9525;CARRIE#0.9525;OBJECTIVE RESPONSE RATE#0.9525;AUTOIMMUNITY#0.9525;ARTERIOVENOUS MALFORMATION#0.9524;RESPIRATORY CHAIN#0.9524;ERYTHROPOIESIS#0.9524;ENDOCARDITIS#0.9524;PROTEIN KINASE C#0.9524;COGNITION#0.9523;THYROTROPIN RELEASING HORMONE#0.9523;INTESTINAL DISEASE#0.9523;CARDIOMYOPATHY#0.9523;CELL-MEDIATED IMMUNITY#0.9523;ENDOTHELIAL CELL#0.9523;STANDARDIZED UPTAKE VALUE#0.9522;ZUCKER DIABETIC FATTY#0.9522;CINACALCET#0.9522;LOW FAT DIET#0.9522;PROTEIN DEGRADATION#0.9522;ELECTRON TRANSFER#0.9521;HYPERTHYROIDISM#0.9521;CARDIOVASCULAR SYSTEM#0.9521;ADHERENS JUNCTION#0.9521;NONALCOHOLIC FATTY LIVER DISEASE#0.9520;EOSIN#0.9520;HEPATOCYTE GROWTH FACTOR#0.9520;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9520;GASTRIC MUCOSA#0.9520;MEMBRANE ATTACK COMPLEX#0.9519;MUTAGENIC#0.9519;EATING DISORDER#0.9519;LUNG CANCER#0.9519;MILD COGNITIVE IMPAIRMENT#0.9518;CELL ADHESION#0.9518;CARDIOVASCULAR RISK FACTOR#0.9518;BRILLIANT BLUE G#0.9518;BRAIN CORTEX#0.9518;NUCLEIC ACID#0.9518;CONSTIPATION#0.9518;BASEMENT MEMBRANE#0.9518;THERAPEUTIC DRUG MONITORING#0.9518;BONE MINERAL DENSITY#0.9517;ALLERGIC REACTION#0.9517;ARYL-ACYLAMIDASE ACTIVITY#0.9517;OXIDATION REDUCTION#0.9517;SEPTUM#0.9517;INTENTION TO TREAT#0.9517;MICROVILLI#0.9517;SCANNING ELECTRON MICROSCOPE#0.9517;TRANSCRIPTION FACTOR#0.9516;NORMAL CONTROL GROUP#0.9516;NEUROTOXIC#0.9515;EXTRACELLULAR VESICLE#0.9515;BRAIN ENDOTHELIAL CELL#0.9515;SUSTAINED VIROLOGICAL RESPONSE#0.9515;ACCESSIBLE SURFACE AREA#0.9515;ADRENAL CORTEX#0.9515;ORGANELLE#0.9514;TIBIA#0.9514;THROMBOCYTOPENIA#0.9514;HODGKIN'S LYMPHOMA#0.9514;PHOSPHOLIPASE C#0.9513;BILE DUCT#0.9513;CROHN'S DISEASE#0.9513;GENOTOXICITY#0.9513;VITAMIN A DEFICIENCY#0.9513;PERIPHERAL BLOOD#0.9513;RESPIRATORY FAILURE#0.9513;GLUCOSE METABOLISM#0.9512;ENZYME INHIBITOR#0.9512;ANEMIA#0.9512;NEPHROTOXIC#0.9512;NIACIN#0.9512;BETA CELL#0.9511;KIDNEY FAILURE#0.9511;PROTEIN PHOSPHORYLATION#0.9511;MUSCLE FIBRE#0.9511;CYTOKINE SECRETION#0.9510;INDUCTION OF APOPTOSIS#0.9510;ORAL TOLERANCE#0.9510;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9510;LASER DESORPTION IONIZATION#0.9510;TO THE PROGRESSION#0.9509;AND NEW ZEALAND#0.9509;NECROTIC#0.9509;TYPE 2 DIABETIC#0.9509;ITCHING#0.9509;MACROPHAGE#0.9508;NEPHROTOXICITY#0.9508;HIGH RISK PATIENTS#0.9508;ACETYL COA CARBOXYLASE#0.9508;PROSTATE CANCER#0.9508;MYOCARDIAL INFARCTION#0.9507;HEPATITIS B#0.9507;FERMENTATION#0.9507;BILIRUBIN TRANSPORT#0.9506;NICKEL BINDING#0.9505;PANCREATIC CARCINOMA#0.9505;LYMPHOID TISSUE#0.9505;MULTIPLE SCLEROSIS#0.9505;ARTERY#0.9505;NEURAL RETINA#0.9505;GASTROINTESTINAL TRACT#0.9505;SKELETON#0.9505;IMMUNOTOXICITY#0.9504;VISCERAL ADIPOSE TISSUE#0.9504;FATTY ACID SYNTHASE#0.9503;PEROXISOME#0.9503;ACYLAMIDASE ACTIVITY#0.9502;PROTEIN PROTEIN INTERACTION#0.9502;RENATURATION#0.9502;HYPERACTIVITY#0.9502;ELECTRONIC HEALTH RECORD#0.9502;DIABETIC KIDNEY DISEASE#0.9501;HYPERCHOLESTEROLEMIA#0.9501;HEMORRHAGE#0.9501;CELL DIVISION#0.9501;IGE RECEPTOR#0.9501;IMATINIB MESYLATE#0.9500;HEPATIC STELLATE CELL#0.9500;MYOCARDIUM#0.9500;PURPURA#0.9499;TYPE 1 DIABETES#0.9499;SIGNALING MOLECULE#0.9499;T LYMPHOCYTE#0.9499;LIVER DAMAGE#0.9499;ADENOSINE 5'-TRIPHOSPHATE#0.9499;KINASE INHIBITOR#0.9499;PRIMARY BILIARY CIRRHOSIS#0.9498;AIRWAY EPITHELIUM#0.9498;TOTAL HIP ARTHROPLASTY#0.9498;PHOSPHATASE I#0.9498;MORPHOGENESIS#0.9497;INNATE IMMUNE SYSTEM#0.9496;ICI 182,780#0.9496;AST-120#0.9496;COMPLEMENT ACTIVATION#0.9496;CHEMOKINE RECEPTOR#0.9496;ALCOHOLIC FATTY LIVER#0.9496;BONE FORMATION#0.9496;IMMUNE CELL#0.9495;RENAL REPLACEMENT THERAPY#0.9495;HEALTH CARE SYSTEM#0.9495;RESONANCE ENERGY TRANSFER#0.9495;RECEPTOR BINDING#0.9494;PNEUMONIA#0.9494;MALNUTRITION#0.9494;COMPLEX I#0.9494;CAUDATE NUCLEUS#0.9494;CYTOKINE PRODUCTION#0.9494;MITOGEN ACTIVATED PROTEIN#0.9493;GUANIDINIUM CHLORIDE#0.9493;IN STENT RESTENOSIS#0.9493;ANOREXIA#0.9493;S PHASE#0.9493;RESPIRATORY DISTRESS#0.9493;LATE ENDOSOME#0.9492;ABDOMINAL PAIN#0.9492;SUBCUTANEOUS ADIPOSE TISSUE#0.9492;ALOPECIA#0.9492;IVERMECTIN#0.9492;ATHEROSCLEROTIC#0.9492;VASCULAR ENDOTHELIUM#0.9492;STROMAL CELL#0.9491;AMYLOIDOSIS#0.9491;LUPUS NEPHRITIS#0.9491;CHLAMYDIA#0.9491;MITRAL VALVE#0.9490;ALLERGIC ASTHMA#0.9490;TRANSFORMING GROWTH FACTOR#0.9490;PLACENTAL GROWTH FACTOR#0.9490;AMYLOID PRECURSOR PROTEIN#0.9490;TUBERCULOSIS#0.9490;LIVER CANCER#0.9489;ELLAGIC ACID#0.9489;DRUG RESISTANCE#0.9489;G1 PHASE#0.9489;CARBACHOL#0.9489;DISEASE FREE SURVIVAL#0.9489;EPITHELIAL CELL#0.9489;SERIOUS ADVERSE EVENT#0.9489;PRIMARY HYPERPARATHYROIDISM#0.9489;CONTROLLED CLINICAL TRIALS#0.9487;MYOFIBROBLAST#0.9487;LEVAMISOLE#0.9487;BONE RESORPTION#0.9486;RIBAVIRIN#0.9486;SYNCYTIOTROPHOBLAST#0.9486;ENDOTHELIN RECEPTOR#0.9484;VASOCONSTRICTION#0.9484;ADVANCED GLYCATION END#0.9484;THROMBOSIS#0.9484;SYNOVIUM#0.9484;INNATE IMMUNITY#0.9484;HORMONE SECRETION#0.9483;VITAMIN D RECEPTOR#0.9483;HYPOGONADISM#0.9483;PLASMALEMMA#0.9483;TOLL LIKE RECEPTOR#0.9483;ORTHOTOPIC LIVER TRANSPLANTATION#0.9483;REGULATORY T CELL#0.9483;MINISTRY OF HEALTH#0.9483;PERICARDIUM#0.9483;RANDOMIZED CLINICAL TRIAL#0.9483;SPERM PLASMA MEMBRANE#0.9483;DIABETIC RETINOPATHY#0.9483;COLITIS#0.9482;MITOCHONDRIAL MEMBRANE#0.9482;VISCERAL FAT AREA#0.9482;ANGIOTENSIN CONVERTING ENZYME#0.9482;GINGIVA#0.9482;INSOMNIA#0.9482;TUMOR NECROSIS FACTOR#0.9482;DIABETIC PERIPHERAL NEUROPATHY#0.9481;ENDOPLASMIC RETICULUM#0.9481;HYPERGLYCEMIA#0.9481;WILSON DISEASE#0.9481;MECHANISMS OF ACTION#0.9480;GLOMERULONEPHRITIS#0.9480;CLEAR CELL RENAL CELL CARCINOMA#0.9480;NON HODGKIN LYMPHOMA#0.9479;HEPATITIS B VIRUS#0.9479;OESTRUS#0.9479;SMOOTH MUSCLE CELL#0.9478;PROGESTIN#0.9478;COLORECTAL#0.9478;MEDIASTINAL LYMPH NODE#0.9477;OSTEOCLAST#0.9477;DENDRITIC CELL#0.9477;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.9476;TISSUE REGENERATION#0.9476;NITRIC OXIDE SYNTHASE#0.9476;RELATIVE STANDARD DEVIATION#0.9476;ENDOTHELIUM#0.9475;RENAL REABSORPTION#0.9475;PLASMA MEMBRANE#0.9475;DIABETES MELLITUS#0.9475;MUSCLE CELL#0.9474;VALVULAR HEART DISEASE#0.9474;ARA-C#0.9474;TRANSFORMING GROWTH FACTOR ALPHA#0.9474;COLORECTAL CANCER#0.9473;TUMOR SUPPRESSOR#0.9472;END STAGE RENAL FAILURE#0.9472;TUMOR CELLS#0.9471;ATP SYNTHESIS#0.9471;ULCERATIVE COLITIS#0.9471;HYPOPHOSPHATEMIA#0.9471;ENDOTHELIAL GROWTH FACTOR#0.9471;FREE ANDROGEN INDEX#0.9470;TROGLITAZONE#0.9470;GOITER#0.9470;NEUTROPENIA#0.9470;ATP BINDING CASSETTE#0.9470;FIBRONECTIN BINDING#0.9470;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9470;ENZYME ACTIVITY#0.9469;PARA-AMINOHIPPURIC ACID#0.9469;SEVELAMER#0.9469;SWELLING#0.9469;GROWTH FACTOR#0.9469;MACULAR DEGENERATION#0.9469;CYCLOPHOSPHAMIDE#0.9468;CELL ACTIVATION#0.9468;RESPIRATORY TRACT#0.9468;SMOOTH MUSCLE#0.9468;METAPHASE#0.9468;TETRODOTOXIN#0.9468;MONONUCLEAR CELLS#0.9468;ACUTE LUNG INJURY#0.9467;RESPONSE TO EXERCISE#0.9467;TRANSFER RNA#0.9467;DEFECATION#0.9467;OBESE#0.9466;ISCHEMIA REPERFUSION INJURY#0.9466;INFLAMMATORY CELL#0.9466;NALIDIXIC ACID#0.9466;NITRIC OXIDE#0.9465;HISTONE DEACETYLASE#0.9464;LAMINA DENSA#0.9463;PHAGOSOME#0.9463;4-ANDROSTENE-3,17-DIONE#0.9462;CHOLESTEROL SYNTHESIS#0.9462;ACID PHOSPHATASE ACTIVITY#0.9462;PARENTERAL#0.9462;CHRONIC HEPATITIS B#0.9462;RANDOMIZED CONTROLLED TRIAL#0.9462;TUMOR GROWTH INHIBITION#0.9461;LIPID TRANSPORT#0.9461;CONNECTIVE TISSUE#0.9461;POSITIVE PREDICTIVE VALUE#0.9461;ACUTE RENAL INJURY#0.9461;MAGNETIC RESONANCE IMAGING#0.9461;VITAMIN D DEFICIENCY#0.9460;LARYNX#0.9460;TNF PRODUCTION#0.9460;GENERALIZED ESTIMATING EQUATION#0.9460;SECONDARY HYPERPARATHYROIDISM#0.9460;RHEUMATOID ARTHRITIS#0.9460;LYMPHOCYTE ACTIVATION#0.9460;TRADITIONAL CHINESE MEDICINE#0.9459;LUPUS ERYTHEMATOSUS#0.9459;ALZHEIMER'S DISEASE#0.9458;GENE EXPRESSION#0.9458;SUSTAINED VIROLOGIC RESPONSE#0.9458;T CELL#0.9458;ACUTE KIDNEY INJURY#0.9458;HEMATOPOIETIC STEM CELL#0.9457;HYPERTENSION#0.9457;MYCOPHENOLATE MOFETIL#0.9457;DIARRHEA#0.9456;DICLOXACILLIN#0.9456;OPTICAL COHERENCE TOMOGRAPHY#0.9456;LIVER CIRRHOSIS#0.9456;PRO-INFLAMMATORY#0.9456;WOUND HEALING#0.9456;NEPHROPATHY#0.9456;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9456;QUANTITATIVE REAL TIME#0.9456;INDUCED PLURIPOTENT STEM CELL#0.9455;SIGNAL TRANSDUCTION#0.9455;HEPATOTOXICITY#0.9455;ANABOLISM#0.9454;LIPID METABOLISM#0.9454;EVEROLIMUS#0.9453;SULINDAC#0.9453;DNA BINDING#0.9453;EYE DISEASE#0.9453;PYREXIA#0.9452;TYPE 2 DIABETES#0.9452;OVERALL RESPONSE RATE#0.9451;PEROXISOMAL#0.9451;CELL MEMBRANE#0.9451;HIGH FAT DIET#0.9451;SIGNALLING PATHWAY#0.9450;HEMATOPOIESIS#0.9450;NEGATIVE PREDICTIVE VALUE#0.9449;PROTEIN KINASE#0.9449;TYPE 2 DIABETES MELLITUS#0.9449;2 DIABETES MELLITUS#0.9449;INFERTILITY#0.9449;ESOPHAGEAL CARCINOMA#0.9449;FERROXIDASE ACTIVITY#0.9448;CORONARY ARTERY LESIONS#0.9448;BODY MASS INDICES#0.9448;BONE MARROW#0.9448;VIRULENCE#0.9448;DIABETIC NEPHROPATHY#0.9447;KIDNEY TRANSPLANT PATIENTS#0.9446;GLUTATHIONE TRANSFERASE#0.9446;DNA REPLICATION#0.9445;STEROIDOGENESIS#0.9445;TEMPORAL LOBE#0.9445;FATTY LIVER DISEASE#0.9444;FATTY LIVER#0.9444;CYTARABINE#0.9444;PROCAINAMIDE#0.9444;MEDIAN SURVIVAL TIME#0.9443;MIDLINE#0.9443;OVERALL SURVIVAL RATE#0.9443;MITOCHONDRIAL DAMAGE#0.9442;CELL GROWTH#0.9442;MEDICAL OUTCOMES STUDY#0.9442;INSOLUBLE FRACTION#0.9442;VESICULAR STOMATITIS VIRUS#0.9442;CELL SURFACE#0.9441;AIRWAY EPITHELIAL CELL#0.9441;FLOW MEDIATED VASODILATION#0.9440;VAN DER WAALS#0.9440;RESPONSE TO HISTAMINE#0.9440;PLURIPOTENT STEM CELL#0.9440;ESTIMATE GLOMERULAR FILTRATION#0.9440;SUCRALFATE#0.9439;INTENSIVE CARE UNIT#0.9438;VASCULAR ENDOTHELIAL DYSFUNCTION#0.9438;ADENOCARCINOMA#0.9438;OSTEOPOROSIS#0.9437;NATIONAL CANCER INSTITUTE#0.9436;GASTRIC ADENOCARCINOMA#0.9435;INSULIN DEGRADATION#0.9435;1,2-PROPANEDIOL#0.9434;MULTIPLE MYELOMA#0.9433;RENAL INTERSTITIAL FIBROSIS#0.9433;FLOW CYTOMETRY ANALYSIS#0.9432;EMBRYONIC STEM CELL#0.9432;VOMITING#0.9432;CHRONIC LIVER DISEASE#0.9432;NEURODEGENERATIVE DISEASE#0.9430;CELL CYCLE ARREST#0.9430;YEAR SURVIVAL RATE#0.9430;TRANEXAMIC ACID#0.9430;MEGESTROL#0.9430;CONVECTION ENHANCED DELIVERY#0.9429;RECEPTOR ANTAGONIST#0.9429;CORNEAL EPITHELIAL CELL#0.9428;STEM CELL TRANSPLANTATION#0.9428;FIBRINOGEN BINDING#0.9428;CANCER CELL#0.9427;SULFATION#0.9427;MYOSIN LIGHT-CHAIN KINASE#0.9426;PROGENITOR CELL#0.9426;LIMIT OF DETECTION#0.9426;CYTOPLASM#0.9426;EZETIMIBE#0.9425;UMBILICAL ARTERY#0.9425;STANDARD MEDICAL THERAPY#0.9425;FIMBRIAE#0.9424;COMPARTMENT SYNDROME#0.9424;HOST CELL#0.9423;RANDOMIZED CONTROL TRIAL#0.9423;SMOOTH ENDOPLASMIC RETICULUM#0.9423;PERIPHERAL NERVOUS SYSTEM#0.9422;ORNITHINE DECARBOXYLASE#0.9422;LETHARGY#0.9422;CELL DIFFERENTIATION#0.9421;VIRAL INFECTION#0.9421;STRIATED MUSCLE#0.9420;SHORTNESS OF BREATH#0.9420;ADAPTIVE IMMUNE RESPONSE#0.9419;CYTOTOXICITY#0.9419;COMPOSITE END POINT#0.9419;PILOCARPINE#0.9419;CELL DEATH#0.9419;LIVER DISEASE#0.9419;POLYMERASE CHAIN REACTION#0.9418;DENGUE HEMORRHAGIC FEVER#0.9418;ANGIOGENESIS#0.9417;STORAGE VACUOLE#0.9417;MUMPS#0.9417;BUTYRYLCHOLINESTERASE ACTIVITY#0.9416;CELL CYCLE#0.9416;CHRONIC HEPATITIS C#0.9416;B CELL#0.9415;PYRAZOLE#0.9415;CO BINDING#0.9414;DIZZINESS#0.9414;IN
2140	PHOSPHATASE ACTIVITY#0.8180;MELATONIN#0.7522;TRANSCRIPTION FACTOR#0.6433;CD8+ T CELL#0.6273;T CELL#0.6206;BREAST CANCER#0.6128
2145	POLYCOMB REPRESSIVE COMPLEX#0.9743;STEM CELL#0.7049
2146	WEAVER SYNDROME#1.1123;ECTODERM DEVELOPMENT#1.0669;POLYCOMB REPRESSOR COMPLEX#1.0635;N METHYLTRANSFERASE#1.0606;HISTONE METHYLTRANSFERASE ACTIVITY#1.0599;METHYLASE#1.0484;ENDOMETRIAL CANCER#1.0482;BREAST CARCINOMA#1.0476;ENDOMETRIAL CARCINOMA#1.0450;INVASIVE CARCINOMA#1.0441;STEM CELL MAINTENANCE#1.0407;METHYLTRANSFERASE ACTIVITY#1.0350;CD8+ T CELL#1.0348;CERVICAL CANCER#1.0345;CERVICAL#1.0340;AKT SIGNALING#1.0322;UVEAL MELANOMA#1.0313;GERMINAL CENTER#1.0290;HISTONE METHYLTRANSFERASE#1.0286;PRC2 COMPLEX#1.0282;METASTATIC PROSTATE CANCER#1.0270;PROTEIN COMPLEX#1.0256;FOLLICULAR LYMPHOMA#1.0255;CELL CYCLE REGULATION#1.0251;RNA INTERFERENCE#1.0235;NON HODGKIN LYMPHOMA#1.0233;CISPLATIN#1.0201;PANCREATIC CANCER#1.0194;AUTOPHAGY#1.0194;DNA HYPERMETHYLATION#1.0189;CD4+ T CELL#1.0188;DUAL LUCIFERASE REPORTER#1.0187;DISEASE FREE SURVIVAL#1.0181;ENDOTHELIAL CELL#1.0177;EPITHELIAL OVARIAN CANCER#1.0172;OVARIAN CANCER#1.0166;SKELETAL MUSCLE#1.0155;MANTLE CELL LYMPHOMA#1.0152;CATALYTIC ACTIVITY#1.0135;DNA METHYLTRANSFERASE#1.0133;LYMPHOMA CELL LINES#1.0132;MEDULLOBLASTOMA#1.0129;MACROPHAGE#1.0128;MULTIPLE MYELOMA#1.0117;RENAL CELL CARCINOMA#1.0107;POLYCOMB REPRESSIVE COMPLEX#1.0105;B CELL LYMPHOMA#1.0104;LUNG ADENOCARCINOMA#1.0103;DIFFUSE LARGE B-CELL LYMPHOMA#1.0100;PROTEASOME#1.0098;ANGIOGENESIS#1.0094;COLON CANCER#1.0089;SQUAMOUS CELL CARCINOMA#1.0080;STEM CELL MARKER#1.0077;BREAST CANCER PATIENTS#1.0068;LIVER CANCER#1.0067;RNA BINDING#1.0065;OVARIAN#1.0064;ONCOGENESIS#1.0061;CYCLIN DEPENDENT KINASE#1.0050;ESTROGEN RECEPTOR#1.0047;PROSTATE CANCER#1.0045;REGENERATION#1.0041;POLYCOMB REPRESSIVE COMPLEXES#1.0039;S PHASE#1.0038;HYPOXIA#1.0032;LYSINE#1.0028;SENESCENCE#1.0027;COLORECTAL CANCER#1.0013;SIGNAL TRANSDUCER#1.0013;BREAST CANCER#1.0012;HISTONE DEACETYLASE#1.0008;GENE SILENCING#1.0007;TUMOR TISSUES#1.0006;CELLULAR SENESCENCE#1.0005;HISTONE DEMETHYLASE#1.0004;COLORECTAL#1.0004;CELL DEATH#1.0002;OSTEOBLAST#0.9994;NEUROBLASTOMA#0.9992;TUMOR INITIATING CELL#0.9988;INFLAMMATORY RESPONSE#0.9982;IMMUNE RESPONSE#0.9981;CHOLANGIOCARCINOMA#0.9978;HETEROCHROMATIN#0.9975;B CELL#0.9974;DRUG RESISTANCE#0.9974;LYMPH NODE METASTASIS#0.9973;HISTONE DEACETYLASE INHIBITOR#0.9969;CELL DIFFERENTIATION#0.9964;GROWTH FACTOR RECEPTOR#0.9960;EPIDERMAL GROWTH FACTOR#0.9957;MESENCHYMAL STEM CELL#0.9954;DNA DAMAGE RESPONSE#0.9947;LUMINAL#0.9943;CANCER STEM CELL#0.9942;LUNG CANCER#0.9937;T CELL#0.9936;HEMATOPOIESIS#0.9931;DEMETHYLATION#0.9927;CHROMATIN REMODELING#0.9926;HUMAN BREAST CANCER#0.9924;LYMPHOCYTIC LEUKEMIA#0.9919;TUMOR CELLS#0.9918;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9918;ADENOCARCINOMA#0.9915;CELL DEVELOPMENT#0.9914;BREAST CANCER CELL#0.9913;STEM CELL DIFFERENTIATION#0.9913;RETINOIC ACID#0.9912;HYDROLASE INHIBITOR#0.9909;OSTEOGENESIS#0.9907;HISTONE METHYLATION#0.9906;SIGNALING PATHWAY#0.9903;ONCOGENIC#0.9902;PROGENITOR CELL#0.9901;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9901;THYROID CARCINOMA#0.9897;PROTEIN KINASE#0.9894;LYSINE SPECIFIC DEMETHYLASE#0.9893;REVERSE TRANSCRIPTION#0.9893;LYMPH NODE#0.9893;ANDROGEN RECEPTOR#0.9887;HEPATOCELLULAR CARCINOMA#0.9885;DNA REPAIR#0.9884;HEMATOPOIETIC STEM CELL#0.9878;NUCLEOSOME#0.9877;MAMMARY GLAND#0.9876;EPITHELIAL MESENCHYMAL TRANSITION#0.9876;CELL GROWTH#0.9869;MECHANISM OF ACTION#0.9867;CELL ADHESION#0.9861;CANCER CELL#0.9861;CHROMATIN MODIFICATION#0.9861;X CHROMOSOME#0.9856;BONE FORMATION#0.9847;EPITHELIAL CELL#0.9846;RNA BINDING PROTEIN#0.9841;CELL CYCLE ARREST#0.9838;MYELOFIBROSIS#0.9829;EPITHELIAL TO MESENCHYMAL#0.9828;EMBRYONIC STEM CELL#0.9826;TUMOR SUPPRESSOR#0.9824;DNA METHYLATION#0.9814;POLYMERASE CHAIN REACTION#0.9812;COMPLEX I#0.9810;CELL EXPANSION#0.9803;APOPTOTIC#0.9801;PERIPHERAL BLOOD#0.9799;MYELOPROLIFERATIVE NEOPLASM#0.9798;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9798;KINASE INHIBITOR#0.9797;GERM CELL#0.9796;CELL CYCLE#0.9793;GROWTH FACTOR#0.9792;NEURAL STEM CELL#0.9792;ACUTE MYELOID LEUKEMIA#0.9790;ADJACENT NORMAL TISSUE#0.9784;CELL MIGRATION#0.9781;BONE MARROW#0.9777;DENDRITIC CELL#0.9764;T CELL DIFFERENTIATION#0.9762;CELL PROLIFERATION#0.9760;STEM CELL#0.9759;MYELOID LEUKEMIA#0.9758;ORAL SQUAMOUS CELL CARCINOMA#0.9758;MUSCLE CELL#0.9752;SIGNALLING PATHWAY#0.9750;APOPTOSIS#0.9747;MYELODYSPLASTIC SYNDROME#0.9744;HEMATOPOIETIC CELL#0.9741;QUANTITATIVE REAL TIME#0.9741;NERVOUS SYSTEM#0.9739;HISTONE MODIFICATION#0.9738;INVASIVE BREAST CARCINOMA#0.9737;PANCREATIC DUCTAL ADENOCARCINOMA#0.9730;TRANSCRIPTION FACTOR#0.9724;DNA REPLICATION#0.9722;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.9711;HISTONE ACETYLATION#0.9704;RETINOBLASTOMA#0.9703;THYROID CANCER#0.9702;REGULATION OF GENE EXPRESSION#0.9700;WOUND HEALING#0.9695;METHIONINE#0.9693;UBIQUITIN#0.9689;G1 PHASE#0.9682;GENE EXPRESSION#0.9673;HODGKIN'S LYMPHOMA#0.9670;5-AZA-2'-DEOXYCYTIDINE#0.9665;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9664;2'-DEOXYCYTIDINE#0.9661;PROGESTERONE#0.9661;QUANTITATIVE REVERSE TRANSCRIPTION#0.9651;POST-TRANSLATIONAL MODIFICATION#0.9646;POLYCOMB REPRESSIVE COMPLEX 1#0.9622;OOCYTE#0.9621;TAMOXIFEN#0.9619;LUNG CARCINOMA#0.9611;CELL ACTIVATION#0.9602;COLONY FORMATION ASSAY#0.9595;CYTOPLASM#0.9593;CYTOTOXICITY#0.9592;ESOPHAGEAL CANCER#0.9585;CARDIOMYOCYTE#0.9584;PROTEIN PROTEIN INTERACTION#0.9584;SMOOTH MUSCLE#0.9579;DNA BINDING#0.9572;GLIOBLASTOMA MULTIFORME#0.9567;HEPATOCELLULAR CARCINOMA CELL#0.9531;INSULIN-LIKE GROWTH FACTOR#0.9530;POSTTRANSLATIONAL MODIFICATION#0.9521;ASTROCYTE#0.9513;SIGNALING CASCADE#0.9509;ADIPOGENESIS#0.9494;INTELLECTUAL DISABILITY#0.9491;CLEAR CELL RENAL CELL CARCINOMA#0.9424;CERVICAL SQUAMOUS CELL CARCINOMA#0.9417;M PHASE#0.9417;T-CELL LEUKEMIA#0.9414;REACTIVE OXYGEN SPECIES#0.9401;DENTAL PULP#0.9391;STROMAL CELL#0.9389;TRANSFORMING GROWTH FACTOR#0.9382;OSTEOBLAST DIFFERENTIATION#0.9381;POLY ADP RIBOSE#0.9374;LEUKOCYTE#0.9361;TOXICITY#0.9343;REGULATORY T CELL#0.9340;HISTONE ACETYLTRANSFERASE#0.9338;CELL DIVISION#0.9335;ANCHORAGE INDEPENDENT GROWTH#0.9328;SYNOVIAL SARCOMA#0.9324;BLADDER CARCINOMA#0.9306;CHRONIC MYELOMONOCYTIC LEUKEMIA#0.9283;NEUROGENESIS#0.9274;T LYMPHOCYTE#0.9268;PLURIPOTENT STEM CELL#0.9268;BASAL CELL#0.9250;PRO-INFLAMMATORY#0.9245;CELL COUNTING KIT#0.9243;TO THE PROGRESSION#0.9226;CELL CYCLE REGULATOR#0.9223;TONGUE SQUAMOUS CELL CARCINOMA#0.9214;AGGRESSIVE BEHAVIOR#0.9179;MAMMARY EPITHELIAL CELL#0.9177;OSTEOPOROSIS#0.9176;HUMAN EMBRYONIC STEM#0.9172;STEM CELL LIKE#0.9158;REPORTER GENE ASSAY#0.9157;SWI-SNF COMPLEX#0.9147;ANTISENSE RNA#0.9136;CELL MOTILITY#0.9129;SOFT TISSUE SARCOMA#0.9123;ADVANCED PROSTATE CANCER#0.9120;MONONUCLEAR CELLS#0.9113;BINDING PROTEIN 1#0.9101;PLASMA CELL#0.9100;PHOSPHATASE AND TENSIN HOMOLOG#0.9099;CANCER RELATED DEATH#0.9083;GEMCITABINE#0.9069;MYOBLAST#0.9064;TREG CELL#0.9063;S-ADENOSYLMETHIONINE#0.9042;LUNG METASTASIS#0.9035;EXTRACELLULAR MATRIX#0.9023;GENE EXPRESSION OMNIBUS#0.9012;NATURAL KILLER T CELL#0.9011;STEM CELL TRANSPLANTATION#0.9007;ARGININE#0.9004;ROS GENERATION#0.8995;ACUTE LEUKEMIA#0.8993;RAPAMYCIN#0.8989;ADIPOCYTE#0.8984;NATURAL KILLER T#0.8979;ESSENTIAL THROMBOCYTHEMIA#0.8972;NEURAL CREST#0.8962;RHABDOMYOSARCOMA#0.8960;CYCLIN DEPENDENT KINASE INHIBITOR#0.8950;PRECURSOR CELL#0.8944;CHONDROCYTE#0.8943;TUMOR GROWTH INHIBITION#0.8937;CENTRAL NERVOUS SYSTEM#0.8885;BILE DUCT#0.8878;CHRONIC MYELOID LEUKEMIA#0.8867;TUMOR NECROSIS FACTOR#0.8864;ENZALUTAMIDE#0.8863;GERMINAL CENTER B#0.8860;FORMALIN#0.8839;WNT SIGNALING PATHWAY#0.8825;RIBOSE#0.8822;ADULT T-CELL LEUKEMIA#0.8816;TRANSCRIPTASE#0.8815;PARATHYROID#0.8812;MYOFIBROBLAST#0.8804;RENAL FIBROSIS#0.8802;CARCINOMA IN SITU#0.8790;OVARIAN CARCINOMA#0.8786;MYOGENESIS#0.8782;MELANOMA CELL LINES#0.8780;POLYCYTHEMIA VERA#0.8776;LUCIFERASE ACTIVITY#0.8775;HEPATOMA CELLS#0.8761;HEAD AND NECK CANCER#0.8724;NECK CANCER#0.8723;MOUSE EMBRYONIC STEM#0.8720;BRONCHIAL EPITHELIAL CELLS#0.8716;S-ADENOSYL-L-HOMOCYSTEINE#0.8708;OVERALL SURVIVAL RATE#0.8699;NEUTROPHIL#0.8698;METASTATIC MELANOMA#0.8696;GERMINAL CENTER B CELL#0.8674;MORPHOGENESIS#0.8668;GALLBLADDER#0.8668;DEDIFFERENTIATION#0.8658;PROSTATE EPITHELIAL CELL#0.8657;CHOLANGIOLOCELLULAR CARCINOMA#0.8630;CELL CYCLE CONTROL#0.8618;UTERUS#0.8615;TRANSACTIVATION#0.8594;CHROMATIN BINDING#0.8562;DECITABINE#0.8552;RNA SPLICING#0.8548;METASTATIC BREAST CANCER#0.8538;DOXORUBICIN#0.8530;HUMAN BRONCHIAL EPITHELIAL#0.8525;STRUCTURE ACTIVITY RELATIONSHIP#0.8469;ANEMIA#0.8463;MONOCYTE#0.8461;DNA DEMETHYLATION#0.8434;ANAPLASTIC THYROID CARCINOMA#0.8431;LYMPH NODE METASTASES#0.8390;TH2 CELL#0.8374;MESENCHYME#0.8367;MYELOID NEOPLASM#0.8352;HETEROCHROMATIN FORMATION#0.8339;ETOPOSIDE#0.8297;ACTIN POLYMERIZATION#0.8283;ACUTE MYELOID LEUKAEMIA#0.8279;PROSTATE SPECIFIC ANTIGEN#0.8275;GASTRIC MUCOSA#0.8267;ERYTHROPOIESIS#0.8265;COPY NUMBER ALTERATION#0.8256;PERIPHERAL NERVE#0.8249;MERKEL CELL#0.8244;IMMUNE SYSTEM#0.8214;RHEUMATOID ARTHRITIS#0.8187;PROTEIN KINASE B#0.8186;MIXED LINEAGE LEUKEMIA#0.8185;PROTEIN METHYLTRANSFERASE#0.8174;ISCHEMIA#0.8110;MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM#0.8107;POLYCYTHEMIA#0.8096;TERMINAL DIFFERENTIATION#0.8085;CARDIOMYOCYTE PROLIFERATION#0.8078;ACTIVATED B CELL#0.8078;TRANSCRIPTION REPRESSOR#0.8053;AUTOIMMUNE DISEASE#0.8033;HYPOXIA INDUCIBLE FACTOR#0.8031;KERATINOCYTE#0.8027;METHYLTRANSFERASE COMPLEX#0.8027;SPERMATOGENESIS#0.8024;INTERNATIONAL PROGNOSTIC INDEX#0.8017;OSTEOARTHRITIS#0.8014;PROTEIN CODING GENE#0.8010;PARATHYROID ADENOMA#0.8000;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7998;MAMMARY EPITHELIUM#0.7993;TRANSCRIPTIONAL CONTROL#0.7987;NON-SMALL CELL LUNG CARCINOMA#0.7975;METASTASIS FREE SURVIVAL#0.7967;ATHEROSCLEROSIS#0.7966;HUMAN MESENCHYMAL STEM#0.7966;COLITIS#0.7961;HISTONE LYSINE METHYLATION#0.7959;PROSTATE CARCINOMA#0.7958;INHIBITION OF CELL PROLIFERATION#0.7954;TYROSINE KINASE INHIBITOR#0.7943;MOUSE EMBRYONIC FIBROBLAST#0.7935;ENDOMETRIUM#0.7925;AZACYTIDINE#0.7921;NEGATIVE CONTROL GROUP#0.7915;FETAL LIVER#0.7902;SPINAL CORD#0.7872;INDUCTION OF APOPTOSIS#0.7861;HEPATITIS B#0.7859;SIGNAL TRANSDUCTION#0.7855;HISTONE DEACETYLATION#0.7849;DOCETAXEL#0.7844;CANCER ASSOCIATED FIBROBLASTS#0.7841;MITOSIS#0.7841;NEURAL CREST CELL#0.7837;GALLBLADDER ADENOCARCINOMA#0.7783;HIGH RISK PATIENTS#0.7755;INNATE IMMUNE RESPONSE#0.7752;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.7747;STEM CELL RENEWAL#0.7745;PCG PROTEIN COMPLEX#0.7733;SMALL NUCLEOLAR RNA#0.7721;SALIVARY GLAND#0.7720;LYMPHOID CELL#0.7717;LEUKEMIA STEM CELL#0.7712;IMMUNE CELL#0.7705;MODE OF ACTION#0.7705;HEPATITIS B VIRUS#0.7697;X CHROMOSOME INACTIVATION#0.7687;CHROMOSOME INACTIVATION#0.7685;GLYCOLYSIS#0.7680;ENZYME ACTIVITY#0.7661;MITOGEN ACTIVATED PROTEIN#0.7655;ENDOTHELIAL GROWTH FACTOR#0.7650;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7650;RETINAL DEVELOPMENT#0.7634;PEROXISOME#0.7611;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7601;HUMAN UMBILICAL VEIN#0.7595;UMBILICAL VEIN#0.7593;LEUKEMIA INITIATING CELLS#0.7571;HUMAN MAMMARY EPITHELIAL#0.7568;DIABETIC NEPHROPATHY#0.7560;SMOOTH MUSCLE CELL#0.7557;COLORECTAL CARCINOMA#0.7553;CYTOTOXIC T-LYMPHOCYTE#0.7551;MUTAGENESIS#0.7551;TROPHOBLAST#0.7536;ACTINIC KERATOSIS#0.7532;TARGET OF RAPAMYCIN#0.7525;SORAFENIB#0.7501;CELL ASSOCIATED#0.7488;INFLAMMATORY BREAST CANCER#0.7470;METHYLATION SPECIFIC PCR#0.7447;GEFITINIB#0.7442;MESOTHELIAL CELL#0.7391;RELAPSE FREE SURVIVAL#0.7380;REPLICATION FORK#0.7377;CHROMATIN ORGANIZATION#0.7374;PROGRAMMED CELL DEATH#0.7360;ADIPOSE TISSUE#0.7358;MESENCHYMAL CELL#0.7346;MAPK SIGNALING#0.7344;INFLAMMATORY BOWEL DISEASE#0.7318;NEURAL TUBE#0.7312;HAIR FOLLICLE#0.7306;CELL CYCLE TRANSITION#0.7304;DEPHOSPHORYLATION#0.7297;MAMMARY GLAND DEVELOPMENT#0.7287;MECHANISMS OF ACTION#0.7284;GENE REGULATORY NETWORK#0.7274;EWING SARCOMA#0.7274;ANDROGEN DEPRIVATION THERAPY#0.7271;GLAND DEVELOPMENT#0.7270;CLEAR CELL CARCINOMA#0.7263;ENDOTHELIUM#0.7241;B CELL DEVELOPMENT#0.7241;SUBEROYLANILIDE HYDROXAMIC ACID#0.7239;LIPID METABOLISM#0.7235;TISSUE REGENERATION#0.7219;METHYL CPG BINDING#0.7195;ALL TRANS RETINOIC ACID#0.7195;EXOSOME#0.7194;RIBAVIRIN#0.7193;HUMAN PANCREATIC CANCER#0.7193;INVASIVE BREAST CANCER#0.7186;SMALL CELL CARCINOMA#0.7182;DISEASE SPECIFIC SURVIVAL#0.7179;IFN-GAMMA#0.7176;TRANSITIONAL CELL CARCINOMA#0.7172;METFORMIN#0.7147;EFFECTOR T CELL#0.7143;NUCLEAR PERIPHERY#0.7135;CELL SURFACE#0.7129;GLYCOGEN SYNTHASE KINASE#0.7127;WHITE BLOOD CELL#0.7107;ACUTE KIDNEY INJURY#0.7102;B CELL RECEPTOR#0.7101;HYPOXIC#0.7095;LUMINAL PROGENITOR#0.7087;SKELETAL DEVELOPMENT#0.7063;HEART DEVELOPMENT#0.7062;5 FLUOROURACIL#0.7062;DE NOVO DNA METHYLATION#0.7060;DOUBLE STRAND BREAK#0.7058;NOTCH LIGAND#0.7042;B CELL DIFFERENTIATION#0.7035;HETEROCHROMATIN PROTEIN 1#0.7023;PODOCYTE#0.7009;SKELETAL MUSCLE CELLS#0.7007;IMMUNE EVASION#0.6990;GRAFT VERSUS HOST#0.6984;HEPATIC STELLATE CELL#0.6971;OVERALL SURVIVAL TIME#0.6969;SIGNALING MOLECULE#0.6936;TRANSCRIPTION FACTOR BINDING#0.6925;HEMATOPOIETIC PROGENITOR CELL#0.6920;MUCINOUS NEOPLASM#0.6909;CIGARETTE SMOKE EXTRACT#0.6904;ADULT STEM CELL#0.6872;SUCROSE#0.6870;EPITHELIOID SARCOMA#0.6837;NORMAL CERVICAL TISSUE#0.6826;MALIGNANT GLIOMA#0.6822;LINES OF EVIDENCE#0.6818;PACLITAXEL#0.6812;TH1 CELL#0.6807;CANCER STEM-LIKE CELL#0.6805;GENE EXPRESSION SIGNATURES#0.6793;ESTRADIOL#0.6776;DENTAL PULP CELL#0.6768;BETA CELL#0.6758;PROMOTER BINDING#0.6750;HUMAN DENTAL PULP#0.6735;REGULATION OF CELL CYCLE#0.6733;HAEMATOPOIETIC STEM CELL#0.6728;NEUROENDOCRINE TUMOR#0.6715;WORLD HEALTH ORGANIZATION#0.6707;LENALIDOMIDE#0.6703;PROTEIN PHOSPHATASE 1#0.6701;CELL CYCLE CHECKPOINT#0.6690;HIGH FAT DIET#0.6685;EPSTEIN BARR VIRUS#0.6684;IMATINIB#0.6682;CHROMATIN REMODELING COMPLEX#0.6680;PANCREATIC ADENOCARCINOMA#0.6679;SKIN CANCER#0.6670;DIETHYLSTILBESTROL#0.6656;PROTEIN SYNTHESIS#0.6652;ADVANCED BREAST CANCER#0.6617;ENDOMETRIOSIS#0.6594;MULTIPLE SCLEROSIS#0.6590;DIFFERENTIAL GENE EXPRESSION#0.6566;INTRAHEPATIC CHOLANGIOCARCINOMA#0.6559;MULTIPLE MYELOMA CELLS#0.6552;ISCHEMIA REPERFUSION INJURY#0.6546;INDUCED PLURIPOTENT STEM CELL#0.6545;ORAL CAVITY#0.6538;S-ADENOSYL-L-METHIONINE#0.6507;NEURAL PROGENITOR CELL#0.6506;DNA HYPOMETHYLATION#0.6495;LIVER METASTASIS#0.6495;PRC1 COMPLEX#0.6492;STEM CELL PROLIFERATION#0.6483;FOREBRAIN#0.6473;L-METHIONINE#0.6464;CYTOPENIA#0.6463;ANTIGEN PRESENTATION#0.6462;FLUOROURACIL#0.6451;ASTROCYTOMA#0.6445;BILE DUCT ADENOMA#0.6423;CELL KILLING#0.6423;STANDARD OF CARE#0.6420;INFLAMMATORY CELL#0.6418;OVARIAN CLEAR CELL CARCINOMA#0.6395;T CELL ACTIVATION#0.6391;RECEPTOR TYROSINE KINASE#0.6388;OLIGODENDROCYTE#0.6387;HISTONE METHYLTRANSFERASE COMPLEX#0.6381;STROMA#0.6353;FLOW CYTOMETRY ASSAY#0.6353;ADRENOCORTICAL CARCINOMA#0.6298;BIOLOGICAL PROCESS#0.6291;MEIOSIS#0.6291;NONSENSE MEDIATED DECAY#0.6288;BONE DEVELOPMENT#0.6266;NEPHROPATHY#0.6253;RESVERATROL#0.6252;PROTEIN TRANSLATION#0.6244;MELATONIN#0.6243;BURKITT LYMPHOMA#0.6236;DUCTAL CARCINOMA IN SITU#0.6225;VIRAL REPLICATION#0.6182;INHIBITION OF CELL GROWTH#0.6182;FACTOR I#0.6180;EPIGALLOCATECHIN#0.6176;SPERMATOCYTES#0.6173;GLIAL CELL#0.6160;ERLOTINIB#0.6158;MOLECULAR FUNCTION#0.6158;EMBRYO DEVELOPMENT#0.6150;HISTONE BINDING#0.6145;CEREBRAL CORTEX#0.6137;REGULATION OF CELLULAR#0.6127;DEATH RECEPTOR#0.6124;T CELL PROLIFERATION#0.6106;ALLERGEN#0.6102;B LYMPHOCYTE#0.6093;BORTEZOMIB#0.6087;17-DMAG#0.6081;ATYPICAL TERATOID RHABDOID TUMOR#0.6072;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6068;LUPUS ERYTHEMATOSUS#0.6066;TRANSCRIPTION REGULATOR#0.6061;METHYLCYTOSINE DIOXYGENASE#0.6040;LEUCINE ZIPPER KINASE#0.6035;SPLICEOSOME#0.6020;MALIGNANT MESOTHELIOMA#0.6018;ANTI APOPTOSIS#0.6017;NUCLEOSOME BINDING#0.6015;NORMAL BREAST TISSUE#0.6010;CHROMATIN REMODELLING#0.6003;LUMINAL CELL#0.6003;COPY NUMBER GAIN#0.6001
2147	COAGULATION#1.0713;FIBRINOGEN#0.9416;BLOOD COAGULATION#0.8930;POLYMERASE CHAIN REACTION#0.7864;PLATELET AGGREGATION#0.7317;VITAMIN K#0.7271;THROMBOSIS#0.7268;THROMBOPLASTIN#0.6419;FACTOR V LEIDEN#0.6125
2149	TRANSACTIVATION#1.0398;PROSTATE CANCER#1.0386;CARDIOMYOCYTE#1.0330;MATRIX METALLOPROTEINASE 1#1.0322;PROTEASE ACTIVATED RECEPTOR#1.0298;LUNG FIBROBLASTS#1.0275;MAST CELL#1.0220;BREAST CANCER CELL#1.0206;THROMBIN ACTIVITY#1.0195;ASTROCYTE#1.0171;THROMBIN RECEPTOR#1.0169;BREAST CANCER#1.0166;PROGENITOR CELL#1.0146;DABIGATRAN#1.0129;PROTEINASE ACTIVATED RECEPTOR#1.0124;RECEPTOR AGONIST#1.0105;THROMBIN RECEPTOR ANTAGONIST#1.0103;VASCULAR ENDOTHELIAL CELL#1.0087;ADP RECEPTOR#1.0065;NMDA RECEPTOR#1.0064;EDEMA#1.0061;SPHINGOSINE 1 PHOSPHATE#1.0061;CELL GROWTH#1.0038;CANCER CELL#1.0027;SELECTIN#1.0022;T CELL#1.0007;BRAIN EDEMA#1.0007;DIRECT THROMBIN INHIBITOR#1.0001;CALCIUM SIGNALING#0.9994;PHOSPHOLIPASE C#0.9993;VASCULAR SMOOTH MUSCLE CELL#0.9981;GROWTH FACTOR RECEPTOR#0.9971;STROMAL CELL#0.9967;FACTOR XA#0.9966;BREAST CARCINOMA#0.9964;TUMOR CELLS#0.9959;CALCIUM MOBILIZATION#0.9959;NEUTROPHIL#0.9950;FIBRINOGEN#0.9947;WOUND HEALING#0.9940;SPINAL CORD#0.9933;CELL ADHESION#0.9932;TRANSFORMING GROWTH FACTOR#0.9927;METASTATIC MELANOMA#0.9918;ENDOTHELIAL CELL#0.9917;PLATELET AGGREGATION#0.9916;ACTIVATED PROTEIN C#0.9911;HEMORRHAGE#0.9911;MAP KINASE#0.9904;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9904;CELL MIGRATION#0.9896;ENDOTHELIAL PROGENITOR CELL#0.9892;SMOOTH MUSCLE CELL#0.9888;CELL SURFACE#0.9881;CELL DEATH#0.9880;HUMAN UMBILICAL VEIN#0.9879;MUSCLE CELL#0.9877;REVERSE TRANSCRIPTION#0.9877;PLATELET ACTIVATION#0.9872;PERCUTANEOUS CORONARY INTERVENTION#0.9870;ANGIOGENESIS#0.9869;APOPTOSIS#0.9867;KINASE INHIBITOR#0.9867;PRO-INFLAMMATORY#0.9866;ENDOTHELIAL GROWTH FACTOR#0.9866;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9866;EPIDERMAL GROWTH FACTOR#0.9865;UMBILICAL VEIN#0.9864;ENDOTHELIUM#0.9861;CELL PROLIFERATION#0.9861;MONOCYTE#0.9860;BONE MARROW#0.9856;APOPTOTIC#0.9854;MITOGEN ACTIVATED PROTEIN#0.9854;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9854;NITRIC OXIDE#0.9851;APROTININ#0.9851;PROTEIN COMPLEX#0.9850;NERVOUS SYSTEM#0.9844;BLOOD VESSEL#0.9844;SMOOTH MUSCLE#0.9843;PROTEIN KINASE C#0.9843;LYSOSOME#0.9835;SIGNAL TRANSDUCTION#0.9835;EPITHELIAL CELL#0.9833;ARTERY DISEASE#0.9832;TUMOR NECROSIS FACTOR#0.9830;SIGNALING PATHWAY#0.9827;INFLAMMATORY RESPONSE#0.9818;MACROPHAGE#0.9814;ISCHEMIA#0.9813;LIPID RAFT#0.9811;STEM CELL#0.9804;EXTRACELLULAR MATRIX#0.9801;DNA SYNTHESIS#0.9800;HEMOSTASIS#0.9798;RECEPTOR ANTAGONIST#0.9787;CORONARY ARTERY DISEASE#0.9786;CORONARY ARTERY#0.9782;POLYMERASE CHAIN REACTION#0.9782;SIGNALING CASCADE#0.9781;ANTICOAGULANT ACTIVITY#0.9775;CLOPIDOGREL#0.9765;PROTEIN KINASE#0.9765;LUNG CANCER#0.9765;LEUKOCYTE#0.9764;ISCHEMIA REPERFUSION INJURY#0.9764;BLOOD BRAIN BARRIER#0.9760;ADENOSINE#0.9760;SPHINGOSINE#0.9755;ACUTE CORONARY SYNDROME#0.9743;GENE EXPRESSION#0.9742;GROWTH FACTOR#0.9741;DIPHOSPHATE#0.9727;CEREBRAL ISCHEMIA#0.9726;ASPIRIN#0.9725;PRASUGREL#0.9719;BLOOD COAGULATION#0.9718;PROTEASE ACTIVITY#0.9706;MYOCARDIAL INFARCTION#0.9705;ATHEROSCLEROTIC#0.9702;ARTERY#0.9701;ATHEROSCLEROSIS#0.9699;COAGULATION#0.9695;TICAGRELOR#0.9694;KERATINOCYTE#0.9676;ARACHIDONIC ACID#0.9662;PULMONARY FIBROSIS#0.9661;TRANSCRIPTION FACTOR#0.9658;THROMBOSIS#0.9649;CLOTTING#0.9626;HEPARIN#0.9622;PERIPHERAL ARTERY DISEASE#0.9587;COLON CANCER#0.9568;OSTEOBLAST#0.9563;GLIAL CELL#0.9494;PANCREATIC CANCER#0.9468;BRAIN DAMAGE#0.9467;CHEMOTAXIS#0.9462;TROPHOBLAST#0.9446;PLASMA MEMBRANE#0.9432;RESONANCE ENERGY TRANSFER#0.9425;NEPHROPATHY#0.9407;ACTIN CYTOSKELETON#0.9405;STRESS FIBER#0.9402;PERIPHERAL BLOOD#0.9391;CENTRAL NERVOUS SYSTEM#0.9369;PERTUSSIS#0.9345;OVARIAN#0.9311;ADENOCARCINOMA#0.9307;MICROVASCULAR ENDOTHELIAL CELL#0.9303;UBIQUITIN#0.9289;PERIPHERAL ARTERIAL DISEASE#0.9278;ADRENERGIC RECEPTOR#0.9267;CELL ACTIVATION#0.9253;TUBE FORMATION#0.9249;DIABETIC NEPHROPATHY#0.9241;HEMATOPOIETIC CELL#0.9204;OVARIAN CANCER#0.9180;MECHANISM OF ACTION#0.9176;HYPOXIA#0.9164;MELANOMA CELL LINES#0.9154;SIGNALLING PATHWAY#0.9131;NEUROPROTECTION#0.9124;MICROPARTICLE#0.9100;FIBRINOLYSIS#0.9097;TRANSCRIPTASE#0.9086;MYOFIBROBLAST#0.9083;ARGININE#0.9082;APC BINDING#0.9065;INFLAMMATORY CELL#0.9055;NITRIC OXIDE SYNTHASE#0.9052;CELL CYCLE#0.9030;PLATELET-DERIVED GROWTH FACTOR#0.9022;CONNECTIVE TISSUE#0.9004;EPINEPHRINE#0.8958;RNA INTERFERENCE#0.8939;MONONUCLEAR CELLS#0.8917;CLATHRIN ADAPTOR#0.8905;CELL ADHESION MOLECULE#0.8897;CATALYTIC ACTIVITY#0.8865;TOXICITY#0.8850;CYTOKINE PRODUCTION#0.8842;SUBSTANCE P#0.8814;RIVAROXABAN#0.8810;STROMA#0.8806;CHEMOKINE RECEPTOR#0.8795;STATUS EPILEPTICUS#0.8789;LYMPH NODE#0.8787;STANDARD OF CARE#0.8759;TRANSFORMING GROWTH FACTOR BETA#0.8758;CEREBRAL ARTERY#0.8737;VASCULAR ENDOTHELIUM#0.8724;FOCAL ADHESION#0.8705;BLEOMYCIN#0.8673;HETEROTRIMERIC G-PROTEIN#0.8673;HYPERTENSION#0.8670;KINASE ACTIVITY#0.8660;REACTIVE OXYGEN SPECIES#0.8656;MIDDLE CEREBRAL ARTERY#0.8643;LUNG DISEASE#0.8637;UROKINASE#0.8636;ACTIVATION OF COAGULATION#0.8622;ARGATROBAN#0.8605;CELL MOTILITY#0.8598;VASCULAR DISEASE#0.8570;THYMIDINE#0.8541;BASILAR ARTERY#0.8517;ALKALINE PHOSPHATASE#0.8508;NEURONAL CELLS#0.8504;AKT SIGNALING#0.8501;ATRIAL FIBRILLATION#0.8429;HEPATOCELLULAR CARCINOMA#0.8418;SMOOTH MUSCLE ACTIN#0.8405;SYNAPTIC TRANSMISSION#0.8371;ASPARTATE#0.8368;SIGNALING MOLECULE#0.8358;HEMORRHAGIC#0.8331;SQUAMOUS CELL CARCINOMA#0.8330;DIABETES MELLITUS#0.8318;FIBROBLAST GROWTH FACTOR#0.8311;SKELETAL MUSCLE#0.8251;OLIGODENDROCYTE#0.8246;TUMOR SUPPRESSOR#0.8227;PNEUMONIA#0.8218;NEUROGENESIS#0.8210;PROTEIN SYNTHESIS#0.8204;HISTAMINE#0.8184;QUANTITATIVE REAL TIME#0.8181;STRUCTURE ACTIVITY RELATIONSHIP#0.8160;TISSUE GROWTH FACTOR#0.8132;HUMAN EMBRYONIC KIDNEY#0.8099;CAROTID ARTERY#0.8096;EMBRYONIC KIDNEY#0.8094;IL-6 PRODUCTION#0.8054;FIBRINOGEN BINDING#0.8052;HEMATOPOIETIC STEM CELL#0.8046;VITAMIN K#0.8017;IDIOPATHIC PULMONARY FIBROSIS#0.8008;FIBROBLAST PROLIFERATION#0.7999;DRUG RESISTANCE#0.7987;ENDOCYTOSIS#0.7948;EPITHELIAL MESENCHYMAL TRANSITION#0.7937;VASCULAR CELL#0.7929;INVASIVE BREAST CARCINOMA#0.7922;DENTAL PULP#0.7913;ALANINE#0.7842;CYTOPLASM#0.7831;RECEPTOR TRANSACTIVATION#0.7816;CELL MEMBRANE#0.7792;PODOCYTE#0.7781;DENTATE GYRUS#0.7756;LONG TERM POTENTIATION#0.7753;DENDRITIC CELL#0.7747;CEREBRAL ARTERY OCCLUSION#0.7743;L-ARGININE#0.7736;CAVEOLAE#0.7731;BLOOD CLOTTING#0.7726;ACUTE LUNG INJURY#0.7717;UROKINASE PLASMINOGEN ACTIVATOR#0.7714;ENDOSOME#0.7711;NODE OF RANVIER#0.7694;TROPHOBLAST CELL#0.7692;INDOMETHACIN#0.7675;CORONARY ARTERY BYPASS#0.7670;GASTRIC MUCOSA#0.7661;ANTICOAGULANT PROTEIN C#0.7627;COLITIS#0.7608;IMMUNE RESPONSE#0.7558;METASTATIC MELANOMA CELLS#0.7543;GLOBAL CEREBRAL ISCHEMIA#0.7536;PERIPHERAL NERVOUS SYSTEM#0.7518;BIVALIRUDIN#0.7482;CLATHRIN-COATED PIT#0.7458;MYOBLAST#0.7452;MODE OF ACTION#0.7437;RECEPTOR INTERNALIZATION#0.7434;ONCOGENIC#0.7428;COATED PIT#0.7416;COLLAGEN RELATED PEPTIDE#0.7410;GENE SILENCING#0.7404;PHOSPHATASE ACTIVITY#0.7401;IMMUNE CELL#0.7400;GASTROINTESTINAL TRACT#0.7392;THROMBOCYTOPENIA#0.7389;ANION BINDING#0.7386;RECEPTOR ACTIVATOR#0.7379;SERINE PROTEASE ACTIVITY#0.7377;COLLAGENASE#0.7374;PHOSPHOLIPASE A2#0.7372;PROSTAGLANDIN E2#0.7351;TYPE 2 DIABETES#0.7351;MYOTUBE#0.7348;ORAL SQUAMOUS CELL CARCINOMA#0.7346;CYCLIC AMP#0.7343;PHOSPHATIDYLSERINE#0.7329;BRAIN WATER CONTENT#0.7320;SIGNAL PEPTIDE#0.7315;APIXABAN#0.7266;HUMAN DENTAL PULP#0.7265;GLYCOSYLATION#0.7243;PLATELET ACTIVATING FACTOR#0.7242;LUCIFERASE ACTIVITY#0.7231;PULMONARY ARTERY#0.7226;SCIATIC NERVE#0.7226;FACTOR VIII#0.7213;BIOLUMINESCENCE#0.7208;TYROSINE KINASE INHIBITOR#0.7193;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7179;NEUROTOXICITY#0.7137;HOST CELL#0.7127;LUNG EPITHELIAL CELL#0.7107;TRANSIENT ISCHEMIC ATTACK#0.7070;LOW DENSITY LIPOPROTEIN#0.7035;HEART DISEASE#0.7031;ADHERENS JUNCTION#0.7013;MONOCYTE CHEMOTACTIC PROTEIN#0.7006;SIGNAL TERMINATION#0.7002;LUNG ADENOCARCINOMA#0.7002;MESANGIAL CELL#0.6999;REGENERATION#0.6986;DOPAMINE#0.6981;NEURAL CELL#0.6980;OSTEOCLAST#0.6967;RECEPTOR TYROSINE KINASE#0.6959;PROSTACYCLIN#0.6954;TOLL LIKE RECEPTOR#0.6940;HIGH MOBILITY GROUP#0.6925;MUTAGENESIS#0.6925;MEGAKARYOCYTE#0.6922;TGF-BETA ACTIVATION#0.6920;FACTOR 2 RECEPTOR#0.6900;LYMPH NODE METASTASIS#0.6897;NITRO-L-ARGININE#0.6893;MECHANISMS OF ACTION#0.6879;ACUTE MYOCARDIAL INFARCTION#0.6832;SPINAL CORD INJURY#0.6826;BRAIN ENDOTHELIAL CELL#0.6795;AIRWAY SMOOTH MUSCLE#0.6792;SMALL INTESTINE#0.6792;ENDOTHELIAL CELL PROLIFERATION#0.6790;MAST CELL DEGRANULATION#0.6752;PROTEIN SECRETION#0.6750;PLASMA PROTEIN#0.6707;HEPARIN BINDING#0.6691;ENDOPLASMIC RETICULUM#0.6675;GAP JUNCTION#0.6675;IMMUNE SYSTEM#0.6672;VASOCONSTRICTION#0.6653;MYOCYTES#0.6641;WARFARIN#0.6639;TYROSINE KINASE RECEPTOR#0.6582;ACTIVATED FACTOR X#0.6578;HIGH RISK PATIENTS#0.6577;FOCAL ADHESION KINASE#0.6572;TETRODOTOXIN#0.6551;COLORECTAL CANCER#0.6540;HEART ATTACK#0.6538;VASODILATOR#0.6537;ACUTE ISCHEMIC STROKE#0.6532;NEURODEGENERATIVE DISEASE#0.6529;STAUROSPORINE#0.6526;ENDOTHELIAL CELL ACTIVATION#0.6524;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6523;MULTIPLE SCLEROSIS#0.6513;OXYGENASE#0.6493;IL-8 PRODUCTION#0.6484;PROTEIN KINASE B#0.6483;PHOSPHOLIPASE A#0.6477;ACETYLCHOLINE#0.6477;NADPH OXIDASE#0.6473;EXTRACELLULAR SPACE#0.6467;FLOW CYTOMETRY ANALYSIS#0.6455;FORSKOLIN#0.6447;NF-KAPPAB ACTIVATION#0.6429;CALCIUM CHANNEL#0.6427;PERIPHERAL NERVE#0.6420;P21 ACTIVATED KINASE#0.6308;AORTIC SMOOTH MUSCLE CELLS#0.6300;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.6286;TISSUE REMODELING#0.6286;CYTOKINE SECRETION#0.6263;DOPAMINERGIC NEURON#0.6258;ACTION POTENTIAL#0.6248;SMC PROLIFERATION#0.6243;ETHANOL#0.6234;RECEPTOR ACTIVITY#0.6207;VIRAL INFECTION#0.6195;PLATELET MONOCYTE AGGREGATES#0.6194;DOXORUBICIN#0.6137;OSTEOBLAST PROLIFERATION#0.6095;DNA BINDING#0.6094;CONNEXIN#0.6070;MICROTUBULE#0.6041;GRANULOCYTE#0.6034;EARLY ENDOSOME#0.6030;MITOCHONDRIA#0.6028;COLORECTAL#0.6016
214	LEUKOCYTE CELL ADHESION#1.0592;LEUKOCYTE#1.0394;PROSTATE CANCER#1.0393;CELL ADHESION MOLECULE#1.0382;CELL ADHESION#1.0333;BREAST CANCER#1.0308;HEMATOPOIETIC CELL#1.0235;CELL MIGRATION#1.0213;PANCREATIC CANCER#1.0209;T CELL ACTIVATION#1.0200;BREAST CANCER CELL#1.0169;STEM CELL MARKER#1.0152;CELL ACTIVATION#1.0145;SQUAMOUS CELL CARCINOMA#1.0096;LYMPH NODE#1.0086;BLOOD BRAIN BARRIER#1.0077;MONOCYTE#1.0043;T CELL#1.0002;HEMATOPOIETIC STEM CELL#0.9991;TUMOR CELLS#0.9984;CELL SURFACE#0.9982;CELL CELL ADHESION#0.9978;MESENCHYMAL CELL#0.9965;COLON CANCER#0.9956;NERVOUS SYSTEM#0.9931;IMMUNOLOGICAL SYNAPSE#0.9915;ENDOTHELIAL CELL#0.9906;CANCER CELL#0.9901;ADENOCARCINOMA#0.9886;APOPTOSIS#0.9881;COLORECTAL#0.9881;IMMUNE RESPONSE#0.9878;COLORECTAL CANCER#0.9868;TRANSCRIPTION FACTOR#0.9843;ENDOTHELIUM#0.9842;CANCER STEM CELL#0.9829;REVERSE TRANSCRIPTION#0.9817;EPITHELIAL CELL#0.9813;SCAVENGER RECEPTOR#0.9806;CELL PROLIFERATION#0.9804;LUNG CANCER#0.9773;POLYMERASE CHAIN REACTION#0.9759;OSTEOBLAST#0.9748;CHONDROCYTE#0.9736;PROGENITOR CELL#0.9734;PERIPHERAL BLOOD#0.9726;EMBRYONIC STEM CELL#0.9726;FLOW CYTOMETRY ANALYSIS#0.9716;SMOOTH MUSCLE#0.9716;ALKALINE PHOSPHATASE#0.9714;SIGNALING PATHWAY#0.9713;STEM CELL#0.9712;GROWTH FACTOR#0.9709;HEMATOPOIESIS#0.9703;CELL SURFACE ANTIGEN#0.9700;STROMAL CELL#0.9696;BONE MARROW#0.9686;ADIPOCYTE#0.9680;GENE EXPRESSION#0.9677;MESENCHYMAL STEM CELL#0.9674;ADIPOSE TISSUE#0.9666;CELL CYCLE#0.9641;STEM CELL LIKE#0.9586;HUMAN MESENCHYMAL STEM#0.9581;MESENCHYMAL STROMAL CELL#0.9548;DENDRITIC CELL#0.9532;REGENERATION#0.9529;UMBILICAL CORD#0.9498;SMOOTH MUSCLE ACTIN#0.9481;EXTRACELLULAR MATRIX#0.9474;GROWTH FACTOR RECEPTOR#0.9461;EPITHELIAL MESENCHYMAL TRANSITION#0.9433;DISEASE FREE SURVIVAL#0.9423;ANGIOGENESIS#0.9382;CD4+ T CELL#0.9378;MONONUCLEAR CELLS#0.9370;OSTEOCYTE#0.9367;MACROPHAGE#0.9332;ACTIN CYTOSKELETON#0.9326;COLORECTAL CARCINOMA#0.9312;BREAST CANCER PATIENTS#0.9288;T CELL PROLIFERATION#0.9282;DENTAL PULP#0.9242;CELL GROWTH#0.9203;OVARIAN#0.9201;CENTRAL NERVOUS SYSTEM#0.9188;LIVER CANCER#0.9153;CELL DIFFERENTIATION#0.9148;OVARIAN CANCER#0.9140;MULTIPLE SCLEROSIS#0.9120;CELL MEMBRANE#0.9094;MESENCHYMAL PROGENITOR CELL#0.9061;QUANTITATIVE REAL TIME#0.9042;ESTROGEN RECEPTOR#0.8950;PLASMA MEMBRANE#0.8936;T LYMPHOCYTE#0.8883;ORAL SQUAMOUS CELL CARCINOMA#0.8806;HUMAN EMBRYONIC STEM#0.8727;CORD BLOOD#0.8705;EPIDERMAL GROWTH FACTOR#0.8697;B CELL#0.8668;BLOOD VESSEL#0.8593;TUMOR NECROSIS FACTOR#0.8561;BREAST CARCINOMA#0.8538;LYMPH NODE METASTASIS#0.8533;CANCER STEM-LIKE CELL#0.8505;HEPATOCELLULAR CARCINOMA#0.8467;GLYCOSYLATION#0.8385;CYTOPLASM#0.8363;OSTEOARTHRITIS#0.8362;PLURIPOTENT STEM CELL#0.8318;MELANOMA CELL LINES#0.8261;BONE MARROW STROMAL#0.8215;TISSUE REGENERATION#0.8144;EPITHELIAL OVARIAN CANCER#0.8141;DIGESTION#0.8118;VASCULAR CELL#0.8112;WOUND HEALING#0.8109;TRANSCRIPTASE#0.8078;UMBILICAL CORD BLOOD#0.8057;DENTAL PULP STEM CELL#0.8049;NEURAL CELL#0.8031;CARDIOMYOCYTE#0.8010;SELECTIN#0.7978;YOLK SAC#0.7973;BONE FORMATION#0.7962;GENE SILENCING#0.7955;RHEUMATOID ARTHRITIS#0.7943;MARROW STROMAL CELLS#0.7895;PRIMARY BREAST CANCER#0.7867;SALIVARY GLAND#0.7846;BONE MARROW STROMAL CELL#0.7797;GALECTIN#0.7747;CD14++CD16- MONOCYTE#0.7734;APOPTOTIC#0.7725;CD8+ T CELL#0.7598;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7567;CELL DEATH#0.7544;TO TUMOR PROGRESSION#0.7511;OSTEOGENESIS#0.7482;LEUKOCYTE ADHESION#0.7474;BONE MARROW CELLS#0.7472;TUBE FORMATION#0.7466;NEUROENDOCRINE TUMOR#0.7440;PERIODONTAL LIGAMENT#0.7439;HUMAN LEUKOCYTE ANTIGEN#0.7415;TUMOR SUPPRESSOR#0.7394;INFLAMMATORY RESPONSE#0.7388;RNA INTERFERENCE#0.7382;ADULT STEM CELL#0.7322;ADIPOSE-DERIVED STEM CELL#0.7317;TRANSFORMING GROWTH FACTOR#0.7309;CHONDROGENESIS#0.7308;THYMOCYTE#0.7305;DISEASE SPECIFIC SURVIVAL#0.7275;MICROVASCULAR ENDOTHELIAL CELL#0.7265;5 FLUOROURACIL#0.7258;PRO-INFLAMMATORY#0.7210;COLLAGENASE#0.7129;ADULT BONE MARROW#0.7114;ENDOTHELIAL GROWTH FACTOR#0.7077;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7077;MUTAGENESIS#0.7047;ENDOMETRIUM#0.7012;AMNION#0.7002;DRUG RESISTANCE#0.7001;FETAL LIVER#0.6984;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6979;NEURONAL CELLS#0.6951;CELL JUNCTION#0.6920;SPINAL CORD#0.6912;TISSUE INVASION#0.6841;CHEMOKINE RECEPTOR#0.6839;IMMUNE CELL#0.6836;EXTRACELLULAR REGION#0.6827;IMMUNE SYSTEM#0.6826;COLLAGEN TYPE II#0.6818;ALKALINE PHOSPHATASE ACTIVITY#0.6774;MULTIPOTENT STEM CELL#0.6764;PHOSPHATASE ACTIVITY#0.6748;METASTATIC MELANOMA#0.6731;PROTEIN KINASE#0.6636;ARTERY#0.6627;RECEPTOR BINDING#0.6626;DEXAMETHASONE#0.6624;FLUOROURACIL#0.6557;STROMA#0.6555;KERATINOCYTE#0.6532;LUNG ADENOCARCINOMA#0.6520;SURFACE PLASMON RESONANCE#0.6490;AMNIOTIC FLUID#0.6481;HYPOXIA#0.6445;NEUROBLASTOMA#0.6445;SYNOVIUM#0.6377;MESOTHELIAL CELL#0.6323;AUTOIMMUNE DISEASE#0.6320;LYMPH NODE INVOLVEMENT#0.6318;COLON CARCINOMA#0.6278;TH17 CELL#0.6275;TUMOR TISSUES#0.6247;QUANTITATIVE REVERSE TRANSCRIPTION#0.6232;IFN-GAMMA#0.6231;ADIPOGENIC CELL#0.6201;ADVANCED GLYCATION END#0.6190;OSTEOARTHRITIC CARTILAGE#0.6183;TIGHT JUNCTION#0.6173;UBIQUITIN#0.6157;CANCER INITIATING CELLS#0.6124;ENCEPHALOMYELITIS#0.6107;MUSCLE CELL#0.6097;NEURITE#0.6089;BLOOD PLASMA#0.6032;PRECURSOR CELL#0.6015;PANCREATIC NEUROENDOCRINE TUMOR#0.6004
2150	BONE CANCER#1.0922;HUMAN PANCREATIC CANCER#1.0469;PANCREATIC CANCER#1.0461;IL-8 PRODUCTION#1.0434;COLON CANCER#1.0410;PROTEINASE ACTIVATED RECEPTOR#1.0367;ASTROCYTE#1.0356;GASTROINTESTINAL TRACT#1.0355;TRANSACTIVATION#1.0344;VASODILATION#1.0338;STROMAL CELL#1.0332;BREAST CANCER#1.0317;PANCREATITIS#1.0302;VASODILATATION#1.0299;ACINAR CELL#1.0299;AIRWAY SMOOTH MUSCLE#1.0288;PULMONARY FIBROSIS#1.0284;CALCIUM MOBILIZATION#1.0275;BREAST CANCER CELL#1.0258;SPINAL CORD#1.0254;MELANOSOME#1.0243;AIRWAY EPITHELIUM#1.0238;HUMAN AIRWAY EPITHELIAL#1.0235;SERINE PROTEASE ACTIVITY#1.0230;AIRWAY EPITHELIAL CELL#1.0217;INTESTINAL EPITHELIAL CELL#1.0204;HYPERSENSITIVITY#1.0203;GM-CSF#1.0197;CELL GROWTH#1.0190;ION TRANSPORT#1.0190;PHAGOCYTOSIS#1.0188;EOSINOPHIL#1.0174;PROTEASE ACTIVATED RECEPTOR#1.0173;MAST CELL DEGRANULATION#1.0163;THROMBIN RECEPTOR#1.0163;LUNG EPITHELIAL CELL#1.0144;HISTAMINE#1.0142;KERATINOCYTE#1.0139;MAP KINASE#1.0138;GASTRIC MUCOSA#1.0138;TRANSIENT RECEPTOR POTENTIAL#1.0135;CALCIUM SIGNALING#1.0121;SMOOTH MUSCLE CELL#1.0117;VASCULAR ENDOTHELIAL CELL#1.0116;SIGNALLING PATHWAY#1.0106;TUMOR CELLS#1.0105;MAST CELL ACTIVATION#1.0104;SMOOTH MUSCLE RELAXATION#1.0099;MUSCLE CELL#1.0095;NOCICEPTION#1.0093;COLITIS#1.0086;PROSTAGLANDIN E2#1.0085;BONE MARROW#1.0084;CELL MIGRATION#1.0079;CYTOKINE PRODUCTION#1.0076;FACTOR XA#1.0075;BRONCHIAL EPITHELIAL CELLS#1.0075;URINARY BLADDER#1.0074;DENDRITIC CELL#1.0073;SENSITIZATION#1.0071;TRANSFORMING GROWTH FACTOR#1.0069;CELL ACTIVATION#1.0067;CANCER CELL#1.0066;ENDOTHELIUM#1.0063;IL-8 SECRETION#1.0061;CELL ADHESION#1.0058;NITRIC OXIDE#1.0054;LUMINAL#1.0054;HUMAN UMBILICAL VEIN#1.0049;FIBROBLAST PROLIFERATION#1.0048;SMOOTH MUSCLE#1.0047;UMBILICAL VEIN ENDOTHELIAL CELLS#1.0044;VASCULAR SMOOTH MUSCLE CELL#1.0043;SUBSTANCE P#1.0040;UMBILICAL VEIN#1.0036;SIGNAL TRANSDUCTION#1.0033;ENDOTHELIAL CELL#1.0032;NEUTROPHIL#1.0029;GROWTH FACTOR RECEPTOR#1.0029;MAST CELL#1.0026;PRO-INFLAMMATORY#1.0021;CELL PROLIFERATION#1.0021;TOLL LIKE RECEPTOR#1.0016;REACTIVE OXYGEN SPECIES#1.0014;PLASMA MEMBRANE#1.0012;ISCHEMIA#0.9996;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9995;INNATE IMMUNE RESPONSE#0.9990;ALLERGEN#0.9985;ENDOTHELIAL GROWTH FACTOR#0.9983;APOPTOSIS#0.9981;PERIODONTITIS#0.9979;MITOGEN ACTIVATED PROTEIN#0.9976;PHOSPHOLIPASE C#0.9973;CELL SURFACE#0.9971;ACUTE PANCREATITIS#0.9971;GASTRIC EPITHELIAL CELLS#0.9969;ADENOCARCINOMA#0.9968;ATOPIC DERMATITIS#0.9966;MACROPHAGE#0.9960;PROTEASE ACTIVITY#0.9959;EPITHELIAL CELL#0.9958;PROTEIN KINASE C#0.9957;TUMOR NECROSIS FACTOR#0.9957;MONOCYTE#0.9953;PROTEIN KINASE#0.9951;REVERSE TRANSCRIPTION#0.9949;HUMAN BRONCHIAL EPITHELIAL#0.9949;ARTERY#0.9946;SIGNALING PATHWAY#0.9927;LEUKOCYTE#0.9926;DERMATITIS#0.9921;COLORECTAL#0.9918;T CELL#0.9917;TOPICAL#0.9904;PROSTATE CANCER#0.9903;ANGIOGENESIS#0.9902;OXYGENASE#0.9899;INDOMETHACIN#0.9897;NITRIC OXIDE SYNTHASE#0.9897;PERIPHERAL BLOOD#0.9896;DORSAL ROOT GANGLION#0.9892;RNA INTERFERENCE#0.9888;GENE EXPRESSION#0.9882;POLYMERASE CHAIN REACTION#0.9880;TIGHT JUNCTION#0.9879;SMALL INTESTINE#0.9877;IRRITABLE BOWEL SYNDROME#0.9876;INFLAMMATORY RESPONSE#0.9867;INFLAMMATORY CELL#0.9866;STEM CELL#0.9863;SWEAT GLAND#0.9862;MUCUS SECRETION#0.9860;HEPATOCELLULAR CARCINOMA#0.9855;GROWTH FACTOR#0.9855;IMMUNE CELL#0.9854;EPIDERMAL GROWTH FACTOR#0.9852;RECEPTOR AGONIST#0.9846;SIGNALING CASCADE#0.9846;CELL MOTILITY#0.9839;IMMUNE RESPONSE#0.9836;COAGULATION#0.9836;CELL DEATH#0.9829;SALIVARY GLAND#0.9829;EXTRACELLULAR MATRIX#0.9824;ARGININE#0.9822;ION CHANNEL#0.9815;ACETYLCHOLINE#0.9814;KINASE INHIBITOR#0.9797;TRANSCRIPTASE#0.9786;CORONARY ARTERY#0.9785;OSTEOARTHRITIS#0.9785;COLORECTAL CANCER#0.9783;TRANSCRIPTION FACTOR#0.9756;MYOFIBROBLAST#0.9750;RECEPTOR ANTAGONIST#0.9732;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9731;BLOOD COAGULATION#0.9729;ALLERGIC AIRWAY INFLAMMATION#0.9714;HYPOTENSION#0.9697;L-ARGININE#0.9695;NITRO-L-ARGININE#0.9693;MICROVASCULAR ENDOTHELIAL CELL#0.9691;LYMPH NODE#0.9661;OSTEOBLAST#0.9658;THROMBOSIS#0.9627;C FIBER#0.9624;MELANOCYTE#0.9623;ISCHEMIA REPERFUSION INJURY#0.9621;OPIOID RECEPTOR#0.9611;DNA SYNTHESIS#0.9603;GOLGI APPARATUS#0.9566;EDEMA#0.9555;NERVOUS SYSTEM#0.9553;CHONDROCYTE#0.9545;WOUND HEALING#0.9526;KINASE ACTIVITY#0.9521;MUSCLE CONTRACTION#0.9512;BLOOD VESSEL#0.9511;SQUAMOUS CELL CARCINOMA#0.9510;ENDOCYTOSIS#0.9481;PERIODONTAL DISEASE#0.9438;QUANTITATIVE REAL TIME#0.9423;HYPOXIA#0.9421;GASTROESOPHAGEAL REFLUX DISEASE#0.9407;CARDIOMYOCYTE#0.9401;ITCHING#0.9391;GRANULOCYTE#0.9358;PERTUSSIS#0.9348;RESPIRATORY TRACT#0.9295;HEPATIC STELLATE CELL#0.9282;SMOOTH MUSCLE CONTRACTION#0.9246;INFLAMMATORY BOWEL DISEASE#0.9234;SIGNALING MOLECULE#0.9184;ALLERGIC RHINITIS#0.9171;ALLERGIC ASTHMA#0.9161;VASCULAR ENDOTHELIUM#0.9148;RIVAROXABAN#0.9127;VANILLOID RECEPTOR 1#0.9122;ATHEROSCLEROSIS#0.9082;CERVICAL CANCER#0.9077;SKIN DISEASE#0.9073;ORAL EPITHELIAL CELLS#0.9011;NERVE FIBER#0.9011;TUBULAR EPITHELIAL CELL#0.8992;INNATE IMMUNITY#0.8990;VASODILATOR#0.8987;ARACHIDONIC ACID#0.8986;STEM CELL FACTOR#0.8980;SMOOTH MUSCLE ACTIN#0.8967;MESENTERIC ARTERY#0.8906;HEPATOCYTE GROWTH FACTOR#0.8898;TYROSINE KINASE INHIBITOR#0.8877;ADENOSINE#0.8871;COLONY-STIMULATING FACTOR#0.8859;RHEUMATOID ARTHRITIS#0.8851;HISTAMINE RECEPTOR#0.8817;SKELETAL MUSCLE#0.8783;APOPTOTIC#0.8781;LYMPH NODE METASTASIS#0.8761;GINGIVAL CREVICULAR FLUID#0.8748;CYTOKINE SECRETION#0.8698;RHINITIS#0.8676;CHEMOTAXIS#0.8655;COLLAGEN SYNTHESIS#0.8641;HUMAN EMBRYONIC KIDNEY#0.8640;LUNG CANCER#0.8640;EMBRYONIC KIDNEY#0.8635;LYSOSOME#0.8626;COAGULATION FACTOR VIIA#0.8626;PROTEIN KINASE A#0.8604;HUMAN BREAST CANCER#0.8581;SPINAL DORSAL HORN#0.8569;ENDOSOME#0.8545;ACTIVATED PROTEIN C#0.8533;LUNG FIBROBLASTS#0.8532;EPITHELIAL BARRIER FUNCTION#0.8511;HEPARIN#0.8502;NERVE GROWTH FACTOR#0.8488;JOINT SWELLING#0.8482;RESONANCE ENERGY TRANSFER#0.8476;NEUTROPHIL ACTIVATION#0.8466;STROMA#0.8449;SWELLING#0.8437;HEMOSTASIS#0.8430;AKT SIGNALING#0.8393;IMMUNE SYSTEM#0.8373;ATHEROSCLEROTIC#0.8368;NASAL MUCOSA#0.8361;CENTRAL NERVOUS SYSTEM#0.8355;VASCULAR CELL#0.8345;TUBE FORMATION#0.8340;CALCIUM SIGNALLING#0.8329;TACHYKININ#0.8295;ALVEOLAR MACROPHAGE#0.8295;IDIOPATHIC PULMONARY FIBROSIS#0.8274;MYELOID CELL#0.8272;SODIUM NITROPRUSSIDE#0.8258;GI TRACT#0.8253;DUCT CELL#0.8244;ASPARTATE#0.8244;OOCYTE#0.8173;THYMIDINE#0.8155;RECEPTOR INTERNALIZATION#0.8136;APROTININ#0.8069;DNA BINDING#0.8049;CARBACHOL#0.8031;ADIPOSE TISSUE#0.8010;PAROTID GLAND#0.7998;ARTERIOLE#0.7994;PROTEASE S#0.7988;ACTIVATED FACTOR X#0.7960;PLATELET ACTIVATING FACTOR#0.7958;NITROPRUSSIDE#0.7958;TRANSMEMBRANE RECEPTOR#0.7951;IFN-GAMMA#0.7948;POTASSIUM CHANNEL#0.7946;TISSUE DAMAGE#0.7931;SPINAL CORD INJURY#0.7922;CELL ADHESION MOLECULE#0.7922;ENDOMETRIOSIS#0.7921;PROTEINASE INHIBITOR#0.7908;IL-6 SECRETION#0.7906;KIDNEY DISEASE#0.7905;TUMOR SUPPRESSOR#0.7897;VEGF PRODUCTION#0.7880;TRACHEA#0.7879;ESOPHAGEAL CANCER#0.7878;TRANSFORMING GROWTH FACTOR BETA#0.7875;MENSTRUAL CYCLE#0.7858;HEPATOMA CELLS#0.7856;ALVEOLAR EPITHELIAL CELL#0.7855;PHOSPHOLIPASE A#0.7849;RETINAL GANGLION CELL#0.7839;ACTIN FILAMENT#0.7812;MONONUCLEAR CELLS#0.7780;GANGLION CELLS#0.7775;PULMONARY ARTERY#0.7745;STRUCTURE ACTIVITY RELATIONSHIP#0.7728;PROTEIN SYNTHESIS#0.7725;PLATELET-DERIVED GROWTH FACTOR#0.7719;NOXIOUS#0.7696;GENE SILENCING#0.7647;SOLUBLE VASCULAR ENDOTHELIAL#0.7642;ULCERATIVE COLITIS#0.7635;TUMOUR NECROSIS FACTOR#0.7622;CONNECTIVE TISSUE#0.7621;TROPHOBLAST#0.7617;CD8+ T CELL#0.7605;UROKINASE#0.7599;NEPHROPATHY#0.7587;BASAL CELL#0.7581;GINGIVAL EPITHELIAL CELLS#0.7537;CERVICAL#0.7536;MYOMETRIUM#0.7527;T LYMPHOCYTE#0.7521;EPIDERMAL PERMEABILITY BARRIER#0.7515;BASILAR ARTERY#0.7510;CROMOLYN#0.7506;ISOLEUCINE#0.7497;T CELL ACTIVATION#0.7479;CYTOPLASM#0.7474;PHENYLEPHRINE#0.7462;SYNOVIUM#0.7458;ACUTE LUNG INJURY#0.7452;ESOPHAGEAL EPITHELIAL CELLS#0.7452;EOSINOPHIL MIGRATION#0.7442;ORAL SQUAMOUS CELL CARCINOMA#0.7425;RESPIRATORY SYSTEM#0.7424;HOST CELL#0.7419;CELL MEMBRANE#0.7404;EXTRACELLULAR LOOP 2#0.7403;HYPERTENSION#0.7397;OVARIAN#0.7392;MAPK SIGNALING#0.7373;SYNOVITIS#0.7366;NMDA RECEPTOR#0.7365;SELECTIN#0.7322;TNF-ALPHA SECRETION#0.7316;ACTIVATOR PROTEIN 1#0.7241;PHOSPHOLIPASE A2#0.7214;CLOTTING#0.7212;ACTION POTENTIAL#0.7212;CATION CHANNEL#0.7179;PARKINSON'S DISEASE#0.7173;CGRP RECEPTOR#0.7159;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7155;PSORIASIS#0.7133;LEUCINE#0.7131;TETRODOTOXIN#0.7124;DEXAMETHASONE#0.7122;BIOLUMINESCENCE#0.7103;TYPE 2 DIABETES#0.7101;CYSTITIS#0.7083;RECEPTOR TRANSACTIVATION#0.7066;N-OMEGA-NITRO-L-ARGININE#0.7049;DERMAL FIBROBLAST#0.7014;FLOW CYTOMETRY ANALYSIS#0.7001;VASCULAR DISEASE#0.6983;GLIAL CELL#0.6982;COMPLEX I#0.6960;MAPK ACTIVATION#0.6946;LOW DENSITY LIPOPROTEIN#0.6928;MUSCARINIC ACETYLCHOLINE RECEPTOR#0.6915;INFLAMMATORY AIRWAY DISEASE#0.6883;ACID SECRETION#0.6849;MESANGIAL CELL#0.6834;ACETYLCHOLINE RECEPTOR#0.6817;LUNG ADENOCARCINOMA#0.6812;EARLY ENDOSOME#0.6801;RENAL CELL CARCINOMA#0.6800;HUMAN CORNEAL EPITHELIAL#0.6800;CD4+ T CELL#0.6797;PROTEIN KINASE D#0.6790;MIGRAINE#0.6776;HUMAN EPIDERMAL KERATINOCYTES#0.6774;ASTROCYTOMA#0.6764;MAP KINASE CASCADE#0.6760;CORNEAL EPITHELIAL CELL#0.6752;TYPE 2 DIABETIC#0.6743;SPERMATOZOA#0.6718;INDUCIBLE NITRIC OXIDE#0.6701;VIRAL INFECTION#0.6700;ENTEROCYTE#0.6680;PERIPHERAL NERVE#0.6671;ALZHEIMER'S DISEASE#0.6669;CELL CYCLE#0.6669;DENTAL PULP#0.6669;SYNAPTIC TRANSMISSION#0.6667;AUTOPHAGY#0.6662;OSTEOCLAST DIFFERENTIATION#0.6657;DIARRHEA#0.6642;KETOTIFEN#0.6635;FIBRINOGEN#0.6627;B CELL#0.6609;HEME OXYGENASE 1#0.6604;MICROVESICLE#0.6597;GENISTEIN#0.6556;PROTEINASE ACTIVITY#0.6551;SPHINGOSINE#0.6542;INTRACELLULAR SIGNALING PATHWAY#0.6518;COLONIC EPITHELIAL CELLS#0.6516;OSTEOCLAST#0.6496;NEURODEGENERATIVE DISEASE#0.6451;GLYCINE#0.6448;COLORECTAL CARCINOMA#0.6435;DIABETIC NEPHROPATHY#0.6435;GLYCOSYLATION#0.6434;NF-KAPPAB ACTIVATION#0.6431;LUNG DISEASE#0.6424;CHEMOKINE RECEPTOR#0.6411;PROGENITOR CELL#0.6397;MECHANISM OF ACTION#0.6396;ALANINE#0.6386;OBESE#0.6382;CHEMOKINESIS#0.6367;HYDROXYPROLINE#0.6328;INTESTINAL MOTILITY#0.6302;BLEOMYCIN#0.6286;EXTRACELLULAR SPACE#0.6285;SPHINGOSINE 1 PHOSPHATE#0.6284;TIGHT JUNCTION PROTEIN#0.6278;ENDOMETRIUM#0.6267;MYOCYTES#0.6257;CEREBRAL ARTERY#0.6256;CHEMOKINE PRODUCTION#0.6255;PLATELET AGGREGATION#0.6253;ENDOTHELIAL NITRIC OXIDE#0.6252;PROSTAGLANDIN SYNTHESIS#0.6245;STAUROSPORINE#0.6236;DIET INDUCED OBESITY#0.6219;EPITHELIAL MESENCHYMAL TRANSITION#0.6205;SIGNALLING CASCADE#0.6193;HYPOXIC#0.6187;TEAR SECRETION#0.6149;HUMAN PROXIMAL TUBULAR#0.6145;NEUROTOXICITY#0.6145;MYOBLAST PROLIFERATION#0.6139;ACTIN FILAMENT SEVERING#0.6123;MULTIPLE SCLEROSIS#0.6117;FACTOR I#0.6110;CYSTIC FIBROSIS#0.6098;INHIBITORY KAPPA B#0.6091;BLOOD BRAIN BARRIER#0.6090;EXOCYTOSIS#0.6080;ACUTE INFLAMMATORY RESPONSE#0.6076;ACTIVATION OF COAGULATION#0.6075;FORSKOLIN#0.6068;SUBLINGUAL GLAND#0.6052;PROXIMAL TUBULAR CELL#0.6040;CHRONIC PELVIC PAIN#0.6033;SPERM MOTILITY#0.6030
2151	THROMBIN RECEPTOR#1.0370;PROTEINASE ACTIVATED RECEPTOR#1.0191;ENDOTHELIAL CELL#0.9961;PROTEASE ACTIVATED RECEPTOR#0.9940;COAGULATION#0.9534;SMOOTH MUSCLE#0.9246;PLATELET ACTIVATION#0.9192;CALCIUM MOBILIZATION#0.9107;POLYMERASE CHAIN REACTION#0.9047;EPITHELIAL CELL#0.8971;MAST CELL#0.8950;CELL SURFACE#0.8806;THROMBOSIS#0.8751;ACTIVATED PROTEIN C#0.8686;PROTEIN KINASE#0.8578;SIGNALING PATHWAY#0.8423;T CELL#0.8414;SMOOTH MUSCLE CELL#0.8360;MUSCLE CELL#0.8354;REVERSE TRANSCRIPTION#0.7930;INFLAMMATORY RESPONSE#0.7739;BLOOD COAGULATION#0.7737;HEMOSTASIS#0.7385;VASCULAR SMOOTH MUSCLE CELL#0.7134;MEGAKARYOCYTE#0.6943;GROWTH FACTOR#0.6899;CALCIUM SIGNALING#0.6876;FACTOR XA#0.6870;PHOSPHOLIPASE C#0.6859;ASTROCYTE#0.6764;MONOCYTE#0.6701;GENE EXPRESSION#0.6624;NEUTROPHIL#0.6615;PLATELET AGGREGATION#0.6586;SIGNAL TRANSDUCTION#0.6520;CELL PROLIFERATION#0.6518;APOPTOSIS#0.6457;LUNG FIBROBLASTS#0.6333;WOUND HEALING#0.6263;PROTEIN KINASE C#0.6101
2152	CATALYTIC COMPLEX#1.0704;BLOOD-COAGULATION FACTOR VIIA#1.0677;ELLAGIC ACID#1.0470;KAOLIN#1.0450;TRANSMEMBRANE RECEPTOR#1.0414;DECIDUAL CELL#1.0354;PLATELET MONOCYTE AGGREGATES#1.0310;FACTOR I#1.0294;COLORECTAL CANCER#1.0224;UROKINASE PLASMINOGEN ACTIVATOR#1.0219;COAGULATION FACTOR VIIA#1.0215;PLATELET ACTIVATING FACTOR#1.0211;CYTOKINE RECEPTOR#1.0204;COLORECTAL#1.0177;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#1.0165;MESOTHELIAL CELL#1.0160;COLORECTAL CARCINOMA#1.0142;CALIBRATED AUTOMATED THROMBOGRAPHY#1.0133;PROTHROMBINASE ACTIVITY#1.0130;ARSENIC TRIOXIDE#1.0130;OVARIAN CANCER#1.0114;MONOCYTE CHEMOTACTIC PROTEIN#1.0114;RIVAROXABAN#1.0094;MAXIMUM CLOT FIRMNESS#1.0094;PANCREATIC CANCER#1.0092;CALIBRATED AUTOMATED THROMBOGRAM#1.0087;EARLY GROWTH RESPONSE#1.0077;DIRECT THROMBIN INHIBITOR#1.0068;ALVEOLAR MACROPHAGE#1.0068;ACTIVATED MONOCYTES#1.0066;CACL2#1.0065;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0064;AMNIOTIC FLUID#1.0053;LEUKOCYTE ADHESION#1.0047;AORTIC SMOOTH MUSCLE CELLS#1.0046;EXTRACELLULAR VESICLE#1.0040;PROTEIN DISULFIDE ISOMERASE#1.0035;MICROVESICLE#1.0023;ACTIVATED FACTOR X#1.0023;DABIGATRAN#1.0018;NITRIC OXIDE SYNTHASE#1.0017;MONOCYTE DERIVED MACROPHAGE#1.0017;BLADDER CARCINOMA#1.0006;PROSTACYCLIN#1.0004;INHIBITION OF FIBRINOLYSIS#0.9993;HUMAN WHOLE BLOOD#0.9989;CORONARY ARTERY ENDOTHELIAL CELLS#0.9985;PERIPHERAL BLOOD MONOCYTES#0.9982;T- PA#0.9981;CIRCULATING ENDOTHELIAL CELL#0.9980;PROTEINASE INHIBITOR#0.9979;ACUTE PROMYELOCYTIC LEUKEMIA#0.9976;ENDOTHELIAL NITRIC OXIDE#0.9975;ACTIVATION OF BLOOD COAGULATION#0.9972;CELL ADHESION MOLECULE#0.9972;ADVANCED GLYCATION END#0.9957;CLOT FORMATION TIME#0.9947;UROKINASE#0.9937;SIMVASTATIN#0.9937;TUMOUR NECROSIS FACTOR#0.9936;MONOCYTE#0.9933;ISCHEMIC REPERFUSION INJURY#0.9925;STROMAL CELL#0.9923;ACTIVATOR PROTEIN 1#0.9921;EOSINOPHIL#0.9920;HEMATOPOIETIC CELL#0.9919;BLOOD COAGULATION#0.9916;BLOOD CLOTTING#0.9909;PROSTATE CANCER#0.9908;PLATELET-DERIVED GROWTH FACTOR#0.9908;SELECTIN#0.9907;OVARIAN#0.9907;GLOMERULONEPHRITIS#0.9904;SUPEROXIDE DISMUTASE#0.9902;MICROPARTICLE#0.9898;CELL ADHESION#0.9895;PRE-ECLAMPSIA#0.9895;TRANSFORMING GROWTH FACTOR#0.9893;BETA-2#0.9885;BLOOD CLOT#0.9884;CATALYTIC ACTIVITY#0.9878;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9877;MONOCYTE ACTIVATION#0.9874;ENDOTHELIAL GROWTH FACTOR#0.9874;FIBROBLAST GROWTH FACTOR#0.9872;LUNG CANCER#0.9872;RETINOIC ACID#0.9869;OBESE#0.9869;COMPLEX I#0.9869;NADPH OXIDASE#0.9867;POLYMORPHONUCLEAR LEUKOCYTES#0.9866;THROMBIN ACTIVITY#0.9862;UMBILICAL CORD#0.9856;LIPID RAFT#0.9855;ONCOGENIC#0.9851;ENDOTHELIAL CELL ACTIVATION#0.9851;GROWTH FACTOR RECEPTOR#0.9850;ALL TRANS RETINOIC ACID#0.9850;THROMBIN RECEPTOR#0.9846;BREAST CANCER CELL#0.9842;COAGULATION#0.9839;C REACTIVE PROTEIN#0.9837;MICROVASCULAR ENDOTHELIAL CELL#0.9836;FACTOR XA#0.9832;BLOOD PLASMA#0.9831;HOST CELL#0.9823;EPIDERMAL GROWTH FACTOR#0.9822;VASCULAR SMOOTH MUSCLE CELL#0.9819;CRESCENTIC GLOMERULONEPHRITIS#0.9817;BREAST CANCER#0.9817;THROMBIN GENERATION ASSAY#0.9816;LEUKOCYTE ACTIVATION#0.9816;ADIPOSE TISSUE#0.9811;MACROPHAGE#0.9809;SICKLE CELL DISEASE#0.9809;PHOSPHATIDYLSERINE#0.9808;HYPOXIA#0.9806;ACUTE LUNG INJURY#0.9804;VASCULAR CELL#0.9803;DENDRITIC CELL#0.9800;GRANULOCYTE#0.9798;THROMBOPLASTIN#0.9796;HUMAN BREAST CANCER#0.9795;ENDOGENOUS THROMBIN POTENTIAL#0.9792;PROTEASE ACTIVATED RECEPTOR#0.9792;PROTEIN KINASE C#0.9792;NITRIC OXIDE#0.9789;CELL ASSOCIATED#0.9788;ENOXAPARIN#0.9788;PROGESTIN#0.9785;CONNECTIVE TISSUE#0.9783;TRANSFORMING GROWTH FACTOR BETA#0.9783;GLUTATHIONE#0.9783;COLONY-STIMULATING FACTOR#0.9782;ACUTE PANCREATITIS#0.9781;RECOMBINANT ACTIVATED FACTOR#0.9779;SYSTEMIC INFLAMMATORY RESPONSE#0.9777;VASCULAR ENDOTHELIAL CELL#0.9777;EPITHELIAL CELL#0.9777;WARFARIN#0.9777;COMPLEMENT ACTIVATION#0.9776;MONONUCLEAR CELLS#0.9775;CANCER CELL#0.9774;ENDOTHELIAL CELL#0.9774;INTERNATIONAL NORMALIZED RATIO#0.9773;COLON CANCER#0.9771;ACTIVATION OF COAGULATION#0.9771;ANTICOAGULANT ACTIVITY#0.9766;HYPERGLYCEMIA#0.9765;LOW DENSITY LIPOPROTEIN#0.9764;TF BINDING#0.9761;PHOSPHOLIPASE C#0.9760;TOLL LIKE RECEPTOR#0.9758;PULMONARY HYPERTENSION#0.9758;ADENOSINE#0.9757;SMOOTH MUSCLE#0.9754;HYPOXIC#0.9753;SMOOTH MUSCLE CELL#0.9752;TUMOR NECROSIS FACTOR#0.9752;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9750;ACTIVATED PROTEIN C#0.9749;ANGIOTENSIN CONVERTING ENZYME#0.9748;MUSCLE CELL#0.9747;RED BLOOD CELL#0.9746;IONOPHORE#0.9745;CLOPIDOGREL#0.9740;PROGESTERONE#0.9740;SURFACE PLASMON RESONANCE#0.9739;LEUKOCYTE#0.9739;CORONARY ARTERY BYPASS#0.9739;ATRIAL FIBRILLATION#0.9738;ANTIPHOSPHOLIPID SYNDROME#0.9736;HIGH DENSITY LIPOPROTEIN#0.9736;FACTOR VIII#0.9735;TUMOR CELLS#0.9734;ANGIOGENESIS#0.9733;GM-CSF#0.9729;THROMBIN GENERATION TEST#0.9728;GROWTH FACTOR#0.9727;T LYMPHOCYTE#0.9726;LYSIS#0.9722;ACUTE MYOCARDIAL INFARCTION#0.9722;WOUND HEALING#0.9722;FACTOR S#0.9722;CYTOKINE PRODUCTION#0.9722;VENOUS BLOOD#0.9716;L-ARGININE#0.9716;ENDOMETRIUM#0.9714;VENA CAVA#0.9713;CELL SURFACE#0.9713;TYPE 2 DIABETES MELLITUS#0.9713;STEM CELL#0.9712;ACUTE CORONARY SYNDROME#0.9712;2 DIABETES MELLITUS#0.9712;CELL MEMBRANE#0.9712;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9711;ADENOCARCINOMA#0.9711;HEMOPHILIA B#0.9709;EMBOLISM#0.9708;MECHANISM OF ACTION#0.9708;DIPHOSPHATE#0.9706;TYPE 2 DIABETES#0.9706;RESPIRATORY DISTRESS#0.9706;CELL MIGRATION#0.9705;INFLAMMATORY CELL#0.9703;FACTOR VII DEFICIENCY#0.9700;DNA BINDING#0.9700;LUMINAL#0.9698;PACLITAXEL#0.9696;VITAMIN K#0.9694;PROTEIN SYNTHESIS#0.9693;HUMAN UMBILICAL VEIN#0.9693;DIABETES MELLITUS#0.9693;CELL BOUND#0.9693;SMOOTH MUSCLE ACTIN#0.9691;DODECYL SULFATE#0.9691;PRO-INFLAMMATORY#0.9691;SODIUM DODECYL SULFATE#0.9691;UMBILICAL VEIN#0.9691;PULMONARY ARTERY#0.9690;B CELL#0.9688;REACTIVE OXYGEN SPECIES#0.9688;VASCULAR ENDOTHELIUM#0.9687;CELL DEATH#0.9685;CLOTTING#0.9680;THROMBOPHILIA#0.9679;PLATELET ACTIVATION#0.9679;TROPHOBLAST#0.9677;PERIPHERAL BLOOD#0.9676;T CELL#0.9674;CELL GROWTH#0.9673;INHIBITION OF COAGULATION#0.9673;NEUTROPHIL#0.9671;PLATELET AGGREGATION#0.9670;CORONARY HEART DISEASE#0.9670;ISCHEMIA REPERFUSION INJURY#0.9668;PULMONARY EMBOLISM#0.9667;DISSEMINATED INTRAVASCULAR COAGULATION#0.9666;CAROTID ARTERY#0.9665;PERCUTANEOUS CORONARY INTERVENTION#0.9663;PLASMA MEMBRANE#0.9661;ARGININE#0.9661;ATHEROSCLEROTIC#0.9659;ESTRADIOL#0.9658;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9657;HEMOPHILIA#0.9656;PULMONARY FIBROSIS#0.9655;LUPUS ERYTHEMATOSUS#0.9655;ISCHEMIA#0.9654;PROGENITOR CELL#0.9654;SIGNAL TRANSDUCTION#0.9651;ARTERY DISEASE#0.9651;LDL RECEPTOR#0.9650;CELL ACTIVATION#0.9649;FIBRINOGEN#0.9649;PLASMA PROTEIN#0.9649;HEMOSTASIS#0.9647;CORONARY ARTERY DISEASE#0.9646;QUANTITATIVE REAL TIME#0.9642;BLOOD VESSEL#0.9640;APOPTOSIS#0.9637;MITOGEN ACTIVATED PROTEIN#0.9636;CORONARY ARTERY#0.9635;ARYL HYDROCARBON RECEPTOR#0.9632;ERYTHROCYTE#0.9632;MAP KINASE#0.9631;LYMPH NODE#0.9631;TRANSCRIPTION FACTOR#0.9628;REVERSE TRANSCRIPTION#0.9627;FACTOR V LEIDEN#0.9620;HEART DISEASE#0.9617;PROTEIN KINASE#0.9613;ARACHIDONIC ACID#0.9613;FIBRINOLYSIS#0.9612;IMMUNE RESPONSE#0.9609;ALANINE#0.9608;ADIPOCYTE#0.9608;ENDOTHELIUM#0.9604;ASPIRIN#0.9602;MYELOID CELL#0.9601;CELL PROLIFERATION#0.9601;RECEPTOR ANTAGONIST#0.9600;BONE MARROW#0.9599;MUTAGENESIS#0.9599;ENDOPLASMIC RETICULUM#0.9598;TISSUE DAMAGE#0.9597;MYOCARDIAL INFARCTION#0.9596;GENE EXPRESSION#0.9595;RESPONSE TO LPS#0.9593;STROMA#0.9585;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.9585;APROTININ#0.9584;IMMUNE CELL#0.9583;SIGNALING PATHWAY#0.9582;APOPTOTIC#0.9575;PROTHROMBIN COMPLEX CONCENTRATE#0.9575;LOW MOLECULAR WEIGHT HEPARIN#0.9574;THROMBOSIS#0.9574;HEMORRHAGE#0.9571;SIGNALLING PATHWAY#0.9567;INDUCIBLE NITRIC OXIDE#0.9567;HEMORRHAGIC#0.9564;EXTRACELLULAR MATRIX#0.9561;TRANSCRIPTASE#0.9560;HEPARIN#0.9559;LIVER DISEASE#0.9559;RAPAMYCIN#0.9558;KINASE INHIBITOR#0.9558;ARTERY#0.9553;PERIPHERAL MONOCYTE#0.9551;POLYMERASE CHAIN REACTION#0.9548;VASCULAR DISEASE#0.9544;HYPERTENSION#0.9544;CYTOTOXICITY#0.9541;ACTINOMYCIN D#0.9541;IMMUNE SYSTEM#0.9541;ARGATROBAN#0.9540;ANEMIA#0.9540;ACTIVATED T CELL#0.9540;CORONARY ATHEROSCLEROTIC PLAQUE#0.9533;ELECTROPHORETIC MOBILITY SHIFT#0.9529;KIDNEY DISEASE#0.9527;ATHEROSCLEROSIS#0.9518;BLOOD LOSS#0.9518;LYSINE#0.9516;DOXORUBICIN#0.9515;FONDAPARINUX#0.9515;HYPOXIA INDUCIBLE FACTOR#0.9512;CORONARY THROMBOSIS#0.9510;MESANGIAL CELL#0.9505;INFLAMMATORY RESPONSE#0.9502;ACTIVATED T-CELLS#0.9502;THROMBOCYTOPENIA#0.9494;PANCREATITIS#0.9493;ENDOCARDITIS#0.9487;TOXICITY#0.9484;HYPERCHOLESTEROLEMIA#0.9483;MULTIPLE ORGAN DYSFUNCTION#0.9472;CARDIOVASCULAR RISK FACTOR#0.9464;HEPATOCELLULAR CARCINOMA#0.9463;CANCER STEM CELL#0.9460;HEPARIN BINDING#0.9458;ENZYME COMPLEX#0.9453;RNA INTERFERENCE#0.9449;COENZYME A#0.9448;INFLAMMATORY BOWEL DISEASE#0.9438;ACUTE LEUKEMIA#0.9437;INTENSIVE CARE UNIT#0.9430;ENDOTHELIAL MICROPARTICLE#0.9430;ECLAMPSIA#0.9423;GLYCOSYLATION#0.9422;HEPARIN INDUCED THROMBOCYTOPENIA#0.9398;WHITE BLOOD CELL#0.9395;REGULATION OF COAGULATION#0.9386;VITAMIN K ANTAGONIST#0.9385;INNATE IMMUNITY#0.9385;SERUM AMYLOID A#0.9371;CHEMOTAXIS#0.9364;CHRONIC KIDNEY DISEASE#0.9361;PNEUMONIA#0.9341;PLATELET LEUKOCYTE AGGREGATES#0.9335;NEUTROPHIL ACTIVATION#0.9335;KUPFFER CELL#0.9329;T CELL ACTIVATION#0.9328;LIVER CIRRHOSIS#0.9322;CYCLIC AMP#0.9320;RHEUMATOID ARTHRITIS#0.9318;PHOSPHOLIPID BINDING#0.9317;ATORVASTATIN#0.9316;MARKERS OF INFLAMMATION#0.9302;VIRAL INFECTION#0.9300;FIBROSARCOMA#0.9296;RESPONSE TO ENDOTOXIN#0.9295;IFN-GAMMA#0.9292;LUNG DISEASE#0.9287;BASEMENT MEMBRANE#0.9284;CYTOPLASM#0.9280;STEM CELL TRANSPLANTATION#0.9273;COLITIS#0.9270;ARTERIOLE#0.9265;TUBE FORMATION#0.9262;COLON CARCINOMA#0.9261;NERVOUS SYSTEM#0.9259;ADVENTITIA#0.9252;ISCHEMIC HEART DISEASE#0.9246;MALARIA#0.9212;INSULIN-LIKE GROWTH FACTOR#0.9205;RECEPTOR AGONIST#0.9203;HUMAN PANCREATIC CANCER#0.9202;POINT OF CARE#0.9200;SCAVENGER RECEPTOR#0.9197;C-LEVEL#0.9189;OVARIAN CARCINOMA#0.9183;HEMOLYTIC UREMIC SYNDROME#0.9173;DECIDUALIZATION#0.9168;PROTEOGLYCAN#0.9166;HEMOLYSIS#0.9159;NF-KAPPAB ACTIVATION#0.9152;PENTOXIFYLLINE#0.9144;DIGESTION#0.9140;MYOCARDIUM#0.9126;HEALTHY CONTROL SUBJECTS#0.9108;PERICYTE#0.9095;VASCULITIS#0.9094;SICKLE CELL ANEMIA#0.9080;TRANSMISSION ELECTRON MICROSCOPY#0.9078;HIGH MOBILITY GROUP#0.9074;LUNG METASTASIS#0.9073;CARDIOMYOCYTE#0.9070;NECROTIC#0.9061;LINES OF EVIDENCE#0.9051;IMMUNOGLOBULIN G#0.9047;CENTRAL NERVOUS SYSTEM#0.9043;EXOSOME#0.9031;CEREBRAL INFARCTION#0.9028;SCANNING ELECTRON MICROSCOPY#0.9002;TRAUMATIC BRAIN INJURY#0.8994;LECTIN#0.8990;HERPES SIMPLEX#0.8990;PHOSPHOLIPASE A2#0.8976;CLEAR CELL CARCINOMA#0.8968;MRNA TRANSCRIPTION#0.8962;CELL CYCLE#0.8958;BREAST CARCINOMA#0.8956;CORD BLOOD#0.8953;PLASMINOGEN ACTIVATOR ACTIVITY#0.8952;TRYPTOPHAN#0.8944;MESENCHYMAL STEM CELL#0.8944;GESTATION#0.8941;PORTAL VEIN#0.8936;CLINICAL ISLET TRANSPLANTATION#0.8918;PLASMINOGEN ACTIVATION#0.8912;MICROPARTICLE GENERATION#0.8893;BLOOD CIRCULATION#0.8877;ACTIVATION OF NF-KAPPAB#0.8874;ENDOTHELIAL PROGENITOR CELL#0.8843;ULCERATIVE COLITIS#0.8833;CEREBRAL ISCHEMIA#0.8828;MONOCYTIC LEUKEMIA#0.8825;COLLAGENASE#0.8819;MEDROXYPROGESTERONE ACETATE#0.8816;MULTIPLE MYELOMA#0.8807;MICROPARTICLE RELEASE#0.8777;PANCREATIC ADENOCARCINOMA#0.8775;METHIONINE#0.8768;TRANEXAMIC ACID#0.8767;BLOOD PLATELETS#0.8767;TUMOR SUPPRESSOR#0.8764;MAGNETIC RESONANCE IMAGING#0.8763;MACROPHAGE ACTIVATION#0.8751;CROHN'S DISEASE#0.8749;ENDOCYTOSIS#0.8741;HERPES SIMPLEX VIRUS#0.8731;PEROXISOME#0.8729;VERY-LOW-DENSITY LIPOPROTEIN#0.8727;MOLAR#0.8712;TUMOR ASSOCIATED MACROPHAGE#0.8707;MAST CELL#0.8701;FOLIC ACID#0.8696;CELLULAR COMPONENT#0.8686;TOPICAL#0.8683;REGULATION OF BLOOD COAGULATION#0.8683;QUANTITATIVE REVERSE TRANSCRIPTION#0.8682;CISPLATIN#0.8675;SEMEN#0.8672;CELLULAR LOCALIZATION#0.8666;FIBRILLAR COLLAGEN#0.8659;BREAST CANCER PATIENTS#0.8658;CELLULAR ADHESION MOLECULE#0.8657;SERUM ALBUMIN#0.8655;ACUTE CORONARY EVENTS#0.8645;OUTER MEMBRANE#0.8640;PANCREATIC ISLET#0.8630;TUMOR ENDOTHELIAL CELL#0.8625;EPINEPHRINE#0.8624;AUTOIMMUNE DISEASE#0.8623;VENOUS THROMBOEMBOLIC EVENTS#0.8622;INNATE IMMUNE RESPONSE#0.8606;IDIOPATHIC PULMONARY FIBROSIS#0.8602;HIGH FAT DIET#0.8595;EDEMA#0.8574;INTIMA MEDIA THICKNESS#0.8573;NEPHROTIC SYNDROME#0.8570;KERATINOCYTE#0.8563;JUGULAR VEIN#0.8560;GENISTEIN#0.8560;DIABETIC RETINOPATHY#0.8548;VASOCONSTRICTION#0.8546;SMOOTH MUSCLE CELL MIGRATION#0.8546;HEMATOPOIETIC STEM CELL#0.8544;MUSCLE CELL MIGRATION#0.8543;COMPLEMENT CASCADE#0.8530;CELL WALL#0.8524;FLUVASTATIN#0.8512;ENDOMETRIOSIS#0.8508;INTRACELLULAR SIGNALING PATHWAY#0.8505;HISTAMINE#0.8503;RESPONSE TO LIPOPOLYSACCHARIDE#0.8502;ACETYLSALICYLIC ACID#0.8498;ENDOTHELIAL CELL DYSFUNCTION#0.8496;AIRWAY EPITHELIAL CELL#0.8475;MODE OF ACTION#0.8474;AORTIC VALVE#0.8469;ENZYME INHIBITOR#0.8466;FIBROSARCOMA CELLS#0.8442;LIPID METABOLISM#0.8432;POST-TRANSLATIONAL MODIFICATION#0.8422;BETA CELL#0.8420;OXYGENASE#0.8412;SENESCENCE#0.8407;MRNA SYNTHESIS#0.8391;PROTEASE ACTIVITY#0.8385;EXCRETION#0.8378;FLUORESCEIN#0.8356;DEXAMETHASONE#0.8342;GLIOBLASTOMA MULTIFORME#0.8337;ANTICOAGULANT PROTEIN C#0.8337;ASTROCYTE#0.8334;CELLULAR MEMBRANE#0.8327;ANGIOGENIC GROWTH FACTORS#0.8326;ACE INHIBITOR#0.8320;LUTEAL PHASE#0.8318;PROSTAGLANDIN E2#0.8316;HYPERHOMOCYSTEINEMIA#0.8315;NOVOSEVEN#0.8307;VENTRICULAR ASSIST DEVICE#0.8302;XANTHINE#0.8287;HEAT SHOCK PROTEIN#0.8281;DECIDUA#0.8270;SQUAMOUS CELL CARCINOMA#0.8270;ENDOTHELIN RECEPTOR#0.8269;FOAM CELL FORMATION#0.8251;PANCREATIC DUCTAL ADENOCARCINOMA#0.8246;ANTECUBITAL VEIN#0.8239;INTERSTITIAL LUNG DISEASE#0.8231;HEMOLYTIC ANEMIA#0.8219;ZYMOGEN ACTIVATION#0.8218;HEPATIC SINUSOIDS#0.8208;BACTERIAL ENDOCARDITIS#0.8200;ALVEOLAR EPITHELIAL CELL#0.8196;CAVEOLAE#0.8183;LPS BINDING#0.8177;MACROPHAGE INFLAMMATORY PROTEIN#0.8171;APIXABAN#0.8170;CELLULAR IMMUNE RESPONSE#0.8166;ABCIXIMAB#0.8164;STREPTOZOTOCIN#0.8161;HYPERSENSITIVITY#0.8161;ALKALINE PHOSPHATASE#0.8137;MEMBRANE ATTACK COMPLEX#0.8130;BIVALIRUDIN#0.8108;LUNG EPITHELIAL CELL#0.8072;TUMOR TISSUES#0.8071;PRAVASTATIN#0.8056;BLAST CELL#0.8054;ROS GENERATION#0.8039;MAPK SIGNALING#0.8032;TYPE 1 DIABETES#0.8015;NUCLEIC ACID#0.7994;SIGNALING CASCADE#0.7990;FEMORAL VEIN#0.7983;CERVICAL#0.7971;ENZYME ACTIVITY#0.7966;MEDROXYPROGESTERONE#0.7961;XANTHINE OXIDASE#0.7957;TUBERCULOSIS#0.7957;PANCREATIC CARCINOMA#0.7941;NITRO-L-ARGININE#0.7937;ANCHORING#0.7926;ESSENTIAL THROMBOCYTHEMIA#0.7921;AORTIC ANEURYSM#0.7910;HIGH CHOLESTEROL DIET#0.7905;TRANSACTIVATION#0.7896;CD4+ T CELL#0.7891;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7878;NEUROBLASTOMA#0.7875;COAGULATION FACTOR IX#0.7870;TUBULAR EPITHELIAL CELL#0.7859;IL-6 PRODUCTION#0.7858;TNF-ALPHA SECRETION#0.7842;EXTRACELLULAR REGION#0.7821;WEIGHT LOSS#0.7821;SMOOTH MUSCLE CELL PROLIFERATION#0.7821;MUSCLE CELL PROLIFERATION#0.7818;GLUTATHIONE PEROXIDASE#0.7810;ADP RECEPTOR#0.7809;NCX 4016#0.7806;TO THE PROGRESSION#0.7801;MEGAKARYOCYTE#0.7787;XIMELAGATRAN#0.7780;DRUG ELUTING STENT#0.7766;SIGNALING MOLECULE#0.7749;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7746;MYELOID LEUKEMIA#0.7740;FOCAL CEREBRAL ISCHEMIA#0.7738;VENULE#0.7733;MYOFIBROBLAST#0.7731;CHLAMYDIA#0.7724;COLLAGEN TYPE I#0.7724;ROSUVASTATIN#0.7719;BINDING PROTEIN 1#0.7714;AKT SIGNALING#0.7691;HEPATOMA CELLS#0.7680;72-HOURS#0.7680;PURPURA#0.7679;CD8+ T CELL#0.7676;UTERUS#0.7673;HEPATOCYTE GROWTH FACTOR#0.7667;GENE SILENCING#0.7667;STAUROSPORINE#0.7664;ACUTE ISCHEMIC STROKE#0.7624;AUTOPHAGY#0.7619;DALTEPARIN#0.7605;REGENERATION#0.7604;MACULAR DEGENERATION#0.7597;PROTEINASE ACTIVATED RECEPTOR#0.7591;ETHANOL#0.7587;LUNG CARCINOMA#0.7578;MECHANISMS OF ACTION#0.7575;NATURAL KILLER CELL#0.7568;TARGET OF RAPAMYCIN#0.7560;ENDOTHELIAL CELL PROLIFERATION#0.7557;VASOCONSTRICTOR#0.7545;CELECOXIB#0.7543;URTICARIA#0.7527;GRANULOCYTE COLONY STIMULATING FACTOR#0.7514;FORSKOLIN#0.7513;TROPHOBLAST CELL#0.7512;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7491;TOTAL KNEE ARTHROPLASTY#0.7474;BULLOUS PEMPHIGOID#0.7461;ACUTE MONOCYTIC LEUKEMIA#0.7460;LYMPH NODE METASTASIS#0.7457;LEPIRUDIN#0.7441;ESTROGEN RECEPTOR#0.7436;FLOW MEDIATED DILATATION#0.7435;SERPIN#0.7429;INJURY SEVERITY SCORE#0.7421;PHAGOCYTOSIS#0.7416;FLOW CYTOMETRY ANALYSIS#0.7402;MIDDLE CEREBRAL ARTERY#0.7387;PROTEIN TYROSINE KINASE#0.7385;CEREBRAL ARTERY#0.7385;C TERMINAL DOMAIN#0.7383;ABDOMINAL AORTIC ANEURYSM#0.7363;BLOOD VESSEL DEVELOPMENT#0.7359;HUMAN IMMUNODEFICIENCY VIRUS#0.7358;LEFT ATRIAL APPENDAGE#0.7358;MELANOMA CELL LINES#0.7344;FACTOR XI DEFICIENCY#0.7311;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7309;SYNCYTIOTROPHOBLAST#0.7285;FENOFIBRATE#0.7273;UREMIC TOXIN#0.7271;THROMBOTIC THROMBOCYTOPENIC PURPURA#0.7240;FACTOR D#0.7233;METFORMIN#0.7209;PROTEINURIA#0.7205;TISSUE GROWTH FACTOR#0.7190;PROSTATE SPECIFIC ANTIGEN#0.7178;CARDIOVASCULAR SYSTEM#0.7178;INNATE IMMUNE SYSTEM#0.7174;DUCT CELL#0.7167;CYTOKINE SECRETION#0.7166;QUERCETIN#0.7164;SPHINGOSINE#0.7161;PHOSPHODIESTERASE#0.7158;SMALL INTESTINE#0.7138;TIGHT JUNCTION#0.7132;CELL DIFFERENTIATION#0.7129;FACTOR IIA#0.7128;THYMIDINE#0.7127;NEPHROPATHY#0.7124;BRONCHIAL EPITHELIAL CELLS#0.7118;TINZAPARIN#0.7113;MYOCARDITIS#0.7112;ACUTE INFLAMMATORY RESPONSE#0.7108;NEPHRITIS#0.7103;RESVERATROL#0.7102;MESENCHYMAL CELL#0.7087;CIRCULATING TUMOR CELL#0.7082;LARGE ARTERIES#0.7045;REGULATION OF HEMOSTASIS#0.7022;MITOGENIC ACTIVITY#0.7009;RESPONSE TO TNF#0.7005;KINASE ACTIVITY#0.6997;BLEOMYCIN#0.6996;THALASSEMIA#0.6995;REACTIVE OXYGEN SPECIES GENERATION#0.6990;SPINAL CORD#0.6990;ENDOTHELIAL CELL MIGRATION#0.6988;NEOPLASTIC DISEASE#0.6982;MALIGNANT GLIOMA#0.6975;PERIPHERAL BLOOD CELLS#0.6972;THORACIC AORTA#0.6967;EPITHELIAL OVARIAN CANCER#0.6967;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6959;CYTOTROPHOBLAST#0.6957;MACROPHAGE MIGRATION#0.6952;RETINOL BINDING#0.6951;POSTTRANSLATIONAL MODIFICATION#0.6939;NEGATIVE PREDICTIVE VALUE#0.6936;N-ACETYLCYSTEINE#0.6934;MENSTRUATION#0.6927;TYPE 2 DIABETIC#0.6916;CAROTID STENOSIS#0.6913;CARDIOLIPIN#0.6903;PERITONEAL MESOTHELIAL CELLS#0.6902;UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR#0.6890;GROWTH HORMONE#0.6889;MRNA SPLICING#0.6884;PHOSPHATIDYLETHANOLAMINE#0.6877;NF KAPPAB BINDING#0.6858;MEMBRANE FRACTION#0.6844;TO TUMOR PROGRESSION#0.6841;M1 MACROPHAGE#0.6828;ECULIZUMAB#0.6828;TPA ACTIVITY#0.6813;TISSUE REMODELING#0.6809;BACTERIAL SEPSIS#0.6803;MAPK ACTIVATION#0.6802;CHRONIC LIVER DISEASE#0.6795;PROTEIN KINASE B#0.6778;NICOTINAMIDE#0.6771;SYSTOLIC BLOOD PRESSURE#0.6761;PROTEIN PROTEIN INTERACTION#0.6760;SIGNAL TRANSDUCER#0.6759;ARTERIOSCLEROSIS#0.6752;ENDOPLASMIC RETICULUM STRESS#0.6751;GRAFT VERSUS HOST#0.6750;ENDOTHELIAL CELL APOPTOSIS#0.6747;FK-506#0.6719;SUBSTANCE P#0.6707;CERIVASTATIN#0.6706;ALPHA-2 MACROGLOBULIN#0.6703;SULFATIDE#0.6696;CYCLOSPORIN A#0.6689;MEMBRANE MICRODOMAIN#0.6687;ACETIC ACID#0.6682;INFLAMMATORY MONOCYTE#0.6673;LOSARTAN#0.6660;ILOPROST#0.6660;LARYNGEAL CARCINOMA#0.6654;CERVICAL CANCER#0.6653;INDUCTION OF APOPTOSIS#0.6644;HISTIDINE#0.6644;ACUTE MYELOID LEUKEMIA#0.6643;DIPYRIDAMOLE#0.6638;CAROTID ARTERY THROMBOSIS#0.6626;TESTOSTERONE#0.6625;GROWTH FACTOR BINDING#0.6622;CONJUGATION#0.6599;BONE MORPHOGENETIC PROTEIN#0.6592;FIBRIL#0.6591;UMBILICAL ARTERY#0.6588;LINEAR REGRESSION ANALYSIS#0.6575;HEPATOTOXICITY#0.6567;CHRONIC HEART FAILURE#0.6560;POLYMORPHONUCLEAR NEUTROPHIL#0.6546;CALCIUM MOBILIZATION#0.6543;LYMPHOID CELL#0.6498;FLUID SHEAR STRESS#0.6495;POTASSIUM CHANNEL#0.6491;VASODILATOR#0.6484;ARTERIOVENOUS MALFORMATION#0.6483;RESPONSE TO TREATMENT#0.6483;TICAGRELOR#0.6482;TNF SECRETION#0.6477;ADENINE#0.6471;SKELETAL MUSCLE#0.6452;ASTROCYTOMA#0.6441;POLYCYTHEMIA VERA#0.6431;PROTEIN SECRETION#0.6410;RECEPTOR LIGAND#0.6378;CREATINE KINASE#0.6374;MOLECULAR DYNAMICS SIMULATION#0.6374;GLUTAMIC ACID#0.6368;RANDOMIZED CONTROLLED TRIAL#0.6358;GALECTIN#0.6353;EOSIN#0.6333;NF-KAPPAB INHIBITOR#0.6331;PNEUMONIC PASTEURELLOSIS#0.6305;REGULATION OF ANGIOGENESIS#0.6304;FIBRINOGEN BINDING#0.6303;PHOSPHATE BUFFERED SALINE#0.6282;ACTIVATION OF HEMOSTASIS#0.6276;PROTEIN TARGETING#0.6256;COMMON CAROTID ARTERY#0.6247;GLUCOSE REGULATED PROTEIN#0.6245;YOLK SAC#0.6240;SEMINAL PLASMA#0.6236;NORPLANT#0.6233;INFLAMMATORY CELL INFILTRATION#0.6232;PLATELET ACTIVATION MARKERS#0.6231;PERITONEAL CAVITY#0.6229;AGE RELATED MACULAR DEGENERATION#0.6218;SEVERE ACUTE PANCREATITIS#0.6218;INTERLEUKIN 1 RECEPTOR#0.6217;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6213;BUSULFAN#0.6210;HEME OXYGENASE 1#0.6197;AS MYOCARDIAL INFARCTION#0.6189;CASPASE-3 ACTIVITY#0.6186;G-CSF#0.6183;DX-88#0.6180;MEDULLOBLASTOMA#0.6177;HEPATITIS C#0.6171;BLOOD PLATELET AGGREGATION#0.6145;EMBRYONIC STEM CELL#0.6131;SYNOVIUM#0.6128;MIGRATION INHIBITORY FACTOR#0.6121;PERIPHERAL ARTERIAL DISEASE#0.6119;DELAYED-TYPE HYPERSENSITIVITY#0.6116;ARRHYTHMIA#0.6107;CRYSTALLOID#0.6099;METASTATIC MELANOMA#0.6096;ADENOSINE TRIPHOSPHATE#0.6093;DRUG DELIVERY SYSTEM#0.6089;ANCROD#0.6079;HIGH RISK PATIENTS#0.6070;BILE DUCT#0.6056;PEPTIDOGLYCAN#0.6051;ADVANCED PANCREATIC CANCER#0.6045;STRUCTURE ACTIVITY RELATIONSHIP#0.6043;PLASMIN ACTIVITY#0.6037;INSULIN SECRETION#0.6034;TYROSINE KINASE INHIBITOR#0.6030;CYCLOSPORIN#0.6026;OVARIAN HYPERSTIMULATION SYNDROME#0.6015;CREATINE#0.6001
2153	FACTOR V DEFICIENCY#1.0476;TETRAHYDROFOLATE#1.0435;ANGIOTENSIN CONVERTING ENZYME#1.0357;CENTRAL RETINAL VEIN OCCLUSION#1.0303;FACTOR V LEIDEN#1.0289;ANTITHROMBIN III DEFICIENCY#1.0278;HELLP SYNDROME#1.0245;CENTRAL RETINAL VEIN#1.0238;BREAST CANCER#1.0234;BUDD-CHIARI SYNDROME#1.0204;ARTERIAL ISCHEMIC STROKE#1.0198;SICKLE CELL DISEASE#1.0181;PROTEIN C DEFICIENCY#1.0181;RETINAL VEIN OCCLUSION#1.0159;CARDIOLIPIN#1.0158;MESENTERIC VEIN#1.0154;OSTEONECROSIS#1.0148;PURPURA FULMINANS#1.0139;PROTEIN S DEFICIENCY#1.0128;ANTIPHOSPHOLIPID SYNDROME#1.0047;PLACENTAL ABRUPTION#1.0035;HYPERHOMOCYSTEINEMIA#1.0030;CENTRAL VENOUS CATHETER#1.0018;RECURRENT PREGNANCY LOSS#1.0017;INFLAMMATORY BOWEL DISEASE#1.0015;FETAL GROWTH RESTRICTION#1.0013;CEREBRAL INFARCTION#1.0010;PRE-ECLAMPSIA#1.0007;ACTIVATED PROTEIN C#0.9998;FACTOR VIII#0.9997;LEGG-CALVE-PERTHES DISEASE#0.9991;PORTAL VEIN THROMBOSIS#0.9969;BLOOD COAGULATION#0.9968;FRAGMENT LENGTH POLYMORPHISM#0.9968;ECLAMPSIA#0.9915;COAGULATION#0.9899;FIBRINOGEN#0.9896;VENA CAVA#0.9888;ACUTE MYOCARDIAL INFARCTION#0.9886;CORONARY ARTERY DISEASE#0.9884;RENAL VEIN#0.9884;CORONARY ARTERY#0.9873;VASCULAR DISEASE#0.9870;ADVERSE PREGNANCY OUTCOME#0.9865;FORAMEN OVALE#0.9854;ARTERY DISEASE#0.9852;HEPARIN INDUCED THROMBOCYTOPENIA#0.9849;PORTAL VEIN#0.9827;ADJUSTED ODDS RATIO#0.9818;SPONTANEOUS ABORTION#0.9813;ATRIAL FIBRILLATION#0.9813;POLYMERASE CHAIN REACTION#0.9812;MYOCARDIAL INFARCTION#0.9805;THROMBOCYTOPENIA#0.9804;POSITIVE FAMILY HISTORY#0.9802;CEREBRAL PALSY#0.9801;PURPURA#0.9800;HEART DISEASE#0.9787;CEREBROVASCULAR DISEASE#0.9773;CARDIOVASCULAR RISK FACTOR#0.9771;MIGRAINE#0.9771;HEMORRHAGE#0.9762;HEPATIC VEIN#0.9761;VENOUS THROMBOEMBOLIC EVENTS#0.9760;NITRIC OXIDE#0.9756;THROMBOPHILIA#0.9755;WARFARIN#0.9755;THROMBOSIS#0.9742;PATENT FORAMEN OVALE#0.9731;CLOTTING#0.9731;DIGESTION#0.9729;ASPIRIN#0.9725;ARTERY#0.9716;VITAMIN B12#0.9706;DIABETES MELLITUS#0.9701;FIBRINOLYSIS#0.9696;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9688;LUPUS ERYTHEMATOSUS#0.9686;ISCHEMIA#0.9684;FOLATE#0.9677;PULMONARY EMBOLISM#0.9676;ACTIVATION OF COAGULATION#0.9674;GESTATION#0.9672;THROMBOPLASTIN#0.9671;HEMOPHILIA#0.9669;VITAMIN K#0.9663;EMBOLISM#0.9662;FACTOR XA#0.9649;COLITIS#0.9639;HEMOSTASIS#0.9638;HYPERTENSION#0.9632;ATHEROSCLEROSIS#0.9627;LOW MOLECULAR WEIGHT HEPARIN#0.9627;HEMORRHAGIC#0.9608;PERIPHERAL BLOOD#0.9601;ULCERATIVE COLITIS#0.9576;HEPARIN#0.9570;NEPHROTIC SYNDROME#0.9560;RETINAL ARTERY OCCLUSION#0.9557;VENOUS BLOOD#0.9524;INTERNATIONAL NORMALIZED RATIO#0.9520;BLOOD CLOTTING#0.9500;MAGNETIC RESONANCE IMAGING#0.9498;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9497;C-LEVEL#0.9473;BONE MARROW#0.9460;NUCLEIC ACID#0.9458;ENDOTHELIAL CELL#0.9414;HEALTHY CONTROL SUBJECTS#0.9407;HOMOCYSTINURIA#0.9407;ANTICOAGULANT ACTIVITY#0.9392;VARICOSE VEINS#0.9391;POLYCYTHEMIA#0.9391;CORONARY HEART DISEASE#0.9378;HEARING LOSS#0.9367;ENOXAPARIN#0.9365;C REACTIVE PROTEIN#0.9358;FACTOR I#0.9350;CEREBRAL ISCHEMIA#0.9341;CYSTIC FIBROSIS#0.9339;TRANSIENT ISCHEMIC ATTACK#0.9331;VASCULAR RISK FACTORS#0.9329;MYELOPROLIFERATIVE NEOPLASM#0.9318;RIVAROXABAN#0.9303;OVARIAN#0.9291;CYSTATHIONINE BETA SYNTHASE#0.9281;MICROPARTICLE#0.9243;ENDOTHELIAL NITRIC OXIDE#0.9196;NITRIC OXIDE SYNTHASE#0.9190;LIVER DISEASE#0.9183;PLACENTAL INFARCTION#0.9136;EMBRYO IMPLANTATION#0.9120;RETINAL VASCULAR OCCLUSION#0.9119;LEUKOCYTE#0.9104;ANEMIA#0.9099;PROGESTIN#0.9093;BETA-2#0.9093;ENDOGENOUS THROMBIN POTENTIAL#0.9079;VASCULITIS#0.9073;POLYCYTHEMIA VERA#0.9070;ARGININE#0.9068;SUBCLAVIAN VEIN#0.9059;CROHN'S DISEASE#0.9051;PORTAL HYPERTENSION#0.9044;SEVERE PRE-ECLAMPSIA#0.9041;INFERTILITY#0.9013;BLOOD LOSS#0.8993;DESOGESTREL#0.8970;VENOUS SYSTEM#0.8940;PLASMA PROTEIN#0.8933;FOLIC ACID#0.8921;OBESE#0.8883;OVARIAN HYPERSTIMULATION SYNDROME#0.8860;TAMOXIFEN#0.8857;THALASSEMIA#0.8843;HEPATITIS C#0.8832;LATE PREGNANCY#0.8825;GENETIC DISORDER#0.8769;CAROTID ARTERY#0.8754;ABDOMINAL PAIN#0.8747;ESSENTIAL THROMBOCYTHEMIA#0.8743;HEPATOCELLULAR CARCINOMA#0.8721;ATHEROSCLEROTIC#0.8703;BLOOD CLOT#0.8665;GENE EXPRESSION#0.8621;CEREBRAL ARTERY#0.8565;INTERNAL JUGULAR VEIN#0.8533;LIVE BIRTH RATE#0.8513;GLUTAMINE#0.8513;EDEMA#0.8508;PULMONARY ARTERY#0.8508;JUGULAR VEIN#0.8504;ADJUSTED HAZARD RATIO#0.8499;GROWTH FACTOR#0.8488;CORONARY ARTERY BYPASS#0.8479;POSITIVE PREDICTIVE VALUE#0.8472;RESONANCE ENERGY TRANSFER#0.8467;OF ANTICOAGULATION THERAPY#0.8426;EARLY PREGNANCY LOSS#0.8410;PERIPHERAL VASCULAR DISEASE#0.8386;SWELLING#0.8342;PULMONARY HYPERTENSION#0.8341;HEPATIC ARTERY#0.8340;CENTRAL NERVOUS SYSTEM#0.8288;NERVOUS SYSTEM#0.8277;SENSORINEURAL HEARING LOSS#0.8264;PLATELET ACTIVATION#0.8261;COMPLETE BLOOD COUNT#0.8244;SICKLE CELL ANEMIA#0.8168;TUMOUR NECROSIS FACTOR#0.8113;POST-THROMBOTIC SYNDROME#0.8076;TESTOSTERONE#0.8054;ENDOTHELIUM#0.8054;FERTILIZATION#0.8043;DISSEMINATED INTRAVASCULAR COAGULATION#0.8007;FACTOR XIIIA#0.7978;TYPE 2 DIABETES#0.7956;LEVONORGESTREL#0.7943;RENAL ARTERY#0.7902;PLATELET AGGREGATION#0.7897;IMMUNOGLOBULIN G#0.7874;THROMBOPHLEBITIS#0.7839;LYSIS#0.7829;HIGH RISK PATIENTS#0.7813;HODGKIN'S LYMPHOMA#0.7796;CORONARY THROMBOSIS#0.7786;PERIPARTUM CARDIOMYOPATHY#0.7738;HEMOLYSIS#0.7729;LOW DOSE ASPIRIN#0.7726;ESTRADIOL#0.7726;FEMORAL VEIN#0.7712;LIPID METABOLISM#0.7708;GUANINE#0.7702;HEMIPLEGIA#0.7670;COLORECTAL CANCER#0.7644;HOMOCYSTEINE METABOLISM#0.7635;ISCHEMIC HEART DISEASE#0.7632;BETA THALASSEMIA#0.7628;VITAMIN K ANTAGONIST#0.7623;INTENSIVE CARE UNIT#0.7610;AUTOIMMUNE DISEASE#0.7571;ACTIVATED FACTOR X#0.7568;MIGRAINE WITH AURA#0.7551;VON WILLEBRAND DISEASE#0.7525;MEGAKARYOCYTE#0.7440;ESTROGEN RECEPTOR#0.7434;RANDOMIZED CONTROLLED TRIAL#0.7390;T- PA#0.7357;LOW DENSITY LIPOPROTEIN#0.7346;SELECTIN#0.7331;MULTIPLE ENDOCRINE NEOPLASIA#0.7330;FABRY DISEASE#0.7291;PHOSPHOLIPID BINDING#0.7274;ESTROGENS#0.7241;LOW BIRTH WEIGHT#0.7238;METHIONINE#0.7222;ISCHEMIC COLITIS#0.7213;NEGATIVE PREDICTIVE VALUE#0.7194;LIVER CIRRHOSIS#0.7188;THROMBIN GENERATION ASSAY#0.7133;ORTHOTOPIC LIVER TRANSPLANTATION#0.7126;FACTOR VIII DEFICIENCY#0.7109;DABIGATRAN#0.7098;INTRACRANIAL HYPERTENSION#0.7095;ADENOCARCINOMA#0.7082;CARDIOMYOPATHY#0.7081;POPULATION ATTRIBUTABLE RISK#0.7074;NEPHROPATHY#0.7042;KIDNEY TRANSPLANT RECIPIENTS#0.7036;PERIPHERAL ARTERIAL DISEASE#0.7030;COUMADIN#0.7026;HARDY WEINBERG EQUILIBRIUM#0.6990;MUTAGENESIS#0.6956;PREMATURITY#0.6953;TRADITIONAL RISK FACTORS#0.6948;CAROTID STENOSIS#0.6944;MIDDLE CEREBRAL ARTERY#0.6944;MELTING CURVE ANALYSIS#0.6927;CHRONIC HEPATITIS C#0.6887;NEUROPATHY#0.6885;CORD BLOOD#0.6871;RENAL TRANSPLANT RECIPIENTS#0.6849;GLOMERULONEPHRITIS#0.6808;DIRECT THROMBIN INHIBITOR#0.6789;GESTODENE#0.6788;RIGHT ATRIUM#0.6772;MEMBRANOUS GLOMERULONEPHRITIS#0.6758;BLOOD VESSEL#0.6744;FETAL GROWTH RETARDATION#0.6712;ENDOCARDITIS#0.6703;ACUTE CORONARY SYNDROME#0.6690;THROMBOCYTOSIS#0.6658;HIGH DENSITY LIPOPROTEIN#0.6638;TUMOR NECROSIS FACTOR#0.6616;LIPOPROTEIN LIPASE#0.6613;INFERTILE#0.6606;DYSPNEA#0.6581;METASTATIC BREAST CANCER#0.6564;MAGNETIC RESONANCE ANGIOGRAPHY#0.6534;RESPIRATORY DISTRESS#0.6518;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.6511;WHITE BLOOD CELL#0.6511;THROMBIN GENERATION TEST#0.6507;AMAUROSIS#0.6507;ANTERIOR ISCHEMIC OPTIC NEUROPATHY#0.6497;ORAL ANTICOAGULATION THERAPY#0.6433;PHOSPHATIDYLSERINE#0.6404;VENOUS INSUFFICIENCY#0.6396;DEHYDRATION#0.6383;COLORECTAL#0.6335;CENTRAL RETINAL ARTERY OCCLUSION#0.6320;MENOPAUSE#0.6293;SEQUENCE SPECIFIC PRIMER#0.6289;HEALTHY CONTROL GROUP#0.6273;CONGENITAL HEART DISEASE#0.6271;PROGESTERONE#0.6222;MANNOSE BINDING#0.6222;NECROTIC#0.6207;HEPATITIS C VIRUS#0.6203;EPIDERMAL GROWTH FACTOR#0.6171;MITRAL VALVE#0.6165;MONOCYTE#0.6162;FLUORESCEIN#0.6157;CARRIE#0.6136;ADENINE#0.6116;MULTIPLE LOGISTIC REGRESSION#0.6106;TRANSIENT ISCHAEMIC ATTACK#0.6092;MORBID OBESITY#0.6038;CHRONIC VENOUS INSUFFICIENCY#0.6030;DEMENTIA#0.6004
2155	FACTOR X DEFICIENCY#1.0574;FACTOR VII DEFICIENCY#1.0410;VITAMIN K1#1.0371;RECOMBINANT ACTIVATED FACTOR#1.0356;GLANZMANN'S THROMBASTHENIA#1.0327;NOVOSEVEN#1.0327;FACTOR V DEFICIENCY#1.0312;FACTOR VIII DEFICIENCY#1.0288;FACTOR XI DEFICIENCY#1.0287;RARE BLEEDING DISORDERS#1.0277;STUART FACTOR#1.0266;PHOSPHOLIPASE C#1.0256;PROTHROMBIN COMPLEX CONCENTRATE#1.0211;VON WILLEBRAND DISEASE#1.0132;ACTIVATED FACTOR X#1.0113;DESMOPRESSIN#1.0109;T- PA#1.0097;HEMOPHILIA B#1.0097;AMINOCAPROIC ACID#1.0091;FACTOR V LEIDEN#1.0090;VON WILLEBRAND'S DISEASE#1.0068;SELECTIN#1.0038;ISCHEMIC HEART DISEASE#1.0038;STEARIC ACID#1.0025;C REACTIVE PROTEIN#1.0023;FACTOR I#1.0012;FIBRINOGEN#1.0010;TRANEXAMIC ACID#1.0005;DIFFUSE ALVEOLAR HEMORRHAGE#0.9993;PLASMA PROTEIN#0.9989;BLOOD CLOTTING#0.9971;EPIDERMAL GROWTH FACTOR#0.9962;HEMOPHILIA#0.9935;CANCER CELL#0.9917;CORONARY ARTERY DISEASE#0.9910;ACTIVATED PROTEIN C#0.9908;ARTERY DISEASE#0.9903;WARFARIN#0.9900;PLASMINOGEN ACTIVATOR ACTIVITY#0.9893;VITAMIN K#0.9891;ACQUIRED HEMOPHILIA A#0.9882;ACTIVATION OF COAGULATION#0.9868;VENTRICULAR ASSIST DEVICE#0.9865;FACTOR VIII#0.9863;ACUTE MYOCARDIAL INFARCTION#0.9862;LIVER CIRRHOSIS#0.9851;FACTOR XA#0.9849;LIVER DISEASE#0.9848;GROWTH FACTOR#0.9837;CELL SURFACE#0.9836;OBESE#0.9834;HEMORRHAGE#0.9823;CORONARY ARTERY#0.9822;PLATELET ACTIVATION#0.9820;C-LEVEL#0.9817;BLOOD COAGULATION#0.9810;BREAST CANCER#0.9809;ARGININE#0.9807;PULMONARY EMBOLISM#0.9806;HEMORRHAGIC#0.9796;MACROPHAGE#0.9795;CLOTTING#0.9793;MECHANISM OF ACTION#0.9792;CENTRAL NERVOUS SYSTEM#0.9783;THROMBOPLASTIN#0.9778;SATURATED FATTY ACID#0.9776;AND NEW ZEALAND#0.9771;NERVOUS SYSTEM#0.9767;COAGULATION#0.9764;CORONARY HEART DISEASE#0.9762;INTERNATIONAL NORMALIZED RATIO#0.9761;ACTIVATION OF BLOOD COAGULATION#0.9759;WHITE BLOOD CELL#0.9758;HEART DISEASE#0.9753;HIGH DENSITY LIPOPROTEIN#0.9752;MYOCARDIAL INFARCTION#0.9742;DISSEMINATED INTRAVASCULAR COAGULATION#0.9739;ACUTE CORONARY SYNDROME#0.9739;LEUKOCYTE#0.9737;EMBOLISM#0.9728;PROTEIN C DEFICIENCY#0.9728;MONOCYTE#0.9719;VITAMIN K ANTAGONIST#0.9714;COMPLEX I#0.9711;SERUM ALBUMIN#0.9710;UROKINASE#0.9707;SYSTOLIC BLOOD PRESSURE#0.9704;THROMBOCYTOPENIA#0.9704;HEPARIN#0.9702;ARTERY#0.9702;POLYMERASE CHAIN REACTION#0.9700;HYPERACTIVITY#0.9686;TUMOR CELLS#0.9681;LOW DENSITY LIPOPROTEIN#0.9681;INTENSIVE CARE UNIT#0.9680;ANGIOTENSIN CONVERTING ENZYME#0.9677;LIPID METABOLISM#0.9666;TRANSCRIPTION FACTOR#0.9666;PLATELET AGGREGATION#0.9658;AMINOCAPROIC#0.9654;ESTRADIOL#0.9653;CARDIOVASCULAR RISK FACTOR#0.9652;TUMOR NECROSIS FACTOR#0.9649;RED BLOOD CELL#0.9639;PROTEASE ACTIVATED RECEPTOR#0.9639;RANDOMIZED CONTROLLED TRIAL#0.9634;BLOOD LOSS#0.9630;ENDOTHELIAL CELL#0.9630;HEMOSTASIS#0.9628;LYSIS#0.9620;PERIPHERAL BLOOD#0.9617;DIABETES MELLITUS#0.9617;BONE MARROW#0.9616;TRAUMATIC BRAIN INJURY#0.9615;GENE EXPRESSION#0.9611;VASCULAR DISEASE#0.9604;ATHEROSCLEROTIC#0.9596;HYPERTENSION#0.9579;ENDOTHELIUM#0.9576;FIBRINOLYSIS#0.9576;TYPE 2 DIABETES#0.9569;STEM CELL#0.9567;ATHEROSCLEROSIS#0.9563;THROMBOSIS#0.9558;ACENOCOUMAROL#0.9555;MENOPAUSE#0.9553;MENORRHAGIA#0.9532;APROTININ#0.9525;RANDOMIZED CLINICAL TRIAL#0.9516;ORTHOTOPIC LIVER TRANSPLANTATION#0.9511;ABDOMINAL AORTIC ANEURYSM#0.9508;AORTIC ANEURYSM#0.9494;MICROPARTICLE#0.9492;BLOOD PLASMA#0.9485;CAROTID ARTERY#0.9485;ANTICOAGULANT ACTIVITY#0.9481;SODIUM DODECYL SULFATE#0.9481;DODECYL SULFATE#0.9480;ATRIAL FIBRILLATION#0.9476;VERY-LOW-DENSITY LIPOPROTEIN#0.9472;DESOGESTREL#0.9459;RIVAROXABAN#0.9453;WEIGHT LOSS#0.9445;GESTATION#0.9444;ISCHEMIA#0.9443;SMOOTH MUSCLE#0.9428;ENDOGENOUS THROMBIN POTENTIAL#0.9424;CEREBROVASCULAR DISEASE#0.9414;CONGENITAL HEART DISEASE#0.9367;ASPIRIN#0.9349;PROTEINASE INHIBITOR#0.9347;CELL ADHESION#0.9341;LOW MOLECULAR WEIGHT HEPARIN#0.9328;DIRECT THROMBIN INHIBITOR#0.9320;VASCULAR CELL#0.9315;EXCRETION#0.9311;CYCLOPHOSPHAMIDE#0.9306;UMBILICAL VEIN#0.9291;ETHINYL ESTRADIOL#0.9273;MENSTRUAL CYCLE#0.9272;ALVEOLAR MACROPHAGE#0.9272;PROGESTIN#0.9263;UPPER GASTROINTESTINAL BLEEDING#0.9262;MONONUCLEAR CELLS#0.9259;CORONARY ARTERY BYPASS#0.9256;PHOSPHATIDYLSERINE#0.9255;ERYTHROCYTE#0.9247;STEM CELL TRANSPLANTATION#0.9239;THROMBOPHILIA#0.9230;THROMBIN ACTIVITY#0.9228;NITRIC OXIDE#0.9222;VENOUS BLOOD#0.9220;ALANINE#0.9202;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9187;FACTOR XIII DEFICIENCY#0.9180;HUMAN UMBILICAL VEIN#0.9172;CEREBRAL INFARCTION#0.9166;INFLAMMATORY RESPONSE#0.9155;MUSCLE CELL#0.9155;ARTHROPATHY#0.9148;LEVONORGESTREL#0.9147;SERIOUS ADVERSE EVENT#0.9146;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9132;IMMUNE TOLERANCE INDUCTION#0.9127;GESTODENE#0.9109;MUTAGENESIS#0.9085;KAOLIN#0.9070;ADIPOSE TISSUE#0.9051;ANEMIA#0.9043;MOLAR#0.9035;TISSUE PLASMINOGEN ACTIVATOR ACTIVITY#0.9028;GLYCOSYLATION#0.9007;SMOOTH MUSCLE CELL#0.8996;CARDIOVASCULAR HEALTH STUDY#0.8987;LOW FAT DIET#0.8982;COAGULATION FACTOR VIIA#0.8977;TOLERANCE INDUCTION#0.8974;CATALYTIC ACTIVITY#0.8972;THROMBIN GENERATION ASSAY#0.8969;BLOOD VESSEL#0.8966;TESTOSTERONE#0.8945;CHRONIC LIVER DISEASE#0.8934;VASCULAR ENDOTHELIUM#0.8932;DDAVP#0.8924;VASCULAR ENDOTHELIAL CELL#0.8906;ANGIOGENESIS#0.8899;APIXABAN#0.8890;OLEIC ACID#0.8868;DABIGATRAN#0.8861;OVARIAN#0.8828;PROTEIN SYNTHESIS#0.8824;NEUTROPHIL#0.8821;SIMVASTATIN#0.8801;GLUTAMIC ACID#0.8758;URIC ACID#0.8755;SURFACE PLASMON RESONANCE#0.8707;CELL ADHESION MOLECULE#0.8700;NORETHISTERONE#0.8693;HYPERCHOLESTEROLEMIA#0.8657;BERNARD-SOULIER SYNDROME#0.8653;CHYLOMICRON#0.8652;MULTIPLE REGRESSION ANALYSIS#0.8651;LIPOPROTEIN LIPASE#0.8646;PREDNISOLONE#0.8642;FONDAPARINUX#0.8637;2 DIABETES MELLITUS#0.8612;CELL MEMBRANE#0.8608;HEPATOCELLULAR CARCINOMA#0.8606;PALMITIC ACID#0.8591;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.8579;DIGESTION#0.8571;CONTROLLED CLINICAL TRIALS#0.8566;OESTRADIOL#0.8565;ANTIHEMOPHILIC FACTOR#0.8548;TYPE 2 DIABETES MELLITUS#0.8513;LYSINE#0.8491;PORTAL VEIN#0.8473;BLOOD CLOT#0.8472;LUNG CANCER#0.8399;APOPTOSIS#0.8396;INTRAVENOUS IMMUNOGLOBULIN#0.8379;COAGULATION FACTOR IX#0.8346;HEMATURIA#0.8291;EDEMA#0.8288;MYELOID LEUKEMIA#0.8283;CELL ASSOCIATED#0.8262;ADENOSINE#0.8222;HIGH FAT DIET#0.8222;ETHYLENE RESPONSE FACTOR#0.8220;RANDOMISED CONTROLLED TRIAL#0.8205;MODE OF ACTION#0.8196;ALPHA 1-ANTITRYPSIN#0.8191;ACUTE MYELOID LEUKEMIA#0.8166;MONOUNSATURATED FATTY ACIDS#0.8156;ENZYME ACTIVITY#0.8149;SIGNAL PEPTIDE#0.8125;GLUTAMINE#0.8115;BLADDER CARCINOMA#0.8114;CORONARY THROMBOSIS#0.8113;POST-TRANSLATIONAL MODIFICATION#0.8098;LIPOPROTEIN METABOLISM#0.8048;ACUTE LIVER FAILURE#0.8017;ENOXAPARIN#0.8013;RITUXIMAB#0.7968;RESPIRATORY DISTRESS#0.7962;HEPATOCYTE NUCLEAR FACTOR#0.7958;RESPONSE TO TREATMENT#0.7956;HEMATOPOIETIC STEM CELL#0.7931;FRAGMENT LENGTH POLYMORPHISM#0.7931;ENDOPLASMIC RETICULUM#0.7904;TOPICAL#0.7889;PURPURA#0.7869;OVARIAN CANCER#0.7864;COLORECTAL CANCER#0.7852;MEDROXYPROGESTERONE ACETATE#0.7851;CHRISTMAS FACTOR#0.7850;RECEPTOR ANTAGONIST#0.7835;LEFT VENTRICULAR MASS#0.7818;DENGUE HEMORRHAGIC FEVER#0.7776;THROMBIN GENERATION TEST#0.7771;MECHANISMS OF ACTION#0.7769;RISK OF DEATH#0.7762;CLOT FORMATION TIME#0.7753;CYTOCHROME P450#0.7682;CELL MIGRATION#0.7673;LUPUS ERYTHEMATOSUS#0.7668;DUBIN-JOHNSON SYNDROME#0.7661;TOXICITY#0.7643;AMYLOIDOSIS#0.7641;ANAEMIA#0.7641;ACUTE ISCHEMIC STROKE#0.7632;ARACHIDONIC ACID#0.7584;PERCUTANEOUS CORONARY INTERVENTION#0.7554;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7545;POINT OF CARE#0.7545;CARRIE#0.7525;CORD BLOOD#0.7517;BREAST CANCER CELL#0.7503;TRANSMEMBRANE RECEPTOR#0.7503;HEPATITIS B#0.7472;HEPATITIS C#0.7464;HEMARTHROSIS#0.7451;VIRAL INFECTION#0.7445;EXTRACELLULAR MATRIX#0.7441;ANESTHETIC#0.7440;PLASMA ANTIOXIDANT CAPACITY#0.7438;IMPAIRED GLUCOSE TOLERANCE#0.7419;COLORECTAL#0.7407;COUMADIN#0.7397;WOUND HEALING#0.7363;ESTROGENS#0.7362;PLASMA THROMBOPLASTIN#0.7351;PARENTERAL#0.7345;PLASMA MEMBRANE#0.7340;COLON CANCER#0.7325;MAXIMUM CLOT FIRMNESS#0.7320;HEMORRHAGIC DISEASE#0.7315;MULTIPLE LOGISTIC REGRESSION#0.7311;GASTROINTESTINAL TRACT#0.7309;PLASMA GLYCOPROTEIN#0.7298;ACUTE LUNG INJURY#0.7291;CHOLESTASIS#0.7287;LIPOLYSIS#0.7283;PERIPHERAL ARTERIAL DISEASE#0.7246;LINEAR REGRESSION ANALYSIS#0.7195;HEALTHY CONTROL SUBJECTS#0.7192;HORMONE BINDING#0.7174;DIURNAL#0.7173;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7167;LUNG DISEASE#0.7166;GRANULOCYTE#0.7148;LIPOPROTEIN PARTICLE#0.7146;LENGTH OF STAY#0.7145;GAMMA GLUTAMYL CARBOXYLASE#0.7135;EPITHELIAL CELL#0.7118;IMMUNE RESPONSE#0.7115;MITRAL VALVE#0.7104;UTERUS#0.7096;GROWTH FACTOR RECEPTOR#0.7095;METHYLPREDNISOLONE#0.7092;HOMOCYSTINURIA#0.7085;MEDROXYPROGESTERONE#0.7076;EICOSAPENTAENOIC ACID#0.7065;NEPHROTIC SYNDROME#0.7058;DIPHOSPHATE#0.7058;TRADITIONAL RISK FACTORS#0.6997;CRYSTALLOID#0.6994;PROTEASE ACTIVITY#0.6985;HIGH RISK PATIENTS#0.6953;ARGATROBAN#0.6941;VITAMIN E#0.6937;GLUCOSE METABOLISM#0.6915;TUMOUR NECROSIS FACTOR#0.6912;PROGESTERONE#0.6912;GENE SILENCING#0.6867;CELL BOUND#0.6865;NORPLANT#0.6860;ETHANOL#0.6842;LATE PREGNANCY#0.6826;HYPOXIA#0.6824;GEMFIBROZIL#0.6813;STANDARD OF CARE#0.6813;TF BINDING#0.6809;GLYCINE#0.6805;PREDNISONE#0.6802;IMMUNOGLOBULIN G#0.6797;ASPARTATE#0.6759;ATORVASTATIN#0.6758;WARFARIN SODIUM#0.6756;LOW BIRTH WEIGHT#0.6728;CELL PROLIFERATION#0.6722;PNEUMONIA#0.6706;COMPARTMENT SYNDROME#0.6698;MEAN PLATELET VOLUME#0.6623;TRANSFORMING GROWTH FACTOR#0.6621;BENZAMIDINE#0.6607;SIGNALING PATHWAY#0.6605;ANTIPHOSPHOLIPID SYNDROME#0.6583;FRAMINGHAM HEART STUDY#0.6575;VASOPRESSIN#0.6554;TYPE 2 DIABETIC#0.6514;COMMON CAROTID ARTERY#0.6490;KIDNEY DISEASE#0.6483;SIGNAL TRANSDUCTION#0.6464;PROSTACYCLIN#0.6460;INTIMA MEDIA THICKNESS#0.6456;ETHINYLESTRADIOL#0.6450;PRE-ECLAMPSIA#0.6440;FOREARM#0.6417;FASTING PLASMA GLUCOSE#0.6412;ARGININE VASOPRESSIN#0.6391;PROTEIN BINDING#0.6380;MAGNETIC RESONANCE IMAGING#0.6358;CEREBRAL HEMORRHAGE#0.6317;HYPERHOMOCYSTEINEMIA#0.6315;TPA ACTIVITY#0.6306;BETA-HYDROXYASPARTIC ACID#0.6297;MULTIPLE LINEAR REGRESSION#0.6295;WAIST HIP RATIO#0.6281;HARDY WEINBERG EQUILIBRIUM#0.6253;INTERSTITIAL LUNG DISEASE#0.6231;UMBILICAL CORD#0.6216;CIRCADIAN RHYTHM#0.6205;T CELL#0.6201;BLOOD CIRCULATION#0.6200;CALIBRATED AUTOMATED THROMBOGRAPHY#0.6198;ACUTE AORTIC DISSECTION#0.6167;CLOPIDOGREL#0.6157;DENGUE SHOCK SYNDROME#0.6150;PRASUGREL#0.6138;TICAGRELOR#0.6138;END OF TREATMENT#0.6136;CELL GROWTH#0.6135;MIGRAINE#0.6135;ACUTE LEUKEMIA#0.6113;HEPATOCYTE GROWTH FACTOR#0.6093;MARKERS OF INFLAMMATION#0.6093;ALPHA-2 MACROGLOBULIN#0.6091;ESSENTIAL HYPERTENSION#0.6072;FACTOR D#0.6066;INJURY SEVERITY SCORE#0.6053;ALKALINE PHOSPHATASE#0.6052;STROMA#0.6007;HYPOXIC#0.6001;MRNA PROCESSING#0.6001
2157	ANTIHEMOPHILIC FACTOR#1.0495;ADVATE#1.0494;REFACTO#1.0485;T- PA#1.0441;DENDRITIC CELL#1.0419;ACQUIRED HEMOPHILIA A#1.0367;KOGENATE#1.0359;DDAVP#1.0351;CD4+ T CELL#1.0335;ANTIGEN PRESENTING CELLS#1.0294;C REACTIVE PROTEIN#1.0264;INTEIN#1.0255;MEMORY B CELL#1.0233;FACTOR VIII DEFICIENCY#1.0224;C-LEVEL#1.0222;BLOOD CLOTTING#1.0216;FACTOR VIII#1.0152;HEMATOPOIETIC STEM CELL#1.0150;SURFACE PLASMON RESONANCE#1.0131;LOW DENSITY LIPOPROTEIN#1.0129;DESMOPRESSIN#1.0126;FIBRINOGEN#1.0126;PHOSPHATIDYLSERINE#1.0113;COLLAGEN BINDING#1.0099;ENDOGENOUS THROMBIN POTENTIAL#1.0093;THROMBIN GENERATION ASSAY#1.0068;ENDOPLASMIC RETICULUM#1.0068;T CELL#1.0067;BLOOD COAGULATION#1.0066;GLYCOSYLATION#1.0062;SUCROSE#1.0056;COAGULATION#1.0053;B CELL#1.0049;ENDOCYTOSIS#1.0042;HEMOPHILIA#1.0037;VASOPRESSIN#1.0036;IMMUNE RESPONSE#1.0007;PROTHROMBIN COMPLEX CONCENTRATE#0.9995;NOVOSEVEN#0.9994;MACROPHAGE#0.9993;IMMUNE TOLERANCE INDUCTION#0.9991;VON WILLEBRAND'S DISEASE#0.9989;RECOMBINANT ACTIVATED FACTOR#0.9979;X CHROMOSOME#0.9973;MEGAKARYOCYTE#0.9965;CATABOLISM#0.9965;PROGENITOR CELL#0.9959;ENDOTHELIUM#0.9958;HEMOPHILIA B#0.9947;STROMAL CELL#0.9937;ADENO ASSOCIATED VIRUS#0.9933;HEMORRHAGIC#0.9930;STEM CELL#0.9929;PLATELET AGGREGATION#0.9928;D-ARGININE#0.9927;SELECTIN#0.9925;FACTOR I#0.9910;ACTIVATED PROTEIN C#0.9906;TOLERANCE INDUCTION#0.9901;ARGININE VASOPRESSIN#0.9895;GENE EXPRESSION#0.9887;BONE MARROW#0.9886;FACTOR V LEIDEN#0.9882;COAGULATION FACTOR IX#0.9881;PLASMA PROTEIN#0.9875;BLOOD LOSS#0.9864;HEPARIN#0.9859;MONOCYTE#0.9849;FACTOR XA#0.9841;SMOOTH MUSCLE#0.9840;THROMBOPLASTIN#0.9830;ENDOTHELIAL CELL#0.9825;VITAMIN K#0.9823;PLATELET ACTIVATION#0.9815;BLOOD VESSEL#0.9814;MUTAGENESIS#0.9810;IMMUNE SYSTEM#0.9798;GROWTH FACTOR#0.9796;CLOTTING#0.9790;THROMBOPHILIA#0.9784;VON WILLEBRAND DISEASE#0.9782;JOINT DAMAGE#0.9780;ARGININE#0.9778;ARTHROPATHY#0.9774;PERIPHERAL BLOOD#0.9761;HEMOSTASIS#0.9756;CELL SURFACE#0.9737;MESENCHYMAL STEM CELL#0.9736;REGULATORY T CELL#0.9733;APOPTOSIS#0.9731;FIBRINOLYSIS#0.9727;POLYMERASE CHAIN REACTION#0.9726;RITUXIMAB#0.9721;AUTOIMMUNE DISEASE#0.9701;THROMBOSIS#0.9694;HEMORRHAGE#0.9687;HUMAN IMMUNODEFICIENCY VIRUS#0.9672;MAMMARY GLAND#0.9661;ARTERY#0.9648;INTRAVENOUS IMMUNOGLOBULIN#0.9629;KOGENATE FS#0.9629;INTERNATIONAL NORMALIZED RATIO#0.9628;STANDARD OF CARE#0.9617;HEPATITIS C#0.9609;RED BLOOD CELL#0.9604;LIVER DISEASE#0.9597;HEMARTHROSIS#0.9594;ANGIOGENESIS#0.9591;TOXICITY#0.9548;THROMBOCYTOPENIA#0.9519;HEPATITIS B#0.9515;TUMOR CELLS#0.9511;CYCLOPHOSPHAMIDE#0.9486;T LYMPHOCYTE#0.9476;PLASMA GLYCOPROTEIN#0.9463;DIABETES MELLITUS#0.9459;HYPERTENSION#0.9439;SECRETORY PATHWAY#0.9436;BLOOD PLASMA#0.9404;POST-TRANSLATIONAL MODIFICATION#0.9401;HOST CELL#0.9400;SERUM ALBUMIN#0.9400;ACQUIRED VON WILLEBRAND SYNDROME#0.9360;SMOOTH MUSCLE ACTIN#0.9312;LECTIN#0.9307;TRANEXAMIC ACID#0.9294;HEPATITIS C VIRUS#0.9266;FRAGMENT LENGTH POLYMORPHISM#0.9240;BAYER#0.9236;HEMORRHAGIC DISEASE#0.9209;1-DEAMINO-8-D-ARGININE VASOPRESSIN#0.9203;VASCULAR ENDOTHELIUM#0.9194;ETHANOL#0.9192;HEPATITIS A#0.9141;SERIOUS ADVERSE EVENT#0.9107;HEART DISEASE#0.9031;CORONARY ARTERY#0.9027;KNEE JOINT#0.8974;UNFOLDED PROTEIN RESPONSE#0.8949;ENDOTHELIAL GROWTH FACTOR#0.8947;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8947;GENETIC DISORDER#0.8941;MICROPARTICLE#0.8909;MONOCYTE DERIVED DENDRITIC CELL#0.8882;VENOUS BLOOD#0.8852;MYOCARDIAL INFARCTION#0.8817;CERVICAL#0.8810;DIGESTION#0.8757;HEMATOPOIETIC CELL#0.8756;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8755;EVERY OTHER DAY#0.8718;WOUND HEALING#0.8698;CELL ACTIVATION#0.8692;PORTAL VEIN#0.8682;LYMPH NODE#0.8681;IFN-GAMMA#0.8678;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8658;T CELL ACTIVATION#0.8656;SODIUM DODECYL SULFATE#0.8653;DODECYL SULFATE#0.8652;ATHEROSCLEROSIS#0.8642;RELATED PROTEIN 1#0.8606;HUMORAL IMMUNE RESPONSE#0.8604;72-HOURS#0.8592;GENETIC DISEASE#0.8583;LYSINE#0.8569;LEUKOCYTE#0.8568;PLURIPOTENT STEM CELL#0.8562;MUSCLE CELL#0.8561;IMMUNOGLOBULIN G#0.8559;PRO-INFLAMMATORY#0.8529;LYSIS#0.8519;INDUCED PLURIPOTENT STEM CELL#0.8466;PREDNISONE#0.8464;DISSEMINATED INTRAVASCULAR COAGULATION#0.8432;HUMAN SERUM ALBUMIN#0.8425;ACUTE PHASE RESPONSE#0.8404;ENDOTHELIAL PROGENITOR CELL#0.8394;ANTIBODY PRODUCTION#0.8393;PREDNISOLONE#0.8370;THROMBIN GENERATION TEST#0.8357;NEUTROPHIL#0.8356;UMBILICAL VEIN#0.8326;LIPID BINDING#0.8316;PHOSPHOLIPID BINDING#0.8302;RARE BLEEDING DISORDERS#0.8262;OUTGROWTH ENDOTHELIAL CELLS#0.8236;CELL PROLIFERATION#0.8185;AGGLUTINATION#0.8168;ERYTHROCYTE#0.8160;LDL RECEPTOR#0.8142;MOLAR#0.8130;PURPURA#0.8120;ACTIVATED FACTOR X#0.8104;ACUTE ISCHEMIC STROKE#0.8076;SMOOTH MUSCLE CELL#0.8074;ACTIVATION OF COAGULATION#0.8057;DESMOPRESSIN ACETATE#0.8054;SIMIAN IMMUNODEFICIENCY VIRUS#0.8049;CARDIOVASCULAR RISK FACTOR#0.8029;RECEPTOR BINDING#0.8020;IMMUNE CELL#0.8019;MONONUCLEAR CELLS#0.7981;CARRIE#0.7948;ARTERY DISEASE#0.7936;MANNOSE RECEPTOR#0.7916;PROTEIN SPLICING#0.7894;MECHANISM OF ACTION#0.7867;EPINEPHRINE#0.7856;L-SERINE#0.7847;COLORECTAL CANCER#0.7803;HUMAN UMBILICAL VEIN#0.7777;LINEAR REGRESSION ANALYSIS#0.7764;MICROVASCULAR ENDOTHELIAL CELL#0.7753;CORD BLOOD#0.7731;ASPIRIN#0.7710;VERY-LOW-DENSITY LIPOPROTEIN#0.7708;SKELETAL MUSCLE#0.7705;NUCLEIC ACID#0.7684;CELL ADHESION#0.7680;ALANINE#0.7667;SWELLING#0.7631;ANTIGEN PRESENTATION#0.7621;APOPTOTIC#0.7596;COLORECTAL#0.7584;ASPARAGINE#0.7580;ER TO GOLGI TRANSPORT#0.7551;RESPONSE TO TREATMENT#0.7547;IMMUNOGLOBULIN BINDING#0.7546;TUMOR NECROSIS FACTOR#0.7541;NERVOUS SYSTEM#0.7474;SULFATION#0.7465;SIZE EXCLUSION CHROMATOGRAPHY#0.7444;SYNOVITIS#0.7427;AMINOLEVULINIC ACID#0.7427;SCANNING ELECTRON MICROSCOPY#0.7412;MENORRHAGIA#0.7405;HEPATITIS B VIRUS#0.7393;RHEUMATOID ARTHRITIS#0.7376;CENTRAL VENOUS ACCESS#0.7360;TRANSFORMING GROWTH FACTOR#0.7343;UMBILICAL CORD#0.7340;RANGE OF MOTION#0.7287;CENTRAL NERVOUS SYSTEM#0.7280;VLDLR BINDING#0.7280;CORONARY ARTERY DISEASE#0.7268;ANEMIA#0.7261;STROMA#0.7243;TELOMERE#0.7235;ALLERGIC REACTION#0.7219;EMBOLISM#0.7202;ANTIPHOSPHOLIPID SYNDROME#0.7191;HUMAN EMBRYONIC KIDNEY#0.7156;EMBRYONIC KIDNEY#0.7152;ATHEROSCLEROTIC#0.7147;KAOLIN#0.7146;GLYCINE#0.7144;GLASS IONOMER CEMENT#0.7136;SHEAR BOND STRENGTH#0.7135;CYTOPLASM#0.7130;BREAST CANCER#0.7092;MAGNETIC RESONANCE IMAGING#0.7082;CALIBRATED AUTOMATED THROMBOGRAM#0.7072;RANDOMIZED CONTROLLED TRIAL#0.7046;CELL MEMBRANE#0.7024;CYTOTOXICITY#0.7021;MESENCHYMAL STROMAL CELL#0.7018;HEMATURIA#0.6977;STEM CELL TRANSPLANTATION#0.6958;GLUCOSE-6-PHOSPHATE#0.6930;COMPLEX I#0.6922;REVERSE TRANSCRIPTION#0.6905;GESTATION#0.6891;EPITHELIAL CELL#0.6878;HYPOXIA#0.6857;PULMONARY EMBOLISM#0.6849;WARFARIN#0.6848;HOMOLOGOUS RECOMBINATION#0.6802;VIRAL INFECTION#0.6786;ANTICOAGULANT ACTIVITY#0.6756;COPPER BINDING#0.6753;SHORT TANDEM REPEAT#0.6722;RANDOMIZED CLINICAL TRIAL#0.6704;MULTIPLE MYELOMA#0.6693;VASCULAR ENDOTHELIAL CELL#0.6678;TYPE 2 DIABETES#0.6650;VITAMIN K ANTAGONIST#0.6614;ORAL TOLERANCE#0.6571;B CELL DEPLETION#0.6570;N GLYCAN#0.6568;LIVER CIRRHOSIS#0.6532;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6516;CLOT FORMATION TIME#0.6489;THROMBIN RECEPTOR#0.6481;CONTROLLED CLINICAL TRIALS#0.6470;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.6425;GOLGI APPARATUS#0.6411;POST-THROMBOTIC SYNDROME#0.6400;CORONARY HEART DISEASE#0.6383;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6382;LUPUS ERYTHEMATOSUS#0.6380;PROGESTERONE#0.6380;B LYMPHOCYTE#0.6369;ALKALINE PHOSPHATASE#0.6362;RAPAMYCIN#0.6361;CYTOKINE PRODUCTION#0.6355;INFLAMMATORY RESPONSE#0.6345;CACL2#0.6344;ANGIOSARCOMA#0.6294;GRADIENT GEL ELECTROPHORESIS#0.6285;UROKINASE#0.6264;PREKALLIKREIN ACTIVATOR#0.6229;TOTAL KNEE ARTHROPLASTY#0.6227;PLASMA CELL#0.6219;ORGANELLE#0.6204;FACTOR S#0.6204;DEXAMETHASONE#0.6194;KUPFFER CELL#0.6181;L-SER#0.6146;APC BINDING#0.6143;MARKERS OF INFLAMMATION#0.6137;IMMUNE GLOBULIN#0.6133;INTERNAL QUALITY CONTROL#0.6115;VASCULAR DISEASE#0.6101;G-CSF#0.6093;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6071;FLUID SHEAR STRESS#0.6070;IMMATURE DENDRITIC CELL#0.6058;EPIDERMAL GROWTH FACTOR#0.6054;FLUORESCEIN#0.6032;ER-GOLGI INTERMEDIATE COMPARTMENT#0.6030
2158	PLASMA THROMBOPLASTIN COMPONENT#1.0922;CHRISTMAS FACTOR#1.0761;PLASMA THROMBOPLASTIN#1.0683;FACTOR VIII DEFICIENCY#1.0562;STROMAL CELL#1.0540;COAGULATION FACTOR IX#1.0445;BETA-HYDROXYASPARTIC ACID#1.0392;SKIN FIBROBLASTS#1.0331;MYOBLAST#1.0320;EMBRYONAL CARCINOMA#1.0281;FACTOR XI DEFICIENCY#1.0258;ANTIHEMOPHILIC FACTOR#1.0248;GLUTAMIC ACID#1.0173;PHOSPHOLIPID BINDING#1.0165;SKELETAL MUSCLE#1.0152;ANAPHYLAXIS#1.0146;VON WILLEBRAND'S DISEASE#1.0144;FRAGMENT LENGTH POLYMORPHISM#1.0136;FACTOR VIII#1.0125;HEMOPHILIA B#1.0125;IMMUNE TOLERANCE INDUCTION#1.0066;NEPHROTIC SYNDROME#1.0060;BLOOD CLOTTING#1.0050;HEMOPHILIA#1.0047;STUART FACTOR#1.0023;ARGININE#1.0018;X CHROMOSOME#1.0010;EPIDERMAL GROWTH FACTOR#0.9996;ENDOTHELIAL CELL#0.9996;WARFARIN#0.9965;BLOOD COAGULATION#0.9951;GROWTH FACTOR#0.9944;FIBRINOGEN#0.9942;PROTHROMBIN COMPLEX CONCENTRATE#0.9930;ALPHA 1-ANTITRYPSIN#0.9921;ACTIVATED FACTOR X#0.9905;COAGULATION#0.9903;VITAMIN K#0.9885;HEMORRHAGIC#0.9885;THROMBOPLASTIN#0.9884;TOLERANCE INDUCTION#0.9880;LIVER DISEASE#0.9875;CYCLOPHOSPHAMIDE#0.9858;CELL SURFACE#0.9858;SODIUM DODECYL SULFATE#0.9853;DODECYL SULFATE#0.9852;ADENO ASSOCIATED VIRUS#0.9841;HEPATITIS A#0.9830;ALLERGIC REACTION#0.9830;CLOTTING#0.9820;MYOCARDIAL INFARCTION#0.9816;STEM CELL#0.9813;HEPARIN#0.9807;HEPATITIS B#0.9806;ALANINE#0.9799;INTERNATIONAL NORMALIZED RATIO#0.9786;POST-TRANSLATIONAL MODIFICATION#0.9784;TRANSCRIPTION FACTOR#0.9779;PLASMA PROTEIN#0.9772;BETA GALACTOSIDASE#0.9762;FACTOR XA#0.9762;RECOMBINANT ACTIVATED FACTOR#0.9761;MUTAGENESIS#0.9761;GROWTH HORMONE#0.9760;POLYMERASE CHAIN REACTION#0.9751;MAMMARY GLAND#0.9748;GENETIC DISEASE#0.9739;FACTOR I#0.9732;HEPATITIS B VIRUS#0.9728;HUMAN IMMUNODEFICIENCY VIRUS#0.9727;PERIPHERAL BLOOD#0.9726;HEMOSTASIS#0.9716;LECTIN#0.9715;THROMBOSIS#0.9707;IMMUNE RESPONSE#0.9698;LOW DENSITY LIPOPROTEIN#0.9697;ANTICOAGULANT ACTIVITY#0.9697;ASPARTIC ACID#0.9673;HEMORRHAGE#0.9672;KERATINOCYTE#0.9665;TOXICITY#0.9660;GLYCOSYLATION#0.9660;FACTOR VII DEFICIENCY#0.9654;GENE EXPRESSION#0.9650;VITAMIN K ANTAGONIST#0.9616;T CELL#0.9615;DIGESTION#0.9615;ACTIVATED PROTEIN C#0.9608;VON WILLEBRAND DISEASE#0.9600;GLUTAMINE#0.9583;GLYCINE#0.9571;FIBRINOLYSIS#0.9569;BONE MARROW#0.9568;ARTERY#0.9559;ARTHROPATHY#0.9554;POSTTRANSLATIONAL MODIFICATION#0.9529;DISSEMINATED INTRAVASCULAR COAGULATION#0.9522;CATALYTIC ACTIVITY#0.9479;RED BLOOD CELL#0.9433;PLATELET AGGREGATION#0.9416;BLOOD LOSS#0.9415;HEPATITIS C#0.9415;VALINE#0.9407;GRADIENT GEL ELECTROPHORESIS#0.9401;ENDOGENOUS THROMBIN POTENTIAL#0.9376;HEMORRHAGIC DISEASE#0.9355;T LYMPHOCYTE#0.9346;C-LEVEL#0.9346;SERUM ALBUMIN#0.9322;MOLAR#0.9309;PORTAL VEIN#0.9308;EPITHELIAL CELL#0.9275;LYSINE#0.9263;UMBILICAL VEIN#0.9261;ACTIVATION OF COAGULATION#0.9254;MARROW STROMAL CELLS#0.9247;B CELL#0.9241;SURFACE PLASMON RESONANCE#0.9203;IMMUNOGLOBULIN G#0.9174;MESENCHYMAL STEM CELL#0.9163;PUBERTY#0.9146;CYSTIC FIBROSIS#0.9059;GENETIC DISORDER#0.9011;PHOSPHATIDYLSERINE#0.9004;T- PA#0.9002;ENDOTHELIUM#0.8972;PROGENITOR CELL#0.8924;WOUND HEALING#0.8913;CACL2#0.8885;THROMBOPHILIA#0.8877;GESTATION#0.8816;TRANEXAMIC ACID#0.8808;KAOLIN#0.8802;MENTAL RETARDATION#0.8737;BONE MARROW STROMAL CELL#0.8731;BONE MARROW STROMAL#0.8725;MUSCLE CELL#0.8704;THROMBIN GENERATION ASSAY#0.8693;CYTOTOXIC T-LYMPHOCYTE#0.8667;PLASMA MEMBRANE#0.8654;ANAPHYLACTIC#0.8638;MECHANISM OF ACTION#0.8611;PROTEIN BINDING#0.8607;GAMMA GLUTAMYL CARBOXYLASE#0.8604;IMMUNE SYSTEM#0.8598;FACTOR V LEIDEN#0.8596;RITUXIMAB#0.8592;THROMBOCYTOPENIA#0.8547;COMPLEX I#0.8536;T-CELL LEUKEMIA#0.8490;RETINOIC ACID#0.8444;ERYTHROCYTE#0.8431;NUCLEIC ACID#0.8420;N GLYCAN#0.8413;CORONARY ARTERY#0.8403;PROTEIN SYNTHESIS#0.8398;HISTIDINE#0.8384;MONOCYTE#0.8354;PROTEIN C DEFICIENCY#0.8353;HEART DISEASE#0.8339;SIGNAL PEPTIDE#0.8323;HOMOLOGOUS RECOMBINATION#0.8312;HEPATITIS C VIRUS#0.8295;CD4+ T CELL#0.8293;TUMOR NECROSIS FACTOR#0.8286;THROMBIN ACTIVITY#0.8238;BLOOD PLASMA#0.8227;CD8+ T CELL#0.8220;NOVOSEVEN#0.8211;HYPERACTIVE#0.8208;AMINOCAPROIC ACID#0.8194;HEMATOPOIETIC STEM CELL#0.8187;FACTOR X DEFICIENCY#0.8119;PLATELET ACTIVATION#0.8117;REGULATORY T CELL#0.8094;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.8093;CORD BLOOD#0.8032;ZYMOGEN ACTIVATION#0.8002;FRAGILE X SYNDROME#0.7963;GUANINE#0.7928;CELL MEMBRANE#0.7926;MESENCHYMAL STROMAL CELL#0.7850;GLOBIN#0.7794;HOST CELL#0.7772;VIRAL INFECTION#0.7760;HYPERSENSITIVITY#0.7758;HUMAN SERUM ALBUMIN#0.7716;TRANSFORMING GROWTH FACTOR#0.7675;C REACTIVE PROTEIN#0.7671;HUMORAL IMMUNE RESPONSE#0.7629;CELLULAR IMMUNE RESPONSE#0.7628;DESMOPRESSIN#0.7602;MUSCULAR DYSTROPHY#0.7557;ALKALINE PHOSPHATASE#0.7495;HEMARTHROSIS#0.7480;EXTRACELLULAR MATRIX#0.7453;PREDNISOLONE#0.7451;VIRAL HEPATITIS#0.7445;LYSIS#0.7442;ATHEROSCLEROSIS#0.7412;AMNIOTIC FLUID#0.7363;ANDROGEN RECEPTOR#0.7344;GLUCOSE-6-PHOSPHATE#0.7312;ENZYME ACTIVITY#0.7292;CELL BOUND#0.7270;COAGULATION FACTOR VIIA#0.7206;BASEMENT MEMBRANE#0.7153;MACROPHAGE#0.7131;GENE SILENCING#0.7113;TRANSACTIVATION#0.7099;LOW MOLECULAR WEIGHT HEPARIN#0.7086;L-LYSINE#0.6998;CARRIE#0.6995;HEPATOMA CELLS#0.6981;SERIOUS ADVERSE EVENT#0.6981;VIRAL TRANSMISSION#0.6977;ACTIVATED PLASMA THROMBOPLASTIN ANTECEDENT#0.6967;MYOTUBE#0.6965;UMBILICAL CORD#0.6957;SELECTIN#0.6955;ACUTE CORONARY SYNDROME#0.6952;LUPUS ERYTHEMATOSUS#0.6948;CAROTID ARTERY#0.6942;AMINOCAPROIC#0.6940;HEMATOPOIETIC CELL#0.6939;AUTOIMMUNE DISEASE#0.6911;ANEMIA#0.6898;MONONUCLEAR CELLS#0.6897;LEUKOCYTE#0.6879;ETHANOL#0.6854;HEPATOCYTE NUCLEAR FACTOR#0.6837;EMBRYONIC KIDNEY#0.6819;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6757;LYMPH NODE#0.6750;ACTIVATION OF BLOOD COAGULATION#0.6735;FIBRILLIN#0.6701;FACTOR XII DEFICIENCY#0.6695;POLY ETHYLENE GLYCOL#0.6679;RANDOMIZED CONTROLLED TRIAL#0.6675;CORONARY HEART DISEASE#0.6674;SWELLING#0.6673;ADENINE#0.6669;MAGNETIC RESONANCE IMAGING#0.6661;BLOOD VESSEL#0.6652;BLINDNESS#0.6647;NERVOUS SYSTEM#0.6628;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.6623;INTRON A#0.6586;PLASMA GLYCOPROTEIN#0.6565;MUTAGEN#0.6560;LIVER DAMAGE#0.6534;HUMAN UMBILICAL VEIN#0.6511;ION BINDING#0.6498;DNA AMPLIFICATION#0.6498;CHLORAMPHENICOL#0.6498;THROMBIN GENERATION TEST#0.6496;APROTININ#0.6482;ASPARAGINE#0.6465;INTRAVENOUS IMMUNOGLOBULIN#0.6443;DNA BINDING#0.6360;PHENPROCOUMON#0.6265;IMMUNE SUPPRESSION#0.6262;TRANSCRIPTION FACTOR BINDING#0.6258;TRYPTOPHAN#0.6256;REVERSE TRANSCRIPTION#0.6243;T HELPER CELL#0.6240;REGENERATION#0.6233;CREATINE KINASE#0.6220;VIRION#0.6220;DUCHENNE MUSCULAR DYSTROPHY#0.6213;FONDAPARINUX#0.6167;TUMOR CELLS#0.6166;RECEPTOR BINDING#0.6157;CORONARY ARTERY BYPASS#0.6137;DEXAMETHASONE#0.6135;CELL MIGRATION#0.6132;HYPERTENSION#0.6111;APOPTOSIS#0.6086;PLURIPOTENT STEM CELL#0.6079;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6067;AMYLOIDOSIS#0.6053;ENDOPLASMIC RETICULUM#0.6036;CENTRAL NERVOUS SYSTEM#0.6029
2159	CATALYTIC COMPLEX#1.0793;FONDAPARINUX SODIUM#1.0623;FACTOR IIA#1.0513;PROTHROMBINASE ACTIVITY#1.0496;PYRAZOLE#1.0465;ARIXTRA#1.0356;ENZYME COMPLEX#1.0326;INHIBITION OF COAGULATION#1.0306;DABIGATRAN ETEXILATE#1.0295;FACTOR X DEFICIENCY#1.0271;FACTOR XA#1.0253;ACTIVATED FACTOR X#1.0207;DIRECT THROMBIN INHIBITOR#1.0196;APIXABAN#1.0175;RIVAROXABAN#1.0166;LEPIRUDIN#1.0160;BENZAMIDINE#1.0133;FONDAPARINUX#1.0131;VASCULAR SMOOTH MUSCLE CELL#1.0108;UROKINASE#1.0100;DABIGATRAN#1.0096;DALTEPARIN#1.0068;PROPANOIC ACID#1.0068;TOTAL KNEE REPLACEMENT#1.0042;XIMELAGATRAN#1.0015;BETA GALACTOSIDASE#1.0006;BIVALIRUDIN#1.0001;THROMBIN GENERATION ASSAY#0.9995;ARGATROBAN#0.9993;COMPLEX I#0.9989;CATALYTIC ACTIVITY#0.9989;DIGESTION#0.9983;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.9982;SERPIN#0.9977;BLOOD CLOT#0.9977;PROTEASE ACTIVATED RECEPTOR#0.9974;ALPHA-2 MACROGLOBULIN#0.9968;TOTAL KNEE ARTHROPLASTY#0.9960;ACTIVATION OF COAGULATION#0.9948;SALIVARY GLAND#0.9947;PHOSPHOLIPID BINDING#0.9942;STRUCTURE ACTIVITY RELATIONSHIP#0.9937;MAP KINASE#0.9917;PHOSPHOLIPASE A2#0.9914;SIGNAL TRANSDUCTION#0.9908;ALPHA 1-ANTITRYPSIN#0.9903;THROMBIN ACTIVITY#0.9902;SMOOTH MUSCLE CELL#0.9893;CACL2#0.9888;PRO-INFLAMMATORY#0.9884;MOLECULAR DYNAMICS SIMULATION#0.9880;BETA-2#0.9879;MUSCLE CELL#0.9875;SURFACE PLASMON RESONANCE#0.9874;RECEPTOR ANTAGONIST#0.9871;MOLAR#0.9870;HUMAN UMBILICAL VEIN#0.9866;TINZAPARIN#0.9866;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9863;DNA SYNTHESIS#0.9858;SMOOTH MUSCLE#0.9855;MICROPARTICLE#0.9850;PROTEINASE INHIBITOR#0.9849;BLOOD CLOTTING#0.9844;UMBILICAL VEIN#0.9838;GLUTATHIONE#0.9832;ENOXAPARIN#0.9829;FACTOR I#0.9824;T- PA#0.9817;GENE EXPRESSION#0.9811;TOTAL HIP ARTHROPLASTY#0.9810;LOW DENSITY LIPOPROTEIN#0.9807;ACTIVATED PROTEIN C#0.9806;MALTOSE BINDING#0.9803;ENDOGENOUS THROMBIN POTENTIAL#0.9802;BLOOD COAGULATION#0.9797;IONOPHORE#0.9795;MALTOSE#0.9793;CELL MEMBRANE#0.9790;VASCULAR ENDOTHELIAL CELL#0.9784;COAGULATION#0.9781;HEPARIN BINDING#0.9779;PHOSPHATIDYLSERINE#0.9773;PROTHROMBIN COMPLEX CONCENTRATE#0.9771;SCOTT SYNDROME#0.9770;FACTOR VIII#0.9770;NEUTROPHIL#0.9770;HEPARIN#0.9762;LEUKOCYTE#0.9760;VENA CAVA#0.9760;ANTIPHOSPHOLIPID SYNDROME#0.9757;VASCULAR CELL#0.9753;CELL PROLIFERATION#0.9753;MECHANISM OF ACTION#0.9750;PROTEIN KINASE#0.9748;SULFATION#0.9748;L-ARGININE#0.9746;ARGININE#0.9745;TUMOR CELLS#0.9744;HISTIDINE#0.9743;CLOTTING#0.9741;ANTICOAGULANT ACTIVITY#0.9741;PARENTERAL#0.9740;THROMBIN RECEPTOR#0.9737;SELECTIN#0.9735;RANDOMIZED CLINICAL TRIAL#0.9731;ARTERY DISEASE#0.9729;CAROTID ARTERY#0.9728;ERYTHROCYTE#0.9726;POINT OF CARE#0.9725;FLUORESCEIN#0.9725;ANGIOGENESIS#0.9724;CORONARY ARTERY DISEASE#0.9723;PLASMA MEMBRANE#0.9717;THROMBOPLASTIN#0.9716;PERCUTANEOUS CORONARY INTERVENTION#0.9715;MACROPHAGE#0.9714;EPIDERMAL GROWTH FACTOR#0.9714;MONOCYTE#0.9712;SIGNALING PATHWAY#0.9711;PLASMA PROTEIN#0.9704;CELL SURFACE#0.9703;WARFARIN#0.9699;AUTOLYSIS#0.9698;CANCER CELL#0.9698;BLOOD LOSS#0.9696;PERIPHERAL BLOOD#0.9696;ATRIAL FIBRILLATION#0.9694;INTERNATIONAL NORMALIZED RATIO#0.9693;LYSIS#0.9693;TUMOR NECROSIS FACTOR#0.9690;LYSINE#0.9687;MODE OF ACTION#0.9687;CORONARY ARTERY#0.9686;MUTAGENESIS#0.9682;CLOPIDOGREL#0.9681;FIBRINOLYSIS#0.9681;DODECYL SULFATE#0.9679;FIBRINOGEN#0.9679;EMBOLISM#0.9677;SODIUM DODECYL SULFATE#0.9675;PLATELET ACTIVATION#0.9671;SIGNAL PEPTIDE#0.9670;HEMOPHILIA#0.9668;RANDOMIZED CONTROLLED TRIAL#0.9668;ENDOTHELIAL CELL#0.9667;LOW MOLECULAR WEIGHT HEPARIN#0.9666;ATHEROSCLEROTIC#0.9665;PLATELET AGGREGATION#0.9662;DISSEMINATED INTRAVASCULAR COAGULATION#0.9662;ACETYLSALICYLIC ACID#0.9662;INFLAMMATORY RESPONSE#0.9655;GLYCOSYLATION#0.9652;ISCHEMIA#0.9651;ATHEROSCLEROSIS#0.9649;CELL ACTIVATION#0.9649;TOXICITY#0.9647;HEPARIN INDUCED THROMBOCYTOPENIA#0.9647;GROWTH FACTOR#0.9645;VITAMIN K#0.9643;ASPIRIN#0.9643;ENDOTHELIUM#0.9637;CYTOKINE PRODUCTION#0.9636;ACUTE CORONARY SYNDROME#0.9632;COAGULATION FACTOR VIIA#0.9629;MITOGEN ACTIVATED PROTEIN#0.9625;RED BLOOD CELL#0.9625;PROTEIN BINDING#0.9624;IMMUNE RESPONSE#0.9622;GLUTAMIC ACID#0.9620;VITAMIN K ANTAGONIST#0.9618;HEMORRHAGIC#0.9613;CELL BOUND#0.9611;EXCRETION#0.9609;PLATELET-DERIVED GROWTH FACTOR#0.9609;ADENOSINE#0.9601;MYOCARDIAL INFARCTION#0.9599;EPITHELIAL CELL#0.9599;ENZYME ACTIVITY#0.9596;HEMOSTASIS#0.9595;MICROVESICLE#0.9593;MONONUCLEAR CELLS#0.9592;VASCULAR ENDOTHELIUM#0.9585;BREAST CANCER#0.9583;PULMONARY EMBOLISM#0.9580;STANDARD OF CARE#0.9578;APOPTOSIS#0.9576;EXTRACELLULAR MATRIX#0.9575;ALANINE#0.9566;ARTERY#0.9566;RANDOMISED CONTROLLED TRIAL#0.9561;ENZYME INHIBITOR#0.9558;POLYMERASE CHAIN REACTION#0.9557;FACTOR V LEIDEN#0.9550;HIGH RISK PATIENTS#0.9550;PROTEOGLYCAN#0.9545;APOPTOTIC#0.9542;ACUTE MYOCARDIAL INFARCTION#0.9539;DIPHOSPHATE#0.9537;VASCULAR DISEASE#0.9535;COMPLEMENT ACTIVATION#0.9534;HEMORRHAGE#0.9534;GLYCINE#0.9531;CELL ASSOCIATED#0.9527;CELL MIGRATION#0.9526;THROMBOCYTOPENIA#0.9524;CYTOCHROME P450#0.9521;T CELL#0.9521;KIDNEY DISEASE#0.9514;THROMBOSIS#0.9514;HYPERTENSION#0.9508;VENOUS THROMBOEMBOLIC EVENTS#0.9487;MECHANISMS OF ACTION#0.9485;THROMBOPHILIA#0.9484;AT BINDING#0.9482;PROTEASE ACTIVITY#0.9476;MAST CELL#0.9469;COAGULATION FACTOR IX#0.9469;CALIBRATED AUTOMATED THROMBOGRAM#0.9468;HEART DISEASE#0.9458;BLOOD VESSEL#0.9455;ZYMOGEN ACTIVATION#0.9443;ARRHYTHMIA#0.9406;INHIBITION OF BLOOD COAGULATION#0.9396;PHOSPHOLIPASE C#0.9394;NITRIC OXIDE#0.9384;LIVER DISEASE#0.9373;LECTIN#0.9358;DIGOXIN#0.9358;C TERMINAL DOMAIN#0.9349;ACTIVATION OF BLOOD COAGULATION#0.9329;LEFT ATRIAL APPENDAGE#0.9295;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9292;NERVOUS SYSTEM#0.9271;UROKINASE PLASMINOGEN ACTIVATOR#0.9270;BLOOD PLASMA#0.9251;SERUM ALBUMIN#0.9247;ORAL ANTICOAGULATION THERAPY#0.9236;DIABETES MELLITUS#0.9227;BIOTIN#0.9212;SIZE EXCLUSION CHROMATOGRAPHY#0.9199;METHIONINE#0.9168;ACETIC ACID#0.9163;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9162;GUANIDINE#0.9157;RECOMBINANT ACTIVATED FACTOR#0.9134;STUART FACTOR#0.9126;DIHYDROFOLATE REDUCTASE#0.9123;PROTEIN SYNTHESIS#0.9115;CAROTID ARTERY THROMBOSIS#0.9109;APROTININ#0.9109;INDOLE#0.9091;IFN-GAMMA#0.9041;REGULATION OF COAGULATION#0.9039;PROSTACYCLIN#0.9027;THYMIDINE#0.9022;WOUND HEALING#0.9010;SCANNING ELECTRON MICROSCOPY#0.9005;C REACTIVE PROTEIN#0.9002;NEPHROPATHY#0.8983;TRANSIENT ISCHEMIC ATTACK#0.8959;CHRONIC KIDNEY DISEASE#0.8949;KAOLIN#0.8919;COUMARINS#0.8918;YELLOW FEVER#0.8916;TRANSCRIPTION FACTOR#0.8897;PANCREATIC KALLIKREIN#0.8869;INTENTION TO TREAT#0.8863;AMIDASE ACTIVITY#0.8862;INTENSIVE CARE UNIT#0.8819;INFLAMMATORY CELL#0.8791;BENZIMIDAZOLE#0.8761;PROTEINASE ACTIVATED RECEPTOR#0.8757;BOVINE PANCREATIC TRYPSIN INHIBITOR#0.8757;NADROPARIN#0.8753;EDEMA#0.8742;JUGULAR VEIN#0.8732;ENDOTHELIAL CELL ACTIVATION#0.8718;OF ANTICOAGULATION THERAPY#0.8714;ANEMIA#0.8699;MITOGENIC ACTIVITY#0.8691;BREAST CANCER CELL#0.8687;PROTEIN KINASE C#0.8685;VIRAL HEPATITIS#0.8667;CENTRAL NERVOUS SYSTEM#0.8659;ESTROGEN RECEPTOR#0.8655;COLLAGENASE#0.8645;ENDOPLASMIC RETICULUM#0.8590;AORTIC VALVE#0.8578;ALPHA-1-PROTEINASE INHIBITOR#0.8575;RESONANCE ENERGY TRANSFER#0.8571;LUMINAL#0.8570;ASPARTIC ACID#0.8561;BONE MARROW#0.8558;CELL ADHESION#0.8537;TRANSFORMING GROWTH FACTOR#0.8532;TRYPTOPHAN#0.8528;PHOSPHATIDYLETHANOLAMINE#0.8528;THROMBIN GENERATION TEST#0.8513;TOBACCO ETCH VIRUS#0.8506;BAYER#0.8469;DIISOPROPYL FLUOROPHOSPHATE#0.8464;PLASMA GLYCOPROTEIN#0.8457;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8455;BLOOD PLATELETS#0.8451;PROTEIN COMPLEX#0.8435;CONGESTIVE HEART FAILURE#0.8423;VERY-LOW-DENSITY LIPOPROTEIN#0.8413;OUTER MEMBRANE#0.8410;GROWTH HORMONE#0.8400;CARRIE#0.8396;FIBROBLAST GROWTH FACTOR#0.8381;SPONTANEOUS ABORTION#0.8380;CYTOTOXICITY#0.8374;B CELL#0.8365;PROTEIN CA#0.8363;ARACHIDONIC ACID#0.8343;ISCHEMIA REPERFUSION INJURY#0.8306;CONNECTIVE TISSUE#0.8288;EPINEPHRINE#0.8244;GRANULOCYTE#0.8237;URINARY KALLIKREIN#0.8228;ISOTHERMAL TITRATION CALORIMETRY#0.8219;PROTEIN PROTEIN INTERACTION#0.8214;PRASUGREL#0.8198;HEPATOMA CELLS#0.8183;HIGH DENSITY LIPOPROTEIN#0.8182;HEMOPHILIA B#0.8181;PANCREATIC CANCER#0.8150;VENOUS BLOOD#0.8096;CELL DEATH#0.8090;MESANGIAL CELL#0.8088;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8076;LUPUS ERYTHEMATOSUS#0.8074;ANILINE#0.8059;HIRULOG#0.8046;REVERSE TRANSCRIPTION#0.8042;PULMONARY FIBROSIS#0.8030;GLUTAMINE#0.8010;SULFONAMIDE#0.8007;HERPES SIMPLEX#0.8005;PHOSPHATIDYLSERINE BINDING#0.8001;FACTOR V DEFICIENCY#0.7978;CORONARY ARTERY BYPASS#0.7964;LUNG FIBROBLASTS#0.7932;REGULATION OF BLOOD COAGULATION#0.7909;CELL GROWTH#0.7882;TRANEXAMIC ACID#0.7841;KINASE INHIBITOR#0.7829;TICAGRELOR#0.7828;ALKALINE PHOSPHATASE#0.7806;FACTOR XIIIA#0.7797;PHOSPHOLIPASE A#0.7795;MEGAKARYOCYTE#0.7790;UMBILICAL CORD#0.7758;ANION BINDING#0.7737;DIABETIC NEPHROPATHY#0.7719;STREPTOKINASE#0.7685;ION BINDING#0.7669;ENDOTHELIAL GROWTH FACTOR#0.7649;ASPARAGINE#0.7647;CYTOPLASM#0.7644;CARDIOLIPIN#0.7637;ACUTE ISCHEMIC STROKE#0.7627;NUCLEOCAPSID#0.7597;TRANSMISSION ELECTRON MICROSCOPY#0.7574;GLOMERULAR FILTRATION#0.7566;GLUCURONIC ACID#0.7560;TROPHOBLAST#0.7556;PLASMINOGEN ACTIVATION#0.7551;PERIPHERAL ARTERIAL DISEASE#0.7551;TYPE 2 DIABETIC#0.7533;ATORVASTATIN#0.7528;HERPES SIMPLEX VIRUS#0.7517;SPHINGOSINE#0.7515;MESOTHELIAL CELL#0.7494;IMMUNOGLOBULIN G#0.7483;TROPISM#0.7464;MAPK ACTIVATION#0.7461;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7460;HOST CELL#0.7458;ENDOCYTOSIS#0.7452;RECEPTOR AGONIST#0.7446;FACTOR VII DEFICIENCY#0.7429;STEM CELL#0.7410;ISCHEMIC HEART DISEASE#0.7406;SKELETAL MUSCLE#0.7400;LEUKOCYTE ADHESION#0.7383;POST-TRANSLATIONAL MODIFICATION#0.7383;TISSUE GROWTH FACTOR#0.7380;GASTROINTESTINAL TRACT#0.7376;L-LYSINE#0.7356;TYPE 2 DIABETES#0.7330;GROWTH FACTOR RECEPTOR#0.7314;VIRION#0.7313;CORONARY HEART DISEASE#0.7296;HUMAN BREAST CANCER#0.7279;SIMVASTATIN#0.7266;PULMONARY ARTERY#0.7247;CEREBROVASCULAR DISEASE#0.7208;ACUTE PULMONARY EMBOLISM#0.7199;CORONARY THROMBOSIS#0.7192;L-SERINE#0.7190;OVARIAN#0.7177;PULMONARY HYPERTENSION#0.7170;TOPICAL#0.7142;IMMUNE SYSTEM#0.7123;HEPATOCELLULAR CARCINOMA#0.7117;NEUROTOXIN#0.7108;GLOMERULONEPHRITIS#0.7076;HYPOTENSION#0.7066;PHENPROCOUMON#0.7058;MICROPARTICLE GENERATION#0.7054;ELLAGIC ACID#0.7047;ACUTE LUNG INJURY#0.7046;VENTRICULAR ASSIST DEVICE#0.7038;MULTIPLE MYELOMA#0.7023;GUANIDINE HYDROCHLORIDE#0.7009;PROTEIN OF INTEREST#0.6994;BLADDER CARCINOMA#0.6983;BLOOD-COAGULATION FACTOR VIIA#0.6964;CALIBRATED AUTOMATED THROMBOGRAPHY#0.6930;CEREBRAL ARTERY#0.6927;ANTITHROMBIN III DEFICIENCY#0.6917;COLON CANCER#0.6906;MICROSOME#0.6890;DNA BINDING#0.6884;POLYMORPHONUCLEAR LEUKOCYTES#0.6883;GLUCOSAMINE#0.6882;MACROPHAGE ACTIVATION#0.6880;T LYMPHOCYTE#0.6878;RESPIRATORY DISTRESS#0.6849;LENGTH OF STAY#0.6831;OBESE#0.6818;FRAGMIN#0.6812;SERIOUS ADVERSE EVENT#0.6809;ADP RECEPTOR#0.6801;TICLOPIDINE#0.6782;TRANSACTIVATION#0.6770;1,10-PHENANTHROLINE#0.6748;CYCLIN DEPENDENT KINASE#0.6728;ADVERSE DRUG REACTION#0.6723;COUMADIN#0.6714;EXTRACELLULAR VESICLE#0.6712;CATABOLISM#0.6695;A-GEL#0.6681;LEUCINE#0.6679;MICROVASCULAR ENDOTHELIAL CELL#0.6671;MIDDLE CEREBRAL ARTERY#0.6664;SERINE PROTEASE ACTIVITY#0.6646;GLOMERULAR FILTRATION RATE#0.6643;SEMEN#0.6623;LYMPHOCYTE ACTIVATION#0.6620;REACTIVE OXYGEN SPECIES#0.6610;PERIPHERAL ARTERY DISEASE#0.6599;METAL ION BINDING#0.6595;RETINAL PIGMENT EPITHELIAL#0.6585;GESTATION#0.6577;PERIPLASM#0.6567;LIPID BINDING#0.6556;NOVOSEVEN#0.6541;DALTEPARIN SODIUM#0.6522;HUMAN SERUM ALBUMIN#0.6490;PLASMIN ACTIVITY#0.6489;ART-123#0.6470;MORBID OBESITY#0.6462;INSULIN-LIKE GROWTH FACTOR#0.6460;ACUTE PHASE RESPONSE#0.6456;AORTIC ANEURYSM#0.6456;LEFT ATRIUM#0.6455;SMOOTH MUSCLE CELL PROLIFERATION#0.6436;MUSCLE CELL PROLIFERATION#0.6433;ASPARTATE#0.6432;BLOOD CIRCULATION#0.6426;ALVEOLAR MACROPHAGE#0.6424;NARROW THERAPEUTIC INDEX#0.6418;TO THE PROGRESSION#0.6415;PROGESTERONE#0.6415;OSTEOPOROSIS#0.6412;ABCIXIMAB#0.6407;FACTOR S#0.6400;RECEPTOR TYROSINE KINASE#0.6391;LEUKOCYTE ACTIVATION#0.6356;MAGNETIC RESONANCE IMAGING#0.6346;CALCIUM CHLORIDE#0.6312;ADJUSTED HAZARD RATIO#0.6306;HYPOXIA#0.6302;HUMAN WHOLE BLOOD#0.6287;NO BINDING#0.6270;ESTERASE ACTIVITY#0.6258;PROSTATE CANCER#0.6225;CHRONIC LIVER DISEASE#0.6201;LIPOPROTEIN LIPASE#0.6199;POST-THROMBOTIC SYNDROME#0.6194;FIBROBLAST PROLIFERATION#0.6188;CHANGE FROM BASELINE#0.6181;LIPID RAFT#0.6179;HUMAN IMMUNODEFICIENCY VIRUS#0.6172;TRANSFORMING GROWTH FACTOR BETA#0.6169;RHEUMATOID ARTHRITIS#0.6163;NITRO-L-ARGININE#0.6155;ANCROD#0.6142;EPTIFIBATIDE#0.6137;MEMBRANE LEAFLET#0.6127;RELATIVE RISK REDUCTION#0.6103;CEREBRAL INFARCTION#0.6098;PHOSPHODIESTERASE#0.6097;DIPYRIDAMOLE#0.6096;PROSTATE SPECIFIC ANTIGEN#0.6095;PLATELET ACTIVATING FACTOR#0.6073;GLOBIN#0.6065;CYCLIC AMP#0.6063;PERIPHERAL MONOCYTE#0.6046;PROTEASE COMPLEX#0.6046;TOLL LIKE RECEPTOR#0.6045;IMMUNE CELL#0.6020;MICROPARTICLE RELEASE#0.6020;NEUROTOXIC#0.6015;UTERUS#0.6004;CELLULOSE BINDING#0.6002
215	PEROXISOMAL MEMBRANE#1.0494;ATP BINDING CASSETTE TRANSPORTER#1.0434;ABC TRANSPORTER#1.0420;ATP BINDING CASSETTE#1.0396;SPINAL CORD#1.0362;ATP BINDING#1.0357;PEROXISOMAL#1.0336;PEROXISOME#1.0144;NEURODEGENERATIVE DISEASE#1.0135;OLIGODENDROCYTE#1.0123;ASTROCYTE#0.9990;NERVOUS SYSTEM#0.9826;DEMYELINATING DISEASE#0.9779;SKIN FIBROBLASTS#0.9705;ADENOSINE TRIPHOSPHATE#0.9675;CENTRAL NERVOUS SYSTEM#0.9673;ADRENAL CORTEX#0.9542;INFLAMMATORY RESPONSE#0.9537;ADRENAL GLAND#0.9433;PEROXISOME MEMBRANE#0.9431;STEM CELL#0.9329;MITOCHONDRIA#0.9281;CELL DEATH#0.9198;GENE EXPRESSION#0.8964;ADENOSINE#0.8895;FATTY ACID OXIDATION#0.8736;HEMATOPOIETIC STEM CELL#0.8585;PEROXISOMAL DISEASE#0.8538;MACROPHAGE#0.8536;PERIPHERAL BLOOD#0.8499;FATTY ACID BETA-OXIDATION#0.8447;STEM CELL TRANSPLANTATION#0.8423;ORGANELLE#0.8398;MAGNETIC RESONANCE IMAGING#0.8338;POLYMERASE CHAIN REACTION#0.8236;GLIAL CELL#0.8172;FATTY ACID METABOLISM#0.8126;GENETIC DISORDER#0.8013;X CHROMOSOME#0.8008;ACYL COA OXIDASE#0.7871;NUCLEOTIDE BINDING#0.7509;COENZYME A#0.7455;NITRIC OXIDE#0.7392;ENDOPLASMIC RETICULUM#0.7365;MONOCYTE#0.7340;LIPID METABOLISM#0.7278;ENDOTHELIAL CELL#0.7233;ADDISON'S DISEASE#0.7189;REACTIVE OXYGEN SPECIES#0.7183;FATTY ACID TRANSPORTER#0.7102;BONE MARROW#0.6859;APOPTOSIS#0.6848;GENETIC DISEASE#0.6831;LEUKODYSTROPHY#0.6692;PARAPLEGIA#0.6672;HEMATOPOIETIC CELL#0.6619;CANCER CELL#0.6617;PRO-INFLAMMATORY#0.6528;INDUCIBLE NITRIC OXIDE#0.6498;NITRIC OXIDE SYNTHASE#0.6470;NEUROPATHY#0.6372;ZELLWEGER SYNDROME#0.6347;LOVASTATIN#0.6325;FRONTAL#0.6227;HISTONE DEACETYLASE#0.6210;MULTIPLE SCLEROSIS#0.6165;TRANSCRIPTION FACTOR#0.6153;MICROGLIAL CELL#0.6107;NEUROLOGICAL DISORDER#0.6089;MICROVASCULAR ENDOTHELIAL CELL#0.6086
2160	ACTIVATED PLASMA THROMBOPLASTIN ANTECEDENT#1.1227;PLASMA THROMBOPLASTIN#1.0702;FIBRINOGEN#1.0329;FACTOR XI DEFICIENCY#1.0295;THROMBOPLASTIN#1.0221;RARE BLEEDING DISORDERS#1.0194;FACTOR VIII#1.0078;BLOOD COAGULATION#1.0033;THROMBOSIS#1.0028;COAGULATION#1.0014;HEMOSTASIS#0.9952;VITAMIN K#0.9885;CLOTTING#0.9863;HEMOPHILIA#0.9854;HEPARIN#0.9777;FIBRINOLYSIS#0.9691;ELLAGIC ACID#0.9430;ACTIVATION OF COAGULATION#0.9389;HK BINDING#0.9330;MYOCARDIAL INFARCTION#0.9310;HEMORRHAGE#0.9300;PLATELET ACTIVATION#0.9260;PLASMA PROTEIN#0.9077;KAOLIN#0.9043;ENDOTHELIAL CELL#0.8945;HEMORRHAGIC#0.8915;CHRISTMAS FACTOR#0.8727;POLYMERASE CHAIN REACTION#0.8489;CELL SURFACE#0.8468;VON WILLEBRAND'S DISEASE#0.8366;ARTERY#0.8285;PLASMA MEMBRANE#0.8237;PLATELET AGGREGATION#0.8118;PLASMA THROMBOPLASTIN COMPONENT#0.8055;LEUKOCYTE#0.7685;STUART FACTOR#0.7600;FACTOR XA#0.7437;DISSEMINATED INTRAVASCULAR COAGULATION#0.7420;VON WILLEBRAND DISEASE#0.7260;THROMBOPHILIA#0.7236;CAROTID ARTERY#0.7227;NEUTROPHIL#0.7128;MICROPARTICLE#0.7094;NEURITE#0.7086;ACTIVATED PROTEIN C#0.7061;BLOOD PLASMA#0.7047;INTRAVENOUS IMMUNOGLOBULIN#0.7025;NEURITE EXTENSION#0.6799;THROMBIN GENERATION ASSAY#0.6791;ALPHA-2 MACROGLOBULIN#0.6761;ENDOGENOUS THROMBIN POTENTIAL#0.6617;HEMOPHILIA B#0.6588;INHIBITION OF COAGULATION#0.6519;SURFACE PLASMON RESONANCE#0.6495;BLOOD CLOTTING#0.6386;MENORRHAGIA#0.6295;ALPHA 1-ANTITRYPSIN#0.6285;GLYCOSYLATION#0.6193;HEPARIN BINDING#0.6052
2161	HAGEMAN FACTOR ACTIVATION#1.1184;PLASMA THROMBOPLASTIN#1.0728;HAGEMAN FACTOR FRAGMENT HFF#1.0583;C1-INH#1.0563;PREKALLIKREIN ACTIVATOR#1.0461;FACTOR I#1.0440;ELLAGIC ACID#1.0372;ACTIVATION OF COAGULATION#1.0359;FACTOR XII DEFICIENCY#1.0357;KAOLIN#1.0233;BLOOD COAGULATION#1.0182;COAGULATION#1.0162;MYOCARDIAL INFARCTION#1.0137;HEREDITARY ANGIOEDEMA#1.0122;FIBRINOLYSIS#1.0117;ANGIOEDEMA#1.0084;FIBRINOGEN#0.9969;THROMBOPLASTIN#0.9948;CLOTTING#0.9929;PLASMA PROTEIN#0.9894;THROMBOSIS#0.9868;HEPARIN#0.9829;MAST CELL#0.9749;ENDOTHELIAL CELL#0.9674;HEMOSTASIS#0.9606;NEUTROPHIL#0.9529;FACTOR VIII#0.9496;ALPHA-2 MACROGLOBULIN#0.9481;BLOOD CLOTTING#0.9365;INFLAMMATORY RESPONSE#0.9348;ARGININE#0.9341;BLOOD PLASMA#0.9326;GROWTH FACTOR#0.9268;EDEMA#0.9244;ANGIOTENSIN CONVERTING ENZYME#0.9114;SODIUM DODECYL SULFATE#0.9058;DODECYL SULFATE#0.9057;SULFATIDE#0.9035;LEUKOCYTE#0.9001;NEPHROTIC SYNDROME#0.8844;FACTOR XII ACTIVATION#0.8804;POLYMERASE CHAIN REACTION#0.8665;COMPLEMENT ACTIVATION#0.8659;ESTERASE ACTIVITY#0.8631;PLATELET AGGREGATION#0.8508;DISSEMINATED INTRAVASCULAR COAGULATION#0.8435;L-ARGININE#0.8365;HISTAMINE#0.8348;SWELLING#0.8284;ALZHEIMER'S DISEASE#0.8268;ENZYME INHIBITOR#0.8168;MONOCYTE#0.8128;BASOPHIL#0.8086;ARTERY#0.8058;ESTROGENS#0.7967;FACTOR XA#0.7956;UROKINASE#0.7841;ACE INHIBITOR#0.7822;THROMBOPHILIA#0.7692;KALLIKREIN I#0.7646;HEMORRHAGE#0.7547;HEPATOCYTE GROWTH FACTOR#0.7403;KININ CASCADE#0.7380;DIGESTION#0.7377;GENE EXPRESSION#0.7311;SYNOVIAL FLUID#0.7232;LYSINE#0.7203;CELL SURFACE#0.7191;HYPOTENSION#0.7153;CHRISTMAS FACTOR#0.7055;ABDOMINAL PAIN#0.7029;MACROPHAGE#0.6991;STUART FACTOR#0.6965;PERIPHERAL BLOOD#0.6953;TRANSCRIPTION FACTOR#0.6944;ANTIHEMOPHILIC FACTOR#0.6895;PROTEINASE INHIBITOR#0.6892;PLATELET ACTIVATION#0.6875;HEMORRHAGIC#0.6853;BETA-2#0.6828;ISCHEMIA#0.6811;CORONARY ARTERY#0.6733;HEART DISEASE#0.6717;IMMUNOGLOBULIN G#0.6714;LIVER DISEASE#0.6656;BISMUTH#0.6617;DIISOPROPYL FLUOROPHOSPHATE#0.6615;ACTIVATED PLASMA THROMBOPLASTIN ANTECEDENT#0.6614;APROTININ#0.6548;STREPTOKINASE#0.6496;CORONARY ARTERY DISEASE#0.6494;ARTERY DISEASE#0.6492;CEREBRAL ISCHEMIA#0.6469;TRASYLOL#0.6252;ESTRADIOL#0.6206;HEMOPHILIA#0.6139;MOLAR#0.6079;SUBARACHNOID SPACE#0.6003
2162	TGASE ACTIVITY#1.0531;FACTOR XIIIA#1.0389;DERMAL DENDRITIC CELLS#1.0382;FIBRIN STABILIZING FACTOR#1.0349;FACTOR XIII DEFICIENCY#1.0341;TISSUE TRANSGLUTAMINASE#1.0326;RECEPTOR ANTAGONIST#1.0311;ALPHA 1-ANTITRYPSIN#1.0303;FACTOR VIII#1.0269;TRANSGLUTAMINASE ACTIVITY#1.0238;SMOOTH MUSCLE ACTIN#1.0215;BLOOD CLOT#1.0214;PUTRESCINE#1.0146;BLOOD COAGULATION#1.0142;SMOOTH MUSCLE#1.0105;COAGULATION#1.0085;TUMOR CELLS#1.0057;KAPOSI'S SARCOMA#1.0052;GLUTAMINE#1.0045;STROMAL CELL#1.0041;DENDRITIC CELL#0.9999;FIBROUS HISTIOCYTOMA#0.9991;MONOCYTE#0.9971;CLOTTING#0.9971;LANGERHANS CELL#0.9969;T LYMPHOCYTE#0.9967;HISTIOCYTOMA#0.9959;FIBRINOGEN#0.9956;LYSINE#0.9947;SODIUM DODECYL SULFATE#0.9940;DODECYL SULFATE#0.9938;DERMATOFIBROSARCOMA PROTUBERANS#0.9926;MACROPHAGE#0.9918;DERMIS#0.9853;GROWTH FACTOR#0.9829;EXTRACELLULAR MATRIX#0.9820;SHORT TANDEM REPEAT#0.9809;T CELL#0.9805;CONNECTIVE TISSUE#0.9791;INFLAMMATORY CELL#0.9774;ENDOTHELIAL CELL#0.9771;JUVENILE XANTHOGRANULOMA#0.9738;LYSIS#0.9725;BLOOD CLOTTING#0.9714;THROMBOSIS#0.9712;MAST CELL#0.9701;FIBRINOLYSIS#0.9699;CYTOPLASM#0.9662;WOUND HEALING#0.9655;PLATELET AGGREGATION#0.9645;STROMA#0.9596;MESENCHYMAL CELL#0.9537;HEPARIN#0.9518;PLASMA PROTEIN#0.9517;CROHN'S DISEASE#0.9510;CELL ADHESION#0.9486;TUMOR NECROSIS FACTOR#0.9461;IMMUNE RESPONSE#0.9425;POLYMERASE CHAIN REACTION#0.9387;KERATINOCYTE#0.9386;BASAL CELL#0.9375;BONE MARROW#0.9371;LYMPH NODE#0.9340;HISTIOCYTOSIS#0.9289;BLOOD VESSEL#0.9143;GENE EXPRESSION#0.9140;HEMOSTASIS#0.9100;ANTIGEN PRESENTING CELLS#0.9039;PSORIASIS#0.9003;FIBROMA#0.9003;BASAL CELL CARCINOMA#0.8939;TRANSCRIPTION FACTOR#0.8899;FIBRINOGEN GAMMA CHAIN#0.8862;CELL SURFACE#0.8861;MYOCARDIAL INFARCTION#0.8855;STEM CELL#0.8835;FORMALIN#0.8833;FIBRIL#0.8831;CELL PROLIFERATION#0.8821;PROTEINASE INHIBITOR#0.8815;OSTEOBLAST#0.8811;BLOOD PLASMA#0.8807;FACTOR V LEIDEN#0.8780;DIGESTION#0.8735;CHONDROCYTE#0.8715;ENDOTHELIAL GROWTH FACTOR#0.8660;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8660;HISTOGENESIS#0.8641;NODULAR#0.8585;ENDOTHELIUM#0.8579;SIGNALING PATHWAY#0.8552;LEUKOCYTE#0.8527;ANGIOGENESIS#0.8525;INTERSTITIAL CELL#0.8520;CATALYTIC ACTIVITY#0.8475;MONONUCLEAR CELLS#0.8443;LANGERHANS CELL HISTIOCYTOSIS#0.8399;ARTERY#0.8395;APOPTOSIS#0.8365;B CELL#0.8323;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8295;SOLITARY FIBROUS TUMOR#0.8269;SCLEROTIC#0.8237;NERVOUS SYSTEM#0.8191;ENDOPLASMIC RETICULUM#0.8115;BIOTIN#0.8103;MUSCLE CELL#0.8101;HEMANGIOPERICYTOMA#0.8039;ERYTHROCYTE#0.8036;FIBRONECTIN BINDING#0.7989;SMOOTH MUSCLE CELL#0.7954;HYPERTENSION#0.7924;PERIPHERAL BLOOD#0.7885;PLATELET ACTIVATION#0.7847;TRANSFORMING GROWTH FACTOR#0.7725;T- PA#0.7680;HEMOCYTE#0.7611;FACTOR XA#0.7602;MUTAGENESIS#0.7592;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7556;PLASMA MEMBRANE#0.7535;PROTEIN KINASE#0.7514;FOLLICULAR DENDRITIC CELL#0.7474;EOSIN#0.7446;NEUROFIBROMA#0.7331;HEMOLYMPH CLOTTING#0.7296;ENZYME ACTIVITY#0.7273;DERMAL FIBROBLAST#0.7260;PLASMA CELL#0.7228;SQUAMOUS CELL CARCINOMA#0.7197;ATHEROSCLEROSIS#0.7173;SALIVARY GLAND#0.7167;GRAFT VERSUS HOST#0.7164;LECTIN#0.7142;BASEMENT MEMBRANE#0.7091;ELASTIC FIBER#0.7057;CALCIUM CHLORIDE#0.7057;LYSOSOME#0.7019;GRANULOCYTE#0.6996;MYOFIBROBLAST#0.6977;COLLAGEN TYPE I#0.6958;RHEUMATOID ARTHRITIS#0.6955;LICHEN PLANUS#0.6942;SERUM ALBUMIN#0.6939;PROGENITOR CELL#0.6888;DISSEMINATED INTRAVASCULAR COAGULATION#0.6880;NEUROFILAMENT#0.6868;EOSINOPHIL#0.6849;CENTRAL NERVOUS SYSTEM#0.6800;DERMATITIS#0.6795;PERIPHERAL NERVE#0.6729;HEPARIN BINDING#0.6708;HEART DISEASE#0.6698;IMMUNE SYSTEM#0.6687;SEBACEOUS CARCINOMA#0.6676;ANDROGEN RECEPTOR#0.6649;HEMORRHAGE#0.6649;ORAL MUCOSA#0.6606;PLASMINOGEN ACTIVATION#0.6583;HAMARTOMA#0.6555;CLEFT LIP#0.6519;ULCERATIVE COLITIS#0.6500;GROWTH PATTERN#0.6472;BLOOD LOSS#0.6468;TRANSMISSION ELECTRON MICROSCOPY#0.6433;CELL CYCLE#0.6424;CELL ADHESION MOLECULE#0.6411;CERVICAL#0.6407;DENDRITIC CELL SUBSETS#0.6376;REGENERATION#0.6328;NEVUS#0.6327;MEGAKARYOCYTE#0.6326;GAMMA GLUTAMYLTRANSFERASE#0.6273;PROGESTERONE#0.6268;RIBOSOMAL PROTEIN#0.6239;FIBRINOGEN BINDING#0.6224;GROWTH FACTOR RECEPTOR#0.6219;NALOXONE#0.6191;CORONARY ARTERY#0.6157;NODULAR MALIGNANT MELANOMA#0.6150;GRANULAR CELL TUMOR#0.6132;COLONY-STIMULATING FACTOR#0.6117;INTEGRIN BINDING#0.6082;MAST CELL DEGRANULATION#0.6077;ANAPLASTIC LYMPHOMA KINASE#0.6049;ARGININE#0.6035
2165	SHORT TANDEM REPEAT#1.0390;COAGULATION#1.0236;PLASMA PROTEIN#0.8600;HARDY WEINBERG EQUILIBRIUM#0.8503;POLYMERASE CHAIN REACTION#0.6554;COPY NUMBER VARIATION#0.6121
2166	HYDROLASE INHIBITOR#1.0531;POSITRON EMISSION TOMOGRAPHY#1.0531;PIPERAZINE#1.0519;HYDROLASE ACTIVITY#1.0504;PHOSPHOLIPASE D#1.0350;PHOSPHATIDYLETHANOLAMINE#1.0340;SERINE HYDROLASE#1.0321;ENZYME ACTIVITY#1.0273;STRUCTURE ACTIVITY RELATIONSHIP#1.0266;CARBAMIC ACID#1.0252;IBUPROFEN#1.0233;AMYGDALA#1.0197;ETHANOLAMINE#1.0175;ADIPOSE TISSUE#1.0175;LIPASE INHIBITOR#1.0149;OBESE#1.0126;STRIATUM#1.0099;HYPERTENSION#1.0093;EPITHELIAL CELL#1.0089;ANTI INFLAMMATORY DRUGS#1.0085;ETHANOL#1.0054;ENZYME INHIBITOR#1.0027;WEIGHT LOSS#1.0027;RECEPTOR LIGAND#1.0025;PROGESTERONE#1.0020;CATABOLISM#0.9964;NOCICEPTION#0.9960;GENE EXPRESSION#0.9959;CELL MEMBRANE#0.9952;TRANSIENT RECEPTOR POTENTIAL#0.9947;FATTY ACID BINDING#0.9941;OPIOID RECEPTOR#0.9932;CENTRAL NERVOUS SYSTEM#0.9899;DOPAMINE#0.9899;RIMONABANT#0.9897;DELTA-9-TETRAHYDROCANNABINOL#0.9883;ENDOGENOUS CANNABINOID SYSTEM#0.9880;MECHANISM OF ACTION#0.9867;ANXIETY DISORDER#0.9860;RECEPTOR AGONIST#0.9859;SPINAL CORD#0.9841;SIGNALING MOLECULE#0.9840;NERVOUS SYSTEM#0.9833;ELEVATED PLUS MAZE#0.9827;PEROXISOME#0.9818;APOPTOSIS#0.9799;CANNABINOID RECEPTOR#0.9798;CANCER CELL#0.9798;TETRAHYDROCANNABINOL#0.9795;ARACHIDONIC ACID#0.9794;ALZHEIMER'S DISEASE#0.9793;CELL DEATH#0.9766;POLYMERASE CHAIN REACTION#0.9749;SIGNALING PATHWAY#0.9746;CANNABINOID RECEPTOR LIGAND#0.9743;COLITIS#0.9741;NITRIC OXIDE#0.9734;RECEPTOR ANTAGONIST#0.9669;SR141716A#0.9641;MACROPHAGE#0.9636;PRO-INFLAMMATORY#0.9610;PALMITOYL#0.9604;INDOMETHACIN#0.9593;PARKINSON'S DISEASE#0.9569;FORMALIN#0.9568;TOXICITY#0.9556;CELL PROLIFERATION#0.9545;GROWTH FACTOR#0.9516;LIPID METABOLISM#0.9493;PROTEIN KINASE#0.9438;UTERUS#0.9411;NEUROBLASTOMA#0.9355;PERIPHERAL BLOOD#0.9335;PLASMA MEMBRANE#0.9318;N ACYLTRANSFERASE#0.9225;BREAST CANCER#0.9207;WEIGHT GAIN#0.9203;NEUROTRANSMISSION#0.9197;APOPTOTIC#0.9147;NEUROPROTECTION#0.9129;FLURBIPROFEN#0.9104;ASTROCYTE#0.9088;PROSTATE CANCER#0.9087;EPOXIDE HYDROLASE#0.9068;REVERSE TRANSCRIPTION#0.9050;SCIATIC NERVE#0.9037;SERTOLI CELL#0.8997;NITRIC OXIDE SYNTHASE#0.8994;PYRAZOLE#0.8989;SOLUBLE EPOXIDE HYDROLASE#0.8987;PHOSPHOLIPASE A2#0.8978;ENDOPLASMIC RETICULUM#0.8964;ENDOTHELIUM#0.8929;PARACETAMOL#0.8880;MECHANISMS OF ACTION#0.8872;MIGRAINE#0.8864;NALOXONE#0.8852;MULTIPLE SCLEROSIS#0.8804;MONONUCLEAR CELLS#0.8801;MICROSOME#0.8762;NEUROPATHY#0.8738;MUTAGENESIS#0.8718;CONDITIONED PLACE PREFERENCE#0.8688;CHOROID PLEXUS#0.8674;FORCED SWIM TEST#0.8670;GESTATION#0.8648;FRONTAL#0.8617;SR141716#0.8585;TROPHOBLAST#0.8567;ACETAMINOPHEN#0.8566;NEUROLOGICAL DISORDER#0.8484;CYTOCHROME P450#0.8442;STROMAL CELL#0.8435;PURKINJE CELL#0.8428;GLUTAMATE RECEPTOR#0.8411;VANILLOID RECEPTOR 1#0.8395;CATION CHANNEL#0.8381;INFLAMMATORY RESPONSE#0.8367;HIGH FAT DIET#0.8358;CANNABIS DEPENDENCE#0.8356;NEURONAL CELLS#0.8348;PROPOFOL#0.8293;TRANSCRIPTION FACTOR#0.8286;COGNITION#0.8231;ION CHANNEL#0.8229;GLYCINE#0.8215;DOPAMINE RECEPTOR#0.8189;OLEIC ACID#0.8130;RECEPTOR BINDING#0.8080;CATALYTIC ACTIVITY#0.8064;FOREBRAIN#0.8063;SENSITIZATION#0.8052;SYNAPTIC TRANSMISSION#0.8051;ACETYLCHOLINE#0.8048;SMOOTH MUSCLE#0.8041;IMMUNE RESPONSE#0.8029;CHRONIC CEREBRAL HYPOPERFUSION#0.8014;CISPLATIN#0.8012;MEMORY IMPAIRMENT#0.7968;DORSAL ROOT GANGLION#0.7968;LONG TERM POTENTIATION#0.7967;REACTIVE OXYGEN SPECIES#0.7942;SMALL INTESTINE#0.7927;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7915;INFLAMMATORY BOWEL DISEASE#0.7915;ADIPOCYTE#0.7898;VISCERAL ADIPOSE TISSUE#0.7885;ANOREXIA NERVOSA#0.7873;THALAMUS#0.7857;LYSINE#0.7819;MIDBRAIN#0.7817;EMBRYO DEVELOPMENT#0.7806;AMIDASE ACTIVITY#0.7762;BREAST CANCER CELL#0.7757;NEUROTOXIC#0.7750;CHRONIC CONSTRICTION INJURY#0.7739;HYPERACTIVITY#0.7724;SMALL MESENTERIC ARTERIES#0.7723;ACETIC ACID#0.7717;VOMITING#0.7621;IMMUNE SYSTEM#0.7602;CELL MIGRATION#0.7602;T LYMPHOCYTE#0.7589;CYSTITIS#0.7586;MOLECULAR DYNAMICS SIMULATION#0.7582;SPERMATOZOA#0.7581;TUMOR NECROSIS FACTOR#0.7577;IMMUNE CELL#0.7538;INTESTINAL MOTILITY#0.7531;NEUROTOXICITY#0.7518;SOCIAL BEHAVIOR#0.7477;OOCYTE#0.7461;SUCROSE#0.7451;SUBCUTANEOUS ADIPOSE TISSUE#0.7442;POST-TRAUMATIC STRESS DISORDER#0.7421;OXIDATIVE METABOLISM#0.7409;BASAL GANGLIA#0.7392;ECTOPIC PREGNANCY#0.7343;EATING DISORDER#0.7318;ENDOMETRIUM#0.7310;HYPERSENSITIVITY#0.7307;NEUROGENESIS#0.7289;AMACRINE CELL#0.7284;PHOSPHOLIPASE A#0.7258;LUNG CANCER#0.7227;MEMBRANE FRACTION#0.7225;POTASSIUM CHANNEL#0.7203;URINARY BLADDER#0.7166;OSTEOARTHRITIS#0.7145;NUCLEUS ACCUMBENS SHELL#0.7125;ARTERY#0.7124;LEUKOCYTE#0.7098;LONG TERM DEPRESSION#0.7071;IODOPHENYL#0.7046;METHAMPHETAMINE#0.7046;MORRIS WATER MAZE#0.7032;SLOW TRANSIT CONSTIPATION#0.7028;MEMBRANE TRANSPORT#0.6990;LOCOMOTION#0.6982;CONJUGATION#0.6974;CONSTRICTION#0.6967;QUANTITATIVE REAL TIME#0.6951;PYRAMIDAL CELL#0.6946;T CELL#0.6898;INDOLE#0.6876;RECEPTOR ACTIVITY#0.6859;EDEMA#0.6813;GLUCOSE METABOLISM#0.6801;ALANINE#0.6801;MICROGLIAL CELL#0.6767;INFERTILITY#0.6754;GROWTH FACTOR RECEPTOR#0.6754;HUMAN WHOLE BLOOD#0.6735;PROSTAGLANDIN E2#0.6732;ROSTRAL VENTROMEDIAL MEDULLA#0.6729;DENTATE GYRUS#0.6718;CONSTIPATION#0.6713;CELLULAR MEMBRANE#0.6712;RETINAL GANGLION CELL#0.6689;PROGENITOR CELL#0.6678;NERVE GROWTH FACTOR#0.6654;GABAPENTIN#0.6645;DIARRHEA#0.6644;BLOOD VESSEL#0.6641;SPINAL NERVE LIGATION#0.6636;POLYCYSTIC OVARY SYNDROME#0.6634;ANOREXIA#0.6624;MOTOR ACTIVITY#0.6604;NIMESULIDE#0.6587;ESTRADIOL#0.6583;BIPOLAR CELL#0.6566;LITHIUM#0.6546;SPERM MOTILITY#0.6543;BLOOD BRAIN BARRIER#0.6542;CARPROFEN#0.6540;ALCOHOL DEPENDENCE#0.6514;STEM CELL#0.6494;PROTEIN KINASE A#0.6471;LIPID RAFT#0.6465;ASPARTATE#0.6446;CELLULAR LOCALIZATION#0.6444;COLONIC TRANSIT#0.6441;PERIPHERAL NERVE#0.6438;TYPE 2 DIABETES#0.6430;MUSCLE CELL#0.6393;MICTURITION#0.6376;CONDITIONED PLACE AVERSION#0.6374;ALCOHOL USE DISORDER#0.6354;NEURODEGENERATIVE DISEASE#0.6293;HUNTINGTON'S DISEASE#0.6285;HYPOTHALAMIC PITUITARY ADRENAL#0.6271;MENSTRUAL CYCLE#0.6270;COLORECTAL#0.6270;ESTROUS CYCLE#0.6260;GRANULOSA CELL#0.6225;GI TRACT#0.6209;CAMP RESPONSE ELEMENT#0.6208;MAST CELL#0.6193;PAIN DISORDER#0.6193;MOOD DISORDER#0.6192;GASTRIC EMPTYING#0.6184;GENISTEIN#0.6184;EPILEPSY#0.6177;EXTRACELLULAR SPACE#0.6173;HEROIN#0.6162;MEDIAL PREFRONTAL CORTEX#0.6162;SERUM ALBUMIN#0.6159;PACLITAXEL#0.6155;TRAUMATIC BRAIN INJURY#0.6154;ISCHEMIA#0.6149;BODY WEIGHT GAIN#0.6132;CEREBRAL CORTEX#0.6126;SMOOTH MUSCLE CELL#0.6101;NMDA RECEPTOR#0.6100;SKELETAL MUSCLE#0.6094;DRONABINOL#0.6046;CATECHOL O METHYLTRANSFERASE#0.6034;O METHYLTRANSFERASE#0.6023;NEUROTRANSMITTER RELEASE#0.6023;ADENOCARCINOMA#0.6019
2167	FATTY ACID TRANSPORT#1.0552;LIPID BINDING PROTEIN#1.0476;RETINOL BINDING#1.0446;LIPID BINDING#1.0419;RETINOL#1.0378;FATTY ACID TRANSLOCASE#1.0369;SYSTOLIC BLOOD PRESSURE#1.0340;STEAROYL COA DESATURASE#1.0313;C REACTIVE PROTEIN#1.0308;FATTY ACID SYNTHASE#1.0295;FATTY ACID BINDING#1.0276;GESTATIONAL DIABETES MELLITUS#1.0264;LIPOPROTEIN LIPASE#1.0254;CORONARY ARTERY DISEASE#1.0248;ARTERY DISEASE#1.0239;CORONARY ARTERY#1.0230;GESTATIONAL DIABETES#1.0206;FATTY ACID TRANSPORTER#1.0171;HORMONE SENSITIVE LIPASE#1.0149;GLOMERULAR FILTRATION#1.0132;CARNITINE#1.0124;STEROL REGULATORY ELEMENT#1.0112;TYPE 2 DIABETIC#1.0110;ARTERY#1.0108;POLYCYSTIC OVARY SYNDROME#1.0107;TRIGLYCERIDE LIPASE#1.0107;BINDING PROTEIN 1#1.0103;COENZYME A#1.0103;ACETYL COA CARBOXYLASE#1.0102;ENHANCER BINDING PROTEIN#1.0068;ENHANCER BINDING#1.0065;ATHEROSCLEROSIS#1.0063;TYPE 2 DIABETES MELLITUS#1.0060;FATTY ACID SYNTHESIS#1.0053;FIBROBLAST GROWTH FACTOR#1.0052;MACROPHAGE#1.0045;2 DIABETES MELLITUS#1.0045;PHOSPHOENOLPYRUVATE CARBOXYKINASE#1.0043;ADIPOCYTE#1.0039;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0034;ATHEROSCLEROTIC#1.0033;TROGLITAZONE#1.0018;SLEEP APNEA#1.0015;PIOGLITAZONE#1.0007;BREAST CANCER#1.0003;LINEAR REGRESSION ANALYSIS#0.9985;WEIGHT LOSS#0.9964;LIPID DROPLET FORMATION#0.9964;MONOCYTE#0.9958;ENDOTHELIAL CELL#0.9949;FOAM CELL FORMATION#0.9946;PLASMA MEMBRANE#0.9943;INSULIN-LIKE GROWTH FACTOR#0.9942;HIGH DENSITY LIPOPROTEIN#0.9932;ACUTE ISCHEMIC STROKE#0.9931;ENDOPLASMIC RETICULUM#0.9929;OLEIC ACID#0.9926;QUANTITATIVE REAL TIME#0.9922;HYPOXIA#0.9917;INSULIN RECEPTOR#0.9912;MULTIPLE REGRESSION ANALYSIS#0.9908;LIPID DROPLET#0.9905;LIVER X RECEPTOR#0.9900;GLUCOSE METABOLISM#0.9899;EPITHELIAL CELL#0.9898;ROSIGLITAZONE#0.9895;FAT CELL#0.9882;TERMINAL DIFFERENTIATION#0.9880;EPIDIDYMAL ADIPOSE TISSUE#0.9877;FATTY LIVER DISEASE#0.9877;PRO-INFLAMMATORY#0.9875;PEROXISOME#0.9869;LIPID HOMEOSTASIS#0.9867;FAT PAD#0.9857;DIABETES MELLITUS#0.9856;FATTY ACID METABOLISM#0.9854;ANGIOGENESIS#0.9852;ACYL COA OXIDASE#0.9852;LIVER DISEASE#0.9849;PALMITATE#0.9848;CANCER CELL#0.9846;VISCERAL ADIPOSE TISSUE#0.9844;LOW DENSITY LIPOPROTEIN#0.9842;REVERSE TRANSCRIPTION#0.9842;OBSTRUCTIVE SLEEP APNEA#0.9838;KERATINOCYTE#0.9837;ALKALINE PHOSPHATASE#0.9831;FATTY ACID OXIDATION#0.9822;TUMOR NECROSIS FACTOR#0.9819;INFLAMMATORY RESPONSE#0.9808;HUMAN ADIPOSE TISSUE#0.9808;TRANSCRIPTION FACTOR#0.9806;LIPOGENESIS#0.9805;BROWN ADIPOSE TISSUE#0.9801;GLOMERULAR FILTRATION RATE#0.9801;HYPERTENSION#0.9800;GROWTH FACTOR#0.9797;POLYMERASE CHAIN REACTION#0.9790;LIPOLYSIS#0.9786;SUBCUTANEOUS ADIPOSE TISSUE#0.9785;DNA METHYLATION#0.9779;RETINOIC ACID#0.9777;GLUCOSE HOMEOSTASIS#0.9768;FATTY LIVER#0.9759;PROSTATE CANCER#0.9755;PRE-ECLAMPSIA#0.9755;TYPE 2 DIABETES#0.9750;DIET INDUCED OBESITY#0.9740;SKELETAL MUSCLE#0.9739;PPAR SIGNALING PATHWAY#0.9738;REACTIVE OXYGEN SPECIES#0.9733;ADIPOCYTE DIFFERENTIATION#0.9724;T CELL#0.9724;WHITE ADIPOSE TISSUE#0.9713;ENDOPLASMIC RETICULUM STRESS#0.9710;CORD BLOOD#0.9709;LIPID METABOLISM#0.9706;OSTEOBLAST#0.9701;OBESE#0.9700;SMOOTH MUSCLE#0.9699;CELL CYCLE#0.9694;ENDOTHELIAL GROWTH FACTOR#0.9681;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9681;STROMAL CELL#0.9671;OSTEOGENESIS#0.9670;RETINOID X RECEPTOR#0.9668;LIPID STORAGE#0.9667;GLUCOSE TOLERANCE TEST#0.9666;PREADIPOCYTE#0.9663;MUSCLE CELL#0.9663;URIC ACID#0.9662;OVARIAN#0.9661;SIGNALLING PATHWAY#0.9659;CELL DIFFERENTIATION#0.9654;APOPTOSIS#0.9649;ADIPOGENESIS#0.9648;CELL PROLIFERATION#0.9648;ADIPOSE TISSUE#0.9643;GLUCOSE UPTAKE#0.9642;GLUTATHIONE#0.9641;DEXAMETHASONE#0.9640;TRANSCRIPTION FACTOR BINDING#0.9627;HYPERGLYCEMIA#0.9624;INSULIN SECRETION#0.9618;CARNITINE PALMITOYL TRANSFERASE#0.9613;BODY WEIGHT GAIN#0.9604;PROTEIN KINASE#0.9601;WEIGHT GAIN#0.9598;GENE EXPRESSION#0.9591;HIGH FAT DIET#0.9581;CYTOPLASM#0.9575;BONE MARROW#0.9560;PROGENITOR CELL#0.9556;SIGNALING PATHWAY#0.9553;CELL GROWTH#0.9546;CARDIOVASCULAR RISK FACTOR#0.9514;INTIMA MEDIA THICKNESS#0.9514;DNA BINDING#0.9514;MOLECULAR DYNAMICS SIMULATION#0.9480;GLUCOSE INTOLERANCE#0.9478;MESENCHYMAL STEM CELL#0.9470;ARACHIDONIC ACID#0.9465;STEM CELL#0.9457;EXTRACELLULAR MATRIX#0.9452;PHOSPHOENOLPYRUVATE#0.9440;TRANSACTIVATION#0.9430;ADIPOSE-DERIVED STEM CELL#0.9425;TROPHOBLAST#0.9419;BONE FORMATION#0.9405;OSTEOBLAST DIFFERENTIATION#0.9399;MITOGEN ACTIVATED PROTEIN#0.9397;FOR ADIPOCYTE DIFFERENTIATION#0.9394;CYTOKINE PRODUCTION#0.9390;NITRIC OXIDE#0.9377;TISSUE DEVELOPMENT#0.9373;BONE MORPHOGENETIC PROTEIN#0.9368;SMOOTH MUSCLE CELL#0.9365;LYSINE#0.9363;APOPTOTIC#0.9358;VASCULAR CELL#0.9356;ALCOHOLIC FATTY LIVER#0.9329;LIPID TRANSPORT#0.9309;ADIPOSE TISSUE MASS#0.9294;OVARIAN CANCER#0.9292;BODY FAT MASS#0.9274;BRAIN NATRIURETIC PEPTIDE#0.9258;CELL SURFACE#0.9257;RNA INTERFERENCE#0.9251;TESTOSTERONE#0.9223;SCAVENGER RECEPTOR#0.9220;LIPID SYNTHESIS#0.9210;REGULATION OF ADIPOGENESIS#0.9209;ADIPOSE TISSUE DEVELOPMENT#0.9199;ORAL GLUCOSE TOLERANCE#0.9195;MESENCHYMAL CELL#0.9194;ADRENERGIC RECEPTOR#0.9193;INHIBITION OF ADIPOGENESIS#0.9183;ADENOSINE#0.9170;PALMITOYL#0.9163;ENDOTHELIUM#0.9159;GESTATION#0.9158;ENERGY HOMEOSTASIS#0.9151;PHOSPHATASE ACTIVITY#0.9142;HUMAN MESENCHYMAL STEM#0.9139;PEROXISOME PROLIFERATION#0.9131;MAMMARY GLAND#0.9108;MINERALIZATION#0.9106;CELL ADHESION#0.9092;BLOOD VESSEL#0.9084;AND BODY COMPOSITION#0.9073;PROTEIN PROTEIN INTERACTION#0.9068;MYOCARDIAL INFARCTION#0.9067;CONJUGATED LINOLEIC ACID#0.9065;OSTEOPOROSIS#0.9064;PRECURSOR CELL#0.9057;3-ISOBUTYL-1-METHYLXANTHINE#0.9049;ALKALINE PHOSPHATASE ACTIVITY#0.9042;ESTROGEN RECEPTOR#0.9039;CYTOCHROME C#0.9036;HEART DISEASE#0.9035;SIGNAL TRANSDUCTION#0.9033;OMENTAL ADIPOSE TISSUE#0.9010;IMMUNE RESPONSE#0.9010;RAPAMYCIN#0.8991;MECHANISM OF ACTION#0.8974;MOUSE EMBRYONIC FIBROBLAST#0.8971;ADIPOGENIC DIFFERENTIATION MEDIUM#0.8967;SUPEROXIDE DISMUTASE#0.8964;PERIPHERAL BLOOD#0.8950;TYPE 1 DIABETES#0.8942;NEUTROPHIL#0.8927;LACTATION#0.8905;BONE MARROW STROMAL#0.8885;MUTAGENESIS#0.8879;REGENERATION#0.8872;TRANSCRIPTASE#0.8847;PALMITIC ACID#0.8816;BONE MARROW STROMAL CELL#0.8812;ALANINE#0.8807;LIPODYSTROPHY#0.8806;LIPID METABOLIC#0.8802;BINDING PROTEIN 3#0.8780;NITRIC OXIDE SYNTHASE#0.8780;POSITIVE AIRWAY PRESSURE#0.8765;DIGESTION#0.8736;GROWTH FACTOR RECEPTOR#0.8734;MARROW STROMAL CELLS#0.8727;CELL DEATH#0.8713;DIABETIC NEPHROPATHY#0.8705;LEFT VENTRICULAR MASS#0.8657;GLUCOSE TRANSPORT#0.8653;CYTOCHROME C OXIDASE#0.8619;LIPASE ACTIVITY#0.8615;NERVOUS SYSTEM#0.8608;BLOOD GLUCOSE LEVEL#0.8602;CHONDROCYTE#0.8582;METFORMIN#0.8578;TRANSFORMING GROWTH FACTOR#0.8573;GLUCOCORTICOID RECEPTOR#0.8559;INTRACELLULAR TRANSPORT#0.8552;CYTOTOXICITY#0.8515;FASTING PLASMA GLUCOSE#0.8512;LYMPH NODE#0.8511;AUTOPHAGY#0.8502;CARDIOVASCULAR HEALTH STUDY#0.8495;MITOTIC CLONAL EXPANSION#0.8489;HUMAN UMBILICAL VEIN#0.8473;UMBILICAL VEIN#0.8470;GROWTH HORMONE#0.8446;STREPTOZOTOCIN#0.8437;SIGNAL TRANSDUCER#0.8434;KIDNEY DISEASE#0.8408;ECLAMPSIA#0.8408;NONALCOHOLIC FATTY LIVER DISEASE#0.8387;HYPOXIA INDUCIBLE FACTOR#0.8363;UMBILICAL CORD#0.8351;HIGH FAT FEEDING#0.8332;TUMOUR NECROSIS FACTOR#0.8309;CARDIOMYOCYTE#0.8299;LUNG CANCER#0.8296;HEAT SHOCK PROTEIN#0.8294;MULTIPLE LINEAR REGRESSION#0.8292;TROPHOBLAST CELL#0.8290;NEPHROPATHY#0.8259;PALMITOLEIC ACID#0.8216;GLYCEROL KINASE#0.8193;AKT SIGNALING#0.8188;MONOCYTE DERIVED MACROPHAGE#0.8165;GLUTATHIONE PEROXIDASE#0.8164;INSULIN RESISTANCE INDEX#0.8155;ABDOMINAL ADIPOSE TISSUE#0.8154;VASCULAR DISEASE#0.8142;ADENOSINE MONOPHOSPHATE#0.8141;TUBE FORMATION#0.8138;EPICARDIAL ADIPOSE TISSUE#0.8110;REPORTER GENE ASSAY#0.8106;ENZYME ACTIVITY#0.8090;ENDOCYTOSIS#0.8088;INSULIN RECEPTOR SUBSTRATE#0.8072;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8046;TOLL LIKE RECEPTOR#0.8018;CELL ADHESION MOLECULE#0.8017;TUMOR CELLS#0.7983;KINASE INHIBITOR#0.7977;2-DEOXYGLUCOSE#0.7977;ESTRADIOL#0.7953;REGULATION OF LIPID METABOLISM#0.7945;ISOPROTERENOL#0.7944;PERIPHERAL ARTERIAL DISEASE#0.7928;ALLERGIC AIRWAY INFLAMMATION#0.7922;SLEEP APNEA SYNDROME#0.7919;MONOCYTE CHEMOTACTIC PROTEIN#0.7919;O ACYLTRANSFERASE#0.7913;FASTING BLOOD GLUCOSE#0.7907;MYOBLAST#0.7870;BETA CELL#0.7867;FAT CELL DIFFERENTIATION#0.7867;NORMAL GLUCOSE TOLERANCE#0.7855;STROMAL VASCULAR FRACTION#0.7853;LIPOSARCOMA#0.7836;CHLORAMPHENICOL#0.7783;MITOCHONDRIA#0.7782;TUBULAR EPITHELIAL CELL#0.7775;FORSKOLIN#0.7719;TRANSDIFFERENTIATION#0.7705;MILK PROTEIN#0.7697;MESENCHYMAL PROGENITOR CELL#0.7648;ADJUSTED ODDS RATIO#0.7643;BODY FAT PERCENTAGE#0.7614;MONOUNSATURATED FATTY ACIDS#0.7590;PROTEIN SYNTHESIS#0.7585;COLLAGEN TYPE I#0.7580;SATURATED FATTY ACID#0.7556;BREAST CANCER CELL#0.7534;CLATHRIN ADAPTOR#0.7532;TOXICITY#0.7524;STROMAL VASCULAR CELLS#0.7512;MONONUCLEAR CELLS#0.7506;RESONANCE ENERGY TRANSFER#0.7502;OSTEOCYTE#0.7480;TISSUE REGENERATION#0.7455;VERY-LOW-DENSITY LIPOPROTEIN#0.7418;HISTONE DEACETYLASE#0.7410;PERIVASCULAR ADIPOSE TISSUE#0.7402;UBIQUITIN#0.7388;MESENCHYMAL STROMAL CELL#0.7386;INSULIN SIGNALING PATHWAY#0.7377;NUCLEAR IMPORT#0.7376;TUMOR SUPPRESSOR#0.7370;CELL MIGRATION#0.7370;CAAT ENHANCER BINDING#0.7340;LIGAND BINDING DOMAIN#0.7332;LIPID BIOSYNTHESIS#0.7311;HEPATOCELLULAR CARCINOMA#0.7307;ARGININE#0.7298;GRANULOSA CELL#0.7291;MUSCLE FIBER#0.7288;S PHASE#0.7280;GENE EXPRESSION OMNIBUS#0.7253;TELMISARTAN#0.7246;DEDIFFERENTIATION#0.7227;TYPE 1 DIABETES MELLITUS#0.7210;SQUAMOUS CELL CARCINOMA#0.7204;CORONARY HEART DISEASE#0.7185;AND VISCERAL FAT#0.7180;STEM CELL DIFFERENTIATION#0.7176;IMMUNE CELL#0.7172;ACETIC ACID#0.7160;LEUKOCYTE#0.7137;ADIPOCYTE PROLIFERATION#0.7106;ONCOGENIC#0.7095;COLORECTAL CANCER#0.7088;BREAST CANCER PATIENTS#0.7067;NICOTINAMIDE#0.7006;IMPAIRED GLUCOSE TOLERANCE#0.6991;NOREPINEPHRINE#0.6990;THYMIDINE#0.6983;LUCIFERASE ACTIVITY#0.6979;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6977;MYOSIN HEAVY CHAIN#0.6975;GLYCOGEN SYNTHASE KINASE#0.6972;QUANTITATIVE REVERSE TRANSCRIPTION#0.6969;LEAN BODY MASS#0.6960;SIGNALING MOLECULE#0.6948;ADIPOGENIC CELL#0.6939;NUCLEAR HORMONE RECEPTOR#0.6923;DENDRITIC CELL#0.6919;MICROVASCULAR ENDOTHELIAL CELL#0.6910;GLYCOLYSIS#0.6889;OXYGENASE#0.6880;STROMA#0.6872;QUANTITATIVE TRAIT LOCI#0.6864;TRANSITIONAL CELL CARCINOMA#0.6863;B CELL#0.6833;HYPERCHOLESTEROLEMIA#0.6833;TOTAL BODY FAT#0.6832;ETHANOL#0.6821;MYOTUBE#0.6820;VACUOLE#0.6810;MECHANISMS OF ACTION#0.6807;DE NOVO LIPOGENESIS#0.6801;RECEPTOR AGONIST#0.6786;RESPIRATION#0.6737;STABLE ANGINA PECTORIS#0.6735;INDOMETHACIN#0.6730;RESVERATROL#0.6729;CAMP RESPONSE ELEMENT#0.6717;ATORVASTATIN#0.6710;MAP KINASE#0.6702;HEME OXYGENASE 1#0.6700;FRUCTOSE#0.6699;ACID PHOSPHATASE#0.6692;MITOCHONDRIAL MEMBRANE#0.6675;RIBOSOMAL PROTEIN#0.6657;ALIZARIN RED S#0.6656;PROTEIN COMPLEX#0.6648;CENTRAL NERVOUS SYSTEM#0.6647;RECEPTOR ANTAGONIST#0.6647;STEARIC ACID#0.6624;FRAMINGHAM HEART STUDY#0.6606;ISCHEMIA#0.6569;VASCULAR ENDOTHELIAL CELL#0.6566;MAMMARY EPITHELIAL CELL#0.6558;PROTEIN KINASE B#0.6542;RETINOIC ACID BINDING#0.6537;ELECTROPHORETIC MOBILITY SHIFT#0.6536;OSTEOARTHRITIS#0.6500;WAX BIOSYNTHESIS#0.6499;CLATHRIN-MEDIATED ENDOCYTOSIS#0.6498;CHRONIC KIDNEY DISEASE#0.6440;ADAPTIVE THERMOGENESIS#0.6421;PANCREATIC ISLET#0.6421;SUCROSE#0.6420;REGULATION OF ADIPOCYTE DIFFERENTIATION#0.6412;MYELOID CELL#0.6411;PLURIPOTENT STEM CELL#0.6411;ADIPOSE-DERIVED STROMAL CELL#0.6410;QUERCETIN#0.6396;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6384;PSORIASIS#0.6381;SOLUBLE LEPTIN RECEPTOR#0.6368;METHIONINE#0.6317;FASTING GLUCOSE LEVELS#0.6286;SIGNALING CASCADE#0.6285;VEGF SIGNALING#0.6282;WOUND HEALING#0.6274;TRADITIONAL RISK FACTORS#0.6273;DIACYLGLYCEROL O ACYLTRANSFERASE#0.6268;LONGISSIMUS DORSI MUSCLE#0.6256;ADIPONECTIN SECRETION#0.6241;FENOFIBRATE#0.6237;GENE SILENCING#0.6236;LYSOSOME#0.6229;GLUCOSE-6-PHOSPHATE#0.6223;INSULIN SENSITIVITY INDEX#0.6222;OSTEOCLAST#0.6211;MULTIPLE LOGISTIC REGRESSION#0.6202;SECRETORY PATHWAY#0.6194;INSULIN RESISTANCE INDICES#0.6191;TIBIA#0.6177;PHOSPHOLIPASE A2#0.6169;EXCRETION#0.6136;VISCERAL FAT AREA#0.6129;HYPOXIC#0.6123;PROTEASOME#0.6123;DUAL LUCIFERASE REPORTER#0.6117;CYSTATIN#0.6115;VASCULAR SMOOTH MUSCLE CELL#0.6104;CORONARY STENOSIS#0.6090;BONE MINERAL DENSITY#0.6081;PERCENT BODY FAT#0.6069;CELL MEMBRANE#0.6058;MULTIVARIATE LINEAR REGRESSION#0.6050;PYRUVATE#0.6033;ADENINE#0.6033;PROTEINURIA#0.6029
2168	ACYL COA OXIDASE#1.0618;KIDNEY INJURY MOLECULE#1.0519;BINDING PROTEIN 1#1.0515;URINARY PROTEIN#1.0479;STEROL CARRIER PROTEIN#1.0467;NEUTROPHIL#1.0402;8-HYDROXY-2'-DEOXYGUANOSINE#1.0389;CYSTATIN#1.0358;LIPID BINDING PROTEIN#1.0341;FATTY ACID TRANSPORT#1.0319;EXCRETION#1.0302;FATTY ACID BINDING#1.0280;LIPID BINDING#1.0277;FATTY ACID SYNTHASE#1.0266;GROWTH FACTOR#1.0259;PLASMA MEMBRANE#1.0238;OLEIC ACID#1.0229;ENTEROCYTE#1.0192;TYPE 2 DIABETES#1.0187;PEROXISOMAL#1.0178;DIABETIC NEPHROPATHY#1.0177;HIGH FAT DIET#1.0149;FATTY ACID OXIDATION#1.0144;PROTEINURIA#1.0143;JEJUNUM#1.0143;FATTY ACID TRANSPORTER#1.0126;SMALL INTESTINE#1.0121;FATTY LIVER DISEASE#1.0109;FATTY ACID METABOLISM#1.0097;NEPHROPATHY#1.0096;HEPATOMA CELLS#1.0090;ISCHEMIA#1.0084;NONALCOHOLIC FATTY LIVER DISEASE#1.0079;PEROXISOME#1.0061;CLOFIBRATE#1.0045;FATTY LIVER#1.0033;LIVER DISEASE#1.0001;DIABETES MELLITUS#0.9985;ARACHIDONIC ACID#0.9978;CARNITINE#0.9973;EPITHELIAL CELL#0.9967;GLOMERULAR FILTRATION RATE#0.9957;GLOMERULAR FILTRATION#0.9954;GENE EXPRESSION#0.9946;GLUTATHIONE#0.9926;ALBUMIN CREATININE RATIO#0.9919;HEPATOCELLULAR CARCINOMA#0.9902;CHRONIC KIDNEY DISEASE#0.9887;LIPID METABOLISM#0.9867;GROWTH HORMONE#0.9867;ACUTE KIDNEY INJURY#0.9854;TRANSCRIPTION FACTOR#0.9853;STEROL REGULATORY ELEMENT#0.9853;KIDNEY DISEASE#0.9851;LOW DENSITY LIPOPROTEIN#0.9748;INSULIN-LIKE GROWTH FACTOR#0.9745;PALMITATE#0.9718;POLYMERASE CHAIN REACTION#0.9717;TUMOR NECROSIS FACTOR#0.9669;ALCOHOLIC FATTY LIVER#0.9656;WEIGHT GAIN#0.9638;COENZYME A#0.9621;OBESE#0.9591;ETHANOL#0.9580;PALMITIC ACID#0.9558;HYPOXIA#0.9533;KIDNEY DAMAGE#0.9532;SIGNALING PATHWAY#0.9503;ADIPOCYTE#0.9492;BILE ACID BINDING#0.9452;TYPE 2 DIABETES MELLITUS#0.9389;2 DIABETES MELLITUS#0.9389;C REACTIVE PROTEIN#0.9387;GROWTH FACTOR BINDING#0.9318;HYPERTENSION#0.9250;REVERSE TRANSCRIPTION#0.9231;TYPE 2 DIABETIC#0.9179;INTENSIVE CARE UNIT#0.9178;ENTEROENDOCRINE CELL#0.9155;BEZAFIBRATE#0.9146;TOXICITY#0.9105;LIPID DROPLET#0.9103;INDUCED RENAL INJURY#0.9099;CYTOPLASM#0.9070;ADIPOSE TISSUE#0.9032;ASPARTATE#0.8999;ALDOSTERONE#0.8990;INTESTINAL MUCOSA#0.8920;MONOCYTE#0.8916;LIPOGENESIS#0.8858;LIPOPROTEIN LIPASE#0.8850;MONOCYTE CHEMOTACTIC PROTEIN#0.8808;ALANINE#0.8795;DUODENUM#0.8762;CARCINOGEN#0.8744;CHOLESTEROL UPTAKE#0.8720;COLORECTAL CANCER#0.8695;APOPTOSIS#0.8646;CELL PROLIFERATION#0.8553;CANCER CELL#0.8517;FATTY ACID TRANSLOCASE#0.8516;FATTY ACID SYNTHESIS#0.8502;FENOFIBRATE#0.8484;COLORECTAL#0.8427;AMLODIPINE#0.8373;DIET INDUCED OBESITY#0.8367;SUPEROXIDE DISMUTASE#0.8365;BRUSH CELL#0.8349;HUMAN PROXIMAL TUBULE#0.8346;TYPE 1 DIABETES#0.8321;ANEMIA#0.8319;INTRACELLULAR TRANSPORT#0.8314;MACROPHAGE#0.8304;BLOOD UREA NITROGEN#0.8273;REACTIVE OXYGEN SPECIES#0.8219;LIPID HOMEOSTASIS#0.8196;PROTEIN KINASE#0.8179;HEPATOCYTE NUCLEAR FACTOR#0.8178;SERUM ALBUMIN#0.8160;PALMITOYL#0.8079;LIVER DAMAGE#0.8008;SYSTOLIC BLOOD PRESSURE#0.7979;PRIMARY HUMAN HEPATOCYTES#0.7962;STEARIC ACID#0.7950;RETINOIC ACID#0.7946;TRANSFORMING GROWTH FACTOR#0.7894;STEROL BINDING#0.7891;CHOLESTEROL METABOLISM#0.7889;ANTIOXIDANT ACTIVITY#0.7869;PROSTATE CANCER#0.7829;STEROL CARRIER PROTEIN-X#0.7823;MITOCHONDRIA#0.7818;RETINOL BINDING#0.7813;INTESTINAL EPITHELIAL CELL#0.7787;HIGH DENSITY LIPOPROTEIN#0.7753;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7744;ENDOTHELIAL GROWTH FACTOR#0.7743;BODY WEIGHT GAIN#0.7701;VERY-LOW-DENSITY LIPOPROTEIN#0.7678;PROXIMAL TUBULAR CELL#0.7661;BRAIN NATRIURETIC PEPTIDE#0.7576;ENDOPLASMIC RETICULUM#0.7531;SATURATED FATTY ACID#0.7517;PEPTIDE TRANSPORTER#0.7509;LIPID TRANSPORT#0.7498;KIDNEY TRANSPLANT PATIENTS#0.7378;INTERMEMBRANE STEROL TRANSFER#0.7347;KIDNEY TRANSPLANT RECIPIENTS#0.7323;LIVER REGENERATION#0.7293;ADENINE#0.7270;NEPHROTOXICITY#0.7193;CHEMICAL SHIFT PERTURBATION#0.7041;CHOLESTEROL BINDING#0.7038;GLUTAMINE#0.7005;HEME BINDING PROTEIN#0.6994;GASTROINTESTINAL TRACT#0.6945;OLMESARTAN#0.6935;ALKALINE PHOSPHATASE#0.6913;PHOSPHATIDIC ACID BIOSYNTHESIS#0.6893;GLOMERULONEPHRITIS#0.6864;MINISTRY OF HEALTH#0.6851;HEME BINDING#0.6834;MUCOUS CELLS#0.6831;DICARBOXYLIC ACID#0.6786;TUBULAR EPITHELIAL CELL#0.6785;RETINOL#0.6763;ORGANIC ANION TRANSPORTER#0.6759;CELL DIFFERENTIATION#0.6742;HEPATOCELLULAR ADENOMA#0.6741;CYTOCHROME P450#0.6725;STEM CELL#0.6688;PPAR SIGNALING PATHWAY#0.6656;CELL CYCLE#0.6644;INFLAMMATORY RESPONSE#0.6603;SKELETAL MUSCLE#0.6549;GESTATION#0.6532;REGENERATION#0.6521;AORTIC ANEURYSM#0.6513;NECROTIZING#0.6508;SERUM AMYLOID A#0.6507;LIPOLYSIS#0.6506;QUANTITATIVE REVERSE TRANSCRIPTION#0.6482;CALCIUM CHANNEL#0.6467;CISPLATIN#0.6443;HEAT SHOCK PROTEIN#0.6431;RECEPTOR ANTAGONIST#0.6410;PEROXISOME PROLIFERATION#0.6400;BILE ACID METABOLISM#0.6373;FATTY ACID BETA-OXIDATION#0.6371;METHIONINE#0.6321;TROPHOBLAST#0.6315;NUCLEOPLASM#0.6311;ARTERY#0.6290;DEXAMETHASONE#0.6266;GLUCOSE METABOLISM#0.6245;LINEAR REGRESSION ANALYSIS#0.6245;ACETYL COA CARBOXYLASE#0.6220;HEALTHY CONTROL SUBJECTS#0.6192;NERVOUS SYSTEM#0.6191;SCAVENGER RECEPTOR#0.6161;OXYGENASE#0.6144;VESICOURETERAL REFLUX#0.6081;ACYL-COA METABOLISM#0.6027
2169	CITRULLINE#1.0714;ADIPOCYTE#1.0375;INTESTINAL EPITHELIAL CELL#1.0308;FATTY ACID BINDING#1.0306;ENTEROCYTE#1.0302;C REACTIVE PROTEIN#1.0300;TYPE 2 DIABETES MELLITUS#1.0248;2 DIABETES MELLITUS#1.0248;ALANINE#1.0221;INTESTINAL DAMAGE#1.0199;TYPE 2 DIABETES#1.0191;CARDIOVASCULAR RISK FACTOR#1.0187;ISCHEMIA#1.0186;DIABETES MELLITUS#1.0180;EPITHELIAL CELL#1.0178;JEJUNUM#1.0176;PEROXISOME#1.0164;OLEIC ACID#1.0142;POLYMERASE CHAIN REACTION#1.0085;SMALL INTESTINE#1.0075;LIPID BINDING PROTEIN#1.0053;LIPOPROTEIN LIPASE#1.0042;LIPID METABOLISM#1.0028;NECROTIZING#0.9990;LIPID BINDING#0.9989;GENE EXPRESSION#0.9948;INTESTINAL MUCOSA#0.9948;LIPOPOLYSACCHARIDE BINDING#0.9946;TUMOR NECROSIS FACTOR#0.9920;OBESE#0.9901;ADRENERGIC RECEPTOR#0.9862;FRAGMENT LENGTH POLYMORPHISM#0.9825;T CELL#0.9784;LIVER DISEASE#0.9599;HIGH FAT DIET#0.9597;ADIPOSE TISSUE#0.9531;LOW DENSITY LIPOPROTEIN#0.9483;CELL DIFFERENTIATION#0.9469;ENHANCER BINDING PROTEIN#0.9450;ENHANCER BINDING#0.9445;INSULIN RECEPTOR#0.9443;WEIGHT LOSS#0.9433;FATTY ACID METABOLISM#0.9430;INFLAMMATORY RESPONSE#0.9411;MONOCYTE#0.9326;BILE ACID BINDING#0.9325;HYPERTENSION#0.9282;ARTERY#0.9263;MONOCYTE ACTIVATION#0.9241;LPS BINDING#0.9211;INSULIN RECEPTOR SUBSTRATE#0.9182;CELIAC DISEASE#0.9033;PALMITATE#0.8967;TIGHT JUNCTION#0.8952;HIGH DENSITY LIPOPROTEIN#0.8884;HEART DISEASE#0.8846;FATTY ACID TRANSPORT#0.8804;DIAMINE OXIDASE#0.8772;IL-1RA#0.8744;CORONARY HEART DISEASE#0.8702;CHYLOMICRON#0.8682;FATTY ACID TRANSPORTER#0.8664;FATTY LIVER#0.8620;GLUTATHIONE#0.8567;INTRACELLULAR TRANSPORT#0.8524;LACTIC ACID#0.8507;INTENSIVE CARE UNIT#0.8407;CORTISOL#0.8386;GLUTEN FREE DIET#0.8362;D-LACTIC ACID#0.8302;CORONARY ARTERY#0.8301;GASTROINTESTINAL TRACT#0.8287;TRANSCRIPTION FACTOR#0.8223;GROWTH FACTOR#0.8210;FATTY LIVER DISEASE#0.8093;HEPATIC LIPASE#0.8081;STEM CELL#0.8052;TYPE 2 DIABETIC#0.8036;GLUCOSE METABOLISM#0.8015;CREATINE KINASE#0.7990;STEARIC ACID#0.7972;DUODENUM#0.7909;LIPID TRANSPORT#0.7885;FATTY ACID SYNTHASE#0.7871;STEROL REGULATORY ELEMENT#0.7738;SYSTEMIC INFLAMMATORY RESPONSE#0.7718;INTESTINAL ABSORPTION#0.7637;CD4+ T CELL#0.7451;TISSUE DAMAGE#0.7416;DIGESTION#0.7332;ALCOHOLIC FATTY LIVER#0.7295;LACTULOSE#0.7282;ATHEROSCLEROSIS#0.7157;LIPID OXIDATION#0.7142;NEGATIVE PREDICTIVE VALUE#0.7086;LIPID DROPLET#0.7052;INSULIN SECRETION#0.7050;COENZYME A#0.7040;INTESTINAL DISEASE#0.7027;GROWTH HORMONE#0.7002;PRO-INFLAMMATORY#0.6990;NEUTROPHIL#0.6983;CELL PROLIFERATION#0.6968;MESENTERIC ARTERY#0.6936;ABDOMINAL PAIN#0.6900;ADIPOGENESIS#0.6885;NEOPTERIN#0.6884;CROHN'S DISEASE#0.6878;WEIGHT GAIN#0.6870;TRYPTOPHAN#0.6856;CEREBROVASCULAR DISEASE#0.6735;ALKALINE PHOSPHATASE#0.6729;ULCERATIVE COLITIS#0.6729;CREATINE#0.6695;APOPTOSIS#0.6689;SMOOTH MUSCLE#0.6669;EXCRETION#0.6669;HUMAN IMMUNODEFICIENCY VIRUS#0.6640;IMMUNE RESPONSE#0.6544;COLITIS#0.6488;ISCHEMIA MODIFIED ALBUMIN#0.6400;ADIPOCYTE DIFFERENTIATION#0.6336;ASPARTATE#0.6322;INFLAMMATORY BOWEL DISEASE#0.6293;SERUM AMYLOID A#0.6286;CELL ACTIVATION#0.6238;SATURATED FATTY ACID#0.6233;COLORECTAL CANCER#0.6231;PSORIASIS#0.6227;BETA CELL#0.6176;MORBID OBESITY#0.6146;DRUG BINDING#0.6128;GLUTAMINE#0.6105;BOWEL OBSTRUCTION#0.6075;PEPTIDE TRANSPORTER#0.6019;T CELL ACTIVATION#0.6010
216	RETINAL DEHYDROGENASE#1.0525;TUMOR TISSUES#1.0333;TUMOR STEM CELL#1.0302;LYMPH NODE METASTASIS#1.0217;ESTROGEN RECEPTOR#1.0177;BREAST CANCER PATIENTS#1.0164;CYCLOPHOSPHAMIDE#1.0163;CERVICAL CANCER#1.0160;CERVICAL#1.0158;INVASIVE BREAST CANCER#1.0150;STEM CELL MARKER#1.0140;COLORECTAL CARCINOMA#1.0140;CELL DIFFERENTIATION#1.0118;LYMPH NODE#1.0112;PROGESTERONE#1.0108;STROMAL CELL#1.0103;BREAST CARCINOMA#1.0070;DISEASE FREE SURVIVAL#1.0063;DETOXIFICATION#1.0058;ADIPOSE TISSUE#1.0056;PITUITARY GLAND#1.0053;OVARIAN CARCINOMA#1.0049;B CELL#1.0048;GROWTH FACTOR RECEPTOR#1.0036;DISULFIRAM#1.0030;CELL ADHESION MOLECULE#1.0028;ENZYME ACTIVITY#1.0015;STROMA#1.0014;T CELL#1.0014;RETINOL#1.0013;EPIDERMAL GROWTH FACTOR#0.9992;OVARIAN#0.9990;QUANTITATIVE REAL TIME#0.9986;TUMOR INITIATING CELL#0.9981;CELL ADHESION#0.9980;OVARIAN CANCER#0.9965;ALL TRANS RETINOIC ACID#0.9965;PROSTATE CANCER#0.9958;COLON CANCER#0.9940;ADENOCARCINOMA#0.9933;METASTATIC BREAST CANCER#0.9931;BREAST CANCER#0.9930;DOPAMINE#0.9928;TOXICITY#0.9927;LUNG CANCER#0.9926;STEM CELL LIKE#0.9922;LUMINAL#0.9919;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9918;BREAST CANCER CELL#0.9915;LUNG ADENOCARCINOMA#0.9907;EPITHELIAL CELL#0.9905;PARKINSON'S DISEASE#0.9898;HUMAN BREAST CANCER#0.9889;TUMOR CELLS#0.9881;CELL DEATH#0.9880;CELL ASSOCIATED#0.9874;STEM CELL#0.9872;RECURRENCE FREE SURVIVAL#0.9870;POLYMERASE CHAIN REACTION#0.9870;COLORECTAL#0.9870;ETHANOL#0.9858;PANCREATIC CANCER#0.9857;CANCER STEM-LIKE CELL#0.9857;RETINOIC ACID RECEPTOR#0.9854;CYTOCHROME P450#0.9847;TRANSCRIPTION FACTOR#0.9844;MACROPHAGE#0.9840;RETINOIC ACID#0.9839;GLUTATHIONE#0.9839;PROGENITOR CELL#0.9838;ORAL SQUAMOUS CELL CARCINOMA#0.9832;SQUAMOUS CELL CARCINOMA#0.9827;GROWTH FACTOR#0.9815;COLORECTAL CANCER#0.9813;CISPLATIN#0.9804;PERIPHERAL BLOOD#0.9801;CELL CYCLE#0.9790;REVERSE TRANSCRIPTION#0.9788;CANCER STEM CELL#0.9775;DRUG RESISTANCE#0.9771;INVASIVE DUCTAL CARCINOMA#0.9766;VITAMIN A#0.9754;ANDROGEN RECEPTOR#0.9750;CELL PROLIFERATION#0.9745;APOPTOSIS#0.9741;EPITHELIAL MESENCHYMAL TRANSITION#0.9741;CELL GROWTH#0.9737;BONE MARROW#0.9732;SUBSTANTIA NIGRA#0.9728;CELL SURFACE#0.9723;SIGNALING PATHWAY#0.9721;CANCER CELL#0.9719;CELL MIGRATION#0.9714;GENE EXPRESSION#0.9707;PRIMARY BREAST CANCER#0.9696;EPITHELIAL TO MESENCHYMAL#0.9679;CANCER INITIATING CELLS#0.9634;LYMPH NODE METASTASES#0.9612;SMOOTH MUSCLE#0.9552;RETINOL BINDING#0.9530;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9527;RETINOID METABOLISM#0.9518;LUNG CARCINOMA#0.9482;HEPATOCELLULAR CARCINOMA#0.9466;APOPTOTIC#0.9462;PACLITAXEL#0.9462;REACTIVE OXYGEN SPECIES#0.9450;ETHANOL METABOLISM#0.9362;MULTIPLE MYELOMA#0.9353;CIRCULATING TUMOR CELL#0.9308;NECK CANCER#0.9292;ANGIOGENESIS#0.9276;DNA REPAIR#0.9220;TUMOR SUPPRESSOR#0.9215;EPITHELIAL OVARIAN CANCER#0.9198;HEAD AND NECK CANCER#0.9190;CYTOTOXICITY#0.9183;HEMATOPOIETIC STEM CELL#0.9170;ALCOHOL DEPENDENCE#0.9130;FORMALIN#0.9116;SMOOTH MUSCLE ACTIN#0.9082;9-CIS-RETINOIC ACID#0.8982;DOXORUBICIN#0.8979;AUTOPHAGY#0.8956;ADIPOCYTE#0.8905;FLOW CYTOMETRY ANALYSIS#0.8892;TUMOR NODE METASTASIS#0.8871;HEMATOPOIETIC CELL#0.8843;METASTATIC LYMPH NODE#0.8804;GASTRIC ADENOCARCINOMA#0.8781;RETINOID X RECEPTOR#0.8740;ONCOGENIC#0.8686;RELAPSE FREE SURVIVAL#0.8669;SMALL INTESTINE#0.8669;NORMAL STEM CELLS#0.8659;ATP BINDING CASSETTE#0.8593;ATP BINDING#0.8577;TRANSFORMING GROWTH FACTOR#0.8564;HYPOXIA#0.8561;CARCINOMA IN SITU#0.8515;GERM CELL#0.8490;MAMMARY GLAND#0.8485;THYROID CARCINOMA#0.8474;LIPID METABOLISM#0.8469;INSULIN-LIKE GROWTH FACTOR#0.8467;CYTOPLASM#0.8457;OVARIES#0.8437;TAMOXIFEN#0.8435;NEURAL RETINA#0.8417;TRANSCRIPTASE#0.8378;BASAL CELL#0.8361;IMMUNE RESPONSE#0.8312;CD8+ T CELL#0.8274;ESOPHAGEAL CANCER#0.8273;NON-SMALL CELL LUNG CARCINOMA#0.8234;EMBRYONIC STEM CELL#0.8231;PROTEIN KINASE#0.8142;DUCTAL CARCINOMA IN SITU#0.8139;DENDRITIC CELL#0.8109;OVERALL SURVIVAL RATE#0.8107;PAPILLARY THYROID CARCINOMA#0.8071;LIVER CANCER#0.8053;DNA METHYLATION#0.7977;BONE MARROW CELLS#0.7955;LIVER DISEASE#0.7949;DNA BINDING#0.7939;SIGNAL TRANSDUCER#0.7922;CATALYTIC ACTIVITY#0.7896;SURFACE EPITHELIUM#0.7891;ALCOHOL METABOLISM#0.7890;AGGRESSIVE BEHAVIOR#0.7874;COLONY FORMATION ASSAY#0.7867;ANCHORAGE INDEPENDENT GROWTH#0.7863;PANCREATIC DUCTAL ADENOCARCINOMA#0.7857;GEMCITABINE#0.7834;KINASE INHIBITOR#0.7784;ESTRADIOL#0.7772;REGULATORY T CELL#0.7744;STRIATUM#0.7667;HEPATOMA CELLS#0.7657;INVASIVE BREAST CARCINOMA#0.7649;IMMUNE CELL#0.7608;CLEAVED CASPASE 3#0.7570;HIGH FAT DIET#0.7555;VITAMIN A DEFICIENCY#0.7553;PRIMARY BREAST TUMORS#0.7541;FIBROBLAST GROWTH FACTOR#0.7540;WHITE ADIPOSE TISSUE#0.7529;MESENCHYMAL STEM CELL#0.7513;ENDOTHELIAL CELL#0.7509;ADIPOGENESIS#0.7482;ADJACENT NORMAL TISSUE#0.7472;ERYTHROCYTE#0.7467;NORMAL BREAST TISSUE#0.7465;CORD BLOOD#0.7459;RNA INTERFERENCE#0.7421;FLUSHING#0.7385;NERVOUS SYSTEM#0.7380;HYPOXIC#0.7288;EXTRACELLULAR MATRIX#0.7278;OPTIC CUP#0.7245;COLON CARCINOMA#0.7230;RENAL CELL CARCINOMA#0.7209;SIGNALING MOLECULE#0.7203;SIDE-POPULATION CELL#0.7179;OVARIAN SURFACE EPITHELIUM#0.7179;ENDOTHELIAL GROWTH FACTOR#0.7171;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7171;RETINOL DEHYDROGENASE#0.7154;INTESTINAL EPITHELIAL CELL#0.7148;LYSINE#0.7090;MITOCHONDRIA#0.7086;ENHANCER BINDING PROTEIN#0.7035;ENHANCER BINDING#0.7030;ASTROCYTOMA#0.7000;ABC TRANSPORTER#0.6995;CANCER SPECIFIC SURVIVAL#0.6991;B CELL LYMPHOMA#0.6970;CELL CYCLE ARREST#0.6958;G1 PHASE#0.6911;TUMOR ASSOCIATED MACROPHAGE#0.6891;WOUND HEALING#0.6867;MAMMARY EPITHELIAL CELL#0.6858;HUMAN LENS EPITHELIAL#0.6848;5 FLUOROURACIL#0.6839;MIDBRAIN#0.6836;MECHANISM OF ACTION#0.6807;ALDO KETO REDUCTASE#0.6789;LIVER METASTASIS#0.6762;DIET INDUCED OBESITY#0.6708;ANTISENSE RNA#0.6685;GROWTH FACTOR BINDING#0.6681;DUODENUM#0.6673;CANCER RELATED DEATH#0.6651;PROTEASOME#0.6633;DOPAMINERGIC NEURON#0.6566;HISTONE DEACETYLASE#0.6545;CORNEAL EPITHELIAL CELL#0.6514;SIGNAL TRANSDUCTION#0.6513;CORNEAL EPITHELIUM#0.6513;NITRIC OXIDE#0.6503;GASTRIC MUCOSA#0.6500;SOFT TISSUE SARCOMA#0.6495;VITAMIN A METABOLISM#0.6484;YEAR SURVIVAL RATE#0.6460;MYELOID LEUKEMIA#0.6454;ARYL HYDROCARBON RECEPTOR#0.6447;BINDING PROTEIN 1#0.6442;GENE SILENCING#0.6441;BUDDING#0.6438;INDUCTION OF APOPTOSIS#0.6425;SIGNALLING PATHWAY#0.6407;PEROXISOME#0.6407;RED BLOOD CELL#0.6404;RETINOL METABOLISM#0.6335;DOCETAXEL#0.6327;MESENCHYME#0.6315;CARCINOGEN#0.6308;CATABOLISM#0.6304;DIFFERENTIAL GENE EXPRESSION#0.6294;MORPHOGENESIS#0.6292;MEIOSIS#0.6274;ENDOMETRIAL CANCER#0.6267;MESENCHYMAL CELL#0.6265;HYPOXIA INDUCIBLE FACTOR#0.6245;FLUOROURACIL#0.6242;TIGHT JUNCTION#0.6218;ADULT STEM CELL#0.6209;ACUTE MYELOID LEUKEMIA#0.6203;ASCITES#0.6198;ASPIRIN#0.6161;QUANTITATIVE REVERSE TRANSCRIPTION#0.6149;OPTIC VESICLE#0.6121;SORAFENIB#0.6107;AKT SIGNALING#0.6104;PHENOBARBITAL#0.6098;MYOFIBROBLAST#0.6086;CLEAR CELL ADENOCARCINOMA#0.6085;2-KETO-3-DEOXYGLUCONATE#0.6082;METAPLASTIC CARCINOMA#0.6063;UROTHELIAL CELL CARCINOMA#0.6061;MYELOID-DERIVED SUPPRESSOR CELL#0.6050;MUTAGENESIS#0.6044;CHLORAL HYDRATE#0.6043;OVARIAN SEROUS CARCINOMA#0.6029;THYROID HORMONE BINDING#0.6016;DIFFUSE LARGE B-CELL LYMPHOMA#0.6014
2170	GLYCOGEN PHOSPHORYLASE#1.0728;ACUTE PULMONARY EMBOLISM#1.0694;BINDING PROTEIN 3#1.0530;CHRONIC HEART FAILURE#1.0514;C REACTIVE PROTEIN#1.0463;BRAIN NATRIURETIC PEPTIDE#1.0454;PULMONARY EMBOLISM#1.0438;ISCHEMIA MODIFIED ALBUMIN#1.0412;EMBOLISM#1.0411;CANCER CELL#1.0393;POINT OF CARE#1.0372;BREAST CANCER#1.0363;CARDIAC TROPONIN I#1.0357;CREATINE KINASE#1.0280;CREATINE#1.0268;FATTY ACID BINDING#1.0264;GROWTH FACTOR#1.0262;FATTY ACID TRANSPORT#1.0189;ISCHEMIA#1.0176;ACUTE CORONARY SYNDROME#1.0166;GROWTH DIFFERENTIATION FACTOR#1.0151;LIPID BINDING#1.0134;MAMMARY GLAND#1.0126;LIPID BINDING PROTEIN#1.0110;NEGATIVE PREDICTIVE VALUE#1.0103;ADIPOCYTE#1.0098;BREAST CANCER CELL#1.0079;MYOCARDIUM#1.0071;CARNITINE#1.0064;ACUTE MYOCARDIAL INFARCTION#1.0055;CORONARY ARTERY BYPASS#1.0054;ADIPOSE TISSUE#1.0054;HUMAN BREAST CANCER#1.0034;CARDIOMYOCYTE#1.0029;MAMMARY EPITHELIAL CELL#1.0021;FATTY ACID OXIDATION#1.0017;FATTY ACID METABOLISM#1.0010;OLEIC ACID#1.0004;MYOCARDIAL INFARCTION#1.0000;EPITHELIAL CELL#0.9992;HEART DISEASE#0.9988;SKELETAL MUSCLE#0.9969;PEROXISOME#0.9958;FATTY ACID TRANSPORTER#0.9941;APOPTOSIS#0.9936;NEUTROPHIL#0.9912;CORONARY ARTERY#0.9912;FATTY ACID TRANSLOCASE#0.9880;LIPID DROPLET#0.9876;ARTERY#0.9830;LIPID METABOLISM#0.9801;ACUTE KIDNEY INJURY#0.9791;HYPERTENSION#0.9764;ARACHIDONIC ACID#0.9749;TUMOR NECROSIS FACTOR#0.9743;CELL PROLIFERATION#0.9733;LIPOPROTEIN LIPASE#0.9727;GENE EXPRESSION#0.9709;KIDNEY INJURY MOLECULE#0.9661;MUSCLE CELL#0.9659;ASPARTATE#0.9590;ATHEROSCLEROSIS#0.9575;LIGHT CHAIN 3#0.9562;TRANSCRIPTION FACTOR#0.9558;ARTERY DISEASE#0.9523;TUMOR SUPPRESSOR#0.9502;CELL GROWTH#0.9474;CARDIOMYOPATHY#0.9466;TOXICITY#0.9461;CARDIAC MUSCLE#0.9460;POLYMERASE CHAIN REACTION#0.9445;SIGNALING PATHWAY#0.9406;ENDOTHELIAL CELL#0.9399;CORONARY ARTERY DISEASE#0.9300;MITOCHONDRIA#0.9263;PALMITATE#0.9249;CONGESTIVE HEART FAILURE#0.9196;HYPOXIA#0.9143;LACTATION#0.9126;PERCUTANEOUS CORONARY INTERVENTION#0.9103;ACYL COA DEHYDROGENASE#0.9082;QUANTITATIVE REAL TIME#0.9067;DEMENTIA#0.8992;ALZHEIMER'S DISEASE#0.8954;MYOCYTES#0.8928;FATTY ACID SYNTHASE#0.8923;SYSTOLIC BLOOD PRESSURE#0.8919;PROTEIN KINASE#0.8914;BROWN ADIPOSE TISSUE#0.8910;PALMITIC ACID#0.8903;HEART MUSCLE#0.8807;AORTIC VALVE#0.8737;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8723;MUSCLE FIBER#0.8693;GLUCOSE UPTAKE#0.8681;ATRIAL FIBRILLATION#0.8646;VENOUS BLOOD#0.8623;DILATED CARDIOMYOPATHY#0.8586;INTRACELLULAR TRANSPORT#0.8562;STEARIC ACID#0.8538;POSITIVE PREDICTIVE VALUE#0.8520;GLOMERULAR FILTRATION RATE#0.8481;GLOMERULAR FILTRATION#0.8477;LOW DENSITY LIPOPROTEIN#0.8462;DIABETES MELLITUS#0.8451;REVERSE TRANSCRIPTION#0.8450;KIDNEY DISEASE#0.8397;CYTOPLASM#0.8386;BINDING PROTEIN 1#0.8379;CARDIOVASCULAR RISK FACTOR#0.8348;GLUTATHIONE#0.8344;INTENSIVE CARE UNIT#0.8270;VENTRICULAR SEPTAL DEFECT#0.8248;COENZYME A#0.8203;TYPE 2 DIABETES#0.8020;LUNG CANCER#0.7987;LIPID DROPLET FORMATION#0.7964;GROWTH HORMONE#0.7939;PLASMA PROTEIN#0.7924;INSULIN-LIKE GROWTH FACTOR#0.7915;PLASMA MEMBRANE#0.7911;MYOTUBE#0.7909;SUPEROXIDE DISMUTASE#0.7904;STEAROYL COA DESATURASE#0.7899;ACUTE HEART FAILURE#0.7804;FUNCTIONAL DIFFERENTIATION#0.7801;OBESE#0.7799;STEM CELL#0.7770;SATURATED FATTY ACID#0.7707;UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR#0.7687;AORTIC VALVE DISEASE#0.7671;MILK PROTEIN#0.7647;TROPHOBLAST#0.7632;BACK FAT THICKNESS#0.7628;UROKINASE PLASMINOGEN ACTIVATOR#0.7608;RIGHT VENTRICULAR DYSFUNCTION#0.7606;CELL CYCLE#0.7600;LIPID TRANSPORT#0.7550;PROTEIN SYNTHESIS#0.7542;DOPAMINE#0.7537;RECEIVER OPERATING CURVE#0.7523;PULMONARY HYPERTENSION#0.7516;LEWY BODY#0.7508;LIVER DISEASE#0.7490;CONGENITAL HEART DISEASE#0.7469;ALANINE#0.7447;STEROL REGULATORY ELEMENT#0.7430;NERVOUS SYSTEM#0.7402;CORONARY HEART DISEASE#0.7394;HIGH FAT DIET#0.7369;LINEAR REGRESSION ANALYSIS#0.7368;CARNITINE PALMITOYL TRANSFERASE#0.7348;CARDIAC DEVELOPMENT#0.7298;UROKINASE#0.7239;ARRHYTHMIA#0.7219;SYNCOPE#0.7154;PALMITOYL#0.7079;DOPAMINE D2 RECEPTOR#0.7075;MACROPHAGE#0.7056;MUSCLE DAMAGE#0.7016;OOCYTE#0.7015;ENDOPLASMIC RETICULUM#0.6986;MITOCHONDRIAL MEMBRANE#0.6979;ENDOTHELIAL GROWTH FACTOR#0.6979;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6979;SERUM ALBUMIN#0.6975;FIBROBLAST GROWTH FACTOR#0.6973;MONOCYTE#0.6970;DNA METHYLATION#0.6921;OBSTRUCTIVE SLEEP APNEA#0.6917;CELL DIFFERENTIATION#0.6905;SLEEP APNEA#0.6903;TACHYCARDIA#0.6885;DOXORUBICIN#0.6854;IMMUNOGLOBULIN G#0.6854;SLEEP APNEA SYNDROME#0.6852;EXCRETION#0.6827;ADVERSE CLINICAL OUTCOME#0.6809;INTIMA MEDIA THICKNESS#0.6796;HIGH RISK PATIENTS#0.6794;FATTY ACID SYNTHESIS#0.6792;INTERNEURON#0.6777;LONGISSIMUS DORSI MUSCLE#0.6757;ADJUSTED HAZARD RATIO#0.6754;GLUCOSE METABOLISM#0.6753;STRIATUM#0.6706;FIBRINOGEN#0.6703;ADIPOGENESIS#0.6677;EPIDERMAL GROWTH FACTOR#0.6645;PROTEINURIA#0.6610;BETA-2#0.6606;NEURODEGENERATIVE DISEASE#0.6556;HIGH DENSITY LIPOPROTEIN#0.6536;NOREPINEPHRINE#0.6518;HYPOXIA INDUCIBLE FACTOR#0.6496;BRAIN DAMAGE#0.6485;VERY-LOW-DENSITY LIPOPROTEIN#0.6247;WHITE BLOOD CELL#0.6234;REACTIVE OXYGEN SPECIES#0.6228;SPINAL CORD#0.6227;VASCULAR CELL#0.6208;ISOPROTERENOL#0.6192;NEUROFILAMENT#0.6154;RAMELTEON#0.6116;VLDL RECEPTOR#0.6112;CARDIAC ARREST#0.6056;MONOCYTE CHEMOTACTIC PROTEIN#0.6049;ESSENTIAL HYPERTENSION#0.6008;RESPONSE TO OLANZAPINE#0.6006;LIPID HOMEOSTASIS#0.6005;ISCHEMIA REPERFUSION INJURY#0.6000
2171	RETINOIC ACID#1.0461;MACROPHAGE#1.0420;PROSTATE CANCER#1.0387;KERATINOCYTE#1.0382;CELL GROWTH#1.0259;FATTY ACID BINDING#1.0259;RETINOIC ACID BINDING#1.0255;ADIPOCYTE#1.0253;BREAST CANCER#1.0221;PEROXISOME#1.0158;GROWTH FACTOR#1.0152;CELL PROLIFERATION#1.0143;CANCER CELL#1.0132;LIPID BINDING#1.0131;ENDOTHELIAL CELL#1.0127;LIPID BINDING PROTEIN#1.0119;LIPID METABOLISM#1.0088;EPITHELIAL CELL#0.9961;GENE EXPRESSION#0.9960;PSORIASIS#0.9946;SIGNALING PATHWAY#0.9873;SQUAMOUS CELL CARCINOMA#0.9687;ADIPOSE TISSUE#0.9662;T CELL#0.9400;C REACTIVE PROTEIN#0.9235;BLOOD BRAIN BARRIER#0.9228;ATHEROSCLEROSIS#0.9136;FATTY ACID TRANSPORT#0.9125;APOPTOSIS#0.8781;BREAST CANCER CELL#0.8739;SEBACEOUS GLAND#0.8639;TRANSCRIPTION FACTOR#0.8632;CYTOKINE PRODUCTION#0.8576;TYPE 2 DIABETES#0.8557;DENDRITIC CELL#0.8537;KERATINOCYTE DIFFERENTIATION#0.8408;LYMPH NODE#0.8398;CYTOPLASM#0.8256;OBESE#0.8227;PROTEIN KINASE#0.8123;NEURITE#0.7994;LIPOLYSIS#0.7957;ARACHIDONIC ACID#0.7737;POLYMERASE CHAIN REACTION#0.7683;EPIDERMAL GROWTH FACTOR#0.7576;PPAR SIGNALING PATHWAY#0.7546;LIPID DROPLET#0.7508;NEURITE OUTGROWTH#0.7475;NERVE GROWTH FACTOR#0.7437;OLEIC ACID#0.7356;MONOCYTE#0.7310;STEM CELL#0.7196;PALMITIC ACID#0.7157;IMMUNE RESPONSE#0.7134;LASER DESORPTION IONIZATION#0.7134;HEPATOCELLULAR CARCINOMA#0.7092;RETINOIC ACID RECEPTOR#0.7062;DIABETES MELLITUS#0.7057;ALVEOLAR MACROPHAGE#0.6963;REGENERATION#0.6922;GROWTH FACTOR RECEPTOR#0.6889;BRAIN ENDOTHELIAL CELL#0.6869;GALECTIN#0.6866;FATTY ACID SYNTHASE#0.6834;SIGNAL TRANSDUCTION#0.6810;ALL TRANS RETINOIC ACID#0.6810;FATTY ACID TRANSPORTER#0.6786;NEUROGENESIS#0.6768;LIPOPROTEIN LIPASE#0.6761;DISEASE FREE SURVIVAL#0.6738;CELL DEATH#0.6720;FATTY ACID METABOLISM#0.6591;REACTIVE OXYGEN SPECIES#0.6548;HIGH FAT DIET#0.6529;PROGENITOR CELL#0.6500;NERVOUS SYSTEM#0.6489;CELL CYCLE#0.6485;STEROL REGULATORY ELEMENT#0.6343;SKELETAL MUSCLE#0.6256;CELL ADHESION#0.6207;REVERSE TRANSCRIPTION#0.6205;MOLECULAR DYNAMICS SIMULATION#0.6119;TUMOR ASSOCIATED MACROPHAGE#0.6027
2172	BILE ACID BINDING#1.0755;LIPID BINDING PROTEIN#1.0607;ENTEROCYTE#1.0585;LIPID BINDING#1.0560;SMALL INTESTINE#1.0384;FATTY ACID BINDING#1.0329;FARNESOID X RECEPTOR#1.0215;GENE EXPRESSION#1.0107;ORGANIC SOLUTE TRANSPORTER#0.9528;RETINOIC ACID#0.9228;COLORECTAL CANCER#0.9168;RETINOIC ACID BINDING#0.8713;CHOLIC ACID#0.8687;BILE ACID TRANSPORT#0.8353;COLORECTAL#0.8347;CHOLESTEROL HOMEOSTASIS#0.7856;SMALL HETERODIMER PARTNER#0.7510;TAUROCHOLATE#0.7461;CHENODEOXYCHOLIC ACID#0.7454;GRANULOSA CELL#0.7398;OVARIES#0.7209;BILE ACID SYNTHESIS#0.7078;EPITHELIAL CELL#0.7008;RETINOL BINDING#0.6868;ADRENAL GLAND#0.6821;PEROXISOME#0.6784;TIGHT JUNCTION#0.6582;WHOLE GENOME DUPLICATION#0.6517;TIGHT JUNCTION PROTEIN#0.6386;EXCRETION#0.6334;GROWTH FACTOR#0.6318;POLYMERASE CHAIN REACTION#0.6222;GUT MORPHOGENESIS#0.6188;BRUSH BORDER MEMBRANE#0.6122;BRUSH BORDER#0.6093;BILE DUCT#0.6091;LIVER X RECEPTOR#0.6031
2173	LIPID BINDING PROTEIN#1.0639;LIPID BINDING#1.0594;RADIAL GLIAL CELL#1.0383;MALIGNANT GLIOMA#1.0379;FATTY ACID BINDING#1.0321;ASTROCYTE#1.0244;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0221;BREAST CANCER#1.0189;CELL PROLIFERATION#1.0183;NEURAL STEM CELL#1.0152;GLIAL CELL#1.0141;RENAL CELL CARCINOMA#1.0117;PROGENITOR CELL#1.0036;STEM CELL#1.0014;CENTRAL NERVOUS SYSTEM#0.9957;NERVOUS SYSTEM#0.9956;OLIGODENDROCYTE#0.9939;NEUROGENESIS#0.9935;TRANSCRIPTION FACTOR#0.9927;SPINAL CORD#0.9738;GENE EXPRESSION#0.9680;GROWTH FACTOR#0.9648;SIGNALING PATHWAY#0.9623;DENTATE GYRUS#0.9594;CANCER CELL#0.9419;BRAIN DEVELOPMENT#0.9387;LIPID METABOLISM#0.9303;CELL MIGRATION#0.9270;CELL CYCLE#0.9261;BREAST CANCER CELL#0.9196;CELL GROWTH#0.8960;MAMMARY GLAND#0.8690;FOREBRAIN#0.8532;SCHWANN CELL#0.8481;CEREBRAL CORTEX#0.8435;HUMAN BREAST CANCER#0.8411;NEURAL PROGENITOR CELL#0.8380;PROTEIN KINASE#0.8327;NEURONAL MIGRATION#0.8083;ASTROCYTOMA#0.7993;OLEIC ACID#0.7991;RETINOIC ACID#0.7866;PRECURSOR CELL#0.7744;QUANTITATIVE REAL TIME#0.7652;EPITHELIAL CELL#0.7552;APOPTOSIS#0.7489;POLYMERASE CHAIN REACTION#0.7475;ARACHIDONIC ACID#0.7463;PLASMA MEMBRANE#0.7448;NEURAL STEM PROGENITOR#0.7436;EPIDERMAL GROWTH FACTOR#0.7426;TELENCEPHALON#0.7423;MELANOMA CELL LINES#0.7382;CYTOPLASM#0.7369;BREAST CARCINOMA#0.7276;NEUROEPITHELIAL CELL#0.7273;NEUROBLAST#0.7001;LIPID DROPLET#0.6970;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6773;GROWTH FACTOR RECEPTOR#0.6772;PEROXISOME#0.6685;OLIGODENDROCYTE PROGENITOR CELL#0.6665;NERVOUS SYSTEM DEVELOPMENT#0.6617;SYSTEM DEVELOPMENT#0.6599;CELL DIFFERENTIATION#0.6507;TUMOR CELLS#0.6475;DIURNAL#0.6416;FETAL BRAIN#0.6404;FRONTAL#0.6392;BIPOLAR DISORDER#0.6372;REGENERATION#0.6365;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6334;STEM CELL MARKER#0.6327;MULTIPLE SCLEROSIS#0.6275;HUMAN NEURAL PROGENITOR#0.6227;DOWN SYNDROME#0.6146;CELLULAR LOCALIZATION#0.6115;GANGLION CELLS#0.6106;MITOGEN ACTIVATED PROTEIN#0.6055;LYMPH NODE#0.6030;ADENOID CYSTIC CARCINOMA#0.6019
2175	FANCONI ANEMIA COMPLEMENTATION GROUP A#1.1428;FANCONI ANEMIA#1.0284;ANEMIA#1.0185;DNA REPAIR#0.9993;STEM CELL#0.9840;BONE MARROW FAILURE#0.9821;BONE MARROW#0.9815;ANAEMIA#0.9692;PROGENITOR CELL#0.9594;MITOMYCIN C#0.9108;FA CORE COMPLEX#0.9013;CELL CYCLE#0.8923;GENE EXPRESSION#0.8878;BREAST CANCER#0.8797;HYPERSENSITIVITY#0.8662;HEMATOPOIETIC STEM CELL#0.8528;MITOMYCIN#0.8333;OVARIAN#0.8182;APOPTOSIS#0.7926;DNA DAMAGE RESPONSE#0.7917;B CELL#0.7913;OVARIAN CANCER#0.7746;HOMOLOGOUS RECOMBINATION#0.7695;DOUBLE STRAND BREAK#0.7479;NUCLEAR LOCALIZATION SIGNAL#0.7054;PROSTATE CANCER#0.6358;CANCER CELL#0.6009
2176	FANCONI ANEMIA COMPLEMENTATION GROUP C#1.1286;HEMATOPOIETIC CELL#1.0562;IFN-GAMMA#1.0541;APOPTOSIS#1.0326;FA CORE COMPLEX#1.0324;PROGENITOR CELL#1.0237;STEM CELL#1.0064;ANAEMIA#1.0058;DNA REPAIR#0.9965;FANCONI ANEMIA#0.9958;BREAST CANCER#0.9945;HEMATOPOIETIC STEM CELL#0.9917;MITOMYCIN C#0.9917;MITOMYCIN#0.9883;ANEMIA#0.9877;HYPERSENSITIVITY#0.9865;BONE MARROW FAILURE#0.9755;BONE MARROW#0.9744;HOMOLOGOUS RECOMBINATION#0.9555;BONE MARROW CELLS#0.9444;CELL CYCLE#0.9332;APOPTOTIC#0.9328;TUMOR NECROSIS FACTOR#0.9258;PANCREATIC CANCER#0.9192;PERIPHERAL BLOOD#0.9115;GENE EXPRESSION#0.8814;LYMPHOBLAST#0.8794;MACROPHAGE#0.8599;FA COMPLEX#0.8583;PROTEIN COMPLEX#0.8580;GENETIC DISORDER#0.8575;REACTIVE OXYGEN SPECIES#0.8567;TUMOR SUPPRESSOR#0.8408;CORD BLOOD#0.8089;AUTOSOMAL RECESSIVE DISEASE#0.8087;CYTOPLASM#0.7909;OVARIAN#0.7863;HEMATOPOIESIS#0.7712;CISPLATIN#0.7669;MYELOID LEUKEMIA#0.7641;B CELL#0.7553;OVARIAN CANCER#0.7512;SIGNALING PATHWAY#0.7401;APLASTIC ANEMIA#0.7386;HEMATOPOIETIC PROGENITOR CELL#0.7366;DOUBLE STRAND BREAK#0.7318;GENETIC DISEASE#0.7259;CELL DEATH#0.7128;CANCER CELL#0.7006;GROWTH FACTOR#0.7004;GERM CELL#0.6728;TRANSCRIPTION FACTOR#0.6697;DNA DAMAGE RESPONSE#0.6662;SQUAMOUS CELL CARCINOMA#0.6616;PROTEIN KINASE#0.6573;CELL DIFFERENTIATION#0.6556;COLONY-STIMULATING FACTOR#0.6556;BREAST CARCINOMA#0.6324;MURINE EMBRYONIC FIBROBLASTS#0.6098;PANCYTOPENIA#0.6078;ACUTE MYELOID LEUKEMIA#0.6063;PRIMORDIAL GERM CELL#0.6055
2177	FAD BINDING#1.0890;FA CORE COMPLEX#1.0500;FATTY ACID DESATURASE#1.0381;PROGENITOR CELL#1.0343;S-PHASE CHECKPOINT#1.0307;ICL REPAIR#1.0297;COMPLEX I#1.0244;OLEIC ACID#1.0186;S PHASE#1.0177;UBIQUITIN#1.0131;PROTEIN COMPLEX#1.0118;HOMOLOGOUS RECOMBINATION REPAIR#1.0084;FA COMPLEX#1.0073;REPLICATION FORK#1.0037;DNA BINDING#1.0006;TELOMERE#0.9997;DNA REPAIR PROTEIN#0.9993;CISPLATIN#0.9977;MITOMYCIN C#0.9968;ANAEMIA#0.9964;STEM CELL#0.9955;DNA DAMAGE RESPONSE#0.9955;MITOMYCIN#0.9951;DNA SYNTHESIS#0.9930;BREAST CANCER#0.9870;GENE EXPRESSION#0.9864;CANCER CELL#0.9863;DOUBLE STRAND BREAK#0.9856;DNA REPAIR#0.9849;DNA REPLICATION#0.9848;CELL CYCLE#0.9836;ENDOPLASMIC RETICULUM#0.9835;TUMOR SUPPRESSOR#0.9819;FANCONI ANEMIA#0.9817;HOMOLOGOUS RECOMBINATION#0.9805;OVARIAN CANCER#0.9766;HYPERSENSITIVITY#0.9765;OVARIAN#0.9758;ANEMIA#0.9757;APOPTOSIS#0.9745;LUNG CANCER#0.9723;HEMATOPOIETIC STEM CELL#0.9703;BONE MARROW FAILURE#0.9674;CELL DEATH#0.9638;BONE MARROW#0.9626;ATAXIA TELANGIECTASIA#0.9595;DOUBLE-STRAND BREAK REPAIR#0.9584;GENETIC DISEASE#0.9494;SPORADIC BREAST CANCER#0.9464;CELL PROLIFERATION#0.9450;HYDROXYUREA#0.9443;FATTY ACID DESATURATION#0.9390;TOXICITY#0.9378;T CELL#0.9300;UBIQUITIN BINDING#0.9294;CHROMOSOME BREAKAGE#0.9270;CHROMATID#0.9230;CELL CYCLE CHECKPOINT#0.9142;SQUAMOUS CELL CARCINOMA#0.9080;GENE SILENCING#0.9073;DEUBIQUITINATION#0.8998;TUMOR CELLS#0.8884;LIGASE ACTIVITY#0.8829;GENETIC DISORDER#0.8800;ELECTRON TRANSFER#0.8760;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8751;SIGNALING PATHWAY#0.8703;LYMPH NODE#0.8688;HEMATOPOIETIC PROGENITOR CELL#0.8684;ENZYME ACTIVITY#0.8682;TRANSLESION SYNTHESIS#0.8662;HEMATOPOIETIC CELL#0.8625;FLAVIN#0.8624;PROTEASOME#0.8464;DEUBIQUITINATING ENZYME#0.8435;MYELOID LEUKEMIA#0.8376;APOPTOTIC#0.8273;CELL CYCLE ARREST#0.8252;RNA INTERFERENCE#0.8232;SENESCENCE#0.8229;HEMATOPOIESIS#0.8123;MISMATCH REPAIR#0.8120;GENOTOXIC#0.8116;CYTOTOXICITY#0.8112;DRUG RESISTANCE#0.8009;NUCLEOTIDE EXCISION REPAIR#0.7982;MOUSE EMBRYONIC FIBROBLAST#0.7976;TRANSCRIPTION FACTOR#0.7959;INTERSTRAND CROSS-LINK REPAIR#0.7956;FAMILIAL BREAST CANCER#0.7943;MEIOSIS#0.7897;COMMON FRAGILE SITES#0.7849;B CELL#0.7802;ETHANOL#0.7770;EPITHELIAL CELL#0.7768;SEED DEVELOPMENT#0.7750;MUTAGENESIS#0.7744;UBIQUITIN LIGASE COMPLEX#0.7701;MITOSIS#0.7616;C TERMINAL DOMAIN#0.7594;CAMPTOTHECIN#0.7542;M PHASE#0.7473;CERVICAL#0.7448;APLASTIC ANEMIA#0.7323;BREAST CANCER CELL#0.7217;PROTEIN KINASE#0.7183;GERM CELL#0.7115;LYSINE#0.7102;HISTIDINE#0.7050;HEAD AND NECK CANCER#0.7035;NECK CANCER#0.7035;REPLICATION FORK STALLING#0.7005;CHROMATIN BINDING#0.6992;LYMPHOBLAST#0.6985;SENSITIZATION#0.6930;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6874;VIRAL REPLICATION#0.6859;MITOCHONDRIA#0.6834;STROMAL CELL#0.6822;ATAXIA TELANGIECTASIA MUTATED#0.6806;NUCLEAR IMPORT#0.6769;PANCREATIC CANCER#0.6764;MULTIPLE MYELOMA#0.6746;POLY ADP RIBOSE#0.6744;MELPHALAN#0.6742;CELL GROWTH#0.6722;BONE MARROW CELLS#0.6711;AUTOSOMAL RECESSIVE DISEASE#0.6711;HOMOLOGY-DIRECTED REPAIR#0.6652;GENE CONVERSION#0.6607;PROTEIN PROTEIN INTERACTION#0.6579;TOPOISOMERASE#0.6554;REACTIVE OXYGEN SPECIES#0.6542;FATTY ACID METABOLISM#0.6520;NULL CELL#0.6517;BASE EXCISION REPAIR#0.6515;HISTONE DEACETYLASE#0.6447;PLASTID#0.6399;CHLOROPLAST#0.6360;ORAL CAVITY#0.6294;UBIQUITIN LIGASE ACTIVITY#0.6278;REPLICATION PROTEIN A#0.6277;CELL DIVISION#0.6276;HEPATOCELLULAR CARCINOMA#0.6214;CHROMOSOME SEGREGATION#0.6214;DNA HELICASE#0.6211;TOTAL FATTY ACIDS#0.6125;TELOMERE MAINTENANCE#0.6117;RESPIRATION#0.6101;NUCLEAR LOCALIZATION SIGNAL#0.6059;APOPTOTIC CELL DEATH#0.6018;CARBOPLATIN#0.6007
2178	FANCONI ANEMIA#0.6885;FA CORE COMPLEX#0.6509
217	RESPONSE TO ALCOHOL#1.0644;ACETALDEHYDE METABOLISM#1.0601;AUTOPHAGY#1.0414;GLYCERYL TRINITRATE#1.0407;CYANAMIDE#1.0382;ISCHEMIA REPERFUSION INJURY#1.0367;ALCOHOLIC LIVER CIRRHOSIS#1.0366;FLUSHING#1.0357;DRINKING BEHAVIOR#1.0348;NITROGLYCERIN#1.0346;DISULFIRAM#1.0327;ESOPHAGEAL CANCER#1.0324;HYPERTENSION#1.0302;LIVER CIRRHOSIS#1.0283;CARDIOMYOCYTE#1.0281;CORONARY ARTERY DISEASE#1.0265;ARTERY DISEASE#1.0263;MYOCARDIAL INFARCTION#1.0250;FRAGMENT LENGTH POLYMORPHISM#1.0249;CYTOCHROME P450#1.0236;ENZYME ACTIVITY#1.0229;ALCOHOL DEPENDENCE#1.0224;PERIPHERAL BLOOD#1.0223;DOPAMINE#1.0210;PANCREATITIS#1.0210;GLUTATHIONE#1.0208;COLORECTAL CANCER#1.0198;COLORECTAL#1.0191;CORONARY ARTERY#1.0182;DETOXIFICATION#1.0167;STOMACH CANCER#1.0166;CARDIOMYOPATHY#1.0163;ISCHEMIA#1.0158;POLYMERASE CHAIN REACTION#1.0147;DIGESTIVE TRACT#1.0129;ETHANOL METABOLISM#1.0125;MITOCHONDRIA#1.0119;HEART DISEASE#1.0116;HEPATOCELLULAR CARCINOMA#1.0110;APOPTOSIS#1.0098;ALCOHOL METABOLISM#1.0091;HEAD AND NECK CANCER#1.0090;NECK CANCER#1.0089;SMOOTH MUSCLE#1.0079;ARTERY#1.0077;ENDOTHELIAL CELL#1.0060;ALZHEIMER'S DISEASE#1.0058;LIPOIC ACID#1.0050;DIABETES MELLITUS#1.0047;SIGNALING PATHWAY#1.0044;CORONARY HEART DISEASE#1.0041;LIVER DISEASE#1.0030;NITRIC OXIDE#1.0025;STEM CELL#1.0007;PROTEIN KINASE#1.0005;REACTIVE OXYGEN SPECIES#0.9987;LEUKOCYTE#0.9975;ETHANOL#0.9973;ACETIC ACID#0.9938;TOXICITY#0.9936;SQUAMOUS CELL CARCINOMA#0.9929;ALCOHOL USE DISORDER#0.9921;GENE EXPRESSION#0.9920;ATHEROSCLEROSIS#0.9912;ALCOHOLIC PANCREATITIS#0.9883;SMOOTH MUSCLE CELL#0.9878;CELL DEATH#0.9876;MUSCLE CELL#0.9871;ADJUSTED ODDS RATIO#0.9871;VASODILATION#0.9863;CELL PROLIFERATION#0.9858;CARCINOGEN#0.9850;ESOPHAGUS#0.9827;SUPEROXIDE DISMUTASE#0.9813;PROTEIN KINASE C#0.9785;HYPOXIA#0.9750;FATTY LIVER#0.9736;MULTIPLE LOGISTIC REGRESSION#0.9717;LYSINE#0.9701;TYPE 2 DIABETES#0.9665;TOLUENE METABOLISM#0.9646;ROS FORMATION#0.9635;ALDEHYDE METABOLISM#0.9624;BLOOD VESSEL#0.9615;C-LEVEL#0.9612;ALCOHOLIC CARDIOMYOPATHY#0.9582;BONE MARROW#0.9570;ESSENTIAL HYPERTENSION#0.9522;PARKINSON'S DISEASE#0.9512;HIGH DENSITY LIPOPROTEIN#0.9481;HIGH FAT DIET#0.9476;CYTOTOXICITY#0.9474;LOW DENSITY LIPOPROTEIN#0.9449;LUNG CANCER#0.9425;FOLATE#0.9403;BREAST CANCER#0.9398;GENOTOXIC#0.9375;GUANYLATE CYCLASE#0.9375;ALANINE#0.9359;ETHANOL OXIDATION#0.9326;HEPATITIS B#0.9270;MYOCARDIUM#0.9244;CANCER CELL#0.9225;DOPAL#0.9224;ROS GENERATION#0.9203;MITOCHONDRIAL MEMBRANE#0.9198;TRANSCRIPTION FACTOR#0.9175;VASODILATOR#0.9170;NADPH OXIDASE#0.9145;PERIPHERAL BLOOD LEUKOCYTE#0.9133;LIVER DAMAGE#0.9060;MULTIPLE REGRESSION ANALYSIS#0.9049;GROWTH FACTOR#0.9048;CLEAVED CASPASE 3#0.9047;TOLUENE#0.9023;DNA REPAIR#0.9012;FANCONI ANEMIA#0.9004;BIPOLAR DISORDER#0.8995;LIVER CANCER#0.8986;PROGENITOR CELL#0.8971;PANCREATIC CANCER#0.8968;ANEMIA#0.8961;TUMOR NECROSIS FACTOR#0.8880;CEREBRAL INFARCTION#0.8874;CATALYTIC ACTIVITY#0.8859;DIGESTION#0.8852;HYPERGLYCEMIA#0.8848;CHLORAL HYDRATE#0.8742;GENOTOXICITY#0.8732;DOPAMINE D2 RECEPTOR#0.8729;CONDITIONAL LOGISTIC REGRESSION#0.8710;CANCER STEM CELL#0.8703;CELL CYCLE#0.8653;KUPFFER CELL#0.8614;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8612;HEPATOMA CELLS#0.8505;ASPARTATE#0.8497;APOPTOTIC#0.8469;RETINOIC ACID#0.8454;FOAM CELL FORMATION#0.8432;MAST CELL#0.8365;ACUTE MYOCARDIAL INFARCTION#0.8354;ATHEROSCLEROTIC#0.8350;ORAL SQUAMOUS CELL CARCINOMA#0.8348;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8316;GASTRIC MUCOSA#0.8309;ORAL CAVITY#0.8278;MACROPHAGE#0.8234;MITOCHONDRIAL DNA#0.8227;PERSONALITY DISORDER#0.8214;RESPIRATION#0.8209;REGULATION OF AUTOPHAGY#0.8206;NICOTINAMIDE#0.8203;NEURODEGENERATIVE DISEASE#0.8194;HEROIN DEPENDENCE#0.8193;MUTAGENESIS#0.8175;SENESCENCE#0.8129;MONONUCLEAR CELLS#0.8122;TUMOR SUPPRESSOR#0.8119;ANXIETY DISORDER#0.8096;URIC ACID#0.8085;DNA METHYLATION#0.8082;FRONTAL#0.8032;EPITHELIAL CELL#0.8012;NEUROTOXICITY#0.7946;ATP SYNTHASE#0.7934;LINEAR REGRESSION ANALYSIS#0.7930;AGE AT ONSET#0.7896;DOXORUBICIN#0.7890;ADENINE#0.7873;PEROXISOME#0.7817;CHICKEN BETA ACTIN#0.7810;MECHANISM OF ACTION#0.7768;MULTIPLE LINEAR REGRESSION#0.7767;CONDUCT DISORDER#0.7733;NERVOUS SYSTEM#0.7705;OXIDATIVE DNA DAMAGE#0.7663;ACETYLCHOLINE#0.7661;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7643;HUMAN UMBILICAL VEIN#0.7637;UMBILICAL VEIN#0.7635;FASTING BLOOD GLUCOSE#0.7627;CATABOLISM#0.7610;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7599;IL-1RN#0.7586;GLYCOLYSIS#0.7582;DEMENTIA#0.7555;MENTAL DISORDER#0.7545;ACUTE PANCREATITIS#0.7531;GLUTAMIC ACID#0.7515;ALPHA LIPOIC ACID#0.7474;ARRHYTHMIA#0.7451;ENDOTHELIUM#0.7431;HISTAMINE#0.7402;DOPAMINE RECEPTOR#0.7385;VENOUS BLOOD#0.7378;LIPID METABOLISM#0.7348;COLORECTAL ADENOMA#0.7293;HEME OXYGENASE 1#0.7227;PERCUTANEOUS CORONARY INTERVENTION#0.7180;TELOMERE#0.7128;HEROIN#0.7109;CENTRAL NERVOUS SYSTEM#0.7102;OVARIAN CANCER#0.7088;T CELL#0.7068;4-METHYLPYRAZOLE#0.7065;CASPASE-3 ACTIVITY#0.7025;GLYCOGEN SYNTHASE KINASE#0.7023;ANTISOCIAL PERSONALITY DISORDER#0.7020;ASCORBATE#0.7004;ESOPHAGEAL CARCINOMA#0.7004;HEMATOPOIETIC STEM CELL#0.6994;SYSTOLIC BLOOD PRESSURE#0.6977;WHITE BLOOD CELL#0.6977;OSTEOPOROSIS#0.6973;SMALL INTESTINE#0.6971;ADIPOSE TISSUE#0.6965;ANGIOGENESIS#0.6962;SKELETAL MUSCLE#0.6958;HYPOXIC#0.6953;C REACTIVE PROTEIN#0.6929;ENDOPLASMIC RETICULUM#0.6877;CEREBRAL ISCHEMIA#0.6819;HYPOXIA INDUCIBLE FACTOR#0.6806;ISCHEMIC HEART DISEASE#0.6751;DRUG RESISTANCE#0.6721;CYTOCHROME C#0.6692;STRIATUM#0.6681;COENZYME BINDING#0.6650;STREPTOZOTOCIN#0.6643;CHRONIC HEPATITIS B#0.6638;ISOSORBIDE DINITRATE#0.6604;RESPONSE TO NITROGLYCERIN#0.6560;CHRONIC ALCOHOL CONSUMPTION#0.6557;ATROPHIC GASTRITIS#0.6528;COMPLEX I#0.6408;ADENOCARCINOMA#0.6389;REVERSE TRANSCRIPTION#0.6380;CARCINOGENICITY#0.6364;HARDY WEINBERG EQUILIBRIUM#0.6362;HYPERSENSITIVITY#0.6282;CISPLATIN#0.6248;SUBSTANTIA NIGRA#0.6221;HEART DAMAGE#0.6219;OVARIAN#0.6217;XENOBIOTIC METABOLISM#0.6192;CELL MIGRATION#0.6178;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6154;CARDIOVASCULAR RISK FACTOR#0.6141;OSTEOBLAST#0.6130;ORAL CAVITY CANCER#0.6128;MACROCYTIC ANEMIA#0.6114;NITRIC OXIDE SYNTHASE#0.6102;MYOCARDIAL INFARCT SIZE#0.6097;TRANSFORMING GROWTH FACTOR#0.6095;CGMP FORMATION#0.6088;ESTERASE ACTIVITY#0.6064;INFLAMMATORY RESPONSE#0.6064;FORMALDEHYDE DEHYDROGENASE#0.6053;RAPAMYCIN#0.6046;CHRONIC HEART FAILURE#0.6014;DIABETIC RETINOPATHY#0.6011;MUTAGENIC#0.6010
2180	FATTY ACID TRANSPORT#1.0522;FATTY ACID BINDING#1.0322;FATTY ACID OXIDATION#1.0249;ADIPOSE TISSUE#1.0211;ADIPOCYTE#1.0122;COENZYME A#1.0110;CARNITINE#1.0096;FATTY ACID METABOLISM#0.9967;SKELETAL MUSCLE#0.9952;LIPID METABOLISM#0.9930;PALMITATE#0.9828;PEROXISOME#0.9816;LIPID DROPLET#0.9801;GENE EXPRESSION#0.9778;HIGH FAT DIET#0.9733;MACROPHAGE#0.9712;TRANSCRIPTION FACTOR#0.9600;COA LIGASE#0.9566;ETHYLENE BIOSYNTHESIS#0.9543;PROTEIN KINASE#0.9439;ETHANOL#0.9386;MITOCHONDRIA#0.9341;FATTY ACID SYNTHASE#0.9297;LIPID SYNTHESIS#0.9248;ENDOPLASMIC RETICULUM#0.9091;SIGNALING PATHWAY#0.9061;STEROL REGULATORY ELEMENT#0.9013;POLYMERASE CHAIN REACTION#0.8997;CANCER CELL#0.8829;PALMITOYL#0.8779;ACETYL COA CARBOXYLASE#0.8665;PLASMA MEMBRANE#0.8645;SYNTHETASE ACTIVITY#0.8642;LIPOLYSIS#0.8596;ACETYL-COENZYME A SYNTHETASE#0.8596;PEROXISOMAL#0.8587;SATURATED FATTY ACID#0.8516;RAPAMYCIN#0.8478;LIPOGENESIS#0.8393;BREAST CANCER#0.8206;HEPATOMA CELLS#0.8014;MITOCHONDRIAL MEMBRANE#0.8013;ENZYME ACTIVITY#0.7995;ATHEROSCLEROSIS#0.7981;OLEIC ACID#0.7948;ACYL-COA SYNTHETASE ACTIVITY#0.7897;CHOLESTEROL EFFLUX#0.7578;FRUIT RIPENING#0.7540;TARGET OF RAPAMYCIN#0.7450;MAMMARY GLAND#0.7315;SIGNAL TRANSDUCTION#0.7263;BINDING PROTEIN 1#0.7251;PALMITIC ACID#0.7116;LIPOPROTEIN LIPASE#0.7094;PYRUVATE#0.7093;LIPID DROPLET FORMATION#0.7092;MONOCYTE#0.7069;OBESE#0.6963;LIPID METABOLIC#0.6920;STEAROYL COA DESATURASE#0.6854;PHA GRANULE#0.6849;FATTY LIVER#0.6801;LIPID BIOSYNTHESIS#0.6758;FATTY ACID TRANSPORTER#0.6691;CARNITINE PALMITOYL TRANSFERASE#0.6670;HORMONE SENSITIVE LIPASE#0.6610;EPITHELIAL CELL#0.6455;GROWTH FACTOR#0.6448;TRIGLYCERIDE SYNTHESIS#0.6426;LACTATION#0.6394;ARACHIDONIC ACID#0.6388;SUBCUTANEOUS ADIPOSE TISSUE#0.6342;QUANTITATIVE REAL TIME#0.6317;FATTY ACID DEGRADATION#0.6296;FATTY ACID SYNTHESIS#0.6240;ACYL COA OXIDASE#0.6205;TRIGLYCERIDE STORAGE#0.6152;FERMENTATION#0.6079;ADIPOGENESIS#0.6078;POLLEN COAT#0.6076;MYELOID CELL#0.6073;LIPID STORAGE#0.6043;AZILSARTAN#0.6018;TUMOR CELLS#0.6011
2181	LIPID DROPLET#0.9831;LIPID METABOLISM#0.9805;FATTY ACID METABOLISM#0.9805;CANCER CELL#0.9782;PROSTATE CANCER#0.9622;COENZYME A#0.9395;GENE EXPRESSION#0.9238;ENDOPLASMIC RETICULUM#0.8718;LUNG CANCER#0.8018;SYNTHETASE ACTIVITY#0.7857;SIGNALING PATHWAY#0.7767;ACYL-COA SYNTHETASE ACTIVITY#0.7532;COA LIGASE#0.7430;ENZYME ACTIVITY#0.7376;FATTY ACID OXIDATION#0.7173;BREAST CANCER#0.6705;PEROXISOME#0.6259;TRIGLYCERIDE LIPASE#0.6240;HORMONE SENSITIVE LIPASE#0.6228;NUCLEAR HORMONE RECEPTOR#0.6197;LIPID SYNTHESIS#0.6114;MITOCHONDRIA#0.6072
2182	FERROPTOSIS#1.0781;BREAST CANCER#1.0697;MENTAL RETARDATION#1.0501;COA LIGASE#1.0454;ARACHIDONIC ACID#1.0448;BREAST CANCER CELL#1.0433;CANCER CELL#1.0202;LIPID METABOLISM#1.0101;CELL DEATH#0.9977;GENE EXPRESSION#0.9945;FATTY ACID METABOLISM#0.9809;HEPATOCELLULAR CARCINOMA#0.9487;ETHYLENE BIOSYNTHESIS#0.9433;ENDOPLASMIC RETICULUM#0.9321;SIGNALING PATHWAY#0.9032;APOPTOSIS#0.9020;COENZYME A#0.8843;TRANSCRIPTION FACTOR#0.8795;CELL PROLIFERATION#0.8773;ROSIGLITAZONE#0.8755;INTELLECTUAL DISABILITY#0.8529;CELL GROWTH#0.8394;ESTROGEN RECEPTOR#0.8052;STEROIDOGENESIS#0.8025;FATTY ACID OXIDATION#0.7995;ALPORT SYNDROME#0.7962;PEROXISOMAL#0.7881;FRUIT RIPENING#0.7800;PEROXISOME#0.7699;PROSTATE CANCER#0.7510;GROWTH FACTOR#0.7432;TERATOGENIC#0.7402;HIGH FAT DIET#0.7352;LIPID DROPLET#0.7170;MITOCHONDRIA#0.7123;HEPATOMA CELLS#0.6822;REACTIVE OXYGEN SPECIES#0.6646;ENZYME ACTIVITY#0.6537;APOPTOTIC#0.6382;FATTY ACID BINDING#0.6364;X CHROMOSOME#0.6249;POLYMERASE CHAIN REACTION#0.6215;POLLEN COAT#0.6172;NORMAL LIVER TISSUES#0.6125;LIPID SYNTHESIS#0.6122;PROTEIN MYRISTOYLATION#0.6093
2184	TYROSINE CATABOLIC#1.0904;TYROSINE CATABOLISM#1.0728;TYROSINEMIA TYPE I#1.0532;TYROSINEMIA#1.0453;TYROSINE METABOLISM#1.0381;TYROSINE DEGRADATION#1.0301;CATABOLISM#1.0225;CELL DEATH#1.0082;GENE EXPRESSION#0.9964;LIVER DISEASE#0.9936;HEPATOCELLULAR CARCINOMA#0.9849;AUTOSOMAL RECESSIVE DISEASE#0.9729;MALEYLACETOACETATE ISOMERASE#0.9445;STEM CELL#0.9437;BONE MARROW#0.9340;AMNIOTIC FLUID#0.9113;GENETIC DISORDER#0.9006;APOPTOSIS#0.8915;GLUTATHIONE#0.8904;CHORIONIC VILLUS#0.8733;LIVER DAMAGE#0.8715;FUMARATE#0.8616;4 HYDROXYPHENYLPYRUVATE DIOXYGENASE#0.8569;ENZYME ACTIVITY#0.8549;EXCRETION#0.8073;TOXICITY#0.8015;RICKETS#0.8003;KIDNEY DAMAGE#0.7981;TRANSCRIPTION FACTOR#0.7765;D-SERINE#0.7730;ACUTE LIVER FAILURE#0.7617;POLYMERASE CHAIN REACTION#0.7597;REGENERATION#0.7502;HOMOLOGOUS RECOMBINATION#0.7337;GENETIC DISEASE#0.7223;ADENO ASSOCIATED VIRUS#0.7163;URIC ACID#0.7137;MUTAGENIC#0.7118;NITISINONE#0.6852;GROWTH FACTOR#0.6741;METHIONINE#0.6617;MUTAGENESIS#0.6357;AMINOLEVULINIC ACID#0.6274;LIVER REGENERATION#0.6239;GLUCOSE REGULATED PROTEIN#0.6167
2185	PTK/ZK#1.1114;PROTEIN KINASE B ACTIVATION#1.0678;PROTEIN KINASE B SIGNALING#1.0589;TYROSINE KINASE 2#1.0430;EXTRACELLULAR REGULATED KINASE#1.0411;C TERMINAL DOMAIN#1.0395;PODOSOME#1.0375;RIBOSOMAL S6 KINASE#1.0278;PTK 787#1.0274;PROTEIN KINASE B#1.0268;PKB SIGNALING#1.0241;PROTEIN TYROSINE KINASE#1.0215;CAMP RESPONSE ELEMENT BINDING#1.0201;PROTEIN KINASE#1.0201;PLATELET AGGREGATION#1.0192;MESANGIAL CELL#1.0164;FOCAL ADHESION KINASE#1.0160;CAMP RESPONSE ELEMENT#1.0139;MAPK SIGNALING#1.0136;FOCAL CONTACT#1.0127;OSTEOCLAST#1.0124;FOCAL ADHESION#1.0120;ENDOTHELIAL NITRIC OXIDE#1.0116;INTEGRIN LINKED KINASE#1.0109;TARGET OF RAPAMYCIN#1.0099;ADENOSINE MONOPHOSPHATE#1.0097;PKC ACTIVATION#1.0078;HEMATOPOIETIC CELL#1.0074;SRC FAMILY KINASE#1.0061;RAPAMYCIN#1.0061;TARGET OF RAPAMYCIN COMPLEX#1.0056;PALMITATE#1.0054;PHOSPHATASE AND TENSIN HOMOLOG#1.0051;NMDA RECEPTOR#1.0048;BETA CELL#1.0036;ACTIN POLYMERIZATION#1.0035;MAP KINASE#1.0033;GLYCOGEN SYNTHASE KINASE#1.0033;GLYCOGEN SYNTHESIS#1.0032;INSULIN RECEPTOR SUBSTRATE#1.0030;SIGNAL TRANSDUCER#1.0012;OOCYTE#1.0001;CHONDROCYTE#0.9997;NUCLEAR EXPORT#0.9986;GENISTEIN#0.9980;PROTEIN KINASE A#0.9977;RIBOSOMAL PROTEIN#0.9973;B CELL LYMPHOMA#0.9959;GLUTAMATE RECEPTOR#0.9958;DOMINANT NEGATIVE MUTANT#0.9957;ASTROCYTE#0.9956;HEAT SHOCK PROTEIN#0.9952;CAMKII#0.9952;INSULIN RECEPTOR#0.9951;MAPK ACTIVATION#0.9945;BETA-2#0.9943;PROSTATE CANCER#0.9941;NITRIC OXIDE SYNTHASE#0.9927;EUKARYOTIC INITIATION FACTOR#0.9926;MAST CELL#0.9925;PI3K SIGNALING#0.9924;SIGNALLING CASCADE#0.9914;PHOSPHODIESTERASE#0.9914;RESPONSE TO INSULIN#0.9912;HYPOXIA INDUCIBLE FACTOR#0.9909;RECEPTOR TYROSINE KINASE#0.9909;MITOGEN ACTIVATED PROTEIN#0.9908;CLEAVED CASPASE 3#0.9906;NEUTROPHIL#0.9902;CELL MOTILITY#0.9899;AUTOPHAGY#0.9893;CYCLIC ADENOSINE MONOPHOSPHATE#0.9893;LIPID RAFT#0.9890;B CELL#0.9889;PHOSPHOLIPASE C#0.9887;OSTEOBLAST#0.9887;BINDING PROTEIN 1#0.9886;PROTEIN KINASE C#0.9884;MICROTUBULE ASSOCIATED PROTEIN#0.9879;PROTEIN PHOSPHATASE 2A#0.9876;GLUCOSE 6 PHOSPHATASE#0.9876;MYOCYTES#0.9875;PHOSPHATASE 2A#0.9874;TRANSACTIVATION#0.9870;NEURONAL CELLS#0.9868;RESVERATROL#0.9868;TRANSLATION INITIATION#0.9865;ACTIN CYTOSKELETON#0.9865;INTRACELLULAR SIGNALING PATHWAY#0.9864;MICROTUBULE#0.9864;ACTIVATOR PROTEIN 1#0.9861;PLATELET ACTIVATION#0.9860;SIGNALING MOLECULE#0.9859;NADPH OXIDASE#0.9854;BONE RESORPTION#0.9852;MYOTUBE#0.9850;GLUCOSE TRANSPORT#0.9849;CELL ADHESION MOLECULE#0.9849;COLORECTAL CANCER#0.9844;ADENOSINE#0.9843;NITRIC OXIDE#0.9840;INSULIN SIGNALING PATHWAY#0.9838;CELL ADHESION#0.9833;HYPOXIA#0.9833;ANOIKIS#0.9829;CYCLIN DEPENDENT KINASE#0.9828;FIBRINOGEN#0.9827;ARACHIDONIC ACID#0.9826;CEREBRAL ISCHEMIA#0.9825;CARBACHOL#0.9822;VASCULAR SMOOTH MUSCLE CELL#0.9822;EPITHELIAL MESENCHYMAL TRANSITION#0.9814;T LYMPHOCYTE#0.9811;CATALYTIC ACTIVITY#0.9808;COLORECTAL#0.9804;ION CHANNEL#0.9803;SIGNALING CASCADE#0.9803;LIGHT CHAIN 3#0.9798;SIGNALLING PATHWAY#0.9794;T CELL ACTIVATION#0.9793;CASPASE-3 ACTIVITY#0.9788;OVARIAN CANCER#0.9788;ENDOTHELIAL GROWTH FACTOR#0.9784;CHEMOTAXIS#0.9781;T CELL#0.9780;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9780;CISPLATIN#0.9768;IONOPHORE#0.9766;TOLL LIKE RECEPTOR#0.9762;DEXAMETHASONE#0.9762;BONE FORMATION#0.9761;RNA INTERFERENCE#0.9760;MEGAKARYOCYTE#0.9759;ESTRADIOL#0.9757;GLUCOSE UPTAKE#0.9757;PROTEIN TYROSINE PHOSPHATASE#0.9754;LEUCINE#0.9754;ROS GENERATION#0.9754;PROTEIN KINASE ACTIVATION#0.9752;CARDIOMYOCYTE#0.9749;CELL MIGRATION#0.9748;CELL DIFFERENTIATION#0.9745;HEPATOCELLULAR CARCINOMA#0.9743;FIBROBLAST GROWTH FACTOR#0.9742;KERATINOCYTE#0.9741;TRANSFORMING GROWTH FACTOR#0.9740;DNA BINDING#0.9739;GROWTH FACTOR RECEPTOR#0.9736;DEPHOSPHORYLATION#0.9736;LIPID PHOSPHATASE#0.9733;FACTOR I#0.9732;CELL ACTIVATION#0.9731;SMOOTH MUSCLE CELL#0.9730;ESTROGEN RECEPTOR#0.9728;RECEPTOR AGONIST#0.9728;POLY ADP RIBOSE#0.9728;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9728;ADIPOCYTE#0.9728;IFN-GAMMA#0.9726;PERTUSSIS#0.9724;KINASE ACTIVITY#0.9724;MULTIPLE MYELOMA#0.9721;SMOOTH MUSCLE#0.9721;DNA SYNTHESIS#0.9718;EPIDERMAL GROWTH FACTOR#0.9715;NUCLEOTIDE EXCHANGE FACTOR#0.9713;ANDROGEN RECEPTOR#0.9712;PLATELET-DERIVED GROWTH FACTOR#0.9710;PERIPHERAL BLOOD#0.9709;CHANNEL ACTIVITY#0.9707;GLUCOSE METABOLISM#0.9706;STROMAL CELL#0.9705;SUPEROXIDE DISMUTASE#0.9705;ENDOTHELIUM#0.9702;HEME OXYGENASE 1#0.9701;AKT SIGNALING#0.9700;CYTOPLASM#0.9699;HEPATOCYTE GROWTH FACTOR#0.9696;CHEMOKINE RECEPTOR#0.9696;MITOCHONDRIAL MEMBRANE#0.9695;SIGNALING PATHWAY#0.9695;RIBOSE#0.9694;MONOCYTE#0.9693;NEUROPROTECTION#0.9691;INSULIN-LIKE GROWTH FACTOR#0.9691;ASPARTATE#0.9691;ISCHEMIA REPERFUSION INJURY#0.9690;CYCLIC AMP#0.9689;INDUCTION OF APOPTOSIS#0.9687;OVARIAN#0.9686;PROTEIN SYNTHESIS#0.9685;PROTEIN KINASE CASCADE#0.9684;ENDOTHELIAL CELL#0.9682;UBIQUITIN#0.9679;ADRENERGIC RECEPTOR#0.9678;PROTEIN PHOSPHORYLATION#0.9675;TYROSINE KINASE RECEPTOR#0.9672;CYTOCHROME C#0.9671;LUNG CANCER#0.9669;OXYGENASE#0.9668;ISCHEMIA#0.9668;MONONUCLEAR CELLS#0.9667;GLUCOSE HOMEOSTASIS#0.9666;BREAST CANCER CELL#0.9666;LONG TERM POTENTIATION#0.9664;OBESE#0.9663;PEROXISOME#0.9663;LEUKOCYTE#0.9662;MACROPHAGE#0.9661;COLONY-STIMULATING FACTOR#0.9661;SPINAL CORD#0.9661;HEPATOCELLULAR CARCINOMA CELL#0.9659;ENDOCYTOSIS#0.9659;INDUCIBLE NITRIC OXIDE#0.9657;COMPLEX I#0.9657;CALCINEURIN#0.9654;PROTEIN KINASE ACTIVITY#0.9654;NEUROBLASTOMA#0.9654;TYROSINE KINASE INHIBITOR#0.9653;INTESTINAL EPITHELIAL CELL#0.9651;BREAST CANCER#0.9651;MUSCLE PROTEIN SYNTHESIS#0.9651;PRO-INFLAMMATORY#0.9650;CYCLIN DEPENDENT KINASE INHIBITOR#0.9650;HUMAN UMBILICAL VEIN#0.9647;ONCOGENIC#0.9646;MUSCLE CELL#0.9645;MYOCARDIUM#0.9644;PROTEIN PROTEIN INTERACTION#0.9643;CENTRAL NERVOUS SYSTEM#0.9640;EPITHELIAL CELL#0.9639;UMBILICAL VEIN#0.9639;ADIPOSE TISSUE#0.9639;DRUG RESISTANCE#0.9637;SQUAMOUS CELL CARCINOMA#0.9637;GRANULOSA CELL#0.9636;GROWTH FACTOR#0.9636;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9631;ENDOPLASMIC RETICULUM#0.9630;PHOSPHATASE ACTIVITY#0.9630;PKCDELTA#0.9629;STEM CELL#0.9628;ANGIOGENESIS#0.9628;NEURITE#0.9627;TRANSCRIPTION FACTOR#0.9626;HYPOXIC#0.9625;INFLAMMATORY RESPONSE#0.9624;SIGNAL TRANSDUCTION#0.9624;GLUTATHIONE#0.9624;CELL MEMBRANE#0.9624;MITOCHONDRIA#0.9623;PROGENITOR CELL#0.9622;APOPTOTIC CELL DEATH#0.9621;LYMPH NODE#0.9621;MECHANISM OF ACTION#0.9619;EPITHELIAL TO MESENCHYMAL#0.9617;GUANINE#0.9615;HUMAN BREAST CANCER#0.9613;CELL GROWTH#0.9609;S PHASE#0.9607;SKELETAL MUSCLE#0.9604;ALZHEIMER'S DISEASE#0.9603;ACETYL COA CARBOXYLASE#0.9601;ACTIVATED T CELL#0.9601;JNK SIGNALING PATHWAY#0.9600;TUMOR SUPPRESSOR#0.9599;CELL CYCLE ARREST#0.9598;NERVOUS SYSTEM#0.9597;ADENOCARCINOMA#0.9597;RECEPTOR ANTAGONIST#0.9596;TUMOR CELLS#0.9594;PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING#0.9592;REVERSE TRANSCRIPTION#0.9587;PYRUVATE#0.9585;BONE MARROW#0.9585;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.9584;WOUND HEALING#0.9584;APOPTOTIC#0.9581;COLON CANCER#0.9577;REACTIVE OXYGEN SPECIES#0.9577;PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY#0.9577;SKELETAL MUSCLE CELLS#0.9577;TUMOR NECROSIS FACTOR#0.9577;TRANSFORMING GROWTH FACTOR BETA#0.9576;APOPTOSIS#0.9575;VASCULAR CELL#0.9575;G1 PHASE#0.9573;BLOOD VESSEL#0.9571;PLASMA MEMBRANE#0.9563;CANCER CELL#0.9561;MTOR COMPLEX#0.9561;HIGH FAT DIET#0.9560;KINASE INHIBITOR#0.9558;POLYMERASE CHAIN REACTION#0.9557;CELL SURFACE#0.9556;ALANINE#0.9554;MYELOID CELL#0.9552;CELL PROLIFERATION#0.9552;MESENCHYMAL STEM CELL#0.9551;CELL CYCLE#0.9548;HYPERGLYCEMIA#0.9547;CELL COUNTING KIT#0.9547;IMMUNE RESPONSE#0.9545;ARTERY#0.9545;TOXICITY#0.9542;EXTRACELLULAR MATRIX#0.9542;STREPTOZOTOCIN#0.9541;DNA FRAGMENTATION#0.9541;CYTOTOXICITY#0.9538;TRANSLATION INITIATION FACTOR#0.9535;HOST CELL#0.9531;INSULIN SECRETION#0.9529;TUBERCULOSIS#0.9529;TUBE FORMATION#0.9528;GENE EXPRESSION#0.9528;CELL DEATH#0.9528;HYPERTENSION#0.9526;METFORMIN#0.9524;CERVICAL CANCER#0.9518;ACTIVATION OF MAP KINASE#0.9516;P21 ACTIVATED KINASE#0.9513;PROTEIN COMPLEX#0.9513;PANCREATIC CANCER#0.9509;GLUCONEOGENESIS#0.9509;ACTIVATED B CELL#0.9509;BREAST CARCINOMA#0.9503;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9502;DIABETES MELLITUS#0.9500;2-DEOXYGLUCOSE#0.9500;REGENERATION#0.9499;STRESS FIBER#0.9498;MICROVASCULAR ENDOTHELIAL CELL#0.9497;CELL DEVELOPMENT#0.9487;MYOCARDIAL INFARCTION#0.9487;TYPE 2 DIABETES#0.9485;ATHEROSCLEROSIS#0.9484;ACINAR CELL#0.9478;NERVE GROWTH FACTOR#0.9477;CERVICAL#0.9472;VASCULAR ENDOTHELIAL CELL#0.9466;PHOSPHOENOLPYRUVATE#0.9466;ACTIVATED T-CELLS#0.9463;DOPAMINE#0.9460;STAUROSPORINE#0.9458;TUBEROUS SCLEROSIS#0.9456;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9455;IMMUNE CELL#0.9455;ARGININE#0.9454;LOW DENSITY LIPOPROTEIN#0.9449;M PHASE#0.9445;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9445;NEUROTOXICITY#0.9433;DENDRITIC CELL#0.9421;PROGRAMMED CELL DEATH#0.9420;MECHANISMS OF ACTION#0.9411;BLOOD GLUCOSE LEVEL#0.9405;INFLAMMATORY CELL#0.9405;TYPE 2 DIABETES MELLITUS#0.9398;2 DIABETES MELLITUS#0.9398;RESPIRATORY BURST#0.9381;TYPE 2 DIABETIC#0.9381;PHOSPHOLIPASE D#0.9379;LYMPH NODE METASTASIS#0.9378;PACLITAXEL#0.9376;STEROL REGULATORY ELEMENT#0.9375;SMOOTH MUSCLE ACTIN#0.9368;ANCHORAGE INDEPENDENT GROWTH#0.9367;LIPID METABOLISM#0.9365;EMBRYONIC KIDNEY#0.9365;SELECTIN#0.9362;QUANTITATIVE REAL TIME#0.9350;NEURODEGENERATIVE DISEASE#0.9349;OOCYTE MATURATION#0.9347;FRUCTOSE#0.9343;PYRUVATE KINASE#0.9341;HUMAN EMBRYONIC KIDNEY#0.9332;DOXORUBICIN#0.9330;ENHANCER BINDING#0.9328;ENZYME ACTIVITY#0.9327;GLYCOLYSIS#0.9327;PHAGOCYTOSIS#0.9309;ACTIN FILAMENT#0.9300;PHOSPHATASE INHIBITOR#0.9294;LIVER CANCER#0.9293;CALCIUM SIGNALING#0.9290;GLUCOSE TOLERANCE TEST#0.9288;RECEPTOR TRANSACTIVATION#0.9283;PROTEASOME#0.9281;CELL CELL ADHESION#0.9277;TUMOR TISSUES#0.9275;GENE SILENCING#0.9269;GTP BINDING#0.9262;INHIBITION OF APOPTOSIS#0.9261;TUMOUR NECROSIS FACTOR#0.9252;GROWTH CONE#0.9243;CELL CYCLE REGULATION#0.9240;IMMUNE SYSTEM#0.9229;LIPID KINASE#0.9227;BRAIN ISCHEMIA#0.9222;HYPERPHOSPHORYLATION#0.9214;LIPOLYSIS#0.9206;MYOBLAST#0.9204;5'-AMP#0.9200;ADIPOCYTE DIFFERENTIATION#0.9198;CORONARY ARTERY#0.9198;NICOTINAMIDE#0.9163;CEREBRAL ARTERY#0.9160;ETHANOL#0.9159;CALCIUM MOBILIZATION#0.9156;GLIAL CELL#0.9152;N-ACETYLCYSTEINE#0.9134;CD4+ T CELL#0.9132;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9128;GM-CSF#0.9113;NEURITE OUTGROWTH#0.9109;SORAFENIB#0.9109;FAT CELL#0.9107;STRIATUM#0.9104;CD8+ T CELL#0.9103;CONNECTIVE TISSUE#0.9097;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9093;CYTOKINE PRODUCTION#0.9080;MAPK CASCADE#0.9077;RHEUMATOID ARTHRITIS#0.9074;NF-KAPPAB ACTIVATION#0.9061;FERTILIZATION#0.9059;CELL PERIPHERY#0.9058;ISOPROTERENOL#0.9056;MIDDLE CEREBRAL ARTERY#0.9053;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9050;MAPK ERK KINASE#0.9045;HISTONE DEACETYLASE#0.9040;OSTEOPOROSIS#0.9034;RENAL CELL CARCINOMA#0.9027;ACETYLCHOLINE#0.9020;CEREBRAL ARTERY OCCLUSION#0.9004;PKCALPHA#0.9001;ENDOPLASMIC RETICULUM STRESS#0.8997;SYNAPTIC TRANSMISSION#0.8996;VASCULAR DISEASE#0.8991;TRANSCRIPTASE#0.8969;MICROTUBULE ORGANIZING CENTER#0.8957;GONADOTROPIN RELEASING HORMONE#0.8953;CELLULAR GROWTH#0.8950;PROPIDIUM#0.8945;FATTY ACID SYNTHASE#0.8942;CYTOKINE RECEPTOR#0.8937;FLUID SHEAR STRESS#0.8932;QUANTITATIVE REVERSE TRANSCRIPTION#0.8924;NIFEDIPINE#0.8919;CANCER STEM CELL#0.8916;CEREBRAL CORTEX#0.8912;GLUTATHIONE PEROXIDASE#0.8903;CALCIUM CHANNEL#0.8903;INTRACELLULAR SIGNAL TRANSDUCTION#0.8902;CYTOCHROME C RELEASE#0.8899;LYSINE#0.8896;HEPATOMA CELLS#0.8890;SENSITIZATION#0.8874;THYMIDINE#0.8871;KIDNEY DISEASE#0.8870;PARKINSON'S DISEASE#0.8870;MALIGNANT GLIOMA#0.8865;MAMMARY EPITHELIAL CELL#0.8862;ENHANCER BINDING PROTEIN#0.8862;L-ARGININE#0.8860;TRADITIONAL CHINESE MEDICINE#0.8849;ANTI APOPTOSIS#0.8833;SWELLING#0.8823;MORRIS WATER MAZE#0.8822;MUTAGENESIS#0.8803;TELOMERASE ACTIVITY#0.8798;LIVER DISEASE#0.8796;MICROGLIAL CELL#0.8793;DOCKING PROTEIN#0.8793;AUTOPHAGOSOME#0.8792;SPHINGOSINE 1 PHOSPHATE#0.8788;BETA CELL MASS#0.8782;GLYCOGEN METABOLISM#0.8766;MAP KINASE CASCADE#0.8763;ETHANE#0.8758;LITHIUM#0.8750;STEM CELL FACTOR#0.8739;AMYLOID PRECURSOR PROTEIN#0.8738;TIGHT JUNCTION#0.8736;PREADIPOCYTE#0.8735;LIPOGENESIS#0.8726;TUBEROUS SCLEROSIS COMPLEX#0.8725;B LYMPHOCYTE#0.8725;GLUCOSE INTOLERANCE#0.8717;OSTEOCLAST DIFFERENTIATION#0.8705;OXYGEN GLUCOSE DEPRIVATION#0.8704;DENDRITIC SPINE#0.8701;MOUSE EMBRYONIC FIBROBLAST#0.8693;ATHEROSCLEROTIC#0.8691;MUSCLE CONTRACTION#0.8672;PHEOCHROMOCYTOMA#0.8665;INTEGRIN ACTIVATION#0.8653;RETINOIC ACID#0.8638;ADENINE#0.8620;CELL DIVISION#0.8616;SPHINGOSINE#0.8615;WEIGHT GAIN#0.8613;GEFITINIB#0.8607;ROSIGLITAZONE#0.8603;MESENCHYMAL CELL#0.8603;PROGESTERONE#0.8593;SALICYLATE#0.8589;GROWTH FACTOR BINDING#0.8578;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8578;LUPUS ERYTHEMATOSUS#0.8576;DNA REPAIR#0.8565;SERTOLI CELL#0.8554;THYROID CANCER#0.8550;ATP BINDING#0.8549;ACETYLCYSTEINE#0.8546;SIMVASTATIN#0.8539;REGULATORY T CELL#0.8538;MUSCLE ATROPHY#0.8529;GROWTH HORMONE#0.8525;DEATH RECEPTOR#0.8501;LINES OF EVIDENCE#0.8499;ADENINE DINUCLEOTIDE PHOSPHATE#0.8490;GLUCOCORTICOID RECEPTOR#0.8476;MACROPHAGE INFLAMMATORY PROTEIN#0.8471;PHENYLEPHRINE#0.8458;3-METHYLADENINE#0.8432;CYTOTOXIC T-LYMPHOCYTE#0.8430;TAMOXIFEN#0.8422;GRANULOCYTE#0.8419;INSULIN TOLERANCE TEST#0.8381;EXTRACELLULARLY REGULATED KINASE#0.8364;TRANSMISSION ELECTRON MICROSCOPY#0.8364;ADIPOGENESIS#0.8359;GLIOBLASTOMA MULTIFORME#0.8358;PKC ACTIVITY#0.8354;OSTEOBLAST DIFFERENTIATION#0.8343;TISSUE GROWTH FACTOR#0.8338;FORSKOLIN#0.8329;EVEROLIMUS#0.8318;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8318;RECEPTOR BINDING#0.8310;BREAST CANCER PATIENTS#0.8302;MYELOID LEUKEMIA#0.8272;NEURONAL CELL DEATH#0.8271;ADENOSINE TRIPHOSPHATE#0.8258;FASTING BLOOD GLUCOSE#0.8253;RETINOBLASTOMA#0.8253;ADHERENS JUNCTION#0.8231;ALDOSTERONE#0.8230;ESOPHAGEAL CANCER#0.8218;HEPARIN#0.8209;MEMBRANE FRACTION#0.8207;NEUROGENESIS#0.8206;PULMONARY ARTERY#0.8200;ONCOGENESIS#0.8199;CARDIOMYOPATHY#0.8177;EOSIN#0.8170;GERM CELL#0.8169;MAGNETIC RESONANCE IMAGING#0.8167;MEMBRANE DEPOLARIZATION#0.8165;FOLLICLE STIMULATING HORMONE#0.8164;LUNG ADENOCARCINOMA#0.8163;DEMENTIA#0.8156;OVARIAN CARCINOMA#0.8113;MITOCHONDRIAL PERMEABILITY TRANSITION#0.8103;NULL CELL#0.8100;ANESTHETIC#0.8100;ADENYLATE CYCLASE#0.8094;PHOSPHOLIPASE A#0.8090;HUMAN IMMUNODEFICIENCY VIRUS#0.8070;COLONY FORMATION ASSAY#0.8070;SENESCENCE#0.8066;TYROSINE AUTOPHOSPHORYLATION#0.8059;PROTEIN DEGRADATION#0.8057;PHOSPHOLIPASE A2#0.8052;NORMAL CONTROL GROUP#0.8052;RENAL FIBROSIS#0.8040;PROTEIN TRANSLATION#0.7999;RHOGEF#0.7996;ACTIVATION OF NF-KAPPAB#0.7978;EXOCYTOSIS#0.7970;CELL MOVEMENT#0.7956;ACUTE LUNG INJURY#0.7946;5 FLUOROURACIL#0.7946;ENDOMETRIAL CARCINOMA#0.7945;T CELL PROLIFERATION#0.7943;HETEROTRIMERIC G-PROTEIN#0.7942;AORTIC SMOOTH MUSCLE CELLS#0.7935;BEVACIZUMAB#0.7926;DUAL LUCIFERASE REPORTER#0.7909;RECEPTOR COMPLEX#0.7905;AIRWAY SMOOTH MUSCLE#0.7904;ENDOTHELIAL PROGENITOR CELL#0.7887;MITOSIS#0.7878;INHIBITION OF PHOSPHORYLATION#0.7865;CHRONIC KIDNEY DISEASE#0.7864;HERPES SIMPLEX VIRUS#0.7861;HERPES SIMPLEX#0.7858;EUKARYOTIC ELONGATION FACTOR#0.7822;ALKALINE PHOSPHATASE#0.7818;QUERCETIN#0.7812;NEPHRITIS#0.7808;WHITE ADIPOSE TISSUE#0.7799;CASPASE ACTIVATION#0.7799;FOREBRAIN#0.7788;BRUSH BORDER#0.7775;HEPATITIS B VIRUS#0.7774;LIPID SYNTHESIS#0.7770;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7766;PROXIMAL TUBULE CELL#0.7760;HEPATITIS B#0.7759;DIET INDUCED OBESITY#0.7739;FLUORESCEIN#0.7735;IGF BINDING#0.7734;MOLECULAR DYNAMICS SIMULATION#0.7731;PROTEIN KINASE INHIBITOR#0.7728;CELLULAR METABOLISM#0.7725;CARDIOVASCULAR SYSTEM#0.7724;CELL CHEMOTAXIS#0.7713;NATURAL KILLER CELL#0.7703;TYPE 1 DIABETES#0.7700;ADVANCED GLYCATION END#0.7696;MEMBRANE RUFFLING#0.7690;NITRO-L-ARGININE#0.7687;GLUTAMINE#0.7680;CONTACT SITE#0.7676;CELL POLARIZATION#0.7671;IMATINIB#0.7641;2'-DEOXYURIDINE#0.7635;TROPOMYOSIN RELATED KINASE#0.7615;ENERGY HOMEOSTASIS#0.7614;ACTINOMYCIN D#0.7608;TRANSIENT RECEPTOR POTENTIAL#0.7604;CONSTRICTION#0.7603;PERMEABILITY TRANSITION PORE#0.7589;GLYCOGEN SYNTHASE ACTIVITY#0.7588;POSTSYNAPTIC DENSITY#0.7585;ASTROCYTOMA#0.7576;B CELL RECEPTOR#0.7565;RESPONSE TO LPS#0.7549;RECEPTOR ACTIVITY#0.7547;EIF4E BINDING#0.7533;PI3-KINASE ACTIVITY#0.7528;L-CYSTEINE#0.7515;RESPONSE TO GROWTH FACTOR#0.7507;AMYGDALA#0.7506;ANAPLASTIC LYMPHOMA KINASE#0.7494;PRECURSOR CELL#0.7485;PROSTAGLANDIN E2#0.7479;SUCROSE#0.7476;INDOLE#0.7462;SUNITINIB#0.7457;ACTIVE CASPASE 3#0.7453;ADVANCED COLORECTAL CANCER#0.7438;SMOOTH MUSCLE CONTRACTION#0.7429;LYMPHOCYTE ACTIVATION#0.7420;MYOSIN HEAVY CHAIN#0.7414;PANCREATIC DUCTAL ADENOCARCINOMA#0.7413;LIPID DROPLET#0.7411;ORAL GLUCOSE TOLERANCE#0.7410;ENDOTHELIAL CELL PROLIFERATION#0.7406;OVARIES#0.7395;MAMMARY GLAND#0.7395;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7393;IKAPPAB KINASE#0.7392;SUBSTANTIA NIGRA#0.7387;PROTEIN BINDING#0.7387;AMPA RECEPTOR#0.7383;BLOOD BRAIN BARRIER#0.7380;INSULIN GROWTH FACTOR#0.7370;PKB SIGNALING CASCADE#0.7370;AMPK ACTIVITY#0.7363;RUFFLE#0.7355;ADRIAMYCIN#0.7352;DIABETIC RETINOPATHY#0.7334;THROMBOSIS#0.7328;PANCREATIC ISLET#0.7321;CAVEOLAE#0.7315;NEPHROPATHY#0.7311;MORPHOGENESIS#0.7308;POTASSIUM CHANNEL#0.7303;ELECTRON TRANSPORT#0.7297;EGFR SIGNALING PATHWAY#0.7296;EXCRETION#0.7296;HEART DISEASE#0.7287;VASODILATION#0.7283;XANTHINE OXIDASE#0.7279;ADENYLATE#0.7269;AKT SIGNAL TRANSDUCTION#0.7264;DISEASE FREE SURVIVAL#0.7262;GERMINAL VESICLE#0.7257;TROPOMYOSIN RECEPTOR KINASE#0.7248;AUTOIMMUNE DISEASE#0.7245;INTEGRIN LIGAND#0.7240;PHOSPHATIDYLSERINE#0.7240;REGULATION OF APOPTOSIS#0.7224;T CELL CHEMOTAXIS#0.7224;REGULATION OF CELLULAR#0.7220;FOAM CELL FORMATION#0.7206;MACROPHAGE MIGRATION#0.7206;ERYTHROID CELL#0.7197;RESONANCE ENERGY TRANSFER#0.7197;FLOW CYTOMETRY ANALYSIS#0.7196;RECEPTOR ACTIVATOR#0.7190;T-CELL LEUKEMIA#0.7186;PROTEOGLYCAN#0.7181;HIGH MOBILITY GROUP#0.7180;TRASTUZUMAB#0.7171;COLORECTAL CARCINOMA#0.7165;TROPHOBLAST#0.7163;LECTIN#0.7140;HIGH DENSITY LIPOPROTEIN#0.7133;VSMC PROLIFERATION#0.7121;DIABETIC NEPHROPATHY#0.7090;FATTY LIVER#0.7087;PROTEASE ACTIVATED RECEPTOR#0.7085;MEMBRANE RUFFLE#0.7081;GRB2 ASSOCIATED BINDER#0.7074;INHIBITION OF GSK#0.7071;TESTOSTERONE#0.7071;OSTEOARTHRITIS#0.7067;NEUTROPHIL CHEMOTAXIS#0.7064;LUCIFERASE ACTIVITY#0.7064;VASCULAR ENDOTHELIAL CADHERIN#0.7064;POSTTRANSLATIONAL MODIFICATION#0.7062;ORAL SQUAMOUS CELL CARCINOMA#0.7059;SERUM ALBUMIN#0.7045;MAP KINASE ACTIVITY#0.7045;FRONTAL#0.7042;T CELL MIGRATION#0.7039;PKCZETA#0.7024;REGULATION OF CELL GROWTH#0.7021;FLUOROURACIL#0.7013;PROTEINURIA#0.6989;ACTIVATED CASPASE 3#0.6989;FIBRINOGEN BINDING#0.6986;ACTIN CYTOSKELETON REORGANIZATION#0.6982;CAMP-RESPONSIVE ELEMENT BINDING#0.6968;FATTY ACID OXIDATION#0.6956;ENDOMETRIAL CANCER#0.6956;ALVEOLAR MACROPHAGE#0.6945;KINASE BINDING#0.6944;DOPAMINERGIC NEURON#0.6942;CYCLIC NUCLEOTIDE PHOSPHODIESTERASE#0.6933;STRUCTURE ACTIVITY RELATIONSHIP#0.6922;BONE MORPHOGENETIC PROTEIN#0.6920;TRAILING EDGE#0.6896;INTRACELLULAR SIGNALING CASCADE#0.6892;PANCREATITIS#0.6882;VASCULAR ENDOTHELIUM#0.6880;DASATINIB#0.6872;MYOFIBROBLAST#0.6871;MEMORY IMPAIRMENT#0.6871;OPIOID RECEPTOR#0.6863;ENDOTHELIAL CELL MIGRATION#0.6860;REGULATION OF CELL MIGRATION#0.6858;OSTEOGENESIS#0.6820;LEUCINE RICH REPEAT#0.6817;DIPHOSPHATE#0.6813;METASTATIC MELANOMA#0.6807;MEIOSIS#0.6796;EXOSOME#0.6790;GUANOSINE#0.6781;NITRIC OXIDE SYNTHASE ACTIVITY#0.6773;ROS FORMATION#0.6769;PROTEIN KINASE G#0.6762;5'-ADENOSINE MONOPHOSPHATE#0.6760;CHLOROQUINE#0.6740;METABOTROPIC GLUTAMATE RECEPTORS#0.6725;ANTI EGFR#0.6723;SIGNAL TRANSMISSION#0.6722;KAPOSI'S SARCOMA#0.6721;PORTAL VEIN#0.6710;GEMCITABINE#0.6707;LOSARTAN#0.6706;PHOSPHOINOSITIDE 3-KINASE ACTIVITY#0.6698;REGULATION OF GENE EXPRESSION#0.6692;CYTOKINE SECRETION#0.6681;TROGLITAZONE#0.6679;NUCLEOTIDE BINDING#0.6676;CAROTID ARTERY#0.6671;COENZYME A#0.6669;NEUROTOXIC#0.6661;BINDING PROTEIN 3#0.6652;CREATINE#0.6649;INTRACELLULAR SIGNAL TRANSDUCTION PATHWAY#0.6641;NERVE TERMINAL#0.6615;RHABDOMYOSARCOMA#0.6612;ORGANELLE#0.6597;PHOSPHOINOSITIDE BINDING#0.6579;FATTY LIVER DISEASE#0.6576;MODE OF ACTION#0.6574;TISSUE DAMAGE#0.6567;SMOOTH MUSCLE CELL PROLIFERATION#0.6567;MUSCLE CELL PROLIFERATION#0.6564;EPILEPSY#0.6561;FOCAL CEREBRAL ISCHEMIA#0.6558;REGULATION OF PROTEIN SYNTHESIS#0.6555;HUMAN MESENCHYMAL STEM#0.6551;TUBULAR EPITHELIAL CELL#0.6540;REPORTER GENE ASSAY#0.6536;PKCEPSILON#0.6533;RETINAL GANGLION CELL#0.6533;MYELOID CELL LEUKEMIA#0.6526;PROTEIN SECRETION#0.6526;NEURAL STEM CELL#0.6526;HEPATOCYTE APOPTOSIS#0.6523;HUNTINGTON'S DISEASE#0.6521;NLRP3 INFLAMMASOME ACTIVATION#0.6515;LONG TERM DEPRESSION#0.6511;GAP ACTIVITY#0.6510;POST-TRANSLATIONAL MODIFICATION#0.6508;PULMONARY HYPERTENSION#0.6505;BASEMENT MEMBRANE#0.6498;HEMATOPOIETIC STEM CELL#0.6496;THYMOCYTE#0.6494;RIBOSOME#0.6493;ACETYLCHOLINE RECEPTOR#0.6491;PROTEIN KINASE C ACTIVITY#0.6489;HEPATITIS C#0.6487;STROMA#0.6481;HEMORRHAGE#0.6480;FILAMENTOUS ACTIN#0.6471;BLOOD PLATELETS#0.6471;MOUSE EMBRYO FIBROBLASTS#0.6470;VEGF SIGNALING#0.6465;EPHRIN#0.6465;MEDULLOBLASTOMA#0.6453;CARNITINE#0.6451;PROXIMAL TUBULAR CELL#0.6451;CYCLOSPORIN A#0.6445;ENDOSOME#0.6434;MAXIMUM TOLERATED DOSE#0.6433;ATORVASTATIN#0.6432;T CELL DEVELOPMENT#0.6430;CELLULAR COMPONENT#0.6425;INTERLEUKIN 1 RECEPTOR#0.6413;TELOMERASE REVERSE TRANSCRIPTASE#0.6412;NEUROFIBRILLARY TANGLE#0.6401;VITAMIN E#0.6397;SCAVENGER RECEPTOR#0.6395;EPIGALLOCATECHIN#0.6393;RECEPTOR LIGAND#0.6384;LYSOSOME#0.6375;HINDLIMB#0.6371;VIRAL INFECTION#0.6365;AUTOPHAGIC CELL DEATH#0.6361;HISTAMINE#0.6354;CYTOCHROME P450#0.6353;UTERUS#0.6346;SPERM CAPACITATION#0.6332;VEMURAFENIB#0.6328;GESTATION#0.6326;TRANSVERSE AORTIC CONSTRICTION#0.6316;INHIBITION OF CELL PROLIFERATION#0.6314;CELLULAR MEMBRANE#0.6309;BORTEZOMIB#0.6299;GROWTH ARREST SPECIFIC#0.6298;CASPASE INHIBITOR#0.6294;HEPATIC STELLATE CELL#0.6294;MUSCLE FIBER#0.6280;ELECTROPHORETIC MOBILITY SHIFT#0.6271;GALECTIN#0.6266;PROPRANOLOL#0.6260;ACUTE MYELOID LEUKEMIA#0.6259;OSTEOCYTE#0.6252;CROSS SECTIONAL AREA#0.6244;TO THE PROGRESSION#0.6244;CELL CYCLE REGULATOR#0.6241;BRONCHIAL EPITHELIAL CELLS#0.6240;EPITHELIAL OVARIAN CANCER#0.6236;CATION CHANNEL#0.6235;PYRAMIDAL CELL#0.6234;NEUROTRANSMITTER RELEASE#0.6233;TOCOPHEROL#0.6228;IL-10 PRODUCTION#0.6223;CYCLOSPORINE#0.6213;PYRAZOLE#0.6211;LYMPHOID CELL#0.6209;DENTATE GYRUS#0.6208;INVASIVE BREAST CANCER#0.6206;CELL MATRIX ADHESION#0.6202;DE NOVO LIPOGENESIS#0.6194;HEPATITIS C VIRUS#0.6193;METHIONINE#0.6183;MULTIPLE MYELOMA CELLS#0.6183;LAMELLIPODIUM FORMATION#0.6174;SMALL INTESTINE#0.6174;CALYCULIN A#0.6173;P38 MAPK SIGNALING#0.6170;LOVASTATIN#0.6170;HORMONE SENSITIVE LIPASE#0.6168;REGULATION OF CELL PROLIFERATION#0.6164;CONSTITUTIVELY ACTIVE MUTANT#0.6161;MAP KINASE KINASE#0.6148;PROSTATE CARCINOMA#0.6134;TRANSMISSION ELECTRON MICROSCOPE#0.6132;LIVER REGENERATION#0.6127;CELL POLARITY#0.6125;MONOCYTE CHEMOTACTIC PROTEIN#0.6123;INSULIN BINDING#0.6122;GLYCERALDEHYDE-3-PHOSPHATE#0.6121;BIPOLAR DISORDER#0.6119;ACTIN BINDING#0.6117;CELL NUCLEUS#0.6113;ADVANCED BREAST CANCER#0.6101;17β-ESTRADIOL#0.6099;CANCER RELATED DEATH#0.6095;PROPOFOL#0.6079;GANGLION CELLS#0.6072;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6072;FOCAL ADHESION COMPLEXES#0.6069;BONE MARROW CELLS#0.6062;VIRAL REPLICATION#0.6062;TONGUE SQUAMOUS CELL CARCINOMA#0.6053;XANTHINE#0.6027;NECROTIC#0.6018;C REACTIVE PROTEIN#0.6014;MYOGENIC CELL#0.6010;EOSINOPHIL#0.6010
2186	CHROMATIN REMODELING#1.0657;TRANSCRIPTION FACTOR#1.0570;GENE EXPRESSION#1.0372;NUCLEOSOME#1.0278;STEM CELL#1.0072;LUNG CANCER#0.9391;NURF COMPLEX#0.9267;ALZHEIMER'S DISEASE#0.9178;CHROMATIN REMODELING COMPLEX#0.9084;CANCER CELL#0.8655;DNA BINDING#0.8579;NATURAL CYTOTOXICITY RECEPTOR#0.8117;T CELL#0.8022;APOPTOSIS#0.7888;CELL GROWTH#0.7723;TUMOR TISSUES#0.7615;BREAST CANCER#0.7417;LYSINE#0.7399;CELL CYCLE#0.7023;CELL PROLIFERATION#0.6599;SIGNALING PATHWAY#0.6302;CELL BODY#0.6193;MELANOMA CELL LINES#0.6187;CHROMATIN REMODELLING#0.6174;EMBRYONIC STEM CELL#0.6111
2187	CHRONIC MYELOMONOCYTIC LEUKEMIA#1.0136;FANCONI ANEMIA#1.0100;ANEMIA#0.9909;MYELODYSPLASTIC SYNDROME#0.9838;PERIPHERAL BLOOD#0.9819;BONE MARROW#0.9798;MYELOID LEUKEMIA#0.9564;ACUTE MYELOID LEUKEMIA#0.9503;STEM CELL#0.9322;FA CORE COMPLEX#0.8674;THROMBOCYTOPENIA#0.8650;BONE MARROW FAILURE#0.8511;ACUTE LEUKEMIA#0.8372;BLAST CELL#0.8268;SIDEROBLASTIC ANEMIA#0.8260;BONE MARROW CELLS#0.8202;CYTOPENIA#0.8145;APLASTIC ANEMIA#0.7737;PANCYTOPENIA#0.7596;DNA REPAIR#0.7548;ARA-C#0.7179;HEMATOPOIETIC STEM CELL#0.6943;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6851;ERYTHROBLAST#0.6653;HEMOLYTIC ANEMIA#0.6618;ANAEMIA#0.6218;REPLICATION FORK#0.6183;SEX CHROMOSOME#0.6116;MOUSE EMBRYONIC STEM#0.6040
2188	OVARIAN#1.0450;OVARIAN CANCER#1.0438;CANCER CELL#1.0248;FANCONI ANEMIA#1.0146;ANEMIA#1.0050;METHYLATION SPECIFIC PCR#0.9798;BREAST CANCER#0.9665;DNA REPAIR#0.9554;CISPLATIN#0.9172;MITOMYCIN C#0.9074;FA CORE COMPLEX#0.9073;BONE MARROW#0.8836;BONE MARROW FAILURE#0.8646;DNA DAMAGE RESPONSE#0.8494;MITOMYCIN#0.8197;GENE EXPRESSION#0.7757;HYPERSENSITIVITY#0.7506;LUNG CANCER#0.7408;ANAEMIA#0.7234;APOPTOSIS#0.7166;POLYMERASE CHAIN REACTION#0.6999;CELL CYCLE#0.6574;SQUAMOUS CELL CARCINOMA#0.6428
2189	FA CORE COMPLEX#1.0676;MITOMYCIN C#1.0210;MITOMYCIN#1.0027;DNA REPAIR#0.9979;FANCONI ANEMIA#0.9965;ANEMIA#0.9894;PROTEIN COMPLEX#0.9880;BONE MARROW FAILURE#0.9825;BONE MARROW#0.9758;PANCREATIC CANCER#0.9695;HYPERSENSITIVITY#0.9686;CELL CYCLE#0.9577;HOMOLOGOUS RECOMBINATION#0.9325;ANAEMIA#0.9261;STEM CELL#0.8986;GENE EXPRESSION#0.8702;PROGENITOR CELL#0.8556;DOUBLE STRAND BREAK#0.8399;MYELOID LEUKEMIA#0.7919;HOMOLOGOUS RECOMBINATION REPAIR#0.7849;HEMATOPOIETIC STEM CELL#0.7781;APLASTIC ANEMIA#0.7657;CANCER CELL#0.7615;PROTEIN PROTEIN INTERACTION#0.7557;BREAST CANCER#0.7530;ACUTE MYELOID LEUKEMIA#0.7370;APOPTOSIS#0.7302;CYTOPLASM#0.7284;GENETIC DISORDER#0.7046;DNA DAMAGE RESPONSE#0.6868;MUTAGENESIS#0.6725;COMPLEX I#0.6572;AUTOSOMAL RECESSIVE DISEASE#0.6516;LYMPHOBLAST#0.6233
218	CORNEAL EPITHELIUM#1.0572;HEPATOMA CELLS#1.0453;CORNEAL EPITHELIAL CELL#1.0404;EPITHELIAL CELL#1.0189;ENZYME ACTIVITY#1.0140;CELL PROLIFERATION#1.0005;CANCER CELL#0.9946;DETOXIFICATION#0.9887;GENE EXPRESSION#0.9849;LUNG CANCER#0.9798;STEM CELL#0.9704;CYCLOPHOSPHAMIDE#0.9703;TRANSCRIPTION FACTOR#0.9580;TOXICITY#0.9571;REACTIVE OXYGEN SPECIES#0.9170;ADENOCARCINOMA#0.9124;APOPTOSIS#0.9123;CELL GROWTH#0.9057;GLUTATHIONE#0.9042;TUMOR CELLS#0.8902;BREAST ADENOCARCINOMA#0.8862;HUMAN CORNEAL EPITHELIAL#0.8675;ARYL HYDROCARBON RECEPTOR#0.8649;HEPATOCELLULAR CARCINOMA#0.8581;CYTOCHROME P450#0.7862;BREAST CANCER#0.7574;POLYCYCLIC AROMATIC HYDROCARBON#0.7547;CYTOTOXICITY#0.7276;CELL DEATH#0.7240;CELL CYCLE#0.7080;STROMA#0.6836;CANCER STEM CELL#0.6835;ARACHIDONIC ACID#0.6800;GLUCOSE-6-PHOSPHATE#0.6759;POLYMERASE CHAIN REACTION#0.6495;PEROXISOME#0.6396;DRUG RESISTANCE#0.6201;ORAL CAVITY#0.6153;VP-16#0.6124;ALDEHYDE METABOLISM#0.6103;PLACENTAL DEVELOPMENT#0.6087;NORMAL BREAST TISSUE#0.6065
2191	DIPEPTIDYL-PEPTIDASE ACTIVITY#1.0557;TISSUE REMODELING#1.0505;FIBROBLAST ACTIVATION PROTEIN#1.0493;SMOOTH MUSCLE ACTIN#1.0474;FIBROBLAST ACTIVATION#1.0449;WOUND HEALING#1.0447;LYMPH NODE#1.0443;CELL SURFACE#1.0354;SMOOTH MUSCLE#1.0351;PEPTIDASE ACTIVITY#1.0347;DIPEPTIDYL PEPTIDASE IV#1.0331;MYOFIBROBLAST#1.0325;STROMAL CELL#1.0296;COLORECTAL CANCER#1.0276;DIPEPTIDYL PEPTIDASE#1.0269;LYMPH NODE METASTASIS#1.0254;ENDOPEPTIDASE ACTIVITY#1.0233;ENZYME ACTIVITY#1.0222;PANCREATIC CANCER#1.0220;T CELL#1.0219;TUMOR ASSOCIATED FIBROBLASTS#1.0219;COLORECTAL#1.0204;STROMA#1.0188;DIPEPTIDYL PEPTIDASE 4#1.0175;EPITHELIAL CELL#1.0165;BREAST CANCER#1.0131;APOPTOSIS#1.0109;ANGIOGENESIS#1.0104;ENDOTHELIAL CELL#1.0103;MACROPHAGE#1.0097;GROWTH FACTOR#1.0094;TUMOR CELLS#1.0068;CANCER CELL#1.0054;ADENOCARCINOMA#1.0035;CELL PROLIFERATION#1.0027;TRANSFORMING GROWTH FACTOR#1.0023;CANCER ASSOCIATED FIBROBLASTS#1.0022;OVARIAN#0.9997;SIGNALING PATHWAY#0.9987;EXTRACELLULAR MATRIX#0.9973;MESENCHYMAL CELL#0.9925;POLYMERASE CHAIN REACTION#0.9922;GENE EXPRESSION#0.9867;IMMUNE RESPONSE#0.9860;BONE MARROW#0.9857;STEM CELL#0.9810;GROWTH FACTOR RECEPTOR#0.9772;SQUAMOUS CELL CARCINOMA#0.9767;OVARIAN CANCER#0.9712;COLON CANCER#0.9702;COLLAGENASE#0.9668;PROTEASE ACTIVITY#0.9488;PERIPHERAL BLOOD#0.9481;HUMAN BREAST CANCER#0.9431;TYPE 2 DIABETES#0.9312;CD8+ T CELL#0.9284;FIBROBLAST GROWTH FACTOR#0.9268;PLASMA MEMBRANE#0.9256;MELANOCYTE#0.9220;CELL ACTIVATION#0.9184;CELL DEATH#0.9088;REVERSE TRANSCRIPTION#0.9037;TUMOR TISSUES#0.9033;T CELL ACTIVATION#0.8995;TUMOR SUPPRESSOR#0.8987;BREAST CANCER CELL#0.8935;PLATELET-DERIVED GROWTH FACTOR#0.8920;CELL MIGRATION#0.8914;TOXICITY#0.8911;OVARIAN CARCINOMA#0.8878;CELL ADHESION#0.8863;SUBSTANCE P#0.8831;CELL CYCLE#0.8766;STRUCTURE ACTIVITY RELATIONSHIP#0.8765;ENDOTHELIAL GROWTH FACTOR#0.8562;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8562;EPITHELIAL CARCINOMA#0.8504;SKELETAL MUSCLE#0.8491;MELANOMA CELL LINES#0.8455;IMMUNE CELL#0.8394;MESENCHYMAL STEM CELL#0.8388;ADIPOSE TISSUE#0.8373;CELL GROWTH#0.8358;PROTEIN KINASE#0.8355;CELL MEMBRANE#0.8248;PROSTATE CANCER#0.8195;FIBROSARCOMA CELLS#0.8122;TRANSFORMING GROWTH FACTOR BETA#0.8113;COLORECTAL CARCINOMA#0.8112;LUNG CANCER#0.8077;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.8037;PANCREATIC DUCTAL ADENOCARCINOMA#0.8030;FIBRIL#0.7937;PULMONARY FIBROSIS#0.7916;MYOCARDIAL INFARCTION#0.7839;DOXORUBICIN#0.7813;B CELL#0.7808;EPIDERMAL GROWTH FACTOR#0.7795;BLOOD VESSEL#0.7794;SERINE PROTEASE ACTIVITY#0.7776;PANCREATIC ADENOCARCINOMA#0.7776;TRANSCRIPTION FACTOR#0.7751;PROTEASE COMPLEX#0.7698;CHIMERIC ANTIGEN RECEPTOR#0.7696;HEPATOCELLULAR CARCINOMA#0.7655;COLLAGENASE ACTIVITY#0.7625;ADIPOCYTE#0.7613;NERVOUS SYSTEM#0.7598;RHEUMATOID ARTHRITIS#0.7463;HEPATOCYTE GROWTH FACTOR#0.7456;EPITHELIAL OVARIAN CARCINOMA#0.7424;TUMOR NECROSIS FACTOR#0.7366;MUTAGENESIS#0.7334;UROKINASE#0.7320;EPITHELIAL OVARIAN CANCER#0.7317;LUNG CARCINOMA#0.7280;EPITHELIAL MESENCHYMAL TRANSITION#0.7273;LAF 237#0.7224;BREAST CARCINOMA#0.7202;ALANINE#0.7167;CYTOTOXICITY#0.7130;CELL SURFACE ANTIGEN#0.7092;PERICYTE#0.7051;REGENERATION#0.7048;FIBROSARCOMA#0.7047;DENDRITIC CELL#0.6935;LIVER CIRRHOSIS#0.6899;UTERUS#0.6898;DIISOPROPYL FLUOROPHOSPHATE#0.6890;DIGESTION#0.6853;INVASIVE DUCTAL CARCINOMA#0.6808;IMMUNE SUPPRESSION#0.6791;COLLAGEN TYPE I#0.6765;SITAGLIPTIN PHOSPHATE#0.6763;CAPTOPRIL#0.6732;TUMOR ANTIGEN#0.6723;MONONUCLEAR CELLS#0.6690;IMMUNE SYSTEM#0.6689;MITOGEN ACTIVATED PROTEIN#0.6624;DERMAL FIBROBLAST#0.6578;PROLYL ENDOPEPTIDASE ACTIVITY#0.6560;CENTRAL NERVOUS SYSTEM#0.6493;DISEASE FREE SURVIVAL#0.6475;RNA INTERFERENCE#0.6468;CYTOPLASM#0.6468;CELL CYCLE ARREST#0.6460;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6453;AMINOPEPTIDASE ACTIVITY#0.6399;SOLUBLE FRACTION#0.6337;LEUKOCYTE#0.6293;BLEOMYCIN#0.6267;APOPTOTIC#0.6191;DPP IV ACTIVITY#0.6174;MALIGNANT PLEURAL MESOTHELIOMA#0.6157;EXOSOME#0.6147;VILDAGLIPTIN#0.6092;ORAL SQUAMOUS CELL CARCINOMA#0.6061;VASCULAR ENDOTHELIAL CELL#0.6049;CORNEAL NEOVASCULARIZATION#0.6020;CELLULAR COMPONENT#0.6017
219285	STERILE ALPHA MOTIF#0.8780;CELL PROLIFERATION#0.7806;PANCYTOPENIA#0.7562;TUMOR SUPPRESSOR#0.7429;MYELODYSPLASTIC SYNDROME#0.7399;BONE MARROW#0.6169
219287	PLASMA MEMBRANE#0.7758;CELL MIGRATION#0.7027;MICROTUBULE#0.6799;NUCLEOTIDE EXCHANGE FACTOR#0.6609
2192	CANCER CELL#1.0570;BREAST CANCER#1.0538;ELASTIC FIBER#1.0433;EXTRACELLULAR MATRIX#1.0131;TYPE 2 DIABETES#1.0130;BASEMENT MEMBRANE#1.0065;SMOOTH MUSCLE#0.9986;GROWTH FACTOR#0.9897;GENE EXPRESSION#0.9830;POLYMERASE CHAIN REACTION#0.9802;CONNECTIVE TISSUE#0.9711;STROMAL CELL#0.9663;OVARIAN#0.9656;BREAST CANCER CELL#0.9635;FIBRILLIN#0.9527;CELL MIGRATION#0.9511;NEURAL CREST#0.9458;BLOOD VESSEL#0.9451;ANGIOGENESIS#0.9428;BREAST CARCINOMA#0.9421;MUSCLE CELL#0.9116;SMOOTH MUSCLE CELL#0.9065;CELL ADHESION#0.8973;EPIDERMAL GROWTH FACTOR#0.8964;PROSTATE CANCER#0.8957;OVARIAN CANCER#0.8917;EPITHELIAL CELL#0.8882;COLORECTAL CANCER#0.8749;STROMA#0.8702;STEM CELL#0.8667;FIBRINOGEN#0.8663;CELL MOTILITY#0.8647;PROGESTERONE#0.8643;ESTRADIOL#0.8623;APOPTOSIS#0.8621;ESTROGEN RECEPTOR#0.8453;PROTEOGLYCAN#0.8237;TUMOR SUPPRESSOR#0.8172;AORTIC VALVE#0.8135;AIRWAY SMOOTH MUSCLE#0.8032;BONE MARROW#0.7906;MESENCHYMAL CELL#0.7675;ENDOTHELIAL CELL#0.7585;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.7294;HEPARIN#0.7292;COLORECTAL#0.7092;MORPHOGENESIS#0.7042;TISSUE REMODELING#0.7021;PULSE WAVE VELOCITY#0.6899;SURFACE PLASMON RESONANCE#0.6867;OSTEOBLAST#0.6834;HUMAN BREAST CANCER#0.6809;CORONARY ARTERY#0.6771;ARTERY#0.6576;PLASMA PROTEIN#0.6562;TRANSFORMING GROWTH FACTOR#0.6521;CELL PROLIFERATION#0.6491;ESTROGENS#0.6428;QUANTITATIVE REAL TIME#0.6242;KIDNEY DISEASE#0.6090;ADENOCARCINOMA#0.6084;HEART DEVELOPMENT#0.6045
219333	DEUBIQUITINATING ENZYME#1.1350;PROSTATE CANCER#0.9695;DEUBIQUITINASE#0.9429;UBIQUITIN#0.8065;UBIQUITIN SPECIFIC PROTEASE#0.7078
219402	MITOCHONDRIAL TRANSLATIONAL INITIATION#1.1058;30S RIBOSOMAL SUBUNIT#1.0792;TRANSLATIONAL INITIATION#1.0683;70S RIBOSOME#1.0611;TRANSLATION INITIATION FACTOR#1.0520;RIBOSOMAL PROTEIN#1.0446;TRANSLATION INITIATION#1.0391;RIBOSOMAL SUBUNIT#1.0326;RIBOSOME#1.0276;C TERMINAL DOMAIN#1.0268;PROTEIN SYNTHESIS#1.0176;RIBOSOME RECYCLING#0.9655;TRNA BINDING#0.9508;RIBOSOME BINDING#0.9253;MITOCHONDRIAL RIBOSOME#0.8887;MITOCHONDRIA#0.8724;PROTEIN SYNTHESIS INITIATION#0.8664;SMALL RIBOSOMAL SUBUNIT#0.8641;STATIONARY PHASE#0.8522;CHLOROPLAST#0.8370;MITOCHONDRIAL TRANSLATION#0.8364;MITOCHONDRIAL TRANSLATION INITIATION#0.8135;RIBOSOMAL RNA#0.7991;NUCLEIC ACID#0.7538;FACTOR I#0.7501;50S RIBOSOMAL SUBUNIT#0.7477;RNA BINDING#0.7302;GENE EXPRESSION#0.7260;MOLAR#0.6842;GTP HYDROLYSIS#0.6648;LYSINE#0.6546;COMPLEX I#0.6355;TRANS-DIAMMINEDICHLOROPLATINUM#0.6189;PROTEIN BIOSYNTHESIS#0.6045;SUCROSE#0.6043
219409	GAMMA-GLUTAMYLCYSTEINE#1.0727;GLUTATHIONE BIOSYNTHESIS#1.0673;GLUTATHIONE#1.0223;TRANSCRIPTION FACTOR#0.9838;GENE EXPRESSION#0.9709;GLUTATHIONE SYNTHESIS#0.9111;PLASTID#0.8542;DETOXIFICATION#0.8192;OLFACTORY BULB#0.8162;SUPEROXIDE DISMUTASE#0.7892;REACTIVE OXYGEN SPECIES#0.7871;FERMENTATION#0.7491;GLUTATHIONE PEROXIDASE#0.7468;NERVOUS SYSTEM#0.7341;GLUTAMATE CYSTEINE LIGASE#0.7297;TRYPANOTHIONE#0.7171;INTERNEURON#0.7168;METHIONINE#0.7141;OXIDATIVE STRESS RESPONSE#0.6774;GLUTATHIONE SYNTHASE#0.6719;CENTRAL NERVOUS SYSTEM#0.6362;TOXICITY#0.6209;CELL DEATH#0.6101;ETHANOL#0.6077;ABC TRANSPORTER#0.6016
2194	DIACYLGLYCEROL O ACYLTRANSFERASE#1.0823;O ACYLTRANSFERASE#1.0703;FATTY ACID SYNTHASE ACTIVITY#1.0638;FAS COMPLEX#1.0603;FATTY ACID TRANSLOCASE#1.0407;STEROL RESPONSE ELEMENT BINDING#1.0403;ORLISTAT#1.0382;STEROL RESPONSE ELEMENT#1.0356;CARBOHYDRATE RESPONSE ELEMENT BINDING#1.0350;BREAST CARCINOMA#1.0332;MALIC ENZYME#1.0301;FATTY ACID SYNTHASE#1.0271;FATTY ACID TRANSPORT#1.0246;STEAROYL COA DESATURASE#1.0245;CERULENIN#1.0242;MALATE DEHYDROGENASE#1.0235;GLUCOSE-6-PHOSPHATE#1.0214;ACETYL COA CARBOXYLASE#1.0201;PYRUVATE KINASE#1.0193;SQUAMOUS CELL CARCINOMA#1.0189;CARNITINE PALMITOYLTRANSFERASE I#1.0186;ACYL COA DEHYDROGENASE#1.0168;OVARIAN CANCER#1.0147;FATTY ACID TRANSPORTER#1.0143;COLORECTAL CANCER#1.0142;ADENOSINE TRIPHOSPHATE#1.0140;FATTY ACID BINDING#1.0139;CARNITINE PALMITOYL TRANSFERASE#1.0136;TRIGLYCERIDE LIPASE#1.0122;COLORECTAL#1.0120;TYPE II FAS#1.0117;LIPOPROTEIN LIPASE#1.0103;HUMAN BREAST CANCER#1.0103;MYCOLIC ACID BIOSYNTHESIS#1.0098;LDL RECEPTOR#1.0096;ONCOGENIC#1.0084;HORMONE SENSITIVE LIPASE#1.0084;COENZYME A#1.0079;MALONYL-COENZYME A#1.0073;ACYL COA OXIDASE#1.0071;LUNG CANCER#1.0069;SIGNAL TRANSDUCER#1.0063;TRIGLYCERIDE SYNTHESIS#1.0059;PANCREATIC CANCER#1.0058;HEPATIC LIPID CONTENT#1.0058;BREAST CANCER PATIENTS#1.0057;BINDING PROTEIN 1#1.0052;STEROL REGULATORY ELEMENT#1.0049;ENHANCER BINDING PROTEIN#1.0046;4'-PHOSPHOPANTETHEINE#1.0044;ENHANCER BINDING#1.0043;RNA INTERFERENCE#1.0042;FATTY ACID BIOSYNTHETIC#1.0037;MALONYL COA DECARBOXYLASE#1.0037;ATP BINDING CASSETTE#1.0026;BREAST CANCER CELL#1.0024;EPIGALLOCATECHIN#1.0018;ATP BINDING#1.0012;B CELL#1.0000;BREAST CANCER#1.0000;OVARIAN#0.9996;HYPOXIA#0.9977;AKT SIGNALING#0.9976;EPIDIDYMAL ADIPOSE TISSUE#0.9974;PROSTATE CANCER#0.9971;QUERCETIN#0.9968;PALMITOYL#0.9965;EPIDERMAL GROWTH FACTOR#0.9963;CARNITINE#0.9955;GLUCOSE 6 PHOSPHATASE#0.9953;ACYL CARRIER PROTEIN#0.9951;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9948;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.9948;T CELL#0.9948;OVARIAN CARCINOMA#0.9945;TRICLOSAN#0.9943;RESVERATROL#0.9941;ACYL CARRIER#0.9941;LYMPH NODE#0.9940;GROWTH FACTOR RECEPTOR#0.9939;ENZYME COMPLEX#0.9939;COLON CANCER#0.9933;HEPATOMA CELLS#0.9929;PHOSPHOENOLPYRUVATE#0.9926;TRIIODOTHYRONINE#0.9923;ANGIOGENESIS#0.9914;LIPID BIOSYNTHESIS#0.9912;FATTY ACID BIOSYNTHESIS#0.9912;MAMMARY GLAND#0.9912;REGULATION OF LIPOGENESIS#0.9911;INSULIN-LIKE GROWTH FACTOR#0.9906;HEAT SHOCK PROTEIN#0.9900;ADENOCARCINOMA#0.9896;UBIQUITIN#0.9892;CYTOCHROME C#0.9891;PROTEIN KINASE B#0.9890;ACETYL-COA CARBOXYLASE ACTIVITY#0.9884;LIVER X RECEPTOR#0.9884;INSULIN RECEPTOR SUBSTRATE#0.9881;TUBERCULOSIS#0.9881;ENDOTHELIAL GROWTH FACTOR#0.9881;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9881;PYRUVATE#0.9879;PEROXISOME#0.9876;CANCER CELL#0.9875;KINASE INHIBITOR#0.9875;CHOLESTEROL SYNTHESIS#0.9874;NADPH BINDING#0.9869;ATP BINDING CASSETTE TRANSPORTER#0.9867;COA CARBOXYLASE ACTIVITY#0.9862;PEROXISOMAL#0.9859;DE NOVO LIPOGENESIS#0.9858;STEARIC ACID#0.9858;STEM CELL#0.9857;TUMOR CELLS#0.9855;ESTROGEN RECEPTOR#0.9853;VISCERAL ADIPOSE TISSUE#0.9851;CYTOCHROME P450#0.9848;FRUCTOSE#0.9842;DEXAMETHASONE#0.9837;CELL MEMBRANE#0.9831;FATTY ACID ELONGASE#0.9830;PALMITATE#0.9829;HYPOXIA INDUCIBLE FACTOR#0.9828;LIPID OXIDATION#0.9826;ENZYME ACTIVITY#0.9817;ADENINE DINUCLEOTIDE PHOSPHATE#0.9812;METFORMIN#0.9808;CELL DEATH#0.9801;REVERSE TRANSCRIPTION#0.9801;MITOGEN ACTIVATED PROTEIN#0.9798;DNA METHYLATION#0.9798;LIPID SYNTHESIS#0.9791;BROWN ADIPOSE TISSUE#0.9790;CHOLINE#0.9789;COMPLEX I#0.9785;CELL MIGRATION#0.9784;AUTOPHAGY#0.9781;CELL ADHESION#0.9778;EICOSAPENTAENOIC ACID#0.9776;GLUCONEOGENESIS#0.9775;TARGET OF RAPAMYCIN#0.9769;PALMITIC ACID#0.9767;SATURATED FATTY ACID#0.9766;INSULIN RECEPTOR#0.9764;PROSTATE CARCINOMA#0.9762;TUMOR NECROSIS FACTOR#0.9762;MAMMARY EPITHELIAL CELL#0.9761;LIPID METABOLIC#0.9760;ADENOSINE#0.9760;CYTOTOXICITY#0.9759;ANDROGEN RECEPTOR#0.9759;APOPTOSIS#0.9755;FATTY ACID SYNTHESIS#0.9754;ADIPOCYTE#0.9753;QUANTITATIVE REAL TIME#0.9748;APOPTOTIC#0.9743;ADENOSINE MONOPHOSPHATE#0.9742;WEIGHT LOSS#0.9740;RAPAMYCIN#0.9735;CHOLESTEROL BIOSYNTHESIS#0.9734;TRANSFORMING GROWTH FACTOR#0.9732;POLYMERASE CHAIN REACTION#0.9732;LIPOGENESIS#0.9727;LIPASE ACTIVITY#0.9725;NITRIC OXIDE#0.9724;LIVER CANCER#0.9717;CHOLESTEROL METABOLISM#0.9715;PALMITOLEIC ACID#0.9714;CELL PROLIFERATION#0.9714;MUTAGENESIS#0.9713;ENERGY HOMEOSTASIS#0.9712;CELL GROWTH#0.9711;FATTY ACID OXIDATION#0.9711;MONOUNSATURATED FATTY ACIDS#0.9710;LOW FAT DIET#0.9709;GROWTH FACTOR#0.9709;LIPID RAFT#0.9707;RETINOIC ACID#0.9706;CONJUGATED LINOLEIC ACID#0.9705;SUBCUTANEOUS ADIPOSE TISSUE#0.9705;NICOTINAMIDE#0.9702;PROTEIN SYNTHESIS#0.9701;ADIPOCYTE DIFFERENTIATION#0.9701;TRANSCRIPTION FACTOR#0.9700;LEUCINE#0.9696;TUMOR SUPPRESSOR#0.9695;SUPEROXIDE DISMUTASE#0.9694;ARACHIDONIC ACID#0.9693;RIBOSOMAL PROTEIN#0.9691;VERY-LOW-DENSITY LIPOPROTEIN#0.9686;MITOCHONDRIA#0.9682;LIPID DROPLET#0.9679;GLYCOLYSIS#0.9679;PREADIPOCYTE#0.9676;LIPOLYSIS#0.9675;TUMOR TISSUES#0.9675;PRO-INFLAMMATORY#0.9670;LIPID STORAGE#0.9669;HEPATOCELLULAR CARCINOMA#0.9667;SIGNAL TRANSDUCTION#0.9666;WHITE ADIPOSE TISSUE#0.9666;DRUG RESISTANCE#0.9665;ADIPOGENESIS#0.9665;OLEIC ACID#0.9662;EPITHELIAL CELL#0.9661;FAT PAD#0.9655;FATTY ACID METABOLISM#0.9652;ETHANOL#0.9651;PLASMA MEMBRANE#0.9649;GROWTH HORMONE#0.9649;ENDOPLASMIC RETICULUM STRESS#0.9646;MACROPHAGE#0.9643;GLUTATHIONE#0.9642;ALPHA LINOLENIC ACID#0.9641;ENDOPLASMIC RETICULUM#0.9640;INFLAMMATORY RESPONSE#0.9639;HEPATITIS C#0.9638;PROTEIN KINASE#0.9638;ADIPOSE TISSUE#0.9637;INSULIN SECRETION#0.9636;EXCRETION#0.9635;GESTATION#0.9633;GLUTATHIONE PEROXIDASE#0.9628;CISPLATIN#0.9627;LACTATION#0.9626;LIPID HOMEOSTASIS#0.9622;CYTOPLASM#0.9620;GLUCOSE HOMEOSTASIS#0.9619;SUCROSE#0.9619;ADENINE#0.9617;SKELETAL MUSCLE#0.9616;PROGESTERONE#0.9615;GENE EXPRESSION#0.9614;ASPARTATE#0.9609;ADIPOSE TISSUE MASS#0.9609;CATABOLISM#0.9604;ESTRADIOL#0.9600;ENDOMETRIAL CANCER#0.9595;GLUCOSE METABOLISM#0.9591;CELL DIFFERENTIATION#0.9591;DNA BINDING#0.9591;SIGNALING PATHWAY#0.9590;LOW DENSITY LIPOPROTEIN#0.9588;GLUCOSE UPTAKE#0.9588;FAT CELL#0.9584;REGULATION OF GENE EXPRESSION#0.9582;AMPK ACTIVITY#0.9581;MYOTUBE#0.9581;MECHANISM OF ACTION#0.9579;CELL CYCLE#0.9569;TOXICITY#0.9569;REGULATION OF LIPID METABOLISM#0.9564;METHIONINE#0.9561;HEPATITIS C VIRUS#0.9561;REACTIVE OXYGEN SPECIES#0.9559;OBESE#0.9551;HYPOXIC#0.9550;ALANINE#0.9549;FATTY ACID ELONGATION#0.9548;RECEPTOR AGONIST#0.9543;BODY WEIGHT GAIN#0.9542;NITRIC OXIDE SYNTHASE#0.9537;DIET INDUCED OBESITY#0.9537;FATTY ACID DESATURASE#0.9535;PROTEIN KINASE C#0.9534;STREPTOZOTOCIN#0.9530;LIPOIC ACID#0.9527;HUMAN ADIPOSE TISSUE#0.9526;CELL WALL#0.9520;DIABETES MELLITUS#0.9520;RETINOBLASTOMA#0.9518;HYPERGLYCEMIA#0.9513;GLUCOSE INTOLERANCE#0.9511;VIRULENCE#0.9510;RETINOID X RECEPTOR#0.9508;ERYTHROCYTE#0.9505;NONALCOHOLIC FATTY LIVER DISEASE#0.9502;NERVOUS SYSTEM#0.9490;GLUCOSE TOLERANCE TEST#0.9488;ATHEROSCLEROSIS#0.9483;ROSIGLITAZONE#0.9482;ALCOHOLIC FATTY LIVER#0.9482;SIGNALLING PATHWAY#0.9481;LIPID METABOLISM#0.9473;HIGH DENSITY LIPOPROTEIN#0.9468;RESPIRATION#0.9468;INDUCTION OF APOPTOSIS#0.9466;GLUCOSE TRANSPORT#0.9465;SQUALENE SYNTHASE#0.9463;GENISTEIN#0.9463;IMMUNE RESPONSE#0.9462;CARBOHYDRATE METABOLISM#0.9461;LUNG CARCINOMA#0.9461;CELL CYCLE ARREST#0.9457;WEIGHT GAIN#0.9456;PROTEASOME#0.9454;MONOCYTE#0.9451;TYPE 2 DIABETES#0.9443;PYRUVATE CARBOXYLASE#0.9440;STEROL RESPONSIVE ELEMENT#0.9438;LIPID DROPLET FORMATION#0.9436;MULTIPLE MYELOMA#0.9422;FATTY LIVER#0.9421;SIGNALING MOLECULE#0.9417;FATTY LIVER DISEASE#0.9416;HIGH FAT DIET#0.9410;LIVER DAMAGE#0.9405;LYSINE#0.9402;KINASE ACTIVITY#0.9397;LIVER DISEASE#0.9389;GLYCERALDEHYDE-3-PHOSPHATE#0.9383;MITOCHONDRIAL MEMBRANE#0.9380;VITAMIN E#0.9375;HEPATIC LIPASE#0.9366;ADRENERGIC RECEPTOR#0.9366;DEATH RECEPTOR#0.9365;DIPHOSPHATE#0.9364;BLOOD GLUCOSE LEVEL#0.9363;BETA CELL#0.9355;MALIC ENZYME ACTIVITY#0.9340;CHRONIC LIVER DISEASE#0.9339;PERIPHERAL BLOOD#0.9336;CELL ADHESION MOLECULE#0.9333;HYPERTENSION#0.9323;PLASTID#0.9314;FIBROBLAST GROWTH FACTOR#0.9290;HIGH SUCROSE DIET#0.9289;TRANSCRIPTASE#0.9275;TUMOUR NECROSIS FACTOR#0.9269;TYPE 2 DIABETIC#0.9268;MUSCLE CELL#0.9258;DNASE I#0.9252;TYPE 2 DIABETES MELLITUS#0.9249;2 DIABETES MELLITUS#0.9249;QUANTITATIVE REVERSE TRANSCRIPTION#0.9247;ADENOSINE 5'-MONOPHOSPHATE#0.9246;EPITHELIAL MESENCHYMAL TRANSITION#0.9243;GLYCOGEN SYNTHASE KINASE#0.9230;LONGISSIMUS DORSI MUSCLE#0.9227;SCAVENGER RECEPTOR#0.9211;CHOLESTEROL TRANSPORT#0.9200;ENDOTHELIAL CELL#0.9191;CATALYTIC ACTIVITY#0.9176;PROTEIN PROTEIN INTERACTION#0.9173;OXIDATIVE PHOSPHORYLATION#0.9172;LAPATINIB#0.9164;BONE MARROW#0.9163;VIRAL REPLICATION#0.9162;EOSIN#0.9159;CELL SURFACE#0.9152;CELLULAR METABOLISM#0.9145;FATTY ACID BETA-OXIDATION#0.9143;ACETIC ACID#0.9142;ARGININE#0.9142;DIGESTION#0.9127;LIPID BINDING PROTEIN#0.9123;LYMPH NODE METASTASIS#0.9114;ABDOMINAL ADIPOSE TISSUE#0.9113;LIPID BINDING#0.9112;CELLULAR FATTY ACID#0.9107;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9103;ANOREXIA#0.9096;GLYCOGEN SYNTHESIS#0.9059;FARNESYL DIPHOSPHATE#0.9051;TCA CYCLE#0.9051;OCULAR CANCER#0.9047;RESPONSE TO INSULIN#0.9039;ISOPROTERENOL#0.9038;FERMENTATION#0.9036;PROTEIN KINASE A#0.9027;CHLOROPLAST#0.9027;WOUND HEALING#0.9027;MECHANISMS OF ACTION#0.8996;APOPTOTIC CELL DEATH#0.8991;AVERAGE DAILY GAIN#0.8985;DNA FRAGMENTATION#0.8975;PRINCIPAL COMPONENT ANALYSIS#0.8974;MILK PROTEIN#0.8965;NORMAL BREAST TISSUE#0.8962;ENDOMETRIAL CARCINOMA#0.8956;HIGH CHOLESTEROL DIET#0.8937;HISTONE MODIFICATION#0.8932;HISTONE ACETYLATION#0.8923;FARNESOID X RECEPTOR#0.8922;CENTRAL NERVOUS SYSTEM#0.8919;FASTING BLOOD GLUCOSE#0.8917;THIOESTERASE II#0.8907;HEPATOCYTE NUCLEAR FACTOR#0.8901;LIPOPROTEIN LIPASE ACTIVITY#0.8900;HYPERACTIVITY#0.8890;FARNESYL#0.8889;FACTOR I#0.8879;FENOFIBRATE#0.8879;STEARATE#0.8864;CHOLESTEROL EFFLUX#0.8841;TRASTUZUMAB#0.8841;PHOSPHATIDYLETHANOLAMINE#0.8828;KERATINOCYTE#0.8826;HEPATITIS B#0.8822;BIOTIN#0.8814;HISTONE DEACETYLASE#0.8810;ATHEROSCLEROTIC#0.8802;INSULIN SIGNALING PATHWAY#0.8792;MYRISTIC ACID#0.8789;EXTRACELLULAR MATRIX#0.8775;PYRUVATE DEHYDROGENASE KINASE#0.8757;UBIQUITIN SPECIFIC PROTEASE#0.8751;ALKALINE PHOSPHATASE#0.8714;FEEDING BEHAVIOR#0.8708;ORGANELLE#0.8689;CYTOCHROME C OXIDASE#0.8686;HEART DISEASE#0.8686;PROTEIN BINDING#0.8677;HYPERCHOLESTEROLEMIA#0.8673;FARNESYL DIPHOSPHATE SYNTHASE#0.8666;TRANSACTIVATION#0.8658;NADH DEHYDROGENASE#0.8643;ORAL GLUCOSE TOLERANCE#0.8629;PENTOSE PHOSPHATE PATHWAY#0.8624;CYCLIN DEPENDENT KINASE#0.8620;SMOOTH MUSCLE#0.8573;ISCHEMIA#0.8556;L-CARNITINE#0.8552;GLUCOCORTICOID RECEPTOR#0.8549;MAP KINASE#0.8542;CHOLESTEROL HOMEOSTASIS#0.8526;PYRAZINAMIDE#0.8526;TRANSFORMING GROWTH FACTOR BETA#0.8510;ISONIAZID#0.8502;MODE OF ACTION#0.8487;PHOSPHOLIPID SYNTHESIS#0.8485;S PHASE#0.8461;INHIBITION OF ADIPOGENESIS#0.8453;GLUTAMINE#0.8451;G1 PHASE#0.8441;B CELL LYMPHOMA#0.8436;DISEASE FREE SURVIVAL#0.8435;5'-ADENOSINE MONOPHOSPHATE#0.8425;OXYGENASE#0.8416;MYCOLIC ACID SYNTHESIS#0.8410;DNA REPAIR#0.8399;NEOPLASTIC TISSUES#0.8395;SERINE PALMITOYL TRANSFERASE#0.8388;BODY FAT MASS#0.8375;VISCERAL FAT ACCUMULATION#0.8364;TRADITIONAL CHINESE MEDICINE#0.8317;DNASE#0.8307;NADPH OXIDASE#0.8304;C REACTIVE PROTEIN#0.8304;MESENCHYMAL STEM CELL#0.8300;TESTOSTERONE#0.8298;NONRIBOSOMAL PEPTIDE SYNTHETASE#0.8270;PANCREATIC DUCTAL ADENOCARCINOMA#0.8261;TARGET OF RAPAMYCIN COMPLEX#0.8228;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8220;STRUCTURE ACTIVITY RELATIONSHIP#0.8216;STATIONARY PHASE#0.8208;RETINOL#0.8204;HIGH FAT FEEDING#0.8194;SENESCENCE#0.8189;PANCREATIC ISLET#0.8166;FEED CONVERSION RATIO#0.8159;L-METHIONINE#0.8153;SIGNALING CASCADE#0.8149;XANTHINE OXIDASE#0.8141;TRANSCRIPTION REGULATOR#0.8130;HEPATOCELLULAR CARCINOMA CELL#0.8127;ANORECTIC#0.8119;HISTIDINE#0.8115;LIPID METABOLISM DISORDER#0.8114;5'-AMP#0.8100;TAMOXIFEN#0.8098;BERBERINE#0.8093;RIBOSE#0.8089;ARTERY#0.8087;17β-ESTRADIOL#0.8087;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8085;SERUM LEPTIN LEVEL#0.8076;MOLAR#0.8066;CAMP RESPONSE ELEMENT#0.8065;SUCCINATE DEHYDROGENASE#0.8065;DIMETHYL SULFOXIDE#0.8060;LIPID TRANSPORT#0.8031;TISSUE DEVELOPMENT#0.8014;POLY ADP RIBOSE#0.8009;OOCYTE#0.8006;REVERSE CHOLESTEROL TRANSPORT#0.8003;NEUTROPHIL#0.7991;TRIGLYCERIDE METABOLISM#0.7990;KIDNEY DISEASE#0.7987;TOLL LIKE RECEPTOR#0.7983;HEPATIC STELLATE CELL#0.7969;EPOXIDE HYDROLASE#0.7966;HATCHING#0.7964;GENE SILENCING#0.7944;ELECTROPHORETIC MOBILITY SHIFT#0.7942;MICROTUBULE#0.7928;CERVICAL#0.7925;RED BLOOD CELL#0.7923;ATP SYNTHASE#0.7911;CELL ACTIVATION#0.7909;SUCCINATE#0.7901;MALIC ENZYME 1#0.7900;COLITIS#0.7891;PHOSPHOLIPASE A2#0.7890;ENDOMETRIUM#0.7855;HEPATITIS B VIRUS#0.7853;DENDRITIC CELL#0.7845;INDUCIBLE NITRIC OXIDE#0.7840;LIVER METASTASIS#0.7820;CLOFIBRATE#0.7811;URIC ACID#0.7776;VISCERAL FAT MASS#0.7773;METASTATIC MELANOMA#0.7764;PACLITAXEL#0.7762;FOCAL ADHESION#0.7755;EUKARYOTIC INITIATION FACTOR#0.7751;MYOCARDIUM#0.7739;ELECTRON TRANSPORT#0.7733;OF DIABETIC RATS#0.7727;RENAL CELL CARCINOMA#0.7719;TYPE II PKS#0.7715;VIRAL INFECTION#0.7713;POSITRON EMISSION TOMOGRAPHY#0.7708;M PHASE#0.7707;DODECYL SULFATE#0.7703;COLON CARCINOMA#0.7698;SYSTOLIC BLOOD PRESSURE#0.7695;COA LIGASE#0.7686;LIPID CATABOLISM#0.7676;REGENERATION#0.7656;ACTIVATING TRANSCRIPTION FACTOR#0.7638;LUNG METASTASIS#0.7634;CAMP RESPONSE ELEMENT BINDING#0.7619;TRANSLATION INITIATION#0.7605;INSULIN TOLERANCE TEST#0.7601;AND VISCERAL FAT#0.7596;TO TUMOR PROGRESSION#0.7593;CORD BLOOD#0.7579;HOST CELL#0.7578;PARTURITION#0.7576;CELL ENVELOPE#0.7576;QUANTITATIVE TRAIT LOCI#0.7572;S-ADENOSYL-L-METHIONINE#0.7571;OCTANOATE#0.7561;ORAL SQUAMOUS CELL CARCINOMA#0.7560;PROSTATE ADENOCARCINOMA#0.7557;ADJACENT NORMAL TISSUE#0.7555;GLUCOKINASE ACTIVITY#0.7554;RETINOL BINDING#0.7537;HEXANE#0.7533;CANCER STEM CELL#0.7521;CYCLIN DEPENDENT KINASE INHIBITOR#0.7519;SODIUM DODECYL SULFATE#0.7514;INTERMEDIARY METABOLISM#0.7509;UNFOLDED PROTEIN RESPONSE#0.7507;ANTIOXIDANT ACTIVITY#0.7493;TOTAL FATTY ACIDS#0.7480;TYROSINE KINASE INHIBITOR#0.7476;CARDIOMYOCYTE#0.7455;PEROXISOME PROLIFERATION#0.7441;OXALIPLATIN#0.7432;OXIDATIVE METABOLISM#0.7425;KREBS CYCLE#0.7422;CHLORAMPHENICOL#0.7416;CELL COUNTING KIT#0.7414;REPORTER GENE ASSAY#0.7414;PHOSPHATE BUFFERED SALINE#0.7413;SECONDARY METABOLISM#0.7406;MITOTIC CLONAL EXPANSION#0.7401;MRNA BINDING#0.7383;STROMAL CELL#0.7366;DNA SYNTHESIS#0.7365;ACYL BINDING#0.7364;DEHYDRATION#0.7355;IMPAIRED GLUCOSE TOLERANCE#0.7348;CERVICAL CANCER#0.7348;ADIPOSE TISSUE DEVELOPMENT#0.7339;INVASIVE DUCTAL CARCINOMA#0.7330;ANTI HER2#0.7329;EARLY GROWTH RESPONSE#0.7329;MONOCYTE CHEMOTACTIC PROTEIN#0.7305;VASCULAR CELL#0.7304;SOLUBLE EPOXIDE HYDROLASE#0.7283;C-LEVEL#0.7276;ESOPHAGEAL CANCER#0.7275;XANTHINE#0.7265;CORONARY HEART DISEASE#0.7262;MELATONIN#0.7260;SMALL HETERODIMER PARTNER#0.7259;ACYL-ACP SYNTHETASE ACTIVITY#0.7253;ELLAGIC ACID#0.7243;IMMUNE CELL#0.7240;ESSENTIAL AMINO ACID#0.7236;CHYLOMICRON#0.7234;SALIVARY GLAND#0.7231;CELLULAR MEMBRANE#0.7208;HIBERNATION#0.7200;MOLECULAR DYNAMICS SIMULATION#0.7183;CARNITINE PALMITOYLTRANSFERASE II#0.7176;TUBE FORMATION#0.7169;CHOLESTEROL UPTAKE#0.7163;METASTATIC BREAST CANCER#0.7163;SMALL INTESTINE#0.7161;LOVASTATIN#0.7159;PROTEIN TRANSLATION#0.7152;HYPERSENSITIVITY#0.7131;LUCIFERASE ACTIVITY#0.7120;PROSTATE SPECIFIC ANTIGEN#0.7113;ULCERATIVE COLITIS#0.7107;CD4+ T CELL#0.7104;PROGESTIN#0.7099;WNT SIGNALING PATHWAY#0.7096;FAS SIGNALING PATHWAY#0.7080;CAAT ENHANCER BINDING#0.7076;NORMAL CONTROL GROUP#0.7074;DRY MATTER INTAKE#0.7072;HEPARIN#0.7070;LIGAND BINDING DOMAIN#0.7069;CARCINOGEN#0.7067;GREEN TEA EXTRACT#0.7064;ACUTE CORONARY SYNDROME#0.7062;MAGNETIC RESONANCE SPECTROSCOPY#0.7053;PYRIDOXAL 5-PHOSPHATE#0.7011;KAS III#0.7007;MONONUCLEAR CELLS#0.6997;GLYCEROL KINASE#0.6994;NUCLEAR HORMONE RECEPTOR#0.6988;2-DEOXYGLUCOSE#0.6986;GREEN TEA CATECHIN#0.6973;PHOSPHOCHOLINE#0.6970;ANCHORAGE INDEPENDENT GROWTH#0.6966;KUPFFER CELL#0.6963;TROGLITAZONE#0.6962;MEMBRANE MICRODOMAIN#0.6954;CIRCADIAN RHYTHM#0.6939;LIPID BIOSYNTHETIC#0.6935;GEMCITABINE#0.6934;MYOCYTES#0.6924;CYCLIC AMP#0.6914;THYROID HORMONE RECEPTOR#0.6912;PHOSPHOLIPID METABOLISM#0.6909;L-CYSTEINE#0.6893;FATTY ACID DESATURATION#0.6889;OLANZAPINE#0.6850;CAROTENOID#0.6849;GLUCOSE REGULATED PROTEIN#0.6839;DIFFERENTIAL GENE EXPRESSION#0.6825;ROS GENERATION#0.6794;HEME OXYGENASE 1#0.6790;CAFFEINE#0.6789;BREAST CANCER MODEL#0.6789;ACYLCARNITINE#0.6783;DETERGENT RESISTANT MEMBRANE#0.6768;CORTISOL#0.6754;PHOSPHATASE AND TENSIN HOMOLOG#0.6736;REGULATION OF ADIPOGENESIS#0.6731;TRIGLYCERIDE STORAGE#0.6731;RISPERIDONE#0.6731;LIVER FAT CONTENT#0.6726;PROGENITOR CELL#0.6720;BINDING PROTEIN 3#0.6696;PHOSPHOLIPID BIOSYNTHESIS#0.6695;TRANSCRIPTIONAL CONTROL#0.6691;ENTEROCYTE#0.6688;CELLULAR LOCALIZATION#0.6684;SPECIFIC GROWTH RATE#0.6684;PLEOMORPHIC ADENOMA#0.6682;OSTEOBLAST#0.6660;VIRGIN OLIVE OIL#0.6646;GLYCINE#0.6639;SMOOTH MUSCLE CELL#0.6632;SERUM ALBUMIN#0.6621;SCHWANN CELL#0.6611;PRIMARY HUMAN HEPATOCYTES#0.6603;ABDOMINAL FAT MASS#0.6592;VITAMIN A#0.6592;VALINE#0.6589;ER STRESS RESPONSE#0.6585;S-ADENOSYLMETHIONINE#0.6557;MOUSE EMBRYONIC FIBROBLAST#0.6537;TERMINAL DIFFERENTIATION#0.6527;PYRIDOXAL#0.6519;CHOLINE KINASE#0.6518;EMODIN#0.6518;PLATELET-DERIVED GROWTH FACTOR#0.6495;RNA REPLICATION#0.6488;CITRATE SYNTHASE ACTIVITY#0.6482;PIOGLITAZONE#0.6475;DEPHOSPHORYLATION#0.6472;GENOTOXIC#0.6467;TRANSCRIPTION ACTIVATOR#0.6459;OVERNUTRITION#0.6452;COLORECTAL CARCINOMA#0.6437;DETOXIFICATION#0.6434;RUTIN#0.6432;TOTAL ANTIOXIDANT CAPACITY#0.6431;UBIQUITIN PROTEASOME SYSTEM#0.6431;GROWTH FACTOR BINDING#0.6403;LINES OF EVIDENCE#0.6400;BASAL CELL#0.6395;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6392;ZUCKER DIABETIC FATTY#0.6384;ESTROGENS#0.6380;POST-TRANSLATIONAL MODIFICATION#0.6376;DOXORUBICIN#0.6374;CITRATE LYASE ACTIVITY#0.6368;TOCOPHEROL#0.6366;POLYKETIDE BIOSYNTHESIS#0.6359;TOPICAL#0.6345;IMMUNE SYSTEM#0.6337;TRIACYLGLYCEROL METABOLISM#0.6328;HCV CORE PROTEIN#0.6323;MESENTERIC ADIPOSE TISSUE#0.6317;BILE ACID SYNTHESIS#0.6302;REGULATION OF MRNA#0.6294;CARRIE#0.6271;BODY WEIGHT LOSS#0.6263;CELECOXIB#0.6260;MALTOSE BINDING#0.6251;DUAL LUCIFERASE REPORTER#0.6236;PHOSPHODIESTERASE#0.6235;PRIMARY METABOLISM#0.6233;PROTEINURIA#0.6232;GLCNAC#0.6232;LACTIC ACID#0.6230;MANTLE CELL LYMPHOMA#0.6224;ABC TRANSPORTER#0.6221;PROTEIN DEGRADATION#0.6216;NUCLEAR RESPIRATORY FACTOR#0.6213;PHOSPHOLIPASE A#0.6208;ENZYME INHIBITOR#0.6201;DNA REPLICATION#0.6194;LUNG ADENOCARCINOMA#0.6187;EXPERIMENTAL MELANOMA#0.6185;INFLAMMATORY CELL#0.6181;RNA SYNTHESIS#0.6177;CLEAVED CASPASE 3#0.6174;ACETYL-COENZYME A SYNTHETASE#0.6169;SIMVASTATIN#0.6164;ELECTRON TRANSPORT CHAIN#0.6141;PROTEIN COMPLEX#0.6127;TRICARBOXYLIC ACID CYCLE#0.6126;FOLATE#0.6121;REGULATION OF LIPID SYNTHESIS#0.6120;ESOPHAGUS#0.6116;RESONANCE ENERGY TRANSFER#0.6110;TRYPTOPHAN#0.6104;CANCER RELATED DEATH#0.6093;TRANSLATION INITIATION FACTOR#0.6093;GLIAL CELL#0.6069;MUSCLE FIBER#0.6069;MALONATE#0.6069;BENIGN MENINGIOMA#0.6049;OMENTAL ADIPOSE TISSUE#0.6048;CHRONIC KIDNEY DISEASE#0.6046;OCTANOIC ACID#0.6045;AGEING#0.6040;LYASE ACTIVITY#0.6039;TOTAL ENERGY INTAKE#0.6032;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6030;CANCER SPECIFIC MORTALITY#0.6029;ANABOLISM#0.6026;HYPERINSULINEMIC EUGLYCEMIC CLAMP#0.6024;TOPOISOMERASE#0.6021;PROTEIN KINASE ACTIVATION#0.6013;METABOLITE REPAIR#0.6006
219527	LEUCINE RICH REPEAT#0.7338;CELL PROLIFERATION#0.6856
219537	SMOOTH MUSCLE#1.0918;INSTITUTE OF MEDICINE#1.0788;HEALTH CARE SYSTEM#1.0241;MYOSIN PHOSPHATASE#0.9166;SKELETAL MUSCLE#0.8925;QUALITY OF CARE#0.8604;MUSCLE CELL#0.7988;CAM BINDING#0.7732;TROPOMYOSIN BINDING#0.7309;EVIDENCE BASED PRACTICE#0.7225;MUSCLE CONTRACTION#0.6913;SMOOTH MUSCLE CELL#0.6862;SMOOTH MUSCLE CONTRACTION#0.6176;STRIATED MUSCLE#0.6150;CARDIAC SARCOIDOSIS#0.6076
219539	CELL PROLIFERATION#1.0410;MITOGEN ACTIVATED PROTEIN#0.8005;PROTEIN KINASE#0.7957
219541	MEDIATOR COMPLEX#1.0964;CANCER CELL#1.0945;CELL PROLIFERATION#1.0870;LUNG CANCER#1.0837;CELL CYCLE#1.0224;BREAST CANCER#1.0153;G1 PHASE#0.9739;HUMAN BREAST CANCER#0.9463;APOPTOSIS#0.8754;BREAST CANCER CELL#0.8634;PROSTATE CANCER#0.8627;CELL CYCLE ARREST#0.8194;RNA INTERFERENCE#0.7896;GENE EXPRESSION#0.7700;RELATED PROTEIN 1#0.7694;CELL GROWTH#0.7567;TRANSCRIPTION FACTOR#0.7546;EPITHELIAL MESENCHYMAL TRANSITION#0.6924;GENE SILENCING#0.6087
219595	L-GLUTAMATE#1.0198;PROSTATE-SPECIFIC MEMBRANE ANTIGEN#1.0166;ASPARTATE#0.9867;PROSTATE CANCER#0.8845;SCHWANN CELL#0.8331;NERVOUS SYSTEM#0.8054;DIPEPTIDASE ACTIVITY#0.7595;GLUTAMATE RECEPTOR#0.7359;ISCHEMIA#0.6883;NAALADASE ACTIVITY#0.6620;FOLATE#0.6418
2195	TUMOR SUPPRESSOR#1.0525;CELL MIGRATION#1.0380;BREAST CANCER#1.0279;SQUAMOUS CELL CARCINOMA#0.9926;CANCER CELL#0.9912;CELL POLARITY#0.9580;SIGNALING PATHWAY#0.9116;HIPPO SIGNALING#0.9068;GENE EXPRESSION#0.9045;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8971;CELL GROWTH#0.8942;ORAL SQUAMOUS CELL CARCINOMA#0.8776;TRANSCRIPTION FACTOR#0.8775;HEAD AND NECK CANCER#0.8706;NECK CANCER#0.8705;CELL PROLIFERATION#0.8705;MUSCLE CELL#0.8522;SMOOTH MUSCLE#0.8510;COLON CANCER#0.8508;FATTY ACID TRANSPORT#0.8492;VASCULAR SMOOTH MUSCLE CELL#0.8473;SMOOTH MUSCLE CELL#0.8467;CELL CYCLE#0.8303;ACTIN POLYMERIZATION#0.8133;T CELL#0.8108;CELL ADHESION#0.8018;HYPOXIA#0.8000;CELL SURFACE#0.7986;CELL DEATH#0.7900;APOPTOSIS#0.7882;GROWTH FACTOR#0.7804;FATTY ACID TRANSPORTER#0.7612;EPITHELIAL CELL#0.7426;B CELL#0.7267;POLYMERASE CHAIN REACTION#0.7233;FATTY ACID BINDING#0.7022;SLIT DIAPHRAGM#0.7008;CELL JUNCTION#0.6883;CERULENIN#0.6864;ADJACENT NORMAL TISSUE#0.6855;COLORECTAL CANCER#0.6826;PLANAR CELL POLARITY#0.6804;COPY NUMBER ALTERATION#0.6774;OLEIC ACID#0.6679;PLASMA MEMBRANE#0.6530;HEPATOCELLULAR CARCINOMA#0.6344;ACYL-COA SYNTHETASE ACTIVITY#0.6340;HYPOXIC#0.6319;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6283;COLORECTAL#0.6254;LUNG CANCER#0.6238;QUANTITATIVE TRAIT LOCUS#0.6236;PODOCYTE#0.6173;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY#0.6161;NOT OTHERWISE SPECIFIED#0.6147;PERIPHERAL T-CELL LYMPHOMA#0.6134;INTERCELLULAR JUNCTION#0.6128;WOUND HEALING#0.6114;EYE DEVELOPMENT#0.6087;NEURAL TUBE#0.6039;SYNTHETASE ACTIVITY#0.6039;ONCOGENIC#0.6017
219623	ADIPOCYTE#1.0211;ADIPOSE TISSUE#0.9769;WHITE ADIPOSE TISSUE#0.9437;BROWN ADIPOSE TISSUE#0.8785;PREADIPOCYTE#0.6699;GENE EXPRESSION#0.6544
219670	SIGNALING PATHWAY#0.9053;AKT SIGNALING#0.6663;COLORECTAL CANCER#0.6598;CANCER CELL#0.6537
219681	CANCER TESTIS ANTIGEN#0.6936;ENDOMETRIAL CANCER#0.6431
219699	NETRIN RECEPTOR#1.0979;CANCER CELL#1.0326;ENDOTHELIAL CELL#1.0209;APOPTOSIS#1.0185;COLORECTAL CANCER#1.0137;ANGIOGENESIS#1.0126;COLORECTAL#1.0121;EPITHELIAL CELL#0.9762;AXON GUIDANCE#0.9751;NERVOUS SYSTEM#0.9687;CELL MIGRATION#0.9561;MACROPHAGE#0.9194;GENE EXPRESSION#0.9184;CELL PROLIFERATION#0.9138;PERIPHERAL NERVE#0.8780;BLOOD VESSEL#0.8649;SIGNALING PATHWAY#0.8632;ISCHEMIA#0.8386;CELL DEATH#0.8342;GROWTH FACTOR#0.8088;OSTEOCLAST#0.8064;REGENERATION#0.7834;ISCHEMIA REPERFUSION INJURY#0.7709;KIDNEY DISEASE#0.7597;STEM CELL#0.7532;COLON CANCER#0.7518;TUMOR SUPPRESSOR#0.7506;HYPOXIA#0.7277;TRANSCRIPTION FACTOR#0.7259;TUBULAR EPITHELIAL CELL#0.7069;CELL SURFACE#0.6961;SCHWANN CELL#0.6904;ARTERY#0.6643;COLORECTAL CARCINOMA#0.6389;NEUTROPHIL#0.6379;CELL ADHESION#0.6372;APOPTOTIC#0.6370;DIABETIC KIDNEY DISEASE#0.6172;SPINAL DORSAL HORN#0.6157;CEREBRAL ARTERY OCCLUSION#0.6109;MIDDLE CEREBRAL ARTERY#0.6096;CEREBRAL ARTERY#0.6094;RESPONSE TO STRESS#0.6093;TRANSMEMBRANE RECEPTOR#0.6047;POLYMERASE CHAIN REACTION#0.6028
2196	CELL MIGRATION#0.9450;CELL POLARITY#0.8990;PLANAR CELL POLARITY#0.8956;SPINAL MENINGIOMA#0.6466
219736	PRE-ECLAMPSIA#1.1047;TROPHOBLAST#1.0601;ECLAMPSIA#1.0316;TROPHOBLAST CELL#1.0278;TRANSCRIPTION FACTOR#1.0168;SIGNALING PATHWAY#0.8241;AKT SIGNALING#0.8051;CELL PROLIFERATION#0.7638;CELL CYCLE#0.7082;APOPTOSIS#0.6221;DECIDUA#0.6027
219743	PEROXISOMAL#0.9085;PEROXISOMAL MATRIX#0.6812
219770	CONNEXIN#0.6761
219771	CELL PROLIFERATION#1.0321;LUNG CANCER#0.9652;CELL CYCLE#0.9506;CANCER CELL#0.8748;CYCLIN DEPENDENT KINASE#0.8198;CELL DIVISION#0.7140;TUMOR TISSUES#0.7129;HEPATOCELLULAR CARCINOMA#0.7089;SIGNALING PATHWAY#0.7044
219790	APOPTOSIS#0.9728;CELL CYCLE#0.9491;CANCER CELL#0.7991;T CELL#0.7355;CELL PROLIFERATION#0.6782;INTRINSIC APOPTOSIS#0.6282;COLON CANCER#0.6048;OVARIAN CANCER#0.6039;RHEUMATOID ARTHRITIS#0.6027;CD4+ T CELL#0.6020
219793	STROMAL CELL#0.7240;CELL PROLIFERATION#0.6681
2197	RIBOSOMAL PROTEIN#1.0745;UBIQUITIN#1.0745;GENE EXPRESSION#0.9642;TRANSCRIPTION FACTOR#0.9427;APOPTOSIS#0.9064;T CELL#0.8841;ARYLSULFATASE B#0.8462;MACROPHAGE#0.8052;DROUGHT TOLERANCE#0.7933;IMMUNE RESPONSE#0.7551;RNA BINDING#0.7420;DNA BINDING#0.6811;FRUIT RIPENING#0.6221;APOPTOTIC#0.6197;PROTEIN SYNTHESIS#0.6157;RIBOSOME#0.6083;RNA BINDING PROTEIN#0.6031;OVARIAN CANCER#0.6024
219854	RETINAL DEGENERATION#0.9158
219855	MAJOR FACILITATOR SUPERFAMILY#0.6501;MACROPHAGE#0.6243;GLUCOSE-6-PHOSPHATE#0.6139
219899	VITAMIN E#1.0895;INDOMETHACIN#0.9773;NORADRENALINE#0.8453;HEPATITIS E#0.8432;ARACHIDONIC ACID#0.8101;EXCRETION#0.7643;PROSTAGLANDIN E2#0.7314;MICROTUBULE#0.7265;GENE EXPRESSION#0.6630;PROSTAGLANDIN SYNTHESIS#0.6516;VENOUS BLOOD#0.6374
219931	LYSOSOME#1.0362;ADENINE DINUCLEOTIDE PHOSPHATE#1.0252;NICOTINIC ACID#1.0251;ION CHANNEL#1.0022;ADENINE#1.0004;ORGANELLE#0.9148;AUTOPHAGY#0.9148;CATION CHANNEL#0.8407;ENDOSOME#0.8314;CANCER CELL#0.8216;SKELETAL MUSCLE#0.8031;RYANODINE RECEPTOR#0.7899;ENDOPLASMIC RETICULUM#0.7827;MUSCLE CELL#0.7613;ENDOLYSOSOME#0.7310;PLASMA MEMBRANE#0.7103;GROWTH FACTOR#0.6990;TARGET OF RAPAMYCIN#0.6930;LUMINAL#0.6654;BAFILOMYCIN A1#0.6465;SMOOTH MUSCLE#0.6417;RAPAMYCIN#0.6401;LYSOSOMAL MEMBRANE#0.6333;CALCIUM SIGNALING#0.6292;SARCOPLASMIC RETICULUM#0.6263;INSULIN SECRETION#0.6094
219938	T CELL#0.9367;PROSTATE CANCER#0.8999;SPERMATOGENESIS#0.7503;MICROTUBULE#0.6808;MITOCHONDRIA#0.6759;CD8+ T CELL#0.6514;TUMOR ANTIGEN#0.6465;TESTIS DEVELOPMENT#0.6140
219970	GLYCINE N ACYLTRANSFERASE#1.0670;N ACYLTRANSFERASE#1.0300;GLYCINE#0.7746;SIGNALING MOLECULE#0.7189
219972	MACROPHAGE#1.0653;GLYCOSYLATION#0.8778;CELL WALL#0.8187;GENE EXPRESSION#0.7968;IMMUNE SYSTEM#0.7155;CELL CYCLE#0.6822;HOST CELL#0.6641;IMMUNE RESPONSE#0.6072
219988	P BODY#1.1109;CELL PLATE#0.8754;MRNA DECAY#0.8511;SALT TOLERANCE#0.6699;FREEZING TOLERANCE#0.6285;P BODY ASSEMBLY#0.6216
2199	FIBRILLIN#1.0590;EXTRACELLULAR MATRIX#1.0156;BASEMENT MEMBRANE#1.0151;ELASTIC FIBER#1.0070;GROWTH FACTOR#0.9918;SMOOTH MUSCLE#0.9915;BREAST CANCER#0.9766;MICROFIBRIL#0.9712;GENE EXPRESSION#0.9546;CONNECTIVE TISSUE#0.9294;TUMOR SUPPRESSOR#0.8926;MYOFIBROBLAST#0.8911;TRANSFORMING GROWTH FACTOR#0.8862;CANCER CELL#0.8609;CELL ADHESION#0.8448;BREAST CANCER CELL#0.7976;HEPATIC STELLATE CELL#0.7917;POLYMERASE CHAIN REACTION#0.7879;BLOOD VESSEL#0.7717;PROTEOGLYCAN#0.7629;STROMA#0.7612;SIGNALING PATHWAY#0.7532;SURFACE PLASMON RESONANCE#0.7416;EPITHELIAL CELL#0.7347;EPIDERMAL GROWTH FACTOR#0.7218;HEPARIN#0.7164;ELASTIC FIBRE#0.7101;MESENCHYMAL CELL#0.6951;SMOOTH MUSCLE ACTIN#0.6853;STEM CELL#0.6832;FIBRIL#0.6704;ENDOTHELIAL CELL#0.6614;BONE MARROW#0.6357;TRANSFORMING GROWTH FACTOR BETA#0.6292;HEART DEVELOPMENT#0.6278;RETINAL DETACHMENT#0.6171;PROTEIN SYNTHESIS#0.6143;TUMOR CELLS#0.6116;WOUND HEALING#0.6072
219	STEM CELL#0.9010;ETHANOL#0.8988;COLON CANCER#0.8654;GENE EXPRESSION#0.7827;PANCREATIC CANCER#0.7529;ADENOCARCINOMA#0.7360;CANCER CELL#0.7239
21	LAMELLAR BODY#1.0812;LIPID TRANSPORTER#1.0806;ATP BINDING CASSETTE TRANSPORTER#1.0520;SURFACTANT HOMEOSTASIS#1.0478;SURFACTANT PROTEIN C#1.0371;RESPIRATORY FAILURE#1.0345;NEONATAL RESPIRATORY FAILURE#1.0337;RESPIRATORY DISTRESS#1.0324;ATP BINDING CASSETTE#1.0322;ATP BINDING#1.0300;INTERSTITIAL LUNG DISEASE#1.0279;ABC TRANSPORTER#1.0227;LUNG DISEASE#1.0208;LIPID TRANSPORT#1.0181;BREAST CANCER#1.0115;TRANSCRIPTION FACTOR#1.0106;EPITHELIAL CELL#1.0101;ADENOSINE TRIPHOSPHATE#1.0058;PULMONARY FIBROSIS#0.9865;GENE EXPRESSION#0.9642;MYELOID LEUKEMIA#0.9485;ADENOSINE#0.9238;PLASMA MEMBRANE#0.9076;INTRACELLULAR VESICLE#0.8996;THYROID TRANSCRIPTION FACTOR#0.8927;POLYMERASE CHAIN REACTION#0.8918;ORGANELLE#0.8841;ALVEOLAR EPITHELIAL CELL#0.8771;DRUG RESISTANCE#0.8700;ADVANCED BREAST CANCER#0.8612;GENETIC DISORDER#0.8611;INTRACELLULAR LOCALIZATION#0.8556;GESTATION#0.8551;PULMONARY HYPERTENSION#0.8495;TYPE II PNEUMOCYTE#0.8469;ENDOPLASMIC RETICULUM#0.8297;CANCER CELL#0.7989;STEM CELL#0.7957;LUNG EPITHELIAL CELL#0.7692;PHOSPHOLIPID TRANSPORTER#0.7612;ATP HYDROLYSIS#0.7571;TRANSITIONAL CELL CARCINOMA#0.7424;VACUOLE#0.7382;MACROPHAGE#0.7334;ALVEOLAR TYPE 2#0.7324;PNEUMONIA#0.7296;HYPERTENSION#0.7181;GROWTH FACTOR#0.7181;CHOLINE#0.6829;ACUTE MYELOID LEUKEMIA#0.6777;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6605;SURFACTANT PROTEINS A#0.6555;LUNG CANCER#0.6554;CELL DEATH#0.6539;IMATINIB#0.6325;LUNG DEVELOPMENT#0.6322;PROGENITOR CELL#0.6304;VACUOLAR MEMBRANE#0.6163
220001	EPITHELIAL MESENCHYMAL TRANSITION#0.8740;CANCER CELL#0.8635;HEPATOCELLULAR CARCINOMA#0.8407;HEPATITIS B#0.8138;CELL PROLIFERATION#0.7531;CELL CYCLE#0.7416;CELL GROWTH#0.7303;HEPATITIS B VIRUS#0.7256;PROSTATE CANCER#0.6545;NORMAL LIVER TISSUES#0.6206
220002	CYTOCHROME B#0.8111
220032	PHOSPHODIESTERASE#0.8395;GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE#0.8140
220042	LUNG CANCER#1.1112;NITRIC OXIDE#1.0967;CANCER CELL#1.0527;APOPTOSIS#1.0042;INDUCIBLE NITRIC OXIDE#0.9975;NITRIC OXIDE SYNTHASE#0.9729;TRANSCRIPTION FACTOR#0.7628;CELL CYCLE#0.7054;BREAST CANCER#0.7053;LYMPH NODE METASTASIS#0.6333;LYMPH NODE#0.6278;DISC FORMATION#0.6145;APOPTOTIC#0.6137
220047	GERM CELL#0.9068;ENDOCYTOSIS#0.6495
220064	SQUAMOUS CELL CARCINOMA#0.9922;ORAL SQUAMOUS CELL CARCINOMA#0.8784;LYMPH NODE#0.7748;CELL GROWTH#0.7680;GENE EXPRESSION#0.7099;CANCER CELL#0.7083;APOPTOSIS#0.6945;LYMPH NODE METASTASIS#0.6837;ORAL CANCER CELL#0.6543;OVERALL SURVIVAL TIME#0.6500;CHROMOSOMAL REGION#0.6493;CELL CYCLE#0.6376;VIRAL RELEASE#0.6236;ANGIOGENESIS#0.6091
220074	HEARING LOSS#0.9255;NONSYNDROMIC DEAFNESS#0.7631;HEARING IMPAIRMENT#0.7555;ALTERNATIVE READING FRAME#0.6318
220082	COLORECTAL CANCER#0.6598;CELL GROWTH#0.6574
2200	ISOLATED ECTOPIA LENTIS#1.0772;WEILL-MARCHESANI SYNDROME#1.0521;FIBRILLIN#1.0365;ELASTIC FIBRE#1.0361;INTEGRIN BINDING#1.0339;ELASTIC FIBER ASSEMBLY#1.0288;TGF-BETA BINDING#1.0262;PREMATURE TERMINATION CODON#1.0213;BINDING PROTEIN 1#1.0198;SCLERODERMA#1.0193;CONNECTIVE TISSUE DISEASE#1.0189;ARACHNODACTYLY#1.0174;MARFAN SYNDROME#1.0158;POLYMERASE CHAIN REACTION#1.0154;AORTIC DISEASE#1.0122;LOEYS-DIETZ SYNDROME#1.0120;MICROFIBRIL#1.0119;PERIODONTAL LIGAMENT#1.0095;LOSARTAN#1.0093;GENETIC DISORDER#1.0055;ENDOTHELIAL CELL#1.0052;CELL ADHESION#1.0034;DERMAL FIBROBLAST#1.0033;LIPODYSTROPHY#1.0032;DERMIS#1.0022;HEPARIN#1.0012;TRANSFORMING GROWTH FACTOR BETA#1.0002;FIBRIL#0.9998;ELASTIC FIBER#0.9997;EPIDERMAL GROWTH FACTOR#0.9993;APOPTOSIS#0.9967;THORACIC AORTA#0.9962;BASEMENT MEMBRANE#0.9944;CONNECTIVE TISSUE#0.9939;THORACIC AORTIC ANEURYSM#0.9938;TRANSFORMING GROWTH FACTOR#0.9934;EPITHELIAL CELL#0.9921;CARDIOVASCULAR SYSTEM#0.9914;STEM CELL#0.9868;GROWTH FACTOR#0.9868;MITRAL VALVE#0.9850;GENE EXPRESSION#0.9847;SMOOTH MUSCLE CELL#0.9834;EXTRACELLULAR MATRIX#0.9824;MUSCLE CELL#0.9819;AORTIC ANEURYSM#0.9810;SMOOTH MUSCLE#0.9793;HUMAN DERMAL FIBROBLAST#0.9787;MITRAL VALVE PROLAPSE#0.9766;HYPERTENSION#0.9746;AORTIC VALVE#0.9735;HEPARIN BINDING#0.9722;COLLAGEN TYPE I#0.9719;ARTERY#0.9718;BLOOD VESSEL#0.9718;SKIN FIBROBLASTS#0.9718;SIGNALING PATHWAY#0.9684;VASCULAR SMOOTH MUSCLE CELL#0.9669;PROTEOGLYCAN#0.9662;EXTRACELLULAR MATRIX COMPONENT#0.9659;SCOLIOSIS#0.9613;BICUSPID AORTIC VALVE#0.9548;COLORECTAL CANCER#0.9454;CELL PROLIFERATION#0.9418;TRANSCRIPTION FACTOR#0.9416;MYOCARDIAL INFARCTION#0.9412;MESANGIAL CELL#0.9410;STROMA#0.9401;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.9385;ADIPOSE TISSUE#0.9380;CELL SURFACE#0.9328;OBESE#0.9314;WOUND HEALING#0.9291;ASCENDING AORTIC ANEURYSM#0.9280;SKELETAL SYSTEM#0.9237;FOCAL ADHESION#0.9206;BONE MORPHOGENETIC PROTEIN#0.9176;SMOOTH MUSCLE ACTIN#0.9116;ELASTIN FIBER#0.9116;ACUTE AORTIC DISSECTION#0.9105;MATRIX METALLOPROTEINASE 1#0.9082;PERIPHERAL BLOOD#0.9045;SKELETAL MUSCLE#0.9037;TYPE 2 DIABETES#0.9026;REVERSE TRANSCRIPTION#0.9010;EHLERS-DANLOS SYNDROME#0.8977;AGEING#0.8957;GLYCINE#0.8921;OSTEOBLAST#0.8921;NERVOUS SYSTEM#0.8636;ADOLESCENT IDIOPATHIC SCOLIOSIS#0.8611;GROWTH FACTOR BINDING#0.8611;CILIARY BODY#0.8586;TRANSMISSION ELECTRON MICROSCOPY#0.8577;PLURIPOTENT STEM CELL#0.8574;LEUKOCYTE#0.8556;IDIOPATHIC SCOLIOSIS#0.8529;ARGININE#0.8513;INDUCED PLURIPOTENT STEM CELL#0.8502;KERATINOCYTE#0.8499;TGFBETA BINDING#0.8492;ATHEROSCLEROTIC#0.8417;RIBOZYME#0.8368;BONE MARROW#0.8304;COLORECTAL#0.8208;REGENERATION#0.8201;CARDIOMYOPATHY#0.8170;SKELETON#0.8164;MESENCHYMAL STEM CELL#0.8076;ABDOMINAL AORTIC ANEURYSM#0.8058;AUTOSOMAL DOMINANT DISEASE#0.8051;BRACHYDACTYLY#0.8038;CENTRAL NERVOUS SYSTEM#0.8018;CANCER CELL#0.8002;DNA METHYLATION#0.7890;TISSUE HOMEOSTASIS#0.7809;EMBRYONIC STEM CELL#0.7770;TOPICAL#0.7750;CELL MIGRATION#0.7740;AORTIC SMOOTH MUSCLE CELLS#0.7715;MORPHOGENESIS#0.7698;GENETIC DISEASE#0.7674;MACROPHAGE#0.7641;HYALURONAN#0.7614;DIABETES MELLITUS#0.7596;EXTRACELLULAR SPACE#0.7595;INTERVERTEBRAL DISC#0.7573;STROMAL CELL#0.7569;GLOMERULUS#0.7566;BILE DUCT#0.7517;OVARIAN#0.7517;MAGNETIC RESONANCE IMAGING#0.7516;LENS SUBLUXATION#0.7492;GLYCOSYLATION#0.7452;HOMOCYSTINURIA#0.7417;LYSINE#0.7415;SUPRAVALVULAR AORTIC STENOSIS#0.7414;ATHEROSCLEROSIS#0.7403;ENDOPLASMIC RETICULUM#0.7401;HYALURONIC ACID#0.7397;VASCULAR DISEASE#0.7324;GROWTH FACTOR RECEPTOR#0.7322;OPEN ANGLE GLAUCOMA#0.7300;GLUCOSE METABOLISM#0.7298;NITRIC OXIDE#0.7270;MESENCHYME#0.7220;PROTEIN PROTEIN INTERACTION#0.7208;ANNULUS FIBROSUS#0.7197;SURFACE PLASMON RESONANCE#0.7173;MYOFIBROBLAST#0.7133;LOW DENSITY LIPOPROTEIN#0.7117;HUMAN EMBRYONIC STEM#0.7057;PULMONARY HYPERTENSION#0.7032;ENDOTHELIUM#0.6927;T CELL#0.6903;PERIODONTAL DISEASE#0.6865;HEART DISEASE#0.6864;ASPARTIC ACID#0.6847;OVARIAN CANCER#0.6786;ANGIOGENESIS#0.6785;ALKALINE PHOSPHATASE#0.6772;KIDNEY DISEASE#0.6714;TGF-BETA ACTIVATION#0.6677;BONE FORMATION#0.6658;TYPE 2 DIABETES MELLITUS#0.6642;2 DIABETES MELLITUS#0.6642;CONGESTIVE HEART FAILURE#0.6636;CERVICAL#0.6623;ANNULUS#0.6622;WESTERN TYPE DIET#0.6597;DIGESTION#0.6595;INSULIN SECRETION#0.6585;PRIMARY OPEN ANGLE GLAUCOMA#0.6511;DILATED CARDIOMYOPATHY#0.6472;GESTATION#0.6457;AND AORTIC ANEURYSM#0.6453;OVARIES#0.6431;CERVICAL ARTERY DISSECTION#0.6423;CELL DIFFERENTIATION#0.6398;PROGENITOR CELL#0.6394;TUMOR NECROSIS FACTOR#0.6362;HUMAN PERIODONTAL LIGAMENT#0.6345;MYOSIN HEAVY CHAIN#0.6276;TRANSCRIPTASE#0.6269;GRADIENT GEL ELECTROPHORESIS#0.6264;C TERMINAL DOMAIN#0.6260;WHITE ADIPOSE TISSUE#0.6214;RETINOIC ACID#0.6195;FIBRONECTIN FIBRIL#0.6180;MIXED CONNECTIVE TISSUE DISEASE#0.6176;CELL GROWTH#0.6162;B CELL#0.6155;VENOUS BLOOD#0.6119;MACROPHAGE CHEMOTAXIS#0.6109;ENDOTHELIAL GROWTH FACTOR#0.6097;ADIPOCYTE#0.6051;HYPOXIA#0.6038;PRIMARY PULMONARY HYPERTENSION#0.6036;CUTIS LAXA#0.6036;FIBRILLAR COLLAGEN#0.6026;FOCAL ADHESION FORMATION#0.6025;RETINAL DETACHMENT#0.6015
220107	B CELL#0.7489;TUMOR SUPPRESSOR#0.7425;LYMPHOCYTIC LEUKEMIA#0.6800;NEURAL TUBE#0.6047
220134	KINETOCHORE#1.0920;MICROTUBULE#1.0657;MICROTUBULE BINDING#1.0585;CELL PROLIFERATION#1.0263;CELL CYCLE#1.0004;MITOSIS#0.9911;CHROMOSOME SEGREGATION#0.9266;SKI COMPLEX#0.8812;SPINDLE MICROTUBULE#0.8692;ANAPHASE#0.7831;SPINDLE CHECKPOINT#0.7587;CANCER CELL#0.7292;KINETOCHORE MICROTUBULE#0.7178;CELL CYCLE ARREST#0.7152;COMPLEX I#0.6984;GENE EXPRESSION#0.6674;APOPTOSIS#0.6656;METAPHASE#0.6595;MICROTUBULE END#0.6553;STREPTOKINASE#0.6464;ADENOID CYSTIC CARCINOMA#0.6373;C TERMINAL DOMAIN#0.6340;SIGNALING PATHWAY#0.6142;CENTROSOME#0.6082;RIBOSOME#0.6029
220136	SITUS INVERSUS#0.7089;CENTRIOLAR SATELLITE#0.7065;CONGENITAL HEART DISEASE#0.6569;HEART DISEASE#0.6410
220164	NEURITE OUTGROWTH#1.1048;NEURITE#0.9427;BREAST CANCER#0.6748;ACUTE MYELOID LEUKEMIA#0.6240;MYELOID LEUKEMIA#0.6219;KINASE ACTIVITY#0.6209
2201	ARACHNODACTYLY#1.0646;FIBRILLIN#1.0515;ELASTIC FIBER#1.0242;MICROFIBRIL#1.0202;MARFAN SYNDROME#1.0112;GENE EXPRESSION#0.9978;GROWTH FACTOR#0.9941;EXTRACELLULAR MATRIX#0.9914;CONNECTIVE TISSUE#0.9908;ELASTIC FIBER ASSEMBLY#0.9689;EPITHELIAL CELL#0.9614;TRANSFORMING GROWTH FACTOR#0.9550;DERMAL FIBROBLAST#0.9440;EPIDERMAL GROWTH FACTOR#0.9122;PERIODONTAL LIGAMENT#0.9102;SMOOTH MUSCLE#0.8413;CANCER CELL#0.8374;TRANSFORMING GROWTH FACTOR BETA#0.8332;TRANSCRIPTION FACTOR#0.8265;ELASTIC FIBRE#0.8223;BLOOD VESSEL#0.8184;MORPHOGENESIS#0.8105;BASEMENT MEMBRANE#0.8042;OSTEOBLAST#0.7969;COLORECTAL CANCER#0.7560;PERIPHERAL NERVE#0.7535;CELL ADHESION#0.7510;SCOLIOSIS#0.7470;SYNDACTYLY#0.7260;CELL SURFACE#0.6891;POLYMERASE CHAIN REACTION#0.6880;BONE FORMATION#0.6590;FIBRIL#0.6534;HEPARIN#0.6494;STEM CELL#0.6471;INTRACRANIAL ANEURYSM#0.6250;BONE MORPHOGENETIC PROTEIN#0.6241;CONNECTIVE TISSUE DISEASE#0.6189;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.6084;COLORECTAL#0.6067;WOUND HEALING#0.6016
220202	OPTIC NERVE#1.0421;CELL CYCLE#1.0347;TRANSCRIPTION FACTOR#1.0319;GANGLION CELLS#1.0289;RETINAL PROGENITOR CELL#1.0272;RETINAL GANGLION CELL#1.0248;OPTIC DISC#1.0246;PROGENITOR CELL#1.0133;STEM CELL#0.9834;RETINAL DEVELOPMENT#0.9792;NEUROGENESIS#0.9748;OPEN ANGLE GLAUCOMA#0.9346;AMACRINE CELL#0.9164;PRIMARY OPEN ANGLE GLAUCOMA#0.9154;RETINOGENESIS#0.8618;CELL DEVELOPMENT#0.8615;GENE EXPRESSION#0.8497;RETINAL STEM CELLS#0.8313;CELL DIFFERENTIATION#0.7379;PLURIPOTENT STEM CELL#0.7025;NEURAL RETINA#0.6371;EYE DEVELOPMENT#0.6200
220213	DEUBIQUITINATING ENZYME#0.7696;DEUBIQUITINASE#0.7494;CELL DEATH#0.6151;BREAST CANCER#0.6148
220296	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS#1.0828;CELL ADHESION MOLECULE#1.0824;CANCER CELL#1.0803;CELL ADHESION#1.0770;CELL JUNCTION#1.0744;CELL PROLIFERATION#1.0642;LEUKOENCEPHALOPATHY#1.0610;TRANSITIONAL CELL CARCINOMA#1.0506;CELL GROWTH#1.0455;GLIAL CELL#1.0427;ASTROCYTE#1.0108;RENAL CELL CARCINOMA#0.9986;LEUKODYSTROPHY#0.9915;CHLORIDE CHANNEL#0.9641;BLADDER CARCINOMA#0.9380;TUMOR SUPPRESSOR#0.9353;PROSTATE CANCER#0.9189;POLYMERASE CHAIN REACTION#0.8930;MACROCEPHALY#0.8324;BREAST CARCINOMA#0.8257;PLASMA MEMBRANE#0.7906;ANDROGEN RECEPTOR#0.7782;CELL MOTILITY#0.7679;G1 PHASE#0.7534;GROWTH FACTOR#0.7106;CELL SURFACE#0.7069;GENE EXPRESSION#0.7041;ADJACENT NORMAL TISSUE#0.7018;SIGNALING PATHWAY#0.6907;CELL CELL JUNCTION#0.6570;REVERSE TRANSCRIPTION#0.6422;RENAL CARCINOMA#0.6269;WOUND HEALING#0.6253;HEPATOCELLULAR CARCINOMA#0.6238;ACTIN CYTOSKELETON#0.6169
2202	DOYNE HONEYCOMB RETINAL DYSTROPHY#1.1300;MATRIX PROTEIN 1#1.0825;ANGIOGENESIS#1.0410;EPIDERMAL GROWTH FACTOR#1.0371;GROWTH FACTOR#1.0310;CANCER CELL#1.0305;EXTRACELLULAR MATRIX#1.0302;LUNG CANCER#1.0263;MALIGNANT MESOTHELIOMA#1.0261;MACULAR DEGENERATION#1.0182;CELL PROLIFERATION#1.0114;TUMOR SUPPRESSOR#1.0006;AGE RELATED MACULAR DEGENERATION#0.9998;LYMPH NODE#0.9872;HEPATOCELLULAR CARCINOMA#0.9816;FIBRILLIN#0.9751;GENE EXPRESSION#0.9749;LYMPH NODE METASTASIS#0.9743;POLYMERASE CHAIN REACTION#0.9718;MALIGNANT PLEURAL MESOTHELIOMA#0.9547;ENDOTHELIAL CELL#0.9488;APOPTOSIS#0.9471;BREAST CANCER#0.9369;SIGNALING PATHWAY#0.9253;CONNECTIVE TISSUE#0.9246;CELL GROWTH#0.9217;RETINAL PIGMENT EPITHELIUM#0.8873;DNA METHYLATION#0.8865;OSTEOARTHRITIS#0.8453;CERVICAL CANCER#0.8042;ENDOTHELIAL GROWTH FACTOR#0.8019;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8019;CELL MIGRATION#0.7980;METHYLATION SPECIFIC PCR#0.7972;PANCREATIC CANCER#0.7925;TUMOR CELLS#0.7881;MALIGNANT GLIOMA#0.7842;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.7827;STEM CELL#0.7718;BLOOD VESSEL#0.7704;ANTI EGFR#0.7662;ENDOMETRIAL CARCINOMA#0.7637;PROSTATE CANCER#0.7610;COLORECTAL CANCER#0.7574;5-AZA-2'-DEOXYCYTIDINE#0.7554;2'-DEOXYCYTIDINE#0.7550;ONCOGENIC#0.7547;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7503;EPITHELIAL TO MESENCHYMAL#0.7500;ELASTIC FIBER#0.7351;OVARIAN CANCER#0.7314;CERVICAL#0.7098;CHONDROCYTE#0.6971;CHONDROCYTE DIFFERENTIATION#0.6917;SMOOTH MUSCLE#0.6901;CANCER STEM CELL#0.6821;AKT SIGNALING#0.6800;HYPERTENSION#0.6789;INSULIN-LIKE GROWTH FACTOR#0.6768;HIGH MOBILITY GROUP#0.6571;CELL ADHESION#0.6520;WERNER SYNDROME#0.6493;CELL CYCLE#0.6202;RETINAL DEGENERATION#0.6169;OLFACTORY EPITHELIUM#0.6093;COLORECTAL#0.6079;OVARIAN#0.6074;SMOOTH MUSCLE CELL#0.6071;MUSCLE CELL#0.6063;DUAL LUCIFERASE REPORTER#0.6014
2203	BINDING PROTEIN 1#1.0697;PHOSPHOENOLPYRUVATE CARBOXYKINASE#1.0645;GLUCOSE REPRESSION#1.0621;FOLATE BINDING#1.0503;HYPOXIA#1.0404;FRUCTOSE -6-PHOSPHATE#1.0374;FOLATE#1.0354;FRUCTOSE#1.0331;PHOSPHOENOLPYRUVATE#1.0314;TUMOR SUPPRESSOR#1.0293;GLUCONEOGENESIS#1.0191;BREAST CANCER#1.0159;ISCHEMIA#1.0148;CANCER CELL#1.0123;HEPATOCELLULAR CARCINOMA#1.0103;GLYCERALDEHYDE-3-PHOSPHATE#1.0100;ADENOSINE#1.0089;SIGNALING PATHWAY#1.0080;CELL PROLIFERATION#1.0069;PYRUVATE#1.0069;APOPTOSIS#1.0042;PYRUVATE KINASE#1.0030;TRANSCRIPTION FACTOR#1.0027;GLUCOSE METABOLISM#1.0021;GLYCOLYSIS#1.0007;VIRULENCE#1.0002;CELL CYCLE#0.9920;PROTEIN KINASE#0.9893;CELL GROWTH#0.9834;GLUCOSE-6-PHOSPHATE#0.9824;GENE EXPRESSION#0.9765;DIHYDROXYACETONE#0.9755;HYPOXIC#0.9680;ADENYLATE CYCLASE#0.9643;BREAST CANCER CELL#0.9584;LUNG CANCER#0.9503;PANCREATIC CANCER#0.9439;CATALYTIC ACTIVITY#0.9374;CELL DEATH#0.9358;ADENYLATE#0.9263;ENZYME ACTIVITY#0.9260;DNA BINDING#0.9250;TUMOR TISSUES#0.9153;GLUCOSE UPTAKE#0.9153;GLYCEROL KINASE#0.9071;MUTAGENESIS#0.9021;LIVER CANCER#0.8987;KUPFFER CELL#0.8937;UBIQUITIN#0.8872;GLUCOSE 6 PHOSPHATASE#0.8826;OVARIAN CANCER#0.8825;MYOCYTES#0.8762;PENTOSE PHOSPHATE PATHWAY#0.8752;L LACTATE DEHYDROGENASE#0.8603;ALANINE#0.8567;CYTOPLASM#0.8494;CHLOROPLAST#0.8470;RIBOSE#0.8419;PROTEASOME#0.8416;ENDOTHELIAL CELL#0.8306;T CELL#0.8282;REACTIVE OXYGEN SPECIES#0.8219;HYPOGLYCEMIA#0.8126;KINASE ACTIVITY#0.8093;RENAL CELL CARCINOMA#0.8079;TYPE 2 DIABETES#0.8078;NITRIC OXIDE#0.8058;RIBOSE-5-PHOSPHATE#0.8029;EPITHELIAL CELL#0.7958;CYCLIC AMP#0.7950;TUMOR CELLS#0.7936;CHROMATIN REMODELING#0.7892;ASTROCYTE#0.7892;CEREBRAL ISCHEMIA#0.7845;CARBOHYDRATE METABOLISM#0.7840;PROTEIN KINASE A#0.7812;ADENOSINE TRIPHOSPHATE#0.7736;ADENINE#0.7654;ETHANOL#0.7563;AUTOPHAGY#0.7526;METFORMIN#0.7518;ADENYLATE CYCLASE ACTIVATION#0.7476;LACTIC ACID#0.7455;STEM CELL#0.7424;HYPOXIA INDUCIBLE FACTOR#0.7414;CATABOLITE REPRESSION#0.7400;GLUTATHIONE#0.7373;CLEAR CELL RENAL CELL CARCINOMA#0.7338;MACROPHAGE#0.7298;FBPASE ACTIVITY#0.7279;TGM SILENCING#0.7218;DIPHOSPHATE#0.7217;METABOLIC ACIDOSIS#0.7189;GLUTAMINE#0.7173;EPITHELIAL MESENCHYMAL TRANSITION#0.7063;PROTEIN PROTEIN INTERACTION#0.7059;ADENOSINE MONOPHOSPHATE#0.6989;OVARIAN#0.6985;MALIC ENZYME#0.6969;POLYMERASE CHAIN REACTION#0.6966;NEURAL TUBE CLOSURE#0.6916;TUBE CLOSURE#0.6915;LACTIC ACIDOSIS#0.6869;LYSINE#0.6848;APOPTOTIC#0.6835;ENZYME COMPLEX#0.6818;TUMOR NECROSIS FACTOR#0.6813;CAMP SIGNALING#0.6803;NEURAL TUBE#0.6766;COMPLEX I#0.6755;MITOGEN ACTIVATED PROTEIN#0.6731;ZINC FINGER PROTEIN#0.6727;DISEASE FREE SURVIVAL#0.6715;AMP BINDING#0.6713;INSULIN SECRETION#0.6711;CELL CYCLE ARREST#0.6697;PHOSPHOLIPASE C#0.6669;MITOCHONDRIA#0.6663;PEROXISOME#0.6643;OXIDATIVE PHOSPHORYLATION#0.6565;ACETYL COA CARBOXYLASE#0.6532;DNA METHYLATION#0.6524;SUCCINATE#0.6522;HEAT SHOCK PROTEIN#0.6453;MECHANISM OF ACTION#0.6452;GROWTH FACTOR#0.6411;TCA CYCLE#0.6376;CELL WALL#0.6302;FRUCTOSE BISPHOSPHATE ALDOLASE#0.6184;EXCRETION#0.6177;SEXUAL REPRODUCTION#0.6095;ONCOGENIC#0.6094;MAGNETIC RESONANCE SPECTROSCOPY#0.6081;SMALL INTESTINE#0.6017;INVASIVE GROWTH#0.6009
220441	LIGASE ACTIVITY#0.6902;LYSOSOME#0.6512;FLOOR PLATE#0.6503
2204	MYELOID CELL#1.0610;IGA BINDING#1.0567;EOSINOPHIL#1.0426;NEUTROPHIL#1.0297;MONOCYTE#1.0259;MACROPHAGE#1.0242;MESANGIAL CELL#1.0210;LEUKOCYTE#1.0203;NEPHROPATHY#1.0115;PHAGOCYTOSIS#1.0055;IMMUNE RESPONSE#0.9936;CELL KILLING#0.9886;TRANSFERRIN RECEPTOR#0.9634;GROWTH FACTOR#0.9304;INFLAMMATORY RESPONSE#0.9298;T CELL#0.9297;LYSIS#0.9295;DENDRITIC CELL#0.9229;CELL SURFACE#0.9196;ANTIGEN PRESENTATION#0.9188;PERIPHERAL BLOOD#0.9103;CYTOTOXICITY#0.9006;B CELL#0.8950;CELL ACTIVATION#0.8878;GRANULOCYTE#0.8864;KUPFFER CELL#0.8859;GLOMERULONEPHRITIS#0.8858;ASIALOGLYCOPROTEIN RECEPTOR#0.8827;IMMUNE SYSTEM#0.8182;N GLYCAN#0.8123;PROTEIN KINASE#0.8094;POLYMORPHONUCLEAR NEUTROPHIL#0.7975;SIGNAL TRANSDUCTION#0.7844;G-CSF#0.7787;MESANGIUM#0.7674;COLONY-STIMULATING FACTOR#0.7314;IMMUNE CELL#0.7311;PROTEINURIA#0.7122;POLYMORPHONUCLEAR LEUKOCYTES#0.7081;MANNOSE RECEPTOR#0.7075;GROWTH FACTOR RECEPTOR#0.6827;MONONUCLEAR CELLS#0.6801;TUMOR NECROSIS FACTOR#0.6740;GLYCOSYLATION#0.6634;CYTOKINE PRODUCTION#0.6592;LEUKOCYTE RECEPTOR COMPLEX#0.6483;RESPIRATORY BURST#0.6376;GM-CSF#0.6358;GENE EXPRESSION#0.6151;RECEPTOR COMPLEX#0.6138;SURFACTANT PROTEIN D#0.6126;GRANULOCYTE COLONY STIMULATING FACTOR#0.6109
2205	IGE BINDING#1.0329;BASOPHIL#1.0247;IGE RECEPTOR#1.0202;MAST CELL#1.0198;CELL SURFACE#1.0042;PERIPHERAL BLOOD#0.9836;HISTAMINE#0.9678;DENDRITIC CELL#0.9593;URTICARIA#0.9413;CELL ACTIVATION#0.9385;GENE EXPRESSION#0.9236;IMMUNE RESPONSE#0.8986;EOSINOPHIL#0.8930;POLYMERASE CHAIN REACTION#0.8811;ALLERGIC REACTION#0.8705;ATOPIC DERMATITIS#0.8704;T CELL#0.8329;ALLERGIC RHINITIS#0.8271;ALLERGEN#0.8172;TRANSCRIPTION FACTOR#0.8004;MACROPHAGE#0.7809;DERMATITIS#0.7463;LANGERHANS CELL#0.7199;RHINITIS#0.7152;SIGNAL TRANSDUCTION#0.7142;MAST CELL ACTIVATION#0.7073;REVERSE TRANSCRIPTION#0.6808;OMALIZUMAB#0.6722;BONE MARROW#0.6540;STEM CELL#0.6236;MONOCYTE#0.6155
2206	FOOD ALLERGY#1.0155;IGE RECEPTOR#1.0110;SKIN PRICK TESTING#1.0086;ECZEMA#1.0068;WHEEZING#1.0036;MAST CELL#1.0022;ATOPIC DERMATITIS#1.0021;SKIN PRICK TEST#1.0016;DERMATITIS#1.0011;ALLERGIC RHINITIS#0.9996;RHINITIS#0.9976;ALLERGEN#0.9913;CONTACT DERMATITIS#0.9900;SENSITIZATION#0.9852;HYPERSENSITIVITY#0.9839;T CELL#0.9797;IMMUNE RESPONSE#0.9778;EOSINOPHIL#0.9776;URTICARIA#0.9604;METHACHOLINE#0.9591;CYSTIC FIBROSIS#0.9542;HISTAMINE#0.9536;NITRIC OXIDE#0.9522;EXHALED NITRIC OXIDE#0.9511;BASOPHIL#0.9465;ALLERGIC ASTHMA#0.9416;ALLERGIC REACTION#0.9415;IMMUNE SYSTEM#0.9411;LATEX ALLERGY#0.9384;FORCED EXPIRATORY VOLUME#0.9331;RESPIRATORY TRACT#0.9145;BRONCHITIS#0.9097;ASPIRIN#0.8945;PERIPHERAL BLOOD#0.8940;ALOPECIA AREATA#0.8934;ANAPHYLAXIS#0.8810;IRRITANT#0.8737;SKIN DISEASE#0.8594;VIRAL INFECTION#0.8496;OTITIS MEDIA#0.8364;ADJUSTED ODDS RATIO#0.8306;MILK ALLERGY#0.8204;RESPIRATORY TRACT INFECTION#0.8088;IGE ANTIBODY#0.8064;IFN-GAMMA#0.7928;ALOPECIA#0.7882;EOSINOPHILIC ESOPHAGITIS#0.7817;ALLERGIC CONTACT DERMATITIS#0.7800;ANTI INFLAMMATORY DRUGS#0.7582;RESPIRATORY ALLERGY#0.7551;CYTOKINE PRODUCTION#0.7416;NEPHROTIC SYNDROME#0.7382;AUTOIMMUNITY#0.7362;CORD BLOOD#0.7245;KERATOCONUS#0.7239;T LYMPHOCYTE#0.7137;BRONCHIOLITIS#0.7100;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6878;POLYMERASE CHAIN REACTION#0.6861;DRUG ALLERGY#0.6732;OTITIS MEDIA WITH EFFUSION#0.6724;FORCED VITAL CAPACITY#0.6721;NON HODGKIN LYMPHOMA#0.6708;GENE EXPRESSION#0.6675;LUNG CANCER#0.6642;ESOPHAGITIS#0.6639;FRAGMENT LENGTH POLYMORPHISM#0.6579;B CELL#0.6536;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6456;DIABETES MELLITUS#0.6413;PSORIASIS#0.6295;PNEUMONIA#0.6219;CONJUNCTIVITIS#0.6177;IL-4 PRODUCTION#0.6085;ANGIOEDEMA#0.6016
2207	TCR COMPLEX#1.0504;MYELOID CELL#1.0094;MAST CELL#1.0075;IGE RECEPTOR#1.0026;SIGNAL TRANSDUCTION#1.0015;B CELL#1.0010;SRC FAMILY KINASE#1.0006;CELL SURFACE#0.9980;T CELL#0.9948;NEUTROPHIL#0.9937;COLLAGEN RELATED PEPTIDE#0.9930;SIGNALING PATHWAY#0.9926;PLATELET ACTIVATION#0.9914;DENDRITIC CELL#0.9911;BONE MARROW#0.9890;MACROPHAGE#0.9884;PHOSPHOLIPASE C#0.9844;IFN-GAMMA#0.9836;MONOCYTE#0.9816;PLATELET AGGREGATION#0.9790;IMMUNE RESPONSE#0.9782;OSTEOCLAST#0.9729;PHAGOCYTOSIS#0.9690;LEUKOCYTE#0.9623;GENE EXPRESSION#0.9601;PERIPHERAL BLOOD#0.9532;RECEPTOR COMPLEX#0.9511;CYTOTOXICITY#0.9475;LECTIN#0.9361;LIPID RAFT#0.9356;COMPLEX I#0.9281;PROTEIN TYROSINE KINASE#0.9214;CYTOKINE PRODUCTION#0.9157;SIGNALING MOLECULE#0.9156;IMMUNE SYSTEM#0.9132;T LYMPHOCYTE#0.9118;INFLAMMATORY RESPONSE#0.8984;THYMOCYTE#0.8979;ANTIGEN PRESENTATION#0.8927;MESANGIAL CELL#0.8904;CELL ACTIVATION#0.8808;BASOPHIL#0.8786;IL-2 PRODUCTION#0.8731;THROMBOSIS#0.8683;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8666;LUPUS ERYTHEMATOSUS#0.8663;NATURAL KILLER CELL#0.8569;CELL DEVELOPMENT#0.8447;HEMATOPOIETIC CELL#0.8365;PRECURSOR CELL#0.8319;TRANSCRIPTION FACTOR#0.8271;GLOMERULONEPHRITIS#0.8238;CELL ADHESION#0.8182;IMMUNE CELL#0.8110;T CELL DEVELOPMENT#0.8072;TUMOR NECROSIS FACTOR#0.8008;TREG CELL#0.7993;PLASMA MEMBRANE#0.7964;KINASE INHIBITOR#0.7938;SIGNALING CASCADE#0.7874;OSTEOCLAST DIFFERENTIATION#0.7861;ENDOTHELIAL CELL#0.7775;COMPLEMENT RECEPTOR#0.7691;CD4+ T CELL#0.7672;INNATE IMMUNE RESPONSE#0.7464;CALCIUM MOBILIZATION#0.7342;AUTOIMMUNE DISEASE#0.7263;IMMUNOGLOBULIN G#0.7062;CELL ADHESION MOLECULE#0.7028;MEGAKARYOCYTE#0.7026;IGE BINDING#0.6872;THROMBOCYTOPENIA#0.6857;GAMMA DELTA T CELL#0.6854;ALLERGEN#0.6715;BONE MARROW CELLS#0.6568;OSTEOCLAST DEVELOPMENT#0.6531;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6498;B LYMPHOCYTE#0.6482;TUMOR CELLS#0.6443;CELL PROLIFERATION#0.6432;FIBRINOGEN#0.6285;APOPTOSIS#0.6208;INNATE IMMUNITY#0.6204;POLYMERASE CHAIN REACTION#0.6147;LYMPH NODE#0.6128;IGG ANTIBODY#0.6116;ERYTHROCYTE#0.6094;ANTIGEN PRESENTING CELLS#0.6048;EOSINOPHIL#0.6034;HEMOSTASIS#0.6007
220832	CELL PROLIFERATION#1.1787
2208	LECTIN#1.0344;INTESTINAL EPITHELIAL CELL#1.0337;IGE RECEPTOR#1.0336;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0293;CLL/SLL#1.0281;TRANSFERRIN RECEPTOR#1.0269;FOLLICULAR B CELL#1.0248;NITRIC OXIDE#1.0245;PERIPHERAL BLOOD MONOCYTES#1.0240;CELL ASSOCIATED#1.0220;IGE BINDING#1.0208;ANTIGEN PRESENTATION#1.0195;SURFACE IGM#1.0150;ALLERGIC ASTHMA#1.0145;TRANSITIONAL B CELL#1.0129;CORD BLOOD#1.0105;PERIPHERAL BLOOD LYMPHOCYTES#1.0078;GM-CSF#1.0070;EPITHELIAL CELL#1.0057;ALVEOLAR MACROPHAGE#1.0052;LANGERHANS CELL#1.0051;IGE ANTIBODY#1.0049;EOSINOPHIL#1.0047;BETA-2#1.0043;BASOPHIL#1.0037;ALLERGIC RHINITIS#1.0022;ACTIVATED B CELL#1.0014;MONOCYTE#0.9996;B CELL ACTIVATION#0.9994;IFN-GAMMA#0.9991;RHEUMATOID ARTHRITIS#0.9991;RHINITIS#0.9990;B CELL PROLIFERATION#0.9987;CELL SURFACE#0.9983;LYMPHOCYTE ACTIVATION#0.9980;SELECTIN#0.9956;HEMATOPOIETIC CELL#0.9955;B CELL#0.9946;TUMOR CELLS#0.9945;RESPONSE TO IL-4#0.9945;ALLERGEN#0.9933;ATOPIC DERMATITIS#0.9931;COLONY-STIMULATING FACTOR#0.9919;B CELL DIFFERENTIATION#0.9915;TRANSFORMING GROWTH FACTOR#0.9915;MARGINAL ZONE B#0.9910;L-ARGININE#0.9910;MARGINAL ZONE B CELL#0.9908;SIGNAL TRANSDUCTION#0.9899;TUMOR NECROSIS FACTOR#0.9899;CD8+ T CELL#0.9896;INTERLEUKIN 2 RECEPTOR#0.9895;CELL ACTIVATION#0.9893;CELL SURFACE ANTIGEN#0.9888;FOLLICULAR DENDRITIC CELL#0.9888;SIGNALING PATHWAY#0.9888;DERMATITIS#0.9885;BURKITT LYMPHOMA#0.9884;MACROPHAGE#0.9881;MAST CELL#0.9880;T CELL ACTIVATION#0.9879;ALLERGIC REACTION#0.9873;SMOOTH MUSCLE#0.9867;SYNOVIAL FLUID#0.9866;SENSITIZATION#0.9865;LEUKOCYTE#0.9864;GRANULOCYTE#0.9861;ANTIGEN PRESENTING CELLS#0.9858;CELL GROWTH#0.9856;COMPLEMENT RECEPTOR#0.9854;DNA SYNTHESIS#0.9853;MALT LYMPHOMA#0.9853;CELL DEVELOPMENT#0.9852;CD4+ T CELL#0.9842;CELL MATURATION#0.9839;B LYMPHOCYTE#0.9834;LYMPHOPROLIFERATIVE DISEASE#0.9832;IMMUNE CELL#0.9830;INFLAMMATORY RESPONSE#0.9829;CELL DIFFERENTIATION#0.9826;PROTEIN KINASE C#0.9824;GROWTH FACTOR#0.9822;FOLLICULAR DENDRITIC CELL SARCOMA#0.9817;PRO-INFLAMMATORY#0.9814;CYTOKINE PRODUCTION#0.9813;PROTEIN KINASE#0.9803;DENDRITIC CELL SARCOMA#0.9802;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9802;LUPUS ERYTHEMATOSUS#0.9800;B CELL RECEPTOR#0.9799;LYMPHOID CELL#0.9786;TONSIL#0.9780;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9780;FOLLICULAR LYMPHOMA#0.9780;MARGINAL ZONE LYMPHOMA#0.9778;B CELL DEVELOPMENT#0.9778;MANTLE CELL LYMPHOMA#0.9777;DENDRITIC CELL#0.9777;T HELPER CELL#0.9775;ISOTYPE SWITCHING#0.9773;GENE EXPRESSION#0.9759;T CELL PROLIFERATION#0.9753;CELL PROLIFERATION#0.9750;EPSTEIN BARR VIRUS#0.9747;APOPTOSIS#0.9742;T LYMPHOCYTE#0.9741;GERMINAL CENTER B#0.9740;GERMINAL CENTER#0.9740;ACTIVATED T-CELLS#0.9731;ACTIVATED T CELL#0.9727;MONONUCLEAR CELLS#0.9727;HODGKIN'S LYMPHOMA#0.9724;HAIRY CELL LEUKEMIA#0.9722;TRANSCRIPTION FACTOR#0.9721;PLASMA CELL#0.9721;NITRIC OXIDE SYNTHASE#0.9720;GERMINAL CENTER B CELL#0.9720;NEUTROPHIL#0.9718;HUMAN INTESTINAL EPITHELIAL#0.9718;SURFACE IGD#0.9717;DIFFUSE LARGE B-CELL LYMPHOMA#0.9716;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9714;CELL CYCLE#0.9712;ANTIBODY PRODUCTION#0.9710;NON HODGKIN LYMPHOMA#0.9709;LYMPHOCYTIC LEUKEMIA#0.9708;HISTAMINE#0.9707;T CELL#0.9687;MEMORY B CELL#0.9684;IMMUNE SYSTEM#0.9682;PERIPHERAL BLOOD#0.9681;TH2 CELL#0.9680;ARGININE#0.9680;CELL MEMBRANE#0.9680;INFLAMMATORY CELL#0.9679;POLYMERASE CHAIN REACTION#0.9669;STEM CELL#0.9668;NODULAR#0.9661;CLASS SWITCHING#0.9651;TRANSFORMING GROWTH FACTOR BETA#0.9648;TNF-ALPHA PRODUCTION#0.9644;ENDOTHELIAL CELL#0.9640;B CELL LYMPHOMA#0.9639;TUMOUR NECROSIS FACTOR#0.9630;IMMUNE RESPONSE#0.9628;LYMPHOID TISSUE#0.9624;AUTOIMMUNE DISEASE#0.9621;BONE MARROW#0.9600;CYTOTOXICITY#0.9599;LYMPH NODE#0.9599;HYPERSENSITIVITY#0.9590;KERATINOCYTE#0.9534;GROWTH PATTERN#0.9518;CYTOPLASM#0.9511;KAWASAKI DISEASE#0.9468;RITUXIMAB#0.9446;CELL DEATH#0.9423;APOPTOTIC#0.9398;DNA BINDING#0.9387;NAIVE B CELL#0.9373;LYMPHOCYTE DOUBLING TIME#0.9353;OMALIZUMAB#0.9352;SPLENIC MARGINAL ZONE LYMPHOMA#0.9343;THYMIDINE#0.9335;LYMPHOMA CELL LINES#0.9329;MULTIPLE MYELOMA#0.9305;B LYMPHOCYTE ACTIVATION#0.9293;FORMALIN#0.9274;FLOW CYTOMETRY ANALYSIS#0.9272;RECEPTOR ANTAGONIST#0.9262;REVERSE TRANSCRIPTION#0.9172;STROMAL CELL#0.9151;LYMPHOPLASMACYTIC LYMPHOMA#0.9148;PHAGOCYTOSIS#0.9142;ENDOCYTOSIS#0.9072;CELL ADHESION#0.9065;MARGINAL ZONE B-CELL LYMPHOMA#0.9046;HUMAN IMMUNODEFICIENCY VIRUS#0.8998;MONOCYTE ACTIVATION#0.8975;LYMPHOBLAST#0.8960;RECEPTOR BINDING#0.8915;CERVICAL#0.8878;ANEMIA#0.8856;SIGNALLING PATHWAY#0.8852;IL-1RA#0.8847;GASTROINTESTINAL TRACT#0.8845;CUTANEOUS LEISHMANIASIS#0.8843;GROWTH FACTOR RECEPTOR#0.8822;MALARIA#0.8805;PROLYMPHOCYTIC LEUKEMIA#0.8793;TRANSCYTOSIS#0.8789;SMOOTH MUSCLE ACTIN#0.8778;MEAN FLUORESCENCE INTENSITY#0.8766;PROTEIN SYNTHESIS#0.8745;REGULATORY T CELL#0.8744;IL-10 PRODUCTION#0.8710;LYMPHOID ORGANS#0.8708;CELL BOUND#0.8694;MALIGNANT LYMPHOMA#0.8603;WHITE BLOOD CELL#0.8591;ERYTHROCYTE#0.8589;BONE MARROW CELLS#0.8582;FINE NEEDLE ASPIRATION#0.8580;IMMUNOGLOBULIN PRODUCTION#0.8578;IL-4 PRODUCTION#0.8576;RETINOIC ACID#0.8565;NATURAL KILLER CELL#0.8558;NF-KAPPAB ACTIVATION#0.8546;NERVOUS SYSTEM#0.8543;BONE MARROW ASPIRATE#0.8530;INFECTIOUS MONONUCLEOSIS#0.8525;THYMOCYTE#0.8509;ADENOSINE#0.8503;URTICARIA#0.8481;CERVICAL LYMPH NODE#0.8449;FLOW CYTOMETRIC IMMUNOPHENOTYPING#0.8444;IGM ANTIBODY#0.8440;ALKALINE PHOSPHATASE#0.8408;PERIPHERAL BLOOD CELLS#0.8407;MYELOID CELL#0.8392;FLUDARABINE#0.8365;MACROGLOBULINEMIA#0.8339;CENTRAL NERVOUS SYSTEM#0.8336;GLYCOSYLATION#0.8335;DERMIS#0.8331;ACTIVATED CD4+ T CELL#0.8312;AUTOIMMUNITY#0.8261;SURFACE IGE#0.8194;STEM CELL TRANSPLANTATION#0.8163;PROGENITOR CELL#0.8153;PERITONEAL CAVITY#0.8083;BULLOUS PEMPHIGOID#0.8032;PERIPHERAL BLOOD T-CELLS#0.8021;CYCLIC AMP#0.8015;SIGNAL TRANSDUCER#0.7957;PROTEIN TYROSINE KINASE#0.7942;TOLL LIKE RECEPTOR#0.7941;COLLAGEN INDUCED ARTHRITIS#0.7940;CYCLOPHOSPHAMIDE#0.7915;STROMA#0.7847;ASIALOGLYCOPROTEIN RECEPTOR#0.7843;NASAL MUCOSA#0.7842;B-LYMPHOBLAST#0.7836;ALLERGIC AIRWAY INFLAMMATION#0.7835;GRAVES' DISEASE#0.7814;TERMINAL DIFFERENTIATION#0.7813;SURFACE PLASMON RESONANCE#0.7797;PROSTAGLANDIN E2#0.7797;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7791;RNA SYNTHESIS#0.7675;PLATELET ACTIVATING FACTOR#0.7652;CLASS SWITCH RECOMBINATION#0.7646;LYMPHOCYTE DEVELOPMENT#0.7633;CELL AGGREGATION#0.7630;LEUPROLIDE ACETATE#0.7626;MESENTERIC LYMPH NODE#0.7599;S PHASE#0.7596;ENDOMETRIOSIS#0.7582;CYTOKINE SECRETION#0.7565;INTERNATIONAL PROGNOSTIC INDEX#0.7525;GALECTIN#0.7507;PLASMA MEMBRANE#0.7501;NEPHROTIC SYNDROME#0.7495;TRANSACTIVATION#0.7493;REGULATORY B CELL#0.7486;KINASE INHIBITOR#0.7485;SCHISTOSOMIASIS#0.7459;LYMPHOBLASTOID CELLS#0.7430;TYPE 1 DIABETES#0.7426;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7420;CALCIUM MOBILIZATION#0.7413;TREG CELL#0.7376;BATIMASTAT#0.7374;DEXAMETHASONE#0.7366;MONOCYTE DERIVED DENDRITIC CELL#0.7364;ELECTROPHORETIC MOBILITY SHIFT#0.7347;ENTEROCYTE#0.7337;ECZEMA#0.7336;MAGNETIC RESONANCE IMAGING#0.7322;CEREBRAL MALARIA#0.7304;BASOPHIL ACTIVATION#0.7281;FOOD ALLERGY#0.7273;CYTIDINE DEAMINASE#0.7254;EXTRACELLULAR REGION#0.7231;IL-6 PRODUCTION#0.7227;LYMPHOCYTE PROLIFERATION#0.7218;LEISHMANIASIS#0.7218;IONOPHORE#0.7191;THYMIDINE KINASE#0.7189;CHEMOKINE RECEPTOR#0.7185;TRANSEPITHELIAL TRANSPORT#0.7161;C REACTIVE PROTEIN#0.7144;HUMAN LEUKOCYTE ANTIGEN#0.7140;EFFECTOR T CELL#0.7132;B1 CELL#0.7126;EPIDERMAL GROWTH FACTOR#0.7093;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7063;INFLAMMATORY BOWEL DISEASE#0.7059;HUMAN UMBILICAL VEIN#0.7058;UMBILICAL VEIN#0.7056;SALBUTAMOL#0.7054;PREDNISONE#0.7050;THROMBOCYTOPENIA#0.7034;ANAPLASTIC LARGE CELL LYMPHOMA#0.7017;CARBOHYDRATE RECOGNITION DOMAIN#0.7009;GESTATION#0.6976;MRNA TRANSCRIPTION#0.6965;G1 PHASE#0.6957;RED BLOOD CELL#0.6944;ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA#0.6856;FLOW CYTOMETRY IMMUNOPHENOTYPING#0.6837;OTITIS MEDIA WITH EFFUSION#0.6820;METALLOPROTEASE INHIBITOR#0.6819;MYASTHENIA GRAVIS#0.6782;IMMUNOGLOBULIN RECEPTOR#0.6779;SEVERE COMBINED IMMUNODEFICIENCY#0.6750;CYTOKINE RECEPTOR#0.6724;POSITIVE PREDICTIVE VALUE#0.6715;EXOSOME#0.6703;PROGRAMMED CELL DEATH#0.6686;OTITIS MEDIA#0.6680;INTERLEUKIN 4 RECEPTOR#0.6677;PREDNISOLONE#0.6649;LYMPHOID LEUKEMIA#0.6648;AMYLOID PRECURSOR PROTEIN#0.6567;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6520;CYTOPLASMIC REGION#0.6499;BIOTIN#0.6487;FENOTEROL#0.6474;MILK PROTEIN#0.6469;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.6466;CELL FRACTION#0.6463;MONOCYTE DERIVED MACROPHAGE#0.6456;PLASMA CELL MYELOMA#0.6440;VITAMIN D3#0.6436;PROTEASE ACTIVITY#0.6435;MYELODYSPLASTIC SYNDROME#0.6435;GOBLET CELL#0.6433;IMMUNOGLOBULIN G#0.6426;VINCRISTINE#0.6395;CELL ADHESION MOLECULE#0.6392;CANCER CELL#0.6344;LYMPHOCYTE DIFFERENTIATION#0.6338;PLASMABLAST#0.6324;VIRAL GENE EXPRESSION#0.6321;HUMORAL IMMUNE RESPONSE#0.6320;FLUORESCEIN#0.6291;HUMAN LEUCOCYTE ANTIGEN#0.6261;GENISTEIN#0.6256;CHRONIC IDIOPATHIC URTICARIA#0.6247;MUTAGENESIS#0.6244;IDIOPATHIC URTICARIA#0.6238;GASTRIC LYMPHOMA#0.6222;ANAPLASTIC LYMPHOMA KINASE#0.6211;CARBOHYDRATE BINDING#0.6204;SALIVARY GLAND#0.6199;MULTIPLE SCLEROSIS#0.6198;ACTIVATED T LYMPHOCYTES#0.6192;LYMPHOCYTE ANTIGEN#0.6179;EXTRINSIC ALLERGIC ALVEOLITIS#0.6164;INTERPHASE#0.6150;LENALIDOMIDE#0.6137;IGG4 ANTIBODY#0.6134;SIGNAL PEPTIDE#0.6130;TH1 CELL#0.6111;SKIN DISEASE#0.6108;WORLD HEALTH ORGANIZATION#0.6106;NERVE GROWTH FACTOR#0.6101;NEPHROPATHY#0.6099;L-CITRULLINE#0.6086;CYTIDINE#0.6076;COLITIS#0.6074;PERTUSSIS#0.6061;ESTROGEN RECEPTOR#0.6055;DERMAL DENDRITIC CELLS#0.6048;EOSIN#0.6040;EOSINOPHIL ACTIVATION#0.6039;IL-1 BETA PRODUCTION#0.6027;ALEMTUZUMAB#0.6008
220929	ANDROGEN RECEPTOR#0.8049;GENE EXPRESSION#0.6829
220930	CANCER CELL#1.1149;CELL PROLIFERATION#1.0728;LYMPH NODE#1.0381;APOPTOSIS#1.0366;E BOX BINDING#1.0151;LYMPH NODE METASTASIS#1.0102;ANTISENSE RNA#0.9985;POLYMERASE CHAIN REACTION#0.9640;QUANTITATIVE REAL TIME#0.9342;COLORECTAL CANCER#0.9216;LUNG CANCER#0.8806;COLORECTAL#0.8289;CERVICAL CANCER#0.8009;CELL GROWTH#0.8001;TUMOR TISSUES#0.7795;EPITHELIAL MESENCHYMAL TRANSITION#0.7795;ONCOGENIC#0.7784;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7262;EPITHELIAL TO MESENCHYMAL#0.7259;CELL MIGRATION#0.7080;SIGNALING PATHWAY#0.7014;RECURRENCE FREE SURVIVAL#0.6618;REVERSE TRANSCRIPTION#0.6532;HEPATOCELLULAR CARCINOMA#0.6351;SQUAMOUS CELL CARCINOMA#0.6263;CAROTID ARTERY ATHEROSCLEROSIS#0.6079;CERVICAL#0.6061
220963	URIC ACID#0.9323;SERUM URIC ACID#0.8082;URATE#0.6504;CARNITINE#0.6258;CREATINE TRANSPORTER#0.6087
220965	PROSTATE CANCER#0.9014
220972	UBIQUITIN#1.0592;IMMUNE RESPONSE#1.0294;T CELL#0.9995;CANCER CELL#0.8258;CD4+ T CELL#0.8209;APOPTOSIS#0.7931;VIRION#0.7609;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7291;LYSINE#0.7091;CELL SURFACE#0.6989;SIGNALING PATHWAY#0.6961;ESTIMATED BREEDING VALUES#0.6658;T CELL SELECTION#0.6606;ANTIGEN PRESENTATION#0.6379;DENDRITIC CELL#0.6195
220988	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.7926
2209	IMMUNOTOXIN#1.0370;IGG BINDING#1.0368;NEUTROPHIL#1.0149;IFN-GAMMA#1.0140;NEGATIVE PREDICTIVE VALUE#1.0135;G-CSF#1.0094;VIRAL INFECTION#1.0090;WHITE BLOOD CELL#1.0084;MAST CELL#1.0077;COMPLEMENT RECEPTOR#1.0076;POLYMORPHONUCLEAR NEUTROPHIL#1.0071;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0070;HUMAN LEUKOCYTE ANTIGEN#1.0058;RESPIRATORY BURST#1.0033;MYELOID CELL#1.0025;C REACTIVE PROTEIN#1.0023;PNEUMONIA#1.0004;RED BLOOD CELL#1.0003;SIGNAL TRANSDUCTION#0.9977;MONOCYTE#0.9977;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9976;LYSIS#0.9965;CELL ACTIVATION#0.9955;INTENSIVE CARE UNIT#0.9945;IMMUNOGLOBULIN G#0.9934;GM-CSF#0.9911;RHEUMATOID ARTHRITIS#0.9902;ERYTHROCYTE#0.9899;TUMOR CELLS#0.9895;PERIPHERAL BLOOD MONOCYTES#0.9889;MACROPHAGE#0.9876;GRANULOCYTE COLONY STIMULATING FACTOR#0.9865;PHAGOCYTOSIS#0.9864;CYTOTOXICITY#0.9852;CELL SURFACE#0.9842;LEUKOCYTE#0.9831;EOSINOPHIL#0.9824;GRANULOCYTE#0.9822;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9816;CELL PROLIFERATION#0.9816;PRO-INFLAMMATORY#0.9807;ACUTE MYELOID LEUKEMIA#0.9802;GROWTH FACTOR#0.9794;PROTEIN TYROSINE KINASE#0.9792;MEAN FLUORESCENCE INTENSITY#0.9791;B CELL#0.9787;MONONUCLEAR CELLS#0.9780;T LYMPHOCYTE#0.9779;MYELOID LEUKEMIA#0.9766;T CELL#0.9757;ENDOTHELIAL CELL#0.9752;MONOCYTE DERIVED MACROPHAGE#0.9750;DENDRITIC CELL#0.9745;TUBERCULOSIS#0.9744;TUMOR NECROSIS FACTOR#0.9744;APOPTOSIS#0.9725;POLYMORPHONUCLEAR LEUKOCYTES#0.9716;PERIPHERAL BLOOD#0.9710;AUTOIMMUNE DISEASE#0.9701;T CELL ACTIVATION#0.9695;COLONY-STIMULATING FACTOR#0.9694;TOLL LIKE RECEPTOR#0.9690;BONE MARROW#0.9677;INFLAMMATORY RESPONSE#0.9676;OXIDATIVE BURST#0.9663;GENE EXPRESSION#0.9653;ANTIGEN PRESENTING CELLS#0.9639;DEXAMETHASONE#0.9629;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9609;LUPUS ERYTHEMATOSUS#0.9607;IMMUNE RESPONSE#0.9593;IMMUNE CELL#0.9592;ANTIGEN PRESENTATION#0.9574;CYTOKINE PRODUCTION#0.9564;SIGNALING PATHWAY#0.9561;POLYMERASE CHAIN REACTION#0.9550;CORD BLOOD#0.9528;SYNOVIAL FLUID#0.9514;STEM CELL#0.9513;NEUTROPHIL ACTIVATION#0.9482;IMMUNE SYSTEM#0.9468;SYSTEMIC INFLAMMATORY RESPONSE#0.9462;CLASSICAL MONOCYTE#0.9462;T CELL PROLIFERATION#0.9460;REACTIVE OXYGEN SPECIES#0.9435;COMPLETE BLOOD COUNT#0.9406;HUMAN IMMUNODEFICIENCY VIRUS#0.9362;CELL MEMBRANE#0.9344;ENDOCYTOSIS#0.9342;CROHN'S DISEASE#0.9286;SCAVENGER RECEPTOR#0.9280;LYMPH NODE#0.9258;FLOW CYTOMETRY ANALYSIS#0.9247;PROTEIN KINASE#0.9231;BLAST CELL#0.9222;B LYMPHOCYTE#0.9208;SELECTIN#0.9185;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME#0.9168;PROGENITOR CELL#0.9160;CD8+ T CELL#0.9156;NADPH OXIDASE#0.9098;TRANSCRIPTION FACTOR#0.9070;MACROPHAGE ACTIVATION#0.9058;CELL SURFACE ANTIGEN#0.9007;ERYTHROCYTE SEDIMENTATION RATE#0.8980;IL-6 PRODUCTION#0.8952;LIPOPOLYSACCHARIDE BINDING#0.8925;PLASMA MEMBRANE#0.8917;EPIDERMAL GROWTH FACTOR#0.8902;MONOCYTE ACTIVATION#0.8894;ACTIVATED MONOCYTES#0.8814;CELL ADHESION#0.8753;DNA BINDING#0.8729;SIGNALLING PATHWAY#0.8716;KINASE ACTIVITY#0.8669;CD4+ T CELL#0.8664;CELL DEATH#0.8629;POSITIVE PREDICTIVE VALUE#0.8615;NATURAL KILLER CELL#0.8611;BASOPHIL#0.8601;BETA-2#0.8598;NITRIC OXIDE#0.8537;CD14++CD16- MONOCYTE#0.8498;CHEMOKINE RECEPTOR#0.8472;MULTIPLE SCLEROSIS#0.8470;BACTERIAL PNEUMONIA#0.8468;CALCIUM MOBILIZATION#0.8465;ALVEOLAR MACROPHAGE#0.8462;GROWTH FACTOR RECEPTOR#0.8462;M2 MACROPHAGE#0.8437;ALZHEIMER'S DISEASE#0.8421;CANCER CELL#0.8402;BREAST CANCER#0.8343;PROTEIN KINASE C#0.8340;PROTEIN TYROSINE PHOSPHATASE#0.8338;ROSETTING#0.8331;ENDOTHELIUM#0.8252;INFLAMMATORY CELL#0.8225;LATE ONSET SEPSIS#0.8193;M1 MACROPHAGE#0.8192;IGE RECEPTOR#0.8186;GLYCOSYLATION#0.8177;PHOSPHOLIPASE C#0.8098;HEMATOPOIETIC CELL#0.8095;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8078;TUMOUR NECROSIS FACTOR#0.7983;RECEPTOR COMPLEX#0.7977;CELL KILLING#0.7975;KINASE INHIBITOR#0.7958;APOPTOTIC#0.7953;TRANSFORMING GROWTH FACTOR#0.7953;RECEPTOR BINDING#0.7927;SENSITIZATION#0.7920;REVERSE TRANSCRIPTION#0.7897;ACUTE LEUKEMIA#0.7758;INFLAMMATORY MONOCYTE#0.7701;INFLAMMATORY BOWEL DISEASE#0.7628;PERITONITIS#0.7625;SPONTANEOUS BACTERIAL PERITONITIS#0.7621;NEUTROPENIA#0.7565;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.7439;VASCULITIS#0.7396;MONOCYTE DIFFERENTIATION#0.7351;SPUTUM#0.7342;NITRIC OXIDE SYNTHASE#0.7333;EPITHELIAL CELL#0.7269;CYTOLYSIS#0.7252;ATOPIC DERMATITIS#0.7244;REGULATORY T CELL#0.7206;CELL ADHESION MOLECULE#0.7199;TOXICITY#0.7181;LOW DENSITY LIPOPROTEIN#0.7180;CELL ASSOCIATED#0.7179;MENINGITIS#0.7161;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7158;INFLIXIMAB#0.7081;CELL DIFFERENTIATION#0.7063;FLUORESCEIN#0.7028;ACTIVATED T-CELLS#0.6985;POINT OF CARE#0.6985;ACTIVATED T CELL#0.6982;TRANSFORMING GROWTH FACTOR BETA#0.6963;TNF SECRETION#0.6950;SURFACE PLASMON RESONANCE#0.6942;TRANSFERRIN RECEPTOR#0.6936;OVARIAN#0.6892;LANGERHANS CELL#0.6873;OXIDATIVE METABOLISM#0.6870;INNATE IMMUNE RESPONSE#0.6835;LOW BIRTH WEIGHT#0.6814;MUTAGENESIS#0.6802;RICIN#0.6778;MYELODYSPLASTIC SYNDROME#0.6740;TRANSCRIPTASE#0.6734;FLOW CYTOMETRIC IMMUNOPHENOTYPING#0.6733;NEPHRITIS#0.6732;NEOPTERIN#0.6728;TYROSINE KINASE INHIBITOR#0.6705;HEALTHY CONTROL GROUP#0.6692;PROTEIN SYNTHESIS#0.6690;NEGATIVE LIKELIHOOD RATIO#0.6689;LUPUS NEPHRITIS#0.6678;LYMPHOID CELL#0.6625;ATHEROSCLEROSIS#0.6622;ACUTE PROMYELOCYTIC LEUKEMIA#0.6583;HEMOGLOBINURIA#0.6573;POSITIVE LIKELIHOOD RATIO#0.6572;INNATE IMMUNITY#0.6554;THROMBOCYTOPENIA#0.6541;TNF-ALPHA PRODUCTION#0.6479;INSULIN-LIKE GROWTH FACTOR#0.6406;MEDIAN FLUORESCENCE INTENSITY#0.6391;MYELOID CELL LINES#0.6389;LEUKOCYTE ACTIVATION#0.6362;TISSUE DAMAGE#0.6319;APPENDICITIS#0.6308;PERIPHERAL BLOOD LEUKOCYTE#0.6304;COLITIS#0.6300;LIPOPOLYSACCHARIDE RECEPTOR#0.6292;AREA UNDER CURVE#0.6275;HODGKIN'S LYMPHOMA#0.6265;NEUROBLASTOMA#0.6258;IMMATURE DENDRITIC CELL#0.6247;STROMAL CELL#0.6233;CORONARY ARTERY#0.6225;MAP KINASE#0.6210;SIGNALING MOLECULE#0.6208;DERMATITIS#0.6200;MACROPHAGE DIFFERENTIATION#0.6189;PROSTATE CANCER#0.6180;ANTIGEN BINDING#0.6165;DISEASE ACTIVITY INDEX#0.6153;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6123;LYMPHOCYTIC LEUKEMIA#0.6117;VIRAL PNEUMONIA#0.6102;INTERMEDIATE MONOCYTE#0.6096;MEMBRANE MICRODOMAIN#0.6081;HYPERSENSITIVITY#0.6066;NERVOUS SYSTEM#0.6059;TUMOR ASSOCIATED ANTIGEN#0.6034;KNEE JOINT#0.6033;ACUTE PANCREATITIS#0.6001
220	BREAST CANCER#1.0221;CANCER CELL#1.0062;INNER EAR#1.0029;STEM CELL MARKER#1.0017;CANCER STEM CELL#0.9971;RETINOIC ACID#0.9929;STEM CELL#0.9911;GENE EXPRESSION#0.9839;TRANSCRIPTION FACTOR#0.9560;SIGNALING PATHWAY#0.9558;VITAMIN A#0.9502;ALL TRANS RETINOIC ACID#0.9434;RETINOL#0.9372;POLYMERASE CHAIN REACTION#0.9343;BREAST CANCER CELL#0.9334;MICROPHTHALMIA#0.9197;APOPTOSIS#0.9155;CELL PROLIFERATION#0.9154;EYE DEVELOPMENT#0.9015;OPTIC CUP#0.8554;CELL CYCLE#0.8344;MESENCHYME#0.8241;EPITHELIAL CELL#0.8204;RETINAL DEHYDROGENASE#0.8180;PROSTATE CANCER#0.8118;LUNG CANCER#0.8030;PROGENITOR CELL#0.7904;SURFACE ECTODERM#0.7734;RETINOIC ACID RECEPTOR#0.7724;MORPHOGENESIS#0.7691;TUMOR CELLS#0.7498;DNA METHYLATION#0.7471;ADENOCARCINOMA#0.7360;PITUITARY GLAND#0.7326;ETHANOL#0.7074;CELL DEDIFFERENTIATION#0.7053;QUANTITATIVE REAL TIME#0.7009;OPTIC VESICLE#0.6993;CISPLATIN#0.6936;NEURAL RETINA#0.6930;CELL DEATH#0.6610;CELL ADHESION#0.6325;COLORECTAL CANCER#0.6324;CELL GROWTH#0.6204;HAIR CYCLE#0.6171;PANCREATIC ISLET#0.6113;FOREBRAIN#0.6110;HUMAN BREAST CANCER#0.6091;PANCREATIC CANCER#0.6090;DEDIFFERENTIATION#0.6067;GERM CELL#0.6026;LIPID METABOLISM#0.6021;BREAST CANCER PATIENTS#0.6020;DRUG RESISTANCE#0.6015
221035	METAPHASE#0.6867;NUCLEAR ENVELOPE#0.6630
221037	HISTONE DEMETHYLASE#1.0805;STEM CELL#0.9867;TRANSCRIPTION FACTOR#0.8860;INTELLECTUAL DISABILITY#0.8357;GENE EXPRESSION#0.8286;LYSINE#0.8219;DEMETHYLASE ACTIVITY#0.7178;ACUTE MYELOID LEUKEMIA#0.6480;MYELOID LEUKEMIA#0.6468;DNA REPAIR#0.6466;RETT SYNDROME#0.6318;AUTISM SPECTRUM DISORDER#0.6190;GERM CELL#0.6131;EMBRYONIC STEM CELL#0.6130
221044	VITAMIN K#1.0807;CHONDROCYTE#1.0134;MATRIX GLA PROTEIN#1.0086;OSTEOARTHRITIS#0.9945;MINERALIZATION#0.8085;OSTEOBLAST DIFFERENTIATION#0.7706;OSTEOBLAST#0.7607;SMOOTH MUSCLE#0.7535;EXTRACELLULAR VESICLE#0.7163;SMOOTH MUSCLE CELL#0.6437;MUSCLE CELL#0.6431;GENE EXPRESSION#0.6169;VASCULAR SMOOTH MUSCLE CELL#0.6148;EXTRACELLULAR MATRIX#0.6018
221061	ESTROGEN RECEPTOR#0.7486;BREAST CANCER#0.6463;CANCER CELL#0.6452
221074	ZINC UPTAKE#0.8771;NERVOUS SYSTEM#0.8480;PULMONARY HYPERTENSION#0.7381;NEURITE OUTGROWTH#0.6601;NERVOUS SYSTEM DEVELOPMENT#0.6571;SYSTEM DEVELOPMENT#0.6548;MOOD DISORDER#0.6042;CAMP RESPONSE ELEMENT BINDING#0.6003
221078	RNA METHYLTRANSFERASE#0.7468
221079	LYSOSOME#1.0013;KINESIN#0.9738;ENDOSOME#0.8713;AXONAL TRANSPORT#0.8478;RNA REPLICATION#0.7231;HOPS COMPLEX#0.6774;MICROTUBULE#0.6714;LATE ENDOSOME#0.6681;PHAGOLYSOSOME FORMATION#0.6523;GTP BINDING#0.6406
221092	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.6730
221120	PROSTATE CANCER ANTIGEN#1.1229;PROSTATE CANCER#1.1136;3-METHYLCYTOSINE#1.0510;CANCER CELL#1.0498;DNA REPAIR#1.0372;DNA REPAIR ENZYME#0.9790;CELL PROLIFERATION#0.9355;OXIDATIVE DEMETHYLATION#0.9185;DEMETHYLATION#0.9050;APOPTOSIS#0.8347;LUNG CANCER#0.8079;CELL CYCLE#0.8035;NUCLEIC ACID#0.7881;DNA ALKYLATION#0.7653;CELL CYCLE ARREST#0.7632;RNA REPAIR#0.7590;PROSTATE CARCINOMA#0.6235
221150	KINETOCHORE#1.0385;MICROTUBULE#0.9842;MITOSIS#0.8946;KINETOCHORE MICROTUBULE#0.8596;SPINDLE CHECKPOINT#0.8038;CELL CYCLE#0.7283;ANAPHASE#0.7154;MICROTUBULE BINDING#0.6980;COMPLEX I#0.6879;KINETOCHORE LOCALIZATION#0.6811;NDC80 COMPLEX#0.6679;KINETOCHORE-MICROTUBULE ATTACHMENT#0.6597;RNA INTERFERENCE#0.6415;SIGNALING PATHWAY#0.6338;CELL DIVISION#0.6334;BREAST CANCER#0.6268;METAPHASE#0.6065
221154	MITOCHONDRIAL CALCIUM UPTAKE#0.9174;MITOCHONDRIA#0.7716
221178	CELL MIGRATION#1.0805;NUCLEOTIDE EXCHANGE FACTOR#1.0723;GUANINE#0.9622;TUMOR CELLS#0.8639;ADENOMATOUS POLYPOSIS COLI#0.8517;COLORECTAL#0.8108;LEADING EDGE OF CELL#0.6717;CELL ADHESION#0.6418;SOCIAL BEHAVIOUR#0.6254;APC BINDING#0.6097;DENDRITIC SPINE#0.6016
221223	EPIDIDYMIS#0.7448;URINARY PROTEIN#0.6033
221264	ADENYLATE KINASE#0.8957;ADENYLATE#0.6970
2212	CETUXIMAB#1.0419;KAWASAKI DISEASE#1.0382;MALARIA#1.0242;COMPLEMENT RECEPTOR#1.0239;RITUXIMAB#1.0113;B CELL#1.0035;POLYMERASE CHAIN REACTION#1.0033;LUPUS NEPHRITIS#1.0030;NEUTROPHIL#1.0008;PLATELET ACTIVATION#1.0000;TRASTUZUMAB#0.9997;EOSINOPHIL#0.9994;THROMBOCYTOPENIA#0.9983;RHEUMATOID ARTHRITIS#0.9967;IMMUNOGLOBULIN G#0.9962;COLORECTAL CANCER#0.9957;TOLL LIKE RECEPTOR#0.9945;IFN-GAMMA#0.9914;PHAGOCYTOSIS#0.9900;SIGNAL TRANSDUCTION#0.9894;MONOCYTE#0.9893;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9882;LUPUS ERYTHEMATOSUS#0.9873;COPY NUMBER VARIATION#0.9868;ENDOTHELIAL CELL#0.9865;T CELL#0.9863;BREAST CANCER#0.9862;TUMOR NECROSIS FACTOR#0.9859;MACROPHAGE#0.9848;DENDRITIC CELL#0.9828;AUTOIMMUNE DISEASE#0.9823;GENE EXPRESSION#0.9785;GROWTH FACTOR#0.9775;HISTIDINE#0.9763;CYTOTOXICITY#0.9755;GRANULOCYTE#0.9753;MONONUCLEAR CELLS#0.9740;CELL SURFACE#0.9738;GM-CSF#0.9736;LEUKOCYTE#0.9725;NEPHRITIS#0.9720;PERIPHERAL BLOOD#0.9717;CELL ACTIVATION#0.9704;COLORECTAL#0.9697;POLYMORPHONUCLEAR NEUTROPHIL#0.9695;C REACTIVE PROTEIN#0.9655;BONE MARROW#0.9648;ARGININE#0.9647;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9588;IMMUNE RESPONSE#0.9582;PLASMA MEMBRANE#0.9574;COLONY-STIMULATING FACTOR#0.9571;NATURAL KILLER CELL#0.9569;ULCERATIVE COLITIS#0.9569;CELL ADHESION#0.9549;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9513;ERYTHROCYTE#0.9511;INFLAMMATORY RESPONSE#0.9475;CD4+ T CELL#0.9459;IMMUNE CELL#0.9366;IGG BINDING#0.9321;RESPIRATORY BURST#0.9306;PERIPHERAL BLOOD MONOCYTES#0.9298;MYELOID CELL#0.9278;SCAVENGER RECEPTOR#0.9276;SIGNALING PATHWAY#0.9258;NEUTROPHIL ACTIVATION#0.9177;METASTATIC COLORECTAL CANCER#0.9159;CYTOKINE PRODUCTION#0.9102;BASOPHIL#0.9100;INTRAVENOUS IMMUNOGLOBULIN#0.9054;THROMBOSIS#0.9044;IMMUNE SYSTEM#0.9033;HEPARIN#0.8996;G-CSF#0.8986;B LYMPHOCYTE#0.8966;FOLLICULAR LYMPHOMA#0.8879;TOXICITY#0.8824;VASCULITIS#0.8820;PRO-INFLAMMATORY#0.8783;PROTEIN KINASE#0.8782;APOPTOTIC#0.8765;HEPARIN INDUCED THROMBOCYTOPENIA#0.8743;KINASE INHIBITOR#0.8704;SELECTIN#0.8653;APOPTOSIS#0.8643;CELL PROLIFERATION#0.8554;HEMATOPOIETIC CELL#0.8540;COLITIS#0.8539;REACTIVE OXYGEN SPECIES#0.8454;PLATELET AGGREGATION#0.8403;T LYMPHOCYTE#0.8357;MAST CELL#0.8256;PERIODONTITIS#0.8202;PROTEIN TYROSINE KINASE#0.8144;CROHN'S DISEASE#0.8064;POLYMORPHONUCLEAR LEUKOCYTES#0.7968;HUMAN IMMUNODEFICIENCY VIRUS#0.7962;KINASE ACTIVITY#0.7956;PHOSPHOLIPASE C#0.7934;EPITHELIAL CELL#0.7912;GRANULOCYTE COLONY STIMULATING FACTOR#0.7850;INFLAMMATORY CELL#0.7819;RED BLOOD CELL#0.7777;STEM CELL#0.7697;ANTIGEN PRESENTATION#0.7683;OXIDATIVE BURST#0.7633;GROWTH FACTOR RECEPTOR#0.7625;LIPID RAFT#0.7577;ATHEROSCLEROSIS#0.7475;PLASMACYTOID DENDRITIC CELL#0.7462;IGG ANTIBODY#0.7454;TYROSINE KINASE INHIBITOR#0.7384;ARTERY#0.7300;ACTIN POLYMERIZATION#0.7284;T CELL PROLIFERATION#0.7249;TRANSFORMING GROWTH FACTOR#0.7203;PURPURA#0.7192;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7169;COMPLEMENT RECEPTOR 3#0.7142;IMMUNE THROMBOCYTOPENIC PURPURA#0.7063;PROGENITOR CELL#0.6972;OPSONIN RECEPTOR#0.6968;AUTOIMMUNITY#0.6881;EPIDERMAL GROWTH FACTOR#0.6821;VALINE#0.6765;NADPH OXIDASE#0.6747;TUMOUR NECROSIS FACTOR#0.6735;LOW DENSITY LIPOPROTEIN#0.6699;CELL ADHESION MOLECULE#0.6682;PNEUMONIA#0.6678;CALCIUM MOBILIZATION#0.6637;ENDOCYTOSIS#0.6633;CORONARY ARTERY#0.6553;MEGAKARYOCYTE#0.6511;INFLAMMATORY BOWEL DISEASE#0.6507;COMPLEMENT ACTIVATION#0.6488;LYMPH NODE#0.6461;DIGESTION#0.6459;TRANSCRIPTASE#0.6398;ADALIMUMAB#0.6393;IMMUNE COMPLEX CLEARANCE#0.6316;N GLYCAN#0.6311;WHITE BLOOD CELL#0.6277;BETA-2#0.6268;REVERSE TRANSCRIPTION#0.6243;RECEPTOR ANTAGONIST#0.6239;MITOGEN ACTIVATED PROTEIN#0.6207;CANCER CELL#0.6201;LYSOSOME#0.6180;LANGERHANS CELL#0.6167;BREAST CANCER PATIENTS#0.6123;MENINGITIS#0.6063;IL-1RA#0.6038;INTERLEUKIN 1 RECEPTOR#0.6038;VITAMIN D RECEPTOR#0.6036;MICROGLIAL CELL#0.6036;DENGUE HEMORRHAGIC FEVER#0.6017;ANTIGEN PRESENTING CELLS#0.6011
221302	UBIQUITIN#0.6802;POLYUBIQUITIN#0.6381
221322	CILIARY MEMBRANE#0.7678
221336	NEURAL STEM CELL#0.7248;STEM CELL#0.7096
221357	GLUTATHIONE#1.0205;ALDEHYDE REDUCTASE#0.6112
221391	OPSIN#1.0973;GANGLION CELLS#0.8137;RETINAL GANGLION CELL#0.7760;GENE EXPRESSION#0.6989
221395	ENDOTHELIAL CELL#0.8441;BREAST CANCER#0.8352;SURFACTANT HOMEOSTASIS#0.7580;CELL MIGRATION#0.6409;TYPE 2 IMMUNE RESPONSE#0.6102
2213	B CELL RECEPTOR#1.0287;B CELL ACTIVATION#1.0165;CELL ACTIVATION#1.0134;B LYMPHOCYTE#1.0096;B CELL#1.0073;MAST CELL#1.0061;NEUTROPHIL#1.0048;MACROPHAGE#1.0026;MONOCYTE#0.9978;COMPLEMENT RECEPTOR#0.9957;CELL SURFACE#0.9921;DENDRITIC CELL#0.9915;CELL PROLIFERATION#0.9914;AUTOIMMUNE DISEASE#0.9900;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9835;LUPUS ERYTHEMATOSUS#0.9833;T CELL#0.9831;ENDOTHELIAL CELL#0.9830;PERIPHERAL BLOOD#0.9800;IMMUNE RESPONSE#0.9738;IMMUNOGLOBULIN G#0.9641;GROWTH FACTOR#0.9612;BONE MARROW#0.9560;PHAGOCYTOSIS#0.9557;RHEUMATOID ARTHRITIS#0.9549;POLYMERASE CHAIN REACTION#0.9519;TUMOR NECROSIS FACTOR#0.9492;MONONUCLEAR CELLS#0.9461;AUTOIMMUNITY#0.9401;SIGNAL TRANSDUCTION#0.9398;SIGNALING PATHWAY#0.9277;COPY NUMBER VARIATION#0.9238;IMMUNE SYSTEM#0.9234;LEUKOCYTE#0.9216;GERMINAL CENTER#0.9208;CYTOTOXICITY#0.9046;GRANULOCYTE#0.8912;PLASMA CELL#0.8871;IFN-GAMMA#0.8836;CD4+ T CELL#0.8830;GENE EXPRESSION#0.8795;IMMUNE CELL#0.8577;ANTIBODY PRODUCTION#0.8516;